Pattern Comp All CDB Nci60 Exp TERT Moldata

Data Type ID Location Correlation P-Value FDR Annotation
exp TERT 5p15.33 1 0 0 DNA Damage Response (DDR)

xai TERT 5p15.33 0.997 1.75e-64 1.46e-59 DNA Damage Response (DDR)
xsq TERT 5p15.33 0.837 7.47e-17 4.17e-12 DNA Damage Response (DDR)
xsq TAF4B 18q11.2 0.598 4.55e-07 0.019 viral reproduction;transcription
initiation, DNA-dependent
xai TAF4B 18q11.2 0.597 5.86e-07 0.0196 viral
reproduction;transcription initiation, DNA-dependent
exp TAF4B 18q11.2 0.587 8.03e-07 0.0224 viral
reproduction;transcription initiation, DNA-dependent
xai SH2D3C 9q34.11 0.587 1.05e-06 0.0251 JNK cascade;small GTPase
mediated signal transduction
xsq KLRG1 12p13.31 0.576 1.49e-06 0.0313 inflammatory
response;cellular defense response
mut SLC5A4 22q12.3 0.565 2.6e-06 0.038 Solute Carriers
exp MBNL2 13q32.1 -0.561 3.2e-06 0.038 mRNA processing;regulation of
RNA splicing
mut MMP15 16q13 0.559 3.39e-06 0.038 Apoptosis
swa CTNNA1 5q31.2 -0.563 3.5e-06 0.038 Apoptosis; Tumor
Suppressors
xsq PIK3R5 17p13.1 0.558 3.63e-06 0.038 Protein Kinases
xai HNRNPA1P37 0.562 3.67e-06 0.038
swa EPHX1 1q42.1 -0.56 3.99e-06 0.038 response to toxin;response to
organic cyclic compound
xai MBNL2 13q32.1 -0.559 4.13e-06 0.038 mRNA processing;regulation of
RNA splicing
xsq FARP1 13q32.2 -0.555 4.21e-06 0.038 negative regulation of
phosphatase activity;regulation of Rho protein signal transduction
xsq CYTH4 22q12.3-q13.1 0.554 4.46e-06 0.038 regulation of ARF protein
signal transduction;regulation of cell adhesion
exp FARP1 13q32.2 -0.552 4.84e-06 0.038 negative regulation of
xai BCL11A 2p16.1 0.556 4.88e-06 0.038 positive regulation of neuron
projection development;positive regulation of transcription from RNA polymerase II
promoter
exp SNRPD1 18q11.2 0.551 5.09e-06 0.038 ncRNA metabolic
process;spliceosome assembly
xai FARP1 13q32.2 -0.554 5.4e-06 0.038 negative regulation of
xai CXXC4 4q22-q24 0.554 5.44e-06 0.038 zygotic specification of
dorsal/ventral axis;negative regulation of Wnt receptor signaling pathway
exp WWC2 4q35.1 -0.549 5.57e-06 0.038
exp CXXC4 4q22-q24 0.549 5.69e-06 0.038 zygotic specification of
exp SH2D3C 9q34.11 0.548 5.98e-06 0.038 JNK cascade;small GTPase
mut ABCB5 7p21.1 0.547 6.12e-06 0.038 ABC Transporters
exp BCL11A 2p16.1 0.546 6.46e-06 0.0381 positive regulation of
neuron projection development;positive regulation of transcription from RNA
polymerase II promoter
xai GZMA 5q11-q12 0.549 6.59e-06 0.0381 cleavage of lamin;immune
response
xai CD37 19q13.3 0.548 7.17e-06 0.0397 positive regulation of
immunoglobulin production;regulation of humoral immune response
xai SNRPD1 18q11.2 0.547 7.36e-06 0.0397 ncRNA metabolic
exp RBMXP2 9p21.1 0.542 7.65e-06 0.0397
xai PUS1 12q24.33 0.546 7.82e-06 0.0397 tRNA processing;metabolic
process
xai RPIA 2p11.2 0.544 8.43e-06 0.0416 carbohydrate metabolic
process;pentose-phosphate shunt
hs4 TERT 5p15.33 0.543 8.78e-06 0.042 DNA Damage Response (DDR)
met PC 11q13.4-q13.5 0.538 9.16e-06 0.0426 carbohydrate metabolic
process;glucose metabolic process
xai CTRL 16q22.1 0.54 1.03e-05 0.0463 proteolysis;digestion
exp HNRNPA1P55 4q13.3 0.539 1.05e-05 0.0463
xsq CXXC4 4q22-q24 0.535 1.09e-05 0.0466 zygotic specification of
xsq CD37 19q13.3 0.532 1.21e-05 0.0495 positive regulation of
met TGIF1 18p11.3 0.531 1.25e-05 0.0495 negative regulation of cell
proliferation;cellular response to growth factor stimulus
xsq BCL11A 2p16.1 0.531 1.26e-05 0.0495 positive regulation of
his KU-MEL-3 6p25.1 -0.535 1.27e-05 0.0495
met BMPR1A 10q22.3 0.529 1.42e-05 0.0535 Apoptosis
exp RASAL2 1q24 -0.528 1.47e-05 0.0535 signal
transduction;positive regulation of Ras GTPase activity
exp PUS1 12q24.33 0.527 1.5e-05 0.0535 tRNA processing;metabolic
process
exp RPIA 2p11.2 0.527 1.5e-05 0.0535 carbohydrate metabolic
xai ORC1 1p32 0.53 1.56e-05 0.0542 DDR (DNA replication)
xsq S100A13 1q21 -0.526 1.59e-05 0.0542 positive regulation of
I-kappaB kinase/NF-kappaB cascade;mast cell degranulation
met RBFOX2 22q13.1 0.525 1.67e-05 0.0548 RNA splicing;regulation
of definitive erythrocyte differentiation
xai HNRNPA1P3 20q13.12 0.529 1.69e-05 0.0548
xsq CHRNA9 4p14 0.524 1.73e-05 0.0548 ion transport;elevation of
cytosolic calcium ion concentration
met LOC100271836 0.524 1.73e-05 0.0548
exp CD37 19q13.3 0.523 1.84e-05 0.0568 positive regulation of
xai HNRNPA1P55 4q13.3 0.526 1.87e-05 0.0568
xai RASAL2 1q24 -0.526 1.91e-05 0.057 signal transduction;positive
regulation of Ras GTPase activity
xai CPXM1 20p13 0.524 2.05e-05 0.0601 proteolysis;cell adhesion
met MOV10 1p13.2 0.519 2.17e-05 0.0627 regulation of transcription,
DNA-dependent;gene silencing by RNA
exp ASAP2 2p25 -0.518 2.26e-05 0.0642 regulation of ARF GTPase
activity;positive regulation of catalytic activity
xai ASAP2 2p25 -0.52 2.41e-05 0.0672 regulation of ARF GTPase
xsq FAM72B 0.515 2.57e-05 0.0707
exp HNRNPA1P12 5q14.1 0.514 2.65e-05 0.0714
exp ANP32A 15q23 0.514 2.71e-05 0.0714 regulation of transcription,
DNA-dependent;nucleocytoplasmic transport
xai SMPD3 16q22.1 0.517 2.77e-05 0.0714 sphingomyelin catabolic
process;glycosphingolipid metabolic process
exp PCED1B-AS1 12q13.11 0.513 2.78e-05 0.0714
xsq SIGLEC10 19q13.3 0.513 2.81e-05 0.0714 cell adhesion
exp CTRL 16q22.1 0.512 2.88e-05 0.0721 proteolysis;digestion
xai EXOSC2 9q34 0.515 2.96e-05 0.073 positive regulation of cell
growth;exonucleolytic nuclear-transcribed mRNA catabolic process involved in
deadenylation-dependent decay
xai SH3BP4 2q37.1-q37.2 -0.515 3.01e-05 0.0731 endocytosis
met MBOAT2 2p25.1 0.51 3.13e-05 0.0749 phospholipid
biosynthetic process
met SHROOM1 5q31.1 -0.509 3.29e-05 0.0775 cell
morphogenesis;actin filament bundle assembly
exp PDE1B 12q13 0.508 3.38e-05 0.078 signal transduction;cellular response to
macrophage colony-stimulating factor stimulus
met GLTSCR1 19q13.3 0.508 3.4e-05 0.078
xsq CD300A 17q25.1 0.508 3.45e-05 0.0781 cell adhesion
exp CPXM1 20p13 0.507 3.51e-05 0.0781 proteolysis;cell adhesion
xai RBMXP2 9p21.1 0.51 3.63e-05 0.0781
exp PRIM1 12q13 0.506 3.66e-05 0.0781 DDR (DNA replication)
swa AP2A1 19q13.33 -0.51 3.71e-05 0.0781 epidermal growth factor
receptor signaling pathway;synaptic transmission
exp HNRNPA1L2 13q14.3 0.506 3.76e-05 0.0781 RNA splicing;mRNA
transport
exp SH3BP4 2q37.1-q37.2 -0.505 3.85e-05 0.0781 endocytosis
hs4 ZNF469 16q24 0.509 3.86e-05 0.0781 regulation of transcription,
DNA-dependent"
xsq SIGLEC12 19q13.4 0.505 3.88e-05 0.0781 cell adhesion
xai NFATC3 16q22.2 0.509 3.92e-05 0.0781 regulation of
transcription from RNA polymerase II promoter;cellular response to lithium ion
exp ORC1 1p32 0.504 3.98e-05 0.0781 DDR (DNA replication)
hs4 COL8A2 1p34.2 0.508 4.03e-05 0.0781 angiogenesis;cell-cell
adhesion
xai PRIM1 12q13 0.508 4.05e-05 0.0781 DDR (DNA replication)
xsq SH2D3C 9q34.11 0.504 4.08e-05 0.0781 JNK cascade;small GTPase
exp RBMXP1 6p12.3 0.507 4.19e-05 0.0781
exp CTNND1 11q11 -0.503 4.2e-05 0.0781 morphogenesis of a
polarized epithelium;adherens junction organization
exp NSF 17q21 0.503 4.23e-05 0.0781 plasma membrane fusion;positive
regulation of receptor recycling
met GALNT11 7q36.1 0.503 4.24e-05 0.0781 O-glycan
processing;post-translational protein modification
xai CD300A 17q25.1 0.506 4.34e-05 0.0789 cell adhesion
xai S100A13 1q21 -0.505 4.47e-05 0.0799 positive regulation of
xai PDE1B 12q13 0.505 4.54e-05 0.0799 signal transduction;cellular
response to macrophage colony-stimulating factor stimulus
his BCL11A 2p16.1 0.504 4.63e-05 0.0799 positive regulation of
exp CEP83 0.5 4.69e-05 0.0799
xsq KIR2DL1 0.5 4.78e-05 0.0799 natural killer cell
inhibitory signaling pathway;immune response
exp GZMA 5q11-q12 0.5 4.83e-05 0.0799 cleavage of lamin;immune
response
xai RBMXP1 6p12.3 0.503 4.84e-05 0.0799
exp HNRNPA1P66 2p15 0.499 4.86e-05 0.0799
exp CDC25A 3p21 0.499 4.89e-05 0.0799 DNA Damage Response (DDR);
DDR (DNA replication); DDR (G2-M checkpoint); Oncogenes
mut TMC5 16p12.3 0.499 4.94e-05 0.0799
xsq IQGAP2 5q13.3 0.498 5.07e-05 0.0799 signal
transduction;regulation of small GTPase mediated signal transduction
xai KLHL8 4q22.1 0.502 5.11e-05 0.0799
xai PIK3R5 17p13.1 0.502 5.12e-05 0.0799 Protein Kinases
xai HNRNPA1L2 13q14.3 0.502 5.21e-05 0.0799 RNA splicing;mRNA
transport
exp PSMA8 18q11.2 0.498 5.24e-05 0.0799 antigen processing and
presentation of peptide antigen via MHC class I;RNA metabolic process
hs4 CD300A 17q25.1 0.501 5.29e-05 0.0799 cell adhesion
xsq KCNK17 6p21.1 0.497 5.29e-05 0.0799 ion transport;potassium
ion transport
xai CCT7 2p13.2 0.501 5.41e-05 0.0799 protein folding;cellular
protein metabolic process
xsq E2F2 1p36 0.497 5.41e-05 0.0799 Tumor Suppressors
xai HIST3H3 1q42 0.5 5.47e-05 0.0799 telomere
maintenance;nucleosome assembly
exp KLHL8 4q22.1 0.496 5.49e-05 0.0799
exp FAM72D 0.496 5.51e-05 0.0799
exp RPL34-AS1 4q25 0.5 5.53e-05 0.0799
xsq NCKAP1L 12q13.1 0.496 5.53e-05 0.0799 myeloid cell
homeostasis;negative regulation of interleukin-6 production
xsq PDE1B 12q13 0.496 5.6e-05 0.0801 signal transduction;cellular
response to macrophage colony-stimulating factor stimulus
xai RPL34-AS1 4q25 0.499 5.79e-05 0.0821
xai CD79A 19q13.2 0.498 5.94e-05 0.0821 B cell differentiation;B cell
proliferation
xai CDC25A 3p21 0.498 5.96e-05 0.0821 DNA Damage Response (DDR);
xai NCKAP1L 12q13.1 0.498 5.97e-05 0.0821 myeloid cell
swa NPC2 14q24.3 -0.498 6.09e-05 0.0821 phospholipid
transport;regulation of isoprenoid metabolic process
his LOC101929468 0.497 6.15e-05 0.0821
his CXXC4 4q22-q24 0.497 6.15e-05 0.0821 zygotic specification of
xai NKRF Xq24 0.497 6.16e-05 0.0821 negative regulation of
transcription, DNA-dependent"
exp NCKAP1L 12q13.1 0.493 6.22e-05 0.0821 myeloid cell
exp NKRF Xq24 0.493 6.28e-05 0.0821 negative regulation of
exp PIK3R5 17p13.1 0.493 6.28e-05 0.0821 Protein Kinases
xsq EMBP1 1p11.2 0.492 6.44e-05 0.0821
exp LMNA 1q22 -0.492 6.47e-05 0.0821 establishment or maintenance
of microtubule cytoskeleton polarity;apoptotic process
exp HIST1H2BPS3 0.496 6.51e-05 0.0821
xai HIST1H2BPS3 0.496 6.54e-05 0.0821
mut IL17RE 3p25.3 0.492 6.57e-05 0.0821
xsq S1PR4 19p13.3 0.492 6.57e-05 0.0821 elevation of cytosolic
calcium ion concentration;immune response
xai NSF 17q21 0.494 6.88e-05 0.0841 plasma membrane fusion;positive
xsq SH3BP4 2q37.1-q37.2 -0.491 6.91e-05 0.0841 endocytosis
exp RBBP4P2 0.494 6.92e-05 0.0841
exp ATG10 5q14.1 0.49 7.06e-05 0.0841 positive regulation of
protein modification process;protein modification by small protein conjugation
exp HNRNPA1P4 8q21.13 0.49 7.1e-05 0.0841
exp HIST1H4I 0.494 7.14e-05 0.0841
xai CEP83 0.493 7.24e-05 0.0841
xai HIST1H4I 0.493 7.25e-05 0.0841
xai RBBP4 1p35.1 0.493 7.29e-05 0.0841 CenH3-containing nucleosome
assembly at centromere;mitotic cell cycle
met DOCK6 19p13.2 0.489 7.32e-05 0.0841 blood coagulation
hs4 PHLDA3 1q31 -0.493 7.35e-05 0.0841 negative regulation of
protein kinase B signaling cascade;apoptotic process
xsq P2RX1 17p13.3 0.489 7.36e-05 0.0841 insemination;purinergic
nucleotide receptor signaling pathway
exp SPECC1 17p11.2 -0.489 7.38e-05 0.0841
exp CD79A 19q13.2 0.489 7.49e-05 0.0848 B cell differentiation;B cell
proliferation
exp TCP1P1 7p14.1 0.488 7.69e-05 0.0848
hs4 CENPVL1 0.491 7.81e-05 0.0848
xai ANP32A 15q23 0.491 7.93e-05 0.0848 regulation of transcription,
DNA-dependent;nucleocytoplasmic transport
xai HNRNPA1P12 5q14.1 0.491 7.96e-05 0.0848
xai TLR9 3p21.3 0.491 7.98e-05 0.0848 negative regulation of
interleukin-8 production;positive regulation of tumor necrosis factor production
xai RBBP4P2 0.491 8e-05 0.0848
xai BLM 15q26.1 0.49 8.04e-05 0.0848 DNA Damage Response (DDR);
DDR (FA)
his MIR6827 -0.49 8.22e-05 0.0848
his AMOTL2 3q21-q22 -0.49 8.22e-05 0.0848
xai LMNA 1q22 -0.489 8.34e-05 0.0848 establishment or maintenance
of microtubule cytoskeleton polarity;apoptotic process
xai TRBV2 7q34 0.489 8.37e-05 0.0848
met CMAHP 6p21.32 -0.489 8.45e-05 0.0848
swa ARHGDIB 12p12.3 0.489 8.47e-05 0.0848 multicellular organismal
development;actin cytoskeleton organization
xai PSMA8 18q11.2 0.489 8.47e-05 0.0848 antigen processing and
hs4 OXT 20p13 0.489 8.49e-05 0.0848 maternal aggressive
behavior;response to sucrose stimulus
his P2RY1 3q25.2 0.489 8.5e-05 0.0848 response to mechanical
stimulus;positive regulation of ion transport
xai HNRNPA1P35 2q33.1 0.489 8.63e-05 0.0848
xsq CD79A 19q13.2 0.485 8.67e-05 0.0848 B cell differentiation;B cell
proliferation
exp SMPD3 16q22.1 0.484 8.77e-05 0.0848 sphingomyelin catabolic
swa HPRT1 Xq26.1 0.488 8.83e-05 0.0848 spermatogenesis;central
nervous system neuron development
xai CPSF3 2p25.1 0.488 8.84e-05 0.0848 nuclear mRNA splicing, via
spliceosome;RNA splicing
xsq AMY1C 0.484 9e-05 0.0848
xsq KIR2DL3 0.484 9.01e-05 0.0848 immune response;regulation of
immune response
exp CPSF3 2p25.1 0.484 9.01e-05 0.0848 nuclear mRNA splicing, via
xsq RASA4CP 0.484 9.04e-05 0.0848
exp LOC647070 1q25.3 0.484 9.09e-05 0.0848
xsq SAMSN1 21q11 0.484 9.09e-05 0.0848 negative regulation of
peptidyl-tyrosine phosphorylation;negative regulation of B cell activation
xai HIST2H2AB 0.487 9.19e-05 0.0848 nucleosome assembly
xai SIN3A 15q24.2 0.487 9.21e-05 0.0848 in utero embryonic
development;cellular lipid metabolic process
met EPN2 17p11.2 0.483 9.45e-05 0.0848 regulation of endocytosis
xai SPECC1 17p11.2 -0.486 9.49e-05 0.0848
xai HNRNPA1P60 11q23.1 0.486 9.51e-05 0.0848
exp BLM 15q26.1 0.482 9.51e-05 0.0848 DNA Damage Response (DDR);
DDR (FA)
exp RBBP4P4 6p11.2 0.482 9.53e-05 0.0848
hs4 ADGRE2 0.486 9.64e-05 0.0848 G-protein coupled receptor
signaling pathway;neuropeptide signaling pathway
xsq RPIA 2p11.2 0.481 9.83e-05 0.0848 carbohydrate metabolic
his PREB 2p23.3 0.485 9.84e-05 0.0848 cellular membrane
organization;vesicle-mediated transport
hs4 PLK2 5q12.1-q13.2 -0.485 9.86e-05 0.0848 Protein Kinases
xai LRMP 12p12.1 0.485 0.000101 0.0848 vesicle targeting;vesicle
fusion
xai CD38 4p15 0.484 0.000102 0.0848 response to hormone
stimulus;response to drug
xai RPS4XP1 12q23.1 0.484 0.000102 0.0848
exp ACTN4 19q13 -0.48 0.000103 0.0848 Apoptosis
xai C12orf57 12p13.31 0.484 0.000105 0.0848
exp HNRNPA1P3 20q13.12 0.48 0.000106 0.0848
exp MYC 8q24.21 0.479 0.000106 0.0848 Apoptosis; Oncogenes; Protein
Kinases
exp HNRNPCP2 0.479 0.000106 0.0848
xai SPAG1 8q22.2 -0.483 0.000106 0.0848 single fertilization
xai TCP1P1 7p14.1 0.483 0.000107 0.0848
xsq RGS18 1q31.2 0.479 0.000107 0.0848 regulation of G-protein
coupled receptor protein signaling pathway;negative regulation of signal
transduction
xsq CD53 1p13 0.479 0.000107 0.0848 signal transduction
xsq HAR1A 20q13.33 0.479 0.000107 0.0848
xai CCDC86 11q12.2 0.483 0.000108 0.0848 interspecies interaction
between organisms
exp TRBV2 7q34 0.483 0.000108 0.0848
exp NFATC3 16q22.2 0.479 0.000108 0.0848 regulation of
transcription from RNA polymerase II promoter;cellular response to lithium ion
exp CAST 5q15 -0.479 0.000108 0.0848 negative regulation of
endopeptidase activity
xai DDX51 12q24.33 0.483 0.000109 0.0848 rRNA processing
exp C12orf57 12p13.31 0.479 0.000109 0.0848
swa PFDN2 1q23.3 0.482 0.00011 0.0848 protein folding;cellular
xsq CREB3L3 19p13.3 0.479 0.00011 0.0848 response to unfolded
protein
xsq STAP1 4q13.2 0.478 0.00011 0.0848 intracellular protein
transport;cellular membrane fusion
hs4 NCKAP1L 12q13.1 0.482 0.000112 0.0848 myeloid cell
xai CCR4 3p24 0.482 0.000112 0.0848 neuron migration;tolerance
induction
exp CD300A 17q25.1 0.478 0.000112 0.0848 cell adhesion
xai CTNND1 11q11 -0.482 0.000112 0.0848 morphogenesis of a
exp S100A13 1q21 -0.478 0.000113 0.0848 positive regulation of
xsq SH2D2A 1q21 0.478 0.000114 0.0848 multicellular organismal
development;cell differentiation
exp ST8SIA4 5q21 0.478 0.000114 0.0848 oligosaccharide metabolic
process;ganglioside biosynthetic process
xai ZFP36L1 14q22-q24 -0.481 0.000114 0.0848 mRNA metabolic
process;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
xai LOC647070 1q25.3 0.481 0.000115 0.0848
xai P2RY8 Xp22.33 0.481 0.000115 0.0848
exp SIGLEC10 19q13.3 0.481 0.000116 0.0848 cell adhesion
xsq BIN2 0.477 0.000116 0.0848
xsq ITGAL 16p11.2 0.477 0.000116 0.0848 cell adhesion;regulation of
immune response
xai RPS4XP3 20q13.31 0.481 0.000117 0.0848
exp TCP1 6q25.3-q26 0.477 0.000117 0.0848 protein folding;tubulin
complex assembly
exp VRK1 14q32 0.477 0.000117 0.0848 Golgi disassembly;protein
phosphorylation
xai LAIR1 19q13.4 0.48 0.000118 0.0848
xai PLK2 5q12.1-q13.2 -0.48 0.000118 0.0848 Protein Kinases
exp RBBP4 1p35.1 0.476 0.000119 0.0848 CenH3-containing nucleosome
xai ATG10 5q14.1 0.48 0.00012 0.0848 positive regulation of
protein modification process;protein modification by small protein conjugation
xai PTCHD2 1p36.22 0.48 0.000121 0.0848 smoothened signaling
pathway;regulation of lipid transport
exp CORO1A 16p11.2 0.476 0.000121 0.0848 phagocytosis;cell-
substrate adhesion
xsq TMC8 17q25.3 0.476 0.000121 0.0848
xai OAT 10q26 -0.48 0.000121 0.0848 cellular nitrogen compound
metabolic process;small molecule metabolic process
exp RPS12P5 3p24.1 -0.476 0.000122 0.0848
xai ACTN4 19q13 -0.48 0.000122 0.0848 Apoptosis
xsq SLC11A1 2q35 0.476 0.000123 0.0848 protein import into nucleus,
translocation;iron ion transport
xsq PRSS57 19p13.3 0.475 0.000123 0.0848 proteolysis
xsq RASAL2 1q24 -0.475 0.000123 0.0848 signal
exp TSPAN9 12p13.33-p13.32 -0.476 0.000123 0.0848
hs4 LINC02139 -0.479 0.000123 0.0848
xai SEPT6 Xq24 0.479 0.000124 0.0848 cytokinesis;cell cycle
xai RBBP4P4 6p11.2 0.479 0.000124 0.0848
xsq CPXM1 20p13 0.475 0.000124 0.0848 proteolysis;cell adhesion
mut MAU2 19p13.11 0.475 0.000124 0.0848 cell cycle;chromosome
segregation
exp LAIR1 19q13.4 0.475 0.000124 0.0848
exp PAPOLG 2p16.1 0.475 0.000125 0.0848 transcription, DNA-
dependent;mRNA processing
exp CCR4 3p24 0.475 0.000125 0.0848 neuron migration;tolerance
induction
hs4 PPP2R3A 3q22.1 -0.479 0.000125 0.0848 protein
dephosphorylation
xsq DOK2 8p21.3 0.475 0.000126 0.0848 signal transduction;cell
surface receptor signaling pathway
exp RPLP0P7 2q24.1 0.478 0.000127 0.0848
xai RPL7AP66 18q12.2 0.478 0.000128 0.0848
xai TAF5 10q24-q25.2 0.478 0.000128 0.0848 viral reproduction;chromatin
modification
exp SIN3A 15q24.2 0.474 0.000128 0.0848 in utero embryonic
exp PLK2 5q12.1-q13.2 -0.474 0.000128 0.0848 Protein Kinases
xai CORO1A 16p11.2 0.478 0.000129 0.0849 phagocytosis;cell-
substrate adhesion
met HRCT1 9p13.3 0.474 0.00013 0.0849
exp DDX51 12q24.33 0.474 0.00013 0.0849 rRNA processing
exp CCT7 2p13.2 0.474 0.000131 0.0849 protein folding;cellular
exp HMHB1 5q31.3 0.474 0.000131 0.0849
xai CAST 5q15 -0.477 0.000132 0.0854 negative regulation of
xai VRK1 14q32 0.477 0.000134 0.086 Golgi disassembly;protein phosphorylation
swa LAMTOR2 1q22 -0.477 0.000134 0.086 cell growth;positive
regulation of TOR signaling cascade
exp HNRNPA1P35 2q33.1 0.477 0.000135 0.086
exp FAM129B 9q34.13 -0.473 0.000135 0.086 negative regulation of
apoptotic process
mut PIWIL4 11q21 0.473 0.000136 0.0861 gene silencing by RNA;piRNA
metabolic process
exp HIST2H2AB 0.473 0.000136 0.0861 nucleosome assembly
exp LRMP 12p12.1 0.473 0.000137 0.0861 vesicle targeting;vesicle
fusion
xsq NKG7 19q13.41 0.472 0.00014 0.0872
exp MEMO1P1 0.472 0.00014 0.0872
xai HNRNPA1P15 0.476 0.000141 0.0872
mut AGTPBP1 9q21.33 0.472 0.000141 0.0872
proteolysis;neuromuscular process
xsq FGF14-AS2 13q33.1 0.472 0.000141 0.0873
exp OAT 10q26 -0.472 0.000143 0.0875 cellular nitrogen compound
xai UBL7-AS1 0.475 0.000144 0.0875
xai S1PR4 19p13.3 0.475 0.000145 0.0875 elevation of cytosolic
xsq CECR1 22q11.2 0.471 0.000145 0.0875 adenosine catabolic
process;multicellular organismal development
xai TBP 6q27 0.475 0.000146 0.0875 transcription from RNA polymerase
III promoter;spermatogenesis
exp EXOSC2 9q34 0.471 0.000146 0.0875 positive regulation of cell
xsq RASGRP4 19q13.1 0.471 0.000146 0.0875 myeloid cell
differentiation;positive regulation of Ras protein signal transduction
exp ZFP36L1 14q22-q24 -0.471 0.000146 0.0875 mRNA metabolic
xai PCED1B-AS1 12q13.11 0.474 0.000147 0.0875
xai ADAT2 6q24.2 0.474 0.000147 0.0875 tRNA processing
xsq FAM86C2P 11q13.2 0.471 0.000148 0.0875
xsq ACAP1 17p13.1 0.471 0.000148 0.0875 regulation of ARF GTPase
activity;intracellular signal transduction
exp SPAG1 8q22.2 -0.471 0.000148 0.0875 single fertilization
xai RPS27A 2p16 0.474 0.000152 0.0885 activation of MAPK
activity;MyD88-independent toll-like receptor signaling pathway
hs4 LRMP 12p12.1 0.473 0.000152 0.0885 vesicle targeting;vesicle
fusion
xsq HSF5 17q22 0.47 0.000152 0.0885
met RRNAD1 1q23.1 0.47 0.000152 0.0885
mut CCND1 11q13 0.47 0.000153 0.089 DNA Damage Response (DDR); DDR (G1-S
checkpoint); Oncogenes
his RAB8A 19p13.1 0.473 0.000155 0.0891 vesicle docking involved in
exocytosis;small GTPase mediated signal transduction
exp RPL7AP66 18q12.2 0.473 0.000156 0.0891
xsq CBX3P2 18p11.32 0.469 0.000156 0.0891
xsq RAB44 0.469 0.000156 0.0891 small GTPase mediated signal
transduction;protein transport
xai PAPOLG 2p16.1 0.473 0.000157 0.0891 transcription, DNA-
exp CD38 4p15 0.469 0.000157 0.0891 response to hormone
xai RPLP0P7 2q24.1 0.472 0.000158 0.0891
met EVI2B 17q11.2 -0.469 0.000158 0.0891
exp SEPT6 Xq24 0.469 0.000159 0.0892 cytokinesis;cell cycle
xsq OPRL1 20q13.33 0.468 0.00016 0.0894 elevation of cytosolic
calcium ion concentration;sensory perception
exp TIPIN 15q22.31 0.468 0.00016 0.0894 DNA Damage Response (DDR)
xai ADAM6 0.472 0.000161 0.0894
exp HNRNPA1P15 0.472 0.000162 0.0894
xai ZBTB4 17p13.1 -0.472 0.000162 0.0894 regulation of
xai THBS1 15q15 -0.472 0.000162 0.0894 sprouting angiogenesis;immune
response
met CEP126 0.468 0.000163 0.0894
exp ZBTB4 17p13.1 -0.468 0.000163 0.0894 regulation of
exp HNRNPA1P60 11q23.1 0.467 0.000166 0.0902
hs4 RASAL2 1q24 -0.471 0.000166 0.0902 signal
hs4 RASAL2-AS1 -0.471 0.000166 0.0902
xai PEA15 1q21.1 -0.471 0.000167 0.0905 transport;anti-apoptosis
exp PAICSP4 8p23.2 0.471 0.000168 0.0906
hs4 IL16 15q26.3 0.471 0.000169 0.0906 regulation of transcription,
DNA-dependent;chemotaxis
xai USP7 16p13.3 0.47 0.00017 0.0911 protein
deubiquitination;regulation of protein stability
exp ZNF101 19p13.11 0.466 0.000172 0.0912 regulation of
exp RGS19 20q13.33 0.466 0.000173 0.0912 autophagy;G-protein coupled
receptor signaling pathway
exp HNRNPA1P37 0.466 0.000174 0.0912
exp CTDSPL 3p21.3 -0.466 0.000174 0.0912
xai RPS7P15 4p16.2 0.47 0.000175 0.0912
xsq LAIR1 19q13.4 0.466 0.000175 0.0912
swa RRAGA 9p22.1 -0.47 0.000176 0.0912 Apoptosis
xsq TTC24 1q23.1 0.466 0.000177 0.0912
mda DOUBLING_TIME -0.466 0.000177 0.0912
xsq IL2RG Xq13.1 0.466 0.000178 0.0912 immune response;signal
transduction
xsq WAS Xp11.4-p11.21 0.466 0.000178 0.0912 defense response;T cell
activation
exp CDC42EP3 2p21 -0.466 0.000178 0.0912 signal
transduction;regulation of cell shape
exp ACTN1 14q24 -0.465 0.00018 0.0912 Apoptosis
xai PAICSP4 8p23.2 0.469 0.000181 0.0912
mut OR6C76 0.465 0.000181 0.0912
xsq ISL2 15q23 0.465 0.000181 0.0912 multicellular organismal
development;neuron development
xai SLC25A19 17q25.3 0.469 0.000182 0.0912 Solute Carriers
xai CDT1 16q24.3 0.469 0.000182 0.0912 DDR (DNA replication)
exp RPS7P15 4p16.2 0.468 0.000182 0.0912
exp RNF138 18q12.1 0.465 0.000182 0.0912 Wnt receptor signaling
pathway
exp DAG1 3p21 -0.465 0.000183 0.0912 interspecies interaction
between organisms;membrane protein ectodomain proteolysis
hs4 FARP1 13q32.2 -0.468 0.000183 0.0912 negative regulation of
hs4 STARD13 13q13.1 -0.468 0.000183 0.0912 Apoptosis
exp CCDC86 11q12.2 0.465 0.000184 0.0912 interspecies interaction
between organisms
xai SNRPA 19q13.1 0.468 0.000185 0.0912 nuclear mRNA splicing, via
exp KDM2B 12q24.31 0.464 0.000186 0.0912 negative regulation of
transcription from RNA polymerase II promoter;third ventricle development
xai ACTN1 14q24 -0.468 0.000186 0.0912 Apoptosis
xai LOC100129324 0.468 0.000187 0.0912
xsq PTCHD2 1p36.22 0.464 0.000188 0.0912 smoothened signaling
met PGAP3 17q12 0.464 0.000188 0.0912 GPI anchor metabolic process;GPI
anchor biosynthetic process
xsq CDC42EP3 2p21 -0.464 0.000188 0.0912 signal
xai UBTF 17q21.31 0.468 0.000189 0.0912 chromatin silencing at
rDNA;regulation of transcription from RNA polymerase I promoter
exp SNRPA 19q13.1 0.464 0.000189 0.0912 nuclear mRNA splicing, via
xsq KIR2DL4 0.464 0.00019 0.0912 cellular defense
response;signal transduction
exp USP7 16p13.3 0.464 0.00019 0.0912 protein
deubiquitination;regulation of protein stability
his LANCL1 2q33-q35 0.467 0.000191 0.0912 G-protein coupled
his CPS1 2q35 0.467 0.000191 0.0912 midgut development;response to drug
xsq RASAL3 19p13.12 0.464 0.000191 0.0912 signal
xai MCM6 2q21 0.467 0.000192 0.0912 DDR (DNA replication)
hs4 FAM129C 19p13.11 0.467 0.000192 0.0912
swa S100A13 1q21 -0.467 0.000193 0.0912 positive regulation of
xai NXN 17p13.3 -0.467 0.000193 0.0912 cell
differentiation;multicellular organismal development
exp CD72 9p13.3 0.463 0.000194 0.0913 cell adhesion;axon guidance
hs4 ITGAL 16p11.2 0.466 0.000197 0.092 cell adhesion;regulation of immune
response
exp E2F2 1p36 0.463 0.000197 0.092 Tumor Suppressors
exp LOC791096 -0.463 0.000197 0.092
hs4 NKG7 19q13.41 0.466 0.000199 0.0925
exp LOC283701 0.466 0.000201 0.0925
mut ATG7 3p25.3 0.462 0.000201 0.0925 protein modification
process;protein transport
xai LOC283701 0.466 0.000202 0.0925
xai NLE1 17q12 0.466 0.000203 0.0925 inner cell mass cell
differentiation;Notch signaling pathway
his MICALL1 22q13.1 -0.466 0.000203 0.0925
hs4 THBS1 15q15 -0.466 0.000203 0.0925 sprouting angiogenesis;immune
response
xai DHX37 12q24.31 0.465 0.000204 0.0925
xsq LINC01215 0.462 0.000204 0.0925
xai TIPIN 15q22.31 0.465 0.000205 0.0925 DNA Damage Response (DDR)
xsq RORB 9q22 0.462 0.000205 0.0925 positive regulation of
transcription, DNA-dependent;response to stimulus
xai CD72 9p13.3 0.465 0.000206 0.0925 cell adhesion;axon guidance
xsq LRMP 12p12.1 0.461 0.000207 0.0925 vesicle targeting;vesicle
fusion
xai RASA4CP 0.465 0.000208 0.0925
exp RORB 9q22 0.461 0.000208 0.0925 positive regulation of
xsq ARHGAP9 12q13.3 0.461 0.000209 0.0925 positive regulation of
GTPase activity;regulation of small GTPase mediated signal transduction
xai ZNF101 19p13.11 0.465 0.00021 0.0925 regulation of
xai GPR63 6q16.1-q16.3 0.464 0.000211 0.0925
xsq LGALS3 14q22.3 -0.461 0.000211 0.0925 skeletal system
development;mRNA processing
xai CNN3 1p22-p21 -0.464 0.000211 0.0925 negative regulation of
ATPase activity;smooth muscle contraction
xai KHDRBS1 1p32 0.464 0.000212 0.0925 negative regulation of
transcription, DNA-dependent;G2/M transition of mitotic cell cycle
xai BCAR3 1p22.1 -0.464 0.000212 0.0925 small GTPase mediated
signal transduction;response to drug
xsq KLHL6 3q27.3 0.461 0.000213 0.0925 germinal center formation;B
cell receptor signaling pathway
exp HNRNPA1P48 16q12.1 0.461 0.000213 0.0925
met CTNND1 11q11 0.461 0.000213 0.0925 morphogenesis of a polarized
epithelium;adherens junction organization
xsq ZFP36L1 14q22-q24 -0.461 0.000213 0.0925 mRNA metabolic
xsq LOC100130872 0.46 0.000214 0.0925
xai SLC7A3 Xq13.1 0.464 0.000215 0.0925 Solute Carriers
xsq KBTBD8 3p14 0.46 0.000215 0.0925
xsq WDR17 4q34 0.46 0.000216 0.0925
xai ARHGAP19 10q24.1 0.464 0.000217 0.0925 signal
transduction;small GTPase mediated signal transduction
xsq KIR3DL2 19q13.4 0.46 0.000219 0.0925 cellular defense
response;regulation of immune response
exp CNN3 1p22-p21 -0.46 0.000219 0.0925 negative regulation of ATPase
activity;smooth muscle contraction
swa APMAP 20p11.2 -0.463 0.000219 0.0925
swa DRG1 22q12.2 0.463 0.00022 0.0925 transcription, DNA-
dependent;multicellular organismal development"
met OAT 10q26 0.46 0.00022 0.0925 cellular nitrogen compound
exp TAF5 10q24-q25.2 0.46 0.000221 0.0925 viral reproduction;chromatin
modification
exp PHB2 12p13 0.46 0.000221 0.0925 negative regulation of
hs4 LY86 6p25.1 0.463 0.000223 0.0925 apoptotic
process;inflammatory response
pro CDK4 12q14 0.459 0.000224 0.0925 DNA Damage Response (DDR); Protein
Kinases
xsq DOCK8 9p24.3 0.459 0.000224 0.0925 blood coagulation
met ZNF214 11p15.4 0.459 0.000225 0.0925 regulation of
xai ST8SIA4 5q21 0.462 0.000227 0.0925 oligosaccharide metabolic
exp DHX37 12q24.31 0.459 0.000227 0.0925
hs4 MBNL2 13q32.1 -0.462 0.000228 0.0925 mRNA
processing;regulation of RNA splicing
xai RPS4XP13 11q12.1 0.462 0.000229 0.0925
his PDE4A 19p13.2 0.462 0.000229 0.0925 response to drug;cAMP
catabolic process
hs4 SNX20 16q12.1 0.462 0.000231 0.0925 cell communication;protein
transport
xsq ST18 8q11.23 0.458 0.000231 0.0925 negative regulation of
transcription from RNA polymerase II promoter
xsq ORC1 1p32 0.458 0.000232 0.0925 DDR (DNA replication)
mut ABCA10 17q24 0.458 0.000232 0.0925 ABC Transporters
xsq LOC729683 17q23.3 0.458 0.000232 0.0925
xai SIGLEC10 19q13.3 0.462 0.000233 0.0925 cell adhesion
exp RASA4CP 0.462 0.000233 0.0925
exp MCM6 2q21 0.458 0.000233 0.0925 DDR (DNA replication)
xsq GOLGA8N 0.458 0.000233 0.0925
xai E2F2 1p36 0.461 0.000234 0.0925 Tumor Suppressors
xsq KRT2 12q13.13 0.458 0.000234 0.0925 keratinocyte
proliferation;keratinocyte migration
xsq HCLS1 3q13 0.458 0.000234 0.0925 regulation of transcription, DNA-
dependent;positive regulation of cell proliferation
hs4 SHISA4 1q32.1 -0.462 0.000234 0.0925
xsq GTSF1 12q13.13 0.458 0.000235 0.0925
xai TSPAN9 12p13.33-p13.32 -0.461 0.000235 0.0925
xai RPL5P26 10q22 0.461 0.000236 0.0925
xai WAS Xp11.4-p11.21 0.461 0.000237 0.0925 defense response;T cell
activation
xai PPP2R3A 3q22.1 -0.461 0.000239 0.0925 protein
dephosphorylation
xai KDM2B 12q24.31 0.461 0.00024 0.0925 negative regulation of
xai NASP 1p34.1 0.461 0.00024 0.0925 cell proliferation;protein
transport
exp RPL5P26 10q22 0.461 0.00024 0.0925
exp SLC7A3 Xq13.1 0.457 0.00024 0.0925 Solute Carriers
exp SLC25A15 13q14 0.457 0.00024 0.0925 Solute Carriers
exp ADAM6 0.461 0.000241 0.0925
exp ADAT2 6q24.2 0.457 0.000241 0.0925 tRNA processing
xsq PSMA8 18q11.2 0.457 0.000242 0.0925 antigen processing and
exp ARHGAP35 19q13.3 -0.457 0.000243 0.0925 axon
guidance;positive regulation of Rho GTPase activity
xai FAM129B 9q34.13 -0.46 0.000243 0.0925 negative regulation of
apoptotic process
xsq GOLGA8S 0.457 0.000244 0.0925
xai CTDSPL 3p21.3 -0.46 0.000244 0.0925
xsq CD93 20p11.21 0.457 0.000245 0.0925 macrophage
activation;interspecies interaction between organisms
xai HIST1H2AH 6p21.33 0.46 0.000246 0.0925 nucleosome assembly
exp CCDC144CP 17p11.2 -0.457 0.000246 0.0925
exp NPM3 10q24.31 0.456 0.000247 0.0925 rRNA transcription;rRNA
processing
exp SNRPF 12q23.1 0.456 0.000248 0.0925 termination of RNA polymerase
II transcription;mRNA processing
exp UBL7-AS1 0.456 0.000249 0.0925
his LINC00578 -0.46 0.000249 0.0925
met CAPS 19p13.3 0.456 0.00025 0.0925 intracellular signal
transduction
xsq GOLGA8J 0.456 0.00025 0.0925
xai ARHGAP35 19q13.3 -0.46 0.00025 0.0925 axon guidance;positive
regulation of Rho GTPase activity
met RHBDL2 1p34.3 0.456 0.000251 0.0925 proteolysis
hs4 RAB37 17q25.1 0.459 0.000252 0.0925 protein transport;small
GTPase mediated signal transduction
his PCSK6-AS1 0.459 0.000252 0.0925
xsq ANKLE1 19p13.11 0.456 0.000252 0.0925
exp DLEU7 13q14.3 0.459 0.000253 0.0925
exp TICRR 15q26.1 0.456 0.000254 0.0925 DDR (DNA replication)
exp DKC1 Xq28 0.456 0.000254 0.0925 DNA Damage Response (DDR)
xai SLC25A15 13q14 0.459 0.000255 0.0925 Solute Carriers
xai PRICKLE2 3p14.1 -0.459 0.000255 0.0925 neuron projection
development;establishment or maintenance of epithelial cell apical/basal polarity
exp ZCCHC3 20p13-p12.2 0.455 0.000256 0.0925
hs4 CRIP1 14q32.33 0.459 0.000258 0.0925 heart development;cell
proliferation
xai LOC642846 12p13.31 0.459 0.000258 0.0925
xsq ZNF101 19p13.11 0.455 0.00026 0.0925 regulation of
exp KHDRBS1 1p32 0.455 0.00026 0.0925 negative regulation of
xai DAG1 3p21 -0.459 0.00026 0.0925 interspecies interaction
between organisms;membrane protein ectodomain proteolysis
xai EEF1A1P25 3q22.3 0.458 0.000261 0.0925
exp EEF1A1P25 3q22.3 0.458 0.000262 0.0925
xsq CDC25A 3p21 0.455 0.000262 0.0925 DNA Damage Response (DDR);
xsq DLEU7 13q14.3 0.455 0.000262 0.0925
exp HIST1H2AH 6p21.33 0.458 0.000263 0.0925 nucleosome assembly
exp LOC642846 12p13.31 0.458 0.000263 0.0925
xai RGS19 20q13.33 0.458 0.000263 0.0925 autophagy;G-protein coupled
his HSD17B11 4q22.1 0.458 0.000263 0.0925 steroid biosynthetic
process;androgen catabolic process
met SRGAP1 12q14.2 0.455 0.000263 0.0925 signal
xsq KRT73 12q13.3 0.455 0.000263 0.0925
exp P2RY8 Xp22.33 0.455 0.000263 0.0925
mut GPATCH2 1q41 0.455 0.000264 0.0925 negative regulation of
phosphatase activity
exp LOC606724 0.458 0.000265 0.0925
exp HAUS1 18q21.1 0.454 0.000265 0.0925 cell cycle;mitosis
exp UBTF 17q21.31 0.454 0.000265 0.0925 chromatin silencing at
mut DENND2C 1p13.2 0.454 0.000266 0.0925
xsq ARHGAP15 2q22.2-q22.3 0.454 0.000267 0.0925 regulation of
small GTPase mediated signal transduction;signal transduction
hs4 LOC729506 5p15.31 -0.458 0.000268 0.0925
hs4 MIR4458HG -0.458 0.000268 0.0925
hs4 MIR4458 -0.458 0.000268 0.0925
xsq HHLA2 3q13.13 0.454 0.000269 0.0925
met ERRFI1 1p36 0.454 0.000269 0.0925 response to stress;lung
vasculature development
xsq CD4 12p13.31 0.454 0.00027 0.0925 cell adhesion;entry into host
cell
xai DUSP2 2q11 0.457 0.000272 0.0925 regulation of apoptotic
process;inactivation of MAPK activity
exp CAPN2 1q41-q42 -0.454 0.000273 0.0925 response to
hypoxia;blastocyst development
xai MYC 8q24.21 0.457 0.000274 0.0925 Apoptosis; Oncogenes; Protein
Kinases
xai HNRNPA1P4 8q21.13 0.457 0.000274 0.0925
xai TTC27 2p22.3 0.457 0.000274 0.0925
xai CAPN2 1q41-q42 -0.457 0.000274 0.0925 response to
xai CCT4 2p15 0.457 0.000275 0.0925 protein folding;cellular protein
metabolic process
xai IL2RG Xq13.1 0.457 0.000276 0.0925 immune response;signal
transduction
xsq C20orf197 20q13.33 0.453 0.000276 0.0925
xai MIB1 18q11.2 0.457 0.000277 0.0925 neural tube formation;heart
looping
exp BCAR3 1p22.1 -0.453 0.000277 0.0925 small GTPase mediated
signal transduction;response to drug
exp PEA15 1q21.1 -0.453 0.000277 0.0925 transport;anti-apoptosis
xai CDCA7 2q31 0.457 0.000279 0.0925 regulation of transcription, DNA-
dependent;regulation of cell proliferation"
xai LOC606724 0.456 0.000279 0.0925
xai RBMXP4 4q25 0.456 0.00028 0.0925
xai NDST1 5q33.1 -0.456 0.00028 0.0925 fibroblast growth factor
receptor signaling pathway;embryonic viscerocranium morphogenesis
met MIR1227 -0.453 0.000281 0.0925
xai SART3 12q24.1 0.456 0.000282 0.0925 RNA processing
exp RBMXP4 4q25 0.456 0.000282 0.0925
xai RPL21P120 17p11.2 0.456 0.000282 0.0925
xai CCR7 17q12-q21.2 0.456 0.000283 0.0925 positive regulation of
dendritic cell antigen processing and presentation;positive regulation of
glycoprotein biosynthetic process
xsq LRRC18 10q11.23 0.453 0.000283 0.0925
met NLRP14 11p15.4 0.453 0.000283 0.0925 cell
his LOC101928163 0.456 0.000284 0.0925
his E2F2 1p36 0.456 0.000284 0.0925 Tumor Suppressors
his ING4 12p13.31 0.456 0.000284 0.0925 Tumor Suppressors
met GPR157 1p36.23 0.452 0.000284 0.0925
xsq PCED1B-AS1 12q13.11 0.452 0.000284 0.0925
exp SPAST 2p24-p21 0.452 0.000284 0.0925 cytokinesis, completion of
separation;cell division
xai PTPN14 1q32.2 -0.456 0.000284 0.0925
lymphangiogenesis;protein dephosphorylation
xai TRBV3-1 0.456 0.000286 0.0925
xai PAICS 4q12 0.456 0.000286 0.0925 purine base metabolic
process;purine nucleotide biosynthetic process
exp LOC152594 4q28.3 0.452 0.000286 0.0925
his C19orf60 19p13.11 0.456 0.000287 0.0925
his ZWINT 10q21-q22 0.456 0.000288 0.0927 spindle organization;mitotic
cell cycle checkpoint
exp PTCHD2 1p36.22 0.456 0.000289 0.0927 smoothened signaling
xai PHB2 12p13 0.455 0.000289 0.0927 negative regulation of
xai C16orf95 0.455 0.00029 0.0927
exp KLRG1 12p13.31 0.452 0.00029 0.0927 inflammatory
response;cellular defense response
xsq CORO1A 16p11.2 0.452 0.000292 0.0931 phagocytosis;cell-
substrate adhesion
xai PYHIN1 1q23.1 0.455 0.000293 0.0931 cell cycle
exp KRT1 12q13.13 0.452 0.000293 0.0931 complement activation, lectin
pathway;response to oxidative stress
exp CDCA7 2q31 0.451 0.000294 0.0931 regulation of transcription, DNA-
xai CDC42EP3 2p21 -0.455 0.000294 0.0931 signal
xai PRR3 6p21.33 0.455 0.000296 0.0931
xai RPS4XP19 18p11.22 0.455 0.000296 0.0931
xai RORB 9q22 0.455 0.000296 0.0931 positive regulation of
his PPP3R1 2p15 0.455 0.000297 0.0931 induction of apoptosis by
intracellular signals;activation of pro-apoptotic gene products
xai HNRNPA1P63 1p32.3 0.455 0.000297 0.0931
exp CCR7 17q12-q21.2 0.451 0.000297 0.0931 positive regulation of
dendritic cell antigen processing and presentation;positive regulation of
glycoprotein biosynthetic process
hs4 RGS18 1q31.2 0.454 3e-04 0.0934 regulation of G-protein coupled
receptor protein signaling pathway;negative regulation of signal transduction
exp RGS18 1q31.2 0.451 3e-04 0.0934 regulation of G-protein coupled
xai RPL7AP14 20q11.2 0.454 0.000302 0.0934
xsq CD52 1p36 0.451 0.000302 0.0934 elevation of cytosolic calcium ion
concentration;respiratory burst
exp CHAC2 2p16 0.451 0.000303 0.0934
xsq SMPD3 16q22.1 0.451 0.000303 0.0934 sphingomyelin catabolic
xai HNRNPA1P8 7q21.11 0.454 0.000304 0.0934
xai C20orf27 20p13 0.454 0.000304 0.0934
exp NEK6 9q33.3-q34.11 -0.45 0.000304 0.0934 DNA Damage Response
(DDR)
exp RPS4XP19 18p11.22 0.454 0.000307 0.0934
xsq DBH-AS1 0.45 0.000307 0.0934
exp ADCY9 16p13.3 -0.45 0.000307 0.0934 signal
transduction;intracellular signal transduction
xai ADCY9 16p13.3 -0.454 0.000307 0.0934 signal
hs4 TLR9 3p21.3 0.454 0.000308 0.0934 negative regulation of
interleukin-8 production;positive regulation of tumor necrosis factor production
xai ANKLE1 19p13.11 0.454 0.000308 0.0934
exp RPL7AP14 20q11.2 0.454 0.000308 0.0934
met CFB 6p21.3 0.45 0.000308 0.0934 complement activation,
alternative pathway;innate immune response
exp PTPN14 1q32.2 -0.45 0.000311 0.0942
hs4 CCR4 3p24 0.453 0.000314 0.095 neuron migration;tolerance induction
exp ISL2 15q23 0.449 0.000316 0.0952 multicellular organismal
exp RASAL2-AS1 -0.453 0.000316 0.0952
xsq CCDC88B 11q12.3 0.449 0.000317 0.0952 microtubule cytoskeleton
organization
xai DLEU7 13q14.3 0.453 0.000318 0.0952
exp NOP56P1 6p22.1 0.449 0.000318 0.0952
xai LYAR 4p16.3 0.453 0.000319 0.0952
xsq PIK3CG 7q22.3 0.449 0.000319 0.0952 Apoptosis; Cell
Signaling; Oncogenes; Protein Kinases
xsq RASGRP2 11q13 0.449 0.000321 0.0952 Ras protein signal
transduction;blood coagulation
xsq ST8SIA4 5q21 0.449 0.000321 0.0952 oligosaccharide metabolic
exp NXN 17p13.3 -0.449 0.000321 0.0952 cell
xai RNF138 18q12.1 0.452 0.000322 0.0952 Wnt receptor signaling
pathway
xsq GOLGA8K 0.449 0.000322 0.0952
exp CCT4 2p15 0.449 0.000324 0.0956 protein folding;cellular protein
metabolic process
hs4 ARHGAP4 Xq28 0.452 0.000326 0.0958 induction of apoptosis by
extracellular signals;positive regulation of Rho GTPase activity
xsq LOC606724 0.449 0.000326 0.0958
exp LOC100129324 0.452 0.000328 0.0958
exp CACTIN 19p13.3 0.448 0.000328 0.0958
mut GPNMB 7p15 0.448 0.000328 0.0958 cell adhesion;negative regulation
of cell proliferation
xsq EMB 5q11.1 0.448 0.000328 0.0958 cell adhesion
xsq RND3 2q23.3 -0.448 0.000328 0.0958 GTP catabolic
process;cell adhesion
swa CYB5R3 22q13.2 -0.452 0.000329 0.0959 cholesterol
biosynthetic process;vitamin metabolic process
exp ANP32E 1q21.2 0.448 0.00033 0.0959 DNA Damage Response
(DDR)
xai RASAL2-AS1 -0.452 0.00033 0.0959
exp LOC100507250 0.451 0.000332 0.0963
xai LOC100507250 0.451 0.000333 0.0963
met SLC39A2 14q11.2 0.448 0.000334 0.0965 Solute Carriers
xai DHODH 16q22 0.451 0.000335 0.0965 nucleobase-containing small
molecule metabolic process;pyrimidine base metabolic process
xsq CD8A 2p12 0.448 0.000335 0.0965 regulation of immune response;T
cell mediated immunity
exp MIB1 18q11.2 0.448 0.000336 0.0967 neural tube formation;heart
looping
met AFAP1 4p16 0.447 0.000337 0.0968
xai CHAC2 2p16 0.451 0.000339 0.0972
his ANKLE1 19p13.11 0.451 0.000341 0.0975
xai RPS7P10 13q12.11 0.45 0.000345 0.0983
exp RPS7P10 13q12.11 0.45 0.000346 0.0983
hs4 IKZF1 7p12.2 0.45 0.000347 0.0983 mesoderm development;positive
regulation of transcription from RNA polymerase II promoter
exp EEF1B2P1 15q21.2 0.447 0.000347 0.0983
xsq IGLL1 22q11.23 0.447 0.000348 0.0983 immune response
xai RPL36AP53 0.45 0.000349 0.0983
exp RPL36AP53 0.45 0.000349 0.0983
xai TICRR 15q26.1 0.45 0.00035 0.0983 DDR (DNA replication)
xai ADRBK1 11q13.1 0.45 0.00035 0.0983 G-protein coupled
acetylcholine receptor signaling pathway;receptor internalization
met SYNJ2 6q25.3 -0.446 0.00035 0.0983 phosphatidylinositol
dephosphorylation;intracellular distribution of mitochondria
mut OSBPL8 12q14 0.446 0.000351 0.0983 transport;lipid transport
exp PTGDR2 11q12-q13.3 0.446 0.000353 0.0983 chemotaxis;immune
response
exp RPL9P18 6q12 0.45 0.000354 0.0983
xsq FAR2 12p11.22 0.446 0.000354 0.0983 ether lipid biosynthetic
process;cellular lipid metabolic process
met DIP2C 10p15.3 0.446 0.000354 0.0983
xsq SCML2 Xp22 0.446 0.000354 0.0983 regulation of transcription, DNA-
dependent;anatomical structure morphogenesis"
xai AAAS 12q13 0.45 0.000355 0.0983 hexose transport;transmembrane
transport
exp SLC25A19 17q25.3 0.446 0.000356 0.0983 Solute Carriers
xai RPL9P18 6q12 0.449 0.000357 0.0983
exp FCHO1 19p13.11 0.449 0.000357 0.0983
met RMDN2 2p22.2 0.446 0.000357 0.0983
met PI4K2A 10q24 0.446 0.000358 0.0983 phosphatidylinositol
exp LYAR 4p16.3 0.446 0.000358 0.0983
swa TBCB 19q13.11-q13.12 0.449 0.000359 0.0983 multicellular organismal
development;nervous system development
met C10orf35 10q22.1 0.446 0.000359 0.0983
xai LGALS3BP 17q25 -0.449 0.000359 0.0983 cellular defense
response;cell adhesion
xai HAR1A 20q13.33 0.453 0.000361 0.0985
xsq FERMT3 11q13.1 0.446 0.000361 0.0985 leukocyte cell-cell
adhesion;integrin activation
exp C2orf44 2p23.3 0.445 0.000362 0.0985
exp PPP2R3A 3q22.1 -0.445 0.000362 0.0985 protein
dephosphorylation
exp HNRNPA1P51 2q33.3 0.445 0.000363 0.0985
met FBXO10 9p13.2 0.445 0.000364 0.0986 protein ubiquitination
xai CD8A 2p12 0.449 0.000365 0.0986 regulation of immune response;T
cell mediated immunity
exp TBP 6q27 0.445 0.000366 0.0986 transcription from RNA polymerase
III promoter;spermatogenesis
met TTLL13P 0.445 0.000366 0.0986 protein modification process
xsq GPR63 6q16.1-q16.3 0.445 0.000368 0.0986
exp LEPROT 1p31.3 -0.445 0.000368 0.0986 negative
regulation of protein localization at cell surface;negative regulation of JAK-STAT
cascade
his RNVU1-17 0.448 0.000369 0.0986
mut TRUB1 10q25.3 0.445 0.000369 0.0986 pseudouridine synthesis;RNA
processing
hs4 SEPT6 Xq24 0.448 0.000371 0.0986 cytokinesis;cell cycle
his MDM4 1q32 0.448 0.000371 0.0986 Apoptosis; DNA Damage Response
(DDR)
exp C9orf3 9q22.32 -0.445 0.000371 0.0986
proteolysis;leukotriene biosynthetic process
xai RPL34P31 17q11.1 0.448 0.000372 0.0986
exp RPL34P31 17q11.1 0.448 0.000372 0.0986
xsq GLB1L3 11q25 0.445 0.000372 0.0986 carbohydrate metabolic
process
xai TOPORS-AS1 9p21.1 0.448 0.000373 0.0986
exp TCERG1 5q31 0.445 0.000373 0.0986 negative regulation of
transcription from RNA polymerase II promoter;regulation of transcription, DNA-
dependent
exp C20orf196 20p12.3 0.444 0.000374 0.0986
xsq IRGM 5q33.1 0.444 0.000374 0.0986 autophagy;inflammatory
response
hs4 CTNND1 11q11 -0.448 0.000374 0.0986 morphogenesis of a
met MDC1 6p21.3 0.444 0.000375 0.0987 DNA Damage Response (DDR);
DDR (NHEJ)
xai URB2 1q42.13 0.448 0.000377 0.0989
exp FAM216A 12q24.11 0.444 0.000377 0.0989
xai PDSS1 10p12.1 0.448 0.000378 0.099 protein
heterotetramerization;ubiquinone biosynthetic process
exp HNRNPUP1 14q21.2 0.444 0.000379 0.099
exp THBS1 15q15 -0.444 0.000379 0.099 sprouting angiogenesis;immune
response
hs4 P2RX1 17p13.3 0.447 0.000381 0.0991 insemination;purinergic
nucleotide receptor signaling pathway
exp HNRNPA1P63 1p32.3 0.447 0.000381 0.0991
xai NPM3 10q24.31 0.447 0.000381 0.0991 rRNA transcription;rRNA
processing
xsq TSKS 19q13.3 0.444 0.000385 0.0996 negative regulation of
xai NEK6 9q33.3-q34.11 -0.447 0.000386 0.0996 DNA Damage
Response (DDR)
xai SPAST 2p24-p21 0.447 0.000387 0.0996 cytokinesis, completion of
xai LIMD2 17q23.3 0.447 0.000388 0.0996
met LRIG3 12q14.1 0.443 0.000388 0.0996
mut RGS6 14q24.3 0.443 0.000388 0.0996 negative regulation of signal
xsq TTC16 9q34.11 0.443 0.000388 0.0996
xai NOB1 16q22.3 0.447 0.000389 0.0996
xai SMIM8 6q15 0.447 0.00039 0.0996
xsq CAMKV 3p21.31 0.443 0.00039 0.0996
exp PRICKLE2 3p14.1 -0.443 0.00039 0.0996 neuron projection
his SLC18A2 10q25 0.447 0.000391 0.0996 Solute Carriers
hs4 PTPN7 1q32.1 0.447 0.000392 0.0996 protein
dephosphorylation;peptidyl-tyrosine dephosphorylation
exp ATP6V0E1 5q35.1 -0.443 0.000392 0.0996 ATP hydrolysis
coupled proton transport;proton transport
his PRIM1 12q13 0.447 0.000393 0.0996 DDR (DNA replication)
his CHAC2 2p16 0.446 0.000393 0.0996
exp TTC27 2p22.3 0.443 0.000393 0.0996
exp LOC442292 7p15.2 0.443 0.000395 0.0996
mut DFNB31 9q32 0.443 0.000395 0.0996 retina homeostasis;sensory
perception of sound
exp RPS4XP13 11q12.1 0.443 0.000396 0.0997
his POLE2 14q21-q22 0.446 0.000397 0.0997 DNA Damage Response (DDR);
DDR (NER); DDR (DNA replication)
xai CEP76 18p11.21 0.446 0.000397 0.0997 G2/M transition of mitotic
cell cycle;mitotic cell cycle
exp LOC100129034 -0.443 0.000398 0.0998
xsq XCL2 0.443 0.000399 0.0998 chemotaxis;immune response
his MAP2K5 15q23 0.446 0.000401 0.1 Protein Kinases
xai ATP6V0E1 5q35.1 -0.446 0.000401 0.1 ATP hydrolysis coupled
proton transport;proton transport
swa ACTN1 14q24 -0.446 0.000403 0.1 Apoptosis
xsq CD38 4p15 0.442 0.000404 0.1 response to hormone stimulus;response to
drug
exp B4GALT1 9p13 -0.442 0.000404 0.101 epithelial cell
development;penetration of zona pellucida
met SPIRE2 16q24 0.442 0.000406 0.101 transport
xsq TREML2 6p21.1 0.442 0.000408 0.101 T cell activation
xsq PAPOLG 2p16.1 0.442 0.000409 0.101 transcription, DNA-
xsq ADCY9 16p13.3 -0.442 0.000409 0.101 signal
xai BEND3 6q21 0.445 0.00041 0.101
exp GPR63 6q16.1-q16.3 0.442 0.00041 0.101
xai TCERG1 5q31 0.445 0.000411 0.101 negative regulation of
dependent
exp LOC317727 7p21 0.442 0.000412 0.101
exp TRBV3-1 0.442 0.000413 0.101
exp GTSF1 12q13.13 0.442 0.000413 0.101
hs4 SDC4 20q12 -0.445 0.000413 0.101 ureteric bud development;positive
regulation of protein kinase activity
exp ADRBK1 11q13.1 0.442 0.000414 0.101 G-protein coupled
xsq SLA 8q24 0.442 0.000414 0.101
hs4 ARHGAP15 2q22.2-q22.3 0.445 0.000415 0.101 regulation of small
GTPase mediated signal transduction;signal transduction
xai LINC00539 0.445 0.000416 0.101
xai GTSF1 12q13.13 0.445 0.000416 0.101
hs4 CD7 17q25.2-q25.3 0.445 0.00042 0.101 homeostasis of number of
cells within a tissue;immune response
exp HNRNPA1P8 7q21.11 0.441 0.00042 0.101
met GPR17 2q21 -0.441 0.00042 0.101 G-protein coupled receptor
signaling pathway
exp NSUN6 10p12.31 0.441 0.000421 0.101
xai NSUN6 10p12.31 0.444 0.000422 0.101
xai SHPRH 6q24.3 0.444 0.000423 0.101 DNA Damage Response (DDR); DDR
(TLS)
xsq CCR4 3p24 0.441 0.000423 0.101 neuron migration;tolerance induction
exp NASP 1p34.1 0.441 0.000424 0.101 cell proliferation;protein
transport
exp P4HA2 5q31 -0.441 0.000424 0.101 peptidyl-proline hydroxylation to
4-hydroxy-L-proline
xai FCHO1 19p13.11 0.444 0.000425 0.101
xsq MGC16142 7q21.2 0.441 0.000425 0.101
met USP9X Xp11.4 0.441 0.000425 0.101 mitosis;transforming growth factor
beta receptor signaling pathway
xai ISL2 15q23 0.444 0.000426 0.101 multicellular organismal
xsq OSM 22q12.2 0.441 0.000426 0.101 multicellular organismal
development;tyrosine phosphorylation of Stat3 protein
met FRMD5 15q15.3 0.441 0.000427 0.101
met BCAR1 16q23.1 0.441 0.000428 0.101 G-protein coupled receptor
signaling pathway;cellular response to hepatocyte growth factor stimulus
exp RPS27A 2p16 0.44 0.000428 0.101 activation of MAPK activity;MyD88-
independent toll-like receptor signaling pathway
mut SOX30 5q33 0.44 0.00043 0.101 regulation of transcription, DNA-
dependent;regulation of transcription from RNA polymerase II promoter
mir hsa-miR-27b -0.44 0.00043 0.101
xsq SAMD4A 14q22.2 -0.44 0.00043 0.101 negative regulation of
translation;positive regulation of translation
xai HNRNPCP3 15q25.1 0.444 0.000432 0.101
pro FADD_26 0.44 0.000432 0.101
hs4 RBPMS 8p12 -0.444 0.000432 0.101 regulation of transcription, DNA-
dependent;RNA processing
hs4 RBPMS-AS1 8p12 -0.444 0.000432 0.101
his SFMBT2 10p14 0.444 0.000433 0.101 regulation of transcription, DNA-
dependent"
exp NLE1 17q12 0.44 0.000434 0.101 inner cell mass cell
xsq NXN 17p13.3 -0.44 0.000434 0.101 cell differentiation;multicellular
organismal development
xai CHRNA9 4p14 0.443 0.000435 0.101 ion transport;elevation of
hs4 KCNK17 6p21.1 0.443 0.000435 0.101 ion transport;potassium ion
transport
his TTK 6q14.1 0.443 0.000435 0.101 Tumor Suppressors
exp EPHA4 2q36.1 -0.44 0.000435 0.101 adult walking behavior;negative
regulation of axon regeneration
xai LAMB2 3p21 -0.443 0.000435 0.101 neuromuscular junction
development;metanephric glomerular basement membrane development
his FBXO5 6q25.2 0.443 0.000437 0.101 G1/S transition of mitotic cell
cycle;regulation of mitotic cell cycle
xai EEF1A1P20 0.443 0.000438 0.101
exp GPX8 5q11.2 -0.44 0.000438 0.101 response to oxidative stress
exp PDSS1 10p12.1 0.44 0.00044 0.102 protein
xsq NCR3 6p21.3 0.44 0.000441 0.102 inflammatory response;immune
response
hs4 SIGLEC12 19q13.4 0.443 0.000443 0.102 cell adhesion
hs4 HMHB1 5q31.3 0.443 0.000445 0.102
xsq ATG10 5q14.1 0.439 0.000447 0.102 positive regulation of protein
modification process;protein modification by small protein conjugation
xsq ZNF683 1p36.11 0.439 0.00045 0.102 regulation of transcription,
DNA-dependent"
xsq CDH23 10q22.1 0.439 0.00045 0.102 inner ear morphogenesis;righting
reflex
exp URB2 1q42.13 0.439 0.000451 0.102
xai KLRG1 12p13.31 0.442 0.000452 0.102 inflammatory response;cellular
defense response
his P2RX1 17p13.3 0.442 0.000452 0.102 insemination;purinergic nucleotide
met S100A13 1q21 0.439 0.000454 0.102 positive regulation of I-kappaB
kinase/NF-kappaB cascade;mast cell degranulation
exp IL2RG Xq13.1 0.439 0.000454 0.102 immune response;signal transduction
swa CNN3 1p22-p21 -0.442 0.000456 0.102 negative regulation of ATPase
exp DDX18P1 14q24.1 0.442 0.000458 0.102
exp LIMD2 17q23.3 0.438 0.000458 0.102
exp DHODH 16q22 0.438 0.000459 0.102 nucleobase-containing small molecule
metabolic process;pyrimidine base metabolic process
met LDOC1L 22q13.31 0.438 0.00046 0.102
swa CTSD 11p15.5 -0.442 0.00046 0.102 cell death;proteolysis
xsq C16orf54 0.438 0.000462 0.102
xsq GOLGA8O 0.438 0.000462 0.102
exp HDAC11 3p25.1 -0.438 0.000463 0.102 regulation of
transcription, DNA-dependent;oligodendrocyte development
met NUDT14 14q32.33 0.438 0.000464 0.102
exp EEF1A1P20 0.442 0.000465 0.102
xai RGS18 1q31.2 0.441 0.000466 0.102 regulation of G-protein coupled
hs4 ITGB7 12q13.13 0.441 0.000466 0.102 cell-matrix adhesion;integrin-
mediated signaling pathway
xai RPS4XP7 6p23 0.441 0.000468 0.102
hs4 PRSS57 19p13.3 0.441 0.000469 0.102 proteolysis
xai RPL32P26 12q14.1 0.441 0.000469 0.102
xai PPAT 4q12 0.441 0.00047 0.102 lactation;nucleobase-containing small
molecule metabolic process
hs4 MBOAT2 2p25.1 -0.441 0.00047 0.102 phospholipid
exp RPL32P26 12q14.1 0.441 0.000471 0.102
xai DDX18P1 14q24.1 0.441 0.000471 0.102
xai ZNF397 18q12.2 0.441 0.000471 0.102 viral reproduction
xai BIN2 0.441 0.000476 0.102
xai C9orf3 9q22.32 -0.441 0.000476 0.102 proteolysis;leukotriene
met TMEM56 1p21.3 0.437 0.000478 0.102
xai GNG12 1p31.3 -0.441 0.000478 0.102 signal transduction;G-protein
coupled receptor signaling pathway
exp RPS4XP7 6p23 0.441 0.000479 0.102
xsq TARP 7p15-p14 0.437 0.000479 0.102
xai FAM86LP 7p22.1 0.441 0.00048 0.102
xai WDR4 21q22.3 0.44 0.000481 0.102 tRNA modification
xai FAM216A 12q24.11 0.44 0.000481 0.102
exp ATXN2L 0.437 0.000481 0.102
xai HNRNPA1P64 1p31.1 0.44 0.000482 0.102
xsq MYC 8q24.21 0.437 0.000483 0.102 Apoptosis; Oncogenes; Protein
Kinases
met UTS2B 3q28 0.437 0.000483 0.102
exp HIST1H2AM 6p22.1 0.437 0.000484 0.102
xai C2orf44 2p23.3 0.44 0.000487 0.102
met ZNF503 10q22.2 0.437 0.000487 0.102 regulation of transcription,
DNA-dependent"
xai HNRNPCP2 0.44 0.000488 0.102
xai EFCAB10 7q22.3 0.44 0.000488 0.102 signal transduction
his LINC01335 -0.44 0.000489 0.102
met MTERF2 0.436 0.000491 0.102 regulation of transcription, DNA-
dependent;transcription, DNA-dependent"
exp NDST1 5q33.1 -0.436 0.000491 0.102 fibroblast growth factor
xai GPX8 5q11.2 -0.44 0.000491 0.102 response to oxidative stress
exp EMB 5q11.1 0.436 0.000494 0.102 cell adhesion
his LEO1 15q21.2 0.44 0.000495 0.102 regulation of transcription, DNA-
dependent;histone monoubiquitination
xai ADHFE1 8q13.1 -0.44 0.000495 0.102 2-oxoglutarate metabolic
process;molecular hydrogen transport
xai UBE3D 6q14.1 0.44 0.000496 0.102
swa SERBP1 1p31 0.44 0.000496 0.102 regulation of anti-
apoptosis;regulation of mRNA stability
exp GNG12 1p31.3 -0.436 0.000496 0.102 signal transduction;G-protein
his FASTKD1 2q31 0.439 5e-04 0.102 cellular respiration
met SPATA6 1p33 0.436 0.000504 0.102 multicellular organismal
development;spermatogenesis
xsq LGALS3BP 17q25 -0.435 0.000508 0.102 cellular defense
xai RPL6P27 18p11.31 0.439 0.000509 0.102
exp RPL6P27 18p11.31 0.439 0.000509 0.102
xai HIST1H3B 6p22.1 0.439 0.000509 0.102
xai C2orf40 2q12.2 0.439 0.000509 0.102 G1 to G0 transition;cellular
senescence
hs4 GPX8 5q11.2 -0.439 0.000509 0.102 response to oxidative stress
exp CHRNA9 4p14 0.435 0.00051 0.102 ion transport;elevation of
exp SHPRH 6q24.3 0.435 0.000512 0.102 DNA Damage Response (DDR); DDR
(TLS)
met S1PR4 19p13.3 -0.435 0.000512 0.102 elevation of cytosolic
exp CD8A 2p12 0.435 0.000513 0.102 regulation of immune response;T cell
mediated immunity
exp NTS 12q21 0.435 0.000514 0.102 signal transduction;regulation of blood
vessel size
exp BEND3 6q21 0.435 0.000515 0.102
exp LINC00539 0.435 0.000515 0.102
hs4 PSMA8 18q11.2 0.438 0.000516 0.102 antigen processing and presentation
of peptide antigen via MHC class I;RNA metabolic process
exp UBE3D 6q14.1 0.435 0.000517 0.102
xai HAUS1 18q21.1 0.438 0.000518 0.102 cell cycle;mitosis
met CDC42BPB 14q32.3 0.435 0.000518 0.102 Protein Kinases
hs4 NR2F2-AS1 -0.438 0.000519 0.102
hs4 ICAM3 19p13.3-p13.2 0.438 0.000521 0.102 cell-cell adhesion;regulation
of immune response
his MMS22L 6q16.1 0.438 0.000522 0.102 DNA Damage Response (DDR)
exp HNRNPA1P64 1p31.1 0.438 0.000523 0.102
exp ZNF397 18q12.2 0.434 0.000524 0.102 viral reproduction
swa EHD2 19q13.3 -0.438 0.000524 0.102 endocytosis;blood coagulation
exp PAICS 4q12 0.434 0.000526 0.102 purine base metabolic process;purine
nucleotide biosynthetic process
exp ADHFE1 8q13.1 -0.434 0.000526 0.102 2-oxoglutarate metabolic
xai HMHB1 5q31.3 0.438 0.000529 0.102
xai RBMS3 3p24-p23 -0.438 0.000529 0.102
his ARHGAP4 Xq28 0.438 0.00053 0.102 induction of apoptosis by
hs4 CEACAM21 19q13.2 0.437 0.00053 0.102
xai ATXN2L 0.437 0.000531 0.102
exp ANKLE1 19p13.11 0.434 0.000531 0.102
exp LOC100132712 5q31.3 -0.434 0.000532 0.102
exp WDR4 21q22.3 0.437 0.000533 0.102 tRNA modification
exp EFCAB10 7q22.3 0.437 0.000536 0.102 signal transduction
met VEGFA 6p12 0.434 0.000537 0.102 patterning of blood vessels;positive
regulation of mesenchymal cell proliferation
exp WAS Xp11.4-p11.21 0.434 0.000537 0.102 defense response;T cell
activation
his CPXM1 20p13 0.437 0.000538 0.102 proteolysis;cell adhesion
xsq RAB37 17q25.1 0.434 0.000538 0.102 protein transport;small GTPase
xai NTS 12q21 0.437 0.00054 0.102 signal transduction;regulation of blood
vessel size
hs4 LINC01215 0.437 0.00054 0.102
exp SNRPGP10 1q32.1 0.434 0.00054 0.102
xai RPL9P32 19q12 0.437 0.000543 0.102
xsq DFFB 1p36.3 0.433 0.000543 0.102 Apoptosis
xai LEPROT 1p31.3 -0.437 0.000543 0.102 negative regulation of
protein localization at cell surface;negative regulation of JAK-STAT cascade
exp RPL9P32 19q12 0.437 0.000544 0.102
met DOCK1 10q26.13-q26.3 0.433 0.000544 0.102 Apoptosis
xsq CCR7 17q12-q21.2 0.433 0.000545 0.102 positive regulation of dendritic
cell antigen processing and presentation;positive regulation of glycoprotein
xai HDAC11 3p25.1 -0.437 0.000545 0.102 regulation of
his DBT 1p31 0.437 0.000547 0.102 metabolic process;branched chain family
amino acid catabolic process
mut PPFIA1 11q13.3 0.433 0.000548 0.102 cell-matrix adhesion;signal
transduction
xsq WT1-AS 11p13 0.433 0.000552 0.102
his SDHAF4 0.436 0.000554 0.102
exp LAMB2 3p21 -0.433 0.000554 0.102 neuromuscular junction
exp ARHGEF12 11q23.3 -0.433 0.000554 0.102 nerve growth factor
receptor signaling pathway;apoptotic process
exp HNRNPA1P14 0.436 0.000555 0.102
xai RPL4P3 1q24.3 0.436 0.000556 0.102
xai YEATS4 12q13-q15 0.436 0.000557 0.102 chromatin
modification;regulation of growth
xai RPL6P25 12q21.31 0.436 0.000558 0.102
exp IQGAP2 5q13.3 0.433 0.000558 0.102 signal
mir hsa-miR-23b -0.432 0.000559 0.102
xsq MBNL2 13q32.1 -0.432 0.00056 0.102 mRNA processing;regulation of
RNA splicing
hs4 FAM114A1 4p14 -0.436 0.000561 0.102
hs4 MIR574 -0.436 0.000561 0.102
xai GZMM 19p13.3 0.436 0.000562 0.102 apoptotic process;cytolysis
xsq XPNPEP2 Xq25 0.432 0.000562 0.102 proteolysis;cellular process
his CRYAB 11q22.3-q23.1 -0.436 0.000562 0.102 protein folding;anti-
apoptosis
his HSPB2 11q22-q23 -0.436 0.000562 0.102 Apoptosis
his HSPB2-C11orf52 -0.436 0.000562 0.102
his C11orf52 11q23.1 -0.436 0.000562 0.102
xai RPS4XP6 5p13.2 0.436 0.000563 0.102
exp RPS4XP1 12q23.1 0.432 0.000563 0.102
met ASAP2 2p25 0.432 0.000563 0.102 regulation of ARF GTPase
xai ALKBH2 12q24.11 0.436 0.000565 0.102 DNA Damage Response (DDR);
DDR (Direct Repair)
exp RBMS3 3p24-p23 -0.432 0.000565 0.102
xai B4GALT1 9p13 -0.436 0.000565 0.102 epithelial cell
hs4 WAS Xp11.4-p11.21 0.435 0.000567 0.102 defense response;T cell
activation
met SLC44A2 19p13.1 0.432 0.000567 0.102 Solute Carriers
exp S1PR4 19p13.3 0.432 0.00057 0.102 elevation of cytosolic calcium ion
concentration;immune response
hs4 LRRC38 1p36.21 0.435 0.000571 0.102
xai HIST1H2AB 6p22.1 0.435 0.000572 0.102 nucleosome assembly
exp HNRNPA1P10 19p13.2 0.432 0.000572 0.102
mut SDC3 1p35.2 0.432 0.000573 0.102 cell adhesion
xsq TRAF3IP3 1q32 0.431 0.000577 0.102
xsq FCHO1 19p13.11 0.431 0.000578 0.102
xai HIST1H2AM 6p22.1 0.435 0.000579 0.102
xai RSL1D1 16p13.13 0.435 0.000579 0.102 translation;regulation of
protein localization
xai ANP32E 1q21.2 0.435 0.00058 0.102 DNA Damage Response (DDR)
mut PPP2R2C 4p16.1 0.431 0.00058 0.102 signal transduction
xsq DMC1 22q13.1 0.431 0.00058 0.102 DNA Damage Response (DDR); DDR (DNA
replication)
xsq LHFP 13q12 -0.431 0.000581 0.102
exp RPL6P25 12q21.31 0.435 0.000582 0.102
exp CDT1 16q24.3 0.431 0.000582 0.102 DDR (DNA replication)
his ASB3 2p16.2 0.435 0.000583 0.102 intracellular signal transduction
his ERLEC1 2p16.2 0.435 0.000583 0.102 ER-associated protein
catabolic process
xai HORMAD2 22q12.2 0.435 0.000583 0.102 meiosis
exp HIST1H2AB 6p22.1 0.435 0.000583 0.102 nucleosome assembly
exp RND3 2q23.3 -0.431 0.000583 0.102 GTP catabolic process;cell
adhesion
exp LGALS3BP 17q25 -0.431 0.000583 0.102 cellular defense
swa ACTN4 19q13 -0.435 0.000583 0.102 Apoptosis
hs4 FCHO1 19p13.11 0.435 0.000584 0.102
exp FAM86LP 7p22.1 0.435 0.000584 0.102
xsq KIF21B 1q32.1 0.431 0.000586 0.102 microtubule-based movement
his DYRK4 12p13.32 0.434 0.000587 0.102 protein phosphorylation
xai RPL21P12 14q32.32 0.434 0.000587 0.102
exp PIGAP1 12q21 -0.431 0.000587 0.102
his EXOSC2 9q34 0.434 0.000588 0.102 positive regulation of cell
hs4 LOC100130417 1p36.33 0.434 0.000589 0.102
swa PAICS 4q12 0.434 0.000589 0.102 purine base metabolic process;purine
xai MBTD1 17q21.33 0.434 0.00059 0.102 regulation of transcription, DNA-
dependent;chromatin modification"
xai RGS16 1q25-q31 0.434 0.000591 0.102 visual perception;regulation of G-
protein coupled receptor protein signaling pathway
exp RPS4XP6 5p13.2 0.434 0.000592 0.102
xai KRT1 12q13.13 0.434 0.000594 0.102 complement activation, lectin
xsq RLTPR 16q22.1 0.431 0.000594 0.102
exp S100PBP 1p35.1 0.43 0.000596 0.102
xai PTPN7 1q32.1 0.434 0.000597 0.102 protein dephosphorylation;peptidyl-
tyrosine dephosphorylation
hs4 TNFSF8 9q33 0.434 0.000597 0.102 cell-cell signaling;cell
proliferation
exp HNRNPA1P41 9p24.1 0.43 0.000597 0.102
hs4 DLEU7 13q14.3 0.434 0.000598 0.102
xai KATNA1 6q25.1 0.434 0.000598 0.102 mitosis;protein localization
exp ARHGAP19 10q24.1 0.43 0.000599 0.102 signal transduction;small
xai C12orf45 12q23.3 0.434 6e-04 0.102
xai ARHGAP9 12q13.3 0.434 0.000603 0.102 positive regulation of GTPase
activity;regulation of small GTPase mediated signal transduction
met LAPTM5 1p34 -0.43 0.000603 0.102 transport
exp RPS4XP2 20p13 0.43 0.000605 0.102
swa FKBP9 7p11.1 -0.433 0.000606 0.102 protein peptidyl-prolyl
isomerization;protein folding
xai SNRPF 12q23.1 0.433 0.000607 0.102 termination of RNA polymerase II
transcription;mRNA processing
xai DAZAP1 19p13.3 0.433 0.000608 0.102 multicellular organismal
exp CTSLP6 -0.43 0.000613 0.102
exp GIPC1 19p13.1 -0.43 0.000614 0.102 protein targeting;regulation of
synaptic plasticity
xai EEF1B2P1 15q21.2 0.433 0.000615 0.102
xai AGBL5 2p23.3 0.433 0.000615 0.102 proteolysis;protein deglutamylation
exp PRR3 6p21.33 0.429 0.000616 0.102
xsq PRRT4 7q32.1 0.429 0.000617 0.102
his FOXO4 Xq13.1 0.433 0.000618 0.102 Apoptosis
his ZNF142 2q35 0.433 0.000619 0.102 regulation of transcription, DNA-
dependent"
his BCS1L 2q33 0.433 0.000619 0.102 mitochondrion organization;mitochondrial
respiratory chain complex I assembly
xsq IKZF1 7p12.2 0.429 0.000619 0.102 mesoderm development;positive
exp NOB1 16q22.3 0.429 0.000619 0.102
met TSPAN9 12p13.33-p13.32 0.429 0.000623 0.102
xai EPHA4 2q36.1 -0.433 0.000624 0.102 adult walking
behavior;negative regulation of axon regeneration
exp KATNA1 6q25.1 0.429 0.000626 0.102 mitosis;protein localization
met B4GALT2 1p34-p33 0.429 0.000626 0.102 post-translational protein
modification;cellular protein metabolic process
exp ILF2P1 0.432 0.000628 0.102
exp HIST1H3B 6p22.1 0.429 0.000631 0.102
his EMB 5q11.1 0.432 0.000634 0.102 cell adhesion
xai HCST 19q13.1 0.432 0.000638 0.102 regulation of immune response
swa NUDCD2 5q34 0.432 0.000639 0.102
exp SMIM8 6q15 0.428 0.000639 0.102
exp RPL4P3 1q24.3 0.432 0.000642 0.102
exp SNORA33 6q23.2 0.432 0.000642 0.102
xai CHRM3-AS2 0.431 0.000645 0.102
xai FLJ37453 1p36.21 0.431 0.000645 0.102
exp PDCD4-AS1 10q25.2 0.428 0.000646 0.102
xsq ADRBK2 22q12.1 0.428 0.000648 0.102 protein
phosphorylation;signal transduction
exp KCNK17 6p21.1 0.428 0.000648 0.102 ion transport;potassium ion
transport
xai RSL24D1 15q21 0.431 0.000649 0.102 translation;ribosome biogenesis
xai SIVA1 14q32.33 0.431 0.000651 0.102 Apoptosis
xai RPLP1P13 0.431 0.000651 0.102
exp LY6H 8q24.3 0.428 0.000651 0.102 nervous system development;organ
morphogenesis
exp RPLP1P13 0.431 0.000652 0.102
met TXLNG Xp22.2 0.428 0.000653 0.102 regulation of transcription, DNA-
dependent;regulation of cell cycle process
xai NOLC1 10q24.32 0.431 0.000654 0.102 positive regulation of cell
proliferation;box H/ACA snoRNA metabolic process
met HSPA12A 10q26.12 0.428 0.000654 0.102
swa WDR77 1p13.2 0.431 0.000655 0.102 regulation of transcription from
RNA polymerase II promoter;positive regulation of cell proliferation
xsq HAAO 2p21 0.428 0.000655 0.102 small molecule metabolic process;response
to cadmium ion
xsq BSN 3p21.31 0.428 0.000655 0.102 synaptic transmission
xsq ZNF397 18q12.2 0.428 0.000655 0.102 viral reproduction
xai RRP1B 21q22.3 0.431 0.000657 0.102 rRNA processing;negative regulation
of phosphatase activity
xai ZCCHC3 20p13-p12.2 0.431 0.000658 0.102
xai ILF2P1 0.431 0.000658 0.102
his NUDT8 11q13.2 0.431 0.000659 0.102
mut ARL3 10q23.3 0.427 0.00066 0.102 photoreceptor cell
development;cilium morphogenesis
mut GIPC1 19p13.1 0.427 0.00066 0.102 protein targeting;regulation of
synaptic plasticity
mut TST 22q13.1 0.427 0.00066 0.102 small molecule metabolic
process;rRNA transport
mut KIF4A Xq13.1 0.427 0.00066 0.102 organelle organization;microtubule-
based movement
xsq XLOC_008559 0.427 0.00066 0.102
xsq SNORA54 0.427 0.00066 0.102
xsq KIR2DS5 0.427 0.00066 0.102 immune response
mut CAMK2N1 1p36.12 0.427 0.00066 0.102 negative regulation of
phosphorylation;negative regulation of catalytic activity
mut FGR 1p36.2-p36.1 0.427 0.00066 0.102 immune response-regulating
cell surface receptor signaling pathway;positive regulation of cell migration
mut MKNK1 1p33 0.427 0.00066 0.102 Protein Kinases
mut GCLM 1p22.1 0.427 0.00066 0.102 cysteine metabolic process;negative
regulation of neuron apoptosis
mut AP4B1 1p13.2 0.427 0.00066 0.102 intracellular protein
transport;vesicle-mediated transport
mut USF1 1q22-q23 0.427 0.00066 0.102 response to hypoxia;positive
mut PPP1R15B 1q32.1 0.427 0.00066 0.102 dephosphorylation;response to
hydrogen peroxide
mut PFKFB2 1q31 0.427 0.00066 0.102 Apoptosis
mut PGBD2 1q44 0.427 0.00066 0.102
mut RHOB 2p24 0.427 0.00066 0.102 Apoptosis
mut TMEM178A 2p22.1 0.427 0.00066 0.102
mut RPIA 2p11.2 0.427 0.00066 0.102 carbohydrate metabolic
mut CDK5R2 2q35 0.427 0.00066 0.102 regulation of cyclin-dependent
protein kinase activity
mut TADA3 3p25.3 0.427 0.00066 0.102 DNA Damage Response (DDR)
mut NEK10 3p24.1 0.427 0.00066 0.102
mut LSAMP 3q13.2-q21 0.427 0.00066 0.102 cell adhesion;nervous system
development
mut FGFRL1 4p16 0.427 0.00066 0.102 negative regulation of cell
proliferation;fibroblast growth factor receptor signaling pathway
mut PI4K2B 4p15.2 0.427 0.00066 0.102
mut PPA2 4q25 0.427 0.00066 0.102 tRNA aminoacylation for protein
translation;gene expression
mut TNPO1 5q13.2 0.427 0.00066 0.102 protein import into nucleus,
translocation;gene expression
mut EXOC2 6p25.3 0.427 0.00066 0.102 exocytosis;protein transport
mut TFEB 6p21 0.427 0.00066 0.102 positive regulation of transcription from
RNA polymerase II promoter;embryonic placenta development
mut PRDM13 6q16.2 0.427 0.00066 0.102 regulation of transcription,
DNA-dependent"
mut GOPC 6q21 0.427 0.00066 0.102 spermatid nucleus differentiation;protein
transport
mut MAN1A1 6q22 0.427 0.00066 0.102 post-translational protein
mut IFRD1 7q31.1 0.427 0.00066 0.102 multicellular organismal
development;myoblast cell fate determination
mut RAB14 9q32-q34.11 0.427 0.00066 0.102 neurotransmitter
secretion;intracellular transport
mut PTRH1 9q34.11 0.427 0.00066 0.102
mut GTF3C4 9q34.13 0.427 0.00066 0.102 positive regulation of
catalytic activity;transcription, DNA-dependent
mut EGR2 10q21.1 0.427 0.00066 0.102 learning or memory;regulation of
ossification
mut MCU 10q22.1 0.427 0.00066 0.102 ion transport;mitochondrial calcium
ion transport
mut CAMK2G 10q22 0.427 0.00066 0.102 cytokine-mediated signaling
pathway;insulin secretion
mut CCNJ 10q23.33 0.427 0.00066 0.102
mut CUTC 10q24.2 0.427 0.00066 0.102 copper ion transport;protein
tetramerization
mut VENTX 10q26.3 0.427 0.00066 0.102
mut ARFIP2 11p15 0.427 0.00066 0.102 cellular component movement;small
mut RBMXL2 11p15 0.427 0.00066 0.102
mut CD6 11q13 0.427 0.00066 0.102 cell adhesion
mut TKFC 0.427 0.00066 0.102 glycerol metabolic process;innate immune
response
mut ARHGAP32 11q24.3 0.427 0.00066 0.102 signal transduction;small
mut NINJ2 12p13 0.427 0.00066 0.102 cell adhesion;neuron cell-cell adhesion
mut TEAD4 12p13.3-p13.2 0.427 0.00066 0.102 regulation of transcription,
DNA-dependent;regulation of transcription from RNA polymerase II promoter
mut LPCAT3 12p13 0.427 0.00066 0.102 phospholipid biosynthetic process
mut PROSER1 13q13.3 0.427 0.00066 0.102
mut KLHDC2 14q21.3 0.427 0.00066 0.102
mut SAV1 14q13-q23 0.427 0.00066 0.102 negative regulation of epithelial
cell proliferation;negative regulation of cardiac muscle cell proliferation
mut ESR2 14q23.2 0.427 0.00066 0.102 neuron migration;intracellular
estrogen receptor signaling pathway
mut RAB8B 15q22.2 0.427 0.00066 0.102 protein transport;positive
regulation of cell projection organization
mut ZDHHC1 16q22.1 0.427 0.00066 0.102 protein palmitoylation
mut CHST5 16q22.3 0.427 0.00066 0.102 carbohydrate metabolic process;N-
acetylglucosamine metabolic process
mut SLC38A8 16q23.3 0.427 0.00066 0.102 Solute Carriers
mut CDT1 16q24.3 0.427 0.00066 0.102 DDR (DNA replication)
mut DHX33 17p13.2 0.427 0.00066 0.102 positive regulation of
transcription from RNA polymerase I promoter
mut PFAS 17p13.1 0.427 0.00066 0.102 purine base metabolic
mut MAP3K3 17q23.3 0.427 0.00066 0.102 Protein Kinases
mut MAFG 17q25.3 0.427 0.00066 0.102 regulation of transcription, DNA-
dependent;blood coagulation
mut SLC35E1 19p13.11 0.427 0.00066 0.102 Solute Carriers
mut SLC7A10 19q13.1 0.427 0.00066 0.102 amino acid transport;blood
coagulation
mut ETHE1 19q13.31 0.427 0.00066 0.102 sulfur amino acid metabolic
process;sulfur amino acid catabolic process
mut PVR 19q13.2 0.427 0.00066 0.102 cell junction assembly;adherens
junction organization
mut LILRB4 19q13.4 0.427 0.00066 0.102 signal transduction;negative
regulation of osteoclast differentiation
mut ZNF547 19q13.43 0.427 0.00066 0.102 regulation of transcription,
DNA-dependent"
mut SOD1 21q22.11 0.427 0.00066 0.102 DNA Damage Response (DDR)
mut IFNAR2 21q22.11 0.427 0.00066 0.102 cell surface receptor
signaling pathway;JAK-STAT cascade
mut C21orf2 21q22.3 0.427 0.00066 0.102 cytoskeleton
organization;regulation of cell shape
mut WNT7B 22q13 0.427 0.00066 0.102 Oncogenes
mut CXorf23 Xp22.12 0.427 0.00066 0.102
mut NR0B1 Xp21.3 0.427 0.00066 0.102 spermatogenesis;male sex
determination
mut DDX3X Xp11.3-p11.23 0.427 0.00066 0.102 interspecies interaction
between organisms
mut MAGED1 Xp11.23 0.427 0.00066 0.102 regulation of transcription,
DNA-dependent;apoptotic process
xsq HMHB1 5q31.3 0.427 0.00066 0.102
mut AGMAT 1p36.21 0.427 0.00066 0.102 polyamine metabolic
process;spermidine biosynthetic process
mut BNIPL 1q21.3 0.427 0.00066 0.102 apoptotic process;induction of
apoptosis
mut RXFP4 0.427 0.00066 0.102
mut STX6 1q25.3 0.427 0.00066 0.102 vesicle fusion;endosome
organization
mut DEGS1 1q42.11 0.427 0.00066 0.102 unsaturated fatty acid biosynthetic
process;sphingolipid metabolic process
mut MFSD9 2q12.1 0.427 0.00066 0.102 transmembrane transport
mut RPL37A 2q35 0.427 0.00066 0.102 gene expression;viral reproduction
mut AGXT 2q37.3 0.427 0.00066 0.102 small molecule metabolic
process;glyoxylate metabolic process
mut RPUSD3 3p25.3 0.427 0.00066 0.102 pseudouridine synthesis
mut CCDC50 3q28 0.427 0.00066 0.102
mut HPSE 4q21.3 0.427 0.00066 0.102 positive regulation vascular
endothelial growth factor production;positive regulation of blood coagulation
mut POU4F2 4q31.2 0.427 0.00066 0.102 MAPK cascade;positive
mut MED20 6p21.1 0.427 0.00066 0.102 transcription, DNA-
mut CLDN3 7q11.23 0.427 0.00066 0.102 response to hypoxia;calcium-
independent cell-cell adhesion
mut AKR1D1 7q32-q33 0.427 0.00066 0.102 small molecule metabolic
process;bile acid biosynthetic process
mut GRHL2 8q22.3 0.427 0.00066 0.102 EMT (Epithelial)
mut TBC1D31 8q24.13 0.427 0.00066 0.102
mut FAM84B 8q24.21 0.427 0.00066 0.102
mut NFX1 9p13.3 0.427 0.00066 0.102 interspecies interaction between
organisms;negative regulation of MHC class II biosynthetic process
mut PHF2 9q22.31 0.427 0.00066 0.102 protein demethylation;chromatin
modification
mut ANKS6 9q22.33 0.427 0.00066 0.102
mut C1QL3 10p13 0.427 0.00066 0.102
mut PGM2L1 11q13.4 0.427 0.00066 0.102 carbohydrate metabolic
process;glucose 1-phosphate metabolic process
mut KCTD21 11q14.1 0.427 0.00066 0.102 potassium ion transport
mut TMEM30B 14q23.1 0.427 0.00066 0.102 positive regulation of
protein exit from endoplasmic reticulum
mut ANKRD9 14q32.31 0.427 0.00066 0.102
mut TPM1 15q22.1 0.427 0.00066 0.102 positive regulation of heart rate
by epinephrine;ruffle organization
mut RCN2 15q23 0.427 0.00066 0.102
mut GUCY2D 17p13.1 0.427 0.00066 0.102 cGMP biosynthetic
process;receptor guanylyl cyclase signaling pathway
mut MGAT5B 17q25.2 0.427 0.00066 0.102
mut SLC5A5 19p13.11 0.427 0.00066 0.102 cellular nitrogen compound
mut ZNF296 19q13.32 0.427 0.00066 0.102 spermatogenesis;regulation of
mut ATP6V1E1 22q11.1 0.427 0.00066 0.102 ion transport;cellular iron
ion homeostasis
mut CCDC157 22q12.2 0.427 0.00066 0.102
mut PRR5 22q13 0.427 0.00066 0.102 cell cycle
mut TAB3 Xp21.2 0.427 0.00066 0.102 MyD88-independent toll-like
receptor signaling pathway;TRIF-dependent toll-like receptor signaling pathway
mut USP11 Xp11.23 0.427 0.00066 0.102 proteolysis;ubiquitin-dependent
protein catabolic process
mut KCND1 Xp11.23 0.427 0.00066 0.102 synaptic transmission;transmembrane
transport
mut CD99L2 Xq28 0.427 0.00066 0.102 cell adhesion
mut SLC45A1 1p36.23 0.427 0.00066 0.102 Solute Carriers
mut SCARB2 4q21.1 0.427 0.00066 0.102 protein targeting to
lysosome;cell adhesion
mut SFRP1 8p11.21 0.427 0.00066 0.102 ureteric bud development;negative
regulation of cell proliferation
mut TRADD 16q22 0.427 0.00066 0.102 Apoptosis
mut GATA1 Xp11.23 0.427 0.00066 0.102 Tumor Suppressors
mut ALAS1 3p21.1 0.427 0.00066 0.102 tetrapyrrole biosynthetic
xai S100PBP 1p35.1 0.431 0.000661 0.102
hs4 PLOD2 3q24 -0.431 0.000664 0.103 response to hypoxia;protein
modification process
xai NOP2 12p13 0.43 0.000666 0.103 rRNA processing;positive regulation of
cell proliferation
exp EEF1B2P2 5q13.1 0.427 0.000666 0.103
xai CREB3 9p13.3 -0.43 0.000666 0.103 reactivation of latent
virus;positive regulation of cell migration
xsq RASA4 7q22 0.427 0.000669 0.103 regulation of small GTPase mediated
signal transduction;positive regulation of Ras GTPase activity
xsq MARS2 2q33.1 0.427 0.000669 0.103 tRNA aminoacylation for protein
translation;methionyl-tRNA aminoacylation
met DBNDD1 16q24.3 0.427 0.00067 0.103
exp BIN2 0.427 0.000671 0.103
xai IKZF1 7p12.2 0.43 0.000672 0.103 mesoderm development;positive
met OTUB2 14q32.12 0.427 0.000672 0.103 proteolysis;cellular amino acid
metabolic process
xai SDC2 8q22-q23 -0.43 0.000674 0.103 response to hypoxia;response to
caffeine
xsq LTA 6p21.3 0.427 0.000675 0.103 response to hypoxia;response to
nutrient
mut HGD 3q13.33 0.427 0.000676 0.103 tyrosine catabolic process;cellular
nitrogen compound metabolic process
exp ANLN 7p15-p14 -0.427 0.000676 0.103 cytokinesis;septin ring
assembly
exp RPL21P12 14q32.32 0.43 0.000677 0.103
his CARF 2q33.2 0.43 0.000678 0.103
his WDR12 2q33.2 0.43 0.000678 0.103 maturation of LSU-rRNA from
tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S
rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
exp LHFP 13q12 -0.427 0.000678 0.103
xai ANLN 7p15-p14 -0.43 0.00068 0.103 cytokinesis;septin ring assembly
hs4 S1PR4 19p13.3 0.43 0.000681 0.103 elevation of cytosolic calcium ion
concentration;immune response
xsq GZMM 19p13.3 0.426 0.000681 0.103 apoptotic process;cytolysis
xai RND3 2q23.3 -0.43 0.000685 0.104 GTP catabolic process;cell adhesion
xsq PTPN7 1q32.1 0.426 0.000687 0.104 protein dephosphorylation;peptidyl-
swa AP1S1 7q22.1 0.429 0.000688 0.104 viral reproduction;cellular
membrane organization
xai DCTPP1 16p11.2 0.429 0.000689 0.104 nucleoside triphosphate
catabolic process;protein homotetramerization
xai ADAM33 20p13 0.429 0.00069 0.104 proteolysis;integrin-mediated
signaling pathway
xai FKBP9 7p11.1 -0.429 0.000695 0.105 protein peptidyl-prolyl
exp CHRM3-AS2 0.429 0.000697 0.105
exp L1CAM Xq28 -0.426 0.000697 0.105 leukocyte cell-cell adhesion;cell
differentiation
exp FAM71F2 7q32.1 -0.429 7e-04 0.105
hs4 SLC18A2 10q25 0.429 0.000708 0.106 Solute Carriers
xai EEF1B2P2 5q13.1 0.429 0.000709 0.106
xai ABCE1 4q31 0.429 0.00071 0.106 ABC Transporters
xai RLTPR 16q22.1 0.428 0.00071 0.106
mut COG1 17q25.1 0.425 0.00071 0.106 intra-Golgi vesicle-mediated
transport;Golgi organization
xai GIPC1 19p13.1 -0.428 0.00071 0.106 protein targeting;regulation
of synaptic plasticity
xai FBXO32 8q24.13 -0.428 0.000711 0.106 muscle atrophy
exp HAR1A 20q13.33 0.425 0.000712 0.106
xsq EPAS1 2p21-p16 -0.425 0.000715 0.107 response to
hypoxia;multicellular organismal development
xsq KRT72 12q13.13 0.425 0.000716 0.107
xai TMC8 17q25.3 0.428 0.000718 0.107
xsq LYL1 19p13.2 0.425 0.000718 0.107 regulation of transcription, DNA-
dependent;B cell differentiation
xai LOC100129034 -0.428 0.000718 0.107
xai ARHGEF12 11q23.3 -0.428 0.00072 0.107 nerve growth factor
his PRAM1 19p13.2 0.428 0.000721 0.107 integrin-mediated signaling
pathway;regulation of neutrophil degranulation
hs4 RHBDL2 1p34.3 -0.428 0.000722 0.107 proteolysis
xsq PEX5 12p13.31 0.424 0.000724 0.107 protein targeting to
peroxisome;protein transport
xsq PTGDR 14q22.1 0.424 0.000724 0.107 G-protein coupled receptor
signaling pathway;male sex determination
xai ICAM3 19p13.3-p13.2 0.428 0.000726 0.107 cell-cell adhesion;regulation
of immune response
xai GMEB1 1p35.3 0.428 0.000726 0.107
met PDE6A 5q31.2-q34 -0.424 0.000726 0.107 signal transduction;blood
coagulation
exp CREB3 9p13.3 -0.424 0.00073 0.108 reactivation of latent
xai MIR142 0.428 0.000732 0.108
xsq SPECC1 17p11.2 -0.424 0.000733 0.108
xsq LOC63930 0.424 0.000735 0.108
met TEAD1 11p15.2 0.424 0.000735 0.108 regulation of transcription, DNA-
dependent;hippo signaling cascade"
xsq HS3ST4 16p11.2 0.424 0.000736 0.108 heparan sulfate proteoglycan
metabolic process
met EMP2 16p13.2 0.424 0.000738 0.108 cell proliferation
exp RPL21P120 17p11.2 0.424 0.000739 0.108
exp PTPN2P1 1q25.2 0.424 0.00074 0.108
exp RSL1D1 16p13.13 0.424 0.000742 0.109 translation;regulation of
exp RLTPR 16q22.1 0.424 0.000744 0.109
exp CEP76 18p11.21 0.424 0.000745 0.109 G2/M transition of mitotic cell
cycle;mitotic cell cycle
hs4 BIN2 0.427 0.000746 0.109
xai CHD1L 1q12 0.427 0.000748 0.109 ATP catabolic process;DNA repair
exp AAAS 12q13 0.423 0.000755 0.11 hexose transport;transmembrane transport
xai C20orf196 20p12.3 0.426 0.000758 0.11
exp RSL24D1 15q21 0.423 0.00076 0.11 translation;ribosome biogenesis
mut OR6K2 1q23.1 0.423 0.000762 0.111
xai SNX20 16q12.1 0.426 0.000764 0.111 cell communication;protein
transport
exp HCST 19q13.1 0.423 0.000764 0.111 regulation of immune response
met KCTD11 17p13.1 0.423 0.000765 0.111 regulation of
growth;regulation of cell proliferation
xai NPC2 14q24.3 -0.426 0.000765 0.111 phospholipid
exp LY9 1q23.3 0.423 0.000766 0.111 cell adhesion;immunoglobulin
mediated immune response
exp ABCE1 4q31 0.423 0.000767 0.111 ABC Transporters
mir hsa-let-7e -0.423 0.000769 0.111
hs4 GALNT11 7q36.1 -0.426 0.00077 0.111 O-glycan
xai SAMD4A 14q22.2 -0.426 0.00077 0.111 negative regulation of
xai PTPRJ 11p11.2 -0.426 0.000771 0.111 positive regulation of
macrophage chemotaxis;positive regulation of cell adhesion
exp PYHIN1 1q23.1 0.422 0.000774 0.111 cell cycle
xsq GOLGA8R 0.422 0.000775 0.111
mir hsa-miR-125a-5p -0.422 0.000776 0.111
xai RPL7AP7 6p21.3 0.425 0.000782 0.112
mut MKX 10p12.1 0.422 0.000783 0.112 multicellular organismal
development;muscle organ development
hs4 LYL1 19p13.2 0.425 0.000785 0.112 regulation of transcription, DNA-
exp CARD8-AS1 0.422 0.000786 0.112
xai PLXNB2 22q13.33 -0.425 0.000786 0.112 brain
development;regulation of cell shape
met GULP1 2q32.3-q33 0.422 0.000789 0.113 Apoptosis
exp PTPRJ 11p11.2 -0.422 0.000789 0.113 positive regulation of
exp RPL36AP7 17q25.1 0.422 0.000792 0.113
exp IKZF1 7p12.2 0.422 0.000795 0.113 mesoderm development;positive
pro GRB2 17q24-q25 0.422 0.000796 0.113 cell-cell signaling;T cell
costimulation
xai LHFP 13q12 -0.425 0.000796 0.113
xai SEPT11 4q21.1 -0.425 0.000796 0.113 cell cycle;protein
heterooligomerization
xai LAPTM4A 2p24.1 -0.425 8e-04 0.114 transport
exp TNFAIP8 5q23.1 0.421 0.000801 0.114 Apoptosis
exp CDC42BPA 1q42.11 -0.421 0.000801 0.114 Protein Kinases
hs4 AMOTL2 3q21-q22 -0.425 0.000805 0.114
hs4 MIR6827 -0.425 0.000805 0.114
xai TUFT1 1q21 -0.425 0.000805 0.114 odontogenesis;bone mineralization
his DOLPP1 9q34.1 0.424 0.000808 0.114 protein N-linked
glycosylation via asparagine;post-translational protein modification
xsq NOB1 16q22.3 0.421 0.000808 0.114
mut ITGB5 3q21.2 0.421 0.000809 0.114 antigen processing and presentation
of exogenous peptide antigen via MHC class I;antigen processing and presentation of
peptide antigen via MHC class I
hs4 TTC23L 5p13.2 -0.424 0.00081 0.114
xsq RBMS3 3p24-p23 -0.421 0.000811 0.114
exp SHISA4 1q32.1 -0.421 0.000811 0.114
xai POLE2 14q21-q22 0.424 0.000812 0.114 DNA Damage Response (DDR); DDR
(NER); DDR (DNA replication)
xai PDCD4-AS1 10q25.2 0.424 0.000814 0.114
xai GEMIN4 17p13 0.424 0.000816 0.114 RNA metabolic process;ncRNA
metabolic process
exp HNRNPCP3 15q25.1 0.421 0.000816 0.114
hs4 P2RY8 Xp22.33 0.424 0.000817 0.114
exp PTPN7 1q32.1 0.421 0.000818 0.114 protein dephosphorylation;peptidyl-
xai RHOC 1p13.1 -0.424 0.00082 0.115 regulation of small GTPase
mediated signal transduction;small GTPase mediated signal transduction
exp C16orf95 0.421 0.000822 0.115
xsq LOC101929715 0.42 0.000823 0.115
xsq KRT1 12q13.13 0.42 0.000823 0.115 complement activation, lectin
hs4 PCDHGA5 0.424 0.000824 0.115 cell adhesion;homophilic cell
adhesion
his SIVA1 14q32.33 0.424 0.000826 0.115 Apoptosis
his OSGEPL1-AS1 0.424 0.000826 0.115
his OSGEPL1 2q32.2 0.424 0.000826 0.115 proteolysis;tRNA processing
mut TMEM181 6q25.3 0.42 0.000828 0.115 pathogenesis
xsq KDM8 16p12.1 0.42 0.000828 0.115 G2/M transition of mitotic cell
cycle;cell cycle
xsq TNNT3 11p15.5 0.42 0.000829 0.115 skeletal muscle
contraction;regulation of striated muscle contraction
exp RRP1B 21q22.3 0.42 0.000829 0.115 rRNA processing;negative regulation
xai PTTG1IP 21q22.3 -0.423 0.000831 0.115 protein import into
nucleus
xsq C2orf40 2q12.2 0.42 0.000834 0.115 G1 to G0 transition;cellular
senescence
exp RPL7AP7 6p21.3 0.42 0.000835 0.115
his GRPEL2-AS1 0.423 0.000838 0.116
his PCYOX1L 5q32 0.423 0.000838 0.116 prenylcysteine catabolic process
met BCL9L 11q23.3 0.42 0.000841 0.116 negative regulation of transforming
growth factor beta receptor signaling pathway;positive regulation of transcription
from RNA polymerase II promoter
xsq ATP6V1E2 2p21 0.42 0.000841 0.116 cellular iron ion
homeostasis;insulin receptor signaling pathway
exp PTTG1IP 21q22.3 -0.42 0.000841 0.116 protein import into nucleus
xai KIF13A 6p23 -0.423 0.000841 0.116 cytokinesis;plus-end-directed
vesicle transport along microtubule
xai CD63 12q12-q13 -0.423 0.000841 0.116 platelet degranulation;blood
coagulation
exp TMC8 17q25.3 0.42 0.000843 0.116
exp PLXNB2 22q13.33 -0.42 0.000843 0.116 brain development;regulation
of cell shape
xsq HMHA1 19p13.3 0.42 0.000844 0.116 small GTPase mediated signal
hs4 CD276 15q23-q24 -0.423 0.000845 0.116 cell proliferation;positive
regulation of osteoblast differentiation
xsq SEPT6 Xq24 0.42 0.000846 0.116 cytokinesis;cell cycle
xsq ST5 11p15 -0.42 0.000847 0.116 positive regulation of ERK1 and ERK2
cascade
his C11orf44 11q24.3 -0.423 0.000847 0.116
mut HOXB1 17q21.3 0.42 0.000848 0.116 facial nerve structural
organization;facial nucleus development
his D2HGDH 2q37.3 0.423 0.000849 0.116 response to manganese
ion;response to zinc ion
xai PDCD2 6q27 0.423 0.00085 0.116 Apoptosis
exp CHD1L 1q12 0.419 0.000853 0.116 ATP catabolic process;DNA repair
xai L1CAM Xq28 -0.423 0.000853 0.116 leukocyte cell-cell adhesion;cell
differentiation
xai MDN1 6q15 0.423 0.000856 0.116 ATP catabolic process;protein complex
assembly
xai GAPDHP65 Xp11.3 0.423 0.000857 0.116
met JOSD2 19q13.33 0.419 0.000857 0.116 proteolysis;protein
deubiquitination
hs4 LTA 6p21.3 0.423 0.000858 0.116 response to hypoxia;response to
nutrient
xai EEF1A1P27 7p21.1 0.422 0.000858 0.116
swa POTEF 2q21.1 -0.422 0.000858 0.116
exp TERF2 16q22.1 0.419 0.000859 0.116 DNA Damage Response (DDR); DDR (DNA
replication)
hs4 CSF3R 1p35-p34.3 0.422 0.000861 0.116 defense response;cell adhesion
hs4 E2F2 1p36 0.422 0.000861 0.116 Tumor Suppressors
xsq ARRDC2 19p13.11 0.419 0.000863 0.116
exp ANP32D 12q13.11 0.419 0.000863 0.116
xsq CARD8-AS1 0.419 0.000863 0.116
xsq N4BP2L1 13q13.1 0.419 0.000864 0.116
xai CD4 12p13.31 0.422 0.000865 0.116 cell adhesion;entry into host cell
exp KIF13A 6p23 -0.419 0.000867 0.116 cytokinesis;plus-end-directed
xsq CEP76 18p11.21 0.419 0.000868 0.117 G2/M transition of mitotic cell
xsq XCL1 1q23 0.419 0.00087 0.117 immune response;positive regulation of
interleukin-10 production
xai TOP1MT 8q24.3 0.422 0.000871 0.117 DNA Damage Response (DDR);
DDR (DNA replication)
exp DST 6p12.1 -0.419 0.000871 0.117 axonogenesis;intracellular
transport
exp ZNRD1 6p21.3 0.419 0.000872 0.117 nucleobase-containing compound
metabolic process
hs4 ATP9A 20q13.2 -0.422 0.000873 0.117 cation transport;phospholipid
translocation
xai HNRNPA1P14 0.422 0.000874 0.117
DNA-dependent"
hs4 DAGLA 11q12.2 -0.422 0.000875 0.117 lipid catabolic
process;platelet activation
exp MDN1 6q15 0.418 0.000878 0.117 ATP catabolic process;protein complex
assembly
hs4 GBP2 1p22.2 -0.422 0.000878 0.117 immune response;cytokine-
exp ZNF280C Xq26.1 0.418 0.000879 0.117 regulation of transcription,
DNA-dependent"
exp MBTD1 17q21.33 0.418 0.000881 0.117 regulation of transcription, DNA-
xai LY6H 8q24.3 0.425 0.000882 0.117 nervous system development;organ
morphogenesis
xsq WWOX 16q23 0.418 0.000882 0.117 positive regulation of apoptotic
process;positive regulation of transcription from RNA polymerase II promoter
xai IQGAP2 5q13.3 0.422 0.000883 0.117 signal
xsq ZBTB4 17p13.1 -0.418 0.000883 0.117 regulation of transcription,
DNA-dependent"
exp SART3 12q24.1 0.418 0.000885 0.117 RNA processing
xai EPAS1 2p21-p16 -0.421 0.000885 0.117 response to
xai RRP9 3p21.2 0.421 0.000886 0.117 rRNA processing
mut ADGRF4 0.418 0.000886 0.117 G-protein coupled receptor
met SH3BP4 2q37.1-q37.2 0.418 0.000886 0.117 endocytosis
xsq P4HA2 5q31 -0.418 0.000886 0.117 peptidyl-proline hydroxylation to
4-hydroxy-L-proline
xai ENDOG 9q34.1 0.421 0.000887 0.117 response to antibiotic;in utero
embryonic development
hs4 SPNS3 17p13.2 0.421 0.000888 0.117 lipid transport;transmembrane
transport
hs4 CENPVL2 0.421 0.00089 0.117
xai GTF3C5 9q34 0.421 0.00089 0.117 tRNA transcription from RNA
polymerase III promoter;transcription, DNA-dependent
mut SEMA5B 3q21.1 0.418 0.00089 0.117 nervous system
his SH2D3C 9q34.11 0.421 0.000891 0.117 JNK cascade;small GTPase
his MIR3960 0.421 0.000891 0.117
his MIR2861 0.421 0.000891 0.117
his CDK9 9q34.1 0.421 0.000891 0.117 Protein Kinases
xsq NLRC3 16p13.3 0.418 0.000893 0.117 I-kappaB kinase/NF-kappaB
cascade;negative regulation of NF-kappaB transcription factor activity
met TMEM132A 11q12.2 0.418 0.000893 0.117
exp TUFT1 1q21 -0.418 0.000893 0.117 odontogenesis;bone mineralization
met SKA1 18q21.1 0.418 0.000894 0.117 mitosis;regulation of microtubule
polymerization or depolymerization
xsq KIAA0408 0.418 0.000895 0.117
hs4 LOC100129083 0.421 0.000896 0.117
xai RPL4P4 3q27.2 0.421 0.000896 0.117
xsq SPNS3 17p13.2 0.418 0.000897 0.117 lipid transport;transmembrane
transport
his BEND4 4p13 0.421 0.000899 0.117
xsq PHLDA3 1q31 -0.418 0.000899 0.117 negative regulation of
swa PFDN6 6p21.3 0.421 9e-04 0.117
hs4 PIK3CG 7q22.3 0.421 0.000903 0.117 Apoptosis; Cell Signaling;
Oncogenes; Protein Kinases
xsq GTPBP3 19p13.11 0.418 0.000903 0.117 tRNA modification
xai CDC42BPA 1q42.11 -0.421 0.000903 0.117 Protein Kinases
exp GAS2L3 12q23.1 -0.417 0.000904 0.117 cell cycle arrest
xai SIT1 9p13-p12 0.421 0.000906 0.117 signal transduction;regulation of T
cell activation
exp CBX3P2 18p11.32 0.417 0.000906 0.117
exp RPL4P4 3q27.2 0.421 0.000911 0.117
his RPA2 1p35 0.421 0.000911 0.117 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
exp FAM226B 0.417 0.000911 0.117
his CEP128 14q31.1 0.42 0.000919 0.118
his PLK2 5q12.1-q13.2 -0.42 0.00092 0.118 Protein Kinases
exp NPC2 14q24.3 -0.417 0.000923 0.119 phospholipid
hs4 CD93 20p11.21 0.42 0.000924 0.119 macrophage activation;interspecies
interaction between organisms
xai PDCD11 10q24.33 0.42 0.000927 0.119 Apoptosis
his CLDN19 1p34.2 0.42 0.000932 0.119 neuronal action potential
propagation;apical junction assembly
xai DST 6p12.1 -0.42 0.000932 0.119 axonogenesis;intracellular
transport
met SOX13 1q32 0.416 0.000933 0.119 regulation of transcription, DNA-
met CD79B 17q23 -0.416 0.000934 0.119 immune response;signal transduction
xai SHISA4 1q32.1 -0.42 0.000934 0.119
his MYH15 3q13.13 0.42 0.000936 0.12
met UAP1 1q23.3 0.416 0.000936 0.12 protein N-linked glycosylation via
asparagine;post-translational protein modification
exp ITGB5 3q21.2 -0.416 0.000939 0.12 antigen processing and
presentation of exogenous peptide antigen via MHC class I;antigen processing and
presentation of peptide antigen via MHC class I
met TCP11 6p21.31 -0.416 0.000943 0.12 multicellular organismal
xai RPL18AP15 Xq23 0.419 0.000944 0.12
his CHD1L 1q12 0.419 0.000945 0.12 ATP catabolic process;DNA repair
exp GAR1 4q25 0.416 0.000945 0.12 DNA Damage Response (DDR)
exp PPAT 4q12 0.416 0.000945 0.12 lactation;nucleobase-containing small
xai PXDC1 6p25.2 -0.419 0.000945 0.12 cell communication
exp SEPT11 4q21.1 -0.416 0.000946 0.12 cell cycle;protein
his VASN 16p13.3 -0.419 0.000947 0.12
xai FAM71F2 7q32.1 -0.419 0.000948 0.12
hs4 VASN 16p13.3 -0.419 0.000949 0.12
xsq SLC25A19 17q25.3 0.416 0.000951 0.12 Solute Carriers
xsq EAF2 3q13.33 0.416 0.000951 0.12 induction of apoptosis;negative
regulation of cell growth
xai RPS27AP3 20q11.2 0.419 0.000953 0.12
xai ZNRD1 6p21.3 0.419 0.000955 0.121 nucleobase-containing compound
metabolic process
hs4 FBXO32 8q24.13 -0.419 0.000956 0.121 muscle atrophy
xsq PRICKLE2 3p14.1 -0.416 0.000957 0.121 neuron projection
exp NOP2 12p13 0.416 0.000961 0.121 rRNA processing;positive regulation of
cell proliferation
exp RNGTT 6q16 0.415 0.000964 0.121 transcription from RNA polymerase II
promoter;mRNA capping
his PIGF 2p21-p16 0.419 0.000966 0.121 preassembly of GPI anchor in ER
membrane;post-translational protein modification
his CRIPT 2p21 0.419 0.000966 0.121 cytoplasmic microtubule
organization;establishment of protein localization
xai ITGB5 3q21.2 -0.419 0.000967 0.121 antigen processing and
xai CLNS1A 11q13.5-q14 0.419 0.000969 0.121 blood circulation;gene
expression
mir hsa-miR-22 -0.415 0.000969 0.121
exp SDC2 8q22-q23 -0.415 0.000969 0.121 response to hypoxia;response
to caffeine
exp ARHGAP9 12q13.3 0.415 0.000971 0.122 positive regulation of GTPase
met BCAM 19q13.2 0.415 0.000972 0.122 cell-matrix adhesion;signal
transduction
exp C12orf45 12q23.3 0.415 0.000973 0.122
xai EEF1A1P17 12q12 0.418 0.000975 0.122
exp STAP1 4q13.2 0.415 0.000975 0.122 intracellular protein
exp FBXO32 8q24.13 -0.415 0.000975 0.122 muscle atrophy
met PPP2R3A 3q22.1 0.415 0.000976 0.122 protein dephosphorylation
hs4 C20orf197 20q13.33 0.418 0.000981 0.122
exp SAMD4A 14q22.2 -0.415 0.000981 0.122 negative regulation of
xsq ICAM3 19p13.3-p13.2 0.415 0.000982 0.122 cell-cell adhesion;regulation
of immune response
swa SRPRB 3q22.1 -0.418 0.000982 0.122 cellular protein metabolic
process;translation
hs4 GTSF1 12q13.13 0.418 0.000984 0.122
xai EMB 5q11.1 0.418 0.000985 0.122 cell adhesion
mut FAM198B 4q32.1 0.415 0.000985 0.122
xai TSEN54 17q25.1 0.418 0.000986 0.122 mRNA processing;tRNA
splicing, via endonucleolytic cleavage and ligation"
mut DOT1L 19p13.3 0.415 0.000986 0.122 DDR (DNA replication)
xsq DUSP2 2q11 0.415 0.000987 0.122 regulation of apoptotic
exp FAM86C2P 11q13.2 0.415 0.000988 0.122
xai ANAPC1P1 2p11.2 0.418 0.000989 0.122
mut TRAM1L1 4q26 0.415 0.000989 0.122 protein transport
xsq FAM129C 19p13.11 0.415 0.00099 0.122
his RASSF1 3p21.3 0.418 0.000991 0.122 positive regulation of
protein ubiquitination;intracellular signal transduction
his RASSF1-AS1 0.418 0.000991 0.122
his ZMYND10 3p21.3 0.418 0.000991 0.122
xsq KIR3DS1 0.415 0.000992 0.122 immune response;natural killer cell
activation
exp CD63 12q12-q13 -0.415 0.000992 0.122 platelet degranulation;blood
coagulation
his HCG2040054 0.418 0.000993 0.122
exp TNKS1BP1 11q12.1 -0.414 0.000993 0.122 nuclear-transcribed mRNA
poly(A) tail shortening;telomere maintenance via telomerase
exp TOP1MT 8q24.3 0.414 0.000997 0.122 DNA Damage Response (DDR);
xai ZNF280C Xq26.1 0.418 0.000999 0.122 regulation of transcription,
DNA-dependent"
exp NDUFAF4 6q16.1 0.414 0.001 0.122 mitochondrial respiratory chain
complex I assembly
xai ST5 11p15 -0.417 0.001 0.122 positive regulation of ERK1 and ERK2
cascade
hs4 F13A1 6p25.3-p24.3 0.417 0.00101 0.123 peptide cross-
linking;platelet activation
hs4 CPXM1 20p13 0.417 0.00101 0.123 proteolysis;cell adhesion
his NECAP1 12p13.31 0.417 0.00101 0.123 endocytosis;protein transport
xsq MFNG 22q12 0.414 0.00101 0.123 pattern specification process
exp SF3B3 16q22.1 0.414 0.00101 0.123 RNA splicing, via
transesterification reactions;nuclear mRNA splicing, via spliceosome
xsq SIT1 9p13-p12 0.414 0.00101 0.123 signal transduction;regulation of T
cell activation
xai GAS2L3 12q23.1 -0.417 0.00101 0.123 cell cycle arrest
xai THOC1 18p11.32 0.417 0.00102 0.123 apoptotic process;signal
transduction
xai NLRP14 11p15.4 0.417 0.00102 0.123 cell
xai CRLF3 17q11.2 0.417 0.00102 0.123 negative regulation of cell
growth;negative regulation of S phase of mitotic cell cycle
hs4 SLA2 20q11.23 0.417 0.00102 0.123 negative regulation of
transcription from RNA polymerase II promoter;B cell mediated immunity
xai HNRNPA1P66 2p15 0.417 0.00102 0.123
xsq LRRC70 5q12.1 0.414 0.00102 0.123
met PLSCR4 3q24 0.414 0.00102 0.123 phospholipid scrambling;cellular
response to lipopolysaccharide
mir hsa-miR-26b 0.414 0.00102 0.123
cop TARP 7p15-p14 -0.414 0.00102 0.123
exp LAMC1 1q31 -0.414 0.00102 0.123 axon guidance;endoderm development
hs4 NR2F2 15q26 -0.417 0.00102 0.123 negative regulation of endothelial
cell proliferation;radial pattern formation
hs4 MIR1469 -0.417 0.00102 0.123
xai SF3B3 16q22.1 0.417 0.00103 0.123 RNA splicing, via
xai RAD9A 11q13.1-q13.2 0.417 0.00103 0.123 DNA Damage Response (DDR)
xai HMGN5 Xq13.3 0.417 0.00103 0.123 regulation of transcription, DNA-
his IL27RA 19p13.11 0.417 0.00103 0.123 cell surface receptor
signaling pathway;positive regulation of interferon-gamma production
xai EAF2 3q13.33 0.417 0.00103 0.123 induction of apoptosis;negative
xsq LOC100505878 0.413 0.00103 0.123
met MUL1 1p36.12 0.413 0.00103 0.123 protein ubiquitination;negative
xsq LINC01046 0.413 0.00103 0.123
exp NUDCD2 5q34 0.413 0.00103 0.123
exp ACTN4P1 4q26 -0.413 0.00103 0.123
exp LAPTM4A 2p24.1 -0.413 0.00103 0.123 transport
exp HIST1H2APS4 6p21.3 0.416 0.00104 0.124
xsq ZCCHC3 20p13-p12.2 0.413 0.00104 0.124
xsq SLC16A10 6q21-q22 0.413 0.00104 0.124 Solute Carriers
mut DDR2 1q23.3 0.413 0.00104 0.124 peptidyl-tyrosine
phosphorylation;positive regulation of sequence-specific DNA binding transcription
factor activity
xsq CD72 9p13.3 0.413 0.00104 0.124 cell adhesion;axon guidance
met IQCE 7p22.3 0.413 0.00104 0.124
hs4 ATCAY 19p13.3 0.416 0.00105 0.124 transport
xai RNGTT 6q16 0.416 0.00105 0.124 transcription from RNA polymerase II
xai CNTRL 9q33.2 0.416 0.00105 0.124 G2/M transition of mitotic cell
met APLP1 19q13.1 0.413 0.00105 0.124 cell death;mRNA polyadenylation
xsq PARVG 22q13.31 0.413 0.00105 0.124 cell adhesion;cell-matrix adhesion
xsq INSL3 19p13.2-p12 0.413 0.00105 0.124 in utero embryonic
development;negative regulation of apoptotic process
xsq KCNK12 2p16.3 0.413 0.00105 0.125 ion transport;potassium ion
transport
xsq SDC2 8q22-q23 -0.413 0.00105 0.124 response to hypoxia;response
to caffeine
swa PPP6C 9q33.3 0.416 0.00106 0.125 DNA Damage Response (DDR)
xai RMND5A 2p11.2 0.416 0.00106 0.125
xai TNFAIP8 5q23.1 0.416 0.00106 0.125 Apoptosis
xsq GFI1 1p22 0.412 0.00106 0.125 negative regulation of calcidiol 1-
monooxygenase activity;cellular response to lipopolysaccharide
hs4 SH3BP4 2q37.1-q37.2 -0.416 0.00106 0.125 endocytosis
xai KATNB1 16q21 0.416 0.00107 0.125 microtubule severing;protein
targeting
xai GEMIN5 5q33.2 0.416 0.00107 0.125 nuclear mRNA splicing, via
spliceosome;protein complex assembly
hs4 BEND4 4p13 0.415 0.00107 0.125
xai ANKRD13B 17q11.2 0.415 0.00107 0.125
hs4 CARMIL2 0.415 0.00107 0.125
his ALG10 12p11.1 0.415 0.00107 0.125 dolichol-linked oligosaccharide
biosynthetic process;protein N-linked glycosylation via asparagine
xsq LCT 2q21 0.412 0.00107 0.125 carbohydrate metabolic process;response
to estrogen stimulus
xsq ELMO1 7p14.1 0.412 0.00107 0.125 actin cytoskeleton
organization;regulation of defense response to virus by virus
met GPD1L 3p22.3 0.412 0.00107 0.125 carbohydrate metabolic
process;glycerol-3-phosphate catabolic process
exp IGLL3P 22q11.23 0.412 0.00107 0.125
mut MLKL 16q23.1 0.412 0.00107 0.125
exp TBC1D2 9q22.33 -0.412 0.00107 0.125 positive regulation of
Rab GTPase activity
exp RHOC 1p13.1 -0.412 0.00107 0.125 regulation of small GTPase
xai CARD8-AS1 0.415 0.00108 0.125
swa CORO1A 16p11.2 0.415 0.00108 0.125 phagocytosis;cell-substrate
adhesion
exp MTHFD2P6 5p13.1 0.415 0.00108 0.125
xai CACTIN 19p13.3 0.415 0.00108 0.125
xsq GIMAP1-GIMAP5 0.412 0.00108 0.125
exp TLR9 3p21.3 0.412 0.00108 0.125 negative regulation of interleukin-
8 production;positive regulation of tumor necrosis factor production
exp RPLP1P6 5q33.1 0.412 0.00108 0.125
exp LINC00202-2 10p12.1 0.412 0.00108 0.125
exp CD4 12p13.31 0.412 0.00108 0.125 cell adhesion;entry into host cell
exp EPAS1 2p21-p16 -0.412 0.00108 0.125 response to
xai ATP1B1 1q24 -0.415 0.00108 0.125 ATP biosynthetic
process;transport
hs4 MFNG 22q12 0.415 0.00109 0.125 pattern specification process
his MIR6815 0.415 0.00109 0.125
xai SNORA33 6q23.2 0.415 0.00109 0.125
his POGLUT1 3q13.33 0.415 0.00109 0.125
swa ATIC 2q35 0.415 0.00109 0.125 purine ribonucleoside monophosphate
biosynthetic process;organ regeneration
xai NAT10 11p13 0.415 0.00109 0.125
swa CSK 15q24.1 0.415 0.00109 0.125 Apoptosis
exp RPS21P4 4p15.32 0.415 0.00109 0.125
met URB1 21q22.11 0.412 0.00109 0.125
exp PTPN2 18p11.3-p11.2 0.412 0.00109 0.125 protein
dephosphorylation;insulin receptor signaling pathway
met CT62 15q23 0.411 0.00109 0.125
xsq IGLL3P 22q11.23 0.411 0.00109 0.125
xsq GOLGA8H 15q13.2 0.411 0.00109 0.125
exp MYO6 6q13 -0.412 0.00109 0.125 regulation of
secretion;intracellular protein transport
xai TBC1D2 9q22.33 -0.415 0.00109 0.125 positive regulation of
Rab GTPase activity
exp HORMAD2 22q12.2 0.415 0.0011 0.125 meiosis
xai HSPA8P11 8p12 0.414 0.0011 0.125
his LOC101927402 0.414 0.0011 0.125
his AFTPH 2p14 0.414 0.0011 0.125 protein transport
his MIR4434 0.414 0.0011 0.125
xai HNRNPA3P8 3p12.2 0.414 0.0011 0.125
exp METAP2 12q22 0.411 0.0011 0.125 proteolysis;cellular process
exp GEMIN5 5q33.2 0.411 0.0011 0.125 nuclear mRNA splicing, via
exp TRAJ17 0.411 0.0011 0.125
xai LPP 3q28 -0.414 0.0011 0.125 cell adhesion
xai ADCY6 12q12-q13 -0.414 0.0011 0.125 water transport;activation of
protein kinase A activity
xai LAMC1 1q31 -0.415 0.0011 0.125 axon guidance;endoderm development
hs4 LOC389199 4p16.1 -0.415 0.0011 0.125
hs4 AFAP1 4p16 -0.415 0.0011 0.125
xai RPS21P4 4p15.32 0.414 0.00111 0.125
xai MIR1244-3 0.414 0.00111 0.125
his ADAMTS13 9q34 0.414 0.00111 0.125 cell-matrix adhesion;response to
chemical stimulus
his REXO4 9q34.2 0.414 0.00111 0.125 regulation of transcription, DNA-
dependent"
xai HCLS1 3q13 0.414 0.00111 0.125 regulation of transcription, DNA-
xai KCNA3 1p13.3 0.414 0.00111 0.125 ion transport;potassium ion
transport
xsq TLR9 3p21.3 0.411 0.00111 0.125 negative regulation of interleukin-
mut FCER1A 0.411 0.00111 0.125
exp CRLF3 17q11.2 0.411 0.00111 0.125 negative regulation of cell
met COPS8 2q37.3 0.411 0.00111 0.125 DNA Damage Response (DDR)
xsq CAPN2 1q41-q42 -0.411 0.00111 0.125 response to
swa MBOAT7 19q13.4 -0.414 0.00111 0.125 phospholipid
hs4 SPACA6P-AS -0.414 0.00111 0.125
hs4 SPACA6 -0.414 0.00111 0.125
hs4 MIR99B -0.414 0.00111 0.125
hs4 MIRLET7E -0.414 0.00111 0.125
hs4 MIR125A -0.414 0.00111 0.125
xai CD52 1p36 0.414 0.00112 0.126 elevation of cytosolic calcium ion
his ADGRE2 0.414 0.00112 0.126 G-protein coupled receptor
met ARSJ 4q26 0.411 0.00112 0.125
exp RPS4XP3 20q13.31 0.411 0.00112 0.125
mut CYP1A1 15q24.1 0.41 0.00112 0.126 amine metabolic
process;response to iron(III) ion
xsq ASAP2 2p25 -0.41 0.00112 0.126 regulation of ARF GTPase
exp ADCY6 12q12-q13 -0.411 0.00112 0.125 water transport;activation of
xsq PPP2R3A 3q22.1 -0.411 0.00112 0.125 protein
dephosphorylation
hs4 FBXO10 9p13.2 -0.414 0.00112 0.126 protein ubiquitination
hs4 CFB 6p21.3 -0.414 0.00112 0.125 complement activation,
hs4 S100A1 1q21 -0.414 0.00112 0.125 negative regulation of
transcription from RNA polymerase II promoter;regulation of heart contraction
hs4 CD28 2q33 0.414 0.00113 0.126 humoral immune response;negative thymic T
cell selection
exp SRSF7 2p22.1 0.414 0.00113 0.126 mRNA export from nucleus;RNA
splicing
his SIGLEC12 19q13.4 0.414 0.00113 0.126 cell adhesion
exp C20orf27 20p13 0.41 0.00113 0.126
met PLPP2 0.41 0.00113 0.126 sphingolipid metabolic
process;sphingolipid biosynthetic process
xsq SCARB2 4q21.1 -0.41 0.00113 0.126 protein targeting to
swa PDLIM7 5q35.3 -0.414 0.00113 0.126 positive regulation of
osteoblast differentiation;ossification
xai TERF2 16q22.1 0.413 0.00114 0.126 DNA Damage Response (DDR); DDR (DNA
replication)
exp PPP3R1 2p15 0.41 0.00114 0.126 induction of apoptosis by
xsq LINC01226 0.41 0.00114 0.126
xai RPS12P5 3p24.1 -0.413 0.00114 0.126
hs4 WNT8A 5q31 0.413 0.00115 0.127 polarity specification of
anterior/posterior axis;response to retinoic acid
xai SMIM24 0.413 0.00115 0.127
exp KCNA3 1p13.3 0.41 0.00115 0.127 ion transport;potassium ion
transport
exp RBBP4P3 6p11.2 0.41 0.00115 0.127
xsq ANP32E 1q21.2 0.41 0.00115 0.127 DNA Damage Response (DDR)
xsq NFATC3 16q22.2 0.41 0.00115 0.127 regulation of transcription
from RNA polymerase II promoter;cellular response to lithium ion
xsq CTSW 11q13.1 0.41 0.00115 0.127 proteolysis;immune response
xsq ADGRB1 0.41 0.00115 0.127 negative regulation of
angiogenesis;cell adhesion
met MGST3 1q23 0.41 0.00115 0.127 signal transduction;leukotriene
cop LOC100506776 -0.41 0.00115 0.127
xai NTN1 17p13-p12 -0.413 0.00115 0.127 mammary gland
development;neuron migration
xai ADAM9 8p11.22 -0.413 0.00115 0.127 membrane protein ectodomain
proteolysis;positive regulation of cell adhesion mediated by integrin
xai KIR3DL2 19q13.4 0.413 0.00116 0.127 cellular defense
exp TRAV22 0.413 0.00116 0.127
xai RPL7AP60 0.413 0.00116 0.127
met CEP170B 14q32.33 0.41 0.00116 0.127
xsq LINC00539 0.409 0.00116 0.127
xsq LRRC16B 14q11.2 0.409 0.00116 0.127
pro GTF2B 1p22-p21 0.409 0.00116 0.127 viral reproduction;interspecies
mut FN3KRP 17q25.3 0.409 0.00116 0.127
xai TRAV22 0.413 0.00117 0.127
xai DDX28 16q22.1 0.412 0.00117 0.128
hs4 LCN15 9q34.3 0.412 0.00117 0.128 lipid metabolic process
xai HNRNPDP1 Xq11.1 0.412 0.00117 0.128
exp RGS16 1q25-q31 0.409 0.00117 0.127 visual perception;regulation of G-
exp MIR142 0.409 0.00117 0.128
his SDC4 20q12 -0.412 0.00117 0.128 ureteric bud development;positive
xai RRAGA 9p22.1 -0.413 0.00117 0.127 Apoptosis
exp RPL7AP60 0.412 0.00118 0.128
xai MTA1 14q32.3 0.412 0.00118 0.128 signal transduction
hs4 DISP3 0.412 0.00118 0.128
xai AMD1 6q21 0.412 0.00118 0.128 small molecule metabolic
process;polyamine metabolic process
his CDT1 16q24.3 0.412 0.00118 0.128 DDR (DNA replication)
his NFYC 1p32 0.412 0.00118 0.128 regulation of transcription from RNA
polymerase II promoter;protein folding
his NFYC-AS1 0.412 0.00118 0.128
hs4 RNU5F-1 1p34.1 0.412 0.00118 0.128
xsq FAM46C 1p12 0.409 0.00118 0.128
exp C1QBPP 21q21.1 0.412 0.00119 0.128
xai SLA2 20q11.23 0.412 0.00119 0.128 negative regulation of
exp RPS27AP3 20q11.2 0.412 0.00119 0.128
xai SNRPGP10 1q32.1 0.412 0.00119 0.128
xai LCT 2q21 0.412 0.00119 0.128 carbohydrate metabolic process;response
xai C1QBPP 21q21.1 0.412 0.00119 0.128
exp HNRNPDP1 Xq11.1 0.412 0.00119 0.128
exp GMEB1 1p35.3 0.409 0.00119 0.128
exp KIR3DL2 19q13.4 0.409 0.00119 0.128 cellular defense
exp AMD1 6q21 0.409 0.00119 0.128 small molecule metabolic
xsq CTNND1 11q11 -0.409 0.00119 0.128 morphogenesis of a polarized
exp FZD7 2q33 -0.409 0.00119 0.128 G-protein signaling, coupled to
cGMP nucleotide second messenger;stem cell maintenance
xsq NEK6 9q33.3-q34.11 -0.409 0.00119 0.128 DNA Damage Response
(DDR)
exp PRR34-AS1 -0.409 0.00119 0.128
exp S100A10 1q21 -0.409 0.00119 0.128 signal transduction;positive
regulation of binding
xai LGALS3 14q22.3 -0.412 0.00119 0.128 skeletal system
hs4 LAIR1 19q13.4 0.412 0.0012 0.128
xai RSAD1 17q21.33 0.412 0.0012 0.128 porphyrin-containing compound
swa RAB28 4p15.33 0.412 0.0012 0.128 GTP catabolic process;small GTPase
xsq RMI1 9q21.32 0.408 0.0012 0.128 DNA Damage Response (DDR)
exp PRND 20p13 0.408 0.0012 0.128 cellular copper ion homeostasis;protein
homooligomerization
xsq CRYBB2 22q11.23 0.408 0.0012 0.128 visual perception;camera-type
eye development
xsq RHOH 4p13 0.408 0.0012 0.128 regulation of transcription, DNA-
dependent;small GTPase mediated signal transduction
exp RPL37P17 9q34 0.408 0.0012 0.128
xsq GNG12 1p31.3 -0.408 0.0012 0.128 signal transduction;G-protein
xai LIMA1 12q13 -0.412 0.0012 0.128 negative regulation of actin
filament depolymerization;ruffle organization
hs4 CD79B 17q23 0.411 0.00121 0.129 immune response;signal transduction
exp AGBL5 2p23.3 0.408 0.00121 0.128 proteolysis;protein deglutamylation
met ARHGEF12 11q23.3 0.408 0.00121 0.128 nerve growth factor receptor
signaling pathway;apoptotic process
mut MOV10L1 22q13.33 0.408 0.00121 0.129 multicellular organismal
development;germ cell development
xai LPP-AS2 3q27.3 -0.411 0.00121 0.129
xai NDUFAF4 6q16.1 0.411 0.00122 0.129 mitochondrial respiratory
chain complex I assembly
his PIN4 Xq13 0.411 0.00122 0.129 rRNA processing;protein folding
xai PTPN2 18p11.3-p11.2 0.411 0.00122 0.129 protein
met ULBP3 6q25 0.408 0.00122 0.129 antigen processing and
presentation;natural killer cell activation
xsq ADAM33 20p13 0.408 0.00122 0.129 proteolysis;integrin-mediated
signaling pathway
xsq CFP Xp11.4 0.408 0.00122 0.129 complement activation;complement
activation, alternative pathway
met PAM 5q14-q21 0.408 0.00122 0.129 response to drug;response to
hypoxia
exp C2orf40 2q12.2 0.408 0.00122 0.129 G1 to G0 transition;cellular
senescence
met PRPH 12q12-q13 -0.408 0.00122 0.129 intermediate filament
cytoskeleton organization
hs4 FRMD5 15q15.3 -0.411 0.00122 0.129
exp GAPDHP65 Xp11.3 0.411 0.00123 0.129
his TTC31 2p13.1 0.411 0.00123 0.129
his CCDC142 2p13.1 0.411 0.00123 0.129
his LOC101927830 0.411 0.00123 0.129
met KLF4 9q31 0.408 0.00123 0.129 mesodermal cell fate
determination;response to retinoic acid
exp FLJ38379 2q37.3 0.408 0.00123 0.129
exp C20orf197 20q13.33 0.408 0.00123 0.129
met GPX8 5q11.2 0.407 0.00123 0.129 response to oxidative stress
exp ADAM9 8p11.22 -0.408 0.00123 0.129 membrane protein ectodomain
mda ADAM9_transcript_expression -0.408 0.00123 0.129
xai CTSW 11q13.1 0.41 0.00124 0.13 proteolysis;immune response
xai TAZ Xq28 0.41 0.00124 0.13 cristae formation;muscle contraction
xsq TOP1MT 8q24.3 0.407 0.00124 0.129 DNA Damage Response (DDR);
met AAED1 9q22.32 0.407 0.00124 0.129
exp UACA 15q22-q24 -0.407 0.00124 0.13
exp FKBP9 7p11.1 -0.407 0.00124 0.129 protein peptidyl-prolyl
his FGFBP3 10q23.32 0.41 0.00125 0.13 positive regulation of
fibroblast growth factor receptor signaling pathway;positive regulation of vascular
permeability
exp EEF1A1P13 5p15.1 0.41 0.00125 0.13
his TMX1 14q22.1 0.41 0.00125 0.13 transport;cell redox homeostasis
xai EEF1A1P13 5p15.1 0.41 0.00125 0.13
exp HNRNPA1P32 10p11.23 0.41 0.00125 0.13
xsq PABPC4L 4q28.3 0.407 0.00125 0.13
his CTDSP1 2q35 0.41 0.00126 0.13 negative regulation of neuron
differentiation;negative regulation of neurogenesis
his MIR26B 0.41 0.00126 0.13
xai RPL18AP7 3p22.2 0.41 0.00126 0.13
xai RFC5 12q24.23 0.41 0.00126 0.13 DNA Damage Response (DDR); DDR
(MMR); DDR (DNA replication)
xai ST18 8q11.23 0.41 0.00126 0.13 negative regulation of
his NCKAP1L 12q13.1 0.41 0.00126 0.13 myeloid cell
exp PTMA 2q37.1 0.407 0.00126 0.13 transcription, DNA-dependent"
exp ICAM3 19p13.3-p13.2 0.407 0.00126 0.13 cell-cell adhesion;regulation
of immune response
exp LIMA1 12q13 -0.407 0.00126 0.13 negative regulation of actin
xai MYO6 6q13 -0.41 0.00126 0.13 regulation of secretion;intracellular
protein transport
his LOC100129083 0.41 0.00127 0.131
hs4 GALR3 22q13.1 0.41 0.00127 0.131 learning or memory;feeding behavior
xai MRPS9 2q12.1 0.41 0.00127 0.131 DNA damage response, detection of
DNA damage;peptide biosynthetic process
exp TSEN54 17q25.1 0.406 0.00127 0.131 mRNA processing;tRNA
exp NOLC1 10q24.32 0.406 0.00127 0.131 positive regulation of cell
xai NEFHP1 1p13.1 0.41 0.00128 0.131
swa NUDC 1p35-p34 0.409 0.00128 0.131 mitotic cell cycle;cytokinesis
xai NIFK-AS1 0.409 0.00128 0.131
hs4 TMEM88B 1p36.33 0.409 0.00128 0.131
xai NFYC 1p32 0.409 0.00128 0.131 regulation of transcription from RNA
xai CAD 2p22-p21 0.409 0.00128 0.131 Apoptosis
exp HSPA8P11 8p12 0.409 0.00128 0.131
exp CNTRL 9q33.2 0.406 0.00128 0.131 G2/M transition of mitotic cell
xsq FAM57B 16p11.2 0.406 0.00128 0.131
exp PDCD11 10q24.33 0.406 0.00128 0.131 Apoptosis
xai TNKS1BP1 11q12.1 -0.41 0.00128 0.131 nuclear-transcribed mRNA
hs4 PLEKHA4 19q13.33 -0.41 0.00128 0.131
exp EEF1GP1 7q31.33 0.409 0.00129 0.131
xai MARS2 2q33.1 0.409 0.00129 0.131 tRNA aminoacylation for protein
xai METAP2 12q22 0.409 0.00129 0.131 proteolysis;cellular process
xai RBFA 18q23 0.409 0.00129 0.131 rRNA processing
xai HNRNPA1P32 10p11.23 0.409 0.00129 0.132
xai SMARCAD1 4q22-q23 0.409 0.00129 0.132 DNA Damage Response (DDR)
exp RPS4XP11 10p11.22 0.406 0.00129 0.131
exp POLE2 14q21-q22 0.406 0.00129 0.132 DNA Damage Response (DDR); DDR
exp SIVA1 14q32.33 0.406 0.00129 0.132 Apoptosis
xai POLR3K 16p13.3 0.409 0.0013 0.132 transcription from RNA
polymerase III promoter;transcription elongation from RNA polymerase III promoter
met KCNQ1OT1 11p15 0.406 0.0013 0.132
exp ADGRE2 0.406 0.0013 0.132 G-protein coupled receptor
mir hsa-miR-188-5p 0.406 0.0013 0.132
exp CEP152 15q21.1 0.406 0.0013 0.132 G2/M transition of mitotic
xsq GPR50 Xq28 0.406 0.0013 0.132 G-protein coupled receptor signaling
pathway;cell-cell signaling
exp PXDC1 6p25.2 -0.406 0.0013 0.132 cell communication
xai HNRNPA1P27 Xq22 0.409 0.00131 0.132
xai ARID3A 19p13.3 0.409 0.00131 0.132 regulation of transcription,
DNA-dependent"
exp HNRNPA3P8 3p12.2 0.409 0.00131 0.132
xai CEP152 15q21.1 0.409 0.00131 0.132 G2/M transition of mitotic
met RAVER1 19p13.2 0.405 0.00131 0.132
exp ST18 8q11.23 0.405 0.00131 0.132 negative regulation of
xai NR2F2 15q26 -0.409 0.00131 0.132 negative regulation of endothelial
his PTPN21 14q31.3 -0.409 0.00131 0.132 protein
xai SDC4 20q12 -0.409 0.00131 0.132 ureteric bud development;positive
swa SCOC 4q31.1 -0.409 0.00131 0.132
xai KBTBD8 3p14 0.408 0.00132 0.132
his LOC101929544 0.408 0.00132 0.132
swa PHF3 6q12 0.408 0.00132 0.132 transcription, DNA-
exp DCTPP1 16p11.2 0.405 0.00132 0.132 nucleoside triphosphate
exp EAF2 3q13.33 0.405 0.00132 0.132 induction of apoptosis;negative
mut DTNA 18q12 0.405 0.00132 0.132 striated muscle contraction;signal
transduction
exp MTA1 14q32.3 0.405 0.00132 0.132 signal transduction
xai HIST1H2APS4 6p21.3 0.408 0.00133 0.133
swa RPS27A 2p16 0.408 0.00133 0.133 activation of MAPK activity;MyD88-
xsq PRKCB 16p11.2 0.405 0.00133 0.133 Protein Kinases
xsq SLC25A15 13q14 0.405 0.00133 0.133 Solute Carriers
pro EP300_21_54312 0.405 0.00133 0.133
exp KBTBD8 3p14 0.405 0.00133 0.133
xsq BLM 15q26.1 0.405 0.00133 0.133 DNA Damage Response (DDR); DDR (FA)
hs4 PLCE1 10q23 -0.408 0.00133 0.133 diacylglycerol biosynthetic
process;heart development
xai EEF1GP1 7q31.33 0.408 0.00134 0.134
xsq FAM86JP 3q21.2 0.405 0.00134 0.133
xai TNS3 7p12.3 -0.408 0.00134 0.133 positive regulation of cell
proliferation;cell migration
exp RPLP0P11 18q21.1 0.408 0.00135 0.134
xai NIP7 16q22.1 0.408 0.00135 0.134 ribosome assembly
hs4 PILRA 7q22.1 0.408 0.00135 0.134 signal transduction;interspecies
exp DOCK8 9p24.3 0.404 0.00135 0.134 blood coagulation
xsq LOC101060498 0.404 0.00135 0.134
xai UACA 15q22-q24 -0.408 0.00135 0.134
xai DOCK1 10q26.13-q26.3 -0.408 0.00135 0.134 Apoptosis
his RNF113B 13q32.2 -0.408 0.00135 0.134
xai RPS8P3 18q21.2 0.408 0.00136 0.134
xai GPR50 Xq28 0.408 0.00136 0.134 G-protein coupled receptor signaling
xai WDR59 16q23.1 0.408 0.00136 0.134
xai HNRNPA1P13 5q31.1 0.408 0.00136 0.134
exp PRKRIRP2 0.408 0.00136 0.134
xai MTHFD2P6 5p13.1 0.407 0.00136 0.134
exp ANAPC1P1 2p11.2 0.404 0.00136 0.134
xsq MALAT1 11q13.1 -0.404 0.00136 0.134
met GABARAPL3 15q26.1 -0.404 0.00136 0.134
swa SLC1A5 19q13.3 -0.407 0.00136 0.134 Solute Carriers
exp NLRP14 11p15.4 0.407 0.00137 0.134 cell
xai MTPAP 10p11.23 0.407 0.00137 0.134 cell death;histone mRNA catabolic
process
xai RPL7AP6 14q24.2 0.407 0.00137 0.134
exp RPL7AP6 14q24.2 0.407 0.00137 0.134
hs4 KCNA3 1p13.3 0.407 0.00137 0.134 ion transport;potassium ion
transport
exp IMPDH2 3p21.2 0.404 0.00137 0.134 nucleobase-containing small
molecule metabolic process;purine base metabolic process
met SAMD12 8q24.12 0.404 0.00137 0.134
xai DAGLA 11q12.2 -0.407 0.00137 0.134 lipid catabolic
hs4 OAT 10q26 -0.407 0.00137 0.134 cellular nitrogen compound
xai EEF1A1P24 3p22.1 0.407 0.00138 0.135
his PUM2 2p22-p21 0.407 0.00138 0.135 regulation of translation
hs4 SP140 2q37.1 0.407 0.00138 0.135
his ATCAY 19p13.3 0.407 0.00138 0.135 transport
xai KDM8 16p12.1 0.407 0.00138 0.135 G2/M transition of mitotic cell
cycle;cell cycle
hs4 ACAP1 17p13.1 0.407 0.00138 0.135 regulation of ARF GTPase
his CTCF 16q21-q22.3 0.407 0.00138 0.135 chromosome segregation;regulation
of molecular function, epigenetic
exp EEF1A1P19 0.407 0.00138 0.135
his KDM8 16p12.1 0.407 0.00138 0.135 G2/M transition of mitotic cell
cycle;cell cycle
xai RPLP0P11 18q21.1 0.407 0.00138 0.135
swa TNXB 6p21.3 0.407 0.00139 0.135 actin cytoskeleton
organization;collagen metabolic process
his MTO1 6q13 0.407 0.00139 0.135 tRNA processing;oxidation-reduction
process
xai ADGRE2 0.407 0.00139 0.135 G-protein coupled receptor
exp RPL13AP3 14q22.3 0.407 0.00139 0.135 translation
xsq MYT1L 2p25.3 0.404 0.00139 0.135 multicellular organismal
exp CAD 2p22-p21 0.403 0.00139 0.135 Apoptosis
xsq LOC101928163 0.403 0.00139 0.135
exp NTN1 17p13-p12 -0.403 0.00139 0.135 mammary gland
xai ACTN4P1 4q26 -0.407 0.00139 0.135
hs4 NFIB 9p24.1 -0.407 0.00139 0.135 negative regulation of cell
proliferation;positive regulation of transcription from RNA polymerase II promoter
swa PDLIM4 5q31.1 -0.407 0.00139 0.135
exp DMC1 22q13.1 0.407 0.0014 0.135 DNA Damage Response (DDR); DDR (DNA
replication)
exp RPL18AP7 3p22.2 0.407 0.0014 0.135
xai TMPO 12q22 0.406 0.0014 0.135 regulation of transcription, DNA-
dependent"
xai SUPV3L1 10q22.1 0.406 0.0014 0.135 positive regulation of cell
growth;DNA duplex unwinding
hs4 HCLS1 3q13 0.406 0.0014 0.135 regulation of transcription, DNA-
xsq LOC101927815 0.403 0.0014 0.135
xsq ODC1 2p25 0.403 0.0014 0.135 small molecule metabolic process;kidney
development
xsq GMFG 19q13.2 0.403 0.0014 0.135 protein phosphorylation;positive
regulation of catalytic activity
exp NOL11 17q24.2 0.403 0.0014 0.135
xai CYTH4 22q12.3-q13.1 0.406 0.00141 0.136 regulation of ARF protein
his LKAAEAR1 0.406 0.00141 0.136
xai ICE2 0.406 0.00141 0.136
his CDCA7 2q31 0.406 0.00141 0.136 regulation of transcription, DNA-
xsq SELPLG 12q24 0.403 0.00141 0.136 leukocyte migration;leukocyte
tethering or rolling
exp THOC1 18p11.32 0.403 0.00141 0.136 apoptotic process;signal
transduction
swa LGALS3 14q22.3 -0.406 0.00141 0.136 skeletal system
xai MZB1 5q31.2 0.406 0.00142 0.136 positive regulation of
immunoglobulin biosynthetic process;apoptotic process
xai PRPF38A 1p32.3 0.406 0.00142 0.136 mRNA processing;RNA splicing
hs4 VAV1 19p13.2 0.406 0.00142 0.136 regulation of transcription, DNA-
dependent;platelet activation
xai RPL13AP3 14q22.3 0.406 0.00142 0.136 translation
xai ATIC 2q35 0.406 0.00142 0.136 purine ribonucleoside monophosphate
his CISD2 4q24 0.406 0.00142 0.136 mitochondrion degradation;multicellular
organismal aging
xai SRSF7 2p22.1 0.406 0.00142 0.136 mRNA export from nucleus;RNA
splicing
xai CEP192 18p11.21 0.406 0.00142 0.136 G2/M transition of mitotic
met PER3 1p36.23 0.403 0.00142 0.136 DNA Damage Response (DDR)
exp SMIM24 0.403 0.00142 0.136
exp EEF1A1P17 12q12 0.406 0.00143 0.136
xai MYT1L 2p25.3 0.406 0.00143 0.136 multicellular organismal
hs4 SAMSN1 21q11 0.406 0.00143 0.136 negative regulation of peptidyl-
tyrosine phosphorylation;negative regulation of B cell activation
exp ATIC 2q35 0.403 0.00143 0.136 purine ribonucleoside monophosphate
xsq MMP25 16p13.3 0.402 0.00143 0.136 proteolysis;inflammatory response
exp NCR3 6p21.3 0.402 0.00143 0.136 inflammatory response;immune
response
exp LPP 3q28 -0.403 0.00143 0.136 cell adhesion
exp IGHV1-45 -0.406 0.00143 0.136
xai IGHV1-45 -0.406 0.00143 0.136
hs4 FAM74A3 0.406 0.00144 0.136
xai RSL24D1P6 20q11 0.406 0.00144 0.136
his CABP4 11q13.2 0.406 0.00144 0.136 photoreceptor cell
morphogenesis;retinal cone cell development
his GPR152 0.406 0.00144 0.136
his FANCL 2p16.1 0.405 0.00144 0.136 DNA Damage Response (DDR); DDR (FA)
hs4 LAX1 1q32.1 0.405 0.00145 0.136 negative regulation of T cell
activation;inactivation of MAPK activity
hs4 LOC101927830 0.405 0.00145 0.137
exp MARS2 2q33.1 0.402 0.00145 0.136 tRNA aminoacylation for protein
exp LTV1 6q24.2 0.402 0.00145 0.136
xsq CTRL 16q22.1 0.402 0.00145 0.137 proteolysis;digestion
xsq LOC101927572 0.402 0.00145 0.137
exp MRPS9 2q12.1 0.402 0.00145 0.137 DNA damage response, detection of
xsq SHISA4 1q32.1 -0.402 0.00145 0.136
xai SLC25A1 22q11.21 -0.405 0.00145 0.137 Solute Carriers
hs4 SOX13 1q32 -0.405 0.00145 0.136 regulation of transcription, DNA-
his MIR2116 -0.405 0.00145 0.136
his MIR5787 0.405 0.00146 0.137
his HDAC8 Xq13 0.405 0.00146 0.137 negative regulation of transcription from
RNA polymerase II promoter;chromatin assembly or disassembly
xai SNRNP40 1p35.2 0.405 0.00146 0.137 RNA splicing;gene expression
his NLE1 17q12 0.405 0.00146 0.137 inner cell mass cell
xai RPL18AP16 Xq28 0.405 0.00146 0.137
mir hsa-miR-940 0.402 0.00146 0.137
xsq RGS19 20q13.33 0.402 0.00146 0.137 autophagy;G-protein coupled
exp DAGLA 11q12.2 -0.402 0.00146 0.137 lipid catabolic
xai LAPTM4B 8q22.1 -0.405 0.00146 0.137 transport
swa ESYT1 12q13.2 -0.405 0.00146 0.137
exp LOC100130876 -0.405 0.00146 0.137
xai LOC100130876 -0.405 0.00146 0.137
xai RASAL3 19p13.12 0.405 0.00147 0.137 signal transduction;positive
hs4 MYO1F 19p13.3-p13.2 0.405 0.00147 0.137 negative regulation of cell
adhesion;positive regulation of cell migration
his TAB1 22q13.1 0.405 0.00147 0.137 toll-like receptor signaling
pathway;lung development
xsq RCSD1 1q24.2 0.402 0.00147 0.137 cellular hyperosmotic
response;skeletal muscle contraction
exp YEATS4 12q13-q15 0.402 0.00147 0.137 chromatin
xai PRR34-AS1 -0.405 0.00147 0.137
xai TPM1 15q22.1 -0.405 0.00147 0.137 positive regulation of heart
rate by epinephrine;ruffle organization
xai MSH2 2p21 0.405 0.00148 0.137 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xai NKX2-5 5q34 0.405 0.00148 0.137 outflow tract septum
morphogenesis;apoptosis involved in heart morphogenesis
met CDC14B 9q22.3 0.401 0.00148 0.137 activation of anaphase-
promoting complex activity;DNA repair
xsq ADAT2 6q24.2 0.401 0.00148 0.137 tRNA processing
exp ADGRB1 0.401 0.00148 0.137 negative regulation of
met RHPN2 19q13.11 0.401 0.00148 0.137 signal transduction
exp NR2F2 15q26 -0.401 0.00148 0.137 negative regulation of endothelial
xai EEF1GP8 4q28.2 0.404 0.00149 0.137
exp HNRNPA1P1 6p22.1 0.404 0.00149 0.137
his PAPOLG 2p16.1 0.404 0.00149 0.137 transcription, DNA-
exp KDM8 16p12.1 0.404 0.00149 0.137 G2/M transition of mitotic cell
cycle;cell cycle
xai NLRC3 16p13.3 0.404 0.00149 0.137 I-kappaB kinase/NF-kappaB
exp HIST3H3 1q42 0.401 0.00149 0.137 telomere maintenance;nucleosome
assembly
mut LTBP2 14q24 0.401 0.00149 0.137 protein targeting;transforming growth
factor beta receptor signaling pathway
exp RMND5A 2p11.2 0.401 0.00149 0.137
met MIR153-2 0.401 0.00149 0.137
xsq GS1-24F4.2 0.401 0.00149 0.137
xsq STAC3 12q13.3 0.401 0.00149 0.137 intracellular signal transduction
hs4 MIR548Z -0.404 0.00149 0.137
hs4 MIR548C -0.404 0.00149 0.137
his FAM159A 1p32.3 0.404 0.0015 0.138
xai SELPLG 12q24 0.404 0.0015 0.138 leukocyte migration;leukocyte
his NSF 17q21 0.404 0.0015 0.138 plasma membrane fusion;positive
xai HNRNPA1P1 6p22.1 0.404 0.0015 0.138
exp NPIPB6 16p11.2 0.401 0.0015 0.137
xsq STXBP5L 3q13.33 0.401 0.0015 0.137 exocytosis;protein transport
xsq DRICH1 0.401 0.0015 0.138
xsq PPP1R16B 20q11.23 0.401 0.0015 0.138 signal
transduction;regulation of filopodium assembly
met NOXA1 9q34.3 0.401 0.0015 0.138 superoxide metabolic
process;regulation of hydrogen peroxide metabolic process
xsq EPHA4 2q36.1 -0.401 0.0015 0.138 adult walking
xai CD93 20p11.21 0.404 0.00151 0.138 macrophage activation;interspecies
hs4 LINC00539 0.404 0.00151 0.138
exp DAZAP1 19p13.3 0.401 0.00151 0.138 multicellular organismal
exp FAM135A 6q13 0.401 0.00151 0.138
exp LPP-AS2 3q27.3 -0.404 0.00151 0.138
his NSFP1 17q21.31 0.404 0.00152 0.138
xai AGAP2 12q14.1 0.404 0.00152 0.138 axon guidance;protein transport
xai STAP1 4q13.2 0.404 0.00152 0.139 intracellular protein
mut SLX4 16p13.3 0.401 0.00152 0.138 DNA Damage Response (DDR); DDR (HR)
xai RHOH 4p13 0.404 0.00153 0.139 regulation of transcription, DNA-
xai GPSM3 6p21.3 0.403 0.00153 0.139 signal transduction;regulation of
G-protein coupled receptor protein signaling pathway
exp HCLS1 3q13 0.4 0.00153 0.139 regulation of transcription, DNA-
xai TRMT11 6q11.1-q22.33 0.403 0.00154 0.139 tRNA processing
xai NUP133 1q42.13 0.403 0.00154 0.139 carbohydrate metabolic
process;cytokine-mediated signaling pathway
xsq ARHGAP19 10q24.1 0.4 0.00154 0.14 signal transduction;small
exp RMI1 9q21.32 0.4 0.00154 0.14 DNA Damage Response (DDR)
exp OPHN1 Xq12 -0.4 0.00154 0.14 substrate-dependent cell migration, cell
extension;filopodium assembly
exp RBFOX2 22q13.1 -0.4 0.00154 0.14 RNA splicing;regulation of
definitive erythrocyte differentiation
exp DOCK1 10q26.13-q26.3 -0.4 0.00154 0.14 Apoptosis
xsq RBPMS 8p12 -0.4 0.00154 0.139 regulation of transcription, DNA-
xai TFAP4 16p13 0.403 0.00155 0.14 protein complex assembly;positive
regulation by host of viral transcription
swa SAMD4A 14q22.2 0.403 0.00155 0.14 negative regulation of
his NFATC2IP 0.403 0.00155 0.14 DNA Damage Response (DDR); DDR (HR)
xai KARSP1 0.403 0.00156 0.14
xai FAM135A 6q13 0.403 0.00156 0.14
xai RMI1 9q21.32 0.403 0.00156 0.14 DNA Damage Response (DDR)
xai DOCK8 9p24.3 0.403 0.00156 0.141 blood coagulation
xsq NTS 12q21 0.4 0.00156 0.14 signal transduction;regulation of blood
vessel size
exp GZMM 19p13.3 0.4 0.00156 0.14 apoptotic process;cytolysis
xsq PTPN22 1p13.2 0.4 0.00156 0.141 regulation of B cell receptor
signaling pathway;negative regulation of T cell receptor signaling pathway
exp SNRNP40 1p35.2 0.4 0.00156 0.141 RNA splicing;gene expression
hs4 RANBP3L 5p13.2 -0.403 0.00156 0.14 intracellular transport
xai FAM86C2P 11q13.2 0.403 0.00157 0.141
xai EEF1A1P19 0.403 0.00157 0.141
xai RFWD3 16q23.1 0.403 0.00157 0.141 DNA repair;response to ionizing
radiation
mir hsa-miR-572 0.399 0.00157 0.141
exp SMARCAD1 4q22-q23 0.399 0.00157 0.141 DNA Damage Response (DDR)
exp RHOH 4p13 0.399 0.00157 0.141 regulation of transcription, DNA-
met CTNNA1 5q31.2 0.399 0.00157 0.141 Apoptosis; Tumor Suppressors
swa LAMP1 13q34 -0.403 0.00157 0.141 autophagy;autophagic cell death
xai RIOK1 6p24.3 0.402 0.00158 0.141
hs4 CD53 1p13 0.402 0.00158 0.141 signal transduction
hs4 IRGM 5q33.1 0.402 0.00158 0.141 autophagy;inflammatory response
xai TRMT44 4p16.1 0.402 0.00158 0.141
xai PEX5 12p13.31 0.402 0.00158 0.141 protein targeting to
met SPR 2p14-p12 0.399 0.00158 0.141 nitric oxide metabolic
process;regulation of nitric-oxide synthase activity
exp OPRL1 20q13.33 0.399 0.00158 0.141 elevation of cytosolic calcium ion
concentration;sensory perception
met PPFIBP2 11p15.4 0.399 0.00158 0.141 cell communication;DNA
integration
xsq P2RX5 17p13.3 0.399 0.00158 0.141 signal transduction;nervous system
development
xai ITGA3 17q21.33 -0.402 0.00158 0.141 leukocyte migration;neuron
migration
xai R3HDM1 2q21.3 0.402 0.00159 0.141
xsq SLA2 20q11.23 0.399 0.00159 0.141 negative regulation of
xsq C2orf44 2p23.3 0.399 0.00159 0.141
xsq HPGD 4q34-q35 0.399 0.00159 0.141 prostaglandin metabolic
process;ductus arteriosus closure
exp CHCHD4 3p25.1 0.399 0.00159 0.141 protein transport
exp ICE2 0.399 0.00159 0.141
xsq GPX8 5q11.2 -0.399 0.00159 0.141 response to oxidative stress
hs4 SLC32A1 20q11.23 0.402 0.0016 0.141 Solute Carriers
xai DDX11 12p11 0.402 0.0016 0.141 DNA Damage Response (DDR)
xsq DKC1 Xq28 0.399 0.0016 0.142 DNA Damage Response (DDR)
exp ATP1B1 1q24 -0.399 0.0016 0.142 ATP biosynthetic
process;transport
swa TJP2 9q13-q21 -0.402 0.0016 0.141 apoptotic process;cellular
component disassembly involved in apoptosis
exp PA2G4P4 3q25.31 0.402 0.00161 0.142
his POLN 4p16.3 0.402 0.00161 0.142 DNA Damage Response (DDR); DDR (DNA
replication); DDR (TLS)
his HAUS3 0.402 0.00161 0.142 centrosome organization;cell division
xsq NUDT8 11q13.2 0.399 0.00161 0.142
xsq CCDC163P 1p34.1 0.398 0.00161 0.142
xsq CTDSPL 3p21.3 -0.398 0.00161 0.142
xai FZD7 2q33 -0.402 0.00161 0.142 G-protein signaling, coupled to
swa NFKBIE 6p21.1 0.402 0.00162 0.142 D-serine
transport;cytoplasmic sequestering of transcription factor
his BCKDHB 6q14.1 0.402 0.00162 0.142 response to nutrient;branched
chain family amino acid catabolic process
exp EEF1A1P24 3p22.1 0.402 0.00162 0.142
exp TRMT11 6q11.1-q22.33 0.402 0.00162 0.142 tRNA processing
xai ITGAL 16p11.2 0.402 0.00162 0.142 cell adhesion;regulation of immune
response
exp RPL4P2 1q24.1 0.401 0.00162 0.142
exp RFC5 12q24.23 0.398 0.00162 0.142 DNA Damage Response (DDR); DDR
exp SF3B5 6q24.2 0.398 0.00162 0.142 nuclear mRNA splicing, via
exp R3HDM1 2q21.3 0.398 0.00162 0.142
xsq PTPRC 1q31-q32 0.398 0.00162 0.142 protein dephosphorylation;peptidyl-
xsq TMEM71 8q24.22 0.398 0.00162 0.142
xsq KIR2DL2 0.398 0.00162 0.142 regulation of immune response
xsq ADGRE2 0.398 0.00162 0.142 G-protein coupled receptor
hs4 FAXC 6q16.2 -0.402 0.00162 0.142
hs4 UMODL1 21q22.3 0.401 0.00163 0.142
xai CD53 1p13 0.401 0.00163 0.142 signal transduction
his GALNT4 12q21.33 0.401 0.00164 0.143
his POC1B 12q21.33 0.401 0.00164 0.143 cell projection organization;cilium
assembly
his POC1B-GALNT4 0.401 0.00164 0.143
exp RPS8P3 18q21.2 0.401 0.00164 0.143
exp DUXAP7 20p11.23 0.401 0.00164 0.143
xai MND1 4q31.3 0.401 0.00164 0.143 DNA recombination;meiosis
his NDUFV2 18p11.22 0.401 0.00164 0.143 mitochondrial electron
transport, NADH to ubiquinone;transport
exp NAT10 11p13 0.398 0.00164 0.143
exp RRP9 3p21.2 0.398 0.00164 0.143 rRNA processing
hs4 SYTL2 11q14 -0.401 0.00164 0.143 intracellular protein
transport;exocytosis
swa TPI1 12p13 0.401 0.00165 0.143 carbohydrate metabolic process;glucose
metabolic process
his NTRK1 1q21-q22 0.401 0.00165 0.143 activation of adenylate cyclase
activity;positive regulation of neuron projection development
his SH2D2A 1q21 0.401 0.00165 0.143 multicellular organismal
xai DUXAP7 20p11.23 0.401 0.00165 0.143
his LOC105376306 0.401 0.00165 0.143
his GTF3C5 9q34 0.401 0.00165 0.143 tRNA transcription from RNA
exp FAM129C 19p13.11 0.398 0.00165 0.143
xai AMOTL2 3q21-q22 -0.401 0.00165 0.143
xai PPP3R1 2p15 0.401 0.00166 0.143 induction of apoptosis by
xai ZBED4 22q13.33 0.401 0.00166 0.143
xai PA2G4P4 3q25.31 0.401 0.00166 0.144
exp TRMT44 4p16.1 0.398 0.00166 0.143
exp ALKBH2 12q24.11 0.397 0.00166 0.144 DNA Damage Response (DDR);
DDR (Direct Repair)
xai TMCO6 5q31.3 0.401 0.00167 0.144 protein import into nucleus
xai RPS12P24 13q13.3 0.4 0.00167 0.144
xai DMC1 22q13.1 0.4 0.00167 0.144 DNA Damage Response (DDR); DDR (DNA
replication)
exp WDR12 2q33.2 0.397 0.00167 0.144 maturation of LSU-rRNA from
xsq LOC439933 0.397 0.00167 0.144
met RASSF1 3p21.3 -0.397 0.00167 0.144 positive regulation of
swa EIF4B 12q13.13 0.4 0.00168 0.144 gene expression;RNA metabolic
process
his GPR55 2q37 0.4 0.00168 0.145 G-protein coupled receptor signaling
pathway;activation of phospholipase C activity
exp TOPORS-AS1 9p21.1 0.397 0.00168 0.144
exp GTF3C5 9q34 0.397 0.00168 0.144 tRNA transcription from RNA
swa ANXA2 15q22.2 -0.4 0.00168 0.144 positive regulation of vesicle
fusion;fibrinolysis
xai HNRNPA1P34 0.4 0.00169 0.145
xai UTP4 0.4 0.00169 0.145
his CD38 4p15 0.4 0.00169 0.145 response to hormone stimulus;response to
drug
met DEFB118 20q11.21 0.397 0.00169 0.145
xsq KDELR3 22q13.1 -0.397 0.00169 0.145 protein retention in ER
lumen;activation of signaling protein activity involved in unfolded protein
response
xai RPL4P2 1q24.1 0.4 0.0017 0.145
mut PDZD4 Xq28 0.397 0.0017 0.145
exp RRAGA 9p22.1 -0.397 0.0017 0.145 Apoptosis
hs4 RBMS3 3p24-p23 -0.4 0.0017 0.145
hs4 RBMS3-AS3 -0.4 0.0017 0.145
exp GPR50 Xq28 0.4 0.00171 0.146 G-protein coupled receptor signaling
exp RPL21P134 Xq13.3 0.4 0.00171 0.146
xai MTO1 6q13 0.4 0.00171 0.146 tRNA processing;oxidation-reduction
process
met NPM1 5q35.1 0.397 0.00171 0.146 Apoptosis; DNA Damage Response
(DDR); Tumor Suppressors
exp KARSP1 0.399 0.00172 0.146
exp RFWD3 16q23.1 0.396 0.00172 0.146 DNA repair;response to ionizing
radiation
exp AGAP2 12q14.1 0.396 0.00172 0.146 axon guidance;protein transport
mut HIST1H4G 6p22.1 0.396 0.00172 0.146 nucleosome assembly
xai AFF4 5q31 -0.399 0.00172 0.146 spermatid development;regulation of
transcription, DNA-dependent
xai LY9 1q23.3 0.399 0.00173 0.146 cell adhesion;immunoglobulin
xai NUDCD2 5q34 0.399 0.00173 0.146
xai PRND 20p13 0.399 0.00173 0.146 cellular copper ion homeostasis;protein
homooligomerization
his HIST1H1D 6p21.3 0.399 0.00173 0.146 nucleosome
assembly;nucleosome positioning
his HIST1H4F 6p22.1 0.399 0.00173 0.146
xsq GZMA 5q11-q12 0.396 0.00173 0.146 cleavage of lamin;immune response
xsq CACNA1C-AS2 0.396 0.00173 0.146
exp CTNNA1 5q31.2 -0.396 0.00173 0.146 Apoptosis; Tumor
Suppressors
exp NFIB 9p24.1 -0.396 0.00173 0.146 negative regulation of cell
exp ST5 11p15 -0.396 0.00173 0.146 positive regulation of ERK1 and
ERK2 cascade
hs4 PLSCR4 3q24 -0.399 0.00173 0.146 phospholipid
scrambling;cellular response to lipopolysaccharide
hs4 LAMC1 1q31 -0.399 0.00173 0.146 axon guidance;endoderm development
xai FHL2 2q12.2 -0.399 0.00173 0.146 negative regulation of
transcription from RNA polymerase II promoter;atrial cardiac muscle cell
development
xai WDR12 2q33.2 0.399 0.00174 0.147 maturation of LSU-rRNA from
xai EEF1A1P9 4q24 0.399 0.00174 0.147
xai P2RY1 3q25.2 0.399 0.00174 0.147 response to mechanical
exp EEF1A1P9 4q24 0.399 0.00174 0.147
xsq ARID3A 19p13.3 0.396 0.00174 0.147 regulation of transcription,
DNA-dependent"
xsq FKBP9 7p11.1 -0.396 0.00174 0.147 protein peptidyl-prolyl
xai RPL19P21 Xq28 0.399 0.00175 0.147
xai LTV1 6q24.2 0.399 0.00175 0.147
exp ITGA3 17q21.33 -0.396 0.00175 0.147 leukocyte migration;neuron
migration
exp FKBP9P1 -0.396 0.00175 0.147
hs4 OSM 22q12.2 0.399 0.00176 0.147 multicellular organismal
xai IMPDH2 3p21.2 0.399 0.00176 0.147 nucleobase-containing small
xai PA2G4P2 20p12.1 0.399 0.00176 0.148
hs4 LINC00891 0.399 0.00176 0.148
xsq GRAP 17p11.2 0.396 0.00176 0.147 Ras protein signal
transduction;cell-cell signaling
exp TFAP4 16p13 0.396 0.00176 0.147 protein complex assembly;positive
hs4 MIR4496 0.399 0.00177 0.148
xai CHRNA3 15q24 0.399 0.00177 0.148 cation transport;locomotory
behavior
xsq PON1 7q21.3 0.395 0.00177 0.148 positive regulation of transporter
activity;negative regulation of plasma lipoprotein particle oxidation
exp TMPO 12q22 0.395 0.00177 0.148 regulation of transcription, DNA-
dependent"
xsq ARHGAP30 1q23.3 0.395 0.00177 0.148 signal transduction;small
xai RBFOX2 22q13.1 -0.398 0.00177 0.148 RNA splicing;regulation
his IKZF3 17q21 0.398 0.00178 0.148 mesoderm development;regulation of B cell
proliferation
his ZPBP2 17q12 0.398 0.00178 0.148 binding of sperm to zona pellucida
met CHAF1B 21q22.13 0.395 0.00178 0.148 DDR (DNA replication)
met PRR34 0.395 0.00178 0.148
met NUAK2 1q32.1 0.395 0.00178 0.148 Apoptosis
exp ITGAL 16p11.2 0.395 0.00178 0.148 cell adhesion;regulation of immune
response
exp TNS3 7p12.3 -0.395 0.00178 0.148 positive regulation of cell
xai GRIK4 11q22.3 -0.398 0.00178 0.148 transport;ion transport
his STK26 0.398 0.00179 0.148
his WAS Xp11.4-p11.21 0.398 0.00179 0.148 defense response;T cell
activation
met TCEANC Xp22.2 0.395 0.00179 0.148 transcription, DNA-
met ARNTL 11p15 0.395 0.00179 0.149 circadian rhythm;positive regulation of
exp DDX11 12p11 0.395 0.00179 0.149 DNA Damage Response (DDR)
xsq CHRNA3 15q24 0.395 0.00179 0.149 cation transport;locomotory
behavior
exp C19orf38 19p13.2 0.398 0.0018 0.149
his DDOST 1p36.1 0.398 0.0018 0.149 translation;post-translational
protein modification
exp WDR43 2p23.2 0.398 0.0018 0.149
swa FARSA 19p13.2 0.398 0.0018 0.149 tRNA aminoacylation for protein
translation;phenylalanyl-tRNA aminoacylation
mut SPTBN1 2p21 0.395 0.0018 0.149 axon guidance;actin filament
capping
xai DIP2C 10p15.3 -0.398 0.0018 0.149
mut KLHL15 Xp22.1-p21 0.395 0.00181 0.15
xsq NPM3 10q24.31 0.395 0.00181 0.15 rRNA transcription;rRNA processing
xsq ACRBP 12p13.31 0.395 0.00181 0.15
exp LAPTM4B 8q22.1 -0.395 0.00181 0.15 transport
xai OPHN1 Xq12 -0.398 0.00181 0.149 substrate-dependent cell migration,
cell extension;filopodium assembly
his KIF25-AS1 0.398 0.00182 0.15
xai RNMTL1 17p13.3 0.398 0.00182 0.15 RNA processing
xai ODC1 2p25 0.397 0.00182 0.15 small molecule metabolic process;kidney
development
xsq SLC7A3 Xq13.1 0.394 0.00182 0.15 Solute Carriers
xsq LST1 6p21.3 0.394 0.00182 0.15 cell morphogenesis;immune response
xsq TMEM204 16p13.3 0.394 0.00182 0.15 lymph vessel
development;response to stress
mut NLRP4 19q13.43 0.394 0.00182 0.15
mut GRIPAP1 Xp11.23 0.394 0.00182 0.15
xsq LOC100129034 -0.394 0.00182 0.15
swa GNA11 19p13.3 -0.398 0.00182 0.15 Oncogenes
xai PTMAP8 3q13.31 0.397 0.00183 0.15
exp PTMAP8 3q13.31 0.397 0.00183 0.15
hs4 CYTH4 22q12.3-q13.1 0.397 0.00183 0.15 regulation of ARF protein
his DPEP2 16q22.1 0.397 0.00183 0.15 leukotriene biosynthetic
process;small molecule metabolic process
exp RPLP1 15q22 0.394 0.00183 0.15 gene expression;viral reproduction
xsq RBFA 18q23 0.394 0.00183 0.15 rRNA processing
exp ANO10 3p22.1 -0.394 0.00183 0.15 ion transport;cell death
mut PRPS1 Xq22.3 0.394 0.00184 0.15 ribonucleoside monophosphate
biosynthetic process;carbohydrate metabolic process
xsq CNTRL 9q33.2 0.394 0.00184 0.15 G2/M transition of mitotic cell
exp HMMR 5q34 0.394 0.00184 0.15
exp TMCO6 5q31.3 0.394 0.00184 0.15 protein import into nucleus
exp CTSW 11q13.1 0.394 0.00184 0.15 proteolysis;immune response
exp PEX5 12p13.31 0.394 0.00184 0.15 protein targeting to
exp NOP56 20p13 0.394 0.00184 0.15 rRNA processing;cell death
exp NKX2-5 5q34 0.394 0.00185 0.15 outflow tract septum
mir hsa-miR-345 0.394 0.00185 0.15
exp QSOX2 9q34.3 0.394 0.00185 0.151 cell redox homeostasis
met SMOX 20p13 0.394 0.00185 0.151 cellular nitrogen compound metabolic
exp WDR59 16q23.1 0.394 0.00185 0.151
his LOC729506 5p15.31 -0.397 0.00185 0.151
his MIR4458HG -0.397 0.00185 0.151
his MIR4458 -0.397 0.00185 0.151
hs4 MYO10 5p15.1-p14.3 -0.397 0.00185 0.15 axon guidance;regulation
of cell shape
his TTC21B 2q24.3 0.397 0.00186 0.151
his LOC102724058 0.397 0.00186 0.151
xai C19orf38 19p13.2 0.397 0.00186 0.151
xai SSBP4 19p13.1 0.397 0.00186 0.151
exp SUPV3L1 10q22.1 0.394 0.00186 0.151 positive regulation of cell
exp GRIK4 11q22.3 -0.394 0.00186 0.151 transport;ion transport
hs4 LINC00346 13q34 -0.397 0.00186 0.151
hs4 GAD2 10p11.23 0.397 0.00187 0.151 carboxylic acid metabolic
process;neurotransmitter biosynthetic process
xai C20orf197 20q13.33 0.397 0.00187 0.151
exp ASUN 12p11.23 0.394 0.00187 0.151 cell cycle;mitosis
mut PRODH2 19q13.1 0.393 0.00187 0.151 glutamate biosynthetic
process;proline catabolic process
exp ODC1 2p25 0.393 0.00187 0.151 small molecule metabolic process;kidney
development
exp SCML2 Xp22 0.393 0.00187 0.151 regulation of transcription, DNA-
hs4 SERTAD4-AS1 1q32.2 -0.397 0.00187 0.151
hs4 SERTAD4 1q32.1-q41 -0.397 0.00187 0.151
his LINC00346 13q34 -0.397 0.00187 0.151
xai C14orf2 14q32.33 0.396 0.00188 0.151
exp NIP7 16q22.1 0.393 0.00188 0.151 ribosome assembly
met PCGF2 17q12 0.393 0.00188 0.151 negative regulation of transcription from
RNA polymerase II promoter;in utero embryonic development
mut SLC2A13 12q12 0.393 0.00188 0.151 Solute Carriers
exp SNRPB 20p13 0.393 0.00188 0.151 RNA splicing;gene expression
mut RIOK3 18q11.2 0.393 0.00188 0.151 protein phosphorylation;chromosome
segregation
met NKX3-1 8p21.2 0.393 0.00188 0.151 DNA Damage Response (DDR)
xsq TOE1 1p33 0.393 0.00188 0.151
xsq DDX28 16q22.1 0.393 0.00188 0.151
exp CLNS1A 11q13.5-q14 0.393 0.00188 0.151 blood circulation;gene
expression
swa NKX2-4 20p11.22 0.396 0.00189 0.151 multicellular organismal
development
exp P2RY1 3q25.2 0.393 0.00189 0.151 response to mechanical
xsq STK26 0.393 0.00189 0.151
xai FARSA 19p13.2 0.396 0.0019 0.152 tRNA aminoacylation for protein
exp EEF1A1P33 12q23.1 0.396 0.0019 0.152
his C12orf45 12q23.3 0.396 0.0019 0.152
xai THOC2 Xq25-q26.3 0.396 0.0019 0.152 mRNA export from nucleus;transport
met SYTL4 Xq21.33 0.393 0.0019 0.152 positive regulation of
exocytosis;negative regulation of insulin secretion
xai CTNNA1 5q31.2 -0.396 0.0019 0.152 Apoptosis; Tumor
Suppressors
hs4 ITGA9-AS1 -0.396 0.0019 0.152
hs4 CTDSPL 3p21.3 -0.396 0.0019 0.152
hs4 CD4 12p13.31 0.396 0.00191 0.152 cell adhesion;entry into host cell
his TIA1 2p13 0.396 0.00191 0.152 Apoptosis
exp ANKRD13B 17q11.2 0.393 0.00191 0.152
swa UBXN4 2q21.3 -0.396 0.00191 0.152 response to unfolded protein
hs4 RAI14 5p13.3-p13.2 -0.396 0.00191 0.152
xai EEF1A1P22 15q21.3 0.396 0.00192 0.152
xai MIR4426 0.396 0.00192 0.152
exp MIR4426 0.396 0.00192 0.152
mut TM9SF4 20q11.21 0.393 0.00192 0.152
mut CAND1 12q14 0.393 0.00192 0.152 regulation of transcription, DNA-
dependent;protein ubiquitination
xsq SHROOM2 Xp22.3 -0.392 0.00192 0.152 eye pigment granule
organization;apical protein localization
exp GNS 12q14 -0.392 0.00192 0.152 glycosaminoglycan catabolic
process;keratan sulfate catabolic process
exp RCN1 11p13 -0.393 0.00192 0.152 in utero embryonic
development;camera-type eye development
hs4 SLC35D2 9q22.32 -0.396 0.00192 0.152 Solute Carriers
his MIR558 0.396 0.00193 0.153
his FCHO1 19p13.11 0.396 0.00193 0.153
met GPT2 16q12.1 0.392 0.00193 0.152 small molecule metabolic process;2-
oxoglutarate metabolic process
exp LCT 2q21 0.392 0.00193 0.153 carbohydrate metabolic process;response
exp C14orf2 14q32.33 0.392 0.00193 0.153
xsq MYO10 5p15.1-p14.3 -0.392 0.00193 0.153 axon guidance;regulation
of cell shape
his FKBP5 6p21.31 0.395 0.00194 0.153 peptidyl-proline
modification;protein peptidyl-prolyl isomerization
his BRI3BP 12q24.31 0.395 0.00194 0.153
xsq LOC730202 14q32.2 0.392 0.00194 0.153
xsq C17orf96 17q12 0.392 0.00194 0.153
xsq SART3 12q24.1 0.392 0.00194 0.153 RNA processing
mut CYP39A1 6p21.1-p11.2 0.392 0.00194 0.153 small molecule metabolic
hs4 SLC2A10 20q13.1 -0.395 0.00194 0.153 Solute Carriers
xai RNF166 16q24.3 0.395 0.00195 0.153
hs4 MOXD2P 7q34 0.395 0.00195 0.153 catecholamine metabolic process
exp RPSAP55 15q21.3 0.395 0.00195 0.153
exp RPS12P24 13q13.3 0.395 0.00195 0.153
met NRP1 10p12 0.392 0.00195 0.153 cell adhesion;response to wounding
xsq HMGB3P1 20q11.22 0.392 0.00195 0.153
exp ARHGEF17 11q13.4 -0.392 0.00195 0.153 regulation of small
GTPase mediated signal transduction;apoptotic process
met DNAJC7 17q11.2 -0.392 0.00195 0.153 protein
folding;chaperone cofactor-dependent protein refolding
his RASAL2 1q24 -0.395 0.00195 0.153 signal transduction;positive
his RASAL2-AS1 -0.395 0.00195 0.153
exp PRKRIRP3 10q21.1 0.395 0.00196 0.153
mut ZSCAN25 7q22.1 0.392 0.00196 0.153
exp THOC2 Xq25-q26.3 0.392 0.00196 0.153 mRNA export from nucleus;transport
xsq ADCK3 1q42.13 0.392 0.00196 0.153 cell death
exp HPRT1 Xq26.1 0.392 0.00196 0.153 spermatogenesis;central nervous
system neuron development
exp TMEM56 1p21.3 -0.392 0.00196 0.153
xai ACTN4P2 1p34.3 -0.395 0.00196 0.153
xai NOL11 17q24.2 0.395 0.00197 0.153
his HADHA 2p23 0.395 0.00197 0.153 cellular lipid metabolic process;small
his HADHB 2p23 0.395 0.00197 0.153 fatty acid metabolic process;fatty acid
beta-oxidation
xai WDR43 2p23.2 0.395 0.00197 0.153
xai SF3B5 6q24.2 0.395 0.00197 0.154 nuclear mRNA splicing, via
his DPY30 2p22.3 0.395 0.00197 0.154 histone H3-K4
methylation;regulation of transcription, DNA-dependent
xai FASTKD1 2q31 0.395 0.00197 0.154 cellular respiration
his MIR628 0.395 0.00197 0.154
exp GNA11 19p13.3 -0.392 0.00197 0.154 Oncogenes
xai AIF1 6p21.3 0.395 0.00198 0.154 positive regulation of muscle
hyperplasia;negative regulation of apoptotic process
xai RPL18A 19p13 0.395 0.00198 0.154 translational initiation;viral
infectious cycle
xai NDUFV1 11q13 0.395 0.00198 0.154 mitochondrial electron transport,
NADH to ubiquinone;transport
xai CORO7 16p13.3 0.395 0.00198 0.154 actin cytoskeleton organization
xai N4BP2 4p14 0.395 0.00198 0.154
xai QSOX2 9q34.3 0.395 0.00198 0.154 cell redox homeostasis
xsq C1orf228 1p34.1 0.392 0.00198 0.154
exp RIOK1 6p24.3 0.392 0.00198 0.154
exp LOC100130872 0.391 0.00198 0.154
hs4 STK26 0.395 0.00199 0.154
hs4 KLHL6 3q27.3 0.395 0.00199 0.154 germinal center formation;B cell
exp MTPAP 10p11.23 0.391 0.00199 0.154 cell death;histone mRNA catabolic
process
met SYAP1 Xp22.2 0.391 0.00199 0.154
exp KATNB1 16q21 0.391 0.00199 0.154 microtubule severing;protein
targeting
exp DLGAP4 20q11.23 -0.391 0.00199 0.154 cell-cell signaling
xai SRRM1 1p36.11 0.394 0.002 0.154 transcription from RNA polymerase II
promoter;termination of RNA polymerase II transcription
xsq IRAK1BP1 6q14-q15 0.391 0.002 0.154 regulation of transcription, DNA-
dependent;I-kappaB kinase/NF-kappaB cascade"
exp DIP2C 10p15.3 -0.391 0.002 0.154
hs4 PLEKHA1 10q26.13 -0.394 0.002 0.154 female gonad
development;skeletal system morphogenesis
xai HSP90AB3P 4q22.1 0.394 0.00201 0.154 response to stress;protein
folding
his SEPT6 Xq24 0.394 0.00201 0.154 cytokinesis;cell cycle
his MIR6766 0.394 0.00201 0.154
his POLG 15q25 0.394 0.00201 0.154 DNA Damage Response (DDR)
xai CTDP1 18q23 0.394 0.00201 0.154 viral reproduction;positive regulation of
viral transcription
mut SLAMF8 1q23.2 0.391 0.00201 0.154
exp N4BP2 4p14 0.391 0.00201 0.154
xsq CRLF3 17q11.2 0.391 0.00201 0.154 negative regulation of cell
exp ADAM33 20p13 0.391 0.00201 0.154 proteolysis;integrin-mediated
signaling pathway
xai STK26 0.394 0.00202 0.154
xai RPL29P12 5p12 0.394 0.00202 0.154
exp HNRNPA1P13 5q31.1 0.394 0.00202 0.155
exp FASTKD1 2q31 0.391 0.00202 0.154 cellular respiration
xsq SERHL2 22q13 0.391 0.00202 0.154
exp DENND1C 19p13.3 0.391 0.00202 0.154
exp CD53 1p13 0.391 0.00202 0.154 signal transduction
exp CHRNA3 15q24 0.391 0.00202 0.155 cation transport;locomotory
behavior
xai EHD4 15q11.1 -0.394 0.00202 0.154 regulation of
endocytosis;endocytic recycling
his PHLDA3 1q31 -0.394 0.00202 0.154 negative regulation of
hs4 GDF10 10q11.22 0.394 0.00203 0.155 skeletal system
development;transforming growth factor beta receptor signaling pathway
his KIAA1143 3p21.31 0.394 0.00203 0.155
his KIF15 3p21.31 0.394 0.00203 0.155 microtubule-based movement;mitosis
xai RPL21P134 Xq13.3 0.394 0.00203 0.155
exp MND1 4q31.3 0.391 0.00203 0.155 DNA recombination;meiosis
exp RPL7AP11 3q13.33 0.391 0.00203 0.155
exp ADAMTS15 11q25 -0.391 0.00203 0.155 proteolysis
xai TMEM56 1p21.3 -0.394 0.00203 0.155
xai ADGRG1 -0.394 0.00203 0.155 cell adhesion;G-protein
xai WDR74 11q12.3 0.394 0.00204 0.155
xsq LOC101927153 0.39 0.00204 0.155
met MRAS 3q22.3 0.39 0.00204 0.155 GTP catabolic process;signal
transduction
mut POLA1 Xp22.1-p21.3 0.39 0.00204 0.155 DNA Damage Response (DDR);
xai SEPT8 5q31 -0.394 0.00204 0.155 cell cycle
swa CDC27 17q21.32 -0.394 0.00204 0.155 mitotic cell cycle;protein
K11-linked ubiquitination
his CR1 1q32 0.393 0.00205 0.155 negative regulation of complement
activation, classical pathway;negative regulation of serine-type endopeptidase
activity
xai RASGRP2 11q13 0.393 0.00205 0.155 Ras protein signal
exp RPL18A 19p13 0.393 0.00205 0.155 translational initiation;viral
infectious cycle
hs4 DLEU7-AS1 0.393 0.00205 0.155
xsq LINC00202-2 10p12.1 0.39 0.00205 0.155
mut USP28 11q23 0.39 0.00205 0.155 DNA damage checkpoint;cellular response
to UV
exp RBFA 18q23 0.39 0.00205 0.155 rRNA processing
xai PARP1P1 13q34 0.393 0.00206 0.156
xai PRKRIRP2 0.393 0.00206 0.156
his GNB3 12p13 0.393 0.00206 0.156 small molecule metabolic process;cellular
response to glucagon stimulus
xsq MYO1G 7p13-p11.2 0.39 0.00206 0.155
met IFITM3 11p15.5 0.39 0.00206 0.156 innate immune response;type I
interferon-mediated signaling pathway
exp SDC4 20q12 -0.39 0.00206 0.155 ureteric bud development;positive
his ANKK1 11q23.2 -0.393 0.00206 0.156
his MB21D1 6q13 0.393 0.00207 0.156 response to virus
xsq NKRF Xq24 0.39 0.00207 0.156 negative regulation of transcription,
DNA-dependent"
exp RASAL3 19p13.12 0.39 0.00207 0.156 signal transduction;positive
xsq SLC9B2 4q24 0.39 0.00207 0.156 cation transport;sodium ion
transport
xsq LAMC1 1q31 -0.39 0.00207 0.156 axon guidance;endoderm development
swa C19orf43 19p13.2 0.393 0.00208 0.156
xai PRR14 16p11.2 0.393 0.00208 0.156
xsq DOC2GP 11q13.2 0.39 0.00208 0.156
exp MSH2 2p21 0.39 0.00208 0.156 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
exp NUP133 1q42.13 0.39 0.00208 0.156 carbohydrate metabolic
xai PITPNC1 17q24.2 0.393 0.00209 0.157 transport;lipid transport
his DDX12P 12p13.31 0.393 0.00209 0.157 nucleobase-containing
compound metabolic process;cell cycle
his QSOX2 9q34.3 0.393 0.00209 0.157 cell redox homeostasis
xsq C22orf15 22q11.23 0.39 0.00209 0.157
xai HSPB1 7q11.23 -0.393 0.00209 0.157 Apoptosis
his PPCDC 15q24.2 0.393 0.0021 0.157 coenzyme A biosynthetic
process;pantothenate metabolic process
hs4 LY6H 8q24.3 0.393 0.0021 0.157 nervous system development;organ
morphogenesis
swa PFDN4 20q13.2 0.393 0.0021 0.157 protein folding;cellular protein
metabolic process
xai CXXC1 18q12 0.393 0.0021 0.157 regulation of transcription, DNA-
dependent;activation of signaling protein activity involved in unfolded protein
response
hs4 CYP4F2 19p13.12 0.393 0.0021 0.157 drug metabolic process;sodium
ion homeostasis
exp CEP192 18p11.21 0.39 0.0021 0.157 G2/M transition of mitotic
exp MIR1244-3 0.389 0.0021 0.157
exp AMOTL2 3q21-q22 -0.389 0.0021 0.157
exp CUEDC1 17q23.2 -0.389 0.0021 0.157
exp RALGPS2 1q25.2 -0.389 0.0021 0.157 small GTPase mediated
signal transduction
xsq CAST 5q15 -0.39 0.0021 0.157 negative regulation of endopeptidase
activity
hs4 LMCD1-AS1 3p26.1 -0.393 0.0021 0.157
hs4 LMCD1 3p26-p24 -0.393 0.0021 0.157 positive regulation of
calcineurin-NFAT signaling cascade;negative regulation of transcription from RNA
xai HIST1H1E 6p21.3 0.393 0.00211 0.157 nucleosome
his FCGR1A 1q21.2-q21.3 0.392 0.00211 0.157 innate immune
response;antigen processing and presentation of peptide antigen via MHC class I
his RBMX2 Xq26.1 0.392 0.00211 0.157
his TNFAIP8L2 1q21.3 0.392 0.00211 0.157 innate immune response
his TNFAIP8L2-SCNM1 0.392 0.00211 0.157
exp RPL36AP39 11p15.5 0.389 0.00211 0.157
xsq RASSF5 1q32.1 0.389 0.00211 0.157 Apoptosis
xsq TCEANC2 1p32.3 0.389 0.00211 0.157 transcription, DNA-dependent"
mut PPARGC1B 5q32 0.389 0.00211 0.157 positive regulation of
transcription from RNA polymerase II promoter;response to glucocorticoid stimulus
xsq THBS1 15q15 -0.389 0.00211 0.157 sprouting angiogenesis;immune
response
exp LOC346329 7q11.21 -0.389 0.00211 0.157
xai DLGAP4 20q11.23 -0.392 0.00211 0.157 cell-cell signaling
hs4 ARSJ 4q26 -0.392 0.00211 0.157
mut APAF1 12q23 0.389 0.00212 0.157 Apoptosis
exp HIST1H4A 6p22.1 0.389 0.00212 0.157
met CFAP69 0.389 0.00212 0.157
exp MTO1 6q13 0.389 0.00212 0.157 tRNA processing;oxidation-reduction
process
met WWC2-AS2 4q35.1 0.389 0.00212 0.157
exp RNF166 16q24.3 0.389 0.00212 0.157
exp PINX1 8p23 0.389 0.00212 0.157 DNA Damage Response (DDR)
hs4 SASH1 6q24.3 -0.392 0.00212 0.157
hs4 FKBP9 7p11.1 -0.392 0.00212 0.157 protein peptidyl-prolyl
hs4 GNG12 1p31.3 -0.392 0.00212 0.157 signal transduction;G-protein
hs4 GNG12-AS1 1p31.3 -0.392 0.00212 0.157
his FAM74A3 0.392 0.00213 0.157
xsq APOBR 16p11 0.389 0.00213 0.157 triglyceride metabolic process;transport
xsq MMP9 20q11.2-q13.1 0.389 0.00213 0.157 Apoptosis
exp LOC100128109 0.389 0.00213 0.157
exp ADGRG1 -0.389 0.00213 0.157 cell adhesion;G-protein
hs4 RHOH 4p13 0.392 0.00214 0.157 regulation of transcription, DNA-
mut PRPF38B 1p13.3 0.389 0.00214 0.157 mRNA processing;RNA splicing
exp TAZ Xq28 0.389 0.00214 0.157 cristae formation;muscle contraction
met NR2F2 15q26 0.389 0.00214 0.157 negative regulation of endothelial cell
proliferation;radial pattern formation
exp TOP1P2 0.389 0.00214 0.157
xsq FBXO32 8q24.13 -0.389 0.00214 0.157 muscle atrophy
exp AFF4 5q31 -0.389 0.00214 0.157 spermatid development;regulation of
xsq SPATS2L 2q33.1 -0.389 0.00214 0.157
xai TJP1 15q13 -0.392 0.00214 0.157 blastocyst formation;apoptotic
process
xai TNFRSF12A 16p13.3 -0.392 0.00214 0.157 Apoptosis
xai SNRNP200 2q11.2 0.395 0.00215 0.157 RNA splicing;gene expression
exp HIST1H1E 6p21.3 0.392 0.00215 0.157 nucleosome
his SMIM8 6q15 0.392 0.00215 0.157
exp POLR3K 16p13.3 0.389 0.00215 0.157 transcription from RNA
mut COPA 1q23.2 0.389 0.00215 0.157 pancreatic juice secretion;COPI
coating of Golgi vesicle
xsq FZD7 2q33 -0.389 0.00215 0.157 G-protein signaling, coupled to
xai ARHGEF17 11q13.4 -0.392 0.00215 0.157 regulation of small
xai PPIH 1p34.1 0.392 0.00216 0.157 nuclear mRNA splicing, via
spliceosome;protein peptidyl-prolyl isomerization
xai RAD54L 1p32 0.392 0.00216 0.157 DNA Damage Response (DDR); DDR (HR)
xai OPRL1 20q13.33 0.392 0.00216 0.157 elevation of cytosolic calcium ion
exp HNRNPA1P58 6p22.3 0.392 0.00216 0.157
xai FAM129C 19p13.11 0.392 0.00216 0.157
met OSCP1 1p34.3 0.389 0.00216 0.157 transport
exp RPL18AP3 0.388 0.00216 0.157
xsq SNX20 16q12.1 0.388 0.00216 0.157 cell communication;protein
transport
xsq WNT2 7q31.2 0.388 0.00216 0.157 Apoptosis; Oncogenes
met SIAH1 16q12.1 0.388 0.00216 0.157 Apoptosis
his CD7 17q25.2-q25.3 0.391 0.00217 0.158 homeostasis of number of
his ORC1 1p32 0.391 0.00217 0.158 DDR (DNA replication)
his PRPF38A 1p32.3 0.391 0.00217 0.158 mRNA processing;RNA splicing
xai RPL4P1 0.391 0.00217 0.158
xsq SLC29A1 6p21.1 0.388 0.00217 0.157 Solute Carriers
xsq CXorf65 Xq13.1 0.388 0.00217 0.158
met UBXN6 19p13 0.388 0.00217 0.158
exp PA2G4P2 20p12.1 0.391 0.00218 0.158
xai RSL24D1P1 6p22.1 0.391 0.00218 0.158
xsq LINC00891 0.388 0.00218 0.158
mut TMCO5A 15q14 0.388 0.00218 0.158
xsq NFATC1 18q23 0.388 0.00218 0.158 transcription from RNA polymerase
II promoter;intracellular signal transduction
met ANKAR 2q32.2 0.388 0.00218 0.158
exp ANP32B 9q22.32 0.388 0.00218 0.158
exp PDCD2 6q27 0.388 0.00218 0.158 Apoptosis
met TDO2 4q31-q32 -0.388 0.00218 0.158 tryptophan catabolic
process;tryptophan catabolic process to kynurenine
xai DENND1C 19p13.3 0.391 0.00219 0.158
xai PRKRIRP3 10q21.1 0.391 0.00219 0.158
xai IGHM 14q32.33 0.391 0.00219 0.158 immune response
exp RPS24P14 0.391 0.00219 0.158
exp LOC100128546 Xq24 0.388 0.00219 0.158
mut RXRG 1q22-q23 0.388 0.00219 0.158 neuron differentiation;response to
retinoic acid
met MIRLET7E -0.388 0.00219 0.158
swa SPECC1 17p11.2 -0.391 0.00219 0.158
exp LOC100506947 0.391 0.0022 0.158
xai SETD1A 16p11.2 0.391 0.0022 0.158 chromatin
modification;histone H3-K4 methylation
hs4 EVI2B 17q11.2 0.391 0.0022 0.158
his CD300A 17q25.1 0.391 0.0022 0.158 cell adhesion
exp RPL19P21 Xq28 0.391 0.0022 0.158
xai LOC100506947 0.391 0.0022 0.158
xai RPS24P14 0.391 0.0022 0.158
xsq SURF6 9q34.2 0.388 0.0022 0.158 ribosome biogenesis
mut MCM3 6p12 0.388 0.0022 0.158 DDR (DNA replication)
exp DUSP2 2q11 0.388 0.0022 0.158 regulation of apoptotic
exp SIT1 9p13-p12 0.388 0.0022 0.158 signal transduction;regulation of T
cell activation
swa WDR90 16p13.3 0.391 0.00221 0.158
exp RPL18AP15 Xq23 0.388 0.00221 0.158
exp EHD4 15q11.1 -0.388 0.00221 0.158 regulation of
hs4 PIEZO1 16q24.3 0.391 0.00222 0.158 ion transport;positive
regulation of integrin activation
swa PA2G4 12q13.2 0.391 0.00222 0.158 rRNA processing;regulation of
translation
xsq BEND3 6q21 0.387 0.00222 0.158
xsq RMND5A 2p11.2 0.387 0.00222 0.158
xsq LMCD1 3p26-p24 -0.388 0.00222 0.158 positive regulation of
exp TJP1 15q13 -0.388 0.00222 0.158 blastocyst formation;apoptotic
process
hs4 PARVA 11p15.3 -0.391 0.00222 0.158 cell projection
organization;actin cytoskeleton organization
swa IMPDH2 3p21.2 0.391 0.00223 0.159 nucleobase-containing small
xsq HCG11 6p22.2 0.387 0.00223 0.159
exp SLA2 20q11.23 0.387 0.00223 0.159 negative regulation of
exp RPS27AP5 1q31.2 0.387 0.00223 0.159
swa OAT 10q26 -0.39 0.00223 0.159 cellular nitrogen compound metabolic
xai S100A10 1q21 -0.39 0.00223 0.159 signal transduction;positive
exp HSP90AB7P 10p14 0.39 0.00224 0.159
xai RPSAP55 15q21.3 0.39 0.00224 0.159
xai RNASEH1-AS1 0.39 0.00224 0.159
exp SETD1A 16p11.2 0.39 0.00224 0.159 chromatin
his TRMT61B 2p23.2 0.39 0.00224 0.159 tRNA methylation;tRNA
processing
his OR4D1 0.39 0.00224 0.159
his MSX2P1 0.39 0.00224 0.159
exp GOLGA8R 0.387 0.00224 0.159
met FAM13A 4q22.1 0.387 0.00224 0.159 signal transduction;small
exp FBXL19 16p11.2 0.387 0.00224 0.159
pro MVP 16p11.2 -0.387 0.00224 0.159 DNA Damage Response (DDR)
xai POLG2 17q 0.39 0.00225 0.159 DNA Damage Response (DDR)
xai DDX19A 16q22.1 0.39 0.00225 0.159 protein transport;mRNA
transport
xsq C19orf38 19p13.2 0.387 0.00225 0.159
met C10orf131 10q24.1 0.387 0.00225 0.159
xsq AGAP2 12q14.1 0.387 0.00225 0.159 axon guidance;protein transport
exp TPM1 15q22.1 -0.387 0.00225 0.159 positive regulation of heart
exp UBTD1 10q24.2 -0.387 0.00225 0.159
hs4 C16orf54 0.39 0.00226 0.159
exp INSL3 19p13.2-p12 0.387 0.00226 0.159 in utero embryonic
exp RPLP0P6 2p22.1 0.387 0.00226 0.159 translational
elongation;ribosome biogenesis
xsq KDM2B 12q24.31 0.387 0.00226 0.159 negative regulation of
mut C11orf70 11q22.1 0.387 0.00226 0.159
xsq CALD1 7q33 -0.387 0.00226 0.159 cellular component movement;muscle
contraction
xai SPI1 11p11.2 0.39 0.00227 0.16 Transcription Factors
his KCNK17 6p21.1 0.39 0.00227 0.16 ion transport;potassium ion
transport
exp SNCAIP 5q23.2 0.387 0.00227 0.159 cell death;dopamine metabolic
process
met ARHGEF18 19p13.3 0.387 0.00227 0.16 regulation of cell
shape;induction of apoptosis by extracellular signals
hs4 SPECC1 17p11.2 -0.39 0.00227 0.159
exp RSL24D1P6 20q11 0.39 0.00228 0.16
met POFUT2 21q22.3 0.387 0.00228 0.16 carbohydrate metabolic
process;fucose metabolic process
met DYRK2 12q15 0.387 0.00228 0.16 DNA damage response, signal transduction
by p53 class mediator resulting in induction of apoptosis;positive regulation of
glycogen biosynthetic process
xai TDRD10 1q21.3 0.389 0.00229 0.161
exp UTP4 0.386 0.00229 0.16
exp MRPL18 6q25.3 0.386 0.00229 0.161 translation;transport
xai NFIB 9p24.1 -0.389 0.00229 0.161 negative regulation of cell
hs4 MRAS 3q22.3 -0.39 0.00229 0.16 GTP catabolic process;signal
transduction
xai ANO10 3p22.1 -0.39 0.00229 0.16 ion transport;cell death
xai TTC28-AS1 22q12.1 0.389 0.0023 0.161
xai PRPF19 11q12.2 0.389 0.0023 0.161 DNA Damage Response (DDR)
xsq RNASE6 14q11.2 0.386 0.0023 0.161 RNA catabolic process;defense
response
met ACAA2 18q21.1 0.386 0.0023 0.161 acetyl-CoA metabolic process;lipid
metabolic process
exp SLC44A2 19p13.1 -0.386 0.0023 0.161 Solute Carriers
xai DCBLD2 3q12.1 -0.389 0.0023 0.161 intracellular receptor
mediated signaling pathway;wound healing
xai FLJ38379 2q37.3 0.389 0.00231 0.161
exp RSAD1 17q21.33 0.386 0.00231 0.161 porphyrin-containing compound
exp RPLP0P2 11cen-q12 0.386 0.00231 0.161
xai ABCB7 Xq13.3 0.389 0.00232 0.161 ABC Transporters
his TSFM 12q14.1 0.389 0.00232 0.161 translational elongation;regulation
of transcription elongation, DNA-dependent"
met ITGB5 3q21.2 0.386 0.00232 0.161 antigen processing and presentation
met BAG3 10q25.2-q26.2 0.386 0.00232 0.161 Apoptosis
xsq ITGB5 3q21.2 -0.386 0.00232 0.161 antigen processing and
pro CTNNB1 3p21 -0.386 0.00232 0.161 Apoptosis; Cell Signaling;
Oncogenes
xsq BCAR3 1p22.1 -0.386 0.00232 0.161 small GTPase mediated signal
transduction;response to drug
xai ENAH 1q42.12 -0.389 0.00232 0.161 intracellular transport;T
xai POLRMT 19p13.3 0.389 0.00233 0.161 transcription from
mitochondrial promoter;transcription initiation from mitochondrial promoter
xsq CD1D 1q23.1 0.386 0.00233 0.161 T cell selection;positive
regulation of innate immune response
xsq KIR3DL3 0.386 0.00233 0.161
xsq LRRTM1 2p12 0.386 0.00233 0.161
xsq RNASEH1-AS1 0.386 0.00233 0.162
xai CCDC138 2q12.3 0.389 0.00234 0.162
xai HIST2H2AC 1q21.2 0.389 0.00234 0.162 nucleosome assembly
xai GNS 12q14 -0.389 0.00234 0.162 glycosaminoglycan catabolic
exp SDCCAG3P1 18q21.32 0.389 0.00235 0.162
xai SLC16A10 6q21-q22 0.389 0.00235 0.163 Solute Carriers
xai ORC2 2q33 0.389 0.00235 0.163 DDR (DNA replication)
pro CDC2 0.386 0.00235 0.162
his RNU5F-1 1p34.1 0.389 0.00236 0.163
exp RSL24D1P1 6p22.1 0.388 0.00236 0.163
exp HNRNPA1P52 19q13.2 0.385 0.00236 0.163
xsq LOC100507547 0.385 0.00236 0.163
exp FHL2 2q12.2 -0.385 0.00236 0.163 negative regulation of
development
xai ADAMTS15 11q25 -0.388 0.00236 0.163 proteolysis
xai HPRT1 Xq26.1 0.388 0.00237 0.163 spermatogenesis;central nervous
swa LSM12 17q21.31 0.388 0.00237 0.163
xsq CRYGN 7q36.1 0.385 0.00237 0.163
met PYCR1 17q25.3 0.385 0.00237 0.163 response to stress;cellular amino
acid biosynthetic process
exp DCBLD2 3q12.1 -0.385 0.00237 0.163 intracellular receptor
xai ANAPC4 4p15.2 0.388 0.00238 0.163 ubiquitin-dependent protein
catabolic process;positive regulation of ubiquitin-protein ligase activity involved
in mitotic cell cycle
met EHD4 15q11.1 0.385 0.00238 0.163 regulation of endocytosis;endocytic
recycling
xsq PSTPIP1 15q24.3 0.385 0.00238 0.163 cell adhesion;signal
transduction
met TRIM44 11p13 0.385 0.00238 0.163
exp SCARB2 4q21.1 -0.385 0.00238 0.163 protein targeting to
xai RPS17P2 5q23.1 0.388 0.00239 0.164
swa ANP32B 9q22.32 0.388 0.00239 0.164
his TGOLN2 2p11.2 0.388 0.00239 0.164
xai ARRDC2 19p13.11 0.388 0.00239 0.164
xsq AIF1 6p21.3 0.385 0.00239 0.164 positive regulation of muscle
exp CNR2 1p36.11 0.385 0.00239 0.164 negative regulation of mast cell
activation;response to amphetamine
exp SLC16A10 6q21-q22 0.385 0.00239 0.164 Solute Carriers
xsq ADGRG1 -0.385 0.00239 0.164 cell adhesion;G-protein
hs4 LAPTM5 1p34 0.388 0.0024 0.164 transport
his MARS2 2q33.1 0.388 0.0024 0.164 tRNA aminoacylation for protein
his ZFP90 16q22.1 0.388 0.0024 0.164 negative regulation of DNA
binding;positive regulation of transcription, DNA-dependent"
exp LOC442517 7p15.3 0.385 0.0024 0.164
exp AIP 11q13.3 0.385 0.0024 0.164 regulation of protein kinase A
signaling cascade;protein maturation by protein folding
xsq NR5A1 9q33 0.385 0.0024 0.164 primary sex determination;regulation of
steroid biosynthetic process
xsq PLK2 5q12.1-q13.2 -0.385 0.0024 0.164 Protein Kinases
exp RPL18AP6 2p16.3 0.385 0.00241 0.164
exp FAM74A3 0.385 0.00241 0.164
exp MZB1 5q31.2 0.385 0.00241 0.164 positive regulation of
exp HTATSF1 Xq26.3 0.385 0.00241 0.164 regulation of transcription
from RNA polymerase II promoter;viral genome replication
xai CYTH3 7p22.1 -0.388 0.00241 0.164 vesicle-mediated
transport;regulation of cell adhesion
xai LST1 6p21.3 0.388 0.00242 0.165 cell morphogenesis;immune response
xai NUDT21 16q12.2 0.388 0.00242 0.165 RNA splicing;gene expression
xai SMCHD1 18p11.32 0.388 0.00242 0.165 inactivation of X chromosome
by DNA methylation;chromosome organization
xai P2RX5 17p13.3 0.388 0.00242 0.165 signal transduction;nervous system
development
exp ARID3A 19p13.3 0.385 0.00242 0.164 regulation of transcription,
DNA-dependent"
met TGFB3 14q24 0.384 0.00242 0.165 Apoptosis
exp HNRNPA1P34 0.387 0.00243 0.165
his ABHD3 18q11.2 0.387 0.00243 0.165
xai SAMD1 19p13.12 0.387 0.00243 0.165
xsq TNFAIP8 5q23.1 0.384 0.00243 0.165 Apoptosis
exp IGLL1 22q11.23 0.384 0.00243 0.165 immune response
mut EPS15L1 19p13.11 0.384 0.00243 0.165 endocytosis;epidermal growth
factor receptor signaling pathway
exp RASA4 7q22 0.384 0.00244 0.165 regulation of small GTPase mediated
signal transduction;positive regulation of Ras GTPase activity
xai NOP14 4p16.3 0.387 0.00245 0.165 endonucleolytic cleavage to
generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-
rRNA);endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA,
5.8S rRNA, LSU-rRNA)
xai AIP 11q13.3 0.387 0.00245 0.165 regulation of protein kinase A
exp SNX20 16q12.1 0.384 0.00245 0.166 cell communication;protein
transport
exp STK26 0.384 0.00245 0.166
exp FNIP1 5q23.3 -0.384 0.00245 0.165 regulation of protein
phosphorylation
hs4 DIP2C 10p15.3 -0.387 0.00245 0.166
xai SLC44A2 19p13.1 -0.387 0.00245 0.165 Solute Carriers
xai P2RX1 17p13.3 0.387 0.00246 0.166 insemination;purinergic nucleotide
exp NUTM2B 10q22.3 0.384 0.00246 0.166
xsq PRND 20p13 0.384 0.00246 0.166 cellular copper ion homeostasis;protein
homooligomerization
xsq DHODH 16q22 0.384 0.00246 0.166 nucleobase-containing small molecule
xsq OPHN1 Xq12 -0.384 0.00246 0.166 substrate-dependent cell migration,
met PRSS30P 16p13.3 -0.384 0.00246 0.166
exp PPIH 1p34.1 0.384 0.00247 0.166 nuclear mRNA splicing, via
pro PCNA 20pter-p12 0.384 0.00247 0.166 DNA Damage Response (DDR); DDR
(BER); DDR (DNA replication)
mir hsa-miR-30a -0.384 0.00247 0.166
xai LOC100505736 -0.387 0.00247 0.166
exp RPL6P30 Xp22.2 0.387 0.00248 0.166
his PTPN7 1q32.1 0.387 0.00248 0.166 protein dephosphorylation;peptidyl-
his PTPRVP 1q32.1 0.387 0.00248 0.166
exp IGKV1OR2-118 0.384 0.00248 0.166
xsq CTSO 4q32.1 -0.384 0.00248 0.166 proteolysis
exp LOC100505736 -0.387 0.00248 0.166
xai RALGPS2 1q25.2 -0.387 0.00248 0.166 small GTPase mediated
signal transduction
xai LMNB1 5q23.2 0.387 0.00249 0.167 apoptotic process;cellular
xai HMMR 5q34 0.387 0.00249 0.167
met DKKL1 19q13.33 0.384 0.00249 0.167 positive regulation of fat cell
differentiation;signal transduction
exp FARSA 19p13.2 0.384 0.00249 0.167 tRNA aminoacylation for protein
exp EEF1GP8 4q28.2 0.383 0.00249 0.167
xsq FASTKD1 2q31 0.383 0.00249 0.167 cellular respiration
exp GALNT11 7q36.1 -0.383 0.00249 0.167 O-glycan
exp LOC100132686 11q23.1 -0.383 0.00249 0.167
his GPR84 12q13.13 0.387 0.0025 0.167
xai MCM10 10p13 0.386 0.0025 0.167 DDR (DNA replication)
exp DDX28 16q22.1 0.383 0.0025 0.167
exp RPL31P56 16q11.2-q13 0.383 0.0025 0.167
exp PHLDB1 11q23.3 -0.383 0.0025 0.167
swa CALD1 7q33 -0.386 0.0025 0.167 cellular component movement;muscle
contraction
his DHODH 16q22 0.386 0.00251 0.167 nucleobase-containing small molecule
xai SLC25A20 3p21.31 0.386 0.00251 0.167 Solute Carriers
xai NOC4L 12q24.33 0.386 0.00251 0.167 rRNA processing
xai GMFG 19q13.2 0.386 0.00251 0.167 protein phosphorylation;positive
exp FAM86B1 8p23.1 0.383 0.00251 0.167
met GTF2IRD1 7q11.23 0.383 0.00251 0.167 regulation of transcription,
DNA-dependent;multicellular organismal development
xai RHOB 2p24 -0.386 0.00251 0.167 Apoptosis
xai RPL6P30 Xp22.2 0.386 0.00252 0.167
his RAB14 9q32-q34.11 0.386 0.00252 0.167 neurotransmitter
xai NPW 16p13.3 0.386 0.00252 0.167 G-protein coupled receptor
xsq CXCR4 2q21 0.383 0.00252 0.167 activation of MAPK activity;viral
reproduction
exp CCDC138 2q12.3 0.383 0.00252 0.167
xsq TBC1D10C 11q13.2 0.383 0.00252 0.167
exp ENAH 1q42.12 -0.383 0.00252 0.167 intracellular transport;T
hs4 PPP1R9A 7q21.3 -0.386 0.00252 0.167 multicellular organismal
xai ASUN 12p11.23 0.386 0.00253 0.167 cell cycle;mitosis
xai LSP1 11p15.5 0.386 0.00253 0.167 chemotaxis;cellular defense
response
exp TREML2 6p21.1 0.383 0.00253 0.167 T cell activation
exp PPRC1 10q24.32 0.383 0.00253 0.167 regulation of transcription, DNA-
dependent"
exp HMGN5 Xq13.3 0.383 0.00253 0.167 regulation of transcription, DNA-
met RILP 17p13.3 0.383 0.00253 0.167 endosome to lysosome
transport;protein transport
exp NACC2 9q34.3 -0.383 0.00253 0.167 positive regulation of cell
proliferation;negative regulation of transcription, DNA-dependent
xai HNRNPA1P23 3q21.1 0.386 0.00254 0.168
his LINC01572 0.386 0.00254 0.168
xsq CKLF-CMTM1 0.383 0.00254 0.168
xsq CDCA7 2q31 0.383 0.00254 0.168 regulation of transcription, DNA-
xsq MYO6 6q13 -0.383 0.00254 0.168 regulation of
secretion;intracellular protein transport
xai CHCHD4 3p25.1 0.386 0.00255 0.168 protein transport
hs4 RAB44 0.386 0.00255 0.168 small GTPase mediated signal
xai FBXL19 16p11.2 0.386 0.00255 0.168
met FAM114A1 4p14 0.383 0.00255 0.168
mut PCDHB14 5q31 0.383 0.00255 0.168 cell adhesion;homophilic cell
adhesion
exp ARRDC2 19p13.11 0.383 0.00255 0.168
xai CTU2 16q24.3 0.386 0.00256 0.168 tRNA wobble uridine
modification;tRNA processing
xai PTGDR 14q22.1 0.386 0.00256 0.168 G-protein coupled receptor
his SLC25A19 17q25.3 0.386 0.00256 0.168 Solute Carriers
exp EEF1A1P22 15q21.3 0.386 0.00256 0.168
mut RAB3IL1 11q12.2 0.383 0.00256 0.168
mut AP3B1 5q14.1 0.382 0.00256 0.168 protein targeting to
lysosome;intracellular protein transport
xsq WDR59 16q23.1 0.382 0.00256 0.168
exp MAGOH3P 14q24.1 -0.383 0.00256 0.168
xai TOP1P2 0.385 0.00257 0.168
exp PRPF38AP2 10p12.33 0.385 0.00257 0.168
exp PRKRIR 11q13.5 0.382 0.00257 0.168 response to stress;signal
transduction
exp CORO7 16p13.3 0.382 0.00257 0.168 actin cytoskeleton organization
hs4 LURAP1L 9p23 -0.385 0.00257 0.168
hs4 LOC100996447 -0.385 0.00257 0.168
hs4 MLF1 3q25.1 -0.385 0.00257 0.168 cell cycle
arrest;multicellular organismal development
swa CTSA 20q13.1 -0.385 0.00257 0.168 positive regulation of
catalytic activity;small molecule metabolic process
his APOA2 1q23.3 0.385 0.00258 0.168 cholesterol metabolic
process;negative regulation of cholesterol transport
his TOMM40L 1q23.3 0.385 0.00258 0.168 protein
transport;transmembrane transport
his MIR5187 0.385 0.00258 0.168
exp ATG4C 1p31.3 0.382 0.00258 0.168 autophagic vacuole
assembly;proteolysis
exp SLA 8q24 0.382 0.00258 0.168
met CDK5R1 17q11.2 0.382 0.00258 0.168 Apoptosis
mut ADAMTS12 5q35 0.382 0.00258 0.168 proteolysis
mir hsa-miR-99b -0.382 0.00258 0.168
his MTRF1L 6q25-q26 0.385 0.00259 0.169 translational termination
xai SLA 8q24 0.385 0.00259 0.169
xai CECR1 22q11.2 0.385 0.00259 0.169 adenosine catabolic
xsq PDE3B 11p15.1 0.382 0.00259 0.168 cellular response to insulin
stimulus;negative regulation of cell adhesion mediated by integrin
exp DDN 12q13.12 0.382 0.00259 0.168
exp ELMO1 7p14.1 0.382 0.00259 0.168 actin cytoskeleton
met ISG20L2 1q23.1 0.382 0.00259 0.169 ribosome biogenesis
exp ACTN4P2 1p34.3 -0.385 0.00259 0.169
hs4 LOC101927596 0.385 0.0026 0.169
xai CSK 15q24.1 0.385 0.0026 0.169 Apoptosis
xsq DANCR 4q12 0.382 0.0026 0.169
xsq LINC00528 22q11.21 0.382 0.0026 0.169
mut PTGS1 9q32-q33.3 0.382 0.0026 0.169 xenobiotic metabolic
process;regulation of cell proliferation
hs4 CLCN4 Xp22.3 -0.385 0.0026 0.169 chloride
xai XRCC3 14q32.3 0.385 0.00261 0.169 DNA Damage Response (DDR); DDR
(NHEJ)
his TLR9 3p21.3 0.385 0.00261 0.169 negative regulation of interleukin-
exp NFYC 1p32 0.382 0.00261 0.169 regulation of transcription from RNA
xsq DIP2C 10p15.3 -0.382 0.00261 0.169
xsq C15orf52 15q15.1 -0.382 0.00261 0.169
exp CTSD 11p15.5 -0.382 0.00261 0.169 cell death;proteolysis
exp ZBED4 22q13.33 0.382 0.00262 0.169
swa SNRPD2 19q13.2 0.385 0.00263 0.17 spliceosome
assembly;spliceosomal snRNP assembly
mut ADAM7 8p21.2 0.382 0.00263 0.17 proteolysis
met PARD6G 18q23 0.382 0.00263 0.17 cell junction assembly;cell-cell
exp NCKAP1 2q32 -0.381 0.00263 0.17 Apoptosis
exp ANXA2P3 10q21.3 -0.382 0.00263 0.17
exp PTGDR 14q22.1 0.381 0.00264 0.17 G-protein coupled receptor
xsq STARD13 13q13.1 -0.381 0.00264 0.171 Apoptosis
exp MYOF 10q24 -0.381 0.00264 0.17 plasma membrane repair;muscle
contraction
hs4 CXorf21 Xp21.2 0.384 0.00265 0.171
hs4 ITM2A Xq13.3-Xq21.2 0.384 0.00265 0.171
exp RPL4P1 0.384 0.00265 0.171
met PEG3 19q13.4 0.381 0.00265 0.171 viral reproduction;apoptotic
process
met LOC401052 3p25.3 0.381 0.00265 0.171
xai MCM7 7q21.3-q22.1 0.384 0.00266 0.171 DDR (DNA replication)
met RAB3IL1 11q12.2 0.381 0.00266 0.171
exp LMNB1 5q23.2 0.381 0.00266 0.171 apoptotic process;cellular
xai CD276 15q23-q24 -0.384 0.00266 0.171 cell proliferation;positive
exp LOC100506342 -0.384 0.00266 0.171
swa MYL9 20q11.23 -0.384 0.00266 0.171 axon guidance;muscle
contraction
xai LOC100506342 -0.384 0.00266 0.171
his FXN 9q21.11 0.384 0.00267 0.171 mitochondrion organization;protein
autoprocessing
xai RPLP0P2 11cen-q12 0.384 0.00267 0.171
exp PITPNC1 17q24.2 0.381 0.00267 0.171 transport;lipid transport
exp CD93 20p11.21 0.381 0.00267 0.171 macrophage activation;interspecies
xsq LRIT3 4q25 0.381 0.00267 0.171
xai ATP6V1D 14q23-q24.2 -0.384 0.00267 0.171 proton
transport;transferrin transport
xai PRPF38AP2 10p12.33 0.384 0.00268 0.171
xai RPL31P41 8q13.1 0.384 0.00268 0.171
xai MAP4K1 19q13.1-q13.4 0.384 0.00268 0.171 response to
stress;intracellular protein kinase cascade
exp RPL31P41 8q13.1 0.384 0.00268 0.171
exp DDX19A 16q22.1 0.381 0.00268 0.171 protein transport;mRNA
transport
xsq LAS1L Xq12 0.381 0.00268 0.171 rRNA processing
xsq IGFBP7 4q12 -0.381 0.00268 0.171 regulation of cell
growth;cell adhesion
xsq CNN3 1p22-p21 -0.381 0.00268 0.171 negative regulation of ATPase
swa ATP6V0D1 16q22.1 -0.384 0.00268 0.171 activation of signaling
protein activity involved in unfolded protein response;transmembrane transport
swa SCARB2 4q21.1 -0.384 0.00268 0.171 protein targeting to
his POLQ 3q13.33 0.384 0.00269 0.171 DNA Damage Response (DDR); DDR (DNA
xai GOT2P2 1q25.1 0.384 0.00269 0.171
exp C20orf96 20p13 0.384 0.00269 0.171
hs4 TNFAIP8L2 1q21.3 0.384 0.00269 0.171 innate immune response
hs4 TNFAIP8L2-SCNM1 0.384 0.00269 0.171
xai ELMO1 7p14.1 0.384 0.00269 0.171 actin cytoskeleton
exp C9 5p14-p12 0.381 0.00269 0.171 blood coagulation;cytolysis
exp RAD54L 1p32 0.381 0.0027 0.171 DNA Damage Response (DDR); DDR (HR)
xsq MIR3939 0.381 0.0027 0.171
exp AIF1 6p21.3 0.381 0.0027 0.171 positive regulation of muscle
xsq PRPF19 11q12.2 0.381 0.0027 0.171 DNA Damage Response (DDR)
exp NOP14 4p16.3 0.381 0.0027 0.171 endonucleolytic cleavage to
xai CTSD 11p15.5 -0.384 0.0027 0.171 cell death;proteolysis
his POLR2C 16q13-q21 0.384 0.00271 0.172 DNA Damage Response (DDR);
DDR (NER)
hs4 MIR223 0.384 0.00271 0.172
xsq C12orf57 12p13.31 0.381 0.00271 0.172
xsq HPDL 1p34.1 0.38 0.00271 0.172 aromatic amino acid family
metabolic process
met PTK2 8q24.3 0.38 0.00271 0.172 Apoptosis
his MCM5 22q13.1 0.383 0.00272 0.172 DDR (DNA replication)
exp CD52 1p36 0.38 0.00272 0.172 elevation of cytosolic calcium ion
xsq HHEX 10q23.33 0.38 0.00272 0.172 in utero embryonic development;cell
proliferation
mut ECE2 3q27.1 0.38 0.00272 0.172 peptide hormone
processing;proteolysis
exp BHMT 5q14.1 -0.38 0.00272 0.172 regulation of homocysteine
metabolic process;sulfur amino acid metabolic process
swa CAPNS1 19q13.12 -0.383 0.00272 0.172 proteolysis;metabolic
process
xai RPS10P28 19q13.2 0.383 0.00273 0.172
xai CUTC 10q24.2 0.383 0.00273 0.172 copper ion transport;protein
tetramerization
his REST 4q12 0.383 0.00273 0.172 positive regulation of apoptotic
process;negative regulation of neurogenesis
xsq IL17REL 22q13.33 0.38 0.00273 0.172
met PNPLA3 22q13.31 0.38 0.00273 0.172 triglyceride catabolic
process;metabolic process
exp CSK 15q24.1 0.38 0.00273 0.172 Apoptosis
exp RPS17P2 5q23.1 0.38 0.00273 0.172
his MIR1256 0.383 0.00274 0.172
his HIRIP3 0.383 0.00274 0.172 chromatin assembly or disassembly
his INO80E 16p11.2 0.383 0.00274 0.172 DNA Damage Response (DDR);
DDR (Chromatin)
mut IGDCC4 15q22.31 0.38 0.00274 0.172
xai GALNT11 7q36.1 -0.383 0.00274 0.172 O-glycan
xai SPNS3 17p13.2 0.383 0.00275 0.172 lipid transport;transmembrane
transport
met CYP39A1 6p21.1-p11.2 0.38 0.00275 0.173 small molecule metabolic
exp SEPT8 5q31 -0.38 0.00275 0.173 cell cycle
exp PHLDA3 1q31 -0.38 0.00275 0.173 negative regulation of protein
kinase B signaling cascade;apoptotic process
exp SLC25A1 22q11.21 -0.38 0.00275 0.172 Solute Carriers
xai NCKAP1 2q32 -0.383 0.00275 0.172 Apoptosis
swa RAB2A 8q12.1 -0.383 0.00275 0.172 GTP catabolic process;ER to
Golgi vesicle-mediated transport
xai PPRC1 10q24.32 0.383 0.00276 0.173 regulation of transcription, DNA-
dependent"
his SOS1 2p21 0.383 0.00276 0.173 Ras protein signal
transduction;regulation of Rho protein signal transduction
xai EEF1A1 6q14.1 0.383 0.00276 0.173 translation;translational
elongation
met TSR3 16p13.3 0.38 0.00276 0.173
xsq KRT80 12q13.13 -0.38 0.00276 0.173
met C2orf90 0.38 0.00277 0.174
xai TCEAL3 Xq22.2 -0.383 0.00277 0.173 regulation of
xai CUEDC1 17q23.2 -0.383 0.00277 0.173
xai CALD1 7q33 -0.383 0.00277 0.173 cellular component movement;muscle
contraction
xai DTL 1q32 0.383 0.00278 0.174 DDR (DNA replication)
xai ZMYM3 Xq13.1 0.383 0.00278 0.174 multicellular organismal
development;regulation of cell morphogenesis
exp BIN2P1 4q21.22 0.38 0.00278 0.174
xsq FAM26F 6q22.1 0.38 0.00278 0.174
xsq ARL5C 17q12 0.379 0.00279 0.174 small GTPase mediated signal transduction
xsq S100A16 1q21 -0.379 0.00279 0.174 response to calcium ion
met TRH 3q13.3-q21 -0.379 0.00279 0.174
xai SCARB2 4q21.1 -0.383 0.00279 0.174 protein targeting to
hs4 RCSD1 1q24.2 0.382 0.0028 0.174 cellular hyperosmotic
xai IMMTP1 0.382 0.0028 0.174
xsq PITPNC1 17q24.2 0.379 0.0028 0.174 transport;lipid transport
xsq LINC01550 0.379 0.0028 0.174
met RIN1 11q13.2 0.379 0.0028 0.174 endocytosis;signal transduction
xai FAM86B1 8p23.1 0.382 0.00281 0.175
xai MCM5 22q13.1 0.382 0.00281 0.175 DDR (DNA replication)
xsq ATP13A4 3q29 0.379 0.00281 0.175 cation transport;ATP biosynthetic
process
xai MGST3 1q23 -0.382 0.00281 0.175 signal transduction;leukotriene
his CD37 19q13.3 0.382 0.00282 0.175 positive regulation of
xai EEF1A1P12 2q12.2 0.382 0.00282 0.175
exp KRT73 12q13.3 0.379 0.00282 0.175
exp RPLP0P9 5q34 0.379 0.00282 0.175
xsq ANP32A 15q23 0.379 0.00282 0.175 regulation of transcription, DNA-
dependent;nucleocytoplasmic transport
exp C1QTNF2 5q33.3 -0.379 0.00282 0.175 positive regulation of
glucose import;protein homooligomerization
swa COPS3 17p11.2 -0.382 0.00282 0.175 DNA Damage Response (DDR)
xai CPQ 8q22.2 -0.382 0.00282 0.175 proteolysis;peptide metabolic
process
xsq CCDC149 4p15.2 -0.379 0.00283 0.175
xsq MIR4458HG -0.379 0.00283 0.175
xai AGRN 1p36.33 -0.382 0.00283 0.175 neuromuscular junction
development;positive regulation of transcription from RNA polymerase II promoter
xai SDCCAG3P1 18q21.32 0.382 0.00284 0.175
xai SAMSN1 21q11 0.382 0.00284 0.175 negative regulation of peptidyl-
exp LGALS3 14q22.3 -0.379 0.00284 0.176 skeletal system
xsq GBP2 1p22.2 -0.379 0.00284 0.175 immune response;cytokine-
xsq DAG1 3p21 -0.379 0.00284 0.175 interspecies interaction between
organisms;membrane protein ectodomain proteolysis
xai MYOF 10q24 -0.382 0.00284 0.176 plasma membrane repair;muscle
contraction
hs4 JPH2 20q13.12 -0.382 0.00284 0.175 regulation of cardiac muscle
tissue development;calcium ion homeostasis
xai SNCAIP 5q23.2 0.382 0.00285 0.176 cell death;dopamine metabolic
process
exp SSBP4 19p13.1 0.379 0.00285 0.176
exp TOP2B 3p24 0.379 0.00285 0.176 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
xai LINC00202-2 10p12.1 0.382 0.00286 0.176
exp SLC25A20 3p21.31 0.379 0.00286 0.176 Solute Carriers
xsq SEPT1 16p11.1 0.379 0.00286 0.176 cell cycle;cell division
exp ANAPC4 4p15.2 0.379 0.00286 0.176 ubiquitin-dependent protein
xai NACC2 9q34.3 -0.382 0.00286 0.176 positive regulation of cell
xai C17orf96 17q12 0.382 0.00287 0.176
exp PRKRIRP4 0.382 0.00287 0.176
exp HNRNPA1P23 3q21.1 0.382 0.00287 0.176
xai RCSD1 1q24.2 0.381 0.00287 0.176 cellular hyperosmotic
xai ATG4C 1p31.3 0.381 0.00287 0.176 autophagic vacuole
exp EEF1A1P12 2q12.2 0.381 0.00287 0.176
his RNF166 16q24.3 0.381 0.00287 0.176
his CTU2 16q24.3 0.381 0.00287 0.176 tRNA wobble uridine
exp GLRX5 14q32.13 0.378 0.00287 0.176 hemopoiesis;cell redox homeostasis
xsq ZSCAN2 15q25.2 0.378 0.00287 0.176 cell
xai SNORA28 0.381 0.00288 0.176
his HAAO 2p21 0.381 0.00288 0.176 small molecule metabolic process;response
to cadmium ion
exp SNORA28 0.381 0.00288 0.176
xai KLHL6 3q27.3 0.381 0.00289 0.177 germinal center formation;B cell
xsq RRN3P2 16p11.2 0.378 0.00289 0.177
exp POLG2 17q 0.378 0.00289 0.177 DNA Damage Response (DDR)
xsq LOC100507250 0.378 0.00289 0.177
exp P2RX1 17p13.3 0.378 0.00289 0.177 insemination;purinergic nucleotide
his KIF13A 6p23 -0.381 0.00289 0.177 cytokinesis;plus-end-directed
mut SLC35G2 3q22.3 0.378 0.0029 0.177
exp RPLP0P10 15q15.1 0.378 0.0029 0.177
exp NUDT16 3q22.1 -0.378 0.0029 0.177
his CFB 6p21.3 -0.381 0.0029 0.177 complement activation,
hs4 ANKLE1 19p13.11 0.381 0.00291 0.177
hs4 IL2RG Xq13.1 0.381 0.00291 0.177 immune response;signal transduction
xai ZC3H8 2q13 0.381 0.00291 0.177 apoptotic process;negative regulation of
T cell differentiation in thymus
xai ACAP1 17p13.1 0.381 0.00291 0.177 regulation of ARF GTPase
his KIR3DL2 19q13.4 0.381 0.00291 0.177 cellular defense
met KIF13A 6p23 0.378 0.00291 0.177 cytokinesis;plus-end-directed
xsq LMO2 11p13 0.378 0.00291 0.177 cellular response to thyroid hormone
stimulus;transcription from RNA polymerase II promoter
met UNC13B 9p13.3 0.378 0.00291 0.177 induction of apoptosis;signal
transduction
his CCDC86 11q12.2 0.381 0.00292 0.177 interspecies interaction
between organisms
exp IMMTP1 0.381 0.00292 0.178
xsq VPREB3 22q11.23 0.378 0.00292 0.177
exp CYTH3 7p22.1 -0.378 0.00292 0.177 vesicle-mediated
xai STARD13 13q13.1 -0.381 0.00292 0.177 Apoptosis
xai FNIP1 5q23.3 -0.381 0.00292 0.177 regulation of protein
phosphorylation
xai DDN 12q13.12 0.381 0.00293 0.178
xsq TXNL4B 16q22.2 0.378 0.00293 0.178 mRNA processing;cell cycle
exp SNORA26 4q12 0.378 0.00293 0.178
exp MRPL42 12q22 0.378 0.00293 0.178 translation
xsq L1CAM Xq28 -0.378 0.00293 0.178 leukocyte cell-cell adhesion;cell
differentiation
hs4 PTPRCAP 11q13.3 0.381 0.00294 0.178 defense response
xai CALML4 15q23 0.381 0.00294 0.178
xai STAC3 12q13.3 0.381 0.00294 0.178 intracellular signal transduction
xsq ANKRD13B 17q11.2 0.378 0.00294 0.178
xsq PWRN1 15q11.2 0.378 0.00294 0.178
xsq SMIM24 0.378 0.00294 0.178
xai RPL23AP46 6q23.2 0.381 0.00295 0.178
xai PREB 2p23.3 0.381 0.00295 0.178 cellular membrane
his SURF6 9q34.2 0.381 0.00295 0.178 ribosome biogenesis
xai HSP90AB7P 10p14 0.38 0.00295 0.178
xai EEF2KMT 0.38 0.00295 0.178
his MYCN 2p24.3 0.38 0.00295 0.178 Protein Kinases
his MYCNOS 2p24.1 0.38 0.00295 0.178
xsq RHOB 2p24 -0.377 0.00295 0.178 Apoptosis
his KRT73 12q13.3 0.38 0.00296 0.178
xai ZNF112 -0.38 0.00296 0.178 regulation of transcription, DNA-
dependent"
hs4 RXFP3 5p15.1-p14 -0.38 0.00296 0.178 G-protein coupled receptor
signaling pathway;elevation of cytosolic calcium ion concentration involved in G-
protein signaling coupled to IP3 second messenger
his CHTF8 16q22.1 0.38 0.00297 0.179 DDR (DNA replication)
his UTP4 0.38 0.00297 0.179
his GTSF1 12q13.13 0.38 0.00297 0.179
his DDN 12q13.12 0.38 0.00297 0.179
his SPOUT1 0.38 0.00297 0.179
xai TRAF3IP3 1q32 0.38 0.00297 0.179
hs4 KCTD11 17p13.1 -0.38 0.00297 0.179 regulation of
hs4 TMEM95 17p13.1 -0.38 0.00297 0.179
swa INF2 14q32.33 -0.38 0.00297 0.179 cellular component
xai MRPL50 9q31.1 0.38 0.00298 0.179
exp RPSAP2 6p22.1 0.38 0.00298 0.179
mut GPR6 6q21 0.377 0.00298 0.179
xsq C17orf49 17p13.1 0.377 0.00298 0.179 chromatin modification
xsq LITAF 16p13.13 -0.377 0.00298 0.179 Apoptosis
exp MYT1L 2p25.3 0.377 0.00299 0.179 multicellular organismal
exp ORC2 2q33 0.377 0.00299 0.179 DDR (DNA replication)
swa CTNNB1 3p21 -0.38 0.00299 0.179 Apoptosis; Cell Signaling;
Oncogenes
swa HSD17B12 11p11.2 -0.38 0.00299 0.179 triglyceride biosynthetic
process;extracellular matrix organization
exp C8B 1p32.2 0.38 0.003 0.179 immune response;complement activation
swa DUT 15q21.1 0.38 0.003 0.179 DNA Damage Response (DDR)
xai FDXACB1 0.38 0.003 0.179 phenylalanyl-tRNA aminoacylation;tRNA
processing
xai ADSL 22q13.2 0.38 0.003 0.179 response to nutrient;aerobic respiration
xsq CHRM3-AS2 0.377 0.003 0.179
xai DLG1 3q29 -0.38 0.003 0.179 mitotic cell cycle G1/S transition
checkpoint;endothelial cell proliferation
mut RYR1 19q13.1 0.377 0.00301 0.18 response to caffeine;calcium ion
transmembrane transport
exp RAD9A 11q13.1-q13.2 0.377 0.00301 0.18 DNA Damage Response (DDR)
xsq PPM1E 17q22 0.377 0.00301 0.18 negative regulation of protein kinase
activity;cellular response to drug
met RHOB 2p24 0.377 0.00301 0.18 Apoptosis
xsq GRAPL 0.377 0.00301 0.18
hs4 LINC00475 -0.38 0.00301 0.179
xai SNORA26 4q12 0.38 0.00302 0.18
his MOB1A 2p13.1 0.38 0.00302 0.18 hippo signaling cascade
xai TMEM170A 16q23.1 0.38 0.00302 0.18
exp SCNN1G 16p12 0.377 0.00302 0.18 response to stimulus;sensory
perception of taste
exp NDUFV1 11q13 0.377 0.00302 0.18 mitochondrial electron transport,
met PCDH1 5q31.3 0.377 0.00302 0.18 nervous system development;cell
adhesion
xai VASN 16p13.3 -0.38 0.00302 0.18
xai DANCR 4q12 0.38 0.00303 0.18
his ANTXR2 4q21.21 0.38 0.00303 0.18
xai TOP2B 3p24 0.38 0.00303 0.18 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
xai SNRPB 20p13 0.379 0.00303 0.18 RNA splicing;gene expression
exp PTMAP4 12p13.31 0.376 0.00303 0.18
exp RPL36AP49 18p11.21 0.376 0.00303 0.18
exp HSPB1 7q11.23 -0.376 0.00303 0.18 Apoptosis
pro ANXA2 15q22.2 -0.377 0.00303 0.18 positive regulation of
vesicle fusion;fibrinolysis
his FARP1 13q32.2 -0.38 0.00303 0.18 negative regulation of phosphatase
activity;regulation of Rho protein signal transduction
xai NAA16 13q14.11 0.379 0.00304 0.18 N-terminal protein amino acid
acetylation;positive regulation of transcription, DNA-dependent"
his LINC01305 0.379 0.00304 0.18
exp PRPF19 11q12.2 0.376 0.00304 0.18 DNA Damage Response (DDR)
exp ASB3 2p16.2 0.376 0.00304 0.18 intracellular signal transduction
exp ANXA2P2 -0.376 0.00304 0.18 positive regulation of
binding;cellular response to acid
xai HNRNPA1P58 6p22.3 0.379 0.00305 0.18
xai PRKRIRP4 0.379 0.00305 0.18
xai YBX3P1 16p11.2 0.379 0.00305 0.18
exp RPS10P23 16q23.1 0.376 0.00305 0.18
xsq ISOC1 5q22.1-q33.3 0.376 0.00305 0.18
xai RPL36AP39 11p15.5 0.379 0.00306 0.18
his MCM10 10p13 0.379 0.00306 0.18 DDR (DNA replication)
xai CTCF 16q21-q22.3 0.379 0.00306 0.18 chromosome segregation;regulation
exp RPS17 0.379 0.00306 0.18 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;viral reproduction
met CTBP2 10q26.13 0.376 0.00306 0.18 negative regulation of
transcription, DNA-dependent;white fat cell differentiation
exp EPS8 12p12.3 -0.376 0.00306 0.18 signal transduction;epidermal
growth factor receptor signaling pathway
xsq TSPAN9 12p13.33-p13.32 -0.376 0.00306 0.18
his VEPH1 3q24-q25 -0.379 0.00306 0.18
his LOC102724265 -0.379 0.00306 0.18
his LOC102724927 -0.379 0.00306 0.18
hs4 LINC01451 0.379 0.00307 0.18
xai METTL21A 2q33.3 0.379 0.00307 0.18
met PYROXD2 10q24.2 0.376 0.00307 0.18
exp KRT80 12q13.13 -0.376 0.00307 0.18
xai SNX18 5q11.2 -0.379 0.00307 0.18 protein transport;positive
regulation of GTPase activity
xai SRPK1 6p21.31 0.379 0.00308 0.18 protein phosphorylation;negative
regulation of viral genome replication
his ADAM22 7q21 0.379 0.00308 0.18 proteolysis;negative regulation of
cell adhesion
xai GLRX5 14q32.13 0.379 0.00308 0.18 hemopoiesis;cell redox homeostasis
met GALNT15 3p25.1 0.376 0.00308 0.18
xsq BZRAP1-AS1 0.376 0.00308 0.18
met GPER1 0.376 0.00308 0.18 intracellular steroid hormone receptor
signaling pathway;positive regulation of epidermal growth factor receptor signaling
pathway
xsq SASH3 Xq26 0.376 0.00308 0.18 positive regulation of interleukin-10
production;positive regulation of lymphocyte activation
xsq LSP1 11p15.5 0.376 0.00308 0.18 chemotaxis;cellular defense
response
met MT1B 16q13 -0.376 0.00308 0.18 negative regulation of
growth;cellular response to zinc ion
xsq PARD3B 2q33.3 -0.376 0.00308 0.18 cell division;cell cycle
exp ENC1 5q13 -0.376 0.00308 0.18 nervous system
development;multicellular organismal development
xai RPS3P6 0.379 0.00309 0.181
xai UGCG 9q31 -0.379 0.00309 0.181 glycosphingolipid biosynthetic
process;epidermis development
xai HMGB1P16 Xp21.1 0.379 0.0031 0.181
xai ARHGEF28 5q13.2 -0.379 0.0031 0.181
xai EPS8 12p12.3 -0.379 0.0031 0.181 signal transduction;epidermal
xai SPATS2L 2q33.1 -0.379 0.0031 0.181
hs4 SLC29A1 6p21.1 0.379 0.00311 0.181 Solute Carriers
xai INSL3 19p13.2-p12 0.379 0.00311 0.181 in utero embryonic
mut ACTN1 14q24 0.376 0.00311 0.181 Apoptosis
xsq C9 5p14-p12 0.376 0.00311 0.181 blood coagulation;cytolysis
hs4 EPHA4 2q36.1 -0.379 0.00311 0.181 adult walking
his PIGS 17p13.2 0.378 0.00312 0.182 C-terminal protein
lipidation;attachment of GPI anchor to protein
mut UNC45A 15q26.1 0.375 0.00312 0.181 cell
mda Pan_compound_response 0.375 0.00312 0.182
swa RCN1 11p13 -0.378 0.00312 0.182 in utero embryonic
exp HSP90AB3P 4q22.1 0.375 0.00313 0.182 response to stress;protein
folding
xsq ZP1 11q12.2 0.375 0.00313 0.182 single fertilization
mut KCNS1 20q12 0.375 0.00313 0.182 potassium ion transport;synaptic
transmission
exp ARHGEF28 5q13.2 -0.375 0.00313 0.182
exp CTNNA1P1 5q22 -0.375 0.00313 0.182
xai RPL3P9 8q21.13 0.378 0.00314 0.182
his CD72 9p13.3 0.378 0.00314 0.182 cell adhesion;axon guidance
mut NPAS3 14q13.1 0.375 0.00314 0.182 maternal behavior;positive
regulation of transcription, DNA-dependent
exp LAS1L Xq12 0.375 0.00314 0.182 rRNA processing
exp HMHA1 19p13.3 0.375 0.00314 0.182 small GTPase mediated signal
exp XPNPEP2 Xq25 0.375 0.00314 0.182 proteolysis;cellular process
exp MYO1C 17p13.3 -0.375 0.00314 0.182 protein transport;mRNA
transport
xsq TUFT1 1q21 -0.375 0.00314 0.182 odontogenesis;bone mineralization
xai PA2G4P3 18q11.2 0.378 0.00315 0.182
xai RPSAP2 6p22.1 0.378 0.00315 0.182
his GRB2 17q24-q25 0.378 0.00315 0.182 cell-cell signaling;T cell
costimulation
his MIR3678 0.378 0.00315 0.182
mut ZNF282 7q36.1 0.375 0.00315 0.182 negative regulation of
transcription, DNA-dependent;regulation of transcription, DNA-dependent"
exp GMFG 19q13.2 0.375 0.00315 0.182 protein phosphorylation;positive
xsq EHD4 15q11.1 -0.375 0.00315 0.182 regulation of
xai SCNN1G 16p12 0.378 0.00316 0.182 response to stimulus;sensory
perception of taste
his CLSPN 1p34.2 0.378 0.00316 0.182 DNA Damage Response (DDR); DDR (G2-
M checkpoint)
exp HMGB1P16 Xp21.1 0.378 0.00316 0.182
xai FGF14-AS2 13q33.1 0.378 0.00316 0.182
exp SRRM1 1p36.11 0.375 0.00316 0.182 transcription from RNA polymerase
II promoter;termination of RNA polymerase II transcription
pro ADNP 20q13.13 0.375 0.00316 0.182 response to inorganic
substance;nitric oxide homeostasis
xai PDCD7 15q22.31 0.378 0.00317 0.182 induction of apoptosis;RNA splicing
xai NUP188 9q34.11 0.378 0.00317 0.182 protein transport;glucose
transport
his HMBS 11q23.3 0.378 0.00317 0.182 porphyrin-containing compound
metabolic process;response to nutrient levels
hs4 CD84 1q24 0.378 0.00317 0.182 defense response;cell adhesion
xai MRPL21 11q13.3 0.378 0.00317 0.182 translation
hs4 LOC100132741 0.378 0.00317 0.182
xai PTMAP4 12p13.31 0.378 0.00317 0.182
hs4 OGN 9q22 0.378 0.00317 0.182 negative regulation of smooth muscle cell
proliferation
exp SELPLG 12q24 0.375 0.00317 0.182 leukocyte migration;leukocyte
xsq EXOSC2 9q34 0.375 0.00317 0.182 positive regulation of cell
exp SMCHD1 18p11.32 0.375 0.00317 0.182 inactivation of X chromosome
exp CD276 15q23-q24 -0.375 0.00317 0.182 cell proliferation;positive
exp HFE 6p21.3 -0.375 0.00317 0.182 female pregnancy;antigen
processing and presentation of peptide antigen via MHC class I
hs4 C1orf127 1p36.22 -0.378 0.00317 0.182
his UQCRC1 3p21.3 0.378 0.00318 0.182 oxidative
phosphorylation;small molecule metabolic process
his LOC100505585 0.378 0.00318 0.182
exp THAP11 16q22.1 0.375 0.00318 0.182 regulation of transcription,
DNA-dependent"
exp RPL7AP58 11p14.1 0.375 0.00318 0.182
xsq DDX26B Xq26.3 0.375 0.00318 0.182
xai ACTN3 11q13.1 -0.378 0.00318 0.182 muscle filament
sliding;regulation of apoptotic process
xai RPL35AP32 15q22 0.378 0.00319 0.182
swa GEMIN5 5q33.2 0.378 0.00319 0.182 nuclear mRNA splicing, via
xai HCFC1 Xq28 0.378 0.00319 0.182 histone H4-K8 acetylation;negative
xsq PLCH1 3q25.31 0.375 0.00319 0.182 intracellular signal
transduction;phosphatidylinositol-mediated signaling
xai PRMT3 11p15.1 0.378 0.0032 0.182 peptidyl-arginine N-methylation
exp RPL35AP32 15q22 0.378 0.0032 0.182
exp DENND4A 15q22.31 0.375 0.0032 0.182 regulation of transcription,
DNA-dependent"
exp CAMKV 3p21.31 0.375 0.0032 0.182
mut LONRF2 2q11.2 0.375 0.0032 0.182 proteolysis
exp PRPF38A 1p32.3 0.374 0.0032 0.182 mRNA processing;RNA splicing
met MIR574 0.374 0.0032 0.182
xsq DLGAP4-AS1 0.374 0.0032 0.182
exp LSM2 6p21.3 0.374 0.0032 0.182 nuclear mRNA splicing, via
exp FAM102A 9q34.11 -0.375 0.0032 0.182
his FLJ42969 -0.378 0.0032 0.182
his RGS18 1q31.2 0.377 0.00321 0.182 regulation of G-protein coupled
xai RPL7AP11 3q13.33 0.377 0.00321 0.182
his WDR33 2q14.3 0.377 0.00321 0.183 postreplication repair;mRNA
processing
his COX18 4q13.3 0.377 0.00321 0.183 protein transport;protein insertion
into mitochondrial membrane
xsq RBBP4 1p35.1 0.374 0.00321 0.182 CenH3-containing nucleosome
xsq PHB2 12p13 0.374 0.00321 0.182 negative regulation of transcription,
DNA-dependent"
exp PTGFRN 1p13.1 -0.374 0.00321 0.183 lipid particle
organization
xsq ZNF703 8p11.23 -0.374 0.00321 0.182 positive regulation of
cell migration;positive regulation of mammary gland epithelial cell proliferation
xai MFNG 22q12 0.377 0.00322 0.183 pattern specification process
xsq FAR2P2 0.374 0.00322 0.183
exp LOC647030 7q32.3 0.374 0.00322 0.183
xsq SYN1 Xp11.23 0.374 0.00322 0.183 transport;synaptic transmission
his PAMR1 11p13 -0.377 0.00322 0.183
swa FARSB 2q36.1 0.377 0.00323 0.183 gene expression;translation
xai LUC7L 16p13.3 0.377 0.00323 0.183 negative regulation of striated
muscle tissue development
exp RPS7P5 1q43 0.377 0.00323 0.183
exp TRBV1 0.377 0.00323 0.183
xai TRBV1 0.377 0.00323 0.183
mir hsa-miR-93 0.374 0.00323 0.183
exp AGRN 1p36.33 -0.374 0.00323 0.183 neuromuscular junction
xsq NOP56 20p13 0.374 0.00324 0.183 rRNA processing;cell death
xsq RNF138 18q12.1 0.374 0.00324 0.183 Wnt receptor signaling
pathway
met SSTR5 16p13.3 0.374 0.00324 0.183 glucose homeostasis;regulation of
insulin secretion
xsq PXDC1 6p25.2 -0.374 0.00324 0.183 cell communication
xai GRAMD3 5q23.2 -0.377 0.00324 0.183
exp RPS10P28 19q13.2 0.377 0.00325 0.183
his ELP6 3p21.31 0.377 0.00325 0.183
xai C20orf96 20p13 0.377 0.00325 0.183
xai EEF1A1P33 12q23.1 0.377 0.00325 0.183
exp YBX3P1 16p11.2 0.374 0.00325 0.183
xai GNA11 19p13.3 -0.377 0.00325 0.183 Oncogenes
exp RPS3P6 0.377 0.00326 0.183
his PSMA8 18q11.2 0.377 0.00326 0.183 antigen processing and presentation
his CD19 0.377 0.00326 0.183 cell surface receptor signaling
pathway;regulation of immune response
xai HMGB1P25 2p25.1 0.377 0.00326 0.183
xai WDR89 14q23.2 0.377 0.00326 0.183
his PDE6D 2q35-q36 0.377 0.00326 0.183 response to stimulus;visual
perception
his COPS7B 2q37.1 0.377 0.00326 0.183 DNA Damage Response (DDR)
xsq UBL7-AS1 0.374 0.00326 0.183
xsq MED12L 3q25.1 0.374 0.00326 0.183 regulation of transcription
exp CYTH4 22q12.3-q13.1 0.374 0.00326 0.183 regulation of ARF protein
exp STARD13 13q13.1 -0.374 0.00326 0.183 Apoptosis
xai LITAF 16p13.13 -0.377 0.00326 0.183 Apoptosis
his SLC39A3 19p13.3 0.377 0.00327 0.183 Solute Carriers
exp TMEM170A 16q23.1 0.374 0.00327 0.183
exp RHOB 2p24 -0.374 0.00327 0.183 Apoptosis
exp DLG1 3q29 -0.374 0.00327 0.183 mitotic cell cycle G1/S transition
exp CAMK2N1 1p36.12 -0.374 0.00327 0.183 negative regulation of
exp ATP6V1D 14q23-q24.2 -0.374 0.00327 0.183 proton
exp MEIS3P2 17p11.2 -0.374 0.00327 0.183
swa ANP32A 15q23 0.377 0.00328 0.183 regulation of transcription, DNA-
xai TSEN2 3p25.2 0.377 0.00328 0.183 tRNA splicing, via endonucleolytic
cleavage and ligation;mRNA processing"
xai LOC401127 4p14 0.377 0.00328 0.183
his BUB1B 15q15 0.377 0.00328 0.183 DNA Damage Response (DDR)
his VRK1 14q32 0.377 0.00328 0.184 Golgi disassembly;protein phosphorylation
exp ZNF112 -0.374 0.00328 0.183 regulation of transcription,
DNA-dependent"
exp KIAA1522 1p35.1 -0.374 0.00328 0.183
exp PA2G4P3 18q11.2 0.377 0.00329 0.184
xsq CD27 12p13 0.373 0.00329 0.184 Apoptosis
exp TDRD10 1q21.3 0.373 0.00329 0.184
xsq LAIR2 19q13.4 0.373 0.00329 0.184
xai RNF126 19p13.3 0.376 0.0033 0.184
xai SCML2 Xp22 0.376 0.0033 0.184 regulation of transcription, DNA-
his SCML2 Xp22 0.376 0.0033 0.184 regulation of transcription, DNA-
mir hsa-miR-18b 0.373 0.0033 0.184
xsq GOLGA8M 15q13.1 0.373 0.0033 0.184
mir hsa-miR-193b -0.373 0.0033 0.184
xai RAI14 5p13.3-p13.2 -0.376 0.0033 0.184
exp SRRM1P3 Xq26.3 0.376 0.00331 0.184
xsq PTGDR2 11q12-q13.3 0.373 0.00331 0.184 chemotaxis;immune response
mut SPIDR 8q11.21 0.373 0.00331 0.184
xai DENND4A 15q22.31 0.376 0.00332 0.185 regulation of transcription,
DNA-dependent"
his LINC00339 1p36.12 0.376 0.00332 0.185
his LINC01635 0.376 0.00332 0.185
exp VASN 16p13.3 -0.373 0.00332 0.185
exp OPTN 10p13 -0.373 0.00332 0.185 protein targeting to Golgi;Golgi
organization
exp EIF3EP1 6q13 0.376 0.00333 0.185
swa WNK1 12p13.3 0.376 0.00333 0.185 negative regulation of phosphatase
activity;neuron development
met LINC00346 13q34 0.373 0.00333 0.185
xsq ASB12 Xq11.2 0.373 0.00333 0.185 intracellular signal transduction
xsq FECH 18q21.3 0.373 0.00333 0.185 generation of precursor metabolites
and energy;porphyrin-containing compound metabolic process
exp UGCG 9q31 -0.373 0.00333 0.185 glycosphingolipid biosynthetic
his MSH2 2p21 0.376 0.00334 0.185 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xsq GTF3C5 9q34 0.373 0.00334 0.185 tRNA transcription from RNA
xsq TNS3 7p12.3 -0.373 0.00334 0.185 positive regulation of cell
xai KRT80 12q13.13 -0.376 0.00334 0.185
his RPAP3 12q13.11 0.376 0.00335 0.185
hs4 RASSF5 1q32.1 0.376 0.00335 0.185 Apoptosis
hs4 IGSF21 1p36.13 0.376 0.00336 0.186
xai FERMT3 11q13.1 0.376 0.00336 0.186 leukocyte cell-cell
xai RPS4XP11 10p11.22 0.376 0.00336 0.186
xai PTGFRN 1p13.1 -0.376 0.00336 0.186 lipid particle
organization
exp EEF1A1P38 16p12.1 0.376 0.00337 0.186
xai TMIGD2 19p13.3 0.376 0.00337 0.186
exp MAPKAPK5-AS1 12q24.12 0.373 0.00337 0.186
xsq ARHGAP4 Xq28 0.373 0.00337 0.186 induction of apoptosis by
xai TXNL4B 16q22.2 0.376 0.00338 0.186 mRNA processing;cell cycle
xai LSM2 6p21.3 0.376 0.00338 0.186 nuclear mRNA splicing, via
xai RPUSD2 15q13.3 0.375 0.00338 0.186 pseudouridine synthesis
xsq AMDHD1 12q23.1 0.373 0.00338 0.186 histidine catabolic
process;histidine catabolic process to glutamate and formamide
xsq SFMBT2 10p14 0.373 0.00338 0.186 regulation of transcription, DNA-
dependent"
exp ADSL 22q13.2 0.372 0.00338 0.186 response to nutrient;aerobic
respiration
exp TIMP2 17q25 -0.372 0.00338 0.186 negative regulation of cell
proliferation;regulation of cAMP metabolic process
xai RNU6-79P -0.376 0.00338 0.186
exp RNU6-79P -0.376 0.00338 0.186
hs4 PTPRJ 11p11.2 -0.376 0.00338 0.186 positive regulation of
xai ARHGAP29 1p22.1 -0.376 0.00338 0.186 small GTPase mediated
signal transduction;Rho protein signal transduction
xai EIF3EP1 6q13 0.375 0.00339 0.186
xai ZNF276 16q24.3 0.375 0.00339 0.186 regulation of transcription,
DNA-dependent"
exp RPLP0P5 1q41 0.372 0.00339 0.186
exp LARS 5q32 0.372 0.00339 0.186 gene expression;tRNA aminoacylation for
protein translation
exp NDUFAB1 16p12.2 0.372 0.00339 0.186 respiratory electron
transport chain;small molecule metabolic process
xsq POLR1B 2q13 0.372 0.00339 0.186 transcription elongation from RNA
polymerase I promoter;termination of RNA polymerase I transcription
exp TSPY26P 20q11.21 0.372 0.00339 0.186 nucleosome assembly
xai LSM11 5q33.3 0.375 0.0034 0.186 histone mRNA 3'-end
processing;histone mRNA metabolic process
xai CNOT1 16q21 0.375 0.0034 0.186 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;nuclear-transcribed mRNA poly(A) tail
shortening
his RSL24D1 15q21 0.375 0.0034 0.186 translation;ribosome biogenesis
exp GPN3 12q24.11 0.372 0.0034 0.186
exp SPATS2L 2q33.1 -0.372 0.0034 0.186
xsq CST3 20p11.21 -0.372 0.0034 0.186 salivary gland
development;negative regulation of histolysis
xai GBP1 1p22.2 -0.375 0.0034 0.186 interferon-gamma-mediated
signaling pathway;cytokine-mediated signaling pathway
hs4 RND3 2q23.3 -0.375 0.0034 0.186 GTP catabolic process;cell
adhesion
his CXorf21 Xp21.2 0.375 0.00341 0.186
exp GOT2P3 12p13.31 0.375 0.00341 0.186
exp SNHG1 11q12.3 0.372 0.00341 0.186
exp ZMYM3 Xq13.1 0.372 0.00341 0.186 multicellular organismal
exp CCDC59 12q21.31 0.372 0.00341 0.186 regulation of transcription,
DNA-dependent"
exp NUDT21 16q12.2 0.372 0.00341 0.186 RNA splicing;gene expression
exp RCSD1 1q24.2 0.372 0.00341 0.186 cellular hyperosmotic
met MAMSTR 19q13.33 -0.372 0.00341 0.186 regulation of
transcription, DNA-dependent;positive regulation of myotube differentiation
xai LAS1L Xq12 0.375 0.00342 0.186 rRNA processing
xai IGLL1 22q11.23 0.375 0.00342 0.186 immune response
met RHOC 1p13.1 0.372 0.00342 0.186 regulation of small GTPase mediated
signal transduction;small GTPase mediated signal transduction
xsq CAMK2N1 1p36.12 -0.372 0.00342 0.186 negative regulation of
swa ERVK-5 -0.375 0.00342 0.186
his SNX18 5q11.2 -0.375 0.00342 0.186 protein transport;positive
his FAM135A 6q13 0.375 0.00343 0.186
his C12orf57 12p13.31 0.375 0.00343 0.186
his RNU7-1 12p13.31 0.375 0.00343 0.186
his PTPN6 12p13 0.375 0.00343 0.186 Apoptosis
exp MCM10 10p13 0.372 0.00343 0.186 DDR (DNA replication)
xsq SEPSECS 4p15.2 0.372 0.00343 0.186 selenocysteine
incorporation;translation
xsq HPR 16q22.1 0.372 0.00343 0.186
mut PPARD 6p21.2 0.372 0.00343 0.186 generation of precursor metabolites
and energy;cell proliferation
hs4 P4HA2 5q31 -0.375 0.00343 0.186 peptidyl-proline hydroxylation to
4-hydroxy-L-proline
xsq MCM6 2q21 0.372 0.00344 0.187 DDR (DNA replication)
xsq DLEU7-AS1 0.372 0.00344 0.187
exp GTPBP3 19p13.11 0.372 0.00344 0.187 tRNA modification
exp LURAP1L 9p23 -0.372 0.00344 0.187
his KRT37 17q21.2 -0.375 0.00344 0.186
xai THAP11 16q22.1 0.375 0.00345 0.187 regulation of transcription,
DNA-dependent"
mut USP14 18p11.32 0.372 0.00345 0.187 proteolysis;ubiquitin-dependent
xsq MIB1 18q11.2 0.372 0.00345 0.187 neural tube formation;heart looping
mir hsa-miR-638 0.372 0.00345 0.187
exp KLHL6 3q27.3 0.372 0.00345 0.187 germinal center formation;B cell
xai HTRA4 8p11.22 -0.375 0.00345 0.187 regulation of cell
growth;proteolysis
xai ANXA2 15q22.2 -0.375 0.00345 0.187 positive regulation of
hs4 PSD4 2q13 0.375 0.00346 0.187 regulation of ARF protein signal
transduction
his ERLIN1 10q24.31 0.375 0.00346 0.187 ER-associated protein
catabolic process
xai TIA1 2p13 0.375 0.00346 0.187 Apoptosis
xai LARS 5q32 0.375 0.00346 0.187 gene expression;tRNA aminoacylation for
protein translation
mut MTMR14 3p26 0.372 0.00346 0.187
exp RPS8P10 15q11.2 0.372 0.00346 0.187
met MIR19B1 -0.372 0.00346 0.187
xai MYO1C 17p13.3 -0.375 0.00346 0.187 protein transport;mRNA
transport
xai TRIP6 7q22 -0.375 0.00346 0.187 cell adhesion;release of
cytoplasmic sequestered NF-kappaB
exp EEF1A1P5 0.371 0.00347 0.187
exp FDXACB1 0.371 0.00347 0.187 phenylalanyl-tRNA
aminoacylation;tRNA processing
xai MIEF2 -0.375 0.00347 0.187 mitochondrion organization
xai CCDC59 12q21.31 0.374 0.00348 0.187 regulation of transcription,
DNA-dependent"
xai RPS6P6 4q21.22 0.374 0.00348 0.187
hs4 GMFG 19q13.2 0.374 0.00348 0.187 protein phosphorylation;positive
xai WNT2 7q31.2 0.374 0.00348 0.187 Apoptosis; Oncogenes
exp HCFC1 Xq28 0.371 0.00348 0.187 histone H4-K8 acetylation;negative
xsq HMMR 5q34 0.371 0.00348 0.187
xsq CUEDC1 17q23.2 -0.371 0.00348 0.187
his HPGD 4q34-q35 0.374 0.00349 0.187 prostaglandin metabolic
hs4 IL9R 0.374 0.00349 0.187 signal transduction;cell proliferation
xsq LOC100422556 0.371 0.00349 0.187
pro RB1_10 0.371 0.00349 0.187
xai ZSCAN32 16p13.3 0.374 0.0035 0.187
his SUZ12P1 17q11.2 0.374 0.0035 0.187
exp ABCB7 Xq13.3 0.371 0.0035 0.187 ABC Transporters
exp DANCR 4q12 0.371 0.0035 0.187
xai PLCE1 10q23 -0.374 0.0035 0.187 diacylglycerol biosynthetic
his LOC100130417 1p36.33 0.374 0.00351 0.188
his SAMD11 1p36.33 0.374 0.00351 0.188
xai RPL34P27 13q12.12 0.374 0.00351 0.188
met C16orf78 16q12.1 0.371 0.00351 0.188
his TIAM2 6q25.2 -0.374 0.00351 0.188 regulation of Rho protein
signal transduction;cellular lipid metabolic process
xai PPDPF 20q13.33 -0.374 0.00351 0.188 multicellular organismal
xai LOC100131826 -0.374 0.00351 0.188
xai GDF10 10q11.22 0.374 0.00352 0.188 skeletal system
xai ECEL1 2q37.1 0.374 0.00352 0.188 proteolysis;neuropeptide signaling
pathway
exp NOL10 2p25.1 0.371 0.00352 0.188
met DUSP5 10q25 0.371 0.00352 0.188 endoderm formation;protein
dephosphorylation
met CADPS2 7q31.3 0.371 0.00352 0.188 synaptic vesicle
priming;positive regulation of exocytosis
hs4 MATN2 8q22 -0.374 0.00352 0.188
xai CST3 20p11.21 -0.374 0.00352 0.188 salivary gland
his DNAJC9 10q22.2 0.374 0.00353 0.188 protein folding;social
behavior
exp JPH2 20q13.12 -0.371 0.00353 0.188 regulation of cardiac muscle
his ATAD5 17q11.2 0.374 0.00354 0.189 DNA Damage Response (DDR)
exp LOC401127 4p14 0.374 0.00354 0.189
exp NUP188 9q34.11 0.371 0.00354 0.189 protein transport;glucose
transport
cop LINC00954 0.371 0.00354 0.189
exp RAI14 5p13.3-p13.2 -0.371 0.00354 0.189
xsq MIR762HG 0.371 0.00355 0.189
exp SAMD1 19p13.12 0.371 0.00355 0.189
xsq CTDP1 18q23 0.371 0.00355 0.189 viral reproduction;positive regulation of
viral transcription
exp MMS22L 6q16.1 0.371 0.00355 0.189 DNA Damage Response (DDR)
exp C15orf52 15q15.1 -0.371 0.00355 0.189
xai ADGRB1 0.374 0.00356 0.189 negative regulation of
xai MMS22L 6q16.1 0.374 0.00356 0.189 DNA Damage Response (DDR)
met SMURF2 17q22-q23 0.371 0.00356 0.189 protein
ubiquitination;regulation of transforming growth factor beta receptor signaling
pathway
xsq PER1 17p13.1 0.371 0.00356 0.189 DNA Damage Response (DDR)
exp FBXL2 3p22.3 -0.371 0.00356 0.189 protein modification
process;proteolysis
xai RPS27P29 19p12 0.374 0.00357 0.189
xai C16orf13 16p13.3 0.374 0.00357 0.189
exp RPL34P27 13q12.12 0.373 0.00357 0.189
his P2RY14 3q24-q25.1 0.373 0.00357 0.189
exp SUB1 5p13.3 0.37 0.00357 0.189 regulation of transcription from
RNA polymerase II promoter
exp LOC100131826 -0.373 0.00357 0.189
exp RPS27P29 19p12 0.373 0.00358 0.189
xai HTATSF1 Xq26.3 0.373 0.00358 0.189 regulation of transcription
xai RFX7 15q21.3 0.373 0.00358 0.189 regulation of transcription, DNA-
dependent"
xai RPS4XP21 19q13.11 0.373 0.00358 0.189
exp HELB 12q14.3 0.37 0.00358 0.189 DNA Damage Response (DDR)
exp LSP1 11p15.5 0.37 0.00358 0.189 chemotaxis;cellular defense
response
xai PLOD2 3q24 -0.373 0.00358 0.189 response to hypoxia;protein
exp RPL29P28 13q13.1 0.373 0.00359 0.189
his APBA3 19p13.3 0.373 0.00359 0.189 protein transport;intracellular
signal transduction
his MRPL54 19p13.3 0.373 0.00359 0.189
hs4 LINC01934 0.373 0.00359 0.189
exp ZNF276 16q24.3 0.37 0.00359 0.189 regulation of transcription,
DNA-dependent"
exp RAD52 12p13-p12.2 0.37 0.00359 0.189 DNA Damage Response (DDR); DDR (HR)
exp RPL9P7 0.37 0.00359 0.189
xai KIF22 16p11.2 0.373 0.0036 0.19 microtubule-based movement;mitosis
his CD93 20p11.21 0.373 0.0036 0.19 macrophage activation;interspecies
xsq TEX19 17q25.3 0.37 0.0036 0.19
exp LOC729683 17q23.3 0.37 0.0036 0.19
his KRI1 19p13.2 0.373 0.00361 0.19
his CDKN2D 19p13 0.373 0.00361 0.19 DNA Damage Response (DDR)
his CORO1A 16p11.2 0.373 0.00361 0.19 phagocytosis;cell-substrate
adhesion
xai HMHA1 19p13.3 0.373 0.00361 0.19 small GTPase mediated signal
his GNPDA2 4p12 0.373 0.00362 0.19 carbohydrate metabolic process;N-
his LEPROTL1 8p12 0.373 0.00362 0.19
hs4 EMB 5q11.1 0.373 0.00362 0.19 cell adhesion
xsq PUS1 12q24.33 0.37 0.00362 0.19 tRNA processing;metabolic process
exp CTU2 16q24.3 0.37 0.00362 0.19 tRNA wobble uridine
his HRCT1 9p13.3 -0.373 0.00362 0.19
his LINC00961 9p13.3 -0.373 0.00362 0.19
xai TTF1 9q34.13 0.373 0.00363 0.19 regulation of transcription, DNA-
dependent;transcription from RNA polymerase I promoter
xai LOC729164 0.373 0.00363 0.19
his ZNF227 0.373 0.00363 0.19 regulation of transcription, DNA-
dependent"
xsq BRI3BP 12q24.31 0.37 0.00363 0.19
mut DEFB125 20p13 0.37 0.00363 0.19
xsq ANP32AP1 15q14 0.37 0.00363 0.19
xai RFC3 13q13.2 0.373 0.00364 0.19 DNA Damage Response (DDR); DDR
exp CCDC88B 11q12.3 0.37 0.00364 0.19 microtubule cytoskeleton
organization
exp RNMTL1 17p13.3 0.37 0.00364 0.19 RNA processing
exp PREB 2p23.3 0.37 0.00364 0.191 cellular membrane
met PKDCC 2p21 0.37 0.00365 0.191 positive regulation of chondrocyte
differentiation;negative regulation of Golgi to plasma membrane protein transport
exp CTCF 16q21-q22.3 0.37 0.00365 0.191 chromosome segregation;regulation
xsq PTPN14 1q32.2 -0.37 0.00365 0.191 lymphangiogenesis;protein
dephosphorylation
his TBKBP1 17q21.32 0.373 0.00366 0.191 innate immune response
pro MSH2 2p21 0.37 0.00366 0.191 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
exp LOC100131482 2q31.3 0.37 0.00366 0.191
exp IGHM 14q32.33 0.37 0.00366 0.191 immune response
exp MRPL21 11q13.3 0.37 0.00366 0.191 translation
exp HIF1A 14q23.2 -0.37 0.00366 0.191 Protein Kinases
swa IGFBP7 4q12 -0.373 0.00366 0.191 regulation of cell
xai LOC100130872 0.373 0.00367 0.191
xai BRI3BP 12q24.31 0.372 0.00367 0.191
xsq NXT2 Xq23 0.369 0.00367 0.191 protein transport;mRNA transport
xsq TRIP6 7q22 -0.369 0.00367 0.191 cell adhesion;release of
xsq HLA-F 6p21.3 -0.37 0.00367 0.191 antigen processing and presentation
of exogenous peptide antigen via MHC class I, TAP-dependent;type I interferon-
his RBMS3-AS3 -0.373 0.00367 0.191
his RBMS3 3p24-p23 -0.373 0.00367 0.191
swa RPA3 7p22 0.372 0.00368 0.191 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
met MIR1469 0.369 0.00368 0.191
xsq ZSWIM3 20q13.12 0.369 0.00368 0.191
exp WDR89 14q23.2 0.369 0.00368 0.191
exp P2RX5 17p13.3 0.369 0.00368 0.191 signal transduction;nervous system
development
xsq TBC1D2 9q22.33 -0.369 0.00368 0.191 positive regulation of
Rab GTPase activity
xai XPNPEP2 Xq25 0.372 0.00369 0.191 proteolysis;cellular process
xai RPL7AP58 11p14.1 0.372 0.00369 0.191
xsq MYT1 20q13.33 0.369 0.00369 0.191 Protein Kinases
exp RPS7P4 1p31.3 0.369 0.00369 0.191
xsq CCDC155 19q13.33 0.369 0.00369 0.191 protein dephosphorylation
exp FAM207BP 13q11 0.369 0.00369 0.191
xsq FMNL1 17q21 0.369 0.00369 0.191 substrate-dependent cell
migration;regulation of cell shape
xai WT1-AS 11p13 0.372 0.0037 0.191
his POP5 12q24.31 0.372 0.0037 0.191 tRNA processing;RNA metabolic
process
xai RPL21P44 4q12 0.372 0.0037 0.191
exp BCL6B 17p13.1 0.369 0.0037 0.191 negative regulation of
exp COX5A 15q24.1 0.369 0.0037 0.191 small molecule metabolic
process;respiratory electron transport chain
xsq PRSS23 11q14.1 -0.369 0.0037 0.191 proteolysis
swa ACTB 7p22 -0.372 0.0037 0.191 axon guidance;blood coagulation
xai CNOT10 3p22.3 0.372 0.00371 0.192 nuclear-transcribed mRNA
catabolic process, deadenylation-dependent decay;nuclear-transcribed mRNA poly(A)
tail shortening
exp RPS15AP11 1p34.1 0.369 0.00371 0.191
xsq LRRC38 1p36.21 0.369 0.00371 0.192
hs4 TUFT1 1q21 -0.372 0.00371 0.191 odontogenesis;bone mineralization
hs4 MIR554 -0.372 0.00371 0.191
xai LIME1 20q13.3 0.372 0.00372 0.192 regulation of release of
sequestered calcium ion into cytosol;regulation of transcription from RNA
xai RFX5 1q21 0.372 0.00372 0.192 negative regulation of transcription from
RNA polymerase II promoter;regulation of transcription, DNA-dependent"
xai ADPGK 15q24.1 0.372 0.00372 0.192 glycolysis;carbohydrate metabolic
process
his JCHAIN 0.372 0.00373 0.192 immune response
his UTP3 4q13.3 0.372 0.00373 0.192 chromatin
modification;multicellular organismal development
xai RPL29P28 13q13.1 0.372 0.00373 0.192
xai MRPL42 12q22 0.372 0.00373 0.192 translation
exp CTDP1 18q23 0.369 0.00373 0.192 viral reproduction;positive regulation of
viral transcription
mut TPP2 13q32-q33 0.369 0.00373 0.192 antigen processing and presentation
of peptide antigen via MHC class I;proteolysis
met CARD8 19q13.33 -0.369 0.00373 0.192 activation of cysteine-type
endopeptidase activity involved in apoptotic process;regulation of apoptotic
process
exp SNORA20 0.372 0.00374 0.192
xai RAD52 12p13-p12.2 0.372 0.00374 0.192 DNA Damage Response (DDR); DDR (HR)
hs4 FERMT3 11q13.1 0.372 0.00374 0.192 leukocyte cell-cell
hs4 TESPA1 12q13.2 0.372 0.00374 0.192
xai SNORA20 0.372 0.00374 0.192
xsq CD7 17q25.2-q25.3 0.369 0.00374 0.192 homeostasis of number of
xai FAM86C1 11q13.4 0.372 0.00375 0.192
exp LOC728743 7q36.1 0.369 0.00375 0.193
swa SF1 11q13 0.372 0.00376 0.193 nuclear mRNA 3'-splice site
recognition;nuclear mRNA splicing, via spliceosome
hs4 PIK3R6 17p13.1 0.372 0.00376 0.193 blood coagulation;platelet
activation
xai ZC3H18 16q24.2 0.372 0.00376 0.193
hs4 PTPRC 1q31-q32 0.372 0.00376 0.193 protein dephosphorylation;peptidyl-
mut KCNV1 8q23.2 0.369 0.00376 0.193 ion transport;potassium ion
transport
exp ECEL1 2q37.1 0.369 0.00376 0.193 proteolysis;neuropeptide signaling
pathway
xsq RASA4B 0.369 0.00376 0.193
met APBB2 4p13 0.369 0.00376 0.193 regulation of transcription, DNA-
dependent;cell cycle arrest
xai SHROOM2 Xp22.3 -0.372 0.00376 0.193 eye pigment granule
xai GOT2P3 12p13.31 0.372 0.00377 0.193
exp PLCE1 10q23 -0.368 0.00377 0.193 diacylglycerol biosynthetic
xai NOP56 20p13 0.371 0.00378 0.193 rRNA processing;cell death
xai TOE1 1p33 0.371 0.00378 0.193
exp SEC14L3 22q12.2 0.371 0.00378 0.193
met ELSPBP1 19q13.33 0.368 0.00378 0.193 single fertilization
exp RFC3 13q13.2 0.368 0.00378 0.193 DNA Damage Response (DDR); DDR
mut AKAP12 6q24-q25 0.368 0.00378 0.193 G-protein coupled receptor
signaling pathway;positive regulation of protein kinase A signaling cascade
exp SNX19 11q25 -0.368 0.00378 0.193 protein transport;cell
communication
his CARMIL2 0.371 0.00379 0.193
exp CXXC1 18q12 0.368 0.00379 0.193 regulation of transcription, DNA-
response
xai LOC729683 17q23.3 0.371 0.0038 0.194
exp RPS15AP24 0.371 0.0038 0.194
met FAM64A 17p13.2 0.368 0.0038 0.194
met RBM24 6p22.3 0.368 0.0038 0.194 regulation of mRNA
stability;regulation of myotube differentiation
exp RPS12 6q23.2 0.368 0.0038 0.194 SRP-dependent cotranslational
protein targeting to membrane;gene expression
xsq HCST 19q13.1 0.368 0.0038 0.194 regulation of immune response
xsq CPT1A 11q13.2 0.368 0.0038 0.194 positive regulation of fatty acid
beta-oxidation;long-chain fatty acid metabolic process
exp MAP4K1 19q13.1-q13.4 0.368 0.0038 0.194 response to
xai CTTNBP2NL 1p13.2 -0.371 0.0038 0.194
xai RPS15AP24 0.371 0.00381 0.194
xai PHF6 Xq26.3 0.371 0.00381 0.194 regulation of transcription, DNA-
dependent"
swa AIP 11q13.3 0.371 0.00381 0.194 regulation of protein kinase A
exp TMEM184B 22q12 -0.368 0.00381 0.194
xai ENC1 5q13 -0.371 0.00381 0.194 nervous system
swa THOC6 16p13.3 0.371 0.00382 0.194 mRNA processing;mRNA export from
nucleus
xai RBBP8 18q11.2 0.371 0.00382 0.194 DNA Damage Response (DDR); DDR (G1-
S checkpoint)
met ZNF501 3p21.31 0.368 0.00382 0.194 regulation of transcription,
DNA-dependent"
xai MAP2K5 15q23 0.371 0.00383 0.194 Protein Kinases
xai GAR1 4q25 0.371 0.00383 0.194 DNA Damage Response (DDR)
exp RASGRP2 11q13 0.368 0.00383 0.194 Ras protein signal
exp PHF6 Xq26.3 0.368 0.00383 0.194 regulation of transcription, DNA-
dependent"
met ENDOV 17q25.3 0.368 0.00383 0.194 DNA repair
mut PCDH12 5q31 0.368 0.00383 0.194 cell adhesion;homophilic cell
adhesion
exp LITAF 16p13.13 -0.368 0.00383 0.194 Apoptosis
exp MCM5 22q13.1 0.368 0.00384 0.195 DDR (DNA replication)
xai HIST1H4A 6p22.1 0.371 0.00385 0.195
xai BCCIP 10q26.1 0.371 0.00385 0.195 regulation of cyclin-dependent
protein kinase activity;DNA repair
xsq DNAAF3 19q13.4 0.368 0.00385 0.195
met ZNF34 8q24.3 0.368 0.00385 0.195 regulation of transcription, DNA-
dependent"
mut NTNG1 1p13.3 0.368 0.00385 0.195 axonogenesis;cell differentiation
xsq RGS3 9q32 -0.368 0.00385 0.195 inactivation of MAPK
activity;regulation of G-protein coupled receptor protein signaling pathway
his CD86 3q21 0.371 0.00386 0.195 immune response;positive regulation of
interleukin-2 biosynthetic process
his OIP5 15q15.1 0.371 0.00386 0.195 cell communication;CenH3-containing
nucleosome assembly at centromere
his NUSAP1 15q15.1 0.371 0.00386 0.195 positive regulation of
mitosis;cell division
xai EEF1A1P38 16p12.1 0.371 0.00386 0.195
exp CUTC 10q24.2 0.368 0.00386 0.195 copper ion transport;protein
tetramerization
exp EEF1A1 6q14.1 0.368 0.00386 0.195 translation;translational
elongation
xsq TSEN54 17q25.1 0.368 0.00386 0.195 mRNA processing;tRNA
mut SOGA3 6q22.33 0.368 0.00386 0.195
exp RPS4X Xq13.1 0.368 0.00386 0.195 translational elongation;mRNA
metabolic process
hs4 WWC2-AS2 4q35.1 -0.371 0.00386 0.195
hs4 WWC2 4q35.1 -0.371 0.00386 0.195
pro RNASEH2A 19p13.2 0.368 0.00387 0.195 DNA Damage Response (DDR);
DNA-dependent"
xsq PEA15 1q21.1 -0.367 0.00387 0.195 transport;anti-apoptosis
hs4 GBP1P1 1p22.2 -0.37 0.00387 0.195
xai RPS26P4 21q22.2 0.37 0.00388 0.195
his LOC100507437 0.37 0.00388 0.195
his MTA1 14q32.3 0.37 0.00388 0.195 signal transduction
exp RPS26P4 21q22.2 0.37 0.00388 0.195
exp NAA16 13q14.11 0.367 0.00388 0.195 N-terminal protein amino acid
exp PDS5A 4p14 0.367 0.00388 0.195 DNA Damage Response (DDR)
xsq SATB1-AS1 0.367 0.00388 0.195
xsq NR2F2 15q26 -0.367 0.00388 0.195 negative regulation of endothelial
xai CD151 11p15.5 -0.37 0.00388 0.195 cell adhesion;hemidesmosome
assembly
his C5 9q33-q34 0.37 0.00389 0.195 inflammatory response;negative
regulation of macrophage chemotaxis
xai CDC123 10p13 0.37 0.00389 0.195 G1 phase of mitotic cell cycle;cell
cycle
xai BCL6B 17p13.1 0.37 0.00389 0.195 negative regulation of
hs4 CAMKV 3p21.31 0.37 0.00389 0.195
exp LOC729496 6q25.1 0.367 0.00389 0.195
exp DDX18P3 6p22.3 0.367 0.00389 0.195
his DUT 15q21.1 0.37 0.0039 0.195 DNA Damage Response (DDR)
xai CROCCP2 1p36.13 0.37 0.0039 0.195
exp TNFRSF12A 16p13.3 -0.367 0.0039 0.195 Apoptosis
hs4 DNAJC5B 8q13.1 -0.37 0.0039 0.195 protein folding
exp PTPN22 1p13.2 0.367 0.00391 0.195 regulation of B cell receptor
exp MYB 6q22-q23 0.367 0.00391 0.195 Apoptosis
exp MECR 1p35.3 0.367 0.00391 0.195 fatty acid metabolic process;fatty
xsq ZBTB39 12q13.3 0.367 0.00391 0.195 regulation of transcription,
DNA-dependent"
exp LINC00528 22q11.21 0.367 0.00391 0.195
exp LRRC8E 19p13.2 -0.367 0.00391 0.195
xai PRMT5 14q11.2 0.37 0.00392 0.195 regulation of transcription, DNA-
dependent;ncRNA metabolic process
xai GPN3 12q24.11 0.37 0.00392 0.195
his MIR3675 0.37 0.00392 0.195
exp NLRC3 16p13.3 0.367 0.00392 0.195 I-kappaB kinase/NF-kappaB
exp ARHGEF40 14q11.2 -0.367 0.00392 0.195 regulation of Rho
protein signal transduction
his PLCE1 10q23 -0.37 0.00392 0.195 diacylglycerol biosynthetic process;heart
development
hs4 MIR4790 -0.37 0.00392 0.195
xai NBL1 1p36.13 -0.37 0.00392 0.195 positive regulation of neuron
differentiation;neuron projection morphogenesis
his GNPAT 1q42 0.37 0.00393 0.196 phospholipid biosynthetic process;small
his C1orf131 1q42.2 0.37 0.00393 0.196
exp SHROOM2 Xp22.3 -0.367 0.00393 0.196 eye pigment granule
his MTIF2 2p16.1 0.37 0.00394 0.196 translation;regulation of
translational initiation
xsq LINC01538 0.367 0.00394 0.196
xsq MZB1 5q31.2 0.367 0.00394 0.196 positive regulation of
exp NCAPH 2q11.2 0.367 0.00394 0.196 DNA Damage Response (DDR)
mut CCDC27 1p36.32 0.367 0.00394 0.196
exp ZSCAN32 16p13.3 0.367 0.00394 0.196
exp CST3 20p11.21 -0.367 0.00394 0.196 salivary gland
hs4 SRGAP1 12q14.2 -0.37 0.00394 0.196 signal transduction;small
xai KIAA1522 1p35.1 -0.37 0.00394 0.196
xai NEK4P2 0.37 0.00395 0.196
exp NEK4P2 0.37 0.00395 0.196
xai TRPM2 21q22.3 0.37 0.00395 0.196 ion transport;calcium ion transport
xsq LY9 1q23.3 0.367 0.00395 0.196 cell adhesion;immunoglobulin
exp ZC3H18 16q24.2 0.367 0.00395 0.196
hs4 WLS 1p31.3 -0.37 0.00395 0.196 Wnt receptor signaling
pathway;positive regulation of I-kappaB kinase/NF-kappaB cascade
swa TTC1 5q33.3 0.37 0.00396 0.196 protein folding
his QRICH1 3p21.31 0.37 0.00396 0.196
exp BRI3BP 12q24.31 0.367 0.00396 0.196
his MIR4450 -0.37 0.00396 0.196
xai C15orf52 15q15.1 -0.37 0.00396 0.196
his LOC100133315 11q13.4 0.37 0.00397 0.196
his RNF121 11q13.4 0.37 0.00397 0.196
exp PPP1R16B 20q11.23 0.367 0.00397 0.196 signal
exp RPA3 7p22 0.367 0.00397 0.196 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xsq LINC01353 0.367 0.00397 0.196
xsq FOXI1 5q34 0.367 0.00397 0.196 Apoptosis
xsq LAPTM5 1p34 0.366 0.00398 0.196 transport
exp SAMSN1 21q11 0.366 0.00398 0.196 negative regulation of peptidyl-
exp FAM46C 1p12 0.366 0.00398 0.196
exp FCHO2 5q13.2 -0.366 0.00398 0.196
his CNN3 1p22-p21 -0.369 0.00398 0.196 negative regulation of ATPase
his LOC729970 1p21.3 -0.369 0.00398 0.196
hs4 SLC22A14 3p21.3 0.369 0.00399 0.196 organic cation transport
his MAST3 19p13.11 0.369 0.00399 0.197
his IL12RB1 19p13.1 0.369 0.00399 0.197 signal transduction;positive
regulation of T-helper 17 type immune response
met FHL2 2q12.2 0.366 0.00399 0.196 negative regulation of
development
swa CTNNA2 2p12-p11.1 -0.369 0.00399 0.196 radial glia guided
migration of Purkinje cell;muscle cell differentiation
exp RPL13AP 6p21.3 0.369 0.004 0.197
exp GAPDHP26 9q31.1 0.369 0.004 0.197
xai RPL13AP 6p21.3 0.369 0.004 0.197
xai PPP1R16B 20q11.23 0.369 0.004 0.197 signal transduction;regulation of
filopodium assembly
hs4 CORO1A 16p11.2 0.369 0.004 0.197 phagocytosis;cell-substrate
adhesion
xsq KIF13A 6p23 -0.366 0.004 0.197 cytokinesis;plus-end-directed
xai HOMER3 19p13.11 -0.369 0.004 0.197 protein targeting;G-protein
coupled glutamate receptor signaling pathway
hs4 THNSL2 2p11.2 -0.369 0.004 0.197 serine family amino acid
catabolic process;threonine biosynthetic process
xai C1orf228 1p34.1 0.369 0.00401 0.197
exp RNASEH1-AS1 0.366 0.00401 0.197
xsq SUSD3 9q22.31 0.366 0.00401 0.197
exp FAR2 12p11.22 0.366 0.00401 0.197 ether lipid biosynthetic
exp WNT2 7q31.2 0.366 0.00401 0.197 Apoptosis; Oncogenes
met CD38 4p15 -0.366 0.00401 0.197 response to hormone
xai PARD3B 2q33.3 -0.369 0.00401 0.197 cell division;cell cycle
hs4 ITGB8 7p21.1 -0.369 0.00402 0.197 multicellular organismal
development;placenta blood vessel development
hs4 LOC101927811 -0.369 0.00402 0.197
xai IGFBP7 4q12 -0.369 0.00402 0.197 regulation of cell
hs4 PRLR 5p13.2 -0.369 0.00402 0.197 embryo implantation;prostate
gland growth
hs4 WWTR1 3q23-q24 -0.369 0.00402 0.197 regulation of transcription,
DNA-dependent;negative regulation of fat cell differentiation
hs4 WWTR1-AS1 3q25.1 -0.369 0.00402 0.197
xai TIMP2 17q25 -0.369 0.00402 0.197 negative regulation of cell
xai LEO1 15q21.2 0.369 0.00403 0.197 regulation of transcription, DNA-
his ZBTB46 20q13.33 0.369 0.00403 0.197 regulation of transcription,
DNA-dependent"
his ZBTB46-AS1 0.369 0.00403 0.197
his MCEMP1 0.369 0.00403 0.197
his TRAPPC5 19p13.2 0.369 0.00403 0.197 vesicle-mediated transport
hs4 NLRC3 16p13.3 0.369 0.00404 0.197 I-kappaB kinase/NF-kappaB
xai TCF3 19p13.3 0.369 0.00404 0.197 transcription, DNA-
dependent;response to drug
exp H3F3AP5 Xp11.22 0.369 0.00404 0.197
xsq COL4A1 13q34 -0.366 0.00404 0.197 epithelial cell
differentiation;cellular response to amino acid stimulus
his LOC102724392 0.369 0.00405 0.197
xai FAM114A1 4p14 -0.369 0.00405 0.197
xai PARVG 22q13.31 0.369 0.00406 0.198 cell adhesion;cell-matrix adhesion
xai CEP128 14q31.1 0.369 0.00406 0.198
exp DBH-AS1 0.366 0.00406 0.198
met PLEKHA1 10q26.13 0.366 0.00406 0.198 female gonad
xsq WWC2 4q35.1 -0.366 0.00406 0.198
hs4 LGALS3 14q22.3 -0.369 0.00406 0.198 skeletal system
hs4 FBXL2 3p22.3 -0.369 0.00406 0.198 protein modification
process;proteolysis
his OR1F2P 16p13.3 0.369 0.00407 0.198 response to stimulus
his PDE3B 11p15.1 0.369 0.00407 0.198 cellular response to insulin
mut MAST2 1p34.1 0.366 0.00407 0.198 protein phosphorylation;regulation
of interleukin-12 biosynthetic process
exp CALD1 7q33 -0.366 0.00407 0.198 cellular component movement;muscle
contraction
xai RRAS2 11p15.2 -0.369 0.00407 0.198 GTP catabolic process;signal
transduction
exp SFMBT2 10p14 0.366 0.00408 0.198 regulation of transcription, DNA-
dependent"
exp CALML4 15q23 0.365 0.00408 0.198
exp FGF14-AS2 13q33.1 0.365 0.00408 0.198
his SIGLEC8 19q13.33-q13.41 0.368 0.00409 0.198 cell adhesion;signal
transduction
his CEACAM18 19q13.41 0.368 0.00409 0.198
xsq SF3B3 16q22.1 0.365 0.00409 0.198 RNA splicing, via
exp ARHGAP29 1p22.1 -0.365 0.00409 0.198 small GTPase mediated
hs4 PRSS23 11q14.1 -0.368 0.00409 0.198 proteolysis
xai ATCAY 19p13.3 0.368 0.0041 0.199 transport
xai PDS5A 4p14 0.368 0.0041 0.199 DNA Damage Response (DDR)
exp STMN2 8q21.13 0.365 0.0041 0.199 positive regulation of microtubule
depolymerization;intracellular signal transduction
hs4 TBC1D8B Xq22.3 -0.368 0.00411 0.199
swa ARL8B 3p26.1 -0.368 0.00411 0.199 cell cycle;chromosome
segregation
xai NCAPH 2q11.2 0.368 0.00412 0.199 DNA Damage Response (DDR)
his MIR28 -0.368 0.00412 0.199
xai RPL7AP10 19p12 0.368 0.00413 0.199
xai GTF2H2 0.368 0.00413 0.199 DNA Damage Response (DDR); DDR
(NER)
exp ACAP1 17p13.1 0.365 0.00413 0.199 regulation of ARF GTPase
xsq TMEM156 4p14 0.365 0.00413 0.2
mut PCDHAC1 0.365 0.00413 0.2 homophilic cell adhesion;nervous
system development
exp PPP1R37 19q13.32 -0.365 0.00413 0.199 negative regulation of
xai ANXA2P2 -0.368 0.00413 0.2 positive regulation of
his LOC101929217 -0.368 0.00413 0.199
his ANP32E 1q21.2 0.368 0.00414 0.2 DNA Damage Response (DDR)
xsq CCDC69 5q33.1 0.365 0.00414 0.2
met ALDH3A2 17p11.2 0.365 0.00414 0.2 cellular aldehyde metabolic
process;oxidation-reduction process
xai AJUBA 14q11.2 -0.368 0.00414 0.2 Cell Signaling
his PRSS57 19p13.3 0.368 0.00415 0.2 proteolysis
his MBLAC1 7q22.1 0.368 0.00415 0.2
hs4 BHLHE23 20q13.33 0.368 0.00415 0.2 regulation of transcription,
DNA-dependent;positive regulation of transcription from RNA polymerase II promoter
hs4 LINC01749 0.368 0.00415 0.2
xsq CD1C 1q23.1 0.365 0.00415 0.2 T cell activation involved in
immune response;immune response
his SPATA21 1p36.13 0.368 0.00416 0.2
his NECAP2 1p36.13 0.368 0.00416 0.2 endocytosis;protein transport
xai DNAAF3 19q13.4 0.368 0.00416 0.2
his PDIA6 2p25.1 0.368 0.00416 0.2 protein folding;glycerol ether
metabolic process
xsq SH2D1A Xq25 0.365 0.00416 0.2 humoral immune response;cellular
defense response
exp KIF22 16p11.2 0.365 0.00416 0.2 microtubule-based movement;mitosis
his LIMD2 17q23.3 0.368 0.00417 0.2
his LOC729683 17q23.3 0.368 0.00417 0.2
his FOXJ2 12p13.31 0.368 0.00417 0.2 regulation of sequence-specific DNA
binding transcription factor activity;pattern specification process
exp MCM7 7q21.3-q22.1 0.365 0.00417 0.2 DDR (DNA replication)
xsq CCDC86 11q12.2 0.365 0.00417 0.2 interspecies interaction
between organisms
met OTUD1 10p12.2 0.365 0.00417 0.2
xsq FLJ37453 1p36.21 0.365 0.00417 0.2
xsq LMNB1 5q23.2 0.365 0.00417 0.2 apoptotic process;cellular
exp C16orf13 16p13.3 0.365 0.00417 0.2
his CAPN2 1q41-q42 -0.368 0.00417 0.2 response to
xai USP39 2p11.2 0.368 0.00418 0.2 spliceosome assembly;mRNA
processing
xai RPS4XP22 19p13.2 0.368 0.00418 0.2
his ICAM3 19p13.3-p13.2 0.368 0.00419 0.2 cell-cell adhesion;regulation
of immune response
xai NUP107 12q15 0.368 0.00419 0.2 mitotic cell cycle;viral
reproduction
hs4 ITGB2-AS1 0.367 0.00419 0.2
xsq CBX2 17q25.3 0.365 0.00419 0.2 development of primary sexual
characteristics;negative regulation of transcription, DNA-dependent
exp LOC100131689 14q22.1 0.365 0.00419 0.2
xai POLR2D 2q21 0.367 0.0042 0.2 DNA Damage Response (DDR); DDR
(NER)
xsq LYRM7 5q23.3 0.364 0.0042 0.2
met LAPTM4B 8q22.1 0.364 0.0042 0.2 transport
mut MC2R 18p11.2 0.364 0.0042 0.2
xsq NDST1 5q33.1 -0.364 0.0042 0.2 fibroblast growth factor
xai TANGO6 16q22.1 0.367 0.00421 0.2
met ADHFE1 8q13.1 0.364 0.00421 0.2 2-oxoglutarate metabolic
xsq NOLC1 10q24.32 0.364 0.00421 0.2 positive regulation of cell
xsq C9orf3 9q22.32 -0.364 0.00421 0.2 proteolysis;leukotriene
exp LETM1P2 0.367 0.00422 0.2
xai MYB 6q22-q23 0.367 0.00422 0.2 Apoptosis
swa DNAJA2 16q12.1 0.367 0.00422 0.2 protein folding;positive
xai CD28 2q33 0.367 0.00422 0.2 humoral immune response;negative thymic T
cell selection
mut SIRT7 17q25 0.364 0.00422 0.2 protein deacetylation;positive regulation
of transcription on exit from mitosis
mut ANXA10 4q33 0.364 0.00422 0.2
xsq TMCO5B 0.364 0.00422 0.2
his LOC101928453 -0.367 0.00422 0.2
xai LOC150577 0.367 0.00423 0.2
his RASAL3 19p13.12 0.367 0.00423 0.2 signal transduction;positive
xai RPS6KB2 11q13.2 0.367 0.00423 0.2 Apoptosis; Protein Kinases
exp HSF5 17q22 0.364 0.00423 0.2
hs4 TMEM265 -0.367 0.00423 0.2
xai ARHGEF40 14q11.2 -0.367 0.00423 0.2 regulation of Rho
his RAP1GAP2 17p13.3 0.367 0.00424 0.2 regulation of small GTPase
his C3orf38 3p11.1 0.367 0.00424 0.2 apoptotic process
his CGGBP1 3p12-p11.1 0.367 0.00424 0.2 regulation of transcription,
DNA-dependent"
exp LOC150577 0.367 0.00424 0.2
xai RPLP0P6 2p22.1 0.367 0.00424 0.2 translational
elongation;ribosome biogenesis
met MATN2 8q22 0.364 0.00424 0.2
xai ZNF384 12p12 0.367 0.00425 0.2 regulation of transcription, DNA-
dependent;nucleocytoplasmic transport"
xsq NCF1C 7q11.23 0.364 0.00425 0.2 cell communication
hs4 MIR153-2 0.367 0.00427 0.2
his NSL1 1q41 0.367 0.00427 0.2 M phase of mitotic cell cycle;mitotic
prometaphase
his TATDN3 1q32.3 0.367 0.00427 0.2
xsq PDHA2 4q22-q23 0.364 0.00427 0.2
mir hsa-miR-630 0.364 0.00427 0.2
xsq DPH2 1p34 0.364 0.00427 0.2 peptidyl-diphthamide biosynthetic process
from peptidyl-histidine
xsq VRK1 14q32 0.364 0.00427 0.2 Golgi disassembly;protein phosphorylation
xai BCL11B 14q32.2 0.367 0.00428 0.2 regulation of lipid metabolic
process;positive T cell selection
exp RPLP0P4 1q21.3 0.364 0.00428 0.2
met SPRED1 15q14 0.364 0.00428 0.2 regulation of signal
transduction;negative regulation of phosphatase activity
exp USP32P2 17p11.2 -0.364 0.00428 0.2
met OR4D2 17q22 0.37 0.00429 0.2 response to stimulus
exp SNRNP200 2q11.2 0.364 0.00429 0.2 RNA splicing;gene expression
exp RFX5 1q21 0.364 0.00429 0.2 negative regulation of transcription from
exp TUT1 11q12.2 0.364 0.00429 0.2 mRNA polyadenylation;mRNA cleavage
exp WWTR1 3q23-q24 -0.364 0.00429 0.2 regulation of transcription,
xai OPTN 10p13 -0.367 0.00429 0.2 protein targeting to Golgi;Golgi
organization
hs4 PIK3R5 17p13.1 0.367 0.0043 0.2 Protein Kinases
his SMIM10L1 0.366 0.0043 0.2
his PRH1 0.366 0.0043 0.2
his PRH1-TAS2R14 0.366 0.0043 0.2
his PRH1-PRR4 0.366 0.0043 0.2
exp RFX7 15q21.3 0.364 0.0043 0.2 regulation of transcription, DNA-
dependent"
cop LAMA3 18q11.2 0.364 0.0043 0.2 regulation of cell
adhesion;regulation of cell migration
pro NME1 0.364 0.0043 0.2 Apoptosis
exp HMGB1P25 2p25.1 0.366 0.00431 0.2
exp CXorf21 Xp21.2 0.363 0.00431 0.2
exp STAC3 12q13.3 0.363 0.00431 0.2 intracellular signal transduction
hs4 CDK20 9q22.1 -0.366 0.00431 0.2 Protein Kinases
swa CTNND1 11q11 -0.366 0.00431 0.2 morphogenesis of a polarized
xai FBXL2 3p22.3 -0.366 0.00431 0.2 protein modification
process;proteolysis
his MRPS9 2q12.1 0.366 0.00432 0.2 DNA damage response, detection of
his LOC102724691 0.366 0.00432 0.2
xsq DDN 12q13.12 0.363 0.00432 0.2
exp DDX11L2 2q13 0.363 0.00432 0.2
exp CNN3P1 6p25.1 -0.366 0.00432 0.2
xai MAPKAPK5-AS1 12q24.12 0.366 0.00433 0.2
mir hsa-miR-765 0.363 0.00433 0.2
hs4 LOC101927070 0.366 0.00434 0.2
his ZNF589 3p21 0.366 0.00434 0.2 regulation of transcription, DNA-
dependent"
xai PTPRC 1q31-q32 0.366 0.00434 0.2 protein dephosphorylation;peptidyl-
exp TMA16P2 1p34.1 0.366 0.00434 0.2
exp PRMT3 11p15.1 0.363 0.00434 0.2 peptidyl-arginine N-methylation
xsq CDT1 16q24.3 0.363 0.00434 0.2 DDR (DNA replication)
xai RPLP1 15q22 0.366 0.00435 0.2 gene expression;viral reproduction
exp WDR75 2q32.2 0.363 0.00435 0.2
exp PARP1P1 13q34 0.363 0.00435 0.2
exp KARS 16q23.1 0.363 0.00435 0.2 tRNA aminoacylation for protein
translation;lysyl-tRNA aminoacylation
xsq LINC00959 10q26.3 0.363 0.00435 0.2
xai CAMK2N1 1p36.12 -0.366 0.00435 0.2 negative regulation of
xai LAMB1 7q22 -0.366 0.00435 0.2 embryo implantation;positive
regulation of cell migration
xsq CEP44 4q34 0.363 0.00436 0.2
xsq DDX51 12q24.33 0.363 0.00436 0.2 rRNA processing
exp BAIAP2 17q25 -0.363 0.00436 0.2 insulin receptor signaling
pathway;response to bacterium
xai C9 5p14-p12 0.366 0.00437 0.2 blood coagulation;cytolysis
exp RPS17P16 22q12.3 0.363 0.00437 0.2
met LGALS3BP 17q25 0.363 0.00437 0.2 cellular defense response;cell
adhesion
exp PDCD7 15q22.31 0.363 0.00437 0.2 induction of apoptosis;RNA splicing
exp IGFBP7 4q12 -0.363 0.00437 0.2 regulation of cell
exp TEAD1 11p15.2 -0.363 0.00437 0.2 regulation of transcription,
DNA-dependent;hippo signaling cascade"
exp MBOAT2 2p25.1 -0.363 0.00437 0.2 phospholipid
xai CAMKV 3p21.31 0.366 0.00438 0.2
xai MECR 1p35.3 0.366 0.00438 0.2 fatty acid metabolic process;fatty
exp FOXD2-AS1 1p33 0.363 0.00438 0.2
xsq GATSL3 22q12 0.363 0.00438 0.2
xsq RAD54L 1p32 0.363 0.00438 0.2 DNA Damage Response (DDR); DDR (HR)
mir hsa-miR-135b -0.363 0.00438 0.2
exp ACTN3 11q13.1 -0.366 0.00438 0.2 muscle filament
sliding;regulation of apoptotic process
xai CCDC88B 11q12.3 0.366 0.00439 0.2 microtubule cytoskeleton
organization
exp CEP170B 14q32.33 -0.363 0.00439 0.2
xai LINC00264 10p12.1 0.366 0.0044 0.2
xai PTGDR2 11q12-q13.3 0.366 0.0044 0.2 chemotaxis;immune response
exp CECR1 22q11.2 0.363 0.0044 0.2 adenosine catabolic
exp LEO1 15q21.2 0.363 0.0044 0.2 regulation of transcription, DNA-
exp SHB 9p13.2 -0.363 0.0044 0.2 Apoptosis
xai ELSPBP1 19q13.33 -0.366 0.0044 0.2 single fertilization
exp LINC00264 10p12.1 0.366 0.00441 0.2
his GPCPD1 20p12.3 0.366 0.00441 0.2 glycerol metabolic
process;lipid metabolic process
xai TBC1D10C 11q13.2 0.366 0.00441 0.2
xai SEC14L3 22q12.2 0.366 0.00441 0.2
xsq TXNL4A 18q23 0.363 0.00441 0.2 nuclear mRNA splicing, via
spliceosome;cell cycle
exp CYTIP 2q11.2 0.363 0.00441 0.2 regulation of cell adhesion
xai SHB 9p13.2 -0.366 0.00441 0.2 Apoptosis
xai CKAP4 12q23.3 -0.366 0.00441 0.2
exp FAM153B 5q35.2 0.362 0.00442 0.2
his C17orf62 17q25.3 0.365 0.00443 0.2
xai REXO4 9q34.2 0.365 0.00443 0.2 regulation of transcription, DNA-
dependent"
xai HESX1 3p14.3 0.365 0.00443 0.2 brain development;otic vesicle
formation
xai EXOSC5 19q13.1 0.365 0.00443 0.2 gene expression;RNA metabolic
process
met LITAF 16p13.13 0.362 0.00443 0.2 Apoptosis
exp HNRNPA1P53 11p15.4 0.362 0.00443 0.2
exp TOE1 1p33 0.362 0.00443 0.2
xsq KLRC4-KLRK1 0.362 0.00443 0.2
hs4 VLDLR-AS1 -0.365 0.00443 0.2
hs4 VLDLR 9p24 -0.365 0.00443 0.2 nervous system development;cerebral
cortex development
hs4 CCDC50 3q28 -0.365 0.00443 0.2
hs4 UTS2B 3q28 -0.365 0.00443 0.2
his BSG 19p13.3 0.365 0.00444 0.2 lactate transmembrane
transport;odontogenesis of dentin-containing tooth
exp RBBP8 18q11.2 0.362 0.00444 0.2 DNA Damage Response (DDR); DDR (G1-
S checkpoint)
exp SPI1 11p11.2 0.362 0.00444 0.2 Transcription Factors
mut KIF21A 12q12 0.362 0.00444 0.2 microtubule-based movement
xsq C10orf2 10q24 0.362 0.00444 0.2 DNA replication;mitochondrial DNA
replication
met NSMF 9q34.3 0.362 0.00444 0.2
xsq EPS8 12p12.3 -0.362 0.00444 0.2 signal transduction;epidermal
xai TMEM184B 22q12 -0.365 0.00444 0.2
xai RPS4XP9 6q22.32 0.365 0.00445 0.2
his KIF22 16p11.2 0.365 0.00445 0.2 microtubule-based movement;mitosis
his STT3B 3p23 0.365 0.00445 0.2 protein glycosylation;protein N-linked
glycosylation via asparagine
xai RNASE6 14q11.2 0.365 0.00445 0.2 RNA catabolic process;defense
response
xai GSTCD 4q24 0.365 0.00445 0.2
his SPECC1 17p11.2 -0.365 0.00445 0.2
his LAIR1 19q13.4 0.365 0.00446 0.2
his SNORD22 0.365 0.00446 0.2
his SNORD31 0.365 0.00446 0.2
his SNORD30 0.365 0.00446 0.2
his SNORD29 0.365 0.00446 0.2
his SNORD28 0.365 0.00446 0.2
his SNORD27 0.365 0.00446 0.2
his SNORD26 0.365 0.00446 0.2
his SNORD25 0.365 0.00446 0.2
his SNHG1 11q12.3 0.365 0.00446 0.2
exp SNRPA1 15q26.3 0.362 0.00446 0.2 RNA splicing;gene expression
swa SNRPD1 18q11.2 0.365 0.00447 0.2 ncRNA metabolic
exp TRAF3IP3 1q32 0.362 0.00447 0.2
mut ULK1 12q24.3 0.362 0.00447 0.2 neuron projection
regeneration;neuron projection development
exp GDF10 10q11.22 0.362 0.00447 0.2 skeletal system
his IRGM 5q33.1 0.365 0.00448 0.2 autophagy;inflammatory response
xai DNA2 10q21.3-q22.1 0.365 0.00448 0.2 DNA Damage Response (DDR);
DDR (FA); DDR (DNA replication)
xai SFMBT2 10p14 0.365 0.00448 0.2 regulation of transcription, DNA-
dependent"
xsq S100A10 1q21 -0.362 0.00448 0.2 signal transduction;positive
hs4 CYP2E1 10q26.3 0.365 0.00449 0.2 heterocycle metabolic
xai ISOC1 5q22.1-q33.3 0.365 0.00449 0.2
exp HESX1 3p14.3 0.362 0.00449 0.2 brain development;otic vesicle
formation
mut GTDC1 2q22.3 0.362 0.00449 0.2 biosynthetic process
mut OR5AU1 0.362 0.00449 0.2
mut DUSP3 17q21 0.362 0.00449 0.2 toll-like receptor 2 signaling
pathway;negative regulation of JNK cascade
mut ITPA 20p 0.362 0.00449 0.2 metabolic process;nucleotide metabolic
process
mut MAVS 20p13 0.362 0.00449 0.2 positive regulation of interferon-alpha
production;interspecies interaction between organisms
xsq LOC101928134 0.362 0.00449 0.2
mut LHX8 1p31.1 0.362 0.00449 0.2 learning or memory;female gonad
development
mut ZNF326 1p22.2 0.362 0.00449 0.2 regulation of transcription,
DNA-dependent"
mut HDGF 1q23.1 0.362 0.00449 0.2 regulation of transcription, DNA-
response
mut NUF2 1q23.3 0.362 0.00449 0.2 M phase of mitotic cell
cycle;mitotic prometaphase
mut KIFAP3 1q24.2 0.362 0.00449 0.2 negative regulation of cell
proliferation;positive regulation of calcium-dependent cell-cell adhesion
mut NCF2 1q25 0.362 0.00449 0.2 response to lipopolysaccharide;innate
immune response
mut KIF21B 1q32.1 0.362 0.00449 0.2 microtubule-based movement
mut KCNK2 1q41 0.362 0.00449 0.2 ion transport;potassium ion transport
mut WNT3A 1q42 0.362 0.00449 0.2
mut OR14C36 1q44 0.362 0.00449 0.2 response to stimulus
mut AFTPH 2p14 0.362 0.00449 0.2 protein transport
mut BMP10 2p13.3 0.362 0.00449 0.2 positive regulation of cardiac
muscle hypertrophy;sarcomere organization
mut CCDC93 2q14.1 0.362 0.00449 0.2
mut CCDC115 2q21.1 0.362 0.00449 0.2
mut UPP2 2q24.1 0.362 0.00449 0.2
mut RFTN2 2q33.1 0.362 0.00449 0.2
mut STK36 2q35 0.362 0.00449 0.2 positive regulation of smoothened
signaling pathway;regulation of sequence-specific DNA binding transcription factor
activity
mut NCKIPSD 3p21 0.362 0.00449 0.2 NLS-bearing substrate import into
nucleus;cytoskeleton organization
mut POU1F1 3p11 0.362 0.00449 0.2 regulation of transcription, DNA-
dependent;transcription from RNA polymerase II promoter
mut IGSF11 3q13.32 0.362 0.00449 0.2 cell adhesion;regulation of
growth
mut C3orf30 3q13.32 0.362 0.00449 0.2
mut STX18 4p16.3-p16.2 0.362 0.00449 0.2 ER to Golgi vesicle-mediated
mut MSX1 4p16.2 0.362 0.00449 0.2 multicellular organismal
development;positive regulation of BMP signaling pathway
mut CSN2 4q21.1 0.362 0.00449 0.2
mut HSD17B13 4q22.1 0.362 0.00449 0.2
mut ASIC5 4q32.1 0.362 0.00449 0.2 ion transport
mut RXFP1 4q32.1 0.362 0.00449 0.2 cell differentiation;extracellular
matrix organization
mut CYP4V2 4q35.2 0.362 0.00449 0.2 fatty acid omega-
oxidation;response to stimulus
mut SOWAHA 5q31.1 0.362 0.00449 0.2
mut CSF1R 5q32 0.362 0.00449 0.2 Oncogenes
mut GABRG2 5q34 0.362 0.00449 0.2 transport;chloride transport
mut NOP16 5q35.2 0.362 0.00449 0.2
DNA-dependent"
mut MGAT1 5q35 0.362 0.00449 0.2 cellular protein metabolic
process;carbohydrate metabolic process
mut SNRNP48 6p24.3 0.362 0.00449 0.2 mRNA processing;RNA splicing
mut EYA4 6q23 0.362 0.00449 0.2 DNA repair;regulation of transcription,
DNA-dependent
mut HOXA6 7p15.2 0.362 0.00449 0.2 multicellular organismal
development;anterior/posterior pattern specification
mut GRB10 7p12.2 0.362 0.00449 0.2 response to insulin
stimulus;negative regulation of phosphorylation
mut SPAM1 7q31.3 0.362 0.00449 0.2 carbohydrate metabolic process;cell
adhesion
mut SH2D4A 8p21.2 0.362 0.00449 0.2 negative regulation of
mut EPHX2 8p21 0.362 0.00449 0.2 inflammatory response;regulation of blood
pressure
mut FAM91A1 8q24.13 0.362 0.00449 0.2
mut ARMC4 10p12.1-p11.23 0.362 0.00449 0.2
mut ARID5B 10q21.2 0.362 0.00449 0.2 fibroblast migration;skeletal
system morphogenesis
mut PBLD 10q21.3 0.362 0.00449 0.2 biosynthetic process
mut SUPV3L1 10q22.1 0.362 0.00449 0.2 positive regulation of cell
mut PDZD7 10q24.31 0.362 0.00449 0.2
mut OR2D3 0.362 0.00449 0.2
mut BTBD10 11p15.2 0.362 0.00449 0.2
mut CALCA 11p15.2 0.362 0.00449 0.2 monocyte chemotaxis;cell-cell
signaling
mut MEN1 11q13 0.362 0.00449 0.2 DNA Damage Response (DDR); Tumor
Suppressors
mut ACRV1 11q24.2 0.362 0.00449 0.2
mut KLRD1 12p13 0.362 0.00449 0.2 cell surface receptor signaling
mut RPAP3 12q13.11 0.362 0.00449 0.2
mut NEMP1 0.362 0.00449 0.2
mut INHBE 12q13.3 0.362 0.00449 0.2 growth
mut TNFRSF19 13q12.11-q12.3 0.362 0.00449 0.2 hair follicle
development;apoptotic process
mut COG6 13q14.11 0.362 0.00449 0.2 intra-Golgi vesicle-mediated
mut SUPT16H 14q11.2 0.362 0.00449 0.2 transcription from RNA
polymerase II promoter;transcription elongation from RNA polymerase II promoter
mut AJUBA 14q11.2 0.362 0.00449 0.2 Cell Signaling
mut DHRS2 14q11.2 0.362 0.00449 0.2 negative regulation of cell
proliferation;response to toxin
mut FUT8 14q24.3 0.362 0.00449 0.2 integrin-mediated signaling
pathway;receptor metabolic process
mut SLC24A4 14q32.12 0.362 0.00449 0.2 potassium ion
transport;sodium ion transport
mut C15orf54 15q14 0.362 0.00449 0.2
mut PDIA3 15q15 0.362 0.00449 0.2 protein retention in ER lumen;cell redox
homeostasis
mut SERINC4 15q15.3 0.362 0.00449 0.2 lipid metabolic
process;phospholipid biosynthetic process
mut MYO5C 15q21 0.362 0.00449 0.2
mut OR4F15 15q26.3 0.362 0.00449 0.2 response to stimulus
mut SEPT1 16p11.1 0.362 0.00449 0.2 cell cycle;cell division
mut MT4 16q13 0.362 0.00449 0.2
mut AP1G1 16q23 0.362 0.00449 0.2 post-Golgi vesicle-mediated
transport;endocytosis
mut TIMM22 17p13 0.362 0.00449 0.2 protein transport;protein import
into mitochondrial inner membrane
mut KDM4B 19p13.3 0.362 0.00449 0.2 regulation of transcription, DNA-
mut RDH8 19p13.2 0.362 0.00449 0.2 response to stimulus;steroid
mut CAPN12 19q13.2 0.362 0.00449 0.2 proteolysis
mut LIG1 19q13.2-q13.3 0.362 0.00449 0.2 DNA Damage Response (DDR);
DDR (BER); DDR (DNA replication)
mut FPR2 19q13.3-q13.4 0.362 0.00449 0.2 G-protein coupled receptor
signaling pathway;cellular component movement
mut TNNT1 19q13.4 0.362 0.00449 0.2 muscle filament sliding;slow-twitch
skeletal muscle fiber contraction
DNA-dependent"
DNA-dependent"
DNA-dependent"
mut TGM3 20q11.2 0.362 0.00449 0.2 hair follicle
morphogenesis;keratinization
mut CSTL1 20p11.21 0.362 0.00449 0.2
mut CST9L 20p11.21 0.362 0.00449 0.2
mut DEFB116 20q11.21 0.362 0.00449 0.2 defense response to bacterium
mut CHODL 21q11.2 0.362 0.00449 0.2 muscle organ development
mut CYYR1 21q21.2 0.362 0.00449 0.2
mut MAGEB3 Xp21.3 0.362 0.00449 0.2
mut PRICKLE3 Xp11.23 0.362 0.00449 0.2
mut FRMD7 Xq26.2 0.362 0.00449 0.2 nervous system
development;regulation of neuron projection development
mut GPC3 Xq26.1 0.362 0.00449 0.2 anatomical structure
morphogenesis;mesenchymal cell proliferation involved in ureteric bud development
exp CTTNBP2NL 1p13.2 -0.362 0.00449 0.2
exp HTRA4 8p11.22 -0.365 0.00449 0.2 regulation of cell
growth;proteolysis
xai DDX21 10q21 0.365 0.0045 0.2
xai WDR75 2q32.2 0.365 0.0045 0.2
his NUP155 5p13.1 0.365 0.0045 0.2 nucleocytoplasmic
transport;mRNA transport
exp NANP 20p11.1 0.362 0.0045 0.2 carbohydrate metabolic
exp METTL21A 2q33.3 0.362 0.0045 0.2
swa GIPC1 19p13.1 -0.365 0.0045 0.2 protein targeting;regulation
his RAB3A 19p13.2 0.365 0.00451 0.2 neuromuscular synaptic
transmission;lung development
his LOC102725254 0.365 0.00451 0.2
met GPNMB 7p15 0.362 0.00451 0.2 cell adhesion;negative regulation of cell
proliferation
exp FAM114A1 4p14 -0.362 0.00451 0.2
swa DNAJA1 9p13.3 0.365 0.00452 0.2 protein folding;response to
unfolded protein
his TTF1 9q34.13 0.365 0.00452 0.2 regulation of transcription, DNA-
xsq ICAM4 19p13.2 0.362 0.00452 0.2 cell-cell adhesion;regulation of
immune response
mut MED14 Xp11.4 0.362 0.00452 0.2 positive regulation of
transcription from RNA polymerase II promoter;regulation of transcription from RNA
exp ELSPBP1 19q13.33 -0.365 0.00452 0.2 single fertilization
his ATP8A1 4p13 0.365 0.00453 0.2 cation transport;aminophospholipid
transport
xai CELF5 19p13 0.365 0.00453 0.2 mRNA processing
exp UBL5P3 3p14.2 0.365 0.00453 0.2
exp CNOT1 16q21 0.362 0.00453 0.2 nuclear-transcribed mRNA catabolic
shortening
xsq SNX29P2 16p11.2 0.362 0.00453 0.2
exp DDX21 10q21 0.362 0.00453 0.2
exp CROCCP2 1p36.13 0.362 0.00453 0.2
hs4 IFIT3 -0.365 0.00453 0.2 cellular response to interferon-
alpha;type I interferon-mediated signaling pathway
his CORIN 4p13-p12 0.365 0.00454 0.2 proteolysis;peptide hormone
processing
his TAF12 1p35.3 0.365 0.00454 0.2 transcription from RNA polymerase
II promoter;transcription initiation from RNA polymerase II promoter
his RNU11 1p35 0.365 0.00454 0.2
xai CEP170B 14q32.33 -0.364 0.00454 0.2
xai PPFIBP1 12p12.1 -0.364 0.00454 0.2 cell adhesion
xai H3F3AP5 Xp11.22 0.364 0.00455 0.2
xai KRI1 19p13.2 0.364 0.00455 0.2
xai PIK3CG 7q22.3 0.364 0.00455 0.2 Apoptosis; Cell Signaling;
xai HELB 12q14.3 0.364 0.00455 0.2 DNA Damage Response (DDR)
xai MIR17HG 13q31.3 0.364 0.00455 0.2
xai ZNF692 1q44 0.364 0.00455 0.2 regulation of transcription, DNA-
dependent"
met PHKG1 7p11.2 0.361 0.00455 0.2 carbohydrate metabolic
process;glycogen biosynthetic process
xsq CFB 6p21.3 -0.361 0.00455 0.2 complement activation,
his INPP4A 2q11.2 0.364 0.00456 0.201 signal transduction
DNA-dependent"
exp RPL21P17 3p26.3 0.364 0.00456 0.201
xai BEND4 4p13 0.364 0.00456 0.201
met CFAP43 0.361 0.00456 0.201
xsq DDX11L5 0.361 0.00456 0.201
exp PRR14 16p11.2 0.361 0.00456 0.201
exp ITGB3BP 1p31.3 0.364 0.00457 0.201 Apoptosis
his ATP5O 21q22.11 0.364 0.00457 0.201 respiratory electron transport
chain;mitochondrial ATP synthesis coupled proton transport
xsq RBMX Xq26.3 0.361 0.00457 0.201 transcription from RNA polymerase
II promoter;cellular response to interleukin-1
xsq KCNA3 1p13.3 0.361 0.00457 0.201 ion transport;potassium ion
transport
exp RRAS2 11p15.2 -0.361 0.00457 0.201 GTP catabolic process;signal
transduction
xai TEAD1 11p15.2 -0.364 0.00457 0.201 regulation of transcription,
xai XPO5 6p21.1 0.364 0.00458 0.201 protein export from
nucleus;intracellular protein transport
xai HIF1A 14q23.2 -0.364 0.00458 0.201 Protein Kinases
exp EEF1A1P4 0.364 0.00459 0.201
hs4 SASH3 Xq26 0.364 0.00459 0.201 positive regulation of interleukin-10
his NDUFB7 19p13.12 0.364 0.00459 0.201 mitochondrial electron
xai CXorf65 Xq13.1 0.364 0.00459 0.201
met RPL8 8q24.3 0.361 0.00459 0.201 translational elongation;viral
transcription
met FERMT3 11q13.1 -0.361 0.00459 0.201 leukocyte cell-cell
exp CCT3 1q23 0.361 0.0046 0.201 protein folding;cellular protein
metabolic process
exp TTF1 9q34.13 0.361 0.0046 0.201 regulation of transcription, DNA-
mut PHLDB1 11q23.3 0.361 0.0046 0.201
xai ADAM22 7q21 0.364 0.00461 0.202 proteolysis;negative regulation of
cell adhesion
met TJP1 15q13 0.361 0.00461 0.202 blastocyst formation;apoptotic process
met GCSAM 3q13.2 -0.361 0.00461 0.202
xsq CD63 12q12-q13 -0.361 0.00461 0.202 platelet degranulation;blood
coagulation
xai EEF1A1P8 3q27.1 0.364 0.00462 0.202
exp CDC123 10p13 0.361 0.00462 0.202 G1 phase of mitotic cell cycle;cell
cycle
mir hsa-miR-671-5p 0.361 0.00462 0.202
exp TLR5 1q41-q42 -0.361 0.00462 0.202 cellular response to
mechanical stimulus;MyD88-dependent toll-like receptor signaling pathway
xai PDCD2L 19q13.11 0.364 0.00463 0.202 cell cycle
exp CSTF3-AS1 0.364 0.00463 0.202
xsq SERHL 0.361 0.00463 0.202
exp E2F4 16q22.1 0.361 0.00463 0.202 mitotic cell cycle;cilium assembly
mut PNRC1 6q15 0.361 0.00463 0.202 regulation of transcription, DNA-
dependent"
exp PCDH9 13q21.32 0.361 0.00463 0.202 cell adhesion;homophilic cell
adhesion
exp ZBTB39 12q13.3 0.361 0.00463 0.202 regulation of transcription,
DNA-dependent"
mut MACC1 7p21.1 0.361 0.00464 0.202 regulation of transcription, DNA-
dependent;positive regulation of cell division"
xsq SPAG1 8q22.2 -0.361 0.00464 0.202 single fertilization
xai PCDH9 13q21.32 0.364 0.00465 0.202 cell adhesion;homophilic cell
adhesion
exp FAU 11q13 0.361 0.00465 0.202 translational initiation;viral infectious
cycle
xsq POLR3E 16p12.2 0.361 0.00465 0.202 transcription from RNA
xai FCHO2 5q13.2 -0.364 0.00465 0.202
xai ZBTB39 12q13.3 0.363 0.00466 0.203 regulation of transcription,
DNA-dependent"
mut PNPLA6 19p13.2 0.36 0.00466 0.203 lipid catabolic
process;phosphatidylcholine metabolic process
hs4 ABCC6P1 16p12.3 -0.363 0.00466 0.203
his TEX261 2p13.3 0.363 0.00467 0.203 positive regulation of
apoptotic process
xsq TMIGD2 19p13.3 0.36 0.00467 0.203
met CCDC80 3q13.2 0.36 0.00467 0.203 positive regulation of cell-
substrate adhesion;extracellular matrix organization
exp ISOC1 5q22.1-q33.3 0.36 0.00467 0.203
hs4 SHROOM2 Xp22.3 -0.363 0.00467 0.203 eye pigment granule
xsq ZNF696 8q24.3 0.36 0.00468 0.203 regulation of transcription,
DNA-dependent"
xsq KIAA1522 1p35.1 -0.36 0.00468 0.203
xai NHP2P2 7p15.2 0.363 0.00469 0.203
xsq HCG27 6p21.33 0.36 0.00469 0.203
met TEAD2 19q13.3 0.36 0.00469 0.203 positive regulation of
transcription from RNA polymerase II promoter;paraxial mesoderm development
mut ZNF141 4p16.3 0.36 0.00469 0.203 regulation of transcription,
DNA-dependent;transcription from RNA polymerase II promoter
mut SAFB2 19p13.3 0.36 0.00469 0.203 regulation of transcription, DNA-
dependent"
xai ACTA2 10q23.3 -0.363 0.00469 0.203 muscle contraction;regulation
of blood pressure
xsq LMNA 1q22 -0.36 0.0047 0.204 establishment or maintenance of
microtubule cytoskeleton polarity;apoptotic process
hs4 ZNRF3-AS1 -0.363 0.0047 0.204
his NME1-NME2 0.363 0.00471 0.204 CTP biosynthetic process;GTP
his NME1 0.363 0.00471 0.204 Apoptosis
xai OGFOD1 16q12.2 0.363 0.00471 0.204
xai IKZF5 10q26 0.363 0.00471 0.204 regulation of transcription, DNA-
dependent"
exp PTPRC 1q31-q32 0.36 0.00471 0.204 protein dephosphorylation;peptidyl-
exp CD151 11p15.5 -0.36 0.00471 0.204 cell adhesion;hemidesmosome
assembly
hs4 TRPM4 19q13.33 -0.363 0.00471 0.204 dendritic cell
chemotaxis;regulation of T cell cytokine production
hs4 HRC 19q13.3 -0.363 0.00471 0.204 muscle contraction
xsq PYHIN1 1q23.1 0.36 0.00472 0.204 cell cycle
exp FBXO41 2p13.2 0.36 0.00472 0.204
xsq ARHGAP35 19q13.3 -0.36 0.00472 0.204 axon guidance;positive
xai PRMT7 16q22.1 0.363 0.00473 0.204 spliceosomal snRNP assembly;histone
arginine methylation
mut TAF3 10p15.1 0.36 0.00473 0.204 negative regulation of
dependent
met WFDC5 20q13.12 -0.36 0.00473 0.204
xai RPS7P5 1q43 0.363 0.00474 0.204
xsq TNFAIP8L2 1q21.3 0.36 0.00474 0.204 innate immune response
xsq CECR6 0.36 0.00474 0.204
exp GRAMD3 5q23.2 -0.36 0.00474 0.204
his NIP7 16q22.1 0.363 0.00475 0.205 ribosome assembly
his COG8 16q22.1 0.363 0.00475 0.205 protein transport
hs4 MIR662 0.363 0.00475 0.205
xai FOXN2 2p22-p16 0.363 0.00475 0.205 regulation of transcription, DNA-
dependent;pattern specification process
xai ARHGAP30 1q23.3 0.363 0.00475 0.205 signal transduction;small
his LOC105376575 0.363 0.00475 0.205
xsq TBX10 11q13.2 0.36 0.00475 0.205 anatomical structure
morphogenesis;regulation of transcription from RNA polymerase II promoter
his ADGRL1 0.363 0.00476 0.205 G-protein coupled receptor
his LINC02111 0.363 0.00476 0.205
exp RPL3P9 8q21.13 0.363 0.00476 0.205
met GAA 17q25.2-q25.3 0.36 0.00476 0.205 heart morphogenesis;tissue
development
met PLD1 3q26 0.36 0.00476 0.205 phospholipid catabolic process;lipid
catabolic process
his CARD8-AS1 0.363 0.00477 0.205
his CARD8 19q13.33 0.363 0.00477 0.205 activation of cysteine-type
process
xai LIPK 10q23.31 0.363 0.00477 0.205 lipid catabolic process
exp RPL23AP46 6q23.2 0.36 0.00477 0.205
xsq FAM27B 9q13 0.36 0.00477 0.205
xai CEP85 1p36.11 0.363 0.00478 0.205
xai ADCK3 1q42.13 0.362 0.00478 0.205 cell death
xai HMGB1P4 2q32 0.362 0.00478 0.205
exp LINC01590 0.36 0.00478 0.205
hs4 KIR3DL2 19q13.4 0.362 0.00479 0.205 cellular defense
his HIBCH 2q32.2 0.362 0.00479 0.205 branched chain family amino acid
catabolic process;cellular nitrogen compound metabolic process
mir hsa-miR-142-5p 0.359 0.00479 0.205
exp ZNF384 12p12 0.359 0.00479 0.205 regulation of transcription, DNA-
xai LURAP1L 9p23 -0.362 0.00479 0.205
his ADI1 2p25.3 0.362 0.0048 0.205 cellular nitrogen compound
xai NANP 20p11.1 0.362 0.0048 0.205 carbohydrate metabolic
xai EEF1A1P4 0.362 0.0048 0.205
his ANKRD36 2q11.2 0.362 0.0048 0.205
hs4 GPA33 1q24.1 0.362 0.0048 0.205
xai PNPT1 2p15 0.362 0.0048 0.205 mitochondrial mRNA catabolic
process;transport
exp POLR2D 2q21 0.359 0.0048 0.205 DNA Damage Response (DDR); DDR
(NER)
exp CELF5 19p13 0.359 0.0048 0.205 mRNA processing
hs4 KRT80 12q13.13 -0.362 0.0048 0.205
his MRPL50 9q31.1 0.362 0.00481 0.205
his ZNF189 9q22-q31 0.362 0.00481 0.205 negative regulation of
xai CYTIP 2q11.2 0.362 0.00481 0.205 regulation of cell adhesion
xai RBMX2 Xq26.1 0.362 0.00481 0.205
hs4 SLA 8q24 0.362 0.00481 0.205
exp SRPK1 6p21.31 0.359 0.00481 0.205 protein phosphorylation;negative
exp FERMT3 11q13.1 0.359 0.00481 0.205 leukocyte cell-cell
his MANBA 4q24 0.362 0.00482 0.205 carbohydrate metabolic process;protein
his PHF19 9q33.2 0.362 0.00482 0.205 regulation of transcription, DNA-
dependent"
exp GTF2H2 0.362 0.00482 0.205 DNA Damage Response (DDR); DDR
(NER)
hs4 CACNA1C-AS1 0.362 0.00482 0.205
xai DDX12P 12p13.31 0.362 0.00482 0.205 nucleobase-containing
xsq TERF2 16q22.1 0.359 0.00482 0.205 DNA Damage Response (DDR); DDR (DNA
replication)
mut HELZ2 20q13.33 0.359 0.00482 0.205
exp CHST3 10q22.1 -0.359 0.00482 0.205 T cell homeostasis;positive
regulation of cellular component movement
exp ABTB2 11p13 -0.359 0.00482 0.205 regulation of cell growth
xsq TRERNA1 0.359 0.00483 0.205
swa MYO1C 17p13.3 -0.362 0.00483 0.205 protein transport;mRNA
transport
his TMEM97 17q11.2 0.362 0.00484 0.206 regulation of cell
growth;cholesterol homeostasis
xsq HSP90AB4P 0.359 0.00484 0.206 response to stress;protein folding
xsq ATCAY 19p13.3 0.359 0.00484 0.206 transport
hs4 CDC42EP3 2p21 -0.362 0.00484 0.206 signal
xai PWP2 21q22.3 0.362 0.00485 0.206 signal transduction
xsq RGL4 22q11.23 0.359 0.00485 0.206 small GTPase mediated signal
transduction
xsq CTSL 9q21.33 -0.359 0.00485 0.206
met SHISA4 1q32.1 0.359 0.00486 0.206
exp GEMIN4 17p13 0.359 0.00486 0.206 RNA metabolic process;ncRNA
metabolic process
exp FAUP1 18q22.3 0.359 0.00486 0.206
xsq LINC00339 1p36.12 0.359 0.00486 0.206
xsq ENO3 17p13.2 0.359 0.00486 0.206 response to drug;skeletal muscle
tissue regeneration
xsq DST 6p12.1 -0.359 0.00486 0.206 axonogenesis;intracellular
transport
xai FKBP9P1 -0.362 0.00486 0.206
hs4 ZNF433 19p13.2 -0.362 0.00486 0.206 regulation of
xai CFB 6p21.3 -0.362 0.00487 0.206 complement activation,
his C3AR1 12p13.31 0.362 0.00488 0.207 blood circulation;regulation of
blood pressure
exp NCAPD2P1 0.362 0.00488 0.207
hs4 LAPTM4B 8q22.1 -0.362 0.00488 0.207 transport
xai PDLIM2 8p21.3 -0.362 0.00488 0.207
his NCLN 19p13.3 0.362 0.00489 0.207 regulation of signal
transduction;proteolysis
hs4 ARHGEF10L 1p36.13 -0.362 0.00489 0.207 positive regulation of
Rho GTPase activity;regulation of Rho protein signal transduction
xai RPS4XP2 20p13 0.362 0.0049 0.207
his PLA2G15 16q22.1 0.362 0.0049 0.207 lipid metabolic
process;ceramide metabolic process
xai CSTF3-AS1 0.362 0.0049 0.207
his ANGPTL6 19p13.2 0.362 0.0049 0.207 angiogenesis;signal
transduction
his PPAN-P2RY11 19p13 0.362 0.0049 0.207
his PPAN 19p13 0.362 0.0049 0.207
his SNORD105 0.362 0.0049 0.207
his SNORD105B 0.362 0.0049 0.207
exp XRCC3 14q32.3 0.359 0.0049 0.207 DNA Damage Response (DDR); DDR
(NHEJ)
exp RPL10P8 5q35.1 0.359 0.0049 0.207
his MIR4797 -0.362 0.0049 0.207
his DLG1-AS1 -0.362 0.0049 0.207
his DLG1 3q29 -0.362 0.0049 0.207 mitotic cell cycle G1/S transition
hs4 TRIP6 7q22 -0.362 0.0049 0.207 cell adhesion;release of
hs4 MIR6875 -0.362 0.0049 0.207
xai SNRPA1 15q26.3 0.361 0.00491 0.207 RNA splicing;gene expression
xai RNF34 12q24.31 0.361 0.00491 0.207 Apoptosis
swa KIAA1715 2q31 -0.361 0.00491 0.207 limb
hs4 SPATA6 1p33 -0.361 0.00491 0.207 multicellular organismal
xai COPB2 3q23 -0.361 0.00492 0.207 COPI coating of Golgi
vesicle;intracellular protein transport
hs4 UACA 15q22-q24 -0.361 0.00492 0.207
his DLAT 11q23.1 0.361 0.00494 0.207 acetyl-CoA biosynthetic
process;pyruvate metabolic process
his CDK11B 0.361 0.00494 0.207 Apoptosis; Protein Kinases
his MDM1 12q15 0.361 0.00494 0.207 retina development in camera-type eye
xai ABCB10 1q42.13 0.361 0.00494 0.207 ABC Transporters
mut ELAC1 18q21 0.358 0.00494 0.207 tRNA processing;tRNA 3'-trailer cleavage
his P2RY8 Xp22.33 0.361 0.00495 0.207
his SEC14L1 17q25.2 0.361 0.00495 0.207 transport
his SNHG20 0.361 0.00495 0.207
his SCARNA16 17q25.2 0.361 0.00495 0.207
his MIR6516 0.361 0.00495 0.207
xai TBX10 11q13.2 0.361 0.00495 0.208 anatomical structure
xsq CHRDL2 11q14 0.358 0.00495 0.207 ossification;multicellular
met CCDC50 3q28 0.358 0.00495 0.207
mda NE 0.358 0.00495 0.208
mut DACH1 13q22 0.358 0.00495 0.208 regulation of transcription, DNA-
dependent;multicellular organismal development
exp LUC7L 16p13.3 0.358 0.00495 0.208 negative regulation of striated
his CNPY3 6p21.1 0.361 0.00496 0.208 innate immune response
his CNPY3-GNMT 0.361 0.00496 0.208
xai NDUFA9 12p13.3 0.361 0.00496 0.208 mitochondrial electron
exp CD86 3q21 0.358 0.00496 0.208 immune response;positive regulation of
exp MYO10 5p15.1-p14.3 -0.358 0.00496 0.208 axon guidance;regulation
of cell shape
xai NDC1 1p32.3 0.361 0.00497 0.208
hs4 ARHGEF37 5q32 -0.361 0.00497 0.208 regulation of Rho protein
signal transduction
his WWTR1 3q23-q24 -0.361 0.00497 0.208 regulation of transcription,
his WWTR1-AS1 3q25.1 -0.361 0.00497 0.208
met PEG3-AS1 19q13.43 0.358 0.00498 0.208
exp RPL18AP16 Xq28 0.358 0.00498 0.208
his ATP13A1 19p13.11 0.361 0.00499 0.208 cation transport
his ZNF101 19p13.11 0.361 0.00499 0.208 regulation of transcription,
DNA-dependent"
exp DTL 1q32 0.358 0.00499 0.209 DDR (DNA replication)
exp LOC643276 2q21.1 0.358 0.005 0.209
met LMCD1 3p26-p24 0.358 0.005 0.209 positive regulation of calcineurin-NFAT
signaling cascade;negative regulation of transcription from RNA polymerase II
promoter
xsq P4HA2-AS1 -0.358 0.005 0.209
swa FGF2 4q26 -0.361 0.005 0.209 branching involved in ureteric bud
morphogenesis;chemotaxis
his KIAA1586 6p12.1 0.361 0.00501 0.209
xai INTS2 17q23.2 0.361 0.00501 0.209 snRNA processing
his SNORA29 6q25.3 0.361 0.00501 0.209
his TCP1 6q25.3-q26 0.361 0.00501 0.209 protein folding;tubulin complex
assembly
his MRPL18 6q25.3 0.361 0.00501 0.209 translation;transport
mir hsa-miR-601 0.358 0.00501 0.209
xsq POLE3 9q33 0.358 0.00501 0.209 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
exp RUNX2 6p21 -0.358 0.00501 0.209 negative regulation of
transcription, DNA-dependent;positive regulation of transcription, DNA-dependent
hs4 ARHGAP30 1q23.3 0.361 0.00502 0.209 signal transduction;small
hs4 C14orf80 14q32.33 0.361 0.00502 0.209
xai SRRM1P3 Xq26.3 0.361 0.00502 0.209
exp LST1 6p21.3 0.358 0.00502 0.209 cell morphogenesis;immune response
mut RHBG 1q21.3 0.358 0.00502 0.209 ammonium transport;transmembrane
transport
exp NUDT8 11q13.2 0.358 0.00502 0.209
exp ADPGK 15q24.1 0.358 0.00502 0.209 glycolysis;carbohydrate metabolic
process
xsq PLEKHA4 19q13.33 -0.358 0.00502 0.209
xai PARVA 11p15.3 -0.361 0.00502 0.209 cell projection
his LMCD1-AS1 3p26.1 -0.361 0.00502 0.209
his LMCD1 3p26-p24 -0.361 0.00502 0.209 positive regulation of
his CCT8 21q22.11 0.361 0.00503 0.209 protein folding;cellular protein
metabolic process
his MAP3K7CL 21q22.3 0.361 0.00503 0.209
xai RPS15AP11 1p34.1 0.361 0.00503 0.209
xai CCDC77 12p13.33 0.361 0.00503 0.209
exp RPL10L 14q21.2 0.358 0.00503 0.209 translation;spermatogenesis
xai FAM102A 9q34.11 -0.361 0.00503 0.209
swa CYFIP1 15q11 -0.36 0.00504 0.209 regulation of cell
shape;lamellipodium assembly
his MIR6830 -0.36 0.00504 0.209
xai NCAPD2P1 0.36 0.00505 0.209
mut GSK3B 3q13.3 0.357 0.00505 0.209 Apoptosis; Protein Kinases
xsq MCM10 10p13 0.357 0.00505 0.209 DDR (DNA replication)
xsq RPLP1 15q22 0.357 0.00505 0.209 gene expression;viral reproduction
xai LETM1P2 0.36 0.00506 0.209
his AUH 9q22.31 0.36 0.00506 0.209 mRNA catabolic process;branched
exp KRI1 19p13.2 0.357 0.00506 0.209
xsq RPRD1A 18q12.2 0.357 0.00506 0.209 dephosphorylation of RNA
polymerase II C-terminal domain
xsq CD276 15q23-q24 -0.357 0.00506 0.209 cell proliferation;positive
xsq LOC100506804 0.357 0.00507 0.209
xai RPL21P17 3p26.3 0.36 0.00508 0.209
hs4 CD8B 2p12 0.36 0.00508 0.209 regulation of immune response;immune
response
hs4 ANAPC1P1 2p11.2 0.36 0.00508 0.209
xai LSP1P2 0.36 0.00508 0.209
xai PTMA 2q37.1 0.36 0.00508 0.209 transcription, DNA-dependent"
xai MCM3AP-AS1 21q22.3 0.36 0.00508 0.21
exp RPL7AP31 4q12 0.357 0.00508 0.209
mda RepStress 0.357 0.00508 0.209
xsq ADHFE1 8q13.1 -0.357 0.00508 0.21 2-oxoglutarate metabolic
met MIR20A -0.357 0.00508 0.209
hs4 GLB1L3 11q25 0.36 0.00509 0.21 carbohydrate metabolic process
exp WT1-AS 11p13 0.357 0.00509 0.21
exp LINC00346 13q34 -0.357 0.00509 0.21
xsq TPM1 15q22.1 -0.357 0.00509 0.21 positive regulation of heart
met TRPC2 11p15.4 -0.357 0.0051 0.21
xai C8B 1p32.2 0.36 0.00511 0.21 immune response;complement
activation
xai ANP32B 9q22.32 0.36 0.00511 0.21
met ABTB2 11p13 0.357 0.00511 0.21 regulation of cell growth
xsq LCP2 5q35.1 0.357 0.00511 0.21 immune response;transmembrane
receptor protein tyrosine kinase signaling pathway
xsq TRMT44 4p16.1 0.357 0.00511 0.21
swa TECR 19p13.12 -0.36 0.00511 0.21 long-chain fatty-acyl-CoA
biosynthetic process;very long-chain fatty acid biosynthetic process
swa PCBP1 2p13-p12 0.36 0.00512 0.21 nuclear mRNA splicing, via
xai IMP3 15q24 0.36 0.00512 0.21 rRNA processing
cop ABHD3 18q11.2 0.357 0.00512 0.21
cop MIR320C1 0.357 0.00512 0.21
cop MIB1 18q11.2 0.357 0.00512 0.21 neural tube formation;heart looping
cop MIR133A1 0.357 0.00512 0.21
cop MIR1-2 0.357 0.00512 0.21
exp AJUBA 14q11.2 -0.357 0.00512 0.21 Cell Signaling
exp TRPM2 21q22.3 0.36 0.00513 0.21 ion transport;calcium ion transport
exp LMNTD1 0.36 0.00513 0.21 cell proliferation
exp RPL7AP12 20p13 0.357 0.00513 0.21
xsq MAP4K1 19q13.1-q13.4 0.357 0.00513 0.21 response to
xsq CRYAB 11q22.3-q23.1 -0.357 0.00513 0.21 protein folding;anti-
apoptosis
xsq PCDH9 13q21.32 0.357 0.00514 0.21 cell adhesion;homophilic cell
adhesion
exp CNOT10 3p22.3 0.357 0.00514 0.21 nuclear-transcribed mRNA
tail shortening
xsq SCNN1G 16p12 0.357 0.00514 0.211 response to stimulus;sensory
perception of taste
mut OR5R1 11q12.1 0.357 0.00514 0.211 response to stimulus
xai CCDC144CP 17p11.2 -0.36 0.00514 0.211
xai CDK8 13q12 0.36 0.00515 0.211 Protein Kinases
xai ARID1A 1p35.3 0.36 0.00515 0.211 DNA Damage Response (DDR);
DDR (Chromatin); Tumor Suppressors
his SYP-AS1 0.36 0.00515 0.211
his SYP Xp11.23-p11.22 0.36 0.00515 0.211 endocytosis;synaptic vesicle
maturation
his CLEC11A 19q13.3 0.36 0.00515 0.211 positive regulation of cell
proliferation
exp ATCAY 19p13.3 0.357 0.00515 0.211 transport
exp ANXA2 15q22.2 -0.357 0.00515 0.211 positive regulation of
his KBTBD6 13q14.11 0.36 0.00516 0.211
his LOC101929140 0.36 0.00516 0.211
cop TTC39C 18q11.2 0.357 0.00516 0.211
exp C1orf228 1p34.1 0.357 0.00516 0.211
met HCST 19q13.1 -0.357 0.00516 0.211 regulation of immune response
xai GOLGA8R 0.359 0.00517 0.211
met GOLGA2P5 12q23.1 0.357 0.00517 0.211
mir hsa-miR-20a* 0.357 0.00517 0.211
exp PPFIBP1 12p12.1 -0.357 0.00517 0.211 cell adhesion
his THOC3 5q35.2 0.359 0.00518 0.211 transport;RNA splicing
his NOP14 4p16.3 0.359 0.00518 0.211 endonucleolytic cleavage to
his GRK4 4p16.3 0.359 0.00518 0.211 regulation of G-protein coupled
receptor protein signaling pathway;receptor internalization
mir hsa-miR-18a 0.356 0.00518 0.211
xai RAB13 1q21.2 -0.359 0.00518 0.211 vesicle-mediated
transport;GTP catabolic process
xai PTCD3 2p11.2 0.359 0.00519 0.211
his NANOS1 10q26.11 -0.359 0.00519 0.211 epithelial cell
migration;cell migration
xai WWTR1 3q23-q24 -0.359 0.00519 0.211 regulation of transcription,
xai DDX18P5 11q24.3 0.359 0.0052 0.211
xsq CALML4 15q23 0.356 0.0052 0.211
hs4 PKIG 20q12-q13.1 -0.359 0.0052 0.211 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of protein kinase
activity
xai RUNX2 6p21 -0.359 0.0052 0.211 negative regulation of
xai FAR2 12p11.22 0.359 0.00521 0.212 ether lipid biosynthetic
xai RPL29P7 1q24.2 0.359 0.00521 0.212
xai MIS18A 21q22.11 0.359 0.00521 0.212 nucleosome assembly;cell
cycle
xsq WDR4 21q22.3 0.356 0.00521 0.212 tRNA modification
his SLFN12 17q12 -0.359 0.00521 0.212
exp DDX18P5 11q24.3 0.359 0.00522 0.212
xai RNU5B-2P 3p22.1 0.359 0.00522 0.212
his HPDL 1p34.1 0.359 0.00522 0.212 aromatic amino acid family
metabolic process
exp PARVA 11p15.3 -0.356 0.00522 0.212 cell projection
cop ESCO1 18q11.2 0.356 0.00523 0.212 regulation of DNA replication;cell
cycle
xai BAIAP2 17q25 -0.359 0.00523 0.212 insulin receptor signaling
xai RPL12P33 12q24.31 0.359 0.00524 0.212
hs4 TMEM156 4p14 0.359 0.00524 0.212
xsq SEPT11 4q21.1 -0.356 0.00524 0.212 cell cycle;protein
xsq LOC729970 1p21.3 -0.356 0.00524 0.212
exp RNU5B-2P 3p22.1 0.359 0.00525 0.213
xai KDELR2 7p22.1 -0.359 0.00525 0.213 vesicle-mediated
transport;protein retention in ER lumen
hs4 SAPCD2 9q34.3 0.359 0.00526 0.213
his CYSLTR1 Xq13.2-q21.1 0.359 0.00526 0.213 respiratory gaseous
exchange;positive regulation of vasoconstriction
his CRTC3-AS1 0.359 0.00526 0.213
his BLM 15q26.1 0.359 0.00526 0.213 DNA Damage Response (DDR); DDR (FA)
xsq ZSCAN5A 19q13.43 0.356 0.00526 0.213 viral reproduction
xsq RHOU 1q42.11-q42.3 0.356 0.00526 0.213 G1/S transition of mitotic
cell cycle;cytoskeleton organization
exp ADAM22 7q21 0.356 0.00526 0.213 proteolysis;negative regulation of
cell adhesion
exp PARD3B 2q33.3 -0.356 0.00526 0.213 cell division;cell cycle
xai TRAP1 16p13.3 0.359 0.00527 0.213 Apoptosis
exp TIA1 2p13 0.356 0.00527 0.213 Apoptosis
his PDCD4-AS1 10q25.2 0.359 0.00528 0.213
his PDCD4 10q24 0.359 0.00528 0.213 Apoptosis
exp IKZF5 10q26 0.356 0.00528 0.213 regulation of transcription, DNA-
dependent"
cop GATA6 18q11.1-q11.2 0.356 0.00528 0.213 pancreatic A cell
differentiation;response to toxin
mir hsa-miR-151-5p -0.356 0.00528 0.213
hs4 EMP2 16p13.2 -0.359 0.00528 0.213 cell proliferation
hs4 COLQ 3p25 0.359 0.00529 0.213 acetylcholine catabolic process in
synaptic cleft;asymmetric protein localization
exp PWP2 21q22.3 0.356 0.00529 0.213 signal transduction
met CYP51A1 7q21.2 0.356 0.00529 0.213 cholesterol biosynthetic
process;xenobiotic metabolic process
exp RPLP0P3 14q13.2 0.356 0.00529 0.213
exp MIEF2 -0.356 0.00529 0.213 mitochondrion organization
hs4 HRCT1 9p13.3 -0.359 0.00529 0.213
hs4 LINC00961 9p13.3 -0.359 0.00529 0.213
xsq THAP11 16q22.1 0.356 0.0053 0.213 regulation of transcription,
DNA-dependent"
exp RPS12P9 4q13.1 0.356 0.0053 0.213
mut BDKRB2 14q32.1-q32.2 0.356 0.0053 0.213 inflammatory
response;arachidonic acid secretion
exp TMIGD2 19p13.3 0.356 0.0053 0.213
exp PLOD2 3q24 -0.356 0.0053 0.213 response to hypoxia;protein
xai LEP 7q31.3 -0.358 0.00531 0.214 regulation of protein
phosphorylation;female pregnancy
hs4 PTPN14 1q32.2 -0.358 0.00531 0.213
his ST8SIA4 5q21 0.358 0.00532 0.214 oligosaccharide metabolic
swa EXOSC6 16q22.1 0.358 0.00532 0.214 DNA deamination;nuclear-
transcribed mRNA catabolic process, deadenylation-dependent decay
xsq PRKCQ 10p15 0.355 0.00532 0.214 Protein Kinases
exp RPL23AP49 0.355 0.00532 0.214
his OSBPL3 7p15 -0.358 0.00532 0.214 transport;lipid transport
exp RPL12P33 12q24.31 0.358 0.00533 0.214
xai DCK 4q13.3-q21.1 0.358 0.00533 0.214 purine base metabolic
process;deoxycytidine metabolic process
exp RANP8 0.358 0.00533 0.214
xai ILF3-AS1 19p13.2 0.358 0.00533 0.214
xai CHGB 20p12.3 0.358 0.00533 0.214
xsq LINC01237 0.355 0.00533 0.214
exp NRBP2 8q24.3 -0.355 0.00533 0.214 negative regulation of neuron
apoptosis;protein phosphorylation
exp CORO2B 15q23 -0.355 0.00533 0.214 actin cytoskeleton
organization
DNA-dependent;RNA splicing"
xsq ARHGAP19-SLIT1 0.355 0.00534 0.214
met INADL 1p31.3 0.355 0.00534 0.214 intracellular signal
transduction;cell-cell junction organization
exp RAB5B 12q13 -0.355 0.00534 0.214 small GTPase mediated signal
exp SDSL 12q24.13 -0.355 0.00534 0.214 cellular amino acid metabolic
process
exp RPS20P1 21q22.12 0.358 0.00535 0.214
xai SUPT16H 14q11.2 0.358 0.00535 0.214 transcription from RNA
exp RPL7AP73 0.358 0.00535 0.214
cop SNRPD1 18q11.2 0.355 0.00535 0.214 ncRNA metabolic
mut CEP152 15q21.1 0.355 0.00535 0.214 G2/M transition of mitotic
xai HFE 6p21.3 -0.358 0.00535 0.214 female pregnancy;antigen
xai RPS20P1 21q22.12 0.358 0.00536 0.214
xsq PWP2 21q22.3 0.355 0.00536 0.214 signal transduction
met SHARPIN 8q24.3 0.355 0.00536 0.214 mitochondrion
organization;protein homooligomerization
xsq APP 21q21.3 -0.355 0.00536 0.214 Apoptosis
exp CPQ 8q22.2 -0.355 0.00536 0.214 proteolysis;peptide metabolic
process
met ALOX5AP 13q12 -0.355 0.00536 0.214 leukotriene production
involved in inflammatory response;leukotriene biosynthetic process
swa EEF1A2 20q13.3 0.358 0.00537 0.214 translation;anti-apoptosis
xsq DOCK11 Xq24 0.355 0.00537 0.214 blood coagulation;regulation of
catalytic activity
mut ATP13A4 3q29 0.355 0.00537 0.214 cation transport;ATP biosynthetic
process
xsq LOC101928043 0.355 0.00537 0.214
swa CAST 5q15 -0.358 0.00537 0.214 negative regulation of
swa PPP1R14B 11q13 0.358 0.00538 0.214 regulation of phosphorylation
xai RPS17 0.358 0.00539 0.215 nuclear-transcribed mRNA catabolic
exp PDLIM2 8p21.3 -0.355 0.00539 0.215
his U2AF1 21q22.3 0.358 0.0054 0.215 Oncogenes
hs4 OR4D1 0.358 0.0054 0.215
hs4 MSX2P1 0.358 0.0054 0.215
xai C10orf2 10q24 0.358 0.0054 0.215 DNA replication;mitochondrial DNA
replication
met NPAS2 2q11.2 0.355 0.0054 0.215 regulation of transcription, DNA-
dependent;central nervous system development
exp MGST3 1q23 -0.355 0.0054 0.215 signal transduction;leukotriene
swa GNG12 1p31.3 -0.358 0.0054 0.215 signal transduction;G-protein
xai RPSAP8 Xq22.1 0.358 0.00541 0.215
exp LIME1 20q13.3 0.355 0.00541 0.215 regulation of release of
met AKR7A2 1p36.13 0.355 0.00541 0.215 carbohydrate metabolic
process;cellular aldehyde metabolic process
xai SNRNP48 6p24.3 0.358 0.00542 0.215 mRNA processing;RNA splicing
xsq PTPN2 18p11.3-p11.2 0.355 0.00542 0.215 protein
xsq SNRPD1 18q11.2 0.355 0.00542 0.215 ncRNA metabolic
xsq THNSL1 10p12.1 0.355 0.00542 0.215 threonine biosynthetic
process
his AGAP7P 0.358 0.00543 0.215 regulation of ARF GTPase activity
xai CSNK2A2 16q21 0.358 0.00543 0.215 Protein Kinases
xai GAPDHP26 9q31.1 0.358 0.00543 0.215
mut FCAR 19q13.42 0.355 0.00543 0.215 immune response
exp RPLP0 12q24.2 0.355 0.00543 0.215 SRP-dependent cotranslational
protein targeting to membrane;cellular protein metabolic process
his LOC729296 20q13.33 0.357 0.00544 0.216
xsq NFIB 9p24.1 -0.355 0.00544 0.216 negative regulation of cell
xai DBH-AS1 0.357 0.00545 0.216
exp ADRBK2 22q12.1 0.355 0.00545 0.216 protein
xai MYO10 5p15.1-p14.3 -0.357 0.00545 0.216 axon guidance;regulation
of cell shape
hs4 ADAMTS15 11q25 -0.357 0.00545 0.216 proteolysis
xai ITGB3BP 1p31.3 0.357 0.00546 0.216 Apoptosis
his PPP2R3A 3q22.1 -0.357 0.00546 0.216 protein
dephosphorylation
his MED12 Xq13 0.357 0.00547 0.216 Oncogenes
xai GTPBP3 19p13.11 0.357 0.00547 0.216 tRNA modification
exp HNRNPA1P40 11q13.4 0.357 0.00547 0.216
mut GRIK4 11q22.3 0.354 0.00547 0.216 transport;ion transport
exp PRMT7 16q22.1 0.354 0.00547 0.216 spliceosomal snRNP assembly;histone
his C20orf197 20q13.33 0.357 0.00548 0.217
xai HNRNPA1P40 11q13.4 0.357 0.00548 0.217
exp NDUFA9 12p13.3 0.354 0.00548 0.216 mitochondrial electron
xai MBOAT2 2p25.1 -0.357 0.00548 0.216 phospholipid
xai PRKRIRP8 1q43 0.357 0.00549 0.217
xai NUDT8 11q13.2 0.357 0.00549 0.217
xai RPS4XP10 8q22.1 0.357 0.00549 0.217
xsq CYP27B1 12q14.1 0.354 0.00549 0.217 negative regulation of
calcidiol 1-monooxygenase activity;response to tumor necrosis factor
exp RPS4XP10 8q22.1 0.357 0.0055 0.217
exp LOC729998 7q33 0.354 0.0055 0.217
exp EXOSC9 4q27 0.354 0.00551 0.217 RNA processing;nuclear
polyadenylation-dependent rRNA catabolic process
mir hsa-miR-106a 0.354 0.00551 0.217
exp APELA 0.354 0.00551 0.217
xsq CPSF3 2p25.1 0.354 0.00551 0.217 nuclear mRNA splicing, via
xai COL4A2 13q34 -0.357 0.00551 0.217 transcription, DNA-
dependent;axon guidance
xai PAGR1 16p11.2 0.357 0.00552 0.217
his LOC728739 12q23.3 0.357 0.00552 0.217
xsq ARHGEF12 11q23.3 -0.354 0.00552 0.217 nerve growth factor
swa PPIC 5q23.2 -0.357 0.00552 0.217 protein folding;signal
transduction
xai S100A16 1q21 -0.357 0.00552 0.217 response to calcium ion
his PTPN2 18p11.3-p11.2 0.357 0.00553 0.217 protein
xai LINC00528 22q11.21 0.357 0.00553 0.217
exp SUPT16H 14q11.2 0.354 0.00553 0.217 transcription from RNA
exp TCP1P3 12p12.2 0.354 0.00553 0.217
swa ACAD9 3q21.3 -0.357 0.00553 0.217
hs4 PRKCB 16p11.2 0.357 0.00554 0.218 Protein Kinases
met MIR100 -0.354 0.00554 0.218
xai FOXD2-AS1 1p33 0.357 0.00555 0.218
his LOC101927166 0.357 0.00555 0.218
xsq DDX11-AS1 0.354 0.00555 0.218
xsq EVA1A 2p12 -0.354 0.00555 0.218
his LOC389199 4p16.1 -0.357 0.00555 0.218
his AFAP1 4p16 -0.357 0.00555 0.218
his TXNDC9 2q11.2 0.357 0.00556 0.218 cell redox homeostasis
his EIF5B 2q11.2 0.357 0.00556 0.218 translation;translational
initiation
his PPP2R5C 14q32.31 0.357 0.00556 0.218 protein processing;DNA damage
response, signal transduction by p53 class mediator resulting in induction of
apoptosis
DNA-dependent"
met TMEM136 11q23.3 0.354 0.00556 0.218
exp RALB 2q14.2 -0.354 0.00556 0.218 cell cycle;signal
transduction
xai PPARGC1B 5q32 0.357 0.00557 0.218 positive regulation of
xai CXorf21 Xp21.2 0.357 0.00557 0.218
xsq ECEL1 2q37.1 0.354 0.00557 0.218 proteolysis;neuropeptide signaling
pathway
met DGKH 13q14.11 0.354 0.00557 0.218 activation of protein kinase C
activity by G-protein coupled receptor protein signaling pathway;blood coagulation
hs4 EPN2 17p11.2 -0.357 0.00557 0.218 regulation of endocytosis
xai HIST1H1C 6p21.3 0.357 0.00558 0.218 nucleosome
positioning;nucleosome assembly
xai GFI1 1p22 0.357 0.00558 0.218 negative regulation of calcidiol 1-
hs4 LOC100506688 0.356 0.00558 0.218
exp CXorf65 Xq13.1 0.354 0.00558 0.218
exp PTPN1 20q13.1-q13.2 -0.354 0.00558 0.218 regulation of
endocytosis;regulation of type I interferon-mediated signaling pathway
xai LOX 5q23.2 -0.357 0.00558 0.218 response to steroid hormone
stimulus;blood vessel development
xai FAM160A1 4q31.3 -0.357 0.00558 0.218
his NDUFB1 14q32.12 0.356 0.00559 0.218 mitochondrial electron
his CPSF2 14q31.1 0.356 0.00559 0.218 gene expression;nuclear mRNA
splicing, via spliceosome
hs4 ATP2A3 17p13.3 0.356 0.00559 0.218 transmembrane transport;ATP
met CYB5A 18q23 0.354 0.00559 0.218 electron transport chain;small molecule
metabolic process
xsq B4GALT6 18q11 0.354 0.00559 0.218 post-translational protein
met MYO15B 17q25.1 -0.354 0.00559 0.218
xai GOLGA2 9q34.11 -0.356 0.00559 0.218 positive regulation of
axonogenesis;Golgi localization
his C14orf93 14q11.2 0.356 0.0056 0.218
mir hsa-miR-19a 0.353 0.0056 0.218
xsq MTO1 6q13 0.353 0.0056 0.218 tRNA processing;oxidation-reduction
process
exp PPARGC1B 5q32 0.353 0.0056 0.218 positive regulation of
his SNRPD1 18q11.2 0.356 0.00561 0.218 ncRNA metabolic
his C21orf58 21q22.3 0.356 0.00561 0.218
his PCNT 21q22.3 0.356 0.00561 0.218 in utero embryonic
development;cilium assembly
hs4 DOK2 8p21.3 0.356 0.00561 0.218 signal transduction;cell surface
xai OR52N3P 11p15.4 0.356 0.00562 0.219
xai GINS3 16q21 0.356 0.00562 0.219 DDR (DNA replication)
xsq CD28 2q33 0.353 0.00562 0.219 humoral immune response;negative thymic T
cell selection
xsq HNRNPA1L2 13q14.3 0.353 0.00562 0.219 RNA splicing;mRNA transport
his PSMC3IP 17q21.2 0.356 0.00563 0.219 DNA recombination;meiosis
xai LY86 6p25.1 0.356 0.00563 0.219 apoptotic process;inflammatory
response
his B4GALT3 1q21-q23 0.356 0.00563 0.219 carbohydrate metabolic
process;protein N-linked glycosylation via asparagine
exp CEP128 14q31.1 0.353 0.00563 0.219
exp TXNL4B 16q22.2 0.353 0.00563 0.219 mRNA processing;cell cycle
mut KRTAP13-4 0.353 0.00563 0.219
xsq LAMB2 3p21 -0.353 0.00563 0.219 neuromuscular junction
xsq AFMID 17q25.3 0.353 0.00564 0.219 tryptophan catabolic
xsq ZBED4 22q13.33 0.353 0.00564 0.219
xsq TAF5 10q24-q25.2 0.353 0.00564 0.219 viral reproduction;chromatin
modification
xsq WWTR1 3q23-q24 -0.353 0.00564 0.219 regulation of transcription,
exp EEF1A1P8 3q27.1 0.356 0.00565 0.219
met IL11 19q13.3-q13.4 0.353 0.00565 0.219 positive regulation of cell
proliferation;negative regulation of hormone secretion
met HELB 12q14.3 0.353 0.00565 0.219 DNA Damage Response (DDR)
cop CABYR 18q11.2 0.353 0.00565 0.219 signal transduction;sperm
capacitation
xsq SIVA1 14q32.33 0.353 0.00565 0.219 Apoptosis
exp TCEAL5 Xq22.1 -0.353 0.00565 0.219 regulation of
xai CASP8AP2 6q15 0.356 0.00566 0.219 Apoptosis
exp TBX10 11q13.2 0.356 0.00566 0.219 anatomical structure
xai CD7 17q25.2-q25.3 0.356 0.00566 0.219 homeostasis of number of
exp RPL21P19 0.356 0.00566 0.219
exp DDX12P 12p13.31 0.356 0.00566 0.219 nucleobase-containing
exp RPS28P5 2p13.1 0.353 0.00566 0.219
exp CKAP4 12q23.3 -0.353 0.00566 0.219
xai GRAP 17p11.2 0.356 0.00567 0.219 Ras protein signal
xai KDELR3 22q13.1 -0.356 0.00567 0.219 protein retention in ER
response
xai POLR1B 2q13 0.356 0.00568 0.219 transcription elongation from RNA
xai PINX1 8p23 0.356 0.00568 0.219 DNA Damage Response (DDR)
hs4 MTERF2 -0.356 0.00568 0.219 regulation of transcription,
DNA-dependent;transcription, DNA-dependent"
his KHK 2p23.3 0.356 0.00569 0.219 response to sucrose
stimulus;response to glucose stimulus
xsq SLIT1 10q23.3-q24 0.353 0.00569 0.219 nervous system development;retinal
ganglion cell axon guidance
mut ADH6 4q23 0.353 0.00569 0.22 ethanol oxidation;xenobiotic metabolic
process
exp RHBDF1 16p13.3 -0.353 0.00569 0.22 regulation of
proteasomal protein catabolic process;proteolysis
xai RGL4 22q11.23 0.356 0.0057 0.22 small GTPase mediated signal
transduction
exp PRMT5 14q11.2 0.353 0.0057 0.22 regulation of transcription, DNA-
xsq PINX1 8p23 0.353 0.0057 0.22 DNA Damage Response (DDR)
xai COL4A1 13q34 -0.356 0.0057 0.22 epithelial cell
xai IGSF10 3q25.1 0.356 0.00571 0.22 multicellular organismal
xai NOL10 2p25.1 0.356 0.00571 0.22
hs4 LIMD2 17q23.3 0.356 0.00571 0.22
hs4 LOC729683 17q23.3 0.356 0.00571 0.22
exp CDK8 13q12 0.353 0.00571 0.22 Protein Kinases
mut PDILT 16p12.3 0.353 0.00571 0.22
his LOC101928042 0.356 0.00572 0.22
his ARHGAP11A 15q13.2 0.356 0.00572 0.22 signal transduction;small
mut RBFOX1 16p13.3 0.353 0.00572 0.22 mRNA processing;RNA splicing
xsq FAM135A 6q13 0.353 0.00572 0.22
hs4 MMP23B 1p36.3 0.355 0.00573 0.22 Apoptosis
xai SEH1L 18p11.21 0.355 0.00573 0.22 mitotic prometaphase;protein
transport
exp PIK3CG 7q22.3 0.353 0.00573 0.22 Apoptosis; Cell Signaling;
met LGMN 14q32.1 0.353 0.00573 0.22 response to acid;proteolysis
swa CRIP2 14q32.3 -0.355 0.00573 0.22 positive regulation of cell
proliferation;hemopoiesis
exp RPS27P23 0.355 0.00574 0.22
xai ADRBK2 22q12.1 0.355 0.00574 0.22 protein
xsq GIMAP6 0.353 0.00574 0.22
exp BMPR2 2q33-q34 -0.352 0.00574 0.22 transmembrane receptor
protein serine/threonine kinase signaling pathway;negative regulation of cell
growth
xai EXOSC9 4q27 0.355 0.00575 0.22 RNA processing;nuclear
xai RPS27P23 0.355 0.00575 0.221
exp RPL7AP38 7p15.2 0.352 0.00575 0.22
met KLF15 3q21.3 0.352 0.00575 0.221 glial cell differentiation;glucose
transport
xai GABPB1 15q21.2 0.355 0.00576 0.221 positive regulation of
xai SH2D1A Xq25 0.355 0.00576 0.221 humoral immune response;cellular
defense response
hs4 ZNF112 -0.355 0.00577 0.221 regulation of transcription,
DNA-dependent"
exp HNRNPA1P18 0.355 0.00578 0.221
xai PRKRIR 11q13.5 0.355 0.00578 0.221 response to stress;signal
transduction
xai RPL12P2 6p21.2 0.355 0.00578 0.221
xsq LIN28B 6q21 0.352 0.00578 0.221 miRNA catabolic process;gene
silencing by RNA
exp CLPX 15q22.31 0.352 0.00578 0.221 ATP catabolic process;protein
folding
exp VLDLR 9p24 -0.352 0.00578 0.221 nervous system development;cerebral
cortex development
xai LATS2 13q11-q12 -0.355 0.00578 0.221 protein
phosphorylation;negative regulation of cyclin-dependent protein kinase activity
xai RAC3 17q25.3 0.355 0.00579 0.221 actin cytoskeleton
organization;neuron projection development
xai AKAP1 17q22 0.355 0.00579 0.221 Apoptosis
xai MYCBP2 13q22 0.355 0.00579 0.221 regulation of transcription, DNA-
dependent;branchiomotor neuron axon guidance
xsq CCDC180 0.352 0.00579 0.221
met NLRP11 19q13.43 0.352 0.00579 0.221 oxidation-reduction process
xai RPL7AP12 20p13 0.355 0.0058 0.221
met MIB2 1p36.33 0.352 0.0058 0.221 signal transduction;Notch signaling
pathway
met TTC23L 5p13.2 0.352 0.0058 0.221
exp GRB2 17q24-q25 0.352 0.0058 0.221 cell-cell signaling;T cell
costimulation
xai PPP1R3B 8p23.1 -0.355 0.0058 0.221 carbohydrate metabolic
process;glycogen metabolic process
xai DZIP1L 3q22.3 -0.355 0.0058 0.221
xai EEF1A1P29 Xq21.2 0.355 0.00581 0.221
xai MEN1 11q13 0.355 0.00581 0.221 DNA Damage Response (DDR); Tumor
Suppressors
exp HIRIP3 0.352 0.00581 0.221 chromatin assembly or disassembly
mut TJP3 19p13.3 0.352 0.00581 0.221 EMT (Epithelial)
exp ZNF692 1q44 0.352 0.00581 0.221 regulation of transcription, DNA-
dependent"
xsq ATP10D 4p12 -0.352 0.00581 0.221 cation transport;ion
xai KLRC4 12p13.2-p12.3 0.355 0.00582 0.221 cellular defense response
exp GVINP1 11p15.4 0.352 0.00582 0.221
mut AASS 7q31.3 0.352 0.00582 0.221 lysine catabolic process;L-lysine
catabolic process
exp ARID1A 1p35.3 0.352 0.00582 0.221 DNA Damage Response (DDR);
met LOC100131496 20q13.12 0.352 0.00582 0.221
mut NFATC2 20q13.2 0.352 0.00582 0.222 response to drug;positive
xai C1orf198 1q42.2 -0.355 0.00582 0.221
xai GCDH 19p13.2 0.355 0.00583 0.222 lysine catabolic process;acyl-CoA
metabolic process
xsq COL4A2 13q34 -0.352 0.00583 0.222 transcription, DNA-
his LINC01146 0.355 0.00584 0.222
his LOC101928791 0.355 0.00584 0.222
exp NUP107 12q15 0.352 0.00584 0.222 mitotic cell cycle;viral
reproduction
xsq KIAA2022 Xq13.3 0.352 0.00584 0.222 S phase of mitotic cell
cycle;base-excision repair, gap-filling
xai PPIC 5q23.2 -0.355 0.00584 0.222 protein folding;signal
transduction
his FCGR1B 0.355 0.00585 0.222
xai TRIM14 9q22.33 0.355 0.00585 0.222
swa MBD3 19p13.3 0.355 0.00585 0.222 negative regulation of
transcription from RNA polymerase II promoter;in utero embryonic development
exp XPO5 6p21.1 0.352 0.00585 0.222 protein export from
exp NIP7P2 3q22.1 0.352 0.00585 0.222
hs4 PC 11q13.4-q13.5 -0.355 0.00585 0.222 carbohydrate metabolic
hs4 FHAD1 1p36.21 -0.355 0.00585 0.222
xai RANP8 0.355 0.00586 0.222
mut TEKT5 16p13.13 0.352 0.00586 0.222 microtubule cytoskeleton
organization
his GCFC2 2p12 0.354 0.00587 0.222 regulation of transcription, DNA-
dependent;negative regulation of transcription, DNA-dependent"
exp GTF3A 13q12.3-q13.1 0.352 0.00587 0.222 gene expression;regulation of
exp HIST2H2AC 1q21.2 0.352 0.00587 0.222 nucleosome assembly
xai TPRKB 2p24.3-p24.1 0.354 0.00588 0.223 protein catabolic process
xai GKAP1 9q21.32 0.354 0.00588 0.223 signal transduction
xsq CD247 1q24.2 0.352 0.00588 0.223 T cell costimulation;interspecies
hs4 RHBDF1 16p13.3 -0.354 0.00588 0.223 regulation of
xai USP32P2 17p11.2 -0.354 0.00588 0.223
his NR1H3 11p11.2 0.354 0.00589 0.223 positive regulation of triglyceride
biosynthetic process;response to progesterone stimulus
his ACP2 11p11.2 0.354 0.00589 0.223 skeletal system
development;lysosome organization
exp PARVG 22q13.31 0.352 0.00589 0.223 cell adhesion;cell-matrix adhesion
pro MCM7_22 0.352 0.00589 0.223
exp RPL7AP10 19p12 0.351 0.00589 0.223
exp DNA2 10q21.3-q22.1 0.351 0.00589 0.223 DNA Damage Response (DDR);
exp ZNF764 16p11.2 0.351 0.00589 0.223 regulation of transcription,
DNA-dependent"
his KIRREL 1q21-q25 -0.354 0.00589 0.223 excretion
exp RPSA 3p22.2 0.354 0.0059 0.223 translational elongation;viral
infectious cycle
xai RPSA 3p22.2 0.354 0.0059 0.223 translational elongation;viral
infectious cycle
exp BEND4 4p13 0.351 0.0059 0.223
xsq NASP 1p34.1 0.351 0.0059 0.223 cell proliferation;protein
transport
xai GBP2 1p22.2 -0.354 0.0059 0.223 immune response;cytokine-
exp PLA2G4E 15q15.1 0.354 0.00591 0.223 phospholipid catabolic
process;lipid catabolic process
his FNDC10 0.354 0.00591 0.223
hs4 SLAMF6 1q23.2 0.354 0.00591 0.223
xsq LOC728554 5q35.3 0.351 0.00591 0.223
exp SNX18 5q11.2 -0.351 0.00591 0.223 protein transport;positive
hs4 MID1 Xp22 -0.354 0.00591 0.223 microtubule cytoskeleton
organization;negative regulation of microtubule depolymerization
xai RPL21P19 0.354 0.00592 0.223
exp NELFA 4p16.3 0.351 0.00592 0.223
xai C16orf54 0.354 0.00593 0.223
exp DHX9P1 13q21 0.354 0.00593 0.223
hs4 PEX5L 3q26.33 0.354 0.00593 0.223 protein import into peroxisome
matrix;regulation of cAMP-mediated signaling
xsq RILPL2 12q24.31 0.351 0.00593 0.223
swa SRM 1p36-p22 0.354 0.00594 0.223 cellular nitrogen compound
xsq KRT73-AS1 0.351 0.00595 0.224
hs4 RASAL3 19p13.12 0.354 0.00596 0.224 signal transduction;positive
exp HNRNPCP8 11q14.2 0.354 0.00596 0.224
xai RPL10AP2 8q11.1 0.354 0.00596 0.224
exp C1orf35 1q42.13 0.351 0.00596 0.224
exp NAF1 4q32.2 0.351 0.00596 0.224 rRNA processing;snRNA pseudouridine
synthesis
exp RPL10AP2 8q11.1 0.354 0.00597 0.224
met IL17RC 3p25.3 0.351 0.00597 0.224
xsq CKAP4 12q23.3 -0.351 0.00597 0.224
xai PGAM5 12q24.33 0.354 0.00599 0.225
his WDR7 18q21.31 0.354 0.00599 0.225
his NKG7 19q13.41 0.354 0.00599 0.225
mut B4GALT1 9p13 0.351 0.00599 0.225 epithelial cell
exp ABCB10 1q42.13 0.351 0.00599 0.225 ABC Transporters
xai BACE1 11q23.2-q23.3 -0.354 0.00599 0.225 proteolysis;membrane
protein ectodomain proteolysis
xai CLPX 15q22.31 0.354 0.006 0.225 ATP catabolic process;protein folding
hs4 NXF3 Xq22 0.354 0.006 0.225 mRNA export from nucleus;transport
xsq LOC642846 12p13.31 0.351 0.006 0.225
xsq CYTIP 2q11.2 0.351 0.006 0.225 regulation of cell adhesion
xsq PTPRJ 11p11.2 -0.351 0.006 0.225 positive regulation of macrophage
chemotaxis;positive regulation of cell adhesion
his PRICKLE2-AS3 -0.354 0.006 0.225
hs4 LRRC70 5q12.1 0.354 0.00601 0.225
hs4 IPO11-LRRC70 0.354 0.00601 0.225
xai PTPN22 1p13.2 0.354 0.00601 0.225 regulation of B cell receptor
his LIN9 1q42.12 0.354 0.00601 0.225 mitotic cell cycle;DNA replication
xsq JAK3 19p13.1 0.351 0.00601 0.225 Oncogenes
exp SGMS2 4q25 -0.351 0.00601 0.225 lipid metabolic
his LOC100507431 -0.354 0.00601 0.225
his UBE2G2 21q22.3 0.354 0.00602 0.225 ubiquitin-dependent protein
catabolic process;ER-associated protein catabolic process
his LINC01424 0.354 0.00602 0.225
xai IGKV1-6 0.353 0.00602 0.225
met NAV2 11p15.1 0.351 0.00602 0.225
swa PSMF1 20p13 0.353 0.00603 0.225 S phase of mitotic cell cycle;apoptotic
process
xai KARS 16q23.1 0.353 0.00603 0.225 tRNA aminoacylation for protein
exp IGKV1-6 0.353 0.00603 0.225
exp ABHD3 18q11.2 0.351 0.00603 0.225
exp ILF2 1q21.3 0.351 0.00603 0.225 positive regulation of
transcription, DNA-dependent;transcription, DNA-dependent
exp MYH9 22q13.1 -0.351 0.00603 0.225 membrane protein ectodomain
proteolysis;actin filament-based movement
hs4 KIF13A 6p23 -0.353 0.00603 0.225 cytokinesis;plus-end-directed
his ADORA2A-AS1 0.353 0.00604 0.225
his UPB1 22q11.2 0.353 0.00604 0.225 nucleobase-containing small
mut RTP5 0.351 0.00604 0.225
exp GKAP1 9q21.32 0.351 0.00604 0.225 signal transduction
exp EXOSC7 3p21.31 0.35 0.00604 0.225 nuclear-transcribed mRNA
catabolic process, deadenylation-dependent decay;rRNA processing
his HNRNPCL1 1p36.21 -0.353 0.00604 0.225
xai RPL7AP31 4q12 0.353 0.00605 0.225
mir hsa-miR-17* 0.35 0.00605 0.225
exp TTC33 5p13.1 0.35 0.00605 0.225
exp IGSF10 3q25.1 0.35 0.00605 0.225 multicellular organismal
exp LOC145694 -0.353 0.00605 0.225
exp EEF1A1P14 1q31.3 0.353 0.00606 0.225
exp PIGF 2p21-p16 0.35 0.00606 0.225 preassembly of GPI anchor in ER
hs4 LAMB2 3p21 -0.353 0.00606 0.225 neuromuscular junction
xai CYBB Xp21.1 0.353 0.00607 0.225 ion transport;oxidation-reduction
process
xai THUMPD2 2p22.1 0.353 0.00607 0.225
exp MIS18A 21q22.11 0.35 0.00607 0.225 nucleosome assembly;cell
cycle
exp MYCBP2 13q22 0.35 0.00607 0.225 regulation of transcription, DNA-
xsq ARHGEF40 14q11.2 -0.35 0.00607 0.225 regulation of Rho protein
signal transduction
xai LOC145694 -0.353 0.00607 0.225
his SNORD17 20p11.23 0.353 0.00608 0.225
his SNX5 20p11 0.353 0.00608 0.225 pinocytosis;cell communication
his MGME1 20p11.23 0.353 0.00608 0.225
exp SMYD5 2p13.2 0.353 0.00608 0.225
exp FOXB1 15q22.2 0.353 0.00608 0.225 urogenital system
development;tissue development
xai LINC00851 -0.353 0.00608 0.225
xai MYH9 22q13.1 -0.353 0.00608 0.225 membrane protein ectodomain
exp LEP 7q31.3 -0.353 0.00608 0.225 regulation of protein
phosphorylation;female pregnancy
xai RPL7AP73 0.353 0.00609 0.225
his TBRG1 11q24.2 0.353 0.00609 0.225 DNA replication;cell cycle
xai PTMAP5 13q31.1 0.353 0.00609 0.225
xsq SEC14L4 22q12.2 0.35 0.00609 0.225
xsq ZADH2 18q22.3 0.35 0.00609 0.225
exp LOC441722 15q14 0.35 0.00609 0.225
hs4 HSPA12A 10q26.12 -0.353 0.00609 0.225
hs4 ENO4 10q25.3 -0.353 0.00609 0.225 glycolysis
his TACO1 17q23.3 0.353 0.0061 0.225 regulation of translation
exp HMGB1P10 22q12.1 0.353 0.0061 0.225
xsq ALOX5AP 13q12 0.35 0.0061 0.225 leukotriene production involved in
inflammatory response;leukotriene biosynthetic process
xai HMGB1P10 22q12.1 0.353 0.00611 0.225
xai THEMIS 6q22.33 0.353 0.00611 0.226 multicellular organismal
development;positive T cell selection
xsq RFWD3 16q23.1 0.35 0.00611 0.225 DNA repair;response to ionizing
radiation
exp ZNF691 1p34.2 0.35 0.00611 0.225
met ARVCF 22q11.21 0.35 0.00611 0.226 cell adhesion;multicellular
exp LINC00851 -0.353 0.00611 0.225
exp BCCIP 10q26.1 0.35 0.00612 0.226 regulation of cyclin-dependent
met ANKRD50 4q28.1 0.35 0.00612 0.226
his TNFAIP8 5q23.1 0.353 0.00613 0.226 Apoptosis
exp SFT2D1 6q27 0.35 0.00613 0.226 protein transport;vesicle-mediated
transport
exp PNPT1 2p15 0.35 0.00613 0.226 mitochondrial mRNA catabolic
process;transport
xai RAB5B 12q13 -0.353 0.00613 0.226 small GTPase mediated signal
exp LIPK 10q23.31 0.353 0.00614 0.226 lipid catabolic process
his SGO1 0.353 0.00614 0.226
exp RPS6KB2 11q13.2 0.35 0.00614 0.226 Apoptosis; Protein Kinases
mir hsa-miR-92a 0.35 0.00614 0.226
mir hsa-miR-92a(2) 0.35 0.00614 0.226
xai TMEM2 9q21.13 -0.353 0.00614 0.226 multicellular organismal
development
xai DHX9P1 13q21 0.353 0.00615 0.226
exp TRGV3 0.353 0.00615 0.226 immune response
xai TRGV3 0.353 0.00615 0.226 immune response
met MYO1E 15q21-q22 0.35 0.00615 0.226 glomerular filtration;nitrogen
compound metabolic process
met NFIB 9p24.1 0.35 0.00615 0.226 negative regulation of cell
exp ITPRIPL2 16p12.3 -0.35 0.00615 0.226
his MIR4506 -0.353 0.00615 0.226
xai E2F8 11p15.1 0.353 0.00616 0.226 cell cycle
exp TANGO6 16q22.1 0.35 0.00616 0.226
cop OSBPL1A 18q11.1 0.35 0.00616 0.226 lipid transport;cholesterol
metabolic process
xai TMEM156 4p14 0.353 0.00617 0.226
xai LMNTD1 0.353 0.00617 0.226 cell proliferation
xsq CCDC144CP 17p11.2 -0.35 0.00617 0.226
exp HSPB1P1 9q21.13 -0.35 0.00617 0.226
xsq NT5E 6q14-q21 -0.35 0.00617 0.226 dephosphorylation;purine base
metabolic process
xai EXT1 8q24.11 -0.353 0.00617 0.226 axon guidance;brain
development
xai NAGS 17q21.31 0.353 0.00618 0.226 urea cycle;glutamate metabolic
process
xai PTPRCAP 11q13.3 0.353 0.00618 0.226 defense response
his MYO15B 17q25.1 0.352 0.00618 0.226
xai GSG2 17p13 0.352 0.00618 0.226 regulation of spindle checkpoint;protein
phosphorylation
mut ZNF143 11p15.4 0.35 0.00618 0.226 gene expression;regulation of
exp LOC100505549 0.35 0.00618 0.226
hs4 NUDT12 5q21.2 -0.353 0.00618 0.226 NADP catabolic
process;NAD catabolic process
his MOB4 2q33.1 0.352 0.00619 0.226 transport
xsq SLC22A31 16q24.3 0.35 0.00619 0.226 ion transport
xsq LINC01058 0.35 0.00619 0.226
xai SPOCK3 4q32.3 0.352 0.0062 0.227 peptide cross-linking via
chondroitin 4-sulfate glycosaminoglycan;signal transduction
hs4 PTPN22 1p13.2 0.352 0.0062 0.227 regulation of B cell receptor
his MIR205HG 1q32.2 -0.352 0.0062 0.227
his MIR205 -0.352 0.0062 0.227
xai PLA2G4E 15q15.1 0.352 0.00621 0.227 phospholipid catabolic
xai RPL6P12 4q32.3-q33 0.352 0.00621 0.227
exp MRPL51 12p13.3-p13.1 0.349 0.00621 0.227 translation
xsq ADRBK1 11q13.1 0.349 0.00621 0.227 G-protein coupled
hs4 SLC4A3 2q36 -0.352 0.00621 0.227 Solute Carriers
his FBXW2 9q34 0.352 0.00622 0.227 proteolysis;protein ubiquitination
his LOC100288842 9q33.2 0.352 0.00622 0.227
hs4 TAGAP 6q25.3 0.352 0.00622 0.227 signal transduction;small GTPase
xai TFB1M 6q25.1-q25.3 0.352 0.00622 0.227 regulation of transcription,
DNA-dependent"
xai ECSIT 19p13.2 0.352 0.00622 0.227 innate immune response;regulation
of oxidoreductase activity
his MOB3A 19p13.3 0.352 0.00622 0.227
his IZUMO4 19p13.3 0.352 0.00622 0.227
xsq ADA 20q13.12 0.349 0.00622 0.227 in utero embryonic
development;negative regulation of mature B cell apoptosis
xsq KIRREL2 19q13.12 0.349 0.00622 0.227 cell adhesion
xsq RAD52 12p13-p12.2 0.349 0.00622 0.227 DNA Damage Response (DDR); DDR (HR)
met RNF130 5q35.3 0.349 0.00622 0.227 Apoptosis
xsq PPARGC1B 5q32 0.349 0.00623 0.227 positive regulation of
xsq REXO4 9q34.2 0.349 0.00623 0.227 regulation of transcription, DNA-
dependent"
xsq ATAD3C 1p36.33 0.349 0.00623 0.227
xai CNN3P1 6p25.1 -0.352 0.00623 0.227
exp RPL6P12 4q32.3-q33 0.352 0.00624 0.227
xai IDH3B 20p13 0.352 0.00624 0.227 tricarboxylic acid cycle;isocitrate
metabolic process
xai SPATA5L1 15q21.1 0.352 0.00624 0.227
xai RPA3 7p22 0.352 0.00624 0.227 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xai ADA 20q13.12 0.352 0.00624 0.227 in utero embryonic
xsq MBLAC2 5q14.3 0.349 0.00624 0.227
cop GREB1L 18q11.2 0.349 0.00624 0.227
xsq TRAT1 3q13 0.349 0.00625 0.227 positive regulation of T cell receptor
signaling pathway;negative regulation of transport
exp SETP8 Xq23 0.352 0.00626 0.227
xai RPUSD1 16p13.3 0.352 0.00626 0.227 pseudouridine synthesis
his CASQ1 1q21 -0.352 0.00626 0.227 response to heat;response to
organic substance
met DNALI1 1p35.1 0.349 0.00627 0.227 cellular component
movement;single fertilization
xsq NKX2-5 5q34 0.349 0.00627 0.227 outflow tract septum
xsq BCL6B 17p13.1 0.349 0.00627 0.227 negative regulation of
exp LAMB1 7q22 -0.349 0.00628 0.227 embryo implantation;positive
exp RPL21P135 -0.352 0.00628 0.227
xai RPL21P135 -0.352 0.00628 0.227
xai RCN1 11p13 -0.352 0.00628 0.227 in utero embryonic
his ADAMTS15 11q25 -0.352 0.00628 0.227 proteolysis
his ROR1-AS1 -0.352 0.00628 0.227
xai XRCC6P2 Xq28 0.352 0.00629 0.227
xai ANKRD30A 10p11.21 0.352 0.00629 0.227 regulation of transcription,
DNA-dependent"
xai GAPDHP44 12q14.2 0.352 0.00629 0.227
xsq FGF17 8p21 0.349 0.00629 0.227 cell-cell signaling;multicellular
exp ZC3H8 2q13 0.349 0.00629 0.227 apoptotic process;negative regulation of
mut ZNF512B 20q13.33 0.349 0.00629 0.227 regulation of transcription,
DNA-dependent"
exp KIF15 3p21.31 0.349 0.00629 0.227 microtubule-based movement;mitosis
met CSGALNACT2 10q11.21 0.349 0.00629 0.227 proteoglycan biosynthetic
process;chondroitin sulfate proteoglycan biosynthetic process
exp ALS2 2q33.1 -0.349 0.00629 0.227 regulation of Rho protein
signal transduction;positive regulation of protein kinase activity
exp CTSB 8p22 -0.349 0.00629 0.227 Apoptosis
hs4 LRIG1 3p14 -0.352 0.00629 0.227
his GPR63 6q16.1-q16.3 0.352 0.0063 0.227
hs4 GRK2 0.352 0.0063 0.228
his CCR4 3p24 0.352 0.0063 0.228 neuron migration;tolerance induction
exp PHBP11 1q41 0.352 0.0063 0.228
his MTERF4 0.352 0.0063 0.228
xai LOC100505920 0.352 0.0063 0.228
xai GRB2 17q24-q25 0.352 0.00631 0.228 cell-cell signaling;T cell
costimulation
his FCER2 19p13.3 0.352 0.00631 0.228 positive regulation of nitric-oxide
synthase biosynthetic process;positive regulation of humoral immune response
mediated by circulating immunoglobulin
exp POLRMTP1 17q23.2 0.349 0.00631 0.228
exp UTRN 6q24 -0.349 0.00631 0.228 positive regulation of cell-matrix
adhesion;muscle contraction
his RFWD3 16q23.1 0.352 0.00632 0.228 DNA repair;response to ionizing
radiation
his MITD1 2q11.2 0.352 0.00632 0.228 protein transport
his MRPL30 2q11.2 0.352 0.00632 0.228 translation
mut SMARCAD1 4q22-q23 0.349 0.00632 0.228 DNA Damage Response (DDR)
DNA-dependent"
exp LSM7 19p13.3 0.349 0.00632 0.228 nuclear mRNA splicing, via
spliceosome;RNA splicing"
xai CD86 3q21 0.352 0.00633 0.228 immune response;positive regulation of
exp NUFIP1P 6q12 0.349 0.00633 0.228
exp TWSG1 18p11.3 -0.349 0.00633 0.228 mesoderm formation;forebrain
development
xai TCEAL5 Xq22.1 -0.352 0.00633 0.228 regulation of
xai VLDLR 9p24 -0.352 0.00633 0.228 nervous system development;cerebral
cortex development
hs4 GLTSCR1 19q13.3 -0.352 0.00633 0.228
xai IGHVIII-47-1 0.351 0.00634 0.228
xai SNORA13 5q22.2 0.351 0.00634 0.228
met GALE 1p36-p35 0.349 0.00634 0.228 carbohydrate metabolic
process;galactose metabolic process
xsq FXN 9q21.11 0.349 0.00634 0.228 mitochondrion organization;protein
autoprocessing
exp RPL7AP43 0.349 0.00634 0.228
his LOC101928505 -0.351 0.00634 0.228
his SDC2 8q22-q23 -0.352 0.00634 0.228 response to hypoxia;response
to caffeine
xai XRCC6BP1 12q14.1 0.351 0.00635 0.228 DNA Damage Response (DDR)
xsq ENOSF1 18p11.32 0.349 0.00635 0.228 cellular amino acid catabolic
process
xsq NAIF1 9q34.11 0.349 0.00635 0.228 apoptotic process;induction of
apoptosis
met UACA 15q22-q24 0.349 0.00635 0.228
exp NUP37 12q23.2 0.349 0.00635 0.228 mitotic cell cycle;cytokine-
xsq LIAS 4p14 0.349 0.00635 0.228 lipoate biosynthetic process;response to
lipopolysaccharide
exp ATP10D 4p12 -0.349 0.00635 0.228 cation transport;ion
exp IGHVIII-47-1 0.351 0.00636 0.228
xai HNRNPA1P18 0.351 0.00636 0.228
exp ILF3-AS1 19p13.2 0.349 0.00636 0.228
hs4 GLP1R 6p21 0.351 0.00637 0.228 positive regulation of cell
proliferation;positive regulation of cell differentiation
exp INTS2 17q23.2 0.348 0.00637 0.228 snRNA processing
exp EEF1A1P1 21q21.1 0.351 0.00638 0.228
xai FAM46C 1p12 0.351 0.00638 0.228
xai POLE 12q24.3 0.351 0.00638 0.228 DNA Damage Response (DDR); DDR
xsq DPEP2 16q22.1 0.348 0.00638 0.228 leukotriene biosynthetic
xsq BCL11B 14q32.2 0.348 0.00638 0.228 regulation of lipid metabolic
exp IDH3B 20p13 0.348 0.00638 0.228 tricarboxylic acid cycle;isocitrate
metabolic process
swa TXNDC17 17p13.1 0.351 0.00639 0.228 tumor necrosis factor-
xai HHEX 10q23.33 0.351 0.00639 0.229 in utero embryonic development;cell
proliferation
hs4 TNFRSF25 1p36.2 0.351 0.00639 0.229 Apoptosis
xsq UBASH3A 21q22.3 0.348 0.00639 0.228 regulation of cytokine
production;negative regulation of T cell receptor signaling pathway
xai ABHD3 18q11.2 0.351 0.0064 0.229
exp GFI1 1p22 0.348 0.0064 0.229 negative regulation of calcidiol 1-
xsq RALGPS2 1q25.2 -0.348 0.0064 0.229 small GTPase mediated
signal transduction
xai BMPR2 2q33-q34 -0.351 0.0064 0.229 transmembrane receptor
growth
exp KCNH4 17q21.2 0.351 0.00641 0.229 regulation of transcription, DNA-
dependent;ion transport
hs4 LOC101928517 0.351 0.00641 0.229
xsq P2RY10 Xq21.1 0.348 0.00641 0.229
xai VPS9D1-AS1 16q24.3 0.351 0.00642 0.229
his DUSP2 2q11 0.351 0.00642 0.229 regulation of apoptotic
exp URGCP 7p13 -0.348 0.00642 0.229 cell cycle
xsq B4GALT1 9p13 -0.348 0.00642 0.229 epithelial cell
exp HIF1A-AS2 -0.351 0.00642 0.229
met ZSCAN25 7q22.1 0.348 0.00643 0.229
exp RPL21P51 4q32.3 0.348 0.00643 0.229
his LOC100506178 -0.351 0.00643 0.229
exp VPS9D1-AS1 16q24.3 0.351 0.00644 0.229
xai PRDM13 6q16.2 0.351 0.00644 0.229 regulation of transcription,
DNA-dependent"
xai FAM26F 6q22.1 0.351 0.00644 0.229
his SLC7A6OS 16q22.1 0.351 0.00644 0.229 Solute Carriers
his PRMT7 16q22.1 0.351 0.00644 0.229 spliceosomal snRNP assembly;histone
exp RPS4XP22 19p13.2 0.351 0.00644 0.229
exp COPZ2 17q21.32 -0.348 0.00644 0.229 intracellular protein
exp CCDC144A -0.351 0.00644 0.229
his SUPT16H 14q11.2 0.351 0.00645 0.229 transcription from RNA
xai UBL5P3 3p14.2 0.351 0.00645 0.229
met FCHO2 5q13.2 0.348 0.00645 0.229
exp TRIP6 7q22 -0.348 0.00645 0.229 cell adhesion;release of
exp KCNQ1OT1 11p15 -0.348 0.00645 0.229
hs4 TCEAL3 Xq22.2 -0.351 0.00645 0.229 regulation of
xai LINC00346 13q34 -0.351 0.00645 0.229
xai SNORA21 17q12 0.351 0.00646 0.229
exp EEF1A1P29 Xq21.2 0.351 0.00646 0.229
met SKIL 3q26 0.348 0.00646 0.229 protein heterotrimerization;cell cycle
arrest
xsq LEPROT 1p31.3 -0.348 0.00646 0.229 negative regulation of
exp THEMIS 6q22.33 0.348 0.00647 0.229 multicellular organismal
xsq PUS10 2p16.1 0.348 0.00647 0.23 pseudouridine synthesis;tRNA
processing
exp TMEM2 9q21.13 -0.348 0.00647 0.229 multicellular organismal
development
xai TSPY26P 20q11.21 0.351 0.00648 0.23 nucleosome assembly
xai COG2 1q42.2 0.351 0.00648 0.23 protein glycosylation;intracellular
protein transport
mut SCLT1 4q28.2 0.348 0.00648 0.23
xsq WDR89 14q23.2 0.348 0.00648 0.23
exp KDELR3 22q13.1 -0.348 0.00648 0.23 protein retention in ER
response
xai COPZ2 17q21.32 -0.351 0.00648 0.23 intracellular protein
xsq GEMIN4 17p13 0.348 0.00649 0.23 RNA metabolic process;ncRNA
metabolic process
xsq CD69 12p13 0.348 0.00649 0.23 cellular response to drug
xsq IKZF5 10q26 0.348 0.00649 0.23 regulation of transcription, DNA-
dependent"
mut MAPRE2 18q12.1 0.348 0.00649 0.23 cell cycle;mitosis
his SAA1 11p15.1 -0.351 0.00649 0.23 acute-phase
response;regulation of protein secretion
his AQP4 18q11.2-q12.1 0.351 0.0065 0.23 transport;water transport
his AQP4-AS1 18q11.2 0.351 0.0065 0.23
his AIP 11q13.3 0.35 0.0065 0.23 regulation of protein kinase A
his MIR6752 0.35 0.0065 0.23
xsq ASUN 12p11.23 0.348 0.0065 0.23 cell cycle;mitosis
xsq CIAPIN1 16q21 0.348 0.0065 0.23 apoptotic process;anti-apoptosis
his PRR14 16p11.2 0.35 0.00651 0.23
exp TCF3 19p13.3 0.348 0.00651 0.23 transcription, DNA-
mir hsa-miR-766 0.348 0.00651 0.23
xai ITFG2 12p13.33 0.353 0.00652 0.23
xai EEF1B2P3 Xp22.11 0.35 0.00652 0.23
xai SMYD5 2p13.2 0.35 0.00652 0.23
exp DNAAF3 19q13.4 0.347 0.00652 0.23
xsq SNX18 5q11.2 -0.348 0.00652 0.23 protein transport;positive
exp EEF1B2P3 Xp22.11 0.35 0.00653 0.23
exp HS3ST4 16p11.2 0.347 0.00653 0.23 heparan sulfate proteoglycan
metabolic process
exp PAGR1 16p11.2 0.347 0.00653 0.23
hs4 LGALS3BP 17q25 -0.35 0.00653 0.23 cellular defense response;cell
adhesion
hs4 LOC101929705 0.35 0.00654 0.23
met ITCH 20q11.22 0.347 0.00654 0.23 protein ubiquitination;innate
immune response
xsq PDCD2L 19q13.11 0.347 0.00654 0.23 cell cycle
swa THBS1 15q15 -0.35 0.00654 0.23 sprouting angiogenesis;immune response
xsq SNHG10 14q32.13 0.347 0.00655 0.231
his LOC101928896 0.35 0.00656 0.231
exp POLE 12q24.3 0.347 0.00656 0.231 DNA Damage Response (DDR); DDR
mut RP1L1 8p23.1 0.347 0.00656 0.231 cell projection
organization;intracellular signal transduction
exp CYBB Xp21.1 0.347 0.00656 0.231 ion transport;oxidation-reduction
process
exp EEF1A1P16 12p12.3 0.35 0.00657 0.231
met ITPRIPL2 16p12.3 0.347 0.00657 0.231
met ZP1 11q12.2 -0.347 0.00657 0.231 single fertilization
xsq LOC100506127 0.347 0.00658 0.231
xai C14orf80 14q32.33 0.35 0.00659 0.231
hs4 GIMAP6 0.35 0.00659 0.231
his NLRC4 2p22-p21 0.35 0.00659 0.231 Apoptosis
exp ARHGAP15 2q22.2-q22.3 0.347 0.00659 0.231 regulation of small
exp KDELR2 7p22.1 -0.347 0.00659 0.231 vesicle-mediated
his PHIP 6q14 0.35 0.0066 0.232 DDR (DNA replication)
exp NPW 16p13.3 0.347 0.0066 0.231 G-protein coupled receptor
xsq CAMKMT 2p21 0.347 0.0066 0.231
xsq CPQ 8q22.2 -0.347 0.0066 0.231 proteolysis;peptide metabolic
process
xai NDUFAB1 16p12.2 0.35 0.00661 0.232 respiratory electron
hs4 LINC01305 0.35 0.00661 0.232
his KLK2 19q13.41 0.35 0.00661 0.232 proteolysis
exp CEP85 1p36.11 0.347 0.00661 0.232
his TERT 5p15.33 0.35 0.00662 0.232 DNA Damage Response (DDR)
xsq PAGR1 16p11.2 0.347 0.00662 0.232
his MCM3 6p12 0.35 0.00663 0.232 DDR (DNA replication)
xsq MUTYH 1p34.1 0.347 0.00663 0.232 DNA Damage Response (DDR); DDR
(BER)
exp NFATC1 18q23 0.347 0.00663 0.232 transcription from RNA polymerase
exp FAM86C1 11q13.4 0.347 0.00663 0.232
exp PPP1CC 12q24.1-q24.2 0.347 0.00663 0.232 carbohydrate metabolic
xai EEF1A1P14 1q31.3 0.35 0.00664 0.232
exp GAPDHP44 12q14.2 0.35 0.00664 0.232
his DNA2 10q21.3-q22.1 0.35 0.00664 0.232 DNA Damage Response (DDR);
xsq NLE1 17q12 0.347 0.00664 0.232 inner cell mass cell
swa FAF2 5q35.2 -0.35 0.00664 0.232 response to unfolded protein
xai MYL9 20q11.23 -0.35 0.00664 0.232 axon guidance;muscle contraction
xai PECAM1 17q23.3 0.35 0.00665 0.232 platelet
degranulation;diapedesis
his TNFSF8 9q33 0.35 0.00665 0.232 cell-cell signaling;cell
proliferation
xsq C20orf196 20p12.3 0.347 0.00665 0.232
xsq RAB39B Xq28 0.347 0.00665 0.232 synapse organization;small GTPase
met PTPRC 1q31-q32 -0.347 0.00665 0.232 protein
exp DGCR2 22q11.21 -0.347 0.00665 0.232 cell adhesion;organ
morphogenesis
xai CCDC144A -0.35 0.00665 0.232
exp WASH1 0.35 0.00666 0.232 transport;endosome transport
his C6orf89 6p21.2 0.35 0.00666 0.232 wound healing;positive
regulation of cell cycle
his PPIL1 6p21.1 0.35 0.00666 0.232 nuclear mRNA splicing, via
spliceosome;protein folding
xai RHBDF1 16p13.3 -0.35 0.00666 0.232 regulation of proteasomal
protein catabolic process;proteolysis
xai UBTD1 10q24.2 -0.35 0.00666 0.232
his MST1 3p21 0.349 0.00667 0.232
his RNF123 3p24.3 0.349 0.00667 0.232
xai GTF3A 13q12.3-q13.1 0.349 0.00667 0.232 gene expression;regulation of
xsq NANP 20p11.1 0.347 0.00667 0.232 carbohydrate metabolic
xsq BLMH 17q11.2 0.347 0.00667 0.232 protein polyubiquitination;antigen
exp SPNS3 17p13.2 0.347 0.00667 0.232 lipid transport;transmembrane
transport
exp RPL10P16 19p13.2 0.347 0.00667 0.232
hs4 IL6 7p21 -0.349 0.00667 0.232 Apoptosis
hs4 LOC541472 7p21 -0.349 0.00667 0.232
his GPN3 12q24.11 0.349 0.00668 0.232
his FAM216A 12q24.11 0.349 0.00668 0.232
xai MRPL51 12p13.3-p13.1 0.349 0.00668 0.232 translation
his NOB1 16q22.3 0.349 0.00668 0.232
xsq CXorf21 Xp21.2 0.347 0.00668 0.232
xsq KLHL8 4q22.1 0.347 0.00668 0.232
exp PXN 12q24.31 -0.347 0.00668 0.232 cell adhesion;focal adhesion
assembly
his COG4 16q22.1 0.349 0.00669 0.232 Golgi vesicle prefusion complex
stabilization;retrograde vesicle-mediated transport, Golgi to ER
his SF3B3 16q22.1 0.349 0.00669 0.232 RNA splicing, via
his SNORD111B 0.349 0.00669 0.232
exp BCL11B 14q32.2 0.346 0.00669 0.232 regulation of lipid metabolic
xsq VAV3-AS1 0.346 0.00669 0.232
exp CD28 2q33 0.346 0.00669 0.232 humoral immune response;negative thymic T
cell selection
xsq FAM86EP 4p16.3 0.346 0.00669 0.232
exp C17orf96 17q12 0.346 0.00669 0.232
exp PPDPF 20q13.33 -0.346 0.00669 0.232 multicellular organismal
swa CALU 7q32.1 -0.349 0.00669 0.232 platelet activation;platelet
degranulation
exp NDC1 1p32.3 0.346 0.0067 0.232
swa HCLS1 3q13 0.349 0.00671 0.232 regulation of transcription, DNA-
his ATP2A1 0.349 0.00671 0.232 cation transport;ion transmembrane
transport
his ATP2A1-AS1 0.349 0.00671 0.232
his LILRA2 19q13.4 0.349 0.00671 0.232 defense response;signal
transduction
met FAXC 6q16.2 0.346 0.00671 0.232
exp TBC1D10C 11q13.2 0.346 0.00671 0.232
exp RNASE6 14q11.2 0.346 0.00671 0.232 RNA catabolic process;defense
response
xsq ZNF80 3q13.3 0.346 0.00671 0.232 regulation of transcription, DNA-
dependent"
xsq LOC100287015 8p23.1 0.346 0.00672 0.232
met CST3 20p11.21 0.346 0.00672 0.232 salivary gland development;negative
regulation of histolysis
xsq KARS 16q23.1 0.346 0.00672 0.232 tRNA aminoacylation for protein
exp TCTN2 12q24.31 -0.349 0.00672 0.232 cell projection
organization;cilium assembly
exp PRKRIRP8 1q43 0.349 0.00673 0.232
xai NFATC1 18q23 0.349 0.00673 0.232 transcription from RNA polymerase
xsq RSL1D1 16p13.13 0.346 0.00673 0.232 translation;regulation of
exp RPL21P93 10p12.1 0.346 0.00673 0.232
exp SEC11C 18q21.32 0.346 0.00673 0.232 small molecule metabolic
process;energy reserve metabolic process
exp HOMER3 19p13.11 -0.346 0.00673 0.232 protein targeting;G-
protein coupled glutamate receptor signaling pathway
xsq LPP 3q28 -0.346 0.00673 0.232 cell adhesion
swa PEA15 1q21.1 -0.349 0.00673 0.232 transport;anti-apoptosis
hs4 LRRC4C 11p12 -0.349 0.00673 0.232 regulation of axonogenesis
xai OR1N1 9q33.2 0.349 0.00674 0.232 response to stimulus
hs4 GPR55 2q37 0.349 0.00674 0.232 G-protein coupled receptor signaling
exp HMGB1P11 0.349 0.00674 0.232
xai HSPB1P1 9q21.13 -0.349 0.00674 0.232
his POLR2D 2q21 0.349 0.00675 0.233 DNA Damage Response (DDR); DDR
(NER)
xai EEF1A1P16 12p12.3 0.349 0.00675 0.233
his GPR19 12p12.3 0.349 0.00675 0.233 G-protein coupled receptor
signaling pathway
xsq LSM11 5q33.3 0.346 0.00675 0.233 histone mRNA 3'-end
swa ECHS1 10q26.2-q26.3 -0.349 0.00675 0.233 fatty acid metabolic
process;fatty acid beta-oxidation
met GPR55 2q37 -0.346 0.00676 0.233 G-protein coupled receptor
signaling pathway;activation of phospholipase C activity
xsq NPC2 14q24.3 -0.346 0.00676 0.233 phospholipid
xai TLR5 1q41-q42 -0.349 0.00676 0.233 cellular response to
xai HIF1A-AS2 -0.349 0.00676 0.233
his MBNL2 13q32.1 -0.349 0.00676 0.233 mRNA processing;regulation of
RNA splicing
exp OR1N1 9q33.2 0.349 0.00677 0.233 response to stimulus
his NDUFS7 19p13.3 0.349 0.00677 0.233 transport;respiratory
electron transport chain
exp ATP5A1P3 16q22.2 0.349 0.00677 0.233
xsq LOC100505920 0.346 0.00677 0.233
exp RPS21 20q13.3 0.346 0.00677 0.233 endonucleolytic cleavage in ITS1 to
separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript
(SSU-rRNA, 5.8S rRNA, LSU-rRNA);viral reproduction
DNA-dependent"
exp SRGAP1 12q14.2 -0.346 0.00677 0.233 signal
swa LGALS3BP 17q25 -0.349 0.00677 0.233 cellular defense
exp SCARNA10 12p13.31 0.349 0.00678 0.233
xai SCARNA10 12p13.31 0.349 0.00678 0.233
xai RPRD1A 18q12.2 0.349 0.00678 0.233 dephosphorylation of RNA
pro EP300_12_26542 0.346 0.00678 0.233
xsq NHLRC4 16p13.3 0.346 0.00678 0.233
xsq TPTE2P5 0.346 0.00678 0.233
xsq FAM114A1 4p14 -0.346 0.00678 0.233
xai WSB2 12q24.23 -0.349 0.00678 0.233 intracellular signal
transduction
xai SETP8 Xq23 0.349 0.00679 0.233
exp RPF2 6q21 0.346 0.00679 0.233
xsq CEBPE 14q11.2 0.346 0.00679 0.233 cellular response to
lipopolysaccharide;phagocytosis
exp RAB13 1q21.2 -0.346 0.00679 0.233 vesicle-mediated
exp LOC391020 1p36.11 -0.346 0.00679 0.233
hs4 SPN 16p11.2 0.349 0.0068 0.233 negative regulation of type IV
hypersensitivity;blood coagulation
his M6PR 12p13 0.349 0.0068 0.233 transport;receptor-mediated endocytosis
his KLRG1 12p13.31 0.349 0.0068 0.233 inflammatory response;cellular
defense response
xai PPP1CC 12q24.1-q24.2 0.349 0.0068 0.233 carbohydrate metabolic
pro JAK1_6 0.346 0.0068 0.233
exp CAMSAP2 1q32.1 -0.346 0.0068 0.233
hs4 KCNQ1OT1 11p15 -0.349 0.0068 0.233
xai PRKCQ-AS1 10p14 0.349 0.00681 0.233
xai MRPL18 6q25.3 0.349 0.00681 0.233 translation;transport
xsq KLRC3 12p13 0.346 0.00681 0.233 cellular defense response
xsq MYCNOS 2p24.1 0.346 0.00681 0.233
exp IMP3 15q24 0.346 0.00681 0.233 rRNA processing
swa BOLA2 16p11.2 0.349 0.00682 0.233
his IKZF1 7p12.2 0.349 0.00682 0.233 mesoderm development;positive
his FCHSD2 11q13.4 0.349 0.00682 0.233
xai SFT2D1 6q27 0.349 0.00682 0.233 protein transport;vesicle-mediated
transport
xsq GBAT2 0.346 0.00682 0.233
mut KRAS 12p12.1 0.346 0.00682 0.233 Cell Signaling; Oncogenes; Protein
Kinases
exp HIST1H1C 6p21.3 0.349 0.00683 0.233 nucleosome
xai IMMT 2p11.2 0.349 0.00683 0.233
exp ALG10B 12q12 0.346 0.00684 0.233 dolichol-linked oligosaccharide
xsq C2CD4C 19p13.3 0.346 0.00684 0.233
hs4 PTK2 8q24.3 -0.348 0.00684 0.233 Apoptosis
xai GAPDHP25 2p22.2 0.348 0.00685 0.233
met ENTPD8 9q34.3 0.346 0.00685 0.233 nucleoside monophosphate
biosynthetic process;nucleoside diphosphate biosynthetic process
xsq SPTLC3 20p12.1 -0.346 0.00685 0.233 small molecule metabolic
process;sphingoid biosynthetic process
his THBS1 15q15 -0.348 0.00685 0.233 sprouting angiogenesis;immune
response
xai PRSS23 11q14.1 -0.348 0.00685 0.233 proteolysis
xai FBXO5 6q25.2 0.348 0.00686 0.234 G1/S transition of mitotic cell
exp TRIM14 9q22.33 0.345 0.00686 0.234
exp NOC4L 12q24.33 0.345 0.00686 0.234 rRNA processing
exp MIR17HG 13q31.3 0.345 0.00686 0.234
xai GAPDHP73 6q23.3 0.348 0.00687 0.234
cop MIR320C2 0.345 0.00687 0.234
cop IMPACT 18q11.2-q12.1 0.345 0.00687 0.234 negative regulation of
protein phosphorylation;regulation of translational initiation
cop HRH4 18q11.2 0.345 0.00687 0.234 inflammatory response
exp COL4A2 13q34 -0.345 0.00687 0.234 transcription, DNA-
his CNTN6 3p26-p25 -0.348 0.00687 0.234 cell adhesion;Notch signaling
pathway
xai TUBBP1 8p12 0.348 0.00688 0.234
mut FBXL2 3p22.3 0.345 0.00688 0.234 protein modification
process;proteolysis
xsq C8orf46 8q13.1 -0.345 0.00688 0.234
xai CTSO 4q32.1 -0.348 0.00688 0.234 proteolysis
his POLR1A 2p11.2 0.348 0.00689 0.234 transcription initiation from
RNA polymerase I promoter;transcription elongation from RNA polymerase I promoter
his PTCD3 2p11.2 0.348 0.00689 0.234
hs4 SLC22A20 11q13.1 0.348 0.00689 0.234 ion transport
xai ARID5A 2q11.2 0.348 0.00689 0.234 negative regulation of
exp REXO4 9q34.2 0.345 0.0069 0.234 regulation of transcription, DNA-
dependent"
exp SRGAP3 3p25.3 -0.345 0.0069 0.234 signal
hs4 CEBPD 8p11.2-p11.1 -0.348 0.0069 0.234 transcription from RNA
exp FAM160A1 4q31.3 -0.348 0.0069 0.234
xai NKG7 19q13.41 0.348 0.00691 0.234
xai HSF5 17q22 0.348 0.00691 0.234
xai ILF2 1q21.3 0.348 0.00691 0.234 positive regulation of
his GOLGA8B 15q14 0.348 0.00691 0.234
exp GOT2P2 1q25.1 0.345 0.00691 0.234
exp ARHGAP4 Xq28 0.345 0.00691 0.234 induction of apoptosis by
xsq RUNX2 6p21 -0.345 0.00691 0.234 negative regulation of
xsq ASPRV1 2p13.3 0.345 0.00692 0.234 proteolysis;protein
processing
exp HAUS7 Xq28 0.345 0.00692 0.234 mitosis;spindle assembly
exp LIN9 1q42.12 0.348 0.00693 0.235 mitotic cell cycle;DNA replication
xsq E2F8 11p15.1 0.345 0.00693 0.235 cell cycle
exp GBP1 1p22.2 -0.345 0.00693 0.235 interferon-gamma-mediated
xai SRGAP3 3p25.3 -0.348 0.00693 0.235 signal
his ABT1 6p22.2 0.348 0.00694 0.235 regulation of transcription from
RNA polymerase II promoter;transcription from RNA polymerase II promoter
his HDAC5 17q21 0.348 0.00694 0.235 chromatin remodeling;cellular response to
insulin stimulus
exp PRKCQ-AS1 10p14 0.345 0.00694 0.235
exp IL13RA1 Xq24 -0.345 0.00694 0.235 cell surface receptor
signaling pathway
exp SNORD12C 0.348 0.00695 0.235
his MCEE 2p13.3 0.348 0.00695 0.235 fatty acid beta-oxidation;short-
chain fatty acid catabolic process
his MPHOSPH10 2p13.3 0.348 0.00695 0.235 RNA processing;RNA splicing
xsq SPAST 2p24-p21 0.345 0.00695 0.235 cytokinesis, completion of
hs4 ZIM2 19q13.4 0.348 0.00696 0.235
hs4 PEG3 19q13.4 0.348 0.00696 0.235 viral reproduction;apoptotic
process
hs4 MIMT1 19q13.43 0.348 0.00696 0.235
his NT5M 17p11.2 0.348 0.00696 0.235 small molecule metabolic
process;dUMP catabolic process
exp EXT1 8q24.11 -0.345 0.00696 0.235 axon guidance;brain
development
xai ZNF532 18q21.32 -0.348 0.00696 0.235 regulation of
xai CCDC66 3p14.3 0.348 0.00697 0.235
exp C16orf54 0.345 0.00697 0.235
xsq BACH2 6q15 0.345 0.00697 0.235
met ADGRG5 -0.345 0.00697 0.235 G-protein coupled receptor
xai ZGRF1 0.348 0.00698 0.235
exp HNRNPCP6 0.348 0.00698 0.235
xsq DAPL1 0.345 0.00698 0.235 apoptotic process;cell differentiation
xai ATP10D 4p12 -0.348 0.00698 0.235 cation transport;ion
xsq ARRB2 17p13 0.345 0.00699 0.235 G-protein coupled receptor
internalization;protein ubiquitination
met KLF9 9q13 0.345 0.00699 0.235 regulation of transcription from RNA
polymerase II promoter;embryo implantation
xsq LPP-AS2 3q27.3 -0.345 0.00699 0.235
exp C1orf198 1q42.2 -0.345 0.00699 0.235
met CDK20 9q22.1 0.345 0.007 0.235 Protein Kinases
exp LINC01550 0.345 0.007 0.235
hs4 ADCY8 8q24 -0.348 0.007 0.235 inhibition of adenylate cyclase activity
by G-protein signaling pathway;small molecule metabolic process
xai ITGAV 2q31-q32 -0.348 0.007 0.235 angiogenesis;blood coagulation
xai NUP37 12q23.2 0.347 0.00701 0.235 mitotic cell cycle;cytokine-
xai CAMKMT 2p21 0.347 0.00701 0.235
xsq PNP 14q13.1 0.345 0.00701 0.235 nicotinamide riboside catabolic
xsq ZNF77 19p13.3 0.345 0.00701 0.235 regulation of transcription, DNA-
dependent"
xai UTRN 6q24 -0.347 0.00701 0.235 positive regulation of cell-matrix
xai SF3A3P2 11q24.1 0.347 0.00702 0.235
his PAXBP1 21q21.3 0.347 0.00702 0.235
his C21orf62-AS1 0.347 0.00702 0.235
xai CAMSAP2 1q32.1 -0.347 0.00702 0.235
exp FOXN2 2p22-p16 0.345 0.00703 0.236 regulation of transcription, DNA-
exp COPB2 3q23 -0.345 0.00703 0.236 COPI coating of Golgi
xai CRIP2 14q32.3 -0.347 0.00703 0.236 positive regulation of cell
his LINC01647 0.347 0.00704 0.236
his SUSD3 9q22.31 0.347 0.00704 0.236
exp MRPL23 11p15.5 0.344 0.00704 0.236 translation
xsq MYCN 2p24.3 0.344 0.00704 0.236 Protein Kinases
hs4 LOC105377590 -0.347 0.00704 0.236
hs4 CCDC110 4q35.1 -0.347 0.00704 0.236
xai EPHX1 1q42.1 -0.347 0.00704 0.236 response to toxin;response to
xai HIRIP3 0.347 0.00705 0.236 chromatin assembly or disassembly
exp SPAG5-AS1 0.347 0.00705 0.236
xai TEX10 9q31.1 0.347 0.00705 0.236
exp RPS13P2 1p32.3 0.344 0.00705 0.236
exp QSOX1 1q24 -0.344 0.00705 0.236 protein thiol-disulfide
exchange;cell redox homeostasis
xai C1orf35 1q42.13 0.347 0.00706 0.236
xsq APOBEC2 6p21 0.344 0.00706 0.236 mRNA processing;cytidine
deamination
xsq HTR1B 6q13 0.344 0.00706 0.236 serotonin receptor signaling
pathway;drinking behavior
met PLAT 8p12 0.344 0.00706 0.236 protein modification process;proteolysis
xsq NRBP2 8q24.3 -0.344 0.00706 0.236 negative regulation of neuron
exp HNRNPA1P27 Xq22 0.347 0.00707 0.236
exp RPL39P36 0.347 0.00707 0.236
xai BCAR1 16q23.1 -0.347 0.00707 0.236 G-protein coupled receptor
xai FCGBP 19q13.1 0.347 0.00708 0.236
xai LOC100996286 0.347 0.00708 0.236
exp SF3A3P2 11q24.1 0.347 0.00708 0.236
xsq USP7 16p13.3 0.344 0.00708 0.236 protein deubiquitination;regulation
of protein stability
exp S100A16 1q21 -0.344 0.00708 0.236 response to calcium ion
exp FAM106CP -0.344 0.00708 0.236
his TACSTD2 1p32 -0.347 0.00708 0.236 response to stimulus;negative
regulation of stress fiber assembly
xai RPS5P2 21q22.11 0.347 0.00709 0.237
his CNTNAP4 16q23.1 0.347 0.0071 0.237 cell adhesion;signal
transduction
exp HSP90AB2P 4p15.33 0.347 0.0071 0.237 response to stress;protein
folding
xsq N4BP2 4p14 0.344 0.0071 0.237
met C1R 12p13 0.344 0.0071 0.237 complement activation, classical
pathway;innate immune response
DNA-dependent"
exp ZNF532 18q21.32 -0.344 0.0071 0.237 regulation of
exp GSTM3 1p13.3 -0.344 0.00711 0.237 metabolic process;response to
estrogen stimulus
dependent"
mir hsa-miR-32 0.344 0.00712 0.237
exp GOLGA2 9q34.11 -0.344 0.00712 0.237 positive regulation of
his AFAP1L2 10q25.3 -0.347 0.00712 0.237 regulation of mitotic
cell cycle;regulation of interleukin-6 production
xai ARSJ 4q26 -0.347 0.00712 0.237
xai FAM86JP 3q21.2 0.347 0.00713 0.237
xsq EPHB6 7q33-q35 0.344 0.00713 0.237 Cell Signaling
hs4 PKD1L2 16q23.2 -0.347 0.00713 0.237 ion
transport;neuropeptide signaling pathway
his FAM226B 0.347 0.00714 0.237
his C12orf4 12p13.3 0.347 0.00714 0.237
his RAD51AP1 12p13.2-p13.1 0.347 0.00714 0.237 DNA Damage Response
(DDR)
xai CNR2 1p36.11 0.347 0.00714 0.237 negative regulation of mast cell
xai DDX18 2q14.1 0.347 0.00714 0.237
his LAGE3 Xq28 0.347 0.00714 0.237
exp MTHFD2P7 3q26.33 0.347 0.00715 0.237
his NPPA 1p36.21 0.347 0.00715 0.237 receptor guanylyl cyclase signaling
pathway;regulation of blood pressure
his RREB1 6p25 0.347 0.00716 0.237 regulation of transcription, DNA-
xsq CCL25 19p13.2 0.344 0.00716 0.237 G-protein coupled receptor
signaling pathway;leukocyte migration
exp RNF34 12q24.31 0.344 0.00716 0.237 Apoptosis
exp RPS15AP1 20p11.23 0.344 0.00716 0.237
exp GBP1P1 1p22.2 -0.344 0.00716 0.237
xai HEG1 3q21.2 -0.347 0.00716 0.237 endothelial cell
morphogenesis;cell-cell junction organization
xai SGF29 0.347 0.00717 0.237 establishment of protein localization to
chromatin;regulation of transcription, DNA-dependent
xai HSD17B11 4q22.1 0.347 0.00717 0.237 steroid biosynthetic
xsq CD84 1q24 0.344 0.00717 0.237 defense response;cell adhesion
xai ZCCHC7 9p13.2 0.347 0.00718 0.237
xai MTHFD2P7 3q26.33 0.346 0.00718 0.237
his RPS19BP1 22q13.1 0.346 0.00718 0.237
xsq RINL 19q13.2 0.344 0.00718 0.237
exp KIR2DS1 0.344 0.00718 0.237 immune response;regulation of
immune response
exp CHGB 20p12.3 0.344 0.00718 0.237
exp XRCC6BP1 12q14.1 0.344 0.00718 0.237 DNA Damage Response (DDR)
xai CTSB 8p22 -0.346 0.00718 0.237 Apoptosis
xai AK1 9q34.1 -0.347 0.00718 0.237 ATP metabolic
process;nucleobase-containing small molecule metabolic process
xai E2F4 16q22.1 0.346 0.00719 0.237 mitotic cell cycle;cilium assembly
xai SUB1 5p13.3 0.346 0.00719 0.237 regulation of transcription from
hs4 CCDC141 2q31.2 0.346 0.00719 0.237
xai PHBP11 1q41 0.346 0.00719 0.237
met FHL3 1p34 0.344 0.00719 0.237 muscle organ development;actin
exp USP39 2p11.2 0.344 0.00719 0.237 spliceosome assembly;mRNA
processing
xsq TAL1 1p32 0.344 0.00719 0.237 neuron differentiation;regulation of cell
proliferation
exp MAP2K5 15q23 0.344 0.00719 0.237 Protein Kinases
xsq CEACAM21 19q13.2 0.344 0.00719 0.237
xai HNRNPUP1 14q21.2 0.346 0.0072 0.237
xai TMA16P2 1p34.1 0.346 0.0072 0.237
xsq GSTM3 1p13.3 -0.344 0.0072 0.237 metabolic process;response to
estrogen stimulus
xsq BCAM 19q13.2 -0.344 0.0072 0.237 cell-matrix adhesion;signal
transduction
xai PFN2 3q25.1 -0.346 0.0072 0.237 regulation of actin
polymerization or depolymerization;actin cytoskeleton organization
xai ALS2 2q33.1 -0.346 0.0072 0.237 regulation of Rho protein
signal transduction;positive regulation of protein kinase activity
xsq UNG 12q23-q24.1 0.344 0.00721 0.238 DNA Damage Response (DDR); DDR
(BER)
exp KIAA1217 10p12.31 -0.343 0.00721 0.238 multicellular organismal
development;embryonic skeletal system development
his COL18A1-AS1 -0.346 0.00721 0.238
xai FLCN 17p11.2 -0.346 0.00721 0.238 regulation of protein
phosphorylation
exp TERF2IP 16q23.1 0.343 0.00722 0.238 DNA Damage Response (DDR)
mut SNCAIP 5q23.2 0.343 0.00722 0.238 cell death;dopamine metabolic
process
xsq LAX1 1q32.1 0.343 0.00722 0.238 negative regulation of T cell
xsq GINS3 16q21 0.343 0.00722 0.238 DDR (DNA replication)
xai QSOX1 1q24 -0.346 0.00722 0.238 protein thiol-disulfide
exchange;cell redox homeostasis
xai SNX19 11q25 -0.346 0.00722 0.238 protein transport;cell
communication
hs4 UNC13B 9p13.3 -0.346 0.00722 0.238 induction of
apoptosis;signal transduction
xai MIR646HG 0.346 0.00723 0.238
exp CASP8AP2 6q15 0.343 0.00723 0.238 Apoptosis
xsq CYP2D7 0.343 0.00723 0.238
xai PHLDA3 1q31 -0.346 0.00723 0.238 negative regulation of
met RAD21L1 20p13 0.343 0.00724 0.238 chromosome segregation;meiosis
exp SH2D1A Xq25 0.343 0.00724 0.238 humoral immune response;cellular
defense response
exp YBX3 12p13.1 0.343 0.00724 0.238
hs4 IL1R1 2q12 -0.346 0.00724 0.238 ovulation;innate immune response
hs4 SLIT1 10q23.3-q24 0.346 0.00725 0.238 nervous system development;retinal
exp PTMAP5 13q31.1 0.346 0.00725 0.238
xai CIAPIN1P 18q11.2 0.346 0.00725 0.238
xsq RAG2 11p13 0.343 0.00725 0.238 B cell homeostatic proliferation;positive
regulation of organ growth
xsq TRG-AS1 0.343 0.00725 0.238
hs4 CCDC8 19q13.32 -0.346 0.00725 0.238 negative regulation of
his FAM198B 4q32.1 -0.346 0.00725 0.238
exp GSTCD 4q24 0.343 0.00726 0.238
xai KIF21B 1q32.1 0.346 0.00727 0.238 microtubule-based movement
met WDR38 9q33.3 0.343 0.00727 0.238
xsq GDF10 10q11.22 0.343 0.00727 0.238 skeletal system
his MIR4725 -0.346 0.00727 0.238
his MIR365B -0.346 0.00727 0.238
xai BRCA2 13q12.3 0.346 0.00728 0.238 Apoptosis; DNA Damage Response
(DDR); DDR (FA); DDR (DNA replication); Tumor Suppressors
exp POU2AF1 11q23.1 0.343 0.00728 0.238 transcription from RNA
polymerase II promoter;humoral immune response
mut ZNF670 0.343 0.00729 0.239 regulation of transcription, DNA-
dependent"
xsq IMPDH2 3p21.2 0.343 0.00729 0.239 nucleobase-containing small
xsq TAGAP 6q25.3 0.343 0.0073 0.239 signal transduction;small GTPase
xsq ADAMTS15 11q25 -0.343 0.0073 0.239 proteolysis
exp APP 21q21.3 -0.343 0.0073 0.239 Apoptosis
xai LEAP2 5q31.1 0.346 0.00731 0.239 defense response to bacterium
xai DCP1A 3p21.1 0.346 0.00731 0.239 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;gene expression
xsq IGFBP5 2q35 -0.343 0.00731 0.239 negative regulation of smooth
muscle cell migration;type B pancreatic cell proliferation
xai LAMP1 13q34 -0.346 0.00731 0.239 autophagy;autophagic cell death
xai KIF15 3p21.31 0.346 0.00732 0.239 microtubule-based movement;mitosis
exp TTC28-AS1 22q12.1 0.343 0.00732 0.239
xai SNORD12C 0.346 0.00733 0.239
exp CAMKMT 2p21 0.343 0.00733 0.239
xsq HAUS7 Xq28 0.343 0.00733 0.24 mitosis;spindle assembly
hs4 MYO1E 15q21-q22 -0.346 0.00733 0.239 glomerular
filtration;nitrogen compound metabolic process
xai CRH 8q13 0.346 0.00734 0.24 parturition;locomotory exploration
behavior
xai HNRNPCP8 11q14.2 0.346 0.00734 0.24
met TNS2 0.343 0.00734 0.24 negative regulation of cell
proliferation;intracellular signal transduction
xsq OPTN 10p13 -0.343 0.00734 0.24 protein targeting to Golgi;Golgi
organization
hs4 SNX18 5q11.2 -0.346 0.00734 0.24 protein transport;positive
xai CCDC174 3p25.1 0.346 0.00735 0.24
xai PABPC4L 4q28.3 0.345 0.00736 0.24
hs4 BCL11A 2p16.1 0.345 0.00736 0.24 positive regulation of neuron
promoter
xsq RNF165 18q21.1 0.343 0.00736 0.24
exp ACTA2 10q23.3 -0.343 0.00736 0.24 muscle contraction;regulation
of blood pressure
his MRPL38 17q25.3 0.345 0.00737 0.24
exp TOM1L2 17p11.2 -0.343 0.00737 0.24 intracellular protein
transport
hs4 MAP2 2q34-q35 -0.345 0.00737 0.24 microtubule bundle
formation;negative regulation of microtubule depolymerization
his RNGTT 6q16 0.345 0.00738 0.24 transcription from RNA polymerase II
mir hsa-miR-378 0.343 0.00738 0.24
exp CCNK 14q32 0.343 0.00738 0.24 cell division;regulation of cyclin-
dependent protein kinase activity
met RHEB 7q36 0.343 0.00738 0.24 small GTPase mediated signal
transduction;insulin receptor signaling pathway
exp COL4A1 13q34 -0.343 0.00738 0.24 epithelial cell
exp HSD17B11 4q22.1 0.343 0.00739 0.24 steroid biosynthetic
met CD52 1p36 -0.342 0.00739 0.241 elevation of cytosolic calcium ion
xai SASH3 Xq26 0.345 0.0074 0.241 positive regulation of interleukin-10
exp SAPCD1 6p21.33 0.342 0.0074 0.241
met ITGB8 7p21.1 0.342 0.0074 0.241 multicellular organismal
xsq ADCY6 12q12-q13 -0.342 0.0074 0.241 water transport;activation of
his ANP32A 15q23 0.345 0.00741 0.241 regulation of transcription, DNA-
mut IGSF21 1p36.13 0.342 0.00741 0.241
xsq DNASE1L2 16p13.3 0.342 0.00741 0.241 DNA metabolic process;DNA
catabolic process
exp LOC101059954 0.342 0.00741 0.241
hs4 AGAP2-AS1 12q14.1 -0.345 0.00741 0.241
his NKRF Xq24 0.345 0.00742 0.241 negative regulation of transcription,
DNA-dependent"
xsq RPUSD2 15q13.3 0.342 0.00742 0.241 pseudouridine synthesis
swa MYADM 19q13.42 -0.345 0.00742 0.241
hs4 GBP1 1p22.2 -0.345 0.00742 0.241 interferon-gamma-mediated
his TSACC 1q22 0.345 0.00743 0.241
his CCT3 1q23 0.345 0.00743 0.241 protein folding;cellular protein
metabolic process
xsq ITK 5q31-q32 0.342 0.00743 0.241 activation of phospholipase C
activity;interferon-gamma production
xsq SMCHD1 18p11.32 0.342 0.00743 0.241 inactivation of X chromosome
xai ATP5A1P3 16q22.2 0.345 0.00744 0.241
xai AFG3L2P1 8p11.1 0.345 0.00744 0.241
xai KCNH4 17q21.2 0.345 0.00744 0.241 regulation of transcription, DNA-
his JPH2 20q13.12 -0.345 0.00744 0.241 regulation of cardiac muscle
swa P4HB 17q25 -0.345 0.00744 0.241 small molecule metabolic
process;cell redox homeostasis
xai RPS26P2 9p21.1 0.345 0.00745 0.241
his SAMSN1 21q11 0.345 0.00745 0.241 negative regulation of peptidyl-
exp TFB1M 6q25.1-q25.3 0.342 0.00745 0.241 regulation of transcription,
DNA-dependent"
xsq LOX 5q23.2 -0.342 0.00745 0.241 response to steroid hormone
his SERPINA3 14q32.1 -0.345 0.00745 0.241 regulation of
proteolysis;maintenance of gastrointestinal epithelium
hs4 LOC100506159 0.345 0.00746 0.241
swa UBQLN1 9q22 0.345 0.00746 0.241 response to hypoxia;apoptotic
process
exp RPS25P8 0.342 0.00746 0.241
exp RPUSD2 15q13.3 0.342 0.00746 0.241 pseudouridine synthesis
exp ENDOG 9q34.1 0.342 0.00746 0.241 response to antibiotic;in utero
his THRAP3 1p34.3 0.345 0.00747 0.241 transcription initiation from
RNA polymerase II promoter;intracellular steroid hormone receptor signaling pathway
xai GVINP1 11p15.4 0.345 0.00747 0.241
met FAN1 15q13.2-q13.3 0.342 0.00747 0.241 DNA Damage Response (DDR);
DDR (FA)
exp EXOSC5 19q13.1 0.342 0.00747 0.241 gene expression;RNA metabolic
process
exp ADA 20q13.12 0.342 0.00747 0.241 in utero embryonic
exp NBL1 1p36.13 -0.342 0.00747 0.241 positive regulation of neuron
xai TCTN2 12q24.31 -0.345 0.00747 0.241 cell projection
xai GAPDHP31 12p13.31 0.345 0.00748 0.241
xai WASH1 0.345 0.00748 0.241 transport;endosome transport
exp WDR74 11q12.3 0.342 0.00748 0.241
exp MRPL50 9q31.1 0.342 0.00748 0.241
his DFFA 1p36.3-p36.2 0.345 0.00749 0.242 Apoptosis
his PEX14 1p36.22 0.345 0.00749 0.242 peroxisome organization;protein
transport
exp C10orf2 10q24 0.342 0.00749 0.242 DNA replication;mitochondrial DNA
replication
xai SRGAP1 12q14.2 -0.345 0.00749 0.242 signal
exp NDUFB8 10q24.31 0.342 0.0075 0.242 transport;respiratory
xsq LOC152578 0.342 0.0075 0.242
exp HNRNPD 4q21 0.342 0.0075 0.242 RNA processing;RNA catabolic
process
xai LIN9 1q42.12 0.345 0.00751 0.242 mitotic cell cycle;DNA replication
xsq ZEB1-AS1 10p11.22 0.342 0.00751 0.242
exp RPL32P7 3q12.3 0.342 0.00751 0.242
mir hsa-miR-101 0.342 0.00751 0.242
mir hsa-miR-101(2) 0.342 0.00751 0.242
exp BACE1 11q23.2-q23.3 -0.342 0.00751 0.242 proteolysis;membrane
xai SP4 7p15.3 0.345 0.00752 0.242 regulation of transcription from
RNA polymerase II promoter;regulation of heart contraction
mut CDH12 5p14.3 0.342 0.00752 0.242 homophilic cell adhesion;cell-cell
adhesion
exp RQCD1 2q35 0.342 0.00752 0.242 cytokine-mediated signaling
pathway;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
xsq LINC00359 0.342 0.00752 0.242
xai NAF1 4q32.2 0.345 0.00753 0.242 rRNA processing;snRNA pseudouridine
synthesis
xai CYB5R4 6pter-q22.33 0.345 0.00753 0.242 cell
development;oxidation-reduction process
met LIMCH1 4p13 0.342 0.00753 0.242 actomyosin structure organization
xai CARD10 22q13.1 -0.345 0.00753 0.242 protein complex
assembly;activation of NF-kappaB-inducing kinase activity
hs4 ARHGAP39 8q24.3 -0.345 0.00753 0.242 signal
his SNAI3 16q24.3 0.345 0.00754 0.242
his FOXN2 2p22-p16 0.345 0.00754 0.242 regulation of transcription, DNA-
xai ZFP1 16q23.1 0.344 0.00754 0.242 regulation of transcription, DNA-
dependent"
xai CTGF 6q23.1 -0.345 0.00754 0.242 response to wounding;positive
regulation of collagen biosynthetic process
xai AP2S1 19q13.2-q13.3 -0.345 0.00754 0.242 protein transport;viral
reproduction
his KARS 16q23.1 0.344 0.00755 0.242 tRNA aminoacylation for protein
his TERF2IP 16q23.1 0.344 0.00755 0.242 DNA Damage Response (DDR)
exp POLR1B 2q13 0.342 0.00755 0.242 transcription elongation from RNA
exp CYB5R1 1q32.1 -0.342 0.00755 0.242 sterol biosynthetic
process
exp KIRREL 1q21-q25 -0.342 0.00755 0.242 excretion
xsq NTN1 17p13-p12 -0.342 0.00755 0.242 mammary gland
exp SIPA1L3 19q13.13 -0.342 0.00755 0.242 regulation of small
xai PTPN21 14q31.3 -0.344 0.00755 0.242 protein
his C20orf196 20p12.3 0.344 0.00756 0.242
exp HIST1H2AI 6p22.1 0.342 0.00756 0.242
exp GPSM3 6p21.3 0.342 0.00756 0.242 signal transduction;regulation of
xsq MYOF 10q24 -0.342 0.00756 0.242 plasma membrane repair;muscle
contraction
his IFIT3 -0.344 0.00756 0.242 cellular response to interferon-
xsq NOS3 7q36 0.342 0.00757 0.242 regulation of sodium ion transport;blood
coagulation
xsq GOLM1 9q21.33 -0.342 0.00757 0.242
hs4 TMEM136 11q23.3 -0.344 0.00757 0.242
exp NXT1 20p12-p11.2 0.341 0.00758 0.242 RNA export from nucleus;protein
export from nucleus
xai CIAPIN1 16q21 0.344 0.00759 0.243 apoptotic process;anti-apoptosis
his CBX3P2 18p11.32 0.344 0.00759 0.243
his SMCHD1 18p11.32 0.344 0.00759 0.243 inactivation of X chromosome
his DPYS 8q22 0.344 0.0076 0.243 uracil catabolic process;beta-alanine
metabolic process
his HTATSF1 Xq26.3 0.344 0.0076 0.243 regulation of transcription
exp PPAN-P2RY11 19p13 0.341 0.0076 0.243
mut ILDR2 1q24.1 0.341 0.0076 0.243 response to glucose
stimulus;insulin secretion
xsq VDR 12q13.11 -0.341 0.0076 0.243 negative regulation of
transcription from RNA polymerase II promoter;positive regulation of keratinocyte
differentiation
xai PTK2 8q24.3 -0.344 0.0076 0.243 Apoptosis
xai IGLL3P 22q11.23 0.344 0.00761 0.243
xsq PASK 2q37.3 0.341 0.00761 0.243 regulation of glucagon
secretion;regulation of energy homeostasis
xsq GAS2L3 12q23.1 -0.341 0.00761 0.243 cell cycle arrest
exp WSB2 12q24.23 -0.341 0.00761 0.243 intracellular signal
transduction
his NXF3 Xq22 0.344 0.00762 0.243 mRNA export from nucleus;transport
exp PGBD3P1 12q13.12 0.341 0.00762 0.243
met MIR21 0.341 0.00762 0.243
his PKD1L2 16q23.2 -0.344 0.00762 0.243 ion
his DKC1 Xq28 0.344 0.00763 0.243 DNA Damage Response (DDR)
xai RPL39P36 0.344 0.00763 0.243
exp ATXN7L2 1p13.3 0.344 0.00763 0.243
his MEMO1 0.344 0.00763 0.243 regulation of microtubule-based process
xsq PRR3 6p21.33 0.341 0.00763 0.243
exp SPATA5L1 15q21.1 0.341 0.00763 0.243
xai TMEM9 -0.344 0.00763 0.243 transport
swa PNP 14q13.1 0.344 0.00764 0.243 nicotinamide riboside catabolic
exp PCBP2P2 8q21-q22 0.341 0.00764 0.243
xai EEF1A1P1 21q21.1 0.344 0.00765 0.243
exp RPL10P2 6p22.1 0.341 0.00765 0.244
exp RPL10P1 21q21.3 0.341 0.00766 0.244
swa RHOC 1p13.1 -0.344 0.00766 0.244 regulation of small GTPase
met PTPRCAP 11q13.3 -0.341 0.00767 0.244 defense response
xsq FAM60A 12p11 0.341 0.00768 0.244
met SDC4 20q12 0.341 0.00768 0.244 ureteric bud development;positive
xai TUT1 11q12.2 0.344 0.00769 0.244 mRNA polyadenylation;mRNA cleavage
xsq WT1 11p13 0.341 0.00769 0.244 Apoptosis; Tumor Suppressors
met CFAP221 0.341 0.00769 0.244
xsq LOC100507600 0.341 0.00769 0.244
exp EFNA5 5q21 -0.341 0.00769 0.244 apoptotic process;regulation of Rho
GTPase activity
xai TMEM161A 19p13.11 0.344 0.0077 0.244 negative regulation of
apoptotic process;positive regulation of DNA repair
hs4 VSX1 20p11.21 0.344 0.0077 0.244 neuron maturation;response to
stimulus
exp ILF3 19p13.2 0.341 0.0077 0.244 M phase;negative regulation of
xsq CPNE4 3q22.1 0.341 0.0077 0.244
hs4 CLEC4G 19p13.2 0.344 0.00771 0.245
exp TUBBP1 8p12 0.344 0.00771 0.245
swa ALPL 1p36.12 -0.344 0.00771 0.245 biomineral tissue
development;response to lipopolysaccharide
xsq LIMD2 17q23.3 0.341 0.00772 0.245
mir hsa-miR-128 0.341 0.00772 0.245
mir hsa-miR-128(2) 0.341 0.00772 0.245
exp GLIPR1L2 12q21.2 0.341 0.00773 0.245
xsq CELF5 19p13 0.341 0.00773 0.245 mRNA processing
exp RNU7-15P 5q31.1 -0.341 0.00773 0.245
xai PPP1R37 19q13.32 -0.343 0.00773 0.245 negative regulation of
his LYAR 4p16.3 0.343 0.00774 0.245
his ZBTB49 4p16.3 0.343 0.00774 0.245 regulation of transcription,
DNA-dependent"
met FBXL2 3p22.3 0.341 0.00774 0.245 protein modification
process;proteolysis
exp CARD10 22q13.1 -0.341 0.00774 0.245 protein complex
hs4 LOC102724552 -0.343 0.00774 0.245
exp ANKRD30A 10p11.21 0.343 0.00775 0.245 regulation of transcription,
DNA-dependent"
xai ISCA1P6 2q14.3 0.343 0.00775 0.245
xsq ZNRD1 6p21.3 0.341 0.00775 0.245 nucleobase-containing compound
metabolic process
xsq CTSB 8p22 -0.341 0.00775 0.245 Apoptosis
hs4 CLDN1 3q28-q29 -0.343 0.00775 0.245 cell adhesion;calcium-
exp ADCK3 1q42.13 0.341 0.00776 0.245 cell death
exp AHNAK 11q12.2 -0.341 0.00776 0.245 nervous system development
xai SLCO4A1 20q13.33 0.343 0.00777 0.245 Solute Carriers
exp CSTF2 Xq22.1 0.34 0.00777 0.245 gene expression;nuclear mRNA
exp THUMPD2 2p22.1 0.34 0.00777 0.245
exp ISCA1P6 2q14.3 0.343 0.00778 0.245
exp RPL36P4 0.343 0.00778 0.245
his SPAG5 17q11.2 0.343 0.00778 0.245 regulation of attachment of spindle
microtubules to kinetochore;mitotic sister chromatid segregation
his SPAG5-AS1 0.343 0.00778 0.245
exp BRCA2 13q12.3 0.34 0.00778 0.245 Apoptosis; DNA Damage Response
exp BCL2L2 14q11.2-q12 -0.34 0.00778 0.245 Apoptosis
his KAZN 1p36.21 -0.343 0.00778 0.245 keratinization
xsq SDK2 17q25.1 0.34 0.00779 0.246 cell adhesion
xsq PHF21B 22q13.31 0.34 0.00779 0.246
exp ARHGAP30 1q23.3 0.34 0.00779 0.246 signal transduction;small
exp HMGB1 13q12 0.34 0.00779 0.246 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
xai HSP90AB2P 4p15.33 0.343 0.0078 0.246 response to stress;protein
folding
xsq OAT 10q26 -0.34 0.0078 0.246 cellular nitrogen compound metabolic
xai AFAP1 4p16 -0.343 0.0078 0.246
swa MVP 16p11.2 -0.343 0.0078 0.246 DNA Damage Response (DDR)
xai MUTYH 1p34.1 0.343 0.00781 0.246 DNA Damage Response (DDR); DDR
(BER)
his ARHGAP11B 15q13.2 0.343 0.00781 0.246
exp BOLA2B 0.34 0.00781 0.246
met GAL3ST4 7q22.1 -0.34 0.00781 0.246 sulfur compound metabolic
process;cell-cell signaling
xsq SVEP1 9q32 0.34 0.00782 0.246 cell adhesion
exp TCEAL3 Xq22.2 -0.34 0.00782 0.246 regulation of transcription,
DNA-dependent"
exp APOL2 22q12 -0.34 0.00782 0.246 lipid metabolic process;transport
xai RAB2A 8q12.1 -0.343 0.00782 0.246 GTP catabolic process;ER to
his DAAM1 14q23.1 -0.343 0.00782 0.246 cellular component
xai RPSAP19 0.343 0.00783 0.246
xai SEPSECS 4p15.2 0.343 0.00783 0.246 selenocysteine
exp FBXO5 6q25.2 0.34 0.00783 0.246 G1/S transition of mitotic cell
xai LRRC8E 19p13.2 -0.343 0.00783 0.246
exp GSG2 17p13 0.34 0.00784 0.246 regulation of spindle checkpoint;protein
phosphorylation
met TTTY19 Yp11.2 -0.621 0.00784 0.246
xsq LOC728739 12q23.3 0.34 0.00785 0.246
xai SLIT1 10q23.3-q24 0.343 0.00786 0.247 nervous system development;retinal
xai MED28 4p16 0.343 0.00786 0.247 regulation of transcription, DNA-
dependent"
xai NDUFAF4P3 0.343 0.00787 0.247
exp NDUFAF4P3 0.343 0.00787 0.247
exp LOC100505938 0.343 0.00787 0.247
mir hsa-miR-142-3p 0.34 0.00787 0.247
met TNNI2 11p15.5 -0.34 0.00787 0.247 skeletal muscle contraction;muscle
filament sliding
xai GSTM3 1p13.3 -0.343 0.00787 0.247 metabolic process;response to
estrogen stimulus
xai HNRNPR 1p36.12 0.343 0.00788 0.247 nuclear mRNA splicing, via
spliceosome;mRNA processing
his CENPO 2p23.3 0.343 0.00788 0.247 nucleosome assembly;chromosome
segregation
his PTRHD1 2p23.3 0.343 0.00788 0.247
mut JAKMIP1 4p16.1 0.34 0.00788 0.247 protein transport
xsq FOXP4-AS1 0.34 0.00788 0.247
mda MutSig1_age 0.34 0.00788 0.247
xai APELA 0.343 0.00789 0.247
xai TERF2IP 16q23.1 0.343 0.00789 0.247 DNA Damage Response (DDR)
exp ELOVL7 5q12.1 -0.34 0.00789 0.247 small molecule metabolic
process;fatty acid biosynthetic process
his NCF4 22q13.1 0.343 0.0079 0.247 immune response;cell communication
met ALDH7A1 5q31 0.34 0.0079 0.247 cellular aldehyde metabolic
process;lysine catabolic process
met SLC1A1 9p24 0.34 0.0079 0.247 Solute Carriers
DNA-dependent"
his NDUFB8 10q24.31 0.343 0.00791 0.247 transport;respiratory
hs4 DOCK1 10q26.13-q26.3 -0.343 0.00791 0.247 Apoptosis
xai PUS10 2p16.1 0.343 0.00792 0.247 pseudouridine synthesis;tRNA
processing
xsq PLA2G4E 15q15.1 0.34 0.00792 0.247 phospholipid catabolic
exp KCNK12 2p16.3 0.34 0.00793 0.248 ion transport;potassium ion
transport
xai TNFRSF10B 8p22-p21 -0.342 0.00793 0.248 Apoptosis
xai HNRNPA3P7 0.342 0.00794 0.248
his PPIL3 2q33.1 0.342 0.00794 0.248 protein folding;RNA splicing
his NIF3L1 2q33 0.342 0.00794 0.248 positive regulation of
xsq CYBB Xp21.1 0.34 0.00794 0.248 ion transport;oxidation-reduction
process
xsq LAPTM4B 8q22.1 -0.34 0.00794 0.248 transport
xsq IL6 7p21 -0.34 0.00794 0.248 Apoptosis
hs4 PYHIN1 1q23.1 0.342 0.00795 0.248 cell cycle
xsq TMEM145 19q13.2 0.34 0.00795 0.248
exp DZIP1L 3q22.3 -0.34 0.00795 0.248
exp HNRNPA3P7 0.342 0.00796 0.248
xai SPEN 1p36 0.342 0.00796 0.248 negative regulation of transcription from
RNA polymerase II promoter;Notch signaling pathway
xsq GALNT11 7q36.1 -0.339 0.00796 0.248 O-glycan
xai CCNT1 12q13.11 0.342 0.00797 0.248 transcription elongation from RNA
polymerase II promoter;protein phosphorylation
exp SEH1L 18p11.21 0.339 0.00797 0.248 mitotic prometaphase;protein
transport
pro EP300_20_26615 0.339 0.00797 0.248
met RAD51AP2 2p24.2 0.339 0.00798 0.249
exp CFB 6p21.3 -0.339 0.00798 0.248 complement activation,
met LAX1 1q32.1 -0.339 0.00798 0.248 negative regulation of T cell
xai KIRREL 1q21-q25 -0.342 0.00798 0.248 excretion
hs4 LINC00605 0.342 0.00799 0.249
met PDLIM7 5q35.3 0.339 0.00799 0.249 positive regulation of
xai NXT1 20p12-p11.2 0.342 0.008 0.249 RNA export from nucleus;protein export
from nucleus
his PTMA 2q37.1 0.342 0.008 0.249 transcription, DNA-dependent"
his MIR1244-1 0.342 0.008 0.249
xai SNX7 1p21.3 -0.342 0.008 0.249 cell communication;protein
transport
xai PPM1G 2p23.3 0.342 0.00801 0.249 protein dephosphorylation;cell
cycle arrest
hs4 CD6 11q13 0.342 0.00801 0.249 cell adhesion
met ZNF57 19p13.3 0.339 0.00801 0.249 regulation of transcription, DNA-
dependent"
swa GRN 17q21.32 -0.342 0.00801 0.249 signal transduction;embryo
implantation
his SLC9B2 4q24 0.342 0.00802 0.249 cation transport;sodium ion
transport
exp RPSAP19 0.342 0.00802 0.249
his NDUFC1 4q31.1 0.342 0.00802 0.249 mitochondrial electron
his NAA15 4q31.1 0.342 0.00802 0.249 angiogenesis;N-terminal protein
amino acid acetylation
xai RPL36P4 0.342 0.00802 0.249
xsq FAM27C 0.339 0.00802 0.249
xsq DBH 9q34 0.339 0.00802 0.249 synaptic transmission;response to
estradiol stimulus
xai TWSG1 18p11.3 -0.342 0.00802 0.249 mesoderm formation;forebrain
development
xai EEF1A1P28 7q21.13 0.342 0.00803 0.249
exp GAPDHP31 12p13.31 0.342 0.00803 0.249
xsq TESC 12q24.22 0.339 0.00803 0.249 positive regulation of gene
expression;regulation of cell adhesion mediated by integrin
xsq ELOVL4 6q14 0.339 0.00803 0.249 fatty acid biosynthetic
process;detection of visible light
xsq DHRS4 14q11.2 0.339 0.00803 0.249
exp TVP23B 17p11.2 -0.339 0.00803 0.249
xsq NR1I2 3q12-q13.3 0.339 0.00804 0.249 signal transduction;drug export
xsq SPN 16p11.2 0.339 0.00804 0.249 negative regulation of type IV
exp REG1CP -0.342 0.00804 0.249
his TIMP3 22q12.3 -0.342 0.00804 0.249 aging;response to stimulus
exp KCTD21-AS1 11q14.1 0.342 0.00805 0.249
his LOC101927770 0.342 0.00805 0.249
hs4 LDLRAD2 1p36.12 0.342 0.00805 0.249
his CELSR2 1p21 -0.342 0.00805 0.249 G-protein coupled receptor
xai RQCD1 2q35 0.342 0.00806 0.249 cytokine-mediated signaling
xsq ORC2 2q33 0.339 0.00806 0.249 DDR (DNA replication)
xsq LOC283575 0.339 0.00806 0.249
his CEBPZ 2p22.2 0.342 0.00807 0.249 regulation of transcription, DNA-
dependent;transcription from RNA polymerase II promoter"
his NDUFAF7 2p22.2 0.342 0.00807 0.249
xai UQCRC2 16p12 0.342 0.00807 0.249 oxidative
phosphorylation;proteolysis
xsq CACTIN 19p13.3 0.339 0.00807 0.249
xsq PRUNE2 9q21.2 -0.339 0.00807 0.249 apoptotic
process;induction of apoptosis
hs4 H19 11p15.5 0.342 0.00808 0.25
exp TSEN2 3p25.2 0.339 0.00808 0.249 tRNA splicing, via endonucleolytic
met KLHL22 22q11.21 0.339 0.00808 0.25 cell division
exp ARID5A 2q11.2 0.339 0.00809 0.25 negative regulation of
exp GABRE Xq28 -0.339 0.00809 0.25 transport;ion transport
xai EXOSC7 3p21.31 0.342 0.0081 0.25 nuclear-transcribed mRNA
his CCDC38 12q23.1 0.342 0.0081 0.25
his AMDHD1 12q23.1 0.342 0.0081 0.25 histidine catabolic
mut PPP1R16A 8q24.3 0.339 0.0081 0.25
exp DDX18 2q14.1 0.339 0.0081 0.25
xai TATDN3 1q32.3 0.342 0.00811 0.25
xai CCDC69 5q33.1 0.342 0.00811 0.25
xsq QSOX2 9q34.3 0.339 0.00811 0.25 cell redox homeostasis
mut TMEM176B 7q36.1 0.339 0.00811 0.25 organ morphogenesis;cell
differentiation
xsq SUPV3L1 10q22.1 0.339 0.00811 0.25 positive regulation of cell
exp LOC646517 6p12.3 0.339 0.00811 0.25
exp COG2 1q42.2 0.339 0.00811 0.25 protein glycosylation;intracellular
protein transport
exp SPEN 1p36 0.339 0.00811 0.25 negative regulation of transcription from
xsq DCBLD2 3q12.1 -0.339 0.00811 0.25 intracellular receptor
xai RPL21P13 14q32.32 0.342 0.00812 0.25
xai EDC4 16q22.1 0.341 0.00812 0.25 mRNA metabolic
process;exonucleolytic nuclear-transcribed mRNA catabolic process involved in
mir hsa-miR-28-5p -0.339 0.00812 0.25
xai JPH2 20q13.12 -0.342 0.00812 0.25 regulation of cardiac muscle
exp EEF1A1P28 7q21.13 0.341 0.00813 0.25
exp NRF1 7q32 0.341 0.00813 0.25 mitochondrion organization;organ
regeneration
met LINC00905 19p13.12 0.339 0.00813 0.25
exp LOC646808 0.339 0.00813 0.25
exp PFN2 3q25.1 -0.339 0.00813 0.25 regulation of actin
xai OR1M1 19p13.2 -0.341 0.00813 0.25 response to stimulus
exp KTN1-AS1 14q22.3 0.341 0.00814 0.25
his FKBP3 14q21.2 0.341 0.00814 0.25 protein folding;peptidyl-proline
modification
his FANCM 14q21.2 0.341 0.00814 0.25 DNA Damage Response (DDR); DDR (FA)
exp RPL21P13 14q32.32 0.341 0.00814 0.25
exp MED15 22q11.2 -0.339 0.00814 0.25 regulation of transcription
from RNA polymerase II promoter;gene expression
exp OR1M1 19p13.2 -0.341 0.00814 0.25 response to stimulus
swa CKAP4 12q23.3 -0.341 0.00814 0.25
his P4HA2 5q31 -0.341 0.00814 0.25 peptidyl-proline hydroxylation to
4-hydroxy-L-proline
xai RPS4XP4 1p36.12 0.341 0.00815 0.25
hs4 PDCD1 2q37.3 0.341 0.00815 0.25 apoptotic process;humoral immune
response
exp RPL21P44 4q12 0.339 0.00815 0.25
xsq RAB33A Xq26.1 0.339 0.00815 0.25 GTP catabolic process;small
hs4 LOC729970 1p21.3 -0.341 0.00815 0.25
hs4 CNN3 1p22-p21 -0.341 0.00815 0.25 negative regulation of ATPase
xsq PDE4D 5q12 0.338 0.00816 0.25 establishment of endothelial barrier;cAMP
catabolic process
xsq SHH 7q36 0.338 0.00816 0.25 response to hypoxia;lymphoid progenitor
cell differentiation
hs4 SPIN3 Xp11.21 -0.341 0.00816 0.25 gamete generation
xai DDIAS 0.341 0.00817 0.25 apoptotic process;cell cycle
xsq LIPK 10q23.31 0.338 0.00817 0.25 lipid catabolic process
hs4 FAM78A 9q34 0.341 0.00818 0.25
xsq CORO7 16p13.3 0.338 0.00818 0.25 actin cytoskeleton organization
exp BCAR1 16q23.1 -0.338 0.00818 0.25 G-protein coupled receptor
xai RPS12P23 0.341 0.00819 0.25
his KCNH4 17q21.2 0.341 0.00819 0.25 regulation of transcription, DNA-
his HCRT 17q21 0.341 0.00819 0.25 elevation of cytosolic calcium ion
concentration;positive regulation of calcium ion transport
exp OGFOD1 16q12.2 0.338 0.00819 0.25
his RRN3P2 16p11.2 0.341 0.0082 0.251
xai CMA1 14q11.2 0.341 0.0082 0.251 proteolysis;interleukin-1 beta
xsq CTCF 16q21-q22.3 0.338 0.0082 0.251 chromosome segregation;regulation
met MICALCL 11p15.3 0.338 0.0082 0.251 multicellular organismal
xai KTN1-AS1 14q22.3 0.341 0.00821 0.251
his MCM6 2q21 0.341 0.00821 0.251 DDR (DNA replication)
xsq GNG11 7q21 -0.338 0.00821 0.251 GTP catabolic process;signal
transduction
xai NAGK 2p13.3 -0.341 0.00822 0.251 N-acetylglucosamine metabolic
process;N-acetylmannosamine metabolic process
exp DUT 15q21.1 0.338 0.00823 0.251 DNA Damage Response (DDR)
xsq ABHD3 18q11.2 0.338 0.00823 0.251
xsq PLCH2 1p36.32 0.338 0.00823 0.251 lipid catabolic
process;intracellular signal transduction
exp CCDC77 12p13.33 0.338 0.00823 0.251
exp MFNG 22q12 0.338 0.00823 0.251 pattern specification process
exp EGFR 7p12 -0.338 0.00823 0.251 Apoptosis; Cell Signaling;
xai RAB9A Xp22.2 -0.341 0.00823 0.251 positive regulation of
exocytosis;GTP catabolic process
his BTK Xq21.33-q22 0.341 0.00824 0.251 regulation of transcription, DNA-
dependent;intracellular signal transduction
his RPL36A-HNRNPH2 0.341 0.00824 0.251
his RPL36A Xq22.1 0.341 0.00824 0.251 translational
initiation;viral infectious cycle
his DDX55 12q24.31 0.341 0.00824 0.251
swa SRP54 14q13.2 0.341 0.00824 0.251 SRP-dependent cotranslational
protein targeting to membrane, translocation;SRP-dependent cotranslational protein
targeting to membrane, signal sequence recognition
exp RPL21P119 16p13.2 0.338 0.00824 0.251
exp PPIC 5q23.2 -0.338 0.00824 0.251 protein folding;signal
transduction
xai CYB5R1 1q32.1 -0.341 0.00824 0.251 sterol biosynthetic
process
his VSIG4 Xq12-q13.3 0.341 0.00825 0.251 complement activation, alternative
pathway;negative regulation of interleukin-2 production
hs4 SIT1 9p13-p12 0.341 0.00825 0.251 signal transduction;regulation of T
cell activation
xai KIR2DS1 0.341 0.00825 0.251 immune response;regulation of
immune response
pro PRKCB1 0.338 0.00825 0.251
swa SAFB 19p13.3-p13.2 0.341 0.00826 0.251 regulation of transcription,
DNA-dependent;intracellular estrogen receptor signaling pathway
his UCK2 1q23 0.341 0.00826 0.251 response to axon injury;nucleobase-
containing small molecule metabolic process
exp DCK 4q13.3-q21.1 0.338 0.00826 0.251 purine base metabolic
xsq SEZ6L 22q12.1 0.338 0.00826 0.251
xsq DKK3 11p15.2 -0.338 0.00826 0.251 negative regulation of
canonical Wnt receptor signaling pathway;negative regulation of cortisol
exp RPL5P24 8q22.3 0.341 0.00827 0.251
exp FAM86JP 3q21.2 0.338 0.00827 0.251
xsq HFE 6p21.3 -0.338 0.00827 0.251 female pregnancy;antigen
exp CRIP2 14q32.3 -0.338 0.00827 0.251 positive regulation of cell
xai TVP23B 17p11.2 -0.341 0.00827 0.251
swa CTTN 11q13 -0.341 0.00828 0.252
xai ERN1 17q24.2 0.341 0.00829 0.252 response to unfolded
protein;activation of signaling protein activity involved in unfolded protein
response
met ARHGEF10L 1p36.13 0.338 0.00829 0.252 positive regulation of Rho
GTPase activity;regulation of Rho protein signal transduction
xsq LRRTM2 5q31.2 -0.338 0.00829 0.252
his HCLS1 3q13 0.341 0.0083 0.252 regulation of transcription, DNA-
xsq AQP4 18q11.2-q12.1 0.338 0.0083 0.252 transport;water transport
xsq NCF1 7q11.23 0.338 0.0083 0.252 response to yeast;cellular defense
response
xsq PSD 10q24 0.338 0.0083 0.252 regulation of ARF protein signal
transduction;signal transduction
xai LAMP3 3q26.3-q27 0.341 0.00831 0.252 cell proliferation
met TMEM67 8q22.1 0.338 0.00831 0.252 cilium assembly;branching
morphogenesis of a tube
exp CYB5R4 6pter-q22.33 0.338 0.00831 0.252 cell
exp RPL21P80 8p12 0.338 0.00831 0.252
xsq FCGBP 19q13.1 0.338 0.00831 0.252
xsq KLHL29 2p24.1 -0.338 0.00831 0.252
met ZNF112 0.338 0.00832 0.252 regulation of transcription, DNA-
dependent"
exp CLIC4 1p36.11 -0.338 0.00832 0.252 ion transport;chloride
transport
exp RIT1 1q22 -0.338 0.00833 0.252 nerve growth factor receptor
signaling pathway;signal transduction
exp MYL9 20q11.23 -0.338 0.00833 0.252 axon guidance;muscle
contraction
xai IL13RA1 Xq24 -0.34 0.00833 0.252 cell surface receptor signaling
pathway
hs4 LRIG3 12q14.1 -0.34 0.00833 0.252
xsq RBM28 7q32.1 0.338 0.00834 0.252 mRNA processing;RNA splicing
exp LCP2 5q35.1 0.338 0.00834 0.252 immune response;transmembrane
xai DGCR2 22q11.21 -0.34 0.00834 0.252 cell adhesion;organ morphogenesis
xai IL6ST 5q11.2 -0.34 0.00834 0.252 JAK-STAT cascade;positive
regulation of T cell proliferation
met CYP4F3 19p13.2 0.338 0.00835 0.252 leukotriene metabolic
exp PRMT1 19q13.3 0.338 0.00835 0.252 histone methylation;peptidyl-
xsq RNF166 16q24.3 0.338 0.00835 0.252
xai TADA2A 17q12-q21 0.34 0.00836 0.252 regulation of transcription,
xai NDUFAF7 2p22.2 0.34 0.00836 0.252
xai MRPS5 2p11.2-q11.2 0.34 0.00836 0.252 translation
xai NRF1 7q32 0.34 0.00836 0.252 mitochondrion organization;organ
regeneration
hs4 SPI1 11p11.2 0.34 0.00836 0.252 Transcription Factors
xsq HTATSF1 Xq26.3 0.338 0.00836 0.252 regulation of transcription
exp CRLS1 20p13-p12.3 0.338 0.00836 0.252 phospholipid biosynthetic process
exp MCM3AP-AS1 21q22.3 0.338 0.00836 0.252
xai KCTD21-AS1 11q14.1 0.34 0.00837 0.252
his MIR1307 0.34 0.00838 0.253
his USMG5 10q24.33 0.34 0.00838 0.253
his PDCD11 10q24.33 0.34 0.00838 0.253 Apoptosis
mut MROH7 1p32.3 0.337 0.00838 0.253
swa TRMT112 11q13.1 0.34 0.00839 0.253 peptidyl-glutamine
methylation
xai POLD3 11q14 0.34 0.00839 0.253 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq OVOL3 0.337 0.00839 0.253
his MRPL51 12p13.3-p13.1 0.34 0.0084 0.253 translation
his NCAPD2 12p13.3 0.34 0.0084 0.253 DNA Damage Response (DDR)
xai BOLA2 16p11.2 0.34 0.0084 0.253
exp LSP1P2 0.34 0.0084 0.253
xsq ALKBH2 12q24.11 0.337 0.0084 0.253 DNA Damage Response (DDR);
DDR (Direct Repair)
exp POLD3 11q14 0.337 0.0084 0.253 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq LANCL1 2q33-q35 0.337 0.0084 0.253 G-protein coupled receptor
signaling pathway
xai ABTB2 11p13 -0.34 0.0084 0.253 regulation of cell growth
exp P2RX6 22q11.21 -0.34 0.0084 0.253 ion transport;cation transport
hs4 ADAMTSL1 9p21.3 -0.34 0.0084 0.253
xsq GSTCD 4q24 0.337 0.00841 0.253
xsq PTGFRN 1p13.1 -0.337 0.00841 0.253 lipid particle
organization
his SULT4A1 22q13.2 0.34 0.00842 0.253 xenobiotic metabolic
process;steroid metabolic process
xai ILF3 19p13.2 0.34 0.00842 0.253 M phase;negative regulation of
xai ARRB2 17p13 0.34 0.00842 0.253 G-protein coupled receptor
xai FBRSL1 12q24.33 0.34 0.00842 0.253
exp SP4 7p15.3 0.337 0.00842 0.253 regulation of transcription from
xsq PAN2 12q13.2 0.337 0.00842 0.253 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;nuclear-transcribed mRNA catabolic process,
swa CD59 11p13 -0.34 0.00842 0.253 cell surface receptor signaling
pathway;blood coagulation
xai CRLS1 20p13-p12.3 0.34 0.00843 0.253 phospholipid biosynthetic process
mut TFPI 2q32 0.337 0.00843 0.253 blood coagulation;blood coagulation,
extrinsic pathway
exp RNF126 19p13.3 0.337 0.00843 0.253
xai SGMS2 4q25 -0.34 0.00843 0.253 lipid metabolic process;sphingolipid
metabolic process
his AGBL5-AS1 0.34 0.00844 0.253
his AGBL5 2p23.3 0.34 0.00844 0.253 proteolysis;protein deglutamylation
xai ZADH2 18q22.3 0.34 0.00844 0.253
exp TMEM9 -0.337 0.00844 0.253 transport
xsq EFNA5 5q21 -0.337 0.00844 0.253 apoptotic process;regulation of Rho
GTPase activity
xai RALB 2q14.2 -0.34 0.00844 0.253 cell cycle;signal transduction
hs4 PARD3B 2q33.3 -0.34 0.00844 0.253 cell division;cell cycle
swa ELOVL1 1p34.2 -0.34 0.00844 0.253 fatty acid elongation,
monounsaturated fatty acid;long-chain fatty-acyl-CoA biosynthetic process
exp NAGK 2p13.3 -0.337 0.00845 0.253 N-acetylglucosamine metabolic
process;N-acetylmannosamine metabolic process
xai MID1 Xp22 -0.34 0.00845 0.253 microtubule cytoskeleton
exp PGAM5 12q24.33 0.337 0.00846 0.253
met SOX9 17q24.3 0.337 0.00846 0.253 epithelial to mesenchymal
transition;heart valve formation
his WDCP 0.34 0.00847 0.253
his FKBP1B 2p23.3 0.34 0.00847 0.253 regulation of cardiac muscle
contraction by regulation of the release of sequestered calcium ion;protein
refolding
mda EGFR_ERBB2_pathway 0.337 0.00847 0.254
exp CSNK2A2 16q21 0.337 0.00847 0.254 Protein Kinases
exp PI4K2A 10q24 -0.337 0.00847 0.253 phosphatidylinositol
exp ITGAV 2q31-q32 -0.337 0.00848 0.254 angiogenesis;blood
coagulation
xsq BACE2 21q22.3 -0.337 0.00848 0.254 proteolysis;membrane protein
ectodomain proteolysis
his PDSS2 6q21 0.34 0.00849 0.254 isoprenoid biosynthetic
process;regulation of body fluid levels
xsq CD6 11q13 0.337 0.00849 0.254 cell adhesion
xai ARHGAP4 Xq28 0.34 0.0085 0.254 induction of apoptosis by
xai LOC100505549 0.34 0.0085 0.254
hs4 LOC729296 20q13.33 0.34 0.0085 0.254
xai HELLS 10q24.2 0.34 0.0085 0.254 mitosis;multicellular organismal
development
swa SQSTM1 5q35 -0.34 0.0085 0.254 Apoptosis
hs4 LOC102724593 -0.34 0.0085 0.254
swa EIF3G 19p13.2 0.34 0.00851 0.254 cellular protein metabolic
process;translation
hs4 GPR65 14q31-q32.1 0.34 0.00851 0.254 multicellular organismal
development;response to acidity
xai SEC11C 18q21.32 0.34 0.00851 0.254 small molecule metabolic
met FAM189A2 9q21.11 0.337 0.00851 0.254
exp HIST1H2BI 6p22.1 0.337 0.00851 0.254
exp CCDC69 5q33.1 0.337 0.00851 0.254
xai RPS15AP1 20p11.23 0.34 0.00852 0.254
xai CCZ1B 7p22.1 0.339 0.00853 0.254
his METTL6 3p25.1 0.339 0.00853 0.254
his EAF1 3p25.1 0.339 0.00853 0.254 regulation of transcription, DNA-
dependent"
exp PRDM13 6q16.2 0.337 0.00853 0.254 regulation of transcription,
DNA-dependent"
mut SPATA18 4q12 0.337 0.00853 0.254 response to DNA damage
stimulus;cellular response to stress
exp TRIO 5p15.2 -0.337 0.00853 0.254 transmembrane receptor
protein tyrosine phosphatase signaling pathway;small GTPase mediated signal
transduction
xsq MUC12 7q22 0.337 0.00854 0.254 post-translational protein
xai NUDT16 3q22.1 -0.339 0.00854 0.254
swa MAT2B 5q34-q35 0.339 0.00855 0.255 cellular nitrogen compound
his LIMD1-AS1 0.339 0.00855 0.255
his SACM1L 3p21.3 0.339 0.00855 0.255
dephosphorylation;phosphatidylinositol dephosphorylation
hs4 ENAH 1q42.12 -0.339 0.00855 0.255 intracellular transport;T
hs4 CIITA 16p13 -0.339 0.00856 0.255 positive regulation of MHC class I
biosynthetic process;positive regulation of MHC class II biosynthetic process
hs4 AK1 9q34.1 -0.339 0.00856 0.255 ATP metabolic
xai LOC100505938 0.339 0.00857 0.255
xsq ANXA2R 5p12 0.337 0.00857 0.255
exp AP2S1 19q13.2-q13.3 -0.336 0.00857 0.255 protein transport;viral
reproduction
swa CCDC124 19p13.11 0.339 0.00858 0.255
xsq PAIP2B 2p13.3 0.336 0.00858 0.255 negative regulation of
xsq IL1R1 2q12 -0.336 0.00858 0.255 ovulation;innate immune response
hs4 POU2AF1 11q23.1 0.339 0.0086 0.255 transcription from RNA
his MAIP1 0.339 0.0086 0.255
his TYW5 2q33.1 0.339 0.0086 0.255 tRNA processing;wybutosine
xsq MCM3 6p12 0.336 0.0086 0.255 DDR (DNA replication)
xsq KBTBD11 8p23.3 0.336 0.0086 0.255
DNA-dependent"
hs4 FAM215A 0.339 0.00861 0.256
exp TPRKB 2p24.3-p24.1 0.336 0.00861 0.256 protein catabolic process
xsq C17orf50 17q12 0.336 0.00861 0.256
hs4 C19orf60 19p13.11 0.339 0.00862 0.256
met DSTN 20p12.1 0.336 0.00862 0.256 cellular component movement;actin
xsq NCF1B 0.336 0.00862 0.256
swa TMEM30A 6q14.1 -0.339 0.00862 0.256 protein localization to
organelle;positive regulation of protein exit from endoplasmic reticulum
xai XAB2 19p13.2 0.339 0.00863 0.256 DNA Damage Response (DDR); DDR
(NER)
xsq LINC00602 6q27 0.336 0.00863 0.256
exp TATDN3 1q32.3 0.336 0.00863 0.256
met HCLS1 3q13 -0.336 0.00863 0.256 regulation of transcription, DNA-
hs4 RMDN2 2p22.2 -0.339 0.00863 0.256
exp LOC100631253 0.339 0.00864 0.256
exp RPS12P23 0.339 0.00865 0.256
xai LOC100631253 0.339 0.00865 0.256
xai NDUFB8 10q24.31 0.339 0.00865 0.256 transport;respiratory
xsq SLC26A8 6p21 0.336 0.00865 0.256 oxalate transport;cell
differentiation
exp MTA2 11q12-q13.1 0.336 0.00865 0.256 negative regulation of
transcription from RNA polymerase II promoter;chromatin assembly or disassembly
swa EIF3L 22q -0.339 0.00865 0.256 translational initiation
swa GNS 12q14 -0.339 0.00865 0.256 glycosaminoglycan catabolic
hs4 CAPS 19p13.3 -0.339 0.00865 0.256 intracellular signal
transduction
exp RPS15P4 2q31.1 0.336 0.00866 0.256
met MIPOL1 14q13.3 0.336 0.00866 0.256
mut B4GALT3 1q21-q23 0.336 0.00866 0.256 carbohydrate metabolic
exp PVR 19q13.2 -0.336 0.00866 0.256 cell junction
assembly;adherens junction organization
exp TANC1 2q24.2 -0.336 0.00866 0.256
xai APOL2 22q12 -0.339 0.00866 0.256 lipid metabolic process;transport
exp RPSAP54 13q12.11 0.339 0.00867 0.256
xai ATXN7L2 1p13.3 0.339 0.00868 0.256
xai CAMKK2 12q24.2 0.339 0.00868 0.256 positive regulation of
transcription, DNA-dependent;protein autophosphorylation
exp PDCD2L 19q13.11 0.336 0.00868 0.256 cell cycle
xsq CHCHD4 3p25.1 0.336 0.00868 0.256 protein transport
xsq RMDN2 2p22.2 -0.336 0.00868 0.256
xai RAPH1 2q33 -0.339 0.00868 0.256 cell-matrix adhesion;signal
transduction
hs4 GPR157 1p36.23 -0.339 0.00868 0.256
swa RAB32 6q24.3 -0.339 0.00868 0.256 small GTPase mediated signal
exp SNORD51 0.339 0.00869 0.256
exp ATAD3C 1p36.33 0.336 0.00869 0.256
xai FTH1P5 6p12.3 -0.339 0.00869 0.256
xai CLIC4 1p36.11 -0.339 0.00869 0.256 ion transport;chloride
transport
xai AHNAK 11q12.2 -0.339 0.00869 0.256 nervous system development
xai SIPA1L3 19q13.13 -0.339 0.00869 0.256 regulation of small
xai LRPPRC 2p21 0.339 0.0087 0.256 regulation of transcription, DNA-
dependent;transport
xai SNORD51 0.339 0.0087 0.256
met WNT4 1p36.23-p35.1 0.336 0.0087 0.256 Oncogenes
exp PPM1E 17q22 0.336 0.0087 0.256 negative regulation of protein kinase
hs4 C15orf52 15q15.1 -0.339 0.0087 0.256
xai DVL3 3q27 -0.339 0.0087 0.256 Wnt receptor signaling pathway;Wnt
receptor signaling pathway, planar cell polarity pathway
exp HNRNPA1P50 12q22 0.339 0.00871 0.256
xai MCM8 20p12.3 0.339 0.00871 0.256 S phase of mitotic cell cycle;M/G1
transition of mitotic cell cycle
xsq MYB 6q22-q23 0.336 0.00871 0.256 Apoptosis
exp RPL12P2 6p21.2 0.336 0.00871 0.256
exp RPL29P12 5p12 0.336 0.00871 0.256
xsq MKRN3 15q11-q13 0.336 0.00871 0.256
xsq CLIP4 2p23.2 -0.336 0.00871 0.256
xai APP 21q21.3 -0.339 0.00871 0.256 Apoptosis
hs4 MEIS3P1 17p12 -0.339 0.00871 0.256
xai BRI3 7q21.3 -0.339 0.00871 0.256
xai RPSAP54 13q12.11 0.339 0.00873 0.256
xsq CXXC1 18q12 0.336 0.00873 0.256 regulation of transcription, DNA-
response
xsq CCDC144B 17p11.2 -0.336 0.00873 0.256
xai WDR18 19p13.3 0.338 0.00874 0.257 multicellular organismal
development
xsq EML6 2p16.1 0.336 0.00874 0.257
xai PPM1E 17q22 0.338 0.00875 0.257 negative regulation of protein kinase
xsq PRMT7 16q22.1 0.336 0.00875 0.257 spliceosomal snRNP assembly;histone
exp TRAP1 16p13.3 0.336 0.00875 0.257 Apoptosis
xsq C1orf109 1p34.3 0.336 0.00875 0.257
xsq PPIC 5q23.2 -0.336 0.00875 0.257 protein folding;signal
transduction
xai PXN 12q24.31 -0.338 0.00875 0.257 cell adhesion;focal adhesion
assembly
his LOC100131496 20q13.12 -0.338 0.00875 0.257
hs4 C7orf57 7p12.3 -0.338 0.00875 0.257
hs4 NR2F6 19p13.1 -0.338 0.00875 0.257 gene expression;intracellular
receptor mediated signaling pathway
xai PDZD2 5p13.3 -0.338 0.00876 0.257 cell adhesion
xai CDC42BPB 14q32.3 -0.338 0.00876 0.257 Protein Kinases
xai HNRNPA1P50 12q22 0.338 0.00877 0.257
his IQGAP2 5q13.3 0.338 0.00877 0.257 signal
his HNRNPA1 12q13.1 0.338 0.00877 0.257 interspecies interaction
between organisms;alternative nuclear mRNA splicing, via spliceosome
his NFE2 12q13 0.338 0.00877 0.257 multicellular organismal
development;blood coagulation
xai MRPL23 11p15.5 0.338 0.00877 0.257 translation
his CASP8AP2 6q15 0.338 0.00877 0.257 Apoptosis
exp ITM2A Xq13.3-Xq21.2 0.336 0.00877 0.257
met LGI2 4p15.2 0.336 0.00878 0.257
xsq NIFK-AS1 0.335 0.00878 0.257
xai HCG11 6p22.2 0.338 0.00879 0.257
hs4 SLC38A5 Xp11.23 0.338 0.00879 0.257 Solute Carriers
xsq MBTD1 17q21.33 0.335 0.00879 0.257 regulation of transcription, DNA-
exp BCAM 19q13.2 -0.335 0.00879 0.257 cell-matrix adhesion;signal
transduction
xai MED15 22q11.2 -0.338 0.0088 0.257 regulation of transcription
hs4 LCP1 13q14.3 0.338 0.00881 0.258 T cell activation involved in
immune response;organ regeneration
xsq P3H2 -0.335 0.00881 0.258 negative regulation of cell
proliferation;peptidyl-proline hydroxylation
xai ARID3B 15q24 0.338 0.00882 0.258 regulation of transcription, DNA-
dependent"
met EPB41L4A-AS1 5q22.2 0.335 0.00882 0.258
xsq C2orf48 2p25.1 0.335 0.00883 0.258
xai PVR 19q13.2 -0.338 0.00883 0.258 cell junction
hs4 C1GALT1C1L -0.338 0.00883 0.258
his ATP5G1 17q21.32 0.338 0.00884 0.258 mitochondrial ATP synthesis
coupled proton transport;small molecule metabolic process
met VGLL4 3p25.3 0.335 0.00884 0.258 regulation of transcription, DNA-
dependent"
xai TTC39B 9p22.3 -0.338 0.00884 0.258
xai RASSF5 1q32.1 0.338 0.00885 0.258 Apoptosis
hs4 SEPT1 16p11.1 0.338 0.00885 0.258 cell cycle;cell division
met SPIN2A Xp11.1 0.335 0.00885 0.258 cell cycle;gamete generation
exp LDOC1L 22q13.31 -0.335 0.00885 0.258
xai SH3RF2 5q32 -0.338 0.00885 0.258 negative regulation of
xai SRCAP 16p11.2 0.338 0.00887 0.258 regulation of transcription from
RNA polymerase II promoter;chromatin modification
exp RPL29P21 11p15.1 0.335 0.00887 0.258
xsq LINC00563 0.335 0.00887 0.258
xai MED26 19p13.11 0.338 0.00888 0.259 regulation of transcription from
RNA polymerase II promoter;transcription initiation from RNA polymerase II promoter
his KLHL8 4q22.1 0.338 0.00888 0.259
xsq MYLK 3q21 -0.335 0.00888 0.259 positive regulation of cell
migration;bleb assembly
xai ERBB2 17q12 -0.338 0.00888 0.259 Apoptosis; Oncogenes; Protein
Kinases
met TMPRSS3 21q22.3 0.335 0.00889 0.259 sensory perception of
sound;proteolysis
xsq MYH15 3q13.13 0.335 0.00889 0.259
exp RPS3 11q13.3-q13.5 0.335 0.00889 0.259 translational
termination;mRNA metabolic process
exp RPRD1A 18q12.2 0.335 0.00889 0.259 dephosphorylation of RNA
met TUFT1 1q21 0.335 0.00889 0.259 odontogenesis;bone mineralization
xsq CORO2B 15q23 -0.335 0.00889 0.259 actin cytoskeleton
organization
met PRF1 10q22 -0.335 0.00889 0.259 defense response to tumor
cell;defense response to virus
xai CTBP2 10q26.13 -0.338 0.00889 0.259 negative regulation of
met RELB 19q13.32 0.335 0.0089 0.259 Apoptosis
exp LY86 6p25.1 0.335 0.0089 0.259 apoptotic process;inflammatory
response
exp HCG11 6p22.2 0.335 0.0089 0.259
xsq PDZD2 5p13.3 -0.335 0.0089 0.259 cell adhesion
exp LOC100130078 -0.338 0.0089 0.259
xai ITPRIPL2 16p12.3 -0.338 0.0089 0.259
exp RPL34P6 1q32.1 0.338 0.00891 0.259
his DLEU7-AS1 0.338 0.00891 0.259
xai TADA1 1q24.1 0.338 0.00891 0.259 regulation of transcription, DNA-
dependent;histone H3 acetylation"
exp PPM1G 2p23.3 0.335 0.00891 0.259 protein dephosphorylation;cell
cycle arrest
met IMPACT 18q11.2-q12.1 0.335 0.00891 0.259 negative regulation of
protein phosphorylation;regulation of translational initiation
mir hsa-miR-150 0.335 0.00891 0.259
met PCDHGA11 5q31 -0.335 0.00891 0.259 cell adhesion;homophilic cell
adhesion
xai LOC100130078 -0.338 0.00891 0.259
xai SCARNA15 15q25.2 0.338 0.00892 0.259
xsq NIP7 16q22.1 0.335 0.00892 0.259 ribosome assembly
exp PTCD3 2p11.2 0.335 0.00892 0.259
exp APOC3 11q23.3 0.335 0.00893 0.259 negative regulation of triglyceride
catabolic process;phospholipid efflux
xsq RAC3 17q25.3 0.335 0.00893 0.259 actin cytoskeleton
his MIR3935 -0.338 0.00893 0.259
his STXBP4 17q22 0.337 0.00895 0.259 protein targeting;insulin receptor
signaling pathway
his COX11 17q22 0.337 0.00895 0.259 respiratory gaseous exchange;respiratory
chain complex IV assembly
xai GLIPR1L2 12q21.2 0.337 0.00895 0.259
exp FCGBP 19q13.1 0.337 0.00895 0.259
swa PGK1 Xq13.3 0.337 0.00895 0.259 glucose metabolic
process;gluconeogenesis
xai KIAA1217 10p12.31 -0.337 0.00895 0.259 multicellular organismal
hs4 CR1 1q32 0.337 0.00896 0.259 negative regulation of complement
activity
xsq KIF25-AS1 0.335 0.00896 0.259
exp SLC12A5 20q13.12 0.335 0.00896 0.259 ammonium
transport;intracellular pH reduction
exp LOC100131565 8p22 0.335 0.00896 0.259
xsq POLR3K 16p13.3 0.335 0.00896 0.259 transcription from RNA
mut TTF2 1p22 0.335 0.00896 0.259 mRNA processing;RNA splicing
xsq ENC1 5q13 -0.335 0.00896 0.259 nervous system
xai TTC4 1p32.3 0.337 0.00897 0.259
exp MGC13053 0.335 0.00897 0.259
exp SLIT1 10q23.3-q24 0.335 0.00897 0.259 nervous system development;retinal
xsq SGCE 7q21.3 -0.335 0.00897 0.259 cell-matrix adhesion;muscle
organ development
xsq TLR5 1q41-q42 -0.335 0.00897 0.259 cellular response to
hs4 LRRC49 15q23 -0.337 0.00897 0.259
hs4 THAP10 15q23 -0.337 0.00897 0.259
exp SRCAP 16p11.2 0.335 0.00898 0.259 regulation of transcription from
xsq ITM2A Xq13.3-Xq21.2 0.335 0.00898 0.259
cop CABLES1 18q11.2 0.335 0.00898 0.259 regulation of cell
cycle;nervous system development
hs4 ARHGEF28 5q13.2 -0.337 0.00898 0.259
xsq CHAC2 2p16 0.335 0.00899 0.259
met SLMAP 3p21.2-p14.3 0.335 0.00899 0.259 protein folding;muscle
contraction
xsq OGN 9q22 0.335 0.00899 0.259 negative regulation of smooth muscle cell
proliferation
xai ZEB1-AS1 10p11.22 0.337 0.009 0.259
his PCBP1-AS1 0.337 0.009 0.259
his PCBP1 2p13-p12 0.337 0.009 0.259 nuclear mRNA splicing, via
xsq EDN1 6p24.1 -0.334 0.009 0.259 negative regulation of
transcription from RNA polymerase II promoter;cell surface receptor signaling
pathway
exp LATS2 13q11-q12 -0.334 0.009 0.259 protein phosphorylation;negative
regulation of cyclin-dependent protein kinase activity
hs4 HTRA1 10q26.3 -0.337 0.009 0.259 regulation of cell
growth;proteolysis
xai CSTF2 Xq22.1 0.337 0.00901 0.259 gene expression;nuclear mRNA
exp EEF1B2P4 12q23.3 0.337 0.00901 0.26
mut PPL 16p13.3 0.334 0.00901 0.26 keratinization
exp MCM8 20p12.3 0.334 0.00901 0.26 S phase of mitotic cell cycle;M/G1
exp PLXNA1 3q21.3 -0.334 0.00901 0.26 signal
transduction;multicellular organismal development
hs4 CHRNA9 4p14 0.337 0.00902 0.26 ion transport;elevation of
exp NUFIP1 13q14 0.334 0.00902 0.26 box C/D snoRNP assembly;RNA
processing
xsq CLNS1A 11q13.5-q14 0.334 0.00902 0.26 blood circulation;gene
expression
xsq PRR29 0.334 0.00902 0.26
xsq VEPH1 3q24-q25 -0.334 0.00902 0.26
xai SPAG5-AS1 0.337 0.00903 0.26
exp CFAP20 0.334 0.00903 0.26 multicellular organismal
development
exp SNORA13 5q22.2 0.334 0.00903 0.26
xai EEF1B2P4 12q23.3 0.337 0.00904 0.26
exp SLCO4A1 20q13.33 0.334 0.00904 0.26 Solute Carriers
cop TMEM241 18q11.2 0.334 0.00904 0.26
cop RIOK3 18q11.2 0.334 0.00904 0.26 protein phosphorylation;chromosome
segregation
cop C18orf8 18q11.2 0.334 0.00904 0.26
cop NPC1 18q11.2 0.334 0.00904 0.26 autophagy;lysosomal transport
cop ANKRD29 18q11.2 0.334 0.00904 0.26
xsq JDP2 14q24.3 -0.334 0.00904 0.26 negative regulation of
exp HEG1 3q21.2 -0.334 0.00904 0.26 endothelial cell
xsq UQCRH 1p34.1 0.334 0.00905 0.26
his FAM219B 15q24.1 0.337 0.00906 0.26
exp LOC100128001 0.337 0.00906 0.26
xai LOC100128001 0.337 0.00906 0.26
exp RPS10P3 9q22.1 0.334 0.00906 0.26
exp SERPINI1 3q26.1 0.334 0.00906 0.26 peripheral nervous system
development;negative regulation of endopeptidase activity
xsq MDN1 6q15 0.334 0.00906 0.26 ATP catabolic process;protein complex
assembly
met CERS2 1q21.3 -0.334 0.00906 0.26 small molecule metabolic
process;ceramide biosynthetic process
xsq MSH5-SAPCD1 0.334 0.00907 0.26
his DUSP11 2p13.1 0.337 0.00908 0.26 RNA processing;peptidyl-
exp RPSAP1 20q13.13 0.337 0.00908 0.26
xsq LOC100507424 0.334 0.00908 0.26
exp FAM98B 15q14 0.334 0.00908 0.26
xsq SNRNP48 6p24.3 0.334 0.00908 0.26 mRNA processing;RNA splicing
exp KIF3B 20q11.21 -0.334 0.00908 0.26 microtubule-based
movement;mitotic spindle organization
exp CTSO 4q32.1 -0.334 0.00908 0.26 proteolysis
xai DARS 2q21.3 0.337 0.00909 0.26 translation;tRNA aminoacylation for
protein translation
xai EEF1GP2 5q32 0.337 0.00909 0.26
exp LOC729275 0.337 0.0091 0.26
exp RPS24P6 2q11.1 0.337 0.0091 0.26
xai RPL7AP26 0.337 0.0091 0.26
xai FTSJ3 17q23.3 0.337 0.00911 0.26 RNA methylation;rRNA processing
xai LOC729275 0.337 0.00911 0.26
his GFRA4 20p13-p12 0.337 0.00911 0.26
mir hsa-miR-20b 0.334 0.00911 0.26
xsq TIMP2 17q25 -0.334 0.00911 0.26 negative regulation of cell
hs4 KIAA1522 1p35.1 -0.337 0.00911 0.26
xai CORO2B 15q23 -0.337 0.00911 0.26 actin cytoskeleton
organization
xai PTPN1 20q13.1-q13.2 -0.337 0.00911 0.26 regulation of
xai LINC01550 0.337 0.00912 0.26
xsq LBHD1 0.334 0.00912 0.26
met BAAT 9q22.3 0.334 0.00912 0.26 lipid metabolic process;small
his LILRP2 19q13.4 0.337 0.00913 0.26
xai RPL34P1 1q23-q24 0.337 0.00913 0.26
xai GTSE1-AS1 22q13.31 0.337 0.00913 0.26
exp RPL34P1 1q23-q24 0.337 0.00913 0.26
exp RPL35P1 1q43 0.334 0.00913 0.26
xsq LURAP1L 9p23 -0.334 0.00913 0.26
his P3H2-AS1 -0.337 0.00913 0.26
his P3H2 -0.337 0.00913 0.26 negative regulation of cell
his NCAPG2 7q36.3 0.337 0.00914 0.26 DNA Damage Response (DDR)
his TPRKB 2p24.3-p24.1 0.337 0.00914 0.26 protein catabolic process
xai SRBD1 2p21 0.337 0.00914 0.26 nucleobase-containing compound metabolic
process
his MIR6854 -0.337 0.00914 0.26
hs4 ITPRIPL2 16p12.3 -0.337 0.00914 0.26
exp TADA2A 17q12-q21 0.334 0.00915 0.261 regulation of transcription,
exp RPL7AP8 10q23.2 0.334 0.00915 0.261
his PUS3 11q24.2 0.337 0.00916 0.261 tRNA processing;tRNA pseudouridine
synthesis
his DDX25 11q24 0.337 0.00916 0.261 transport;multicellular organismal
development
xai YBX3 12p13.1 0.337 0.00916 0.261
xsq AP4B1 1p13.2 0.334 0.00916 0.261 intracellular protein
xsq SMIM17 19q13.43 0.334 0.00916 0.261
hs4 RNF217 6q22.31 -0.337 0.00916 0.261 protein ubiquitination
involved in ubiquitin-dependent protein catabolic process
hs4 RNF217-AS1 -0.337 0.00916 0.261
his FAM78A 9q34 0.336 0.00917 0.261
xsq SARDH 9q33-q34 0.334 0.00917 0.261 glycine catabolic process
DNA-dependent"
xsq SLCO4A1 20q13.33 0.334 0.00917 0.261 Solute Carriers
hs4 GPC6 13q32 -0.336 0.00917 0.261
exp RASSF5 1q32.1 0.334 0.00918 0.261 Apoptosis
exp CCNT1 12q13.11 0.334 0.00918 0.261 transcription elongation from RNA
exp FAM86FP 12p13.31 0.334 0.00918 0.261
his VPS37C 11q12.2 -0.336 0.00919 0.261 protein transport;viral
reproduction
hs4 LINC01010 -0.336 0.00919 0.261
his MPHOSPH9 12q24.31 0.336 0.0092 0.261 M phase of mitotic cell cycle
his C12orf65 12q24.31 0.336 0.0092 0.261 translational termination
exp TEX10 9q31.1 0.334 0.00921 0.261
exp RPS15AP17 4q13.1 0.334 0.00921 0.261
xai RPL34P6 1q32.1 0.336 0.00922 0.261
his MLKL 16q23.1 0.336 0.00922 0.261
his SPC25 2q31.1 0.336 0.00922 0.261 mitotic cell cycle;mitotic spindle
organization
xsq SERPINI1 3q26.1 0.333 0.00922 0.261 peripheral nervous system
exp COX5AP1 14q22 0.333 0.00922 0.262
xai TOM1L2 17p11.2 -0.336 0.00922 0.261 intracellular protein
transport
xai CDC14A 1p21 0.336 0.00923 0.262 cell cycle;cell proliferation
xsq NOP14 4p16.3 0.333 0.00923 0.262 endonucleolytic cleavage to
exp RILPL2 12q24.31 0.333 0.00923 0.262
exp SNRNP48 6p24.3 0.333 0.00923 0.262 mRNA processing;RNA splicing
his RTCA 1p21.2 0.336 0.00924 0.262 RNA processing
his RTCA-AS1 0.336 0.00924 0.262
exp SNORD46 0.336 0.00924 0.262
met GPR39 2q21-q22 0.333 0.00924 0.262 G-protein coupled receptor
signaling pathway
exp CCDC66 3p14.3 0.333 0.00924 0.262
his PRADC1 2p13.2 0.336 0.00925 0.262
his CCT7 2p13.2 0.336 0.00925 0.262 protein folding;cellular protein
metabolic process
exp TTC39B 9p22.3 -0.333 0.00925 0.262
his GABPB1-AS1 15q21.2 0.336 0.00926 0.262
his FLJ10038 15q21.2 0.336 0.00926 0.262
his GABPB1 15q21.2 0.336 0.00926 0.262 positive regulation of
his MIR4712 0.336 0.00926 0.262
his MKKS 20p12 0.336 0.00926 0.262 heart development;melanosome transport
his SLX4IP 20p12.2 0.336 0.00926 0.262
xsq ATG4C 1p31.3 0.333 0.00926 0.262 autophagic vacuole
xai SF3A3 1p34.3 0.336 0.00927 0.262 RNA splicing;gene expression
xai CFAP20 0.336 0.00927 0.262 multicellular organismal
development
xai SNORD46 0.336 0.00927 0.262
swa PCBP3 21q22.3 0.336 0.00927 0.262 mRNA metabolic process
exp RNF40 16p11.2-p11.1 0.333 0.00927 0.262 ubiquitin-dependent protein
catabolic process;histone monoubiquitination
swa PCYOX1 2p13.3 -0.336 0.00927 0.262 chloride
transport;prenylated protein catabolic process
xai BORCS6 0.336 0.00928 0.262
his MIR4487 0.336 0.00928 0.262
exp PMS1 2q31.1 0.336 0.00928 0.262 DNA Damage Response (DDR); DDR
(MMR)
swa PFN2 3q25.1 -0.336 0.00928 0.262 regulation of actin
xai SMIM5 17q25.1 -0.336 0.00928 0.262
hs4 RASGRP4 19q13.1 0.336 0.00929 0.262 myeloid cell
exp RPS26P11 0.336 0.00929 0.262
xsq NKD2 5p15.3 0.333 0.00929 0.262 transport;exocytosis
his DDX23 12q13.12 0.336 0.0093 0.262 RNA splicing, via
hs4 PLCH2 1p36.32 0.336 0.0093 0.262 lipid catabolic
xsq HEG1 3q21.2 -0.333 0.0093 0.262 endothelial cell
exp DDX18P6 10q23.31 0.336 0.00931 0.262
xai PTP4A3 8q24.3 0.336 0.00931 0.262
swa CTTNBP2NL 1p13.2 0.336 0.00931 0.262
xsq CYP2E1 10q26.3 0.333 0.00931 0.262 heterocycle metabolic
xai CEP295NL -0.336 0.00931 0.262
exp RPL7AP26 0.336 0.00932 0.262
xai NCAPD2 12p13.3 0.336 0.00932 0.262 DNA Damage Response (DDR)
his KCNC4-AS1 0.336 0.00932 0.262
his KCNC4 1p21 0.336 0.00932 0.262 ion transport;potassium ion transport
his LAS1L Xq12 0.336 0.00932 0.262 rRNA processing
his MCM2 3q21 0.336 0.00932 0.262 DDR (DNA replication)
exp SEPSECS 4p15.2 0.333 0.00932 0.262 selenocysteine
exp PDZD2 5p13.3 -0.333 0.00932 0.262 cell adhesion
xai RPSAP4 14q32.13 0.336 0.00933 0.262
met MICA 6p21.33 0.333 0.00933 0.262 response to heat;cytolysis
xsq NRF1 7q32 0.333 0.00933 0.262 mitochondrion organization;organ
regeneration
xsq KIAA1217 10p12.31 -0.333 0.00933 0.262 multicellular organismal
met FIGNL2 12q13.13 -0.333 0.00933 0.262
xai HIST1H4K 6p22.1 0.336 0.00934 0.262
exp C2orf49 2q12.1 0.336 0.00934 0.262 embryonic morphogenesis
exp SRSF9 12q24.31 0.333 0.00934 0.262 termination of RNA polymerase II
transcription;mRNA splice site selection
met TEKT3 17p12 0.333 0.00934 0.262 microtubule cytoskeleton organization
exp ZP1 11q12.2 0.333 0.00934 0.262 single fertilization
exp CDC42BPB 14q32.3 -0.333 0.00934 0.262 Protein Kinases
xai NAV2 11p15.1 -0.336 0.00934 0.262
xai RNASEH2B 13q14.3 0.336 0.00935 0.262 DNA Damage Response (DDR);
his LOC101927069 0.336 0.00935 0.262
xsq PLD6 17p11.2 0.333 0.00935 0.262 piRNA metabolic process;meiosis
xsq CYP4F2 19p13.12 0.333 0.00935 0.262 drug metabolic process;sodium
ion homeostasis
xsq PECAM1 17q23.3 0.333 0.00935 0.262 platelet
exp SNX7 1p21.3 -0.333 0.00935 0.262 cell communication;protein
transport
xai MXRA8 1p36.33 -0.336 0.00935 0.262
his ZMYM3 Xq13.1 0.336 0.00936 0.262 multicellular organismal
xai RPS26P11 0.336 0.00936 0.262
exp RPSAP4 14q32.13 0.336 0.00936 0.262
xai TRMT6 20p12.3 0.336 0.00937 0.262 regulation of translational
initiation;tRNA processing
hs4 MYO1G 7p13-p11.2 0.336 0.00937 0.262
xai CYSLTR1 Xq13.2-q21.1 0.336 0.00938 0.263 respiratory gaseous
exp EPB41 1p33-p32 0.333 0.00938 0.263 blood circulation;actin
exp GMNN 6p22.3 0.333 0.00938 0.263 DDR (DNA replication)
xsq CBR1 21q22.13 -0.333 0.00938 0.263 oxidation-reduction
process;drug metabolic process
exp LAMP1 13q34 -0.333 0.00938 0.263 autophagy;autophagic cell death
xai EPB41 1p33-p32 0.335 0.00939 0.263 blood circulation;actin
xai SLC38A5 Xp11.23 0.335 0.00939 0.263 Solute Carriers
exp KIR3DL1 0.333 0.00939 0.263 regulation of immune
response;immune response
exp IL6ST 5q11.2 -0.333 0.00939 0.263 JAK-STAT cascade;positive
hs4 NEDD9 6p25-p24 -0.335 0.0094 0.263 regulation of growth;actin
filament bundle assembly
xai PDGFC 4q32 -0.335 0.0094 0.263 positive regulation of DNA
replication;platelet-derived growth factor receptor signaling pathway
xai GAPDHP28 10q23.32 0.335 0.00941 0.263
mir hsa-miR-10a -0.333 0.00941 0.263
his CYBB Xp21.1 0.335 0.00942 0.263 ion transport;oxidation-reduction
process
exp RPL27A 11p15 0.333 0.00942 0.263 translational initiation;viral
infectious cycle
DNA-dependent"
met CKMT2 5q13.3 0.333 0.00943 0.263 creatine metabolic process;muscle
contraction
exp FCHSD2 11q13.4 0.333 0.00943 0.263
met ARHGEF19 1p36.13 -0.333 0.00943 0.263 positive regulation of
Rho GTPase activity;regulation of actin cytoskeleton organization
his ARHGAP35 19q13.3 -0.335 0.00943 0.263 axon guidance;positive
exp SNORA50C 0.333 0.00944 0.263
hs4 LINC00111 -0.335 0.00944 0.263
xsq CD79B 17q23 0.332 0.00945 0.264 immune response;signal transduction
swa AHNAK 11q12.2 -0.335 0.00945 0.264 nervous system development
xai LDOC1L 22q13.31 -0.335 0.00945 0.264
xai GPC6 13q32 -0.335 0.00946 0.264
swa MYH9 22q13.1 -0.335 0.00946 0.264 membrane protein ectodomain
hs4 AIF1 6p21.3 0.335 0.00947 0.264 positive regulation of muscle
exp TTC16 9q34.11 0.332 0.00948 0.264
mut GAA 17q25.2-q25.3 0.332 0.00948 0.264 heart morphogenesis;tissue
development
exp PNP 14q13.1 0.332 0.00948 0.264 nicotinamide riboside catabolic
hs4 RHPN2 19q13.11 -0.335 0.00948 0.264 signal transduction
xai C19orf54 19q13.2 0.335 0.00949 0.264
met OR2G2 1q44 0.332 0.00949 0.264 response to stimulus
exp ERN1 17q24.2 0.332 0.00949 0.264 response to unfolded
response
met GABRE Xq28 0.332 0.00949 0.264 transport;ion transport
mut PTPN4 2q14.2 0.332 0.00949 0.264 protein dephosphorylation
exp CDC14A 1p21 0.332 0.00949 0.264 cell cycle;cell proliferation
xai ATP8B1 18q21.31 -0.335 0.00949 0.264 bile acid and bile salt
transport;ion transmembrane transport
his C10orf131 10q24.1 0.335 0.0095 0.264
xsq BCL6 3q27 -0.332 0.0095 0.264 cell morphogenesis;negative
xai KLRC2 0.335 0.00951 0.264 cellular defense response;signal
transduction
swa FKBP4 12p13.33 0.335 0.00951 0.264 peptidyl-proline
modification;androgen receptor signaling pathway
xai RPS23P7 0.335 0.00951 0.264
exp SNRPGP8 0.335 0.00952 0.264
xsq FEN1 11q12 0.332 0.00952 0.264 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
exp HNRNPR 1p36.12 0.332 0.00952 0.264 nuclear mRNA splicing, via
mir hsa-miR-134 0.332 0.00952 0.264
exp EML6 2p16.1 0.332 0.00952 0.264
his RARS2 6q16.1 0.335 0.00953 0.264 tRNA aminoacylation for protein
translation;arginyl-tRNA aminoacylation
his ORC3 6q14.3-q16.1 0.335 0.00953 0.264 DDR (DNA replication)
hs4 RRM2 2p25-p24 0.335 0.00953 0.264 DNA Damage Response (DDR)
met SLC35B2 6p12.1-p11.2 0.332 0.00953 0.264 Solute Carriers
xsq CTNNA1 5q31.2 -0.332 0.00953 0.264 Apoptosis; Tumor
Suppressors
exp RAPH1 2q33 -0.332 0.00953 0.264 cell-matrix adhesion;signal
transduction
xai RPL27A 11p15 0.338 0.00954 0.264 translational initiation;viral
infectious cycle
xai SNRPGP8 0.335 0.00954 0.264
exp ZGRF1 0.332 0.00954 0.264
xai ELOVL7 5q12.1 -0.335 0.00954 0.264 small molecule metabolic
his C16orf95 0.335 0.00955 0.265
his LOC101928659 0.335 0.00955 0.265
xai MYO1G 7p13-p11.2 0.335 0.00955 0.265
hs4 DDX12P 12p13.31 0.335 0.00955 0.265 nucleobase-containing
xsq C16orf95 0.332 0.00955 0.265
exp C12orf73 12q23.3 0.332 0.00955 0.265
cop CTAGE1 18p11.2 0.332 0.00955 0.265
his LOC730202 14q32.2 0.335 0.00956 0.265
his PAPOLA 14q32.31 0.335 0.00956 0.265 RNA splicing;gene expression
xsq PRICKLE1 12q12 -0.332 0.00956 0.265 negative regulation of
transcription, DNA-dependent;negative regulation of canonical Wnt receptor
signaling pathway
his CLNS1A 11q13.5-q14 0.335 0.00957 0.265 blood circulation;gene
expression
exp DCP1A 3p21.1 0.332 0.00957 0.265 nuclear-transcribed mRNA catabolic
his C16orf92 16p11.2 0.335 0.00958 0.265
xai GAL 11q13.3 0.335 0.00958 0.265 inflammatory response;response to
insulin stimulus
exp C6orf163 6q15 0.335 0.00958 0.265
met KDELR3 22q13.1 0.332 0.00958 0.265 protein retention in ER
response
exp RPS10P8 1q23.1 0.332 0.00958 0.265
exp C19orf54 19q13.2 0.332 0.00958 0.265
exp EMBP1 1p11.2 0.332 0.00958 0.265
DNA-dependent"
xai ANXA2P3 10q21.3 -0.335 0.00959 0.265
exp SRBD1 2p21 0.332 0.0096 0.265 nucleobase-containing compound metabolic
process
mut PLD3 19q13.2 0.332 0.0096 0.265 lipid catabolic process
exp LOX 5q23.2 -0.332 0.0096 0.265 response to steroid hormone
xai LOC100129406 -0.335 0.0096 0.265
exp TMCO3 13q34 -0.332 0.00962 0.265 cation transport;transmembrane
transport
swa PLEC 8q24 -0.334 0.00962 0.265 cell junction assembly;apoptotic
process
xai NXT2 Xq23 0.334 0.00963 0.266 protein transport;mRNA transport
exp RBM33 7q36.3 0.334 0.00963 0.266
exp EPM2A 6q24 0.332 0.00963 0.266 carbohydrate metabolic process;glycogen
metabolic process
exp EXOSC8 13q13.1 0.332 0.00963 0.266 mRNA metabolic
exp FLJ37453 1p36.21 0.332 0.00963 0.266
xsq TEAD1 11p15.2 -0.332 0.00963 0.266 regulation of transcription,
xai RPL9P3 0.334 0.00964 0.266
hs4 PCAT18 0.334 0.00964 0.266
exp CPT1A 11q13.2 0.332 0.00964 0.266 positive regulation of fatty acid
met ST8SIA4 5q21 -0.332 0.00964 0.266 oligosaccharide metabolic
hs4 ABCC6P2 -0.334 0.00964 0.266
swa WDR5 9q34 0.334 0.00965 0.266 regulation of transcription, DNA-
dependent;chromatin modification
swa MZB1 5q31.2 0.334 0.00965 0.266 positive regulation of
xsq TSEN2 3p25.2 0.332 0.00965 0.266 tRNA splicing, via endonucleolytic
exp ARSJ 4q26 -0.332 0.00965 0.266
exp CTGF 6q23.1 -0.332 0.00965 0.266 response to wounding;positive
his LINC01876 0.334 0.00966 0.266
exp HOMER1 5q14.2 0.332 0.00966 0.266 regulation of store-operated
calcium entry;regulation of cation channel activity
xsq CRIP2 14q32.3 -0.332 0.00966 0.266 positive regulation of cell
exp TRIM16 17p11.2 -0.332 0.00966 0.266 positive regulation of
keratinocyte differentiation;positive regulation of transcription, DNA-dependent
xai TANC1 2q24.2 -0.334 0.00966 0.266
swa GRB2 17q24-q25 0.334 0.00967 0.266 cell-cell signaling;T cell
costimulation
exp ARRB2 17p13 0.332 0.00967 0.266 G-protein coupled receptor
exp LOC728533 19q13.12 0.331 0.00967 0.266
hs4 NGB 0.334 0.00968 0.266
xsq FUCA2 6q24 -0.331 0.00968 0.266 fucose metabolic
his CMTM2 -0.334 0.00968 0.266
his EXOSC3 9p11 0.334 0.00969 0.266 exonucleolytic nuclear-transcribed
mRNA catabolic process involved in deadenylation-dependent decay;DNA deamination
xai NCR3 6p21.3 0.334 0.00969 0.266 inflammatory response;immune
response
exp EPHX1 1q42.1 -0.331 0.00969 0.266 response to toxin;response to
xai RBM33 7q36.3 0.334 0.0097 0.266
exp CCT8P1 0.334 0.0097 0.266
xai RPF2 6q21 0.334 0.0097 0.266
xai ARHGAP1 11p11.2 -0.334 0.0097 0.266 positive regulation of
Rho GTPase activity;regulation of GTPase activity
xai RPL5P22 8p21.1 0.334 0.00971 0.266
his SNCAIP 5q23.2 0.334 0.00971 0.266 cell death;dopamine metabolic
process
hs4 TTC24 1q23.1 0.334 0.00971 0.266
met LRRC49 15q23 0.331 0.00971 0.266
exp LAPTM5 1p34 0.331 0.00971 0.266 transport
DNA-dependent;induction of apoptosis
swa SERPINH1 11q13.5 -0.334 0.00971 0.266 response to
stress;response to unfolded protein
xai EGFR 7p12 -0.334 0.00971 0.266 Apoptosis; Cell Signaling;
exp PTMAP3 20p11.23 0.331 0.00972 0.266
xsq GPR65 14q31-q32.1 0.331 0.00972 0.266 multicellular organismal
xsq MAGOH 1p32.3 0.331 0.00972 0.266 transcription from RNA polymerase
II promoter;mRNA metabolic process
xai POLRMTP1 17q23.2 0.334 0.00973 0.266
exp POLRMT 19p13.3 0.331 0.00973 0.266 transcription from
exp SH3RF2 5q32 -0.331 0.00973 0.266 negative regulation of
hs4 DPEP2 16q22.1 0.334 0.00974 0.267 leukotriene biosynthetic
xsq ZNF280C Xq26.1 0.331 0.00974 0.266 regulation of transcription,
DNA-dependent"
exp LOC93622 4p16.1 0.331 0.00974 0.267
hs4 ASAP2 2p25 -0.334 0.00974 0.267 regulation of ARF GTPase
xai GRPEL1 4p16 0.334 0.00976 0.267 protein folding;protein import into
mitochondrial matrix
xai DDX18P6 10q23.31 0.334 0.00976 0.267
swa MCM5 22q13.1 0.334 0.00976 0.267 DDR (DNA replication)
xsq PARTICL 0.331 0.00976 0.267
xai SSBP3 1p32.3 0.334 0.00977 0.267 prechordal plate
formation;midbrain-hindbrain boundary initiation
his ERAL1 17q11.2 0.334 0.00977 0.267 ribosomal small subunit
assembly;ribosome biogenesis
exp ERBB2 17q12 -0.331 0.00977 0.267 Apoptosis; Oncogenes; Protein
Kinases
exp RIMBP3C 0.331 0.00978 0.267
met VASN 16p13.3 0.331 0.00978 0.267
exp ATP8B1 18q21.31 -0.331 0.00978 0.267 bile acid and bile salt
exp ZBTB47 3p22.1 -0.331 0.00978 0.267 regulation of
hs4 P2RY1 3q25.2 0.334 0.00979 0.267 response to mechanical
exp GCDH 19p13.2 0.331 0.00979 0.267 lysine catabolic process;acyl-CoA
metabolic process
xsq FAM163B 9q34.2 0.331 0.00979 0.267
exp YKT6 7p15.1 -0.331 0.00979 0.267 protein transport;retrograde
transport, endosome to Golgi
xsq TCEAL3 Xq22.2 -0.331 0.00979 0.267 regulation of
xsq ACTN1 14q24 -0.331 0.0098 0.267 Apoptosis
xai RNF217 6q22.31 -0.334 0.0098 0.267 protein ubiquitination
hs4 MXRA5 Xp22.33 -0.334 0.0098 0.267
exp CAMKK2 12q24.2 0.331 0.00981 0.267 positive regulation of
his SLC7A3 Xq13.1 0.334 0.00982 0.267 Solute Carriers
xai ZNF227 0.334 0.00982 0.267 regulation of transcription, DNA-
dependent"
his ACTN1 14q24 -0.334 0.00982 0.267 Apoptosis
his ACTN1-AS1 -0.334 0.00982 0.267
xsq PTPN6 12p13 0.331 0.00983 0.267 Apoptosis
exp ARHGAP1 11p11.2 -0.331 0.00983 0.267 positive regulation of
Rho GTPase activity;regulation of GTPase activity
met FAM129C 19p13.11 -0.331 0.00983 0.267
xai P2RX6 22q11.21 -0.334 0.00983 0.267 ion transport;cation
transport
xai TUBB2A 6p25 -0.334 0.00983 0.267 protein
polymerization;protein folding
his SF3B1 2q33.1 0.334 0.00984 0.267 Oncogenes
xai SEPT1 16p11.1 0.334 0.00984 0.267 cell cycle;cell division
exp SETP16 0.331 0.00984 0.267
xsq PPP3R1 2p15 0.331 0.00984 0.267 induction of apoptosis by
xsq SRPK1 6p21.31 0.331 0.00984 0.267 protein phosphorylation;negative
exp RHBDL2 1p34.3 -0.331 0.00984 0.267 proteolysis
his ANAPC1P1 2p11.2 0.333 0.00985 0.267
his CD8B 2p12 0.333 0.00985 0.267 regulation of immune response;immune
response
exp HNRNPKP4 3q11.2 0.331 0.00985 0.267
exp HHEX 10q23.33 0.331 0.00985 0.267 in utero embryonic development;cell
proliferation
xsq AMOTL2 3q21-q22 -0.331 0.00985 0.267
xai AP2M1 3q28 -0.333 0.00985 0.267 vesicle-mediated
transport;transport
hs4 CCDC149 4p15.2 -0.333 0.00985 0.267
hs4 TSPOAP1 0.333 0.00986 0.267
hs4 MIR142 0.333 0.00986 0.267
hs4 MIR4736 0.333 0.00986 0.267
xai RPS7P11 0.333 0.00986 0.267
xai ABHD18 0.333 0.00986 0.267
xai HNRNPCP6 0.333 0.00986 0.267
xsq LIN9 1q42.12 0.331 0.00986 0.267 mitotic cell cycle;DNA replication
dependent"
xsq LINC00977 0.331 0.00986 0.267
exp PRSS23 11q14.1 -0.331 0.00986 0.267 proteolysis
xsq ARHGEF28 5q13.2 -0.331 0.00986 0.267
xsq TMEM62 15q15.2 -0.331 0.00986 0.267
xai PIGF 2p21-p16 0.333 0.00987 0.267 preassembly of GPI anchor in ER
swa ANP32E 1q21.2 0.333 0.00987 0.268 DNA Damage Response (DDR)
exp UQCRC2 16p12 0.331 0.00987 0.267 oxidative
DNA-dependent"
his CD84 1q24 0.333 0.00988 0.268 defense response;cell adhesion
exp SVOP 12q24.11 0.331 0.00988 0.268
hs4 SYTL4 Xq21.33 -0.333 0.00989 0.268 positive regulation of
exp RPS7P11 0.333 0.0099 0.268
xai C2orf49 2q12.1 0.333 0.0099 0.268 embryonic morphogenesis
xai MTA2 11q12-q13.1 0.333 0.0099 0.268 negative regulation of
exp ANXA2P1 4q31.3 -0.33 0.00991 0.268
xai TTC33 5p13.1 0.333 0.00992 0.268
hs4 LOC105372280 0.333 0.00992 0.268
exp IGHV3-38 0.333 0.00992 0.269
xsq NTNG2 9q34 0.33 0.00992 0.268 multicellular organismal
hs4 EXOSC6 16q22.1 0.333 0.00993 0.269 DNA deamination;nuclear-
xai PHF14 7p21.3 0.333 0.00993 0.269
xsq SFPQ 1p34.3 0.33 0.00993 0.269 alternative nuclear mRNA splicing,
via spliceosome;DNA repair
xai YAP1 11q13 -0.333 0.00993 0.269 Apoptosis
xsq LINC01115 0.33 0.00994 0.269
xsq C20orf27 20p13 0.33 0.00994 0.269
exp TRNAV33P -0.33 0.00994 0.269
hs4 SLC7A3 Xq13.1 0.333 0.00995 0.269 Solute Carriers
xai DUT 15q21.1 0.333 0.00995 0.269 DNA Damage Response (DDR)
xai PIAS1 15q 0.333 0.00995 0.269 DNA Damage Response (DDR)
exp ZFP1 16q23.1 0.33 0.00995 0.269 regulation of transcription, DNA-
dependent"
hs4 TNFSF14 19p13.3 0.333 0.00996 0.269 T cell proliferation;T cell
activation
exp PUM2 2p22-p21 0.33 0.00996 0.269 regulation of translation
his C3orf33 3q25.31 0.333 0.00997 0.269
exp BOLA2 16p11.2 0.333 0.00997 0.269
xai DDX31 9q34.13 0.333 0.00997 0.269
exp RNF44 5q35.2 0.33 0.00997 0.269
hs4 CAP2 6p22.3 -0.333 0.00997 0.269 activation of adenylate
cyclase activity;axon guidance
xsq ADAM22 7q21 0.33 0.00998 0.269 proteolysis;negative regulation of
cell adhesion
met TNFRSF25 1p36.2 -0.33 0.00998 0.269 Apoptosis
xai LCP2 5q35.1 0.333 0.00999 0.269 immune response;transmembrane
his EIF2B3 1p34.1 0.333 0.00999 0.269 negative regulation of
translational initiation in response to stress;translation
exp RPSAP14 Xq13.2 0.333 0.00999 0.269
hs4 ST8SIA4 5q21 0.333 0.00999 0.269 oligosaccharide metabolic
exp TIMM21 18q22.3 0.33 0.00999 0.269 protein transport
xsq AFAP1 4p16 -0.33 0.00999 0.269
hs4 ALOX5AP 13q12 0.333 0.01 0.269 leukotriene production involved in
swa RFC4 3q27 0.333 0.01 0.269 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
xai MCM3 6p12 0.333 0.01 0.269 DDR (DNA replication)
xai RPSAP14 Xq13.2 0.333 0.01 0.269
his NOP58 2q33.1 0.333 0.01 0.269 rRNA processing;snRNP protein import into
nucleus
xai ACTR5 20q11.23 0.333 0.01 0.269 DNA Damage Response (DDR); DDR
(Chromatin)
xai IL21R 16p11 0.333 0.01 0.269 natural killer cell activation
his PCDHGA10 0.333 0.01 0.27 cell adhesion;homophilic cell adhesion
exp RPS23P7 0.333 0.01 0.27
xsq PLCB2 15q15 0.33 0.01 0.269 phospholipid metabolic process;activation of
phospholipase C activity
met NOLC1 10q24.32 0.33 0.01 0.269 positive regulation of cell
xsq CCT7 2p13.2 0.33 0.01 0.269 protein folding;cellular protein
metabolic process
exp RBM27 5q32 0.33 0.01 0.269 mRNA processing
exp KIF21B 1q32.1 0.33 0.01 0.269 microtubule-based movement
exp C1orf174 1p36.32 0.33 0.01 0.269
exp MCM3 6p12 0.33 0.01 0.269 DDR (DNA replication)
xsq NFYC 1p32 0.33 0.01 0.269 regulation of transcription from RNA polymerase
II promoter;protein folding
exp SCNN1B 16p12.2-p12.1 0.33 0.01 0.269 ion transport;sodium ion
transport
xsq SIGLEC6 19q13.3 0.33 0.01 0.27 cell adhesion;cell-cell signaling
exp AK1 9q34.1 -0.33 0.01 0.27 ATP metabolic process;nucleobase-
xsq PHLDB1 11q23.3 -0.33 0.01 0.269
exp PRICKLE1 12q12 -0.33 0.01 0.269 negative regulation of transcription,
DNA-dependent;negative regulation of canonical Wnt receptor signaling pathway
exp SNX33 15q24.2 -0.33 0.01 0.269 cell communication
xsq PLXNB2 22q13.33 -0.33 0.01 0.269 brain development;regulation of
cell shape
xai ZFHX3 16q22.3 -0.333 0.01 0.269 negative regulation of myoblast
differentiation;positive regulation of myoblast differentiation
his MIR6803 0.333 0.0101 0.27
his PPP6R1 19q13.42 0.333 0.0101 0.27 DNA Damage Response (DDR)
his SMG1P7 0.333 0.0101 0.27
xai LRRC3-AS1 0.333 0.0101 0.27
xai PNPT1P1 0.333 0.0101 0.27
xai NCF4 22q13.1 0.332 0.0101 0.27 immune response;cell communication
exp LRRC3-AS1 0.332 0.0101 0.27
his CD33 19q13.3 0.332 0.0101 0.271 cell adhesion;signal transduction
xai HPDL 1p34.1 0.332 0.0101 0.271 aromatic amino acid family
metabolic process
his PRCP 11q14 0.332 0.0101 0.271 proteolysis;blood coagulation
his DDIAS 0.332 0.0101 0.271 apoptotic process;cell cycle
xai EML6 2p16.1 0.332 0.0101 0.271
xai RASGRP4 19q13.1 0.332 0.0101 0.271 myeloid cell
hs4 THEMIS 6q22.33 0.332 0.0101 0.271 multicellular organismal
his ESR2 14q23.2 0.332 0.0101 0.271 neuron migration;intracellular
exp CYSLTR1 Xq13.2-q21.1 0.33 0.0101 0.27 respiratory gaseous
xsq TSSC1 2p25.3 0.33 0.0101 0.27
exp RPL21P39 3q24 0.33 0.0101 0.27
xsq SNRK 3p22.1 0.33 0.0101 0.27 Apoptosis
xsq CRH 8q13 0.33 0.0101 0.27 parturition;locomotory exploration
behavior
met FN3K 17q25.3 0.33 0.0101 0.27 fructoselysine metabolic process
exp SLC38A5 Xp11.23 0.33 0.0101 0.271 Solute Carriers
exp ALG8 11q14.1 0.33 0.0101 0.271 dolichol-linked oligosaccharide
exp FAM153A 5q35.3 0.33 0.0101 0.271
xsq RUNDC3A 17q21.31 0.33 0.0101 0.271 small GTPase mediated signal
transduction
xsq CEP72 5p15.33 0.33 0.0101 0.271 mitotic cell cycle;spindle
organization
xsq SSRP1 11q12 0.33 0.0101 0.271 DNA replication;DNA repair
exp LOC100996286 0.33 0.0101 0.271
exp CCDC167 6p21.2 0.33 0.0101 0.271
exp DARS 2q21.3 0.33 0.0101 0.271 translation;tRNA aminoacylation for
protein translation
exp EDC4 16q22.1 0.329 0.0101 0.271 mRNA metabolic
xsq IKZF3 17q21 0.329 0.0101 0.271 mesoderm development;regulation of B cell
proliferation
met HCG22 6p21.33 -0.33 0.0101 0.271
exp LOC341378 12q23.3 -0.33 0.0101 0.27
his DENND4A 15q22.31 0.332 0.0102 0.271 regulation of transcription,
DNA-dependent"
his MZB1 5q31.2 0.332 0.0102 0.271 positive regulation of
his PROB1 5q31.2 0.332 0.0102 0.271
hs4 CHI3L2 1p13.3 0.332 0.0102 0.271 carbohydrate metabolic
process;chitin catabolic process
xai EEF1A1P26 7p21.2 0.332 0.0102 0.271
xai POLD1 19q13.3 0.332 0.0102 0.271 DNA Damage Response (DDR); DDR
exp SNORA71A 0.332 0.0102 0.271
xai HNRNPA1P25 Xq13.2 0.332 0.0102 0.272
xai SNORA71A 0.332 0.0102 0.272
exp RPL27 17q21 0.329 0.0102 0.271 translational termination;cellular
met PKHD1L1 8q23 0.329 0.0102 0.271 immune response
exp TMA16 4q32.2 0.329 0.0102 0.271
exp RPL5P22 8p21.1 0.329 0.0102 0.271
xsq SURF2 9q34.2 0.329 0.0102 0.271
xsq CFL1P1 10q23.31 0.329 0.0102 0.271
exp RGL4 22q11.23 0.329 0.0102 0.272 small GTPase mediated signal
transduction
xsq YRDC 1p34.3 0.329 0.0102 0.272 negative regulation of transport
xsq C11orf21 11p15.5 0.329 0.0102 0.272
met THAP10 15q23 0.329 0.0102 0.272
xsq LOC79999 0.329 0.0102 0.272
xsq STRBP 9q33.3 0.329 0.0102 0.272 cellular component
movement;multicellular organismal development
exp CCDC50 3q28 -0.329 0.0102 0.272
met OSM 22q12.2 -0.329 0.0102 0.272 multicellular organismal
exp MIR22HG 17p13.3 -0.329 0.0102 0.272
hs4 MOCS1 6p21.3 -0.332 0.0102 0.272 vitamin metabolic
process;water-soluble vitamin metabolic process
xai SDSL 12q24.13 -0.332 0.0102 0.272 cellular amino acid metabolic
process
swa GBA 1q21 -0.332 0.0102 0.271 termination of signal
transduction;cellular response to tumor necrosis factor
xai RPL35P5 7q11.21 0.332 0.0103 0.272
xai DTWD1 15q21.2 0.332 0.0103 0.272
xai INPP4A 2q11.2 0.332 0.0103 0.272 signal transduction
xai RNF44 5q35.2 0.332 0.0103 0.272
hs4 CFP Xp11.4 0.332 0.0103 0.272 complement activation;complement
xai RILPL2 12q24.31 0.332 0.0103 0.272
xai RNASEH1 2p25 0.332 0.0103 0.272 DDR (DNA replication)
xai CTC1 17p13.1 0.332 0.0103 0.272 DNA Damage Response (DDR)
his ZADH2 18q22.3 0.332 0.0103 0.272
his TSHZ1 18q22.3 0.332 0.0103 0.272 multicellular organismal
xai C6orf163 6q15 0.332 0.0103 0.272
his SSTR3 22q13.1 0.332 0.0103 0.272 cell-cell signaling;cellular
response to estradiol stimulus
xai APOC3 11q23.3 0.331 0.0103 0.273 negative regulation of triglyceride
catabolic process;phospholipid efflux
xai AGAP4 0.331 0.0103 0.273 regulation of ARF GTPase activity
exp PHF14 7p21.3 0.329 0.0103 0.272
xsq LOC102723927 0.329 0.0103 0.272
xsq RRP1B 21q22.3 0.329 0.0103 0.272 rRNA processing;negative regulation
xsq PRORSD1P 2p16.1 0.329 0.0103 0.272
exp CXCR4 2q21 0.329 0.0103 0.272 activation of MAPK activity;viral
reproduction
exp DTWD1 15q21.2 0.329 0.0103 0.272
xsq PYGM 11q12-q13.2 0.329 0.0103 0.272 glycogen metabolic process;glycogen
catabolic process
exp SPOCK3 4q32.3 0.329 0.0103 0.272 peptide cross-linking via
met CEBPD 8p11.2-p11.1 0.329 0.0103 0.272 transcription from RNA
exp AKAP1 17q22 0.329 0.0103 0.272 Apoptosis
xsq NSUN6 10p12.31 0.329 0.0103 0.272
xsq SNHG3 0.329 0.0103 0.273
xsq POU2AF1 11q23.1 0.329 0.0103 0.273 transcription from RNA
xsq EXOSC7 3p21.31 0.329 0.0103 0.273 nuclear-transcribed mRNA
xsq KRTAP12-1 21q22.3 0.329 0.0103 0.273
met EXOC6B 2p13.2 0.329 0.0103 0.273 protein transport;vesicle
docking involved in exocytosis
xsq MTHFD2 2p13.1 0.329 0.0103 0.273 one-carbon metabolic
process;folic acid-containing compound biosynthetic process
xsq LOC729867 -0.329 0.0103 0.272
exp MET 7q31 -0.329 0.0103 0.272 Oncogenes; Protein Kinases
his IFIT1B -0.332 0.0103 0.272
hs4 PLS3 Xq23 -0.332 0.0103 0.272
hs4 PLS3-AS1 -0.332 0.0103 0.272
xai YKT6 7p15.1 -0.332 0.0103 0.272 protein transport;retrograde
xai PAX5 9p13 -0.332 0.0103 0.272 Tumor Suppressors
xai RPL21P71 3q24 0.331 0.0104 0.273
his CEP68 2p14 0.331 0.0104 0.274 centrosome organization
his EXO1 1q42-q43 0.331 0.0104 0.274 DNA Damage Response (DDR); DDR
(MMR)
his ZDHHC6 10q25.2 0.331 0.0104 0.274
his VTI1A 10q25.2 0.331 0.0104 0.274 intracellular protein transport;ER
to Golgi vesicle-mediated transport
xai PARP1 1q41-q42 0.331 0.0104 0.274 Apoptosis; DNA Damage Response
(DDR); DDR (BER)
xai GAPDHP63 6q14.1 0.331 0.0104 0.274
xai RPS26P47 13q32.3 0.331 0.0104 0.274
exp RPS26P47 13q32.3 0.331 0.0104 0.274
xai PHB2P1 10q25.1 0.331 0.0104 0.274
xai ADNP2 18q23 0.331 0.0104 0.274 neuron differentiation;positive
hs4 PCSK6-AS1 0.331 0.0104 0.274
swa SGTA 19p13 0.331 0.0104 0.274 interspecies interaction between
organisms
xai ZNF691 1p34.2 0.331 0.0104 0.274
his SNUPN 15q24.2 0.331 0.0104 0.274 ncRNA metabolic process;snRNA
import into nucleus
xai IST1 16q22.2 0.331 0.0104 0.274 cell division;cell cycle
xai KNTC1 12q24.31 0.331 0.0104 0.274 mitotic cell cycle;protein complex
assembly
exp RPS10P30 22q11.23 0.329 0.0104 0.273
xsq GPCPD1 20p12.3 0.329 0.0104 0.274 glycerol metabolic
exp GRAP 17p11.2 0.329 0.0104 0.274 Ras protein signal
xsq LINC00909 18q22.3 0.329 0.0104 0.274
xsq SLC38A5 Xp11.23 0.329 0.0104 0.274 Solute Carriers
mut STEAP2 7q21.13 0.329 0.0104 0.274 regulated secretory
pathway;iron ion homeostasis
xsq ATIC 2q35 0.329 0.0104 0.274 purine ribonucleoside monophosphate
exp LEAP2 5q31.1 0.328 0.0104 0.274 defense response to bacterium
xsq SAFB 19p13.3-p13.2 0.328 0.0104 0.274 regulation of transcription,
exp DDIAS 0.328 0.0104 0.274 apoptotic process;cell cycle
mut KIF6 6p21.2 0.328 0.0104 0.274 microtubule-based movement
met EFCAB2 1q44 0.328 0.0104 0.274
xsq FBXW4P1 22q11 0.328 0.0104 0.274
exp PARP1 1q41-q42 0.328 0.0104 0.274 Apoptosis; DNA Damage Response
(DDR); DDR (BER)
exp PTK2 8q24.3 -0.328 0.0104 0.274 Apoptosis
exp RNF217 6q22.31 -0.328 0.0104 0.274 protein ubiquitination
xai NR2F2-AS1 -0.331 0.0104 0.274
xai RUSC2 9p13.3 -0.331 0.0104 0.274
hs4 DCN 12q21.33 -0.331 0.0104 0.274 peptide cross-linking via
chondroitin 4-sulfate glycosaminoglycan;response to lipopolysaccharide
xai MET 7q31 -0.331 0.0104 0.274 Oncogenes; Protein Kinases
xai IFITM3 11p15.5 -0.331 0.0104 0.274 innate immune
response;type I interferon-mediated signaling pathway
hs4 L1CAM Xq28 -0.331 0.0104 0.273 leukocyte cell-cell adhesion;cell
differentiation
his ANKRD36B 2q11.2 0.331 0.0105 0.274
his CD27 12p13 0.331 0.0105 0.274 Apoptosis
xai HIST3H2BA 1q42.13 0.331 0.0105 0.274
xai DHX30 3p21.31 0.331 0.0105 0.274
hs4 CDT1 16q24.3 0.331 0.0105 0.274 DDR (DNA replication)
his NUP85 17q25.1 0.331 0.0105 0.275 protein transport;transmembrane
transport
hs4 HIST2H2BC 1q21.2 0.331 0.0105 0.275
hs4 HIST2H2AA4 1q21.2 0.331 0.0105 0.275 nucleosome assembly
hs4 HIST2H3A 1q21.2 0.331 0.0105 0.275
xai RBM27 5q32 0.331 0.0105 0.275 mRNA processing
xai RPS3 11q13.3-q13.5 0.331 0.0105 0.275 translational
xai CCDC167 6p21.2 0.331 0.0105 0.275
exp EEF1A1P26 7p21.2 0.331 0.0105 0.275
xai HSPD1P6 3p22.2 0.331 0.0105 0.275
xai LOC100130476 0.331 0.0105 0.275
his LPCAT4 15q14 0.331 0.0105 0.275 metabolic process;phospholipid
his C1orf35 1q42.13 0.331 0.0105 0.275
mir hsa-miR-1225-5p 0.328 0.0105 0.274
exp RPS24P19 Xq26.2 0.328 0.0105 0.274
xsq NT5M 17p11.2 0.328 0.0105 0.274 small molecule metabolic
xsq VPREB1 0.328 0.0105 0.275 immune response
exp PUS7 7q22.3 0.328 0.0105 0.275 pseudouridine synthesis;tRNA
processing
xsq RAD51L3-RFFL 0.328 0.0105 0.275
exp LOC729164 0.328 0.0105 0.275
exp XRCC6P2 Xq28 0.328 0.0105 0.275
xsq MGC70870 0.328 0.0105 0.275
pro EP300_13_26560 0.328 0.0105 0.275
xsq CDC42BPA 1q42.11 -0.328 0.0105 0.275 Protein Kinases
exp CAPS 19p13.3 -0.328 0.0105 0.275 intracellular signal
transduction
exp BRI3 7q21.3 -0.328 0.0105 0.275
exp NAV2 11p15.1 -0.328 0.0105 0.275
exp ARL8A 1q32.1 -0.328 0.0105 0.275 GTP catabolic process;cell
cycle
xsq TNS1 2q35-q36 -0.328 0.0105 0.275 cell-substrate junction
assembly;fibroblast migration
xsq ITGA3 17q21.33 -0.328 0.0105 0.275 leukocyte migration;neuron
migration
met CYP1B1-AS1 2p22.2 -0.328 0.0105 0.275
hs4 PNOC 8p21 -0.331 0.0105 0.275 signal transduction;neuropeptide
signaling pathway
hs4 C11orf52 11q23.1 -0.331 0.0105 0.275
swa FRMPD1 9p13.2 -0.331 0.0105 0.275
xai ARF4 3p21.2-p21.1 -0.331 0.0105 0.275 GTP catabolic
process;epidermal growth factor receptor signaling pathway
hs4 EPHB3 3q27.1 -0.331 0.0105 0.275 axon guidance;substrate
adhesion-dependent cell spreading
xai FUCA2 6q24 -0.331 0.0105 0.275 fucose metabolic
xai TRIO 5p15.2 -0.331 0.0105 0.275 transmembrane receptor
transduction
hs4 MICALL1 22q13.1 -0.331 0.0105 0.274
exp GAPDHP28 10q23.32 0.331 0.0106 0.275
xai PASK 2q37.3 0.331 0.0106 0.275 regulation of glucagon
xai LINC01089 0.33 0.0106 0.275
xai WDR77 1p13.2 0.33 0.0106 0.275 regulation of transcription from
xai NSMCE4A 10q26.13 0.33 0.0106 0.275 DNA Damage Response (DDR);
DDR (HR)
his HAUS1 18q21.1 0.33 0.0106 0.275 cell cycle;mitosis
xai EXOC6 10q23.33 0.33 0.0106 0.275 protein transport;vesicle docking
involved in exocytosis
xai ZNF184 6p21.3 0.33 0.0106 0.275 regulation of transcription,
DNA-dependent"
his CENPL 1q25.1 0.33 0.0106 0.275 M phase of mitotic cell
his DARS2 1q25.1 0.33 0.0106 0.275 tRNA aminoacylation for protein
xai PMS1 2q31.1 0.33 0.0106 0.276 DNA Damage Response (DDR); DDR
(MMR)
xai NUFIP1 13q14 0.33 0.0106 0.276 box C/D snoRNP assembly;RNA
processing
xai PNP 14q13.1 0.33 0.0106 0.276 nicotinamide riboside catabolic
exp POLR2I 19q12 0.328 0.0106 0.275 DNA Damage Response (DDR); DDR
(NER)
xsq APITD1-CORT 0.328 0.0106 0.275
exp PPIHP2 Xq23 0.328 0.0106 0.275
xsq ARID5A 2q11.2 0.328 0.0106 0.275 negative regulation of
exp HELLS 10q24.2 0.328 0.0106 0.275 mitosis;multicellular organismal
development
exp HIST1H4K 6p22.1 0.328 0.0106 0.275
xsq NOP2 12p13 0.328 0.0106 0.275 rRNA processing;positive regulation of
cell proliferation
met DDR1 6p21.3 0.328 0.0106 0.276 embryo implantation;skin
development
DNA-dependent"
exp ZNF227 0.328 0.0106 0.276 regulation of transcription, DNA-
dependent"
exp SASH3 Xq26 0.328 0.0106 0.276 positive regulation of interleukin-10
mir hsa-miR-19b 0.328 0.0106 0.276
mir hsa-miR-19b(2) 0.328 0.0106 0.276
xsq ACRC Xq13.1 0.327 0.0106 0.276
mir hsa-let-7b -0.328 0.0106 0.275
exp C5orf42 5p13.2 -0.328 0.0106 0.275
xsq IFIT3 -0.328 0.0106 0.275 cellular response to interferon-
xai ANXA2P1 4q31.3 -0.33 0.0106 0.275
his SLC2A10 20q13.1 -0.33 0.0106 0.275 Solute Carriers
hs4 LINC00472 6q13 -0.331 0.0106 0.275
hs4 LINC01626 -0.331 0.0106 0.275
xai PRICKLE1 12q12 -0.331 0.0106 0.275 negative regulation of
signaling pathway
xai PPP6R3 11q13 0.33 0.0107 0.276 DNA Damage Response (DDR)
xai RPL21P111 13q31.1 0.33 0.0107 0.276
dependent"
xai MBLAC2 5q14.3 0.33 0.0107 0.276
xai ITM2A Xq13.3-Xq21.2 0.33 0.0107 0.276
exp HNRNPA1P25 Xq13.2 0.33 0.0107 0.276
exp RPL21P71 3q24 0.33 0.0107 0.276
xai LAPTM5 1p34 0.33 0.0107 0.276 transport
his PMPCA 9q34.3 0.33 0.0107 0.277 proteolysis
his SDCCAG3 9q34.3 0.33 0.0107 0.277
xsq RPA2 1p35 0.327 0.0107 0.276 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xsq RASSF1-AS1 0.327 0.0107 0.276
xsq GMEB1 1p35.3 0.327 0.0107 0.276
xsq PGAM5 12q24.33 0.327 0.0107 0.276
xsq HIRIP3 0.327 0.0107 0.276 chromatin assembly or disassembly
xsq RCCD1 15q26.1 0.327 0.0107 0.276
met CASR 3q13 0.327 0.0107 0.276 detection of calcium ion;cellular calcium
ion homeostasis
exp PTPRCAP 11q13.3 0.327 0.0107 0.276 defense response
met SIX5 19q13.32 0.327 0.0107 0.276 multicellular organismal
development;spermatid development
met CRIM1 2p21 0.327 0.0107 0.276 regulation of cell growth;nervous system
development
met OOSP2 0.327 0.0107 0.276
exp AGAP4 0.327 0.0107 0.276 regulation of ARF GTPase activity
exp RSBN1L 7q11.23 0.327 0.0107 0.276
xsq SNRNP40 1p35.2 0.327 0.0107 0.276 RNA splicing;gene expression
met SNX18 5q11.2 0.327 0.0107 0.276 protein transport;positive
met FAM210B 20q13.2 0.327 0.0107 0.276
xsq MCM2 3q21 0.327 0.0107 0.276 DDR (DNA replication)
exp RPS13 11p15 0.327 0.0107 0.276 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;RNA metabolic process
xsq TATDN3 1q32.3 0.327 0.0107 0.277
exp PTPN21 14q31.3 -0.327 0.0107 0.277 protein
exp CCDC149 4p15.2 -0.327 0.0107 0.276
xsq PPFIBP1 12p12.1 -0.327 0.0107 0.276 cell adhesion
xsq TANC1 2q24.2 -0.327 0.0107 0.276
met LINC01512 -0.327 0.0107 0.276
xai LOC100133299 -0.33 0.0107 0.276
exp CEP295NL -0.33 0.0107 0.276
hs4 PRR34 -0.33 0.0107 0.276
hs4 PRR34-AS1 -0.33 0.0107 0.276
swa ALCAM 3q13.1 -0.33 0.0107 0.276 cell adhesion;signal transduction
xai MYBL1 8q13.1 -0.33 0.0107 0.276 regulation of transcription, DNA-
dependent;positive regulation of transcription, DNA-dependent"
his LSM4 19p13.11 0.33 0.0108 0.277 RNA splicing;gene expression
xai EPM2A 6q24 0.33 0.0108 0.277 carbohydrate metabolic process;glycogen
metabolic process
his MIB1 18q11.2 0.33 0.0108 0.277 neural tube formation;heart looping
xai PMS2P5 7q11.23 0.33 0.0108 0.277 DNA Damage Response (DDR)
xai ALG8 11q14.1 0.33 0.0108 0.277 dolichol-linked oligosaccharide
xai PRMT1 19q13.3 0.33 0.0108 0.277 histone methylation;peptidyl-
exp PASK 2q37.3 0.33 0.0108 0.277 regulation of glucagon
hs4 SLCO4A1 20q13.33 0.33 0.0108 0.277 Solute Carriers
xai ZP1 11q12.2 0.33 0.0108 0.277 single fertilization
xai IGHV3-38 0.33 0.0108 0.277
his PIK3R5 17p13.1 0.33 0.0108 0.277 Protein Kinases
his FAM213B 1p36.32 0.33 0.0108 0.277 prostaglandin biosynthetic
his GRK2 0.329 0.0108 0.277
his ANKRD13D 11q13.2 0.329 0.0108 0.277
swa DARS 2q21.3 0.329 0.0108 0.277 translation;tRNA aminoacylation for
protein translation
xai FXN 9q21.11 0.329 0.0108 0.277 mitochondrion organization;protein
autoprocessing
xai FOXB1 15q22.2 0.329 0.0108 0.277 urogenital system
his MST1P2 1p36.2 0.329 0.0108 0.277
xai PUS7 7q22.3 0.329 0.0108 0.277 pseudouridine synthesis;tRNA
processing
met MESTIT1 7q32.2 0.327 0.0108 0.277
exp FTSJ3 17q23.3 0.327 0.0108 0.277 RNA methylation;rRNA processing
xsq INPP5D 2q37.1 0.327 0.0108 0.277 phosphate-containing compound
metabolic process;negative regulation of B cell proliferation
mut SNX20 16q12.1 0.327 0.0108 0.277 cell communication;protein
transport
xsq MRPS5 2p11.2-q11.2 0.327 0.0108 0.277 translation
mut GGT5 22q11.23 0.327 0.0108 0.277 metabolic process;leukotriene
xsq CYSLTR1 Xq13.2-q21.1 0.327 0.0108 0.277 respiratory gaseous
exp EIF4EP2 17q21.33 0.327 0.0108 0.277
xsq SNORA20 0.327 0.0108 0.277
xsq PDCD4-AS1 10q25.2 0.327 0.0108 0.277
DNA-dependent"
xsq DOC2A 0.327 0.0108 0.277 synaptic transmission;nervous system
development
xsq DOCK2 5q35.1 0.327 0.0108 0.277 actin cytoskeleton
organization;positive thymic T cell selection
met SNX19 11q25 0.327 0.0108 0.277 protein transport;cell communication
xsq LOC101927311 0.327 0.0108 0.277
met GNA12 7p22.2 0.327 0.0108 0.277 G-protein signaling, coupled to
cAMP nucleotide second messenger;embryonic digit morphogenesis
mut IGF1R 15q26.3 0.327 0.0108 0.277 Apoptosis; Protein Kinases
exp YAP1 11q13 -0.327 0.0108 0.277 Apoptosis
xsq ZBTB47 3p22.1 -0.327 0.0108 0.277 regulation of
met MIR1228 -0.327 0.0108 0.277
exp FUCA2 6q24 -0.327 0.0108 0.277 fucose metabolic
exp TNFRSF10B 8p22-p21 -0.327 0.0108 0.277 Apoptosis
xai ADAM12 10q26 -0.329 0.0108 0.277 myoblast fusion;proteolysis
hs4 NUAK2 1q32.1 -0.33 0.0108 0.277 Apoptosis
swa APOBEC3G 22q13.1-q13.2 -0.33 0.0108 0.277 negative regulation of
viral genome replication;positive regulation of defense response to virus by host
xai DEGS1 1q42.11 -0.33 0.0108 0.277 unsaturated fatty acid biosynthetic
xai CEP89 19q13.11 -0.33 0.0108 0.277
xai LINC00575 4q21.3 -0.33 0.0108 0.277
exp LINC00575 4q21.3 -0.33 0.0108 0.277
hs4 ZC3H12D 6q25.1 0.329 0.0109 0.278 negative regulation of cell
growth;negative regulation of G1/S transition of mitotic cell cycle
his NAE1 16q22 0.329 0.0109 0.278 Apoptosis
xai REL 2p13-p12 0.329 0.0109 0.278 Apoptosis; Oncogenes
exp RPL21P111 13q31.1 0.329 0.0109 0.278
his C1orf185 1p32.3 0.329 0.0109 0.278
his PEG3 19q13.4 0.329 0.0109 0.278 viral reproduction;apoptotic
process
his ZIM2 19q13.4 0.329 0.0109 0.278
his MIMT1 19q13.43 0.329 0.0109 0.278
xai LINC01226 0.329 0.0109 0.278
his MRPL27 17q21.3-q22 0.329 0.0109 0.278 translation
his EME1 17q21.33 0.329 0.0109 0.278 DNA Damage Response (DDR); DDR
(HR); DDR (DNA replication)
swa DCTPP1 16p11.2 0.329 0.0109 0.278 nucleoside triphosphate
xai CEBPZ 2p22.2 0.329 0.0109 0.278 regulation of transcription, DNA-
xsq SP4 7p15.3 0.327 0.0109 0.277 regulation of transcription from
exp RPL18AP10 0.327 0.0109 0.278
xsq PDCD11 10q24.33 0.327 0.0109 0.278 Apoptosis
exp FAM60CP 18q21.32 0.327 0.0109 0.278
exp RPL7AP50 10q21.3 0.326 0.0109 0.278
xsq SIGLEC7 19q13.3 0.326 0.0109 0.278 cell adhesion
xsq INPP4A 2q11.2 0.326 0.0109 0.278 signal transduction
exp MCM2 3q21 0.326 0.0109 0.278 DDR (DNA replication)
exp NCF4 22q13.1 0.326 0.0109 0.278 immune response;cell communication
exp RAB37 17q25.1 0.326 0.0109 0.278 protein transport;small GTPase
mut NSMF 9q34.3 0.326 0.0109 0.278
exp XPO1 2p15 0.326 0.0109 0.278 Apoptosis
xsq PPAT 4q12 0.326 0.0109 0.278 lactation;nucleobase-containing small
met C19orf73 19q13.33 0.326 0.0109 0.278
xsq PAM16 16p13.3 0.326 0.0109 0.278 protein transport
exp CMA1 14q11.2 0.326 0.0109 0.278 proteolysis;interleukin-1 beta
exp NT5E 6q14-q21 -0.326 0.0109 0.278 dephosphorylation;purine base
metabolic process
met MZB1 5q31.2 -0.326 0.0109 0.278 positive regulation of
exp IL6STP1 17p11 -0.326 0.0109 0.278
xsq GBP1 1p22.2 -0.327 0.0109 0.278 interferon-gamma-mediated
swa SPATS2L 2q33.1 -0.329 0.0109 0.278
xai VCL 10q22.2 -0.329 0.0109 0.278 cellular component
movement;negative regulation of cell migration
hs4 PPP6R1 19q13.42 0.329 0.011 0.278 DNA Damage Response (DDR)
xai XPO1 2p15 0.329 0.011 0.279 Apoptosis
hs4 CNTNAP4 16q23.1 0.329 0.011 0.279 cell adhesion;signal transduction
xai CCT8P1 0.329 0.011 0.279
xai RAB37 17q25.1 0.329 0.011 0.279 protein transport;small GTPase mediated
signal transduction
his KRT1 12q13.13 0.329 0.011 0.279 complement activation, lectin
xai KRT73 12q13.3 0.329 0.011 0.279
his KIAA0825 5q15 0.329 0.011 0.28
his SLF1 0.329 0.011 0.28
xai TOP1 20q12-q13.1 0.329 0.011 0.28 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
hs4 LOC102724392 0.329 0.011 0.28
xai NUS1 6q22.1 0.329 0.011 0.28 cell differentiation;angiogenesis
his BEND3 6q21 0.329 0.011 0.28
his PAIP2B 2p13.3 0.329 0.011 0.28 negative regulation of
met BLVRB 19q13.1-q13.2 0.326 0.011 0.278 small molecule metabolic
process;porphyrin-containing compound metabolic process
xsq SNAP25-AS1 0.326 0.011 0.278
exp RPSAP8 Xq22.1 0.326 0.011 0.279
xsq GCHFR 15q15 0.326 0.011 0.279 negative regulation of GTP cyclohydrolase I
activity;small molecule metabolic process
xsq HSH2D 19p13.12 0.326 0.011 0.279 T cell activation
xsq PAICS 4q12 0.326 0.011 0.279 purine base metabolic process;purine nucleotide
xsq HIST1H4I 0.326 0.011 0.279
met RCAN1 21q22.12 0.326 0.011 0.279 regulation of phosphoprotein phosphatase
activity;regulation of transcription, DNA-dependent
exp MEN1 11q13 0.326 0.011 0.279 DNA Damage Response (DDR); Tumor Suppressors
xsq SP140 2q37.1 0.326 0.011 0.28
met NLRP9 19q13.42 0.326 0.011 0.28
met MMP14 14q11.2 0.326 0.011 0.28 Apoptosis
met PARK2 6q25.2-q27 0.326 0.011 0.28 mitochondrion degradation;adult
locomotory behavior
exp NCS1 9q34 -0.326 0.011 0.279 positive regulation of
exocytosis;phosphatidylinositol-mediated signaling
xsq LOC101929709 -0.326 0.011 0.279
hs4 ADCY9 16p13.3 -0.329 0.011 0.28 signal transduction;intracellular
signal transduction
hs4 GSTT2B 22q11.23 -0.329 0.011 0.279
exp MRPS21P2 1q22 0.329 0.0111 0.28
xai LSM7 19p13.3 0.329 0.0111 0.28 nuclear mRNA splicing, via
xai MRPS21P2 1q22 0.329 0.0111 0.28
xai RPSAP53 13q21.32 0.329 0.0111 0.28
xai RPL5P24 8q22.3 0.329 0.0111 0.28
exp DDX11-AS1 0.329 0.0111 0.28
his FANCG 9p13 0.328 0.0111 0.28 DNA Damage Response (DDR); DDR (FA)
exp DDX31 9q34.13 0.328 0.0111 0.28
his NEK4 3p21.1 0.328 0.0111 0.28 cell division;protein
phosphorylation
xai TRAPPC8 18q12.1 0.328 0.0111 0.28 vesicle-mediated transport;ER
his DDX1 2p24 0.328 0.0111 0.28 regulation of translational
initiation;multicellular organismal development
xai N4BP2L1 13q13.1 0.328 0.0111 0.28
his RSL1D1 16p13.13 0.328 0.0111 0.28 translation;regulation of
xai ENKUR 10p12.1 0.328 0.0111 0.28
his CALML6 1p36.33 0.328 0.0111 0.28
xai FCHSD2 11q13.4 0.328 0.0111 0.28
exp GTSE1-AS1 22q13.31 0.328 0.0111 0.28
exp LAMP3 3q26.3-q27 0.326 0.0111 0.28 cell proliferation
met CCL1 17q12 0.326 0.0111 0.28 cellular calcium ion
homeostasis;chemotaxis
xsq LINC00551 0.326 0.0111 0.28
met ADGRA3 0.326 0.0111 0.28 G-protein coupled receptor
xsq FAM72A 1q32.1 0.326 0.0111 0.28
met SASH1 6q24.3 0.326 0.0111 0.28
mut TLR4 9q33.1 0.326 0.0111 0.28 Cell Signaling
exp RPL3P4 14q32.2 0.326 0.0111 0.28
xsq KRI1 19p13.2 0.326 0.0111 0.28
DNA-dependent"
xsq MYO1F 19p13.3-p13.2 0.326 0.0111 0.28 negative regulation of cell
exp RPS2 16p13.3 0.326 0.0111 0.28 translation;mRNA metabolic process
exp MMP25 16p13.3 0.326 0.0111 0.28 proteolysis;inflammatory response
exp RPS5P5 8q21.13 0.326 0.0111 0.28
exp NOP16 5q35.2 0.326 0.0111 0.28
exp ARF4 3p21.2-p21.1 -0.326 0.0111 0.28 GTP catabolic
xsq SLC2A10 20q13.1 -0.326 0.0111 0.28 Solute Carriers
met MUC21 6p21.32 -0.326 0.0111 0.28 O-glycan processing;post-
translational protein modification
xsq ARSJ 4q26 -0.326 0.0111 0.28
exp GBP2 1p22.2 -0.326 0.0111 0.28 immune response;cytokine-
exp AFAP1 4p16 -0.326 0.0111 0.28
xsq FLJ23867 1q25.2 -0.326 0.0111 0.28
hs4 NCS1 9q34 -0.328 0.0111 0.28 positive regulation of
hs4 FAM198B 4q32.1 -0.328 0.0111 0.28
swa BAG3 10q25.2-q26.2 -0.328 0.0111 0.28 Apoptosis
hs4 MYOF 10q24 -0.328 0.0111 0.28 plasma membrane repair;muscle
contraction
xai MMP9 20q11.2-q13.1 0.328 0.0112 0.28 Apoptosis
his SLX1A 0.328 0.0112 0.28 DNA Damage Response (DDR); DDR (HR)
his BOLA2B 0.328 0.0112 0.28
his SLX1A-SULT1A3 0.328 0.0112 0.28
xai RNF40 16p11.2-p11.1 0.328 0.0112 0.281 ubiquitin-dependent protein
his DCTPP1 16p11.2 0.328 0.0112 0.281 nucleoside triphosphate
his SPIB 19q13.3-q13.4 0.328 0.0112 0.281 Transcription Factors
xai C12orf73 12q23.3 0.328 0.0112 0.281
exp HNRNPA3P14 0.328 0.0112 0.281
his OIP5-AS1 15q15.1 0.328 0.0112 0.281
xai C1orf109 1p34.3 0.328 0.0112 0.281
xai MTHFD2 2p13.1 0.328 0.0112 0.281 one-carbon metabolic
his COQ2 4q21.23 0.328 0.0112 0.281 glycerol metabolic
process;ubiquinone biosynthetic process
xsq CTSG 14q11.2 0.325 0.0112 0.28 positive regulation of immune
response;defense response to fungus
pro EP300_21_54296 0.325 0.0112 0.281
xsq CROCCP2 1p36.13 0.325 0.0112 0.281
met ERBB2 17q12 0.325 0.0112 0.281 Apoptosis; Oncogenes; Protein Kinases
xsq ERAS Xp11.23 0.325 0.0112 0.281 signal transduction;small GTPase
met FAM83E 19q13.33 0.325 0.0112 0.281
mut MAD1L1 7p22 0.325 0.0112 0.281 mitotic anaphase;mitotic telophase
xsq SPI1 11p11.2 0.325 0.0112 0.281 Transcription Factors
exp SNRPFP1 20q13.13 0.325 0.0112 0.281
exp WDR18 19p13.3 0.325 0.0112 0.281 multicellular organismal
development
exp RAB2A 8q12.1 -0.325 0.0112 0.281 GTP catabolic process;ER to
exp IFITM10 -0.325 0.0112 0.281 response to biotic stimulus
his PSG9 19q13.2 -0.328 0.0112 0.281 defense response;female
pregnancy
his MIR23B -0.328 0.0112 0.281
his MIR27B -0.328 0.0112 0.281
his MIR24-1 -0.328 0.0112 0.281
his MIR3074 -0.328 0.0112 0.281
xai STAC 3p22.3 -0.328 0.0112 0.281 signal transduction;cellular
response to heat
xai SHTN1 -0.328 0.0112 0.281 multicellular organismal
development;axon guidance
hs4 NAV2 11p15.1 -0.328 0.0112 0.281
hs4 LOC100126784 11p15.1 -0.328 0.0112 0.281
his TAF1C 16q24 0.328 0.0113 0.282 regulation of transcription, DNA-
xai LOC101060264 0.328 0.0113 0.282
xai TRIM27 6p22 0.328 0.0113 0.282 cell proliferation;negative
regulation of gene expression, epigenetic
hs4 MIR4321 0.328 0.0113 0.282
xai KLRC1 12p13 0.328 0.0113 0.282 regulation of immune response;cell
xai RPSAP1 20q13.13 0.328 0.0113 0.282
swa GART 21q22.11 0.328 0.0113 0.282 purine base biosynthetic
process;purine ribonucleoside monophosphate biosynthetic process
xai ITGB2-AS1 0.328 0.0113 0.282
xai SERPINI1 3q26.1 0.328 0.0113 0.282 peripheral nervous system
hs4 PCDHGA10 0.328 0.0113 0.282 cell adhesion;homophilic cell
adhesion
exp RPS5P2 21q22.11 0.328 0.0113 0.282
xai EEF1GP5 Xq23 0.327 0.0113 0.282
met MRPS2 9q34 0.325 0.0113 0.282 translation
xsq ATP2A3 17p13.3 0.325 0.0113 0.282 transmembrane transport;ATP
mut FLG2 1q21.3 0.325 0.0113 0.282
exp CCDC174 3p25.1 0.325 0.0113 0.282
exp LSM11 5q33.3 0.325 0.0113 0.282 histone mRNA 3'-end
exp PPP6R3 11q13 0.325 0.0113 0.282 DNA Damage Response (DDR)
met LOC150381 0.325 0.0113 0.282
met AGAP1 2q37 0.325 0.0113 0.282 small GTPase mediated signal
xsq RRN3P1 0.325 0.0113 0.282
exp CPSF6 12q15 0.325 0.0113 0.282 mRNA polyadenylation;mRNA processing
exp MTHFD2 2p13.1 0.325 0.0113 0.282 one-carbon metabolic
exp RPL7AP18 1p36.23 0.325 0.0113 0.282
exp IGSF3 1p13 -0.325 0.0113 0.282
exp FLJ23867 1q25.2 -0.325 0.0113 0.282
exp SCOC 4q31.1 -0.325 0.0113 0.282
xsq ANKRD36BP1 1q24.2 -0.325 0.0113 0.282
exp VAMP3 1p36.23 -0.325 0.0113 0.282 protein complex
assembly;retrograde transport, endosome to Golgi
his LOC101927480 -0.327 0.0113 0.282
xai HLA-F 6p21.3 -0.327 0.0113 0.282 antigen processing and
presentation of exogenous peptide antigen via MHC class I, TAP-dependent;type I
hs4 S100A16 1q21 -0.328 0.0113 0.282 response to calcium ion
his LAMC2 1q25-q31 -0.328 0.0113 0.282 cell adhesion;epidermis
development
xai IFITM10 -0.328 0.0113 0.282 response to biotic stimulus
xai C5orf42 5p13.2 -0.328 0.0113 0.282
xai LOC101059954 0.327 0.0114 0.282
xai EXOSC8 13q13.1 0.327 0.0114 0.282 mRNA metabolic
swa CNBP 3q21 0.327 0.0114 0.282 regulation of transcription, DNA-
dependent;cholesterol biosynthetic process
xai HNRNPH1P3 5q11.2 0.327 0.0114 0.282
his CDH23 10q22.1 0.327 0.0114 0.282 inner ear morphogenesis;righting
reflex
hs4 RUNX3 1p36 0.327 0.0114 0.282 Apoptosis
his BOLA2-SMG1P6 0.327 0.0114 0.282
his BOLA2 16p11.2 0.327 0.0114 0.282
his SLX1B 0.327 0.0114 0.282 DNA Damage Response (DDR)
his SLX1B-SULT1A4 0.327 0.0114 0.282
xai CLK2 1q21 0.327 0.0114 0.282 DNA Damage Response (DDR)
his CDKN1B 12p13.1-p12 0.327 0.0114 0.283 DDR (DNA replication)
his APOLD1 12p13.1 0.327 0.0114 0.283 endothelial cell
activation;lipoprotein metabolic process
exp MAGOHB 12p13.2 0.327 0.0114 0.283 RNA splicing;mRNA transport
exp RPSAP53 13q21.32 0.327 0.0114 0.283
xai HMGB1P11 0.327 0.0114 0.283
his SMG8 17q22 0.327 0.0114 0.283 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;gene expression
swa UBE2O 17q25.1 0.327 0.0114 0.283
hs4 DENND1C 19p13.3 0.327 0.0114 0.283
xai CCR2 3p21.31 0.327 0.0114 0.283 cellular calcium ion
homeostasis;response to wounding
xsq NEIL3 4q34.3 0.325 0.0114 0.282 DNA Damage Response (DDR); DDR
(BER)
xsq FAM78A 9q34 0.325 0.0114 0.282
DNA-dependent"
exp PECAM1 17q23.3 0.325 0.0114 0.282 platelet
met PAK4 19q13.2 0.325 0.0114 0.282 Protein Kinases
mut VIT 2p22.2 0.325 0.0114 0.282
exp RPL23AP51 7p22 0.325 0.0114 0.283
xsq SF3A3 1p34.3 0.325 0.0114 0.283 RNA splicing;gene expression
exp CIAPIN1 16q21 0.325 0.0114 0.283 apoptotic process;anti-apoptosis
xsq SETD3 14q32.2 0.324 0.0114 0.283 positive regulation of
transcription, DNA-dependent;histone H3-K36 methylation
met TNFAIP8L2 1q21.3 -0.324 0.0114 0.283 innate immune response
met CD2 1p13.1 -0.327 0.0114 0.283 blood coagulation;cell-cell
adhesion
his LINC01333 -0.327 0.0114 0.283
his S100A1 1q21 -0.327 0.0114 0.283 negative regulation of
xai ATXN1 6p23 -0.327 0.0114 0.283 cell death;regulation of excitatory
postsynaptic membrane potential
his ARHGEF37 5q32 -0.327 0.0114 0.282 regulation of Rho protein
signal transduction
his IQCJ-SCHIP1-AS1 -0.327 0.0114 0.282
xai PLXNA1 3q21.3 -0.327 0.0114 0.282 signal
xai STX18-AS1 0.327 0.0115 0.283
hs4 MIR3680-2 0.327 0.0115 0.284
his NSUN6 10p12.31 0.327 0.0115 0.284
xai GMNN 6p22.3 0.327 0.0115 0.284 DDR (DNA replication)
DNA-dependent"
DNA-dependent"
exp HNRNPH1P3 5q11.2 0.327 0.0115 0.284
exp MSH5 6p21.3 0.327 0.0115 0.284 DNA Damage Response (DDR); DDR
(MMR)
his INTS13 0.327 0.0115 0.284
his FGFR1OP2 12p11.23 0.327 0.0115 0.284 response to wounding
exp GAPDHP63 6q14.1 0.327 0.0115 0.284
his CD4 12p13.31 0.327 0.0115 0.284 cell adhesion;entry into host cell
his TMEM101 17q21.31 0.327 0.0115 0.284 signal transduction;positive
regulation of I-kappaB kinase/NF-kappaB cascade
his MIR6800 0.327 0.0115 0.284
xai CBX2 17q25.3 0.327 0.0115 0.284 development of primary sexual
his PPP6R3 11q13 0.327 0.0115 0.284 DNA Damage Response (DDR)
exp LOC100128563 0.327 0.0115 0.284
hs4 MIR3679 0.327 0.0115 0.284
exp SGF29 0.324 0.0115 0.284 establishment of protein localization to
exp RPA2 1p35 0.324 0.0115 0.284 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
met NT5DC3 12q22-q23.1 0.324 0.0115 0.284
exp MIR646HG 0.324 0.0115 0.284
exp RPL35P5 7q11.21 0.324 0.0115 0.284
exp TOP1 20q12-q13.1 0.324 0.0115 0.284 Apoptosis; DNA Damage Response
(DDR); DDR (DNA replication)
xsq S100PBP 1p35.1 0.324 0.0115 0.284
pro FADD_9 0.324 0.0115 0.284
xsq TUSC5 17p13.3 0.324 0.0115 0.284 response to biotic stimulus
exp SLX4 16p13.3 0.324 0.0115 0.284 DNA Damage Response (DDR); DDR (HR)
mut SULF2 20q12-q13.2 0.324 0.0115 0.284 glomerular basement membrane
development;kidney development
exp N4BP2L1 13q13.1 0.324 0.0115 0.284
xsq RAB13 1q21.2 -0.324 0.0115 0.284 vesicle-mediated
xsq ADAM9 8p11.22 -0.324 0.0115 0.284 membrane protein ectodomain
exp ZFHX3 16q22.3 -0.324 0.0115 0.284 negative regulation of
myoblast differentiation;positive regulation of myoblast differentiation
pro CDH1_6 -0.324 0.0115 0.284
hs4 LOC101928453 -0.327 0.0115 0.284
his OSCP1 1p34.3 -0.327 0.0115 0.284 transport
exp LRRIQ4 3q26.2 -0.327 0.0115 0.284
xai ATP6V0D1 16q22.1 -0.327 0.0115 0.284 activation of signaling
xai LOC100128563 0.327 0.0116 0.284
his PLCXD1 Xp22.33 0.327 0.0116 0.284 lipid metabolic
his TATDN2 3p25.3 0.327 0.0116 0.285 activation of signaling
protein activity involved in unfolded protein response;endoplasmic reticulum
unfolded protein response
xai HIST2H2BC 1q21.2 0.327 0.0116 0.285
xai C9orf114 9q34.11 0.326 0.0116 0.285
his ZC3H8 2q13 0.326 0.0116 0.285 apoptotic process;negative regulation of
xai CPT1A 11q13.2 0.326 0.0116 0.285 positive regulation of fatty acid
swa INA 10q24.33 0.326 0.0116 0.285 multicellular organismal
xai NAA15 4q31.1 0.326 0.0116 0.285 angiogenesis;N-terminal protein
exp HSPD1P6 3p22.2 0.324 0.0116 0.284
xsq SV2B 15q26.1 0.324 0.0116 0.284 neurotransmitter transport
met RBMS3 3p24-p23 0.324 0.0116 0.284
exp HMGB1P4 2q32 0.324 0.0116 0.285
met BBS1 11q13 0.324 0.0116 0.285 retina homeostasis;nonmotile primary
cilium assembly
xsq ARID3B 15q24 0.324 0.0116 0.285 regulation of transcription, DNA-
dependent"
met IQSEC2 Xp11.22 0.324 0.0116 0.285 regulation of ARF protein
signal transduction
exp DPH2 1p34 0.324 0.0116 0.285 peptidyl-diphthamide biosynthetic process
met OR8B8 11q24.2 0.324 0.0116 0.285
mut CDH22 20q13.1 0.324 0.0116 0.285 homophilic cell adhesion;cell
adhesion
exp ENKUR 10p12.1 0.324 0.0116 0.285
exp STBD1 4q21.1 -0.324 0.0116 0.285 muscle contraction
exp PCYT1A 3q29 -0.324 0.0116 0.285 CDP-choline
pathway;phospholipid biosynthetic process
xsq ABHD4 14q11.2 -0.324 0.0116 0.285 lipid catabolic process
xsq GNS 12q14 -0.324 0.0116 0.285 glycosaminoglycan catabolic
exp MYBL1 8q13.1 -0.324 0.0116 0.285 regulation of transcription,
DNA-dependent;positive regulation of transcription, DNA-dependent"
exp LZTS2 10q24 -0.324 0.0116 0.284 cell cycle;mitosis
his RHBDL2 1p34.3 -0.326 0.0116 0.285 proteolysis
xai RHOBTB3 5q15 -0.326 0.0116 0.285 ATP catabolic
process;transport
hs4 GPER1 -0.327 0.0116 0.285 intracellular steroid hormone
receptor signaling pathway;positive regulation of epidermal growth factor receptor
signaling pathway
xai MOXD1 6q23.2 -0.327 0.0116 0.285 catecholamine metabolic
process
hs4 SEPT11 4q21.1 -0.327 0.0116 0.285 cell cycle;protein
xai ITM2B 13q14.3 -0.327 0.0116 0.284 nervous system
xai LINC00593 15q23 -0.327 0.0116 0.284
exp RASGRP4 19q13.1 0.326 0.0117 0.285 myeloid cell
his CDKL4 2p22.1 0.326 0.0117 0.285
his TICRR 15q26.1 0.326 0.0117 0.286 DDR (DNA replication)
exp OR52N3P 11p15.4 0.326 0.0117 0.286
exp RPL17P26 6p12.1 0.326 0.0117 0.286
hs4 TMEM71 8q24.22 0.326 0.0117 0.286
xai MCM2 3q21 0.326 0.0117 0.286 DDR (DNA replication)
xai CXCR4 2q21 0.326 0.0117 0.286 activation of MAPK activity;viral
reproduction
xai CD84 1q24 0.326 0.0117 0.286 defense response;cell adhesion
his RAD51D 17q11 0.326 0.0117 0.286 DNA Damage Response (DDR); DDR (HR)
his RAD51L3-RFFL 0.326 0.0117 0.286
his FNDC8 17q12 0.326 0.0117 0.286
his KCNN4 19q13.2 0.326 0.0117 0.286 phospholipid translocation;ion
transport
hs4 LGALS7B 19q13.2 0.326 0.0117 0.286 apoptotic
process;heterophilic cell-cell adhesion
mir hsa-miR-1224-5p 0.324 0.0117 0.286
xsq PPM1G 2p23.3 0.324 0.0117 0.286 protein dephosphorylation;cell
cycle arrest
exp FAM26F 6q22.1 0.323 0.0117 0.286
exp QRSL1P1 1q24.2 0.323 0.0117 0.286
exp ANAPC1 2q12.1 0.323 0.0117 0.286 mitotic cell cycle;protein
xsq FRG2C 3p12.3 0.323 0.0117 0.286
exp RPL19 17q12 0.323 0.0117 0.286 SRP-dependent cotranslational protein
targeting to membrane;gene expression
xsq DCAF7 17q23.3 0.323 0.0117 0.286 multicellular organismal
development;protein ubiquitination
met FAM217B 20q13.33 0.323 0.0117 0.286
pro CDH2_26 -0.323 0.0117 0.286
exp LMCD1 3p26-p24 -0.324 0.0117 0.286 positive regulation of
exp CRYAB 11q22.3-q23.1 -0.324 0.0117 0.286 protein folding;anti-
apoptosis
his SHROOM2 Xp22.3 -0.326 0.0117 0.286 eye pigment granule
hs4 EVA1A 2p12 -0.326 0.0117 0.286
xai TMEM9B 11p15.3 -0.326 0.0117 0.286 signal
transduction;positive regulation of I-kappaB kinase/NF-kappaB cascade
hs4 FIGN 2q24.3 -0.326 0.0117 0.286 locomotory behavior
his CLIP4 2p23.2 -0.326 0.0117 0.285
hs4 SLC16A10 6q21-q22 0.326 0.0118 0.287 Solute Carriers
hs4 LRRC14B 0.326 0.0118 0.287
exp EEF1GP5 Xq23 0.326 0.0118 0.287
his C11orf72 0.326 0.0118 0.287
his NDUFV1 11q13 0.326 0.0118 0.287 mitochondrial electron transport,
his C2orf69 2q33.1 0.326 0.0118 0.287
xai DPH2 1p34 0.326 0.0118 0.287 peptidyl-diphthamide biosynthetic process
hs4 GPR139 16p12.3 0.326 0.0118 0.287
swa TXNL1 18q21.31 0.326 0.0118 0.287 Apoptosis
his SPOCK2 10pter-q25.3 0.326 0.0118 0.287 peptide cross-linking
via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization
his EMC1 1p36.13 0.326 0.0118 0.287
his MRTO4 1p36.13 0.326 0.0118 0.287 ribosome biogenesis
swa CAD 2p22-p21 0.326 0.0118 0.287 Apoptosis
exp TXNL4A 18q23 0.323 0.0118 0.286 nuclear mRNA splicing, via
exp NIFK-AS1 0.323 0.0118 0.286
exp MUTYH 1p34.1 0.323 0.0118 0.286 DNA Damage Response (DDR); DDR
(BER)
exp PDP2 16q22.1 0.323 0.0118 0.287 pyruvate metabolic process;protein
dephosphorylation
exp RPL21P20 1p34.2 0.323 0.0118 0.287
xsq NOM1 7q36.3 0.323 0.0118 0.287 RNA metabolic process
met ADGRF1 0.323 0.0118 0.287 G-protein coupled receptor
xsq C1orf74 1q32.2 0.323 0.0118 0.287
met MAF1 8q24.3 0.323 0.0118 0.287 regulation of transcription, DNA-
dependent;negative regulation of transcription from RNA polymerase III promoter"
exp EFEMP1 2p16 -0.323 0.0118 0.287 peptidyl-tyrosine
phosphorylation;negative regulation of chondrocyte differentiation
exp PPP1R15A 19q13.2 -0.323 0.0118 0.287 Apoptosis
exp SLC35F6 2p23.3 -0.323 0.0118 0.287
xsq FAM129B 9q34.13 -0.323 0.0118 0.287 negative regulation of
apoptotic process
exp CRAT 9q34.1 -0.323 0.0118 0.287 transport;fatty acid beta-
oxidation using acyl-CoA oxidase
swa ETHE1 19q13.31 -0.326 0.0118 0.287 sulfur amino acid metabolic
his HS1BP3-IT1 -0.326 0.0118 0.287
swa ATP6V1F 7q32 -0.326 0.0118 0.287 transferrin
his ITGA9-AS1 -0.326 0.0118 0.287
his CTDSPL 3p21.3 -0.326 0.0118 0.287
xai RBPMS 8p12 -0.326 0.0118 0.287 regulation of transcription, DNA-
xai RIPPLY2 6q14.2 0.328 0.0119 0.289 ossification;somitogenesis
xai C9orf78 9q34.11 0.326 0.0119 0.288
xai ALOX5AP 13q12 0.326 0.0119 0.288 leukotriene production involved in
xai SVOP 12q24.11 0.326 0.0119 0.288
DNA-dependent"
his MIR548B 0.326 0.0119 0.288
xai LCN1 0.325 0.0119 0.288 proteolysis;response to stimulus
xai RPL7AP34 6q12 0.325 0.0119 0.288
his TRMT6 20p12.3 0.325 0.0119 0.288 regulation of translational
his MCM8 20p12.3 0.325 0.0119 0.288 S phase of mitotic cell cycle;M/G1
xai BCOR Xp11.4 0.325 0.0119 0.288 Tumor Suppressors
xai GAPDHP58 1p12 0.325 0.0119 0.289
his MED16 19p13.3 0.325 0.0119 0.289 positive regulation of
transcription, DNA-dependent;regulation of transcription from RNA polymerase II
promoter
his RNU6-9 0.325 0.0119 0.289
exp RPL34 4q25 0.323 0.0119 0.288 nuclear-transcribed mRNA catabolic
exp MED28 4p16 0.323 0.0119 0.288 regulation of transcription, DNA-
dependent"
exp ADNP2 18q23 0.323 0.0119 0.288 neuron differentiation;positive
met BCL6 3q27 0.323 0.0119 0.288 cell morphogenesis;negative regulation of
cell proliferation
exp TRIML2 4q35.2 0.323 0.0119 0.288
xsq TRMT10A 4q23 0.323 0.0119 0.289
exp ECE1 1p36.1 -0.323 0.0119 0.288 heart development;hormone
catabolic process
exp MXRA8 1p36.33 -0.323 0.0119 0.288
xsq HSPB8 12q24.23 -0.323 0.0119 0.288 response to stress;cell death
xai SCOC 4q31.1 -0.325 0.0119 0.289
xai LMCD1 3p26-p24 -0.325 0.0119 0.288 positive regulation of
xai CRYAB 11q22.3-q23.1 -0.325 0.0119 0.288 protein folding;anti-
apoptosis
xai ABHD4 14q11.2 -0.325 0.0119 0.288 lipid catabolic process
his SLC4A1AP 2p23.3 0.325 0.012 0.289 Solute Carriers
his SUPT7L 2p23.3 0.325 0.012 0.289 regulation of transcription, DNA-
dependent;histone H3 acetylation
his FAM26F 6q22.1 0.325 0.012 0.289
xai RPS4XP5 2p15 0.325 0.012 0.289
xai CHD4 12p13 0.325 0.012 0.289 DNA Damage Response (DDR)
exp LOC100130476 0.325 0.012 0.289
his MRGPRE 11p15.4 0.325 0.012 0.289
xai TIMM21 18q22.3 0.325 0.012 0.289 protein transport
his HBS1L 6q23.3 0.325 0.012 0.289 signal transduction;translation
his TMEM242 6q25.3 0.325 0.012 0.289
his SNORD61 Xq26.3 0.325 0.012 0.289
his RBMX Xq26.3 0.325 0.012 0.289 transcription from RNA polymerase II
promoter;cellular response to interleukin-1
his ZNF17 19q13.4 0.325 0.012 0.289 regulation of transcription, DNA-
dependent"
his LINC00539 0.325 0.012 0.289
exp PNPT1P1 0.325 0.012 0.289
hs4 POTEI 2q21.1 0.325 0.012 0.289
swa EDF1 9q34.3 0.325 0.012 0.289 regulation of transcription, DNA-
xsq LOC100996286 0.323 0.012 0.289
exp NCAPD2 12p13.3 0.323 0.012 0.289 DNA Damage Response (DDR)
xsq ZBTB49 4p16.3 0.323 0.012 0.289 regulation of transcription, DNA-
dependent"
xsq PUS7 7q22.3 0.323 0.012 0.289 pseudouridine synthesis;tRNA processing
xsq PTPRCAP 11q13.3 0.322 0.012 0.289 defense response
exp TMBIM1 2q35 0.322 0.012 0.289
exp ATAD5 17q11.2 0.322 0.012 0.289 DNA Damage Response (DDR)
xsq LAT2 7q11.23 0.322 0.012 0.289 intracellular signal transduction;B cell
activation
met CHP1 15q13.3 0.322 0.012 0.289
xsq GOLGA2P5 12q23.1 0.322 0.012 0.289
exp LOC392181 8p23.1 0.322 0.012 0.289
xsq RNMTL1 17p13.3 0.322 0.012 0.289 RNA processing
exp ZBTB14 18p11.31 0.322 0.012 0.289
met LZTFL1 3p21.3 0.322 0.012 0.289
met C4orf3 4q26 0.322 0.012 0.289
exp AFG3L2P1 8p11.1 0.322 0.012 0.289
mut MUC13 3q21.2 0.322 0.012 0.289 cellular protein metabolic process;O-
glycan processing
exp RPL11 1p36.1-p35 0.322 0.012 0.289 translational elongation;viral infectious
cycle
exp TUFM 16p11.2 0.322 0.012 0.289 translational elongation
exp TRAPPC8 18q12.1 0.322 0.012 0.289 vesicle-mediated transport;ER to
mir hsa-miR-24 -0.322 0.012 0.289
mir hsa-miR-24(2) -0.322 0.012 0.289
exp SHTN1 -0.322 0.012 0.289 multicellular organismal development;axon
guidance
exp VCL 10q22.2 -0.322 0.012 0.289 cellular component
swa PMVK 1q22 -0.325 0.012 0.289 response to cholesterol;cholesterol
xai TRIM16 17p11.2 -0.325 0.012 0.289 positive regulation of
hs4 GSTT2 -0.325 0.012 0.289
xai CHST3 10q22.1 -0.325 0.012 0.289 T cell homeostasis;positive
xai BCAM 19q13.2 -0.325 0.012 0.289 cell-matrix adhesion;signal
transduction
his ANAPC1 2q12.1 0.325 0.0121 0.29 mitotic cell cycle;protein
xai FMNL1 17q21 0.325 0.0121 0.29 substrate-dependent cell
hs4 FMNL1 17q21 0.325 0.0121 0.29 substrate-dependent cell
xai FANCI 15q26.1 0.325 0.0121 0.29 DNA Damage Response (DDR); DDR (FA)
xai TMED8 14q24.3 0.325 0.0121 0.29 transport
xai HSP90AB6P 13q32.1 0.325 0.0121 0.29
swa KARS 16q23.1 0.325 0.0121 0.29 tRNA aminoacylation for protein
exp GAPDHP58 1p12 0.325 0.0121 0.29
xai RPL5P29 11q12.1 0.325 0.0121 0.29
xai NEU3 11q13.5 0.325 0.0121 0.29 carbohydrate metabolic
swa SNRPF 12q23.1 0.325 0.0121 0.29 termination of RNA polymerase II
his MIR1268A 0.325 0.0121 0.29
exp LINC01089 0.322 0.0121 0.289
exp CLK2 1q21 0.322 0.0121 0.289 DNA Damage Response (DDR)
pro MCM7_4 0.322 0.0121 0.289
exp GRPEL1 4p16 0.322 0.0121 0.29 protein folding;protein import into
exp RPUSD1 16p13.3 0.322 0.0121 0.29 pseudouridine synthesis
xsq LINGO1-AS1 0.322 0.0121 0.29
exp SSBP3 1p32.3 0.322 0.0121 0.29 prechordal plate
xsq LOC388882 22q11.23 0.322 0.0121 0.29
met PRSS23 11q14.1 0.322 0.0121 0.29 proteolysis
xsq RNF113A Xq24 0.322 0.0121 0.29
met SLC35B3 6p24.3 0.322 0.0121 0.29 Solute Carriers
xsq DSG4 18q12.1 0.322 0.0121 0.29 cell adhesion;homophilic cell
adhesion
exp CTPS1 1p34.1 0.322 0.0121 0.29 nucleobase-containing small
molecule interconversion;response to drug
xsq C9orf114 9q34.11 0.322 0.0121 0.29
xsq PLOD2 3q24 -0.322 0.0121 0.29 response to hypoxia;protein
xsq MOXD1 6q23.2 -0.322 0.0121 0.29 catecholamine metabolic
process
exp TSPAN14 10q23.1 -0.322 0.0121 0.29
exp KIAA1279 10q22.1 -0.322 0.0121 0.29 cell
differentiation;mitochondrial transport
met MIR143 -0.322 0.0121 0.29
exp MXRA5 Xp22.33 -0.322 0.0121 0.289
his WWC3 Xp22.32 -0.325 0.0121 0.29
xai DENND5A 11p15.4 -0.325 0.0121 0.29
hs4 MET 7q31 -0.325 0.0121 0.29 Oncogenes; Protein Kinases
his ARHGAP29 1p22.1 -0.325 0.0121 0.289 small GTPase mediated
his SDE2 1q42.12 0.325 0.0122 0.29
xai PAN2 12q13.2 0.325 0.0122 0.29 nuclear-transcribed mRNA catabolic
his C21orf33 21q22.3 0.324 0.0122 0.29
dependent"
xai CCNK 14q32 0.324 0.0122 0.29 cell division;regulation of cyclin-
xai FAM192A 16q13 0.324 0.0122 0.291
his ITM2C 2q37 0.324 0.0122 0.291 negative regulation of neuron projection
development;induction of programmed cell death
hs4 PNMAL2 19q13.32 0.324 0.0122 0.291
xai HS3ST4 16p11.2 0.324 0.0122 0.291 heparan sulfate proteoglycan
metabolic process
xai CDCA5 11q12.1 0.324 0.0122 0.291 cell division;G1/S transition of
mitotic cell cycle
his VAV1 19p13.2 0.324 0.0122 0.291 regulation of transcription, DNA-
his CCT6P1 7q11.21 0.324 0.0122 0.291
his SNORA22 7q11.21 0.324 0.0122 0.291
hs4 KLHDC7B 22q13.33 0.324 0.0122 0.291
xai CSNK2A1 20p13 0.324 0.0122 0.291 Protein Kinases
exp KNTC1 12q24.31 0.322 0.0122 0.29 mitotic cell cycle;protein complex
assembly
xsq TAAR2 0.322 0.0122 0.29
mut BICD2 9q22.31 0.322 0.0122 0.29 EMT (Mesenchymal)
xsq PDIK1L 1p36.11 0.322 0.0122 0.291
xsq LOC100132077 0.322 0.0122 0.291
exp ABHD18 0.322 0.0122 0.291
xsq ACTA2 10q23.3 -0.322 0.0122 0.291 muscle contraction;regulation
of blood pressure
xsq AGRN 1p36.33 -0.322 0.0122 0.291 neuromuscular junction
exp FAM71F1 7q32.1 -0.322 0.0122 0.291
exp TMEM9B 11p15.3 -0.322 0.0122 0.291 signal
exp PDGFC 4q32 -0.322 0.0122 0.29 positive regulation of DNA
hs4 EFNA5 5q21 -0.324 0.0122 0.291 apoptotic process;regulation of Rho
GTPase activity
hs4 TJP1 15q13 -0.324 0.0122 0.291 blastocyst formation;apoptotic
process
xai YPEL5 2p23.1 -0.324 0.0122 0.291 oxidation-reduction process
hs4 LOC101929596 -0.324 0.0122 0.29
xai NT5E 6q14-q21 -0.324 0.0122 0.29 dephosphorylation;purine base
metabolic process
hs4 LOC100505585 0.324 0.0123 0.291
hs4 LGALS7 0.324 0.0123 0.291
xai ATAD3C 1p36.33 0.324 0.0123 0.292
xai TIMM8A Xq22.1 0.324 0.0123 0.292 chaperone-mediated protein
transport;nervous system development
his MRPS27 5q13.2 0.324 0.0123 0.292
his PTCD2 5q13.2 0.324 0.0123 0.292 mitochondrion organization;heart
development
his BMS1P4 10q22.2 0.324 0.0123 0.292
his GLUD1P3 10q22.2 0.324 0.0123 0.292
his RRM2 2p25-p24 0.324 0.0123 0.292 DNA Damage Response (DDR)
his PTPRCAP 11q13.3 0.324 0.0123 0.292 defense response
xai ATAD5 17q11.2 0.324 0.0123 0.292 DNA Damage Response (DDR)
xai PPP1CA 11q13 0.324 0.0123 0.292 Apoptosis
exp ELAVL4 1p34 0.321 0.0123 0.291 RNA processing;mRNA processing
exp TRMT6 20p12.3 0.321 0.0123 0.291 regulation of translational
mut CACNB2 10p12 0.321 0.0123 0.291 calcium ion transport;synaptic
transmission
met MET 7q31 0.321 0.0123 0.291 Oncogenes; Protein Kinases
exp PAN2 12q13.2 0.321 0.0123 0.292 nuclear-transcribed mRNA catabolic
mut SPAG17 1p12 0.321 0.0123 0.292
mut CYP3A5 7q21.1 0.321 0.0123 0.292 small molecule metabolic
process;oxidative demethylation
met SPACA7 13q34 0.321 0.0123 0.292
mut OR6C3 0.321 0.0123 0.292
met TMOD1 9q22.3 0.321 0.0123 0.292 muscle filament sliding;myofibril
assembly
met ALDH1L1 3q21.3 0.321 0.0123 0.292 biosynthetic process;10-
formyltetrahydrofolate catabolic process
exp SEPT1 16p11.1 0.321 0.0123 0.292 cell cycle;cell division
exp CRH 8q13 0.321 0.0123 0.292 parturition;locomotory exploration
behavior
xsq LCP1 13q14.3 0.321 0.0123 0.292 T cell activation involved in
exp INPP4A 2q11.2 0.321 0.0123 0.292 signal transduction
xsq MAML2 11q21 -0.321 0.0123 0.292 regulation of transcription, DNA-
dependent;Notch signaling pathway
xsq BAIAP2 17q25 -0.321 0.0123 0.292 insulin receptor signaling
xsq NAV2 11p15.1 -0.321 0.0123 0.292
xsq DOCK1 10q26.13-q26.3 -0.321 0.0123 0.291 Apoptosis
exp STAC 3p22.3 -0.321 0.0123 0.291 signal transduction;cellular
response to heat
exp GPR161 1q24.2 -0.321 0.0123 0.291 multicellular organismal
development
xai EFNA5 5q21 -0.324 0.0123 0.292 apoptotic process;regulation of Rho
GTPase activity
his SERTAD4 1q32.1-q41 -0.324 0.0123 0.292
his SERTAD4-AS1 1q32.2 -0.324 0.0123 0.292
xai ZNF703 8p11.23 -0.324 0.0123 0.292 positive regulation of
his LINC00475 -0.324 0.0123 0.292
swa DHCR24 1p32.3 -0.324 0.0123 0.292 Apoptosis
xai PLCB4 20p12 -0.324 0.0123 0.292 lipid metabolic process;lipid
catabolic process
his ERVV-1 -0.324 0.0123 0.291
his CEP192 18p11.21 0.324 0.0124 0.292 G2/M transition of mitotic
xai RPL12P8 10q21.3 0.324 0.0124 0.292
exp RPL7AP34 6q12 0.324 0.0124 0.292
his RASGRP4 19q13.1 0.324 0.0124 0.292 myeloid cell
xai GAPDHP24 1q41 0.324 0.0124 0.292
xai PINLYP 19q13.31 0.324 0.0124 0.292
xai PDP2 16q22.1 0.324 0.0124 0.292 pyruvate metabolic process;protein
dephosphorylation
exp DKK4 8p11.2-p11.1 0.324 0.0124 0.293 multicellular organismal
development;negative regulation of Wnt receptor signaling pathway
xai DPH5 1p21.2 0.324 0.0124 0.293 peptidyl-diphthamide biosynthetic
process from peptidyl-histidine;metabolic process
his MANEA-AS1 0.324 0.0124 0.293
his MANEA 6q16.1 0.324 0.0124 0.293 protein N-linked glycosylation via
xai AQR 15q14 0.324 0.0124 0.293 nuclear mRNA splicing, via
swa ARMT1 0.324 0.0124 0.293
swa RPL11 1p36.1-p35 0.324 0.0124 0.293 translational elongation;viral
infectious cycle
his HMHB1 5q31.3 0.324 0.0124 0.293
his MYB 6q22-q23 0.324 0.0124 0.293 Apoptosis
xai RSBN1L 7q11.23 0.324 0.0124 0.293
xai LOC93622 4p16.1 0.324 0.0124 0.293
met CCDC144B 17p11.2 0.321 0.0124 0.292
exp RPS8P4 0.321 0.0124 0.292
exp TIMM8A Xq22.1 0.321 0.0124 0.292 chaperone-mediated protein
xsq TFAP2E 1p34.3 0.321 0.0124 0.293 positive regulation of
mir hsa-miR-106b 0.321 0.0124 0.293
xsq GOT2 16q21 0.321 0.0124 0.293 2-oxoglutarate metabolic
process;biosynthetic process
met S100A16 1q21 0.321 0.0124 0.293 response to calcium ion
xsq RFC5 12q24.23 0.321 0.0124 0.293 DNA Damage Response (DDR); DDR
exp GRB10 7p12.2 -0.321 0.0124 0.293 response to insulin
exp DVL3 3q27 -0.321 0.0124 0.292 Wnt receptor signaling pathway;Wnt
exp MOXD1 6q23.2 -0.321 0.0124 0.292 catecholamine metabolic
process
xai BCL2L2 14q11.2-q12 -0.324 0.0124 0.293 Apoptosis
hs4 KLF4 9q31 -0.324 0.0124 0.293 mesodermal cell fate
hs4 ZNF608 5q23.2 -0.324 0.0124 0.292
xai MGAT4B 5q35 -0.324 0.0124 0.292 protein N-linked
xai URGCP 7p13 -0.324 0.0124 0.292 cell cycle
xai PFAS 17p13.1 0.323 0.0125 0.293 purine base metabolic
exp RPS4XP5 2p15 0.323 0.0125 0.294
xai WRAP53 17p13.1 0.323 0.0125 0.294 DNA Damage Response (DDR)
xai GAPDHP64 1p13.1 0.323 0.0125 0.294
xai RPS24P6 2q11.1 0.323 0.0125 0.294
met PDIA5 3q21.1 0.321 0.0125 0.293
xsq NUP93 16q13 0.321 0.0125 0.293 regulation of glucose transport;protein
transport
mut TRPC4 13q13.3 0.321 0.0125 0.293 ion transport;calcium ion transport
xsq CLEC12A 12p13.2 0.321 0.0125 0.293
exp LANCL1 2q33-q35 0.321 0.0125 0.294 G-protein coupled receptor
signaling pathway
xsq FDXACB1 0.321 0.0125 0.294 phenylalanyl-tRNA
aminoacylation;tRNA processing
met C15orf52 15q15.1 0.321 0.0125 0.294
mut SPO11 20q13.31 0.321 0.0125 0.294 DNA Damage Response (DDR); DDR (HR)
exp AQR 15q14 0.32 0.0125 0.294 nuclear mRNA splicing, via
exp ITM2B 13q14.3 -0.321 0.0125 0.294 nervous system
exp DEGS1 1q42.11 -0.321 0.0125 0.293 unsaturated fatty acid
biosynthetic process;sphingolipid metabolic process
exp CTBP2 10q26.13 -0.321 0.0125 0.293 negative regulation of
xai RPL36AP33 -0.323 0.0125 0.294
his GRAMD3 5q23.2 -0.323 0.0125 0.294
exp NAP1L1P3 3q13.33 0.323 0.0126 0.295
xai RCCD1 15q26.1 0.323 0.0126 0.295
hs4 CXCR2 2q35 0.323 0.0126 0.295 dendritic cell chemotaxis;neutrophil
chemotaxis
his ODF4 17p13.1 0.323 0.0126 0.295 cell differentiation;multicellular
his HERC2 15q13 0.323 0.0126 0.295 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;DNA repair
xai POC1B 12q21.33 0.323 0.0126 0.295 cell projection organization;cilium
assembly
xai RPS26P3 9p23 0.323 0.0126 0.295
xai PA2G4 12q13.2 0.323 0.0126 0.295 rRNA processing;regulation of
translation
his MIR550A3 0.323 0.0126 0.295
his LOC646762 7p14.3 0.323 0.0126 0.295
his DPY19L2P3 7p15.1 0.323 0.0126 0.295
his ZNRF2P2 0.323 0.0126 0.295
xai GLI1 12q13.2-q13.3 0.323 0.0126 0.295 multicellular organismal
development;digestive tract morphogenesis
xai TRIML2 4q35.2 0.323 0.0126 0.295
met KDM7A 0.32 0.0126 0.295 chromatin modification;midbrain
development
exp SETD3 14q32.2 0.32 0.0126 0.295 positive regulation of
exp PABPC4L 4q28.3 0.32 0.0126 0.295
met THBS1 15q15 0.32 0.0126 0.295 sprouting angiogenesis;immune response
met TPCN2 11q13.3 0.32 0.0126 0.295 ion transport;cellular calcium ion
homeostasis
xsq TIMM13 19p13.3 0.32 0.0126 0.295 sensory perception of
sound;protein import into mitochondrial inner membrane
exp IQCB2P 6p22.1 0.32 0.0126 0.295
mut FBXL18 7p22.2 0.32 0.0126 0.295
xsq SSTR5-AS1 16p13.3 0.32 0.0126 0.295
xsq ELP5 17p13.1 0.32 0.0126 0.295
exp RPL36AP5 0.32 0.0126 0.295
met CILD2 0.32 0.0126 0.295
exp SF3A3 1p34.3 0.32 0.0126 0.295 RNA splicing;gene expression
exp RPL36AP8 15q14 0.32 0.0126 0.295
exp MYO1G 7p13-p11.2 0.32 0.0126 0.295
exp DDHD1 14q21 0.32 0.0126 0.295 lipid catabolic process
cop CHEK2P2 15q11.1 0.32 0.0126 0.295
met FLRT3 20p11 0.32 0.0126 0.295 cell adhesion
exp PRKCQ 10p15 0.32 0.0126 0.295 Protein Kinases
exp REL 2p13-p12 0.32 0.0126 0.295 Apoptosis; Oncogenes
exp ARID3B 15q24 0.32 0.0126 0.295 regulation of transcription, DNA-
dependent"
xsq LOC101593348 0.32 0.0126 0.295
xsq LOC100996324 0.32 0.0126 0.295
met LDLRAD2 1p36.12 -0.32 0.0126 0.295
xsq PRKCDBP 11p15.4 -0.32 0.0126 0.295
exp SPTAN1 9q34.11 -0.32 0.0126 0.295 apoptotic process;cellular
xai TNS1 2q35-q36 -0.323 0.0126 0.295 cell-substrate junction
exp RPS26P3 9p23 0.323 0.0127 0.295
his NFATC3 16q22.2 0.323 0.0127 0.295 regulation of transcription
xai HSPD1P5 4q31.21 0.323 0.0127 0.295
his CCDC69 5q33.1 0.323 0.0127 0.295
xai DOC2A 0.323 0.0127 0.295 synaptic transmission;nervous system
development
xai RPRD2 1q21.3 0.323 0.0127 0.295
xai CTPS1 1p34.1 0.323 0.0127 0.295 nucleobase-containing small
his CYTIP 2q11.2 0.323 0.0127 0.295 regulation of cell adhesion
xai SLC13A1 7q31.32 0.323 0.0127 0.295 ion transmembrane
his VBP1 Xq28 0.323 0.0127 0.295 cellular protein metabolic process;'de
novo' posttranslational protein folding
xai HOMER1 5q14.2 0.323 0.0127 0.296 regulation of store-operated
swa PEBP1 12q24.23 0.323 0.0127 0.296 regulation of neurotransmitter
levels;response to wounding
xai COX5A 15q24.1 0.323 0.0127 0.296 small molecule metabolic
xai LOC100128310 0.323 0.0127 0.296
xai KLHDC4 16q24 0.323 0.0127 0.296
met PEX11A 15q26.1 0.32 0.0127 0.295 peroxisome
organization;signal transduction
xsq FAM117B 2q33.2 0.32 0.0127 0.295
exp RPL37P23 0.32 0.0127 0.295
exp HPDL 1p34.1 0.32 0.0127 0.295 aromatic amino acid family
metabolic process
mut DLEC1 3p21.3 0.32 0.0127 0.295 negative regulation of cell
proliferation
exp E2F8 11p15.1 0.32 0.0127 0.295 cell cycle
exp RPS26P2 9p21.1 0.32 0.0127 0.296
xsq GLP1R 6p21 0.32 0.0127 0.296 positive regulation of cell
proliferation;positive regulation of cell differentiation
mut HHIPL2 1q41 0.32 0.0127 0.296 carbohydrate metabolic process
exp RNASEH2B 13q14.3 0.32 0.0127 0.296 DNA Damage Response (DDR);
exp MAZ 16p11.2 0.32 0.0127 0.296 regulation of transcription, DNA-
dependent;transcription initiation from RNA polymerase II promoter
exp WDFY3 4q21.23 -0.32 0.0127 0.295 metabolic process
xai ECE1 1p36.1 -0.323 0.0127 0.295 heart development;hormone
catabolic process
xai GLIS2 16p13.3 -0.323 0.0127 0.295 positive regulation of
transcription, DNA-dependent;negative regulation of transcription from RNA
xai LSM12 17q21.31 0.322 0.0128 0.296
his MIS18A 21q22.11 0.322 0.0128 0.296 nucleosome assembly;cell
cycle
xai SRD5A3 4q12 0.322 0.0128 0.296 dolichol-linked oligosaccharide
biosynthetic process;androgen biosynthetic process
swa RPS28 19p13.2 0.322 0.0128 0.296 nuclear-transcribed mRNA catabolic
swa TROVE2 1q31 0.322 0.0128 0.296 transcription from RNA polymerase
III promoter
his COX5B 2q11.2 0.322 0.0128 0.296 respiratory gaseous
exchange;respiratory electron transport chain
his CEP152 15q21.1 0.322 0.0128 0.296 G2/M transition of mitotic
xai RPL17P26 6p12.1 0.322 0.0128 0.297
xai LYL1 19p13.2 0.322 0.0128 0.297 regulation of transcription, DNA-
hs4 BCL11B 14q32.2 0.322 0.0128 0.297 regulation of lipid metabolic
swa PFDN5 12q12 0.322 0.0128 0.297 protein folding;cellular protein
metabolic process
exp PPP1CA 11q13 0.32 0.0128 0.296 Apoptosis
cop EMILIN2 18p11.3 0.32 0.0128 0.296 cell adhesion
cop LPIN2 18p11.31 0.32 0.0128 0.296 triglyceride biosynthetic
cop LOC727896 0.32 0.0128 0.296
mut NT5DC3 12q22-q23.1 0.32 0.0128 0.296
exp CIAPIN1P 18q11.2 0.32 0.0128 0.297
met ZFP2 5q35.3 0.319 0.0128 0.297 regulation of transcription, DNA-
dependent"
xsq SIPA1L3 19q13.13 -0.32 0.0128 0.297 regulation of small GTPase
exp PLCB4 20p12 -0.32 0.0128 0.297 lipid metabolic process;lipid catabolic
process
xsq ARHGEF10L 1p36.13 -0.32 0.0128 0.297 positive regulation of Rho
exp ASL 7q11.21 -0.32 0.0128 0.296 argininosuccinate metabolic
process;response to nutrient
cop OSTN 3q28 -0.32 0.0128 0.296 ossification;multicellular organismal
development
xsq NUDT16 3q22.1 -0.32 0.0128 0.296
exp RCN1P2 -0.32 0.0128 0.296
his LOC101928539 -0.322 0.0128 0.297
hs4 DNAH2 17p13.1 -0.322 0.0128 0.296 ciliary or flagellar
motility;microtubule-based movement
hs4 TLR3 4q35 -0.322 0.0128 0.296 activation of NF-kappaB-inducing
kinase activity;positive regulation of interleukin-8 production
his USP37 2q35 0.322 0.0129 0.298 proteolysis;ubiquitin-dependent protein
catabolic process
his CNOT9 0.322 0.0129 0.298
swa UBE2K 4p14 0.322 0.0129 0.298 ubiquitin-dependent protein catabolic
process;protein ubiquitination
xai NAP1L1P3 3q13.33 0.322 0.0129 0.298
his ZNF224 19q13.2 0.322 0.0129 0.298 negative regulation of
xai DSCC1 8q24.12 0.322 0.0129 0.298 cell cycle;maintenance of mitotic
sister chromatid cohesion
exp RPL10 Xq28 0.322 0.0129 0.298 translation;mRNA metabolic process
his SPN 16p11.2 0.322 0.0129 0.298 negative regulation of type IV
his TIPIN 15q22.31 0.322 0.0129 0.298 DNA Damage Response (DDR)
xai MSH5 6p21.3 0.322 0.0129 0.298 DNA Damage Response (DDR); DDR
(MMR)
his CCDC28A 6q23.1-q24.1 0.322 0.0129 0.298
his GVQW2 0.322 0.0129 0.298
exp DSCC1 8q24.12 0.319 0.0129 0.297 cell cycle;maintenance of mitotic
pro MSH6 2p16 0.319 0.0129 0.297 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xsq PRKCQ-AS1 10p14 0.319 0.0129 0.298
met NEK6 9q33.3-q34.11 0.319 0.0129 0.298 DNA Damage Response (DDR)
xsq ILF3-AS1 19p13.2 0.319 0.0129 0.298
xsq CSTF2 Xq22.1 0.319 0.0129 0.298 gene expression;nuclear mRNA
exp ZCCHC7 9p13.2 0.319 0.0129 0.298
xsq RIOK1 6p24.3 0.319 0.0129 0.298
exp ELF2 4q28 0.319 0.0129 0.298 Transcription Factors
cop LOC729950 0.319 0.0129 0.298
xsq LYAR 4p16.3 0.319 0.0129 0.298
met PLOD2 3q24 0.319 0.0129 0.298 response to hypoxia;protein modification
process
exp NXT2 Xq23 0.319 0.0129 0.298 protein transport;mRNA transport
xsq SORCS2 4p16.1 -0.319 0.0129 0.298 neuropeptide signaling
pathway
exp MICALL1 22q13.1 -0.319 0.0129 0.298
met HSD17B14 19q13.33 -0.319 0.0129 0.297 steroid catabolic
process
hs4 TPM1 15q22.1 -0.322 0.0129 0.298 positive regulation of heart
his LOC100505841 -0.322 0.0129 0.298
hs4 AKR1B15 -0.322 0.0129 0.298
swa MTCH2 11p11.2 -0.322 0.0129 0.298 transport
xai TMCO3 13q34 -0.322 0.0129 0.298 cation transport;transmembrane
transport
xai KLHL29 2p24.1 -0.322 0.0129 0.298
his FAM136A 2p13.3 0.322 0.013 0.298
his SAC3D1 11q13.1 0.322 0.013 0.298 cell cycle;mitosis
his LOC100132741 0.322 0.013 0.298
his OXA1L 14q11.2 0.322 0.013 0.299 mitochondrial proton-transporting ATP
synthase complex assembly;protein insertion into membrane
dependent"
his GRPEL1 4p16 0.321 0.013 0.299 protein folding;protein import into
his RAC3 17q25.3 0.321 0.013 0.299 actin cytoskeleton organization;neuron
projection development
exp RPF2P1 20q11.22 0.319 0.013 0.298
xsq PLCL2 3p24.3 0.319 0.013 0.298 lipid metabolic process;intracellular
signal transduction
met MIR1283-1 0.319 0.013 0.298
exp LCP1 13q14.3 0.319 0.013 0.298 T cell activation involved in immune
response;organ regeneration
met PPP1R3D 20q13.3 0.319 0.013 0.298 regulation of glycogen catabolic
xsq TMEM170A 16q23.1 0.319 0.013 0.298
exp C1QBP 17p13.3 0.319 0.013 0.298 blood coagulation;blood coagulation,
intrinsic pathway
xsq CDC14A 1p21 0.319 0.013 0.299 cell cycle;cell proliferation
exp RPS10P7 1q32.1 0.319 0.013 0.299
exp BRF1 14q 0.319 0.013 0.299 positive regulation of transcription, DNA-
dependent;transcription initiation, DNA-dependent
xsq DCK 4q13.3-q21.1 0.319 0.013 0.299 purine base metabolic
exp CSNK2A1 20p13 0.319 0.013 0.299 Protein Kinases
xsq LOC401127 4p14 0.319 0.013 0.299
xsq TRIP13 5p15.33 0.319 0.013 0.299 DNA Damage Response (DDR)
xsq DFNA5 7p15 -0.319 0.013 0.299 sensory perception of sound;inner ear
receptor cell differentiation
exp PCBP4 3p21 -0.319 0.013 0.299 DNA damage response, signal transduction
by p53 class mediator resulting in cell cycle arrest;cell cycle arrest
xsq TJP1 15q13 -0.319 0.013 0.299 blastocyst formation;apoptotic process
exp ITGA10 1q21 -0.319 0.013 0.299 cell adhesion;cell-matrix adhesion
xsq CCDC144A -0.319 0.013 0.299
exp FLCN 17p11.2 -0.319 0.013 0.299 regulation of protein
phosphorylation
xsq TACSTD2 1p32 -0.319 0.013 0.298 response to stimulus;negative
exp LOC100133299 -0.321 0.013 0.299
xai ITGA10 1q21 -0.322 0.013 0.299 cell adhesion;cell-matrix adhesion
swa HSPB1 7q11.23 -0.322 0.013 0.298 Apoptosis
hs4 CELSR1 22q13.3 -0.322 0.013 0.298 locomotory
behavior;orthogonal dichotomous subdivision of terminal units involved in lung
branching morphogenesis
xai TSPAN14 10q23.1 -0.322 0.013 0.298
his C16orf54 0.321 0.0131 0.299
xai DDHD1 14q21 0.321 0.0131 0.299 lipid catabolic process
swa FERMT3 11q13.1 0.321 0.0131 0.299 leukocyte cell-cell
xai ANKRD13D 11q13.2 0.321 0.0131 0.299
his MTHFD1 14q24 0.321 0.0131 0.299 water-soluble vitamin metabolic
process;cellular amino acid biosynthetic process
hs4 LINC01221 0.321 0.0131 0.3
xai RPL10 Xq28 0.321 0.0131 0.3 translation;mRNA metabolic process
his SRSF1 17q22 0.321 0.0131 0.3 transcription from RNA polymerase II
promoter;cardiac muscle contraction
xai NFATC2IP 0.321 0.0131 0.3 DNA Damage Response (DDR); DDR (HR)
DNA-dependent"
exp MPHOSPH6 16q23.3 0.319 0.0131 0.299 M phase of mitotic cell
cycle;maturation of 5.8S rRNA
mut MCF2L2 3q27.1 0.319 0.0131 0.299 regulation of Rho protein
signal transduction
xsq OGFOD1 16q12.2 0.319 0.0131 0.299
exp NOP58 2q33.1 0.319 0.0131 0.3 rRNA processing;snRNP protein
import into nucleus
mut SBNO1 12q24.31 0.319 0.0131 0.3
xsq TEX10 9q31.1 0.319 0.0131 0.3
mut HPD 12q24.31 0.318 0.0131 0.3 L-phenylalanine catabolic
process;tyrosine catabolic process
mir hsa-miR-483-5p 0.318 0.0131 0.3
exp GLIS2 16p13.3 -0.318 0.0131 0.3 positive regulation of
met PRSS48 4q31.3 -0.319 0.0131 0.3 proteolysis
exp PLEKHA4 19q13.33 -0.319 0.0131 0.3
exp MVP 16p11.2 -0.319 0.0131 0.3 DNA Damage Response (DDR)
exp OFD1P7Y Yq11.222 -0.319 0.0131 0.3
pro MCC 5q21 -0.319 0.0131 0.3 signal transduction;negative
regulation of epithelial cell migration
xai LRRIQ4 3q26.2 -0.321 0.0131 0.3
xai MVP 16p11.2 -0.321 0.0131 0.3 DNA Damage Response (DDR)
xai KIAA1279 10q22.1 -0.321 0.0131 0.3 cell
hs4 LINC01546 -0.321 0.0131 0.299
exp NR2F2-AS1 -0.321 0.0131 0.299
hs4 OPHN1 Xq12 -0.321 0.0131 0.299 substrate-dependent cell migration,
exp HSP90AB6P 13q32.1 0.321 0.0132 0.301
xai ELF2 4q28 0.321 0.0132 0.301 Transcription Factors
his SCARNA9 0.321 0.0132 0.301
xai NUP155 5p13.1 0.321 0.0132 0.301 nucleocytoplasmic
xai CYB5B 16q22.1 0.321 0.0132 0.301 transport;electron transport chain
xai CSF2RB 22q13.1 0.321 0.0132 0.301 signal
transduction;respiratory gaseous exchange
exp LINC01226 0.318 0.0132 0.3
exp HIST2H2BC 1q21.2 0.318 0.0132 0.3
xsq LINC00226 0.318 0.0132 0.301
xsq TICRR 15q26.1 0.318 0.0132 0.301 DDR (DNA replication)
xsq RFX5 1q21 0.318 0.0132 0.301 negative regulation of transcription from
pro EP300_14_26534 0.318 0.0132 0.301
exp FANCI 15q26.1 0.318 0.0132 0.301 DNA Damage Response (DDR); DDR (FA)
xsq LOC100506688 0.318 0.0132 0.301
exp RPL23AP38 3p26.3 0.318 0.0132 0.301
exp DOC2A 0.318 0.0132 0.301 synaptic transmission;nervous system
development
exp FXN 9q21.11 0.318 0.0132 0.301 mitochondrion organization;protein
autoprocessing
met EXD1 15q15.1 0.318 0.0132 0.301 nucleobase-containing compound
metabolic process
xsq PRG2 11q12 0.318 0.0132 0.301 immune response;defense response to
bacterium
xsq LINC01132 0.318 0.0132 0.301
xsq GMDS-AS1 0.318 0.0132 0.301
met GTSF1 12q13.13 -0.318 0.0132 0.301
exp TOM1 22q13.1 -0.318 0.0132 0.301 intracellular protein
xsq RHBDF1 16p13.3 -0.318 0.0132 0.301 regulation of
xai SNX33 15q24.2 -0.321 0.0132 0.301 cell communication
hs4 MIR135B -0.321 0.0132 0.301
xai DAP3P2 0.321 0.0133 0.301
xai HIST1H2BI 6p22.1 0.321 0.0133 0.301
hs4 LINC01120 0.321 0.0133 0.302
exp DAP3P2 0.321 0.0133 0.302
his CCNA2 4q27 0.321 0.0133 0.302 DNA Damage Response (DDR); DDR (DNA
replication)
xai BCL7A 12q24.13 0.321 0.0133 0.302 negative regulation of
xai NOP58 2q33.1 0.321 0.0133 0.302 rRNA processing;snRNP protein
import into nucleus
xai TMA16 4q32.2 0.321 0.0133 0.302
his VAV3-AS1 0.321 0.0133 0.302
hs4 GAS6-AS1 0.321 0.0133 0.302
his TSSC1 2p25.3 0.321 0.0133 0.302
his TRAPPC12 2p25.3 0.321 0.0133 0.302 vesicle-mediated transport
his FCGR1CP 0.32 0.0133 0.302
exp FKBP4P1 4q26 0.318 0.0133 0.301
mut NETO2 16q11 0.318 0.0133 0.302
exp SERBP1 1p31 0.318 0.0133 0.302 regulation of anti-
xsq TIMM8A Xq22.1 0.318 0.0133 0.302 chaperone-mediated protein
xsq TANGO6 16q22.1 0.318 0.0133 0.302
exp PUS10 2p16.1 0.318 0.0133 0.302 pseudouridine synthesis;tRNA
processing
xsq KLHL7-AS1 0.318 0.0133 0.302
xsq HENMT1 1p13.3 0.318 0.0133 0.302 RNA methylation;gene
silencing by RNA
exp RBMX2 Xq26.1 0.318 0.0133 0.302
mut MAGI2 7q21 0.318 0.0133 0.302 protein heterooligomerization;positive
regulation of receptor internalization
met HLA-J 6p21.31 0.318 0.0133 0.302
his VLDLR 9p24 -0.32 0.0133 0.302 nervous system development;cerebral
cortex development
his VLDLR-AS1 -0.32 0.0133 0.302
xai FLJ42393 -0.321 0.0133 0.302
xai ZNF366 5q13.2 -0.321 0.0133 0.302 negative regulation of
dependent
his GBP1 1p22.2 -0.321 0.0133 0.302 interferon-gamma-mediated
xai CTSL3P 9q21.33 -0.321 0.0133 0.302
his KRT85 12q13 -0.321 0.0133 0.302 epidermis development
xai CHIT1 1q32.1 -0.321 0.0133 0.302 response to
bacterium;polysaccharide catabolic process
met OR2T11 1q44 0.323 0.0134 0.302 response to stimulus
his LOC100130872 0.32 0.0134 0.302
his CTBP1-AS 0.32 0.0134 0.302
xai TESPA1 12q13.2 0.32 0.0134 0.302
his MIR17HG 13q31.3 0.32 0.0134 0.302
his MIR17 0.32 0.0134 0.302
his MIR18A 0.32 0.0134 0.302
his MIR19A 0.32 0.0134 0.302
his MIR20A 0.32 0.0134 0.302
his MIR19B1 0.32 0.0134 0.302
his MIR92A1 0.32 0.0134 0.302
his TOP2B 3p24 0.32 0.0134 0.302 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
his MIR4442 0.32 0.0134 0.302
his C17orf53 17q21.31 0.32 0.0134 0.302
his NOP2 12p13 0.32 0.0134 0.302 rRNA processing;positive regulation of
cell proliferation
exp DDX6P1 6p22.1 0.32 0.0134 0.302
xai SLC26A8 6p21 0.32 0.0134 0.303 oxalate transport;cell
differentiation
dependent"
his AQR 15q14 0.32 0.0134 0.303 nuclear mRNA splicing, via
mut SYNJ1 21q22.2 0.318 0.0134 0.302 synaptic vesicle uncoating;response
to retinoic acid
pro CDK7 5q12.1 0.318 0.0134 0.302 DNA Damage Response (DDR); DDR
(NER); Protein Kinases
met FKBP9 7p11.1 0.318 0.0134 0.302 protein peptidyl-prolyl
exp IKZF3 17q21 0.318 0.0134 0.302 mesoderm development;regulation of B cell
proliferation
exp RPL23AP77 18q11.2 0.318 0.0134 0.302
exp CCT2 12q15 0.318 0.0134 0.302 protein folding;cellular protein
metabolic process
met CD276 15q23-q24 0.318 0.0134 0.302 cell proliferation;positive
met EFEMP1 2p16 0.318 0.0134 0.302 peptidyl-tyrosine
xsq ITGB2 21q22.3 0.318 0.0134 0.302 Apoptosis
exp DMRTC1 0.318 0.0134 0.303
exp KLRC3 12p13 0.318 0.0134 0.303 cellular defense response
met IFI27 14q32 0.318 0.0134 0.303 activation of cysteine-type endopeptidase
activity involved in apoptotic process;induction of apoptosis by extracellular
signals
exp NAIF1 9q34.11 0.318 0.0134 0.303 apoptotic process;induction of
apoptosis
exp MRPS5 2p11.2-q11.2 0.317 0.0134 0.303 translation
exp RPS25 11q23.3 0.317 0.0134 0.303 translation;mRNA metabolic process
exp GPC6 13q32 -0.317 0.0134 0.303
xsq HOMER3 19p13.11 -0.318 0.0134 0.302 protein targeting;G-
exp TGFA 2p13 -0.318 0.0134 0.302 anti-apoptosis;positive regulation
of mitosis
swa VAPB 20q13.33 -0.32 0.0134 0.303 endoplasmic reticulum unfolded
protein response;small molecule metabolic process
xai USP17L7 8p23.1 -0.32 0.0134 0.302 ubiquitin-dependent protein
catabolic process
hs4 FLJ42969 -0.32 0.0134 0.302
xai LZTS2 10q24 -0.32 0.0134 0.302 cell cycle;mitosis
his CD276 15q23-q24 -0.32 0.0134 0.302 cell proliferation;positive
xai MYO1F 19p13.3-p13.2 0.32 0.0135 0.303 negative regulation of cell
his CRBN 3p26.2 0.32 0.0135 0.303 negative regulation of protein
homooligomerization;negative regulation of ion transmembrane transport
hs4 TRAT1 3q13 0.32 0.0135 0.303 positive regulation of T cell receptor
exp LOC101060405 0.32 0.0135 0.303
his MRPL53 2p13.1 0.32 0.0135 0.303
xai C1orf174 1p36.32 0.32 0.0135 0.303
xai LOC101060405 0.32 0.0135 0.303
hs4 LOC101927815 0.32 0.0135 0.304
xai KIR3DL1 0.32 0.0135 0.304 regulation of immune
his ERCC6L Xq13.1 0.32 0.0135 0.304 mitotic prometaphase;mitotic
cell cycle
hs4 PTGER1 19p13.1 0.32 0.0135 0.304 G-protein coupled receptor
signaling pathway
hs4 KCNC4 1p21 0.32 0.0135 0.304 ion transport;potassium ion transport
hs4 KCNC4-AS1 0.32 0.0135 0.304
xsq RPS4X Xq13.1 0.317 0.0135 0.303 translational elongation;mRNA
metabolic process
exp LETM1 4p16.3 0.317 0.0135 0.303 cristae formation
xsq NANOS3 19p13.13 0.317 0.0135 0.303 cell
differentiation;oogenesis
exp CCR2 3p21.31 0.317 0.0135 0.303 cellular calcium ion
exp CYC1 8q24.3 0.317 0.0135 0.303 transport;respiratory electron
transport chain
mir hsa-miR-652 0.317 0.0135 0.304
exp RPS25P2 1q32.2 0.317 0.0135 0.304
xsq SEH1L 18p11.21 0.317 0.0135 0.304 mitotic prometaphase;protein
transport
xsq TCF3 19p13.3 0.317 0.0135 0.304 transcription, DNA-
xsq RCOR2 11q13.1 0.317 0.0135 0.304 negative regulation of
xsq PHF5A 22q13.2 0.317 0.0135 0.304 nuclear mRNA splicing, via
exp RILPL1 12q24.31 -0.317 0.0135 0.304 neuroprotection
xsq CPM 12q14.3 -0.317 0.0135 0.304 proteolysis;anatomical
structure morphogenesis
xsq COL8A1 3q12.3 -0.317 0.0135 0.303 angiogenesis;cell
adhesion
met SPOCK2 10pter-q25.3 -0.317 0.0135 0.303 peptide cross-
linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix
organization
his ARHGEF28 5q13.2 -0.32 0.0135 0.303
hs4 MIR4279 -0.32 0.0135 0.303
exp USP17L7 8p23.1 -0.32 0.0135 0.303 ubiquitin-dependent protein
catabolic process
his LAMTOR4 7q22.1 0.32 0.0136 0.304
his LOC642943 0.32 0.0136 0.304
xai JRK 8q24.3 0.32 0.0136 0.304 regulation of transcription, DNA-
dependent"
xai SURF2 9q34.2 0.32 0.0136 0.304
swa AKR1A1 1p33-p32 0.32 0.0136 0.304 cellular aldehyde metabolic
process;L-ascorbic acid biosynthetic process
his TANGO6 16q22.1 0.32 0.0136 0.304
xai POU2F1 1q24.2 0.32 0.0136 0.304 lens induction in camera-type
eye;regulation of transcription, DNA-dependent
xai SETP2 14q22.1 0.32 0.0136 0.304
hs4 NKD2 5p15.3 0.32 0.0136 0.304 transport;exocytosis
xai MATR3 5q31.2 0.32 0.0136 0.305
hs4 LAT2 7q11.23 0.32 0.0136 0.305 intracellular signal transduction;B
cell activation
xai LMO2 11p13 0.32 0.0136 0.305 cellular response to thyroid hormone
xai PROSER1 13q13.3 0.319 0.0136 0.305
xai MAPK6PS4 8q11.1 0.319 0.0136 0.305
xai PVRIG 7q22.1 0.319 0.0136 0.305
xsq TESPA1 12q13.2 0.317 0.0136 0.304
exp BAZ1A 14q13.2 0.317 0.0136 0.304 DNA Damage Response (DDR); DDR
(Chromatin)
met TM4SF1 3q21-q25 0.317 0.0136 0.304
xsq CD5 11q13 0.317 0.0136 0.304 induction of apoptosis by extracellular
signals;T cell costimulation
DNA-dependent"
xsq ZFP1 16q23.1 0.317 0.0136 0.304 regulation of transcription, DNA-
dependent"
exp FMNL1 17q21 0.317 0.0136 0.304 substrate-dependent cell
exp EMG1 12p13.3 0.317 0.0136 0.304 rRNA processing;ribosomal small
subunit biogenesis
xsq ALG1L9P 11q13.4 0.317 0.0136 0.304
met PDE8A 15q25.3 0.317 0.0136 0.304 regulation of transcription, DNA-
dependent;cyclic nucleotide metabolic process"
met CPNE3 8q21.3 0.317 0.0136 0.305 lipid metabolic process;vesicle-
mediated transport
exp EVA1A 2p12 -0.317 0.0136 0.304
xsq CTGF 6q23.1 -0.317 0.0136 0.304 response to wounding;positive
met ATP5L2 22q13.2 -0.317 0.0136 0.304 ion transport;ATP
synthesis coupled proton transport
hs4 RNASE11 14q11.2 -0.32 0.0136 0.304
hs4 RNASE12 -0.32 0.0136 0.304
xai CTSL 9q21.33 -0.32 0.0136 0.304
xai IGSF3 1p13 -0.32 0.0136 0.304
exp RPL31P61 19q13.12 0.319 0.0137 0.305
his HAR1A 20q13.33 0.319 0.0137 0.305
his HAR1B 20q13.33 0.319 0.0137 0.305
swa PFKL 21q22.3 0.319 0.0137 0.305 small molecule metabolic
process;negative regulation of insulin secretion
xai HSPD1P1 5p14.3 0.319 0.0137 0.305
his ZSCAN30 18q12.2 0.319 0.0137 0.305 viral reproduction
his ZNF271P 0.319 0.0137 0.305
xai PRKCQ 10p15 0.319 0.0137 0.305 Protein Kinases
his CDS2 20p13 0.319 0.0137 0.305 phospholipid biosynthetic process
his FRAT1 10q24.1 0.319 0.0137 0.305 Wnt receptor signaling
pathway;embryonic axis specification
xai VARS 6p21.3 0.319 0.0137 0.305 gene expression;translational
elongation
xai BAZ1A 14q13.2 0.319 0.0137 0.306 DNA Damage Response (DDR); DDR
(Chromatin)
exp TMPO-AS1 12q23.1 0.319 0.0137 0.306
exp KIR2DS4 19q13.4 0.317 0.0137 0.305
xsq GPSM3 6p21.3 0.317 0.0137 0.305 signal transduction;regulation of
exp WTAP 6q25-q27 0.317 0.0137 0.305 mRNA processing;cell cycle
met PRELID2 5q32 0.317 0.0137 0.305
exp ZNF22 10q11 0.317 0.0137 0.305 odontogenesis;regulation of
xsq OXCT1 5p13.1 0.317 0.0137 0.305 response to nutrient;response to
ethanol
exp IST1 16q22.2 0.317 0.0137 0.305 cell division;cell cycle
exp C9orf78 9q34.11 0.317 0.0137 0.305
xsq RASAL2-AS1 -0.317 0.0137 0.305
xsq RNF144B 6p22.3 -0.317 0.0137 0.305 apoptotic
process;protein ubiquitination involved in ubiquitin-dependent protein catabolic
process
xsq SPACA6P -0.317 0.0137 0.305
hs4 INTU 4q28.1 -0.319 0.0137 0.306 nervous system
development;regulation of smoothened signaling pathway
exp CTSL3P 9q21.33 -0.319 0.0137 0.305
xai PRUNE2 9q21.2 -0.319 0.0137 0.305 apoptotic
hs4 SNX7 1p21.3 -0.319 0.0137 0.305 cell communication;protein
transport
hs4 LYPD1 2q21.2 -0.319 0.0137 0.305
xai PCYT1A 3q29 -0.319 0.0137 0.305 CDP-choline
pathway;phospholipid biosynthetic process
his CCDC150 2q33.1 0.319 0.0138 0.306
his PIGB 15q21.3 0.319 0.0138 0.306 post-translational protein
his PIGBOS1 0.319 0.0138 0.306
xai IL9R 0.319 0.0138 0.306 signal transduction;cell proliferation
xai HIST1H2BO 6p22.1 0.319 0.0138 0.306 nucleosome assembly
xai SNORA75 0.319 0.0138 0.306
xai DDX3YP3 4q24 0.319 0.0138 0.306
hs4 CD48 1q21.3-q22 0.319 0.0138 0.307 T cell activation;mast cell
activation
exp SNORA75 0.319 0.0138 0.307
exp UNG 12q23-q24.1 0.316 0.0138 0.306 DNA Damage Response (DDR); DDR
(BER)
met LRRN4 20p12.3 0.316 0.0138 0.306
exp CBWD3 0.316 0.0138 0.306
xsq LOC728743 7q36.1 0.316 0.0138 0.306
xsq CERKL 2q31.3 0.316 0.0138 0.306 anti-apoptosis;activation of
protein kinase C activity by G-protein coupled receptor protein signaling pathway
exp YAP1P1 6q24.3 -0.316 0.0138 0.307
xsq GRIK4 11q22.3 -0.316 0.0138 0.306 transport;ion transport
swa AP2M1 3q28 -0.319 0.0138 0.307 vesicle-mediated
transport;transport
his IFI27 14q32 -0.319 0.0138 0.307 activation of cysteine-type
endopeptidase activity involved in apoptotic process;induction of apoptosis by
extracellular signals
xai ZBTB47 3p22.1 -0.319 0.0138 0.306 regulation of
xai VAMP3 1p36.23 -0.319 0.0138 0.306 protein complex
his PLEKHF1 19q12 -0.319 0.0138 0.306 apoptotic process
hs4 IFI27 14q32 -0.319 0.0138 0.306 activation of cysteine-type
exp CD101 1p13 -0.319 0.0138 0.306 cell surface receptor signaling
pathway
his HIST1H3G 0.319 0.0139 0.307
his HIST1H2BI 6p22.1 0.319 0.0139 0.307
xai ARPP21 3p22.3 0.319 0.0139 0.307 cellular response to heat
swa LRRC40 1p31.1 0.319 0.0139 0.307
xai EXO1 1q42-q43 0.319 0.0139 0.307 DNA Damage Response (DDR); DDR
(MMR)
exp RPS4XP4 1p36.12 0.319 0.0139 0.307
his BLOC1S4 4p16.1 0.319 0.0139 0.307
xai SETD3 14q32.2 0.319 0.0139 0.307 positive regulation of
hs4 CSF2RB 22q13.1 0.319 0.0139 0.307 signal
his GGCX 2p12 0.319 0.0139 0.307 protein modification process;blood
coagulation
his PSD4 2q13 0.319 0.0139 0.307 regulation of ARF protein signal
transduction
xai RPL12P11 20q12 0.319 0.0139 0.307
his PGLYRP4 1q21 0.319 0.0139 0.307 innate immune response;defense
response to Gram-positive bacterium
exp PA2G4 12q13.2 0.316 0.0139 0.307 rRNA processing;regulation of
translation
xsq CDCA5 11q12.1 0.316 0.0139 0.307 cell division;G1/S transition of
mitotic cell cycle
exp GAPDHP64 1p13.1 0.316 0.0139 0.307
exp RAC3 17q25.3 0.316 0.0139 0.307 actin cytoskeleton
met ABHD5 3p21 0.316 0.0139 0.307 negative regulation of sequestering of
triglyceride;positive regulation of triglyceride catabolic process
xsq TNFSF8 9q33 0.316 0.0139 0.307 cell-cell signaling;cell
proliferation
mut OR10S1 11q24.1 0.316 0.0139 0.307 response to stimulus
exp GPCPD1 20p12.3 0.316 0.0139 0.307 glycerol metabolic
exp HIST1H2AJ 6p22.1 0.316 0.0139 0.307
xsq CSK 15q24.1 0.316 0.0139 0.307 Apoptosis
exp UCK2 1q23 0.316 0.0139 0.307 response to axon injury;nucleobase-
exp RBBP4P5 14q11.2 0.316 0.0139 0.307
exp LRWD1 7q22.1 0.316 0.0139 0.307 G1 phase of mitotic cell cycle;DNA
replication
xsq INTS2 17q23.2 0.316 0.0139 0.307 snRNA processing
met SNRPA1 15q26.3 0.316 0.0139 0.307 RNA splicing;gene expression
exp TMEM156 4p14 0.316 0.0139 0.307
exp DENND5A 11p15.4 -0.316 0.0139 0.307
exp CEACAMP10 19q13.2 -0.316 0.0139 0.307
swa NDUFB4 3q13.33 -0.319 0.0139 0.307 response to oxidative
stress;respiratory electron transport chain
xai GALNT10 5q33.2 -0.319 0.0139 0.307 O-glycan
xai HECTD2 10q23.32 -0.319 0.0139 0.307 protein modification
process
xai TOM1 22q13.1 -0.319 0.0139 0.307 intracellular protein
swa EIF2B5 3q27.1 0.319 0.014 0.307 response to glucose
stimulus;cellular protein metabolic process
xai PCBP1-AS1 0.318 0.014 0.307
xai NEDD1 12q23.1 0.318 0.014 0.307 G2/M transition of mitotic cell
his ARHGAP15 2q22.2-q22.3 0.318 0.014 0.307 regulation of small GTPase
mediated signal transduction;signal transduction
exp LOC100128310 0.318 0.014 0.307
xai RNF165 18q21.1 0.318 0.014 0.307
xai LINC00612 0.318 0.014 0.307
his TIMM8B 11q23.1-q23.2 0.318 0.014 0.307 protein targeting to
mitochondrion;sensory perception of sound
his SDHD 0.318 0.014 0.307 respiratory electron transport chain;small
his DQX1 2p13.1 0.318 0.014 0.307
his HTRA2 2p12 0.318 0.014 0.307 Apoptosis
his AUP1 2p13 0.318 0.014 0.307
hs4 GFI1 1p22 0.318 0.014 0.307 negative regulation of calcidiol 1-
exp HSPD1P1 5p14.3 0.318 0.014 0.307
his TTC27 2p22.3 0.318 0.014 0.307
xai VPS16 20p13 0.318 0.014 0.307 intracellular protein transport
hs4 RGS19 20q13.33 0.318 0.014 0.307 autophagy;G-protein coupled receptor
signaling pathway
hs4 MIR6813 0.318 0.014 0.307
hs4 OPRL1 20q13.33 0.318 0.014 0.307 elevation of cytosolic calcium ion
xai KMT2D 12q13.12 0.318 0.014 0.308
his CD28 2q33 0.318 0.014 0.308 humoral immune response;negative thymic T cell
selection
xai LOC100506127 0.318 0.014 0.308
cop TMEM181 6q25.3 0.316 0.014 0.307 pathogenesis
cop DYNLT1 6q25.2-q25.3 0.316 0.014 0.307 regulation of Rac GTPase
activity;establishment of mitotic spindle orientation
mir hsa-miR-623 0.316 0.014 0.307
xsq RFX3-AS1 0.316 0.014 0.307
xsq OXER1 2p21 0.316 0.014 0.307 G-protein coupled receptor signaling
pathway;regulation of cAMP biosynthetic process
met TICAM1 19p13.3 0.316 0.014 0.307 inflammatory response;positive
regulation of protein binding
exp POLD1 19q13.3 0.316 0.014 0.307 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
exp GPATCH4 1q22 0.316 0.014 0.307
xsq TM6SF1 15q24-q26 0.316 0.014 0.307
met NLRP13 19q13.43 0.316 0.014 0.307
met PQLC2 1p36.13 0.316 0.014 0.307
xsq WDR5 9q34 0.316 0.014 0.307 regulation of transcription, DNA-
mut XRCC5 2q35 0.316 0.014 0.307 DNA Damage Response (DDR); DDR (NHEJ)
xsq CLK3 15q24 0.316 0.014 0.308 protein autophosphorylation;protein
phosphorylation
exp NEFHP1 1p13.1 0.316 0.014 0.308
exp ATP5A1 18q21 0.316 0.014 0.308 lipid metabolic process;small molecule
metabolic process
exp AHDC1 1p36.13 -0.316 0.014 0.308
met MIR711 -0.316 0.014 0.307
his LOC102724593 -0.318 0.014 0.308
his LOC100130880 7q33 -0.318 0.014 0.308
swa HMGCL 1p36.1-p35 -0.318 0.014 0.307 response to starvation;cellular
lipid metabolic process
xai SYNC 1p35.1 -0.318 0.014 0.307 intermediate filament-based process
xai EFEMP1 2p16 -0.319 0.014 0.307 peptidyl-tyrosine
xai FAM98B 15q14 0.318 0.0141 0.308
xai TREML2 6p21.1 0.318 0.0141 0.308 T cell activation
hs4 GIMAP1 7q36.1 0.318 0.0141 0.308 B cell differentiation;T cell
differentiation
hs4 GIMAP1-GIMAP5 0.318 0.0141 0.308
xai UNG 12q23-q24.1 0.318 0.0141 0.308 DNA Damage Response (DDR); DDR
(BER)
xai SCNN1B 16p12.2-p12.1 0.318 0.0141 0.308 ion transport;sodium ion
transport
xai CLPB 11q13.4 0.318 0.0141 0.308 cellular response to heat
his CARNMT1 0.318 0.0141 0.308
his LPCAT3 12p13 0.318 0.0141 0.308 phospholipid biosynthetic process
his SNORD50A 0.318 0.0141 0.308
his SNORD50B 6q14.3 0.318 0.0141 0.308
his SNHG5 6q14.3 0.318 0.0141 0.308
xai SLX4 16p13.3 0.318 0.0141 0.308 DNA Damage Response (DDR); DDR (HR)
xai KCNN3 1q21.3 0.318 0.0141 0.308 potassium ion transmembrane
transport;ion transport
xai ZBTB49 4p16.3 0.318 0.0141 0.308 regulation of transcription,
DNA-dependent"
xai ARHGEF33 2p22.1 0.318 0.0141 0.308 regulation of Rho protein
signal transduction
xai TRAT1 3q13 0.318 0.0141 0.308 positive regulation of T cell receptor
xai TUFM 16p11.2 0.318 0.0141 0.309 translational elongation
exp VARS 6p21.3 0.316 0.0141 0.308 gene expression;translational
elongation
exp TRIM27 6p22 0.316 0.0141 0.308 cell proliferation;negative
exp LOC100287430 6q22.1 0.315 0.0141 0.308
xsq USP39 2p11.2 0.315 0.0141 0.308 spliceosome assembly;mRNA
processing
xsq URB2 1q42.13 0.315 0.0141 0.308
xsq FAM136A 2p13.3 0.315 0.0141 0.309
met PNPLA2 11p15.5 0.315 0.0141 0.309 metabolic process;negative
regulation of sequestering of triglyceride
xsq MAMDC2 9q21.12 -0.315 0.0141 0.308
exp RHPN2P1 15q11.1 -0.315 0.0141 0.308
mir hsa-miR-30a* -0.316 0.0141 0.308
xai ASL 7q11.21 -0.318 0.0141 0.309 argininosuccinate metabolic
xai PPP1R15A 19q13.2 -0.318 0.0141 0.309 Apoptosis
xai CCDC149 4p15.2 -0.318 0.0141 0.309
xai SPTAN1 9q34.11 -0.318 0.0141 0.309 apoptotic
process;cellular component disassembly involved in apoptosis
swa CAPN2 1q41-q42 -0.318 0.0141 0.308 response to
his HPRT1 Xq26.1 0.318 0.0142 0.309 spermatogenesis;central nervous
xai RPA2 1p35 0.318 0.0142 0.309 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
exp LINC00612 0.318 0.0142 0.309
exp CLUHP4 0.318 0.0142 0.31
his LPAR5 12p13.31 0.318 0.0142 0.31
xai BOLA3 2p13.1 0.318 0.0142 0.31
exp RPL6P3 1q43 0.315 0.0142 0.309
met METTL20 12p11.21 0.315 0.0142 0.309
exp ARPP21 3p22.3 0.315 0.0142 0.309 cellular response to heat
exp FAM27B 9q13 0.315 0.0142 0.309
exp HPGD 4q34-q35 0.315 0.0142 0.309 prostaglandin metabolic
exp IMMT 2p11.2 0.315 0.0142 0.309
exp RPL7AP30 4q25 0.315 0.0142 0.309
met F2RL2 5q13 0.315 0.0142 0.31 blood coagulation;response to wounding
exp ELOVL4 6q14 0.315 0.0142 0.31 fatty acid biosynthetic
exp PFDN2 1q23.3 0.315 0.0142 0.31 protein folding;cellular protein
metabolic process
exp RPL39P3 0.315 0.0142 0.31
exp ANKRD13D 11q13.2 0.315 0.0142 0.31
exp CEBPZ 2p22.2 0.315 0.0142 0.31 regulation of transcription, DNA-
exp ATXN1 6p23 -0.315 0.0142 0.31 cell death;regulation of excitatory
exp RHOBTB3 5q15 -0.315 0.0142 0.31 ATP catabolic
process;transport
exp DNASE2 19p13.2 -0.315 0.0142 0.31 Apoptosis
hs4 CCDC144NL 17p11.2 -0.318 0.0142 0.309
hs4 TM4SF1 3q21-q25 -0.318 0.0142 0.309
hs4 TM4SF1-AS1 -0.318 0.0142 0.309
xai COIL 17q22 0.318 0.0143 0.31 oxidation-reduction process
exp GAPDHP24 1q41 0.318 0.0143 0.31
xai CSNK1G2 19p13.3 0.317 0.0143 0.31 Protein Kinases
hs4 FGF4 11q13.3 0.317 0.0143 0.31
xai FKBP5 6p21.31 0.317 0.0143 0.311 peptidyl-proline
xai COX7BP1 22q13 0.317 0.0143 0.311
xai RPS10P3 9q22.1 0.317 0.0143 0.311
exp SNORD53 2p23.2 0.317 0.0143 0.311
his STAG2 Xq25 0.317 0.0143 0.311 DNA Damage Response (DDR); Tumor
Suppressors
his LOC101928402 0.317 0.0143 0.311
xai SNORD53 2p23.2 0.317 0.0143 0.311
xsq GPC2 7q22.1 0.315 0.0143 0.31 neuron differentiation
exp DSC1 18q12.1 0.315 0.0143 0.31 cell adhesion;homophilic cell
adhesion
exp NAA15 4q31.1 0.315 0.0143 0.31 angiogenesis;N-terminal protein
exp CCT8 21q22.11 0.315 0.0143 0.31 protein folding;cellular protein
metabolic process
exp CENPVP3 Xp11.22 0.315 0.0143 0.31
exp ECSIT 19p13.2 0.315 0.0143 0.31 innate immune response;regulation
cop SYTL3 6q25.3 0.315 0.0143 0.31 intracellular protein transport
xsq KATNA1 6q25.1 0.315 0.0143 0.311 mitosis;protein localization
exp ZNF830 17q12 0.315 0.0143 0.311 blastocyst growth;cell cycle
met MOCS1 6p21.3 0.315 0.0143 0.311 vitamin metabolic process;water-
soluble vitamin metabolic process
xsq GTF2E1 3q21-q24 0.315 0.0143 0.311 interspecies interaction
between organisms;regulation of transcription, DNA-dependent
xsq UBQLN1 9q22 0.315 0.0143 0.311 response to hypoxia;apoptotic
process
exp GP5 3q29 0.315 0.0143 0.311 cell adhesion;cell-matrix adhesion
exp MB21D1 6q13 0.315 0.0143 0.311 response to virus
mda MB21D1_transcript_expression 0.315 0.0143 0.311
met GPAA1 8q24.3 0.315 0.0143 0.311 C-terminal protein
lipidation;protein retention in ER lumen
xsq AGPAT5 8p23.1 0.315 0.0143 0.311 metabolic
xsq ZFPM2-AS1 -0.315 0.0143 0.311
xai SLC9A7 Xp11.3 -0.317 0.0143 0.311 Solute Carriers
his CASQ2 1p13.1 -0.317 0.0143 0.311 striated muscle
contraction;heart development
xai CAV2 7q31.1 -0.317 0.0143 0.311 mitochondrion
organization;protein oligomerization
xai CCDC50 3q28 -0.317 0.0143 0.311
xai MYCN 2p24.3 0.317 0.0144 0.311 Protein Kinases
his RNF165 18q21.1 0.317 0.0144 0.311
his CCNL2 1p36.33 0.317 0.0144 0.311 regulation of cyclin-dependent
protein kinase activity;regulation of transcription, DNA-dependent
his LOC148413 1p36.33 0.317 0.0144 0.311
his CCL1 17q12 0.317 0.0144 0.311 cellular calcium ion
xai WTAP 6q25-q27 0.317 0.0144 0.311 mRNA processing;cell cycle
his PAGR1 16p11.2 0.317 0.0144 0.311
his MVP 16p11.2 0.317 0.0144 0.311 DNA Damage Response (DDR)
his CPT2 1p32 0.317 0.0144 0.311 fatty acid beta-oxidation;transport
exp HIST3H2BA 1q42.13 0.317 0.0144 0.311
xai MGA 15q14 0.317 0.0144 0.311 Apoptosis
his ALG8 11q14.1 0.317 0.0144 0.311 dolichol-linked oligosaccharide
his KCTD21-AS1 11q14.1 0.317 0.0144 0.311
xai ATP2A3 17p13.3 0.317 0.0144 0.311 transmembrane transport;ATP
xai GPCPD1 20p12.3 0.317 0.0144 0.311 glycerol metabolic
his TEX9 15q21.3 0.317 0.0144 0.311
xai DKK4 8p11.2-p11.1 0.317 0.0144 0.311 multicellular organismal
xai GAPDHP61 15q22.31 0.317 0.0144 0.311
his LOC105369635 0.317 0.0144 0.311
his MIR200C 0.317 0.0144 0.311
his MIR141 0.317 0.0144 0.311
xai ATP5D 19p13.3 0.317 0.0144 0.311 ATP catabolic process;ATP
his METTL2A 17q23.2 0.317 0.0144 0.311
exp C1orf131 1q42.2 0.315 0.0144 0.311
xsq NELFA 4p16.3 0.315 0.0144 0.311
mut ATP1A3 19q13.31 0.315 0.0144 0.311
met EGF 4q25 0.315 0.0144 0.311 Apoptosis
xsq KLLN 10q23 0.315 0.0144 0.311 cell cycle;apoptotic process
exp NUP155 5p13.1 0.315 0.0144 0.311 nucleocytoplasmic
xsq SHE 1q21.3 0.315 0.0144 0.311
exp PRPF40A 2q23.3 0.315 0.0144 0.311 cell cycle;regulation of cell
shape
xsq CYP2R1 11p15.2 0.315 0.0144 0.311 vitamin metabolic
exp ZFP69B 1p34.2 0.315 0.0144 0.311
mut NR3C1 5q31.3 0.314 0.0144 0.311 EMT (Mesenchymal)
exp PFAS 17p13.1 0.314 0.0144 0.311 purine base metabolic
mut COBL 7p12.1 0.314 0.0144 0.311 neural tube closure
xsq LY86 6p25.1 0.314 0.0144 0.311 apoptotic process;inflammatory
response
xsq CIRH1A 16q22.1 0.314 0.0144 0.311
xsq POLR2D 2q21 0.314 0.0144 0.311 DNA Damage Response (DDR); DDR
(NER)
exp RNF165 18q21.1 0.314 0.0144 0.311
exp RPL35P2 6p21.31 0.314 0.0144 0.311
exp ANKRD17 4q13.3 0.314 0.0144 0.311 interspecies interaction
between organisms
exp EXT2 11p12-p11 -0.314 0.0144 0.311 ossification;mesoderm
formation
met FGD2 6p21.2 -0.314 0.0144 0.311 regulation of cell
exp SEPT9 17q25 -0.314 0.0144 0.311 GTP catabolic process;cell cycle
exp MICAL3 22q11.21 -0.315 0.0144 0.311
hs4 LOC102724153 -0.317 0.0144 0.311
hs4 FLVCR2 14q24.3 -0.317 0.0144 0.311 heme
hs4 PDLIM3 4q35 -0.317 0.0144 0.311 actin filament
organization;heart development
hs4 SYNC 1p35.1 -0.317 0.0144 0.311 intermediate filament-based
process
xai TFAM 10q21 0.317 0.0145 0.311 regulation of transcription from RNA
polymerase I promoter;transcription from mitochondrial promoter
his TMEM143 19q13.33 0.317 0.0145 0.311
his SYNGR4 19q13.3 0.317 0.0145 0.311
exp LOC100996324 0.317 0.0145 0.311
xai CHST8 19q13.1 0.317 0.0145 0.311 proteoglycan biosynthetic
process;hormone biosynthetic process
xai SLF1 0.317 0.0145 0.311
his LIN28B 6q21 0.317 0.0145 0.311 miRNA catabolic process;gene
silencing by RNA
xai GNL2 1p34.3 0.317 0.0145 0.311 GTP catabolic process;ribosome
biogenesis
xai NKD2 5p15.3 0.317 0.0145 0.311 transport;exocytosis
xai NCBP3 0.317 0.0145 0.311
xai LANCL1 2q33-q35 0.317 0.0145 0.311 G-protein coupled receptor
signaling pathway
his SCARNA13 14q32.12 0.317 0.0145 0.311
his SNHG10 14q32.13 0.317 0.0145 0.311
his GLRX5 14q32.13 0.317 0.0145 0.311 hemopoiesis;cell redox homeostasis
xai COPS7B 2q37.1 0.317 0.0145 0.312 DNA Damage Response (DDR)
exp ALOX5AP 13q12 0.314 0.0145 0.311 leukotriene production involved in
exp YY1 14q 0.314 0.0145 0.311 DNA recombination;cellular response to UV
exp GOLGA2P5 12q23.1 0.314 0.0145 0.311
xsq SMAP2 1p35.3-p34.1 0.314 0.0145 0.311 regulation of ARF GTPase
activity
xsq BCO2 11q23.1 0.314 0.0145 0.311 carotene metabolic process;retinoic
acid metabolic process
pro CASP2_6 0.314 0.0145 0.311
xsq LOC653786 16p12.2 0.314 0.0145 0.311
xsq NAT10 11p13 0.314 0.0145 0.311
xsq EEF2KMT 0.314 0.0145 0.312
exp GPC1 2q35-q37 -0.314 0.0145 0.311 axon guidance
exp MAML2 11q21 -0.314 0.0145 0.311 regulation of transcription, DNA-
mir hsa-miR-151-3p -0.314 0.0145 0.311
xsq UBTD1 10q24.2 -0.314 0.0145 0.311
exp RGL3 19p13.2 -0.314 0.0145 0.311 signal
xai NEU1 6p21.3 -0.317 0.0145 0.311 sphingolipid metabolic
xai GRB10 7p12.2 -0.317 0.0145 0.311 response to insulin
his CUEDC1 17q23.2 -0.317 0.0145 0.311
his MAFB 20q11.2-q13.1 -0.317 0.0145 0.311 negative regulation of
erythrocyte differentiation;segment specification
hs4 NOS1AP 1q23.3 -0.317 0.0145 0.311 regulation of apoptotic
process;regulation of nitric oxide biosynthetic process
hs4 NUPR1 16p11.2 -0.317 0.0145 0.311 induction of apoptosis;cell
growth
hs4 CNTN6 3p26-p25 -0.317 0.0145 0.311 cell adhesion;Notch signaling
pathway
hs4 PITPNM3 -0.317 0.0145 0.311
swa MAP2K1 15q22.1-q22.33 0.317 0.0146 0.312 Oncogenes; Protein
Kinases
hs4 GRAP 17p11.2 0.317 0.0146 0.312 Ras protein signal
xai FBXO33 14q21.1 0.316 0.0146 0.312
xai RPS6KB1 17q23.1 0.316 0.0146 0.312 Apoptosis; Protein Kinases
DNA-dependent"
exp PRSS57 19p13.3 0.316 0.0146 0.312 proteolysis
exp SLC9B2 4q24 0.314 0.0146 0.312 cation transport;sodium ion
transport
exp GABPB1 15q21.2 0.314 0.0146 0.312 positive regulation of
met RFC3 13q13.2 0.314 0.0146 0.312 DNA Damage Response (DDR); DDR
cop RBBP8 18q11.2 0.314 0.0146 0.312 DNA Damage Response (DDR); DDR (G1-
S checkpoint)
xsq SLAMF6 1q23.2 0.314 0.0146 0.312
exp GINS3 16q21 0.314 0.0146 0.312 DDR (DNA replication)
exp LRPPRC 2p21 0.314 0.0146 0.312 regulation of transcription, DNA-
dependent;transport
xsq PRSS30P 16p13.3 0.314 0.0146 0.312
exp METTL3 14q11.1 0.314 0.0146 0.312 gene expression;RNA
methylation
exp NEU3 11q13.5 0.314 0.0146 0.312 carbohydrate metabolic
xsq TFEC 7q31.2 0.314 0.0146 0.312 regulation of transcription, DNA-
dependent;cellular response to heat"
exp SPN 16p11.2 0.314 0.0146 0.312 negative regulation of type IV
exp RPL12P40 18q12.2 0.314 0.0146 0.312
exp RPRD2 1q21.3 0.314 0.0146 0.312
exp OSER1 20q13.11 -0.314 0.0146 0.312
exp GFRAL 6p12.1 -0.314 0.0146 0.312 anti-apoptosis;stress-
activated protein kinase signaling cascade
exp LOC100289060 15q21.3 -0.314 0.0146 0.312
xsq NQO1 16q22.1 -0.314 0.0146 0.312 xenobiotic metabolic
xai TSC22D2 3q25.1 -0.316 0.0146 0.312 response to osmotic
stress
xai CYB5R3 22q13.2 -0.316 0.0146 0.312 cholesterol biosynthetic
process;vitamin metabolic process
hs4 MIPOL1 14q13.3 -0.316 0.0146 0.312
hs4 ARNTL 11p15 -0.316 0.0146 0.312 circadian rhythm;positive
hs4 RHOB 2p24 -0.317 0.0146 0.312 Apoptosis
xai TAX1BP3 17p13 -0.317 0.0146 0.312 negative regulation of cell
proliferation;negative regulation of Wnt receptor signaling pathway
xai RILPL1 12q24.31 -0.317 0.0146 0.312 neuroprotection
swa CCDC50 3q28 -0.317 0.0146 0.312
xai PUM2 2p22-p21 0.316 0.0147 0.312 regulation of translation
xai ZBTB14 18p11.31 0.316 0.0147 0.313
his LOC100506302 0.316 0.0147 0.313
his RBM33 7q36.3 0.316 0.0147 0.313
his LCP1 13q14.3 0.316 0.0147 0.313 T cell activation involved in
xai CLUHP4 0.316 0.0147 0.313
xai CCDC75P1 3p13 0.316 0.0147 0.313
xai RPL21P39 3q24 0.316 0.0147 0.313
his SH2B1 0.316 0.0147 0.313 blood coagulation;intracellular signal
transduction
exp DDX3YP3 4q24 0.316 0.0147 0.313
xai CRYBB2 22q11.23 0.316 0.0147 0.313 visual perception;camera-type
eye development
xai DERL3 22q11.23 0.316 0.0147 0.313 ER-associated protein catabolic
process;endoplasmic reticulum unfolded protein response
mut TACC2 10q26 0.314 0.0147 0.312 interkinetic nuclear migration;astral
microtubule organization
xsq DNA2 10q21.3-q22.1 0.314 0.0147 0.313 DNA Damage Response (DDR);
xsq DERL3 22q11.23 0.314 0.0147 0.313 ER-associated protein catabolic
met WDR93 15q26.1 0.314 0.0147 0.313 electron transport chain
xsq MC4R 18q22 0.314 0.0147 0.313 positive regulation of cAMP biosynthetic
process;response to insulin stimulus
xsq ADM5 19q13.33 0.314 0.0147 0.313
exp TDG 12q24.1 0.314 0.0147 0.313 DNA Damage Response (DDR); DDR
(BER)
xsq SRBD1 2p21 0.313 0.0147 0.313 nucleobase-containing compound metabolic
process
xsq SGK223 8p23.1 -0.313 0.0147 0.313
xsq FHL2 2q12.2 -0.314 0.0147 0.313 negative regulation of
development
exp RPS28P4 2q37.1 -0.314 0.0147 0.313
xsq ACTN4 19q13 -0.314 0.0147 0.313 Apoptosis
xai MLF1 3q25.1 -0.316 0.0147 0.313 cell cycle
xai RHBDL2 1p34.3 -0.316 0.0147 0.313 proteolysis
xai WDFY3 4q21.23 -0.316 0.0147 0.313 metabolic process
xai PCBP4 3p21 -0.316 0.0147 0.313 DNA damage response, signal
transduction by p53 class mediator resulting in cell cycle arrest;cell cycle arrest
hs4 OSCP1 1p34.3 -0.316 0.0147 0.313 transport
his KLHDC7A 1p36.13 -0.316 0.0147 0.313
xai NQO1 16q22.1 -0.316 0.0147 0.312 xenobiotic metabolic
xai PI4K2A 10q24 -0.316 0.0147 0.312 phosphatidylinositol
xai FARSB 2q36.1 0.316 0.0148 0.313 gene expression;translation
xai GOLGA2P5 12q23.1 0.316 0.0148 0.313
hs4 TAF4B 18q11.2 0.316 0.0148 0.314 viral reproduction;transcription
his HSH2D 19p13.12 0.316 0.0148 0.314 T cell activation
his SENP6 6q13-q14.3 0.316 0.0148 0.314 protein modification by small
protein removal;regulation of spindle assembly
xai AASDHPPT 11q22 0.316 0.0148 0.314 macromolecule biosynthetic
his STARD7-AS1 0.316 0.0148 0.314
his STARD7 2q11.2 0.316 0.0148 0.314
xai OGT Xq13 0.316 0.0148 0.314 induction of apoptosis;histone H4-K8
acetylation
exp SRSF10 1p36.11 0.316 0.0148 0.314 nuclear mRNA splicing, via
spliceosome;regulation of transcription, DNA-dependent
his ADAM6 0.316 0.0148 0.314
his RPS6KB2 11q13.2 0.316 0.0148 0.314 Apoptosis; Protein Kinases
exp TRIM65 17q25.1 0.313 0.0148 0.314
exp H3.Y 0.313 0.0148 0.314
exp PA2G4P6 0.313 0.0148 0.314
xsq QTRTD1 3q13.31 0.313 0.0148 0.314 queuosine biosynthetic
process
xsq KHDC1 6q13 0.313 0.0148 0.314
xsq PRMT3 11p15.1 0.313 0.0148 0.314 peptidyl-arginine N-methylation
xsq CYP2D6 22q13.1 0.313 0.0148 0.314 alkaloid catabolic
met PTPRE 10q26 0.313 0.0148 0.314 protein phosphorylation;protein
dephosphorylation
met PACS1 11q13.1-q13.2 0.313 0.0148 0.314 positive regulation of
protein binding;cellular protein localization
exp CTC1 17p13.1 0.313 0.0148 0.314 DNA Damage Response (DDR)
exp ZNF703 8p11.23 -0.313 0.0148 0.314 positive regulation of
exp GALNT10 5q33.2 -0.313 0.0148 0.314 O-glycan
exp FIGN 2q24.3 -0.313 0.0148 0.314 locomotory behavior
xsq BMPR2 2q33-q34 -0.313 0.0148 0.314 transmembrane receptor
growth
met IL4 5q31.1 -0.313 0.0148 0.314 negative regulation of
chronic inflammatory response;regulation of proton transport
xai PLS3 Xq23 -0.316 0.0148 0.314
xai COL18A1 21q22.3 -0.316 0.0148 0.314 negative regulation of
cell proliferation;organ morphogenesis
exp LOC100129406 -0.316 0.0148 0.314
xai SFXN4 10q26.11 0.316 0.0149 0.314 iron ion homeostasis;transmembrane
transport
his KIAA1958 9q32 0.316 0.0149 0.314
xai TDG 12q24.1 0.316 0.0149 0.314 DNA Damage Response (DDR); DDR
(BER)
xai C1QBP 17p13.3 0.316 0.0149 0.314 blood coagulation;blood
coagulation, intrinsic pathway
his SH3BGRL3 1p36.11 0.316 0.0149 0.314 cell redox homeostasis
xai KLHL17 1p36.33 0.316 0.0149 0.314 brain development;actin
hs4 ARHGDIB 12p12.3 0.316 0.0149 0.314 multicellular organismal
xai RCC1 1p36.1 0.316 0.0149 0.314 cell cycle;mitotic spindle
organization
xai MRPS30 5q11 0.316 0.0149 0.314 Apoptosis
his CCDC77 12p13.33 0.316 0.0149 0.314
his KDM5A 12p11 0.316 0.0149 0.314 positive regulation of transcription,
DNA-dependent;regulation of transcription, DNA-dependent
xai LYRM7 5q23.3 0.316 0.0149 0.314
his LOC105378183 0.316 0.0149 0.314
xai RPL13AP20 12p13.1 0.316 0.0149 0.315
xai NUFIP1P 6q12 0.315 0.0149 0.315
xai GAPDHP46 1p22.1 0.315 0.0149 0.315
xai XRCC6P1 10q23.33 0.315 0.0149 0.315
exp STX18-AS1 0.315 0.0149 0.315
exp PLD4 14q32.33 0.313 0.0149 0.314 lipid catabolic process
cop ZNF521 18q11.2 0.313 0.0149 0.314 regulation of transcription,
met CTIF 18q21.1 0.313 0.0149 0.314 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;regulation of translational initiation
exp RPL36AP42 14q 0.313 0.0149 0.314
exp WDR77 1p13.2 0.313 0.0149 0.314 regulation of transcription from
xsq AKAP1 17q22 0.313 0.0149 0.314 Apoptosis
exp TMEM241 18q11.2 0.313 0.0149 0.314
xsq PPP1R8 1p35.3 0.313 0.0149 0.314 regulation of transcription,
DNA-dependent;mRNA processing
exp XAB2 19p13.2 0.313 0.0149 0.314 DNA Damage Response (DDR); DDR
(NER)
mut CAAP1 9p21.2 0.313 0.0149 0.314 apoptotic process
exp ALMS1 2p13 0.313 0.0149 0.315 sensory perception of sound;epithelial
cell proliferation
xsq LOC100507557 0.313 0.0149 0.315
cop TULP4 6q25-q26 0.313 0.0149 0.315 regulation of transcription, DNA-
dependent;response to nutrient
exp KIAA0513 16q24.1 -0.313 0.0149 0.315
xsq PARVA 11p15.3 -0.313 0.0149 0.314 cell projection
exp AP2M1 3q28 -0.313 0.0149 0.314 vesicle-mediated
transport;transport
exp GGCX 2p12 -0.313 0.0149 0.314 protein modification process;blood
coagulation
xsq LAMB1 7q22 -0.313 0.0149 0.314 embryo implantation;positive
exp PLS3 Xq23 -0.313 0.0149 0.314
exp HRCT1 9p13.3 -0.313 0.0149 0.314
xai AHDC1 1p36.13 -0.316 0.0149 0.315
xai HLA-F-AS1 6p22.1 -0.316 0.0149 0.314
xai FHDC1 4q31.3 -0.316 0.0149 0.314 cellular component
his TRAF3IP2 6q21 -0.316 0.0149 0.314 intracellular signal
hs4 LMOD1 1q32 -0.316 0.0149 0.314 muscle contraction
exp RPL13AP20 12p13.1 0.315 0.015 0.315
exp GAPDHP68 7p21.3 0.315 0.015 0.315
hs4 ARID3A 19p13.3 0.315 0.015 0.315 regulation of transcription, DNA-
dependent"
exp BHLHE23 20q13.33 0.315 0.015 0.315 regulation of transcription, DNA-
dependent;positive regulation of transcription from RNA polymerase II promoter
xai GAPDHP68 7p21.3 0.315 0.015 0.315
xai IKZF3 17q21 0.315 0.015 0.315 mesoderm development;regulation of B cell
proliferation
his NAIP 0.315 0.015 0.315 Apoptosis
xai CARNMT1 0.315 0.015 0.315
hs4 NCF4 22q13.1 0.315 0.015 0.315 immune response;cell communication
xai TNFAIP8L2 1q21.3 0.315 0.015 0.315 innate immune response
his DMC1 22q13.1 0.315 0.015 0.315 DNA Damage Response (DDR); DDR (DNA
replication)
his LOC105373031 0.315 0.015 0.315
his NOC2L 1p36.33 0.315 0.015 0.315 negative regulation of apoptotic
process;negative regulation of transcription from RNA polymerase II promoter
his KLHL17 1p36.33 0.315 0.015 0.315 brain development;actin
xai MAGOHB 12p13.2 0.315 0.015 0.315 RNA splicing;mRNA transport
his C1QBP 17p13.3 0.315 0.015 0.315 blood coagulation;blood coagulation,
intrinsic pathway
xai GTF3C2 2p23.3 0.315 0.015 0.315 transcription, DNA-
dependent;transcription from RNA polymerase III promoter
mir hsa-miR-19b-1* 0.313 0.015 0.315
pro EP300_20_26599 0.313 0.015 0.315
exp RPL19P3 1p31.3 0.313 0.015 0.315
exp HSPA14 10p13 0.313 0.015 0.315 'de novo' cotranslational protein folding
exp CYB5B 16q22.1 0.313 0.015 0.315 transport;electron transport chain
xsq ZAP70 2q12 0.313 0.015 0.315 T cell activation;B cell activation
exp DDX26B Xq26.3 0.313 0.015 0.315
xsq LCN10 9q34.3 0.313 0.015 0.315 transport
xsq YBEY 21q22.3 0.313 0.015 0.315
exp GLI1 12q13.2-q13.3 0.313 0.015 0.315 multicellular organismal
xsq MXRA8 1p36.33 -0.313 0.015 0.315
xsq TSPAN14 10q23.1 -0.313 0.015 0.315
exp TNS1 2q35-q36 -0.313 0.015 0.315 cell-substrate junction
exp IL6 7p21 -0.313 0.015 0.315 Apoptosis
exp ATP6V0D1 16q22.1 -0.313 0.015 0.315 activation of signaling
xai CRAT 9q34.1 -0.315 0.015 0.315 transport;fatty acid beta-oxidation
using acyl-CoA oxidase
hs4 LOC101929217 -0.315 0.015 0.315
xai AMER1 Xq11.2 0.315 0.0151 0.315
xai GPHN 14q23.3 0.315 0.0151 0.315 vitamin metabolic process;water-
xai UCHL5 1q32 0.315 0.0151 0.315 DNA repair;midbrain development
xai ZNF830 17q12 0.315 0.0151 0.315 blastocyst growth;cell cycle
hs4 XRCC3 14q32.3 0.315 0.0151 0.315 DNA Damage Response (DDR); DDR
(NHEJ)
hs4 ZFYVE21 14q32.33 0.315 0.0151 0.315
xai HNRNPD 4q21 0.315 0.0151 0.315 RNA processing;RNA catabolic
process
his KNL1 0.315 0.0151 0.315
his APOBEC2 6p21 0.315 0.0151 0.315 mRNA processing;cytidine
deamination
hs4 HIST2H3C 0.315 0.0151 0.316
hs4 HIST2H2AA3 0.315 0.0151 0.316
his TMEM241 18q11.2 0.315 0.0151 0.316
exp RPL13 16q24.3 0.313 0.0151 0.315 gene expression;viral reproduction
exp SLF1 0.313 0.0151 0.315
xsq FAM159A 1p32.3 0.313 0.0151 0.315
exp LINC00895 22q11.21 0.313 0.0151 0.315
exp RUVBL1 3q21 0.312 0.0151 0.315 Apoptosis; DNA Damage Response
(DDR); DDR (Chromatin)
met NUDT16 3q22.1 0.312 0.0151 0.315
xsq STX18-AS1 0.312 0.0151 0.315
exp TESPA1 12q13.2 0.312 0.0151 0.315
DNA-dependent"
exp RCCD1 15q26.1 0.312 0.0151 0.315
met MIR589 0.312 0.0151 0.315
exp CD84 1q24 0.312 0.0151 0.316 defense response;cell adhesion
xsq WDR43 2p23.2 0.312 0.0151 0.316
xsq ATP1A3 19q13.31 0.312 0.0151 0.316
xsq EXT1 8q24.11 -0.312 0.0151 0.316 axon guidance;brain
development
xsq NNMT 11q23.1 -0.312 0.0151 0.316 small molecule metabolic
xsq C6orf132 6p21.1 -0.312 0.0151 0.315
exp NNMT 11q23.1 -0.312 0.0151 0.315 small molecule metabolic
exp YWHAZP4 6q23.1 -0.312 0.0151 0.315
xsq CDC14B 9q22.3 -0.312 0.0151 0.315 activation of anaphase-
hs4 SKAP2 7p15.2 -0.315 0.0151 0.316 negative regulation of cell
proliferation;B cell activation
xai P3H2 -0.315 0.0151 0.315 negative regulation of cell
xai ARMCX3 Xq22.1 -0.315 0.0151 0.315
xai CD101 1p13 -0.315 0.0151 0.315 cell surface receptor signaling
pathway
hs4 PATJ -0.315 0.0151 0.315
hs4 C1orf140 1q41 -0.315 0.0151 0.315
hs4 PTP4A3 8q24.3 0.315 0.0152 0.316
exp MPHOSPH10 2p13.3 0.315 0.0152 0.316 RNA processing;RNA splicing
his CYP2E1 10q26.3 0.315 0.0152 0.316 heterocycle metabolic
his LRMP 12p12.1 0.315 0.0152 0.316 vesicle targeting;vesicle fusion
his TCTEX1D1 1p31.3 0.315 0.0152 0.316
exp SETP2 14q22.1 0.315 0.0152 0.316
xai RPL10P14 16q12.1 0.315 0.0152 0.317
exp RPL10P14 16q12.1 0.315 0.0152 0.317
exp NAGS 17q21.31 0.312 0.0152 0.316 urea cycle;glutamate metabolic
process
met ZNF697 1p12 0.312 0.0152 0.316 regulation of transcription, DNA-
dependent"
exp RPL5P34 22q13.2 0.312 0.0152 0.316
xsq WDR74 11q12.3 0.312 0.0152 0.316
exp LYRM7 5q23.3 0.312 0.0152 0.316
exp KLRC4 12p13.2-p12.3 0.312 0.0152 0.316 cellular defense response
exp MBLAC2 5q14.3 0.312 0.0152 0.316
xsq CLEC4D 12p13.31 0.312 0.0152 0.316 innate immune response
exp TRAT1 3q13 0.312 0.0152 0.316 positive regulation of T cell receptor
exp ZSCAN2 15q25.2 0.312 0.0152 0.316 cell
xsq ATP5B 12q13.13 0.312 0.0152 0.316 ADP biosynthetic process;ATP
hydrolysis coupled proton transport
exp PPP1R3B 8p23.1 -0.312 0.0152 0.316 carbohydrate metabolic
xsq SORBS2 4q35.1 -0.312 0.0152 0.316
exp COL18A1 21q22.3 -0.312 0.0152 0.316 negative regulation of
exp NEU1 6p21.3 -0.312 0.0152 0.316 sphingolipid metabolic
exp FAM46B 1p36.11 -0.312 0.0152 0.316
hs4 MARCH1 4q32.2 -0.315 0.0152 0.317 protein
polyubiquitination;antigen processing and presentation of peptide antigen via MHC
class II
his COL21A1 6p12.3-p11.2 -0.315 0.0152 0.316 cell adhesion
hs4 PCBP4 3p21 -0.315 0.0152 0.316 DNA damage response, signal
hs4 CUEDC1 17q23.2 -0.315 0.0152 0.316
hs4 FAM201B 2q21.2 -0.315 0.0152 0.316
his FARSB 2q36.1 0.315 0.0153 0.317 gene expression;translation
exp PRELID1P3 0.315 0.0153 0.317
his LUC7L3 17q21.33 0.314 0.0153 0.317 mRNA processing;apoptotic
process
hs4 PSTPIP1 15q24.3 0.314 0.0153 0.317 cell adhesion;signal
transduction
xai CALCB 0.314 0.0153 0.317 vasodilation;cellular calcium ion
homeostasis
xai PRELID1P3 0.314 0.0153 0.317
exp GAPDHP46 1p22.1 0.314 0.0153 0.317
exp SLC26A8 6p21 0.314 0.0153 0.317 oxalate transport;cell
differentiation
his ERCC4 16p13.12 0.314 0.0153 0.317 DNA Damage Response (DDR); DDR
(NER)
xai GPR174 Xq21.1 0.314 0.0153 0.317
his PUS7 7q22.3 0.314 0.0153 0.317 pseudouridine synthesis;tRNA
processing
his RORB 9q22 0.314 0.0153 0.318 positive regulation of transcription,
DNA-dependent;response to stimulus
his RORB-AS1 0.314 0.0153 0.318
xai WDHD1 14q22.2 0.314 0.0153 0.318 DDR (DNA replication)
his CCNB1IP1 14q11.2 0.314 0.0153 0.318 meiotic metaphase I;spermatid
development
xsq DNAH11 7p21 0.312 0.0153 0.317 ciliary or flagellar
met PACRG 6q26 0.312 0.0153 0.317
met CBR1 21q22.13 0.312 0.0153 0.317 oxidation-reduction process;drug
metabolic process
xsq BTK Xq21.33-q22 0.312 0.0153 0.317 regulation of transcription, DNA-
mut CCDC88A 2p16.1 0.312 0.0153 0.317 EMT (Mesenchymal)
xsq U2AF1 21q22.3 0.312 0.0153 0.317 Oncogenes
xsq EEF1A1 6q14.1 0.312 0.0153 0.317 translation;translational
elongation
mut SCAP 3p21.31 0.312 0.0153 0.317 negative regulation of cholesterol
biosynthetic process;response to hypoxia
xsq THAP9 4q21.22 0.312 0.0153 0.318
met MIR520B 0.312 0.0153 0.318
exp CBX2 17q25.3 0.312 0.0153 0.318 development of primary sexual
met CES3 16q22.1 -0.312 0.0153 0.318
exp RUSC2 9p13.3 -0.312 0.0153 0.318
exp CEP89 19q13.11 -0.312 0.0153 0.317
xsq DLGAP4 20q11.23 -0.312 0.0153 0.317 cell-cell signaling
swa ANXA8L1 10q11.22 -0.314 0.0153 0.318
hs4 LINC01057 -0.314 0.0153 0.317
hs4 SLC44A3 1p21.3 -0.314 0.0153 0.317 Solute Carriers
his IGFBP5 2q35 -0.314 0.0153 0.317 negative regulation of smooth
xai COL8A1 3q12.3 -0.314 0.0153 0.317 angiogenesis;cell
adhesion
his LINC01987 0.314 0.0154 0.318
xai NOP16 5q35.2 0.314 0.0154 0.318
xai BRF1 14q 0.314 0.0154 0.318 positive regulation of transcription,
DNA-dependent;transcription initiation, DNA-dependent
his MRPL19 2p11.1-q11.2 0.314 0.0154 0.318 translation
his LOC283710 15q13.3 0.314 0.0154 0.318
xai UBQLN1 9q22 0.314 0.0154 0.318 response to hypoxia;apoptotic
process
his MEF2D 1q12-q23 0.314 0.0154 0.318 multicellular organismal
xai CRYBB1 22q12.1 0.314 0.0154 0.318 visual perception
his UMODL1 21q22.3 0.314 0.0154 0.319
xai EEF1DP2 9q22.31 0.314 0.0154 0.319
xsq ADTRP 6p24.1 0.312 0.0154 0.318
xsq VASH2 1q32.3 0.312 0.0154 0.318 positive regulation of endothelial
cell proliferation;positive regulation of angiogenesis
exp CARNMT1 0.312 0.0154 0.318
xsq CD86 3q21 0.311 0.0154 0.318 immune response;positive regulation of
xsq LTB 6p21.3 0.311 0.0154 0.318 immune response;signal transduction
DNA-dependent"
exp RPS6P6 4q21.22 0.311 0.0154 0.319
exp FHDC1 4q31.3 -0.311 0.0154 0.318 cellular component
xsq ERBB2 17q12 -0.312 0.0154 0.318 Apoptosis; Oncogenes; Protein
Kinases
exp ABL2 1q25.2 -0.312 0.0154 0.318 signal transduction;cellular
response to retinoic acid
hs4 FAM149A 4q35.1 -0.314 0.0154 0.318
xai DNASE2 19p13.2 -0.314 0.0154 0.318 Apoptosis
xai CRISPLD2 16q24.1 -0.314 0.0154 0.318
xai YWHAZ 8q23.1 -0.314 0.0154 0.318 Apoptosis
his ANAPC5 12q24.31 0.314 0.0155 0.319 G2/M transition of mitotic
cell cycle;negative regulation of ubiquitin-protein ligase activity involved in
mitotic cell cycle
xai EIF4B 12q13.13 0.314 0.0155 0.319 gene expression;RNA metabolic
process
xai SLC25A3P2 12q24.13 0.314 0.0155 0.319
xai DDX26B Xq26.3 0.314 0.0155 0.319
exp HIST1H2BO 6p22.1 0.314 0.0155 0.319 nucleosome assembly
his BOLA3 2p13.1 0.314 0.0155 0.319
his BOLA3-AS1 0.314 0.0155 0.319
exp RPL12P11 20q12 0.314 0.0155 0.319
xai ZSCAN2 15q25.2 0.314 0.0155 0.319 cell
xai RPL31P7 17q25.3 0.314 0.0155 0.319
exp RPL9P3 0.314 0.0155 0.319
xai ZFP69B 1p34.2 0.314 0.0155 0.319
his RCOR1 14q32.31 0.314 0.0155 0.319 interspecies interaction between
organisms;positive regulation of megakaryocyte differentiation
his RAVER2 1p31.3 0.314 0.0155 0.319
his C11orf42 11p15.4 0.314 0.0155 0.319
xsq DCTPP1 16p11.2 0.311 0.0155 0.319 nucleoside triphosphate
xsq LRPPRC 2p21 0.311 0.0155 0.319 regulation of transcription, DNA-
dependent;transport
cop MIR3918 0.311 0.0155 0.319
cop EZR 6q25.3 0.311 0.0155 0.319 cytoskeletal anchoring at plasma
membrane;leukocyte cell-cell adhesion
exp CEP44 4q34 0.311 0.0155 0.319
exp IFNA6 0.311 0.0155 0.319 cytokine-mediated signaling
exp KCNN3 1q21.3 0.311 0.0155 0.319 potassium ion transmembrane
xsq DICER1-AS1 14q32.13 0.311 0.0155 0.319
exp MAN1B1-AS1 9q34.3 0.311 0.0155 0.319
met PGM1 1p31 0.311 0.0155 0.319 glycogen biosynthetic process;glycogen
catabolic process
exp CD8B 2p12 0.311 0.0155 0.319 regulation of immune response;immune
response
exp RPL21P125 17p13.2 0.311 0.0155 0.319
xsq TGFA 2p13 -0.311 0.0155 0.319 anti-apoptosis;positive regulation
of mitosis
exp P3H2 -0.311 0.0155 0.319 negative regulation of cell
xsq B4GALT1-AS1 -0.311 0.0155 0.319
xsq CYTH3 7p22.1 -0.311 0.0155 0.319 vesicle-mediated
exp COL8A1 3q12.3 -0.311 0.0155 0.319 angiogenesis;cell
adhesion
his SH3BP4 2q37.1-q37.2 -0.314 0.0155 0.319 endocytosis
xai SYTL2 11q14 -0.314 0.0155 0.319 intracellular protein
his SHISA4 1q32.1 -0.314 0.0155 0.319
hs4 NEK6 9q33.3-q34.11 -0.314 0.0155 0.319 DNA Damage Response
(DDR)
xai ZBTB38 3q23 -0.314 0.0155 0.319 positive regulation of
hs4 MZB1 5q31.2 0.314 0.0156 0.319 positive regulation of
hs4 PROB1 5q31.2 0.314 0.0156 0.319
his PRPF19 11q12.2 0.314 0.0156 0.32 DNA Damage Response (DDR)
his PDCD2 6q27 0.314 0.0156 0.32 Apoptosis
xai HSPA14 10p13 0.314 0.0156 0.32 'de novo' cotranslational protein
folding
xai RPL36P18 Xq23 0.314 0.0156 0.32
his TRMT2B Xq22.1 0.313 0.0156 0.32 tRNA processing
xai PRPF40A 2q23.3 0.313 0.0156 0.32 cell cycle;regulation of cell
shape
exp LINC00618 0.313 0.0156 0.32
xai SSRP1 11q12 0.313 0.0156 0.32 DNA replication;DNA repair
his AKAP8L 19p13.12 0.313 0.0156 0.32
xai CBFB 16q22.1 0.313 0.0156 0.32 regulation of transcription, DNA-
exp PSMG2 18p11.21 0.311 0.0156 0.319 mitotic cell cycle spindle assembly
checkpoint;regulation of apoptotic process
exp ATXN3 14q21 0.311 0.0156 0.32 DNA Damage Response (DDR)
mut TMEM171 5q13.2 0.311 0.0156 0.32
exp DHX30 3p21.31 0.311 0.0156 0.32
xsq HEPN1 11q24 0.311 0.0156 0.32
xsq ANKRD46 8q22.2 0.311 0.0156 0.32
xsq GCDH 19p13.2 0.311 0.0156 0.32 lysine catabolic process;acyl-CoA
metabolic process
exp C12orf65 12q24.31 0.311 0.0156 0.32 translational termination
xsq PFN2 3q25.1 -0.311 0.0156 0.32 regulation of actin
exp SLC9A7 Xp11.3 -0.311 0.0156 0.32 Solute Carriers
exp GCNT2 6p24.2 -0.311 0.0156 0.32 glycosaminoglycan
biosynthetic process;multicellular organismal development
his EPS8L2 11p15.5 -0.313 0.0156 0.32
hs4 COL1A2 7q22.1 -0.313 0.0156 0.32 axon guidance;protein
heterotrimerization
xai TVP23C 17p12 -0.313 0.0156 0.32
xai KCNH1 1q32.2 -0.314 0.0156 0.32 ion transport;potassium ion
transport
xai SEPT10 2q13 -0.314 0.0156 0.32 cell cycle;cell division
his FARSA 19p13.2 0.313 0.0157 0.32 tRNA aminoacylation for protein
his CALR 19p13.3-p13.2 0.313 0.0157 0.32 Apoptosis
his MIR6515 0.313 0.0157 0.32
his RAD23A 19p13.2 0.313 0.0157 0.32 DNA Damage Response (DDR);
DDR (NER)
xai COX7A2P2 4q22.3 0.313 0.0157 0.32
xai LINC00618 0.313 0.0157 0.32
his COPS7A 12p13.31 0.313 0.0157 0.32 DNA Damage Response (DDR)
xai RPL22P19 12q24.31 0.313 0.0157 0.32
xai PRSS57 19p13.3 0.313 0.0157 0.32 proteolysis
his JPX Xq13.2 0.313 0.0157 0.32
his STAC3 12q13.3 0.313 0.0157 0.32 intracellular signal transduction
xai ANKRD17 4q13.3 0.313 0.0157 0.32 interspecies interaction
between organisms
xai ATXN3 14q21 0.313 0.0157 0.32 DNA Damage Response (DDR)
xai MNX1-AS1 0.313 0.0157 0.321
xai GPX7 1p32 0.313 0.0157 0.321 response to oxidative stress
his FAM161A 2p15 0.313 0.0157 0.321 response to stimulus;visual
perception
xsq CTPS1 1p34.1 0.311 0.0157 0.32 nucleobase-containing small
xsq RRP9 3p21.2 0.311 0.0157 0.32 rRNA processing
exp GTF2E1 3q21-q24 0.311 0.0157 0.32 interspecies interaction
xsq SEC24B-AS1 0.311 0.0157 0.32
mut STXBP5L 3q13.33 0.311 0.0157 0.32 exocytosis;protein transport
exp RPS9P4 19q13.33 0.311 0.0157 0.32
xsq MCM7 7q21.3-q22.1 0.311 0.0157 0.321 DDR (DNA replication)
exp TRG-AS1 0.311 0.0157 0.321
xsq GABPA 21q21.3 0.311 0.0157 0.321 Transcription Factors
exp KIF2A 5q12-q13 0.311 0.0157 0.321 mitotic cell cycle;microtubule-
based movement
exp POU2F1 1q24.2 0.311 0.0157 0.321 lens induction in camera-type
exp PTPN6 12p13 0.311 0.0157 0.321 Apoptosis
exp WWC2-AS2 4q35.1 -0.311 0.0157 0.321
exp CGNL1 15q21.3 -0.311 0.0157 0.321
xai SORBS2 4q35.1 -0.313 0.0157 0.321
xai GPR161 1q24.2 -0.313 0.0157 0.321 multicellular organismal
development
xai MXRA5 Xp22.33 -0.313 0.0157 0.321
hs4 SAMD9 7q21.2 -0.313 0.0157 0.32
swa CDK6 7q21-q22 0.313 0.0158 0.321 Protein Kinases
swa C20orf27 20p13 0.313 0.0158 0.321
his RPRD2 1q21.3 0.313 0.0158 0.321
his NDNF 4q27 0.313 0.0158 0.321 cell growth;peptide cross-linking via
chondroitin 4-sulfate glycosaminoglycan
xai MIR133A2 0.313 0.0158 0.321
xai PAAF1 11q13.4 0.313 0.0158 0.321 interspecies interaction between
organisms
exp MIR133A2 0.313 0.0158 0.321
his TAF4B 18q11.2 0.313 0.0158 0.321 viral reproduction;transcription
xai OGN 9q22 0.313 0.0158 0.321 negative regulation of smooth muscle cell
proliferation
xai KIF2A 5q12-q13 0.313 0.0158 0.322 mitotic cell cycle;microtubule-
based movement
xai FBXW7 4q31.3 0.313 0.0158 0.322 DNA Damage Response (DDR); Tumor
Suppressors
exp C1orf109 1p34.3 0.311 0.0158 0.321
xsq PRIM1 12q13 0.31 0.0158 0.321 DDR (DNA replication)
xsq MCEMP1 0.31 0.0158 0.321
exp KMT2D 12q13.12 0.31 0.0158 0.321
exp SLBP 4p16.3 0.31 0.0158 0.321 transcription from RNA polymerase
II promoter;regulation of S phase
met ARHGEF17 11q13.4 0.31 0.0158 0.322 regulation of small GTPase
mediated signal transduction;apoptotic process
met DENND5A 11p15.4 0.31 0.0158 0.322
met KLRC1 12p13 0.31 0.0158 0.322 regulation of immune response;cell
exp RAB9A Xp22.2 -0.31 0.0158 0.321 positive regulation of
hs4 PTPRB 12q15-q21 -0.313 0.0158 0.321 protein
dephosphorylation;phosphate-containing compound metabolic process
swa CRELD2 22q13.33 -0.313 0.0158 0.321
hs4 NPY1R 4q31.3-q32 -0.313 0.0158 0.321 feeding behavior;regulation
of blood pressure
xai NCS1 9q34 -0.313 0.0158 0.321 positive regulation of
xai SCRN1 7p14.3-p14.1 -0.313 0.0158 0.321 proteolysis;exocytosis
hs4 MYBPC3 11p11.2 -0.313 0.0158 0.321 muscle filament
sliding;positive regulation of ATPase activity
hs4 NXN 17p13.3 -0.313 0.0158 0.321 cell
exp FLJ42393 -0.313 0.0158 0.321
hs4 LOC100271832 0.313 0.0159 0.322
hs4 NTSR1 20q13 0.313 0.0159 0.322 G-protein coupled receptor signaling
pathway;synaptic transmission
xai GOT2 16q21 0.313 0.0159 0.322 2-oxoglutarate metabolic
exp GAPDHP61 15q22.31 0.313 0.0159 0.322
hs4 LINC00273 16p11.2 0.313 0.0159 0.322
hs4 DDN 12q13.12 0.313 0.0159 0.322
exp LOC100506127 0.313 0.0159 0.322
xai MB21D1 6q13 0.313 0.0159 0.322 response to virus
swa ANO8 19p13.11 0.313 0.0159 0.322 ion transport
his CHCHD4 3p25.1 0.313 0.0159 0.322 protein transport
his TMEM43 3p25.1 0.313 0.0159 0.322
his LRRC41 1p34.1 0.313 0.0159 0.322
his UQCRH 1p34.1 0.313 0.0159 0.322
xai MAN1B1-AS1 9q34.3 0.313 0.0159 0.322
xai CEP44 4q34 0.313 0.0159 0.322
mut CAPN3 15q15.1 0.31 0.0159 0.322 proteolysis;response to drug
exp ZADH2 18q22.3 0.31 0.0159 0.322
xsq TOMM40L 1q23.3 0.31 0.0159 0.322 protein
xsq DEF6 6p21.33-p21.1 0.31 0.0159 0.322
xsq CCT3 1q23 0.31 0.0159 0.322 protein folding;cellular protein
metabolic process
xsq LOC100506023 0.31 0.0159 0.322
xsq ANP32B 9q22.32 0.31 0.0159 0.322
exp COX7C 5q14 0.31 0.0159 0.322 generation of precursor metabolites and
energy;respiratory electron transport chain
xsq LOC93622 4p16.1 0.31 0.0159 0.322
xsq MBNL1 3q25 0.31 0.0159 0.322 embryonic limb morphogenesis;regulation
of alternative nuclear mRNA splicing, via spliceosome
met RAB27B 18q21.2 0.31 0.0159 0.322 small GTPase mediated signal
xsq XPO5 6p21.1 0.31 0.0159 0.322 protein export from
exp MGAT4B 5q35 -0.31 0.0159 0.322 protein N-linked glycosylation via
exp STK3 8q22.2 -0.31 0.0159 0.322 Apoptosis
xsq UACA 15q22-q24 -0.31 0.0159 0.322
met MMP23B 1p36.3 -0.31 0.0159 0.322 Apoptosis
xsq MEIS3P1 17p12 -0.31 0.0159 0.322
exp SCRN1 7p14.3-p14.1 -0.31 0.0159 0.322 proteolysis;exocytosis
xai GOLGA2P4 -0.313 0.0159 0.322
xai PER3 1p36.23 -0.313 0.0159 0.322 DNA Damage Response (DDR)
swa FAM134C 17q21.2 -0.313 0.0159 0.322
hs4 MESTIT1 7q32.2 -0.313 0.0159 0.322
hs4 MIR335 -0.313 0.0159 0.322
swa CANX 5q35 -0.313 0.0159 0.322 protein folding;protein secretion
xai IL6 7p21 -0.313 0.0159 0.322 Apoptosis
exp GOLGA2P4 -0.313 0.0159 0.322
exp ARHGEF33 2p22.1 0.313 0.016 0.322 regulation of Rho protein signal
transduction
his LINC00891 0.312 0.016 0.323
his AGPAT2 9q34.3 0.312 0.016 0.323 positive regulation of cytokine
production;small molecule metabolic process
cop AIP 11q13.3 0.312 0.016 0.323 regulation of protein kinase A signaling
cascade;protein maturation by protein folding
his ICE2 0.312 0.016 0.323
his RORA-AS1 0.312 0.016 0.323
xai LILRA2 19q13.4 0.312 0.016 0.323 defense response;signal
transduction
his HMGN2 1p36.1 0.312 0.016 0.323 chromatin organization;regulation of
xai VPRBP 3p21.2 0.312 0.016 0.323 interspecies interaction between
organisms
met MYO10 5p15.1-p14.3 0.31 0.016 0.323 axon guidance;regulation of cell
shape
xsq FBXO41 2p13.2 0.31 0.016 0.323
exp MTHFD2P1 3q11.2 0.31 0.016 0.323
cop GTF2H5 6q25.3 0.31 0.016 0.323 DNA Damage Response (DDR); DDR
(NER)
exp POC1B 12q21.33 0.31 0.016 0.323 cell projection organization;cilium
assembly
xsq NAGS 17q21.31 0.31 0.016 0.323 urea cycle;glutamate metabolic process
mut OR52D1 11p15.4 0.31 0.016 0.323
exp RPS15P7 12p13 0.31 0.016 0.323
met KRT13 17q21.2 -0.31 0.016 0.323 tongue morphogenesis;cellular response to
retinoic acid
exp MID1 Xp22 -0.31 0.016 0.323 microtubule cytoskeleton organization;negative
regulation of microtubule depolymerization
xai ASAP3 1p36.12 -0.312 0.016 0.323 regulation of ARF GTPase activity
hs4 MITF 3p14.2-p14.1 -0.312 0.016 0.323 multicellular organismal
development;melanocyte differentiation
xai CYR61 1p22.3 -0.312 0.016 0.323 positive regulation of protein
phosphorylation;positive regulation of phospholipase activity
his MIR4253 -0.312 0.016 0.323
xai ARL8A 1q32.1 -0.312 0.016 0.323 GTP catabolic process;cell cycle
xai GATSL3 22q12 0.312 0.0161 0.323
his MED24 17q21.1 0.312 0.0161 0.324 protein
heterooligomerization;regulation of transcription, DNA-dependent
his BRAP 12q24 0.312 0.0161 0.324 MAPK cascade;Ras protein signal
transduction
his ACAD10 12q24.12 0.312 0.0161 0.324
xai KLF13 15q12 0.312 0.0161 0.324 negative regulation of cell
proliferation;negative regulation of erythrocyte differentiation
swa ABCE1 4q31 0.312 0.0161 0.324 ABC Transporters
swa IDE 10q23-q25 0.312 0.0161 0.324 proteolysis;protein
homotetramerization
xai GMCL1 2p13.3 0.312 0.0161 0.324 regulation of transcription, DNA-
exp LSM6 4q31.22 0.31 0.0161 0.324 mRNA processing;tRNA processing
exp LOC390306 12q12 0.31 0.0161 0.324
xsq SLC4A5 2p13 0.31 0.0161 0.324 Solute Carriers
xsq KAT8 16p11.2 0.31 0.0161 0.324 histone H4-K16 acetylation;negative
xsq SPOCK2 10pter-q25.3 0.309 0.0161 0.324 peptide cross-linking
exp NSMCE4A 10q26.13 0.309 0.0161 0.324 DNA Damage Response (DDR);
DDR (HR)
xsq UBE3D 6q14.1 0.309 0.0161 0.324
met UGGT2 13q32.1 0.309 0.0161 0.324 protein folding;protein
glycosylation
exp LOC100129637 0.309 0.0161 0.324
exp DAB2IP 9q33.1-q33.3 -0.309 0.0161 0.324 negative
regulation of epithelial cell migration;negative regulation of I-kappaB kinase/NF-
kappaB cascade
xsq FKBP9P1 -0.31 0.0161 0.324
cop TMEM207 3q28 -0.31 0.0161 0.324
exp EHD2 19q13.3 -0.31 0.0161 0.324 endocytosis;blood coagulation
xai MYLK 3q21 -0.312 0.0161 0.324 positive regulation of cell
xai ABL2 1q25.2 -0.312 0.0161 0.324 signal transduction;cellular
hs4 ARHGEF3 3p14.3 -0.312 0.0161 0.324 regulation of small
his CDH23-AS1 -0.312 0.0161 0.324
xai LAYN 11q23.1 -0.312 0.0161 0.324
hs4 MAP3K13 3q27 -0.312 0.0161 0.324 Protein Kinases
xai MEIS3P1 17p12 -0.312 0.0161 0.324
xai CNOT6L 4q13.3 0.312 0.0162 0.325 nuclear-transcribed mRNA
tail shortening
his BTD 3p25 0.312 0.0162 0.325 epidermis development;nitrogen compound
metabolic process
his HACL1 3p25.1 0.312 0.0162 0.325 small molecule metabolic
process;protein oligomerization
xai SNORA70 0.312 0.0162 0.325
xai DFFB 1p36.3 0.312 0.0162 0.325 Apoptosis
his IGLON5 19q13.41 0.312 0.0162 0.325
his FAM86C2P 11q13.2 0.312 0.0162 0.325
xai DHX9 1q25 0.312 0.0162 0.325 nuclear mRNA splicing, via
xsq PDSS1 10p12.1 0.309 0.0162 0.325 protein
exp GATSL3 22q12 0.309 0.0162 0.325
exp SERBP1P5 4q21.21 0.309 0.0162 0.325
xsq CDC123 10p13 0.309 0.0162 0.325 G1 phase of mitotic cell cycle;cell
cycle
xsq NCBP1 9q34.1 0.309 0.0162 0.325 termination of RNA polymerase II
transcription;RNA splicing
mut CEP97 3q12.3 0.309 0.0162 0.325
xsq PARPBP 12q23.2 0.309 0.0162 0.325 DNA Damage Response (DDR)
exp GAL 11q13.3 0.309 0.0162 0.325 inflammatory response;response to
insulin stimulus
exp TRNAE41P 0.309 0.0162 0.325
exp TACSTD2 1p32 -0.309 0.0162 0.325 response to stimulus;negative
exp CYB5R3 22q13.2 -0.309 0.0162 0.325 cholesterol biosynthetic
hs4 MGP 12p12.3 -0.312 0.0162 0.325 response to hormone
stimulus;cell differentiation
xai MYO1E 15q21-q22 -0.312 0.0162 0.325 glomerular
his LINC00545 -0.312 0.0162 0.325
exp CHIT1 1q32.1 -0.312 0.0162 0.325 response to
xai BHLHE23 20q13.33 0.312 0.0163 0.326 regulation of transcription,
hs4 LAIR2 19q13.4 0.312 0.0163 0.326
his AKAP1 17q22 0.312 0.0163 0.326 Apoptosis
xai LOC100996324 0.312 0.0163 0.326
his MIR885 0.312 0.0163 0.326
xai LOC285696 5p15.1 0.312 0.0163 0.326
xai RUVBL1 3q21 0.312 0.0163 0.326 Apoptosis; DNA Damage Response
xai SMARCC1 3p21.31 0.311 0.0163 0.326 DNA Damage Response (DDR);
DDR (Chromatin)
his HIST1H2AL 6p22.1 0.311 0.0163 0.326
his HIST1H1B 6p22.1 0.311 0.0163 0.326 nucleosome assembly
his HIST1H3I 6p22.1 0.311 0.0163 0.326
his HIST1H4L 6p22.1 0.311 0.0163 0.326
his HIST1H3J 6p22.1 0.311 0.0163 0.326
his HIST1H2AM 6p22.1 0.311 0.0163 0.326
his HIST1H2BO 6p22.1 0.311 0.0163 0.326 nucleosome assembly
his DHRS4L1 14q11.2 0.311 0.0163 0.326
exp JRK 8q24.3 0.309 0.0163 0.326 regulation of transcription, DNA-
dependent"
exp RPLP1P4 2q31.1 0.309 0.0163 0.326
cop OSTCP1 6q25.3 0.309 0.0163 0.326
cop C6orf99 6q25.3 0.309 0.0163 0.326
exp PAXIP1 7q36 0.309 0.0163 0.326 DNA Damage Response (DDR); DDR (HR)
mut HSPA2 14q24.1 0.309 0.0163 0.326 Apoptosis
mir hsa-miR-17 0.309 0.0163 0.326
exp GNL2 1p34.3 0.309 0.0163 0.326 GTP catabolic process;ribosome
biogenesis
met TP53I3 2p23.3 0.309 0.0163 0.326 induction of apoptosis by
oxidative stress;NADP metabolic process
xsq FAM72D 0.309 0.0163 0.326
mut CASC1 12p12.1 0.309 0.0163 0.326
exp YBX1P2 7q22.3 0.309 0.0163 0.326
exp TNFAIP8L2 1q21.3 0.309 0.0163 0.326 innate immune response
met OR4N3P 15q11.2 0.309 0.0163 0.326
pro SEC8 0.309 0.0163 0.326
exp LOC729970 1p21.3 -0.309 0.0163 0.326
exp VDR 12q13.11 -0.309 0.0163 0.326 negative regulation of
differentiation
exp LOC143666 11p15.5 -0.309 0.0163 0.326
exp AFAP1L2 10q25.3 -0.309 0.0163 0.326 regulation of mitotic
xai EVA1A 2p12 -0.312 0.0163 0.326
xai TTYH3 7p22 -0.312 0.0163 0.326 ion transport;chloride transport
his LINC01968 -0.312 0.0163 0.326
his MUC22 -0.312 0.0163 0.326
hs4 OLFM3 1p22 0.311 0.0164 0.326
xai SLTM 15q22.1 0.311 0.0164 0.326 regulation of transcription, DNA-
dependent;apoptotic process"
xai NAIF1 9q34.11 0.311 0.0164 0.326 apoptotic process;induction of
apoptosis
xai MMP25 16p13.3 0.311 0.0164 0.326 proteolysis;inflammatory response
dependent"
his ZNF782 9q22.33 0.311 0.0164 0.326 regulation of transcription,
DNA-dependent"
his AKAP3 12p13.3 0.311 0.0164 0.326 cellular component
movement;transmembrane receptor protein serine/threonine kinase signaling pathway
his NDUFA9 12p13.3 0.311 0.0164 0.326 mitochondrial electron
hs4 APOA1 0.311 0.0164 0.326 cholesterol biosynthetic process;lipid
storage
hs4 APOA1-AS 0.311 0.0164 0.326
his PIK3CD 1p36.2 0.311 0.0164 0.326 Oncogenes; Protein Kinases
met ZFAND2A 7p22.3 0.309 0.0164 0.326
met RAB11FIP5 2p13 0.309 0.0164 0.326 protein transport
xsq FAM27E3 0.309 0.0164 0.326
exp NEDD1 12q23.1 0.309 0.0164 0.326 G2/M transition of mitotic cell
exp DHX9 1q25 0.309 0.0164 0.326 nuclear mRNA splicing, via
xsq CELP 9q34.3 0.309 0.0164 0.326
exp MYCN 2p24.3 0.309 0.0164 0.326 Protein Kinases
mut SMPD3 16q22.1 0.309 0.0164 0.326 sphingomyelin catabolic
xsq LOC403323 0.309 0.0164 0.326
met C11orf74 11p12 0.309 0.0164 0.326
xsq ABCB10 1q42.13 0.309 0.0164 0.326 ABC Transporters
exp NHP2P2 7p15.2 0.309 0.0164 0.326
exp TMED8 14q24.3 0.309 0.0164 0.326 transport
met TDRP 8p23.3 0.309 0.0164 0.326
mda CDH1_protein_expression -0.309 0.0164 0.326
exp ITGB8 7p21.1 -0.309 0.0164 0.326 multicellular organismal
exp LOC729839 17q12 -0.309 0.0164 0.326
met LTA 6p21.3 -0.309 0.0164 0.326 response to hypoxia;response
to nutrient
xsq SPG20 13q13.3 -0.309 0.0164 0.326 EMT (Mesenchymal)
hs4 ACVR2A 2q22.3 -0.311 0.0164 0.326 Cell Signaling; Tumor
Suppressors
his GBP5 1p22.2 -0.311 0.0164 0.326 cellular response to
interferon-gamma
xai BCL6 3q27 -0.311 0.0164 0.326 cell morphogenesis;negative
his GBP1P1 1p22.2 -0.311 0.0164 0.326
xai LARP6 15q23 -0.311 0.0164 0.326 RNA processing;regulation of
translation
xai TGFA 2p13 -0.311 0.0164 0.326 anti-apoptosis;positive regulation
of mitosis
hs4 DZIP1L 3q22.3 -0.311 0.0164 0.326
xai ZNF22 10q11 0.311 0.0165 0.327 odontogenesis;regulation of
xai HNRNPA3P14 0.311 0.0165 0.327
swa SRSF3 6p21 0.311 0.0165 0.327 nuclear mRNA splicing, via
spliceosome;transcription from RNA polymerase II promoter
his MCMBP 10q26.11 0.311 0.0165 0.327 sister chromatid cohesion;mitosis
exp RPS27P15 6q14-q15 0.311 0.0165 0.327
his LATS1 6q25.1 0.311 0.0165 0.327 G2/M transition of mitotic cell
cycle;hippo signaling cascade
his LOC645967 6q25.1 0.311 0.0165 0.327
xai RPS27P15 6q14-q15 0.311 0.0165 0.327
his COQ3 6q16.2 0.311 0.0165 0.327 ubiquinone biosynthetic
xai BCS1L 2q33 0.311 0.0165 0.327 mitochondrion organization;mitochondrial
his GRK3 0.311 0.0165 0.327
his UBE2G1 17p13.2 0.311 0.0165 0.327 protein K63-linked
ubiquitination;protein K48-linked ubiquitination
xsq ACTG1P17 0.309 0.0165 0.326
xsq SNORA26 4q12 0.309 0.0165 0.326
xsq UBE2NL Xq27.3 0.309 0.0165 0.327 DNA Damage Response (DDR)
xsq CD48 1q21.3-q22 0.308 0.0165 0.327 T cell activation;mast cell
activation
xsq CLASP2 3p22.3 0.308 0.0165 0.327 microtubule organizing center
organization;M phase of mitotic cell cycle
xsq PTPRVP 1q32.1 0.308 0.0165 0.327
exp RPL17P43 17p11.2 0.308 0.0165 0.327
met PDE6B 4p16.3 0.308 0.0165 0.327 GMP metabolic process;response to
stimulus
met PDE2A 11q13.4 0.308 0.0165 0.327 metabolic process;negative
regulation of vascular permeability
exp EXOC6 10q23.33 0.308 0.0165 0.327 protein transport;vesicle docking
exp MEGF6 1p36.3 -0.308 0.0165 0.327
pro CDH1_21 -0.309 0.0165 0.327
exp GNPTG 16p13.3 -0.309 0.0165 0.327
exp LINC00593 15q23 -0.311 0.0165 0.327
swa FLNA Xq28 -0.311 0.0165 0.327 actin cytoskeleton
reorganization;early endosome to late endosome transport
xai NUP88 17p13.2 0.311 0.0166 0.327 protein transport;glucose transport
xai SET 9q34 0.311 0.0166 0.327 nucleosome disassembly;nucleocytoplasmic
transport
exp HSPD1P5 4q31.21 0.311 0.0166 0.328
his CEP97 3q12.3 0.311 0.0166 0.328
his NAALADL1 11q12 0.311 0.0166 0.328 proteolysis
his CXCR2P1 2q35 0.311 0.0166 0.328
xai HMGB1 13q12 0.311 0.0166 0.328 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
his ATP6V0CP3 6p21.1 0.311 0.0166 0.328
xai GABPA 21q21.3 0.311 0.0166 0.328 Transcription Factors
xai SNORD60 16p13.3 0.311 0.0166 0.328
xai MCM4 8q11.2 0.311 0.0166 0.328 DDR (DNA replication)
xai MSL2 3q22.3 0.311 0.0166 0.328 histone H4-K16 acetylation
xai RPS2P45 0.311 0.0166 0.328
exp KLHL17 1p36.33 0.311 0.0166 0.328 brain development;actin
xsq ERVH48-1 0.308 0.0166 0.327
met PPFIA3 19q13.33 0.308 0.0166 0.327 regulation of short-term
neuronal synaptic plasticity;neurotransmitter secretion
xsq TRPM2 21q22.3 0.308 0.0166 0.328 ion transport;calcium ion transport
exp RABEPK 9q33.3 0.308 0.0166 0.328 receptor-mediated
endocytosis;vesicle docking involved in exocytosis
met PRR19 19q13.2 0.308 0.0166 0.328
xsq POLD3 11q14 0.308 0.0166 0.328 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
exp NQO1 16q22.1 -0.308 0.0166 0.328 xenobiotic metabolic
xsq GRAMD3 5q23.2 -0.308 0.0166 0.328
exp KLHL29 2p24.1 -0.308 0.0166 0.328
exp ABHD4 14q11.2 -0.308 0.0166 0.328 lipid catabolic process
exp RPL36AP33 -0.311 0.0166 0.328
swa RAB5C 17q21.2 -0.311 0.0166 0.328 regulation of endocytosis;GTP
catabolic process
xai RIN2 20p11.22 -0.311 0.0166 0.328 endocytosis;signal
transduction
xai GPC1 2q35-q37 -0.311 0.0166 0.328 axon guidance
xai MICAL3 22q11.21 -0.311 0.0166 0.328
xai ALDH7A1 5q31 -0.311 0.0166 0.327 cellular aldehyde metabolic
xai DDX54 12q24.13 0.311 0.0167 0.328 regulation of transcription, DNA-
exp SNORD60 16p13.3 0.311 0.0167 0.328
xai TMPO-AS1 12q23.1 0.311 0.0167 0.328
xai C17orf80 17q25.1 0.311 0.0167 0.328
his LIN7B 19q13.3 0.311 0.0167 0.328 exocytosis;neurotransmitter
secretion
hs4 LINC01140 0.311 0.0167 0.328
his METTL4 18p11.32 0.311 0.0167 0.328 nucleobase-containing
his NDC80 18p11.32 0.311 0.0167 0.328 attachment of spindle microtubules
to kinetochore;establishment of mitotic spindle orientation
xai PAXIP1 7q36 0.311 0.0167 0.328 DNA Damage Response (DDR); DDR (HR)
xai RPL31P61 19q13.12 0.311 0.0167 0.328
xai AFG3L2 18p11 0.311 0.0167 0.328 myelination;proteolysis
exp MAPK6PS4 8q11.1 0.311 0.0167 0.328
his IMP3 15q24 0.311 0.0167 0.328 rRNA processing
xai NEURL4 17p13 0.31 0.0167 0.328
his LINC01144 0.31 0.0167 0.328
xai TMEM241 18q11.2 0.31 0.0167 0.328
his ITFG2 12p13.33 0.31 0.0167 0.328
xai HEPN1 11q24 0.31 0.0167 0.328
xai STRBP 9q33.3 0.31 0.0167 0.328 cellular component
met PLCE1 10q23 0.308 0.0167 0.328 diacylglycerol biosynthetic process;heart
development
exp LYSMD2 15q21.2 0.308 0.0167 0.328 cell wall macromolecule
catabolic process
exp RNASEH1 2p25 0.308 0.0167 0.328 DDR (DNA replication)
xsq NR2C1 12q22 0.308 0.0167 0.328 positive regulation of retinoic acid
receptor signaling pathway;negative regulation of transcription from RNA polymerase
II promoter
xsq LOC101928093 0.308 0.0167 0.328
xsq NAP1L2 Xq13 0.308 0.0167 0.328 nucleosome assembly
mut STXBP5 6q24.3 0.308 0.0167 0.328 protein transport;positive
regulation of exocytosis
exp SURF6 9q34.2 0.308 0.0167 0.328 ribosome biogenesis
xsq GAR1 4q25 0.308 0.0167 0.328 DNA Damage Response (DDR)
exp RIN2 20p11.22 -0.308 0.0167 0.328 endocytosis;signal
transduction
met HSF5 17q22 -0.308 0.0167 0.328
exp TWF1 12q12 -0.308 0.0167 0.328 negative regulation of actin
filament polymerization;sequestering of actin monomers
exp BCL6 3q27 -0.308 0.0167 0.328 cell morphogenesis;negative
exp PRMT2 21q22.3 -0.308 0.0167 0.328 negative regulation of
transcription, DNA-dependent;protein methylation
xsq FHDC1 4q31.3 -0.308 0.0167 0.328 cellular component
xsq ARHGEF37 5q32 -0.308 0.0167 0.328 regulation of Rho protein
signal transduction
exp YPEL5 2p23.1 -0.308 0.0167 0.328 oxidation-reduction process
met TMC8 17q25.3 -0.308 0.0167 0.328
xai GNG10 9q31.3 -0.31 0.0167 0.328 energy reserve metabolic
process;GTP catabolic process
swa PTCD3 2p11.2 -0.31 0.0167 0.328
hs4 TPD52L1 6q22-q23 -0.311 0.0167 0.328 G2/M transition of
mitotic cell cycle;DNA fragmentation involved in apoptotic nuclear change
xai SPARC 5q31.3-q32 -0.311 0.0167 0.328 ossification;lung development
xai LETM1 4p16.3 0.31 0.0168 0.329 cristae formation
hs4 SUSD3 9q22.31 0.31 0.0168 0.329
xai HIST1H2BF 6p22.1 0.31 0.0168 0.329
xai RPS3AP47 15q15.2 0.31 0.0168 0.329
xai MAZ 16p11.2 0.31 0.0168 0.329 regulation of transcription, DNA-
xai LIN28B 6q21 0.31 0.0168 0.329 miRNA catabolic process;gene
silencing by RNA
his RHOH 4p13 0.31 0.0168 0.329 regulation of transcription, DNA-
hs4 PROCA1 17q11.2 0.31 0.0168 0.329 lipid catabolic process
his MIR646HG 0.31 0.0168 0.329
DNA-dependent"
xsq ECE2 3q27.1 0.308 0.0168 0.329 peptide hormone
exp GEMIN2 14q13 0.308 0.0168 0.329 RNA metabolic process;ncRNA
metabolic process
pro STAT1_9 0.308 0.0168 0.329
met SEMA4C 2q11.2 0.308 0.0168 0.329 neural tube
closure;multicellular organismal development
exp GNL3L Xp11.22 0.308 0.0168 0.329 ribosome biogenesis
xsq RPL34-AS1 4q25 0.308 0.0168 0.329
cop PITPNM1 11q13 0.308 0.0168 0.329 protein transport;lipid metabolic
process
cop CDK2AP2 11q13 0.308 0.0168 0.329
cop CABP2 11q13.1 0.308 0.0168 0.329
cop GSTP1 11q13 0.308 0.0168 0.329 Apoptosis
cop NDUFV1 11q13 0.308 0.0168 0.329 mitochondrial electron transport,
cop DOC2GP 11q13.2 0.308 0.0168 0.329
cop NUDT8 11q13.2 0.308 0.0168 0.329
cop TBX10 11q13.2 0.308 0.0168 0.329 anatomical structure
xsq RAD51 15q15.1 0.308 0.0168 0.329 DNA Damage Response (DDR); DDR (FA)
exp SLTM 15q22.1 0.308 0.0168 0.329 regulation of transcription, DNA-
exp UCHL5 1q32 0.308 0.0168 0.329 DNA repair;midbrain development
exp PIK3CB 3q22.3 -0.308 0.0168 0.329 Oncogenes; Protein
Kinases
hs4 ITGB5 3q21.2 -0.31 0.0168 0.329 antigen processing and presentation
xai STK3 8q22.2 -0.31 0.0168 0.329 Apoptosis
hs4 SEPT5 22q11.21 -0.31 0.0168 0.329 GTP catabolic process;cell cycle
hs4 SEPT5-GP1BB -0.31 0.0168 0.329
xai AFAP1L2 10q25.3 -0.31 0.0168 0.329 regulation of mitotic cell
cycle;regulation of interleukin-6 production
xai TRIM65 17q25.1 0.31 0.0169 0.329
exp GAPDHP71 5q35.2 0.31 0.0169 0.329
his PIKFYVE 2q34 0.31 0.0169 0.329 protein localization to
nucleus;intracellular signal transduction
his PDE1B 12q13 0.31 0.0169 0.329 signal transduction;cellular response to
exp XRCC6P4 0.31 0.0169 0.329
his ESCO1 18q11.2 0.31 0.0169 0.329 regulation of DNA replication;cell
cycle
hs4 MYO15B 17q25.1 0.31 0.0169 0.329
xai CCNJP1 7p11.2 0.31 0.0169 0.33
his RCSD1 1q24.2 0.31 0.0169 0.33 cellular hyperosmotic
exp IL9R 0.31 0.0169 0.33 signal transduction;cell proliferation
his MGEA5 10q24.1-q24.3 0.31 0.0169 0.33 N-acetylglucosamine metabolic
process;positive regulation of protein complex disassembly
his KCNIP2-AS1 10q24.32 0.31 0.0169 0.33
mut SEMA3E 7q21.11 0.307 0.0169 0.329 multicellular organismal
development;regulation of actin cytoskeleton reorganization
exp TCEANC2 1p32.3 0.307 0.0169 0.329 transcription, DNA-dependent"
mut ASH1L 1q22 0.307 0.0169 0.329 regulation of transcription, DNA-
exp CDCA5 11q12.1 0.307 0.0169 0.33 cell division;G1/S transition of
mitotic cell cycle
exp WWOX 16q23 0.307 0.0169 0.33 positive regulation of apoptotic
cop TGIF1 18p11.3 0.307 0.0169 0.33 negative regulation of cell
cop DLGAP1-AS1 18p11.31 0.307 0.0169 0.33
xsq ENAH 1q42.12 -0.307 0.0169 0.33 intracellular transport;T
exp ADORA2B 17p12 -0.307 0.0169 0.33 activation of MAPK
activity;positive regulation of cell proliferation
his ZNF702P 19q13.41 -0.31 0.0169 0.33 regulation of transcription,
DNA-dependent"
xai KANK2 19p13.2 -0.31 0.0169 0.329
hs4 ABCC6 16p13.1 -0.31 0.0169 0.329 ABC Transporters
his FAM207A 21q22.3 0.31 0.017 0.33
his LINC01547 0.31 0.017 0.33
xai ALMS1 2p13 0.31 0.017 0.331 sensory perception of sound;epithelial cell
proliferation
xai PLD4 14q32.33 0.31 0.017 0.331 lipid catabolic process
his RNF40 16p11.2-p11.1 0.31 0.017 0.331 ubiquitin-dependent protein
his CCDC189 0.31 0.017 0.331
his IGHV1OR15-3 0.31 0.017 0.331
xai UBIAD1 1p36.22 0.31 0.017 0.331 menaquinone biosynthetic
process;vitamin K biosynthetic process
his ATP5G3 2q31.1 0.31 0.017 0.331 aging;ATP synthesis coupled proton
transport
exp POLI 18q21.1 0.307 0.017 0.33 DNA Damage Response (DDR); DDR (DNA
exp CHD4 12p13 0.307 0.017 0.331 DNA Damage Response (DDR)
xsq POC1B 12q21.33 0.307 0.017 0.331 cell projection organization;cilium
assembly
xsq TMLHE-AS1 0.307 0.017 0.331
met TTC14 3q26.33 0.307 0.017 0.331
exp SFXN4 10q26.11 0.307 0.017 0.331 iron ion homeostasis;transmembrane
transport
xsq C10orf105 0.307 0.017 0.331
exp QRSL1 6q21 0.307 0.017 0.331 glutaminyl-tRNAGln biosynthesis via
transamidation;mitochondrial translation
mut EEPD1 7p14.2 0.307 0.017 0.331 DNA repair
cop GMNC 3q28 -0.307 0.017 0.331 cell cycle;cell proliferation
cop SNAR-I 3q28 -0.307 0.017 0.331
exp TSC22D1 13q14 -0.307 0.017 0.331 negative regulation of apoptotic
process;transcription from RNA polymerase II promoter
his IFITM10 -0.31 0.017 0.331 response to biotic stimulus
his COL8A1 3q12.3 -0.31 0.017 0.331 angiogenesis;cell adhesion
his ZP3 7q11.23 -0.31 0.017 0.331 blastocyst formation;positive regulation
of phosphatidylinositol biosynthetic process
xai SLC35F6 2p23.3 -0.31 0.017 0.331
hs4 CCDC144B 17p11.2 -0.31 0.017 0.331
his RFLNA -0.31 0.017 0.331
exp HNRNPA1P42 1q43 0.31 0.0171 0.331
his ARRB2 17p13 0.309 0.0171 0.331 G-protein coupled receptor
his KIRREL2 19q13.12 0.309 0.0171 0.331 cell adhesion
swa PFDN1 5q31 0.309 0.0171 0.331 'de novo' posttranslational protein
folding;regulation of transcription, DNA-dependent
his C9orf50 9q34.11 0.309 0.0171 0.331
his NTMT1 9q34.11 0.309 0.0171 0.331
hs4 ANTXRLP1 0.309 0.0171 0.331
xai WWOX 16q23 0.309 0.0171 0.332 positive regulation of apoptotic
xai MCEMP1 0.309 0.0171 0.332
his CCDC66 3p14.3 0.309 0.0171 0.332
exp NGLY1 3p24.2 0.307 0.0171 0.331 glycoprotein catabolic process
xsq SCNN1B 16p12.2-p12.1 0.307 0.0171 0.331 ion transport;sodium ion
transport
exp GTPBP4 10p15-p14 0.307 0.0171 0.331 negative regulation of cell-
cell adhesion;negative regulation of cell migration
met SSC5D 19q13.42 0.307 0.0171 0.331
mut RDM1 17q11.2 0.307 0.0171 0.332 DNA Damage Response (DDR); DDR (HR)
xsq TRIM27 6p22 0.307 0.0171 0.332 cell proliferation;negative
exp NDUFAF7 2p22.2 0.307 0.0171 0.332
mir hsa-miR-421 0.307 0.0171 0.332
exp LOC100507303 0.307 0.0171 0.332
xsq GRPEL1 4p16 0.307 0.0171 0.332 protein folding;protein import into
exp CLIP4 2p23.2 -0.307 0.0171 0.332
exp GPR157 1p36.23 -0.307 0.0171 0.332
met MIR1304 -0.307 0.0171 0.332
xai SEPT9 17q25 -0.309 0.0171 0.332 GTP catabolic process;cell cycle
his IL6 7p21 -0.309 0.0171 0.332 Apoptosis
his LOC541472 7p21 -0.309 0.0171 0.332
his TRIM55 8q13.1 -0.309 0.0171 0.332 signal transduction
xai RELL1 4p14 -0.31 0.0171 0.331
hs4 CST3 20p11.21 -0.31 0.0171 0.331 salivary gland development;negative
regulation of histolysis
his PPP6C 9q33.3 0.309 0.0172 0.332 DNA Damage Response (DDR)
exp SLC25A3P2 12q24.13 0.309 0.0172 0.332
xai POLR1A 2p11.2 0.309 0.0172 0.332 transcription initiation from
his VAMP1 12p 0.309 0.0172 0.332 neurotransmitter secretion;vesicle-
mediated transport
swa PCNP 3q12.3 0.309 0.0172 0.333 cell cycle;protein ubiquitination
exp KIF4CP Xq21.1 0.309 0.0172 0.333
exp CD27 12p13 0.309 0.0172 0.333 Apoptosis
xai CD1D 1q23.1 0.309 0.0172 0.333 T cell selection;positive
xai METTL3 14q11.1 0.309 0.0172 0.333 gene expression;RNA
methylation
his BIRC6 2p22.3 0.309 0.0172 0.333 Apoptosis
hs4 C1QL2 2q14.2 0.309 0.0172 0.333
xai TRG-AS1 0.309 0.0172 0.333
exp RPL19P8 4q34.3 0.307 0.0172 0.333
exp RPL29P15 5q14.1 0.307 0.0172 0.333
exp MNX1-AS1 0.307 0.0172 0.333
met HOXB3 17q21.3 0.306 0.0172 0.333 multicellular organismal
cop PNLDC1 6q25.3 0.306 0.0172 0.333
exp ZBTB38 3q23 -0.307 0.0172 0.333 positive regulation of
xsq ABCC6 16p13.1 -0.307 0.0172 0.332 ABC Transporters
hs4 EDN1 6p24.1 -0.309 0.0172 0.333 negative regulation of
pathway
hs4 ZBTB20-AS5 -0.309 0.0172 0.332
hs4 GHSR 3q26.31 -0.309 0.0172 0.332
exp RPL5P29 11q12.1 0.309 0.0173 0.333
his SMC3 10q25 0.309 0.0173 0.333 DNA Damage Response (DDR); DDR (DNA
replication)
exp XRCC6P1 10q23.33 0.309 0.0173 0.333
his SYNDIG1 20p11.21 0.309 0.0173 0.334 intracellular protein
transport;response to biotic stimulus
his SHCBP1 16q11.2 0.309 0.0173 0.334
his APC 5q21-q22 0.309 0.0173 0.334 Apoptosis; Cell Signaling; DNA
Damage Response (DDR); Tumor Suppressors
xsq CEP152 15q21.1 0.306 0.0173 0.333 G2/M transition of mitotic
xsq KGFLP2 0.306 0.0173 0.333
exp RPL23A 17q11.2 0.306 0.0173 0.334 SRP-dependent cotranslational
exp GTF3C2 2p23.3 0.306 0.0173 0.334 transcription, DNA-
exp ZNF639 3q26.33 0.306 0.0173 0.334 negative regulation of
transcription, DNA-dependent;initiation of viral infection
exp ITPRIPL1 2q11.2 0.306 0.0173 0.334
exp NUP88 17p13.2 0.306 0.0173 0.334 protein transport;glucose transport
xsq RPLP0 12q24.2 0.306 0.0173 0.334 SRP-dependent cotranslational
exp SCML1 Xp22 -0.306 0.0173 0.333 regulation of transcription, DNA-
exp EPB41L4A 5q21.3 -0.306 0.0173 0.333
mda proportion_genomic_gain_and_losses -0.306 0.0173 0.333
swa PIGT 20q12-q13.12 -0.309 0.0173 0.334 attachment of GPI anchor
to protein;neuron differentiation
hs4 FAM13C 10q21.1 -0.309 0.0173 0.334
his CHST3 10q22.1 -0.309 0.0173 0.334 T cell homeostasis;positive
his IL33 9p24.1 -0.309 0.0173 0.334 negative regulation of T-
helper 1 type immune response;positive regulation of macrophage activation
his CARD10 22q13.1 -0.309 0.0173 0.334 protein complex
his FRMPD2 10q11.22 -0.309 0.0173 0.333
hs4 SPTLC3 20p12.1 -0.309 0.0173 0.333 small molecule metabolic
xai RAD51D 17q11 0.309 0.0174 0.335 DNA Damage Response (DDR); DDR (HR)
his EMC3-AS1 0.309 0.0174 0.335
his CYP4F2 19p13.12 0.309 0.0174 0.335 drug metabolic process;sodium
ion homeostasis
his DISP3 0.309 0.0174 0.335
xai CFP Xp11.4 0.309 0.0174 0.335 complement activation;complement
exp RPL15P18 13q32.3 0.308 0.0174 0.335
xai EEF1A1P11 1p21.3 0.308 0.0174 0.335
xsq ZNF202 11q24 0.306 0.0174 0.335 transcription from RNA polymerase
II promoter;lipid metabolic process
xsq RLN3 19p13.2 0.306 0.0174 0.335
exp COX7A2 6q12 0.306 0.0174 0.335
exp THBS3 1q21 -0.306 0.0174 0.335 cell adhesion;cell-matrix adhesion
exp RELL1 4p14 -0.306 0.0174 0.335
xsq FBXL2 3p22.3 -0.306 0.0174 0.334 protein modification
process;proteolysis
hs4 ARHGEF12 11q23.3 -0.309 0.0174 0.335 nerve growth factor
hs4 LARP6 15q23 -0.309 0.0174 0.335 RNA processing;regulation of
translation
hs4 ARHGAP29 1p22.1 -0.309 0.0174 0.335 small GTPase mediated
xai METTL17 14q11.2 0.308 0.0175 0.335 translation
swa TTLL12 22q13.31 0.308 0.0175 0.335 protein modification process
xai RPL15P18 13q32.3 0.308 0.0175 0.335
his RABL6 9q34.3 0.308 0.0175 0.335
his CCDC183-AS1 0.308 0.0175 0.335
his ANKRD36C 2q11.1 0.308 0.0175 0.335
xai QRSL1 6q21 0.308 0.0175 0.335 glutaminyl-tRNAGln biosynthesis via
his HP1BP3 1p36.12 0.308 0.0175 0.335 nucleosome assembly
his SNORD59B 0.308 0.0175 0.335
his SNORD59A 0.308 0.0175 0.335
his ATP5B 12q13.13 0.308 0.0175 0.335 ADP biosynthetic process;ATP
his CHGB 20p12.3 0.308 0.0175 0.335
his ABLIM2 4p16.1 0.308 0.0175 0.335 cytoskeleton
organization;axon guidance
hs4 UCP2 11q13 0.308 0.0175 0.335 transport;small molecule metabolic
process
xai ALYREF 17q25.3 0.308 0.0175 0.335 gene expression;mRNA 3'-end
processing
his TMEM18 2p25.3 0.308 0.0175 0.336 transcription, DNA-
dependent;cell migration"
swa NUMBL 19q13.13-q13.2 0.308 0.0175 0.336 multicellular organismal
development;forebrain development
xai ADTRP 6p24.1 0.308 0.0175 0.336
xai NGLY1 3p24.2 0.308 0.0175 0.336 glycoprotein catabolic process
exp PROSER1 13q13.3 0.306 0.0175 0.335
xsq FANCE 6p22-p21 0.306 0.0175 0.335 DNA Damage Response (DDR); DDR (FA)
exp PIAS1 15q 0.306 0.0175 0.335 DNA Damage Response (DDR)
exp ATP5D 19p13.3 0.306 0.0175 0.335 ATP catabolic process;ATP
xsq KCNMB2-AS1 0.306 0.0175 0.335
xsq GEMIN5 5q33.2 0.306 0.0175 0.335 nuclear mRNA splicing, via
exp SRD5A3 4q12 0.306 0.0175 0.335 dolichol-linked oligosaccharide
met PLPPR2 0.306 0.0175 0.335
cop SNORA29 6q25.3 0.306 0.0175 0.335
xsq METTL21A 2q33.3 0.306 0.0175 0.336
xsq PANX3 11q24.2 0.306 0.0175 0.336 cell-cell signaling;protein
hexamerization
exp EXO1 1q42-q43 0.306 0.0175 0.336 DNA Damage Response (DDR); DDR
(MMR)
xsq HSPB1 7q11.23 -0.306 0.0175 0.336 Apoptosis
xsq HSPB6 19q13.12 -0.306 0.0175 0.336 regulation of muscle
contraction;response to stress
hs4 CYTH3 7p22.1 -0.308 0.0175 0.336 vesicle-mediated
exp C5orf64 5q12.1 -0.308 0.0175 0.336
his RCAN1 21q22.12 -0.308 0.0175 0.336 regulation of phosphoprotein
phosphatase activity;regulation of transcription, DNA-dependent
xai FAM84B 8q24.21 -0.308 0.0175 0.335
xai SURF6 9q34.2 0.308 0.0176 0.336 ribosome biogenesis
his C17orf64 17q23.2 0.308 0.0176 0.336
xai RREB1 6p25 0.308 0.0176 0.336 regulation of transcription, DNA-
xai CD3D 11q23 0.308 0.0176 0.336 T cell differentiation;T cell
costimulation
xai MRI1 19p13.2 0.308 0.0176 0.336 L-methionine salvage from
methylthioadenosine;cellular nitrogen compound metabolic process
swa CELF2 10p13 0.308 0.0176 0.336 RNA processing;mRNA processing
exp CALCB 0.308 0.0176 0.336 vasodilation;cellular calcium ion
homeostasis
his CUL2 10p11.21 0.308 0.0176 0.336 Apoptosis
xai TMEM233 12q24.23 0.308 0.0176 0.336 response to biotic stimulus
xai COA7 0.308 0.0176 0.336
xai PTPN6 12p13 0.308 0.0176 0.336 Apoptosis
xai FAUP1 18q22.3 0.308 0.0176 0.336
his MPZL1 1q24.2 0.308 0.0176 0.337 transmembrane receptor protein
tyrosine kinase signaling pathway;cell-cell signaling
exp CD7 17q25.2-q25.3 0.306 0.0176 0.336 homeostasis of number of
cop MRPL18 6q25.3 0.306 0.0176 0.336 translation;transport
xsq PMFBP1 16q22.2 0.306 0.0176 0.336
xsq POLD1 19q13.3 0.306 0.0176 0.336 DNA Damage Response (DDR); DDR
xsq MECR 1p35.3 0.306 0.0176 0.336 fatty acid metabolic process;fatty
cop TCP1 6q25.3-q26 0.306 0.0176 0.336 protein folding;tubulin complex
assembly
xsq DHX37 12q24.31 0.305 0.0176 0.336
exp NSL1 1q41 0.305 0.0176 0.337 M phase of mitotic cell cycle;mitotic
prometaphase
exp CTSL 9q21.33 -0.305 0.0176 0.336
xsq HDAC11 3p25.1 -0.305 0.0176 0.336 regulation of
exp KCNIP3 2q21.1 -0.306 0.0176 0.336 behavior;sensory
perception of pain
exp SMIM5 17q25.1 -0.306 0.0176 0.336
xsq RAB29 -0.306 0.0176 0.336 GTP catabolic process;small GTPase
xsq P2RX6 22q11.21 -0.306 0.0176 0.336 ion transport;cation
transport
xsq GALNT10 5q33.2 -0.306 0.0176 0.336 O-glycan
swa SEC11A 15q25.3 -0.308 0.0176 0.337 energy reserve metabolic
process;regulation of insulin secretion
xai AHNAK2 14q32.33 -0.308 0.0176 0.336
xai C8orf31 8q24.3 -0.308 0.0176 0.336
hs4 IQSEC2 Xp11.22 -0.308 0.0176 0.336 regulation of ARF
xai KIF3B 20q11.21 -0.308 0.0176 0.336 microtubule-based
hs4 FAM160A1 4q31.3 -0.308 0.0176 0.336
xai CYC1 8q24.3 0.308 0.0177 0.337 transport;respiratory electron
transport chain
his PRAMEF6 0.308 0.0177 0.337
hs4 GP5 3q29 0.308 0.0177 0.337 cell adhesion;cell-matrix adhesion
his PRAMEF15 0.308 0.0177 0.337
xai C11orf1 11q23.1 0.308 0.0177 0.337
xai PRG2 11q12 0.308 0.0177 0.337 immune response;defense response to
bacterium
xai HNRNPA1P42 1q43 0.308 0.0177 0.337
xai ITPA 20p 0.308 0.0177 0.337 metabolic process;nucleotide metabolic
process
his PCAT18 0.308 0.0177 0.337
his CTC1 17p13.1 0.308 0.0177 0.337 DNA Damage Response (DDR)
his PFAS 17p13.1 0.308 0.0177 0.337 purine base metabolic
his HBQ1 16p13.3 0.308 0.0177 0.337 transport;oxygen transport
his PHLPP1 18q21.33 0.308 0.0177 0.337 Apoptosis
exp CCNJP1 7p11.2 0.308 0.0177 0.337
DNA-dependent"
xsq RBL1 20q11.2 0.305 0.0177 0.337 G1 phase of mitotic cell
cycle;negative regulation of transcription from RNA polymerase II promoter
xsq GJC2 1q42.13 0.305 0.0177 0.337 transmembrane transport;cell-cell
signaling
xsq CDCA4 14q32.33 0.305 0.0177 0.337
xsq TCP1 6q25.3-q26 0.305 0.0177 0.337 protein folding;tubulin complex
assembly
exp ZEB1-AS1 10p11.22 0.305 0.0177 0.337
exp KLHDC4 16q24 0.305 0.0177 0.337
xsq CHD5 1p36.31 0.305 0.0177 0.337 regulation of transcription, DNA-
exp MYO1F 19p13.3-p13.2 0.305 0.0177 0.337 negative regulation of cell
exp LOC728931 5p12 0.305 0.0177 0.337
exp NCBP3 0.305 0.0177 0.337
exp FKBP5 6p21.31 0.305 0.0177 0.337 peptidyl-proline
exp NKG7 19q13.41 0.305 0.0177 0.337
exp RPL23AP43 3p22.3 0.305 0.0177 0.337
xsq HSD17B11 4q22.1 0.305 0.0177 0.337 steroid biosynthetic
cop SOD2 6q25.3 0.305 0.0177 0.337 liver development;heart development
cop WTAP 6q25-q27 0.305 0.0177 0.337 mRNA processing;cell cycle
cop LOC100129518 0.305 0.0177 0.337
cop ACAT2 6q25.3 0.305 0.0177 0.337 lipid metabolic process
exp NT5M 17p11.2 0.305 0.0177 0.337 small molecule metabolic
xsq SNHG20 0.305 0.0177 0.337
exp MALAT1 11q13.1 -0.305 0.0177 0.337
xsq LINC00346 13q34 -0.305 0.0177 0.337
xsq CEP170B 14q32.33 -0.305 0.0177 0.337
xai TACSTD2 1p32 -0.308 0.0177 0.337 response to stimulus;negative
xai ADAMTSL1 9p21.3 -0.308 0.0177 0.337
hs4 AFAP1L2 10q25.3 -0.308 0.0177 0.337 regulation of mitotic
xai GBP1P1 1p22.2 -0.308 0.0177 0.337
swa UBR5 8q22 -0.308 0.0177 0.337 DNA Damage Response (DDR)
swa S100A16 1q21 -0.308 0.0177 0.337 response to calcium ion
hs4 EMC3 3p25.3 -0.308 0.0177 0.337
hs4 LOC401052 3p25.3 -0.308 0.0177 0.337
his KLF16 19p13.3 0.308 0.0178 0.337 regulation of transcription from
RNA polymerase II promoter;dopamine receptor signaling pathway
his METAP1 4q23 0.308 0.0178 0.337 regulation of
translation;proteolysis
his MIR3684 0.308 0.0178 0.337
his GBGT1 0.308 0.0178 0.337 metabolic process;glycolipid biosynthetic
process
his UGGT1 2q14.3 0.308 0.0178 0.337 protein folding;protein
glycosylation
exp SNHG4 0.308 0.0178 0.337
xai RPGR Xp21.1 0.308 0.0178 0.337 visual perception;cell projection
organization
his RBAKDN 7p22.1 0.308 0.0178 0.337
his PRDM8 4q21 0.308 0.0178 0.337 regulation of transcription, DNA-
dependent"
his ARRDC5 19p13.3 0.308 0.0178 0.337 signal transduction
xai GTPBP4 10p15-p14 0.308 0.0178 0.337 negative regulation of cell-
his PRAMEF5 0.307 0.0178 0.337
xsq TRMT6 20p12.3 0.305 0.0178 0.337 regulation of translational
exp RPL23AP59 10q23-q25 0.305 0.0178 0.337
exp RHOG 11p15.5-p15.4 0.305 0.0178 0.337 small GTPase mediated signal
transduction;activation of Rac GTPase activity
xsq ZBTB14 18p11.31 0.305 0.0178 0.337
met ISX 22q12.3 0.305 0.0178 0.337
xsq UBIAD1 1p36.22 0.305 0.0178 0.337 menaquinone biosynthetic
xsq BACE1 11q23.2-q23.3 -0.305 0.0178 0.337 proteolysis;membrane
xsq TNKS1BP1 11q12.1 -0.305 0.0178 0.337 nuclear-transcribed mRNA
xsq ALDH1L2 12q23.3 -0.305 0.0178 0.337 biosynthetic process;10-
his ASAP1-IT1 8q24.21 -0.307 0.0178 0.337
his GNG12-AS1 1p31.3 -0.308 0.0178 0.337
his GNG12 1p31.3 -0.308 0.0178 0.337 signal transduction;G-protein
xai RPL7AP30 4q25 0.307 0.0179 0.337
exp SNORD59A 0.307 0.0179 0.337
xai C12orf65 12q24.31 0.307 0.0179 0.337 translational termination
xai NDST2 10q22 0.307 0.0179 0.337 cellular process;heparan sulfate
proteoglycan biosynthetic process
xai SNORD59A 0.307 0.0179 0.337
his MRPL39 21q21.3 0.307 0.0179 0.337
his KAZALD1 10q24.31 0.307 0.0179 0.338 ossification;regulation of
cell growth
hs4 SFMBT2 10p14 0.307 0.0179 0.338 regulation of transcription, DNA-
dependent"
exp ATP2A3 17p13.3 0.305 0.0179 0.337 transmembrane transport;ATP
exp ITPA 20p 0.305 0.0179 0.337 metabolic process;nucleotide metabolic
process
exp PTP4A3 8q24.3 0.305 0.0179 0.338
exp RREB1 6p25 0.305 0.0179 0.338 regulation of transcription, DNA-
xsq PRPF38A 1p32.3 0.305 0.0179 0.339 mRNA processing;RNA splicing
exp RPS10P13 6p21.31 0.305 0.0179 0.339
xsq PLSCR4 3q24 -0.305 0.0179 0.339 phospholipid
xsq SPARC 5q31.3-q32 -0.305 0.0179 0.338 ossification;lung development
xsq SERTAD4-AS1 1q32.2 -0.305 0.0179 0.337
hs4 ETNK2 1q32.1 -0.307 0.0179 0.339 phosphatidylethanolamine
biosynthetic process;phospholipid biosynthetic process
swa P4HA2 5q31 -0.307 0.0179 0.338 peptidyl-proline hydroxylation to
4-hydroxy-L-proline
xai ACOT9 Xp22.11 -0.307 0.0179 0.338 acyl-CoA metabolic process
xai COTL1 16q24.1 -0.307 0.0179 0.337 defense response to fungus
hs4 COL4A1 13q34 -0.307 0.0179 0.337 epithelial cell
hs4 COL4A2 13q34 -0.307 0.0179 0.337 transcription, DNA-
hs4 COL8A1 3q12.3 -0.307 0.0179 0.337 angiogenesis;cell
adhesion
hs4 LRRC8E 19p13.2 -0.307 0.0179 0.337
xai SNHG4 0.31 0.018 0.339
his ITM2A Xq13.3-Xq21.2 0.307 0.018 0.339
his PARVG 22q13.31 0.307 0.018 0.339 cell adhesion;cell-matrix adhesion
his SLC22A20 11q13.1 0.307 0.018 0.339 ion transport
xai ANKRD55 5q11.2 0.307 0.018 0.339
his ARPC2 2q36.1 0.307 0.018 0.339 cellular component movement;positive
regulation of actin filament polymerization
xai OGFOD2 12q24.31 0.307 0.018 0.339
xai GPATCH4 1q22 0.307 0.018 0.339
xai PLK4 4q28 0.307 0.018 0.339 Protein Kinases
exp RPS4XP8 6q25.2 0.307 0.018 0.339
xai MPHOSPH6 16q23.3 0.307 0.018 0.339 M phase of mitotic cell
xai PAXBP1 21q21.3 0.307 0.018 0.339
his SLC25A53 Xq22.2 0.307 0.018 0.339 transport
exp CD247 1q24.2 0.305 0.018 0.339 T cell costimulation;interspecies
exp GABPA 21q21.3 0.305 0.018 0.339 Transcription Factors
exp BOLA3 2p13.1 0.305 0.018 0.339
exp CLPB 11q13.4 0.305 0.018 0.339 cellular response to heat
xsq PREB 2p23.3 0.304 0.018 0.339 cellular membrane organization;vesicle-
mediated transport
pro KLK3 19q13.41 0.304 0.018 0.339 proteolysis;negative regulation of
angiogenesis
exp PHBP1 6q25 0.304 0.018 0.339
exp FAM192A 16q13 0.304 0.018 0.339
exp SURF2 9q34.2 0.304 0.018 0.339
xsq PPIH 1p34.1 0.304 0.018 0.339 nuclear mRNA splicing, via
exp ZBTB49 4p16.3 0.304 0.018 0.339 regulation of transcription, DNA-
dependent"
xsq RAD51D 17q11 0.304 0.018 0.339 DNA Damage Response (DDR); DDR (HR)
met ADAMTS12 5q35 0.304 0.018 0.339 proteolysis
dependent"
exp SPARC 5q31.3-q32 -0.304 0.018 0.339 ossification;lung development
exp ITPKC 19q13.1 -0.304 0.018 0.339
exp MLF1 3q25.1 -0.304 0.018 0.339 cell cycle arrest;multicellular
xsq ZNF417 19q13.43 -0.304 0.018 0.339 regulation of transcription,
DNA-dependent"
exp RBPMS 8p12 -0.304 0.018 0.339 regulation of transcription, DNA-
xai VDR 12q13.11 -0.307 0.018 0.339 negative regulation of
differentiation
xai GCNT2 6p24.2 -0.307 0.018 0.339 glycosaminoglycan biosynthetic
his COPS4 4q21.22 0.307 0.0181 0.339 DNA Damage Response (DDR)
his NBDY 0.307 0.0181 0.339
xai SLC9B2 4q24 0.307 0.0181 0.339 cation transport;sodium ion
transport
his TMEM161B 5q14.3 0.307 0.0181 0.339
his TMEM161B-AS1 0.307 0.0181 0.339
his PSKH1 16q22.1 0.307 0.0181 0.339 protein phosphorylation
exp ATP5G1P6 0.307 0.0181 0.339
his ORC5 7q22.1 0.307 0.0181 0.339 DDR (DNA replication)
xai ZNF733P 0.307 0.0181 0.339
xai POLR2I 19q12 0.307 0.0181 0.339 DNA Damage Response (DDR); DDR
(NER)
xai PUSL1 1p36.33 0.307 0.0181 0.339 pseudouridine synthesis;tRNA
processing
his MIR545 0.307 0.0181 0.339
exp ZNF733P 0.307 0.0181 0.339
hs4 SH2D1A Xq25 0.307 0.0181 0.339 humoral immune response;cellular
defense response
xsq PDP2 16q22.1 0.304 0.0181 0.339 pyruvate metabolic process;protein
dephosphorylation
dependent"
xsq SPOCK3 4q32.3 0.304 0.0181 0.339 peptide cross-linking via
met CALM3 19q13.2-q13.3 0.304 0.0181 0.339 carbohydrate metabolic
process;synaptic transmission
exp LAGE3 Xq28 0.304 0.0181 0.339
exp RIOK2 5q15 0.304 0.0181 0.339 protein phosphorylation
exp LOC392426 Xp22.31 0.304 0.0181 0.339
met C14orf177 14q32.2 0.304 0.0181 0.339
xsq SAT2 17p13.1 -0.304 0.0181 0.339
exp SCHIP1 3q25.32-q25.33 -0.304 0.0181 0.339
exp C6orf132 6p21.1 -0.304 0.0181 0.339
cop CCDC50 3q28 -0.304 0.0181 0.339
cop PYDC2 3q28 -0.304 0.0181 0.339
exp PRUNE2 9q21.2 -0.304 0.0181 0.339 apoptotic
his STOML1 15q24-q25 -0.307 0.0181 0.339
his PML 15q22 -0.307 0.0181 0.339 Apoptosis; Oncogenes
hs4 ACTN4 19q13 -0.307 0.0181 0.339 Apoptosis
hs4 CCDC144A -0.307 0.0181 0.339
hs4 RNF157 17q25.1 -0.307 0.0181 0.339
xai GNPTG 16p13.3 -0.307 0.0181 0.339
hs4 FHL2 2q12.2 -0.307 0.0181 0.339 negative regulation of
development
his PRUNE2 9q21.2 -0.307 0.0181 0.339 apoptotic
hs4 XG Xp22.33 -0.307 0.0181 0.339
his FIBIN 11p14.2 -0.307 0.0181 0.339
xai CAPS 19p13.3 -0.307 0.0181 0.339 intracellular signal
transduction
his LINC00572 -0.307 0.0181 0.339
xai MEGF6 1p36.3 -0.307 0.0181 0.339
xai CBX3P2 18p11.32 0.307 0.0182 0.34
xai GIMAP6 0.307 0.0182 0.34
hs4 CD3D 11q23 0.307 0.0182 0.34 T cell differentiation;T cell
costimulation
hs4 CD3G 11q23 0.307 0.0182 0.34 protein transport;T cell costimulation
xai RPL29P33 19q13.11 0.307 0.0182 0.34
xai XRCC6P4 0.307 0.0182 0.34
hs4 LINC01869 0.307 0.0182 0.34
hs4 KLK1 19q13.3 0.307 0.0182 0.34 proteolysis
swa AFG3L2 18p11 0.306 0.0182 0.34 myelination;proteolysis
hs4 BEST4 1p33-p32.3 0.306 0.0182 0.34 ion transport
mut CUL5 11q22.3 0.304 0.0182 0.34 Apoptosis; DNA Damage Response
(DDR); DDR (NER)
exp PLCXD1 Xp22.33 0.304 0.0182 0.34 lipid metabolic
exp HIST1H4C 6p22.1 0.304 0.0182 0.34
met SPIN3 Xp11.21 0.304 0.0182 0.34 gamete generation
met GJC2 1q42.13 -0.304 0.0182 0.34 transmembrane transport;cell-
cell signaling
cop IL1RAP 3q28 -0.304 0.0182 0.34 signal transduction;innate
immune response
xai COL12A1 6q12-q13 -0.306 0.0182 0.34 skeletal system
development;cell adhesion
his LOX 5q23.2 -0.307 0.0182 0.34 response to steroid hormone
his CDC25A 3p21 0.306 0.0183 0.341 DNA Damage Response (DDR); DDR (DNA
replication); DDR (G2-M checkpoint); Oncogenes
exp RPL13AP2 0.306 0.0183 0.341
his NTS 12q21 0.306 0.0183 0.341 signal transduction;regulation of blood
vessel size
his RNF4 4p16.3 0.306 0.0183 0.341 DNA Damage Response (DDR)
his PLCL2 3p24.3 0.306 0.0183 0.341 lipid metabolic
his NRDC 0.306 0.0183 0.341 neuromuscular junction development;cell
proliferation
xai ATP5G1P6 0.306 0.0183 0.341
xai PNRC2 1p36.11 0.306 0.0183 0.341 regulation of transcription, DNA-
dependent;deadenylation-independent decapping of nuclear-transcribed mRNA
his RCCD1 15q26.1 0.306 0.0183 0.341
xai RPS4XP8 6q25.2 0.306 0.0183 0.341
xai DDX11-AS1 0.306 0.0183 0.341
xsq ILF3 19p13.2 0.304 0.0183 0.341 M phase;negative regulation of
exp GAPDHP25 2p22.2 0.304 0.0183 0.341
exp RPL23AP18 0.304 0.0183 0.341
exp AASDHPPT 11q22 0.304 0.0183 0.341 macromolecule biosynthetic
exp OGN 9q22 0.304 0.0183 0.341 negative regulation of smooth muscle cell
proliferation
exp C15orf61 15q23 0.304 0.0183 0.341
exp MRPS30 5q11 0.304 0.0183 0.341 Apoptosis
exp PCBP1 2p13-p12 0.304 0.0183 0.341 nuclear mRNA splicing, via
xsq NOL10 2p25.1 0.304 0.0183 0.341
xsq SNRPB 20p13 0.304 0.0183 0.341 RNA splicing;gene expression
xsq MOB3A 19p13.3 0.304 0.0183 0.341
exp TIMP3 22q12.3 -0.304 0.0183 0.341 aging;response to stimulus
exp CAV3 3p25 -0.304 0.0183 0.341 regulation of heart contraction;T-
tubule organization
met PCDHGC5 5q31 -0.304 0.0183 0.341
swa TLDC1 16q24.1 -0.306 0.0183 0.341
swa CDC42 1p36.1 -0.306 0.0183 0.341 small GTPase mediated signal
transduction;hair follicle morphogenesis
hs4 DENND5A 11p15.4 -0.306 0.0183 0.341
hs4 LOC646730 3q23 -0.306 0.0183 0.341
xai RPL19P20 Xp11.3 0.306 0.0184 0.341
exp GAPDHP38 19q13.32 0.306 0.0184 0.341
hs4 DOCK2 5q35.1 0.306 0.0184 0.341 actin cytoskeleton
hs4 ITK 5q31-q32 0.306 0.0184 0.341 activation of phospholipase C
his TXNDC5 6p24.3 0.306 0.0184 0.342 glycerol ether metabolic
process;post-Golgi vesicle-mediated transport
xai ALKBH4 7q22.1 0.306 0.0184 0.342 DNA Damage Response (DDR)
hs4 LCP2 5q35.1 0.306 0.0184 0.342 immune response;transmembrane
his FAM226A Xq13.2 0.306 0.0184 0.342
xai GAPDHP71 5q35.2 0.306 0.0184 0.342
xai GAPDHP38 19q13.32 0.306 0.0184 0.342
cop SNORA20 0.306 0.0184 0.342
xai DDX6P1 6p22.1 0.306 0.0184 0.342
exp NHP2 5q35.3 0.304 0.0184 0.341 DNA Damage Response (DDR)
exp FAM136A 2p13.3 0.304 0.0184 0.341
exp VBP1 Xq28 0.304 0.0184 0.341 cellular protein metabolic process;'de
exp TADA1 1q24.1 0.304 0.0184 0.341 regulation of transcription, DNA-
xsq QRSL1 6q21 0.304 0.0184 0.341 glutaminyl-tRNAGln biosynthesis via
xsq PRAM1 19p13.2 0.304 0.0184 0.341 integrin-mediated signaling
xsq MAP2K5 15q23 0.304 0.0184 0.342 Protein Kinases
mut LTBP1 2p22-p21 0.303 0.0184 0.342 negative regulation of transforming
growth factor beta receptor signaling pathway by extracellular sequestering of
TGFbeta
xsq REG4 1p13.1-p12 0.303 0.0184 0.342
exp SORCS2 4p16.1 -0.303 0.0184 0.342 neuropeptide signaling
pathway
exp SEPT10 2q13 -0.303 0.0184 0.342 cell cycle;cell division
xsq LARP6 15q23 -0.304 0.0184 0.342 RNA processing;regulation of
translation
exp IGFBP5 2q35 -0.304 0.0184 0.341 negative regulation of smooth
met MIR142 -0.304 0.0184 0.341
exp LOC100130169 7q34 -0.306 0.0184 0.342
xai LOC100130169 7q34 -0.306 0.0184 0.342
xai RPL13AP2 0.306 0.0185 0.342
xai PPP2R1B 11q23.2 0.306 0.0185 0.342 Apoptosis
his FBXL4 6q16.1-q16.3 0.306 0.0185 0.342 ubiquitin-dependent protein
catabolic process
xai ZNF639 3q26.33 0.306 0.0185 0.343 negative regulation of
exp KC6 0.306 0.0185 0.343
xai TAGAP 6q25.3 0.306 0.0185 0.343 signal transduction;small GTPase
xai TM6SF1 15q24-q26 0.306 0.0185 0.343
xai POLA2 11q13.1 0.306 0.0185 0.343 DNA Damage Response (DDR); DDR (DNA
replication)
met MRPS17 7p11 0.303 0.0185 0.342 translation
met LURAP1 1p34 0.303 0.0185 0.342 positive regulation of cytokine
production;positive regulation of I-kappaB kinase/NF-kappaB cascade
exp PVRIG 7q22.1 0.303 0.0185 0.342
xsq TRAP1 16p13.3 0.303 0.0185 0.342 Apoptosis
xsq PNLDC1 6q25.3 0.303 0.0185 0.342
exp UBE2I 16p13.3 0.303 0.0185 0.342 DNA Damage Response (DDR)
xsq NCF4 22q13.1 0.303 0.0185 0.343 immune response;cell communication
exp COMMD3 10p12.2 0.303 0.0185 0.343
xsq CD226 18q22.3 0.303 0.0185 0.343 signal transduction;cell
recognition
xsq ABT1 6p22.2 0.303 0.0185 0.343 regulation of transcription from
xsq CPEB2 4p15.33 -0.303 0.0185 0.343 regulation of translation
xsq NUPR1 16p11.2 -0.303 0.0185 0.342 induction of apoptosis;cell
growth
xai ITGB8 7p21.1 -0.306 0.0185 0.343 multicellular organismal
his FLJ41200 -0.306 0.0185 0.343
hs4 AKAP5 14q23.3 -0.306 0.0185 0.343 regulation of insulin
secretion;energy reserve metabolic process
swa PURB 7p13 -0.306 0.0185 0.342 regulation of myeloid cell
differentiation;negative regulation of transcription, DNA-dependent"
hs4 NDP Xp11.4 -0.306 0.0185 0.342 visual perception;canonical
Wnt receptor signaling pathway
his CLK2 1q21 0.306 0.0186 0.343 DNA Damage Response (DDR)
his HCN3 1q22 0.306 0.0186 0.343 ion transport;potassium ion transport
his POP7 7q22 0.306 0.0186 0.343 tRNA processing
xai SYNCRIP 6q14-q15 0.306 0.0186 0.343 RNA splicing;interspecies
his NEU3 11q13.5 0.306 0.0186 0.343 carbohydrate metabolic
swa GALK1 17q24 0.306 0.0186 0.343 small molecule metabolic
process;carbohydrate phosphorylation
xai NEIL3 4q34.3 0.306 0.0186 0.343 DNA Damage Response (DDR); DDR
(BER)
xai CPSF6 12q15 0.306 0.0186 0.343 mRNA polyadenylation;mRNA processing
his WDR75 2q32.2 0.306 0.0186 0.344
his SELENOT 0.306 0.0186 0.344
xai DIAPH1 5q31 0.305 0.0186 0.344 regulation of microtubule-based
process;cytoskeleton organization
exp CCL25 19p13.2 0.305 0.0186 0.344 G-protein coupled receptor
his MIR4437 0.305 0.0186 0.344
exp SNRK 3p22.1 0.303 0.0186 0.343 Apoptosis
mut SDCBP 8q12 0.303 0.0186 0.343 axon guidance;actin cytoskeleton
organization
exp DOCK2 5q35.1 0.303 0.0186 0.343 actin cytoskeleton
xsq CCDC101 16p11.2 0.303 0.0186 0.344
exp RPGR Xp21.1 0.303 0.0186 0.344 visual perception;cell projection
organization
xsq CTC1 17p13.1 0.303 0.0186 0.344 DNA Damage Response (DDR)
met COG5 7q31 0.303 0.0186 0.344 intra-Golgi vesicle-mediated
met GPR84 12q13.13 -0.303 0.0186 0.344
xsq FCHO2 5q13.2 -0.303 0.0186 0.344
xai MICALL1 22q13.1 -0.306 0.0186 0.344
xai DAB2IP 9q33.1-q33.3 -0.306 0.0186 0.343 negative
kappaB cascade
xai POFUT2 21q22.3 -0.306 0.0186 0.343 carbohydrate metabolic
xai RIOK2 5q15 0.305 0.0187 0.344 protein phosphorylation
hs4 PCAT14 0.305 0.0187 0.344
xai GGA3 17q25.1 0.305 0.0187 0.344 intracellular protein
swa HNRNPA2B1 7p15 0.305 0.0187 0.344 RNA transport;nuclear mRNA
his DCAF7 17q23.3 0.305 0.0187 0.344 multicellular organismal
xai MAPK6PS3 13q14.13 0.305 0.0187 0.344
xai DLAT 11q23.1 0.305 0.0187 0.344 acetyl-CoA biosynthetic
xai RPS10P7 1q32.1 0.305 0.0187 0.344
xai NPM1P39 1p36.11 0.305 0.0187 0.344
his SEPT2 2q37 0.305 0.0187 0.344 mitosis;neuron projection development
his HDLBP 2q37.3 0.305 0.0187 0.344 lipid transport;steroid metabolic
process
pro STAT6_9 0.303 0.0187 0.344
xsq BRF1 14q 0.303 0.0187 0.344 positive regulation of transcription,
xsq FKBP5 6p21.31 0.303 0.0187 0.344 peptidyl-proline
xsq CDC6 17q21.3 0.303 0.0187 0.344 DDR (DNA replication)
cop FNDC1 6q25 0.303 0.0187 0.344 cellular response to hypoxia;positive
regulation of protein phosphorylation
xsq DCP2 5q22.2 0.303 0.0187 0.344 histone mRNA catabolic
process;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
exp RPS6KB1 17q23.1 0.303 0.0187 0.344 Apoptosis; Protein Kinases
xsq ENOX2 Xq25 0.303 0.0187 0.344 transport;ultradian rhythm
exp TTYH3 7p22 -0.303 0.0187 0.344 ion transport;chloride transport
exp SYTL2 11q14 -0.303 0.0187 0.344 intracellular protein
xsq LAYN 11q23.1 -0.303 0.0187 0.344
xsq VASN 16p13.3 -0.303 0.0187 0.344
exp EPS8L2 11p15.5 -0.303 0.0187 0.344
xsq ITGB8 7p21.1 -0.303 0.0187 0.344 multicellular organismal
xai REG1CP -0.305 0.0187 0.344
his KCTD4 13q14.12 -0.305 0.0187 0.344 potassium ion transport
xai SUMF1 3p26.1 -0.305 0.0187 0.344
his STARD13-AS -0.305 0.0187 0.344
his STARD13 13q13.1 -0.305 0.0187 0.344 Apoptosis
xai ACD 16q22.1 0.305 0.0188 0.344 DNA Damage Response (DDR)
his USP7 16p13.3 0.305 0.0188 0.344 protein deubiquitination;regulation
xai ACTL8 1p36.2-p35 0.305 0.0188 0.344
xai PM20D2 6q15 0.305 0.0188 0.344 metabolic process
xai MPHOSPH10 2p13.3 0.305 0.0188 0.344 RNA processing;RNA splicing
his SPNS3 17p13.2 0.305 0.0188 0.344 lipid transport;transmembrane
transport
his HIST2H4A 0.305 0.0188 0.344
his HIST2H3C 0.305 0.0188 0.344
his HIST2H2AA3 0.305 0.0188 0.344
his HIST2H2BC 1q21.2 0.305 0.0188 0.344
his HIST2H2AA4 1q21.2 0.305 0.0188 0.344 nucleosome assembly
his HIST2H3A 1q21.2 0.305 0.0188 0.344
his HIST2H4B 0.305 0.0188 0.344 nucleosome assembly;CenH3-
containing nucleosome assembly at centromere
xai MOB3A 19p13.3 0.305 0.0188 0.345
exp RPL10A 6p21.31 0.303 0.0188 0.344 translational
termination;viral transcription
xsq CNR2 1p36.11 0.303 0.0188 0.344 negative regulation of mast cell
xsq MRI1 19p13.2 0.303 0.0188 0.344 L-methionine salvage from
xsq MTFP1 22q 0.303 0.0188 0.344 mitochondrial fission;apoptotic process
exp PAAF1 11q13.4 0.303 0.0188 0.344 interspecies interaction between
organisms
mir hsa-miR-425 0.303 0.0188 0.344
exp EEF1DP2 9q22.31 0.303 0.0188 0.344
xsq RPS8 1p34.1-p32 0.303 0.0188 0.344 translational elongation;viral
transcription
exp ROCK1 18q11.1 0.303 0.0188 0.344 Apoptosis; Protein Kinases
exp LOC100287072 17p11.2 0.303 0.0188 0.344
met HSPB6 19q13.12 0.303 0.0188 0.344 regulation of muscle
xsq SMN2 0.303 0.0188 0.344
met URM1 9q34.11 0.303 0.0188 0.344 tRNA wobble uridine
met MYH1 17p13.1 0.303 0.0188 0.344
exp GPR174 Xq21.1 0.303 0.0188 0.344
mut BRIP1 17q22.2 0.302 0.0188 0.344 DNA Damage Response (DDR); DDR (FA)
exp RPL22P22 Xq21.1 0.302 0.0188 0.344
met NT5C3B 17q21.2 0.302 0.0188 0.344
exp VPS16 20p13 0.302 0.0188 0.344 intracellular protein transport
mut PRKAA2 1p31 0.302 0.0188 0.344 Protein Kinases
exp FARSB 2q36.1 0.302 0.0188 0.344 gene expression;translation
xsq LOC101927070 0.302 0.0188 0.345
exp OSBPL10 3p22.3 -0.303 0.0188 0.344 transport;lipid
transport
exp CDRT4 17p12 -0.303 0.0188 0.344
exp ADAMTSL1 9p21.3 -0.303 0.0188 0.344
his CIB4 2p23.3 -0.305 0.0188 0.344
xai PPP1R13L 19q13.32 -0.305 0.0188 0.344 apoptotic process;post-
xai OSER1 20q13.11 -0.305 0.0188 0.344
swa PDIA4 7q35 -0.305 0.0188 0.344 glycerol ether metabolic
process;protein secretion
xai SAT2 17p13.1 -0.305 0.0188 0.344
hs4 FAM47E-STBD1 -0.305 0.0188 0.344
hs4 SHROOM4 Xp11.22 -0.305 0.0188 0.344 actin filament
organization;multicellular organismal development
xai FAM50A Xq28 -0.305 0.0188 0.344 spermatogenesis
hs4 C3 19p13.3-p13.2 -0.305 0.0188 0.344 complement
activation;positive regulation of phagocytosis
met PADI6 1p36.13 -0.308 0.0188 0.344 peptidyl-citrulline
biosynthetic process from peptidyl-arginine;protein modification process
his RFC5 12q24.23 0.305 0.0189 0.345 DNA Damage Response (DDR); DDR
dependent"
hs4 FCMR 0.305 0.0189 0.345 anti-apoptosis;cellular defense response
xai RFXAP 13q14 0.305 0.0189 0.345 positive regulation of transcription,
DNA-dependent;regulation of transcription, DNA-dependent"
xai STARD7 2q11.2 0.305 0.0189 0.345
xai NAA25 12q24.13 0.305 0.0189 0.345
his FAM168A 11q13.4 0.305 0.0189 0.346
xsq TRIML2 4q35.2 0.302 0.0189 0.345
xsq CEP128 14q31.1 0.302 0.0189 0.345
exp SRM 1p36-p22 0.302 0.0189 0.345 cellular nitrogen compound
xsq TCEB3-AS1 0.302 0.0189 0.345
mut DUSP10 1q41 0.302 0.0189 0.345 JNK cascade;response to organic
substance
xsq MTHFD1L 6q25.1 0.302 0.0189 0.346 one-carbon metabolic
process;folic acid-containing compound metabolic process
exp MYO1E 15q21-q22 -0.302 0.0189 0.345 glomerular
his NR2F2 15q26 -0.305 0.0189 0.346 negative regulation of endothelial
his NR2F2-AS1 -0.305 0.0189 0.346
his MIR1469 -0.305 0.0189 0.346
hs4 C14orf132 14q32.2 -0.305 0.0189 0.346
hs4 CTSL 9q21.33 -0.305 0.0189 0.345
xai BMP1 8p21.3 -0.305 0.0189 0.345 cartilage
condensation;positive regulation of cartilage development
xai PRMT2 21q22.3 -0.305 0.0189 0.345 negative regulation of
his GJB6 13q12 -0.305 0.0189 0.345 cell communication;sensory
perception of sound
xai RPL7AP38 7p15.2 0.305 0.019 0.346
xai NUP43 6q25.1 0.305 0.019 0.346 mitotic cell cycle;cytokine-mediated
signaling pathway
xai MED23 6q22.33-q24.1 0.305 0.019 0.346 regulation of transcription from
his INIP 9q32 0.305 0.019 0.346
exp LRRC19 9p21.2 0.305 0.019 0.346
xai GNL3L Xp11.22 0.305 0.019 0.346 ribosome biogenesis
swa RPUSD2 15q13.3 0.305 0.019 0.346 pseudouridine synthesis
hs4 FUT7 9q34.3 0.305 0.019 0.346 leukocyte migration involved in immune
response;protein glycosylation
his NPBWR2 20q13.3 0.305 0.019 0.346 opioid receptor signaling
pathway;G-protein coupled receptor signaling pathway
his KRR1 12q21.2 0.305 0.019 0.346 rRNA processing
swa PRMT5 14q11.2 0.304 0.019 0.346 regulation of transcription, DNA-
xsq PSD4 2q13 0.302 0.019 0.346 regulation of ARF protein signal transduction
exp SUZ12 17q11.2 0.302 0.019 0.346 regulation of transcription, DNA-
exp RAD51D 17q11 0.302 0.019 0.346 DNA Damage Response (DDR); DDR (HR)
xsq PIM2 Xp11.23 0.302 0.019 0.346 anti-apoptosis;positive regulation of I-
kappaB kinase/NF-kappaB cascade
met DCP2 5q22.2 0.302 0.019 0.346 histone mRNA catabolic process;nuclear-
transcribed mRNA catabolic process, nonsense-mediated decay
exp SYNCRIP 6q14-q15 0.302 0.019 0.346 RNA splicing;interspecies
exp MGA 15q14 0.302 0.019 0.346 Apoptosis
mut GGPS1 1q43 0.302 0.019 0.346 small molecule metabolic process;cholesterol
mut RRP8 11p15.4 0.302 0.019 0.346 chromatin silencing at rDNA;regulation of
met MIR125A -0.302 0.019 0.346
exp AHNAK2 14q32.33 -0.302 0.019 0.346
met HCAR3 12q24.31 -0.302 0.019 0.346 G-protein coupled receptor
signaling pathway
his NECTIN4 -0.304 0.019 0.346
hs4 RNF130 5q35.3 -0.305 0.019 0.346 Apoptosis
hs4 DDR2 1q23.3 -0.305 0.019 0.346 peptidyl-tyrosine
factor activity
hs4 MAOB Xp11.23 -0.305 0.019 0.346 xenobiotic metabolic
process;response to ethanol
xai EPB41L4A 5q21.3 -0.305 0.019 0.346
xai LRFN4 11q13.2 0.304 0.0191 0.346
his GLB1L3 11q25 0.304 0.0191 0.346 carbohydrate metabolic process
his SURF1 9q34.2 0.304 0.0191 0.347 proton transport;ion transmembrane
transport
his SURF2 9q34.2 0.304 0.0191 0.347
xai SH2D2A 1q21 0.304 0.0191 0.347 multicellular organismal
xai GABRD 1p36.3 0.304 0.0191 0.347 transport;ion transport
hs4 CES4A 16q22.1 0.304 0.0191 0.347
xai EIF4E 4q21-q25 0.304 0.0191 0.347 translation;cellular protein
metabolic process
his AURKA 20q13 0.304 0.0191 0.347 DNA Damage Response (DDR); Protein
Kinases
his CSTF1 20q13.2 0.304 0.0191 0.347 transcription from RNA polymerase
II promoter;mRNA 3'-end processing
xai RPL23AP51 7p22 0.304 0.0191 0.347
xai NUP93 16q13 0.304 0.0191 0.347 regulation of glucose transport;protein
transport
mut CBLC 19q13.2 0.302 0.0191 0.346 DNA Damage Response (DDR); EMT
(Epithelial)
xsq EEF1G 11q12.3 0.302 0.0191 0.346 translation;translational
elongation
xsq GPHN 14q23.3 0.302 0.0191 0.347 vitamin metabolic process;water-
exp RPL27AP 20q13.12 0.302 0.0191 0.347
xsq SRP14-AS1 0.302 0.0191 0.347
exp TMEM161A 19p13.11 0.302 0.0191 0.347 negative regulation of
exp POLR3G 5q14.3 0.302 0.0191 0.347 positive regulation of innate
immune response;regulation of transcription from RNA polymerase III promoter
met CYB5B 16q22.1 0.302 0.0191 0.347 transport;electron transport chain
xsq PDCD2 6q27 0.302 0.0191 0.347 Apoptosis
exp SUMF1 3p26.1 -0.302 0.0191 0.347
exp KCNH1 1q32.2 -0.302 0.0191 0.347 ion transport;potassium ion
transport
xsq TNFRSF10B 8p22-p21 -0.302 0.0191 0.347 Apoptosis
xai MXRA5P1 -0.304 0.0191 0.347
xai LOC100129042 -0.304 0.0191 0.347
exp LOC100129042 -0.304 0.0191 0.347
xai OSBPL10 3p22.3 -0.304 0.0191 0.347 transport;lipid
transport
xai DBF4 7q21.3 0.304 0.0192 0.347 DDR (DNA replication)
hs4 GRAPL 0.304 0.0192 0.347
his TYK2 19p13.2 0.304 0.0192 0.347 intracellular protein kinase
cascade;cytokine-mediated signaling pathway
his KAT2B 3p24 0.304 0.0192 0.347 Apoptosis
xai ADAM3A 8p11.23 0.304 0.0192 0.347
exp IFNG 12q14 0.304 0.0192 0.347 negative regulation of mesenchymal to
epithelial transition involved in metanephros morphogenesis;cytokine-mediated
signaling pathway
his ABCB10 1q42.13 0.304 0.0192 0.348 ABC Transporters
xai KCNK17 6p21.1 0.304 0.0192 0.348 ion transport;potassium ion
transport
xai SLBP 4p16.3 0.304 0.0192 0.348 transcription from RNA polymerase
hs4 FAM226A Xq13.2 0.304 0.0192 0.348
xai POLR3G 5q14.3 0.304 0.0192 0.348 positive regulation of innate
his CD8A 2p12 0.304 0.0192 0.348 regulation of immune response;T cell
mediated immunity
met TSPAN4 11p15.5 0.302 0.0192 0.347 protein complex assembly
xsq FUT7 9q34.3 0.302 0.0192 0.347 leukocyte migration involved in
immune response;protein glycosylation
exp CLK2P1 0.302 0.0192 0.347
xsq LY6G5C 6p21.33 0.302 0.0192 0.347
exp FBXW7 4q31.3 0.302 0.0192 0.347 DNA Damage Response (DDR); Tumor
Suppressors
mut SHANK1 19q13.3 0.302 0.0192 0.347 neuromuscular process
controlling balance;protein complex assembly
met RNF217-AS1 0.302 0.0192 0.347
xsq LOC101927692 0.302 0.0192 0.348
exp TMEM127 2q11.2 -0.301 0.0192 0.348 negative regulation of
TOR signaling cascade;negative regulation of cell proliferation
exp ADAM12 10q26 -0.302 0.0192 0.347 myoblast fusion;proteolysis
xsq COPZ2 17q21.32 -0.302 0.0192 0.347 intracellular protein
exp RYK 3q22 -0.302 0.0192 0.347 Wnt receptor signaling
pathway;commissural neuron axon guidance
exp CYTH2 19q13.33 -0.304 0.0192 0.348 endocytosis;actin
swa NEDD4 15q -0.304 0.0192 0.347 nervous system development;neuron
xai LOC729970 1p21.3 -0.304 0.0192 0.347
exp FIGNL2 12q13.13 0.304 0.0193 0.348
his TRMO 0.304 0.0193 0.348 interspecies interaction between
organisms
xai CCT2 12q15 0.304 0.0193 0.348 protein folding;cellular protein
metabolic process
xai FRAT1 10q24.1 0.304 0.0193 0.348 Wnt receptor signaling
his ASGR2 17p 0.304 0.0193 0.348 glycoprotein metabolic process;bone
mineralization
his MIR223 0.304 0.0193 0.348
hs4 MTA1 14q32.3 0.304 0.0193 0.348 signal transduction
hs4 LOC100507437 0.304 0.0193 0.348
hs4 CYTIP 2q11.2 0.304 0.0193 0.348 regulation of cell adhesion
exp ISCUP1 0.304 0.0193 0.348
his ORAI2 7q22.1 0.304 0.0193 0.348
exp RPL9P2 17p12 0.304 0.0193 0.348
met LRRN4CL 11q12.3 0.301 0.0193 0.348
exp SHH 7q36 0.301 0.0193 0.348 response to hypoxia;lymphoid progenitor
exp ACD 16q22.1 0.301 0.0193 0.348 DNA Damage Response (DDR)
met HDLBP 2q37.3 0.301 0.0193 0.348 lipid transport;steroid metabolic
process
mut PLD1 3q26 0.301 0.0193 0.348 phospholipid catabolic process;lipid
catabolic process
xsq CCDC88C 14q32.11 0.301 0.0193 0.348 microtubule cytoskeleton
organization;regulation of protein phosphorylation
met LINC00114 21q22.2 0.301 0.0193 0.348
xsq SNHG7 9q34.3 0.301 0.0193 0.348
met FPR3 19q13.3-q13.4 0.301 0.0193 0.348
exp EEF1GP2 5q32 0.301 0.0193 0.348
xsq STAT2 12q13.3 -0.301 0.0193 0.348 Apoptosis
met ARHGAP30 1q23.3 -0.301 0.0193 0.348 signal
met RASIP1 19q13.33 -0.301 0.0193 0.348 regulation of Rho GTPase
activity;branching morphogenesis of a tube
hs4 KDELR3 22q13.1 -0.304 0.0193 0.348 protein retention in ER
response
xai RHBDF1P1 3p25.1 -0.304 0.0193 0.348
swa SEPT9 17q25 -0.304 0.0193 0.348 GTP catabolic process;cell cycle
hs4 PHYHIP 8p21.3 -0.304 0.0193 0.348
hs4 MPP2 17q12-q21 -0.304 0.0193 0.348 signal transduction
xai ISCUP1 0.304 0.0194 0.349
his ISOC1 5q22.1-q33.3 0.304 0.0194 0.349
his MIR4633 0.304 0.0194 0.349
hs4 ADGRG5 0.304 0.0194 0.349 G-protein coupled receptor
exp ADAM3A 8p11.23 0.304 0.0194 0.349
xai TMEM206 1q32.3 0.304 0.0194 0.349
his SRRM2 16p13.3 0.304 0.0194 0.349 nuclear mRNA splicing, via
his SRRM2-AS1 16p13.3 0.304 0.0194 0.349
his SAFB2 19p13.3 0.304 0.0194 0.349 regulation of transcription, DNA-
dependent"
his SAFB 19p13.3-p13.2 0.304 0.0194 0.349 regulation of transcription,
his TRIM65 17q25.1 0.304 0.0194 0.349
his EEF2K 16p12.2 0.304 0.0194 0.349 insulin receptor signaling
pathway;regulation of protein autophosphorylation
xsq MRPS9 2q12.1 0.301 0.0194 0.349 DNA damage response, detection of
met ADAMTS9 3p14.1 0.301 0.0194 0.349 proteolysis;glycoprotein
catabolic process
exp RPL7AP27 4q35.2 0.301 0.0194 0.349
exp BZRAP1-AS1 0.301 0.0194 0.349
xsq GUSBP11 22q11.23 0.301 0.0194 0.349
mut CWH43 4p11 0.301 0.0194 0.349 GPI anchor biosynthetic process
exp NUP43 6q25.1 0.301 0.0194 0.349 mitotic cell cycle;cytokine-
exp C2orf48 2p25.1 0.301 0.0194 0.349
met SEC23IP 10q25-q26 0.301 0.0194 0.349 intracellular protein
xsq HAVCR2 5q33.3 0.301 0.0194 0.349
exp LOC100133183 0.301 0.0194 0.349
xsq ABCC6P2 -0.301 0.0194 0.349
exp CYR61 1p22.3 -0.301 0.0194 0.349 positive regulation of
protein phosphorylation;positive regulation of phospholipase activity
exp GOLM1 9q21.33 -0.301 0.0194 0.349
exp CAV2 7q31.1 -0.301 0.0194 0.349 mitochondrion
exp SLC2A1-AS1 -0.304 0.0194 0.349
xai POLI 18q21.1 0.303 0.0195 0.349 DNA Damage Response (DDR); DDR (DNA
xai RPL5P34 22q13.2 0.303 0.0195 0.349
his LINC00324 17p13.1 0.303 0.0195 0.349
exp RPL12P3 20q11.21 0.303 0.0195 0.349
xai NSL1 1q41 0.303 0.0195 0.349 M phase of mitotic cell cycle;mitotic
prometaphase
xai RABEPK 9q33.3 0.303 0.0195 0.349 receptor-mediated
his PPP1CA 11q13 0.303 0.0195 0.349 Apoptosis
his TBC1D10C 11q13.2 0.303 0.0195 0.349
his CARNS1 11q13.2 0.303 0.0195 0.349 carnosine biosynthetic
process
his LOC105369723 0.303 0.0195 0.349
his SNX20 16q12.1 0.303 0.0195 0.349 cell communication;protein
transport
xai RPL12P3 20q11.21 0.303 0.0195 0.349
his MRGBP 20q13.33 0.303 0.0195 0.349
his LDHB 12p12.2-p12.1 0.303 0.0195 0.349 lactate metabolic
his LOC105370489 0.303 0.0195 0.349
his AHSA2 2p15 0.303 0.0195 0.349 response to stress
his MRPL36 5p15.3 0.303 0.0195 0.349 translation
his NDUFS6 5p15.33 0.303 0.0195 0.349 transport;respiratory
exp SNORD38A 0.303 0.0195 0.349
exp MAPK6PS3 13q14.13 0.303 0.0195 0.349
xai LYSMD2 15q21.2 0.303 0.0195 0.349 cell wall macromolecule
catabolic process
xai RPS10P27 18q11.2 0.303 0.0195 0.349
xai SNORD38A 0.303 0.0195 0.349
his ANGEL2 1q32.3 0.303 0.0195 0.349
his HIST1H2BJ 6p22.1 0.303 0.0195 0.349 nucleosome assembly;defense
response to bacterium
his HIST1H2AG 6p22.1 0.303 0.0195 0.349
his HIST1H4I 0.303 0.0195 0.349
his HIST1H2BK 6p21.33 0.303 0.0195 0.349 nucleosome assembly;defense
his HIST1H2AH 6p21.33 0.303 0.0195 0.349 nucleosome assembly
his MIR3143 0.303 0.0195 0.349
his CCDC138 2q12.3 0.303 0.0195 0.349
xsq MCM5 22q13.1 0.301 0.0195 0.349 DDR (DNA replication)
mut PLXND1 3q22.1 0.301 0.0195 0.349 multicellular organismal
exp STRBP 9q33.3 0.301 0.0195 0.349 cellular component
mut LAMA2 6q22-q23 0.301 0.0195 0.349 muscle organ development;regulation
of cell adhesion
met SLC35F2 11q22.3 0.301 0.0195 0.349 Solute Carriers
xsq WDR92 2p14 0.301 0.0195 0.349 apoptotic process;histone lysine
methylation
mut NALCN 13q32.3 0.301 0.0195 0.349 ion transport;transmembrane
transport
xsq C14orf80 14q32.33 0.301 0.0195 0.349
exp REEP5 5q22-q23 -0.301 0.0195 0.349
exp RMDN2 2p22.2 -0.301 0.0195 0.349
xsq EGFR 7p12 -0.301 0.0195 0.349 Apoptosis; Cell Signaling;
xsq EPHX1 1q42.1 -0.301 0.0195 0.349 response to toxin;response to
hs4 ZDHHC1 16q22.1 -0.303 0.0195 0.349 protein palmitoylation
hs4 TEAD2 19q13.3 -0.303 0.0195 0.349 positive regulation of
hs4 DKKL1 19q13.33 -0.303 0.0195 0.349 positive regulation of fat
cell differentiation;signal transduction
his CD52 1p36 0.303 0.0196 0.349 elevation of cytosolic calcium ion
his EID1 15q21.1 0.303 0.0196 0.35 cell cycle;cell differentiation
exp ATP5C1P1 14q22.2 0.303 0.0196 0.35
his LRRC57 15q15.2 0.303 0.0196 0.35
his HAUS2 15q15.2 0.303 0.0196 0.35 cell division;G2/M transition of
mitotic cell cycle
his PMS1 2q31.1 0.303 0.0196 0.35 DNA Damage Response (DDR); DDR
(MMR)
his ORMDL1 2q32 0.303 0.0196 0.35 ceramide metabolic process
xai KC6 0.303 0.0196 0.35
his GMEB1 1p35.3 0.303 0.0196 0.35
his LOC554249 0.303 0.0196 0.35
his FGF7P3 0.303 0.0196 0.35
his NUP214 9q34.1 0.303 0.0196 0.35 mRNA export from
nucleus;viral reproduction
his GINS3 16q21 0.303 0.0196 0.35 DDR (DNA replication)
xai POLR1C 6p21.1 0.303 0.0196 0.35 DNA Damage Response (DDR)
xai LOC100505771 0.303 0.0196 0.35
his PPP1R8 1p35.3 0.303 0.0196 0.35 regulation of transcription,
his SCARNA1 1p35.3 0.303 0.0196 0.35
xai ATP13A1 19p13.11 0.303 0.0196 0.35 cation transport
met AGAP2 12q14.1 0.301 0.0196 0.349 axon guidance;protein transport
exp CSF2RB 22q13.1 0.301 0.0196 0.349 signal
met ADO 10q21.3 0.301 0.0196 0.35
exp PAXBP1 21q21.3 0.301 0.0196 0.35
met HKR1 19q13.12 0.301 0.0196 0.35 regulation of transcription, DNA-
exp MRI1 19p13.2 0.301 0.0196 0.35 L-methionine salvage from
exp NME1 0.301 0.0196 0.35 Apoptosis
exp EME1 17q21.33 0.301 0.0196 0.35 DNA Damage Response (DDR); DDR
exp TLCD2 17p13.3 -0.301 0.0196 0.35
met RBPJL 20q13.12 -0.301 0.0196 0.35 regulation of transcription,
DNA-dependent;signal transduction"
exp SAT2 17p13.1 -0.301 0.0196 0.35
met RUNX3 1p36 -0.301 0.0196 0.35 Apoptosis
exp EGLN1 1q42.1 -0.301 0.0196 0.349 heart trabecula
formation;ventricular septum morphogenesis
xai SCML1 Xp22 -0.303 0.0196 0.35 regulation of transcription, DNA-
xai PKIG 20q12-q13.1 -0.303 0.0196 0.35 negative regulation of
activity
hs4 TIMP3 22q12.3 -0.303 0.0196 0.35 aging;response to stimulus
xai MIR635 -0.303 0.0196 0.35
exp MIR635 -0.303 0.0196 0.35
xai EHD2 19q13.3 -0.303 0.0196 0.35 endocytosis;blood coagulation
his ASB8 12q13.11 0.303 0.0197 0.35 intracellular signal transduction
xai GAPDHP60 4q22.1 0.303 0.0197 0.35
xai BSN 3p21.31 0.303 0.0197 0.35 synaptic transmission
his TXNL4B 16q22.2 0.303 0.0197 0.35 mRNA processing;cell cycle
his DHX38 16q22 0.303 0.0197 0.35 RNA splicing;gene expression
xai SUZ12 17q11.2 0.303 0.0197 0.35 regulation of transcription, DNA-
his EXOSC6 16q22.1 0.303 0.0197 0.35 DNA deamination;nuclear-
his TPGS1 19p13.3 0.303 0.0197 0.35 adult behavior;multicellular
swa VARS 6p21.3 0.303 0.0197 0.35 gene expression;translational
elongation
xai HSP90AB5P 3p13 0.303 0.0197 0.35
exp ANKRD55 5q11.2 0.3 0.0197 0.35
mut RC3H2 9q34 0.3 0.0197 0.35
mut AK5 1p31 0.3 0.0197 0.35 nucleotide biosynthetic
process;pyrimidine ribonucleotide biosynthetic process
xsq FARSA 19p13.2 0.3 0.0197 0.35 tRNA aminoacylation for protein
exp MRTO4 1p36.13 0.3 0.0197 0.35 ribosome biogenesis
exp LOC728554 5q35.3 0.3 0.0197 0.35
met PNPLA7 9q34.3 0.3 0.0197 0.35 lipid metabolic
met MRPL41 9q34.3 0.3 0.0197 0.35 translation;apoptotic process
exp RPS4XP9 6q22.32 0.3 0.0197 0.35
xsq GPC6 13q32 -0.3 0.0197 0.35
cop UTS2B 3q28 -0.3 0.0197 0.35
xsq SIPA1L2 1q42.2 -0.3 0.0197 0.35 regulation of small GTPase
mir hsa-miR-224 -0.3 0.0197 0.35
exp PPP1R13L 19q13.32 -0.3 0.0197 0.35 apoptotic process;post-
his PTPN14 1q32.2 -0.303 0.0197 0.35
xai RIT1 1q22 -0.303 0.0197 0.35 nerve growth factor receptor
hs4 TSPAN6 Xq22 -0.303 0.0197 0.35 signal transduction;positive
swa PTRF 17q21.2 -0.303 0.0197 0.35 transcription initiation from
RNA polymerase I promoter;termination of RNA polymerase I transcription
hs4 CHRM3-AS2 0.303 0.0198 0.351
his LOC400927-CSNK1E 0.303 0.0198 0.351
his LOC400927 22q13.1 0.303 0.0198 0.351
his HIF1AN 10q24 0.303 0.0198 0.351 oxidation-reduction
process;regulation of transcription, DNA-dependent
xai RPPH1 14q11.2 0.303 0.0198 0.351
xai ATP5A1 18q21 0.303 0.0198 0.351 lipid metabolic process;small
swa ADA 20q13.12 0.303 0.0198 0.351 in utero embryonic
xai ATP5C1P1 14q22.2 0.303 0.0198 0.351
xai HELQ 4q21.23 0.303 0.0198 0.351 DNA Damage Response (DDR); DDR (FA)
mut NIPBL 5p13.2 0.3 0.0198 0.351 brain development;positive
regulation of multicellular organism growth
exp RPL3P12 Xq25 0.3 0.0198 0.351
xsq LOC101927156 0.3 0.0198 0.351
exp ZNHIT2 11q13 0.3 0.0198 0.351
xsq GPATCH4 1q22 0.3 0.0198 0.351
xsq GABPB1 15q21.2 0.3 0.0198 0.351 positive regulation of
exp VPRBP 3p21.2 0.3 0.0198 0.351 interspecies interaction between
organisms
met UPK3A 22q13.31 0.3 0.0198 0.351 urinary bladder development;cell
morphogenesis
exp SNAI3 16q24.3 0.3 0.0198 0.351
xsq DLEU2 13q14.3 0.3 0.0198 0.351
exp TEX28P1 -0.3 0.0198 0.351
xsq RNF217 6q22.31 -0.3 0.0198 0.351 protein ubiquitination
xsq TMEM2 9q21.13 -0.3 0.0198 0.351 multicellular organismal
development
met GJA3 13q12.11 -0.3 0.0198 0.351 transport;cell-cell signaling
pregnancy
hs4 EPS8L2 11p15.5 -0.303 0.0198 0.351
xai PALLD 4q32.3 -0.303 0.0198 0.351 cytoskeleton organization
xai IGFBP5 2q35 -0.303 0.0198 0.351 negative regulation of smooth
hs4 KIRREL 1q21-q25 -0.303 0.0198 0.351 excretion
his EPHA4 2q36.1 -0.303 0.0198 0.351 adult walking
xai ORC3 6q14.3-q16.1 0.303 0.0199 0.351 DDR (DNA replication)
his TERF2 16q22.1 0.303 0.0199 0.351 DNA Damage Response (DDR); DDR (DNA
replication)
his AIFM1 Xq26.1 0.303 0.0199 0.351 Apoptosis
xai EIF3C 0.303 0.0199 0.351 translation;translational initiation
exp PMFBP1 16q22.2 0.303 0.0199 0.351
exp HEPN1 11q24 0.302 0.0199 0.351
xai THAP9 4q21.22 0.302 0.0199 0.351
his ZBTB3 11q12.3 0.302 0.0199 0.351 regulation of transcription, DNA-
dependent"
xai SARDH 9q33-q34 0.302 0.0199 0.352 glycine catabolic process
exp SF3B1 2q33.1 0.3 0.0199 0.351 Oncogenes
xsq C17orf53 17q21.31 0.3 0.0199 0.351
exp WDHD1 14q22.2 0.3 0.0199 0.351 DDR (DNA replication)
xsq LINC00264 10p12.1 0.3 0.0199 0.351
cop RSPH3 6q25.3 0.3 0.0199 0.351
xsq TDG 12q24.1 0.3 0.0199 0.351 DNA Damage Response (DDR); DDR
(BER)
xsq SCARF1 17p13.3 0.3 0.0199 0.352 neuron remodeling;dendrite
development
cop TAGAP 6q25.3 0.3 0.0199 0.352 signal transduction;small GTPase
mir hsa-miR-20a 0.3 0.0199 0.352
met PAGE1 Xp11.23 0.3 0.0199 0.352 cellular defense response
mda SF2 -0.3 0.0199 0.352
xsq LOC101928323 -0.3 0.0199 0.351
his HERC2P3 15q11.1 0.302 0.02 0.352 spermatogenesis
xai LRRC19 9p21.2 0.302 0.02 0.352
his LOC400958 0.302 0.02 0.353
xai NXF3 Xq22 0.302 0.02 0.353 mRNA export from nucleus;transport
xai LOC728099 0.302 0.02 0.353
xai POLR3A 10q22-q23 0.302 0.02 0.353 innate immune
response;transcription, DNA-dependent
his MAPRE2 18q12.1 0.302 0.02 0.353 cell cycle;mitosis
xai UBASH3A 21q22.3 0.302 0.02 0.353 regulation of cytokine
his PSMC5 17q23.3 0.302 0.02 0.353 S phase of mitotic cell cycle;regulation
of cellular amino acid metabolic process
his FTSJ3 17q23.3 0.302 0.02 0.353 RNA methylation;rRNA processing
xai DOCK2 5q35.1 0.302 0.02 0.353 actin cytoskeleton organization;positive
thymic T cell selection
exp HAUS4 14q11.2 0.302 0.02 0.353 cell cycle;mitosis
exp ITGB2-AS1 0.3 0.02 0.352
xsq OR6N2 0.3 0.02 0.352 response to stimulus
exp UBA52 19p13.1-p12 0.3 0.02 0.353 protein polyubiquitination;DNA repair
xsq PNO1 2p14 0.3 0.02 0.353
dependent"
xsq DUSP8 11p15.5 -0.3 0.02 0.353 inactivation of MAPK activity;protein
dephosphorylation
met LOC285627 5q33.3 -0.3 0.02 0.353
met NDUFS6 5p15.33 -0.3 0.02 0.353 transport;respiratory electron
transport chain
met SASH3 Xq26 -0.3 0.02 0.353 positive regulation of interleukin-10
xsq ATXN1 6p23 -0.3 0.02 0.352 cell death;regulation of excitatory
exp HECTD2 10q23.32 -0.3 0.02 0.352 protein modification
process
xai KCNIP3 2q21.1 -0.302 0.02 0.353 behavior;sensory perception
of pain
his PRKCDBP 11p15.4 -0.302 0.02 0.353
his SERPINB9P1 -0.302 0.02 0.353
hs4 BCO2 11q23.1 -0.302 0.02 0.353 carotene metabolic process;retinoic
hs4 LOC101929718 -0.302 0.02 0.352
xai TSC22D1 13q14 -0.302 0.02 0.352 negative regulation of apoptotic
hs4 KLHDC7A 1p36.13 -0.302 0.02 0.352
xai TIMM44 19p13.3-p13.2 0.302 0.0201 0.353 protein targeting to
mitochondrion;intracellular protein transport
xai ABCD2 12q12 0.302 0.0201 0.353 ABC Transporters
his RNVU1-18 0.302 0.0201 0.353
swa NUDT5 10p14 0.302 0.0201 0.353 nucleobase-containing compound metabolic
process;nucleotide metabolic process
xai FAU 11q13 0.302 0.0201 0.354 translational initiation;viral infectious
cycle
xai ME2 18q21 0.302 0.0201 0.354 malate metabolic process
xai DDB1 11q12-q13 0.302 0.0201 0.354 DNA Damage Response (DDR); DDR
xai HAUS4 14q11.2 0.302 0.0201 0.354 cell cycle;mitosis
his AARS2 6p21.1 0.302 0.0201 0.354 alanyl-tRNA aminoacylation;gene
expression
exp LSM12P1 8p12 0.3 0.0201 0.353
xsq CCL1 17q12 0.299 0.0201 0.353 cellular calcium ion
xsq KLK1 19q13.3 0.299 0.0201 0.353 proteolysis
exp RPL34P18 8q22.1 0.299 0.0201 0.354
xsq GALM 2p22.1 0.299 0.0201 0.354 carbohydrate metabolic
process;hexose metabolic process
exp RPL12 9q34 0.299 0.0201 0.354 translational elongation;viral
transcription
cop AIRN 0.299 0.0201 0.354
xsq MBOAT2 2p25.1 -0.299 0.0201 0.354 phospholipid
exp KANK2 19p13.2 -0.299 0.0201 0.354
xai LOC729770 2q36.1 -0.302 0.0201 0.354
hs4 LOC105370024 -0.302 0.0201 0.354
hs4 HSPB8 12q24.23 -0.302 0.0201 0.354 response to stress;cell death
hs4 IGFL2-AS1 -0.302 0.0201 0.353
hs4 BCAR1 16q23.1 -0.302 0.0201 0.353 G-protein coupled receptor
xai KCNK12 2p16.3 0.304 0.0202 0.354 ion transport;potassium ion
transport
his RRP1 21q22.3 0.302 0.0202 0.354 rRNA processing
his SUB1 5p13.3 0.302 0.0202 0.354 regulation of transcription from
his LINC01150 0.302 0.0202 0.354
exp HSP90AB5P 3p13 0.302 0.0202 0.354
his ALKBH4 7q22.1 0.302 0.0202 0.354 DNA Damage Response (DDR)
his LRWD1 7q22.1 0.302 0.0202 0.354 G1 phase of mitotic cell cycle;DNA
replication
his MIR5090 0.302 0.0202 0.354
xai GRK6 5q35 0.302 0.0202 0.354 signal transduction;regulation of G-
his MESDC2 15q13 0.302 0.0202 0.354 protein folding;mesoderm
development
xai C1orf131 1q42.2 0.302 0.0202 0.354
exp LOC100505771 0.302 0.0202 0.354
his WDR4 21q22.3 0.302 0.0202 0.354 tRNA modification
hs4 MIR4326 0.302 0.0202 0.354
swa MRPL13 8q22.1-q22.3 0.302 0.0202 0.354 translation
xai ASXL3 18q11 0.302 0.0202 0.354 regulation of transcription, DNA-
dependent"
met SEMA5A 5p15.2 0.299 0.0202 0.354 cell
differentiation;patterning of blood vessels
exp SNORA21 17q12 0.299 0.0202 0.354
xsq CMTR2 0.299 0.0202 0.354
exp CBFB 16q22.1 0.299 0.0202 0.354 regulation of transcription, DNA-
exp RPS3AP47 15q15.2 0.299 0.0202 0.354
met SNED1 2q37.3 0.299 0.0202 0.354 cell-matrix adhesion
exp RPL29P26 12q22 0.299 0.0202 0.354
xsq RPS3 11q13.3-q13.5 0.299 0.0202 0.354 translational
exp TAGAP 6q25.3 0.299 0.0202 0.354 signal transduction;small GTPase
mut HIVEP1 6p24-p22.3 0.299 0.0202 0.354 negative regulation of
xsq TIMM21 18q22.3 0.299 0.0202 0.354 protein transport
xsq ENDOG 9q34.1 0.299 0.0202 0.354 response to antibiotic;in utero
exp MAPK6 15q21 0.299 0.0202 0.354 Protein Kinases
exp ABCC6 16p13.1 -0.299 0.0202 0.354 ABC Transporters
xai THBS3 1q21 -0.302 0.0202 0.354 cell adhesion;cell-matrix adhesion
xai RGL3 19p13.2 -0.302 0.0202 0.354 signal
xai CYTH2 19q13.33 -0.302 0.0202 0.354 endocytosis;actin
xai PDLIM7 5q35.3 -0.302 0.0202 0.354 positive regulation of
swa LAMB1 7q22 -0.302 0.0202 0.354 embryo implantation;positive
hs4 CBR1 21q22.13 -0.302 0.0202 0.354 oxidation-reduction
his ERVK3-1 0.302 0.0203 0.354
xai GTF2E1 3q21-q24 0.302 0.0203 0.354 interspecies interaction
xai EHMT2 6p21.31 0.302 0.0203 0.354 negative regulation of
transcription from RNA polymerase II promoter;organ growth
his ABCB7 Xq13.3 0.302 0.0203 0.354 ABC Transporters
his MARK3 14q32.32 0.302 0.0203 0.354
xai LCP1 13q14.3 0.302 0.0203 0.354 T cell activation involved in
hs4 TLX1 10q24 0.302 0.0203 0.354 cell fate commitment;positive regulation
of transcription from RNA polymerase II promoter
hs4 TLX1NB 10q24 0.302 0.0203 0.354
his DEF6 6p21.33-p21.1 0.301 0.0203 0.355
met MIR591 0.299 0.0203 0.354
exp CDC40 6q21 0.299 0.0203 0.354 gene expression;mRNA 3'-end processing
pro CDK5 7q36 0.299 0.0203 0.354 Apoptosis; Protein Kinases
met OR2W5 1q44 0.299 0.0203 0.354 response to stimulus
exp RIPPLY2 6q14.2 0.299 0.0203 0.354 ossification;somitogenesis
cop IGF2R 6q26 0.299 0.0203 0.355 receptor-mediated endocytosis;signal
transduction
xsq MCM8-AS1 0.299 0.0203 0.355
met LOC728819 2p21 0.299 0.0203 0.355
xsq RASA3 13q34 0.299 0.0203 0.355 positive regulation of GTPase
activity;negative regulation of Ras protein signal transduction
xsq DAGLA 11q12.2 -0.299 0.0203 0.355 lipid catabolic
exp FAM134A 2q35 -0.299 0.0203 0.355
exp CRISPLD2 16q24.1 -0.299 0.0203 0.354
hs4 SOD3 4p15.2 -0.301 0.0203 0.355 removal of superoxide
radicals;response to copper ion
his PHF6 Xq26.3 0.301 0.0204 0.355 regulation of transcription, DNA-
dependent"
exp RPPH1 14q11.2 0.301 0.0204 0.355
exp RPL19P20 Xp11.3 0.301 0.0204 0.355
xai TNFRSF18 1p36.3 0.301 0.0204 0.355 signal transduction;tumor
necrosis factor-mediated signaling pathway
swa WDR18 19p13.3 0.301 0.0204 0.355 multicellular organismal
development
xai RPL23AP77 18q11.2 0.301 0.0204 0.355
DNA-dependent"
his FH 1q42.1 0.301 0.0204 0.355 tricarboxylic acid cycle;fumarate
metabolic process
xai RPL19P12 0.301 0.0204 0.355
exp AMER1 Xq11.2 0.301 0.0204 0.355
his PIGN 18q21.33 0.301 0.0204 0.355 C-terminal protein
lipidation;preassembly of GPI anchor in ER membrane
his KIAA1468 18q21.33 0.301 0.0204 0.355
xsq DDX12P 12p13.31 0.299 0.0204 0.355 nucleobase-containing
exp LMO2 11p13 0.299 0.0204 0.355 cellular response to thyroid hormone
exp ALKBH4 7q22.1 0.299 0.0204 0.355 DNA Damage Response (DDR)
exp NUP93 16q13 0.299 0.0204 0.355 regulation of glucose transport;protein
transport
xsq LOC100128361 9q22.31 0.299 0.0204 0.355
met CEMIP 0.299 0.0204 0.355
exp KLF13 15q12 0.299 0.0204 0.355 negative regulation of cell
exp STARD7 2q11.2 0.299 0.0204 0.355
exp SENP1 12q13.1 0.299 0.0204 0.355 proteolysis;activation of cysteine-
type endopeptidase activity involved in apoptotic process
exp LOC100505920 0.299 0.0204 0.355
xsq SMIM8 6q15 0.299 0.0204 0.355
exp RPS27P3 12p13.32 0.299 0.0204 0.356
exp ARMCX3 Xq22.1 -0.299 0.0204 0.355
cop FGF12 3q28 -0.299 0.0204 0.355 signal transduction;JNK cascade
exp ASAP3 1p36.12 -0.299 0.0204 0.355 regulation of ARF GTPase
activity
exp OSBPL3 7p15 -0.299 0.0204 0.355 transport;lipid transport
xsq SRGAP3 3p25.3 -0.299 0.0204 0.355 signal
exp MRAS 3q22.3 -0.299 0.0204 0.355 GTP catabolic process;signal
transduction
met MRPL36 5p15.3 -0.299 0.0204 0.355 translation
met TSKS 19q13.3 -0.299 0.0204 0.355 negative regulation of
hs4 LOC100506388 0.301 0.0205 0.356
xai PLCXD1 Xp22.33 0.301 0.0205 0.356 lipid metabolic
hs4 RASGRP2 11q13 0.301 0.0205 0.356 Ras protein signal
xai MRM1 17q12 0.301 0.0205 0.356 RNA processing
xai TXNL4A 18q23 0.301 0.0205 0.356 nuclear mRNA splicing, via
swa DNAJC7 17q11.2 0.301 0.0205 0.356 protein folding;chaperone
cofactor-dependent protein refolding
DNA-dependent"
xai UTP20 12q23 0.301 0.0205 0.356 rRNA processing;negative regulation of
cell proliferation
his PIGK 1p31.1 0.301 0.0205 0.356 protein thiol-disulfide exchange;C-
terminal protein lipidation
exp BCS1L 2q33 0.299 0.0205 0.356 mitochondrion organization;mitochondrial
xsq PLEK 2p13.3 0.299 0.0205 0.356 integrin-mediated signaling
pathway;inhibition of phospholipase C activity involved in G-protein coupled
xsq MST1P2 1p36.2 0.299 0.0205 0.356
met SFXN4 10q26.11 0.299 0.0205 0.356 iron ion homeostasis;transmembrane
transport
cop LOC729603 0.299 0.0205 0.356
exp NEIL3 4q34.3 0.299 0.0205 0.356 DNA Damage Response (DDR); DDR
(BER)
xsq MIR600HG 9q33.3 0.298 0.0205 0.356
exp C11orf1 11q23.1 0.298 0.0205 0.356
exp FAM84B 8q24.21 -0.299 0.0205 0.356
swa ISOC2 19q13.42 -0.301 0.0205 0.356 protein destabilization
xai EIF4BP5 0.301 0.0206 0.357
exp EEF1A1P11 1p21.3 0.301 0.0206 0.357
hs4 LOC101928087 0.301 0.0206 0.357
xai MACROD1 11q11 0.301 0.0206 0.357 purine nucleoside metabolic process
xai SNRNP25 16p13.3 0.301 0.0206 0.357 mRNA processing;RNA splicing
his MIR4721 0.301 0.0206 0.357
his TUFM 16p11.2 0.301 0.0206 0.357 translational elongation
xai RTN4RL2 11q12.1 0.301 0.0206 0.357 axon regeneration
hs4 SEZ6L 22q12.1 0.301 0.0206 0.357
exp CD1C 1q23.1 0.298 0.0206 0.357 T cell activation involved in
xsq SIN3A 15q24.2 0.298 0.0206 0.357 in utero embryonic
exp NFATC2IP 0.298 0.0206 0.357 DNA Damage Response (DDR); DDR (HR)
exp C9orf114 9q34.11 0.298 0.0206 0.357
exp ROCK1P1 18p11.32 0.298 0.0206 0.357
exp PCBP1-AS1 0.298 0.0206 0.357
mut BTG3 21q21.1 0.298 0.0206 0.357 negative regulation of cell
proliferation;negative regulation of mitotic cell cycle
exp CD3D 11q23 0.298 0.0206 0.357 T cell differentiation;T cell
costimulation
met MLF1 3q25.1 0.298 0.0206 0.357 cell cycle arrest;multicellular
xsq MXRA5 Xp22.33 -0.298 0.0206 0.357
xsq CHST3 10q22.1 -0.298 0.0206 0.357 T cell homeostasis;positive
xsq MGST3 1q23 -0.298 0.0206 0.357 signal transduction;leukotriene
xsq RIN2 20p11.22 -0.298 0.0206 0.357 endocytosis;signal
transduction
exp PER3 1p36.23 -0.298 0.0206 0.357 DNA Damage Response (DDR)
pro CDH2_24 -0.298 0.0206 0.357
xsq ZBTB38 3q23 -0.298 0.0206 0.357 positive regulation of
exp EDN1 6p24.1 -0.298 0.0206 0.357 negative regulation of
pathway
xai ERVV-2 -0.301 0.0206 0.357
xai KIAA0513 16q24.1 -0.301 0.0206 0.357
exp ERVV-2 -0.301 0.0206 0.357
xai CADM4 19q13.31 -0.301 0.0206 0.357 cell adhesion
xai ADORA2B 17p12 -0.301 0.0206 0.357 activation of MAPK
hs4 ABCA12 2q34 -0.301 0.0206 0.357 ABC Transporters
hs4 LPP 3q28 -0.301 0.0206 0.357 cell adhesion
hs4 LPP-AS2 3q27.3 -0.301 0.0206 0.357
swa PTPN1 20q13.1-q13.2 -0.301 0.0206 0.357 regulation of
his LRPPRC 2p21 0.301 0.0207 0.357 regulation of transcription, DNA-
dependent;transport
xai PRKCB 16p11.2 0.301 0.0207 0.357 Protein Kinases
xai C17orf53 17q21.31 0.301 0.0207 0.357
his C2orf76 2q14.2 0.301 0.0207 0.357
his DBI 2q12-q21 0.301 0.0207 0.357 transport
hs4 GIMAP5 7q36.1 0.301 0.0207 0.357 positive regulation of
humoral immune response mediated by circulating immunoglobulin;negative regulation
of nitric oxide biosynthetic process
xai BZRAP1-AS1 0.301 0.0207 0.357
his BHLHE23 20q13.33 0.301 0.0207 0.357 regulation of transcription,
his LINC01749 0.301 0.0207 0.357
exp EIF4BP8 3q21.1 0.301 0.0207 0.357
xai RPL5P4 1p34.3 0.301 0.0207 0.358
xsq GALNT8 12p13.3 0.298 0.0207 0.357 cellular protein metabolic
process;O-glycan processing
exp UBQLN1 9q22 0.298 0.0207 0.357 response to hypoxia;apoptotic
process
exp NCBP1 9q34.1 0.298 0.0207 0.357 termination of RNA polymerase II
exp SMARCC1 3p21.31 0.298 0.0207 0.357 DNA Damage Response (DDR);
DDR (Chromatin)
exp TFAM 10q21 0.298 0.0207 0.358 regulation of transcription from RNA
exp FLOT1 6p21.3 -0.298 0.0207 0.358
xsq CAMSAP2 1q32.1 -0.298 0.0207 0.357
xsq SERTAD4 1q32.1-q41 -0.298 0.0207 0.357
xsq ARHGEF17 11q13.4 -0.298 0.0207 0.357 regulation of small
his EFHC1 6p12.3 -0.301 0.0207 0.358
xai ITGA1 5q11.2 -0.301 0.0207 0.357 activation of MAPK
activity;positive regulation of neuron apoptosis
xai BLVRA 7p13 -0.301 0.0207 0.357 porphyrin-containing compound
metabolic process;heme catabolic process
his RAB42 1p35.3 -0.301 0.0207 0.357 small GTPase mediated signal
transduction
xai BLZF1 1q24 -0.301 0.0207 0.357 vesicle-mediated transport;Golgi to
plasma membrane protein transport
xai MAMDC2 9q21.12 -0.301 0.0207 0.357
xai ATF5 19q13.3 0.3 0.0208 0.358 negative regulation of astrocyte
xai RPL11 1p36.1-p35 0.3 0.0208 0.358 translational elongation;viral
infectious cycle
xai RNPS1 16p13.3 0.3 0.0208 0.358 termination of RNA polymerase II
transcription;mRNA export from nucleus
xai FIGNL2 12q13.13 0.3 0.0208 0.358
hs4 NFATC2IP 0.3 0.0208 0.358 DNA Damage Response (DDR); DDR (HR)
xai IRAK1BP1 6q14-q15 0.3 0.0208 0.358 regulation of transcription,
DNA-dependent;I-kappaB kinase/NF-kappaB cascade"
xai STMN2 8q21.13 0.3 0.0208 0.358 positive regulation of microtubule
his MIR4672 0.3 0.0208 0.358
xsq TMCO6 5q31.3 0.298 0.0208 0.358 protein import into nucleus
mut VPS13C 15q22.2 0.298 0.0208 0.358 protein localization
xsq TYMS 18p11.32 0.298 0.0208 0.358 DNA Damage Response (DDR)
exp RPS26P33 7q21.3-q22.1 0.298 0.0208 0.358
exp LILRA2 19q13.4 0.298 0.0208 0.358 defense response;signal
transduction
exp NUDT5 10p14 0.298 0.0208 0.358 nucleobase-containing compound metabolic
exp SH2D2A 1q21 0.298 0.0208 0.358 multicellular organismal
exp MED23 6q22.33-q24.1 0.298 0.0208 0.358 regulation of transcription
from RNA polymerase II promoter;transcription initiation from RNA polymerase II
promoter
met HJURP 2q37.1 0.298 0.0208 0.358 nucleosome assembly;cell cycle
xsq CEP83 0.298 0.0208 0.358
exp EIF4B 12q13.13 0.298 0.0208 0.358 gene expression;RNA metabolic
process
xsq SSBP3-AS1 0.298 0.0208 0.358
exp LIN28B 6q21 0.298 0.0208 0.358 miRNA catabolic process;gene
silencing by RNA
exp DERL3 22q11.23 0.298 0.0208 0.358 ER-associated protein catabolic
xsq KLF13 15q12 0.298 0.0208 0.358 negative regulation of cell
exp RBMXP3 11q14.1 0.298 0.0208 0.358
xsq LINC01225 0.298 0.0208 0.358
hs4 TMEM132A 11q12.2 -0.3 0.0208 0.358
xai ENTPD3 3p21.3 -0.3 0.0208 0.358 nucleoside diphosphate
catabolic process;nucleoside triphosphate catabolic process
swa PGRMC1 Xq22-q24 -0.3 0.0208 0.358
his LSM2 6p21.3 0.3 0.0209 0.358 nuclear mRNA splicing, via
his CLEC12A 12p13.2 0.3 0.0209 0.358
his LOC400002 0.3 0.0209 0.358
exp RPL5P4 1p34.3 0.3 0.0209 0.359
xai BUD13 11q23.3 0.3 0.0209 0.359 nuclear mRNA splicing, via
spliceosome;mRNA export from nucleus"
hs4 POTEB 0.3 0.0209 0.359
hs4 ATP8A1 4p13 0.3 0.0209 0.359 cation transport;aminophospholipid
transport
xai CLK2P1 0.3 0.0209 0.359
xai RAB33A Xq26.1 0.3 0.0209 0.359 GTP catabolic process;small
exp LAX1 1q32.1 0.298 0.0209 0.358 negative regulation of T cell
exp FBXO33 14q21.1 0.298 0.0209 0.359
xsq HSPD1 2q33.1 0.298 0.0209 0.359 Apoptosis
exp EIF4A1 17p13 0.298 0.0209 0.359 translational initiation;gene
expression
xsq LINC00899 22q13.31 -0.298 0.0209 0.359
xai HSPB8 12q24.23 -0.3 0.0209 0.359 response to stress;cell death
xai WBP5 Xq22.2 -0.3 0.0209 0.359
swa MYO1B 2q12-q34 -0.3 0.0209 0.359 actin filament-based movement;actin
hs4 LOC105371433 -0.3 0.0209 0.359
xai TWF1 12q12 -0.3 0.0209 0.359 negative regulation of actin filament
polymerization;sequestering of actin monomers
his PRSS30P 16p13.3 -0.3 0.0209 0.359
xai REEP5 5q22-q23 -0.3 0.0209 0.359
xai SERBP1P3 3p21.1 0.3 0.021 0.36
xai FAM117B 2q33.2 0.3 0.021 0.36
dependent"
hs4 NCF1 7q11.23 0.3 0.021 0.36 response to yeast;cellular defense
response
xai SDHAF3 0.3 0.021 0.36 regulation of gluconeogenesis
xai METAP1 4q23 0.3 0.021 0.36 regulation of translation;proteolysis
xai SNRK 3p22.1 0.3 0.021 0.36 Apoptosis
xai PPP2R2B-IT1 0.3 0.021 0.36
xsq SOAT2 12q13.13 0.297 0.021 0.36 steroid metabolic process;cholesterol
metabolic process
mut UNC79 14q32.12 0.297 0.021 0.36
dependent"
xsq GABRD 1p36.3 0.297 0.021 0.36 transport;ion transport
mut ZIM3 0.297 0.021 0.36 regulation of transcription, DNA-dependent"
exp LOC391587 3q25.1 -0.297 0.021 0.36
exp PDLIM7 5q35.3 -0.297 0.021 0.36 positive regulation of
xsq CADM4 19q13.31 -0.297 0.021 0.36 cell adhesion
met RTN2 19q13.32 -0.297 0.021 0.36 signal transduction
cop PRSS2 -0.297 0.021 0.36 proteolysis;digestion
cop PRSS1 -0.297 0.021 0.36 digestion;proteolysis
cop PRSS3P2 7q34 -0.297 0.021 0.36
hs4 GULP1 2q32.3-q33 -0.3 0.021 0.36 Apoptosis
hs4 MIR561 -0.3 0.021 0.36
hs4 XGY2 -0.3 0.021 0.36
swa TPM1 15q22.1 -0.3 0.021 0.36 positive regulation of heart rate by
epinephrine;ruffle organization
xai EME1 17q21.33 0.3 0.0211 0.36 DNA Damage Response (DDR); DDR
swa VTA1 6q24.1 0.3 0.0211 0.36 endosome transport;protein
transport
xai ITPRIPL1 2q11.2 0.3 0.0211 0.36
his UBR7 14q32.12 0.3 0.0211 0.361
his GON7 0.3 0.0211 0.361
exp GAPDHP60 4q22.1 0.3 0.0211 0.361
his STOM 9q34.1 0.3 0.0211 0.361 protein homooligomerization
his USP15 12q14 0.3 0.0211 0.361 proteolysis;ubiquitin-dependent protein
catabolic process
his MIR6125 0.3 0.0211 0.361
xai DSC1 18q12.1 0.3 0.0211 0.361 cell adhesion;homophilic cell
adhesion
hs4 CD33 19q13.3 0.3 0.0211 0.361 cell adhesion;signal transduction
xai FECH 18q21.3 0.3 0.0211 0.361 generation of precursor metabolites
xsq RAD51C 17q22 0.297 0.0211 0.36 DNA Damage Response (DDR); DDR (FA)
xsq WDR12 2q33.2 0.297 0.0211 0.36 maturation of LSU-rRNA from
exp EHMT2 6p21.31 0.297 0.0211 0.36 negative regulation of
xsq TIMM44 19p13.3-p13.2 0.297 0.0211 0.36 protein targeting to
xsq FTSJ3 17q23.3 0.297 0.0211 0.361 RNA methylation;rRNA processing
xsq RTP1 3q27.3 0.297 0.0211 0.361 protein insertion into membrane
met PTPRK 6q22.2-q22.3 0.297 0.0211 0.361 cell migration;focal adhesion
assembly
xsq MEF2B 0.297 0.0211 0.361 Oncogenes
cop LOC339535 -0.297 0.0211 0.36
mir hsa-miR-149 -0.297 0.0211 0.36
met MATN4 20q13.1-q13.2 -0.297 0.0211 0.36
xsq TIMP3 22q12.3 -0.297 0.0211 0.36 aging;response to stimulus
xai FIGN 2q24.3 -0.3 0.0211 0.361 locomotory behavior
his LINC02130 -0.3 0.0211 0.361
xai PIK3CB 3q22.3 -0.3 0.0211 0.361 Oncogenes; Protein Kinases
xai MBOAT7 19q13.4 -0.3 0.0211 0.36 phospholipid biosynthetic
process
hs4 CPT1A 11q13.2 0.3 0.0212 0.361 positive regulation of fatty acid
his LOC101928307 0.3 0.0212 0.361
his ADGRB3 0.3 0.0212 0.361 G-protein coupled receptor
swa CACYBP 1q24-q25 0.3 0.0212 0.361 response to growth hormone
stimulus;negative regulation of cell death
xai SLC25A5P7 6q22.31 0.3 0.0212 0.361 Solute Carriers
his ATRX Xq21.1 0.3 0.0212 0.361 DNA Damage Response (DDR); Tumor
Suppressors
his GBA 1q21 0.299 0.0212 0.361 termination of signal
xai HNRNPA1P2 6p21.32 0.299 0.0212 0.361
xai RPL38 17q25.1 0.299 0.0212 0.361 translation;mRNA metabolic process
his ST7L 1p13.2 0.299 0.0212 0.361 negative regulation of cell growth
his CAPZA1 1p13.2 0.299 0.0212 0.361 cellular component
movement;blood coagulation
xai SBNO1 12q24.31 0.299 0.0212 0.361
his FBXO15 18q22.3 0.299 0.0212 0.361
his TIMM21 18q22.3 0.299 0.0212 0.361 protein transport
met CCNJL 5q33.3 0.297 0.0212 0.361
met HSPD1 2q33.1 0.297 0.0212 0.361 Apoptosis
exp MED12L 3q25.1 0.297 0.0212 0.361 regulation of transcription
xsq ACTL8 1p36.2-p35 0.297 0.0212 0.361
exp ITFG2 12p13.33 0.297 0.0212 0.361
exp FBRSL1 12q24.33 0.297 0.0212 0.361
xsq USP14 18p11.32 0.297 0.0212 0.362 proteolysis;ubiquitin-dependent
met TBATA 10q22.1 -0.297 0.0212 0.362
met CLCNKA 1p36 -0.297 0.0212 0.362 transport;ion transport
met HMHB1 5q31.3 -0.297 0.0212 0.361
cop MTRNR2L6 -0.297 0.0212 0.361
xsq GLIS3 9p24.2 -0.297 0.0212 0.361 negative regulation of
transcription from RNA polymerase II promoter;transcription from RNA polymerase II
promoter
xai PFKFB2 1q31 -0.3 0.0212 0.361 Apoptosis
xai SRM 1p36-p22 0.299 0.0213 0.362 cellular nitrogen compound
xai HPGD 4q34-q35 0.299 0.0213 0.362 prostaglandin metabolic
his HELB 12q14.3 0.299 0.0213 0.362 DNA Damage Response (DDR)
hs4 UBASH3A 21q22.3 0.299 0.0213 0.362 regulation of cytokine
xai RPL35P1 1q43 0.299 0.0213 0.362
his RNF126 19p13.3 0.299 0.0213 0.362
xai TAL1 1p32 0.299 0.0213 0.362 neuron differentiation;regulation of cell
proliferation
xai TRIT1 1p34.2 0.299 0.0213 0.362 tRNA processing
xai IFNG-AS1 0.299 0.0213 0.362
his MYO1F 19p13.3-p13.2 0.299 0.0213 0.362 negative regulation of cell
exp NDUFB11P1 11q14.3 0.299 0.0213 0.362
met ATP11C Xq27.1 0.297 0.0213 0.362 cation transport;ion
xsq CFAP20 0.297 0.0213 0.362 multicellular organismal
development
xsq AQP4-AS1 18q11.2 0.297 0.0213 0.362
xsq GALNT6 12q13 0.297 0.0213 0.362 post-translational protein
exp DPH5 1p21.2 0.297 0.0213 0.362 peptidyl-diphthamide biosynthetic
mut PKHD1 6p12.2 0.297 0.0213 0.362 cilium assembly;homeostatic process
exp POLA2 11q13.1 0.297 0.0213 0.362 DNA Damage Response (DDR); DDR (DNA
replication)
mir hsa-miR-574-5p 0.297 0.0213 0.362
xsq CACNA1C-AS1 0.297 0.0213 0.362
exp PLCB2 15q15 0.297 0.0213 0.362 phospholipid metabolic process;activation
of phospholipase C activity
exp RAD51AP1 12p13.2-p13.1 0.297 0.0213 0.362 DNA Damage Response
(DDR)
mut FCRL5 1q21 0.297 0.0213 0.362
xsq CNOT10 3p22.3 0.297 0.0213 0.362 nuclear-transcribed mRNA
tail shortening
xsq CCDC167 6p21.2 0.297 0.0213 0.362
exp SYNC 1p35.1 -0.297 0.0213 0.362 intermediate filament-based
process
xsq C5orf42 5p13.2 -0.297 0.0213 0.362
exp ARHGEF37 5q32 -0.297 0.0213 0.362 regulation of Rho protein
signal transduction
hs4 TFAP2A 6p24 -0.299 0.0213 0.362 optic vesicle
morphogenesis;trigeminal nerve development
hs4 HIPSTR -0.299 0.0213 0.362
hs4 TFAP2A-AS1 -0.299 0.0213 0.362
hs4 LOC101927100 -0.299 0.0213 0.362
hs4 TICAM2 5q23.1 -0.299 0.0213 0.362 inflammatory
response;innate immune response
hs4 GSTM3 1p13.3 -0.299 0.0213 0.362 metabolic process;response to
estrogen stimulus
xai GOLM1 9q21.33 -0.299 0.0213 0.362
hs4 LIMCH1 4p13 -0.299 0.0213 0.362 actomyosin structure
organization
swa SLC25A24 1p13.3 -0.299 0.0213 0.362 Solute Carriers
xai NRROS 3q29 0.299 0.0214 0.362
exp ATP5BP1 0.299 0.0214 0.362
xai EIF3LP1 14q31.1 0.299 0.0214 0.362
his SMAD1-AS2 0.299 0.0214 0.362
his BRK1 3p25.3 0.299 0.0214 0.362
his LOC101928134 0.299 0.0214 0.362
his RYR3 15q14-q15 0.299 0.0214 0.362 cellular response to calcium
ion;ion transport
his CLASP1 2q14.2-q14.3 0.299 0.0214 0.362 microtubule cytoskeleton
organization;exit from mitosis
his NIFK-AS1 0.299 0.0214 0.362
xai INTS7 1q32.3 0.299 0.0214 0.362 snRNA processing;cellular response
to ionizing radiation
xsq TDP1 14q32.11 0.297 0.0214 0.362 DNA Damage Response (DDR); DDR
(BER)
exp UTP20 12q23 0.297 0.0214 0.362 rRNA processing;negative regulation of
cell proliferation
xsq HDAC1 1p34 0.297 0.0214 0.362 Apoptosis
pro FADD_6 0.297 0.0214 0.362
xsq GSG2 17p13 0.297 0.0214 0.362 regulation of spindle checkpoint;protein
phosphorylation
exp ORC3 6q14.3-q16.1 0.297 0.0214 0.362 DDR (DNA replication)
met MAGED2 Xp11.2 0.296 0.0214 0.362
xsq IGSF10 3q25.1 0.296 0.0214 0.362 multicellular organismal
dependent;spermatogenesis
exp EFHD1 2q37.1 -0.297 0.0214 0.362 neuron projection development
exp ACOT9 Xp22.11 -0.297 0.0214 0.362 acyl-CoA metabolic process
exp LAMA3 18q11.2 -0.297 0.0214 0.362 regulation of cell
his SYTL2 11q14 -0.299 0.0214 0.362 intracellular protein
his KCNJ1 11q24 -0.299 0.0214 0.362 synaptic transmission;excretion
xai CALU 7q32.1 -0.299 0.0214 0.362 platelet activation;platelet
degranulation
xai JOSD2 19q13.33 -0.299 0.0214 0.362 proteolysis;protein
deubiquitination
xai RHOG 11p15.5-p15.4 0.299 0.0215 0.362 small GTPase mediated signal
his MFSD9 2q12.1 0.299 0.0215 0.362 transmembrane transport
his TMEM182 2q12.1 0.299 0.0215 0.362
his ACTL6A 3q26.33 0.299 0.0215 0.362 DNA Damage Response (DDR);
DDR (Chromatin)
his MIR3180-3 0.299 0.0215 0.362
his MIR3670-3 0.299 0.0215 0.362
his ADAT2 6q24.2 0.299 0.0215 0.362 tRNA processing
his PEX3 6q24.2 0.299 0.0215 0.362 peroxisome organization;peroxisome
membrane biogenesis
xai NECAP2 1p36.13 0.299 0.0215 0.362 endocytosis;protein transport
his CEP76 18p11.21 0.299 0.0215 0.362 G2/M transition of mitotic cell
his PSMG2 18p11.21 0.299 0.0215 0.362 mitotic cell cycle spindle assembly
his SETD1A 16p11.2 0.299 0.0215 0.362 chromatin
his CCDC85C 14q32.31 0.299 0.0215 0.362 cerebral cortex development
his HHIPL1 14q32 0.299 0.0215 0.362 carbohydrate metabolic process
xai SF3B1 2q33.1 0.299 0.0215 0.362 Oncogenes
swa MAT2A 2p11.2 0.299 0.0215 0.363 response to light stimulus;response
to hormone stimulus
xai C15orf61 15q23 0.299 0.0215 0.363
his ATP2A2 12q24.11 0.299 0.0215 0.363 transmembrane transport;ATP
xsq FAM153B 5q35.2 0.296 0.0215 0.362
met PROSER3 0.296 0.0215 0.362
mir hsa-miR-877 0.296 0.0215 0.362
mir hsa-miR-877(2) 0.296 0.0215 0.362
mir hsa-miR-877(3) 0.296 0.0215 0.362
mir hsa-miR-877(4) 0.296 0.0215 0.362
mir hsa-miR-877(5) 0.296 0.0215 0.362
mir hsa-miR-877(6) 0.296 0.0215 0.362
mir hsa-miR-877(7) 0.296 0.0215 0.362
exp RPL29P7 1q24.2 0.296 0.0215 0.362
xsq LAG3 12p13.32 0.296 0.0215 0.362 cell surface receptor signaling
pathway;negative regulation of interleukin-2 biosynthetic process
xsq TTC39B 9p22.3 -0.296 0.0215 0.362
xsq HOXB3 17q21.3 -0.296 0.0215 0.362 multicellular organismal
exp BLZF1 1q24 -0.296 0.0215 0.362 vesicle-mediated transport;Golgi to
exp FAM57A 17p13.3 -0.296 0.0215 0.362
swa PXN 12q24.31 -0.299 0.0215 0.362 cell adhesion;focal adhesion
assembly
his LOC100996447 -0.299 0.0215 0.362
his MLF1 3q25.1 -0.299 0.0215 0.362 cell cycle
his LAMC1 1q31 -0.299 0.0215 0.362 axon guidance;endoderm development
exp RHBDF1P1 3p25.1 -0.299 0.0215 0.362
his RBP1 3q23 -0.299 0.0215 0.362 response to vitamin A;retinol
metabolic process
xai ADAMTS7 15q24.2 -0.299 0.0215 0.362 proteolysis
exp HADHAP1 4q32 0.299 0.0216 0.363
xai PPP6R1 19q13.42 0.299 0.0216 0.363 DNA Damage Response (DDR)
his FLAD1 1q21.3 0.299 0.0216 0.363 small molecule metabolic
process;FAD biosynthetic process
his HMGN3-AS1 0.299 0.0216 0.363
his HMGN3 6q14.1 0.299 0.0216 0.363 regulation of insulin secretion
involved in cellular response to glucose stimulus;chromatin modification
exp PAICSP1 9p13 0.299 0.0216 0.363
his POLD1 19q13.3 0.299 0.0216 0.363 DNA Damage Response (DDR); DDR
his SUZ12 17q11.2 0.299 0.0216 0.363 regulation of transcription, DNA-
xai SENP1 12q13.1 0.299 0.0216 0.363 proteolysis;activation of cysteine-
type endopeptidase activity involved in apoptotic process
xai SRSF10 1p36.11 0.299 0.0216 0.363 nuclear mRNA splicing, via
his POLR3K 16p13.3 0.299 0.0216 0.363 transcription from RNA
his SNRNP25 16p13.3 0.299 0.0216 0.363 mRNA processing;RNA splicing
his DERL3 22q11.23 0.299 0.0216 0.364 ER-associated protein catabolic
xsq ZNF852 3p21.31 0.296 0.0216 0.363
met FER 5q21 0.296 0.0216 0.363 cell adhesion;regulation of epidermal
xsq SIGLEC16 0.296 0.0216 0.363
exp NECAP2 1p36.13 0.296 0.0216 0.363 endocytosis;protein transport
xsq KATNB1 16q21 0.296 0.0216 0.363 microtubule severing;protein
targeting
exp CHST8 19q13.1 0.296 0.0216 0.363 proteoglycan biosynthetic
process;hormone biosynthetic process
xsq NCS1 9q34 -0.296 0.0216 0.363 positive regulation of
exp LMO4 1p22.3 -0.296 0.0216 0.363 spinal cord association
neuron differentiation;negative regulation of protein complex assembly
exp FBXL5 4p15.32 -0.296 0.0216 0.363 protein ubiquitination;SCF-
dependent proteasomal ubiquitin-dependent protein catabolic process
xai PLOD1 1p36.22 -0.299 0.0216 0.364 response to hypoxia;protein
xai CFL2 14q12 -0.299 0.0216 0.363
xai ITPKC 19q13.1 -0.299 0.0216 0.363
xai FLOT1 6p21.3 -0.299 0.0216 0.363
hs4 ANKAR 2q32.2 -0.299 0.0216 0.363
swa OAS2 12q24.2 0.299 0.0217 0.364 purine nucleotide biosynthetic
process;RNA catabolic process
xai RPL9P2 17p12 0.299 0.0217 0.364
xai ROCK1 18q11.1 0.298 0.0217 0.364 Apoptosis; Protein Kinases
his NCF1 7q11.23 0.298 0.0217 0.364 response to yeast;cellular defense
response
mut SIX5 19q13.32 0.296 0.0217 0.364 multicellular organismal
xsq DHFRL1 3q11.1 0.296 0.0217 0.364 nucleotide biosynthetic
process;thymidine biosynthetic process
xsq GIMAP2 7q36.1 0.296 0.0217 0.364
DNA-dependent"
xsq BOP1 8q24.3 0.296 0.0217 0.364
met BAG5 14q32.33 0.296 0.0217 0.364 Apoptosis
exp COX11 17q22 0.296 0.0217 0.364 respiratory gaseous exchange;respiratory
xsq GRAP2 22q13.2 0.296 0.0217 0.364 Ras protein signal
mut PDE4B 1p31 0.296 0.0217 0.364 cAMP catabolic process;signal
transduction
xsq FNIP1 5q23.3 -0.296 0.0217 0.364 regulation of protein
phosphorylation
xsq TBC1D12 10q23.33 -0.296 0.0217 0.364
his GRIK4 11q22.3 -0.298 0.0217 0.364 transport;ion transport
swa S100A10 1q21 -0.298 0.0217 0.364 signal transduction;positive
xai FAM213A 10q23.1 -0.298 0.0217 0.364 regulation of osteoclast
differentiation;oxidation-reduction process
xai MT2A 16q13 -0.298 0.0217 0.364 cellular response to interleukin-
3;cellular response to erythropoietin
xai GRINA 8q24.3 -0.298 0.0217 0.364
xai MS4A6E 11q12.2 -0.299 0.0217 0.364
xai DDX11L2 2q13 0.301 0.0218 0.364
xai NCBP1 9q34.1 0.298 0.0218 0.364 termination of RNA polymerase II
xai CLK3 15q24 0.298 0.0218 0.364 protein autophosphorylation;protein
phosphorylation
xai CD27 12p13 0.298 0.0218 0.364 Apoptosis
his SHANK2 11q13.2 0.298 0.0218 0.364 intracellular signal
transduction
exp RPL3P10 8p11.22 0.298 0.0218 0.364
hs4 RNF166 16q24.3 0.298 0.0218 0.364
hs4 CTU2 16q24.3 0.298 0.0218 0.364 tRNA wobble uridine
xai SERBP1 1p31 0.298 0.0218 0.365 regulation of anti-
his CBY3 5q35.3 0.298 0.0218 0.365
xai HADHAP1 4q32 0.298 0.0218 0.365
exp RPL21P46 4p15.31 0.296 0.0218 0.364
cop METTL4 18p11.32 0.296 0.0218 0.364 nucleobase-containing
exp MSH6 2p16 0.296 0.0218 0.364 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
exp SULT1A3 16p11.2 0.296 0.0218 0.365
exp MATR3 5q31.2 0.296 0.0218 0.365
xsq C9orf78 9q34.11 0.296 0.0218 0.365
exp GMCL1 2p13.3 0.296 0.0218 0.365 regulation of transcription, DNA-
exp CADM4 19q13.31 -0.296 0.0218 0.365 cell adhesion
pro PRSS8 16p11.2 -0.296 0.0218 0.365 EMT (Epithelial)
exp OSCP1 1p34.3 -0.296 0.0218 0.365 transport
xsq MYO1C 17p13.3 -0.296 0.0218 0.364 protein transport;mRNA
transport
exp LOC100127902 Xq12 -0.296 0.0218 0.364
met TYRO3P 15q24.2 -0.296 0.0218 0.364
his HEG1 3q21.2 -0.298 0.0218 0.365 endothelial cell
xai DSTN 20p12.1 -0.298 0.0218 0.364 cellular component
movement;actin polymerization or depolymerization
xai DYNC1I2 2q31.1 -0.298 0.0218 0.364 G2/M transition of
mitotic cell cycle;mitotic cell cycle
hs4 PIP5KL1 9q34.11 -0.298 0.0218 0.364
his PKN2 1p22.2 0.298 0.0219 0.365 Apoptosis
his PKN2-AS1 0.298 0.0219 0.365
xai ENOSF1 18p11.32 0.298 0.0219 0.365 cellular amino acid catabolic
process
his CHD4 12p13 0.298 0.0219 0.365 DNA Damage Response (DDR)
xai RPS10P5 20p13 0.298 0.0219 0.365
his RAN 12q24.3 0.298 0.0219 0.365 nucleocytoplasmic
transport;androgen receptor signaling pathway
his RNF125 18q12.1 0.298 0.0219 0.365 negative regulation of type I
interferon production;innate immune response
xai PLCL2 3p24.3 0.298 0.0219 0.365 lipid metabolic
xai SNAP25-AS1 0.298 0.0219 0.365
his LOC100996263 0.298 0.0219 0.365
his FAM46C 1p12 0.298 0.0219 0.365
xai ZCCHC10 5q31.1 0.298 0.0219 0.365
exp ABCD2 12q12 0.298 0.0219 0.366 ABC Transporters
xsq DHX38 16q22 0.296 0.0219 0.365 RNA splicing;gene expression
exp NPM1P18 7p14.2 0.296 0.0219 0.365
exp CNOT6L 4q13.3 0.296 0.0219 0.365 nuclear-transcribed mRNA
tail shortening
xsq FAM155B Xq13.1 0.296 0.0219 0.365
cop MYL12A 18p11.31 0.295 0.0219 0.365
cop MYL12B 18p11.31 0.295 0.0219 0.365 muscle contraction;axon
guidance
mut PPP4R3A 0.295 0.0219 0.365
exp C17orf80 17q25.1 0.295 0.0219 0.365
met VRK3 19q13 0.295 0.0219 0.365 positive regulation of phosphoprotein
phosphatase activity;negative regulation of ERK1 and ERK2 cascade
xsq ZNF891 0.295 0.0219 0.366 regulation of transcription, DNA-
dependent"
xsq NDUFA9 12p13.3 0.295 0.0219 0.366 mitochondrial electron
exp H3F3BP1 0.295 0.0219 0.366
exp SHROOM1 5q31.1 -0.295 0.0219 0.365 cell morphogenesis;actin
exp PFKFB2 1q31 -0.296 0.0219 0.365 Apoptosis
his NAT14 19q13.42 -0.298 0.0219 0.366 transcription initiation,
his SSC5D 19q13.42 -0.298 0.0219 0.366
xai SERPINB6 6p25 -0.298 0.0219 0.365 negative regulation of
endopeptidase activity;regulation of proteolysis
his POLR3A 10q22-q23 0.298 0.022 0.366 innate immune
his ITGB7 12q13.13 0.298 0.022 0.366 cell-matrix adhesion;integrin-mediated
signaling pathway
xai ZNF273 7q11.21 0.298 0.022 0.366 regulation of transcription, DNA-
dependent"
his PVALB 22q13.1 0.298 0.022 0.366
his NDUFAF1 15q11.2-q21.3 0.298 0.022 0.366 mitochondrial electron
transport, NADH to ubiquinone;protein complex assembly"
xai NTHL1 16p13.3 0.298 0.022 0.366 DNA Damage Response (DDR); DDR (BER)
xai TRMT1 19p13.2 0.298 0.022 0.366 tRNA processing
met ZNF473 19q13.33 0.295 0.022 0.366 mRNA processing;histone mRNA 3'-end
processing
exp RPL17P20 4q12 0.295 0.022 0.366
met TSNARE1 8q24.3 0.295 0.022 0.366 vesicle-mediated transport
mut TRIM62 1p35.1 0.295 0.022 0.366
mut UNC13D 17q25.1 0.295 0.022 0.366 phagocytosis;regulation of mast
cell degranulation
exp PELI3 11q13.2 -0.295 0.022 0.366
xsq ADAM12 10q26 -0.295 0.022 0.366 myoblast fusion;proteolysis
hs4 GAS2L3 12q23.1 -0.298 0.022 0.367 cell cycle arrest
hs4 TSPAN16 19p13.2 -0.298 0.022 0.367
xai PGAM2 7p13-p12 -0.298 0.022 0.366 response to inorganic
substance;small molecule metabolic process
his ADGRF2 -0.298 0.022 0.366 G-protein coupled receptor
swa TNKS1BP1 11q12.1 -0.298 0.022 0.366 nuclear-transcribed mRNA
swa PDHB 3p21.1-p14.2 -0.298 0.022 0.366 glycolysis;tricarboxylic acid
cycle
xai ARHGEF37 5q32 -0.298 0.022 0.366 regulation of Rho protein signal
transduction
exp DCLK3 3p22.2 -0.298 0.022 0.366
xai CX3CR1 3p21.3 0.298 0.0221 0.367 negative regulation of
angiogenesis;cellular response to transforming growth factor beta stimulus
xai CD1C 1q23.1 0.298 0.0221 0.367 T cell activation involved in
xai HNRNPA1P52 19q13.2 0.298 0.0221 0.367
xai LOC100505797 0.298 0.0221 0.367
his LOC101929431 0.298 0.0221 0.367
his CCDC7 10p11.22 0.298 0.0221 0.367
xai COA4 11q13.4 0.298 0.0221 0.367
his RBBP9 20p11.2 0.298 0.0221 0.367 regulation of cell proliferation
swa ARMC10 7q22.1 0.298 0.0221 0.367 regulation of growth
cop MIR4741 0.298 0.0221 0.367
xai LINC00895 22q11.21 0.298 0.0221 0.367
exp HNRNPA1P2 6p21.32 0.297 0.0221 0.367
his RPAP2 1p22.1 0.297 0.0221 0.367 snRNA
transcription;dephosphorylation of RNA polymerase II C-terminal domain
his GLMN 1p22.1 0.297 0.0221 0.367 muscle cell
differentiation;positive regulation of interleukin-2 biosynthetic process
xsq LOC101928880 0.295 0.0221 0.367
exp CES4A 16q22.1 0.295 0.0221 0.367
xsq DDX31 9q34.13 0.295 0.0221 0.367
xsq POLR2C 16q13-q21 0.295 0.0221 0.367 DNA Damage Response (DDR);
DDR (NER)
xsq SSBP3 1p32.3 0.295 0.0221 0.367 prechordal plate
xsq MAPKAPK5-AS1 12q24.12 0.295 0.0221 0.367
met CHRM1 11q13 0.295 0.0221 0.367 signal transduction;positive regulation
exp ATP13A1 19p13.11 0.295 0.0221 0.367 cation transport
xsq VLDLR 9p24 -0.295 0.0221 0.367 nervous system development;cerebral
cortex development
exp TNFAIP8L3 15q21.2 -0.295 0.0221 0.367
exp ENTPD3 3p21.3 -0.295 0.0221 0.367 nucleoside diphosphate
xsq BRI3 7q21.3 -0.295 0.0221 0.367
exp LINC00475 -0.295 0.0221 0.367
hs4 CSF1 1p13.3 -0.298 0.0221 0.367 positive regulation of gene
expression;positive regulation of cell migration
his NOP56 20p13 0.297 0.0222 0.367 rRNA processing;cell death
his MIR1292 0.297 0.0222 0.367
his SNORD110 0.297 0.0222 0.367
his SNORA51 0.297 0.0222 0.367
his SNORD86 0.297 0.0222 0.367
his SNORD56 0.297 0.0222 0.367
his SNORD57 0.297 0.0222 0.367
his TBX6 16p11.2 0.297 0.0222 0.367 mesoderm development;anatomical
his YPEL3 16p11.2 0.297 0.0222 0.367
his LOC101928595 0.297 0.0222 0.367
xai RPL3P10 8p11.22 0.297 0.0222 0.367
his CLECL1 0.297 0.0222 0.367
xai NUDT5 10p14 0.297 0.0222 0.367 nucleobase-containing compound metabolic
mut ADAMTSL2 9q34.2 0.295 0.0222 0.367 negative regulation of
transforming growth factor beta receptor signaling pathway
exp OGT Xq13 0.295 0.0222 0.367 induction of apoptosis;histone H4-K8
acetylation
met COPRS 17q11.2 0.295 0.0222 0.367
xsq EXOSC5 19q13.1 0.295 0.0222 0.367 gene expression;RNA metabolic
process
xsq DENND1C 19p13.3 0.295 0.0222 0.367
xsq CAMKK2 12q24.2 0.295 0.0222 0.367 positive regulation of
exp CTNNA3 10q22.2 0.295 0.0222 0.367 cell-cell adhesion
exp RPL36 19p13.3 0.295 0.0222 0.367 translational termination;cellular
exp RPL38 17q25.1 0.295 0.0222 0.367 translation;mRNA metabolic process
xsq LOC641746 7q11.21 0.295 0.0222 0.367
met HTRA1 10q26.3 0.295 0.0222 0.367 regulation of cell
growth;proteolysis
exp LARP6 15q23 -0.295 0.0222 0.367 RNA processing;regulation of
translation
exp GLIS3 9p24.2 -0.295 0.0222 0.367 negative regulation of
promoter
exp PALLD 4q32.3 -0.295 0.0222 0.367 cytoskeleton organization
xsq ARPIN -0.295 0.0222 0.367
xai HSPA12A 10q26.12 -0.297 0.0222 0.367
his CPA4 7q32 -0.297 0.0222 0.367 proteolysis;histone acetylation
his RAI14 5p13.3-p13.2 -0.297 0.0222 0.367
his ARSI 5q32 -0.297 0.0222 0.367
exp HLA-F-AS1 6p22.1 -0.297 0.0222 0.367
xai GLIS3 9p24.2 -0.297 0.0222 0.367 negative regulation of
promoter
hs4 PP14571 2q37.3 -0.297 0.0222 0.367
hs4 MIR149 -0.297 0.0222 0.367
hs4 SEMA3G 3p21.1 0.297 0.0223 0.367 multicellular organismal
development
xai CCDC38 12q23.1 0.297 0.0223 0.368
his TGFB1 19q13.1 0.297 0.0223 0.368 Apoptosis; DDR (DNA replication);
Tumor Suppressors
his RANBP2 2q12.3 0.297 0.0223 0.368 protein import into
nucleus;small molecule metabolic process
met ACVR2B 3p22 0.295 0.0223 0.367 signal
transduction;anterior/posterior pattern specification
cop ROCK1 18q11.1 0.295 0.0223 0.367 Apoptosis; Protein Kinases
xsq UQCRHL 1p36.21 0.295 0.0223 0.367
xsq ZNF197-AS1 0.295 0.0223 0.367
cop CARNS1 11q13.2 0.295 0.0223 0.367 carnosine biosynthetic
process
cop RPS6KB2 11q13.2 0.295 0.0223 0.367 Apoptosis; Protein Kinases
cop PTPRCAP 11q13.3 0.295 0.0223 0.367 defense response
cop CORO1B 11q13.2 0.295 0.0223 0.367 actin cytoskeleton
organization
cop GPR152 0.295 0.0223 0.367
cop CABP4 11q13.2 0.295 0.0223 0.367 photoreceptor cell
cop TMEM134 11q13.2 0.295 0.0223 0.367
xsq TAZ Xq28 0.295 0.0223 0.368 cristae formation;muscle contraction
met ZC3H12C 11q22.3 0.295 0.0223 0.368
exp HIST2H3D 0.295 0.0223 0.368 blood coagulation;negative
exp EIF4E 4q21-q25 0.295 0.0223 0.368 translation;cellular protein
metabolic process
met SCARNA10 12p13.31 -0.295 0.0223 0.368
exp SERPINB6 6p25 -0.295 0.0223 0.368 negative regulation of
pro ERBB2 17q12 -0.295 0.0223 0.367 Apoptosis; Oncogenes; Protein
Kinases
xai NBEAL1 2q33.2 -0.297 0.0223 0.368
xai MRAS 3q22.3 -0.297 0.0223 0.368 GTP catabolic process;signal
transduction
his MIR6511B1 -0.297 0.0223 0.368
hs4 CX3CL1 16q13 -0.297 0.0223 0.368 defense response;positive
regulation of transforming growth factor beta1 production
hs4 ARL9 4q12 -0.297 0.0223 0.368 small GTPase mediated signal
transduction
swa FAM114A1 4p14 -0.297 0.0223 0.368
exp NBEAL1 2q33.2 -0.297 0.0223 0.367
his LINC00323 21q22.2 -0.297 0.0223 0.367
hs4 FAM20C 7p22.3 -0.297 0.0223 0.367
hs4 LRP1 12q13.3 -0.297 0.0223 0.367 multicellular organismal
development;regulation of phospholipase A2 activity
xai FBXL5 4p15.32 -0.297 0.0223 0.367 protein ubiquitination;SCF-
his RTTN 18q22.2 0.297 0.0224 0.368 determination of left/right
symmetry;multicellular organismal development
his USP45 6q16.2 0.297 0.0224 0.368 proteolysis;ubiquitin-dependent
his SDK2 17q25.1 0.297 0.0224 0.368 cell adhesion
exp LOC100132077 0.297 0.0224 0.368
xai DCAF15 19p13.12 0.297 0.0224 0.368
xai RBM10 Xp11.23 0.297 0.0224 0.368 mRNA processing;RNA splicing
dependent"
xsq BUB3 10q26 0.294 0.0224 0.368 attachment of spindle microtubules to
kinetochore;mitotic sister chromatid segregation
exp RPL32 3p25-p24 0.294 0.0224 0.368 SRP-dependent cotranslational
exp RPS20P6 1p21 0.294 0.0224 0.368
xsq LOC100506083 0.294 0.0224 0.368
xsq MBNL3 Xq26.2 0.294 0.0224 0.368 mRNA processing;multicellular
met CTGF 6q23.1 0.294 0.0224 0.368 response to wounding;positive
met RARRES1 3q25.32 0.294 0.0224 0.368 negative regulation of cell
proliferation
exp RNPS1 16p13.3 0.294 0.0224 0.368 termination of RNA polymerase II
exp CWF19L1 10q24.31 0.294 0.0224 0.368
exp RIF1 2q23.3 0.294 0.0224 0.368 DNA Damage Response (DDR)
xsq PIK3R6 17p13.1 0.294 0.0224 0.368 blood coagulation;platelet
activation
met NUPR1 16p11.2 0.294 0.0224 0.368 induction of apoptosis;cell growth
exp F3 1p22-p21 -0.294 0.0224 0.368 anti-apoptosis;positive
regulation of platelet-derived growth factor receptor signaling pathway
xsq PTTG1IP 21q22.3 -0.294 0.0224 0.368 protein import into
nucleus
exp CHMP4B 20q11.22 -0.294 0.0224 0.368 protein
transport;cellular membrane organization
xai TIMP3 22q12.3 -0.297 0.0224 0.368 aging;response to stimulus
swa MTDH 8q22.1 -0.297 0.0224 0.368 lipopolysaccharide-mediated
signaling pathway;negative regulation of apoptotic process
his COL1A2 7q22.1 -0.297 0.0224 0.368 axon guidance;protein
heterotrimerization
hs4 TTLL13P -0.297 0.0224 0.368 protein modification process
hs4 ADORA1 1q32.1 -0.297 0.0224 0.368 Apoptosis
hs4 CPM 12q14.3 -0.297 0.0224 0.368 proteolysis;anatomical
his UBE3A 15q11.2 0.297 0.0225 0.369 positive regulation of
phosphatidylinositol 3-kinase cascade;androgen receptor signaling pathway
his LEFTY2 1q42.1 0.297 0.0225 0.369 transforming growth factor
beta receptor signaling pathway;multicellular organismal development
hs4 CDCA4 14q32.33 0.297 0.0225 0.369
exp LOC728099 0.297 0.0225 0.369
xai ACTR6 12q23.1 0.297 0.0225 0.369
his PTPRC 1q31-q32 0.297 0.0225 0.369 protein dephosphorylation;peptidyl-
xai PSMG2 18p11.21 0.297 0.0225 0.369 mitotic cell cycle spindle assembly
his MCM8-AS1 0.297 0.0225 0.369
his CRLS1 20p13-p12.3 0.297 0.0225 0.369 phospholipid biosynthetic process
xai SLC5A6 2p23 0.297 0.0225 0.369 Solute Carriers
xai MRTO4 1p36.13 0.297 0.0225 0.369 ribosome biogenesis
exp RPL19P12 0.297 0.0225 0.369
his HDAC1 1p34 0.297 0.0225 0.369 Apoptosis
exp INTS12 4q24 0.297 0.0225 0.369 snRNA processing
xsq MIR142 0.294 0.0225 0.369
exp NXF3 Xq22 0.294 0.0225 0.369 mRNA export from nucleus;transport
xsq MED28 4p16 0.294 0.0225 0.369 regulation of transcription, DNA-
dependent"
mut CTH 1p31.1 0.294 0.0225 0.369 cellular amino acid biosynthetic
process;hydrogen sulfide biosynthetic process
exp RPL21P68 6p22.2 0.294 0.0225 0.369
xsq OVGP1 1p13 0.294 0.0225 0.369 carbohydrate metabolic process;chitin
catabolic process
exp MRPL9 1q21 0.294 0.0225 0.369 translation
exp PLK4 4q28 0.294 0.0225 0.369 Protein Kinases
cop HERC2P3 15q11.1 0.294 0.0225 0.369 spermatogenesis
xsq PRKRIR 11q13.5 0.294 0.0225 0.369 response to stress;signal
transduction
xsq ITGB1BP2 Xq12-q13.1 0.294 0.0225 0.369 muscle organ
development;signal transduction
exp RPL6P19 7q33 0.294 0.0225 0.369
met MARCH1 4q32.2 0.294 0.0225 0.369 protein
class II
met CCR1 3p21 -0.294 0.0225 0.369 dendritic cell chemotaxis;cell
exp IFITM3 11p15.5 -0.294 0.0225 0.369 innate immune
response;type I interferon-mediated signaling pathway
exp FGFR2 10q26 -0.294 0.0225 0.369 Cell Signaling; Oncogenes; Protein
Kinases
his BCAR1 16q23.1 -0.297 0.0225 0.369 G-protein coupled receptor
hs4 EPHX1 1q42.1 -0.297 0.0225 0.369 response to toxin;response to
xai F3 1p22-p21 -0.297 0.0225 0.369 anti-apoptosis;positive
swa MCM7 7q21.3-q22.1 0.297 0.0226 0.369 DDR (DNA replication)
his FLOT2 17q11-q12 0.297 0.0226 0.369 epidermis development;cell adhesion
his ITPA 20p 0.296 0.0226 0.369 metabolic process;nucleotide metabolic
process
xai CTNNA3 10q22.2 0.296 0.0226 0.369 cell-cell adhesion
xai HSF2 6q22.31 0.296 0.0226 0.369 regulation of transcription, DNA-
xai NPIPB5 16p12.2 0.296 0.0226 0.369
xai RPL3P5 2q37.3 0.296 0.0226 0.369
xai ING5 2q37.3 0.296 0.0226 0.369 histone H3 acetylation;positive
xai TXLNG Xp22.2 0.296 0.0226 0.369 regulation of transcription, DNA-
mut IQGAP1 15q26.1 0.294 0.0226 0.369 energy reserve metabolic
process;signal transduction
xsq SNRNP25 16p13.3 0.294 0.0226 0.369 mRNA processing;RNA splicing
exp ENOSF1 18p11.32 0.294 0.0226 0.369 cellular amino acid catabolic
process
xsq SMG1P2 0.294 0.0226 0.369
exp RFXAP 13q14 0.294 0.0226 0.369 positive regulation of transcription,
met AKAP5 14q23.3 0.294 0.0226 0.369 regulation of insulin
secretion;energy reserve metabolic process
exp TRIT1 1p34.2 0.294 0.0226 0.369 tRNA processing
mir hsa-miR-505 0.294 0.0226 0.369
met MYC 8q24.21 0.294 0.0226 0.369 Apoptosis; Oncogenes; Protein
Kinases
met PAQR6 1q22 0.294 0.0226 0.369
exp ACTR6 12q23.1 0.294 0.0226 0.369
exp RCC1 1p36.1 0.294 0.0226 0.369 cell cycle;mitotic spindle
organization
xsq ZKSCAN7 3p21.32 0.294 0.0226 0.369
exp KIR2DL5A 0.294 0.0226 0.369
xsq TMEM56 1p21.3 -0.294 0.0226 0.369
met C19orf60 19p13.11 -0.294 0.0226 0.369
exp FADS3 11q12-q13.1 -0.294 0.0226 0.369 electron transport
chain;unsaturated fatty acid biosynthetic process
xai MRPS24 7p14 -0.296 0.0226 0.369 translation
xai EPS8L2 11p15.5 -0.296 0.0226 0.369
swa ITGB1 10p11.2 -0.296 0.0226 0.369 Apoptosis
his MIR1262 -0.297 0.0226 0.369
xai RPL34P18 8q22.1 0.296 0.0227 0.369
hs4 TRIM65 17q25.1 0.296 0.0227 0.369
xai HSH2D 19p13.12 0.296 0.0227 0.37 T cell activation
xai ENTPD1-AS1 10q24.1 0.296 0.0227 0.37
swa PLCB4 20p12 0.296 0.0227 0.37 lipid metabolic process;lipid catabolic
process
exp PPP2R2B-IT1 0.296 0.0227 0.37
his RSAD1 17q21.33 0.296 0.0227 0.37 porphyrin-containing compound
xai CWF19L1 10q24.31 0.296 0.0227 0.37
pro EP300_30_GBL00152 0.294 0.0227 0.369
exp WDR17 4q34 0.294 0.0227 0.369
xsq LMNTD1 0.294 0.0227 0.369 cell proliferation
cop NDC80 18p11.32 0.294 0.0227 0.37 attachment of spindle microtubules
xsq HIST1H4F 6p22.1 0.294 0.0227 0.37
met SPN 16p11.2 -0.294 0.0227 0.37 negative regulation of type
IV hypersensitivity;blood coagulation
xsq PLCE1 10q23 -0.294 0.0227 0.369 diacylglycerol biosynthetic
xai FRMD4A 10p13 -0.296 0.0227 0.37
his NCCRP1 19q13.2 -0.296 0.0227 0.37 protein catabolic
process
exp MXRA5P1 -0.296 0.0227 0.37
xai LMO4 1p22.3 -0.296 0.0227 0.37 spinal cord association
hs4 VEPH1 3q24-q25 -0.296 0.0227 0.37
hs4 ULBP3 6q25 -0.296 0.0227 0.37 antigen processing and
xai LINC00472 6q13 -0.296 0.0227 0.369
xai CCDC80 3q13.2 -0.296 0.0227 0.369 positive regulation of
cell-substrate adhesion;extracellular matrix organization
xai PLPP4 -0.296 0.0227 0.369 phospholipid dephosphorylation
xai RPS17P5 6p12.3 0.299 0.0228 0.371
hs4 NCF1B 0.296 0.0228 0.37
xai CCAR1 10q21.3 0.296 0.0228 0.37 Apoptosis
swa FTSJ1 Xp11.23 0.296 0.0228 0.37 RNA methylation;rRNA processing
his FAM96A 15q22.31 0.296 0.0228 0.37 chromosome segregation
his SNX1 15q22.31 0.296 0.0228 0.37 cell communication;early endosome
to Golgi transport
xai RAB44 0.296 0.0228 0.371 small GTPase mediated signal
his LINC01451 0.296 0.0228 0.371
his EXOG 3p21.3 0.296 0.0228 0.371 DNA Damage Response (DDR)
his XPO1 2p15 0.296 0.0228 0.371 Apoptosis
hs4 MIR548AV 0.296 0.0228 0.371
xai YY1 14q 0.296 0.0228 0.371 DNA recombination;cellular response to UV
exp HELQ 4q21.23 0.294 0.0228 0.37 DNA Damage Response (DDR); DDR (FA)
exp SNORD15B 11q13.4 0.294 0.0228 0.37
exp UTP3 4q13.3 0.294 0.0228 0.37 chromatin
modification;multicellular organismal development
exp BRD3 9q34 0.294 0.0228 0.37
exp CD1D 1q23.1 0.294 0.0228 0.371 T cell selection;positive
xsq RFX8 2q11.2 0.294 0.0228 0.371 regulation of transcription, DNA-
dependent"
xsq LINC00494 20q13.13 0.294 0.0228 0.371
xsq MIS18A 21q22.11 0.294 0.0228 0.371 nucleosome assembly;cell
cycle
xsq SLC35F2 11q22.3 0.294 0.0228 0.371 Solute Carriers
exp INTS7 1q32.3 0.293 0.0228 0.371 snRNA processing;cellular response
xsq LVCAT1 -0.294 0.0228 0.371
cop RALYL 8q21.2 -0.294 0.0228 0.371
xsq CCDC50 3q28 -0.294 0.0228 0.37
exp BEAN1 16q21 -0.294 0.0228 0.37 cell death
hs4 RBM24 6p22.3 -0.296 0.0228 0.371 regulation of mRNA
hs4 PYROXD2 10q24.2 -0.296 0.0228 0.37
hs4 DDR1 6p21.3 -0.296 0.0228 0.37 embryo implantation;skin
development
hs4 SHROOM1 5q31.1 -0.296 0.0228 0.37 cell morphogenesis;actin
xai RPL22P22 Xq21.1 0.296 0.0229 0.371
xai POLA1 Xp22.1-p21.3 0.296 0.0229 0.371 DNA Damage Response (DDR);
xai PRRT4 7q32.1 0.296 0.0229 0.371
his RBL1 20q11.2 0.296 0.0229 0.371 G1 phase of mitotic cell
his AUNIP 1p36.11 0.296 0.0229 0.371
xai EIF4BP8 3q21.1 0.296 0.0229 0.371
xai NDUFB11P1 11q14.3 0.296 0.0229 0.371
his LINC01455 0.296 0.0229 0.371
DNA-dependent"
swa GPRIN1 5q35.2 0.296 0.0229 0.371 neuron projection development
swa SRPK2 7q22-q31.1 0.296 0.0229 0.371 intracellular protein kinase
cascade;negative regulation of viral genome replication
xai RAVER2 1p31.3 0.296 0.0229 0.371
exp KIR2DL3 0.293 0.0229 0.371 immune response;regulation of
immune response
exp NAA25 12q24.13 0.293 0.0229 0.371
xsq TMPO 12q22 0.293 0.0229 0.371 regulation of transcription, DNA-
dependent"
xsq LOC55338 0.293 0.0229 0.371
exp SBNO1 12q24.31 0.293 0.0229 0.371
exp TM6SF1 15q24-q26 0.293 0.0229 0.371
exp RPS26P37 9q22.3 0.293 0.0229 0.371
met TREX1 3p21.31 0.293 0.0229 0.371 DNA Damage Response (DDR)
exp PHIP 6q14 0.293 0.0229 0.371 DDR (DNA replication)
exp BCOR Xp11.4 0.293 0.0229 0.371 Tumor Suppressors
xsq RAB39A 11q22.3 0.293 0.0229 0.371 small GTPase mediated signal
exp MTMR3 22q12.2 -0.293 0.0229 0.371 phosphatidylinositol
dephosphorylation;protein dephosphorylation
exp MYO5BP2 -0.293 0.0229 0.371
xai CLIP4 2p23.2 -0.296 0.0229 0.371
xai NOS1AP 1q23.3 -0.296 0.0229 0.371 regulation of apoptotic
hs4 SEMA3A 7p12.1 -0.296 0.0229 0.371 cell
differentiation;regulation of heart rate
swa CTSB 8p22 -0.296 0.0229 0.371 Apoptosis
his LOC100996664 -0.296 0.0229 0.371
xai C5orf64 5q12.1 -0.296 0.0229 0.371
xai FEM1A 19p13.3 0.296 0.023 0.371 regulation of ubiquitin-protein ligase
activity;protein ubiquitination
his CFC1 0.296 0.023 0.371
xai LOC100132077 0.296 0.023 0.372
swa ADSS 1q44 0.296 0.023 0.372 purine nucleotide biosynthetic process;AMP
xai ISG20L2 1q23.1 0.296 0.023 0.372 ribosome biogenesis
his CELF2-AS1 0.296 0.023 0.372
xai CCT8 21q22.11 0.296 0.023 0.372 protein folding;cellular protein
metabolic process
xsq ZBED3-AS1 5q13.3 0.293 0.023 0.371
exp METTL17 14q11.2 0.293 0.023 0.371 translation
xsq GLRX5 14q32.13 0.293 0.023 0.371 hemopoiesis;cell redox homeostasis
xsq C1QL3 10p13 0.293 0.023 0.372
xsq NAA16 13q14.11 0.293 0.023 0.372 N-terminal protein amino acid
exp VWA9 15q22.31 0.293 0.023 0.372
exp ACTL8 1p36.2-p35 0.293 0.023 0.372
exp CALU 7q32.1 -0.293 0.023 0.372 platelet activation;platelet
degranulation
exp CX3CL1 16q13 -0.293 0.023 0.371 defense response;positive
xsq GPC1 2q35-q37 -0.293 0.023 0.371 axon guidance
xsq TPST1 7q11.21 -0.293 0.023 0.371 peptidyl-tyrosine
sulfation;inflammatory response
xai RAB11AP1 10q23.33 -0.296 0.023 0.372
exp RAB11AP1 10q23.33 -0.296 0.023 0.372
xai ELOVL4 6q14 0.296 0.0231 0.372 fatty acid biosynthetic
his KPNB1 17q21.32 0.295 0.0231 0.372 NLS-bearing substrate import into
nucleus;viral genome transport in host cell
his C8orf37-AS1 0.295 0.0231 0.373
his C8orf37 8q22.1 0.295 0.0231 0.373
mut REC8 14q11.2-q12 0.293 0.0231 0.372 synapsis;reciprocal meiotic
recombination
exp RPS26P58 Xp22.11 0.293 0.0231 0.372
exp THUMPD1 16p12.3 0.293 0.0231 0.372
DNA-dependent;multicellular organismal development"
xsq ITGB2-AS1 0.293 0.0231 0.373
exp TYMS 18p11.32 0.293 0.0231 0.373 DNA Damage Response (DDR)
exp RPL17P18 3q29 0.293 0.0231 0.373
xsq C1orf198 1q42.2 -0.293 0.0231 0.373
exp ASAP1 8q24.1-q24.2 -0.293 0.0231 0.373 signal transduction;cell
projection organization
exp PLOD1 1p36.22 -0.293 0.0231 0.372 response to hypoxia;protein
hs4 CNTNAP5 2q14.3 -0.295 0.0231 0.373 cell adhesion;signal
transduction
hs4 CARD10 22q13.1 -0.295 0.0231 0.373 protein complex
hs4 PXDC1 6p25.2 -0.295 0.0231 0.372 cell communication
xai BPTF 17q24.3 0.295 0.0232 0.373 chromatin remodeling;transcription,
DNA-dependent
his LOC100131655 0.295 0.0232 0.373
his ZNF236 18q22-q23 0.295 0.0232 0.373 regulation of transcription,
DNA-dependent;cellular response to glucose stimulus"
his NELFE 6p21.3 0.295 0.0232 0.373
his MIR1236 0.295 0.0232 0.373
his SKIV2L 6p21 0.295 0.0232 0.373
his COX8A 11q12-q13 0.295 0.0232 0.373 generation of precursor metabolites
and energy;respiratory electron transport chain
his LOC100996455 0.295 0.0232 0.374
xai RPL27 17q21 0.295 0.0232 0.374 translational termination;cellular
xai KDM1A 1p36.12 0.295 0.0232 0.374 negative regulation of protein
binding;positive regulation of transcription from RNA polymerase II promoter
met AKAP13 15q24-q25 0.293 0.0232 0.373 nerve growth factor receptor
signaling pathway;regulation of small GTPase mediated signal transduction
xsq ANP32C 4q32.3 0.293 0.0232 0.373
met TMC7 16p12.3 0.293 0.0232 0.373
exp IGHV1OR15-1 15q11.2 0.293 0.0232 0.373 immune response
xsq MRPL10 17q21.32 0.293 0.0232 0.373 translation;ribosome
biogenesis
exp TVP23C 17p12 -0.293 0.0232 0.373
exp MBOAT7 19q13.4 -0.293 0.0232 0.373 phospholipid
exp SLC35G3 17q12 -0.293 0.0232 0.373
xsq PROM2 2q11.1 -0.293 0.0232 0.373
swa CASK Xp11.4 -0.295 0.0232 0.374 negative regulation of wound
healing;negative regulation of cellular response to growth factor stimulus
hs4 DOCK6 19p13.2 -0.295 0.0232 0.373 blood coagulation
hs4 KREMEN1 22q12.1 -0.295 0.0232 0.373 cell communication;Wnt
exp FAT1P1 20p12.2 -0.295 0.0232 0.373
xai CCL8 17q11.2 -0.295 0.0232 0.373 calcium ion
transport;response to virus
xai DFNA5 7p15 -0.295 0.0232 0.373 sensory perception of sound;inner
ear receptor cell differentiation
his RND3 2q23.3 -0.295 0.0232 0.373 GTP catabolic process;cell
adhesion
his LOC100505984 -0.295 0.0232 0.373
exp EIF4BP5 0.295 0.0233 0.374
hs4 CCDC85C 14q32.31 0.295 0.0233 0.374 cerebral cortex development
hs4 HHIPL1 14q32 0.295 0.0233 0.374 carbohydrate metabolic process
xai NOC2L 1p36.33 0.295 0.0233 0.374 negative regulation of apoptotic
xai GTF3C3 2q33.1 0.295 0.0233 0.374 transcription, DNA-
his LINC01841 0.295 0.0233 0.374
his PPAT 4q12 0.295 0.0233 0.374 lactation;nucleobase-containing small
his PAICS 4q12 0.295 0.0233 0.374 purine base metabolic process;purine
xai EZH2 7q35-q36 0.295 0.0233 0.375 Oncogenes; Tumor Suppressors
exp NR1I2 3q12-q13.3 0.293 0.0233 0.374 signal transduction;drug export
xsq ITPA 20p 0.293 0.0233 0.374 metabolic process;nucleotide metabolic
process
met STK32A 5q32 0.293 0.0233 0.374
exp RAB39A 11q22.3 0.293 0.0233 0.374 small GTPase mediated signal
exp DOK2 8p21.3 0.293 0.0233 0.374 signal transduction;cell surface
met ATN1 12p13.31 0.293 0.0233 0.374 negative regulation of
transcription from RNA polymerase II promoter;neuron apoptosis
exp PYCR2 1q42.12 0.293 0.0233 0.374 proline biosynthetic
xsq POLA2 11q13.1 0.293 0.0233 0.374 DNA Damage Response (DDR); DDR (DNA
replication)
exp RAD51 15q15.1 0.292 0.0233 0.375 DNA Damage Response (DDR); DDR (FA)
exp LOC728811 4q13.2 -0.293 0.0233 0.374
his MIR1249 -0.295 0.0233 0.375
hs4 FLJ46906 6q24.1 -0.295 0.0233 0.374
xai FAT1P1 20p12.2 -0.295 0.0233 0.374
his EMC4 15q14 0.295 0.0234 0.375
xai CD247 1q24.2 0.295 0.0234 0.375 T cell costimulation;interspecies
exp LOC729681 6q27 0.295 0.0234 0.375
DNA-dependent"
his DUS2 0.295 0.0234 0.375 tRNA processing
his DDX28 16q22.1 0.295 0.0234 0.375
his PSMG1 21q22.3 0.295 0.0234 0.375 proteasome assembly
xai ZGPAT 20q13.3 0.295 0.0234 0.375 negative regulation of epidermal
growth factor-activated receptor activity;negative regulation of transcription,
DNA-dependent"
exp PM20D2 6q15 0.292 0.0234 0.375 metabolic process
xsq MLKL 16q23.1 0.292 0.0234 0.375
exp RPL23AP1 6p21.3 0.292 0.0234 0.375
exp PNRC2 1p36.11 0.292 0.0234 0.375 regulation of transcription, DNA-
exp THAP9 4q21.22 0.292 0.0234 0.375
met GABARAP 17p13.1 0.292 0.0234 0.375 protein targeting;apoptotic
process
xsq FRAT1 10q24.1 0.292 0.0234 0.375 Wnt receptor signaling
xsq RFXAP 13q14 0.292 0.0234 0.375 positive regulation of transcription,
exp NLRP11 19q13.43 0.292 0.0234 0.375 oxidation-reduction process
xsq KRTAP12-2 0.292 0.0234 0.375
exp UPF2 10p14-p13 0.292 0.0234 0.375 mRNA export from nucleus;gene
expression
exp MMP9 20q11.2-q13.1 0.292 0.0234 0.375 Apoptosis
xsq LOC731157 5q14.3 0.292 0.0234 0.375
met BPIFA4P 20q11.21 0.292 0.0234 0.375
xsq IFIT2 10q23.31 -0.292 0.0234 0.375 negative regulation of
protein binding;cellular response to interferon-alpha
xsq TRIM16L -0.292 0.0234 0.375
xsq BCAR1 16q23.1 -0.292 0.0234 0.375 G-protein coupled receptor
met DOK2 8p21.3 -0.292 0.0234 0.375 signal transduction;cell
exp YWHAZP5 10q25.1 -0.292 0.0234 0.375
xai ARHGAP23 17q12 -0.295 0.0234 0.375 signal transduction
hs4 DLGAP4 20q11.23 -0.295 0.0234 0.375 cell-cell signaling
xai LAMA3 18q11.2 -0.295 0.0234 0.375 regulation of cell
hs4 ARHGEF11 1q21 -0.295 0.0234 0.375 Rho protein signal
transduction;nerve growth factor receptor signaling pathway
hs4 RASSF1 3p21.3 0.295 0.0235 0.375 positive regulation of
hs4 RASSF1-AS1 0.295 0.0235 0.375
xai PMFBP1 16q22.2 0.295 0.0235 0.376
swa UBE3A 15q11.2 0.295 0.0235 0.376 positive regulation of
his CEPT1 1p13.3 0.295 0.0235 0.376 lipid metabolic
his DRAM2 1p13.3 0.295 0.0235 0.376 apoptotic process;induction of
apoptosis
exp SERBP1P3 3p21.1 0.295 0.0235 0.376
xsq ZNF711 Xq21.1 0.292 0.0235 0.375 positive regulation of
xsq LRRC47 1p36.32 0.292 0.0235 0.375
exp COIL 17q22 0.292 0.0235 0.375 oxidation-reduction process
exp PRKCB 16p11.2 0.292 0.0235 0.375 Protein Kinases
xsq ZASP 0.292 0.0235 0.375
xsq ZSCAN32 16p13.3 0.292 0.0235 0.375
xsq ALG8 11q14.1 0.292 0.0235 0.376 dolichol-linked oligosaccharide
xsq SDC4 20q12 -0.292 0.0235 0.376 ureteric bud development;positive
xsq MLPH 2q37.3 -0.292 0.0235 0.376 intracellular protein
transport
exp MAP1LC3C 1q43 -0.292 0.0235 0.375 autophagy
his IGFL2-AS1 -0.295 0.0235 0.376
his LOC93429 -0.295 0.0235 0.376
swa PRKCSH 19p13.2 -0.295 0.0235 0.376 protein
folding;intracellular protein kinase cascade
xai GGCX 2p12 -0.295 0.0235 0.375 protein modification process;blood
coagulation
hs4 ARL4D 17q21.31 -0.295 0.0235 0.375 GTP catabolic process;small
xai SCHIP1 3q25.32-q25.33 -0.295 0.0235 0.375
his GDF10 10q11.22 0.295 0.0236 0.376 skeletal system
xai HSPA8P1 Xq24 0.294 0.0236 0.376
xai RPL27AP 20q13.12 0.294 0.0236 0.376
xai MAPK6 15q21 0.294 0.0236 0.376 Protein Kinases
xai ARL6IP6 2q23.3 0.294 0.0236 0.376
exp EEF1GP3 3p22.1 0.294 0.0236 0.376
hs4 ARL5C 17q12 0.294 0.0236 0.376 small GTPase mediated signal transduction
his TBX10 11q13.2 0.294 0.0236 0.376 anatomical structure
xsq ITGAM 16p11.2 0.292 0.0236 0.376 cell adhesion;integrin-mediated
signaling pathway
xsq C1orf131 1q42.2 0.292 0.0236 0.376
exp MRPS26 20p13 0.292 0.0236 0.376 DNA damage response, detection of
DNA damage;peptide biosynthetic process"
met MIR203A 0.292 0.0236 0.376
xsq PCBP1 2p13-p12 0.292 0.0236 0.376 nuclear mRNA splicing, via
met ZNF16 8q24 0.292 0.0236 0.376 regulation of transcription, DNA-
dependent"
exp UTS2 1p36 0.292 0.0236 0.376 muscle contraction;synaptic transmission
exp ASAP1-IT1 8q24.21 -0.292 0.0236 0.376
exp MAMDC2 9q21.12 -0.292 0.0236 0.376
mir hsa-miR-365 -0.292 0.0236 0.376
mir hsa-miR-365(2) -0.292 0.0236 0.376
exp LOXL4 10q24 -0.292 0.0236 0.376
xai KRTAP6-1 21q22.1 -0.294 0.0236 0.376
swa TMED10 14q24.3 -0.294 0.0236 0.376 retrograde vesicle-
mediated transport, Golgi to ER;COPII vesicle coating
exp KRTAP6-1 21q22.1 -0.294 0.0236 0.376
hs4 CDC42BPA 1q42.11 -0.294 0.0236 0.376 Protein Kinases
xai MGP 12p12.3 -0.294 0.0236 0.376 response to hormone
his CLEC4D 12p13.31 0.294 0.0237 0.377 innate immune response
his MIR5001 0.294 0.0237 0.377
his EIF4E2 2q37.1 0.294 0.0237 0.377 translation;regulation of
translation
his TIGD1 2q37.1 0.294 0.0237 0.377 regulation of transcription, DNA-
dependent"
his MYO1G 7p13-p11.2 0.294 0.0237 0.377
his SNORA9 0.294 0.0237 0.377
his SNHG15 7p13 0.294 0.0237 0.377
his CCM2 7p13 0.294 0.0237 0.377 multicellular organismal
development;stress-activated MAPK cascade
his CCNB2 15q22.2 0.294 0.0237 0.377 DNA Damage Response (DDR)
his COG1 17q25.1 0.294 0.0237 0.377 intra-Golgi vesicle-mediated
his FAM231B 0.294 0.0237 0.377
exp RPS17P5 6p12.3 0.292 0.0237 0.377
met FTL 19q13.33 0.292 0.0237 0.377 transmembrane transport;iron ion
transport
xsq NCL 2q37.1 0.292 0.0237 0.377 angiogenesis
exp ZNF831 20q13.32 0.292 0.0237 0.377
xsq LY6H 8q24.3 0.292 0.0237 0.377 nervous system development;organ
morphogenesis
xsq LINC01590 0.292 0.0237 0.377
xsq RSBN1L 7q11.23 0.292 0.0237 0.377
exp UBASH3A 21q22.3 0.292 0.0237 0.377 regulation of cytokine
exp ATAD3A 1p36.33 0.292 0.0237 0.377 cell growth;negative
regulation of apoptotic process
met MORN4 10q24.2 0.292 0.0237 0.377
cop CBX3P2 18p11.32 0.292 0.0237 0.377
xai DCLK3 3p22.2 -0.294 0.0237 0.377
xai PLEKHA4 19q13.33 -0.294 0.0237 0.377
his LINC01173 -0.294 0.0237 0.377
his CLDN25 -0.294 0.0237 0.377
his FAM110C 2p25.3 -0.294 0.0237 0.377
xai RAD51 15q15.1 0.294 0.0238 0.377 DNA Damage Response (DDR); DDR (FA)
his PPIG 2q31.1 0.294 0.0238 0.377 protein folding;RNA splicing
xai MTHFD2P1 3q11.2 0.294 0.0238 0.377
his TMEM129 4p16.3 0.294 0.0238 0.377
his TACC3 4p16.3 0.294 0.0238 0.377 microtubule cytoskeleton
organization;regulation of microtubule-based process
exp ST13P15 0.294 0.0238 0.377
his ZNHIT3 17q12 0.294 0.0238 0.377 regulation of transcription, DNA-
dependent"
his PRG2 11q12 0.294 0.0238 0.378 immune response;defense response to
bacterium
xai ST13P15 0.294 0.0238 0.378
xsq RFC3 13q13.2 0.292 0.0238 0.377 DNA Damage Response (DDR); DDR
xsq FOXCUT 0.292 0.0238 0.377
cop PLEKHB1 11q13.5-q14.1 0.292 0.0238 0.377 multicellular organismal
development;phototransduction
xsq EEF1E1-BLOC1S5 0.292 0.0238 0.378
xsq DLK1 14q32 0.292 0.0238 0.378 multicellular organismal
development;embryo development
xsq SCOC-AS1 0.292 0.0238 0.378
exp LAYN 11q23.1 -0.291 0.0238 0.378
xsq UGCG 9q31 -0.292 0.0238 0.378 glycosphingolipid biosynthetic
exp BMP1 8p21.3 -0.292 0.0238 0.378 cartilage
exp MEIS3P1 17p12 -0.292 0.0238 0.377
xsq IL13RA1 Xq24 -0.292 0.0238 0.377 cell surface receptor
signaling pathway
met TBC1D10C 11q13.2 -0.292 0.0238 0.377
xai FSTL1 3q13.33 -0.294 0.0238 0.378 BMP signaling pathway
swa ATP1B1 1q24 -0.294 0.0238 0.378 ATP biosynthetic
process;transport
xai FADS3 11q12-q13.1 -0.294 0.0238 0.378 electron transport
his LOC100128233 -0.294 0.0238 0.377
his SYCE2 19p13.2 0.294 0.0239 0.378 cell division;cell cycle
his MIR5695 0.294 0.0239 0.378
his MIR374A 0.294 0.0239 0.378
his FTX 0.294 0.0239 0.378
his FAM98B 15q14 0.294 0.0239 0.378
his LOC101060498 0.294 0.0239 0.378
his CHRNA9 4p14 0.294 0.0239 0.378 ion transport;elevation of
swa EEFSEC 3q21.3 0.294 0.0239 0.378 selenocysteine
incorporation;GTP catabolic process
exp NARG2P2 0.294 0.0239 0.378
xai NARG2P2 0.294 0.0239 0.378
xai INTS12 4q24 0.294 0.0239 0.378 snRNA processing
xsq METTL16 17p13.3 0.291 0.0239 0.378
met UBE2V2 8q11.21 0.291 0.0239 0.378 DNA Damage Response (DDR);
DDR (TLS)
exp NEURL4 17p13 0.291 0.0239 0.378
met RAG2 11p13 0.291 0.0239 0.378 B cell homeostatic proliferation;positive
xsq MCM3AP-AS1 21q22.3 0.291 0.0239 0.378
exp RPL5P28 10q26.3 0.291 0.0239 0.378
exp TAF4 20q13.33 0.291 0.0239 0.378 ovarian follicle
development;interspecies interaction between organisms
exp ASXL3 18q11 0.291 0.0239 0.378 regulation of transcription, DNA-
dependent"
exp IL17RC 3p25.3 -0.291 0.0239 0.378
xai OTUD1 10p12.2 -0.294 0.0239 0.378
exp CEACAMP6 -0.294 0.0239 0.378
hs4 FN3K 17q25.3 -0.294 0.0239 0.378 fructoselysine metabolic
process
his MCRS1 12q13.12 0.294 0.024 0.378 DNA Damage Response (DDR); DDR
(Chromatin)
xai ACRBP 12p13.31 0.294 0.024 0.378
xai C16orf91 16p13.3 0.294 0.024 0.379
his AARSD1 17q21.31 0.294 0.024 0.379 translation;alanyl-tRNA
aminoacylation
xai PHIP 6q14 0.294 0.024 0.379 DDR (DNA replication)
xai ETNK1 12p12.1 0.294 0.024 0.379 phosphatidylethanolamine biosynthetic
exp LOC100505811 0.294 0.024 0.379
his VPS13A 9q21 0.294 0.024 0.379 Golgi to endosome transport;nervous
system development
his VPS13A-AS1 9q21.2 0.294 0.024 0.379
xai LOC100505811 0.294 0.024 0.379
his NDUFA8 9q33.2 0.294 0.024 0.379 mitochondrial electron transport,
his MORN5 9q33.2 0.294 0.024 0.379
met SOWAHC 2q13 0.291 0.024 0.378
exp DNAJC7 17q11.2 0.291 0.024 0.379 protein folding;chaperone cofactor-
dependent protein refolding
xsq RPS5 19q13.4 0.291 0.024 0.379 regulation of translational
fidelity;cellular protein metabolic process
xsq COG2 1q42.2 0.291 0.024 0.379 protein glycosylation;intracellular
protein transport
exp CWC22 2q31.3 0.291 0.024 0.379 nuclear mRNA splicing, via
exp FAM27A 0.291 0.024 0.379
exp IGHMBP2 11q13.3 0.291 0.024 0.379 DNA Damage Response (DDR)
exp AIMP1 4q24 0.291 0.024 0.379 glucose metabolic process;response to wounding
exp CCAR1 10q21.3 0.291 0.024 0.379 Apoptosis
exp KDELR1 19q13.3 -0.291 0.024 0.379 protein retention in ER
lumen;intracellular protein transport
exp GTF2IRD1 7q11.23 -0.291 0.024 0.379 regulation of transcription,
xsq ANO10 3p22.1 -0.291 0.024 0.379 ion transport;cell death
pro AP2M1 3q28 -0.291 0.024 0.379 vesicle-mediated transport;transport
mda proportion_genomic_gains -0.291 0.024 0.378
hs4 PLEKHF1 19q12 -0.294 0.024 0.379 apoptotic process
hs4 SDC2 8q22-q23 -0.294 0.024 0.379 response to hypoxia;response to
caffeine
xai LINC00475 -0.294 0.024 0.379
xai ANXA5 4q27 -0.294 0.024 0.379 Apoptosis
swa CES2 16q22.1 -0.294 0.024 0.379 catabolic process
hs4 MYL9 20q11.23 -0.294 0.024 0.379 axon guidance;muscle contraction
his PAX8 2q13 -0.294 0.024 0.379 mesenchymal to epithelial transition
involved in metanephros morphogenesis;pronephric field specification
xai IGKV1D-33 0.294 0.0241 0.379 immune response;complement
activation
xai AEBP2 12p12.3 0.294 0.0241 0.379 regulation of transcription, DNA-
his ATF7 12q13 0.293 0.0241 0.379 regulation of transcription, DNA-
dependent;interspecies interaction between organisms"
his SUMO1 2q33 0.293 0.0241 0.379 Apoptosis; DNA Damage Response (DDR)
swa LCP1 13q14.3 0.293 0.0241 0.379 T cell activation involved in
xai VWA9 15q22.31 0.293 0.0241 0.379
xai MRPS26 20p13 0.293 0.0241 0.379 DNA damage response, detection of
xai BRCA1 17q21 0.293 0.0241 0.379 Apoptosis; DNA Damage Response (DDR); DDR
(FA); DDR (DNA replication); Tumor Suppressors
his BCL11B 14q32.2 0.293 0.0241 0.379 regulation of lipid metabolic
exp IGKV1D-33 0.293 0.0241 0.379 immune response;complement
activation
xsq HMGN5 Xq13.3 0.291 0.0241 0.379 regulation of transcription, DNA-
exp GTF3C3 2q33.1 0.291 0.0241 0.379 transcription, DNA-
xsq CEP83-AS1 0.291 0.0241 0.379
exp POLR3A 10q22-q23 0.291 0.0241 0.379 innate immune
exp AEBP2 12p12.3 0.291 0.0241 0.379 regulation of transcription, DNA-
xsq WDR3 1p12 0.291 0.0241 0.379
exp GRPEL2 5q32 0.291 0.0241 0.379 protein folding
exp CENPP 9q22.31 0.291 0.0241 0.379 M phase of mitotic cell
exp ISG20L2 1q23.1 0.291 0.0241 0.379 ribosome biogenesis
exp PCNA 20pter-p12 0.291 0.0241 0.379 DNA Damage Response (DDR); DDR
exp JOSD2 19q13.33 -0.291 0.0241 0.379 proteolysis;protein
deubiquitination
xsq TMEM47 Xp11.4 -0.291 0.0241 0.379
exp SEMA4F 2p13.1 -0.291 0.0241 0.379 cell
differentiation;negative regulation of axon extension
exp MYLK 3q21 -0.291 0.0241 0.379 positive regulation of cell
xsq LOC541472 7p21 -0.291 0.0241 0.379
exp CA13 8q21.2 -0.291 0.0241 0.379 one-carbon metabolic process
exp DFNA5 7p15 -0.291 0.0241 0.379 sensory perception of sound;inner
ear receptor cell differentiation
xsq RALB 2q14.2 -0.291 0.0241 0.379 cell cycle;signal
transduction
xai KIRREL-IT1 -0.293 0.0241 0.379
xai KIAA0895 7p14.2 -0.293 0.0241 0.379
his TFAMP1 7p22.3 -0.293 0.0241 0.379
hs4 PLD1 3q26 -0.293 0.0241 0.379 phospholipid catabolic
hs4 DNAH12 3p14.3 -0.294 0.0241 0.379 microtubule-based
movement
xai RTN4IP1 6q21 0.293 0.0242 0.379
his PLA2G4D 15q15.1 0.293 0.0242 0.379 metabolic
process;phospholipid catabolic process
exp GALNT8 12p13.3 0.293 0.0242 0.379 cellular protein metabolic
xai HNRNPA1P24 0.293 0.0242 0.38
exp SF1 11q13 0.293 0.0242 0.38 nuclear mRNA 3'-splice site
hs4 PTPRVP 1q32.1 0.293 0.0242 0.38
his SCRN2 17q21.32 0.293 0.0242 0.38 proteolysis
xai SDK2 17q25.1 0.293 0.0242 0.38 cell adhesion
swa DTX3L 3q21.1 0.293 0.0242 0.38 response to DNA damage
stimulus;histone monoubiquitination
xai DCAF17 2q31.1 0.293 0.0242 0.38 protein ubiquitination
his C18orf61 0.293 0.0242 0.38
swa EPS15 1p32 0.293 0.0242 0.38 cell proliferation;protein transport
his SETMAR 3p26.1 0.293 0.0242 0.38 DNA Damage Response (DDR)
exp TRIM77 11q14.3 0.293 0.0242 0.38
met DNAAF5 0.291 0.0242 0.379
exp RPL23AP42 3q26.1 0.291 0.0242 0.38
exp RPAP3 12q13.11 0.291 0.0242 0.38
exp COG8 16q22.1 0.291 0.0242 0.38 protein transport
xsq LRWD1 7q22.1 0.291 0.0242 0.38 G1 phase of mitotic cell cycle;DNA
replication
mut GOT1 10q24.1-q25.1 0.291 0.0242 0.38 carbohydrate metabolic
process;aspartate catabolic process
exp ZNF711 Xq21.1 0.291 0.0242 0.38 positive regulation of
exp PARPBP 12q23.2 0.291 0.0242 0.38 DNA Damage Response (DDR)
xsq DOHH 19p13.3 0.291 0.0242 0.38 peptidyl-lysine modification to
hypusine;post-translational protein modification
met REG4 1p13.1-p12 -0.291 0.0242 0.379
exp ADAMTS7 15q24.2 -0.293 0.0242 0.38 proteolysis
exp LYZL6 17q11.2 -0.293 0.0242 0.38 metabolic process;cell wall
macromolecule catabolic process
xai GTF2IRD1 7q11.23 -0.293 0.0242 0.379 regulation of
transcription, DNA-dependent;multicellular organismal development
his LINC01213 -0.293 0.0242 0.379
hs4 LOC200772 0.293 0.0243 0.38
his E2F8 11p15.1 0.293 0.0243 0.38 cell cycle
his FASTKD5 0.293 0.0243 0.38 cellular respiration
his UBOX5 20p13 0.293 0.0243 0.38 protein polyubiquitination
xai FAM86FP 12p13.31 0.293 0.0243 0.38
xai RMI2 16p13.13 0.293 0.0243 0.38 DNA Damage Response (DDR); DDR (FA)
exp FAM136BP 6p25.2 0.291 0.0243 0.38
xsq BUB1B 15q15 0.291 0.0243 0.38 DNA Damage Response (DDR)
exp RPL15P22 22q12.1 0.291 0.0243 0.38
xsq IZUMO4 19p13.3 0.291 0.0243 0.38
met CCDC9 19q13.32 0.291 0.0243 0.38
exp KLRC2 0.291 0.0243 0.38 cellular defense response;signal
transduction
xsq IQCB1 3q13.33 0.291 0.0243 0.38 cilium assembly;photoreceptor cell
maintenance
xsq ASF1B 19p13.12 0.291 0.0243 0.38 DNA Damage Response (DDR); DDR (DNA
replication)
xsq LINC01337 0.291 0.0243 0.38
mut PPP3CA 4q24 0.291 0.0243 0.38 protein dephosphorylation;negative
regulation of insulin secretion
exp RNU7-41P 14q13.2 0.291 0.0243 0.38
mir hsa-miR-30e 0.291 0.0243 0.38
xsq EME1 17q21.33 0.291 0.0243 0.38 DNA Damage Response (DDR); DDR
mut GLI3 7p13 0.291 0.0243 0.38 axon guidance;pallium development
met BMI1 10p11.23 0.291 0.0243 0.38 segment specification;positive
regulation of B cell proliferation
met HYKK 15q25.1 0.291 0.0243 0.38
met ARHGAP15 2q22.2-q22.3 -0.291 0.0243 0.38 regulation of
small GTPase mediated signal transduction;signal transduction
xsq JPH2 20q13.12 -0.291 0.0243 0.38 regulation of cardiac muscle
xai PON2 7q21.3 -0.293 0.0243 0.38 response to oxidative
stress;aromatic compound catabolic process
his CX3CL1 16q13 -0.293 0.0243 0.38 defense response;positive
swa GNAQ 9q21 -0.293 0.0243 0.38 Oncogenes
xai LY6G5C 6p21.33 0.293 0.0244 0.38
exp PHB2P1 10q25.1 0.293 0.0244 0.381
his ASB16-AS1 17q21.31 0.293 0.0244 0.381
his TMUB2 17q21.31 0.293 0.0244 0.381
swa CCT6B 17q12 0.293 0.0244 0.381 spermatogenesis;protein transport
xai CENPP 9q22.31 0.293 0.0244 0.381 M phase of mitotic cell
his PHF3 6q12 0.293 0.0244 0.381 transcription, DNA-
swa SMC4 3q26.1 0.293 0.0244 0.381 DNA Damage Response (DDR)
xai DCAF12 9p13.3 0.293 0.0244 0.381 protein ubiquitination
xsq TMEM97 17q11.2 0.29 0.0244 0.381 regulation of cell
xsq PM20D2 6q15 0.29 0.0244 0.381 metabolic process
mut OR1B1 0.29 0.0244 0.381 response to stimulus
exp COPS7B 2q37.1 0.29 0.0244 0.381 DNA Damage Response (DDR)
met PCYT1B Xp22.11 0.29 0.0244 0.381 CDP-choline
pathway;spermatogenesis
exp HNRNPA3P5 13q21.32 0.29 0.0244 0.381
xsq RPL39L 3q27 0.29 0.0244 0.381 translation;spermatogenesis
mut FBXL13 7q22.1 0.29 0.0244 0.381
exp YBX1P1 14q23.3 0.29 0.0244 0.381
mut CCDC65 12q13.12 0.29 0.0244 0.381
mda
number_amino_acid_changing_genetic_variants_present_in_either_ESP5400_or_1000G
0.29 0.0244 0.381
exp ARHGEF10L 1p36.13 -0.29 0.0244 0.381 positive regulation of Rho
xai C1QTNF2 5q33.3 -0.293 0.0244 0.381 positive regulation of
hs4 TMEM100 17q22 -0.293 0.0244 0.381
xai FBLN1 22q13.31 -0.293 0.0244 0.381 embryo
implantation;extracellular matrix organization
xai CIC 19q13.2 -0.293 0.0244 0.381 Tumor Suppressors
his PQLC2L -0.293 0.0244 0.381
hs4 TRPV4 12q24.1 -0.293 0.0244 0.381 ion transport;cell death
hs4 MIR4497 -0.293 0.0244 0.381
his NPIPA5 16p13.11 -0.293 0.0244 0.38
his ABCD2 12q12 0.293 0.0245 0.381 ABC Transporters
cop MAS1 6q25.3-q26 0.293 0.0245 0.381 cell proliferation;positive
regulation of DNA replication
xai UPF2 10p14-p13 0.293 0.0245 0.381 mRNA export from nucleus;gene
expression
xai POLR3B 12q23.3 0.293 0.0245 0.381 transcription elongation from
RNA polymerase III promoter;termination of RNA polymerase III transcription
xai MED12L 3q25.1 0.293 0.0245 0.382 regulation of transcription
xai ATF1 12q13 0.293 0.0245 0.382 positive regulation of neuron projection
development;cellular protein complex assembly
xai CD8B 2p12 0.293 0.0245 0.382 regulation of immune response;immune
response
dependent"
exp PRRT4 7q32.1 0.293 0.0245 0.382
xai LIAS 4p14 0.293 0.0245 0.382 lipoate biosynthetic process;response to
lipopolysaccharide
his PARP11 12p13.3 0.293 0.0245 0.382
xai FLJ45248 8q22.3 0.293 0.0245 0.382
hs4 PHACTR3 20q13.32-q13.33 0.293 0.0245 0.382
met SRXN1 20p13 0.29 0.0245 0.381 response to oxidative stress
exp POLA1 Xp22.1-p21.3 0.29 0.0245 0.381 DNA Damage Response (DDR);
xsq FES 15q26.1 0.29 0.0245 0.382 regulation of cell shape;positive
regulation of myeloid cell differentiation
met EIF3I 1p34.1 0.29 0.0245 0.382 gene expression;cellular protein
metabolic process
xsq CCDC77 12p13.33 0.29 0.0245 0.382
exp SPACA5 Xp11.23 0.29 0.0245 0.382
xsq MDH2 7cen-q22 0.29 0.0245 0.382 glucose metabolic process;small
exp SARDH 9q33-q34 0.29 0.0245 0.382 glycine catabolic process
xai DYNLRB1 20q11.21 -0.293 0.0245 0.382 transport;microtubule-
based movement
his IL1RL2 2q12 -0.293 0.0245 0.382 cellular defense
hs4 EXT1 8q24.11 -0.293 0.0245 0.382 axon guidance;brain
development
xai SLC35D2 9q22.32 -0.293 0.0245 0.382 Solute Carriers
xai TMEM127 2q11.2 -0.293 0.0245 0.382 negative regulation of
TOR signaling cascade;negative regulation of cell proliferation
hs4 EGFR 7p12 -0.293 0.0245 0.382 Apoptosis; Cell Signaling;
hs4 BCAM 19q13.2 -0.293 0.0245 0.381 cell-matrix adhesion;signal
transduction
his SNORD129 0.293 0.0246 0.382
his GIT1 17p11.2 0.293 0.0246 0.382 regulation of G-protein coupled
receptor protein signaling pathway;regulation of ARF GTPase activity
his ANKRD13B 17q11.2 0.293 0.0246 0.382
his MEX3B 15q25.2 0.293 0.0246 0.382 protein phosphorylation;protein
autophosphorylation
xai AFMID 17q25.3 0.292 0.0246 0.382 tryptophan catabolic
xai GEMIN2 14q13 0.292 0.0246 0.382 RNA metabolic process;ncRNA
metabolic process
xai LOC729681 6q27 0.292 0.0246 0.382
mut TMEM2 9q21.13 0.29 0.0246 0.382 multicellular organismal
development
cop MYOM1 18p11.31 0.29 0.0246 0.382 muscle contraction
met LCN2 9q34 0.29 0.0246 0.382 siderophore transport;regulation of
apoptotic process
mut COL6A3 2q37 0.29 0.0246 0.382 response to glucose stimulus;cell
adhesion
xsq CD3E 11q23 0.29 0.0246 0.382 cell surface receptor signaling
pathway;positive regulation of interleukin-4 production
exp LOC727980 0.29 0.0246 0.382
pro ISGF3G_9 0.29 0.0246 0.382
xsq PRKX Xp22.3 0.29 0.0246 0.382 cell adhesion;protein
autophosphorylation
met RAP2A 13q34 0.29 0.0246 0.382 actin cytoskeleton
reorganization;positive regulation of protein autophosphorylation
xsq LINC01150 0.29 0.0246 0.382
cop TCF7L1 2p11.2 0.29 0.0246 0.382 regulation of transcription
from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent
exp RELT 11q13.4 0.29 0.0246 0.382
exp DNAL1 14q24.3 -0.29 0.0246 0.382
exp FRMD4A 10p13 -0.29 0.0246 0.382
exp CFL2 14q12 -0.29 0.0246 0.382
exp RPS27AP8 3q26.31 -0.29 0.0246 0.382
xai DOCK7 1p31.3 -0.292 0.0246 0.382 axonogenesis;cell
differentiation
hs4 ZFP36L1 14q22-q24 -0.292 0.0246 0.382 mRNA metabolic
hs4 PRKCA 17q22-q23.2 -0.292 0.0246 0.382 Apoptosis; Protein Kinases
xai PCYOX1L 5q32 0.292 0.0247 0.382 prenylcysteine catabolic process
swa APRT 16q24 0.292 0.0247 0.382 nucleoside metabolic process;purine-
containing compound salvage
swa RRM2 2p25-p24 0.292 0.0247 0.382 DNA Damage Response (DDR)
exp SNAP25-AS1 0.292 0.0247 0.382
xai AIMP1 4q24 0.292 0.0247 0.382 glucose metabolic process;response to
wounding
his CLASP2 3p22.3 0.292 0.0247 0.382 microtubule organizing center
his LOC105379450 0.292 0.0247 0.383
xai TRIM77 11q14.3 0.292 0.0247 0.383
his COX6A1 12q24.2 0.292 0.0247 0.383 generation of precursor
metabolites and energy;respiratory electron transport chain
xai POU2AF1 11q23.1 0.292 0.0247 0.383 transcription from RNA
his IQCB1 3q13.33 0.292 0.0247 0.383 cilium assembly;photoreceptor cell
maintenance
his EAF2 3q13.33 0.292 0.0247 0.383 induction of apoptosis;negative
xai CEP135 4q12 0.292 0.0247 0.383 G2/M transition of mitotic cell
his POTEI 2q21.1 0.292 0.0247 0.383
exp MFSD13A 0.29 0.0247 0.382
xsq ZNF598 16p13.3 0.29 0.0247 0.382
exp RAVER2 1p31.3 0.29 0.0247 0.382
mut ANK2 4q25-q27 0.29 0.0247 0.382 axon guidance;signal transduction
xsq ELAC2 17p11.2 0.29 0.0247 0.382 tRNA processing
cop SERAC1 6q25.3 0.29 0.0247 0.383 GPI anchor metabolic
process;intracellular protein transport
exp ARHGAP21 10p12.1 -0.29 0.0247 0.383 signal transduction
met MIR609 -0.29 0.0247 0.382
xsq NACC2 9q34.3 -0.29 0.0247 0.382 positive regulation of cell
met CCR7 17q12-q21.2 -0.29 0.0247 0.382 positive regulation of dendritic
cell antigen processing and presentation;positive regulation of glycoprotein
exp YWHAZ 8q23.1 -0.29 0.0247 0.382 Apoptosis
xai ANKRD6 6q14.2-q16.1 -0.292 0.0247 0.383
hs4 P3H2 -0.292 0.0247 0.383 negative regulation of cell
hs4 P3H2-AS1 -0.292 0.0247 0.383
xai TLCD2 17p13.3 -0.292 0.0247 0.382
hs4 YAP1 11q13 -0.292 0.0247 0.382 Apoptosis
exp HNRNPA1P24 0.292 0.0248 0.383
swa RBBP4 1p35.1 0.292 0.0248 0.383 CenH3-containing nucleosome
his ANKRD63 0.292 0.0248 0.383
exp IFNG-AS1 0.292 0.0248 0.383
his LRRC37B 0.292 0.0248 0.383
exp RPS26P35 8q24.12 0.292 0.0248 0.383
xai RPS26P35 8q24.12 0.292 0.0248 0.383
exp IGHV7-40 0.292 0.0248 0.383
hs4 CD3E 11q23 0.292 0.0248 0.383 cell surface receptor signaling
his LYPD8 0.292 0.0248 0.383
mut CCDC151 19p13.2 0.29 0.0248 0.383
met ADCY9 16p13.3 0.29 0.0248 0.383 signal transduction;intracellular
signal transduction
xsq FPR2 19q13.3-q13.4 0.29 0.0248 0.383 G-protein coupled receptor
xsq CCT4 2p15 0.29 0.0248 0.383 protein folding;cellular protein
metabolic process
mir hsa-miR-186 0.29 0.0248 0.383
xsq MEMO1 0.29 0.0248 0.383 regulation of microtubule-based process
exp CEP135 4q12 0.29 0.0248 0.383 G2/M transition of mitotic cell
exp HSPA12A 10q26.12 -0.29 0.0248 0.383
xsq APOL1 22q13.1 -0.29 0.0248 0.383 lipoprotein metabolic
process;transport
xsq KCNIP3 2q21.1 -0.29 0.0248 0.383 behavior;sensory perception
of pain
exp DDR1 6p21.3 -0.29 0.0248 0.383 embryo implantation;skin
development
his LINC02012 -0.292 0.0248 0.383
hs4 GPRC5B 16p12 -0.292 0.0248 0.383
hs4 LNX1 4q12 -0.292 0.0248 0.383 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;protein homooligomerization
hs4 LNX1-AS2 -0.292 0.0248 0.383
xai C6orf132 6p21.1 -0.292 0.0248 0.383
hs4 SMURF1 7q22.1 -0.292 0.0248 0.383 protein
polyubiquitination;BMP signaling pathway
xai CHMP4B 20q11.22 -0.292 0.0248 0.383 protein
his LINC01075 0.292 0.0249 0.383
xai IGHV7-40 0.292 0.0249 0.383
swa PHPT1 9q34.3 0.292 0.0249 0.383 negative regulation of ATP citrate
synthase activity;protein dephosphorylation
xai EXOSC1 10q24 0.292 0.0249 0.384 mRNA metabolic
hs4 GPRIN3 4q22.1 0.292 0.0249 0.384
xai SHH 7q36 0.292 0.0249 0.384 response to hypoxia;lymphoid progenitor
xai CCBL1 9q34.11 0.292 0.0249 0.384 cellular amino acid biosynthetic
xai HNRNPKP2 2q22.1 0.292 0.0249 0.384
xai RPAP3 12q13.11 0.292 0.0249 0.384
hs4 ORAI1 12q24.31 0.292 0.0249 0.384 ion transport;blood coagulation
exp GCHFR 15q15 0.29 0.0249 0.383 negative regulation of GTP cyclohydrolase
I activity;small molecule metabolic process
met MAPRE3 2p23.3-p23.1 0.29 0.0249 0.383 cell division;cell cycle
xsq CTNNA3 10q22.2 0.29 0.0249 0.383 cell-cell adhesion
exp MCM4 8q11.2 0.289 0.0249 0.383 DDR (DNA replication)
exp NDST2 10q22 0.289 0.0249 0.383 cellular process;heparan sulfate
exp ME2 18q21 0.289 0.0249 0.383 malate metabolic process
xsq CTU2 16q24.3 0.289 0.0249 0.384 tRNA wobble uridine
cop SMCHD1 18p11.32 0.289 0.0249 0.384 inactivation of X chromosome
hs4 IL1RAP 3q28 -0.292 0.0249 0.384 signal transduction;innate
immune response
xai DKK3 11p15.2 -0.292 0.0249 0.383 negative regulation of
canonical Wnt receptor signaling pathway;negative regulation of cortisol
xai KIF1C 17p13.2 -0.292 0.0249 0.383 retrograde vesicle-mediated
transport, Golgi to ER;microtubule-based movement"
xai LRP1 12q13.3 -0.292 0.0249 0.383 multicellular organismal
xai RNA45S5 0.294 0.025 0.384
xai UTP3 4q13.3 0.292 0.025 0.384 chromatin modification;multicellular
xai ELP5 17p13.1 0.292 0.025 0.384
swa LTA4H 12q22 0.292 0.025 0.384 prostanoid metabolic process;inflammatory
response
xai NFXL1 4p12 0.292 0.025 0.384
xai KLRC3 12p13 0.292 0.025 0.384 cellular defense response
xai KIR2DL3 0.292 0.025 0.384 immune response;regulation of immune
response
xai RPS3AP25 7q21.3 0.292 0.025 0.384
xai HADHA 2p23 0.292 0.025 0.384 cellular lipid metabolic process;small molecule
metabolic process
his RPP25L 9p13.3 0.292 0.025 0.384
met GEN1 2p24.2 0.289 0.025 0.384 DNA Damage Response (DDR); DDR (HR)
exp YBX1P10 9p13.1 0.289 0.025 0.384
exp ALYREF 17q25.3 0.289 0.025 0.384 gene expression;mRNA 3'-end
processing
met DNAH3 16p12.3 0.289 0.025 0.384 ciliary or flagellar
exp TMEM145 19q13.2 0.289 0.025 0.384
xsq CD3D 11q23 0.289 0.025 0.384 T cell differentiation;T cell costimulation
exp IRAK1BP1 6q14-q15 0.289 0.025 0.384 regulation of transcription, DNA-
dependent;I-kappaB kinase/NF-kappaB cascade"
exp KRT2 12q13.13 0.289 0.025 0.384 keratinocyte proliferation;keratinocyte
migration
xsq POU5F1P3 12p13.31 0.289 0.025 0.384
met OR10G4 11q24.1 0.289 0.025 0.384 response to stimulus
met MPP3 17q21.31 0.289 0.025 0.384 signal transduction
xsq DMTN 8p21.1 -0.289 0.025 0.384
xsq ADORA2B 17p12 -0.289 0.025 0.384 activation of MAPK
exp RDX 11q23 -0.289 0.025 0.384 microvillus assembly;apical protein
localization
xsq SH3PXD2A 10q24.33 -0.289 0.025 0.384 superoxide metabolic
process;cell communication
met OPRL1 20q13.33 -0.289 0.025 0.384 elevation of cytosolic calcium ion
exp NDFIP1 5q31.3 -0.289 0.025 0.384 regulation of myeloid
leukocyte differentiation;negative regulation of T cell proliferation
exp NEDD9 6p25-p24 -0.289 0.025 0.384 regulation of growth;actin filament
bundle assembly
hs4 C8orf86 8p11.22 -0.292 0.025 0.384
xai TP53INP2 20q11.22 -0.292 0.025 0.384
xai DCLK1 13q13 -0.292 0.025 0.384 response to virus;endosome transport
xai PHLDB2 3q13.2 -0.292 0.025 0.384
his MRAS 3q22.3 -0.292 0.025 0.384 GTP catabolic process;signal
transduction
his FERMT3 11q13.1 0.292 0.0251 0.384 leukocyte cell-cell
xai CDC40 6q21 0.292 0.0251 0.384 gene expression;mRNA 3'-end processing
his GUF1 4p12 0.292 0.0251 0.385 translation
xai THUMPD1 16p12.3 0.292 0.0251 0.385
his APRT 16q24 0.291 0.0251 0.385 nucleoside metabolic process;purine-
his CASP6 4q25 0.291 0.0251 0.385 Apoptosis
hs4 GRAP2 22q13.2 0.291 0.0251 0.385 Ras protein signal
hs4 CYSLTR1 Xq13.2-q21.1 0.291 0.0251 0.385 respiratory gaseous
xai SHQ1 3p13 0.291 0.0251 0.385 ribonucleoprotein complex assembly
exp PADI4 1p36.13 0.289 0.0251 0.385 regulation of transcription, DNA-
dependent;protein modification process
exp SSRP1 11q12 0.289 0.0251 0.385 DNA replication;DNA repair
exp AARSD1 17q21.31 0.289 0.0251 0.385 translation;alanyl-tRNA
aminoacylation
exp CDC7 1p22 0.289 0.0251 0.385 DDR (DNA replication)
exp LOC402360 0.289 0.0251 0.385
xsq RNASEH2B-AS1 0.289 0.0251 0.385
xsq FAM74A4 0.289 0.0251 0.385
xsq HOXC4 12q13.3 -0.289 0.0251 0.385 regulation of transcription,
xai DNAL1 14q24.3 -0.291 0.0251 0.385
xai CLIC3 9q34.3 -0.291 0.0251 0.385 ion transport;chloride
transport
swa CSTF3 11p13 -0.291 0.0251 0.385 mRNA processing;RNA splicing
his THOC1 18p11.32 0.291 0.0252 0.385 apoptotic process;signal
transduction
xai RPL21P110 13q22.1 0.291 0.0252 0.386
xai ENOPH1 4q21.22 0.291 0.0252 0.386 sulfur amino acid metabolic
his PRB1 12p13.2 0.291 0.0252 0.386
his RWDD2B 21q22.11 0.291 0.0252 0.386
swa BUD31 7q22.1 0.291 0.0252 0.386 regulation of transcription from
xai DCAF7 17q23.3 0.291 0.0252 0.386 multicellular organismal
his MFAP1 15q15-q21 0.291 0.0252 0.386
his WDR76 15q15.3 0.291 0.0252 0.386
xai MSH6 2p16 0.291 0.0252 0.386 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xsq FBXO5 6q25.2 0.289 0.0252 0.385 G1/S transition of mitotic cell
exp MOB3A 19p13.3 0.289 0.0252 0.385
xsq AMD1 6q21 0.289 0.0252 0.385 small molecule metabolic
mut CIPC 0.289 0.0252 0.385
met TBC1D16 17q25.3 0.289 0.0252 0.386
xsq THOC3 5q35.2 0.289 0.0252 0.386 transport;RNA splicing
exp ABCB10P3 15q13.1 0.289 0.0252 0.386
xsq RELT 11q13.4 0.289 0.0252 0.386
xsq ABCB7 Xq13.3 0.289 0.0252 0.386 ABC Transporters
exp ZFPL1 11q13 -0.289 0.0252 0.386 regulation of transcription, DNA-
dependent;vesicle-mediated transport"
met PHYKPL 5q35.3 -0.289 0.0252 0.386
xai WIPI1 17q24.2 -0.291 0.0252 0.386 autophagy;activation of
signaling protein activity involved in unfolded protein response
swa SEC24A 5q31.1 -0.291 0.0252 0.386 ER to Golgi vesicle-
mediated transport;cellular membrane organization
xai DDX3X Xp11.3-p11.23 0.291 0.0253 0.386 interspecies interaction
between organisms
his NCF2 1q25 0.291 0.0253 0.386 response to lipopolysaccharide;innate
immune response
his ZNF37BP 10q11.21 0.291 0.0253 0.386
his ITPKB 1q42.13 0.291 0.0253 0.386 positive regulation of alpha-beta T
cell differentiation;MAPK cascade
his TRAIP 3p21.31 0.291 0.0253 0.386 induction of apoptosis;signal
transduction
xai LOC100507303 0.291 0.0253 0.386
his LCN15 9q34.3 0.291 0.0253 0.386 lipid metabolic process
his CLIC1 6p21.3 0.291 0.0253 0.386 transport;ion transport
his MSH5 6p21.3 0.291 0.0253 0.386 DNA Damage Response (DDR); DDR
(MMR)
his MSH5-SAPCD1 0.291 0.0253 0.386
xai ITGB2 21q22.3 0.291 0.0253 0.386 Apoptosis
xai IGHVII-40-1 0.291 0.0253 0.386
exp ILF2P2 14q13.2 0.289 0.0253 0.386
exp CX3CR1 3p21.3 0.289 0.0253 0.386 negative regulation of
xsq POM121L2 6p22.1 0.289 0.0253 0.386
mut ARL6IP5 3p14 0.289 0.0253 0.386 negative regulation of transport;L-
glutamate transport
exp SLC35D2 9q22.32 -0.289 0.0253 0.386 Solute Carriers
pro VIL2 -0.289 0.0253 0.386
exp PAK4 19q13.2 -0.289 0.0253 0.386 Protein Kinases
xsq ROR1 1p32-p31 -0.289 0.0253 0.386 transmembrane receptor
protein tyrosine kinase signaling pathway
xai GLRB 4q31.3 -0.291 0.0253 0.386 startle response;ion
hs4 RAET1L 6q25.1 -0.291 0.0253 0.386 immune response;antigen
processing and presentation
xai KDELR1 19q13.3 -0.291 0.0253 0.386 protein retention in ER
exp RPS10P16 8q24.11 0.291 0.0254 0.387
exp HNRNPKP2 2q22.1 0.291 0.0254 0.387
exp IGHVII-40-1 0.291 0.0254 0.387
his SMNDC1 10q23 0.291 0.0254 0.387 Apoptosis
his PPIAL4E 0.291 0.0254 0.387
his HSD17B4 5q21 0.291 0.0254 0.387 fatty acid metabolic process;bile
swa RUVBL1 3q21 0.291 0.0254 0.387 Apoptosis; DNA Damage Response
xai TAF12 1p35.3 0.291 0.0254 0.387 transcription from RNA polymerase
exp UBA52P3 14q23.1 0.291 0.0254 0.387
xai BRD3 9q34 0.291 0.0254 0.387
exp ING5 2q37.3 0.289 0.0254 0.387 histone H3 acetylation;positive
exp WDR36 5q22.1 0.289 0.0254 0.387 response to stimulus;rRNA
processing
exp SDHAF3 0.289 0.0254 0.387 regulation of gluconeogenesis
xsq BEND4 4p13 0.288 0.0254 0.387
met RUSC2 9p13.3 0.288 0.0254 0.387
cop TGOLN2 2p11.2 0.288 0.0254 0.387
exp RPL35 9q34.1 0.288 0.0254 0.387 viral reproduction;nuclear-
xsq CD8B 2p12 0.288 0.0254 0.387 regulation of immune response;immune
response
met POU2AF1 11q23.1 -0.288 0.0254 0.387 transcription from RNA
exp LINC01197 -0.288 0.0254 0.387
xsq RHBDL2 1p34.3 -0.288 0.0254 0.387 proteolysis
xsq GSN 9q33 -0.288 0.0254 0.387 cell projection
organization;response to folic acid
swa SEC61B 9q22.32-q31.3 -0.291 0.0254 0.387 translation;SRP-
dependent cotranslational protein targeting to membrane
hs4 BAIAP2L1 7q22.1 -0.291 0.0254 0.387 response to
bacterium;positive regulation of actin filament polymerization
his SCHIP1 3q25.32-q25.33 -0.291 0.0254 0.387
his MIR6736 -0.291 0.0254 0.387
hs4 GNG11 7q21 -0.291 0.0254 0.387 GTP catabolic process;signal
transduction
xai XRCC6P3 1q41 0.291 0.0255 0.387
exp LINC01122 0.291 0.0255 0.387
xai GALNT8 12p13.3 0.291 0.0255 0.387 cellular protein metabolic
his ZC3H12D 6q25.1 0.291 0.0255 0.387 negative regulation of cell
xai IFNG 12q14 0.291 0.0255 0.387 negative regulation of mesenchymal to
epithelial transition involved in metanephros morphogenesis;cytokine-mediated
signaling pathway
his THOC2 Xq25-q26.3 0.291 0.0255 0.388 mRNA export from nucleus;transport
xai UBA52P3 14q23.1 0.291 0.0255 0.388
xsq TTC4 1p32.3 0.288 0.0255 0.387
met PTPN20 0.288 0.0255 0.387
met PTPN20A 0.288 0.0255 0.387
exp POLR1A 2p11.2 0.288 0.0255 0.387 transcription initiation from
met TMEM263 0.288 0.0255 0.388
exp HSH2D 19p13.12 0.288 0.0255 0.388 T cell activation
exp LOC100507600 0.288 0.0255 0.388
exp DNAJB2 2q32-q34 -0.288 0.0255 0.388 response to unfolded
protein;negative regulation of cell proliferation
xsq LOC102546298 -0.288 0.0255 0.387
exp ZNF528 19q13 -0.288 0.0255 0.387 regulation of transcription,
DNA-dependent"
xsq ABL2 1q25.2 -0.288 0.0255 0.387 signal transduction;cellular
met UQCRH 1p34.1 -0.288 0.0255 0.387
xai HOXC4 12q13.3 -0.291 0.0255 0.388 regulation of transcription,
hs4 OLFML3 1p13.2 -0.291 0.0255 0.388 multicellular organismal
development
xai EGLN1 1q42.1 -0.291 0.0255 0.387 heart trabecula
xai EML3 11q12.3 0.291 0.0256 0.388
xai TCEANC2 1p32.3 0.291 0.0256 0.388 transcription, DNA-dependent"
hs4 CEBPE 14q11.2 0.291 0.0256 0.388 cellular response to
his HNRNPD 4q21 0.291 0.0256 0.388 RNA processing;RNA catabolic
process
xai TTC5 14q11.2 0.291 0.0256 0.388 DNA repair
xai IGHMBP2 11q13.3 0.291 0.0256 0.388 DNA Damage Response (DDR)
swa COIL 17q22 0.291 0.0256 0.388 oxidation-reduction process
his PIK3CG 7q22.3 0.291 0.0256 0.388 Apoptosis; Cell Signaling;
hs4 FAM226B 0.291 0.0256 0.388
hs4 JSRP1 19p13.3 0.291 0.0256 0.388
his MRFAP1 4p16.1 0.29 0.0256 0.388
xai RNF169 11q13.4 0.29 0.0256 0.388
exp HSPA8P1 Xq24 0.29 0.0256 0.388
hs4 MIR4526 0.29 0.0256 0.388
met C14orf93 14q11.2 0.288 0.0256 0.388
xsq LNP1 3q12.2 0.288 0.0256 0.388
xsq PARP1 1q41-q42 0.288 0.0256 0.388 Apoptosis; DNA Damage Response
(DDR); DDR (BER)
xsq TRIT1 1p34.2 0.288 0.0256 0.388 tRNA processing
exp NAE1 16q22 0.288 0.0256 0.388 Apoptosis
xsq EEF1B2 2q33.3 0.288 0.0256 0.388 translational elongation;gene
expression
xsq TUBD1 17q23.1 0.288 0.0256 0.388 protein polymerization;microtubule-
based movement
xsq OR2T1 1q44 0.288 0.0256 0.388 response to stimulus
exp SKAP2 7p15.2 -0.288 0.0256 0.388 negative regulation of cell
exp LINC00472 6q13 -0.288 0.0256 0.388
xsq HIF1A 14q23.2 -0.288 0.0256 0.388 Protein Kinases
exp DOCK7 1p31.3 -0.288 0.0256 0.388 axonogenesis;cell
differentiation
xai ARHGAP40 20q11.23 -0.29 0.0256 0.388 signal transduction;small
xai CXXC5 5q31.2 -0.29 0.0256 0.388 signal transduction;positive
his FHL2 2q12.2 -0.29 0.0256 0.388 negative regulation of
development
hs4 ZCCHC14 16q24.2 -0.291 0.0256 0.388 cell communication
hs4 LOC101928737 -0.291 0.0256 0.388
hs4 DCLK1 13q13 -0.291 0.0256 0.388 response to virus;endosome
transport
xai LOC553103 -0.291 0.0256 0.388
xai FKBP4P1 4q26 0.29 0.0257 0.388
his CACNA2D4 12p13.33 0.29 0.0257 0.388 ion transport
his TUBGCP4 15q15 0.29 0.0257 0.388 G2/M transition of mitotic cell
his HEXDC 17q25.3 0.29 0.0257 0.388 carbohydrate metabolic process
his OGFOD3 17q25.3 0.29 0.0257 0.388
xai MFSD13A 0.29 0.0257 0.388
xai WDR36 5q22.1 0.29 0.0257 0.389 response to stimulus;rRNA
processing
his ICK 6p12.1 0.29 0.0257 0.389 multicellular organismal
development;protein phosphorylation
his FBXO9 6p12.3-p11.2 0.29 0.0257 0.389 protein ubiquitination
xai TUBD1 17q23.1 0.29 0.0257 0.389 protein polymerization;microtubule-
based movement
xai RNU6ATAC3P 17q21.32 0.29 0.0257 0.389
xsq ARMC12 6p21.31 0.288 0.0257 0.388
xsq SCARNA12 0.288 0.0257 0.388
xsq PRMT5 14q11.2 0.288 0.0257 0.388 regulation of transcription, DNA-
xsq SSBP4 19p13.1 0.288 0.0257 0.388
exp BRCA1 17q21 0.288 0.0257 0.389 Apoptosis; DNA Damage Response (DDR); DDR
exp NTHL1 16p13.3 0.288 0.0257 0.389 DNA Damage Response (DDR); DDR
(BER)
met CARD10 22q13.1 0.288 0.0257 0.389 protein complex
exp THRB 3p24.2 -0.288 0.0257 0.388 regulation of transcription,
DNA-dependent;gene expression
xsq PPP1R3C 10q23-q24 -0.288 0.0257 0.388 carbohydrate metabolic
process;regulation of glycogen biosynthetic process
exp RAB18 10p12.1 -0.288 0.0257 0.388 protein transport;eye
development
swa M6PR 12p13 -0.29 0.0257 0.389 transport;receptor-mediated endocytosis
hs4 STXBP6 14q12 -0.29 0.0257 0.389 vesicle-mediated transport
hs4 LOC100506885 -0.29 0.0257 0.388
xai FAM57A 17p13.3 -0.29 0.0257 0.388
his LOXL4 10q24 -0.29 0.0257 0.388
his KANSL2 12q13.11 0.29 0.0258 0.389 histone H4-K5
acetylation;histone H4-K8 acetylation
exp RNU6ATAC3P 17q21.32 0.29 0.0258 0.389
his WNT8A 5q31 0.29 0.0258 0.389 polarity specification of
anterior/posterior axis;response to retinoic acid
his FAM172BP 3q12.3 0.29 0.0258 0.389
his MTRNR2L2 0.29 0.0258 0.389
his MSH3 5q11-q12 0.29 0.0258 0.389 DNA Damage Response (DDR); DDR
(MMR)
his DHFR 5q11.2-q13.2 0.29 0.0258 0.389
xai NT5M 17p11.2 0.29 0.0258 0.389 small molecule metabolic
his IL6R 1q21 0.29 0.0258 0.389 positive regulation of cell
proliferation;positive regulation of chemokine production
xai L2HGDH 14q21.3 0.29 0.0258 0.389 cellular protein metabolic
xsq ING5 2q37.3 0.288 0.0258 0.389 histone H3 acetylation;positive
xsq FBRSL1 12q24.33 0.288 0.0258 0.389
xsq TAF12 1p35.3 0.288 0.0258 0.389 transcription from RNA polymerase
exp BLVRA 7p13 -0.288 0.0258 0.389 porphyrin-containing compound
metabolic process;heme catabolic process
exp ANXA5 4q27 -0.288 0.0258 0.389 Apoptosis
xai SH3RF1 4q32.3 -0.29 0.0258 0.39 induction of
apoptosis;negative regulation of apoptotic process
hs4 CDC42BPB 14q32.3 -0.29 0.0258 0.389 Protein Kinases
his LOC101927623 -0.29 0.0258 0.389
his TNS1 2q35-q36 -0.29 0.0258 0.389 cell-substrate junction
hs4 BDKRB2 14q32.1-q32.2 -0.29 0.0258 0.389 inflammatory
swa CNOT1 16q21 0.29 0.0259 0.39 nuclear-transcribed mRNA catabolic
shortening
exp RNA45S5 0.29 0.0259 0.39
xai QTRTD1 3q13.31 0.29 0.0259 0.39 queuosine biosynthetic
process
his DMXL2 15q21.2 0.29 0.0259 0.39
swa AIMP1 4q24 0.29 0.0259 0.39 glucose metabolic process;response to
wounding
xai FAM60A 12p11 0.29 0.0259 0.39
exp KDM1A 1p36.12 0.288 0.0259 0.39 negative regulation of protein
exp RPS15 19p13.3 0.288 0.0259 0.39 ribosomal small subunit export from
nucleus;gene expression
xsq AOX2P 2q33.1 0.288 0.0259 0.39
exp CETN3 5q14.3 0.288 0.0259 0.39 centrosome cycle;cell division
xsq PMS2P1 7q22.1 0.288 0.0259 0.39 ATP catabolic
process;mismatch repair
mut NTF3 12p13 0.288 0.0259 0.39 neuromuscular synaptic
transmission;mechanoreceptor differentiation
exp BSN 3p21.31 0.287 0.0259 0.39 synaptic transmission
xsq MCF2L2 3q27.1 0.287 0.0259 0.39 regulation of Rho protein
signal transduction
exp GLMN 1p22.1 0.287 0.0259 0.39 muscle cell
xsq FRMD4A 10p13 -0.288 0.0259 0.39
xai THRB 3p24.2 -0.29 0.0259 0.39 regulation of transcription, DNA-
dependent;gene expression
hs4 PPFIA4 1q32.1 -0.29 0.0259 0.39 cell communication
dependent"
xai MAGEB2 Xp21.3 0.29 0.026 0.391
swa EIF3H 8q24.11 0.29 0.026 0.391 translation;translational initiation
xai BTK Xq21.33-q22 0.29 0.026 0.391 regulation of transcription, DNA-
xai MCMBP 10q26.11 0.29 0.026 0.391 sister chromatid cohesion;mitosis
xai RHOT1P2 0.29 0.026 0.391
xai RPL13P 6p21 0.29 0.026 0.391
exp RHOT1P2 0.29 0.026 0.391
xai XRN2 20p11.2-p11.1 0.29 0.026 0.391 RNA processing;mRNA processing
xai ZNF598 16p13.3 0.29 0.026 0.391
hs4 HSD17B11 4q22.1 0.29 0.026 0.391 steroid biosynthetic
xsq CEP135 4q12 0.287 0.026 0.39 G2/M transition of mitotic cell
met YIF1A 11q13 0.287 0.026 0.391 activation of signaling protein activity
involved in unfolded protein response;protein transport
xsq ACSM4 12p13.31 0.287 0.026 0.391
exp PNO1 2p14 0.287 0.026 0.391
exp HSF2 6q22.31 0.287 0.026 0.391 regulation of transcription, DNA-
xsq TERF2IP 16q23.1 0.287 0.026 0.391 DNA Damage Response (DDR)
xsq HAUS8 19p13.11 0.287 0.026 0.391 cell cycle;mitosis
mut MAGEE2 Xq13.3 0.287 0.026 0.391
exp ANAPC10 4q31 0.287 0.026 0.391 G2/M transition of mitotic cell
cycle;anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein
catabolic process
exp FAM213A 10q23.1 -0.287 0.026 0.391 regulation of osteoclast
exp DKK3 11p15.2 -0.287 0.026 0.39 negative regulation of canonical
Wnt receptor signaling pathway;negative regulation of cortisol biosynthetic process
exp YIPF5 5q31.3 -0.287 0.026 0.39 protein transport;vesicle-mediated
transport
hs4 SLC1A1 9p24 -0.29 0.026 0.391 Solute Carriers
swa CDH2 18q11.2 -0.29 0.026 0.391 homophilic cell adhesion;adherens
xai SKAP2 7p15.2 -0.29 0.026 0.391 negative regulation of cell
hs4 IL11RA 9p13 -0.29 0.026 0.391 signal transduction;developmental process
xai NPM1P18 7p14.2 0.29 0.0261 0.391
his LYRM7 5q23.3 0.29 0.0261 0.391
xai KAT8 16p11.2 0.29 0.0261 0.391 histone H4-K16 acetylation;negative
his BRD8 5q31 0.29 0.0261 0.391 histone H4 acetylation;histone H2A
acetylation
his KIF20A 5q31 0.29 0.0261 0.391 microtubule bundle
formation;microtubule-based movement
hs4 SHISA3 4p13 0.29 0.0261 0.391 multicellular organismal
development
xai RCOR1 14q32.31 0.29 0.0261 0.391 interspecies interaction between
his LINC01922 0.29 0.0261 0.391
exp XRCC6P3 1q41 0.29 0.0261 0.391
xai NOM1 7q36.3 0.29 0.0261 0.391 RNA metabolic process
hs4 DLK1 14q32 0.29 0.0261 0.391 multicellular organismal
xai IGJP1 8q21.2 0.29 0.0261 0.391
xsq CES4A 16q22.1 0.287 0.0261 0.391
met SHC2 19p13.3 0.287 0.0261 0.391 insulin receptor signaling
pathway;intracellular signal transduction
exp LINC00342 0.287 0.0261 0.391
mir hsa-miR-330-3p 0.287 0.0261 0.391
exp P2RY10 Xq21.1 0.287 0.0261 0.391
xsq DLGAP3 1p35.3-p34.1 0.287 0.0261 0.391 cell-cell signaling
xsq RASSF1 3p21.3 0.287 0.0261 0.391 positive regulation of
mut MUC4 3q29 0.287 0.0261 0.391 cell adhesion;cell-matrix adhesion
exp GPHN 14q23.3 0.287 0.0261 0.391 vitamin metabolic process;water-
exp FAM50A Xq28 -0.287 0.0261 0.391 spermatogenesis
exp ANKRD6 6q14.2-q16.1 -0.287 0.0261 0.391
met BTLA 3q13.2 -0.287 0.0261 0.391 T cell costimulation
xsq LOXL4 10q24 -0.287 0.0261 0.391
exp PCGF5 10q23.32 -0.287 0.0261 0.391 regulation of transcription,
DNA-dependent"
his PDLIM4 5q31.1 -0.29 0.0261 0.391
his MIR938 -0.29 0.0261 0.391
hs4 SNX21 20q13.12 -0.29 0.0261 0.391 cell communication;protein
transport
xai LOC646730 3q23 -0.29 0.0261 0.391
xai LOXL4 10q24 -0.29 0.0261 0.391
his NAV2 11p15.1 -0.29 0.0261 0.391
his LOC100126784 11p15.1 -0.29 0.0261 0.391
xai CYP27B1 12q14.1 0.289 0.0262 0.391 negative regulation of
xai WDR17 4q34 0.289 0.0262 0.391
xai RBM28 7q32.1 0.289 0.0262 0.391 mRNA processing;RNA splicing
his NME4 16p13.3 0.289 0.0262 0.391 CTP biosynthetic process;nucleoside
metabolic process
his DECR2 16p13.3 0.289 0.0262 0.391 unsaturated fatty acid biosynthetic
process
xai DNAJC7 17q11.2 0.289 0.0262 0.392 protein folding;chaperone
xai LAX1 1q32.1 0.289 0.0262 0.392 negative regulation of T cell
xai CD33 19q13.3 0.289 0.0262 0.392 cell adhesion;signal transduction
his DDX43 6q13 0.289 0.0262 0.392
xai LSM6 4q31.22 0.289 0.0262 0.392 mRNA processing;tRNA processing
his LOC642846 12p13.31 0.289 0.0262 0.392
exp RPLP1P7 5q23.2 0.287 0.0262 0.391
met CACNA1D 3p14.3 0.287 0.0262 0.391 regulation of calcium ion
transport via voltage-gated calcium channel activity;transmembrane transport
met TMEM242 6q25.3 0.287 0.0262 0.391
exp DCAF17 2q31.1 0.287 0.0262 0.391 protein ubiquitination
xsq HSP90AB1 6p12 0.287 0.0262 0.392 Apoptosis
met DOCK9 13q32.3 0.287 0.0262 0.392 blood coagulation
met C7orf57 7p12.3 0.287 0.0262 0.392
xsq PUSL1 1p36.33 0.287 0.0262 0.392 pseudouridine synthesis;tRNA
processing
exp DUSP3 17q21 -0.287 0.0262 0.392 toll-like receptor 2 signaling
xsq FAM213A 10q23.1 -0.287 0.0262 0.392 regulation of osteoclast
exp RNF144B 6p22.3 -0.287 0.0262 0.391 apoptotic
process
his MBOAT2 2p25.1 -0.289 0.0262 0.392 phospholipid
his SLC1A7 1p32.3 -0.289 0.0262 0.392 Solute Carriers
his ADGRG1 -0.289 0.0262 0.392 cell adhesion;G-protein
xai TTC16 9q34.11 0.289 0.0263 0.392
xai ORAI1 12q24.31 0.289 0.0263 0.392 ion transport;blood coagulation
xai PPM1L 3q26.1 0.289 0.0263 0.392 small molecule metabolic
process;MAPK cascade
xai HCG27 6p21.33 0.289 0.0263 0.392
his MIR3187 0.289 0.0263 0.392
his ITGB1BP1 2p25.2 0.289 0.0263 0.392 intracellular protein kinase
cascade;cell migration
his CPSF3 2p25.1 0.289 0.0263 0.392 nuclear mRNA splicing, via
exp RPS3AP25 7q21.3 0.289 0.0263 0.392
xai C2orf48 2p25.1 0.289 0.0263 0.392
xai COX11 17q22 0.289 0.0263 0.392 respiratory gaseous exchange;respiratory
xai NUDT6 4q26 0.289 0.0263 0.392
hs4 MIR770 0.289 0.0263 0.392
xai NMD3P1 7q11.21 0.289 0.0263 0.392
his HELQ 4q21.23 0.289 0.0263 0.392 DNA Damage Response (DDR); DDR (FA)
his MRPS18C 4q21.23 0.289 0.0263 0.392 translation
his XRCC3 14q32.3 0.289 0.0263 0.392 DNA Damage Response (DDR); DDR
(NHEJ)
his ZFYVE21 14q32.33 0.289 0.0263 0.392
his CNOT10 3p22.3 0.289 0.0263 0.392 nuclear-transcribed mRNA
tail shortening
xsq NME8 7p14.1 0.287 0.0263 0.392
met GLOD5 Xp11.23 0.287 0.0263 0.392
xsq BIK 22q13.31 0.287 0.0263 0.392 Apoptosis
xsq C15orf61 15q23 0.287 0.0263 0.392
met CYP2J2 1p31.3-p31.2 0.287 0.0263 0.392 xenobiotic metabolic
process;regulation of heart contraction
met SPOPL 2q22.1 0.287 0.0263 0.392
xsq PAAF1 11q13.4 0.287 0.0263 0.392 interspecies interaction between
organisms
cop ACY3 11q13.2 0.287 0.0263 0.392 metabolic process;interspecies
exp ATP6V1H 8q11.2 -0.287 0.0263 0.392 ion
exp LOC729770 2q36.1 -0.289 0.0263 0.392
xai LOC285692 5p15.31 -0.289 0.0263 0.392
hs4 PLCB4 20p12 -0.289 0.0263 0.392 lipid metabolic process;lipid
catabolic process
xai OSBPL3 7p15 -0.289 0.0263 0.392 transport;lipid transport
his RASSF5 1q32.1 -0.289 0.0263 0.392 Apoptosis
exp ACER1 19p13.3 -0.289 0.0263 0.392 sphingolipid metabolic
process;regulation of lipid metabolic process
xai LINC01122 0.289 0.0264 0.392
xai MTIF2 2p16.1 0.289 0.0264 0.392 translation;regulation of
his GIPR 19q13.3 0.289 0.0264 0.392 desensitization of G-protein
coupled receptor protein signaling pathway;positive regulation of cAMP biosynthetic
process
his GMNN 6p22.3 0.289 0.0264 0.392 DDR (DNA replication)
xai CWC22 2q31.3 0.289 0.0264 0.392 nuclear mRNA splicing, via
his MRPL42 12q22 0.289 0.0264 0.393 translation
xai IL10RA 11q23 0.289 0.0264 0.393 signal transduction
hs4 CNR2 1p36.11 0.289 0.0264 0.393 negative regulation of mast cell
his C17orf102 17q12 0.289 0.0264 0.393
his TMEM132E 17q12 0.289 0.0264 0.393
xai RPS12 6q23.2 0.289 0.0264 0.393 SRP-dependent cotranslational
his BTBD8 1p22.1 0.289 0.0264 0.393
xsq LINC01088 0.287 0.0264 0.392
dependent"
xsq NUDT21 16q12.2 0.287 0.0264 0.392 RNA splicing;gene expression
xsq EMG1 12p13.3 0.287 0.0264 0.392 rRNA processing;ribosomal small
subunit biogenesis
exp PINLYP 19q13.31 0.287 0.0264 0.392
xsq MPV17L2 19p13.11 0.287 0.0264 0.393
xsq CEP192 18p11.21 0.287 0.0264 0.393 G2/M transition of mitotic
exp KIF1C 17p13.2 -0.287 0.0264 0.392 retrograde vesicle-mediated
exp SEMA3B 3p21.3 -0.287 0.0264 0.392 axon guidance;cell-cell
signaling
xsq FGFR2 10q26 -0.287 0.0264 0.392 Cell Signaling; Oncogenes; Protein
Kinases
hs4 GRIK4 11q22.3 -0.289 0.0264 0.393 transport;ion transport
xai TGFBI 5q31 -0.289 0.0264 0.393 visual perception;cell
proliferation
xai JDP2 14q24.3 -0.289 0.0264 0.392 negative regulation of
his WWC2-AS2 4q35.1 -0.289 0.0264 0.392
his WWC2 4q35.1 -0.289 0.0264 0.392
hs4 CFAP69 -0.289 0.0264 0.392
xai DNAJB2 2q32-q34 -0.289 0.0264 0.392 response to unfolded
hs4 ADAM22 7q21 0.289 0.0265 0.393 proteolysis;negative regulation of
cell adhesion
his RBFA 18q23 0.289 0.0265 0.393 rRNA processing
xai IL27RA 19p13.11 0.289 0.0265 0.393 cell surface receptor
xai MKS1 17q22 0.289 0.0265 0.393 cilium morphogenesis;cell projection
organization
xai GIT1 17p11.2 0.289 0.0265 0.393 regulation of G-protein coupled
his UCP2 11q13 0.289 0.0265 0.393 transport;small molecule metabolic
process
xai RPS4XP12 11q23.3 0.289 0.0265 0.393
hs4 CCND2-AS1 0.289 0.0265 0.393
hs4 CCND2 12p13 0.289 0.0265 0.393 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
xai RPL36P16 19q13.2 0.289 0.0265 0.393
hs4 CCDC63 12q24.11 0.289 0.0265 0.393
exp RPS4XP12 11q23.3 0.289 0.0265 0.393
hs4 PIK3CD 1p36.2 0.289 0.0265 0.393 Oncogenes; Protein Kinases
hs4 PIK3CD-AS1 0.289 0.0265 0.393
xai FAM153A 5q35.3 0.289 0.0265 0.393
exp RPL3P5 2q37.3 0.287 0.0265 0.393
xsq NDST3 4q26 0.287 0.0265 0.393
met FOXO3 6q21 0.287 0.0265 0.393 Apoptosis
exp RPL32P17 0.286 0.0265 0.393
met DHRS11 17q12 0.286 0.0265 0.393
xsq TEX15 8p12 0.286 0.0265 0.393 regulation of double-strand break repair
via homologous recombination;male genitalia development
exp NRROS 3q29 0.286 0.0265 0.393
xsq SRSF1 17q22 0.286 0.0265 0.393 transcription from RNA polymerase II
xsq DDX11L10 0.286 0.0265 0.393
xsq SH3RF2 5q32 -0.286 0.0265 0.393 negative regulation of
xai LOXL1 15q22 -0.289 0.0265 0.393 protein deamination;oxidation-
reduction process
hs4 CLDN16 3q28 -0.289 0.0265 0.393 cellular metal ion
homeostasis;excretion
xai MLPH 2q37.3 -0.289 0.0265 0.393 intracellular protein
transport
xai GNG11 7q21 -0.289 0.0265 0.393 GTP catabolic process;signal
transduction
xai MRPL9 1q21 0.289 0.0266 0.393 translation
xai DYRK4 12p13.32 0.289 0.0266 0.393 protein phosphorylation
his COPS9 0.289 0.0266 0.394
xai NLRP11 19q13.43 0.289 0.0266 0.394 oxidation-reduction process
xai CES4A 16q22.1 0.289 0.0266 0.394
xai CHAT 10q11.2 0.289 0.0266 0.394 synaptic transmission;adult walking
behavior
his NUP37 12q23.2 0.289 0.0266 0.394 mitotic cell cycle;cytokine-
his PARPBP 12q23.2 0.289 0.0266 0.394 DNA Damage Response (DDR)
his PRKCB 16p11.2 0.289 0.0266 0.394 Protein Kinases
exp SNORA2B 0.289 0.0266 0.394
met FBXL13 7q22.1 0.286 0.0266 0.393
exp CFDP1 16q22.2-q22.3 0.286 0.0266 0.394 regulation of cell
proliferation;anti-apoptosis
xsq SYT9 11p15.4 0.286 0.0266 0.394 regulation of calcium ion-dependent
exocytosis;regulation of insulin secretion
exp SNORA70 0.286 0.0266 0.394
met CARS 11p15.5 0.286 0.0266 0.394 tRNA aminoacylation for protein
translation;cysteinyl-tRNA aminoacylation
xsq COMMD3-BMI1 0.286 0.0266 0.394
xsq TM4SF1 3q21-q25 -0.286 0.0266 0.394
exp MFSD7 4p16.3 -0.286 0.0266 0.394 transmembrane transport
xsq IL12A 3q25.33 -0.286 0.0266 0.394 cell cycle arrest;positive
regulation of smooth muscle cell apoptosis
exp HOXB3 17q21.3 -0.286 0.0266 0.394 multicellular organismal
his SRGAP3-AS3 3p25.3 -0.289 0.0266 0.394
his SASH1 6q24.3 -0.289 0.0266 0.394
exp SNX18P2 9q22.31 -0.289 0.0266 0.393
xai SNORA2B 0.289 0.0267 0.394
his TEX22 14q32.33 0.289 0.0267 0.394
xai RPL31P49 12q24.11 0.289 0.0267 0.394
his GALK1 17q24 0.288 0.0267 0.394 small molecule metabolic
process;carbohydrate phosphorylation
xai CDC7 1p22 0.288 0.0267 0.394 DDR (DNA replication)
DNA-dependent;viral reproduction"
his CCR3 3p21.3 0.288 0.0267 0.394 cellular defense response;cell
adhesion
his GPAM 10q25.2 0.288 0.0267 0.394 response to glucose
stimulus;positive regulation of activated T cell proliferation
xsq SUPT16H 14q11.2 0.286 0.0267 0.394 transcription from RNA
met PEA15 1q21.1 0.286 0.0267 0.394 transport;anti-apoptosis
exp LOC100505797 0.286 0.0267 0.394
exp FECH 18q21.3 0.286 0.0267 0.394 generation of precursor metabolites
exp COX7A2P2 4q22.3 0.286 0.0267 0.394
exp L3MBTL2 22q13.31-q13.33 0.286 0.0267 0.394 regulation of
transcription, DNA-dependent;chromatin modification"
xsq PADI4 1p36.13 0.286 0.0267 0.394 regulation of transcription, DNA-
xsq HAUS4 14q11.2 0.286 0.0267 0.394 cell cycle;mitosis
DNA-dependent"
exp ARL6IP6 2q23.3 0.286 0.0267 0.394
met E2F5 8q21.2 0.286 0.0267 0.394 G1 phase of mitotic cell
exp PLEKHF1 19q12 -0.286 0.0267 0.394 apoptotic process
met GRXCR2 5q32 -0.286 0.0267 0.394
hs4 PNPLA3 22q13.31 -0.288 0.0267 0.394 triglyceride catabolic
hs4 MIR5702 -0.289 0.0267 0.394
hs4 SLC2A2 3q26.1-q26.2 -0.289 0.0267 0.394 Solute Carriers
his SEC11C 18q21.32 0.288 0.0268 0.395 small molecule metabolic
xai KMT5A 0.288 0.0268 0.395 negative regulation of transcription,
DNA-dependent;negative regulation of transcription from RNA polymerase II promoter
xai ELAC2 17p11.2 0.288 0.0268 0.395 tRNA processing
his RPS24 10q22 0.288 0.0268 0.395 translation;mRNA metabolic process
his FOCAD 9p21 0.288 0.0268 0.395
xai TFEC 7q31.2 0.288 0.0268 0.395 regulation of transcription, DNA-
exp DDB1 11q12-q13 0.286 0.0268 0.395 DNA Damage Response (DDR); DDR
xsq LOC100132781 0.286 0.0268 0.395
xsq DDX18 2q14.1 0.286 0.0268 0.395
xsq FCAR 19q13.42 0.286 0.0268 0.395 immune response
exp NUS1 6q22.1 0.286 0.0268 0.395 cell differentiation;angiogenesis
exp TAF12 1p35.3 0.286 0.0268 0.395 transcription from RNA polymerase
exp RBM28 7q32.1 0.286 0.0268 0.395 mRNA processing;RNA splicing
met FAM84B 8q24.21 0.286 0.0268 0.395
xsq SAFB2 19p13.3 0.286 0.0268 0.395 regulation of transcription, DNA-
dependent"
hs4 POU3F1 1p34.1 -0.288 0.0268 0.395 myelination in
peripheral nervous system;keratinocyte differentiation
swa APOH 17q24.2 -0.288 0.0268 0.395 positive regulation of blood
coagulation;regulation of fibrinolysis
xai RDX 11q23 -0.288 0.0268 0.395 microvillus assembly;apical protein
localization
his GINS1 20p11.21 0.288 0.0269 0.395 DDR (DNA replication)
xai CARD8 19q13.33 0.288 0.0269 0.395 activation of cysteine-type
process
xai FBXL14 12p13.33 0.288 0.0269 0.396 protein ubiquitination
his GIMAP8 7q36.1 0.288 0.0269 0.396
his MIR9-3 0.288 0.0269 0.396
xai DDX55 12q24.31 0.288 0.0269 0.396
xai THOP1 19p13.3 0.288 0.0269 0.396 proteolysis
his RPS19 19q13.2 0.288 0.0269 0.396 translation;viral reproduction
his MIR6797 0.288 0.0269 0.396
his CD79A 19q13.2 0.288 0.0269 0.396 B cell differentiation;B cell
proliferation
his LOC200772 0.288 0.0269 0.396
his ZCCHC4 4p15.2 0.288 0.0269 0.396
exp XRN2 20p11.2-p11.1 0.286 0.0269 0.395 RNA processing;mRNA
processing
exp RPL29P30 15q23 0.286 0.0269 0.395
exp MAGEB2 Xp21.3 0.286 0.0269 0.396
exp HIST2H4B 0.286 0.0269 0.396 nucleosome assembly;CenH3-
met CFI 4q25 0.286 0.0269 0.396 complement activation, classical
xsq ZMYND19 9q34.3 0.286 0.0269 0.396
xsq CACNA1B 9q34 0.286 0.0269 0.396 transmembrane transport;transport
met ASB8 12q13.11 -0.286 0.0269 0.396 intracellular signal
transduction
his LOC102724357 -0.288 0.0269 0.396
xai FGFR2 10q26 -0.288 0.0269 0.396 Cell Signaling; Oncogenes; Protein
Kinases
hs4 DMPK 19q13.3 0.288 0.027 0.396 regulation of excitatory postsynaptic
membrane potential involved in skeletal muscle contraction;regulation of sodium ion
transport
his ATP5A1 18q21 0.288 0.027 0.396 lipid metabolic process;small molecule
metabolic process
exp TPI1P3 6q22.1 0.288 0.027 0.396
his MIR4519 0.288 0.027 0.396
his MIR762HG 0.288 0.027 0.396
his SASS6 1p21.2 0.288 0.027 0.396 cell cycle;centriole replication
his TRMT13 1p21.2 0.288 0.027 0.396
his GALNTL6 4q34.1 0.288 0.027 0.396
his LOC441052 4q34.1 0.288 0.027 0.396
xai C1orf191 0.288 0.027 0.396
his NEMP1 0.288 0.027 0.396
exp SSB 2q31.1 0.288 0.027 0.396 RNA processing;tRNA modification
xsq CD1A 1q23.1 0.286 0.027 0.396 immune response;antigen processing and
presentation
xsq CHD1L 1q12 0.286 0.027 0.396 ATP catabolic process;DNA repair
exp DIMT1 5q12.1 0.286 0.027 0.396
xsq CD300LF 17q25.1 0.286 0.027 0.396
exp SH3RF1 4q32.3 -0.285 0.027 0.396 induction of
xsq AJUBA 14q11.2 -0.286 0.027 0.396 Cell Signaling
exp PICALM 11q14 -0.286 0.027 0.396 vesicle-mediated transport;clathrin
coat assembly
exp CCDC80 3q13.2 -0.286 0.027 0.396 positive regulation of cell-
hs4 PDGFC 4q32 -0.288 0.027 0.396 positive regulation of DNA
his LINC01139 -0.288 0.027 0.396
hs4 MFSD2B 2p23.3 -0.288 0.027 0.396 transport
hs4 LOC100652768 -0.288 0.027 0.396
hs4 TAGLN 11q23.2 -0.288 0.027 0.396 muscle organ development
swa PPP1R13L 19q13.32 -0.288 0.027 0.396 apoptotic process;post-
his TGFB2 1q41 -0.288 0.027 0.396 Apoptosis
his TGFB2-AS1 -0.288 0.027 0.396
hs4 LOC100289333 19p13.2 -0.288 0.027 0.396
his LINC01628 -0.288 0.027 0.396
hs4 GPCPD1 20p12.3 0.288 0.0271 0.396 glycerol metabolic
xai EIF4BP3 9q22.32 0.288 0.0271 0.396
his KIAA1324L 7q21.12 0.288 0.0271 0.396
xai CD3E 11q23 0.288 0.0271 0.397 cell surface receptor signaling
his SLC39A8 4q22-q24 0.288 0.0271 0.397 Solute Carriers
his TCAIM 3p21.31 0.288 0.0271 0.397
his CDK5RAP1 20q11.21 0.288 0.0271 0.397 tRNA modification;brain
development
xai ESCO1 18q11.2 0.288 0.0271 0.397 regulation of DNA replication;cell
cycle
his COX5A 15q24.1 0.288 0.0271 0.397 small molecule metabolic
exp GAPDHP40 5q33.3 0.288 0.0271 0.397
xai ELP6 3p21.31 0.288 0.0271 0.397
his AIF1 6p21.3 0.288 0.0271 0.397 positive regulation of muscle
his METTL21A 2q33.3 0.288 0.0271 0.397
xai CDC6 17q21.3 0.288 0.0271 0.397 DDR (DNA replication)
swa OSTF1 9q13-q21.2 0.288 0.0271 0.397 ossification;signal transduction
xsq GPR68 14q31 0.285 0.0271 0.396 inflammatory response;G-protein coupled
exp HNRNPA3P1 10q11.21 0.285 0.0271 0.397
xsq HAL 12q22-q24.1 0.285 0.0271 0.397 histidine catabolic
xsq PSMD5-AS1 9q33.2 0.285 0.0271 0.397
xsq SAP30L-AS1 -0.285 0.0271 0.397
xsq NFIX 19p13.3 -0.285 0.0271 0.397 negative regulation of
transcription from RNA polymerase II promoter;DNA replication
xsq FAM160A1 4q31.3 -0.285 0.0271 0.397
exp CD44 11p13 -0.285 0.0271 0.397 cell-matrix adhesion;negative
regulation of DNA damage response, signal transduction by p53 class mediator
xsq LTBR 12p13 -0.285 0.0271 0.397 Apoptosis
met LOC100132111 1q21.3 -0.285 0.0271 0.397
exp ACO1 9p21.1 -0.285 0.0271 0.396 response to iron(II)
ion;regulation of gene expression
hs4 MIR1245A -0.288 0.0271 0.397
hs4 MIR1245B -0.288 0.0271 0.397
xai NUAK1 12q23.3 -0.288 0.0271 0.397 regulation of myosin-light-
chain-phosphatase activity;regulation of cell proliferation
hs4 P2RX6P 22q11.21 -0.288 0.0271 0.397
hs4 LRRC74B -0.288 0.0271 0.397
xai RAVER1 19p13.2 0.288 0.0272 0.397
his MFNG 22q12 0.288 0.0272 0.397 pattern specification process
his PITPNC1 17q24.2 0.288 0.0272 0.397 transport;lipid transport
exp RPL13AP7 21q21.2 0.288 0.0272 0.397
xai CLPP 19p13.3 0.288 0.0272 0.397 proteolysis
xai SCARNA5 0.288 0.0272 0.397
hs4 RAC3 17q25.3 0.288 0.0272 0.397 actin cytoskeleton
his CFC1B 0.288 0.0272 0.397
xai KIF27 9q21.32 0.288 0.0272 0.397 cilium assembly;microtubule-based
movement
his MIR4637 0.288 0.0272 0.397
exp SCARNA5 0.288 0.0272 0.397
his PTP4A3 8q24.3 0.288 0.0272 0.397
xai MED27 9q34.13 0.288 0.0272 0.397 regulation of transcription from
hs4 CSK 15q24.1 0.288 0.0272 0.397 Apoptosis
xsq SMG1P7 0.285 0.0272 0.397
cop SHANK2 11q13.2 0.285 0.0272 0.397 intracellular signal
transduction
exp USP14 18p11.32 0.285 0.0272 0.397 proteolysis;ubiquitin-dependent
xsq ADCYAP1R1 7p14 0.285 0.0272 0.397 activation of phospholipase C
activity;multicellular organismal response to stress
xsq NHP2 5q35.3 0.285 0.0272 0.397 DNA Damage Response (DDR)
met ASL 7q11.21 0.285 0.0272 0.397 argininosuccinate metabolic
exp CDC6 17q21.3 0.285 0.0272 0.397 DDR (DNA replication)
pro EP300_9_8925 0.285 0.0272 0.397
exp RRP1 21q22.3 0.285 0.0272 0.397 rRNA processing
exp NPIPB5 16p12.2 0.285 0.0272 0.397
xsq ZNF831 20q13.32 0.285 0.0272 0.397
exp BACE2 21q22.3 -0.285 0.0272 0.397 proteolysis;membrane protein
exp CDC42EP1 22q13.1 -0.285 0.0272 0.397 regulation of cell
shape;positive regulation of pseudopodium assembly
exp MIRLET7BHG 22q13.31 -0.285 0.0272 0.397
exp FAM19A1 3p14.1 -0.288 0.0272 0.397
hs4 CHST3 10q22.1 -0.288 0.0272 0.397 T cell homeostasis;positive
swa SEC62 3q26.2 -0.288 0.0272 0.397 cotranslational protein
targeting to membrane
xai DHX32 10q26.2 -0.288 0.0272 0.397
xai ENO3 17p13.2 0.287 0.0273 0.397 response to drug;skeletal muscle
tissue regeneration
xai VBP1 Xq28 0.287 0.0273 0.397 cellular protein metabolic process;'de
xai EMG1 12p13.3 0.287 0.0273 0.397 rRNA processing;ribosomal small
subunit biogenesis
xai FIP1L1 4q12 0.287 0.0273 0.397 mRNA processing
hs4 UNCX 7p22.3 0.287 0.0273 0.397
his LOC101926911 0.287 0.0273 0.397
his VPS33B 15q26.1 0.287 0.0273 0.397 protein transport;vesicle-
mediated transport
xai NHP2 5q35.3 0.287 0.0273 0.397 DNA Damage Response (DDR)
xai WDR3 1p12 0.287 0.0273 0.397
xai TMEM52 1p36.33 0.287 0.0273 0.397
xai RAD51AP1 12p13.2-p13.1 0.287 0.0273 0.397 DNA Damage Response
(DDR)
met FLJ33360 5p15.31 0.285 0.0273 0.397
exp MKS1 17q22 0.285 0.0273 0.397 cilium morphogenesis;cell projection
organization
exp PDXP 22q12.3 0.285 0.0273 0.397 regulation of mitosis;metabolic
process
exp BUD13 11q23.3 0.285 0.0273 0.397 nuclear mRNA splicing, via
mut SPINK5 5q32 0.285 0.0273 0.397 anagen;regulation of T cell
differentiation
xsq GRPEL2 5q32 0.285 0.0273 0.397 protein folding
exp DHX38 16q22 0.285 0.0273 0.397 RNA splicing;gene expression
xsq DDX11L2 2q13 0.285 0.0273 0.397
exp MRM1 17q12 0.285 0.0273 0.397 RNA processing
xsq CHAF1A 19p13.3 0.285 0.0273 0.397 DNA Damage Response (DDR);
xsq SNX29P1 0.285 0.0273 0.397
exp IL10RA 11q23 0.285 0.0273 0.397 signal transduction
pro CASP2_26 0.285 0.0273 0.397
xsq MYOM1 18p11.31 0.285 0.0273 0.397 muscle contraction
exp ERBB2IP 5q12.3 -0.285 0.0273 0.397 signal
transduction;epidermal growth factor receptor signaling pathway
cop CLDN1 3q28-q29 -0.285 0.0273 0.397 cell adhesion;calcium-
cop CLDN16 3q28 -0.285 0.0273 0.397 cellular metal ion
hs4 EDN2 1p34 -0.287 0.0273 0.397 prostaglandin biosynthetic
process;activation of protein kinase C activity by G-protein coupled receptor
protein signaling pathway
xai ATP6V1E1 22q11.1 -0.287 0.0273 0.397 ion transport;cellular
iron ion homeostasis
his LOC101928851 -0.287 0.0273 0.397
xai ASAP1 8q24.1-q24.2 -0.287 0.0273 0.397 signal transduction;cell
xai SLC2A1-AS1 -0.287 0.0273 0.397
mda Numerical_complexity -0.29 0.0273 0.397
xai HIST1H4PS1 6p22.1 0.287 0.0274 0.398
his ANKHD1 0.287 0.0274 0.398
his ANKHD1-EIF4EBP3 5q31.3 0.287 0.0274 0.398
his KREMEN2 16p13.3 0.287 0.0274 0.398 Wnt receptor signaling
pathway
his STPG3 0.287 0.0274 0.398
his STPG3-AS1 0.287 0.0274 0.398
his NELFB 9q34 0.287 0.0274 0.398
xai RPL13AP7 21q21.2 0.287 0.0274 0.398
xai SECISBP2 9q22.2 0.287 0.0274 0.398 translation
xai RPS11P7 Xp11.4 0.287 0.0274 0.398
his CENPC 4q13.2 0.287 0.0274 0.398
xai CD48 1q21.3-q22 0.287 0.0274 0.398 T cell activation;mast cell
activation
xai TAB1 22q13.1 0.287 0.0274 0.398 toll-like receptor signaling
xai RPL3P3 14q22.3 0.287 0.0274 0.398
mut PHLPP2 16q22.2 0.285 0.0274 0.398
exp ENOPH1 4q21.22 0.285 0.0274 0.398 sulfur amino acid metabolic
exp LRFN4 11q13.2 0.285 0.0274 0.398
exp GAPDHP37 22q13.2 0.285 0.0274 0.398
exp CFP Xp11.4 0.285 0.0274 0.398 complement activation;complement
DNA-dependent"
exp METAP1 4q23 0.285 0.0274 0.398 regulation of
met WDR35 2p24.1 0.285 0.0274 0.398 cell projection organization;cilium
assembly
xsq RAI14 5p13.3-p13.2 -0.285 0.0274 0.398
his FLJ46906 6q24.1 -0.287 0.0274 0.398
hs4 ZNF223 19q13.2 -0.287 0.0274 0.398 regulation of
his STAC 3p22.3 -0.287 0.0274 0.398 signal transduction;cellular
response to heat
hs4 TXNRD3 -0.287 0.0274 0.398
xai RPS10P16 8q24.11 0.287 0.0275 0.398
exp HIST1H4PS1 6p22.1 0.287 0.0275 0.398
xai ATAD2B 2p24.1-p23.3 0.287 0.0275 0.398
xai GEMIN6 2p22.1 0.287 0.0275 0.398 RNA splicing;gene expression
xai KIAA2022 Xq13.3 0.287 0.0275 0.398 S phase of mitotic cell
swa FAM192A 16q13 0.287 0.0275 0.398
xai NDUFS5P2 1p21.3 0.287 0.0275 0.398
his TMX3 18q22 0.287 0.0275 0.398 glycerol ether metabolic process;cell
redox homeostasis
his CCDC102B 18q22.1 0.287 0.0275 0.398
xsq CCDC26 0.285 0.0275 0.398
met NEDD4 15q 0.285 0.0275 0.398 nervous system development;neuron
met GK5 3q23 0.285 0.0275 0.398 glycerol metabolic process;carbohydrate
metabolic process
xsq MRPS25 3p25 0.285 0.0275 0.398 translation
xsq LOC100133985 0.285 0.0275 0.398
exp COA4 11q13.4 0.285 0.0275 0.398
xsq IMP3 15q24 0.285 0.0275 0.398 rRNA processing
exp EWSR1 22q12.2 0.285 0.0275 0.398 regulation of transcription, DNA-
dependent"
exp DHX32 10q26.2 -0.285 0.0275 0.399
exp CDK20 9q22.1 -0.285 0.0275 0.398 Protein Kinases
exp SLC35B3 6p24.3 -0.285 0.0275 0.398 Solute Carriers
exp TRPM4 19q13.33 -0.285 0.0275 0.398 dendritic cell
exp CPM 12q14.3 -0.285 0.0275 0.398 proteolysis;anatomical
met SPI1 11p11.2 -0.285 0.0275 0.398 Transcription Factors
swa HM13 20q11.21 -0.287 0.0275 0.398 membrane protein proteolysis
his LOC105375504 -0.287 0.0275 0.398
xai MXRA7 17q25.1 -0.287 0.0275 0.398
his ARHGAP40 20q11.23 -0.287 0.0275 0.398 signal
xai DIMT1 5q12.1 0.287 0.0276 0.399
xai CD3G 11q23 0.287 0.0276 0.399 protein transport;T cell costimulation
his CHPT1 12q 0.287 0.0276 0.399 regulation of cell growth;lipid metabolic
process
xai LINC00342 0.287 0.0276 0.399
xai L3MBTL2 22q13.31-q13.33 0.287 0.0276 0.399 regulation of
hs4 TRIM74 0.287 0.0276 0.399
his SEMA4A 1q22 0.287 0.0276 0.399 multicellular organismal
his LOC105372493 0.287 0.0276 0.399
his PSMF1 20p13 0.287 0.0276 0.399 S phase of mitotic cell cycle;apoptotic
process
xai ENPP7P2 0.287 0.0276 0.399
xai COMMD3 10p12.2 0.287 0.0276 0.399
his MIR4523 0.287 0.0276 0.399
his TAOK1 17q11.2 0.287 0.0276 0.399 Protein Kinases
xai YRDC 1p34.3 0.287 0.0276 0.399 negative regulation of transport
his BRWD3 Xq21.1 0.287 0.0276 0.399 cytoskeleton
exp ATAD2B 2p24.1-p23.3 0.285 0.0276 0.399
xsq NCAPH 2q11.2 0.285 0.0276 0.399 DNA Damage Response (DDR)
exp KAT8 16p11.2 0.285 0.0276 0.399 histone H4-K16 acetylation;negative
exp LBR 1q42.1 0.285 0.0276 0.399 cholesterol biosynthetic
xsq UBE2I 16p13.3 0.284 0.0276 0.399 DNA Damage Response (DDR)
xsq BRCA1 17q21 0.284 0.0276 0.399 Apoptosis; DNA Damage Response (DDR); DDR
met DPYS 8q22 0.284 0.0276 0.399 uracil catabolic process;beta-alanine
metabolic process
exp NTNG2 9q34 0.284 0.0276 0.399 multicellular organismal
exp DHCR24 1p32.3 -0.284 0.0276 0.399 Apoptosis
xai SCARF2 22q11.21 -0.287 0.0276 0.399 cell adhesion
xai CD59 11p13 -0.287 0.0276 0.399 cell surface receptor signaling
hs4 RUSC2 9p13.3 -0.287 0.0276 0.399
xai MED15P9 0.287 0.0277 0.399
xai PSMD4P1 0.287 0.0277 0.399
his RRP15 1q41 0.287 0.0277 0.399
exp NAP1L4P3 13q14.2 0.287 0.0277 0.399
xai UBE2G2 21q22.3 0.287 0.0277 0.399 ubiquitin-dependent protein
xai GCHFR 15q15 0.287 0.0277 0.399 negative regulation of GTP cyclohydrolase
his DNPH1 6p21.1 0.287 0.0277 0.399
his CCDC18-AS1 0.287 0.0277 0.399
his DR1 1p22.1 0.287 0.0277 0.399 negative regulation of
dependent
exp RPL36P16 19q13.2 0.287 0.0277 0.399
swa DTYMK 2q37.3 0.287 0.0277 0.399 cell cycle;cell proliferation
met MYH4 17p13.1 0.284 0.0277 0.399 muscle contraction;response to
activity
exp RBM45 2q31.2 0.284 0.0277 0.399 multicellular organismal
met RAB17 2q37.3 0.284 0.0277 0.399 protein transport;small GTPase
xsq FAM231B 0.284 0.0277 0.399
exp SLC9B1 4q24 0.284 0.0277 0.399 cation transport;transmembrane
transport
met CCDC40 17q25.3 0.284 0.0277 0.399 axonemal dynein complex
assembly;ciliary cell motility
DNA-dependent"
xsq TEX21P 14q23.3 0.284 0.0277 0.399
met TRIM73 7q11.23 0.284 0.0277 0.399
xsq KIF22 16p11.2 0.284 0.0277 0.399 microtubule-based movement;mitosis
met ACVR2A 2q22.3 0.284 0.0277 0.399 Cell Signaling; Tumor
Suppressors
exp CCBL1 9q34.11 0.284 0.0277 0.399 cellular amino acid biosynthetic
xsq HRCT1 9p13.3 -0.284 0.0277 0.399
exp CLIC3 9q34.3 -0.284 0.0277 0.399 ion transport;chloride
transport
exp PPP1R14C 6q24.3-q25.3 -0.284 0.0277 0.399 regulation of
phosphorylation
exp FAM204BP -0.287 0.0277 0.399
hs4 ERICH1-AS1 -0.287 0.0277 0.399
hs4 DLGAP2 8p23 -0.287 0.0277 0.399
hs4 LOC401442 8p23.3 -0.287 0.0277 0.399
swa CLTA 9p13 -0.287 0.0277 0.399 post-Golgi vesicle-mediated
hs4 CADM4 19q13.31 -0.287 0.0277 0.399 cell adhesion
hs4 CCDC80 3q13.2 -0.287 0.0277 0.399 positive regulation of
xai ARHGEF10L 1p36.13 -0.287 0.0277 0.399 positive regulation of
Rho GTPase activity;regulation of Rho protein signal transduction
xai RPS29P28 Xq21.33 0.289 0.0278 0.4
xai PSMF1 20p13 0.287 0.0278 0.4 S phase of mitotic cell cycle;apoptotic
process
his TMEM11 17p11.2 0.287 0.0278 0.4 mitochondrion organization
his ADAT1 16q23.1 0.287 0.0278 0.4 RNA processing;tRNA processing
exp PSMD4P1 0.287 0.0278 0.4
his POLR2J2 0.286 0.0278 0.4
xsq NMNAT1 1p36.22 0.284 0.0278 0.4 water-soluble vitamin
metabolic process;biosynthetic process
xsq MSH2 2p21 0.284 0.0278 0.4 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
exp SHQ1 3p13 0.284 0.0278 0.4 ribonucleoprotein complex assembly
met CNNM3 2p12-p11.2 0.284 0.0278 0.4 ion transport
mut SPNS1 0.284 0.0278 0.4 lipid transport;transmembrane transport
mut ASB15 7q31.31 0.284 0.0278 0.4 intracellular signal transduction
exp PON2 7q21.3 -0.284 0.0278 0.4 response to oxidative
exp MLPH 2q37.3 -0.284 0.0278 0.4 intracellular protein
transport
met ETV3L 1q23.1 -0.284 0.0278 0.4 Transcription Factors
xsq CCNJL 5q33.3 -0.284 0.0278 0.4
xsq STAC 3p22.3 -0.284 0.0278 0.399 signal transduction;cellular
response to heat
hs4 CTGF 6q23.1 -0.286 0.0278 0.4 response to wounding;positive
xai RNF11 1p32 -0.286 0.0278 0.4 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process
exp AMY1A -0.286 0.0278 0.4
swa EHD1 11q13 -0.286 0.0278 0.4 protein
homooligomerization;intracellular protein transport
his MTMR1 Xq28 -0.287 0.0278 0.4
xai FAM204BP -0.287 0.0278 0.4
swa HID1 17q25.1 -0.287 0.0278 0.399
hs4 PRAG1 -0.287 0.0278 0.399
his SPI1 11p11.2 0.286 0.0279 0.4 Transcription Factors
hs4 UNK 17q25.1 0.286 0.0279 0.4
hs4 MIR4738 0.286 0.0279 0.4
his CDC42 1p36.1 0.286 0.0279 0.401 small GTPase mediated signal
his TMEM161A 19p13.11 0.286 0.0279 0.401 negative regulation of
his SAMD1 19p13.12 0.286 0.0279 0.401
exp SETP4 Xq21.1 0.286 0.0279 0.401
xai HGF 7q21.1 0.286 0.0279 0.401 proteolysis;positive regulation of
peptidyl-tyrosine phosphorylation
xsq MRPS26 20p13 0.284 0.0279 0.4 DNA damage response, detection of
exp PPP6R1 19q13.42 0.284 0.0279 0.4 DNA Damage Response (DDR)
exp DCP2 5q22.2 0.284 0.0279 0.4 histone mRNA catabolic
exp RPS10P26 17q23 0.284 0.0279 0.4
exp NBEAP1 15q11.2 0.284 0.0279 0.4
xsq POLR1E 9p13.2 0.284 0.0279 0.4 rRNA transcription
exp ACTR5 20q11.23 0.284 0.0279 0.401 DNA Damage Response (DDR); DDR
(Chromatin)
exp DYNLRB1 20q11.21 -0.284 0.0279 0.401 transport;microtubule-
based movement
exp SORBS2 4q35.1 -0.284 0.0279 0.4
met MIR452 -0.284 0.0279 0.4
his EVA1A 2p12 -0.286 0.0279 0.401
swa PLS3 Xq23 -0.286 0.0279 0.4
xai TPI1P3 6q22.1 0.286 0.028 0.401
xai EIF4BP6 0.286 0.028 0.401
exp ZDHHC22 14q24.3 0.286 0.028 0.401
exp ATP13A4 3q29 0.286 0.028 0.401 cation transport;ATP biosynthetic process
xai LTB 6p21.3 0.286 0.028 0.401 immune response;signal transduction
hs4 C17orf62 17q25.3 0.286 0.028 0.401
his CD99L2 Xq28 0.286 0.028 0.401 cell adhesion
his LETMD1 12q13.12 0.286 0.028 0.401
xai LBR 1q42.1 0.286 0.028 0.401 cholesterol biosynthetic process;small
dependent"
exp DDX55 12q24.31 0.284 0.028 0.401
exp USP37 2q35 0.284 0.028 0.401 proteolysis;ubiquitin-dependent protein
catabolic process
exp DIAPH1 5q31 0.284 0.028 0.401 regulation of microtubule-based
xsq MAP10 1q42.2 0.284 0.028 0.401
mut CEP250 20q11.22 0.284 0.028 0.401 regulation of centriole-centriole
cohesion;G2/M transition of mitotic cell cycle
exp KIAA2022 Xq13.3 0.284 0.028 0.401 S phase of mitotic cell cycle;base-
excision repair, gap-filling
exp DDX3X Xp11.3-p11.23 0.284 0.028 0.401 interspecies interaction between
organisms
exp NEDD4L 18q21.31 -0.284 0.028 0.401 protein ubiquitination;water
homeostasis
xsq SNX7 1p21.3 -0.284 0.028 0.401 cell communication;protein
transport
exp SGCE 7q21.3 -0.284 0.028 0.401 cell-matrix adhesion;muscle organ
development
exp HLA-F 6p21.3 -0.284 0.028 0.401 antigen processing and presentation
xai RMDN2 2p22.2 -0.286 0.028 0.401
hs4 CFAP221 -0.286 0.028 0.401
hs4 SNX8 7p22.3 -0.286 0.028 0.401
hs4 GSDMC 8q24.21 -0.286 0.028 0.401
swa RAVER1 19p13.2 0.286 0.0281 0.401
xai RPL7A 9q34 0.286 0.0281 0.401 translation;mRNA metabolic process
exp TAB1 22q13.1 0.286 0.0281 0.401 toll-like receptor signaling
xai GALNT6 12q13 0.286 0.0281 0.402 post-translational protein
xai GLMN 1p22.1 0.286 0.0281 0.402 muscle cell
his HMGXB4 22q13.1 0.286 0.0281 0.402 negative regulation of Wnt
receptor signaling pathway;endosome to lysosome transport
his BMS1P20 0.286 0.0281 0.402
his NARS2 11q14.1 0.286 0.0281 0.402 asparaginyl-tRNA
aminoacylation;gene expression
his TEFM 0.286 0.0281 0.402 transcription from mitochondrial
promoter;oxidative phosphorylation
his KLF13 15q12 0.286 0.0281 0.402 negative regulation of cell
his TMA16 4q32.2 0.286 0.0281 0.402
xsq RQCD1 2q35 0.284 0.0281 0.401 cytokine-mediated signaling
met MOCOS 18q12 0.284 0.0281 0.401 molybdopterin cofactor metabolic
xsq BYSL 6p21.1 0.284 0.0281 0.401 cell adhesion;female pregnancy
exp BPTF 17q24.3 0.284 0.0281 0.401 chromatin remodeling;transcription,
DNA-dependent
met TRNP1 1p36.11 0.284 0.0281 0.402 cell cycle
xsq XK Xp21.1 0.284 0.0281 0.402 transport;amino acid transport
exp PRG2 11q12 0.284 0.0281 0.402 immune response;defense response to
bacterium
xsq SHTN1 -0.284 0.0281 0.402 multicellular organismal
his ENO4 10q25.3 -0.286 0.0281 0.402 glycolysis
his HSPA12A 10q26.12 -0.286 0.0281 0.402
hs4 TGFBI 5q31 -0.286 0.0281 0.402 visual perception;cell
proliferation
his GBP6 1p22.2 -0.286 0.0281 0.402
xai RNF144B 6p22.3 -0.286 0.0281 0.401 apoptotic
process
xai NAE1 16q22 0.286 0.0282 0.402 Apoptosis
xai NUP205 7q33 0.286 0.0282 0.402 protein transport;glucose transport
his CFD 19p13.3 0.286 0.0282 0.402 innate immune response;platelet
degranulation
xai RPSAP56 16q22.3 0.286 0.0282 0.402
his RC3H2 9q34 0.286 0.0282 0.402
his LOC440600 0.286 0.0282 0.402
his RBM15 1p13 0.286 0.0282 0.402 positive regulation of transcription of
Notch receptor target;interspecies interaction between organisms
exp EPHB6 7q33-q35 0.283 0.0282 0.402 Cell Signaling
exp COA7 0.283 0.0282 0.402
mir hsa-miR-423-3p 0.283 0.0282 0.402
mut BRINP2 0.283 0.0282 0.402 nervous system development;negative
exp SLC5A6 2p23 0.283 0.0282 0.402 Solute Carriers
xsq MIR3911 0.283 0.0282 0.402
exp OGFOD2 12q24.31 0.283 0.0282 0.402
hs4 FAM213A 10q23.1 -0.286 0.0282 0.402 regulation of osteoclast
xai SORCS2 4p16.1 -0.286 0.0282 0.402 neuropeptide signaling
pathway
hs4 FAM84B 8q24.21 -0.286 0.0282 0.402
his PADI1 1p36.13 -0.286 0.0282 0.402 protein modification
process;peptidyl-citrulline biosynthetic process from peptidyl-arginine
his HNRNPUL2-BSCL2 0.286 0.0283 0.402
his HNRNPUL2 11q12.3 0.286 0.0283 0.402
his TTC9C 11q12.3 0.286 0.0283 0.402
hs4 LINC01624 0.286 0.0283 0.402
xai SDCCAG3 9q34.3 0.286 0.0283 0.402
his KLHL20 1q25.1 0.286 0.0283 0.403 cytoskeleton
organization;protein ubiquitination
xai RPL35AP4 6p21 0.286 0.0283 0.403
xai MID1IP1-AS1 0.286 0.0283 0.403
his SIDT2 11q23.3 0.286 0.0283 0.403
hs4 PAQR6 1q22 0.286 0.0283 0.403
xai TOMM40L 1q23.3 0.286 0.0283 0.403 protein
xai PIM2 Xp11.23 0.286 0.0283 0.403 anti-apoptosis;positive regulation
of I-kappaB kinase/NF-kappaB cascade
his PDZD3 11q23.3 0.286 0.0283 0.403 ion transport;water transport
exp RANP2 0.286 0.0283 0.403
xai MPHOSPH9 12q24.31 0.286 0.0283 0.403 M phase of mitotic cell cycle
xsq FIGNL2 12q13.13 0.283 0.0283 0.402
exp FAM35A 10q23.2 0.283 0.0283 0.403
exp ABCB10P4 15q13.1 0.283 0.0283 0.403
xsq POLR1C 6p21.1 0.283 0.0283 0.403 DNA Damage Response (DDR)
mut IVNS1ABP 1q25.1-q31.1 0.283 0.0283 0.403 transcription from RNA
polymerase III promoter;RNA splicing
exp RPL21P63 6p24.2 -0.283 0.0283 0.403
xsq LRRC8E 19p13.2 -0.283 0.0283 0.403
met SLA 8q24 -0.283 0.0283 0.402
hs4 MAK 6p24 -0.286 0.0283 0.403 protein
phosphorylation;multicellular organismal development
xai RYK 3q22 -0.286 0.0283 0.403 Wnt receptor signaling
hs4 MAML2 11q21 -0.286 0.0283 0.402 regulation of transcription, DNA-
hs4 MIR1260B -0.286 0.0283 0.402
xai RANP2 0.286 0.0284 0.403
his MIR600 0.286 0.0284 0.403
his MIR600HG 9q33.3 0.286 0.0284 0.403
his METAP1D 2q31.1 0.286 0.0284 0.403 proteolysis;cellular process
exp RPL35AP4 6p21 0.286 0.0284 0.403
his PILRA 7q22.1 0.286 0.0284 0.403 signal transduction;interspecies
xai SAAL1 11p15.1 0.286 0.0284 0.403 acute-phase response
xai RBBP6 16p12.2 0.286 0.0284 0.403 protein ubiquitination involved in
xai JAK3 19p13.1 0.285 0.0284 0.403 Oncogenes
xai RSBN1 1p13.2 0.285 0.0284 0.403
exp EIF4BP9 Xq12 0.285 0.0284 0.404
met ANXA9 1q21 0.283 0.0284 0.403 cell-cell adhesion
cop AKAP12 6q24-q25 0.283 0.0284 0.403 G-protein coupled receptor
signaling pathway;positive regulation of protein kinase A signaling cascade
exp WDR3 1p12 0.283 0.0284 0.403
xsq UQCRC2 16p12 0.283 0.0284 0.403 oxidative
xsq METTL13 1q24-q25.3 0.283 0.0284 0.403 metabolic process
exp MED26 19p13.11 0.283 0.0284 0.403 regulation of transcription from
exp LOC441505 0.283 0.0284 0.404
his NEK6 9q33.3-q34.11 -0.285 0.0284 0.403 DNA Damage Response
(DDR)
xai GGNBP1 6p21 -0.286 0.0284 0.403 mitochondrial
fission;multicellular organismal development
xai OR5M12P 11q12.1 -0.286 0.0284 0.403
his SNX24 5q23.2 -0.286 0.0284 0.403 cell communication;protein
transport
his CHORDC1 11q14.3 0.285 0.0285 0.404 regulation of centrosome
duplication;chaperone-mediated protein folding
his ORAI1 12q24.31 0.285 0.0285 0.404 ion transport;blood coagulation
his PSMB6 17p13 0.285 0.0285 0.404 antigen processing and presentation of
peptide antigen via MHC class I;RNA metabolic process
exp HIST1H3G 0.285 0.0285 0.404
swa RUVBL2 19q13.3 0.285 0.0285 0.404 Apoptosis; DNA Damage
Response (DDR); DDR (Chromatin)
met LOC152225 3q12.3 0.283 0.0285 0.404
exp SLC35G4 0.283 0.0285 0.404
xsq CARF 2q33.2 0.283 0.0285 0.404
xsq PYCR2 1q42.12 0.283 0.0285 0.404 proline biosynthetic
xsq SCAI 9q33.3 0.283 0.0285 0.404 regulation of transcription, DNA-
dependent;negative regulation of signal transduction
exp CXXC5 5q31.2 -0.283 0.0285 0.404 signal transduction;positive
exp KREMEN1 22q12.1 -0.283 0.0285 0.404 cell communication;Wnt
his MXRA5 Xp22.33 -0.285 0.0285 0.404
xai NEDD9 6p25-p24 -0.285 0.0285 0.404 regulation of growth;actin
hs4 BHLHB9 Xq23 -0.285 0.0285 0.404
his TRIM16L -0.285 0.0285 0.404
xai USP14 18p11.32 0.285 0.0286 0.405 proteolysis;ubiquitin-dependent
his MBTD1 17q21.33 0.285 0.0286 0.405 regulation of transcription, DNA-
his UTP18 17q21.33 0.285 0.0286 0.405 rRNA processing
xai RPL17P45 18q12.3 0.285 0.0286 0.405
exp RPS29P28 Xq21.33 0.285 0.0286 0.405
exp RPSAP56 16q22.3 0.285 0.0286 0.405
exp RPL17P45 18q12.3 0.285 0.0286 0.405
xsq FAM216A 12q24.11 0.283 0.0286 0.405
xsq LOC400927-CSNK1E 0.283 0.0286 0.405
xsq RAPH1 2q33 -0.283 0.0286 0.405 cell-matrix adhesion;signal
transduction
exp SPTBN5 15q21 -0.283 0.0286 0.405 axon guidance;actin
xai EXT2 11p12-p11 -0.285 0.0286 0.405 ossification;mesoderm
formation
his ARSJ 4q26 -0.285 0.0286 0.405
hs4 TRIM16L -0.285 0.0286 0.405
hs4 NUDT16P1 3q22.1 -0.285 0.0286 0.405
his DENND1C 19p13.3 0.285 0.0287 0.405
swa HNRNPLL 2p22.1 0.285 0.0287 0.405
his KIF18B 17q21.31 0.285 0.0287 0.406 mitotic cell
cycle;microtubule-based movement
xai CDK5RAP3 17q21.32 0.285 0.0287 0.406 regulation of cyclin-
dependent protein kinase activity;brain development
his DTL 1q32 0.285 0.0287 0.406 DDR (DNA replication)
his INTS7 1q32.3 0.285 0.0287 0.406 snRNA processing;cellular response
swa HNRNPH1 5q35.3 0.285 0.0287 0.406 gene expression;regulation of
RNA splicing
his CRTC1 19p13.11 0.285 0.0287 0.406 regulation of transcription, DNA-
dependent;positive regulation of CREB transcription factor activity
hs4 MIR548A2 0.285 0.0287 0.406
xai ATP13A4 3q29 0.285 0.0287 0.406 cation transport;ATP biosynthetic
process
exp LOC101060609 0.283 0.0287 0.405
exp UBE3A 15q11.2 0.283 0.0287 0.406 positive regulation of
met RHBDF1 16p13.3 0.283 0.0287 0.406 regulation of proteasomal
protein catabolic process;proteolysis
exp BORCS6 0.282 0.0287 0.406
xsq SH3RF1 4q32.3 -0.283 0.0287 0.406 induction of
exp HSPB1P2 Xp11.23 -0.283 0.0287 0.406
xsq MLF1 3q25.1 -0.283 0.0287 0.406 cell cycle
hs4 STK32A 5q32 -0.285 0.0287 0.406
hs4 NWD1 19p13.11 -0.285 0.0287 0.406
his CDKN2AIPNL 5q31.1 0.285 0.0288 0.406
his VASH2 1q32.3 0.285 0.0288 0.406 positive regulation of endothelial
xai TAF4 20q13.33 0.285 0.0288 0.406 ovarian follicle
swa CCT6A 7p11.2 0.285 0.0288 0.406 protein folding;cellular protein
metabolic process
xai ATP5BP1 0.285 0.0288 0.406
swa MTA1 14q32.3 0.285 0.0288 0.407 signal transduction
xsq RCC1 1p36.1 0.282 0.0288 0.406 cell cycle;mitotic spindle
organization
exp SDK2 17q25.1 0.282 0.0288 0.406 cell adhesion
exp FCER2 19p13.3 0.282 0.0288 0.406 positive regulation of nitric-oxide
xsq DTX1 12q24.13 0.282 0.0288 0.406 transcription, DNA-
exp YRDC 1p34.3 0.282 0.0288 0.406 negative regulation of transport
xsq SYNGR4 19q13.3 0.282 0.0288 0.406
met TBC1D12 10q23.33 0.282 0.0288 0.406
xsq CCR2 3p21.31 0.282 0.0288 0.406 cellular calcium ion
xsq F13A1 6p25.3-p24.3 0.282 0.0288 0.406 peptide cross-
xsq DDHD1 14q21 0.282 0.0288 0.407 lipid catabolic process
exp ATG12P1 17q25.1 -0.282 0.0288 0.407
xsq TEAD3 6p21.2 -0.282 0.0288 0.407 female pregnancy;hippo
signaling cascade
xsq GNA11 19p13.3 -0.282 0.0288 0.406 Oncogenes
exp GRINA 8q24.3 -0.282 0.0288 0.406
exp DUSP15 20q11.21 -0.282 0.0288 0.406 protein
dephosphorylation
hs4 GPNMB 7p15 -0.285 0.0288 0.407 cell adhesion;negative regulation
xai SGCE 7q21.3 -0.285 0.0288 0.406 cell-matrix adhesion;muscle
organ development
xai FOXI3 2p11.2 -0.285 0.0288 0.406 epidermal cell fate
specification;otic placode formation
met SIGLEC5 19q13.3 0.29 0.0289 0.407 cell adhesion
hs4 LINC01550 0.285 0.0289 0.407
xai SNORA50C 0.285 0.0289 0.407
xai EIF4BP9 Xq12 0.285 0.0289 0.407
exp ATF1 12q13 0.282 0.0289 0.407 positive regulation of neuron projection
exp NOL8 9q22.31 0.282 0.0289 0.407 DNA replication;rRNA processing
exp ZNF598 16p13.3 0.282 0.0289 0.407
met CBLN4 20q13 0.282 0.0289 0.407
exp DFFB 1p36.3 0.282 0.0289 0.407 Apoptosis
xsq TSPAN7 Xp11.4 0.282 0.0289 0.407 interspecies interaction
between organisms
met MSI1 12q24 0.282 0.0289 0.407 nervous system development;response to
hormone stimulus
xsq C17orf85 17p13.2 0.282 0.0289 0.407
exp SDCCAG3 9q34.3 0.282 0.0289 0.407
exp SLC35F2 11q22.3 0.282 0.0289 0.407 Solute Carriers
xsq KCNH1 1q32.2 -0.282 0.0289 0.407 ion transport;potassium ion
transport
exp TSC22D2 3q25.1 -0.282 0.0289 0.407 response to osmotic
stress
exp FOSL2 2p23.3 -0.282 0.0289 0.407 regulation of transcription
from RNA polymerase II promoter;cell death
exp MGP 12p12.3 -0.282 0.0289 0.407 response to hormone
xai FAM46B 1p36.11 -0.285 0.0289 0.407
swa COL6A2 21q22.3 -0.285 0.0289 0.407 axon guidance;response
to glucose stimulus
hs4 PHLDB2 3q13.2 -0.285 0.0289 0.407
hs4 LYPD6 2q23.2 -0.285 0.0289 0.407
swa MAVS 20p13 -0.285 0.0289 0.407 positive regulation of interferon-
alpha production;interspecies interaction between organisms
xai SLC35B3 6p24.3 -0.285 0.0289 0.407 Solute Carriers
xai ERBB2IP 5q12.3 -0.285 0.0289 0.407 signal
transduction;epidermal growth factor receptor signaling pathway
xai FOSL2 2p23.3 -0.285 0.0289 0.407 regulation of transcription
from RNA polymerase II promoter;cell death
swa TOMM40 19q13 -0.285 0.0289 0.407 protein targeting to
mitochondrion;protein transport
hs4 MIR497HG -0.285 0.0289 0.407
his KIZ 0.285 0.029 0.407 spindle organization
his SUMO2 17q25.1 0.284 0.029 0.407 DNA Damage Response (DDR)
xai NIFK 0.284 0.029 0.407 rRNA transcription;negative regulation of
his TMEM116 12q24.13 0.284 0.029 0.407
his ERP29 12q24.13 0.284 0.029 0.407 protein folding;intracellular protein
transport
exp RPL7A 9q34 0.284 0.029 0.407 translation;mRNA metabolic process
xai CCL25 19p13.2 0.284 0.029 0.407 G-protein coupled receptor signaling
pathway;leukocyte migration
his LOC102723557 0.284 0.029 0.407
his LMNB1 5q23.2 0.284 0.029 0.407 apoptotic process;cellular component
disassembly involved in apoptosis
xai ZWILCH 15q22.31 0.284 0.029 0.408 DNA Damage Response (DDR)
exp LOC100129367 8q24.23 0.282 0.029 0.407
xsq PCYOX1L 5q32 0.282 0.029 0.407 prenylcysteine catabolic process
exp NFXL1 4p12 0.282 0.029 0.407
met TBC1D2 9q22.33 0.282 0.029 0.407 positive regulation of Rab GTPase
activity
cop DSC2 18q12.1 0.282 0.029 0.407 cell adhesion;homophilic cell adhesion
met JPH2 20q13.12 0.282 0.029 0.407 regulation of cardiac muscle tissue
development;calcium ion homeostasis
xsq GAL 11q13.3 0.282 0.029 0.407 inflammatory response;response to insulin
stimulus
xsq MEPCE 7q22.1 0.282 0.029 0.408
exp ELP5 17p13.1 0.282 0.029 0.408
exp MANBAL 20q11.23 -0.282 0.029 0.407
met UQCRHL 1p36.21 -0.282 0.029 0.407
xsq PAM 5q14-q21 -0.282 0.029 0.407 response to drug;response to
hypoxia
exp EFCAB14 1p33 -0.282 0.029 0.407
exp DOCK9 13q32.3 -0.282 0.029 0.407 blood coagulation
hs4 SOX9-AS1 -0.284 0.029 0.408
hs4 SOX9 17q24.3 -0.284 0.029 0.408 epithelial to mesenchymal
hs4 MIR3170 -0.284 0.029 0.407
xai PHBP1 6q25 0.284 0.0291 0.408
xai CDCA4 14q32.33 0.284 0.0291 0.408
his VIPAS39 14q24.3-q31 0.284 0.0291 0.408
his AHSA1 14q24 0.284 0.0291 0.408 positive regulation of ATPase
activity;protein folding
his UBE2K 4p14 0.284 0.0291 0.408 ubiquitin-dependent protein catabolic
xai ZNF423 16q12 0.284 0.0291 0.408 cell differentiation;positive
regulation of BMP signaling pathway
xai NBEAP1 15q11.2 0.284 0.0291 0.408
xai WDR7 18q21.31 0.284 0.0291 0.408
xai COG8 16q22.1 0.284 0.0291 0.408 protein transport
swa RPS29 14q 0.284 0.0291 0.408 mRNA metabolic process;translation
hs4 MIR199B 0.284 0.0291 0.408
hs4 MIR3154 0.284 0.0291 0.408
xai DCP2 5q22.2 0.284 0.0291 0.408 histone mRNA catabolic
met RPL31 2q11.2 0.282 0.0291 0.408 translational initiation;viral
infectious cycle
exp RCOR1 14q32.31 0.282 0.0291 0.408 interspecies interaction between
xsq TBP 6q27 0.282 0.0291 0.408 transcription from RNA polymerase III
promoter;spermatogenesis
xsq LYG1 2q11.2 0.282 0.0291 0.408 cell wall macromolecule catabolic
xsq CEP85 1p36.11 0.282 0.0291 0.408
xsq LOC100270804 0.282 0.0291 0.408
met KCNIP2 10q24 -0.282 0.0291 0.408 signal transduction;synaptic
transmission
exp BIN1 2q14 -0.282 0.0291 0.408 positive regulation of GTPase
activity;interspecies interaction between organisms
met LRRC41 1p34.1 -0.282 0.0291 0.408
his LINC00111 -0.284 0.0291 0.408
hs4 SAMD9L 7q21.2 -0.284 0.0291 0.408
hs4 SGCE 7q21.3 -0.284 0.0291 0.408 cell-matrix adhesion;muscle
organ development
hs4 PEG10 7q21 -0.284 0.0291 0.408 apoptotic process;cell
differentiation
hs4 C1QTNF6 22q13.1 -0.284 0.0291 0.408
swa COTL1 16q24.1 -0.284 0.0291 0.408 defense response to fungus
xai SRP72 4q11 0.284 0.0292 0.408 translation;SRP-dependent cotranslational
protein targeting to membrane
his ROCK1 18q11.1 0.284 0.0292 0.408 Apoptosis; Protein Kinases
swa METAP1 4q23 0.284 0.0292 0.408 regulation of
hs4 CERS2 1q21.3 0.284 0.0292 0.409 small molecule metabolic
exp ZWILCH 15q22.31 0.282 0.0292 0.408 DNA Damage Response (DDR)
exp RRN3P2 16p11.2 0.282 0.0292 0.408
xsq CD1E 1q23.1 0.282 0.0292 0.408 immune response;antigen processing
and presentation
xsq LOC101926963 0.282 0.0292 0.408
xsq MIEF1 0.282 0.0292 0.408 mitochondrial fusion
exp NDUFA1 Xq24 0.282 0.0292 0.408 mitochondrial electron transport,
met GLT6D1 9q34.3 0.282 0.0292 0.408
exp MLKL 16q23.1 0.282 0.0292 0.408
met COMT 22q11.21 0.282 0.0292 0.408 methylation;response to pain
exp KIF27 9q21.32 0.282 0.0292 0.409 cilium assembly;microtubule-based
movement
xsq RBM38 20q13.31 0.282 0.0292 0.409 DNA damage response, signal
transduction by p53 class mediator resulting in transcription of p21 class
mediator;cell cycle
exp ARHGAP20 11q23.1 -0.282 0.0292 0.408 signal
exp WWC3 Xp22.32 -0.282 0.0292 0.408
xai FAM198B 4q32.1 -0.284 0.0292 0.408
hs4 TMEM45A 3q12.2 -0.284 0.0292 0.408
xai LYZL6 17q11.2 -0.284 0.0292 0.408 metabolic process;cell wall
his CXCR3 Xq13 0.284 0.0293 0.409 cellular component movement;chemotaxis
his LOC101927365 0.284 0.0293 0.409
his PNISR 6q16.3 0.284 0.0293 0.409
xai BIN2P1 4q21.22 0.284 0.0293 0.409
xai PLCB2 15q15 0.284 0.0293 0.409 phospholipid metabolic process;activation
xai CCDC180 0.284 0.0293 0.409
xai SMAP2 1p35.3-p34.1 0.284 0.0293 0.409 regulation of ARF GTPase
activity
exp ANKRD46 8q22.2 0.282 0.0293 0.409
xsq SEC11C 18q21.32 0.282 0.0293 0.409 small molecule metabolic
exp DLAT 11q23.1 0.282 0.0293 0.409 acetyl-CoA biosynthetic
exp C17orf53 17q21.31 0.282 0.0293 0.409
met TIMM17A 1q32.1 0.282 0.0293 0.409 protein targeting to
exp HIST1H3A 6p22.1 0.281 0.0293 0.409
xsq NXT1 20p12-p11.2 0.281 0.0293 0.409 RNA export from nucleus;protein
export from nucleus
exp OTUD1 10p12.2 -0.282 0.0293 0.409
xsq USP32P1 17p11.2 -0.282 0.0293 0.409
xsq METRNL 17q25.3 -0.282 0.0293 0.409
xai ARHGAP20 11q23.1 -0.284 0.0293 0.409 signal
hs4 NKX3-1 8p21.2 -0.284 0.0293 0.409 DNA Damage Response
(DDR)
exp ZNF816-ZNF321P -0.284 0.0293 0.409
xai ZNF816-ZNF321P -0.284 0.0293 0.409
his ACOT8 20q13.12 0.284 0.0294 0.409 cellular lipid metabolic
his ZSWIM3 20q13.12 0.284 0.0294 0.409
his VAMP2 17p13.1 0.284 0.0294 0.41 cellular membrane
organization;synaptic vesicle exocytosis
his MIRLET7A1 0.284 0.0294 0.41
his MIRLET7F1 0.284 0.0294 0.41
xai MYBBP1A 17p13.3 0.284 0.0294 0.41 DNA Damage Response (DDR)
xsq OLFM3 1p22 0.281 0.0294 0.409
exp GPX7 1p32 0.281 0.0294 0.409 response to oxidative stress
exp NKD2 5p15.3 0.281 0.0294 0.41 transport;exocytosis
xsq JRK 8q24.3 0.281 0.0294 0.41 regulation of transcription, DNA-
dependent"
exp CRYBB1 22q12.1 0.281 0.0294 0.41 visual perception
xsq PDCD7 15q22.31 0.281 0.0294 0.41 induction of apoptosis;RNA splicing
exp RPS10P10 3p14.2 0.281 0.0294 0.41
exp EZH2 7q35-q36 0.281 0.0294 0.41 Oncogenes; Tumor Suppressors
met EGFR 7p12 0.281 0.0294 0.41 Apoptosis; Cell Signaling; Oncogenes;
Protein Kinases
exp PPP2R1B 11q23.2 0.281 0.0294 0.41 Apoptosis
xsq GPR161 1q24.2 -0.281 0.0294 0.41 multicellular organismal
development
xsq STON2 14q31.1 -0.281 0.0294 0.41 intracellular protein
transport;regulation of endocytosis
exp NUAK1 12q23.3 -0.281 0.0294 0.409 regulation of myosin-light-
exp KRT17P3 17q11.2 -0.281 0.0294 0.409
swa GALNT2 1q41-q42 -0.284 0.0294 0.41 immunoglobulin
biosynthetic process;O-glycan processing
hs4 IFITM10 -0.284 0.0294 0.41 response to biotic stimulus
xai RAB18 10p12.1 -0.284 0.0294 0.409 protein transport;eye
development
xai FGR 1p36.2-p36.1 0.284 0.0295 0.41 immune response-regulating
xai CEPT1 1p13.3 0.284 0.0295 0.41 lipid metabolic
xai ATP5B 12q13.13 0.284 0.0295 0.41 ADP biosynthetic process;ATP
his RPPH1 14q11.2 0.284 0.0295 0.411
his PARP2 14q11.2-q12 0.284 0.0295 0.411 DNA Damage Response (DDR); DDR
(BER)
xai ATP5G1 17q21.32 0.284 0.0295 0.411 mitochondrial ATP synthesis
hs4 PTGDR 14q22.1 0.284 0.0295 0.411 G-protein coupled receptor
his PIK3R4 3q22.1 0.284 0.0295 0.411 protein
phosphorylation;insulin receptor signaling pathway
his YEATS4 12q13-q15 0.284 0.0295 0.411 chromatin
xai MLKL 16q23.1 0.284 0.0295 0.411
exp CRYBB2 22q11.23 0.281 0.0295 0.41 visual perception;camera-type
eye development
xsq DDX11L9 0.281 0.0295 0.41
met SNX21 20q13.12 0.281 0.0295 0.411 cell communication;protein
transport
exp ALDH7A1 5q31 -0.281 0.0295 0.411 cellular aldehyde metabolic
hs4 ABCA5 17q24.3 -0.284 0.0295 0.411 ABC Transporters
his IL34 16q22.1 -0.284 0.0295 0.411 positive regulation of
protein phosphorylation;inflammatory response
his EGFR-AS1 -0.284 0.0295 0.411
his LEMD2 6p21.31 -0.284 0.0295 0.41 skeletal muscle cell
differentiation
his ZNF426 19p13.2 -0.284 0.0295 0.41 regulation of
his LOC101928238 -0.284 0.0295 0.41
xai LOC100421439 0.284 0.0296 0.411
his SCARA5 8p21.1 0.283 0.0296 0.411 cellular response to
heat;iron ion transmembrane transport
xai FAM76B 11q21 0.283 0.0296 0.411
xai PIGM 1q23.2 0.283 0.0296 0.411 C-terminal protein
exp PTMAP2 5q23.1 0.281 0.0296 0.411
xsq SLC25A5 Xq24 0.281 0.0296 0.411 Solute Carriers
exp SRP72 4q11 0.281 0.0296 0.411 translation;SRP-dependent cotranslational
xsq HPRT1 Xq26.1 0.281 0.0296 0.411 spermatogenesis;central nervous
exp NBAS 2p24 0.281 0.0296 0.411
exp MDM1 12q15 0.281 0.0296 0.411 retina development in camera-type eye
xsq NXF3 Xq22 0.281 0.0296 0.411 mRNA export from nucleus;transport
exp PCYOX1L 5q32 0.281 0.0296 0.411 prenylcysteine catabolic process
exp DSTN 20p12.1 -0.281 0.0296 0.411 cellular component
movement;actin polymerization or depolymerization
exp PYROXD2 10q24.2 -0.281 0.0296 0.411
exp RPL36AP44 15q22.2 -0.281 0.0296 0.411
xai HLA-G 6p21.3 -0.283 0.0296 0.411 cytokine-mediated signaling
pathway;type I interferon-mediated signaling pathway
xai ARHGAP21 10p12.1 -0.283 0.0296 0.411 signal transduction
exp LOC553103 -0.283 0.0296 0.411
met MIR520C 0.299 0.0297 0.411
his LINC01230 0.283 0.0297 0.411
his DMRT2 9p24.3 0.283 0.0297 0.411 regulation of transcription, DNA-
dependent;sex determination
xai MIR2052HG 0.283 0.0297 0.411
hs4 WNT1 12q13 0.283 0.0297 0.411 Apoptosis; Oncogenes
xai HMGB2P1 19p13.3 0.283 0.0297 0.411
exp HMGB2P1 19p13.3 0.283 0.0297 0.411
xai HNRNPA1P41 9p24.1 0.283 0.0297 0.411
swa DNAJC9 10q22.2 0.283 0.0297 0.411 protein folding;social
behavior
hs4 CD244 1q23.3 0.283 0.0297 0.411 leukocyte migration;signal
transduction
his TYMS 18p11.32 0.283 0.0297 0.411 DNA Damage Response (DDR)
his TYMSOS 0.283 0.0297 0.411
xai IGLC1 0.283 0.0297 0.412 immune response;complement activation
his LOC101927596 0.283 0.0297 0.412
xsq MYOM2 8p23.3 0.281 0.0297 0.411 muscle contraction
xsq TTLL13P 0.281 0.0297 0.411 protein modification process
exp CYP27B1 12q14.1 0.281 0.0297 0.411 negative regulation of
xsq BCL7A 12q24.13 0.281 0.0297 0.411 negative regulation of
xsq P2RX5-TAX1BP3 0.281 0.0297 0.411
exp RPL29P5 1p31.1 0.281 0.0297 0.411
exp PPM1L 3q26.1 0.281 0.0297 0.411 small molecule metabolic
DNA-dependent"
exp FAM60A 12p11 0.281 0.0297 0.411
xsq ORC6 16q12 0.281 0.0297 0.411 DDR (DNA replication)
exp RPL23AP14 12p13.33 0.281 0.0297 0.412
pro ESR1 6q25.1 -0.281 0.0297 0.411 androgen metabolic
process;negative regulation of sequence-specific DNA binding transcription factor
activity
xsq SLC44A2 19p13.1 -0.281 0.0297 0.411 Solute Carriers
exp FSTL1 3q13.33 -0.281 0.0297 0.411 BMP signaling pathway
exp ZNF426 19p13.2 -0.281 0.0297 0.411 regulation of
xsq TCF7L1 2p11.2 -0.281 0.0297 0.411 regulation of
transcription from RNA polymerase II promoter;negative regulation of transcription,
DNA-dependent
xsq PVRL2 19q13.2 -0.281 0.0297 0.411 positive regulation of
immunoglobulin mediated immune response;sperm mitochondrion organization
his ERP27 12p12.3 -0.283 0.0297 0.411
hs4 C18orf63 18q22.3 -0.283 0.0297 0.411
hs4 C6orf132 6p21.1 -0.283 0.0297 0.411
xai HEATR5B 2p22.2 0.283 0.0298 0.412
xai UBE3A 15q11.2 0.283 0.0298 0.412 positive regulation of
swa RFC2 7q11.23 0.283 0.0298 0.412 DNA Damage Response (DDR); DDR
exp CR1 1q32 0.283 0.0298 0.412 negative regulation of complement
activity
his ATG4C 1p31.3 0.283 0.0298 0.412 autophagic vacuole
xai SMARCA5 4q31.1-q31.2 0.283 0.0298 0.412 DNA Damage Response
exp MPHOSPH9 12q24.31 0.281 0.0298 0.412 M phase of mitotic cell cycle
met ADCY8 8q24 0.281 0.0298 0.412 inhibition of adenylate cyclase activity
by G-protein signaling pathway;small molecule metabolic process
xsq RBM14 11q13.2 0.281 0.0298 0.412 glucocorticoid receptor signaling
pathway;DNA replication
met PLEC 8q24 0.281 0.0298 0.412 cell junction assembly;apoptotic process
xsq COX11 17q22 0.281 0.0298 0.412 respiratory gaseous exchange;respiratory
xsq IDH3B 20p13 0.281 0.0298 0.412 tricarboxylic acid cycle;isocitrate
metabolic process
xsq LOC101929374 0.281 0.0298 0.412
exp EXOSC1 10q24 0.281 0.0298 0.412 mRNA metabolic
xsq TOP2B 3p24 0.281 0.0298 0.412 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
exp WIPI1 17q24.2 -0.281 0.0298 0.412 autophagy;activation of
xai PTPRK 6q22.2-q22.3 -0.283 0.0298 0.412 cell migration;focal
adhesion assembly
xai ZNF528 19q13 -0.283 0.0298 0.412 regulation of transcription,
DNA-dependent"
his SYNC 1p35.1 -0.283 0.0298 0.412 intermediate filament-based
process
exp GGNBP1 6p21 -0.283 0.0298 0.412 mitochondrial
fission;multicellular organismal development
swa PPM1G 2p23.3 0.283 0.0299 0.412 protein dephosphorylation;cell
cycle arrest
xai HNRNPM 19p13.2 0.283 0.0299 0.412 alternative nuclear mRNA
splicing, via spliceosome;nuclear mRNA splicing, via spliceosome
hs4 C17orf64 17q23.2 0.283 0.0299 0.412
swa NASP 1p34.1 0.283 0.0299 0.412 cell proliferation;protein
transport
his RMND5A 2p11.2 0.283 0.0299 0.412
his RNF103-CHMP3 0.283 0.0299 0.412
xai SAPCD1 6p21.33 0.283 0.0299 0.412
his CEACAM5 19q13.1-q13.2 0.283 0.0299 0.413
his FAM126B 2q33.1 0.283 0.0299 0.413
his NDUFB3 2q31.3 0.283 0.0299 0.413 mitochondrial electron
exp MED15P9 0.283 0.0299 0.413
hs4 LINC01876 0.283 0.0299 0.413
xsq KHK 2p23.3 0.281 0.0299 0.412 response to sucrose
DNA-dependent"
xsq MSX2P1 0.281 0.0299 0.412
exp IL27RA 19p13.11 0.281 0.0299 0.412 cell surface receptor
xsq NUP88 17p13.2 0.281 0.0299 0.412 protein transport;glucose transport
met IL15 4q31 0.281 0.0299 0.412 immune response;positive regulation of
xsq COA7 0.281 0.0299 0.412
xsq RPL7A 9q34 0.281 0.0299 0.413 translation;mRNA metabolic process
mir hsa-miR-181d 0.281 0.0299 0.413
exp TMCC1 3q22.1 -0.281 0.0299 0.413
exp SH3GL1 19p13.3 -0.281 0.0299 0.413 endocytosis;signal
transduction
exp LOC100506827 -0.281 0.0299 0.412
exp ARHGAP23 17q12 -0.281 0.0299 0.412 signal transduction
exp FAM189A1 15q13.1 -0.281 0.0299 0.412
xai CDC42EP1 22q13.1 -0.283 0.0299 0.413 regulation of cell
his PARVA 11p15.3 -0.283 0.0299 0.412 cell projection
hs4 CFAP157 -0.283 0.0299 0.412
his C12orf29 12q21.32 0.283 0.03 0.413
his MIR548A2 0.283 0.03 0.413
xai DOK2 8p21.3 0.283 0.03 0.413 signal transduction;cell surface receptor
signaling pathway
his DOCK2 5q35.1 0.283 0.03 0.413 actin cytoskeleton organization;positive
his DBF4 7q21.3 0.283 0.03 0.413 DDR (DNA replication)
his PARP1 1q41-q42 0.283 0.03 0.413 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
exp RPL21P110 13q22.1 0.283 0.03 0.413
xai RPL34 4q25 0.283 0.03 0.413 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;RNA metabolic process
xai TYMS 18p11.32 0.283 0.03 0.413 DNA Damage Response (DDR)
xai C2orf68 2p11.2 0.283 0.03 0.413
hs4 PCED1B-AS1 12q13.11 0.283 0.03 0.413
xai LAGE3 Xq28 0.283 0.03 0.413
xai GRAPL 0.283 0.03 0.413
exp LDHBP2 Xq13.3 0.283 0.03 0.413
exp LEFTY2 1q42.1 0.28 0.03 0.413 transforming growth factor beta
receptor signaling pathway;multicellular organismal development
exp QTRTD1 3q13.31 0.28 0.03 0.413 queuosine biosynthetic process
met PRAMEF20 1p36.21 0.28 0.03 0.413
met NUDT12 5q21.2 0.28 0.03 0.413 NADP catabolic process;NAD
catabolic process
exp SNHG8 4q26 0.28 0.03 0.413
xsq ZNF589 3p21 0.28 0.03 0.413 regulation of transcription, DNA-
dependent"
exp AFG3L2 18p11 0.28 0.03 0.413 myelination;proteolysis
xsq SLC6A19 5p15.33 0.28 0.03 0.413 amino acid transmembrane
xsq EHD2 19q13.3 -0.28 0.03 0.413 endocytosis;blood coagulation
met CD27 12p13 -0.28 0.03 0.413 Apoptosis
xsq LCA10 Xq28 -0.28 0.03 0.413
xai PCGF5 10q23.32 -0.283 0.03 0.413 regulation of transcription, DNA-
dependent"
xai DYSF 2p13.3 -0.283 0.03 0.413
xai ZNF426 19p13.2 -0.283 0.03 0.413 regulation of transcription,
DNA-dependent"
xai NME1 0.283 0.0301 0.413 Apoptosis
xai MRPS27 5q13.2 0.283 0.0301 0.413
xai FAM159A 1p32.3 0.283 0.0301 0.413
his USP21 1q22 0.283 0.0301 0.413 protein modification process;proteolysis
xai RPL8P2 21q22.11 0.283 0.0301 0.414
his LOC101927815 0.283 0.0301 0.414
xai UTS2 1p36 0.283 0.0301 0.414 muscle contraction;synaptic transmission
met ARMCX3 Xq22.1 0.28 0.0301 0.413
mir hsa-miR-181c 0.28 0.0301 0.413
met AK1 9q34.1 0.28 0.0301 0.413 ATP metabolic process;nucleobase-
cop MYC 8q24.21 0.28 0.0301 0.414 Apoptosis; Oncogenes; Protein
Kinases
exp CYB5A 18q23 -0.28 0.0301 0.414 electron transport chain;small molecule
metabolic process
met CRYBB1 22q12.1 -0.28 0.0301 0.413 visual perception
xai GNAO1 16q13 -0.283 0.0301 0.414 GTP catabolic process;response to
organic nitrogen
his FOXS1 20q11.21 -0.283 0.0301 0.414 lymphangiogenesis;collagen
fibril organization
xai WBP1LP2 -0.283 0.0301 0.413
hs4 NDST1 5q33.1 -0.283 0.0301 0.413 fibroblast growth factor
hs4 FAT1 4q35 -0.283 0.0301 0.413 anatomical structure
morphogenesis;cell-cell adhesion
swa LAMTOR1 11q13.4 -0.283 0.0301 0.413 lysosome
localization;regulation of receptor recycling
xai SH3GL1 19p13.3 -0.283 0.0301 0.413 endocytosis;signal
transduction
xai PCYOX1 2p13.3 -0.283 0.0301 0.413 chloride
exp LOC100506235 0.283 0.0302 0.414
his INTS5 11q12.3 0.282 0.0302 0.414 snRNA processing
his LOC100128108 15q26.3 0.282 0.0302 0.414
his LMAN2 5q35.3 0.282 0.0302 0.414 protein transport
his RGS14 5q35.3 0.282 0.0302 0.414 spindle organization;zygote
asymmetric cell division
his POLR2J 7q22.1 0.282 0.0302 0.414 DNA Damage Response (DDR);
DDR (NER)
hs4 SEMA4A 1q22 0.282 0.0302 0.415 multicellular organismal
xsq NUDCD2 5q34 0.28 0.0302 0.414
met UPRT Xq13.3 0.28 0.0302 0.414
exp CCDC28A 6q23.1-q24.1 0.28 0.0302 0.414
xsq CTXN2 0.28 0.0302 0.414
exp DAAM1 14q23.1 -0.28 0.0302 0.414 cellular component
xsq IFITM3 11p15.5 -0.28 0.0302 0.414 innate immune response;type I
xsq SUMF1 3p26.1 -0.28 0.0302 0.414
hs4 IQCJ-SCHIP1-AS1 -0.282 0.0302 0.414
hs4 MYH11 16p13.11 -0.282 0.0302 0.414 muscle contraction;smooth
muscle contraction
his DNAJC6 1p31.3 -0.283 0.0302 0.414 post-Golgi vesicle-
xai LHFPL2 5q14.1 -0.283 0.0302 0.414
xai COX7A2 6q12 0.282 0.0303 0.415
xai SEPT7P9 10p11.1 0.282 0.0303 0.415
his ATP23 0.282 0.0303 0.415
xai UBE2I 16p13.3 0.282 0.0303 0.415 DNA Damage Response (DDR)
xsq YBX3 12p13.1 0.28 0.0303 0.415
mut PGR 11q22-q23 0.28 0.0303 0.415 epithelial cell
maturation;progesterone receptor signaling pathway
xsq DRAXIN 1p36.22 0.28 0.0303 0.415
exp LOC648987 5p12 0.28 0.0303 0.415
exp IGLJCOR18 18p11.31 0.28 0.0303 0.415
met EPHA2 1p36 0.28 0.0303 0.415 Protein Kinases
xsq PLA2G16 11q12.3 -0.28 0.0303 0.415 phospholipid metabolic
xsq RGL3 19p13.2 -0.28 0.0303 0.415 signal transduction;regulation of
small GTPase mediated signal transduction
hs4 IGFBP3 7p12.3 -0.282 0.0303 0.415 Apoptosis
xai TAGLN 11q23.2 -0.282 0.0303 0.415 muscle organ development
hs4 AK4 1p31.3 -0.282 0.0303 0.415
his EHD4-AS1 -0.282 0.0303 0.415
hs4 MIR34AHG -0.282 0.0303 0.415
hs4 LINC01759 -0.282 0.0303 0.415
his ITGB8 7p21.1 -0.282 0.0303 0.415 multicellular organismal
his LOC101927811 -0.282 0.0303 0.415
xai CD44 11p13 -0.282 0.0303 0.415 cell-matrix adhesion;negative
regulation of DNA damage response, signal transduction by p53 class mediator
xai FAM35CP 14q31.3 0.282 0.0304 0.415
exp SEPT7P9 10p11.1 0.282 0.0304 0.415
his GMIP 19p13.11 0.282 0.0304 0.415 positive regulation of Rho GTPase
activity;negative regulation of Rho GTPase activity
exp NPM1P36 6p12.1 0.282 0.0304 0.415
xai CYP2E1 10q26.3 0.282 0.0304 0.416 heterocycle metabolic
xai PARPBP 12q23.2 0.282 0.0304 0.416 DNA Damage Response (DDR)
xai KDM5A 12p11 0.282 0.0304 0.416 positive regulation of transcription,
hs4 CYBB Xp21.1 0.282 0.0304 0.416 ion transport;oxidation-reduction
process
exp GRPEL2P2 0.282 0.0304 0.416
xai FAM227B 15q21.2 0.282 0.0304 0.416
xai INO80C 18q12.2 0.282 0.0304 0.416 DNA Damage Response (DDR);
DDR (Chromatin)
exp GABRD 1p36.3 0.28 0.0304 0.415 transport;ion transport
xsq TMEM39B 1p35.1 0.28 0.0304 0.415
xsq SRD5A3 4q12 0.28 0.0304 0.415 dolichol-linked oligosaccharide
xsq BREA2 0.28 0.0304 0.416
xsq LOC729080 0.28 0.0304 0.416
exp RPL39 Xq24 0.28 0.0304 0.416 translational termination;cellular
xsq SSPO 7q36.1 0.28 0.0304 0.416 cell adhesion
exp RPL4P5 9p24.1 0.28 0.0304 0.416
xsq IST1 16q22.2 0.28 0.0304 0.416 cell division;cell cycle
exp ATP6V1E1 22q11.1 -0.28 0.0304 0.415 ion transport;cellular iron
ion homeostasis
exp ZFYVE1 14q24.2 -0.28 0.0304 0.415 negative regulation of
xai MED24 17q21.1 0.282 0.0305 0.416 protein
his NKX2-5 5q34 0.282 0.0305 0.416 outflow tract septum
xai RPL30P14 18q21.33 0.282 0.0305 0.416
xai SCAI 9q33.3 0.282 0.0305 0.416 regulation of transcription, DNA-
exp RPL30P14 18q21.33 0.282 0.0305 0.416
mut FLCN 17p11.2 0.28 0.0305 0.416 regulation of protein
phosphorylation
xsq CBFB 16q22.1 0.28 0.0305 0.416 regulation of transcription, DNA-
xsq DCLRE1A 10q25.1 0.28 0.0305 0.416 DNA Damage Response (DDR)
exp RPL39P35 0.28 0.0305 0.416
met OR2T8 1q44 0.28 0.0305 0.416 response to stimulus
xsq TOMM22 22q12-q13 0.28 0.0305 0.416 intracellular protein
transport;protein import into mitochondrial outer membrane
xsq TIPIN 15q22.31 0.28 0.0305 0.416 DNA Damage Response (DDR)
xsq ZNF559-ZNF177 0.28 0.0305 0.416
xsq YBX3P1 16p11.2 0.28 0.0305 0.416
exp PCYOX1 2p13.3 -0.28 0.0305 0.416 chloride transport;prenylated
xsq HERC6 4q22.1 -0.28 0.0305 0.416 protein modification
process
xai NUPR1 16p11.2 -0.282 0.0305 0.416 induction of apoptosis;cell
growth
hs4 LZTFL1 3p21.3 -0.282 0.0305 0.416
his EGFR 7p12 -0.282 0.0305 0.416 Apoptosis; Cell Signaling;
xai PPP1R14C 6q24.3-q25.3 -0.282 0.0305 0.416 regulation of
phosphorylation
xai DHCR24 1p32.3 -0.282 0.0305 0.416 Apoptosis
hs4 PALLD 4q32.3 -0.282 0.0305 0.416 cytoskeleton organization
hs4 ACTN1 14q24 -0.282 0.0305 0.416 Apoptosis
hs4 ACTN1-AS1 -0.282 0.0305 0.416
hs4 TCERG1L 10q26.3 0.282 0.0306 0.416
his NCF1C 7q11.23 0.282 0.0306 0.416 cell communication
exp SUMO2P6 0.282 0.0306 0.417
exp CHCHD2P9 0.282 0.0306 0.417
xai PHF7 3p21.1 0.282 0.0306 0.417
exp LOC100421439 0.282 0.0306 0.417
his CD53 1p13 0.282 0.0306 0.417 signal transduction
xai MTFP1 22q 0.282 0.0306 0.417 mitochondrial fission;apoptotic process
xai CHCHD2P9 0.282 0.0306 0.417
his GATM 15q21.1 0.282 0.0306 0.417 response to oxidative
stress;response to mercury ion
his SPATA5L1 15q21.1 0.282 0.0306 0.417
xsq PARP16 15q22.31 0.279 0.0306 0.417
xsq EP400NL 12q24.33 0.279 0.0306 0.417
met FAM110C 2p25.3 0.279 0.0306 0.417
xsq PDIA2 16p13.3 0.279 0.0306 0.417 response to hypoxia;protein folding
exp TGFBI 5q31 -0.279 0.0306 0.417 visual perception;cell
proliferation
exp PTPRK 6q22.2-q22.3 -0.279 0.0306 0.417 cell migration;focal
adhesion assembly
exp PLPP4 -0.279 0.0306 0.417 phospholipid dephosphorylation
exp ARVCF 22q11.21 -0.279 0.0306 0.417 cell adhesion;multicellular
exp PRTG 15q21.3 -0.279 0.0306 0.417 multicellular organismal
development
exp PLPP1 -0.279 0.0306 0.417 lipid metabolic process;androgen
xsq ATP8B1 18q21.31 -0.28 0.0306 0.416 bile acid and bile salt
his RERE 1p36.23 -0.282 0.0306 0.417 multicellular organismal
development;chromatin remodeling
his LOC102724552 -0.282 0.0306 0.417
xai TBC1D17 19q13.33 -0.282 0.0306 0.416
xai SUMO2P6 0.282 0.0307 0.417
his CDCA3 12p13 0.282 0.0307 0.417 cell cycle;mitosis
his USP5 12p13 0.282 0.0307 0.417 positive regulation of proteasomal
ubiquitin-dependent protein catabolic process;protein K48-linked deubiquitination
hs4 HIST1H2BJ 6p22.1 0.282 0.0307 0.417 nucleosome assembly;defense
hs4 HIST1H2AG 6p22.1 0.282 0.0307 0.417
xai SSB 2q31.1 0.282 0.0307 0.417 RNA processing;tRNA modification
swa NAP1L4 11p15.5 0.282 0.0307 0.417 nucleosome assembly
xai CTSG 14q11.2 0.282 0.0307 0.417 positive regulation of immune
hs4 ELAVL4 1p34 0.282 0.0307 0.417 RNA processing;mRNA processing
his RHOG 11p15.5-p15.4 0.282 0.0307 0.417 small GTPase mediated signal
exp GTF3C4 9q34.13 0.279 0.0307 0.417 positive regulation of
mut BMPR1B 4q22-q24 0.279 0.0307 0.417 skeletal system
development;limb morphogenesis
exp KDM5A 12p11 0.279 0.0307 0.417 positive regulation of transcription,
met LOC91450 15q24.3 0.279 0.0307 0.417
exp RPS14 5q31-q33 0.279 0.0307 0.417 nuclear-transcribed mRNA catabolic
xsq ADSL 22q13.2 0.279 0.0307 0.417 response to nutrient;aerobic
respiration
xsq PHOSPHO2-KLHL23 0.279 0.0307 0.417
exp POFUT2 21q22.3 -0.279 0.0307 0.417 carbohydrate metabolic
cop MB21D2 3q29 -0.279 0.0307 0.417
xsq FIGN 2q24.3 -0.279 0.0307 0.417 locomotory behavior
swa PLA2G4A 1q25 -0.282 0.0307 0.417 metabolic process;platelet
activation
swa PGM1 1p31 -0.282 0.0307 0.417 glycogen biosynthetic
process;glycogen catabolic process
hs4 PEX11A 15q26.1 -0.282 0.0307 0.417 peroxisome
hs4 WDR93 15q26.1 -0.282 0.0307 0.417 electron transport chain
hs4 HRH2 5q35.2 0.282 0.0308 0.418 G-protein signaling, coupled to
cyclic nucleotide second messenger;immune response"
exp RPSAP63 Xq26.2 0.281 0.0308 0.418
his SNU13 0.281 0.0308 0.418 gene expression;ribosome biogenesis
his C22orf46 22q13.2 0.281 0.0308 0.418
met TSPAN6 Xq22 0.279 0.0308 0.418 signal transduction;positive
xsq RHOG 11p15.5-p15.4 0.279 0.0308 0.418 small GTPase mediated signal
xsq LINC00669 18q12.2-q12.3 0.279 0.0308 0.418
xsq HNRNPR 1p36.12 0.279 0.0308 0.418 nuclear mRNA splicing, via
exp LOC441862 0.279 0.0308 0.418
exp SAAL1 11p15.1 0.279 0.0308 0.418 acute-phase response
exp NOC2L 1p36.33 0.279 0.0308 0.418 negative regulation of apoptotic
xsq EFEMP1 2p16 -0.279 0.0308 0.418 peptidyl-tyrosine
xsq SOX13 1q32 -0.279 0.0308 0.418 regulation of transcription, DNA-
xsq AFAP1L2 10q25.3 -0.279 0.0308 0.418 regulation of mitotic
xsq ZNF608 5q23.2 -0.279 0.0308 0.418
met MIR92A1 -0.279 0.0308 0.418
his LINC01634 -0.281 0.0308 0.418
hs4 LITAF 16p13.13 -0.282 0.0308 0.418 Apoptosis
xai NFIX 19p13.3 -0.282 0.0308 0.418 negative regulation of
xai PLK1 16p12.2 0.281 0.0309 0.418 DDR (DNA replication); Protein
Kinases
his LYL1 19p13.2 0.281 0.0309 0.418 regulation of transcription, DNA-
xai NOL8 9q22.31 0.281 0.0309 0.418 DNA replication;rRNA processing
hs4 KCNJ9 1q23.2 0.281 0.0309 0.418 potassium ion transport;synaptic
transmission
his MRPS5 2p11.2-q11.2 0.281 0.0309 0.419 translation
his TEX14 17q22 0.281 0.0309 0.419
his RAD51C 17q22 0.281 0.0309 0.419 DNA Damage Response (DDR); DDR (FA)
xai TLK1P1 9q33.2 0.281 0.0309 0.419
xsq PHF7 3p21.1 0.279 0.0309 0.418
xsq GPR75-ASB3 0.279 0.0309 0.418
met RHOBTB2 8p21.3 0.279 0.0309 0.418 small GTPase mediated signal
exp SNX29P1 0.279 0.0309 0.419
xsq TFAP4 16p13 0.279 0.0309 0.419 protein complex assembly;positive
exp NUP205 7q33 0.279 0.0309 0.419 protein transport;glucose transport
met CAP2 6p22.3 0.279 0.0309 0.419 activation of adenylate cyclase
activity;axon guidance
exp EVI2B 17q11.2 0.279 0.0309 0.419
exp TSPAN7 Xp11.4 0.279 0.0309 0.419 interspecies interaction
between organisms
xsq IL12RB1 19p13.1 0.279 0.0309 0.419 signal transduction;positive
exp PSMF1 20p13 0.279 0.0309 0.419 S phase of mitotic cell cycle;apoptotic
process
xsq SERPINH1 11q13.5 -0.279 0.0309 0.419 response to
exp RAB32 6q24.3 -0.279 0.0309 0.419 small GTPase mediated signal
exp DYSF 2p13.3 -0.279 0.0309 0.419
his AQP1 7p14 -0.281 0.0309 0.418 cell volume
homeostasis;establishment or maintenance of actin cytoskeleton polarity
xai GMIP 19p13.11 0.281 0.031 0.419 positive regulation of Rho GTPase
his CYTH4 22q12.3-q13.1 0.281 0.031 0.419 regulation of ARF protein signal
transduction;regulation of cell adhesion
hs4 RAG2 11p13 0.281 0.031 0.419 B cell homeostatic proliferation;positive
exp FAM227B 15q21.2 0.281 0.031 0.419
xai POM121L1P 22q11.22 0.281 0.031 0.419
hs4 PHF19 9q33.2 0.281 0.031 0.419 regulation of transcription, DNA-
dependent"
exp EIF3C 0.279 0.031 0.419 translation;translational initiation
exp TMEM206 1q32.3 0.279 0.031 0.419
exp GCSH 16q23.2 0.279 0.031 0.419 glycine catabolic process;glycine
decarboxylation via glycine cleavage system
xsq NGLY1 3p24.2 0.279 0.031 0.419 glycoprotein catabolic process
mir hsa-miR-1234 0.279 0.031 0.419
xsq SKA3 13q12.11 0.279 0.031 0.419 chromosome segregation;mitosis
xsq TADA1 1q24.1 0.279 0.031 0.419 regulation of transcription, DNA-
exp GABRG1 4p12 0.279 0.031 0.419 gamma-aminobutyric acid signaling
exp MAGOH2P 0.279 0.031 0.419
exp NIFK 0.279 0.031 0.419 rRNA transcription;negative regulation of
met SLA2 20q11.23 -0.279 0.031 0.419 negative regulation of
exp TUBB2A 6p25 -0.279 0.031 0.419 protein polymerization;protein
folding
xsq THRB 3p24.2 -0.279 0.031 0.419 regulation of transcription, DNA-
xsq SASH1 6q24.3 -0.279 0.031 0.419
xai FAM134A 2q35 -0.281 0.031 0.419
his PSG8 19q13.2 -0.281 0.031 0.419
hs4 PPP1R15A 19q13.2 -0.281 0.031 0.419 Apoptosis
xai BACE2 21q22.3 -0.281 0.031 0.419 proteolysis;membrane protein
xai PRTG 15q21.3 -0.281 0.031 0.419 multicellular organismal
development
exp YBX1P8 -0.281 0.031 0.419
his NAXE 0.281 0.0311 0.419
his LOC401127 4p14 0.281 0.0311 0.419
xai SLC35F2 11q22.3 0.281 0.0311 0.419 Solute Carriers
xai LRRTM3 10q21.3 0.281 0.0311 0.419
xai CCR8 3p22 0.281 0.0311 0.419 G-protein coupled receptor signaling
pathway;elevation of cytosolic calcium ion concentration
xai EPHB6 7q33-q35 0.281 0.0311 0.419 Cell Signaling
hs4 SYNDIG1 20p11.21 0.281 0.0311 0.419 intracellular protein
xai KISS1R 19p13.3 0.281 0.0311 0.419 neuropeptide signaling
pathway;positive regulation of stress fiber assembly
hs4 SEC14L4 22q12.2 0.281 0.0311 0.419
hs4 T 6q27 0.281 0.0311 0.419 heart morphogenesis;reproductive process
exp MIR2052HG 0.281 0.0311 0.42
swa SUB1 5p13.3 0.281 0.0311 0.42 regulation of transcription from
xsq WDR18 19p13.3 0.279 0.0311 0.419 multicellular organismal
development
xsq FOXD2-AS1 1p33 0.279 0.0311 0.419
exp CLPP 19p13.3 0.279 0.0311 0.419 proteolysis
xsq SAMD13 1p31.1 0.279 0.0311 0.419
xsq SLF1 0.279 0.0311 0.419
xsq SHPRH 6q24.3 0.279 0.0311 0.419 DNA Damage Response (DDR); DDR
(TLS)
pro EP300_25_GBL00049 0.279 0.0311 0.42
xai HSPG2 1p36.1-p34 -0.281 0.0311 0.419 chondrocyte
differentiation;cardiac muscle tissue development
xai ACO1 9p21.1 -0.281 0.0311 0.419 response to iron(II)
ion;regulation of gene expression
xai FAM19A1 3p14.1 -0.281 0.0311 0.419
xai YBX1P8 -0.281 0.0311 0.419
hs4 SAMD4A 14q22.2 -0.281 0.0311 0.419 negative regulation of
hs4 LOC100996286 0.281 0.0312 0.42
exp RPL10P3 0.281 0.0312 0.42
hs4 VIPR2 7q36.3 0.281 0.0312 0.42 G-protein coupled receptor
signaling pathway;activation of adenylate cyclase activity
xai OXNAD1 3p25-p24 0.281 0.0312 0.42
xai HIST1H3G 0.281 0.0312 0.42
his KRAS 12p12.1 0.281 0.0312 0.42 Cell Signaling; Oncogenes; Protein
Kinases
xsq INA 10q24.33 0.278 0.0312 0.421 multicellular organismal
exp SIRT2 19q13 -0.278 0.0312 0.42 regulation of exit from
mitosis;response to redox state
exp PHKG1P2 7q11.21 -0.281 0.0312 0.421
xai PHKG1P2 7q11.21 -0.281 0.0312 0.42
his LINC01111 -0.281 0.0312 0.42
swa SEC22B 1q21.1 -0.281 0.0312 0.42 ER to Golgi vesicle-
mediated transport;protein transport
his PRKACA 19p13.1 -0.281 0.0312 0.42 Protein Kinases
swa ACAP1 17p13.1 0.281 0.0313 0.421 regulation of ARF GTPase
his GAR1 4q25 0.281 0.0313 0.421 DNA Damage Response (DDR)
xai COX7C 5q14 0.281 0.0313 0.421 generation of precursor metabolites and
exp CCR8 3p22 0.281 0.0313 0.421 G-protein coupled receptor signaling
exp RPL8P2 21q22.11 0.281 0.0313 0.421
his INTS12 4q24 0.281 0.0313 0.421 snRNA processing
his GSTCD 4q24 0.281 0.0313 0.421
xsq MRM1 17q12 0.278 0.0313 0.421 RNA processing
met OR11L1 1q44 0.278 0.0313 0.421
xsq SDCCAG3 9q34.3 0.278 0.0313 0.421
met NLRP4 19q13.43 0.278 0.0313 0.421
xsq VPS16 20p13 0.278 0.0313 0.421 intracellular protein transport
exp MED24 17q21.1 0.278 0.0313 0.421 protein
exp NUDT6 4q26 0.278 0.0313 0.421
dependent"
exp SMARCA5 4q31.1-q31.2 0.278 0.0313 0.421 DNA Damage Response
xsq MRTO4 1p36.13 0.278 0.0313 0.421 ribosome biogenesis
met PLPP3 0.278 0.0313 0.421 negative regulation of protein
phosphorylation;homotypic cell-cell adhesion
exp CYP2E1 10q26.3 0.278 0.0313 0.421 heterocycle metabolic
exp POLR3F 20p11.23 0.278 0.0313 0.421 transcription, DNA-
dependent;positive regulation of innate immune response
exp POLR1C 6p21.1 0.278 0.0313 0.421 DNA Damage Response (DDR)
exp MT2A 16q13 -0.278 0.0313 0.421 cellular response to interleukin-
xsq GCNT2 6p24.2 -0.278 0.0313 0.421 glycosaminoglycan
met LST1 6p21.3 -0.278 0.0313 0.421 cell morphogenesis;immune
response
cop CA13 8q21.2 -0.278 0.0313 0.421 one-carbon metabolic process
xsq CX3CL1 16q13 -0.278 0.0313 0.421 defense response;positive
exp ACTN1-AS1 -0.281 0.0313 0.421
his TRIML1 4q35.2 0.281 0.0314 0.421
his SNRPB 20p13 0.281 0.0314 0.421 RNA splicing;gene expression
xai GTF3C4 9q34.13 0.281 0.0314 0.421 positive regulation of
his LOC101928728 0.281 0.0314 0.421
his ARID1A 1p35.3 0.281 0.0314 0.421 DNA Damage Response (DDR);
hs4 RNF165 18q21.1 0.281 0.0314 0.421
exp LOC63930 0.281 0.0314 0.421
xai ANKRD46 8q22.2 0.281 0.0314 0.421
xai CETN3 5q14.3 0.28 0.0314 0.421 centrosome cycle;cell division
xai LOC100506235 0.28 0.0314 0.421
xsq USP44 12q22 0.278 0.0314 0.421 cell division;anaphase
mut CHRM2 7q31-q35 0.278 0.0314 0.421 nervous system
development;regulation of heart contraction
xsq RBBP8 18q11.2 0.278 0.0314 0.421 DNA Damage Response (DDR); DDR (G1-
S checkpoint)
exp RBBP6 16p12.2 0.278 0.0314 0.421 protein ubiquitination involved in
exp GOT2 16q21 0.278 0.0314 0.421 2-oxoglutarate metabolic
exp NPR2 9p21-p12 -0.278 0.0314 0.421 cell surface receptor
signaling pathway;receptor guanylyl cyclase signaling pathway
xsq ZNF300 5q33.1 -0.278 0.0314 0.421 regulation of
met ANTXRL 10q11.22 -0.278 0.0314 0.421
xsq PLOD1 1p36.22 -0.278 0.0314 0.421 response to hypoxia;protein
exp DCLK1 13q13 -0.278 0.0314 0.421 response to virus;endosome
transport
hs4 ZNF578 19q13.41 -0.28 0.0314 0.421 regulation of transcription,
DNA-dependent"
hs4 OSGIN1 16q23.3 -0.281 0.0314 0.421 multicellular organismal
his DNAJB13 11q13.4 -0.281 0.0314 0.421 protein
folding;apoptotic process
his FAT2 5q33.1 -0.281 0.0314 0.421 cell adhesion;homophilic cell
adhesion
his MIR548H1 -0.281 0.0314 0.421
his TIMMDC1 3q13.33 0.28 0.0315 0.421
swa UBE2L3 22q11.21 0.28 0.0315 0.421 protein
polyubiquitination;cellular response to steroid hormone stimulus
xai TAF1D 11q21 0.28 0.0315 0.421 regulation of transcription, DNA-
dependent"
his MCAT 22q13.31 0.28 0.0315 0.421 fatty acid biosynthetic
xai PSD4 2q13 0.28 0.0315 0.422 regulation of ARF protein signal
transduction
xai DHX38 16q22 0.28 0.0315 0.422 RNA splicing;gene expression
his PDE6H 12p13 0.28 0.0315 0.422
his STARD6 18q21.2 0.28 0.0315 0.422 transport;lipid transport
his C18orf54 18q21.2 0.28 0.0315 0.422
xsq CCDC28A 6q23.1-q24.1 0.278 0.0315 0.421
exp ARMC5 16p11.2 0.278 0.0315 0.421
xsq CHRAC1 8q24.3 0.278 0.0315 0.422 DNA Damage Response (DDR);
DDR (Chromatin)
exp RPL9 4p13 0.278 0.0315 0.422 gene expression;viral reproduction
met LETM1 4p16.3 0.278 0.0315 0.422 cristae formation
met FAM135B 8q24.23 0.278 0.0315 0.422
exp NPM1P39 1p36.11 0.278 0.0315 0.422
exp AFMID 17q25.3 0.278 0.0315 0.422 tryptophan catabolic
xsq PALLD 4q32.3 -0.278 0.0315 0.422 cytoskeleton organization
xsq PRR26 10p15.3 -0.278 0.0315 0.422
exp SCARA3 8p21 -0.278 0.0315 0.421 response to oxidative
stress;UV protection
met LYL1 19p13.2 -0.278 0.0315 0.421 regulation of transcription,
DNA-dependent;B cell differentiation
exp DNAH7 2q32.3 -0.28 0.0315 0.422 ciliary or flagellar
his FIGN 2q24.3 -0.28 0.0315 0.422 locomotory behavior
hs4 PCDHB7 5q31 -0.28 0.0315 0.422 cell adhesion;homophilic cell
adhesion
his TANC1 2q24.2 -0.28 0.0315 0.421
his SMG1P1 0.28 0.0316 0.422
his RRN3P3 16p12.2 0.28 0.0316 0.422
swa PSMC6 14q22.1 0.28 0.0316 0.422 M/G1 transition of mitotic cell
cycle;DNA damage response, signal transduction by p53 class mediator resulting in
cell cycle arrest
his ALKBH1 14q24.3 0.28 0.0316 0.422 DNA Damage Response (DDR);
DDR (BER)
his SLIRP 14q24.3 0.28 0.0316 0.422 regulation of transcription, DNA-
dependent"
his BUD13 11q23.3 0.28 0.0316 0.422 nuclear mRNA splicing, via
his CDH12 5p14.3 0.28 0.0316 0.422 homophilic cell adhesion;cell-cell
adhesion
his TOMM22 22q12-q13 0.28 0.0316 0.422 intracellular protein
xai PNO1 2p14 0.28 0.0316 0.422
his ASNSD1 2p24.3-q21.3 0.28 0.0316 0.422 asparagine biosynthetic
process;glutamine metabolic process
xai GRPEL2 5q32 0.28 0.0316 0.422 protein folding
his PNP 14q13.1 0.28 0.0316 0.422 nicotinamide riboside catabolic
exp PTPRN 2q35-q36.1 0.278 0.0316 0.422 cytokine-mediated signaling
pathway;response to insulin stimulus
exp RMI2 16p13.13 0.278 0.0316 0.422 DNA Damage Response (DDR); DDR (FA)
xsq KLHL15 Xp22.1-p21 0.278 0.0316 0.422
mir hsa-miR-557 0.278 0.0316 0.422
met SNX15 11q12 0.278 0.0316 0.422 cell communication;intracellular protein
transport
xsq DZIP1L 3q22.3 -0.278 0.0316 0.422
xsq LZTS2 10q24 -0.278 0.0316 0.422 cell cycle;mitosis
xsq ARHGAP23 17q12 -0.278 0.0316 0.422 signal transduction
met FUT7 9q34.3 -0.278 0.0316 0.422 leukocyte migration involved
in immune response;protein glycosylation
exp RTN4R 22q11.21 -0.278 0.0316 0.422 axonogenesis;nerve growth
exp NFIX 19p13.3 -0.278 0.0316 0.422 negative regulation of
xsq FAM106B -0.278 0.0316 0.422
his GPX8 5q11.2 -0.28 0.0316 0.422 response to oxidative stress
his LRRC4C 11p12 -0.28 0.0316 0.422 regulation of axonogenesis
hs4 LOC339874 -0.28 0.0316 0.422
hs4 NUDT16 3q22.1 -0.28 0.0316 0.422
xai FLJ11292 0.282 0.0317 0.422
xai RETN 19p13.2 0.282 0.0317 0.423 response to insulin stimulus;fat
xai CR1 1q32 0.28 0.0317 0.422 negative regulation of complement
activity
his MPIG6B 0.28 0.0317 0.422
xai NARS2 11q14.1 0.28 0.0317 0.422 asparaginyl-tRNA
xai APRT 16q24 0.28 0.0317 0.422 nucleoside metabolic process;purine-
his HERC2P2 15q11.2 0.28 0.0317 0.422
xai ZNF711 Xq21.1 0.28 0.0317 0.422 positive regulation of
xai TTI2 8p12 0.28 0.0317 0.423 DNA Damage Response (DDR)
xai LOC63930 0.28 0.0317 0.423
his RNU1-1 1p36.1 0.28 0.0317 0.423
exp KHK 2p23.3 0.278 0.0317 0.422 response to sucrose
xsq ECSIT 19p13.2 0.278 0.0317 0.422 innate immune response;regulation
exp KRT72 12q13.13 0.278 0.0317 0.422
xsq GTPBP4 10p15-p14 0.278 0.0317 0.422 negative regulation of cell-
met SDHAP1 3q29 0.278 0.0317 0.422
met PTP4A1 6q12 0.278 0.0317 0.422 multicellular organismal
development;positive regulation of cell migration
xsq PDXP 22q12.3 0.278 0.0317 0.422 regulation of mitosis;metabolic
process
xsq DDX19A 16q22.1 0.278 0.0317 0.423 protein transport;mRNA
transport
xsq FXYD7 19q13.12 -0.278 0.0317 0.422 regulation of ion transport
xsq FAM198B 4q32.1 -0.278 0.0317 0.422
exp MS4A6E 11q12.2 -0.278 0.0317 0.422
exp UBE2H 7q32 -0.278 0.0317 0.422 protein K11-linked
ubiquitination;ubiquitin-dependent protein catabolic process
his ANKUB1 3q25.1 -0.28 0.0317 0.422
his ADRA1B 5q33.3 -0.28 0.0317 0.422 G-protein coupled receptor
signaling pathway;visual learning
exp WBP1LP2 -0.28 0.0317 0.422
his SERPINA6 14q32.1 -0.28 0.0317 0.422 regulation of
proteolysis;transport
his MIR3170 -0.28 0.0317 0.422
xai PYROXD2 10q24.2 -0.28 0.0317 0.422
xai STBD1 4q21.1 -0.28 0.0317 0.422 muscle contraction
swa TMX1 14q22.1 -0.28 0.0317 0.422 transport;cell redox homeostasis
exp GRAPL 0.28 0.0318 0.423
xai C7orf77 0.28 0.0318 0.423
xai MAGOH2P 0.28 0.0318 0.423
xai MTVR2 17q23 0.28 0.0318 0.423
xai MED12 Xq13 0.28 0.0318 0.423 Oncogenes
his LINC01684 0.28 0.0318 0.423
his CCDC141 2q31.2 0.28 0.0318 0.423
his PIK3R6 17p13.1 0.28 0.0318 0.423 blood coagulation;platelet
activation
his FAM129C 19p13.11 0.28 0.0318 0.423
his ELMO1 7p14.1 0.28 0.0318 0.423 actin cytoskeleton
met ZDHHC1 16q22.1 0.278 0.0318 0.423 protein palmitoylation
xsq P2RY1 3q25.2 0.278 0.0318 0.423 response to mechanical
exp TTC5 14q11.2 0.278 0.0318 0.423 DNA repair
xsq ZGRF1 0.277 0.0318 0.423
exp FTH1P5 6p12.3 -0.277 0.0318 0.423
xsq MVP 16p11.2 -0.278 0.0318 0.423 DNA Damage Response (DDR)
his IL4 5q31.1 -0.28 0.0318 0.423 negative regulation of chronic
inflammatory response;regulation of proton transport
exp AK3P5 10p11.22 -0.28 0.0318 0.423
xai ATP6V1H 8q11.2 -0.28 0.0318 0.423 ion transport;transferrin
transport
xai DNAH7 2q32.3 -0.28 0.0318 0.423 ciliary or flagellar
xai SERPINH1P1 9p13.3 -0.28 0.0318 0.423
xai CPM 12q14.3 -0.28 0.0318 0.423 proteolysis;anatomical structure
morphogenesis
his LEPROT 1p31.3 -0.28 0.0318 0.423 negative regulation of
his LEPR 1p31 -0.28 0.0318 0.423 energy reserve metabolic process;cell
xai C11orf52 11q23.1 -0.28 0.0318 0.423
xai LDAH 0.28 0.0319 0.423
his CXorf65 Xq13.1 0.28 0.0319 0.423
his IL2RG Xq13.1 0.28 0.0319 0.423 immune response;signal transduction
his FCAMR 1q32.1 0.28 0.0319 0.423
xai C12orf29 12q21.32 0.28 0.0319 0.423
exp OR4Q3 0.28 0.0319 0.423 response to stimulus
his TMEM50A 1p36.11 0.28 0.0319 0.423
his TESMIN 0.28 0.0319 0.423
his EMID1 22q12.2 0.28 0.0319 0.424
his PDE4D 5q12 0.28 0.0319 0.424 establishment of endothelial barrier;cAMP
catabolic process
dependent"
exp PSMG1 21q22.3 0.277 0.0319 0.423 proteasome assembly
met TCEAL4 Xq22.2 0.277 0.0319 0.423 regulation of transcription,
DNA-dependent"
met MIR942 0.277 0.0319 0.423
exp FIP1L1 4q12 0.277 0.0319 0.423 mRNA processing
xsq PPP1CC 12q24.1-q24.2 0.277 0.0319 0.423 carbohydrate metabolic
exp MTFP1 22q 0.277 0.0319 0.423 mitochondrial fission;apoptotic process
xsq CXXC5 5q31.2 -0.277 0.0319 0.423 signal transduction;positive
his MIR8073 -0.28 0.0319 0.423
xai GRIK1 21q22.11 -0.28 0.0319 0.423 nervous system
development;regulation of synaptic transmission, glutamatergic
xai ABLIM3 5q32 -0.28 0.0319 0.423 cytoskeleton organization;axon
guidance
xai HOXB3 17q21.3 -0.28 0.0319 0.423 multicellular organismal
xai GGPS1 1q43 -0.28 0.0319 0.423 small molecule metabolic
process;cholesterol biosynthetic process
his OR9Q1 11q12.1 -0.28 0.0319 0.423
xai WWC3 Xp22.32 -0.28 0.0319 0.423
xai DOCK9 13q32.3 -0.28 0.0319 0.423 blood coagulation
his ADORA1 1q32.1 -0.28 0.0319 0.423 Apoptosis
xai RPS9 19q13.4 0.28 0.032 0.424 SRP-dependent cotranslational protein
targeting to membrane;cellular protein metabolic process
his R3HDM4 19p13.3 0.28 0.032 0.424
his KISS1R 19p13.3 0.28 0.032 0.424 neuropeptide signaling
his ARID3A 19p13.3 0.28 0.032 0.424 regulation of transcription, DNA-
dependent"
xai ZUFSP 6q22.1 0.28 0.032 0.424
xai RPS10P2 20p12 0.28 0.032 0.424
xai RPS7P4 1p31.3 0.28 0.032 0.424
mut GRIN3A 9q31.1 0.277 0.032 0.424 ion transport;calcium ion transport
xsq E2F4 16q22.1 0.277 0.032 0.424 mitotic cell cycle;cilium assembly
exp BTK Xq21.33-q22 0.277 0.032 0.424 regulation of transcription, DNA-
exp SF3A3P1 20p13 0.277 0.032 0.424
xsq NFAM1 22q13.2 0.277 0.032 0.424 regulation of B cell
differentiation;positive regulation of B cell receptor signaling pathway
xsq ALDH1A2 15q21.3 0.277 0.032 0.424 heart morphogenesis;positive
regulation of gene expression
xsq FUS 16p11.2 0.277 0.032 0.424 nuclear mRNA splicing, via
spliceosome;cell death
xsq LSM7 19p13.3 0.277 0.032 0.424 nuclear mRNA splicing, via
exp DFFA 1p36.3-p36.2 0.277 0.032 0.424 Apoptosis
xsq LDAH 0.277 0.032 0.424
xsq TMEM54 1p35-p34 -0.277 0.032 0.424
hs4 ABLIM3 5q32 -0.279 0.032 0.424 cytoskeleton organization;axon
guidance
xai FLJ20712 7p14.3 -0.279 0.032 0.424
xai AK3P5 10p11.22 -0.28 0.032 0.424
exp FLJ20712 7p14.3 -0.28 0.032 0.424
hs4 PCDHGA6 -0.28 0.032 0.424 cell adhesion;homophilic cell adhesion
xai PDP1 8q22.1 -0.28 0.032 0.424 pyruvate metabolic process;regulation of
acetyl-CoA biosynthetic process from pyruvate
hs4 SPTBN4 19q13.13 -0.28 0.032 0.424 cytoskeletal anchoring at plasma
membrane;positive regulation of multicellular organism growth
hs4 BLVRB 19q13.1-q13.2 -0.28 0.032 0.424 small molecule metabolic
hs4 APOA2 1q23.3 0.279 0.0321 0.424 cholesterol metabolic
hs4 TOMM40L 1q23.3 0.279 0.0321 0.424 protein
hs4 MIR5187 0.279 0.0321 0.424
his MOSPD3 7q22 0.279 0.0321 0.424 heart development
xai NBAS 2p24 0.279 0.0321 0.424
xai PER2 2q37.3 0.279 0.0321 0.424 DNA Damage Response (DDR)
xai LOC100507600 0.279 0.0321 0.424
exp EIF3LP1 14q31.1 0.277 0.0321 0.424
met CDRT4 17p12 0.277 0.0321 0.424
xsq LUC7L 16p13.3 0.277 0.0321 0.424 negative regulation of striated
exp PIM2 Xp11.23 0.277 0.0321 0.424 anti-apoptosis;positive regulation
met PID1 2q36.3 0.277 0.0321 0.424 regulation of mitochondrial
fusion;cellular response to interleukin-6
exp CLK3 15q24 0.277 0.0321 0.424 protein autophosphorylation;protein
phosphorylation
DNA-dependent"
xsq C1QBP 17p13.3 0.277 0.0321 0.424 blood coagulation;blood
coagulation, intrinsic pathway
exp PARP1P2 14q22 0.277 0.0321 0.425
exp GNAO1 16q13 -0.277 0.0321 0.424 GTP catabolic process;response to
organic nitrogen
exp ARL4D 17q21.31 -0.277 0.0321 0.424 GTP catabolic process;small
exp SEMA3F 3p21.3 -0.277 0.0321 0.424 neural crest cell
migration;multicellular organismal development
xsq EFHD1 2q37.1 -0.277 0.0321 0.424 neuron projection development
xai TRPM4 19q13.33 -0.279 0.0321 0.424 dendritic cell
hs4 XAGE2 -0.279 0.0321 0.424
swa TNS3 7p12.3 -0.279 0.0321 0.424 positive regulation of cell
his ITGB2-AS1 0.279 0.0322 0.425
his MIR7852 0.279 0.0322 0.425
xai EWSR1 22q12.2 0.279 0.0322 0.425 regulation of transcription, DNA-
dependent"
xai PFDN2 1q23.3 0.279 0.0322 0.425 protein folding;cellular protein
metabolic process
his MIR7152 0.279 0.0322 0.425
his CDC7 1p22 0.279 0.0322 0.425 DDR (DNA replication)
swa MUC13 3q21.2 0.279 0.0322 0.425 cellular protein metabolic
his IDNK 9q21.32 0.279 0.0322 0.425 carbohydrate metabolic process
his ZNF182 Xp11.23 0.279 0.0322 0.425 regulation of transcription,
DNA-dependent"
his SPACA5 Xp11.23 0.279 0.0322 0.425
his C17orf75 17q11.2 0.279 0.0322 0.425 spermatogenesis
xai CLASP2 3p22.3 0.279 0.0322 0.425 microtubule organizing center
xsq LOC400685 0.277 0.0322 0.425
xsq INTS10 8p21.3 0.277 0.0322 0.425 snRNA processing
met ARPIN 0.277 0.0322 0.425
exp CARD8 19q13.33 0.277 0.0322 0.425 activation of cysteine-type
process
xsq SERPINB6 6p25 -0.277 0.0322 0.425 negative regulation of
exp PHLDB2 3q13.2 -0.277 0.0322 0.425
exp AGAP1 2q37 -0.277 0.0322 0.425 small GTPase mediated signal
xsq NXPH4 12q13.3 -0.277 0.0322 0.425 neuropeptide signaling
pathway
exp ARL6IP1 16p12-p11.2 -0.277 0.0322 0.425 cotranslational protein
xai HLA-J 6p21.31 -0.279 0.0322 0.425
hs4 NECTIN4 -0.279 0.0322 0.425
hs4 LINC00535 -0.279 0.0322 0.425
hs4 FAM92A -0.279 0.0322 0.425
xai IL17RC 3p25.3 -0.279 0.0322 0.425
xai DRICH1 0.279 0.0323 0.425
xai DGUOK 2p13 0.279 0.0323 0.425 nucleotide biosynthetic process;negative
regulation of neuron projection development
his XCR1 0.279 0.0323 0.425
his POC5 5q13.3 0.279 0.0323 0.425 cell cycle
his CMC1 3p24.1 0.279 0.0323 0.425
his PTGES3 12q13.3 0.279 0.0323 0.425 glycogen biosynthetic
process;lung saccule development
xai UNC93B6 0.279 0.0323 0.425
xsq GLIPR1L2 12q21.2 0.277 0.0323 0.425
met USP18 22q11.21 0.277 0.0323 0.425 proteolysis;ubiquitin-dependent
xsq RNPS1 16p13.3 0.277 0.0323 0.425 termination of RNA polymerase II
exp PUSL1 1p36.33 0.277 0.0323 0.425 pseudouridine synthesis;tRNA
processing
xsq ZFAND4 10q11.22 0.277 0.0323 0.425
exp TRIM6-TRIM34 -0.277 0.0323 0.425
xsq GLRB 4q31.3 -0.277 0.0323 0.425 startle response;ion
exp FLNA Xq28 -0.277 0.0323 0.425 actin cytoskeleton
exp WBP5 Xq22.2 -0.277 0.0323 0.425
xai EDN1 6p24.1 -0.279 0.0323 0.425 negative regulation of
pathway
his CDK15 2q33.2 -0.279 0.0323 0.425 Protein Kinases
xai BHMT 5q14.1 -0.279 0.0323 0.425 regulation of homocysteine
metabolic process;sulfur amino acid metabolic process
xai BAG3 10q25.2-q26.2 -0.279 0.0323 0.425 Apoptosis
xai ACTR2 2p14 0.279 0.0324 0.426 cellular component movement
hs4 LOC100996634 0.279 0.0324 0.426
exp RPS27 1q21 0.279 0.0324 0.426 translational elongation;viral infectious
cycle
xai MDM1 12q15 0.279 0.0324 0.426 retina development in camera-type eye
his YY1 14q 0.279 0.0324 0.426 DNA recombination;cellular response to UV
xai HMGCLL1 6p12.1 0.279 0.0324 0.426
dependent"
swa EIF3E 8q22-q23 0.279 0.0324 0.426 negative regulation of
translational initiation;nuclear-transcribed mRNA catabolic process, nonsense-
mediated decay
xai LOC100129395 17q12 0.279 0.0324 0.426
xai NANOS3 19p13.13 0.279 0.0324 0.426 cell
his JSRP1 19p13.3 0.279 0.0324 0.426
his OAZ1 19p13.3 0.279 0.0324 0.426 regulation of cellular amino acid
metabolic process;polyamine biosynthetic process
his ING3 7q31 0.279 0.0324 0.426 regulation of transcription, DNA-
xai DHX15 4p15.3 0.279 0.0324 0.426 mRNA processing;RNA splicing
his UPF3B Xq25-q26 0.279 0.0324 0.426 transport;nucleocytoplasmic
transport
xai RASSF1 3p21.3 0.279 0.0324 0.426 positive regulation of
his UBE3D 6q14.1 0.279 0.0324 0.426
his DOPEY1 6q15 0.279 0.0324 0.426 endoplasmic reticulum
organization;protein transport
xsq FOXN2 2p22-p16 0.277 0.0324 0.426 regulation of transcription, DNA-
xsq S100A7 1q21 0.277 0.0324 0.426
exp CDC42EP4 17q24-q25 -0.277 0.0324 0.426 Rho protein signal
xsq PON2 7q21.3 -0.277 0.0324 0.426 response to oxidative
exp TAGLN 11q23.2 -0.277 0.0324 0.426 muscle organ development
exp SKINTL 1p33 -0.279 0.0324 0.426
his ARL4D 17q21.31 -0.279 0.0324 0.426 GTP catabolic process;small
his ABHD16A 6p21.3 0.279 0.0325 0.426
his MIR4646 0.279 0.0325 0.426
swa HMGB1 13q12 0.279 0.0325 0.426 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
xai LIPJ 10q23.31 0.279 0.0325 0.426 lipid catabolic process
exp C7orf77 0.279 0.0325 0.426
exp LOC100129395 17q12 0.279 0.0325 0.426
xai LGSN 6pter-q22.33 0.279 0.0325 0.426 glutamine biosynthetic
process;nitrogen compound metabolic process
his MRI1 19p13.2 0.279 0.0325 0.426 L-methionine salvage from
his DDX51 12q24.33 0.279 0.0325 0.426 rRNA processing
his NOC4L 12q24.33 0.279 0.0325 0.426 rRNA processing
xai TMEM33 4p13 0.279 0.0325 0.426
met GLRA1 5q32 0.277 0.0325 0.426 startle response;adult walking behavior
exp WDR7 18q21.31 0.277 0.0325 0.426
xsq CCNT1 12q13.11 0.277 0.0325 0.426 transcription elongation from RNA
exp MACROD1 11q11 0.276 0.0325 0.426 purine nucleoside metabolic process
xsq RRP1 21q22.3 0.276 0.0325 0.426 rRNA processing
xsq SNORD23 0.276 0.0325 0.426
exp APRT 16q24 0.276 0.0325 0.426 nucleoside metabolic process;purine-
cop ALG1L2 3q22.1 -0.276 0.0325 0.426
cop FAM86HP 3q22.1 -0.276 0.0325 0.426
exp COL12A1 6q12-q13 -0.276 0.0325 0.426 skeletal system
met SCARF1 17p13.3 -0.276 0.0325 0.426 neuron
remodeling;dendrite development
xsq CDH6 5p13.3 -0.277 0.0325 0.426 cell adhesion;homophilic cell
adhesion
xai GPR157 1p36.23 -0.279 0.0325 0.426
exp ALDH7A1P1 5q14 -0.279 0.0325 0.426
his PDE1C 7p14.3 -0.279 0.0325 0.426 activation of phospholipase C
activity;fibroblast growth factor receptor signaling pathway
hs4 MIR193BHG -0.279 0.0325 0.426
hs4 MIR193B -0.279 0.0325 0.426
hs4 MIR365A -0.279 0.0325 0.426
xai AP4B1 1p13.2 0.279 0.0326 0.426 intracellular protein
swa AASDHPPT 11q22 0.279 0.0326 0.427 macromolecule biosynthetic
xai P2RY10 Xq21.1 0.279 0.0326 0.427
hs4 TYMS 18p11.32 0.279 0.0326 0.427 DNA Damage Response (DDR)
hs4 TYMSOS 0.279 0.0326 0.427
his POLA1 Xp22.1-p21.3 0.279 0.0326 0.427 DNA Damage Response (DDR);
swa PCBP4 3p21 0.279 0.0326 0.427 DNA damage response, signal transduction
his MEGF8 19q12 0.279 0.0326 0.427
hs4 LOC728743 7q36.1 0.279 0.0326 0.427
hs4 STAC3 12q13.3 0.279 0.0326 0.427 intracellular signal transduction
exp MTIF2 2p16.1 0.276 0.0326 0.426 translation;regulation of
xsq OLAH 0.276 0.0326 0.427
mut ZNFX1 20q13.13 0.276 0.0326 0.427
met ATP6V1H 8q11.2 0.276 0.0326 0.427 ion transport;transferrin
transport
xsq RNF20 9q22 0.276 0.0326 0.427 regulation of transcription, DNA-
dependent;ubiquitin-dependent protein catabolic process
xsq KRT77 12q13.13 0.276 0.0326 0.427
mir hsa-let-7c -0.276 0.0326 0.427
exp C8orf31 8q24.3 -0.276 0.0326 0.427
exp COTL1 16q24.1 -0.276 0.0326 0.426 defense response to fungus
xai HRCT1 9p13.3 -0.279 0.0326 0.427
swa TBL2 7q11.23 -0.279 0.0326 0.426
exp HSPA8P9 3q22.3 0.279 0.0327 0.427
swa LSM3 3p25.1 0.279 0.0327 0.427 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;nuclear mRNA splicing, via spliceosome
hs4 CD5 11q13 0.278 0.0327 0.427 induction of apoptosis by extracellular
his HPSE2 10q23-q24 0.278 0.0327 0.427 carbohydrate metabolic process
his ARID3B 15q24 0.278 0.0327 0.427 regulation of transcription, DNA-
dependent"
xsq NPW 16p13.3 0.276 0.0327 0.427 G-protein coupled receptor
met PTGR1 9q31.3 0.276 0.0327 0.427 leukotriene metabolic
process;response to toxin
DNA-dependent"
exp MZT2A 2q21.1 0.276 0.0327 0.427
met AQP4 18q11.2-q12.1 0.276 0.0327 0.427 transport;water transport
xsq LINC01333 0.276 0.0327 0.427
exp RBM10 Xp11.23 0.276 0.0327 0.427 mRNA processing;RNA splicing
exp POM121L1P 22q11.22 0.276 0.0327 0.427
xsq LOC101928517 0.276 0.0327 0.427
exp ZNF77 19p13.3 0.276 0.0327 0.427 regulation of transcription, DNA-
dependent"
exp TIMM44 19p13.3-p13.2 0.276 0.0327 0.427 protein targeting to
xsq NSUN2 5p15.31 0.276 0.0327 0.427 tRNA processing;tRNA methylation
xsq MMS22L 6q16.1 0.276 0.0327 0.427 DNA Damage Response (DDR)
met HLA-F 6p21.3 0.276 0.0327 0.427 antigen processing and presentation
cop P3H2 -0.276 0.0327 0.427 negative regulation of cell
exp HSPB8 12q24.23 -0.276 0.0327 0.427 response to stress;cell death
xsq MIRLET7BHG 22q13.31 -0.276 0.0327 0.427
xsq MEIS1-AS2 -0.276 0.0327 0.427
exp ATP6V0C 16p13.3 -0.276 0.0327 0.427 cellular iron ion
hs4 CLDN23 8p23.1 -0.278 0.0327 0.427 tight junction
assembly;calcium-independent cell-cell adhesion
hs4 FAM134B 5p15.1 -0.279 0.0327 0.427 sensory perception of
pain
hs4 LOC101929524 -0.279 0.0327 0.427
hs4 LOC102723766 -0.279 0.0327 0.427
xai FUBP1 1p31.1 0.278 0.0328 0.427 Tumor Suppressors
xai OR8K1 11q12.1 0.278 0.0328 0.428 response to stimulus
his SLC35G1 10q23.33 0.278 0.0328 0.428
his SHPRH 6q24.3 0.278 0.0328 0.428 DNA Damage Response (DDR); DDR
(TLS)
his OCIAD1 4p11 0.278 0.0328 0.428
hs4 LOC284798 20p11.21 0.278 0.0328 0.428
exp OR8K1 11q12.1 0.278 0.0328 0.428 response to stimulus
his TMPO 12q22 0.278 0.0328 0.428 regulation of transcription, DNA-
dependent"
his TMPO-AS1 12q23.1 0.278 0.0328 0.428
xai TSPEAR-AS1 0.278 0.0328 0.428
exp LOC646197 8q21.11 0.276 0.0328 0.427
exp LDAH 0.276 0.0328 0.428
met SGSH 17q25.3 0.276 0.0328 0.428 proteoglycan metabolic process
exp LOC100132046 0.276 0.0328 0.428
xsq PA2G4P4 3q25.31 0.276 0.0328 0.428
xsq BUD13 11q23.3 0.276 0.0328 0.428 nuclear mRNA splicing, via
xsq ZNF691 1p34.2 0.276 0.0328 0.428
xsq SUSD4 1q41 -0.276 0.0328 0.428
exp NINJ1 9q22 -0.276 0.0328 0.428 cell adhesion;nervous system
development
exp TP53BP2 1q41 -0.276 0.0328 0.428 Apoptosis
met HBD 11p15.5 -0.276 0.0328 0.427 transport;blood coagulation
exp SQSTM1 5q35 -0.276 0.0328 0.427 Apoptosis
exp SEC14L2 22q12.2 -0.276 0.0328 0.427 regulation of
cholesterol biosynthetic process;positive regulation of transcription, DNA-
dependent"
hs4 KITLG 12q22 -0.278 0.0328 0.428 ovarian follicle
development;hemopoiesis
exp LOC401021 -0.278 0.0328 0.428
xai SEC14L2 22q12.2 -0.278 0.0328 0.428 regulation of
dependent"
xai LOC401021 -0.278 0.0328 0.428
his CHMP4A 14q12 0.278 0.0329 0.428 endosome transport;protein
transport
his MDP1 14q12 0.278 0.0329 0.428
xai TGIF2 20q11.23 0.278 0.0329 0.428 regulation of transcription, DNA-
dependent;positive regulation of neuron differentiation
exp MID1IP1-AS1 0.278 0.0329 0.428
his ADPGK-AS1 15q24.1 0.278 0.0329 0.428
his ADPGK 15q24.1 0.278 0.0329 0.428 glycolysis;carbohydrate metabolic
process
hs4 RETN 19p13.2 0.278 0.0329 0.428 response to insulin stimulus;fat
xai SKP2 5p13 0.278 0.0329 0.428 G1/S transition of mitotic cell
catabolic process
hs4 LRRC25 0.278 0.0329 0.428
his CXCR5 11q23.3 0.278 0.0329 0.428 B cell activation;lymph node
development
hs4 LOC400958 0.278 0.0329 0.428
his CYP46A1 14q32.1 0.278 0.0329 0.428 bile acid biosynthetic
process;cholesterol catabolic process
met ALDOA 16p11.2 0.276 0.0329 0.428 striated muscle contraction;protein
homotetramerization
xsq LINC01490 0.276 0.0329 0.428
xsq RUNX3 1p36 0.276 0.0329 0.428 Apoptosis
cop MIR539 0.276 0.0329 0.428
cop MIR889 0.276 0.0329 0.428
cop MIR655 0.276 0.0329 0.428
cop MIR487A 0.276 0.0329 0.428
cop MIR382 0.276 0.0329 0.428
cop MIR134 0.276 0.0329 0.428
cop MIR668 0.276 0.0329 0.428
cop MIR485 0.276 0.0329 0.428
cop MIR323B 0.276 0.0329 0.428
cop MIR154 0.276 0.0329 0.428
cop MIR496 0.276 0.0329 0.428
cop MIR377 0.276 0.0329 0.428
cop MIR541 0.276 0.0329 0.428
cop MIR409 0.276 0.0329 0.428
cop MIR412 0.276 0.0329 0.428
cop MIR369 0.276 0.0329 0.428
cop MIR410 0.276 0.0329 0.428
cop MIR656 0.276 0.0329 0.428
cop MEG9 0.276 0.0329 0.428
exp GEMIN6 2p22.1 0.276 0.0329 0.428 RNA splicing;gene expression
xsq RAD21L1 20p13 0.276 0.0329 0.428 chromosome segregation;meiosis
xsq SNRPA 19q13.1 0.276 0.0329 0.428 nuclear mRNA splicing, via
xsq TVP23C 17p12 -0.276 0.0329 0.428
xsq TNFRSF12A 16p13.3 -0.276 0.0329 0.428 Apoptosis
exp XG Xp22.33 -0.276 0.0329 0.428
xsq LENG8-AS1 -0.276 0.0329 0.428
met CCL17 16q13 -0.276 0.0329 0.428 chemotaxis;inflammatory response
hs4 ASAP1 8q24.1-q24.2 -0.278 0.0329 0.428 signal transduction;cell
xai PTRF 17q21.2 -0.278 0.0329 0.428 transcription initiation from
hs4 LURAP1 1p34 -0.278 0.0329 0.428 positive regulation of
cytokine production;positive regulation of I-kappaB kinase/NF-kappaB cascade
xai RPL18AP8 3q11.2 0.278 0.033 0.428
exp LOC730183 0.278 0.033 0.428
his HNRNPK 9q21.32-q21.33 0.278 0.033 0.428 nuclear mRNA splicing, via
spliceosome;positive regulation of transcription from RNA polymerase II promoter
his RMI1 9q21.32 0.278 0.033 0.428 DNA Damage Response (DDR)
xai PDF 16q22.1 0.278 0.033 0.428 translation;positive regulation of cell
proliferation
xai IQCB1 3q13.33 0.278 0.033 0.428 cilium assembly;photoreceptor cell
maintenance
his PRCAT47 0.278 0.033 0.428
exp HNRNPCP7 7q11.21 0.278 0.033 0.428
his GABPB2 1q21.3 0.278 0.033 0.428 regulation of transcription, DNA-
dependent;positive regulation of transcription from RNA polymerase II promoter"
his PRAMEF4 0.278 0.033 0.428
xsq TTC27 2p22.3 0.276 0.033 0.428
met DNAI1 9p13.3 0.276 0.033 0.428 cell projection organization
xsq TMEM31 Xq22.2 0.276 0.033 0.428
xsq RPLP2 11p15.5 0.276 0.033 0.428 translation;mRNA metabolic process
met SEPT10 2q13 0.276 0.033 0.428 cell cycle;cell division
exp HNRNPM 19p13.2 0.276 0.033 0.428 alternative nuclear mRNA splicing,
via spliceosome;nuclear mRNA splicing, via spliceosome
met CXCL14 5q31 0.276 0.033 0.428 chemotaxis;immune response
mut NFATC3 16q22.2 -0.276 0.033 0.428 regulation of transcription
xai BIN1 2q14 -0.278 0.033 0.428 positive regulation of GTPase
xai SKINTL 1p33 -0.278 0.033 0.428
exp FCHSD1 5q31.3 -0.278 0.033 0.428
xai NXNL2 9q22.1 -0.278 0.033 0.428
his CTB-113P19.1 -0.278 0.033 0.428
his SPARC 5q31.3-q32 -0.278 0.033 0.428 ossification;lung development
his ZBTB9 6p21.32 0.278 0.0331 0.428 regulation of transcription, DNA-
dependent"
xai PTMAP3 20p11.23 0.278 0.0331 0.428
xai GAPDHP37 22q13.2 0.278 0.0331 0.428
xai YBX1P10 9p13.1 0.278 0.0331 0.428
xai NOS3 7q36 0.278 0.0331 0.428 regulation of sodium ion transport;blood
coagulation
xai LRRTM1 2p12 0.278 0.0331 0.429
his SHF 15q21.1 0.278 0.0331 0.429 apoptotic process
xsq APOA1 0.276 0.0331 0.428 cholesterol biosynthetic process;lipid
storage
xsq PRPF3 1q21.1 0.276 0.0331 0.428 RNA splicing, via
xsq METAP2 12q22 0.276 0.0331 0.428 proteolysis;cellular process
xsq CFAP74 0.276 0.0331 0.428
xsq TOR2A 9q34.11 0.276 0.0331 0.428 chaperone mediated protein folding
requiring cofactor
xsq GRB2 17q24-q25 0.276 0.0331 0.428 cell-cell signaling;T cell
costimulation
exp RHPN1-AS1 8q24 0.276 0.0331 0.428
xsq WDR83 19p13.2 0.275 0.0331 0.429 RNA splicing, via
transesterification reactions;nuclear mRNA splicing, via spliceosome"
xsq CELSR2 1p21 -0.276 0.0331 0.428 G-protein coupled receptor
xsq NEDD9 6p25-p24 -0.276 0.0331 0.428 regulation of growth;actin
xsq C8orf31 8q24.3 -0.276 0.0331 0.428
hs4 SPATS2L 2q33.1 -0.278 0.0331 0.429
hs4 LINC01563 -0.278 0.0331 0.429
his KIF11 10q24.1 0.278 0.0332 0.429 spindle organization;mitotic
spindle organization
xai BCLAF1 6q22-q23 0.278 0.0332 0.429 Apoptosis
xai DUSP11 2p13.1 0.278 0.0332 0.429 RNA processing;peptidyl-
xai LOC100506388 0.278 0.0332 0.429
xai LIG3 17q11.2-q12 0.278 0.0332 0.429 DNA Damage Response (DDR); DDR
(BER)
swa RRM1 11p15.5 0.278 0.0332 0.429 DNA Damage Response (DDR)
his THYN1 11q25 0.278 0.0332 0.429
his ACAD8 11q25 0.278 0.0332 0.429 regulation of transcription, DNA-
dependent;lipid metabolic process
met HLCS 21q22.13 0.275 0.0332 0.429 cell proliferation;protein
biotinylation
xsq AIP 11q13.3 0.275 0.0332 0.429 regulation of protein kinase A
met ISPD 7p21.2 0.275 0.0332 0.429 isoprenoid biosynthetic process
xsq EPB41 1p33-p32 0.275 0.0332 0.429 blood circulation;actin
mut SLC2A2 3q26.1-q26.2 0.275 0.0332 0.429 Solute Carriers
exp POLR3B 12q23.3 0.275 0.0332 0.429 transcription elongation from
xsq CBFA2T3 16q24 0.275 0.0332 0.429 cell differentiation;granulocyte
differentiation
xsq USP32P2 17p11.2 -0.275 0.0332 0.429
xsq ZFHX3 16q22.3 -0.275 0.0332 0.429 negative regulation of
his TSPAN14 10q23.1 -0.278 0.0332 0.429
hs4 LOC105373553 -0.278 0.0332 0.429
xai ASAH1 8p22 -0.278 0.0332 0.429 lipid metabolic
xai ANGPTL2 9q34 -0.278 0.0332 0.429 signal
his PRPF38B 1p13.3 0.278 0.0333 0.429 mRNA processing;RNA splicing
xai RPL10P3 0.278 0.0333 0.429
swa NEBL 10p12 0.278 0.0333 0.429 cardiac muscle thin filament assembly
his MTA2 11q12-q13.1 0.278 0.0333 0.429 negative regulation of
xai EEF1GP3 3p22.1 0.278 0.0333 0.429
xai LOC648987 5p12 0.278 0.0333 0.429
his SMAP2 1p35.3-p34.1 0.278 0.0333 0.429 regulation of ARF GTPase
activity
exp LOC101060341 0.278 0.0333 0.429
his PRDX4 Xp22.11 0.278 0.0333 0.429 I-kappaB phosphorylation
xai TBKBP1 17q21.32 0.278 0.0333 0.429 innate immune response
xai PCBP1 2p13-p12 0.278 0.0333 0.429 nuclear mRNA splicing, via
his EXOC6 10q23.33 0.278 0.0333 0.429 protein transport;vesicle docking
xsq PDE6G 17q25 0.275 0.0333 0.429 activation of MAPK activity;blood
coagulation
exp EML3 11q12.3 0.275 0.0333 0.429
mut CFP Xp11.4 0.275 0.0333 0.429 complement activation;complement
met FANCC 9q22.3 0.275 0.0333 0.429 DNA Damage Response (DDR); DDR (FA)
exp CEPT1 1p13.3 0.275 0.0333 0.429 lipid metabolic
xsq TNFRSF10C 8p22-p21 -0.275 0.0333 0.429 Apoptosis
xsq ITPRIPL2 16p12.3 -0.275 0.0333 0.429
xsq UTRN 6q24 -0.275 0.0333 0.429 positive regulation of cell-matrix
exp LOC353194 -0.275 0.0333 0.429
met NLGN2 17p13.1 -0.275 0.0333 0.429 locomotory exploration
behavior;presynaptic membrane assembly
xsq CTTNBP2NL 1p13.2 -0.275 0.0333 0.429
hs4 CRIP2 14q32.3 -0.278 0.0333 0.429 positive regulation of cell
xai TENM2 5q34 -0.278 0.0333 0.429
xai LOC101060341 0.277 0.0334 0.43
xai FCER2 19p13.3 0.277 0.0334 0.43 positive regulation of nitric-oxide
his FAR2 12p11.22 0.277 0.0334 0.43 ether lipid biosynthetic
his NARS 18q21.31 0.277 0.0334 0.43 tRNA aminoacylation for protein
translation;asparaginyl-tRNA aminoacylation
exp IGJP1 8q21.2 0.277 0.0334 0.43
xai UBE2V2P1 10p12.31 0.277 0.0334 0.43
exp UBE2V2P1 10p12.31 0.277 0.0334 0.43
exp CYB5RL 1p32.3 0.275 0.0334 0.43
exp C16orf91 16p13.3 0.275 0.0334 0.43
exp CENPH 5p15.2 0.275 0.0334 0.43 kinetochore organization;M phase of
mitotic cell cycle
exp FBXL14 12p13.33 0.275 0.0334 0.43 protein ubiquitination
xsq ILF2 1q21.3 0.275 0.0334 0.43 positive regulation of
xsq POLE 12q24.3 0.275 0.0334 0.43 DNA Damage Response (DDR); DDR
mda H_K_NRAS_activation_pattern 0.275 0.0334 0.43
mda H_K_NRAS_activation_status 0.275 0.0334 0.43
exp LIAS 4p14 0.275 0.0334 0.43 lipoate biosynthetic process;response to
lipopolysaccharide
met MKL1 22q13 0.275 0.0334 0.43 anti-apoptosis;positive regulation of
exp HSPG2 1p36.1-p34 -0.275 0.0334 0.43 chondrocyte
xsq F3 1p22-p21 -0.275 0.0334 0.43 anti-apoptosis;positive
exp TCF7L1 2p11.2 -0.275 0.0334 0.43 regulation of
DNA-dependent
xsq SYTL2 11q14 -0.275 0.0334 0.43 intracellular protein
xsq FOLR1 11q13.3-q14.1 -0.275 0.0334 0.43 cell death;folic acid
transport
hs4 ZNF806 -0.277 0.0334 0.43 regulation of transcription,
DNA-dependent"
xai FCHSD1 5q31.3 -0.277 0.0334 0.43
xai EFCAB14 1p33 -0.277 0.0334 0.43
his PXDC1 6p25.2 -0.277 0.0334 0.43 cell communication
xai TP53BP2 1q41 -0.277 0.0334 0.43 Apoptosis
xai LOC100506621 -0.277 0.0334 0.43
his CDK19 6q21 0.277 0.0335 0.43 Protein Kinases
his POTEJ 0.277 0.0335 0.43
his PDSS1 10p12.1 0.277 0.0335 0.43 protein
xai ATAD3A 1p36.33 0.277 0.0335 0.43 cell growth;negative
his UBL7 15q24.1 0.277 0.0335 0.43
his UBL7-AS1 0.277 0.0335 0.43
xai UCKL1 20q13.33 0.277 0.0335 0.431 interspecies interaction between
organisms;metabolic process
his ICAM5 19p13.2 0.277 0.0335 0.431 cell-cell adhesion
xai PELP1 17p13.2 0.277 0.0335 0.431 transcription, DNA-dependent"
xsq CYMP 1p13.3 0.275 0.0335 0.43
met KCNE5 0.275 0.0335 0.43 regulation of heart contraction
xsq METTL3 14q11.1 0.275 0.0335 0.43 gene expression;RNA
methylation
exp SMN1 0.275 0.0335 0.43
met SUGT1 13q14.3 0.275 0.0335 0.431 mitosis;nucleotide-binding domain,
leucine rich repeat containing receptor signaling pathway
xsq FLI1 11q24.1-q24.3 0.275 0.0335 0.431 Transcription Factors
xsq DRAM1 12q23.2 -0.275 0.0335 0.431 autophagy;apoptotic process
exp RNF11 1p32 -0.275 0.0335 0.431 protein ubiquitination involved in
xsq SHROOM1 5q31.1 -0.275 0.0335 0.431 cell morphogenesis;actin
exp FRS2 12q15 -0.275 0.0335 0.43 activation of phospholipase C
activity;regulation of epithelial cell proliferation
exp SGK223 8p23.1 -0.275 0.0335 0.43
exp ARPIN -0.275 0.0335 0.43
his RFC3 13q13.2 0.277 0.0336 0.431 DNA Damage Response (DDR); DDR
his RNU6ATAC 9q34.2 0.277 0.0336 0.431
xai RHOU 1q42.11-q42.3 0.277 0.0336 0.431 G1/S transition of mitotic
xai POLR2C 16q13-q21 0.277 0.0336 0.431 DNA Damage Response (DDR);
DDR (NER)
hs4 ADARB2-AS1 10p15.3 0.277 0.0336 0.431
cop ALDH3B2 11q13 0.275 0.0336 0.431 alcohol metabolic process;cellular
aldehyde metabolic process
xsq RPS6KA1 1p 0.275 0.0336 0.431 Protein Kinases
exp CD3G 11q23 0.275 0.0336 0.431 protein transport;T cell costimulation
exp RPS26 12q13 0.275 0.0336 0.431 translational termination;negative
regulation of RNA splicing
met FDX1L 19p13.2 0.275 0.0336 0.431 transport;electron transport chain
exp NPIPB7 0.275 0.0336 0.431
pro EP300_16_40563 0.275 0.0336 0.431
exp NOM1 7q36.3 0.275 0.0336 0.431 RNA metabolic process
exp CCNO 5q11.2 -0.275 0.0336 0.431 DNA Damage Response (DDR)
xsq HSPA12A 10q26.12 -0.275 0.0336 0.431
xsq IRS2 13q34 -0.275 0.0336 0.431 Apoptosis
exp RAB29 -0.275 0.0336 0.431 GTP catabolic process;small GTPase
xsq IL6ST 5q11.2 -0.275 0.0336 0.431 JAK-STAT cascade;positive
hs4 ADGRG1 -0.277 0.0336 0.431 cell adhesion;G-protein
his NDST1-AS1 -0.277 0.0336 0.431
his NDST1 5q33.1 -0.277 0.0336 0.431 fibroblast growth factor
swa EMC2 8q23.1 -0.277 0.0336 0.431
xai FLNA Xq28 -0.277 0.0336 0.431 actin cytoskeleton
exp IFIT1P1 13q13.1 0.277 0.0337 0.431
his METTL18 1q24.2 0.277 0.0337 0.431
his C1orf112 1q24.2 0.277 0.0337 0.431
his CRLF3 17q11.2 0.277 0.0337 0.432 negative regulation of cell
his MTPAP 10p11.23 0.277 0.0337 0.432 cell death;histone mRNA catabolic
process
xai RPL37A 2q35 0.277 0.0337 0.432 gene expression;viral reproduction
xai TCTE3 6q27 0.277 0.0337 0.432 transport
his OLIG2 21q22.11 0.277 0.0337 0.432 myelination;negative regulation of
neuron differentiation
xsq UVRAG 11q13.5 0.275 0.0337 0.431 DNA Damage Response (DDR)
met OR1F1 16p13.3 0.275 0.0337 0.431 signal transduction;response to
stimulus
xsq NLRP7 19q13.42 0.275 0.0337 0.431
met LSMEM1 7q31.1 0.275 0.0337 0.432
met OSBPL1A 18q11.1 0.275 0.0337 0.432 lipid transport;cholesterol
metabolic process
xsq MIXL1 1q42.12 0.275 0.0337 0.432 endoderm formation;multicellular
xsq RHOC 1p13.1 -0.275 0.0337 0.432 regulation of small GTPase
met MMP20 11q22.3 -0.275 0.0337 0.431 Apoptosis
xsq BCL2L2 14q11.2-q12 -0.275 0.0337 0.431 Apoptosis
xsq SDC3 1p35.2 -0.275 0.0337 0.431 cell adhesion
xai ACTN1-AS1 -0.277 0.0337 0.431
his TIMM13 19p13.3 0.277 0.0338 0.432 sensory perception of
xai CTDSP1 2q35 0.277 0.0338 0.432 negative regulation of neuron
his MIR4707 0.277 0.0338 0.432
his HAUS4 14q11.2 0.277 0.0338 0.432 cell cycle;mitosis
his MIF4GD 17q25.1 0.277 0.0338 0.432 RNA metabolic
process;regulation of translation
his LOC100287042 17q25.1 0.277 0.0338 0.432
exp RAB44 0.277 0.0338 0.432 small GTPase mediated signal
xai SNAI3 16q24.3 0.277 0.0338 0.432
his NCF1B 0.277 0.0338 0.432
his MIR7846 0.277 0.0338 0.432
his TNFRSF1B 1p36.22 0.277 0.0338 0.432 Apoptosis
xsq PER2 2q37.3 0.275 0.0338 0.432 DNA Damage Response (DDR)
xsq TTI2 8p12 0.275 0.0338 0.432 DNA Damage Response (DDR)
xsq DNASE1L3 3p14.3 0.275 0.0338 0.432 apoptotic process;DNA
metabolic process
xsq LOC100506548 0.275 0.0338 0.432
xsq AGAP7P 0.274 0.0338 0.432 regulation of ARF GTPase activity
xsq ALOX12P2 17p13 0.274 0.0338 0.432
xsq CLPX 15q22.31 0.274 0.0338 0.432 ATP catabolic process;protein
folding
xsq NLRP11 19q13.43 0.274 0.0338 0.432 oxidation-reduction process
xsq KBTBD11-OT1 0.274 0.0338 0.432
exp MS4A6A 11q12.1 0.274 0.0338 0.432
exp ANKRD52 12q13.3 -0.274 0.0338 0.432 DNA Damage Response
(DDR)
exp ZBTB20 3q13.2 -0.275 0.0338 0.432 regulation of
xai SQSTM1 5q35 -0.277 0.0338 0.432 Apoptosis
xai RAB29 -0.277 0.0338 0.432 GTP catabolic process;small GTPase
hs4 ZNF697 1p12 -0.277 0.0338 0.432 regulation of transcription,
DNA-dependent"
swa ITGB5 3q21.2 -0.277 0.0338 0.432 antigen processing and
xai ITGB1 10p11.2 -0.277 0.0338 0.432 Apoptosis
his TLK1 2q31.1 0.277 0.0339 0.432 DDR (DNA replication)
exp LIPJ 10q23.31 0.277 0.0339 0.432 lipid catabolic process
xai MTF2 1p22.1 0.277 0.0339 0.433
xai GP5 3q29 0.277 0.0339 0.433 cell adhesion;cell-matrix adhesion
exp TCTE3 6q27 0.277 0.0339 0.433 transport
his AURKAPS1 0.277 0.0339 0.433
xai CNPY3 6p21.1 0.277 0.0339 0.433 innate immune response
his MVD 16q24.3 0.277 0.0339 0.433 response to drug;small molecule
metabolic process
his SNAI3-AS1 16q24.3 0.277 0.0339 0.433
exp CDK5RAP3 17q21.32 0.274 0.0339 0.432 regulation of cyclin-
xsq THSD7B 2q22.1 0.274 0.0339 0.432
met KDM4B 19p13.3 0.274 0.0339 0.432 regulation of transcription, DNA-
xsq ALKBH4 7q22.1 0.274 0.0339 0.432 DNA Damage Response (DDR)
xsq TTF1 9q34.13 0.274 0.0339 0.433 regulation of transcription, DNA-
xsq ATAD2B 2p24.1-p23.3 0.274 0.0339 0.433
xsq GVINP1 11p15.4 0.274 0.0339 0.433
exp GRIK1 21q22.11 -0.274 0.0339 0.433 nervous system
development;regulation of synaptic transmission, glutamatergic
exp SMPD1 11p15.4-p15.1 -0.274 0.0339 0.433 cell death;ceramide
exp PGRMC2 4q26 -0.274 0.0339 0.432 steroid hormone mediated
signaling pathway
exp KIAA0895 7p14.2 -0.274 0.0339 0.432
his LINC01920 -0.277 0.0339 0.433
xai MTMR3 22q12.2 -0.277 0.0339 0.432 phosphatidylinositol
exp PHF7 3p21.1 0.277 0.034 0.433
his XRRA1 11q13.4 0.277 0.034 0.433 response to X-ray
his SPCS2 11q13.4 0.277 0.034 0.433 signal peptide processing;proteolysis
his CSNK2A2 16q21 0.277 0.034 0.433 Protein Kinases
exp NXT1P1 0.277 0.034 0.433
xai EIF4BP4 3p22.1 0.277 0.034 0.433
xai ZNF77 19p13.3 0.276 0.034 0.433 regulation of transcription, DNA-
dependent"
dependent"
mut FLRT2 14q24-q32 0.274 0.034 0.433 cell adhesion
xsq ARMC2 6q21 0.274 0.034 0.433
exp HSPA8P8 7p21.3 0.274 0.034 0.433
met SHC1 1q21 0.274 0.034 0.433 response to toxin;response to insulin stimulus
xsq CDK5RAP1 20q11.21 0.274 0.034 0.433 tRNA modification;brain development
dependent"
exp COPS4 4q21.22 0.274 0.034 0.433 DNA Damage Response (DDR)
exp NOS1AP 1q23.3 -0.274 0.034 0.433 regulation of apoptotic
xsq LOC101928118 -0.274 0.034 0.433
xsq CARD10 22q13.1 -0.274 0.034 0.433 protein complex
swa GAA 17q25.2-q25.3 -0.276 0.034 0.433 heart morphogenesis;tissue
development
hs4 C11orf70 11q22.1 -0.276 0.034 0.433
xai ASAP1-IT1 8q24.21 -0.276 0.034 0.433
hs4 PFN2 3q25.1 -0.277 0.034 0.433 regulation of actin polymerization
or depolymerization;actin cytoskeleton organization
hs4 LOC646903 -0.277 0.034 0.433
his LINC01271 -0.277 0.034 0.433
his POU3F1 1p34.1 -0.277 0.034 0.433 myelination in peripheral
nervous system;keratinocyte differentiation
xai EVI5 1p22.1 -0.277 0.034 0.433 cell cycle;multicellular organismal
development
xai POLR3C 1q21.1 0.276 0.0341 0.433 positive regulation of innate
his HNRNPR 1p36.12 0.276 0.0341 0.433 nuclear mRNA splicing, via
xai BRIX1 5p13.2 0.276 0.0341 0.433 ribosome biogenesis
swa BTF3 5q13.2 0.276 0.0341 0.433 in utero embryonic
development;regulation of transcription, DNA-dependent
his METTL3 14q11.1 0.276 0.0341 0.433 gene expression;RNA
methylation
his KCNQ2 20q13.3 0.276 0.0341 0.434 potassium ion transmembrane
exp UTP18 17q21.33 0.274 0.0341 0.433 rRNA processing
pro EP300_19_40619 0.274 0.0341 0.434
met BOK 2q37.3 0.274 0.0341 0.434 male gonad
development;oligodendrocyte differentiation
xsq LINC00921 16p13.3 0.274 0.0341 0.434
xsq ATP1B1 1q24 -0.274 0.0341 0.434 ATP biosynthetic
process;transport
xsq TRIO 5p15.2 -0.274 0.0341 0.434 transmembrane receptor
transduction
xsq PPP1R3B 8p23.1 -0.274 0.0341 0.434 carbohydrate metabolic
xsq IFITM10 -0.274 0.0341 0.434 response to biotic stimulus
exp FBLN1 22q13.31 -0.274 0.0341 0.433 embryo
exp PLBD2 12q24.13 -0.274 0.0341 0.433 lipid catabolic process
xai NEDD4L 18q21.31 -0.276 0.0341 0.434 protein
ubiquitination;water homeostasis
xai MANBAL 20q11.23 -0.276 0.0341 0.433
xai PGRMC2 4q26 -0.276 0.0341 0.433 steroid hormone mediated
signaling pathway
xai LOC100190924 0.276 0.0342 0.434
exp LOC100190924 0.276 0.0342 0.434
hs4 GRM3 7q21.1-q21.2 0.276 0.0342 0.434
exp MTVR2 17q23 0.276 0.0342 0.434
hs4 MBLAC1 7q22.1 0.276 0.0342 0.434
xai FOXK2 17q25 0.276 0.0342 0.434 regulation of transcription, DNA-
xai UBL7 15q24.1 0.276 0.0342 0.434
hs4 LST1 6p21.3 0.276 0.0342 0.434 cell morphogenesis;immune response
his INO80B 2p13.1 0.276 0.0342 0.434 DNA Damage Response (DDR);
DDR (Chromatin)
his INO80B-WBP1 0.276 0.0342 0.434
his WBP1 2p12 0.276 0.0342 0.434
xai RPL12 9q34 0.276 0.0342 0.434 translational elongation;viral
transcription
xsq PRPF4 9q31-q33 0.274 0.0342 0.434 nuclear mRNA splicing, via
spliceosome;RNA processing
xsq NDC80 18p11.32 0.274 0.0342 0.434 attachment of spindle microtubules
xsq PDSS2 6q21 0.274 0.0342 0.434 isoprenoid biosynthetic
xsq LOC102724050 0.274 0.0342 0.434
xsq FANCA 16q24.3 0.274 0.0342 0.434 DNA Damage Response (DDR); DDR (FA)
exp NUS1P1 Xp11.23 0.274 0.0342 0.434
exp CSNK1G2 19p13.3 0.274 0.0342 0.434 Protein Kinases
met C6orf15 6p21.3 -0.274 0.0342 0.434 extracellular matrix
organization
xai IL1R1 2q12 -0.276 0.0342 0.434 ovulation;innate immune response
hs4 MAGED1 Xp11.23 -0.276 0.0342 0.434 regulation of
transcription, DNA-dependent;apoptotic process
hs4 HTR1B 6q13 -0.276 0.0342 0.434 serotonin receptor signaling
pathway;drinking behavior
xai MTAPP2 -0.276 0.0342 0.434
xai CBR1 21q22.13 -0.276 0.0342 0.434 oxidation-reduction
xai CCDC28A 6q23.1-q24.1 0.276 0.0343 0.434
his CTDSPL2 15q15.3-q21.1 0.276 0.0343 0.434
xai PRPF4 9q31-q33 0.276 0.0343 0.434 nuclear mRNA splicing, via
exp ACRBP 12p13.31 0.276 0.0343 0.435
exp CHAT 10q11.2 0.276 0.0343 0.435 synaptic transmission;adult walking
behavior
his ENKD1 16q22.1 0.276 0.0343 0.435
his C16orf86 16q22.1 0.276 0.0343 0.435
xsq NHEJ1 2q35 0.274 0.0343 0.434 DNA Damage Response (DDR); DDR (NHEJ)
xsq C7orf55-LUC7L2 0.274 0.0343 0.434
xsq SHQ1 3p13 0.274 0.0343 0.434 ribonucleoprotein complex assembly
exp GIT1 17p11.2 0.274 0.0343 0.435 regulation of G-protein coupled
cop SLC22A1 6q25.3 0.274 0.0343 0.435 epinephrine
exp CD48 1q21.3-q22 0.274 0.0343 0.435 T cell activation;mast cell
activation
xsq GFRA4 20p13-p12 0.274 0.0343 0.435
xsq ZDHHC1 16q22.1 -0.274 0.0343 0.435 protein palmitoylation
exp APOL1 22q13.1 -0.274 0.0343 0.435 lipoprotein metabolic
process;transport
exp LOC100507431 -0.274 0.0343 0.435
xsq ARHGAP29 1p22.1 -0.274 0.0343 0.434 small GTPase mediated
hs4 KLHL29 2p24.1 -0.276 0.0343 0.435
hs4 CYP27A1 2q35 -0.276 0.0343 0.434 bile acid metabolic
his METTL5 2q31.1 0.276 0.0344 0.435
his UBR3 2q31.1 0.276 0.0344 0.435 ubiquitin-dependent protein
catabolic process;sensory perception of smell
xai STIP1 11q13 0.276 0.0344 0.435 response to stress;axon guidance
his PPP1R26-AS1 0.276 0.0344 0.435
xai AMDHD1 12q23.1 0.276 0.0344 0.435 histidine catabolic
his SNRNP35 12q24.31 0.276 0.0344 0.435 mRNA processing;RNA splicing
xsq LINC01554 0.274 0.0344 0.435
exp ESCO1 18q11.2 0.274 0.0344 0.435 regulation of DNA replication;cell
cycle
xsq CCNB2 15q22.2 0.274 0.0344 0.435 DNA Damage Response (DDR)
exp LOC389641 0.274 0.0344 0.435
xsq ALKBH1 14q24.3 0.274 0.0344 0.435 DNA Damage Response (DDR);
DDR (BER)
exp UBIAD1 1p36.22 0.274 0.0344 0.435 menaquinone biosynthetic
xsq NCAPD2 12p13.3 0.274 0.0344 0.435 DNA Damage Response (DDR)
hs4 LINC00673 -0.276 0.0344 0.435
his MYLK-AS2 -0.276 0.0344 0.435
xai YIPF5 5q31.3 -0.276 0.0344 0.435 protein transport;vesicle-
mediated transport
xai ARL6IP1 16p12-p11.2 -0.276 0.0344 0.435 cotranslational protein
exp NF1P8 2q21.1 0.276 0.0345 0.435
his WDR92 2p14 0.276 0.0345 0.435 apoptotic process;histone lysine
methylation
his PNO1 2p14 0.276 0.0345 0.435
xai ST13P10 11q23.1 0.276 0.0345 0.436
exp RPS26P43 11q24.1 0.276 0.0345 0.436
xai BMS1 10q11.21 0.276 0.0345 0.436 ribosome assembly
xai RPS26P43 11q24.1 0.276 0.0345 0.436
xai POLR3F 20p11.23 0.276 0.0345 0.436 transcription, DNA-
exp LOC100506083 0.276 0.0345 0.436
hs4 ZAP70 2q12 0.276 0.0345 0.436 T cell activation;B cell activation
his LINC01237 0.276 0.0345 0.436
swa MCM4 8q11.2 0.276 0.0345 0.436 DDR (DNA replication)
his PRAMEF11 1p36.21 0.276 0.0345 0.436
exp SECISBP2 9q22.2 0.274 0.0345 0.436 translation
exp LRRTM1 2p12 0.273 0.0345 0.436
exp C1orf191 0.273 0.0345 0.436
xsq INTS7 1q32.3 0.273 0.0345 0.436 snRNA processing;cellular response
met HLA-B 6p21.3 0.273 0.0345 0.436 antigen processing and presentation
of peptide antigen via MHC class I;regulation of interleukin-12 production
exp TXLNG Xp22.2 0.273 0.0345 0.436 regulation of transcription, DNA-
exp OXNAD1 3p25-p24 0.273 0.0345 0.436
xsq PDE4A 19p13.2 0.273 0.0345 0.436 response to drug;cAMP catabolic
process
xai CYB5A 18q23 -0.276 0.0345 0.436 electron transport chain;small
swa GAPVD1 9q33.3 -0.276 0.0345 0.436 endocytosis;signal
transduction
hs4 DDAH1 1p22 -0.276 0.0345 0.436 arginine catabolic process;nitric
oxide mediated signal transduction
hs4 CYR61 1p22.3 -0.276 0.0345 0.436 positive regulation of
protein phosphorylation;positive regulation of phospholipase activity
xai TRIM2 4q31.3 -0.276 0.0345 0.435 protein
ubiquitination;neuroprotection
xai RPL10L 14q21.2 0.278 0.0346 0.437 translation;spermatogenesis
his TEX10 9q31.1 0.276 0.0346 0.436
xai SERHL2 22q13 0.276 0.0346 0.436
xai GRPEL2P2 0.276 0.0346 0.436
his PLA2G4A 1q25 0.276 0.0346 0.436 metabolic process;platelet
activation
hs4 ALOX12P2 17p13 0.276 0.0346 0.436
xsq RPS6KB1 17q23.1 0.273 0.0346 0.436 Apoptosis; Protein Kinases
xsq C20orf203 20q11.21 0.273 0.0346 0.436
exp C14orf80 14q32.33 0.273 0.0346 0.436
cop RAB6A 11q13.3 0.273 0.0346 0.436 peptidyl-cysteine
methylation;protein localization in Golgi apparatus
exp USP9X Xp11.4 -0.273 0.0346 0.436 mitosis;transforming growth
xsq PDGFC 4q32 -0.273 0.0346 0.436 positive regulation of DNA
hs4 PRUNE2 9q21.2 -0.276 0.0346 0.436 apoptotic
hs4 BDNF 11p13 -0.276 0.0346 0.436 feeding behavior;fear response
xai SHROOM1 5q31.1 -0.276 0.0346 0.436 cell morphogenesis;actin
swa PYGB 20p11.21 -0.276 0.0346 0.436 carbohydrate metabolic
his TRMT10A 4q23 0.276 0.0347 0.437
his MTTP 4q24 0.276 0.0347 0.437 transport;lipid transport
his SLC39A11 17q24.3-q25.1 0.276 0.0347 0.437 Solute Carriers
his RPUSD2 15q13.3 0.276 0.0347 0.437 pseudouridine synthesis
hs4 CDCA7 2q31 0.276 0.0347 0.437 regulation of transcription, DNA-
his CAT 11p13 0.275 0.0347 0.437 response to hypoxia;positive regulation
of phosphatidylinositol 3-kinase cascade
his SNAP47 1q42.13 0.275 0.0347 0.437
his JMJD4 1q42.13 0.275 0.0347 0.437
his PEX5 12p13.31 0.275 0.0347 0.437 protein targeting to
xai ASH1L-AS1 1q22 0.275 0.0347 0.437
xsq SNORA51 0.273 0.0347 0.437
xsq TDRKH 1q21 0.273 0.0347 0.437
xsq TEX22 14q32.33 0.273 0.0347 0.437
met RNF157 17q25.1 0.273 0.0347 0.437
xsq DDX21 10q21 0.273 0.0347 0.437
mir hsa-miR-494 0.273 0.0347 0.437
exp DHX15 4p15.3 0.273 0.0347 0.437 mRNA processing;RNA splicing
exp LOC402191 0.273 0.0347 0.437
exp LOC440353 16p11.2 0.273 0.0347 0.437
xsq TGIF2 20q11.23 0.273 0.0347 0.437 regulation of transcription, DNA-
xsq KRT17 17q21.2 -0.273 0.0347 0.437
exp ANGPTL2 9q34 -0.273 0.0347 0.437 signal
swa ATP2B4 1q32.1 -0.275 0.0347 0.437 ion transmembrane
exp EIF4BP4 3p22.1 0.275 0.0348 0.437
his FAM32A 19pter-p13.3 0.275 0.0348 0.437
his SCARNA12 0.275 0.0348 0.438
his PHB2 12p13 0.275 0.0348 0.438 negative regulation of transcription,
DNA-dependent"
his EMG1 12p13.3 0.275 0.0348 0.438 rRNA processing;ribosomal small
subunit biogenesis
mut TEX15 8p12 0.273 0.0348 0.437 regulation of double-strand break repair
exp ETNK1 12p12.1 0.273 0.0348 0.437 phosphatidylethanolamine
xsq AIFM1 Xq26.1 0.273 0.0348 0.438 Apoptosis
exp PDF 16q22.1 0.273 0.0348 0.438 translation;positive regulation of
cell proliferation
exp ADTRP 6p24.1 0.273 0.0348 0.438
cop HRASLS 3q29 -0.273 0.0348 0.437
cop MGC2889 3q29 -0.273 0.0348 0.437
xsq KCNK2 1q41 -0.273 0.0348 0.437 ion transport;potassium ion
transport
exp BMPR1A 10q22.3 -0.273 0.0348 0.437 Apoptosis
xai BMPR1A 10q22.3 -0.275 0.0348 0.438 Apoptosis
xai PLEKHF1 19q12 -0.275 0.0348 0.438 apoptotic process
swa ERLIN2 8p11.2 -0.275 0.0348 0.438 ER-associated protein
catabolic process
his ZDHHC1 16q22.1 -0.275 0.0348 0.437 protein palmitoylation
xai ABT1 6p22.2 0.275 0.0349 0.438 regulation of transcription from
xai METTL13 1q24-q25.3 0.275 0.0349 0.438 metabolic process
his TOE1 1p33 0.275 0.0349 0.438
his MUTYH 1p34.1 0.275 0.0349 0.438 DNA Damage Response (DDR); DDR
(BER)
DNA-dependent"
his C12orf43 12q24.31 0.275 0.0349 0.438
xsq LGALS12 11q13 0.273 0.0349 0.438 induction of apoptosis by
intracellular signals;apoptotic process
exp RASSF1 3p21.3 0.273 0.0349 0.438 positive regulation of
xsq PFAS 17p13.1 0.273 0.0349 0.438 purine base metabolic
xsq LRRC63 13q14.13 0.273 0.0349 0.438
xsq PPM1L 3q26.1 0.273 0.0349 0.438 small molecule metabolic
met PRG3 11q12 0.273 0.0349 0.438
xsq PHLDA1 12q15 -0.273 0.0349 0.438 Apoptosis
hs4 ZFHX3 16q22.3 -0.275 0.0349 0.438 negative regulation of
xai SGK223 8p23.1 -0.275 0.0349 0.438
xai PAK4 19q13.2 -0.275 0.0349 0.438 Protein Kinases
his MIR1260B -0.275 0.0349 0.438
his MAML2 11q21 -0.275 0.0349 0.438 regulation of transcription, DNA-
his CASC18 -0.275 0.0349 0.438
xai NINJ1 9q22 -0.275 0.0349 0.438 cell adhesion;nervous system
development
swa GMDS 6p25 -0.275 0.0349 0.438 'de novo' GDP-L-fucose biosynthetic
process;cellular metabolic process
his SNAR-A12 0.275 0.035 0.438
his SNAR-C5 0.275 0.035 0.438
his EXOC3L4 14q32.32 0.275 0.035 0.438
exp RNU7-1 12p13.31 0.275 0.035 0.439
xai PATZ1 22q12.2 0.275 0.035 0.439 regulation of transcription, DNA-
xai HTRA2 2p12 0.275 0.035 0.439 Apoptosis
xsq LOC727896 0.273 0.035 0.438
exp NUP35 2q32.1 0.273 0.035 0.438 regulation of glucose transport;protein
transport
xsq LOC101929512 0.273 0.035 0.438
met PKP3 11p15 0.273 0.035 0.438 cell adhesion
exp FOXI3 2p11.2 -0.273 0.035 0.439 epidermal cell fate
specification;otic placode formation
exp TRIL 7p14.3 -0.273 0.035 0.438 innate immune response;regulation
of cytokine production involved in immune response
xsq GLTSCR1 19q13.3 -0.273 0.035 0.438
xsq SCUBE2 11p15.3 -0.273 0.035 0.438
exp CTSLP4 10q11.23 -0.273 0.035 0.438
his CCDC30 1p34.2 -0.275 0.035 0.439
xai ZBTB20 3q13.2 -0.275 0.035 0.439 regulation of transcription,
DNA-dependent"
xai MIR30C2 -0.275 0.035 0.439
xai NDFIP1 5q31.3 -0.275 0.035 0.438 regulation of myeloid
leukocyte differentiation;negative regulation of T cell proliferation
xai STARD3NL 7p14-p13 -0.275 0.035 0.438
xai PLEKHA1 10q26.13 -0.275 0.035 0.438 female gonad
exp MIR30C2 -0.275 0.035 0.438
his APPL1 3p21.1-p14.3 0.275 0.0351 0.439 signal transduction;cell
proliferation
his ANAPC7 12q24.11 0.275 0.0351 0.439 anaphase-promoting complex-
dependent proteasomal ubiquitin-dependent protein catabolic process;cell division
exp LOC100128670 0.275 0.0351 0.439
xai RNU7-1 12p13.31 0.275 0.0351 0.439
xai NUP35 2q32.1 0.275 0.0351 0.439 regulation of glucose
exp TRNG 0.275 0.0351 0.439
xai RPL36 19p13.3 0.275 0.0351 0.439 translational termination;cellular
xai CCT7P1 0.275 0.0351 0.439
xai PCNA 20pter-p12 0.275 0.0351 0.439 DNA Damage Response (DDR); DDR
xai TRNG 0.275 0.0351 0.439
xai RPS26P56 0.275 0.0351 0.439
his LINC01524 0.275 0.0351 0.439
xai USP37 2q35 0.275 0.0351 0.439 proteolysis;ubiquitin-dependent protein
catabolic process
exp LGSN 6pter-q22.33 0.273 0.0351 0.439 glutamine biosynthetic
xsq GTF3C2 2p23.3 0.273 0.0351 0.439 transcription, DNA-
xsq LOC101928995 0.273 0.0351 0.439
exp CCL20 2q36.3 0.273 0.0351 0.439 immune response;signal transduction
exp PAN3-AS1 13q12.2 0.273 0.0351 0.439
xsq SOCS7 17q12 0.273 0.0351 0.439 insulin receptor signaling
pathway;negative regulation of signal transduction
exp TMEM139 7q34 -0.273 0.0351 0.439
exp FERMT2 14q22.1 -0.273 0.0351 0.439 cell adhesion;regulation
of cell shape
exp PCA3 -0.275 0.0351 0.439
his PKP4-AS1 -0.275 0.0351 0.439
his MIR548AH -0.275 0.0351 0.439
hs4 HYAL1 3p21.31 -0.275 0.0351 0.439 response to virus;positive
regulation of angiogenesis
xai AMY1A -0.275 0.0351 0.439
xai RPS4XP18 18q11.2 0.275 0.0352 0.439
his SPOCK3 4q32.3 0.275 0.0352 0.439 peptide cross-linking via
his NEURL4 17p13 0.275 0.0352 0.439
his IGHMBP2 11q13.3 0.275 0.0352 0.439 DNA Damage Response (DDR)
xai HSPA8P8 7p21.3 0.275 0.0352 0.439
his DMAP1 1p34 0.275 0.0352 0.439 negative regulation of transcription from
RNA polymerase II promoter;DNA methylation
hs4 TRIML2 4q35.2 0.275 0.0352 0.439
exp RPS26P56 0.275 0.0352 0.44
xai PXN-AS1 0.275 0.0352 0.44
his ZDHHC3 3p21.31 0.275 0.0352 0.44 protein targeting;protein
palmitoylation
his EXOSC7 3p21.31 0.275 0.0352 0.44 nuclear-transcribed mRNA
exp ZBTB8OSP1 0.275 0.0352 0.44
hs4 FOXI2 10q26.2 0.275 0.0352 0.44 pattern specification
process;epidermal cell fate specification
xsq VSIG4 Xq12-q13.3 0.273 0.0352 0.439 complement activation, alternative
DNA-dependent"
exp RPS10P5 20p13 0.272 0.0352 0.439
exp ATG16L2 11q13.4 0.272 0.0352 0.439 autophagy;protein transport
xsq RPL15 3p24.2 0.272 0.0352 0.439 translation;mRNA metabolic process
met USP47 11p15.3 0.272 0.0352 0.439 cellular response to
UV;monoubiquitinated protein deubiquitination
exp LYL1 19p13.2 0.272 0.0352 0.44 regulation of transcription, DNA-
xsq LINC01139 -0.272 0.0352 0.44
cop LRRCC1 8q21.2 -0.272 0.0352 0.439 cell cycle;mitosis
exp PIP4K2C 12q13.3 -0.272 0.0352 0.439
xsq PPP1R14C 6q24.3-q25.3 -0.272 0.0352 0.439 regulation of
phosphorylation
exp CBR1 21q22.13 -0.272 0.0352 0.439 oxidation-reduction
xai DAAM1 14q23.1 -0.275 0.0352 0.439 cellular component
his GBAT2 0.275 0.0353 0.44
his RFX5 1q21 0.275 0.0353 0.44 negative regulation of transcription from
xai NAP1L4P3 13q14.2 0.275 0.0353 0.44
cop BCKDK 16p11.2 0.275 0.0353 0.44 branched chain family amino acid
catabolic process;phosphorylation
DNA-dependent"
exp RPL37A 2q35 0.275 0.0353 0.44 gene expression;viral reproduction
hs4 NETO1 18q22.2 0.275 0.0353 0.44 visual learning;regulation of long-
term neuronal synaptic plasticity
hs4 LOC100505797 0.275 0.0353 0.44
xai KAT6B 10q22.2 0.275 0.0353 0.44 positive regulation of
transcription, DNA-dependent;nucleosome assembly
exp LDHAL6A 11p15.1 0.275 0.0353 0.44 glycolysis;cellular
carbohydrate metabolic process
xai HNRNPCP7 7q11.21 0.275 0.0353 0.44
xsq LOC102724096 0.272 0.0353 0.44
exp SCAI 9q33.3 0.272 0.0353 0.44 regulation of transcription, DNA-
xsq SLC39A8 4q22-q24 0.272 0.0353 0.44 Solute Carriers
exp RPS5 19q13.4 0.272 0.0353 0.44 regulation of translational
xsq GPX7 1p32 0.272 0.0353 0.44 response to oxidative stress
xsq BANP 16q24 0.272 0.0353 0.44 multicellular organismal
development;chromatin modification
cop LPAL2 6q26-q27 0.272 0.0353 0.44
xsq CDRT4 17p12 -0.272 0.0353 0.44
hs4 TMEM144 4q32.1 -0.275 0.0353 0.44
xai LOC339874 -0.275 0.0353 0.44
hs4 CGNL1 15q21.3 -0.275 0.0353 0.44
his TTC5 14q11.2 0.274 0.0354 0.44 DNA repair
his TCF12 15q21 0.274 0.0354 0.441 regulation of transcription from RNA
polymerase II promoter;immune response
his LOC145783 15q21.3 0.274 0.0354 0.441
his SNAR-A3 0.274 0.0354 0.441
his SNAR-C2 0.274 0.0354 0.441
met NRGN 11q24 0.272 0.0354 0.44 signal transduction;nervous system
development
exp TNFRSF13B 17p11.2 0.272 0.0354 0.44 B cell homeostasis;cell
met EPHX1 1q42.1 0.272 0.0354 0.44 response to toxin;response to
exp LOC100128108 15q26.3 0.272 0.0354 0.44
mut SLCO2A1 3q21 0.272 0.0354 0.441 Solute Carriers
exp RPL29 3p21.3-p21.2 0.272 0.0354 0.441 nuclear-transcribed mRNA
catabolic process, nonsense-mediated decay;viral reproduction
exp UIMC1 5q35.2 0.272 0.0354 0.441 DNA Damage Response (DDR); DDR (HR)
xsq LYPD1 2q21.2 -0.272 0.0354 0.441
exp PKIG 20q12-q13.1 -0.272 0.0354 0.441 negative regulation of
activity
his LOC100130691 2q31.2 -0.274 0.0354 0.441
his AGPS 2q31.2 -0.274 0.0354 0.441 lipid biosynthetic
process;ether lipid biosynthetic process
his MTRNR2L3 -0.274 0.0354 0.441
xai SEMA3F 3p21.3 -0.275 0.0354 0.44 neural crest cell
exp MIR3936 -0.275 0.0354 0.44
his ALG5 13q13.3 0.274 0.0355 0.441 cellular protein metabolic
process;protein glycosylation
his EXOSC8 13q13.1 0.274 0.0355 0.441 mRNA metabolic
his MRFAP1L1 4p16.1 0.274 0.0355 0.441
exp UNC93B6 0.274 0.0355 0.441
DNA-dependent"
xai SNORD4A 0.274 0.0355 0.441
xai C1D 2p13-p12 0.274 0.0355 0.441 negative regulation of
transcription, DNA-dependent;maturation of 5.8S rRNA
hs4 TGFBR3L 0.274 0.0355 0.441
swa OLA1 2q31.1 0.274 0.0355 0.441 ATP catabolic process
xai RAG2 11p13 0.274 0.0355 0.441 B cell homeostatic proliferation;positive
xai TNPO2 19p13.2 0.274 0.0355 0.441 intracellular protein transport
xsq CPEB1-AS1 0.272 0.0355 0.441
exp SSTR5 16p13.3 0.272 0.0355 0.441 glucose homeostasis;regulation of
insulin secretion
xsq STARD7-AS1 0.272 0.0355 0.441
xsq VAV1 19p13.2 0.272 0.0355 0.441 regulation of transcription, DNA-
hs4 RAPH1 2q33 -0.274 0.0355 0.441 cell-matrix adhesion;signal
transduction
swa ABCC4 13q32 -0.274 0.0355 0.441 ABC Transporters
his ITGB3 17q21.32 -0.274 0.0355 0.441 integrin-mediated signaling
pathway;positive regulation of vascular endothelial growth factor receptor
signaling pathway
xai MIR3936 -0.274 0.0355 0.441
xai EFHD1 2q37.1 -0.274 0.0355 0.441 neuron projection development
his IL1RAP 3q28 -0.274 0.0355 0.441 signal transduction;innate
immune response
his LOC100506746 0.274 0.0356 0.441
his AFF1 4q21 0.274 0.0356 0.441 regulation of transcription, DNA-
dependent"
his PDZD11 Xq13.1 0.274 0.0356 0.441
his KIF4A Xq13.1 0.274 0.0356 0.441 organelle organization;microtubule-
based movement
hs4 FOXD4 9p24.3 0.274 0.0356 0.442 regulation of transcription, DNA-
dependent;enteric nervous system development
exp ENO3 17p13.2 0.272 0.0356 0.441 response to drug;skeletal muscle
tissue regeneration
exp SV2B 15q26.1 0.272 0.0356 0.441 neurotransmitter transport
cop FAM86C2P 11q13.2 0.272 0.0356 0.441
cop UNC93B1 11q13 0.272 0.0356 0.441 toll-like receptor 7 signaling
pathway;toll-like receptor 9 signaling pathway
cop ALDH3B1 11q13 0.272 0.0356 0.441 alcohol metabolic process;lipid
metabolic process
cop NDUFS8 11q13 0.272 0.0356 0.441 small molecule metabolic
process;mitochondrial electron transport, NADH to ubiquinone
cop MIR4691 0.272 0.0356 0.441
mut EFCAB2 1q44 0.272 0.0356 0.442
exp HDAC2 6q21 0.272 0.0356 0.442 negative regulation of neuron projection
development;negative regulation of MHC class II biosynthetic process
xsq MDS2 1p36 0.272 0.0356 0.442
exp ZCCHC10 5q31.1 0.272 0.0356 0.442
xsq RUFY4 2q35 0.272 0.0356 0.442
xsq LRRC39 1p21.2 0.272 0.0356 0.442
exp HMGB1P1 20q13.32 0.272 0.0356 0.442
exp ADAMTS4 1q21-q23 -0.272 0.0356 0.442 proteolysis;skeletal
system development
xsq ADAMTSL1 9p21.3 -0.272 0.0356 0.442
cop RYR2 1q43 -0.272 0.0356 0.442 multicellular organismal
development;cytosolic calcium ion homeostasis
xsq COL18A1 21q22.3 -0.272 0.0356 0.441 negative regulation of
met PEAR1 1q23.1 -0.272 0.0356 0.441 recognition of apoptotic cell
swa PSAP 10q21-q22 -0.274 0.0356 0.442 glycosphingolipid metabolic
process;lipid transport
swa RAB11B 19p13.2 -0.274 0.0356 0.442 cell cycle;small GTPase
hs4 MIR4267 -0.274 0.0356 0.441
xai TPD52L1 6q22-q23 -0.274 0.0356 0.441 G2/M transition of
xai IFIT1P1 13q13.1 0.274 0.0357 0.442
xai NDUFAF4P2 7q21.3 0.274 0.0357 0.442
xai NELFA 4p16.3 0.274 0.0357 0.442
xai RBFOX3 17q25.3 0.274 0.0357 0.442 mRNA processing;RNA splicing
his ZNF839 14q32.31 0.274 0.0357 0.442
xsq C20orf96 20p13 0.272 0.0357 0.442
xsq STT3B 3p23 0.272 0.0357 0.442 protein glycosylation;protein N-linked
xsq LINC00938 12q12 0.272 0.0357 0.442
exp CDCA4 14q32.33 0.272 0.0357 0.442
mir hsa-miR-183* 0.272 0.0357 0.442
exp INO80C 18q12.2 0.272 0.0357 0.442 DNA Damage Response (DDR);
DDR (Chromatin)
exp RPL7AP42 7q31.1 0.272 0.0357 0.442
exp LRRC38 1p36.21 0.272 0.0357 0.442
exp RPL7AP47 9p23 0.272 0.0357 0.442
cop E2F5 8q21.2 -0.272 0.0357 0.442 G1 phase of mitotic cell
cop C8orf59 8q21.2 -0.272 0.0357 0.442
exp CIC 19q13.2 -0.272 0.0357 0.442 Tumor Suppressors
exp TRAV40 -0.274 0.0357 0.442
xai CBR3-AS1 -0.274 0.0357 0.442
xai SLFN12 17q12 -0.274 0.0357 0.442
his KIAA0100 17q11.2 0.274 0.0358 0.442
his C12orf73 12q23.3 0.274 0.0358 0.442
his ANKRD36BP2 2p11.2 0.274 0.0358 0.443
his HSP90AA1 14q32.33 0.274 0.0358 0.443 Apoptosis
his WDR20 14q32.31 0.274 0.0358 0.443
his CCDC88A 2p16.1 0.274 0.0358 0.443 EMT (Mesenchymal)
his CDC14A 1p21 0.274 0.0358 0.443 cell cycle;cell proliferation
his PPM1A 14q23.1 0.274 0.0358 0.443 insulin receptor signaling
pathway;positive regulation of transcription, DNA-dependent
his ATP9B 18q23 0.274 0.0358 0.443 cation transport;aminophospholipid
transport
met TMEM150A 2p11.2 0.272 0.0358 0.442 catabolic process
xsq MDM1 12q15 0.272 0.0358 0.442 retina development in camera-type eye
exp SMAP2 1p35.3-p34.1 0.272 0.0358 0.443 regulation of ARF GTPase
activity
xsq MRPL2 6p21.3 0.272 0.0358 0.443 translation
met PLCL2 3p24.3 -0.272 0.0358 0.443 lipid metabolic
xsq SMAD7 18q21.1 -0.272 0.0358 0.442 Apoptosis
his BBOX1-AS1 -0.274 0.0358 0.443
his C1orf140 1q41 -0.274 0.0358 0.443
his SNORA87 -0.274 0.0358 0.442
his PLEKHM2 1p36.21 -0.274 0.0358 0.442 Golgi organization
xai TRAV40 -0.274 0.0358 0.442
hs4 LOC729870 4q31.3 -0.274 0.0358 0.442
his TEP1 14q11.2 0.274 0.0359 0.443 DNA Damage Response (DDR)
xai CAPN10 2q37.3 0.274 0.0359 0.443 positive regulation of
insulin secretion;positive regulation of intracellular transport
his MIR6077 0.274 0.0359 0.443
swa CLIC1 6p21.3 0.274 0.0359 0.443 transport;ion transport
his SF3B4 1q21.2 0.274 0.0359 0.443 mRNA processing;RNA splicing
hs4 S100A8 1q21 0.274 0.0359 0.443 inflammatory response;response to
zinc ion
his TRAPPC9 8q24.3 0.274 0.0359 0.443 cell differentiation
his ORC4 2q22-q23 0.274 0.0359 0.443 DDR (DNA replication)
his MBD5 2q23.1 0.274 0.0359 0.443
xai ATG16L2 11q13.4 0.274 0.0359 0.443 autophagy;protein transport
exp RTN4IP1 6q21 0.272 0.0359 0.443
met NDUFS2 1q23 0.272 0.0359 0.443 response to oxidative
met LYPD6 2q23.2 0.272 0.0359 0.443
xsq PCAT18 0.271 0.0359 0.443
met C1orf100 1q44 0.271 0.0359 0.443
xsq ANGPTL6 19p13.2 0.271 0.0359 0.443 angiogenesis;signal
transduction
cop SLC22A3 6q25.3 0.271 0.0359 0.443 Solute Carriers
xsq TOB1-AS1 0.271 0.0359 0.443
exp DCAF12 9p13.3 0.271 0.0359 0.443 protein ubiquitination
xsq HNRNPKP3 11p12 0.271 0.0359 0.443
met ATP8B4 15q21.2 -0.271 0.0359 0.443 phospholipid
transport;cation transport
exp CAPG 2p11.2 -0.272 0.0359 0.443 protein complex assembly;cell
projection assembly
exp RPL35AP13 5q13.2 -0.272 0.0359 0.443
his MIR619 -0.274 0.0359 0.443
hs4 FSBP -0.274 0.0359 0.443
xai ETNK2 1q32.1 -0.274 0.0359 0.443 phosphatidylethanolamine
hs4 SLC46A2 9q32 -0.274 0.0359 0.443 transport;transmembrane
transport
xai RAB32 6q24.3 -0.274 0.0359 0.443 small GTPase mediated signal
his C6orf47 6p21.3 0.274 0.036 0.443
his GPANK1 6p21.3 0.274 0.036 0.443
his CSNK2B 6p21.3 0.274 0.036 0.443 Protein Kinases
dependent"
his MAML3 4q28 0.274 0.036 0.443 positive regulation of transcription from RNA
polymerase II promoter;regulation of transcription, DNA-dependent
his MRPS16 10q22.1 0.274 0.036 0.443 translation
his DNAJC9-AS1 0.274 0.036 0.443
xai DBP 19q13.3 0.274 0.036 0.443 regulation of cell proliferation;positive
his MS4A3 11q12.1 0.274 0.036 0.443
hs4 GPR150 5q15 0.274 0.036 0.443
xsq CEL 9q34.3 0.271 0.036 0.443 fatty acid catabolic process;ceramide
catabolic process
cop MTHFD1L 6q25.1 0.271 0.036 0.443 one-carbon metabolic process;folic
acid-containing compound metabolic process
xsq HNRNPA1 12q13.1 0.271 0.036 0.443 interspecies interaction between
organisms;alternative nuclear mRNA splicing, via spliceosome
cop UXS1 2q12.2 0.271 0.036 0.443 cellular metabolic process
mut ABCA5 17q24.3 0.271 0.036 0.443 ABC Transporters
xsq DHFR 5q11.2-q13.2 0.271 0.036 0.443
xsq AUNIP 1p36.11 0.271 0.036 0.443
dependent"
xsq LOC100129055 10p11.1 0.271 0.036 0.443
exp TFEC 7q31.2 0.271 0.036 0.443 regulation of transcription, DNA-
exp S100A11P1 -0.271 0.036 0.443
exp ITGB1 10p11.2 -0.271 0.036 0.443 Apoptosis
xsq VTCN1 1p13.1 -0.271 0.036 0.443 negative regulation of T cell
activation
xai SIRT2 19q13 -0.274 0.036 0.443 regulation of exit from mitosis;response
to redox state
xai ACER1 19p13.3 -0.274 0.036 0.443 sphingolipid metabolic
his C1QTNF6 22q13.1 -0.274 0.036 0.443
xai MAML2 11q21 -0.274 0.036 0.443 regulation of transcription, DNA-
hs4 FAM214B 9p13.3 -0.274 0.036 0.443
xai WLS 1p31.3 -0.274 0.036 0.443 Wnt receptor signaling
xai TM4SF1 3q21-q25 -0.274 0.036 0.443
xai CA15P1 -0.274 0.036 0.443
exp TRNM 0.274 0.0361 0.443
his SIRT4 12q 0.273 0.0361 0.444 protein ADP-ribosylation;protein
deacetylation
his TSSK6 19p13.11 0.273 0.0361 0.444 cell differentiation;sperm
chromatin condensation
his NDUFA13 19p13.2 0.273 0.0361 0.444 apoptotic nuclear
change;protein import into nucleus
xsq SFXN4 10q26.11 0.271 0.0361 0.443 iron ion homeostasis;transmembrane
transport
exp BCLAF1 6q22-q23 0.271 0.0361 0.443 Apoptosis
cop PAPOLG 2p16.1 0.271 0.0361 0.444 transcription, DNA-
exp GALNT6 12q13 0.271 0.0361 0.444 post-translational protein
met DZIP1L 3q22.3 0.271 0.0361 0.444
mut POLR1E 9p13.2 0.271 0.0361 0.444 rRNA transcription
exp IGKV1D-16 2p12 0.271 0.0361 0.444
xsq LOC102724190 0.271 0.0361 0.444
met SNX33 15q24.2 0.271 0.0361 0.444 cell communication
cop C2orf40 2q12.2 0.271 0.0361 0.444 G1 to G0 transition;cellular
senescence
exp TGIF2 20q11.23 0.271 0.0361 0.444 regulation of transcription, DNA-
xsq NUAK1 12q23.3 -0.271 0.0361 0.444 regulation of myosin-light-
exp ARFGEF1 8q13 -0.271 0.0361 0.444 exocytosis;regulation of ARF
met OXCT1 5p13.1 -0.271 0.0361 0.443 response to nutrient;response
to ethanol
hs4 XIRP2-AS1 -0.273 0.0361 0.444
xai APOA5 11q23 -0.273 0.0361 0.444 response to hormone
stimulus;cholesterol homeostasis
hs4 TACSTD2 1p32 -0.273 0.0361 0.444 response to stimulus;negative
his NFE2L3 7p15.2 -0.274 0.0361 0.443 regulation of
transcription, DNA-dependent;transcription from RNA polymerase II promoter"
hs4 CFC1 0.273 0.0362 0.444
exp RPS12P27 0.273 0.0362 0.444
his NRF1 7q32 0.273 0.0362 0.444 mitochondrion organization;organ
regeneration
swa RPS14 5q31-q33 0.273 0.0362 0.444 nuclear-transcribed mRNA catabolic
his FOXJ3 1p34.2 0.273 0.0362 0.444 regulation of sequence-specific DNA
his THOC5 22q12.2 0.273 0.0362 0.444 cell differentiation;monocyte
differentiation
xai HMGB1P39 0.273 0.0362 0.444
his LINC01869 0.273 0.0362 0.444
his KLK1 19q13.3 0.273 0.0362 0.444 proteolysis
exp HIST1H4B 6p22.1 0.271 0.0362 0.444
cop TCIRG1 11q13.2 0.271 0.0362 0.444 proton transport;transferrin
transport
xsq LOC390705 16p11.2 0.271 0.0362 0.444
xsq OXSM 3p24.2 0.271 0.0362 0.444 acyl-CoA metabolic process;short-
chain fatty acid biosynthetic process
exp GPR150 5q15 0.271 0.0362 0.444
xsq HEXDC 17q25.3 0.271 0.0362 0.444 carbohydrate metabolic process
xsq NDUFAF7 2p22.2 0.271 0.0362 0.444
xsq TRIM16 17p11.2 -0.271 0.0362 0.444 positive regulation of
exp ETNK2 1q32.1 -0.271 0.0362 0.444 phosphatidylethanolamine
exp EPHB3 3q27.1 -0.271 0.0362 0.444 axon guidance;substrate
hs4 WNT4 1p36.23-p35.1 -0.273 0.0362 0.444 Oncogenes
xai SRMP2 14q23.1 -0.273 0.0362 0.444
xai SNORA46 0.273 0.0363 0.444
xai LOC100506083 0.273 0.0363 0.444
hs4 REG4 1p13.1-p12 0.273 0.0363 0.444
exp SNORA46 0.273 0.0363 0.445
his WDR5 9q34 0.273 0.0363 0.445 regulation of transcription, DNA-
his AKAP11 13q14.11 0.273 0.0363 0.445 intracellular protein kinase
cascade;regulation of protein kinase A signaling cascade
exp TSPEAR-AS1 0.273 0.0363 0.445
his KCNK12 2p16.3 0.273 0.0363 0.445 ion transport;potassium ion
transport
xai RHOT2 16p13.3 0.273 0.0363 0.445 Apoptosis
DNA-dependent"
xsq EPM2A 6q24 0.271 0.0363 0.444 carbohydrate metabolic process;glycogen
metabolic process
exp CLASP2 3p22.3 0.271 0.0363 0.445 microtubule organizing center
xsq RPL3 22q13 0.271 0.0363 0.445 translational termination;cellular
exp VAV1 19p13.2 0.271 0.0363 0.445 regulation of transcription, DNA-
xsq KHDRBS1 1p32 0.271 0.0363 0.445 negative regulation of
xsq KBTBD7 13q14.11 0.271 0.0363 0.445
exp ITGB2 21q22.3 0.271 0.0363 0.445 Apoptosis
exp CTSG 14q11.2 0.271 0.0363 0.445 positive regulation of immune
cop PSKH2 8q21.3 -0.271 0.0363 0.445
xsq TEAD2 19q13.3 -0.271 0.0363 0.445 positive regulation of
exp TIGIT 3q13.31 -0.271 0.0363 0.444 negative regulation of
interleukin-12 production;positive regulation of interleukin-10 production
hs4 EPHA2 1p36 -0.273 0.0363 0.445 Protein Kinases
xai AGAP1-IT1 -0.273 0.0363 0.445
exp SRMP2 14q23.1 -0.273 0.0363 0.445
exp AGAP1-IT1 -0.273 0.0363 0.445
hs4 TMEM54 1p35-p34 -0.273 0.0363 0.444
his ELOVL4 6q14 0.273 0.0364 0.445 fatty acid biosynthetic
his MUM1 19p13.3 0.273 0.0364 0.445 DNA repair;chromatin organization
his RNU5A-1 15q22.31 0.273 0.0364 0.445
hs4 QSOX2 9q34.3 0.273 0.0364 0.445 cell redox homeostasis
exp TMEM78 0.273 0.0364 0.445
xai RBM45 2q31.2 0.273 0.0364 0.445 multicellular organismal
his CYB561D2 3p21.3 0.273 0.0364 0.445 transport;electron transport
chain
his NPRL2 3p21.3 0.273 0.0364 0.445 protein phosphorylation;negative
regulation of kinase activity
xai IGLV1-44 0.273 0.0364 0.445
xai LZTFL1 3p21.3 0.273 0.0364 0.445
his PIGC 1q23-q25 0.273 0.0364 0.445 C-terminal protein lipidation;GPI
exp C19orf48 19q13.33 0.271 0.0364 0.445
exp METTL8 2q31.1 0.271 0.0364 0.445
xsq DCP1A 3p21.1 0.271 0.0364 0.445 nuclear-transcribed mRNA catabolic
xsq CCP110 16p12.3 0.271 0.0364 0.445 G2/M transition of mitotic
xsq CCDC80 3q13.2 -0.271 0.0364 0.445 positive regulation of
exp PC 11q13.4-q13.5 -0.271 0.0364 0.445 carbohydrate metabolic
met TMC6 17q25.3 -0.271 0.0364 0.445
exp C8orf46 8q13.1 -0.271 0.0364 0.445
exp VEGFB 11q13 -0.271 0.0364 0.445 positive regulation of vascular
endothelial growth factor receptor signaling pathway;positive regulation of cell
division
hs4 SGMS2 4q25 -0.273 0.0364 0.445 lipid metabolic
xai CLSTN1 1p36.22 -0.273 0.0364 0.445 cell adhesion;homophilic
cell adhesion
exp TLK1P1 9q33.2 0.273 0.0365 0.445
xai TMEM78 0.273 0.0365 0.446
xai WDR92 2p14 0.273 0.0365 0.446 apoptotic process;histone lysine
methylation
his SPTY2D1 11p15.1 0.273 0.0365 0.446
exp ZC3H15 2q32.1 0.271 0.0365 0.445 cytokine-mediated signaling
pathway
met BCAR3 1p22.1 0.271 0.0365 0.446 small GTPase mediated signal
transduction;response to drug
cop ZNF839 14q32.31 0.271 0.0365 0.446
cop CINP 14q32.31 0.271 0.0365 0.446 DNA replication;DNA repair
xsq SRM 1p36-p22 0.271 0.0365 0.446 cellular nitrogen compound
cop ADCYAP1 18p11 0.271 0.0365 0.446 cell-cell signaling;female
pregnancy
exp STIP1 11q13 0.271 0.0365 0.446 response to stress;axon guidance
cop ENOSF1 18p11.32 0.271 0.0365 0.446 cellular amino acid catabolic
process
met NPY1R 4q31.3-q32 0.271 0.0365 0.446 feeding behavior;regulation of
blood pressure
xsq CHGB 20p12.3 0.271 0.0365 0.446
xsq ARHGAP21 10p12.1 -0.271 0.0365 0.446 signal transduction
exp MATN3 2p24-p23 -0.271 0.0365 0.446 skeletal system development
exp SLFN12 17q12 -0.271 0.0365 0.446
hs4 CAPN2 1q41-q42 -0.273 0.0365 0.445 response to
swa PLOD2 3q24 -0.273 0.0365 0.445 response to hypoxia;protein
swa MDH1 2p13.3 0.273 0.0366 0.446 carbohydrate metabolic
his SLC16A10 6q21-q22 0.273 0.0366 0.446 Solute Carriers
exp RPSAP47 8q21.13 0.273 0.0366 0.446
his LOC101928517 0.273 0.0366 0.446
his LOC100506388 0.273 0.0366 0.446
swa YWHAB 20q13.1 0.273 0.0366 0.446 small GTPase mediated signal
transduction;RNA metabolic process
his TBCD 17q25.3 0.273 0.0366 0.446 negative regulation of cell-
substrate adhesion;negative regulation of microtubule polymerization
xai UBR7 14q32.12 0.273 0.0366 0.446
exp LRRC40 1p31.1 0.271 0.0366 0.446
cop WDR25 14q32.2 0.271 0.0366 0.446
exp GOT2P4 12p12.3 0.271 0.0366 0.446
mut CDH1 16q22.1 0.27 0.0366 0.446 Cell Signaling; Tumor Suppressors
xsq NOP16 5q35.2 0.27 0.0366 0.446
xsq KCNH4 17q21.2 0.27 0.0366 0.446 regulation of transcription, DNA-
xsq GMCL1 2p13.3 0.27 0.0366 0.446 regulation of transcription, DNA-
exp REPS1 6q24.1 0.27 0.0366 0.446
cop YES1 18p11.31-p11.21 0.27 0.0366 0.446 Apoptosis
xsq CCNO 5q11.2 -0.27 0.0366 0.446 DNA Damage Response (DDR)
exp SUSD4 1q41 -0.27 0.0366 0.446
hs4 CORT -0.273 0.0366 0.446
xai ZDHHC1 16q22.1 -0.273 0.0366 0.446 protein palmitoylation
swa APOL2 22q12 -0.273 0.0366 0.446 lipid metabolic process;transport
exp LOC285692 5p15.31 -0.273 0.0366 0.446
xai PRR5L 11p13-p12 -0.273 0.0366 0.446
hs4 RNF144B 6p22.3 -0.273 0.0366 0.446 apoptotic
process
xai RNF19A 8q22 -0.273 0.0366 0.446 microtubule cytoskeleton
organization;protein modification process
his PKD2L2 5q31 0.273 0.0367 0.446 ion transport
his PCDH12 5q31 0.273 0.0367 0.446 cell adhesion;homophilic cell
adhesion
his HDHD2 18q21.1 0.273 0.0367 0.446 metabolic process
xai YBX1P1 14q23.3 0.273 0.0367 0.446
his CECR6 0.273 0.0367 0.446
swa DDX47 12p13.1 0.273 0.0367 0.446 mRNA processing;apoptotic process
exp APEX1 14q11.2 0.27 0.0367 0.446 DNA Damage Response (DDR); DDR
(BER)
xsq EDC4 16q22.1 0.27 0.0367 0.446 mRNA metabolic
xsq NPY 7p15.1 0.27 0.0367 0.446 G-protein signaling, coupled to
cyclic nucleotide second messenger;adult feeding behavior
met FAM189A1 15q13.1 0.27 0.0367 0.446
met PRRX1 1q24 0.27 0.0367 0.446 multicellular organismal development
cop MIR345 0.27 0.0367 0.446
cop SLC25A47 14q32.2 0.27 0.0367 0.446
cop WARS 14q32.31 0.27 0.0367 0.446 translation;tRNA aminoacylation for
protein translation
met SIGLEC8 19q13.33-q13.41 0.27 0.0367 0.446 cell adhesion;signal
transduction
xsq MAPT-AS1 17q21.31 0.27 0.0367 0.446
his CYTH3 7p22.1 -0.273 0.0367 0.446 vesicle-mediated
exp BRWD1-AS1 -0.273 0.0367 0.446
hs4 LOC102724927 -0.273 0.0367 0.446
xai CCNJL 5q33.3 -0.273 0.0367 0.446
xai ZNF608 5q23.2 -0.273 0.0367 0.446
hs4 JOSD2 19q13.33 -0.273 0.0367 0.446 proteolysis;protein
deubiquitination
hs4 ASPDH 19q13.33 -0.273 0.0367 0.446 NADP catabolic process;NAD
hs4 RPSAP52 12q14.3 -0.273 0.0367 0.446
hs4 HMGA2 12q15 -0.273 0.0367 0.446 mesodermal-endodermal cell
signaling;spermatogenesis
his TCEAL3 Xq22.2 -0.273 0.0367 0.446 regulation of
his DNMT1 19p13.2 0.273 0.0368 0.447 DNA Damage Response (DDR)
xai OR4Q3 0.273 0.0368 0.447 response to stimulus
his CASC3 17q21.1 0.273 0.0368 0.447 intracellular mRNA localization;RNA
splicing
xai FAM35A 10q23.2 0.272 0.0368 0.447
xsq GYS2 12p12.2 0.27 0.0368 0.446 carbohydrate metabolic
cop CETN1 0.27 0.0368 0.446
xsq HNRNPM 19p13.2 0.27 0.0368 0.447 alternative nuclear mRNA
splicing, via spliceosome;nuclear mRNA splicing, via spliceosome
xsq LINC01547 0.27 0.0368 0.447
exp MANEA 6q16.1 0.27 0.0368 0.447 protein N-linked glycosylation via
exp TMEM62 15q15.2 -0.27 0.0368 0.447
xsq SNX33 15q24.2 -0.27 0.0368 0.447 cell communication
exp SLIT3 5q35 -0.27 0.0368 0.447 multicellular organismal development;axon
extension involved in axon guidance
xai FERMT2 14q22.1 -0.272 0.0368 0.447 cell adhesion;regulation
of cell shape
hs4 A4GALT 22q13.2 -0.272 0.0368 0.447 lipid biosynthetic
process;glycosphingolipid biosynthetic process
exp ASMT Xp22.3 -0.272 0.0368 0.447 cellular nitrogen compound
hs4 PARD6G 18q23 -0.272 0.0368 0.447 cell junction assembly;cell-
cell junction organization
xai BRWD1-AS1 -0.272 0.0368 0.447
his GFAP 17q21 -0.272 0.0368 0.447 response to wounding;regulation of
neurotransmitter uptake
his C1QTNF4 11q11 0.272 0.0369 0.447
his C19orf25 19p13.3 0.272 0.0369 0.447
his VPS9D1-AS1 16q24.3 0.272 0.0369 0.447
xsq ACTR5 20q11.23 0.27 0.0369 0.447 DNA Damage Response (DDR); DDR
(Chromatin)
exp RPS10P2 20p12 0.27 0.0369 0.447
DNA-dependent"
xsq UPF3B Xq25-q26 0.27 0.0369 0.447 transport;nucleocytoplasmic
transport
exp CNPY3 6p21.1 0.27 0.0369 0.447 innate immune response
exp GIMAP6 0.27 0.0369 0.447
cop ZBTB2 6q25.1 0.27 0.0369 0.447 regulation of transcription, DNA-
dependent"
xsq THSD7A 7p21.3 0.27 0.0369 0.447
met NPR2 9p21-p12 0.27 0.0369 0.447 cell surface receptor signaling
pathway;receptor guanylyl cyclase signaling pathway
xsq NBPF3 1p36.12 0.27 0.0369 0.447
exp GPR65 14q31-q32.1 0.27 0.0369 0.447 multicellular organismal
met SERPING1 11q12.1 0.27 0.0369 0.447 blood circulation;negative
regulation of endopeptidase activity
xsq TUFM 16p11.2 0.27 0.0369 0.447 translational elongation
exp MPZL1 1q24.2 -0.27 0.0369 0.447 transmembrane receptor protein
exp DNAJB12 10q22.1 -0.27 0.0369 0.447 protein folding
exp RNF19A 8q22 -0.27 0.0369 0.447 microtubule cytoskeleton
xsq MYL9 20q11.23 -0.27 0.0369 0.447 axon guidance;muscle contraction
hs4 IL13RA1 Xq24 -0.272 0.0369 0.447 cell surface receptor
signaling pathway
his LINC01546 -0.272 0.0369 0.447
xai STX3 11q12.1 -0.272 0.0369 0.447 cellular membrane
fusion;neuron projection development
his LINC01141 -0.272 0.0369 0.447
hs4 CC2D2A 4p15.32 -0.272 0.0369 0.447 cilium assembly;cilium
morphogenesis
hs4 TRIO 5p15.2 -0.272 0.0369 0.447 transmembrane receptor
transduction
hs4 CASP4 11q22.2-q22.3 -0.272 0.0369 0.447 Apoptosis
hs4 GLMP -0.272 0.0369 0.447 intracellular receptor mediated
signaling pathway;positive regulation of transcription from RNA polymerase II
promoter
his KIAA1644 -0.272 0.0369 0.447
his LOC100507616 0.272 0.037 0.448
his TMEM72 10q11.21 0.272 0.037 0.448
hs4 CD52 1p36 0.272 0.037 0.448 elevation of cytosolic calcium ion
xai VPS51 11q13 0.272 0.037 0.448
xai AARSD1 17q21.31 0.272 0.037 0.448 translation;alanyl-tRNA
aminoacylation
met BCAP29 7q22.3 0.27 0.037 0.447 Apoptosis
met SLC6A8 Xq28 0.27 0.037 0.447 Solute Carriers
exp LY6G5C 6p21.33 0.27 0.037 0.448
pro TYR 11q14.3 -0.27 0.037 0.448 pigmentation;thymus development
exp ABHD12 20p11.21 -0.27 0.037 0.448
xai NPM1P36 6p12.1 0.272 0.0371 0.448
his FEM1A 19p13.3 0.272 0.0371 0.448 regulation of ubiquitin-protein
ligase activity;protein ubiquitination
swa EHMT2 6p21.31 0.272 0.0371 0.449 negative regulation of
xai KHK 2p23.3 0.272 0.0371 0.449 response to sucrose
met COTL1 16q24.1 0.27 0.0371 0.448 defense response to fungus
exp RPL31P49 12q24.11 0.27 0.0371 0.448
cop LOC100862671 0.27 0.0371 0.448
cop PHKG2 16p11.2 0.27 0.0371 0.448 glycogen metabolic process;glycogen
cop C16orf93 16p11.2 0.27 0.0371 0.448
cop RNF40 16p11.2-p11.1 0.27 0.0371 0.448 ubiquitin-dependent protein
cop ZNF629 16p11.2 0.27 0.0371 0.448 regulation of transcription,
DNA-dependent"
cop MIR4519 0.27 0.0371 0.448
xsq CDK8 13q12 0.27 0.0371 0.448 Protein Kinases
DNA-dependent"
exp DUSP11 2p13.1 0.27 0.0371 0.449 RNA processing;peptidyl-
met PTPN21 14q31.3 0.27 0.0371 0.449 protein
exp RNF169 11q13.4 0.27 0.0371 0.449
xsq POLE2 14q21-q22 0.27 0.0371 0.449 DNA Damage Response (DDR); DDR
xsq TBX4 17q21-q22 0.27 0.0371 0.449 skeletal system
morphogenesis;angiogenesis
met PROCA1 17q11.2 -0.27 0.0371 0.449 lipid catabolic process
xsq CYR61 1p22.3 -0.27 0.0371 0.449 positive regulation of protein
hs4 MICAL3 22q11.21 -0.272 0.0371 0.448
exp DOK7 4p16.3 -0.272 0.0371 0.448 positive regulation of
protein tyrosine kinase activity
xai RPS12P27 0.272 0.0372 0.449
swa ITPA 20p 0.272 0.0372 0.449 metabolic process;nucleotide metabolic
process
his SRPK1 6p21.31 0.272 0.0372 0.449 protein phosphorylation;negative
his WTAP 6q25-q27 0.272 0.0372 0.449 mRNA processing;cell cycle
hs4 VRK1 14q32 0.272 0.0372 0.449 Golgi disassembly;protein phosphorylation
xai SIGLEC6 19q13.3 0.272 0.0372 0.449 cell adhesion;cell-cell
signaling
xai DFFA 1p36.3-p36.2 0.272 0.0372 0.449 Apoptosis
xai UTP18 17q21.33 0.272 0.0372 0.449 rRNA processing
xsq AURKB 17p13.1 0.27 0.0372 0.449 Protein Kinases
xsq FBL 19q13.1 0.27 0.0372 0.449 snoRNA metabolic process;rRNA
processing
exp RPS10 6p21.31 0.27 0.0372 0.449 viral reproduction;nuclear-
exp SLAMF6 1q23.2 0.27 0.0372 0.449
exp ASF1A 6q22.31 0.27 0.0372 0.449 DNA Damage Response (DDR); DDR (DNA
replication)
cop CLUL1 18p11.32 0.27 0.0372 0.449 cell death
cop C18orf56 0.27 0.0372 0.449
cop TYMS 18p11.32 0.27 0.0372 0.449 DNA Damage Response (DDR)
xsq UBAC1 9q34.3 0.27 0.0372 0.449
exp TAL1 1p32 0.27 0.0372 0.449 neuron differentiation;regulation of cell
proliferation
exp WT1 11p13 0.27 0.0372 0.449 Apoptosis; Tumor Suppressors
cop LINC01185 0.27 0.0372 0.449
xsq HTRA2 2p12 0.27 0.0372 0.449 Apoptosis
met NTHL1 16p13.3 0.27 0.0372 0.449 DNA Damage Response (DDR); DDR
(BER)
xsq LINC00659 0.27 0.0372 0.449
met ADGRG7 -0.27 0.0372 0.449 G-protein coupled receptor
pro ANXA4 2p13 -0.27 0.0372 0.449 Apoptosis
xsq FGF12 3q28 -0.27 0.0372 0.449 signal transduction;JNK cascade
exp DNAJC25-GNG10 9q31.3 -0.27 0.0372 0.449
exp CHIAP2 1p13.2 -0.272 0.0372 0.449
hs4 ALDH7A1 5q31 -0.272 0.0372 0.449 cellular aldehyde metabolic
hs4 RUNX2 6p21 -0.272 0.0372 0.449 negative regulation of
hs4 SORCS2 4p16.1 -0.272 0.0372 0.449 neuropeptide signaling
pathway
swa PPIA 7p13 0.272 0.0373 0.449 provirus integration;initiation of viral
infection
his ARL5C 17q12 0.272 0.0373 0.449 small GTPase mediated signal transduction
xai PARTICL 0.272 0.0373 0.449
cop KCMF1 2p11.2 0.27 0.0373 0.449
xsq CDK11A 1p36.33 0.27 0.0373 0.449 Protein Kinases
xsq NDUFV1 11q13 0.27 0.0373 0.449 mitochondrial electron transport,
met ZC3H4 19q13.32 0.27 0.0373 0.449
exp ELAC2 17p11.2 0.269 0.0373 0.449 tRNA processing
cop SRCAP 16p11.2 0.269 0.0373 0.449 regulation of transcription from
met MSANTD1 4p16.3 -0.269 0.0373 0.449
exp SYT8 11p15.5 -0.27 0.0373 0.449
xsq IL1RAP 3q28 -0.27 0.0373 0.449 signal transduction;innate immune
response
exp ZNF608 5q23.2 -0.27 0.0373 0.449
exp SMURF1 7q22.1 -0.27 0.0373 0.449 protein
xai FCRL3 1q21-q22 -0.272 0.0373 0.449
xai SERTAD4 1q32.1-q41 -0.272 0.0373 0.449
xai ARL5B 10p12.31 0.272 0.0374 0.45 small GTPase mediated signal
transduction
xai SDE2 1q42.12 0.272 0.0374 0.45
xai C10orf113 10p12.31 0.272 0.0374 0.45
xai MS4A6A 11q12.1 0.272 0.0374 0.45
xai DCLRE1B 1p13.2 0.272 0.0374 0.45 DNA Damage Response (DDR)
his EIF2B4 2p23.3 0.272 0.0374 0.45 gene expression;cellular
response to stimulus
his SNX17 2p23-p22 0.272 0.0374 0.45 receptor-mediated
endocytosis;signal transduction
his CORO1B 11q13.2 0.272 0.0374 0.45 actin cytoskeleton
organization
xai RPL9 4p13 0.272 0.0374 0.45 gene expression;viral reproduction
his PSMB5 14q11.2 0.272 0.0374 0.45 cell cycle checkpoint;regulation of
cellular amino acid metabolic process
exp HNRNPA0 5q31 0.269 0.0374 0.45 response to lipopolysaccharide;3'-
UTR-mediated mRNA stabilization
xsq PKDREJ 22q13.31 0.269 0.0374 0.45 ion transport;neuropeptide
signaling pathway
exp IGKC 0.269 0.0374 0.45 innate immune response;regulation of
immune response
exp MSL2 3q22.3 0.269 0.0374 0.45 histone H4-K16 acetylation
met PCBP1 2p13-p12 -0.269 0.0374 0.45 nuclear mRNA splicing, via
exp ADRA1B 5q33.3 -0.269 0.0374 0.45 G-protein coupled
receptor signaling pathway;visual learning
exp SCARF2 22q11.21 -0.269 0.0374 0.45 cell adhesion
exp EVI5 1p22.1 -0.269 0.0374 0.45 cell cycle;multicellular
swa RBM28 7q32.1 -0.272 0.0374 0.45 mRNA processing;RNA splicing
xai PLPP1 -0.272 0.0374 0.45 lipid metabolic process;androgen
hs4 C15orf38-AP3S2 -0.272 0.0374 0.45
hs4 ARPIN -0.272 0.0374 0.45
his SPEG 2q35 -0.272 0.0374 0.45 muscle organ development;negative
his COX7C 5q14 0.272 0.0375 0.45 generation of precursor metabolites and
his MIR3607 0.272 0.0375 0.45
his H2AFV 7p13 0.272 0.0375 0.45 nucleosome assembly
his SNRPG 2p13.3 0.272 0.0375 0.45 spliceosomal snRNP assembly;RNA
metabolic process
xai SCARNA14 15q22.31 0.272 0.0375 0.45
xai MPV17L2 19p13.11 0.272 0.0375 0.45
xai ATP5G1P7 10q22.1 0.272 0.0375 0.45
xai IGKC 0.271 0.0375 0.45 innate immune response;regulation of
immune response
his KRT2 12q13.13 0.271 0.0375 0.45 keratinocyte
proliferation;keratinocyte migration
met SCGB1D2 11q13 0.269 0.0375 0.45
xsq CD300LB 17q25.1 0.269 0.0375 0.45
xsq RHEBL1 12q13.12 0.269 0.0375 0.45 TOR signaling
cascade;positive regulation of NF-kappaB transcription factor activity
exp UBL7 15q24.1 0.269 0.0375 0.45
exp PLD6 17p11.2 0.269 0.0375 0.45 piRNA metabolic process;meiosis
xsq FAM90A7P 0.269 0.0375 0.45
exp LSM12 17q21.31 0.269 0.0375 0.45
xsq GART 21q22.11 0.269 0.0375 0.45 purine base biosynthetic
process;purine ribonucleoside monophosphate biosynthetic process
met TPRN 9q34.3 0.269 0.0375 0.45 sensory perception of sound
met ZCCHC2 18q21.33 0.269 0.0375 0.45 cell communication
xsq ASAH1 8p22 -0.269 0.0375 0.45 lipid metabolic
hs4 GRAMD3 5q23.2 -0.271 0.0375 0.45
xai FILIP1L 3q12.1 -0.272 0.0375 0.45
hs4 PDK4 7q21.3 -0.272 0.0375 0.45 peptidyl-histidine
xai LINC00526 18p11.31 0.271 0.0376 0.45
swa CLNS1A 11q13.5-q14 0.271 0.0376 0.45 blood circulation;gene
expression
his NR1I2 3q12-q13.3 0.271 0.0376 0.45 signal transduction;drug export
his LRRK1 15q26.3 0.271 0.0376 0.45 small GTPase mediated signal
transduction
his LOC101927751 0.271 0.0376 0.45
his LINC01962 0.271 0.0376 0.45
xai MFAP1P1 13q12.3 0.271 0.0376 0.45
xai PMPCA 9q34.3 0.271 0.0376 0.45 proteolysis
hs4 KCNH4 17q21.2 0.271 0.0376 0.45 regulation of transcription, DNA-
hs4 HCRT 17q21 0.271 0.0376 0.45 elevation of cytosolic calcium ion
his MIR3679 0.271 0.0376 0.45
exp SCARNA14 15q22.31 0.271 0.0376 0.45
xai TESC 12q24.22 0.271 0.0376 0.45 positive regulation of gene
cop SCAF8 6q25.1-q25.3 0.269 0.0376 0.45 transcription from RNA
polymerase II promoter;mRNA processing
xsq TRMT61A 14q32 0.269 0.0376 0.45 tRNA processing;tRNA methylation
xsq MAPRE2 18q12.1 0.269 0.0376 0.45 cell cycle;mitosis
exp IGLV1-44 0.269 0.0376 0.45
DNA-dependent"
DNA-dependent"
DNA-dependent"
DNA-dependent"
DNA-dependent"
cop PRR14 16p11.2 0.269 0.0376 0.45
cop FBRS 16p11.2 0.269 0.0376 0.45
cop LOC730183 0.269 0.0376 0.45
cop SNORA30 16p11.2 0.269 0.0376 0.45
exp DNAJC2 7q22 0.269 0.0376 0.45 positive regulation of
transcription, DNA-dependent;'de novo' cotranslational protein folding
exp LZTFL1 3p21.3 0.269 0.0376 0.45
xsq NDC1 1p32.3 0.269 0.0376 0.45
cop BCL11A 2p16.1 0.269 0.0376 0.45 positive regulation of neuron
promoter
exp BRINP3 0.269 0.0376 0.45 nervous system development;negative
met LRP5 11q13.4 -0.269 0.0376 0.45 positive regulation of cell
proliferation;positive regulation of mitosis
exp CREB5 7p15.1 -0.269 0.0376 0.45 transcription from RNA
polymerase II promoter;positive regulation of transcription, DNA-dependent"
hs4 NOX4 11q14.2-q21 -0.271 0.0376 0.45 superoxide anion
generation;homocysteine metabolic process
swa ACADVL 17p13.1 -0.271 0.0376 0.45 fatty acid metabolic
swa BCL2L13 22q11.1 -0.271 0.0376 0.45 Apoptosis
hs4 PLXNA1 3q21.3 -0.271 0.0376 0.45 signal
his ABL2 1q25.2 -0.271 0.0376 0.45 signal transduction;cellular
xai APOL1 22q13.1 -0.271 0.0376 0.45 lipoprotein metabolic
process;transport
xai LRRC40 1p31.1 0.271 0.0377 0.45
xai TRGC2 7p14 0.271 0.0377 0.451 immune response
exp TRGC2 7p14 0.271 0.0377 0.451 immune response
his UBE2E1 3p24.2 0.271 0.0377 0.451 mitotic cell cycle spindle
assembly checkpoint;positive regulation of ubiquitin-protein ligase activity
involved in mitotic cell cycle
his UBE2E1-AS1 0.271 0.0377 0.451
his CETN3 5q14.3 0.271 0.0377 0.451 centrosome cycle;cell division
his LOC731157 5q14.3 0.271 0.0377 0.451
his PAFAH2 1p36 0.271 0.0377 0.451 lipid metabolic process;anti-
apoptosis
his DRC7 0.271 0.0377 0.451 ciliary or flagellar
motility;spermatogenesis
hs4 LOC101929415 0.271 0.0377 0.451
hs4 PENK 8q23-q24 0.271 0.0377 0.451 behavioral fear response;signal
transduction
his GIGYF1 7q22 0.271 0.0377 0.451 insulin-like growth factor receptor
signaling pathway
xai CHCHD2P6 1p36.21 0.271 0.0377 0.451
his NAA16 13q14.11 0.271 0.0377 0.451 N-terminal protein amino acid
xai MIR3684 0.271 0.0377 0.451
his HPF1 0.271 0.0377 0.451
xsq FOLR2 11q13.3-q13.5 0.269 0.0377 0.45 folic acid transport
xsq C16orf91 16p13.3 0.269 0.0377 0.45
xsq PPP1CA 11q13 0.269 0.0377 0.45 Apoptosis
exp HADHA 2p23 0.269 0.0377 0.451 cellular lipid metabolic process;small
exp TBKBP1 17q21.32 0.269 0.0377 0.451 innate immune response
xsq PLAC1 Xq26 0.269 0.0377 0.451 placenta development;multicellular
exp TRIM2 4q31.3 -0.269 0.0377 0.451 protein
xsq TP53INP1 8q22 -0.269 0.0377 0.451 apoptotic process;induction
of apoptosis
hs4 FAM189A2 9q21.11 -0.271 0.0377 0.451
xai CERCAM 9q34.11 -0.271 0.0377 0.45 cellular component
movement;cell adhesion
xai HAUS7 Xq28 0.271 0.0378 0.451 mitosis;spindle assembly
xai BUB1 2q14 0.271 0.0378 0.451 DNA Damage Response (DDR); Protein
Kinases
exp MIR3684 0.271 0.0378 0.451
hs4 MIR5692B 0.271 0.0378 0.451
xai NKX2-3 10q24.2 0.271 0.0378 0.451 gland morphogenesis;spleen
development
his GTF3C2 2p23.3 0.271 0.0378 0.451 transcription, DNA-
his ANKRD26 10p12.1 0.271 0.0378 0.451
exp HGF 7q21.1 0.269 0.0378 0.451 proteolysis;positive regulation of
xsq DTL 1q32 0.269 0.0378 0.451 DDR (DNA replication)
xsq ATP5A1 18q21 0.269 0.0378 0.451 lipid metabolic process;small
exp SLC25A5P1 22q13.2 0.269 0.0378 0.451 Solute Carriers
xsq RPS15 19p13.3 0.269 0.0378 0.451 ribosomal small subunit export from
xsq LINC01216 0.269 0.0378 0.451
exp LGALSL 2p14 -0.269 0.0378 0.451
exp ROR1 1p32-p31 -0.269 0.0378 0.451 transmembrane receptor
his SAMD4A 14q22.2 -0.271 0.0378 0.451 negative regulation of
xai CX3CL1 16q13 -0.271 0.0378 0.451 defense response;positive
his KAAG1 6p22.1 -0.271 0.0378 0.451 immune response
hs4 LINC01213 -0.271 0.0378 0.451
xai KREMEN1 22q12.1 -0.271 0.0378 0.451 cell communication;Wnt
his LOC101928909 -0.271 0.0378 0.451
xai SH3D19 4q31.3 -0.271 0.0378 0.451 post-Golgi vesicle-
mediated transport;cytoskeleton organization
xai DEF6 6p21.33-p21.1 0.271 0.0379 0.452
xai SUGT1P3 13q14.11 0.271 0.0379 0.452
xai PDE3B 11p15.1 0.271 0.0379 0.452 cellular response to insulin
xsq RAG1 11p13 0.269 0.0379 0.451 B cell differentiation;T cell
differentiation in thymus
xsq CIDEB 14q12 0.269 0.0379 0.451 apoptotic process;induction of apoptosis
met CFAP44 0.269 0.0379 0.451
met OR6K2 1q23.1 0.269 0.0379 0.451
mut PRPF19 11q12.2 0.269 0.0379 0.451 DNA Damage Response (DDR)
exp PFN1P10 1p36.12 0.269 0.0379 0.451
mir hsa-miR-7-1* 0.269 0.0379 0.451
met PLCD3 17q21.31 0.269 0.0379 0.451 angiogenesis;lipid catabolic
process
xsq STAG2 Xq25 0.269 0.0379 0.452 DNA Damage Response (DDR); Tumor
Suppressors
met WWTR1 3q23-q24 0.269 0.0379 0.452 regulation of transcription, DNA-
dependent;negative regulation of fat cell differentiation
xsq GRK6 5q35 0.269 0.0379 0.452 signal transduction;regulation of G-
exp PLEKHA1 10q26.13 -0.269 0.0379 0.452 female gonad
xsq CAV2 7q31.1 -0.269 0.0379 0.451 mitochondrion
his LINC01668 -0.271 0.0379 0.452
xai SNX16 8q21.13 -0.271 0.0379 0.452 protein targeting to
lysosome;cell communication
swa ATP5D 19p13.3 -0.271 0.0379 0.451 ATP catabolic process;ATP
his ENAH 1q42.12 -0.271 0.0379 0.451 intracellular transport;T
hs4 CBARP 0.271 0.038 0.452
hs4 ATP5D 19p13.3 0.271 0.038 0.452 ATP catabolic process;ATP biosynthetic
process
xai GABRG1 4p12 0.271 0.038 0.452 gamma-aminobutyric acid signaling
exp RPS3AP44 13q12.13 0.271 0.038 0.452
his OGFOD2 12q24.31 0.271 0.038 0.452
xai MRPS35 12p11 0.271 0.038 0.452 peptide biosynthetic process;DNA damage
response, detection of DNA damage"
his HES3 1p36.31 0.271 0.038 0.452
his PIGM 1q23.2 0.271 0.038 0.452 C-terminal protein lipidation;preassembly
of GPI anchor in ER membrane
met STK25 2q37.3 0.269 0.038 0.452 Golgi localization;protein
phosphorylation
xsq ZNF473 19q13.33 0.269 0.038 0.452 mRNA processing;histone mRNA 3'-end
processing
cop ST6GAL2 2q11.2-q12.1 0.269 0.038 0.452 multicellular organismal
development;oligosaccharide metabolic process
exp HMGN1P38 15q26.1 0.269 0.038 0.452
met CNTNAP5 2q14.3 0.269 0.038 0.452 cell adhesion;signal transduction
cop TECPR2 14q32.31 0.269 0.038 0.452
exp SDE2 1q42.12 0.269 0.038 0.452
exp MMP14 14q11.2 -0.269 0.038 0.452 Apoptosis
exp GNG11 7q21 -0.269 0.038 0.452 GTP catabolic process;signal transduction
exp EFHC1 6p12.3 -0.269 0.038 0.452
exp SLCO2A1 3q21 -0.269 0.038 0.452 Solute Carriers
xsq CNIH3 1q42.12 -0.269 0.038 0.452 intracellular signal
transduction;regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate
selective glutamate receptor activity
xsq TGFBI 5q31 -0.269 0.038 0.452 visual perception;cell proliferation
his CASC6 -0.271 0.038 0.452
xai ASPH 8q12.1 -0.271 0.038 0.452 peptidyl-amino acid
modification;limb morphogenesis
his LRRC38 1p36.21 0.271 0.0381 0.452
xai LOC389641 0.271 0.0381 0.452
exp RPL5P14 5p13.3 0.271 0.0381 0.452
his CCT6B 17q12 0.271 0.0381 0.452 spermatogenesis;protein transport
his ZNF830 17q12 0.271 0.0381 0.452 blastocyst growth;cell cycle
his ZSCAN25 7q22.1 0.271 0.0381 0.452
his HAVCR2 5q33.3 0.271 0.0381 0.452
xsq WTAP 6q25-q27 0.268 0.0381 0.452 mRNA processing;cell cycle
exp ZNF423 16q12 0.268 0.0381 0.452 cell differentiation;positive
exp ITK 5q31-q32 0.268 0.0381 0.452 activation of phospholipase C
cop EXOC3L4 14q32.32 0.268 0.0381 0.452
cop TNFAIP2 14q32 0.268 0.0381 0.452 angiogenesis;multicellular
cop LINC00605 0.268 0.0381 0.452
cop EIF5 14q32.32 0.268 0.0381 0.452 translational initiation;regulation
of translational initiation
cop SNORA28 0.268 0.0381 0.452
cop MARK3 14q32.32 0.268 0.0381 0.452
cop CKB 14q32 0.268 0.0381 0.452 creatine metabolic process;brain
development
cop TRMT61A 14q32 0.268 0.0381 0.452 tRNA processing;tRNA methylation
cop BAG5 14q32.33 0.268 0.0381 0.452 Apoptosis
cop APOPT1 14q32.33 0.268 0.0381 0.452 positive regulation of
release of cytochrome c from mitochondria;induction of apoptosis by intracellular
signals
cop KLC1 14q32.3 0.268 0.0381 0.452 microtubule-based movement;blood
coagulation
cop XRCC3 14q32.3 0.268 0.0381 0.452 DNA Damage Response (DDR); DDR
(NHEJ)
cop ZFYVE21 14q32.33 0.268 0.0381 0.452
cop PPP1R13B 14q32.33 0.268 0.0381 0.452 apoptotic process;induction
of apoptosis
cop LINC00637 0.268 0.0381 0.452
cop C14orf2 14q32.33 0.268 0.0381 0.452
cop RD3L 0.268 0.0381 0.452
xsq LIPN 10q23.31 0.268 0.0381 0.452 lipid catabolic process
mut CHD4 12p13 0.268 0.0381 0.452 DNA Damage Response (DDR)
exp LIMCH1 4p13 -0.268 0.0381 0.452 actomyosin structure
organization
mir hsa-miR-21 -0.268 0.0381 0.452
exp NR1D2 3p24.2 -0.268 0.0381 0.452 regulation of transcription,
exp SMAD7 18q21.1 -0.268 0.0381 0.452 Apoptosis
xai USP9X Xp11.4 -0.271 0.0381 0.452 mitosis;transforming growth
his CTNND1 11q11 -0.271 0.0381 0.452 morphogenesis of a polarized
his TMEM230 20p13 0.271 0.0382 0.452
xai ITK 5q31-q32 0.271 0.0382 0.452 activation of phospholipase C
exp SHROOM2P1 Yq11.21 0.271 0.0382 0.452
xai RPL5P20 6p22.3 0.271 0.0382 0.452
his EXOC7 17q25.1 0.271 0.0382 0.453 exocytosis;protein transport
his TXNL4A 18q23 0.271 0.0382 0.453 nuclear mRNA splicing, via
swa PPP1CA 11q13 0.271 0.0382 0.453 Apoptosis
xsq FANCI 15q26.1 0.268 0.0382 0.452 DNA Damage Response (DDR); DDR (FA)
mut TTC39B 9p22.3 0.268 0.0382 0.452
xsq BZRAP1 17q22-q23 0.268 0.0382 0.452
xsq GSPT2 Xp11.22 0.268 0.0382 0.452 translational termination;cell
cycle
cop STX4 16p11.2 0.268 0.0382 0.452 blood coagulation;cellular membrane
organization
DNA-dependent"
xsq AKR7L 1p36.13 0.268 0.0382 0.452
xsq XRCC6BP1 12q14.1 0.268 0.0382 0.452 DNA Damage Response (DDR)
cop PLGLA 2q12.2 0.268 0.0382 0.452
cop RGPD3 2q13 0.268 0.0382 0.452
exp RPS29 14q 0.268 0.0382 0.452 mRNA metabolic process;translation
cop SYNJ2-IT1 0.268 0.0382 0.453
xsq TNF 6p21.3 0.268 0.0382 0.453 Apoptosis
mir hsa-miR-153 0.268 0.0382 0.453
mir hsa-miR-153(2) 0.268 0.0382 0.453
xsq RCN1 11p13 -0.268 0.0382 0.453 in utero embryonic
exp RIPK4 21q22.3 -0.268 0.0382 0.452
xai ARVCF 22q11.21 -0.271 0.0382 0.452 cell adhesion;multicellular
his LINC01798 -0.271 0.0382 0.452
xai ZNFX1 20q13.13 -0.271 0.0382 0.452
xai MANEA 6q16.1 0.27 0.0383 0.453 protein N-linked glycosylation via
his HVCN1 12q24.11 0.27 0.0383 0.453 response to zinc ion;proton
transport
swa TIA1 2p13 0.27 0.0383 0.453 Apoptosis
xai USP10 16q24.1 0.27 0.0383 0.453 protein deubiquitination;DNA damage
response, signal transduction by p53 class mediator
xai NPM1P35 11q12.3 0.27 0.0383 0.453
his ZDHHC12 9q34.11 0.27 0.0383 0.453
his LOC100506100 0.27 0.0383 0.453
xsq C16orf13 16p13.3 0.268 0.0383 0.453
xsq ZFP69 1p34.2 0.268 0.0383 0.453
exp SET 9q34 0.268 0.0383 0.453 nucleosome disassembly;nucleocytoplasmic
transport
met OSMR 5p13.1 0.268 0.0383 0.453 positive regulation of acute
inflammatory response;cell surface receptor signaling pathway
xsq C19orf54 19q13.2 0.268 0.0383 0.453
exp POLE3 9q33 0.268 0.0383 0.453 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
exp DYNC1I2 2q31.1 -0.268 0.0383 0.453 G2/M transition of
mitotic cell cycle;mitotic cell cycle
exp ILK 11p15.4 -0.268 0.0383 0.453 Apoptosis
xai ASMT Xp22.3 -0.27 0.0383 0.453 cellular nitrogen compound
hs4 IGSF3 1p13 -0.27 0.0383 0.453
his LOC105378292 -0.27 0.0383 0.453
his LOC107001062 -0.27 0.0383 0.453
xai ALDH7A1P1 5q14 -0.27 0.0383 0.453
xai REPS1 6q24.1 0.27 0.0384 0.453
his SNRNP200 2q11.2 0.27 0.0384 0.453 RNA splicing;gene expression
exp RPL37 5p13 0.27 0.0384 0.453 translational elongation;viral
transcription
xai RPL21P7 0.27 0.0384 0.453
exp SRP68P2 0.27 0.0384 0.453
xai LOC100420587 0.27 0.0384 0.453
his LOC101448202 0.27 0.0384 0.453
xsq ZNF22 10q11 0.268 0.0384 0.453 odontogenesis;regulation of
xsq ZKSCAN4 6p21 0.268 0.0384 0.453 viral reproduction
cop DLGAP1 18p11.31 0.268 0.0384 0.453 synaptic transmission
exp TRMT1 19p13.2 0.268 0.0384 0.453 tRNA processing
xsq PARS2 1p32.2 0.268 0.0384 0.453 tRNA aminoacylation for protein
translation;prolyl-tRNA aminoacylation
cop CHKA 11q13.2 0.268 0.0384 0.453 choline metabolic process;lipid
metabolic process
exp C12orf29 12q21.32 0.268 0.0384 0.453
xsq TCERG1 5q31 0.268 0.0384 0.453 negative regulation of
dependent
exp JAK3 19p13.1 0.268 0.0384 0.453 Oncogenes
xsq ARPP21 3p22.3 0.268 0.0384 0.453 cellular response to heat
met SP140 2q37.1 -0.268 0.0384 0.453
exp BAG3 10q25.2-q26.2 -0.268 0.0384 0.453 Apoptosis
exp PVRL2 19q13.2 -0.268 0.0384 0.453 positive regulation of
exp SPACA6 -0.268 0.0384 0.453
xsq HIF1A-AS2 -0.268 0.0384 0.453
xsq PRR34-AS1 -0.268 0.0384 0.453
exp PTRF 17q21.2 -0.268 0.0384 0.453 transcription initiation from
xai PLBD2 12q24.13 -0.27 0.0384 0.453 lipid catabolic process
his MIR1265 -0.27 0.0384 0.453
xai SHROOM4 Xp11.22 -0.27 0.0384 0.453 actin filament
swa MMP14 14q11.2 -0.27 0.0384 0.453 Apoptosis
swa FAM3C 7q31 -0.27 0.0384 0.453 multicellular organismal development
his HECW1-IT1 -0.27 0.0384 0.453
xai TMEM62 15q15.2 -0.27 0.0384 0.453
hs4 LINC01111 -0.27 0.0384 0.453
hs4 TINAGL1 1p35.2 -0.27 0.0384 0.453 proteolysis;immune response
his MIR124-1 0.27 0.0385 0.453
his FBXO40 3q13.33 0.27 0.0385 0.453 muscle cell differentiation
xai SRP68P2 0.27 0.0385 0.453
his SIRT6 19p13.3 0.27 0.0385 0.453 protein deacetylation;protein ADP-
ribosylation
his ANKRD24 19p13.3 0.27 0.0385 0.453
xai POLG 15q25 0.27 0.0385 0.453 DNA Damage Response (DDR)
his NUP35 2q32.1 0.27 0.0385 0.453 regulation of glucose
his HIST1H4H 6p22.1 0.27 0.0385 0.453
swa PSMG1 21q22.3 0.27 0.0385 0.453 proteasome assembly
his TMEM206 1q32.3 0.27 0.0385 0.454
exp PSD4 2q13 0.268 0.0385 0.453 regulation of ARF protein signal
transduction
mir hsa-miR-106b* 0.268 0.0385 0.453
xsq IL27RA 19p13.11 0.268 0.0385 0.453 cell surface receptor
xsq ERG 21q22.3 0.268 0.0385 0.453 Transcription Factors
xsq ZCCHC8 12q24.31 0.268 0.0385 0.454 nuclear mRNA splicing, via
xsq FAM84B 8q24.21 -0.268 0.0385 0.453
xsq NEDD4L 18q21.31 -0.268 0.0385 0.453 protein
ubiquitination;water homeostasis
exp ZNFX1 20q13.13 -0.268 0.0385 0.453
exp KIAA1161 9p13.3 -0.268 0.0385 0.453 carbohydrate metabolic
process;positive regulation of insulin-like growth factor receptor signaling
pathway
hs4 IQSEC1 3p25.2 -0.27 0.0385 0.454 regulation of ARF protein
signal transduction
his DCAF16 4p15.31 0.27 0.0386 0.454 protein ubiquitination
his NCAPG 4p15.33 0.27 0.0386 0.454 DNA Damage Response (DDR)
his LOC728554 5q35.3 0.27 0.0386 0.454
his MRPS25 3p25 0.27 0.0386 0.454 translation
his CDC26 9q32 0.27 0.0386 0.454 cell division;negative regulation of
ubiquitin-protein ligase activity involved in mitotic cell cycle
his PRPF4 9q31-q33 0.27 0.0386 0.454 nuclear mRNA splicing, via
his SDHAF3 0.27 0.0386 0.454 regulation of gluconeogenesis
swa STK26 0.27 0.0386 0.454
his COCH 14q11.2-q13 0.27 0.0386 0.454 sensory perception of sound
xsq RPL4 15q22 0.268 0.0386 0.454 translational initiation;viral infectious
cycle
cop COLEC12 18p11.32 0.268 0.0386 0.454 innate immune
response;protein homooligomerization
exp TUBD1 17q23.1 0.268 0.0386 0.454 protein polymerization;microtubule-
based movement
exp FAM76B 11q21 0.268 0.0386 0.454
xsq LL22NC03-75H12.2 0.268 0.0386 0.454
xsq FBXO33 14q21.1 0.268 0.0386 0.454
exp JCHAIN 0.268 0.0386 0.454 immune response
xsq NLRP5 19q13.43 0.268 0.0386 0.454
met C6orf132 6p21.1 0.268 0.0386 0.454
met SH2D3A 19p13.3 -0.268 0.0386 0.454 small GTPase mediated
signal transduction;JNK cascade
xai SUSD4 1q41 -0.27 0.0386 0.454
swa SMCHD1 18p11.32 -0.27 0.0386 0.454 inactivation of X chromosome
xai STARD13-AS -0.27 0.0386 0.454
xai TCEAL4 Xq22.2 -0.27 0.0386 0.454 regulation of transcription,
DNA-dependent"
his FCRL2 1q21 0.27 0.0387 0.454 cell-cell signaling
xai CENPH 5p15.2 0.27 0.0387 0.454 kinetochore organization;M phase of
mitotic cell cycle
hs4 ADAMTSL2 9q34.2 0.27 0.0387 0.454 negative regulation of
xai LINC01225 0.27 0.0387 0.455
exp GABRR2 6q15 0.27 0.0387 0.455 gamma-aminobutyric acid signaling
xsq NSUN4 1p34 0.268 0.0387 0.454
xsq LINC00618 0.268 0.0387 0.454
DNA-dependent"
exp RPS27P8 1q32.1 0.268 0.0387 0.454
xsq KLKB1 4q35 0.268 0.0387 0.455 inflammatory response;blood coagulation
xsq DCUN1D2 13q34 0.268 0.0387 0.455
met ARHGAP25 2p13.3 -0.268 0.0387 0.455 regulation of small
xsq TMEM51 1p36.21 -0.268 0.0387 0.455
xsq LINC01278 -0.268 0.0387 0.454
exp TBC1D17 19q13.33 -0.27 0.0387 0.454
xai ANAPC10 4q31 0.27 0.0388 0.455 G2/M transition of mitotic cell
catabolic process
exp RPS15P5 3p14.3 0.27 0.0388 0.455
swa HDAC1 1p34 0.27 0.0388 0.455 Apoptosis
xai SLC25A5-AS1 0.27 0.0388 0.455
his KDM3B 5q31 0.27 0.0388 0.455 regulation of transcription, DNA-
xai ICAM5 19p13.2 0.27 0.0388 0.455 cell-cell adhesion
exp CAPN10 2q37.3 0.268 0.0388 0.455 positive regulation of
xsq CYB5B 16q22.1 0.268 0.0388 0.455 transport;electron transport chain
pro PTPN11 12q24 0.268 0.0388 0.455 Oncogenes
xsq GLI1 12q13.2-q13.3 0.267 0.0388 0.455 multicellular organismal
met TP53BP2 1q41 0.267 0.0388 0.455 Apoptosis
mut PRUNE2 9q21.2 0.267 0.0388 0.455 apoptotic process;induction
of apoptosis
met C2orf50 2p25.1 0.267 0.0388 0.455
xsq GIPC1 19p13.1 -0.267 0.0388 0.455 protein targeting;regulation
exp SFXN3 10q24.31 -0.267 0.0388 0.455 iron ion
homeostasis;transmembrane transport
swa ATP6V1B2 8p21.3 -0.27 0.0388 0.455 cellular iron ion
xai CTTN 11q13 -0.27 0.0388 0.455
exp LOC100420587 0.27 0.0389 0.455
his TMEM170A 16q23.1 0.27 0.0389 0.455
xai GCN1 0.27 0.0389 0.455 translation;regulation of translation
his TBC1D13 9q34.11 0.27 0.0389 0.455
his CAD 2p22-p21 0.27 0.0389 0.455 Apoptosis
xai FGFR1OP 6q27 0.27 0.0389 0.455 positive regulation of cell
migration;microtubule anchoring
his NCAPD3 11q25 0.27 0.0389 0.455 DNA Damage Response (DDR)
his VPS26B 11q25 0.27 0.0389 0.455 vacuolar transport;protein
transport
his RSRC2 12q24.31 0.27 0.0389 0.455
his KNTC1 12q24.31 0.27 0.0389 0.455 mitotic cell cycle;protein complex
assembly
xai RPS15P5 3p14.3 0.27 0.0389 0.455
exp MFAP1P1 13q12.3 0.27 0.0389 0.455
his LINC01353 0.27 0.0389 0.455
his LINC01136 0.27 0.0389 0.455
his BTG2 1q32 0.27 0.0389 0.455 DNA Damage Response (DDR)
xai NR2C1 12q22 0.27 0.0389 0.455 positive regulation of retinoic acid
receptor signaling pathway;negative regulation of transcription from RNA polymerase
II promoter
exp RNU6-67P 0.27 0.0389 0.455
mut GRIN2B 12p12 0.267 0.0389 0.455 learning or memory;hippocampus
development
met PNPLA4 Xp22.3 0.267 0.0389 0.455 metabolic process;lipid
catabolic process
exp TRABD 22q13.33 0.267 0.0389 0.455
exp KIAA0922 4q31.3 0.267 0.0389 0.455
exp LOC100129107 0.267 0.0389 0.455
xsq WRAP73 1p36.3 0.267 0.0389 0.455
exp TRIAP1 12q24.31 0.267 0.0389 0.455 anti-apoptosis;DNA damage
response, signal transduction by p53 class mediator resulting in cell cycle arrest
cop BEGAIN 14q32.2 0.267 0.0389 0.455
xsq MKS1 17q22 0.267 0.0389 0.455 cilium morphogenesis;cell projection
organization
exp LRRTM3 10q21.3 0.267 0.0389 0.455
xsq TCEAL5 Xq22.1 -0.267 0.0389 0.455 regulation of
xsq ANXA2 15q22.2 -0.267 0.0389 0.455 positive regulation of
xsq DGKI 7q32.3-q33 -0.267 0.0389 0.455 blood coagulation;platelet
activation
hs4 IL12A 3q25.33 -0.27 0.0389 0.455 cell cycle arrest;positive
hs4 GLIS2 16p13.3 -0.27 0.0389 0.455 positive regulation of
xai ZFPL1 11q13 -0.27 0.0389 0.455 regulation of transcription, DNA-
hs4 AZIN2 -0.27 0.0389 0.455 agmatine biosynthetic process;ornithine
metabolic process
hs4 GOLGA6C 15q24.2 -0.27 0.0389 0.455
hs4 SLCO2A1 3q21 -0.27 0.0389 0.455 Solute Carriers
swa ALDH1B1 9p11.1 -0.27 0.0389 0.455 carbohydrate metabolic
process
swa BMS1 10q11.21 -0.27 0.0389 0.455 ribosome assembly
xai RNU6-67P 0.27 0.039 0.456
swa ATG3 3q13.2 0.27 0.039 0.456 autophagic vacuole assembly;protein
his SIGLEC6 19q13.3 0.269 0.039 0.456 cell adhesion;cell-cell signaling
xai CD1E 1q23.1 0.269 0.039 0.456 immune response;antigen processing and
presentation
xai UBE2O 17q25.1 0.269 0.039 0.456
xsq ITPRIPL1 2q11.2 0.267 0.039 0.456
met FAM86B1 8p23.1 0.267 0.039 0.456
mut NOP14 4p16.3 0.267 0.039 0.456 endonucleolytic cleavage to generate
mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA);endonucleolytic
cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
exp POLG 15q25 0.267 0.039 0.456 DNA Damage Response (DDR)
xsq EMC8 16q24 0.267 0.039 0.456
xsq AFG3L2 18p11 0.267 0.039 0.456 myelination;proteolysis
exp MRPS27 5q13.2 0.267 0.039 0.456
xsq DBF4 7q21.3 0.267 0.039 0.456 DDR (DNA replication)
exp CCDC58P3 18p11.21 0.267 0.039 0.456
exp UBR7 14q32.12 0.267 0.039 0.456
exp ASIC1 12q12 0.267 0.039 0.456 transport;ion transport
cop ATP13A5 3q29 -0.267 0.039 0.456 ATP biosynthetic process;cation
transport
cop CFH 1q32 -0.267 0.039 0.456 complement activation, alternative
pathway;complement activation"
his LINC02003 -0.269 0.039 0.456
hs4 SPARC 5q31.3-q32 -0.27 0.039 0.456 ossification;lung development
hs4 CTB-113P19.1 -0.27 0.039 0.456
xai CYP2A13 19q13.2 -0.27 0.039 0.456 xenobiotic metabolic process;small
his CSAD 12q13.11-q14.3 0.269 0.0391 0.456 sulfur amino acid catabolic
process;carboxylic acid metabolic process
DNA-dependent"
xai GABRR2 6q15 0.269 0.0391 0.456 gamma-aminobutyric acid signaling
hs4 SPOCK2 10pter-q25.3 0.269 0.0391 0.456 peptide cross-linking
his MIR181A1HG 1q32.1 0.269 0.0391 0.456
xai ZNF518A 10q24.1 0.269 0.0391 0.456 regulation of transcription,
DNA-dependent"
swa TBCA 5q14.1 0.269 0.0391 0.456 'de novo' posttranslational protein
folding;protein folding
exp SNORD20 0.269 0.0391 0.456
mut EIF3A 10q26 0.267 0.0391 0.456 translational initiation;gene expression
met ATXN7L1 7q22.3 0.267 0.0391 0.456
xsq CD3G 11q23 0.267 0.0391 0.456 protein transport;T cell costimulation
met OTULIN 0.267 0.0391 0.456
cop CCDC170 6q25.1 0.267 0.0391 0.456
cop LINC00523 14q32.2 0.267 0.0391 0.456
cop DLK1 14q32 0.267 0.0391 0.456 multicellular organismal
met SNX9 6q25.1-q26 0.267 0.0391 0.456 intracellular protein
transport;receptor-mediated endocytosis
exp LIG3 17q11.2-q12 0.267 0.0391 0.456 DNA Damage Response (DDR); DDR
(BER)
exp CLSTN1 1p36.22 -0.267 0.0391 0.456 cell adhesion;homophilic
cell adhesion
exp NUPR1 16p11.2 -0.267 0.0391 0.456 induction of apoptosis;cell
growth
xsq ASAP1-IT1 8q24.21 -0.267 0.0391 0.456
exp CHMP3 2p11.2 -0.267 0.0391 0.456 cellular membrane
organization;endosome transport
exp LRP1 12q13.3 -0.267 0.0391 0.456 multicellular organismal
swa YIPF5 5q31.3 -0.269 0.0391 0.456 protein transport;vesicle-
mediated transport
his RIT1 1q22 -0.269 0.0391 0.456 nerve growth factor receptor
his PROM2 2q11.1 -0.269 0.0391 0.456
xai RPL37 5p13 0.269 0.0392 0.456 translational elongation;viral
transcription
his TPRN 9q34.3 0.269 0.0392 0.457 sensory perception of sound
his TMEM203 9q34.3 0.269 0.0392 0.457
his NDOR1 9q34.3 0.269 0.0392 0.457 cell death;oxidation-reduction
process
xai LOC100130920 0.269 0.0392 0.457
exp LOC100130920 0.269 0.0392 0.457
exp FAM110D 1p36.11 0.267 0.0392 0.456
exp RPL12P1 0.267 0.0392 0.456
cop MIR4309 0.267 0.0392 0.457
exp HDAC1 1p34 0.267 0.0392 0.457 Apoptosis
xsq POLA1 Xp22.1-p21.3 0.267 0.0392 0.457 DNA Damage Response (DDR);
mut FAM120B 6q27 0.267 0.0392 0.457 regulation of transcription, DNA-
dependent;cell differentiation"
exp MCMBP 10q26.11 0.267 0.0392 0.457 sister chromatid cohesion;mitosis
exp GNG10 9q31.3 -0.267 0.0392 0.457 energy reserve metabolic
process;GTP catabolic process
exp SERPINH1P1 9p13.3 -0.267 0.0392 0.457
exp VTCN1 1p13.1 -0.267 0.0392 0.457 negative regulation of T cell
activation
his CPM 12q14.3 -0.269 0.0392 0.457 proteolysis;anatomical
hs4 LGI3 8p21.3 -0.269 0.0392 0.457 regulation of exocytosis
hs4 LOX 5q23.2 -0.269 0.0392 0.457 response to steroid hormone
hs4 TCF7L1 2p11.2 -0.269 0.0392 0.457 regulation of
DNA-dependent
xai TCF7L1 2p11.2 -0.269 0.0392 0.457 regulation of
DNA-dependent
xai DUSP3 17q21 -0.269 0.0392 0.457 toll-like receptor 2 signaling
exp LOC100507209 -0.269 0.0392 0.457
xai LOC100507209 -0.269 0.0392 0.457
xai SNORD20 0.269 0.0393 0.457
xai PDE4A 19p13.2 0.269 0.0393 0.457 response to drug;cAMP catabolic
process
hs4 INPP5D 2q37.1 0.269 0.0393 0.457 phosphate-containing compound
swa LRRC47 1p36.32 0.269 0.0393 0.457
xai KIAA0922 4q31.3 0.269 0.0393 0.457
his OAZ3 1q21.3 0.269 0.0393 0.457 regulation of cellular amino acid
metabolic process;spermatogenesis
met ANGPTL2 9q34 0.267 0.0393 0.457 signal transduction;multicellular
xsq DSCC1 8q24.12 0.267 0.0393 0.457 cell cycle;maintenance of mitotic
cop SS18 18q11.2 0.267 0.0393 0.457 intracellular protein kinase
cascade;response to drug
xsq ATP8A1 4p13 0.267 0.0393 0.457 cation transport;aminophospholipid
transport
xsq NUP133 1q42.13 0.267 0.0393 0.457 carbohydrate metabolic
xsq LL22NC01-81G9.3 0.267 0.0393 0.457
met SCRN1 7p14.3-p14.1 0.267 0.0393 0.457 proteolysis;exocytosis
xsq KDM1A 1p36.12 0.267 0.0393 0.457 negative regulation of protein
xsq RSAD1 17q21.33 0.267 0.0393 0.457 porphyrin-containing compound
mut MPPED2 11p13 0.267 0.0393 0.457 nervous system development
cop RCOR1 14q32.31 0.267 0.0393 0.457 interspecies interaction between
met GMFG 19q13.2 -0.267 0.0393 0.457 protein
phosphorylation;positive regulation of catalytic activity
his IL20RB 3q22.3 -0.269 0.0393 0.457 positive regulation of
interleukin-4 production;negative regulation of T cell proliferation
xai ANKRD52 12q13.3 -0.269 0.0393 0.457 DNA Damage Response
(DDR)
swa LRRC1 6p12.1 -0.269 0.0393 0.457
his MEIS3P1 17p12 -0.269 0.0393 0.457
exp STARD13-AS -0.269 0.0393 0.457
exp SIGLEC27P 19q13.41 -0.269 0.0393 0.457
his MDS2 1p36 0.269 0.0394 0.457
hs4 PYGO2 1q21.3 0.269 0.0394 0.457 developmental growth;palate
development
hs4 LOC101928120 0.269 0.0394 0.457
xai RPS3AP44 13q12.13 0.269 0.0394 0.457
his RRM1 11p15.5 0.269 0.0394 0.457 DNA Damage Response (DDR)
xai GPC2 7q22.1 0.269 0.0394 0.457 neuron differentiation
xai GAPDHP29 1p21.3 0.269 0.0394 0.457
his SPPL2A 15q21.2 0.269 0.0394 0.457 proteolysis
his MRPS31 13q14.11 0.269 0.0394 0.457
hs4 TSHR 14q31 0.269 0.0394 0.457 Oncogenes
exp RPS27AP1 17p13.1 0.269 0.0394 0.457
exp RAG2 11p13 0.267 0.0394 0.457 B cell homeostatic proliferation;positive
xsq EZH2 7q35-q36 0.267 0.0394 0.457 Oncogenes; Tumor Suppressors
xsq NAP1L6 0.267 0.0394 0.457
xsq THOC1 18p11.32 0.267 0.0394 0.457 apoptotic process;signal
transduction
xsq CUZD1 10q26.13 0.267 0.0394 0.457 hormone-mediated signaling
pathway;trypsinogen activation
xsq DUT 15q21.1 0.267 0.0394 0.457 DNA Damage Response (DDR)
xsq RIMBP3B 22q11.21 0.267 0.0394 0.457
cop FAM168A 11q13.4 0.267 0.0394 0.457
xsq UHRF1 19p13.3 0.267 0.0394 0.457 positive regulation of DNA
topoisomerase (ATP-hydrolyzing) activity;DNA repair
xsq JUN 1p32-p31 -0.267 0.0394 0.457 Apoptosis; Protein Kinases
hs4 DNAI1 9p13.3 -0.269 0.0394 0.457 cell projection organization
hs4 FAM219A 9p13.3 -0.269 0.0394 0.457
xai PVRL2 19q13.2 -0.269 0.0394 0.457 positive regulation of
his NT5DC3 12q22-q23.1 -0.269 0.0394 0.457
his SNORD137 -0.269 0.0394 0.457
xai IQGAP3 1q21.3 -0.269 0.0394 0.457 G1/S transition of
mitotic cell cycle;positive regulation of mammary gland epithelial cell
proliferation
his MIR4293 -0.269 0.0394 0.457
xai TMEM39B 1p35.1 0.269 0.0395 0.457
his FAM122B Xq26.3 0.269 0.0395 0.457
his TK1 17q23.2-q25.3 0.269 0.0395 0.457 DNA replication;nucleotide
his AFMID 17q25.3 0.269 0.0395 0.457 tryptophan catabolic
his TUBG1 17q21 0.269 0.0395 0.457 G2/M transition of mitotic cell
cycle;meiotic spindle organization
his FAM134C 17q21.2 0.269 0.0395 0.457
xai KERA 12q22 0.269 0.0395 0.457 visual perception;response to stimulus
his TNFRSF17 16p13.1 0.269 0.0395 0.457 multicellular organismal
development;cell proliferation
his FGF7P6 0.269 0.0395 0.458
his LOC102724238 0.269 0.0395 0.458
xai UIMC1 5q35.2 0.269 0.0395 0.458 DNA Damage Response (DDR); DDR (HR)
xsq WDR75 2q32.2 0.267 0.0395 0.457
exp LINC00938 12q12 0.267 0.0395 0.457
met SGK3 8q12 0.267 0.0395 0.457
exp LUC7L3 17q21.33 0.267 0.0395 0.457 mRNA processing;apoptotic
process
xsq ISG20L2 1q23.1 0.267 0.0395 0.457 ribosome biogenesis
exp NCF1 7q11.23 0.267 0.0395 0.458 response to yeast;cellular defense
response
met STARD13 13q13.1 0.267 0.0395 0.458 Apoptosis
exp CD59 11p13 -0.267 0.0395 0.457 cell surface receptor signaling
xsq SLFN12 17q12 -0.267 0.0395 0.457
cop TP63 3q28 -0.267 0.0395 0.457 Apoptosis; Oncogenes
cop MIR944 -0.267 0.0395 0.457
exp NOTCH2 1p13-p11 -0.267 0.0395 0.457 Apoptosis; Tumor
Suppressors
xsq ZNF112 -0.267 0.0395 0.457 regulation of transcription,
DNA-dependent"
xai UBE2H 7q32 -0.269 0.0395 0.457 protein K11-linked
xai CEACAMP6 -0.269 0.0395 0.457
exp HLA-T -0.269 0.0395 0.457
his MIR579 -0.269 0.0395 0.457
swa LAMP2 Xq24 -0.269 0.0395 0.457 platelet activation;platelet
degranulation
xai RPS27AP1 17p13.1 0.269 0.0396 0.458
xai USP42 7p22.1 0.269 0.0396 0.458 spermatogenesis;protein
deubiquitination
xai PAIP2B 2p13.3 0.269 0.0396 0.458 negative regulation of
xai ATP6V1G2 6p21.3 0.269 0.0396 0.458 insulin receptor signaling
pathway;proton transport
xai NUP85 17q25.1 0.269 0.0396 0.458 protein transport;transmembrane
transport
his OR2M5 1q44 0.269 0.0396 0.458
hs4 LOC101927870 0.269 0.0396 0.458
xai PAICSP1 9p13 0.269 0.0396 0.458
exp RPL21P7 0.269 0.0396 0.458
xsq LOC101927359 0.267 0.0396 0.458
xsq CYP4F30P 2q21.1 0.267 0.0396 0.458
xsq ICAM2 17q23.3 0.266 0.0396 0.458 cell-cell adhesion;regulation of
immune response
xsq THUMPD1 16p12.3 0.266 0.0396 0.458
met KDM4D 11q21 0.266 0.0396 0.458 regulation of transcription, DNA-
xsq FOXO4 Xq13.1 0.266 0.0396 0.458 Apoptosis
exp AMDHD1 12q23.1 0.266 0.0396 0.458 histidine catabolic
xsq KIF15 3p21.31 0.266 0.0396 0.458 microtubule-based movement;mitosis
xsq CCR8 3p22 0.266 0.0396 0.458 G-protein coupled receptor signaling
met IFT140 16p13.3 0.266 0.0396 0.458
exp SOGA1 20q11.23 -0.266 0.0396 0.458
xsq SSC4D -0.266 0.0396 0.458
hs4 NRP2 2q33.3 -0.269 0.0396 0.458 angiogenesis;positive
regulation of endothelial cell migration
hs4 FANK1 10q26.2 -0.269 0.0396 0.458
xai HLA-T -0.269 0.0396 0.458
xai TMCC1 3q22.1 -0.269 0.0396 0.458
his ATP5H 17q25 0.269 0.0397 0.458 ATP catabolic process;ion transport
his FCMR 0.269 0.0397 0.458 anti-apoptosis;cellular defense response
his IL3RA 0.269 0.0397 0.458 cellular response to interleukin-3
xai C19orf60 19p13.11 0.269 0.0397 0.458
xai RPL23AP83 Xp11.21 0.269 0.0397 0.458
his PDCL 9q12-q13 0.269 0.0397 0.458 visual perception;response to
stimulus
swa CPSF3 2p25.1 0.269 0.0397 0.458 nuclear mRNA splicing, via
xai YTHDC2 5q22.2 0.269 0.0397 0.458
his NAP1L2 Xq13 0.269 0.0397 0.458 nucleosome assembly
his COQ5 12q24.31 0.269 0.0397 0.458 ubiquinone biosynthetic process
his LCP2 5q35.1 0.269 0.0397 0.458 immune response;transmembrane
exp OSTCP5 0.269 0.0397 0.458
exp LINC00959 10q26.3 0.266 0.0397 0.458
xsq LOC100506606 0.266 0.0397 0.458
exp PLCL2 3p24.3 0.266 0.0397 0.458 lipid metabolic
met LRRC29 16q22.1 0.266 0.0397 0.458
exp TCOF1 5q32 0.266 0.0397 0.458 transport;skeletal system development
xsq ICE2 0.266 0.0397 0.458
xsq BMP10 2p13.3 0.266 0.0397 0.458 positive regulation of cardiac
muscle hypertrophy;sarcomere organization
mut FAM160A2 11p15.4 0.266 0.0397 0.458 endosome
organization;lysosome organization
mut MYH4 17p13.1 0.266 0.0397 0.458 muscle contraction;response to
activity
xsq MAPK6 15q21 0.266 0.0397 0.458 Protein Kinases
xsq OR2G6 1q44 0.266 0.0397 0.458
xsq CLEC5A 7q33 0.266 0.0397 0.458 signal transduction;response to
virus
cop ANKRD9 14q32.31 0.266 0.0397 0.458
mir hsa-miR-760 0.266 0.0397 0.458
exp LINC00652 -0.266 0.0397 0.458
met MIR1205 -0.266 0.0397 0.458
xsq FSTL1 3q13.33 -0.266 0.0397 0.458 BMP signaling pathway
exp GGPS1 1q43 -0.266 0.0397 0.458 small molecule metabolic
exp ITGA1 5q11.2 -0.266 0.0397 0.458 activation of MAPK
exp IQGAP3 1q21.3 -0.266 0.0397 0.458 G1/S transition of
mitotic cell cycle;positive regulation of mammary gland epithelial cell
proliferation
xai LOC100506827 -0.269 0.0397 0.458
xai STON2 14q31.1 -0.269 0.0397 0.458 intracellular protein
exp RPL21P50 4q28.1 0.269 0.0398 0.458
exp FAM35CP 14q31.3 0.269 0.0398 0.458
his RFX7 15q21.3 0.268 0.0398 0.458 regulation of transcription, DNA-
dependent"
xai DNAJC2 7q22 0.268 0.0398 0.458 positive regulation of
xai NDUFS7 19p13.3 0.268 0.0398 0.458 transport;respiratory
xsq ANKRD16 10p15.1 0.266 0.0398 0.458
xsq GPAM 10q25.2 0.266 0.0398 0.458 response to glucose
met CES5A 16q12.2 0.266 0.0398 0.458
exp SKP2 5p13 0.266 0.0398 0.458 G1/S transition of mitotic cell
catabolic process
xsq NECAP2 1p36.13 0.266 0.0398 0.458 endocytosis;protein transport
xsq NARF 17q25.3 0.266 0.0398 0.458
exp HNRNPA1P70 12q15 0.266 0.0398 0.458
met SLC26A2 5q31-q34 0.266 0.0398 0.458 Solute Carriers
exp PELP1 17p13.2 0.266 0.0398 0.458 transcription, DNA-dependent"
met ACVR1 2q23-q24 0.266 0.0398 0.458 G1/S transition of mitotic cell
cycle;protein phosphorylation
exp RPS3AP5 10q23.1 0.266 0.0398 0.458
xsq ITGAV 2q31-q32 -0.266 0.0398 0.458 angiogenesis;blood
coagulation
xsq ETNK2 1q32.1 -0.266 0.0398 0.458 phosphatidylethanolamine
met LINC01558 -0.266 0.0398 0.458
xai GSN 9q33 -0.269 0.0398 0.458 cell projection
xai CLC 19q13.1 0.268 0.0399 0.458 multicellular organismal
development;lipid catabolic process
his CNOT1 16q21 0.268 0.0399 0.458 nuclear-transcribed mRNA catabolic
shortening
xai RPL5P3 15q23 0.268 0.0399 0.458
exp LINC01225 0.268 0.0399 0.458
exp LOC100130597 0.268 0.0399 0.458
mut CCDC138 2q12.3 0.266 0.0399 0.458
exp MYBBP1A 17p13.3 0.266 0.0399 0.458 DNA Damage Response (DDR)
xsq TAMM41 3p25.2 0.266 0.0399 0.458 protein transport;protein
import into mitochondrial matrix
xsq LOC105373383 0.266 0.0399 0.458
exp LOC285696 5p15.1 0.266 0.0399 0.458
exp UBE2E1 3p24.2 0.266 0.0399 0.458 mitotic cell cycle spindle
exp MS4A4A 11q12 0.266 0.0399 0.458
exp M6PR 12p13 0.266 0.0399 0.458 transport;receptor-mediated endocytosis
exp SCAMP4 19p13.3 -0.266 0.0399 0.458 protein transport
exp PDP1 8q22.1 -0.266 0.0399 0.458 pyruvate metabolic
process;regulation of acetyl-CoA biosynthetic process from pyruvate
exp KIAA1683 19p13.1 -0.266 0.0399 0.458
exp TPD52L1 6q22-q23 -0.266 0.0399 0.458 G2/M transition of
hs4 ART1 11p15 -0.268 0.0399 0.458 protein ADP-ribosylation;innate
immune response
hs4 ART5 -0.268 0.0399 0.458
hs4 PKIA-AS1 -0.268 0.0399 0.458
xai CAV1 7q31.1 -0.268 0.0399 0.458 vasculogenesis;skeletal
hs4 LINC00484 -0.268 0.0399 0.458
xai PLPP7 -0.268 0.0399 0.458
exp RPL13P5 12p13.31 0.268 0.04 0.458
xai RPL13P5 12p13.31 0.268 0.04 0.458
his MIR4427 0.268 0.04 0.458
xai METTL8 2q31.1 0.268 0.04 0.458
exp CCDC38 12q23.1 0.268 0.04 0.458
xai LOC100130597 0.268 0.04 0.458
exp ST13P10 11q23.1 0.268 0.04 0.458
xai COPS4 4q21.22 0.268 0.04 0.458 DNA Damage Response (DDR)
exp NR2C1 12q22 0.266 0.04 0.458 positive regulation of retinoic acid receptor
signaling pathway;negative regulation of transcription from RNA polymerase II
promoter
xsq DCAF13P3 0.266 0.04 0.458
exp RPS4XP16 13q14.3 0.266 0.04 0.458
exp HMGCLL1 6p12.1 0.266 0.04 0.458
xsq PHF19 9q33.2 0.266 0.04 0.458 regulation of transcription, DNA-
dependent"
mut AFF3 2q11.2-q12 0.266 0.04 0.458 embryonic hindlimb
morphogenesis;regulation of transcription, DNA-dependent
exp DCAF7 17q23.3 0.266 0.04 0.458 multicellular organismal
cop DIO3 14q32 0.266 0.04 0.458 thyroid hormone generation;cellular nitrogen
met OR1G1 17p13.3 0.266 0.04 0.458 signal transduction;response to stimulus
exp IGLC1 0.266 0.04 0.458 immune response;complement activation
exp LHFPL2 5q14.1 -0.266 0.04 0.458
exp DUSP14 17q12 -0.266 0.04 0.458 peptidyl-tyrosine dephosphorylation
hs4 TTC9B 19q13.2 -0.268 0.04 0.458
his KIAA1671 22q11.23 -0.268 0.04 0.458
his AP3S2 15q26.1 0.268 0.0401 0.458 intracellular protein
xai RPS11P6 12q14.2 0.268 0.0401 0.458
hs4 CTRB1 0.268 0.0401 0.458
swa EIF2B4 2p23.3 0.268 0.0401 0.458 gene expression;cellular
xai REST 4q12 0.268 0.0401 0.458 positive regulation of apoptotic
his CCT8L2 0.268 0.0401 0.458
met EPHB3 3q27.1 0.266 0.0401 0.458 axon guidance;substrate adhesion-
dependent cell spreading
exp CD3E 11q23 0.266 0.0401 0.458 cell surface receptor signaling
xsq FAAH2 Xp11.21 0.266 0.0401 0.458
met LYNX1 8q24.3 0.266 0.0401 0.458
xsq UBTF 17q21.31 0.266 0.0401 0.458 chromatin silencing at
met MAGOH 1p32.3 0.266 0.0401 0.458 transcription from RNA polymerase
exp EEF2KMT 0.266 0.0401 0.458
xsq TAS2R39 0.266 0.0401 0.458
exp NAP1L2 Xq13 0.266 0.0401 0.458 nucleosome assembly
exp PRPF4 9q31-q33 0.266 0.0401 0.458 nuclear mRNA splicing, via
exp RPL37P22 -0.266 0.0401 0.458
xsq KIRREL 1q21-q25 -0.266 0.0401 0.458 excretion
exp LINC00899 22q13.31 -0.266 0.0401 0.458
exp GLYATL2 11q12.1 -0.266 0.0401 0.458
xsq FAM102A 9q34.11 -0.266 0.0401 0.458
exp FLVCR2 14q24.3 -0.266 0.0401 0.458 heme
xai NR1D2 3p24.2 -0.268 0.0401 0.458 regulation of transcription,
hs4 MMP14 14q11.2 -0.268 0.0401 0.458 Apoptosis
his MTRF1 13q14.1-q14.3 0.268 0.0402 0.458 regulation of translational
termination
his ARHGEF3-AS1 0.268 0.0402 0.458
his XPO4 13q11 0.268 0.0402 0.458 protein transport;positive regulation of
protein export from nucleus
xai MYBL2 20q13.1 0.268 0.0402 0.458 Apoptosis
xai ZDHHC22 14q24.3 0.268 0.0402 0.458
xai RPSAP47 8q21.13 0.268 0.0402 0.458
xai NOA1 4q12 0.268 0.0402 0.458 mitochondrial translation;regulation of
cellular respiration
hs4 ZNF80 3q13.3 0.268 0.0402 0.458 regulation of transcription, DNA-
dependent"
met CEP70 3q22.3 0.266 0.0402 0.458 mitotic cell cycle;G2/M transition
of mitotic cell cycle
cop LINC00239 14q32.31 0.266 0.0402 0.458
cop PPP2R5C 14q32.31 0.266 0.0402 0.458 protein processing;DNA damage
apoptosis
cop DYNC1H1 14q32 0.266 0.0402 0.458 mitotic cell cycle;transport
cop HSP90AA1 14q32.33 0.266 0.0402 0.458 Apoptosis
cop WDR20 14q32.31 0.266 0.0402 0.458
cop MOK 14q32 0.266 0.0402 0.458 protein phosphorylation;signal
transduction
cop SNORD113-9 14q32.31 0.266 0.0402 0.458
cop SNORD114-1 14q32 0.266 0.0402 0.458
cop SNORD114-2 0.266 0.0402 0.458
cop SNORD114-3 0.266 0.0402 0.458
cop SNORD114-4 0.266 0.0402 0.458
cop SNORD114-5 14q32 0.266 0.0402 0.458
cop SNORD114-6 14q32 0.266 0.0402 0.458
cop SNORD114-7 0.266 0.0402 0.458
cop SNORD114-8 14q32 0.266 0.0402 0.458
cop SNORD114-9 14q32 0.266 0.0402 0.458
cop SNORD114-10 14q32 0.266 0.0402 0.458
cop SNORD114-11 0.266 0.0402 0.458
cop SNORD114-12 14q32 0.266 0.0402 0.458
cop SNORD114-13 14q32 0.266 0.0402 0.458
cop SNORD114-14 14q32 0.266 0.0402 0.458
cop SNORD114-15 14q32 0.266 0.0402 0.458
cop SNORD114-16 14q32 0.266 0.0402 0.458
cop SNORD114-17 14q32 0.266 0.0402 0.458
cop SNORD114-18 14q32 0.266 0.0402 0.458
cop SNORD114-19 14q32 0.266 0.0402 0.458
cop SNORD114-20 0.266 0.0402 0.458
cop SNORD114-21 0.266 0.0402 0.458
cop SNORD114-22 0.266 0.0402 0.458
cop SNORD114-23 14q32 0.266 0.0402 0.458
cop SNORD114-24 0.266 0.0402 0.458
cop SNORD114-25 14q32 0.266 0.0402 0.458
cop SNORD114-26 14q32 0.266 0.0402 0.458
cop SNORD114-27 14q32 0.266 0.0402 0.458
cop SNORD114-28 14q32 0.266 0.0402 0.458
cop SNORD114-29 0.266 0.0402 0.458
cop SNORD114-30 14q32 0.266 0.0402 0.458
cop SNORD114-31 14q32 0.266 0.0402 0.458
cop MIR379 0.266 0.0402 0.458
cop MIR411 0.266 0.0402 0.458
cop MIR299 0.266 0.0402 0.458
cop MIR380 0.266 0.0402 0.458
cop MIR1197 0.266 0.0402 0.458
cop MIR323A 0.266 0.0402 0.458
cop MIR758 0.266 0.0402 0.458
cop MIR329-1 0.266 0.0402 0.458
cop MIR329-2 0.266 0.0402 0.458
cop MIR494 0.266 0.0402 0.458
cop MIR1193 0.266 0.0402 0.458
cop MIR543 0.266 0.0402 0.458
cop MIR495 0.266 0.0402 0.458
cop MIR376C 0.266 0.0402 0.458
cop MIR376A2 0.266 0.0402 0.458
cop MIR654 0.266 0.0402 0.458
cop MIR376B 0.266 0.0402 0.458
cop MIR376A1 0.266 0.0402 0.458
cop MIR300 0.266 0.0402 0.458
xsq BAHCC1 17q25.3 0.266 0.0402 0.458
xsq TUT1 11q12.2 0.266 0.0402 0.458 mRNA polyadenylation;mRNA cleavage
exp MCEMP1 0.266 0.0402 0.458
xsq MTPAP 10p11.23 0.266 0.0402 0.459 cell death;histone mRNA catabolic
process
exp MXRA7 17q25.1 -0.266 0.0402 0.458
xsq PLCB4 20p12 -0.266 0.0402 0.458 lipid metabolic process;lipid
catabolic process
xsq AFF4 5q31 -0.266 0.0402 0.458 spermatid development;regulation of
his ETNK2 1q32.1 -0.268 0.0402 0.459 phosphatidylethanolamine
swa PTGR1 9q31.3 -0.268 0.0402 0.458 leukotriene metabolic
xai ZRANB2 1p31 0.268 0.0403 0.459 regulation of transcription, DNA-
xai RPL17P20 4q12 0.268 0.0403 0.459
xai CENPC 4q13.2 0.268 0.0403 0.459
his MIR5698 0.268 0.0403 0.459
his ATG16L2 11q13.4 0.268 0.0403 0.459 autophagy;protein transport
DNA-dependent"
his NLRP6 11p15 0.268 0.0403 0.459 regulation of inflammatory response
xsq GK Xp21.3 0.266 0.0403 0.459 glycerol metabolic
process;triglyceride metabolic process
cop STX1B 16p11.2 0.266 0.0403 0.459 intracellular protein
transport;synaptic transmission
xsq CNOT6L 4q13.3 0.266 0.0403 0.459 nuclear-transcribed mRNA
tail shortening
met TMBIM6 12q13.12 0.266 0.0403 0.459 Apoptosis
xsq PODN 1p32.3 0.266 0.0403 0.459 negative regulation of cell
proliferation;negative regulation of cell migration
met LINC00467 1q32.3 0.265 0.0403 0.459
xsq SRGAP1 12q14.2 -0.266 0.0403 0.459 signal
exp PLEKHA2 8p11.22 -0.266 0.0403 0.459 positive regulation of
cell-matrix adhesion
swa STEAP3 2q14.2 -0.268 0.0403 0.459 ion transport;cellular
iron ion homeostasis
hs4 GRB10 7p12.2 -0.268 0.0403 0.459 response to insulin
exp ENPP7P2 0.268 0.0404 0.459
xai HIST1H2AK 6p22.1 0.268 0.0404 0.459 nucleosome assembly
his WDR74 11q12.3 0.268 0.0404 0.459
xai OSTCP5 0.268 0.0404 0.459
his AASDHPPT 11q22 0.268 0.0404 0.459 macromolecule biosynthetic
his KBTBD3 11q22.3 0.268 0.0404 0.459
hs4 SBK1 16p11.2 0.268 0.0404 0.459 peptidyl-serine
phosphorylation;peptidyl-threonine phosphorylation
his DNMT3A 2p23 0.268 0.0404 0.459 Oncogenes
hs4 ISL2 15q23 0.268 0.0404 0.459 multicellular organismal
his CIDECP 3p25.3 0.268 0.0404 0.459
his FANCD2 3p26 0.268 0.0404 0.459 DNA Damage Response (DDR); DDR (FA)
xsq TAF1A-AS1 0.265 0.0404 0.459
xsq SLC5A5 19p13.11 0.265 0.0404 0.459 cellular nitrogen compound
exp RPP25L 9p13.3 0.265 0.0404 0.459
exp CD33 19q13.3 0.265 0.0404 0.459 cell adhesion;signal transduction
exp LOC643923 11q22.3 0.265 0.0404 0.459
exp RPSAP15 Xq21.31 0.265 0.0404 0.459
exp PPHLN1 12q12 0.265 0.0404 0.459 keratinization
xsq LINC00967 0.265 0.0404 0.459
cop TDRD9 14q32.33 0.265 0.0404 0.459 fertilization;cell differentiation
exp H3F3AP4 2q31.1 0.265 0.0404 0.459
exp NARS2 11q14.1 0.265 0.0404 0.459 asparaginyl-tRNA
xsq TCTN2 12q24.31 -0.265 0.0404 0.459 cell projection
xai TTLL7 1p31.1 -0.268 0.0404 0.459 multicellular organismal
xai SOGA1 20q11.23 -0.268 0.0404 0.459
xai ILK 11p15.4 -0.268 0.0404 0.459 Apoptosis
swa PBXIP1 1q21.3 0.268 0.0405 0.459 negative regulation of
xai FANCG 9p13 0.268 0.0405 0.459 DNA Damage Response (DDR); DDR (FA)
xai FANCA 16q24.3 0.268 0.0405 0.459 DNA Damage Response (DDR); DDR (FA)
exp HDAC10 22q13.31 0.268 0.0405 0.46 negative regulation of
dependent
hs4 CNTFR 9p13 0.267 0.0405 0.46 positive regulation of cell
proliferation;negative regulation of neuron apoptosis
xsq HMGB2 4q31 0.265 0.0405 0.459 DNA Damage Response (DDR); DDR (BER)
cop NCK2 2q12 0.265 0.0405 0.459 signal transduction;positive regulation
of actin filament polymerization
exp MYBL2 20q13.1 0.265 0.0405 0.459 Apoptosis
exp RPS26P32 0.265 0.0405 0.459
xsq RPL11 1p36.1-p35 0.265 0.0405 0.46 translational elongation;viral
infectious cycle
exp ARL5B 10p12.31 0.265 0.0405 0.46 small GTPase mediated signal
transduction
exp TNFRSF18 1p36.3 0.265 0.0405 0.46 signal transduction;tumor
met SLC2A5 1p36.2 -0.265 0.0405 0.46 Solute Carriers
met AKAP12 6q24-q25 -0.265 0.0405 0.46 G-protein coupled
receptor signaling pathway;positive regulation of protein kinase A signaling
cascade
exp SHROOM4 Xp11.22 -0.265 0.0405 0.46 actin filament
xsq COL1A2 7q22.1 -0.265 0.0405 0.459 axon guidance;protein
heterotrimerization
xsq RBFOX2 22q13.1 -0.265 0.0405 0.459 RNA splicing;regulation
his NDRG4 16q21-q22.1 -0.268 0.0405 0.46 cell growth;cell
differentiation
xai METRNL 17q25.3 -0.268 0.0405 0.459
his AP2M1 3q28 -0.268 0.0405 0.459 vesicle-mediated
transport;transport
hs4 GRIP1 12q14.3 -0.268 0.0405 0.459 positive regulation of
transcription, DNA-dependent;synaptic transmission
xai ZSWIM3 20q13.12 0.267 0.0406 0.46
xai HMBS 11q23.3 0.267 0.0406 0.46 porphyrin-containing compound
his SLC5A5 19p13.11 0.267 0.0406 0.46 cellular nitrogen compound
hs4 ARPP21 3p22.3 0.267 0.0406 0.46 cellular response to heat
his GUCY2C 12p12 0.267 0.0406 0.46 regulation of cell
proliferation;cGMP biosynthetic process
xai STRADA 17q23.3 0.267 0.0406 0.46 positive regulation of
protein phosphorylation;protein heterooligomerization
xai HSPA8P16 7q21.11 0.267 0.0406 0.46
his STRADA 17q23.3 0.267 0.0406 0.46 positive regulation of
xsq RORC 1q21 0.265 0.0406 0.46 multicellular organismal development;gene
expression
met WISP1 8q24.22 0.265 0.0406 0.46 Oncogenes
xsq VWCE 11q12.2 0.265 0.0406 0.46
xsq ITGB3BP 1p31.3 0.265 0.0406 0.46 Apoptosis
met ITGA1 5q11.2 0.265 0.0406 0.46 activation of MAPK
xsq ZNF705E 11q13.4 0.265 0.0406 0.46
cop LPA 6q26 0.265 0.0406 0.46 transport;lipid transport
exp TOMM40L 1q23.3 0.265 0.0406 0.46 protein
exp LOC149935 20q11.21 0.265 0.0406 0.46
exp HERPUD2 7p14.2 -0.265 0.0406 0.46 response to unfolded
protein;spermatogenesis
exp WWC1 5q34 -0.265 0.0406 0.46 regulation of transcription, DNA-
dependent;cell migration
met RGS19 20q13.33 -0.265 0.0406 0.46 autophagy;G-protein coupled
xsq SLC35D2 9q22.32 -0.265 0.0406 0.46 Solute Carriers
xai KIFC3 16q13-q21 -0.267 0.0406 0.46 zonula adherens
maintenance;epithelial cell-cell adhesion
swa SEH1L 18p11.21 0.267 0.0407 0.46 mitotic prometaphase;protein
transport
his C19orf35 0.267 0.0407 0.46
his ITGAL 16p11.2 0.267 0.0407 0.46 cell adhesion;regulation of immune
response
xai RPF2P1 20q11.22 0.267 0.0407 0.461
exp YTHDC2 5q22.2 0.267 0.0407 0.461
hs4 HIST2H4B 0.267 0.0407 0.461 nucleosome assembly;CenH3-
mir hsa-miR-150* 0.265 0.0407 0.461
xsq FGD3 0.265 0.0407 0.461 regulation of Cdc42 GTPase
activity;apoptotic process
met L3MBTL4 18p11.31 0.265 0.0407 0.461 chromatin modification
mut PKD2L1 10q24 0.265 0.0407 0.461 potassium ion transmembrane
transport;detection of chemical stimulus involved in sensory perception of sour
taste
xsq GLIS2 16p13.3 -0.265 0.0407 0.461 positive regulation of
exp BICC1 10q21.1 -0.265 0.0407 0.461 multicellular organismal
development;negative regulation of canonical Wnt receptor signaling pathway
exp IL1R1 2q12 -0.265 0.0407 0.46 ovulation;innate immune response
xsq CKMT2 5q13.3 -0.265 0.0407 0.46 creatine metabolic
process;muscle contraction
exp TRIM32 9q33.1 -0.265 0.0407 0.46 response to tumor
necrosis factor;positive regulation of proteolysis
hs4 DOPEY2 21q22.2 -0.267 0.0407 0.461 Golgi to endosome
transport;endoplasmic reticulum organization
hs4 CBR3-AS1 -0.267 0.0407 0.461
hs4 LINC01693 -0.267 0.0407 0.461
xai TGFB2 1q41 -0.267 0.0407 0.461 Apoptosis
exp C11orf52 11q23.1 -0.267 0.0407 0.461
hs4 TNS3 7p12.3 -0.267 0.0407 0.461 positive regulation of cell
hs4 HOXA3 7p15.2 -0.267 0.0407 0.46 glossopharyngeal nerve
morphogenesis;thyroid gland development
hs4 HOXA-AS2 7p15.2 -0.267 0.0407 0.46
his SAA2-SAA4 -0.267 0.0407 0.46
his SAA2 11p15.1-p14 -0.267 0.0407 0.46
his SMURF1 7q22.1 -0.267 0.0407 0.46 protein
swa AP2A2 11p15.5 -0.267 0.0407 0.46 endocytosis;epidermal growth
swa DDX3X Xp11.3-p11.23 0.267 0.0408 0.461 interspecies interaction
between organisms
exp TSSK6 19p13.11 0.267 0.0408 0.461 cell differentiation;sperm
his TRMT61A 14q32 0.267 0.0408 0.461 tRNA processing;tRNA methylation
exp LINC00471 2q37.1 0.267 0.0408 0.461
his RIPPLY2 6q14.2 0.267 0.0408 0.461 ossification;somitogenesis
his NDUFAB1 16p12.2 0.267 0.0408 0.461 respiratory electron
his QTRT1 19p13.3 0.267 0.0408 0.461 tRNA modification;queuosine
his TCIRG1 11q13.2 0.267 0.0408 0.461 proton transport;transferrin
transport
his MIR6753 0.267 0.0408 0.461
xai MIR3943 0.267 0.0408 0.461
xai DNAJA3 16p13.3 0.267 0.0408 0.461 Apoptosis
xai TSSK6 19p13.11 0.267 0.0408 0.461 cell differentiation;sperm
his GTPBP10 7q21.13 0.267 0.0408 0.461
his LOC102467214 0.267 0.0408 0.461
his LOC101929237 0.267 0.0408 0.461
met RFPL4A 19q13.42 0.265 0.0408 0.461
met BTF3 5q13.2 0.265 0.0408 0.461 in utero embryonic
xsq PSMB10 16q22.1 0.265 0.0408 0.461 mitotic cell cycle;viral
reproduction
xsq NRROS 3q29 0.265 0.0408 0.461
exp ASH1L-AS1 1q22 0.265 0.0408 0.461
xsq LSM2 6p21.3 0.265 0.0408 0.461 nuclear mRNA splicing, via
exp ARL5A 2q23.3 0.265 0.0408 0.461 small GTPase mediated signal
transduction
mir hsa-miR-126 0.265 0.0408 0.461
xsq MED26 19p13.11 0.265 0.0408 0.461 regulation of transcription from
exp FAM117B 2q33.2 0.265 0.0408 0.461
xsq IQCC 1p36.11-p34.2 0.265 0.0408 0.461
xsq CLK2 1q21 0.265 0.0408 0.461 DNA Damage Response (DDR)
exp BORCS8 -0.265 0.0408 0.461 heart development
xsq BAALC 8q22.3 -0.265 0.0408 0.461
met CD28 2q33 -0.265 0.0408 0.461 humoral immune response;negative
xsq SFXN3 10q24.31 -0.265 0.0408 0.461 iron ion
exp KIFC3 16q13-q21 -0.265 0.0408 0.461 zonula adherens
xsq GLIS3-AS1 9p24.2 -0.265 0.0408 0.461
exp BCL2L1 20q11.21 -0.265 0.0408 0.461 Apoptosis; Protein
Kinases
xai SERPINH1 11q13.5 -0.267 0.0408 0.461 response to
hs4 ZFYVE1 14q24.2 -0.267 0.0408 0.461 negative regulation of
xai GAS6 13q34 -0.267 0.0408 0.461 proteolysis;cellular protein
metabolic process
his LOC100506498 -0.267 0.0408 0.461
hs4 DPYSL3 5q32 -0.267 0.0408 0.461 axon guidance;actin crosslink
formation
his SNX7 1p21.3 -0.267 0.0408 0.461 cell communication;protein
transport
xai PDSS2 6q21 0.267 0.0409 0.461 isoprenoid biosynthetic
his POLR2J4 7p13 0.267 0.0409 0.461
his NPIPB6 16p11.2 0.267 0.0409 0.461
exp EXOSC3P1 21q22.11 0.267 0.0409 0.461
his RABGGTB 1p31 0.267 0.0409 0.461 visual perception;protein
his SNORD45C 0.267 0.0409 0.461
his SNORD45A 0.267 0.0409 0.461
his SNORD45B 0.267 0.0409 0.461
exp RPL5P11 4q34.1 0.267 0.0409 0.461
his MAP2K2 19p13.3 0.267 0.0409 0.461 Protein Kinases
his SLCO4C1 5q21.2 0.267 0.0409 0.461 Solute Carriers
exp MIR3943 0.267 0.0409 0.461
exp GIMAP4 7q36.1 0.265 0.0409 0.461
xsq UCP3 11q13.4 0.265 0.0409 0.461 response to nutrient;small molecule
metabolic process
xsq FAM207A 21q22.3 0.265 0.0409 0.461
mut DUSP13 10q22.2 0.265 0.0409 0.461 protein
dephosphorylation;meiosis
xsq SNHG1 11q12.3 0.265 0.0409 0.461
met ZMYM1 1p34.3 0.265 0.0409 0.461
mut UGT3A2 5p13.2 0.265 0.0409 0.461 metabolic process
xsq NPR3 5p13.3 -0.265 0.0409 0.461 inhibition of adenylate
cyclase activity by G-protein signaling pathway;activation of phospholipase C
activity by G-protein coupled receptor protein signaling pathway coupled to IP3
second messenger
exp TM4SF1 3q21-q25 -0.265 0.0409 0.461
xai DMPK 19q13.3 -0.267 0.0409 0.461 regulation of excitatory
postsynaptic membrane potential involved in skeletal muscle contraction;regulation
of sodium ion transport
swa P4HA1 10q21.3-q23.1 -0.267 0.0409 0.461 peptidyl-proline
hydroxylation to 4-hydroxy-L-proline;collagen fibril organization
hs4 ERP27 12p12.3 -0.267 0.0409 0.461
xai HERPUD2 7p14.2 -0.267 0.0409 0.461 response to unfolded
hs4 KCNH1 1q32.2 -0.267 0.0409 0.461 ion transport;potassium ion
transport
his MIR4433A -0.267 0.0409 0.461
his MIR4433B -0.267 0.0409 0.461
xai LUC7L3 17q21.33 0.267 0.041 0.461 mRNA processing;apoptotic process
xai CXCL9 4q21 0.267 0.041 0.461 immune response;cellular defense response
his STRIP1 1p13.3 0.267 0.041 0.461
swa XPO5 6p21.1 0.267 0.041 0.461 protein export from nucleus;intracellular
protein transport
xai SIRPD 20p13 0.267 0.041 0.461
xsq COQ3 6q16.2 0.265 0.041 0.461 ubiquinone biosynthetic process;metabolic
process
exp IL21R 16p11 0.265 0.041 0.461 natural killer cell activation
exp VASH2 1q32.3 0.265 0.041 0.461 positive regulation of endothelial cell
proliferation;positive regulation of angiogenesis
met ZHX3 20q12 0.265 0.041 0.461 positive regulation of osteoblast
exp EIF4BP6 0.265 0.041 0.461
exp MAD2L1 4q27 0.265 0.041 0.461 DNA Damage Response (DDR)
xsq GRB10 7p12.2 -0.265 0.041 0.461 response to insulin
met ZNF385A 12q13.13 -0.265 0.041 0.461 regulation of transcription,
DNA-dependent"
swa GSN 9q33 -0.267 0.041 0.461 cell projection organization;response to
folic acid
hs4 VILL 3p21.3 0.267 0.0411 0.461 cytoskeleton organization;actin
filament capping
xai GRID2 4q22 0.267 0.0411 0.461 transport;ion transport
his MIR6813 0.267 0.0411 0.461
his RGS19 20q13.33 0.267 0.0411 0.461 autophagy;G-protein coupled
his OPRL1 20q13.33 0.267 0.0411 0.461 elevation of cytosolic calcium ion
his ABHD10 3q13.2 0.267 0.0411 0.461 proteolysis
xai TMEM145 19q13.2 0.267 0.0411 0.461
xai PRPF38B 1p13.3 0.267 0.0411 0.461 mRNA processing;RNA splicing
exp PARTICL 0.267 0.0411 0.461
his IRAK1BP1 6q14-q15 0.267 0.0411 0.461 regulation of transcription,
DNA-dependent;I-kappaB kinase/NF-kappaB cascade"
exp MIR34B 0.267 0.0411 0.461
his HMGN1 21q22.2 0.267 0.0411 0.461 positive regulation of
transcription elongation, DNA-dependent"
xai HSPA8P9 3q22.3 0.267 0.0411 0.461
his TK2 16q22-q23.1 0.267 0.0411 0.461 DNA replication;pyrimidine
nucleoside salvage
his CKLF 16q21 0.267 0.0411 0.461 neutrophil chemotaxis;secretion by cell
his CKLF-CMTM1 0.267 0.0411 0.461
cop GPR45 2q11.1-q12 0.265 0.0411 0.461
cop TGFBRAP1 2q12.1 0.265 0.0411 0.461 regulation of transcription,
DNA-dependent;intracellular protein transport
cop C2orf49 2q12.1 0.265 0.0411 0.461 embryonic morphogenesis
cop FHL2 2q12.2 0.265 0.0411 0.461 negative regulation of
development
cop LOC285000 0.265 0.0411 0.461
dependent"
met TNC 9q33 0.265 0.0411 0.461 positive regulation of gene
expression;peripheral nervous system axon regeneration
xsq PTPRN2 7q36 0.265 0.0411 0.461 protein dephosphorylation;negative
met HPYR1 8q24.22 0.265 0.0411 0.461
cop MIR4432 0.264 0.0411 0.461
exp RPSAP9 9q21.13 0.264 0.0411 0.461
exp LYPD6 2q23.2 -0.265 0.0411 0.461
xsq KREMEN1 22q12.1 -0.265 0.0411 0.461 cell communication;Wnt
hs4 LOC101927286 -0.267 0.0411 0.461
xai CDC42EP4 17q24-q25 -0.267 0.0411 0.461 Rho protein signal
xai C5orf15 5q31.1 -0.267 0.0411 0.461
xai TNFAIP8L3 15q21.2 -0.267 0.0411 0.461
xai FRMD6 14q22.1 -0.267 0.0411 0.461
xai KCP 7q32.1 -0.267 0.0411 0.461
exp API5P2 0.267 0.0412 0.462
xai HSPD1P10 6q15 0.267 0.0412 0.462
his OGT Xq13 0.267 0.0412 0.462 induction of apoptosis;histone H4-K8
acetylation
his AASDH 4q12 0.267 0.0412 0.462 lipid metabolic process;fatty acid
metabolic process
DNA-dependent"
his KIF26A 14q32.33 0.267 0.0412 0.462 regulation of cell growth by
extracellular stimulus;microtubule-based movement
hs4 HIST2H4A 0.267 0.0412 0.462
exp CCDC112 5q22.3 0.264 0.0412 0.462
exp DGUOK 2p13 0.264 0.0412 0.462 nucleotide biosynthetic process;negative
xsq ZNF124 1q44 0.264 0.0412 0.462 regulation of transcription, DNA-
dependent"
mut SRRT 7q21 0.264 0.0412 0.462 gene silencing by RNA;primary miRNA
processing
met DMGDH 5q14.1 0.264 0.0412 0.462 glycine metabolic process;glycine
catabolic process
hs4 LAMA4 6q21 -0.267 0.0412 0.462 regulation of embryonic
development;brown fat cell differentiation
hs4 PLPP3 -0.267 0.0412 0.462 negative regulation of protein
swa ATP1A1 1p21 -0.267 0.0412 0.462 ATP biosynthetic
process;positive regulation of heart contraction
xai CACNB4 2q22-q23 -0.267 0.0412 0.462 synaptic
transmission;axon guidance
his LNX1-AS1 -0.267 0.0412 0.462
xai TMEM139 7q34 -0.267 0.0412 0.462
xai NPR2 9p21-p12 -0.267 0.0412 0.462 cell surface receptor
signaling pathway;receptor guanylyl cyclase signaling pathway
xai MIR34B 0.267 0.0413 0.462
his ATP5L 11q23.3 0.267 0.0413 0.462 ATP catabolic process;ion transport
exp FLJ40712 0.267 0.0413 0.462
his GPR89A 1q21.1 0.267 0.0413 0.462 signal transduction;protein
transport
xai CD5 11q13 0.266 0.0413 0.463 induction of apoptosis by extracellular
met PARVA 11p15.3 0.264 0.0413 0.462 cell projection organization;actin
exp KIAA1324L 7q21.12 0.264 0.0413 0.462
exp FAR2P2 0.264 0.0413 0.462
xsq LBR 1q42.1 0.264 0.0413 0.462 cholesterol biosynthetic
exp CCDC58 3q21.1 0.264 0.0413 0.462
exp RPL15P5 2q22.1 0.264 0.0413 0.462
xsq CALU 7q32.1 -0.264 0.0413 0.462 platelet activation;platelet
degranulation
xsq BICC1 10q21.1 -0.264 0.0413 0.462 multicellular organismal
xsq IGSF3 1p13 -0.264 0.0413 0.462
exp LOXL1 15q22 -0.264 0.0413 0.462 protein deamination;oxidation-
reduction process
xsq SGMS2 4q25 -0.264 0.0413 0.462 lipid metabolic
his MYL9 20q11.23 -0.267 0.0413 0.462 axon guidance;muscle
contraction
his MIR149 -0.267 0.0413 0.462
his PP14571 2q37.3 -0.267 0.0413 0.462
his MIR6131 -0.267 0.0413 0.462
xai LDHBP2 Xq13.3 0.266 0.0414 0.463
his GS1-24F4.2 0.266 0.0414 0.463
his XKR5 8p23.1 0.266 0.0414 0.463
his LINC01659 0.266 0.0414 0.463
xai API5P2 0.266 0.0414 0.463
hs4 ERVFRD-1 6p24.1 0.266 0.0414 0.463
hs4 ATG16L2 11q13.4 0.266 0.0414 0.463 autophagy;protein transport
hs4 CTDSP1 2q35 0.266 0.0414 0.463 negative regulation of neuron
hs4 MIR26B 0.266 0.0414 0.463
xai C21orf58 21q22.3 0.266 0.0414 0.463
xai DENND4B 1q21 0.266 0.0414 0.463
exp USP10 16q24.1 0.264 0.0414 0.463 protein deubiquitination;DNA damage
mut KCNA1 12p13.32 0.264 0.0414 0.463 potassium ion transport;synaptic
transmission
met SKAP2 7p15.2 0.264 0.0414 0.463 negative regulation of cell
xsq LIME1 20q13.3 0.264 0.0414 0.463 regulation of release of
xsq NADK 1p36.33 0.264 0.0414 0.463 vitamin metabolic process;water-
xsq ATAD3A 1p36.33 0.264 0.0414 0.463 cell growth;negative
met EPHB2 1p36.1-p35 0.264 0.0414 0.463 Protein Kinases
exp MAP10 1q42.2 0.264 0.0414 0.463
met PLK2 5q12.1-q13.2 0.264 0.0414 0.463 Protein Kinases
exp RPS23P8 Xq13.1 0.264 0.0414 0.463
xsq DNMT3A 2p23 0.264 0.0414 0.463 Oncogenes
exp NACAD 7p13 -0.264 0.0414 0.463 protein transport
xsq ZNF502 3p21.31 -0.264 0.0414 0.463 regulation of
met LINC00474 9q31.3 -0.264 0.0414 0.463
xai BEAN1 16q21 -0.266 0.0414 0.463 cell death
xai TIAM2 6q25.2 -0.266 0.0414 0.463 regulation of Rho protein
xai MYL6 12q13.2 -0.266 0.0414 0.463 muscle contraction;axon
guidance
hs4 MORN4 10q24.2 -0.266 0.0414 0.463
his GEMIN4 17p13 0.266 0.0415 0.463 RNA metabolic process;ncRNA
metabolic process
his DBIL5P 17p13.3 0.266 0.0415 0.463
his GFI1 1p22 0.266 0.0415 0.463 negative regulation of calcidiol 1-
his METAP2 12q22 0.266 0.0415 0.463 proteolysis;cellular process
his CD320 19p13.3-p13.2 0.266 0.0415 0.463 regulation of cell growth
his CNOT6L 4q13.3 0.266 0.0415 0.463 nuclear-transcribed mRNA
tail shortening
his TOP1MT 8q24.3 0.266 0.0415 0.463 DNA Damage Response (DDR);
his PPA2 4q25 0.266 0.0415 0.463 tRNA aminoacylation for protein
xai RPS25 11q23.3 0.266 0.0415 0.463 translation;mRNA metabolic process
hs4 FOXD4L4 0.266 0.0415 0.463
xai TSHZ1 18q22.3 0.266 0.0415 0.463 multicellular organismal
xai CPLX1 4p16.3 0.266 0.0415 0.463 exocytosis;synaptic transmission
his THRA 17q11.2 0.266 0.0415 0.463 regulation of transcription from
met SWAP70 11p15 0.264 0.0415 0.463 somatic cell DNA
recombination;isotype switching
exp LOC440311 15q26.2 0.264 0.0415 0.463
DNA-dependent"
cop PRSS53 16p11.2 0.264 0.0415 0.463 proteolysis
cop VKORC1 16p11.2 0.264 0.0415 0.463 cellular protein metabolic
process;response to organic nitrogen
xsq HSFX2 0.264 0.0415 0.463
xsq GTSE1-AS1 22q13.31 0.264 0.0415 0.463
xai OR52E8 11p15.4 -0.266 0.0415 0.463 response to stimulus
xai FRMD5 15q15.3 -0.266 0.0415 0.463
xai BICC1 10q21.1 -0.266 0.0415 0.463 multicellular organismal
xai GCFC2 2p12 0.266 0.0416 0.463 regulation of transcription, DNA-
exp ATP5G1P7 10q22.1 0.266 0.0416 0.463
xai RPL5P11 4q34.1 0.266 0.0416 0.463
his LINC01993 0.266 0.0416 0.463
DNA-dependent"
his LOC643711 12q23.1 0.266 0.0416 0.463
exp B4GALT6 18q11 0.264 0.0416 0.463 post-translational protein
met CALU 7q32.1 0.264 0.0416 0.463 platelet activation;platelet
degranulation
exp DDX54 12q24.13 0.264 0.0416 0.463 regulation of transcription, DNA-
cop TBC1D10C 11q13.2 0.264 0.0416 0.463
met MB21D2 3q29 0.264 0.0416 0.463
exp C1D 2p13-p12 0.264 0.0416 0.463 negative regulation of
exp TNFRSF17 16p13.1 0.264 0.0416 0.463 multicellular organismal
exp RAG1 11p13 0.264 0.0416 0.463 B cell differentiation;T cell
exp LOC100506388 0.264 0.0416 0.463
xsq PTBP1 19p13.3 0.264 0.0416 0.463 negative regulation of RNA
splicing;negative regulation of nuclear mRNA splicing, via spliceosome
xsq SLC4A3 2q36 -0.264 0.0416 0.463 Solute Carriers
exp RPL36AP26 7p21.2 -0.264 0.0416 0.463
cop LOC100505806 -0.264 0.0416 0.463
cop SNORD123 5p15.2 -0.264 0.0416 0.463
xsq CTSD 11p15.5 -0.264 0.0416 0.463 cell death;proteolysis
hs4 EMP1 12p12.3 -0.266 0.0416 0.463 multicellular organismal
xai DMWD 19q13.3 -0.266 0.0416 0.463 meiosis
his FBXO11 2p16.3 0.266 0.0417 0.463 protein
ubiquitination;peptidyl-arginine N-methylation
his C14orf2 14q32.33 0.266 0.0417 0.463
his TTTY9A 0.266 0.0417 0.463
his RPUSD1 16p13.3 0.266 0.0417 0.463 pseudouridine synthesis
his CHTF18 16p13.3 0.266 0.0417 0.463 DDR (DNA replication)
xai CACNA1B 9q34 0.266 0.0417 0.463 transmembrane transport;transport
xai RAG1 11p13 0.266 0.0417 0.463 B cell differentiation;T cell
his FGD5-AS1 0.266 0.0417 0.463
his NR2C2 3p25 0.266 0.0417 0.463 regulation of transcription, DNA-
xai RELT 11q13.4 0.266 0.0417 0.463
his CERS6 2q24.3 0.266 0.0417 0.463 sphingolipid metabolic
process;lipid biosynthetic process
his INTS10 8p21.3 0.266 0.0417 0.463 snRNA processing
xai RCL1 9p24.1-p23 0.266 0.0417 0.463 RNA processing;ribosome biogenesis
hs4 PLCB2 15q15 0.266 0.0417 0.463 phospholipid metabolic process;activation
his KCTD20 6p21.31 0.266 0.0417 0.463 potassium ion transport
his PXT1 0.266 0.0417 0.463
xsq FAU 11q13 0.264 0.0417 0.463 translational initiation;viral infectious
cycle
mut HOXD10 2q31.1 0.264 0.0417 0.463 spinal cord motor neuron cell
fate specification;embryonic limb morphogenesis
exp TMEM52 1p36.33 0.264 0.0417 0.463
mut SIX4 14q23 0.264 0.0417 0.463 generation of neurons;multicellular
met SEPT11 4q21.1 0.264 0.0417 0.463 cell cycle;protein
xsq HSPA1L 6p21.3 0.264 0.0417 0.463 Apoptosis
xsq LINC00341 14q32.13 0.264 0.0417 0.463
xsq PRDM13 6q16.2 0.264 0.0417 0.463 regulation of transcription,
DNA-dependent"
xsq KHDC3L 6q13 0.264 0.0417 0.463
xsq CENPM 22q13.2 0.264 0.0417 0.463 M phase of mitotic cell
cop KMT5B 0.264 0.0417 0.463 regulation of transcription, DNA-
xsq DACH1 13q22 0.264 0.0417 0.463 regulation of transcription, DNA-
exp HSPD1P2 8p23.1 0.264 0.0417 0.463
cop LOC100130331 1q43 -0.264 0.0417 0.463
cop ZP4 1q43 -0.264 0.0417 0.463 positive regulation of protein
kinase activity;acrosomal vesicle exocytosis
met SLC38A5 Xp11.23 -0.264 0.0417 0.463 Solute Carriers
exp NABP1 2q32.3 -0.264 0.0417 0.463 DNA Damage Response (DDR)
xai TRIL 7p14.3 -0.266 0.0417 0.463 innate immune
response;regulation of cytokine production involved in immune response
xai LINC00899 22q13.31 -0.266 0.0417 0.463
swa SUCLG2 3p14.1 -0.266 0.0417 0.463 succinyl-CoA metabolic
hs4 TBC1D12 10q23.33 -0.266 0.0417 0.463
xai MDC1 6p21.3 0.266 0.0418 0.463 DNA Damage Response (DDR); DDR
(NHEJ)
his RHO 3q21-q24 0.266 0.0418 0.463
exp RPS4XP18 18q11.2 0.266 0.0418 0.463
his VRK2 2p16.1 0.266 0.0418 0.463 protein phosphorylation;response to
oxidative stress
xai TSFM 12q14.1 0.266 0.0418 0.463 translational elongation;regulation
his CTR9 11p15.3 0.266 0.0418 0.464 histone monoubiquitination;histone
H2B ubiquitination
exp SNORD4A 0.266 0.0418 0.464
xsq PABPC1P2 2q22.3 0.264 0.0418 0.463
exp SLC22A31 16q24.3 0.264 0.0418 0.463 ion transport
xsq TMEM52 1p36.33 0.264 0.0418 0.464
DNA-dependent"
xsq XRCC3 14q32.3 0.264 0.0418 0.464 DNA Damage Response (DDR); DDR
(NHEJ)
met TBC1D8B Xq22.3 0.264 0.0418 0.464
exp ITGB3 17q21.32 -0.264 0.0418 0.464 integrin-mediated signaling
signaling pathway
xsq PVR 19q13.2 -0.264 0.0418 0.464 cell junction
xai EIF3KP1 5q21.1 -0.266 0.0418 0.464
his LINC02000 -0.266 0.0418 0.464
his SHROOM4 Xp11.22 -0.266 0.0418 0.464 actin filament
his GOLGA8A 15q11.2 0.266 0.0419 0.464
xai TRMT61A 14q32 0.266 0.0419 0.464 tRNA processing;tRNA methylation
xai ARHGDIG 16p13.3 0.266 0.0419 0.464 regulation of small GTPase
mediated signal transduction;negative regulation of cell adhesion
exp AIFM1 Xq26.1 0.264 0.0419 0.464 Apoptosis
xsq KRTAP11-1 21q22.1 0.264 0.0419 0.464
met DCAF12L1 Xq25 0.264 0.0419 0.464
xsq RNF126 19p13.3 0.264 0.0419 0.464
xsq HMBS 11q23.3 0.264 0.0419 0.464 porphyrin-containing compound
xsq IRF8 16q24.1 0.264 0.0419 0.464 immune response;positive regulation
of transcription, DNA-dependent
met SORBS1 10q23.33 0.264 0.0419 0.464 cellular response to insulin
stimulus;stress fiber assembly
met S100A3 1q21 0.264 0.0419 0.464
pro RELA_11 0.264 0.0419 0.464
exp CARNS1 11q13.2 0.264 0.0419 0.464 carnosine biosynthetic
process
xsq LAMP3 3q26.3-q27 0.263 0.0419 0.464 cell proliferation
met PKD2L2 5q31 -0.263 0.0419 0.464 ion transport
exp STOML1 15q24-q25 -0.263 0.0419 0.464
xsq RAB5B 12q13 -0.264 0.0419 0.464 small GTPase mediated signal
xai DUSP14 17q12 -0.266 0.0419 0.464 peptidyl-tyrosine
dephosphorylation
hs4 C4orf19 4p14 -0.266 0.0419 0.464
his GPNMB 7p15 -0.266 0.0419 0.464 cell adhesion;negative regulation
xai SLIT3 5q35 -0.266 0.0419 0.464 multicellular organismal
development;axon extension involved in axon guidance
xai F12 5q35.3 0.266 0.042 0.465 protein autoprocessing;plasma kallikrein-
kinin cascade
his WDHD1 14q22.2 0.266 0.042 0.465 DDR (DNA replication)
his SOCS4 14q22.1 0.266 0.042 0.465 negative regulation of epidermal growth
factor-activated receptor activity;negative regulation of signal transduction
xai PLD6 17p11.2 0.266 0.042 0.465 piRNA metabolic process;meiosis
his APTR 0.266 0.042 0.465
his RSBN1L 7q11.23 0.266 0.042 0.465
hs4 PKD2L2 5q31 0.266 0.042 0.465 ion transport
xai C7orf26 7p22.1 0.266 0.042 0.465
exp RPL27AP5 5q13.3 0.263 0.042 0.465
xsq YEATS4 12q13-q15 0.263 0.042 0.465 chromatin modification;regulation
of growth
xsq HADHA 2p23 0.263 0.042 0.465 cellular lipid metabolic process;small molecule
metabolic process
met DDX25 11q24 0.263 0.042 0.465 transport;multicellular organismal development
mut LLGL1 17p11.2 0.263 0.042 0.465 protein complex assembly;exocytosis
xsq MEP1B 18q12.2-q12.3 0.263 0.042 0.465 digestion;proteolysis
exp LOC339760 -0.263 0.042 0.465
xsq SCML1 Xp22 -0.263 0.042 0.465 regulation of transcription, DNA-
exp ZNF223 19q13.2 -0.263 0.042 0.465 regulation of transcription,
DNA-dependent"
exp DRAM1 12q23.2 -0.263 0.042 0.465 autophagy;apoptotic process
exp STX3 11q12.1 -0.263 0.042 0.465 cellular membrane fusion;neuron
exp WLS 1p31.3 -0.263 0.042 0.465 Wnt receptor signaling
his THNSL2 2p11.2 -0.266 0.042 0.465 serine family amino acid
xai DRAM1 12q23.2 -0.266 0.042 0.465 autophagy;apoptotic process
his FAM188A 10p13 0.266 0.0421 0.465 apoptotic process
xai SMG8 17q22 0.266 0.0421 0.465 nuclear-transcribed mRNA catabolic
exp GPC2 7q22.1 0.265 0.0421 0.465 neuron differentiation
mir hsa-miR-106a* 0.263 0.0421 0.465
mut HTR3A 11q23.1 0.263 0.0421 0.465 ion transmembrane
xsq CDO1 5q23.2 0.263 0.0421 0.465 sulfur amino acid metabolic
process;response to glucagon stimulus
xsq PIGF 2p21-p16 0.263 0.0421 0.465 preassembly of GPI anchor in ER
met TRIM13 13q14 0.263 0.0421 0.465 signal transduction;anatomical
xsq RPL10 Xq28 0.263 0.0421 0.465 translation;mRNA metabolic process
exp ACTR2 2p14 0.263 0.0421 0.465 cellular component movement
cop DIO3OS 14q32.31 0.263 0.0421 0.465
mut HDLBP 2q37.3 0.263 0.0421 0.465 lipid transport;steroid metabolic
process
xsq CSF1 1p13.3 -0.263 0.0421 0.465 positive regulation of gene
xai SMAD7 18q21.1 -0.266 0.0421 0.465 Apoptosis
xai MT2P1 4q13.2 -0.266 0.0421 0.465
xai DACH1 13q22 0.265 0.0422 0.465 regulation of transcription, DNA-
xai LPCAT3 12p13 0.265 0.0422 0.465 phospholipid biosynthetic process
swa PSMA5 1p13 0.265 0.0422 0.465 mitotic cell cycle;viral reproduction
xai RPS27 1q21 0.265 0.0422 0.465 translational elongation;viral infectious
cycle
xai EVI2B 17q11.2 0.265 0.0422 0.465
hs4 TMEM129 4p16.3 0.265 0.0422 0.465
hs4 TACC3 4p16.3 0.265 0.0422 0.465 microtubule cytoskeleton
hs4 GBGT1 0.265 0.0422 0.465 metabolic process;glycolipid biosynthetic
process
xai HGH1 0.265 0.0422 0.465
xai NUP160 11p11.2 0.265 0.0422 0.465 hexose transport;regulation
of glucose transport
exp KERA 12q22 0.265 0.0422 0.465 visual perception;response to stimulus
cop FBXL19-AS1 16p11.2 0.263 0.0422 0.465
cop FBXL19 16p11.2 0.263 0.0422 0.465
cop ORAI3 16p11.2 0.263 0.0422 0.465
cop SETD1A 16p11.2 0.263 0.0422 0.465 chromatin
mut SYT1 12cen-q21 0.263 0.0422 0.465 synaptic
transmission;neurotransmitter secretion
exp PRPF38B 1p13.3 0.263 0.0422 0.465 mRNA processing;RNA splicing
xsq USP20 9q34.11 0.263 0.0422 0.465 protein K48-linked
deubiquitination;proteolysis
met SBNO2 19p13.3 0.263 0.0422 0.465 macrophage activation involved in
immune response;negative regulation of transcription, DNA-dependent
xsq WRAP53 17p13.1 0.263 0.0422 0.465 DNA Damage Response (DDR)
met HSPA5 9q33.3 0.263 0.0422 0.465 Apoptosis
exp ZBTB24 6q21 0.263 0.0422 0.465 regulation of transcription, DNA-
dependent"
met EPS15 1p32 0.263 0.0422 0.465 cell proliferation;protein transport
xsq PRR5L 11p13-p12 -0.263 0.0422 0.465
xai MATN3 2p24-p23 -0.265 0.0422 0.465 skeletal system development
xai TPST1 7q11.21 -0.265 0.0422 0.465 peptidyl-tyrosine
hs4 RAB3IL1 11q12.2 -0.265 0.0422 0.465
xai SIGLEC27P 19q13.41 -0.265 0.0422 0.465
xai DNAJB12 10q22.1 -0.265 0.0422 0.465 protein folding
hs4 MIR99AHG -0.265 0.0422 0.465
hs4 MIR99A -0.265 0.0422 0.465
hs4 MIRLET7C -0.265 0.0422 0.465
hs4 LOC400043 12q13.13 -0.265 0.0422 0.465
swa HINT1 5q31.2 0.265 0.0423 0.465 signal transduction
exp FLJ11292 0.265 0.0423 0.465
swa TARS 5p13.2 0.265 0.0423 0.465 translation;tRNA aminoacylation for
protein translation
his TIMM8A Xq22.1 0.265 0.0423 0.465 chaperone-mediated protein
xai SUSD3 9q22.31 0.265 0.0423 0.465
his IFNAR1 21q22.11 0.265 0.0423 0.465 cytokine-mediated signaling
pathway;positive regulation of interferon-gamma production
his MNDA 1q22 0.265 0.0423 0.465 negative regulation of B cell
proliferation;positive regulation of apoptotic process
exp PPIL4 6q25.1 0.263 0.0423 0.465 protein folding
xsq LEF1-AS1 0.263 0.0423 0.465
exp RIMS2 8q22.3 0.263 0.0423 0.465 intracellular protein transport
xsq METTL8 2q31.1 0.263 0.0423 0.465
exp RPL5P33 17q21.33 0.263 0.0423 0.465
xsq ATXN3 14q21 0.263 0.0423 0.465 DNA Damage Response (DDR)
xsq KCNC4 1p21 0.263 0.0423 0.465 ion transport;potassium ion transport
exp DICER1-AS1 14q32.13 0.263 0.0423 0.465
xsq BCS1L 2q33 0.263 0.0423 0.465 mitochondrion organization;mitochondrial
DNA-dependent"
exp STON2 14q31.1 -0.263 0.0423 0.465 intracellular protein
xsq MATN2 8q22 -0.263 0.0423 0.465
his DCDC2 6p22.1 -0.265 0.0423 0.465 cellular defense
response;nervous system development
xai VTCN1 1p13.1 -0.265 0.0423 0.465 negative regulation of T cell
activation
xai OSCP1 1p34.3 -0.265 0.0423 0.465 transport
xai LDHAL6A 11p15.1 0.265 0.0424 0.465 glycolysis;cellular
swa NAA38 17p13.1 0.265 0.0424 0.465
xai OXSM 3p24.2 0.265 0.0424 0.465 acyl-CoA metabolic process;short-
xai MS4A1 11q12 0.265 0.0424 0.465 immune response;B cell activation
exp HSPA8P16 7q21.11 0.265 0.0424 0.465
his TKFC 0.265 0.0424 0.465 glycerol metabolic process;innate immune
response
his DDB1 11q12-q13 0.265 0.0424 0.465 DNA Damage Response (DDR); DDR
exp SAFB2 19p13.3 0.265 0.0424 0.465 regulation of transcription, DNA-
dependent"
xai LINC00909 18q22.3 0.265 0.0424 0.465
his MIR606 0.265 0.0424 0.465
pro STAT5A_9 0.263 0.0424 0.465
met FHAD1 1p36.21 0.263 0.0424 0.465
xsq SEC31B 10q24.31 0.263 0.0424 0.465 protein transport;vesicle-
mediated transport
xsq NTRK1 1q21-q22 0.263 0.0424 0.465 activation of adenylate cyclase
xsq PRAMEF26 0.263 0.0424 0.465
met CBY3 5q35.3 0.263 0.0424 0.465
xsq PRAMEF16 0.263 0.0424 0.465
xsq C3orf79 3q25.2 0.263 0.0424 0.465
xsq EIF2B5-AS1 0.263 0.0424 0.465
xsq MUC21 6p21.32 0.263 0.0424 0.465 O-glycan processing;post-
xsq FAM74A6 0.263 0.0424 0.465
xsq OR4C11 11q11 0.263 0.0424 0.465 response to stimulus
xsq OR4P4 0.263 0.0424 0.465
xsq KRTAP9-7 0.263 0.0424 0.465
mut TMEM201 1p36.22 0.263 0.0424 0.465
mut ATP13A2 1p36 0.263 0.0424 0.465 cation transport
mut SESN2 1p35.3 0.263 0.0424 0.465 cell cycle arrest
mut EPB41 1p33-p32 0.263 0.0424 0.465 blood circulation;actin
mut TSEN15 1q25 0.263 0.0424 0.465 mRNA processing;tRNA processing
mut CRIM1 2p21 0.263 0.0424 0.465 regulation of cell growth;nervous system
development
mut FIGN 2q24.3 0.263 0.0424 0.465 locomotory behavior
mut ARHGAP24 4q22.1 0.263 0.0424 0.465 cell
differentiation;regulation of small GTPase mediated signal transduction
mut GLRA3 4q34.1 0.263 0.0424 0.465 synaptic transmission;ion
mut CAMK2A 5q32 0.263 0.0424 0.465 synaptic transmission;cytokine-
mut IL6 7p21 0.263 0.0424 0.465 Apoptosis
mut PAFAH1B2 11q23 0.263 0.0424 0.465 lipid metabolic process;lipid
catabolic process
mut CDCA3 12p13 0.263 0.0424 0.465 cell cycle;mitosis
mut OR6C65 0.263 0.0424 0.465
mut CDX2 13q12.3 0.263 0.0424 0.465 regulation of transcription, DNA-
mut OXGR1 13q32.1 0.263 0.0424 0.465 G-protein coupled receptor
signaling pathway
mut GRTP1 13q34 0.263 0.0424 0.465
mut NOXO1 16p13.3 0.263 0.0424 0.465 regulation of respiratory
burst;superoxide metabolic process
mut NOL3 16q22.1 0.263 0.0424 0.465 Apoptosis
mut ADAT1 16q23.1 0.263 0.0424 0.465 RNA processing;tRNA processing
mut DHRS13 17q11.2 0.263 0.0424 0.465
mut CHST9 18q11.2 0.263 0.0424 0.465 proteoglycan biosynthetic
process;glycosaminoglycan metabolic process
mut TUBB4A 19p13.3 0.263 0.0424 0.465 protein folding;microtubule-
based movement
mut HCST 19q13.1 0.263 0.0424 0.465 regulation of immune response
mut ZNF28 19q13.41 0.263 0.0424 0.465 regulation of transcription, DNA-
dependent"
mut U2AF1 21q22.3 0.263 0.0424 0.465 Oncogenes
mut MFNG 22q12 0.263 0.0424 0.465 pattern specification process
mut CDC42EP1 22q13.1 0.263 0.0424 0.465 regulation of cell
mut POU3F4 Xq21.1 0.263 0.0424 0.465 cochlea
morphogenesis;negative regulation of mesenchymal cell apoptosis
xsq LINC01298 0.263 0.0424 0.465
xsq OR6C75 12q13.2 0.263 0.0424 0.465
xsq MAGEA9B 0.263 0.0424 0.465
mut C8B 1p32.2 0.263 0.0424 0.465 immune response;complement
activation
mut NHLH2 1p12-p11 0.263 0.0424 0.465
mut AMOTL2 3q21-q22 0.263 0.0424 0.465
mut SNX24 5q23.2 0.263 0.0424 0.465 cell communication;protein
transport
mut WDR55 5q31.3 0.263 0.0424 0.465 rRNA processing
mut HIST1H4L 6p22.1 0.263 0.0424 0.465
mut TRMT10B 9p13.2 0.263 0.0424 0.465
mut ALDH1B1 9p11.1 0.263 0.0424 0.465 carbohydrate metabolic
process
mut XYLT2 17q21.33 0.263 0.0424 0.465 glycosaminoglycan biosynthetic
process
mut MED25 19q13.3 0.263 0.0424 0.465 negative regulation of
dependent
xsq UCK2 1q23 0.263 0.0424 0.465 response to axon injury;nucleobase-
xsq ACD 16q22.1 0.263 0.0424 0.465 DNA Damage Response (DDR)
xsq SHOX2 3q25.32 -0.263 0.0424 0.465 nervous system
development;heart development
exp RAB11FIP5 2p13 -0.263 0.0424 0.465 protein transport
xsq MAP3K13 3q27 -0.263 0.0424 0.465 Protein Kinases
xai ADRA1B 5q33.3 -0.265 0.0424 0.465 G-protein coupled
his GPR157 1p36.23 -0.265 0.0424 0.465
xai MYLKP1 3p13 -0.265 0.0424 0.465
xai MMP14 14q11.2 -0.265 0.0424 0.465 Apoptosis
his TPRG1-AS1 -0.265 0.0424 0.465
xai LOC100506473 0.265 0.0425 0.465
his ECSIT 19p13.2 0.265 0.0425 0.465 innate immune response;regulation
xai NCF1 7q11.23 0.265 0.0425 0.465 response to yeast;cellular defense
response
his TUT1 11q12.2 0.265 0.0425 0.465 mRNA polyadenylation;mRNA cleavage
exp CYCSP12 3p25.2 0.265 0.0425 0.465
xai CYCSP12 3p25.2 0.265 0.0425 0.465
xai AZU1 19p13.3 0.265 0.0425 0.465 microglial cell activation;positive
regulation of tumor necrosis factor biosynthetic process
his BEX5 Xq22.1 0.265 0.0425 0.465
his CRADD 12q21.33-q23.1 0.265 0.0425 0.465 Apoptosis
his ATF7IP 12p13.1 0.265 0.0425 0.465 negative regulation of
transcription from RNA polymerase II promoter;DNA methylation
his MBD3 19p13.3 0.265 0.0425 0.465 negative regulation of
transcription from RNA polymerase II promoter;in utero embryonic development
xsq SP7 12q13.13 0.263 0.0425 0.465
met FLVCR2 14q24.3 0.263 0.0425 0.465 heme transport;transmembrane
transport
met CASZ1 1p36.22 0.263 0.0425 0.465 regulation of transcription, DNA-
dependent"
xsq PCBP1-AS1 0.263 0.0425 0.465
xsq KLHL32 6q16.1 0.263 0.0425 0.465
exp TRMT61A 14q32 0.263 0.0425 0.465 tRNA processing;tRNA methylation
xsq FAM20C 7p22.3 -0.263 0.0425 0.465
xsq CRELD1 3p25.3 -0.263 0.0425 0.465 endocardial cushion
development;cardiac septum development
exp CAV1 7q31.1 -0.263 0.0425 0.465 vasculogenesis;skeletal
mda CAV1_transcript_expression -0.263 0.0425 0.465
exp LURAP1 1p34 -0.263 0.0425 0.465 positive regulation of
hs4 LOC105373878 -0.265 0.0425 0.465
xai SCAMP4 19p13.3 -0.265 0.0425 0.465 protein transport
xai KIAA1161 9p13.3 -0.265 0.0425 0.465 carbohydrate metabolic
pathway
xai PC 11q13.4-q13.5 -0.265 0.0425 0.465 carbohydrate metabolic
exp GAS6-AS2 -0.265 0.0425 0.465
swa COL4A2 13q34 -0.265 0.0425 0.465 transcription, DNA-
his RINT1 7q22.3 0.265 0.0426 0.465 cell cycle;protein transport
exp RPS18P9 6q25.1 0.265 0.0426 0.465
xai ACVR2B 3p22 0.265 0.0426 0.465 signal
exp PHBP7 9q21 0.265 0.0426 0.465
hs4 LEO1 15q21.2 0.265 0.0426 0.465 regulation of transcription, DNA-
xai TNFRSF17 16p13.1 0.265 0.0426 0.465 multicellular organismal
exp PDE3B 11p15.1 0.263 0.0426 0.465 cellular response to insulin
xsq MRPL48 11q13.4 0.263 0.0426 0.465 translation
xsq DCPS 11q24.2 0.263 0.0426 0.465 deadenylation-dependent decapping
of nuclear-transcribed mRNA;gene expression
met HRASLS 3q29 0.263 0.0426 0.465
met TMEM53 1p34.1 0.263 0.0426 0.465
exp GCFC2 2p12 0.263 0.0426 0.465 regulation of transcription, DNA-
exp TNFRSF10C 8p22-p21 -0.263 0.0426 0.465 Apoptosis
xsq TGFB1I1 16p11.2 -0.263 0.0426 0.465 cell adhesion;ubiquitin-
dependent SMAD protein catabolic process
met CALHM1 10q24.33 -0.263 0.0426 0.465 ion transport
exp FGF12 3q28 -0.263 0.0426 0.465 signal transduction;JNK cascade
exp SLC25A1P1 11q14.2 -0.263 0.0426 0.465
exp RBMS2 12q13.3 -0.263 0.0426 0.465 RNA processing
swa IBA57 1q42.13 -0.265 0.0426 0.465 glycine catabolic
process;heme biosynthetic process
hs4 TGFB1I1 16p11.2 -0.265 0.0426 0.465 cell adhesion;ubiquitin-
exp FLJ38773 -0.265 0.0426 0.465
hs4 SH3RF2 5q32 -0.265 0.0426 0.465 negative regulation of
xai MCAT 22q13.31 0.265 0.0427 0.465 fatty acid biosynthetic
xai LINC00959 10q26.3 0.265 0.0427 0.466
his GPRIN3 4q22.1 0.265 0.0427 0.466
his SPOP 17q21.33 0.265 0.0427 0.466 mRNA processing
his HIST1H2BL 6p22.1 0.265 0.0427 0.466 nucleosome assembly
his HIST1H2AI 6p22.1 0.265 0.0427 0.466
his HIST1H3H 6p22.1 0.265 0.0427 0.466
his HIST1H2AJ 6p22.1 0.265 0.0427 0.466
his HIST1H2BM 6p22.1 0.265 0.0427 0.466 nucleosome assembly
his HIST1H4J 6p22.1 0.265 0.0427 0.466
his HIST1H4K 6p22.1 0.265 0.0427 0.466
his HIST1H2AK 6p22.1 0.265 0.0427 0.466 nucleosome assembly
his HIST1H2BN 6p22.1 0.265 0.0427 0.466 nucleosome assembly
xai MON1B 16q23.1 0.265 0.0427 0.466
xsq MAGEB2 Xp21.3 0.263 0.0427 0.466
xsq CSTF2T 10q11 0.263 0.0427 0.466 mRNA processing
met RASA1 5q13.3 0.263 0.0427 0.466 Apoptosis
xsq PI16 6p21.2 0.263 0.0427 0.466
met SYT7 11q12-q13.1 0.263 0.0427 0.466 plasma membrane repair;regulation
of calcium ion-dependent exocytosis
xsq LYZL6 17q11.2 0.262 0.0427 0.466 metabolic process;cell wall
exp DHRSX Xp22.33 -0.263 0.0427 0.466
exp KCP 7q32.1 -0.263 0.0427 0.466
exp NR2F6 19p13.1 -0.263 0.0427 0.466 gene expression;intracellular
xsq TBX15 1p11.1 -0.263 0.0427 0.466 embryonic cranial skeleton
morphogenesis
xai LIMCH1 4p13 -0.265 0.0427 0.466 actomyosin structure
organization
hs4 FOXO3B 17p11.2 -0.265 0.0427 0.466
hs4 KIAA1644 -0.265 0.0427 0.466
xai DOK7 4p16.3 -0.265 0.0427 0.466 positive regulation of
hs4 EPS8 12p12.3 -0.265 0.0427 0.466 signal transduction;epidermal
xai LINC00977 0.265 0.0428 0.466
hs4 GIMAP7 7q36.1 0.265 0.0428 0.466
his DSCAM 21q22.2 0.265 0.0428 0.466 cell adhesion;dendrite self-
avoidance
xai ANP32A-IT1 15q23 0.265 0.0428 0.466
xai RPL39 Xq24 0.265 0.0428 0.466 translational termination;cellular
his H3F3A 1q42.12 0.265 0.0428 0.466
xai YBEY 21q22.3 0.265 0.0428 0.466
xai CCDC112 5q22.3 0.265 0.0428 0.466
xai NTNG2 9q34 0.265 0.0428 0.466 multicellular organismal
xsq ZNF423 16q12 0.262 0.0428 0.466 cell differentiation;positive
xsq RBMX2 Xq26.1 0.262 0.0428 0.466
xsq FBXO43 8q22.2 0.262 0.0428 0.466 meiosis
exp U2AF1 21q22.3 0.262 0.0428 0.466 Oncogenes
cop LINC00602 6q27 0.262 0.0428 0.466
xsq COX4I1 16q24.1 0.262 0.0428 0.466 generation of precursor
metabolites and energy;response to nutrient
exp TP53INP2 20q11.22 -0.262 0.0428 0.466
xsq MATN3 2p24-p23 -0.262 0.0428 0.466 skeletal system development
xai COPRS 17q11.2 -0.265 0.0428 0.466
xai RPL35P2 6p21.31 0.265 0.0429 0.466
xai SEPT5-GP1BB 0.265 0.0429 0.466
DNA-dependent"
DNA-dependent"
xai COX18 4q13.3 0.265 0.0429 0.466 protein transport;protein insertion
his MIR133A1 0.265 0.0429 0.466
his MIR1-2 0.265 0.0429 0.466
his MIR133A1HG 0.265 0.0429 0.466
his NUP54 4q21.1 0.265 0.0429 0.466 viral reproduction;cytokine-
his SNORD118 0.265 0.0429 0.466
his TMEM107 17p13.1 0.265 0.0429 0.466
his ERCC6L2 9q22.32 0.265 0.0429 0.466 DNA repair
his LINC00476 9q22.32 0.265 0.0429 0.466
his DBF4B 17q21.31 0.265 0.0429 0.466 cell cycle
his LINC00582 1q42.2 0.264 0.0429 0.466
xsq FAM227B 15q21.2 0.262 0.0429 0.466
cop LINC00473 6q27 0.262 0.0429 0.466
xsq AURKAPS1 0.262 0.0429 0.466
xsq GLCCI1 7p21.3 0.262 0.0429 0.466
exp HEATR5B 2p22.2 0.262 0.0429 0.466
exp DHFR 5q11.2-q13.2 0.262 0.0429 0.466
exp KIR2DS2 0.262 0.0429 0.466 immune response;regulation of
immune response
xsq UBR7 14q32.12 0.262 0.0429 0.466
exp KLHL22 22q11.21 -0.262 0.0429 0.466 cell division
exp JDP2 14q24.3 -0.262 0.0429 0.466 negative regulation of
xsq C11orf52 11q23.1 -0.262 0.0429 0.466
exp TAX1BP3 17p13 -0.262 0.0429 0.466 negative regulation of cell
exp FAM200B 4p15.32 -0.262 0.0429 0.466
xsq MIR22HG 17p13.3 -0.262 0.0429 0.466
xai CDK20 9q22.1 -0.265 0.0429 0.466 Protein Kinases
xai TCOF1 5q32 0.264 0.043 0.466 transport;skeletal system development
his TSR2 Xp11.22 0.264 0.043 0.466 rRNA processing
hs4 APRT 16q24 0.264 0.043 0.467 nucleoside metabolic process;purine-containing
compound salvage
his ZNF397 18q12.2 0.264 0.043 0.467 viral reproduction
xai PPHLN1 12q12 0.264 0.043 0.467 keratinization
swa HMGB2 4q31 0.264 0.043 0.467 DNA Damage Response (DDR); DDR (BER)
his CDK5RAP3 17q21.32 0.264 0.043 0.467 regulation of cyclin-dependent
protein kinase activity;brain development
xsq RPL17-C18orf32 0.262 0.043 0.466
met LINC01587 0.262 0.043 0.467
exp RNF20 9q22 0.262 0.043 0.467 regulation of transcription, DNA-
met GOLGA3 12q24.33 0.262 0.043 0.467 intra-Golgi vesicle-mediated
transport
xsq MCMBP 10q26.11 0.262 0.043 0.467 sister chromatid cohesion;mitosis
exp SCYL1 11q13 -0.262 0.043 0.467 regulation of transcription, DNA-
dependent;retrograde vesicle-mediated transport, Golgi to ER
exp SOD3 4p15.2 -0.262 0.043 0.467 removal of superoxide
exp CTNNB1 3p21 -0.262 0.043 0.467 Apoptosis; Cell Signaling;
Oncogenes
exp GSN 9q33 -0.262 0.043 0.467 cell projection organization;response to
folic acid
xsq FAM132B 2q37.3 -0.262 0.043 0.467
swa KDELC2 11q22.3 -0.264 0.043 0.467
exp ZDHHC1 16q22.1 -0.264 0.043 0.467 protein palmitoylation
xai PRKCDBP 11p15.4 -0.264 0.043 0.467
xai ARFGEF1 8q13 -0.264 0.043 0.467 exocytosis;regulation of ARF
xai MPI 15q24.1 0.264 0.0431 0.467 carbohydrate metabolic
process;dolichol-linked oligosaccharide biosynthetic process
xai AIFM1 Xq26.1 0.264 0.0431 0.467 Apoptosis
xai PHBP7 9q21 0.264 0.0431 0.467
xai LARS2 3p21.3 0.264 0.0431 0.467 tRNA aminoacylation for protein
translation;leucyl-tRNA aminoacylation
his TMEM219 16p11.2 0.264 0.0431 0.467
hs4 SIVA1 14q32.33 0.264 0.0431 0.467 Apoptosis
xai HNRNPA0 5q31 0.264 0.0431 0.467 response to lipopolysaccharide;3'-
xai OMA1 1p32.2-p32.1 0.264 0.0431 0.467 proteolysis
his SEC63 6q21 0.264 0.0431 0.467 protein folding;protein targeting to
membrane
met PDLIM3 4q35 0.262 0.0431 0.467 actin filament organization;heart
development
xsq RCOR1 14q32.31 0.262 0.0431 0.467 interspecies interaction between
exp HDDC3 15q26.1 0.262 0.0431 0.467 guanosine tetraphosphate metabolic
process
xsq H2BFM Xq22.2 0.262 0.0431 0.467
xsq C12orf65 12q24.31 0.262 0.0431 0.467 translational termination
exp MED12 Xq13 0.262 0.0431 0.467 Oncogenes
cop DSC3 18q12.1 0.262 0.0431 0.467 cell adhesion;homophilic cell
adhesion
met PIP5K1P1 6p24.3 0.262 0.0431 0.467
exp FAM27E4 9p11.2 0.262 0.0431 0.467
met ARHGEF37 5q32 0.262 0.0431 0.467 regulation of Rho protein signal
transduction
exp ATP6V1E1P1 1p34.2 -0.262 0.0431 0.467
hs4 GRINA 8q24.3 -0.264 0.0431 0.467
his KLHL29 2p24.1 -0.264 0.0431 0.467
his LINC00601 -0.264 0.0431 0.467
exp EIF3KP1 5q21.1 -0.264 0.0431 0.467
his EEF1AKMT1 0.264 0.0432 0.467
xai THYN1 11q25 0.264 0.0432 0.467
DNA-dependent"
hs4 PIGV 1p36.11 0.264 0.0432 0.467 GPI anchor biosynthetic
process;preassembly of GPI anchor in ER membrane
DNA-dependent"
xai NOP9 14q12 0.264 0.0432 0.467
dependent"
xai WDR48 3p21.33 0.264 0.0432 0.467 DNA Damage Response (DDR); DDR (FA)
his ISL2 15q23 0.264 0.0432 0.467 multicellular organismal
xai NDUFA1 Xq24 0.264 0.0432 0.467 mitochondrial electron transport,
xsq GTF3A 13q12.3-q13.1 0.262 0.0432 0.467 gene expression;regulation of
met OR13A1 10q11.21 0.262 0.0432 0.467
exp CTR9 11p15.3 0.262 0.0432 0.467 histone monoubiquitination;histone
H2B ubiquitination
exp NPM1P6 8q12.2 0.262 0.0432 0.467
exp ANP32AP1 15q14 0.262 0.0432 0.467
xsq KRTAP6-3 0.262 0.0432 0.467
exp ASAH1 8p22 -0.262 0.0432 0.467 lipid metabolic
exp CPEB2 4p15.33 -0.262 0.0432 0.467 regulation of translation
exp LOC100506621 -0.262 0.0432 0.467
met ERMN 2q24.1 -0.262 0.0432 0.467 morphogenesis of a branching
structure;actin filament organization
xsq PDCD1LG2 9p24.2 -0.262 0.0432 0.467 immune response;T cell
costimulation
xai FLVCR2 14q24.3 -0.264 0.0432 0.467 heme
his MT1B 16q13 -0.264 0.0432 0.467 negative regulation of
his SNORD130 -0.264 0.0432 0.467
xai DNAJC17 15q15.1 0.264 0.0433 0.468 protein folding
met GRIA2 4q32.1 0.262 0.0433 0.468 synaptic transmission;ion transport
exp IGLL5 0.262 0.0433 0.468
exp ICAM5 19p13.2 0.262 0.0433 0.468 cell-cell adhesion
cop HSD3B7 16p11.2 0.262 0.0433 0.468 bile acid biosynthetic
process;bile acid metabolic process
xsq ANAPC1 2q12.1 0.262 0.0433 0.468 mitotic cell cycle;protein
exp HENMT1 1p13.3 0.262 0.0433 0.468 RNA methylation;gene
silencing by RNA
met CCDC57 17q25.3 0.262 0.0433 0.468
xsq PSMB11 14q11.2 0.262 0.0433 0.468
xsq LEAP2 5q31.1 0.262 0.0433 0.468 defense response to bacterium
mut ADCY4 14q12 0.262 0.0433 0.468 energy reserve metabolic
process;inhibition of adenylate cyclase activity by G-protein signaling pathway
exp RPL35AP17 0.262 0.0433 0.468
xsq YBX1 1p34 0.262 0.0433 0.468 DNA Damage Response (DDR)
xsq RABEPK 9q33.3 0.262 0.0433 0.468 receptor-mediated
exp MAP4K4 2q11.2-q12 -0.262 0.0433 0.468 response to
exp STC2 5q35.1 -0.262 0.0433 0.468 cell surface receptor
signaling pathway;cell-cell signaling
his PNPLA3 22q13.31 -0.264 0.0433 0.468 triglyceride catabolic
xai RNF130 5q35.3 -0.264 0.0433 0.468 Apoptosis
hs4 SEMA3C 7q21-q31 -0.264 0.0433 0.468 blood vessel
remodeling;neural tube development
hs4 MSX1 4p16.2 -0.264 0.0433 0.468 multicellular organismal
xai CHIAP2 1p13.2 -0.264 0.0433 0.468
xai AKAP14 Xq24 -0.264 0.0433 0.468 spermatogenesis
xai ITGB3 17q21.32 -0.264 0.0433 0.468 integrin-mediated signaling
signaling pathway
xai JCHAIN 0.264 0.0434 0.468 immune response
his FANCA 16q24.3 0.264 0.0434 0.468 DNA Damage Response (DDR); DDR (FA)
swa GSPT1 16p13.1 0.264 0.0434 0.468 G1/S transition of mitotic cell
cycle;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
xai RPS18P9 6q25.1 0.264 0.0434 0.468
xai DNAJC9 10q22.2 0.264 0.0434 0.468 protein folding;social
behavior
his CD1D 1q23.1 0.264 0.0434 0.468 T cell selection;positive
met SLIT2 4p15.2 0.262 0.0434 0.468 cell migration involved in
sprouting angiogenesis;negative regulation of smooth muscle cell migration
xsq PLGLB1 0.262 0.0434 0.468
exp FANCA 16q24.3 0.262 0.0434 0.468 DNA Damage Response (DDR); DDR (FA)
met MIR519C 0.262 0.0434 0.468
xsq BBOX1 11p14.2 -0.262 0.0434 0.468 cellular nitrogen compound
xai FLJ38773 -0.264 0.0434 0.468
his MIR4711 -0.264 0.0434 0.468
his ITPRIPL1 2q11.2 0.264 0.0435 0.468
his NCAPH 2q11.2 0.264 0.0435 0.468 DNA Damage Response (DDR)
xai SV2B 15q26.1 0.264 0.0435 0.468 neurotransmitter transport
xai KIAA1324L 7q21.12 0.264 0.0435 0.468
xai KBTBD6 13q14.11 0.264 0.0435 0.468
xai GAPDHP32 1p12 0.264 0.0435 0.468
xai TYMSOS 0.264 0.0435 0.468
xai RPS21 20q13.3 0.264 0.0435 0.468 endonucleolytic cleavage in ITS1 to
cop MIR1185-1 0.264 0.0435 0.468
cop MIR1185-2 0.264 0.0435 0.468
cop MIR381 0.264 0.0435 0.468
cop MIR487B 0.264 0.0435 0.468
xai EIF4EBP2 10q21-q22 0.264 0.0435 0.468 negative regulation of
translational initiation;translation
xai FKBP4 12p13.33 0.264 0.0435 0.469 peptidyl-proline
met MYH2 17p13.1 0.262 0.0435 0.468 muscle contraction;muscle filament
sliding
met FAM63A 1q21.3 0.262 0.0435 0.468
met OPRM1 6q24-q25 0.262 0.0435 0.468 sensory perception;negative
regulation of nitric oxide biosynthetic process
xsq TCERG1L 10q26.3 0.262 0.0435 0.468
xsq PLK4 4q28 0.262 0.0435 0.468 Protein Kinases
xsq TMEM186 16p13.2 0.262 0.0435 0.469
mut MARK1 1q41 0.262 0.0435 0.469 Wnt receptor signaling
pathway;microtubule cytoskeleton organization
exp SNX16 8q21.13 -0.262 0.0435 0.469 protein targeting to
xsq CAPSL 5p13.2 -0.262 0.0435 0.469
xsq LOC102723809 -0.262 0.0435 0.468
exp LOC100288712 7p22.1 -0.262 0.0435 0.468
xsq TLR3 4q35 -0.262 0.0435 0.468 activation of NF-kappaB-inducing
exp LOC646730 3q23 -0.264 0.0435 0.469
hs4 LOC100506178 -0.264 0.0435 0.469
exp APOA5 11q23 -0.264 0.0435 0.468 response to hormone
stimulus;cholesterol homeostasis
his LOC105376554 -0.264 0.0435 0.468
xai GAS6-AS2 -0.264 0.0435 0.468
his C9orf131 9p13.3 -0.264 0.0435 0.468
xai SPG20 13q13.3 -0.264 0.0435 0.468 EMT (Mesenchymal)
his CA11 19q13.3 0.264 0.0436 0.469
exp RPL26P37 0.264 0.0436 0.469
his E2F1 20q11.2 0.264 0.0436 0.469 Apoptosis; Tumor Suppressors
his MRPL45 17q21.2 0.264 0.0436 0.469 translation;intracellular
protein transport
his MPEG1 11q12.1 0.264 0.0436 0.469
xai LINC00938 12q12 0.264 0.0436 0.469
xai HDAC2 6q21 0.264 0.0436 0.469 negative regulation of neuron projection
xsq POLRMT 19p13.3 0.262 0.0436 0.469 transcription from
exp USMG5 10q24.33 0.261 0.0436 0.469
xsq RMI2 16p13.13 0.261 0.0436 0.469 DNA Damage Response (DDR); DDR (FA)
exp DUSP10 1q41 -0.261 0.0436 0.469 JNK cascade;response to
organic substance
hs4 KIAA1217 10p12.31 -0.264 0.0436 0.469 multicellular organismal
his DVL3 3q27 -0.264 0.0436 0.469 Wnt receptor signaling pathway;Wnt
his ZSWIM4 19p13.13 -0.264 0.0436 0.469
xai RIPK4 21q22.3 -0.264 0.0436 0.469
swa SEC24C 10q22.2 -0.264 0.0436 0.469 post-translational
protein modification;cellular protein metabolic process
swa HEBP1 12p13.1 -0.264 0.0436 0.469 circadian rhythm
hs4 GIMAP8 7q36.1 0.264 0.0437 0.469
xai SLAMF6 1q23.2 0.264 0.0437 0.47
his MMP23B 1p36.3 0.264 0.0437 0.47 Apoptosis
his KIF21B 1q32.1 0.264 0.0437 0.47 microtubule-based movement
xai MAK16 8p12 0.264 0.0437 0.47 translation
xsq TAF4 20q13.33 0.261 0.0437 0.469 ovarian follicle
exp BCKDHB 6q14.1 0.261 0.0437 0.469 response to nutrient;branched
exp NDUFV2 18p11.22 0.261 0.0437 0.469 mitochondrial electron
xsq RNASEH2B 13q14.3 0.261 0.0437 0.469 DNA Damage Response (DDR);
exp WRAP53 17p13.1 0.261 0.0437 0.469 DNA Damage Response (DDR)
exp DBF4 7q21.3 0.261 0.0437 0.469 DDR (DNA replication)
xsq AQP3 9p13 0.261 0.0437 0.469 urea transport;response to retinoic acid
met MS4A2 11q12-q13 0.261 0.0437 0.469 activation of protein kinase C
activity by G-protein coupled receptor protein signaling pathway;cell proliferation
xsq SKAP2 7p15.2 -0.261 0.0437 0.47 negative regulation of cell
xsq MYBL1 8q13.1 -0.261 0.0437 0.47 regulation of transcription,
xsq DDR2 1q23.3 -0.261 0.0437 0.469 peptidyl-tyrosine
factor activity
exp CDRT1 17p12 -0.261 0.0437 0.469
xai KIAA1683 19p13.1 -0.264 0.0437 0.47
his PRICKLE2 3p14.1 -0.264 0.0437 0.47 neuron projection
swa FLOT1 6p21.3 -0.264 0.0437 0.469
hs4 RRAS2 11p15.2 -0.264 0.0437 0.469 GTP catabolic process;signal
transduction
hs4 CASC8 8q24.21 -0.264 0.0437 0.469
xai ISM1 20p12.1 -0.264 0.0437 0.469
exp LOC100506473 0.263 0.0438 0.47
swa EIF2D 1q32.1 0.263 0.0438 0.47 translational
initiation;intracellular protein transport
his LOC100130452 0.263 0.0438 0.47
his NGLY1 3p24.2 0.263 0.0438 0.47 glycoprotein catabolic process
his OXSM 3p24.2 0.263 0.0438 0.47 acyl-CoA metabolic process;short-
xai SKA3 13q12.11 0.263 0.0438 0.47 chromosome segregation;mitosis
his GPX7 1p32 0.263 0.0438 0.47 response to oxidative stress
his TRPM6 9q21.13 0.263 0.0438 0.47 ion transport;response to toxin
his GEMIN2 14q13 0.263 0.0438 0.47 RNA metabolic process;ncRNA
metabolic process
xsq DFNB59 2q31.2 0.261 0.0438 0.47 sensory perception of sound
met OGG1 3p26.2 0.261 0.0438 0.47 DNA Damage Response (DDR); DDR
(BER)
exp GPANK1 6p21.3 0.261 0.0438 0.47
exp AP4B1 1p13.2 0.261 0.0438 0.47 intracellular protein
xsq ELP2 18q12.2 0.261 0.0438 0.47 regulation of transcription from
RNA polymerase II promoter;transcription elongation from RNA polymerase II promoter
xsq GEMIN6 2p22.1 0.261 0.0438 0.47 RNA splicing;gene expression
met FAM196B 5q35.1 0.261 0.0438 0.47
xsq STC2 5q35.1 -0.261 0.0438 0.47 cell surface receptor
xsq HTRA1 10q26.3 -0.261 0.0438 0.47 regulation of cell
growth;proteolysis
exp GLRB 4q31.3 -0.261 0.0438 0.47 startle response;ion
xai CLN5 13q21.1-q32 -0.263 0.0438 0.47 cell death;neurogenesis
xai STC2 5q35.1 -0.263 0.0438 0.47 cell surface receptor
exp CBX3P4 -0.263 0.0438 0.47
xai CBX3P4 -0.263 0.0438 0.47
swa PPP1CB 2p23 -0.263 0.0438 0.47 cell cycle;triglyceride
catabolic process
xai TNFRSF10C 8p22-p21 -0.263 0.0438 0.47 Apoptosis
his SNORA92 -0.263 0.0438 0.47
his LOC401312 -0.263 0.0438 0.47
his RPS27A 2p16 0.263 0.0439 0.47 activation of MAPK activity;MyD88-
his CLHC1 2p16.1 0.263 0.0439 0.47
xai PSTPIP1 15q24.3 0.263 0.0439 0.47 cell adhesion;signal
transduction
exp MGAT4C 12q21 0.263 0.0439 0.47 cellular protein metabolic
his SDF4 1p36.33 0.263 0.0439 0.47 response to ethanol;zymogen granule
exocytosis
his B3GALT6 1p36.33 0.263 0.0439 0.47 protein
glycosylation;glycosaminoglycan biosynthetic process
exp C10orf113 10p12.31 0.263 0.0439 0.47
his HDGFRP2 19p13.3 0.263 0.0439 0.47
xai NDUFA7 19p13.2 0.263 0.0439 0.47 mitochondrial electron
exp LINC01012 0.263 0.0439 0.47
xai IGLC4 0.263 0.0439 0.47
hs4 MIR4513 0.263 0.0439 0.47
met MYH8 17p13.1 0.261 0.0439 0.47 muscle filament sliding;muscle
contraction
xsq LAGE3 Xq28 0.261 0.0439 0.47
xsq ITGB3 17q21.32 -0.261 0.0439 0.47 integrin-mediated signaling
signaling pathway
exp FNDC3B 3q26.31 -0.261 0.0439 0.47
xsq ELOVL7 5q12.1 -0.261 0.0439 0.47 small molecule metabolic
his ZNF578 19q13.41 -0.263 0.0439 0.47 regulation of
hs4 SPEF1 20p13 -0.263 0.0439 0.47
his PPP1R14C 6q24.3-q25.3 -0.263 0.0439 0.47 regulation of
phosphorylation
his SIGLEC9 19q13.41 -0.263 0.0439 0.47 cell adhesion;cell
xai PCA3 -0.263 0.0439 0.47
xai NIP7P2 3q22.1 0.263 0.044 0.47
xai KLHL12 1q32.1 0.263 0.044 0.47 Wnt receptor signaling pathway
his VSX1 20p11.21 0.263 0.044 0.47 neuron maturation;response to stimulus
swa CCDC12 3p21.31 0.263 0.044 0.47
his MARCH7 2q24.2 0.263 0.044 0.47
xsq SDHB 1p36.1-p35 0.261 0.044 0.47 tricarboxylic acid cycle;succinate
metabolic process
xsq HIST1H2BI 6p22.1 0.261 0.044 0.47
xsq TRAPPC8 18q12.1 0.261 0.044 0.47 vesicle-mediated transport;ER to
xsq NAA25 12q24.13 0.261 0.044 0.47
xsq CASC11 0.261 0.044 0.47
xsq DHX30 3p21.31 0.261 0.044 0.47
met FUCA1 1p34 0.261 0.044 0.47 carbohydrate metabolic process;fucose metabolic
process
met TRUB2 9q34.11 0.261 0.044 0.47 RNA processing;tRNA processing
xsq ME2 18q21 0.261 0.044 0.47 malate metabolic process
xsq LILRA2 19q13.4 0.261 0.044 0.47 defense response;signal
transduction
exp SUV39H2 10p13 0.261 0.044 0.47 chromatin assembly or
disassembly;chromatin remodeling
exp HMBS 11q23.3 0.261 0.044 0.47 porphyrin-containing compound metabolic
process;response to nutrient levels
met MARCH11 5p15.1 0.261 0.044 0.471
xsq HIF1A-AS1 -0.261 0.044 0.471
met PRM3 16p13.3 -0.261 0.044 0.47 multicellular organismal
met TEX10 9q31.1 -0.261 0.044 0.47
exp OR5M12P 11q12.1 -0.263 0.044 0.471
his SYNJ2-IT1 -0.263 0.044 0.47
his LOC105369739 -0.263 0.044 0.47
xai CAPG 2p11.2 -0.263 0.044 0.47 protein complex assembly;cell
projection assembly
hs4 TBX21 17q21.32 0.263 0.0441 0.471 positive regulation of
transcription, DNA-dependent;positive regulation of isotype switching to IgG
isotypes
xai CYB5RL 1p32.3 0.263 0.0441 0.471
his LOC650226 7p11.2 0.263 0.0441 0.471
his CHD3 17p13.1 0.263 0.0441 0.471 regulation of transcription, DNA-
xai RPP25L 9p13.3 0.263 0.0441 0.471
xai CARNS1 11q13.2 0.263 0.0441 0.471 carnosine biosynthetic
process
xai ZBTB24 6q21 0.263 0.0441 0.471 regulation of transcription, DNA-
dependent"
DNA-dependent;positive regulation of transcription from RNA polymerase II promoter"
xai ARHGAP15 2q22.2-q22.3 0.263 0.0441 0.471 regulation of small
xai FPGS 9q34.1 0.263 0.0441 0.471 water-soluble vitamin metabolic
xai ZNF831 20q13.32 0.263 0.0441 0.471
xsq CRAT37 0.261 0.0441 0.471
exp MRPL20 1p36.3-p36.2 0.261 0.0441 0.471 translation
xsq RGPD1 0.261 0.0441 0.471
exp PMPCA 9q34.3 0.261 0.0441 0.471 proteolysis
met WBP2NL 22q13.2 0.261 0.0441 0.471 meiosis;egg activation
xsq DNAJC7 17q11.2 0.261 0.0441 0.471 protein folding;chaperone
met MIR150 -0.261 0.0441 0.471
hs4 TSPOAP1-AS1 -0.263 0.0441 0.471
hs4 ROS1 6q22 -0.263 0.0441 0.471 spermatogenesis;cell proliferation
xai SEMA3B 3p21.3 -0.263 0.0441 0.471 axon guidance;cell-cell
signaling
xai LYPD6 2q23.2 -0.263 0.0441 0.471
swa MMGT1 Xq26.3 -0.263 0.0441 0.471 transport;magnesium ion
transport
his RTBDN 19p12 0.263 0.0442 0.471
his MAST1 19p13.2 0.263 0.0442 0.471 cytoskeleton
organization;intracellular protein kinase cascade
xai LOC100507046 0.263 0.0442 0.471
his ZSCAN2 15q25.2 0.263 0.0442 0.471 cell
his CCDC94 19p13.3 0.263 0.0442 0.471
swa ISOC1 5q22.1-q33.3 0.263 0.0442 0.471
hs4 THSD7B 2q22.1 0.263 0.0442 0.471
exp KLRC1 12p13 0.261 0.0442 0.471 regulation of immune response;cell
exp LINC00977 0.261 0.0442 0.471
exp CCDC180 0.261 0.0442 0.471
exp ZRANB2 1p31 0.261 0.0442 0.471 regulation of transcription, DNA-
xsq PRDM8 4q21 0.261 0.0442 0.471 regulation of transcription, DNA-
dependent"
cop TRAF3 14q32.32 0.261 0.0442 0.471 Apoptosis
met PAK1IP1 6p24.2 0.261 0.0442 0.471 negative regulation of signal
transduction
mut ANKRD11 16q24.3 0.261 0.0442 0.471 in utero embryonic
development;tissue homeostasis
met JAG1 20p12.1-p11.23 0.261 0.0442 0.471 cell communication;regulation
of cell migration
xsq PVRIG 7q22.1 0.261 0.0442 0.471
cop TAS2R1 5p15 -0.261 0.0442 0.471 response to
stimulus;detection of chemical stimulus involved in sensory perception of taste
cop SEMA5A 5p15.2 -0.261 0.0442 0.471 cell
exp RGS3 9q32 -0.263 0.0442 0.471 inactivation of MAPK
hs4 FLRT3 20p11 -0.263 0.0442 0.471 cell adhesion
swa NEFL 8p21 -0.263 0.0442 0.471 axon transport of
mitochondrion;neurofilament bundle assembly
exp LOC101060376 -0.263 0.0442 0.471
his ID4 6p22.3 -0.263 0.0442 0.471 negative regulation of
transcription from RNA polymerase II promoter;cellular protein localization
his ARHGAP20 11q23.1 -0.263 0.0442 0.471 signal
his PLA2G16 11q12.3 -0.263 0.0442 0.471 phospholipid metabolic
hs4 MGAT4D 0.263 0.0443 0.471
his ADD1 4p16.3 0.263 0.0443 0.471 cellular component disassembly
involved in apoptosis;activation of signaling protein activity involved in unfolded
protein response
his DENND4B 1q21 0.263 0.0443 0.471
xai TNF 6p21.3 0.263 0.0443 0.471 Apoptosis
his POMT1 9q34.1 0.263 0.0443 0.471 extracellular matrix
organization;carbohydrate metabolic process
xai NF1P8 2q21.1 0.263 0.0443 0.472
exp NUP160 11p11.2 0.261 0.0443 0.471 hexose transport;regulation
exp C21orf58 21q22.3 0.261 0.0443 0.472
xsq XRCC6 22q13.2 0.261 0.0443 0.472 DNA Damage Response (DDR); DDR
(NHEJ)
exp KANK1 9p24.3 -0.261 0.0443 0.472 negative regulation of actin
filament polymerization
xsq IL17RC 3p25.3 -0.261 0.0443 0.472
pro KRT8 12q13 -0.261 0.0443 0.471 cytoskeleton
organization;interspecies interaction between organisms
met PLIN2 9p22.1 -0.261 0.0443 0.471 lipid storage;response to
drug
xsq UPK3B 7q11.2 -0.261 0.0443 0.471 negative regulation of gene
expression
his BTBD16 10q26.13 -0.263 0.0443 0.472
his SHROOM1 5q31.1 -0.263 0.0443 0.472 cell morphogenesis;actin
his FAM84B 8q24.21 -0.263 0.0443 0.471
xai PITPNM3 -0.263 0.0443 0.471
his MYO10 5p15.1-p14.3 -0.263 0.0443 0.471 axon guidance;regulation
of cell shape
xai CCDC58 3q21.1 0.263 0.0444 0.472
xai PVALB 22q13.1 0.263 0.0444 0.472
xai CHORDC2P 14q32.11 0.263 0.0444 0.472
xai HSPA8P20 Xq25 0.263 0.0444 0.472
exp MRPS35 12p11 0.261 0.0444 0.472 peptide biosynthetic process;DNA
damage response, detection of DNA damage"
xsq DCAF4L1 4p13 0.261 0.0444 0.472
met C16orf62 16p12.3 0.261 0.0444 0.472
xsq IL10RA 11q23 0.261 0.0444 0.472 signal transduction
xsq DDX6 11q23.3 0.261 0.0444 0.472 nuclear-transcribed mRNA catabolic
exp ISM1 20p12.1 -0.261 0.0444 0.472
xai ROR1 1p32-p31 -0.263 0.0444 0.472 transmembrane receptor
his TGFB1I1 16p11.2 -0.263 0.0444 0.472 cell adhesion;ubiquitin-
swa DHX9 1q25 -0.263 0.0444 0.472 nuclear mRNA splicing, via
xai SPIRE1 18p11.21 -0.263 0.0444 0.472 transport
xai SPTLC3 20p12.1 -0.263 0.0444 0.472 small molecule metabolic
exp HIST1H4L 6p22.1 0.263 0.0445 0.472
xai RPSAP63 Xq26.2 0.263 0.0445 0.472
exp LOC100133089 0.263 0.0445 0.472
hs4 PVALB 22q13.1 0.263 0.0445 0.472
his SLC38A2 12q 0.263 0.0445 0.472 Solute Carriers
his SGO2 0.263 0.0445 0.472
xai MYH15 3q13.13 0.263 0.0445 0.472
his MIR4265 0.263 0.0445 0.472
his UBQLN4 1q21 0.263 0.0445 0.472 regulation of proteasomal
his LAMTOR2 1q22 0.263 0.0445 0.472 cell growth;positive regulation of
TOR signaling cascade
his ZC3H18 16q24.2 0.263 0.0445 0.472
xai TTLL12 22q13.31 0.263 0.0445 0.472 protein modification process
xai PPTC7 12q24.11 0.263 0.0445 0.472
exp GPATCH8 17q21.31 0.26 0.0445 0.472
xsq MTHFD2L 4q13.3 0.26 0.0445 0.472 methionine biosynthetic
exp CCZ1B 7p22.1 0.26 0.0445 0.472
met PVR 19q13.2 0.26 0.0445 0.472 cell junction assembly;adherens
xsq C1orf174 1p36.32 0.26 0.0445 0.472
xsq GUCY1B3 4q31.3-q33 -0.26 0.0445 0.472 nitric oxide mediated signal
exp ZNF702P 19q13.41 -0.26 0.0445 0.472 regulation of transcription,
DNA-dependent"
pro FN1 2q34 -0.26 0.0445 0.472 response to wounding;cell migration
exp GUCY1B3 4q31.3-q33 -0.26 0.0445 0.472 nitric oxide mediated signal
his LOC285593 5q35.2 -0.263 0.0445 0.472
hs4 BRI3 7q21.3 -0.263 0.0445 0.472
swa MRPL17 11p15.5-p15.4 -0.263 0.0445 0.472 translation
hs4 KAZN 1p36.21 -0.263 0.0445 0.472 keratinization
his RTN4RL2 11q12.1 0.263 0.0446 0.473 axon regeneration
exp NPM1P35 11q12.3 0.263 0.0446 0.473
his NDUFV2-AS1 0.263 0.0446 0.473
his ANKRD12 18p11.22 0.263 0.0446 0.473
his CXXC1 18q12 0.263 0.0446 0.473 regulation of transcription, DNA-
response
exp RPL5P20 6p22.3 0.262 0.0446 0.473
his PBXIP1 1q21.3 0.262 0.0446 0.473 negative regulation of
xai DHFR 5q11.2-q13.2 0.262 0.0446 0.473
xai SETP4 Xq21.1 0.262 0.0446 0.473
xai TRNW 0.262 0.0446 0.473
his CD200R1L 3q13.2 0.262 0.0446 0.473
dependent"
exp ZNF518A 10q24.1 0.26 0.0446 0.473 regulation of transcription,
DNA-dependent"
xsq MAD2L2 1p36 0.26 0.0446 0.473 DNA Damage Response (DDR); DDR (DNA
exp SNU13 0.26 0.0446 0.473 gene expression;ribosome biogenesis
xsq HNRNPA0 5q31 0.26 0.0446 0.473 response to lipopolysaccharide;3'-
exp PSMD7 16q22.3 0.26 0.0446 0.473 protein polyubiquitination;gene
expression
xsq SF3B5 6q24.2 0.26 0.0446 0.473 nuclear mRNA splicing, via
xsq KCP 7q32.1 -0.26 0.0446 0.473
xai TRIM32 9q33.1 -0.262 0.0446 0.473 response to tumor
necrosis factor;positive regulation of proteolysis
xai FAM71F1 7q32.1 -0.263 0.0446 0.473
xai C17orf62 17q25.3 0.262 0.0447 0.473
xai SHPK 17p13 0.262 0.0447 0.473 carbohydrate metabolic process
hs4 CX3CR1 3p21.3 0.262 0.0447 0.473 negative regulation of
xai GAPDHP40 5q33.3 0.262 0.0447 0.473
xai LINC00339 1p36.12 0.262 0.0447 0.473
hs4 MB21D1 6q13 0.262 0.0447 0.473 response to virus
xai DICER1-AS1 14q32.13 0.262 0.0447 0.473
xsq AP1AR 4q25 0.26 0.0447 0.473 protein transport
mut SPATA31E1 9q22.1 0.26 0.0447 0.473
met NLRP8 19q13.43 0.26 0.0447 0.473
cop TMEM242 6q25.3 0.26 0.0447 0.473
cop C11orf24 11q13 0.26 0.0447 0.473
xsq SH2D4A 8p21.2 -0.26 0.0447 0.473 negative regulation of
met GLI1 12q13.2-q13.3 -0.26 0.0447 0.473 multicellular organismal
exp TSPAN6 Xq22 -0.26 0.0447 0.473 signal transduction;positive
xai CERS1 19p12 -0.262 0.0447 0.473 small molecule metabolic
xai SKP1 5q31 -0.262 0.0447 0.473 Apoptosis
his TTYH3 7p22 -0.262 0.0447 0.473 ion transport;chloride transport
exp IPO8P1 -0.262 0.0447 0.473
hs4 TRPM3 9q21.12 -0.262 0.0447 0.473 cation
his PPIH 1p34.1 0.262 0.0448 0.473 nuclear mRNA splicing, via
hs4 CELF2-AS1 0.262 0.0448 0.473
xai TAF1 Xq13.1 0.262 0.0448 0.473 regulation of transcription
involved in G2/M-phase of mitotic cell cycle;gene expression
xai CCDC124 19p13.11 0.262 0.0448 0.474
his ANKRD20A1 0.262 0.0448 0.474
xai CFDP1 16q22.2-q22.3 0.262 0.0448 0.474 regulation of cell
exp NPM1P2 18q11.2 0.262 0.0448 0.474
exp GAPDHP73 6q23.3 0.26 0.0448 0.474
exp HTRA2 2p12 0.26 0.0448 0.474 Apoptosis
met HSPB8 12q24.23 0.26 0.0448 0.474 response to stress;cell death
xsq CTTN 11q13 -0.26 0.0448 0.474
exp FRMD6 14q22.1 -0.26 0.0448 0.474
exp ABLIM3 5q32 -0.26 0.0448 0.474 cytoskeleton organization;axon
guidance
xsq RDX 11q23 -0.26 0.0448 0.473 microvillus assembly;apical protein
localization
exp CACNB4 2q22-q23 -0.26 0.0448 0.473 synaptic transmission;axon
guidance
xai UGGT2 13q32.1 -0.262 0.0448 0.474 protein folding;protein
glycosylation
xai NPM1P2 18q11.2 0.262 0.0449 0.474
swa S100A9 1q21 0.262 0.0449 0.474 signal transduction;cell-cell
signaling
exp RPL15P2 14q32.13 0.262 0.0449 0.474
his RRP7BP 0.262 0.0449 0.474
exp TRNW 0.262 0.0449 0.474
his KIAA1429 8q22.1 0.262 0.0449 0.474 RNA splicing;mRNA processing
xsq RIOK2 5q15 0.26 0.0449 0.474 protein phosphorylation
xsq MGC45922 0.26 0.0449 0.474
xsq NTHL1 16p13.3 0.26 0.0449 0.474 DNA Damage Response (DDR); DDR
(BER)
exp ABT1 6p22.2 0.26 0.0449 0.474 regulation of transcription from
exp CACNA1B 9q34 0.26 0.0449 0.474 transmembrane transport;transport
xsq IFIT5 10q23.31 -0.26 0.0449 0.474
xsq MCC 5q21 -0.26 0.0449 0.474 signal transduction;negative regulation
of epithelial cell migration
xai FAM189A1 15q13.1 -0.262 0.0449 0.474
his COL4A1 13q34 -0.262 0.0449 0.474 epithelial cell
his COL4A2 13q34 -0.262 0.0449 0.474 transcription, DNA-
hs4 L3MBTL1 20q13.12 -0.262 0.0449 0.474 regulation of
mitosis;chromatin modification
xai PICALM 11q14 -0.262 0.0449 0.474 vesicle-mediated
transport;clathrin coat assembly
his PHF12 17q11.2 0.262 0.045 0.474 negative regulation of transcription,
DNA-dependent"
xai CD69 12p13 0.262 0.045 0.475 cellular response to drug
hs4 RHOG 11p15.5-p15.4 0.262 0.045 0.475 small GTPase mediated signal
his ZNF215 11p15.4 0.262 0.045 0.475 regulation of transcription, DNA-
dependent;viral reproduction"
exp HAAO 2p21 0.262 0.045 0.475 small molecule metabolic process;response to
cadmium ion
xai PPIAP6 14q24.1 0.262 0.045 0.475
his SRP68 17q25.1 0.262 0.045 0.475 gene expression;response to drug
his GALR2 17q25.3 0.262 0.045 0.475
xsq VWA9 15q22.31 0.26 0.045 0.475
met LINC00202-1 10p12.1 0.26 0.045 0.475
met NUB1 7q36 0.26 0.045 0.475 response to interferon-gamma;response to tumor
necrosis factor
exp FANCG 9p13 0.26 0.045 0.475 DNA Damage Response (DDR); DDR (FA)
xsq LOC100049716 12p13.33 0.26 0.045 0.475
xsq DDX55 12q24.31 0.26 0.045 0.475
exp FUBP1 1p31.1 0.26 0.045 0.475 Tumor Suppressors
xsq LARS 5q32 0.26 0.045 0.475 gene expression;tRNA aminoacylation for protein
translation
xsq WWC3 Xp22.32 -0.26 0.045 0.475
exp SH3D19 4q31.3 -0.26 0.045 0.475 post-Golgi vesicle-mediated
transport;cytoskeleton organization
swa NPC1 18q11.2 -0.262 0.045 0.475 autophagy;lysosomal transport
hs4 TMEM56-RWDD3 -0.262 0.045 0.475
hs4 TMEM56 1p21.3 -0.262 0.045 0.475
his CRH 8q13 -0.262 0.045 0.475 parturition;locomotory exploration
behavior
his GIMAP6 0.262 0.0451 0.475
swa DBI 2q12-q21 0.262 0.0451 0.475 transport
his ACTR1A 10q24.32 0.262 0.0451 0.475 G2/M transition of mitotic
his SUFU 10q24.32 0.262 0.0451 0.475 negative regulation of
transcription from RNA polymerase II promoter;determination of left/right symmetry
xai MRPS18C 4q21.23 0.262 0.0451 0.475 translation
xai HENMT1 1p13.3 0.262 0.0451 0.475 RNA methylation;gene
silencing by RNA
xai HDDC3 15q26.1 0.262 0.0451 0.475 guanosine tetraphosphate metabolic
process
his LCE3A 1q21.3 0.262 0.0451 0.475 keratinization
met TMPRSS4 11q23.3 0.26 0.0451 0.475 proteolysis
mut TRPA1 8q13 0.26 0.0451 0.475 detection of mechanical stimulus involved
in sensory perception of pain;ion transport
exp UBE2G2 21q22.3 0.26 0.0451 0.475 ubiquitin-dependent protein
met CYP11B1 8q21 0.26 0.0451 0.475 xenobiotic metabolic
process;cellular response to potassium ion
met GRWD1 19q13.33 0.26 0.0451 0.475
met MIR766 0.26 0.0451 0.475
xsq RPSA 3p22.2 0.26 0.0451 0.475 translational elongation;viral
infectious cycle
xai BCL2L1 20q11.21 -0.262 0.0451 0.475 Apoptosis; Protein
Kinases
xai MFSD7 4p16.3 -0.262 0.0451 0.475 transmembrane transport
exp RPL23AP83 Xp11.21 0.262 0.0452 0.476
his LINC01596 0.262 0.0452 0.476
hs4 FBXO5 6q25.2 0.262 0.0452 0.476 G1/S transition of mitotic cell
xai ZNF445 3p21.32 0.262 0.0452 0.476 viral reproduction
hs4 XYLB 3p22-p21.3 0.262 0.0452 0.476 generation of precursor metabolites
and energy;D-xylose metabolic process
xai AK2P2 2p23.1 0.262 0.0452 0.476
his CHCHD1 10q22.2 0.262 0.0452 0.476
his ZSWIM8 10q22.2 0.262 0.0452 0.476
his PDIA4 7q35 0.262 0.0452 0.476 glycerol ether metabolic process;protein
secretion
hs4 PHOX2A 11q13.2 0.262 0.0452 0.476 regulation of transcription,
DNA-dependent;somatic motor neuron differentiation
xai HAND2-AS1 4q34.1 0.262 0.0452 0.476
met ZNF32 10q22-q25 0.26 0.0452 0.476 regulation of transcription, DNA-
dependent"
xsq SDE2 1q42.12 0.26 0.0452 0.476
met YPEL3 16p11.2 0.26 0.0452 0.476
xsq APRT 16q24 0.26 0.0452 0.476 nucleoside metabolic process;purine-
exp ATP5B 12q13.13 0.26 0.0452 0.476 ADP biosynthetic process;ATP
xsq SYCE2 19p13.2 0.26 0.0452 0.476 cell division;cell cycle
xsq SNRPF 12q23.1 0.26 0.0452 0.476 termination of RNA polymerase II
met PYDC2 3q28 -0.26 0.0452 0.476
xai ZCCHC8 12q24.31 0.262 0.0453 0.476 nuclear mRNA splicing, via
his ACAP3 0.262 0.0453 0.476 filopodium assembly;signal transduction
his PUSL1 1p36.33 0.262 0.0453 0.476 pseudouridine synthesis;tRNA
processing
his MIR6727 0.262 0.0453 0.476
exp AK2P2 2p23.1 0.262 0.0453 0.476
exp WDR54 2p13.1 0.26 0.0453 0.476
xsq PA2G4 12q13.2 0.259 0.0453 0.476 rRNA processing;regulation of
translation
exp NUDT1 7p22 0.259 0.0453 0.476 DNA Damage Response (DDR)
exp H2AFZ 4q24 0.259 0.0453 0.476 DNA Damage Response (DDR)
exp CLN5 13q21.1-q32 -0.259 0.0453 0.476 cell death;neurogenesis
exp CELSR2 1p21 -0.259 0.0453 0.476 G-protein coupled receptor
xai AF357530 -0.262 0.0453 0.476
his FAM20C 7p22.3 -0.262 0.0453 0.476
xai ADAMTS4 1q21-q23 -0.262 0.0453 0.476 proteolysis;skeletal
system development
his FZD7 2q33 -0.262 0.0453 0.476 G-protein signaling, coupled to
xai HACD1 -0.262 0.0453 0.476 fatty acid biosynthetic
hs4 PTN 7q33 -0.262 0.0453 0.476 positive regulation of cell
proliferation;bone mineralization
exp AF357530 -0.262 0.0453 0.476
xai KBTBD11 8p23.3 0.262 0.0454 0.476
swa PALLD 4q32.3 0.262 0.0454 0.477 cytoskeleton organization
his LST1 6p21.3 0.262 0.0454 0.477 cell morphogenesis;immune response
swa HSPH1 13q12.3 0.262 0.0454 0.477 response to stress;response to
unfolded protein
xai MRPL10 17q21.32 0.262 0.0454 0.477 translation;ribosome
biogenesis
xai MRPS34 16p13.3 0.262 0.0454 0.477
xai SYT5 19q13.42 0.262 0.0454 0.477 energy reserve metabolic
his IFT27 22q13.1 0.262 0.0454 0.477 small GTPase mediated signal
transduction
his MRPL12 17q25 0.262 0.0454 0.477 transcription from mitochondrial
promoter;translation
cop LRP5 11q13.4 0.259 0.0454 0.477 positive regulation of cell
xsq DEF8 16q24.3 0.259 0.0454 0.477 intracellular signal transduction
exp RPL35P8 22q13.33 0.259 0.0454 0.477
xsq LOC101928103 0.259 0.0454 0.477
cop REL 2p13-p12 0.259 0.0454 0.477 Apoptosis; Oncogenes
exp GAS8 16q24.3 -0.259 0.0454 0.477 negative regulation of cell
proliferation;sperm motility
xsq ANGPTL1 1q25.2 -0.259 0.0454 0.477 signal
transduction;transmembrane receptor protein tyrosine kinase signaling pathway
xsq CPSF4L 17q25.1 -0.259 0.0454 0.477
hs4 CAMSAP2 1q32.1 -0.261 0.0454 0.477
swa IQGAP1 15q26.1 -0.262 0.0454 0.477 energy reserve metabolic
xai ZNF702P 19q13.41 -0.262 0.0454 0.477 regulation of
xai RPL21P50 4q28.1 0.261 0.0455 0.477
his PGGT1B 5q22.3 0.261 0.0455 0.477 positive regulation of cell
proliferation;protein geranylgeranylation
xai BRD2 6p21.3 0.261 0.0455 0.477 spermatogenesis
his TUBD1 17q23.1 0.261 0.0455 0.477 protein polymerization;microtubule-
based movement
his RPS6KB1 17q23.1 0.261 0.0455 0.477 Apoptosis; Protein Kinases
xai UTP15 5q13.2 0.261 0.0455 0.477 rRNA processing
his TMEM222 1p36.11 0.261 0.0455 0.477
his ACTG1P20 0.261 0.0455 0.477
his PACS2 14q32.33 0.261 0.0455 0.477 apoptotic process;interspecies
his BRF1 14q 0.261 0.0455 0.477 positive regulation of transcription,
xai TAF5L 1q42.13 0.261 0.0455 0.477 regulation of transcription, DNA-
his UBE2T 1q32.1 0.261 0.0455 0.477 DNA Damage Response (DDR); DDR (FA)
xai RPL4P5 9p24.1 0.261 0.0455 0.477
his ABHD14B 3p21.2 0.261 0.0455 0.477
his ABHD14A 3p21.1 0.261 0.0455 0.477
his ABHD14A-ACY1 0.261 0.0455 0.477
xsq ERCC6L Xq13.1 0.259 0.0455 0.477 mitotic prometaphase;mitotic
cell cycle
met CAB39 2q37.1 0.259 0.0455 0.477 protein
heterooligomerization;positive regulation of protein phosphorylation
exp MAK16 8p12 0.259 0.0455 0.477 translation
xsq ZDHHC22 14q24.3 0.259 0.0455 0.477
exp USP1 1p31.3 0.259 0.0455 0.477 DNA Damage Response (DDR); DDR (FA)
exp CELSR1 22q13.3 -0.259 0.0455 0.477 locomotory
exp TPST1 7q11.21 -0.259 0.0455 0.477 peptidyl-tyrosine
xsq ANXA2P2 -0.259 0.0455 0.477 positive regulation of
his LINC01655 -0.261 0.0455 0.477
xai GUCY1B3 4q31.3-q33 -0.261 0.0455 0.477 nitric oxide mediated
signal transduction;blood coagulation
hs4 RASD2 22q13.1 -0.261 0.0455 0.477 synaptic transmission,
dopaminergic;positive regulation of protein kinase B signaling cascade
his PTGFRN 1p13.1 -0.261 0.0455 0.477 lipid particle
organization
hs4 KRI1 19p13.2 0.261 0.0456 0.477
hs4 CDKN2D 19p13 0.261 0.0456 0.477 DNA Damage Response (DDR)
his PIAS4 19p13.3 0.261 0.0456 0.477 DNA Damage Response (DDR)
xai PROK2 3p13 0.261 0.0456 0.477 spermatogenesis;activation of MAPK
activity
his NEDD8 14q12 0.261 0.0456 0.477 response to organic cyclic
compound;protein neddylation
his NEDD8-MDP1 0.261 0.0456 0.477
his GMPR2 14q12 0.261 0.0456 0.477 nucleobase-containing small molecule
metabolic process;purine base metabolic process
xai SAFB2 19p13.3 0.261 0.0456 0.477 regulation of transcription, DNA-
dependent"
his UBR4 1p36.13 0.261 0.0456 0.477 Tumor Suppressors
his LOC101927895 0.261 0.0456 0.477
his LOC102723704 0.261 0.0456 0.477
xai ASF1A 6q22.31 0.261 0.0456 0.477 DNA Damage Response (DDR); DDR (DNA
replication)
xai IDH1-AS1 0.261 0.0456 0.477
his PLK1 16p12.2 0.261 0.0456 0.477 DDR (DNA replication); Protein
Kinases
xsq RNGTT 6q16 0.259 0.0456 0.477 transcription from RNA polymerase II
xsq COQ10A 12q13.3 0.259 0.0456 0.477
exp ATP6V1G2 6p21.3 0.259 0.0456 0.477 insulin receptor signaling
met SIAE 11q24 0.259 0.0456 0.477
xsq TBCCD1 3q27.3 0.259 0.0456 0.477 cell morphogenesis;regulation
of cell shape
exp ZCCHC8 12q24.31 0.259 0.0456 0.477 nuclear mRNA splicing, via
met LEFTY2 1q42.1 -0.259 0.0456 0.477 transforming growth
factor beta receptor signaling pathway;multicellular organismal development
xai PIP4K2C 12q13.3 -0.261 0.0456 0.477
hs4 MXRA8 1p36.33 -0.261 0.0456 0.477
xai LINC00571 -0.261 0.0456 0.477
exp RPS14P3 0.261 0.0457 0.478
xai ATP8A1 4p13 0.261 0.0457 0.478 cation transport;aminophospholipid
transport
his ANKRD23 2q11.2 0.261 0.0457 0.478 fatty acid metabolic process
his TTI2 8p12 0.261 0.0457 0.478 DNA Damage Response (DDR)
his SNORD13 8p12 0.261 0.0457 0.478
xai UBE2K 4p14 0.261 0.0457 0.478 ubiquitin-dependent protein catabolic
his SSX2IP 1p22.3 0.261 0.0457 0.478 cell adhesion
exp NIP7P3 0.261 0.0457 0.478
his MEX3C 18q21.2 0.261 0.0457 0.478
met IL1RN 2q14.2 0.259 0.0457 0.477 negative regulation of cytokine-
mediated signaling pathway;acute-phase response
exp LOC101060264 0.259 0.0457 0.478
xsq TMEM180 10q24.32 0.259 0.0457 0.478
met MIR525 0.259 0.0457 0.478
xsq ALG10B 12q12 0.259 0.0457 0.478 dolichol-linked oligosaccharide
xsq LIMCH1 4p13 -0.259 0.0457 0.478 actomyosin structure
organization
pro CDH1_9 -0.259 0.0457 0.478
xai LOC728040 -0.261 0.0457 0.478
exp LOC100129781 -0.261 0.0457 0.478
xai RIMS2 8q22.3 0.261 0.0458 0.478 intracellular protein transport
his MED17 11q14 0.261 0.0458 0.478 positive regulation of transcription,
exp IBSP 4q21.1 0.261 0.0458 0.478 ossification;cell adhesion
xai HHIP-AS1 4q31.21 0.261 0.0458 0.478
his SPATS2 12q13.12 0.261 0.0458 0.478
xai CPS1-IT1 2q34 0.261 0.0458 0.478
his PMVK 1q22 0.261 0.0458 0.478 response to cholesterol;cholesterol
xsq LINC01251 0.259 0.0458 0.478
met PDE4D 5q12 0.259 0.0458 0.478 establishment of endothelial barrier;cAMP
catabolic process
exp RAVER1 19p13.2 0.259 0.0458 0.478
met MGC2889 3q29 0.259 0.0458 0.478
met ZBTB48 1p36.3 0.259 0.0458 0.478 regulation of transcription,
DNA-dependent"
xsq RPL23AP53 8p23.3 0.259 0.0458 0.478
exp HOXC4 12q13.3 -0.259 0.0458 0.478 regulation of transcription,
xsq PCBP4 3p21 -0.259 0.0458 0.478 DNA damage response, signal
met CCL25 19p13.2 -0.259 0.0458 0.478 G-protein coupled receptor
met MIR34A -0.259 0.0458 0.478
exp KRTAP22-1 21q22.1 -0.261 0.0458 0.478
xai KRTAP22-1 21q22.1 -0.261 0.0458 0.478
hs4 SERPINB6 6p25 -0.261 0.0458 0.478 negative regulation of
hs4 SHC2 19p13.3 -0.261 0.0458 0.478 insulin receptor signaling
pathway;intracellular signal transduction
xai GABPB1-AS1 15q21.2 0.261 0.0459 0.478
xai RCC2P6 0.261 0.0459 0.478
xai BCKDHB 6q14.1 0.261 0.0459 0.478 response to nutrient;branched
hs4 JCHAIN 0.261 0.0459 0.478 immune response
xai DUS1L 17q25.3 0.261 0.0459 0.478 tRNA processing
xai NAP1L2 Xq13 0.261 0.0459 0.478 nucleosome assembly
hs4 ELMO1 7p14.1 0.261 0.0459 0.478 actin cytoskeleton
his CACNA1C-AS1 0.261 0.0459 0.478
his CLPB 11q13.4 0.261 0.0459 0.478 cellular response to heat
exp FKBP4 12p13.33 0.259 0.0459 0.478 peptidyl-proline
mut ADAM15 1q21.3 0.259 0.0459 0.478 proteolysis;cell adhesion
cop DEGS2 14q32.2 0.259 0.0459 0.478 sphingolipid biosynthetic
cop YY1 14q 0.259 0.0459 0.478 DNA recombination;cellular response to UV
xsq NDST2 10q22 0.259 0.0459 0.478 cellular process;heparan sulfate
xsq GOLPH3L 1q21.3 0.259 0.0459 0.478
exp FBXO31 16q24.2 0.259 0.0459 0.478 response to DNA damage
stimulus;cell cycle
exp SDHB 1p36.1-p35 0.259 0.0459 0.478 tricarboxylic acid cycle;succinate
metabolic process
exp CD69 12p13 0.259 0.0459 0.478 cellular response to drug
xsq CTNNBL1 20q11.23-q12 0.259 0.0459 0.478 Apoptosis
met ANKRD1 10q23.31 0.259 0.0459 0.478 positive regulation of
protein secretion;response to muscle stretch
exp GDF9 5q31.1 0.259 0.0459 0.478 oocyte growth;transforming growth
exp PTPRU 1p35.3 -0.259 0.0459 0.478 homotypic cell-cell
adhesion;protein dephosphorylation
exp KIAA0319L 1p34.2 -0.259 0.0459 0.478
his AMZ1 7p22.3 -0.261 0.0459 0.478 proteolysis
xai LOC100129781 -0.261 0.0459 0.478
xai COL1A2 7q22.1 -0.261 0.0459 0.478 axon guidance;protein
heterotrimerization
hs4 ANGPTL2 9q34 -0.261 0.0459 0.478 signal
swa TP53 17p13.1 -0.261 0.0459 0.478 Apoptosis; DNA Damage
Response (DDR); DDR (DNA replication); Tumor Suppressors
his SYNPO 5q33.1 -0.261 0.0459 0.478 positive regulation of actin
filament bundle assembly;regulation of stress fiber assembly
xai DLC1 8p22 -0.261 0.0459 0.478 induction of apoptosis;actin
exp LOC728040 -0.261 0.0459 0.478
exp ANKRD34C-AS1 -0.261 0.0459 0.478
hs4 PER1 17p13.1 0.261 0.046 0.479 DNA Damage Response (DDR)
his LOC101559451 0.261 0.046 0.479
his PELP1 17p13.2 0.261 0.046 0.479 transcription, DNA-dependent"
xai HMGB3P2 20q11.23 0.261 0.046 0.479
his FAM57B 16p11.2 0.261 0.046 0.479
his RNASEH2B 13q14.3 0.261 0.046 0.479 DNA Damage Response (DDR); DDR (DNA
replication)
his RNASEH2B-AS1 0.261 0.046 0.479
xsq TRNT1 3p25.1 0.259 0.046 0.479 RNA processing;protein targeting to
mitochondrion
xsq AK2 1p34 0.259 0.046 0.479 nucleobase-containing small molecule
interconversion;small molecule metabolic process
exp STXBP5L 3q13.33 0.259 0.046 0.479 exocytosis;protein transport
xsq BRD3 9q34 0.259 0.046 0.479
xsq DLAT 11q23.1 0.259 0.046 0.479 acetyl-CoA biosynthetic process;pyruvate
metabolic process
his FADS3 11q12-q13.1 -0.261 0.046 0.479 electron transport
exp LOC100130976 -0.261 0.046 0.479
hs4 LINC01271 -0.261 0.046 0.478
xai TNFRSF13B 17p11.2 0.261 0.0461 0.479 B cell homeostasis;cell
swa RBMX Xq26.3 0.261 0.0461 0.479 transcription from RNA polymerase
II promoter;cellular response to interleukin-1
his LINC01072 0.261 0.0461 0.479
his FAM173A 16p13.3 0.261 0.0461 0.48
xsq PRAMEF9 0.259 0.0461 0.479
xsq GMIP 19p13.11 0.259 0.0461 0.479 positive regulation of Rho GTPase
exp ANXA2R 5p12 0.259 0.0461 0.479
exp HCG27 6p21.33 0.259 0.0461 0.479
met HDX Xq21.1 0.258 0.0461 0.48
xsq TRIM22 11p15 -0.258 0.0461 0.479 immune response;response to
virus
exp GFPT1 2p13 -0.259 0.0461 0.479 carbohydrate biosynthetic
process;fructose 6-phosphate metabolic process
exp C8orf58 8p21 -0.259 0.0461 0.479
his FAM218A 4q32.3 -0.261 0.0461 0.48
his CDC42EP3 2p21 -0.261 0.0461 0.479 signal
exp LINC00571 -0.261 0.0461 0.479
xai LOC100130976 -0.261 0.0461 0.479
xai LOC153684 5p12 0.261 0.0462 0.48
his UMPS 3q13 0.261 0.0462 0.48 'de novo' UMP biosynthetic process;small
his MIR544B 0.261 0.0462 0.48
hs4 TM6SF1 15q24-q26 0.261 0.0462 0.48
xai RAB39A 11q22.3 0.261 0.0462 0.48 small GTPase mediated signal
hs4 ADGRE5 0.261 0.0462 0.48 cell adhesion;cell surface receptor
signaling pathway
his PTPN22 1p13.2 0.261 0.0462 0.48 regulation of B cell receptor
met ENPP5 6p21.1-p11.2 0.258 0.0462 0.48 cell communication
xsq ABCG2 4q22 0.258 0.0462 0.48 ABC Transporters
exp LINC00339 1p36.12 0.258 0.0462 0.48
xsq PTK2B 8p21.1 0.258 0.0462 0.48 MAPK cascade;apoptotic process
exp MYO1B 2q12-q34 -0.258 0.0462 0.48 actin filament-based
movement;actin filament bundle assembly
xsq MGAT4B 5q35 -0.258 0.0462 0.48 protein N-linked
xai NOTCH2 1p13-p11 -0.261 0.0462 0.48 Apoptosis; Tumor
Suppressors
xai TSPAN6 Xq22 -0.261 0.0462 0.48 signal transduction;positive
his ACVR2A 2q22.3 -0.261 0.0462 0.48 Cell Signaling; Tumor
Suppressors
hs4 RAB20 13q34 -0.261 0.0462 0.48 small GTPase mediated signal
xai CAP2 6p22.3 -0.261 0.0462 0.48 activation of adenylate
hs4 STAC 3p22.3 -0.261 0.0462 0.48 signal transduction;cellular
response to heat
his ADCY9 16p13.3 -0.261 0.0462 0.48 signal
hs4 CFC1B 0.261 0.0463 0.48
exp NKX2-3 10q24.2 0.261 0.0463 0.48 gland morphogenesis;spleen
development
xai TBCCD1 3q27.3 0.261 0.0463 0.48 cell morphogenesis;regulation
of cell shape
his MYCBP2 13q22 0.261 0.0463 0.48 regulation of transcription, DNA-
exp PPIAP6 14q24.1 0.261 0.0463 0.48
xai SYT9 11p15.4 0.261 0.0463 0.48 regulation of calcium ion-dependent
xai LINC01012 0.26 0.0463 0.48
xai LINC00471 2q37.1 0.26 0.0463 0.48
xai WDR54 2p13.1 0.26 0.0463 0.48
exp BRPF1 3p26-p25 0.258 0.0463 0.48 chromatin modification;histone H3
acetylation
DNA-dependent"
exp NCF1C 7q11.23 0.258 0.0463 0.48 cell communication
dependent"
exp RAB33A Xq26.1 0.258 0.0463 0.48 GTP catabolic process;small
xsq TOMM70A 3q12.2 0.258 0.0463 0.48 protein targeting to
mitochondrion
xsq CHMP1B 18p11.21 0.258 0.0463 0.48 cell division;cell cycle
exp NGDN 14q11.2 0.258 0.0463 0.48 regulation of translation
xsq ABCE1 4q31 0.258 0.0463 0.48 ABC Transporters
met RNF113B 13q32.2 -0.258 0.0463 0.48
xsq LOC101926940 -0.258 0.0463 0.48
hs4 FIBIN 11p14.2 -0.26 0.0463 0.48
xai SNX18P2 9q22.31 -0.26 0.0463 0.48
xai KLHL22 22q11.21 -0.261 0.0463 0.48 cell division
xai LOC100130856 19p13.3 -0.261 0.0463 0.48
his NDUFA1 Xq24 0.26 0.0464 0.48 mitochondrial electron transport,
his RNF113A Xq24 0.26 0.0464 0.48
xai FANCD2OS 3p25.3 0.26 0.0464 0.48
his GRAMD4 22q13.31 0.26 0.0464 0.48 apoptotic process
his KLRC4 12p13.2-p12.3 0.26 0.0464 0.48 cellular defense response
his KLRC4-KLRK1 0.26 0.0464 0.48
his RASGRP2 11q13 0.26 0.0464 0.481 Ras protein signal
xai LOC100133089 0.26 0.0464 0.481
swa DDX6 11q23.3 0.26 0.0464 0.481 nuclear-transcribed mRNA catabolic
xai PSMG1 21q22.3 0.26 0.0464 0.481 proteasome assembly
xai CYP1D1P 9q21.13 0.26 0.0464 0.481
xsq NOC4L 12q24.33 0.258 0.0464 0.48 rRNA processing
met SP100 2q37.1 0.258 0.0464 0.48 response to type I
interferon;positive regulation of sequence-specific DNA binding transcription
factor activity
cop MTL5 11q13.2-q13.3 0.258 0.0464 0.48 cellular metal ion
homeostasis;multicellular organismal development
xsq POPDC2 3q13.33 0.258 0.0464 0.48
met CEP128 14q31.1 0.258 0.0464 0.48
exp OOEP 6q13 0.258 0.0464 0.481 establishment or maintenance of
apical/basal cell polarity;cellular protein complex assembly
exp LBHD1 0.258 0.0464 0.481
exp THYN1 11q25 0.258 0.0464 0.481
exp TNPO2 19p13.2 0.258 0.0464 0.481 intracellular protein transport
met CA9 9p13.3 0.258 0.0464 0.481 secretion;morphogenesis of an
epithelium
exp TRPV1 17p13.2 -0.258 0.0464 0.481 temperature
homeostasis;elevation of cytosolic calcium ion concentration
met PALM3 19p13.12 -0.258 0.0464 0.481 negative regulation of
cytokine-mediated signaling pathway;Toll signaling pathway
exp DIAPH3 13q21.2 -0.258 0.0464 0.48 cellular component
his CLDN1 3q28-q29 -0.26 0.0464 0.481 cell adhesion;calcium-independent
cell-cell adhesion
his CORO2B 15q23 -0.26 0.0464 0.48 actin cytoskeleton organization
xai EFHC1 6p12.3 -0.26 0.0464 0.48
hs4 FCER2 19p13.3 0.26 0.0465 0.481 positive regulation of nitric-oxide
xai EMC8 16q24 0.26 0.0465 0.481
xai RPS14P3 0.26 0.0465 0.481
xai WDR97 0.26 0.0465 0.481
xsq ZKSCAN2 16p12.1 0.258 0.0465 0.481 viral reproduction
xsq LINC01351 0.258 0.0465 0.481
met XAGE5 Xp11.22 0.258 0.0465 0.481
exp SLC25A5 Xq24 0.258 0.0465 0.481 Solute Carriers
exp ZUFSP 6q22.1 0.258 0.0465 0.481
met DGCR6L 22q11.21 0.258 0.0465 0.481
met TMBIM1 2q35 0.258 0.0465 0.481
xsq COX5A 15q24.1 0.258 0.0465 0.481 small molecule metabolic
xai AMIGO2 12q13.11 -0.26 0.0465 0.481 anti-apoptosis;cell adhesion
hs4 TPRG1-AS1 -0.26 0.0465 0.481
swa PPIG 2q31.1 0.26 0.0466 0.481 protein folding;RNA splicing
xai STT3B 3p23 0.26 0.0466 0.481 protein glycosylation;protein N-linked
xai ZNF282 7q36.1 0.26 0.0466 0.481 negative regulation of
xai CTR9 11p15.3 0.26 0.0466 0.481 histone monoubiquitination;histone
H2B ubiquitination
his TNKS2-AS1 0.26 0.0466 0.481
his TNKS2 10q23.3 0.26 0.0466 0.481 protein auto-ADP-
ribosylation;positive regulation of canonical Wnt receptor signaling pathway
his TRMT11 6q11.1-q22.33 0.26 0.0466 0.481 tRNA processing
xsq C12orf66 12q14.2 0.258 0.0466 0.481
xsq SVOP 12q24.11 0.258 0.0466 0.481
exp UTP15 5q13.2 0.258 0.0466 0.481 rRNA processing
exp ISCU 12q24.1 0.258 0.0466 0.481 nitrogen fixation;iron-sulfur
cluster assembly
xsq FAM153A 5q35.3 0.258 0.0466 0.481
xsq TDRD9 14q32.33 0.258 0.0466 0.481 fertilization;cell differentiation
cop EVL 14q32.2 0.258 0.0466 0.481 nervous system development;axon
guidance
exp NDUFA12 12q22 0.258 0.0466 0.481 transport;response to oxidative
stress
exp RPL12P8 10q21.3 0.258 0.0466 0.481
met MAGOHB 12p13.2 -0.258 0.0466 0.481 RNA splicing;mRNA
transport
exp CYBRD1 2q31.1 -0.258 0.0466 0.481 transmembrane
transport;cellular iron ion homeostasis
exp CCNJL 5q33.3 -0.258 0.0466 0.481
exp AMOT Xq23 -0.258 0.0466 0.481 regulation of cell
migration;positive regulation of stress fiber assembly
his LINC01151 -0.26 0.0466 0.481
hs4 CYB5A 18q23 -0.26 0.0466 0.481 electron transport chain;small molecule
metabolic process
his MUT 6p12.3 0.26 0.0467 0.481 fatty acid beta-oxidation;post-
his CENPQ 6p12.3 0.26 0.0467 0.481 M phase of mitotic cell
exp SIGLEC6 19q13.3 0.26 0.0467 0.482 cell adhesion;cell-cell
signaling
his FAM222A-AS1 12q24.11 0.26 0.0467 0.482
his CPSF6 12q15 0.26 0.0467 0.482 mRNA polyadenylation;mRNA processing
exp EFCAB3 17q23.2 0.26 0.0467 0.482
xai RPL3P12 Xq25 0.26 0.0467 0.482
xai CCDC26 0.26 0.0467 0.482
xai TRNM 0.26 0.0467 0.482
xsq ARHGEF1 19q13.13 0.258 0.0467 0.482 regulation of
axonogenesis;negative regulation of axonogenesis
met GABRA4 4p12 0.258 0.0467 0.482 ion transmembrane
exp DDX1 2p24 0.258 0.0467 0.482 regulation of translational
exp DNAJC17 15q15.1 0.258 0.0467 0.482 protein folding
exp TAF1 Xq13.1 0.258 0.0467 0.482 regulation of transcription
involved in G2/M-phase of mitotic cell cycle;gene expression
xsq HSD17B10 Xp11.2 0.258 0.0467 0.482 protein
homotetramerization;lipid metabolic process
xsq SHROOM4 Xp11.22 -0.258 0.0467 0.482 actin filament
exp SPG20 13q13.3 -0.258 0.0467 0.482 EMT (Mesenchymal)
exp IDO1 8p12-p11 -0.258 0.0467 0.482 female pregnancy;cellular
met MT1IP 16q13 -0.258 0.0467 0.482
exp TRIP10 19p13.3 -0.258 0.0467 0.482 cell
communication;signal transduction
xai SCARA3 8p21 -0.26 0.0467 0.482 response to oxidative stress;UV
protection
swa MAP1B 5q13 -0.26 0.0467 0.481 central nervous system
development;response to insecticide
his TUBGCP5 15q11.2 0.26 0.0468 0.482 mitotic cell
cycle;microtubule nucleation
xsq RRN3 16p12 0.258 0.0468 0.482 regulation of transcription, DNA-
met TNS3 7p12.3 0.258 0.0468 0.482 positive regulation of cell
xsq SORD 15q15.3 0.258 0.0468 0.482 glucose metabolic process;sorbitol
catabolic process
xsq ATG16L2 11q13.4 0.258 0.0468 0.482 autophagy;protein transport
cop SHANK2-AS3 11q13.4 0.258 0.0468 0.482
cop MIR3664 0.258 0.0468 0.482
met ETV1 7p21.3 0.258 0.0468 0.482 Transcription Factors
xsq CPS1 2q35 0.258 0.0468 0.482 midgut development;response to drug
xsq LINC01193 0.258 0.0468 0.482
mut PABPC1 8q22.2-q23 0.258 0.0468 0.482 nuclear-transcribed mRNA
catabolic process, deadenylation-dependent decay;RNA metabolic process
xsq SPATA16 3q26.31 0.258 0.0468 0.482 cell
xsq SNX9 6q25.1-q26 -0.258 0.0468 0.482 intracellular protein
xsq NRP2 2q33.3 -0.258 0.0468 0.482 angiogenesis;positive
regulation of endothelial cell migration
his KRT31 17q21.2 -0.26 0.0468 0.482 epidermis development
his LOC100505782 -0.26 0.0468 0.482
his ETV7 6p21 -0.26 0.0468 0.482 Transcription Factors
his LOC283299 -0.26 0.0468 0.482
his TNFRSF25 1p36.2 0.26 0.0469 0.482 Apoptosis
xai RRP1 21q22.3 0.26 0.0469 0.482 rRNA processing
xai ALOX12P2 17p13 0.26 0.0469 0.483
swa ERCC5 13q33 0.26 0.0469 0.483 DNA Damage Response (DDR); DDR (NER)
xai MEPCE 7q22.1 0.26 0.0469 0.483
xai KIR2DS2 0.26 0.0469 0.483 immune response;regulation of
immune response
his KCNJ11 11p15.1 0.26 0.0469 0.483 potassium ion
transport;negative regulation of insulin secretion
swa SMN1 0.26 0.0469 0.483
his HSPC324 0.26 0.0469 0.483
xsq TMEM179 14q32.33 0.258 0.0469 0.482
xsq RNF44 5q35.2 0.258 0.0469 0.483
cop SHANK2-AS1 0.258 0.0469 0.483
xsq LOC101929099 0.258 0.0469 0.483
exp TAF1L 9p21.1 0.258 0.0469 0.483 male meiosis;histone acetylation
exp KMT5A 0.258 0.0469 0.483 negative regulation of transcription,
DNA-dependent;negative regulation of transcription from RNA polymerase II promoter
xsq FUT4 11q21 0.258 0.0469 0.483 carbohydrate metabolic process;protein
glycosylation
xsq KRT33A 17q21.2 0.258 0.0469 0.483
exp MYLKP1 3p13 -0.258 0.0469 0.483
exp OR7E121P 3p12.3 -0.258 0.0469 0.483
xsq IFI27 14q32 -0.258 0.0469 0.483 activation of cysteine-type
xai SPACA6 -0.26 0.0469 0.483
his FAM129B 9q34.13 -0.26 0.0469 0.483 negative regulation of
apoptotic process
xai BICD1 12p11.2-p11.1 -0.26 0.0469 0.483 positive regulation of
receptor-mediated endocytosis;RNA processing
xai ZFYVE1 14q24.2 -0.26 0.0469 0.482 negative regulation of
swa RAE1 20q13.31 0.26 0.047 0.483 mRNA export from nucleus;cellular
response to organic cyclic compound
exp PMCH 12q23.2 0.26 0.047 0.483 lactation;negative regulation of blood
pressure
his TROAP 12q13.12 0.26 0.047 0.483 cell adhesion
his LOC101927267 0.26 0.047 0.483
xai SAFB 19p13.3-p13.2 0.26 0.047 0.483 regulation of transcription, DNA-
dependent;intracellular estrogen receptor signaling pathway
xai OIP5-AS1 15q15.1 0.26 0.047 0.483
xai RPL15P2 14q32.13 0.26 0.047 0.483
exp AGGF1P4 0.26 0.047 0.483
xai AGGF1P4 0.26 0.047 0.483
exp RPS3AP6 0.258 0.047 0.483
xsq PRR14 16p11.2 0.258 0.047 0.483
exp RPL34P34 19p12 0.258 0.047 0.483
xsq MRRF 9q33.2 0.258 0.047 0.483 translation;ribosome disassembly
met DNMBP-AS1 10q24.2 0.258 0.047 0.483
xsq UTP14A Xq26.1 0.258 0.047 0.483 rRNA processing
mut LHFPL4 3p25.3 0.258 0.047 0.483
exp TBCCD1 3q27.3 0.258 0.047 0.483 cell morphogenesis;regulation of
cell shape
exp FGL1 8p22 0.258 0.047 0.483 signal transduction
xsq C14orf2 14q32.33 0.257 0.047 0.483
met SNORD123 5p15.2 0.257 0.047 0.483
cop POU3F3 2q12.1 0.257 0.047 0.483 cerebral cortex radially oriented
cell migration;metanephric thick ascending limb development
xsq FAM122A 0.257 0.047 0.483
met PHYH 10p13 0.257 0.047 0.483 fatty acid alpha-oxidation;cellular lipid
metabolic process
xsq BLVRA 7p13 -0.257 0.047 0.483 porphyrin-containing compound metabolic
process;heme catabolic process
xsq PLS3 Xq23 -0.257 0.047 0.483
exp FLNB 3p14.3 -0.258 0.047 0.483 multicellular organismal
his IL11RA 9p13 -0.26 0.047 0.483 signal transduction;developmental process
hs4 NLRP14 11p15.4 -0.26 0.047 0.483 cell differentiation;multicellular
hs4 ZNF214 11p15.4 -0.26 0.047 0.483 regulation of transcription, DNA-
dependent"
his LINC01693 -0.26 0.047 0.483
xai TGFB1I1 16p11.2 -0.26 0.047 0.483 cell adhesion;ubiquitin-dependent
SMAD protein catabolic process
xai PAM 5q14-q21 -0.26 0.047 0.483 response to drug;response to hypoxia
swa KIF23 15q23 -0.26 0.047 0.483 M phase of mitotic cell cycle;positive
regulation of cell cycle cytokinesis
his BIRC5 17q25 0.26 0.0471 0.483 Apoptosis
hs4 TRIM71 3p22.3 0.26 0.0471 0.483 multicellular organismal
development;cellular response to organic substance
his RPL29 3p21.3-p21.2 0.26 0.0471 0.483 nuclear-transcribed mRNA
hs4 CXADRP2 0.26 0.0471 0.483
his ZNF445 3p21.32 0.26 0.0471 0.483 viral reproduction
xai LRIT3 4q25 0.26 0.0471 0.483
xsq PANK1 10q23.31 0.257 0.0471 0.483 small molecule metabolic
xsq CCKBR 11p15.4 0.257 0.0471 0.483 behavioral defense response;cell
proliferation
exp ATXN7L3B 12q21 0.257 0.0471 0.483
exp PDE4A 19p13.2 0.257 0.0471 0.483 response to drug;cAMP catabolic
process
xsq C7orf61 7q22.1 0.257 0.0471 0.483
xsq KPNA5 6q22.1 0.257 0.0471 0.483 cytokine-mediated signaling
pathway;protein import into nucleus
xsq PAN3-AS1 13q12.2 0.257 0.0471 0.483
xsq ZWILCH 15q22.31 0.257 0.0471 0.483 DNA Damage Response (DDR)
exp TOR1AIP2 1q25.2 -0.257 0.0471 0.483
hs4 FAM129B 9q34.13 -0.26 0.0471 0.483 negative regulation of
apoptotic process
his SNORD96B -0.26 0.0471 0.483
hs4 C12orf57 12p13.31 0.26 0.0472 0.483
hs4 RNU7-1 12p13.31 0.26 0.0472 0.483
hs4 PTPN6 12p13 0.26 0.0472 0.483 Apoptosis
xai NXT1P1 0.259 0.0472 0.483
his BEST4 1p33-p32.3 0.259 0.0472 0.483 ion transport
met NBR1 17q21.31 0.257 0.0472 0.483 macroautophagy;regulation of bone
mineralization
xsq SUCNR1 3q25.1 0.257 0.0472 0.483
met GPRIN1 5q35.2 0.257 0.0472 0.483 neuron projection development
cop PPP6R3 11q13 0.257 0.0472 0.483 DNA Damage Response (DDR)
cop GAL 11q13.3 0.257 0.0472 0.483 inflammatory response;response to
insulin stimulus
exp KIAA0101 15q22.31 0.257 0.0472 0.483
met LOC340357 8p23.1 0.257 0.0472 0.483
cop MRPS9 2q12.1 0.257 0.0472 0.483 DNA damage response, detection of
met ZFYVE28 4p16.3 0.257 0.0472 0.483 negative regulation of
epidermal growth factor-activated receptor activity;negative regulation of
epidermal growth factor receptor signaling pathway
exp TGFB1I1 16p11.2 -0.257 0.0472 0.483 cell adhesion;ubiquitin-
exp ARMC9 2q37.1 -0.257 0.0472 0.483
xsq FBLN1 22q13.31 -0.257 0.0472 0.483 embryo
xsq CYBRD1 2q31.1 -0.257 0.0472 0.483 transmembrane
xai FRS2 12q15 -0.259 0.0472 0.483 activation of phospholipase C
hs4 TSHZ2 20q13.2 -0.259 0.0472 0.483 multicellular organismal
development
xai IDS Xq28 -0.259 0.0472 0.483
exp LOC339874 -0.259 0.0472 0.483
his PPARGC1A 4p15.1 -0.259 0.0472 0.483 mRNA
processing;respiratory electron transport chain
xai HGSNAT 8p11.1 -0.26 0.0472 0.483 protein
oligomerization;lysosomal transport
hs4 KIF22 16p11.2 0.259 0.0473 0.484 microtubule-based movement;mitosis
xai FAM155B Xq13.1 0.259 0.0473 0.484
his N4BP2 4p14 0.259 0.0473 0.484
his LOC344967 4p14 0.259 0.0473 0.484
swa PSMC1 14q32.11 0.259 0.0473 0.484 protein polyubiquitination;DNA
damage response, signal transduction by p53 class mediator resulting in cell cycle
arrest
xai DUS4L 7q22-q31 0.259 0.0473 0.484 tRNA processing
swa EIF3I 1p34.1 0.259 0.0473 0.484 gene expression;cellular protein
metabolic process
xsq RCE1 11q13 0.257 0.0473 0.484 proteolysis
exp CD1E 1q23.1 0.257 0.0473 0.484 immune response;antigen processing
and presentation
exp UBE2O 17q25.1 0.257 0.0473 0.484
xsq KRTAP27-1 0.257 0.0473 0.484
xsq KIF13B 8p12 -0.257 0.0473 0.484 protein
targeting;microtubule-based movement
exp TTLL7 1p31.1 -0.257 0.0473 0.484 multicellular organismal
xsq CD200 3q13.2 -0.257 0.0473 0.484 regulation of immune response
xai SMPD1 11p15.4-p15.1 -0.259 0.0473 0.484 cell death;ceramide
xai TMEM51 1p36.21 -0.259 0.0473 0.484
xai HDLBP 2q37.3 -0.259 0.0473 0.484 lipid transport;steroid
metabolic process
hs4 CAMK1 3p25.3 -0.259 0.0473 0.484 nervous system
development;positive regulation of synapse structural plasticity
xai CKMT2 5q13.3 -0.259 0.0473 0.484 creatine metabolic
xai AMOT Xq23 -0.259 0.0473 0.484 regulation of cell
his MIR573 -0.259 0.0473 0.484
hs4 BUB1B 15q15 0.259 0.0474 0.484 DNA Damage Response (DDR)
exp TAF5L 1q42.13 0.259 0.0474 0.484 regulation of transcription, DNA-
swa EIF3K 19q13.2 0.259 0.0474 0.484 translation;translational
initiation
his APOC1 19q13.2 0.259 0.0474 0.484 regulation of lipid
transport;chylomicron remnant clearance
xai DHRS9 2q31.1 0.259 0.0474 0.484 9-cis-retinoic acid biosynthetic
process;androgen metabolic process
xai USP1 1p31.3 0.259 0.0474 0.484 DNA Damage Response (DDR); DDR (FA)
his GPR89B 1q21.1 0.259 0.0474 0.484
exp CRAMP1 0.257 0.0474 0.484
xsq FNDC8 17q12 0.257 0.0474 0.484
xsq SAPCD1 6p21.33 0.257 0.0474 0.484
exp TPI1 12p13 0.257 0.0474 0.484 carbohydrate metabolic process;glucose
metabolic process
met AQP11 11q14.1 0.257 0.0474 0.484 urea transport;endosomal lumen
acidification
xsq FANCF 11p15 0.257 0.0474 0.484 DNA Damage Response (DDR); DDR (FA)
exp FAM132B 2q37.3 -0.257 0.0474 0.484
met APOBR 16p11 -0.257 0.0474 0.484 triglyceride metabolic
process;transport
his LINC00535 -0.259 0.0474 0.484
his FAM92A -0.259 0.0474 0.484
hs4 PTPRG-AS1 -0.259 0.0474 0.484
hs4 C3orf14 3p14.2 -0.259 0.0474 0.484
xai DLG5 10q23 -0.259 0.0474 0.484 signal transduction;negative
his WDR24 16p13.3 0.259 0.0475 0.484
his DPH5 1p21.2 0.259 0.0475 0.484 peptidyl-diphthamide biosynthetic
his LOC102606465 0.259 0.0475 0.484
xai GPR65 14q31-q32.1 0.259 0.0475 0.485 multicellular organismal
xai RPL12P41 0.259 0.0475 0.485
his FAM153A 5q35.3 0.259 0.0475 0.485
xai SNHG7 9q34.3 0.259 0.0475 0.485
xai RPSAP15 Xq21.31 0.259 0.0475 0.485
xsq TNFRSF17 16p13.1 0.257 0.0475 0.484 multicellular organismal
xsq PPM1D 17q23.2 0.257 0.0475 0.484 DNA Damage Response (DDR)
met DNASE1L2 16p13.3 0.257 0.0475 0.485 DNA metabolic process;DNA
catabolic process
xsq GPR1 2q33.3 -0.257 0.0475 0.485 G-protein coupled receptor
signaling pathway
exp FLII 17p11.2 -0.257 0.0475 0.485 regulation of transcription,
DNA-dependent;muscle contraction
cop CA1 8q21.2 -0.257 0.0475 0.485 one-carbon metabolic process
xsq ABLIM3 5q32 -0.257 0.0475 0.485 cytoskeleton
exp FAM198B 4q32.1 -0.257 0.0475 0.485
xsq HOXB2 17q21.32 -0.257 0.0475 0.484 anterior/posterior pattern
specification;dorsal/ventral pattern formation
xsq RGS20 8q11.23 -0.257 0.0475 0.484 regulation of G-protein
coupled receptor protein signaling pathway;negative regulation of signal
transduction
his PHLDB2 3q13.2 -0.259 0.0475 0.485
his KLHL31 6p12.1 -0.259 0.0475 0.485 regulation of
hs4 GPR39 2q21-q22 -0.259 0.0475 0.485 G-protein coupled receptor
signaling pathway
swa ASB9 Xp22.2 -0.259 0.0475 0.485 protein
ubiquitination;intracellular signal transduction
hs4 RIT1 1q22 -0.259 0.0475 0.485 nerve growth factor receptor
xai CEBPE 14q11.2 0.259 0.0476 0.485 cellular response to
his GDPD1 17q22 0.259 0.0476 0.485 lipid metabolic process;glycerol
metabolic process
xai PAN3-AS1 13q12.2 0.259 0.0476 0.485
xsq TTC33 5p13.1 0.257 0.0476 0.485
xsq ZNF518A 10q24.1 0.257 0.0476 0.485 regulation of transcription,
DNA-dependent"
exp GMIP 19p13.11 0.257 0.0476 0.485 positive regulation of Rho GTPase
xsq HNRNPK 9q21.32-q21.33 0.257 0.0476 0.485 nuclear mRNA splicing,
via spliceosome;positive regulation of transcription from RNA polymerase II
promoter
exp PAIP2B 2p13.3 0.257 0.0476 0.485 negative regulation of
xsq CSTF3-AS1 0.257 0.0476 0.485
xsq MED24 17q21.1 0.257 0.0476 0.485 protein
exp SH3PXD2A 10q24.33 -0.257 0.0476 0.485 superoxide metabolic
exp CAP2 6p22.3 -0.257 0.0476 0.485 activation of adenylate
exp NPHP1 2q13 -0.257 0.0476 0.485 signal transduction;excretion
exp SPTLC3 20p12.1 -0.257 0.0476 0.485 small molecule metabolic
xsq PPP1R15A 19q13.2 -0.257 0.0476 0.485 Apoptosis
mut NYX Xp11.4 -0.257 0.0476 0.485 visual perception;response to
stimulus
swa EPHB2 1p36.1-p35 -0.259 0.0476 0.485 Protein Kinases
his PXN 12q24.31 -0.259 0.0476 0.485 cell adhesion;focal adhesion
assembly
hs4 EFEMP1 2p16 -0.259 0.0476 0.485 peptidyl-tyrosine
swa CTSH 15q25.1 -0.259 0.0476 0.485 positive regulation of cell
proliferation;zymogen activation
his ZNF474 5q23.2 -0.259 0.0476 0.485
swa COL1A2 7q22.1 -0.259 0.0476 0.485 axon guidance;protein
heterotrimerization
xai MRPL57 0.259 0.0477 0.485 translation
hs4 LINC01044 0.259 0.0477 0.485
xai OR7E38P 7q21.3 0.259 0.0477 0.485
xai ICAM2 17q23.3 0.259 0.0477 0.485 cell-cell adhesion;regulation of
immune response
his HMGN4 6p21.3 0.259 0.0477 0.485
his LYSMD3 5q14.3 0.259 0.0477 0.485 cell wall macromolecule
catabolic process
xai CRYM-AS1 16p12.2 0.259 0.0477 0.485
his RANBP3 19p13.3 0.259 0.0477 0.485 protein
transport;intracellular transport
his LOC100128568 0.259 0.0477 0.485
exp RCC2P6 0.259 0.0477 0.485
xai BLOC1S5 6p25.1-p24.3 0.259 0.0477 0.485
his MYO7A 11q13.5 0.259 0.0477 0.485 inner ear
morphogenesis;phagolysosome assembly
xai KIR2DL5A 0.259 0.0477 0.485
xsq NUDC 1p35-p34 0.257 0.0477 0.485 mitotic cell cycle;cytokinesis
exp FEN1 11q12 0.257 0.0477 0.485 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq POLG2 17q 0.257 0.0477 0.485 DNA Damage Response (DDR)
mut OGFR 20q13.3 0.257 0.0477 0.485 opioid receptor signaling
pathway;regulation of cell growth
xsq TRMT1 19p13.2 0.257 0.0477 0.485 tRNA processing
xsq NCAN 19p12 0.257 0.0477 0.485 cell adhesion;axon guidance
met SLC35D2 9q22.32 0.257 0.0477 0.485 Solute Carriers
exp PRKCDBP 11p15.4 -0.257 0.0477 0.485
exp LOC100128482 -0.259 0.0477 0.485
xai NR2F6 19p13.1 -0.259 0.0477 0.485 gene expression;intracellular
hs4 KIAA1755 20q11.23 -0.259 0.0477 0.485
hs4 LOC149684 -0.259 0.0477 0.485
hs4 RAB33A Xq26.1 0.259 0.0478 0.485 GTP catabolic process;small
exp RPL12P41 0.259 0.0478 0.485
his ZNF711 Xq21.1 0.259 0.0478 0.485 positive regulation of
xai SF1 11q13 0.259 0.0478 0.485 nuclear mRNA 3'-splice site
his ZC3H6 2q13 0.259 0.0478 0.485
his XYLB 3p22-p21.3 0.259 0.0478 0.485 generation of precursor metabolites
swa UFM1 13q13.3 0.259 0.0478 0.485 protein ufmylation
xai NIP7P3 0.259 0.0478 0.485
xai TSSC1 2p25.3 0.259 0.0478 0.485
xai SMC1A Xp11.22-p11.21 0.259 0.0478 0.485 DNA Damage Response (DDR);
his SIN3A 15q24.2 0.259 0.0478 0.486 in utero embryonic
his LIM2 19q13.4 0.259 0.0478 0.486 lens development in camera-type
eye;cell-cell junction assembly
xsq NETO1 18q22.2 0.257 0.0478 0.485 visual learning;regulation of long-
xsq APEX1 14q11.2 0.257 0.0478 0.485 DNA Damage Response (DDR); DDR
(BER)
xsq THEMIS 6q22.33 0.257 0.0478 0.485 multicellular organismal
exp SMC1A Xp11.22-p11.21 0.257 0.0478 0.485 DNA Damage Response (DDR);
exp POLR2A 17p13.1 0.257 0.0478 0.485 DNA Damage Response (DDR);
DDR (NER)
xsq FEM1A 19p13.3 0.257 0.0478 0.485 regulation of ubiquitin-protein
met ARTN 1p33-p32 0.257 0.0478 0.485 signal transduction;neuroblast
proliferation
xsq EEF2 19p13.3 0.257 0.0478 0.486 gene expression;cellular protein
metabolic process
exp FILIP1L 3q12.1 -0.257 0.0478 0.486
xsq SHB 9p13.2 -0.257 0.0478 0.485 Apoptosis
xsq ANKRD6 6q14.2-q16.1 -0.257 0.0478 0.485
xai FAM200B 4p15.32 -0.259 0.0478 0.486
his LOC105370622 -0.259 0.0478 0.486
his LINC01048 -0.259 0.0478 0.485
his CWF19L2 11q22.3 0.259 0.0479 0.486
his DEF8 16q24.3 0.259 0.0479 0.486 intracellular signal transduction
his MIR4521 0.259 0.0479 0.486
his BORCS6 0.259 0.0479 0.486
his SYCP3 12q 0.259 0.0479 0.486 cell division;cell cycle
DNA-dependent"
hs4 LKAAEAR1 0.259 0.0479 0.486
swa ANAPC7 12q24.11 0.259 0.0479 0.486 anaphase-promoting complex-
met HYDIN 16q22.2 0.257 0.0479 0.486
exp LOC100131126 16q23.1 0.257 0.0479 0.486
met MIR130B 0.257 0.0479 0.486
xsq STYK1 12p13.2 0.256 0.0479 0.486
xsq PKIA 8q21.12 0.256 0.0479 0.486 negative regulation of
transcription from RNA polymerase II promoter;regulation of G2/M transition of
mitotic cell cycle
exp GRK6 5q35 0.256 0.0479 0.486 signal transduction;regulation of G-
exp C16orf59 16p13.3 0.256 0.0479 0.486
met MFSD5 12q13.13 0.256 0.0479 0.486 transport
met KRT37 17q21.2 -0.256 0.0479 0.486
exp ASPH 8q12.1 -0.256 0.0479 0.486 peptidyl-amino acid
exp IFT43 14q24.3 -0.257 0.0479 0.486 cell projection
organization;intraflagellar retrograde transport
xai KANK1 9p24.3 -0.259 0.0479 0.486 negative regulation of actin
hs4 UGCG 9q31 -0.259 0.0479 0.486 glycosphingolipid biosynthetic
xai LOC100507431 -0.259 0.0479 0.486
xai CALN1 7q11 0.259 0.048 0.486
his SLC2A4 17p13 0.259 0.048 0.486 Solute Carriers
hs4 LRRC41 1p34.1 0.259 0.048 0.486
hs4 UQCRH 1p34.1 0.259 0.048 0.486
his CUL3 2q36.2 0.259 0.048 0.486 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
hs4 DSCAM 21q22.2 0.259 0.048 0.486 cell adhesion;dendrite self-avoidance
exp ASIP 20q11.2-q12 0.259 0.048 0.486 hormone-mediated signaling
pathway;melanosome transport
xai KCNC4 1p21 0.259 0.048 0.486 ion transport;potassium ion transport
his TAMM41 3p25.2 0.259 0.048 0.486 protein transport;protein import
into mitochondrial matrix
mut CAPZA3 12p12.3 0.256 0.048 0.486
met CDON 11q24.2 0.256 0.048 0.486 cell adhesion;muscle cell differentiation
dependent"
xsq HIGD2B 0.256 0.048 0.486
exp SMARCE1P3 14q11.2 0.256 0.048 0.486
xsq DUSP10 1q41 -0.256 0.048 0.486 JNK cascade;response to organic
substance
exp STARD3NL 7p14-p13 -0.256 0.048 0.486
exp AKAP14 Xq24 -0.256 0.048 0.486 spermatogenesis
xsq SYCP2 20q13.33 -0.256 0.048 0.486 cell cycle;meiosis
exp PLA2G16 11q12.3 -0.256 0.048 0.486 phospholipid metabolic
exp FRMD5 15q15.3 -0.256 0.048 0.486
xai FLNB 3p14.3 -0.259 0.048 0.486 multicellular organismal
his SPEN 1p36 0.258 0.0481 0.486 negative regulation of transcription from
his FLJ37453 1p36.21 0.258 0.0481 0.486
his PHB 17q21 0.258 0.0481 0.486 Apoptosis
his ZMAT2 5q31.3 0.258 0.0481 0.486
his NPIPB9 0.258 0.0481 0.486
his TMEM86B 19q13.42 0.258 0.0481 0.486 ether lipid metabolic process
his MIR6804 0.258 0.0481 0.486
hs4 STAR 8p11.2 0.258 0.0481 0.487 lipid transport;steroid metabolic
process
xai LOC731157 5q14.3 0.258 0.0481 0.487
his TXNDC15 5q31.1 0.258 0.0481 0.487 cell redox homeostasis
cop SETD3 14q32.2 0.256 0.0481 0.486 positive regulation of
mut TUSC3 8p22 0.256 0.0481 0.486 Tumor Suppressors
xsq MLC1 22q13.33 0.256 0.0481 0.486 cellular response to
cholesterol;caveolin-mediated endocytosis
cop CNKSR3 6q25.2 0.256 0.0481 0.486 negative regulation of
peptidyl-serine phosphorylation;negative regulation of ERK1 and ERK2 cascade
cop MIR1231 -0.256 0.0481 0.487
cop RNU6-79P -0.256 0.0481 0.487
exp TMEM47 Xp11.4 -0.256 0.0481 0.487
xsq GAS6 13q34 -0.256 0.0481 0.487 proteolysis;cellular protein
metabolic process
exp IRS2 13q34 -0.256 0.0481 0.486 Apoptosis
exp ANXA9 1q21 -0.256 0.0481 0.486 cell-cell adhesion
exp CARD14 17q25 -0.256 0.0481 0.486 positive regulation of
protein phosphorylation;activation of NF-kappaB-inducing kinase activity
xai KRT8P13 3q26.2 -0.258 0.0481 0.487
xai DYNLT1 6q25.2-q25.3 -0.258 0.0481 0.486 regulation of Rac
GTPase activity;establishment of mitotic spindle orientation
exp KRT8P15 -0.258 0.0481 0.486
his SOAT2 12q13.13 0.258 0.0482 0.487 steroid metabolic
process;cholesterol metabolic process
xai HDAC1 1p34 0.258 0.0482 0.487 Apoptosis
his SNAR-F 0.258 0.0482 0.487
his TOR1B 9q34 0.258 0.0482 0.487 chaperone mediated protein folding
requiring cofactor;response to unfolded protein
his SLC35F2 11q22.3 0.258 0.0482 0.487 Solute Carriers
swa HSPB11 1p32 0.258 0.0482 0.487 response to stress;cell adhesion
xai INPP5D 2q37.1 0.258 0.0482 0.487 phosphate-containing compound
exp NAP1L1P1 11q24.2 0.258 0.0482 0.487
exp TAF1D 11q21 0.256 0.0482 0.487 regulation of transcription, DNA-
dependent"
xsq BCL2 18q21.3 0.256 0.0482 0.487 Apoptosis; Protein Kinases
xsq CYP4F62P 0.256 0.0482 0.487
mut PLXNA4 7q32.3 0.256 0.0482 0.487 vagus nerve
morphogenesis;semaphorin-plexin signaling pathway
exp ATP6V1E2 2p21 0.256 0.0482 0.487 cellular iron ion
xsq HOMER1 5q14.2 0.256 0.0482 0.487 regulation of store-operated
met RAET1L 6q25.1 0.256 0.0482 0.487 immune response;antigen
exp PER2 2q37.3 0.256 0.0482 0.487 DNA Damage Response (DDR)
xsq MEN1 11q13 0.256 0.0482 0.487 DNA Damage Response (DDR); Tumor
Suppressors
xsq KIF1A 2q37.3 0.256 0.0482 0.487 microtubule-based
movement;anterograde axon cargo transport
met AMOT Xq23 0.256 0.0482 0.487 regulation of cell migration;positive
exp CCDC26 0.256 0.0482 0.487
cop LOC729506 5p15.31 -0.256 0.0482 0.487
cop LOC100505738 -0.256 0.0482 0.487
cop MIR4458 -0.256 0.0482 0.487
hs4 RCAN2 6p12.3 -0.258 0.0482 0.487 calcium-mediated
signaling;central nervous system development
hs4 LOC101926898 -0.258 0.0482 0.487
his GRAMD2 15q23 -0.258 0.0482 0.487
his CTGF 6q23.1 -0.258 0.0482 0.487 response to wounding;positive
hs4 CTBP2 10q26.13 -0.258 0.0482 0.487 negative regulation of
swa NCOA5 20q12-q13.12 -0.258 0.0482 0.487 regulation of
exp SLC25A5-AS1 0.258 0.0483 0.487
his SNORA17B 0.258 0.0483 0.487
his SNORA17A 0.258 0.0483 0.487
his SNHG7 9q34.3 0.258 0.0483 0.487
xai ASIC1 12q12 0.258 0.0483 0.487 transport;ion transport
his MIR3939 0.258 0.0483 0.487
his FGFR1OP 6q27 0.258 0.0483 0.487 positive regulation of cell
exp EIF4A1P6 13q21.2 0.258 0.0483 0.487
xai ATP6V1E2 2p21 0.258 0.0483 0.487 cellular iron ion
his EBP Xp11.23-p11.22 0.258 0.0483 0.487 cholesterol metabolic
process;hemopoiesis
exp PAQR3 4q21.21 0.256 0.0483 0.487
cop ATP9B 18q23 0.256 0.0483 0.487 cation transport;aminophospholipid
transport
met IVD 15q14-q15 0.256 0.0483 0.487 leucine catabolic process;branched
exp EIF2B3 1p34.1 0.256 0.0483 0.487 negative regulation of
xsq FOXN4 12q24.11 0.256 0.0483 0.487 neuron fate commitment;axon
extension
exp L2HGDH 14q21.3 0.256 0.0483 0.487 cellular protein metabolic
exp PRR5L 11p13-p12 -0.256 0.0483 0.487
his URGCP-MRPS24 -0.258 0.0483 0.487
exp MTAPP2 -0.258 0.0483 0.487
hs4 MAPRE3 2p23.3-p23.1 -0.258 0.0483 0.487 cell division;cell
cycle
his LOC101929523 -0.258 0.0483 0.487
his PFN3 5q35.3 0.258 0.0484 0.487 actin cytoskeleton organization
xai RHPN1-AS1 8q24 0.258 0.0484 0.487
xai ABCC8 11p15.1 0.258 0.0484 0.487 ABC Transporters
xai CHRM3 1q43 0.258 0.0484 0.487 signal transduction;regulation of insulin
secretion
xai YBX1P2 7q22.3 0.258 0.0484 0.487
xai LOC100506031 0.258 0.0484 0.487
hs4 ONECUT3 19p13.3 0.258 0.0484 0.488 endocrine pancreas
development;regulation of transcription from RNA polymerase II promoter
xai TMEM186 16p13.2 0.258 0.0484 0.488
his OR1G1 17p13.3 0.258 0.0484 0.488 signal transduction;response to
stimulus
xai EIF4A1P6 13q21.2 0.258 0.0484 0.488
xsq RFPL3S 22q12.3 0.256 0.0484 0.487
exp ATF5 19q13.3 0.256 0.0484 0.488 negative regulation of astrocyte
exp SPIRE1 18p11.21 -0.256 0.0484 0.487 transport
met DNAJC12 10q22.1 -0.256 0.0484 0.487 protein folding
exp SERTAD3 19q13.2 -0.256 0.0484 0.487 negative regulation of
cell growth;positive regulation of transcription, DNA-dependent"
xai ANKRD34C-AS1 -0.258 0.0484 0.487
xai AGAP1 2q37 -0.258 0.0484 0.487 small GTPase mediated signal
his CNTRL 9q33.2 0.258 0.0485 0.488 G2/M transition of mitotic cell
his USP14 18p11.32 0.258 0.0485 0.488 proteolysis;ubiquitin-dependent
hs4 C22orf15 22q11.23 0.258 0.0485 0.488
xai LARP1 5q33.2 0.258 0.0485 0.488
xai RBM38 20q13.31 0.258 0.0485 0.488 DNA damage response, signal
mediator;cell cycle
his POLA2 11q13.1 0.258 0.0485 0.488 DNA Damage Response (DDR); DDR (DNA
replication)
DNA-dependent"
his TSSC2 0.258 0.0485 0.488
hs4 C3AR1 12p13.31 0.258 0.0485 0.488 blood circulation;regulation of
blood pressure
met SMPDL3A 6q22.31 0.256 0.0485 0.488 sphingomyelin catabolic
cop CCNK 14q32 0.256 0.0485 0.488 cell division;regulation of cyclin-
exp LOC390876 19p13.3 0.256 0.0485 0.488
xsq NIF3L1 2q33 0.256 0.0485 0.488 positive regulation of
cop CETP 16q21 0.256 0.0485 0.488 cholesterol metabolic process;lipoprotein
metabolic process
exp CRIM1 2p21 -0.256 0.0485 0.488 regulation of cell growth;nervous
system development
met NANOS2 19q13.32 -0.256 0.0485 0.488 spermatogenesis;cell
differentiation
xai ARL4D 17q21.31 -0.258 0.0485 0.488 GTP catabolic process;small
hs4 TANC1 2q24.2 -0.258 0.0485 0.488
hs4 HOXA1 7p15.3 -0.258 0.0485 0.488 multicellular organismal
development;rhombomere 4 development
hs4 HOTAIRM1 -0.258 0.0485 0.488
hs4 HOXA2 7p15.2 -0.258 0.0485 0.488 anterior/posterior pattern
specification;embryonic viscerocranium morphogenesis
his FAM53B-AS1 0.258 0.0486 0.488
xai CCNJ 10q23.33 0.258 0.0486 0.488
his LOC105374366 0.258 0.0486 0.488
his LOC93622 4p16.1 0.258 0.0486 0.488
his DNAJA1 9p13.3 0.258 0.0486 0.488 protein folding;response to
unfolded protein
hs4 CD38 4p15 0.258 0.0486 0.488 response to hormone stimulus;response to
drug
xai KIF4CP Xq21.1 0.258 0.0486 0.488
xai RANP6 4q34.1 0.258 0.0486 0.488
xai TELO2 16p13.3 0.258 0.0486 0.488 DNA Damage Response (DDR); DDR (FA)
exp RSPH10B2 7p22.1 0.256 0.0486 0.488
xsq DAZAP1 19p13.3 0.256 0.0486 0.488 multicellular organismal
exp USP42 7p22.1 0.256 0.0486 0.488 spermatogenesis;protein
deubiquitination
xsq IGSF6 0.256 0.0486 0.488 immune response;cell surface receptor
signaling pathway
met RPS6KA6 Xq21 0.256 0.0486 0.488 Protein Kinases
mut ATP8A2 13q12 0.256 0.0486 0.488 cation transport;negative
cop PLEKHG6 12p13.31 0.256 0.0486 0.488 regulation of Rho protein
signal transduction
cop TNFRSF1A 12p13.2 0.256 0.0486 0.488 Apoptosis
cop SCNN1A 12p13 0.256 0.0486 0.488 ion transport;sodium ion transport
cop LTBR 12p13 0.256 0.0486 0.488 Apoptosis
cop CD27-AS1 12p13.31 0.256 0.0486 0.488
cop CD27 12p13 0.256 0.0486 0.488 Apoptosis
cop TAPBPL 12p13.31 0.256 0.0486 0.488 antigen processing and
presentation of endogenous peptide antigen via MHC class I
exp POLR2C 16q13-q21 0.256 0.0486 0.488 DNA Damage Response (DDR);
DDR (NER)
exp LOC644295 14q12 0.256 0.0486 0.488
xsq NOL11 17q24.2 0.256 0.0486 0.488
xai WWC1 5q34 -0.258 0.0486 0.488 regulation of transcription, DNA-
hs4 ADAMTS9 3p14.1 -0.258 0.0486 0.488 proteolysis;glycoprotein
catabolic process
hs4 ADAMTS9-AS2 -0.258 0.0486 0.488
hs4 GABRE Xq28 -0.258 0.0486 0.488 transport;ion transport
his MIR3681HG -0.258 0.0486 0.488
his LOC101929297 0.258 0.0487 0.488
his RPS25 11q23.3 0.258 0.0487 0.488 translation;mRNA metabolic process
his TRAPPC4 11q23.3 0.258 0.0487 0.488 ER to Golgi vesicle-mediated
his MIR3656 0.258 0.0487 0.488
exp C9orf153 9q21.33 0.258 0.0487 0.488
his LMAN1 18q21.3-q22 0.258 0.0487 0.488 blood coagulation;cellular protein
metabolic process
his CYP27B1 12q14.1 0.258 0.0487 0.488 negative regulation of
xai EXOSC3P1 21q22.11 0.258 0.0487 0.488
his ENDOG 9q34.1 0.258 0.0487 0.489 response to antibiotic;in utero
xsq RPS10 6p21.31 0.256 0.0487 0.488 viral reproduction;nuclear-
xsq PDHA1 Xp22.1 0.256 0.0487 0.488 pyruvate metabolic
process;glycolysis
xsq SECISBP2 9q22.2 0.256 0.0487 0.488 translation
mut ZC3HAV1 7q34 0.256 0.0487 0.488 response to virus;regulation of
defense response to virus by host
exp KLHL12 1q32.1 0.256 0.0487 0.488 Wnt receptor signaling
pathway
exp LOC550644 2q11.2 0.256 0.0487 0.489
xsq C17orf80 17q25.1 0.256 0.0487 0.489
exp CTAGE9 6q23.2 -0.256 0.0487 0.488
hs4 ZNF35 3p21.32 -0.258 0.0487 0.488 regulation of transcription,
DNA-dependent;spermatogenesis
his TNC 9q33 -0.258 0.0487 0.488 positive regulation of gene
xai ANAPC5 12q24.31 0.258 0.0488 0.489 G2/M transition of mitotic
mitotic cell cycle
hs4 CRMP1 4p16.1 0.258 0.0488 0.489 nervous system development;axon
guidance
his GNAS 20q13.3 0.258 0.0488 0.489 Oncogenes
his LOC101927932 0.258 0.0488 0.489
hs4 LINC01684 0.258 0.0488 0.489
hs4 RNASE2 14q11.2 0.258 0.0488 0.489 RNA catabolic
process;chemotaxis
xai RNF20 9q22 0.258 0.0488 0.489 regulation of transcription, DNA-
his NDST2 10q22 0.258 0.0488 0.489 cellular process;heparan sulfate
xai MAP10 1q42.2 0.258 0.0488 0.489
met FFAR4 10q23.33 0.256 0.0488 0.489
xsq HINT3 6q22.32 0.256 0.0488 0.489
xsq METAP1 4q23 0.256 0.0488 0.489 regulation of
met SQSTM1 5q35 0.255 0.0488 0.489 Apoptosis
met PKD2 4q22.1 0.255 0.0488 0.489 embryonic placenta
xsq CHRM3 1q43 0.255 0.0488 0.489 signal transduction;regulation of insulin
secretion
pro KRT20 17q21.2 -0.255 0.0488 0.489 cellular response to
stress;intermediate filament organization
exp ANKRD9 14q32.31 -0.255 0.0488 0.489
xai DUSP10 1q41 -0.258 0.0488 0.489 JNK cascade;response to
organic substance
hs4 TBC1D16 17q25.3 -0.258 0.0488 0.489
hs4 CCDC40 17q25.3 -0.258 0.0488 0.489 axonemal dynein complex
exp IGHEP2 9p24.1 -0.258 0.0488 0.489
his LOC100506271 -0.258 0.0488 0.489
hs4 NUDT8 11q13.2 0.258 0.0489 0.489
xai RPSAP9 9q21.13 0.258 0.0489 0.489
xai TIMM13 19p13.3 0.258 0.0489 0.489 sensory perception of
his NGRN 15q26.1 0.258 0.0489 0.489 multicellular organismal
his CIB1 15q25.3-q26 0.258 0.0489 0.489 Apoptosis; DNA Damage Response
(DDR)
xai GPATCH8 17q21.31 0.258 0.0489 0.489
xai GPANK1 6p21.3 0.258 0.0489 0.489
his RGL4 22q11.23 0.258 0.0489 0.489 small GTPase mediated signal
transduction
xai SNORD15B 11q13.4 0.258 0.0489 0.489
his NDUFB6 9p21.1 0.258 0.0489 0.489 transport;respiratory
xai ANXA2R 5p12 0.258 0.0489 0.489
xsq EIF4B 12q13.13 0.255 0.0489 0.489 gene expression;RNA metabolic
process
met CTSH 15q25.1 0.255 0.0489 0.489 positive regulation of cell
exp MYH15 3q13.13 0.255 0.0489 0.489
exp NOP9 14q12 0.255 0.0489 0.489
exp HAND2-AS1 4q34.1 0.255 0.0489 0.489
exp EIF4A1P2 Yp11.2 0.255 0.0489 0.489
exp TMEM54 1p35-p34 -0.255 0.0489 0.489
met ADCY3 2p23.3 -0.255 0.0489 0.489 energy reserve metabolic
xsq TMEM139 7q34 -0.255 0.0489 0.489
hs4 HAGLR -0.258 0.0489 0.489
hs4 HOXD1 2q31.1 -0.258 0.0489 0.489 multicellular organismal
hs4 MIR7704 -0.258 0.0489 0.489
hs4 MCHR1 22q13.2 -0.258 0.0489 0.489
hs4 SLFN12 17q12 -0.258 0.0489 0.489
his MIR138-1 -0.258 0.0489 0.489
xai S100A11P1 -0.258 0.0489 0.489
xai IGHEP2 9p24.1 -0.258 0.0489 0.489
his MBLAC2 5q14.3 0.258 0.049 0.489
his POLR3G 5q14.3 0.258 0.049 0.489 positive regulation of innate
swa HAS1 19q13.4 0.257 0.049 0.489 glycosaminoglycan biosynthetic
his CCDC43 17q21.31 0.257 0.049 0.489
xai MGAT4C 12q21 0.257 0.049 0.489 cellular protein metabolic
his UCKL1 20q13.33 0.257 0.049 0.489 interspecies interaction between
his UCKL1-AS1 20q13.33 0.257 0.049 0.489
his JAML 0.257 0.049 0.489 cell adhesion;heterophilic cell-cell adhesion
xai SDHB 1p36.1-p35 0.257 0.049 0.489 tricarboxylic acid cycle;succinate
metabolic process
xai NAP1L1P1 11q24.2 0.257 0.049 0.489
xai SSTR3 22q13.1 0.257 0.049 0.489 cell-cell signaling;cellular response to
estradiol stimulus
dependent"
exp GAPDHP32 1p12 0.257 0.049 0.489
dependent"
xai RPL6 12q24.1 0.257 0.049 0.489 SRP-dependent cotranslational protein
exp RANP6 4q34.1 0.257 0.049 0.489
exp ALOX12P2 17p13 0.255 0.049 0.489
met LGALS13 19q13.1 0.255 0.049 0.489 phospholipid metabolic
met SHROOM2 Xp22.3 0.255 0.049 0.489 eye pigment granule
exp LARP4 12q13.12 0.255 0.049 0.489 cytoskeleton organization;regulation of
cell morphogenesis
exp RPL26P12 1q24.1 0.255 0.049 0.489
cop MIR302F 0.255 0.049 0.489
xsq SEMA3B 3p21.3 -0.255 0.049 0.489 axon guidance;cell-cell
signaling
xsq VEGFA 6p12 -0.255 0.049 0.489 patterning of blood vessels;positive
met SYNPO 5q33.1 -0.255 0.049 0.489 positive regulation of actin
met TXK 4p12 -0.255 0.049 0.489 cytokine production;protein
autophosphorylation
exp PAM 5q14-q21 -0.255 0.049 0.489 response to drug;response to
hypoxia
xsq CDC42EP4 17q24-q25 -0.255 0.049 0.489 Rho protein signal
exp CDK16 Xp11 -0.255 0.049 0.489 Protein Kinases
his ABCA12 2q34 -0.257 0.049 0.489 ABC Transporters
xai GATA6 18q11.1-q11.2 -0.258 0.049 0.489 pancreatic A cell
xai HSDL1 16q23.3 0.257 0.0491 0.489
xai ATXN7L3B 12q21 0.257 0.0491 0.489
exp LOC731157 5q14.3 0.257 0.0491 0.489
exp DRICH1 0.257 0.0491 0.489
xai TRIM28 19q13.4 0.257 0.0491 0.489 DNA Damage Response (DDR)
his C1orf162 1p13.2 0.257 0.0491 0.489
his MPHOSPH6 16q23.3 0.257 0.0491 0.489 M phase of mitotic cell
his EGFL7 9q34.3 0.257 0.0491 0.489 angiogenesis;blood vessel
development
swa SUV39H2 10p13 0.257 0.0491 0.489 chromatin assembly or
his FKBP8 19p12 0.257 0.0491 0.489 interspecies interaction between
organisms;protein peptidyl-prolyl isomerization
xai MKI67IPP4 0.257 0.0491 0.489
exp NOS3 7q36 0.255 0.0491 0.489 regulation of sodium ion transport;blood
coagulation
exp MTF2 1p22.1 0.255 0.0491 0.489
xsq RPGR Xp21.1 0.255 0.0491 0.489 visual perception;cell projection
organization
xsq MAP9 4q32.1 -0.255 0.0491 0.489 cell division;cell cycle
xsq LOC102724927 -0.255 0.0491 0.489
hs4 FBLN5 14q32.1 -0.257 0.0491 0.489 regulation of removal of
superoxide radicals;cell adhesion
xai RTP1 3q27.3 -0.257 0.0491 0.489 protein insertion into
membrane
hs4 CYP39A1 6p21.1-p11.2 -0.257 0.0491 0.489 small molecule
metabolic process;bile acid biosynthetic process
hs4 SLC25A21-AS1 14q13.3 -0.257 0.0491 0.489
xai VAV1 19p13.2 0.257 0.0492 0.49 regulation of transcription, DNA-
his ABCC10 6p21.1 0.257 0.0492 0.49 ABC Transporters
his SNORA69 0.257 0.0492 0.49
his RPL39 Xq24 0.257 0.0492 0.49 translational termination;cellular
xai NSUN4 1p34 0.257 0.0492 0.49
exp LINC01193 0.257 0.0492 0.49
xai RPL27AP5 5q13.3 0.257 0.0492 0.49
xai HMGA1 6p21 0.257 0.0492 0.49 protein complex assembly;interspecies
swa SMARCE1 17q21.2 0.257 0.0492 0.49 DNA Damage Response (DDR);
DDR (Chromatin)
hs4 LOC102724467 0.257 0.0492 0.49
xai LRRC16B 14q11.2 0.257 0.0492 0.49
xai TSPAN7 Xp11.4 0.257 0.0492 0.49 interspecies interaction
between organisms
exp FLT3 13q12 0.255 0.0492 0.49 Cell Signaling; Oncogenes
xsq CCBL1 9q34.11 0.255 0.0492 0.49 cellular amino acid biosynthetic
exp PLEKHG3 14q23.3 -0.255 0.0492 0.49 regulation of Rho
swa TWF1 12q12 -0.257 0.0492 0.49 negative regulation of actin
filament polymerization;sequestering of actin monomers
his C1QL1 17q21 -0.257 0.0492 0.49 locomotory behavior
hs4 RGS3 9q32 -0.257 0.0492 0.49 inactivation of MAPK
his MIR6070 -0.257 0.0492 0.49
his LOC101929076 0.257 0.0493 0.49
his RNU6-1 15q23 0.257 0.0493 0.49
his MIR586 0.257 0.0493 0.49
his CBX2 17q25.3 0.257 0.0493 0.49 development of primary sexual
xai NDUFA5P12 8q11.1 0.257 0.0493 0.49
hs4 NEUROD4 12q13.2 0.257 0.0493 0.49
hs4 GAB3 Xq28 0.257 0.0493 0.49
his PSMD7 16q22.3 0.257 0.0493 0.49 protein polyubiquitination;gene
expression
xai TATDN2 3p25.3 0.257 0.0493 0.49 activation of signaling
xai HIGD1C 0.257 0.0493 0.49
mut OR5D14 0.255 0.0493 0.49
exp TMEM33 4p13 0.255 0.0493 0.49
exp RHOU 1q42.11-q42.3 0.255 0.0493 0.49 G1/S transition of mitotic
exp SUMO2P3 0.255 0.0493 0.49
mut LRRTM3 10q21.3 0.255 0.0493 0.49
exp KRTAP4-8 17q21.2 0.255 0.0493 0.49
exp VPS13A 9q21 0.255 0.0493 0.49 Golgi to endosome transport;nervous
system development
exp BICD1 12p11.2-p11.1 -0.255 0.0493 0.49 positive regulation of
hs4 RTN4R 22q11.21 -0.257 0.0493 0.49 axonogenesis;nerve growth
xai ATP6V1E1P1 1p34.2 -0.257 0.0493 0.49
his MIR152 -0.257 0.0493 0.49
his COPZ2 17q21.32 -0.257 0.0493 0.49 intracellular protein
xai MLLT4-AS1 6q27 -0.257 0.0493 0.49
xai PROM2 2q11.1 -0.257 0.0493 0.49
his LINC00536 -0.257 0.0493 0.49
xai ABCC6P1 16p12.3 -0.257 0.0493 0.49
his CCT4 2p15 0.257 0.0494 0.49 protein folding;cellular protein
metabolic process
his COMMD1 2p15 0.257 0.0494 0.49 positive regulation of protein
ubiquitination;negative regulation of NF-kappaB transcription factor activity
swa PSMA1 11p15.1 0.257 0.0494 0.49 M/G1 transition of mitotic cell
cycle;gene expression
his RAB6A 11q13.3 0.257 0.0494 0.49 peptidyl-cysteine
exp HIGD1C 0.257 0.0494 0.49
his LINC00461 5q14.3 0.257 0.0494 0.49
xai M6PR 12p13 0.257 0.0494 0.49 transport;receptor-mediated endocytosis
exp OR7E38P 7q21.3 0.257 0.0494 0.49
xai TRBV4-2 7q34 0.257 0.0494 0.49
swa PHB2 12p13 0.257 0.0494 0.49 negative regulation of transcription,
DNA-dependent"
xai LARP4 12q13.12 0.257 0.0494 0.49 cytoskeleton
organization;regulation of cell morphogenesis
xai RPL19 17q12 0.257 0.0494 0.49 SRP-dependent cotranslational protein
hs4 DNASE1L1 Xq28 0.257 0.0494 0.49 DNA metabolic process;DNA catabolic
process
hs4 TAZ Xq28 0.257 0.0494 0.49 cristae formation;muscle contraction
xai RPS14 5q31-q33 0.257 0.0494 0.49 nuclear-transcribed mRNA catabolic
his TFDP1 13q34 0.257 0.0494 0.49 Apoptosis
xsq LINC00926 15q21.3 0.255 0.0494 0.49
xsq FARSB 2q36.1 0.255 0.0494 0.49 gene expression;translation
xsq USP1 1p31.3 0.255 0.0494 0.49 DNA Damage Response (DDR); DDR (FA)
met KIF16B 20p11.23 0.255 0.0494 0.49 transport;early endosome to
late endosome transport
exp MLLT6 17q21 0.255 0.0494 0.49 regulation of transcription, DNA-
dependent"
exp MEAF6 1p35.3-p33 0.255 0.0494 0.49 regulation of transcription, DNA-
xsq STARD7 2q11.2 0.255 0.0494 0.49
cop ARID1B 6q25.1 0.255 0.0494 0.49 DNA Damage Response (DDR);
DDR (Chromatin)
xsq ADRA2B 2q11.1 0.255 0.0494 0.49 cell-cell signaling;positive
regulation of blood pressure
xsq ZC3H12B Xq12 0.255 0.0494 0.49
exp HACD1 -0.255 0.0494 0.49 fatty acid biosynthetic
xsq FNDC4 2p23.3 -0.255 0.0494 0.49
hs4 LINC01273 -0.257 0.0494 0.49
hs4 SYT2 1q32.1 -0.257 0.0494 0.49 synaptic
exp MIR3605 -0.257 0.0494 0.49
hs4 IFI44L 1p31.1 -0.257 0.0494 0.49 immune response;response
to virus
xai VPS13A 9q21 0.257 0.0495 0.49 Golgi to endosome transport;nervous
system development
xai HNRNPA3P1 10q11.21 0.257 0.0495 0.49
his SNRK 3p22.1 0.257 0.0495 0.49 Apoptosis
xai RPS3AP5 10q23.1 0.257 0.0495 0.491
hs4 RRN3P2 16p11.2 0.257 0.0495 0.491
swa SMU1 9p12 0.257 0.0495 0.491
exp GCN1 0.255 0.0495 0.49 translation;regulation of translation
met GRM7 3p26.1-p25.1 0.255 0.0495 0.49 negative regulation of
glutamate secretion;conditioned taste aversion
xsq GPR139 16p12.3 0.255 0.0495 0.49
xsq NDUFB8 10q24.31 0.255 0.0495 0.49 transport;respiratory
xsq GPN3 12q24.11 0.255 0.0495 0.49
exp STT3B 3p23 0.255 0.0495 0.491 protein glycosylation;protein N-linked
exp C2CD5 12p12.1 0.255 0.0495 0.491
met C1orf228 1p34.1 0.255 0.0495 0.491
xsq RRM2 2p25-p24 0.255 0.0495 0.491 DNA Damage Response (DDR)
xsq FCAMR 1q32.1 0.255 0.0495 0.491
met STRA6 15q24.1 -0.255 0.0495 0.49 ventricular septum
development;vocal learning
hs4 OLFML2A 9q33.3 -0.257 0.0495 0.491 extracellular matrix
organization
exp MLLT4-AS1 6q27 -0.257 0.0495 0.49
swa COL5A2 2q14-q32 -0.257 0.0495 0.49 collagen fibril
organization;skin development
xai MIR3605 -0.257 0.0495 0.49
his MXI1 10q24-q25 0.257 0.0496 0.491 Apoptosis
hs4 PRAM1 19p13.2 0.257 0.0496 0.491 integrin-mediated signaling
exp TRBV4-2 7q34 0.257 0.0496 0.491
his FGF8 10q24 0.257 0.0496 0.491 outflow tract septum
morphogenesis;odontogenesis
his NPM3 10q24.31 0.257 0.0496 0.491 rRNA transcription;rRNA processing
xai HMGB3P11 2q12.1 0.257 0.0496 0.491
xai PTPRN 2q35-q36.1 0.257 0.0496 0.491 cytokine-mediated signaling
xai ALDH1A2 15q21.3 0.257 0.0496 0.491 heart morphogenesis;positive
swa SOD1 21q22.11 0.257 0.0496 0.491 DNA Damage Response (DDR)
hs4 TNFRSF17 16p13.1 0.257 0.0496 0.491 multicellular organismal
xai SNUPN 15q24.2 0.257 0.0496 0.491 ncRNA metabolic process;snRNA
import into nucleus
xai PSMD7 16q22.3 0.257 0.0496 0.491 protein polyubiquitination;gene
expression
xai FANCM 14q21.2 0.257 0.0496 0.491 DNA Damage Response (DDR); DDR (FA)
hs4 TNFRSF13B 17p11.2 0.257 0.0496 0.491 B cell homeostasis;cell
xai MED1 17q12 0.257 0.0496 0.491 positive regulation of interferon-gamma-
mediated signaling pathway;cellular response to steroid hormone stimulus
exp NLRP5 19q13.43 0.255 0.0496 0.491
met ARL4D 17q21.31 0.255 0.0496 0.491 GTP catabolic process;small GTPase
xsq OR2G2 1q44 0.255 0.0496 0.491 response to stimulus
exp HLA-G 6p21.3 -0.255 0.0496 0.491 cytokine-mediated signaling
xsq ZBTB20 3q13.2 -0.255 0.0496 0.491 regulation of
hs4 DNAAF3 19q13.4 -0.257 0.0496 0.491
his TPD52L1 6q22-q23 -0.257 0.0496 0.491 G2/M transition of
hs4 BOK-AS1 -0.257 0.0496 0.491
hs4 BOK 2q37.3 -0.257 0.0496 0.491 male gonad
his LOC105371907 -0.257 0.0496 0.491
xai GLYATL2 11q12.1 -0.257 0.0496 0.491
xai MYO1B 2q12-q34 -0.257 0.0496 0.491 actin filament-based
movement;actin filament bundle assembly
his MIR5006 -0.257 0.0496 0.491
xai ZBTB8OSP1 0.257 0.0497 0.491
xai CIDEB 14q12 0.257 0.0497 0.491 apoptotic process;induction of apoptosis
exp HSPA8P5 12p13.32 0.257 0.0497 0.491
his CSTF2T 10q11 0.257 0.0497 0.491 mRNA processing
exp CHRNA4 20q13.33 0.257 0.0497 0.491 signal transduction;B cell
activation
xai CCL20 2q36.3 0.257 0.0497 0.491 immune response;signal transduction
exp LOC100507046 0.257 0.0497 0.491
hs4 LOC101928961 0.257 0.0497 0.491
met TMEM132D 12q24.33 0.255 0.0497 0.491 negative regulation of
exp CTDSP1 2q35 0.255 0.0497 0.491 negative regulation of neuron
xsq AAAS 12q13 0.255 0.0497 0.491 hexose transport;transmembrane transport
met P3H2 0.254 0.0497 0.491 negative regulation of cell
exp KISS1R 19p13.3 0.254 0.0497 0.491 neuropeptide signaling
exp VPS51 11q13 0.254 0.0497 0.491
xsq FLJ46906 6q24.1 -0.255 0.0497 0.491
xsq BAG3 10q25.2-q26.2 -0.255 0.0497 0.491 Apoptosis
met SRSF8 11q22 -0.255 0.0497 0.491 mRNA processing;RNA splicing
exp LYPD1 2q21.2 -0.255 0.0497 0.491
exp DYX1C1 15q21.3 -0.255 0.0497 0.491 neuron migration;nervous
system development
exp DMWD 19q13.3 -0.255 0.0497 0.491 meiosis
his THSD4-AS2 -0.257 0.0497 0.491
xai ACTB 7p22 -0.257 0.0497 0.491 axon guidance;blood coagulation
hs4 PCDHB16 5q31 -0.257 0.0497 0.491 synapse assembly;calcium-
dependent cell-cell adhesion
xai TUBB6 18p11.21 -0.257 0.0497 0.491 microtubule-based
movement;cellular protein metabolic process
hs4 MAP3K7CL 21q22.3 0.257 0.0498 0.491
his CSTF2 Xq22.1 0.257 0.0498 0.491 gene expression;nuclear mRNA
xai AQP3 9p13 0.257 0.0498 0.491 urea transport;response to retinoic acid
his BUB3 10q26 0.257 0.0498 0.491 attachment of spindle microtubules to
swa SMARCAD1 4q22-q23 0.257 0.0498 0.491 DNA Damage Response (DDR)
xai SOCS7 17q12 0.257 0.0498 0.491 insulin receptor signaling
xsq MYBL2 20q13.1 0.254 0.0498 0.491 Apoptosis
xsq IGBP1 Xq13.1-q13.3 0.254 0.0498 0.491 negative regulation of
stress-activated MAPK cascade;regulation of microtubule-based movement
xsq NUP43 6q25.1 0.254 0.0498 0.491 mitotic cell cycle;cytokine-
exp NUP85 17q25.1 0.254 0.0498 0.491 protein transport;transmembrane
transport
xsq LETM1 4p16.3 0.254 0.0498 0.491 cristae formation
xsq MAD2L1 4q27 0.254 0.0498 0.491 DNA Damage Response (DDR)
mut ARFGAP1 20q13.33 0.254 0.0498 0.491 vesicle-mediated
transport;endoplasmic reticulum unfolded protein response
cop BCL11B 14q32.2 0.254 0.0498 0.491 regulation of lipid metabolic
xsq PYGO1 15q21.3 -0.254 0.0498 0.491 kidney development;post-
xsq FAM196A 10q26.2 -0.254 0.0498 0.491
exp CERCAM 9q34.11 -0.254 0.0498 0.491 cellular component
met SLC28A1 15q25.3 -0.254 0.0498 0.491 nucleobase-containing
compound metabolic process;nucleoside transport
cop AMPH 7p14-p13 -0.254 0.0498 0.491 synaptic
transmission;learning
xai NPTN 15q22 -0.257 0.0498 0.491 elevation of cytosolic calcium ion
concentration;nervous system development
xai GAS8 16q24.3 -0.257 0.0498 0.491 negative regulation of cell
his FBXL2 3p22.3 -0.257 0.0498 0.491 protein modification
process;proteolysis
xai HLA-C 6p21.3 -0.257 0.0498 0.491 antigen processing and
presentation of peptide antigen via MHC class I;regulation of immune response
hs4 DYNC2H1 11q21-q22.1 -0.257 0.0498 0.491 microtubule-based
movement;Golgi organization
xai POLR2A 17p13.1 0.257 0.0499 0.491 DNA Damage Response (DDR);
DDR (NER)
his LINC01339 0.257 0.0499 0.491
hs4 MIR181C 0.257 0.0499 0.491
hs4 MIR181D 0.257 0.0499 0.491
exp LOC650226 7p11.2 0.257 0.0499 0.491
xai MAD2L1 4q27 0.256 0.0499 0.491 DNA Damage Response (DDR)
his CDCA5 11q12.1 0.256 0.0499 0.491 cell division;G1/S transition of
mitotic cell cycle
his ZFPL1 11q13 0.256 0.0499 0.491 regulation of transcription, DNA-
exp GRID2 4q22 0.256 0.0499 0.491 transport;ion transport
xai DEPDC4 12q23.1 0.256 0.0499 0.491 intracellular signal
transduction
exp LOC100506031 0.256 0.0499 0.491
xsq REL 2p13-p12 0.254 0.0499 0.491 Apoptosis; Oncogenes
xsq DENND4A 15q22.31 0.254 0.0499 0.491 regulation of transcription,
DNA-dependent"
met KIAA1456 8p22 0.254 0.0499 0.491 metabolic process
xsq METTL4 18p11.32 0.254 0.0499 0.491 nucleobase-containing
xsq KCNH2 7q36.1 0.254 0.0499 0.491 synaptic transmission;blood
circulation
exp DLC1 8p22 -0.254 0.0499 0.491 induction of apoptosis;actin
cop C5orf49 5p15.31 -0.254 0.0499 0.491
met HIST3H3 1q42 -0.254 0.0499 0.491 telomere
maintenance;nucleosome assembly
exp MAP1B 5q13 -0.254 0.0499 0.491 central nervous system
xsq EXD3 9q34.3 -0.254 0.0499 0.491 nucleobase-containing
xsq LMO4 1p22.3 -0.254 0.0499 0.491 spinal cord association
xai TTTY7 -0.256 0.0499 0.491
exp ST7 7q31.2 -0.256 0.0499 0.491
hs4 RAB6B 3q22.1 -0.256 0.0499 0.491 retrograde vesicle-mediated
transport, Golgi to ER;small GTPase mediated signal transduction
xai NABP1 2q32.3 -0.256 0.0499 0.491 DNA Damage Response (DDR)
xai IPO8P1 -0.256 0.0499 0.491
xai ST7 7q31.2 -0.257 0.0499 0.491
exp FAM183A 1p34.2 -0.257 0.0499 0.491
xai RPL35P8 22q13.33 0.259 0.05 0.492
his EGFEM1P 3q26.2 0.256 0.05 0.491
xai PHF21B 22q13.31 0.256 0.05 0.492
xai TPO 2p25 0.256 0.05 0.492 thyroid hormone generation;response to
oxidative stress
xai SNORA30 16p11.2 0.256 0.05 0.492
his SMAP1 6q13 0.256 0.05 0.492 regulation of ARF GTPase activity;positive
regulation of erythrocyte differentiation
xai DUS2 0.256 0.05 0.492 tRNA processing
xai GUF1 4p12 0.256 0.05 0.492 translation
his EDEM1 3p26.1 0.256 0.05 0.492 protein N-linked glycosylation via
asparagine;ER-associated protein catabolic process
xsq TRUB2 9q34.11 0.254 0.05 0.492 RNA processing;tRNA processing
cop SYNJ2 6q25.3 0.254 0.05 0.492 phosphatidylinositol
exp RTP1 3q27.3 -0.256 0.05 0.492 protein insertion into membrane
xai IDO1 8p12-p11 -0.256 0.05 0.492 female pregnancy;cellular nitrogen
xai SLCO2A1 3q21 -0.256 0.05 0.492 Solute Carriers
xai YAP1P1 6q24.3 -0.256 0.05 0.492
his PTN 7q33 -0.256 0.05 0.492 positive regulation of cell
exp IGLC4 0.256 0.0501 0.492
exp SCARNA6 0.256 0.0501 0.492
hs4 MLC1 22q13.33 0.256 0.0501 0.492 cellular response to
xai SCARNA6 0.256 0.0501 0.492
xai HSD17B13 4q22.1 0.256 0.0501 0.492
xai CRMP1 4p16.1 0.256 0.0501 0.492 nervous system development;axon
guidance
cop MIR1247 0.256 0.0501 0.492
hs4 ARPP19 15q21.2 0.256 0.0501 0.492 G2/M transition of mitotic
cell cycle;cell cycle
exp SNORA30 16p11.2 0.256 0.0501 0.492
xai MIEF1 0.256 0.0501 0.492 mitochondrial fusion
xai CCND2 12p13 0.256 0.0501 0.492 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
xsq MPI 15q24.1 0.254 0.0501 0.492 carbohydrate metabolic
xsq AMN1 12p11.21 0.254 0.0501 0.492 DNA Damage Response (DDR)
xsq AMICA1 11q23.3 0.254 0.0501 0.492
exp MC4R 18q22 0.254 0.0501 0.492 positive regulation of cAMP biosynthetic
met GPC6 13q32 0.254 0.0501 0.492
DNA-dependent"
mut CARNMT1 0.254 0.0501 0.492
exp SYT9 11p15.4 0.254 0.0501 0.492 regulation of calcium ion-dependent
xsq LURAP1 1p34 -0.254 0.0501 0.492 positive regulation of
exp CRELD1 3p25.3 -0.254 0.0501 0.492 endocardial cushion
met SEC14L4 22q12.2 -0.254 0.0501 0.492
hs4 CFAP43 -0.256 0.0501 0.492
his LOC284344 -0.256 0.0501 0.492
hs4 RGL3 19p13.2 -0.256 0.0501 0.492 signal
xai SVEP1 9q32 0.256 0.0502 0.492 cell adhesion
exp RD3L 0.256 0.0502 0.492
his RNY3 7q36 0.256 0.0502 0.492
his RNY1 7q36 0.256 0.0502 0.492
his GHET1 0.256 0.0502 0.492
xai LINC01193 0.256 0.0502 0.492
xai REG4 1p13.1-p12 0.256 0.0502 0.492
his LBR 1q42.1 0.256 0.0502 0.492 cholesterol biosynthetic
his TOPORS-AS1 9p21.1 0.256 0.0502 0.492
his TOPORS 9p21 0.256 0.0502 0.492 transcription, DNA-
dependent;regulation of cell proliferation
his MIR3123 0.256 0.0502 0.492
xai ZC3H15 2q32.1 0.256 0.0502 0.492 cytokine-mediated signaling
pathway
his LYSMD2 15q21.2 0.256 0.0502 0.492 cell wall macromolecule
catabolic process
xai RD3L 0.256 0.0502 0.492
exp PATZ1 22q12.2 0.254 0.0502 0.492 regulation of transcription, DNA-
xsq USP17L15 0.254 0.0502 0.492
xsq RPL13P5 12p13.31 0.254 0.0502 0.492
exp RPS11P7 Xp11.4 0.254 0.0502 0.492
exp AHSA1 14q24 0.254 0.0502 0.492 positive regulation of ATPase
xsq SOD3 4p15.2 -0.254 0.0502 0.492 removal of superoxide
exp ARTN 1p33-p32 -0.254 0.0502 0.492 signal
transduction;neuroblast proliferation
met FASLG 1q23 -0.254 0.0502 0.492 Apoptosis
xai IFT43 14q24.3 -0.256 0.0502 0.492 cell projection
his TNNT2 1q32 -0.256 0.0502 0.492 response to calcium ion;ventricular
cardiac muscle tissue morphogenesis
hs4 S100A10 1q21 -0.256 0.0502 0.492 signal transduction;positive
swa CDK1 10q21.1 0.256 0.0503 0.492 DDR (DNA replication); Protein
Kinases
his MDH1 2p13.3 0.256 0.0503 0.492 carbohydrate metabolic
his WDPCP 2p15 0.256 0.0503 0.492 regulation of embryonic cell shape;cell
his PPIAL4G 0.256 0.0503 0.493 protein folding
hs4 RNASE6 14q11.2 0.256 0.0503 0.493 RNA catabolic process;defense
response
his THUMPD2 2p22.1 0.256 0.0503 0.493
swa GSS 20q11.2 0.256 0.0503 0.493 xenobiotic metabolic process;small
exp GGA3 17q25.1 0.254 0.0503 0.492 intracellular protein
exp BRIX1 5p13.2 0.254 0.0503 0.492 ribosome biogenesis
met SWT1 1q25 0.254 0.0503 0.493
met FAM78A 9q34 -0.254 0.0503 0.493
exp TRIM62 1p35.1 -0.254 0.0503 0.493
xsq AUTS2 7q11.22 -0.254 0.0503 0.492
hs4 FABP3 1p33-p32 -0.256 0.0503 0.493 fatty acid metabolic
process;phosphatidylcholine biosynthetic process
xai BHLHE40 3p26 -0.256 0.0503 0.493 circadian regulation of gene
expression;entrainment of circadian clock by photoperiod
his ACOT6 14q24.3 -0.256 0.0503 0.492
hs4 PRKCQ 10p15 0.256 0.0504 0.493 Protein Kinases
hs4 PRKCQ-AS1 10p14 0.256 0.0504 0.493
his KCNA3 1p13.3 0.256 0.0504 0.493 ion transport;potassium ion
transport
hs4 MISP3 0.256 0.0504 0.493
hs4 MIR1199 0.256 0.0504 0.493
his NOL10 2p25.1 0.256 0.0504 0.493
his RN7SL832P 0.256 0.0504 0.493
xai C14orf93 14q11.2 0.256 0.0504 0.493
xai RPL7P24 0.256 0.0504 0.493
met ATP6V1B2 8p21.3 0.254 0.0504 0.493 cellular iron ion
xsq METTL25 12q21.31 0.254 0.0504 0.493
exp RPL14P1 12q14.2 0.254 0.0504 0.493
met C7orf50 7p22.3 0.254 0.0504 0.493
mut KANK4 1p31.3 0.254 0.0504 0.493
exp RPL13AP25 13q14.3 0.254 0.0504 0.493
exp RPS2P45 0.254 0.0504 0.493
met LAG3 12p13.32 -0.254 0.0504 0.493 cell surface receptor
signaling pathway;negative regulation of interleukin-2 biosynthetic process
exp RNF130 5q35.3 -0.254 0.0504 0.493 Apoptosis
hs4 EHD2 19q13.3 -0.256 0.0504 0.493 endocytosis;blood coagulation
hs4 ZNF462 9q31.2 -0.256 0.0504 0.493 positive regulation of
dependent
hs4 PLEKHS1 10q25.3 -0.256 0.0504 0.493
xai PLA2G16 11q12.3 -0.256 0.0504 0.493 phospholipid metabolic
his AKR1A1 1p33-p32 0.256 0.0505 0.494 cellular aldehyde metabolic
process;L-ascorbic acid biosynthetic process
his LOC102724601 0.256 0.0505 0.494
his RABGAP1L 1q24 0.256 0.0505 0.494 positive regulation of Rab GTPase
activity;regulation of protein localization
his CLPX 15q22.31 0.256 0.0505 0.494 ATP catabolic process;protein
folding
xai DIS3L 15q22.31 0.256 0.0505 0.494 rRNA catabolic process
his MAPK3 0.256 0.0505 0.494 Protein Kinases
swa FAM49B 8q24.21 0.256 0.0505 0.494
mut NLE1 17q12 0.254 0.0505 0.494 inner cell mass cell
xsq KCNK7 11q13 0.254 0.0505 0.494 ion transport;potassium ion transport
xsq CCNJ 10q23.33 0.254 0.0505 0.494
mut FN1 2q34 0.254 0.0505 0.494 response to wounding;cell migration
exp LOC153684 5p12 0.254 0.0505 0.494
xsq LOC100506388 0.254 0.0505 0.494
xsq RAB20 13q34 -0.254 0.0505 0.494 small GTPase mediated signal
xsq CD9 12p13.3 -0.254 0.0505 0.494 response to water
deprivation;platelet degranulation
hs4 LINC01094 -0.256 0.0505 0.494
his FLNB 3p14.3 -0.256 0.0505 0.494 multicellular organismal
his CTD-2297D10.2 -0.256 0.0505 0.494
his ADAMTS16 5p15 -0.256 0.0505 0.494 proteolysis
xai LOC646903 -0.256 0.0505 0.494
hs4 LOC101929468 0.256 0.0506 0.494
hs4 CXXC4 4q22-q24 0.256 0.0506 0.494 zygotic specification of
xai BRPF1 3p26-p25 0.256 0.0506 0.494 chromatin modification;histone H3
acetylation
his NCR3LG1 11p15.1 0.256 0.0506 0.494
his LOC101928120 0.256 0.0506 0.494
his PYGO2 1q21.3 0.256 0.0506 0.494 developmental growth;palate
development
xai POLR1E 9p13.2 0.256 0.0506 0.494 rRNA transcription
his UBL4A Xq28 0.256 0.0506 0.494 protein modification process;transport
his SLC10A3 Xq28 0.256 0.0506 0.494 Solute Carriers
his LINC00854 0.256 0.0506 0.494
his FAM231A 0.256 0.0506 0.494
met DGCR8 22q11.2 0.254 0.0506 0.494 primary miRNA processing
xsq RSPH14 0.254 0.0506 0.494
xsq KLRC1 12p13 0.254 0.0506 0.494 regulation of immune response;cell
xsq ANKRD55 5q11.2 0.254 0.0506 0.494
xsq KIR3DL1 0.254 0.0506 0.494 regulation of immune
exp ITPR3 6p21 -0.254 0.0506 0.494 activation of phospholipase C
activity;regulation of insulin secretion
exp HIPK2 7q32-q34 -0.254 0.0506 0.494 Apoptosis
xsq RILPL1 12q24.31 -0.254 0.0506 0.494 neuroprotection
exp TTYH1 19q13.4 -0.254 0.0506 0.494 ion transport;iron ion
transport
exp AUTS2 7q11.22 -0.254 0.0506 0.494
hs4 GSN 9q33 -0.256 0.0506 0.494 cell projection
xai CYBRD1 2q31.1 -0.256 0.0506 0.494 transmembrane
his LRP1-AS -0.256 0.0506 0.494
xai MRPS31 13q14.11 0.256 0.0507 0.494
his EEF1A1 6q14.1 0.256 0.0507 0.494 translation;translational
elongation
his NHLRC4 16p13.3 0.256 0.0507 0.494
his PIGQ 16p13.3 0.256 0.0507 0.494 cellular protein metabolic
his MSI2 17q22 0.256 0.0507 0.494 stem cell development
xai DDX1 2p24 0.256 0.0507 0.494 regulation of translational
xai C2CD5 12p12.1 0.256 0.0507 0.494
xsq CAD 2p22-p21 0.253 0.0507 0.494 Apoptosis
met PPIC 5q23.2 0.253 0.0507 0.494 protein folding;signal transduction
exp METTL5 2q31.1 0.253 0.0507 0.494
xsq POMC 2p23.3 0.253 0.0507 0.494
cop CCDC85C 14q32.31 0.253 0.0507 0.494 cerebral cortex development
exp TGFB2 1q41 -0.253 0.0507 0.494 Apoptosis
exp CTTN 11q13 -0.253 0.0507 0.494
cop FASTKD3 5p15.31 -0.253 0.0507 0.494 cellular respiration
xai LOC645195 1p31.3 -0.256 0.0507 0.494
his C1orf137 -0.256 0.0507 0.494
exp ANKRD20A10P -0.256 0.0507 0.494
hs4 PCDHB2 5q31 -0.256 0.0507 0.494 synaptic transmission;nervous
system development
hs4 ARMCX2 Xq21.33-q22.2 -0.256 0.0507 0.494
xai ATP6V0C 16p13.3 -0.256 0.0507 0.494 cellular iron ion
xai TMEM47 Xp11.4 -0.256 0.0507 0.494
his LMNB2 19p13.3 0.256 0.0508 0.494
hs4 CHD1L 1q12 0.256 0.0508 0.494 ATP catabolic process;DNA repair
his NBPF1 1p36.13 0.256 0.0508 0.495
his TAF5 10q24-q25.2 0.256 0.0508 0.495 viral reproduction;chromatin
modification
xai RFT1 3p21.1 0.256 0.0508 0.495 cellular protein metabolic
his ELF2 4q28 0.255 0.0508 0.495 Transcription Factors
his ADIPOR2 12p13.31 0.255 0.0508 0.495 lipid metabolic
process;hormone-mediated signaling pathway
cop PSMA8 18q11.2 0.253 0.0508 0.494 antigen processing and presentation
exp CHRM3 1q43 0.253 0.0508 0.494 signal transduction;regulation of insulin
secretion
exp TIMM13 19p13.3 0.253 0.0508 0.495 sensory perception of
exp PGBD4 15q14 0.253 0.0508 0.495
met FANK1 10q26.2 0.253 0.0508 0.495
exp ANOS1 -0.253 0.0508 0.495 cell adhesion;axon guidance
exp VIPR1 3p22 -0.253 0.0508 0.494 muscle contraction;immune response
exp DLG5 10q23 -0.253 0.0508 0.494 signal transduction;negative
hs4 FAM13A 4q22.1 -0.255 0.0508 0.495 signal
xai LOC101060376 -0.255 0.0508 0.495
xai ANKRD20A10P -0.255 0.0508 0.495
hs4 GXYLT2 3p13 -0.255 0.0508 0.495 O-glycan processing
his C1orf194 1p13.3 -0.256 0.0508 0.495
his KIAA1324 1p13.3 -0.256 0.0508 0.495 positive regulation of
vacuole organization;positive regulation of autophagic vacuole assembly
xai PP12719 -0.256 0.0508 0.494
exp PP12719 -0.256 0.0508 0.494
xai SNORD32B 0.255 0.0509 0.495
DNA-dependent"
his DNAJC12 10q22.1 0.255 0.0509 0.495 protein folding
his CSNK2A1 20p13 0.255 0.0509 0.495 Protein Kinases
exp SNORD32B 0.255 0.0509 0.495
exp ADAMDEC1 8p21.2 0.255 0.0509 0.495 proteolysis;immune response
exp CYP1D1P 9q21.13 0.255 0.0509 0.495
exp HGH1 0.253 0.0509 0.495
exp TRMT61B 2p23.2 0.253 0.0509 0.495 tRNA methylation;tRNA
processing
met SORCS2 4p16.1 0.253 0.0509 0.495 neuropeptide signaling
pathway
xsq GKAP1 9q21.32 0.253 0.0509 0.495 signal transduction
cop VAMP1 12p 0.253 0.0509 0.495 neurotransmitter secretion;vesicle-
mediated transport
met CCNE1 19q12 0.253 0.0509 0.495 DNA Damage Response (DDR); Oncogenes
exp ACADM 1p31 0.253 0.0509 0.495 carnitine metabolic process, CoA-
linked;fatty acid beta-oxidation using acyl-CoA dehydrogenase
xsq HHIP 4q28-q32 0.253 0.0509 0.495 skeletal system
morphogenesis;epithelial tube branching involved in lung morphogenesis
exp GATA6 18q11.1-q11.2 -0.253 0.0509 0.495 pancreatic A cell
xsq PXN 12q24.31 -0.253 0.0509 0.495 cell adhesion;focal adhesion
assembly
his ARL9 4q12 -0.255 0.0509 0.495 small GTPase mediated signal
transduction
his CP 3q23-q25 -0.255 0.0509 0.495 cellular iron ion
hs4 CORO2B 15q23 -0.255 0.0509 0.495 actin cytoskeleton
organization
xai DIAPH3 13q21.2 -0.255 0.0509 0.495 cellular component
his C1orf198 1q42.2 -0.255 0.0509 0.495
xai OLFML3 1p13.2 -0.255 0.0509 0.495 multicellular organismal
development
xai ARMC9 2q37.1 -0.255 0.0509 0.495
his HMGB2 4q31 0.255 0.051 0.495 DNA Damage Response (DDR); DDR (BER)
xai TIGD1 2q37.1 0.255 0.051 0.495 regulation of transcription, DNA-
dependent"
his KHDC1 6q13 0.255 0.051 0.495
exp HMGB1P31 0.255 0.051 0.495
his IFRD2 3p21.3 0.255 0.051 0.495
exp SAFB 19p13.3-p13.2 0.255 0.051 0.495 regulation of transcription, DNA-
dependent;intracellular estrogen receptor signaling pathway
xai LOC100128670 0.255 0.051 0.495
xai EFTUD1 15q25.2 0.255 0.051 0.495 GTP catabolic process;ribosome
biogenesis
his MUC12 7q22 0.255 0.051 0.495 post-translational protein
his RFXANK 19p12 0.255 0.051 0.495 regulation of transcription, DNA-
dependent;Ras protein signal transduction
his BORCS8-MEF2B 0.255 0.051 0.495
his BORCS8 0.255 0.051 0.495 heart development
xai C3AR1 12p13.31 0.255 0.051 0.495 blood circulation;regulation of blood
pressure
exp TFB2M 1q44 0.253 0.051 0.495 transcription from mitochondrial
promoter;transcription initiation from mitochondrial promoter
met LINC00472 6q13 0.253 0.051 0.495
met TMEM237 2q33.2 0.253 0.051 0.495 regulation of Wnt receptor
signaling pathway;cilium assembly
exp SCN1B 19q13.1 -0.253 0.051 0.495 axon guidance;sodium ion
xsq TICAM2 5q23.1 -0.253 0.051 0.495 inflammatory response;innate
immune response
cop ADCY2 5p15.3 -0.253 0.051 0.495 cAMP biosynthetic process;synaptic
transmission
xsq LOC388849 22q11.21 -0.253 0.051 0.495
his ZNF433 19p13.2 -0.255 0.051 0.495 regulation of transcription,
DNA-dependent"
xai HMGB1P31 0.255 0.0511 0.495
xai RASL10A 22q12.2 0.255 0.0511 0.495 small GTPase mediated signal
transduction;GTP catabolic process
exp GRIN1 9q34.3 0.255 0.0511 0.495 synaptic transmission;calcium ion
his MLNR 13q14-q21 0.255 0.0511 0.495 G-protein coupled receptor
signaling pathway;digestion
cop MIR2392 0.255 0.0511 0.495
cop MEG3 14q32 0.255 0.0511 0.495
cop MIR770 0.255 0.0511 0.495
cop MIR493 0.255 0.0511 0.495
cop MIR337 0.255 0.0511 0.495
cop MIR665 0.255 0.0511 0.495
cop RTL1 14q32.2 0.255 0.0511 0.495 multicellular organismal
development
cop MIR431 0.255 0.0511 0.495
cop MIR433 0.255 0.0511 0.495
cop MIR127 0.255 0.0511 0.495
cop MIR432 0.255 0.0511 0.495
cop MIR136 0.255 0.0511 0.495
cop MEG8 14q32.31 0.255 0.0511 0.495
cop SNORD113-1 14q32.31 0.255 0.0511 0.495
cop SNORD113-2 14q32.31 0.255 0.0511 0.495
cop SNORD113-4 0.255 0.0511 0.495
cop SNORD113-5 0.255 0.0511 0.495
cop SNORD113-6 14q32.31 0.255 0.0511 0.495
cop SNORD113-7 14q32.31 0.255 0.0511 0.495
his DDX6 11q23.3 0.255 0.0511 0.495 nuclear-transcribed mRNA catabolic
xai UVRAG 11q13.5 0.255 0.0511 0.495 DNA Damage Response (DDR)
xai HAAO 2p21 0.255 0.0511 0.495 small molecule metabolic process;response
to cadmium ion
xai C1orf162 1p13.2 0.255 0.0511 0.495
his TMSB15A Xq21.33-q22.3 0.255 0.0511 0.495 actin cytoskeleton
organization;sequestering of actin monomers
xsq MSL2 3q22.3 0.253 0.0511 0.495 histone H4-K16 acetylation
xsq DOCK9-AS2 0.253 0.0511 0.495
xsq PLA2G4D 15q15.1 0.253 0.0511 0.495 metabolic
xsq NEDD1 12q23.1 0.253 0.0511 0.495 G2/M transition of mitotic cell
exp DACH1 13q22 0.253 0.0511 0.495 regulation of transcription, DNA-
xsq ACRV1 11q24.2 0.253 0.0511 0.495
met RPRD1B 20q11.21-q12 0.253 0.0511 0.495 dephosphorylation of RNA
xsq TPD52L1 6q22-q23 -0.253 0.0511 0.495 G2/M transition of
exp BAALC 8q22.3 -0.253 0.0511 0.495
exp GBF1 10q24 -0.253 0.0511 0.495 retrograde vesicle-mediated
transport, Golgi to ER;post-Golgi vesicle-mediated transport
hs4 SAMHD1 20pter-q12 -0.255 0.0511 0.495 DNA Damage Response
(DDR)
exp SIGLECL1 19q13.41 -0.255 0.0511 0.495
xai RPL27AP8 13q14.2 -0.255 0.0511 0.495
exp RPL27AP8 13q14.2 -0.255 0.0511 0.495
his C8orf58 8p21 -0.255 0.0511 0.495
his CCAR2 -0.255 0.0511 0.495 positive regulation of apoptotic
process;negative regulation of catalytic activity
xai TRIP10 19p13.3 -0.255 0.0511 0.495 cell
communication;signal transduction
hs4 POP3 -0.255 0.0511 0.495
exp LOC646021 17q11.2 -0.255 0.0511 0.495
xai SFXN3 10q24.31 -0.255 0.0511 0.495 iron ion
xai TARP 7p15-p14 0.255 0.0512 0.495
his MRPL45P2 0.255 0.0512 0.495
xai MLLT6 17q21 0.255 0.0512 0.495 regulation of transcription, DNA-
dependent"
his MKI67 10q26.2 0.255 0.0512 0.495 meiosis;cell proliferation
hs4 GABRB2 5q34 0.255 0.0512 0.495 chloride transport;gamma-
aminobutyric acid signaling pathway
xai VASH2 1q32.3 0.255 0.0512 0.495 positive regulation of endothelial
his TNFRSF1A 12p13.2 0.255 0.0512 0.495 Apoptosis
exp SNUPN 15q24.2 0.253 0.0512 0.495 ncRNA metabolic process;snRNA
import into nucleus
exp HSDL1 16q23.3 0.253 0.0512 0.495
met GAS2L3 12q23.1 0.253 0.0512 0.495 cell cycle arrest
met SLC37A3 7q34 0.253 0.0512 0.495 Solute Carriers
xsq TGM6 20p13 0.253 0.0512 0.495 peptide cross-linking;cell death
xsq STOML2 9p13.1 0.253 0.0512 0.495
xsq JADE3 0.253 0.0512 0.495 histone H3 acetylation;histone H4-K5
acetylation
exp HDLBP 2q37.3 -0.253 0.0512 0.495 lipid transport;steroid
metabolic process
his LOC103611081 -0.255 0.0512 0.495
hs4 HOMER3 19p13.11 -0.255 0.0512 0.495 protein targeting;G-
hs4 LOC102724360 -0.255 0.0512 0.495
his PALLD 4q32.3 -0.255 0.0512 0.495 cytoskeleton organization
xai LOC100289230 5q21.1 0.257 0.0513 0.496
his PLA2G2D 1p36.12 0.255 0.0513 0.495 phospholipid metabolic
exp HMGB3P2 20q11.23 0.255 0.0513 0.495
exp TARP 7p15-p14 0.255 0.0513 0.496
xai ARMC5 16p11.2 0.255 0.0513 0.496
xsq FH 1q42.1 0.253 0.0513 0.495 tricarboxylic acid cycle;fumarate
metabolic process
met MIR219A2 0.253 0.0513 0.495
mut PGBD1 6p22.1 0.253 0.0513 0.495 viral reproduction
exp TPI1P1 1p31.1 0.253 0.0513 0.496
exp CALN1 7q11 0.253 0.0513 0.496
exp LOC389465 7p21.3 0.253 0.0513 0.496
met GPC1 2q35-q37 0.253 0.0513 0.496 axon guidance
exp KLHL11 17q21.2 0.253 0.0513 0.496
xsq UTP6 17q11.2 0.253 0.0513 0.496 rRNA processing;RNA processing
exp FANCM 14q21.2 0.253 0.0513 0.496 DNA Damage Response (DDR); DDR (FA)
xsq LOC254896 -0.253 0.0513 0.496
xsq LINC01239 -0.253 0.0513 0.496
exp TMEM8B 9p13.3 -0.253 0.0513 0.495 cell adhesion;cell-
matrix adhesion
exp LOC100128591 -0.255 0.0513 0.496
hs4 CAMK2N1 1p36.12 -0.255 0.0513 0.496 negative regulation of
hs4 PRR5L 11p13-p12 -0.255 0.0513 0.496
swa NT5E 6q14-q21 -0.255 0.0513 0.495 dephosphorylation;purine base
metabolic process
his MTX2 2q31.1 0.255 0.0514 0.496 protein targeting to
mitochondrion;mitochondrial transport
xai SLC25A5P9 0.255 0.0514 0.496 Solute Carriers
xai ITGB7 12q13.13 0.255 0.0514 0.496 cell-matrix adhesion;integrin-
xai LOC642620 0.255 0.0514 0.496
exp SLC25A5P9 0.255 0.0514 0.496 Solute Carriers
xai CHRNA4 20q13.33 0.255 0.0514 0.496 signal transduction;B cell
activation
xai EFCAB3 17q23.2 0.255 0.0514 0.496
swa SEPT1_Q9NVA2 0.255 0.0514 0.496
mut FBN1 15q21.1 0.253 0.0514 0.496 skeletal system development;heart
development
cop C1RL-AS1 12p13.31 0.253 0.0514 0.496
cop RBP5 12p13.31 0.253 0.0514 0.496 transport
mir hsa-miR-622 0.253 0.0514 0.496
cop EML6 2p16.1 0.253 0.0514 0.496
xsq RNF126P1 17q22 0.253 0.0514 0.496
xsq OXNAD1 3p25-p24 0.253 0.0514 0.496
exp NDUFB4P1 3p14.1 -0.253 0.0514 0.496
exp LIMK1 7q11.23 -0.253 0.0514 0.496 Protein Kinases
xsq BHMT2 5q13 -0.253 0.0514 0.496 methionine biosynthetic process
hs4 P2RY13 3q24 -0.255 0.0514 0.496
xai CDC14B 9q22.3 -0.255 0.0514 0.496 activation of anaphase-
xai PHLDA1 12q15 -0.255 0.0514 0.496 Apoptosis
exp CBR3-AS1 -0.255 0.0514 0.496
hs4 GLRB 4q31.3 -0.255 0.0514 0.496 startle response;ion
exp LOC642620 0.255 0.0515 0.496
exp FAM86EP 4p16.3 0.255 0.0515 0.496
his HSPA1B 6p21.3 0.255 0.0515 0.496 Apoptosis
his C6orf48 6p21.3 0.255 0.0515 0.496
his SNORD48 0.255 0.0515 0.496
his SNORD52 6p21.33 0.255 0.0515 0.496
xai UHRF1 19p13.3 0.255 0.0515 0.496 positive regulation of DNA
exp ANAPC5 12q24.31 0.253 0.0515 0.496 G2/M transition of mitotic
mitotic cell cycle
DNA-dependent"
xsq NAA35 9q21.33 0.253 0.0515 0.496 smooth muscle cell proliferation
exp RAD51C 17q22 0.253 0.0515 0.496 DNA Damage Response (DDR); DDR (FA)
DNA-dependent"
exp WASH6P Xq28 0.253 0.0515 0.496 transport;endosome transport
xsq WDR36 5q22.1 0.253 0.0515 0.496 response to stimulus;rRNA
processing
exp RSBN1 1p13.2 0.253 0.0515 0.496
cop MTRR 5p15.31 -0.253 0.0515 0.496 methionine metabolic
xsq PPP1R13L 19q13.32 -0.253 0.0515 0.496 apoptotic process;post-
xsq LINC00312 3p25.3 -0.253 0.0515 0.496
xsq FAS-AS1 -0.253 0.0515 0.496
xai LRP11 6q25.1 -0.255 0.0515 0.496
xai LOC100128591 -0.255 0.0515 0.496
exp TTTY7 -0.255 0.0515 0.496
xai YBX1P6 9q31.3 0.255 0.0516 0.497
xai GIMAP4 7q36.1 0.255 0.0516 0.497
his PCBP2-OT1 0.255 0.0516 0.497
his LOC105374988 0.255 0.0516 0.497
his CENPP 9q22.31 0.255 0.0516 0.497 M phase of mitotic cell
his NOL8 9q22.31 0.255 0.0516 0.497 DNA replication;rRNA processing
xai ELANE 19p13.3 0.255 0.0516 0.497 cellular calcium ion
homeostasis;negative regulation of interleukin-8 biosynthetic process
his PRMT3 11p15.1 0.255 0.0516 0.497 peptidyl-arginine N-methylation
exp CHORDC2P 14q32.11 0.255 0.0516 0.497
xai NAA40 11q13.1 0.255 0.0516 0.497
DNA-dependent"
exp RPL7P24 0.255 0.0516 0.497
exp MRPS18C 4q21.23 0.253 0.0516 0.497 translation
xsq LOC285074 2p11.2 0.253 0.0516 0.497
xsq RPARP-AS1 0.253 0.0516 0.497
exp TMEM183A 1q32.1 0.253 0.0516 0.497
met OSTM1 6q21 0.253 0.0516 0.497 osteoclast differentiation
xsq KPTN 19q13.32 0.252 0.0516 0.497 cellular component movement;actin
filament organization
exp ASB16 17q21.31 -0.252 0.0516 0.497 intracellular signal
transduction
xsq SYT8 11p15.5 -0.252 0.0516 0.497
xsq RRAS2 11p15.2 -0.252 0.0516 0.497 GTP catabolic process;signal
transduction
exp NXNL2 9q22.1 -0.253 0.0516 0.497
xsq LHFPL2 5q14.1 -0.253 0.0516 0.497
xsq XG Xp22.33 -0.253 0.0516 0.497
xai LOC100128482 -0.255 0.0516 0.497
hs4 ZFPM2-AS1 -0.255 0.0516 0.497
his TMEM265 -0.255 0.0516 0.497
his LINC01031 0.255 0.0517 0.497
DNA-dependent"
xai IRGM 5q33.1 0.255 0.0517 0.497 autophagy;inflammatory response
his GSK3A 19q13.2 0.255 0.0517 0.497 protein phosphorylation;Wnt
xai C7orf55 0.255 0.0517 0.497
his TRIM71 3p22.3 0.255 0.0517 0.497 multicellular organismal
swa ARHGEF1 19q13.13 0.255 0.0517 0.497 regulation of
axonogenesis;negative regulation of axonogenesis
xai TMEM101 17q21.31 0.255 0.0517 0.497 signal transduction;positive
cop NBAS 2p24 0.252 0.0517 0.497
xsq SYT5 19q13.42 0.252 0.0517 0.497 energy reserve metabolic
met TMEM42 3p21.31 0.252 0.0517 0.497
xsq ESCO1 18q11.2 0.252 0.0517 0.497 regulation of DNA replication;cell
cycle
exp PVALB 22q13.1 0.252 0.0517 0.497
xsq DCAF17 2q31.1 0.252 0.0517 0.497 protein ubiquitination
xsq RTTN 18q22.2 0.252 0.0517 0.497 determination of left/right
xsq PTRF 17q21.2 -0.252 0.0517 0.497 transcription initiation from
exp FGD4 12p11.21 -0.252 0.0517 0.497 lamellipodium
assembly;microspike assembly
cop LOC285692 5p15.31 -0.252 0.0517 0.497
exp PDE1C 7p14.3 -0.252 0.0517 0.497 activation of phospholipase C
xai ENPP1 6q22-q23 -0.255 0.0517 0.497 nucleoside triphosphate
catabolic process;negative regulation of protein autophosphorylation
xai YWHAZP3 10p12.2 -0.255 0.0517 0.497
xai RHPN2 19q13.11 -0.255 0.0517 0.497 signal transduction
his USF1 1q22-q23 0.254 0.0518 0.497 response to hypoxia;positive
exp MKI67IPP4 0.254 0.0518 0.497
xai GRIN1 9q34.3 0.254 0.0518 0.497 synaptic transmission;calcium ion
hs4 GCHFR 15q15 0.254 0.0518 0.497 negative regulation of GTP cyclohydrolase
his CPT1A 11q13.2 0.254 0.0518 0.497 positive regulation of fatty acid
exp SNORA80A 0.254 0.0518 0.497
xai SNORA80A 0.254 0.0518 0.497
his SPIN2B Xp11.1 0.254 0.0518 0.497 gamete generation;apoptotic
process
swa LDHB 12p12.2-p12.1 0.254 0.0518 0.497 lactate metabolic
his LINC01063 0.254 0.0518 0.497
his NRROS 3q29 0.254 0.0518 0.497
xsq GABPB1-AS1 15q21.2 0.252 0.0518 0.497
met CHKA 11q13.2 0.252 0.0518 0.497 choline metabolic process;lipid
metabolic process
cop MRPL51 12p13.3-p13.1 0.252 0.0518 0.497 translation
cop NCAPD2 12p13.3 0.252 0.0518 0.497 DNA Damage Response (DDR)
cop SCARNA10 12p13.31 0.252 0.0518 0.497
cop GAPDH 12p13 0.252 0.0518 0.497 glucose metabolic process;gluconeogenesis
cop IFFO1 12p13.3 0.252 0.0518 0.497
cop NOP2 12p13 0.252 0.0518 0.497 rRNA processing;positive regulation of
cell proliferation
cop SCARNA11 12p13.31 0.252 0.0518 0.497
exp NUP54 4q21.1 0.252 0.0518 0.497 viral reproduction;cytokine-
xsq EWSR1 22q12.2 0.252 0.0518 0.497 regulation of transcription, DNA-
dependent"
xsq LGALSL 2p14 -0.252 0.0518 0.497
exp GLMP -0.252 0.0518 0.497 intracellular receptor mediated
promoter
xai TOR1AIP2 1q25.2 -0.254 0.0518 0.497
his LOC100506497 -0.254 0.0518 0.497
xai SEMA4F 2p13.1 -0.254 0.0518 0.497 cell
differentiation;negative regulation of axon extension
xai B3GLCT -0.254 0.0518 0.497 carbohydrate metabolic
hs4 RAB27B 18q21.2 -0.254 0.0518 0.497 small GTPase mediated
signal transduction;protein transport
his ABHD1 2p23.3 0.254 0.0519 0.497
xai TUBBP6 7p11.2 0.254 0.0519 0.497
xai IGLL5 0.254 0.0519 0.497
his TMCO6 5q31.3 0.254 0.0519 0.497 protein import into nucleus
his CCDC115 2q21.1 0.254 0.0519 0.497
his IMP4 2q21.1 0.254 0.0519 0.497 rRNA processing
cop ACTR2 2p14 0.252 0.0519 0.497 cellular component movement
exp SKA3 13q12.11 0.252 0.0519 0.497 chromosome segregation;mitosis
xsq PPCDC 15q24.2 0.252 0.0519 0.497 coenzyme A biosynthetic
exp NDUFA5 7q31.33 0.252 0.0519 0.497 mitochondrial electron
exp LOC100506844 0.252 0.0519 0.497
exp HNRNPLP2 15q14 0.252 0.0519 0.497
met ITGAL 16p11.2 -0.252 0.0519 0.497 cell adhesion;regulation of
immune response
exp KIAA1549 7q34 -0.252 0.0519 0.497
exp PHLDA1 12q15 -0.252 0.0519 0.497 Apoptosis
exp ABCC6P1 16p12.3 -0.252 0.0519 0.497
xai ANOS1 -0.254 0.0519 0.497 cell adhesion;axon guidance
his MIR8052 -0.254 0.0519 0.497
his RGS3 9q32 -0.254 0.0519 0.497 inactivation of MAPK
xai PLSCR4 3q24 -0.254 0.0519 0.497 phospholipid
hs4 ANKRD13B 17q11.2 0.254 0.052 0.498
hs4 HPRT1 Xq26.1 0.254 0.052 0.498 spermatogenesis;central nervous system
neuron development
xsq PTDSS1 8q22 0.252 0.052 0.498 phosphatidylserine biosynthetic
exp CPS1-IT1 2q34 0.252 0.052 0.498
xsq EPT1 2p23.3 0.252 0.052 0.498 phospholipid biosynthetic process
xsq ELAVL4 1p34 0.252 0.052 0.498 RNA processing;mRNA processing
exp KIRREL-IT1 -0.252 0.052 0.498
xsq CGNL1 15q21.3 -0.252 0.052 0.498
xsq APOL2 22q12 -0.252 0.052 0.498 lipid metabolic process;transport
xsq FERMT2 14q22.1 -0.252 0.052 0.498 cell adhesion;regulation of
cell shape
hs4 PSEN2 1q42.13 -0.254 0.052 0.498 Apoptosis
hs4 ELOVL7 5q12.1 -0.254 0.052 0.498 small molecule metabolic
xai GLMP -0.254 0.052 0.498 intracellular receptor mediated signaling
pathway;positive regulation of transcription from RNA polymerase II promoter
xai MPZL1 1q24.2 -0.254 0.052 0.497 transmembrane receptor protein
his TRAPPC2L 16q24.3 0.254 0.0521 0.498 ER to Golgi vesicle-mediated
his GALNS 16q24.3 0.254 0.0521 0.498
xai IPO4 14q12 0.254 0.0521 0.498 intracellular protein transport;protein
transport
his CHEK2P2 15q11.1 0.254 0.0521 0.498
swa PLCB3 11q13 0.254 0.0521 0.498 lipid catabolic process;intracellular
signal transduction
his LOC101928961 0.254 0.0521 0.498
his LRRTM3 10q21.3 0.254 0.0521 0.498
his P2RX5-TAX1BP3 0.254 0.0521 0.498
his P2RX5 17p13.3 0.254 0.0521 0.498 signal transduction;nervous system
development
his SLX4 16p13.3 0.254 0.0521 0.498 DNA Damage Response (DDR); DDR (HR)
his IFNG-AS1 0.254 0.0521 0.498
xai PLEKHA8 7p21-p11.2 0.254 0.0521 0.498 protein transport
exp TMEM134 11q13.2 0.252 0.0521 0.498
xsq PARG 10q11.23 0.252 0.0521 0.498 DNA Damage Response (DDR); DDR
(BER)
xsq CHAT 10q11.2 0.252 0.0521 0.498 synaptic transmission;adult walking
behavior
exp INPP5D 2q37.1 0.252 0.0521 0.498 phosphate-containing compound
xsq SRSF2 17q25.1 0.252 0.0521 0.498 Oncogenes
cop SPRED2 2p14 0.252 0.0521 0.498 multicellular organismal
development;regulation of signal transduction
met LOC400043 12q13.13 0.252 0.0521 0.498
xsq CDK11B 0.252 0.0521 0.498 Apoptosis; Protein Kinases
exp DENND4B 1q21 0.252 0.0521 0.498
xsq HDAC11-AS1 -0.252 0.0521 0.498
xsq CA12 15q22 -0.252 0.0521 0.498 one-carbon metabolic process
xsq CREBRF 5q35.1 -0.252 0.0521 0.498
hs4 PBX1 1q23 -0.254 0.0521 0.498 organ morphogenesis;negative
regulation of sequence-specific DNA binding transcription factor activity
swa ATP2A2 12q24.11 -0.254 0.0521 0.498 transmembrane
transport;ATP biosynthetic process
hs4 EHHADH 3q26.3-q28 -0.254 0.0521 0.498 fatty acid beta-
oxidation;internal protein amino acid acetylation
hs4 MIR5588 -0.254 0.0521 0.498
hs4 CACNA2D4 12p13.33 0.254 0.0522 0.499 ion transport
mut HR 8p21.2 0.252 0.0522 0.498 regulation of transcription, DNA-
dependent;negative regulation of sequence-specific DNA binding transcription factor
activity
xsq OR10R2 0.252 0.0522 0.498 response to stimulus
cop EML1 14q32 0.252 0.0522 0.498
xsq ADAMTSL2 9q34.2 0.252 0.0522 0.498 negative regulation of
met OR6X1 11q24.1 0.252 0.0522 0.499 response to stimulus
exp PPTC7 12q24.11 0.252 0.0522 0.499
met KCNV1 8q23.2 0.252 0.0522 0.499 ion transport;potassium ion
transport
xsq DPPA5 6q13 0.252 0.0522 0.499
mut TPH1 11p15.3-p14 0.252 0.0522 0.499 response to stress;aromatic amino
acid family metabolic process
xsq KCNQ1OT1 11p15 -0.252 0.0522 0.499
xai HTRA1 10q26.3 -0.254 0.0522 0.498 regulation of cell
growth;proteolysis
his CNTN5 11q22.1 0.254 0.0523 0.499 cell adhesion
exp FBXO38 5q32 0.254 0.0523 0.499
his SLFN14 17q12 0.254 0.0523 0.499
his LINC02001 0.254 0.0523 0.499
his IRF5 7q32 0.254 0.0523 0.499 Apoptosis
xai SHROOM2P1 Yq11.21 0.254 0.0523 0.499
xai RPLP0 12q24.2 0.254 0.0523 0.499 SRP-dependent cotranslational
xsq TNFRSF18 1p36.3 0.252 0.0523 0.499 signal transduction;tumor
xsq ZNF192P1 6p22.1 0.252 0.0523 0.499
met EEF2KMT 0.252 0.0523 0.499
mir hsa-miR-342-5p 0.252 0.0523 0.499
xsq TMEM216 11q13.1 0.252 0.0523 0.499 cell projection
organization;cilium morphogenesis
met FNDC8 17q12 0.252 0.0523 0.499
exp SCARNA15 15q25.2 0.252 0.0523 0.499
xsq TMEM143 19q13.33 0.252 0.0523 0.499
exp HTRA1 10q26.3 -0.252 0.0523 0.499 regulation of cell
growth;proteolysis
xsq SNX19 11q25 -0.252 0.0523 0.499 protein transport;cell
communication
exp CDC14B 9q22.3 -0.252 0.0523 0.499 activation of anaphase-
his PPP1R3G 6p25.1 -0.254 0.0523 0.499
cop MIR4636 -0.254 0.0523 0.499
xai SMURF1 7q22.1 -0.254 0.0523 0.499 protein
xai LYPD1 2q21.2 -0.254 0.0523 0.499
his TNNI1 1q31.3 -0.254 0.0523 0.499 muscle filament
sliding;ventricular cardiac muscle tissue morphogenesis
xai LGALS9 17q11.2 0.254 0.0524 0.499 signal transduction;positive
his SCAF11 12q12 0.254 0.0524 0.499 spliceosome assembly;RNA splicing,
via transesterification reactions
his ATP8B4 15q21.2 0.254 0.0524 0.499 phospholipid transport;cation
transport
exp RPL6 12q24.1 0.254 0.0524 0.5 SRP-dependent cotranslational
DNA-dependent"
xsq IDI2 10p15.3 0.252 0.0524 0.499 cholesterol biosynthetic
process;isoprenoid biosynthetic process
xsq PUM2 2p22-p21 0.252 0.0524 0.499 regulation of translation
exp SMG8 17q22 0.252 0.0524 0.499 nuclear-transcribed mRNA catabolic
xsq DUS4L 7q22-q31 0.252 0.0524 0.499 tRNA processing
exp ADM5 19q13.33 0.252 0.0524 0.5
hs4 RP9P 7p14.3 -0.254 0.0524 0.499
xai MRPL33 2p21 -0.254 0.0524 0.499 translation
hs4 SEPT10 2q13 -0.254 0.0524 0.499 cell cycle;cell division
hs4 SOWAHC 2q13 -0.254 0.0524 0.499
exp MT2P1 4q13.2 -0.254 0.0524 0.499
xai NADK 1p36.33 0.254 0.0525 0.5 vitamin metabolic process;water-
exp FLI1 11q24.1-q24.3 0.252 0.0525 0.5 Transcription Factors
exp LOC101559451 0.252 0.0525 0.5
xsq HIST1H4C 6p22.1 0.252 0.0525 0.5
xsq RYR3 15q14-q15 0.252 0.0525 0.5 cellular response to calcium
ion;ion transport
met TMEM44 3q29 0.252 0.0525 0.5
exp NDUFA13 19p13.2 0.252 0.0525 0.5 apoptotic nuclear
exp LARS2 3p21.3 0.252 0.0525 0.5 tRNA aminoacylation for protein
met GAREM1 0.252 0.0525 0.5
cop CHD4 12p13 0.252 0.0525 0.5 DNA Damage Response (DDR)
exp AAED1 9q22.32 -0.252 0.0525 0.5
xsq CYB5A 18q23 -0.252 0.0525 0.5 electron transport chain;small
his RNASEH2A 19p13.2 0.254 0.0526 0.5 DNA Damage Response (DDR);
swa PNO1 2p14 0.254 0.0526 0.5
his PPT1 1p32 0.254 0.0526 0.5 receptor-mediated endocytosis;grooming
behavior
xai PPIL4 6q25.1 0.254 0.0526 0.5 protein folding
xai RPUSD4 11q24.2 0.254 0.0526 0.5 pseudouridine synthesis
xai NGDN 14q11.2 0.254 0.0526 0.5 regulation of translation
xai IPO5 13q32.2 0.254 0.0526 0.5 intracellular protein
transport;interspecies interaction between organisms
exp PEBP1P3 1q31.3 0.254 0.0526 0.5
xsq RPP25L 9p13.3 0.252 0.0526 0.5
xsq ANO1-AS2 0.251 0.0526 0.5
xsq HNRNPD 4q21 0.251 0.0526 0.5 RNA processing;RNA catabolic
process
xsq CTR9 11p15.3 0.251 0.0526 0.5 histone monoubiquitination;histone
H2B ubiquitination
exp MS4A1 11q12 0.251 0.0526 0.5 immune response;B cell activation
xsq POLQ 3q13.33 0.251 0.0526 0.5 DNA Damage Response (DDR); DDR (DNA
exp RPS26P10 0.251 0.0526 0.5
xsq LINGO4 1q21.3 0.251 0.0526 0.5
mir hsa-miR-27a -0.251 0.0526 0.5
xsq DYSF 2p13.3 -0.251 0.0526 0.5
exp NXPH3 17q21.33 -0.251 0.0526 0.5 neuropeptide signaling
pathway
xsq EPHB3 3q27.1 -0.251 0.0526 0.5 axon guidance;substrate
exp MT1B 16q13 -0.252 0.0526 0.5 negative regulation of
xsq ARL4D 17q21.31 -0.252 0.0526 0.5 GTP catabolic process;small
xai CDRT4 17p12 -0.254 0.0526 0.5
hs4 PBX4 19p12 -0.254 0.0526 0.5 transcription from RNA polymerase
II promoter;positive regulation of transcription, DNA-dependent"
his TTC39B 9p22.3 -0.254 0.0526 0.5
hs4 PTGFRN 1p13.1 -0.254 0.0526 0.5 lipid particle
organization
his E2F3 6p22 0.254 0.0527 0.5 Tumor Suppressors
xai SLC22A31 16q24.3 0.254 0.0527 0.5 ion transport
xai HNRNPA1P70 12q15 0.254 0.0527 0.5
xai RPL14P1 12q14.2 0.254 0.0527 0.5
hs4 TRIM14 9q22.33 0.254 0.0527 0.5
his BAP1 3p21.31-p21.2 0.254 0.0527 0.5 DNA Damage Response (DDR);
Tumor Suppressors
his PHF7 3p21.1 0.254 0.0527 0.5
his CX3CR1 3p21.3 0.254 0.0527 0.5 negative regulation of
hs4 LOC646214 0.254 0.0527 0.5
his SLC26A8 6p21 0.253 0.0527 0.5 oxalate transport;cell
differentiation
his MAPK14 6p21.3-p21.2 0.253 0.0527 0.5 Protein Kinases
exp RPL5P1 15q11.2 0.253 0.0527 0.5
his LOC101928166 0.253 0.0527 0.5
his C9orf40 9q21.13 0.253 0.0527 0.5
his C9orf41-AS1 0.253 0.0527 0.5
xai PGBD4 15q14 0.253 0.0527 0.5
mir hsa-miR-425* 0.251 0.0527 0.5
exp FEM1A 19p13.3 0.251 0.0527 0.5 regulation of ubiquitin-protein
xsq LILRA4 19q13.4 0.251 0.0527 0.5
exp RUFY2 10q21.3 -0.251 0.0527 0.5
xsq TGFB3 14q24 -0.251 0.0527 0.5 Apoptosis
xsq ARHGAP40 20q11.23 -0.251 0.0527 0.5 signal
swa TGFB1I1 16p11.2 -0.253 0.0527 0.5 cell adhesion;ubiquitin-
his LOC101929282 -0.253 0.0527 0.5
xai IFI27 14q32 -0.254 0.0527 0.5 activation of cysteine-type
xai DHRSX Xp22.33 -0.254 0.0527 0.5
xai RPL5P14 5p13.3 0.253 0.0528 0.501
swa API5 11p11.2 0.253 0.0528 0.501 Apoptosis
his TSTD3 6q16.2 0.253 0.0528 0.501
xai LRRC38 1p36.21 0.253 0.0528 0.501
his CRMP1 4p16.1 0.253 0.0528 0.501 nervous system development;axon
guidance
xai SLC25A5 Xq24 0.253 0.0528 0.501 Solute Carriers
xai CDC26 9q32 0.253 0.0528 0.501 cell division;negative regulation of
his CTNNBIP1 1p36.22 0.253 0.0528 0.501 anterior/posterior pattern
specification;negative regulation of smooth muscle cell proliferation
exp LOC100133315 11q13.4 0.251 0.0528 0.501
cop PLG 6q26 0.251 0.0528 0.501 fibrinolysis;platelet degranulation
exp C14orf93 14q11.2 0.251 0.0528 0.501
xsq HMGN2P46 15q21.1 0.251 0.0528 0.501
xsq KCNRG 13q14.2 0.251 0.0528 0.501 potassium ion transport
cop ESR1 6q25.1 0.251 0.0528 0.501 androgen metabolic process;negative
xsq SDHAF1 19q13.12 0.251 0.0528 0.501 iron-sulfur cluster
assembly;mitochondrial respiratory chain complex II assembly
exp GANC 15q15.2 0.251 0.0528 0.501 carbohydrate metabolic process
mir hsa-miR-542-5p 0.251 0.0528 0.501
met FNDC3A 13q14.2 0.251 0.0528 0.501 cell-cell adhesion;Sertoli
cell development
xsq LRIG3 12q14.1 -0.251 0.0528 0.501
exp IFIT6P 10q23.31 -0.251 0.0528 0.501
exp SERTAD4-AS1 1q32.2 -0.251 0.0528 0.501
exp CCDC183-AS1 -0.251 0.0528 0.501
xsq FAM129A 1q25 -0.251 0.0528 0.501 positive regulation of
protein phosphorylation;response to stress
xai SIGLECL1 19q13.41 -0.253 0.0528 0.501
his LARP6 15q23 -0.253 0.0528 0.501 RNA processing;regulation of
translation
hs4 PDZRN3 3p13 -0.253 0.0528 0.501 neuromuscular junction
hs4 PDZRN3-AS1 -0.253 0.0528 0.501
exp CA15P1 -0.253 0.0528 0.501
xai CELSR1 22q13.3 -0.253 0.0528 0.501 locomotory
xai LOC646021 17q11.2 -0.253 0.0528 0.501
xai ITPR3 6p21 -0.253 0.0528 0.501 activation of phospholipase C
activity;regulation of insulin secretion
hs4 COL12A1 6q12-q13 -0.253 0.0528 0.501 skeletal system
met ZNF204P 6p21.3 0.258 0.0529 0.501
swa TKFC 0.253 0.0529 0.501 glycerol metabolic process;innate immune
response
DNA-dependent"
xai MAPRE2 18q12.1 0.253 0.0529 0.501 cell cycle;mitosis
exp MED1 17q12 0.251 0.0529 0.501 positive regulation of interferon-gamma-
exp AFF2 Xq28 0.251 0.0529 0.501 learning or memory;regulation of RNA
splicing
exp NDUFS7 19p13.3 0.251 0.0529 0.501 transport;respiratory
exp STK31 7p15.3 0.251 0.0529 0.501
xsq AMY2B 1p21 0.251 0.0529 0.501
exp HEXB 5q13 -0.251 0.0529 0.501 carbohydrate metabolic
process;sensory perception of sound
xsq SLC6A8 Xq28 -0.251 0.0529 0.501 Solute Carriers
xsq TDRP 8p23.3 -0.251 0.0529 0.501
his PTPRB 12q15-q21 -0.253 0.0529 0.501 protein
xai EMP2 16p13.2 -0.253 0.0529 0.501 cell proliferation
xai DKFZp667F0711 10p15.1 -0.253 0.0529 0.501
xai RUFY2 10q21.3 -0.253 0.0529 0.501
hs4 PLPP2 -0.253 0.0529 0.501 sphingolipid metabolic
his CCDC90B 11q14.1 0.253 0.053 0.501
xai SNRPFP1 20q13.13 0.253 0.053 0.501
xai GANC 15q15.2 0.253 0.053 0.501 carbohydrate metabolic process
xai BRINP3 0.253 0.053 0.501 nervous system development;negative
his NOA1 4q12 0.253 0.053 0.501 mitochondrial translation;regulation of
his POLR2B 4q12 0.253 0.053 0.501 DNA Damage Response (DDR); DDR (NER)
xai SNU13 0.253 0.053 0.501 gene expression;ribosome biogenesis
cop C1RL 12p13.31 0.251 0.053 0.501 proteolysis;complement activation,
classical pathway
xsq AK1 9q34.1 -0.251 0.053 0.501 ATP metabolic process;nucleobase-
xsq MIR205HG 1q32.2 -0.251 0.053 0.501
xsq TNFSF12 -0.251 0.053 0.501 apoptotic process;positive
exp MAPK7 17p11.2 -0.251 0.053 0.501 Protein Kinases
xsq HOXC-AS2 -0.251 0.053 0.501
exp SERTAD4 1q32.1-q41 -0.251 0.053 0.501
his MIR3198-2 -0.253 0.053 0.501
xai PPP2CB 8p12 -0.253 0.053 0.501 regulation of gene
expression;response to hydrogen peroxide
xai CELSR2 1p21 -0.253 0.053 0.501 G-protein coupled receptor
xai RPL3 22q13 0.255 0.0531 0.502 translational termination;cellular
exp UQCRFS1P3 6p22.3 0.253 0.0531 0.502
his CNOT2 12q15 0.253 0.0531 0.502 RNA metabolic process;mRNA metabolic
process
his LINC01481 0.253 0.0531 0.502
xai B3GALT6 1p36.33 0.253 0.0531 0.502 protein
swa PDCD5 19q13.11 0.253 0.0531 0.502 Apoptosis
hs4 DENND4B 1q21 0.253 0.0531 0.502
xai LINC01126 0.253 0.0531 0.502
xsq C15orf59-AS1 0.251 0.0531 0.502
mut FMO3 1q24.3 0.251 0.0531 0.502 xenobiotic metabolic process;drug
metabolic process
xsq CSTF1 20q13.2 0.251 0.0531 0.502 transcription from RNA polymerase
exp KLRK1 12p13.2-p12.3 0.251 0.0531 0.502
exp LINC01096 0.251 0.0531 0.502
exp RPL21P131 19q13.11 0.251 0.0531 0.502
xsq TNRC18P1 4q31.21 0.251 0.0531 0.502
exp SNHG7 9q34.3 0.251 0.0531 0.502
xsq CAPN10 2q37.3 0.251 0.0531 0.502 positive regulation of
met C1QTNF2 5q33.3 0.251 0.0531 0.502 positive regulation of
met ZNF396 18q12 0.251 0.0531 0.502 viral reproduction
exp C18orf21 18q12.2 0.251 0.0531 0.502
hs4 ARRDC4 15q26.3 -0.253 0.0531 0.502 signal transduction
swa MRPS27 5q13.2 -0.253 0.0531 0.502
xai BNIP3L 8p21 -0.253 0.0531 0.502 Apoptosis
swa CDKN2A_P42771 -0.253 0.0531 0.501
xai FLJ30064 7q21.3 -0.253 0.0531 0.501
his PSMB1 6q27 0.253 0.0532 0.502 antigen processing and presentation of
exogenous peptide antigen via MHC class I, TAP-dependent;anaphase-promoting
complex-dependent proteasomal ubiquitin-dependent protein catabolic process
his TBP 6q27 0.253 0.0532 0.502 transcription from RNA polymerase III
his RNU1-2 0.253 0.0532 0.502
xai C16orf59 16p13.3 0.253 0.0532 0.502
his ATP2A3 17p13.3 0.253 0.0532 0.502 transmembrane transport;ATP
his VKORC1 16p11.2 0.253 0.0532 0.502 cellular protein metabolic
process;response to organic nitrogen
cop PDE10A 6q26 0.251 0.0532 0.502 signal transduction;blood
coagulation
exp C3AR1 12p13.31 0.251 0.0532 0.502 blood circulation;regulation of
blood pressure
exp SVEP1 9q32 0.251 0.0532 0.502 cell adhesion
cop GPR162 12p13 0.251 0.0532 0.502
cop P3H3 0.251 0.0532 0.502 negative regulation of cell proliferation
cop GNB3 12p13 0.251 0.0532 0.502 small molecule metabolic process;cellular
cop CDCA3 12p13 0.251 0.0532 0.502 cell cycle;mitosis
cop USP5 12p13 0.251 0.0532 0.502 positive regulation of proteasomal
exp PDSS2 6q21 0.251 0.0532 0.502 isoprenoid biosynthetic
xsq PPAN 19p13 0.251 0.0532 0.502
mut PKD1L1 7p12.3 0.251 0.0532 0.502 detection of nodal flow;cell-
cell adhesion
exp ZNF445 3p21.32 0.251 0.0532 0.502 viral reproduction
xsq VCL 10q22.2 -0.251 0.0532 0.502 cellular component
exp CD24 -0.251 0.0532 0.502 regulation of cytokine-mediated
signaling pathway;cell migration
hs4 OPN5 6p12.3 -0.253 0.0532 0.502 protein-chromophore
linkage;response to stimulus
hs4 MDGA1 6p21 -0.253 0.0532 0.502 neuron migration;multicellular
hs4 PDGFB 22q13.1 -0.253 0.0532 0.502 Apoptosis; Oncogenes
xai UQCRFS1P3 6p22.3 0.253 0.0533 0.502
his SMAD2 18q21.1 0.253 0.0533 0.502 Apoptosis; Cell Signaling
xai QTRT1 19p13.3 0.253 0.0533 0.502 tRNA modification;queuosine
exp RTN4RL2 11q12.1 0.251 0.0533 0.502 axon regeneration
exp OMA1 1p32.2-p32.1 0.251 0.0533 0.502 proteolysis
cop CD4 12p13.31 0.251 0.0533 0.502 cell adhesion;entry into host cell
met NEDD4L 18q21.31 0.251 0.0533 0.502 protein ubiquitination;water
homeostasis
cop LPAR5 12p13.31 0.251 0.0533 0.502
cop ACRBP 12p13.31 0.251 0.0533 0.502
cop ING4 12p13.31 0.251 0.0533 0.502 Tumor Suppressors
xsq KLHL17 1p36.33 0.251 0.0533 0.502 brain development;actin
xsq AHSA1 14q24 0.251 0.0533 0.502 positive regulation of ATPase
xsq LOC283710 15q13.3 0.251 0.0533 0.502
exp TTI2 8p12 0.251 0.0533 0.502 DNA Damage Response (DDR)
exp FAM155B Xq13.1 0.251 0.0533 0.502
xsq CYC1 8q24.3 0.251 0.0533 0.502 transport;respiratory electron
transport chain
met OR6A2 11p15 0.251 0.0533 0.502
xsq LOC100131347 17q12 0.251 0.0533 0.502
xsq LILRB4 19q13.4 0.251 0.0533 0.502 signal transduction;negative
xai CPEB2 4p15.33 -0.253 0.0533 0.502 regulation of translation
his LINC01206 -0.253 0.0533 0.502
hs4 NANOS1 10q26.11 -0.253 0.0533 0.502 epithelial cell
his CDK20 9q22.1 -0.253 0.0533 0.502 Protein Kinases
his TTI1 20q11.23 0.253 0.0534 0.502 DNA Damage Response (DDR)
his RPRD1B 20q11.21-q12 0.253 0.0534 0.502 dephosphorylation of RNA
xai EEF2 19p13.3 0.253 0.0534 0.502 gene expression;cellular protein
metabolic process
exp RPL15P1 20p11.23 0.253 0.0534 0.502
xai TFB2M 1q44 0.253 0.0534 0.502 transcription from mitochondrial
xai BDP1 5q13 0.253 0.0534 0.502 regulation of transcription, DNA-
xai ZAP70 2q12 0.253 0.0534 0.503 T cell activation;B cell activation
xai FBXO31 16q24.2 0.253 0.0534 0.503 response to DNA damage
stimulus;cell cycle
xai MRGBP 20q13.33 0.253 0.0534 0.503
xsq IL25 14q11.2 0.251 0.0534 0.502 eosinophil
differentiation;inflammatory response to antigenic stimulus
exp HMGB3P5 10q25.2 0.251 0.0534 0.502
xsq ALKBH8 11q22.3 0.251 0.0534 0.502 DNA Damage Response (DDR)
xsq UBE2O 17q25.1 0.251 0.0534 0.503
xsq CLUL1 18p11.32 0.251 0.0534 0.503 cell death
exp ACVR2B 3p22 0.251 0.0534 0.503 signal
exp ATP8A1 4p13 0.251 0.0534 0.503 cation transport;aminophospholipid
transport
xsq PTPRG 3p21-p14 -0.251 0.0534 0.503 transmembrane receptor
protein tyrosine kinase signaling pathway;peptidyl-tyrosine dephosphorylation
exp VEPH1 3q24-q25 -0.251 0.0534 0.503
exp EIF5AP3 19q13.2 -0.253 0.0534 0.502
his ACAP1 17p13.1 0.253 0.0535 0.503 regulation of ARF GTPase
his GTF3C3 2q33.1 0.253 0.0535 0.503 transcription, DNA-
his CCDC151 19p13.2 0.253 0.0535 0.503
his PRKCSH 19p13.2 0.253 0.0535 0.503 protein folding;intracellular
protein kinase cascade
xai HDAC10 22q13.31 0.253 0.0535 0.503 negative regulation of
dependent
xai RPL5P1 15q11.2 0.253 0.0535 0.503
xsq KIF4B 5q33.1 0.251 0.0535 0.503
xsq HIST1H2AG 6p22.1 0.251 0.0535 0.503
met CTSL 9q21.33 0.251 0.0535 0.503
met RRP1B 21q22.3 0.251 0.0535 0.503 rRNA processing;negative regulation
xsq CYB5RL 1p32.3 0.251 0.0535 0.503
met C20orf196 20p12.3 -0.251 0.0535 0.503
exp RBPMS-AS1 8p12 -0.251 0.0535 0.503
xai PGAM1P7 -0.253 0.0535 0.503
his DBH 9q34 0.253 0.0536 0.503 synaptic transmission;response to
estradiol stimulus
exp PWRN2 15q11.2 0.253 0.0536 0.503
swa TACC1 8p11.22 0.253 0.0536 0.503 regulation of microtubule-based
process;cell division
xai RPL13AP6 10q25.2 0.253 0.0536 0.503
xai CD300LB 17q25.1 0.253 0.0536 0.503
his EXOSC5 19q13.1 0.253 0.0536 0.504 gene expression;RNA metabolic
process
his BCKDHA 19q13.1-q13.2 0.253 0.0536 0.504 branched chain family
amino acid catabolic process;cellular nitrogen compound metabolic process
xsq LINC01229 0.25 0.0536 0.503
xsq FAM27E2 0.25 0.0536 0.503
xsq VN1R10P 0.25 0.0536 0.503
exp UHRF1 19p13.3 0.25 0.0536 0.503 positive regulation of DNA
exp KDM3B 5q31 0.25 0.0536 0.503 regulation of transcription, DNA-
xai PSORS1C3 6p21.33 -0.253 0.0536 0.503
xai LINC00312 3p25.3 -0.253 0.0536 0.503
his LSP1 11p15.5 -0.253 0.0536 0.503 chemotaxis;cellular defense
response
hs4 GTF3C5 9q34 0.253 0.0537 0.504 tRNA transcription from RNA
hs4 LOC105376306 0.253 0.0537 0.504
xai LOC100507054 0.253 0.0537 0.504
his SARDH 9q33-q34 0.252 0.0537 0.504 glycine catabolic process
exp SYT5 19q13.42 0.252 0.0537 0.504 energy reserve metabolic
his DDX24 14q32 0.252 0.0537 0.504 RNA metabolic process
his IFI27L1 14q32.12 0.252 0.0537 0.504
exp CRMP1 4p16.1 0.25 0.0537 0.504 nervous system development;axon
guidance
xsq OTUD3 1p36.13 0.25 0.0537 0.504
exp SERHL2 22q13 0.25 0.0537 0.504
xsq EIF3D 22q13.1 0.25 0.0537 0.504 cellular protein metabolic
process;formation of translation initiation complex
met MLLT4 6q27 0.25 0.0537 0.504 cell junction assembly;adherens junction
organization
xsq STK31 7p15.3 0.25 0.0537 0.504
hs4 PRRG1 Xp21.1 -0.252 0.0537 0.504
his MIR5010 -0.252 0.0537 0.504
his LOC101928126 -0.252 0.0537 0.504
hs4 SH3RF1 4q32.3 -0.252 0.0537 0.504 induction of
his DDR2 1q23.3 -0.252 0.0537 0.504 peptidyl-tyrosine
factor activity
exp LOC100128982 0.252 0.0538 0.504
xai TG 8q24 0.252 0.0538 0.504 regulation of myelination;response to
lipopolysaccharide
xai PEBP1P3 1q31.3 0.252 0.0538 0.504
his CREM 10p11.21 0.252 0.0538 0.504 cell differentiation;regulation of
xai NLRP5 19q13.43 0.252 0.0538 0.504
his SFT2D1 6q27 0.252 0.0538 0.504 protein transport;vesicle-mediated
transport
his LOC100289495 0.252 0.0538 0.504
hs4 ADSSL1 14q32.33 0.252 0.0538 0.504 immune system process;purine
base metabolic process
hs4 MPZ 1q23.3 0.252 0.0538 0.504 synaptic transmission
xai WT1 11p13 0.252 0.0538 0.504 Apoptosis; Tumor Suppressors
xsq MSH6 2p16 0.25 0.0538 0.504 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xsq RFT1 3p21.1 0.25 0.0538 0.504 cellular protein metabolic
met TOP3B 22q11.22 0.25 0.0538 0.504 DNA Damage Response (DDR); DDR
(FA); DDR (DNA replication)
cop CYP46A1 14q32.1 0.25 0.0538 0.504 bile acid biosynthetic
xsq MAGEE1 Xq13.3 0.25 0.0538 0.504
cop THOC1 18p11.32 0.25 0.0538 0.504 apoptotic process;signal
transduction
xsq OR5AK2 11q12.1 0.25 0.0538 0.504
xsq AQP8 16p12 0.25 0.0538 0.504 transport;water transport
xsq D2HGDH 2q37.3 0.25 0.0538 0.504 response to manganese
ion;response to zinc ion
exp LOC441228 7p11.2 0.25 0.0538 0.504
xsq RBM10 Xp11.23 0.25 0.0538 0.504 mRNA processing;RNA splicing
mut USP29 0.25 0.0538 0.504
exp LPCAT3 12p13 0.25 0.0538 0.504 phospholipid biosynthetic process
xsq FAXC 6q16.2 -0.25 0.0538 0.504
exp RAB5C 17q21.2 -0.25 0.0538 0.504 regulation of endocytosis;GTP
catabolic process
met MFNG 22q12 -0.25 0.0538 0.504 pattern specification process
xsq LAMA3 18q11.2 -0.25 0.0538 0.504 regulation of cell
cop TRIL 7p14.3 -0.25 0.0538 0.504 innate immune response;regulation
cop LOC100506497 -0.25 0.0538 0.504
his JRK 8q24.3 -0.252 0.0538 0.504 regulation of transcription,
DNA-dependent"
his PSCA 8q24.2 -0.252 0.0538 0.504
his PRODH 22q11.21 -0.252 0.0538 0.504 proline catabolic
process;induction of apoptosis by oxidative stress
xai TRABD 22q13.33 0.252 0.0539 0.504
xai FCF1P8 0.252 0.0539 0.504
xai AFF2 Xq28 0.252 0.0539 0.504 learning or memory;regulation of RNA
splicing
his NELFCD 20q13 0.252 0.0539 0.505
his LINC01347 0.252 0.0539 0.505
his AP3B1 5q14.1 0.252 0.0539 0.505 protein targeting to
xsq MYCBP2 13q22 0.25 0.0539 0.504 regulation of transcription, DNA-
met CSDE1 1p22 0.25 0.0539 0.504 regulation of transcription, DNA-
dependent;male gonad development"
cop TMCC1 3q22.1 -0.25 0.0539 0.505
hs4 CRYAB 11q22.3-q23.1 -0.252 0.0539 0.505 protein folding;anti-
apoptosis
hs4 HSPB2 11q22-q23 -0.252 0.0539 0.505 Apoptosis
hs4 HSPB2-C11orf52 -0.252 0.0539 0.505
his PTPRU 1p35.3 -0.252 0.0539 0.504 homotypic cell-cell
his MPO 17q23.1 0.252 0.054 0.505 defense response;hydrogen peroxide
catabolic process
exp POC5 5q13.3 0.252 0.054 0.505 cell cycle
hs4 MIR373 0.252 0.054 0.505
hs4 TBX6 16p11.2 0.252 0.054 0.505 mesoderm development;anatomical structure
morphogenesis
xai HBQ1 16p13.3 0.252 0.054 0.505 transport;oxygen transport
exp FCF1P8 0.252 0.054 0.505
hs4 LGALS12 11q13 0.252 0.054 0.505 induction of apoptosis by intracellular
signals;apoptotic process
swa POLR2E 19p13.3 0.252 0.054 0.505 DNA Damage Response (DDR); DDR
(NER)
exp TESC 12q24.22 0.25 0.054 0.505 positive regulation of gene
exp MIR600HG 9q33.3 0.25 0.054 0.505
mut AHCYL1 1p13.2 0.25 0.054 0.505 mRNA polyadenylation;protein export
from nucleus
exp NADK 1p36.33 0.25 0.054 0.505 vitamin metabolic process;water-soluble
vitamin metabolic process
xsq KDM4A-AS1 0.25 0.054 0.505
xsq ADCY7 16q12.1 0.25 0.054 0.505 GTP catabolic process;fibroblast growth
exp TMEM258 11q12.2 0.25 0.054 0.505
exp C1DP1 10p11.22 0.25 0.054 0.505
exp LOC646762 7p14.3 0.25 0.054 0.505
cop ZNF384 12p12 0.25 0.054 0.505 regulation of transcription, DNA-
xsq FANK1 10q26.2 -0.25 0.054 0.505
cop INHBA 7p15-p13 -0.25 0.054 0.505 hair follicle development;nervous system
development
exp PROM2 2q11.1 -0.25 0.054 0.505
exp RRAS 19q13.33 -0.25 0.054 0.505 GTP catabolic process;signal transduction
xai TLR3 4q35 -0.252 0.054 0.505 activation of NF-kappaB-inducing kinase
activity;positive regulation of interleukin-8 production
his GJA5 1q21.1 -0.252 0.054 0.505 muscle contraction;cell-cell
junction assembly
xai CD24 -0.252 0.054 0.505 regulation of cytokine-mediated signaling
pathway;cell migration
hs4 FMN1 15q13.3 -0.252 0.054 0.505 cellular component
his RBP2 3q23 -0.252 0.054 0.505 retinoid metabolic process;vitamin A
metabolic process
DNA-dependent"
swa FKBP14 7p14.3 -0.252 0.054 0.505 protein folding;activation of
hs4 CTSO 4q32.1 -0.252 0.054 0.505 proteolysis
xai NAV2-AS2 -0.252 0.054 0.505
his CMTR2 0.252 0.0541 0.505
his HCG25 0.252 0.0541 0.505
xai KLHL11 17q21.2 0.252 0.0541 0.505
his ACACA 17q21 0.252 0.0541 0.505 long-chain fatty-acyl-CoA biosynthetic
process;tissue homeostasis
his TADA2A 17q12-q21 0.252 0.0541 0.505 regulation of transcription,
his CD69 12p13 0.252 0.0541 0.505 cellular response to drug
his C14orf119 14q11.2 0.252 0.0541 0.505
his ACIN1 14q11.2 0.252 0.0541 0.505 apoptotic chromosome
condensation;positive regulation of monocyte differentiation
exp RNY1 7q36 0.252 0.0541 0.505
xai MIR25 0.252 0.0541 0.505
exp MIR25 0.252 0.0541 0.505
xai FLT3 13q12 0.252 0.0541 0.505 Cell Signaling; Oncogenes
exp IQCB1 3q13.33 0.25 0.0541 0.505 cilium assembly;photoreceptor cell
maintenance
xsq RNF34 12q24.31 0.25 0.0541 0.505 Apoptosis
xsq MRPL20 1p36.3-p36.2 0.25 0.0541 0.505 translation
exp FAM109B 22q13.2 -0.25 0.0541 0.505 endosome
organization;retrograde transport, endosome to Golgi
exp PITPNM3 -0.25 0.0541 0.505
exp SLC6A8 Xq28 -0.25 0.0541 0.505 Solute Carriers
exp EMP2 16p13.2 -0.25 0.0541 0.505 cell proliferation
xsq UGGT2 13q32.1 -0.25 0.0541 0.505 protein folding;protein
glycosylation
met KRT31 17q21.2 -0.25 0.0541 0.505 epidermis development
his STXBP6 14q12 -0.252 0.0541 0.505 vesicle-mediated transport
xai RPL15P1 20p11.23 0.252 0.0542 0.505
his PTPN4 2q14.2 0.252 0.0542 0.505 protein dephosphorylation
swa ARMC5 16p11.2 0.252 0.0542 0.505
hs4 CD247 1q24.2 0.252 0.0542 0.505 T cell costimulation;interspecies
DNA-dependent"
xsq NFATC2IP 0.25 0.0542 0.505 DNA Damage Response (DDR); DDR (HR)
exp RPL10AP10 5q31.2 0.25 0.0542 0.505
xsq IMMT 2p11.2 0.25 0.0542 0.505
exp UGGT2 13q32.1 -0.25 0.0542 0.505 protein folding;protein
glycosylation
exp YWHAZP3 10p12.2 -0.25 0.0542 0.505
met NTN5 19q13.33 -0.25 0.0542 0.505
swa ATP5J 21q21.1 -0.252 0.0542 0.505 ATP catabolic
process;transport
xai PTPRU 1p35.3 -0.252 0.0542 0.505 homotypic cell-cell
hs4 MLPH 2q37.3 -0.252 0.0542 0.505 intracellular protein
transport
mir hsa-miR-663 0.252 0.0543 0.505
xai ARID2 12q12 0.252 0.0543 0.505 DNA Damage Response (DDR); DDR
(Chromatin)
his TUBGCP6 22q13.31-q13.33 0.252 0.0543 0.505 mitotic cell
exp HSPA8P7 0.252 0.0543 0.505
xai RPL17P43 17p11.2 0.252 0.0543 0.505
hs4 KCNQ2 20q13.3 0.252 0.0543 0.505 potassium ion transmembrane
his CDK8 13q12 0.252 0.0543 0.505 Protein Kinases
xai USP34 2p15 0.252 0.0543 0.506 protein K48-linked
deubiquitination;positive regulation of canonical Wnt receptor signaling pathway
exp ZSCAN16-AS1 0.252 0.0543 0.506
exp UTP14A Xq26.1 0.25 0.0543 0.505 rRNA processing
xsq PNRC2 1p36.11 0.25 0.0543 0.505 regulation of transcription, DNA-
xsq C10orf25 10q11.21 0.25 0.0543 0.505
exp RPL29P13 5p15.2 0.25 0.0543 0.505
exp BUB1 2q14 0.25 0.0543 0.506 DNA Damage Response (DDR); Protein
Kinases
exp RPL12P13 1p36.11 0.25 0.0543 0.506
xsq HSPBAP1 3q21.1 0.25 0.0543 0.506 DDR (DNA replication)
exp TENM2 5q34 -0.25 0.0543 0.506
exp PCP4L1 1q23.3 -0.25 0.0543 0.505
exp PGAM1P7 -0.252 0.0543 0.506
hs4 CKMT2 5q13.3 -0.252 0.0543 0.506 creatine metabolic
xai DDAH1 1p22 -0.252 0.0543 0.505 arginine catabolic process;nitric
xai MAP4K4 2q11.2-q12 -0.252 0.0543 0.505 response to
his SGCE 7q21.3 -0.252 0.0543 0.505 cell-matrix adhesion;muscle
organ development
his PEG10 7q21 -0.252 0.0543 0.505 apoptotic process;cell
differentiation
exp BDP1 5q13 0.252 0.0544 0.506 regulation of transcription, DNA-
hs4 TNFAIP8 5q23.1 0.252 0.0544 0.506 Apoptosis
his KMT2D 12q13.12 0.252 0.0544 0.506
his IL16 15q26.3 0.252 0.0544 0.506 regulation of transcription, DNA-
dependent;chemotaxis
xai PPIL3 2q33.1 0.252 0.0544 0.506 protein folding;RNA splicing
his WNT10B 12q13 0.252 0.0544 0.506 Apoptosis; Oncogenes
xsq SERBP1 1p31 0.25 0.0544 0.506 regulation of anti-
exp POLR3C 1q21.1 0.25 0.0544 0.506 positive regulation of innate
cop TAF4B 18q11.2 0.25 0.0544 0.506 viral reproduction;transcription
exp AZU1 19p13.3 0.25 0.0544 0.506 microglial cell activation;positive
exp LOC728048 4q13.2 -0.25 0.0544 0.506
xai MKRN3 15q11-q13 0.252 0.0545 0.506
xai ERCC6L Xq13.1 0.252 0.0545 0.506 mitotic prometaphase;mitotic
cell cycle
xai SYNDIG1 20p11.21 0.252 0.0545 0.507 intracellular protein
met OR2B11 1q44 0.25 0.0545 0.506 response to stimulus
xsq ZNF75D Xq26.3 0.25 0.0545 0.506 regulation of transcription,
cop DMXL2 15q21.2 0.25 0.0545 0.506
cop SCG3 15q21 0.25 0.0545 0.506 platelet degranulation;blood coagulation
cop LYSMD2 15q21.2 0.25 0.0545 0.506 cell wall macromolecule
catabolic process
cop TMOD2 15q21.2 0.25 0.0545 0.506 learning or memory;positive
regulation of G-protein coupled receptor protein signaling pathway
cop TMOD3 15q21.1-q21.2 0.25 0.0545 0.506
cop LEO1 15q21.2 0.25 0.0545 0.506 regulation of transcription, DNA-
cop MAPK6 15q21 0.25 0.0545 0.506 Protein Kinases
cop BCL2L10 15q21 0.25 0.0545 0.506 Apoptosis
xsq RIPPLY2 6q14.2 0.25 0.0545 0.506 ossification;somitogenesis
cop CD163 12p13.3 0.249 0.0545 0.507 acute-phase response;inflammatory
response
met SUMO2 17q25.1 -0.25 0.0545 0.507 DNA Damage Response (DDR)
exp BOK 2q37.3 -0.25 0.0545 0.507 male gonad
xsq WFDC21P -0.25 0.0545 0.507
exp PITX1 5q31.1 -0.25 0.0545 0.506 anatomical structure
morphogenesis;branchiomeric skeletal muscle development
xai FAM132B 2q37.3 -0.252 0.0545 0.507
his PTX4 16p13.3 0.252 0.0546 0.507
his TELO2 16p13.3 0.252 0.0546 0.507 DNA Damage Response (DDR); DDR (FA)
his TRAPPC8 18q12.1 0.252 0.0546 0.507 vesicle-mediated transport;ER
his EYA3 1p36 0.252 0.0546 0.507 DNA Damage Response (DDR)
xsq SLBP 4p16.3 0.249 0.0546 0.507 transcription from RNA polymerase
exp RNU4ATAC 2q14.2 0.249 0.0546 0.507
xsq RRN3P3 16p12.2 0.249 0.0546 0.507
exp GAFA3 4p14 0.249 0.0546 0.507
xsq KLHDC4 16q24 0.249 0.0546 0.507
exp LOC440973 3q13.13 -0.249 0.0546 0.507
xai LIMK1 7q11.23 -0.252 0.0546 0.507 Protein Kinases
exp BLZF2P 14q24.1 -0.252 0.0546 0.507
exp RNF32 7q36 0.249 0.0547 0.507
exp PLA2G4A 1q25 0.249 0.0547 0.507 metabolic process;platelet
activation
exp OR7A19P 12q13.11 0.249 0.0547 0.507
cop C1S 12p13 0.249 0.0547 0.508 proteolysis;complement activation
cop C1R 12p13 0.249 0.0547 0.508 complement activation, classical
exp LTB 6p21.3 0.249 0.0547 0.508 immune response;signal transduction
xsq ASH1L-AS1 1q22 0.249 0.0547 0.508
xsq LOC101929380 0.249 0.0547 0.508
xsq AK4 1p31.3 -0.249 0.0547 0.508
xsq LATS2 13q11-q12 -0.249 0.0547 0.508 protein
phosphorylation;negative regulation of cyclin-dependent protein kinase activity
xsq TRIM38 6p21.3 -0.249 0.0547 0.508 signal
xai CGNL1 15q21.3 -0.251 0.0547 0.507
xai KIAA1549 7q34 -0.252 0.0547 0.507
his FJX1 11p13 -0.252 0.0547 0.507
his LRR1 14q21.3 0.251 0.0548 0.508
exp THAP9-AS1 0.251 0.0548 0.508
his PRKDC 8q11 0.251 0.0548 0.508 Apoptosis; DNA Damage Response (DDR); DDR
(NHEJ); Protein Kinases
his MCM4 8q11.2 0.251 0.0548 0.508 DDR (DNA replication)
his PCBD2 5q31.1 0.251 0.0548 0.508 protein
heterooligomerization;oxidation-reduction process
xai CLCA4 1p31-p22 0.251 0.0548 0.508 transport;chloride transport
xai LOC100128108 15q26.3 0.251 0.0548 0.508
xsq TOPBP1 3q22.1 0.249 0.0548 0.508 DNA Damage Response (DDR);
DDR (DNA replication); DDR (G2-M checkpoint)
xsq NDUFAB1 16p12.2 0.249 0.0548 0.508 respiratory electron
xsq SMC1A Xp11.22-p11.21 0.249 0.0548 0.508 DNA Damage Response (DDR);
exp ZSWIM3 20q13.12 0.249 0.0548 0.508
met ADAM28 8p21.2 0.249 0.0548 0.508 proteolysis;spermatogenesis
exp TLR3 4q35 -0.249 0.0548 0.508 activation of NF-kappaB-inducing
exp FEM1C 5q22 -0.249 0.0548 0.508
met FAM53C 5q31 -0.249 0.0548 0.508
his BBOX1 11p14.2 -0.251 0.0548 0.508 cellular nitrogen compound
xai RGS3 9q32 -0.251 0.0548 0.508 inactivation of MAPK
swa VAMP3 1p36.23 -0.251 0.0548 0.508 protein complex
xai MAFB 20q11.2-q13.1 -0.251 0.0548 0.508 negative regulation of
his GOT2 16q21 0.251 0.0549 0.508 2-oxoglutarate metabolic
xai RRN3 16p12 0.251 0.0549 0.508 regulation of transcription, DNA-
hs4 LOC728739 12q23.3 0.251 0.0549 0.508
his GDI2 10p15 0.251 0.0549 0.508 signal transduction;small GTPase mediated
signal transduction
swa SART3 12q24.1 0.251 0.0549 0.508 RNA processing
xai CD6 11q13 0.251 0.0549 0.508 cell adhesion
exp OR4X1 11p11.2 0.251 0.0549 0.508 response to stimulus
swa RPL35A 3q29 0.251 0.0549 0.508 translational initiation;viral
infectious cycle
his NPAT 11q22-q23 0.251 0.0549 0.508 regulation of gene
expression;positive regulation of transcription, DNA-dependent
his ATM 11q22-q23 0.251 0.0549 0.508 Apoptosis; DNA Damage Response
(DDR); DDR (NHEJ); DDR (DNA replication); Protein Kinases; Tumor Suppressors
xai RPL13AP25 13q14.3 0.251 0.0549 0.508
his LINC01016 0.251 0.0549 0.508
his MIR7159 0.251 0.0549 0.508
exp MDC1 6p21.3 0.249 0.0549 0.508 DNA Damage Response (DDR); DDR
(NHEJ)
met PHF2P1 13q11 0.249 0.0549 0.508
xsq EXO1 1q42-q43 0.249 0.0549 0.508 DNA Damage Response (DDR); DDR
(MMR)
exp ERCC6L Xq13.1 0.249 0.0549 0.508 mitotic prometaphase;mitotic
cell cycle
exp LOC284685 1q24.1 0.249 0.0549 0.508
met TLCD1 17q11.2 0.249 0.0549 0.508
cop PIANP 12p13.31 0.249 0.0549 0.508
cop COPS7A 12p13.31 0.249 0.0549 0.508 DNA Damage Response (DDR)
cop MLF2 12p13 0.249 0.0549 0.508 defense response
cop PTMS 12p13 0.249 0.0549 0.508 DNA replication
cop LAG3 12p13.32 0.249 0.0549 0.508 cell surface receptor signaling
xsq C3orf62 3p21.31 0.249 0.0549 0.508
mut TRAK2 2q33 0.249 0.0549 0.508 regulation of transcription from RNA
polymerase II promoter;protein O-linked glycosylation
xsq DIMT1 5q12.1 0.249 0.0549 0.508
cop C7orf25 7p14.1 -0.249 0.0549 0.508
exp MIR205 -0.249 0.0549 0.508
exp GLTSCR1 19q13.3 -0.249 0.0549 0.508
xai MAP1B 5q13 -0.251 0.0549 0.508 central nervous system
hs4 DIRAS3 1p31 -0.251 0.0549 0.508 regulation of cyclin-
dependent protein kinase activity;GTP catabolic process
his TCERG1L-AS1 -0.251 0.0549 0.508
hs4 CDC42EP1 22q13.1 -0.251 0.0549 0.508 regulation of cell
xai SETD1B 12q24.31 0.251 0.055 0.508 regulation of transcription, DNA-
his WDR70 5p13.2 0.251 0.055 0.508
xai EFTUD2 17q21.31 0.251 0.055 0.508 RNA splicing;gene expression
xsq LOC645434 0.249 0.055 0.508
xsq NUS1 6q22.1 0.249 0.055 0.508 cell differentiation;angiogenesis
dependent"
exp TRNT1 3p25.1 0.249 0.055 0.508 RNA processing;protein targeting to
mitochondrion
exp PPIL3 2q33.1 0.249 0.055 0.508 protein folding;RNA splicing
xsq SNORA70 0.249 0.055 0.508
met ARF5 7q31.3 0.249 0.055 0.508 GTP catabolic process;small GTPase
exp FGFR1OP 6q27 0.249 0.055 0.508 positive regulation of cell
mir hsa-miR-1225-3p 0.249 0.055 0.509
cop TPI1 12p13 0.249 0.055 0.509 carbohydrate metabolic process;glucose
metabolic process
xsq LOC100131626 -0.249 0.055 0.509
xsq SEMA3F 3p21.3 -0.249 0.055 0.508 neural crest cell
DNA-dependent"
swa ABCF1 6p21.33 0.251 0.0551 0.509 ABC Transporters
his JAK3 19p13.1 0.251 0.0551 0.509 Oncogenes
xai E4F1 16p13.3 0.251 0.0551 0.509 negative regulation of
transcription from RNA polymerase II promoter;regulation of cell cycle process
his TIMP1 Xp11.3-p11.23 0.251 0.0551 0.509 platelet
degranulation;erythrocyte maturation
his MIR4769 0.251 0.0551 0.509
hs4 GALNT6 12q13 0.251 0.0551 0.509 post-translational protein
swa TCEA1 8q11.2 0.251 0.0551 0.509 DNA Damage Response (DDR)
xai FBXO38 5q32 0.251 0.0551 0.509
exp COX7B Xq21.1 0.249 0.0551 0.509 respiratory electron transport
chain;small molecule metabolic process
exp RPL13AP6 10q25.2 0.249 0.0551 0.509
mut DNAH8 6p21.2 0.249 0.0551 0.509 ciliary or flagellar
xsq HIPK2 7q32-q34 -0.249 0.0551 0.509 Apoptosis
xsq ALKBH3-AS1 -0.249 0.0551 0.509
xai ARRDC4 15q26.3 -0.251 0.0551 0.509 signal transduction
his UQCRB 8q22 0.251 0.0552 0.509 oxidative phosphorylation;mitochondrial
electron transport, ubiquinol to cytochrome c
xai KDM3B 5q31 0.251 0.0552 0.509 regulation of transcription, DNA-
swa TUBB4B 9q34 0.251 0.0552 0.509 Apoptosis
xai TET3 2p13.1 0.251 0.0552 0.509
his RPL36 19p13.3 0.251 0.0552 0.509 translational termination;cellular
xai HSPA8P5 12p13.32 0.251 0.0552 0.509
xai CCDC88C 14q32.11 0.251 0.0552 0.51 microtubule cytoskeleton
xai STX10 19p13.2 0.251 0.0552 0.51 intracellular protein
transport;retrograde transport, endosome to Golgi
cop ARHGEF17 11q13.4 0.249 0.0552 0.509 regulation of small GTPase
exp BCL7A 12q24.13 0.249 0.0552 0.509 negative regulation of
xsq GNA13 17q24.3 0.249 0.0552 0.509 cellular component movement;cell
differentiation
exp RPL13P 6p21 0.249 0.0552 0.509
exp RNF113A Xq24 0.249 0.0552 0.51
exp KAT6B 10q22.2 0.249 0.0552 0.51 positive regulation of
hs4 LINC01508 -0.251 0.0552 0.51
xai HEXB 5q13 -0.251 0.0552 0.51 carbohydrate metabolic
process;sensory perception of sound
xai PLEKHA2 8p11.22 -0.251 0.0552 0.51 positive regulation of
cell-matrix adhesion
exp RPEP4 -0.251 0.0552 0.509
his MOCS2 5q11 0.251 0.0553 0.51 vitamin metabolic process;water-soluble
his LOC257396 5q11.2 0.251 0.0553 0.51
exp YBX1P6 9q31.3 0.251 0.0553 0.51
xai MMRN1 4q22 0.251 0.0553 0.51 platelet degranulation;cell adhesion
his DIAPH1 5q31 0.251 0.0553 0.51 regulation of microtubule-based
exp FRAT1 10q24.1 0.249 0.0553 0.51 Wnt receptor signaling
cop GNB5 15q21.2 0.249 0.0553 0.51 GTP catabolic process;signal
transduction
xsq BNIP2 15q22.2 0.249 0.0553 0.51 Apoptosis
met FAM47E 4q21.1 0.249 0.0553 0.51
xsq RPL13AP17 7q21.11 0.249 0.0553 0.51
xsq ABTB2 11p13 -0.249 0.0553 0.51 regulation of cell growth
xsq MAPRE3 2p23.3-p23.1 -0.249 0.0553 0.51 cell division;cell
cycle
exp CLDN12 7q21 -0.249 0.0553 0.51 calcium-independent cell-cell
adhesion;cell junction assembly
hs4 NRADDP -0.251 0.0553 0.51
hs4 LINC01446 -0.251 0.0553 0.51
exp WWTR1-AS1 3q25.1 -0.251 0.0553 0.51
hs4 LOC101926913 -0.251 0.0553 0.51
hs4 ERICH2 2q31.1 -0.251 0.0553 0.51
xai METTL5 2q31.1 0.251 0.0554 0.51
exp LOC100129995 0.251 0.0554 0.51
xai DNAJA2 16q12.1 0.251 0.0554 0.51 protein folding;positive
xai LOC283710 15q13.3 0.251 0.0554 0.51
hs4 KRTAP12-3 0.251 0.0554 0.51
hs4 LOC105371083 0.251 0.0554 0.51
hs4 RMI2 16p13.13 0.251 0.0554 0.51 DNA Damage Response (DDR); DDR (FA)
hs4 LINC00977 0.251 0.0554 0.51
met LOC100126784 11p15.1 0.249 0.0554 0.51
met AMT 3p21.2-p21.1 0.249 0.0554 0.51 glycine catabolic process
exp REST 4q12 0.249 0.0554 0.51 positive regulation of apoptotic
xsq HEYL 1p34.3 0.249 0.0554 0.51 multicellular organismal
development;negative regulation of androgen receptor activity
xsq FCGR1C 0.249 0.0554 0.51
met CAMKK2 12q24.2 -0.249 0.0554 0.51 positive regulation of
xsq NBPF18P 1q21.3 -0.249 0.0554 0.51
exp GDPD5 11q13.4-q13.5 -0.249 0.0554 0.51 glycerol metabolic
xai PGM3 6q14.1-q15 -0.251 0.0554 0.51 glucosamine metabolic
process;cellular protein metabolic process
hs4 LINC01776 -0.251 0.0554 0.51
xai GBP3 1p22.2 -0.251 0.0554 0.51
xai PTGR1 9q31.3 -0.251 0.0554 0.51 leukotriene metabolic
his MED15 22q11.2 -0.251 0.0554 0.51 regulation of transcription
hs4 ETV1 7p21.3 -0.251 0.0554 0.51 Transcription Factors
his MIR199B 0.251 0.0555 0.51
his MIR3154 0.251 0.0555 0.51
xai DHX34 19q13.3 0.251 0.0555 0.51
his SALRNA2 0.251 0.0555 0.51
his PSMA2 7p13 0.251 0.0555 0.51 protein polyubiquitination;DNA damage
his MRPL32 7p14 0.251 0.0555 0.51 translation
cop HHIPL1 14q32 0.251 0.0555 0.51 carbohydrate metabolic process
cop MIR5698 0.251 0.0555 0.51
his RPS3 11q13.3-q13.5 0.251 0.0555 0.51 translational
his SNORD15A 0.251 0.0555 0.51
his SNORD15B 11q13.4 0.251 0.0555 0.51
cop CLSTN3 12p13.31 0.249 0.0555 0.51 cell adhesion;homophilic cell
adhesion
exp WDR48 3p21.33 0.249 0.0555 0.51 DNA Damage Response (DDR); DDR (FA)
xsq RPS14 5q31-q33 0.249 0.0555 0.51 nuclear-transcribed mRNA catabolic
met SH3BGRL Xq13.3 0.249 0.0555 0.51
cop MIR4713 0.249 0.0555 0.51
xsq ASF1A 6q22.31 0.249 0.0555 0.51 DNA Damage Response (DDR); DDR (DNA
replication)
mut MOCS1 6p21.3 0.249 0.0555 0.51 vitamin metabolic process;water-
exp COX18 4q13.3 0.249 0.0555 0.51 protein transport;protein insertion
exp MAFB 20q11.2-q13.1 -0.249 0.0555 0.51 negative regulation of
xsq FRMD6 14q22.1 -0.249 0.0555 0.51
his MAP1LC3C 1q43 -0.251 0.0555 0.51 autophagy
xai SH3PXD2A 10q24.33 -0.251 0.0555 0.51 superoxide metabolic
his NPAS3 14q13.1 -0.251 0.0555 0.51 maternal behavior;positive
xai AHSA1 14q24 0.251 0.0556 0.511 positive regulation of ATPase
xai MAT2A 2p11.2 0.251 0.0556 0.511 response to light stimulus;response
to hormone stimulus
his ACTR1B 2q11.1-q11.2 0.251 0.0556 0.511
xai PAQR3 4q21.21 0.251 0.0556 0.511
exp LINC01126 0.251 0.0556 0.511
hs4 TRPM5 11p15.5 0.251 0.0556 0.511 ion transport
his MAD2L2 1p36 0.251 0.0556 0.511 DNA Damage Response (DDR); DDR (DNA
xai UTP14A Xq26.1 0.251 0.0556 0.511 rRNA processing
xai FLJ40712 0.251 0.0556 0.511
xai EPT1 2p23.3 0.251 0.0556 0.511 phospholipid biosynthetic process
xsq BATF3 1q32.3 0.248 0.0556 0.511 regulation of transcription, DNA-
cop MIR4466 0.248 0.0556 0.511
exp LOC442263 6q23.3 0.248 0.0556 0.511
cop ASPG 14q32.33 0.248 0.0556 0.511 cellular amino acid metabolic
xsq LINC00029 0.248 0.0556 0.511
exp IDS Xq28 -0.248 0.0556 0.511
cop LOC100507032 -0.248 0.0556 0.511
exp AKT1S1 19q13.33 -0.249 0.0556 0.511 nerve growth factor
receptor signaling pathway;negative regulation of protein kinase activity
hs4 MIR3165 -0.251 0.0556 0.511
xai ZNF296 19q13.32 0.251 0.0557 0.511 spermatogenesis;regulation of
xai CHAF1A 19p13.3 0.251 0.0557 0.511 DNA Damage Response (DDR);
xai SF3A2 19p13.3 0.25 0.0557 0.511 mRNA processing;RNA splicing
xai LOC100129995 0.25 0.0557 0.511
xai LOC440311 15q26.2 0.25 0.0557 0.511
swa GCLC 6p12 0.25 0.0557 0.511 response to heat;small molecule metabolic
process
his FANCI 15q26.1 0.25 0.0557 0.511 DNA Damage Response (DDR); DDR (FA)
xai PLA2G4A 1q25 0.25 0.0557 0.511 metabolic process;platelet
activation
xai LOC100133315 11q13.4 0.25 0.0557 0.511
his DNLZ 9q34.3 0.25 0.0557 0.511
met CYP26C1 10q23.33 0.248 0.0557 0.511 small molecule metabolic
process;organelle fusion
met TREML3P 6p21.1 0.248 0.0557 0.511
xsq VBP1 Xq28 0.248 0.0557 0.511 cellular protein metabolic process;'de
exp TCEAL4 Xq22.2 -0.248 0.0557 0.511 regulation of
cop GLI3 7p13 -0.248 0.0557 0.511 axon guidance;pallium development
exp TEAD2 19q13.3 -0.248 0.0557 0.511 positive regulation of
exp TMEM51 1p36.21 -0.248 0.0557 0.511
his LOC101928075 -0.25 0.0557 0.511
his TTC9 14q24.2 -0.25 0.0557 0.511
xai TEAD2 19q13.3 -0.25 0.0557 0.511 positive regulation of
his LOC102724323 0.25 0.0558 0.511
his TMEM218 11q24.2 0.25 0.0558 0.512
hs4 HS3ST4 16p11.2 0.25 0.0558 0.512 heparan sulfate proteoglycan
metabolic process
xai KPNA5 6q22.1 0.25 0.0558 0.512 cytokine-mediated signaling
xsq AKAP8 19p13.1 0.248 0.0558 0.511 signal transduction;mitosis
xsq FBXW7 4q31.3 0.248 0.0558 0.512 DNA Damage Response (DDR); Tumor
Suppressors
met G6PC2 2q24.3 0.248 0.0558 0.512 gluconeogenesis;hexose transport
met PDE9A 21q22.3 0.248 0.0558 0.512 signal transduction;blood
coagulation
xsq MXRA7 17q25.1 -0.248 0.0558 0.511
xai CEACAM22P 19q13.31 -0.25 0.0558 0.512
swa RCN2 15q23 -0.25 0.0558 0.511
exp KNCN 1p33 -0.25 0.0558 0.511
xai SASS6 1p21.2 0.25 0.0559 0.512 cell cycle;centriole replication
xai CPSF2 14q31.1 0.25 0.0559 0.512 gene expression;nuclear mRNA
his MRPL44 2q36.1 0.25 0.0559 0.512 RNA processing
his PMPCB 7q22.1 0.25 0.0559 0.512 proteolysis
his UBP1 3p22.3 0.25 0.0559 0.512 angiogenesis;regulation of
met PTPN18 2q21.1 0.248 0.0559 0.512 protein dephosphorylation
xsq NUP160 11p11.2 0.248 0.0559 0.512 hexose transport;regulation
xsq APLNR 11q12 0.248 0.0559 0.512 G-protein coupled receptor signaling
pathway;regulation of body fluid levels
exp LOC100289381 6p22.3 0.248 0.0559 0.512
xsq ADPGK 15q24.1 0.248 0.0559 0.512 glycolysis;carbohydrate metabolic
process
mut ZNF287 17p11.2 0.248 0.0559 0.512 positive regulation of
transcription, DNA-dependent;viral reproduction
exp PLSCR4 3q24 -0.248 0.0559 0.512 phospholipid
xsq FRMD5 15q15.3 -0.248 0.0559 0.512
xsq TP53INP2 20q11.22 -0.248 0.0559 0.512
xsq DAB2 5p13.1 -0.248 0.0559 0.512 negative regulation of cell
growth;cell morphogenesis involved in differentiation
xai AUTS2 7q11.22 -0.25 0.0559 0.512
swa SDCBP 8q12 -0.25 0.0559 0.512 axon guidance;actin cytoskeleton
organization
xai TAF13 1p13.3 -0.25 0.0559 0.512 regulation of transcription, DNA-
xai NACAD 7p13 -0.25 0.0559 0.512 protein transport
his MIR193A -0.25 0.0559 0.512
his BNIP2 15q22.2 0.25 0.056 0.512 Apoptosis
his SCFD2 4q12 0.25 0.056 0.512 vesicle docking involved in exocytosis;protein
transport
his CDC73 1q25 0.25 0.056 0.513 Tumor Suppressors
xai NUP54 4q21.1 0.25 0.056 0.513 viral reproduction;cytokine-mediated
signaling pathway
his CCDC134 22q13.2 0.25 0.056 0.513
his LY86 6p25.1 0.25 0.056 0.513 apoptotic process;inflammatory response
exp ITGB7 12q13.13 0.248 0.056 0.512 cell-matrix adhesion;integrin-mediated
signaling pathway
xsq PIGV 1p36.11 0.248 0.056 0.512 GPI anchor biosynthetic
exp LOC100130403 6p12.1 0.248 0.056 0.512
exp MRPS31 13q14.11 0.248 0.056 0.513
exp CPS1 2q35 0.248 0.056 0.513 midgut development;response to drug
exp MRPL10 17q21.32 0.248 0.056 0.513 translation;ribosome biogenesis
cop MYO5C 15q21 0.248 0.056 0.513
cop MIR1266 0.248 0.056 0.513
cop INHBA-AS1 7p14.1 -0.248 0.056 0.513
xsq RNF130 5q35.3 -0.248 0.056 0.512 Apoptosis
his MIR505 0.25 0.0561 0.513
xai RPS19BP1 22q13.1 0.25 0.0561 0.513
his WDR48 3p21.33 0.25 0.0561 0.513 DNA Damage Response (DDR); DDR (FA)
xai DDX20 1p21.1-p13.2 0.25 0.0561 0.513 negative regulation of
transcription from RNA polymerase II promoter;RNA metabolic process
xai FLJ45832 0.25 0.0561 0.513
xsq NUDT1 7p22 0.248 0.0561 0.513 DNA Damage Response (DDR)
met ARHGEF10 8p23 0.248 0.0561 0.513 myelination in peripheral nervous
system;positive regulation of GTP catabolic process
cop MIR203A 0.248 0.0561 0.513
cop MIR203B 0.248 0.0561 0.513
cop KIF26A 14q32.33 0.248 0.0561 0.513 regulation of cell growth by
met STAT5B 17q11.2 0.248 0.0561 0.513 Apoptosis
met RILPL1 12q24.31 0.248 0.0561 0.513 neuroprotection
met C2orf27A 2q21.2 0.248 0.0561 0.513
xsq SAC3D1 11q13.1 0.248 0.0561 0.513 cell cycle;mitosis
xsq CSF3R 1p35-p34.3 0.248 0.0561 0.513 defense response;cell adhesion
xsq LOC100505549 0.248 0.0561 0.513
met INPP5D 2q37.1 -0.248 0.0561 0.513 phosphate-containing
compound metabolic process;negative regulation of B cell proliferation
his SBNO2 19p13.3 -0.25 0.0561 0.513 macrophage activation involved in
his C7orf69 7p12.3 -0.25 0.0561 0.513
his LINC00303 1q32.1 -0.25 0.0561 0.513
xai EIF2B3 1p34.1 0.25 0.0562 0.513 negative regulation of
his PPIAL4D 0.25 0.0562 0.513
xai NARF 17q25.3 0.25 0.0562 0.513
his SRP9 1q42.12 0.25 0.0562 0.513 translation;SRP-dependent
cotranslational protein targeting to membrane
exp NDUFC1 4q31.1 0.248 0.0562 0.513 mitochondrial electron
xsq IL23A 12q13.3 0.248 0.0562 0.513 positive regulation of activation
of JAK2 kinase activity;positive regulation of natural killer cell activation
cop MYO5A 15q21 0.248 0.0562 0.513 transport;regulation of inositol 1,4,5-
trisphosphate-sensitive calcium-release channel activity
met PRELID3A 0.248 0.0562 0.513
exp COPRS 17q11.2 -0.248 0.0562 0.513
exp DOCK5 8p21.2 -0.248 0.0562 0.513
xsq C1orf226 1q23.3 -0.248 0.0562 0.513
his LOC100128076 9q22.31 -0.25 0.0562 0.513
xai KIAA0319L 1p34.2 -0.25 0.0562 0.513
hs4 LOC400706 19q13.32 -0.25 0.0562 0.513
his VTCN1 1p13.1 -0.25 0.0562 0.513 negative regulation of T cell
activation
xai FGD4 12p11.21 -0.25 0.0562 0.513 lamellipodium assembly;microspike
assembly
xai ARPIN -0.25 0.0562 0.513
swa MRPL40 22q11.2 -0.25 0.0562 0.513 anatomical structure
morphogenesis
xai SNORA70E 0.25 0.0563 0.513
exp SNORA70E 0.25 0.0563 0.513
xai NDUFB11 Xp11.23 0.25 0.0563 0.513 transport;respiratory
exp LOC100130887 0.25 0.0563 0.513
hs4 LILRA2 19q13.4 0.25 0.0563 0.513 defense response;signal
transduction
xsq HAUS2 15q15.2 0.248 0.0563 0.513 cell division;G2/M transition of
mitotic cell cycle
xsq HVCN1 12q24.11 0.248 0.0563 0.513 response to zinc ion;proton
transport
exp TRIM28 19q13.4 0.248 0.0563 0.513 DNA Damage Response (DDR)
xsq CALN1 7q11 0.248 0.0563 0.513
exp HSPE1 2q33.1 0.248 0.0563 0.513 Apoptosis
exp ZNF236 18q22-q23 0.248 0.0563 0.513 regulation of transcription,
DNA-dependent;cellular response to glucose stimulus"
exp GUF1 4p12 0.248 0.0563 0.513 translation
exp MAPRE2 18q12.1 0.248 0.0563 0.513 cell cycle;mitosis
met C11orf84 11q13.1 0.248 0.0563 0.513
met SH3BGR 21q22.3 0.248 0.0563 0.513 protein complex assembly
xsq ZNF438 10p11.23 0.248 0.0563 0.514 negative regulation of
xsq KLRAP1 12p13.2 0.248 0.0563 0.514
exp CD200 3q13.2 -0.248 0.0563 0.513 regulation of immune response
met CD5 11q13 -0.248 0.0563 0.513 induction of apoptosis by
extracellular signals;T cell costimulation
exp HLA-C 6p21.3 -0.248 0.0563 0.513 antigen processing and
presentation of peptide antigen via MHC class I;regulation of immune response
xai RAB11FIP5 2p13 -0.25 0.0563 0.513 protein transport
swa TRIP6 7q22 -0.25 0.0563 0.513 cell adhesion;release of cytoplasmic
sequestered NF-kappaB
xai RPL29 3p21.3-p21.2 0.25 0.0564 0.514 nuclear-transcribed mRNA
hs4 SPC24 19p13.2 0.25 0.0564 0.514 M phase of mitotic cell
xsq LINC00662 19q11 0.248 0.0564 0.514
xsq ARHGAP11A 15q13.2 0.248 0.0564 0.514 signal transduction;small
xsq PHF6 Xq26.3 0.248 0.0564 0.514 regulation of transcription, DNA-
dependent"
xsq JARID2-AS1 0.248 0.0564 0.514
exp SASS6 1p21.2 0.248 0.0564 0.514 cell cycle;centriole replication
xsq PRMT1 19q13.3 0.248 0.0564 0.514 histone methylation;peptidyl-
xsq LINC00996 0.248 0.0564 0.514
pro EP300_24_GBL00023 0.248 0.0564 0.514
met KLHL36 16q24.1 0.248 0.0564 0.514
exp SYNDIG1 20p11.21 0.248 0.0564 0.514 intracellular protein
xsq SEC24A 5q31.1 -0.248 0.0564 0.514 ER to Golgi vesicle-
xsq WBP5 Xq22.2 -0.248 0.0564 0.514
hs4 PLXNB2 22q13.33 -0.25 0.0564 0.514 brain development;regulation
of cell shape
xai HSPD1P11 -0.25 0.0564 0.514
xai SUN1 7p22.3 -0.25 0.0564 0.514 cytoskeletal anchoring at nuclear
membrane;nuclear matrix anchoring at nuclear membrane
his CCDC167 6p21.2 0.25 0.0565 0.514
DNA-dependent"
xai ADAMDEC1 8p21.2 0.25 0.0565 0.514 proteolysis;immune response
his GDAP1 8q21.11 0.25 0.0565 0.514 response to retinoic acid
exp RPL22P8 2q12 0.248 0.0565 0.514
DNA-dependent"
met OVCA2 17p13.3 0.248 0.0565 0.514 response to retinoic acid
exp DNAJA1P3 Xq22.3 0.248 0.0565 0.514
exp TSSC1 2p25.3 0.248 0.0565 0.514
xsq MNX1-AS1 0.248 0.0565 0.514
DNA-dependent"
xsq CABP7 22q12.2 0.248 0.0565 0.514
cop ARPP19 15q21.2 0.248 0.0565 0.514 G2/M transition of mitotic
exp SETD1B 12q24.31 0.248 0.0565 0.514 regulation of transcription,
DNA-dependent;chromatin modification
exp YBX1 1p34 0.248 0.0565 0.514 DNA Damage Response (DDR)
exp CPD 17q11.2 -0.248 0.0565 0.514 proteolysis;cellular response
to interleukin-2
xsq CREB3L2 7q34 -0.248 0.0565 0.514 chondrocyte
differentiation;ER to Golgi vesicle-mediated transport
swa TMED2 12q24.31 -0.25 0.0565 0.514 embryonic placenta
development;negative regulation of GTPase activity
xai TMED9 5q35.3 -0.25 0.0565 0.514 Golgi organization;positive
regulation of organelle organization
xai KLHDC7A 1p36.13 -0.25 0.0565 0.514
his LINC01122 0.25 0.0566 0.514
DNA-dependent"
his SSPO 7q36.1 0.25 0.0566 0.514 cell adhesion
xai STXBP5L 3q13.33 0.25 0.0566 0.514 exocytosis;protein transport
exp LALBA 12q13 0.25 0.0566 0.514 cell-cell signaling;defense response to
bacterium
his APOA1-AS 0.25 0.0566 0.514
his APOA1 0.25 0.0566 0.514 cholesterol biosynthetic process;lipid
storage
his KIF20B 10q23.31 0.25 0.0566 0.514 cell cycle arrest;regulation
of mitosis
xsq MB21D1 6q13 0.248 0.0566 0.514 response to virus
xsq ZNF137P 19q13.4 0.247 0.0566 0.514
mir hsa-miR-25 0.247 0.0566 0.514
exp LOC283710 15q13.3 0.247 0.0566 0.514
exp NPTN 15q22 -0.247 0.0566 0.514 elevation of cytosolic calcium ion
xsq RPS6KA2 6q27 -0.247 0.0566 0.514 Protein Kinases
met JAK3 19p13.1 -0.247 0.0566 0.514 Oncogenes
exp TGFB3 14q24 -0.247 0.0566 0.514 Apoptosis
met SRRM2 16p13.3 -0.247 0.0566 0.514 nuclear mRNA splicing, via
xsq BMP1 8p21.3 -0.248 0.0566 0.514 cartilage
xsq NR2F2-AS1 -0.248 0.0566 0.514
hs4 RTP4 3q27.3 -0.25 0.0566 0.514 protein targeting to
membrane;detection of chemical stimulus involved in sensory perception of bitter
taste
hs4 IL17RD 3p14.3 -0.25 0.0566 0.514
hs4 VSX2 14q24.3 -0.25 0.0566 0.514 multicellular organismal
development;retinal bipolar neuron differentiation
hs4 ID4 6p22.3 -0.25 0.0566 0.514 negative regulation of
hs4 SYNE1-AS1 -0.25 0.0566 0.514
swa PDHA1 Xp22.1 -0.25 0.0566 0.514 pyruvate metabolic
process;glycolysis
met MAGEA3 Xq28 0.261 0.0567 0.515
xai ATP5LP6 0.25 0.0567 0.514
his METTL13 1q24-q25.3 0.25 0.0567 0.515 metabolic process
exp SNORA12 0.25 0.0567 0.515
his RAD9A 11q13.1-q13.2 0.25 0.0567 0.515 DNA Damage Response (DDR)
xai SNORA12 0.249 0.0567 0.515
xai C9orf153 9q21.33 0.249 0.0567 0.515
his PLEKHM3 2q33.3 0.249 0.0567 0.515 intracellular signal
transduction
his NLRP11 19q13.43 0.249 0.0567 0.515 oxidation-reduction process
his NLRP4 19q13.43 0.249 0.0567 0.515
exp BRD2 6p21.3 0.247 0.0567 0.514 spermatogenesis
xsq MAK16 8p12 0.247 0.0567 0.515 translation
exp UPF3B Xq25-q26 0.247 0.0567 0.515 transport;nucleocytoplasmic
transport
met KIFAP3 1q24.2 0.247 0.0567 0.515 negative regulation of cell
xsq AGRP 16q22 0.247 0.0567 0.515
xsq TMEM241 18q11.2 0.247 0.0567 0.515
mut PTPRN 2q35-q36.1 0.247 0.0567 0.515 cytokine-mediated signaling
exp DMPK 19q13.3 -0.247 0.0567 0.515 regulation of excitatory
exp RTKN2 10q21.2 -0.247 0.0567 0.515 signal transduction;positive
his LOC101929718 -0.249 0.0567 0.515
xai FLII 17p11.2 -0.249 0.0567 0.515 regulation of transcription,
DNA-dependent;muscle contraction
his LOC101927058 -0.249 0.0567 0.515
his LOC105369738 -0.249 0.0567 0.515
xai CACNA1C 12p13.3 -0.249 0.0567 0.515 transmembrane
transport;energy reserve metabolic process
xai RRAS 19q13.33 -0.25 0.0567 0.514 GTP catabolic process;signal
transduction
DNA-dependent"
exp ATP5LP6 0.249 0.0568 0.515
exp TG 8q24 0.249 0.0568 0.515 regulation of myelination;response to
lipopolysaccharide
his TOMM34 0.249 0.0568 0.515 protein targeting to mitochondrion
his STK4-AS1 0.249 0.0568 0.515
his STK4 20q11.2-q13.2 0.249 0.0568 0.515 Apoptosis
xai CINP 14q32.31 0.249 0.0568 0.515 DNA replication;DNA repair
his RNF20 9q22 0.249 0.0568 0.515 regulation of transcription, DNA-
exp LOC643348 7p11.2 0.247 0.0568 0.515
xsq SYT6 1p13.2 0.247 0.0568 0.515 acrosomal vesicle exocytosis
cop PEX13 2p16.1 0.247 0.0568 0.515 microtubule-based peroxisome
localization;fatty acid alpha-oxidation
cop KIAA1841 2q14 0.247 0.0568 0.515
met CNN3 1p22-p21 0.247 0.0568 0.515 negative regulation of ATPase
xsq SPAG5 17q11.2 0.247 0.0568 0.515 regulation of attachment of spindle
cop FAM214A 15q21.2-q21.3 0.247 0.0568 0.515
exp HGSNAT 8p11.1 -0.247 0.0568 0.515 protein
swa RTN4 2p16.3 -0.249 0.0568 0.515 Apoptosis
hs4 MOXD1 6q23.2 -0.249 0.0568 0.515 catecholamine metabolic
process
hs4 IGLON5 19q13.41 0.249 0.0569 0.515
his BPTF 17q24.3 0.249 0.0569 0.515 chromatin remodeling;transcription,
DNA-dependent
hs4 PPP1R16B 20q11.23 0.249 0.0569 0.515 signal
met FBLL1 5q34 0.247 0.0569 0.515 rRNA processing;tRNA processing
met STEAP2 7q21.13 0.247 0.0569 0.516 regulated secretory
xsq KC6 0.247 0.0569 0.516
exp DMTN 8p21.1 -0.247 0.0569 0.515
xsq RAB17 2q37.3 -0.247 0.0569 0.515 protein transport;small
xsq PCDHB14 5q31 -0.247 0.0569 0.515 cell adhesion;homophilic cell
adhesion
exp KLHDC7A 1p36.13 -0.247 0.0569 0.515
hs4 NCKAP1 2q32 -0.249 0.0569 0.516 Apoptosis
hs4 SHROOM3 4q21.1 -0.249 0.0569 0.515 columnar/cuboidal
epithelial cell development;pattern specification process
his GUSBP1 5p14.3 0.249 0.057 0.516
xai THAP9-AS1 0.249 0.057 0.516
his ATP2B1-AS1 0.249 0.057 0.516
exp TRAPPC2L 16q24.3 0.247 0.057 0.516 ER to Golgi vesicle-mediated
cop LRRC23 12p13 0.247 0.057 0.516
cop SPSB2 12p13.31 0.247 0.057 0.516 intracellular signal transduction
cop RPL13P5 12p13.31 0.247 0.057 0.516
cop DSTNP2 0.247 0.057 0.516
met MMS19 10q24-q25 0.247 0.057 0.516 DNA Damage Response (DDR)
xsq SNAI3 16q24.3 0.247 0.057 0.516
xsq LINC01179 0.247 0.057 0.516
exp EEF2 19p13.3 0.247 0.057 0.516 gene expression;cellular protein
metabolic process
cop GLDN 15q21.2 0.247 0.057 0.516 multicellular organismal
exp FUCA1 1p34 -0.247 0.057 0.516 carbohydrate metabolic process;fucose
metabolic process
xai KRT18P12 1q41 -0.249 0.057 0.516
xai PMEPA1 20q13.31-q13.33 -0.249 0.057 0.516 androgen receptor
signaling pathway
xai FTH1 11q13 -0.249 0.057 0.516 iron ion transport;transmembrane
transport
xai FAIM 3q22.3 -0.249 0.057 0.516 Apoptosis
his SLC6A2 16q12.2 -0.249 0.057 0.516 synaptic
transmission;monoamine transport
xai UBA52 19p13.1-p12 0.249 0.0571 0.516 protein polyubiquitination;DNA
repair
xai APEX1 14q11.2 0.249 0.0571 0.516 DNA Damage Response (DDR); DDR
(BER)
xai CTNNBL1 20q11.23-q12 0.249 0.0571 0.516 Apoptosis
xai NOC3L 10q23.33 0.249 0.0571 0.516 fat cell differentiation
xai KRR1 12q21.2 0.249 0.0571 0.516 rRNA processing
his DHFR2 0.249 0.0571 0.516
his NSUN3 3q11.1 0.249 0.0571 0.516
xai U2AF1 21q22.3 0.249 0.0571 0.516 Oncogenes
xai RPS29 14q 0.249 0.0571 0.516 mRNA metabolic process;translation
met FFAR2 19q13.1 0.247 0.0571 0.516
xsq ANAPC5 12q24.31 0.247 0.0571 0.516 G2/M transition of mitotic
mitotic cell cycle
met LOC284023 17p13.1 0.247 0.0571 0.516
cop LOC100506060 0.247 0.0571 0.516
cop EXOSC6 16q22.1 0.247 0.0571 0.516 DNA deamination;nuclear-
xsq LOC553103 -0.247 0.0571 0.516
exp FNBP1L 1p22.1 -0.247 0.0571 0.516 endocytosis
his GCNT2 6p24.2 -0.249 0.0571 0.516 glycosaminoglycan
his ADAM12 10q26 -0.249 0.0571 0.516 myoblast fusion;proteolysis
hs4 MAFIP -0.249 0.0571 0.516 microtubule cytoskeleton
organization;regulation of transcription, DNA-dependent"
his MRPL46 15q25.3 0.249 0.0572 0.516
his MRPS11 15q25 0.249 0.0572 0.516 translation;DNA damage response,
detection of DNA damage"
xai RRN3P2 16p11.2 0.249 0.0572 0.517
hs4 FASN 17q25 0.249 0.0572 0.517 energy reserve metabolic process;long-
chain fatty-acyl-CoA biosynthetic process
exp DEFA4 8p23 0.247 0.0572 0.516 killing of cells of other
organism;defense response to bacterium
exp NUP58 0.247 0.0572 0.516 nucleocytoplasmic transport;mRNA
transport
cop CPT1A 11q13.2 0.247 0.0572 0.516 positive regulation of fatty acid
met PPP4R1L 20q13.32 0.247 0.0572 0.516
xsq LYSMD2 15q21.2 0.247 0.0572 0.517 cell wall macromolecule
catabolic process
exp CEBPE 14q11.2 0.247 0.0572 0.517 cellular response to
xsq ANAPC4 4p15.2 0.247 0.0572 0.517 ubiquitin-dependent protein
exp NPR3 5p13.3 -0.247 0.0572 0.517 inhibition of adenylate
cyclase activity by G-protein signaling pathway;activation of phospholipase C
second messenger
exp PMEPA1 20q13.31-q13.33 -0.247 0.0572 0.516 androgen receptor
signaling pathway
hs4 ARTN 1p33-p32 -0.249 0.0572 0.517 signal
transduction;neuroblast proliferation
hs4 SOX15 17p13.1 -0.249 0.0572 0.517 regulation of transcription
from RNA polymerase II promoter;male gonad development
xai MPRIP 17p11.2 -0.249 0.0572 0.516
his MTG2 20q13.33 0.249 0.0573 0.517
xai TMEM204 16p13.3 0.249 0.0573 0.517 lymph vessel
his ARPP19 15q21.2 0.249 0.0573 0.517 G2/M transition of mitotic
his APEH 3p21.31 0.249 0.0573 0.517 proteolysis
xai SNX5P1 4q21.1 0.249 0.0573 0.517
xsq NBPF22P 5q14.3 0.247 0.0573 0.517
exp SLC7A6OS 16q22.1 0.247 0.0573 0.517 Solute Carriers
xsq ATP6V1G2 6p21.3 0.247 0.0573 0.517 insulin receptor signaling
met TMEM51 1p36.21 0.247 0.0573 0.517
xsq TCHP 12q24.11 0.247 0.0573 0.517 apoptotic process;negative
xsq UBA52 19p13.1-p12 0.247 0.0573 0.517 protein polyubiquitination;DNA
repair
exp RPL21P118 16q22.3 0.247 0.0573 0.517
xsq LETMD1 12q13.12 0.247 0.0573 0.517
met BTBD16 10q26.13 -0.247 0.0573 0.517
exp PGAM2 7p13-p12 -0.247 0.0573 0.517 response to inorganic
substance;small molecule metabolic process
hs4 SCML1 Xp22 -0.249 0.0573 0.517 regulation of transcription, DNA-
xai EPHB3 3q27.1 -0.249 0.0573 0.517 axon guidance;substrate
his VGLL4 3p25.3 -0.249 0.0573 0.517 regulation of transcription,
DNA-dependent"
his HSPD1 2q33.1 0.249 0.0574 0.517 Apoptosis
his HSPE1 2q33.1 0.249 0.0574 0.517 Apoptosis
his HSPE1-MOB4 0.249 0.0574 0.517
his EPOP 0.249 0.0574 0.517
his RNU5B-1 15q22.31 0.249 0.0574 0.517
hs4 KAZALD1 10q24.31 0.249 0.0574 0.517 ossification;regulation of
cell growth
xai OR4Q1P 0.249 0.0574 0.517
his POLR2G 11q13.1 0.249 0.0574 0.517 DNA Damage Response (DDR);
DDR (NER)
his USP8 15q21.2 0.249 0.0574 0.517 protein K63-linked
deubiquitination;protein K48-linked deubiquitination
hs4 FRG2KP 0.249 0.0574 0.517
hs4 YBX3P1 16p11.2 0.249 0.0574 0.517
his USP22 17p11.2 0.249 0.0574 0.517 ubiquitin-dependent protein
catabolic process;positive regulation of transcription, DNA-dependent
exp METTL13 1q24-q25.3 0.247 0.0574 0.517 metabolic process
xsq VPS33A 12q24.31 0.247 0.0574 0.517 protein transport;vesicle-
mediated transport
xsq NUP188 9q34.11 0.247 0.0574 0.517 protein transport;glucose
transport
cop TPRG1 3q28 -0.247 0.0574 0.517
xsq LAPTM4A 2p24.1 -0.247 0.0574 0.517 transport
swa C21orf33 21q22.3 -0.249 0.0574 0.517
his VWCE 11q12.2 -0.249 0.0574 0.517
hs4 AOAH 7p14-p12 0.249 0.0575 0.518 lipopolysaccharide metabolic
process;negative regulation of inflammatory response
his KCNAB3 17p13.1 0.249 0.0575 0.518 potassium ion
his TRAPPC1 17p13.1 0.249 0.0575 0.518 ER to Golgi vesicle-mediated
his CNTROB 17p13.1 0.249 0.0575 0.518 centrosome
separation;cytokinesis
exp HMGB3P11 2q12.1 0.249 0.0575 0.518
hs4 ABCA7 19p13.3 0.249 0.0575 0.518 ABC Transporters
hs4 KLC1 14q32.3 0.249 0.0575 0.518 microtubule-based movement;blood
coagulation
xsq KIAA1656 0.247 0.0575 0.518
exp CCND2 12p13 0.247 0.0575 0.518 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
exp ARHGDIB 12p12.3 0.247 0.0575 0.518 multicellular organismal
xsq AWAT2 Xq13.1 0.247 0.0575 0.518 lipid biosynthetic process;wax
xsq CCL20 2q36.3 0.247 0.0575 0.518 immune response;signal transduction
exp TTLL12 22q13.31 0.247 0.0575 0.518 protein modification process
exp PMF1 1q12 0.247 0.0575 0.518 cell division;M phase of mitotic cell
cycle
xsq MTMR6 13q12 0.247 0.0575 0.518 protein dephosphorylation;peptidyl-
cop PUS10 2p16.1 0.247 0.0575 0.518 pseudouridine synthesis;tRNA
processing
exp LOC390600 15q23 0.247 0.0575 0.518
exp CD6 11q13 0.247 0.0575 0.518 cell adhesion
mut NKX6-2 10q26 0.247 0.0575 0.518 regulation of transcription, DNA-
dependent;endocrine pancreas development
exp EIF4A3 17q25.3 0.247 0.0575 0.518 gene expression;nuclear-
exp JAK1 1p32.3-p31.3 -0.247 0.0575 0.518 Oncogenes
exp CHST1 11p11.2 -0.247 0.0575 0.518 polysaccharide metabolic
met MYBPH 1q32.1 -0.247 0.0575 0.518 regulation of striated muscle
contraction;cell adhesion
swa GNAI1 7q21 -0.249 0.0575 0.518 inhibition of adenylate cyclase
activity by G-protein signaling pathway;synaptic transmission
hs4 BIN1 2q14 -0.249 0.0575 0.518 positive regulation of GTPase
xai AP4B1-AS1 0.249 0.0576 0.518
xai B4GALT6 18q11 0.249 0.0576 0.518 post-translational protein
his TXNL1 18q21.31 0.249 0.0576 0.518 Apoptosis
met LGALS14 19q13.2 0.247 0.0576 0.518
exp KRR1 12q21.2 0.247 0.0576 0.518 rRNA processing
xsq FBXO45 3q29 0.247 0.0576 0.518 nervous system development;protein
ubiquitination
met GPR6 6q21 0.247 0.0576 0.518
met TTI1 20q11.23 0.246 0.0576 0.518 DNA Damage Response (DDR)
exp GRIA4 11q22 0.246 0.0576 0.518 transport;ion transport
xsq ITGB7 12q13.13 0.246 0.0576 0.518 cell-matrix adhesion;integrin-
met ABAT 16p13.2 0.246 0.0576 0.518 behavior;response to ethanol
exp PIGM 1q23.2 0.246 0.0576 0.518 C-terminal protein
xsq MFSD7 4p16.3 -0.247 0.0576 0.518 transmembrane transport
mut ELFN2 22q13.1 -0.247 0.0576 0.518 negative regulation of
his LINC01845 -0.249 0.0576 0.518
his KRT23 17q21.2 -0.249 0.0576 0.518
his ANKRD35 1q21.1 -0.249 0.0576 0.518
hs4 THEMIS2 1p35.3 0.249 0.0577 0.518
xai IGLV2-33 0.249 0.0577 0.518
his PRCC 1q21.1 0.249 0.0577 0.518 cell cycle;mitotic cell cycle
checkpoint
xai PMCH 12q23.2 0.249 0.0577 0.518 lactation;negative regulation of
blood pressure
xai ACADM 1p31 0.249 0.0577 0.518 carnitine metabolic process, CoA-
linked;fatty acid beta-oxidation using acyl-CoA dehydrogenase
his SRBD1 2p21 0.249 0.0577 0.518 nucleobase-containing compound metabolic
process
his ANAPC11 17q25.3 0.248 0.0577 0.518 mitosis;protein K11-linked
ubiquitination
his ALYREF 17q25.3 0.248 0.0577 0.518 gene expression;mRNA 3'-end
processing
xai HSPA12B 20p13 0.248 0.0577 0.518 response to stress
exp PPIP5K2 5q21.1 0.246 0.0577 0.518 inositol metabolic process
xsq DYNAP 18q21.2 0.246 0.0577 0.518
exp DIS3L 15q22.31 0.246 0.0577 0.518 rRNA catabolic process
xsq FBXW2 9q34 0.246 0.0577 0.518 proteolysis;protein ubiquitination
xsq RUVBL1 3q21 0.246 0.0577 0.518 Apoptosis; DNA Damage Response
exp DYRK4 12p13.32 0.246 0.0577 0.518 protein phosphorylation
exp LOC100507054 0.246 0.0577 0.518
exp FAXC 6q16.2 -0.246 0.0577 0.518
met CLDN5 22q11.21 -0.246 0.0577 0.518 calcium-independent cell-cell
adhesion
exp FNDC4 2p23.3 -0.246 0.0577 0.518
exp TAX1BP1 7p15 -0.246 0.0577 0.518 Apoptosis
xai FGF12 3q28 -0.248 0.0577 0.518 signal transduction;JNK cascade
xai SLC6A8 Xq28 -0.248 0.0577 0.518 Solute Carriers
xai RPEP4 -0.248 0.0577 0.518
xai CYP7B1 8q21.3 -0.248 0.0577 0.518 memory;positive
regulation of epithelial cell proliferation
exp OR52E6 11p15.4 -0.249 0.0577 0.518 response to stimulus
his GPATCH3 1p35.3-p35.1 0.248 0.0578 0.518
exp IGLV2-33 0.248 0.0578 0.518
his LOC101929241 0.248 0.0578 0.518
xai POC5 5q13.3 0.248 0.0578 0.519 cell cycle
xsq GNL2 1p34.3 0.246 0.0578 0.518 GTP catabolic process;ribosome
biogenesis
xsq CCND2 12p13 0.246 0.0578 0.518 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
cop MIR200C 0.246 0.0578 0.518
cop MIR141 0.246 0.0578 0.518
cop PHB2 12p13 0.246 0.0578 0.518 negative regulation of transcription,
DNA-dependent"
cop SCARNA12 0.246 0.0578 0.518
exp LGALS9 17q11.2 0.246 0.0578 0.518 signal transduction;positive
exp RPL19P4 2q21.1 0.246 0.0578 0.518
xsq BRS3 0.246 0.0578 0.518 glucose metabolic process;regulation of
blood pressure
cop LOC100506421 0.246 0.0578 0.519
xsq LINC00458 0.246 0.0578 0.519
exp GPR39 2q21-q22 -0.246 0.0578 0.518 G-protein coupled receptor
signaling pathway
cop MIR4454 -0.246 0.0578 0.518
cop LOC442132 5p15.31 -0.246 0.0578 0.518
exp RPL21P123 17p11.2 -0.248 0.0578 0.519
exp LOC100505782 -0.248 0.0578 0.519
his EPS8 12p12.3 -0.248 0.0578 0.519 signal transduction;epidermal
xai IGKV2-4 -0.248 0.0578 0.518
his FLVCR1-AS1 1q32.3 0.248 0.0579 0.519
his FLVCR1 1q32.3 0.248 0.0579 0.519 heme transport;head
morphogenesis
xai NDUFB10 16p13.3 0.248 0.0579 0.519 mitochondrial electron
his HSDL2 9q32 0.248 0.0579 0.519
xsq NAA10 Xq28 0.246 0.0579 0.519 N-terminal protein amino acid
acetylation;internal protein amino acid acetylation
cop PTPN6 12p13 0.246 0.0579 0.519 Apoptosis
met LCE2B 1q21 0.246 0.0579 0.519
xsq HDDC3 15q26.1 0.246 0.0579 0.519 guanosine tetraphosphate metabolic
process
xsq DDAH1 1p22 -0.246 0.0579 0.519 arginine catabolic process;nitric
exp C7orf76 7q21.3 -0.246 0.0579 0.519
exp C5orf15 5q31.1 -0.246 0.0579 0.519
hs4 LIPG 18q21.1 -0.248 0.0579 0.519 cell proliferation;regulation
of lipoprotein metabolic process
xai RPL21P123 17p11.2 -0.248 0.0579 0.519
his GBP2 1p22.2 -0.248 0.0579 0.519 immune response;cytokine-
his NPIPB5 16p12.2 -0.248 0.0579 0.519
hs4 LOC101928238 -0.248 0.0579 0.519
hs4 CCDC160 Xq26.2 -0.248 0.0579 0.519
hs4 KCNK2 1q41 -0.248 0.0579 0.519 ion transport;potassium ion
transport
hs4 LOC100507600 0.248 0.058 0.519
xai GNA13 17q24.3 0.248 0.058 0.519 cellular component movement;cell
differentiation
his PDZRN4 12q12 0.248 0.058 0.519
his PDCL3 2q11.2 0.248 0.058 0.519 Apoptosis
exp OR4A44P 0.248 0.058 0.519
his TMEM59 1p32.3 0.248 0.058 0.519
his TCEANC2 1p32.3 0.248 0.058 0.519 transcription, DNA-dependent"
his MIR4781 0.248 0.058 0.519
xai OR4A44P 0.248 0.058 0.519
xsq CSNK2A1 20p13 0.246 0.058 0.519 Protein Kinases
xsq PARP8 5q11.1 0.246 0.058 0.519
exp KLHL18 3p21.31 0.246 0.058 0.519
xsq MTA1 14q32.3 0.246 0.058 0.519 signal transduction
xsq ZNRF1 16q23.1 0.246 0.058 0.519 proteasomal ubiquitin-dependent protein
catabolic process;protein K48-linked ubiquitination
exp LOC100128010 0.246 0.058 0.519
met P2RX6 22q11.21 0.246 0.058 0.519 ion transport;cation transport
xsq MET 7q31 -0.246 0.058 0.519 Oncogenes; Protein Kinases
exp FAT2 5q33.1 -0.246 0.058 0.519 cell adhesion;homophilic cell
adhesion
mut SEMA3G 3p21.1 -0.246 0.058 0.519 multicellular organismal
development
xsq CETN4P 4q27 -0.246 0.058 0.519
exp IGKV2-4 -0.248 0.058 0.519
his CSE1L-AS1 0.248 0.0581 0.519
his CSE1L 20q13 0.248 0.0581 0.519 Apoptosis
hs4 FEV 2q36 0.248 0.0581 0.52 Transcription Factors
his JTB 1q21 0.248 0.0581 0.52 regulation of cell proliferation;negative
exp KCNC4 1p21 0.246 0.0581 0.519 ion transport;potassium ion transport
exp ETFA 15q23-q25 0.246 0.0581 0.519 transport;respiratory electron
transport chain
xsq TRIM14 9q22.33 0.246 0.0581 0.519
exp NUTF2 16q22.1 0.246 0.0581 0.519 protein import into nucleus;protein
export from nucleus
xsq BAG4 8p11.23 0.246 0.0581 0.519 Apoptosis
xsq LOC100506747 0.246 0.0581 0.519
cop ENO2 12p13 0.246 0.0581 0.52 gluconeogenesis;glycolysis
cop ATN1 12p13.31 0.246 0.0581 0.52 negative regulation of
cop C12orf57 12p13.31 0.246 0.0581 0.52
xsq NDUFAF4 6q16.1 0.246 0.0581 0.52 mitochondrial respiratory
met C6orf25 6p21.33 -0.246 0.0581 0.52
mut GSDMB 17q12 -0.246 0.0581 0.519
xai LOC100289347 5q14.3 -0.248 0.0581 0.52
exp PSORS1C3 6p21.33 -0.248 0.0581 0.519
xai HIPK4 19q13.2 -0.248 0.0581 0.519
xai FAM92A1 8q22.1 -0.248 0.0581 0.519
xai C8orf58 8p21 -0.248 0.0581 0.519
xai GOLGB1 3q13 -0.248 0.0581 0.519 Golgi organization
his LOC100506083 0.248 0.0582 0.52
his DDX19A 16q22.1 0.248 0.0582 0.52 protein transport;mRNA
transport
his FAM155B Xq13.1 0.248 0.0582 0.52
his ING5 2q37.3 0.248 0.0582 0.52 histone H3 acetylation;positive
his EIF4E 4q21-q25 0.248 0.0582 0.52 translation;cellular protein
metabolic process
his RAPGEF4-AS1 2q31.1 0.248 0.0582 0.52
exp RPL5P3 15q23 0.248 0.0582 0.52
his SF3A3 1p34.3 0.248 0.0582 0.52 RNA splicing;gene expression
his PUS1 12q24.33 0.248 0.0582 0.52 tRNA processing;metabolic process
xai DTX2P1-UPK3BP1-PMS2P11 7q11.23 0.248 0.0582 0.52
hs4 EDEM1 3p26.1 0.248 0.0582 0.52 protein N-linked glycosylation via
xsq HSPA14 10p13 0.246 0.0582 0.52 'de novo' cotranslational protein
folding
exp RRM1 11p15.5 0.246 0.0582 0.52 DNA Damage Response (DDR)
cop MRPL48 11q13.4 0.246 0.0582 0.52 translation
cop COA4 11q13.4 0.246 0.0582 0.52
cop PAAF1 11q13.4 0.246 0.0582 0.52 interspecies interaction between
organisms
exp KIAA0408 0.246 0.0582 0.52
exp MKRN3 15q11-q13 0.246 0.0582 0.52
cop CYP19A1 15q21.1 0.246 0.0582 0.52 male gonad
development;hippocampus development
exp ELMSAN1 14q24.3 -0.246 0.0582 0.52
xsq PTGR1 9q31.3 -0.246 0.0582 0.52 leukotriene metabolic
xai MOCS1 6p21.3 -0.248 0.0582 0.52 vitamin metabolic
xai FAT2 5q33.1 -0.248 0.0582 0.52 cell adhesion;homophilic cell
adhesion
exp LOC100289347 5q14.3 -0.248 0.0582 0.52
his MIR4734 0.248 0.0583 0.52
his MLLT6 17q21 0.248 0.0583 0.52 regulation of transcription, DNA-
dependent"
his PPP4R3B 0.248 0.0583 0.52 DNA Damage Response (DDR)
his UGT3A2 5p13.2 0.248 0.0583 0.52 metabolic process
xai MRPS16 10q22.1 0.248 0.0583 0.52 translation
hs4 KCNN4 19q13.2 0.248 0.0583 0.52 phospholipid translocation;ion
transport
exp RPS2P24 0.246 0.0583 0.52
xsq ZNF639 3q26.33 0.246 0.0583 0.52 negative regulation of
exp MRGBP 20q13.33 0.246 0.0583 0.52
xsq SLC7A6OS 16q22.1 0.246 0.0583 0.52 Solute Carriers
mut GKAP1 9q21.32 -0.246 0.0583 0.52 signal transduction
exp CYP7B1 8q21.3 -0.246 0.0583 0.52 memory;positive
regulation of epithelial cell proliferation
swa LPP 3q28 -0.248 0.0583 0.52 cell adhesion
exp GJA6P -0.248 0.0583 0.52
hs4 LAMB1 7q22 -0.248 0.0583 0.52 embryo implantation;positive
xai RPL10A 6p21.31 0.248 0.0584 0.52 translational
xai MIS12 17p13.2 0.248 0.0584 0.52 kinetochore assembly;M phase of
mitotic cell cycle
his HOXC12 12q13.13 0.248 0.0584 0.52 multicellular organismal
development
hs4 LOC283710 15q13.3 0.248 0.0584 0.52
his TIMM9 14q21 0.248 0.0584 0.52 sensory perception of sound;protein
import into mitochondrial inner membrane
his KIAA0586 14q23.1 0.248 0.0584 0.52
his OXLD1 17q25.3 0.248 0.0584 0.52
his CCDC137 17q25.3 0.248 0.0584 0.52
xai MRPL20 1p36.3-p36.2 0.248 0.0584 0.52 translation
xai MLX 17q21.1 0.248 0.0584 0.52 energy reserve metabolic
xsq L2HGDH 14q21.3 0.246 0.0584 0.52 cellular protein metabolic
xsq OIP5 15q15.1 0.246 0.0584 0.52 cell communication;CenH3-containing
met PSTK 10q26.13 0.246 0.0584 0.52 selenocysteine
met PRSS27 16p13.3 0.246 0.0584 0.52 proteolysis
exp MEPCE 7q22.1 0.246 0.0584 0.52
xsq PAXBP1 21q21.3 0.246 0.0584 0.52
xsq DDIAS 0.246 0.0584 0.52 apoptotic process;cell cycle
met GABRG2 5q34 0.246 0.0584 0.52 transport;chloride transport
exp RHEB 7q36 -0.246 0.0584 0.52 small GTPase mediated signal
xsq PRTG 15q21.3 -0.246 0.0584 0.52 multicellular organismal
development
xai ABHD12 20p11.21 -0.248 0.0584 0.52
his CKAP4 12q23.3 -0.248 0.0584 0.52
his SMS Xp22.1 -0.248 0.0584 0.52 methionine metabolic
xai RTKN2 10q21.2 -0.248 0.0584 0.52 signal transduction;positive
xai RBMS2 12q13.3 -0.248 0.0584 0.52 RNA processing
his CLCN4 Xp22.3 -0.248 0.0584 0.52 chloride
his SERINC1 6q22.31 0.248 0.0585 0.52 lipid metabolic
process;phosphatidylserine metabolic process
his PKIB 6q22.31 0.248 0.0585 0.52 negative regulation of protein
kinase activity
xai TRNT1 3p25.1 0.248 0.0585 0.521 RNA processing;protein targeting to
mitochondrion
met TSSK6 19p13.11 0.246 0.0585 0.52 cell differentiation;sperm
exp SFSWAP 12q24.33 0.246 0.0585 0.52 RNA splicing;negative
regulation of nuclear mRNA splicing, via spliceosome
xsq FADD 11q13.3 0.246 0.0585 0.52 Apoptosis
met DBH 9q34 0.246 0.0585 0.521 synaptic transmission;response to
estradiol stimulus
exp GOLGA8M 15q13.1 0.246 0.0585 0.521
xsq ZC3H18 16q24.2 0.246 0.0585 0.521
xsq COL5A1 9q34.2-q34.3 -0.246 0.0585 0.521 wound healing,
spreading of epidermal cells;blood vessel development
xsq DAB2IP 9q33.1-q33.3 -0.246 0.0585 0.521 negative
kappaB cascade
xsq NRXN3 14q31 -0.246 0.0585 0.52 angiogenesis;cell adhesion
exp GAS6 13q34 -0.246 0.0585 0.52 proteolysis;cellular protein
metabolic process
xai VEPH1 3q24-q25 -0.248 0.0585 0.521
cop TRH 3q13.3-q21 -0.248 0.0585 0.521
hs4 PLPP4 -0.248 0.0585 0.521 phospholipid dephosphorylation
his LINC01766 -0.248 0.0585 0.52
xai TBX15 1p11.1 -0.248 0.0585 0.52 embryonic cranial skeleton
morphogenesis
his TCF23 2p23.3 0.248 0.0586 0.521 multicellular organismal
his SNORD14A 0.248 0.0586 0.521
his SNORD14B 11p15 0.248 0.0586 0.521
his RPS13 11p15 0.248 0.0586 0.521 nuclear-transcribed mRNA catabolic
xai TLR7 Xp22.3 0.248 0.0586 0.521 microglial cell activation involved
in immune response;positive regulation of NF-kappaB import into nucleus
his HENMT1 1p13.3 0.248 0.0586 0.521 RNA methylation;gene
silencing by RNA
xsq MAGOHB 12p13.2 0.246 0.0586 0.521 RNA splicing;mRNA transport
exp REG4 1p13.1-p12 0.246 0.0586 0.521
exp TATDN2 3p25.3 0.246 0.0586 0.521 activation of signaling
exp RPL24P8 0.246 0.0586 0.521
exp ZNF365 10q21.2 -0.246 0.0586 0.521
xsq TMBIM1 2q35 -0.246 0.0586 0.521
exp TRAF3IP2 6q21 -0.246 0.0586 0.521 intracellular signal
mut DLX3 17q21 -0.246 0.0586 0.521 placenta development;regulation of
mut RBP3 10q11.2 -0.246 0.0586 0.521 proteolysis;lipid metabolic
process
swa VDAC1 5q31 -0.248 0.0586 0.521 Apoptosis
hs4 PPIC 5q23.2 -0.248 0.0586 0.521 protein folding;signal
transduction
his SEMA5B 3q21.1 -0.248 0.0586 0.521 nervous system
hs4 ULK2 17p11.2 -0.248 0.0586 0.521 signal transduction;nervous
system development
his RNF217 6q22.31 -0.248 0.0586 0.521 protein ubiquitination
his RNF217-AS1 -0.248 0.0586 0.521
his LOC100131257 7p22.1 -0.248 0.0586 0.521
xai CTNNB1 3p21 -0.248 0.0586 0.521 Apoptosis; Cell Signaling;
Oncogenes
his TMEM39B 1p35.1 0.248 0.0587 0.521
xai PPIP5K2 5q21.1 0.248 0.0587 0.521 inositol metabolic process
xai RAD51C 17q22 0.248 0.0587 0.521 DNA Damage Response (DDR); DDR (FA)
his ESPL1 12q 0.248 0.0587 0.521 Apoptosis
exp TTC4 1p32.3 0.246 0.0587 0.521
mut NOTCH2 1p13-p11 0.245 0.0587 0.521 Apoptosis; Tumor Suppressors
xsq NEURL4 17p13 0.245 0.0587 0.521
xsq ENOPH1 4q21.22 0.245 0.0587 0.521 sulfur amino acid metabolic
xsq SNAPC5 15q22.31 0.245 0.0587 0.521 regulation of transcription,
xsq MEF2C-AS1 0.245 0.0587 0.521
mir hsa-miR-34b* -0.245 0.0587 0.521
exp PLSCR3 17p13.1 -0.245 0.0587 0.521 phospholipid scrambling
exp TAF13 1p13.3 -0.245 0.0587 0.521 regulation of transcription,
exp RHPN2 19q13.11 -0.245 0.0587 0.521 signal transduction
exp B3GLCT -0.245 0.0587 0.521 carbohydrate metabolic
met CLDN6 16p13.3 -0.246 0.0587 0.521 calcium-independent cell-cell
adhesion
xai CD58 1p13 -0.248 0.0587 0.521 Tumor Suppressors
exp CKMT2 5q13.3 -0.248 0.0587 0.521 creatine metabolic
his IL12A 3q25.33 -0.248 0.0587 0.521 cell cycle arrest;positive
swa CRKL 22q11.21 0.248 0.0588 0.521 heart development;organ
morphogenesis
his SSR2 1q21-q23 0.247 0.0588 0.521 translation;cotranslational protein
hs4 AIP 11q13.3 0.247 0.0588 0.521 regulation of protein kinase A
DNA-dependent"
xai RCC2P8 4q25 0.247 0.0588 0.521
his RNF34 12q24.31 0.247 0.0588 0.521 Apoptosis
xai KLHL18 3p21.31 0.247 0.0588 0.522
xsq ARL11 13q14.2 0.245 0.0588 0.521 small GTPase mediated signal
transduction
xsq EIF2B3 1p34.1 0.245 0.0588 0.521 negative regulation of
mut INHBA 7p15-p13 0.245 0.0588 0.521 hair follicle development;nervous
system development
cop EMG1 12p13.3 0.245 0.0588 0.521 rRNA processing;ribosomal small
subunit biogenesis
mut RANBP17 5q34 0.245 0.0588 0.521 protein import into
xsq ATF1 12q13 0.245 0.0588 0.521 positive regulation of neuron projection
xsq KISS1R 19p13.3 0.245 0.0588 0.521 neuropeptide signaling
mut PDZD3 11q23.3 0.245 0.0588 0.521 ion transport;water transport
xsq BTF3P11 13q22 0.245 0.0588 0.522
xsq HAUS1 18q21.1 0.245 0.0588 0.522 cell cycle;mitosis
mut ABCG8 2p21 0.245 0.0588 0.522 ABC Transporters
cop C6orf211 6q25.1 0.245 0.0588 0.522
xsq PTPN13 4q21.3 -0.245 0.0588 0.521 protein
his GLIS3 9p24.2 -0.247 0.0588 0.522 negative regulation of
promoter
his PADI6 1p36.13 -0.247 0.0588 0.522 peptidyl-citrulline
biosynthetic process from peptidyl-arginine;protein modification process
xai DOCK5 8p21.2 -0.247 0.0588 0.521
xai VEGFB 11q13 -0.247 0.0588 0.521 positive regulation of vascular
division
hs4 IDO1 8p12-p11 -0.248 0.0588 0.521 female pregnancy;cellular
xai IRS2 13q34 -0.248 0.0588 0.521 Apoptosis
hs4 ATP8B4 15q21.2 0.247 0.0589 0.522 phospholipid transport;cation
transport
his ZBTB25 14q23-q24 0.247 0.0589 0.522 regulation of transcription,
DNA-dependent;gene expression"
dependent"
his PLK4 4q28 0.247 0.0589 0.522 Protein Kinases
exp LOC145845 15q14 0.247 0.0589 0.522
xai LALBA 12q13 0.247 0.0589 0.522 cell-cell signaling;defense response to
bacterium
swa RPIA 2p11.2 0.247 0.0589 0.522 carbohydrate metabolic
his MAPKAPK5 12q24.13 0.247 0.0589 0.522 Ras protein signal
transduction;negative regulation of TOR signaling cascade
his MAPKAPK5-AS1 12q24.12 0.247 0.0589 0.522
exp PCDH9-AS3 0.247 0.0589 0.522
exp AGPAT5 8p23.1 0.245 0.0589 0.522 metabolic
xsq LZTFL1 3p21.3 0.245 0.0589 0.522
DNA-dependent"
exp RPL9P21 10q11.21 0.245 0.0589 0.522
mut NDST3 4q26 0.245 0.0589 0.522
xsq RBM48 7q21.2 0.245 0.0589 0.522
met BTBD19 1p34.1 0.245 0.0589 0.522
xsq TLX2 2p13.1 0.245 0.0589 0.522
xsq AGAP1 2q37 -0.245 0.0589 0.522 small GTPase mediated signal
his SORCS2 4p16.1 -0.247 0.0589 0.522 neuropeptide signaling
pathway
xai PLCD3 17q21.31 -0.247 0.0589 0.522 angiogenesis;lipid catabolic
process
hs4 NNMT 11q23.1 -0.247 0.0589 0.522 small molecule metabolic
his LARGE-AS1 -0.247 0.0589 0.522
hs4 PRDM11 11p11 -0.247 0.0589 0.522
exp PHBP3 1p32.1 0.247 0.059 0.522
xai DYM 18q21.1 0.247 0.059 0.522
exp EIF4A1P5 13q13.3 0.247 0.059 0.522
xai PCDH9-AS3 0.247 0.059 0.522
his RPL7L1 6p21.1 0.247 0.059 0.522 translation
xai ZNF236 18q22-q23 0.247 0.059 0.522 regulation of transcription, DNA-
dependent;cellular response to glucose stimulus"
xai LOC100128816 12p13.32 0.247 0.059 0.522
xsq SLC22A20 11q13.1 0.245 0.059 0.522 ion transport
cop LPCAT3 12p13 0.245 0.059 0.522 phospholipid biosynthetic process
met RUSC1-AS1 1q22 0.245 0.059 0.522
xsq PCDHAC1 0.245 0.059 0.522 homophilic cell adhesion;nervous system
development
xsq ANGPTL2 9q34 -0.245 0.059 0.522 signal transduction;multicellular
xsq OSBPL10 3p22.3 -0.245 0.059 0.522 transport;lipid transport
xsq CFL2 14q12 -0.245 0.059 0.522
xsq FAM106CP -0.245 0.059 0.522
xsq ARNTL 11p15 -0.245 0.059 0.522 circadian rhythm;positive regulation of
his NPIPB3 16p12.2 -0.247 0.059 0.522
xai CDK16 Xp11 -0.247 0.059 0.522 Protein Kinases
xai AMZ2P1 17q24.1 0.247 0.0591 0.522
hs4 GRPEL2-AS1 0.247 0.0591 0.522
hs4 PCYOX1L 5q32 0.247 0.0591 0.522 prenylcysteine catabolic process
exp RPL5P9 0.247 0.0591 0.522
xai STK31 7p15.3 0.247 0.0591 0.522
xai PPA1 10q11.1-q24 0.247 0.0591 0.522 tRNA aminoacylation for protein
translation;phosphate-containing compound metabolic process
his PRKAA1 5p12 0.247 0.0591 0.522 Apoptosis; Protein Kinases
xsq ALG10 12p11.1 0.245 0.0591 0.522 dolichol-linked oligosaccharide
xsq LOC101929164 0.245 0.0591 0.522
cop MAF 16q22-q23 0.245 0.0591 0.522 transcription from RNA polymerase
II promoter
met CDC16 13q34 0.245 0.0591 0.522 mitotic cell cycle spindle assembly
checkpoint;cell proliferation
exp HMGB2 4q31 0.245 0.0591 0.522 DNA Damage Response (DDR); DDR (BER)
xsq CHRNB4 15q24 0.245 0.0591 0.522 synaptic transmission;synaptic
transmission, cholinergic
xsq HEATR5B 2p22.2 0.245 0.0591 0.522
exp SPATA9 5q15 -0.245 0.0591 0.522 multicellular organismal
exp MT1HL1 1q43 -0.245 0.0591 0.522
exp FLJ30064 7q21.3 -0.245 0.0591 0.522
exp LOC100127909 18q21.1 -0.247 0.0591 0.522
xai CRIM1 2p21 -0.247 0.0591 0.522 regulation of cell growth;nervous
system development
exp AK3P2 -0.247 0.0591 0.522
hs4 LRP1B 2q21.2 -0.247 0.0591 0.522 receptor-mediated
endocytosis;protein transport
exp KRT18P37 8p11.21 -0.247 0.0591 0.522
xai FNDC4 2p23.3 -0.247 0.0591 0.522
his CEP131 0.247 0.0592 0.523 mitotic cell cycle;multicellular
xai LOC100507373 0.247 0.0592 0.523
his LOC143666 11p15.5 0.247 0.0592 0.523
his PHRF1 11p15.5 0.247 0.0592 0.523 transcription from RNA polymerase
II promoter;mRNA processing
his PARVB 22q13.2-q13.33 0.247 0.0592 0.523 cell adhesion;cell junction
assembly
hs4 RAP1GAP2 17p13.3 0.247 0.0592 0.523 regulation of small GTPase
his MRPL57 0.247 0.0592 0.523 translation
his SKA3 13q12.11 0.247 0.0592 0.523 chromosome segregation;mitosis
cop LOC100506083 0.245 0.0592 0.522
cop DDX19A 16q22.1 0.245 0.0592 0.522 protein transport;mRNA
transport
xsq TSPEAR 21q22.3 0.245 0.0592 0.523 cell adhesion
exp ZNF174 16p13.3 0.245 0.0592 0.523 negative regulation of
transcription from RNA polymerase II promoter;viral reproduction
xsq TUBB1 20q13.32 0.245 0.0592 0.523 protein folding;microtubule-based
movement
xsq PDCD4 10q24 0.245 0.0592 0.523 Apoptosis
mir hsa-miR-338-5p 0.245 0.0592 0.523
met CYP27A1 2q35 0.245 0.0592 0.523 bile acid metabolic process;small
xsq CD59 11p13 -0.245 0.0592 0.523 cell surface receptor signaling
xsq CYP1B1 2p22.2 -0.245 0.0592 0.523 cellular aromatic
compound metabolic process;small molecule metabolic process
xai ZC2HC1A 8q21.12 -0.247 0.0592 0.523
xai LOC100127909 18q21.1 -0.247 0.0592 0.523
xai MIR222 -0.247 0.0592 0.523
xai AK3P2 -0.247 0.0592 0.523
xai BORCS8 -0.247 0.0592 0.523 heart development
hs4 CDH6 5p13.3 -0.247 0.0592 0.522 cell adhesion;homophilic cell
adhesion
his MRPL3 3q21-q23 0.247 0.0593 0.523 translation
hs4 SNRPD1 18q11.2 0.247 0.0593 0.523 ncRNA metabolic
xai HEXDC 17q25.3 0.247 0.0593 0.523 carbohydrate metabolic process
xai DDX10P2 9q21.32 0.247 0.0593 0.523
exp FOXK2 17q25 0.245 0.0593 0.523 regulation of transcription, DNA-
exp ZAP70 2q12 0.245 0.0593 0.523 T cell activation;B cell activation
xsq FAM98B 15q14 0.245 0.0593 0.523
cop RMND1 6q25.1 0.245 0.0593 0.523
xsq PTCD3 2p11.2 0.245 0.0593 0.523
met ANKLE1 19p13.11 -0.245 0.0593 0.523
exp AMIGO2 12q13.11 -0.245 0.0593 0.523 anti-apoptosis;cell
adhesion
xsq PTN 7q33 -0.245 0.0593 0.523 positive regulation of cell
met FSD1 19p13.3 -0.245 0.0593 0.523 cell division;cell cycle
exp MYL6 12q13.2 -0.245 0.0593 0.523 muscle contraction;axon
guidance
xai AAED1 9q22.32 -0.247 0.0593 0.523
his CLDN16 3q28 -0.247 0.0593 0.523 cellular metal ion
swa PPIB 15q21-q22 -0.247 0.0593 0.523 protein peptidyl-prolyl
exp NAV2-AS2 -0.247 0.0593 0.523
his ANAPC10 4q31 0.247 0.0594 0.523 G2/M transition of mitotic cell
catabolic process
his ABCE1 4q31 0.247 0.0594 0.523 ABC Transporters
hs4 AQP3 9p13 0.247 0.0594 0.523 urea transport;response to retinoic acid
exp SNX5P1 4q21.1 0.247 0.0594 0.523
exp RCC2P8 4q25 0.247 0.0594 0.523
xai SLC12A5 20q13.12 0.247 0.0594 0.523 ammonium
xsq PROCA1 17q11.2 0.245 0.0594 0.523 lipid catabolic process
met MIR376C 0.245 0.0594 0.523
exp DUS1L 17q25.3 0.245 0.0594 0.523 tRNA processing
met DHDH 19q13.3 0.245 0.0594 0.523 D-xylose catabolic
xsq PHB 17q21 0.245 0.0594 0.523 Apoptosis
xsq EVI2B 17q11.2 0.245 0.0594 0.523
exp TMEM186 16p13.2 0.245 0.0594 0.523
exp RPS9 19q13.4 0.245 0.0594 0.523 SRP-dependent cotranslational
met DAGLA 11q12.2 0.245 0.0594 0.523 lipid catabolic process;platelet
activation
xsq C21orf58 21q22.3 0.245 0.0594 0.523
xsq RPS2 16p13.3 0.245 0.0594 0.523 translation;mRNA metabolic process
exp ELP6 3p21.31 0.245 0.0594 0.523
met MIR205 -0.245 0.0594 0.523
exp CACNA1C 12p13.3 -0.245 0.0594 0.523 transmembrane
met ASB14 3p21.1 -0.245 0.0594 0.523 intracellular signal
transduction
met CDH16 16q22.1 -0.245 0.0594 0.523 cell adhesion;homophilic cell
adhesion
xsq MAP1B 5q13 -0.245 0.0594 0.523 central nervous system
exp SNX21 20q13.12 -0.245 0.0594 0.523 cell communication;protein
transport
exp MIR222 -0.247 0.0594 0.523
his COL7A1 3p21.1 -0.247 0.0594 0.523 cell adhesion;epidermis
development
xai ISCU 12q24.1 0.247 0.0595 0.523 nitrogen fixation;iron-sulfur
cluster assembly
his ATRAID 2p23.3 0.247 0.0595 0.523
his DHX33 17p13.2 0.247 0.0595 0.523 positive regulation of
his LOC105371506 0.247 0.0595 0.523
his PPP1R9B 17q21.33 0.247 0.0595 0.523 RNA splicing;cell migration
his PAQR3 4q21.21 0.247 0.0595 0.523
his ZFPM1 16q24.2 0.247 0.0595 0.523 negative regulation of
transcription from RNA polymerase II promoter;blood coagulation
his CD79B 17q23 0.247 0.0595 0.523 immune response;signal transduction
xai ASIP 20q11.2-q12 0.247 0.0595 0.523 hormone-mediated signaling
xai PRCC 1q21.1 0.247 0.0595 0.523 cell cycle;mitotic cell cycle
checkpoint
xsq DDX11 12p11 0.245 0.0595 0.523 DNA Damage Response (DDR)
xsq PAXIP1-AS1 0.245 0.0595 0.523
met ABCC3 17q22 0.245 0.0595 0.523 ABC Transporters
xsq ZNF76 6p21.31 0.245 0.0595 0.523 regulation of transcription from
RNA polymerase III promoter;regulation of transcription from RNA polymerase II
promoter
xsq MAST1 19p13.2 0.245 0.0595 0.523 cytoskeleton
organization;intracellular protein kinase cascade
exp LINC00312 3p25.3 -0.245 0.0595 0.523
his PSG7 -0.247 0.0595 0.523 female pregnancy
his CFAP73 -0.247 0.0595 0.523
hs4 NPY4R 10q11.2 -0.247 0.0595 0.523
swa PDIA3 15q15 -0.247 0.0595 0.523 protein retention in ER lumen;cell
redox homeostasis
his LOC101929622 -0.247 0.0595 0.523
his TAGLN 11q23.2 -0.247 0.0595 0.523 muscle organ development
his LOC100652768 -0.247 0.0595 0.523
hs4 DCDC2 6p22.1 -0.247 0.0595 0.523 cellular defense
xai HIPK2 7q32-q34 -0.247 0.0595 0.523 Apoptosis
his SHC3 9q22.1 0.247 0.0596 0.523 intracellular signal
xai CHTF8 16q22.1 0.247 0.0596 0.523 DDR (DNA replication)
xai DCLRE1A 10q25.1 0.247 0.0596 0.524 DNA Damage Response (DDR)
exp ABCC8 11p15.1 0.245 0.0596 0.523 ABC Transporters
xsq OGT Xq13 0.245 0.0596 0.523 induction of apoptosis;histone H4-K8
acetylation
cop AARS 16q22 0.245 0.0596 0.523 hair follicle development;endoplasmic
reticulum unfolded protein response
exp RPL29P33 19q13.11 0.245 0.0596 0.523
xsq DDX49 19p12 0.245 0.0596 0.523
cop ONECUT1 15q21.3 0.245 0.0596 0.523 glucose metabolic
process;cilium assembly
xsq FIGNL1 7p12.1 0.245 0.0596 0.523 regulation of cell
cycle;osteoblast differentiation
met HSF2BP 21q22.3 0.245 0.0596 0.524 transcription from RNA
polymerase II promoter;spermatogenesis
exp MIEF1 0.245 0.0596 0.524 mitochondrial fusion
xsq THOC2 Xq25-q26.3 0.245 0.0596 0.524 mRNA export from nucleus;transport
xsq EMP2 16p13.2 -0.245 0.0596 0.523 cell proliferation
exp DMRTA1 9p21.3 -0.245 0.0596 0.523 regulation of
transcription, DNA-dependent;sex differentiation
hs4 ABTB2 11p13 -0.247 0.0596 0.524 regulation of cell growth
his CHAD 17q21.33 0.247 0.0597 0.524 regulation of cell growth
xai USP44 12q22 0.247 0.0597 0.524 cell division;anaphase
hs4 GAPDH 12p13 0.247 0.0597 0.524 glucose metabolic process;gluconeogenesis
his COLGALT1 19p13.11 0.247 0.0597 0.524
his IL10RA 11q23 0.247 0.0597 0.524 signal transduction
xai SF3A3P1 20p13 0.247 0.0597 0.524
xsq ARC 8q24.3 0.245 0.0597 0.524 regulation of cell
morphogenesis;endocytosis
xsq SETDB1 1q21 0.245 0.0597 0.524 regulation of transcription, DNA-
xsq LCK 1p34.3 0.245 0.0597 0.524 Protein Kinases
met ARHGAP5 14q12 0.245 0.0597 0.524 Rho protein signal
transduction;positive regulation of Rho GTPase activity
exp PURG 8p11 0.244 0.0597 0.524
exp DCAF15 19p13.12 0.244 0.0597 0.524
exp DEF6 6p21.33-p21.1 0.244 0.0597 0.524
exp ARRDC4 15q26.3 -0.244 0.0597 0.524 signal transduction
xsq IGF2BP2 3q27.2 -0.245 0.0597 0.524 anatomical structure
morphogenesis;negative regulation of translation
xsq PELI3 11q13.2 -0.245 0.0597 0.524
xai SHROOM3 4q21.1 -0.247 0.0597 0.524 columnar/cuboidal
his ZBTB8OS 1p35.1 0.247 0.0598 0.525
his RBBP4 1p35.1 0.247 0.0598 0.525 CenH3-containing nucleosome
his YTHDC2 5q22.2 0.246 0.0598 0.525
exp ATP5G1 17q21.32 0.244 0.0598 0.524 mitochondrial ATP synthesis
exp GOLGB1 3q13 -0.244 0.0598 0.524 Golgi organization
exp SHROOM3 4q21.1 -0.244 0.0598 0.524 columnar/cuboidal
his B4GALT1-AS1 -0.246 0.0598 0.525
his B4GALT1 9p13 -0.246 0.0598 0.525 epithelial cell
hs4 NUAK1 12q23.3 -0.247 0.0598 0.525 regulation of myosin-light-
hs4 PPP1R3C 10q23-q24 -0.247 0.0598 0.524 carbohydrate metabolic
xai COG7 16p12.2 0.246 0.0599 0.525 protein localization to
organelle;protein localization in Golgi apparatus
his BTN3A1 6p22.1 0.246 0.0599 0.525 lipid metabolic process
his STK38 6p21 0.246 0.0599 0.525 protein phosphorylation;intracellular
xai NSFP1 17q21.31 0.246 0.0599 0.525
exp LOC100653005 0.246 0.0599 0.525
xsq FBXO40 3q13.33 0.244 0.0599 0.525 muscle cell differentiation
exp ICAM2 17q23.3 0.244 0.0599 0.525 cell-cell adhesion;regulation of
immune response
exp MPRIP 17p11.2 -0.244 0.0599 0.525
xai JAK1 1p32.3-p31.3 -0.246 0.0599 0.525 Oncogenes
xai PLAU 10q22.2 -0.246 0.0599 0.525 response to
hypoxia;regulation of cell adhesion mediated by integrin
hs4 FAM81A 15q22.2 -0.246 0.0599 0.525
hs4 LINC01659 0.246 0.06 0.526
exp PHBP8 0.246 0.06 0.526
his MIR659 0.246 0.06 0.526
his EIF3L 22q 0.246 0.06 0.526 translational initiation
xai WRAP73 1p36.3 0.246 0.06 0.526
exp RRP15 1q41 0.246 0.06 0.526
his PIK3AP1 10q24.1 0.246 0.06 0.526
cop CD163L1 12p13.3 0.244 0.06 0.526
xsq ELAVL1 19p13.2 0.244 0.06 0.526 mRNA stabilization;3'-UTR-mediated
mRNA stabilization
xsq TXLNG Xp22.2 0.244 0.06 0.526 regulation of transcription, DNA-
exp RPL39P16 2q13 0.244 0.06 0.526
xai TNPO1P1 -0.246 0.06 0.526
his TPRG1 3q28 -0.246 0.06 0.526
hs4 HOPX 4q12 -0.246 0.06 0.525 negative regulation of cell
differentiation;trophectodermal cell differentiation
xai POLE3 9q33 0.246 0.0601 0.526 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
his LINC01185 0.246 0.0601 0.526
his REL 2p13-p12 0.246 0.0601 0.526 Apoptosis; Oncogenes
xai TFF2 21q22.3 0.246 0.0601 0.526 digestion
xai HMGN1P26 15q22.2 0.246 0.0601 0.526
his MIR9-1 0.246 0.0601 0.526
his C1orf61 1q22 0.246 0.0601 0.526
xai SMC3 10q25 0.246 0.0601 0.526 DNA Damage Response (DDR); DDR (DNA
replication)
xsq PCNA 20pter-p12 0.244 0.0601 0.526 DNA Damage Response (DDR); DDR
met SH3TC2 5q32 0.244 0.0601 0.526
met ANGPTL5 11q22.1 0.244 0.0601 0.526 signal transduction
xsq C3AR1 12p13.31 0.244 0.0601 0.526 blood circulation;regulation of
blood pressure
met C5orf58 5q35.1 0.244 0.0601 0.526
exp EPT1 2p23.3 0.244 0.0601 0.526 phospholipid biosynthetic process
xsq WDR54 2p13.1 0.244 0.0601 0.526
met THNSL2 2p11.2 0.244 0.0601 0.526 serine family amino acid
xsq CLK2P1 0.244 0.0601 0.526
xsq LINC00919 0.244 0.0601 0.526
xsq IGLL5 0.244 0.0601 0.526
exp BNIP3L 8p21 -0.244 0.0601 0.526 Apoptosis
exp DHRS12 13q14.3 -0.244 0.0601 0.526
xsq TENM2 5q34 -0.244 0.0601 0.526
exp KRT8P13 3q26.2 -0.246 0.0601 0.526
hs4 TOM1L2 17p11.2 -0.246 0.0601 0.526 intracellular protein
transport
hs4 DRC3 -0.246 0.0601 0.526
hs4 MIR564 -0.246 0.0601 0.526
hs4 TMEM42 3p21.31 -0.246 0.0601 0.526
his SEPT8 5q31 -0.246 0.0601 0.526 cell cycle
his ANAPC4 4p15.2 0.246 0.0602 0.526 ubiquitin-dependent protein
exp HMGN1P26 15q22.2 0.246 0.0602 0.526
xai PRKX Xp22.3 0.246 0.0602 0.526 cell adhesion;protein
autophosphorylation
exp DEPDC4 12q23.1 0.244 0.0602 0.526 intracellular signal
transduction
met IL17RD 3p14.3 0.244 0.0602 0.526
xsq L3MBTL2 22q13.31-q13.33 0.244 0.0602 0.526 regulation of
xsq LOC100287042 17q25.1 0.244 0.0602 0.526
exp WDR97 0.244 0.0602 0.526
exp NOC3L 10q23.33 0.244 0.0602 0.526 fat cell differentiation
xsq TRMT11 6q11.1-q22.33 0.244 0.0602 0.526 tRNA processing
exp CCDC124 19p13.11 0.244 0.0602 0.526
xsq SHROOM3 4q21.1 -0.244 0.0602 0.526 columnar/cuboidal
exp TCEAL1 Xq22.1 -0.244 0.0602 0.526 negative regulation of
dependent"
exp ZC2HC1A 8q21.12 -0.244 0.0602 0.526
xsq VWA1 1p36.33 -0.244 0.0602 0.526 extracellular matrix
organization
exp EPN2 17p11.2 -0.244 0.0602 0.526 regulation of endocytosis
hs4 BHMT2 5q13 -0.246 0.0602 0.526 methionine biosynthetic process
hs4 DMGDH 5q14.1 -0.246 0.0602 0.526 glycine metabolic
process;glycine catabolic process
his GPC6 13q32 -0.246 0.0602 0.526
his TBC1D10B 16p11.2 0.246 0.0603 0.527 positive regulation of Rab
GTPase activity;regulation of Rab GTPase activity
xsq SH2D7 15q25.1 0.244 0.0603 0.526
xsq AGER 6p21.3 0.244 0.0603 0.526 inflammatory response;positive
xsq FANCM 14q21.2 0.244 0.0603 0.527 DNA Damage Response (DDR); DDR (FA)
met CYP7B1 8q21.3 0.244 0.0603 0.527 memory;positive regulation of
epithelial cell proliferation
exp SH3GL1P2 17q11.2 0.244 0.0603 0.527
xsq MTMR8 Xq11.2 0.244 0.0603 0.527
DNA-dependent"
xsq ZMYM2 13q11-q12 0.244 0.0603 0.527 regulation of transcription, DNA-
dependent"
xsq NBL1 1p36.13 -0.244 0.0603 0.527 positive regulation of neuron
his TTC23L 5p13.2 -0.246 0.0603 0.527
his ANLN 7p15-p14 -0.246 0.0603 0.527 cytokinesis;septin ring
assembly
his KIAA0895 7p14.2 -0.246 0.0603 0.527
hs4 ECT2L 6q24.1 -0.246 0.0603 0.526 regulation of Rho protein
signal transduction
his RPL13P5 12p13.31 0.246 0.0604 0.527
his DSTNP2 0.246 0.0604 0.527
his LOC105369632 0.246 0.0604 0.527
xai OR11J2P 15q11.2 0.246 0.0604 0.527
xai LOC650226 7p11.2 0.246 0.0604 0.527
his MIR7851 0.246 0.0604 0.527
his ZCRB1 12q12 0.246 0.0604 0.527 mRNA processing;RNA splicing
his PPHLN1 12q12 0.246 0.0604 0.527 keratinization
his C11orf98 0.246 0.0604 0.527
his METTL12 11q12.3 0.246 0.0604 0.527
his SNORA57 11q12.2 0.246 0.0604 0.527
his UQCC3 0.246 0.0604 0.527
his LBHD1 0.246 0.0604 0.527
exp SPINT3 0.246 0.0604 0.527
xai UBC 12q24.3 -0.246 0.0604 0.527 DNA Damage Response (DDR)
his HHEX 10q23.33 0.246 0.0605 0.527 in utero embryonic development;cell
proliferation
his MAN2B1 19p13.2 0.246 0.0605 0.527 protein
deglycosylation;learning or memory
his WDR83 19p13.2 0.246 0.0605 0.527 RNA splicing, via
his WDR83OS 19p13.2 0.246 0.0605 0.527
his AHCTF1 1q44 0.246 0.0605 0.528 cytokinesis;protein transport
xai PHBP9 10q24.31 0.246 0.0605 0.528
hs4 COL9A2 1p33-p32 0.246 0.0605 0.528 skeletal system
xsq KLHL12 1q32.1 0.244 0.0605 0.527 Wnt receptor signaling
pathway
met FAR1 11p15.2 0.244 0.0605 0.527 small molecule metabolic
exp ERCC4 16p13.12 0.244 0.0605 0.527 DNA Damage Response (DDR); DDR
(NER)
met PTPN14 1q32.2 0.244 0.0605 0.528 lymphangiogenesis;protein
dephosphorylation
exp CENPC 4q13.2 0.244 0.0605 0.528
xsq GJB6 13q12 -0.244 0.0605 0.528 cell communication;sensory
perception of sound
xsq GTF2IRD1 7q11.23 -0.244 0.0605 0.528 regulation of
xai PDE1C 7p14.3 -0.246 0.0605 0.527 activation of phospholipase C
his LOC101929319 -0.246 0.0605 0.527
swa LANCL1 2q33-q35 0.246 0.0606 0.528 G-protein coupled receptor
signaling pathway
his LINC00599 8p23.1 0.246 0.0606 0.528
xai TCF20 22q13.3 0.246 0.0606 0.528 regulation of transcription, DNA-
dependent"
his TTL 2q13 0.246 0.0606 0.528 regulation of axon extension;microtubule
his PTCH1 9q22.3 0.246 0.0606 0.528 Tumor Suppressors
mut GPAM 10q25.2 0.244 0.0606 0.528 response to glucose
xsq NME1 0.244 0.0606 0.528 Apoptosis
exp MRPS21 1q21 0.244 0.0606 0.528 translation
met TPTE 21p11 0.244 0.0606 0.528 protein dephosphorylation;ion transport
cop OPRM1 6q24-q25 0.244 0.0606 0.528 sensory perception;negative
regulation of nitric oxide biosynthetic process
cop DDX19B 16q22.1 0.244 0.0606 0.528 mRNA export from
nucleus;protein transport
exp SNAPC5 15q22.31 0.244 0.0606 0.528 regulation of transcription,
xsq SIAH2 3q25 0.244 0.0606 0.528 Apoptosis
met FHOD3 18q12 0.244 0.0606 0.528 cellular component organization;actin
hs4 HTR2A 13q14-q21 -0.246 0.0606 0.528 aging;response to drug
his AFF3 2q11.2-q12 -0.246 0.0606 0.528 embryonic hindlimb
xai ATP9A 20q13.2 -0.246 0.0606 0.528 cation transport;phospholipid
translocation
his PGF 14q24.3 -0.246 0.0606 0.528 cell differentiation;vascular
endothelial growth factor receptor signaling pathway
xai CRELD1 3p25.3 -0.246 0.0606 0.528 endocardial cushion
his ALMS1 2p13 0.246 0.0607 0.528 sensory perception of sound;epithelial
cell proliferation
his GPC2 7q22.1 0.246 0.0607 0.528 neuron differentiation
his STAG3 7q22.1 0.246 0.0607 0.528 cell cycle;chromosome segregation
exp ZNF725P 19p12 0.246 0.0607 0.528 regulation of transcription, DNA-
dependent"
xsq KBTBD6 13q14.11 0.244 0.0607 0.528
xsq VSTM5 11q21 0.244 0.0607 0.528
exp NDUFB3P3 14q22.1 0.244 0.0607 0.528
exp GABPB1-AS1 15q21.2 0.244 0.0607 0.528
exp RPS19BP1 22q13.1 0.244 0.0607 0.528
exp ANKMY1 2q37.3 0.244 0.0607 0.528
exp HMGA1 6p21 0.244 0.0607 0.528 protein complex assembly;interspecies
met NDUFA13 19p13.2 0.244 0.0607 0.528 apoptotic nuclear
exp DYNLT1 6q25.2-q25.3 -0.244 0.0607 0.528 regulation of Rac
GTPase activity;establishment of mitotic spindle orientation
xsq TWSG1 18p11.3 -0.244 0.0607 0.528 mesoderm formation;forebrain
development
hs4 WNK3 Xp11.22 -0.246 0.0607 0.528 positive regulation of sodium
ion transport;regulation of ion homeostasis
hs4 UPK3B 7q11.2 -0.246 0.0607 0.528 negative regulation of gene
expression
his RNF144B 6p22.3 -0.246 0.0607 0.528 apoptotic
process
his MIR4296 -0.246 0.0607 0.528
xai CNIH3 1q42.12 -0.246 0.0607 0.528 intracellular signal
hs4 ATP8B1 18q21.31 -0.246 0.0607 0.528 bile acid and bile salt
his OPHN1 Xq12 -0.246 0.0607 0.528 substrate-dependent cell migration,
xai CCNO 5q11.2 -0.246 0.0607 0.528 DNA Damage Response (DDR)
swa BDH2 4q24 -0.246 0.0607 0.528 siderophore biosynthetic
process;heme metabolic process
swa GNAI3 1p13 -0.246 0.0607 0.528 GTP catabolic process;synaptic
transmission
hs4 SIGLEC9 19q13.41 0.246 0.0608 0.528 cell adhesion;cell surface
xai OR4X2 11p11.2 0.246 0.0608 0.528 response to stimulus
xai NDUFA13 19p13.2 0.246 0.0608 0.528 apoptotic nuclear
exp CXADRP2 0.246 0.0608 0.528
his C2orf68 2p11.2 0.246 0.0608 0.528
his USP39 2p11.2 0.246 0.0608 0.528 spliceosome assembly;mRNA
processing
xai GABPB2 1q21.3 0.246 0.0608 0.528 regulation of transcription,
his POU2AF1 11q23.1 0.246 0.0608 0.528 transcription from RNA
his NOLC1 10q24.32 0.246 0.0608 0.528 positive regulation of cell
xsq RCVRN 0.244 0.0608 0.528
exp ALG6 1p31.3 0.244 0.0608 0.528 protein N-linked
glycosylation;dolichol-linked oligosaccharide biosynthetic process
xsq CRYBB1 22q12.1 0.244 0.0608 0.528 visual perception
xsq LINC01287 0.243 0.0608 0.528
met PDZRN3 3p13 0.243 0.0608 0.528 neuromuscular junction
xsq COL12A1 6q12-q13 -0.243 0.0608 0.528 skeletal system
xsq PPAPDC1A 10q26.12 -0.244 0.0608 0.528
exp CLIP2 7q11.23 -0.244 0.0608 0.528
hs4 PTPN21 14q31.3 -0.246 0.0608 0.528 protein
swa AP2B1 17q11.2-q12 -0.246 0.0608 0.528 synaptic transmission;axon
guidance
xai KNCN 1p33 -0.246 0.0608 0.528
xai LOC100505782 -0.246 0.0608 0.528
his GLG1 16q22.3 0.246 0.0609 0.529 negative regulation of protein
processing;negative regulation of transforming growth factor beta receptor
signaling pathway
xai RPS23P2 4q28.3 0.246 0.0609 0.529
his PHKA1 Xq12-q13 0.246 0.0609 0.529 glucose metabolic
process;generation of precursor metabolites and energy
hs4 TRIM50 7q11.23 0.246 0.0609 0.529
xai PTCD2 5q13.2 0.245 0.0609 0.529 mitochondrion organization;heart
development
his MAN1A1 6q22 0.245 0.0609 0.529 post-translational protein
xsq KCNH6 17q23.3 0.243 0.0609 0.529 potassium ion transport;signal
transduction
cop PEX5 12p13.31 0.243 0.0609 0.529 protein targeting to
xsq PSMG2 18p11.21 0.243 0.0609 0.529 mitotic cell cycle spindle assembly
pro EP300_25_GBL00046 0.243 0.0609 0.529
xsq OR6C1 12q13.2 0.243 0.0609 0.529 response to stimulus
cop RTN4 2p16.3 0.243 0.0609 0.529 Apoptosis
mut TRAF5 1q32 0.243 0.0609 0.529 Apoptosis
exp RPS3AP13 0.243 0.0609 0.529
xsq ASAP1-IT2 -0.243 0.0609 0.529
xsq DKFZp434J0226 19q13.32 -0.243 0.0609 0.529
hs4 B4GALT1 9p13 -0.245 0.0609 0.529 epithelial cell
hs4 B4GALT1-AS1 -0.245 0.0609 0.529
hs4 EFCAB12 3q21.3 -0.246 0.0609 0.529
xai ASAP1-IT2 -0.246 0.0609 0.529
his PLEKHG7 12q22 -0.246 0.0609 0.529 regulation of Rho protein
signal transduction
his GLRB 4q31.3 -0.246 0.0609 0.529 startle response;ion
xai CRACR2A 0.245 0.061 0.529 activation of store-operated calcium
channel activity;positive regulation of calcium ion transport
his RBBP8 18q11.2 0.245 0.061 0.529 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
his MIR4741 0.245 0.061 0.529
his LOC286177 8q12.1 0.245 0.061 0.529
xai UPF3B Xq25-q26 0.245 0.061 0.529 transport;nucleocytoplasmic transport
exp RPL15P11 7q33 0.243 0.061 0.529
exp NDUFB11 Xp11.23 0.243 0.061 0.529 transport;respiratory electron
transport chain
met ROBO2 3p12.3 0.243 0.061 0.529 metanephros development;olfactory bulb
interneuron development
exp MRPS23 17q22-q23 0.243 0.061 0.529 translation
mut SHKBP1 19q13.2 0.243 0.061 0.529 potassium ion transport
exp INO80 15q15.1 0.243 0.061 0.529 DNA Damage Response (DDR); DDR
(Chromatin)
xsq HAND1 5q33 0.243 0.061 0.529
exp MOCS1 6p21.3 -0.243 0.061 0.529 vitamin metabolic process;water-
cop MMP16 8q21.3 -0.243 0.061 0.529 Apoptosis
xsq FOSL2 2p23.3 -0.243 0.061 0.529 regulation of transcription from
RNA polymerase II promoter;cell death
cop IPO9 1q32.1 -0.243 0.061 0.529 protein import into
cop SHISA4 1q32.1 -0.243 0.061 0.529
cop LMOD1 1q32 -0.243 0.061 0.529 muscle contraction
cop TIMM17A 1q32.1 -0.243 0.061 0.529 protein targeting to
exp MAST2 1p34.1 -0.243 0.061 0.529 protein phosphorylation;regulation
hs4 SH3PXD2B 5q35.1 -0.245 0.061 0.529 extracellular matrix
disassembly;cell differentiation
xai SFT2D3 2q14.3 0.245 0.0611 0.529 protein transport;vesicle-
mediated transport
exp LOC339622 0.245 0.0611 0.529
xai JPH3 16q24.3 0.245 0.0611 0.529 memory;exploration behavior
xai HMGB3P1 20q11.22 0.245 0.0611 0.529
xai ORC6 16q12 0.245 0.0611 0.529 DDR (DNA replication)
exp HSPA12B 20p13 0.245 0.0611 0.529 response to stress
xai CPS1 2q35 0.245 0.0611 0.529 midgut development;response to drug
xai IBSP 4q21.1 0.245 0.0611 0.529 ossification;cell adhesion
xsq FAM192A 16q13 0.243 0.0611 0.529
xsq NOP9 14q12 0.243 0.0611 0.529
xsq MRPS35 12p11 0.243 0.0611 0.529 peptide biosynthetic process;DNA
xsq RPL36 19p13.3 0.243 0.0611 0.529 translational termination;cellular
cop IPCEF1 6q25.2 0.243 0.0611 0.529 response to oxidative
stress;oxygen transport
exp MAT2A 2p11.2 0.243 0.0611 0.529 response to light stimulus;response
to hormone stimulus
met ZNF462 9q31.2 0.243 0.0611 0.529 positive regulation of
dependent
met DDX50 10q22.1 0.243 0.0611 0.529
met DNAJC21 5p13.2 0.243 0.0611 0.529 protein folding
xsq WASL 7q31.3 -0.243 0.0611 0.529 nitric oxide metabolic
xai TRAF3IP2 6q21 -0.245 0.0611 0.529 intracellular signal
xai OR52E6 11p15.4 -0.245 0.0611 0.529 response to stimulus
his MIR378D2 -0.245 0.0611 0.529
his PDP1 8q22.1 -0.245 0.0611 0.529 pyruvate metabolic
xai FAM183A 1p34.2 -0.245 0.0611 0.529
his LOC101928087 0.245 0.0612 0.529
xai GRIA4 11q22 0.245 0.0612 0.529 transport;ion transport
his IMPDH2 3p21.2 0.245 0.0612 0.529 nucleobase-containing small
cop DLGAP1-AS3 0.245 0.0612 0.529
mut TAT 16q22.1 0.243 0.0612 0.529 tyrosine catabolic process;response
to oxidative stress
exp NUDC 1p35-p34 0.243 0.0612 0.529 mitotic cell cycle;cytokinesis
xsq C19orf84 0.243 0.0612 0.529
met DOCK7 1p31.3 0.243 0.0612 0.529 axonogenesis;cell differentiation
exp FBL 19q13.1 0.243 0.0612 0.529 snoRNA metabolic process;rRNA
processing
xsq SNU13 0.243 0.0612 0.529 gene expression;ribosome biogenesis
exp PROK2 3p13 0.243 0.0612 0.529 spermatogenesis;activation of MAPK
activity
mut MIB1 18q11.2 0.243 0.0612 0.529 neural tube formation;heart looping
xsq CNKSR3 6q25.2 -0.243 0.0612 0.529 negative regulation of
exp PTPN23 3p21.3 -0.243 0.0612 0.529 cell projection
his LOC100507534 -0.245 0.0612 0.53
exp RPS14P4 2q13 -0.245 0.0612 0.529
xai RPS14P4 2q13 -0.245 0.0612 0.529
hs4 TRPV6 7q34 -0.245 0.0612 0.529 transmembrane transport;calcium ion
his FAM133CP -0.245 0.0612 0.529
hs4 BCYRN1 2p21 -0.245 0.0612 0.529
xai GSN-AS1 9q33.2 -0.245 0.0612 0.529
his DCXR 17q25.3 0.245 0.0613 0.53 glucose metabolic process;NADP
metabolic process
hs4 MYBL2 20q13.1 0.245 0.0613 0.53 Apoptosis
xai TAS2R60 7q35 0.245 0.0613 0.53 response to stimulus;sensory
perception of bitter taste
his MOGS 2p13.1 0.245 0.0613 0.53 protein folding;protein N-linked
glycosylation
xai C9orf139 9q34.3 0.245 0.0613 0.53
exp TMEM39B 1p35.1 0.243 0.0613 0.53
xsq TUBGCP5 15q11.2 0.243 0.0613 0.53 mitotic cell
xsq TMEM202 15q24.1 0.243 0.0613 0.53
xsq HGC6.3 6q27 0.243 0.0613 0.53
exp IPO4 14q12 0.243 0.0613 0.53 intracellular protein transport;protein
transport
xsq RAE1 20q13.31 0.243 0.0613 0.53 mRNA export from nucleus;cellular
xsq LOC100287010 0.243 0.0613 0.53
hs4 ATP13A4 3q29 -0.245 0.0613 0.53 cation transport;ATP
hs4 ATP13A4-AS1 -0.245 0.0613 0.53
his PLGRKT 9p24.1 -0.245 0.0613 0.53 positive regulation of
plasminogen activation
swa MOGS 2p13.1 -0.245 0.0613 0.53 protein folding;protein N-
linked glycosylation
swa HK1 10q22 -0.245 0.0613 0.53 transmembrane
transport;carbohydrate metabolic process
xai FOXI1 5q34 0.245 0.0614 0.53 Apoptosis
xai THNSL1 10p12.1 0.245 0.0614 0.53 threonine biosynthetic
process
his LINC01719 0.245 0.0614 0.53
his RNVU1-6 0.245 0.0614 0.53
his NUDT21 16q12.2 0.245 0.0614 0.53 RNA splicing;gene expression
his OGFOD1 16q12.2 0.245 0.0614 0.53
his MLEC 12q24.31 0.245 0.0614 0.53 post-translational protein
his SULT1B1 4q13.3 0.245 0.0614 0.53 phenol-containing compound
metabolic process;thyroid hormone metabolic process
xai TRMT61B 2p23.2 0.245 0.0614 0.53 tRNA methylation;tRNA
processing
xai TYW3 1p31.1 0.245 0.0614 0.53 tRNA processing
xai RPL5P9 0.245 0.0614 0.53
hs4 ZNF589 3p21 0.245 0.0614 0.53 regulation of transcription, DNA-
dependent"
met ELMO2 20q13 0.243 0.0614 0.53 Apoptosis
exp FEN1P1 1p22.2 0.243 0.0614 0.53
xsq ASB3 2p16.2 0.243 0.0614 0.53 intracellular signal transduction
xsq C9orf139 9q34.3 0.243 0.0614 0.53
xsq CXCR2 2q35 0.243 0.0614 0.53 dendritic cell chemotaxis;neutrophil
chemotaxis
xsq ST3GAL6-AS1 -0.243 0.0614 0.53
xai COL5A1 9q34.2-q34.3 -0.245 0.0614 0.53 wound healing,
his TWNK 0.245 0.0615 0.53
exp CRYM-AS1 16p12.2 0.245 0.0615 0.53
xai ADCY7 16q12.1 0.245 0.0615 0.53 GTP catabolic process;fibroblast
cop MT3 16q13 0.243 0.0615 0.53 energy reserve metabolic process;positive
regulation of necrotic cell death
cop MT2A 16q13 0.243 0.0615 0.53 cellular response to interleukin-
cop MT1L 16q13 0.243 0.0615 0.53
cop MT1E 16q13 0.243 0.0615 0.53 negative regulation of growth;cellular
response to cadmium ion
cop MT1M 16q13 0.243 0.0615 0.53 negative regulation of growth
cop MT1JP 16q13 0.243 0.0615 0.53
cop MT1A 16q13 0.243 0.0615 0.53 negative regulation of growth;cellular
cop MT1DP 16q13 0.243 0.0615 0.53
cop MT1B 16q13 0.243 0.0615 0.53 negative regulation of growth;cellular
response to zinc ion
cop MT1F 16q13 0.243 0.0615 0.53 negative regulation of growth;cellular
cop MT1G 16q13 0.243 0.0615 0.53 cellular response to zinc ion;monocyte
differentiation
exp KBTBD6 13q14.11 0.243 0.0615 0.53
met NDST4 4q26 0.243 0.0615 0.53
mut KIAA0355 19q13.11 0.243 0.0615 0.53
xsq HOXB-AS1 -0.243 0.0615 0.53
xsq ANLN 7p15-p14 -0.243 0.0615 0.53 cytokinesis;septin ring
assembly
xsq LOC102724163 -0.243 0.0615 0.53
met HENMT1 1p13.3 -0.243 0.0615 0.53 RNA methylation;gene
silencing by RNA
exp HLA-J 6p21.31 -0.243 0.0615 0.53
met MIR26A1 -0.243 0.0615 0.53
xai RTTN 18q22.2 0.245 0.0616 0.53 determination of left/right
his LOC728673 0.245 0.0616 0.53
his LOC403323 0.245 0.0616 0.53
swa RPL23A 17q11.2 0.245 0.0616 0.531 SRP-dependent cotranslational
his MEG9 0.245 0.0616 0.531
xai NFAM1 22q13.2 0.245 0.0616 0.531 regulation of B cell
xai IGHG4 14q32.33 0.245 0.0616 0.531 complement activation, classical
xai TWISTNB 7p21.1 0.245 0.0616 0.531
xai DNMT1 19p13.2 0.245 0.0616 0.531 DNA Damage Response (DDR)
his WNT1 12q13 0.245 0.0616 0.531 Apoptosis; Oncogenes
exp NSUN4 1p34 0.243 0.0616 0.53
met LOC441666 10q11.21 0.243 0.0616 0.53
mut NDUFA9 12p13.3 0.243 0.0616 0.531 mitochondrial electron
exp PMS2P1 7q22.1 0.243 0.0616 0.531 ATP catabolic
exp PHC1P1 0.243 0.0616 0.531
exp RPS2P11 1p32.3 0.243 0.0616 0.531
exp CCNC 6q21 0.243 0.0616 0.531 DNA Damage Response (DDR)
xsq C4orf29 4q28.2 0.243 0.0616 0.531
xsq OR4F6 0.243 0.0616 0.531
xsq PPP1R27 17q25.3 0.243 0.0616 0.531 negative regulation of
xsq WDFY3-AS2 4q21.3 -0.243 0.0616 0.531
exp TMPRSS13 11q23 -0.243 0.0616 0.53 proteolysis
exp ASAP1-IT2 -0.243 0.0616 0.53
xai MIR205 -0.245 0.0616 0.531
hs4 SORBS2 4q35.1 -0.245 0.0616 0.531
xai TMEM8B 9p13.3 -0.245 0.0616 0.53 cell adhesion;cell-
matrix adhesion
swa TGOLN2 2p11.2 -0.245 0.0616 0.53
his SMG7-AS1 0.245 0.0617 0.531
his SMG7 1q25 0.245 0.0617 0.531 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;mRNA export from nucleus
xai PRPH2 6p21.1 0.245 0.0617 0.531 cell adhesion;visual perception
xai THUMPD3 3p25.3 0.245 0.0617 0.531
xai HSPA8P7 0.245 0.0617 0.531
xai GTF2A1 14q31.1 0.245 0.0617 0.531 viral reproduction;regulation
xai NRARP 9q34.3 0.245 0.0617 0.531 regulation of cell-cell
adhesion;negative regulation of T cell differentiation
xai ARL2 11q13 0.245 0.0617 0.531 tubulin complex assembly;centrosome
organization
xsq NME1-NME2 0.243 0.0617 0.531 CTP biosynthetic process;GTP
met HOMER3 19p13.11 0.243 0.0617 0.531 protein targeting;G-protein
xsq RACGAP1P 12q12 0.243 0.0617 0.531
exp THOP1 19p13.3 0.243 0.0617 0.531 proteolysis
exp CNIH3 1q42.12 -0.243 0.0617 0.531 intracellular signal
xsq CFAP126 -0.243 0.0617 0.531
hs4 C10orf107 10q21.2 -0.245 0.0617 0.531
xai NPHP1 2q13 -0.245 0.0617 0.531 signal transduction;excretion
his MIR4435-2 -0.245 0.0617 0.531
hs4 ZFP57 6p22.1 -0.245 0.0617 0.531 DNA methylation involved in
embryo development;regulation of gene expression by genetic imprinting
exp TAS2R60 7q35 0.245 0.0618 0.531 response to stimulus;sensory
perception of bitter taste
xai MDM4 1q32 0.245 0.0618 0.531 Apoptosis; DNA Damage Response (DDR)
xai RRM1 11p15.5 0.245 0.0618 0.531 DNA Damage Response (DDR)
hs4 MXD3 5q35.3 0.245 0.0618 0.531 negative regulation of
xai MYOM1 18p11.31 0.245 0.0618 0.531 muscle contraction
his DPP8 15q22 0.245 0.0618 0.531 proteolysis;immune response
xsq LOC400958 0.243 0.0618 0.531
met UGT3A2 5p13.2 0.243 0.0618 0.531 metabolic process
exp USP34 2p15 0.243 0.0618 0.531 protein K48-linked
xsq PINLYP 19q13.31 0.243 0.0618 0.531
exp PLK1 16p12.2 0.243 0.0618 0.531 DDR (DNA replication); Protein
Kinases
xsq FLT1 13q12 0.243 0.0618 0.531 Protein Kinases
xsq CCT8 21q22.11 0.243 0.0618 0.531 protein folding;cellular protein
metabolic process
exp KPNA5 6q22.1 0.243 0.0618 0.531 cytokine-mediated signaling
exp KLC3 19q13 -0.243 0.0618 0.531 metabolic process
exp YIPF3 6p21.1 -0.243 0.0618 0.531 cell differentiation
met MIR1265 -0.243 0.0618 0.531
his LOC284080 -0.245 0.0618 0.531
his ITGA3 17q21.33 -0.245 0.0618 0.531 leukocyte migration;neuron
migration
exp IGLJ4 -0.245 0.0618 0.531
hs4 DNAJC6 1p31.3 -0.245 0.0618 0.531 post-Golgi vesicle-
his ACY3 11q13.2 0.245 0.0619 0.531 metabolic process;interspecies
his B3GNT2 2p15 0.245 0.0619 0.531 post-translational protein
his CUEDC2 10q24.32 0.245 0.0619 0.531
his MIR146B 0.245 0.0619 0.531
xai SBK1 16p11.2 0.245 0.0619 0.531 peptidyl-serine
cop MT4 16q13 0.243 0.0619 0.531
xsq SLX4 16p13.3 0.243 0.0619 0.531 DNA Damage Response (DDR); DDR (HR)
met GALNT5 2q24.1 0.243 0.0619 0.531 glycosaminoglycan
met GALR1 18q23 0.243 0.0619 0.531 neuropeptide signaling pathway;digestion
exp CHTF8 16q22.1 0.243 0.0619 0.531 DDR (DNA replication)
met FAM111B 11q12.1 0.243 0.0619 0.531
exp DDX20 1p21.1-p13.2 0.243 0.0619 0.531 negative regulation of
exp ZKSCAN2 16p12.1 0.243 0.0619 0.531 viral reproduction
DNA-dependent"
exp SNRPE 1q32 0.242 0.0619 0.531 histone mRNA metabolic process;RNA
splicing
exp FTH1 11q13 -0.243 0.0619 0.531 iron ion transport;transmembrane
transport
mut IGFN1 1q32.1 -0.243 0.0619 0.531
xai IGLJ4 -0.245 0.0619 0.531
xai BOK 2q37.3 -0.245 0.0619 0.531 male gonad
his PGAM1P5 12q22 -0.245 0.0619 0.531
hs4 COL18A1 21q22.3 -0.245 0.0619 0.531 negative regulation of
his MOCS1 6p21.3 -0.245 0.0619 0.531 vitamin metabolic
his LOC101929741 0.245 0.062 0.531
his METTL14 4q26 0.245 0.062 0.531 RNA methylation;nucleobase-containing
exp CHRNB3 8p11.2 0.245 0.062 0.532 ion transport;signal transduction
his MRM3 0.244 0.062 0.532
his GLOD4 17p13.3 0.244 0.062 0.532
his RHNO1 12p13.33 0.244 0.062 0.532
his FOXM1 12p13 0.244 0.062 0.532 Apoptosis
xai C6orf10 6p21.3 0.244 0.062 0.532
xsq BCL2L2-PABPN1 0.242 0.062 0.532
exp NPRL2 3p21.3 0.242 0.062 0.532 protein phosphorylation;negative
met FAM200A 7q22.1 0.242 0.062 0.532
xsq LOC90784 2p11.2 0.242 0.062 0.532
mut SNX10 7p15.2 0.242 0.062 0.532 endosome organization;cell communication
met SSH3 11q13.2 0.242 0.062 0.532 protein dephosphorylation;regulation of
actin polymerization or depolymerization
met POPDC2 3q13.33 0.242 0.062 0.532
xsq LOC101928295 0.242 0.062 0.532
cop PSMA2 7p13 -0.242 0.062 0.532 protein polyubiquitination;DNA damage
exp LOC644924 Xp11.21 -0.242 0.062 0.532
cop CFHR2 -0.242 0.062 0.532
exp PTPRB 12q15-q21 -0.242 0.062 0.532 protein
xai SSC5D 19q13.42 -0.244 0.062 0.532
xai CCDC183-AS1 -0.244 0.062 0.532
xai PTPRB 12q15-q21 -0.244 0.062 0.532 protein
hs4 LYNX1 8q24.3 -0.244 0.062 0.532
hs4 MIR548AJ1 -0.245 0.062 0.532
swa ENY2 8q23.1 0.244 0.0621 0.532 transport;chromatin modification
xai MRPS25 3p25 0.244 0.0621 0.532 translation
xai HMGB3P5 10q25.2 0.244 0.0621 0.532
his NIFK 0.244 0.0621 0.532 rRNA transcription;negative regulation of
xai INTS10 8p21.3 0.244 0.0621 0.532 snRNA processing
his SUPT4H1 17q22 0.244 0.0621 0.532 viral reproduction;negative
exp FOXI1 5q34 0.242 0.0621 0.532 Apoptosis
xsq CARNS1 11q13.2 0.242 0.0621 0.532 carnosine biosynthetic
process
exp NAT6 3p21.3 0.242 0.0621 0.532
exp TCF20 22q13.3 0.242 0.0621 0.532 regulation of transcription, DNA-
dependent"
xsq LINC01260 0.242 0.0621 0.532
met SALL4 20q13.2 -0.242 0.0621 0.532 DNA Damage Response (DDR)
xsq CTBP2 10q26.13 -0.242 0.0621 0.532 negative regulation of
met CAMK2A 5q32 -0.242 0.0621 0.532 synaptic
transmission;cytokine-mediated signaling pathway
met TNFRSF18 1p36.3 -0.242 0.0621 0.532 signal
transduction;tumor necrosis factor-mediated signaling pathway
exp RPS3AP35 -0.244 0.0621 0.532
his LOC101927189 -0.244 0.0621 0.532
hs4 IFNG-AS1 0.244 0.0622 0.532
xai TRMT2B Xq22.1 0.244 0.0622 0.532 tRNA processing
his BCL2L12 19q13.3 0.244 0.0622 0.532 apoptotic process
his IRF3 19q13.3-q13.4 0.244 0.0622 0.532 Apoptosis
hs4 LINC01222 0.244 0.0622 0.532
his ALAS1 3p21.1 0.244 0.0622 0.532 tetrapyrrole biosynthetic
his ZC3H15 2q32.1 0.244 0.0622 0.532 cytokine-mediated signaling
pathway
exp KIR2DS3 0.244 0.0622 0.532 cellular defense response
xsq FBXL19 16p11.2 0.242 0.0622 0.532
xsq GRAMD1B 11q24.1 0.242 0.0622 0.532
met ANKRD53 2p13.3 0.242 0.0622 0.532
xsq GOLGA8G 0.242 0.0622 0.532
exp TYMSOS 0.242 0.0622 0.532
exp ANKRD36BP2 2p11.2 0.242 0.0622 0.532
met COPB2 3q23 0.242 0.0622 0.532 COPI coating of Golgi
xsq ANAPC1P1 2p11.2 0.242 0.0622 0.532
xsq RAET1K 6q25.1 0.242 0.0622 0.532
xsq C4orf45 4q32.1 0.242 0.0622 0.532
exp TLR7 Xp22.3 0.242 0.0622 0.532 microglial cell activation involved
xsq SLC9A7 Xp11.3 -0.242 0.0622 0.532 Solute Carriers
exp PGM3 6q14.1-q15 -0.242 0.0622 0.532 glucosamine metabolic
cop NELL1 11p15.1 -0.242 0.0622 0.532 induction of apoptosis;cell
adhesion
cop DCAF4L2 8q21.3 -0.242 0.0622 0.532
xsq ZNFX1 20q13.13 -0.242 0.0622 0.532
hs4 RILPL1 12q24.31 -0.244 0.0622 0.532 neuroprotection
hs4 MIR3908 -0.244 0.0622 0.532
his UNC5B 10q22.1 -0.244 0.0622 0.532 Apoptosis
xai CUL4AP1 4q26 -0.244 0.0622 0.532
xai RPS3AP35 -0.244 0.0622 0.532
swa ESYT2 7q36.3 -0.244 0.0622 0.532
hs4 FAR2 12p11.22 0.244 0.0623 0.532 ether lipid biosynthetic
xai FEN1 11q12 0.244 0.0623 0.533 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq ZNF830 17q12 0.242 0.0623 0.532 blastocyst growth;cell cycle
xsq FAM19A2 12q14.1 0.242 0.0623 0.532
met ACCS 11p11 0.242 0.0623 0.532 biosynthetic process
xsq ORAI1 12q24.31 0.242 0.0623 0.532 ion transport;blood coagulation
exp TANC2 17q23.3 -0.242 0.0623 0.533
exp SNORD123 5p15.2 -0.242 0.0623 0.532
xai CDK15 2q33.2 -0.244 0.0623 0.533 Protein Kinases
exp HSPD1P11 -0.244 0.0623 0.532
swa RAB14 9q32-q34.11 -0.244 0.0623 0.532 neurotransmitter
swa RRBP1 20p12 -0.244 0.0623 0.532 protein transport;translation
exp CUL4AP1 4q26 -0.244 0.0623 0.532
xai NUP58 0.244 0.0624 0.533 nucleocytoplasmic transport;mRNA
transport
exp FLJ45832 0.244 0.0624 0.533
hs4 IKZF3 17q21 0.244 0.0624 0.533 mesoderm development;regulation of B cell
proliferation
xai NPM1P6 8q12.2 0.244 0.0624 0.533
his MIR1182 0.244 0.0624 0.533
his RMDN3 15q15.1 0.244 0.0624 0.533
xsq LOC101927021 0.242 0.0624 0.533
xsq SERPINB10 18q21.3 0.242 0.0624 0.533 negative regulation of
met EPB41L5 2q14.2 0.242 0.0624 0.533
xsq FAM90A27P 19q13.42 0.242 0.0624 0.533
exp ZNF462 9q31.2 -0.242 0.0624 0.533 positive regulation of
dependent
exp DCAF6 1q24.2 -0.242 0.0624 0.533 protein
ubiquitination;positive regulation of transcription from RNA polymerase II promoter
adhesion
xai PLEKHG3 14q23.3 -0.244 0.0624 0.533 regulation of Rho
his ARHGAP30 1q23.3 0.244 0.0625 0.533 signal transduction;small
xai TUBGCP4 15q15 0.244 0.0625 0.533 G2/M transition of mitotic cell
his LRRC47 1p36.32 0.244 0.0625 0.533
hs4 FAM19A5 22q13.32 0.244 0.0625 0.533
met GCC1 7q32.1 0.242 0.0625 0.533 protein targeting to Golgi
xsq PGLYRP3 1q21 0.242 0.0625 0.533 peptidoglycan catabolic
process;detection of bacterium
exp HNRNPA3P3 Xq27.1 0.242 0.0625 0.533
exp DNAH11 7p21 0.242 0.0625 0.533 ciliary or flagellar
xsq BRPF1 3p26-p25 0.242 0.0625 0.533 chromatin modification;histone H3
acetylation
mir hsa-miR-874 0.242 0.0625 0.533
mut LRRC8E 19p13.2 0.242 0.0625 0.533
exp GLB1L3 11q25 0.242 0.0625 0.533 carbohydrate metabolic process
met SDPR 2q32-q33 0.242 0.0625 0.533
exp DDX58 9p12 -0.242 0.0625 0.533 innate immune response;positive
exp ANGPTL5 11q22.1 -0.242 0.0625 0.533 signal transduction
xai GBF1 10q24 -0.244 0.0625 0.533 retrograde vesicle-mediated
exp LOC100506813 -0.244 0.0625 0.533
his RNU1-3 0.244 0.0626 0.533
his RPL22 1p36.31 0.244 0.0626 0.534 translational elongation;viral
transcription
exp CEP120 5q23.2 0.244 0.0626 0.534 microtubule cytoskeleton
organization;cell proliferation
xai PFN1P10 1p36.12 0.244 0.0626 0.534
his ANKRD20A4 0.244 0.0626 0.534
his TTC33 5p13.1 0.244 0.0626 0.534
his NOL11 17q24.2 0.244 0.0626 0.534
his EMSY 0.244 0.0626 0.534 DNA repair;regulation of transcription,
DNA-dependent
xsq FCGR1A 1q21.2-q21.3 0.242 0.0626 0.534 innate immune
xsq NAF1 4q32.2 0.242 0.0626 0.534 rRNA processing;snRNA pseudouridine
synthesis
met S100A7A 1q21.3 0.242 0.0626 0.534
xsq WBSCR22 7q11.23 0.242 0.0626 0.534 metabolic process;methylation
xsq PPM1M 3p21.2 0.242 0.0626 0.534 protein dephosphorylation
exp TET3 2p13.1 0.242 0.0626 0.534
exp RNU6ATAC 9q34.2 -0.242 0.0626 0.534
exp FAM177A1 14q13.2 -0.242 0.0626 0.534
exp TERF1P5 13q11 -0.242 0.0626 0.533
xai BLZF2P 14q24.1 -0.244 0.0626 0.534
xai FAT1 4q35 -0.244 0.0626 0.534 anatomical structure
hs4 KCNJ5 11q24 -0.244 0.0626 0.534 Oncogenes
hs4 PRRT2 16p11.2 0.244 0.0627 0.534 response to biotic stimulus
xai KLHL15 Xp22.1-p21 0.244 0.0627 0.534
swa EIF5 14q32.32 0.244 0.0627 0.534 translational initiation;regulation
xai ITM2C 2q37 0.244 0.0627 0.534 negative regulation of neuron projection
his PPP2R5D 6p21.1 0.244 0.0627 0.534 signal transduction;nervous
system development
exp DIAPH3-AS2 0.244 0.0627 0.534
xsq USP37 2q35 0.242 0.0627 0.534 proteolysis;ubiquitin-dependent protein
catabolic process
xsq CHUK 10q24-q25 0.242 0.0627 0.534 Apoptosis; Protein Kinases
exp NARF 17q25.3 0.242 0.0627 0.534
xsq RPUSD4 11q24.2 0.242 0.0627 0.534 pseudouridine synthesis
xsq WDR7 18q21.31 0.242 0.0627 0.534
met TMEM72 10q11.21 0.242 0.0627 0.534
xsq AARSD1 17q21.31 0.242 0.0627 0.534 translation;alanyl-tRNA
aminoacylation
xsq DDX58 9p12 -0.242 0.0627 0.534 innate immune response;positive
exp LINC01191 -0.242 0.0627 0.534
hs4 TMEM47 Xp11.4 -0.244 0.0627 0.534
his KHSRP 19p13.3 0.244 0.0628 0.534 RNA splicing;gene expression
his CCDC112 5q22.3 0.244 0.0628 0.534
hs4 ABHD14B 3p21.2 0.244 0.0628 0.534
hs4 ABHD14A 3p21.1 0.244 0.0628 0.534
hs4 ABHD14A-ACY1 0.244 0.0628 0.534
his LOC285074 2p11.2 0.244 0.0628 0.534
xai PHBP3 1p32.1 0.244 0.0628 0.534
xai PIEZO1 16q24.3 0.244 0.0628 0.534 ion transport;positive
exp MPI 15q24.1 0.242 0.0628 0.534 carbohydrate metabolic
exp DRD5P2 1q21.1 0.242 0.0628 0.534
mir hsa-miR-498 0.242 0.0628 0.534
mut ZCCHC13 Xq13.2 0.242 0.0628 0.534
xsq AQP10 1q21.3 0.242 0.0628 0.534 water transport;response to toxin
cop FADD 11q13.3 0.242 0.0628 0.534 Apoptosis
cop ANO1 11q13.3 0.242 0.0628 0.534 chloride transport;multicellular
xsq C1QA 0.242 0.0628 0.534
cop SEPT7 7p14.2 -0.242 0.0628 0.534 cytokinesis;cell cycle
exp ENPP1 6q22-q23 -0.242 0.0628 0.534 nucleoside triphosphate
catabolic process;negative regulation of protein autophosphorylation
his LOC105373553 -0.244 0.0628 0.534
hs4 MIR205HG 1q32.2 -0.244 0.0628 0.534
hs4 MIR205 -0.244 0.0628 0.534
swa PIGK 1p31.1 -0.244 0.0628 0.534 protein thiol-disulfide
exchange;C-terminal protein lipidation
hs4 LDLRAD3 11p13 -0.244 0.0628 0.534
xai RPL32 3p25-p24 0.244 0.0629 0.534 SRP-dependent cotranslational
xai DIAPH3-AS2 0.244 0.0629 0.534
swa PRPF40A 2q23.3 0.244 0.0629 0.534 cell cycle;regulation of cell
shape
xai ERMARD 0.244 0.0629 0.534
his TAF6 7q22.1 0.244 0.0629 0.534 transcription elongation from RNA
polymerase II promoter;negative regulation of cell proliferation
his CNPY4 7q22.1 0.244 0.0629 0.534
xsq ATP5L2 22q13.2 0.242 0.0629 0.534 ion transport;ATP synthesis
coupled proton transport
exp CTNNBL1 20q11.23-q12 0.242 0.0629 0.534 Apoptosis
xsq GINS2 16q24.1 0.242 0.0629 0.534 DDR (DNA replication)
met PTCH1 9q22.3 0.242 0.0629 0.534 Tumor Suppressors
xsq PARP15 3q21.1 0.242 0.0629 0.534 regulation of transcription,
DNA-dependent"
DNA-dependent"
xsq C1orf35 1q42.13 0.242 0.0629 0.534
met CCR4 3p24 -0.242 0.0629 0.534 neuron migration;tolerance
induction
his PROSER2 10p14 -0.244 0.0629 0.535
hs4 RAET1E 6q25.1 -0.244 0.0629 0.534 immune response;antigen
his KRT80 12q13.13 -0.244 0.0629 0.534
his C12orf80 -0.244 0.0629 0.534
his LINC00592 -0.244 0.0629 0.534
hs4 MAGEA9B 0.244 0.063 0.535
xai FADS2 11q12.2 0.244 0.063 0.535 unsaturated fatty acid biosynthetic
process;transport
hs4 LOC642846 12p13.31 0.244 0.063 0.535
xai CBFA2T3 16q24 0.244 0.063 0.535 cell differentiation;granulocyte
differentiation
xai EIF4A3 17q25.3 0.244 0.063 0.535 gene expression;nuclear-transcribed
mRNA catabolic process, nonsense-mediated decay
xai TCEB3-AS1 0.244 0.063 0.535
xai MRPS21 1q21 0.244 0.063 0.535 translation
xai ZNF174 16p13.3 0.244 0.063 0.535 negative regulation of
xsq TCHH 1q21.3 0.242 0.063 0.535 keratinization
xsq LOC101929549 0.242 0.063 0.535
exp EIF5 14q32.32 0.242 0.063 0.535 translational initiation;regulation of
xsq LINC01096 0.242 0.063 0.535
xsq CRY2 11p11.2 0.242 0.063 0.535 DNA Damage Response (DDR)
exp AMZ2P1 17q24.1 0.242 0.063 0.535
xsq ERN1 17q24.2 0.242 0.063 0.535 response to unfolded protein;activation
of signaling protein activity involved in unfolded protein response
exp KBTBD7 13q14.11 0.242 0.063 0.535
met GRIK1 21q22.11 0.242 0.063 0.535 nervous system development;regulation of
synaptic transmission, glutamatergic
cop KCNT2 1q31.3 -0.242 0.063 0.535 potassium ion transport;potassium
ion transmembrane transport
cop MIR4735 -0.242 0.063 0.535
cop SUGCT -0.242 0.063 0.535
his KCNQ1OT1 11p15 -0.244 0.063 0.535
his AQP5 12q13 -0.244 0.063 0.535 excretion;carbon dioxide transport
his LOC101927318 -0.244 0.063 0.535
hs4 LOC101930010 -0.244 0.063 0.535
hs4 UNC5B 10q22.1 -0.244 0.063 0.535 Apoptosis
xai FUCA1 1p34 -0.244 0.063 0.535 carbohydrate metabolic process;fucose
metabolic process
DNA-dependent"
xai RNF113A Xq24 0.244 0.0631 0.535
exp LINC01532 0.244 0.0631 0.535
his GNB1 1p36.33 0.243 0.0631 0.535 activation of phospholipase C
second messenger;small molecule metabolic process
hs4 SNHG1 11q12.3 0.243 0.0631 0.535
hs4 SNORD22 0.243 0.0631 0.535
hs4 SNORD31 0.243 0.0631 0.535
hs4 SNORD30 0.243 0.0631 0.535
hs4 SNORD29 0.243 0.0631 0.535
hs4 SNORD28 0.243 0.0631 0.535
hs4 SNORD27 0.243 0.0631 0.535
hs4 SNORD26 0.243 0.0631 0.535
hs4 SNORD25 0.243 0.0631 0.535
his OR7E47P 12q13.13 0.243 0.0631 0.535
xsq OBP2B 0.241 0.0631 0.535 sensory perception of smell;chemosensory
behavior
xsq ELAC1 18q21 0.241 0.0631 0.535 tRNA processing;tRNA 3'-trailer cleavage
exp DNMT1 19p13.2 0.241 0.0631 0.535 DNA Damage Response (DDR)
xsq WIPI1 17q24.2 -0.241 0.0631 0.535 autophagy;activation of
exp IL17RD 3p14.3 -0.241 0.0631 0.535
xsq PTK2 8q24.3 -0.241 0.0631 0.535 Apoptosis
exp PPP1R9A 7q21.3 -0.241 0.0631 0.535 multicellular organismal
met CASC4 15q15.3 -0.241 0.0631 0.535
exp KIAA1671 22q11.23 -0.241 0.0631 0.535
hs4 PCDHB11 5q31 -0.243 0.0631 0.535 homophilic cell
adhesion;synaptic transmission
swa ARF4 3p21.2-p21.1 -0.243 0.0631 0.535 GTP catabolic
his LDHD 16q23.1 0.243 0.0632 0.535
his DIP2A 21q22.3 0.243 0.0632 0.535 multicellular organismal
development
his DIP2A-IT1 0.243 0.0632 0.535
his CHEK1 11q24.2 0.243 0.0632 0.535 DNA Damage Response (DDR); Protein
Kinases
exp LARP1 5q33.2 0.241 0.0632 0.535
met DEFA4 8p23 0.241 0.0632 0.535 killing of cells of other
met STH 17q21.1 -0.241 0.0632 0.535
exp ATG9A 2q35 -0.241 0.0632 0.535 autophagy;protein transport
hs4 ZNF503-AS2 10q22.2 -0.243 0.0632 0.535
his DAG1 3p21 -0.243 0.0632 0.535 interspecies interaction between
his PLOD2 3q24 -0.243 0.0632 0.535 response to hypoxia;protein
dependent"
xai LOC646762 7p14.3 0.243 0.0633 0.535
xai USP5 12p13 0.243 0.0633 0.536 positive regulation of proteasomal
xai CHRAC1 8q24.3 0.243 0.0633 0.536 DNA Damage Response (DDR);
DDR (Chromatin)
xai COX15 10q24 0.243 0.0633 0.536 mitochondrial electron transport,
cytochrome c to oxygen;heme a biosynthetic process
xai CREBZF 11q14 0.243 0.0633 0.536 transcription, DNA-
dependent;response to virus
xai FLI1 11q24.1-q24.3 0.243 0.0633 0.536 Transcription Factors
exp RANBP20P 14q11.2 0.243 0.0633 0.536
swa NLE1 17q12 0.243 0.0633 0.536 inner cell mass cell
xai NPRL2 3p21.3 0.243 0.0633 0.536 protein phosphorylation;negative
xsq ARID1A 1p35.3 0.241 0.0633 0.536 DNA Damage Response (DDR);
cop RELT 11q13.4 0.241 0.0633 0.536
exp UVRAG 11q13.5 0.241 0.0633 0.536 DNA Damage Response (DDR)
xsq NDNF 4q27 0.241 0.0633 0.536 cell growth;peptide cross-linking via
cop USP14 18p11.32 0.241 0.0633 0.536 proteolysis;ubiquitin-dependent
mut FLT3 13q12 0.241 0.0633 0.536 Cell Signaling; Oncogenes
xsq DNAJC9 10q22.2 0.241 0.0633 0.536 protein folding;social
behavior
his RTP1 3q27.3 -0.243 0.0633 0.536 protein insertion into
membrane
xai MPHOSPH8 13q12.11 0.243 0.0634 0.536 cell cycle;regulation of DNA
methylation
his ATP7A Xq21.1 0.243 0.0634 0.536 in utero embryonic development;ATP
hs4 SRGN 10q22.1 0.243 0.0634 0.536 mast cell secretory granule
organization;platelet degranulation
xai SPOCK2 10pter-q25.3 0.243 0.0634 0.536 peptide cross-linking
xsq GID4 17p11.2 0.241 0.0634 0.536
exp USP44 12q22 0.241 0.0634 0.536 cell division;anaphase
xsq TBC1D3 17q12 0.241 0.0634 0.536
mut CORO2B 15q23 0.241 0.0634 0.536 actin cytoskeleton organization
met FBXO17 19q13.2 0.241 0.0634 0.536 protein catabolic process
dependent"
xsq NRIR 0.241 0.0634 0.536
met SAMHD1 20pter-q12 0.241 0.0634 0.536 DNA Damage Response (DDR)
exp CDH6 5p13.3 -0.241 0.0634 0.536 cell adhesion;homophilic cell
adhesion
exp PLCD3 17q21.31 -0.241 0.0634 0.536 angiogenesis;lipid catabolic
process
exp CCND1 11q13 -0.241 0.0634 0.536 DNA Damage Response (DDR); DDR (G1-
S checkpoint); Oncogenes
his FBXO32 8q24.13 -0.243 0.0634 0.536 muscle atrophy
xai LRRN1 3p26.2 -0.243 0.0634 0.536
xai LOC100287072 17p11.2 0.243 0.0635 0.536
xai KIF1A 2q37.3 0.243 0.0635 0.536 microtubule-based
his PROCA1 17q11.2 0.243 0.0635 0.536 lipid catabolic process
his TARS2 1q21.3 0.243 0.0635 0.536 threonyl-tRNA aminoacylation;gene
expression
his DUSP22 6p25.3 0.243 0.0635 0.536 Apoptosis
swa MAD2L1 4q27 0.243 0.0635 0.536 DNA Damage Response (DDR)
xai NOL12 22q13.1 0.243 0.0635 0.536
exp C17orf62 17q25.3 0.241 0.0635 0.536
exp ORAI1 12q24.31 0.241 0.0635 0.536 ion transport;blood coagulation
exp DBP 19q13.3 0.241 0.0635 0.536 regulation of cell
exp HMGN1P21 11p15.4 0.241 0.0635 0.536
xsq USP49 6p21 0.241 0.0635 0.536 ubiquitin-dependent protein catabolic
process;proteolysis
exp PCNAP3 Xp11.3 0.241 0.0635 0.536
met GRID2IP 7p22.1 0.241 0.0635 0.536 long term synaptic
depression;cellular component organization
xsq DCUN1D1 3q26.3 0.241 0.0635 0.536
exp DESI2 1q44 0.241 0.0635 0.536
met CHDH 3p21.1 0.241 0.0635 0.536 alcohol metabolic process
met FAM166B 9p13.3 -0.241 0.0635 0.536
xai CD200 3q13.2 -0.243 0.0635 0.536 regulation of immune response
xai ZNF502 3p21.31 -0.243 0.0635 0.536 regulation of
hs4 LPIN3 20q12 -0.243 0.0635 0.536 dephosphorylation;lipid metabolic
process
xai TMEM54 1p35-p34 -0.243 0.0635 0.536
his SNAR-A13 19q13.33 0.243 0.0636 0.536
his MMD 17q 0.243 0.0636 0.536 cytolysis
exp HNRNPH1P2 Xq27.3 0.243 0.0636 0.537
his FGL1 8p22 0.243 0.0636 0.537 signal transduction
his LINC01184 0.243 0.0636 0.537
xsq FGF9 13q11-q12 0.241 0.0636 0.536 positive regulation of mesenchymal
cell proliferation;male gonad development
xsq FBXO24 7q22 0.241 0.0636 0.536 protein ubiquitination
xsq LOC440704 0.241 0.0636 0.536
met WFS1 4p16.1 0.241 0.0636 0.536 sensory perception of
sound;regulation of apoptotic process
exp C12orf66 12q14.2 0.241 0.0636 0.537
xsq C2CD5 12p12.1 0.241 0.0636 0.537
cop AQP4 18q11.2-q12.1 0.241 0.0636 0.537 transport;water transport
DNA-dependent"
exp C7orf55 0.241 0.0636 0.537
exp GDF5 20q11.2 -0.241 0.0636 0.537 cell-cell signaling;cartilage
development
hs4 LOC101927311 -0.243 0.0636 0.537
his CSK 15q24.1 0.243 0.0637 0.537 Apoptosis
his MIR4513 0.243 0.0637 0.537
DNA-dependent"
his ANKRD20A3 9p12 0.243 0.0637 0.537
xai MAML3 4q28 0.243 0.0637 0.537 positive regulation of transcription from
RNA polymerase II promoter;regulation of transcription, DNA-dependent
hs4 ALOX15P1 0.243 0.0637 0.537
xsq KANSL2 12q13.11 0.241 0.0637 0.537 histone H4-K5
xsq IBA57-AS1 0.241 0.0637 0.537
exp LOC100289095 3q22.1 0.241 0.0637 0.537
xsq PEBP1 12q24.23 0.241 0.0637 0.537 regulation of neurotransmitter
xsq GNL3 3p21.1 0.241 0.0637 0.537 regulation of cell proliferation
exp MRPL57 0.241 0.0637 0.537 translation
xsq VIPR1 3p22 -0.241 0.0637 0.537 muscle contraction;immune response
xsq NPTXR 22q13.1 -0.241 0.0637 0.537 response to hydrogen peroxide
exp MAP4K3 2p22.1 -0.241 0.0637 0.537 response to
xai LOC100130442 -0.243 0.0637 0.537
exp LOC100130442 -0.243 0.0637 0.537
his IGFL3 19q13.32 -0.243 0.0637 0.537
xai PHF8 Xp11.22 0.243 0.0638 0.537 G1/S transition of mitotic cell
cycle;negative regulation of chromatin silencing at rDNA
swa NPM3 10q24.31 0.243 0.0638 0.537 rRNA transcription;rRNA processing
his CATSPER1 11q12.1 0.243 0.0638 0.537 spermatogenesis;fusion of
sperm to egg plasma membrane
xai PHBP8 0.243 0.0638 0.537
xai DCAF4L1 4p13 0.243 0.0638 0.537
exp USP5 12p13 0.241 0.0638 0.537 positive regulation of proteasomal
xsq SMARCAD1 4q22-q23 0.241 0.0638 0.537 DNA Damage Response (DDR)
met CLEC1A 12p13.2 0.241 0.0638 0.537 defense response;cell surface
xsq LEO1 15q21.2 0.241 0.0638 0.537 regulation of transcription, DNA-
xsq SMA5 5q13 0.241 0.0638 0.537
cop FAM161A 2p15 0.241 0.0638 0.537 response to stimulus;visual
perception
cop CCT4 2p15 0.241 0.0638 0.537 protein folding;cellular protein
metabolic process
cop COMMD1 2p15 0.241 0.0638 0.537 positive regulation of protein
cop B3GNT2 2p15 0.241 0.0638 0.537 post-translational protein
cop MIR5192 0.241 0.0638 0.537
cop TMEM17 2p15 0.241 0.0638 0.537 smoothened signaling pathway;cell
xsq C1QL1 17q21 -0.241 0.0638 0.537 locomotory behavior
hs4 GIPC1 19p13.1 -0.243 0.0638 0.537 protein targeting;regulation
hs4 NEU1 6p21.3 -0.243 0.0638 0.537 sphingolipid metabolic
his ZNF532 18q21.32 -0.243 0.0638 0.537 regulation of
xai SDC3 1p35.2 -0.243 0.0638 0.537 cell adhesion
xai ANXA9 1q21 -0.243 0.0638 0.537 cell-cell adhesion
xai SYNE3 14q32.13 0.243 0.0639 0.537
his SUGP1 19p13.11 0.243 0.0639 0.537 RNA splicing;gene expression
his MAU2 19p13.11 0.243 0.0639 0.537 cell cycle;chromosome segregation
xai NDUFA12 12q22 0.243 0.0639 0.537 transport;response to oxidative
stress
his RPLP1 15q22 0.243 0.0639 0.537 gene expression;viral reproduction
met ADGRG1 0.241 0.0639 0.537 cell adhesion;G-protein coupled
met ACSM5 16p12.3 0.241 0.0639 0.537 lipid metabolic process;fatty acid
metabolic process
met PALM 19p13.3 0.241 0.0639 0.537 negative regulation of adenylate
cyclase activity;protein targeting to plasma membrane
met PLEKHN1 1p36.33 0.241 0.0639 0.537
xsq CD33 19q13.3 0.241 0.0639 0.537 cell adhesion;signal transduction
xsq UPRT Xq13.3 0.241 0.0639 0.537
xsq LINC00426 13q12.3 0.241 0.0639 0.537
xsq RIMKLA 1p34.2 0.241 0.0639 0.537 protein modification process
met TMEM41A 3q27.2 0.241 0.0639 0.537
xsq LOC100506585 0.241 0.0639 0.538
dependent"
xsq MECOM 3q26.2 -0.241 0.0639 0.538 response to external
stimulus;regulation of cell proliferation
exp PDGFD 11q22.3 -0.241 0.0639 0.537 multicellular organismal
development;regulation of peptidyl-tyrosine phosphorylation
xsq PTPRK 6q22.2-q22.3 -0.241 0.0639 0.537 cell migration;focal
adhesion assembly
exp TTC9 14q24.2 -0.241 0.0639 0.537
xsq KANK1 9p24.3 -0.241 0.0639 0.537 negative regulation of actin
xai SCYL1 11q13 -0.243 0.0639 0.537 regulation of transcription, DNA-
xai RPL17P41 17q24.2 0.243 0.064 0.538
his NUDT3 6p21.2 0.243 0.064 0.538 diadenosine polyphosphate catabolic
process;diphosphoinositol polyphosphate catabolic process
his TUBA1B 12q13.12 0.243 0.064 0.538 microtubule cytoskeleton
organization;cell division
xai HEATR3 16q12.1 0.243 0.064 0.538
xai PLCH1 3q25.31 0.243 0.064 0.538 intracellular signal
xai ERCC4 16p13.12 0.243 0.064 0.538 DNA Damage Response (DDR); DDR (NER)
his TUBAL3 10p15.1 0.243 0.064 0.538 microtubule-based movement;protein
polymerization
his MIAT 22q12.1 0.243 0.064 0.538
xsq NUP107 12q15 0.241 0.064 0.538 mitotic cell cycle;viral reproduction
met ARNT2 15q24 0.241 0.064 0.538 positive regulation of transcription, DNA-
dependent;response to hypoxia
xsq PGPEP1L 15q26.3 0.241 0.064 0.538 proteolysis
exp PPA1 10q11.1-q24 0.241 0.064 0.538 tRNA aminoacylation for protein
xsq SWSAP1 19p13.2 0.241 0.064 0.538 DNA repair;DNA recombination
xsq C1R 12p13 -0.241 0.064 0.538 complement activation, classical
exp INADL 1p31.3 -0.241 0.064 0.538 intracellular signal
xsq RAB11FIP5 2p13 -0.241 0.064 0.538 protein transport
xsq ITGA1 5q11.2 -0.241 0.064 0.538 activation of MAPK
hs4 TMPRSS3 21q22.3 -0.243 0.064 0.538 sensory perception of
sound;proteolysis
his LINC02104 -0.243 0.064 0.538
swa ARMC6 19p13.11 0.243 0.0641 0.538
xai SUCNR1 3q25.1 0.243 0.0641 0.538
xai TRAIP 3p21.31 0.243 0.0641 0.538 induction of apoptosis;signal
transduction
his KCNQ5 6q14 0.243 0.0641 0.538 protein complex assembly;ion transport
xai GDF9 5q31.1 0.243 0.0641 0.538 oocyte growth;transforming growth
met CPA4 7q32 0.241 0.0641 0.538 proteolysis;histone acetylation
xsq TUBG1 17q21 0.241 0.0641 0.538 G2/M transition of mitotic cell
cycle;meiotic spindle organization
xsq TFDP2 3q23 0.241 0.0641 0.538 Apoptosis
xsq PXT1 0.241 0.0641 0.538
xsq FBXO15 18q22.3 0.241 0.0641 0.538
xsq RAVER2 1p31.3 0.241 0.0641 0.538
xsq LDHAL6A 11p15.1 0.241 0.0641 0.538 glycolysis;cellular
met TIA1 2p13 -0.241 0.0641 0.538 Apoptosis
cop CNBD1 8q21.3 -0.241 0.0641 0.538
exp FAT3 11q14.3 -0.241 0.0641 0.538 multicellular organismal
exp LOC401602 Xq21.32 -0.241 0.0641 0.538
hs4 LINC01515 -0.243 0.0641 0.538
xai DHRS12 13q14.3 -0.243 0.0641 0.538
xai RANBP20P 14q11.2 0.243 0.0642 0.538
xai TRPC7 5q31.1 0.243 0.0642 0.538 ion transport;manganese ion
transport
hs4 IRAK1 Xq28 0.243 0.0642 0.538 Apoptosis; Protein Kinases
hs4 MIR718 0.243 0.0642 0.538
xsq IGLON5 19q13.41 0.241 0.0642 0.538
mut PPIP5K2 5q21.1 0.241 0.0642 0.538 inositol metabolic process
cop PLEKHG1 6q25.1 0.241 0.0642 0.538 regulation of Rho protein
signal transduction
xsq AFF2 Xq28 0.241 0.0642 0.538 learning or memory;regulation of RNA
splicing
xsq TMIGD1 17q11.2 0.24 0.0642 0.538
met SEMA3A 7p12.1 0.24 0.0642 0.538 cell
xsq HIST1H4A 6p22.1 0.24 0.0642 0.538
xsq SACM1L 3p21.3 0.24 0.0642 0.538
xsq NGDN 14q11.2 0.24 0.0642 0.538 regulation of translation
exp FBXW10 17p12 -0.24 0.0642 0.538
xsq TOM1L2 17p11.2 -0.24 0.0642 0.538 intracellular protein
transport
exp CD58 1p13 -0.24 0.0642 0.538 Tumor Suppressors
exp TMEM200B 1p35 -0.24 0.0642 0.538
exp PVRL4 1q22-q23.2 -0.241 0.0642 0.538 adherens junction
his THY1 11q23.3 -0.243 0.0642 0.538 cytoskeleton organization;T
his PLSCR4 3q24 -0.243 0.0642 0.538 phospholipid
hs4 JAK3 19p13.1 0.242 0.0643 0.539 Oncogenes
exp RPS23P2 4q28.3 0.242 0.0643 0.539
his RNF183 9q32 0.242 0.0643 0.539
his DHRS13 17q11.2 0.242 0.0643 0.539
xai WDR83 19p13.2 0.242 0.0643 0.539 RNA splicing, via
met TCF19 6p21.3 0.24 0.0643 0.539 regulation of transcription from
RNA polymerase II promoter;cell proliferation
xsq DSTNP2 0.24 0.0643 0.539
met MARVELD1 10q24.2 -0.24 0.0643 0.539 cell cycle
xsq MIR210HG -0.24 0.0643 0.539
xsq MYO1E 15q21-q22 -0.24 0.0643 0.539 glomerular filtration;nitrogen
xsq VCAN 5q14.3 -0.24 0.0643 0.539 axon regeneration;cell adhesion
exp TBC1D9B 5q35.3 -0.24 0.0643 0.538
xai CSF1 1p13.3 -0.242 0.0643 0.539 positive regulation of gene
xai IGHV1-18 -0.242 0.0643 0.539
hs4 SLIT2 4p15.2 -0.242 0.0643 0.539 cell migration involved in
swa FAM98A 2p22.3 -0.242 0.0643 0.539
xai GPR39 2q21-q22 -0.242 0.0643 0.539 G-protein coupled receptor
signaling pathway
xai KIR2DS3 0.245 0.0644 0.539 cellular defense response
his PDCD2L 19q13.11 0.242 0.0644 0.539 cell cycle
hs4 LSM4 19p13.11 0.242 0.0644 0.539 RNA splicing;gene expression
xai NETO1 18q22.2 0.242 0.0644 0.539 visual learning;regulation of long-
his FANCC 9q22.3 0.242 0.0644 0.539 DNA Damage Response (DDR); DDR (FA)
his C9orf78 9q34.11 0.242 0.0644 0.539
his USP20 9q34.11 0.242 0.0644 0.539 protein K48-linked
dependent"
xsq OBSCN 1q42.13 0.24 0.0644 0.539 apoptotic process;small GTPase
cop AQP4-AS1 18q11.2 0.24 0.0644 0.539
exp ORC6 16q12 0.24 0.0644 0.539 DDR (DNA replication)
xsq NPR2 9p21-p12 -0.24 0.0644 0.539 cell surface receptor signaling
pathway;receptor guanylyl cyclase signaling pathway
xsq EYA4 6q23 -0.24 0.0644 0.539 DNA repair;regulation of transcription,
DNA-dependent
hs4 PRKAA2 1p31 -0.242 0.0644 0.539 Protein Kinases
hs4 LOC101929935 -0.242 0.0644 0.539
xai DYNLL1 12q24.23 -0.242 0.0644 0.539 Apoptosis
exp IGHV1-18 -0.242 0.0644 0.539
his SAMD3 6q23.1 0.242 0.0645 0.539
his TMEM200A 6q23.1 0.242 0.0645 0.539
xai PTGES2 9q34.11 0.242 0.0645 0.54 prostaglandin biosynthetic
xai IGBP1 Xq13.1-q13.3 0.242 0.0645 0.54 negative regulation of
his SNORD82 0.242 0.0645 0.54
his NCL 2q37.1 0.242 0.0645 0.54 angiogenesis
xai EIF5 14q32.32 0.242 0.0645 0.54 translational initiation;regulation
exp STX10 19p13.2 0.24 0.0645 0.539 intracellular protein
xsq MRPS27 5q13.2 0.24 0.0645 0.539
met MIR542 0.24 0.0645 0.539
xsq NUP85 17q25.1 0.24 0.0645 0.539 protein transport;transmembrane
transport
cop SALL3 18q23 0.24 0.0645 0.54 regulation of transcription, DNA-
dependent"
exp GCNT1 9q13 -0.24 0.0645 0.54 O-glycan processing;post-translational
exp KCNK2 1q41 -0.24 0.0645 0.539 ion transport;potassium ion transport
xsq SCARF2 22q11.21 -0.24 0.0645 0.539 cell adhesion
exp DSTNP3 8q21.11 -0.24 0.0645 0.539
xai MT1H -0.242 0.0645 0.54 cellular zinc ion
homeostasis;nitric oxide mediated signal transduction
his MKX-AS1 -0.242 0.0645 0.539
his MKX 10p12.1 -0.242 0.0645 0.539 multicellular organismal
xai PDIA2 16p13.3 0.242 0.0646 0.54 response to hypoxia;protein folding
xai USP19 3p21.31 0.242 0.0646 0.54 negative regulation of skeletal
muscle tissue development;proteolysis
his BRMS1L 14q13.2 0.242 0.0646 0.54 regulation of transcription,
DNA-dependent;regulation of growth"
his PROSC 8p11.2 0.242 0.0646 0.54
xai CXCR2 2q35 0.242 0.0646 0.54 dendritic cell chemotaxis;neutrophil
chemotaxis
xsq GPR174 Xq21.1 0.24 0.0646 0.54
met CITED1 Xq13.1 0.24 0.0646 0.54 branching involved in
ureteric bud morphogenesis;cell proliferation
cop CDH18 5p14.3 -0.24 0.0646 0.54 adherens junction
organization;cell-cell junction organization
his ZNRF3-AS1 -0.242 0.0646 0.54
xai FAM20C 7p22.3 -0.242 0.0646 0.54
his MIR4729 -0.242 0.0646 0.54
his LINC01426 -0.242 0.0646 0.54
hs4 RSPH4A 6q22.1 -0.242 0.0646 0.54 cilium axoneme
assembly;cilium movement
xai TTC24 1q23.1 0.242 0.0647 0.54
xai RET 10q11.2 0.242 0.0647 0.54 Oncogenes
xai PLAGL2 20q11.21 0.242 0.0647 0.54 positive regulation of
dependent
hs4 ENDOG 9q34.1 0.242 0.0647 0.54 response to antibiotic;in utero
xai RPF2P2 4q26 0.242 0.0647 0.54
his NDUFA10 2q37.3 0.242 0.0647 0.54 transport;respiratory
met RERGL 12p12.3 0.24 0.0647 0.54 small GTPase mediated signal
met FAM109B 22q13.2 0.24 0.0647 0.54 endosome
xsq OTOA 16p12.2 0.24 0.0647 0.54 sensory perception of sound
xsq LOC101928241 0.24 0.0647 0.54
xsq ALS2CL 3p21.31 -0.24 0.0647 0.54 endosome
organization;regulation of Rho protein signal transduction
exp SASH1 6q24.3 -0.24 0.0647 0.54
xai DDX58 9p12 -0.242 0.0647 0.54 innate immune response;positive
xai MT3 16q13 -0.242 0.0647 0.54 energy reserve metabolic
process;positive regulation of necrotic cell death
xai LGALSL 2p14 -0.242 0.0647 0.54
exp RPF2P2 4q26 0.242 0.0648 0.54
his NSMF 9q34.3 0.242 0.0648 0.54
his YWHAH 22q12.3 0.242 0.0648 0.541 Apoptosis
his C22orf24 22q12.1-q12.3 0.242 0.0648 0.541
his KNSTRN 15q15.1 0.242 0.0648 0.541
exp DNAJA2 16q12.1 0.24 0.0648 0.54 protein folding;positive
exp LINC00909 18q22.3 0.24 0.0648 0.54
exp CCDC75P1 3p13 0.24 0.0648 0.54
xsq C6orf163 6q15 0.24 0.0648 0.54
exp HSP90AB1 6p12 0.24 0.0648 0.541 Apoptosis
met MAP3K7CL 21q22.3 0.24 0.0648 0.541
xsq TLE3 15q22 0.24 0.0648 0.541 regulation of transcription, DNA-
dependent;signal transduction
exp PIEZO1 16q24.3 0.24 0.0648 0.541 ion transport;positive
xsq IQSEC2 Xp11.22 -0.24 0.0648 0.541 regulation of ARF protein
signal transduction
exp LRRN1 3p26.2 -0.24 0.0648 0.54
his DIRC3-AS1 -0.242 0.0648 0.541
his ATOX1 5q32 -0.242 0.0648 0.541 ion transport;copper ion transport
xai LOC100506901 -0.242 0.0648 0.541
hs4 KLC3 19q13 -0.242 0.0648 0.541 metabolic process
hs4 POU2F3 11q23.3 -0.242 0.0648 0.54 epidermis
development;keratinocyte differentiation
his SPAG1 8q22.2 -0.242 0.0648 0.54 single fertilization
his YIPF3 6p21.1 0.242 0.0649 0.541 cell differentiation
his POLR1C 6p21.1 0.242 0.0649 0.541 DNA Damage Response (DDR)
exp RPL7P45 13q33.2 0.242 0.0649 0.541
his LOC100131347 17q12 0.242 0.0649 0.541
DNA-dependent"
his NTN3 16p13.3 0.242 0.0649 0.541 axon guidance;muscle cell
differentiation
his TBC1D24 16p13.3 0.242 0.0649 0.541 neuron projection development
xai INO80 15q15.1 0.242 0.0649 0.541 DNA Damage Response (DDR); DDR
(Chromatin)
xsq NIPBL-AS1 0.24 0.0649 0.541
xsq LINC01346 0.24 0.0649 0.541
met EXT1 8q24.11 0.24 0.0649 0.541 axon guidance;brain development
xsq CHKB-CPT1B 0.24 0.0649 0.541
met ARSE Xp22.3 0.24 0.0649 0.541 skeletal system development
xsq LOC338694 0.24 0.0649 0.541
exp ACOT4 14q24.3 -0.24 0.0649 0.541 unsaturated monocarboxylic acid
metabolic process;very long-chain fatty acid metabolic process
met HEYL 1p34.3 -0.24 0.0649 0.541 multicellular organismal
xsq KLF7 2q32 -0.24 0.0649 0.541 regulation of transcription from RNA
polymerase II promoter;axon guidance
met TMEM88B 1p36.33 -0.24 0.0649 0.541
exp GAB1 4q31.21 -0.24 0.0649 0.541 epidermal growth factor receptor
signaling pathway;cell proliferation
cop RNPEP 1q32 -0.24 0.0649 0.541 retina development in camera-type
eye;proteolysis
exp AMY2A -0.242 0.0649 0.541 carbohydrate catabolic
process;polysaccharide digestion
his PCED1B 12q13.11 -0.242 0.0649 0.541
his AMIGO2 12q13.11 -0.242 0.0649 0.541 anti-apoptosis;cell
adhesion
xai LOC100506813 -0.242 0.0649 0.541
hs4 CARD14 17q25 -0.242 0.0649 0.541 positive regulation of
xai C18orf21 18q12.2 0.242 0.065 0.541
xai CHRNB3 8p11.2 0.242 0.065 0.541 ion transport;signal transduction
exp SNORA80E 0.242 0.065 0.541
xai FGFR1OP2 12p11.23 0.242 0.065 0.541 response to wounding
mut CPSF7 11q12.2 0.24 0.065 0.541 protein tetramerization;nuclear mRNA
xsq RNASEH1 2p25 0.24 0.065 0.541 DDR (DNA replication)
xsq SAAL1 11p15.1 0.24 0.065 0.541 acute-phase response
xsq LOC101928516 -0.24 0.065 0.541
exp SYNJ2BP 14q24.2 -0.24 0.065 0.541 intracellular distribution of
mitochondria
exp FAM214B 9p13.3 -0.24 0.065 0.541
hs4 CRIM1 2p21 -0.242 0.065 0.541 regulation of cell growth;nervous system
development
hs4 LOC100288911 2p22.3 -0.242 0.065 0.541
hs4 LINC01564 -0.242 0.065 0.541
hs4 FRK 6q21-q22.3 -0.242 0.065 0.541 negative regulation of cell
proliferation;cell differentiation
hs4 APP 21q21.3 -0.242 0.065 0.541 Apoptosis
swa RAD23A 19p13.2 0.242 0.0651 0.541 DNA Damage Response (DDR);
DDR (NER)
xai IGHV1OR15-1 15q11.2 0.242 0.0651 0.542 immune response
swa EIF4A1 17p13 0.242 0.0651 0.542 translational initiation;gene
expression
xai POLR2B 4q12 0.242 0.0651 0.542 DNA Damage Response (DDR); DDR
(NER)
his PHF21A 11p11.2 0.242 0.0651 0.542 suckling behavior;regulation
xsq CCDC138 2q12.3 0.24 0.0651 0.542
xsq ZNF18 17p11.2 0.24 0.0651 0.542 viral reproduction
xsq ELF2 4q28 0.24 0.0651 0.542 Transcription Factors
exp RPL21P94 11p15 0.24 0.0651 0.542
mut CDH8 16q22.1 0.24 0.0651 0.542 cell adhesion;homophilic cell
adhesion
exp KBTBD11 8p23.3 0.24 0.0651 0.542
xsq PRKRIP1 7q22.1 0.24 0.0651 0.542 negative regulation of
phosphorylation;negative regulation of protein kinase activity
exp METRNL 17q25.3 -0.24 0.0651 0.541
hs4 MTMR11 1q12-q21 -0.242 0.0651 0.542
xai AMY2A -0.242 0.0651 0.542 carbohydrate catabolic
xai TANC2 17q23.3 -0.242 0.0651 0.541
his CEP85 1p36.11 0.242 0.0652 0.542
xai LINC00269 0.242 0.0652 0.542
xai MC4R 18q22 0.242 0.0652 0.542 positive regulation of cAMP biosynthetic
his FAM212A 3p21.31 0.242 0.0652 0.542
his MIR5193 0.242 0.0652 0.542
xsq DGKE 17q22 0.24 0.0652 0.542 activation of protein kinase C activity
by G-protein coupled receptor protein signaling pathway;blood coagulation
exp CXCL9 4q21 0.24 0.0652 0.542 immune response;cellular defense response
xsq OR4D1 0.24 0.0652 0.542
mir hsa-miR-374a 0.24 0.0652 0.542
exp FADS2 11q12.2 0.24 0.0652 0.542 unsaturated fatty acid biosynthetic
process;transport
xsq MIR17HG 13q31.3 0.24 0.0652 0.542
xsq CYP7B1 8q21.3 -0.24 0.0652 0.542 memory;positive regulation of
met KRTAP5-6 11p15.5 -0.24 0.0652 0.542
exp RAB20 13q34 -0.24 0.0652 0.542 small GTPase mediated signal
his RBM5 3p21.3 0.242 0.0653 0.542 RNA splicing;gene expression
xai SNORA80E 0.242 0.0653 0.542
xai FAM86EP 4p16.3 0.242 0.0653 0.542
xai ETFA 15q23-q25 0.242 0.0653 0.542 transport;respiratory electron
transport chain
xai RAB8A 19p13.1 0.242 0.0653 0.542 vesicle docking involved in
his ZW10 11q23.2 0.242 0.0653 0.542 DNA Damage Response (DDR)
xsq NDUFV2 18p11.22 0.24 0.0653 0.542 mitochondrial electron
cop PRC1 15q26.1 0.24 0.0653 0.542 cell cycle;mitotic spindle
elongation
xsq H3F3AP4 2q31.1 0.24 0.0653 0.542
xsq FAM99B 0.24 0.0653 0.542
xsq PAXIP1 7q36 0.24 0.0653 0.542 DNA Damage Response (DDR); DDR (HR)
xsq RSL24D1 15q21 0.24 0.0653 0.542 translation;ribosome biogenesis
exp RCL1 9p24.1-p23 0.24 0.0653 0.542 RNA processing;ribosome biogenesis
exp KIF1A 2q37.3 0.239 0.0653 0.542 microtubule-based
exp YBEY 21q22.3 0.239 0.0653 0.542
xsq LOC340512 -0.239 0.0653 0.542
exp TP53INP1 8q22 -0.239 0.0653 0.542 apoptotic process;induction
of apoptosis
xsq SSC5D 19q13.42 -0.24 0.0653 0.542
xsq SMAD1-AS1 -0.24 0.0653 0.542
met MIR1238 -0.24 0.0653 0.542
hs4 LINC02104 -0.242 0.0653 0.542
xai HABP4 9q22.3-q31 -0.242 0.0653 0.542 cellular response to
mechanical stimulus;platelet degranulation
xai GPC4 Xq26.1 -0.242 0.0653 0.542 cell proliferation;anatomical
his AP3M1 10q22.2 0.242 0.0654 0.542 protein targeting to
his ADK 10q22 0.242 0.0654 0.542 purine base metabolic process;adenosine
metabolic process
xai PRTN3 19p13.3 0.242 0.0654 0.542 proteolysis;positive regulation of
cell proliferation
his SELENOF 0.241 0.0654 0.542
his HS2ST1 1p22.3 0.241 0.0654 0.542 heparin metabolic
process;ureteric bud formation
xai DUS3L 19p13.3 0.241 0.0654 0.542 tRNA processing
his PHACTR3 20q13.32-q13.33 0.241 0.0654 0.542
xai HMGA1P8 2p13.1 0.241 0.0654 0.542
xsq DNAJC2 7q22 0.239 0.0654 0.542 positive regulation of
met LRRC28 15q26.3 0.239 0.0654 0.542
exp CPSF2 14q31.1 0.239 0.0654 0.542 gene expression;nuclear mRNA
xsq LINC00343 0.239 0.0654 0.542
exp FBXL15 10q24.32 0.239 0.0654 0.542 protein ubiquitination;bone
mineralization
xsq ASCC1 10pter-q25.3 0.239 0.0654 0.542 regulation of transcription,
DNA-dependent"
xsq FXYD4 10q11.21 0.239 0.0654 0.542 ion transport
exp PRKX Xp22.3 0.239 0.0654 0.542 cell adhesion;protein
autophosphorylation
cop SLC12A3 16q13 0.239 0.0654 0.542 Solute Carriers
xsq RPL18A 19p13 0.239 0.0654 0.542 translational initiation;viral
infectious cycle
met FZD1 7q21 0.239 0.0654 0.542 Oncogenes
met PELO 5q11.2 0.239 0.0654 0.542 cell cycle;cell proliferation
xsq CLIC3 9q34.3 -0.239 0.0654 0.542 ion transport;chloride
transport
xsq MGLL 3q21.3 -0.239 0.0654 0.542 regulation of signal
transduction;regulation of sensory perception of pain
hs4 ZNF750 17q25.3 -0.241 0.0654 0.542
xai VEZF1P1 3q29 -0.241 0.0654 0.542
hs4 COL2A1 12q13.11 -0.241 0.0654 0.542 heart
morphogenesis;notochord development
his RBPMS 8p12 -0.241 0.0654 0.542 regulation of transcription, DNA-
his RBPMS-AS1 8p12 -0.241 0.0654 0.542
swa RABEPK 9q33.3 -0.241 0.0654 0.542 receptor-mediated
exp HMGA1P8 2p13.1 0.241 0.0655 0.543
xai FGD3 0.241 0.0655 0.543 regulation of Cdc42 GTPase
xai RPL31P35 7p11.2 0.241 0.0655 0.543
xsq LINC01184 0.239 0.0655 0.542
met FBXO32 8q24.13 0.239 0.0655 0.542 muscle atrophy
cop HERPUD1 16q13 0.239 0.0655 0.543 cellular calcium ion
homeostasis;response to stress
xsq NPVF 7p21-p15 0.239 0.0655 0.543 neuropeptide signaling
pathway;sensory perception of pain
xsq LOC101927666 0.239 0.0655 0.543
met HMGN5 Xq13.3 0.239 0.0655 0.543 regulation of transcription, DNA-
exp TRNAV37P -0.239 0.0655 0.543
xai GCNT1 9q13 -0.241 0.0655 0.543 O-glycan processing;post-
hs4 MAP4K4 2q11.2-q12 -0.241 0.0655 0.543 response to
hs4 UGT3A1 5p13.2 -0.241 0.0655 0.543 metabolic process
hs4 LGR4 11p14-p13 -0.241 0.0655 0.543 male genitalia
development;metanephric nephron tubule morphogenesis
hs4 LOC105376671 -0.241 0.0655 0.543
exp SSTR3 22q13.1 0.241 0.0656 0.543 cell-cell signaling;cellular
his PPM1D 17q23.2 0.241 0.0656 0.543 DNA Damage Response (DDR)
xai TPTEP1 22q11.1 0.241 0.0656 0.543
xai FOXN4 12q24.11 0.241 0.0656 0.543 neuron fate commitment;axon
extension
xai MARK3 14q32.32 0.241 0.0656 0.543
his LOC102723526 0.241 0.0656 0.543
exp LINC00269 0.241 0.0656 0.543
xai ANGEL1 14q24.3 0.241 0.0656 0.543
swa EIF3F 11p15.4 0.241 0.0656 0.543 translation;translational
initiation
exp LINC00526 18p11.31 0.239 0.0656 0.543
exp ZNF282 7q36.1 0.239 0.0656 0.543 negative regulation of
mut WDFY3 4q21.23 0.239 0.0656 0.543 metabolic process
xsq LINC00305 18q22.1 0.239 0.0656 0.543
exp C12orf42 12q23.2 0.239 0.0656 0.543
exp TRMT10C 3q12.3 0.239 0.0656 0.543
cop ATP13A4 3q29 -0.239 0.0656 0.543 cation transport;ATP
xsq MEDAG 13q12.3 -0.239 0.0656 0.543
xai KIAA1671 22q11.23 -0.241 0.0656 0.543
xai GDPD5 11q13.4-q13.5 -0.241 0.0656 0.543 glycerol metabolic
xai GAB1 4q31.21 -0.241 0.0656 0.543 epidermal growth factor
receptor signaling pathway;cell proliferation
his NDP Xp11.4 -0.241 0.0656 0.543 visual perception;canonical
Wnt receptor signaling pathway
hs4 MIRLET7BHG 22q13.31 -0.241 0.0656 0.543
hs4 MIR3619 -0.241 0.0656 0.543
xai FAM21C 10q11.1 -0.241 0.0656 0.543 transport;retrograde
transport, endosome to Golgi"
his TMEM262 0.241 0.0657 0.543
xai TOMM22 22q12-q13 0.241 0.0657 0.543 intracellular protein
xai VWA3A 16p12.2 0.241 0.0657 0.543
his PRKX Xp22.3 0.241 0.0657 0.543 cell adhesion;protein
autophosphorylation
xai ERLEC1P1 21q11.2 0.241 0.0657 0.543
xai PPM1D 17q23.2 0.241 0.0657 0.543 DNA Damage Response (DDR)
met GNPTG 16p13.3 0.239 0.0657 0.543
xsq ANKRD34B 5q14.1 0.239 0.0657 0.543
exp DUS4L 7q22-q31 0.239 0.0657 0.543 tRNA processing
met TMEM144 4q32.1 0.239 0.0657 0.543
met CLIP3 19q13.12 0.239 0.0657 0.543 negative regulation of microtubule
polymerization;positive regulation of apoptotic process
met C6orf47 6p21.3 0.239 0.0657 0.543
xsq FBXO31 16q24.2 0.239 0.0657 0.543 response to DNA damage
stimulus;cell cycle
cop NLRC5 16q13 0.239 0.0657 0.543 defense response to virus;positive
regulation of interferon-gamma-mediated signaling pathway
xsq UCP2 11q13 0.239 0.0657 0.543 transport;small molecule metabolic
process
xsq CLDN34 -0.239 0.0657 0.543
exp RAB11FIP4 17q11.2 -0.239 0.0657 0.543 cytokinesis;transport
exp SH2D4A 8p21.2 -0.239 0.0657 0.543 negative regulation of
exp FAIM 3q22.3 -0.239 0.0657 0.543 Apoptosis
exp TBC1D12 10q23.33 -0.239 0.0657 0.543
xai DISP1 1q41 -0.241 0.0657 0.543 diaphragm development;smoothened
signaling pathway
xai ELMSAN1 14q24.3 -0.241 0.0657 0.543
his FAM117A 17q21.33 0.241 0.0658 0.543
his OST4 2p23.3 0.241 0.0658 0.543
his EMILIN1 2p23.3-p23.2 0.241 0.0658 0.543 cell adhesion;positive
regulation of cell-substrate adhesion
exp SLC25A5P3 7p11.2 0.241 0.0658 0.543 Solute Carriers
his RFC1 4p14-p13 0.241 0.0658 0.544 DNA Damage Response (DDR); DDR
his XPA 9q22.3 0.241 0.0658 0.544 DNA Damage Response (DDR); DDR
(NER)
cop NUP93 16q13 0.239 0.0658 0.543 regulation of glucose transport;protein
transport
cop MIR138-2 0.239 0.0658 0.543
mir hsa-miR-450a 0.239 0.0658 0.544
mir hsa-miR-450a(2) 0.239 0.0658 0.544
xsq LGSN 6pter-q22.33 0.239 0.0658 0.544 glutamine biosynthetic
cop HERPUD2 7p14.2 -0.239 0.0658 0.544 response to unfolded
exp PRRG1 Xp21.1 -0.239 0.0658 0.543
DNA-dependent"
his RRAS2 11p15.2 -0.241 0.0658 0.544 GTP catabolic process;signal
transduction
hs4 USP18 22q11.21 -0.241 0.0658 0.543 proteolysis;ubiquitin-
dependent protein catabolic process
exp LOC100507412 0.241 0.0659 0.544
xai AGPAT5 8p23.1 0.241 0.0659 0.544 metabolic
xai TMEM134 11q13.2 0.241 0.0659 0.544
met IL17RB 3p21.1 0.239 0.0659 0.544 regulation of cell
growth;defense response
met ZKSCAN3 6p22.1 0.239 0.0659 0.544 viral reproduction;positive
regulation of transcription, DNA-dependent"
exp HIST1H3C 6p22.1 0.239 0.0659 0.544
xsq ENKUR 10p12.1 0.239 0.0659 0.544
exp CD5 11q13 0.239 0.0659 0.544 induction of apoptosis by extracellular
exp H1FX 3q21.3 0.239 0.0659 0.544 nucleosome assembly
exp PSTPIP1 15q24.3 0.239 0.0659 0.544 cell adhesion;signal
transduction
exp UEVLD 11p15.1 -0.239 0.0659 0.544 protein modification
met PYCR2 1q42.12 -0.239 0.0659 0.544 proline biosynthetic
xsq NCKAP1 2q32 -0.239 0.0659 0.544 Apoptosis
xsq GLMP -0.239 0.0659 0.544 intracellular receptor mediated
promoter
xai PRRG1 Xp21.1 -0.241 0.0659 0.544
his DOK7 4p16.3 -0.241 0.0659 0.544 positive regulation of
his TMEM45A 3q12.2 -0.241 0.0659 0.544
his LOC100506725 -0.241 0.0659 0.544
his C8orf31 8q24.3 -0.241 0.0659 0.544
hs4 HMOX1 22q13.1 -0.241 0.0659 0.544 negative regulation of
leukocyte migration;small GTPase mediated signal transduction
his IQCH-AS1 0.241 0.066 0.544
his C15orf61 15q23 0.241 0.066 0.544
his POT1-AS1 0.241 0.066 0.544
his POT1 7q31.33 0.241 0.066 0.544 DNA Damage Response (DDR)
his SLCO1A2 12p12 0.241 0.066 0.544 Solute Carriers
swa EFHD2 1p36.21 0.241 0.066 0.544
his ALOX12P2 17p13 0.241 0.066 0.544
xsq CFC1B 0.239 0.066 0.544
xsq UCN3 10p15.1 0.239 0.066 0.544
cop MT1H 0.239 0.066 0.544 cellular zinc ion homeostasis;nitric oxide
cop MT1IP 16q13 0.239 0.066 0.544
cop MT1X 16q13 0.239 0.066 0.544 response to metal ion;cellular response to
erythropoietin
exp HEXDC 17q25.3 0.239 0.066 0.544 carbohydrate metabolic process
met DEFB116 20q11.21 0.239 0.066 0.544 defense response to bacterium
exp LOC400036 12q13.13 0.239 0.066 0.544
met CLCN4 Xp22.3 0.239 0.066 0.544 chloride transport;transmembrane
transport
xsq CAV1 7q31.1 -0.239 0.066 0.544 vasculogenesis;skeletal muscle
tissue development
xai SPTBN5 15q21 -0.241 0.066 0.544 axon guidance;actin cytoskeleton
organization
hs4 C8orf58 8p21 -0.241 0.066 0.544
his LINC01787 -0.241 0.066 0.544
his C11orf91 11p13 -0.241 0.066 0.544
xai FLVCR1 1q32.3 0.241 0.0661 0.544 heme transport;head
morphogenesis
his HYAL3 3p21.3 0.241 0.0661 0.544 response to antibiotic;cartilage
development
his NAT6 3p21.3 0.241 0.0661 0.544
his HYAL1 3p21.31 0.241 0.0661 0.544 response to virus;positive
xai PTX4 16p13.3 0.241 0.0661 0.544
his CEP104 1p36.32 0.241 0.0661 0.544
his DFFB 1p36.3 0.241 0.0661 0.544 Apoptosis
his SH2D1A Xq25 0.241 0.0661 0.545 humoral immune response;cellular
defense response
xai CNOT8 5q31-q33 0.241 0.0661 0.545 gene expression;RNA metabolic
process
xai VPREB1 0.241 0.0661 0.545 immune response
xai BAHCC1 17q25.3 0.241 0.0661 0.545
xsq ANKRD13D 11q13.2 0.239 0.0661 0.544
exp RRN3 16p12 0.239 0.0661 0.544 regulation of transcription, DNA-
exp SUSD3 9q22.31 0.239 0.0661 0.545
xsq DNPH1 6p21.1 0.239 0.0661 0.545
xsq TNFRSF8 1p36 0.239 0.0661 0.545 Apoptosis
exp MARCH1 4q32.2 -0.239 0.0661 0.545 protein
class II
xsq PLSCR1 3q23 -0.239 0.0661 0.545 apoptotic process;positive
exp RNF185 22q12.2 -0.239 0.0661 0.544 autophagy
his ALS2CR12 2q33.1 -0.241 0.0661 0.544 regulation of GTPase
activity
xai SLC7A6OS 16q22.1 0.241 0.0662 0.545 Solute Carriers
his PLCL1 2q33 0.241 0.0662 0.545 lipid metabolic process;behavior
xai CYMP 1p13.3 0.241 0.0662 0.545
xai PWRN2 15q11.2 0.241 0.0662 0.545
his ZKSCAN5 7q22 0.241 0.0662 0.545 regulation of transcription, DNA-
his ATAD1 10q23.31 0.241 0.0662 0.545 positive regulation of receptor
internalization;ATP catabolic process
his CFL1P1 10q23.31 0.241 0.0662 0.545
exp HSPD1 2q33.1 0.239 0.0662 0.545 Apoptosis
mut STOML3 13q13.3 0.239 0.0662 0.545
xsq CLPP 19p13.3 0.239 0.0662 0.545 proteolysis
exp PARP8 5q11.1 0.239 0.0662 0.545
exp DYM 18q21.1 0.239 0.0662 0.545
xsq ACOT4 14q24.3 -0.239 0.0662 0.545 unsaturated monocarboxylic
acid metabolic process;very long-chain fatty acid metabolic process
his DZIP1L 3q22.3 -0.241 0.0662 0.545
xai CLIP2 7q11.23 -0.241 0.0662 0.545
his LINC01331 -0.241 0.0662 0.545
xai RNASE2 14q11.2 0.241 0.0663 0.545 RNA catabolic
process;chemotaxis
xai EIF2B4 2p23.3 0.241 0.0663 0.545 gene expression;cellular
his NUP133 1q42.13 0.241 0.0663 0.545 carbohydrate metabolic
his LOC101927478 0.241 0.0663 0.545
his ZRANB3 2q21.3 0.241 0.0663 0.545 DNA Damage Response (DDR)
his R3HDM1 2q21.3 0.241 0.0663 0.545
xai BEST3 12q14.2-q15 0.241 0.0663 0.545 ion transmembrane
transport;negative regulation of ion transport
xai LINC00987 0.241 0.0663 0.545
his MKNK1 1p33 0.241 0.0663 0.545 Protein Kinases
exp RBM38 20q13.31 0.239 0.0663 0.545 DNA damage response, signal
mediator;cell cycle
xsq CD244 1q23.3 0.239 0.0663 0.545 leukocyte migration;signal
transduction
xsq THEMIS2 1p35.3 0.239 0.0663 0.545
xsq TMEM101 17q21.31 0.239 0.0663 0.545 signal transduction;positive
xsq HNRNPA3P1 10q11.21 0.239 0.0663 0.545
exp BANP 16q24 0.239 0.0663 0.545 multicellular organismal
development;chromatin modification
exp MRPL2P1 12q21.33 -0.239 0.0663 0.545
exp RNF152 18q21.33 -0.239 0.0663 0.545 apoptotic
process;protein K48-linked ubiquitination
hs4 C2orf70 2p23.3 -0.241 0.0663 0.545
xai DMXL2 15q21.2 0.241 0.0664 0.545
hs4 POLE2 14q21-q22 0.241 0.0664 0.545 DNA Damage Response (DDR); DDR
his NDUFA6-AS1 22q13.2 0.241 0.0664 0.545
his NDUFA6 22q13.2 0.241 0.0664 0.545 response to oxidative
his RRN3 16p12 0.241 0.0664 0.545 regulation of transcription, DNA-
his LOC100505915 0.241 0.0664 0.545
his PARK7 1p36.23 0.241 0.0664 0.545 proteolysis;hydrogen peroxide
metabolic process
his INO80C 18q12.2 0.241 0.0664 0.545 DNA Damage Response (DDR);
DDR (Chromatin)
xai DNAJC8 1p35.3 0.241 0.0664 0.545 nuclear mRNA splicing, via
his KCNAB2 1p36.3 0.241 0.0664 0.545 potassium ion
his NPHP4 1p36 0.241 0.0664 0.545 signal transduction;visual behavior
DNA-dependent"
xai LOC100288358 16q23.1 0.241 0.0664 0.545
met ARL9 4q12 0.239 0.0664 0.545 small GTPase mediated signal transduction
met MIR564 0.239 0.0664 0.545
cop PLEK 2p13.3 0.239 0.0664 0.545 integrin-mediated signaling
xsq GOLGA8CP 15q11.2 0.239 0.0664 0.545
exp SUN1 7p22.3 -0.239 0.0664 0.545 cytoskeletal anchoring at
nuclear membrane;nuclear matrix anchoring at nuclear membrane
xsq NKX3-1 8p21.2 -0.239 0.0664 0.545 DNA Damage Response
(DDR)
hs4 RBFOX2 22q13.1 -0.241 0.0664 0.545 RNA splicing;regulation
his LINC01618 -0.241 0.0664 0.545
hs4 EGF 4q25 -0.241 0.0664 0.545 Apoptosis
exp GAPDHP21 10q21.1 0.241 0.0665 0.545
xai TAF1A 1q42 0.241 0.0665 0.546 transcription from RNA polymerase I
promoter;transcription initiation from RNA polymerase I promoter
exp LINC00987 0.241 0.0665 0.546
his PRPF40A 2q23.3 0.241 0.0665 0.546 cell cycle;regulation of cell
shape
his ARL6IP6 2q23.3 0.241 0.0665 0.546
his RETSAT 2p11.2 0.241 0.0665 0.546 retinol metabolic
his ELMOD3 2p11.2 0.241 0.0665 0.546 phagocytosis
hs4 ARRDC2 19p13.11 0.24 0.0665 0.546
his NSD2 0.24 0.0665 0.546
exp LOC100288358 16q23.1 0.24 0.0665 0.546
exp MRPL46 15q25.3 0.239 0.0665 0.546
xsq NUP37 12q23.2 0.239 0.0665 0.546 mitotic cell cycle;cytokine-
xsq GTF2H2B 5q13.2 0.238 0.0665 0.546
met FAM213A 10q23.1 0.238 0.0665 0.546 regulation of osteoclast
xsq LOC284933 0.238 0.0665 0.546
mda MutSig6_MMR_MSI 0.238 0.0665 0.546
mut PLXNA1 3q21.3 0.238 0.0665 0.546 signal
exp CHRDL1 Xq23 -0.238 0.0665 0.546 nervous system
xsq LINC01279 -0.239 0.0665 0.546
xai TTC9 14q24.2 -0.241 0.0665 0.546
hs4 RSAD2 2p25.2 -0.241 0.0665 0.546 regulation of
ossification;defense response to virus
his PSG5 19q13.2 -0.241 0.0665 0.546 female pregnancy
his NAV2-AS2 -0.241 0.0665 0.546
xai CARD14 17q25 -0.241 0.0665 0.546 positive regulation of
hs4 MTUS1 8p22 -0.241 0.0665 0.546
his LINC00957 7p13 0.24 0.0666 0.546
his RASA4CP 0.24 0.0666 0.546
xai PPP1R1C 2q31.3 0.24 0.0666 0.546 signal transduction
his PPP1R3D 20q13.3 0.24 0.0666 0.546 regulation of glycogen
catabolic process;carbohydrate metabolic process
his FAM217B 20q13.33 0.24 0.0666 0.546
exp IRGM 5q33.1 0.24 0.0666 0.546 autophagy;inflammatory response
xai SFSWAP 12q24.33 0.24 0.0666 0.546 RNA splicing;negative
his UTP14A Xq26.1 0.24 0.0666 0.546 rRNA processing
his C1orf174 1p36.32 0.24 0.0666 0.546
his LINC01134 0.24 0.0666 0.546
his MED26 19p13.11 0.24 0.0666 0.546 regulation of transcription from
xsq ATAD5 17q11.2 0.238 0.0666 0.546 DNA Damage Response (DDR)
exp OXSM 3p24.2 0.238 0.0666 0.546 acyl-CoA metabolic process;short-
xsq TYROBP 19q13.1 0.238 0.0666 0.546 cellular defense
exp TSHZ1 18q22.3 0.238 0.0666 0.546 multicellular organismal
cop B4GALT6 18q11 0.238 0.0666 0.546 post-translational protein
cop SLC25A52 18q12.1 0.238 0.0666 0.546
met PHACTR3 20q13.32-q13.33 0.238 0.0666 0.546
met GNB1L 22q11.2 0.238 0.0666 0.546 G-protein coupled receptor
signaling pathway;social behavior
xsq LOC101929023 -0.238 0.0666 0.546
xsq IDO1 8p12-p11 -0.238 0.0666 0.546 female pregnancy;cellular
swa CLIC4 1p36.11 -0.24 0.0666 0.546 ion transport;chloride transport
swa SFT2D2 1q24.2 -0.24 0.0666 0.546 protein transport;vesicle-
mediated transport
hs4 MRPL36 5p15.3 0.24 0.0667 0.546 translation
hs4 NDUFS6 5p15.33 0.24 0.0667 0.546 transport;respiratory
his HNRNPDL 4q21.22 0.24 0.0667 0.546
his ENOPH1 4q21.22 0.24 0.0667 0.546 sulfur amino acid metabolic
his WDR18 19p13.3 0.24 0.0667 0.546 multicellular organismal
development
xai DARS2 1q25.1 0.24 0.0667 0.546 tRNA aminoacylation for protein
hs4 SPAG5 17q11.2 0.24 0.0667 0.546 regulation of attachment of spindle
hs4 SPAG5-AS1 0.24 0.0667 0.546
xai DCUN1D1 3q26.3 0.24 0.0667 0.546
his LOC105376114 0.24 0.0667 0.546
his UBQLN1 9q22 0.24 0.0667 0.546 response to hypoxia;apoptotic
process
exp SSR4 Xq28 0.238 0.0667 0.546 translation;SRP-dependent cotranslational
exp MS4A3 11q12.1 0.238 0.0667 0.546
exp DMXL2 15q21.2 0.238 0.0667 0.546
mut ALMS1 2p13 0.238 0.0667 0.546 sensory perception of sound;epithelial
cell proliferation
xsq MTA2 11q12-q13.1 0.238 0.0667 0.546 negative regulation of
exp RNASE2 14q11.2 0.238 0.0667 0.546 RNA catabolic
process;chemotaxis
xsq LOC101928269 0.238 0.0667 0.546
exp MED29 19q13.2 -0.238 0.0667 0.546 regulation of transcription,
DNA-dependent"
exp SDC3 1p35.2 -0.238 0.0667 0.546 cell adhesion
xsq ARVCF 22q11.21 -0.238 0.0667 0.546 cell adhesion;multicellular
xai LINC00639 14q21.1 -0.24 0.0667 0.546
xai GJA6P -0.24 0.0667 0.546
hs4 DGCR5 22q11 -0.24 0.0667 0.546
xai WFDC21P -0.24 0.0667 0.546
his C1QTNF7 4p15.3 -0.24 0.0667 0.546
xai MT1HL1 1q43 -0.24 0.0667 0.546
xai HIC2 22q11.21 0.24 0.0668 0.546 negative regulation of
his NME6 3p21 0.24 0.0668 0.546 Apoptosis
xai SLC25A5P3 7p11.2 0.24 0.0668 0.546 Solute Carriers
his POLR1B 2q13 0.24 0.0668 0.546 transcription elongation from RNA
his LOC105373562 0.24 0.0668 0.546
his FMNL1 17q21 0.24 0.0668 0.546 substrate-dependent cell
exp CYMP 1p13.3 0.24 0.0668 0.546
his HIST1H2BE 6p22.1 0.24 0.0668 0.546
his HIST1H4D 6p22.1 0.24 0.0668 0.546
his HIST1H3D 6p22.1 0.24 0.0668 0.546
his HIST1H2AD 6p21.3 0.24 0.0668 0.546
his HIST1H2BF 6p22.1 0.24 0.0668 0.546
his HIST1H4E 6p22.1 0.24 0.0668 0.546
xsq UGT2B17 0.238 0.0668 0.546
xsq ZBTB20-AS4 0.238 0.0668 0.546
xsq AAGAB 15q22.33-q23 0.238 0.0668 0.546 protein transport
xsq SCRN1 7p14.3-p14.1 -0.238 0.0668 0.546 proteolysis;exocytosis
xsq ASAP1 8q24.1-q24.2 -0.238 0.0668 0.546 signal transduction;cell
hs4 SEMA3B-AS1 -0.24 0.0668 0.546
hs4 IGFN1 1q32.1 -0.24 0.0668 0.546
xai TGFB1 19q13.1 0.24 0.0669 0.546 Apoptosis; DDR (DNA replication);
Tumor Suppressors
xai GLCCI1 7p21.3 0.24 0.0669 0.546
swa ETF1 5q31.1 0.24 0.0669 0.546 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;cellular protein metabolic process
swa NUP88 17p13.2 0.24 0.0669 0.546 protein transport;glucose transport
xai CCNC 6q21 0.24 0.0669 0.546 DNA Damage Response (DDR)
his METTL22 16p13.2 0.24 0.0669 0.546
xsq MLLT10 10p12 0.238 0.0669 0.546 regulation of transcription, DNA-
exp LOC389842 Xp21.3 0.238 0.0669 0.546
met FAM27L 17p11.2 0.238 0.0669 0.546
xsq NELFCD 20q13 0.238 0.0669 0.546
xsq DHX33 17p13.2 0.238 0.0669 0.546 positive regulation of
cop NANOGNB 0.238 0.0669 0.546
cop NANOG 0.238 0.0669 0.546
cop SLC2A14 12p13.31 0.238 0.0669 0.546 Solute Carriers
exp FAM192BP 4q31.3 0.238 0.0669 0.546
exp WNT6 2q35 0.238 0.0669 0.546 axis specification;epithelial-mesenchymal
cell signaling
xsq PSMG1 21q22.3 0.238 0.0669 0.546 proteasome assembly
mir hsa-miR-9 0.238 0.0669 0.546
mir hsa-miR-9(2) 0.238 0.0669 0.546
mir hsa-miR-9(3) 0.238 0.0669 0.546
xsq CES3 16q22.1 0.238 0.0669 0.546
exp SGOL1 3p24.3 0.238 0.0669 0.546 centriole-centriole
cohesion;meiotic chromosome segregation
DNA-dependent"
met TAGLN 11q23.2 0.238 0.0669 0.546 muscle organ development
met LRRFIP1 2q37.3 -0.238 0.0669 0.546 regulation of
DNA-dependent"
hs4 DNAH7 2q32.3 -0.24 0.0669 0.546 ciliary or flagellar
xai INADL 1p31.3 -0.24 0.0669 0.546 intracellular signal
xai IL12RB1 19p13.1 0.24 0.067 0.546 signal transduction;positive
swa PHF5A 22q13.2 0.24 0.067 0.546 nuclear mRNA splicing, via
his MED1 17q12 0.24 0.067 0.546 positive regulation of interferon-gamma-
his LOC101927870 0.24 0.067 0.546
swa COL4A3BP 5q13.3 0.24 0.067 0.546 cell morphogenesis;muscle
contraction
xai LAMTOR2 1q22 0.24 0.067 0.546 cell growth;positive regulation of TOR
signaling cascade
hs4 SNHG10 14q32.13 0.24 0.067 0.546
hs4 SCARNA13 14q32.12 0.24 0.067 0.546
hs4 GLRX5 14q32.13 0.24 0.067 0.546 hemopoiesis;cell redox homeostasis
xai C12orf66 12q14.2 0.24 0.067 0.546
exp SCARNA2 1q13.1 0.24 0.067 0.546
his SFT2D3 2q14.3 0.24 0.067 0.546 protein transport;vesicle-mediated
transport
swa CPT1A 11q13.2 0.24 0.067 0.546 positive regulation of fatty acid beta-
oxidation;long-chain fatty acid metabolic process
exp AK2P1 1p32.1 0.238 0.067 0.546
met ATP10D 4p12 0.238 0.067 0.546 cation transport;ion transmembrane
transport
met RMND5B 5q35.3 0.238 0.067 0.546
xsq BOLA2B 0.238 0.067 0.546
xsq RAB32 6q24.3 -0.238 0.067 0.546 small GTPase mediated signal
xai DDR2 1q23.3 -0.24 0.067 0.546 peptidyl-tyrosine
factor activity
xai SEMA3C 7q21-q31 -0.24 0.067 0.546 blood vessel remodeling;neural tube
development
xai CEP120 5q23.2 0.24 0.0671 0.546 microtubule cytoskeleton
xai SNORA71C 20q11.23 0.24 0.0671 0.546
his PANK2 20p13 0.24 0.0671 0.546 coenzyme A biosynthetic
exp ASZ1 7q31.2 0.24 0.0671 0.547 spermatogenesis;cell
differentiation
xai LOC646938 15q25.1 0.24 0.0671 0.547
exp SNORA71C 20q11.23 0.24 0.0671 0.547
his HYLS1 11q24.2 0.24 0.0671 0.547
xsq USP10 16q24.1 0.238 0.0671 0.547 protein deubiquitination;DNA damage
xsq C2orf68 2p11.2 0.238 0.0671 0.547
xsq PLCD3 17q21.31 -0.238 0.0671 0.547 angiogenesis;lipid catabolic
process
xsq WLS 1p31.3 -0.238 0.0671 0.546 Wnt receptor signaling
exp PLAU 10q22.2 -0.238 0.0671 0.546 response to
hypoxia;regulation of cell adhesion mediated by integrin
his GSDMC 8q24.21 -0.24 0.0671 0.547
swa CD276 15q23-q24 -0.24 0.0671 0.547 cell proliferation;positive
his CCDC50 3q28 -0.24 0.0671 0.546
his UTS2B 3q28 -0.24 0.0671 0.546
his POMK 0.24 0.0672 0.547
xai RPL29P30 15q23 0.24 0.0672 0.547
hs4 NAE1 16q22 0.24 0.0672 0.547 Apoptosis
his GAPDH 12p13 0.24 0.0672 0.547 glucose metabolic process;gluconeogenesis
hs4 ARID5A 2q11.2 0.24 0.0672 0.547 negative regulation of
xai ODF2 9q34.11 0.24 0.0672 0.547 cell differentiation;G2/M
met ZNF622 5p15.1 0.238 0.0672 0.547 positive regulation of JNK
cascade;induction of apoptosis by oxidative stress
xsq SMG8 17q22 0.238 0.0672 0.547 nuclear-transcribed mRNA catabolic
exp EFTUD1 15q25.2 0.238 0.0672 0.547 GTP catabolic
process;ribosome biogenesis
xsq HAX1 1q21.3 0.238 0.0672 0.547
xsq KLRC4 12p13.2-p12.3 0.238 0.0672 0.547 cellular defense response
cop SLC6A5 11p15.1 -0.238 0.0672 0.547 Solute Carriers
exp TP53I3 2p23.3 -0.238 0.0672 0.547 induction of apoptosis
by oxidative stress;NADP metabolic process
xsq PP14571 2q37.3 -0.238 0.0672 0.547
xsq TTYH1 19q13.4 -0.238 0.0672 0.547 ion transport;iron ion
transport
cop VSTM2A 7p11.2 -0.238 0.0672 0.547
cop LOC285878 -0.238 0.0672 0.547
his GSTT2B 22q11.23 -0.24 0.0672 0.547
swa ANLN 7p15-p14 -0.24 0.0672 0.547 cytokinesis;septin ring assembly
xai NPR3 5p13.3 -0.24 0.0672 0.547 inhibition of adenylate cyclase
activity by G-protein signaling pathway;activation of phospholipase C activity by
G-protein coupled receptor protein signaling pathway coupled to IP3 second
messenger
xai LTBR 12p13 -0.24 0.0672 0.547 Apoptosis
his FAM120AOS 9q22.31 0.24 0.0673 0.547
his FAM120A 9q22.31 0.24 0.0673 0.547
xai ADM5 19q13.33 0.24 0.0673 0.547
his MICU1 10q22.1 0.24 0.0673 0.547 calcium ion import;ion transport
xsq ZBTB10 8q13-q21.1 0.238 0.0673 0.547 negative regulation of
dependent"
xsq FCGR1B 0.238 0.0673 0.547
exp RPL8 8q24.3 0.238 0.0673 0.547 translational elongation;viral
transcription
xsq RPL10L 14q21.2 0.238 0.0673 0.547 translation;spermatogenesis
exp PLGLA 2q12.2 0.238 0.0673 0.547
exp DTX2P1-UPK3BP1-PMS2P11 7q11.23 0.238 0.0673 0.547
exp OIP5-AS1 15q15.1 0.238 0.0673 0.547
xsq CEPT1 1p13.3 0.238 0.0673 0.547 lipid metabolic
met LOC116437 0.238 0.0673 0.547
exp DISP1 1q41 -0.238 0.0673 0.547 diaphragm development;smoothened
signaling pathway
xsq GAB1 4q31.21 -0.238 0.0673 0.547 epidermal growth factor
receptor signaling pathway;cell proliferation
exp MIR4435-2HG -0.238 0.0673 0.547
swa CTSL 9q21.33 -0.24 0.0673 0.547
his LINC01567 -0.24 0.0673 0.547
xai ZKSCAN2 16p12.1 0.24 0.0674 0.547 viral reproduction
hs4 SNORA1 0.24 0.0674 0.547
hs4 SNORA8 0.24 0.0674 0.547
xai SCARNA2 1q13.1 0.24 0.0674 0.547
his HERC1 15q22 0.24 0.0674 0.547 protein modification process;transport
xai IBA57 1q42.13 0.24 0.0674 0.547 glycine catabolic process;heme
his RGS5 1q23.1 0.24 0.0674 0.547 signal transduction;regulation of
his NUF2 1q23.3 0.24 0.0674 0.547 M phase of mitotic cell
xai LOC100129373 0.24 0.0674 0.548
xai DENND6B 22q13.33 0.24 0.0674 0.548
his SUPT3H 6p21.1-p21.3 0.24 0.0674 0.548 histone
deubiquitination;histone H3 acetylation
xai LOC100653005 0.24 0.0674 0.548
met MEIS2 15q14 0.238 0.0674 0.547 negative regulation of transcription from
pro MGMT_9 0.238 0.0674 0.547
mut SPP1 4q22.1 0.238 0.0674 0.547 ossification;response to vitamin D
exp DNAJA3 16p13.3 0.238 0.0674 0.548 Apoptosis
xsq DSCR9 21q22.13 0.238 0.0674 0.548
exp NEURL1B 5q35.1 -0.238 0.0674 0.548
exp PGF 14q24.3 -0.238 0.0674 0.548 cell differentiation;vascular
exp SGSH 17q25.3 -0.238 0.0674 0.548 proteoglycan metabolic
process
xai PNMA1 14q24.3 -0.24 0.0674 0.548 inflammatory response to antigenic
stimulus;apoptotic process
xai CAV3 3p25 -0.24 0.0674 0.547 regulation of heart contraction;T-tubule
organization
xai RCC2P4 0.24 0.0675 0.548
xai KIAA1586 6p12.1 0.24 0.0675 0.548
his USP34 2p15 0.24 0.0675 0.548 protein K48-linked
exp LOC100129373 0.24 0.0675 0.548
swa RNASEH2B 13q14.3 0.24 0.0675 0.548 DNA Damage Response (DDR);
swa DCK 4q13.3-q21.1 0.24 0.0675 0.548 purine base metabolic
xai EPB41L4A-AS1 5q22.2 0.24 0.0675 0.548
met DPEP3 16q22.1 0.238 0.0675 0.548 proteolysis;meiosis
exp MIS12 17p13.2 0.238 0.0675 0.548 kinetochore assembly;M phase of
mitotic cell cycle
xsq FBXO11 2p16.3 0.238 0.0675 0.548 protein
exp FAM27E2 0.238 0.0675 0.548
exp HIST1H2AK 6p22.1 0.238 0.0675 0.548 nucleosome assembly
xsq CLEC4G 19p13.2 0.238 0.0675 0.548
xsq CSF2RB 22q13.1 0.238 0.0675 0.548 signal
exp ADORA1 1q32.1 -0.238 0.0675 0.548 Apoptosis
xsq SERTAD3 19q13.2 -0.238 0.0675 0.548 negative regulation of
swa BCAM 19q13.2 -0.24 0.0675 0.548 cell-matrix adhesion;signal
transduction
hs4 CCNJL 5q33.3 -0.24 0.0675 0.548
hs4 PAX8 2q13 -0.24 0.0675 0.548 mesenchymal to epithelial transition
hs4 GDPD3 -0.24 0.0675 0.548 glycerol metabolic process;lipid
metabolic process
xai TRPS1 8q24.12 -0.24 0.0675 0.548 skeletal system
xai PDGFD 11q22.3 -0.24 0.0675 0.548 multicellular organismal
exp GAPDHP72 6q27 0.24 0.0676 0.548
his KRTAP16-1 0.24 0.0676 0.548
his NOL12 22q13.1 0.24 0.0676 0.548
his MIR4512 0.24 0.0676 0.548
his SNAPC5 15q22.31 0.24 0.0676 0.548 regulation of transcription,
exp RPL17P41 17q24.2 0.24 0.0676 0.548
xai LOC339622 0.24 0.0676 0.548
xai EMILIN2 18p11.3 0.24 0.0676 0.548 cell adhesion
exp DUXAP3 10q11.21 0.24 0.0676 0.548
xsq CNOT1 16q21 0.238 0.0676 0.548 nuclear-transcribed mRNA catabolic
shortening
exp EFTUD2 17q21.31 0.238 0.0676 0.548 RNA splicing;gene expression
exp POLR1E 9p13.2 0.238 0.0676 0.548 rRNA transcription
xsq E4F1 16p13.3 0.238 0.0676 0.548 negative regulation of
transcription from RNA polymerase II promoter;regulation of cell cycle process
xsq CDR2 16p12.3 0.238 0.0676 0.548
xsq TRPS1 8q24.12 -0.238 0.0676 0.548 skeletal system
exp EEA1 12q22 -0.238 0.0676 0.548 endocytosis;vesicle fusion
xai MALAT1 11q13.1 -0.24 0.0676 0.548
swa SSR1 6p24.3 -0.24 0.0676 0.548 endoplasmic reticulum unfolded
protein response;cellular protein metabolic process
his CTXN1 19p13.2 -0.24 0.0676 0.548
his ITM2B 13q14.3 -0.24 0.0676 0.548 nervous system
exp PATE1 11q24.2 -0.24 0.0676 0.548
his FAM167A 8p23-p22 0.24 0.0677 0.548
his DALRD3 3p21.31 0.24 0.0677 0.548 arginyl-tRNA aminoacylation
his MIR425 0.24 0.0677 0.548
his NDUFAF3 3p21.31 0.24 0.0677 0.548 mitochondrial respiratory
his MIR191 0.24 0.0677 0.548
xai HIST1H4L 6p22.1 0.24 0.0677 0.548
his ANP32B 9q22.32 0.24 0.0677 0.548
his TONSL 8q24.3 0.24 0.0677 0.548 DNA Damage Response (DDR)
his SCARB1 12q24.31 0.239 0.0677 0.548 Apoptosis
xsq PQBP1 Xp11.23 0.238 0.0677 0.548 regulation of transcription, DNA-
dependent"
exp TAF1A 1q42 0.237 0.0677 0.548 transcription from RNA polymerase I
cop APOBEC1 12p13.1 0.237 0.0677 0.548 cytidine
deamination;lipoprotein biosynthetic process
cop GDF3 0.237 0.0677 0.548
cop DPPA3 0.237 0.0677 0.548
exp PTBP1 19p13.3 0.237 0.0677 0.548 negative regulation of RNA
exp LINC00602 6q27 0.237 0.0677 0.548
xsq CDC40 6q21 0.237 0.0677 0.548 gene expression;mRNA 3'-end processing
met RNASE1 14q11.2 0.237 0.0677 0.548
exp UCKL1 20q13.33 0.237 0.0677 0.548 interspecies interaction between
exp GTF2A1 14q31.1 0.237 0.0677 0.548 viral reproduction;regulation
cop GPR141 7p14.1 -0.237 0.0677 0.548 G-protein coupled
cop NME8 7p14.1 -0.237 0.0677 0.548
cop SFRP4 7p14.1 -0.237 0.0677 0.548 response to hormone
stimulus;negative regulation of sequence-specific DNA binding transcription factor
activity
cop EPDR1 7p14.1 -0.237 0.0677 0.548 cell-matrix adhesion
xsq RUSC2 9p13.3 -0.238 0.0677 0.548
xai FNBP1L 1p22.1 -0.239 0.0677 0.548 endocytosis
hs4 NT5DC3 12q22-q23.1 -0.239 0.0677 0.548
his FCHO2 5q13.2 -0.239 0.0677 0.548
xai PGF 14q24.3 -0.24 0.0677 0.548 cell differentiation;vascular
hs4 CYP2J2 1p31.3-p31.2 -0.24 0.0677 0.548 xenobiotic metabolic
swa TOM1 22q13.1 -0.24 0.0677 0.548 intracellular protein
hs4 LINC01048 -0.24 0.0677 0.548
hs4 TK1 17q23.2-q25.3 0.239 0.0678 0.548 DNA replication;nucleotide
hs4 AFMID 17q25.3 0.239 0.0678 0.548 tryptophan catabolic
exp SLC25A1P5 19q11 0.239 0.0678 0.548
his B4GALNT1 12q13.3 0.239 0.0678 0.548 glycosphingolipid metabolic
process;spermatogenesis
hs4 MAGEA9 Xq28 0.239 0.0678 0.548
his OSTC 4q25 0.239 0.0678 0.548 protein N-linked glycosylation via
asparagine
his PRKCQ 10p15 0.239 0.0678 0.548 Protein Kinases
his PRKCQ-AS1 10p14 0.239 0.0678 0.548
xai TRIAP1 12q24.31 0.239 0.0678 0.548 anti-apoptosis;DNA damage
hs4 CCR2 3p21.31 0.239 0.0678 0.548 cellular calcium ion
exp IGHV3-37 0.239 0.0678 0.548
xai KCNQ2 20q13.3 0.239 0.0678 0.548 potassium ion transmembrane
xsq RPS26P11 0.237 0.0678 0.548
dependent"
cop CPNE2 16q13 0.237 0.0678 0.548
xsq OSGEPL1-AS1 0.237 0.0678 0.548
xsq NDUFA7 19p13.2 0.237 0.0678 0.548 mitochondrial electron
exp C2CD4C 19p13.3 0.237 0.0678 0.548
xsq DHX35 20q11.22-q12 0.237 0.0678 0.548 nuclear mRNA splicing, via
xsq WDFY4 10q11.23 0.237 0.0678 0.548
exp SLC35F5 2q14.1 -0.237 0.0678 0.548 Solute Carriers
exp REEP3 10q21.3 -0.237 0.0678 0.548
his MIR4423 -0.239 0.0678 0.548
xai LOC100507412 0.239 0.0679 0.548
his KANTR 0.239 0.0679 0.549
his CSTF3 11p13 0.239 0.0679 0.549 mRNA processing;RNA splicing
his CSTF3-AS1 0.239 0.0679 0.549
his MDN1 6q15 0.239 0.0679 0.549 ATP catabolic process;protein complex
assembly
cop NECAP1 12p13.31 0.237 0.0679 0.548 endocytosis;protein transport
cop CLEC4A 12p13 0.237 0.0679 0.548 cell adhesion;cell surface receptor
signaling pathway
cop POU5F1P3 12p13.31 0.237 0.0679 0.548
exp LOC646505 0.237 0.0679 0.548
xsq LOC100128714 15q12 0.237 0.0679 0.548
xsq ACMSD 2q21.3 0.237 0.0679 0.549 quinolinate metabolic
process;tryptophan catabolic process
xsq SSBP2 5q14.1 0.237 0.0679 0.549 regulation of transcription, DNA-
dependent"
xsq TPGS2 18q12.2 0.237 0.0679 0.549
xai FAM66A -0.239 0.0679 0.549
xai ACOT4 14q24.3 -0.239 0.0679 0.549 unsaturated monocarboxylic
acid metabolic process;very long-chain fatty acid metabolic process
swa NSDHL Xq28 -0.239 0.0679 0.549 small molecule metabolic
process;labyrinthine layer blood vessel development
xai EIF5AP3 19q13.2 -0.239 0.0679 0.548
exp FAM66A -0.239 0.0679 0.548
swa CSE1L 20q13 0.239 0.068 0.549 Apoptosis
xai DUXAP3 10q11.21 0.239 0.068 0.549
swa THOC2 Xq25-q26.3 0.239 0.068 0.549 mRNA export from nucleus;transport
his LOC101927974 0.239 0.068 0.549
his CBLL1 7q22.3 0.239 0.068 0.549 negative regulation of cell
adhesion;cell-cell adhesion
xai IFRD2 3p21.3 0.239 0.068 0.549
xsq ZRANB3 2q21.3 0.237 0.068 0.549 DNA Damage Response (DDR)
exp HNRNPFP1 1p34.2 0.237 0.068 0.549
exp EIF3LP2 10q11.21 0.237 0.068 0.549
mut FANCI 15q26.1 0.237 0.068 0.549 DNA Damage Response (DDR); DDR (FA)
xsq RPS18P9 6q25.1 0.237 0.068 0.549
exp PDIA2 16p13.3 0.237 0.068 0.549 response to hypoxia;protein folding
mut GALNT15 3p25.1 0.237 0.068 0.549
met NLK 17q11.2 0.237 0.068 0.549 negative regulation of Wnt receptor
signaling pathway;serine phosphorylation of STAT3 protein
exp MAPK12 22q13.33 0.237 0.068 0.549 Protein Kinases
xsq PMEPA1 20q13.31-q13.33 -0.237 0.068 0.549 androgen receptor
signaling pathway
xai MAP4K3 2p22.1 -0.239 0.068 0.549 response to
xai CPD 17q11.2 -0.239 0.068 0.549 proteolysis;cellular response to
interleukin-2
xai TSPAN4 11p15.5 -0.239 0.068 0.549 protein complex assembly
xai PHF12 17q11.2 0.239 0.0681 0.549 negative regulation of
xai ZFP69 1p34.2 0.239 0.0681 0.549
his PRDM13 6q16.2 0.239 0.0681 0.549 regulation of transcription,
DNA-dependent"
swa KIAA0368 9q31.3 0.239 0.0681 0.549 ER-associated protein
catabolic process
xai PPP4R3A 0.239 0.0681 0.549
his KLRC3 12p13 0.239 0.0681 0.549 cellular defense response
xai TOR2A 9q34.11 0.239 0.0681 0.549 chaperone mediated protein folding
requiring cofactor
his THAP12 0.239 0.0681 0.549
his LOC100506127 0.239 0.0681 0.549
hs4 HAVCR2 5q33.3 0.239 0.0681 0.549
xai LINC01532 0.239 0.0681 0.549
his ANKRD20A11P 21q11.2 0.239 0.0681 0.549
xsq INTS6-AS1 0.237 0.0681 0.549
exp WDR83 19p13.2 0.237 0.0681 0.549 RNA splicing, via
met TMLHE Xq28 0.237 0.0681 0.549 cellular nitrogen compound metabolic
exp RTTN 18q22.2 0.237 0.0681 0.549 determination of left/right
exp FBXO45 3q29 0.237 0.0681 0.549 nervous system development;protein
ubiquitination
xsq KLHL18 3p21.31 0.237 0.0681 0.549
xsq ENTPD3 3p21.3 -0.237 0.0681 0.549 nucleoside diphosphate
exp RAB17 2q37.3 -0.237 0.0681 0.549 protein transport;small
met TNP1 2q35-q36 -0.237 0.0681 0.549 DNA Damage Response (DDR)
hs4 C11orf74 11p12 -0.239 0.0681 0.549
his MIR4279 -0.239 0.0681 0.549
xai ANKRD9 14q32.31 -0.239 0.0681 0.549
xai LRRC28 15q26.3 0.239 0.0682 0.549
hs4 DOT1L 19p13.3 0.239 0.0682 0.549 DDR (DNA replication)
his SLBP 4p16.3 0.239 0.0682 0.549 transcription from RNA polymerase
hs4 PREB 2p23.3 0.239 0.0682 0.549 cellular membrane
xsq SYTL1 1p36.11 0.237 0.0682 0.549 intracellular protein
met KCNC3 19q13.33 0.237 0.0682 0.549 ion transport;potassium ion
transport
mut SERPINB13 18q21.33 0.237 0.0682 0.549 response to UV;negative
xsq RPS28 19p13.2 0.237 0.0682 0.549 nuclear-transcribed mRNA catabolic
exp STOML2 9p13.1 0.237 0.0682 0.549
xsq EXOC3L4 14q32.32 0.237 0.0682 0.549
xsq TSFM 12q14.1 0.237 0.0682 0.549 translational elongation;regulation
cop CLEC4C 12p13.2-p12.3 0.237 0.0682 0.549 innate immune response
exp TIGD1 2q37.1 0.237 0.0682 0.549 regulation of transcription, DNA-
dependent"
exp EPB41L4A-AS1 5q22.2 0.237 0.0682 0.549
exp CRYBG3 3q11.2 -0.237 0.0682 0.549
xai TAX1BP1 7p15 -0.239 0.0682 0.549 Apoptosis
xai PATE1 11q24.2 -0.239 0.0682 0.549
xai BHMT2 5q13 -0.239 0.0682 0.549 methionine biosynthetic process
xai CTDSPL2 15q15.3-q21.1 0.239 0.0683 0.549
his GSX1 13q12.2 0.239 0.0683 0.549 hypothalamus
development;adenohypophysis development
his NDUFB4 3q13.33 0.239 0.0683 0.549 response to oxidative
his ARL17B 17q21.31 0.239 0.0683 0.55 small GTPase mediated signal
hs4 FOXI1 5q34 0.239 0.0683 0.55 Apoptosis
xai NAT6 3p21.3 0.239 0.0683 0.55
xai ZC3H3 8q24.3 0.239 0.0683 0.55 mRNA polyadenylation;regulation of
mRNA export from nucleus
his TRIM14 9q22.33 0.239 0.0683 0.55
hs4 SH2D6 2p11.2 0.239 0.0683 0.55
exp TOMM22 22q12-q13 0.237 0.0683 0.549 intracellular protein
xsq RPL5 1p22.1 0.237 0.0683 0.549 translational termination;ribosomal
large subunit biogenesis
xsq LOC100996579 0.237 0.0683 0.549
xsq CUTC 10q24.2 0.237 0.0683 0.549 copper ion transport;protein
tetramerization
xsq OR2T3 0.237 0.0683 0.549
exp IPO5 13q32.2 0.237 0.0683 0.549 intracellular protein
exp NMD3P1 7q11.21 0.237 0.0683 0.549
xsq LOC100506844 0.237 0.0683 0.55
xsq ZNF280B 22q11.22 0.237 0.0683 0.55 regulation of transcription,
DNA-dependent"
xsq AEBP2 12p12.3 0.237 0.0683 0.55 regulation of transcription, DNA-
met UPP1 7p12.3 0.237 0.0683 0.55 nucleotide catabolic
process;pyrimidine nucleoside salvage
exp NAA40 11q13.1 0.237 0.0683 0.55
xsq CCBE1 18q21.32 -0.237 0.0683 0.549 multicellular organismal
development;venous blood vessel morphogenesis
hs4 TEKT3 17p12 -0.239 0.0683 0.55 microtubule cytoskeleton
organization
his LY6G6F 0.239 0.0684 0.55
xai ARID1B 6q25.1 0.239 0.0684 0.55 DNA Damage Response (DDR);
DDR (Chromatin)
xai SORD 15q15.3 0.239 0.0684 0.55 glucose metabolic process;sorbitol
catabolic process
xai KANSL2 12q13.11 0.239 0.0684 0.55 histone H4-K5
his PDS5A 4p14 0.239 0.0684 0.55 DNA Damage Response (DDR)
xai LOC100500773 0.239 0.0684 0.55
xai CYP2R1 11p15.2 0.239 0.0684 0.55 vitamin metabolic
cop FURIN 15q26.1 0.237 0.0684 0.55 peptide hormone processing;negative
regulation of nerve growth factor production
cop FES 15q26.1 0.237 0.0684 0.55 regulation of cell shape;positive
cop MAN2A2 15q26.1 0.237 0.0684 0.55 carbohydrate metabolic
process;mannose metabolic process
cop UNC45A 15q26.1 0.237 0.0684 0.55 cell
cop HDDC3 15q26.1 0.237 0.0684 0.55 guanosine tetraphosphate metabolic
process
cop RCCD1 15q26.1 0.237 0.0684 0.55
exp DHRS9 2q31.1 0.237 0.0684 0.55 9-cis-retinoic acid biosynthetic
met MIR424 0.237 0.0684 0.55
met PDK4 7q21.3 0.237 0.0684 0.55 peptidyl-histidine
exp STAT2 12q13.3 -0.237 0.0684 0.55 Apoptosis
met MAGEB2 Xp21.3 -0.237 0.0684 0.55
met TMEM133 11q22.1 -0.237 0.0684 0.55
xai TJP2 9q13-q21 -0.239 0.0684 0.55 apoptotic process;cellular
his ACTN4 19q13 -0.239 0.0684 0.55 Apoptosis
his ACTL7A 9q31 -0.239 0.0684 0.55
his MEA1 6p21.3-p21.1 0.239 0.0685 0.55 multicellular organismal
his RRP36 6p21.1 0.239 0.0685 0.55 rRNA processing;ribosomal small
subunit biogenesis
exp DCAF4L1 4p13 0.239 0.0685 0.55
his TPI1 12p13 0.239 0.0685 0.55 carbohydrate metabolic process;glucose
metabolic process
his SPSB2 12p13.31 0.239 0.0685 0.55 intracellular signal transduction
hs4 HAUS1 18q21.1 0.239 0.0685 0.55 cell cycle;mitosis
xai ELP4 11p13 0.239 0.0685 0.55 transcription elongation from RNA
polymerase II promoter;histone acetylation
his MIR4515 0.239 0.0685 0.55
his BTBD1 15q24 0.239 0.0685 0.55 regulation of protein binding
exp LOC100500773 0.239 0.0685 0.55
xai NDUFC1 4q31.1 0.239 0.0685 0.55 mitochondrial electron
his GRAP 17p11.2 0.239 0.0685 0.55 Ras protein signal
his DDX18 2q14.1 0.239 0.0685 0.55
xsq FGFBP3 10q23.32 0.237 0.0685 0.55 positive regulation of
fibroblast growth factor receptor signaling pathway;positive regulation of vascular
permeability
xsq ALYREF 17q25.3 0.237 0.0685 0.55 gene expression;mRNA 3'-end
processing
met ZBTB4 17p13.1 0.237 0.0685 0.55 regulation of transcription, DNA-
dependent"
exp DNAJC9 10q22.2 0.237 0.0685 0.55 protein folding;social
behavior
met N6AMT1 21q21.3 0.237 0.0685 0.55 protein methylation;positive
xsq TSTD2 9q22.33 0.237 0.0685 0.55
exp PLPP2 -0.237 0.0685 0.55 sphingolipid metabolic
exp PTN 7q33 -0.237 0.0685 0.55 positive regulation of cell
his FAT1 4q35 -0.239 0.0685 0.55 anatomical structure
xai WWTR1-AS1 3q25.1 -0.239 0.0685 0.55
xai CSF3 17q11.2-q12 0.239 0.0686 0.55 granulocyte differentiation;immune
response
xai IGHV3-37 0.239 0.0686 0.55
swa CD58 1p13 0.239 0.0686 0.55 Tumor Suppressors
swa NOC2L 1p36.33 0.239 0.0686 0.55 negative regulation of apoptotic
swa LAP3 4p15.32 0.239 0.0686 0.55 proteolysis;metabolic process
met BAIAP2L1 7q22.1 0.237 0.0686 0.55 response to
dependent"
met KIAA1522 1p35.1 0.237 0.0686 0.55
exp C19orf60 19p13.11 0.237 0.0686 0.55
met LYPD1 2q21.2 0.237 0.0686 0.55
met CTTNBP2 7q31 0.237 0.0686 0.55 brain development
xsq MCPH1 8p23.1 0.237 0.0686 0.55 DNA Damage Response (DDR)
mut DCAF5 14q23-q24.1 0.237 0.0686 0.55 protein ubiquitination
exp MMRN1 4q22 0.237 0.0686 0.55 platelet degranulation;cell adhesion
xsq GP5 3q29 0.237 0.0686 0.55 cell adhesion;cell-matrix adhesion
xsq CFLAR-AS1 -0.237 0.0686 0.55
exp TIAM2 6q25.2 -0.237 0.0686 0.55 regulation of Rho protein
cop STARD3NL 7p14-p13 -0.237 0.0686 0.55
met DLX1 2q32 -0.237 0.0686 0.55 cell differentiation;negative
hs4 LOC100270746 6p22.2 -0.239 0.0686 0.55
his CSF2RB 22q13.1 0.239 0.0687 0.551 signal
his PPP1R16B 20q11.23 0.239 0.0687 0.551 signal
xai TBL3 16p13.3 0.239 0.0687 0.551 G-protein signaling, coupled to
cGMP nucleotide second messenger;rRNA processing"
xsq FAM74A3 0.237 0.0687 0.55
mut GPALPP1 0.237 0.0687 0.551
xsq NARS 18q21.31 0.237 0.0687 0.551 tRNA aminoacylation for protein
cop ACSM4 12p13.31 0.237 0.0687 0.551
xsq C7orf55 0.237 0.0687 0.551
met CRYGS 3q27.3 0.237 0.0687 0.551 morphogenesis of an epithelium;lens
development in camera-type eye
exp SDR39U1 14q12 0.237 0.0687 0.551
exp RIC3 11p15.4 0.237 0.0687 0.551
xsq MMRN1 4q22 0.237 0.0687 0.551 platelet degranulation;cell adhesion
met STMN4 8p21.2 0.237 0.0687 0.551 intracellular signal transduction
exp KIAA0825 5q15 0.237 0.0687 0.551
xsq LIMA1 12q13 -0.237 0.0687 0.551 negative regulation of actin
cop ELMO1 7p14.1 -0.237 0.0687 0.551 actin cytoskeleton
met GFI1 1p22 -0.237 0.0687 0.551 negative regulation of calcidiol 1-
met PRRX2 9q34.1 -0.237 0.0687 0.55 embryonic limb
morphogenesis;inner ear morphogenesis
cop CREB5 7p15.1 -0.237 0.0687 0.55 transcription from RNA
polymerase II promoter;positive regulation of transcription, DNA-dependent"
hs4 DMD Xp21.2 -0.239 0.0687 0.551 muscle organ
development;skeletal muscle tissue development
hs4 LOC101928123 0.239 0.0688 0.551
xai HNRNPK 9q21.32-q21.33 0.239 0.0688 0.551 nuclear mRNA splicing,
promoter
hs4 SLC5A7 2q12 0.239 0.0688 0.551 ion transport;transmembrane
transport
his SCARNA18B 0.239 0.0688 0.551
his UCHL5 1q32 0.239 0.0688 0.551 DNA repair;midbrain development
his TROVE2 1q31 0.239 0.0688 0.551 transcription from RNA polymerase
III promoter
xai GLB1L3 11q25 0.239 0.0688 0.551 carbohydrate metabolic process
his FAM117B 2q33.2 0.239 0.0688 0.551
xsq SBK1 16p11.2 0.237 0.0688 0.551 peptidyl-serine
xsq GOPC 6q21 0.237 0.0688 0.551 spermatid nucleus differentiation;protein
transport
xsq LPAR5 12p13.31 0.237 0.0688 0.551
xsq LOC101929337 0.237 0.0688 0.551
xsq LOC101927069 0.237 0.0688 0.551
mut KDM1B 6p22.3 0.237 0.0688 0.551 regulation of transcription, DNA-
mut ADGRG4 0.237 0.0688 0.551 G-protein coupled receptor
exp EMILIN2 18p11.3 0.237 0.0688 0.551 cell adhesion
xsq TFDP1 13q34 0.237 0.0688 0.551 Apoptosis
exp KCTD7 -0.237 0.0688 0.551 potassium ion transport
exp BHMT2 5q13 -0.237 0.0688 0.551 methionine biosynthetic process
exp SERPINH1 11q13.5 -0.237 0.0688 0.551 response to
hs4 LINC00322 21q22.3 -0.239 0.0688 0.551
DNA-dependent"
his LINC01252 0.239 0.0689 0.551
xai C4orf46 4q32.1 0.238 0.0689 0.551
xai NAA35 9q21.33 0.238 0.0689 0.551 smooth muscle cell proliferation
his PAAF1 11q13.4 0.238 0.0689 0.551 interspecies interaction between
organisms
his COA4 11q13.4 0.238 0.0689 0.551
xsq GRAMD4 22q13.31 0.237 0.0689 0.551 apoptotic process
xsq CELF3 1q21 0.236 0.0689 0.551 spermatogenesis;RNA splicing
exp WASL 7q31.3 -0.236 0.0689 0.551 nitric oxide metabolic
cop MRPL32 7p14 -0.236 0.0689 0.551 translation
xai GFPT1 2p13 -0.238 0.0689 0.551 carbohydrate biosynthetic
process;fructose 6-phosphate metabolic process
his LOC105369532 -0.238 0.0689 0.551
hs4 CEMIP -0.238 0.0689 0.551
xai TGFB3 14q24 -0.239 0.0689 0.551 Apoptosis
his CNNM3 2p12-p11.2 0.238 0.069 0.551 ion transport
xai CA11 19q13.3 0.238 0.069 0.551
xai TAC1 7q21-q22 0.238 0.069 0.551 insemination;sensory perception of pain
exp TPTEP1 22q11.1 0.236 0.069 0.551
xsq OR5T2 0.236 0.069 0.551 response to stimulus
xsq MIMT1 19q13.43 0.236 0.069 0.551
exp ARHGEF6 Xq26.3 0.236 0.069 0.552 positive regulation of GTPase
activity;nerve growth factor receptor signaling pathway
exp BMS1 10q11.21 0.236 0.069 0.552 ribosome assembly
exp HSPB6 19q13.12 -0.236 0.069 0.552 regulation of muscle
cop ELF3 1q32.2 -0.236 0.069 0.552 Transcription Factors
exp KCTD11 17p13.1 -0.236 0.069 0.551 regulation of
xai SNORA70F -0.238 0.069 0.552
hs4 BACE2 21q22.3 -0.238 0.069 0.552 proteolysis;membrane protein
hs4 MIR3197 -0.238 0.069 0.552
xai CHRDL1 Xq23 -0.238 0.069 0.551 nervous system development;cell
differentiation
xai ZNF365 10q21.2 -0.238 0.069 0.551
xai RPS15 19p13.3 0.238 0.0691 0.552 ribosomal small subunit export from
xai SLC25A1P5 19q11 0.238 0.0691 0.552
xsq TRMT2B Xq22.1 0.236 0.0691 0.552 tRNA processing
xsq CDKN2B-AS1 9p21.3 0.236 0.0691 0.552
mut HOXA2 7p15.2 0.236 0.0691 0.552 anterior/posterior pattern
xsq SRSF8 11q22 0.236 0.0691 0.552 mRNA processing;RNA splicing
met CXorf67 Xp11.22 0.236 0.0691 0.552
met TLX3 5q35.1 0.236 0.0691 0.552 respiratory gaseous
exchange;negative regulation of neuron differentiation
xsq PHKG2 16p11.2 0.236 0.0691 0.552 glycogen metabolic process;glycogen
xsq NRXN2 11q13 0.236 0.0691 0.552 neuroligin clustering;postsynaptic
density protein 95 clustering
exp DENND4C 9p22.1 -0.236 0.0691 0.552
exp MICA 6p21.33 -0.236 0.0691 0.552 response to heat;cytolysis
exp BHLHE40 3p26 -0.236 0.0691 0.552 circadian regulation of gene
his RNF220 1p34.1 -0.238 0.0691 0.552 protein
ubiquitination;protein autoubiquitination
his OTOR 20p12.1-p11.23 -0.238 0.0691 0.552 cartilage
condensation;sensory perception of sound
his DMGDH 5q14.1 -0.238 0.0691 0.552 glycine metabolic
his BHMT2 5q13 -0.238 0.0691 0.552 methionine biosynthetic process
hs4 SCARF2 22q11.21 -0.238 0.0691 0.552 cell adhesion
xai LURAP1 1p34 -0.238 0.0691 0.552 positive regulation of
exp PTX4 16p13.3 0.238 0.0692 0.552
his ATG10 5q14.1 0.238 0.0692 0.552 positive regulation of protein
modification process;protein modification by small protein conjugation
xai HIST1H2AL 6p22.1 0.238 0.0692 0.552
DNA-dependent"
xsq DDB1 11q12-q13 0.236 0.0692 0.552 DNA Damage Response (DDR); DDR
met PAGE2B Xp11.21 0.236 0.0692 0.552
xsq CDCA7L 7p15.3 0.236 0.0692 0.552 regulation of transcription,
DNA-dependent;positive regulation of cell proliferation"
met CRTC3 15q26.1 0.236 0.0692 0.552 positive regulation of CREB
transcription factor activity;interspecies interaction between organisms
xsq MPHOSPH6 16q23.3 0.236 0.0692 0.552 M phase of mitotic cell
cop EEPD1 7p14.2 -0.236 0.0692 0.552 DNA repair
cop CPVL 7p15.1 -0.236 0.0692 0.552 proteolysis
exp ADIPOQ-AS1 -0.238 0.0692 0.552
xai RAB5C 17q21.2 -0.238 0.0692 0.552 regulation of endocytosis;GTP
catabolic process
his RNU105C 8q11.23 -0.238 0.0692 0.552
exp SNORA70F -0.238 0.0692 0.552
hs4 TUBAL3 10p15.1 0.238 0.0693 0.552 microtubule-based
movement;protein polymerization
his LOC100128317 7q21.11 0.238 0.0693 0.552
xai RRP15 1q41 0.238 0.0693 0.553
exp SCARNA21 0.238 0.0693 0.553
xai HNRNPH1P2 Xq27.3 0.238 0.0693 0.553
his LOC101929552 0.238 0.0693 0.553
his FN3KRP 17q25.3 0.238 0.0693 0.553
DNA-dependent"
xsq MYH3 17p13.1 0.236 0.0693 0.552 muscle organ development;actin
filament-based movement
exp FAM217B 20q13.33 0.236 0.0693 0.553
met ACCSL 11p11.2 0.236 0.0693 0.553 biosynthetic process
exp SMURF2 17q22-q23 -0.236 0.0693 0.553 protein
pathway
xai CRYBG3 3q11.2 -0.238 0.0693 0.552
xai KIAA0825 5q15 0.238 0.0694 0.553
xai SCARNA21 0.238 0.0694 0.553
xai HAO2 1p13.3-p13.1 0.238 0.0694 0.553 mandelate metabolic
process;fatty acid oxidation
met DACT2 6q27 0.236 0.0694 0.553
mut ADCY5 3q21.1 0.236 0.0694 0.553 signal transduction;intracellular
signal transduction
exp F12 5q35.3 0.236 0.0694 0.553 protein autoprocessing;plasma
kallikrein-kinin cascade
exp USP19 3p21.31 0.236 0.0694 0.553 negative regulation of skeletal
exp RAB39B Xq28 0.236 0.0694 0.553 synapse organization;small GTPase
exp ARL2 11q13 0.236 0.0694 0.553 tubulin complex assembly;centrosome
organization
exp TRAIP 3p21.31 0.236 0.0694 0.553 induction of apoptosis;signal
transduction
xsq ITGA10 1q21 -0.236 0.0694 0.553 cell adhesion;cell-matrix
adhesion
exp MEF2A 15q26 -0.236 0.0694 0.553 MAPK cascade;nervous system
development
xsq SMIM10L2B -0.236 0.0694 0.553
xsq DENND5A 11p15.4 -0.236 0.0694 0.553
cop FAM183B 7p14.1 -0.236 0.0694 0.553
xai ZNF462 9q31.2 -0.238 0.0694 0.553 positive regulation of
dependent
hs4 C1orf220 1q25.2 -0.238 0.0694 0.553
hs4 LDOC1L 22q13.31 -0.238 0.0694 0.553
hs4 MCM2 3q21 0.238 0.0695 0.553 DDR (DNA replication)
xai GSTM3P2 0.238 0.0695 0.553
xai ALKBH8 11q22.3 0.238 0.0695 0.553 DNA Damage Response (DDR)
xai ARHGAP11A 15q13.2 0.238 0.0695 0.553 signal transduction;small
exp UCP2 11q13 0.236 0.0695 0.553 transport;small molecule metabolic
process
xsq TKFC 0.236 0.0695 0.553 glycerol metabolic process;innate immune
response
xsq PLIN4 19p13.3 0.236 0.0695 0.553
exp SYNE3 14q32.13 0.236 0.0695 0.553
met GRAMD2 15q23 0.236 0.0695 0.553
exp HNRNPL 19q13.2 0.236 0.0695 0.553 nuclear mRNA splicing, via
exp KIF13B 8p12 -0.236 0.0695 0.553 protein
mut RIMS3 1p34.2 -0.236 0.0695 0.553 neurotransmitter
transport;calcium ion-dependent exocytosis
met RLTPR 16q22.1 -0.236 0.0695 0.553
exp LOC541472 7p21 -0.236 0.0695 0.553
xai BAALC 8q22.3 -0.238 0.0695 0.553
xai CCND1 11q13 -0.238 0.0695 0.553 DNA Damage Response (DDR); DDR (G1-
his MIR4747 0.238 0.0696 0.553
exp GSTM3P2 0.238 0.0696 0.554
his ESRRA 11q13 0.238 0.0696 0.554 positive regulation of transcription from
RNA polymerase II promoter;cartilage development
his XK Xp21.1 0.238 0.0696 0.554 transport;amino acid transport
hs4 RASSF2 20p13 0.238 0.0696 0.554 cell cycle;signal transduction
dependent"
met MAGED1 Xp11.23 0.236 0.0696 0.553 regulation of transcription,
DNA-dependent"
xsq DDX11L1 0.236 0.0696 0.554
met SERTAD4 1q32.1-q41 0.236 0.0696 0.554
xsq CENPJ 13q12.12 0.236 0.0696 0.554 G2/M transition of mitotic cell
exp SKP1 5q31 -0.236 0.0696 0.554 Apoptosis
met SUMO1P1 20q13.2 -0.236 0.0696 0.553
hs4 TOB2P1 6p22.1 -0.238 0.0696 0.554
swa PGRMC2 4q26 -0.238 0.0696 0.553 steroid hormone mediated
signaling pathway
xai BTAF1 10q22-q23 0.238 0.0697 0.554 negative regulation of
xai DNAH11 7p21 0.238 0.0697 0.554 ciliary or flagellar
hs4 UHRF1 19p13.3 0.238 0.0697 0.554 positive regulation of DNA
his GRAPL 0.238 0.0697 0.554
his BIRC6-AS2 0.238 0.0697 0.554
xai HMGB2 4q31 0.238 0.0697 0.554 DNA Damage Response (DDR); DDR (BER)
met ZNF843 16p11.2 0.236 0.0697 0.554
xsq CRIP1 14q32.33 0.236 0.0697 0.554 heart development;cell
proliferation
xsq ARPC5L 9q33.3 0.236 0.0697 0.554 regulation of actin filament
polymerization
exp PPP4R3A 0.236 0.0697 0.554
exp ENAM 4q13.3 0.236 0.0697 0.554 bone mineralization;odontogenesis
xsq CLP1 11q12 0.236 0.0697 0.554 nuclear mRNA splicing, via
spliceosome;mRNA 3'-end processing
xsq PSMD7 16q22.3 0.236 0.0697 0.554 protein polyubiquitination;gene
expression
xsq TMEM38B 9q31.2 0.236 0.0697 0.554 ion transport;potassium ion
transport
hs4 PROSER2 10p14 -0.238 0.0697 0.554
swa MFI2 3q28-q29 -0.238 0.0697 0.554 ion transport;iron ion
transport
his GOLGA2P3Y 0.238 0.0698 0.554
xai RPS5 19q13.4 0.238 0.0698 0.554 regulation of translational
xai HMGN1P6 0.238 0.0698 0.554
his KIDINS220 2p24 0.238 0.0698 0.554 activation of MAPKK activity;nerve
exp HMGN1P6 0.238 0.0698 0.554
his BRIP1 17q22.2 0.238 0.0698 0.555 DNA Damage Response (DDR); DDR (FA)
his TRAPPC10 21q22.3 0.238 0.0698 0.555 sodium ion export;sodium ion
transport
met HAUS6 9p22.1 0.236 0.0698 0.555 centrosome organization;cell
division
xsq PKD2L1 10q24 0.236 0.0698 0.555 potassium ion transmembrane
taste
xsq RIMBP3 0.236 0.0698 0.555
cop LOC643401 -0.236 0.0698 0.555
exp FAM115B -0.236 0.0698 0.554
xsq GDF5 20q11.2 -0.236 0.0698 0.554 cell-cell signaling;cartilage
development
hs4 SCARA3 8p21 -0.238 0.0698 0.555 response to oxidative
his LAMB2 3p21 -0.238 0.0698 0.554 neuromuscular junction
swa OTULIN -0.238 0.0698 0.554
xai PITX1 5q31.1 -0.238 0.0698 0.554 anatomical structure
his TMEM57 1p36.11 0.238 0.0699 0.555 brain development
his UMODL1-AS1 0.238 0.0699 0.555
xai UBAC1 9q34.3 0.238 0.0699 0.555
his RBFOX1 16p13.3 0.238 0.0699 0.555 mRNA processing;RNA splicing
his PSMA4 15q25.1 0.238 0.0699 0.555 antigen processing and presentation
of exogenous peptide antigen via MHC class I, TAP-dependent;mRNA metabolic process
hs4 PRR14 16p11.2 0.238 0.0699 0.555
xai KBTBD7 13q14.11 0.238 0.0699 0.555
exp NDUFA7 19p13.2 0.236 0.0699 0.555 mitochondrial electron
exp CDC26 9q32 0.236 0.0699 0.555 cell division;negative regulation of
xsq ITGA4 2q31.3 0.236 0.0699 0.555 B cell differentiation;blood vessel
remodeling
xsq IGHMBP2 11q13.3 0.236 0.0699 0.555 DNA Damage Response (DDR)
exp MRPS31P2 13q12.11 0.236 0.0699 0.555
xsq EXOSC6 16q22.1 0.236 0.0699 0.555 DNA deamination;nuclear-
xsq MRAS 3q22.3 -0.236 0.0699 0.555 GTP catabolic process;signal
transduction
exp DDAH1 1p22 -0.236 0.0699 0.555 arginine catabolic process;nitric
exp ZNF366 5q13.2 -0.236 0.0699 0.555 negative regulation of
dependent
hs4 SCIN 7p21.3 -0.238 0.0699 0.555 regulation of chondrocyte
differentiation;positive regulation of apoptotic process
xai SLC9A3P3 10q11.23 -0.238 0.0699 0.555
xai TMPRSS13 11q23 -0.238 0.0699 0.555 proteolysis
hs4 CRISP3 6p12.3 -0.238 0.0699 0.555 innate immune
response;defense response
his ZNF804A 2q32.1 0.238 0.07 0.555
xai WDR70 5p13.2 0.238 0.07 0.555
his BIN2 0.238 0.07 0.555
hs4 BAHCC1 17q25.3 0.238 0.07 0.555
hs4 MIR4740 0.238 0.07 0.555
xsq ATP2A1 0.236 0.07 0.555 cation transport;ion transmembrane
transport
cop GPATCH11 2p22.2 0.236 0.07 0.555
exp NRBF2P5 10p 0.236 0.07 0.555
xsq ARMC5 16p11.2 0.236 0.07 0.555
exp UQCC2 0.236 0.07 0.555
xsq LINC00298 0.236 0.07 0.555
met MYOZ2 4q26-q27 -0.236 0.07 0.555
exp NUCB1 19q13.33 -0.236 0.07 0.555
xsq LRIG1 3p14 -0.236 0.07 0.555
cop OPA1-AS1 -0.236 0.07 0.555
his LINC00521 14q32.12 -0.238 0.07 0.555
his AKT3 1q44 -0.238 0.07 0.555 Protein Kinases
his MKS1 17q22 0.238 0.0701 0.555 cilium morphogenesis;cell projection
organization
exp ANP32A-IT1 15q23 0.238 0.0701 0.555
his UBAP2 9p13.3 0.238 0.0701 0.555
his WWOX 16q23 0.238 0.0701 0.555 positive regulation of apoptotic
xai ZNF202 11q24 0.237 0.0701 0.555 transcription from RNA polymerase
II promoter;lipid metabolic process
his HNRNPC 14q11.2 0.237 0.0701 0.555 nuclear mRNA splicing, via
exp HNRNPK 9q21.32-q21.33 0.237 0.0701 0.555 nuclear mRNA splicing,
promoter
xsq ARL14 3q25.33 0.236 0.0701 0.555 small GTPase mediated signal
transduction
cop FAM192A 16q13 0.235 0.0701 0.555
cop RSPRY1 16q13 0.235 0.0701 0.555
cop ARL2BP 16q13 0.235 0.0701 0.555 maintenance of protein location in
nucleus;signal transduction
cop PLLP 16q13 0.235 0.0701 0.555 ion transport;response to wounding
cop CCL22 16q13 0.235 0.0701 0.555 immune response;signal transduction
met DMKN 19q13.12 0.235 0.0701 0.555
DNA-dependent"
exp ACKR2 3p21.3 -0.235 0.0701 0.555
met SNORA41 2q33 -0.236 0.0701 0.555
xai FAM204CP -0.237 0.0701 0.555
exp FAM204CP -0.238 0.0701 0.555
xai MAPK12 22q13.33 0.237 0.0702 0.556 Protein Kinases
his ALKBH2 12q24.11 0.237 0.0702 0.556 DNA Damage Response (DDR);
DDR (Direct Repair)
his GPR3 1p36.1-p35 0.237 0.0702 0.556 regulation of meiosis;activation of
adenylate cyclase activity by G-protein signaling pathway
his SNRNP40 1p35.2 0.237 0.0702 0.556 RNA splicing;gene expression
his ZCCHC17 1p35.2 0.237 0.0702 0.556
his NOP10 15q14-q15 0.237 0.0702 0.556 DNA Damage Response (DDR)
his NUTM1 15q14 0.237 0.0702 0.556
DNA-dependent"
his EEF2KMT 0.237 0.0702 0.556
exp CA11 19q13.3 0.235 0.0702 0.555
met C16orf82 16p12.1 0.235 0.0702 0.556
met AASS 7q31.3 0.235 0.0702 0.556 lysine catabolic process;L-lysine
catabolic process
cop MIR1200 -0.235 0.0702 0.556
exp GBP3 1p22.2 -0.235 0.0702 0.556
exp LOC100233198 -0.235 0.0702 0.556
hs4 LAMA5 20q13.2-q13.3 -0.237 0.0702 0.556 integrin-mediated
signaling pathway;cell differentiation
hs4 WDR63 1p22.3 -0.237 0.0702 0.556
his PTX3 3q25 -0.237 0.0702 0.556 response to yeast;inflammatory
response
his MYL10 7q22.1 -0.237 0.0702 0.556
xai HMX2 10q26.13 0.237 0.0703 0.556 multicellular organismal
hs4 USP7 16p13.3 0.237 0.0703 0.556 protein deubiquitination;regulation
his C2CD4C 19p13.3 0.237 0.0703 0.556
his MIR933 0.237 0.0703 0.556
his ATF2 2q32 0.237 0.0703 0.556 DNA Damage Response (DDR)
his BAZ1B 7q11.23 0.237 0.0703 0.556 DNA Damage Response (DDR)
xsq FAM217B 20q13.33 0.235 0.0703 0.556
exp GOLGA8O 0.235 0.0703 0.556
xsq KIR2DS4 19q13.4 0.235 0.0703 0.556
xsq TAGLN 11q23.2 -0.235 0.0703 0.556 muscle organ development
exp VEZF1P1 3q29 -0.237 0.0703 0.556
xai PTN 7q33 -0.237 0.0703 0.556 positive regulation of cell
his RRS1-AS1 -0.237 0.0703 0.556
his RRS1 8q13.1 -0.237 0.0703 0.556 mitotic metaphase plate
congression;ribosome biogenesis
his ADHFE1 8q13.1 -0.237 0.0703 0.556 2-oxoglutarate metabolic
xai SCLY 2q37.3 0.237 0.0704 0.556 cellular amino acid metabolic
process
his IL17C 0.237 0.0704 0.556
his ZFP36L2 2p22.3-p21 0.237 0.0704 0.556 nuclear-transcribed mRNA
catabolic process, deadenylation-dependent decay;regulation of transcription, DNA-
dependent
his LINC01126 0.237 0.0704 0.556
xai FAM217B 20q13.33 0.237 0.0704 0.556
xsq MORN3 12q24.31 0.235 0.0704 0.556
xsq GIMAP1 7q36.1 0.235 0.0704 0.556 B cell differentiation;T cell
differentiation
xsq RNASEH2A 19p13.2 0.235 0.0704 0.556 DNA Damage Response (DDR);
cop SPTBN1 2p21 0.235 0.0704 0.556 axon guidance;actin filament
capping
xsq PIP5K1P1 6p24.3 0.235 0.0704 0.556
xsq PROK2 3p13 0.235 0.0704 0.556 spermatogenesis;activation of MAPK
activity
exp ALG14 1p21.3 -0.235 0.0704 0.556 post-translational protein
cop CDH9 5p14 -0.235 0.0704 0.556 homophilic cell adhesion;cell-cell
adhesion
exp RAB3GAP1 2q21.3 -0.235 0.0704 0.556 face morphogenesis;brain
development
xsq LRRK2 12q12 -0.235 0.0704 0.556 negative regulation of neuroblast
proliferation;tangential migration from the subventricular zone to the olfactory
bulb
hs4 PRELID2 5q32 -0.237 0.0704 0.556
his ARHGEF12 11q23.3 -0.237 0.0704 0.556 nerve growth factor
exp LOC100505625 -0.237 0.0704 0.556
his MIR1252 -0.237 0.0704 0.556
xai LRP1B 2q21.2 -0.237 0.0704 0.556 receptor-mediated
xai GAPDHP21 10q21.1 0.237 0.0705 0.556
swa SMC1A Xp11.22-p11.21 0.237 0.0705 0.557 DNA Damage Response (DDR);
hs4 DUSP2 2q11 0.237 0.0705 0.557 regulation of apoptotic
exp HMX2 10q26.13 0.237 0.0705 0.557 multicellular organismal
his CCDC88C 14q32.11 0.237 0.0705 0.557 microtubule cytoskeleton
xai MTRF1 13q14.1-q14.3 0.237 0.0705 0.557 regulation of translational
termination
exp PSMB3P2 2q35 0.237 0.0705 0.557
exp RPL14P3 4q31.1 0.235 0.0705 0.557
exp MRPS34 16p13.3 0.235 0.0705 0.557
xsq GPA33 1q24.1 0.235 0.0705 0.557
xsq CEBPD 8p11.2-p11.1 -0.235 0.0705 0.557 transcription from RNA
met MIR130A -0.235 0.0705 0.557
xsq ETV7 6p21 -0.235 0.0705 0.557 Transcription Factors
his LRRC32 11q13.5-q14 -0.237 0.0705 0.557
his CSF1 1p13.3 -0.237 0.0705 0.556 positive regulation of gene
hs4 SHOX Xp22.33 0.237 0.0706 0.557 skeletal system
his MCRIP1 0.237 0.0706 0.557
his PPP1R27 17q25.3 0.237 0.0706 0.557 negative regulation of
his P4HB 17q25 0.237 0.0706 0.557 small molecule metabolic process;cell
redox homeostasis
his ARHGDIA 17q25.3 0.237 0.0706 0.557 Apoptosis
his SIKE1 1p13.2 0.237 0.0706 0.557 innate immune response
his LINC01221 0.237 0.0706 0.557
his LINC01222 0.237 0.0706 0.557
his NELFA 4p16.3 0.237 0.0706 0.557
exp SOCS7 17q12 0.235 0.0706 0.557 insulin receptor signaling
xsq JMY 5q14.1 0.235 0.0706 0.557 DNA repair;actin polymerization-
dependent cell motility
met C12orf40 12q12 0.235 0.0706 0.557
xsq LOC100289495 0.235 0.0706 0.557
xsq HHIP-AS1 4q31.21 0.235 0.0706 0.557
xsq LELP1 1q21.3 0.235 0.0706 0.557
exp ARID1B 6q25.1 0.235 0.0706 0.557 DNA Damage Response (DDR);
DDR (Chromatin)
exp LRP1B 2q21.2 -0.235 0.0706 0.557 receptor-mediated
xai VIPR1 3p22 -0.237 0.0706 0.557 muscle contraction;immune response
xai HOXB2 17q21.32 -0.237 0.0706 0.557 anterior/posterior pattern
xai LOC100128333 0.237 0.0707 0.557
his WDFY4 10q11.23 0.237 0.0707 0.557
exp COQ3 6q16.2 0.235 0.0707 0.557 ubiquinone biosynthetic
xsq FLVCR1-AS1 1q32.3 0.235 0.0707 0.557
exp GKN2 2p13.3 0.235 0.0707 0.557
xsq MYH4 17p13.1 0.235 0.0707 0.557 muscle contraction;response to
activity
met TRPM4 19q13.33 0.235 0.0707 0.557 dendritic cell
cop C3AR1 12p13.31 0.235 0.0707 0.557 blood circulation;regulation of
blood pressure
exp ADCY7 16q12.1 0.235 0.0707 0.557 GTP catabolic process;fibroblast
xsq KTI12 1p32.3 0.235 0.0707 0.557
cop PCMT1 6q24-q25 0.235 0.0707 0.557 protein repair;S-
adenosylhomocysteine metabolic process
xsq PIGBOS1 0.235 0.0707 0.557
xsq SIRT1 10q21.3 0.235 0.0707 0.557 Apoptosis; DNA Damage Response
(DDR)
xsq SRSF7 2p22.1 0.235 0.0707 0.557 mRNA export from nucleus;RNA
splicing
xsq ABCA7 19p13.3 0.235 0.0707 0.557 ABC Transporters
xsq TRAIP 3p21.31 0.235 0.0707 0.557 induction of apoptosis;signal
transduction
exp LOC392536 Xq25 -0.235 0.0707 0.557
swa GOLPH3 5p13.3 -0.237 0.0707 0.557 regulation of
mitochondrion organization;positive regulation of TOR signaling cascade
exp RPS15AP10 0.237 0.0708 0.557
hs4 PRSS30P 16p13.3 0.237 0.0708 0.557
xai C11orf21 11p15.5 0.237 0.0708 0.557
xai CCDC163P 1p34.1 0.237 0.0708 0.558
exp ESRRA 11q13 0.235 0.0708 0.557 positive regulation of transcription from
xsq MGC27345 7q32.1 0.235 0.0708 0.557
exp LAMTOR2 1q22 0.235 0.0708 0.558 cell growth;positive regulation of
xsq TMEM161A 19p13.11 0.235 0.0708 0.558 negative regulation of
xsq SDPR 2q32-q33 -0.235 0.0708 0.558
exp PSG11 19q13.2 -0.235 0.0708 0.558 female pregnancy
exp SEMA3C 7q21-q31 -0.235 0.0708 0.558 blood vessel
xsq FAM71F2 7q32.1 -0.235 0.0708 0.557
xai ADIPOQ-AS1 -0.237 0.0708 0.558
xai SDR39U1 14q12 0.237 0.0709 0.558
his KAT6B 10q22.2 0.237 0.0709 0.558 positive regulation of
his SLC35E3 12q15 0.237 0.0709 0.558 Solute Carriers
xai OR4X1 11p11.2 0.237 0.0709 0.558 response to stimulus
exp LYPLA1P2 4q25 0.237 0.0709 0.558
his ILVBL 19p13.1 0.237 0.0709 0.558
xai NEMP2 0.237 0.0709 0.558
his ABHD18 0.237 0.0709 0.558
his MFSD8 4q28.2 0.237 0.0709 0.558 cell death;transmembrane transport
his SNHG3 0.237 0.0709 0.558
his RCC1 1p36.1 0.237 0.0709 0.558 cell cycle;mitotic spindle
organization
his SNORA73A 0.237 0.0709 0.558
his SNORA73B 0.237 0.0709 0.558
xai TNNI3 19q13.4 0.237 0.0709 0.558 regulation of smooth muscle
his IST1 16q22.2 0.237 0.0709 0.558 cell division;cell cycle
xai FH 1q42.1 0.237 0.0709 0.558 tricarboxylic acid cycle;fumarate
metabolic process
xsq CDCA8 1p34.3 0.235 0.0709 0.558 M phase of mitotic cell
cycle;mitotic metaphase
xsq GTF2H2 0.235 0.0709 0.558 DNA Damage Response (DDR); DDR
(NER)
xsq RAD51AP1 12p13.2-p13.1 0.235 0.0709 0.558 DNA Damage Response
(DDR)
met HCG27 6p21.33 0.235 0.0709 0.558
cop LINC01114 0.235 0.0709 0.558
exp GPC4 Xq26.1 -0.235 0.0709 0.558 cell proliferation;anatomical
met LIME1 20q13.3 -0.235 0.0709 0.558 regulation of release of
xsq DHX32 10q26.2 -0.235 0.0709 0.558
xsq PPAP2C 19p13 -0.235 0.0709 0.558
hs4 AMOT Xq23 -0.237 0.0709 0.558 regulation of cell
xai HLA-A -0.237 0.0709 0.558 cytokine-mediated signaling
pathway;antigen processing and presentation
xai CHCHD2P4 0.237 0.071 0.558
hs4 LSP1P3 5p13.3 0.237 0.071 0.558
xai LOC440910 0.237 0.071 0.558
his PNPLA5 22q13.31 0.237 0.071 0.558 metabolic process;lipid catabolic
process
his ORC2 2q33 0.237 0.071 0.558 DDR (DNA replication)
his ARFGAP2 11p11.2-p11.12 0.237 0.071 0.558 protein transport;vesicle-
mediated transport
his MIR6745 0.237 0.071 0.558
hs4 SLC10A4 4p11 0.237 0.071 0.558 Solute Carriers
hs4 TRAPPC8 18q12.1 0.237 0.071 0.558 vesicle-mediated transport;ER to
his LOC100128988 0.237 0.071 0.558
cop FBXO48 2p13.3 0.235 0.071 0.558
exp PRCC 1q21.1 0.235 0.071 0.558 cell cycle;mitotic cell cycle checkpoint
met KNDC1 10q26.3 0.235 0.071 0.558 regulation of dendrite
morphogenesis;regulation of catalytic activity
xsq PLK1 16p12.2 0.235 0.071 0.558 DDR (DNA replication); Protein Kinases
cop TPRG1-AS2 -0.235 0.071 0.558
swa TP53I3 2p23.3 -0.237 0.071 0.558 induction of apoptosis by
his ANKAR 2q32.2 -0.237 0.071 0.558
his GABRP 5q35.1 -0.237 0.071 0.558 ion transport
xai TRAPPC2L 16q24.3 0.237 0.0711 0.558 ER to Golgi vesicle-mediated
his PRTN3 19p13.3 0.237 0.0711 0.558 proteolysis;positive regulation of
cell proliferation
his ELANE 19p13.3 0.237 0.0711 0.558 cellular calcium ion
xai PMS2 7p22.2 0.237 0.0711 0.558 DNA Damage Response (DDR); DDR
(MMR)
his LOC101928295 0.237 0.0711 0.558
his CCDC155 19q13.33 0.237 0.0711 0.558 protein dephosphorylation
his TRUB2 9q34.11 0.237 0.0711 0.558 RNA processing;tRNA processing
his COQ4 9q34.11 0.237 0.0711 0.558 ubiquinone biosynthetic process
his MYO1A 12q13-q14 0.237 0.0711 0.558 microvillus assembly;vesicle
localization
xai MIR378E 0.237 0.0711 0.558
swa ZC3H15 2q32.1 0.237 0.0711 0.558 cytokine-mediated signaling
pathway
exp MIR378E 0.237 0.0711 0.558
xai LOC100506844 0.237 0.0711 0.558
his TRIAP1 12q24.31 0.237 0.0711 0.558 anti-apoptosis;DNA damage
his GATC 12q24.31 0.237 0.0711 0.558 regulation of translational
fidelity;mitochondrial translation
hs4 PCOLCE 7q22 0.237 0.0711 0.558 proteolysis;multicellular
hs4 PCOLCE-AS1 7q22.1 0.237 0.0711 0.558
his C18orf8 18q11.2 0.237 0.0711 0.558
xai FBXO45 3q29 0.237 0.0711 0.558 nervous system development;protein
ubiquitination
hs4 CNPY1 7q36.3 0.237 0.0711 0.558
mut POTEA 8p11.1 0.235 0.0711 0.558
xsq ZFP36L2 2p22.3-p21 0.235 0.0711 0.558 nuclear-transcribed mRNA
dependent
exp POLR2B 4q12 0.235 0.0711 0.558 DNA Damage Response (DDR); DDR
(NER)
xsq FRAT2 10q24.1 0.235 0.0711 0.558 Apoptosis
met TUBG2 17q21 0.235 0.0711 0.558 G2/M transition of mitotic cell
exp BEST3 12q14.2-q15 0.235 0.0711 0.558 ion transmembrane
transport;negative regulation of ion transport
exp FTH1P8 Xq28 -0.235 0.0711 0.558
exp TMEM125 1p34.2 -0.235 0.0711 0.558 EMT (Epithelial)
his RARRES2 7q36.1 -0.237 0.0711 0.558 retinoid metabolic
process;in utero embryonic development
xai PLPP2 -0.237 0.0711 0.558 sphingolipid metabolic
met CCL20 2q36.3 -0.237 0.0711 0.558 immune response;signal
transduction
his LINC00184 -0.237 0.0711 0.558
his KCNIP1 5q35.1 -0.237 0.0711 0.558 synaptic
transmission;positive regulation of action potential
hs4 PTGR1 9q31.3 -0.237 0.0711 0.558 leukotriene metabolic
hs4 ABCC3 17q22 -0.237 0.0711 0.558 ABC Transporters
his UROS 10q25.2-q26.3 0.237 0.0712 0.558 heme biosynthetic
process;tetrapyrrole biosynthetic process
his BCCIP 10q26.1 0.237 0.0712 0.558 regulation of cyclin-dependent
xai MAPKAPK5 12q24.13 0.237 0.0712 0.558 Ras protein signal
his SNORA71C 20q11.23 0.237 0.0712 0.558
his SNORA71D 20q11.23 0.237 0.0712 0.558
his SNHG17 20q11.23 0.237 0.0712 0.558
xai FUT7 9q34.3 0.237 0.0712 0.558 leukocyte migration involved in
xai ZNF804A 2q32.1 0.237 0.0712 0.558
his HTR1E 6q14-q15 0.237 0.0712 0.558 G-protein coupled receptor
signaling pathway;G-protein signaling, coupled to cyclic nucleotide second
messenger
his SF3B6 0.237 0.0712 0.558
his FAM228B 2p23.3 0.237 0.0712 0.558
DNA-dependent"
his GCN1 0.237 0.0712 0.558 translation;regulation of translation
xai CXADRP2 0.237 0.0712 0.558
xai SPSB2 12p13.31 0.237 0.0712 0.558 intracellular signal transduction
xsq MAP2K6 17q24.3 0.235 0.0712 0.558 Protein Kinases
cop AGPAT4 6q26 0.235 0.0712 0.558 metabolic process;phospholipid
xsq POP5 12q24.31 0.235 0.0712 0.558 tRNA processing;RNA metabolic
process
exp WBSCR22 7q11.23 0.235 0.0712 0.558 metabolic process;methylation
exp PPIAP24 13q33.3 -0.235 0.0712 0.558
exp COL1A2 7q22.1 -0.235 0.0712 0.558 axon guidance;protein
heterotrimerization
hs4 RARRES2 7q36.1 -0.237 0.0712 0.558 retinoid metabolic
his KCNH1 1q32.2 -0.237 0.0712 0.558 ion transport;potassium ion
transport
hs4 ASAP3 1p36.12 -0.237 0.0712 0.558 regulation of ARF GTPase
activity
his LINC02044 -0.237 0.0712 0.558
his ZNF503-AS1 -0.237 0.0712 0.558
xai NTRK1 1q21-q22 0.237 0.0713 0.558 activation of adenylate cyclase
xai SUV39H2 10p13 0.237 0.0713 0.558 chromatin assembly or
his PCYOX1 2p13.3 0.237 0.0713 0.558 chloride transport;prenylated
xai MRPS23 17q22-q23 0.236 0.0713 0.558 translation
exp LRIT3 4q25 0.236 0.0713 0.558
his KPTN 19q13.32 0.236 0.0713 0.558 cellular component movement;actin
his NAPA-AS1 0.236 0.0713 0.558
met PTGFRN 1p13.1 0.235 0.0713 0.558 lipid particle organization
exp BTAF1 10q22-q23 0.235 0.0713 0.558 negative regulation of
xsq TNNC2 20q12-q13.11 0.235 0.0713 0.558 regulation of muscle
contraction;muscle filament sliding
xsq MDH1B 2q33.3 0.235 0.0713 0.558 carbohydrate metabolic
process;tricarboxylic acid cycle
mut SMC5 9q21.12 0.235 0.0713 0.558 DNA Damage Response (DDR); DDR
exp CXCR2 2q35 0.235 0.0713 0.558 dendritic cell chemotaxis;neutrophil
chemotaxis
exp PTCD2 5q13.2 0.235 0.0713 0.558 mitochondrion organization;heart
development
xsq TTC21B 2q24.3 0.234 0.0713 0.558
xsq LINC01572 0.234 0.0713 0.558
xsq HNRNPLL 2p22.1 0.234 0.0713 0.558
xsq CATSPER1 11q12.1 -0.234 0.0713 0.558 spermatogenesis;fusion
of sperm to egg plasma membrane
exp CLMN 14q32.13 -0.234 0.0713 0.558
cop CFHR4 -0.235 0.0713 0.558 lipid transport
xsq FGD4 12p11.21 -0.235 0.0713 0.558 lamellipodium
assembly;microspike assembly
xai OR1R1P 17p13.3 0.236 0.0714 0.558
xai RGS14 5q35.3 0.236 0.0714 0.559 spindle organization;zygote
his PI4KB 1q21 0.236 0.0714 0.559 phosphatidylinositol biosynthetic
process;receptor-mediated endocytosis
his ICAM2 17q23.3 0.236 0.0714 0.559 cell-cell adhesion;regulation of
immune response
exp PHF8 Xp11.22 0.234 0.0714 0.559 G1/S transition of mitotic cell
xsq BRCA2 13q12.3 0.234 0.0714 0.559 Apoptosis; DNA Damage Response
exp FAT1 4q35 -0.234 0.0714 0.559 anatomical structure
xsq PQLC2L -0.234 0.0714 0.559
hs4 NALCN 13q32.3 -0.236 0.0714 0.559 ion transport;transmembrane
transport
his ANP32C 4q32.3 -0.236 0.0714 0.559
xai HSPB6 19q13.12 -0.236 0.0714 0.559 regulation of muscle
hs4 AGAP1 2q37 -0.236 0.0714 0.559 small GTPase mediated signal
his LMO2 11p13 0.236 0.0715 0.559 cellular response to thyroid hormone
his WDR34 9q34.11 0.236 0.0715 0.559
his LOC102723345 0.236 0.0715 0.559
his ILF3-AS1 19p13.2 0.236 0.0715 0.559
his ILF3 19p13.2 0.236 0.0715 0.559 M phase;negative regulation of
hs4 GABPB1 15q21.2 0.236 0.0715 0.559 positive regulation of
hs4 FLJ10038 15q21.2 0.236 0.0715 0.559
hs4 GABPB1-AS1 15q21.2 0.236 0.0715 0.559
xai POM121L10P 22q11.23 0.236 0.0715 0.559
xai SNORA74A 0.236 0.0715 0.559
exp SNORA74A 0.236 0.0715 0.559
met KLHL23 2q31.1 0.234 0.0715 0.559
exp DENND6B 22q13.33 0.234 0.0715 0.559
xsq PPP6R3 11q13 0.234 0.0715 0.559 DNA Damage Response (DDR)
exp IER2 19p13.2 0.234 0.0715 0.559
exp ARID2 12q12 0.234 0.0715 0.559 DNA Damage Response (DDR); DDR
(Chromatin)
exp NDUFB10 16p13.3 0.234 0.0715 0.559 mitochondrial electron
xsq CR1 1q32 0.234 0.0715 0.559 negative regulation of complement
activity
met SGPP1 14q23.2 0.234 0.0715 0.559 sphingolipid metabolic
process;sphinganine-1-phosphate metabolic process
exp LRR1 14q21.3 0.234 0.0715 0.559
xsq C12orf43 12q24.31 0.234 0.0715 0.559
xsq PTPRD-AS2 0.234 0.0715 0.559
xsq ACAA2 18q21.1 0.234 0.0715 0.559 acetyl-CoA metabolic process;lipid
metabolic process
cop CFHR1 1q32 -0.234 0.0715 0.559 complement activation
his LOC105377162 -0.236 0.0715 0.559
his SUN1 7p22.3 -0.236 0.0715 0.559 cytoskeletal anchoring at
nuclear membrane;nuclear matrix anchoring at nuclear membrane
xai PVRL3 3q13 -0.236 0.0715 0.559 adherens junction
xai CTSA 20q13.1 -0.236 0.0715 0.559 positive regulation of
his SPTLC3 20p12.1 -0.236 0.0715 0.559 small molecule metabolic
xai DDX6 11q23.3 0.236 0.0716 0.559 nuclear-transcribed mRNA catabolic
xai SNORA23 0.236 0.0716 0.559
exp SNORA23 0.236 0.0716 0.559
xai CISD2 4q24 0.236 0.0716 0.559 mitochondrion degradation;multicellular
organismal aging
exp RPS3AP20 5q14.1 0.234 0.0716 0.559
exp TCERG1L 10q26.3 0.234 0.0716 0.559
xsq LOC100131289 6p22.1 0.234 0.0716 0.559
xsq UBE2E1 3p24.2 0.234 0.0716 0.559 mitotic cell cycle spindle
met SPA17 11q24.2 0.234 0.0716 0.559 spermatogenesis;single
fertilization
exp LTBP2 14q24 -0.234 0.0716 0.559 protein targeting;transforming
growth factor beta receptor signaling pathway
met DLEC1 3p21.3 -0.234 0.0716 0.559 negative regulation of cell
proliferation
exp IFI27 14q32 -0.234 0.0716 0.559 activation of cysteine-type
exp PORCN Xp11.23 -0.234 0.0716 0.559 Wnt receptor signaling
pathway
mut SLITRK3 3q26.1 -0.234 0.0716 0.559 axonogenesis
his HTR1D 1p36.3-p34.3 -0.236 0.0716 0.559 synaptic
transmission;response to toxin
xai KRT18P37 8p11.21 -0.236 0.0716 0.559
his NPIPB13 -0.236 0.0716 0.559
xai CSTF1 20q13.2 0.236 0.0717 0.559 transcription from RNA polymerase
exp LOC440910 0.236 0.0717 0.559
his PIF1 15q22.31 0.236 0.0717 0.559 DNA Damage Response (DDR); DDR (DNA
replication)
his PPP4R3A 0.236 0.0717 0.56
exp PHF12 17q11.2 0.234 0.0717 0.559 negative regulation of
xsq SLC35E2B 1p36.33 0.234 0.0717 0.559 Solute Carriers
exp DCX Xq22.3-q23 0.234 0.0717 0.559 neuron migration;intracellular
signal transduction
cop KCTD1 18q11.2 0.234 0.0717 0.559 potassium ion transport;negative
xsq SSTR5 16p13.3 0.234 0.0717 0.559 glucose homeostasis;regulation of
insulin secretion
xsq USP51 Xp11.21 0.234 0.0717 0.559 proteolysis;ubiquitin-dependent
exp TNFSF12 -0.234 0.0717 0.559 apoptotic process;positive
his EPHX1 1q42.1 -0.236 0.0717 0.559 response to toxin;response to
xai SLC35F5 2q14.1 -0.236 0.0717 0.559 Solute Carriers
xai RAB17 2q37.3 -0.236 0.0717 0.559 protein transport;small
hs4 UGGT2 13q32.1 -0.236 0.0717 0.559 protein folding;protein
glycosylation
xai WBSCR22 7q11.23 0.236 0.0718 0.56 metabolic process;methylation
xai ESF1 20p12.1 0.236 0.0718 0.56 regulation of transcription, DNA-
dependent"
xai PPP2R5C 14q32.31 0.236 0.0718 0.56 protein processing;DNA damage
apoptosis
hs4 PARVG 22q13.31 0.236 0.0718 0.56 cell adhesion;cell-matrix adhesion
hs4 KIAA0895L 16q22.1 0.236 0.0718 0.56
xai EXOSC3 9p11 0.236 0.0718 0.56 exonucleolytic nuclear-transcribed
mRNA catabolic process involved in deadenylation-dependent decay;DNA deamination
cop RPS18P9 6q25.1 0.234 0.0718 0.56
cop KATNA1 6q25.1 0.234 0.0718 0.56 mitosis;protein localization
cop LATS1 6q25.1 0.234 0.0718 0.56 G2/M transition of mitotic cell
cop NUP43 6q25.1 0.234 0.0718 0.56 mitotic cell cycle;cytokine-
mut PIGW 17q12 0.234 0.0718 0.56 C-terminal protein lipidation;preassembly
met LOC100270746 6p22.2 0.234 0.0718 0.56
cop NEU3 11q13.5 0.234 0.0718 0.56 carbohydrate metabolic
met MED15 22q11.2 0.234 0.0718 0.56 regulation of transcription from
RNA polymerase II promoter;gene expression
exp NIF3L1 2q33 0.234 0.0718 0.56 positive regulation of
xsq LUM 12q21.33 -0.234 0.0718 0.56 visual perception;response to
cop VPS41 7p14-p13 -0.234 0.0718 0.56 intracellular protein
exp CSF1 1p13.3 -0.234 0.0718 0.56 positive regulation of gene
xai SH2D4A 8p21.2 -0.236 0.0718 0.56 negative regulation of
exp HMX1 4p16.1 0.236 0.0719 0.56 multicellular organismal
development;negative regulation of transcription, DNA-dependent"
his SSR4 Xq28 0.236 0.0719 0.56 translation;SRP-dependent cotranslational
his IDH3G Xq28 0.236 0.0719 0.56 2-oxoglutarate metabolic process;NADH
metabolic process
hs4 ACAP3 0.236 0.0719 0.56 filopodium assembly;signal transduction
hs4 PUSL1 1p36.33 0.236 0.0719 0.56 pseudouridine synthesis;tRNA
processing
hs4 MIR6727 0.236 0.0719 0.56
xai KIAA0101 15q22.31 0.236 0.0719 0.56
xai COQ3 6q16.2 0.236 0.0719 0.56 ubiquinone biosynthetic
xsq OMA1 1p32.2-p32.1 0.234 0.0719 0.56 proteolysis
mut LETM2 8p11.23 0.234 0.0719 0.56
met SLC25A51 9p13.3-p12 0.234 0.0719 0.56 transport
cop CHST9 18q11.2 0.234 0.0719 0.56 proteoglycan biosynthetic
mut PIWIL2 8p21.3 0.234 0.0719 0.56 multicellular organismal
development;oogenesis
exp RPL13P6 14q32.32 0.234 0.0719 0.56
exp AES 19p13.3 0.234 0.0719 0.56 cellular response to extracellular
stimulus;negative regulation of protein binding
exp ANKRD20A6P -0.234 0.0719 0.56
cop TBX20 7p14.3 -0.234 0.0719 0.56 endoderm formation;cardiac
right ventricle morphogenesis
cop SEC61G 7p11.2 -0.234 0.0719 0.56 antigen processing and
presentation of exogenous peptide antigen via MHC class I;cellular protein
metabolic process
hs4 RIN1 11q13.2 -0.236 0.0719 0.56 endocytosis;signal
transduction
his ATP1A4 1q23.2 -0.236 0.0719 0.56 potassium ion
xai MS4A3 11q12.1 0.236 0.072 0.56
his GOSR2 17q21 0.236 0.072 0.56 activation of signaling protein activity
involved in unfolded protein response;protein transport
xai DDX10 11q22-q23 0.236 0.072 0.56
xsq GAPT 5q11.2 0.234 0.072 0.56 B cell activation
cop FOXJ2 12p13.31 0.234 0.072 0.56 regulation of sequence-specific DNA
cop PARP11 12p13.3 0.234 0.072 0.56
met ZFP37 9q32 0.234 0.072 0.56 regulation of transcription, DNA-dependent;cell
proliferation
exp UBE2NL Xq27.3 0.234 0.072 0.56 DNA Damage Response (DDR)
cop EFCAB4B 0.234 0.072 0.56
exp GIMAP2 7q36.1 0.234 0.072 0.56
met CLEC18B 16q22.3 0.234 0.072 0.56
exp UBE2K 4p14 0.234 0.072 0.561 ubiquitin-dependent protein catabolic
xsq SLCO2A1 3q21 -0.234 0.072 0.56 Solute Carriers
his LINC00884 3q29 -0.236 0.072 0.56
his SGTA 19p13 0.236 0.0721 0.561 interspecies interaction between
organisms
his THOP1 19p13.3 0.236 0.0721 0.561 proteolysis
xai FAM27E2 0.236 0.0721 0.561
xsq CXorf56 Xq23 0.234 0.0721 0.561
xsq KCNAB3 17p13.1 0.234 0.0721 0.561 potassium ion
met RBP4 10q23.33 0.234 0.0721 0.561 male gonad development;retinol
metabolic process
xsq MRPL50 9q31.1 0.234 0.0721 0.561
cop KIAA0020 9p24.2 -0.234 0.0721 0.561
exp TBX15 1p11.1 -0.234 0.0721 0.561 embryonic cranial skeleton
morphogenesis
xsq PLBD2 12q24.13 -0.234 0.0721 0.561 lipid catabolic process
xsq TENM3 4q35.1 -0.234 0.0721 0.561
xsq LOC653513 -0.234 0.0721 0.561
xai ACKR2 3p21.3 -0.236 0.0721 0.561
xai MAFIP -0.236 0.0721 0.561 microtubule cytoskeleton
xai MGC24103 -0.236 0.0721 0.561
xai LOC100505625 -0.236 0.0721 0.561
hs4 ZNF30-AS1 -0.236 0.0721 0.561
DNA-dependent"
hs4 CD300LF 17q25.1 0.236 0.0722 0.561
hs4 GIPR 19q13.3 0.236 0.0722 0.561 desensitization of G-protein
process
xai SGOL1 3p24.3 0.236 0.0722 0.561 centriole-centriole
cohesion;meiotic chromosome segregation
xsq POLR3G 5q14.3 0.234 0.0722 0.561 positive regulation of innate
exp MRPS25 3p25 0.234 0.0722 0.561 translation
xsq PLD4 14q32.33 0.234 0.0722 0.561 lipid catabolic process
xsq SUCLG1 2p11.2 0.234 0.0722 0.561 tricarboxylic acid
cycle;succinyl-CoA metabolic process
exp LRP11 6q25.1 -0.234 0.0722 0.561
exp MAP3K6 1p36.11 -0.234 0.0722 0.561 Protein Kinases
xsq C11orf88 11q23.1 -0.234 0.0722 0.561
exp PRR16 5q23.1 -0.234 0.0722 0.561
xsq ZNF35 3p21.32 -0.234 0.0722 0.561 regulation of transcription,
exp DNAJC6 1p31.3 -0.234 0.0722 0.561 post-Golgi vesicle-
xai FAT3 11q14.3 -0.236 0.0722 0.561 multicellular organismal
his SORD 15q15.3 0.236 0.0723 0.561 glucose metabolic process;sorbitol
catabolic process
xai TTI1 20q11.23 0.236 0.0723 0.561 DNA Damage Response (DDR)
his MIB2 1p36.33 0.236 0.0723 0.561 signal transduction;Notch signaling
pathway
hs4 ANTXR2 4q21.21 0.236 0.0723 0.561
xai C1orf50 1p34.2 0.236 0.0723 0.561
xai C10orf112 0.236 0.0723 0.561
his FAM98A 2p22.3 0.236 0.0723 0.561
hs4 SSTR3 22q13.1 0.236 0.0723 0.561 cell-cell signaling;cellular
xsq MLX 17q21.1 0.234 0.0723 0.561 energy reserve metabolic
exp OIP5 15q15.1 0.234 0.0723 0.561 cell communication;CenH3-containing
met NEUROD4 12q13.2 0.234 0.0723 0.561
exp LOC727713 2q22.3 0.234 0.0723 0.561
exp TEX19 17q25.3 0.234 0.0723 0.561
exp MYOM2 8p23.3 0.234 0.0723 0.561 muscle contraction
exp ZFP69 1p34.2 0.234 0.0723 0.561
exp HIST1H2BF 6p22.1 0.234 0.0723 0.561
xsq LOC440602 0.234 0.0723 0.561
exp MPV17L2 19p13.11 0.234 0.0723 0.561
xsq LOC101928514 0.234 0.0723 0.561
xsq DYRK4 12p13.32 0.234 0.0723 0.561 protein phosphorylation
xsq SPIN3 Xp11.21 -0.234 0.0723 0.561 gamete generation
xsq CDC42EP1 22q13.1 -0.234 0.0723 0.561 regulation of cell
hs4 KCNIP4 4p15.32 -0.236 0.0723 0.561 ion transport;potassium
ion transport
his MYOF 10q24 -0.236 0.0723 0.561 plasma membrane repair;muscle
contraction
hs4 PCDH1 5q31.3 -0.236 0.0723 0.561 nervous system
xai CPSF3L 1p36.33 0.238 0.0724 0.561
his SZRD1 1p36.13 0.236 0.0724 0.561
his H2AFX 11q23.3 0.236 0.0724 0.561 DNA Damage Response (DDR); DDR (HR)
xai KCNH2 7q36.1 0.236 0.0724 0.561 synaptic transmission;blood
circulation
xai NIF3L1 2q33 0.236 0.0724 0.561 positive regulation of
xai USMG5 10q24.33 0.236 0.0724 0.561
his C4orf17 4q23 0.236 0.0724 0.561
his CCDC59 12q21.31 0.236 0.0724 0.561 regulation of transcription,
DNA-dependent"
his METTL25 12q21.31 0.236 0.0724 0.561
his PARM1 4q13.3-q21.3 0.236 0.0724 0.561 positive regulation of
telomerase activity
xai DPAGT1 11q23.3 0.236 0.0724 0.561 dolichol biosynthetic
process;post-translational protein modification
exp HNRNPA1P54 0.236 0.0724 0.561
xsq MGME1 20p11.23 0.234 0.0724 0.561
xsq GID8 20q13.33 0.234 0.0724 0.561
xsq YDJC 22q11.21 0.234 0.0724 0.561 carbohydrate metabolic process
met PRKCD 3p21.31 0.234 0.0724 0.561 Protein Kinases
xsq TTC28-AS1 22q12.1 0.234 0.0724 0.561
exp ANGEL1 14q24.3 0.234 0.0724 0.561
xsq SMYD5 2p13.2 0.234 0.0724 0.561
exp PQLC2L -0.234 0.0724 0.561
met CTRC 1p36.21 -0.234 0.0724 0.561 proteolysis
cop LOC401324 -0.234 0.0724 0.561
exp PTGR1 9q31.3 -0.234 0.0724 0.561 leukotriene metabolic
hs4 PLAT 8p12 -0.236 0.0724 0.561 protein modification
process;proteolysis
xai DNAJC6 1p31.3 -0.236 0.0724 0.561 post-Golgi vesicle-
his GBA3 4p15.2 -0.236 0.0724 0.561 small molecule metabolic
process;glycosylceramide catabolic process
xai TLE3 15q22 0.236 0.0725 0.562 regulation of transcription, DNA-
his SHISA3 4p13 0.236 0.0725 0.562 multicellular organismal
development
his NONO Xq13.1 0.236 0.0725 0.562 DNA repair;DNA recombination
xai ZNF346 5q35.2 0.236 0.0725 0.562 apoptotic process
xai DCX Xq22.3-q23 0.236 0.0725 0.562 neuron migration;intracellular
signal transduction
exp LOC728739 12q23.3 0.236 0.0725 0.562
mir hsa-miR-125a-3p 0.234 0.0725 0.562
xsq COPS7B 2q37.1 0.234 0.0725 0.562 DNA Damage Response (DDR)
xsq LOC105372795 0.234 0.0725 0.562
met RRBP1 20p12 0.234 0.0725 0.562 protein transport;translation
exp CCDC88C 14q32.11 0.234 0.0725 0.562 microtubule cytoskeleton
exp UBC 12q24.3 -0.234 0.0725 0.562 DNA Damage Response (DDR)
exp PTGIS 20q13.13 -0.234 0.0725 0.562 prostaglandin biosynthetic
process;cellular response to interleukin-1
his SYS1 20q13.12 -0.236 0.0725 0.562 protein transport
his SYS1-DBNDD2 20q13.12 -0.236 0.0725 0.562
his CPB2 13q14.11 0.236 0.0726 0.562 blood coagulation;metabolic process
xai XPO6 16p11.2 0.236 0.0726 0.562 protein export from
DNA-dependent"
his PCGF6 10q24.33 0.235 0.0726 0.562 negative regulation of
xai ERICH1 8p23.3 0.235 0.0726 0.562
xai ALG6 1p31.3 0.235 0.0726 0.562 protein N-linked
his SMARCC1 3p21.31 0.235 0.0726 0.562 DNA Damage Response (DDR);
DDR (Chromatin)
xai GAPDHP72 6q27 0.235 0.0726 0.562
cop BCL7A 12q24.13 0.234 0.0726 0.562 negative regulation of
cop MLXIP 12q24.31 0.234 0.0726 0.562 regulation of transcription, DNA-
dependent"
cop IL31 12q24.31 0.234 0.0726 0.562
mut AHDC1 1p36.13 0.234 0.0726 0.562
exp RFT1 3p21.1 0.234 0.0726 0.562 cellular protein metabolic
xsq MIF4GD 17q25.1 0.234 0.0726 0.562 RNA metabolic
process;regulation of translation
cop MAP3K4 6q26 0.233 0.0726 0.562 Protein Kinases
cop AGPAT4-IT1 6q26 0.233 0.0726 0.562
xsq LOC399815 10q26.13 0.233 0.0726 0.562
exp PLCH1 3q25.31 0.233 0.0726 0.562 intracellular signal
xsq LOC442497 0.233 0.0726 0.562
exp HINT3 6q22.32 0.233 0.0726 0.562
cop APLF 2p13.3 0.233 0.0726 0.562 DNA Damage Response (DDR); DDR
(BER)
xsq NPRL2 3p21.3 0.233 0.0726 0.562 protein phosphorylation;negative
exp CRACR2A 0.233 0.0726 0.562 activation of store-operated
calcium channel activity;positive regulation of calcium ion transport
xsq EVC 4p16 -0.233 0.0726 0.562 muscle organ development;positive
regulation of smoothened signaling pathway
exp SEMA5B 3q21.1 -0.233 0.0726 0.562 nervous system
exp HNMT 2q22.1 -0.233 0.0726 0.562 brain development;respiratory
gaseous exchange
xsq PDGFD 11q22.3 -0.233 0.0726 0.562 multicellular organismal
hs4 LMO7-AS1 -0.235 0.0726 0.562
hs4 LMO7 13q22.2 -0.235 0.0726 0.562 protein ubiquitination
his RPP30 10q23.31 0.235 0.0727 0.562 tRNA processing
his UTP20 12q23 0.235 0.0727 0.562 rRNA processing;negative regulation of
cell proliferation
exp RPL5P6 1p22.2 0.235 0.0727 0.562
exp TMEM215 9p21.1 0.235 0.0727 0.562
his ZNF691 1p34.2 0.235 0.0727 0.562
his MIR4784 0.235 0.0727 0.562
his MZT2A 2q21.1 0.235 0.0727 0.562
his LOC150776 2q21.1 0.235 0.0727 0.562
hs4 TYROBP 19q13.1 0.235 0.0727 0.562 cellular defense
xsq CDAN1 15q15.2 0.233 0.0727 0.562
exp NOA1 4q12 0.233 0.0727 0.562 mitochondrial translation;regulation of
xsq MEAF6 1p35.3-p33 0.233 0.0727 0.562 regulation of transcription, DNA-
exp THSD7A 7p21.3 0.233 0.0727 0.562
met DGKQ 4p16.3 0.233 0.0727 0.562 G-protein coupled receptor
signaling pathway;protein kinase C signaling cascade
xsq WDR77 1p13.2 0.233 0.0727 0.562 regulation of transcription from
exp DNAJC8 1p35.3 0.233 0.0727 0.562 nuclear mRNA splicing, via
exp TYW3 1p31.1 0.233 0.0727 0.562 tRNA processing
his IGFN1 1q32.1 -0.235 0.0727 0.562
hs4 MIR4757 -0.235 0.0727 0.562
hs4 DYRK2 12q15 -0.235 0.0727 0.562 DNA damage response, signal
transduction by p53 class mediator resulting in induction of apoptosis;positive
regulation of glycogen biosynthetic process
his OR2A9P -0.235 0.0727 0.562
his MIR4786 0.235 0.0728 0.562
hs4 SHANK1 19q13.3 0.235 0.0728 0.562 neuromuscular process
controlling balance;protein complex assembly
xai STOML2 9p13.1 0.235 0.0728 0.562
xai KIR3DL3 0.235 0.0728 0.562
xai VPS72 1q21 0.235 0.0728 0.562 somatic stem cell maintenance;negative
swa SEPT6 Xq24 0.235 0.0728 0.562 cytokinesis;cell cycle
xsq SRSF3 6p21 0.233 0.0728 0.562 nuclear mRNA splicing, via
xsq LOC389641 0.233 0.0728 0.562
met BACE2 21q22.3 0.233 0.0728 0.562 proteolysis;membrane protein
cop HEATR5B 2p22.2 0.233 0.0728 0.562
DNA-dependent"
cop SPCS2 11q13.4 0.233 0.0728 0.562 signal peptide
xsq CCDC39 3q26.33 0.233 0.0728 0.562 axonemal dynein complex
met ITGB1 10p11.2 0.233 0.0728 0.562 Apoptosis
met LY6K 8q24.3 0.233 0.0728 0.562
exp SCUBE2 11p15.3 -0.233 0.0728 0.562
exp RAB42 1p35.3 -0.233 0.0728 0.562 small GTPase mediated signal
transduction
exp XAGE2B -0.233 0.0728 0.562
exp CDRT8 -0.235 0.0728 0.562
hs4 PRICKLE2-AS3 -0.235 0.0728 0.562
xai GAPDHP70 11q14.2 0.235 0.0729 0.562
swa UBA1 Xp11.23 0.235 0.0729 0.563 DNA Damage Response (DDR)
exp ESF1 20p12.1 0.235 0.0729 0.563 regulation of transcription, DNA-
dependent"
xai MFSD2B 2p23.3 0.235 0.0729 0.563 transport
xai EIF3LP2 10q11.21 0.235 0.0729 0.563
xai CRAMP1 0.235 0.0729 0.563
his PPP5C 19q13.3 0.235 0.0729 0.563 signal transduction;positive
met ARHGEF3 3p14.3 0.233 0.0729 0.562 regulation of small GTPase
met FBXO34 14q22.3 0.233 0.0729 0.562
mut ITGB7 12q13.13 0.233 0.0729 0.563 cell-matrix adhesion;integrin-
met GAB1 4q31.21 0.233 0.0729 0.563 epidermal growth factor receptor
exp SPOCK2 10pter-q25.3 0.233 0.0729 0.563 peptide cross-linking
xsq NFXL1 4p12 0.233 0.0729 0.563
exp ITM2C 2q37 0.233 0.0729 0.563 negative regulation of neuron projection
exp SOX13 1q32 -0.233 0.0729 0.562 regulation of transcription, DNA-
exp PAMR1 11p13 -0.233 0.0729 0.562
xai FAM127A Xq26 -0.235 0.0729 0.563
his LGALS3BP 17q25 -0.235 0.0729 0.562 cellular defense
his NXPH2 2q22.1 -0.235 0.0729 0.562 neuropeptide signaling
pathway
xai DMRTA1 9p21.3 -0.235 0.0729 0.562 regulation of
transcription, DNA-dependent;sex differentiation
his MCM9 6q22.31 0.235 0.073 0.563 DNA replication
xai RPARP-AS1 0.235 0.073 0.563
xai FBXO15 18q22.3 0.235 0.073 0.563
exp PMS2 7p22.2 0.235 0.073 0.563 DNA Damage Response (DDR); DDR (MMR)
xai UCP2 11q13 0.235 0.073 0.563 transport;small molecule metabolic process
hs4 PROKR2 20p12.3 0.235 0.073 0.563
his HCG11 6p22.2 0.235 0.073 0.563
mut C12orf60 12p12.3 0.233 0.073 0.563
exp B3GALT6 1p36.33 0.233 0.073 0.563 protein
xsq SPATA32 17q21.31 0.233 0.073 0.563
met KALRN 3q21.2 0.233 0.073 0.563 protein phosphorylation;intracellular
signal transduction
xsq CLPB 11q13.4 0.233 0.073 0.563 cellular response to heat
exp SF3A2 19p13.3 0.233 0.073 0.563 mRNA processing;RNA splicing
exp ADAMTS16 5p15 -0.233 0.073 0.563 proteolysis
exp ALDH1L2 12q23.3 -0.233 0.073 0.563 biosynthetic process;10-
xsq SPEG 2q35 -0.233 0.073 0.563 muscle organ development;negative
xai CDRT8 -0.235 0.073 0.563
hs4 SH3D19 4q31.3 -0.235 0.073 0.563 post-Golgi vesicle-mediated
xai ZNF300 5q33.1 -0.235 0.073 0.563 regulation of transcription,
DNA-dependent"
xai PADI4 1p36.13 0.235 0.0731 0.563 regulation of transcription, DNA-
hs4 GAS7 17p13.1 0.235 0.0731 0.563 neuron projection
his NUP205 7q33 0.235 0.0731 0.563 protein transport;glucose transport
exp TPO 2p25 0.235 0.0731 0.563 thyroid hormone generation;response to
oxidative stress
his GPATCH4 1q22 0.235 0.0731 0.563
hs4 EPOR 19p13.3-p13.2 0.235 0.0731 0.563 signal transduction;elevation
of cytosolic calcium ion concentration
xai LOC100507316 0.235 0.0731 0.563
xai PARP8 5q11.1 0.235 0.0731 0.563
cop MYLPF 16p11.2 0.233 0.0731 0.563 immune response;skeletal muscle
tissue development
cop SEPT1 16p11.1 0.233 0.0731 0.563 cell cycle;cell division
cop ZNF48 16p11.2 0.233 0.0731 0.563 regulation of transcription, DNA-
dependent"
DNA-dependent"
cop DCTPP1 16p11.2 0.233 0.0731 0.563 nucleoside triphosphate
cop SEPHS2 16p11.2 0.233 0.0731 0.563 selenocysteine biosynthetic
process
met CADM1 11q23.2 0.233 0.0731 0.563 homophilic cell
adhesion;susceptibility to natural killer cell mediated cytotoxicity
xsq POLI 18q21.1 0.233 0.0731 0.563 DNA Damage Response (DDR); DDR (DNA
met LHX3 9q34.3 0.233 0.0731 0.563 positive regulation of
transcription, DNA-dependent;inner ear development
exp DCUN1D1 3q26.3 0.233 0.0731 0.563
xsq EXOC6 10q23.33 0.233 0.0731 0.563 protein transport;vesicle docking
xsq C17orf62 17q25.3 0.233 0.0731 0.563
cop CLEC6A 0.233 0.0731 0.563
xsq CTDNEP1 17p13 0.233 0.0731 0.563 protein dephosphorylation;nuclear
envelope organization
xsq SUZ12 17q11.2 0.233 0.0731 0.563 regulation of transcription, DNA-
xsq C8orf37 8q22.1 0.233 0.0731 0.563
xsq KLRC2 0.233 0.0731 0.563 cellular defense response;signal
transduction
met MIR1296 -0.233 0.0731 0.563
met HRASLS2 11q12.3 -0.233 0.0731 0.563 lipid catabolic process
his TTC39A-AS1 -0.235 0.0731 0.563
his LINC02102 -0.235 0.0731 0.563
xai FETUB 3q27 -0.235 0.0731 0.563
xai LOC645553 -0.235 0.0731 0.563
xai STAT2 12q13.3 -0.235 0.0731 0.563 Apoptosis
xai EIF3FP3 2p16.1 0.235 0.0732 0.563
DNA-dependent"
his MRPS35 12p11 0.235 0.0732 0.563 peptide biosynthetic process;DNA
swa COPS4 4q21.22 0.235 0.0732 0.563 DNA Damage Response (DDR)
xsq CERS6-AS1 0.233 0.0732 0.563
exp DCLRE1B 1p13.2 0.233 0.0732 0.563 DNA Damage Response (DDR)
xsq TRA2B 3q26.2-q27 0.233 0.0732 0.563 response to reactive oxygen
species;RNA splicing, via transesterification reactions
cop FAM84A 2p24.3 0.233 0.0732 0.563
xsq LINC00210 0.233 0.0732 0.563
mut KEAP1 19p13.2 0.233 0.0732 0.563 in utero embryonic
met C2orf44 2p23.3 -0.233 0.0732 0.563
met CD101 1p13 -0.233 0.0732 0.563 cell surface receptor signaling
pathway
xsq ASAP3 1p36.12 -0.233 0.0732 0.563 regulation of ARF GTPase
activity
xai PNPLA3 22q13.31 -0.235 0.0732 0.563 triglyceride catabolic
exp C2orf73 2p16.2 -0.235 0.0732 0.563
xai SERTAD4-AS1 1q32.2 -0.235 0.0732 0.563
exp FCRL3 1q21-q22 -0.235 0.0732 0.563
his LYPD1 2q21.2 -0.235 0.0732 0.563
hs4 NPAS2 2q11.2 -0.235 0.0732 0.563 regulation of transcription,
DNA-dependent;central nervous system development
DNA-dependent"
xai THAP4 2q37.3 0.235 0.0733 0.563
hs4 CHRNA3 15q24 0.235 0.0733 0.563 cation transport;locomotory
behavior
exp QRSL1P2 0.235 0.0733 0.563
his FGR 1p36.2-p36.1 0.235 0.0733 0.563 immune response-regulating
his STAT5B 17q11.2 0.235 0.0733 0.563 Apoptosis
xai QRSL1P2 0.235 0.0733 0.563
xai POGZ 1q21.3 0.235 0.0733 0.563 regulation of transcription, DNA-
dependent;cell cycle
xai NDFIP2-AS1 0.235 0.0733 0.563
exp MBNL3 Xq26.2 0.233 0.0733 0.563 mRNA processing;multicellular
xsq PAN3 13q12.2 0.233 0.0733 0.563 gene expression;RNA metabolic
process
xsq KRTAP10-6 0.233 0.0733 0.563
exp CDCA7L 7p15.3 0.233 0.0733 0.563 regulation of transcription,
exp NME1-NME2 0.233 0.0733 0.563 CTP biosynthetic process;GTP
xsq COX7A2L 2p21 0.233 0.0733 0.563 respiratory electron transport
xsq ODF2 9q34.11 0.233 0.0733 0.563 cell differentiation;G2/M
cop AICDA 0.233 0.0733 0.563
xsq FAM49A 2p24.2 -0.233 0.0733 0.563
xsq TRPM4 19q13.33 -0.233 0.0733 0.563 dendritic cell
hs4 CEP112 17q24.1 -0.235 0.0733 0.563
hs4 WDR35 2p24.1 -0.235 0.0733 0.563 cell projection
hs4 LOC101928222 -0.235 0.0733 0.563
xai MRPL46 15q25.3 0.235 0.0734 0.563
his SMG5 1q21.2 0.235 0.0734 0.563 mRNA metabolic process;regulation
of dephosphorylation
his TMEM79 1q22 0.235 0.0734 0.563
his ABHD15 17q11.2 0.235 0.0734 0.563
his TP53I13 17q11.2 0.235 0.0734 0.563
his IP6K2 3p21.31 0.235 0.0734 0.563 Apoptosis
his DOK3 5q35.3 0.235 0.0734 0.563 Ras protein signal transduction
xai FUNDC2P4 22q13.1 0.235 0.0734 0.563
his IL18RAP 2q12 0.235 0.0734 0.563 inflammatory response;immune
response
his SARNP 12q13.2 0.235 0.0734 0.563 regulation of transcription, DNA-
dependent;regulation of translation"
his ORMDL2 12q13.2 0.235 0.0734 0.563 ceramide metabolic process
exp NDFIP2-AS1 0.235 0.0734 0.563
met JUP 17q21 0.233 0.0734 0.563 desmosome assembly;morphogenesis of
embryonic epithelium
mut PEX5L 3q26.33 0.233 0.0734 0.563 protein import into peroxisome
xsq BEX5 Xq22.1 0.233 0.0734 0.563
cop CCND2 12p13 0.233 0.0734 0.563 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
cop BBS2 16q21 0.233 0.0734 0.563 striatum development;negative regulation
of multicellular organism growth
xsq MYLK2 20q13.31 0.233 0.0734 0.563 positive regulation of gene
expression;regulation of neuronal synaptic plasticity
exp HSPA8 11q24.1 0.233 0.0734 0.563 Apoptosis
met CFH 1q32 0.233 0.0734 0.563 complement activation, alternative
xsq CNOT8 5q31-q33 0.233 0.0734 0.563 gene expression;RNA metabolic
process
exp GNPAT 1q42 0.233 0.0734 0.563 phospholipid biosynthetic process;small
exp USP32P3 17p11.1 -0.233 0.0734 0.563
xsq A4GALT 22q13.2 -0.233 0.0734 0.563 lipid biosynthetic
met PER1 17p13.1 -0.233 0.0734 0.563 DNA Damage Response (DDR)
xai CAMK2D 4q26 -0.235 0.0734 0.563 calcium ion
transport;regulation of ryanodine-sensitive calcium-release channel activity
xai MAST2 1p34.1 -0.235 0.0734 0.563 protein
phosphorylation;regulation of interleukin-12 biosynthetic process
xai TGIF1 18p11.3 -0.235 0.0734 0.563 negative regulation of cell
xai PKDREJ 22q13.31 0.235 0.0735 0.563 ion transport;neuropeptide
signaling pathway
his PA2G4 12q13.2 0.235 0.0735 0.563 rRNA processing;regulation of
translation
hs4 OR2L13 1q44 0.235 0.0735 0.563 response to stimulus
his DOHH 19p13.3 0.235 0.0735 0.564 peptidyl-lysine modification to
hypusine;post-translational protein modification
hs4 NRIP2 12p13.33 0.235 0.0735 0.564
hs4 LOC100507424 0.235 0.0735 0.564
his LRRC55 11q12.1 0.235 0.0735 0.564
met ERGIC3 20pter-q12 0.233 0.0735 0.563 vesicle-mediated transport
xsq DCAF12 9p13.3 0.233 0.0735 0.563 protein ubiquitination
met GPR180 13q32.1 0.233 0.0735 0.563
exp RPUSD4 11q24.2 0.233 0.0735 0.563 pseudouridine synthesis
met PIM3 22q13 0.233 0.0735 0.563 cell cycle;regulation of mitotic cell
cycle
exp STRADA 17q23.3 0.233 0.0735 0.564 positive regulation of
exp ELANE 19p13.3 0.233 0.0735 0.564 cellular calcium ion
xsq AEN 15q26.1 0.233 0.0735 0.564 apoptotic process;response to DNA
damage stimulus
cop CTTN 11q13 0.233 0.0735 0.564
exp SAA4 11p15.1-p14 -0.233 0.0735 0.563 acute-phase response
xai SASH1 6q24.3 -0.235 0.0735 0.563
hs4 KLHDC8A 1q32.1 -0.235 0.0735 0.563
xai MT1B 16q13 -0.235 0.0735 0.563 negative regulation of
swa PPP5C 19q13.3 0.235 0.0736 0.564 signal transduction;positive
his CENPM 22q13.2 0.235 0.0736 0.564 M phase of mitotic cell
his LINC00634 0.235 0.0736 0.564
swa PELP1 17p13.2 0.235 0.0736 0.564 transcription, DNA-dependent"
met ZSCAN21 7q22.1 0.233 0.0736 0.564 regulation of transcription,
DNA-dependent;viral reproduction
met C1orf229 1q44 0.233 0.0736 0.564
exp FGFR1OP2 12p11.23 0.233 0.0736 0.564 response to wounding
exp LOC100287015 8p23.1 0.233 0.0736 0.564
xsq UBE2D3 4q24 0.233 0.0736 0.564 protein modification
process;proteasomal ubiquitin-dependent protein catabolic process
exp GNA13 17q24.3 0.233 0.0736 0.564 cellular component movement;cell
differentiation
xsq EPX 17q23.1 0.233 0.0736 0.564 response to oxidative
stress;hydrogen peroxide catabolic process
met PYY 17q21.1 -0.233 0.0736 0.564 negative regulation of
response to food;cellular component movement
met KRT85 12q13 -0.233 0.0736 0.564 epidermis development
exp SUSD6 -0.233 0.0736 0.564
hs4 INHBA 7p15-p13 -0.235 0.0736 0.564 hair follicle
xai ENAM 4q13.3 0.235 0.0737 0.564 bone mineralization;odontogenesis
xai HMGB3P30 Xq23 0.235 0.0737 0.564
his PTPDC1 9q22.32 0.235 0.0737 0.564
exp FOXO4 Xq13.1 0.233 0.0737 0.564 Apoptosis
xsq LINC01007 0.233 0.0737 0.564
xsq WDHD1 14q22.2 0.233 0.0737 0.564 DDR (DNA replication)
xsq ATXN7L2 1p13.3 0.233 0.0737 0.564
exp CELSR3 3p21.31 0.233 0.0737 0.564 G-protein coupled receptor
xsq C11orf1 11q23.1 0.233 0.0737 0.564
exp LINC01278 -0.233 0.0737 0.564
exp SNX9 6q25.1-q26 -0.233 0.0737 0.564 intracellular protein
exp CREB3L2 7q34 -0.233 0.0737 0.564 chondrocyte
met UMODL1-AS1 -0.233 0.0737 0.564
exp FETUB 3q27 -0.235 0.0737 0.564
swa LGALS1 22q13.1 -0.235 0.0737 0.564 Apoptosis
exp LOC645553 -0.235 0.0737 0.564
hs4 TRAF3IP2 6q21 -0.235 0.0737 0.564 intracellular signal
hs4 CIRBP-AS1 19p13.3 0.235 0.0738 0.564
hs4 CIRBP 19p13.3 0.235 0.0738 0.564 response to cold;response to UV
hs4 C19orf24 19p13.3 0.235 0.0738 0.564
exp DGKZP1 13q14.11 0.235 0.0738 0.564
mut XIRP2 2q24.3 0.233 0.0738 0.565 actin cytoskeleton organization
exp BLOC1S5 6p25.1-p24.3 0.232 0.0738 0.565
exp CHAF1A 19p13.3 0.232 0.0738 0.565 DNA Damage Response (DDR);
xsq FAM117A 17q21.33 0.232 0.0738 0.565
xsq KANK2 19p13.2 -0.233 0.0738 0.565
xsq DLC1 8p22 -0.233 0.0738 0.565 induction of apoptosis;actin
xai DMTN 8p21.1 -0.234 0.0738 0.565
his FLVCR2 14q24.3 -0.235 0.0738 0.565 heme
his LOC102724153 -0.235 0.0738 0.565
his SLC35F6 2p23.3 -0.235 0.0738 0.564
his MLC1 22q13.33 0.234 0.0739 0.565 cellular response to
hs4 LIN28B 6q21 0.234 0.0739 0.565 miRNA catabolic process;gene
silencing by RNA
xai DGKZP1 13q14.11 0.234 0.0739 0.565
xai LOC100506858 0.234 0.0739 0.565
his SRD5A3-AS1 0.234 0.0739 0.565
exp LOC100507373 0.234 0.0739 0.565
his SMC2-AS1 0.234 0.0739 0.565
his SMC2 9q31.1 0.234 0.0739 0.565 DNA Damage Response (DDR); DDR (DNA
replication)
xai LGALS12 11q13 0.234 0.0739 0.565 induction of apoptosis by
xsq RPL29 3p21.3-p21.2 0.232 0.0739 0.565 nuclear-transcribed mRNA
exp CISD2 4q24 0.232 0.0739 0.565 mitochondrion degradation;multicellular
organismal aging
exp IL12RB1 19p13.1 0.232 0.0739 0.565 signal transduction;positive
xsq SET 9q34 0.232 0.0739 0.565 nucleosome disassembly;nucleocytoplasmic
transport
met SRPX2 Xq21.33-q23 0.232 0.0739 0.565 angiogenesis;cell-cell adhesion
exp MAPK6PS6 10q11.23 0.232 0.0739 0.565
exp SMC3 10q25 0.232 0.0739 0.565 DNA Damage Response (DDR); DDR (DNA
replication)
xsq CCNB1IP1 14q11.2 0.232 0.0739 0.565 meiotic metaphase I;spermatid
development
exp ZC3H4 19q13.32 0.232 0.0739 0.565
xsq LOC100240728 0.232 0.0739 0.565
xsq MCAT 22q13.31 0.232 0.0739 0.565 fatty acid biosynthetic
exp HSD17B1 17q11-q21 -0.232 0.0739 0.565 small molecule metabolic
process;steroid biosynthetic process
met LIAS 4p14 -0.232 0.0739 0.565 lipoate biosynthetic
process;response to lipopolysaccharide
cop PTPRD 9p23-p24.3 -0.232 0.0739 0.565 transmembrane receptor
protein tyrosine phosphatase signaling pathway;protein dephosphorylation
xsq RELL1 4p14 -0.232 0.0739 0.565
exp TTC12 11q23.2 -0.232 0.0739 0.565
xai OSTCP1 6q25.3 0.234 0.074 0.565
xai GIMAP2 7q36.1 0.234 0.074 0.565
his COQ8A 0.234 0.074 0.565
his CSPG4P1Y 0.234 0.074 0.565
his KAT7 17q21.32 0.234 0.074 0.565 chromatin modification;histone H3
acetylation
his KPNA5 6q22.1 0.234 0.074 0.565 cytokine-mediated signaling
xai RNY1 7q36 0.234 0.074 0.565
xsq ANAPC7 12q24.11 0.232 0.074 0.565 anaphase-promoting complex-
dependent"
xsq NAV1 1q32.3 -0.232 0.074 0.565 microtubule bundle formation;neuron
migration
exp HOXB2 17q21.32 -0.232 0.074 0.565 anterior/posterior pattern
exp GSTA2 6p12.1 -0.232 0.074 0.565 small molecule metabolic
process;glutathione metabolic process
xai C8orf46 8q13.1 -0.234 0.074 0.565
xai S100A11 1q21 -0.234 0.074 0.565 signal transduction;negative
hs4 DNASE1L2 16p13.3 -0.234 0.074 0.565 DNA metabolic process;DNA
catabolic process
exp LOC100506901 -0.234 0.074 0.565
his UBTF 17q21.31 0.234 0.0741 0.565 chromatin silencing at
his FLT3 13q12 0.234 0.0741 0.565 Cell Signaling; Oncogenes
cop SETD6 16q21 0.234 0.0741 0.565 peptidyl-lysine monomethylation;negative
regulation of NF-kappaB transcription factor activity
xai RPL5P6 1p22.2 0.234 0.0741 0.565
xai ANKRD36BP2 2p11.2 0.234 0.0741 0.565
his CDX1 5q32 0.234 0.0741 0.565 anterior/posterior pattern
specification;positive regulation of transcription from RNA polymerase II promoter
xai SCAP 3p21.31 0.234 0.0741 0.565 negative regulation of cholesterol
met CNGA3 2q11.2 0.232 0.0741 0.565 retinal cone cell
development;response to stimulus
met CACHD1 1p31.3 0.232 0.0741 0.565 ion transport;calcium ion
transport
xsq RPL17 18q21 0.232 0.0741 0.565 translational termination;cellular
xsq CHML 1q43 0.232 0.0741 0.565 intracellular protein transport;visual
perception
xsq PLCL1 2q33 0.232 0.0741 0.565 lipid metabolic process;behavior
exp PVRL3 3q13 -0.232 0.0741 0.565 adherens junction
cop AOAH 7p14-p12 -0.232 0.0741 0.565 lipopolysaccharide metabolic
hs4 WTIP 19q13.11 -0.234 0.0741 0.565 regulation of transcription,
DNA-dependent;cytoskeleton organization
his C8orf86 8p11.22 -0.234 0.0741 0.565
hs4 MCOLN2 1p22 -0.234 0.0741 0.565 ion transport
xai RNF152 18q21.33 -0.234 0.0741 0.565 apoptotic
process;protein K48-linked ubiquitination
his NHSL2 Xq13.1 0.234 0.0742 0.565
hs4 CPNE7 16q24.3 0.234 0.0742 0.566 lipid metabolic process;transport
swa PYM1 0.234 0.0742 0.566 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;positive regulation of translation"
xai GRAP2 22q13.2 0.234 0.0742 0.566 Ras protein signal
xsq CYB5R4 6pter-q22.33 0.232 0.0742 0.565 cell
met KITLG 12q22 0.232 0.0742 0.565 ovarian follicle development;hemopoiesis
exp FBXO11 2p16.3 0.232 0.0742 0.565 protein
exp RPL13P7 1q25.2 0.232 0.0742 0.566
cop LOC400958 0.232 0.0742 0.566
xsq HYKK 15q25.1 0.232 0.0742 0.566
xsq LOC101929420 0.232 0.0742 0.566
exp MDM4 1q32 0.232 0.0742 0.566 Apoptosis; DNA Damage Response (DDR)
xsq COX6A1 12q24.2 0.232 0.0742 0.566 generation of precursor
xsq UBE2G1 17p13.2 0.232 0.0742 0.566 protein K63-linked
xsq GAD1 2q31 -0.232 0.0742 0.565 neurotransmitter secretion;protein-
pyridoxal-5-phosphate linkage
hs4 CA12 15q22 -0.234 0.0742 0.566 one-carbon metabolic process
xai RHEB 7q36 -0.234 0.0742 0.566 small GTPase mediated signal
hs4 ACP7 -0.234 0.0742 0.566
xai GPR45 2q11.1-q12 -0.234 0.0742 0.565
his LINC01776 -0.234 0.0742 0.565
exp LINC00605 0.234 0.0743 0.566
his LOC642361 10q22.3 0.234 0.0743 0.566
his NUTM2B-AS1 0.234 0.0743 0.566
xai PARG 10q11.23 0.234 0.0743 0.566 DNA Damage Response (DDR); DDR
(BER)
exp PRPF38AP1 10p14 0.232 0.0743 0.566
met MOB3C 1p33 0.232 0.0743 0.566
cop DSG1 18q12.1 0.232 0.0743 0.566 calcium-dependent cell-cell
adhesion;protein stabilization
met MAP7 6q23.3 0.232 0.0743 0.566 microtubule cytoskeleton
organization;response to osmotic stress
met RAB9B Xq22.1-q22.3 0.232 0.0743 0.566 small GTPase mediated signal
xsq EGFR-AS1 -0.232 0.0743 0.566
met RPA4 Xq21.33 -0.232 0.0743 0.566 DNA Damage Response (DDR);
DDR (MMR); DDR (DNA replication)
exp TEAD3 6p21.2 -0.232 0.0743 0.566 female pregnancy;hippo
signaling cascade
his LIMK2 22q12.2 -0.234 0.0743 0.566 Protein Kinases
hs4 BCL6 3q27 -0.234 0.0743 0.566 cell morphogenesis;negative
his LOC105374727 -0.234 0.0743 0.566
his C5orf42 5p13.2 -0.234 0.0743 0.566
xai FEM1C 5q22 -0.234 0.0743 0.566
his SGMS2 4q25 -0.234 0.0743 0.566 lipid metabolic
xai TBC1D9B 5q35.3 -0.234 0.0743 0.566
xai LINC00605 0.234 0.0744 0.566
his ZZEF1 17p13.2 0.234 0.0744 0.566
his CYB5D2 17p13.2 0.234 0.0744 0.566 nervous system development
his RPS26 12q13 0.234 0.0744 0.566 translational termination;negative
exp CHCHD2P4 0.234 0.0744 0.566
xai MLC1 22q13.33 0.234 0.0744 0.566 cellular response to
hs4 TNF 6p21.3 0.234 0.0744 0.566 Apoptosis
exp SNX5 20p11 0.232 0.0744 0.566 pinocytosis;cell communication
exp SIGLEC9 19q13.41 0.232 0.0744 0.566 cell adhesion;cell surface
xsq KIAA0825 5q15 0.232 0.0744 0.566
exp XPOTP1 20q11.22 0.232 0.0744 0.566
exp ETF1P3 Xq12 0.232 0.0744 0.566
xsq CASC3 17q21.1 0.232 0.0744 0.566 intracellular mRNA localization;RNA
splicing
xsq GIMAP4 7q36.1 0.232 0.0744 0.566
xsq PPP1R1C 2q31.3 0.232 0.0744 0.566 signal transduction
met SOX11 2p25 0.232 0.0744 0.566 outflow tract morphogenesis;negative
xsq LDLRAD2 1p36.12 -0.232 0.0744 0.566
hs4 C1orf198 1q42.2 -0.234 0.0744 0.566
xai GABARAP 17p13.1 -0.234 0.0744 0.566 protein
targeting;apoptotic process
xai REEP3 10q21.3 -0.234 0.0744 0.566
his TMCC3 12q22 -0.234 0.0744 0.566
swa PLAA 9p21 -0.234 0.0744 0.566 phospholipid metabolic
xai EEA1 12q22 -0.234 0.0744 0.566 endocytosis;vesicle fusion
xai ARHGEF6 Xq26.3 0.234 0.0745 0.566 positive regulation of GTPase
his PRPF4B 6p25.2 0.234 0.0745 0.566 nuclear mRNA splicing, via
spliceosome;protein phosphorylation
xai LOC100128982 0.234 0.0745 0.566
xai INO80E 16p11.2 0.234 0.0745 0.566 DNA Damage Response (DDR);
DDR (Chromatin)
exp LRRC16B 14q11.2 0.234 0.0745 0.566
DNA-dependent"
xai LOC283585 0.234 0.0745 0.566
xai PMS2P8 0.234 0.0745 0.566
met SLC35C1 11p11.2 0.232 0.0745 0.566 Solute Carriers
exp MTRF1 13q14.1-q14.3 0.232 0.0745 0.566 regulation of translational
termination
xsq CLEC4A 12p13 0.232 0.0745 0.566 cell adhesion;cell surface receptor
signaling pathway
exp TMEM63B 6p21.1 -0.232 0.0745 0.566
exp NKX3-1 8p21.2 -0.232 0.0745 0.566 DNA Damage Response
(DDR)
xsq CRAT 9q34.1 -0.232 0.0745 0.566 transport;fatty acid beta-
oxidation using acyl-CoA oxidase
exp SPEG 2q35 -0.232 0.0745 0.566 muscle organ development;negative
xai SNAPC1 14q22 -0.234 0.0745 0.566 regulation of transcription,
DNA-dependent;transcription from RNA polymerase III promoter
his STK3 8q22.2 -0.234 0.0745 0.566 Apoptosis
hs4 LINC00609 -0.234 0.0745 0.566
xai MIRLET7E -0.234 0.0745 0.566
his SLIT1 10q23.3-q24 0.234 0.0746 0.566 nervous system development;retinal
his TMEM71 8q24.22 0.234 0.0746 0.566
swa GPHN 14q23.3 0.234 0.0746 0.567 vitamin metabolic process;water-
his ASH1L-AS1 1q22 0.234 0.0746 0.567
his ASH1L 1q22 0.234 0.0746 0.567 regulation of transcription, DNA-
hs4 PEAR1 1q23.1 0.234 0.0746 0.567 recognition of apoptotic cell
xai NPM1P33 2q33.2 0.234 0.0746 0.567
exp NDUFS8 11q13 0.232 0.0746 0.566 small molecule metabolic
xsq HSPB9 17q21.2 0.232 0.0746 0.566 response to stress
exp ZNF852 3p21.31 0.232 0.0746 0.567
mut CALCRL 2q32.1 0.232 0.0746 0.567 calcium ion
transport;positive regulation of smooth muscle cell proliferation
exp TPMT 6p22.3 -0.232 0.0746 0.567 nucleobase-containing
compound metabolic process;xenobiotic metabolic process
met CENPV 17p11.2 -0.232 0.0746 0.567 cell cycle;mitosis
met ZCCHC5 Xq21.1 -0.232 0.0746 0.566
xsq SEPT8 5q31 -0.232 0.0746 0.566 cell cycle
his NDUFS4 5q11.1 0.234 0.0747 0.567 transport;response to cAMP
xai USP38 0.234 0.0747 0.567 proteolysis;ubiquitin-dependent protein
catabolic process
swa NOC3L 10q23.33 0.234 0.0747 0.567 fat cell differentiation
exp HMGB3P6 1q23.3 0.234 0.0747 0.567
met SKI 1p36.33 0.232 0.0747 0.567 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of Schwann cell
proliferation
met SEC31B 10q24.31 0.232 0.0747 0.567 protein transport;vesicle-
mediated transport
cop LOC100287010 0.232 0.0747 0.567
cop LOC150568 0.232 0.0747 0.567
pro EP300_2_8430 0.232 0.0747 0.567
xsq TTLL11 9q33.2 0.232 0.0747 0.567 protein modification process
mut ZMYM1 1p34.3 0.232 0.0747 0.567
cop PPFIA1 11q13.3 0.232 0.0747 0.567 cell-matrix adhesion;signal
transduction
cop MIR548K 0.232 0.0747 0.567
xsq HELLS 10q24.2 0.232 0.0747 0.567 mitosis;multicellular organismal
development
xsq UBL7 15q24.1 0.232 0.0747 0.567
exp PLPP7 -0.232 0.0747 0.567
xsq MGP 12p12.3 -0.232 0.0747 0.567 response to hormone
hs4 TTC39B 9p22.3 -0.234 0.0747 0.567
his EPB41L4A 5q21.3 -0.234 0.0747 0.567
his EPB41L4A-AS2 -0.234 0.0747 0.567
exp MIRLET7E -0.234 0.0747 0.567
xai SPATA12 3p14.3 -0.234 0.0747 0.567
hs4 PAQR5 15q23 -0.234 0.0747 0.567 multicellular organismal
hs4 VTCN1 1p13.1 -0.234 0.0747 0.567 negative regulation of T cell
activation
xai SEC14L4 22q12.2 0.234 0.0748 0.567
xai TXNDC5 6p24.3 0.234 0.0748 0.567 glycerol ether metabolic
his PIAS1 15q 0.234 0.0748 0.567 DNA Damage Response (DDR)
xai NDUFA5 7q31.33 0.234 0.0748 0.567 mitochondrial electron
his MIR5705 0.234 0.0748 0.567
xsq PNPLA5 22q13.31 0.232 0.0748 0.567 metabolic process;lipid
catabolic process
xsq KIF2A 5q12-q13 0.232 0.0748 0.567 mitotic cell cycle;microtubule-
based movement
mut ARHGEF40 14q11.2 0.232 0.0748 0.567 regulation of Rho protein
signal transduction
cop SNX9 6q25.1-q26 0.232 0.0748 0.567 intracellular protein
xsq KCNQ2 20q13.3 0.232 0.0748 0.567 potassium ion transmembrane
exp FNTAP1 11q14.2 -0.232 0.0748 0.567
exp CSRP1 1q32 -0.232 0.0748 0.567
xsq GDPD5 11q13.4-q13.5 -0.232 0.0748 0.567 glycerol metabolic
xsq LAMP1 13q34 -0.232 0.0748 0.567 autophagy;autophagic cell death
xsq SYT11 1q21.2 -0.232 0.0748 0.567
xai EPHX4 1p22.1 -0.234 0.0748 0.567
xai FAM83D 20q11.23 -0.234 0.0748 0.567 cell division;cell cycle
hs4 TGFB2-AS1 -0.234 0.0748 0.567
hs4 TGFB2 1q41 -0.234 0.0748 0.567 Apoptosis
swa ADAM30 1p12 -0.234 0.0748 0.567 proteolysis
exp MAFIP -0.234 0.0748 0.567 microtubule cytoskeleton
xai ASZ1 7q31.2 0.234 0.0749 0.567 spermatogenesis;cell
differentiation
xai RBM17 10p15.1 0.234 0.0749 0.567 mRNA processing;RNA splicing
mut SEMA7A 15q22.3-q23 0.232 0.0749 0.567 positive regulation of axon
extension;regulation of inflammatory response
mut PLEKHH2 2p21 0.232 0.0749 0.567
cop TAS2R43 0.232 0.0749 0.567 sensory perception of
taste;detection of chemical stimulus involved in sensory perception of bitter taste
cop TAS2R30 0.232 0.0749 0.567 sensory perception of
taste;response to stimulus
cop LOC100129361 12p13.2 0.232 0.0749 0.567
cop TAS2R42 12p13 0.232 0.0749 0.567
met FUT8 14q24.3 0.232 0.0749 0.567 integrin-mediated signaling
pathway;receptor metabolic process
met PAGE3 Xp11.21 0.232 0.0749 0.567
xsq SEPT4-AS1 -0.232 0.0749 0.567
exp TRPS1 8q24.12 -0.232 0.0749 0.567 skeletal system
met CGB2 19q13.32 -0.232 0.0749 0.567
his GSTT2 -0.234 0.0749 0.567
his MET 7q31 -0.234 0.0749 0.567 Oncogenes; Protein Kinases
xai PELI3 11q13.2 -0.234 0.0749 0.567
his ASIP 20q11.2-q12 -0.234 0.0749 0.567 hormone-mediated signaling
his SMARCA4 19p13.2 0.234 0.075 0.567 DNA Damage Response (DDR); DDR
(Chromatin); Tumor Suppressors
his TNF 6p21.3 0.234 0.075 0.568 Apoptosis
his LTB 6p21.3 0.234 0.075 0.568 immune response;signal transduction
his COIL 17q22 0.234 0.075 0.568 oxidation-reduction process
xai ESRRA 11q13 0.234 0.075 0.568 positive regulation of transcription from RNA
polymerase II promoter;cartilage development
xai TCERG1L 10q26.3 0.234 0.075 0.568
hs4 HENMT1 1p13.3 0.234 0.075 0.568 RNA methylation;gene silencing by
RNA
exp DDX10 11q22-q23 0.232 0.075 0.568
exp PIH1D1 19q13.33 0.232 0.075 0.568 box C/D snoRNP assembly
xsq PRPF39 14q21.2 0.232 0.075 0.568 mRNA processing;RNA splicing
dependent"
xsq SOHLH1 9q34.3 0.232 0.075 0.568 oogenesis;regulation of
xsq GIMAP7 7q36.1 0.232 0.075 0.568
exp KDM5B 1q32.1 -0.232 0.075 0.568 histone H3-K4 demethylation,
trimethyl-H3-K4-specific;negative regulation of transcription, DNA-dependent
met MIR10B -0.232 0.075 0.568
swa ERBB2IP 5q12.3 -0.234 0.075 0.568 signal transduction;epidermal
xai ADORA1 1q32.1 -0.234 0.075 0.568 Apoptosis
hs4 SNED1 2q37.3 -0.234 0.075 0.568 cell-matrix adhesion
his HIST1H2BG 6p21.3 0.234 0.0751 0.568
his HIST1H2AE 6p22.1 0.234 0.0751 0.568
his HIST1H3E 6p22.1 0.234 0.0751 0.568
his SASH3 Xq26 0.234 0.0751 0.568 positive regulation of interleukin-10
his SNORD114-19 14q32 0.234 0.0751 0.568
his SNORD114-20 0.234 0.0751 0.568
his SNORD114-21 0.234 0.0751 0.568
his SNORD114-22 0.234 0.0751 0.568
his SNORD114-23 14q32 0.234 0.0751 0.568
his ENOSF1 18p11.32 0.234 0.0751 0.568 cellular amino acid catabolic
process
xai VAMP1 12p 0.234 0.0751 0.568 neurotransmitter secretion;vesicle-
mediated transport
his LOC100131303 0.233 0.0751 0.568
xai LINC00290 0.233 0.0751 0.568
xai RAB39B Xq28 0.233 0.0751 0.568 synapse organization;small GTPase
his MIR4706 0.233 0.0751 0.568
mut HSPG2 1p36.1-p34 0.232 0.0751 0.568 chondrocyte differentiation;cardiac
xsq CSNK2A2 16q21 0.231 0.0751 0.568 Protein Kinases
exp NEMP2 0.231 0.0751 0.568
xsq OSCP1 1p34.3 -0.232 0.0751 0.568 transport
hs4 ADAMTS8 11q25 -0.233 0.0751 0.568 proteolysis;negative
xai IFIT5 10q23.31 -0.234 0.0751 0.568
xai LOC101060195 0.233 0.0752 0.568
xai SGK494 17q11.2 0.233 0.0752 0.568
his BCKDK 16p11.2 0.233 0.0752 0.568 branched chain family amino acid
xai PMS2P1 7q22.1 0.233 0.0752 0.568 ATP catabolic
xai GRAMD4 22q13.31 0.233 0.0752 0.568 apoptotic process
exp HSD17B13 4q22.1 0.233 0.0752 0.568
xai SYNGR4 19q13.3 0.233 0.0752 0.568
hs4 KANK3 19p13.2 0.233 0.0752 0.568
exp LOC101060195 0.233 0.0752 0.568
met C10orf107 10q21.2 0.231 0.0752 0.568
cop DSG4 18q12.1 0.231 0.0752 0.568 cell adhesion;homophilic cell
adhesion
xsq RTN4IP1 6q21 0.231 0.0752 0.568
xsq OGFOD2 12q24.31 0.231 0.0752 0.568
xsq PDILT 16p12.3 0.231 0.0752 0.568
xsq FLT3 13q12 0.231 0.0752 0.568 Cell Signaling; Oncogenes
xsq TMPO-AS1 12q23.1 0.231 0.0752 0.568
exp PSMA4 15q25.1 0.231 0.0752 0.568 antigen processing and presentation
exp GRAP2 22q13.2 0.231 0.0752 0.568 Ras protein signal
met FAM172A 5q15 0.231 0.0752 0.568
met CMPK1 1p32 0.231 0.0752 0.568 small molecule metabolic
cop LOC340107 -0.231 0.0752 0.568
xsq LOXL1 15q22 -0.231 0.0752 0.568 protein deamination;oxidation-
reduction process
exp GPRC5B 16p12 -0.231 0.0752 0.568
met OSR2 8q22.2 -0.231 0.0752 0.568 cell
differentiation;embryonic digit morphogenesis
cop SRD5A1 5p15 -0.231 0.0752 0.568 sex differentiation;thalamus
development
cop PAPD7 5p15 -0.231 0.0752 0.568 DNA Damage Response (DDR)
exp CNKSR3 6q25.2 -0.231 0.0752 0.568 negative regulation of
xsq OLFML2A 9q33.3 -0.231 0.0752 0.568 extracellular matrix
organization
xsq SMPD1 11p15.4-p15.1 -0.231 0.0752 0.568 cell death;ceramide
swa RAB18 10p12.1 -0.233 0.0752 0.568 protein transport;eye
development
xai IL17RD 3p14.3 -0.233 0.0752 0.568
hs4 NLRP6 11p15 0.233 0.0753 0.568 regulation of inflammatory response
swa RPS25 11q23.3 0.233 0.0753 0.568 translation;mRNA metabolic process
his DNAJB14 4q23 0.233 0.0753 0.568 protein folding
his H2AFZ 4q24 0.233 0.0753 0.568 DNA Damage Response (DDR)
his LOC256880 4q23 0.233 0.0753 0.568
xai B3GAT3 11q12.3 0.233 0.0753 0.568 glycosaminoglycan
his NRTN 19p13.3 0.233 0.0753 0.568 MAPK cascade;neural crest cell
migration
exp LOC643308 0.233 0.0753 0.568
xai GKN2 2p13.3 0.233 0.0753 0.568
his CLN6 15q23 0.233 0.0753 0.568 protein catabolic
his DCK 4q13.3-q21.1 0.233 0.0753 0.568 purine base metabolic
exp RPP40 6p25.1 0.231 0.0753 0.568 tRNA processing
hs4 MRGPRF 11q13.3 -0.233 0.0753 0.568
hs4 MRGPRF-AS1 -0.233 0.0753 0.568
his LOC101929705 -0.233 0.0753 0.568
xai TP53I3 2p23.3 -0.233 0.0753 0.568 induction of apoptosis
by oxidative stress;NADP metabolic process
xai FBXO11 2p16.3 0.233 0.0754 0.568 protein
hs4 ARL11 13q14.2 0.233 0.0754 0.568 small GTPase mediated signal
transduction
exp ONECUT3 19p13.3 0.233 0.0754 0.568 endocrine pancreas
xai IQCB2P 6p22.1 0.233 0.0754 0.568
xai NUDT1 7p22 0.233 0.0754 0.568 DNA Damage Response (DDR)
his ATAD2B 2p24.1-p23.3 0.233 0.0754 0.568
exp LOC283585 0.233 0.0754 0.568
swa RPS18 6p21.3 0.233 0.0754 0.568 nuclear-transcribed mRNA catabolic
xsq MGAT4A 2q12 0.231 0.0754 0.568 carbohydrate metabolic process;N-
glycan processing
exp PRDM10 11q25 0.231 0.0754 0.568 regulation of transcription, DNA-
dependent"
exp FAM49B 8q24.21 0.231 0.0754 0.568
cop MAPK3 0.231 0.0754 0.568 Protein Kinases
met EXD3 9q34.3 0.231 0.0754 0.568 nucleobase-containing compound
metabolic process
cop CORO1A 16p11.2 0.231 0.0754 0.568 phagocytosis;cell-substrate
adhesion
cop LOC613037 16p11.2 0.231 0.0754 0.568
cop LOC595101 0.231 0.0754 0.568
cop CD2BP2 16p11.2 0.231 0.0754 0.568 nuclear mRNA splicing, via
cop TBC1D10B 16p11.2 0.231 0.0754 0.568 positive regulation of Rab
xsq PALD1 10q22.1 0.231 0.0754 0.568
xsq RPL19 17q12 0.231 0.0754 0.568 SRP-dependent cotranslational protein
cop ZNF705A 0.231 0.0754 0.568
cop FAM66C 12p13.31 0.231 0.0754 0.568
cop FAM90A1 12p13.31 0.231 0.0754 0.568
cop FAM86FP 12p13.31 0.231 0.0754 0.568
exp EHD1 11q13 -0.231 0.0754 0.568 protein
homooligomerization;intracellular protein transport
hs4 SOWAHB 4q21.1 -0.233 0.0754 0.568 EMT (Epithelial)
xai KIAA0754 -0.233 0.0754 0.568
hs4 TMEM204 16p13.3 0.233 0.0755 0.568 lymph vessel
his SNORD18C 0.233 0.0755 0.568
his SNORD18B 0.233 0.0755 0.568
his SNORD16 0.233 0.0755 0.568
his SNORD18A 15q22 0.233 0.0755 0.568
his RPL4 15q22 0.233 0.0755 0.568 translational initiation;viral infectious
cycle
his ZWILCH 15q22.31 0.233 0.0755 0.568 DNA Damage Response (DDR)
hs4 MIXL1 1q42.12 0.233 0.0755 0.568 endoderm formation;multicellular
xsq LRRC34 3q26.2 0.231 0.0755 0.568
met HOXD1 2q31.1 0.231 0.0755 0.568 multicellular organismal
met OPCML 11q25 0.231 0.0755 0.568 cell adhesion;neuron recognition
exp CSTF1 20q13.2 0.231 0.0755 0.568 transcription from RNA polymerase
xsq THRB-AS1 3p24.2 -0.231 0.0755 0.568
exp FOXD4 9p24.3 -0.231 0.0755 0.568 regulation of transcription,
DNA-dependent;enteric nervous system development
xsq DOK7 4p16.3 -0.231 0.0755 0.568 positive regulation of
hs4 ZNF385D 3p24.3 -0.233 0.0755 0.568
his SKAP2 7p15.2 -0.233 0.0755 0.568 negative regulation of cell
xai TRAM2 6p21.1-p12 -0.233 0.0755 0.568 protein transport;collagen
his SHCBP1L 1q25.3 -0.233 0.0755 0.568
his ABCC6P2 -0.233 0.0755 0.568
xai MICA 6p21.33 -0.233 0.0755 0.568 response to heat;cytolysis
xai CDCA7L 7p15.3 0.233 0.0756 0.568 regulation of transcription,
xai RPS2 16p13.3 0.233 0.0756 0.568 translation;mRNA metabolic process
xai TBC1D10B 16p11.2 0.233 0.0756 0.568 positive regulation of Rab
DNA-dependent"
xsq DCAF8 1q22-q23 0.231 0.0756 0.568 protein ubiquitination
exp RPS27AP17 Xp22.31 0.231 0.0756 0.568
xsq PRIMPOL 0.231 0.0756 0.568 DDR (DNA replication)
exp TSFM 12q14.1 0.231 0.0756 0.568 translational elongation;regulation
met C2orf88 2q32.2 0.231 0.0756 0.569
xsq TADA2A 17q12-q21 0.231 0.0756 0.569 regulation of transcription,
cop PROKR1 2p13.1 0.231 0.0756 0.569 anti-apoptosis
met PHLDA2 11p15.4 0.231 0.0756 0.569 apoptotic process;organ
morphogenesis
exp NONOP1 16q22.1 -0.231 0.0756 0.569
met ZNF469 16q24 -0.231 0.0756 0.569 regulation of transcription,
DNA-dependent"
hs4 BMPR1A 10q22.3 -0.233 0.0756 0.569 Apoptosis
xai SHOX2 3q25.32 -0.233 0.0756 0.568 nervous system
xai KCTD11 17p13.1 -0.233 0.0756 0.568 regulation of
hs4 FAM196A 10q26.2 -0.233 0.0756 0.568
xai CDK5RAP1 20q11.21 0.233 0.0757 0.569 tRNA modification;brain
development
xai SNAPC5 15q22.31 0.233 0.0757 0.569 regulation of transcription,
xai SIPA1 11q13 0.233 0.0757 0.569 Apoptosis
his TRPM5 11p15.5 0.233 0.0757 0.569 ion transport
xai RPS15AP10 0.233 0.0757 0.569
xai LOC285741 0.233 0.0757 0.569
exp SCLY 2q37.3 0.233 0.0757 0.569 cellular amino acid metabolic
process
cop RASGRP3 2p25.1-p24.1 0.231 0.0757 0.569 small GTPase mediated
signal transduction;Ras protein signal transduction
xsq HSDL1 16q23.3 0.231 0.0757 0.569
cop ODC1 2p25 0.231 0.0757 0.569 small molecule metabolic process;kidney
development
cop SNORA80B 0.231 0.0757 0.569
exp TMEM204 16p13.3 0.231 0.0757 0.569 lymph vessel
mut ALDH2 12q24.2 0.231 0.0757 0.569 synaptic
transmission;neurotransmitter biosynthetic process
exp TNNI3 19q13.4 0.231 0.0757 0.569 regulation of smooth muscle
exp PPP2R5C 14q32.31 0.231 0.0757 0.569 protein processing;DNA damage
apoptosis
xai PPP1R9A 7q21.3 -0.233 0.0757 0.569 multicellular organismal
hs4 CMYA5 5q14.1 -0.233 0.0757 0.569
his LINC01550 0.233 0.0758 0.569
his C6orf136 6p21.33 0.233 0.0758 0.569
xai KGFLP2 0.233 0.0758 0.569
xai PEX3 6q24.2 0.233 0.0758 0.569 peroxisome organization;peroxisome
membrane biogenesis
his C22orf15 22q11.23 0.233 0.0758 0.569
his CHCHD10 22q11.23 0.233 0.0758 0.569
his MMP11 22q11.23 0.233 0.0758 0.569 Apoptosis
xai LINC00996 0.233 0.0758 0.569
xai BMP6 6p24-p23 0.233 0.0758 0.569 immune response;positive regulation
of endothelial cell differentiation
swa NACAP1 8q22.3 0.233 0.0758 0.569
xai PIWIL3 22q11.23 0.233 0.0758 0.569 regulation of
translation;meiosis
exp TRIM72 16p11.2 0.231 0.0758 0.569 protein
homooligomerization;plasma membrane repair
cop PRB3 12p13.2 0.231 0.0758 0.569
cop PRB4 0.231 0.0758 0.569
xsq HMGB1 13q12 0.231 0.0758 0.569 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
exp ESRRAP2 13q12.11 0.231 0.0758 0.569
cop CREBL2 12p13 0.231 0.0758 0.569 positive regulation of
cop GPR19 12p12.3 0.231 0.0758 0.569 G-protein coupled receptor
signaling pathway
cop CDKN1B 12p13.1-p12 0.231 0.0758 0.569 DDR (DNA replication)
xsq PPP1R2P9 Xp11.3 0.231 0.0758 0.569
exp RPS23P4 4q31.22 0.231 0.0758 0.569
exp HABP4 9q22.3-q31 -0.231 0.0758 0.569 cellular response to
exp HIP1 7q11.23 -0.231 0.0758 0.569 Apoptosis
exp IRGQ 19q13.31 -0.231 0.0758 0.569
xai LASP1 17q11-q21.3 -0.233 0.0758 0.569 ion transport;ion
xai CSRP1 1q32 -0.233 0.0758 0.569
hs4 SMAD9 13q12-q14 -0.233 0.0758 0.569 BMP signaling
pathway;midbrain development
xai PTK7 6p21.1-p12.2 -0.233 0.0758 0.569 establishment of planar
polarity;wound healing
his ZMYND19 9q34.3 0.233 0.0759 0.569
met ZMIZ2 7p13 0.231 0.0759 0.569 regulation of transcription, DNA-
xsq DNAAF2 14q21.3 0.231 0.0759 0.569 ciliary cell
motility;flagellar cell motility
exp SFT2D3 2q14.3 0.231 0.0759 0.569 protein transport;vesicle-
mediated transport
mut UBE2E2 3p24.2 0.231 0.0759 0.569 ISG15-protein
conjugation;protein K63-linked ubiquitination
met PRDM13 6q16.2 0.231 0.0759 0.569 regulation of transcription,
DNA-dependent"
pregnancy
xai TCEAL1 Xq22.1 -0.233 0.0759 0.569 negative regulation of
dependent"
his PLEKHS1 10q25.3 -0.233 0.0759 0.569
exp LOC100128019 -0.233 0.0759 0.569
swa ARAP1 11q13.4 0.233 0.076 0.569 actin filament reorganization involved in
cell cycle;regulation of ARF GTPase activity
xai RPL7P16 3q22.1 0.233 0.076 0.569
xai KLK1 19q13.3 0.233 0.076 0.569 proteolysis
xai ABCF2P1 3p11.1 0.233 0.076 0.569
xai ZMYND19 9q34.3 0.233 0.076 0.569
xai LOC400685 0.233 0.076 0.569
his INSR 19p13.3-p13.2 0.233 0.076 0.569 positive regulation of cell
proliferation;negative regulation of gene expression
xsq KCNK9 8q24.3 0.231 0.076 0.569 synaptic transmission;potassium ion
met TPD52L1 6q22-q23 0.231 0.076 0.569 G2/M transition of mitotic cell
cycle;DNA fragmentation involved in apoptotic nuclear change
xsq PMS1 2q31.1 0.231 0.076 0.569 DNA Damage Response (DDR); DDR (MMR)
xsq DHRS9 2q31.1 0.231 0.076 0.569 9-cis-retinoic acid biosynthetic
exp RPS2P50 17q12 0.231 0.076 0.569
xsq STOML3 13q13.3 0.231 0.076 0.569
xsq TOR3A 1q25.2 0.231 0.076 0.57 chaperone mediated protein folding
requiring cofactor
exp OXCT1 5p13.1 0.231 0.076 0.57 response to nutrient;response to ethanol
met GRIN2D 19q13.33 -0.231 0.076 0.57 signal transduction;synaptic
transmission
xsq C3 19p13.3-p13.2 -0.231 0.076 0.569 complement
hs4 RASSF9 12q21.31 -0.233 0.076 0.57 signal transduction;endosome
transport
hs4 DOK5 20q13.2 -0.233 0.076 0.569 MAPK cascade;transmembrane receptor
xai C2orf73 2p16.2 -0.233 0.076 0.569
his ITPRIPL2 16p12.3 -0.233 0.076 0.569
his MIR135B -0.233 0.076 0.569
xai STOML1 15q24-q25 -0.233 0.076 0.569
his TMEM132B 12q24.31 0.233 0.0761 0.57
his RSU1 10p13 0.233 0.0761 0.57 signal transduction;Ras protein signal
transduction
his CENPK 5q12.3 0.233 0.0761 0.57 M phase of mitotic cell
his PPWD1 5q12.3 0.233 0.0761 0.57 nuclear mRNA splicing, via
his LINC01623 0.233 0.0761 0.57
exp EIF4A1P9 17p13.3 0.233 0.0761 0.57
exp ABHD14A 3p21.1 0.231 0.0761 0.57
xsq RRM1 11p15.5 0.231 0.0761 0.57 DNA Damage Response (DDR)
cop CLEC4D 12p13.31 0.231 0.0761 0.57 innate immune response
exp ENTPD1-AS1 10q24.1 0.231 0.0761 0.57
xsq CENPH 5p15.2 0.231 0.0761 0.57 kinetochore organization;M phase of
mitotic cell cycle
xsq KRTAP9-2 0.231 0.0761 0.57
xsq CCDC174 3p25.1 0.231 0.0761 0.57
mir hsa-miR-23a -0.231 0.0761 0.57
mut NWD1 19p13.11 -0.231 0.0761 0.57
xai LOC100128019 -0.233 0.0761 0.57
hs4 NPAS3 14q13.1 -0.233 0.0761 0.57 maternal behavior;positive
xai MOP-1 0.233 0.0762 0.57
exp MOP-1 0.233 0.0762 0.57
xai LAMTOR5-AS1 0.233 0.0762 0.57
his RNU1-4 1p36.1 0.233 0.0762 0.57
met SH3GL2 9p22 0.233 0.0762 0.57 axon guidance;central nervous
system development
xai GSPT1 16p13.1 0.233 0.0762 0.57 G1/S transition of mitotic cell
exp EIF4BP3 9q22.32 0.231 0.0762 0.57
met GAS2 11p14.3 0.231 0.0762 0.57 apoptotic process;cellular
xsq CGA 6q12-q21 0.231 0.0762 0.57 thyroid hormone generation;cellular
mut PLEKHA5 12p12 0.231 0.0762 0.57
cop LRRC43 12q24.31 0.231 0.0762 0.57
exp SEC14L4 22q12.2 0.231 0.0762 0.57
xsq NFATC2 20q13.2 0.231 0.0762 0.57 response to drug;positive
xsq MS4A3 11q12.1 0.231 0.0762 0.57
exp PAX8 2q13 -0.231 0.0762 0.57 mesenchymal to epithelial
transition involved in metanephros morphogenesis;pronephric field specification
exp ATP6V0A4 7q34 -0.231 0.0762 0.57 ion transport;transferrin
transport
exp SNAPC1 14q22 -0.231 0.0762 0.57 regulation of transcription,
DNA-dependent;transcription from RNA polymerase III promoter
xsq ZNF341-AS1 -0.231 0.0762 0.57
exp COBLL1 2q24.3 -0.231 0.0762 0.57
hs4 PI4K2A 10q24 -0.233 0.0762 0.57 phosphatidylinositol
xai SIGLEC28P 0.233 0.0763 0.57
exp MAP3K14-AS1 17q21.31 0.233 0.0763 0.57
exp GLYATL1P1 11q12.1 0.233 0.0763 0.57
his ARL5A 2q23.3 0.233 0.0763 0.57 small GTPase mediated signal
transduction
xai RFX1 19p13.1 0.233 0.0763 0.57 regulation of transcription, DNA-
dependent;immune response"
hs4 LINC01225 0.233 0.0763 0.57
exp TTI1 20q11.23 0.231 0.0763 0.57 DNA Damage Response (DDR)
exp RET 10q11.2 0.231 0.0763 0.57 Oncogenes
mut ZNF804B 7q21.13 0.231 0.0763 0.57
met NOX4 11q14.2-q21 0.231 0.0763 0.57 superoxide anion
DNA-dependent"
DNA-dependent"
exp TJP2 9q13-q21 -0.231 0.0763 0.57 apoptotic process;cellular
xai FCGR3B -0.233 0.0763 0.57 immune response
xai TSPAN17 5q35.3 -0.233 0.0763 0.57 protein ubiquitination
exp FCGR3B -0.233 0.0763 0.57 immune response
swa ADRM1 20q13.33 0.233 0.0764 0.571 transcription elongation from RNA
polymerase II promoter;positive regulation of endopeptidase activity
xai LOC145845 15q14 0.232 0.0764 0.571
swa CEP97 3q12.3 0.232 0.0764 0.571
xai FAM175B 10q26.13 0.232 0.0764 0.571 DNA Damage Response (DDR)
swa MARS 12q13.3 0.232 0.0764 0.571 tRNA aminoacylation for protein
exp RPS10P27 18q11.2 0.231 0.0764 0.571
exp GLCCI1 7p21.3 0.231 0.0764 0.571
mut MGMT 10q26 0.231 0.0764 0.571 DNA Damage Response (DDR); DDR (Direct
Repair)
xsq HLA-DOB 6p21.3 0.23 0.0764 0.571 T cell costimulation;T cell
exp CAMK2D 4q26 -0.231 0.0764 0.571 calcium ion
cop CDH6 5p13.3 -0.231 0.0764 0.571 cell adhesion;homophilic cell
adhesion
exp TSPAN1 1p34.1 -0.231 0.0764 0.571
xsq ECE1 1p36.1 -0.231 0.0764 0.571 heart development;hormone
catabolic process
xai UEVLD 11p15.1 -0.232 0.0764 0.571 protein modification
his SHROOM3 4q21.1 -0.232 0.0764 0.571 columnar/cuboidal
his LINC01264 0.232 0.0765 0.571
xai LOC389787 0.232 0.0765 0.571
exp SIGLEC28P 0.232 0.0765 0.571
xai JAGN1 3p25.2 0.232 0.0765 0.571
his WIZ 19p13.1 0.232 0.0765 0.571
xai AES 19p13.3 0.232 0.0765 0.571 cellular response to extracellular
exp TTLL13P 0.232 0.0765 0.571 protein modification process
his ADORA2A 22q11.23 0.232 0.0765 0.571 G-protein signaling, coupled
to cAMP nucleotide second messenger;activation of adenylate cyclase activity
xsq ELP4 11p13 0.23 0.0765 0.571 transcription elongation from RNA
xsq RPS12 6q23.2 0.23 0.0765 0.571 SRP-dependent cotranslational
cop DSG3 18q12.1 0.23 0.0765 0.571 cellular component disassembly
involved in apoptosis;cell adhesion
xsq OR2D2 11p15.4 0.23 0.0765 0.571 sensory perception of
smell;response to stimulus
xsq PIH1D3 Xq22.3 0.23 0.0765 0.571
met TNIK 3q26.31 0.23 0.0765 0.571 protein phosphorylation;protein
autophosphorylation
exp EPHA8 1p36.12 -0.23 0.0765 0.571 substrate-dependent cell
migration;positive regulation of MAPK cascade
met CLUL1 18p11.32 -0.23 0.0765 0.571 cell death
xsq BHLHE40 3p26 -0.23 0.0765 0.571 circadian regulation of gene
mut ALDH1L1 3q21.3 -0.23 0.0765 0.571 biosynthetic process;10-
xai MIR604 -0.232 0.0765 0.571
hs4 ADCY6 12q12-q13 -0.232 0.0765 0.571 water transport;activation of
hs4 LOC100506125 -0.232 0.0765 0.571
his FABP3 1p33-p32 -0.232 0.0765 0.571 fatty acid metabolic
hs4 IGF2BP2 3q27.2 -0.232 0.0765 0.571 anatomical structure
swa PKN2 1p22.2 -0.232 0.0765 0.571 Apoptosis
xai MARCH1 4q32.2 -0.232 0.0765 0.571 protein
class II
xai CDH6 5p13.3 -0.232 0.0765 0.571 cell adhesion;homophilic cell
adhesion
xai PTBP1 19p13.3 0.234 0.0766 0.571 negative regulation of RNA
his MAGEB18 Xp21.3 0.232 0.0766 0.571
swa PDS5A 4p14 0.232 0.0766 0.571 DNA Damage Response (DDR)
exp CD300LB 17q25.1 0.232 0.0766 0.571
xsq ATP8B4 15q21.2 0.23 0.0766 0.571 phospholipid transport;cation
transport
xsq NOC2L 1p36.33 0.23 0.0766 0.571 negative regulation of apoptotic
exp BAHCC1 17q25.3 0.23 0.0766 0.571
exp WBP11 12p12.3 0.23 0.0766 0.571 rRNA processing;mRNA processing
xsq LOC101929076 0.23 0.0766 0.571
cop TIAM2 6q25.2 0.23 0.0766 0.571 regulation of Rho protein signal
transduction;cellular lipid metabolic process
cop CLDN20 6q25 0.23 0.0766 0.571 tight junction assembly;calcium-
exp IFIT5 10q23.31 -0.23 0.0766 0.571
xsq IFIT1 10q23.31 -0.23 0.0766 0.571 negative regulation of viral genome
replication;regulation of defense response to virus
xai LUM 12q21.33 -0.232 0.0766 0.571 visual perception;response to
swa COL18A1 21q22.3 -0.232 0.0766 0.571 negative regulation of
exp MIR604 -0.232 0.0766 0.571
swa FEN1 11q12 0.232 0.0767 0.571 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
his RACGAP1 12q13.12 0.232 0.0767 0.571 cytokinesis, actomyosin
contractile ring assembly;blood coagulation
hs4 CENPX 0.232 0.0767 0.571
hs4 LRRC45 17q25.3 0.232 0.0767 0.571
xsq YARS 1p35.1 0.23 0.0767 0.571 Apoptosis
cop XRRA1 11q13.4 0.23 0.0767 0.571 response to X-ray
exp RBFOX3 17q25.3 0.23 0.0767 0.571 mRNA processing;RNA splicing
cop TXNL4B 16q22.2 0.23 0.0767 0.571 mRNA processing;cell cycle
exp C10orf112 0.23 0.0767 0.571
cop DSG2 18q12.1 0.23 0.0767 0.571 apoptotic process;cellular
cop LOC100652770 0.23 0.0767 0.571
cop TTR 18q12.1 0.23 0.0767 0.571
met PPP2R3C 14q13.2 0.23 0.0767 0.571
cop KIAA0895 7p14.2 -0.23 0.0767 0.571
cop ANLN 7p15-p14 -0.23 0.0767 0.571 cytokinesis;septin ring assembly
exp DNAI1 9p13.3 -0.23 0.0767 0.571 cell projection organization
cop KCNV2 9p24.2 -0.23 0.0767 0.571 transmembrane transport;ion
transport
met MAL 2q11.1 -0.23 0.0767 0.571 membrane raft
polarization;induction of apoptosis
xai CD9 12p13.3 -0.232 0.0767 0.571 response to water
exp GSN-AS1 9q33.2 -0.232 0.0767 0.571
his UOX 1p22 -0.232 0.0767 0.571
xai OXCT1 5p13.1 0.232 0.0768 0.571 response to nutrient;response to
ethanol
exp EFTUD1P1 15q25.2 0.232 0.0768 0.571
exp GRIK5 19q13.2 0.232 0.0768 0.571 ion transport;synaptic transmission
exp THNSL1 10p12.1 0.23 0.0768 0.571 threonine biosynthetic
process
xsq LYG2 2q11.2 0.23 0.0768 0.572 metabolic process;peptidoglycan
catabolic process
xsq LOC100506302 0.23 0.0768 0.572
exp CCNJ 10q23.33 0.23 0.0768 0.572
cop GINM1 6q25.1 0.23 0.0768 0.572
exp PARM1 4q13.3-q21.3 0.23 0.0768 0.572 positive regulation of
telomerase activity
xsq CYP4F22 19p13.12 0.23 0.0768 0.572
xsq HILPDA 7q32.1 0.23 0.0768 0.572 positive regulation of cell
proliferation;positive regulation of lipid storage
xsq LOC100420587 0.23 0.0768 0.572
xsq HGSNAT 8p11.1 -0.23 0.0768 0.572 protein
his RTN4R 22q11.21 -0.232 0.0768 0.572 axonogenesis;nerve growth
his HSD52 1p32.1 -0.232 0.0768 0.572
his LINC00907 -0.232 0.0768 0.572
his MICAL3 22q11.21 -0.232 0.0768 0.572
hs4 TRIM44 11p13 -0.232 0.0768 0.572
xai TOMM20L 14q23.1 0.232 0.0769 0.572 protein targeting
his LOC100996634 0.232 0.0769 0.572
his PLIN3 19p13.3 0.232 0.0769 0.572 vesicle-mediated transport
hs4 RNPEPL1 2q37.3 0.232 0.0769 0.572 proteolysis;leukotriene
his LINC00909 18q22.3 0.232 0.0769 0.572
swa GATAD2B 1q21.3 0.232 0.0769 0.572
xsq HMGCLL1 6p12.1 0.23 0.0769 0.572
mut VWF 12p13.3 0.23 0.0769 0.572 platelet degranulation;protein
homooligomerization
xsq MED27 9q34.13 0.23 0.0769 0.572 regulation of transcription from
met A4GALT 22q13.2 0.23 0.0769 0.572 lipid biosynthetic
xsq CNPY3 6p21.1 0.23 0.0769 0.572 innate immune response
exp CHCHD2P6 1p36.21 0.23 0.0769 0.572
exp LRRC75A -0.23 0.0769 0.572
xsq TGIF1 18p11.3 -0.23 0.0769 0.572 negative regulation of cell
xsq GLYATL2 11q12.1 -0.23 0.0769 0.572
exp CCL8 17q11.2 -0.23 0.0769 0.572 calcium ion transport;response to
virus
xai NKX3-1 8p21.2 -0.232 0.0769 0.572 DNA Damage Response
(DDR)
xai ECRP 14q11.2 0.232 0.077 0.572
xai RHPN1 8q24.3 0.232 0.077 0.572 signal transduction
his RPL34-AS1 4q25 0.232 0.077 0.572
his RPL34 4q25 0.232 0.077 0.572 nuclear-transcribed mRNA catabolic process,
dependent"
xai RPL35 9q34.1 0.232 0.077 0.572 viral reproduction;nuclear-transcribed
xai PPP1R21 2p16.3 0.232 0.077 0.572
cop POLD4 11q13 0.23 0.077 0.572 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
cop CLCF1 11q13.3 0.23 0.077 0.572 cytokine-mediated signaling pathway;B
cop RAD9A 11q13.1-q13.2 0.23 0.077 0.572 DNA Damage Response (DDR)
cop PPP1CA 11q13 0.23 0.077 0.572 Apoptosis
cop BLM 15q26.1 0.23 0.077 0.572 DNA Damage Response (DDR); DDR (FA)
cop DHX38 16q22 0.23 0.077 0.572 RNA splicing;gene expression
cop MFAP5 12p13.1-p12.3 0.23 0.077 0.572
hs4 TFAP2C 20q13.2 -0.232 0.077 0.572 trophectodermal cell
differentiation;germ-line stem cell maintenance
hs4 HCAR1 12q24.31 -0.232 0.077 0.572 response to estradiol stimulus
hs4 ELDR -0.232 0.077 0.572
his LINC01471 0.232 0.0771 0.572
swa VPS4B 18q21.33 0.232 0.0771 0.573 protein transport;cellular membrane
organization
hs4 CENPA 2p23.3 0.232 0.0771 0.573 kinetochore assembly;M phase of
mitotic cell cycle
xai LYPLA1P2 4q25 0.232 0.0771 0.573
met SLC6A1 3p25.3 0.23 0.0771 0.572 learning;response to
estradiol stimulus
xsq LINC00244 7q36 0.23 0.0771 0.572
cop SLC1A4 2p15-p13 0.23 0.0771 0.572 Solute Carriers
mut ZC3H13 13q14.13 0.23 0.0771 0.572
xsq PSMF1 20p13 0.23 0.0771 0.573 S phase of mitotic cell cycle;apoptotic
process
exp TOMM40 19q13 0.23 0.0771 0.573 protein targeting to
xsq CAP2 6p22.3 -0.23 0.0771 0.573 activation of adenylate cyclase
met RPL9 4p13 -0.23 0.0771 0.573 gene expression;viral reproduction
exp TRIM3 11p15.5 -0.23 0.0771 0.572 nervous system development;protein
transport
met PON1 7q21.3 -0.23 0.0771 0.572 positive regulation of transporter
mut NCKAP1 2q32 -0.23 0.0771 0.572 Apoptosis
exp CASQ2 1p13.1 -0.232 0.0771 0.573 striated muscle
hs4 DVL3 3q27 -0.232 0.0771 0.573 Wnt receptor signaling pathway;Wnt
xai TEAD3 6p21.2 -0.232 0.0771 0.573 female pregnancy;hippo
signaling cascade
hs4 LINC01186 -0.232 0.0771 0.573
his IL1F10 2q13 -0.232 0.0771 0.572
xai PREX2 8q13.2 -0.232 0.0771 0.572 G-protein coupled receptor
signaling pathway;positive regulation of Rac GTPase activity
his FLJ21408 0.232 0.0772 0.573
his NSMCE1 16p12.1 0.232 0.0772 0.573 DNA Damage Response (DDR);
DDR (HR)
his CTBP1 4p16 0.232 0.0772 0.573 protein phosphorylation;negative
his CTBP1-AS2 4p16.3 0.232 0.0772 0.573
xai LOC728739 12q23.3 0.232 0.0772 0.573
his TFRC 3q29 0.232 0.0772 0.573 response to hypoxia;response to inorganic
substance
xai RCOR2 11q13.1 0.232 0.0772 0.573 negative regulation of
his EXOSC9 4q27 0.232 0.0772 0.573 RNA processing;nuclear
xsq LOC100129697 16q24.3 0.23 0.0772 0.573
met FBXL5 4p15.32 0.23 0.0772 0.573 protein ubiquitination;SCF-
exp TUBGCP4 15q15 0.23 0.0772 0.573 G2/M transition of mitotic cell
pro EP300_10_24332 0.23 0.0772 0.573
cop CA3 8q21.2 -0.23 0.0772 0.573 one-carbon metabolic
process;response to oxidative stress
cop CA2 8q22 -0.23 0.0772 0.573 response to organic substance;secretion
xsq FZD2 17q21.1 -0.23 0.0772 0.573 axonogenesis;epithelial cell
differentiation
exp PLXNB1 3p21.31 -0.23 0.0772 0.573 negative regulation of
osteoblast proliferation;semaphorin-plexin signaling pathway
xsq EFEMP2 11q13.1 -0.23 0.0772 0.573 blood coagulation
hs4 PDE7B 6q23-q24 -0.232 0.0772 0.573 signal transduction;synaptic
transmission
hs4 NCKAP5L 12q13.12 -0.232 0.0772 0.573
hs4 BCDIN3D-AS1 -0.232 0.0772 0.573
hs4 RASSF10 11p15.2 -0.232 0.0772 0.573 signal transduction
hs4 PIFO 1p13.2 -0.232 0.0772 0.573
xai FBL 19q13.1 0.232 0.0773 0.573 snoRNA metabolic process;rRNA
processing
xai TOMM40 19q13 0.232 0.0773 0.573 protein targeting to
his CXCL8 0.232 0.0773 0.573 activation of signaling protein activity
involved in unfolded protein response;endoplasmic reticulum unfolded protein
response
hs4 MDM4 1q32 0.232 0.0773 0.573 Apoptosis; DNA Damage Response (DDR)
his UQCRFS1 19q12 0.232 0.0773 0.573 transport;response to hormone
stimulus
xai PPATP1 3p12.1 0.232 0.0773 0.573
his B4GALT6 18q11 0.232 0.0773 0.573 post-translational protein
his SOBP 6q21 0.232 0.0773 0.573 sensory perception of sound;locomotory
behavior
his TSPOAP1-AS1 0.232 0.0773 0.573
his TSPOAP1 0.232 0.0773 0.573
his MIR142 0.232 0.0773 0.573
his MIR4736 0.232 0.0773 0.573
exp NRARP 9q34.3 0.23 0.0773 0.573 regulation of cell-cell
adhesion;negative regulation of T cell differentiation
exp NACA3P 4q32.3 0.23 0.0773 0.573
exp CELF2 10p13 0.23 0.0773 0.573 RNA processing;mRNA processing
cop PNPT1 2p15 0.23 0.0773 0.573 mitochondrial mRNA catabolic
process;transport
cop VLDLR 9p24 -0.23 0.0773 0.573 nervous system development;cerebral
cortex development
exp KRT13 17q21.2 -0.23 0.0773 0.573 tongue morphogenesis;cellular
cop MT1HL1 1q43 -0.23 0.0773 0.573
xsq APOD 3q29 -0.23 0.0773 0.573 lipid transport;negative regulation of
smooth muscle cell proliferation
swa DDOST 1p36.1 -0.232 0.0773 0.573 translation;post-
xai NUDT3 6p21.2 0.232 0.0774 0.573 diadenosine polyphosphate catabolic
his UNC45A 15q26.1 0.232 0.0774 0.573 cell
his HDDC3 15q26.1 0.232 0.0774 0.573 guanosine tetraphosphate metabolic
process
xai LOC100507103 0.232 0.0774 0.573
swa PRIM2 6p12-p11.1 0.232 0.0774 0.573 DNA replication;DNA replication,
synthesis of RNA primer
his PRDM7 16q24.3 0.232 0.0774 0.573 chromatin modification;regulation
of transcription, DNA-dependent"
exp MLX 17q21.1 0.23 0.0774 0.573 energy reserve metabolic
exp NKAP Xq24 0.23 0.0774 0.573 Notch signaling pathway;negative
met LOX 5q23.2 0.23 0.0774 0.573 response to steroid hormone
xsq PHKA1 Xq12-q13 0.23 0.0774 0.573 glucose metabolic
exp BTD 3p25 -0.23 0.0774 0.573 epidermis development;nitrogen compound
metabolic process
cop SMARCA2 9p22.3 -0.23 0.0774 0.573 DNA Damage Response (DDR);
DDR (Chromatin)
exp RPL27P9 3p14.3 -0.23 0.0774 0.573
exp SLC6A12 12p13 -0.23 0.0774 0.573 Solute Carriers
xai LDLR 19p13.2 -0.232 0.0774 0.573 lipid metabolic
process;phospholipid transport
xai KIF13B 8p12 -0.232 0.0774 0.573 protein
hs4 C10orf10 10q11.21 -0.232 0.0774 0.573
his MIR6871 -0.232 0.0774 0.573
xai USP20 9q34.11 0.232 0.0775 0.573 protein K48-linked
DNA-dependent"
xai NELFCD 20q13 0.232 0.0775 0.573
hs4 HIST1H3G 0.232 0.0775 0.573
hs4 HIST1H2BI 6p22.1 0.232 0.0775 0.573
his LILRA1 19q13.4 0.232 0.0775 0.573 defense response;cell surface
exp HSPA8P20 Xq25 0.232 0.0775 0.573
exp LOC100287036 16q24.3 0.232 0.0775 0.573
hs4 FOXM1 12p13 0.232 0.0775 0.573 Apoptosis
hs4 RHNO1 12p13.33 0.232 0.0775 0.573
cop BCL2L14 12p13-p12 0.23 0.0775 0.573 apoptotic process;regulation
of apoptotic process
cop LRP6 12p13.2 0.23 0.0775 0.573 pericardium morphogenesis;neural
crest cell differentiation
met MOXD1 6q23.2 0.23 0.0775 0.573 catecholamine metabolic process
exp RAB8A 19p13.1 0.23 0.0775 0.573 vesicle docking involved in
cop SMEK2 2p16.1 0.23 0.0775 0.573
exp HRH2 5q35.2 0.23 0.0775 0.573 G-protein signaling, coupled to
exp IGBP1 Xq13.1-q13.3 0.23 0.0775 0.573 negative regulation of
exp HIST1H2AL 6p22.1 0.23 0.0775 0.573
xsq RPS19BP1 22q13.1 0.23 0.0775 0.573
cop APOLD1 12p13.1 0.23 0.0775 0.573 endothelial cell
xsq AGT 1q42.2 -0.23 0.0775 0.573 regulation of cell growth;renin-
angiotensin regulation of aldosterone production
exp CPA4 7q32 -0.23 0.0775 0.573 proteolysis;histone acetylation
cop NEUROD6 7p14.3 -0.23 0.0775 0.573
xai KCNK2 1q41 -0.232 0.0775 0.573 ion transport;potassium ion
transport
xai CLPSL1 6p21.31 -0.232 0.0775 0.573 digestion;lipid
catabolic process
hs4 SYDE1 19p13.12 -0.232 0.0775 0.573 EMT (Mesenchymal)
swa MPV17 2p23.3 -0.232 0.0775 0.573 regulation of reactive oxygen
species metabolic process;mitochondrial genome maintenance
hs4 HIST1H3J 6p22.1 0.232 0.0776 0.573
hs4 HIST1H2AM 6p22.1 0.232 0.0776 0.573
hs4 HIST1H2BO 6p22.1 0.232 0.0776 0.573 nucleosome assembly
hs4 EEF1A1 6q14.1 0.232 0.0776 0.573 translation;translational
elongation
his CHRFAM7A 0.232 0.0776 0.573
xai CLDN6 16p13.3 0.232 0.0776 0.573 calcium-independent cell-cell
adhesion
hs4 EGR4 2p13 0.232 0.0776 0.573 regulation of transcription, DNA-
dependent;positive regulation of cell proliferation"
exp MRPL35P3 10q22.2 0.232 0.0776 0.573
cop CCDC104 0.23 0.0776 0.573
xsq LOC339298 0.23 0.0776 0.573
met CREG2 2q11.2 0.23 0.0776 0.573
xsq PLA2G2D 1p36.12 0.23 0.0776 0.573 phospholipid metabolic
cop CEP68 2p14 0.23 0.0776 0.573 centrosome organization
cop RAB1A 2p14 0.23 0.0776 0.573 protein transport;vesicle-mediated
transport
xsq TFAM 10q21 0.23 0.0776 0.573 regulation of transcription from RNA
xsq TMEM69 1p34.1 0.23 0.0776 0.573
xsq LOC100506371 0.23 0.0776 0.573
exp RPL3P3 14q22.3 0.23 0.0776 0.573
xsq ATP2A1-AS1 0.23 0.0776 0.573
xsq TPSB2 16p13.3 0.23 0.0776 0.573 proteolysis
xsq DDIT4L 4q24 0.23 0.0776 0.573 negative regulation of signal
transduction
exp CPSF3L 1p36.33 0.23 0.0776 0.573
cop CNGB3 8q21.3 -0.23 0.0776 0.573 cation transport;signal
transduction
cop PMCHL1 5p14.3 -0.23 0.0776 0.573
xai DCAF6 1q24.2 -0.232 0.0776 0.573 protein
ubiquitination;positive regulation of transcription from RNA polymerase II promoter
xai EPHA8 1p36.12 -0.232 0.0776 0.573 substrate-dependent cell
xai LRIG1 3p14 -0.232 0.0776 0.573
xai WASL 7q31.3 -0.232 0.0776 0.573 nitric oxide metabolic
xai MRPL35P3 10q22.2 0.232 0.0777 0.573
xai LRR1 14q21.3 0.232 0.0777 0.573
hs4 STT3B 3p23 0.232 0.0777 0.573 protein glycosylation;protein N-linked
xai RUNX3 1p36 0.231 0.0777 0.573 Apoptosis
xsq CRSP8P 0.23 0.0777 0.573
xsq DDX39A 19p13.12 0.23 0.0777 0.573 nuclear mRNA splicing, via
spliceosome;mRNA export from nucleus
exp WDR92 2p14 0.23 0.0777 0.574 apoptotic process;histone lysine
methylation
exp OLFML3 1p13.2 -0.23 0.0777 0.574 multicellular organismal
development
met NCCRP1 19q13.2 -0.23 0.0777 0.573 protein catabolic process
xsq TRIM2 4q31.3 -0.23 0.0777 0.573 protein
exp SDR9C7 12q13.3 -0.23 0.0777 0.573
hs4 ANXA9 1q21 -0.231 0.0777 0.574 cell-cell adhesion
hs4 LVCAT1 -0.232 0.0777 0.573
xai TBC1D12 10q23.33 -0.232 0.0777 0.573
xai NEK4 3p21.1 0.231 0.0778 0.574 cell division;protein
phosphorylation
exp OR2L13 1q44 0.231 0.0778 0.574 response to stimulus
hs4 AMZ2P1 17q24.1 0.231 0.0778 0.574
xai CD320 19p13.3-p13.2 0.231 0.0778 0.574 regulation of cell growth
his DCLRE1B 1p13.2 0.231 0.0778 0.574 DNA Damage Response (DDR)
his AP4B1 1p13.2 0.231 0.0778 0.574 intracellular protein
xsq HCRT 17q21 0.229 0.0778 0.574 elevation of cytosolic calcium ion
exp FH 1q42.1 0.229 0.0778 0.574 tricarboxylic acid cycle;fumarate
metabolic process
mut FSHR 2p21-p16 0.229 0.0778 0.574 female gonad development;regulation
of chromosome organization
met NACC2 9q34.3 0.229 0.0778 0.574 positive regulation of cell
xsq PPIP5K2 5q21.1 0.229 0.0778 0.574 inositol metabolic process
exp ZDHHC21 9p22.3 -0.229 0.0778 0.574 small molecule metabolic
process;nitric oxide metabolic process
met GNG8 19q13.32 -0.229 0.0778 0.574
mut UBQLNL 11p15.4 -0.229 0.0778 0.574
met MIR1284 -0.229 0.0778 0.574
his CCDC149 4p15.2 -0.231 0.0778 0.574
hs4 RERG 12p12.3 -0.231 0.0778 0.574 GTP catabolic process;signal
transduction
xai MCEE 2p13.3 0.231 0.0779 0.574 fatty acid beta-oxidation;short-
xai LOC100287036 16q24.3 0.231 0.0779 0.574
his PDCD7 15q22.31 0.231 0.0779 0.574 induction of apoptosis;RNA splicing
xai EMSY 0.231 0.0779 0.574 DNA repair;regulation of transcription,
DNA-dependent
xai PALB2 16p12.2 0.231 0.0779 0.574 DNA Damage Response (DDR); DDR (FA)
xai FANCE 6p22-p21 0.231 0.0779 0.574 DNA Damage Response (DDR); DDR (FA)
hs4 LOC101928166 0.231 0.0779 0.574
his PARTICL 0.231 0.0779 0.574
his MAT2A 2p11.2 0.231 0.0779 0.574 response to light stimulus;response
to hormone stimulus
xai AKNA 9q32 0.231 0.0779 0.574 regulation of transcription, DNA-
dependent"
his IMPA1 8q21.13-q21.3 0.231 0.0779 0.574 phosphatidylinositol
biosynthetic process;phosphate-containing compound metabolic process
his DNASE2 19p13.2 0.231 0.0779 0.574 Apoptosis
his KLF1 19p13.2 0.231 0.0779 0.574 regulation of transcription, DNA-
dependent;erythrocyte differentiation
his GCDH 19p13.2 0.231 0.0779 0.574 lysine catabolic process;acyl-CoA
metabolic process
his MRPS12 19q13.1-q13.2 0.231 0.0779 0.574 translation
his SARS2 19q13.2 0.231 0.0779 0.574 tRNA aminoacylation for protein
translation;seryl-tRNA aminoacylation
mir hsa-miR-1226* 0.229 0.0779 0.574
xsq PTGES3 12q13.3 0.229 0.0779 0.574 glycogen biosynthetic
process;lung saccule development
xsq SERPINI2 3q26.1 0.229 0.0779 0.574
met MYOM3 1p36.11 0.229 0.0779 0.574
met PTGS1 9q32-q33.3 0.229 0.0779 0.574 xenobiotic metabolic
exp VPS72 1q21 0.229 0.0779 0.574 somatic stem cell maintenance;negative
exp LASP1 17q11-q21.3 -0.229 0.0779 0.574 ion transport;ion
met HSD3B2 1p13.1 -0.229 0.0779 0.574 steroid biosynthetic
process;androgen biosynthetic process
exp STK17A 7p13 -0.229 0.0779 0.574 Apoptosis
met CARD14 17q25 -0.229 0.0779 0.574 positive regulation of
hs4 DDX58 9p12 -0.231 0.0779 0.574 innate immune response;positive
xai ABCF2 7q36 0.231 0.078 0.574 ABC Transporters
xai GNPAT 1q42 0.231 0.078 0.574 phospholipid biosynthetic process;small
xai ZBTB48 1p36.3 0.231 0.078 0.574 regulation of transcription, DNA-
dependent"
his COA7 0.231 0.078 0.574
xai EIF4A1P9 17p13.3 0.231 0.078 0.574
xai PARM1 4q13.3-q21.3 0.231 0.078 0.574 positive regulation of telomerase
activity
cop MIR4426 0.229 0.078 0.574
cop CLHC1 2p16.1 0.229 0.078 0.574
cop RPS27A 2p16 0.229 0.078 0.574 activation of MAPK activity;MyD88-
met MIR758 0.229 0.078 0.574
met KLC1 14q32.3 0.229 0.078 0.574 microtubule-based movement;blood
coagulation
cop MED10 5p15.31 -0.229 0.078 0.574 gene expression;positive regulation
cop UBE2QL1 5p15.31 -0.229 0.078 0.574
xsq CRIM1 2p21 -0.229 0.078 0.574 regulation of cell growth;nervous system
development
cop LINGO2 9p21.2 -0.229 0.078 0.574
cop FLJ35024 -0.229 0.078 0.574
exp THAP10 15q23 -0.229 0.078 0.574
his IL36RN 2q14 -0.231 0.078 0.574 negative regulation of cytokine-
hs4 ARHGEF18 19p13.3 -0.231 0.078 0.574 regulation of cell
hs4 AGT 1q42.2 -0.231 0.078 0.574 regulation of cell growth;renin-
xai RAB42 1p35.3 -0.231 0.078 0.574 small GTPase mediated signal
transduction
his ATIC 2q35 0.231 0.0781 0.574 purine ribonucleoside monophosphate
hs4 LINC00599 8p23.1 0.231 0.0781 0.574
hs4 MIR124-1 0.231 0.0781 0.574
his FAM110A 20p13 0.231 0.0781 0.574
hs4 HPDL 1p34.1 0.231 0.0781 0.574 aromatic amino acid family
metabolic process
exp ABCF2P1 3p11.1 0.231 0.0781 0.574
swa USP15 12q14 0.231 0.0781 0.574 proteolysis;ubiquitin-dependent protein
catabolic process
xai LOC730183 0.231 0.0781 0.574
hs4 LRP8 1p34 0.231 0.0781 0.574 cytokine-mediated signaling
pathway;hippocampus development
hs4 LINC01771 0.231 0.0781 0.574
xai C17orf49 17p13.1 0.231 0.0781 0.574 chromatin modification
his C10orf88 10q26.13 0.231 0.0781 0.574
exp LOC100652999 0.231 0.0781 0.574
met ENG 9q34.11 0.229 0.0781 0.574 heart looping;cell migration
cop MTIF2 2p16.1 0.229 0.0781 0.574 translation;regulation of
met TANC1 2q24.2 0.229 0.0781 0.574
cop LOC100130987 11q13.2 0.229 0.0781 0.574
xsq MAGEA9 Xq28 0.229 0.0781 0.574
met CECR1 22q11.2 0.229 0.0781 0.574 adenosine catabolic
xsq E2F3 6p22 0.229 0.0781 0.574 Tumor Suppressors
xsq MRPL45 17q21.2 0.229 0.0781 0.574 translation;intracellular
protein transport
xsq MSC-AS1 -0.229 0.0781 0.574
xsq CAB39L 13q14.2 -0.229 0.0781 0.574 cell cycle
arrest;insulin receptor signaling pathway
xai CLDN12 7q21 -0.231 0.0781 0.574 calcium-independent cell-cell
his STS Xp22.32 0.231 0.0782 0.574 female pregnancy;response to
estrogen stimulus
his MIR4767 0.231 0.0782 0.574
his PUDP 0.231 0.0782 0.574 nucleotide metabolic process
his TEC 4p12 0.231 0.0782 0.574 protein phosphorylation;integrin-mediated
signaling pathway
his MARCO 2q14.2 0.231 0.0782 0.574 pattern recognition receptor
signaling pathway;cell surface receptor signaling pathway
xai HNRNPA1P54 0.231 0.0782 0.574
xai ILF2P2 14q13.2 0.231 0.0782 0.574
exp IGLV2-34 0.231 0.0782 0.574
hs4 ENOSF1 18p11.32 0.231 0.0782 0.574 cellular amino acid catabolic
process
his HINT3 6q22.32 0.231 0.0782 0.574
exp RPLP1P8 6q23.3 0.229 0.0782 0.574
exp MPHOSPH8 13q12.11 0.229 0.0782 0.574 cell cycle;regulation of DNA
methylation
pro CCNA2 4q27 0.229 0.0782 0.574 DNA Damage Response (DDR); DDR (DNA
replication)
cop PRORSD1P 2p16.1 0.229 0.0782 0.574
cop CCDC88A 2p16.1 0.229 0.0782 0.574 EMT (Mesenchymal)
exp LINC00290 0.229 0.0782 0.574
exp ATP6V0A2 12q24.31 0.229 0.0782 0.574 immune response;insulin
xsq SNIP1 1p34.3 0.229 0.0782 0.574 regulation of transcription, DNA-
dependent;I-kappaB kinase/NF-kappaB cascade
xsq LOC728485 19q13.12 0.229 0.0782 0.574
xsq HDAC8 Xq13 0.229 0.0782 0.574 negative regulation of transcription from
exp ARAP3 5q31.3 -0.229 0.0782 0.574 regulation of cell
shape;vesicle-mediated transport
exp PCDHB15 5q31 -0.229 0.0782 0.574 homophilic cell
adhesion;nervous system development
xsq PCDHGA6 -0.229 0.0782 0.574 cell adhesion;homophilic cell
adhesion
exp TSPAN4 11p15.5 -0.229 0.0782 0.574 protein complex assembly
hs4 NPHP1 2q13 -0.231 0.0782 0.574 signal transduction;excretion
xai CLMN 14q32.13 -0.231 0.0782 0.574
swa ATL3 11q13.1 -0.231 0.0782 0.574 GTP catabolic process;ER to
xai LAMA5 20q13.2-q13.3 -0.231 0.0782 0.574 integrin-mediated
his KRT38 17q21.2 -0.231 0.0782 0.574
swa AKT1S1 19q13.33 0.231 0.0783 0.574 nerve growth factor receptor
signaling pathway;negative regulation of protein kinase activity
dependent"
his ARSA 22q13.33 0.231 0.0783 0.574 sphingolipid metabolic
xai IGLV2-34 0.231 0.0783 0.574
xai NPM1P27 0.231 0.0783 0.574
exp MS4A15 11q12.2 0.231 0.0783 0.574
swa NOLC1 10q24.32 0.231 0.0783 0.574 positive regulation of cell
met ORAOV1 11q13.3 0.229 0.0783 0.574
exp EIF4EBP2 10q21-q22 0.229 0.0783 0.574 negative regulation of
xsq UIMC1 5q35.2 0.229 0.0783 0.574 DNA Damage Response (DDR); DDR (HR)
xsq EYA3 1p36 0.229 0.0783 0.574 DNA Damage Response (DDR)
cop T 6q27 0.229 0.0783 0.574 heart morphogenesis;reproductive process
exp CTSA 20q13.1 -0.229 0.0783 0.574 positive regulation of
xsq FAM189A1 15q13.1 -0.229 0.0783 0.574
met TRIM65 17q25.1 -0.229 0.0783 0.574
cop GUSBP1 5p14.3 -0.229 0.0783 0.574
mut GABRR1 6q15 -0.229 0.0783 0.574 chloride transport;gamma-
aminobutyric acid signaling pathway
cop CDH10 5p14.2 -0.229 0.0783 0.574 adherens junction
xsq ACTA2-AS1 10q23.31 -0.229 0.0783 0.574
his ANGPTL1 1q25.2 -0.231 0.0783 0.574 signal
xai TBX19 1q24.2 -0.231 0.0783 0.574 regulation of transcription
from RNA polymerase II promoter;anatomical structure morphogenesis
hs4 LOC100129940 -0.231 0.0783 0.574
exp BRD7P1 14q11.2 -0.231 0.0783 0.574
xai XG Xp22.33 -0.233 0.0783 0.574
exp LOC100507316 0.231 0.0784 0.574
his FBXO28 1q42.11 0.231 0.0784 0.574
hs4 SPANXN2 Xq27.3 0.231 0.0784 0.574
exp CLSPN 1p34.2 0.231 0.0784 0.575 DNA Damage Response (DDR); DDR (G2-
M checkpoint)
exp TMSB4XP3 0.231 0.0784 0.575
hs4 MAGEB2 Xp21.3 0.231 0.0784 0.575
xai FOXO4 Xq13.1 0.231 0.0784 0.575 Apoptosis
xai FLVCR1-AS1 1q32.3 0.231 0.0784 0.575
xai HIST1H4G 6p22.1 0.231 0.0784 0.575 nucleosome assembly
exp NPM1P27 0.231 0.0784 0.575
his KRT16P1 0.231 0.0784 0.575
xai TMSB4XP3 0.231 0.0784 0.575
his PRC1 15q26.1 0.231 0.0784 0.575 cell cycle;mitotic spindle
elongation
exp MYOM1 18p11.31 0.229 0.0784 0.574 muscle contraction
exp ATP2A1 0.229 0.0784 0.575 cation transport;ion transmembrane
transport
exp CMTR2 0.229 0.0784 0.575
xsq EIF3I 1p34.1 0.229 0.0784 0.575 gene expression;cellular protein
metabolic process
xsq DOLPP1 9q34.1 0.229 0.0784 0.575 protein N-linked
xsq CYTH1 17q25 0.229 0.0784 0.575 vesicle-mediated transport;regulation of
cell adhesion
exp TRAM2 6p21.1-p12 -0.229 0.0784 0.574 protein transport;collagen
his NNMT 11q23.1 -0.231 0.0784 0.575 small molecule metabolic
his HAX1 1q21.3 0.231 0.0785 0.575
xai PHF5A 22q13.2 0.231 0.0785 0.575 nuclear mRNA splicing, via
xai RPL7P45 13q33.2 0.231 0.0785 0.575
exp LOC100507459 0.231 0.0785 0.575
exp RFX1 19p13.1 0.229 0.0785 0.575 regulation of transcription, DNA-
xsq NAPG 18p11.22 0.229 0.0785 0.575 protein complex
assembly;intracellular protein transport
met LOC400927 22q13.1 0.229 0.0785 0.575
met DPP6 7q36.2 0.229 0.0785 0.575 proteolysis;cell death
xsq CENPV 17p11.2 0.229 0.0785 0.575 cell cycle;mitosis
exp SERPINB10 18q21.3 0.229 0.0785 0.575 negative regulation of
met TPTE2 13q12.11 0.229 0.0785 0.575 transmembrane transport;ion
transport
met PTK7 6p21.1-p12.2 0.229 0.0785 0.575 establishment of planar
exp CCNA2 4q27 0.229 0.0785 0.575 DNA Damage Response (DDR); DDR (DNA
replication)
met ARHGAP5-AS1 14q12 0.229 0.0785 0.575
xsq EMID1 22q12.2 0.229 0.0785 0.575
exp MCAT 22q13.31 0.229 0.0785 0.575 fatty acid biosynthetic
exp GABARAP 17p13.1 -0.229 0.0785 0.575 protein
targeting;apoptotic process
xai LINC01278 -0.231 0.0785 0.575
hs4 SAT2 17p13.1 -0.231 0.0785 0.575
hs4 SHBG 17p13.1 -0.231 0.0785 0.575 hormone transport;primary
spermatocyte growth
hs4 RNF19B 1p35.1 -0.231 0.0785 0.575
xai HLA-B 6p21.3 -0.231 0.0785 0.575 antigen processing and
presentation of peptide antigen via MHC class I;regulation of interleukin-12
production
exp EIF2AP4 -0.231 0.0785 0.575
xai PTRHD1 2p23.3 0.231 0.0786 0.575
exp RRN3P1 0.231 0.0786 0.575
his KLRC2 0.231 0.0786 0.575 cellular defense response;signal
transduction
xai TRMT10C 3q12.3 0.231 0.0786 0.575
his CCND2 12p13 0.231 0.0786 0.575 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
his CCND2-AS1 0.231 0.0786 0.575
met ITGA7 12q13 0.229 0.0786 0.575 regulation of cell shape;cell adhesion
exp NETO1 18q22.2 0.229 0.0786 0.575 visual learning;regulation of long-
xsq ATP5SL 19q13.2 0.229 0.0786 0.575
mut ACO2 22q13.2 0.229 0.0786 0.575 generation of precursor metabolites
and energy;tricarboxylic acid cycle
xsq BCL2L12 19q13.3 0.229 0.0786 0.575 apoptotic process
xsq CACNA2D4 12p13.33 0.229 0.0786 0.575 ion transport
xsq SFSWAP 12q24.33 0.229 0.0786 0.575 RNA splicing;negative
cop STRN 2p22.2 0.229 0.0786 0.575 locomotory behavior;negative
met MICAL3 22q11.21 0.229 0.0786 0.575
xsq MICAL3 22q11.21 -0.229 0.0786 0.575
exp LRIG1 3p14 -0.229 0.0786 0.575
exp GPX3 5q23 -0.229 0.0786 0.575 response to organic cyclic
compound;response to drug
met RPL12 9q34 -0.229 0.0786 0.575 translational elongation;viral
transcription
xsq MID1 Xp22 -0.229 0.0786 0.575 microtubule cytoskeleton
xai EIF2AP4 -0.231 0.0786 0.575
his AK7 14q32.2 0.231 0.0787 0.575 nucleobase-containing compound
metabolic process;cell projection organization
exp NDST3 4q26 0.229 0.0787 0.575
xsq LOC554249 0.229 0.0787 0.575
xsq MBD1 18q21 0.229 0.0787 0.575 regulation of transcription, DNA-
mut SYDE1 19p13.12 0.229 0.0787 0.575 EMT (Mesenchymal)
cop KDM2A 11q13.2 0.229 0.0787 0.575 regulation of transcription, DNA-
met RHBG 1q21.3 0.229 0.0787 0.575 ammonium transport;transmembrane
transport
xsq LAMA5 20q13.2-q13.3 -0.229 0.0787 0.575 integrin-mediated
exp TSPAN17 5q35.3 -0.229 0.0787 0.575 protein ubiquitination
his MAP4K4 2q11.2-q12 -0.231 0.0787 0.575 response to
hs4 JPH1 8q21 -0.231 0.0787 0.575 muscle organ development;regulation
of ryanodine-sensitive calcium-release channel activity
hs4 TCEAL9 -0.231 0.0787 0.575
his LURAP1L 9p23 -0.231 0.0787 0.575
his LURAP1L-AS1 -0.231 0.0787 0.575
his UBE2J1 6q15 0.231 0.0788 0.575
xai KANSL1 17q21.31 0.231 0.0788 0.575 histone H4-K5
his MSANTD4 11q22 0.231 0.0788 0.576
hs4 PLA2G2C 1p36.12 0.231 0.0788 0.576 phospholipid metabolic
xai MED16 19p13.3 0.231 0.0788 0.576 positive regulation of
promoter
his NUP43 6q25.1 0.231 0.0788 0.576 mitotic cell cycle;cytokine-
his PCMT1 6q24-q25 0.231 0.0788 0.576 protein repair;S-
adenosylhomocysteine metabolic process
xai SYN1 Xp11.23 0.231 0.0788 0.576 transport;synaptic transmission
xsq FLJ10038 15q21.2 0.229 0.0788 0.575
exp PEX3 6q24.2 0.229 0.0788 0.576 peroxisome organization;peroxisome
membrane biogenesis
exp USPL1 13q12-q14 0.229 0.0788 0.576 ubiquitin-dependent protein
catabolic process
xsq P2RX3 11q12 0.229 0.0788 0.576 response to hypoxia;positive regulation
of calcium ion transport into cytosol
exp CA10 17q21.33 -0.229 0.0788 0.576 brain development
xsq CAPG 2p11.2 -0.229 0.0788 0.576 protein complex assembly;cell
projection assembly
his PRR5L 11p13-p12 -0.231 0.0788 0.576
xai SUSD6 -0.231 0.0788 0.576
his PLPP4 -0.231 0.0788 0.575 phospholipid dephosphorylation
xai TUBGCP5 15q11.2 0.231 0.0789 0.576 mitotic cell
xai SMARCB1 22q11.23 0.231 0.0789 0.576 DNA Damage Response (DDR);
xai XPOTP1 20q11.22 0.231 0.0789 0.576
his TESC 12q24.22 0.231 0.0789 0.576 positive regulation of gene
his TESC-AS1 0.231 0.0789 0.576
his PVRIG 7q22.1 0.231 0.0789 0.576
his RNF181 2p11.2 0.231 0.0789 0.576
xai MRRF 9q33.2 0.231 0.0789 0.576 translation;ribosome disassembly
swa MSH6 2p16 0.231 0.0789 0.576 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xsq BRAP 12q24 0.229 0.0789 0.576 MAPK cascade;Ras protein signal
transduction
xsq C9orf163 0.229 0.0789 0.576
met LMLN 3q29 0.229 0.0789 0.576 cell cycle;mitosis
xsq SRSF10 1p36.11 0.229 0.0789 0.576 nuclear mRNA splicing, via
met FAM86B2 8p23.1 0.229 0.0789 0.576
xsq PLA2G4C 19q13.3 -0.229 0.0789 0.576 metabolic process;lipid
catabolic process
met MPO 17q23.1 -0.229 0.0789 0.576 defense response;hydrogen
peroxide catabolic process
exp SLC37A3 7q34 -0.229 0.0789 0.576 Solute Carriers
exp C1QL1 17q21 -0.229 0.0789 0.576 locomotory behavior
his LACTBL1 1p36.12 -0.231 0.0789 0.576
his LDOC1L 22q13.31 -0.231 0.0789 0.576
xai FAM214B 9p13.3 -0.231 0.0789 0.576
his IFIT2 10q23.31 -0.231 0.0789 0.576 negative regulation of
xai DNMT3A 2p23 0.231 0.079 0.576 Oncogenes
his ZKSCAN8 6p21.3 0.231 0.079 0.576
xai RBM26 13q31.1 0.231 0.079 0.576 mRNA processing;negative regulation of
xai BRAP 12q24 0.231 0.079 0.576 MAPK cascade;Ras protein signal transduction
his CCR2 3p21.31 0.231 0.079 0.576 cellular calcium ion homeostasis;response
to wounding
xai LSM4 19p13.11 0.23 0.079 0.576 RNA splicing;gene expression
hs4 PLK1 16p12.2 0.23 0.079 0.576 DDR (DNA replication); Protein Kinases
xsq TARBP2 12q13.13 0.229 0.079 0.576 negative regulation of protein
kinase activity;negative regulation of defense response to virus by host
xsq LINC00928 15q26.1 0.229 0.079 0.576
cop PACRG 6q26 0.229 0.079 0.576
exp ANKHD1 0.229 0.079 0.576
xsq RPUSD1 16p13.3 0.229 0.079 0.576 pseudouridine synthesis
xsq ADGRE3 0.229 0.079 0.576 G-protein coupled receptor signaling
pathway;neuropeptide signaling pathway
xsq COQ5 12q24.31 0.229 0.079 0.576 ubiquinone biosynthetic process
xsq MSL3P1 2q37.1 0.229 0.079 0.576 regulation of transcription, DNA-
exp FBXL18 7p22.2 -0.229 0.079 0.576
hs4 MIR22 -0.23 0.079 0.576
hs4 CYYR1-AS1 -0.23 0.079 0.576
his IGFBP3 7p12.3 -0.231 0.079 0.576 Apoptosis
xai NUDT12 5q21.2 -0.231 0.079 0.576 NADP catabolic process;NAD
catabolic process
his MAD2L1 4q27 0.23 0.0791 0.576 DNA Damage Response (DDR)
hs4 B4GALT6 18q11 0.23 0.0791 0.576 post-translational protein
xai AADACP1 0.23 0.0791 0.576
his HCG14 0.23 0.0791 0.576
his C2orf49 2q12.1 0.23 0.0791 0.576 embryonic morphogenesis
xsq SYCP2L 6p24.2 0.229 0.0791 0.576
exp FPGS 9q34.1 0.229 0.0791 0.576 water-soluble vitamin metabolic
met KIF21A 12q12 0.228 0.0791 0.576 microtubule-based movement
cop DUSP16 12p13 0.228 0.0791 0.576 protein
dephosphorylation;dephosphorylation
exp EVL 14q32.2 0.228 0.0791 0.576 nervous system development;axon
guidance
xsq MND1 4q31.3 0.228 0.0791 0.576 DNA recombination;meiosis
exp OXA1L 14q11.2 0.228 0.0791 0.576 mitochondrial proton-transporting
ATP synthase complex assembly;protein insertion into membrane
met POTEF 2q21.1 0.228 0.0791 0.576
cop PRB2 12p13.2 0.228 0.0791 0.576
mut TGS1 8q11 -0.228 0.0791 0.576 regulation of transcription, DNA-
dependent;ribonucleoprotein complex import into nucleus
xai KLC3 19q13 -0.23 0.0791 0.576 metabolic process
his ALDH3A1 17p11.2 -0.23 0.0791 0.576 response to organic cyclic
hs4 PLCD3 17q21.31 -0.23 0.0791 0.576 angiogenesis;lipid catabolic
process
hs4 ADAM12 10q26 -0.23 0.0791 0.576 myoblast fusion;proteolysis
xai CLSPN 1p34.2 0.23 0.0792 0.576 DNA Damage Response (DDR); DDR (G2-
M checkpoint)
swa FDPS 1q22 0.23 0.0792 0.576 cholesterol biosynthetic
process;isoprenoid biosynthetic process
xai TYROBP 19q13.1 0.23 0.0792 0.576 cellular defense
his MXD4 4p16.3 0.23 0.0792 0.576 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of cell
proliferation
his LAPTM5 1p34 0.23 0.0792 0.577 transport
xai SELL 1q23-q25 0.23 0.0792 0.577 cell adhesion;blood coagulation
xsq HNRNPC 14q11.2 0.228 0.0792 0.576 nuclear mRNA splicing, via
xsq SNORD104 17q23.3 0.228 0.0792 0.576
xsq CLDN17 0.228 0.0792 0.576
exp TMEM101 17q21.31 0.228 0.0792 0.577 signal transduction;positive
met ARFGEF3 0.228 0.0792 0.577 negative regulation of phosphatase
activity;regulation of ARF protein signal transduction
mut KLHL14 18q12.1 0.228 0.0792 0.577
met DNAAF1 16q24.1 0.228 0.0792 0.577 cilium morphogenesis;axonemal
dynein complex assembly
xsq LINC00472 6q13 -0.228 0.0792 0.577
xai GPR1 2q33.3 -0.23 0.0792 0.577 G-protein coupled receptor
signaling pathway
xai EFTUD1P1 15q25.2 0.23 0.0793 0.577
his CCDC163 0.23 0.0793 0.577
his MMACHC 1p34.1 0.23 0.0793 0.577
xai FLJ10038 15q21.2 0.23 0.0793 0.577
swa CCS 11q13 0.23 0.0793 0.577 oxidation-reduction process;superoxide
metabolic process
his SPAG8 9p13.3 0.23 0.0793 0.577
his HINT2 9p13.3 0.23 0.0793 0.577 steroid biosynthetic
process;apoptotic process
xai NLRP7 19q13.42 0.23 0.0793 0.577
hs4 CEP192 18p11.21 0.23 0.0793 0.577 G2/M transition of mitotic
xai EPX 17q23.1 0.23 0.0793 0.577 response to oxidative
hs4 POTEB2 0.23 0.0793 0.577
mut SLC4A5 2p13 0.228 0.0793 0.577 Solute Carriers
met AMZ1 7p22.3 0.228 0.0793 0.577 proteolysis
xsq NOL12 22q13.1 0.228 0.0793 0.577
cop MIR613 0.228 0.0793 0.577
xsq RNF40 16p11.2-p11.1 0.228 0.0793 0.577 ubiquitin-dependent protein
cop WDR66 12q24.31 0.228 0.0793 0.577
exp KLHL15 Xp22.1-p21 0.228 0.0793 0.577
exp AADACP1 0.228 0.0793 0.577
mut BRAT1 7p22.3 0.228 0.0793 0.577 response to ionizing radiation
met PSCA 8q24.2 -0.228 0.0793 0.577
xsq GPX3 5q23 -0.228 0.0793 0.577 response to organic cyclic
exp PREX2 8q13.2 -0.228 0.0793 0.577 G-protein coupled receptor
exp CYP27A1 2q35 -0.228 0.0793 0.577 bile acid metabolic
xsq GBP7 1p22.2 -0.228 0.0793 0.577
xsq TAS2R31 -0.228 0.0793 0.577 response to stimulus;sensory
perception of taste
xai SLC6A12 12p13 -0.23 0.0793 0.577 Solute Carriers
xai EPHA2 1p36 -0.23 0.0793 0.577 Protein Kinases
xai BRD7P1 14q11.2 -0.23 0.0793 0.577
xai IFFO2 1p36.13 -0.23 0.0793 0.577
xai SLC37A3 7q34 -0.23 0.0793 0.577 Solute Carriers
xai NSMCE1 16p12.1 0.23 0.0794 0.577 DNA Damage Response (DDR);
DDR (HR)
his LINC01835 0.23 0.0794 0.577
his SNAR-C3 0.23 0.0794 0.577
xai TRIM72 16p11.2 0.23 0.0794 0.577 protein
his SBK1 16p11.2 0.23 0.0794 0.577 peptidyl-serine
xai PIH1D1 19q13.33 0.23 0.0794 0.577 box C/D snoRNP assembly
swa CPSF2 14q31.1 0.23 0.0794 0.577 gene expression;nuclear mRNA
his C9orf43 9q32 0.23 0.0794 0.577
his POLE3 9q33 0.23 0.0794 0.577 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
xsq PMPCA 9q34.3 0.228 0.0794 0.577 proteolysis
xsq CRNKL1 20p11.2 0.228 0.0794 0.577 RNA splicing;spliceosome
assembly
xsq RHPN1 8q24.3 0.228 0.0794 0.577 signal transduction
xsq MTCP1 Xq28 0.228 0.0794 0.577 cell proliferation
exp PTGES3P1 1p22.2 0.228 0.0794 0.577
xsq TRAF3IP2 6q21 -0.228 0.0794 0.577 intracellular signal
mir hsa-miR-886-3p -0.228 0.0794 0.577
exp ACSL1 4q35.1 -0.228 0.0794 0.577 fatty acid metabolic
process;triglyceride biosynthetic process
xsq PCDHGC3 -0.228 0.0794 0.577 cell adhesion;homophilic cell
adhesion
xsq ANXA2P1 4q31.3 -0.228 0.0794 0.577
cop BBS9 7p14 -0.228 0.0794 0.577 visual perception;fat cell
differentiation
exp FXYD6P3 Xq13.2 -0.23 0.0794 0.577 ion transport
xai FXYD6P3 Xq13.2 -0.23 0.0794 0.577 ion transport
xai TRAV17 -0.23 0.0794 0.577
his AACSP1 5q35.3 0.23 0.0795 0.577
exp OR4Q1P 0.23 0.0795 0.577
xai SS18L2 3p21 0.23 0.0795 0.577
xai GRIK5 19q13.2 0.23 0.0795 0.577 ion transport;synaptic transmission
xai TPI1 12p13 0.23 0.0795 0.577 carbohydrate metabolic process;glucose
metabolic process
xai GNB1L 22q11.2 0.23 0.0795 0.577 G-protein coupled receptor
xsq DUS3L 19p13.3 0.228 0.0795 0.577 tRNA processing
exp PMS2P12 0.228 0.0795 0.577
cop TIGAR 0.228 0.0795 0.577
cop FGF23 12p13.3 0.228 0.0795 0.577 insulin receptor signaling
pathway;negative regulation of osteoblast differentiation
cop FGF6 12p13 0.228 0.0795 0.577 cartilage condensation;fibroblast growth
xsq MTIF2 2p16.1 0.228 0.0795 0.577 translation;regulation of
xsq C6orf203 6q21 0.228 0.0795 0.577
exp AQP3 9p13 0.228 0.0795 0.577 urea transport;response to retinoic acid
exp EPS8L1 19q13.42 -0.228 0.0795 0.577
cop NSUN2 5p15.31 -0.228 0.0795 0.577 tRNA processing;tRNA
methylation
cop WWP1 8q21 -0.228 0.0795 0.577 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;interspecies interaction between
organisms
xsq XAGE2 -0.228 0.0795 0.577
xsq LOC102546294 -0.228 0.0795 0.577
exp KDM4B 19p13.3 -0.228 0.0795 0.577 regulation of transcription,
DNA-dependent;chromatin modification"
his SOD3 4p15.2 -0.23 0.0795 0.577 removal of superoxide
hs4 TMEM150A 2p11.2 -0.23 0.0795 0.577 catabolic process
his LOC101928748 -0.23 0.0795 0.577
exp TRAV17 -0.23 0.0795 0.577
xai PRKAG2 7q36.1 -0.23 0.0795 0.577 negative regulation of
protein kinase activity;regulation of fatty acid metabolic process
xai ALG14 1p21.3 -0.23 0.0795 0.577 post-translational protein
xai ZC3H12D 6q25.1 0.23 0.0796 0.577 negative regulation of cell
xai LOC100130987 11q13.2 0.23 0.0796 0.577
xai NR1I2 3q12-q13.3 0.23 0.0796 0.577 signal transduction;drug export
exp RPS9P1 21q22.2 0.228 0.0796 0.577
exp GRAMD4 22q13.31 0.228 0.0796 0.577 apoptotic process
xsq GPATCH11 2p22.2 0.228 0.0796 0.577
met CGNL1 15q21.3 0.228 0.0796 0.577
xsq NINJ2 12p13 0.228 0.0796 0.577 cell adhesion;neuron cell-cell adhesion
exp WDR33 2q14.3 0.228 0.0796 0.577 postreplication repair;mRNA
processing
xsq BCCIP 10q26.1 0.228 0.0796 0.577 regulation of cyclin-dependent
met PWP2 21q22.3 0.228 0.0796 0.577 signal transduction
met HSPA7 1q23.3 0.228 0.0796 0.577
exp HM13 20q11.21 -0.228 0.0796 0.577 membrane protein proteolysis
his ACTBL2 5q11.2 -0.23 0.0796 0.577
xai FAM49A 2p24.2 -0.23 0.0796 0.577
his FBLN2 3p25.1 -0.23 0.0796 0.577
his CDCP1 3p21.31 -0.23 0.0796 0.577
hs4 SEC11C 18q21.32 0.23 0.0797 0.577 small molecule metabolic
xai FAM49B 8q24.21 0.23 0.0797 0.577
xai WDFY4 10q11.23 0.23 0.0797 0.577
his FIP1L1 4q12 0.23 0.0797 0.577 mRNA processing
his USP1 1p31.3 0.23 0.0797 0.577 DNA Damage Response (DDR); DDR (FA)
his NDUFAF6 8q22.1 0.23 0.0797 0.577
his FCAR 19q13.42 0.23 0.0797 0.577 immune response
xsq ATRIP 0.228 0.0797 0.577 DNA Damage Response (DDR); DDR (G1-S
checkpoint); DDR (DNA replication)
cop ADRBK1 11q13.1 0.228 0.0797 0.577 G-protein coupled
cop ANKRD13D 11q13.2 0.228 0.0797 0.577
cop SSH3 11q13.2 0.228 0.0797 0.577 protein
dephosphorylation;regulation of actin polymerization or depolymerization
xsq ZC3H15 2q32.1 0.228 0.0797 0.577 cytokine-mediated signaling
pathway
hs4 LINC01102 -0.23 0.0797 0.577
exp NFYAP1 13q21.31 -0.23 0.0797 0.577
hs4 SEPT8 5q31 -0.23 0.0797 0.577 cell cycle
his LPP 3q28 -0.23 0.0797 0.577 cell adhesion
his LPP-AS2 3q27.3 -0.23 0.0797 0.577
his HELLS 10q24.2 0.23 0.0798 0.577 mitosis;multicellular organismal
development
his ATP5J2-PTCD1 0.23 0.0798 0.578
his ATP5J2 0.23 0.0798 0.578 respiratory electron transport
his ENTPD3-AS1 0.23 0.0798 0.578
met DMD Xp21.2 0.228 0.0798 0.577 muscle organ development;skeletal
xsq FLJ30679 0.228 0.0798 0.577
xsq MORF4L2-AS1 0.228 0.0798 0.577
xsq GIMAP5 7q36.1 0.228 0.0798 0.577 positive regulation of
humoral immune response mediated by circulating immunoglobulin;negative regulation
of nitric oxide biosynthetic process
exp NELFCD 20q13 0.228 0.0798 0.577
mut IL12A 3q25.33 0.228 0.0798 0.577 cell cycle arrest;positive
xsq RPL29P2 0.228 0.0798 0.578
cop GINS3 16q21 0.228 0.0798 0.578 DDR (DNA replication)
xsq PRPF4B 6p25.2 0.228 0.0798 0.578 nuclear mRNA splicing, via
xsq PKD1L2 16q23.2 -0.228 0.0798 0.578 ion
exp PNPLA3 22q13.31 -0.228 0.0798 0.577 triglyceride catabolic
met PIK3R5 17p13.1 -0.228 0.0798 0.577 Protein Kinases
hs4 IDS Xq28 -0.23 0.0798 0.578
xai LOC220729 3q29 -0.23 0.0798 0.578
xai GPNMB 7p15 -0.23 0.0798 0.577 cell adhesion;negative regulation of cell
proliferation
hs4 OSBPL10 3p22.3 -0.23 0.0798 0.577 transport;lipid transport
hs4 ZNF860 3p23 -0.23 0.0798 0.577 regulation of transcription, DNA-
dependent"
hs4 FAM102A 9q34.11 -0.23 0.0798 0.577
his PPIAL4F 0.23 0.0799 0.578
xai SEPHS1P5 0.23 0.0799 0.578
xai CLUH 17p13.3 0.23 0.0799 0.578
exp LOC728445 0.23 0.0799 0.578
exp LOC100128343 0.23 0.0799 0.578
met TRIO 5p15.2 0.228 0.0799 0.578 transmembrane receptor protein
tyrosine phosphatase signaling pathway;small GTPase mediated signal transduction
exp DDX6 11q23.3 0.228 0.0799 0.578 nuclear-transcribed mRNA catabolic
xsq COA4 11q13.4 0.228 0.0799 0.578
xsq GNRHR2 1q12 0.228 0.0799 0.578
exp LAMTOR5-AS1 0.228 0.0799 0.578
xsq SNHG17 20q11.23 0.228 0.0799 0.578
xsq SNORA6 0.228 0.0799 0.578
cop ITGAL 16p11.2 0.228 0.0799 0.578 cell adhesion;regulation of immune
response
exp LOC401052 3p25.3 -0.228 0.0799 0.578
exp SNORA77 1q32.1 -0.23 0.0799 0.578
xai SNORA77 1q32.1 -0.23 0.0799 0.578
exp HSPA9P1 2q36.3 0.23 0.08 0.578
his N6AMT1 21q21.3 0.23 0.08 0.578 protein methylation;positive
xai CLEC4C 12p13.2-p12.3 0.23 0.08 0.578 innate immune response
hs4 LINC01347 0.23 0.08 0.578
his RAB10 2p23.3 0.23 0.08 0.578 small GTPase mediated signal
xai COA5 2q11.2 0.23 0.08 0.578
xai RPL26P37 0.23 0.08 0.578
exp LOC729217 16q21 0.228 0.08 0.578
met SPACA3 17q11.2 0.228 0.08 0.578 defense response to Gram-positive
bacterium;peptidoglycan catabolic process
xsq AVPR2 Xq28 0.228 0.08 0.578 G-protein signaling, coupled to cAMP nucleotide
second messenger;interferon-gamma production
xsq RAD17 5q13 0.228 0.08 0.578 DNA Damage Response (DDR)
met HTR1A 5q11.2-q13 0.228 0.08 0.578 serotonin receptor signaling
pathway;behavior
cop DDX47 12p13.1 0.228 0.08 0.578 mRNA processing;apoptotic process
cop RPL13AP20 12p13.1 0.228 0.08 0.578
met SPATA32 17q21.31 -0.228 0.08 0.578
hs4 NTN4 12q22 -0.23 0.08 0.578 axon guidance;neuron remodeling
hs4 CTTNBP2 7q31 -0.23 0.08 0.578 brain development
xai BLMH 17q11.2 0.23 0.0801 0.578 protein polyubiquitination;antigen
his CDC123 10p13 0.23 0.0801 0.578 G1 phase of mitotic cell cycle;cell
cycle
his NUDT5 10p14 0.23 0.0801 0.578 nucleobase-containing compound metabolic
xai POLM 7p13 0.23 0.0801 0.578 DNA Damage Response (DDR); DDR (NHEJ);
xai BUB1B 15q15 0.23 0.0801 0.578 DNA Damage Response (DDR)
xai LOC728445 0.23 0.0801 0.578
hs4 CDCA3 12p13 0.23 0.0801 0.578 cell cycle;mitosis
hs4 USP5 12p13 0.23 0.0801 0.578 positive regulation of proteasomal
exp SEPHS1P5 0.23 0.0801 0.578
his CECR1 22q11.2 0.23 0.0801 0.578 adenosine catabolic
xai ACTL6B 7q22 0.23 0.0801 0.578 chromatin organization;chromatin
remodeling
xai LOC100128343 0.23 0.0801 0.578
his TECPR2 14q32.31 0.23 0.0801 0.578
his CINP 14q32.31 0.23 0.0801 0.578 DNA replication;DNA repair
met FAM171A1 10p13 0.228 0.0801 0.578
xsq RPS6KB2 11q13.2 0.228 0.0801 0.578 Apoptosis; Protein Kinases
exp LOC728688 0.228 0.0801 0.578
cop M6PR 12p13 0.228 0.0801 0.578 transport;receptor-mediated endocytosis
exp COCH 14q11.2-q13 0.228 0.0801 0.578 sensory perception of sound
xsq LOC102724467 0.228 0.0801 0.578
exp CPSF1 8q24.23 0.228 0.0801 0.578 nuclear mRNA splicing, via
spliceosome;gene expression
cop RIMKLB 12p13.31 0.228 0.0801 0.578 protein modification process
cop A2ML1 12p13.31 0.228 0.0801 0.578 negative regulation of peptidase
activity;regulation of endopeptidase activity
cop PHC1 12p13 0.228 0.0801 0.578 multicellular organismal development
hs4 LIMS2 2q14.3 -0.23 0.0801 0.578 cell junction assembly
his VTRNA2-1 -0.23 0.0801 0.578
his MIR5191 -0.23 0.0801 0.578
hs4 ABI3BP 3q12 -0.23 0.0801 0.578 positive regulation of cell-
hs4 F3 1p22-p21 -0.23 0.0801 0.578 anti-apoptosis;positive regulation
of platelet-derived growth factor receptor signaling pathway
hs4 SPRY2 13q31.1 -0.23 0.0801 0.578 sensory perception of
sound;negative regulation of epidermal growth factor receptor signaling pathway
xai HAP1 17q21.2-q21.3 0.23 0.0802 0.578 protein localization;synaptic
transmission
exp HAUS3 0.23 0.0802 0.578 centrosome organization;cell division
xai PHKG2 16p11.2 0.23 0.0802 0.578 glycogen metabolic process;glycogen
his LOC100507071 0.23 0.0802 0.578
his PIWIL2 8p21.3 0.23 0.0802 0.578 multicellular organismal
exp LOC100507103 0.23 0.0802 0.578
exp ARL5AP2 0.23 0.0802 0.578
xai ARL5AP2 0.23 0.0802 0.578
his PIH1D2 11q23.1 0.23 0.0802 0.578
his C11orf57 11q23.1 0.23 0.0802 0.578
xai CEP57L1 6q21 0.23 0.0802 0.578
exp CUEDC2 10q24.32 0.228 0.0802 0.578
exp FAM225B 9q32 -0.228 0.0802 0.578
met CD93 20p11.21 -0.228 0.0802 0.578 macrophage
activation;interspecies interaction between organisms
xai ACSL1 4q35.1 -0.23 0.0802 0.578 fatty acid metabolic
hs4 SWAP70 11p15 -0.23 0.0802 0.578 somatic cell DNA
xai NRP2 2q33.3 -0.23 0.0802 0.578 angiogenesis;positive regulation of
endothelial cell migration
hs4 NRXN3 14q31 -0.23 0.0802 0.578 angiogenesis;cell adhesion
his C3 19p13.3-p13.2 -0.23 0.0802 0.578 complement
hs4 TNC 9q33 -0.23 0.0802 0.578 positive regulation of gene
xai SNX9 6q25.1-q26 -0.23 0.0802 0.578 intracellular protein
swa OPA1 3q29 -0.23 0.0802 0.578 Apoptosis
his C6orf132 6p21.1 -0.23 0.0802 0.578
hs4 WFDC21P -0.23 0.0802 0.578
his LOC643770 0.23 0.0803 0.578
swa PGLS 19p13.2 0.23 0.0803 0.579 pentose-phosphate shunt, oxidative
branch;small molecule metabolic process
xsq RTL1 14q32.2 0.228 0.0803 0.578 multicellular organismal
development
exp KLF7 2q32 -0.228 0.0803 0.579 regulation of transcription from
RNA polymerase II promoter;axon guidance
cop SOX2 3q26.3-q27 -0.228 0.0803 0.579 eye development;glial cell
fate commitment
xsq SORT1 1p13.3 -0.228 0.0803 0.578 transport;regulation of gene
expression
hs4 ZNF702P 19q13.41 -0.23 0.0803 0.579 regulation of transcription,
DNA-dependent"
swa DSP 6p24 -0.23 0.0803 0.578 cell-cell adhesion;peptide cross-linking
xai KIF9 3p21.31 0.229 0.0804 0.579 microtubule-based movement;blood
coagulation
exp CEP57L1 6q21 0.229 0.0804 0.579
xai ZNF852 3p21.31 0.229 0.0804 0.579
his RHEBL1 12q13.12 0.229 0.0804 0.579 TOR signaling
his QARS 3p21.31 0.229 0.0804 0.579 tRNA aminoacylation for protein
translation;glutaminyl-tRNA aminoacylation
his TEX264 3p21.31 0.229 0.0804 0.579
xsq TUBGCP3 13q34 0.228 0.0804 0.579 mitotic cell cycle;microtubule
nucleation
exp UBAC1 9q34.3 0.228 0.0804 0.579
exp POTED 21q11.2 0.228 0.0804 0.579
met SEC14L2 22q12.2 0.228 0.0804 0.579 regulation of cholesterol
biosynthetic process;positive regulation of transcription, DNA-dependent"
xsq RNASE3 14q11.2 0.228 0.0804 0.579 RNA catabolic process;defense
xsq MYCL 1p34.2 0.228 0.0804 0.579
cop B3GNT4 12q24 0.228 0.0804 0.579 post-translational protein
xsq SULT1A4 16p11.2 0.228 0.0804 0.579 catecholamine metabolic
process;sulfation
met FABP7 6q22-q23 0.228 0.0804 0.579 nervous system development;negative
cop CDH12 5p14.3 -0.228 0.0804 0.579 homophilic cell
exp ATOH8 2p11.2 -0.228 0.0804 0.579 regulation of transcription,
hs4 MIR21 -0.229 0.0804 0.579
exp MYO16-AS1 -0.229 0.0804 0.579
hs4 TSPAN17 5q35.3 -0.23 0.0804 0.579 protein ubiquitination
xai PAN3 13q12.2 0.229 0.0805 0.579 gene expression;RNA metabolic
process
his CDK1 10q21.1 0.229 0.0805 0.579 DDR (DNA replication); Protein
Kinases
his VPS52 6p21.3 0.229 0.0805 0.579 protein transport
his RPS18 6p21.3 0.229 0.0805 0.579 nuclear-transcribed mRNA catabolic
his RHOT2 16p13.3 0.229 0.0805 0.579 Apoptosis
xsq PPP2R5C 14q32.31 0.227 0.0805 0.579 protein processing;DNA damage
apoptosis
mut COL23A1 5q35.3 0.227 0.0805 0.579 protein homotrimerization
xsq PARD6A 16q22.1 0.227 0.0805 0.579 cell-cell junction
maintenance;cell division
met GSTM3 1p13.3 0.227 0.0805 0.579 metabolic process;response to
estrogen stimulus
xsq USP38 0.227 0.0805 0.579 proteolysis;ubiquitin-dependent protein
catabolic process
xsq TMEM212-AS1 0.227 0.0805 0.579
exp POGZ 1q21.3 0.227 0.0805 0.579 regulation of transcription, DNA-
xsq NTSR1 20q13 0.227 0.0805 0.579 G-protein coupled receptor signaling
exp SFT2D2 1q24.2 -0.227 0.0805 0.579 protein
xsq SLC35F5 2q14.1 -0.227 0.0805 0.579 Solute Carriers
exp TLL2 10q23-q24 -0.227 0.0805 0.579 proteolysis;multicellular
xsq LOC100132215 2p15 -0.227 0.0805 0.579
exp IFIT3 -0.227 0.0805 0.579 cellular response to interferon-
cop AOAH-IT1 -0.227 0.0805 0.579
xai SNX24 5q23.2 -0.229 0.0805 0.579 cell communication;protein
transport
hs4 ZNF219 14q11 0.229 0.0806 0.579 transcription, DNA-
dependent;regulation of transcription, DNA-dependent
his STN1 0.229 0.0806 0.579
exp BUB1B 15q15 0.229 0.0806 0.579 DNA Damage Response (DDR)
xai HNRNPA3 2q31.2 0.229 0.0806 0.579 nuclear mRNA splicing, via
his UBA52 19p13.1-p12 0.229 0.0806 0.58 protein polyubiquitination;DNA
repair
exp PHF21B 22q13.31 0.227 0.0806 0.579
mut HP1BP3 1p36.12 0.227 0.0806 0.579 nucleosome assembly
exp COA5 2q11.2 0.227 0.0806 0.579
cop PARK2 6q25.2-q27 0.227 0.0806 0.579 mitochondrion degradation;adult
locomotory behavior
mut MDFI 6p21 -0.227 0.0806 0.58 cytoplasmic sequestering of
transcription factor;negative regulation of DNA binding
exp NMT2 10p13 -0.227 0.0806 0.579 N-terminal protein
myristoylation;protein lipoylation
his MYBL1 8q13.1 -0.229 0.0806 0.579 regulation of transcription,
his NPIPB11 16p11.2 -0.229 0.0806 0.579
hs4 KLF15 3q21.3 -0.229 0.0806 0.579 glial cell
differentiation;glucose transport
DNA-dependent"
DNA-dependent"
hs4 RINL 19q13.2 0.229 0.0807 0.58
his FAM131B 7q34 0.229 0.0807 0.58
xai AHSA2 2p15 0.229 0.0807 0.58 response to stress
xsq AASDHPPT 11q22 0.227 0.0807 0.58 macromolecule biosynthetic
xsq PDS5A 4p14 0.227 0.0807 0.58 DNA Damage Response (DDR)
met IL18BP 11q13 0.227 0.0807 0.58 negative regulation of signal
transduction;response to lipopolysaccharide
xsq NAT6 3p21.3 0.227 0.0807 0.58
exp AKAP8 19p13.1 0.227 0.0807 0.58 signal transduction;mitosis
exp TBX19 1q24.2 -0.227 0.0807 0.58 regulation of transcription
from RNA polymerase II promoter;anatomical structure morphogenesis
his FRMD5 15q15.3 -0.229 0.0807 0.58
swa FKBP10 17q21.2 -0.229 0.0807 0.58 peptidyl-proline
hs4 KIAA0754 -0.229 0.0807 0.58
xai TMEM217 6p21.2 -0.229 0.0807 0.58
hs4 RBMS2 12q13.3 -0.229 0.0807 0.58 RNA processing
xai ROPN1L 5p15.2 0.229 0.0808 0.58 ciliary or flagellar
motility;signal transduction
his RFC4 3q27 0.229 0.0808 0.58 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xai ZSCAN16-AS1 0.229 0.0808 0.58
exp RPL37P2 11q13 0.229 0.0808 0.58
his LOC101928902 0.229 0.0808 0.58
his ADCK5 8q24.3 0.229 0.0808 0.58
exp TRMT10A 4q23 0.227 0.0808 0.58
cop C2orf73 2p16.2 0.227 0.0808 0.58
cop RPL23AP32 0.227 0.0808 0.58
exp EIF3L 22q 0.227 0.0808 0.58 translational initiation
cop LINC00470 0.227 0.0808 0.58
exp EIF2B4 2p23.3 0.227 0.0808 0.58 gene expression;cellular
xsq RRAS 19q13.33 -0.227 0.0808 0.58 GTP catabolic process;signal
transduction
exp EPHX4 1p22.1 -0.227 0.0808 0.58
hs4 CKAP4 12q23.3 -0.229 0.0808 0.58
xai SNX21 20q13.12 -0.229 0.0808 0.58 cell communication;protein
transport
his PTOV1-AS2 -0.229 0.0808 0.58
hs4 DDO 6q21 -0.229 0.0808 0.58 grooming behavior;hormone metabolic
process
xai ATP6V0A4 7q34 -0.229 0.0808 0.58 ion transport;transferrin
transport
xai ADGRE1 0.229 0.0809 0.58 cell adhesion;G-protein coupled
his PSMA6 14q13 0.229 0.0809 0.58 M/G1 transition of mitotic cell
his PNPT1 2p15 0.229 0.0809 0.58 mitochondrial mRNA catabolic
process;transport
hs4 CRTC3-AS1 0.229 0.0809 0.58
hs4 BLM 15q26.1 0.229 0.0809 0.58 DNA Damage Response (DDR); DDR (FA)
swa PSMD10 Xq22.3 0.229 0.0809 0.58 cell cycle checkpoint;antigen
processing and presentation of exogenous peptide antigen via MHC class I, TAP-
dependent
exp ACTL6B 7q22 0.229 0.0809 0.58 chromatin organization;chromatin
remodeling
met FLJ26850 19q13.33 0.227 0.0809 0.58
mut PRKCE 2p21 0.227 0.0809 0.58 Protein Kinases
cop CLEC4E 12p13.31 0.227 0.0809 0.58 immune response;positive
regulation of cytokine secretion
exp HSPD1P10 6q15 0.227 0.0809 0.58
met GYLTL1B 11p11.2 0.227 0.0809 0.58 muscle cell homeostasis
xsq ATP5D 19p13.3 0.227 0.0809 0.58 ATP catabolic process;ATP
exp KIR3DL3 0.227 0.0809 0.58
xsq MYCBP 1p33-p32.2 0.227 0.0809 0.58 spermatogenesis;regulation of
xsq CDK15 2q33.2 -0.227 0.0809 0.58 Protein Kinases
xsq INADL 1p31.3 -0.227 0.0809 0.58 intracellular signal
met COCH 14q11.2-q13 -0.227 0.0809 0.58 sensory perception of sound
xai UNC5B 10q22.1 -0.229 0.0809 0.58 Apoptosis
his C15orf52 15q15.1 -0.229 0.0809 0.58
his PHGR1 15q15.1 -0.229 0.0809 0.58
his PPP1R42 8q13.1 -0.229 0.0809 0.58
his EPS15L1 19p13.11 -0.229 0.0809 0.58 endocytosis;epidermal
xai STK17A 7p13 -0.229 0.0809 0.58 Apoptosis
xai RCC2P7 6p12.1 0.229 0.081 0.58
his ARIH2 3p21 0.229 0.081 0.58 protein polyubiquitination;multicellular
his ARIH2OS 3p21.31 0.229 0.081 0.58
his SERBP1 1p31 0.229 0.081 0.58 regulation of anti-apoptosis;regulation
of mRNA stability
xsq LIG3 17q11.2-q12 0.227 0.081 0.58 DNA Damage Response (DDR); DDR (BER)
exp RBM17 10p15.1 0.227 0.081 0.58 mRNA processing;RNA splicing
xsq GPR12 13q12 0.227 0.081 0.58 cellular calcium ion homeostasis;G-protein
xsq CLIC4 1p36.11 -0.227 0.081 0.58 ion transport;chloride transport
cop ATP6V0D2 -0.227 0.081 0.58 transmembrane transport;ion
transport
cop SLC7A13 8q21.3 -0.227 0.081 0.58 Solute Carriers
exp PRKCA 17q22-q23.2 -0.227 0.081 0.58 Apoptosis; Protein Kinases
xsq SQSTM1 5q35 -0.227 0.081 0.58 Apoptosis
exp FAM20C 7p22.3 -0.227 0.081 0.58
xsq LOC100128176 -0.227 0.081 0.58
xai MYO16-AS1 -0.229 0.081 0.58
his MIR769 -0.229 0.081 0.58
hs4 ITGA1 5q11.2 -0.229 0.081 0.58 activation of MAPK
hs4 PELO 5q11.2 -0.229 0.081 0.58 cell cycle;cell proliferation
exp AP4B1-AS1 0.229 0.0811 0.58
hs4 LOC101926963 0.229 0.0811 0.581
hs4 POTEJ 0.229 0.0811 0.581
xai ANKMY1 2q37.3 0.229 0.0811 0.581
his MIR3613 0.229 0.0811 0.581
his TRIM13 13q14 0.229 0.0811 0.581 signal transduction;anatomical
xai HAUS3 0.229 0.0811 0.581 centrosome organization;cell division
exp AGAP6 10q11.23 0.229 0.0811 0.581 regulation of ARF GTPase activity
xsq OR52B4 11p15.4 0.227 0.0811 0.58 response to stimulus
DNA-dependent"
exp DNMT3A 2p23 0.227 0.0811 0.581 Oncogenes
cop MYCNOS 2p24.1 0.227 0.0811 0.581
cop MYCN 2p24.3 0.227 0.0811 0.581 Protein Kinases
mut STAMBPL1 10q23.31 0.227 0.0811 0.581 proteolysis
exp YWHAZP2 2q14.3 -0.227 0.0811 0.581
exp ARHGEF11 1q21 -0.227 0.0811 0.581 Rho protein signal
hs4 GPR1 2q33.3 -0.229 0.0811 0.581 G-protein coupled receptor
signaling pathway
xai BYSL 6p21.1 0.229 0.0812 0.581 cell adhesion;female pregnancy
xai SLAIN1 13q22.3 0.229 0.0812 0.581
his HEMGN 9q22.33 0.229 0.0812 0.581 multicellular organismal
exp RBM6 3p21.3 0.227 0.0812 0.581 RNA processing
met LINC00200 10p15.3 0.227 0.0812 0.581
cop C12orf4 12p13.3 0.227 0.0812 0.581
xsq METTL21EP 13q33.1 0.227 0.0812 0.581
mir hsa-miR-374b 0.227 0.0812 0.581
cop ACYP2 2p16.2 0.227 0.0812 0.581 phosphate-containing compound
metabolic process
pro EP300_2_8439 0.227 0.0812 0.581
exp EIF4EP1 20p13 0.227 0.0812 0.581
xsq HSPG2 1p36.1-p34 -0.227 0.0812 0.581 chondrocyte
exp GAD1 2q31 -0.227 0.0812 0.581 neurotransmitter secretion;protein-
xai LTBP2 14q24 -0.229 0.0812 0.581 protein targeting;transforming
xai RAB11FIP4 17q11.2 -0.229 0.0812 0.581 cytokinesis;transport
xai RTN4 2p16.3 -0.229 0.0812 0.581 Apoptosis
xai AKT1S1 19q13.33 -0.229 0.0812 0.581 nerve growth factor
receptor signaling pathway;negative regulation of protein kinase activity
xai MT1JP 16q13 -0.229 0.0812 0.581
xai NDST3 4q26 0.229 0.0813 0.581
his MEN1 11q13 0.229 0.0813 0.581 DNA Damage Response (DDR); Tumor
Suppressors
exp FLVCR1 1q32.3 0.227 0.0813 0.581 heme transport;head
morphogenesis
xsq DEPDC1B 5q12.1 0.227 0.0813 0.581 small GTPase mediated signal
cop TRPM7 15q21 0.227 0.0813 0.581 transmembrane transport;ion transport
exp SNRPD2 19q13.2 0.227 0.0813 0.581 spliceosome
assembly;spliceosomal snRNP assembly
xsq RAN 12q24.3 0.227 0.0813 0.581 nucleocytoplasmic
exp CHERP 19p13.1 0.227 0.0813 0.581 nervous system development;negative
met CEACAM6 19q13.2 0.227 0.0813 0.581 signal transduction;cell-cell
signaling
xsq POLR3B 12q23.3 0.227 0.0813 0.581 transcription elongation from
met CYP2W1 7p22.3 -0.227 0.0813 0.581 small molecule metabolic
exp CPNE5 6p21.1 -0.227 0.0813 0.581
swa ANXA4 2p13 -0.229 0.0813 0.581 Apoptosis
his SREK1IP1 5q12.3 0.229 0.0814 0.581 mRNA processing;RNA splicing
his CWC27 5q12.3 0.229 0.0814 0.581 nuclear mRNA splicing, via
spliceosome;protein folding"
his GPHN 14q23.3 0.229 0.0814 0.581 vitamin metabolic process;water-
hs4 NCAPG2 7q36.3 0.229 0.0814 0.581 DNA Damage Response (DDR)
xai CEP57 11q21 0.229 0.0814 0.581 protein import into nucleus,
translocation;G2/M transition of mitotic cell cycle
xai METTL21EP 13q33.1 0.229 0.0814 0.582
exp EMSY 0.227 0.0814 0.581 DNA repair;regulation of transcription,
DNA-dependent
exp TRMT2B Xq22.1 0.227 0.0814 0.581 tRNA processing
xsq LOC102723704 0.227 0.0814 0.581
exp SF3B6 0.227 0.0814 0.581
xsq BCDIN3D 12q13.12 0.227 0.0814 0.581
xsq SLAIN1 13q22.3 0.227 0.0814 0.581
cop CHRDL2 11q14 0.227 0.0814 0.581 ossification;multicellular
cop MIR4696 0.227 0.0814 0.581
cop RNF169 11q13.4 0.227 0.0814 0.581
cop PRH1-PRR4 0.227 0.0814 0.581
xsq LINC00605 0.227 0.0814 0.581
cop TSPYL6 2p16.2 0.227 0.0814 0.581 nucleosome assembly
xsq MMP14 14q11.2 -0.227 0.0814 0.581 Apoptosis
hs4 ERBB2 17q12 -0.229 0.0814 0.581 Apoptosis; Oncogenes; Protein
Kinases
hs4 PGAP3 17q12 -0.229 0.0814 0.581 GPI anchor metabolic process;GPI
his LOC101929596 -0.229 0.0814 0.581
hs4 TIMP2 17q25 -0.229 0.0814 0.581 negative regulation of cell
xai PTPN23 3p21.3 -0.229 0.0814 0.581 cell projection
exp GPR156 3q13.33 -0.229 0.0814 0.581
xai CTBP1-AS2 4p16.3 0.229 0.0815 0.582
xai TDRKH 1q21 0.229 0.0815 0.582
his ANAPC16 10q22.1 0.229 0.0815 0.582 cell cycle;mitosis
his ASCC1 10pter-q25.3 0.229 0.0815 0.582 regulation of transcription,
DNA-dependent"
exp USP45 6q16.2 0.229 0.0815 0.582 proteolysis;ubiquitin-dependent
his ZSCAN16-AS1 0.229 0.0815 0.582
DNA-dependent"
hs4 PDE3B 11p15.1 0.229 0.0815 0.582 cellular response to insulin
exp DCLRE1A 10q25.1 0.227 0.0815 0.582 DNA Damage Response (DDR)
xsq MBD3L4 0.227 0.0815 0.582
xsq DUS2 0.227 0.0815 0.582 tRNA processing
met OR2V2 5q35.3 0.227 0.0815 0.582
cop LOC728606 0.227 0.0815 0.582
exp IQGAP1 15q26.1 -0.227 0.0815 0.582 energy reserve metabolic
exp TM2D1 1p31.3 -0.227 0.0815 0.582 apoptotic process;induction
of apoptosis by extracellular signals
xsq UGT2B7 4q13 -0.227 0.0815 0.582 metabolic process;cellular
glucuronidation
exp PTPRG 3p21-p14 -0.227 0.0815 0.582 transmembrane receptor
xai KPRP 1q21.3 -0.229 0.0815 0.582
xai PSEN1 14q24.3 -0.229 0.0815 0.582 Apoptosis
xai ANXA3 4q21.21 -0.229 0.0815 0.582 positive regulation of
angiogenesis;positive regulation of DNA metabolic process
xai SERPINB10 18q21.3 0.229 0.0816 0.582 negative regulation of
hs4 C1orf162 1p13.2 0.229 0.0816 0.582
met SH2D3C 9q34.11 0.227 0.0816 0.582 JNK cascade;small GTPase
cop C16orf80 0.227 0.0816 0.582
xsq IRG1 13q22.3 0.227 0.0816 0.582 propionate catabolic process
xsq BCOR Xp11.4 0.227 0.0816 0.582 Tumor Suppressors
cop KCNE3 11q13.4 0.227 0.0816 0.582 ion transport;regulation of
potassium ion transport
cop LIPT2 11q13.4 0.227 0.0816 0.582 protein modification
process;lipoate biosynthetic process
cop POLD3 11q14 0.227 0.0816 0.582 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq OXLD1 17q25.3 0.227 0.0816 0.582
cop SPPL2A 15q21.2 0.227 0.0816 0.582 proteolysis
xsq GTF3C3 2q33.1 0.227 0.0816 0.582 transcription, DNA-
met HNMT 2q22.1 0.227 0.0816 0.582 brain development;respiratory
gaseous exchange
xsq MESP2 15q26.1 0.227 0.0816 0.582 mesodermal cell migration;signal
transduction involved in regulation of gene expression
met COL4A2 13q34 0.227 0.0816 0.582 transcription, DNA-dependent;axon
guidance
xsq C2orf81 2p13.1 0.227 0.0816 0.582
exp PXMP4 20q11.22 -0.227 0.0816 0.582
xai FOLR1 11q13.3-q14.1 -0.229 0.0816 0.582 cell death;folic acid
transport
his GOLPH3 5p13.3 0.229 0.0817 0.582 regulation of mitochondrion
organization;positive regulation of TOR signaling cascade
hs4 HAAO 2p21 0.229 0.0817 0.582 small molecule metabolic process;response
to cadmium ion
exp ANKRD23 2q11.2 0.227 0.0817 0.582 fatty acid metabolic process
xsq CDC45 22q11.21 0.227 0.0817 0.582 DDR (DNA replication)
cop ETV6 12p13 0.227 0.0817 0.582 Transcription Factors
cop USP8 15q21.2 0.227 0.0817 0.582 protein K63-linked
cop USP50 15q21.1 0.227 0.0817 0.582 ubiquitin-dependent protein
catabolic process
exp ELP2 18q12.2 0.227 0.0817 0.582 regulation of transcription from
exp MTSS1 8p22 -0.227 0.0817 0.582 negative regulation of epithelial
cell proliferation;cellular component movement
cop RMDN1 8q21.3 -0.227 0.0817 0.582
exp ACOT1 14q24.3 -0.228 0.0817 0.582 lipid metabolic process;acyl-
CoA metabolic process
hs4 CRH 8q13 -0.229 0.0817 0.582 parturition;locomotory exploration
behavior
exp HOXD4 2q31.1 -0.229 0.0817 0.582 stem cell
differentiation;regulation of transcription, DNA-dependent
xai TRMT10A 4q23 0.228 0.0818 0.582
exp RNU5A-1 15q22.31 0.228 0.0818 0.583
exp ACMSD 2q21.3 0.228 0.0818 0.583 quinolinate metabolic
xsq SLC12A5 20q13.12 0.227 0.0818 0.582 ammonium
xsq C12orf45 12q23.3 0.227 0.0818 0.582
xsq GRIN2D 19q13.33 0.227 0.0818 0.583 signal transduction;synaptic
transmission
xsq STX10 19p13.2 0.226 0.0818 0.583 intracellular protein
exp PIKFYVE 2q34 0.226 0.0818 0.583 protein localization to
mir hsa-miR-378* 0.226 0.0818 0.583
cop RUNX1T1 8q22 -0.226 0.0818 0.583 generation of precursor
metabolites and energy;regulation of transcription, DNA-dependent
met MIR147B -0.226 0.0818 0.583
exp MT1H -0.227 0.0818 0.583 cellular zinc ion
homeostasis;nitric oxide mediated signal transduction
xsq SOX9 17q24.3 -0.227 0.0818 0.582 epithelial to mesenchymal
xsq MYH9 22q13.1 -0.227 0.0818 0.582 membrane protein ectodomain
xai GAS2L1 22q12.2 -0.228 0.0818 0.582 regulation of cell
cycle;microtubule bundle formation
xai RTN4R 22q11.21 -0.228 0.0818 0.582 axonogenesis;nerve growth
his ELOVL6 4q25 0.228 0.0819 0.583 fatty acid elongation,
xai AKAP8 19p13.1 0.228 0.0819 0.583 signal transduction;mitosis
hs4 NAV3 12q14.3 0.228 0.0819 0.583
exp SNORD94 2p11.2 0.228 0.0819 0.583
xai RNU5A-1 15q22.31 0.228 0.0819 0.583
xai GLYATL1P1 11q12.1 0.228 0.0819 0.583
his YIPF2 19p13.2 0.228 0.0819 0.583
his TIMM29 0.228 0.0819 0.583
his ABCA11P 4p16.3 0.228 0.0819 0.583
mir hsa-miR-181a* 0.226 0.0819 0.583
xsq TATDN2 3p25.3 0.226 0.0819 0.583 activation of signaling
exp SNHG10 14q32.13 0.226 0.0819 0.583
exp SUCNR1 3q25.1 0.226 0.0819 0.583
exp ZDHHC7 16q24.1 -0.226 0.0819 0.583
xsq ITGA7 12q13 -0.226 0.0819 0.583 regulation of cell shape;cell
adhesion
xsq PTPN21 14q31.3 -0.226 0.0819 0.583 protein
exp NPAS3 14q13.1 -0.226 0.0819 0.583 maternal behavior;positive
his GRB10 7p12.2 -0.228 0.0819 0.583 response to insulin
xai SNORD94 2p11.2 0.228 0.082 0.583
xai CELSR3 3p21.31 0.228 0.082 0.583 G-protein coupled receptor
swa RAC2 22q13.1 0.228 0.082 0.583 GTP catabolic process;actin cytoskeleton
organization
his ZDHHC20 13q12.11 0.228 0.082 0.583
xai TKFC 0.228 0.082 0.583 glycerol metabolic process;innate immune
response
exp OR4X2 11p11.2 0.228 0.082 0.583 response to stimulus
exp RBBP5 1q32 0.228 0.082 0.583 regulation of transcription, DNA-
xsq TMEM182 2q12.1 0.226 0.082 0.583
xsq LOC101929241 0.226 0.082 0.583
met VTRNA2-1 0.226 0.082 0.583
hs4 KNDC1 10q26.3 -0.228 0.082 0.583 regulation of dendrite
xai GALK2 15q21.1-q21.2 0.228 0.0821 0.583 carbohydrate metabolic
exp IGLC5 0.228 0.0821 0.583
his LINC00938 12q12 0.228 0.0821 0.583
his ARID2 12q12 0.228 0.0821 0.583 DNA Damage Response (DDR); DDR
(Chromatin)
his PABPN1 14q11.2 0.228 0.0821 0.583 muscle
contraction;modification by virus of host mRNA processing
his PPIB 15q21-q22 0.228 0.0821 0.583 protein peptidyl-prolyl
met RING1 6p21.3 0.226 0.0821 0.583 anterior/posterior pattern
specification;chromatin modification
exp POLM 7p13 0.226 0.0821 0.583 DNA Damage Response (DDR); DDR (NHEJ);
xsq P2RY12 3q24-q25 0.226 0.0821 0.583 blood coagulation;hemostasis
cop LRP11 6q25.1 0.226 0.0821 0.583
dependent"
exp RPL15P8 4q28.2 0.226 0.0821 0.583
exp PPA2 4q25 0.226 0.0821 0.583 tRNA aminoacylation for protein
xsq LLPH-AS1 0.226 0.0821 0.583
xsq ZNF296 19q13.32 0.226 0.0821 0.584 spermatogenesis;regulation of
xsq CCL13 17q11.2 0.226 0.0821 0.584 regulation of cell shape;cellular
calcium ion homeostasis
xsq EOMES 3p24.1 0.226 0.0821 0.584 mesoderm formation;positive
regulation of cell differentiation
cop CPNE3 8q21.3 -0.226 0.0821 0.583 lipid metabolic
process;vesicle-mediated transport
met REP15 12p11.22 -0.226 0.0821 0.583
xsq FLJ42393 -0.226 0.0821 0.583
his IP6K3 6p21.31 -0.228 0.0821 0.583 DNA Damage Response (DDR)
xai HOXD4 2q31.1 -0.228 0.0821 0.583 stem cell
exp RPL24P4 6p21.1 0.228 0.0822 0.584
exp LOC400685 0.228 0.0822 0.584
xai OSTC 4q25 0.228 0.0822 0.584 protein N-linked glycosylation via
asparagine
exp OR11J2P 15q11.2 0.228 0.0822 0.584
xsq TMEM147-AS1 0.226 0.0822 0.584
met MAOB Xp11.23 0.226 0.0822 0.584 xenobiotic metabolic
process;response to ethanol
xsq FAM127A Xq26 -0.226 0.0822 0.584
xai TINAGL1 1p35.2 -0.228 0.0822 0.584 proteolysis;immune
response
hs4 EPN3 17q21.33 -0.228 0.0822 0.584
xai ALCAM 3q13.1 -0.228 0.0822 0.584 cell adhesion;signal
transduction
cop MIR4278 -0.228 0.0822 0.584
his SPTLC1 9q22.2 0.228 0.0823 0.584 sphinganine biosynthetic
process;sphingosine biosynthetic process
xai SNORD78 0.228 0.0823 0.584
his FOXP2 7q31 0.228 0.0823 0.584 positive regulation of mesenchymal cell
proliferation;cerebral cortex development
cop DCAF13P3 0.226 0.0823 0.584
mut MLH1 3p21.3 0.226 0.0823 0.584 DNA Damage Response (DDR); DDR
(MMR); Tumor Suppressors
xsq TBKBP1 17q21.32 0.226 0.0823 0.584 innate immune response
cop LOC338817 0.226 0.0823 0.584
met SPIRE1 18p11.21 0.226 0.0823 0.584 transport
xsq MTRF1 13q14.1-q14.3 0.226 0.0823 0.584 regulation of translational
termination
cop DIABLO 12q24.31 0.226 0.0823 0.584 Apoptosis
exp COL5A1 9q34.2-q34.3 -0.226 0.0823 0.584 wound healing,
cop PRDM9 5p14 -0.226 0.0823 0.584 meiosis;chromatin modification
hs4 GSE1 16q24.1 0.228 0.0824 0.584
his RPL18A 19p13 0.228 0.0824 0.584 translational initiation;viral
infectious cycle
his SNORA68 0.228 0.0824 0.584
exp C18orf61 0.228 0.0824 0.584
exp SNORD78 0.228 0.0824 0.585
his POLD3 11q14 0.228 0.0824 0.585 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
exp METTL21EP 13q33.1 0.228 0.0824 0.585
his SNORA104 0.228 0.0824 0.585
xsq ZMAT1 Xq21 0.226 0.0824 0.584
xsq WNT6 2q35 0.226 0.0824 0.584 axis specification;epithelial-mesenchymal
cell signaling
xsq SLC24A4 14q32.12 0.226 0.0824 0.584 potassium ion
exp PARG 10q11.23 0.226 0.0824 0.584 DNA Damage Response (DDR); DDR
(BER)
met LAMC1 1q31 0.226 0.0824 0.584 axon guidance;endoderm development
mir hsa-miR-654-5p 0.226 0.0824 0.584
exp KIF11 10q24.1 0.226 0.0824 0.584 spindle organization;mitotic
xsq MUSTN1 3p21.1 0.226 0.0824 0.584 embryonic limb
morphogenesis;tissue regeneration
xsq ZCCHC7 9p13.2 0.226 0.0824 0.584
exp ZBTB40 1p36 0.226 0.0824 0.585 bone mineralization;regulation of
exp TBC1D10B 16p11.2 0.226 0.0824 0.585 positive regulation of Rab
exp KIAA0754 -0.226 0.0824 0.584
mir hsa-miR-34a -0.226 0.0824 0.584
xai PRKCA 17q22-q23.2 -0.228 0.0824 0.584 Apoptosis; Protein Kinases
his SEC14L4 22q12.2 0.228 0.0825 0.585
his ANKRD40 17q21.33 0.228 0.0825 0.585
hs4 CLDN5 22q11.21 0.228 0.0825 0.585 calcium-independent cell-cell
adhesion
xai MAD2L2 1p36 0.228 0.0825 0.585 DNA Damage Response (DDR); DDR (DNA
swa NRDC 0.228 0.0825 0.585 neuromuscular junction development;cell
proliferation
exp KGFLP2 0.228 0.0825 0.585
xsq LZIC 1p36.22 0.226 0.0825 0.585 response to ionizing radiation
xsq LOC100996325 0.226 0.0825 0.585
xsq CD3EAP 19q13.3 0.226 0.0825 0.585 rRNA
transcription;transmembrane receptor protein tyrosine kinase signaling pathway
xsq CHST5 16q22.3 0.226 0.0825 0.585 carbohydrate metabolic process;N-
xsq INHBC 12q13.1 0.226 0.0825 0.585 growth
xsq POU2F1 1q24.2 0.226 0.0825 0.585 lens induction in camera-type
exp RHPN1 8q24.3 0.226 0.0825 0.585 signal transduction
cop REXO1L2P -0.226 0.0825 0.585
cop REXO1L1 -0.226 0.0825 0.585
xsq AMIGO2 12q13.11 -0.226 0.0825 0.585 anti-apoptosis;cell
adhesion
xai CNKSR3 6q25.2 -0.228 0.0825 0.585 negative regulation of
his CATIP-AS1 0.228 0.0826 0.585
xai CUEDC2 10q24.32 0.228 0.0826 0.585
his SNORA80B 0.228 0.0826 0.585
his ODC1 2p25 0.228 0.0826 0.585 small molecule metabolic process;kidney
development
his LOC101929715 0.228 0.0826 0.585
his LAT2 7q11.23 0.228 0.0826 0.585 intracellular signal transduction;B
cell activation
exp CLEC4C 12p13.2-p12.3 0.228 0.0826 0.585 innate immune response
his PSMD3 17q21.1 0.228 0.0826 0.585 S phase of mitotic cell cycle;DNA
arrest
hs4 KCNH6 17q23.3 0.228 0.0826 0.585 potassium ion transport;signal
transduction
xai RIMS3 1p34.2 0.228 0.0826 0.585 neurotransmitter transport;calcium
ion-dependent exocytosis
exp RPS24 10q22 0.226 0.0826 0.585 translation;mRNA metabolic process
exp MAML3 4q28 0.226 0.0826 0.585 positive regulation of transcription from
mut NRP2 2q33.3 0.226 0.0826 0.585 angiogenesis;positive regulation of
xsq GEMIN7 19q13.32 0.226 0.0826 0.585 RNA splicing;gene expression
xsq OR4K2 0.226 0.0826 0.585
cop QPCT 2p22.2 0.226 0.0826 0.585 protein modification
process;proteolysis
xsq KCNN3 1q21.3 0.226 0.0826 0.585 potassium ion transmembrane
xsq PROSER2 10p14 -0.226 0.0826 0.585
met MIR585 -0.226 0.0826 0.585
hs4 LTBR 12p13 -0.228 0.0826 0.585 Apoptosis
xai MTSS1 8p22 -0.228 0.0826 0.585 negative regulation of epithelial
cell proliferation;cellular component movement
his ARHGAP45 0.228 0.0827 0.585
swa DNAJB1 19p13.2 0.228 0.0827 0.585 response to stress;response
to unfolded protein
his COLQ 3p25 0.228 0.0827 0.585 acetylcholine catabolic process in
synaptic cleft;asymmetric protein localization
his PSTPIP1 15q24.3 0.228 0.0827 0.585 cell adhesion;signal
transduction
xsq FCHSD2 11q13.4 0.226 0.0827 0.585
xsq NOA1 4q12 0.226 0.0827 0.585 mitochondrial translation;regulation of
mut LDB2 4p16 0.226 0.0827 0.585 positive regulation of cellular component
biogenesis;positive regulation of transcription from RNA polymerase II promoter
xsq MANEA-AS1 0.226 0.0827 0.585
mut GRID1 10q22 0.226 0.0827 0.585 ion transport
xsq OR9A4 7q34 0.226 0.0827 0.585
DNA-dependent"
exp RPL32P20 8q24.22 -0.226 0.0827 0.585
exp FAM49A 2p24.2 -0.226 0.0827 0.585
xsq HOXC9 12q13.3 -0.226 0.0827 0.585 multicellular organismal
development
xsq CD151 11p15.5 -0.226 0.0827 0.585 cell adhesion;hemidesmosome
assembly
hs4 LINC01567 -0.228 0.0827 0.585
xai SERTAD3 19q13.2 -0.228 0.0827 0.585 negative regulation of
hs4 BOLL 2q33 0.228 0.0828 0.585 meiosis;multicellular organismal
development
xai PDIK1L 1p36.11 0.228 0.0828 0.585
his TNFRSF18 1p36.3 0.228 0.0828 0.585 signal transduction;tumor
his NTHL1 16p13.3 0.228 0.0828 0.586 DNA Damage Response (DDR); DDR
(BER)
his TSC2 16p13.3 0.228 0.0828 0.586 Apoptosis; Protein Kinases; Tumor
Suppressors
his HORMAD2 22q12.2 0.228 0.0828 0.586 meiosis
his HORMAD2-AS1 0.228 0.0828 0.586
xsq CRYM-AS1 16p12.2 0.226 0.0828 0.585
met TESPA1 12q13.2 0.226 0.0828 0.585
met RDH14 2p24.2 0.226 0.0828 0.585
met MIR22 0.226 0.0828 0.585
exp CD320 19p13.3-p13.2 0.226 0.0828 0.586 regulation of cell growth
xsq MED23 6q22.33-q24.1 0.226 0.0828 0.586 regulation of transcription
from RNA polymerase II promoter;transcription initiation from RNA polymerase II
promoter
xsq HABP4 9q22.3-q31 -0.226 0.0828 0.585 cellular response to
xsq FAT2 5q33.1 -0.226 0.0828 0.585 cell adhesion;homophilic cell
adhesion
hs4 CEP170B 14q32.33 -0.228 0.0828 0.586
xai PTPRG 3p21-p14 -0.228 0.0828 0.586 transmembrane receptor
his CDO1 5q23.2 0.228 0.0829 0.586 sulfur amino acid metabolic
xai PRAM1 19p13.2 0.228 0.0829 0.586 integrin-mediated signaling
xai ABCG2 4q22 0.228 0.0829 0.586 ABC Transporters
xai MTMR4 17q22-q23 0.228 0.0829 0.586 protein dephosphorylation;peptidyl-
xsq LAMTOR2 1q22 0.226 0.0829 0.586 cell growth;positive regulation of
met CSN1S1 4q21.1 0.226 0.0829 0.586
DNA-dependent"
xsq PAQR9-AS1 0.226 0.0829 0.586
exp FOLR1 11q13.3-q14.1 -0.226 0.0829 0.586 cell death;folic acid
transport
exp BRE-AS1 -0.228 0.0829 0.586
xai DENND4C 9p22.1 -0.228 0.0829 0.586
hs4 PTPN3 9q31 -0.228 0.0829 0.586 protein dephosphorylation;peptidyl-
his SH3D19 4q31.3 -0.228 0.0829 0.586 post-Golgi vesicle-
xai NUCB1 19q13.33 -0.228 0.0829 0.586
exp BRAP 12q24 0.228 0.083 0.586 MAPK cascade;Ras protein signal transduction
xai FUT4 11q21 0.228 0.083 0.586 carbohydrate metabolic process;protein
glycosylation
his WNK1 12p13.3 0.228 0.083 0.586 negative regulation of phosphatase
xai C18orf61 0.228 0.083 0.586
xsq EIF3L 22q 0.226 0.083 0.586 translational initiation
xsq DPH7 9q34.3 0.226 0.083 0.586
xsq ACVR2B 3p22 0.226 0.083 0.586 signal transduction;anterior/posterior
pattern specification
xsq SMAD2 18q21.1 0.226 0.083 0.586 Apoptosis; Cell Signaling
cop PPIL4 6q25.1 0.226 0.083 0.586 protein folding
xsq PIWIL4 11q21 0.226 0.083 0.586 gene silencing by RNA;piRNA metabolic
process
xsq DTX3L 3q21.1 -0.226 0.083 0.586 response to DNA damage
xsq GBP3 1p22.2 -0.226 0.083 0.586
hs4 EVI5 1p22.1 -0.228 0.083 0.586 cell cycle;multicellular organismal
development
his MIR4462 -0.228 0.083 0.586
xai GLTSCR1 19q13.3 -0.228 0.083 0.586
his MRGPRF-AS1 -0.228 0.083 0.586
his MRGPRF 11q13.3 -0.228 0.083 0.586
his C2orf70 2p23.3 -0.228 0.083 0.586
xai ZNF76 6p21.31 0.228 0.0831 0.586 regulation of transcription from
RNA polymerase III promoter;regulation of transcription from RNA polymerase II
promoter
exp LOC100128333 0.228 0.0831 0.586
exp PPATP1 3p12.1 0.227 0.0831 0.586
mir hsa-miR-29c* 0.226 0.0831 0.586
xsq UBE2QL1 5p15.31 0.226 0.0831 0.586
exp UBE2D3 4q24 0.226 0.0831 0.586 protein modification
cop NIPAL2 8q22.2 -0.226 0.0831 0.586
cop KCNS2 8q22 -0.226 0.0831 0.586 ion transport;potassium ion
transport
xsq ALS2CR11 2q33.1 -0.226 0.0831 0.586
cop MPLKIP 7p14.1 -0.226 0.0831 0.586 DNA Damage Response
(DDR)
exp DDR2 1q23.3 -0.226 0.0831 0.586 peptidyl-tyrosine
factor activity
xai C1orf220 1q25.2 -0.227 0.0831 0.586
his TIMP4 3p25 -0.228 0.0831 0.586 response to peptide hormone
stimulus;central nervous system development
hs4 C5orf58 5q35.1 -0.228 0.0831 0.586
swa MARCKS 6q22.2 -0.228 0.0831 0.586 energy reserve metabolic
xai DCDC2 6p22.1 -0.228 0.0831 0.586 cellular defense
his KCNH2 7q36.1 0.227 0.0832 0.587 synaptic transmission;blood
circulation
his MAP2K1 15q22.1-q22.33 0.227 0.0832 0.587 Oncogenes; Protein
Kinases
his HIST1H1E 6p21.3 0.227 0.0832 0.587 nucleosome
his HIST1H2BD 6p21.3 0.227 0.0832 0.587 nucleosome assembly
exp PAN3 13q12.2 0.226 0.0832 0.587 gene expression;RNA metabolic
process
exp KANSL2 12q13.11 0.226 0.0832 0.587 histone H4-K5
mut QRFPR 4q27 0.226 0.0832 0.587 G-protein coupled receptor signaling
pathway
met AIRE 21q22.3 0.226 0.0832 0.587 positive regulation of
transcription, DNA-dependent;positive regulation of transcription from RNA
exp LRRC28 15q26.3 0.226 0.0832 0.587
exp GOLGA8A 15q11.2 0.225 0.0832 0.587
xsq MLLT4 6q27 -0.226 0.0832 0.587 cell junction assembly;adherens
his IQCD 12q24.13 -0.227 0.0832 0.587
hs4 MATN3 2p24-p23 -0.227 0.0832 0.587 skeletal system development
hs4 PTRF 17q21.2 -0.227 0.0832 0.587 transcription initiation from
xai FBXO46 19q13.3 0.227 0.0833 0.587
xai CAND1 12q14 0.227 0.0833 0.587 regulation of transcription, DNA-
exp RPS15AP9 1p13.1 0.227 0.0833 0.587
xai RPS15AP9 1p13.1 0.227 0.0833 0.587
mut CD300C 17q25.1 0.225 0.0833 0.587 cellular defense response
xsq LOC151121 2q21.1 0.225 0.0833 0.587
exp DOT1L 19p13.3 0.225 0.0833 0.587 DDR (DNA replication)
cop HPCAL1 2p25.1 0.225 0.0833 0.587
mir hsa-miR-33a 0.225 0.0833 0.587
xsq PCNXL2 1q42.2 -0.225 0.0833 0.587
met PRKAG3 2q35 -0.225 0.0833 0.587 intracellular protein kinase
cascade;insulin receptor signaling pathway
his LINC01181 -0.227 0.0833 0.587
hs4 LINC01608 -0.227 0.0833 0.587
his C1orf168 1p32.2 -0.227 0.0833 0.587
xai MECOM 3q26.2 -0.227 0.0833 0.587 response to external
xai AGAP6 10q11.23 0.229 0.0834 0.587 regulation of ARF GTPase activity
xai KIAA1958 9q32 0.227 0.0834 0.587
his FAM220A 7p22.1 0.227 0.0834 0.587
his LOC105375787 0.227 0.0834 0.587
his RNF167 17p13.2 0.227 0.0834 0.587 protein
polyubiquitination;negative regulation of cell cycle
his PFN1 17p13.3 0.227 0.0834 0.587 neural tube closure;positive
regulation of DNA metabolic process
his ENO3 17p13.2 0.227 0.0834 0.587 response to drug;skeletal muscle
tissue regeneration
xai INA 10q24.33 0.227 0.0834 0.587 multicellular organismal
his SEPT1 16p11.1 0.227 0.0834 0.587 cell cycle;cell division
his LY9 1q23.3 0.227 0.0834 0.587 cell adhesion;immunoglobulin
xsq FCRL4 1q21 0.225 0.0834 0.587
exp HEATR3 16q12.1 0.225 0.0834 0.587
xsq NCAPD3 11q25 0.225 0.0834 0.587 DNA Damage Response (DDR)
xsq ZNF462 9q31.2 -0.225 0.0834 0.587 positive regulation of
dependent
exp FZD2 17q21.1 -0.225 0.0834 0.587 axonogenesis;epithelial cell
differentiation
xai PQLC2L -0.227 0.0834 0.587
his CD200 3q13.2 -0.227 0.0834 0.587 regulation of immune response
xai ZAR1 4p11 0.227 0.0835 0.587 sodium ion transport;multicellular
cop POLE4 2p12 0.227 0.0835 0.588 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
his CDC25B 20p13 0.227 0.0835 0.588 DNA Damage Response (DDR)
his EXOC3-AS1 0.227 0.0835 0.588
his EXOC3 5p15.33 0.227 0.0835 0.588 exocytosis;protein transport
cop RSRC2 12q24.31 0.225 0.0835 0.587
xsq RAB8A 19p13.1 0.225 0.0835 0.588 vesicle docking involved in
met ZNF706 8q22.3 0.225 0.0835 0.588
xsq NOS2 17q11.2 0.225 0.0835 0.588 nitric oxide biosynthetic
process;defense response to Gram-negative bacterium
met THOC5 22q12.2 0.225 0.0835 0.588 cell differentiation;monocyte
differentiation
exp NAA35 9q21.33 0.225 0.0835 0.588 smooth muscle cell proliferation
DNA-dependent"
met C1orf94 1p34.3 0.225 0.0835 0.588
xsq SBK3 0.225 0.0835 0.588
exp KIAA1586 6p12.1 0.225 0.0835 0.588
xsq TMEM130 7q22.1 -0.225 0.0835 0.588
exp MDGA1 6p21 -0.225 0.0835 0.588 neuron migration;multicellular
xsq RBMS2 12q13.3 -0.225 0.0835 0.588 RNA processing
exp GYS1 19q13.3 -0.225 0.0835 0.588 small molecule metabolic
his GRIP1 12q14.3 -0.227 0.0835 0.588 positive regulation of
transcription, DNA-dependent;synaptic transmission
xai ALDH1L2 12q23.3 -0.227 0.0835 0.588 biosynthetic process;10-
xai ADAMTS16 5p15 -0.227 0.0835 0.588 proteolysis
xai NMT2 10p13 -0.227 0.0835 0.588 N-terminal protein
myristoylation;protein lipoylation
his PDE2A 11q13.4 -0.227 0.0835 0.588 metabolic process;negative
xai ACTBP7 -0.227 0.0835 0.588
his ACSF3 16q24.3 0.227 0.0836 0.588 lipid metabolic process;fatty acid
metabolic process
his CLEC7A 12p13.2 0.227 0.0836 0.588 phagocytosis,
recognition;defense response to protozoan
xai ZNHIT2 11q13 0.227 0.0836 0.588
his HP 16q22.2 0.227 0.0836 0.588 negative regulation of hydrogen
peroxide catabolic process;cellular iron ion homeostasis
cop HCAR1 12q24.31 0.227 0.0836 0.588 response to estradiol stimulus
xai CMTR2 0.227 0.0836 0.588
hs4 ZFP90 16q22.1 0.227 0.0836 0.588 negative regulation of DNA
xsq LOC100130849 7p11.2 0.225 0.0836 0.588
xsq HNRNPF 10q11.21 0.225 0.0836 0.588 nuclear mRNA splicing, via
xsq DEPDC4 12q23.1 0.225 0.0836 0.588 intracellular signal
transduction
xsq OTP 5q13.3 0.225 0.0836 0.588 forebrain neuron
differentiation;hypothalamus cell differentiation
xsq CHTOP 1q21.3 0.225 0.0836 0.588 regulation of transcription, DNA-
dependent"
xsq ROBO2 3p12.3 -0.225 0.0836 0.588 metanephros
development;olfactory bulb interneuron development
xai MCAM 11q23.3 -0.227 0.0836 0.588 vascular wound
healing;glomerular filtration
cop C2orf68 2p11.2 0.227 0.0837 0.588
xai RBM6 3p21.3 0.227 0.0837 0.588 RNA processing
exp RPL22P18 10q23 0.227 0.0837 0.588
swa PSMB6 17p13 0.227 0.0837 0.588 antigen processing and presentation of
peptide antigen via MHC class I;RNA metabolic process
exp MGC27345 7q32.1 0.225 0.0837 0.588
exp MED27 9q34.13 0.225 0.0837 0.588 regulation of transcription from
met CECR5 0.225 0.0837 0.588 metabolic process
cop KLRB1 12p13 0.225 0.0837 0.588
cop LOC374443 12p13.31 0.225 0.0837 0.588
cop CLEC2D 12p13 0.225 0.0837 0.588 cell surface receptor signaling
pathway
cop CLECL1 0.225 0.0837 0.588
xsq DPY19L2P2 7q22.1 0.225 0.0837 0.588
cop CD69 12p13 0.225 0.0837 0.588 cellular response to drug
cop NDRG4 16q21-q22.1 0.225 0.0837 0.588 cell growth;cell differentiation
met PRAC1 -0.225 0.0837 0.588
cop CFHR5 1q31.3 -0.225 0.0837 0.588 complement activation,
alternative pathway"
hs4 SYCP2 20q13.33 -0.227 0.0837 0.588 cell cycle;meiosis
his TINAGL1 1p35.2 -0.227 0.0837 0.588 proteolysis;immune
response
his KRT78 12q13.13 -0.227 0.0837 0.588
xai RPL22P18 10q23 0.227 0.0838 0.588
swa VCP 9p13.3 0.227 0.0838 0.588 Apoptosis; DNA Damage Response
(DDR)
his BRD9 5p15.33 0.227 0.0838 0.588
his TRIP13 5p15.33 0.227 0.0838 0.588 DNA Damage Response (DDR)
xai RPS11P1 20p12.2 0.227 0.0838 0.588
his PGM2 4p14 0.227 0.0838 0.588 glycogen catabolic process;glucose
metabolic process
hs4 ALDH1A2 15q21.3 0.227 0.0838 0.588 heart morphogenesis;positive
met CRISP2 6p12.3 0.225 0.0838 0.588
met SPATS2L 2q33.1 0.225 0.0838 0.588
xsq VWC2L 2q34-q35 0.225 0.0838 0.588
cop GABARAPL1 12p13.2 0.225 0.0838 0.588
met SMIM10L2A 0.225 0.0838 0.588
xsq DUSP19 2q32.1 0.225 0.0838 0.588 JNK cascade;positive
regulation of MAPK cascade
xsq STMN1 1p36.11 0.225 0.0838 0.588 response to virus;cell
differentiation
met PYHIN1 1q23.1 0.225 0.0838 0.588 cell cycle
cop POU6F2 7p14.1 -0.225 0.0838 0.588 regulation of
transcription, DNA-dependent;transcription from RNA polymerase II promoter
xsq TTYH3 7p22 -0.225 0.0838 0.588 ion transport;chloride transport
xsq PDPN 1p36.21 -0.225 0.0838 0.588 lymphangiogenesis;cell
proliferation
xai GLT8D2 12q -0.227 0.0838 0.588
hs4 PAPPA 9q33.2 -0.227 0.0838 0.588 proteolysis;female pregnancy
swa AQR 15q14 -0.227 0.0838 0.588 nuclear mRNA splicing, via
his MIR4693 -0.227 0.0838 0.588
his ASAP1 8q24.1-q24.2 -0.227 0.0838 0.588 signal transduction;cell
xai STK35 20p13 0.227 0.0839 0.588
xai DDX24 14q32 0.227 0.0839 0.588 RNA metabolic process
xai GRAMD1B 11q24.1 0.227 0.0839 0.588
his RPS29 14q 0.227 0.0839 0.588 mRNA metabolic process;translation
his RN7SL1 0.227 0.0839 0.588
his TSGA10 2q11.2 0.227 0.0839 0.588 spermatogenesis;cell
projection assembly
his LIPT1 0.227 0.0839 0.588 protein modification process;lipid
metabolic process
xai FABP5P3 7q36.1 0.227 0.0839 0.588 glucose metabolic
xai DGKE 17q22 0.227 0.0839 0.588 activation of protein kinase C activity
met LAIR2 19q13.4 0.225 0.0839 0.588
exp ERMARD 0.225 0.0839 0.588
xsq SLC25A25-AS1 0.225 0.0839 0.588
exp ODF2 9q34.11 0.225 0.0839 0.588 cell differentiation;G2/M
cop LINC00299 0.225 0.0839 0.588
met PEG10 7q21 0.225 0.0839 0.588 apoptotic process;cell differentiation
cop ZCCHC8 12q24.31 0.225 0.0839 0.588 nuclear mRNA splicing, via
xsq MTRNR2L1 -0.225 0.0839 0.588
exp GPER1 -0.225 0.0839 0.588 intracellular steroid hormone
receptor signaling pathway;positive regulation of epidermal growth factor receptor
signaling pathway
xai MED29 19q13.2 -0.227 0.0839 0.588 regulation of transcription,
DNA-dependent"
swa FARP1 13q32.2 -0.227 0.0839 0.588 negative regulation of
xai PLXNB1 3p21.31 -0.227 0.0839 0.588 negative regulation of
xai NTSR1 20q13 0.227 0.084 0.589 G-protein coupled receptor signaling
his TMIGD2 19p13.3 0.227 0.084 0.589
his FSD1 19p13.3 0.227 0.084 0.589 cell division;cell cycle
hs4 C17orf53 17q21.31 0.227 0.084 0.589
mut GPR142 17q25.1 0.225 0.084 0.589
xsq SNUPN 15q24.2 0.225 0.084 0.589 ncRNA metabolic process;snRNA import into
nucleus
xsq LMAN1 18q21.3-q22 0.225 0.084 0.589 blood coagulation;cellular protein
metabolic process
xsq PIKFYVE 2q34 0.225 0.084 0.589 protein localization to
exp VPREB1 0.225 0.084 0.589 immune response
xsq SLX1A 0.225 0.084 0.589 DNA Damage Response (DDR); DDR (HR)
met C17orf77 17q25.1 0.225 0.084 0.589
exp RPS2P29 6p21.1 0.225 0.084 0.589
his TMEM86A 11p15.1 -0.227 0.084 0.589
his PRMT5 14q11.2 0.227 0.0841 0.589 regulation of transcription, DNA-
his LOC101926933 0.227 0.0841 0.589
his TRMT10C 3q12.3 0.227 0.0841 0.589
his PRG3 11q12 0.227 0.0841 0.589
his NRDE2 14q32.11 0.227 0.0841 0.589
his CEP44 4q34 0.227 0.0841 0.589
his FBXO8 4q34.1 0.227 0.0841 0.589 ubiquitin-dependent protein
catabolic process;regulation of ARF protein signal transduction
his BSND 1p32.1 0.227 0.0841 0.589 chloride transport
met HEBP2 6q24 0.225 0.0841 0.589
xsq SLX1B 0.225 0.0841 0.589 DNA Damage Response (DDR)
exp CDC42SE2 5q31.1 0.225 0.0841 0.589 phagocytosis;regulation of
cell shape
xsq BORCS6 0.225 0.0841 0.589
exp ABCG2 4q22 0.225 0.0841 0.589 ABC Transporters
exp MEDAG 13q12.3 -0.225 0.0841 0.589
cop LOC286189 -0.225 0.0841 0.589
cop C8orf34 8q13 -0.225 0.0841 0.589 signal transduction
exp PPP2CB 8p12 -0.225 0.0841 0.589 regulation of gene
xai NPAS3 14q13.1 -0.227 0.0841 0.589 maternal behavior;positive
xai FBLIM1 1p36.21 -0.227 0.0841 0.589 cell adhesion;regulation
of cell shape
his ANGPTL2 9q34 -0.227 0.0841 0.589 signal
xai CREB3L2 7q34 -0.227 0.0841 0.589 chondrocyte
xai NAPA-AS1 0.227 0.0842 0.589
hs4 PCNT 21q22.3 0.227 0.0842 0.589 in utero embryonic
development;cilium assembly
hs4 C21orf58 21q22.3 0.227 0.0842 0.589
his TOMM5 9p13.2 0.227 0.0842 0.589 protein targeting to mitochondrion
met CLIC5 6p12.3 0.225 0.0842 0.589 ion transport;chloride transport
mir hsa-miR-542-3p 0.225 0.0842 0.589
xsq DLEU2L 0.225 0.0842 0.589
xsq RPA1 17p13.3 0.225 0.0842 0.589 DNA Damage Response (DDR); DDR
cop PXN-AS1 0.225 0.0842 0.589
cop PXN 12q24.31 0.225 0.0842 0.589 cell adhesion;focal adhesion
assembly
xsq AQR 15q14 0.225 0.0842 0.589 nuclear mRNA splicing, via
exp SMIM10L1 0.225 0.0842 0.589
exp IFRD2 3p21.3 0.225 0.0842 0.589
exp SORD 15q15.3 0.225 0.0842 0.589 glucose metabolic process;sorbitol
catabolic process
xsq RPL23A 17q11.2 0.225 0.0842 0.589 SRP-dependent cotranslational
met LIMK2 22q12.2 -0.225 0.0842 0.589 Protein Kinases
exp PIGZ 3q29 -0.225 0.0842 0.589 GPI anchor biosynthetic process
xsq DAAM1 14q23.1 -0.225 0.0842 0.589 cellular component
cop LOC255167 -0.225 0.0842 0.589
xai PTCHD3P1 10p11.23 -0.227 0.0842 0.589
xai ATP2B4 1q32.1 -0.227 0.0842 0.589 ion transmembrane
xai PIKFYVE 2q34 0.227 0.0843 0.589 protein localization to
his MLST8 16p13.3 0.227 0.0843 0.589 fibroblast growth factor receptor
signaling pathway;positive regulation of peptidyl-tyrosine phosphorylation
cop LOC339803 2p15 0.227 0.0843 0.589
cop C2orf74 2p15 0.227 0.0843 0.589
hs4 KLF13 15q12 0.227 0.0843 0.589 negative regulation of cell
xai ZBTB40 1p36 0.227 0.0843 0.589 bone mineralization;regulation of
xai SNAPC4 9q34.3 0.227 0.0843 0.589 regulation of transcription,
his PRDM9 5p14 0.227 0.0843 0.589 meiosis;chromatin modification
mir hsa-miR-301a 0.225 0.0843 0.589
exp HHIP-AS1 4q31.21 0.225 0.0843 0.589
exp ALKBH8 11q22.3 0.225 0.0843 0.589 DNA Damage Response (DDR)
exp MPLKIP 7p14.1 0.225 0.0843 0.589 DNA Damage Response (DDR)
exp SH3RF3-AS1 2q12.3 0.225 0.0843 0.589
exp C1orf162 1p13.2 0.225 0.0843 0.589
xsq PCDHB16 5q31 -0.225 0.0843 0.589 synapse assembly;calcium-
mir hsa-miR-221* -0.225 0.0843 0.589
xai SMURF2 17q22-q23 -0.227 0.0843 0.589 protein
pathway
his KRT86 12q13 -0.227 0.0843 0.589 cytoskeleton organization
his KRT81 12q13 -0.227 0.0843 0.589
hs4 PLA2R1 2q23-q24 -0.227 0.0843 0.589 positive regulation of
arachidonic acid secretion;cytokine production
hs4 CFHR1 1q32 -0.227 0.0843 0.589 complement activation
his WDR36 5q22.1 0.227 0.0844 0.589 response to stimulus;rRNA
processing
his DHFRP3 0.227 0.0844 0.589
dependent"
xai OR2L13 1q44 0.227 0.0844 0.589 response to stimulus
exp RPS3AP43 0.227 0.0844 0.589
xai SLC46A2 9q32 0.227 0.0844 0.589 transport;transmembrane transport
xai MIAT 22q12.1 0.227 0.0844 0.589
cop VPS33A 12q24.31 0.225 0.0844 0.589 protein transport;vesicle-
mediated transport
cop CLIP1 12q24.3 0.225 0.0844 0.589 transport;mitosis
cop LOC100507066 0.225 0.0844 0.589
xsq SNORA24 4q26 0.225 0.0844 0.589
xsq LIG1 19q13.2-q13.3 0.225 0.0844 0.589 DNA Damage Response (DDR);
DNA-dependent"
cop ST3GAL2 16q22.1 0.225 0.0844 0.589 protein glycosylation;O-
glycan processing
xsq KIF2C 1p34.1 0.225 0.0844 0.589 M phase of mitotic cell
cycle;establishment or maintenance of microtubule cytoskeleton polarity
met TCL1B 14q32.1 0.225 0.0844 0.589
xsq POTED 21q11.2 0.225 0.0844 0.589
xsq KIF3B 20q11.21 -0.225 0.0844 0.589 microtubule-based
xsq DLG1 3q29 -0.225 0.0844 0.589 mitotic cell cycle G1/S transition
exp MED8 1p34.2 -0.225 0.0844 0.589 regulation of transcription
exp FABP7 6q22-q23 -0.225 0.0844 0.589 nervous system
development;negative regulation of cell proliferation
his PLXNB2 22q13.33 -0.227 0.0844 0.589 brain
development;regulation of cell shape
hs4 MTURN -0.227 0.0844 0.589
xai CHST12 7p22 0.227 0.0845 0.59 carbohydrate biosynthetic
process;chondroitin sulfate biosynthetic process
his CDIPT 16p11.2 0.227 0.0845 0.59 phosphatidylinositol biosynthetic
his CDIPT-AS1 16p11.2 0.227 0.0845 0.59
xai CD300C 17q25.1 0.227 0.0845 0.59 cellular defense response
xsq SF1 11q13 0.225 0.0845 0.59 nuclear mRNA 3'-splice site
xsq LOC647323 0.225 0.0845 0.59
cop FAM138D 12p13.33 0.225 0.0845 0.59
cop LOC100288778 12p13.33 0.225 0.0845 0.59
cop IQSEC3 12p13.33 0.225 0.0845 0.59 regulation of ARF protein
signal transduction
cop LOC574538 0.225 0.0845 0.59
cop SLC6A12 12p13 0.225 0.0845 0.59 Solute Carriers
exp LOC100506858 0.225 0.0845 0.59
xsq FZD4 11q14.2 -0.225 0.0845 0.59 brain development;substrate
exp UBE2Z 17q21.32 -0.225 0.0845 0.59 apoptotic process
exp PRKAG2 7q36.1 -0.225 0.0845 0.59 negative regulation of
exp BOC 3q13.2 -0.225 0.0845 0.59 muscle cell
exp RPS6KA2 6q27 -0.225 0.0845 0.59 Protein Kinases
his LINC01508 -0.226 0.0845 0.59
his DNAL4 22q13.1 -0.227 0.0845 0.59 nerve growth factor receptor
signaling pathway;microtubule-based movement
xai RGPD5 -0.227 0.0845 0.59
xai TUBA1C 12q13.12 -0.227 0.0845 0.59 microtubule-based
process;microtubule-based movement
hs4 FBXO17 19q13.2 -0.227 0.0845 0.59 protein catabolic
process
xai CALHM1 10q24.33 0.226 0.0846 0.59 ion transport
his ZFP64 20q13.2 0.226 0.0846 0.59 regulation of transcription, DNA-
dependent"
xai FBXL15 10q24.32 0.226 0.0846 0.59 protein ubiquitination;bone
mineralization
his NCOR2 12q24 0.226 0.0846 0.59 negative regulation of transcription from
his GABRQ Xq28 0.226 0.0846 0.59 signal transduction;ion transport
exp TGFB1 19q13.1 0.225 0.0846 0.59 Apoptosis; DDR (DNA replication);
Tumor Suppressors
xsq PRKAB1 12q24.1-q24.3 0.225 0.0846 0.59 Protein Kinases
cop PRSS54 16q21 0.225 0.0846 0.59
xsq SSR4 Xq28 0.225 0.0846 0.59 translation;SRP-dependent cotranslational
met HMGA2 12q15 0.225 0.0846 0.59 mesodermal-endodermal cell
exp PHKG2 16p11.2 0.225 0.0846 0.59 glycogen metabolic process;glycogen
xsq HLA-G 6p21.3 -0.225 0.0846 0.59 cytokine-mediated signaling
exp LDLR 19p13.2 -0.225 0.0846 0.59 lipid metabolic
process;phospholipid transport
exp RPS3AP12 1p13.3-p13.1 0.226 0.0847 0.59
his SERPINB2 18q21.3 0.226 0.0847 0.59 fibrinolysis;anti-apoptosis
his FAM19A5 22q13.32 0.226 0.0847 0.59
xai MPO 17q23.1 0.226 0.0847 0.59 defense response;hydrogen peroxide
catabolic process
xai GDI2P1 7p12.3 0.226 0.0847 0.59
xai HMX1 4p16.1 0.226 0.0847 0.59 multicellular organismal
his SSBP4 19p13.1 0.226 0.0847 0.59
his NUP188 9q34.11 0.226 0.0847 0.59 protein transport;glucose
transport
his DOLK 9q34.11 0.226 0.0847 0.59 protein N-linked glycosylation via
asparagine;dolichyl monophosphate biosynthetic process
his SKA1 18q21.1 0.226 0.0847 0.59 mitosis;regulation of microtubule
exp IQCJ 3q25.32 0.226 0.0847 0.59
xai IL23A 12q13.3 0.226 0.0847 0.59 positive regulation of activation
of JAK2 kinase activity;positive regulation of natural killer cell activation
xsq CACNB2 10p12 0.224 0.0847 0.59 calcium ion transport;synaptic
transmission
met RWDD2A 6q14.2 0.224 0.0847 0.59
exp COX15 10q24 0.224 0.0847 0.59 mitochondrial electron transport,
cop ANKS1B 12q23.1 0.224 0.0847 0.59
xsq LTV1 6q24.2 0.224 0.0847 0.59
xsq MRGBP 20q13.33 0.224 0.0847 0.59
cop LINC00612 0.224 0.0847 0.59
cop A2M-AS1 12p13.31 0.224 0.0847 0.59
cop A2M 12p13.31 0.224 0.0847 0.59 negative regulation of complement
activation, lectin pathway;platelet degranulation
cop PZP 12p13-p12.2 0.224 0.0847 0.59 female pregnancy;negative
cop A2MP1 12p13.31 0.224 0.0847 0.59
cop LOC642846 12p13.31 0.224 0.0847 0.59
xsq KRTAP4-6 0.224 0.0847 0.59
met CLCA1 1p22.3 -0.224 0.0847 0.59 calcium ion
transport;chloride transport
his SPSB1 1p36.22 -0.226 0.0847 0.59 intracellular signal
transduction
xai OR4C2P -0.226 0.0847 0.59
his CSF1R 5q32 -0.226 0.0847 0.59 Oncogenes
exp IGHV7-27 -0.226 0.0847 0.59
xai IGHV7-27 -0.226 0.0847 0.59
hs4 CADPS2 7q31.3 -0.226 0.0847 0.59 synaptic vesicle
priming;positive regulation of exocytosis
xai KDM6B 17p13.1 0.226 0.0848 0.59 negative regulation of
transcription from RNA polymerase II promoter;inflammatory response
xai ELP2 18q12.2 0.226 0.0848 0.59 regulation of transcription from
his PRKAB1 12q24.1-q24.3 0.226 0.0848 0.59 Protein Kinases
xai DNAJA1P3 Xq22.3 0.226 0.0848 0.59
xsq BRD9 5p15.33 0.224 0.0848 0.59
mut PCK1 20q13.31 0.224 0.0848 0.59 internal protein amino acid
acetylation;lipid metabolic process
cop TAS2R20 0.224 0.0848 0.59 response to stimulus;sensory
perception of taste
cop TAS2R19 0.224 0.0848 0.59
perception of taste
perception of taste
xsq FCER2 19p13.3 0.224 0.0848 0.59 positive regulation of nitric-oxide
cop AP4E1 15q21.2 0.224 0.0848 0.59 intracellular protein
met HIST1H4L 6p22.1 -0.224 0.0848 0.59
exp MOV10 1p13.2 -0.224 0.0848 0.59 regulation of transcription,
DNA-dependent;gene silencing by RNA
xai MAP3K6 1p36.11 -0.226 0.0848 0.59 Protein Kinases
exp MKI67IPP3 0.226 0.0849 0.59
his ARRDC2 19p13.11 0.226 0.0849 0.59
xai TUBE1 6q21 0.226 0.0849 0.59 microtubule-based movement;centrosome
cycle
xsq NIFK 0.224 0.0849 0.59 rRNA transcription;negative regulation of
xsq DAP3 1q22 0.224 0.0849 0.59 Apoptosis
met ICOSLG 21q22.3 0.224 0.0849 0.59 T cell activation;B cell
activation
cop FAM49A 2p24.2 0.224 0.0849 0.59
xsq TREX2 Xq28 0.224 0.0849 0.59 DNA Damage Response (DDR)
exp RPS15AP14 2q31.1 0.224 0.0849 0.59
met LILRB5 19q13.4 0.224 0.0849 0.59 defense response;cell surface
exp MAPKAPK5 12q24.13 0.224 0.0849 0.59 Ras protein signal
xsq FAM13C 10q21.1 -0.224 0.0849 0.59
mut TPX2 20q11.2 -0.224 0.0849 0.59 regulation of mitotic spindle
organization;apoptotic process
xsq LRP1 12q13.3 -0.224 0.0849 0.59 multicellular organismal
exp CASK Xp11.4 -0.224 0.0849 0.59 negative regulation of wound
exp ATP2B4 1q32.1 -0.224 0.0849 0.59 ion transmembrane
exp TBC1D16 17q25.3 -0.224 0.0849 0.59
exp RAB22A 20q13.32 -0.224 0.0849 0.59 GTP catabolic
process;endocytosis
hs4 CDC14B 9q22.3 -0.226 0.0849 0.59 activation of anaphase-
xai GDF5 20q11.2 -0.226 0.0849 0.59 cell-cell signaling;cartilage
development
exp C1orf220 1q25.2 -0.226 0.0849 0.59
swa PLP2 Xp11.23 -0.226 0.0849 0.59 ion transport;chemotaxis
his SUCO 1q24 0.226 0.085 0.59
hs4 FAM72D 0.226 0.085 0.59
xai COX7B Xq21.1 0.226 0.085 0.59 respiratory electron transport
xai MKI67IPP3 0.226 0.085 0.59
xai THSD7A 7p21.3 0.226 0.085 0.59
xsq LSM14B 20q13.33 0.224 0.085 0.59 multicellular organismal
development;regulation of translation
met MAPK15 0.224 0.085 0.59 EMT (Epithelial); Protein Kinases
xsq SLCO6A1 5q21.1 0.224 0.085 0.59 Solute Carriers
met FAHD1 16p13.3 0.224 0.085 0.59
exp JUN 1p32-p31 -0.224 0.085 0.59 Apoptosis; Protein Kinases
met C4orf45 4q32.1 -0.224 0.085 0.59
exp CISD1P1 2p24.1 -0.224 0.085 0.59
xsq CPA4 7q32 -0.224 0.085 0.59 proteolysis;histone acetylation
hs4 NDST1-AS1 -0.226 0.085 0.591
xai IFIT3 -0.226 0.085 0.59 cellular response to interferon-
exp OR4C2P -0.226 0.085 0.59
hs4 SHB 9p13.2 -0.226 0.085 0.59 Apoptosis
xai TENM3 4q35.1 -0.226 0.085 0.59
his TRIM22 11p15 -0.226 0.085 0.59 immune response;response to virus
xai TMEM72 10q11.21 0.226 0.0851 0.591
hs4 C20orf27 20p13 0.226 0.0851 0.591
his CHERP 19p13.1 0.226 0.0851 0.591 nervous system development;negative
his MIR4779 0.226 0.0851 0.591
his IMMT 2p11.2 0.226 0.0851 0.591
xai DEFA4 8p23 0.226 0.0851 0.591 killing of cells of other
his GPBP1L1 1p34.1 0.226 0.0851 0.591 regulation of transcription,
DNA-dependent"
his TMEM69 1p34.1 0.226 0.0851 0.591
hs4 TGOLN2 2p11.2 0.226 0.0851 0.591
his SETD2 3p21.31 0.226 0.0851 0.591 Tumor Suppressors
his KIF9-AS1 0.226 0.0851 0.591
xsq THUMPD3 3p25.3 0.224 0.0851 0.591
met TTC12 11q23.2 0.224 0.0851 0.591
exp PPP1R1C 2q31.3 0.224 0.0851 0.591 signal transduction
met ARRDC4 15q26.3 0.224 0.0851 0.591 signal transduction
mut KIAA0196 8q24.13 0.224 0.0851 0.591 cell death
met ATP1A2 1q23.2 -0.224 0.0851 0.591 ATP biosynthetic
process;ATP hydrolysis coupled proton transport
met EOMES 3p24.1 -0.224 0.0851 0.591 mesoderm formation;positive
regulation of cell differentiation
cop RFX3 9p24.2 -0.224 0.0851 0.591 cell differentiation;ciliary
cell motility
xsq YAP1 11q13 -0.224 0.0851 0.591 Apoptosis
his DIO1 1p33-p32 -0.226 0.0851 0.591 hormone biosynthetic
xai JAZF1 7p15.2-p15.1 -0.226 0.0851 0.591 negative regulation of
dependent"
exp SLC9A3P3 10q11.23 -0.226 0.0851 0.591
hs4 SLC9A7 Xp11.3 -0.226 0.0851 0.591 Solute Carriers
swa EHD4 15q11.1 -0.226 0.0851 0.591 regulation of
xai NEURL1B 5q35.1 -0.226 0.0851 0.591
his ATXN1L 16q22.2 0.226 0.0852 0.591 regulation of transcription,
DNA-dependent"
xai PPP1R8 1p35.3 0.226 0.0852 0.591 regulation of transcription,
his WDR44 Xq24 0.226 0.0852 0.591 regulation of cell migration
his TCF4 18q21.1 0.226 0.0852 0.591 positive regulation of
his SBF1 22q13.33 0.226 0.0852 0.591 protein dephosphorylation
xai SSTR5 16p13.3 0.226 0.0852 0.591 glucose homeostasis;regulation of
insulin secretion
cop UCP2 11q13 0.224 0.0852 0.591 transport;small molecule metabolic
process
cop UCP3 11q13.4 0.224 0.0852 0.591 response to nutrient;small molecule
metabolic process
cop C2CD3 11q13.4 0.224 0.0852 0.591
exp NUP50P1 14q23.3 0.224 0.0852 0.591
xsq GTF2H2C 5q13.2 0.224 0.0852 0.591
xsq CDK5RAP3 17q21.32 0.224 0.0852 0.591 regulation of cyclin-
exp RBM26 13q31.1 0.224 0.0852 0.591 mRNA processing;negative regulation
exp MON1B 16q23.1 0.224 0.0852 0.591
exp FLJ10038 15q21.2 0.224 0.0852 0.591
xsq POLR2J2 0.224 0.0852 0.591
xsq PKIG 20q12-q13.1 -0.224 0.0852 0.591 negative regulation of
activity
xsq SNORA5C -0.224 0.0852 0.591
xai ZDHHC7 16q24.1 -0.226 0.0852 0.591
hs4 IFIT2 10q23.31 -0.226 0.0852 0.591 negative regulation of
hs4 FHOD3 18q12 -0.226 0.0852 0.591 cellular component
xai OXLD1 17q25.3 0.226 0.0853 0.591
his COX7A2L 2p21 0.226 0.0853 0.591 respiratory electron transport
his ADGRE3 0.226 0.0853 0.591 G-protein coupled receptor
his ERCC3 2q21 0.226 0.0853 0.591 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
his TRNAU1AP 1p35.3 0.226 0.0853 0.591 selenocysteine
xai MIR218-1 0.226 0.0853 0.591
exp WRAP73 1p36.3 0.224 0.0853 0.591
exp PTRHD1 2p23.3 0.224 0.0853 0.591
xsq ZAN 7q22 0.224 0.0853 0.591 binding of sperm to zona pellucida;cell-
cell adhesion
xsq DDC 7p12.2 0.224 0.0853 0.591 isoquinoline alkaloid metabolic
process;response to pyrethroid
xsq RORB-AS1 0.224 0.0853 0.591
exp KRT8P10 2q32.1 -0.224 0.0853 0.591
xsq PREX2 8q13.2 -0.224 0.0853 0.591 G-protein coupled receptor
hs4 IFIT1 10q23.31 -0.226 0.0853 0.591 negative regulation of viral
genome replication;regulation of defense response to virus
hs4 BBOX1 11p14.2 -0.226 0.0853 0.591 cellular nitrogen compound
his CUBN 10p12.31 -0.226 0.0853 0.591 cholesterol metabolic
process;cobalamin transport
hs4 SDPR 2q32-q33 -0.226 0.0853 0.591
exp MIR218-1 0.226 0.0854 0.591
xai RBBP5 1q32 0.226 0.0854 0.591 regulation of transcription, DNA-
his GORAB 1q24.2 0.226 0.0854 0.591
his LOC101928650 0.226 0.0854 0.591
xai LINC00524 0.226 0.0854 0.591
his TRIP11 14q31-q32 0.226 0.0854 0.591 protein targeting to
Golgi;transcription from RNA polymerase II promoter
xai HADH 4q22-q26 0.226 0.0854 0.591 fatty acid beta-oxidation;response
to hormone stimulus
cop ANO2 12p13.3 0.224 0.0854 0.591 ion transport;chloride transport
xsq RPS26 12q13 0.224 0.0854 0.591 translational termination;negative
exp PPP1R21 2p16.3 0.224 0.0854 0.591
xsq SIPA1 11q13 0.224 0.0854 0.591 Apoptosis
exp TMEM71 8q24.22 0.224 0.0854 0.591
met UBXN2B 8q12.1 0.224 0.0854 0.591
mut FAM120A 9q22.31 0.224 0.0854 0.591
xsq POLR3A 10q22-q23 0.224 0.0854 0.591 innate immune
xsq CFC1 0.224 0.0854 0.591
cop CNOT1 16q21 0.224 0.0854 0.591 nuclear-transcribed mRNA catabolic
shortening
cop SNORA46 0.224 0.0854 0.591
cop SNORA50 0.224 0.0854 0.591
xsq GNGT1 7q21.3 -0.224 0.0854 0.591 synaptic
transmission;phototransduction
xsq TRAM2 6p21.1-p12 -0.224 0.0854 0.591 protein transport;collagen
exp AAK1 2p14 -0.224 0.0854 0.591 regulation of clathrin-mediated
endocytosis;protein phosphorylation
his SH3RF2 5q32 -0.226 0.0854 0.591 negative regulation of
xai SPACA7 13q34 -0.226 0.0854 0.591
cop FLJ41200 -0.226 0.0854 0.591
hs4 LOC100049716 12p13.33 -0.226 0.0854 0.591
xai HNMT 2q22.1 -0.226 0.0854 0.591 brain development;respiratory
gaseous exchange
swa PC 11q13.4-q13.5 -0.226 0.0854 0.591 carbohydrate metabolic
xai PORCN Xp11.23 -0.226 0.0854 0.591 Wnt receptor signaling
pathway
his ZCCHC7 9p13.2 0.226 0.0855 0.591
exp NAPA-AS1 0.226 0.0855 0.591
xai YTHDF1 20q13.33 0.226 0.0855 0.591
his LINC01606 0.226 0.0855 0.591
xai HSPA1L 6p21.3 0.226 0.0855 0.591 Apoptosis
his LIMD1 3p21.3 0.226 0.0855 0.591 cell migration;cytoplasmic mRNA
processing body assembly
hs4 CCNA2 4q27 0.226 0.0855 0.591 DNA Damage Response (DDR); DDR (DNA
replication)
xai PRDM10 11q25 0.226 0.0855 0.591 regulation of transcription, DNA-
dependent"
xsq CNGA3 2q11.2 0.224 0.0855 0.591 retinal cone cell
met EFCAB12 3q21.3 0.224 0.0855 0.591
xsq C1orf162 1p13.2 0.224 0.0855 0.591
cop MAGOHB 12p13.2 0.224 0.0855 0.591 RNA splicing;mRNA transport
xsq CTF1 16p11.2 -0.224 0.0855 0.591 neuron development;leukemia
inhibitory factor signaling pathway
xsq SCHIP1 3q25.32-q25.33 -0.224 0.0855 0.591
his KIAA1522 1p35.1 -0.226 0.0855 0.591
his DDX27 20q13.13 0.226 0.0856 0.591
his STAU1 20q13.1 0.226 0.0856 0.591 intracellular mRNA localization
xai FREM3 4q31.21 0.226 0.0856 0.591 cell communication;cell adhesion
xai SP1 12q13.1 0.226 0.0856 0.591 megakaryocyte
differentiation;embryonic skeletal system development
hs4 TLX2 2p13.1 0.226 0.0856 0.591
his SETX 9q34.13 0.226 0.0856 0.591 DNA Damage Response (DDR)
his POLR2J3 7q22.1 0.226 0.0856 0.591
hs4 KLK2 19q13.41 0.226 0.0856 0.591 proteolysis
xai TMEM71 8q24.22 0.226 0.0856 0.591
his NDUFS1 2q33-q34 0.226 0.0856 0.591 ATP synthesis coupled
electron transport;small molecule metabolic process
his EEF1B2 2q33.3 0.226 0.0856 0.591 translational elongation;gene
expression
his SNORD51 0.226 0.0856 0.591
his SNORA41 2q33 0.226 0.0856 0.591
xai EIF4A1P5 13q13.3 0.226 0.0856 0.591
xai MEP1A 6p12-p11 0.226 0.0856 0.591 proteolysis;digestion
xai LOC100507599 0.226 0.0856 0.591
his LOC101927151 0.226 0.0856 0.591
his LINC00662 19q11 0.226 0.0856 0.591
met SMG1 16p12.3 0.224 0.0856 0.591 gene expression;RNA metabolic
process
cop HYDIN 16q22.2 0.224 0.0856 0.591
met CYP4F12 19p13.1 0.224 0.0856 0.591 long-chain fatty acid
metabolic process;leukotriene B4 catabolic process
exp TRIM59 3q25.33 0.224 0.0856 0.591
met C1orf220 1q25.2 0.224 0.0856 0.591
mut COL27A1 9q32 0.224 0.0856 0.591 cell adhesion
met UCN 2p23-p21 0.224 0.0856 0.591 positive regulation of cell
growth;positive regulation of DNA replication
xsq GTF2A1 14q31.1 0.224 0.0856 0.591 viral reproduction;regulation
exp TNF 6p21.3 0.224 0.0856 0.591 Apoptosis
xsq TMEM72 10q11.21 0.224 0.0856 0.591
met SCRN3 2q31.1 0.224 0.0856 0.591 proteolysis
met WNT2 7q31.2 0.224 0.0856 0.591 Apoptosis; Oncogenes
cop CTNND2 5p15.2 -0.224 0.0856 0.591 signal
exp HIBADH 7p15.2 -0.224 0.0856 0.591 valine metabolic
process;branched chain family amino acid catabolic process
xai TP53INP1 8q22 -0.226 0.0856 0.591 apoptotic process;induction
of apoptosis
hs4 PCDH7 4p15 -0.226 0.0856 0.591 cell adhesion;homophilic cell
adhesion
xai MAGED2 Xp11.2 -0.226 0.0856 0.591
xai PRAF2 Xp11.23 -0.226 0.0856 0.591 L-glutamate transport;protein
transport
his ZNF608 5q23.2 -0.226 0.0856 0.591
xai SYT8 11p15.5 -0.226 0.0856 0.591
his XAGE2 -0.226 0.0856 0.591
hs4 SNX9 6q25.1-q26 -0.226 0.0856 0.591 intracellular protein
hs4 DIXDC1 11q23.1 0.226 0.0857 0.591 cerebral cortex radially
oriented cell migration;Wnt receptor signaling pathway, planar cell polarity
pathway
his S100PBP 1p35.1 0.226 0.0857 0.591
his YARS 1p35.1 0.226 0.0857 0.591 Apoptosis
his LINC01816 0.226 0.0857 0.591
his TRPM7 15q21 0.226 0.0857 0.591 transmembrane transport;ion transport
his RABGGTA 14q11.2 0.226 0.0857 0.591 protein modification
process;visual perception
xai GLRA3 4q34.1 0.226 0.0857 0.591 synaptic transmission;ion
his CLPP 19p13.3 0.226 0.0857 0.591 proteolysis
xai FOXP2 7q31 0.226 0.0857 0.591 positive regulation of mesenchymal cell
exp COX7BP1 22q13 0.224 0.0857 0.591
xsq TRIM35 8p21.2 0.224 0.0857 0.591 positive regulation of
apoptotic process;negative regulation of mitotic cell cycle
exp FAM122A 0.224 0.0857 0.591
cop YBX3 12p13.1 0.224 0.0857 0.591
exp STYXL1 7q11.23 -0.224 0.0857 0.591 protein
dephosphorylation;intracellular signal transduction
xsq ITGB1 10p11.2 -0.224 0.0857 0.591 Apoptosis
exp LRRTM2 5q31.2 -0.224 0.0857 0.591
exp RGPD5 -0.226 0.0857 0.591
hs4 LINC01276 -0.226 0.0857 0.591
his SCRN1 7p14.3-p14.1 -0.226 0.0857 0.591 proteolysis;exocytosis
xai LINC00674 -0.226 0.0857 0.591
xai BNC2 9p22.2 -0.226 0.0857 0.591 regulation of transcription,
DNA-dependent"
xai ZC3H4 19q13.32 0.226 0.0858 0.591
xai RPP40 6p25.1 0.226 0.0858 0.591 tRNA processing
xai SNORA65 9q34 0.226 0.0858 0.591
his TCHP 12q24.11 0.226 0.0858 0.592 apoptotic process;negative
xsq CDK17 12q23.1 0.224 0.0858 0.591 Protein Kinases
met CD1B 1q23.1 0.224 0.0858 0.591 immune response;antigen processing
and presentation
exp DLK1 14q32 0.224 0.0858 0.591 multicellular organismal
exp MAGOH 1p32.3 0.224 0.0858 0.592 transcription from RNA polymerase
cop RAD51AP1 12p13.2-p13.1 0.224 0.0858 0.592 DNA Damage Response
(DDR)
xsq ZC3H8 2q13 0.224 0.0858 0.592 apoptotic process;negative regulation of
transcription, DNA-dependent;stem cell maintenance
xsq SCARA3 8p21 -0.224 0.0858 0.591 response to oxidative
xai LOC100128607 -0.226 0.0858 0.592
hs4 SH3BP2 4p16.3 -0.226 0.0858 0.591 signal transduction
xai BST2 19p13.1 -0.226 0.0858 0.591 positive regulation of I-
kappaB kinase/NF-kappaB cascade;innate immune response
his LOC101929106 -0.226 0.0858 0.591
his MIR6514 0.226 0.0859 0.592
his MTF2 1p22.1 0.226 0.0859 0.592
xai RPL26P20 0.226 0.0859 0.592
his WDR11 10q26 0.226 0.0859 0.592
his WDR11-AS1 0.226 0.0859 0.592
his CYMP-AS1 0.225 0.0859 0.592
mut STAG3 7q22.1 0.224 0.0859 0.592 cell cycle;chromosome segregation
exp INTS10 8p21.3 0.224 0.0859 0.592 snRNA processing
xsq B3GNTL1 17q25.3 0.224 0.0859 0.592
exp INA 10q24.33 0.224 0.0859 0.592 multicellular organismal
xsq DDX23 12q13.12 0.224 0.0859 0.592 RNA splicing, via
met ELF4 Xq26 0.224 0.0859 0.592 Transcription Factors
exp ZMIZ2 7p13 -0.224 0.0859 0.592 regulation of transcription, DNA-
hs4 CDON 11q24.2 -0.226 0.0859 0.592 cell adhesion;muscle cell
differentiation
hs4 CACNA1E 1q25.3 0.225 0.086 0.592 locomotory behavior;membrane
depolarization
xai EEF1A1P7 19q13.12 0.225 0.086 0.592
xai SNX5 20p11 0.225 0.086 0.592 pinocytosis;cell communication
his RNF219 13q31.1 0.225 0.086 0.592
his SF3B5 6q24.2 0.225 0.086 0.592 nuclear mRNA splicing, via
exp XRCC6P5 Xq22.1 0.225 0.086 0.592
met GABRG1 4p12 0.224 0.086 0.592 gamma-aminobutyric acid signaling
cop KLRG1 12p13.31 0.224 0.086 0.592 inflammatory response;cellular defense
response
xsq LRRTM3 10q21.3 0.224 0.086 0.592
met PIAS2 18q21.1 0.224 0.086 0.592 DNA Damage Response (DDR)
xsq UNKL 16p13.3 0.224 0.086 0.592
exp DENND1A 9q33.3 0.224 0.086 0.592 synaptic vesicle endocytosis
met TSSK3 1p35-p34 0.224 0.086 0.592 protein phosphorylation;multicellular
exp PARP16 15q22.31 0.224 0.086 0.592
met MROH2B 5p13.1 -0.224 0.086 0.592
xai KDM5B 1q32.1 -0.225 0.086 0.592 histone H3-K4 demethylation,
exp LOC100128607 -0.225 0.086 0.592
swa RBMS1 2q24.2 -0.225 0.086 0.592 DNA replication;RNA processing
xai GPR156 3q13.33 -0.225 0.086 0.592
hs4 URGCP-MRPS24 -0.225 0.086 0.592
xai FAM122A 0.225 0.0861 0.592
exp SNORA65 9q34 0.225 0.0861 0.592
his PCDHGA11 5q31 0.225 0.0861 0.592 cell adhesion;homophilic cell
adhesion
xsq PPP4R3A 0.223 0.0861 0.592
met OR14A16 1q44 0.223 0.0861 0.592 response to stimulus
xsq ATXN7L3B 12q21 0.223 0.0861 0.592
xsq WHSC1 4p16.3 0.223 0.0861 0.592 regulation of transcription, DNA-
dependent;anatomical structure morphogenesis
xsq PFDN6 6p21.3 0.223 0.0861 0.592
met PDGFD 11q22.3 0.223 0.0861 0.592 multicellular organismal
exp OLFML2A 9q33.3 -0.223 0.0861 0.592 extracellular matrix
organization
xai GPRC5B 16p12 -0.225 0.0861 0.592
his LOC105373878 -0.225 0.0861 0.592
his MIR6741 0.225 0.0862 0.592
his PYCR2 1q42.12 0.225 0.0862 0.592 proline biosynthetic
his MALRD1 0.225 0.0862 0.592
hs4 DANCR 4q12 0.225 0.0862 0.592
hs4 MIR4449 0.225 0.0862 0.592
hs4 SNORA26 4q12 0.225 0.0862 0.592
his DHRS7B 17p12 0.225 0.0862 0.592
hs4 DCHS1 11p15.4 0.225 0.0862 0.592 homophilic cell adhesion;calcium-
xai LOC100507459 0.225 0.0862 0.593
mut SH3PXD2A 10q24.33 0.223 0.0862 0.592 superoxide metabolic
xsq SEPHS1 10p14 0.223 0.0862 0.592 protein modification process
met LURAP1L 9p23 0.223 0.0862 0.592
exp GTF3C6 6q21 0.223 0.0862 0.593 transcription, DNA-
met SEMA3G 3p21.1 -0.223 0.0862 0.593 multicellular organismal
development
met GZMM 19p13.3 -0.223 0.0862 0.593 apoptotic process;cytolysis
xsq MT2A 16q13 -0.223 0.0862 0.593 cellular response to interleukin-
cop MIR3152 -0.223 0.0862 0.592
dependent"
exp RPL26P20 0.225 0.0863 0.593
his DHH 0.225 0.0863 0.593
exp LOC100506257 0.225 0.0863 0.593
exp LOC100507599 0.225 0.0863 0.593
xai NAAA 4q21.1 0.225 0.0863 0.593 lipid metabolic process
exp COG7 16p12.2 0.223 0.0863 0.593 protein localization to
organelle;protein localization in Golgi apparatus
met CNNM4 2q11 0.223 0.0863 0.593 ion transport;visual perception
xsq MATK 19p13.3 0.223 0.0863 0.593 mesoderm development;cell
proliferation
met CPM 12q14.3 0.223 0.0863 0.593 proteolysis;anatomical structure
morphogenesis
met STRADB 2q33.1 0.223 0.0863 0.593 protein
phosphorylation;regulation of fatty acid oxidation
exp ANXA3 4q21.21 -0.223 0.0863 0.593 positive regulation of
xsq CLIP3 19q13.12 -0.223 0.0863 0.593 negative regulation of
microtubule polymerization;positive regulation of apoptotic process
xai CHST1 11p11.2 -0.225 0.0863 0.593 polysaccharide metabolic
hs4 GAP43 3q13.31 -0.225 0.0863 0.593 activation of protein kinase
C activity by G-protein coupled receptor protein signaling pathway;multicellular
exp GAPDHP70 11q14.2 0.225 0.0864 0.593
exp ANKRD31 5q13.3 0.225 0.0864 0.593
xai DESI2 1q44 0.225 0.0864 0.593
his MED22 9q34.2 0.225 0.0864 0.593 regulation of transcription from
his RPL7A 9q34 0.225 0.0864 0.593 translation;mRNA metabolic process
his SNORD24 0.225 0.0864 0.593
his SNORD36B 0.225 0.0864 0.593
his SNORD36A 0.225 0.0864 0.593
his SNORD36C 9q34 0.225 0.0864 0.593
hs4 RNU5E-1 1p36.22 0.225 0.0864 0.593
xai LOC100506257 0.225 0.0864 0.593
xai RNF32 7q36 0.225 0.0864 0.593
xsq RCBTB2 13q14.3 0.223 0.0864 0.593
cop CA12 15q22 0.223 0.0864 0.593 one-carbon metabolic process
cop KLRAP1 12p13.2 0.223 0.0864 0.593
xsq ITLN1 1q21.3 0.223 0.0864 0.593 positive regulation of glucose
import;positive regulation of protein phosphorylation
exp CPAMD8 19p13.11 -0.223 0.0864 0.593
mut RBM19 12q24.21 -0.223 0.0864 0.593 multicellular organismal
development;positive regulation of embryonic development
swa VPS45 1q21.2 -0.225 0.0864 0.593 intracellular protein
transport;vesicle docking involved in exocytosis
his SLC9A7 Xp11.3 -0.225 0.0864 0.593 Solute Carriers
xai ANKRD31 5q13.3 0.225 0.0865 0.593
xai PCNAP3 Xp11.3 0.225 0.0865 0.593
exp TRGV2 0.225 0.0865 0.593
xai KIF11 10q24.1 0.225 0.0865 0.593 spindle organization;mitotic
his RPRD1A 18q12.2 0.225 0.0865 0.593 dephosphorylation of RNA
hs4 SOD2 6q25.3 0.225 0.0865 0.593 liver development;heart development
hs4 LOC100129518 0.225 0.0865 0.593
hs4 ACAT2 6q25.3 0.225 0.0865 0.593 lipid metabolic process
his DAPP1 4q25-q27 0.225 0.0865 0.593 protein dephosphorylation;signal
transduction
exp GIMAP8 7q36.1 0.223 0.0865 0.593
xsq CHTF8 16q22.1 0.223 0.0865 0.593 DDR (DNA replication)
xsq EXD1 15q15.1 0.223 0.0865 0.593 nucleobase-containing compound
metabolic process
cop DNAJB13 11q13.4 0.223 0.0865 0.593 protein folding;apoptotic
process
xsq C14orf93 14q11.2 0.223 0.0865 0.593
cop DDX1 2p24 0.223 0.0865 0.593 regulation of translational
exp RARRES3 11q23 -0.223 0.0865 0.593 phospholipid metabolic
process;negative regulation of cell proliferation
xsq SCN1B 19q13.1 -0.223 0.0865 0.593 axon guidance;sodium ion
hs4 CT62 15q23 -0.225 0.0865 0.593
xai VAPB 20q13.33 -0.225 0.0865 0.593 endoplasmic reticulum
unfolded protein response;small molecule metabolic process
his MIR2278 -0.225 0.0865 0.593
xai FAXC 6q16.2 -0.225 0.0865 0.593
hs4 RASL10A 22q12.2 0.225 0.0866 0.593 small GTPase mediated signal
swa ANXA11 10q23 0.225 0.0866 0.593 phagocytosis;cell cycle
his GLI4 8q24.3 0.225 0.0866 0.593
hs4 TRH 3q13.3-q21 0.225 0.0866 0.593
xai DLK1 14q32 0.225 0.0866 0.593 multicellular organismal
xai ONECUT3 19p13.3 0.225 0.0866 0.593 endocrine pancreas
xai AUNIP 1p36.11 0.225 0.0866 0.593
his GPR65 14q31-q32.1 0.225 0.0866 0.594 multicellular organismal
mut TNFAIP6 2q23.3 0.223 0.0866 0.593 inflammatory response;cell
adhesion
xsq ACTR2 2p14 0.223 0.0866 0.593 cellular component movement
xsq THAP2 12q21.1 0.223 0.0866 0.593
met C6orf106 6p21.31 0.223 0.0866 0.594
exp PSEN1 14q24.3 -0.223 0.0866 0.594 Apoptosis
xsq PSORS1C1 6p21.3 -0.223 0.0866 0.593
xsq VGLL1 Xq26.3 -0.223 0.0866 0.593 regulation of transcription,
DNA-dependent"
exp IL1RAP 3q28 -0.223 0.0866 0.593 signal transduction;innate
immune response
his ELOVL7 5q12.1 -0.225 0.0866 0.593 small molecule metabolic
his MARCH1 4q32.2 -0.225 0.0866 0.593 protein
class II
hs4 ITGA7 12q13 -0.225 0.0866 0.593 regulation of cell shape;cell
adhesion
xai KCNH6 17q23.3 0.225 0.0867 0.594 potassium ion transport;signal
transduction
xai TMEM61 1p32.3 0.225 0.0867 0.594
hs4 CRACR2A 0.225 0.0867 0.594 activation of store-operated
xai C11orf57 11q23.1 0.225 0.0867 0.594
xai CHERP 19p13.1 0.225 0.0867 0.594 nervous system development;negative
xai PEX5L 3q26.33 0.225 0.0867 0.594 protein import into peroxisome
met PKP2 12p11 0.223 0.0867 0.594 heart development;cell-cell adhesion
xsq CARNMT1 0.223 0.0867 0.594
xsq ESRRA 11q13 0.223 0.0867 0.594 positive regulation of transcription from
met SERPINB8 18q22.1 0.223 0.0867 0.594 negative regulation of
exp GK Xp21.3 0.223 0.0867 0.594 glycerol metabolic
process;triglyceride metabolic process
xsq COX18 4q13.3 0.223 0.0867 0.594 protein transport;protein insertion
cop TFB1M 6q25.1-q25.3 0.223 0.0867 0.594 regulation of transcription,
DNA-dependent"
mut LRRC15 3q29 0.223 0.0867 0.594
met PECAM1 17q23.3 -0.223 0.0867 0.594 platelet
his C18orf25 18q21.1 0.225 0.0868 0.594
his KHDRBS1 1p32 0.225 0.0868 0.594 negative regulation of
hs4 LCAL1 0.225 0.0868 0.594
his HCFC1-AS1 0.225 0.0868 0.594
his HCFC1 Xq28 0.225 0.0868 0.594 histone H4-K8 acetylation;negative
his TMEM187 Xq28 0.225 0.0868 0.594
exp RPL24 3q12 0.223 0.0868 0.594 SRP-dependent cotranslational protein
targeting to membrane;optic nerve development
xsq CPA5 7q32 0.223 0.0868 0.594 proteolysis;metabolic process
exp PTK2B 8p21.1 0.223 0.0868 0.594 MAPK cascade;apoptotic process
cop EIF2AK2 2p22-p21 0.223 0.0868 0.594 Apoptosis
cop SULT6B1 0.223 0.0868 0.594
cop LOC100505876 0.223 0.0868 0.594
xsq RGN Xp11.3 0.223 0.0868 0.594
xsq ERCC4 16p13.12 0.223 0.0868 0.594 DNA Damage Response (DDR); DDR
(NER)
exp SERBP1P1 Xq13.1 0.223 0.0868 0.594
exp LAMA5 20q13.2-q13.3 -0.223 0.0868 0.594 integrin-mediated
exp B9D1 17p11.2 -0.223 0.0868 0.594 smoothened signaling
pathway;cell projection organization
xai ITGAX 16p11.2 -0.225 0.0868 0.594 leukocyte migration;defense
response to virus
exp PSMC1P12 1p12 -0.225 0.0868 0.594
his DYRK2 12q15 -0.225 0.0868 0.594 DNA damage response, signal
xai TTYH1 19q13.4 -0.225 0.0868 0.594 ion transport;iron ion
transport
xai IQCJ 3q25.32 0.225 0.0869 0.594
xai MIR7-3HG 19p13.3 0.225 0.0869 0.594
his MSL2 3q22.3 0.225 0.0869 0.594 histone H4-K16 acetylation
xai BTF3P5 2p16.1 0.225 0.0869 0.594
xsq LINC00667 18p11.31 0.223 0.0869 0.594
exp GAPDHP29 1p21.3 0.223 0.0869 0.594
met FCAR 19q13.42 0.223 0.0869 0.594 immune response
xsq FAM184A 6q22.31 0.223 0.0869 0.594
met SATB1 3p23 -0.223 0.0869 0.594 interspecies interaction between
organisms;negative regulation of transcription from RNA polymerase II promoter
xsq FEM1C 5q22 -0.223 0.0869 0.594
met RSG1 1p36.13 -0.223 0.0869 0.594 small GTPase mediated signal
met LIMD2 17q23.3 -0.223 0.0869 0.594
exp KIAA1191 5q35.2 -0.223 0.0869 0.594
met OR13J1 9p13.3 -0.223 0.0869 0.594 response to stimulus
cop LPP-AS2 3q27.3 -0.223 0.0869 0.594
swa AARS2 6p21.1 -0.225 0.0869 0.594 alanyl-tRNA
his LINC00519 -0.225 0.0869 0.594
swa APEH 3p21.31 0.225 0.087 0.594 proteolysis
cop MIR1204 0.225 0.087 0.594
swa EEF1D 8q24.3 0.225 0.087 0.594 cellular protein metabolic
process;translation
xsq CENPBD1 16q24.3 0.223 0.087 0.594 regulation of transcription, DNA-
dependent"
xsq BMP8A 1p34.3 0.223 0.087 0.594 ossification;multicellular organismal
development
exp KIF9 3p21.31 0.223 0.087 0.594 microtubule-based movement;blood
coagulation
cop SYNE1 6q25 0.223 0.087 0.594 nucleus organization;Golgi organization
mir hsa-miR-431* 0.223 0.087 0.594
xsq PDCD1 2q37.3 0.223 0.087 0.594 apoptotic process;humoral immune response
exp LSM4 19p13.11 0.223 0.087 0.594 RNA splicing;gene expression
met SPIN2B Xp11.1 0.223 0.087 0.594 gamete generation;apoptotic process
xsq ENPP1 6q22-q23 -0.223 0.087 0.594 nucleoside triphosphate catabolic
process;negative regulation of protein autophosphorylation
exp PPM1J 1p13.2 -0.223 0.087 0.594 protein dephosphorylation
xsq CRISPLD2 16q24.1 -0.223 0.087 0.594
exp MAGED2 Xp11.2 -0.223 0.087 0.594
met IL10 1q31-q32 -0.223 0.087 0.594 Apoptosis
xsq UBE2Q2P2 -0.223 0.087 0.594
met CDK14 7q21-q22 -0.223 0.087 0.594 Protein Kinases
xai CYTL1 4p16-p15 -0.225 0.087 0.594 positive regulation of
transcription from RNA polymerase II promoter;chondroitin sulfate proteoglycan
exp OR52E8 11p15.4 -0.225 0.087 0.594 response to stimulus
xai SLC25A5P8 9p21.1 0.225 0.0871 0.595
xai C12orf43 12q24.31 0.225 0.0871 0.595
xai LOC148413 1p36.33 0.225 0.0871 0.595
xai PARP16 15q22.31 0.225 0.0871 0.595
swa ATRIP 0.225 0.0871 0.595 DNA Damage Response (DDR); DDR (G1-S
exp SYNGR4 19q13.3 0.225 0.0871 0.595
cop LOC100652739 0.223 0.0871 0.595
cop RAET1E 6q25.1 0.223 0.0871 0.595 immune response;antigen
xsq STK4 20q11.2-q13.2 0.223 0.0871 0.595 Apoptosis
met SGCE 7q21.3 0.223 0.0871 0.595 cell-matrix adhesion;muscle organ
development
xsq STARD13-AS -0.223 0.0871 0.595
met PLSCR2 3q24 -0.223 0.0871 0.595 phospholipid scrambling
exp EFEMP2 11q13.1 -0.223 0.0871 0.595 blood coagulation
xai MTCL1 -0.225 0.0871 0.595
swa HACD3 -0.225 0.0871 0.595 small GTPase mediated signal
transduction;Rho protein signal transduction
hs4 VTRNA1-2 -0.225 0.0871 0.595
xai OSTCP4 0.225 0.0872 0.595
his RCHY1 4q21.1 0.225 0.0872 0.595 protein autoubiquitination;protein
ubiquitination
his THAP6 4q21.1 0.225 0.0872 0.595
his GOPC 6q21 0.225 0.0872 0.595 spermatid nucleus differentiation;protein
transport
his ZBTB14 18p11.31 0.225 0.0872 0.595
exp TWISTNB 7p21.1 0.223 0.0872 0.595
exp HTR3A 11q23.1 0.223 0.0872 0.595 ion transmembrane
xsq EFTUD2 17q21.31 0.223 0.0872 0.595 RNA splicing;gene expression
mut USP31 16p12.2 0.223 0.0872 0.595 proteolysis;ubiquitin-dependent
met KIRREL 1q21-q25 0.223 0.0872 0.595 excretion
exp ERLEC1P1 21q11.2 0.223 0.0872 0.595
cop CDK13 7p13 -0.223 0.0872 0.595 Protein Kinases
exp ATP9A 20q13.2 -0.223 0.0872 0.595 cation transport;phospholipid
translocation
cop F13B 1q31-q32.1 -0.223 0.0872 0.595 blood coagulation
met LOC153684 5p12 -0.223 0.0872 0.595
xsq CLMN 14q32.13 -0.223 0.0872 0.595
exp SIL1 5q31 -0.223 0.0872 0.595 protein folding;intracellular
protein transport
exp DYRK2 12q15 -0.223 0.0872 0.595 DNA damage response, signal
xai RBM24 6p22.3 -0.225 0.0872 0.595 regulation of mRNA
xai PRR16 5q23.1 -0.225 0.0872 0.595
xai FAM219A 9p13.3 -0.225 0.0872 0.595
his MMP7 11q21-q22 -0.225 0.0872 0.595 Apoptosis
exp URAHP 16q24.3 -0.225 0.0872 0.595
his ADRA2B 2q11.1 0.225 0.0873 0.595 cell-cell signaling;positive
hs4 KIAA2022 Xq13.3 0.225 0.0873 0.595 S phase of mitotic cell
swa ARCN1 11q23.3 0.225 0.0873 0.595 retrograde vesicle-mediated
transport, Golgi to ER;cellular membrane organization
hs4 C1orf105 1q24.3 0.225 0.0873 0.595
his NUDT15 13q14.2 0.225 0.0873 0.595
his PDE4B 1p31 0.225 0.0873 0.595 cAMP catabolic process;signal
transduction
his FITM1 14q12 0.225 0.0873 0.595 positive regulation of sequestering of
triglyceride;lipid particle organization
his EHMT2 6p21.31 0.225 0.0873 0.595 negative regulation of
his C2 6p21.3 0.225 0.0873 0.595 proteolysis;complement activation
exp CXorf24 Xp11.23 0.223 0.0873 0.595
xsq E2F6 2p25.1 0.223 0.0873 0.595 regulation of transcription
involved in G1/S phase of mitotic cell cycle;negative regulation of transcription
xsq TTLL2 6q27 0.223 0.0873 0.595 protein modification process
exp ESX1 Xq22.1 0.223 0.0873 0.595 labyrinthine layer blood vessel
development;blood vessel development
xsq MEIS1 2p14 -0.223 0.0873 0.595 multicellular organismal
development
exp JAZF1-AS1 7p15.1 -0.223 0.0873 0.595
exp TFE3 Xp11.22 -0.223 0.0873 0.595 regulation of transcription,
DNA-dependent;humoral immune response
xai RAB20 13q34 -0.225 0.0873 0.595 small GTPase mediated signal
hs4 FAM183A 1p34.2 -0.225 0.0873 0.595
xai AAK1 2p14 -0.225 0.0873 0.595 regulation of clathrin-mediated
xai URAHP 16q24.3 -0.225 0.0873 0.595
exp LOC100128219 -0.225 0.0873 0.595
hs4 PCED1B 12q13.11 -0.225 0.0873 0.595
hs4 AMIGO2 12q13.11 -0.225 0.0873 0.595 anti-apoptosis;cell
adhesion
xai TMEM132E 17q12 0.225 0.0874 0.595
xai KLHL23 2q31.1 0.224 0.0874 0.595
exp PROB1 5q31.2 0.224 0.0874 0.595
xai RPS2P6 18q22.2 0.224 0.0874 0.595
xai COCH 14q11.2-q13 0.224 0.0874 0.595 sensory perception of sound
cop DYRK4 12p13.32 0.223 0.0874 0.595 protein phosphorylation
exp RPL14 3p22-p21.2 0.223 0.0874 0.595 SRP-dependent cotranslational
mut CHIT1 1q32.1 0.223 0.0874 0.595 response to
cop USP3 15q22.3 0.223 0.0874 0.595 proteolysis;ubiquitin-dependent
cop FBXL22 15q22.31 0.223 0.0874 0.595
cop HERC1 15q22 0.223 0.0874 0.595 protein modification process;transport
xsq CINP 14q32.31 0.223 0.0874 0.595 DNA replication;DNA repair
cop AHSA2 2p15 0.223 0.0874 0.595 response to stress
cop USP34 2p15 0.223 0.0874 0.595 protein K48-linked
cop SNORA70B 0.223 0.0874 0.595
cop XPO1 2p15 0.223 0.0874 0.595 Apoptosis
exp TFF2 21q22.3 0.223 0.0874 0.595 digestion
xsq CAPS 19p13.3 -0.223 0.0874 0.595 intracellular signal
transduction
xsq PCYOX1 2p13.3 -0.223 0.0874 0.595 chloride
xsq TSC22D1 13q14 -0.223 0.0874 0.595 negative regulation of
apoptotic process;transcription from RNA polymerase II promoter
xsq CC2D2A 4p15.32 -0.223 0.0874 0.595 cilium assembly;cilium
morphogenesis
xai LOC100128219 -0.224 0.0874 0.595
cop BCL7C 16p11 0.224 0.0875 0.595 Apoptosis
cop MIR762 0.224 0.0875 0.595
cop CTF1 16p11.2 0.224 0.0875 0.595 neuron development;leukemia
his CCL24 7q11.23 0.224 0.0875 0.595 inflammatory response;positive
regulation of Rac GTPase activity
xai XRCC6P5 Xq22.1 0.224 0.0875 0.595
exp RPS2P6 18q22.2 0.224 0.0875 0.595
xai H3F3C 12p11.21 0.224 0.0875 0.595 nucleosome assembly
xai PPP1R27 17q25.3 0.224 0.0875 0.595 negative regulation of
his DICER1 14q32.13 0.224 0.0875 0.595 Oncogenes
his DICER1-AS1 14q32.13 0.224 0.0875 0.595
met MAGEA12 Xq28 0.223 0.0875 0.595
met RAB36 22q11.22 0.223 0.0875 0.595 small GTPase mediated signal
exp ZNF346 5q35.2 0.222 0.0875 0.595 apoptotic process
xsq GUCY2F Xq22 0.222 0.0875 0.595 cGMP biosynthetic process;receptor
guanylyl cyclase signaling pathway
xsq NEMP2 0.222 0.0875 0.595
met RPL28 19q13.4 -0.222 0.0875 0.595
xsq CLDN23 8p23.1 -0.222 0.0875 0.595 tight junction
mut SUZ12 17q11.2 -0.223 0.0875 0.595 regulation of transcription,
DNA-dependent;positive regulation of cell proliferation
his LRRC17 7q22.1 -0.224 0.0875 0.595 osteoblast
differentiation;osteoblast proliferation
hs4 ADORA2B 17p12 -0.224 0.0875 0.595 activation of MAPK
exp PTCHD3P1 10p11.23 -0.224 0.0875 0.595
xai STIM2 4p15.2 0.224 0.0876 0.595 negative regulation of calcium ion
transport via store-operated calcium channel activity;activation of store-operated
calcium channel activity
exp VWA3A 16p12.2 0.224 0.0876 0.595
his DIDO1 20q13.33 0.224 0.0876 0.595 transcription, DNA-
his GID8 20q13.33 0.224 0.0876 0.595
his SEMA6B 19p13.3 0.224 0.0876 0.595 multicellular organismal
xsq GSKIP 14q32.2 0.222 0.0876 0.595
exp PPP1R3E 14q11.2 0.222 0.0876 0.595 regulation of glycogen
mut PLCXD3 5p13.1 0.222 0.0876 0.595 lipid catabolic
xsq LSP1P3 5p13.3 0.222 0.0876 0.595
exp H3F3C 12p11.21 0.222 0.0876 0.595 nucleosome assembly
xsq ICA1L 2q33.2 0.222 0.0876 0.595
cop TNFAIP8L3 15q21.2 0.222 0.0876 0.595
xsq TAF5L 1q42.13 0.222 0.0876 0.595 regulation of transcription, DNA-
xsq ISCA1 9q21.33 0.222 0.0876 0.595 iron-sulfur cluster assembly
exp BLMH 17q11.2 0.222 0.0876 0.595 protein polyubiquitination;antigen
met MLXIPL 7q11.23 0.222 0.0876 0.595 regulation of transcription,
DNA-dependent;glucose homeostasis
met PVRIG 7q22.1 -0.222 0.0876 0.595
met LGALS2 22q13.1 -0.222 0.0876 0.595
xsq EPB41L1 20q11.2-q12 -0.222 0.0876 0.595 synaptic
transmission;cortical actin cytoskeleton organization
cop LOC100505718 -0.222 0.0876 0.595
met UROC1 3q21.3 -0.222 0.0876 0.595 histidine catabolic
process;cellular nitrogen compound metabolic process
swa MYLK 3q21 -0.224 0.0876 0.595 positive regulation of cell
his ADORA2B 17p12 -0.224 0.0876 0.595 activation of MAPK
hs4 TMEM140 7q33 -0.224 0.0876 0.595
xai GIGYF1 7q22 0.224 0.0877 0.595 insulin-like growth factor receptor
signaling pathway
hs4 ERN1 17q24.2 0.224 0.0877 0.595 response to unfolded
response
his GJA3 13q12.11 0.224 0.0877 0.595 transport;cell-cell signaling
his CENPE 4q24-q25 0.224 0.0877 0.595 mitotic chromosome movement towards
spindle pole;positive regulation of protein kinase activity
xai MAP3K14-AS1 17q21.31 0.224 0.0877 0.595
hs4 MCM6 2q21 0.224 0.0877 0.595 DDR (DNA replication)
xai HNRNPL 19q13.2 0.224 0.0877 0.595 nuclear mRNA splicing, via
his SAAL1 11p15.1 0.224 0.0877 0.596 acute-phase response
xsq VPS51 11q13 0.222 0.0877 0.595
exp ELP4 11p13 0.222 0.0877 0.595 transcription elongation from RNA
exp PCBP2 12q13.13 0.222 0.0877 0.595 mRNA metabolic process;negative
regulation of type I interferon production
xsq LINC01512 0.222 0.0877 0.595
dependent"
cop STYK1 12p13.2 0.222 0.0877 0.595
exp MLC1 22q13.33 0.222 0.0877 0.595 cellular response to
xsq C21orf62 21q22.11 0.222 0.0877 0.595
xsq LOC102723831 0.222 0.0877 0.595
exp PPP1R8 1p35.3 0.222 0.0877 0.595 regulation of transcription,
xsq FAM206A 9q31.3 0.222 0.0877 0.595 glycine catabolic process
exp F13A1 6p25.3-p24.3 0.222 0.0877 0.595 peptide cross-
cop RTP4 3q27.3 -0.222 0.0877 0.595 protein targeting to
taste
exp IQSEC2 Xp11.22 -0.222 0.0877 0.595 regulation of ARF
xsq LINC01546 -0.222 0.0877 0.595
exp RRBP1 20p12 -0.222 0.0877 0.595 protein transport;translation
xai GAD1 2q31 -0.224 0.0877 0.595 neurotransmitter secretion;protein-
his LAYN 11q23.1 -0.224 0.0877 0.595
xai PCDHB15 5q31 -0.224 0.0877 0.595 homophilic cell
adhesion;nervous system development
his BEAN1-AS1 0.224 0.0878 0.596
his YY1AP1 1q22 0.224 0.0878 0.596 regulation of transcription, DNA-
dependent;regulation of cell cycle"
his DAP3 1q22 0.224 0.0878 0.596 Apoptosis
xai TRAPPC12 2p25.3 0.224 0.0878 0.596 vesicle-mediated transport
hs4 TMEM206 1q32.3 0.224 0.0878 0.596
xai OXA1L 14q11.2 0.224 0.0878 0.596 mitochondrial proton-transporting
exp RPL7P55 0.224 0.0878 0.596
xsq PIK3CD-AS1 0.222 0.0878 0.596
xsq SAPCD2 9q34.3 0.222 0.0878 0.596
exp FAM35BP 10q11.22 0.222 0.0878 0.596
exp KMT5B 0.222 0.0878 0.596 regulation of transcription, DNA-
xsq AAR2 20pter-q12 0.222 0.0878 0.596
xsq CHEK2 22q12.1 0.222 0.0878 0.596 DNA Damage Response (DDR); Protein
Kinases
xsq TASP1 20p12.1 0.222 0.0878 0.596 proteolysis;asparagine catabolic
process via L-aspartate
xsq LOC613266 -0.222 0.0878 0.596
xsq TLCD2 17p13.3 -0.222 0.0878 0.596
exp LOC204800 19q13.41 -0.222 0.0878 0.596
xsq C2orf54 2q37.3 -0.222 0.0878 0.596
xsq PVRL4 1q22-q23.2 -0.222 0.0878 0.596 adherens junction
exp SNX24 5q23.2 -0.222 0.0878 0.596 cell communication;protein
transport
his CHST1 11p11.2 -0.224 0.0878 0.596 polysaccharide metabolic
hs4 GUCY1B3 4q31.3-q33 -0.224 0.0878 0.596 nitric oxide mediated
signal transduction;blood coagulation
xai PSMD12P 3p14 0.224 0.0879 0.596
his ATP6V0B 1p32.3 0.224 0.0879 0.596 cellular iron ion
xai CCNB1IP1 14q11.2 0.224 0.0879 0.596 meiotic metaphase I;spermatid
development
his PCCB 3q21-q22 0.224 0.0879 0.596 fatty acid beta-oxidation;short-
his RSBN1 1p13.2 0.224 0.0879 0.596
his AP4B1-AS1 0.224 0.0879 0.596
his ELOVL5 6p21.1-p12.1 0.224 0.0879 0.596 EMT (Mesenchymal)
xsq GRM4 6p21.3 0.222 0.0879 0.596 activation of MAPK activity;G-
protein coupled receptor signaling pathway
xsq LRRC20 10q22.1 0.222 0.0879 0.596
xsq AGBL5 2p23.3 0.222 0.0879 0.596 proteolysis;protein deglutamylation
cop MIR4518 0.222 0.0879 0.596
met RAI14 5p13.3-p13.2 0.222 0.0879 0.596
exp CLC 19q13.1 0.222 0.0879 0.596 multicellular organismal
xsq POP7 7q22 0.222 0.0879 0.596 tRNA processing
exp FBXL4 6q16.1-q16.3 0.222 0.0879 0.596 ubiquitin-dependent protein
catabolic process
exp AP2A1 19q13.33 -0.222 0.0879 0.596 epidermal growth factor
receptor signaling pathway;synaptic transmission
met PROM1 4p15.32 -0.222 0.0879 0.596 retina layer
formation;photoreceptor cell maintenance
cop OXR1 8q23 -0.222 0.0879 0.596 response to oxidative stress;cell
wall macromolecule catabolic process
hs4 TMPRSS13 11q23 -0.224 0.0879 0.596 proteolysis
his LARP7 4q25 0.224 0.088 0.596 RNA processing
his ZGRF1 0.224 0.088 0.596
hs4 CES3 16q22.1 0.224 0.088 0.596
exp OSTCP4 0.224 0.088 0.596
hs4 NFYC-AS1 0.224 0.088 0.596
hs4 NFYC 1p32 0.224 0.088 0.596 regulation of transcription from RNA polymerase
II promoter;protein folding
hs4 IL27RA 19p13.11 0.224 0.088 0.596 cell surface receptor signaling
pathway;positive regulation of interferon-gamma production
xai GAPT 5q11.2 0.224 0.088 0.596 B cell activation
met DRAM1 12q23.2 0.222 0.088 0.596 autophagy;apoptotic process
met C15orf62 15q15.1 0.222 0.088 0.596
xsq CHI3L2 1p13.3 0.222 0.088 0.596 carbohydrate metabolic
cop TAS2R7 0.222 0.088 0.596
cop TAS2R8 12p13 0.222 0.088 0.596 response to stimulus;detection of
chemical stimulus involved in sensory perception of taste
cop PRR4 12p13 0.222 0.088 0.596 visual perception
cop PRH1 0.222 0.088 0.596
cop TAS2R13 0.222 0.088 0.596 response to stimulus;detection of
cop PRH2 12p13.2 0.222 0.088 0.596
cop TAS2R14 0.222 0.088 0.596 detection of chemical stimulus involved
in sensory perception of bitter taste;G-protein coupled receptor signaling pathway
cop TAS2R50 0.222 0.088 0.596
exp RPSAP26 2p15 0.222 0.088 0.596
exp NFE2L1 17q21.3 -0.222 0.088 0.596 heme biosynthetic
exp TPMTP1 18q21.1 -0.222 0.088 0.596
exp SYNDIG1L 14q24.3 -0.222 0.088 0.596 response to biotic stimulus
xsq GLB1L 2q35 -0.222 0.088 0.596 carbohydrate metabolic process
xai TLL2 10q23-q24 -0.224 0.088 0.596 proteolysis;multicellular
swa ABCD3 1p21.3 -0.224 0.088 0.596 ABC Transporters
xai CASZ1 1p36.22 -0.224 0.088 0.596 regulation of transcription, DNA-
dependent"
his PATJ -0.224 0.088 0.596
xai RPL7P55 0.224 0.0881 0.596
his RELT 11q13.4 0.224 0.0881 0.596
hs4 BRI3BP 12q24.31 0.224 0.0881 0.596
xsq ENKD1 16q22.1 0.222 0.0881 0.596
exp BYSL 6p21.1 0.222 0.0881 0.596 cell adhesion;female pregnancy
cop CRTC3 15q26.1 0.222 0.0881 0.596 positive regulation of CREB
xsq DPH5 1p21.2 0.222 0.0881 0.596 peptidyl-diphthamide biosynthetic
cop CCDC113 16q21 0.222 0.0881 0.596
xsq UST 6q25.1 -0.222 0.0881 0.596 protein sulfation
xsq LNPEP 5q15 -0.222 0.0881 0.596 antigen processing and presentation
of exogenous peptide antigen via MHC class I, TAP-independent;proteolysis
xai TRIM62 1p35.1 -0.224 0.0881 0.596
hs4 C16orf47 -0.224 0.0881 0.596
hs4 PSG8 19q13.2 -0.224 0.0881 0.596
xai TPTE 21p11 0.224 0.0882 0.596 protein dephosphorylation;ion transport
xai PSMA4 15q25.1 0.224 0.0882 0.596 antigen processing and presentation
DNA-dependent;induction of apoptosis
exp NOL12 22q13.1 0.222 0.0882 0.596
met FABP3 1p33-p32 0.222 0.0882 0.596 fatty acid metabolic
xsq DFFA 1p36.3-p36.2 0.222 0.0882 0.596 Apoptosis
mut CTSW 11q13.1 0.222 0.0882 0.596 proteolysis;immune response
exp CIDEB 14q12 0.222 0.0882 0.596 apoptotic process;induction of apoptosis
met LINC00469 17q25.1 0.222 0.0882 0.596
met ARMCX6 Xq21.33-q22.3 0.222 0.0882 0.596
mut DEPDC5 22q12.3 0.222 0.0882 0.597 intracellular signal
transduction
cop SOX2-OT 3q26.33 -0.222 0.0882 0.596
xsq SH3D19 4q31.3 -0.222 0.0882 0.596 post-Golgi vesicle-
exp MIR221 -0.224 0.0882 0.597
xai HIP1 7q11.23 -0.224 0.0882 0.596 Apoptosis
his ANKRD33B 5p15.2 -0.224 0.0882 0.596
xai APCDD1L 20q13.32 -0.224 0.0882 0.596
exp EP400NL 12q24.33 0.224 0.0883 0.597
xai HINT3 6q22.32 0.224 0.0883 0.597
exp SNORD116-27 0.224 0.0883 0.597
xai SNORD116-27 0.224 0.0883 0.597
his MYBBP1A 17p13.3 0.224 0.0883 0.597 DNA Damage Response (DDR)
met ATP2C2 16q24.1 0.222 0.0883 0.597 EMT (Epithelial)
cop PACRG-AS1 0.222 0.0883 0.597
cop DKFZp451B082 0.222 0.0883 0.597
cop CAHM 0.222 0.0883 0.597
cop QKI 6q26 0.222 0.0883 0.597 EMT (Mesenchymal)
xsq PTCD2 5q13.2 0.222 0.0883 0.597 mitochondrion organization;heart
development
met SREBF2 22q13 0.222 0.0883 0.597 response to hormone
stimulus;cellular response to laminar fluid shear stress
met TICAM2 5q23.1 0.222 0.0883 0.597 inflammatory response;innate
immune response
exp SCAP 3p21.31 0.222 0.0883 0.597 negative regulation of cholesterol
met THAP11 16q22.1 -0.222 0.0883 0.597 regulation of
exp CBX7 22q13.1 -0.222 0.0883 0.597 negative regulation of
dependent
exp MGC24103 -0.222 0.0883 0.597
met THEMIS2 1p35.3 -0.222 0.0883 0.597
hs4 OTUB2 14q32.12 -0.224 0.0883 0.597 proteolysis;cellular amino
his FGFR2 10q26 -0.224 0.0883 0.597 Cell Signaling; Oncogenes; Protein
Kinases
his MIR5689HG -0.224 0.0883 0.597
his LINC00518 6p24.3 -0.224 0.0883 0.597
his MIR5689 -0.224 0.0883 0.597
exp LOC220729 3q29 -0.224 0.0883 0.597
his ZFAND2B 2q35 0.224 0.0884 0.597
xai LINC01192 0.224 0.0884 0.597
xai SMIM10L1 0.224 0.0884 0.597
met SPINK13 5q32 0.222 0.0884 0.597
exp KDM6B 17p13.1 0.222 0.0884 0.597 negative regulation of
exp HHIP 4q28-q32 0.222 0.0884 0.597 skeletal system
morphogenesis;epithelial tube branching involved in lung morphogenesis
met MIR600HG 9q33.3 0.222 0.0884 0.597
met MIR573 -0.222 0.0884 0.597
exp PNMA1 14q24.3 -0.222 0.0884 0.597 inflammatory response to
antigenic stimulus;apoptotic process
xsq EPS8L2 11p15.5 -0.222 0.0884 0.597
exp LOC100289061 1q21.3 -0.224 0.0884 0.597
xai MIR221 -0.224 0.0884 0.597
his SMG1P5 0.224 0.0885 0.597
xai COQ10A 12q13.3 0.224 0.0885 0.597
his RPS10 6p21.31 0.224 0.0885 0.597 viral reproduction;nuclear-
his RPS10-NUDT3 0.224 0.0885 0.597
his LOC284632 1p36.11 0.224 0.0885 0.597
his CCR5 3p21.31 0.224 0.0885 0.597 calcium ion transport;cell-cell
signaling
met HSDL1 16q23.3 0.222 0.0885 0.597
met KIAA0355 19q13.11 0.222 0.0885 0.597
xsq CNNM3 2p12-p11.2 0.222 0.0885 0.597 ion transport
xsq SIRT5 6p23 0.222 0.0885 0.597 chromatin silencing;protein ADP-
ribosylation
exp LINC00674 -0.222 0.0885 0.597
xai IFNGR2 21q22.11 -0.224 0.0885 0.597 cell surface receptor
signaling pathway;response to virus
hs4 LGALSL 2p14 -0.224 0.0885 0.597
swa ACSL1 4q35.1 -0.224 0.0885 0.597 fatty acid metabolic
xai NEK7 1q31.3 -0.224 0.0885 0.597 cytokinesis;protein
phosphorylation
exp CYP11B2 8q21-q22 0.224 0.0886 0.597 xenobiotic metabolic
process;sodium ion homeostasis
xai ZNF3 7q22.1 0.224 0.0886 0.597 cell differentiation;leukocyte
activation
hs4 JTB 1q21 0.224 0.0886 0.597 regulation of cell proliferation;negative
hs4 NPHP4 1p36 0.224 0.0886 0.597 signal transduction;visual behavior
hs4 KCNAB2 1p36.3 0.224 0.0886 0.597 potassium ion
xai CCDC43 17q21.31 0.224 0.0886 0.597
hs4 THAP11 16q22.1 0.224 0.0886 0.597 regulation of transcription,
DNA-dependent"
xai MIB2 1p36.33 0.224 0.0886 0.597 signal transduction;Notch signaling
pathway
hs4 MCM5 22q13.1 0.224 0.0886 0.597 DDR (DNA replication)
xsq AIMP1 4q24 0.222 0.0886 0.597 glucose metabolic process;response to
wounding
xsq KIAA1328 18q12.2 0.222 0.0886 0.597
exp RRM2 2p25-p24 0.222 0.0886 0.597 DNA Damage Response (DDR)
cop USP39 2p11.2 0.222 0.0886 0.597 spliceosome assembly;mRNA
processing
cop GPRC5A 12p13-p12.3 0.222 0.0886 0.597 G-protein coupled receptor
met NDUFA9 12p13.3 -0.222 0.0886 0.597 mitochondrial electron
xsq ITM2B 13q14.3 -0.222 0.0886 0.597 nervous system
hs4 ACKR3 2q37.3 -0.224 0.0886 0.597
dephosphorylation
hs4 CCDC88C 14q32.11 0.224 0.0887 0.598 microtubule cytoskeleton
xai MEAF6 1p35.3-p33 0.224 0.0887 0.598 regulation of transcription, DNA-
xai ZNF182 Xp11.23 0.224 0.0887 0.598 regulation of transcription,
DNA-dependent"
his RPL39L 3q27 0.224 0.0887 0.598 translation;spermatogenesis
hs4 MIR146B 0.224 0.0887 0.598
xsq LPAR6 13q14 0.222 0.0887 0.598 G-protein coupled receptor signaling
pathway
xsq RIC8B 12q23.3 0.222 0.0887 0.598 regulation of G-protein coupled
receptor protein signaling pathway
met MTUS1 8p22 0.222 0.0887 0.598
met C1orf174 1p36.32 0.222 0.0887 0.598
exp S100A11 1q21 -0.222 0.0887 0.598 signal transduction;negative
xsq WWC1 5q34 -0.222 0.0887 0.598 regulation of transcription, DNA-
xsq CCND1 11q13 -0.222 0.0887 0.598 DNA Damage Response (DDR); DDR (G1-
exp TUBB6 18p11.21 -0.222 0.0887 0.598 microtubule-based
movement;cellular protein metabolic process
xsq CST6 11q13 -0.222 0.0887 0.598 epidermis development;anatomical
hs4 LOC100134868 20p11.1 -0.224 0.0887 0.598
his LIMA1 12q13 -0.224 0.0887 0.598 negative regulation of actin
xai TMEM45A 3q12.2 -0.224 0.0887 0.598
exp AHCYP4 2q22.1 0.224 0.0888 0.598
xai TRIM11 1q42.13 0.224 0.0888 0.598 response to virus
his FNDC3A 13q14.2 0.224 0.0888 0.598 cell-cell adhesion;Sertoli
cell development
cop ZNF768 16p11.2 0.224 0.0888 0.598
hs4 CCDC189 0.223 0.0888 0.598
hs4 RNF40 16p11.2-p11.1 0.223 0.0888 0.598 ubiquitin-dependent protein
xsq LOC100289561 0.222 0.0888 0.598
exp FAM175B 10q26.13 0.222 0.0888 0.598 DNA Damage Response (DDR)
exp DNAJC12 10q22.1 0.222 0.0888 0.598 protein folding
exp CLN8 8p23 -0.222 0.0888 0.598 lysosome organization;somatic motor
exp ALCAM 3q13.1 -0.222 0.0888 0.598 cell adhesion;signal
transduction
cop EGFR 7p12 -0.222 0.0888 0.598 Apoptosis; Cell Signaling;
xsq CARD14 17q25 -0.222 0.0888 0.598 positive regulation of
met IL1R1 2q12 -0.222 0.0888 0.598 ovulation;innate immune response
exp MLLT4 6q27 -0.222 0.0888 0.598 cell junction assembly;adherens
hs4 NLGN3 Xq13.1 -0.224 0.0888 0.598 social behavior;axon
extension
xai RPS6KA2 6q27 -0.224 0.0888 0.598 Protein Kinases
hs4 GTF2IRD1 7q11.23 -0.224 0.0888 0.598 regulation of
hs4 KANK4 1p31.3 -0.224 0.0888 0.598
xai RPL24P4 6p21.1 0.223 0.0889 0.598
hs4 LINC01381 0.223 0.0889 0.598
his PCSK7 11q23-q24 0.223 0.0889 0.598 proteolysis;peptide hormone
processing
his RNF214 11q23.3 0.223 0.0889 0.598
his PGK1 Xq13.3 0.223 0.0889 0.598 glucose metabolic
met RGS3 9q32 0.222 0.0889 0.598 inactivation of MAPK activity;regulation
of G-protein coupled receptor protein signaling pathway
met ZSCAN1 19q13.43 0.222 0.0889 0.598 viral reproduction
cop AKAP3 12p13.3 0.222 0.0889 0.598 cellular component
movement;transmembrane receptor protein serine/threonine kinase signaling pathway
cop NDUFA9 12p13.3 0.222 0.0889 0.598 mitochondrial electron
cop GALNT8 12p13.3 0.222 0.0889 0.598 cellular protein metabolic
exp CASZ1 1p36.22 -0.222 0.0889 0.598 regulation of transcription,
DNA-dependent"
cop CFHR3 1q32 -0.222 0.0889 0.598
xsq HECTD2 10q23.32 -0.222 0.0889 0.598 protein modification
process
xai OR4C4P -0.223 0.0889 0.598
xai LOC91450 15q24.3 -0.223 0.0889 0.598
xai LOC101559451 0.223 0.089 0.598
exp CCDC163P 1p34.1 0.223 0.089 0.598
hs4 EPHB6 7q33-q35 0.223 0.089 0.598 Cell Signaling
his ITGAM 16p11.2 0.223 0.089 0.598 cell adhesion;integrin-mediated signaling
pathway
cop TRAPPC8 18q12.1 0.222 0.089 0.598 vesicle-mediated transport;ER to
cop RNF125 18q12.1 0.222 0.089 0.598 negative regulation of type I
cop CEBPZ 2p22.2 0.222 0.089 0.598 regulation of transcription, DNA-
met IQSEC1 3p25.2 0.221 0.089 0.598 regulation of ARF protein signal
transduction
xsq IBA57 1q42.13 0.221 0.089 0.598 glycine catabolic process;heme
met EPS8 12p12.3 0.221 0.089 0.598 signal transduction;epidermal growth
xsq LOC102724776 -0.221 0.089 0.598
exp TRIM38 6p21.3 -0.221 0.089 0.598 signal transduction;positive
cop ADCYAP1R1 7p14 -0.222 0.089 0.598 activation of phospholipase C
activity;multicellular organismal response to stress
xsq HSBP1L1 18q23 -0.222 0.089 0.598 viral envelope fusion with host
membrane
hs4 TACC2 10q26 -0.223 0.089 0.598 interkinetic nuclear migration;astral
his SLED1 4q35.1 -0.223 0.089 0.598
hs4 SEMA5A 5p15.2 -0.223 0.089 0.598 cell
hs4 SNHG18 -0.223 0.089 0.598
hs4 SNORD123 5p15.2 -0.223 0.089 0.598
exp OR4C4P -0.223 0.089 0.598
hs4 LOC100507144 -0.223 0.089 0.598
hs4 CD44 11p13 -0.223 0.089 0.598 cell-matrix adhesion;negative regulation
of DNA damage response, signal transduction by p53 class mediator
hs4 CSNK1G2 19p13.3 0.223 0.0891 0.599 Protein Kinases
exp LOC100505878 0.223 0.0891 0.599
his TBC1D31 8q24.13 0.223 0.0891 0.599
hs4 PARP11 12p13.3 0.223 0.0891 0.599
xai CCNA2 4q27 0.223 0.0891 0.599 DNA Damage Response (DDR); DDR (DNA
replication)
xai RPS3AP43 0.223 0.0891 0.599
hs4 KIF21B 1q32.1 0.223 0.0891 0.599 microtubule-based movement
xsq PSMB2 1p34.2 0.221 0.0891 0.599 antigen processing and presentation
of peptide antigen via MHC class I;viral reproduction
mut RAB5C 17q21.2 0.221 0.0891 0.599 regulation of endocytosis;GTP
catabolic process
met CCDC144NL 17p11.2 0.221 0.0891 0.599
met WDSUB1 2q24.2 0.221 0.0891 0.599
xsq ALDH3A2 17p11.2 -0.221 0.0891 0.599 cellular aldehyde
metabolic process;oxidation-reduction process
cop MPDZ 9p23 -0.221 0.0891 0.599 interspecies interaction between
organisms
hs4 PDGFD 11q22.3 -0.223 0.0891 0.599 multicellular organismal
exp LOC91450 15q24.3 -0.223 0.0891 0.599
his CERS4 19p13.2 -0.223 0.0891 0.599 ceramide biosynthetic
his NT5DC1 6q22.1 0.223 0.0892 0.599
xai RCC2 1p36.13 0.223 0.0892 0.599 M phase of mitotic cell
xai CTBP1 4p16 0.223 0.0892 0.599 protein phosphorylation;negative
hs4 NSD2 0.223 0.0892 0.599
xsq KIAA0922 4q31.3 0.221 0.0892 0.599
exp AKAP16BP 0.221 0.0892 0.599
xsq LOC401010 2q21.1 0.221 0.0892 0.599
xsq C11orf72 0.221 0.0892 0.599
exp CDK5RAP1 20q11.21 0.221 0.0892 0.599 tRNA modification;brain
development
exp ZC3H12D 6q25.1 0.221 0.0892 0.599 negative regulation of cell
xsq XAB2 19p13.2 0.221 0.0892 0.599 DNA Damage Response (DDR); DDR
(NER)
exp USP20 9q34.11 0.221 0.0892 0.599 protein K48-linked
exp RCC2P7 6p12.1 0.221 0.0892 0.599
exp PRYP3 0.221 0.0892 0.599
xsq GRIK2 6q16.3 -0.221 0.0892 0.599 intracellular protein
transport;negative regulation of neuron apoptosis
hs4 PLPPR2 -0.223 0.0892 0.599
hs4 SAMMSON -0.223 0.0892 0.599
xai CDY1 0.225 0.0893 0.599
xai RANBP2 2q12.3 0.223 0.0893 0.599 protein import into
exp CASP14 19p13.1 0.223 0.0893 0.599 apoptotic process;induction
of apoptosis
exp PPP1R27 17q25.3 0.223 0.0893 0.599 negative regulation of
his USP4 3p21.3 0.223 0.0893 0.599 negative regulation of protein
ubiquitination;regulation of protein stability
met SYT17 16p12.3 0.221 0.0893 0.599
met SNRPE 1q32 0.221 0.0893 0.599 histone mRNA metabolic process;RNA
splicing
xsq TMEM206 1q32.3 0.221 0.0893 0.599
exp FASTK 7q35 -0.221 0.0893 0.599 apoptotic process;induction of
apoptosis by extracellular signals
exp MECOM 3q26.2 -0.221 0.0893 0.599 response to external
swa POSTN 13q13.3 -0.223 0.0893 0.599 extracellular matrix
organization;skeletal system development
hs4 LINC01637 -0.223 0.0893 0.599
his LINC00336 6p21.31 -0.223 0.0893 0.599
hs4 BGN Xq28 -0.223 0.0893 0.599 blood vessel remodeling;peptide
cross-linking via chondroitin 4-sulfate glycosaminoglycan
hs4 C22orf34 22q13.33 0.223 0.0894 0.599
his TRPM2 21q22.3 0.223 0.0894 0.599 ion transport;calcium ion transport
his TRPM2-AS 0.223 0.0894 0.599
hs4 CDC6 17q21.3 0.223 0.0894 0.599 DDR (DNA replication)
exp LOC100288315 0.221 0.0894 0.599
exp YARS 1p35.1 0.221 0.0894 0.599 Apoptosis
xsq FAM186A 12q13.12 0.221 0.0894 0.599
xsq DSG3 18q12.1 0.221 0.0894 0.599 cellular component disassembly
involved in apoptosis;cell adhesion
xsq LINC01484 0.221 0.0894 0.599
xsq LILRA1 19q13.4 0.221 0.0894 0.599 defense response;cell surface
xsq STIP1 11q13 0.221 0.0894 0.599 response to stress;axon guidance
exp FAXDC2 5q31-q32 -0.221 0.0894 0.6
met FKBP5 6p21.31 -0.221 0.0894 0.599 peptidyl-proline
his MDGA1 6p21 -0.223 0.0894 0.6 neuron migration;multicellular
xai KRT17P3 17q11.2 -0.223 0.0894 0.599
xai DYNC1LI2 16q22.1 -0.223 0.0894 0.599 transport
hs4 PRKCDBP 11p15.4 -0.223 0.0894 0.599
hs4 FAM69B 9q34.3 0.223 0.0895 0.6
hs4 KLF1 19p13.2 0.223 0.0895 0.6 regulation of transcription, DNA-
xai TARBP2 12q13.13 0.223 0.0895 0.6 negative regulation of
protein kinase activity;negative regulation of defense response to virus by host
xai TTLL13P 0.223 0.0895 0.6 protein modification process
xai SMC6 2p24.2 0.223 0.0895 0.6 DNA Damage Response (DDR); DDR
exp MZT2B 2q21.1 0.221 0.0895 0.6
exp ZMYND19 9q34.3 0.221 0.0895 0.6
xsq TAS1R1 1p36.23 0.221 0.0895 0.6 response to
stimulus;detection of chemical stimulus involved in sensory perception of taste
mut SLC7A14 3q26.2 0.221 0.0895 0.6 transport;negative regulation
exp FGD3 0.221 0.0895 0.6 regulation of Cdc42 GTPase
xsq MNDA 1q22 0.221 0.0895 0.6 negative regulation of B cell
cop CSNK2A2 16q21 0.221 0.0895 0.6 Protein Kinases
met VEPH1 3q24-q25 -0.221 0.0895 0.6
exp LINC00152 2p11.2 -0.221 0.0895 0.6
exp POFUT1 20q11 -0.221 0.0895 0.6 somitogenesis;embryo
development
mut MYRF 11q12-q13.1 -0.221 0.0895 0.6
cop SST -0.221 0.0895 0.6
cop RTP2 3q27.3 -0.221 0.0895 0.6
cop LOC100131635 3q27.3 -0.221 0.0895 0.6
cop BCL6 3q27 -0.221 0.0895 0.6 cell morphogenesis;negative
swa BCAP31 Xq28 -0.223 0.0895 0.6 Apoptosis
his BOK 2q37.3 -0.223 0.0895 0.6 male gonad
his BOK-AS1 -0.223 0.0895 0.6
exp ZAR1 4p11 0.223 0.0896 0.6 sodium ion transport;multicellular
xai PPP1R3E 14q11.2 0.223 0.0896 0.6 regulation of glycogen
his CACNB3 12q13 0.223 0.0896 0.6 ion transport;calcium ion transport
exp TMEM132E 17q12 0.221 0.0896 0.6
xsq CD96 3q13.13-q13.2 0.221 0.0896 0.6 cell adhesion;regulation of
immune response
xsq BAG5 14q32.33 0.221 0.0896 0.6 Apoptosis
xsq RPL8 8q24.3 0.221 0.0896 0.6 translational elongation;viral
transcription
exp C11orf57 11q23.1 0.221 0.0896 0.6
xsq MOB2 11p15.5 0.221 0.0896 0.6
cop ORAI1 12q24.31 0.221 0.0896 0.6 ion transport;blood coagulation
cop MORN3 12q24.31 0.221 0.0896 0.6
cop TMEM120B 12q24.31 0.221 0.0896 0.6
cop RHOF 12q24.31 0.221 0.0896 0.6 GTP catabolic process;actin
cop LOC338799 0.221 0.0896 0.6
cop SETD1B 12q24.31 0.221 0.0896 0.6 regulation of transcription,
DNA-dependent;chromatin modification
cop HPD 12q24.31 0.221 0.0896 0.6 L-phenylalanine catabolic
cop PSMD9 12q24.31-q24.32 0.221 0.0896 0.6 M/G1 transition of mitotic
cell cycle;gene expression
cop ASPM 1q31 -0.221 0.0896 0.6 cell cycle;mitosis
exp ULK2 17p11.2 -0.221 0.0896 0.6 signal transduction;nervous
system development
xsq PRKAA2 1p31 -0.221 0.0896 0.6 Protein Kinases
exp NAT8B 2p13.1 -0.221 0.0896 0.6 gastrulation with mouth
forming second;multicellular organismal development
xsq DUSP3 17q21 -0.221 0.0896 0.6 toll-like receptor 2 signaling
hs4 SRGAP3 3p25.3 -0.223 0.0896 0.6 signal
xai PTS 11q22.3 -0.223 0.0896 0.6 regulation of nitric-oxide
synthase activity;cellular amino acid metabolic process
his NEURL3 2q11.2 -0.223 0.0896 0.6
hs4 PLA2G6 22q13.1 0.223 0.0897 0.6 metabolic process;cell death
xai DNAJC19P1 10q21.3 0.223 0.0897 0.6
xai DOT1L 19p13.3 0.223 0.0897 0.6 DDR (DNA replication)
exp DNAJC19P1 10q21.3 0.223 0.0897 0.6
his MIR1227 0.223 0.0897 0.6
his MIR6789 0.223 0.0897 0.6
his PLEKHJ1 19p13.3 0.223 0.0897 0.6
his SF3A2 19p13.3 0.223 0.0897 0.6 mRNA processing;RNA splicing
hs4 INA 10q24.33 0.223 0.0897 0.6 multicellular organismal
met HMCN1 1q25.3-q31.1 0.221 0.0897 0.6 visual perception;response to
stimulus
exp DEFA3 8p23.1 0.221 0.0897 0.6 killing of cells of other
xsq PATZ1 22q12.2 0.221 0.0897 0.6 regulation of transcription, DNA-
xsq DEFA4 8p23 0.221 0.0897 0.6 killing of cells of other
xsq TAPT1-AS1 4p15.32 0.221 0.0897 0.6
cop APH1B 15q22.2 0.221 0.0897 0.6 nerve growth factor receptor
exp ACSF3 16q24.3 0.221 0.0897 0.6 lipid metabolic process;fatty acid
metabolic process
exp TSPYL2 Xp11.2 0.221 0.0897 0.6 negative regulation of cell
growth;endoplasmic reticulum unfolded protein response
xsq SNORD67 11p11.2 -0.221 0.0897 0.6
xsq FMN1 15q13.3 -0.221 0.0897 0.6 cellular component
hs4 ERVV-2 -0.223 0.0897 0.6
swa SEPT3 22q13.2 -0.223 0.0897 0.6 cell cycle;cytokinesis
xai PPP2R3B Xp22.33 0.223 0.0898 0.6 G1/S transition of mitotic
xai CASP14 19p13.1 0.223 0.0898 0.6 apoptotic process;induction
of apoptosis
xai RBM19 12q24.21 0.223 0.0898 0.6 multicellular organismal
met CYP2A13 19q13.2 0.223 0.0898 0.6 xenobiotic metabolic
his SUCLG1 2p11.2 0.223 0.0898 0.6 tricarboxylic acid
xsq SRRD 22q12.1 0.221 0.0898 0.6 rhythmic process
exp CAND1 12q14 0.221 0.0898 0.6 regulation of transcription, DNA-
xsq SEMA4D 9q22.2 0.221 0.0898 0.6 multicellular organismal
development;regulation of cell projection organization
exp HTR4 5q31-q33 0.221 0.0898 0.6 G-protein coupled receptor
messenger
xsq THRIL 0.221 0.0898 0.6
exp PROSER2 10p14 -0.221 0.0898 0.6
met FDX1 11q22 -0.221 0.0898 0.6 electron transport chain;cellular
response to epinephrine stimulus
exp STMND1 6p22.3 -0.221 0.0898 0.6
his MYL4 17q21.32 -0.223 0.0898 0.6 regulation of the force of
heart contraction;muscle organ development
his HGFAC 4p16 -0.223 0.0898 0.6 proteolysis
hs4 ATOH7 10q21.3 -0.223 0.0898 0.6
hs4 PKHD1L1 8q23 -0.223 0.0898 0.6 immune response
his C6orf15 6p21.3 -0.223 0.0898 0.6 extracellular matrix
organization
his PSORS1C1 6p21.3 -0.223 0.0898 0.6
xai CPA4 7q32 -0.223 0.0898 0.6 proteolysis;histone acetylation
xai COBLL1 2q24.3 -0.223 0.0898 0.6
xai TRNS2 0.223 0.0899 0.6
xai LNP1 3q12.2 0.223 0.0899 0.6
hs4 MRPL48 11q13.4 0.223 0.0899 0.6 translation
xai OR8D4 0.223 0.0899 0.6 response to stimulus
swa MRI1 19p13.2 0.223 0.0899 0.6 L-methionine salvage from
his TMEM74 8q23.1 0.223 0.0899 0.6 autophagy
hs4 LINC00261 20p11.21 0.223 0.0899 0.6
hs4 MYCBPAP 17q21.33 0.223 0.0899 0.6 synaptic
transmission;multicellular organismal development
hs4 C11orf21 11p15.5 0.223 0.0899 0.6
hs4 TSPAN32 11p15.5 0.223 0.0899 0.6 cell-cell signaling
his VMP1 17q23.1 0.223 0.0899 0.6 regulation of autophagy;cell-cell
adhesion
his PTRH2 17q23.1 0.223 0.0899 0.6 apoptotic process
xai PPIAP1 21q21.1 0.223 0.0899 0.6
xai MYH1 17p13.1 0.223 0.0899 0.6
met SP110 2q37.1 0.221 0.0899 0.6 regulation of transcription, DNA-
met MGAT1 5q35 0.221 0.0899 0.6 cellular protein metabolic
mut TMEM67 8q22.1 0.221 0.0899 0.6 cilium assembly;branching
met STAC 3p22.3 0.221 0.0899 0.6 signal transduction;cellular
response to heat
exp EPHA2 1p36 -0.221 0.0899 0.6 Protein Kinases
cop LURAP1L 9p23 -0.221 0.0899 0.6
exp ZNF35 3p21.32 -0.221 0.0899 0.6 regulation of transcription,
met PTGER1 19p13.1 -0.221 0.0899 0.6 G-protein coupled
xai OLFML2A 9q33.3 -0.223 0.0899 0.6 extracellular matrix
organization
hs4 GPR37 7q31 -0.223 0.0899 0.6 G-protein coupled receptor
signaling pathway
hs4 FCHO2 5q13.2 -0.223 0.0899 0.6
cop FLJ42393 -0.223 0.0899 0.6
hs4 SELENOP -0.223 0.0899 0.6
exp OR8D4 0.223 0.09 0.6 response to stimulus
his GMFG 19q13.2 0.223 0.09 0.6 protein phosphorylation;positive
his SAMD4B 19q13.2 0.223 0.09 0.6
exp FGR 1p36.2-p36.1 0.221 0.09 0.6 immune response-regulating cell
surface receptor signaling pathway;positive regulation of cell migration
exp CDK2AP2 11q13 0.221 0.09 0.6
xsq LGALS9 17q11.2 0.221 0.09 0.6 signal transduction;positive
exp ZNF76 6p21.31 0.221 0.09 0.6 regulation of transcription from RNA
polymerase III promoter;regulation of transcription from RNA polymerase II promoter
mut CCDC80 3q13.2 0.221 0.09 0.6 positive regulation of cell-
xsq HELB 12q14.3 0.221 0.09 0.6 DNA Damage Response (DDR)
met FGF6 12p13 0.221 0.09 0.6 cartilage condensation;fibroblast growth factor
exp IGIP 5q31 -0.221 0.09 0.6
swa AK4 1p31.3 -0.223 0.09 0.6
his OXT 20p13 -0.223 0.09 0.6 maternal aggressive behavior;response to
sucrose stimulus
hs4 APBB2 4p13 -0.223 0.09 0.6 regulation of transcription, DNA-
xai FAM71A 1q32.3 -0.223 0.09 0.6
hs4 LOC101928429 0.223 0.0901 0.601
xai KMT5B 0.223 0.0901 0.601 regulation of transcription, DNA-
xai ECE2 3q27.1 0.223 0.0901 0.601 peptide hormone
exp ZFAND4 10q11.22 0.221 0.0901 0.6
xsq UCHL5 1q32 0.221 0.0901 0.601 DNA repair;midbrain development
DNA-dependent"
exp EEF1DP1 19p13.12 0.221 0.0901 0.601
xsq HCN3 1q22 0.221 0.0901 0.601 ion transport;potassium ion transport
xsq DYRK2 12q15 -0.221 0.0901 0.601 DNA damage response, signal
xai CASK Xp11.4 -0.223 0.0901 0.601 negative regulation of wound
xai DGKI 7q32.3-q33 -0.223 0.0901 0.601 blood coagulation;platelet
activation
his ESYT1 12q13.2 0.223 0.0902 0.601
his CYB5B 16q22.1 0.223 0.0902 0.601 transport;electron transport chain
swa FKBP1A 20p13 0.223 0.0902 0.601 'de novo' protein
folding;regulation of activin receptor signaling pathway
exp MEP1A 6p12-p11 0.223 0.0902 0.601 proteolysis;digestion
xai TRIM59 3q25.33 0.223 0.0902 0.601
hs4 ANKRD20A11P 21q11.2 0.223 0.0902 0.601
his SNAR-C4 0.223 0.0902 0.601
exp MMP27 11q24 0.223 0.0902 0.601 proteolysis;metabolic process
met CCDC22 Xp11.23 0.221 0.0902 0.601
exp LGALS12 11q13 0.221 0.0902 0.601 induction of apoptosis by
xsq MPND 19p13.3 0.221 0.0902 0.601 proteolysis
exp RRP7BP 0.221 0.0902 0.601
met SGCB 4q12 0.221 0.0902 0.601 cytoskeleton organization;muscle organ
development
xsq DNAJA2 16q12.1 0.221 0.0902 0.601 protein folding;positive
xsq IGFLR1 19q13.12 0.221 0.0902 0.601
exp LIPT2 11q13.4 0.221 0.0902 0.601 protein modification
process;lipoate biosynthetic process
cop KLRK1 12p13.2-p12.3 0.221 0.0902 0.601
cop KLRC4-KLRK1 0.221 0.0902 0.601
cop KLRC4 12p13.2-p12.3 0.221 0.0902 0.601 cellular defense response
cop KLRC3 12p13 0.221 0.0902 0.601 cellular defense response
cop KLRC2 0.221 0.0902 0.601 cellular defense response;signal
transduction
cop KLRC1 12p13 0.221 0.0902 0.601 regulation of immune response;cell
exp HPS3 3q24 -0.221 0.0902 0.601 organelle organization;pigmentation
hs4 WIPI1 17q24.2 -0.223 0.0902 0.601 autophagy;activation of
his SOWAHB 4q21.1 -0.223 0.0902 0.601 EMT (Epithelial)
his PHYKPL 5q35.3 0.223 0.0903 0.601
pro EP300_10_24347 0.221 0.0903 0.601
exp NME2P1 0.221 0.0903 0.601 nucleotide metabolic process;GTP
xsq FBXO38 5q32 0.221 0.0903 0.601
exp NTRK1 1q21-q22 0.221 0.0903 0.601 activation of adenylate cyclase
xsq LINC01089 0.221 0.0903 0.601
cop OGFOD1 16q12.2 0.221 0.0903 0.601
xsq C16orf90 16p13.3 0.221 0.0903 0.601
met SAT2 17p13.1 0.221 0.0903 0.601
hs4 SGSH 17q25.3 -0.223 0.0903 0.601 proteoglycan metabolic
process
xai RPL37P2 11q13 0.222 0.0904 0.601
his CCL4 17q12 0.222 0.0904 0.601
xai IRF8 16q24.1 0.222 0.0904 0.601 immune response;positive regulation
hs4 LINC01081 0.222 0.0904 0.601
hs4 LINC02135 0.222 0.0904 0.601
hs4 VPS9D1-AS1 16q24.3 0.222 0.0904 0.601
swa DNPH1 6p21.1 0.222 0.0904 0.601
exp RPS11P5 12q24.33 0.222 0.0904 0.601
xai EIF3L 22q 0.222 0.0904 0.601 translational initiation
xsq BZW2 7p21.1 0.221 0.0904 0.601 multicellular organismal
xsq LOC440910 0.221 0.0904 0.601
cop KIDINS220 2p24 0.221 0.0904 0.601 activation of MAPKK activity;nerve
met GYS1 19q13.3 0.221 0.0904 0.601 small molecule metabolic
exp DARS2 1q25.1 0.221 0.0904 0.601 tRNA aminoacylation for protein
exp MYO3B 2q31.1-q31.2 -0.221 0.0904 0.601 visual
perception;response to stimulus
exp LOC100288703 1q42.2 -0.221 0.0904 0.601
exp BCAS4 20q13.13 -0.221 0.0904 0.601
cop TYRP1 9p23 -0.221 0.0904 0.601 acetoacetic acid metabolic
process;pigmentation
exp LINC00639 14q21.1 -0.222 0.0904 0.601
hs4 ENPP5 6p21.1-p11.2 -0.222 0.0904 0.601 cell communication
exp NDUFA5P12 8q11.1 0.222 0.0905 0.601
xai PRPF3 1q21.1 0.222 0.0905 0.601 RNA splicing, via
xai LINC00999 0.222 0.0905 0.602
xai MMACHC 1p34.1 0.222 0.0905 0.602
hs4 MNDA 1q22 0.222 0.0905 0.602 negative regulation of B cell
xsq KRTAP10-7 21q22.3 0.22 0.0905 0.601
xsq LOC101409256 0.22 0.0905 0.601
xsq PRG4 1q25-q31 0.22 0.0905 0.602 immune response;cell proliferation
exp WDFY4 10q11.23 0.22 0.0905 0.602
exp INO80E 16p11.2 0.22 0.0905 0.602 DNA Damage Response (DDR);
DDR (Chromatin)
xsq GRIK5 19q13.2 0.22 0.0905 0.602 ion transport;synaptic transmission
xsq UTP15 5q13.2 0.22 0.0905 0.602 rRNA processing
xsq HLA-F-AS1 6p22.1 -0.22 0.0905 0.602
exp HLA-P 6p21.2 -0.22 0.0905 0.602
xsq EMP1 12p12.3 -0.22 0.0905 0.602 multicellular organismal
exp GPR107 9q34.11 -0.22 0.0905 0.601
xsq NUDT12 5q21.2 -0.22 0.0905 0.601 NADP catabolic process;NAD
catabolic process
swa EEA1 12q22 -0.222 0.0905 0.602 endocytosis;vesicle fusion
his LINCR-0003 -0.222 0.0905 0.601
xai RPS11P5 12q24.33 0.222 0.0906 0.602
xai TMEM258 11q12.2 0.222 0.0906 0.602
swa MSH2 2p21 0.222 0.0906 0.602 DNA Damage Response (DDR); DDR (MMR);
Tumor Suppressors
xai PSMB3P2 2q35 0.222 0.0906 0.602
hs4 GHRL 3p26-p25 0.222 0.0906 0.602 negative regulation of endothelial
cell proliferation;hormone-mediated signaling pathway
hs4 VENTX 10q26.3 0.222 0.0906 0.602
his PDCD1 2q37.3 0.222 0.0906 0.602 apoptotic process;humoral immune
response
xai FOXJ2 12p13.31 0.222 0.0906 0.602 regulation of sequence-specific DNA
exp TEX15 8p12 0.22 0.0906 0.602 regulation of double-strand break repair
exp RGS14 5q35.3 0.22 0.0906 0.602 spindle organization;zygote
met SDSL 12q24.13 0.22 0.0906 0.602 cellular amino acid metabolic
process
xsq RHOF 12q24.31 0.22 0.0906 0.602 GTP catabolic process;actin
cop CLEC1A 12p13.2 0.22 0.0906 0.602 defense response;cell surface
cop CLEC7A 12p13.2 0.22 0.0906 0.602 phagocytosis,
recognition;defense response to protozoan
cop OLR1 12p13.2-p12.3 0.22 0.0906 0.602 blood circulation;cell death
cop TMEM52B 0.22 0.0906 0.602
xsq LINC00689 7q36.3 0.22 0.0906 0.602
xsq SCN2A 2q24.3 0.22 0.0906 0.602 nervous system
development;myelination
exp IFNGR2 21q22.11 -0.22 0.0906 0.602 cell surface receptor
exp GLB1 3p21.33 -0.22 0.0906 0.602 small molecule metabolic
exp NECAB3 20q11.22 -0.22 0.0906 0.602 protein secretion;protein
metabolic process
xai TPMT 6p22.3 -0.222 0.0906 0.602 nucleobase-containing
compound metabolic process;xenobiotic metabolic process
hs4 STARD8 Xq13.1 -0.222 0.0906 0.602 signal
hs4 CA13 8q21.2 -0.222 0.0906 0.602 one-carbon metabolic process
swa ITGAV 2q31-q32 -0.222 0.0906 0.602 angiogenesis;blood
coagulation
met GSTT1 22q11.23 0.228 0.0907 0.602 glutathione metabolic process
his ELFN1-AS1 0.222 0.0907 0.602
exp SLC46A2 9q32 0.222 0.0907 0.602 transport;transmembrane transport
his RALBP1 18p11.3 0.222 0.0907 0.602 transport;regulation of small
swa PSMD14 2q24.2 0.222 0.0907 0.602 G1/S transition of mitotic
cell cycle;ubiquitin-dependent protein catabolic process
exp TRAV29DV5 0.222 0.0907 0.602
xsq LSM4 19p13.11 0.22 0.0907 0.602 RNA splicing;gene expression
exp FOXJ2 12p13.31 0.22 0.0907 0.602 regulation of sequence-specific DNA
mut MAP3K9 14q24.2 -0.22 0.0907 0.602 Protein Kinases
xai TFE3 Xp11.22 -0.222 0.0907 0.602 regulation of transcription,
DNA-dependent;humoral immune response
xai PIGV 1p36.11 0.222 0.0908 0.602 GPI anchor biosynthetic
his LOC285847 6p21.31 0.222 0.0908 0.602
his ARMC12 6p21.31 0.222 0.0908 0.602
his MIR4326 0.222 0.0908 0.602
hs4 KIF11 10q24.1 0.222 0.0908 0.602 spindle organization;mitotic
xai OLIG1 21q22.11 0.222 0.0908 0.602 multicellular organismal
development;neuron fate commitment
his MSRA 8p23.1 0.222 0.0908 0.602 protein modification
process;methionine metabolic process
his PCNA-AS1 0.222 0.0908 0.602 DDR (DNA replication)
his PCNA 20pter-p12 0.222 0.0908 0.602 DNA Damage Response (DDR); DDR
his BRINP3 0.222 0.0908 0.602 nervous system development;negative
his LINC01351 0.222 0.0908 0.602
xai TRAV29DV5 0.222 0.0908 0.602
his LINC00996 0.222 0.0908 0.602
his UQCR11 19p13.3 0.222 0.0908 0.602 generation of precursor
metabolites and energy;transport
xai RAB28 4p15.33 0.222 0.0908 0.602 GTP catabolic process;small GTPase
xai NONO Xq13.1 0.222 0.0908 0.602 DNA repair;DNA recombination
xsq GRIN1 9q34.3 0.22 0.0908 0.602 synaptic transmission;calcium ion
mut FAM47A Xp21.1 0.22 0.0908 0.602
exp POLR3GL 1q21.1 0.22 0.0908 0.602 transcription from RNA
xsq PELP1 17p13.2 0.22 0.0908 0.602 transcription, DNA-dependent"
exp EPX 17q23.1 0.22 0.0908 0.602 response to oxidative
cop ADAMTSL1 9p21.3 -0.22 0.0908 0.602
xsq PTPRB 12q15-q21 -0.22 0.0908 0.602 protein
xsq CHRDL1 Xq23 -0.22 0.0908 0.602 nervous system development;cell
differentiation
xsq ARID5B 10q21.2 -0.22 0.0908 0.602 fibroblast migration;skeletal
his C1orf229 1q44 -0.222 0.0908 0.602
xai KRT8P15 -0.222 0.0908 0.602
hs4 FOXD4L5 0.222 0.0909 0.602
xai GOLGA8A 15q11.2 0.222 0.0909 0.602
exp TUBGCP6 22q13.31-q13.33 0.22 0.0909 0.602 mitotic cell
met NR1H4 12q23.1 0.22 0.0909 0.602 intracellular receptor mediated
signaling pathway;regulation of urea metabolic process
dependent"
met KIAA0391 14q13.2 0.22 0.0909 0.602 tRNA processing
met OR2B3 6p22.1 0.22 0.0909 0.602 response to stimulus
mut PIGQ 16p13.3 0.22 0.0909 0.602 cellular protein metabolic
xsq LOC101929577 0.22 0.0909 0.602
xsq NDP Xp11.4 -0.22 0.0909 0.602 visual perception;canonical Wnt
xsq FAT3 11q14.3 -0.22 0.0909 0.602 multicellular organismal
cop LPP 3q28 -0.22 0.0909 0.602 cell adhesion
exp TTC23 15q26.3 -0.22 0.0909 0.602
cop TEX35 1q25.2 -0.22 0.0909 0.602
cop C1orf220 1q25.2 -0.22 0.0909 0.602
hs4 OSBPL3 7p15 -0.222 0.0909 0.602 transport;lipid transport
exp LOC100129540 15q25.1 -0.222 0.0909 0.602
his MIR221 -0.222 0.0909 0.602
his MIR222 -0.222 0.0909 0.602
his FERMT2 14q22.1 -0.222 0.0909 0.602 cell adhesion;regulation
of cell shape
xai TGS1 8q11 0.222 0.091 0.602 regulation of transcription, DNA-
exp CALHM1 10q24.33 0.222 0.091 0.602 ion transport
his ILF2 1q21.3 0.222 0.091 0.602 positive regulation of transcription,
DNA-dependent;transcription, DNA-dependent
hs4 YBX3 12p13.1 0.222 0.091 0.602
exp TUBGCP5 15q11.2 0.22 0.091 0.602 mitotic cell cycle;microtubule
nucleation
met GUSB 7q21.11 0.22 0.091 0.602 carbohydrate metabolic
process;glycosaminoglycan catabolic process
cop KLRD1 12p13 0.22 0.091 0.602 cell surface receptor signaling
met HIRA 22q11.21 0.22 0.091 0.602 anatomical structure
morphogenesis;chromatin modification
xsq ETV3L 1q23.1 0.22 0.091 0.602 Transcription Factors
cop SKAP2 7p15.2 -0.22 0.091 0.602 negative regulation of cell
cop HOXA1 7p15.3 -0.22 0.091 0.602 multicellular organismal
cop HOTAIRM1 -0.22 0.091 0.602
cop HOXA2 7p15.2 -0.22 0.091 0.602 anterior/posterior pattern
cop HOXA3 7p15.2 -0.22 0.091 0.602 glossopharyngeal nerve
cop HOXA4 7p15.2 -0.22 0.091 0.602 anatomical structure
morphogenesis;multicellular organismal development
cop HOXA-AS3 7p15.2 -0.22 0.091 0.602
cop HOXA5 7p15.2 -0.22 0.091 0.602 thyroid gland development;embryonic
skeletal system morphogenesis
cop HOXA6 7p15.2 -0.22 0.091 0.602 multicellular organismal
cop HOXA7 7p15.2 -0.22 0.091 0.602 negative regulation of cell-matrix
adhesion;embryonic skeletal system morphogenesis
cop HOXA10-HOXA9 -0.22 0.091 0.602
cop HOXA9 7p15.2 -0.22 0.091 0.602 definitive hemopoiesis;multicellular
cop HOXA10-AS -0.22 0.091 0.602
cop MIR196B -0.22 0.091 0.602
cop HOXA10 7p15.2 -0.22 0.091 0.602 skeletal system
cop HOXA11 7p15.2 -0.22 0.091 0.602 metanephros
development;proximal/distal pattern formation
cop HOXA11-AS 7p15.2 -0.22 0.091 0.602
cop HOXA13 7p15.2 -0.22 0.091 0.602 skeletal system development;male
genitalia development
cop HOTTIP -0.22 0.091 0.602
cop EVX1 7p15.2 -0.22 0.091 0.602 regulation of transcription from RNA
polymerase II promoter involved in ventral spinal cord interneuron
pro TP53_10_24337 -0.22 0.091 0.602
exp IGFBP3 7p12.3 -0.22 0.091 0.602 Apoptosis
his SHB 9p13.2 -0.222 0.091 0.602 Apoptosis
hs4 CARMIL1 -0.222 0.091 0.602
xai LOC100129540 15q25.1 -0.222 0.091 0.602
his PBK 8p21.2 0.222 0.0911 0.602 protein phosphorylation;mitosis
hs4 GPR132 14q32.3 0.222 0.0911 0.602 G1/S transition of mitotic
cell cycle;response to stress
his C1D 2p13-p12 0.222 0.0911 0.602 negative regulation of
his PTENP1-AS 0.222 0.0911 0.602
his PTENP1 9p21 0.222 0.0911 0.602
xai RPS4X Xq13.1 0.222 0.0911 0.602 translational elongation;mRNA
metabolic process
his CDNF 10p13 0.222 0.0911 0.602
his HSPA14 10p13 0.222 0.0911 0.602 'de novo' cotranslational protein
folding
exp DLEU7-AS1 0.222 0.0911 0.602
xai BUB3 10q26 0.222 0.0911 0.602 attachment of spindle microtubules to
cop PSMB1 6q27 0.22 0.0911 0.602 antigen processing and presentation of
cop TBP 6q27 0.22 0.0911 0.602 transcription from RNA polymerase III
cop PDCD2 6q27 0.22 0.0911 0.602 Apoptosis
exp ARHGAP11A 15q13.2 0.22 0.0911 0.602 signal transduction;small
cop PLA2G1B 12q24.31 0.22 0.0911 0.602
cop MSI1 12q24 0.22 0.0911 0.602 nervous system development;response to
hormone stimulus
cop COX6A1 12q24.2 0.22 0.0911 0.602 generation of precursor
exp SCUBE3 6p21.3 -0.22 0.0911 0.602 protein
homooligomerization;protein heterooligomerization
xsq KLHDC7A 1p36.13 -0.22 0.0911 0.602
cop RALGPS2 1q25.2 -0.22 0.0911 0.602 small GTPase mediated signal
transduction
cop ANGPTL1 1q25.2 -0.22 0.0911 0.602 signal
hs4 CTSL3P 9q21.33 -0.222 0.0911 0.602
xai YTHDF3 8q12.3 -0.222 0.0911 0.602
hs4 DHDH 19q13.3 -0.222 0.0911 0.602 D-xylose catabolic
hs4 ATP9B 18q23 0.222 0.0912 0.602 cation transport;aminophospholipid
transport
hs4 PTX4 16p13.3 0.222 0.0912 0.602
hs4 TELO2 16p13.3 0.222 0.0912 0.602 DNA Damage Response (DDR); DDR (FA)
xai ORM1 9q32 0.222 0.0912 0.602 regulation of immune system
process;transport
exp ARHGDIG 16p13.3 0.22 0.0912 0.602 regulation of small GTPase
exp PRTN3 19p13.3 0.22 0.0912 0.602 proteolysis;positive regulation of
cell proliferation
xsq MTM1 Xq28 0.22 0.0912 0.602 protein dephosphorylation;endosome to
lysosome transport
met GPR119 Xq26.1 0.22 0.0912 0.602 insulin secretion
cop FAM120B 6q27 0.22 0.0912 0.602 regulation of transcription, DNA-
exp METTL1 12q13 0.22 0.0912 0.602 tRNA modification
exp OR1B1 -0.222 0.0912 0.603 response to stimulus
xai ZDHHC21 9p22.3 -0.222 0.0912 0.602 small molecule metabolic
his LINC00460 13q33.3 -0.222 0.0912 0.602
hs4 CDKN1B 12p13.1-p12 0.222 0.0913 0.603 DDR (DNA replication)
hs4 APOLD1 12p13.1 0.222 0.0913 0.603 endothelial cell
exp LOC646778 0.222 0.0913 0.603
his ABCG2 4q22 0.222 0.0913 0.603 ABC Transporters
xai SSR4 Xq28 0.222 0.0913 0.603 translation;SRP-dependent cotranslational
his CKMT2 5q13.3 0.222 0.0913 0.603 creatine metabolic process;muscle
contraction
hs4 ATIC 2q35 0.222 0.0913 0.603 purine ribonucleoside monophosphate
xai NR2C2 3p25 0.222 0.0913 0.603 regulation of transcription, DNA-
his KMT2A 11q23 0.222 0.0913 0.603
met GPR26 10q26.13 0.22 0.0913 0.603 activation of adenylate cyclase
activity by G-protein signaling pathway
exp MAD2L2 1p36 0.22 0.0913 0.603 DNA Damage Response (DDR); DDR (DNA
exp TATDN1P1 10q21.3 0.22 0.0913 0.603
xsq SNHG15 7p13 0.22 0.0913 0.603
xai BOC 3q13.2 -0.222 0.0913 0.603 muscle cell
xai NRXN3 14q31 -0.222 0.0913 0.603 angiogenesis;cell adhesion
xai LRIG3 12q14.1 -0.222 0.0913 0.603
xai IL1RAP 3q28 -0.222 0.0913 0.603 signal transduction;innate
immune response
his TNPO2 19p13.2 0.222 0.0914 0.603 intracellular protein transport
xai RBM22P2 0.222 0.0914 0.603
hs4 MIB1 18q11.2 0.222 0.0914 0.603 neural tube formation;heart looping
his LTA 6p21.3 0.222 0.0914 0.603 response to hypoxia;response to
nutrient
exp CDY1 0.222 0.0914 0.603
xai ATP8A2P1 0.222 0.0914 0.603
met ELK4 1q32 0.22 0.0914 0.603 Transcription Factors
xsq MPHOSPH10 2p13.3 0.22 0.0914 0.603 RNA processing;RNA splicing
cop NDUFAF7 2p22.2 0.22 0.0914 0.603
cop PRKD3 2p21 0.22 0.0914 0.603 protein phosphorylation;activation of
xsq CENPP 9q22.31 0.22 0.0914 0.603 M phase of mitotic cell
cop ID2 2p25 0.22 0.0914 0.603 multicellular organismal
development;mammary gland epithelial cell proliferation
met NLRP5 19q13.43 0.22 0.0914 0.603
cop LOC154449 6q27 0.22 0.0914 0.603
cop DLL1 6q27 0.22 0.0914 0.603 compartment pattern
specification;regulation of neurogenesis
cop MIR4644 0.22 0.0914 0.603
xsq OTOL1 3q26.1 0.22 0.0914 0.603
exp BNC2 9p22.2 -0.22 0.0914 0.603 regulation of transcription, DNA-
dependent"
xsq SNHG18 -0.22 0.0914 0.603
his TGFA 2p13 -0.222 0.0914 0.603 anti-apoptosis;positive regulation
of mitosis
xai TM2D1 1p31.3 -0.222 0.0914 0.603 apoptotic process;induction
hs4 LOC284080 -0.222 0.0914 0.603
hs4 ITGA3 17q21.33 -0.222 0.0914 0.603 leukocyte migration;neuron
migration
xai OR1B1 -0.222 0.0914 0.603 response to stimulus
xai MLLT4 6q27 -0.222 0.0914 0.603 cell junction assembly;adherens
xai OR51E1 11p15.4 0.222 0.0915 0.603 response to stimulus
his ZBED9 0.222 0.0915 0.603 DNA integration;viral reproduction
cop RNF181 2p11.2 0.222 0.0915 0.603
his CBFB 16q22.1 0.222 0.0915 0.603 regulation of transcription, DNA-
xai IL4 5q31.1 0.222 0.0915 0.603 negative regulation of chronic
xai MMGT1 Xq26.3 0.222 0.0915 0.603 transport;magnesium ion transport
xsq FLJ38576 4q35.2 0.22 0.0915 0.603
exp NSFP1 17q21.31 0.22 0.0915 0.603
exp LOC100128361 9q22.31 0.22 0.0915 0.603
xsq DEFA8P 8p23.1 0.22 0.0915 0.603
xsq DEFA1 8p23.1 0.22 0.0915 0.603
mut CSRNP3 2q24.3 0.22 0.0915 0.603 negative regulation of
phosphatase activity;positive regulation of apoptotic process
mut SSUH2 3p26.1 0.22 0.0915 0.603
mut TUBAL3 10p15.1 0.22 0.0915 0.603 microtubule-based
movement;protein polymerization
mut METTL12 11q12.3 0.22 0.0915 0.603
mut GXYLT1 12q12 0.22 0.0915 0.603 O-glycan processing
mut ENTPD5 14q24 0.22 0.0915 0.603 metabolic process;cell
proliferation
mut ACPT 19q13.4 0.22 0.0915 0.603
mut CCDC22 Xp11.23 0.22 0.0915 0.603
xsq PLA2G2C 1p36.12 0.22 0.0915 0.603 phospholipid metabolic
xsq DEFA6 8p23.1 0.22 0.0915 0.603
xsq PWAR4 0.22 0.0915 0.603
xsq CCL23 17q12 0.22 0.0915 0.603 immune response;signal transduction
mut GOLM1 9q21.33 0.22 0.0915 0.603
mut DCPS 11q24.2 0.22 0.0915 0.603 deadenylation-dependent decapping
of nuclear-transcribed mRNA;gene expression
mut NOX5 15q23 0.22 0.0915 0.603 induction of apoptosis;oxidation-
reduction process
mut GGN 19q13.2 0.22 0.0915 0.603 cell differentiation;multicellular
mut C20orf27 20p13 0.22 0.0915 0.603
xsq F10 13q34 0.22 0.0915 0.603 post-translational protein
met XKR6 8p23.1 0.22 0.0915 0.603
cop TAB2 6q25.1 0.22 0.0915 0.603 Toll signaling pathway;innate
immune response
cop SUMO4 6q25 0.22 0.0915 0.603 DNA Damage Response (DDR)
cop ZC3H12D 6q25.1 0.22 0.0915 0.603 negative regulation of cell
xsq DEFA1B 0.22 0.0915 0.603
xsq TMEM183A 1q32.1 0.22 0.0915 0.603
met FAM9B Xp22.32 0.22 0.0915 0.603
xsq CD274 9p24 -0.22 0.0915 0.603 immune response;signal transduction
met PSG10P 19q13.2 -0.22 0.0915 0.603
exp MRPL33 2p21 -0.22 0.0915 0.603 translation
xai PXMP4 20q11.22 -0.222 0.0915 0.603
exp SOGA2P1 -0.222 0.0915 0.603
xai PAX8 2q13 -0.222 0.0915 0.603 mesenchymal to epithelial
transition involved in metanephros morphogenesis;pronephric field specification
exp TTC24 1q23.1 0.222 0.0916 0.603
exp C17orf49 17p13.1 0.222 0.0916 0.603 chromatin modification
xai TUBGCP6 22q13.31-q13.33 0.222 0.0916 0.603 mitotic cell
DNA-dependent"
xsq RBM23 14q11.2 0.22 0.0916 0.603 mRNA processing
met KLHL1 13q21 0.22 0.0916 0.603 cerebellar Purkinje cell layer
xsq SUV420H1 11q13.2 0.22 0.0916 0.603
xsq NGB 0.22 0.0916 0.603
exp ACOT2 -0.22 0.0916 0.603 very long-chain fatty acid metabolic
process;long-chain fatty acid metabolic process
exp VEGFA 6p12 -0.22 0.0916 0.603 patterning of blood vessels;positive
exp LZTS3 20p13 -0.22 0.0916 0.603
hs4 EVC2 4p16.2-p16.1 -0.222 0.0916 0.603 smoothened signaling
pathway
hs4 EVC 4p16 -0.222 0.0916 0.603 muscle organ development;positive
his RBM4 11q13 0.222 0.0917 0.603 cell differentiation;regulation of
nucleocytoplasmic transport
his PUS10 2p16.1 0.222 0.0917 0.603 pseudouridine synthesis;tRNA
processing
his PEX13 2p16.1 0.222 0.0917 0.603 microtubule-based peroxisome
localization;fatty acid alpha-oxidation
exp EEF1A1P41 0.222 0.0917 0.603
xai CPSF1 8q24.23 0.222 0.0917 0.603 nuclear mRNA splicing, via
his AAAS 12q13 0.222 0.0917 0.603 hexose transport;transmembrane transport
xai TFDP1 13q34 0.222 0.0917 0.603 Apoptosis
his PBX2 6p21.3 0.222 0.0917 0.603 positive regulation of
transcription from RNA polymerase II promoter;proximal/distal pattern formation
xai KRT37 17q21.2 0.222 0.0917 0.603
his ROM1 11q13 0.222 0.0917 0.603 cell adhesion;visual perception
his EML3 11q12.3 0.222 0.0917 0.603
met CRB3 19p13.3 0.22 0.0917 0.603 cell junction assembly;cell-cell
exp MARK3 14q32.32 0.22 0.0917 0.603
exp RPL13AP13 5q11.2 0.22 0.0917 0.603
exp CNN2P6 3p23 0.22 0.0917 0.603
met PTGS2 1q25.2-q25.3 0.22 0.0917 0.603 prostaglandin metabolic
process;response to fructose stimulus
exp VAPB 20q13.33 -0.22 0.0917 0.603 endoplasmic reticulum unfolded
protein response;small molecule metabolic process
xai FAM3C 7q31 -0.222 0.0917 0.603 multicellular organismal
development
hs4 PLXNB3 Xq28 -0.222 0.0917 0.603 signal
exp MRPL37P1 -0.222 0.0917 0.603
xai TTC23 15q26.3 -0.222 0.0917 0.603
exp LINC00304 16q24.3 -0.222 0.0917 0.603
his LOC105378430 -0.222 0.0917 0.603
xai OBSL1 2q35 -0.222 0.0917 0.603 cardiac myofibril
assembly;cytoskeleton organization
his CDH6 5p13.3 -0.222 0.0917 0.603 cell adhesion;homophilic cell
adhesion
hs4 CDC20B 5q11.2 -0.222 0.0917 0.603
hs4 MIR449A -0.222 0.0917 0.603
hs4 MIR449B -0.222 0.0917 0.603
hs4 MIR449C -0.222 0.0917 0.603
xai WNT6 2q35 0.223 0.0918 0.603 axis specification;epithelial-mesenchymal
cell signaling
exp SNORD105 0.222 0.0918 0.603
xai SNORD105 0.221 0.0918 0.603
his RFXAP 13q14 0.221 0.0918 0.603 positive regulation of transcription,
his SLA2 20q11.23 0.221 0.0918 0.603 negative regulation of
his ARL6IP4 12q24.31 0.221 0.0918 0.603 RNA splicing
exp WDR70 5p13.2 0.22 0.0918 0.603
mut TMEM132D 12q24.33 0.22 0.0918 0.603 negative regulation of
exp GAPDH 12p13 0.22 0.0918 0.603 glucose metabolic process;gluconeogenesis
exp TTTY23 -0.22 0.0918 0.603
xsq ITGB6 2q24.2 -0.22 0.0918 0.603
exp SEPT10P1 8q12.1 -0.221 0.0918 0.603
swa GLB1 3p21.33 -0.222 0.0918 0.603 small molecule metabolic
xai CYP27A1 2q35 -0.222 0.0918 0.603 bile acid metabolic
xai POU1F1 3p11 0.221 0.0919 0.603 regulation of transcription, DNA-
his LOC100996251 0.221 0.0919 0.603
his LRIG2 1p13.1 0.221 0.0919 0.603
his SELPLG 12q24 0.221 0.0919 0.603 leukocyte migration;leukocyte
his MIR4496 0.221 0.0919 0.603
xai FAM175A 4q21.23 0.221 0.0919 0.603 DNA Damage Response (DDR)
xai EEF1A1P41 0.221 0.0919 0.603
swa DDX21 10q21 0.221 0.0919 0.603
his CCDC12 3p21.31 0.221 0.0919 0.603
his NBEAL2 3p21.31 0.221 0.0919 0.603 platelet formation
exp SPCS2 11q13.4 0.22 0.0919 0.603 signal peptide
cop VIT 2p22.2 0.22 0.0919 0.603
cop NOL10 2p25.1 0.22 0.0919 0.603
exp EEF1A1P27 7p21.1 0.22 0.0919 0.603
exp PDLIM1 10q23.1 -0.22 0.0919 0.603 response to oxidative
stress;response to hypoxia
xsq IQCJ-SCHIP1 -0.22 0.0919 0.603
met CLUH 17p13.3 -0.22 0.0919 0.603
xai CTSLP2 -0.221 0.0919 0.603
hs4 LINC00882 -0.221 0.0919 0.603
hs4 DUBR -0.221 0.0919 0.603
xai RARRES3 11q23 -0.221 0.0919 0.603 phospholipid metabolic
his TPM4 19p13.1 0.221 0.092 0.603 cellular component movement;muscle
contraction
xai ZMYM2 13q11-q12 0.221 0.092 0.603 regulation of transcription, DNA-
dependent"
xai METTL1 12q13 0.221 0.092 0.603 tRNA modification
his HCG16 0.221 0.092 0.603
his POTEB2 0.221 0.092 0.603
his TESPA1 12q13.2 0.221 0.092 0.603
xsq EIF4A3 17q25.3 0.22 0.092 0.603 gene expression;nuclear-transcribed
xsq LRIF1 1p13.3 0.219 0.092 0.603 regulation of transcription, DNA-
dependent"
exp ZNF804A 2q32.1 0.219 0.092 0.603
exp DUS2 0.219 0.092 0.603 tRNA processing
xsq MTF2 1p22.1 0.219 0.092 0.603
exp IBA57 1q42.13 0.219 0.092 0.603 glycine catabolic process;heme
xsq CSF3 17q11.2-q12 0.219 0.092 0.603 granulocyte differentiation;immune
response
mut PEAK1 15q24.3 0.219 0.092 0.603
xsq PGGT1B 5q22.3 0.219 0.092 0.603 positive regulation of cell
exp ALPP 2q37 -0.219 0.092 0.603
cop VPS8 3q27.2 -0.219 0.092 0.603
exp FAM73A 1p31.1 -0.219 0.092 0.603
exp NRP1 10p12 -0.22 0.092 0.603 cell adhesion;response to wounding
exp AXL 19q13.1 -0.22 0.092 0.603 Protein Kinases
mda AXL_transcript_expression -0.22 0.092 0.603
his ST6GALNAC5 1p31.1 -0.221 0.092 0.603 protein
glycosylation;glycosphingolipid biosynthetic process
exp KPRP 1q21.3 -0.221 0.092 0.603
hs4 NDRG2 14q11.2 -0.221 0.092 0.603 Wnt receptor signaling pathway;cell
differentiation
hs4 ARHGEF40 14q11.2 -0.221 0.092 0.603 regulation of Rho protein
signal transduction
his MIR3651 0.221 0.0921 0.603
his SNORA84 0.221 0.0921 0.603
his IARS 9q21 0.221 0.0921 0.603 gene expression;tRNA aminoacylation for
protein translation
xai CECR5 0.221 0.0921 0.603 metabolic process
his HEATR3 16q12.1 0.221 0.0921 0.603
DNA-dependent"
mut FCGBP 19q13.1 0.219 0.0921 0.603
xsq ASPDH 19q13.33 0.219 0.0921 0.603 NADP catabolic process;NAD
xsq TSSC2 0.219 0.0921 0.603
xsq CDK2AP2 11q13 0.219 0.0921 0.603
xsq DUS1L 17q25.3 0.219 0.0921 0.603 tRNA processing
xsq DDX39B 6p21.3 0.219 0.0921 0.603 spliceosome assembly;nuclear
mRNA splicing, via spliceosome
cop MIR4261 0.219 0.0921 0.603
cop LGALSL 2p14 0.219 0.0921 0.603
cop AFTPH 2p14 0.219 0.0921 0.603 protein transport
cop MIR4434 0.219 0.0921 0.603
cop LOC339807 0.219 0.0921 0.603
cop SERTAD2 2p14 0.219 0.0921 0.603 negative regulation of cell
growth;positive regulation of transcription, DNA-dependent"
xsq GPR39 2q21-q22 -0.219 0.0921 0.603 G-protein coupled receptor
signaling pathway
met DIABLO 12q24.31 -0.219 0.0921 0.603 Apoptosis
xai COL16A1 1p35-p34 -0.221 0.0921 0.603 cell adhesion;integrin-
his CCDC33 15q24.1 -0.221 0.0921 0.603
xai CLN8 8p23 -0.221 0.0921 0.603 lysosome organization;somatic motor
exp CCT7P1 0.221 0.0922 0.604
xai CD300LF 17q25.1 0.221 0.0922 0.604
exp UBE2N 12q22 0.219 0.0922 0.603 DNA Damage Response (DDR); DDR (TLS)
met OPHN1 Xq12 0.219 0.0922 0.604 substrate-dependent cell migration, cell
extension;filopodium assembly
exp MMGT1 Xq26.3 0.219 0.0922 0.604 transport;magnesium ion transport
xsq FOXB1 15q22.2 0.219 0.0922 0.604 urogenital system
xsq MZT2A 2q21.1 0.219 0.0922 0.604
met CHM Xq21.2 -0.219 0.0922 0.604 protein
geranylgeranylation;response to stimulus
xsq FNDC3B 3q26.31 -0.219 0.0922 0.604
xsq ARHGAP20 11q23.1 -0.219 0.0922 0.604 signal
xsq EGLN1 1q42.1 -0.219 0.0922 0.604 heart trabecula
cop STAG1 3q22.3 -0.219 0.0922 0.603 DNA Damage Response (DDR)
his LOC101927865 -0.221 0.0922 0.604
xai AXL 19q13.1 -0.221 0.0922 0.604 Protein Kinases
xai FAM13C 10q21.1 -0.221 0.0922 0.603
swa HN1 17q25.1 0.221 0.0923 0.604
his ATF1 12q13 0.221 0.0923 0.604 positive regulation of neuron projection
his SCAMP1 5q14.1 0.221 0.0923 0.604 post-Golgi vesicle-mediated
his SCAMP1-AS1 0.221 0.0923 0.604
swa MAGEC1 Xq26 0.221 0.0923 0.604
xai RPS2P4 14q32.33 0.221 0.0923 0.604
his HERC2P7 15q11.2 0.221 0.0923 0.604
his POLR2M 15q21.3 0.221 0.0923 0.604 maintenance of ER location
xai DNPH1 6p21.1 0.221 0.0923 0.604
met NFKB2 10q24 0.219 0.0923 0.604 Apoptosis
xsq RIMS3 1p34.2 0.219 0.0923 0.604 neurotransmitter transport;calcium
ion-dependent exocytosis
xsq NTN4 12q22 -0.219 0.0923 0.604 axon guidance;neuron remodeling
exp APCDD1L 20q13.32 -0.219 0.0923 0.604
exp BDKRB2 14q32.1-q32.2 -0.219 0.0923 0.604 inflammatory
hs4 ADRA1B 5q33.3 -0.221 0.0923 0.604 G-protein coupled
hs4 ALDH3A2 17p11.2 -0.221 0.0923 0.604 cellular aldehyde
metabolic process;oxidation-reduction process
xai HSD17B1 17q11-q21 -0.221 0.0923 0.604 small molecule metabolic
exp CTSLP2 -0.221 0.0923 0.604
his SMARCAL1 2q35 0.221 0.0924 0.604 DNA Damage Response (DDR)
his DPH7 9q34.3 0.221 0.0924 0.604
his RAI1-AS1 0.221 0.0924 0.604
xsq PIDD1 0.219 0.0924 0.604 response to DNA damage stimulus;DNA
arrest
met ZNF831 20q13.32 0.219 0.0924 0.604
met CRISP3 6p12.3 0.219 0.0924 0.604 innate immune
exp KCTD4 13q14.12 -0.219 0.0924 0.604 potassium ion transport
cop C3orf70 3q27.2 -0.219 0.0924 0.604
cop EHHADH-AS1 -0.219 0.0924 0.604
cop EHHADH 3q26.3-q28 -0.219 0.0924 0.604 fatty acid beta-
hs4 DCLK2 4q31.3 -0.221 0.0924 0.604 intracellular signal
transduction
swa DCBLD2 3q12.1 -0.221 0.0924 0.604 intracellular receptor
his SAMSN1-AS1 0.221 0.0925 0.604
his RBBP5 1q32 0.221 0.0925 0.604 regulation of transcription, DNA-
xai IGLC5 0.221 0.0925 0.605
xai UBA52P8 16q12 0.221 0.0925 0.605
exp KIAA1958 9q32 0.219 0.0925 0.604
met CWH43 4p11 0.219 0.0925 0.604 GPI anchor biosynthetic process
xsq AGTPBP1 9q21.33 0.219 0.0925 0.604 proteolysis;neuromuscular
process
xsq YY1 14q 0.219 0.0925 0.605 DNA recombination;cellular response to UV
xsq SBNO1 12q24.31 0.219 0.0925 0.605
mir hsa-miR-152 -0.219 0.0925 0.605
xsq MCAM 11q23.3 -0.219 0.0925 0.605 vascular wound
healing;glomerular filtration
xsq ADAMTS5 21q21.3 -0.219 0.0925 0.604 proteolysis
hs4 CDK15 2q33.2 -0.221 0.0925 0.605 Protein Kinases
xai RAB3GAP1 2q21.3 -0.221 0.0925 0.604 face morphogenesis;brain
development
xai MRPL37P1 -0.221 0.0925 0.604
xai NXF1 11q12-q13 0.221 0.0926 0.605 mRNA export from nucleus;transport
his EDC4 16q22.1 0.221 0.0926 0.605 mRNA metabolic
xai EP400NL 12q24.33 0.221 0.0926 0.605
his GEMIN7 19q13.32 0.221 0.0926 0.605 RNA splicing;gene expression
his ZNF296 19q13.32 0.221 0.0926 0.605 spermatogenesis;regulation of
xsq LARS2 3p21.3 0.219 0.0926 0.605 tRNA aminoacylation for protein
xsq VPS4A 16q22.1 0.219 0.0926 0.605 cellular membrane
xsq PATE2 11q24.2 0.219 0.0926 0.605
met ADAMTSL4 1q21.3 0.219 0.0926 0.605 extracellular matrix
organization;positive regulation of apoptotic process
xsq IKBKAP 9q31 0.219 0.0926 0.605 protein complex assembly;protein
phosphorylation
xsq EXOSC9 4q27 0.219 0.0926 0.605 RNA processing;nuclear
exp FADD 11q13.3 0.219 0.0926 0.605 Apoptosis
mir hsa-miR-575 0.219 0.0926 0.605
xsq ISM2 14q24.3 0.219 0.0926 0.605
cop ST6GAL1 3q27-q28 -0.219 0.0926 0.605 protein modification
exp PARD6G 18q23 -0.219 0.0926 0.605 cell junction assembly;cell-
cop CHN2 7p15.3 -0.219 0.0926 0.605 acrosome assembly;small
hs4 GRIFIN 7p22.3 -0.221 0.0926 0.605
his ABLIM3 5q32 -0.221 0.0926 0.605 cytoskeleton
xai THAP10 15q23 -0.221 0.0926 0.605
hs4 PTPN13 4q21.3 -0.221 0.0926 0.605 protein
swa MYL6 12q13.2 -0.221 0.0926 0.605 muscle contraction;axon
guidance
xai MIRLET7D 0.221 0.0927 0.605
his SAPCD2 9q34.3 0.221 0.0927 0.605
xsq SUV39H1 Xp11.23 0.219 0.0927 0.605 peptidyl-lysine
methylation;chromatin silencing at rDNA
mut LECT1 13q14.3 0.219 0.0927 0.605 negative regulation of vascular
endothelial growth factor receptor signaling pathway;skeletal system development
xsq NARS2 11q14.1 0.219 0.0927 0.605 asparaginyl-tRNA
exp KANSL1 17q21.31 0.219 0.0927 0.605 histone H4-K5
met BAZ2B 2q24.2 0.219 0.0927 0.605 transcription, DNA-
dependent;regulation of transcription, DNA-dependent"
exp TGS1 8q11 0.219 0.0927 0.605 regulation of transcription, DNA-
exp DKFZp667F0711 10p15.1 -0.219 0.0927 0.605
cop MIR4283-1 -0.219 0.0927 0.605
cop MIR4283-2 -0.219 0.0927 0.605
met RASL10A 22q12.2 -0.219 0.0927 0.605 small GTPase mediated
signal transduction;GTP catabolic process
hs4 DPYS 8q22 -0.221 0.0927 0.605 uracil catabolic process;beta-
alanine metabolic process
his BRI3 7q21.3 -0.221 0.0927 0.605
his HCAR2 12q24.31 -0.221 0.0927 0.605 neutrophil
apoptosis;apoptotic process
exp MIR7-3HG 19p13.3 0.221 0.0928 0.605
his JARID2 6p24-p23 0.221 0.0928 0.605 multicellular organismal
development;stem cell differentiation
his JARID2-AS1 0.221 0.0928 0.605
swa EIF4A3 17q25.3 0.221 0.0928 0.605 gene expression;nuclear-
swa RBBP7 Xp22.2 0.221 0.0928 0.605 nucleosome assembly;regulation of
pro EP300_19_40603 0.219 0.0928 0.605
cop RAET1G 6q24.1-q25.1 0.219 0.0928 0.605 immune response;antigen
xsq RGSL1 1q25 0.219 0.0928 0.605 termination of G-protein coupled receptor
signaling pathway
met LTBR 12p13 0.219 0.0928 0.605 Apoptosis
xsq KREMEN2 16p13.3 0.219 0.0928 0.605 Wnt receptor signaling
pathway
xsq NSMCE4A 10q26.13 0.219 0.0928 0.605 DNA Damage Response (DDR);
DDR (HR)
exp PHB 17q21 0.219 0.0928 0.605 Apoptosis
xsq HACE1 6q16.3 0.219 0.0928 0.605 protein ubiquitination;Rac protein
signal transduction
exp ITGAX 16p11.2 -0.219 0.0928 0.605 leukocyte migration;defense
response to virus
xsq PDP1 8q22.1 -0.219 0.0928 0.605 pyruvate metabolic
hs4 NT5E 6q14-q21 -0.221 0.0928 0.605 dephosphorylation;purine base
metabolic process
his SETDB1 1q21 0.221 0.0929 0.605 regulation of transcription, DNA-
his SCNN1B 16p12.2-p12.1 0.221 0.0929 0.605 ion transport;sodium ion
transport
xai NARS 18q21.31 0.221 0.0929 0.605 tRNA aminoacylation for protein
hs4 ADGRB3 0.221 0.0929 0.605 G-protein coupled receptor
hs4 LOC101928307 0.221 0.0929 0.605
xai APEX2 Xp11.21 0.221 0.0929 0.605 DNA Damage Response (DDR); DDR
(BER)
xai SART1 11q13.1 0.221 0.0929 0.605 Apoptosis
xai USP45 6q16.2 0.221 0.0929 0.606 proteolysis;ubiquitin-dependent
xsq JAGN1 3p25.2 0.219 0.0929 0.605
xsq RFESD 5q15 0.219 0.0929 0.605
exp MCEE 2p13.3 0.219 0.0929 0.605 fatty acid beta-oxidation;short-
exp CCDC43 17q21.31 0.219 0.0929 0.605
exp AP1AR 4q25 0.219 0.0929 0.606 protein transport
exp KLHDC8B 3p21.31 -0.219 0.0929 0.606
xsq PPP1R42 8q13.1 -0.219 0.0929 0.605
cop WIPF3 7p14.3 -0.219 0.0929 0.605 multicellular organismal
cop RASAL2 1q24 -0.219 0.0929 0.605 signal transduction;positive
xai SOD3 4p15.2 -0.221 0.0929 0.606 removal of superoxide
swa LRRC59 17q21.33 -0.221 0.0929 0.605
hs4 TICRR 15q26.1 0.221 0.093 0.606 DDR (DNA replication)
dependent"
hs4 ECEL1 2q37.1 0.221 0.093 0.606 proteolysis;neuropeptide signaling
pathway
met ZNF98 19p12 0.219 0.093 0.606 regulation of transcription, DNA-dependent"
pro PTPN6 12p13 0.219 0.093 0.606 Apoptosis
met CAMSAP3 19p13.2 0.219 0.093 0.606 microtubule anchoring;zonula
adherens maintenance
exp JAGN1 3p25.2 0.219 0.093 0.606
exp LOC100131831 19p13.13 -0.219 0.093 0.606
exp DMBX1 1p33 -0.219 0.093 0.606 negative regulation of transcription,
DNA-dependent;developmental growth
exp FAM127A Xq26 -0.219 0.093 0.606
exp FTH1P10 5p15.1 -0.219 0.093 0.606
his MIR7855 -0.221 0.093 0.606
met C2orf72 2q37.1 0.221 0.0931 0.606
his GPR162 12p13 0.221 0.0931 0.606
xai BAG1 9p12 0.221 0.0931 0.606 Apoptosis
xai SEC31B 10q24.31 0.221 0.0931 0.606 protein transport;vesicle-
mediated transport
hs4 SH2D2A 1q21 0.221 0.0931 0.606 multicellular organismal
met FAM131A 3q27.1 0.219 0.0931 0.606
exp TRMT13 1p21.2 0.219 0.0931 0.606
met AKR1C8P 0.219 0.0931 0.606
xsq UBE2G2 21q22.3 0.219 0.0931 0.606 ubiquitin-dependent protein
exp NUDT3 6p21.2 0.219 0.0931 0.606 diadenosine polyphosphate catabolic
met HNRNPU-AS1 1q44 -0.219 0.0931 0.606
his HILS1 17q21.33 -0.221 0.0931 0.606 germ cell
his RRAD 16q22 -0.221 0.0931 0.606 GTP catabolic process;signal
transduction
hs4 SEC14L2 22q12.2 -0.221 0.0931 0.606 regulation of
dependent"
hs4 ARHGEF10 8p23 -0.221 0.0931 0.606 myelination in peripheral
nervous system;positive regulation of GTP catabolic process
xai PROSER2 10p14 -0.221 0.0931 0.606
xai EVC 4p16 -0.221 0.0931 0.606 muscle organ development;positive
xai C21orf33 21q22.3 0.221 0.0932 0.606
xai GALM 2p22.1 0.221 0.0932 0.606 carbohydrate metabolic
process;hexose metabolic process
his LOC101927157 0.221 0.0932 0.606
his NFXL1 4p12 0.221 0.0932 0.606
his LUZP6 7q33 0.221 0.0932 0.606
his MTPN 0.221 0.0932 0.606 cerebellar granule cell
differentiation;neuron differentiation
cop MIR4291 0.219 0.0932 0.606
xsq METTL17 14q11.2 0.219 0.0932 0.606 translation
met TP53INP1 8q22 0.219 0.0932 0.606 apoptotic process;induction of
apoptosis
exp LATS1 6q25.1 0.219 0.0932 0.606 G2/M transition of mitotic cell
met HRH1 3p25 0.219 0.0932 0.606 synaptic transmission;response to gravity
cop IQGAP1 15q26.1 0.219 0.0932 0.606 energy reserve metabolic
xsq ANP32D 12q13.11 0.219 0.0932 0.606
cop ULBP2 6q25 0.219 0.0932 0.606 antigen processing and
cop RAET1K 6q25.1 0.219 0.0932 0.606
cop RAET1L 6q25.1 0.219 0.0932 0.606 immune response;antigen
met PTGR2 14q24.3 0.219 0.0932 0.606 prostaglandin metabolic process
met POU3F4 Xq21.1 0.219 0.0932 0.606 cochlea
morphogenesis;negative regulation of mesenchymal cell apoptosis
exp LOC613266 -0.219 0.0932 0.606
cop SCRN1 7p14.3-p14.1 -0.219 0.0932 0.606 proteolysis;exocytosis
cop PRR15 7p14.3 -0.219 0.0932 0.606 multicellular organismal
development
cop LOC646762 7p14.3 -0.219 0.0932 0.606
cop MIR550A3 -0.219 0.0932 0.606
cop ZNRF2P2 -0.219 0.0932 0.606
cop DPY19L2P3 7p15.1 -0.219 0.0932 0.606
xsq SMPX Xp22.1 -0.219 0.0932 0.606 striated muscle contraction
exp LOC100507022 -0.221 0.0932 0.606
xai LOC100130931 -0.221 0.0932 0.606
xai DLEU7-AS1 0.221 0.0933 0.606
xai HCN3 1q22 0.22 0.0933 0.606 ion transport;potassium ion transport
xai RPS3AP12 1p13.3-p13.1 0.22 0.0933 0.606
xsq UGT3A2 5p13.2 0.219 0.0933 0.606 metabolic process
cop MBOAT2 2p25.1 0.219 0.0933 0.606 phospholipid biosynthetic
process
xsq ECRP 14q11.2 0.219 0.0933 0.606
cop PPME1 11q13.4 0.219 0.0933 0.606 protein demethylation
xsq DBP 19q13.3 0.219 0.0933 0.606 regulation of cell
exp NONO Xq13.1 0.219 0.0933 0.606 DNA repair;DNA recombination
xsq NBR2 17q21 0.219 0.0933 0.606
xsq DOCK5 8p21.2 -0.219 0.0933 0.606
met MIR455 -0.219 0.0933 0.606
dephosphorylation
cop MIR4424 -0.219 0.0933 0.606
hs4 RAB15 14q23.3 -0.22 0.0933 0.606 small GTPase mediated signal
xai RNF185 22q12.2 -0.221 0.0933 0.606 autophagy
his IGF2BP1 17q21.32 0.22 0.0934 0.606 RNA localization;regulation
of mRNA stability involved in response to stress
xai IER2 19p13.2 0.22 0.0934 0.606
his PTPRD-AS2 0.22 0.0934 0.607
his CEP295 0.22 0.0934 0.607
xai TEX19 17q25.3 0.22 0.0934 0.607
met MIER2 19p13.3 0.219 0.0934 0.606 regulation of transcription, DNA-
dependent"
xsq C12orf60 12p12.3 0.219 0.0934 0.606
met ZNF20 19p13.2 0.219 0.0934 0.606
xsq S100A12 1q21 0.219 0.0934 0.607 killing of cells of other
xsq LZTS3 20p13 -0.219 0.0934 0.607
xsq ANXA9 1q21 -0.219 0.0934 0.606 cell-cell adhesion
cop SLC26A7 8q23 -0.219 0.0934 0.606 Solute Carriers
his OSGEP 14q11.2 0.22 0.0935 0.607 proteolysis;tRNA processing
his APEX1 14q11.2 0.22 0.0935 0.607 DNA Damage Response (DDR); DDR
(BER)
dependent"
xai ZFP36L2 2p22.3-p21 0.22 0.0935 0.607 nuclear-transcribed mRNA
dependent
his AFG3L1P 16q24.3 0.22 0.0935 0.607
his CENPBD1 16q24.3 0.22 0.0935 0.607 regulation of transcription,
DNA-dependent"
his SNRPA1 15q26.3 0.22 0.0935 0.607 RNA splicing;gene expression
xai HIST1H2AJ 6p22.1 0.22 0.0935 0.607
xsq SETD8 12q24.31 0.219 0.0935 0.607
exp PSMD12P 3p14 0.218 0.0935 0.607
exp USP38 0.218 0.0935 0.607 proteolysis;ubiquitin-dependent protein
catabolic process
mut CDKN2A 9p21 0.218 0.0935 0.607 Apoptosis; DNA Damage Response
(DDR); DDR (DNA replication); Protein Kinases; Tumor Suppressors
xsq HNRNPA3 2q31.2 0.218 0.0935 0.607 nuclear mRNA splicing, via
xsq PHLDB2 3q13.2 -0.218 0.0935 0.607
exp MTERF2 -0.219 0.0935 0.607 regulation of transcription,
DNA-dependent;transcription, DNA-dependent"
xsq FADS3 11q12-q13.1 -0.219 0.0935 0.607 electron transport
swa RAB6A 11q13.3 -0.22 0.0935 0.607 peptidyl-cysteine
exp LOC100130931 -0.22 0.0935 0.607
exp MTND4P2 0.22 0.0936 0.607
xai RAPGEF6 5q31.1 0.22 0.0936 0.607 signal transduction;Ras
xai PHB 17q21 0.22 0.0936 0.607 Apoptosis
xai CYP11B2 8q21-q22 0.22 0.0936 0.607 xenobiotic metabolic
process;sodium ion homeostasis
xai USPL1 13q12-q14 0.22 0.0936 0.607 ubiquitin-dependent protein
catabolic process
xai FYB 5p13.1 0.22 0.0936 0.607 protein phosphorylation;NLS-bearing
substrate import into nucleus
xai JSRP1 19p13.3 0.22 0.0936 0.607
xsq NOP58 2q33.1 0.218 0.0936 0.607 rRNA processing;snRNP protein
import into nucleus
met RUNDC3B 7q21.12 0.218 0.0936 0.607
xsq CA9 9p13.3 -0.218 0.0936 0.607 secretion;morphogenesis of an
epithelium
his GNAT3 7q21.11 -0.22 0.0936 0.607 GTP catabolic process;G-protein
hs4 RALGPS2 1q25.2 -0.22 0.0936 0.607 small GTPase mediated signal
transduction
exp LOC100240734 0.22 0.0937 0.607
xai MTND4P2 0.22 0.0937 0.607
swa DFFA 1p36.3-p36.2 0.22 0.0937 0.607 Apoptosis
hs4 PPP6R3 11q13 0.22 0.0937 0.607 DNA Damage Response (DDR)
xai RPS20P14 3q27.3 0.22 0.0937 0.607
xai SF3A1 22q12.2 0.22 0.0937 0.607 gene expression;nuclear mRNA 3'-
splice site recognition
his C2orf42 2p13.3 0.22 0.0937 0.607
xsq METTL1 12q13 0.218 0.0937 0.607 tRNA modification
xsq RCC2 1p36.13 0.218 0.0937 0.607 M phase of mitotic cell
exp FAM175A 4q21.23 0.218 0.0937 0.607 DNA Damage Response (DDR)
cop PPP1R14C 6q24.3-q25.3 0.218 0.0937 0.607 regulation of
phosphorylation
cop FKBP14 7p14.3 -0.218 0.0937 0.607 protein
folding;activation of signaling protein activity involved in unfolded protein
response
cop PLEKHA8 7p21-p11.2 -0.218 0.0937 0.607 protein transport
cop MTURN -0.218 0.0937 0.607
xsq RHPN2 19q13.11 -0.218 0.0937 0.607 signal transduction
exp LOC100127978 12q13.11 -0.218 0.0937 0.607
xai RRBP1 20p12 -0.22 0.0937 0.607 protein transport;translation
his LTBP2 14q24 -0.22 0.0937 0.607 protein targeting;transforming growth
his TULP3 12p13.3 -0.22 0.0937 0.607 regulation of transcription, DNA-
dependent;G-protein coupled receptor signaling pathway
xai CASQ2 1p13.1 -0.22 0.0937 0.607 striated muscle contraction;heart
development
swa CASP8 2q33-q34 0.22 0.0938 0.607 Apoptosis
his BOLA1 1q21 0.22 0.0938 0.607
his HECTD4 12q24.13 0.22 0.0938 0.608
exp GAPDHP66 18p11.31 0.22 0.0938 0.608
met TSPAN14 10q23.1 0.218 0.0938 0.607
met PPEF2 4q21.1 0.218 0.0938 0.607 regulation of MAP kinase
activity;negative regulation of MAPK cascade
xsq MLLT6 17q21 0.218 0.0938 0.608 regulation of transcription, DNA-
dependent"
exp LOC148413 1p36.33 0.218 0.0938 0.608
xsq DKFZP434K028 11q12.2 0.218 0.0938 0.608
cop KCNA6 12p13 0.218 0.0938 0.608 ion transport;potassium ion transport
exp GPR45 2q11.1-q12 -0.218 0.0938 0.608
xsq BMPR1B 4q22-q24 -0.218 0.0938 0.608 skeletal system
xai HSPB1P2 Xp11.23 -0.22 0.0938 0.607
his LINC01622 -0.22 0.0938 0.607
hs4 PCDHB18P -0.22 0.0938 0.607 cell adhesion;homophilic cell
adhesion
his C1orf195 -0.22 0.0938 0.607
his TMEM204 16p13.3 0.22 0.0939 0.608 lymph vessel
hs4 NPY 7p15.1 0.22 0.0939 0.608 G-protein signaling, coupled to
xai GLI4 8q24.3 0.22 0.0939 0.608
exp MIR99B 0.22 0.0939 0.608
swa FNTA 8p11 0.22 0.0939 0.608 transforming growth factor beta receptor
signaling pathway;protein farnesylation
xai NAPSB 19q13.33 0.22 0.0939 0.608
xai AP1AR 4q25 0.22 0.0939 0.608 protein transport
his MRPS23 17q22-q23 0.22 0.0939 0.608 translation
swa LXN 3q25.32 0.22 0.0939 0.608 negative regulation of
endopeptidase activity;detection of temperature stimulus involved in sensory
perception of pain
xsq BRCAT107 0.218 0.0939 0.608
cop LOC339788 0.218 0.0939 0.608
xsq CHTF18 16p13.3 0.218 0.0939 0.608 DDR (DNA replication)
exp ORM1 9q32 0.218 0.0939 0.608 regulation of immune system
process;transport
DNA-dependent"
xsq SEPHS2 16p11.2 0.218 0.0939 0.608 selenocysteine biosynthetic
process
xsq C19orf33 19q13.2 -0.218 0.0939 0.608
hs4 FBLN1 22q13.31 -0.22 0.0939 0.608 embryo implantation;extracellular
matrix organization
exp VN1R28P -0.22 0.0939 0.608
his VPS36 13q14.3 0.22 0.094 0.608 regulation of transcription, DNA-
dependent;protein transport
his CKAP2 13q14 0.22 0.094 0.608 Apoptosis
xai MIR99B 0.22 0.094 0.608
xai LINC00926 15q21.3 0.22 0.094 0.608
xai ACAP3 0.22 0.094 0.608 filopodium assembly;signal transduction
xsq LINC00703 0.218 0.094 0.608
xsq FMO6P 1q24.3 0.218 0.094 0.608
exp NDC80 18p11.32 0.218 0.094 0.608 attachment of spindle microtubules to
kinetochore;establishment of mitotic spindle orientation
exp CD300LF 17q25.1 0.218 0.094 0.608
xsq C10orf10 10q11.21 -0.218 0.094 0.608
xsq GPRC5B 16p12 -0.218 0.094 0.608
xsq BNC2 9p22.2 -0.218 0.094 0.608 regulation of transcription, DNA-
dependent"
cop AQP1 7p14 -0.218 0.094 0.608 cell volume homeostasis;establishment or
maintenance of actin cytoskeleton polarity
met PRDM7 16q24.3 -0.218 0.094 0.608 chromatin modification;regulation
his ZNF341-AS1 -0.22 0.094 0.608
his CHMP4B 20q11.22 -0.22 0.094 0.608 protein transport;cellular membrane
organization
xai TSEN34 19q13.4 -0.22 0.094 0.608 tRNA-type intron splice site
recognition and cleavage;mRNA processing
hs4 AFDN -0.22 0.094 0.608
hs4 AFDN-AS1 -0.22 0.094 0.608
xai UBE2NL Xq27.3 0.22 0.0941 0.608 DNA Damage Response (DDR)
hs4 CIDEB 14q12 0.22 0.0941 0.608 apoptotic process;induction of apoptosis
hs4 LTB4R2 14q12 0.22 0.0941 0.608 chemotaxis;signal transduction
hs4 LTB4R 14q11.2-q12 0.22 0.0941 0.608 cellular component movement;muscle
contraction
his SOX18 20q13.33 0.22 0.0941 0.608 angiogenesis;outflow tract
morphogenesis
his ZNF280C Xq26.1 0.22 0.0941 0.608 regulation of transcription,
DNA-dependent"
xai EP400 12q24.33 0.22 0.0941 0.608 regulation of transcription, DNA-
xai BCL2L10 15q21 0.22 0.0941 0.608 Apoptosis
exp RETN 19p13.2 0.218 0.0941 0.608 response to insulin stimulus;fat
cop GOT2 16q21 0.218 0.0941 0.608 2-oxoglutarate metabolic
xsq LINC01480 0.218 0.0941 0.608
cop WWOX 16q23 0.218 0.0941 0.608 positive regulation of apoptotic
xsq ZNF143 11p15.4 0.218 0.0941 0.608 gene expression;regulation of
xsq LINC00851 0.218 0.0941 0.608
met OR2C1 16p13.3 0.218 0.0941 0.608
cop KCNA1 12p13.32 0.218 0.0941 0.608 potassium ion transport;synaptic
transmission
cop KCNA5 12p13 0.218 0.0941 0.608 protein oligomerization;reduction of
exp CHRAC1 8q24.3 0.218 0.0941 0.608 DNA Damage Response (DDR);
DDR (Chromatin)
cop DAPK2 15q22.31 0.218 0.0941 0.608 Apoptosis
exp CHUK 10q24-q25 0.218 0.0941 0.608 Apoptosis; Protein Kinases
xsq SNCG 10q23.2-q23.3 -0.218 0.0941 0.608 regulation of dopamine
secretion;regulation of neurotransmitter secretion
xsq MPZL1 1q24.2 -0.218 0.0941 0.608 transmembrane receptor
protein tyrosine kinase signaling pathway;cell-cell signaling
exp IQCE 7p22.3 -0.218 0.0941 0.608
xsq FLVCR2 14q24.3 -0.218 0.0941 0.608 heme
xai KLF7 2q32 -0.22 0.0941 0.608 regulation of transcription from RNA
his NRXN3 14q31 -0.22 0.0941 0.608 angiogenesis;cell adhesion
xai HPS3 3q24 -0.22 0.0941 0.608 organelle organization;pigmentation
xai TMEM169 2q35 -0.22 0.0941 0.608
exp CERS3 15q26.3 0.22 0.0942 0.608 sphingolipid metabolic
his COG2 1q42.2 0.22 0.0942 0.608 protein glycosylation;intracellular
protein transport
xai RGS2 1q31 0.22 0.0942 0.608 negative regulation of phospholipase
activity;positive regulation of cardiac muscle contraction
xai SALL4 20q13.2 0.22 0.0942 0.608 DNA Damage Response (DDR)
his FBXW9 19p13.2 0.22 0.0942 0.608
his MIR339 0.22 0.0942 0.608
xsq GEMIN8 Xp22.2 0.218 0.0942 0.608 RNA splicing;spliceosomal
snRNP assembly
xsq ALG6 1p31.3 0.218 0.0942 0.608 protein N-linked
exp HSD17B6 12q13 0.218 0.0942 0.608 androgen catabolic process;steroid
metabolic process
xsq RGMA 15q26.1 0.218 0.0942 0.608 axon guidance
exp RPS28P7 11q14.1 0.218 0.0942 0.608
xsq FAM120AOS 9q22.31 0.218 0.0942 0.608
xsq FANCD2 3p26 0.218 0.0942 0.608 DNA Damage Response (DDR); DDR (FA)
cop CCDC129 7p14.3 -0.218 0.0942 0.608
xsq KLHDC8B 3p21.31 -0.218 0.0942 0.608
exp HLA-B 6p21.3 -0.218 0.0942 0.608 antigen processing and
presentation of peptide antigen via MHC class I;regulation of interleukin-12
production
mir hsa-let-7a -0.218 0.0942 0.608
mir hsa-let-7a(2) -0.218 0.0942 0.608
mir hsa-let-7a(3) -0.218 0.0942 0.608
xai CA10 17q21.33 -0.22 0.0942 0.608 brain development
his ENC1 5q13 -0.22 0.0942 0.608 nervous system development;multicellular
his TMEM174 5q13.2 -0.22 0.0942 0.608
his SSBP3 1p32.3 0.22 0.0943 0.608 prechordal plate
his VPS4A 16q22.1 0.22 0.0943 0.608 cellular membrane
his RPL10A 6p21.31 0.22 0.0943 0.609 translational
his MIR7111 0.22 0.0943 0.609
xsq DENND6A 3p14.3 0.218 0.0943 0.608
exp IGLON5 19q13.41 0.218 0.0943 0.608
exp MRPL54 19p13.3 0.218 0.0943 0.608
cop RAB35 12q24.31 0.218 0.0943 0.608 endosome transport;cytokinesis
exp GSPT1 16p13.1 0.218 0.0943 0.608 G1/S transition of mitotic cell
exp GSPT2 Xp11.22 0.218 0.0943 0.608 translational termination;cell
cycle
xsq LOC653712 3q21.3 0.218 0.0943 0.609
xsq CP 3q23-q25 -0.218 0.0943 0.608 cellular iron ion
xsq MANSC1 12p13.2 -0.218 0.0943 0.608
xai VN1R28P -0.22 0.0943 0.608
his TXN2 22q13.1 0.22 0.0944 0.609 response to nutrient;response to
axon injury
exp OR10AA1P 1q23.1 0.22 0.0944 0.609
his EPHB6 7q33-q35 0.22 0.0944 0.609 Cell Signaling
his SART3 12q24.1 0.22 0.0944 0.609 RNA processing
his ISCU 12q24.1 0.22 0.0944 0.609 nitrogen fixation;iron-sulfur
cluster assembly
hs4 RALGDS 9q34.3 0.22 0.0944 0.609 Ras protein signal
his EDC3 15q24.1 0.22 0.0944 0.609 RNA metabolic process;mRNA
metabolic process
his IGHV1OR15-1 15q11.2 0.22 0.0944 0.609 immune response
xsq LOC100505530 0.218 0.0944 0.609
met NOS1AP 1q23.3 0.218 0.0944 0.609 regulation of apoptotic
xsq FYB 5p13.1 0.218 0.0944 0.609 protein phosphorylation;NLS-bearing
xsq NUDT5 10p14 0.218 0.0944 0.609 nucleobase-containing compound metabolic
exp RGS2 1q31 0.218 0.0944 0.609 negative regulation of phospholipase
exp IDH1-AS1 0.218 0.0944 0.609
cop NAV1 1q32.3 -0.218 0.0944 0.609 microtubule bundle
formation;neuron migration
cop GHRHR 7p14 -0.218 0.0944 0.609 determination of adult
lifespan;positive regulation of multicellular organism growth
met PSMA8 18q11.2 -0.218 0.0944 0.609 antigen processing and
xsq RTP3 3p21.3 -0.218 0.0944 0.609 detection of chemical
stimulus involved in sensory perception of bitter taste;protein targeting to
membrane
hs4 TMEM67 8q22.1 -0.22 0.0944 0.609 cilium assembly;branching
his AOC4P 17q21.31 -0.22 0.0944 0.609
xai PLSCR1 3q23 -0.22 0.0944 0.609 apoptotic process;positive
his TLR7 Xp22.3 0.22 0.0945 0.609 microglial cell activation involved
xai RRN3P1 0.22 0.0945 0.609
hs4 SV2C 5q13.3 0.22 0.0945 0.609 neurotransmitter transport
hs4 FAM86FP 12p13.31 0.22 0.0945 0.609
exp UBA52P8 16q12 0.22 0.0945 0.609
met EDN1 6p24.1 0.218 0.0945 0.609 negative regulation of
pathway
cop SIRT4 12q 0.218 0.0945 0.609 protein ADP-ribosylation;protein
deacetylation
DNA-dependent"
met RTP4 3q27.3 0.218 0.0945 0.609 protein targeting to
taste
met SLCO3A1 15q26 0.218 0.0945 0.609 Solute Carriers
met TMEM45A 3q12.2 0.218 0.0945 0.609
met CTSV 9q22.2 0.218 0.0945 0.609
cop FBXO5 6q25.2 0.218 0.0945 0.609 G1/S transition of mitotic cell
cop MTRF1L 6q25-q26 0.218 0.0945 0.609 translational termination
cop METTL11B 1q24.2 -0.218 0.0945 0.609
cop MIR3119-2 -0.218 0.0945 0.609
cop MIR3119-1 -0.218 0.0945 0.609
hs4 RUNDC3B 7q21.12 -0.22 0.0945 0.609
hs4 COMMD7 20q11.21 -0.22 0.0945 0.609 negative regulation of NF-
kappaB transcription factor activity;tumor necrosis factor-mediated signaling
pathway
hs4 FCHSD1 5q31.3 -0.22 0.0945 0.609
his PAQR5 15q23 -0.22 0.0945 0.609 multicellular organismal development;cell
differentiation
his MIR1302-7 -0.22 0.0945 0.609
xai CTSZ 20q13.32 -0.22 0.0945 0.609 proteolysis;epithelial tube
branching involved in lung morphogenesis
exp PKDREJ 22q13.31 0.22 0.0946 0.609 ion transport;neuropeptide
signaling pathway
xai LOC100240734 0.22 0.0946 0.609
xai OOEP 6q13 0.22 0.0946 0.609 establishment or maintenance of
apical/basal cell polarity;cellular protein complex assembly
his JMJD7 0.22 0.0946 0.609
his JMJD7-PLA2G4B 15q11.2-q21.3 0.22 0.0946 0.609
hs4 ZNF385D-AS1 0.22 0.0946 0.609
xsq ESPL1 12q 0.218 0.0946 0.609 Apoptosis
xsq ZBTB48 1p36.3 0.218 0.0946 0.609 regulation of transcription,
DNA-dependent"
xsq XPO1 2p15 0.218 0.0946 0.609 Apoptosis
exp CNOT8 5q31-q33 0.218 0.0946 0.609 gene expression;RNA metabolic
process
exp DPAGT1 11q23.3 0.218 0.0946 0.609 dolichol biosynthetic
process;post-translational protein modification
met DDB2 11p12-p11 -0.218 0.0946 0.609 DNA Damage Response (DDR);
DDR (NER); DDR (DNA replication)
cop POU6F2-AS1 -0.218 0.0946 0.609
cop YAE1D1 7p14.1 -0.218 0.0946 0.609
cop LOC646999 7p14.1 -0.218 0.0946 0.609
cop RALA 7p15-p13 -0.218 0.0946 0.609 interspecies interaction
between organisms;cytokinesis
cop LINC00265 7p14.1 -0.218 0.0946 0.609
mir hsa-miR-205 -0.218 0.0946 0.609
exp CAPNS1 19q13.12 -0.218 0.0946 0.609 proteolysis;metabolic
process
xsq BLVRB 19q13.1-q13.2 -0.218 0.0946 0.609 small molecule metabolic
exp BMPR1B 4q22-q24 -0.218 0.0946 0.609 skeletal system
met MDM4 1q32 -0.218 0.0946 0.609 Apoptosis; DNA Damage Response
(DDR)
hs4 PRDM6 5q23.2 -0.22 0.0946 0.609 chromatin modification;neurogenesis
xai CLDN8 21q22.11 -0.22 0.0946 0.609 calcium-independent cell-cell
adhesion
xai PTGIS 20q13.13 -0.22 0.0946 0.609 prostaglandin biosynthetic
swa RPN2 20q12-q13.1 -0.22 0.0946 0.609 translation;protein modification
process
his C16orf59 16p13.3 0.22 0.0947 0.609
his BSPRY 9q32 0.22 0.0947 0.609 EMT (Epithelial)
his POTEB 0.22 0.0947 0.609
his KRTAP10-3 0.22 0.0947 0.609
exp XXYLT1-AS2 0.22 0.0947 0.609
his WDR59 16q23.1 0.22 0.0947 0.609
xsq FAM209B 20q13.31 0.218 0.0947 0.609
xsq AMZ2P1 17q24.1 0.218 0.0947 0.609
exp SAMD10 20q13.33 0.218 0.0947 0.609
exp NEK4 3p21.1 0.218 0.0947 0.609 cell division;protein
phosphorylation
xsq RPL13 16q24.3 0.218 0.0947 0.609 gene expression;viral reproduction
xsq LOC100128531 -0.218 0.0947 0.609
xsq PRR16 5q23.1 -0.218 0.0947 0.609
exp B4GALT4 3q13.3 -0.218 0.0947 0.609 post-translational
protein modification;cellular protein metabolic process
hs4 WNT2 7q31.2 -0.22 0.0947 0.609 Apoptosis; Oncogenes
his CACNA1F Xp11.23 0.22 0.0948 0.609 visual perception;dendrite
morphogenesis
his CCDC22 Xp11.23 0.22 0.0948 0.609
swa NOL7 6p23 0.22 0.0948 0.609
his CEACAM21 19q13.2 0.22 0.0948 0.609
xai XXYLT1-AS2 0.22 0.0948 0.609
exp EDARADD 1q42.3 0.22 0.0948 0.609 hair follicle
xai WISP2 20q13.12 0.22 0.0948 0.609 Oncogenes
met FLJ35024 0.218 0.0948 0.609
xsq NLRP14 11p15.4 0.218 0.0948 0.609 cell
met OR2G6 1q44 0.218 0.0948 0.609
exp COX11P1 6p23-p22 0.218 0.0948 0.609
xsq CASP3 4q34 0.218 0.0948 0.609 Apoptosis
mut CDO1 5q23.2 0.218 0.0948 0.609 sulfur amino acid metabolic
mut MVP 16p11.2 0.218 0.0948 0.609 DNA Damage Response (DDR)
xsq RHOBTB3 5q15 -0.218 0.0948 0.609 ATP catabolic
process;transport
exp EPB41L4A-AS2 -0.218 0.0948 0.609
exp LRIG3 12q14.1 -0.218 0.0948 0.609
exp CCDC146 7q11.23 -0.218 0.0948 0.609
exp LOC642487 3p14.1 -0.218 0.0948 0.609
xsq PSEN2 1q42.13 -0.218 0.0948 0.609 Apoptosis
exp DCDC2 6p22.1 -0.218 0.0948 0.609 cellular defense
xai MDGA1 6p21 -0.22 0.0948 0.609 neuron migration;multicellular organismal
development
xai MYO3B 2q31.1-q31.2 -0.22 0.0948 0.609 visual perception;response to
stimulus
his LOC101929457 -0.22 0.0948 0.609
xai CHUK 10q24-q25 0.219 0.0949 0.609 Apoptosis; Protein Kinases
xai LINC01096 0.219 0.0949 0.609
xai KCNA5 12p13 0.219 0.0949 0.609 protein oligomerization;reduction of
xai ATP6V0A2 12q24.31 0.219 0.0949 0.609 immune response;insulin
xai SMARCD2 17q23.3 0.219 0.0949 0.609 nucleosome
exp FBXO15 18q22.3 0.218 0.0949 0.609
xsq GTF2H2C_2 0.218 0.0949 0.609
exp TUBE1 6q21 0.218 0.0949 0.609 microtubule-based movement;centrosome
cycle
xsq MTRNR2L8 -0.218 0.0949 0.609
exp TMEM217 6p21.2 -0.218 0.0949 0.609
met C9orf84 9q31.3 -0.218 0.0949 0.609
exp SORT1 1p13.3 -0.218 0.0949 0.609 transport;regulation of gene
expression
met SLCO4A1 20q13.33 -0.218 0.0949 0.609 Solute Carriers
xsq RAB11FIP4 17q11.2 -0.218 0.0949 0.609 cytokinesis;transport
his SORBS2 4q35.1 -0.219 0.0949 0.609
his MIR3165 -0.219 0.0949 0.609
his ADAMTS14 10q21 -0.219 0.0949 0.609 proteolysis;collagen
catabolic process
xai RARRES2 7q36.1 -0.219 0.0949 0.609 retinoid metabolic
his AKR1B15 -0.219 0.0949 0.609
xai HTR4 5q31-q33 0.219 0.095 0.609 G-protein coupled receptor signaling
pathway;G-protein signaling, coupled to cyclic nucleotide second messenger
his EMC7 15q14 0.219 0.095 0.609
his PGBD4 15q14 0.219 0.095 0.609
exp EMC8 16q24 0.218 0.095 0.609
met IL1RAPL2 Xq22 0.218 0.095 0.609 signal transduction;central nervous
system development
xsq RPL19P12 0.218 0.095 0.61
exp POLR2G 11q13.1 0.218 0.095 0.61 DNA Damage Response (DDR); DDR
(NER)
exp SPSB2 12p13.31 0.218 0.095 0.61 intracellular signal transduction
xsq LPXN 11q12.1 0.218 0.095 0.61 negative regulation of B cell receptor
signaling pathway;protein complex assembly
xsq ESX1 Xq22.1 0.218 0.095 0.61 labyrinthine layer blood vessel
exp OGFRL1 6q13 -0.218 0.095 0.61
exp CACNA2D3 3p21.1 -0.218 0.095 0.61 ion transport
DNA-dependent"
xsq SAMHD1 20pter-q12 -0.218 0.095 0.609 DNA Damage Response (DDR)
met MMP23A 1p36.33 -0.218 0.095 0.609 Apoptosis
hs4 FABP7 6q22-q23 -0.219 0.095 0.61 nervous system development;negative
hs4 MIR125B1 -0.219 0.095 0.609
hs4 GPR161 1q24.2 -0.219 0.095 0.609 multicellular organismal
development
xai LGALS1 22q13.1 -0.219 0.095 0.609 Apoptosis
xai LIG1 19q13.2-q13.3 0.219 0.0951 0.61 DNA Damage Response (DDR);
DNA-dependent;meiosis"
xai HBG1 0.219 0.0951 0.61 transport;blood coagulation
his NFAM1 22q13.2 0.219 0.0951 0.61 regulation of B cell
xai DPH7 9q34.3 0.219 0.0951 0.61
exp HBG1 0.219 0.0951 0.61 transport;blood coagulation
xai MS4A4A 11q12 0.219 0.0951 0.61
hs4 MACROD1 11q11 0.219 0.0951 0.61 purine nucleoside metabolic process
hs4 SPATA32 17q21.31 0.219 0.0951 0.61
his REPIN1 7q36.1 0.219 0.0951 0.61 DNA replication
DNA-dependent"
xai MRPL12 17q25 0.219 0.0951 0.61 transcription from mitochondrial
met IRF2BPL 14q24.3 0.217 0.0951 0.61
exp CD24P2 15q21.3 0.217 0.0951 0.61
exp EIF3FP3 2p16.1 0.217 0.0951 0.61
met FCRLA 1q23.3 0.217 0.0951 0.61 cell differentiation
exp AKNA 9q32 0.217 0.0951 0.61 regulation of transcription, DNA-
dependent"
met VAMP3 1p36.23 0.217 0.0951 0.61 protein complex assembly;retrograde
cop IYD 6q25.1 0.217 0.0951 0.61 thyroid hormone generation;cellular
cop FAM96A 15q22.31 0.217 0.0951 0.61 chromosome segregation
xsq SYCP3 12q 0.217 0.0951 0.61 cell division;cell cycle
xsq GLDC 9p22 -0.217 0.0951 0.61 cellular amino acid metabolic
exp BAIAP2L1 7q22.1 -0.217 0.0951 0.61 response to
exp SIPA1L2 1q42.2 -0.217 0.0951 0.61 regulation of small
cop HECW1 7p13 -0.217 0.0951 0.61 protein modification
process
hs4 NEURL1B 5q35.1 -0.219 0.0951 0.61
xai LINC00304 16q24.3 -0.219 0.0951 0.61
xai LRRN4CL 11q12.3 -0.219 0.0951 0.61
xai RXRA 9q34.3 -0.219 0.0951 0.61 female pregnancy;virus-host
interaction
xai SIRT5 6p23 0.219 0.0952 0.61 chromatin silencing;protein ADP-
ribosylation
his MIR3975 0.219 0.0952 0.61
exp RCOR2 11q13.1 0.219 0.0952 0.61 negative regulation of
xai YARS 1p35.1 0.219 0.0952 0.61 Apoptosis
xai WBP11 12p12.3 0.219 0.0952 0.61 rRNA processing;mRNA processing
hs4 CD2 1p13.1 0.219 0.0952 0.61 blood coagulation;cell-cell
adhesion
his WASF1 6q21 0.219 0.0952 0.61 protein complex assembly;cellular
component movement
his CDC40 6q21 0.219 0.0952 0.61 gene expression;mRNA 3'-end processing
cop PARD6G 18q23 0.217 0.0952 0.61 cell junction assembly;cell-cell
xsq SKP2 5p13 0.217 0.0952 0.61 G1/S transition of mitotic cell
catabolic process
exp PHC1 12p13 0.217 0.0952 0.61 multicellular organismal development
exp MAPRE3 2p23.3-p23.1 -0.217 0.0952 0.61 cell division;cell
cycle
mut KRTAP1-5 17q21.2 -0.217 0.0952 0.61
xai MEDAG 13q12.3 -0.219 0.0952 0.61
his CENPW 6q22.32 0.219 0.0953 0.61 chromosome segregation;centromeric
core chromatin assembly
his NADK 1p36.33 0.219 0.0953 0.61 vitamin metabolic process;water-
xai PI3 20q13.12 0.219 0.0953 0.61 copulation;negative regulation of
DNA-dependent"
exp GINS2 16q24.1 0.217 0.0953 0.61 DDR (DNA replication)
xsq CPB1 3q24 0.217 0.0953 0.61 proteolysis
met FRK 6q21-q22.3 0.217 0.0953 0.61 negative regulation of cell
proliferation;cell differentiation
xsq TSPEAR-AS1 0.217 0.0953 0.61
xsq THUMPD2 2p22.1 0.217 0.0953 0.61
cop HCAR2 12q24.31 0.217 0.0953 0.61 neutrophil apoptosis;apoptotic
process
cop HCAR3 12q24.31 0.217 0.0953 0.61 G-protein coupled receptor
signaling pathway
exp C2CD4B 15q22.2 0.217 0.0953 0.61
cop PELO 5q11.2 -0.217 0.0953 0.61 cell cycle;cell proliferation
cop KIFAP3 1q24.2 -0.217 0.0953 0.61 negative regulation of
cell proliferation;positive regulation of calcium-dependent cell-cell adhesion
met CATSPER2P1 15q15.3 -0.217 0.0953 0.61
exp SSPN 12p11.2 -0.217 0.0953 0.61 muscle contraction;cell
adhesion
met CNPY1 7q36.3 -0.217 0.0953 0.61
exp OR2J2 -0.219 0.0953 0.61 response to stimulus
hs4 ZNF365 10q21.2 -0.219 0.0953 0.61
hs4 LOC283045 -0.219 0.0953 0.61
swa LAMTOR5 1p13.3 -0.219 0.0953 0.61
xai LOC100507022 -0.219 0.0953 0.61
xai MYOM2 8p23.3 0.219 0.0954 0.61 muscle contraction
his PABPC4L 4q28.3 0.219 0.0954 0.61
his LCN10 9q34.3 0.219 0.0954 0.61 transport
exp GAPT 5q11.2 0.217 0.0954 0.61 B cell activation
exp ZMYM2 13q11-q12 0.217 0.0954 0.61 regulation of transcription, DNA-
dependent"
met MIR1229 -0.217 0.0954 0.61
exp UGT2B27P 4q13 -0.217 0.0954 0.61
his LOC100130331 1q43 -0.219 0.0954 0.61
xai OR2J2 -0.219 0.0954 0.61 response to stimulus
xai KIAA1191 5q35.2 -0.219 0.0954 0.61
xai DGKZ 11p11.2 0.219 0.0955 0.61 negative regulation of mitotic cell
cycle;negative regulation of Ras protein signal transduction
xai FAM96A 15q22.31 0.219 0.0955 0.61 chromosome segregation
his OSCAR 19q13.42 0.219 0.0955 0.61
his NDUFA3 19q13.42 0.219 0.0955 0.61 mitochondrial electron
his BANF1 11q13.1 0.219 0.0955 0.61 provirus integration;initiation of
viral infection
his EIF1AD 11q13.1 0.219 0.0955 0.61
his CST6 11q13 0.219 0.0955 0.61 epidermis development;anatomical
his NFKBID 19q13.12 0.219 0.0955 0.61 positive regulation of
thymocyte apoptosis;inflammatory response
his HCST 19q13.1 0.219 0.0955 0.61 regulation of immune response
his TYROBP 19q13.1 0.219 0.0955 0.61 cellular defense
his FGF14-IT1 0.219 0.0955 0.61
his FGF14-AS2 13q33.1 0.219 0.0955 0.61
his NDUFA5 7q31.33 0.219 0.0955 0.61 mitochondrial electron
xai TPI1P1 1p31.1 0.219 0.0955 0.61
xai LATS1 6q25.1 0.219 0.0955 0.61 G2/M transition of mitotic cell
swa BYSL 6p21.1 0.219 0.0955 0.61 cell adhesion;female pregnancy
met FAM221A 7p15.3 0.217 0.0955 0.61
met CYP4F2 19p13.12 0.217 0.0955 0.61 drug metabolic process;sodium
ion homeostasis
cop TMEM150A 2p11.2 0.217 0.0955 0.61 catabolic process
cop CMTR2 0.217 0.0955 0.61
cop NTF3 12p13 0.217 0.0955 0.61 neuromuscular synaptic
xsq MRPS21 1q21 0.217 0.0955 0.61 translation
exp PALB2 16p12.2 0.217 0.0955 0.61 DNA Damage Response (DDR); DDR (FA)
met TTI2 8p12 -0.217 0.0955 0.61 DNA Damage Response (DDR)
exp MOB3C 1p33 -0.217 0.0955 0.61
exp LTBR 12p13 -0.217 0.0955 0.61 Apoptosis
hs4 TRPS1 8q24.12 -0.219 0.0955 0.61 skeletal system
exp FN3K 17q25.3 -0.219 0.0955 0.61 fructoselysine metabolic
process
cop PSG2 19q13.1-q13.2 -0.219 0.0955 0.61 cell migration;female
pregnancy
hs4 ROR1 1p32-p31 -0.219 0.0955 0.61 transmembrane receptor
his RAD51-AS1 0.219 0.0956 0.61
his RAD51 15q15.1 0.219 0.0956 0.61 DNA Damage Response (DDR); DDR (FA)
exp ERVFC1-1 0.219 0.0956 0.611
hs4 RPS16P5 6p12.1 0.219 0.0956 0.611
xsq PGK1 Xq13.3 0.217 0.0956 0.61 glucose metabolic
xsq CCR5 3p21.31 0.217 0.0956 0.611 calcium ion transport;cell-cell
signaling
xsq LOC100288911 2p22.3 -0.217 0.0956 0.611
cop AGMO 7p21.2 -0.217 0.0956 0.611 fatty acid biosynthetic
process;membrane lipid metabolic process
exp GLB1L 2q35 -0.217 0.0956 0.61 carbohydrate metabolic process
exp PLEKHM1 17q21.31 -0.217 0.0956 0.61 intracellular signal
transduction
xai KRCC1 2p11.2 -0.219 0.0956 0.611
xai NLGN4X Xp22.33 -0.219 0.0956 0.611 social behavior;cell-
his GADD45GIP1 19p13.2 0.219 0.0957 0.611 cell cycle;interspecies
his LOC105376736 0.219 0.0957 0.611
his EXOSC10 1p36.22 0.219 0.0957 0.611 CUT catabolic
his ELP2 18q12.2 0.219 0.0957 0.611 regulation of transcription from
xai UBE2E1 3p24.2 0.219 0.0957 0.611 mitotic cell cycle spindle
xai TOR3A 1q25.2 0.219 0.0957 0.611 chaperone mediated protein folding
requiring cofactor
his RASSF2 20p13 0.219 0.0957 0.611 cell cycle;signal transduction
his ARMC8 3q22.3 0.219 0.0957 0.611
mut PPFIBP2 11p15.4 0.217 0.0957 0.611 cell communication;DNA
integration
xsq LOC200726 0.217 0.0957 0.611
met BPGM 7q33 0.217 0.0957 0.611 carbohydrate metabolic process;glycolysis
xsq SERPINB12 18q21.33 0.217 0.0957 0.611
exp USP15 12q14 0.217 0.0957 0.611 proteolysis;ubiquitin-dependent protein
catabolic process
exp TMED9 5q35.3 -0.217 0.0957 0.611 Golgi organization;positive
his MIR3945HG -0.219 0.0957 0.611
xai TSPAN1 1p34.1 -0.219 0.0957 0.611
exp OR1AB1P 19p13.12 -0.219 0.0957 0.611
xai ARAP3 5q31.3 -0.219 0.0957 0.611 regulation of cell
shape;vesicle-mediated transport
his MIR4713 0.219 0.0958 0.611
his CYP19A1 15q21.1 0.219 0.0958 0.611 male gonad
development;hippocampus development
xai KEL 7q33 0.219 0.0958 0.611 proteolysis;vasoconstriction
his LOC101929726 0.219 0.0958 0.611
exp RBMY2QP Yp11.2 0.219 0.0958 0.611
cop CX3CL1 16q13 0.217 0.0958 0.611 defense response;positive
cop CCL17 16q13 0.217 0.0958 0.611 chemotaxis;inflammatory response
cop CIAPIN1 16q21 0.217 0.0958 0.611 apoptotic process;anti-apoptosis
cop COQ9 16q21 0.217 0.0958 0.611 ubiquinone biosynthetic process
cop POLR2C 16q13-q21 0.217 0.0958 0.611 DNA Damage Response (DDR);
DDR (NER)
cop DOK4 16q21 0.217 0.0958 0.611 MAPK cascade;transmembrane receptor
cop CCDC102A 16q21 0.217 0.0958 0.611
cop GPR114 16q21 0.217 0.0958 0.611
exp RPL26P19 5q11.2 0.217 0.0958 0.611
xsq MPHOSPH8 13q12.11 0.217 0.0958 0.611 cell cycle;regulation of DNA
methylation
xsq DEFA3 8p23.1 0.217 0.0958 0.611 killing of cells of other
exp U2AF2 19q13.42 0.217 0.0958 0.611 mRNA export from nucleus;RNA
splicing
xsq RARRES3 11q23 -0.217 0.0958 0.611 phospholipid metabolic
xai PPP1R3C 10q23-q24 -0.219 0.0958 0.611 carbohydrate metabolic
his CACNA2D3 3p21.1 -0.219 0.0958 0.611 ion transport
DNA-dependent"
his AVEN 15q13.1 0.219 0.0959 0.611 Apoptosis
exp LOC157740 0.219 0.0959 0.611
exp DNM3-IT1 0.219 0.0959 0.611
xai PPP1R15B 1q32.1 0.219 0.0959 0.611 dephosphorylation;response to
hydrogen peroxide
hs4 METTL4 18p11.32 0.219 0.0959 0.611 nucleobase-containing
hs4 NDC80 18p11.32 0.219 0.0959 0.611 attachment of spindle microtubules
xai AHCYP4 2q22.1 0.219 0.0959 0.611
xsq SPSB4 3q23 0.217 0.0959 0.611 intracellular signal transduction
met KLHDC9 1q23.3 0.217 0.0959 0.611
met KLHL10 17q21.2 0.217 0.0959 0.611
met RNF13 3q25.1 0.217 0.0959 0.611 protein autoubiquitination
exp CLUH 17p13.3 0.217 0.0959 0.611
exp PPM1D 17q23.2 0.217 0.0959 0.611 DNA Damage Response (DDR)
met MRGPRX4 11p15.1 0.217 0.0959 0.611
exp IGBP1P2 17q22 0.217 0.0959 0.611
cop ABRA 8q23.1 -0.217 0.0959 0.611
xsq DVL3 3q27 -0.217 0.0959 0.611 Wnt receptor signaling pathway;Wnt
xsq CYP27A1 2q35 -0.217 0.0959 0.611 bile acid metabolic
exp TBC1D3 17q12 -0.217 0.0959 0.611
xai OR1AB1P 19p13.12 -0.219 0.0959 0.611
hs4 TTPAL 20q13.12 -0.219 0.0959 0.611
xai NUDC 1p35-p34 0.219 0.096 0.611 mitotic cell cycle;cytokinesis
his PACSIN1 6p21.3 0.219 0.096 0.611 endocytosis;cytoskeleton
organization
his QSER1 11p13 0.219 0.096 0.611
exp TYROBP 19q13.1 0.217 0.096 0.611 cellular defense response;signal
transduction
xsq LOC91450 15q24.3 0.217 0.096 0.611
met MIR1224 0.217 0.096 0.611
exp CECR5 0.217 0.096 0.611 metabolic process
cop PCCB 3q21-q22 -0.217 0.096 0.611 fatty acid beta-oxidation;short-
xsq ABCC6P1 16p12.3 -0.217 0.096 0.611
xsq LAMA4 6q21 -0.217 0.096 0.611 regulation of embryonic development;brown
fat cell differentiation
exp LOC646976 1q25.2 -0.217 0.096 0.611
cop CYCS 7p15.3 -0.217 0.096 0.611 Apoptosis
cop C7orf31 7p15.3 -0.217 0.096 0.611
cop NPVF 7p21-p15 -0.217 0.096 0.611 neuropeptide signaling
pathway;sensory perception of pain
exp FAM83D 20q11.23 -0.217 0.096 0.611 cell division;cell cycle
xai B4GALT4 3q13.3 -0.219 0.096 0.611 post-translational protein
his LINC00861 0.219 0.0961 0.611
his CLK1 2q33 0.219 0.0961 0.611 cell proliferation;peptidyl-serine
phosphorylation
xai OTUD6B 8q21.3 0.219 0.0961 0.612
his C15orf40 15q25.2 0.219 0.0961 0.612
xai GINS2 16q24.1 0.219 0.0961 0.612 DDR (DNA replication)
met MLLT4-AS1 6q27 0.217 0.0961 0.612
xsq OR5AK4P 0.217 0.0961 0.612
met FAM46D Xq21.1 0.217 0.0961 0.612
exp C7orf26 7p22.1 0.217 0.0961 0.612
met CHID1 11p15.5 -0.217 0.0961 0.612 innate immune
response;carbohydrate metabolic process
exp NUDT12 5q21.2 -0.217 0.0961 0.612 NADP catabolic
process;NAD catabolic process
cop MIR5708 -0.217 0.0961 0.612
cop ZBTB10 8q13-q21.1 -0.217 0.0961 0.612 negative regulation of
dependent"
cop SCYL3 1q24.2 -0.217 0.0961 0.611 cell migration
xai PSMC1P12 1p12 -0.219 0.0961 0.612
xai S100A6 1q21 -0.219 0.0961 0.611 positive regulation of
fibroblast proliferation;signal transduction
xai PHC1 12p13 0.219 0.0962 0.612 multicellular organismal development
his RPS15 19p13.3 0.219 0.0962 0.612 ribosomal small subunit export from
his RPSA 3p22.2 0.219 0.0962 0.612 translational elongation;viral
infectious cycle
his SNORA6 0.219 0.0962 0.612
his SNORA62 3p22.1 0.219 0.0962 0.612
hs4 POLR3GL 1q21.1 0.219 0.0962 0.612 transcription from RNA
hs4 ANKRD34A 1q21.1 0.219 0.0962 0.612
xai MOB1A 2p13.1 0.219 0.0962 0.612 hippo signaling cascade
swa IFITM1 11p15.5 0.219 0.0962 0.612 response to virus;cytokine-
exp CYCSP20 7q32.1 0.219 0.0962 0.612
his PIDD1 0.219 0.0962 0.612 response to DNA damage stimulus;DNA
arrest
his RPLP2 11p15.5 0.219 0.0962 0.612 translation;mRNA metabolic process
his SNORA52 0.219 0.0962 0.612
xsq POLR2J 7q22.1 0.217 0.0962 0.612 DNA Damage Response (DDR);
DDR (NER)
mut POGZ 1q21.3 0.217 0.0962 0.612 regulation of transcription, DNA-
xsq DNAJC3-AS1 13q32.1 0.217 0.0962 0.612
xsq EDRF1 0.217 0.0962 0.612 regulation of transcription, DNA-
dependent"
exp KCTD19 16q22.1 0.217 0.0962 0.612 potassium ion transport
xsq SNORA64 0.217 0.0962 0.612
xsq PCGF1 2p13.1 0.217 0.0962 0.612 regulation of transcription, DNA-
dependent;histone H2A monoubiquitination"
xsq TBC1D10B 16p11.2 0.217 0.0962 0.612 positive regulation of Rab
cop FXR1 3q28 -0.217 0.0962 0.612 Apoptosis
exp LINC00592 -0.217 0.0962 0.612
xsq NACAD 7p13 -0.217 0.0962 0.612 protein transport
exp ZFYVE26 14q24.1 -0.217 0.0962 0.612 double-strand break
repair via homologous recombination;cytokinesis
hs4 ESR1 6q25.1 -0.219 0.0962 0.612 androgen metabolic
process;negative regulation of sequence-specific DNA binding transcription factor
activity
hs4 MIR125B2 -0.219 0.0962 0.612
hs4 TTC28 22q12.1 -0.219 0.0962 0.612
xai SGSH 17q25.3 -0.219 0.0962 0.612 proteoglycan metabolic
process
his KCNMB2-AS1 0.219 0.0963 0.612
his MAZ 16p11.2 0.219 0.0963 0.612 regulation of transcription, DNA-
his PRRT2 16p11.2 0.219 0.0963 0.612 response to biotic stimulus
xai UBE2D3 4q24 0.219 0.0963 0.612 protein modification
his GLO1 6p21.3-p21.1 0.219 0.0963 0.612 Apoptosis
cop VPS33B 15q26.1 0.217 0.0963 0.612 protein transport;vesicle-
mediated transport
xsq NOL8 9q22.31 0.217 0.0963 0.612 DNA replication;rRNA processing
xsq MTFR2 6q23.3 0.217 0.0963 0.612
exp LINC00996 0.217 0.0963 0.612
met CUL5 11q22.3 0.217 0.0963 0.612 Apoptosis; DNA Damage Response
(DDR); DDR (NER)
xsq FAM120C Xp11.22 0.217 0.0963 0.612
xsq ABCG1 21q22.3 0.217 0.0963 0.612 ABC Transporters
xsq C18orf61 0.217 0.0963 0.612
cop STK3 8q22.2 -0.217 0.0963 0.612 Apoptosis
exp ERLIN2 8p11.2 -0.217 0.0963 0.612 ER-associated protein
catabolic process
cop PARP8 5q11.1 -0.217 0.0963 0.612
exp DYNC1LI2 16q22.1 -0.217 0.0963 0.612 transport
his ELDR -0.219 0.0963 0.612
hs4 HMCN1 1q25.3-q31.1 -0.219 0.0963 0.612 visual
perception;response to stimulus
xai MAGED1 Xp11.23 -0.219 0.0963 0.612 regulation of
transcription, DNA-dependent;apoptotic process
xai FZD2 17q21.1 -0.219 0.0963 0.612 axonogenesis;epithelial cell
differentiation
xai GYS1 19q13.3 -0.219 0.0963 0.612 small molecule metabolic
his TFAP4 16p13 0.219 0.0964 0.612 protein complex assembly;positive
exp KCNH6 17q23.3 0.218 0.0964 0.612 potassium ion transport;signal
transduction
his LOC101928000 0.218 0.0964 0.612
hs4 CXCR4 2q21 0.218 0.0964 0.612 activation of MAPK activity;viral
reproduction
cop EFR3B 2p23.3 0.217 0.0964 0.612
exp PMS2P5 7q11.23 0.217 0.0964 0.612 DNA Damage Response (DDR)
xsq CEACAM18 19q13.41 0.217 0.0964 0.612
xsq CCDC51 3p21.31 0.217 0.0964 0.612
met SURF4 9q34.2 0.217 0.0964 0.612 Golgi organization;positive
xsq NRG4 15q24.2 0.217 0.0964 0.612
xsq TFAP2A 6p24 -0.217 0.0964 0.612 optic vesicle
met RFPL1S 22q12 -0.217 0.0964 0.612
cop SNX16 8q21.13 -0.217 0.0964 0.612 protein targeting to
exp OBSL1 2q35 -0.217 0.0964 0.612 cardiac myofibril
assembly;cytoskeleton organization
xsq NOTCH2 1p13-p11 -0.217 0.0964 0.612 Apoptosis; Tumor
Suppressors
his CXCL14 5q31 -0.218 0.0964 0.612 chemotaxis;immune response
his C15orf54 15q14 -0.218 0.0964 0.612
xai MCC 5q21 -0.219 0.0964 0.612 signal transduction;negative
regulation of epithelial cell migration
hs4 STK3 8q22.2 -0.219 0.0964 0.612 Apoptosis
hs4 PON1 7q21.3 0.218 0.0965 0.612 positive regulation of transporter
swa EXOSC8 13q13.1 0.218 0.0965 0.612 mRNA metabolic
hs4 FANCE 6p22-p21 0.218 0.0965 0.612 DNA Damage Response (DDR); DDR (FA)
swa GLOD4 17p13.3 0.218 0.0965 0.612
exp RPS11P1 20p12.2 0.218 0.0965 0.612
hs4 GPR63 6q16.1-q16.3 0.218 0.0965 0.612
xsq FASTKD5 0.217 0.0965 0.612 cellular respiration
xsq C21orf33 21q22.3 0.217 0.0965 0.612
mut PHKG2 16p11.2 -0.217 0.0965 0.612 glycogen metabolic
his MIR8086 -0.218 0.0965 0.612
his MPP7 10p12.1 -0.218 0.0965 0.612 protein localization to
adherens junction;positive regulation of signal transduction
exp DTX2 7q11.23 -0.218 0.0965 0.612 Notch signaling pathway
xai ZFP57 6p22.1 -0.218 0.0965 0.612 DNA methylation involved in
embryo development;regulation of gene expression by genetic imprinting
his MIR378F -0.218 0.0965 0.612
his ABCC6 16p13.1 -0.218 0.0965 0.612 ABC Transporters
his LTN1 21q22.11 0.218 0.0966 0.612 protein autoubiquitination
xai U2AF2 19q13.42 0.218 0.0966 0.613 mRNA export from nucleus;RNA
splicing
his DUS1L 17q25.3 0.218 0.0966 0.613 tRNA processing
xsq GSPT1 16p13.1 0.217 0.0966 0.612 G1/S transition of mitotic cell
exp SMIM10L2A 0.217 0.0966 0.612
xsq RHPN1-AS1 8q24 0.216 0.0966 0.613
exp KAZN 1p36.21 -0.216 0.0966 0.613 keratinization
exp MT1DP 16q13 -0.218 0.0966 0.612
exp RPS10P18 10q26 -0.218 0.0966 0.612
hs4 ERCC6L Xq13.1 0.218 0.0967 0.613 mitotic prometaphase;mitotic
cell cycle
his AIMP1 4q24 0.218 0.0967 0.613 glucose metabolic process;response to
wounding
his TBCK 4q24 0.218 0.0967 0.613 protein phosphorylation
xai ASCL1 12q23.2 0.218 0.0967 0.613 noradrenergic neuron fate
commitment;spinal cord oligodendrocyte cell fate specification
his SH2B2 7q22 0.218 0.0967 0.613 signal transduction;blood coagulation
xai CLEC12A 12p13.2 0.218 0.0967 0.613
his TMEM126A 11q14.1 0.218 0.0967 0.613 optic nerve development
his CYB5R1 1q32.1 0.218 0.0967 0.613 sterol biosynthetic process
xai MPLKIP 7p14.1 0.218 0.0967 0.613 DNA Damage Response (DDR)
xsq PDF 16q22.1 0.216 0.0967 0.613 translation;positive regulation of
cell proliferation
xsq GPR141 7p14.1 0.216 0.0967 0.613 G-protein coupled receptor
signaling pathway
xsq EIF3J 15q21.1 0.216 0.0967 0.613 translation;translational
initiation
xsq CEACAM5 19q13.1-q13.2 0.216 0.0967 0.613
met TNK1 17p13.1 0.216 0.0967 0.613 protein autophosphorylation;protein
phosphorylation
exp VEZF1 17q22 -0.216 0.0967 0.613 transcription from RNA polymerase
II promoter;cellular defense response
xsq PLEKHF1 19q12 -0.216 0.0967 0.613 apoptotic process
exp PDZK1 1q21 -0.216 0.0967 0.613 transport;cell proliferation
exp ENDOU 12q13.1 -0.216 0.0967 0.613 female pregnancy;proteolysis
xsq TRIL 7p14.3 -0.216 0.0967 0.613 innate immune
response;regulation of cytokine production involved in immune response
his VNN3 6q23.2 -0.218 0.0967 0.613 nitrogen compound metabolic
process
xai RPS10P18 10q26 -0.218 0.0967 0.613
xai LOC100288897 0.218 0.0968 0.613
exp AGBL4 1p33 0.218 0.0968 0.613 C-terminal protein
deglutamylation;protein side chain deglutamylation
his ST6GALNAC6 9q34.11 0.218 0.0968 0.613 glycosylceramide metabolic
his MIR4659A 0.218 0.0968 0.613
his MIR4659B 0.218 0.0968 0.613
his EBPL 13q12-q13 0.218 0.0968 0.613 sterol metabolic process
his SNORD140 0.218 0.0968 0.613
cop PHF10 6q27 0.216 0.0968 0.613 regulation of transcription, DNA-
dependent;nervous system development"
cop TCTE3 6q27 0.216 0.0968 0.613 transport
cop ERMARD 0.216 0.0968 0.613
cop LINC00242 6q27 0.216 0.0968 0.613
cop LINC00574 6q27 0.216 0.0968 0.613
met NPPB 1p36.2 0.216 0.0968 0.613 cell surface receptor signaling
pathway;positive regulation of urine volume
mut CILP 15q22 0.216 0.0968 0.613 negative regulation of insulin-like
xsq ADRA1B 5q33.3 -0.216 0.0968 0.613 G-protein coupled
xsq SEPT10 2q13 -0.216 0.0968 0.613 cell cycle;cell division
xsq EXT2 11p12-p11 -0.216 0.0968 0.613 ossification;mesoderm
formation
xai GLRA2 Xp22.2 -0.218 0.0968 0.613 ion transport;neuropeptide
signaling pathway
swa UBXN1 11q12.3 0.218 0.0969 0.613 negative regulation of protein
ubiquitination;negative regulation of proteasomal ubiquitin-dependent protein
catabolic process
his PANX3 11q24.2 0.218 0.0969 0.613 cell-cell signaling;protein
hexamerization
xai KIRREL2 19q13.12 0.218 0.0969 0.613 cell adhesion
his LOC101929353 0.218 0.0969 0.613
his DDIT4L 4q24 0.218 0.0969 0.613 negative regulation of signal
transduction
xai TEX15 8p12 0.218 0.0969 0.613 regulation of double-strand break repair
xai CLDN14 21q22.3 0.218 0.0969 0.613 cell junction assembly;cell-
swa PPP2R4 9q34 0.218 0.0969 0.613 Apoptosis
his PPP6R2 22q13.33 0.218 0.0969 0.613 DNA Damage Response (DDR)
exp APEX2 Xp11.21 0.216 0.0969 0.613 DNA Damage Response (DDR); DDR
(BER)
exp NAA10 Xq28 0.216 0.0969 0.613 N-terminal protein amino acid
xsq TIGD3 11q13.1 0.216 0.0969 0.613 regulation of transcription, DNA-
dependent"
dependent"
xsq RBM6 3p21.3 0.216 0.0969 0.613 RNA processing
xsq NPFF 12q13.13 0.216 0.0969 0.613 neuropeptide signaling
cop M1AP 2p13.1 0.216 0.0969 0.613
cop SEMA4F 2p13.1 0.216 0.0969 0.613 cell differentiation;negative
regulation of axon extension
cop DNAJC19 3q26.33 -0.216 0.0969 0.613 protein folding;protein
targeting to mitochondrion
exp PSG1 19q13.2 -0.216 0.0969 0.613 female pregnancy
mut MMP25 16p13.3 -0.216 0.0969 0.613 proteolysis;inflammatory
response
xai APOBEC3F 22q13.1 -0.218 0.0969 0.613 negative regulation of
retroviral genome replication;positive regulation of defense response to virus by
host
his CCDC126 7p15.3 -0.218 0.0969 0.613
his SOX13 1q32 -0.218 0.0969 0.613 regulation of transcription, DNA-
xai B9D1 17p11.2 -0.218 0.0969 0.613 smoothened signaling
pathway;cell projection organization
hs4 NAPA 19q13.33 -0.218 0.0969 0.613 post-Golgi vesicle-mediated
transport;apical protein localization
his SPDYC 11q13.1 0.218 0.097 0.613 cell cycle
his PWP2 21q22.3 0.218 0.097 0.613 signal transduction
exp KIR2DL1 0.218 0.097 0.613 natural killer cell inhibitory signaling
pathway;immune response
xai LOC387810 0.218 0.097 0.613
exp SNORD8 0.218 0.097 0.613
xai SNORD8 0.218 0.097 0.613
xai RBL2 16q12.2 0.218 0.097 0.613 G1 phase of mitotic cell cycle;mitotic
cell cycle
swa AKR1C3 10p15-p14 0.218 0.097 0.613 G-protein coupled receptor
signaling pathway;antibiotic metabolic process
xsq TMEM161B 5q14.3 0.216 0.097 0.613
met LAMA3 18q11.2 0.216 0.097 0.613 regulation of cell adhesion;regulation of
cell migration
xsq KRTAP10-10 0.216 0.097 0.613
exp NSMCE1 16p12.1 0.216 0.097 0.613 DNA Damage Response (DDR); DDR (HR)
xsq RHOXF1 Xq24 0.216 0.097 0.613
met COL4A1 13q34 0.216 0.097 0.613 epithelial cell differentiation;cellular
response to amino acid stimulus
met MYH13 17p13 0.216 0.097 0.613 muscle contraction;cellular response to
starvation
cop ADIPOQ -0.216 0.097 0.613
cop ADIPOQ-AS1 -0.216 0.097 0.613
met EMB 5q11.1 -0.216 0.097 0.613 cell adhesion
exp GMPPA 2q35 -0.216 0.097 0.613 post-translational protein
xsq OBSL1 2q35 -0.216 0.097 0.613 cardiac myofibril assembly;cytoskeleton
organization
cop IMPA1 8q21.13-q21.3 -0.216 0.097 0.613 phosphatidylinositol
biosynthetic process;phosphate-containing compound metabolic process
xsq SNRK-AS1 -0.216 0.097 0.613
his FKBP9 7p11.1 -0.218 0.097 0.613 protein peptidyl-prolyl
his EHD4 15q11.1 -0.218 0.097 0.613 regulation of endocytosis;endocytic
recycling
his PLA2G4E-AS1 -0.218 0.097 0.613
his AMOT Xq23 -0.218 0.097 0.613 regulation of cell migration;positive
his NAA10 Xq28 0.218 0.0971 0.613 N-terminal protein amino acid
exp CLCA4 1p31-p22 0.218 0.0971 0.613 transport;chloride transport
his TNNI3 19q13.4 0.218 0.0971 0.613 regulation of smooth muscle
dependent"
DNA-dependent"
his CCDC106 19q13.42 0.218 0.0971 0.613
his TOR1A 9q34 0.218 0.0971 0.613 protein folding;response to unfolded
protein
xai SEPHS1P6 2q33.1 0.218 0.0971 0.613
met BRSK2 11p15.5 0.216 0.0971 0.613 protein phosphorylation;nervous
system development
exp DPY19L2P3 7p15.1 0.216 0.0971 0.613
exp DDX39B 6p21.3 0.216 0.0971 0.613 spliceosome assembly;nuclear
exp RPL36P18 Xq23 0.216 0.0971 0.613
xsq ANKRD62P1-PARP4P3 0.216 0.0971 0.613
cop TMEM247 2p21 0.216 0.0971 0.613
cop ATP6V1E2 2p21 0.216 0.0971 0.613 cellular iron ion
cop RHOQ 2p21 0.216 0.0971 0.613 insulin receptor signaling
pathway;positive regulation of filopodium assembly
cop ROCK1P1 18p11.32 0.216 0.0971 0.613
exp FAM110C 2p25.3 -0.216 0.0971 0.613
exp WFDC21P -0.216 0.0971 0.613
cop DGKB 7p21.2 -0.216 0.0971 0.613 platelet
activation;intracellular signal transduction
exp AGPAT3 21q22.3 -0.216 0.0971 0.613 metabolic
met THEM5 1q21.3 -0.216 0.0971 0.613
his COX6A2 16p11.12 -0.218 0.0971 0.613 generation of precursor
metabolites and energy
xai THAP8 19q13.12 -0.218 0.0971 0.613
xai TMEM263 -0.218 0.0971 0.613
hs4 CLIC5 6p12.3 -0.218 0.0971 0.613 ion transport;chloride
transport
xai SERTAD1 19q13.1-q13.2 -0.218 0.0971 0.613 regulation of
cyclin-dependent protein kinase activity;positive regulation of cell proliferation
xai KNOP1 16p12.3 0.218 0.0972 0.613
xai ENOX2 Xq25 0.218 0.0972 0.613 transport;ultradian rhythm
xsq GCFC2 2p12 0.216 0.0972 0.613 regulation of transcription, DNA-
dependent"
cop SMYD5 2p13.2 0.216 0.0972 0.613
cop PRADC1 2p13.2 0.216 0.0972 0.613
cop CCT7 2p13.2 0.216 0.0972 0.613 protein folding;cellular protein
metabolic process
cop FBXO41 2p13.2 0.216 0.0972 0.613
cop EGR4 2p13 0.216 0.0972 0.613 regulation of transcription, DNA-
cop ALMS1 2p13 0.216 0.0972 0.613 sensory perception of sound;epithelial
cell proliferation
cop NAT8 2p13.2 0.216 0.0972 0.613 gastrulation with mouth forming
second;multicellular organismal development
cop ALMS1P 2p13.1 0.216 0.0972 0.613
cop NAT8B 2p13.1 0.216 0.0972 0.613 gastrulation with mouth forming
cop TPRKB 2p24.3-p24.1 0.216 0.0972 0.613 protein catabolic process
cop DUSP11 2p13.1 0.216 0.0972 0.613 RNA processing;peptidyl-
cop C2orf78 2p13.1 0.216 0.0972 0.613
cop STAMBP 2p13.1 0.216 0.0972 0.613 proteolysis;anti-apoptosis
cop ACTG2 2p13.1 0.216 0.0972 0.613 muscle contraction
cop DGUOK 2p13 0.216 0.0972 0.613 nucleotide biosynthetic process;negative
cop TET3 2p13.1 0.216 0.0972 0.613
cop BOLA3 2p13.1 0.216 0.0972 0.613
cop BOLA3-AS1 0.216 0.0972 0.613
cop MOB1A 2p13.1 0.216 0.0972 0.613 hippo signaling cascade
cop MTHFD2 2p13.1 0.216 0.0972 0.613 one-carbon metabolic
cop CRHR2 7p14.3 -0.216 0.0972 0.613 G-protein signaling, coupled
to cAMP nucleotide second messenger;cellular response to corticotropin-releasing
hormone stimulus"
cop INMT-FAM188B -0.216 0.0972 0.613
cop INMT 7p14.3 -0.216 0.0972 0.613
cop FAM188B 7p14.3 -0.216 0.0972 0.613
hs4 HLA-F-AS1 6p22.1 -0.218 0.0972 0.613
xai HK1 10q22 -0.218 0.0972 0.613 transmembrane
transport;carbohydrate metabolic process
his AOAH-IT1 -0.218 0.0972 0.613
hs4 PXMP4 20q11.22 -0.218 0.0972 0.613
xai CYP4Z2P 1p33 -0.218 0.0972 0.613 oxidation-reduction process
his GAB3 Xq28 0.218 0.0973 0.613
his SEMA3G 3p21.1 0.218 0.0973 0.613 multicellular organismal
development
exp KIF14 1q32.1 0.218 0.0973 0.613 microtubule-based movement
xai ZNF75D Xq26.3 0.218 0.0973 0.613 regulation of transcription,
xai ZKSCAN7 3p21.32 0.218 0.0973 0.613
his UBIAD1 1p36.22 0.218 0.0973 0.613 menaquinone biosynthetic
xai LINS1 0.218 0.0973 0.613
exp ATP8A2P1 0.218 0.0973 0.613
exp TDRKH 1q21 0.216 0.0973 0.613
xsq HSD17B6 12q13 0.216 0.0973 0.613 androgen catabolic process;steroid
metabolic process
xsq JCHAIN 0.216 0.0973 0.613 immune response
met PUF60 8q24.3 0.216 0.0973 0.613 RNA splicing;regulation of
exp CPLX1 4p16.3 0.216 0.0973 0.613 exocytosis;synaptic transmission
exp RCC2 1p36.13 0.216 0.0973 0.613 M phase of mitotic cell
exp INIP 9q32 0.216 0.0973 0.613
xsq FLJ37201 10q23.31 0.216 0.0973 0.613
met MIR1252 -0.216 0.0973 0.613
exp LOC100130990 5q11.2 -0.216 0.0973 0.613
his ZFP36L1 14q22-q24 -0.218 0.0973 0.613 mRNA metabolic
hs4 NRG1-IT1 -0.218 0.0973 0.613
hs4 PHLDA1 12q15 -0.218 0.0973 0.613 Apoptosis
hs4 PTX3 3q25 -0.218 0.0973 0.613 response to yeast;inflammatory
response
hs4 MSI1 12q24 -0.218 0.0973 0.613 nervous system development;response
to hormone stimulus
his MAN2A1 5q21.3 0.218 0.0974 0.613 respiratory gaseous
exchange;in utero embryonic development
his INPP5D 2q37.1 0.218 0.0974 0.613 phosphate-containing compound
his DNASE1L1 Xq28 0.218 0.0974 0.613 DNA metabolic process;DNA catabolic
process
his TAZ Xq28 0.218 0.0974 0.613 cristae formation;muscle contraction
xai USP21 1q22 0.218 0.0974 0.613 protein modification process;proteolysis
his MIR5591 0.218 0.0974 0.613
xsq RNASE2 14q11.2 0.216 0.0974 0.613 RNA catabolic
process;chemotaxis
cop ZNF774 15q26.1 0.216 0.0974 0.613 regulation of transcription,
DNA-dependent"
cop RAB8B 15q22.2 0.216 0.0974 0.613 protein transport;positive
regulation of cell projection organization
dependent"
xsq IPO5 13q32.2 0.216 0.0974 0.613 intracellular protein
met FAAH2 Xp11.21 0.216 0.0974 0.613
exp PECR 2q35 -0.216 0.0974 0.613 regulation of apoptotic
xsq BAMBI 10p12.3-p11.2 -0.216 0.0974 0.613 cell migration;negative
regulation of transforming growth factor beta receptor signaling pathway
xsq ST6GALNAC5 1p31.1 -0.216 0.0974 0.613 protein
met USP39 2p11.2 -0.216 0.0974 0.613 spliceosome assembly;mRNA
processing
xsq HSPB2 11q22-q23 -0.216 0.0974 0.613 Apoptosis
xai LOC100128035 3q13.2 -0.218 0.0974 0.613
hs4 FAM155A-IT1 -0.218 0.0974 0.613
xai MOB3C 1p33 -0.218 0.0974 0.613
xai ARNTL 11p15 -0.218 0.0974 0.613 circadian rhythm;positive
hs4 PTK7 6p21.1-p12.2 -0.218 0.0974 0.613 establishment of planar
exp POTEKP 2q21.1 0.218 0.0975 0.613 platelet degranulation;blood
coagulation
exp LOC100288897 0.218 0.0975 0.613
swa MRGBP 20q13.33 0.218 0.0975 0.613
hs4 FAM26F 6q22.1 0.218 0.0975 0.613
his CDK11A 1p36.33 0.218 0.0975 0.613 Protein Kinases
xai PPA2 4q25 0.218 0.0975 0.613 tRNA aminoacylation for protein
hs4 MYB 6q22-q23 0.218 0.0975 0.613 Apoptosis
xsq GOLGA8EP 0.216 0.0975 0.613
xsq MMACHC 1p34.1 0.216 0.0975 0.613
exp SREK1IP1 5q12.3 0.216 0.0975 0.613 mRNA processing;RNA splicing
cop EPAS1 2p21-p16 0.216 0.0975 0.613 response to hypoxia;multicellular
exp RPS4XP21 19q13.11 0.216 0.0975 0.613
exp NARS 18q21.31 0.216 0.0975 0.613 tRNA aminoacylation for protein
exp SLAIN1 13q22.3 0.216 0.0975 0.613
cop DSC1 18q12.1 0.216 0.0975 0.613 cell adhesion;homophilic cell
adhesion
met ATHL1 11p15.5 -0.216 0.0975 0.613 carbohydrate metabolic
process
xsq ASPH 8q12.1 -0.216 0.0975 0.613 peptidyl-amino acid
his MRPL33 2p21 -0.218 0.0975 0.613 translation
hs4 MST1L 1p36.13 -0.218 0.0975 0.613
his LRRC20 10q22.1 0.218 0.0976 0.613
his CEACAM6 19q13.2 0.218 0.0976 0.613 signal transduction;cell-cell
signaling
xai CDK2AP2 11q13 0.218 0.0976 0.613
xsq LOC102467226 0.216 0.0976 0.613
met ATF3 1q32.3 0.216 0.0976 0.613 activation of signaling protein
activity involved in unfolded protein response;positive regulation of cell
proliferation
mut PRICKLE2 3p14.1 0.216 0.0976 0.613 neuron projection
xsq ZDHHC17 12q21.2 0.216 0.0976 0.613 signal transduction;magnesium
ion transport
exp ABCF2 7q36 0.216 0.0976 0.613 ABC Transporters
xsq ANTXRLP1 0.216 0.0976 0.613
xsq MORN1 1p36.33-p36.32 0.216 0.0976 0.613
cop MYADML 2p22.3 0.216 0.0976 0.613
exp FLT1 13q12 0.216 0.0976 0.614 Protein Kinases
xsq TRANK1 3p22.2 -0.216 0.0976 0.614
xsq PDGFB 22q13.1 -0.216 0.0976 0.613 Apoptosis; Oncogenes
met TRABD 22q13.33 -0.216 0.0976 0.613
exp RCC2P4 0.218 0.0977 0.614
hs4 PRORSD1P 2p16.1 0.218 0.0977 0.614
his TIMELESS 12q13.3 0.218 0.0977 0.614 DNA Damage Response (DDR)
his POLRMT 19p13.3 0.218 0.0977 0.614 transcription from
exp EEF1A1P7 19q13.12 0.218 0.0977 0.614
xsq TTI1 20q11.23 0.216 0.0977 0.614 DNA Damage Response (DDR)
xsq FAM179A 2p23.2 0.216 0.0977 0.614
xsq NMS 2q11.2 0.216 0.0977 0.614 regulation of smooth muscle
contraction;neuropeptide signaling pathway
xsq GIPR 19q13.3 0.216 0.0977 0.614 desensitization of G-protein
process
xsq PORCN Xp11.23 -0.216 0.0977 0.614 Wnt receptor signaling
pathway
exp EVC 4p16 -0.216 0.0977 0.614 muscle organ development;positive
exp IFFO2 1p36.13 -0.216 0.0977 0.614
xsq THNSL2 2p11.2 -0.216 0.0977 0.614 serine family amino acid
exp PCNXL2 1q42.2 -0.216 0.0977 0.614
cop ZFAND1 8q21.13 -0.216 0.0977 0.614
hs4 CYP26B1 2p13.2 -0.218 0.0977 0.614 male meiosis;negative
regulation of retinoic acid receptor signaling pathway
xai FN3K 17q25.3 -0.218 0.0977 0.614 fructoselysine metabolic
process
swa GPD2 2q24.1 -0.218 0.0977 0.614 cellular lipid metabolic
his DCTN1 2p13 0.218 0.0978 0.614 G2/M transition of mitotic cell
his MIR5087 0.218 0.0978 0.614
his HACE1 6q16.3 0.218 0.0978 0.614 protein ubiquitination;Rac protein
signal transduction
hs4 PRADC1 2p13.2 0.218 0.0978 0.614
hs4 CCT7 2p13.2 0.218 0.0978 0.614 protein folding;cellular protein
metabolic process
hs4 PLCL2 3p24.3 0.218 0.0978 0.614 lipid metabolic
his C16orf52 16p12.2 0.218 0.0978 0.614
xsq SLTM 15q22.1 0.216 0.0978 0.614 regulation of transcription, DNA-
exp ZNF75D Xq26.3 0.216 0.0978 0.614 regulation of transcription,
xsq CUL4A 13q34 0.216 0.0978 0.614 Apoptosis; DNA Damage Response (DDR); DDR
xsq ZMYM6 1p34.2 0.216 0.0978 0.614 cytoskeleton
exp HADH 4q22-q26 0.216 0.0978 0.614 fatty acid beta-oxidation;response
to hormone stimulus
xsq TUBE1 6q21 0.216 0.0978 0.614 microtubule-based movement;centrosome
cycle
mut LAMB1 7q22 0.216 0.0978 0.614 embryo implantation;positive regulation
of cell migration
xsq CFI 4q25 -0.216 0.0978 0.614 complement activation, classical
xai MMP19 12q14 -0.218 0.0978 0.614 Apoptosis
his PAX8-AS1 -0.218 0.0978 0.614
hs4 CLDN9 16p13.3 -0.218 0.0978 0.614 calcium-independent cell-cell
hs4 OSMR-AS1 -0.218 0.0978 0.614
hs4 OSMR 5p13.1 -0.218 0.0978 0.614 positive regulation of acute
swa TGM2 20q12 -0.218 0.0978 0.614 metabolic process;protein
homooligomerization
xai ATG9A 2q35 -0.218 0.0978 0.614 autophagy;protein transport
hs4 NME5 5q31 -0.218 0.0978 0.614 GTP biosynthetic process;UTP
his SULF2 20q12-q13.2 -0.218 0.0978 0.614 glomerular basement membrane
his LINC00997 0.218 0.0979 0.614
xai POP7 7q22 0.218 0.0979 0.614 tRNA processing
xai LINC01005 0.218 0.0979 0.614
xai FBXL4 6q16.1-q16.3 0.218 0.0979 0.614 ubiquitin-dependent protein
catabolic process
xsq TYW3 1p31.1 0.216 0.0979 0.614 tRNA processing
met TIGD2 4q22.1 0.216 0.0979 0.614 regulation of transcription, DNA-
dependent"
met GPRC5B 16p12 0.216 0.0979 0.614
xsq PAQR3 4q21.21 0.216 0.0979 0.614
xsq RBM33 7q36.3 0.216 0.0979 0.614
exp CHCHD2P8 13q12.2 0.216 0.0979 0.614
exp DGKE 17q22 0.216 0.0979 0.614 activation of protein kinase C activity
mut WAPL 0.216 0.0979 0.614 cell division;cell cycle
xsq PMP2 8q21.3-q22.1 -0.216 0.0979 0.614
exp RHOBTB2 8p21.3 -0.216 0.0979 0.614 small GTPase mediated
signal transduction;regulation of small GTPase mediated signal transduction
met CABP4 11q13.2 -0.216 0.0979 0.614 photoreceptor cell
his ASB18 2q37.2 -0.218 0.0979 0.614 intracellular signal
transduction
hs4 CADM1 11q23.2 -0.218 0.0979 0.614 homophilic cell
his MICALCL 11p15.3 -0.218 0.0979 0.614 multicellular organismal
his MBD1 18q21 0.217 0.098 0.614 regulation of transcription, DNA-
xai LOC100128993 8p21.3 0.217 0.098 0.614
xai CDC45 22q11.21 0.217 0.098 0.614 DDR (DNA replication)
his RNFT1 17q23.1 0.217 0.098 0.614
his LOC101927755 0.217 0.098 0.614
swa UBE2S 19q13.43 0.217 0.098 0.614 protein modification process;activation
of anaphase-promoting complex activity
exp RPS15AP19 6p21.31 0.216 0.098 0.614
met ZAK 2q24.2 0.216 0.098 0.614
exp LOC388955 2p15 0.216 0.098 0.614
exp TPTE 21p11 0.216 0.098 0.614 protein dephosphorylation;ion transport
exp ELOVL1 1p34.2 -0.216 0.098 0.614 fatty acid elongation,
xsq SAMD9L 7q21.2 -0.216 0.098 0.614
mda D0 -0.216 0.098 0.614
swa MAPK1 22q11.21 -0.217 0.098 0.614 Apoptosis; Protein Kinases
his FBXO22 15q24.2 0.217 0.0981 0.614 protein modification
process;ubiquitin-dependent protein catabolic process
xai NDUFV2 18p11.22 0.217 0.0981 0.614 mitochondrial electron
his RPS12 6q23.2 0.217 0.0981 0.614 SRP-dependent cotranslational
his SNORD101 0.217 0.0981 0.614
his SNORD100 6q23.2 0.217 0.0981 0.614
his SNORA33 6q23.2 0.217 0.0981 0.614
hs4 HIST1H2BK 6p21.33 0.217 0.0981 0.614 nucleosome assembly;defense
hs4 HIST1H4I 0.217 0.0981 0.614
hs4 HIST1H2AH 6p21.33 0.217 0.0981 0.614 nucleosome assembly
hs4 MIR3143 0.217 0.0981 0.614
cop MIR614 0.216 0.0981 0.614
cop GPRC5D 12p13.3 0.216 0.0981 0.614
cop HEBP1 12p13.1 0.216 0.0981 0.614 circadian rhythm
cop LOC100506314 0.216 0.0981 0.614
cop HTR7P1 12p13.1 0.216 0.0981 0.614
cop KIAA1467 12p13.1 0.216 0.0981 0.614
cop GSG1 12p13.1 0.216 0.0981 0.614
xsq C19orf48 19q13.33 0.216 0.0981 0.614
met SNX29P2 16p11.2 0.216 0.0981 0.614
cop KCNG2 18q23 0.216 0.0981 0.614 small molecule metabolic
cop RETSAT 2p11.2 0.216 0.0981 0.614 retinol metabolic
cop ELMOD3 2p11.2 0.216 0.0981 0.614 phagocytosis
cop CAPG 2p11.2 0.216 0.0981 0.614 protein complex assembly;cell
projection assembly
cop SH2D6 2p11.2 0.216 0.0981 0.614
cop LOC100630918 0.216 0.0981 0.614
cop MAT2A 2p11.2 0.216 0.0981 0.614 response to light stimulus;response
to hormone stimulus
cop GGCX 2p12 0.216 0.0981 0.614 protein modification process;blood
coagulation
cop VAMP8 2p12-p11.2 0.216 0.0981 0.614 protein complex assembly;post-Golgi
vesicle-mediated transport
cop VAMP5 2p11.2 0.216 0.0981 0.614 multicellular organismal
xsq ULK2 17p11.2 -0.216 0.0981 0.614 signal transduction;nervous
system development
hs4 ERBB3 12q13 -0.217 0.0981 0.614 signal transduction;Schwann cell
differentiation
xai TMEM63B 6p21.1 -0.217 0.0981 0.614
xai LOC284581 -0.217 0.0981 0.614
hs4 TENM3 4q35.1 -0.217 0.0981 0.614
xai PDLIM1 10q23.1 -0.217 0.0981 0.614 response to oxidative
xai APIP 11p13 0.217 0.0982 0.614 methionine biosynthetic process;L-
methionine salvage from methylthioadenosine
xai CHML 1q43 0.217 0.0982 0.614 intracellular protein transport;visual
perception
hs4 ADGRL1 0.217 0.0982 0.614 G-protein coupled receptor
exp RPL7P16 3q22.1 0.217 0.0982 0.614
his CENPS 0.217 0.0982 0.614
his APITD1-CORT 0.217 0.0982 0.614
met ZCCHC18 Xq22.2 0.216 0.0982 0.614
xsq IL21R 16p11 0.216 0.0982 0.614 natural killer cell activation
cop NOTO 0.215 0.0982 0.614
exp GABPB2 1q21.3 0.215 0.0982 0.614 regulation of transcription,
cop PIGF 2p21-p16 0.215 0.0982 0.614 preassembly of GPI anchor in ER
exp NPR1 1q21-q22 -0.216 0.0982 0.614 body fluid
secretion;regulation of vasodilation
xsq ARNT2 15q24 -0.216 0.0982 0.614 positive regulation of
transcription, DNA-dependent;response to hypoxia
xsq ZC3H12C 11q22.3 -0.216 0.0982 0.614
xai NANOS1 10q26.11 -0.217 0.0982 0.614 epithelial cell
xai BOD1 5q35.2 -0.217 0.0982 0.614 cell cycle;mitosis
hs4 HNMT 2q22.1 -0.217 0.0982 0.614 brain development;respiratory
gaseous exchange
xai CPAMD8 19p13.11 -0.217 0.0982 0.614
hs4 FAM150B 2p25.3 -0.217 0.0982 0.614
xai EVL 14q32.2 0.217 0.0983 0.614 nervous system development;axon
guidance
his TMEM109 11q12.2 0.217 0.0983 0.614
xai RPL26 17p13 0.217 0.0983 0.614 translational initiation;viral infectious
cycle
xai MSI2 17q22 0.217 0.0983 0.614 stem cell development
xai DYNAP 18q21.2 0.217 0.0983 0.614
met CRISPLD2 16q24.1 0.215 0.0983 0.614
DNA-dependent"
xsq SIRT6 19p13.3 0.215 0.0983 0.614 protein deacetylation;protein ADP-
ribosylation
exp CBFA2T3 16q24 0.215 0.0983 0.614 cell differentiation;granulocyte
differentiation
xsq LOC339568 20q12 0.215 0.0983 0.614
xsq CTDSP1 2q35 0.215 0.0983 0.614 negative regulation of neuron
xsq FABP5 8q21.13 0.215 0.0983 0.614 lipid metabolic
xsq NUPL1 13q12.13 0.215 0.0983 0.615
xsq DHCR24 1p32.3 -0.215 0.0983 0.614 Apoptosis
cop CHMP4C 8q21.13 -0.215 0.0983 0.614 protein
hs4 NHEG1 -0.217 0.0983 0.614
xai OR4F13P 15q26.3 -0.217 0.0983 0.614
hs4 PIWIL4 11q21 0.217 0.0984 0.615 gene silencing by RNA;piRNA
metabolic process
exp SMC6 2p24.2 0.217 0.0984 0.615 DNA Damage Response (DDR); DDR
xai KIF14 1q32.1 0.217 0.0984 0.615 microtubule-based movement
xai PTK2B 8p21.1 0.217 0.0984 0.615 MAPK cascade;apoptotic process
his C4orf32 4q25 0.217 0.0984 0.615
xai RPL7P32 7q31.1 0.217 0.0984 0.615
xai YDJC 22q11.21 0.217 0.0984 0.615 carbohydrate metabolic process
exp RSL24D1P5 0.217 0.0984 0.615
met ZNF503-AS2 10q22.2 0.215 0.0984 0.615
exp KLHDC7B 22q13.33 0.215 0.0984 0.615
exp SIRT4 12q 0.215 0.0984 0.615 protein ADP-ribosylation;protein
deacetylation
cop KNTC1 12q24.31 0.215 0.0984 0.615 mitotic cell cycle;protein complex
assembly
xsq ELL 19p13.1 0.215 0.0984 0.615 negative regulation of phosphatase
activity;viral reproduction
exp PLAGL2 20q11.21 0.215 0.0984 0.615 positive regulation of
dependent
met AOAH 7p14-p12 -0.215 0.0984 0.615 lipopolysaccharide metabolic
xsq SPANXN5 -0.215 0.0984 0.615
hs4 CACNA1D 3p14.3 -0.217 0.0984 0.615 regulation of calcium
ion transport via voltage-gated calcium channel activity;transmembrane transport
his FAM65C 20q13.13 -0.217 0.0984 0.615
his LOC100506175 -0.217 0.0984 0.615
hs4 ST6GALNAC5 1p31.1 -0.217 0.0984 0.615 protein
xai CELF2 10p13 0.217 0.0985 0.615 RNA processing;mRNA processing
hs4 DMC1 22q13.1 0.217 0.0985 0.615 DNA Damage Response (DDR); DDR (DNA
replication)
hs4 LOC105373031 0.217 0.0985 0.615
his NBPF11 0.217 0.0985 0.615
his UCP3 11q13.4 0.217 0.0985 0.615 response to nutrient;small molecule
metabolic process
his EGR4 2p13 0.217 0.0985 0.615 regulation of transcription, DNA-
xai C8orf37 8q22.1 0.217 0.0985 0.615
swa ADPGK 15q24.1 0.217 0.0985 0.615 glycolysis;carbohydrate metabolic
process
his C3orf18 3p21.3 0.217 0.0985 0.615
his HEMK1 3p21.3 0.217 0.0985 0.615 DNA methylation
his HEATR5B 2p22.2 0.217 0.0985 0.615
his GPATCH11 2p22.2 0.217 0.0985 0.615
exp LOC389787 0.215 0.0985 0.615
met ABCB7 Xq13.3 0.215 0.0985 0.615 ABC Transporters
xsq LOC101927577 0.215 0.0985 0.615
xsq SPICE1 3q13.2 0.215 0.0985 0.615 cell cycle;regulation of
centriole replication
met SLCO1C1 12p12.2 0.215 0.0985 0.615 Solute Carriers
mut ACSM3 16p13.11 -0.215 0.0985 0.615 lipid metabolic process;fatty
exp GSTT2 -0.215 0.0985 0.615
exp CTSZ 20q13.32 -0.215 0.0985 0.615 proteolysis;epithelial tube
hs4 OTUD1 10p12.2 -0.217 0.0985 0.615
xai UNC13A 19p13.11 0.217 0.0986 0.615 exocytosis;intracellular
signal transduction
exp LOC100506446 0.217 0.0986 0.615
xai RSL24D1P5 0.217 0.0986 0.615
swa MAPRE1 20q11.1-q11.23 0.217 0.0986 0.615 protein localization to
microtubule;cell division
xai GLTSCR1L 6p21.1 0.217 0.0986 0.615
xsq LUC7L2 7q34 0.215 0.0986 0.615
cop TPM1 15q22.1 0.215 0.0986 0.615 positive regulation of heart rate
cop LACTB 15q22.1 0.215 0.0986 0.615
cop RPS27L 15q22.2 0.215 0.0986 0.615 DNA Damage Response (DDR)
exp PRPF3 1q21.1 0.215 0.0986 0.615 RNA splicing, via
exp LINC00599 8p23.1 0.215 0.0986 0.615
exp TCTA 3p21 -0.215 0.0986 0.615
met C17orf64 17q23.2 -0.215 0.0986 0.615
xsq SEMA5B 3q21.1 -0.215 0.0986 0.615 nervous system
hs4 TTLL3 3p25.3 -0.217 0.0986 0.615 protein
polyglycylation;axoneme assembly
hs4 LUM 12q21.33 -0.217 0.0986 0.615 visual perception;response to
his OGN 9q22 0.217 0.0987 0.615 negative regulation of smooth muscle cell
proliferation
xai RP1L1 8p23.1 0.217 0.0987 0.615 cell projection
his VAPA 18p11.22 0.217 0.0987 0.615 sphingolipid biosynthetic
process;neuron projection development
xai NKAPP1 Xq24 0.217 0.0987 0.615
xai JMY 5q14.1 0.217 0.0987 0.615 DNA repair;actin polymerization-
dependent cell motility
xai RTP5 0.217 0.0987 0.615
hs4 SLC35F2 11q22.3 0.217 0.0987 0.615 Solute Carriers
dependent"
exp PXN-AS1 0.215 0.0987 0.615
exp SALL4 20q13.2 0.215 0.0987 0.615 DNA Damage Response (DDR)
met CCL13 17q11.2 0.215 0.0987 0.615 regulation of cell shape;cellular
xsq OR9I1 11q12.1 0.215 0.0987 0.615
xsq C9orf47 9q22.1 0.215 0.0987 0.615
xsq SNORA33 6q23.2 0.215 0.0987 0.615
met DRC1 2p23.3 0.215 0.0987 0.615
xsq BDNF 11p13 -0.215 0.0987 0.615 feeding behavior;fear response
exp ARNTL 11p15 -0.215 0.0987 0.615 circadian rhythm;positive
xsq TMEM184B 22q12 -0.215 0.0987 0.615
his LINC01265 -0.217 0.0987 0.615
xai PLPP3 -0.217 0.0987 0.615 negative regulation of protein
xai KLF8 Xp11.21 -0.217 0.0987 0.615 regulation of transcription,
DNA-dependent"
his PRRT4 7q32.1 0.217 0.0988 0.615
his GIMAP1 7q36.1 0.217 0.0988 0.615 B cell differentiation;T cell
differentiation
his GIMAP1-GIMAP5 0.217 0.0988 0.615
his GGH 8q12.3 0.217 0.0988 0.616 response to insulin
cop BRI3BP 12q24.31 0.215 0.0988 0.615
xsq TMPRSS13 11q23 -0.215 0.0988 0.615 proteolysis
cop GARS 7p15 -0.215 0.0988 0.615 glycyl-tRNA aminoacylation;cell
death
hs4 LAYN 11q23.1 -0.217 0.0988 0.615
xai NDC80 18p11.32 0.217 0.0989 0.616 attachment of spindle microtubules
hs4 C16orf92 16p11.2 0.217 0.0989 0.616
his MTFR2 6q23.3 0.217 0.0989 0.616
his SLC11A1 2q35 0.217 0.0989 0.616 protein import into nucleus,
xai AP5M1 14q22.3 0.217 0.0989 0.616 intracellular protein
met MEG8 14q32.31 0.215 0.0989 0.616
xsq C14orf180 14q32.33 0.215 0.0989 0.616
xsq MRPL9 1q21 0.215 0.0989 0.616 translation
exp ADGRE1 0.215 0.0989 0.616 cell adhesion;G-protein coupled
met CABS1 4q13.3 0.215 0.0989 0.616 spermatogenesis
cop MIR4778 0.215 0.0989 0.616
exp CCNB1IP1 14q11.2 0.215 0.0989 0.616 meiotic metaphase I;spermatid
development
exp COQ10A 12q13.3 0.215 0.0989 0.616
met RALBP1 18p11.3 0.215 0.0989 0.616 transport;regulation of small
exp WDR5 9q34 0.215 0.0989 0.616 regulation of transcription, DNA-
exp RPL23AP21 0.215 0.0989 0.616
exp CTBP1 4p16 0.215 0.0989 0.616 protein phosphorylation;negative
xsq FAM109B 22q13.2 -0.215 0.0989 0.616 endosome
exp KRCC1 2p11.2 -0.215 0.0989 0.616
xai COL2A1 12q13.11 -0.217 0.0989 0.616 heart
morphogenesis;notochord development
his PRKCA 17q22-q23.2 -0.217 0.0989 0.616 Apoptosis; Protein Kinases
his CHRNA10 11p15.5 -0.217 0.0989 0.616 cation
transport;elevation of cytosolic calcium ion concentration
hs4 ADGRF5 -0.217 0.0989 0.616 G-protein coupled receptor
hs4 SLPI 20q12 -0.217 0.0989 0.616 negative regulation of protein
binding;negative regulation of viral genome replication
xai IGIP 5q31 -0.217 0.0989 0.616
xai ZNF625 19p13.2 -0.217 0.0989 0.616 regulation of
his DEDD 1q23.3 0.217 0.099 0.616 Apoptosis
xai CPNE4 3q22.1 0.217 0.099 0.616
xai PURG 8p11 0.217 0.099 0.616
xai ZNF385D-AS1 0.217 0.099 0.616
his ASH2L 8p11.2 0.217 0.099 0.616 transcription from RNA polymerase II
promoter;response to DNA damage stimulus
exp LINC01005 0.217 0.099 0.616
xai RPS3AP49 18q21.32 0.217 0.099 0.616
his SH3GL1 19p13.3 0.217 0.099 0.616 endocytosis;signal transduction
his CHAF1A 19p13.3 0.217 0.099 0.616 DNA Damage Response (DDR); DDR (DNA
replication)
met CARD6 5p13.1 0.215 0.099 0.616 regulation of apoptotic process
dependent"
xsq UQCRFS1 19q12 0.215 0.099 0.616 transport;response to hormone stimulus
xsq CD24 -0.215 0.099 0.616 regulation of cytokine-mediated signaling
pathway;cell migration
exp TINAGL1 1p35.2 -0.215 0.099 0.616 proteolysis;immune response
exp CTAGE4 -0.215 0.099 0.616
xai ARNT2 15q24 -0.217 0.099 0.616 positive regulation of transcription,
DNA-dependent;response to hypoxia
his FSTL1 3q13.33 -0.217 0.099 0.616 BMP signaling pathway
his MATN3 2p24-p23 -0.217 0.099 0.616 skeletal system development
his SULT1C2 2q12.3 -0.217 0.099 0.616 xenobiotic metabolic
process;amine metabolic process
exp YWHAEP7 -0.217 0.099 0.616
xai SOGA2P1 -0.217 0.099 0.616
his SYT8 11p15.5 -0.217 0.099 0.616
his TNNI2 11p15.5 -0.217 0.099 0.616 skeletal muscle contraction;muscle
filament sliding
xai IGKV1D-35 0.217 0.0991 0.616
hs4 GOLGA8B 15q14 0.217 0.0991 0.616
hs4 GPR50-AS1 Xq28 0.217 0.0991 0.616
hs4 GPR50 Xq28 0.217 0.0991 0.616 G-protein coupled receptor signaling
exp RPS3AP49 18q21.32 0.217 0.0991 0.616
hs4 FAM159A 1p32.3 0.217 0.0991 0.616
xai ACMSD 2q21.3 0.217 0.0991 0.616 quinolinate metabolic
xai TMEM215 9p21.1 0.217 0.0991 0.616
mut PHKA1 Xq12-q13 0.215 0.0991 0.616 glucose metabolic
xsq KRT37 17q21.2 0.215 0.0991 0.616
cop KDM2B 12q24.31 0.215 0.0991 0.616 negative regulation of
exp PTGES2 9q34.11 0.215 0.0991 0.616 prostaglandin biosynthetic
xsq CAMK2D 4q26 -0.215 0.0991 0.616 calcium ion
met NAT10 11p13 -0.215 0.0991 0.616
swa NDUFB11 Xp11.23 -0.217 0.0991 0.616 transport;respiratory
xai ERAL1 17q11.2 0.217 0.0992 0.616 ribosomal small subunit
assembly;ribosome biogenesis
exp IGKV1D-35 0.217 0.0992 0.616
swa NOP58 2q33.1 0.217 0.0992 0.616 rRNA processing;snRNP protein
import into nucleus
his SAMD10 20q13.33 0.217 0.0992 0.616
his PRPF6 20q13.33 0.217 0.0992 0.616 RNA splicing, via
met RASAL2 1q24 0.215 0.0992 0.616 signal transduction;positive
xsq CD320 19p13.3-p13.2 0.215 0.0992 0.616 regulation of cell growth
exp NANOS3 19p13.13 0.215 0.0992 0.616 cell
xsq GANC 15q15.2 0.215 0.0992 0.616 carbohydrate metabolic process
xsq CACNB4 2q22-q23 -0.215 0.0992 0.616 synaptic
transmission;axon guidance
xsq SCGB2A2 11q13 -0.215 0.0992 0.616
xai GPR107 9q34.11 -0.217 0.0992 0.616
his FMN1 15q13.3 -0.217 0.0992 0.616 cellular component
his ZMAT5 22cen-q12.3 0.217 0.0993 0.616 mRNA processing;RNA splicing
his UQCR10 22q12.2 0.217 0.0993 0.616 transport;respiratory
hs4 KIF18B 17q21.31 0.217 0.0993 0.616 mitotic cell
cycle;microtubule-based movement
xai PYGM 11q12-q13.2 0.217 0.0993 0.616 glycogen metabolic process;glycogen
catabolic process
xai ZNF394 7q22.1 0.217 0.0993 0.616 viral reproduction
his RPL6 12q24.1 0.217 0.0993 0.616 SRP-dependent cotranslational
cop DAO 12q24 0.215 0.0993 0.616 proline catabolic process;cellular
cop SVOP 12q24.11 0.215 0.0993 0.616
cop CRIPT 2p21 0.215 0.0993 0.616 cytoplasmic microtubule
organization;establishment of protein localization
exp FABP5P3 7q36.1 0.215 0.0993 0.616 glucose metabolic
xsq ACSL6 5q31.1 0.215 0.0993 0.616 fatty acid metabolic process;acyl-
xsq MGAT4C 12q21 0.215 0.0993 0.616 cellular protein metabolic
met MTX3 5q14.1 0.215 0.0993 0.616 protein targeting to
cop FAM98A 2p22.3 0.215 0.0993 0.616
exp XRCC2 7q36.1 0.215 0.0993 0.616 DNA Damage Response (DDR); DDR
(NHEJ)
exp PPP1R3C 10q23-q24 -0.215 0.0993 0.616 carbohydrate metabolic
exp MT3 16q13 -0.215 0.0993 0.616 energy reserve metabolic
process;positive regulation of necrotic cell death
met MIR26B -0.215 0.0993 0.616
xai NRP1 10p12 -0.217 0.0993 0.616 cell adhesion;response to wounding
hs4 PROM2 2q11.1 -0.217 0.0993 0.616
swa CPOX 3q12 -0.217 0.0993 0.616 response to insecticide;small
his SCARNA10 12p13.31 -0.217 0.0993 0.616
his FAM219A 9p13.3 -0.217 0.0993 0.616
his DNAI1 9p13.3 -0.217 0.0993 0.616 cell projection organization
xai C1orf194 1p13.3 -0.219 0.0993 0.616
his TM9SF1 14q11.2 0.217 0.0994 0.616 autophagy
xai TRMT13 1p21.2 0.217 0.0994 0.616
his ZCCHC3 20p13-p12.2 0.217 0.0994 0.617
xai RPL8 8q24.3 0.217 0.0994 0.617 translational elongation;viral
transcription
xai EIF2B1 12q24.31 0.217 0.0994 0.617 regulation of translational
initiation;cellular response to stimulus
hs4 RAC2 22q13.1 0.217 0.0994 0.617 GTP catabolic process;actin
hs4 MIR7846 0.217 0.0994 0.617
hs4 TNFRSF1B 1p36.22 0.217 0.0994 0.617 Apoptosis
xsq C18orf8 18q11.2 0.215 0.0994 0.616
xsq IL2RB 22q13.1 0.215 0.0994 0.616 protein complex assembly;signal
transduction
exp UNC13A 19p13.11 0.215 0.0994 0.617 exocytosis;intracellular
signal transduction
exp LOC284196 -0.215 0.0994 0.617
xsq NCKAP5 2q21.2 -0.215 0.0994 0.617
exp LUM 12q21.33 -0.215 0.0994 0.616 visual perception;response to
xai CCDC107 9p13.3 -0.217 0.0994 0.617
swa BIN1 2q14 -0.217 0.0994 0.617 positive regulation of GTPase
xai STYXL1 7q11.23 -0.217 0.0994 0.617 protein
xai DYX1C1 15q21.3 -0.217 0.0994 0.616 neuron migration;nervous
system development
his LMOD1 1q32 -0.217 0.0994 0.616 muscle contraction
xai KIR2DL1 0.218 0.0995 0.617 natural killer cell inhibitory
signaling pathway;immune response
hs4 MRPL51 12p13.3-p13.1 0.217 0.0995 0.617 translation
hs4 NCAPD2 12p13.3 0.217 0.0995 0.617 DNA Damage Response (DDR)
his PRPS2 Xp22.2 0.217 0.0995 0.617 nucleotide biosynthetic
process;cellular biosynthetic process
his QRFP 0.217 0.0995 0.617
exp RBM15 1p13 0.217 0.0995 0.617 positive regulation of transcription of
Notch receptor target;interspecies interaction between organisms
swa ABCF2 7q36 0.217 0.0995 0.617 ABC Transporters
xai POU4F2 4q31.2 0.217 0.0995 0.617 MAPK cascade;positive
xai KIAA1328 18q12.2 0.217 0.0995 0.617
exp USP2-AS1 0.217 0.0995 0.617
xsq LINC00910 17q21.31 0.215 0.0995 0.617
exp FUT7 9q34.3 0.215 0.0995 0.617 leukocyte migration involved in
cop NOX3 6q25.3 0.215 0.0995 0.617 temperature homeostasis;detection
of gravity
xsq LOC101928435 0.215 0.0995 0.617
met HES3 1p36.31 0.215 0.0995 0.617
xsq LRRC8C 1p22.2 0.215 0.0995 0.617
exp TARBP2 12q13.13 0.215 0.0995 0.617 negative regulation of
xsq LIG4 13q33-q34 0.215 0.0995 0.617 DNA Damage Response (DDR); DDR
(NHEJ)
cop NGRN 15q26.1 0.215 0.0995 0.617 multicellular organismal
exp LINC00886 0.215 0.0995 0.617
exp DKFZp686L13185 -0.215 0.0995 0.617
xsq NFKBIZ 3p12-q12 -0.215 0.0995 0.617 regulation of
transcription, DNA-dependent;inflammatory response"
exp IZUMO3 -0.217 0.0995 0.617
exp MIR141 -0.217 0.0995 0.617
hs4 NRG1 8p12 -0.217 0.0995 0.617 transmembrane receptor protein
tyrosine kinase signaling pathway;positive regulation of cell growth
xai TAF1L 9p21.1 0.217 0.0996 0.617 male meiosis;histone acetylation
swa BRAT1 7p22.3 0.217 0.0996 0.617 response to ionizing radiation
exp RPS15A 16p 0.216 0.0996 0.617 nuclear-transcribed mRNA catabolic
his NCBP3 0.216 0.0996 0.617
exp LILRP2 19q13.4 0.216 0.0996 0.617
xai PSMD13 11p15.5 0.216 0.0996 0.617 antigen processing and
presentation of exogenous peptide antigen via MHC class I, TAP-dependent;mRNA
metabolic process
xsq ANKMY1 2q37.3 0.215 0.0996 0.617
xsq HESX1 3p14.3 0.215 0.0996 0.617 brain development;otic vesicle
formation
exp ITGB1BP2 Xq12-q13.1 0.215 0.0996 0.617 muscle organ
met FZD7 2q33 0.215 0.0996 0.617 G-protein signaling, coupled to cGMP
nucleotide second messenger;stem cell maintenance
met PCED1A 20p13 0.215 0.0996 0.617
mut FAM63B 15q21.3 0.215 0.0996 0.617
exp FNDC5 1p35.1 -0.215 0.0996 0.617
xsq INPP4B 4q31.21 -0.215 0.0996 0.617 signal
transduction;phosphatidylinositol-3-phosphate biosynthetic process
exp MTCL1 -0.215 0.0996 0.617
cop SCARNA3 1q25.1 -0.215 0.0996 0.617
exp SSC5D 19q13.42 -0.215 0.0996 0.617
xai LOC613266 -0.216 0.0996 0.617
his SH3PXD2B 5q35.1 -0.216 0.0996 0.617 extracellular matrix
his PTPRE 10q26 -0.216 0.0996 0.617 protein phosphorylation;protein
dephosphorylation
his GSTK1 7q34 0.216 0.0997 0.617
his CCDC39 3q26.33 0.216 0.0997 0.617 axonemal dynein complex
exp TRNR 0.216 0.0997 0.617
xai TRNR 0.216 0.0997 0.617
met CHRNB2 1q21.3 0.215 0.0997 0.617 calcium ion transport;memory
exp GIGYF1 7q22 0.215 0.0997 0.617 insulin-like growth factor receptor
signaling pathway
mut OR4B1 0.215 0.0997 0.617 response to stimulus
cop CTDP1 18q23 0.215 0.0997 0.617 viral reproduction;positive regulation of
viral transcription
xsq HAUS5 19q13.12 0.215 0.0997 0.617 spindle assembly;centrosome
organization
DNA-dependent"
met CD5L 1q21-q23 0.215 0.0997 0.617 apoptotic process;cellular defense
response
met CCDC36 3p21.31 0.215 0.0997 0.617
xsq KLRB1 12p13 0.215 0.0997 0.617
xsq MPO 17q23.1 0.215 0.0997 0.617 defense response;hydrogen peroxide
catabolic process
xsq BOLA1 1q21 0.215 0.0997 0.617
xsq FOXK2 17q25 0.215 0.0997 0.617 regulation of transcription, DNA-
cop GPR52 -0.215 0.0997 0.617 G-protein coupled receptor
signaling pathway
pro VIL1 2q35 -0.215 0.0997 0.617 response to bacterium;negative
regulation of cysteine-type endopeptidase activity involved in apoptotic process
xsq THBD 20p11.2 -0.215 0.0997 0.617 response to
lipopolysaccharide;leukocyte migration
xsq CLDN1 3q28-q29 -0.215 0.0997 0.617 cell adhesion;calcium-
his TMEM47 Xp11.4 -0.216 0.0997 0.617
swa ARL6IP5 3p14 -0.216 0.0997 0.617 negative regulation of
transport;L-glutamate transport
xai MIR141 -0.216 0.0997 0.617
xai C3 19p13.3-p13.2 -0.216 0.0997 0.617 complement
xai TM2D2 8p11.22 -0.216 0.0997 0.617
swa TMPO_P42166 0.216 0.0998 0.617
his ATE1 10q26.13 0.216 0.0998 0.617 protein arginylation
his ATE1-AS1 0.216 0.0998 0.617
his RIPK3 14q11.2 0.216 0.0998 0.617 induction of apoptosis by
extracellular signals;protein modification process
xai LOC100129148 7q34 0.216 0.0998 0.617
his LOC101927027 0.216 0.0998 0.617
exp FOXP2 7q31 0.215 0.0998 0.617 positive regulation of mesenchymal cell
met EVC 4p16 0.215 0.0998 0.617 muscle organ development;positive
exp TBL3 16p13.3 0.215 0.0998 0.617 G-protein signaling, coupled to
exp NIPBL-AS1 0.215 0.0998 0.617
met TCF23 2p23.3 0.214 0.0998 0.617 multicellular organismal
xsq FSD1 19p13.3 0.214 0.0998 0.617 cell division;cell cycle
cop POMC 2p23.3 0.214 0.0998 0.617
cop DNMT3A 2p23 0.214 0.0998 0.617 Oncogenes
cop MIR1301 0.214 0.0998 0.617
xsq LINC00674 -0.214 0.0998 0.617
exp GAS2L1 22q12.2 -0.215 0.0998 0.617 regulation of cell
mut FAM209B 20q13.31 -0.215 0.0998 0.617
his MIR4636 -0.216 0.0998 0.617
xai FBXL18 7p22.2 -0.216 0.0998 0.617
his INTS4P2 0.216 0.0999 0.617
xai OR5J7P 11q 0.216 0.0999 0.617
xai GOLGA8J 0.216 0.0999 0.617
xai SIRT1 10q21.3 0.216 0.0999 0.617 Apoptosis; DNA Damage Response
(DDR)
his CNDP1 18q22.3 0.216 0.0999 0.617 proteolysis;metabolic process
his RFT1 3p21.1 0.216 0.0999 0.617 cellular protein metabolic
his GLTSCR2-AS1 0.216 0.0999 0.617
xsq CCL3L3 0.214 0.0999 0.617
cop C9orf89 9q22.31 0.214 0.0999 0.617
cop NINJ1 9q22 0.214 0.0999 0.617 cell adhesion;nervous system development
xsq GLTSCR2 19q13.3 0.214 0.0999 0.617
exp CHML 1q43 0.214 0.0999 0.617 intracellular protein transport;visual
perception
xsq BUB1 2q14 0.214 0.0999 0.617 DNA Damage Response (DDR); Protein
Kinases
met THAP7 22q11.2 0.214 0.0999 0.617 negative regulation of
exp PPP4R3B 0.214 0.0999 0.617 DNA Damage Response (DDR)
met ABCG2 4q22 0.214 0.0999 0.617 ABC Transporters
xsq SYTL4 Xq21.33 -0.214 0.0999 0.617 positive regulation of
cop RPS7P5 1q43 -0.214 0.0999 0.617
his LOC101929532 -0.216 0.0999 0.617
swa GBF1 10q24 -0.216 0.0999 0.617 retrograde vesicle-mediated
his LINC01553 -0.216 0.0999 0.617
his BHLHB9 Xq23 -0.216 0.0999 0.617
hs4 ABAT 16p13.2 -0.216 0.0999 0.617 behavior;response to ethanol
his LOC102723427 0.216 0.1 0.617
xai LOC100506446 0.216 0.1 0.617
xai VTA1 6q24.1 0.216 0.1 0.617 endosome transport;protein transport
xai CTDNEP1 17p13 0.216 0.1 0.617 protein dephosphorylation;nuclear
xai DIDO1 20q13.33 0.216 0.1 0.617 transcription, DNA-dependent;apoptotic
process"
his C1orf109 1p34.3 0.216 0.1 0.617
his CDCA8 1p34.3 0.216 0.1 0.617 M phase of mitotic cell cycle;mitotic
metaphase
his ALG6 1p31.3 0.216 0.1 0.617 protein N-linked glycosylation;dolichol-
linked oligosaccharide biosynthetic process
xai BZRAP1 17q22-q23 0.216 0.1 0.617
hs4 LRRC20 10q22.1 0.216 0.1 0.617
xai CHEK2 22q12.1 0.216 0.1 0.617 DNA Damage Response (DDR); Protein
Kinases
xai ERVFC1-1 0.216 0.1 0.617
his LINC-ROR 0.216 0.1 0.618
xai RGS13 1q31.2 0.216 0.1 0.618 termination of G-protein coupled receptor
signaling pathway;positive regulation of GTPase activity
xai LOC100507564 0.216 0.1 0.618
his CYP1B1-AS1 2p22.2 0.216 0.1 0.618
swa RFC5 12q24.23 0.216 0.1 0.618 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
hs4 LINC01150 0.216 0.1 0.618
xai PRUNE 1q21 0.216 0.1 0.618
his DHPS 19p13.2 0.216 0.1 0.618 protein homotetramerization;translation
his LOC284241 0.216 0.1 0.618
his CTDP1 18q23 0.216 0.1 0.618 viral reproduction;positive regulation of viral
transcription
exp OR5J7P 11q 0.216 0.1 0.618
exp ZNF835 19q13.43 0.216 0.1 0.618 regulation of transcription, DNA-
dependent"
xai LOC100130887 0.216 0.1 0.618
xai LINC00337 1p36.31 0.216 0.1 0.618
his SDAD1 4q21.1 0.216 0.1 0.618 protein transport;ribosomal large subunit
biogenesis
his LRPAP1 4p16.3 0.216 0.1 0.618 protein folding;negative regulation
of signal transduction
xai RRN3P3 16p12.2 0.216 0.1 0.618
xai LOC646778 0.216 0.1 0.618
his SNAR-C1 0.216 0.1 0.618
his CUZD1 10q26.13 0.216 0.1 0.618 hormone-mediated signaling
dependent"
mut GPSM1 9q34.3 0.214 0.1 0.617 signal transduction;multicellular
exp CYP2R1 11p15.2 0.214 0.1 0.617 vitamin metabolic
met NKX2-1 14q13 0.214 0.1 0.617 endoderm development;hippocampus
development
cop HPR 16q22.1 0.214 0.1 0.617
xsq NAA50 3q13.2 0.214 0.1 0.617 N-terminal protein amino acid acetylation
dependent"
xsq ULBP1 6q25 0.214 0.1 0.617 antigen processing and presentation;natural
killer cell activation
exp FPR2 19q13.3-q13.4 0.214 0.1 0.617 G-protein coupled receptor
xsq XRN2 20p11.2-p11.1 0.214 0.1 0.617 RNA processing;mRNA processing
cop PQLC1 18q23 0.214 0.1 0.617
cop HSBP1L1 18q23 0.214 0.1 0.617 viral envelope fusion with host membrane
cop TXNL4A 18q23 0.214 0.1 0.617 nuclear mRNA splicing, via
cop RBFA 18q23 0.214 0.1 0.617 rRNA processing
cop ADNP2 18q23 0.214 0.1 0.617 neuron differentiation;positive regulation of
cell growth
cop PARD6G-AS1 18q23 0.214 0.1 0.617
xsq GAB3 Xq28 0.214 0.1 0.618
xsq ZBTB11-AS1 3q12.3 0.214 0.1 0.618
met NOP9 14q12 0.214 0.1 0.618
met OR3A1 17p13.3 0.214 0.1 0.618
dependent"
cop ZDHHC14 6q25.3 0.214 0.1 0.618
xsq PMS2P2 0.214 0.1 0.618 ATP catabolic process;mismatch repair
xsq IGBP1P1 14q13.2 0.214 0.1 0.618
mut OTOF 2p23.1 0.214 0.1 0.618 cellular membrane fusion;sensory
perception of sound
exp DET1 15q25.3 0.214 0.1 0.618
xsq TIA1 2p13 0.214 0.1 0.618 Apoptosis
xsq MST1 3p21 0.214 0.1 0.618
xsq ALDOB 9q21.3-q22.2 0.214 0.1 0.618 fructose 1,6-bisphosphate metabolic
xsq FAM86B2 8p23.1 0.214 0.1 0.618
xsq AGAP6 10q11.23 0.214 0.1 0.618 regulation of ARF GTPase activity
cop BARX1 9q12 0.214 0.1 0.618 anterior/posterior pattern
specification;negative regulation of Wnt receptor signaling pathway
xsq CHPT1 12q 0.214 0.1 0.618 regulation of cell growth;lipid metabolic
process
cop ARHGAP25 2p13.3 0.214 0.1 0.618 regulation of small GTPase mediated
signal transduction;signal transduction
xsq GCSH 16q23.2 0.214 0.1 0.618 glycine catabolic process;glycine
xsq HMGA1 6p21 0.214 0.1 0.618 protein complex assembly;interspecies
exp PARP11 12p13.3 0.214 0.1 0.618
cop TTLL13 15q26.1 0.214 0.1 0.618
cop SSH1 12q24.11 0.214 0.1 0.618 protein dephosphorylation;regulation of
met KDM3B 5q31 -0.214 0.1 0.618 regulation of transcription, DNA-
cop DKFZP586I1420 7p14.3 -0.214 0.1 0.618
cop NOD1 7p15-p14 -0.214 0.1 0.618 apoptotic process;detection of
biotic stimulus
cop GGCT 7p15-p14 -0.214 0.1 0.618 glutathione biosynthetic
cop LOC401320 -0.214 0.1 0.618
cop ZNRF2 7p14.3 -0.214 0.1 0.618
cop MIR550A1 -0.214 0.1 0.618
cop MIR550B1 -0.214 0.1 0.618
exp VMP1 17q23.1 -0.214 0.1 0.618 regulation of autophagy;cell-cell
adhesion
exp ACTG2 2p13.1 -0.214 0.1 0.618 muscle contraction
cop FMN2 1q43 -0.214 0.1 0.618 meiotic chromosome movement towards
spindle pole;actin cytoskeleton organization
exp PLPPR2 -0.214 0.1 0.618
met MYL4 17q21.32 -0.214 0.1 0.618 regulation of the force of heart
contraction;muscle organ development
exp HSBP1L1 18q23 -0.214 0.1 0.618 viral envelope fusion with host
membrane
exp HLA-K -0.214 0.1 0.617
met CLUAP1 16p13.3 -0.214 0.1 0.617
exp SMPX Xp22.1 -0.214 0.1 0.617 striated muscle contraction
cop PAG1 8q21.13 -0.214 0.1 0.617 signal transduction;epidermal
exp YTHDF3 8q12.3 -0.214 0.1 0.617
hs4 AFF3 2q11.2-q12 -0.216 0.1 0.618 embryonic hindlimb
xai FTH1P8 Xq28 -0.216 0.1 0.618
xai ALPK2 18q21.31 -0.216 0.1 0.618 protein phosphorylation
his FLJ40194 17q21.32 -0.216 0.1 0.618
xai CFAP58 -0.216 0.1 0.618
hs4 COX6A2 16p11.12 -0.216 0.1 0.618 generation of precursor
hs4 PTPRE 10q26 -0.216 0.1 0.618 protein phosphorylation;protein
dephosphorylation
xai PLEC 8q24 -0.216 0.1 0.618 cell junction assembly;apoptotic process
exp OR4F13P 15q26.3 -0.216 0.1 0.618
his C18orf63 18q22.3 -0.216 0.1 0.618
exp KRT74 12q13.13 -0.216 0.1 0.618
his CGB1 -0.216 0.1 0.617
his SNAR-G1 19q13.33 -0.216 0.1 0.617
his CGB5 19q13.32 -0.216 0.1 0.617
xai ASGR2 17p -0.216 0.1 0.617 glycoprotein metabolic process;bone
mineralization
xai HOXD-AS2 -0.216 0.1 0.617
his ZNF81 Xp11.23 0.216 0.101 0.618 regulation of transcription, DNA-
dependent"
xai ARHGDIB 12p12.3 0.216 0.101 0.618 multicellular organismal
his PRR19 19q13.2 0.216 0.101 0.618
his PAFAH1B3 19q13.1 0.216 0.101 0.618 lipid metabolic process;nervous
system development
xai TLK2 17q23 0.216 0.101 0.618 DDR (DNA replication)
swa HBE1 11p15.5 0.216 0.101 0.618 oxygen transport;negative regulation of
hs4 SYP Xp11.23-p11.22 0.216 0.101 0.618 endocytosis;synaptic vesicle
maturation
hs4 SYP-AS1 0.216 0.101 0.618
xai PCBP2 12q13.13 0.216 0.101 0.618 mRNA metabolic process;negative
xai IZUMO4 19p13.3 0.216 0.101 0.618
his OR52W1 11p15.4 0.216 0.101 0.618 response to stimulus
his MIGA2 0.216 0.101 0.618
exp ZNF663P 0.216 0.101 0.618 regulation of transcription, DNA-
dependent"
exp RPS2P4 14q32.33 0.216 0.101 0.618
xai ATP2A1 0.216 0.101 0.618 cation transport;ion transmembrane
transport
his UBE2Q2 15q24.2 0.216 0.101 0.618 protein K48-linked ubiquitination
xai FLT1 13q12 0.216 0.101 0.618 Protein Kinases
xai DDX23 12q13.12 0.216 0.101 0.618 RNA splicing, via transesterification
reactions;nuclear mRNA splicing, via spliceosome
his UQCC2 0.216 0.101 0.618
his GALM 2p22.1 0.216 0.101 0.618 carbohydrate metabolic process;hexose
metabolic process
xai CENPO 2p23.3 0.216 0.101 0.618 nucleosome assembly;chromosome
segregation
his ZSCAN32 16p13.3 0.216 0.101 0.618
his ZNF174 16p13.3 0.216 0.101 0.618 negative regulation of
hs4 ONECUT1 15q21.3 0.216 0.101 0.618 glucose metabolic process;cilium
assembly
xai UBE2G1 17p13.2 0.216 0.101 0.619 protein K63-linked
xai LOC100505878 0.216 0.101 0.619
hs4 WDFY4 10q11.23 0.216 0.101 0.619
xai CXorf24 Xp11.23 0.216 0.101 0.619
xai KCNQ1 11p15.5 0.216 0.101 0.619 synaptic transmission;regulation of
membrane repolarization
his CALN1 7q11 0.216 0.101 0.619
xai HAVCR2 5q33.3 0.216 0.101 0.619
his BCOR Xp11.4 0.216 0.101 0.619 Tumor Suppressors
xai AUH 9q22.31 0.216 0.101 0.619 mRNA catabolic process;branched chain
family amino acid catabolic process
his SPRED1 15q14 0.216 0.101 0.619 regulation of signal
transduction;negative regulation of phosphatase activity
his HSP90AB1 6p12 0.216 0.101 0.619 Apoptosis
hs4 CDC25A 3p21 0.216 0.101 0.619 DNA Damage Response (DDR); DDR (DNA
replication); DDR (G2-M checkpoint); Oncogenes
his MYBL2 20q13.1 0.216 0.101 0.619 Apoptosis
exp CATSPERD 19p13.3 0.215 0.101 0.619
exp RPS29P13 6q22.1 0.215 0.101 0.619
xai UBN1 16p13.3 0.215 0.101 0.619 negative regulation of phosphatase
activity;chromatin modification
his SNORD143 0.215 0.101 0.619
his SNORD144 0.215 0.101 0.619
his SEC31A 4q21.22 0.215 0.101 0.619 activation of signaling protein
activity involved in unfolded protein response;COPII vesicle coating
his THAP9 4q21.22 0.215 0.101 0.619
his THAP9-AS1 0.215 0.101 0.619
his SLURP1 8q24.3 0.215 0.101 0.619 cell activation;cell adhesion
xai SAMD10 20q13.33 0.215 0.101 0.619
xai RPS29P13 6q22.1 0.215 0.101 0.619
swa RPS3A 4q31.2-q31.3 0.215 0.101 0.619 Apoptosis
exp HUS1B 6p25.3 0.215 0.101 0.619 DNA Damage Response (DDR)
his LOC101927572 0.215 0.101 0.619
swa ACAT2 6q25.3 0.215 0.101 0.619 lipid metabolic process
his RBSN 0.215 0.101 0.619 protein transport;endosome transport
his CABLES2 20q13.33 0.215 0.101 0.619 regulation of cell
division;regulation of cell cycle
xsq TAF9 5q13.2 0.214 0.101 0.618 regulation of transcription, DNA-
dependent;negative regulation of proteasomal ubiquitin-dependent protein catabolic
process
cop WBP11P1 18q12.1 0.214 0.101 0.618
met CFAP100 0.214 0.101 0.618
dependent"
xsq HNRNPU 1q44 0.214 0.101 0.618 RNA processing;RNA splicing
xsq MAP3K14-AS1 17q21.31 0.214 0.101 0.618
exp CCDC39 3q26.33 0.214 0.101 0.618 axonemal dynein complex
xsq RGS14 5q35.3 0.214 0.101 0.618 spindle organization;zygote asymmetric
cell division
met CALCR 7q21.3 0.214 0.101 0.618 positive regulation of adenylate cyclase
activity;activation of adenylate cyclase activity by G-protein signaling pathway
xsq LOC400541 0.214 0.101 0.618
exp MORC2 22q12.2 0.214 0.101 0.618
met SALL1 16q12.1 0.214 0.101 0.618 regulation of transcription, DNA-
dependent;positive regulation of Wnt receptor signaling pathway
xsq PYCARD 16p11.2 0.214 0.101 0.618 nucleotide-binding domain, leucine
rich repeat containing receptor signaling pathway;regulation of apoptotic process
exp FAM27E1 0.214 0.101 0.618
dependent"
met ABHD4 14q11.2 0.214 0.101 0.618 lipid catabolic process
cop SCARB1 12q24.31 0.214 0.101 0.618 Apoptosis
exp RUNX3 1p36 0.214 0.101 0.618 Apoptosis
exp BMP6 6p24-p23 0.214 0.101 0.618 immune response;positive regulation of
endothelial cell differentiation
met CELSR1 22q13.3 0.214 0.101 0.618 locomotory behavior;orthogonal
dichotomous subdivision of terminal units involved in lung branching morphogenesis
met PRMT9 0.214 0.101 0.618
exp CTDNEP1 17p13 0.214 0.101 0.618 protein dephosphorylation;nuclear
exp HNRNPDL 4q21.22 0.214 0.101 0.618
mut GIT2 12q24.1 0.214 0.101 0.619 regulation of G-protein coupled receptor
protein signaling pathway;regulation of ARF GTPase activity
exp GATC 12q24.31 0.214 0.101 0.619 regulation of translational
exp SPDYE3 7q22.1 0.214 0.101 0.619
exp EIF3LP3 10p11.1 0.214 0.101 0.619
xsq APELA 0.214 0.101 0.619
xsq MAP4K2 11q13 0.214 0.101 0.619 JNK cascade;activation of JUN kinase
activity
cop SPEF1 20p13 0.214 0.101 0.619
cop CENPB 20p13 0.214 0.101 0.619 regulation of transcription, DNA-dependent"
xsq SENP1 12q13.1 0.214 0.101 0.619 proteolysis;activation of cysteine-type
endopeptidase activity involved in apoptotic process
met FAM83H 8q24.3 0.214 0.101 0.619 biomineral tissue development
met PSEN2 1q42.13 0.214 0.101 0.619 Apoptosis
xsq VILL 3p21.3 0.214 0.101 0.619 cytoskeleton organization;actin filament
capping
xsq RPL13A 19q13.3 0.214 0.101 0.619
exp NTSR1 20q13 0.214 0.101 0.619 G-protein coupled receptor signaling
xsq ROCK1P1 18p11.32 0.214 0.101 0.619
met ZNF121 19p 0.214 0.101 0.619 regulation of transcription, DNA-
dependent"
xsq CFAP53 0.214 0.101 0.619
exp MOB1A 2p13.1 0.214 0.101 0.619 hippo signaling cascade
xsq IL10 1q31-q32 0.214 0.101 0.619 Apoptosis
met PHYHIP 8p21.3 0.214 0.101 0.619
xsq RPL36A Xq22.1 0.214 0.101 0.619 translational initiation;viral
infectious cycle
xsq LOC284825 0.214 0.101 0.619
xsq HELQ 4q21.23 0.214 0.101 0.619 DNA Damage Response (DDR); DDR (FA)
met RNF128 Xq22.3 0.214 0.101 0.619 negative regulation of cytokine
exp UBE2QL1 5p15.31 0.214 0.101 0.619
cop HNRNPLL 2p22.1 0.214 0.101 0.619
cop GALM 2p22.1 0.214 0.101 0.619 carbohydrate metabolic process;hexose
metabolic process
cop SRSF7 2p22.1 0.214 0.101 0.619 mRNA export from nucleus;RNA splicing
cop GEMIN6 2p22.1 0.214 0.101 0.619 RNA splicing;gene expression
met SWI5 9q34.11 0.214 0.101 0.619 DNA Damage Response (DDR)
exp NLRP7 19q13.42 0.214 0.101 0.619
mut TAF7 5q31 0.214 0.101 0.619 transcription initiation, DNA-
met KCNK1 1q42-q43 0.214 0.101 0.619 ion transport;potassium ion transport
mir hsa-miR-486-5p 0.214 0.101 0.619
met MIR488 0.214 0.101 0.619
exp SRGN 10q22.1 0.214 0.101 0.619 mast cell secretory granule
met RAPGEF3 12q13.1 0.214 0.101 0.619 small molecule metabolic
process;regulation of catalytic activity
xsq DTWD1 15q21.2 0.214 0.101 0.619
cop NFATC1 18q23 0.214 0.101 0.619 transcription from RNA polymerase II
promoter;intracellular signal transduction
cop RGS17 6q25.3 0.213 0.101 0.619 positive regulation of GTPase
activity;negative regulation of signal transduction
xsq GACAT3 0.213 0.101 0.619
xsq OIP5-AS1 15q15.1 0.213 0.101 0.619
exp LGALS1 22q13.1 -0.213 0.101 0.619 Apoptosis
exp CRTAP 3p22.3 -0.213 0.101 0.619 spermatogenesis
xsq KIAA2026 9p24.1 -0.213 0.101 0.619
xsq FAM57A 17p13.3 -0.214 0.101 0.619
xsq FAM101A 12q24.31 -0.214 0.101 0.619
met GPR65 14q31-q32.1 -0.214 0.101 0.619 multicellular organismal
xsq AMZ1 7p22.3 -0.214 0.101 0.619 proteolysis
xsq PITX1 5q31.1 -0.214 0.101 0.619 anatomical structure
exp HOXC6 12q13.3 -0.214 0.101 0.619 regulation of transcription from
RNA polymerase II promoter;multicellular organismal development
xsq PER3 1p36.23 -0.214 0.101 0.619 DNA Damage Response (DDR)
exp HK1 10q22 -0.214 0.101 0.619 transmembrane transport;carbohydrate
metabolic process
exp GPR1 2q33.3 -0.214 0.101 0.619 G-protein coupled receptor
signaling pathway
met NCR3 6p21.3 -0.214 0.101 0.619 inflammatory response;immune
response
cop TWISTNB 7p21.1 -0.214 0.101 0.619
cop MIR3146 -0.214 0.101 0.619
met ITPRIPL1 2q11.2 -0.214 0.101 0.619
exp VGLL1 Xq26.3 -0.214 0.101 0.619 regulation of transcription, DNA-
dependent"
xsq OSMR 5p13.1 -0.214 0.101 0.619 positive regulation of acute
exp PIP 7q34 -0.214 0.101 0.619
xsq BVES 6q21 -0.214 0.101 0.619 vesicle-mediated transport;regulation of
Rac GTPase activity
xsq LTBP2 14q24 -0.214 0.101 0.619 protein targeting;transforming growth
exp BCAS1 20q13.2 -0.214 0.101 0.619
exp SULT1C2 2q12.3 -0.214 0.101 0.619 xenobiotic metabolic
exp ZFP57 6p22.1 -0.214 0.101 0.619 DNA methylation involved in embryo
development;regulation of gene expression by genetic imprinting
xsq TMEM173 5q31.2 -0.214 0.101 0.619 apoptotic process;cellular
response to exogenous dsRNA
cop OSR2 8q22.2 -0.214 0.101 0.619 cell differentiation;embryonic
digit morphogenesis
xsq ERBB3 12q13 -0.214 0.101 0.619 signal transduction;Schwann cell
differentiation
met MYEOV2 2q37.3 -0.214 0.101 0.619
exp FAM219A 9p13.3 -0.214 0.101 0.619
met SNORD93 7p15.3 -0.214 0.101 0.619
exp FBLN7 2q13 -0.214 0.101 0.619 cell adhesion
xsq QSOX1 1q24 -0.214 0.101 0.618 protein thiol-disulfide exchange;cell
redox homeostasis
xsq PLXNB3 Xq28 -0.214 0.101 0.618 signal transduction;multicellular
met TLR8 Xp22 -0.214 0.101 0.618
exp DAB2 5p13.1 -0.214 0.101 0.618 negative regulation of cell
xsq IFI44L 1p31.1 -0.214 0.101 0.618 immune response;response to
virus
cop CHD7 8q12.2 -0.214 0.101 0.618 heart morphogenesis;chromatin
modification
cop SP4 7p15.3 -0.214 0.101 0.618 regulation of transcription from
exp ALPK2 18q21.31 -0.214 0.101 0.618 protein phosphorylation
exp DAPK2 15q22.31 -0.214 0.101 0.618 Apoptosis
exp LOC645195 1p31.3 -0.214 0.101 0.618
cop GREM2 1q43 -0.214 0.101 0.618 BMP signaling pathway
exp ZBTB18 1q44 -0.214 0.101 0.618
exp COPG1 3q21.3 -0.214 0.101 0.618 intracellular protein
transport;retrograde vesicle-mediated transport, Golgi to ER
cop DPY19L2P1 7p14.2 -0.214 0.101 0.618
exp PDIA3 15q15 -0.214 0.101 0.618 protein retention in ER lumen;cell redox
homeostasis
xai TMEM14A 6p12.2 -0.215 0.101 0.619
exp ANKRD35 1q21.1 -0.215 0.101 0.619
his MFSD7 4p16.3 -0.215 0.101 0.619 transmembrane transport
his ARRDC4 15q26.3 -0.215 0.101 0.619 signal transduction
xai KRT13 17q21.2 -0.215 0.101 0.619 tongue morphogenesis;cellular
hs4 TEAD1 11p15.2 -0.215 0.101 0.619 regulation of transcription, DNA-
dependent;hippo signaling cascade"
his KIAA1456 8p22 -0.215 0.101 0.619 metabolic process
hs4 RAET1G 6q24.1-q25.1 -0.215 0.101 0.619 immune response;antigen
xai SNAI2 8q11 -0.215 0.101 0.619 multicellular organismal
development;regulation of chemokine production
xai CBX7 22q13.1 -0.215 0.101 0.619 negative regulation of
dependent
hs4 TSPAN9 12p13.33-p13.32 -0.215 0.101 0.619
hs4 TRIM22 11p15 -0.215 0.101 0.619 immune response;response to virus
his MIR548AJ1 -0.215 0.101 0.619
swa GNB2 7q22 -0.215 0.101 0.619 synaptic transmission;small molecule
metabolic process
xai COPG1 3q21.3 -0.216 0.101 0.619 intracellular protein
hs4 CWH43 4p11 -0.216 0.101 0.619 GPI anchor biosynthetic process
xai ARID5B 10q21.2 -0.216 0.101 0.619 fibroblast migration;skeletal
swa FBXO2 1p36.22 -0.216 0.101 0.619 glycoprotein catabolic
hs4 BAX 19q13.3-q13.4 -0.216 0.101 0.619 Apoptosis; Protein Kinases
xai FAM151B 5q14.1 -0.216 0.101 0.619
hs4 CD200 3q13.2 -0.216 0.101 0.619 regulation of immune response
xai ZNF35 3p21.32 -0.216 0.101 0.618 regulation of transcription, DNA-
exp ZBED1P1 4q25 -0.216 0.101 0.618
xai ZBED1P1 4q25 -0.216 0.101 0.618
hs4 PDE4D 5q12 -0.216 0.101 0.618 establishment of endothelial barrier;cAMP
catabolic process
xai PVRL4 1q22-q23.2 -0.216 0.101 0.618 adherens junction
xai C6orf1 6p21.31 -0.216 0.101 0.618
DNA-dependent"
hs4 EHD4 15q11.1 -0.216 0.101 0.618 regulation of endocytosis;endocytic
recycling
hs4 PLA2G4E-AS1 -0.216 0.101 0.618
swa RAB5B 12q13 -0.216 0.101 0.618 small GTPase mediated signal
xai MTCH1 6p21.2 -0.216 0.101 0.618 Apoptosis
his LOC283332 12q13.12 -0.216 0.101 0.618
his LOC101927292 -0.216 0.101 0.618
exp LOC646903 -0.216 0.101 0.618
his LOC101928404 -0.216 0.101 0.618
xai RIC3 11p15.4 0.215 0.102 0.619
exp TRAPPC12 2p25.3 0.215 0.102 0.62 vesicle-mediated transport
his TRAT1 3q13 0.215 0.102 0.62 positive regulation of T cell receptor
xai MBNL3 Xq26.2 0.215 0.102 0.62 mRNA processing;multicellular organismal
development
xai RPS6P8 6q13 0.215 0.102 0.62
xai HAGHL 16p13.3 0.215 0.102 0.62
swa HMGA1 6p21 0.215 0.102 0.62 protein complex assembly;interspecies
xai CYCSP20 7q32.1 0.215 0.102 0.62
swa ZC3HAV1 7q34 0.215 0.102 0.62 response to virus;regulation of defense
response to virus by host
his MIR4690 0.215 0.102 0.62
his SIPA1 11q13 0.215 0.102 0.62 Apoptosis
xai CD1A 1q23.1 0.215 0.102 0.62 immune response;antigen processing and
presentation
hs4 TRAF3IP3 1q32 0.215 0.102 0.62
his LINC01287 0.215 0.102 0.62
xai POLR3GL 1q21.1 0.215 0.102 0.62 transcription from RNA polymerase
III promoter;transcription elongation from RNA polymerase III promoter
his DPP6 7q36.2 0.215 0.102 0.62 proteolysis;cell death
exp TRPC7 5q31.1 0.215 0.102 0.62 ion transport;manganese ion transport
cop PRB1 12p13.2 0.215 0.102 0.62
xai GAPVD1 9q33.3 0.215 0.102 0.62 endocytosis;signal transduction
swa URB2 1q42.13 0.215 0.102 0.62
xai LOC100652999 0.215 0.102 0.62
exp NCAN 19p12 0.215 0.102 0.62 cell adhesion;axon guidance
exp ZNF385D-AS1 0.215 0.102 0.62
xai RPS28P8 13q14.11 0.215 0.102 0.62
exp HMGN2P30 7p14.1 0.215 0.102 0.62
exp FREM3 4q31.21 0.215 0.102 0.62 cell communication;cell adhesion
dependent"
his SFXN5 2p13 0.215 0.102 0.62 iron ion homeostasis;transmembrane transport
his PSTK 10q26.13 0.215 0.102 0.62 selenocysteine incorporation;translation
xai SREK1IP1 5q12.3 0.215 0.102 0.62 mRNA processing;RNA splicing
xai CDX1 5q32 0.215 0.102 0.62 anterior/posterior pattern
xai DNAJC12 10q22.1 0.215 0.102 0.62 protein folding
exp RPS28P8 13q14.11 0.215 0.102 0.62
his PSMA3-AS1 0.215 0.102 0.62
his ARID4A 14q23.1 0.215 0.102 0.62 regulation of transcription, DNA-
hs4 TCF4 18q21.1 0.215 0.102 0.62 positive regulation of transcription,
xai ARMC6 19p13.11 0.215 0.102 0.621
swa CHRAC1 8q24.3 0.215 0.102 0.621 DNA Damage Response (DDR); DDR
(Chromatin)
xai UBLCP1 5q33.3 0.215 0.102 0.621
xai GOT2P5 0.215 0.102 0.621
xai XCL1 1q23 0.215 0.102 0.621 immune response;positive regulation of
xai PALD1 10q22.1 0.215 0.102 0.621
exp SLC25A5P8 9p21.1 0.215 0.102 0.621
xai FKSG49 0.215 0.102 0.621
his RPL15 3p24.2 0.215 0.102 0.621 translation;mRNA metabolic process
his NKIRAS1 3p24.2 0.215 0.102 0.621 GTP catabolic process;signal
transduction
xai LMBR1 7q36 0.215 0.102 0.621 embryonic digit morphogenesis
exp GOLGA8J 0.215 0.102 0.621
his EML6 2p16.1 0.215 0.102 0.621
xai LOC285074 2p11.2 0.215 0.102 0.621
xai TMEM242 6q25.3 0.215 0.102 0.621
exp GOT2P5 0.215 0.102 0.621
xai F13A1 6p25.3-p24.3 0.215 0.102 0.621 peptide cross-linking;platelet
activation
his CHRAC1 8q24.3 0.215 0.102 0.621 DNA Damage Response (DDR); DDR
(Chromatin)
his LOC100506844 0.215 0.102 0.621
his RTN4IP1 6q21 0.215 0.102 0.621
his QRSL1 6q21 0.215 0.102 0.621 glutaminyl-tRNAGln biosynthesis via
cop IDH2 15q26.1 0.213 0.102 0.619 Oncogenes
cop SEMA4B 15q25 0.213 0.102 0.619 multicellular organismal
cop CIB1 15q25.3-q26 0.213 0.102 0.619 Apoptosis; DNA Damage Response (DDR)
cop GDPGP1 15q26.1 0.213 0.102 0.619
xsq FAM86C1 11q13.4 0.213 0.102 0.619
exp RAPGEF6 5q31.1 0.213 0.102 0.619 signal transduction;Ras protein
signal transduction
xsq FGR 1p36.2-p36.1 0.213 0.102 0.619 immune response-regulating cell
met ASB9 Xp22.2 0.213 0.102 0.62 protein ubiquitination;intracellular
signal transduction
exp HBA2 16p13.3 0.213 0.102 0.62 transport;positive regulation of cell
death
xsq THAP9-AS1 0.213 0.102 0.62
mut OPN4 10q22 0.213 0.102 0.62 detection of visible light;protein-chromophore
linkage
xsq KLF16 19p13.3 0.213 0.102 0.62 regulation of transcription from RNA
polymerase II promoter;dopamine receptor signaling pathway
xsq EBAG9 8q23 0.213 0.102 0.62 Apoptosis
xsq RNMT 18p11.21 0.213 0.102 0.62 viral reproduction;transcription from RNA
xsq CLSPN 1p34.2 0.213 0.102 0.62 DNA Damage Response (DDR); DDR (G2-M
checkpoint)
xsq LRRC4B 19q13.33 0.213 0.102 0.62
exp RSRC2 12q24.31 0.213 0.102 0.62
xsq RSBN1 1p13.2 0.213 0.102 0.62
met H2AFB3 Xq28 0.213 0.102 0.62
exp NCR3LG1 11p15.1 0.213 0.102 0.62
met DNAH12 3p14.3 0.213 0.102 0.62 microtubule-based movement
xsq FGFR1OP 6q27 0.213 0.102 0.62 positive regulation of cell
cop SELPLG 12q24 0.213 0.102 0.62 leukocyte migration;leukocyte tethering
or rolling
cop CORO1C 12q24.1 0.213 0.102 0.62 phagocytosis;signal transduction
exp GADD45GIP1 19p13.2 0.213 0.102 0.62 cell cycle;interspecies interaction
between organisms
exp ALKBH1 14q24.3 0.213 0.102 0.62 DNA Damage Response (DDR); DDR
(BER)
xsq FAM131B 7q34 0.213 0.102 0.62
exp WASH7P 0.213 0.102 0.62
cop HKDC1 10q22.1 0.213 0.102 0.62 carbohydrate metabolic process;glycolysis
xsq LY75-CD302 0.213 0.102 0.62
exp HTR1E 6q14-q15 0.213 0.102 0.62 G-protein coupled receptor signaling
xsq C2orf49 2q12.1 0.213 0.102 0.62 embryonic morphogenesis
met MIR323B 0.213 0.102 0.62
cop USP30 12q24.11 0.213 0.102 0.62 ubiquitin-dependent protein catabolic
process;proteolysis
cop USP30-AS1 12q24.11 0.213 0.102 0.62
cop ALKBH2 12q24.11 0.213 0.102 0.62 DNA Damage Response (DDR); DDR
(Direct Repair)
cop UNG 12q23-q24.1 0.213 0.102 0.62 DNA Damage Response (DDR); DDR (BER)
cop ACACB 12q24.11 0.213 0.102 0.62 energy reserve metabolic process;fatty
cop FOXN4 12q24.11 0.213 0.102 0.62 neuron fate commitment;axon extension
cop MYO1H 12q24.11 0.213 0.102 0.62
cop KCTD10 12q24.11 0.213 0.102 0.62 potassium ion transport;protein
ubiquitination
cop UBE3B 12q24.11 0.213 0.102 0.62 protein modification process;protein
ubiquitination involved in ubiquitin-dependent protein catabolic process
exp H3F3B 17q25.1 0.213 0.102 0.62 nucleosome assembly;blood coagulation
xsq FCRL2 1q21 0.213 0.102 0.62 cell-cell signaling
exp ARID4A 14q23.1 0.213 0.102 0.62 regulation of transcription, DNA-
xsq TPP2 13q32-q33 0.213 0.102 0.62 antigen processing and presentation of
peptide antigen via MHC class I;proteolysis
xsq ARPP19 15q21.2 0.213 0.102 0.62 G2/M transition of mitotic cell
cycle;cell cycle
xsq RBM8A 1q21.1 0.213 0.102 0.62 RNA splicing;nuclear-transcribed mRNA
catabolic process, nonsense-mediated decay
xsq KDM5A 12p11 0.213 0.102 0.621 positive regulation of transcription, DNA-
exp LOC200772 0.213 0.102 0.621
exp EXOSC3 9p11 0.213 0.102 0.621 exonucleolytic nuclear-transcribed mRNA
catabolic process involved in deadenylation-dependent decay;DNA deamination
cop PSME4 2p16.2 0.213 0.102 0.621 antigen processing and presentation of
peptide antigen via MHC class I;viral reproduction
mut TLN2 15q15-q21 0.213 0.102 0.621 cell-cell junction assembly;cell adhesion
xsq JSRP1 19p13.3 0.213 0.102 0.621
xsq NPTX1 17q25.3 0.213 0.102 0.621 axonogenesis involved in
innervation;transport
cop P4HA3 11q13.4 0.213 0.102 0.621
cop PGM2L1 11q13.4 0.213 0.102 0.621 carbohydrate metabolic
met STXBP6 14q12 0.213 0.102 0.621 vesicle-mediated transport
xsq FAHD2CP 2q11.1 0.213 0.102 0.621
exp PEX5L 3q26.33 0.213 0.102 0.621 protein import into peroxisome
xsq IL31 12q24.31 0.213 0.102 0.621
exp AHSA2 2p15 0.213 0.102 0.621 response to stress
met KRAS 12p12.1 0.213 0.102 0.621 Cell Signaling; Oncogenes; Protein
Kinases
cop NQO1 16q22.1 0.213 0.102 0.621 xenobiotic metabolic process;small
exp MIAT 22q12.1 0.213 0.102 0.621
exp DHX34 19q13.3 0.213 0.102 0.621
exp LOC653375 0.213 0.102 0.621
xsq KIF18B 17q21.31 0.213 0.102 0.621 mitotic cell cycle;microtubule-
based movement
cop LINC00309 0.213 0.102 0.621
met COMMD5 8q24.3 0.213 0.102 0.621 cell cycle arrest
xsq NRDE2 14q32.11 0.213 0.102 0.621
dependent"
mut PIEZO2 18p11.22 0.213 0.102 0.621 ion transport
xsq LOC101927502 0.213 0.102 0.621
xsq PCDH12 5q31 0.213 0.102 0.621 cell adhesion;homophilic cell adhesion
cop TMEM196 7p21.1 -0.213 0.102 0.621
cop ETV1 7p21.3 -0.213 0.102 0.621 Transcription Factors
xsq DUSP15 20q11.21 -0.213 0.102 0.621 protein dephosphorylation
exp CYP4X1 1p33 -0.213 0.102 0.621
cop C7orf71 7p15.2 -0.213 0.102 0.621
cop CHRM3 1q43 -0.213 0.102 0.621 signal transduction;regulation of insulin
secretion
xsq SGSH 17q25.3 -0.213 0.102 0.62 proteoglycan metabolic process
met FADS2 11q12.2 -0.213 0.102 0.62 unsaturated fatty acid biosynthetic
process;transport
cop JAZF1-AS1 7p15.1 -0.213 0.102 0.62
cop NPSR1-AS1 7p14.3 -0.213 0.102 0.62
cop NPSR1 7p14.3 -0.213 0.102 0.62
cop DPY19L1 7p14.3-p14.2 -0.213 0.102 0.62
xsq CYB5R1 1q32.1 -0.213 0.102 0.62 sterol biosynthetic process
exp PLEC 8q24 -0.213 0.102 0.62 cell junction assembly;apoptotic process
xsq MSC 8q21 -0.213 0.102 0.62 regulation of transcription, DNA-
exp MCC 5q21 -0.213 0.102 0.62 signal transduction;negative regulation
cop AHR 7p15 -0.213 0.102 0.62 Apoptosis
cop OPA1 3q29 -0.213 0.102 0.62 Apoptosis
met GIP 17q21.3-q22 -0.213 0.102 0.62 response to selenium ion;positive
regulation of cAMP-mediated signaling
cop HNF4G 8q21.11 -0.213 0.102 0.62 regulation of transcription from
met TRAPPC9 8q24.3 -0.213 0.102 0.62 cell differentiation
exp PLXNA3 Xq28 -0.213 0.102 0.62 axon guidance;hippocampus
development
exp UBL3 13q12-q13 -0.213 0.102 0.62
exp TSEN34 19q13.4 -0.213 0.102 0.62 tRNA-type intron splice site
xsq MMP2 16q13-q21 -0.213 0.102 0.62 Apoptosis
met HRC 19q13.3 -0.213 0.102 0.62 muscle contraction
exp PKD1L1 7p12.3 -0.213 0.102 0.62 detection of nodal flow;cell-
cell adhesion
exp BST2 19p13.1 -0.213 0.102 0.62 positive regulation of I-kappaB
kinase/NF-kappaB cascade;innate immune response
exp RNF103 -0.213 0.102 0.62 protein ubiquitination;ER-
associated protein catabolic process
xsq LRP10 14q11.2 -0.213 0.102 0.62 lipid metabolic process;lipid
transport
exp CERS4 19p13.2 -0.213 0.102 0.62 ceramide biosynthetic
exp TENM3 4q35.1 -0.213 0.102 0.62
xsq MED15 22q11.2 -0.213 0.102 0.619 regulation of transcription from
his LRRC8E 19p13.2 -0.215 0.102 0.621
hs4 LOC283299 -0.215 0.102 0.621
exp XKR9 8q13.3 -0.215 0.102 0.621
hs4 CAPN13 2p22-p21 -0.215 0.102 0.621 proteolysis
hs4 C1orf229 1q44 -0.215 0.102 0.621
hs4 MMRN2 10q23.2 -0.215 0.102 0.621
hs4 SNCG 10q23.2-q23.3 -0.215 0.102 0.621 regulation of dopamine
his SAT2 17p13.1 -0.215 0.102 0.621
his SHBG 17p13.1 -0.215 0.102 0.621 hormone transport;primary
spermatocyte growth
hs4 GFRA1 10q26.11 -0.215 0.102 0.621 glial cell-derived neurotrophic
factor receptor signaling pathway;cell surface receptor signaling pathway
his RUVBL1-AS1 -0.215 0.102 0.621
xai C1QL1 17q21 -0.215 0.102 0.621 locomotory behavior
his LGALSL 2p14 -0.215 0.102 0.62
hs4 DOCK9 13q32.3 -0.215 0.102 0.62 blood coagulation
hs4 DOCK9-AS2 -0.215 0.102 0.62
hs4 PRSS8 16p11.2 -0.215 0.102 0.62 EMT (Epithelial)
his HCAR3 12q24.31 -0.215 0.102 0.62 G-protein coupled receptor
signaling pathway
hs4 ABCC5-AS1 -0.215 0.102 0.62
xai IER3 6p21.3 -0.215 0.102 0.62 Apoptosis
DNA-dependent"
xai SFT2D2 1q24.2 -0.215 0.102 0.62 protein transport;vesicle-
mediated transport
xai CCDC146 7q11.23 -0.215 0.102 0.62
xai IL12A 3q25.33 -0.215 0.102 0.62 cell cycle arrest;positive
his MIR6792 -0.215 0.102 0.62
hs4 HS3ST1 4p16 -0.215 0.102 0.62
his LINC00887 3q29 -0.215 0.102 0.62
xai HOXB-AS1 -0.215 0.102 0.62
hs4 LINC01272 -0.215 0.102 0.62
xai PSG1 19q13.2 -0.215 0.102 0.62 female pregnancy
hs4 DLEU1-AS1 -0.215 0.102 0.62
his MIR548H3 -0.215 0.102 0.62
xai CAPNS1 19q13.12 -0.215 0.102 0.62 proteolysis;metabolic process
xai TRIM38 6p21.3 -0.215 0.102 0.62 signal transduction;positive
hs4 TTYH3 7p22 -0.215 0.102 0.619 ion transport;chloride transport
swa GOT1 10q24.1-q25.1 0.215 0.103 0.621 carbohydrate metabolic
xai PDXP 22q12.3 0.215 0.103 0.621 regulation of mitosis;metabolic process
his AKT1 14q32.32 0.215 0.103 0.621 Apoptosis; Cell Signaling; Oncogenes;
Protein Kinases
dependent"
xai VGLL2 6q22.1 0.215 0.103 0.621 regulation of transcription, DNA-
dependent;skeletal muscle tissue development
dependent"
hs4 CBX3P2 18p11.32 0.215 0.103 0.621
hs4 SMCHD1 18p11.32 0.215 0.103 0.621 inactivation of X chromosome by DNA
methylation;chromosome organization
his DANCR 4q12 0.215 0.103 0.621
his MIR4449 0.215 0.103 0.621
his SNORA26 4q12 0.215 0.103 0.621
his MIR626 0.215 0.103 0.621
xai SP3 2q31 0.215 0.103 0.621 liver development;granulocyte differentiation
exp PYGM 11q12-q13.2 0.215 0.103 0.621 glycogen metabolic process;glycogen
catabolic process
his SERPINB10 18q21.3 0.215 0.103 0.622 negative regulation of
xai TRGV2 0.215 0.103 0.622
xai NKAP Xq24 0.214 0.103 0.622 Notch signaling pathway;negative regulation of
his GPR148 0.214 0.103 0.622
his FAM175B 10q26.13 0.214 0.103 0.622 DNA Damage Response (DDR)
hs4 PRG2 11q12 0.214 0.103 0.622 immune response;defense response to bacterium
his POU2F1 1q24.2 0.214 0.103 0.622 lens induction in camera-type
swa RPS5 19q13.4 0.214 0.103 0.622 regulation of translational
his VPS33A 12q24.31 0.214 0.103 0.622 protein transport;vesicle-mediated
transport
swa NCAPH 2q11.2 0.214 0.103 0.622 DNA Damage Response (DDR)
xai SLC25A5P2 2p22.3 0.214 0.103 0.622
his CYFIP2 5q33.3 0.214 0.103 0.622 apoptotic process;cell-cell
adhesion
his SNORD37 19p13.3 0.214 0.103 0.622
his EEF2 19p13.3 0.214 0.103 0.622 gene expression;cellular protein
metabolic process
his C11orf1 11q23.1 0.214 0.103 0.622
his FDXACB1 0.214 0.103 0.622 phenylalanyl-tRNA aminoacylation;tRNA
processing
his JAGN1 3p25.2 0.214 0.103 0.622
his FXR1 3q28 0.214 0.103 0.622 Apoptosis
xai TIAL1 10q 0.214 0.103 0.622 Apoptosis
his CCDC51 3p21.31 0.214 0.103 0.622
his TMA7 3p21.31 0.214 0.103 0.622
hs4 CHID1 11p15.5 0.214 0.103 0.622 innate immune response;carbohydrate
metabolic process
his METTL8 2q31.1 0.214 0.103 0.622
his DCAF17 2q31.1 0.214 0.103 0.622 protein ubiquitination
hs4 CRHR2 7p14.3 0.214 0.103 0.622 G-protein signaling, coupled to cAMP
nucleotide second messenger;cellular response to corticotropin-releasing hormone
stimulus"
his AES 19p13.3 0.214 0.103 0.622 cellular response to extracellular
xai FIGNL1 7p12.1 0.214 0.103 0.622 regulation of cell cycle;osteoblast
differentiation
swa EXOSC1 10q24 0.214 0.103 0.622 mRNA metabolic process;exonucleolytic
nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent
decay
his ZBTB16 11q23.1 0.214 0.103 0.622 mesonephros development;positive
regulation of chondrocyte differentiation
hs4 UNC13A 19p13.11 0.214 0.103 0.622 exocytosis;intracellular signal
transduction
xai MAPKAPK3 3p21.3 0.214 0.103 0.622 signal transduction;toll-like
receptor 4 signaling pathway
xai MED30 8q24.11 0.214 0.103 0.622 transcription initiation from RNA
polymerase II promoter;gene expression
his KIAA0391 14q13.2 0.214 0.103 0.622 tRNA processing
his PPP2R3C 14q13.2 0.214 0.103 0.622
his MIR4638 0.214 0.103 0.622
his TRIM41 5q35.3 0.214 0.103 0.622
swa NAA50 3q13.2 0.214 0.103 0.622 N-terminal protein amino acid acetylation
his MAP3K11 11q13.1-q13.3 0.214 0.103 0.622 Apoptosis; Protein Kinases
his PCNX3 0.214 0.103 0.622
xai SPATA5 4q28.1 0.214 0.103 0.622 multicellular organismal
xai LOC100132346 0.214 0.103 0.622
his THTPA 14q11.2 0.214 0.103 0.622 thiamine metabolic
process;dephosphorylation
his CD48 1q21.3-q22 0.214 0.103 0.622 T cell activation;mast cell activation
xai MBNL1 3q25 0.214 0.103 0.622 embryonic limb morphogenesis;regulation of
alternative nuclear mRNA splicing, via spliceosome
exp LOC100132346 0.214 0.103 0.622
exp RPL7P20 5q34 0.214 0.103 0.622
his INSRR 1q21-q23 0.214 0.103 0.622 protein autophosphorylation;cellular
response to alkalinity
cop NAGK 2p13.3 0.214 0.103 0.622 N-acetylglucosamine metabolic process;N-
acetylmannosamine metabolic process
xai OIP5 15q15.1 0.214 0.103 0.622 cell communication;CenH3-containing
exp IGF2BP2-AS1 0.214 0.103 0.622
his HAUS5 19q13.12 0.214 0.103 0.622 spindle assembly;centrosome organization
xsq MARK3 14q32.32 0.213 0.103 0.621
met WIZ 19p13.1 0.213 0.103 0.621
met MROH1 8q24.3 0.213 0.103 0.621
xsq CELSR3 3p21.31 0.213 0.103 0.621 G-protein coupled receptor
cop UBC 12q24.3 0.213 0.103 0.621 DNA Damage Response (DDR)
cop MIR5188 0.213 0.103 0.621
cop DHX37 12q24.31 0.213 0.103 0.621
met TMEM100 17q22 0.213 0.103 0.621
mut INTS5 11q12.3 0.213 0.103 0.621 snRNA processing
exp C12orf43 12q24.31 0.213 0.103 0.621
exp PSMB1 6q27 0.213 0.103 0.621 antigen processing and presentation of
mut SIGLEC1 20p13 0.213 0.103 0.621 endocytosis;inflammatory response
exp ECRP 14q11.2 0.213 0.103 0.622
met PLEKHH2 2p21 0.213 0.103 0.622
exp NCAPG2 7q36.3 0.213 0.103 0.622 DNA Damage Response (DDR)
met GPR75 2p16 0.213 0.103 0.622 G-protein coupled receptor signaling pathway
met LOC284661 1p36.32 0.213 0.103 0.622
xsq RPP38 10p13 0.213 0.103 0.622 tRNA processing
xsq DCAF15 19p13.12 0.213 0.103 0.622
cop DCTN1 2p13 0.213 0.103 0.622 G2/M transition of mitotic cell cycle;mitotic
cell cycle
cop DCTN1-AS1 0.213 0.103 0.622
cop C2orf81 2p13.1 0.213 0.103 0.622
cop WDR54 2p13.1 0.213 0.103 0.622
cop RTKN 2p13.1 0.213 0.103 0.622 Apoptosis
cop INO80B 2p13.1 0.213 0.103 0.622 DNA Damage Response (DDR); DDR
(Chromatin)
cop INO80B-WBP1 0.213 0.103 0.622
cop WBP1 2p12 0.213 0.103 0.622
cop MOGS 2p13.1 0.213 0.103 0.622 protein folding;protein N-linked
glycosylation
cop MRPL53 2p13.1 0.213 0.103 0.622
cop CCDC142 2p13.1 0.213 0.103 0.622
cop TTC31 2p13.1 0.213 0.103 0.622
cop LBX2 2p13.1 0.213 0.103 0.622
cop LBX2-AS1 2p13.1 0.213 0.103 0.622
cop PCGF1 2p13.1 0.213 0.103 0.622 regulation of transcription, DNA-
cop TLX2 2p13.1 0.213 0.103 0.622
cop DQX1 2p13.1 0.213 0.103 0.622
cop AUP1 2p13 0.213 0.103 0.622
cop HTRA2 2p12 0.213 0.103 0.622 Apoptosis
cop LOXL3 2p13 0.213 0.103 0.622 oxidation-reduction process
cop DOK1 2p13 0.213 0.103 0.622 intracellular protein kinase cascade;Ras
exp NR2C2 3p25 0.213 0.103 0.622 regulation of transcription, DNA-
xsq ASZ1 7q31.2 0.213 0.103 0.622 spermatogenesis;cell differentiation
xsq PLEKHA8P1 12q 0.213 0.103 0.622
mut ISX 22q12.3 0.213 0.103 0.622
xsq OR6K3 1q23.1 0.213 0.103 0.622
xsq LOC100506100 0.213 0.103 0.622
met LRRC2 3p21.31 0.212 0.103 0.622
met CD99L2 Xq28 0.212 0.103 0.622 cell adhesion
exp GALK2 15q21.1-q21.2 0.212 0.103 0.622 carbohydrate metabolic
met LCE2C 1q21.3 0.212 0.103 0.622 keratinization
xsq DCAKD 17q21.31 0.212 0.103 0.622 coenzyme A biosynthetic process
xsq DNMT1 19p13.2 0.212 0.103 0.622 DNA Damage Response (DDR)
xsq CLEC2D 12p13 0.212 0.103 0.622 cell surface receptor signaling pathway
exp ZC3H3 8q24.3 0.212 0.103 0.622 mRNA polyadenylation;regulation of mRNA
export from nucleus
xsq DPY19L2P3 7p15.1 0.212 0.103 0.622
exp POLQ 3q13.33 0.212 0.103 0.622 DNA Damage Response (DDR); DDR (DNA
exp MPO 17q23.1 0.212 0.103 0.622 defense response;hydrogen peroxide
catabolic process
exp KCNQ2 20q13.3 0.212 0.103 0.622 potassium ion transmembrane transport;ion
transport
met ABCB9 12q24 0.212 0.103 0.622 ABC Transporters
exp RPL32P25 11q21 0.212 0.103 0.622
met ACTC1 15q14 0.212 0.103 0.622 ATP catabolic process;response to ethanol
exp ATP8B4 15q21.2 0.212 0.103 0.622 phospholipid transport;cation
transport
xsq BPIFA3 20q11.21 0.212 0.103 0.622
exp C15orf40 15q25.2 0.212 0.103 0.622
exp TKFC 0.212 0.103 0.622 glycerol metabolic process;innate immune
response
xsq PPHLN1 12q12 0.212 0.103 0.622 keratinization
xsq FAM27L 17p11.2 0.212 0.103 0.622
xsq CISD2 4q24 0.212 0.103 0.622 mitochondrion degradation;multicellular
organismal aging
met CTF1 16p11.2 0.212 0.103 0.622 neuron development;leukemia inhibitory
factor signaling pathway
xsq PIF1 15q22.31 0.212 0.103 0.622 DNA Damage Response (DDR); DDR (DNA
replication)
exp ZRANB3 2q21.3 0.212 0.103 0.622 DNA Damage Response (DDR)
xsq PITHD1 1p36.11 0.212 0.103 0.622
xsq DDX24 14q32 0.212 0.103 0.622 RNA metabolic process
exp HSPA1L 6p21.3 0.212 0.103 0.622 Apoptosis
xsq KRT38 17q21.2 0.212 0.103 0.622
exp CCDC107 9p13.3 -0.212 0.103 0.622
mut DPP10 2q14.1 -0.212 0.103 0.622 proteolysis
xsq SRPX Xp21.1 -0.212 0.103 0.622 cell adhesion
exp PRELID2 5q32 -0.212 0.103 0.622
exp KCNIP1 5q35.1 -0.212 0.103 0.622 synaptic
mut LRRIQ3 1p31.1 -0.212 0.103 0.622
exp CEACAM22P 19q13.31 -0.212 0.103 0.622
met PSG5 19q13.2 -0.213 0.103 0.622 female pregnancy
xsq LINC01320 -0.213 0.103 0.622
mut ZNF8 19q13.43 -0.213 0.103 0.622 negative regulation of
dependent
xsq LOC100126784 11p15.1 -0.213 0.103 0.622
exp RAPGEF3 12q13.1 -0.213 0.103 0.622 small molecule metabolic
exp FKTN 9q31-q33 -0.213 0.103 0.622 nervous system development;muscle
organ development
mut RASA1 5q13.3 -0.213 0.103 0.622 Apoptosis
exp CA12 15q22 -0.213 0.103 0.622 one-carbon metabolic process
exp OR5H1 3q11.2 -0.213 0.103 0.622 response to stimulus
exp VANGL1 1p13.1 -0.213 0.103 0.621 multicellular organismal
development
met OR2L13 1q44 -0.213 0.103 0.621 response to stimulus
exp RWDD3 1p21.3 -0.213 0.103 0.621
xsq ZNF321P 19q13.41 -0.213 0.103 0.621
xsq SYNC 1p35.1 -0.213 0.103 0.621 intermediate filament-based process
xsq KIAA1683 19p13.1 -0.213 0.103 0.621
met MIR320C2 -0.213 0.103 0.621
met IL12RB1 19p13.1 -0.213 0.103 0.621 signal transduction;positive
met STPG1 1p36.11 -0.213 0.103 0.621
met ZNF200 16p13.3 -0.213 0.103 0.621 regulation of transcription,
DNA-dependent"
his EFEMP1 2p16 -0.214 0.103 0.622 peptidyl-tyrosine
xai GMPPA 2q35 -0.214 0.103 0.622 post-translational protein
hs4 ZDHHC21 9p22.3 -0.214 0.103 0.622 small molecule metabolic
xai MOV10 1p13.2 -0.214 0.103 0.622 regulation of transcription, DNA-
dependent;gene silencing by RNA
xai SEMA5B 3q21.1 -0.214 0.103 0.622 nervous system
xai RNU4-9P -0.214 0.103 0.622
his LINC01605 -0.214 0.103 0.622
xai TMEM200B 1p35 -0.214 0.103 0.622
exp RNU4-9P -0.214 0.103 0.622
cop C8orf87 8q22.1 -0.214 0.103 0.622
his MYO6 6q13 -0.214 0.103 0.622 regulation of secretion;intracellular
protein transport
his PPP1R14D 15q15.1 -0.214 0.103 0.622 EMT (Epithelial)
xai COL1A1 17q21.33 -0.214 0.103 0.622 blood vessel
development;sensory perception of sound
xai PCP4L1 1q23.3 -0.214 0.103 0.622
swa MAP7 6q23.3 -0.214 0.103 0.622 microtubule cytoskeleton
xai JUN 1p32-p31 -0.214 0.103 0.622 Apoptosis; Protein Kinases
his MIR4803 -0.214 0.103 0.622
xai HOXC6 12q13.3 -0.214 0.103 0.622 regulation of transcription from
xai FABP7 6q22-q23 -0.214 0.103 0.622 nervous system development;negative
xai IVL 1q21 -0.214 0.103 0.622 keratinocyte
differentiation;keratinization
xai ARHGEF11 1q21 -0.214 0.103 0.622 Rho protein signal
xai C1QTNF6 22q13.1 -0.214 0.103 0.622
xai CACNA2D3 3p21.1 -0.214 0.103 0.622 ion transport
xai FASTK 7q35 -0.214 0.103 0.622 apoptotic process;induction of apoptosis
by extracellular signals
xai UGT2B7 4q13 -0.214 0.103 0.622 metabolic process;cellular
glucuronidation
xai ACTBL2 5q11.2 -0.214 0.103 0.622
his GUCY1B3 4q31.3-q33 -0.214 0.103 0.622 nitric oxide mediated signal
his PTPN1 20q13.1-q13.2 -0.214 0.103 0.622 regulation of
hs4 EPHA3 3p11.2 -0.214 0.103 0.622 Cell Signaling
xai NFKBIZ 3p12-q12 -0.214 0.103 0.622 regulation of transcription,
DNA-dependent;inflammatory response"
his XAF1 17p13.1 -0.214 0.103 0.622 apoptotic process;cytokine-mediated
signaling pathway
exp MT1JP 16q13 -0.214 0.103 0.622
his TRIM44 11p13 -0.214 0.103 0.622
hs4 ACCS 11p11 -0.215 0.103 0.622 biosynthetic process
xai SCN1B 19q13.1 -0.215 0.103 0.622 axon guidance;sodium ion
xai BLVRB 19q13.1-q13.2 -0.215 0.103 0.622 small molecule metabolic
his DNAI2 17q25 -0.215 0.103 0.622 cell projection organization;cilium
assembly
xai PRELID2 5q32 -0.215 0.103 0.622
his ARMC9 2q37.1 -0.215 0.103 0.622
hs4 AP2M1 3q28 -0.215 0.103 0.621 vesicle-mediated transport;transport
xai IFIT2 10q23.31 -0.215 0.103 0.621 negative regulation of protein
binding;cellular response to interferon-alpha
his PTK7 6p21.1-p12.2 -0.215 0.103 0.621 establishment of planar
hs4 RAB17 2q37.3 -0.215 0.103 0.621 protein transport;small GTPase
his MTURN -0.215 0.103 0.621
swa YAP1 11q13 -0.215 0.103 0.621 Apoptosis
xai OGFRL1 6q13 -0.215 0.103 0.621
hs4 VARS2 6p21.33 0.214 0.104 0.622 tRNA aminoacylation for protein
translation;valyl-tRNA aminoacylation
his ADGRE1 0.214 0.104 0.622 cell adhesion;G-protein coupled receptor
signaling pathway
his TRAP1 16p13.3 0.214 0.104 0.622 Apoptosis
his DOCK11 Xq24 0.214 0.104 0.623 blood coagulation;regulation of catalytic
activity
his NDUFB11 Xp11.23 0.214 0.104 0.623 transport;respiratory electron
transport chain
his RBM10 Xp11.23 0.214 0.104 0.623 mRNA processing;RNA splicing
his SEH1L 18p11.21 0.214 0.104 0.623 mitotic prometaphase;protein transport
his KRT40 17q21.2 0.214 0.104 0.623
his TIMM22 17p13 0.214 0.104 0.623 protein transport;protein import into
mitochondrial inner membrane
exp GDI2P2 0.214 0.104 0.623
xai BCRP8 0.214 0.104 0.623
his SDHB 1p36.1-p35 0.214 0.104 0.623 tricarboxylic acid cycle;succinate
metabolic process
xai POLR2G 11q13.1 0.214 0.104 0.623 DNA Damage Response (DDR); DDR
(NER)
his PDPR 16q22.1 0.214 0.104 0.623 pyruvate metabolic process;glycine
catabolic process
xai FRY-AS1 0.214 0.104 0.623
xai HTR1E 6q14-q15 0.214 0.104 0.623 G-protein coupled receptor signaling
xai APOOL Xq21.1 0.214 0.104 0.623
exp POM121L10P 22q11.23 0.214 0.104 0.623
exp RPS2P28 6p21.1 0.214 0.104 0.623
xai MMP27 11q24 0.214 0.104 0.623 proteolysis;metabolic process
his HACD3 0.214 0.104 0.623 small GTPase mediated signal transduction;Rho
exp BCRP8 0.214 0.104 0.623
his RAC2 22q13.1 0.214 0.104 0.623 GTP catabolic process;actin cytoskeleton
organization
xai SENP6 6q13-q14.3 0.214 0.104 0.623 protein modification by small protein
removal;regulation of spindle assembly
his LINC00680-GUSBP4 0.214 0.104 0.623
his LINC00680 0.214 0.104 0.623
his NSMCE3 0.214 0.104 0.623 regulation of transcription, DNA-
dependent;positive regulation of protein ubiquitination
hs4 KIAA0100 17q11.2 0.214 0.104 0.623
xai ASB13 10p15.1 0.214 0.104 0.623 intracellular signal transduction
his ZMAT4 8p11.21 0.214 0.104 0.624
xai RBMY2QP Yp11.2 0.214 0.104 0.624
his HIST2H2BE 1q21.2 0.214 0.104 0.624 nucleosome assembly;defense
his HIST2H2AC 1q21.2 0.214 0.104 0.624 nucleosome assembly
his HIST2H2AB 0.214 0.104 0.624 nucleosome assembly
his DHRS7 14q23.1 0.214 0.104 0.624
his SCAMP5 15q24.2 0.214 0.104 0.624 exocytosis;protein transport
xai OR51A4 0.214 0.104 0.624 response to stimulus
xai NREP 5q22.1 0.214 0.104 0.624 regulation of neuron
differentiation;regulation of transforming growth factor beta receptor signaling
pathway
exp PPP1R14BP2 2q33.3 0.214 0.104 0.624
his RPS17 0.214 0.104 0.624 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;viral reproduction
xai ATP8B4 15q21.2 0.214 0.104 0.624 phospholipid transport;cation
transport
exp OR51A4 0.214 0.104 0.624 response to stimulus
hs4 PPP1R9B 17q21.33 0.214 0.104 0.624 RNA splicing;cell migration
his LINC00176 0.214 0.104 0.624
exp IGLVI-63 0.214 0.104 0.624
his LYRM4-AS1 0.214 0.104 0.624
his RPP40 6p25.1 0.214 0.104 0.624 tRNA processing
his GOSR1 17q11 0.214 0.104 0.624 ER to Golgi vesicle-mediated transport;intra-
hs4 LOC100996263 0.214 0.104 0.624
hs4 FAM46C 1p12 0.214 0.104 0.624
his DNM1P46 0.214 0.104 0.624
his LOC400464 15q26.3 0.214 0.104 0.624
exp LOC100506374 0.214 0.104 0.624
xai ACSF3 16q24.3 0.214 0.104 0.624 lipid metabolic process;fatty acid
metabolic process
swa EIF3A 10q26 0.214 0.104 0.624 translational initiation;gene expression
his LOC101928436 0.214 0.104 0.624
his RNPC3 1p21 0.214 0.104 0.624 mRNA processing;RNA splicing
xai FGD2 6p21.2 0.214 0.104 0.624 regulation of cell shape;induction of
xai RPS2P28 6p21.1 0.214 0.104 0.624
his ATF5 19q13.3 0.214 0.104 0.624 negative regulation of astrocyte
his NUP62 0.214 0.104 0.624 Apoptosis
his IL4I1 19q13.3-q13.4 0.214 0.104 0.624
his MIR4751 0.214 0.104 0.624
xai KRT2 12q13.13 0.214 0.104 0.624 keratinocyte proliferation;keratinocyte
migration
xai ARID4A 14q23.1 0.214 0.104 0.624 regulation of transcription, DNA-
exp LOC100127974 0.214 0.104 0.624
his LOC102724596 0.213 0.104 0.624
dependent"
xai HSD17B6 12q13 0.213 0.104 0.624 androgen catabolic process;steroid
metabolic process
xai NCAPG2 7q36.3 0.213 0.104 0.624 DNA Damage Response (DDR)
his LOC101928177 0.213 0.104 0.624
exp HNRNPA3 2q31.2 0.212 0.104 0.622 nuclear mRNA splicing, via
exp OR4C46 11p11.12 0.212 0.104 0.622 response to stimulus
xsq KLKP1 0.212 0.104 0.622
mut PIWIL3 22q11.23 0.212 0.104 0.622 regulation of translation;meiosis
xsq DYNC1LI1 3p22.3 0.212 0.104 0.622 cell cycle;mitosis
xsq LOC101927919 0.212 0.104 0.622
xsq COIL 17q22 0.212 0.104 0.622 oxidation-reduction process
mir hsa-miR-650 0.212 0.104 0.622
xsq TAF1A 1q42 0.212 0.104 0.623 transcription from RNA polymerase I
exp RBL2 16q12.2 0.212 0.104 0.623 G1 phase of mitotic cell cycle;mitotic
cell cycle
xsq SIGLEC8 19q13.33-q13.41 0.212 0.104 0.623 cell adhesion;signal
transduction
cop FAM71C 12q23.1 0.212 0.104 0.623
exp TSPEAR 21q22.3 0.212 0.104 0.623 cell adhesion
xsq HNRNPH3 10q22 0.212 0.104 0.623 nuclear mRNA splicing, via
mut CD163 12p13.3 0.212 0.104 0.623 acute-phase response;inflammatory
response
xsq DHX8 17q21.31 0.212 0.104 0.623 RNA splicing;nuclear mRNA splicing, via
spliceosome
xsq PRR20E 0.212 0.104 0.623
met CNTF 11q12.2 0.212 0.104 0.623
exp XCL1 1q23 0.212 0.104 0.623 immune response;positive regulation of
mut MYH6 14q12 0.212 0.104 0.623 muscle contraction;myofibril assembly
exp AMN1 12p11.21 0.212 0.104 0.623 DNA Damage Response (DDR)
exp THAP4 2q37.3 0.212 0.104 0.623
met SYT14 1q32.2 0.212 0.104 0.623 cell death
exp ZNF3 7q22.1 0.212 0.104 0.623 cell differentiation;leukocyte activation
cop GCN1 0.212 0.104 0.623 translation;regulation of translation
exp THAP5P1 7q36.3 0.212 0.104 0.623
exp TUBG1 17q21 0.212 0.104 0.623 G2/M transition of mitotic cell cycle;meiotic
xsq SATB1 3p23 0.212 0.104 0.623 interspecies interaction between
exp RUNDC3A 17q21.31 0.212 0.104 0.623 small GTPase mediated signal
transduction
xsq CCDC37-AS1 0.212 0.104 0.624
exp RPL17P38 12q23.3 0.212 0.104 0.624
xsq ZSCAN16-AS1 0.212 0.104 0.624
met FAM196A 10q26.2 0.212 0.104 0.624
met MIR1179 0.212 0.104 0.624
cop MMAB 12q24 0.212 0.104 0.624 cobalamin biosynthetic process
exp FYB 5p13.1 0.212 0.104 0.624 protein phosphorylation;NLS-bearing
met ATP5EP2 13q12 0.212 0.104 0.624 proton transport;ion transport
met CSAG1 Xq28 0.212 0.104 0.624
xsq TMEM33 4p13 0.212 0.104 0.624
exp LINC00341 14q32.13 0.212 0.104 0.624
xsq SRP72 4q11 0.212 0.104 0.624 translation;SRP-dependent cotranslational
xsq COX5B 2q11.2 0.212 0.104 0.624 respiratory gaseous exchange;respiratory
exp SNRPEP4 0.212 0.104 0.624
xsq ACSF3 16q24.3 0.212 0.104 0.624 lipid metabolic process;fatty acid
metabolic process
met TCHHL1 1q21.3 0.212 0.104 0.624
met TSKU 11q13.5 0.212 0.104 0.624
cop CYP1B1-AS1 2p22.2 0.212 0.104 0.624
cop ATL2 2p22.3 0.212 0.104 0.624 GTP catabolic process;ER to Golgi
met POM121L12 7p12.1 0.212 0.104 0.624
xsq TTK 6q14.1 0.212 0.104 0.624 Tumor Suppressors
pro ADPRT_22 0.212 0.104 0.624
exp STK35 20p13 0.212 0.104 0.624
xsq PSMG3-AS1 7p22.3 0.212 0.104 0.624
exp ITGA7 12q13 -0.212 0.104 0.624 regulation of cell shape;cell adhesion
cop ZFHX4 8q21.11 -0.212 0.104 0.624
exp TMEM263 -0.212 0.104 0.624
xsq NINJ1 9q22 -0.212 0.104 0.624 cell adhesion;nervous system development
mut FLNA Xq28 -0.212 0.104 0.624 actin cytoskeleton reorganization;early
endosome to late endosome transport
xsq TSPAN1 1p34.1 -0.212 0.104 0.624
exp TMEM45A 3q12.2 -0.212 0.104 0.624
xsq ADGRA2 -0.212 0.104 0.624 sprouting angiogenesis;G-protein
met RPH3AL 17p13.3 -0.212 0.104 0.624 intracellular protein
exp LOC100506791 -0.212 0.104 0.624
cop PEX2 8q21.1 -0.212 0.104 0.623 cholesterol homeostasis;regulation
of cholesterol biosynthetic process
xsq APCDD1L 20q13.32 -0.212 0.104 0.623
xsq PCDHB15 5q31 -0.212 0.104 0.623 homophilic cell adhesion;nervous
system development
exp BOD1 5q35.2 -0.212 0.104 0.623 cell cycle;mitosis
xsq PCDHGA7 -0.212 0.104 0.623 cell adhesion;homophilic cell
adhesion
met SNORA33 6q23.2 -0.212 0.104 0.623
xsq MPDZ 9p23 -0.212 0.104 0.623 interspecies interaction between
organisms
xsq PNCK Xq28 -0.212 0.104 0.623
exp SPA17 11q24.2 -0.212 0.104 0.623 spermatogenesis;single
fertilization
exp RTN4 2p16.3 -0.212 0.104 0.623 Apoptosis
xsq SFT2D2 1q24.2 -0.212 0.104 0.623 protein transport;vesicle-
mediated transport
cop PI15 8q21.11 -0.212 0.104 0.623
exp NRXN3 14q31 -0.212 0.104 0.623 angiogenesis;cell adhesion
met ZBP1 20q13.31 -0.212 0.104 0.623 innate immune response
cop MIR4797 -0.212 0.104 0.622
cop DLG1-AS1 -0.212 0.104 0.622
xsq BAIAP2L1 7q22.1 -0.212 0.104 0.622 response to
exp KIF1B 1p36.2 -0.212 0.104 0.622 microtubule-based movement;neuron-
neuron synaptic transmission
met SLC16A1 1p12 -0.212 0.104 0.622 Solute Carriers
cop BMPER 7p14.3 -0.212 0.104 0.622 ureteric bud development;blood
vessel endothelial cell proliferation involved in sprouting angiogenesis
met SLC35D1 1p32-p31 -0.212 0.104 0.622 Solute Carriers
his KLHL6-AS1 -0.213 0.104 0.624
xai HRG 3q27 -0.213 0.104 0.624 regulation of platelet
activation;negative regulation of angiogenesis
hs4 LMOD3 3p14.1 -0.213 0.104 0.624
hs4 AMZ1 7p22.3 -0.214 0.104 0.624 proteolysis
hs4 SPIRE2 16q24 -0.214 0.104 0.624 transport
exp LRRC37A16P 17q24.2 -0.214 0.104 0.624
his NT5E 6q14-q21 -0.214 0.104 0.624 dephosphorylation;purine base
metabolic process
hs4 FAM127C Xq26.3 -0.214 0.104 0.624
hs4 MTSS1 8p22 -0.214 0.104 0.624 negative regulation of epithelial cell
proliferation;cellular component movement
exp DGKI 7q32.3-q33 -0.214 0.104 0.624 blood coagulation;platelet
activation
his NPIPB4 16p12.2 -0.214 0.104 0.624
hs4 INHBA-AS1 7p14.1 -0.214 0.104 0.623
his ECEL1P2 2q37.1 -0.214 0.104 0.623
xai LPIN3 20q12 -0.214 0.104 0.623 dephosphorylation;lipid metabolic process
his GLIPR2 9p13.3 -0.214 0.104 0.623
his L1CAM Xq28 -0.214 0.104 0.623 leukocyte cell-cell adhesion;cell
differentiation
his LCA10 Xq28 -0.214 0.104 0.623
xai RWDD3 1p21.3 -0.214 0.104 0.623
hs4 C6orf15 6p21.3 -0.214 0.104 0.623 extracellular matrix
organization
hs4 PSORS1C1 6p21.3 -0.214 0.104 0.623
xai EFEMP2 11q13.1 -0.214 0.104 0.623 blood coagulation
xai MDGA2 14q21.3 -0.214 0.104 0.623 spinal cord motor neuron
differentiation
hs4 PLEKHG3 14q23.3 -0.214 0.104 0.623 regulation of Rho protein
signal transduction
exp LOC729987 -0.214 0.104 0.623
hs4 ABHD12B 14q22.1 -0.214 0.104 0.623
xai UBL3 13q12-q13 -0.214 0.104 0.622
hs4 ZBTB20-AS4 -0.214 0.104 0.622
xai NNMT 11q23.1 -0.216 0.104 0.622 small molecule metabolic
his VTRNA1-1 5q31.3 0.213 0.105 0.624
xai IGLVI-63 0.213 0.105 0.624
exp HAP1 17q21.2-q21.3 0.213 0.105 0.624 protein localization;synaptic
transmission
his JADE1 0.213 0.105 0.624 histone H4-K5 acetylation;histone H4-K8
acetylation
exp KLHL32 6q16.1 0.213 0.105 0.624
his VWDE 7p21.3 0.213 0.105 0.624
xai DCAKD 17q21.31 0.213 0.105 0.624 coenzyme A biosynthetic process
xai NCR3LG1 11p15.1 0.213 0.105 0.624
xai POLQ 3q13.33 0.213 0.105 0.624 DNA Damage Response (DDR); DDR (DNA
hs4 LAGE3 Xq28 0.213 0.105 0.624
his SRRT 7q21 0.213 0.105 0.625 gene silencing by RNA;primary miRNA processing
xai PCGF6 10q24.33 0.213 0.105 0.625 negative regulation of transcription,
DNA-dependent"
xai GK Xp21.3 0.213 0.105 0.625 glycerol metabolic process;triglyceride
metabolic process
his FKTN 9q31-q33 0.213 0.105 0.625 nervous system development;muscle organ
development
xai UTP6 17q11.2 0.213 0.105 0.625 rRNA processing;RNA processing
xai LOC100127974 0.213 0.105 0.625
his CLN3 16p12.1 0.213 0.105 0.625 cellular amino acid metabolic
process;lysosome organization
his APOBR 16p11 0.213 0.105 0.625 triglyceride metabolic process;transport
his SSB 2q31.1 0.213 0.105 0.625 RNA processing;tRNA modification
swa NHP2 5q35.3 0.213 0.105 0.625 DNA Damage Response (DDR)
xai SMNDC1 10q23 0.213 0.105 0.625 Apoptosis
xai PLA2G4D 15q15.1 0.213 0.105 0.625 metabolic process;phospholipid
catabolic process
his TXLNB 6q24.1 0.213 0.105 0.625
his ZKSCAN2 16p12.1 0.213 0.105 0.625 viral reproduction
xai PLGLA 2q12.2 0.213 0.105 0.625
xai UNKL 16p13.3 0.213 0.105 0.625
hs4 TPSAB1 0.213 0.105 0.625 defense response;proteolysis
hs4 SIRPB2 20p13 0.213 0.105 0.625
his C14orf180 14q32.33 0.213 0.105 0.625
his C22orf34 22q13.33 0.213 0.105 0.625
his APPBP2 17q23.2 0.213 0.105 0.625 intracellular protein
exp HSPA8P6 2q34 0.213 0.105 0.625
dependent"
xai LOC100506374 0.213 0.105 0.625
his C14orf166 14q22.1 0.213 0.105 0.625 positive regulation of
dependent"
xai PLPPR5 0.213 0.105 0.625
exp LOC285074 2p11.2 0.213 0.105 0.625
xai FGL1 8p22 0.213 0.105 0.625 signal transduction
his C9orf16 9q34.1 0.213 0.105 0.625
hs4 RCOR1 14q32.31 0.213 0.105 0.625 interspecies interaction between
xai HBS1L 6q23.3 0.213 0.105 0.625 signal transduction;translation
xai INPP5B 1p34 0.213 0.105 0.625 signal transduction;small GTPase mediated
signal transduction
his SNAR-A2 0.213 0.105 0.625
cop MIR190A 0.213 0.105 0.625
his UNG 12q23-q24.1 0.213 0.105 0.625 DNA Damage Response (DDR); DDR (BER)
xai DEXI 16p13.13 0.213 0.105 0.625
xai RNF214 11q23.3 0.213 0.105 0.625
his PHF5A 22q13.2 0.213 0.105 0.625 nuclear mRNA splicing, via
his ACO2 22q13.2 0.213 0.105 0.625 generation of precursor metabolites and
energy;tricarboxylic acid cycle
his CXorf56 Xq23 0.213 0.105 0.625
his COMMD4 15q24.2 0.213 0.105 0.625
exp HIST1H1D 6p21.3 0.213 0.105 0.625 nucleosome assembly;nucleosome
positioning
xai UPF1 19p13.2-p13.11 0.213 0.105 0.625 DNA Damage Response (DDR)
exp PLA2G4D 15q15.1 0.213 0.105 0.625 metabolic process;phospholipid
catabolic process
his TTC37 5q15 0.213 0.105 0.625
his ARSK 5q15 0.213 0.105 0.625
cop KCNF1 2p25 0.212 0.105 0.624 transmembrane transport;potassium ion
exp XPOT 12q14.2 0.212 0.105 0.624 tRNA export from nucleus;transport
xsq LOC101928886 0.212 0.105 0.624
exp SMARCB1 22q11.23 0.212 0.105 0.624 DNA Damage Response (DDR); DDR
xsq COX7C 5q14 0.212 0.105 0.624 generation of precursor metabolites and
exp CKMT1B 15q15 0.212 0.105 0.624
exp TLE3 15q22 0.212 0.105 0.624 regulation of transcription, DNA-
xsq C3orf80 3q25.33 0.212 0.105 0.625
exp MMACHC 1p34.1 0.212 0.105 0.625
cop MYCT1 6q25.2 0.212 0.105 0.625
cop VIP 6q25 0.212 0.105 0.625 G-protein coupled receptor signaling
pathway;body fluid secretion
xsq MATR3 5q31.2 0.212 0.105 0.625
xsq LOC101928885 0.211 0.105 0.625
exp PBX2 6p21.3 0.211 0.105 0.625 positive regulation of transcription from
RNA polymerase II promoter;proximal/distal pattern formation
cop FLJ33534 0.211 0.105 0.625
cop C2orf50 2p25.1 0.211 0.105 0.625
cop LOC286359 9q22.33 0.211 0.105 0.625
met DIAPH2 Xq21.33 0.211 0.105 0.625 actin cytoskeleton
organization;actin filament polymerization
cop SUPV3L1 10q22.1 0.211 0.105 0.625 positive regulation of cell
exp RPL17P31 8q13.2 0.211 0.105 0.625
xsq ING2 4q35.1 0.211 0.105 0.625 positive regulation of transforming
growth factor beta receptor signaling pathway;regulation of transcription, DNA-
dependent
cop RAB11FIP5 2p13 0.211 0.105 0.625 protein transport
cop LOC100288911 2p22.3 0.211 0.105 0.625
exp LOC728535 5q13.2 0.211 0.105 0.625
mut GPR85 7q31 0.211 0.105 0.625 signal transduction;G-protein coupled receptor
signaling pathway
exp UTP6 17q11.2 0.211 0.105 0.625 rRNA processing;RNA processing
xsq AKNA 9q32 0.211 0.105 0.625 regulation of transcription, DNA-dependent"
xsq NSUN5 7q11.23 0.211 0.105 0.625
cop MIR3692 0.211 0.105 0.625
dependent"
cop DNAJC27-AS1 0.211 0.105 0.625
met GGA2 16p12 0.211 0.105 0.625 vesicle-mediated transport;intracellular
protein transport
xsq NAE1 16q22 0.211 0.105 0.625 Apoptosis
exp NXF1 11q12-q13 0.211 0.105 0.625 mRNA export from nucleus;transport
xsq PARM1 4q13.3-q21.3 0.211 0.105 0.625 positive regulation of telomerase
activity
exp SBK1 16p11.2 0.211 0.105 0.625 peptidyl-serine phosphorylation;peptidyl-
threonine phosphorylation
dependent"
met ZNF385B 2q31.2-q31.3 0.211 0.105 0.625
met CCDC149 4p15.2 0.211 0.105 0.625
cop CCDC64 12q24.23 0.211 0.105 0.625 transport;nervous system
development
exp SIPA1 11q13 0.211 0.105 0.625 Apoptosis
xsq FER1L6 8q24.1 0.211 0.105 0.625
xsq NTMT1 9q34.11 0.211 0.105 0.625
mut ARHGAP12 10p11.22 0.211 0.105 0.625 signal transduction;small GTPase
met SELENBP1 1q21.3 0.211 0.105 0.625 protein transport
xsq GATC 12q24.31 0.211 0.105 0.625 regulation of translational
xsq DNAJC8 1p35.3 0.211 0.105 0.625 nuclear mRNA splicing, via
xsq CORT 0.211 0.105 0.625
exp INPP5B 1p34 0.211 0.105 0.625 signal transduction;small GTPase mediated
signal transduction
met GPR37L1 1q32.1 0.211 0.105 0.625
met GPN1 2p23.3 0.211 0.105 0.625
met NMNAT2 1q25 0.211 0.105 0.625 vitamin metabolic process;water-soluble
exp C8orf37 8q22.1 0.211 0.105 0.625
cop TRIM14 9q22.33 0.211 0.105 0.625
xsq LINC00599 8p23.1 0.211 0.105 0.625
met ANKRD30A 10p11.21 0.211 0.105 0.625 regulation of transcription, DNA-
dependent"
met THADA 2p21 0.211 0.105 0.625
mut GRIK1 21q22.11 0.211 0.105 0.625 nervous system development;regulation of
synaptic transmission, glutamatergic
cop HK2 2p13 0.211 0.105 0.625 Apoptosis
exp PUS7L 12q12 0.211 0.105 0.625 pseudouridine synthesis;tRNA processing
met NXPE2 11q23.3 0.211 0.105 0.625
met HOXB2 17q21.32 0.211 0.105 0.625 anterior/posterior pattern
xsq BMP6 6p24-p23 0.211 0.105 0.625 immune response;positive regulation of
met CLEC3A 16q23 0.211 0.105 0.625
cop LRRC69 8q21.3 -0.211 0.105 0.625
exp FOXF2 6p25.3 -0.211 0.105 0.625 Apoptosis
exp APOD 3q29 -0.211 0.105 0.625 lipid transport;negative regulation of
met VWA1 1p36.33 -0.211 0.105 0.625 extracellular matrix organization
exp LIPG 18q21.1 -0.211 0.105 0.625 cell proliferation;regulation of
lipoprotein metabolic process
exp CCSER2 10q23.1 -0.211 0.105 0.625
cop CRISPLD1 8q21.11 -0.211 0.105 0.625
met RASGRP2 11q13 -0.211 0.105 0.625 Ras protein signal
xsq EGR2 10q21.1 -0.211 0.105 0.625 learning or memory;regulation of
ossification
cop MASP1 3q27-q28 -0.211 0.105 0.625 negative regulation of complement
activation;complement activation, lectin pathway
xsq ACOT6 14q24.3 -0.211 0.105 0.625
exp KRT19P2 12q22 -0.211 0.105 0.625
cop GAS5-AS1 -0.211 0.105 0.625
cop GAS5 1q25.1 -0.211 0.105 0.625
cop SNORD81 -0.211 0.105 0.625
cop SNORD47 -0.211 0.105 0.625
cop SNORD80 -0.211 0.105 0.625
cop SNORD79 -0.211 0.105 0.625
cop SNORD78 -0.211 0.105 0.625
cop SNORD44 -0.211 0.105 0.625
cop SNORD77 -0.211 0.105 0.625
cop SNORD76 -0.211 0.105 0.625
cop SNORD75 -0.211 0.105 0.625
cop SNORD74 1q25.1 -0.211 0.105 0.625
cop ZBTB37 1q25.1 -0.211 0.105 0.625 regulation of transcription,
DNA-dependent"
cop SERPINC1 1q25.1 -0.211 0.105 0.625 blood coagulation;negative
xsq ITGAX 16p11.2 -0.211 0.105 0.625 leukocyte migration;defense
response to virus
cop RC3H1 1q25.1 -0.211 0.105 0.625 nuclear-transcribed mRNA catabolic
process;negative regulation of T-helper cell differentiation
xsq HACD1 -0.211 0.105 0.625 fatty acid biosynthetic process;signal
transduction
exp SRRM3 7q11.23 -0.211 0.105 0.625
exp LOC646701 -0.211 0.105 0.625
exp TTPAL 20q13.12 -0.211 0.105 0.625
cop VWC2 7p12.2 -0.211 0.105 0.625
cop PMP2 8q21.3-q22.1 -0.211 0.105 0.625
cop FABP9 -0.211 0.105 0.625
cop FABP4 8q21 -0.211 0.105 0.625 cholesterol homeostasis;small molecule
metabolic process
cop FABP12 8q21.13 -0.211 0.105 0.625
xsq TAC3 12q13-q21 -0.211 0.105 0.625 response to morphine;positive
cop ZFHX4-AS1 8q21.11 -0.211 0.105 0.625
cop GRB10 7p12.2 -0.211 0.105 0.625 response to insulin
xsq GBP1P1 1p22.2 -0.212 0.105 0.625
exp PLEKHG5 1p36.31 -0.212 0.105 0.625 small GTPase mediated signal
transduction;cell death
xsq IVL 1q21 -0.212 0.105 0.624 keratinocyte
exp EPG5 18q12.3 -0.212 0.105 0.624 autophagy
xsq FN3K 17q25.3 -0.212 0.105 0.624 fructoselysine metabolic process
exp PLPP3 -0.212 0.105 0.624 negative regulation of protein
xai SLC7A14 3q26.2 -0.213 0.105 0.625 transport;negative regulation
xai APOD 3q29 -0.213 0.105 0.625 lipid transport;negative regulation of
his MIR1180 -0.213 0.105 0.625
exp APOBEC3F 22q13.1 -0.213 0.105 0.625 negative regulation of
host
xai PKD1L1 7p12.3 -0.213 0.105 0.625 detection of nodal flow;cell-
cell adhesion
exp LZTS1-AS1 -0.213 0.105 0.625
xai LRRC49 15q23 -0.213 0.105 0.625
exp YAP1P2 -0.213 0.105 0.625
xai SORT1 1p13.3 -0.213 0.105 0.625 transport;regulation of gene
expression
xai ACTR3P2 Xq13.1 -0.213 0.105 0.625
his ADAM30 1p12 -0.213 0.105 0.625 proteolysis
xai IQCE 7p22.3 -0.213 0.105 0.625
hs4 KRT17 17q21.2 -0.213 0.105 0.625
xai KAZN 1p36.21 -0.213 0.105 0.625 keratinization
hs4 ARHGAP20 11q23.1 -0.213 0.105 0.625 signal transduction;small
xai IQGAP1 15q26.1 -0.213 0.105 0.625 energy reserve metabolic
xai TTC12 11q23.2 -0.213 0.105 0.625
hs4 FAM110C 2p25.3 -0.213 0.105 0.625
his LOC102724784 -0.213 0.105 0.625
swa RDH11 14q24.1 -0.213 0.105 0.625 small molecule metabolic
process;retinoid metabolic process
hs4 USP54 10q22.2 -0.213 0.105 0.625 ubiquitin-dependent protein
catabolic process
hs4 BMPR1B-AS1 -0.213 0.105 0.625
hs4 BMPR1B 4q22-q24 -0.213 0.105 0.625 skeletal system
xai LRRC37A16P 17q24.2 -0.213 0.105 0.625
xai IGFBP3 7p12.3 -0.213 0.105 0.625 Apoptosis
his LINC00958 -0.213 0.105 0.625
his TPCN1 12q24.13 -0.213 0.105 0.625 ion transport;transmembrane
transport
his LINC00906 19q12 -0.213 0.105 0.625
xai RNPEP 1q32 -0.213 0.105 0.625 retina development in camera-type
eye;proteolysis
xai PACSIN2 22q13.2-q13.33 -0.213 0.105 0.625 negative regulation of
endocytosis;transport
xai PCNXL2 1q42.2 -0.213 0.105 0.625
xai EMP1 12p12.3 -0.213 0.105 0.625 multicellular organismal
his CCDC130 19p13.2 -0.213 0.105 0.625 response to virus
xai DTX2 7q11.23 -0.213 0.105 0.625 Notch signaling pathway
swa SPRYD4 12q13.3 -0.213 0.105 0.625
xai LINC01239 -0.213 0.105 0.625
xai CTBP2P7 19q13.12 -0.213 0.105 0.625
xai ACTG2 2p13.1 -0.213 0.105 0.624 muscle contraction
exp RPS6KA2-IT1 -0.213 0.105 0.624
xai ZBTB18 1q44 -0.213 0.105 0.624
xai SCUBE2 11p15.3 -0.213 0.105 0.624
hs4 COL5A2 2q14-q32 -0.213 0.105 0.624 collagen fibril
organization;skin development
his LINC01460 -0.213 0.105 0.624
hs4 SPAG1 8q22.2 -0.213 0.105 0.624 single fertilization
hs4 SP100 2q37.1 -0.213 0.105 0.624 response to type I
factor activity
exp LOC100131796 0.213 0.106 0.625
his FNBP1 9q34 0.213 0.106 0.625 endocytosis;nervous system development
his DNAJC2 7q22 0.213 0.106 0.626 positive regulation of transcription,
DNA-dependent;'de novo' cotranslational protein folding
his PSMC2 7q22.1-q22.3 0.213 0.106 0.626 S phase of mitotic cell
cycle;regulation of cellular amino acid metabolic process
xai H1FX 3q21.3 0.213 0.106 0.626 nucleosome assembly
his LOC105376351 0.213 0.106 0.626
his GATAD2B 1q21.3 0.213 0.106 0.626
xai GDI2P2 0.213 0.106 0.626
his LINC01480 0.213 0.106 0.626
xai MDH2 7cen-q22 0.213 0.106 0.626 glucose metabolic process;small molecule
metabolic process
exp LINC01192 0.213 0.106 0.626
xai KIAA1551 12p11.21 0.213 0.106 0.626
his CEP78 9q21.2 0.213 0.106 0.626 G2/M transition of mitotic cell
xai CBLL1 7q22.3 0.213 0.106 0.626 negative regulation of cell
his DUS3L 19p13.3 0.213 0.106 0.626 tRNA processing
xai ATP5SL 19q13.2 0.213 0.106 0.626
his KRT16P3 0.213 0.106 0.626
his FMO1 1q24.3 0.213 0.106 0.626 small molecule metabolic process;NADPH
oxidation
his SDF2 17q11.2 0.213 0.106 0.626 protein glycosylation
his SUPT6H 17q11.2 0.213 0.106 0.626 regulation of transcription from
RNA polymerase II promoter;regulation of transcription elongation, DNA-dependent
his EFCAB14 1p33 0.213 0.106 0.626
xai QRICH1 3p21.31 0.213 0.106 0.626
hs4 PCDHGB3 0.213 0.106 0.626
exp POU1F1 3p11 0.213 0.106 0.626 regulation of transcription, DNA-
exp ANKRD26P3 13q12.11 0.213 0.106 0.626
xai PRDM8 4q21 0.213 0.106 0.626 regulation of transcription, DNA-dependent"
his NMB 15q22-qter 0.212 0.106 0.627 neuropeptide signaling pathway;cell-cell
signaling
his MIR662 0.212 0.106 0.627
xai MTCO2P1 20q13.33 0.212 0.106 0.627
hs4 MIR675 0.212 0.106 0.627
his CD300C 17q25.1 0.212 0.106 0.627 cellular defense response
his LOC101926948 0.212 0.106 0.627
his SIT1 9p13-p12 0.212 0.106 0.627 signal transduction;regulation of T cell
activation
hs4 PPP1R18 6p21.3 0.212 0.106 0.627
hs4 NRM 6p21.33 0.212 0.106 0.627
his DDX39B 6p21.3 0.212 0.106 0.627 spliceosome assembly;nuclear mRNA
his SNORD84 0.212 0.106 0.627
his DDX39B-AS1 0.212 0.106 0.627
exp MTCO2P1 20q13.33 0.212 0.106 0.627
xai CEP68 2p14 0.212 0.106 0.627 centrosome organization
xai MRPL38 17q25.3 0.212 0.106 0.627
xai NUDT7 16q23.1 0.212 0.106 0.627 nucleoside diphosphate metabolic process
exp DNAJC5B 8q13.1 0.212 0.106 0.627 protein folding
xai LOC100131796 0.212 0.106 0.627
his S100A8 1q21 0.212 0.106 0.627 inflammatory response;response to zinc
ion
hs4 LINC01415 0.212 0.106 0.627
his IPP 1p34-p32 0.212 0.106 0.627
exp OSTF1P1 0.212 0.106 0.627
xai OSTF1P1 0.212 0.106 0.627
swa COA4 11q13.4 0.212 0.106 0.627
exp SIRT1 10q21.3 0.211 0.106 0.625 Apoptosis; DNA Damage Response (DDR)
xsq DIS3L 15q22.31 0.211 0.106 0.625 rRNA catabolic process
xsq WISP2 20q13.12 0.211 0.106 0.625 Oncogenes
xsq SDHAF3 0.211 0.106 0.626 regulation of gluconeogenesis
xsq DNTT 10q23-q24 0.211 0.106 0.626 DNA Damage Response (DDR); DDR (NHEJ);
cop TDRD7 9q22.33 0.211 0.106 0.626 lens morphogenesis in camera-type
eye;germ cell development
exp ZSCAN5A 19q13.43 0.211 0.106 0.626 viral reproduction
xsq ATP11C Xq27.1 0.211 0.106 0.626 cation transport;ion transmembrane
transport
pro DSG1 18q12.1 0.211 0.106 0.626 calcium-dependent cell-cell
mut SAMD9L 7q21.2 0.211 0.106 0.626
xsq ZFP69B 1p34.2 0.211 0.106 0.626
xsq RPSAP9 9q21.13 0.211 0.106 0.626
xsq TEX12 11q22 0.211 0.106 0.626
xsq GNL3L Xp11.22 0.211 0.106 0.626 ribosome biogenesis
xsq HMGB3 Xq28 0.211 0.106 0.626 DNA recombination;multicellular organismal
development
xsq OR5M10 0.211 0.106 0.626
met SORCS1 10q23-q25 0.211 0.106 0.626 neuropeptide signaling pathway
mir hsa-miR-636 0.211 0.106 0.626
exp CENPO 2p23.3 0.211 0.106 0.626 nucleosome assembly;chromosome
segregation
xsq CBWD3 0.211 0.106 0.626
exp BIRC6 2p22.3 0.211 0.106 0.626 Apoptosis
cop REREP3 15q11.2 0.211 0.106 0.626
xsq RPL12 9q34 0.211 0.106 0.626 translational elongation;viral transcription
cop MIR4435-1 0.211 0.106 0.626
cop MIR4435-2 0.211 0.106 0.626
exp EP400 12q24.33 0.211 0.106 0.626 regulation of transcription, DNA-
xsq EXOSC4 8q24.3 0.211 0.106 0.626 RNA metabolic process;mRNA
metabolic process
mut SLCO1B3 12p12 0.211 0.106 0.626 Solute Carriers
xsq PYY2 17q11 0.211 0.106 0.626
xsq FANCD2OS 3p25.3 0.211 0.106 0.626
xsq NDUFS8 11q13 0.211 0.106 0.626 small molecule metabolic
xsq IQCJ 3q25.32 0.211 0.106 0.626
exp ERICH1 8p23.3 0.211 0.106 0.626
xsq BORCS5 0.211 0.106 0.626
xsq C1orf140 1q41 0.211 0.106 0.626
met TUSC5 17p13.3 0.211 0.106 0.627 response to biotic stimulus
exp BUB3 10q26 0.211 0.106 0.627 attachment of spindle microtubules to
met PDGFRL 8p22-p21.3 0.211 0.106 0.627 platelet-derived growth factor
receptor-beta signaling pathway
met LYST 1q42.1-q42.2 0.211 0.106 0.627 natural killer cell mediated
cytotoxicity;defense response to bacterium
xsq DNAH17 17q25.3 0.211 0.106 0.627 ciliary or flagellar
met YY2 Xp22.2-p22.1 0.211 0.106 0.627 regulation of transcription, DNA-
dependent"
met MATN3 2p24-p23 0.211 0.106 0.627 skeletal system development
xsq PSMD4 1q21.3 0.211 0.106 0.627 S phase of mitotic cell cycle;DNA damage
exp C1DP3 0.211 0.106 0.627
xsq GRIN3B 19p13.3 0.211 0.106 0.627
xsq NRL 14q11.1-q11.2 0.211 0.106 0.627 transcription from RNA polymerase
II promoter;multicellular organismal development
xsq NICN1 3p21.31 0.211 0.106 0.627
cop MIR5000 0.211 0.106 0.627
xsq LDHB 12p12.2-p12.1 0.211 0.106 0.627 lactate metabolic process;pyruvate
metabolic process
exp TROVE2 1q31 0.211 0.106 0.627 transcription from RNA polymerase III
promoter
xsq GDI2 10p15 0.211 0.106 0.627 signal transduction;small GTPase mediated
signal transduction
xsq B4GALT3 1q21-q23 0.211 0.106 0.627 carbohydrate metabolic
dependent"
met OR4C46 11p11.12 0.211 0.106 0.627 response to stimulus
exp RPL26P32 12q21.31 0.211 0.106 0.627
exp RPL31P7 17q25.3 0.211 0.106 0.627
xsq LOC643339 12q22 0.211 0.106 0.627
xsq LINC01519 0.211 0.106 0.627
cop TMOD1 9q22.3 0.211 0.106 0.627 muscle filament sliding;myofibril
assembly
cop TSTD2 9q22.33 0.211 0.106 0.627
cop NCBP1 9q34.1 0.211 0.106 0.627 termination of RNA polymerase II
cop XPA 9q22.3 0.211 0.106 0.627 DNA Damage Response (DDR); DDR (NER)
cop FOXE1 9q22 0.211 0.106 0.627 Apoptosis
cop C9orf156 9q22.33 0.211 0.106 0.627
cop HEMGN 9q22.33 0.211 0.106 0.627 multicellular organismal development;cell
differentiation
cop ANP32B 9q22.32 0.211 0.106 0.627
cop NANS 9p24.1-p23 0.211 0.106 0.627 lipopolysaccharide biosynthetic
process;carbohydrate biosynthetic process
exp NHEJ1 2q35 0.211 0.106 0.627 DNA Damage Response (DDR); DDR (NHEJ)
met KCNB1 20q13.2 0.21 0.106 0.627 energy reserve metabolic process;ion
transport
xsq CRISP3 6p12.3 -0.21 0.106 0.627 innate immune response;defense
response
met C9orf47 9q22.1 -0.21 0.106 0.627
exp ST6GALNAC2 17q25.1 -0.211 0.106 0.627 protein glycosylation;O-
glycan processing
xsq DNALI1 1p35.1 -0.211 0.106 0.627 cellular component
met IL2RA 10p15-p14 -0.211 0.106 0.627 cell surface receptor signaling
pathway;negative regulation of defense response to virus
cop DNAH5 5p15.2 -0.211 0.106 0.627 ciliary or flagellar
cop FLJ45974 -0.211 0.106 0.627
exp MCAM 11q23.3 -0.211 0.106 0.627 vascular wound healing;glomerular
filtration
cop LOC100127983 -0.211 0.106 0.627
xsq TP53I3 2p23.3 -0.211 0.106 0.627 induction of apoptosis by
cop LOC220729 3q29 -0.211 0.106 0.627
cop KIAA0226 3q29 -0.211 0.106 0.627
cop MIR922 -0.211 0.106 0.627
exp AK4P4 9p24.1 -0.211 0.106 0.626
met FAM225A 9q32 -0.211 0.106 0.626
xsq TTC21A 3p22.2 -0.211 0.106 0.626
exp S100A6 1q21 -0.211 0.106 0.626 positive regulation of fibroblast
proliferation;signal transduction
met GMEB1 1p35.3 -0.211 0.106 0.626
xsq FAXDC2 5q31-q32 -0.211 0.106 0.626
exp THNSL2 2p11.2 -0.211 0.106 0.626 serine family amino acid
cop RABGAP1L 1q24 -0.211 0.106 0.626 positive regulation of Rab GTPase
activity;regulation of protein localization
exp ACTB 7p22 -0.211 0.106 0.626 axon guidance;blood coagulation
exp NDP Xp11.4 -0.211 0.106 0.626 visual perception;canonical Wnt
cop TMEM106B 7p21.3 -0.211 0.106 0.626
cop VWDE 7p21.3 -0.211 0.106 0.626
cop SCIN 7p21.3 -0.211 0.106 0.626 regulation of chondrocyte
cop ARL4A 7p21.3 -0.211 0.106 0.626 brown fat cell
differentiation;small GTPase mediated signal transduction
mut ADCK4 19q13.2 -0.211 0.106 0.626
xsq DSTYK 1q32.1 -0.211 0.106 0.626
met DNAH2 17p13.1 -0.211 0.106 0.626 ciliary or flagellar
exp NFKBIZ 3p12-q12 -0.211 0.106 0.626 regulation of transcription,
exp FBLIM1 1p36.21 -0.211 0.106 0.626 cell adhesion;regulation of
cell shape
xsq TSPAN15 10q22.1 -0.211 0.106 0.626
xsq ZFP57 6p22.1 -0.211 0.106 0.626 DNA methylation involved in embryo
xsq UBE2H 7q32 -0.211 0.106 0.626 protein K11-linked
cop DNAH11 7p21 -0.211 0.106 0.626 ciliary or flagellar
xsq NRP1 10p12 -0.211 0.106 0.626 cell adhesion;response to wounding
xai IZUMO3 -0.212 0.106 0.627
xai SYNPO 5q33.1 -0.212 0.106 0.627 positive regulation of actin
xai FAM129A 1q25 -0.212 0.106 0.627 positive regulation of protein
phosphorylation;response to stress
swa MGST3 1q23 -0.212 0.106 0.627 signal transduction;leukotriene
hs4 EVPLL 17p11.2 -0.212 0.106 0.627
xai HIBADH 7p15.2 -0.212 0.106 0.627 valine metabolic
hs4 MMP16 8q21.3 -0.212 0.106 0.627 Apoptosis
his GSTM3 1p13.3 -0.212 0.106 0.627 metabolic process;response to
estrogen stimulus
swa HIPK4 19q13.2 -0.212 0.106 0.627
his KCTD11 17p13.1 -0.213 0.106 0.626 regulation of
his TMEM95 17p13.1 -0.213 0.106 0.626
hs4 MPDZ 9p23 -0.213 0.106 0.626 interspecies interaction between
organisms
exp DOCK9-AS2 -0.213 0.106 0.626
exp KLF17 1p34.1 -0.213 0.106 0.626 regulation of transcription from
RNA polymerase II promoter;gamete generation
swa DLST 14q24.3 -0.213 0.106 0.626 small molecule metabolic
his MIR455 -0.213 0.106 0.626
swa SCP2 1p32 -0.213 0.106 0.626 lipid transport;peroxisome organization
his LOC339593 -0.213 0.106 0.626
his LINC02015 -0.213 0.106 0.626
his S100A10 1q21 -0.213 0.106 0.626 signal transduction;positive
his TNFSF18 1q23 -0.213 0.106 0.626 cell-cell signaling;tumor necrosis
factor-mediated signaling pathway
hs4 PTPRF 1p34 -0.213 0.106 0.626 cell adhesion;positive regulation of
neuron apoptosis
hs4 TNFAIP8L3 15q21.2 -0.213 0.106 0.626
hs4 PCDHGA1 5q31 -0.213 0.106 0.626 cell adhesion;homophilic cell
adhesion
xai HDAC1P1 -0.213 0.106 0.626
hs4 COL11A1 1p21 -0.213 0.106 0.626 ossification;collagen fibril
organization
exp ACTBL2 5q11.2 -0.213 0.106 0.626
hs4 PRKCG 19q13.4 -0.213 0.106 0.626 DNA Damage Response (DDR)
his CLRN1-AS1 3q25.1 -0.213 0.106 0.626
his CLRN1 3q25 -0.213 0.106 0.626 sensory perception of sound;photoreceptor
cell maintenance
hs4 GRK7 3q24 -0.213 0.106 0.626
xai TIMELESS 12q13.3 0.212 0.107 0.627 DNA Damage Response (DDR)
his MIR7848 0.212 0.107 0.627
his SLA 8q24 0.212 0.107 0.627
hs4 SLC5A5 19p13.11 0.212 0.107 0.627 cellular nitrogen compound
his FAM175A 4q21.23 0.212 0.107 0.627 DNA Damage Response (DDR)
his PSMD14 2q24.2 0.212 0.107 0.627 G1/S transition of mitotic cell
cycle;ubiquitin-dependent protein catabolic process
xai AQP4 18q11.2-q12.1 0.212 0.107 0.627 transport;water transport
his S100Z 5q13.3 0.212 0.107 0.627
his KCTD13 0.212 0.107 0.627 proteasomal ubiquitin-dependent protein
catabolic process;DNA replication
his SSRP1 11q12 0.212 0.107 0.627 DNA replication;DNA repair
his P2RX3 11q12 0.212 0.107 0.627 response to hypoxia;positive regulation of
calcium ion transport into cytosol
xai LIPT2 11q13.4 0.212 0.107 0.627 protein modification process;lipoate
xai ZFAND4 10q11.22 0.212 0.107 0.627
exp FRY-AS1 0.212 0.107 0.627
xai ALKBH1 14q24.3 0.212 0.107 0.627 DNA Damage Response (DDR); DDR
(BER)
xai CHD5 1p36.31 0.212 0.107 0.628 regulation of transcription, DNA-
his ELOA 0.212 0.107 0.628
hs4 ADARB2 10p15.3 0.212 0.107 0.628 mRNA processing;RNA processing
swa SHC1 1q21 0.212 0.107 0.628 response to toxin;response to insulin stimulus
his MAGT1 Xq21.1 0.212 0.107 0.628 protein N-linked glycosylation;transport
his COX7B Xq21.1 0.212 0.107 0.628 respiratory electron transport
his MLF2 12p13 0.212 0.107 0.628 defense response
his SYMPK 19q13.3 0.212 0.107 0.628 mRNA processing;cell adhesion
his FOXA3 19q13.32 0.212 0.107 0.628 embryo development;regulation of
sequence-specific DNA binding transcription factor activity
his DCP1A 3p21.1 0.212 0.107 0.628 nuclear-transcribed mRNA catabolic
xai PGGT1BP1 10q11.23 0.212 0.107 0.628
hs4 PHB2 12p13 0.212 0.107 0.628 negative regulation of transcription, DNA-
dependent"
hs4 SCARNA12 0.212 0.107 0.628
hs4 EMG1 12p13.3 0.212 0.107 0.628 rRNA processing;ribosomal small subunit
biogenesis
xai ADAM2 8p11.2 0.212 0.107 0.628 proteolysis;cell adhesion
his LOC100419583 0.212 0.107 0.628
exp PGGT1BP1 10q11.23 0.212 0.107 0.628
xai TROVE2 1q31 0.212 0.107 0.628 transcription from RNA polymerase III
promoter
xai MATK 19p13.3 0.212 0.107 0.628 mesoderm development;cell proliferation
his JUND 19p13.2 0.212 0.107 0.628 osteoblast development;regulation of
his MIR3188 0.212 0.107 0.628
xai AGBL4 1p33 0.212 0.107 0.628 C-terminal protein deglutamylation;protein side
chain deglutamylation
his ETV2 19q13.12 0.212 0.107 0.628 Transcription Factors
his COX6B1 19q13.1 0.212 0.107 0.628 small molecule metabolic
hs4 E2F8 11p15.1 0.212 0.107 0.628 cell cycle
xai TSPYL2 Xp11.2 0.212 0.107 0.628 negative regulation of cell
exp LOC100129148 7q34 0.212 0.107 0.628
swa TMED7 5q22.3 0.212 0.107 0.629 protein transport
xai TGFBRAP1 2q12.1 0.212 0.107 0.629 regulation of transcription, DNA-
dependent;intracellular protein transport
exp RPL18P13 16q23.1 0.212 0.107 0.629
dependent"
hs4 C2CD4B 15q22.2 0.212 0.107 0.629
xai RPS7P2 1q21 0.212 0.107 0.629
xai HSP90AB1 6p12 0.212 0.107 0.629 Apoptosis
swa GFM2 5q13 0.212 0.107 0.629 mitochondrial translational elongation;GTP
catabolic process
xai LOC157740 0.212 0.107 0.629
xsq POLR3GL 1q21.1 0.21 0.107 0.627 transcription from RNA polymerase
cop CORO2A 9q22.3 0.21 0.107 0.627 actin cytoskeleton
exp TBPL2 14q22.3 0.21 0.107 0.627 transcription initiation from RNA
polymerase II promoter;multicellular organismal development
xsq PPP1R21 2p16.3 0.21 0.107 0.627
xsq YPEL1 22q11.2 0.21 0.107 0.627
xsq AMN 14q32.3 0.21 0.107 0.627 multicellular organismal
development;excretion
xsq IFRD2 3p21.3 0.21 0.107 0.627
met LZTR1 22q11.21 0.21 0.107 0.627 regulation of transcription, DNA-
cop FECH 18q21.3 0.21 0.107 0.627 generation of precursor metabolites and
energy;porphyrin-containing compound metabolic process
cop RNF34 12q24.31 0.21 0.107 0.627 Apoptosis
exp UBN1 16p13.3 0.21 0.107 0.628 negative regulation of phosphatase
met KCNA6 12p13 0.21 0.107 0.628 ion transport;potassium ion transport
xsq OR5R1 11q12.1 0.21 0.107 0.628 response to stimulus
cop MVK 12q24 0.21 0.107 0.628 cholesterol biosynthetic process;isoprenoid
met TMC3 15q25.1 0.21 0.107 0.628
exp CLEC12A 12p13.2 0.21 0.107 0.628
exp ANKRD18DP 3q29 0.21 0.107 0.628
met CCDC106 19q13.42 0.21 0.107 0.628
exp SENP6 6q13-q14.3 0.21 0.107 0.628 protein modification by small protein
exp KLK1 19q13.3 0.21 0.107 0.628 proteolysis
exp WDR76 15q15.3 0.21 0.107 0.628
exp APIP 11p13 0.21 0.107 0.628 methionine biosynthetic process;L-methionine
salvage from methylthioadenosine
cop DYX1C1-CCPG1 0.21 0.107 0.628
cop CCPG1 15q21.1 0.21 0.107 0.628 cell cycle
mir hsa-miR-7 0.21 0.107 0.628
mir hsa-miR-7(2) 0.21 0.107 0.628
mir hsa-miR-7(3) 0.21 0.107 0.628
xsq RPP40 6p25.1 0.21 0.107 0.628 tRNA processing
met NDOR1 9q34.3 0.21 0.107 0.628 cell death;oxidation-reduction process
xsq ACTR6 12q23.1 0.21 0.107 0.628
xsq RAD9A 11q13.1-q13.2 0.21 0.107 0.628 DNA Damage Response (DDR)
met TMEM203 9q34.3 0.21 0.107 0.628
xsq LOC100499484-C9ORF174 0.21 0.107 0.628
xsq SIRPB2 20p13 0.21 0.107 0.628
exp JMY 5q14.1 0.21 0.107 0.628 DNA repair;actin polymerization-dependent
cell motility
xsq GPR83 11q21 0.21 0.107 0.628 G-protein coupled receptor signaling
pathway;response to glucocorticoid stimulus
met LAMB1 7q22 0.21 0.107 0.628 embryo implantation;positive regulation of cell
migration
cop LINC00487 2p25.2 0.21 0.107 0.628
met CCDC127 5p15.33 0.21 0.107 0.628
exp TXNDC5 6p24.3 0.21 0.107 0.628 glycerol ether metabolic
xsq TBC1D1 4p14 0.21 0.107 0.628 regulation of protein localization
exp AUH 9q22.31 0.21 0.107 0.628 mRNA catabolic process;branched chain
xsq BAZ1A 14q13.2 0.21 0.107 0.628 DNA Damage Response (DDR); DDR
(Chromatin)
dependent"
met TMEM181 6q25.3 0.21 0.107 0.628 pathogenesis
xsq CCDC73 11p13 0.21 0.107 0.628
xsq USP3-AS1 15q22.31 0.21 0.107 0.629
xsq LOC101928786 0.21 0.107 0.629
exp LOC131054 3q26.33 0.21 0.107 0.629
xsq PNPT1 2p15 0.21 0.107 0.629 mitochondrial mRNA catabolic process;transport
xsq LOC643406 20p12.3 0.21 0.107 0.629
xsq SNRPA1 15q26.3 0.21 0.107 0.629 RNA splicing;gene expression
xsq DGKG 3q27.2-q27.3 0.21 0.107 0.629 signal transduction;activation of
cop GKN2 2p13.3 0.21 0.107 0.629
met CUTA 6p21.32 0.21 0.107 0.629 protein localization;response to metal
ion
xsq KIAA1324L 7q21.12 0.21 0.107 0.629
exp PTK7 6p21.1-p12.2 -0.21 0.107 0.629 establishment of planar
cop ITGA1 5q11.2 -0.21 0.107 0.629 activation of MAPK activity;positive
exp LIMK2 22q12.2 -0.21 0.107 0.629 Protein Kinases
xsq POPDC3 6q21 -0.21 0.107 0.629
exp ARL6IP5 3p14 -0.21 0.107 0.629 negative regulation of transport;L-
glutamate transport
exp MTCH1 6p21.2 -0.21 0.107 0.629 Apoptosis
exp ZNF415 19q13.42 -0.21 0.107 0.629 regulation of transcription, DNA-
dependent"
exp PTS 11q22.3 -0.21 0.107 0.629 regulation of nitric-oxide synthase
activity;cellular amino acid metabolic process
met SCML4 6q21 -0.21 0.107 0.629 regulation of transcription, DNA-dependent"
exp RBM24 6p22.3 -0.21 0.107 0.629 regulation of mRNA stability;regulation
of myotube differentiation
exp EPN1 19q13.42 -0.21 0.107 0.629 endocytosis;epidermal growth factor
cop PKIA 8q21.12 -0.21 0.107 0.628 negative regulation of transcription from
RNA polymerase II promoter;regulation of G2/M transition of mitotic cell cycle
cop ZC2HC1A 8q21.12 -0.21 0.107 0.628
cop LOC101241902 -0.21 0.107 0.628
cop IL7 8q12-q13 -0.21 0.107 0.628 positive regulation of cell
proliferation;positive regulation of T cell differentiation
xsq ADORA1 1q32.1 -0.21 0.107 0.628 Apoptosis
cop PREX2 8q13.2 -0.21 0.107 0.628 G-protein coupled receptor signaling
pathway;positive regulation of Rac GTPase activity
xsq TP53BP2 1q41 -0.21 0.107 0.628 Apoptosis
cop TMEM55A 8q21.3 -0.21 0.107 0.628
exp FAM92A1 8q22.1 -0.21 0.107 0.628
exp ABCA12 2q34 -0.21 0.107 0.628 ABC Transporters
xsq DUX4 -0.21 0.107 0.628
mut CPXM2 10q26.13 -0.21 0.107 0.628 proteolysis;cell adhesion
exp C19orf33 19q13.2 -0.21 0.107 0.628
met PPEF1 Xp22 -0.21 0.107 0.628 protein dephosphorylation;detection of stimulus
involved in sensory perception
cop STMN2 8q21.13 -0.21 0.107 0.628 positive regulation of microtubule
xsq FAM127C Xq26.3 -0.21 0.107 0.628
cop MIR4661 -0.21 0.107 0.628
exp VTI1BP3 12q13.13 -0.21 0.107 0.628
xsq AGPAT3 21q22.3 -0.21 0.107 0.628 metabolic process;phospholipid
xsq LOC100240734 -0.21 0.107 0.628
xsq LOC101929066 -0.21 0.107 0.628
met CFD 19p13.3 -0.21 0.107 0.627 innate immune response;platelet
degranulation
mut BCL11B 14q32.2 -0.21 0.107 0.627 regulation of lipid metabolic
cop MAP3K13 3q27 -0.21 0.107 0.627 Protein Kinases
exp ALS2CL 3p21.31 -0.21 0.107 0.627 endosome organization;regulation of
Rho protein signal transduction
exp CLDN1 3q28-q29 -0.21 0.107 0.627 cell adhesion;calcium-independent cell-
cell adhesion
exp FAM3C 7q31 -0.21 0.107 0.627 multicellular organismal development
exp C1R 12p13 -0.21 0.107 0.627 complement activation, classical pathway;innate
immune response
swa RRAS2 11p15.2 -0.212 0.107 0.629 GTP catabolic process;signal
transduction
hs4 ZFP2 5q35.3 -0.212 0.107 0.629 regulation of transcription, DNA-
dependent"
his TM4SF18 3q25.1 -0.212 0.107 0.629
his LINC00265 7p14.1 -0.212 0.107 0.629
hs4 LPAR4 Xq21.1 -0.212 0.107 0.629 G-protein coupled receptor
signaling pathway
hs4 LURAP1L-AS1 -0.212 0.107 0.629
hs4 KLF5 13q22.1 -0.212 0.107 0.629 microvillus assembly;positive
xai ST6GALNAC2 17q25.1 -0.212 0.107 0.629 protein glycosylation;O-
glycan processing
xai C1R 12p13 -0.212 0.107 0.629 complement activation, classical
hs4 RAPGEFL1 17q21.1 -0.212 0.107 0.628 G-protein coupled receptor
signaling pathway;small GTPase mediated signal transduction
his XIRP2-AS1 -0.212 0.107 0.628
hs4 AJUBA 14q11.2 -0.212 0.107 0.628 Cell Signaling
xai RPL9P16 4q32.3 -0.212 0.107 0.628
exp FAM151B 5q14.1 -0.212 0.107 0.628
exp CYB561D1 1p13.3 -0.212 0.107 0.628 electron transport
chain;transport
his LOC101929460 -0.212 0.107 0.628
xai CPNE5 6p21.1 -0.212 0.107 0.628
exp SPACA7 13q34 -0.212 0.107 0.628
hs4 TM4SF18 3q25.1 -0.212 0.107 0.628
hs4 DKK3 11p15.2 -0.212 0.107 0.628 negative regulation of canonical
his C3orf67 3p14.2 -0.212 0.107 0.628
xai BCAS4 20q13.13 -0.212 0.107 0.628
swa DDRGK1 20p13 -0.212 0.107 0.628
xai ACKR1 -0.212 0.107 0.628 G-protein coupled receptor signaling
pathway;defense response
hs4 ZNF341-AS1 -0.212 0.107 0.628
hs4 CHMP4B 20q11.22 -0.212 0.107 0.628 protein transport;cellular
xai STX17-AS1 -0.212 0.107 0.628
xai IDH1 2q33.3 -0.212 0.107 0.627 Oncogenes
hs4 LAMA3 18q11.2 -0.212 0.107 0.627 regulation of cell
xai NFYAP1 13q21.31 -0.212 0.107 0.627
hs4 MYO1B 2q12-q34 -0.212 0.107 0.627 actin filament-based movement;actin
xai KIF1B 1p36.2 -0.212 0.107 0.627 microtubule-based movement;neuron-
hs4 FGD1 Xp11.21 -0.212 0.107 0.627 organ morphogenesis;apoptotic
process
xai GPX3 5q23 -0.212 0.107 0.627 response to organic cyclic
xai APMAP 20p11.2 -0.212 0.107 0.627
his RTF1 15q15.1 0.212 0.108 0.629 transcription initiation, DNA-
exp GPR89A 1q21.1 0.212 0.108 0.629 signal transduction;protein
transport
exp RPS7P2 1q21 0.212 0.108 0.629
his UTP6 17q11.2 0.212 0.108 0.629 rRNA processing;RNA processing
his NDUFB5 3q26.33 0.212 0.108 0.629 mitochondrial electron transport,
his SLC35E2B 1p36.33 0.212 0.108 0.629 Solute Carriers
his EFHB 3p24.3 0.212 0.108 0.629
his RAB5A 3p24-p22 0.212 0.108 0.629 nervous system development;blood
coagulation
hs4 SAMD3 6q23.1 0.212 0.108 0.629
hs4 TMEM200A 6q23.1 0.212 0.108 0.629
xai LYRM4 6p25.1 0.212 0.108 0.629
swa MCM3 6p12 0.212 0.108 0.629 DDR (DNA replication)
xai ZNRF1 16q23.1 0.212 0.108 0.629 proteasomal ubiquitin-dependent protein
swa MDH2 7cen-q22 0.212 0.108 0.629 glucose metabolic process;small molecule
metabolic process
hs4 GMEB1 1p35.3 0.212 0.108 0.629
his STXBP5L 3q13.33 0.212 0.108 0.629 exocytosis;protein transport
xai MORC2 22q12.2 0.212 0.108 0.629
exp ZEB2-AS1 0.212 0.108 0.629
xai WDR5 9q34 0.212 0.108 0.629 regulation of transcription, DNA-
exp RPL26 17p13 0.212 0.108 0.629 translational initiation;viral infectious cycle
his RCN2 15q23 0.212 0.108 0.629
cop PRR18 6q27 0.212 0.108 0.629
his MIR4766 0.211 0.108 0.629
xai RPL35P9 0.211 0.108 0.629
his ZNF121 19p 0.211 0.108 0.629 regulation of transcription, DNA-
dependent"
xai PPP4R3B 0.211 0.108 0.629 DNA Damage Response (DDR)
his CCDC88B 11q12.3 0.211 0.108 0.629 microtubule cytoskeleton
organization
his MIR7155 0.211 0.108 0.629
xai ZEB2-AS1 0.211 0.108 0.629
his PAM16 16p13.3 0.211 0.108 0.629 protein transport
his APTX 9p13.3 0.211 0.108 0.629 DNA Damage Response (DDR); DDR (BER)
swa NOP10 15q14-q15 0.211 0.108 0.63 DNA Damage Response (DDR)
xai NR4A2 2q22-q23 0.211 0.108 0.63 post-embryonic development;intracellular
his CD226 18q22.3 0.211 0.108 0.63 signal transduction;cell recognition
his MRE11 0.211 0.108 0.63
his ANKRD49 11q21 0.211 0.108 0.63 positive regulation of transcription,
DNA-dependent"
hs4 CACNA2D2 3p21.3 0.211 0.108 0.63 small molecule metabolic
process;positive regulation of organ growth
his PRR12 19q13.33 0.211 0.108 0.63
xai ELF1 13q13 0.211 0.108 0.63 Transcription Factors
exp RPL35P9 0.211 0.108 0.63
xai TUBG1 17q21 0.211 0.108 0.63 G2/M transition of mitotic cell cycle;meiotic
his IQCA1L 0.211 0.108 0.63
his ARHGAP1 11p11.2 0.211 0.108 0.63 positive regulation of Rho GTPase
activity;regulation of GTPase activity
dependent"
hs4 FLT3 13q12 0.211 0.108 0.63 Cell Signaling; Oncogenes
his ZDHHC17 12q21.2 0.211 0.108 0.63 signal transduction;magnesium ion
transport
xai HMG20A 15q24 0.211 0.108 0.63 chromatin organization;regulation of
xai RSRC2 12q24.31 0.211 0.108 0.63
xai HMGN2P30 7p14.1 0.211 0.108 0.63
xai C15orf40 15q25.2 0.211 0.108 0.63
his ADGRG2 0.211 0.108 0.63 G-protein coupled receptor signaling
xai MCRS1 12q13.12 0.211 0.108 0.63 DNA Damage Response (DDR); DDR
(Chromatin)
xai TRPM7 15q21 0.211 0.108 0.63 transmembrane transport;ion transport
his NEMF 14q22 0.211 0.108 0.63 nuclear export
xai BIRC6 2p22.3 0.211 0.108 0.63 Apoptosis
his ABCA7 19p13.3 0.211 0.108 0.63 ABC Transporters
xai CENPJ 13q12.12 0.211 0.108 0.63 G2/M transition of mitotic cell
hs4 NARS 18q21.31 0.211 0.108 0.63 tRNA aminoacylation for protein
xai TRIP13 5p15.33 0.211 0.108 0.63 DNA Damage Response (DDR)
his ATP5SL 19q13.2 0.211 0.108 0.63
his FAM193B 5q35.3 0.211 0.108 0.63
his ITGA2B 17q21.32 0.211 0.108 0.63 blood coagulation;platelet
activation
xai C10orf25 10q11.21 0.211 0.108 0.63
his MKRN2 3p25 0.211 0.108 0.63
swa YTHDF1 20q13.33 0.211 0.108 0.63
his EMBP1 1p11.2 0.211 0.108 0.63
met GRM2 3p21.2 0.21 0.108 0.629 inhibition of adenylate cyclase activity
by G-protein coupled glutamate receptor signaling pathway;synaptic transmission
exp ASMTL Xp22.3 0.21 0.108 0.629
xsq WBP11P1 18q12.1 0.21 0.108 0.629
xsq LINC00322 21q22.3 0.21 0.108 0.629
exp GALK1 17q24 0.21 0.108 0.629 small molecule metabolic process;carbohydrate
phosphorylation
met LOC100130093 1q42.13 0.21 0.108 0.629
cop FBXO15 18q22.3 0.21 0.108 0.629
cop TIMM21 18q22.3 0.21 0.108 0.629 protein transport
cop CYB5A 18q23 0.21 0.108 0.629 electron transport chain;small molecule
metabolic process
cop C18orf63 18q22.3 0.21 0.108 0.629
mut LYST 1q42.1-q42.2 0.21 0.108 0.629 natural killer cell mediated
exp HMGA1P4 0.21 0.108 0.629
exp MSI2 17q22 0.21 0.108 0.629 stem cell development
dependent"
xsq ATP9B 18q23 0.21 0.108 0.629 cation transport;aminophospholipid transport
xsq LOC650226 7p11.2 0.21 0.108 0.629
cop PTPDC1 9q22.32 0.21 0.108 0.629
cop MIRLET7A1 0.21 0.108 0.629
cop MIRLET7F1 0.21 0.108 0.629
cop MIRLET7DHG 0.21 0.108 0.629
cop MIRLET7D 0.21 0.108 0.629
cop ZNF169 9q22.32 0.21 0.108 0.629 regulation of transcription, DNA-
dependent"
cop LOC100132077 0.21 0.108 0.629
cop HIATL1 9q22.32 0.21 0.108 0.629
cop FBP2 9q22.3 0.21 0.108 0.629 glucose metabolic process;gluconeogenesis
xsq TYW1B 7q11.23 0.21 0.108 0.629 tRNA processing
cop WNK1 12p13.3 0.21 0.108 0.629 negative regulation of phosphatase
mut OLFM4 13q14.3 0.21 0.108 0.629 cell adhesion
xsq LOC100288966 0.21 0.108 0.629
met CACNA1F Xp11.23 0.21 0.108 0.629 visual perception;dendrite
morphogenesis
xsq SLC9B1 4q24 0.21 0.108 0.629 cation transport;transmembrane transport
xsq PAXBP1-AS1 0.21 0.108 0.629
xsq DYM 18q21.1 0.21 0.108 0.63
met ITPK1-AS1 14q32.12 0.21 0.108 0.63
xsq PVALB 22q13.1 0.21 0.108 0.63
xsq RETN 19p13.2 0.21 0.108 0.63 response to insulin stimulus;fat cell
differentiation
met PLS3 Xq23 0.21 0.108 0.63
mut CPT2 1p32 0.21 0.108 0.63 fatty acid beta-oxidation;transport
xsq MRPL3 3q21-q23 0.21 0.108 0.63 translation
exp DDX24 14q32 0.21 0.108 0.63 RNA metabolic process
exp LOC100507564 0.21 0.108 0.63
met ACRC Xq13.1 0.21 0.108 0.63
dependent"
xsq CSNK1G2 19p13.3 0.209 0.108 0.63 Protein Kinases
xsq SPRR4 1q21.3 0.209 0.108 0.63
cop PRKCE 2p21 0.209 0.108 0.63 Protein Kinases
xsq NDUFA6-AS1 22q13.2 0.209 0.108 0.63
exp OTUD6B 8q21.3 0.209 0.108 0.63
xsq C12orf73 12q23.3 0.209 0.108 0.63
mut FAM196A 10q26.2 0.209 0.108 0.63
cop CCDC180 0.209 0.108 0.63
dependent"
xsq LOC100129316 0.209 0.108 0.63
met TTPA 8q12.3 0.209 0.108 0.63 response to pH;response to toxin
met GALK1 17q24 0.209 0.108 0.63 small molecule metabolic process;carbohydrate
phosphorylation
xsq LOC101927151 0.209 0.108 0.63
xsq MYSM1 1p32.1 0.209 0.108 0.63 proteolysis;chromatin modification
xsq LOC401177 0.209 0.108 0.63
xsq PHIP 6q14 0.209 0.108 0.63 DDR (DNA replication)
cop CLEC2B 12p13-p12 0.209 0.108 0.63
cop KLRF2 0.209 0.108 0.63
cop CLEC2A 12p13.31 0.209 0.108 0.63
cop CLEC12A 12p13.2 0.209 0.108 0.63
cop CLEC1B 12p13.2 0.209 0.108 0.63 defense response;cell surface
cop CLEC12B 0.209 0.108 0.63
cop CLEC9A 0.209 0.108 0.63 receptor-mediated endocytosis;positive
cop TACR1 2p12 0.209 0.108 0.63 inflammatory response;response to heat
met MIR376B 0.209 0.108 0.63
exp TIMELESS 12q13.3 0.209 0.108 0.63 DNA Damage Response (DDR)
xsq DEPDC1-AS1 0.209 0.108 0.63
cop H2AFY2 10q22.1 0.209 0.108 0.63 nucleosome assembly;dosage
compensation
cop AIFM2 10q22.1 0.209 0.108 0.63 apoptotic mitochondrial
changes;chromosome condensation
cop TYSND1 10q22.1 0.209 0.108 0.63 proteolysis;protein processing
cop SAR1A 10q22.1 0.209 0.108 0.63 intracellular protein transport;ER to
cop PPA1 10q11.1-q24 0.209 0.108 0.63 tRNA aminoacylation for protein
xsq TAF1 Xq13.1 0.209 0.108 0.63 regulation of transcription involved in
G2/M-phase of mitotic cell cycle;gene expression
xsq TFF2 21q22.3 0.209 0.108 0.63 digestion
exp TFDP1 13q34 0.209 0.108 0.63 Apoptosis
exp LINC00622 -0.209 0.108 0.63
met MMRN1 4q22 -0.209 0.108 0.63 platelet degranulation;cell adhesion
exp IQCD 12q24.13 -0.209 0.108 0.63
xsq PBX1 1q23 -0.209 0.108 0.63 organ morphogenesis;negative regulation
of sequence-specific DNA binding transcription factor activity
cop ETV5 3q28 -0.209 0.108 0.63 Transcription Factors
met C17orf105 17q21.31 -0.209 0.108 0.63
met SMYD5 2p13.2 -0.209 0.108 0.63
cop OTUD6B 8q21.3 -0.21 0.108 0.63
xsq RARRES2 7q36.1 -0.21 0.108 0.63 retinoid metabolic process;in utero
met MYOC 1q23-q24 -0.21 0.108 0.629 anatomical structure morphogenesis
xsq S100A2 1q21 -0.21 0.108 0.629 endothelial cell migration
exp NEK7 1q31.3 -0.21 0.108 0.629 cytokinesis;protein phosphorylation
xsq PTPRZ1 7q31.3 -0.21 0.108 0.629 protein
dephosphorylation;axonogenesis
xsq PLAC4 21q22.2 -0.21 0.108 0.629
xsq RAB2A 8q12.1 -0.21 0.108 0.629 GTP catabolic process;ER to Golgi
xsq NPHP1 2q13 -0.21 0.108 0.629 signal transduction;excretion
cop POM121L12 7p12.1 -0.21 0.108 0.629
mut PHEX Xp22.2-p22.1 -0.21 0.108 0.629 protein modification
process;proteolysis
xsq CFHR3 1q32 -0.21 0.108 0.629
exp TRIM44 11p13 -0.21 0.108 0.629
exp MIR34A -0.21 0.108 0.629
met PRKCB 16p11.2 -0.21 0.108 0.629 Protein Kinases
hs4 GRTP1 13q34 -0.211 0.108 0.63
swa SERPINA3 14q32.1 -0.211 0.108 0.63 regulation of
exp LOC100129363 -0.211 0.108 0.63
his PRSS23 11q14.1 -0.211 0.108 0.63 proteolysis
exp CLPSL1 6p21.31 -0.211 0.108 0.63 digestion;lipid catabolic
process
xai SLIT2 4p15.2 -0.211 0.108 0.63 cell migration involved in
exp RPL9P16 4q32.3 -0.211 0.108 0.63
xai DAB2 5p13.1 -0.211 0.108 0.63 negative regulation of cell
his NPIPA2 -0.211 0.108 0.63
xai ULK2 17p11.2 -0.211 0.108 0.63 signal transduction;nervous system
development
xai GEM 8q13-q21 -0.211 0.108 0.63 GTP catabolic process;immune
response
his ZBTB47 3p22.1 -0.211 0.108 0.63 regulation of transcription,
DNA-dependent"
his LOC101928323 -0.211 0.108 0.63
his SEMA5A 5p15.2 -0.211 0.108 0.63 cell
his SNHG18 -0.211 0.108 0.63
his SNORD123 5p15.2 -0.211 0.108 0.63
hs4 HSPB1 7q11.23 -0.211 0.108 0.63 Apoptosis
xai KRT8P40 -0.211 0.108 0.63
xai KLHDC8B 3p21.31 -0.211 0.108 0.63
xai YIPF3 6p21.1 -0.211 0.108 0.629 cell differentiation
his LGI4 19q13.12 -0.212 0.108 0.629 adult locomotory
behavior;myelination in peripheral nervous system
DNA-dependent"
xai VWA1 1p36.33 -0.212 0.108 0.629 extracellular matrix organization
xai SPA17 11q24.2 -0.212 0.108 0.629 spermatogenesis;single
fertilization
xai HS1BP3-IT1 -0.212 0.108 0.629
his RLN2 9p24.1 -0.212 0.108 0.629 female pregnancy
his TSHZ2 20q13.2 -0.212 0.108 0.629 multicellular organismal
development
hs4 NAALADL2 3q26.31 -0.212 0.108 0.629 proteolysis
hs4 MIR521-1 -0.212 0.108 0.629
hs4 GGT7 20q11.22 -0.212 0.108 0.629 glutathione metabolic
process;glutathione biosynthetic process
hs4 LOC728084 -0.212 0.108 0.629
hs4 LINC02003 -0.212 0.108 0.629
hs4 TP53INP1 8q22 -0.212 0.108 0.629 apoptotic process;induction of
apoptosis
hs4 SMC1B 22q13.31 -0.212 0.108 0.629 DNA Damage Response (DDR); DDR (DNA
replication)
hs4 RIBC2 22q13.31 -0.212 0.108 0.629
exp C9orf131 9p13.3 -0.212 0.108 0.629
exp PKMP2 Xq12 -0.212 0.108 0.629
mda AGE -0.243 0.108 0.629
hs4 FCGR1B 0.211 0.109 0.63
his CCNI 4q21.1 0.211 0.109 0.63 spermatogenesis
his SMPD4 2q21.1 0.211 0.109 0.63 sphingomyelin catabolic
his MZT2B 2q21.1 0.211 0.109 0.63
dependent"
his RUVBL1 3q21 0.211 0.109 0.63 Apoptosis; DNA Damage Response (DDR); DDR
(Chromatin)
xai FDPSP1 1q31 0.211 0.109 0.63
his RBM26 13q31.1 0.211 0.109 0.63 mRNA processing;negative regulation of
his RBM26-AS1 0.211 0.109 0.63
his GDPGP1 15q26.1 0.211 0.109 0.63
his METTL2B 7q32.1 0.211 0.109 0.63
his TOB2 22q13.2 0.211 0.109 0.63 female gamete generation;negative
his RABL3 3q13.33 0.211 0.109 0.63 small GTPase mediated signal transduction
his GTF2E1 3q21-q24 0.211 0.109 0.63 interspecies interaction between
organisms;regulation of transcription, DNA-dependent
hs4 DCC 18q21.3 0.211 0.109 0.63 Tumor Suppressors
his PPIAL4C 0.211 0.109 0.63
hs4 LOC650226 7p11.2 0.211 0.109 0.63
his PSMG4 6p25.2 0.211 0.109 0.63
xai C9orf40 9q21.13 0.211 0.109 0.63
xai SPAG5 17q11.2 0.211 0.109 0.63 regulation of attachment of spindle
xai TMX1 14q22.1 0.211 0.109 0.63 transport;cell redox homeostasis
xai PPIAP25 13q14.13 0.211 0.109 0.63
xai FAM195A 16p13.3 0.211 0.109 0.631
xai SDHAF1 19q13.12 0.211 0.109 0.631 iron-sulfur cluster
exp PPIAP25 13q14.13 0.211 0.109 0.631
hs4 ATP5A1 18q21 0.211 0.109 0.631 lipid metabolic process;small molecule
metabolic process
xai S100A8 1q21 0.211 0.109 0.631 inflammatory response;response to zinc
ion
his RIOK2 5q15 0.211 0.109 0.631 protein phosphorylation
swa RBMXL1 0.211 0.109 0.631 RNA splicing;mRNA processing
his NME2 0.211 0.109 0.631
xai EEF1A1P15 Xq21.33 0.211 0.109 0.631
xai RPTOR 17q25.3 0.211 0.109 0.631 cell growth;cellular response to nutrient
levels
xai PIDD1 0.211 0.109 0.631 response to DNA damage stimulus;DNA damage
xai HMGB3P6 1q23.3 0.211 0.109 0.631
his CXCR1 2q35 0.211 0.109 0.631 cell surface receptor signaling pathway;G-
hs4 RPS6KB2 11q13.2 0.211 0.109 0.631 Apoptosis; Protein Kinases
his CCDC15 11q24.2 0.211 0.109 0.631
swa SNRPD3 22q11.23 0.211 0.109 0.631 spliceosomal snRNP assembly;RNA
metabolic process
xai PAXIP1-AS1 0.211 0.109 0.631
his BSDC1 1p35.1 0.211 0.109 0.631
his ALDOB 9q21.3-q22.2 0.211 0.109 0.631 fructose 1,6-bisphosphate metabolic
his LETM1 4p16.3 0.211 0.109 0.631 cristae formation
xai PIN4 Xq13 0.211 0.109 0.631 rRNA processing;protein folding
his LNPEP 5q15 0.211 0.109 0.631 antigen processing and presentation of
exogenous peptide antigen via MHC class I, TAP-independent;proteolysis
hs4 SSBP4 19p13.1 0.211 0.109 0.631
xai MNDA 1q22 0.211 0.109 0.631 negative regulation of B cell
his PRMT9 0.211 0.109 0.631
xai GART 21q22.11 0.211 0.109 0.631 purine base biosynthetic process;purine
ribonucleoside monophosphate biosynthetic process
his RPS23 5q14.2 0.211 0.109 0.631 nuclear-transcribed mRNA catabolic
his ATP6AP1L 5q14.2 0.211 0.109 0.631 ATP hydrolysis coupled proton
transport
his DAXX 6p21.3 0.211 0.109 0.631 Apoptosis; DNA Damage Response (DDR);
Tumor Suppressors
exp TMEM72 10q11.21 0.211 0.109 0.631
his LMF2 22q13.33 0.211 0.109 0.631
his NCAPH2 22q13.33 0.211 0.109 0.631 DNA Damage Response (DDR)
xai PHKA2 Xp22.2-p22.1 0.211 0.109 0.631 generation of precursor metabolites
and energy;protein modification process
xai CRADD 12q21.33-q23.1 0.211 0.109 0.631 Apoptosis
his MED21 12p11.23 0.211 0.109 0.631 regulation of transcription from RNA
polymerase II promoter;positive regulation of transcription from RNA polymerase II
promoter
his CTRL 16q22.1 0.211 0.109 0.631 proteolysis;digestion
his PSMB10 16q22.1 0.211 0.109 0.631 mitotic cell cycle;viral
reproduction
his IFNLR1 1p36.11 0.211 0.109 0.631
hs4 ZNF688 16p11.2 0.211 0.109 0.631 regulation of transcription, DNA-
dependent"
his ATAD3A 1p36.33 0.211 0.109 0.631 cell growth;negative regulation of
apoptotic process
his GAL 11q13.3 0.211 0.109 0.631 inflammatory response;response to insulin
stimulus
xai IGLON5 19q13.41 0.211 0.109 0.631
xai PPP1R14BP2 2q33.3 0.211 0.109 0.631
xsq CENPA 2p23.3 0.209 0.109 0.63 kinetochore assembly;M phase of mitotic
cell cycle
exp UCN 2p23-p21 0.209 0.109 0.63 positive regulation of cell
xsq DCLRE1B 1p13.2 0.209 0.109 0.63 DNA Damage Response (DDR)
exp ENOX2 Xq25 0.209 0.109 0.63 transport;ultradian rhythm
exp YTHDF1 20q13.33 0.209 0.109 0.63
xsq ELMO1-AS1 0.209 0.109 0.63
xsq MSH5 6p21.3 0.209 0.109 0.63 DNA Damage Response (DDR); DDR (MMR)
xsq SRP68 17q25.1 0.209 0.109 0.63 gene expression;response to drug
xsq NBPF12 0.209 0.109 0.63
xsq RBM17 10p15.1 0.209 0.109 0.63 mRNA processing;RNA splicing
xsq PPP2R1B 11q23.2 0.209 0.109 0.63 Apoptosis
xsq OR8U8 0.209 0.109 0.63
met C1orf198 1q42.2 0.209 0.109 0.631
exp UBLCP1 5q33.3 0.209 0.109 0.631
xsq HRH2 5q35.2 0.209 0.109 0.631 G-protein signaling, coupled to cyclic
nucleotide second messenger;immune response"
xsq ORC5 7q22.1 0.209 0.109 0.631 DDR (DNA replication)
met INTU 4q28.1 0.209 0.109 0.631 nervous system development;regulation of
smoothened signaling pathway
xsq SMAD1 4q31 0.209 0.109 0.631 ureteric bud development;transforming growth
xsq ZNHIT2 11q13 0.209 0.109 0.631
xsq SPACA5 Xp11.23 0.209 0.109 0.631
xsq TMA16 4q32.2 0.209 0.109 0.631
cop KLRF1 12p13.31 0.209 0.109 0.631 cell surface receptor signaling pathway
exp ZNF182 Xp11.23 0.209 0.109 0.631 regulation of transcription, DNA-
dependent"
xsq GALK2 15q21.1-q21.2 0.209 0.109 0.631 carbohydrate metabolic
cop NINJ2 12p13 0.209 0.109 0.631 cell adhesion;neuron cell-cell adhesion
exp DOCK11 Xq24 0.209 0.109 0.631 blood coagulation;regulation of catalytic
activity
xsq LOC101929439 0.209 0.109 0.631
xsq LRRIQ3 1p31.1 0.209 0.109 0.631
exp LINC00689 7q36.3 0.209 0.109 0.631
xsq GATA5 20q13.33 0.209 0.109 0.631 blood coagulation;positive regulation of
xsq ZUFSP 6q22.1 0.209 0.109 0.631
met EDNRA 4q31.22 0.209 0.109 0.631 positive regulation of protein
phosphorylation;activation of protein kinase C activity by G-protein coupled
receptor protein signaling pathway
exp RNASE3 14q11.2 0.209 0.109 0.631 RNA catabolic process;defense
met C4orf26 4q21.1 0.209 0.109 0.631
mut GRIA2 4q32.1 0.209 0.109 0.631 synaptic transmission;ion transport
xsq PGAP2 11p15.5 0.209 0.109 0.631 GPI anchor biosynthetic process;anti-
apoptosis
cop GATC 12q24.31 0.209 0.109 0.631 regulation of translational
cop SRSF9 12q24.31 0.209 0.109 0.631 termination of RNA polymerase II
cop DYNLL1 12q24.23 0.209 0.109 0.631 Apoptosis
cop COQ5 12q24.31 0.209 0.109 0.631 ubiquinone biosynthetic process
cop RNF10 12q24.31 0.209 0.109 0.631 negative regulation of Schwann cell
proliferation;positive regulation of myelination
cop POP5 12q24.31 0.209 0.109 0.631 tRNA processing;RNA metabolic process
cop CABP1 12q24.31 0.209 0.109 0.631 negative regulation of catalytic activity
cop MLEC 12q24.31 0.209 0.109 0.631 post-translational protein
cop UNC119B 12q24.31 0.209 0.109 0.631 cell projection
organization;lipoprotein transport
cop MIR4700 0.209 0.109 0.631
cop ACADS 12q24.31 0.209 0.109 0.631 fatty acid metabolic process;response to
glucocorticoid stimulus
exp CCNB2 15q22.2 0.209 0.109 0.631 DNA Damage Response (DDR)
xsq WRB 21q22.3 0.209 0.109 0.631
xsq MRPS23 17q22-q23 0.209 0.109 0.631 translation
xsq PDE6H 12p13 0.209 0.109 0.631
xsq GUCY1B2 13q14.3 0.209 0.109 0.631
xsq ITM2C 2q37 0.209 0.109 0.631 negative regulation of neuron projection
xsq TOP1P2 0.209 0.109 0.631
exp NRXN2 11q13 0.209 0.109 0.631 neuroligin clustering;postsynaptic density
protein 95 clustering
cop NARS 18q21.31 0.209 0.109 0.631 tRNA aminoacylation for protein
cop LOC100505549 0.209 0.109 0.631
cop ATP8B1 18q21.31 0.209 0.109 0.631 bile acid and bile salt
cop TBC1D2 9q22.33 0.209 0.109 0.631 positive regulation of Rab GTPase
activity
xsq SLC4A1 17q21.31 0.209 0.109 0.631 anion transport;chloride transport
xsq ZNF367 9q22 0.209 0.109 0.631 regulation of transcription from RNA
cop SPPL3 12q24.31 0.209 0.109 0.631 proteolysis
met ORAI3 16p11.2 0.209 0.109 0.631
exp KCNH2 7q36.1 0.209 0.109 0.631 synaptic transmission;blood circulation
exp XRCC6 22q13.2 0.209 0.109 0.631 DNA Damage Response (DDR); DDR (NHEJ)
xsq PPM1N 19q13.32 0.209 0.109 0.631
xsq DSCR10 21q22.13 0.209 0.109 0.631
xsq RRP7BP 0.209 0.109 0.631
xsq LRRC40 1p31.1 0.209 0.109 0.631
xsq LINC01192 0.209 0.109 0.631
cop HNF1A-AS1 12q24.31 0.209 0.109 0.631
cop HNF1A 12q24.2 0.209 0.109 0.631 Tumor Suppressors
cop C12orf43 12q24.31 0.209 0.109 0.631
cop OASL 12q24.2 0.209 0.109 0.631 immune response;cytokine-mediated
signaling pathway
exp STIM2 4p15.2 0.209 0.109 0.631 negative regulation of calcium ion
xsq KLC1 14q32.3 0.209 0.109 0.631 microtubule-based movement;blood
coagulation
exp MED16 19p13.3 0.209 0.109 0.631 positive regulation of transcription,
exp TMEM233 12q24.23 0.209 0.109 0.631 response to biotic stimulus
cop C6orf118 6q27 0.209 0.109 0.631
exp AGT 1q42.2 -0.209 0.109 0.631 regulation of cell growth;renin-
xsq SULF1 8q13.2 -0.209 0.109 0.631 esophagus smooth muscle
contraction;regulation of fibroblast growth factor receptor signaling pathway
exp NLGN4X Xp22.33 -0.209 0.109 0.631 social behavior;cell-cell
exp LOC441996 22q12.3 -0.209 0.109 0.631
exp CDK15 2q33.2 -0.209 0.109 0.631 Protein Kinases
exp ARHGAP12 10p11.22 -0.209 0.109 0.631 signal transduction;small
exp NAV1 1q32.3 -0.209 0.109 0.631 microtubule bundle formation;neuron
migration
met MIR2116 -0.209 0.109 0.631
xsq ZNF883 9q32 -0.209 0.109 0.631 regulation of transcription, DNA-
dependent"
exp COL16A1 1p35-p34 -0.209 0.109 0.631 cell adhesion;integrin-
met RBBP4 1p35.1 -0.209 0.109 0.631 CenH3-containing nucleosome
xsq TMCC1 3q22.1 -0.209 0.109 0.631
mut JAK3 19p13.1 -0.209 0.109 0.631 Oncogenes
xsq LOC730102 -0.209 0.109 0.631
exp RNPEP 1q32 -0.209 0.109 0.631 retina development in camera-type
eye;proteolysis
exp NRP2 2q33.3 -0.209 0.109 0.631 angiogenesis;positive regulation of
xsq KIF1C 17p13.2 -0.209 0.109 0.631 retrograde vesicle-mediated
exp C3 19p13.3-p13.2 -0.209 0.109 0.631 complement
xsq SPIRE1 18p11.21 -0.209 0.109 0.631 transport
xsq ADAMTS4 1q21-q23 -0.209 0.109 0.631 proteolysis;skeletal system
development
exp SLC9A3R2 16p13.3 -0.209 0.109 0.631 Solute Carriers
xsq LOC101929829 -0.209 0.109 0.63
exp PLXNB3 Xq28 -0.209 0.109 0.63 signal transduction;multicellular
exp TRNAK38P -0.209 0.109 0.63
xsq IER5L 9q34.11 -0.209 0.109 0.63
exp KRT16P2 17p11.2 -0.209 0.109 0.63
exp OR8U1 -0.209 0.109 0.63 response to stimulus
xsq EDA2R Xq12 -0.209 0.109 0.63 positive regulation of JNK
met SNORD100 6q23.2 -0.209 0.109 0.63
hs4 MUC15 11p14.3 -0.211 0.109 0.631 post-translational protein
hs4 LHFPL2 5q14.1 -0.211 0.109 0.631
xai LOC284865 -0.211 0.109 0.631
xai CERS4 19p13.2 -0.211 0.109 0.631 ceramide biosynthetic
xai NECAB3 20q11.22 -0.211 0.109 0.631 protein secretion;protein
metabolic process
his SOX9-AS1 -0.211 0.109 0.631
his SOX9 17q24.3 -0.211 0.109 0.631 epithelial to mesenchymal
xai SEPT10P1 8q12.1 -0.211 0.109 0.631
xai MEF2A 15q26 -0.211 0.109 0.631 MAPK cascade;nervous system development
xai CDRT1 17p12 -0.211 0.109 0.631
xai KCTD4 13q14.12 -0.211 0.109 0.631 potassium ion transport
his LINC00565 -0.211 0.109 0.631
hs4 COLCA1 -0.211 0.109 0.631
hs4 COLCA2 -0.211 0.109 0.631
xai SULT1C2 2q12.3 -0.211 0.109 0.631 xenobiotic metabolic
his LOC104054148 -0.211 0.109 0.631
hs4 TPST1 7q11.21 -0.211 0.109 0.631 peptidyl-tyrosine
his CNR1 6q14-q15 -0.211 0.109 0.631 positive regulation of acute
inflammatory response to antigenic stimulus;memory
his PIFO 1p13.2 -0.211 0.109 0.631
xai PCDHB14 5q31 -0.211 0.109 0.631 cell adhesion;homophilic cell
adhesion
xai PSAP 10q21-q22 -0.211 0.109 0.631 glycosphingolipid metabolic
xai ZC3H12C 11q22.3 -0.211 0.109 0.631
xai HM13 20q11.21 -0.211 0.109 0.63 membrane protein proteolysis
exp LOC399898 -0.211 0.109 0.63
hs4 IRF9 14q11.2 -0.211 0.109 0.63 type I interferon-mediated
signaling pathway;regulation of transcription, DNA-dependent
xai LOC399898 -0.211 0.109 0.63
xai ADAMTS5 21q21.3 -0.211 0.109 0.63 proteolysis
his SRPX2 Xq21.33-q23 -0.211 0.109 0.63 angiogenesis;cell-cell adhesion
hs4 LINC01166 -0.211 0.109 0.63
hs4 LINC01167 -0.211 0.109 0.63
hs4 LINC01168 -0.211 0.109 0.63
his ARHGEF17 11q13.4 -0.211 0.109 0.63 regulation of small GTPase
xai EGF 4q25 -0.211 0.109 0.63 Apoptosis
exp LOC284581 -0.211 0.109 0.63
xai MT1DP 16q13 -0.211 0.109 0.63
his TIAF1 17q11.2 -0.211 0.109 0.63 Apoptosis
xai YWHAEP7 -0.211 0.109 0.63
xai LOC100129363 -0.211 0.109 0.63
exp ASGR2 17p -0.211 0.109 0.63 glycoprotein metabolic process;bone
mineralization
xai CYB561D1 1p13.3 -0.211 0.109 0.63 electron transport
chain;transport
xai LOC100289061 1q21.3 -0.211 0.109 0.63
his KCNH3 12q13 -0.211 0.109 0.63 regulation of transcription, DNA-
hs4 UBL3 13q12-q13 -0.211 0.109 0.63
his MIR4421 -0.211 0.109 0.63
his MIR6500 -0.211 0.109 0.63
hs4 BEAN1 16q21 -0.211 0.109 0.63 cell death
his USP31 16p12.2 -0.211 0.109 0.63 proteolysis;ubiquitin-dependent
exp SEPHS1P6 2q33.1 0.211 0.11 0.631
exp PPP2R3B Xp22.33 0.211 0.11 0.631 G1/S transition of mitotic cell
xai TMEM38B 9q31.2 0.211 0.11 0.631 ion transport;potassium ion
transport
his BMP8B 1p35-p32 0.211 0.11 0.631 cartilage development;skeletal system
development
his LOC101929536 0.211 0.11 0.631
his CRELD1 3p25.3 0.211 0.11 0.631 endocardial cushion
his IL13 5q31 0.21 0.11 0.631
exp MIR551B 0.21 0.11 0.631
swa EXOSC4 8q24.3 0.21 0.11 0.631 RNA metabolic process;mRNA
metabolic process
hs4 COCH 14q11.2-q13 0.21 0.11 0.631 sensory perception of sound
xai DNAJC5B 8q13.1 0.21 0.11 0.631 protein folding
hs4 MIR4710 0.21 0.11 0.631
his PFKFB1 Xp11.21 0.21 0.11 0.631 Apoptosis
his APEX2 Xp11.21 0.21 0.11 0.631 DNA Damage Response (DDR); DDR (BER)
xai RGMA 15q26.1 0.21 0.11 0.631 axon guidance
xai MRPL45 17q21.2 0.21 0.11 0.631 translation;intracellular protein
transport
his TMEM248 7q11.21 0.21 0.11 0.631
xai MIR551B 0.21 0.11 0.632
xai PCF11 11q13 0.21 0.11 0.632 RNA splicing;gene expression
his SLC35B1 17q21.33 0.21 0.11 0.632 Solute Carriers
xai VWC2L 2q34-q35 0.21 0.11 0.632
xai BNIP2 15q22.2 0.21 0.11 0.632 Apoptosis
xai BACH2 6q15 0.21 0.11 0.632
xai TRAV13-1 0.21 0.11 0.632
his AMACR 5p13 0.21 0.11 0.632 bile acid biosynthetic process;bile acid
metabolic process
hs4 KISS1R 19p13.3 0.21 0.11 0.632 neuropeptide signaling
his ARL17A 17q21.31 0.21 0.11 0.632
hs4 IMP3 15q24 0.21 0.11 0.632 rRNA processing
his KIF2C 1p34.1 0.21 0.11 0.632 M phase of mitotic cell
cycle;establishment or maintenance of microtubule cytoskeleton polarity
exp MTX1P1 1q22 0.21 0.11 0.632
his UBE4A 11q23.3 0.21 0.11 0.632 ubiquitin-dependent protein catabolic
process
his ST20-AS1 0.21 0.11 0.632
his ST20-MTHFS 0.21 0.11 0.632
his ST20 15q25.1 0.21 0.11 0.632
xai AP3B1 5q14.1 0.21 0.11 0.632 protein targeting to
his BRD4 19p13.1 0.21 0.11 0.632 protein phosphorylation;chromosome
segregation
exp RBM22P2 0.21 0.11 0.632
xai PPP1R10 6p21.3 0.21 0.11 0.632 transcription, DNA-
dependent;protein import into nucleus"
xai LOC100129888 0.21 0.11 0.632
xai TRMT5 14q23.1 0.21 0.11 0.632 tRNA processing
exp TRAV13-1 0.21 0.11 0.632
his AKAP10 17p11.1 0.21 0.11 0.632 signal transduction;blood
coagulation
xai ZNF24 18q12 0.21 0.11 0.633 viral reproduction;myelination
his DRG2 17p11.2 0.21 0.11 0.633 signal transduction
his STIP1 11q13 0.21 0.11 0.633 response to stress;axon guidance
xai PUS7L 12q12 0.21 0.11 0.633 pseudouridine synthesis;tRNA processing
his ZP1 11q12.2 0.21 0.11 0.633 single fertilization
his ICMT 1p36.21 0.21 0.11 0.633 protein targeting to membrane;protein
localization
his LINC00337 1p36.31 0.21 0.11 0.633
xai NFYA 6p21.3 0.21 0.11 0.633 regulation of transcription, DNA-
exp FUNDC2P4 22q13.1 0.21 0.11 0.633
exp CENPJ 13q12.12 0.209 0.11 0.631 G2/M transition of mitotic cell
xsq LINC01481 0.209 0.11 0.631
xsq HIC2 22q11.21 0.209 0.11 0.631 negative regulation of transcription,
DNA-dependent"
exp KIAA1328 18q12.2 0.209 0.11 0.631
met C12orf66 12q14.2 0.209 0.11 0.631
xsq CCNC 6q21 0.209 0.11 0.631 DNA Damage Response (DDR)
xsq TEX33 22q12.3 0.209 0.11 0.631
xsq SLC7A11-AS1 0.209 0.11 0.631
met ADIPOR2 12p13.31 0.209 0.11 0.631 lipid metabolic process;hormone-
xsq NSF 17q21 0.209 0.11 0.631 plasma membrane fusion;positive regulation of
receptor recycling
xsq PATE4 0.209 0.11 0.631
xsq PHACTR3 20q13.32-q13.33 0.209 0.11 0.631
xsq F13B 1q31-q32.1 0.209 0.11 0.631 blood coagulation
exp CTBP1-AS2 4p16.3 0.209 0.11 0.632
xsq POLR3F 20p11.23 0.209 0.11 0.632 transcription, DNA-
mut GHR 5p13-p12 0.209 0.11 0.632 succinate metabolic process;hormone-
exp SRRT 7q21 0.209 0.11 0.632 gene silencing by RNA;primary miRNA processing
xsq LOC100996291 0.209 0.11 0.632
xsq FOCAD 9p21 0.209 0.11 0.632
exp AQP4 18q11.2-q12.1 0.209 0.11 0.632 transport;water transport
xsq HIST1H2BE 6p22.1 0.209 0.11 0.632
mut SNRNP200 2q11.2 0.209 0.11 0.632 RNA splicing;gene expression
xsq PRAC1 0.209 0.11 0.632
xsq GSE1 16q24.1 0.209 0.11 0.632
exp CDK2AP2P1 9p11.2 0.208 0.11 0.632
xsq LOC284578 0.208 0.11 0.632
exp TMEM242 6q25.3 0.208 0.11 0.632
dependent"
met ZNF704 8q21.13 0.208 0.11 0.632
xsq NUSAP1 15q15.1 0.208 0.11 0.632 positive regulation of mitosis;cell
division
exp TRIM11 1q42.13 0.208 0.11 0.632 response to virus
xsq CCNA2 4q27 0.208 0.11 0.632 DNA Damage Response (DDR); DDR (DNA
replication)
xsq LRRC3 21q22.3 0.208 0.11 0.632
xsq TIMM17B Xp11.23 0.208 0.11 0.632 protein targeting to
met CGRRF1 14q22.2 0.208 0.11 0.632 response to stress;cell cycle
met NRAS 1p13.2 0.208 0.11 0.632 Cell Signaling; Oncogenes; Protein
Kinases
exp RRN3P3 16p12.2 0.208 0.11 0.632
met LRRC69 8q21.3 0.208 0.11 0.632
met ST5 11p15 0.208 0.11 0.632 positive regulation of ERK1 and ERK2 cascade
exp BZRAP1 17q22-q23 0.208 0.11 0.632
xsq SCARA5 8p21.1 0.208 0.11 0.632 cellular response to heat;iron ion
exp RPS26P40 10q22.1 0.208 0.11 0.632
met MIR1204 0.208 0.11 0.633
xsq RPS2P32 7p15.3 0.208 0.11 0.633
dependent"
cop NEDD4L 18q21.31 0.208 0.11 0.633 protein ubiquitination;water
homeostasis
exp KIRREL2 19q13.12 0.208 0.11 0.633 cell adhesion
met RASSF9 12q21.31 0.208 0.11 0.633 signal transduction;endosome
transport
xsq LINC01580 0.208 0.11 0.633
cop FBP1 9q22.3 0.208 0.11 0.633 dephosphorylation;cellular response to
magnesium ion
cop MIR2278 0.208 0.11 0.633
xsq DDX10 11q22-q23 0.208 0.11 0.633
exp ITGA4 2q31.3 0.208 0.11 0.633 B cell differentiation;blood vessel
remodeling
met NR6A1 9q33.3 0.208 0.11 0.633 negative regulation of transcription from
exp DDX10P2 9q21.32 0.208 0.11 0.633
xsq RANGRF 17p13.1 0.208 0.11 0.633 protein transport
cop CLEC3A 16q23 0.208 0.11 0.633
xsq PIGM 1q23.2 0.208 0.11 0.633 C-terminal protein lipidation;preassembly
xsq PRR20C 0.208 0.11 0.633
cop CRIM1 2p21 0.208 0.11 0.633 regulation of cell growth;nervous system
development
xsq LRRC74A 0.208 0.11 0.633
exp RAB9AP5 0.208 0.11 0.633
met FIGN 2q24.3 0.208 0.11 0.633 locomotory behavior
xsq TIAM2 6q25.2 -0.208 0.11 0.633 regulation of Rho protein signal
exp EGF 4q25 -0.208 0.11 0.633 Apoptosis
exp SNCG 10q23.2-q23.3 -0.208 0.11 0.633 regulation of dopamine
met DGKZ 11p11.2 -0.208 0.11 0.633 negative regulation of mitotic cell
exp CAPN5 11q14 -0.208 0.11 0.633 granulosa cell differentiation;ovarian
follicle development
exp SWAP70 11p15 -0.208 0.11 0.633 somatic cell DNA
exp CLIP3 19q13.12 -0.208 0.11 0.632 negative regulation of microtubule
cop LOC286184 -0.208 0.11 0.632
exp PSEN2 1q42.13 -0.208 0.11 0.632 Apoptosis
xsq CEACAM19 19q13.31 -0.208 0.11 0.632
xsq FAM124A 13q14.3 -0.208 0.11 0.632
cop FYTTD1 3q29 -0.208 0.11 0.632 mRNA export from nucleus;transport
xsq BOC 3q13.2 -0.208 0.11 0.632 muscle cell
exp TRPV4 12q24.1 -0.208 0.11 0.632 ion transport;cell death
xsq LINC00540 -0.209 0.11 0.632
xsq LOC102467080 -0.209 0.11 0.632
cop DGKG 3q27.2-q27.3 -0.209 0.11 0.632 signal
transduction;activation of protein kinase C activity by G-protein coupled receptor
exp WFIKKN1 -0.209 0.11 0.632
exp APMAP 20p11.2 -0.209 0.11 0.632
exp MOCS2 5q11 -0.209 0.11 0.632 vitamin metabolic process;water-soluble
met KLHL9 9p22 -0.209 0.11 0.632 protein ubiquitination;cytokinesis
met SMCO2 12p11.23 -0.209 0.11 0.632
xsq KIAA0754 -0.209 0.11 0.631
cop ZBTB41 1q31.3 -0.209 0.11 0.631 regulation of transcription,
DNA-dependent"
cop FLJ46066 -0.209 0.11 0.631
met PCDHGA12 5q31 -0.209 0.11 0.631 homophilic cell adhesion;cell
adhesion
exp C7orf25 7p14.1 -0.209 0.11 0.631
exp GLT8D2 12q -0.209 0.11 0.631
xsq ECM1 1q21 -0.209 0.11 0.631 positive regulation of endothelial cell
cop FABP5 8q21.13 -0.209 0.11 0.631 lipid metabolic
his LINC00160 21q22.12 -0.21 0.11 0.633
hs4 RAB9B Xq22.1-q22.3 -0.21 0.11 0.633 small GTPase mediated signal
his DAOA 13q33.2 -0.21 0.11 0.633
xai CPA6 8q13.2 -0.21 0.11 0.633 proteolysis
hs4 ZNF205-AS1 16p13.3 -0.21 0.11 0.633
dependent"
his CASC8 8q24.21 -0.21 0.11 0.632
his MEDAG 13q12.3 -0.21 0.11 0.632
his LOC101927379 -0.21 0.11 0.632
exp NAT16 7q22.1 -0.21 0.11 0.632
his C11orf16 11p15.3 -0.21 0.11 0.632
his CTTNBP2NL 1p13.2 -0.21 0.11 0.632
his LOC101929413 -0.21 0.11 0.632
xai ERLIN2 8p11.2 -0.21 0.11 0.632 ER-associated protein catabolic
process
exp LOC100133131 -0.21 0.11 0.632
his LARS2-AS1 -0.21 0.11 0.632
exp LOC100130547 -0.21 0.11 0.632
hs4 HGD 3q13.33 -0.21 0.11 0.632 tyrosine catabolic process;cellular
xai LOC100506791 -0.21 0.11 0.632
hs4 TMEM232 5q22.1 -0.21 0.11 0.631
exp GOLGA2P9 -0.21 0.11 0.631
cop PSG11 19q13.2 -0.21 0.11 0.631 female pregnancy
his FER 5q21 -0.21 0.11 0.631 cell adhesion;regulation of epidermal growth
xai LOC100133131 -0.21 0.11 0.631
xai CCSER2 10q23.1 -0.21 0.11 0.631
xai C9orf131 9p13.3 -0.21 0.11 0.631
xai ABCA12 2q34 -0.21 0.11 0.631 ABC Transporters
hs4 DACT1 14q23.1 -0.21 0.11 0.631 multicellular organismal development;Wnt
exp SPATA12 3p14.3 -0.21 0.11 0.631
his TSEN2 3p25.2 0.21 0.111 0.633 tRNA splicing, via endonucleolytic
his LINC01743 0.21 0.111 0.633
xai HNRNPA3P3 Xq27.1 0.21 0.111 0.633
xai GLOD4 17p13.3 0.21 0.111 0.633
xai CDC42SE2 5q31.1 0.21 0.111 0.633 phagocytosis;regulation of cell
shape
his VPS45 1q21.2 0.21 0.111 0.633 intracellular protein transport;vesicle
exp SNX29P2 16p11.2 0.21 0.111 0.634
xai SOS1 2p21 0.21 0.111 0.634 Ras protein signal transduction;regulation of
xai TIMM17B Xp11.23 0.21 0.111 0.634 protein targeting to
xai CCNB2 15q22.2 0.21 0.111 0.634 DNA Damage Response (DDR)
xai RPL18P13 16q23.1 0.21 0.111 0.634
his CCDC25 8p21.1 0.21 0.111 0.634
his ESCO2 8p21.1 0.21 0.111 0.634 regulation of DNA replication;cell cycle
hs4 ZPBP 0.21 0.111 0.634 binding of sperm to zona pellucida
his SWSAP1 19p13.2 0.21 0.111 0.634 DNA repair;DNA recombination
his EPOR 19p13.3-p13.2 0.21 0.111 0.634 signal transduction;elevation of
hs4 CD69 12p13 0.21 0.111 0.634 cellular response to drug
his CASC21 0.21 0.111 0.634
cop C6orf120 6q27 0.21 0.111 0.634
his PLXDC1 17q21.1 0.21 0.111 0.634 angiogenesis;spinal cord
development
xai YPEL1 22q11.2 0.21 0.111 0.634
hs4 LINC01341 0.21 0.111 0.634
xai PWP1 12q23.3 0.21 0.111 0.634 transcription, DNA-dependent"
cop GABARAPL3 15q26.1 0.21 0.111 0.634
xai BCORL1 Xq25-q26.1 0.21 0.111 0.634 regulation of transcription, DNA-
xai VSIG4 Xq12-q13.3 0.21 0.111 0.634 complement activation, alternative
his LOC102724908 0.21 0.111 0.634
his URI1 19q12 0.21 0.111 0.634 negative regulation of transcription from RNA
polymerase II promoter;cellular response to steroid hormone stimulus
dependent"
xai C8A 1p32 0.21 0.111 0.634 immune response;complement activation
hs4 UBIAD1 1p36.22 0.21 0.111 0.634 menaquinone biosynthetic
his DNASE1L3 3p14.3 0.21 0.111 0.634 apoptotic process;DNA metabolic
process
xai SSSCA1 11q13.1 0.21 0.111 0.634 cell division;cell cycle
his FAM110D 1p36.11 0.21 0.111 0.634
xai YAF2 12q12 0.21 0.111 0.634 negative regulation of transcription, DNA-
exp LOC100129888 0.21 0.111 0.634
his IKZF5 10q26 0.21 0.111 0.634 regulation of transcription, DNA-dependent"
his ACADSB 10q26.13 0.21 0.111 0.634 lipid metabolic process;fatty acid
metabolic process
his THAP5 7q31.1 0.21 0.111 0.634 negative regulation of cell cycle
his DNAJB9 7q31 0.21 0.111 0.634 protein folding;activation of signaling
protein activity involved in unfolded protein response
swa CAPZB 1p36.1 0.21 0.111 0.634 cell projection
organization;lamellipodium assembly
xai XPOT 12q14.2 0.21 0.111 0.634 tRNA export from nucleus;transport
his SNAR-A1 0.21 0.111 0.634
his SNORA25 0.21 0.111 0.634
his SNORA32 0.21 0.111 0.634
his SNORD6 0.21 0.111 0.634
his SNORA1 0.21 0.111 0.634
dependent"
his ZNF561-AS1 0.21 0.111 0.634
xai SLC8A2 19q13.3 0.21 0.111 0.634 transmembrane transport;ion
transport
xai GATC 12q24.31 0.209 0.111 0.634 regulation of translational
his TGFBR3L 0.209 0.111 0.634
his SNAPC2 19p13 0.209 0.111 0.634 snRNA transcription;gene expression
his FAM208B 10p15.1 0.209 0.111 0.634
his GDAP2 1p12 0.209 0.111 0.634 response to retinoic acid
his WDR3 1p12 0.209 0.111 0.634
hs4 ABHD3 18q11.2 0.209 0.111 0.634
his PCIF1 20q13.12 0.209 0.111 0.634 negative regulation of phosphatase
activity
xai CASC5 15q14 0.209 0.111 0.634 acrosome assembly;nucleosome assembly
his NVL 1q41-q42.2 0.209 0.111 0.634
exp SRP14-AS1 0.209 0.111 0.634
xai FBXW4P1 22q11 0.209 0.111 0.634
hs4 LINC01993 0.209 0.111 0.634
his GHRL 3p26-p25 0.209 0.111 0.634 negative regulation of endothelial cell
proliferation;hormone-mediated signaling pathway
exp C10orf91 10q26.3 0.209 0.111 0.634
xai HILPDA 7q32.1 0.209 0.111 0.634 positive regulation of cell
xai RPS6KA1 1p 0.209 0.111 0.634 Protein Kinases
swa PSMA7 20q13.33 0.209 0.111 0.634 G1/S transition of mitotic cell
cycle;regulation of cellular amino acid metabolic process
his CPSF1 8q24.23 0.209 0.111 0.634 nuclear mRNA splicing, via
xai LOC100996428 0.209 0.111 0.634
exp HMG20A 15q24 0.208 0.111 0.633 chromatin organization;regulation of
xsq TMEM91 19q13.2 0.208 0.111 0.633 response to biotic stimulus
met TAF7 5q31 0.208 0.111 0.633 transcription initiation, DNA-
xsq PRR20B 0.208 0.111 0.633
mut HOXA9 7p15.2 0.208 0.111 0.633 definitive hemopoiesis;multicellular
cop ACTC1 15q14 0.208 0.111 0.633 ATP catabolic process;response to ethanol
met CLDN4 7q11.23 0.208 0.111 0.633 EMT (Epithelial)
exp RPL29P9 3q27.3 0.208 0.111 0.633
xsq FGF23 12p13.3 0.208 0.111 0.633 insulin receptor signaling
met TMEM47 Xp11.4 0.208 0.111 0.633
xsq ARHGAP25 2p13.3 0.208 0.111 0.634 regulation of small GTPase mediated
exp MPC1 6q27 0.208 0.111 0.634
xsq USP2-AS1 0.208 0.111 0.634
exp FAM96A 15q22.31 0.208 0.111 0.634 chromosome segregation
xsq APITD1 1p36.22 0.208 0.111 0.634 DNA Damage Response (DDR); DDR (FA)
xsq ABI1 10p11.2 0.208 0.111 0.634 peptidyl-tyrosine
phosphorylation;somitogenesis
met BPIFB6 20q11.21 0.208 0.111 0.634
xsq NUDT7 16q23.1 0.208 0.111 0.634 nucleoside diphosphate metabolic process
xsq JPH3 16q24.3 0.208 0.111 0.634 memory;exploration behavior
met TARS 5p13.2 0.208 0.111 0.634 translation;tRNA aminoacylation for
protein translation
cop P2RX4 12q24.32 0.208 0.111 0.634 response to stress;response to ATP
cop CAMKK2 12q24.2 0.208 0.111 0.634 positive regulation of
cop ANAPC5 12q24.31 0.208 0.111 0.634 G2/M transition of mitotic cell
cycle;negative regulation of ubiquitin-protein ligase activity involved in mitotic
cell cycle
xsq ASRGL1 11q12.3 0.208 0.111 0.634 asparagine catabolic process via L-
aspartate;protein maturation
xsq NAA40 11q13.1 0.208 0.111 0.634
met CD302 2q24.2 0.208 0.111 0.634
exp BAG4 8p11.23 0.208 0.111 0.634 Apoptosis
xsq TARS2 1q21.3 0.208 0.111 0.634 threonyl-tRNA aminoacylation;gene
expression
exp GLI4 8q24.3 0.208 0.111 0.634
xsq PIK3CD-AS2 0.208 0.111 0.634
xsq OCSTAMP 20q13.12 0.208 0.111 0.634
mir hsa-miR-1238 0.208 0.111 0.634
xsq ECH1 19q13.1 0.208 0.111 0.634 lipid metabolic process;fatty acid
metabolic process
exp FBXW4P1 22q11 0.208 0.111 0.634
xsq KRTAP4-11 0.208 0.111 0.634
xsq POLR2I 19q12 0.208 0.111 0.634 DNA Damage Response (DDR); DDR (NER)
cop C15orf65 0.208 0.111 0.634
cop DYX1C1 15q21.3 0.208 0.111 0.634 neuron migration;nervous system
development
cop PYGO1 15q21.3 0.208 0.111 0.634 kidney development;post-embryonic
development
met MIR124-2 0.208 0.111 0.634
xsq NPM2 8p21.3 0.208 0.111 0.634 chromatin remodeling;regulation of exit
from mitosis
dependent"
exp EXD1 15q15.1 0.208 0.111 0.634 nucleobase-containing compound metabolic
process
cop FICD 12q24.1 0.208 0.111 0.634 protein adenylylation;negative regulation
of Rho GTPase activity
cop DEAF1 11p15.5 0.208 0.111 0.634 multicellular organismal development;germ
cell development
cop TMEM80 11p15.5 0.208 0.111 0.634
cop EPS8L2 11p15.5 0.208 0.111 0.634
cop TALDO1 11p15.5-p15.4 0.208 0.111 0.634 fructose 6-phosphate
metabolic process;pentose-phosphate shunt
cop PDDC1 11p15.5 0.208 0.111 0.634
cop NS3BP 11p15.5 0.208 0.111 0.634
cop CEND1 11p15.5 0.208 0.111 0.634
cop PIDD 0.208 0.111 0.634 Apoptosis
cop RPLP2 11p15.5 0.208 0.111 0.634 translation;mRNA metabolic process
cop SNORA52 0.208 0.111 0.634
cop PNPLA2 11p15.5 0.208 0.111 0.634 metabolic process;negative
regulation of sequestering of triglyceride
cop EFCAB4A 0.208 0.111 0.634
cop CD151 11p15.5 0.208 0.111 0.634 cell adhesion;hemidesmosome assembly
cop POLR2L 11p15 0.208 0.111 0.634 DNA Damage Response (DDR); DDR (NER)
cop MIR122 0.208 0.111 0.634
cop MIR3591 0.208 0.111 0.634
exp VTA1 6q24.1 0.208 0.111 0.634 endosome transport;protein transport
exp TFRC 3q29 0.208 0.111 0.634 response to hypoxia;response to inorganic
substance
exp ARMC6 19p13.11 0.208 0.111 0.634
exp LIG1 19q13.2-q13.3 0.208 0.111 0.634 DNA Damage Response (DDR); DDR
exp C4orf46 4q32.1 0.208 0.111 0.634
cop HK1 10q22 0.208 0.111 0.634 transmembrane transport;carbohydrate metabolic
process
xsq OBFC1 10q24.33 0.208 0.111 0.634 DNA Damage Response (DDR)
xsq WDFY3 4q21.23 -0.208 0.111 0.634 metabolic process
xsq SPDYE1 7p13 -0.208 0.111 0.634
xsq TRAK1 3p22.1 -0.208 0.111 0.634 protein targeting;endosome to
lysosome transport
exp TGOLN2 2p11.2 -0.208 0.111 0.634
xsq ALCAM 3q13.1 -0.208 0.111 0.634 cell adhesion;signal transduction
exp MDGA2 14q21.3 -0.208 0.111 0.634 spinal cord motor neuron
differentiation
exp TMEM14A 6p12.2 -0.208 0.111 0.634
xsq ENG 9q34.11 -0.208 0.111 0.634 heart looping;cell migration
xsq PAK3 Xq23 -0.208 0.111 0.634 Protein Kinases
exp PLSCR1 3q23 -0.208 0.111 0.634 apoptotic process;positive
exp TRAK2 2q33 -0.208 0.111 0.634 regulation of transcription from RNA
exp TNFAIP1 17q22-q23 -0.208 0.111 0.634 protein
ubiquitination;negative regulation of Rho protein signal transduction
exp TMEM40 3p25.2 -0.208 0.111 0.634
xsq COTL1 16q24.1 -0.208 0.111 0.634 defense response to fungus
cop MIR124-2 -0.208 0.111 0.634
xsq PRLR 5p13.2 -0.208 0.111 0.634 embryo implantation;prostate gland
growth
xsq FMNL2 2q23.3 -0.208 0.111 0.634 cytoskeleton organization;cellular
component organization
exp EBF3 10q26.3 -0.208 0.111 0.634 regulation of transcription, DNA-
xsq PTGIS 20q13.13 -0.208 0.111 0.634 prostaglandin biosynthetic
exp CPA6 8q13.2 -0.208 0.111 0.634 proteolysis
met OXER1 2p21 -0.208 0.111 0.634 G-protein coupled receptor signaling
exp PRKCE 2p21 -0.208 0.111 0.634 Protein Kinases
xsq ALDH7A1 5q31 -0.208 0.111 0.633 cellular aldehyde metabolic
xsq LCN12 9q34.3 -0.208 0.111 0.633 lipid metabolic process
hs4 TNFSF18 1q23 -0.209 0.111 0.634 cell-cell signaling;tumor necrosis
factor-mediated signaling pathway
xai EPN1 19q13.42 -0.209 0.111 0.634 endocytosis;epidermal growth factor
xai TRPV4 12q24.1 -0.209 0.111 0.634 ion transport;cell death
hs4 DHX58 17q21.2 -0.209 0.111 0.634 innate immune response
his PKIG 20q12-q13.1 -0.209 0.111 0.634 negative regulation of
activity
exp KRT19P1 6q13 -0.209 0.111 0.634
hs4 MYO6 6q13 -0.209 0.111 0.634 regulation of secretion;intracellular
protein transport
his DOCK7 1p31.3 -0.209 0.111 0.634 axonogenesis;cell differentiation
xai CYP2AB1P 3q27.1 -0.209 0.111 0.634
hs4 KLKB1 4q35 -0.209 0.111 0.634 inflammatory response;blood coagulation
his SNCG 10q23.2-q23.3 -0.209 0.111 0.634 regulation of dopamine
his MMRN2 10q23.2 -0.209 0.111 0.634
xai PHYH 10p13 -0.209 0.111 0.634 fatty acid alpha-oxidation;cellular lipid
metabolic process
his UGCG 9q31 -0.21 0.111 0.634 glycosphingolipid biosynthetic
his MIR4668 -0.21 0.111 0.634
xai SOX13 1q32 -0.21 0.111 0.634 regulation of transcription, DNA-
xai ARTN 1p33-p32 -0.21 0.111 0.634 signal transduction;neuroblast
proliferation
xai CLDN1 3q28-q29 -0.21 0.111 0.634 cell adhesion;calcium-independent cell-
cell adhesion
hs4 C2orf73 2p16.2 -0.21 0.111 0.634
xai ADGRA2 -0.21 0.111 0.634 sprouting angiogenesis;G-protein coupled
xai LOC100506895 -0.21 0.111 0.634
xai COMMD7 20q11.21 -0.21 0.111 0.634 negative regulation of NF-kappaB
transcription factor activity;tumor necrosis factor-mediated signaling pathway
his MRVI1 11p15 -0.21 0.111 0.634 blood coagulation
his TSPAN1 1p34.1 -0.21 0.111 0.634
swa GPC1 2q35-q37 -0.21 0.111 0.634 axon guidance
his DACT1 14q23.1 -0.21 0.111 0.634 multicellular organismal development;Wnt
his FOLR3 11q13 -0.21 0.111 0.634 folic acid transport
his SDPR 2q32-q33 -0.21 0.111 0.634
his MATN2 8q22 -0.21 0.111 0.634
xai DOCK9-AS2 -0.21 0.111 0.634
xai UPP1 7p12.3 -0.21 0.111 0.634 nucleotide catabolic process;pyrimidine
nucleoside salvage
his IRAK2 3p25.3 -0.21 0.111 0.634 Protein Kinases
xai LINC00622 -0.21 0.111 0.634
xai BAIAP2L1 7q22.1 -0.21 0.111 0.633 response to bacterium;positive
xai NFE2L1 17q21.3 -0.21 0.111 0.633 heme biosynthetic
xai GLB1L 2q35 -0.21 0.111 0.633 carbohydrate metabolic process
mir hsa-miR-455-3p -0.21 0.111 0.633
his LINC02138 0.209 0.112 0.635
his TMEM202 15q24.1 0.209 0.112 0.635
xai UTP11L 1p34.3 0.209 0.112 0.635 rRNA processing;induction of
apoptosis
exp DOC2GP 11q13.2 0.209 0.112 0.635
exp PSMD13 11p15.5 0.209 0.112 0.635 antigen processing and presentation
xai NDUFAF4P1 0.209 0.112 0.635
xai ARC 8q24.3 0.209 0.112 0.635 regulation of cell
hs4 LINC01237 0.209 0.112 0.635
exp NDUFAF4P1 0.209 0.112 0.635
hs4 HHEX 10q23.33 0.209 0.112 0.635 in utero embryonic development;cell
proliferation
hs4 PTGDR2 11q12-q13.3 0.209 0.112 0.635 chemotaxis;immune response
exp LINC01061 0.209 0.112 0.635
xai TAPBPL 12p13.31 0.209 0.112 0.635 antigen processing and presentation
of endogenous peptide antigen via MHC class I
his ETV6 12p13 0.209 0.112 0.635 Transcription Factors
exp ADAM2 8p11.2 0.209 0.112 0.635 proteolysis;cell adhesion
swa SSNA1 9q34.3 0.209 0.112 0.635 G2/M transition of mitotic cell
his TIMM23 10q11.23 0.209 0.112 0.635 protein targeting to
his USP19 3p21.31 0.209 0.112 0.635 negative regulation of skeletal muscle
tissue development;proteolysis
his RPL35 9q34.1 0.209 0.112 0.635 viral reproduction;nuclear-transcribed
his ARPC5L 9q33.3 0.209 0.112 0.635 regulation of actin filament
polymerization
his MIR9-2 0.209 0.112 0.635
xai CYTH1 17q25 0.209 0.112 0.635 vesicle-mediated transport;regulation of cell
adhesion
xai ESX1 Xq22.1 0.209 0.112 0.635 labyrinthine layer blood vessel
xai KIZ 0.209 0.112 0.635 spindle organization
xai FAM193A 4p16.3 0.209 0.112 0.635
xai EYA3 1p36 0.209 0.112 0.635 DNA Damage Response (DDR)
xai HDHD2 18q21.1 0.209 0.112 0.635 metabolic process
xai PSME3 17q21 0.209 0.112 0.635 M/G1 transition of mitotic cell cycle;positive
hs4 DALRD3 3p21.31 0.209 0.112 0.635 arginyl-tRNA aminoacylation
hs4 MIR425 0.209 0.112 0.635
hs4 NDUFAF3 3p21.31 0.209 0.112 0.635 mitochondrial respiratory chain
complex I assembly
hs4 MIR191 0.209 0.112 0.635
xai SAMD13 1p31.1 0.209 0.112 0.635
hs4 FOXD4L1 2q13 0.209 0.112 0.635 positive regulation of BMP signaling
pathway;cartilage development
his ITGB3BP 1p31.3 0.209 0.112 0.635 Apoptosis
his EFCAB7 1p31.3 0.209 0.112 0.635
cop RPLP0 12q24.2 0.209 0.112 0.635 SRP-dependent cotranslational protein
exp TOMM20L 14q23.1 0.209 0.112 0.635 protein targeting
hs4 PDF 16q22.1 0.209 0.112 0.636 translation;positive regulation of cell
proliferation
xai HAUS4P1 1q24.2 0.209 0.112 0.636
hs4 LINC01602 0.209 0.112 0.636
hs4 NT5M 17p11.2 0.209 0.112 0.636 small molecule metabolic process;dUMP
catabolic process
xai NCAN 19p12 0.209 0.112 0.636 cell adhesion;axon guidance
his EIF2S3 Xp22.2-p22.1 0.209 0.112 0.636 GTP catabolic
process;translation
hs4 SELENOT 0.209 0.112 0.636
xai RHOF 12q24.31 0.209 0.112 0.636 GTP catabolic process;actin filament
organization
exp RPS6P8 6q13 0.209 0.112 0.636
xai RPS2P2 0.209 0.112 0.636
his METTL10 10q26.13 0.209 0.112 0.636
xai HHIP 4q28-q32 0.209 0.112 0.636 skeletal system morphogenesis;epithelial
tube branching involved in lung morphogenesis
hs4 GJC3 7q22.1 0.209 0.112 0.636 myelination;cell communication
his ZBTB11-AS1 3q12.3 0.209 0.112 0.636
dependent"
xai C2CD4C 19p13.3 0.209 0.112 0.636
his CCDC14 3q21.1 0.209 0.112 0.636
his ZMYM2 13q11-q12 0.209 0.112 0.636 regulation of transcription, DNA-
dependent"
exp RPS2P2 0.209 0.112 0.636
hs4 LOC100506585 0.209 0.112 0.636
xai NUP153 6p22.3 0.209 0.112 0.636 carbohydrate metabolic
process;interspecies interaction between organisms
his MSL1 17q21.1 0.209 0.112 0.636 chromatin modification;histone H4-K16
acetylation
xsq PFDN2 1q23.3 0.208 0.112 0.635 protein folding;cellular protein
metabolic process
pro EP300_9_8907 0.208 0.112 0.635
met HECTD2 10q23.32 0.208 0.112 0.635 protein modification
process
cop LDHD 16q23.1 0.208 0.112 0.635
cop ZFP1 16q23.1 0.208 0.112 0.635 regulation of transcription, DNA-
dependent"
met ANK3 10q21 0.208 0.112 0.635 signal transduction;establishment of protein
localization
cop ZNRF1 16q23.1 0.208 0.112 0.635 proteasomal ubiquitin-dependent protein
cop PIGB 15q21.3 0.208 0.112 0.635 post-translational protein
met FXR2 17p13.1 0.208 0.112 0.635
xsq ZIM2-AS1 0.208 0.112 0.635
met MCOLN2 1p22 0.208 0.112 0.635 ion transport
met ZMYM3 Xq13.1 0.208 0.112 0.635 multicellular organismal
exp IGHV3-53 0.208 0.112 0.635
cop COL13A1 10q22 0.208 0.112 0.635 morphogenesis of a branching
structure;endochondral ossification
xsq SCARNA9 0.207 0.112 0.635
met LINC00304 16q24.3 0.207 0.112 0.635
xsq OGDHL 10q11.23 0.207 0.112 0.635 glycolysis;tricarboxylic acid cycle
exp CPNE4 3q22.1 0.207 0.112 0.635
mut ACSL6 5q31.1 0.207 0.112 0.635 fatty acid metabolic process;acyl-CoA
metabolic process
met CD1A 1q23.1 0.207 0.112 0.635 immune response;antigen processing and
presentation
xsq LINC01144 0.207 0.112 0.635
xsq PIAS4 19p13.3 0.207 0.112 0.635 DNA Damage Response (DDR)
cop CTRB2 16q23.1 0.207 0.112 0.635 proteolysis;digestion
exp MBNL1 3q25 0.207 0.112 0.635 embryonic limb morphogenesis;regulation of
cop DUSP6 12q22-q23 0.207 0.112 0.635 MyD88-independent toll-like receptor
signaling pathway;toll-like receptor 4 signaling pathway
cop POC1B 12q21.33 0.207 0.112 0.635 cell projection organization;cilium
assembly
cop GALNT4 12q21.33 0.207 0.112 0.635
cop POC1B-GALNT4 0.207 0.112 0.635
xsq YTHDC2 5q22.2 0.207 0.112 0.635
xsq MRPS18B 6p21.3 0.207 0.112 0.635 translation
cop COL15A1 9q21-q22 0.207 0.112 0.635 signal transduction;multicellular
cop DENR 12q24.31 0.207 0.112 0.635
cop CCDC62 12q24.31 0.207 0.112 0.635
cop HIP1R 12q24 0.207 0.112 0.635 receptor-mediated endocytosis
cop VPS37B 12q24.31 0.207 0.112 0.635 egress of virus within host
cell;protein transport
xsq LINC01510 0.207 0.112 0.635
xsq XPO4 13q11 0.207 0.112 0.635 protein transport;positive regulation of
cop RAB27A 15q15-q21.1 0.207 0.112 0.635 melanosome localization;GTP
catabolic process
met FAM181A-AS1 14q32.12 0.207 0.112 0.635
xsq TIMM10 11q12.1-q12.3 0.207 0.112 0.635 protein targeting to
xsq USP3 15q22.3 0.207 0.112 0.635 proteolysis;ubiquitin-dependent protein
catabolic process
exp C10orf25 10q11.21 0.207 0.112 0.635
exp FABP5P7 0.207 0.112 0.635
xsq CTD-3080P12.3 0.207 0.112 0.635
xsq PRAMEF19 0.207 0.112 0.635
xsq PTP4A3 8q24.3 0.207 0.112 0.635
exp RSC1A1 1p36.1 0.207 0.112 0.635 regulation of transcription, DNA-
dependent;transport
cop GABBR2 9q22.1-q22.3 0.207 0.112 0.635 negative regulation of
adenylate cyclase activity;gamma-aminobutyric acid signaling pathway
exp DPY19L2 12q14.2 0.207 0.112 0.636 cell differentiation;multicellular
exp PGGT1B 5q22.3 0.207 0.112 0.636 positive regulation of cell
xsq C21orf59 21q22.1 0.207 0.112 0.636
xsq SNHG12 1p35.3 0.207 0.112 0.636
mut UPF2 10p14-p13 0.207 0.112 0.636 mRNA export from nucleus;gene expression
exp RPTOR 17q25.3 0.207 0.112 0.636 cell growth;cellular response to nutrient
levels
xsq COX8A 11q12-q13 0.207 0.112 0.636 generation of precursor metabolites and
xsq RUNDC1 17q21.31 0.207 0.112 0.636
cop PRTG 15q21.3 0.207 0.112 0.636 multicellular organismal development
exp QTRT1 19p13.3 0.207 0.112 0.636 tRNA modification;queuosine biosynthetic
process
met ZC3H18 16q24.2 0.207 0.112 0.636
xsq ZCCHC12 Xq24 0.207 0.112 0.636 regulation of transcription, DNA-
dependent"
exp FANCE 6p22-p21 0.207 0.112 0.636 DNA Damage Response (DDR); DDR (FA)
xsq NAA15 4q31.1 0.207 0.112 0.636 angiogenesis;N-terminal protein amino
acid acetylation
xsq POC1A 3p21.2 0.207 0.112 0.636
met MS4A5 11q12 0.207 0.112 0.636
exp MAGEA9B 0.207 0.112 0.636
xsq NDUFB2-AS1 7q34 0.207 0.112 0.636
cop RSL24D1 15q21 0.207 0.112 0.636 translation;ribosome biogenesis
xsq HTR6 1p36-p35 0.207 0.112 0.636 synaptic transmission;G-protein
signaling, coupled to cyclic nucleotide second messenger"
cop SFXN5 2p13 0.207 0.112 0.636 iron ion homeostasis;transmembrane transport
exp SETDB1 1q21 0.207 0.112 0.636 regulation of transcription, DNA-
met ADAMTS7 15q24.2 0.207 0.112 0.636 proteolysis
mut RBM25 14q24.3 0.207 0.112 0.636 regulation of alternative nuclear mRNA
splicing, via spliceosome;mRNA processing
exp LINC01139 -0.207 0.112 0.636
xsq PDLIM1 10q23.1 -0.207 0.112 0.636 response to oxidative
cop EGFR-AS1 -0.207 0.112 0.636
exp PGAP3 17q12 -0.207 0.112 0.636 GPI anchor metabolic process;GPI anchor
exp LIN37 19q13.1 -0.207 0.112 0.636 mitotic cell cycle
exp NMT1 17q21.31 -0.207 0.112 0.636 N-terminal protein
myristoylation;apoptotic process
cop IGFBP1 7p12.3 -0.207 0.112 0.636 positive regulation of cell
exp TRIM6 11p15.4 -0.207 0.112 0.636 protein trimerization
xsq BLZF1 1q24 -0.207 0.112 0.636 vesicle-mediated transport;Golgi to
cop TRIQK 8q22.1 -0.207 0.112 0.635
exp SHOX2 3q25.32 -0.207 0.112 0.635 nervous system development;heart
development
exp STAP2 19p13.3 -0.207 0.112 0.635
exp SLC9A1 1p36.1-p35 -0.207 0.112 0.635 Solute Carriers
xsq PARP9 3q21 -0.207 0.112 0.635 cell migration;regulation of response to
interferon-gamma
exp FZD4 11q14.2 -0.207 0.112 0.635 brain development;substrate
xsq CRYBG3 3q11.2 -0.207 0.112 0.635
xsq POU2F3 11q23.3 -0.207 0.112 0.635 epidermis
xsq MMP19 12q14 -0.207 0.112 0.635 Apoptosis
exp CFAP58 -0.207 0.112 0.635
exp TMTC3 12q21.32 -0.208 0.112 0.635
met FAM58BP 1q32.1 -0.208 0.112 0.635
hs4 NECAB3 20q11.22 -0.209 0.112 0.636 protein secretion;protein
metabolic process
his MGC15885 15q22.2 -0.209 0.112 0.636
his TLN2 15q15-q21 -0.209 0.112 0.636 cell-cell junction assembly;cell
adhesion
exp HDAC1P1 -0.209 0.112 0.636
his ARSE Xp22.3 -0.209 0.112 0.636 skeletal system development
hs4 MIR320C1 -0.209 0.112 0.636
hs4 IFI44 1p31.1 -0.209 0.112 0.636 response to virus
xai KRT74 12q13.13 -0.209 0.112 0.636
xai IRGQ 19q13.31 -0.209 0.112 0.636
exp LPIN3 20q12 -0.209 0.112 0.636 dephosphorylation;lipid metabolic process
hs4 C3orf67 3p14.2 -0.209 0.112 0.636
his LINC00211 -0.209 0.112 0.636
xai LOC100129884 -0.209 0.112 0.636
his DNM3-IT1 -0.209 0.112 0.636
his C1orf234 1p36.12 -0.209 0.112 0.636
his ZFP57 6p22.1 -0.209 0.112 0.636 DNA methylation involved in embryo
his PATL1 11q12.1 -0.209 0.112 0.635 deadenylation-dependent decapping
of nuclear-transcribed mRNA;cytoplasmic mRNA processing body assembly
cop MIR4634 -0.209 0.112 0.635
xai A4GALT 22q13.2 -0.209 0.112 0.635 lipid biosynthetic
hs4 AMIGO1 1p13.3 -0.209 0.112 0.635 heterophilic cell-cell
adhesion;multicellular organismal development
xai SPOCK1 5q31.2 -0.209 0.112 0.635 cell adhesion;signal
transduction
xai CDR2L 17q25.1 -0.209 0.112 0.635
xai HLA-K -0.209 0.112 0.635
hs4 GPR173 Xp11 -0.209 0.112 0.635 signal transduction;G-protein
xai LINC00282 13q14.3 -0.209 0.112 0.635
hs4 PLSCR1 3q23 -0.209 0.112 0.635 apoptotic process;positive
xai PLXNA2 1q32.2 -0.209 0.112 0.635 multicellular organismal
development;semaphorin-plexin signaling pathway
xai SIPA1L2 1q42.2 -0.209 0.112 0.635 regulation of small GTPase
xai FAM109B 22q13.2 -0.209 0.112 0.635 endosome
hs4 RUVBL1-AS1 -0.209 0.112 0.635
his LINC00702 -0.209 0.112 0.635
exp PDLIM1P -0.209 0.112 0.635
his LOC102724579 -0.209 0.112 0.635
cop RASAL2-AS1 -0.213 0.112 0.636
xai TSSK4 14q12 0.209 0.113 0.636 spermatogenesis;cell differentiation
his CCDC47 17q23.3 0.209 0.113 0.636 ER overload response;embryo
development
his DDX42 17q23.3 0.209 0.113 0.636 regulation of anti-apoptosis;protein
localization
xai DPY19L2 12q14.2 0.209 0.113 0.636 cell differentiation;multicellular
exp PPP1R26P1 0.209 0.113 0.636
xai WDR76 15q15.3 0.209 0.113 0.636
hs4 LYSMD2 15q21.2 0.209 0.113 0.636 cell wall macromolecule catabolic
process
his CD80 3q13.3-q21 0.209 0.113 0.636 interspecies interaction between
organisms;positive regulation of interleukin-2 biosynthetic process
exp SLC7A11-AS1 0.209 0.113 0.636
xai LINC01115 0.209 0.113 0.636
xai GK3P 4q32.1 0.209 0.113 0.636
hs4 NCF1C 7q11.23 0.209 0.113 0.636 cell communication
hs4 NINJ2 12p13 0.209 0.113 0.636 cell adhesion;neuron cell-cell adhesion
swa SNX1 15q22.31 0.209 0.113 0.636 cell communication;early endosome to
Golgi transport
exp FEM1AP3 6q21 0.209 0.113 0.636
his TIFA 4q25 0.209 0.113 0.636 I-kappaB kinase/NF-kappaB cascade
exp SPATA31E1 9q22.1 0.209 0.113 0.636
hs4 PTBP1 19p13.3 0.209 0.113 0.636 negative regulation of RNA
swa RBM15 1p13 0.209 0.113 0.636 positive regulation of transcription of Notch
receptor target;interspecies interaction between organisms
dependent"
xai LOC101060609 0.209 0.113 0.636
xai PPIAP7 1p21.2 0.209 0.113 0.636
his LINC01560 0.209 0.113 0.636
his ZNF41 Xp11.23 0.209 0.113 0.636 regulation of transcription, DNA-
dependent"
his KIF14 1q32.1 0.209 0.113 0.636 microtubule-based movement
xai PRRC2C 1q23.3 0.209 0.113 0.636
his EXOC2 6p25.3 0.209 0.113 0.636 exocytosis;protein transport
xai MTX1P1 1q22 0.209 0.113 0.637
his AP5M1 14q22.3 0.209 0.113 0.637 intracellular protein transport;vesicle-
mediated transport
his EXOC5 14q22.3 0.209 0.113 0.637 exocytosis;post-Golgi vesicle-mediated
transport
exp HIST1H2BH 6p21.3 0.209 0.113 0.637 nucleosome assembly
xai GAB3 Xq28 0.209 0.113 0.637
dependent;cell death"
xai ZRANB3 2q21.3 0.208 0.113 0.637 DNA Damage Response (DDR)
his ITGB1BP2 Xq12-q13.1 0.208 0.113 0.637 muscle organ development;signal
transduction
xai SCAF4 21q22.1 0.208 0.113 0.637 mRNA processing
his IGBP1 Xq13.1-q13.3 0.208 0.113 0.637 negative regulation of stress-
activated MAPK cascade;regulation of microtubule-based movement
xai CAPN15 16p13.3 0.208 0.113 0.637
xai GALK1 17q24 0.208 0.113 0.637 small molecule metabolic process;carbohydrate
phosphorylation
xai PCDH11X Xq21.3 0.208 0.113 0.637 cell adhesion;homophilic cell
adhesion
xai KCTD19 16q22.1 0.208 0.113 0.637 potassium ion transport
xai INIP 9q32 0.208 0.113 0.637
xai QRSL1P1 1q24.2 0.208 0.113 0.637
xai POTEKP 2q21.1 0.208 0.113 0.637 platelet degranulation;blood
coagulation
exp SOS1 2p21 0.208 0.113 0.637 Ras protein signal transduction;regulation of
swa FIP1L1 4q12 0.208 0.113 0.638 mRNA processing
swa CHMP4A 14q12 0.208 0.113 0.638 endosome transport;protein transport
his TAF11 6p21.31 0.208 0.113 0.638 regulation of transcription, DNA-
his ANKS1A 6p21.31 0.208 0.113 0.638 neuron remodeling;ephrin receptor
signaling pathway
xai TCAIM 3p21.31 0.208 0.113 0.638
exp KLHL7-AS1 0.208 0.113 0.638
his LOC100287015 8p23.1 0.208 0.113 0.638
his MCPH1 8p23.1 0.208 0.113 0.638 DNA Damage Response (DDR)
his MIR766 0.208 0.113 0.638
xai USP49 6p21 0.208 0.113 0.638 ubiquitin-dependent protein catabolic
process;proteolysis
hs4 NSD1 5q35 0.208 0.113 0.638 negative regulation of transcription from RNA
polymerase II promoter;gastrulation with mouth forming second
swa CLPB 11q13.4 0.208 0.113 0.638 cellular response to heat
xai C10orf91 10q26.3 0.208 0.113 0.638
xsq KNTC1 12q24.31 0.207 0.113 0.636 mitotic cell cycle;protein complex
assembly
mut TSSK6 19p13.11 0.207 0.113 0.636 cell differentiation;sperm chromatin
condensation
xsq SSNA1 9q34.3 0.207 0.113 0.636 G2/M transition of mitotic cell
xsq LINC00350 0.207 0.113 0.636
met MRPS36 5q13.2 0.207 0.113 0.636 translation
exp SLIRP 14q24.3 0.207 0.113 0.636 regulation of transcription, DNA-
dependent"
cop CMPK2 2p25.2 0.207 0.113 0.636 pyrimidine nucleotide biosynthetic
process;dTDP biosynthetic process
cop RSAD2 2p25.2 0.207 0.113 0.636 regulation of ossification;defense
response to virus
cop RNF144A-AS1 0.207 0.113 0.636
exp CSF3 17q11.2-q12 0.207 0.113 0.636 granulocyte differentiation;immune
response
met PBDC1 Xq13.3 0.207 0.113 0.636
exp E2F6 2p25.1 0.207 0.113 0.636 regulation of transcription involved in
G1/S phase of mitotic cell cycle;negative regulation of transcription from RNA
xsq FBXL19-AS1 16p11.2 0.207 0.113 0.636
xsq PHKA2 Xp22.2-p22.1 0.207 0.113 0.636 generation of precursor metabolites
xsq SIGLEC17P 19q13.3 0.207 0.113 0.636
exp HNRNPKP3 11p12 0.207 0.113 0.636
cop TSPAN4 11p15.5 0.207 0.113 0.636 protein complex assembly
met SEPT8 5q31 0.207 0.113 0.636 cell cycle
met LRRC4 7q31.3 0.207 0.113 0.636
exp ABCA7 19p13.3 0.207 0.113 0.636 ABC Transporters
exp GOLGA8F 0.207 0.113 0.636
met RRP15 1q41 0.207 0.113 0.636
xsq MAML3 4q28 0.207 0.113 0.636 positive regulation of transcription from RNA
met RAB42 1p35.3 0.207 0.113 0.636 small GTPase mediated signal transduction
xsq KRTAP4-2 0.207 0.113 0.636
cop TMSB10 2p11.2 0.207 0.113 0.637 actin cytoskeleton
exp GALM 2p22.1 0.207 0.113 0.637 carbohydrate metabolic process;hexose
metabolic process
xsq RAB4B-EGLN2 0.207 0.113 0.637
met CECR7 22q11.1 0.207 0.113 0.637
dependent"
cop EMX1 2p13.2 0.207 0.113 0.637 neuron differentiation;response to drug
xsq CBWD6 0.207 0.113 0.637
xsq AGAP4 0.207 0.113 0.637 regulation of ARF GTPase activity
cop LOC339298 0.207 0.113 0.637
xsq RPS27A 2p16 0.207 0.113 0.637 activation of MAPK activity;MyD88-
xsq PEX3 6q24.2 0.207 0.113 0.637 peroxisome organization;peroxisome
membrane biogenesis
xsq CCDC12 3p21.31 0.207 0.113 0.637
met GPRC5C 17q25 0.207 0.113 0.637 G-protein coupled receptor signaling
pathway
exp MTMR4 17q22-q23 0.207 0.113 0.637 protein dephosphorylation;peptidyl-
xsq OR1L1 0.207 0.113 0.637
met NBL1 1p36.13 0.207 0.113 0.637 positive regulation of neuron
cop SV2B 15q26.1 0.207 0.113 0.637 neurotransmitter transport
xsq PRAMEF18 0.207 0.113 0.637
exp FABP5 8q21.13 0.207 0.113 0.637 lipid metabolic
met FGFR4 5q35.2 0.207 0.113 0.638 glucose homeostasis;positive regulation
of DNA biosynthetic process
cop SART3 12q24.1 0.207 0.113 0.638 RNA processing
mir hsa-miR-126* 0.207 0.113 0.638
cop C2orf42 2p13.3 0.207 0.113 0.638
cop TIA1 2p13 0.207 0.113 0.638 Apoptosis
mut HS6ST3 13q32.1 0.207 0.113 0.638
xsq LINC00705 10p15.1 0.207 0.113 0.638
xsq LINC01354 0.207 0.113 0.638
exp RBM19 12q24.21 0.207 0.113 0.638 multicellular organismal
cop FEZ2 2p21 0.206 0.113 0.638 signal transduction;nervous system development
exp NR4A2 2q22-q23 0.206 0.113 0.638 post-embryonic development;intracellular
xsq NOBOX 7q35 0.206 0.113 0.638 cell differentiation;positive regulation of
exp PDCD1LG2 9p24.2 -0.206 0.113 0.638 immune response;T cell
costimulation
mut HAS2 8q24.12 -0.206 0.113 0.638 hyaluronan biosynthetic
process;positive regulation of urine volume
exp FAM129A 1q25 -0.206 0.113 0.638 positive regulation of protein
exp CYTL1 4p16-p15 -0.207 0.113 0.638 positive regulation of
met CCDC144CP 17p11.2 -0.207 0.113 0.638
cop LRRTM2 5q31.2 -0.207 0.113 0.638
exp PLXNA2 1q32.2 -0.207 0.113 0.638 multicellular organismal
exp B4GALT5 20q13.1-q13.2 -0.207 0.113 0.638 O-glycan
processing;protein N-linked glycosylation via asparagine
xsq PPDPF 20q13.33 -0.207 0.113 0.638 multicellular organismal
xsq MIR671 -0.207 0.113 0.637
cop CDCA7L 7p15.3 -0.207 0.113 0.637 regulation of transcription,
met COPS7A 12p13.31 -0.207 0.113 0.637 DNA Damage Response (DDR)
cop LOC441204 7p15.2 -0.207 0.113 0.637
mut CDHR1 10q23.1 -0.207 0.113 0.637 cell adhesion;homophilic cell
adhesion
met CHCHD10 22q11.23 -0.207 0.113 0.637
exp SPIN3 Xp11.21 -0.207 0.113 0.636 gamete generation
exp MAP9 4q32.1 -0.207 0.113 0.636 cell division;cell cycle
xsq NAV2-AS2 -0.207 0.113 0.636
xsq CTSLP8 9q22.1 -0.207 0.113 0.636
cop TARS 5p13.2 -0.207 0.113 0.636 translation;tRNA aminoacylation for
protein translation
exp GHR 5p13-p12 -0.207 0.113 0.636 succinate metabolic
xsq SEPT4 17q22 -0.207 0.113 0.636 brain development;sperm mitochondrion
organization
exp PACS1 11q13.1-q13.2 -0.207 0.113 0.636 positive regulation of
exp LINC00657 20q11.23 -0.207 0.113 0.636
his RIN3 14q32.12 -0.208 0.113 0.638 endocytosis;signal transduction
hs4 FAM184B 4p16 -0.208 0.113 0.638
hs4 COTL1 16q24.1 -0.208 0.113 0.638 defense response to fungus
xai FEZ1 11q24.2 -0.208 0.113 0.638 transport;cell adhesion
xai THNSL2 2p11.2 -0.208 0.113 0.638 serine family amino acid
his LOC730159 1q25.1 -0.208 0.113 0.638
his FAM160A1 4q31.3 -0.208 0.113 0.637
xai TRPC1 3q23 -0.208 0.113 0.637 ion transport;calcium ion transport
swa NNMT 11q23.1 -0.208 0.113 0.637 small molecule metabolic
his ALPL 1p36.12 -0.208 0.113 0.637 biomineral tissue
swa PSMB9 6p21.3 -0.208 0.113 0.637 antigen processing and presentation
of peptide antigen via MHC class I;mRNA metabolic process
his IRX1 5p15.3 -0.208 0.113 0.637
exp ACTBP7 -0.209 0.113 0.637
xai EHD1 11q13 -0.209 0.113 0.637 protein homooligomerization;intracellular
protein transport
his ADAMTSL1 9p21.3 -0.209 0.113 0.637
swa ALDH2 12q24.2 -0.209 0.113 0.636 synaptic
hs4 IL1RN 2q14.2 -0.209 0.113 0.636 negative regulation of cytokine-
xai BDKRB2 14q32.1-q32.2 -0.209 0.113 0.636 inflammatory
xai LSM3P4 4q31.21 -0.209 0.113 0.636
his MIR6511B2 -0.209 0.113 0.636
his FBLN1 22q13.31 -0.209 0.113 0.636 embryo implantation;extracellular
matrix organization
his BMP7-AS1 -0.209 0.113 0.636
his LINC01449 -0.209 0.113 0.636
hs4 KIAA1549 7q34 -0.209 0.113 0.636
hs4 ROBO2 3p12.3 -0.209 0.113 0.636 metanephros development;olfactory
bulb interneuron development
exp LSM3P4 4q31.21 -0.209 0.113 0.636
xai ZMIZ2 7p13 -0.209 0.113 0.636 regulation of transcription, DNA-
his MIR4516 -0.209 0.113 0.636
his PKD1 16p13.3 -0.209 0.113 0.636 cartilage condensation;homophilic
cell adhesion
his MIR3180-5 -0.209 0.113 0.636
his TCF7L1 2p11.2 -0.209 0.113 0.636 regulation of transcription
from RNA polymerase II promoter;negative regulation of transcription, DNA-dependent
his CFAP44 -0.209 0.113 0.636
exp LOC100129884 -0.209 0.113 0.636
his SPINT3 -0.209 0.113 0.636
his LOC100506314 -0.209 0.113 0.636
xai LCK 1p34.3 0.208 0.114 0.638 Protein Kinases
swa CSTF1 20q13.2 0.208 0.114 0.638 transcription from RNA polymerase II
promoter;mRNA 3'-end processing
hs4 ATP2A1 0.208 0.114 0.638 cation transport;ion transmembrane
transport
hs4 ATP2A1-AS1 0.208 0.114 0.638
his HSF2BP 21q22.3 0.208 0.114 0.638 transcription from RNA polymerase
II promoter;spermatogenesis
his RRP1B 21q22.3 0.208 0.114 0.638 rRNA processing;negative regulation of
his C2orf27B 2q21 0.208 0.114 0.638
exp CLEC1A 12p13.2 0.208 0.114 0.638 defense response;cell surface
hs4 FAM136A 2p13.3 0.208 0.114 0.638
his NUDT7 16q23.1 0.208 0.114 0.638 nucleoside diphosphate metabolic process
xai TDP2 6p22.3-p22.1 0.208 0.114 0.638 DNA Damage Response (DDR)
his TAF6L 11q12.3 0.208 0.114 0.638 chromatin remodeling;transcription
hs4 CEP128 14q31.1 0.208 0.114 0.638
xai RPL13 16q24.3 0.208 0.114 0.638 gene expression;viral reproduction
hs4 MEGF6 1p36.3 0.208 0.114 0.638
his SNAR-A4 19q13.33 0.208 0.114 0.638
his SNAR-A14 0.208 0.114 0.638
his SNAR-A5 0.208 0.114 0.638
his SNAR-A6 0.208 0.114 0.638
his SNAR-A7 0.208 0.114 0.638
his SNAR-A8 0.208 0.114 0.638
his SNAR-A9 0.208 0.114 0.638
his SNAR-A10 0.208 0.114 0.638
his SNAR-A11 0.208 0.114 0.638
his SNAR-B1 0.208 0.114 0.638
his SNAR-B2 0.208 0.114 0.638
his SNAR-D 0.208 0.114 0.638
xai SRSF4 1p35.3 0.208 0.114 0.638 RNA splicing, via transesterification
reactions;mRNA 3'-end processing
his TRIM7 5q35.3 0.208 0.114 0.638
xai OR4H6P 0.208 0.114 0.638
xai ABCA7 19p13.3 0.208 0.114 0.638 ABC Transporters
his XRCC2 7q36.1 0.208 0.114 0.638 DNA Damage Response (DDR); DDR (NHEJ)
exp DPH7 9q34.3 0.208 0.114 0.638
his EXOC3L1 16q22.1 0.208 0.114 0.638 exocytosis;peptide hormone
secretion
his E2F4 16q22.1 0.208 0.114 0.638 mitotic cell cycle;cilium assembly
his YAE1D1 7p14.1 0.208 0.114 0.638
exp OR4H6P 0.208 0.114 0.638
hs4 NOP2 12p13 0.208 0.114 0.638 rRNA processing;positive regulation of cell
proliferation
exp ARMC2 6q21 0.208 0.114 0.638
xai GADD45GIP1 19p13.2 0.208 0.114 0.638 cell cycle;interspecies interaction
between organisms
his TARBP1 1q42.3 0.208 0.114 0.638 regulation of transcription from
RNA polymerase II promoter;RNA processing
xai SETDB1 1q21 0.208 0.114 0.638 regulation of transcription, DNA-
xai FAAP100 0.208 0.114 0.638 DNA Damage Response (DDR); DDR (FA)
his D21S2088E 0.208 0.114 0.638
his DHX35 20q11.22-q12 0.208 0.114 0.638 nuclear mRNA splicing, via
xai SIGLEC22P 19q13.41 0.208 0.114 0.638
hs4 MTO1 6q13 0.208 0.114 0.639 tRNA processing;oxidation-reduction process
his PPIP5K1 15q15.3 0.208 0.114 0.639 inositol metabolic process
his CKMT1B 15q15 0.208 0.114 0.639
his KRTCAP2 1q22 0.208 0.114 0.639
his TRIM46 1q22 0.208 0.114 0.639
his TMED5 1p22.1 0.208 0.114 0.639 protein transport;Golgi ribbon formation
his CCDC18 1p22.1 0.208 0.114 0.639
swa CALB1 8q21.3 0.208 0.114 0.639 metanephric distal convoluted tubule
development;learning or memory
his ATP2B1 12q21.3 0.208 0.114 0.639 ATP biosynthetic process;transport
xai IL19 1q32.2 0.208 0.114 0.639 induction of apoptosis;immune response
his ZC3H14 14q31.3 0.208 0.114 0.639
hs4 C12orf45 12q23.3 0.208 0.114 0.639
swa UMPS 3q13 0.208 0.114 0.639 'de novo' UMP biosynthetic process;small
xai DENND1A 9q33.3 0.208 0.114 0.639 synaptic vesicle endocytosis
met CD59 11p13 0.206 0.114 0.638 cell surface receptor signaling pathway;blood
coagulation
xsq DNAJC17 15q15.1 0.206 0.114 0.638 protein folding
cop ATP6V1C2 0.206 0.114 0.638 transmembrane transport;ATP catabolic
process
cop PDIA6 2p25.1 0.206 0.114 0.638 protein folding;glycerol ether metabolic
process
xsq CEP57L1 6q21 0.206 0.114 0.638
exp TOR3A 1q25.2 0.206 0.114 0.638 chaperone mediated protein folding
requiring cofactor
xsq GKN2 2p13.3 0.206 0.114 0.638
cop C9orf3 9q22.32 0.206 0.114 0.638 proteolysis;leukotriene
exp SMNDC1 10q23 0.206 0.114 0.638 Apoptosis
xsq DDX54 12q24.13 0.206 0.114 0.638 regulation of transcription, DNA-
xsq CHD4 12p13 0.206 0.114 0.638 DNA Damage Response (DDR)
xsq CCDC64 12q24.23 0.206 0.114 0.638 transport;nervous system
development
xsq LOC101927497 0.206 0.114 0.638
xsq POLM 7p13 0.206 0.114 0.638 DNA Damage Response (DDR); DDR (NHEJ); DDR (DNA
replication)
met LINC00588 8q12.1 0.206 0.114 0.638
dependent"
cop MIR3975 0.206 0.114 0.638
mir hsa-miR-1228 0.206 0.114 0.638
exp MRPL38 17q25.3 0.206 0.114 0.638
exp LOC643909 0.206 0.114 0.638
met RRAS2 11p15.2 0.206 0.114 0.638 GTP catabolic process;signal transduction
xsq GFOD2 16q22.1 0.206 0.114 0.638 extracellular matrix organization
exp ACAP3 0.206 0.114 0.638 filopodium assembly;signal transduction
met RPL22L1 3q26.2 0.206 0.114 0.638 translation
exp DUS3L 19p13.3 0.206 0.114 0.638 tRNA processing
cop PMFBP1 16q22.2 0.206 0.114 0.638
met LRRC16A 6p22.2 0.206 0.114 0.638 lamellipodium assembly;ruffle
organization
exp TIAL1 10q 0.206 0.114 0.638 Apoptosis
exp GAB3 Xq28 0.206 0.114 0.638
cop LOC100499484-C9ORF174 0.206 0.114 0.638
xsq UTP3 4q13.3 0.206 0.114 0.638 chromatin modification;multicellular
mut SSH2 17q11.2 0.206 0.114 0.638 regulation of lamellipodium
assembly;actin cytoskeleton organization
exp RPL36A Xq22.1 0.206 0.114 0.638 translational initiation;viral
infectious cycle
xsq MYOC 1q23-q24 0.206 0.114 0.638 anatomical structure morphogenesis
met TBL1XR1 3q26.32 0.206 0.114 0.638 Cell Signaling
cop LINC00476 9q22.32 0.206 0.114 0.638
cop ERCC6L2 9q22.32 0.206 0.114 0.638 DNA repair
cop LINC00092 9q22.32 0.206 0.114 0.638
cop LOC158435 0.206 0.114 0.638
cop LOC158434 0.206 0.114 0.638
cop HSD17B3 9q22 0.206 0.114 0.638 insecticide metabolic process;response to
L-ascorbic acid
cop SLC35D2 9q22.32 0.206 0.114 0.638 Solute Carriers
cop ZNF367 9q22 0.206 0.114 0.638 regulation of transcription from RNA
cop HABP4 9q22.3-q31 0.206 0.114 0.638 cellular response to mechanical
stimulus;platelet degranulation
cop CDC14B 9q22.3 0.206 0.114 0.638 activation of anaphase-promoting
complex activity;DNA repair
cop AAED1 9q22.32 0.206 0.114 0.638
cop LOC441455 9q22.33 0.206 0.114 0.638
dependent"
xsq CHCHD10 22q11.23 0.206 0.114 0.638
exp TCAIM 3p21.31 0.206 0.114 0.638
cop NOB1 16q22.3 0.206 0.114 0.638
met ELOVL7 5q12.1 0.206 0.114 0.638 small molecule metabolic
exp UBE2G1 17p13.2 0.206 0.114 0.638 protein K63-linked
exp YDJC 22q11.21 0.206 0.114 0.638 carbohydrate metabolic process
cop CHID1 11p15.5 0.206 0.114 0.638 innate immune response;carbohydrate
metabolic process
exp BCL2 18q21.3 0.206 0.114 0.638 Apoptosis; Protein Kinases
xsq ATL2 2p22.3 0.206 0.114 0.638 GTP catabolic process;ER to Golgi
xsq KIAA0125 14q32.33 0.206 0.114 0.638
exp STRA13 17q25.3 0.206 0.114 0.638 DNA Damage Response (DDR); DDR (FA)
exp BAG1 9p12 0.206 0.114 0.639 Apoptosis
cop VEZT 12q22 0.206 0.114 0.639 cell-cell adhesion;chordate embryonic
development
cop GALNT1 18q12.1 0.206 0.114 0.639 protein O-linked glycosylation;O-
glycan processing
exp OXLD1 17q25.3 0.206 0.114 0.639
mut SLC8A2 19q13.3 0.206 0.114 0.639 transmembrane transport;ion
transport
met CHRAC1 8q24.3 0.206 0.114 0.639 DNA Damage Response (DDR); DDR
(Chromatin)
xsq RNF133 0.206 0.114 0.639
met PRG2 11q12 0.206 0.114 0.639 immune response;defense response to bacterium
xsq CEBPZ 2p22.2 0.206 0.114 0.639 regulation of transcription, DNA-
xsq HGH1 0.206 0.114 0.639
xsq GNB2L1 5q35.3 0.206 0.114 0.639
cop ANKS6 9q22.33 0.206 0.114 0.639
met MAGEE1 Xq13.3 0.206 0.114 0.639
exp KNSTRN 15q15.1 0.206 0.114 0.639
xsq DCC 18q21.3 0.206 0.114 0.639 Tumor Suppressors
xsq LINC01097 0.206 0.114 0.639
exp CMSS1 3q12.1 0.206 0.114 0.639
xsq KRAS 12p12.1 0.206 0.114 0.639 Cell Signaling; Oncogenes; Protein
Kinases
cop LOC728084 0.206 0.114 0.639
exp LINC00939 0.206 0.114 0.639
exp TMEM143 19q13.33 0.206 0.114 0.639
exp BCORL1 Xq25-q26.1 0.206 0.114 0.639 regulation of transcription, DNA-
exp SGK3 8q12 -0.206 0.114 0.639
cop LOC344887 3q27.2 -0.206 0.114 0.639
met NAGS 17q21.31 -0.206 0.114 0.639 urea cycle;glutamate metabolic
process
met HORMAD2 22q12.2 -0.206 0.114 0.639 meiosis
exp LOXL3 2p13 -0.206 0.114 0.639 oxidation-reduction process
met UHRF1 19p13.3 -0.206 0.114 0.639 positive regulation of DNA
exp TAB2 6q25.1 -0.206 0.114 0.638 Toll signaling pathway;innate
immune response
exp TLDC1 16q24.1 -0.206 0.114 0.638
exp GAP43 3q13.31 -0.206 0.114 0.638 activation of protein kinase C
activity by G-protein coupled receptor protein signaling pathway;multicellular
xsq DGCR10 22q11 -0.206 0.114 0.638
cop LRCH3 3q29 -0.206 0.114 0.638
cop IQCG 3q29 -0.206 0.114 0.638
cop RPL35A 3q29 -0.206 0.114 0.638 translational initiation;viral
infectious cycle
cop LMLN 3q29 -0.206 0.114 0.638 cell cycle;mitosis
cop ANKRD18DP 3q29 -0.206 0.114 0.638
cop FAM157A -0.206 0.114 0.638
met TMEM101 17q21.31 -0.206 0.114 0.638 signal transduction;positive
exp JAZF1 7p15.2-p15.1 -0.206 0.114 0.638 negative regulation of
dependent"
exp AMT 3p21.2-p21.1 -0.206 0.114 0.638 glycine catabolic process
xsq SUSD6 -0.206 0.114 0.638
xsq FEZ1 11q24.2 -0.206 0.114 0.638 transport;cell adhesion
xsq KIAA1671 22q11.23 -0.206 0.114 0.638
xsq NOV 8q24.1 -0.206 0.114 0.638 regulation of cell growth
exp IDH1 2q33.3 -0.206 0.114 0.638 Oncogenes
xai PLXNB3 Xq28 -0.208 0.114 0.639 signal transduction;multicellular
xai DUSP15 20q11.21 -0.208 0.114 0.639 protein dephosphorylation
xai LOC100507516 -0.208 0.114 0.639
his MXRA8 1p36.33 -0.208 0.114 0.639
xai SWAP70 11p15 -0.208 0.114 0.639 somatic cell DNA
his MIR4315-2 -0.208 0.114 0.639
xai FAM110C 2p25.3 -0.208 0.114 0.639
hs4 RIPK4 21q22.3 -0.208 0.114 0.639
hs4 HCG22 6p21.33 -0.208 0.114 0.639
hs4 RAPGEF2 4q32.1 -0.208 0.114 0.639 cAMP-mediated
signaling;positive regulation of Rap GTPase activity
xai ARHGAP12 10p11.22 -0.208 0.114 0.639 signal transduction;small
swa HDLBP 2q37.3 -0.208 0.114 0.638 lipid transport;steroid metabolic
process
his AIM1L 1p36.11 -0.208 0.114 0.638
xai SIL1 5q31 -0.208 0.114 0.638 protein folding;intracellular protein
transport
his KIAA1147 7q34 -0.208 0.114 0.638
hs4 TBCEL 11q23.3 -0.208 0.114 0.638
xai RNU5F-7P -0.208 0.114 0.638
his TCF7 5q31.1 -0.208 0.114 0.638 brain development;Wnt receptor
signaling pathway
xai TEX36 10q26.13 -0.208 0.114 0.638
exp RNU5F-7P -0.208 0.114 0.638
xai ACOT2 -0.208 0.114 0.638 very long-chain fatty acid metabolic
xai ALS2CL 3p21.31 -0.208 0.114 0.638 endosome
hs4 SMPDL3A 6q22.31 -0.208 0.114 0.638 sphingomyelin catabolic
swa MGP 12p12.3 -0.208 0.114 0.638 response to hormone stimulus;cell
differentiation
his INPP5A 10q26.3 -0.208 0.114 0.638 cell
communication;phosphatidylinositol phosphorylation
xai DBX2 12q12 -0.208 0.114 0.638
xai AVEN 15q13.1 -0.208 0.114 0.638 Apoptosis
xai LIPG 18q21.1 -0.208 0.114 0.638 cell proliferation;regulation of
his SIGLEC17P 19q13.3 -0.208 0.114 0.638
hs4 C1S 12p13 -0.208 0.114 0.638 proteolysis;complement activation
xai ARL6IP5 3p14 -0.208 0.114 0.638 negative regulation of transport;L-
glutamate transport
hs4 PHACTR2 6q24.2 -0.208 0.114 0.638
his MIR4455 -0.208 0.114 0.638
hs4 TMOD1 9q22.3 -0.208 0.114 0.638 muscle filament sliding;myofibril
assembly
xai GPR176 15q14-q15.1 -0.208 0.114 0.638 G-protein coupled receptor
signaling pathway;synaptic transmission
xai PRX 19q13.2 -0.208 0.114 0.638 axon ensheathment;nerve development
exp RPS16P8 17q11.1 0.208 0.115 0.639
dependent"
xai XRCC2 7q36.1 0.208 0.115 0.639 DNA Damage Response (DDR); DDR (NHEJ)
xai IGKV1D-42 2p12 0.208 0.115 0.639
his STARD9 15q15.2 0.208 0.115 0.639 EMT (Mesenchymal)
cop MIR628 0.208 0.115 0.639
swa CSNK2B 6p21.3 0.208 0.115 0.639 Protein Kinases
exp HAUS4P1 1q24.2 0.208 0.115 0.639
his WRAP73 1p36.3 0.208 0.115 0.639
his TP73 1p36.3 0.208 0.115 0.639 Apoptosis; DNA Damage Response (DDR); DDR
(G2-M checkpoint)
his ANKFY1 17p13.3 0.208 0.115 0.639
exp RPS5P3 21q22.11 0.208 0.115 0.639
his AGL 1p21 0.208 0.115 0.639 carbohydrate metabolic process;glycogen
xai BHLHA15 7q21.3 0.208 0.115 0.639 Golgi organization;G-protein
xai HNRNPDL 4q21.22 0.208 0.115 0.639
xai TFRC 3q29 0.208 0.115 0.639 response to hypoxia;response to inorganic
substance
xai DET1 15q25.3 0.208 0.115 0.639
his LIME1 20q13.3 0.208 0.115 0.639 regulation of release of sequestered
calcium ion into cytosol;regulation of transcription from RNA polymerase II
promoter
his SLC2A4RG 20q13.33 0.208 0.115 0.639 Solute Carriers
exp IGKV1D-42 2p12 0.208 0.115 0.639
xai RPL7P20 5q34 0.208 0.115 0.639
his LOC283922 16q23.1 0.208 0.115 0.639
his BANP 16q24 0.208 0.115 0.639 multicellular organismal development;chromatin
modification
xai CNNM3 2p12-p11.2 0.208 0.115 0.639 ion transport
xai RHNO1 12p13.33 0.208 0.115 0.639
xai ACTR3BP6 22q11.1 0.208 0.115 0.639
his TEX19 17q25.3 0.208 0.115 0.639
his MAG 19q13.1 0.208 0.115 0.639 nerve growth factor receptor signaling
pathway;regulation of axonogenesis
his GNA15 19p13.3 0.208 0.115 0.639 blood coagulation;GTP catabolic process
hs4 LOC100128108 15q26.3 0.207 0.115 0.639
his MANF 3p21.1 0.207 0.115 0.639 response to unfolded protein
his RBM15B 3p21.2 0.207 0.115 0.639 mRNA processing;nucleocytoplasmic
transport
his ATF6 1q22-q23 0.207 0.115 0.64 positive regulation of transcription from
RNA polymerase II promoter involved in unfolded protein response;signal
transduction
hs4 FAM72A 1q32.1 0.207 0.115 0.64
hs4 IQGAP2 5q13.3 0.207 0.115 0.64 signal transduction;regulation of
hs4 NEIL3 4q34.3 0.207 0.115 0.64 DNA Damage Response (DDR); DDR (BER)
exp LOC100507487 0.207 0.115 0.64
his ZFYVE19 15q15.1 0.207 0.115 0.64
exp ACTR3BP6 22q11.1 0.207 0.115 0.64
cop PCBP1 2p13-p12 0.207 0.115 0.64 nuclear mRNA splicing, via
xai DIO1 1p33-p32 0.207 0.115 0.64 hormone biosynthetic process;small
his LSM12 17q21.31 0.207 0.115 0.64
his G6PC3 17q21.31 0.207 0.115 0.64 carbohydrate metabolic
process;transmembrane transport
his ACBD5 10p12.1 0.207 0.115 0.64 transport
exp C19orf44 19p13.11 0.207 0.115 0.64
his OSBPL5 11p15.4 0.207 0.115 0.64 transport;lipid transport
xai LOC100507487 0.207 0.115 0.64
his CYB5RL 1p32.3 0.207 0.115 0.64
xai PARP11 12p13.3 0.207 0.115 0.64
his HSD17B10 Xp11.2 0.207 0.115 0.64 protein homotetramerization;lipid
metabolic process
hs4 CCDC175 14q23.1 0.207 0.115 0.64
xai CD2BP2 16p11.2 0.207 0.115 0.64 nuclear mRNA splicing, via
xai SNORD82 0.207 0.115 0.64
his OGFRP1 0.207 0.115 0.64
exp LINC01115 0.207 0.115 0.64
his LINC01530 0.207 0.115 0.64
hs4 OTOP1 0.207 0.115 0.64 biomineral tissue development
his CORO7 16p13.3 0.207 0.115 0.64 actin cytoskeleton organization
his CORO7-PAM16 0.207 0.115 0.64
his MAGOHB 12p13.2 0.207 0.115 0.64 RNA splicing;mRNA transport
his NETO1 18q22.2 0.207 0.115 0.64 visual learning;regulation of long-term
neuronal synaptic plasticity
his LOC100505797 0.207 0.115 0.64
his LGALS1 22q13.1 0.207 0.115 0.64 Apoptosis
xai TPP2 13q32-q33 0.207 0.115 0.64 antigen processing and presentation of
exp SNORD82 0.207 0.115 0.64
xai TM4SF20 2q36.3 0.207 0.115 0.64
his SPCS3 4q34.2 0.207 0.115 0.64 small molecule metabolic process;energy
reserve metabolic process
his PRDX3 10q25-q26 0.207 0.115 0.64 cellular response to reactive oxygen
species;maternal placenta development
hs4 TAL1 1p32 0.207 0.115 0.64 neuron differentiation;regulation of cell
proliferation
xai FANCD2 3p26 0.207 0.115 0.64 DNA Damage Response (DDR); DDR (FA)
his LINC00910 17q21.31 0.207 0.115 0.64
xsq UBE2N 12q22 0.206 0.115 0.639 DNA Damage Response (DDR); DDR (TLS)
cop TMEM119 12q23.3 0.206 0.115 0.639
exp DDX43 6q13 0.206 0.115 0.639
exp PRRC2C 1q23.3 0.206 0.115 0.639
xsq BTAF1 10q22-q23 0.206 0.115 0.639 negative regulation of transcription,
DNA-dependent"
exp ECE2 3q27.1 0.206 0.115 0.639 peptide hormone processing;proteolysis
met HOXA3 7p15.2 0.206 0.115 0.639 glossopharyngeal nerve
xsq PANO1 0.206 0.115 0.639
xsq ABHD17B 9q21.13 0.206 0.115 0.639
mut TROAP 12q13.12 0.206 0.115 0.639 cell adhesion
xsq PCID2 13q34 0.206 0.115 0.639 positive regulation of mitotic cell cycle
spindle assembly checkpoint;negative regulation of cysteine-type endopeptidase
activity
cop KDM5A 12p11 0.206 0.115 0.639 positive regulation of transcription, DNA-
cop CCDC77 12p13.33 0.206 0.115 0.639
cop B4GALNT3 12p13.33 0.206 0.115 0.639
cop MIR4765 0.206 0.115 0.639
met OR11H4 14q11.2 0.206 0.115 0.639 response to stimulus
xsq CAPZA3 12p12.3 0.206 0.115 0.64
mut SORCS3 10q23-q25 0.206 0.115 0.64 neuropeptide signaling pathway
met TMEM74B 20p13 0.206 0.115 0.64
xsq FNBP1 9q34 0.206 0.115 0.64 endocytosis;nervous system development
cop P2RY2 11q13.5-q14.1 0.206 0.115 0.64 aging;wound healing
cop P2RY6 11q13.5 0.206 0.115 0.64 activation of phospholipase C activity by
messenger
cop PRMT8 12p13.3 0.206 0.115 0.64 histone methylation;peptidyl-arginine
methylation
xsq OR1J2 9q34.11 0.206 0.115 0.64 response to stimulus
met IL10RB 21q22.11 0.206 0.115 0.64 inflammatory response;immune
response
exp TRPM7 15q21 0.206 0.115 0.64 transmembrane transport;ion transport
met VPS39 15q15.1 0.206 0.115 0.64 protein transport
met KIAA1644 0.206 0.115 0.64
dependent"
cop WWP2 16q22.1 0.206 0.115 0.64 negative regulation of transporter
activity;protein K63-linked ubiquitination
mut ADAM17 2p25 0.206 0.115 0.64 Apoptosis
cop HRAS 11p15.5 0.206 0.115 0.64 Apoptosis; Oncogenes; Protein Kinases
cop LRRC56 11p15.5 0.206 0.115 0.64
cop C11orf35 0.206 0.115 0.64
cop RASSF7 11p15.5 0.206 0.115 0.64 DNA Damage Response (DDR)
cop MIR210HG 0.206 0.115 0.64
cop MIR210 0.206 0.115 0.64
cop LOC143666 11p15.5 0.206 0.115 0.64
cop PHRF1 11p15.5 0.206 0.115 0.64 transcription from RNA polymerase II
promoter;mRNA processing
cop IRF7 11p15.5 0.206 0.115 0.64 Apoptosis
exp CTDSPL2 15q15.3-q21.1 0.206 0.115 0.64
exp MRPL12 17q25 0.206 0.115 0.64 transcription from mitochondrial
xsq SNCA-AS1 0.206 0.115 0.64
cop WDR59 16q23.1 0.206 0.115 0.64
xsq GLE1 9q34.11 0.206 0.115 0.64 protein transport;poly(A)+ mRNA export
from nucleus
cop PCYOX1 2p13.3 0.206 0.115 0.64 chloride transport;prenylated
met CYP2U1 4q25 0.206 0.115 0.64 xenobiotic metabolic process;small
met ARMCX4 Xq22.1 0.206 0.115 0.64
xsq DLEU1 13q14.3 0.206 0.115 0.64
exp TEX9 15q21.3 0.205 0.115 0.64
xsq DDX19B 16q22.1 0.205 0.115 0.64 mRNA export from nucleus;protein
transport
xsq EMILIN2 18p11.3 0.205 0.115 0.64 cell adhesion
xsq JMJD6 17q25 0.205 0.115 0.64 cell surface receptor signaling pathway;T cell
cop ONECUT2 18q21.31 0.205 0.115 0.64 organ morphogenesis;positive
cop PDPR 16q22.1 0.205 0.115 0.64 pyruvate metabolic process;glycine
catabolic process
cop CLEC18C 16q22.1 0.205 0.115 0.64
met MAPK8IP2 22q13.33 0.205 0.115 0.64 Apoptosis
exp HIST1H3H 6p22.1 0.205 0.115 0.64
exp DGKZ 11p11.2 0.205 0.115 0.64 negative regulation of mitotic cell
xsq HIST1H3G 0.205 0.115 0.64
xsq MIS12 17p13.2 0.205 0.115 0.64 kinetochore assembly;M phase of mitotic
cell cycle
xsq LINC00290 0.205 0.115 0.64
xsq IPO4 14q12 0.205 0.115 0.64 intracellular protein transport;protein
transport
xsq BAG1 9p12 0.205 0.115 0.64 Apoptosis
mut PRNP 20p13 0.205 0.115 0.64 negative regulation of protein
phosphorylation;negative regulation of interferon-gamma production
exp PACSIN2 22q13.2-q13.33 -0.205 0.115 0.64 negative regulation of
exp TNRC6C-AS1 -0.205 0.115 0.64
met THEMIS 6q22.33 -0.205 0.115 0.64 multicellular organismal
exp CTAGE11P 13q22.2 -0.205 0.115 0.64
cop SNX10 7p15.2 -0.205 0.115 0.64 endosome organization;cell
communication
xsq AMTN 4q13.3 -0.205 0.115 0.64 cell adhesion;biomineral tissue
development
xsq TMEM132A 11q12.2 -0.205 0.115 0.64
exp DYNC1I2P1 10q11.23 -0.205 0.115 0.64
cop LOC253573 -0.205 0.115 0.64
exp ADAMTS5 21q21.3 -0.205 0.115 0.64 proteolysis
xsq NOS1AP 1q23.3 -0.205 0.115 0.64 regulation of apoptotic
mut TLL1 4q32-q33 -0.206 0.115 0.64 proteolysis;multicellular
exp LOXL2 8p21.3 -0.206 0.115 0.64 protein modification process;cell
adhesion
xsq SSPN 12p11.2 -0.206 0.115 0.64 muscle contraction;cell adhesion
cop CYP7B1 8q21.3 -0.206 0.115 0.64 memory;positive regulation of
exp CTAGE12P 9p21.2 -0.206 0.115 0.64
xsq FRMD6-AS1 -0.206 0.115 0.64
met ARL11 13q14.2 -0.206 0.115 0.64 small GTPase mediated signal
transduction
exp RXRA 9q34.3 -0.206 0.115 0.64 female pregnancy;virus-host
interaction
cop HIBADH 7p15.2 -0.206 0.115 0.64 valine metabolic
cop TAX1BP1 7p15 -0.206 0.115 0.64 Apoptosis
exp TRIM45 1p13.1 -0.206 0.115 0.64
exp IL12A 3q25.33 -0.206 0.115 0.64 cell cycle arrest;positive
xsq PNPLA3 22q13.31 -0.206 0.115 0.64 triglyceride catabolic
met MCM6 2q21 -0.206 0.115 0.64 DDR (DNA replication)
mut ZFP41 8q24.3 -0.206 0.115 0.64 regulation of transcription, DNA-
exp CST6 11q13 -0.206 0.115 0.64 epidermis development;anatomical
xsq SLC6A12 12p13 -0.206 0.115 0.639 Solute Carriers
exp TDRP 8p23.3 -0.206 0.115 0.639
exp RARRES2 7q36.1 -0.206 0.115 0.639 retinoid metabolic process;in
utero embryonic development
cop MEOX2 7p22.1-p21.3 -0.206 0.115 0.639 multicellular organismal
xsq GNAO1 16q13 -0.206 0.115 0.639 GTP catabolic process;response to organic
nitrogen
xsq STX3 11q12.1 -0.206 0.115 0.639 cellular membrane fusion;neuron
cop KIAA0087 7p15.2 -0.206 0.115 0.639
xsq MDGA1 6p21 -0.206 0.115 0.639 neuron migration;multicellular organismal
development
cop CDC14C 7p12.3 -0.206 0.115 0.639
xai NCEH1 3q26.31 -0.207 0.115 0.64 lipid catabolic process;metabolic
process
hs4 LINC01139 -0.207 0.115 0.64
xai PPM1J 1p13.2 -0.207 0.115 0.64 protein dephosphorylation
swa KRT20 17q21.2 -0.207 0.115 0.64 cellular response to
stress;intermediate filament organization
his BFSP1 20p12.1 -0.207 0.115 0.64 cell maturation;lens fiber cell
development
his DSTN 20p12.1 -0.207 0.115 0.64 cellular component movement;actin
xai CA12 15q22 -0.207 0.115 0.64 one-carbon metabolic process
hs4 C1orf186 1q32.1 -0.207 0.115 0.64
his LOC105378933 -0.207 0.115 0.64
his DDAH1 1p22 -0.207 0.115 0.64 arginine catabolic process;nitric oxide
his CYR61 1p22.3 -0.207 0.115 0.64 positive regulation of protein
his LY6D 8q24 -0.207 0.115 0.64 cell adhesion;lymphocyte differentiation
his MTHFD1L 6q25.1 -0.207 0.115 0.64 one-carbon metabolic
process;folic acid-containing compound metabolic process
hs4 CNTD2 19q13.2 -0.207 0.115 0.64
xai FAM73A 1p31.1 -0.207 0.115 0.64
his KLHL38 8q24.13 -0.207 0.115 0.64
his NCS1 9q34 -0.207 0.115 0.64 positive regulation of
xai RNF103 -0.207 0.115 0.64 protein ubiquitination;ER-
swa S100A11 1q21 -0.207 0.115 0.64 signal transduction;negative
hs4 SERPINA5 14q32.1 -0.207 0.115 0.64 spermatogenesis;fusion of
hs4 ADGRA3 -0.207 0.115 0.64 G-protein coupled receptor
hs4 APOL1 22q13.1 -0.207 0.115 0.639 lipoprotein metabolic
process;transport
hs4 ECHDC3 10p14 -0.208 0.115 0.639
exp CT47B1 Xq24 -0.208 0.115 0.639
hs4 FBXO16 8p21.1 -0.208 0.115 0.639
swa GSTM3 1p13.3 -0.208 0.115 0.639 metabolic process;response to
estrogen stimulus
hs4 RHOC 1p13.1 -0.208 0.115 0.639 regulation of small GTPase mediated
hs4 MED15 22q11.2 -0.208 0.115 0.639 regulation of transcription from
swa CCAR1 10q21.3 -0.208 0.115 0.639 Apoptosis
hs4 GSTT1 22q11.23 -0.208 0.115 0.639 glutathione metabolic process
xai IGFN1 1q32.1 -0.208 0.115 0.639
his NUDT16P1 3q22.1 -0.208 0.115 0.639
xai NAV1 1q32.3 -0.208 0.115 0.639 microtubule bundle formation;neuron
migration
hs4 HECTD2 10q23.32 -0.208 0.115 0.639 protein modification
process
xai PTPRS 19p13.3 -0.208 0.115 0.639 cell adhesion;spinal cord
development
xai PADI1 1p36.13 -0.208 0.115 0.639 protein modification
his PHF14 7p21.3 0.207 0.116 0.64
exp SNX18P24 0.207 0.116 0.64
swa MSN Xq11.1 0.207 0.116 0.64 EMT (Mesenchymal)
hs4 DNPH1 6p21.1 0.207 0.116 0.64
hs4 FOXJ2 12p13.31 0.207 0.116 0.64 regulation of sequence-specific DNA
xai ETFDH 4q32-q35 0.207 0.116 0.64 transport;response to oxidative stress
exp HAL 12q22-q24.1 0.207 0.116 0.64 histidine catabolic process;biosynthetic
process
xai SNX18P24 0.207 0.116 0.64
xai NAA10 Xq28 0.207 0.116 0.64 N-terminal protein amino acid
his RAB33B 4q28 0.207 0.116 0.64 small GTPase mediated signal
exp PCF11 11q13 0.207 0.116 0.641 RNA splicing;gene expression
xai USP30-AS1 12q24.11 0.207 0.116 0.641
his LINC01814 0.207 0.116 0.641
hs4 APBB1IP 10p12.1 0.207 0.116 0.641 signal transduction;blood
coagulation
xai ARMC12 6p21.31 0.207 0.116 0.641
xai RPS15A 16p 0.207 0.116 0.641 nuclear-transcribed mRNA catabolic
his PCLAF 0.207 0.116 0.641
his TRIP4 15q22.31 0.207 0.116 0.641 transcription from RNA polymerase II
promoter;positive regulation of transcription, DNA-dependent"
xai C17orf75 17q11.2 0.207 0.116 0.641 spermatogenesis
his GOLPH3L 1q21.3 0.207 0.116 0.641
xai E2F6 2p25.1 0.207 0.116 0.641 regulation of transcription involved in
exp CCDC144NL 17p11.2 0.207 0.116 0.641
his F8 Xq28 0.207 0.116 0.641 blood coagulation;blood coagulation, intrinsic
pathway
his FUNDC2 Xq28 0.207 0.116 0.641
his MACROD1 11q11 0.207 0.116 0.641 purine nucleoside metabolic process
his ATP6V0D1 16q22.1 0.207 0.116 0.641 activation of signaling protein
activity involved in unfolded protein response;transmembrane transport
his AGRP 16q22 0.207 0.116 0.641
xai EXOSC4 8q24.3 0.207 0.116 0.641 RNA metabolic process;mRNA
metabolic process
xai SLIRP 14q24.3 0.207 0.116 0.641 regulation of transcription, DNA-
dependent"
xai PGM2 4p14 0.207 0.116 0.641 glycogen catabolic process;glucose metabolic
process
xai CCDC144NL 17p11.2 0.207 0.116 0.641
xai HNRNPF 10q11.21 0.207 0.116 0.641 nuclear mRNA splicing, via
his BTG3 21q21.1 0.207 0.116 0.641 negative regulation of cell
proliferation;negative regulation of mitotic cell cycle
his NR2C2AP 19p13.11 0.207 0.116 0.641 cell adhesion;gene expression
swa TIAL1 10q 0.207 0.116 0.641 Apoptosis
xai R3HDM4 19p13.3 0.207 0.116 0.642
his CD27-AS1 12p13.31 0.207 0.116 0.642
his TAPBPL 12p13.31 0.207 0.116 0.642 antigen processing and presentation
his ZNF428 19q13.31 0.207 0.116 0.642
xai FBXO22 15q24.2 0.207 0.116 0.642 protein modification
his FCN3 1p36.11 0.207 0.116 0.642 complement activation, lectin
pathway;signal transduction"
exp OR52E2 11p15.4 0.207 0.116 0.642 response to stimulus
xai AMN 14q32.3 0.207 0.116 0.642 multicellular organismal
his COMMD3 10p12.2 0.207 0.116 0.642
his COMMD3-BMI1 0.207 0.116 0.642
his BMI1 10p11.23 0.207 0.116 0.642 segment specification;positive regulation
of B cell proliferation
cop EMP1 12p12.3 0.205 0.116 0.64 multicellular organismal development;cell
proliferation
xsq S100Z 5q13.3 0.205 0.116 0.64
xsq ASGR1 17p13.2 0.205 0.116 0.64 receptor-mediated endocytosis;cellular
response to extracellular stimulus
xsq RBM19 12q24.21 0.205 0.116 0.64 multicellular organismal
cop LOC283922 16q23.1 0.205 0.116 0.64
cop CLEC18B 16q22.3 0.205 0.116 0.64
xsq MED16 19p13.3 0.205 0.116 0.641 positive regulation of transcription,
exp RASA3 13q34 0.205 0.116 0.641 positive regulation of GTPase activity;negative
regulation of Ras protein signal transduction
xsq GLMN 1p22.1 0.205 0.116 0.641 muscle cell differentiation;positive
regulation of interleukin-2 biosynthetic process
met A1CF 10q11.23 0.205 0.116 0.641 gene expression;cytidine to uridine
editing
met TLR3 4q35 0.205 0.116 0.641 activation of NF-kappaB-inducing kinase
cop GALNT12 9q22.33 0.205 0.116 0.641 cellular protein metabolic
xsq RBM27 5q32 0.205 0.116 0.641 mRNA processing
xsq DIAPH1 5q31 0.205 0.116 0.641 regulation of microtubule-based
exp TAPBPL 12p13.31 0.205 0.116 0.641 antigen processing and presentation
met FZD3 8p21 0.205 0.116 0.641 multicellular organismal development;gonad
development
xsq MYO19 17q12 0.205 0.116 0.641
xsq LOC101928858 0.205 0.116 0.641
xsq TRIM65 17q25.1 0.205 0.116 0.641
exp EXOSC4 8q24.3 0.205 0.116 0.641 RNA metabolic process;mRNA
metabolic process
xsq N6AMT2 13q12.11 0.205 0.116 0.641
cop PTCH1 9q22.3 0.205 0.116 0.641 Tumor Suppressors
cop LOC100507346 0.205 0.116 0.641
exp SPATA5 4q28.1 0.205 0.116 0.641 multicellular organismal
xsq ADAMTS10 19p13.2 0.205 0.116 0.641 proteolysis;integrin-mediated
signaling pathway
exp ARC 8q24.3 0.205 0.116 0.641 regulation of cell
met GABRR1 6q15 0.205 0.116 0.641 chloride transport;gamma-aminobutyric
acid signaling pathway
exp CASC5 15q14 0.205 0.116 0.641 acrosome assembly;nucleosome assembly
xsq KTN1-AS1 14q22.3 0.205 0.116 0.641
xsq OR52W1 11p15.4 0.205 0.116 0.641 response to stimulus
met CIRBP-AS1 19p13.3 0.205 0.116 0.641
met ERCC6 10q11.23 0.205 0.116 0.641 DNA Damage Response (DDR); DDR (NER)
met SYTL2 11q14 0.205 0.116 0.641 intracellular protein transport;exocytosis
met UNC5B 10q22.1 0.205 0.116 0.641 Apoptosis
xsq CENPVP1 0.205 0.116 0.641
xsq PDDC1 11p15.5 0.205 0.116 0.641
cop TACR2 10q22.1 0.205 0.116 0.641 muscle contraction;tachykinin receptor
signaling pathway
met CSMD1 8p23.2 0.205 0.116 0.641
xsq MAPKAPK5 12q24.13 0.205 0.116 0.641 Ras protein signal
xsq HNRNPAB 5q35.3 0.205 0.116 0.641 epithelial to mesenchymal
transition;positive regulation of transcription, DNA-dependent"
xsq MSTO2P 1q22 0.205 0.116 0.641
exp LOC644357 1p36.32 0.205 0.116 0.641
met RAB34 17q11.2 0.205 0.116 0.641 protein transport;endocytosis
exp CHD1 5q15-q21 0.205 0.116 0.641 chromatin remodeling;regulation of
exp TRIP13 5p15.33 0.205 0.116 0.642 DNA Damage Response (DDR)
exp TAF9 5q13.2 0.205 0.116 0.642 regulation of transcription, DNA-
process
exp KEL 7q33 0.205 0.116 0.642 proteolysis;vasoconstriction
exp SEC31B 10q24.31 0.205 0.116 0.642 protein transport;vesicle-mediated
transport
met SCRIB 8q24.3 0.205 0.116 0.642 multicellular organismal
xsq STX18 4p16.3-p16.2 0.205 0.116 0.642 ER to Golgi vesicle-mediated
cop NUDT21 16q12.2 0.205 0.116 0.642 RNA splicing;gene expression
xsq SNORA72 8q22 0.205 0.116 0.642
cop INO80C 18q12.2 0.205 0.116 0.642 DNA Damage Response (DDR); DDR
(Chromatin)
cop FANCC 9q22.3 0.205 0.116 0.642 DNA Damage Response (DDR); DDR (FA)
met VPS16 20p13 0.205 0.116 0.642 intracellular protein transport
xsq NSL1 1q41 0.205 0.116 0.642 M phase of mitotic cell cycle;mitotic
prometaphase
xsq EZH1 17q21.1-q21.3 0.205 0.116 0.642 peptidyl-lysine
methylation;negative regulation of transcription from RNA polymerase II promoter
xsq CLC 19q13.1 0.205 0.116 0.642 multicellular organismal
exp CD82 11p11.2 -0.205 0.116 0.642
exp SDPR 2q32-q33 -0.205 0.116 0.642
exp TNS2 -0.205 0.116 0.642 negative regulation of cell
met ADGRG3 -0.205 0.116 0.642 neuropeptide signaling pathway
cop LANCL2 7q31.1-q31.33 -0.205 0.116 0.642 negative regulation of
transcription, DNA-dependent;positive regulation of abscisic acid mediated
signaling pathway"
exp MPP5 14q23.3 -0.205 0.116 0.642 tight junction
assembly;establishment of protein localization in plasma membrane
xsq LOC101928266 -0.205 0.116 0.641
xsq COL5A3 19p13.2 -0.205 0.116 0.641 cell adhesion;cell-matrix
adhesion
cop GPR37L1 1q32.1 -0.205 0.116 0.641
cop ARL8A 1q32.1 -0.205 0.116 0.641 GTP catabolic process;cell cycle
cop PTPN7 1q32.1 -0.205 0.116 0.641 protein dephosphorylation;peptidyl-
cop PTPRVP 1q32.1 -0.205 0.116 0.641
met EXOC3L4 14q32.32 -0.205 0.116 0.641
met FABP5 8q21.13 -0.205 0.116 0.641 lipid metabolic
cop C5orf22 5p13.3 -0.205 0.116 0.641
cop SULF1 8q13.2 -0.205 0.116 0.641 esophagus smooth muscle
xsq EBF4 20p13 -0.205 0.116 0.641 regulation of transcription, DNA-
xsq RHOBTB1 10q21.2 -0.205 0.116 0.641 small GTPase mediated signal
exp GRHPR 9q12 -0.205 0.116 0.641 excretion;metabolic process
cop JAZF1 7p15.2-p15.1 -0.205 0.116 0.641 negative regulation of
dependent"
xsq POU5F1P5 -0.205 0.116 0.641
mut AAAS 12q13 -0.205 0.116 0.641 hexose transport;transmembrane transport
exp CPP -0.205 0.116 0.641
xsq DACT1 14q23.1 -0.205 0.116 0.641 multicellular organismal
development;Wnt receptor signaling pathway
met SCD 10q24.31 -0.205 0.116 0.641 fatty acid biosynthetic process
cop TWIST1 7p21.2 -0.205 0.116 0.64 mitral valve
morphogenesis;regulation of bone mineralization
cop FERD3L 7p21.1 -0.205 0.116 0.64
met BCL6B 17p13.1 -0.205 0.116 0.64 negative regulation of
exp USP40 2q37.1 -0.205 0.116 0.64 proteolysis;ubiquitin-dependent
hs4 PPFIBP1 12p12.1 -0.207 0.116 0.642 cell adhesion
hs4 ACER2 9p22.1 -0.207 0.116 0.642 lipid metabolic process;sphingosine
his DFNA5 7p15 -0.207 0.116 0.642 sensory perception of sound;inner ear
hs4 HHLA2 3q13.13 -0.207 0.116 0.642
hs4 MGST3 1q23 -0.207 0.116 0.642 signal transduction;leukotriene
his LOC101928820 -0.207 0.116 0.642
hs4 CSF2 5q31.1 -0.207 0.116 0.641 positive regulation of tyrosine
phosphorylation of Stat5 protein;embryonic placenta development
his KRT13 17q21.2 -0.207 0.116 0.641 tongue morphogenesis;cellular
xai COPA 1q23.2 -0.207 0.116 0.641 pancreatic juice secretion;COPI
exp NLRP9 19q13.42 -0.207 0.116 0.641
xai YAP1P2 -0.207 0.116 0.641
xai VEGFA 6p12 -0.207 0.116 0.641 patterning of blood vessels;positive
hs4 FAM131A 3q27.1 -0.207 0.116 0.641
his VCAM1 1p32-p31 -0.207 0.116 0.641 heart development;interspecies
xai TRIM6 11p15.4 -0.207 0.116 0.641 protein trimerization
xai BRE-AS1 -0.207 0.116 0.641
hs4 CFI 4q25 -0.207 0.116 0.641 complement activation, classical
xai SYDE1 19p13.12 -0.207 0.116 0.641 EMT (Mesenchymal)
xai ACOT1 14q24.3 -0.207 0.116 0.641 lipid metabolic process;acyl-CoA
metabolic process
xai TUBB2BP1 6p25.2 -0.207 0.116 0.641
xai LINC01139 -0.207 0.116 0.641
his LINC02060 -0.207 0.116 0.641
his PABPC1P2 2q22.3 -0.207 0.116 0.641
his ADIPOQ -0.207 0.116 0.641
xai TMEM125 1p34.2 -0.207 0.116 0.641 EMT (Epithelial)
xai PRKCE 2p21 -0.207 0.116 0.641 Protein Kinases
his LHFPL2 5q14.1 -0.207 0.116 0.64
xai BMPR1B 4q22-q24 -0.207 0.116 0.64 skeletal system
swa PLOD3 7q22 -0.207 0.116 0.64 cellular response to hormone
stimulus;vasodilation
hs4 ZNF625-ZNF20 -0.207 0.116 0.64
DNA-dependent"
hs4 PRODH 22q11.21 -0.207 0.116 0.64 proline catabolic process;induction
of apoptosis by oxidative stress
xai DNAI1 9p13.3 -0.207 0.116 0.64 cell projection organization
xai TDRP 8p23.3 -0.207 0.116 0.64
xai EIF3LP3 10p11.1 0.208 0.117 0.644
his LINC01976 0.207 0.117 0.642
xai GDI2 10p15 0.207 0.117 0.642 signal transduction;small GTPase mediated
signal transduction
his TMBIM4 12q14.3 0.207 0.117 0.642 anti-apoptosis;regulation of
calcium-mediated signaling
xai LINC00922 16q21 0.207 0.117 0.642
xai RNASE3 14q11.2 0.207 0.117 0.642 RNA catabolic process;defense
exp LOC100127991 0.207 0.117 0.642
hs4 NRROS 3q29 0.206 0.117 0.642
hs4 FAM213B 1p36.32 0.206 0.117 0.642 prostaglandin biosynthetic
xai LOC100128775 1p31.1 0.206 0.117 0.642
xai OR52E2 11p15.4 0.206 0.117 0.642 response to stimulus
his UBL5 19p13.3 0.206 0.117 0.642
his UBE3C 7q36.3 0.206 0.117 0.642 protein polyubiquitination;protein
hs4 KLRC3 12p13 0.206 0.117 0.643 cellular defense response
his ASB16 17q21.31 0.206 0.117 0.643 intracellular signal transduction
xai UBE2QL1 5p15.31 0.206 0.117 0.643
his THEMIS 6q22.33 0.206 0.117 0.643 multicellular organismal
his LOC101928063 0.206 0.117 0.643
dependent"
hs4 SLBP 4p16.3 0.206 0.117 0.643 transcription from RNA polymerase II
promoter;regulation of S phase
xai CRIP1 14q32.33 0.206 0.117 0.643 heart development;cell proliferation
his GRIA4 11q22 0.206 0.117 0.643 transport;ion transport
his DGAT1 8q24.3 0.206 0.117 0.643 triglyceride metabolic
process;diacylglycerol metabolic process
exp EIF4A1P8 10q23.32 0.206 0.117 0.643
xai ZNF192P1 6p22.1 0.206 0.117 0.643
his RNASE2 14q11.2 0.206 0.117 0.643 RNA catabolic process;chemotaxis
his LSM7 19p13.3 0.206 0.117 0.643 nuclear mRNA splicing, via
his SPPL2B 19p13.3 0.206 0.117 0.643 proteolysis
his KATNA1 6q25.1 0.206 0.117 0.643 mitosis;protein localization
xai ZFR 5p13.3 0.206 0.117 0.643 multicellular organismal development
hs4 LOC105376351 0.206 0.117 0.643
hs4 SERPINB10 18q21.3 0.206 0.117 0.643 negative regulation of
exp NAPSB 19q13.33 0.206 0.117 0.643
his FAM86EP 4p16.3 0.206 0.117 0.644
his NDUFA12 12q22 0.206 0.117 0.644 transport;response to oxidative stress
xai ZC4H2 Xq11.2 0.206 0.117 0.644
exp C8A 1p32 0.206 0.117 0.644 immune response;complement activation
swa LSM6 4q31.22 0.206 0.117 0.644 mRNA processing;tRNA processing
hs4 BOLA3 2p13.1 0.206 0.117 0.644
hs4 BOLA3-AS1 0.206 0.117 0.644
xai GPR89A 1q21.1 0.206 0.117 0.644 signal transduction;protein
transport
xai NPM1P42 15q24.1 0.206 0.117 0.644
xai SMARCD1 12q13-q14 0.206 0.117 0.644 DNA Damage Response (DDR); DDR
(Chromatin)
xai NCL 2q37.1 0.206 0.117 0.644 angiogenesis
xai SNX29P2 16p11.2 0.206 0.117 0.644
xai SCN2A 2q24.3 0.206 0.117 0.644 nervous system development;myelination
swa GNL3 3p21.1 0.206 0.117 0.644 regulation of cell proliferation
hs4 LOC101928728 0.206 0.117 0.645
hs4 ARID1A 1p35.3 0.206 0.117 0.645 DNA Damage Response (DDR); DDR
hs4 GIT2 12q24.1 0.206 0.117 0.645 regulation of G-protein coupled receptor
hs4 ANKRD13A 12q24.11 0.206 0.117 0.645
xsq LCNL1 9q34.3 0.205 0.117 0.642
met LRRC55 11q12.1 0.205 0.117 0.642
met ASTN1 1q25.2 0.205 0.117 0.642 cell adhesion;neuron cell-cell adhesion
exp AP3B1 5q14.1 0.205 0.117 0.642 protein targeting to
cop MIR140 0.205 0.117 0.642
cop CLEC18A 16q22.1 0.205 0.117 0.642
cop PDXDC2P 16q22.1 0.205 0.117 0.642 carboxylic acid metabolic process
cop MIR1972-1 0.205 0.117 0.642
cop MIR1972-2 0.205 0.117 0.642
met BCL2L13 22q11.1 0.205 0.117 0.642 Apoptosis
exp LOC100128816 12p13.32 0.205 0.117 0.642
exp LOC149844 20p12.3 0.205 0.117 0.642
met CST11 20p11.21 0.205 0.117 0.642
exp LOC390617 15q25.1 0.205 0.117 0.643
xsq SHANK1 19q13.3 0.205 0.117 0.643 neuromuscular process controlling
balance;protein complex assembly
xsq LMAN1L 15q24.1 0.205 0.117 0.643
xsq SPATA5L1 15q21.1 0.205 0.117 0.643
xsq LRP4-AS1 0.205 0.117 0.643
cop SNX1 15q22.31 0.205 0.117 0.643 cell communication;early endosome to
Golgi transport
xsq MOCS3 20q13.13 0.205 0.117 0.643 tRNA thio-modification;tRNA wobble
uridine modification
xsq TMEM86B 19q13.42 0.205 0.117 0.643 ether lipid metabolic process
met HMOX1 22q13.1 0.205 0.117 0.643 negative regulation of leukocyte
migration;small GTPase mediated signal transduction
xsq RALBP1 18p11.3 0.205 0.117 0.643 transport;regulation of small
cop MIR23B 0.205 0.117 0.643
cop MIR27B 0.205 0.117 0.643
cop MIR3074 0.205 0.117 0.643
cop MIR24-1 0.205 0.117 0.643
mut WBSCR17 7q11.23 0.205 0.117 0.643
dependent"
cop ZNF396 18q12 0.205 0.117 0.643 viral reproduction
mut IL1R2 2q12 0.205 0.117 0.643 immune response
exp CMC2 16q23.2 0.205 0.117 0.643
xsq DHPS 19p13.2 0.204 0.117 0.643 protein homotetramerization;translation
dependent"
met DEFB1 8p23.1 0.204 0.117 0.644 acute inflammatory response;chemotaxis
xsq TUBAL3 10p15.1 0.204 0.117 0.644 microtubule-based movement;protein
polymerization
exp HMGB3P1 20q11.22 0.204 0.117 0.644
met ABCB6 2q36 0.204 0.117 0.644 ABC Transporters
exp SNAPC4 9q34.3 0.204 0.117 0.644 regulation of transcription, DNA-
xsq TNFRSF13B 17p11.2 0.204 0.117 0.644 B cell homeostasis;cell surface
xsq DARS2 1q25.1 0.204 0.117 0.644 tRNA aminoacylation for protein
xsq LINC01506 0.204 0.117 0.644
xsq LOC286359 9q22.33 0.204 0.117 0.644
met SGK1 6q23 0.204 0.117 0.644 Apoptosis
xsq ADNP2 18q23 0.204 0.117 0.644 neuron differentiation;positive regulation of
cell growth
xsq EIF4E 4q21-q25 0.204 0.117 0.644 translation;cellular protein metabolic
process
exp GABRA1 5q34 0.204 0.117 0.645 transport;chloride transport
cop FAM92A1 8q22.1 -0.204 0.117 0.645
met UBE3D 6q14.1 -0.204 0.117 0.645
exp KRT19 17q21.2 -0.204 0.117 0.644 cell differentiation involved in
embryonic placenta development;response to estrogen stimulus
cop IGFBP3 7p12.3 -0.204 0.117 0.644 Apoptosis
exp DTX3L 3q21.1 -0.204 0.117 0.644 response to DNA damage
exp LOC401442 8p23.3 -0.204 0.117 0.644
xsq ZBED6 -0.204 0.117 0.644 negative regulation of transcription,
DNA-dependent"
met ABCC12 16q12.1 -0.204 0.117 0.644 ABC Transporters
exp VWA1 1p36.33 -0.204 0.117 0.644 extracellular matrix organization
xsq HOXC6 12q13.3 -0.204 0.117 0.644 regulation of transcription from
exp PPP1R1A 12q13.2 -0.204 0.117 0.643 carbohydrate metabolic
exp NCEH1 3q26.31 -0.204 0.117 0.643 lipid catabolic process;metabolic
process
exp C6orf106 6p21.31 -0.204 0.117 0.643
xsq AHDC1 1p36.13 -0.204 0.117 0.643
exp DIRAS2 9q22.2 -0.205 0.117 0.643 signal transduction;small
cop FAM213A 10q23.1 -0.205 0.117 0.643 regulation of osteoclast
cop PLOD2 3q24 -0.205 0.117 0.643 response to hypoxia;protein modification
process
xsq GGCX 2p12 -0.205 0.117 0.643 protein modification process;blood
coagulation
cop KIAA0040 1q24-q25 -0.205 0.117 0.643
exp BLVRB 19q13.1-q13.2 -0.205 0.117 0.643 small molecule metabolic
exp PDPN 1p36.21 -0.205 0.117 0.643 lymphangiogenesis;cell
proliferation
exp SEPT4 17q22 -0.205 0.117 0.643 brain development;sperm mitochondrion
organization
met SLC25A39 17q12 -0.205 0.117 0.643 Solute Carriers
xsq RAB42 1p35.3 -0.205 0.117 0.643 small GTPase mediated signal
transduction
xsq THBS3 1q21 -0.205 0.117 0.642 cell adhesion;cell-matrix adhesion
DNA-dependent"
xsq GABRE Xq28 -0.205 0.117 0.642 transport;ion transport
exp SPOCK1 5q31.2 -0.205 0.117 0.642 cell adhesion;signal
transduction
xsq PFKFB2 1q31 -0.205 0.117 0.642 Apoptosis
his EDA2R Xq12 -0.206 0.117 0.644 positive regulation of JNK
his PLXNA1 3q21.3 -0.206 0.117 0.644 signal
hs4 C1orf195 -0.206 0.117 0.644
xai SH3GLB1 1p22 -0.206 0.117 0.644 Apoptosis
xai SP100 2q37.1 -0.206 0.117 0.644 response to type I
factor activity
hs4 MFSD7 4p16.3 -0.206 0.117 0.644 transmembrane transport
xai AGPAT3 21q22.3 -0.206 0.117 0.643 metabolic
xai TNRC6C-AS1 -0.206 0.117 0.643
hs4 SAXO1 -0.206 0.117 0.643
hs4 RRAGA 9p22.1 -0.206 0.117 0.643 Apoptosis
xai MKX 10p12.1 -0.206 0.117 0.643 multicellular organismal
his HPN-AS1 19q13.12 -0.206 0.117 0.643
his FXYD3 19q13.12 -0.206 0.117 0.643 chloride transport;regulation of
catalytic activity
his MIR6887 -0.206 0.117 0.643
hs4 LOC105372582 -0.206 0.117 0.643
xai NDP Xp11.4 -0.206 0.117 0.643 visual perception;canonical Wnt
xai ZFYVE26 14q24.1 -0.206 0.117 0.642 double-strand break repair
via homologous recombination;cytokinesis
xai HOXA3 7p15.2 -0.207 0.117 0.642 glossopharyngeal nerve
hs4 PID1 2q36.3 -0.207 0.117 0.642 regulation of mitochondrial
fusion;cellular response to interleukin-6
xai NLRP9 19q13.42 -0.207 0.117 0.642
his PLCG2 16q24.1 0.206 0.118 0.645 blood coagulation;response to magnesium
ion
xai KNSTRN 15q15.1 0.206 0.118 0.645
his LARS2 3p21.3 0.206 0.118 0.645 tRNA aminoacylation for protein
swa KHSRP 19p13.3 0.206 0.118 0.645 RNA splicing;gene expression
his UBB 17p12-p11.2 0.206 0.118 0.645 DNA Damage Response (DDR)
his DHX9 1q25 0.206 0.118 0.645 nuclear mRNA splicing, via spliceosome;RNA
splicing
his CLUH 17p13.3 0.206 0.118 0.645
his LOC105371592 0.206 0.118 0.645
hs4 HCK 20q11-q12 0.206 0.118 0.645 exocytosis;cytokine-mediated signaling
pathway
his AP1M1 19p13.12 0.206 0.118 0.645 EMT (Mesenchymal)
xai SLX4IP 20p12.2 0.206 0.118 0.645
hs4 GPR88 1p21.3 0.206 0.118 0.645 G-protein coupled receptor signaling
pathway
his KEAP1 19p13.2 0.206 0.118 0.645 in utero embryonic development;regulation
hs4 TXNDC5 6p24.3 0.206 0.118 0.645 glycerol ether metabolic
his LOC100132057 0.206 0.118 0.645
his RNVU1-3 0.206 0.118 0.645
hs4 HMGN2 1p36.1 0.206 0.118 0.645 chromatin organization;regulation of
his CDC20 1p34.1 0.206 0.118 0.645 cell cycle checkpoint;cell
differentiation
his ABCF2 7q36 0.206 0.118 0.645 ABC Transporters
swa NTMT1 9q34.11 0.206 0.118 0.646
exp RAD17P1 7p21 0.206 0.118 0.646
his JAK1 1p32.3-p31.3 0.206 0.118 0.646 Oncogenes
his CYB5R4 6pter-q22.33 0.206 0.118 0.646 cell development;oxidation-
reduction process
exp SH2B1 0.206 0.118 0.646 blood coagulation;intracellular signal
transduction
his LINC00921 16p13.3 0.206 0.118 0.646
his PIGW 17q12 0.206 0.118 0.646 C-terminal protein lipidation;preassembly of
GPI anchor in ER membrane
his MYO19 17q12 0.206 0.118 0.646
his PRPS1 Xq22.3 0.206 0.118 0.646 ribonucleoside monophosphate biosynthetic
xai CCDC141 2q31.2 0.206 0.118 0.646
xai TSPEAR 21q22.3 0.206 0.118 0.646 cell adhesion
xai SH2B1 0.206 0.118 0.646 blood coagulation;intracellular signal
transduction
exp LOC646484 4q31.1 0.206 0.118 0.646
hs4 MAST3 19p13.11 0.206 0.118 0.646
hs4 IL12RB1 19p13.1 0.206 0.118 0.646 signal transduction;positive
xai EZH1 17q21.1-q21.3 0.206 0.118 0.646 peptidyl-lysine
xai LOC646484 4q31.1 0.206 0.118 0.646
his TTC24 1q23.1 0.206 0.118 0.646
xai ANTXRLP1 0.206 0.118 0.646
xai ZNF663P 0.205 0.118 0.646 regulation of transcription, DNA-
dependent"
mut PCDH15 10q21.1 0.204 0.118 0.645 equilibrioception;cell adhesion
cop RAD52 12p13-p12.2 0.204 0.118 0.645 DNA Damage Response (DDR); DDR (HR)
exp GAPVD1 9q33.3 0.204 0.118 0.645 endocytosis;signal transduction
cop ZNF397 18q12.2 0.204 0.118 0.645 viral reproduction
cop ZNF24 18q12 0.204 0.118 0.645 viral reproduction;myelination
met TMEM106C 12q13.1 0.204 0.118 0.645
met SMOC2 6q27 0.204 0.118 0.645 signal transduction
exp RPL23AP32 0.204 0.118 0.645
cop SNRPG 2p13.3 0.204 0.118 0.645 spliceosomal snRNP assembly;RNA metabolic
process
met KCNA1 12p13.32 0.204 0.118 0.645 potassium ion transport;synaptic
transmission
xsq PXN-AS1 0.204 0.118 0.645
exp PRDM8 4q21 0.204 0.118 0.645 regulation of transcription, DNA-dependent"
xsq LIPT2 11q13.4 0.204 0.118 0.645 protein modification process;lipoate
exp ERAL1 17q11.2 0.204 0.118 0.645 ribosomal small subunit assembly;ribosome
biogenesis
dependent"
exp TAF6L 11q12.3 0.204 0.118 0.645 chromatin remodeling;transcription
exp SP1 12q13.1 0.204 0.118 0.645 megakaryocyte differentiation;embryonic
skeletal system development
cop LOC100499484 0.204 0.118 0.645
met PMP22 17p12 0.204 0.118 0.645 peripheral nervous system development;negative
exp IRF8 16q24.1 0.204 0.118 0.645 immune response;positive regulation of
xsq MTG2 20q13.33 0.204 0.118 0.645
xsq LOC101928053 0.204 0.118 0.645
xsq RPL18 19q13 0.204 0.118 0.645 viral reproduction;nuclear-transcribed mRNA
xsq LOC100335030 0.204 0.118 0.645
cop MUC2 11p15.5 0.204 0.118 0.645 O-glycan processing;post-translational
met LOC494141 11p15.1 0.204 0.118 0.645
xsq RAB11B-AS1 0.204 0.118 0.645
xsq LINC00526 18p11.31 0.204 0.118 0.645
xsq RBBP5 1q32 0.204 0.118 0.645 regulation of transcription, DNA-
met TRAPPC2 Xp22 0.204 0.118 0.645 skeletal system development;regulation of
xsq C19orf24 19p13.3 0.204 0.118 0.645
exp DCAKD 17q21.31 0.204 0.118 0.646 coenzyme A biosynthetic process
xsq RPS6KA6 Xq21 0.204 0.118 0.646 Protein Kinases
xsq PSMD9 12q24.31-q24.32 0.204 0.118 0.646 M/G1 transition of mitotic cell
exp DAB1 1p32-p31 0.204 0.118 0.646 cell differentiation;multicellular
xsq MCM4 8q11.2 0.204 0.118 0.646 DDR (DNA replication)
xsq LOC101927450 0.204 0.118 0.646
xsq ACTL6A 3q26.33 0.204 0.118 0.646 DNA Damage Response (DDR); DDR
(Chromatin)
xsq MTUS2-AS1 0.204 0.118 0.646
xsq HCG25 0.204 0.118 0.646
exp PTRH2 17q23.1 0.204 0.118 0.646 apoptotic process
xsq RPP21 6p22.1 0.204 0.118 0.646 tRNA processing;response to drug
exp SIRT6 19p13.3 0.204 0.118 0.646 protein deacetylation;protein ADP-
ribosylation
exp GPRIN3 4q22.1 0.204 0.118 0.646
mut SRP54 14q13.2 0.204 0.118 0.646 SRP-dependent cotranslational protein
targeting to membrane, translocation;SRP-dependent cotranslational protein
xsq GINS1 20p11.21 0.204 0.118 0.646 DDR (DNA replication)
met RGAG1 Xq23 0.204 0.118 0.646
mut MAGEC2 Xq27 0.204 0.118 0.646
xsq CX3CR1 3p21.3 0.204 0.118 0.646 negative regulation of
exp BNIP2 15q22.2 0.204 0.118 0.646 Apoptosis
met TANGO2 22q11.21 0.204 0.118 0.646
mut GABBR2 9q22.1-q22.3 0.204 0.118 0.646 negative regulation of
adenylate cyclase activity;gamma-aminobutyric acid signaling pathway
met KLHDC8B 3p21.31 0.204 0.118 0.646
xsq AMY2A 0.204 0.118 0.646 carbohydrate catabolic process;polysaccharide
digestion
cop ZSCAN30 18q12.2 0.204 0.118 0.646 viral reproduction
cop ZNF271 18q12 0.204 0.118 0.646
xsq SETD1A 16p11.2 0.204 0.118 0.646 chromatin modification;histone H3-
K4 methylation
xsq USPL1 13q12-q14 0.204 0.118 0.646 ubiquitin-dependent protein catabolic
process
met PLEKHG3 14q23.3 0.204 0.118 0.646 regulation of Rho protein signal
transduction
xsq CCT2 12q15 0.204 0.118 0.646 protein folding;cellular protein metabolic
process
met DDR2 1q23.3 0.204 0.118 0.646 peptidyl-tyrosine
factor activity
met CELSR3 3p21.31 0.204 0.118 0.646 G-protein coupled receptor
xsq LY86-AS1 6p25.1 0.204 0.118 0.646
exp UTP11L 1p34.3 0.204 0.118 0.646 rRNA processing;induction of
apoptosis
exp GRAMD1B 11q24.1 0.204 0.118 0.646
xsq LOC101927207 0.204 0.118 0.646
met MIR1272 -0.204 0.118 0.646
mut EIF4G2 11p15 -0.204 0.118 0.646 translational initiation;regulation
exp IGFN1 1q32.1 -0.204 0.118 0.646
xsq FOLR3 11q13 -0.204 0.118 0.646 folic acid transport
cop LOC401463 8q12.3 -0.204 0.118 0.646
cop BHLHE22 8q13 -0.204 0.118 0.646
exp ENTPD4 8p21.3 -0.204 0.118 0.646 UDP catabolic process
exp POLH 6p21.1 -0.204 0.118 0.646 DNA Damage Response (DDR); DDR
xsq GHR 5p13-p12 -0.204 0.118 0.646 succinate metabolic
met GRAP2 22q13.2 -0.204 0.118 0.646 Ras protein signal
met SEPT6 Xq24 -0.204 0.118 0.646 cytokinesis;cell cycle
exp NUDCD3 7p13-p12 -0.204 0.118 0.646
DNA-dependent"
mir hsa-miR-210 -0.204 0.118 0.646
xsq BGN Xq28 -0.204 0.118 0.646 blood vessel remodeling;peptide cross-
linking via chondroitin 4-sulfate glycosaminoglycan
exp HOXD-AS2 -0.204 0.118 0.645
exp PCDHGB4 -0.204 0.118 0.645 cell adhesion;homophilic cell
adhesion
met ZNF446 19q13.43 -0.204 0.118 0.645 viral reproduction
xsq EFCAB14-AS1 -0.204 0.118 0.645
mut RPH3AL 17p13.3 -0.204 0.118 0.645 intracellular protein
exp SH3D21 1p34.3 -0.204 0.118 0.645
xsq EPB41L4A 5q21.3 -0.204 0.118 0.645
exp SULF1 8q13.2 -0.204 0.118 0.645 esophagus smooth muscle
exp FAM13C 10q21.1 -0.204 0.118 0.645
exp LINC00282 13q14.3 -0.204 0.118 0.645
xsq KLF11 2p25 -0.204 0.118 0.645 negative regulation of cell
met GUCA2A 1p35-p34 -0.204 0.118 0.645 signal transduction
xsq PAX8 2q13 -0.204 0.118 0.645 mesenchymal to epithelial transition
exp LOC643562 6q14.1 -0.204 0.118 0.645
xsq TRPC4 13q13.3 -0.204 0.118 0.645 ion transport;calcium ion transport
xsq DENND4C 9p22.1 -0.204 0.118 0.645
cop TNN 1q23-q24 -0.204 0.118 0.645 cell growth;cell migration
xai PDIA3 15q15 -0.205 0.118 0.646 protein retention in ER lumen;cell redox
homeostasis
his BIN1 2q14 -0.205 0.118 0.646 positive regulation of GTPase
hs4 CREB5 7p15.1 -0.206 0.118 0.646 transcription from RNA polymerase
exp KRT86 12q13 -0.206 0.118 0.646 cytoskeleton organization
his CCK 3p22.1 -0.206 0.118 0.646 activation of cysteine-type
endopeptidase activity involved in apoptotic process;positive regulation of
apoptotic process
xai CRTAP 3p22.3 -0.206 0.118 0.646 spermatogenesis
xai ABCC12 16q12.1 -0.206 0.118 0.646 ABC Transporters
his ARMCX1 Xq21.33-q22.2 -0.206 0.118 0.646
hs4 PCYT1B Xp22.11 -0.206 0.118 0.646 CDP-choline
hs4 PCYT1B-AS1 -0.206 0.118 0.646
swa NDUFB3 2q31.3 -0.206 0.118 0.646 mitochondrial electron
xai PDCD1LG2 9p24.2 -0.206 0.118 0.646 immune response;T cell
costimulation
xai FKTN 9q31-q33 -0.206 0.118 0.646 nervous system development;muscle
organ development
his BDKRB2 14q32.1-q32.2 -0.206 0.118 0.646 inflammatory
swa ADCK4 19q13.2 -0.206 0.118 0.646
his SNX21 20q13.12 -0.206 0.118 0.646 cell communication;protein
transport
his RBM24 6p22.3 -0.206 0.118 0.646 regulation of mRNA
xai PLXNA3 Xq28 -0.206 0.118 0.646 axon guidance;hippocampus
development
his FAP 2q23 -0.206 0.118 0.646 endothelial cell migration;regulation of
fibrinolysis
xai PACS1 11q13.1-q13.2 -0.206 0.118 0.646 positive regulation of
hs4 GNA11 19p13.3 -0.206 0.118 0.646 Oncogenes
hs4 C4orf26 4q21.1 -0.206 0.118 0.646
exp KRT8P34 -0.206 0.118 0.645
xai RAB1A 2p14 -0.206 0.118 0.645 protein transport;vesicle-mediated
transport
exp VN1R78P -0.206 0.118 0.645
his HIF1A-AS2 -0.206 0.118 0.645
his LOC105370526 -0.206 0.118 0.645
xai VN1R78P -0.206 0.118 0.645
swa EPHA2 1p36 -0.206 0.118 0.645 Protein Kinases
his LINC00692 -0.206 0.118 0.645
his SNX19 11q25 -0.206 0.118 0.645 protein transport;cell communication
hs4 SCUBE3 6p21.3 -0.206 0.118 0.645 protein
exp C10orf131 10q24.1 -0.206 0.118 0.645
xai BCAS1 20q13.2 -0.206 0.118 0.645
hs4 ERRFI1 1p36 -0.206 0.118 0.645 response to stress;lung vasculature
development
xai PAPSS2 10q24 -0.206 0.118 0.645 xenobiotic metabolic process;small
xai BCL2 18q21.3 0.205 0.119 0.646 Apoptosis; Protein Kinases
exp CYP4F30P 2q21.1 0.205 0.119 0.646
xai ANKRD18DP 3q29 0.205 0.119 0.647
his UBE2I 16p13.3 0.205 0.119 0.647 DNA Damage Response (DDR)
his CPSF7 11q12.2 0.205 0.119 0.647 protein tetramerization;nuclear mRNA
his SDHAF2 11q12.2 0.205 0.119 0.647 mitochondrial electron transport,
succinate to ubiquinone;protein-FAD linkage"
xai LEMD3 12q14 0.205 0.119 0.647 negative regulation of transforming growth
factor beta receptor signaling pathway;negative regulation of BMP signaling pathway
his HAUS7 Xq28 0.205 0.119 0.647 mitosis;spindle assembly
xai TIGD5 8q24.3 0.205 0.119 0.647 regulation of transcription, DNA-
dependent"
his TAGAP 6q25.3 0.205 0.119 0.647 signal transduction;small GTPase mediated
signal transduction
his FBXL19 16p11.2 0.205 0.119 0.647
his FBXL19-AS1 16p11.2 0.205 0.119 0.647
xai EDARADD 1q42.3 0.205 0.119 0.647 hair follicle development;signal
transduction
exp PANX3 11q24.2 0.205 0.119 0.647 cell-cell signaling;protein
hexamerization
xai USP2-AS1 0.205 0.119 0.647
his MRM2 0.205 0.119 0.647
his NUDT1 7p22 0.205 0.119 0.647 DNA Damage Response (DDR)
his GINS4 8p11.21 0.205 0.119 0.647 DDR (DNA replication)
his NUP210 3p25.1 0.205 0.119 0.647 glucose transport;viral
reproduction
exp OR10Q2P 11q12.1 0.205 0.119 0.647
xai YY1AP1 1q22 0.205 0.119 0.647 regulation of transcription, DNA-
xai NDNF 4q27 0.205 0.119 0.647 cell growth;peptide cross-linking via
swa HRSP12 8q22 0.205 0.119 0.647 regulation of translational termination
his LMTK3 19q13.33 0.205 0.119 0.647 negative regulation of phosphatase
activity
hs4 TWF2 3p21.1 0.205 0.119 0.647 sequestering of actin monomers;positive
hs4 LOC101929054 0.205 0.119 0.647
xai NTMT1 9q34.11 0.205 0.119 0.647
xai B3GNTL1 17q25.3 0.205 0.119 0.648
xai GPRIN3 4q22.1 0.205 0.119 0.648
his ADSSL1 14q32.33 0.205 0.119 0.648 immune system process;purine base
metabolic process
xai ZBED3-AS1 5q13.3 0.205 0.119 0.648
exp PIWIL3 22q11.23 0.205 0.119 0.648 regulation of translation;meiosis
xai SF3B6 0.205 0.119 0.648
xai SLC35B1 17q21.33 0.205 0.119 0.648 Solute Carriers
his RPLP0 12q24.2 0.205 0.119 0.648 SRP-dependent cotranslational protein
his PXN-AS1 0.205 0.119 0.648
exp PRELID1P1 6q22.32 0.205 0.119 0.648
his NACA 12q23-q24.1 0.205 0.119 0.648 transcription, DNA-dependent;translation
his ZSWIM1 20q13.12 0.205 0.119 0.648
xai HRH2 5q35.2 0.205 0.119 0.648 G-protein signaling, coupled to cyclic
nucleotide second messenger;immune response"
xai ARMC2 6q21 0.205 0.119 0.648
exp IL19 1q32.2 0.205 0.119 0.648 induction of apoptosis;immune response
xai ING4 12p13.31 0.205 0.119 0.648 Tumor Suppressors
his ZZZ3 1p31.1 0.205 0.119 0.648 regulation of transcription, DNA-
dependent"
his VPS13C 15q22.2 0.205 0.119 0.648 protein localization
his LOC101928907 0.205 0.119 0.648
xai PPP1R26P1 0.205 0.119 0.648
swa ADH5 4q23 0.205 0.119 0.648 retinoid metabolic process;formaldehyde
catabolic process
hs4 HCG25 0.205 0.119 0.648
his LOC105375773 0.205 0.119 0.648
xai TEX9 15q21.3 0.205 0.119 0.648
his LINC01913 0.205 0.119 0.648
his RNVU1-15 0.205 0.119 0.648
xai POGLUT1 3q13.33 0.205 0.119 0.648
xai HSPD1 2q33.1 0.205 0.119 0.648 Apoptosis
hs4 MIR4690 0.205 0.119 0.648
hs4 SIPA1 11q13 0.205 0.119 0.648 Apoptosis
exp ARIH2OS 3p21.31 0.204 0.119 0.646
cop ST8SIA3 18q21.31 0.204 0.119 0.646 oligosaccharide metabolic
xsq OR2M4 1q44 0.204 0.119 0.647
mut CELSR1 22q13.3 0.204 0.119 0.647 locomotory behavior;orthogonal
exp KIAA1551 12p11.21 0.204 0.119 0.647
met GLIPR1 12q21.2 0.204 0.119 0.647 cellular lipid metabolic
cop C2orf48 2p25.1 0.204 0.119 0.647
xsq EARS2 16p12.2 0.204 0.119 0.647 glutamyl-tRNA aminoacylation;gene
expression
cop DHX57 2p22.1 0.204 0.119 0.647
xsq RPL31P11 1q23.3 0.204 0.119 0.647
cop CDH1 16q22.1 0.204 0.119 0.647 Cell Signaling; Tumor Suppressors
exp ING4 12p13.31 0.204 0.119 0.647 Tumor Suppressors
xsq GUF1 4p12 0.204 0.119 0.647 translation
met OR6C75 12q13.2 0.204 0.119 0.647
exp RPS12P8 4q25 0.204 0.119 0.647
exp B3GAT3 11q12.3 0.204 0.119 0.647 glycosaminoglycan biosynthetic
process
cop TSPAN15 10q22.1 0.204 0.119 0.647
exp LOC284620 1q22 0.204 0.119 0.647
exp CHST12 7p22 0.203 0.119 0.647 carbohydrate biosynthetic
xsq LOC440600 0.203 0.119 0.647
met PTPRB 12q15-q21 0.203 0.119 0.647 protein dephosphorylation;phosphate-
containing compound metabolic process
met OFD1 Xp22 0.203 0.119 0.647 epithelial cilium movement involved in
determination of left/right asymmetry;G2/M transition of mitotic cell cycle
cop AP2A2 11p15.5 0.203 0.119 0.648 endocytosis;epidermal growth factor
xsq UBP1 3p22.3 0.203 0.119 0.648 angiogenesis;regulation of transcription
met ADAMTSL5 19p13.3 0.203 0.119 0.648
cop TEX9 15q21.3 0.203 0.119 0.648
cop MNS1 15q21.3 0.203 0.119 0.648 meiosis
xsq ACAT1 11q22.3 0.203 0.119 0.648 response to organic cyclic
compound;protein homooligomerization
exp ACOT13 6p22.3 0.203 0.119 0.648 protein homotetramerization
met NEXN 1p31.1 0.203 0.119 0.648 regulation of cell migration;regulation
of cytoskeleton organization
xsq CBWD2 2q13 0.203 0.119 0.648
met CHRM3 1q43 0.203 0.119 0.648 signal transduction;regulation of insulin
secretion
met MXI1 10q24-q25 0.203 0.119 0.648 Apoptosis
exp HSD17B10 Xp11.2 0.203 0.119 0.648 protein homotetramerization;lipid
metabolic process
exp PHF5A 22q13.2 0.203 0.119 0.648 nuclear mRNA splicing, via
exp PRELID3B 0.203 0.119 0.648
exp TCEB3-AS1 0.203 0.119 0.648
cop NEDD4 15q 0.203 0.119 0.648 nervous system development;neuron projection
development
xsq NACAP1 8q22.3 0.203 0.119 0.648
xsq TGDS 13q32.1 0.203 0.119 0.648 nucleotide-sugar metabolic
exp LMBR1 7q36 0.203 0.119 0.648 embryonic digit morphogenesis
xsq WDR70 5p13.2 0.203 0.119 0.648
xsq CRADD 12q21.33-q23.1 0.203 0.119 0.648 Apoptosis
mut SLIT2 4p15.2 0.203 0.119 0.648 cell migration involved in sprouting
angiogenesis;negative regulation of smooth muscle cell migration
met PSAP 10q21-q22 0.203 0.119 0.648 glycosphingolipid metabolic process;lipid
transport
met GNRH1 8p21-p11.2 -0.203 0.119 0.648 multicellular organismal
development;female pregnancy
mut USP48 1p36.12 -0.203 0.119 0.648 proteolysis;ubiquitin-dependent
cop DROSHA 5p13.3 -0.203 0.119 0.648 gene silencing by
RNA;ribosome biogenesis
met ATP6V0C 16p13.3 -0.203 0.119 0.648 cellular iron ion
cop ITGA2 5q11.2 -0.203 0.119 0.648 blood coagulation;organ
morphogenesis
cop MOCS2 5q11 -0.203 0.119 0.648 vitamin metabolic process;water-soluble
cop LOC257396 5q11.2 -0.203 0.119 0.648
cop TSPAN14 10q23.1 -0.203 0.119 0.648
exp VAV2 9q34.1 -0.203 0.119 0.648 angiogenesis;lamellipodium assembly
cop MIR148A -0.203 0.119 0.648
cop NFE2L3 7p15.2 -0.203 0.119 0.648 regulation of transcription,
DNA-dependent;transcription from RNA polymerase II promoter"
cop HNRNPA2B1 7p15 -0.203 0.119 0.648 RNA transport;nuclear mRNA
cop CBX3 7p15.2 -0.203 0.119 0.648 chromatin remodeling;negative
exp FEZ1 11q24.2 -0.203 0.119 0.648 transport;cell adhesion
exp COMMD7 20q11.21 -0.203 0.119 0.648 negative regulation of NF-
kappaB transcription factor activity;tumor necrosis factor-mediated signaling
pathway
cop LINC00535 -0.203 0.119 0.648
xsq KDELR2 7p22.1 -0.203 0.119 0.648 vesicle-mediated
exp COPA 1q23.2 -0.203 0.119 0.648 pancreatic juice secretion;COPI
exp C1QTNF6 22q13.1 -0.203 0.119 0.648
exp FMN1 15q13.3 -0.203 0.119 0.648 cellular component
xsq HNMT 2q22.1 -0.203 0.119 0.648 brain development;respiratory
gaseous exchange
xsq C1S 12p13 -0.203 0.119 0.647 proteolysis;complement activation
exp MIR205HG 1q32.2 -0.203 0.119 0.647
cop FBXL7 5p15.1 -0.203 0.119 0.647 ubiquitin-dependent protein
catabolic process;protein ubiquitination
xsq DISC1-IT1 -0.203 0.119 0.647
xsq COL16A1 1p35-p34 -0.204 0.119 0.647 cell adhesion;integrin-
xsq S100A1 1q21 -0.204 0.119 0.647 negative regulation of
exp NCSTN 1q22-q23 -0.204 0.119 0.647 protein processing;membrane protein
intracellular domain proteolysis
cop MACC1 7p21.1 -0.204 0.119 0.647 regulation of transcription, DNA-
dependent;positive regulation of cell division"
cop MACC1-AS1 -0.204 0.119 0.647
xsq C1QTNF2 5q33.3 -0.204 0.119 0.647 positive regulation of
exp USP43 17p13.1 -0.204 0.119 0.647 proteolysis;ubiquitin-dependent
exp TGIF1 18p11.3 -0.204 0.119 0.647 negative regulation of cell
exp PADI1 1p36.13 -0.204 0.119 0.646 protein modification
xai UBE2Z 17q21.32 -0.205 0.119 0.648 apoptotic process
xai CASC1 12p12.1 -0.205 0.119 0.648
exp HS1BP3-IT1 -0.205 0.119 0.648
xai KRT8P37 10p14 -0.205 0.119 0.648
exp USMG5P1 Xq13.2 -0.205 0.119 0.648
xai TBC1D16 17q25.3 -0.205 0.119 0.648
his BCL6 3q27 -0.205 0.119 0.648 cell morphogenesis;negative regulation of
cell proliferation
xai USMG5P1 Xq13.2 -0.205 0.119 0.648
swa CHERP 19p13.1 -0.205 0.119 0.648 nervous system development;negative
xai TERF1P1 21q11.2 -0.205 0.119 0.648
xai NAT16 7q22.1 -0.205 0.119 0.648
exp TERF1P1 21q11.2 -0.205 0.119 0.647
xai EPS8L1 19q13.42 -0.205 0.119 0.647
his KRT5 12q13.13 -0.205 0.119 0.647 epidermis development;hemidesmosome
assembly
hs4 COL27A1 9q32 -0.205 0.119 0.647 cell adhesion
hs4 PGBD1 6p22.1 -0.205 0.119 0.647 viral reproduction
hs4 CA3 8q21.2 -0.205 0.119 0.647 one-carbon metabolic
xai LINC00657 20q11.23 -0.205 0.119 0.647
exp FAM71A 1q32.3 -0.205 0.119 0.647
hs4 NECTIN2 -0.205 0.119 0.647
exp LOC284865 -0.205 0.119 0.647
xai MSANTD1 4p16.3 -0.205 0.119 0.647
his IFIT5 10q23.31 -0.205 0.119 0.646
xai MAP1LC3C 1q43 -0.207 0.119 0.647 autophagy
xai ALG10 12p11.1 0.207 0.12 0.648 dolichol-linked oligosaccharide
xai LOC100128320 0.205 0.12 0.648
hs4 CDX1 5q32 0.205 0.12 0.648 anterior/posterior pattern
hs4 ZNF385A 12q13.13 0.205 0.12 0.648 regulation of transcription, DNA-
dependent"
xai GPC3 Xq26.1 0.205 0.12 0.648 anatomical structure
hs4 TRMT61A 14q32 0.205 0.12 0.648 tRNA processing;tRNA methylation
his LINC00426 13q12.3 0.205 0.12 0.648
his NAP1L4 11p15.5 0.205 0.12 0.648 nucleosome assembly
his PLEKHH3 17q21.2 0.205 0.12 0.648 signal transduction
his CCR10 17q21.1-q21.3 0.205 0.12 0.648 chemotaxis;G-protein coupled
his CNTNAP1 17q21 0.205 0.12 0.648 signal transduction;axon guidance
hs4 RELT 11q13.4 0.205 0.12 0.648
xai DPY19L2P3 7p15.1 0.205 0.12 0.648
his DHX16 6p21.3 0.205 0.12 0.649 mRNA processing;RNA splicing
exp RP1L1 8p23.1 0.205 0.12 0.649 cell projection
xai LOC100129408 0.205 0.12 0.649
hs4 LINC00052 15q25.3 0.205 0.12 0.649
xai ANO7 2q37.3 0.205 0.12 0.649 ion transport
xai MBD1 18q21 0.205 0.12 0.649 regulation of transcription, DNA-
xai LOC100127991 0.205 0.12 0.649
his GGTLC1 20p11.1 0.205 0.12 0.649 glutathione metabolic
process;leukotriene biosynthetic process
hs4 CD86 3q21 0.205 0.12 0.649 immune response;positive regulation of
exp LOC100129408 0.205 0.12 0.649
xai PLEK 2p13.3 0.205 0.12 0.649 integrin-mediated signaling
his EIF3C 0.205 0.12 0.649 translation;translational initiation
his PCOLCE 7q22 0.205 0.12 0.649 proteolysis;multicellular organismal
development
his PCOLCE-AS1 7q22.1 0.205 0.12 0.649
his AAR2 20pter-q12 0.205 0.12 0.649
xai LINC00886 0.205 0.12 0.649
his MSL3P1 2q37.1 0.205 0.12 0.649 regulation of transcription, DNA-
his KLHDC3 6p21.1 0.205 0.12 0.649 activation of signaling protein
activity involved in unfolded protein response;meiosis
xai MUC12 7q22 0.205 0.12 0.649 post-translational protein
his OS9 12q13 0.205 0.12 0.649 protein retention in ER lumen;protein
ubiquitination
his KDM1A 1p36.12 0.205 0.12 0.649 negative regulation of protein
his LINC02027 0.205 0.12 0.649
his ZFAT-AS1 8q24.22 0.205 0.12 0.649
hs4 DCXR 17q25.3 0.205 0.12 0.649 glucose metabolic process;NADP metabolic
process
his CELF4 18q12 0.205 0.12 0.649 regulation of alternative nuclear mRNA
xai IGF2BP2-AS1 0.205 0.12 0.649
hs4 C12orf4 12p13.3 0.205 0.12 0.649
hs4 RAD51AP1 12p13.2-p13.1 0.205 0.12 0.649 DNA Damage Response (DDR)
his AMPD1 1p13 0.205 0.12 0.649 small molecule metabolic process;nucleobase-
xai XK Xp21.1 0.205 0.12 0.649 transport;amino acid transport
xai GPR68 14q31 0.205 0.12 0.649 inflammatory response;G-protein coupled
his ATPAF2 17p11.2 0.205 0.12 0.649 proton-transporting ATP synthase
complex assembly
his GID4 17p11.2 0.205 0.12 0.649
exp RBM44 2q37.3 0.205 0.12 0.649
hs4 TMEM170A 16q23.1 0.205 0.12 0.649
swa SPAG9 17q21.33 0.205 0.12 0.649 positive regulation of cell
migration;negative regulation of protein homodimerization activity
his IL9R 0.204 0.12 0.649 signal transduction;cell proliferation
his SLC9A6 Xq26.3 0.204 0.12 0.649 Solute Carriers
xai C11orf71 11q23.2 0.204 0.12 0.65
exp OR4A6P 0.204 0.12 0.65
dependent"
xai GPATCH11 2p22.2 0.204 0.12 0.65
xai ZPR1 0.204 0.12 0.65 signal transduction;cell proliferation
his GGA3 17q25.1 0.204 0.12 0.65 intracellular protein transport;vesicle-
mediated transport
his MRPS7 17q25 0.204 0.12 0.65 translation
his DDX56 7p13 0.204 0.12 0.65 rRNA processing
xsq PIGN 18q21.33 0.203 0.12 0.648 C-terminal protein lipidation;preassembly
exp AP5M1 14q22.3 0.203 0.12 0.648 intracellular protein transport;vesicle-
mediated transport
met ZNF382 19q13.12 0.203 0.12 0.648 negative regulation of
mut ZNF14 19p13.11 0.203 0.12 0.648 regulation of transcription, DNA-
dependent"
met TPD52 8q21.13 0.203 0.12 0.648 secretion;anatomical structure
morphogenesis
cop ALPK2 18q21.31 0.203 0.12 0.648 protein phosphorylation
exp GATAD2B 1q21.3 0.203 0.12 0.648
exp LOC285741 0.203 0.12 0.648
xsq DUSP28 2q37.3 0.203 0.12 0.649 peptidyl-tyrosine dephosphorylation
exp HCN3 1q22 0.203 0.12 0.649 ion transport;potassium ion transport
exp PET117 0.203 0.12 0.649
xsq KCNH3 12q13 0.203 0.12 0.649 regulation of transcription, DNA-dependent;ion
transport
xsq LOC494127 9q21.33 0.203 0.12 0.649
exp TPP2 13q32-q33 0.203 0.12 0.649 antigen processing and presentation of
xsq TXNDC5 6p24.3 0.203 0.12 0.649 glycerol ether metabolic
met FIBCD1 9q34.12 0.203 0.12 0.649 signal transduction
xsq LOC100131303 0.203 0.12 0.649
exp TGFBRAP1 2q12.1 0.203 0.12 0.649 regulation of transcription, DNA-
xsq PRMT8 12p13.3 0.203 0.12 0.649 histone methylation;peptidyl-arginine
methylation
exp TMEM183B 3q25.1 0.203 0.12 0.649
xsq SMARCD2 17q23.3 0.203 0.12 0.649 nucleosome disassembly;chromatin
remodeling
met LMOD3 3p14.1 0.203 0.12 0.649
exp TAF3 10p15.1 0.203 0.12 0.649 negative regulation of transcription from
xsq LOC101927526 0.203 0.12 0.649
xsq AHCY 20q11.22 0.203 0.12 0.649 sulfur amino acid metabolic process;one-
carbon metabolic process
cop ISCU 12q24.1 0.203 0.12 0.649 nitrogen fixation;iron-sulfur cluster
assembly
met TSPAN1 1p34.1 0.203 0.12 0.649
exp NDNF 4q27 0.203 0.12 0.649 cell growth;peptide cross-linking via
cop FAM136A 2p13.3 0.203 0.12 0.649
xsq LRRC28 15q26.3 0.203 0.12 0.649
met SAMD9 7q21.2 0.203 0.12 0.649
exp BZW2 7p21.1 0.203 0.12 0.649 multicellular organismal
xsq SART1 11q13.1 0.203 0.12 0.649 Apoptosis
xsq COCH 14q11.2-q13 0.203 0.12 0.649 sensory perception of sound
exp NUP153 6p22.3 0.203 0.12 0.649 carbohydrate metabolic
xsq CASKIN1 16p13.3 0.203 0.12 0.649 signal transduction
xsq LINC00562 0.203 0.12 0.649
pro SMARCB1 22q11.23 0.203 0.12 0.649 DNA Damage Response (DDR); DDR
mut RHOT1 17q11.2 0.203 0.12 0.649 Apoptosis
xsq APEX2 Xp11.21 0.203 0.12 0.649 DNA Damage Response (DDR); DDR (BER)
exp PIN4 Xq13 0.203 0.12 0.649 rRNA processing;protein folding
met YES1 18p11.31-p11.21 0.203 0.12 0.649 Apoptosis
exp CD2BP2 16p11.2 0.203 0.12 0.649 nuclear mRNA splicing, via
exp UBAC2-AS1 13q32.3 0.203 0.12 0.65
exp EYA3 1p36 0.203 0.12 0.65 DNA Damage Response (DDR)
xsq IFNA7 0.203 0.12 0.65 innate immune response;type I interferon-
exp FAM193A 4p16.3 0.203 0.12 0.65
xsq RDH16 12q13.3 0.203 0.12 0.65 lipid metabolic process
cop C10orf35 10q22.1 0.203 0.12 0.65
exp TOMM70A 3q12.2 0.203 0.12 0.65 protein targeting to mitochondrion
xsq ABCC8 11p15.1 0.203 0.12 0.65 ABC Transporters
met KCNK17 6p21.1 -0.203 0.12 0.65 ion transport;potassium ion
transport
exp CYP4Z2P 1p33 -0.203 0.12 0.65 oxidation-reduction process
exp RPS15AP34 16q21 -0.203 0.12 0.65
exp MAP3K9 14q24.2 -0.203 0.12 0.65 Protein Kinases
exp OS9 12q13 -0.203 0.12 0.65 protein retention in ER lumen;protein
ubiquitination
mut EPHA7 6q16.1 -0.203 0.12 0.649 regulation of protein
autophosphorylation;regulation of cysteine-type endopeptidase activity involved in
apoptotic process
xsq MAMLD1 Xq28 -0.203 0.12 0.649 regulation of transcription, DNA-
xsq GSTT2B 22q11.23 -0.203 0.12 0.649
exp HOXA3 7p15.2 -0.203 0.12 0.649 glossopharyngeal nerve
met CENPP 9q22.31 -0.203 0.12 0.649 M phase of mitotic cell
exp LIF 22q12.2 -0.203 0.12 0.649 multicellular organismal
development;positive regulation of peptidyl-serine phosphorylation
exp GEM 8q13-q21 -0.203 0.12 0.649 GTP catabolic process;immune
response
cop ADAMTS12 5q35 -0.203 0.12 0.649 proteolysis
met PIEZO1 16q24.3 -0.203 0.12 0.649 ion transport;positive
met TMPRSS7 3q13.2 -0.203 0.12 0.649 proteolysis
exp LOC642502 17p13.3 -0.203 0.12 0.649
xsq AMOT Xq23 -0.203 0.12 0.649 regulation of cell migration;positive
exp MAGED1 Xp11.23 -0.203 0.12 0.649 regulation of transcription,
cop LOC340113 -0.203 0.12 0.648
met IL3 5q31.1 -0.203 0.12 0.648
xsq SPATA6 1p33 -0.203 0.12 0.648 multicellular organismal
cop CRYGS 3q27.3 -0.203 0.12 0.648 morphogenesis of an epithelium;lens
cop TBCCD1 3q27.3 -0.203 0.12 0.648 cell morphogenesis;regulation
of cell shape
cop DNAJB11 3q27.3 -0.203 0.12 0.648 protein folding;activation of
exp DEFB4B -0.203 0.12 0.648
xsq LINC01503 -0.203 0.12 0.648
xai SEPT4 17q22 -0.204 0.12 0.65 brain development;sperm mitochondrion
organization
swa POLDIP2 17q11.2 -0.204 0.12 0.65 DDR (DNA replication)
his AZIN2 -0.204 0.12 0.65 agmatine biosynthetic process;ornithine
metabolic process
swa ACOT9 Xp22.11 -0.204 0.12 0.649 acyl-CoA metabolic process
his NR2F6 19p13.1 -0.205 0.12 0.649 gene expression;intracellular
hs4 EFNA1 1q21-q22 -0.205 0.12 0.649 endocardial cushion to mesenchymal
transition involved in heart valve formation;regulation of blood vessel endothelial
cell migration
his FAM114A1 4p14 -0.205 0.12 0.649
his MIR574 -0.205 0.12 0.649
hs4 MYZAP -0.205 0.12 0.649
hs4 GCOM1 15q21.3 -0.205 0.12 0.649
hs4 LOC105375304 -0.205 0.12 0.649
his DISP1 1q41 -0.205 0.12 0.649 diaphragm development;smoothened
signaling pathway
xai OR2T27 1q44 -0.205 0.12 0.649 response to stimulus
hs4 BOC 3q13.2 -0.205 0.12 0.649 muscle cell
swa BAIAP2 17q25 -0.205 0.12 0.649 insulin receptor signaling
hs4 CNGA3 2q11.2 -0.205 0.12 0.649 retinal cone cell
hs4 VEGFA 6p12 -0.205 0.12 0.649 patterning of blood vessels;positive
hs4 RPL23AP87 -0.205 0.12 0.649
his NACAD 7p13 -0.205 0.12 0.649 protein transport
his LHFP 13q12 -0.205 0.12 0.649
xai C10orf131 10q24.1 -0.205 0.12 0.649
hs4 PXN 12q24.31 -0.205 0.12 0.649 cell adhesion;focal adhesion
assembly
hs4 SHTN1 -0.205 0.12 0.649 multicellular organismal development;axon
guidance
his LOC101929439 -0.205 0.12 0.649
his C7orf57 7p12.3 -0.205 0.12 0.649
exp KCNE2 21q22.12 -0.205 0.12 0.649 muscle contraction;blood
circulation
hs4 DAB2IP 9q33.1-q33.3 -0.205 0.12 0.649 negative regulation of
epithelial cell migration;negative regulation of I-kappaB kinase/NF-kappaB cascade
cop POM121L4P -0.205 0.12 0.649
hs4 ZNF20 19p13.2 -0.205 0.12 0.649
xai OR4F15 15q26.3 -0.205 0.12 0.649 response to stimulus
xai LINC01191 -0.205 0.12 0.649
his MIR378G -0.205 0.12 0.649
xai CEP112 17q24.1 -0.205 0.12 0.649
his TRIM29 11q23.3 -0.205 0.12 0.649 regulation of transcription,
xai VAV2 9q34.1 -0.205 0.12 0.648 angiogenesis;lamellipodium assembly
xai MPDZ 9p23 -0.205 0.12 0.648 interspecies interaction between
organisms
his DIRC1 2q33 -0.205 0.12 0.648
xai NTN4 12q22 -0.205 0.12 0.648 axon guidance;neuron remodeling
hs4 RHOD 11q14.3 -0.205 0.12 0.648 GTP catabolic process;small GTPase
hs4 PLAC9P1 -0.205 0.12 0.648
xai CCDC65 12q13.12 -0.207 0.12 0.649
xai SSTR5-AS1 16p13.3 0.206 0.121 0.651
xai POM121C 7q11.2 0.204 0.121 0.65 protein transport;mRNA transport
xai SNORD83A 0.204 0.121 0.65
hs4 LYPD8 0.204 0.121 0.65
exp SNORD83A 0.204 0.121 0.65
exp PAICSP3 6q13 0.204 0.121 0.65
xai FASTKD5 0.204 0.121 0.65 cellular respiration
xai SIKE1 1p13.2 0.204 0.121 0.65 innate immune response
cop TRIAP1 12q24.31 0.204 0.121 0.65 anti-apoptosis;DNA damage response,
signal transduction by p53 class mediator resulting in cell cycle arrest
his CHST2 3q24 0.204 0.121 0.65 metabolic process;carbohydrate metabolic
process
xai RPSAP41 6q13 0.204 0.121 0.65
xai OR4A6P 0.204 0.121 0.65
xai FAM185A 7q22.1 0.204 0.121 0.65
xai RASA3 13q34 0.204 0.121 0.651 positive regulation of GTPase activity;negative
regulation of Ras protein signal transduction
exp RPSAP41 6q13 0.204 0.121 0.651
swa NUP58 0.204 0.121 0.651 nucleocytoplasmic transport;mRNA transport
his SEC24C 10q22.2 0.204 0.121 0.651 post-translational protein
dependent"
dependent"
his TOLLIP 11p15.5 0.204 0.121 0.651 inflammatory response;signal
transduction
his TOLLIP-AS1 11p15.5 0.204 0.121 0.651
hs4 C14orf39 14q23.1 0.204 0.121 0.651 regulation of sequence-specific DNA
binding transcription factor activity;multicellular organismal development
exp KIR3DS1 0.204 0.121 0.651 immune response;natural killer cell
activation
xai NUP98 11p15.5 0.204 0.121 0.651 M phase of mitotic cell cycle;regulation
xai OR8J3 0.204 0.121 0.651 response to stimulus
hs4 NUCB2 11p15.1 0.204 0.121 0.651
his ISG20L2 1q23.1 0.204 0.121 0.651 ribosome biogenesis
his RRNAD1 1q23.1 0.204 0.121 0.651
exp OR8J3 0.204 0.121 0.651 response to stimulus
his TRIM27 6p22 0.204 0.121 0.651 cell proliferation;negative regulation of
gene expression, epigenetic
xai RPS5P3 21q22.11 0.204 0.121 0.651
cop MIR331 0.204 0.121 0.651
cop MIR3685 0.204 0.121 0.651
his FRRS1 1p21.2 0.204 0.121 0.651 transport;electron transport chain
cop LOC100133985 0.204 0.121 0.651
xai UBP1 3p22.3 0.204 0.121 0.651 angiogenesis;regulation of transcription
hs4 MIR137HG 1p21.3 0.204 0.121 0.651
his TTC32 2p24.1 0.204 0.121 0.651
xai DHRS4L2 14q11.2 0.204 0.121 0.651
his GEMIN5 5q33.2 0.204 0.121 0.651 nuclear mRNA splicing, via
his KCTD10 12q24.11 0.204 0.121 0.651 potassium ion transport;protein
ubiquitination
his UBE3B 12q24.11 0.204 0.121 0.651 protein modification process;protein
met CNTLN 9p22.2 0.204 0.121 0.651
his LOC102606466 0.204 0.121 0.651
xai CYP4F30P 2q21.1 0.204 0.121 0.651
xai ECEL1P2 2q37.1 0.204 0.121 0.651
exp LSP1P3 5p13.3 0.204 0.121 0.652
dependent"
xai E2F3 6p22 0.204 0.121 0.652 Tumor Suppressors
xai HMGN1P4 0.204 0.121 0.652
his UBXN11 1p36.11 0.204 0.121 0.652
exp DHRS4L2 14q11.2 0.204 0.121 0.652
exp PFN1P1 0.203 0.121 0.65
met LMNA 1q22 0.203 0.121 0.65 establishment or maintenance of microtubule
cytoskeleton polarity;apoptotic process
exp CINP 14q32.31 0.203 0.121 0.65 DNA replication;DNA repair
exp AEN 15q26.1 0.203 0.121 0.65 apoptotic process;response to DNA damage
stimulus
exp TFDP2 3q23 0.203 0.121 0.65 Apoptosis
xsq COMP 19p13.1 0.203 0.121 0.65 organ morphogenesis;limb development
xsq C16orf82 16p12.1 0.203 0.121 0.65
met RNF213 17q25.3 0.203 0.121 0.65 protein ubiquitination;protein
autoubiquitination
xsq MCM8 20p12.3 0.203 0.121 0.65 S phase of mitotic cell cycle;M/G1
xsq CRYBB2P1 22q11.2-q12.1 0.203 0.121 0.65
xsq ATP5G3 2q31.1 0.203 0.121 0.65 aging;ATP synthesis coupled proton
transport
xsq NDUFB9 8q13.3 0.203 0.121 0.65 mitochondrial electron transport,
exp TDP2 6p22.3-p22.1 0.203 0.121 0.65 DNA Damage Response (DDR)
met LRRC73 6p21.1 0.203 0.121 0.65
exp ZNF202 11q24 0.203 0.121 0.65 transcription from RNA polymerase II
promoter;lipid metabolic process
xsq TPTE2 13q12.11 0.203 0.121 0.65 transmembrane transport;ion transport
xsq TRO Xp11.22-p11.21 0.203 0.121 0.65 cell adhesion;homophilic cell
adhesion
exp TM4SF20 2q36.3 0.202 0.121 0.651
exp C2orf68 2p11.2 0.202 0.121 0.651
exp RHOF 12q24.31 0.202 0.121 0.651 GTP catabolic process;actin filament
organization
xsq EIF4A1 17p13 0.202 0.121 0.651 translational initiation;gene expression
met BCO1 0.202 0.121 0.651 retinoid metabolic process;steroid metabolic
process
xsq HMMR-AS1 0.202 0.121 0.651
xsq KLHL3 5q31 0.202 0.121 0.651
exp HAX1 1q21.3 0.202 0.121 0.651
xsq TSPAN32 11p15.5 0.202 0.121 0.651 cell-cell signaling
xsq CKM 19q13.32 0.202 0.121 0.651
exp MTCP1 Xq28 0.202 0.121 0.651 cell proliferation
exp ALDH1A2 15q21.3 0.202 0.121 0.651 heart morphogenesis;positive
cop C20orf96 20p13 0.202 0.121 0.651
cop ZCCHC3 20p13-p12.2 0.202 0.121 0.651
cop CNDP2 18q22.3 0.202 0.121 0.651 glutathione biosynthetic
exp ASCL1 12q23.2 0.202 0.121 0.651 noradrenergic neuron fate
commitment;spinal cord oligodendrocyte cell fate specification
xsq DYTN 2q33.3 0.202 0.121 0.651
met AGTRAP 1p36.22 0.202 0.121 0.651 response to hypoxia;G-protein
xsq UBE3A 15q11.2 0.202 0.121 0.651 positive regulation of
exp PMS2P8 0.202 0.121 0.651
exp RPL7P32 7q31.1 0.202 0.121 0.651
mut DOPEY2 21q22.2 0.202 0.121 0.651 Golgi to endosome
xsq CBWD1 0.202 0.121 0.651
xsq MGA 15q14 0.202 0.121 0.651 Apoptosis
xsq LOC101927606 0.202 0.121 0.651
cop SLCO2B1 11q13 0.202 0.121 0.651 Solute Carriers
cop TPBGL 0.202 0.121 0.651
xsq UPF2 10p14-p13 0.202 0.121 0.651 mRNA export from nucleus;gene expression
dependent"
xsq GPR84 12q13.13 0.202 0.121 0.651
xsq DTD2 0.202 0.121 0.651
cop GAREM 18q12.1 0.202 0.121 0.651
exp C9orf139 9q34.3 0.202 0.121 0.651
cop GLG1 16q22.3 0.202 0.121 0.651 negative regulation of protein
signaling pathway
cop MIR3126 0.202 0.121 0.651
exp MGC39584 0.202 0.121 0.651
cop TGFA 2p13 0.202 0.121 0.651 anti-apoptosis;positive regulation of mitosis
exp SCN2A 2q24.3 0.202 0.121 0.651 nervous system development;myelination
exp RPL23 17q 0.202 0.121 0.651 nuclear-transcribed mRNA catabolic process,
xsq FANCC 9q22.3 0.202 0.121 0.651 DNA Damage Response (DDR); DDR (FA)
met POTED 21q11.2 0.202 0.121 0.651
xsq RBL2 16q12.2 0.202 0.121 0.651 G1 phase of mitotic cell cycle;mitotic
cell cycle
xsq SNAPC4 9q34.3 0.202 0.121 0.651 regulation of transcription, DNA-
cop GPR97 16q21 0.202 0.121 0.651
cop CCDC135 0.202 0.121 0.651
cop KATNB1 16q21 0.202 0.121 0.651 microtubule severing;protein targeting
xsq EEF1D 8q24.3 0.202 0.121 0.651 cellular protein metabolic
process;translation
xsq AMPD3 11p15 0.202 0.121 0.651 purine base metabolic process;IMP biosynthetic
process
xsq LOC728175 4q35.1 0.202 0.121 0.651
met GTF2A1 14q31.1 0.202 0.121 0.652 viral reproduction;regulation of
cop CIT 12q24 0.202 0.121 0.652
xsq RPS21 20q13.3 0.202 0.121 0.652 endonucleolytic cleavage in ITS1 to
xsq LOC100996694 0.202 0.121 0.652
cop FUK 16q22.1 0.202 0.121 0.652 metabolic process
xsq SFTA1P 10p14 -0.202 0.121 0.652
met DDN 12q13.12 -0.202 0.121 0.652
met RALGDS 9q34.3 -0.202 0.121 0.652 Ras protein signal
met NOL8 9q22.31 -0.202 0.121 0.651 DNA replication;rRNA processing
cop RBM12B 8q22.1 -0.202 0.121 0.651
cop RBM12B-AS1 8q22.1 -0.202 0.121 0.651
exp PIK3C2A 11p15.5-p14 -0.202 0.121 0.651 Protein Kinases
exp FDX1L 19p13.2 -0.202 0.121 0.651 transport;electron transport chain
met TRIM59 3q25.33 -0.202 0.121 0.651
xsq KCNIP1 5q35.1 -0.202 0.121 0.651 synaptic
exp ABCC12 16q12.1 -0.202 0.121 0.651 ABC Transporters
exp SLIT2 4p15.2 -0.202 0.121 0.651 cell migration involved in
met SSUH2 3p26.1 -0.202 0.121 0.651
cop DENND1B 1q31.3 -0.202 0.121 0.651
xsq PPP1R9A 7q21.3 -0.202 0.121 0.651 multicellular organismal
xsq NABP1 2q32.3 -0.202 0.121 0.651 DNA Damage Response (DDR)
cop PPP1R17 7p15 -0.203 0.121 0.65 signal transduction;intracellular
xsq MCOLN2 1p22 -0.203 0.121 0.65 ion transport
cop SNX18 5q11.2 -0.203 0.121 0.65 protein transport;positive
cop SLC35G2 3q22.3 -0.203 0.121 0.65
met LRMP 12p12.1 -0.203 0.121 0.65 vesicle targeting;vesicle fusion
exp ARID5B 10q21.2 -0.203 0.121 0.65 fibroblast migration;skeletal
xsq GMPR 6p23 -0.203 0.121 0.65 purine base metabolic process;nucleotide
metabolic process
cop HDAC9 7p21.1 -0.203 0.121 0.65 inflammatory response;negative
xsq KIAA1161 9p13.3 -0.203 0.121 0.65 carbohydrate metabolic
pathway
hs4 HOXB2 17q21.32 -0.204 0.121 0.652 anterior/posterior pattern
hs4 HOXB-AS1 -0.204 0.121 0.652
his FZD6 8q22.3-q23.1 -0.204 0.121 0.652 gonad development;cell
proliferation in midbrain
xai IQSEC2 Xp11.22 -0.204 0.121 0.652 regulation of ARF protein
signal transduction
his B3GALT5 21q22.3 -0.204 0.121 0.652 protein glycosylation
his GXYLT2 3p13 -0.204 0.121 0.652 O-glycan processing
xai USP40 2q37.1 -0.204 0.121 0.652 proteolysis;ubiquitin-dependent
swa GPNMB 7p15 -0.204 0.121 0.652 cell adhesion;negative regulation of cell
proliferation
xai LIMK2 22q12.2 -0.204 0.121 0.652 Protein Kinases
hs4 PRICKLE2 3p14.1 -0.204 0.121 0.651 neuron projection
swa CLTCL1 22q11.21 -0.204 0.121 0.651 vesicle-mediated
transport;positive regulation of glucose import
exp CYP2AB1P 3q27.1 -0.204 0.121 0.651
hs4 MIR6787 -0.204 0.121 0.651
hs4 EHF 11p12 -0.204 0.121 0.651 Transcription Factors
his CEACAM19 19q13.31 -0.204 0.121 0.651
xai BCL2L13 22q11.1 -0.204 0.121 0.651 Apoptosis
xai UCMA 10p13 -0.204 0.121 0.651 negative regulation of osteoblast
differentiation
cop PSG6 -0.204 0.121 0.651 female pregnancy
cop PSG7 -0.204 0.121 0.651 female pregnancy
hs4 SFTA1P 10p14 -0.204 0.121 0.651
xai RAB22A 20q13.32 -0.204 0.121 0.651 GTP catabolic
process;endocytosis
hs4 PCDHA5 5q31 -0.204 0.121 0.651 cell adhesion;homophilic cell
adhesion
xai CD82 11p11.2 -0.204 0.121 0.651
his TUFT1 1q21 -0.204 0.121 0.651 odontogenesis;bone mineralization
his MIR554 -0.204 0.121 0.651
xai PDLIM4 5q31.1 -0.204 0.121 0.651
swa MFGE8 15q25 -0.204 0.121 0.651 phagocytosis, recognition;phagocytosis,
engulfment
xai NEDD4 15q -0.204 0.121 0.651 nervous system development;neuron
xai NMT1 17q21.31 -0.204 0.121 0.651 N-terminal protein
hs4 CTNNA1 5q31.2 -0.204 0.121 0.651 Apoptosis; Tumor Suppressors
hs4 LOC105379194 -0.204 0.121 0.651
his TBC1D28 -0.204 0.121 0.65
swa ANXA7 10q22.2 0.204 0.122 0.652 cellular calcium ion
homeostasis;hemostasis
xai MGC12916 17p12 0.204 0.122 0.652
hs4 TSC22D4 7p21-p15 0.204 0.122 0.652 regulation of transcription, DNA-
dependent;response to osmotic stress
xai ASCC1 10pter-q25.3 0.204 0.122 0.652 regulation of transcription, DNA-
dependent"
exp HMGN1P4 0.204 0.122 0.652
his CLEC5A 7q33 0.204 0.122 0.652 signal transduction;response to virus
exp DMRTB1 1p32.3 0.204 0.122 0.652 regulation of transcription, DNA-
dependent;sex differentiation"
xai FOSB 19q13.32 0.204 0.122 0.652 behavior;cellular response to calcium ion
xai HAL 12q22-q24.1 0.204 0.122 0.652 histidine catabolic process;biosynthetic
process
exp CCDC141 2q31.2 0.204 0.122 0.652
his KBTBD7 13q14.11 0.204 0.122 0.652
his LOC389247 0.204 0.122 0.652
his ING2 4q35.1 0.204 0.122 0.652 positive regulation of transforming
dependent
xai UTS2B 3q28 0.204 0.122 0.652
xai PROB1 5q31.2 0.204 0.122 0.652
hs4 ST6GALNAC4 9q34 0.204 0.122 0.652 glycolipid metabolic process;O-glycan
processing
his USP12 13q12.13 0.204 0.122 0.652 proteolysis;ubiquitin-dependent protein
catabolic process
his USP12-AS2 0.204 0.122 0.652
xai RRP7BP 0.204 0.122 0.652
xai DUSP6 12q22-q23 0.204 0.122 0.652 MyD88-independent toll-like receptor
xai GOPC 6q21 0.204 0.122 0.652 spermatid nucleus differentiation;protein
transport
exp ECEL1P2 2q37.1 0.204 0.122 0.652
xai PRMT9 0.204 0.122 0.652
his RNU4-2 0.204 0.122 0.653
his RNU4-1 12q24.31 0.204 0.122 0.653
his SPATC1 8q24.3 0.204 0.122 0.653
his LINC01229 0.204 0.122 0.653
his MAFTRR 0.204 0.122 0.653
hs4 NDUFV2 18p11.22 0.204 0.122 0.653 mitochondrial electron transport,
swa PTPN11 12q24 0.204 0.122 0.653 Oncogenes
his PYCARD-AS1 0.203 0.122 0.653
his PYCARD 16p11.2 0.203 0.122 0.653 nucleotide-binding domain, leucine
his C19orf73 19q13.33 0.203 0.122 0.653
his PPFIA3 19q13.33 0.203 0.122 0.653 regulation of short-term neuronal
synaptic plasticity;neurotransmitter secretion
xai PEG3 19q13.4 0.203 0.122 0.653 viral reproduction;apoptotic process
xai CHD1 5q15-q21 0.203 0.122 0.653 chromatin remodeling;regulation of
xai NFATC2 20q13.2 0.203 0.122 0.653 response to drug;positive
his SMARCA5 4q31.1-q31.2 0.203 0.122 0.653 DNA Damage Response (DDR);
DDR (Chromatin)
his SMARCA5-AS1 0.203 0.122 0.653
his BBS1 11q13 0.203 0.122 0.653 retina homeostasis;nonmotile primary cilium
assembly
his EIF5 14q32.32 0.203 0.122 0.653 translational initiation;regulation of
his SNORA28 0.203 0.122 0.653
xai FADD 11q13.3 0.203 0.122 0.653 Apoptosis
his C8orf33 8q24.3 0.203 0.122 0.653
his PGAM5 12q24.33 0.203 0.122 0.653
dependent"
dependent"
his PRDM15 21q22.3 0.203 0.122 0.653 regulation of transcription, DNA-
dependent"
xai MYSM1 1p32.1 0.203 0.122 0.653 proteolysis;chromatin modification
his INE2 0.203 0.122 0.653
his ZRSR2 Xp22.1 0.203 0.122 0.653 RNA splicing;spliceosome assembly
xai NSUN5P1 0.203 0.122 0.653
xai TXN2 22q13.1 0.203 0.122 0.653 response to nutrient;response to axon
injury
his DPP7 9q34.3 0.203 0.122 0.653 proteolysis
his DTD2 0.203 0.122 0.653
his GHDC 17q21.2 0.203 0.122 0.653
his FAM104A 17q25.1 0.203 0.122 0.653
his C17orf80 17q25.1 0.203 0.122 0.653
xai NMB 15q22-qter 0.203 0.122 0.653 neuropeptide signaling pathway;cell-cell
signaling
his GRIPAP1 Xp11.23 0.203 0.122 0.653
xsq ADGRF3 0.202 0.122 0.652 G-protein coupled receptor signaling
cop NEUROG3 10q21.3 0.202 0.122 0.652
cop MUC6 11p15.5 0.202 0.122 0.652 cellular protein metabolic process;O-
glycan processing
xsq OTX2 14q22.3 0.202 0.122 0.652 axon guidance;primitive streak formation
xsq BORA 13q22.1 0.202 0.122 0.652 cell cycle;regulation of mitosis
met CMYA5 5q14.1 0.202 0.122 0.652
xsq ARL6IP6 2q23.3 0.202 0.122 0.652
xsq MORC2-AS1 22q12.2 0.202 0.122 0.652
met ZCRB1 12q12 0.202 0.122 0.652 mRNA processing;RNA splicing
cop ITGB1BP1 2p25.2 0.202 0.122 0.652 intracellular protein kinase
cascade;cell migration
cop CPSF3 2p25.1 0.202 0.122 0.652 nuclear mRNA splicing, via
cop IAH1 2p25.1 0.202 0.122 0.652 lipid catabolic process
cop ADAM17 2p25 0.202 0.122 0.652 Apoptosis
xsq LOC101926933 0.202 0.122 0.652
cop GKN1 2p13.3 0.202 0.122 0.652 digestion;positive regulation of cell
proliferation
cop ERC1 12p13.3 0.202 0.122 0.652 positive regulation of anti-
apoptosis;positive regulation of NF-kappaB transcription factor activity
mut SLC34A1 5q35 0.202 0.122 0.652 sodium-dependent phosphate
transport;response to cadmium ion
xsq NMRAL1 16p13.3 0.202 0.122 0.652
exp KCNRG 13q14.2 0.202 0.122 0.652 potassium ion transport
xsq VAMP1 12p 0.202 0.122 0.652 neurotransmitter secretion;vesicle-mediated
transport
xsq BICD2 9q22.31 0.202 0.122 0.652 EMT (Mesenchymal)
xsq TOP2A 17q21-q22 0.202 0.122 0.652 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
dependent;cell death"
xsq KCNQ1 11p15.5 0.202 0.122 0.652 synaptic transmission;regulation of
xsq TMEM242 6q25.3 0.202 0.122 0.652
xsq SERPINC1 1q25.1 0.202 0.122 0.652 blood coagulation;negative
xsq C16orf59 16p13.3 0.202 0.122 0.652
exp EIF2B1 12q24.31 0.202 0.122 0.652 regulation of translational
cop TSHZ1 18q22.3 0.202 0.122 0.652 multicellular organismal
dependent"
xsq NR6A1 9q33.3 0.202 0.122 0.652 negative regulation of transcription from
xsq MRPL57 0.202 0.122 0.653 translation
met C11orf70 11q22.1 0.202 0.122 0.653
mir hsa-miR-98 0.202 0.122 0.653
xsq GSDMB 17q12 0.202 0.122 0.653
met PDE4C 19p13.11 0.202 0.122 0.653 cAMP catabolic process;signal
transduction
exp SPAG5 17q11.2 0.202 0.122 0.653 regulation of attachment of spindle
met C22orf29 22q11.21 0.202 0.122 0.653
xsq CKS1B 1q21.2 0.202 0.122 0.653 cell proliferation;cell division
exp S100A8 1q21 0.202 0.122 0.653 inflammatory response;response to zinc
ion
exp ATRAID 2p23.3 0.202 0.122 0.653
cop CMKLR1 12q24.1 0.202 0.122 0.653 negative regulation of interleukin-
12 production;regulation of calcium-mediated signaling
cop RFX7 15q21.3 0.202 0.122 0.653 regulation of transcription, DNA-
dependent"
cop EFEMP1 2p16 0.202 0.122 0.653 peptidyl-tyrosine
met PHKA1 Xq12-q13 0.202 0.122 0.653 glucose metabolic process;generation of
precursor metabolites and energy
xsq THOP1 19p13.3 0.202 0.122 0.653 proteolysis
mut ATM 11q22-q23 0.202 0.122 0.653 Apoptosis; DNA Damage Response (DDR); DDR
(NHEJ); DDR (DNA replication); Protein Kinases; Tumor Suppressors
xsq CDC42SE2 5q31.1 0.202 0.122 0.653 phagocytosis;regulation of cell
shape
mut BRDT 1p22.1 0.202 0.122 0.653 regulation of transcription, DNA-
dependent;chromatin remodeling"
dependent"
xsq TAS2R20 0.202 0.122 0.653 response to stimulus;sensory perception
of taste
xsq NR1D2 3p24.2 -0.202 0.122 0.653 regulation of transcription, DNA-
met HAR1B 20q13.33 -0.202 0.122 0.653
cop C9orf92 -0.202 0.122 0.653
met HMGA1 6p21 -0.202 0.122 0.653 protein complex assembly;interspecies
xsq PLXNA2 1q32.2 -0.202 0.122 0.653 multicellular organismal
xsq MIR589 -0.202 0.122 0.653
exp MPDZ 9p23 -0.202 0.122 0.653 interspecies interaction between
organisms
met MEST 7q32 -0.202 0.122 0.653 mesoderm development;regulation of lipid
storage
cop RGS4 1q23.3 -0.202 0.122 0.653 regulation of G-protein coupled
exp LACC1 13q14.11 -0.202 0.122 0.653
exp PEX11A 15q26.1 -0.202 0.122 0.653 peroxisome
exp A4GALT 22q13.2 -0.202 0.122 0.653 lipid biosynthetic
met UQCC1 -0.202 0.122 0.653
exp SC5D 11q23.3 -0.202 0.122 0.652
exp SYDE1 19p13.12 -0.202 0.122 0.652 EMT (Mesenchymal)
exp CLIP1 12q24.3 -0.202 0.122 0.652 transport;mitosis
mut RIC8A 11p15.5 -0.202 0.122 0.652
exp CTAGE6 -0.202 0.122 0.652
xsq ADAM21P1 14q24.2 -0.202 0.122 0.652
exp MYH14 19q13.33 -0.202 0.122 0.652 ATP catabolic process;axon guidance
xsq CDR2L 17q25.1 -0.202 0.122 0.652
exp SERTAD1 19q13.1-q13.2 -0.202 0.122 0.652 regulation of cyclin-
dependent protein kinase activity;positive regulation of cell proliferation
xsq EPN2 17p11.2 -0.202 0.122 0.652 regulation of endocytosis
xsq CERCAM 9q34.11 -0.202 0.122 0.652 cellular component
xsq PDLIM4 5q31.1 -0.202 0.122 0.652
xsq TMEM169 2q35 -0.202 0.122 0.652
xsq LYPD6 2q23.2 -0.202 0.122 0.652
cop HSPB3 5q11.2 -0.202 0.122 0.652 Apoptosis
cop BDH1 3q29 -0.202 0.122 0.652 liver development;response to drug
exp CST13P 20p11.21 -0.202 0.122 0.652
hs4 VAX2 2p13 -0.203 0.122 0.653 multicellular organismal
development;ectoderm development
xai MYO5BP3 -0.203 0.122 0.653
his PLA2R1 2q23-q24 -0.203 0.122 0.653 positive regulation of
exp NAT2 8p22 -0.203 0.122 0.653 xenobiotic metabolic process;small
xai VEZF1 17q22 -0.203 0.122 0.653 transcription from RNA polymerase II
promoter;cellular defense response
xai CETN2 Xq28 -0.203 0.122 0.653 DNA Damage Response (DDR); DDR (NER)
hs4 LINC01197 -0.203 0.122 0.653
xai RAPGEF3 12q13.1 -0.203 0.122 0.653 small molecule metabolic
hs4 RAMP3 7p13-p12 -0.203 0.122 0.653
his FANK1-AS1 -0.203 0.122 0.653
hs4 NGF 1p13.1 -0.203 0.122 0.653 transmembrane receptor protein
tyrosine kinase signaling pathway;induction of apoptosis by extracellular signals
xai LINC01446 -0.204 0.122 0.652
his EVPLL 17p11.2 -0.204 0.122 0.652
hs4 ARMCX1 Xq21.33-q22.2 -0.204 0.122 0.652
hs4 KLF12 13q22 -0.204 0.122 0.652 negative regulation of transcription from
RNA polymerase II promoter;regulation of transcription from RNA polymerase II
promoter
his DKK3 11p15.2 -0.204 0.122 0.652 negative regulation of canonical
his IL1RN 2q14.2 -0.204 0.122 0.652 negative regulation of cytokine-
xai ATP6AP2 Xp11.4 -0.204 0.122 0.652 regulation of MAPK
cascade;angiotensin maturation
his SLC1A1 9p24 -0.204 0.122 0.652 Solute Carriers
his CEP295NL -0.204 0.122 0.652
hs4 SLC25A51P1 6q12 -0.204 0.122 0.652
DNA-dependent"
swa THY1 11q23.3 -0.204 0.122 0.652 cytoskeleton organization;T cell
his LOC101928708 -0.204 0.122 0.652
hs4 PIP 7q34 -0.204 0.122 0.652
his CDV3 3q22.1 -0.204 0.122 0.652 cell proliferation
hs4 STX19 3q11 -0.204 0.122 0.652 intracellular protein transport;vesicle-
mediated transport
his CLCA2 1p22.3 -0.204 0.122 0.652 transport;chloride transport
his SULF1 8q13.2 -0.204 0.122 0.652 esophagus smooth muscle
hs4 LOC339166 -0.204 0.122 0.652
xai NPR1 1q21-q22 -0.204 0.122 0.652 body fluid secretion;regulation of
vasodilation
met KRTAP7-1 21q22.1 0.21 0.123 0.654
his SCLT1 4q28.2 0.203 0.123 0.653
his C4orf33 4q28.2 0.203 0.123 0.653
xai ESRRAP2 13q12.11 0.203 0.123 0.653
his CACNA2D1 7q21-q22 0.203 0.123 0.653 regulation of calcium ion transport
via voltage-gated calcium channel activity;ion transport
his ZAP70 2q12 0.203 0.123 0.653 T cell activation;B cell activation
xai RNF220 1p34.1 0.203 0.123 0.653 protein ubiquitination;protein
autoubiquitination
his LENEP 1q22 0.203 0.123 0.653
xai PSMD5-AS1 9q33.2 0.203 0.123 0.653
xai GABRA1 5q34 0.203 0.123 0.653 transport;chloride transport
xai SRSF8 11q22 0.203 0.123 0.653 mRNA processing;RNA splicing
hs4 TCP11 6p21.31 0.203 0.123 0.653 multicellular organismal
hs4 VAV3 1p13.3 0.203 0.123 0.653 response to DNA damage stimulus;positive
regulation of B cell proliferation
hs4 VAV3-AS1 0.203 0.123 0.653
xai ERVH48-1 0.203 0.123 0.653
his LINC00350 0.203 0.123 0.653
xai ZNF8 19q13.43 0.203 0.123 0.653 negative regulation of transcription from
swa EIF2S3 Xp22.2-p22.1 0.203 0.123 0.653 GTP catabolic
process;translation
his RNU5E-1 1p36.22 0.203 0.123 0.653
exp LOC283194 0.203 0.123 0.653
his PCOLCE2 3q21-q24 0.203 0.123 0.653 positive regulation of peptidase
activity
exp LOC387810 0.203 0.123 0.653
xai ANKRD16 10p15.1 0.203 0.123 0.653
exp RPS4XP14 12p13.33 0.203 0.123 0.653
swa TCEB1 8q21.11 0.203 0.123 0.653 DNA Damage Response (DDR); DDR (NER)
xai PGDP1 18q12.1 0.203 0.123 0.653
xai PAICSP3 6q13 0.203 0.123 0.653
his YBX1 1p34 0.203 0.123 0.653 DNA Damage Response (DDR)
xai XPO4 13q11 0.203 0.123 0.653 protein transport;positive regulation of
dependent"
hs4 LINC01679 0.203 0.123 0.653
his FALEC 0.203 0.123 0.654
his RPF1 1p22.3 0.203 0.123 0.654 rRNA processing
xai TAF3 10p15.1 0.203 0.123 0.654 negative regulation of transcription from
xai RRP12 10q24.1 0.203 0.123 0.654
xai SIGLEC9 19q13.41 0.203 0.123 0.654 cell adhesion;cell surface receptor
signaling pathway
exp ZNF192P1 6p22.1 0.203 0.123 0.654
his LINC00367 0.203 0.123 0.654
xai DDX43 6q13 0.203 0.123 0.654
his NDUFB2 7q34 0.203 0.123 0.654 respiratory electron transport
his NDUFB2-AS1 7q34 0.203 0.123 0.654
exp LOC100996428 0.203 0.123 0.654
xai DEAF1 11p15.5 0.203 0.123 0.654 multicellular organismal development;germ
cell development
his SMAD1 4q31 0.203 0.123 0.654 ureteric bud development;transforming growth
xai RAD17P1 7p21 0.203 0.123 0.654
xai DICER1 14q32.13 0.203 0.123 0.654 Oncogenes
his HYAL2 3p21.3 0.203 0.123 0.654 response to virus;negative regulation of
MAP kinase activity
xai LSP1P3 5p13.3 0.203 0.123 0.654
his PALB2 16p12.2 0.203 0.123 0.654 DNA Damage Response (DDR); DDR (FA)
his DCTN5 16p12.2 0.203 0.123 0.654
his MIR1827 0.203 0.123 0.654
his TRIM50 7q11.23 0.203 0.123 0.654
xai PIK3R6 17p13.1 0.203 0.123 0.655 blood coagulation;platelet
activation
hs4 RCCD1 15q26.1 0.203 0.123 0.655
cop P2RX7 12q24 0.202 0.123 0.653 positive regulation of calcium ion transport
into cytosol;negative regulation of MAPK cascade
exp CAMSAP1 9q34.3 0.202 0.123 0.653 cytoskeleton
cop RNF144A 2p25.2 0.202 0.123 0.653
exp PIDD1 0.202 0.123 0.653 response to DNA damage stimulus;DNA damage
cop ZFP90 16q22.1 0.202 0.123 0.653 negative regulation of DNA
xsq PPP2R5A 1q32.2-q32.3 0.202 0.123 0.653 signal transduction;positive
regulation of protein dephosphorylation
cop ZADH2 18q22.3 0.202 0.123 0.653
xsq DRG1 22q12.2 0.202 0.123 0.653 transcription, DNA-
exp SART1 11q13.1 0.202 0.123 0.653 Apoptosis
exp IZUMO4 19p13.3 0.202 0.123 0.653
xsq HSD11B2 16q22 0.201 0.123 0.653 response to insulin stimulus;response to
drug
exp ATP8B2 1q21.3 0.201 0.123 0.653 cation transport;phospholipid
transport
xsq LOC101927583 0.201 0.123 0.653
xsq LOC101928519 0.201 0.123 0.653
dependent"
cop FA2H 16q23 0.201 0.123 0.653 fatty acid biosynthetic process;sphingolipid
metabolic process
xsq TYMSOS 0.201 0.123 0.653
xsq CCNF 16p13.3 0.201 0.123 0.653 placenta development;cell cycle
xsq SRSF4 1p35.3 0.201 0.123 0.653 RNA splicing, via transesterification
met FAM222A 12q24.11 0.201 0.123 0.653
met DAPK2 15q22.31 0.201 0.123 0.653 Apoptosis
dependent"
cop LOC100132781 0.201 0.123 0.653
cop LOC441454 9q22.33 0.201 0.123 0.653
cop HIATL2 0.201 0.123 0.653
cop CTSV 9q22.2 0.201 0.123 0.653
cop LOC340508 0.201 0.123 0.653
xsq MRPL18 6q25.3 0.201 0.123 0.653 translation;transport
exp ZKSCAN7 3p21.32 0.201 0.123 0.653
met LOC400940 2p25.2 0.201 0.123 0.653
xsq H2AFZ 4q24 0.201 0.123 0.653 DNA Damage Response (DDR)
exp RAB28 4p15.33 0.201 0.123 0.653 GTP catabolic process;small GTPase
met PLCH1 3q25.31 0.201 0.123 0.653 intracellular signal
xsq CDC7 1p22 0.201 0.123 0.653 DDR (DNA replication)
exp TBC1D32 6q22.31 0.201 0.123 0.653
exp THUMPD3 3p25.3 0.201 0.123 0.653
met SLC16A2 Xq13.2 0.201 0.123 0.653 Solute Carriers
cop MIR217 0.201 0.123 0.653
cop MIR216A 0.201 0.123 0.653
cop MIR216B 0.201 0.123 0.653
met FAM153A 5q35.3 0.201 0.123 0.653
met C9orf152 9q31.3 0.201 0.123 0.653
met SPG11 15q14 0.201 0.123 0.653 cell death
met PPM1G 2p23.3 0.201 0.123 0.654 protein dephosphorylation;cell cycle
arrest
xsq HADH 4q22-q26 0.201 0.123 0.654 fatty acid beta-oxidation;response to
hormone stimulus
exp HBS1L 6q23.3 0.201 0.123 0.654 signal transduction;translation
met ELAVL4 1p34 0.201 0.123 0.654 RNA processing;mRNA processing
xsq DSG1 18q12.1 0.201 0.123 0.654 calcium-dependent cell-cell
exp SDHAF1 19q13.12 0.201 0.123 0.654 iron-sulfur cluster
exp EBAG9 8q23 0.201 0.123 0.654 Apoptosis
mir hsa-miR-423-5p 0.201 0.123 0.654
exp PSMB2 1p34.2 0.201 0.123 0.654 antigen processing and presentation of
xsq TACC3 4p16.3 0.201 0.123 0.654 microtubule cytoskeleton
mut HIP1 7q11.23 0.201 0.123 0.654 Apoptosis
exp CDC45 22q11.21 0.201 0.123 0.654 DDR (DNA replication)
exp SS18L2 3p21 0.201 0.123 0.654
xsq RPF2 6q21 0.201 0.123 0.654
xsq PDE7A 8q13 0.201 0.123 0.654 signal transduction;cAMP-mediated signaling
met LHX4 1q25.2 0.201 0.123 0.654 anti-apoptosis;motor axon guidance
exp PLEK 2p13.3 0.201 0.123 0.654 integrin-mediated signaling
exp ARPP19 15q21.2 0.201 0.123 0.654 G2/M transition of mitotic cell
cycle;cell cycle
xsq LCMT1 16p12.1 0.201 0.123 0.654 C-terminal protein methylation;protein
cop CNDP1 18q22.3 0.201 0.123 0.654 proteolysis;metabolic process
xsq LINC01602 0.201 0.123 0.654
xsq VPS9D1-AS1 16q24.3 0.201 0.123 0.654
cop WSCD2 12q23.3 0.201 0.123 0.654
cop FAM69C 18q22.3 0.201 0.123 0.655
exp HEXIM1 17q21.31 -0.201 0.123 0.654 negative regulation of
exp PRAF2 Xp11.23 -0.201 0.123 0.654 L-glutamate transport;protein
transport
xsq SMIM5 17q25.1 -0.201 0.123 0.654
met PIK3CG 7q22.3 -0.201 0.123 0.654 Apoptosis; Cell Signaling;
exp CDR2L 17q25.1 -0.201 0.123 0.654
exp TRAM1 8q13.3 -0.201 0.123 0.654 translation;cotranslational protein
xsq LINC00673 -0.201 0.123 0.654
exp ARNT2 15q24 -0.201 0.123 0.654 positive regulation of transcription,
exp TM2D2 8p11.22 -0.201 0.123 0.654
met IDO2 8p11.21 -0.201 0.123 0.654 tryptophan catabolic
xsq EGR1 5q31.1 -0.201 0.123 0.654 Apoptosis
xsq ESRRG 1q41 -0.201 0.123 0.654 gene expression;positive regulation of
met MAP4K1 19q13.1-q13.4 -0.201 0.123 0.653 response to
cop RAB2A 8q12.1 -0.201 0.123 0.653 GTP catabolic process;ER to Golgi
mut SELPLG 12q24 -0.201 0.123 0.653 leukocyte migration;leukocyte
xsq DACT3-AS1 -0.201 0.123 0.653
exp PHYH 10p13 -0.201 0.123 0.653 fatty acid alpha-oxidation;cellular lipid
metabolic process
xsq FJX1 11p13 -0.201 0.123 0.653
cop NCK1 3q21 -0.201 0.123 0.653 actin filament organization;positive
xsq MYO16-AS1 -0.201 0.123 0.653
xsq GAS1 9q21.3-q22 -0.201 0.123 0.653 cell cycle;cellular response to
vascular endothelial growth factor stimulus
exp MGAT5B 17q25.2 -0.201 0.123 0.653
mir hsa-miR-218 -0.201 0.123 0.653
mir hsa-miR-218(2) -0.201 0.123 0.653
exp DNALI1 1p35.1 -0.201 0.123 0.653 cellular component
exp HOXB-AS1 -0.201 0.123 0.653
exp TTC21A 3p22.2 -0.202 0.123 0.653
his MUC4 3q29 -0.203 0.123 0.655 cell adhesion;cell-matrix adhesion
hs4 MEX3D 19p13.3 -0.203 0.123 0.654 posttranscriptional regulation of
gene expression by mRNA localization;regulation of anti-apoptosis
swa FLNB 3p14.3 -0.203 0.123 0.654 multicellular organismal
hs4 MAGI1 3p14.1 -0.203 0.123 0.654 protein complex assembly;cell
adhesion
hs4 MIR6845 -0.203 0.123 0.654
hs4 NRBP2 8q24.3 -0.203 0.123 0.654 negative regulation of neuron
xai TLDC1 16q24.1 -0.203 0.123 0.654
xai LOXL2 8p21.3 -0.203 0.123 0.654 protein modification process;cell
adhesion
swa SLC35F6 2p23.3 -0.203 0.123 0.654
xai VANGL1 1p13.1 -0.203 0.123 0.654 multicellular organismal
development
hs4 SERPINA6 14q32.1 -0.203 0.123 0.654 regulation of
hs4 TSPAN14 10q23.1 -0.203 0.123 0.654
hs4 CD63 12q12-q13 -0.203 0.123 0.654 platelet degranulation;blood
coagulation
hs4 LCTL 15q22.31 -0.203 0.123 0.654 carbohydrate metabolic process
his KIF26B 1q44 -0.203 0.123 0.654 microtubule-based
his FAXC 6q16.2 -0.203 0.123 0.654
his FAM43A 3q29 -0.203 0.123 0.654
xai PLEKHG5 1p36.31 -0.203 0.123 0.654 small GTPase mediated signal
exp CROCCP4 -0.203 0.123 0.654
xai RBPMS-AS1 8p12 -0.203 0.123 0.654
xai DYRK2 12q15 -0.203 0.123 0.654 DNA damage response, signal transduction
by p53 class mediator resulting in induction of apoptosis;positive regulation of
glycogen biosynthetic process
exp PIN4P1 15q15.3 -0.203 0.123 0.654
xai TNS2 -0.203 0.123 0.654 negative regulation of cell
xai ZNF705G -0.203 0.123 0.654 regulation of transcription, DNA-
dependent"
xai PARD6G 18q23 -0.203 0.123 0.653 cell junction assembly;cell-cell
his UNC5B-AS1 -0.203 0.123 0.653
xai C19orf71 19p13.3 -0.203 0.123 0.653
xai CROCCP4 -0.203 0.123 0.653
xai PIN4P1 15q15.3 -0.203 0.123 0.653
swa ANXA3 4q21.21 -0.203 0.123 0.653 positive regulation of
his SEMA3B-AS1 -0.203 0.123 0.653
his SEMA3B 3p21.3 -0.203 0.123 0.653 axon guidance;cell-cell
signaling
his MIR6872 -0.203 0.123 0.653
xai POFUT1 20q11 -0.203 0.123 0.653 somitogenesis;embryo development
xai GAP43 3q13.31 -0.203 0.123 0.653 activation of protein kinase C
hs4 PPP1R14C 6q24.3-q25.3 -0.203 0.123 0.653 regulation of
phosphorylation
his GALNT11 7q36.1 -0.203 0.123 0.653 O-glycan processing;post-
exp ZNF705G -0.203 0.123 0.653 regulation of transcription, DNA-
dependent"
hs4 LINGO2 9p21.2 -0.203 0.123 0.653
his LINC01969 -0.203 0.123 0.653
his DCBLD2 3q12.1 -0.203 0.123 0.653 intracellular receptor
xai CLIP1 12q24.3 -0.203 0.123 0.653 transport;mitosis
xai ZFYVE9 1p32.3 -0.203 0.123 0.653 endocytosis;transforming
hs4 LINC01798 -0.203 0.123 0.653
xai MOCOS 18q12 -0.203 0.123 0.653 molybdopterin cofactor metabolic
xai KIR3DS1 0.204 0.124 0.655 immune response;natural killer cell
activation
hs4 TESC-AS1 0.203 0.124 0.655
hs4 TESC 12q24.22 0.203 0.124 0.655 positive regulation of gene
hs4 LOC102503427 0.203 0.124 0.655
xai WNT10B 12q13 0.203 0.124 0.655 Apoptosis; Oncogenes
xai PTPRN2 7q36 0.203 0.124 0.655 protein dephosphorylation;negative
his STIL 1p32 0.203 0.124 0.655 neural tube closure;notochord development
hs4 MATN1-AS1 1p35.2 0.203 0.124 0.655
his LOC101928718 0.203 0.124 0.655
his DDX20 1p21.1-p13.2 0.203 0.124 0.655 negative regulation of
his FAM212B 1p13.2 0.203 0.124 0.655
his FRG1HP 0.203 0.124 0.655
his BMS1P21 0.203 0.124 0.655
his LRRC8B 1p22.2 0.203 0.124 0.655
xai IMPA1P 8q21.13 0.203 0.124 0.655
xai VPS33B 15q26.1 0.203 0.124 0.655 protein transport;vesicle-mediated
transport
xai SPANXN5 0.203 0.124 0.655
his FAHD2A 2q11.2 0.203 0.124 0.655
xai CERS3 15q26.3 0.203 0.124 0.655 sphingolipid metabolic process;lipid
exp SPANXN5 0.203 0.124 0.655
his PLCB1-IT1 0.203 0.124 0.655
xai MLST8 16p13.3 0.203 0.124 0.655 fibroblast growth factor receptor
his ENTPD8 9q34.3 0.203 0.124 0.655 nucleoside monophosphate
his SMOC1 14q24.2 0.203 0.124 0.655 eye development;signal transduction
exp POTEE 0.203 0.124 0.655
hs4 MS4A3 11q12.1 0.203 0.124 0.655
xai DSG3 18q12.1 0.203 0.124 0.655 cellular component disassembly involved
in apoptosis;cell adhesion
swa EIF3J 15q21.1 0.203 0.124 0.655 translation;translational initiation
xai SCAF11 12q12 0.203 0.124 0.655 spliceosome assembly;RNA splicing, via
transesterification reactions
swa RBM10 Xp11.23 0.203 0.124 0.655 mRNA processing;RNA splicing
exp IMPA1P 8q21.13 0.203 0.124 0.655
his HNRNPF 10q11.21 0.203 0.124 0.655 nuclear mRNA splicing, via
exp EIF4A1P7 13q12.3 0.203 0.124 0.655
his UBE2Q1-AS1 0.202 0.124 0.655
his UBE2Q1 1q21.3 0.202 0.124 0.655
xai RPS10P21 13q21.33 0.202 0.124 0.655
xai BTBD2 19p13.3 0.202 0.124 0.655
xai EPC2 2q23.1 0.202 0.124 0.655 chromatin modification;DNA repair
exp DDX3YP1 Xq13.2 0.202 0.124 0.655
hs4 RBFA 18q23 0.202 0.124 0.655 rRNA processing
dependent"
swa MCM2 3q21 0.202 0.124 0.655 DDR (DNA replication)
xai MTFR2 6q23.3 0.202 0.124 0.655
his PSPC1 13q12.11 0.202 0.124 0.655 regulation of transcription, DNA-
dependent"
exp RPS10P21 13q21.33 0.202 0.124 0.656
his E2F6 2p25.1 0.202 0.124 0.656 regulation of transcription involved in
his CENPN 16q23.2 0.202 0.124 0.656 M phase of mitotic cell cycle;mitotic
prometaphase
his CMC2 16q23.2 0.202 0.124 0.656
xai PTRH2 17q23.1 0.202 0.124 0.656 apoptotic process
xai FOXO1B 5q35.3 0.202 0.124 0.656
xai HNRNPA1P20 3q24 0.202 0.124 0.656
his ADSL 22q13.2 0.202 0.124 0.656 response to nutrient;aerobic respiration
hs4 SRPK1 6p21.31 0.202 0.124 0.656 protein phosphorylation;negative
his PARG 10q11.23 0.202 0.124 0.656 DNA Damage Response (DDR); DDR (BER)
his TIMM23B 0.202 0.124 0.656
hs4 SHCBP1 16q11.2 0.202 0.124 0.656
xai LILRP2 19q13.4 0.202 0.124 0.656
exp SATB1 3p23 0.201 0.124 0.655 interspecies interaction between
xsq CDH26 20q13.33 0.201 0.124 0.655 cell adhesion;homophilic cell adhesion
cop SMIM21 18q23 0.201 0.124 0.655
cop OR5W2 0.201 0.124 0.655
xsq LOC101927410 0.201 0.124 0.655
cop TLN2 15q15-q21 0.201 0.124 0.655 cell-cell junction assembly;cell adhesion
xsq SEC23B 20p11.23 0.201 0.124 0.655 intracellular protein transport;ER
exp WDR82 3p21.2 0.201 0.124 0.655 histone H3-K4 methylation
cop CDH3 16q22.1 0.201 0.124 0.655 response to stimulus;cell adhesion
xsq TNFSF14 19p13.3 0.201 0.124 0.655 T cell proliferation;T cell
activation
xsq LOC100506472 0.201 0.124 0.655
exp SGK494 17q11.2 0.201 0.124 0.655
dependent"
xsq IRAK4 12q12 0.201 0.124 0.655 Protein Kinases
cop DNAJC27 2p23.3 0.201 0.124 0.655 small GTPase mediated signal
transduction;protein folding
xsq MALRD1 0.201 0.124 0.655
exp SSBP2 5q14.1 0.201 0.124 0.655 regulation of transcription, DNA-
dependent"
xsq EIF2B4 2p23.3 0.201 0.124 0.655 gene expression;cellular response
to stimulus
exp RPL17P27 7q34 0.201 0.124 0.655
mut CRYGA 2q34 0.201 0.124 0.655 visual perception;eye development
cop MIR1538 0.201 0.124 0.655
cop NFAT5 16q22.1 0.201 0.124 0.655 regulation of transcription, DNA-
exp MBD1 18q21 0.201 0.124 0.655 regulation of transcription, DNA-
cop EIF4EBP2 10q21-q22 0.201 0.124 0.655 negative regulation of
cop NODAL 10q22.1 0.201 0.124 0.655 heart looping;polarity specification of
proximal/distal axis
xsq EPC1 10p11 0.201 0.124 0.655 histone H2A acetylation;negative regulation of
exp NKAPP1 Xq24 0.201 0.124 0.655
mut MYH15 3q13.13 0.201 0.124 0.655
met PCSK5 9q21.3 0.201 0.124 0.655 cell-cell signaling;nerve growth factor
processing
met KCTD4 13q14.12 0.201 0.124 0.655 potassium ion transport
exp TPTE2P6 13q12.12 0.201 0.124 0.655
xsq EIF5 14q32.32 0.201 0.124 0.655 translational initiation;regulation of
xsq NONO Xq13.1 0.201 0.124 0.655 DNA repair;DNA recombination
cop BMP10 2p13.3 0.201 0.124 0.655 positive regulation of cardiac muscle
hypertrophy;sarcomere organization
exp ACAA2 18q21.1 0.201 0.124 0.655 acetyl-CoA metabolic process;lipid
metabolic process
xsq POC5 5q13.3 0.201 0.124 0.655 cell cycle
exp SELL 1q23-q25 0.201 0.124 0.655 cell adhesion;blood coagulation
met HDAC2 6q21 0.201 0.124 0.655 negative regulation of neuron projection
xsq ITFG2 12p13.33 0.201 0.124 0.655
exp DAPP1 4q25-q27 0.201 0.124 0.655 protein dephosphorylation;signal
transduction
xsq CCR3 3p21.3 0.201 0.124 0.656 cellular defense response;cell adhesion
xsq CUL3 2q36.2 0.201 0.124 0.656 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
exp PHBP9 10q24.31 0.201 0.124 0.656
exp LINC00843 0.201 0.124 0.656
cop TANGO6 16q22.1 0.201 0.124 0.656
exp SP3 2q31 0.201 0.124 0.656 liver development;granulocyte differentiation
mir hsa-miR-296-5p 0.201 0.124 0.656
met SLC22A25 11q12.3 0.201 0.124 0.656 transmembrane transport
xsq ARIH2OS 3p21.31 0.201 0.124 0.656
xsq HNRNPH1 5q35.3 0.201 0.124 0.656 gene expression;regulation of RNA
splicing
exp RCE1 11q13 0.201 0.124 0.656 proteolysis
exp SULT1A4 16p11.2 0.201 0.124 0.656 catecholamine metabolic
process;sulfation
met ZKSCAN4 6p21 0.201 0.124 0.656 viral reproduction
xsq PIPSL 10q23.33 0.201 0.124 0.656
cop DTNB 2p24 0.201 0.124 0.656
met KCNE4 2q36.1 0.201 0.124 0.656 ion transport;potassium ion transport
xsq TIMM23B 0.201 0.124 0.656
exp GDI2 10p15 0.201 0.124 0.656 signal transduction;small GTPase mediated
signal transduction
exp SLC35B1 17q21.33 0.201 0.124 0.656 Solute Carriers
exp CEP57 11q21 0.201 0.124 0.656 protein import into nucleus, translocation;G2/M
xsq OR4A47 0.201 0.124 0.656
exp CLDN23 8p23.1 -0.201 0.124 0.656 tight junction
cop MIR581 -0.201 0.124 0.656
exp CYGB 17q25 -0.201 0.124 0.656 transport;response to oxidative stress
DNA-dependent"
xsq AHNAK2 14q32.33 -0.201 0.124 0.656
cop HPVC1 7p11.2 -0.201 0.124 0.656
exp FZD1 7q21 -0.201 0.124 0.656 Oncogenes
xsq SEPP1 5q31 -0.201 0.124 0.656 response to oxidative stress
cop YTHDF3 8q12.3 -0.201 0.124 0.655
exp BCL2L13 22q11.1 -0.201 0.124 0.655 Apoptosis
mut CTSE 1q31 -0.201 0.124 0.655 proteolysis;digestion
exp MMP19 12q14 -0.201 0.124 0.655 Apoptosis
xsq SAMD9 7q21.2 -0.201 0.124 0.655
xsq PRKCA 17q22-q23.2 -0.201 0.124 0.655 Apoptosis; Protein Kinases
cop SLCO2A1 3q21 -0.201 0.124 0.655 Solute Carriers
met CHRNB3 8p11.2 -0.201 0.124 0.655 ion transport;signal
transduction
xsq ALPK2 18q21.31 -0.201 0.124 0.655 protein phosphorylation
exp ZMIZ1-AS1 10q22.3 -0.201 0.124 0.655
xsq PLAU 10q22.2 -0.201 0.124 0.655 response to hypoxia;regulation of
cell adhesion mediated by integrin
xsq PRKAG2 7q36.1 -0.201 0.124 0.655 negative regulation of
exp AVIL 12q14.1 -0.201 0.124 0.655 nervous system development;positive
exp TEKT4P2 21p11.2 -0.201 0.124 0.655
xsq LOC339874 -0.201 0.124 0.655
cop HMCN1 1q25.3-q31.1 -0.201 0.124 0.655 visual perception;response to
stimulus
exp ABCB9 12q24 -0.201 0.124 0.655 ABC Transporters
exp HSPB2 11q22-q23 -0.201 0.124 0.655 Apoptosis
his MIR4654 -0.202 0.124 0.656
his HK2 2p13 -0.202 0.124 0.656 Apoptosis
xai DCLK2 4q31.3 -0.202 0.124 0.656 intracellular signal transduction
swa ADD1 4p16.3 -0.202 0.124 0.656 cellular component disassembly
involved in apoptosis;activation of signaling protein activity involved in unfolded
protein response
xai DTX3L 3q21.1 -0.202 0.124 0.656 response to DNA damage
his MIR6891 -0.202 0.124 0.656
his HLA-B 6p21.3 -0.202 0.124 0.656 antigen processing and presentation
hs4 STARD3NL 7p14-p13 -0.202 0.124 0.656
xai TRAK2 2q33 -0.202 0.124 0.656 regulation of transcription from RNA
xai LRGUK 7q33 -0.202 0.124 0.656
hs4 ARNT2 15q24 -0.202 0.124 0.656 positive regulation of transcription,
xai NAT2 8p22 -0.202 0.124 0.656 xenobiotic metabolic process;small
DNA-dependent"
xai SEPT14 7p11.2 -0.202 0.124 0.655 cell cycle;cell division
his SOWAHA 5q31.1 -0.202 0.124 0.655
his ZNF611 19q13.41 -0.202 0.124 0.655 regulation of transcription,
DNA-dependent"
swa FERMT2 14q22.1 -0.202 0.124 0.655 cell adhesion;regulation of
cell shape
swa SCAF11 12q12 -0.202 0.124 0.655 spliceosome assembly;RNA splicing,
hs4 DLC1 8p22 -0.202 0.124 0.655 induction of apoptosis;actin cytoskeleton
organization
hs4 ASTN2 9q33.1 -0.202 0.124 0.655
hs4 TRIM32 9q33.1 -0.202 0.124 0.655 response to tumor necrosis
factor;positive regulation of proteolysis
his MIR7978 -0.202 0.124 0.655
hs4 DAW1 2q36.3 -0.202 0.124 0.655
his C4orf19 4p14 -0.202 0.124 0.655
xai SC5D 11q23.3 -0.203 0.124 0.655
hs4 HDX Xq21.1 -0.203 0.124 0.655
swa HLA-A_P04439 -0.203 0.124 0.655
xai PECR 2q35 -0.203 0.124 0.655 regulation of apoptotic
his ART4 12p13-p12 -0.203 0.124 0.655 protein ADP-ribosylation;arginine
metabolic process
xai CUX2 12q24.12 -0.203 0.124 0.655 regulation of transcription, DNA-
exp LOC100506895 -0.203 0.124 0.655
hs4 MIR378D2 -0.203 0.124 0.655
hs4 PDP1 8q22.1 -0.203 0.124 0.655 pyruvate metabolic
swa CRYAB 11q22.3-q23.1 -0.203 0.124 0.655 protein folding;anti-
apoptosis
xai SSPN 12p11.2 -0.203 0.124 0.655 muscle contraction;cell adhesion
hs4 SOGA1 20q11.23 -0.203 0.124 0.655
swa EIF4EBP1 8p12 -0.203 0.124 0.655 negative regulation of protein
complex assembly;TOR signaling cascade
exp FAM90A1 12p13.31 -0.203 0.124 0.655
his ARMCX4 Xq22.1 -0.203 0.124 0.655
xai MAPK8IP1 11p11.2 -0.203 0.124 0.655 Cell Signaling
exp UCMA 10p13 -0.203 0.124 0.655 negative regulation of osteoblast
differentiation
xai TPMTP1 18q21.1 -0.203 0.124 0.655
xai CAPN5 11q14 -0.203 0.124 0.655 granulosa cell differentiation;ovarian
xai MAPRE3 2p23.3-p23.1 -0.203 0.124 0.655 cell division;cell cycle
swa YWHAZ 8q23.1 -0.203 0.124 0.655 Apoptosis
his PRRG1 Xp21.1 -0.203 0.124 0.655
xai MAP9 4q32.1 -0.203 0.124 0.655 cell division;cell cycle
hs4 FAM196B 5q35.1 -0.203 0.124 0.655
swa EXOC4 7q31 0.202 0.125 0.656 positive regulation of calcium-mediated
signaling;regulation of protein transport
dependent"
hs4 LOC105374366 0.202 0.125 0.656
hs4 LOC93622 4p16.1 0.202 0.125 0.656
exp SPATA3-AS1 0.202 0.125 0.656
his SPSB4 3q23 0.202 0.125 0.656 intracellular signal transduction
his SPICE1 3q13.2 0.202 0.125 0.656 cell cycle;regulation of centriole
replication
xai IGLV1-50 0.202 0.125 0.656
xai GPBP1L1 1p34.1 0.202 0.125 0.656 regulation of transcription, DNA-
dependent"
xai DYNC1LI1 3p22.3 0.202 0.125 0.656 cell cycle;mitosis
hs4 DNAH17-AS1 0.202 0.125 0.656
xai INTS9 8p21.1 0.202 0.125 0.656 snRNA processing
exp LOC400590 17q11.2 0.202 0.125 0.656
exp IGLV1-50 0.202 0.125 0.656
xai LOC400590 17q11.2 0.202 0.125 0.656
his SPIN4 Xq11.1 0.202 0.125 0.656 gamete generation
xai HSPD1P9 13q13.3 0.202 0.125 0.656
xai VIPR2 7q36.3 0.202 0.125 0.656 G-protein coupled receptor signaling
pathway;activation of adenylate cyclase activity
xai PRSS3P2 7q34 0.202 0.125 0.657
xai TBC1D27 17p11.2 0.202 0.125 0.657
his NIN 14q22.1 0.202 0.125 0.657 microtubule anchoring at
centrosome;centrosome localization
his LRRC3-AS1 0.202 0.125 0.657
his LRRC3 21q22.3 0.202 0.125 0.657
exp FOXO1B 5q35.3 0.202 0.125 0.657
his BARD1 2q34-q35 0.202 0.125 0.657 Apoptosis; DNA Damage Response (DDR); DDR
(FA)
his LOC101928103 0.202 0.125 0.657
his TCF3 19p13.3 0.202 0.125 0.657 transcription, DNA-dependent;response to
drug
xai ZDHHC17 12q21.2 0.202 0.125 0.657 signal transduction;magnesium ion
transport
xai SNORD41 0.202 0.125 0.657
exp LOC1720 2p12 0.202 0.125 0.657
xai LOC643308 0.202 0.125 0.657
exp ANO7 2q37.3 0.202 0.125 0.657 ion transport
exp LOC100631249 0.202 0.125 0.657
xai CAMSAP1 9q34.3 0.202 0.125 0.657 cytoskeleton
his ZKSCAN4 6p21 0.202 0.125 0.657 viral reproduction
exp SNORD41 0.202 0.125 0.657
his RHBDD1 2q36.3 0.202 0.125 0.657 proteolysis
xai CCNF 16p13.3 0.202 0.125 0.657 placenta development;cell cycle
xai SLC39A8 4q22-q24 0.202 0.125 0.657 Solute Carriers
hs4 UBE2QL1 5p15.31 0.202 0.125 0.657
his MT1X 16q13 0.202 0.125 0.657 response to metal ion;cellular response to
erythropoietin
his BTN2A3P 6p22.1 0.202 0.125 0.657
his LIN54 4q21.22 0.202 0.125 0.657 regulation of transcription, DNA-
dependent;mitotic cell cycle"
xsq GNAT3 7q21.11 0.2 0.125 0.656 GTP catabolic process;G-protein coupled
exp SRSF4 1p35.3 0.2 0.125 0.656 RNA splicing, via transesterification
xsq RPS17 0.2 0.125 0.656 nuclear-transcribed mRNA catabolic process,
mut LPA 6q26 0.2 0.125 0.656 transport;lipid transport
exp STK4 20q11.2-q13.2 0.2 0.125 0.656 Apoptosis
exp ZNRF1 16q23.1 0.2 0.125 0.656 proteasomal ubiquitin-dependent protein
mut PCDHGC3 0.2 0.125 0.656 cell adhesion;homophilic cell adhesion
mut KIAA0319L 1p34.2 0.2 0.125 0.656
met HOGA1 10q24.2 0.2 0.125 0.656 glyoxylate catabolic process
xsq TRABD 22q13.33 0.2 0.125 0.656
mut RSPRY1 16q13 0.2 0.125 0.656
xsq C22orf24 22q12.1-q12.3 0.2 0.125 0.656
xsq OXA1L 14q11.2 0.2 0.125 0.656 mitochondrial proton-transporting ATP
mut SIRT1 10q21.3 0.2 0.125 0.656 Apoptosis; DNA Damage Response (DDR)
xsq AP3B2 15q 0.2 0.125 0.656 post-Golgi vesicle-mediated
xsq ALDH8A1 6q23.2 0.2 0.125 0.656 retinoic acid metabolic
process;retinal metabolic process
cop RBKS 2p23.3 0.2 0.125 0.656 carbohydrate metabolic process;D-ribose
metabolic process
exp RPL15 3p24.2 0.2 0.125 0.656 translation;mRNA metabolic process
exp TIMM17B Xp11.23 0.2 0.125 0.656 protein targeting to
exp LOC100130748 5p15.33 0.2 0.125 0.656
met PSAPL1 4p16.1 0.2 0.125 0.656 lipid metabolic
xsq GABRA1 5q34 0.2 0.125 0.656 transport;chloride transport
exp RPL32P27 12q13 0.2 0.125 0.656
xsq KDM3A 2p11.2 0.2 0.125 0.656 histone H3-K9 demethylation;positive
xsq SYNCRIP 6q14-q15 0.2 0.125 0.656 RNA splicing;interspecies
exp NMB 15q22-qter 0.2 0.125 0.656 neuropeptide signaling pathway;cell-cell
signaling
met MNDA 1q22 0.2 0.125 0.656 negative regulation of B cell
exp ERVH48-1 0.2 0.125 0.656
exp PPP1R14B 11q13 0.2 0.125 0.656 regulation of phosphorylation
mut FIP1L1 4q12 0.2 0.125 0.656 mRNA processing
met FAM109A 12q24.12 0.2 0.125 0.656 receptor recycling;endosome
organization
xsq EXOSC8 13q13.1 0.2 0.125 0.656 mRNA metabolic
exp CDKN1B 12p13.1-p12 0.2 0.125 0.657 DDR (DNA replication)
met MRS2 6p22.3-p22.1 0.2 0.125 0.657 ion transport
xsq CHST12 7p22 0.2 0.125 0.657 carbohydrate biosynthetic
exp ZMAT1 Xq21 0.2 0.125 0.657
mut METTL14 4q26 0.2 0.125 0.657 RNA methylation;nucleobase-containing
met RIPK2 8q21 0.2 0.125 0.657 Apoptosis
xsq RTEL1 20q13.3 0.2 0.125 0.657 DNA Damage Response (DDR); DDR (DNA
replication)
xsq BTNL10 1q42.13 0.2 0.125 0.657
exp PLA2G7 6p21.2-p12 0.2 0.125 0.657 low-density lipoprotein particle
remodeling;lipid oxidation
met CPXCR1 Xq21.3 0.2 0.125 0.657
mut VIPAS39 14q24.3-q31 0.2 0.125 0.657
dependent;induction of apoptosis
exp DNAJC8P1 14q13.2 0.2 0.125 0.657
exp SF3A1 22q12.2 0.2 0.125 0.657 gene expression;nuclear mRNA 3'-splice
site recognition
cop IL34 16q22.1 0.2 0.125 0.657 positive regulation of protein
phosphorylation;inflammatory response
met HERC2 15q13 0.2 0.125 0.657 protein ubiquitination involved in ubiquitin-
dependent protein catabolic process;DNA repair
exp POP7 7q22 0.2 0.125 0.657 tRNA processing
met MCTS2P 0.2 0.125 0.657
mut FIG4 6q21 0.2 0.125 0.657 pigmentation;phosphatidylinositol metabolic
process
exp SUMO2 17q25.1 0.2 0.125 0.657 DNA Damage Response (DDR)
exp DIDO1 20q13.33 0.2 0.125 0.657 transcription, DNA-dependent;apoptotic
process"
xsq EIF2B1 12q24.31 0.2 0.125 0.657 regulation of translational
xsq MRPS31 13q14.11 0.2 0.125 0.657
exp NDUFAF4P2 7q21.3 0.2 0.125 0.657
met SERTAD2 2p14 0.2 0.125 0.657 negative regulation of cell
cop DGAT2 11q13.5 0.2 0.125 0.657 triglyceride biosynthetic
met PGM3 6q14.1-q15 0.2 0.125 0.657 glucosamine metabolic process;cellular
xsq C20orf195 20q13.33 0.2 0.125 0.657
met AAR2 20pter-q12 0.2 0.125 0.657
xsq ATG4A Xq22.1-q22.3 0.2 0.125 0.657 proteolysis;autophagy
met TMEM261 -0.2 0.125 0.657
exp IGF2BP2 3q27.2 -0.2 0.125 0.657 anatomical structure
xsq CHST1 11p11.2 -0.2 0.125 0.657 polysaccharide metabolic
exp FXYD7 19q13.12 -0.2 0.125 0.657 regulation of ion transport
exp ZFYVE9 1p32.3 -0.2 0.125 0.657 endocytosis;transforming growth
cop PRRX1 1q24 -0.2 0.125 0.657 multicellular organismal development
xsq C4orf19 4p14 -0.2 0.125 0.657
met SLC28A3 9q22.2 -0.2 0.125 0.657 Solute Carriers
cop TF 3q22.1 -0.2 0.125 0.657 ion transport;iron ion transport
cop SRPRB 3q22.1 -0.2 0.125 0.657 cellular protein metabolic
process;translation
exp TRPC1 3q23 -0.2 0.125 0.657 ion transport;calcium ion transport
met TSPAN32 11p15.5 -0.2 0.125 0.657 cell-cell signaling
met RAD52 12p13-p12.2 -0.2 0.125 0.657 DNA Damage Response (DDR); DDR (HR)
cop STK17A 7p13 -0.2 0.125 0.657 Apoptosis
xsq ZBTB20-AS1 -0.2 0.125 0.657
exp HOXD3 2q31.1 -0.2 0.125 0.657 thyroid gland development;positive
regulation of neuron differentiation
xsq SNTB1 8q23-q24 -0.2 0.125 0.657 muscle contraction
exp CEP112 17q24.1 -0.2 0.125 0.657
cop AHSG 3q27 -0.2 0.125 0.656 cerebral cortex development;negative regulation
of insulin receptor signaling pathway
cop FETUB 3q27 -0.2 0.125 0.656
cop HRG 3q27 -0.2 0.125 0.656 regulation of platelet activation;negative
cop KNG1 3q27 -0.2 0.125 0.656 inflammatory response;positive regulation of
renal sodium excretion
cop EIF4A2 3q28 -0.2 0.125 0.656
cop SNORD2 -0.2 0.125 0.656
cop MIR1248 -0.2 0.125 0.656
cop SNORA81 -0.2 0.125 0.656
cop SNORA63 -0.2 0.125 0.656
cop SNORA4 3q27 -0.2 0.125 0.656
cop RFC4 3q27 -0.2 0.125 0.656 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
cop ACER2 9p22.1 -0.2 0.125 0.656 lipid metabolic process;sphingosine
cop MIR3943 -0.2 0.125 0.656
xsq PTPRS 19p13.3 -0.2 0.125 0.656 cell adhesion;spinal cord development
cop MIR5007 -0.2 0.125 0.656
exp KLF8 Xp11.21 -0.2 0.125 0.656 regulation of transcription, DNA-
dependent"
cop VOPP1 7p11.2 -0.2 0.125 0.656 regulation of transcription, DNA-
dependent;signal transduction"
xsq SPA17 11q24.2 -0.2 0.125 0.656 spermatogenesis;single fertilization
xsq RHOD 11q14.3 -0.2 0.125 0.656 GTP catabolic process;small GTPase
xsq ANOS1 -0.2 0.125 0.656 cell adhesion;axon guidance
cop FLJ46284 -0.2 0.125 0.656
met OR10A6 11p15.4 -0.2 0.125 0.656 response to stimulus
xsq LOC100288846 14q21.1 -0.2 0.125 0.656
hs4 UCN 2p23-p21 -0.202 0.125 0.657 positive regulation of cell
xai GPER1 -0.202 0.125 0.657 intracellular steroid hormone receptor
pathway
his LINC01867 -0.202 0.125 0.657
his CLDN8 21q22.11 -0.202 0.125 0.657 calcium-independent cell-cell
adhesion
his RTP4 3q27.3 -0.202 0.125 0.657 protein targeting to
taste
his FGF12 3q28 -0.202 0.125 0.657 signal transduction;JNK cascade
xai CT47B1 Xq24 -0.202 0.125 0.657
hs4 B3GLCT -0.202 0.125 0.657 carbohydrate metabolic
his LY6K 8q24.3 -0.202 0.125 0.657
swa SELENBP1 1q21.3 -0.202 0.125 0.657 protein transport
hs4 ENPP1 6q22-q23 -0.202 0.125 0.657 nucleoside triphosphate catabolic
hs4 RAD51AP2 2p24.2 -0.202 0.125 0.657
his IGFL1 19q13.32 -0.202 0.125 0.657
hs4 GBP3 1p22.2 -0.202 0.125 0.657
his LOC145845 15q14 -0.202 0.125 0.656
his ITGBL1 13q33 -0.202 0.125 0.656 integrin-mediated signaling
pathway;cell adhesion
his SPTAN1 9q34.11 -0.202 0.125 0.656 apoptotic process;cellular
xai VGLL1 Xq26.3 -0.202 0.125 0.656 regulation of transcription, DNA-
dependent"
exp OR6K6 1q23.1 -0.202 0.125 0.656 response to stimulus
xai PKM 15q22 -0.202 0.125 0.656
xai IQCD 12q24.13 -0.202 0.125 0.656
xai ATP5G1P4 -0.202 0.125 0.656
hs4 RRAGC 1p34 -0.202 0.125 0.656 Apoptosis
his FAM213A 10q23.1 -0.202 0.125 0.656 regulation of osteoclast
xai TTLL10-AS1 -0.202 0.125 0.656
swa RABL3 3q13.33 -0.202 0.125 0.656 small GTPase mediated signal
transduction
his LINGO2 9p21.2 -0.202 0.125 0.656
his LOC100507487 -0.202 0.125 0.656
xai KRT8P10 2q32.1 -0.202 0.125 0.656
his CIB2 15q24 -0.202 0.125 0.656 integrin-mediated signaling pathway
his MIR3161 -0.202 0.125 0.656
xai FMN1 15q13.3 -0.202 0.125 0.656 cellular component
hs4 IER5 1q25.3 -0.202 0.125 0.656
xai KRT19P1 6q13 -0.202 0.125 0.656
xai TNFRSF11B 8q24 -0.202 0.125 0.656 response to nutrient;extracellular
matrix organization
exp TTLL10-AS1 -0.202 0.125 0.656
hs4 C1orf141 1p31.3 -0.202 0.125 0.656
hs4 CFAP44 -0.202 0.125 0.656
exp OR2T27 1q44 -0.202 0.125 0.656 response to stimulus
xai EEF1A1P42 6p12.3 0.203 0.126 0.658
swa DIEXF 1q32.2 0.202 0.126 0.657 multicellular organismal development
his MDC1 6p21.3 0.202 0.126 0.657 DNA Damage Response (DDR); DDR (NHEJ)
his TUBB 6p21.33 0.202 0.126 0.657 Apoptosis
xai CRTC2 1q21.3 0.202 0.126 0.657 gluconeogenesis;regulation of
xai FABP2 4q28-q31 0.202 0.126 0.657 intestinal absorption;fatty acid
metabolic process
exp KCNA5 12p13 0.202 0.126 0.657 protein oligomerization;reduction of cytosolic
calcium ion concentration
his DDX10 11q22-q23 0.202 0.126 0.657
his ZNF394 7q22.1 0.202 0.126 0.657 viral reproduction
xai CMSS1 3q12.1 0.202 0.126 0.657
xai NRXN2 11q13 0.202 0.126 0.657 neuroligin clustering;postsynaptic density
his LOC100506585 0.202 0.126 0.657
xai SRGN 10q22.1 0.202 0.126 0.658 mast cell secretory granule
his CS 12q13.2 0.202 0.126 0.658 small molecule metabolic
exp FAM86HP 3q22.1 0.202 0.126 0.658
xai PINK1-AS 0.202 0.126 0.658
xai SHANK1 19q13.3 0.202 0.126 0.658 neuromuscular process controlling
his SLC9B1 4q24 0.202 0.126 0.658 cation transport;transmembrane transport
his PDE3A 12p12 0.202 0.126 0.658 cGMP-mediated signaling;cellular response to
cGMP
his C11orf58 11p15.1 0.202 0.126 0.658
his ONECUT1 15q21.3 0.202 0.126 0.658 glucose metabolic process;cilium
assembly
xai MUC2 11p15.5 0.202 0.126 0.658 O-glycan processing;post-translational
his TDRD15 2p24.1 0.202 0.126 0.658
xai HSD17B10 Xp11.2 0.202 0.126 0.658 protein homotetramerization;lipid
metabolic process
xai ZMAT1 Xq21 0.201 0.126 0.658
xai SLC35E1P1 0.201 0.126 0.658
exp NPM1P42 15q24.1 0.201 0.126 0.658
xai SMIM10L2A 0.201 0.126 0.658
hs4 MIR663AHG 0.201 0.126 0.658
hs4 MIR663A 0.201 0.126 0.658
hs4 ERLIN1 10q24.31 0.201 0.126 0.658 ER-associated protein catabolic
process
xai BAG4 8p11.23 0.201 0.126 0.658 Apoptosis
xai LOC100631249 0.201 0.126 0.658
xai AGTPBP1 9q21.33 0.201 0.126 0.658 proteolysis;neuromuscular process
exp SLC35E2B 1p36.33 0.201 0.126 0.658 Solute Carriers
exp FABP2 4q28-q31 0.201 0.126 0.658 intestinal absorption;fatty acid
metabolic process
his SDHAF1 19q13.12 0.201 0.126 0.658 iron-sulfur cluster
his PYHIN1 1q23.1 0.201 0.126 0.658 cell cycle
swa COASY 17q12-q21 0.201 0.126 0.658 pantothenate metabolic process;small
xai HIPK1 1p13.2 0.201 0.126 0.658 eye development;regulation of
his MTMR4 17q22-q23 0.201 0.126 0.658 protein dephosphorylation;peptidyl-
his SEPT4-AS1 0.201 0.126 0.658
his GAN 16q24.1 0.201 0.126 0.658 cell death
his PEX10 1p36.32 0.201 0.126 0.658 peroxisome organization;protein import
into peroxisome matrix
his UNKL 16p13.3 0.201 0.126 0.658
his C16orf91 16p13.3 0.201 0.126 0.658
xai PAPD4 5q14.1 0.201 0.126 0.658 RNA polyadenylation;histone mRNA
catabolic process
xai YME1L1P1 0.201 0.126 0.658
his TOP3B 22q11.22 0.201 0.126 0.658 DNA Damage Response (DDR); DDR (FA); DDR
(DNA replication)
xai TAF1C 16q24 0.201 0.126 0.658 regulation of transcription, DNA-
xai DOC2GP 11q13.2 0.201 0.126 0.658
hs4 LINC00403 0.201 0.126 0.658
his CTD-2201I18.1 0.201 0.126 0.658
xai SOX12 20p13 0.201 0.126 0.658 spinal cord development;cell fate commitment
xsq NXF1 11q12-q13 0.2 0.126 0.657 mRNA export from nucleus;transport
xsq FAM126B 2q33.1 0.2 0.126 0.657
xsq TOP1P1 0.2 0.126 0.657
xsq METTL12 11q12.3 0.2 0.126 0.657
xsq MRPS31P5 0.2 0.126 0.657
exp DEXI 16p13.13 0.2 0.126 0.657
xsq LOC101928259 0.2 0.126 0.657
exp TXNL1 18q21.31 0.2 0.126 0.657 Apoptosis
met PCCA 13q32 0.2 0.126 0.657 small molecule metabolic process;fatty acid
beta-oxidation
cop BRE-AS1 0.2 0.126 0.657
cop MIR4263 0.2 0.126 0.657
dependent"
xsq GGA3 17q25.1 0.2 0.126 0.658 intracellular protein transport;vesicle-
mediated transport
xsq TUBA3E 0.2 0.126 0.658
met KCNA4 11p14 0.2 0.126 0.658 synaptic transmission;transmembrane transport
met ABCA7 19p13.3 0.2 0.126 0.658 ABC Transporters
xsq LOC101929140 0.2 0.126 0.658
mut ABCD2 12q12 0.2 0.126 0.658 ABC Transporters
met ZSCAN20 1p34.3 0.2 0.126 0.658 viral reproduction
met THEM4 1q21 0.2 0.126 0.658 Apoptosis
xsq KRTAP10-8 0.2 0.126 0.658
exp ZFR 5p13.3 0.2 0.126 0.658 multicellular organismal development
cop LOC375196 0.2 0.126 0.658
xsq ASH2L 8p11.2 0.2 0.126 0.658 transcription from RNA polymerase II
xsq PRMT6 1p13.3 0.2 0.126 0.658 DNA Damage Response (DDR)
xsq PAPD4 5q14.1 0.2 0.126 0.658 RNA polyadenylation;histone mRNA
catabolic process
met ZCCHC10 5q31.1 0.2 0.126 0.658
xsq MORC2 22q12.2 0.2 0.126 0.658
xsq FANCL 2p16.1 0.2 0.126 0.658 DNA Damage Response (DDR); DDR (FA)
xsq PTGES2 9q34.11 0.2 0.126 0.658 prostaglandin biosynthetic
mut FGF8 10q24 0.2 0.126 0.658 outflow tract septum
exp CLINT1 5q33.3 0.2 0.126 0.658 post-Golgi vesicle-mediated
exp KRTAP4-9 17q21.2 0.2 0.126 0.658
mut METTL21A 2q33.3 0.2 0.126 0.658
dependent"
exp GLOD4 17p13.3 0.2 0.126 0.658
exp HDHD2 18q21.1 0.2 0.126 0.658 metabolic process
xsq TSN 2q21.1 0.2 0.126 0.658 DNA recombination
xsq GUSBP1 5p14.3 0.2 0.126 0.658
exp FAM195A 16p13.3 0.2 0.126 0.658
xsq HIF3A 19q13.32 0.2 0.126 0.658 response to hypoxia;positive regulation
met FBXO2 1p36.22 0.2 0.126 0.658 glycoprotein catabolic process;protein
ubiquitination
xsq OR1S1 11q12.1 0.2 0.126 0.658 response to stimulus
mut C3 19p13.3-p13.2 0.2 0.126 0.658 complement activation;positive
regulation of phagocytosis
xsq FAM175B 10q26.13 0.2 0.126 0.658 DNA Damage Response (DDR)
exp AGTPBP1 9q21.33 0.2 0.126 0.658 proteolysis;neuromuscular process
mut COQ3 6q16.2 0.2 0.126 0.658 ubiquinone biosynthetic process;metabolic
process
met KCNK2 1q41 0.2 0.126 0.658 ion transport;potassium ion transport
cop DDX12P 12p13.31 0.2 0.126 0.658 nucleobase-containing compound
metabolic process;cell cycle
met NCKAP1 2q32 0.2 0.126 0.658 Apoptosis
exp TTK 6q14.1 0.2 0.126 0.658 Tumor Suppressors
dependent"
xsq C9orf153 9q21.33 0.2 0.126 0.658
xsq CEP78 9q21.2 0.2 0.126 0.658 G2/M transition of mitotic cell
exp KCNT2 1q31.3 0.2 0.126 0.658 potassium ion transport;potassium ion
xsq ANGEL1 14q24.3 0.2 0.126 0.658
xsq TMEM170B 6p24.2 0.2 0.126 0.658
met HABP4 9q22.3-q31 0.2 0.126 0.658 cellular response to mechanical
stimulus;platelet degranulation
exp C21orf33 21q22.3 0.2 0.126 0.658
xsq FBXO4 5p12 0.2 0.126 0.658 positive regulation of protein
ubiquitination;protein polyubiquitination
xsq NUP35 2q32.1 0.2 0.126 0.658 regulation of glucose transport;protein
transport
met OR6C1 12q13.2 0.2 0.126 0.658 response to stimulus
xsq KIAA0195 17q25.1 0.199 0.126 0.658
met MPP6 7p15 0.199 0.126 0.658 protein complex assembly
mut KBTBD4 11p11.2 0.199 0.126 0.658
cop LTBP1 2p22-p21 0.199 0.126 0.658 negative regulation of transforming
growth factor beta receptor signaling pathway by extracellular sequestering of
TGFbeta
cop PKDCC 2p21 0.199 0.126 0.658 positive regulation of chondrocyte
differentiation;negative regulation of Golgi to plasma membrane protein transport
mut GBP5 1p22.2 0.199 0.126 0.658 cellular response to interferon-gamma
pro AKAP5 14q23.3 0.199 0.126 0.658 regulation of insulin secretion;energy
met MIR614 -0.199 0.126 0.658
xsq RERG-AS1 -0.199 0.126 0.658
mut ZNF660 3p21.31 -0.199 0.126 0.658 regulation of transcription,
DNA-dependent"
mut CHST2 3q24 -0.199 0.126 0.658 metabolic process;carbohydrate metabolic
process
mut PACSIN3 11p12-p11.12 -0.199 0.126 0.658 negative regulation of
endocytosis;positive regulation of membrane protein ectodomain proteolysis
mut BCAS1 20q13.2 -0.199 0.126 0.658
xsq SNORD90 -0.199 0.126 0.658
mut TTC13 1q42.2 -0.199 0.126 0.658
mut RASSF6 4q13.3 -0.199 0.126 0.658 signal
transduction;regulation of apoptotic process
mut TIRAP 11q24.2 -0.199 0.126 0.658 MyD88-dependent toll-like receptor
signaling pathway;positive regulation of interleukin-12 production
mut PSMB11 14q11.2 -0.199 0.126 0.658
mut SLC22A17 14q11.2 -0.199 0.126 0.658 Solute Carriers
mut LCTL 15q22.31 -0.199 0.126 0.658 carbohydrate metabolic process
mut TBL3 16p13.3 -0.199 0.126 0.658 G-protein signaling, coupled to
mut MYO1C 17p13.3 -0.199 0.126 0.658 protein transport;mRNA transport
mut ICAM2 17q23.3 -0.199 0.126 0.658 cell-cell adhesion;regulation of
immune response
mut PRDX2 19p13.2 -0.199 0.126 0.658 Apoptosis
mut NFS1 20q11.22 -0.199 0.126 0.658 vitamin metabolic process;water-
mut ZNF74 22q11.21 -0.199 0.126 0.658 regulation of transcription, DNA-
mut KDM5C Xp11.22-p11.21 -0.199 0.126 0.658 Tumor Suppressors
exp PSG8 19q13.2 -0.2 0.126 0.658
cop TNR 1q24 -0.2 0.126 0.658 negative regulation of neuron projection
development;neuromuscular process controlling balance
met BEND4 4p13 -0.2 0.126 0.658
xsq IRAK2 3p25.3 -0.2 0.126 0.658 Protein Kinases
xsq CADM1 11q23.2 -0.2 0.126 0.658 homophilic cell adhesion;susceptibility
to natural killer cell mediated cytotoxicity
xsq GOLGA4 3p22-p21.3 -0.2 0.126 0.658 protein targeting to Golgi;vesicle-
mediated transport
cop MRPS28 8q21.1-q21.2 -0.2 0.126 0.658
exp MOCOS 18q12 -0.2 0.126 0.658 molybdopterin cofactor metabolic process;small
exp PAPSS2 10q24 -0.2 0.126 0.658 xenobiotic metabolic process;small
xsq PDE1C 7p14.3 -0.2 0.126 0.658 activation of phospholipase C
xsq ARTN 1p33-p32 -0.2 0.126 0.658 signal transduction;neuroblast
proliferation
xsq IL15RA 10p15.1 -0.2 0.126 0.658 cytokine-mediated signaling
pathway;positive regulation of natural killer cell differentiation
exp PDLIM4 5q31.1 -0.2 0.126 0.658
exp KIAA2026 9p24.1 -0.2 0.126 0.658
cop FLJ39080 -0.2 0.126 0.658
exp EPN3 17q21.33 -0.2 0.126 0.657
cop PLA2G4A 1q25 -0.2 0.126 0.657 metabolic process;platelet activation
xsq CDK20 9q22.1 -0.2 0.126 0.657 Protein Kinases
met MT1DP 16q13 -0.2 0.126 0.657
exp PTPRS 19p13.3 -0.2 0.126 0.657 cell adhesion;spinal cord development
exp RNASE1 14q11.2 -0.2 0.126 0.657
xsq IQCE 7p22.3 -0.2 0.126 0.657
xsq GNPTG 16p13.3 -0.2 0.126 0.657
exp PSG9 19q13.2 -0.2 0.126 0.657 defense response;female pregnancy
his IGFBP7-AS1 -0.201 0.126 0.658
his IGFBP7 4q12 -0.201 0.126 0.658 regulation of cell growth;cell
adhesion
xai KCNIP1 5q35.1 -0.201 0.126 0.658 synaptic
xai MBTPS2 Xp22.12-p22.11 -0.201 0.126 0.658 endoplasmic reticulum
unfolded protein response;proteolysis
his PLXNB1 3p21.31 -0.201 0.126 0.658 negative regulation of
his SEMA5A-AS1 -0.201 0.126 0.658
xai ESRP2 16q22.1 -0.201 0.126 0.658 EMT (Epithelial)
swa NUCB1 19q13.33 -0.201 0.126 0.658
hs4 CCDC126 7p15.3 -0.201 0.126 0.658
xai CSPG4P11 -0.201 0.126 0.658
his FIBCD1 9q34.12 -0.201 0.126 0.658 signal transduction
xai LOC729987 -0.201 0.126 0.658
exp SEPT14 7p11.2 -0.201 0.126 0.658 cell cycle;cell division
xai MRPS6 21q22.11 -0.201 0.126 0.658 translation
swa PEX14 1p36.22 -0.201 0.126 0.658 peroxisome organization;protein
transport
exp CSPG4P5 15q25.2 -0.201 0.126 0.658
xai SPATA6L 9p24.2 -0.201 0.126 0.658
his MIR924 -0.202 0.126 0.658
xai RIT2 18q12.3 -0.202 0.126 0.658 GTP catabolic process;signal
transduction
xai OR6K6 1q23.1 -0.202 0.126 0.658 response to stimulus
xai SDPR 2q32-q33 -0.202 0.126 0.658
xai FBLN7 2q13 -0.202 0.126 0.658 cell adhesion
exp C19orf71 19p13.3 -0.202 0.126 0.658
hs4 SCN1B 19q13.1 -0.202 0.126 0.657 axon guidance;sodium ion
his FAM189A2 9q21.11 -0.202 0.126 0.657
hs4 UPP1 7p12.3 -0.202 0.126 0.657 nucleotide catabolic
hs4 FRMD6 14q22.1 -0.202 0.126 0.657
hs4 FRMD6-AS1 -0.202 0.126 0.657
exp ATP5G1P4 -0.202 0.126 0.657
xai TRIM45 1p13.1 -0.202 0.126 0.657
dependent"
hs4 GIGYF1 7q22 0.201 0.127 0.658 insulin-like growth factor receptor
signaling pathway
xai PRELID1P1 6q22.32 0.201 0.127 0.658
xai ATP5G2P1 1q32.2 0.201 0.127 0.658
xai TFDP2 3q23 0.201 0.127 0.659 Apoptosis
his F12 5q35.3 0.201 0.127 0.659 protein autoprocessing;plasma kallikrein-
kinin cascade
xai KCNRG 13q14.2 0.201 0.127 0.659 potassium ion transport
his ALAD 9q33.1 0.201 0.127 0.659 porphyrin-containing compound metabolic
his SCAP 3p21.31 0.201 0.127 0.659 negative regulation of cholesterol
xai RPS6P21 12q24.33 0.201 0.127 0.659
his SNORD141A 0.201 0.127 0.659
xai PAPOLB 0.201 0.127 0.659 DDR (DNA replication)
xai ASMTL Xp22.3 0.201 0.127 0.659
hs4 LOC101929241 0.201 0.127 0.659
hs4 DDX11-AS1 0.201 0.127 0.659
hs4 DDX11 12p11 0.201 0.127 0.659 DNA Damage Response (DDR)
his ULK4P1 15q13.3 0.201 0.127 0.659
hs4 LCN12 9q34.3 0.201 0.127 0.659 lipid metabolic process
xai PSMB10 16q22.1 0.201 0.127 0.659 mitotic cell cycle;viral
reproduction
his UQCRC2 16p12 0.201 0.127 0.659 oxidative phosphorylation;proteolysis
exp LOC400707 0.201 0.127 0.659
his ALDOC 17cen-q12 0.201 0.127 0.659 gluconeogenesis;small molecule metabolic
process
xai KLHL32 6q16.1 0.201 0.127 0.659
his MED28 4p16 0.201 0.127 0.659 regulation of transcription, DNA-dependent"
hs4 LINC00426 13q12.3 0.201 0.127 0.659
his GANAB 11q12.3 0.201 0.127 0.659 carbohydrate metabolic process;protein
folding
xai RBM15 1p13 0.201 0.127 0.659 positive regulation of transcription of Notch
receptor target;interspecies interaction between organisms
his RHPN1-AS1 8q24 0.201 0.127 0.659
his RHPN1 8q24.3 0.201 0.127 0.659 signal transduction
hs4 LOC100996455 0.201 0.127 0.659
his MSTO1 1q22 0.201 0.127 0.659 mitochondrion organization;mitochondrion
distribution
xai GTPBP8 3q13.2 0.201 0.127 0.659 barrier septum assembly
his RTEL1 20q13.3 0.201 0.127 0.659 DNA Damage Response (DDR); DDR (DNA
replication)
his RTEL1-TNFRSF6B 0.201 0.127 0.659
his GTF2H3 12q24.31 0.201 0.127 0.659 DNA Damage Response (DDR); DDR
(NER)
his EIF2B1 12q24.31 0.201 0.127 0.659 regulation of translational
xai CSHL1 17q24.2 0.201 0.127 0.659
his SETD6 16q21 0.201 0.127 0.659 peptidyl-lysine monomethylation;negative
his CKMT1A 15q15 0.201 0.127 0.659 creatine metabolic process;cellular
his PVRIG2P 0.201 0.127 0.659
xai LOC400707 0.201 0.127 0.659
xai ELAVL1 19p13.2 0.201 0.127 0.659 mRNA stabilization;3'-UTR-mediated
mRNA stabilization
his C4orf46 4q32.1 0.201 0.127 0.659
his ETFDH 4q32-q35 0.201 0.127 0.659 transport;response to oxidative stress
xai BEND3P3 10q22.3 0.201 0.127 0.659
xai ITGB1BP2 Xq12-q13.1 0.201 0.127 0.659 muscle organ development;signal
transduction
his TDRD3 13q21.2 0.201 0.127 0.659 chromatin modification
xai C19orf24 19p13.3 0.201 0.127 0.659
xai SPOP 17q21.33 0.201 0.127 0.659 mRNA processing
swa EIF2S1 14q23.3 0.201 0.127 0.659 activation of signaling protein
activity involved in unfolded protein response;gene expression
xai RUNDC3A 17q21.31 0.201 0.127 0.66 small GTPase mediated signal
transduction
xai NUP50 22q13.31 0.201 0.127 0.66 protein transport;glucose transport
his MANEAL 1p34.3 0.201 0.127 0.66
exp ATP5G1P1 14q32.33 0.201 0.127 0.66
his RBM38 20q13.31 0.201 0.127 0.66 DNA damage response, signal transduction
by p53 class mediator resulting in transcription of p21 class mediator;cell cycle
xai SIAH2 3q25 0.201 0.127 0.66 Apoptosis
exp DICER1 14q32.13 0.199 0.127 0.658 Oncogenes
met SETD6 16q21 0.199 0.127 0.659 peptidyl-lysine monomethylation;negative
mut SV2B 15q26.1 0.199 0.127 0.659 neurotransmitter transport
mut RAPGEF2 4q32.1 0.199 0.127 0.659 cAMP-mediated signaling;positive
regulation of Rap GTPase activity
dependent"
mut OSBP 11q12-q13 0.199 0.127 0.659 transport;lipid transport
cop OR2AT4 11q13.4 0.199 0.127 0.659
mut CACNA1S 1q32 0.199 0.127 0.659 extraocular skeletal muscle
development;neuromuscular junction development
xsq ZBTB25 14q23-q24 0.199 0.127 0.659 regulation of transcription, DNA-
dependent;gene expression"
xsq KIF14 1q32.1 0.199 0.127 0.659 microtubule-based movement
met PRUNE2 9q21.2 0.199 0.127 0.659 apoptotic process;induction of
apoptosis
cop COG4 16q22.1 0.199 0.127 0.659 Golgi vesicle prefusion complex
xsq POLR2B 4q12 0.199 0.127 0.659 DNA Damage Response (DDR); DDR (NER)
met TPRG1L 1p36.32 0.199 0.127 0.659
mut BRWD3 Xq21.1 0.199 0.127 0.659 cytoskeleton organization;regulation of
cell shape
met MIR345 0.199 0.127 0.659
xsq HSD17B8 6p21.3 0.199 0.127 0.659 fatty acid biosynthetic
process;estrogen biosynthetic process
xsq SYP Xp11.23-p11.22 0.199 0.127 0.659 endocytosis;synaptic vesicle
maturation
exp ADGRL4 0.199 0.127 0.659 G-protein coupled receptor signaling
xsq CCDC66 3p14.3 0.199 0.127 0.659
xsq OR52I2 11p15.4 0.199 0.127 0.659 response to stimulus
exp TIGD5 8q24.3 0.199 0.127 0.659 regulation of transcription, DNA-
dependent"
exp PHKA2 Xp22.2-p22.1 0.199 0.127 0.659 generation of precursor metabolites
exp HAVCR2 5q33.3 0.199 0.127 0.659
exp PEG3 19q13.4 0.199 0.127 0.659 viral reproduction;apoptotic process
xsq ARMC6 19p13.11 0.199 0.127 0.659
dependent"
xsq CENPO 2p23.3 0.199 0.127 0.659 nucleosome assembly;chromosome
segregation
mut CHAF1A 19p13.3 0.199 0.127 0.659 DNA Damage Response (DDR); DDR (DNA
replication)
xsq LARP4 12q13.12 0.199 0.127 0.659 cytoskeleton organization;regulation of
cell morphogenesis
met KANK1 9p24.3 0.199 0.127 0.659 negative regulation of actin filament
polymerization
exp USP10P2 0.199 0.127 0.659
cop MTSS1L 16q22.1 0.199 0.127 0.659 filopodium assembly;signal
transduction
xsq CXorf49 0.199 0.127 0.659
xsq SMNDC1 10q23 0.199 0.127 0.659 Apoptosis
met ZC4H2 Xq11.2 0.199 0.127 0.659
cop TPCN2 11q13.3 0.199 0.127 0.659 ion transport;cellular calcium ion
homeostasis
mut KLK8 19q13 0.199 0.127 0.659 cell death;response to wounding
xsq GMDS 6p25 0.199 0.127 0.659 'de novo' GDP-L-fucose biosynthetic
xsq KIAA2018 3q13.2 0.199 0.127 0.659
cop PHLPP1 18q21.33 0.199 0.127 0.659 Apoptosis
met FAM86C1 11q13.4 0.199 0.127 0.659
mut LAMP3 3q26.3-q27 0.199 0.127 0.659 cell proliferation
met RAB2A 8q12.1 0.199 0.127 0.659 GTP catabolic process;ER to Golgi
exp STARD7-AS1 0.199 0.127 0.659
exp FAM159A 1p32.3 0.199 0.127 0.659
exp LOC100133301 0.199 0.127 0.659
xsq YTHDF1 20q13.33 0.199 0.127 0.659
mut TBC1D1 4p14 0.199 0.127 0.659 regulation of protein localization
mut OR6S1 14q11.2 0.199 0.127 0.659 response to stimulus
xsq LINC00437 0.199 0.127 0.659
cop RFWD3 16q23.1 0.199 0.127 0.659 DNA repair;response to ionizing radiation
cop MLKL 16q23.1 0.199 0.127 0.659
xsq NLN 5q12.3 0.199 0.127 0.659 proteolysis
exp YY1AP1 1q22 0.199 0.127 0.659 regulation of transcription, DNA-
cop LRRC20 10q22.1 0.199 0.127 0.659
cop C2orf16 2p23.3 0.199 0.127 0.659
xsq C11orf71 11q23.2 0.199 0.127 0.659
exp NREP 5q22.1 0.199 0.127 0.659 regulation of neuron
pathway
xsq MUM1 19p13.3 0.199 0.127 0.659 DNA repair;chromatin organization
xsq HDGF 1q23.1 0.199 0.127 0.659 regulation of transcription, DNA-
response
dependent"
xsq SENP8 15q23 0.199 0.127 0.66 proteolysis
xsq LINC00877 0.199 0.127 0.66
mut URB2 1q42.13 0.199 0.127 0.66
exp TNFRSF10A 8p21 0.199 0.127 0.66 Apoptosis
xsq TSHZ1 18q22.3 0.199 0.127 0.66 multicellular organismal
exp LNP1 3q12.2 0.199 0.127 0.66
exp ZBED3-AS1 5q13.3 0.199 0.127 0.66
xsq NOTCH1 9q34.3 0.199 0.127 0.66 Tumor Suppressors
xsq THAP1 8p11.21 0.199 0.127 0.66 transcription, DNA-dependent;regulation
cop AMFR 16q21 0.199 0.127 0.66 ER-associated protein catabolic process;protein
polyubiquitination
exp LRRC26 9q34.3 0.199 0.127 0.66 ion transport
met TMEM120B 12q24.31 0.199 0.127 0.66
met PGAM4 Xq13 0.199 0.127 0.66 glycolysis
xsq FCHSD1 5q31.3 -0.199 0.127 0.66
exp PPFIA4 1q32.1 -0.199 0.127 0.66 cell communication
met CASQ2 1p13.1 -0.199 0.127 0.659 striated muscle contraction;heart
development
exp FAM78A 9q34 -0.199 0.127 0.659
met KCTD15 19q13.11 -0.199 0.127 0.659 potassium ion transport
exp AVEN 15q13.1 -0.199 0.127 0.659 Apoptosis
exp IRS3P 7q22.1 -0.199 0.127 0.659
xsq TGFB2 1q41 -0.199 0.127 0.659 Apoptosis
cop VPS13B 8q22.2 -0.199 0.127 0.659 protein localization;protein
transport
exp TEX36 10q26.13 -0.199 0.127 0.659
exp DACT1 14q23.1 -0.199 0.127 0.659 multicellular organismal
exp CLPTM1 19q13.3 -0.199 0.127 0.659 multicellular organismal
exp MYO5B 18q21 -0.199 0.127 0.659 regulation of protein
localization;protein transport
cop HEY1 8q21 -0.199 0.127 0.659 negative regulation of Notch signaling
pathway;negative regulation of transcription, DNA-dependent
exp PRELP 1q32 -0.199 0.127 0.659 skeletal system development;cell aging
met STX16 20q13.32 -0.199 0.127 0.659 retrograde transport, endosome to
Golgi;intracellular protein transport
xsq CFAP58 -0.199 0.127 0.659
cop CACYBP 1q24-q25 -0.199 0.127 0.659 response to growth hormone
cop MRPS14 1q25.1 -0.199 0.127 0.659 translation
xsq FOSL1 11q13 -0.199 0.127 0.659 Apoptosis
mut FZD10 12q24.33 -0.199 0.127 0.659 brain development;positive
regulation of JUN kinase activity
exp DPY19L4 8q22.1 -0.199 0.127 0.659
xsq GAP43 3q13.31 -0.199 0.127 0.659 activation of protein kinase C
xsq RIPK4 21q22.3 -0.199 0.127 0.659
exp WDR91 7q33 -0.199 0.127 0.659
exp INPP4B 4q31.21 -0.199 0.127 0.659 signal
cop IL20RB 3q22.3 -0.199 0.127 0.659 positive regulation of
cop MSX2 5q35.2 -0.199 0.127 0.659 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of cell
proliferation
met ACSS1 20p11.23-p11.21 -0.199 0.127 0.658 xenobiotic metabolic
process;acetate biosynthetic process
cop TPD52 8q21.13 -0.199 0.127 0.658 secretion;anatomical structure
morphogenesis
xsq HDAC9 7p21.1 -0.199 0.127 0.658 inflammatory response;negative
cop ABCF3 3q27.1 -0.201 0.127 0.66
xai MYO5B 18q21 -0.201 0.127 0.66 regulation of protein
his MIR5092 -0.201 0.127 0.66
xai VWF 12p13.3 -0.201 0.127 0.66 platelet degranulation;protein
homooligomerization
xai XKR9 8q13.3 -0.201 0.127 0.66
hs4 AKT3 1q44 -0.201 0.127 0.66 Protein Kinases
xai FAM183BP -0.201 0.127 0.66
his CDSN 6p21.3 -0.201 0.127 0.66 epidermis development;cell-cell
adhesion
xai GOLGA2P9 -0.201 0.127 0.659
xai AHCYL1 1p13.2 -0.201 0.127 0.659 mRNA polyadenylation;protein
export from nucleus
xai SLC2A4RG 20q13.33 -0.201 0.127 0.659 Solute Carriers
xai B4GALT5 20q13.1-q13.2 -0.201 0.127 0.659 O-glycan
hs4 POPDC3 6q21 -0.201 0.127 0.659
exp ALS2CR11 2q33.1 -0.201 0.127 0.659
xai PPFIA4 1q32.1 -0.201 0.127 0.659 cell communication
xai SCUBE3 6p21.3 -0.201 0.127 0.659 protein
xai ADAD1 4q27 -0.201 0.127 0.659 spermatogenesis;spermatid development
hs4 JAZF1-AS1 7p15.1 -0.201 0.127 0.659
hs4 JAZF1 7p15.2-p15.1 -0.201 0.127 0.659 negative regulation of
dependent"
hs4 SEC31B 10q24.31 -0.201 0.127 0.659 protein transport;vesicle-
mediated transport
xai MPP5 14q23.3 -0.201 0.127 0.659 tight junction
assembly;establishment of protein localization in plasma membrane
xai ACSM1 16p12.3 -0.201 0.127 0.659 xenobiotic metabolic process;energy
derivation by oxidation of organic compounds
xai EPG5 18q12.3 -0.201 0.127 0.659 autophagy
xai BCL9L 11q23.3 -0.201 0.127 0.659 negative regulation of transforming
hs4 GRIA3 Xq25 -0.201 0.127 0.659 regulation of receptor
recycling;transport
hs4 MYOC 1q23-q24 -0.201 0.127 0.659 anatomical structure morphogenesis
his CC2D2A 4p15.32 -0.201 0.127 0.659 cilium assembly;cilium
morphogenesis
xai ZCCHC14 16q24.2 -0.201 0.127 0.659 cell communication
mda Modal_chromosomal_number -0.203 0.127 0.659
his LOC100506747 0.201 0.128 0.66
his TMEM183A 1q32.1 0.201 0.128 0.66
cop OXER1 2p21 0.201 0.128 0.66 G-protein coupled receptor signaling
hs4 DCK 4q13.3-q21.1 0.201 0.128 0.66 purine base metabolic
xai SACM1L 3p21.3 0.201 0.128 0.66
his KLC1 14q32.3 0.201 0.128 0.66 microtubule-based movement;blood
coagulation
xai ATP5G1P1 14q32.33 0.201 0.128 0.66
xai SLC7A11-AS1 0.201 0.128 0.66
xai TNFRSF10A 8p21 0.201 0.128 0.66 Apoptosis
his SMAD6 15q22.31 0.201 0.128 0.66 negative regulation of SMAD protein
complex assembly;response to estrogen stimulus
hs4 SEH1L 18p11.21 0.201 0.128 0.66 mitotic prometaphase;protein transport
his TMEM179B 11q12.3 0.201 0.128 0.66
his MIR6748 0.201 0.128 0.66
his TMEM223 11q12.3 0.201 0.128 0.66
exp GRK6P1 13q12.11 0.201 0.128 0.66
xai PET117 0.201 0.128 0.66
his BRD3 9q34 0.201 0.128 0.66
xai GTPBP1 22q13.1 0.201 0.128 0.66 GTP catabolic process;immune
response
his NDRG3 20q11.21-q11.23 0.201 0.128 0.66 spermatogenesis;cell
differentiation
xai PCIF1 20q13.12 0.201 0.128 0.66 negative regulation of phosphatase
activity
swa ATP6 0.201 0.128 0.66
his RNF146 6q22.1-q22.33 0.2 0.128 0.66 Wnt receptor signaling
pathway;protein ubiquitination involved in ubiquitin-dependent protein catabolic
process
exp DLG3-AS1 0.2 0.128 0.66
hs4 LDHB 12p12.2-p12.1 0.2 0.128 0.66 lactate metabolic process;pyruvate
metabolic process
his STK35 20p13 0.2 0.128 0.66
xai LINC01061 0.2 0.128 0.66
met CACNG4 17q24 0.2 0.128 0.66 transport;ion transport
exp TRNS2 0.2 0.128 0.66
hs4 KCNJ6 21q22.1 0.2 0.128 0.66 potassium ion transport;synaptic
transmission
his ATG3 3q13.2 0.2 0.128 0.66 autophagic vacuole assembly;protein
his GKAP1 9q21.32 0.2 0.128 0.66 signal transduction
his MED4 13q14.2 0.2 0.128 0.66 transcription initiation from RNA
xai DLG3-AS1 0.2 0.128 0.66
xai ANKRD26P3 13q12.11 0.2 0.128 0.66
xai TBC1D32 6q22.31 0.2 0.128 0.66
swa STK10 5q35.1 0.2 0.128 0.66 protein phosphorylation;cell cycle
xai METTL25 12q21.31 0.2 0.128 0.66
xai CCL1 17q12 0.2 0.128 0.66 cellular calcium ion homeostasis;chemotaxis
his TMED3 15q24-q25 0.2 0.128 0.66 protein transport
his MIR6860 0.2 0.128 0.66
his FANCE 6p22-p21 0.2 0.128 0.66 DNA Damage Response (DDR); DDR (FA)
swa AK2 1p34 0.2 0.128 0.66 nucleobase-containing small molecule
xai CMC1 3p24.1 0.2 0.128 0.66
xai ATP8B2 1q21.3 0.2 0.128 0.66 cation transport;phospholipid
transport
hs4 HIBCH 2q32.2 0.2 0.128 0.66 branched chain family amino acid
xai DOCK11 Xq24 0.2 0.128 0.661 blood coagulation;regulation of catalytic
activity
xai ID2B 3p14.2 0.2 0.128 0.661
xai AMN1 12p11.21 0.2 0.128 0.661 DNA Damage Response (DDR)
his FDXR 17q25.1 0.2 0.128 0.661 generation of precursor metabolites and
energy;steroid biosynthetic process
hs4 HAUS7 Xq28 0.2 0.128 0.661 mitosis;spindle assembly
xai RRM2 2p25-p24 0.2 0.128 0.661 DNA Damage Response (DDR)
his LINC00888 0.2 0.128 0.661
xai RPL23AP53 8p23.3 0.2 0.128 0.661
xai ZBTB16 11q23.1 0.2 0.128 0.661 mesonephros development;positive
his NKAIN3 8q12.3 0.2 0.128 0.661
xai DNM3-IT1 0.2 0.128 0.661
his CCDC102A 16q21 0.2 0.128 0.661
his NPL 1q25 0.2 0.128 0.661 carbohydrate metabolic process
swa LIMS1 2q12.3 0.2 0.128 0.661 cell aging;cell junction assembly
cop FOXN2 2p22-p16 0.199 0.128 0.66 regulation of transcription, DNA-
mut CHAMP1 13q34 0.199 0.128 0.66 sister chromatid biorientation;protein
localization to kinetochore
exp ECHDC1 6q22.33 0.199 0.128 0.66
xsq SPATA31A5 0.199 0.128 0.66
exp ALG5 13q13.3 0.199 0.128 0.66 cellular protein metabolic
cop CDH2 18q11.2 0.199 0.128 0.66 homophilic cell adhesion;adherens
xsq PAXIP1-AS2 0.199 0.128 0.66
cop SF3B3 16q22.1 0.199 0.128 0.66 RNA splicing, via transesterification
xsq PSMB3 17q12 0.199 0.128 0.66 protein polyubiquitination;gene expression
exp C12orf60 12p12.3 0.199 0.128 0.66
xsq AGBL1-AS1 0.199 0.128 0.66
exp PEBP1 12q24.23 0.199 0.128 0.66 regulation of neurotransmitter
xsq SPC25 2q31.1 0.199 0.128 0.66 mitotic cell cycle;mitotic spindle
organization
met OR3A2 17p13.3 0.199 0.128 0.66
cop MUC5B 0.199 0.128 0.66 O-glycan processing;post-translational protein
modification
cop TOLLIP 11p15.5 0.199 0.128 0.66 inflammatory response;signal
transduction
exp DNPH1 6p21.1 0.199 0.128 0.66
mut GBX1 7q36.1 0.199 0.128 0.66
mut IL10RA 11q23 0.199 0.128 0.66 signal transduction
exp OLIG1 21q22.11 0.199 0.128 0.66 multicellular organismal
xsq VCPKMT 0.199 0.128 0.66
cop ZNF407 18q23 0.199 0.128 0.66 regulation of transcription, DNA-
dependent"
xsq FAM13A-AS1 4q22.1 0.199 0.128 0.66
exp HNRNPF 10q11.21 0.199 0.128 0.66 nuclear mRNA splicing, via
met SHANK1 19q13.3 0.199 0.128 0.66 neuromuscular process controlling
xsq KIF11 10q24.1 0.199 0.128 0.66 spindle organization;mitotic spindle
organization
xsq ZC3H4 19q13.32 0.199 0.128 0.66
cop ASAP2 2p25 0.199 0.128 0.66 regulation of ARF GTPase activity;positive
exp SACM1L 3p21.3 0.199 0.128 0.66
exp TMX1 14q22.1 0.199 0.128 0.66 transport;cell redox homeostasis
met ZSCAN16 6p22.1 0.199 0.128 0.66 viral reproduction
mut REPS1 6q24.1 0.199 0.128 0.66
exp KIAA1143 3p21.31 0.199 0.128 0.66
mut HAO1 20p12 0.199 0.128 0.66
xsq GIMAP8 7q36.1 0.199 0.128 0.66
met FCN2 9q34.3 0.199 0.128 0.66 complement activation, lectin
pathway;signal transduction
xsq LONP1 19p13.2 0.199 0.128 0.66 cellular response to oxidative
stress;protein homooligomerization
met PEX11G 19p13.2 0.199 0.128 0.66
exp LINC00922 16q21 0.199 0.128 0.66
mut RASAL2 1q24 0.199 0.128 0.66 signal transduction;positive regulation
of Ras GTPase activity
xsq XIAP Xq25 0.199 0.128 0.66 Apoptosis
met GBP3 1p22.2 0.199 0.128 0.66
exp TCF12 15q21 0.199 0.128 0.66 regulation of transcription from RNA polymerase
II promoter;immune response
xsq RPS10-NUDT3 0.199 0.128 0.66
exp PRSS3P2 7q34 0.199 0.128 0.66
xsq DNTTIP1 20q13.12 0.199 0.128 0.66 DNA Damage Response (DDR); DDR (DNA
replication)
exp ZGPAT 20q13.3 0.199 0.128 0.66 negative regulation of epidermal growth
factor-activated receptor activity;negative regulation of transcription, DNA-
dependent"
mut C1orf168 1p32.2 0.199 0.128 0.66
cop ZNF280D 15q21.3 0.199 0.128 0.66
xsq UPF1 19p13.2-p13.11 0.199 0.128 0.661 DNA Damage Response (DDR)
xsq NAP1L4 11p15.5 0.199 0.128 0.661 nucleosome assembly
mut LRP12 8q22.2 0.199 0.128 0.661 EMT (Mesenchymal)
exp ZNF24 18q12 0.199 0.128 0.661 viral reproduction;myelination
met SCGN 6p22.3-p22.1 0.198 0.128 0.661
met TMEM173 5q31.2 0.198 0.128 0.661 apoptotic process;cellular response
to exogenous dsRNA
xsq PEG3 19q13.4 0.198 0.128 0.661 viral reproduction;apoptotic process
xsq MAT2B 5q34-q35 0.198 0.128 0.661 cellular nitrogen compound metabolic
exp LRRC49 15q23 -0.198 0.128 0.661
exp LOC791126 18q12.2 -0.199 0.128 0.661
xsq NBEAL1 2q33.2 -0.199 0.128 0.661
exp TCTN1 12q24.11 -0.199 0.128 0.661 cilium morphogenesis;multicellular
cop ZNF733P -0.199 0.128 0.66
cop LOC100287834 -0.199 0.128 0.66
cop LOC100287704 -0.199 0.128 0.66
met DDHD1 14q21 -0.199 0.128 0.66 lipid catabolic process
mda SF5 -0.199 0.128 0.66
met XIST Xq13.2 -0.199 0.128 0.66 DDR (DNA replication); Tumor
Suppressors
exp SFTPC 8p21 -0.199 0.128 0.66 response to hormone stimulus;response to
interleukin-6
mut SIGLEC12 19q13.4 -0.199 0.128 0.66 cell adhesion
exp COL22A1 8q24.3 -0.199 0.128 0.66 cell adhesion
exp JKAMP 14q23.1 -0.199 0.128 0.66 response to unfolded protein;ER-
exp PDLIM3 4q35 -0.199 0.128 0.66 actin filament organization;heart
development
cop LSP1P3 5p13.3 -0.199 0.128 0.66
mda proportion_genomic_losses -0.199 0.128 0.66
exp FBLN5 14q32.1 -0.199 0.128 0.66 regulation of removal of superoxide
radicals;cell adhesion
cop PAPPA2 1q23-q25 -0.199 0.128 0.66 regulation of cell
growth;proteolysis
exp ASCC2 22q12.1 -0.199 0.128 0.66 regulation of transcription, DNA-
dependent"
exp LOC266619 -0.199 0.128 0.66
exp PCDHB14 5q31 -0.199 0.128 0.66 cell adhesion;homophilic cell
adhesion
exp HCP5 6p21.3 -0.199 0.128 0.66 defense response
exp PDGFB 22q13.1 -0.199 0.128 0.66 Apoptosis; Oncogenes
cop DPPA2P3 3q29 -0.199 0.128 0.66
xsq MN1 22q12.1 -0.199 0.128 0.66 intramembranous ossification
xai GAPDHP54 -0.2 0.128 0.661
xai TRPV1 17p13.2 -0.2 0.128 0.661 temperature homeostasis;elevation of
xai KCNE2 21q22.12 -0.2 0.128 0.661 muscle contraction;blood circulation
his C1GALT1C1L -0.2 0.128 0.661
his MIR5702 -0.2 0.128 0.661
hs4 ANKRD45 1q25.1 -0.2 0.128 0.661
his LNX1 4q12 -0.2 0.128 0.66 protein ubiquitination involved in ubiquitin-
dependent protein catabolic process;protein homooligomerization
his LNX1-AS2 -0.2 0.128 0.66
hs4 DNMBP 10q24.2 -0.2 0.128 0.66 regulation of Rho protein signal
xai SMPX Xp22.1 -0.2 0.128 0.66 striated muscle contraction
xai MIPEPP1 -0.2 0.128 0.66
xai LOXL3 2p13 -0.2 0.128 0.66 oxidation-reduction process
his GAL3ST1 22q12.2 -0.2 0.128 0.66 spermatogenesis;biosynthetic
process
his MIR3150A -0.2 0.128 0.66
his LOC105375650 -0.2 0.128 0.66
his MIR3150B -0.2 0.128 0.66
his MIR5094 -0.2 0.128 0.66
swa NCEH1 3q26.31 -0.2 0.128 0.66 lipid catabolic process;metabolic process
his LOC101927635 -0.2 0.128 0.66
his PORCN Xp11.23 -0.2 0.128 0.66 Wnt receptor signaling pathway
xai GHR 5p13-p12 -0.2 0.128 0.66 succinate metabolic process;hormone-
his RAB19 7q34 -0.2 0.128 0.66 protein transport;small GTPase mediated signal
transduction
his LOC101927100 -0.2 0.128 0.66
his TICAM2 5q23.1 -0.2 0.128 0.66 inflammatory response;innate immune
response
his LINC01511 -0.2 0.128 0.66
his CARD14 17q25 -0.201 0.128 0.66 positive regulation of protein
phosphorylation;activation of NF-kappaB-inducing kinase activity
his CRB2 9q33.3 -0.201 0.128 0.66
his SP100 2q37.1 -0.201 0.128 0.66 response to type I
factor activity
xai COL10A1 6q21-q22 -0.201 0.128 0.66 skeletal system development
hs4 KIF26B 1q44 -0.201 0.128 0.66 microtubule-based
swa BAG2 6p12.1-p11.2 -0.201 0.128 0.66 Apoptosis
cop RAMP3 7p13-p12 -0.201 0.128 0.66
exp LOC100996348 -0.201 0.128 0.66
xai LIN37 19q13.1 -0.201 0.128 0.66 mitotic cell cycle
his LOC339874 -0.201 0.128 0.66
his NUDT16 3q22.1 -0.201 0.128 0.66
his LOC101929427 -0.201 0.128 0.66
his LDB3 10q22.3-q23.2 -0.201 0.128 0.66
xai LIN7A 12q21 0.2 0.129 0.661 protein transport;protein complex assembly
his LOC101929748 0.2 0.129 0.661
his ANKRD19P 9q22.31 0.2 0.129 0.661
his PSMA1 11p15.1 0.2 0.129 0.661 M/G1 transition of mitotic cell
hs4 LDHAL6A 11p15.1 0.2 0.129 0.661 glycolysis;cellular carbohydrate
metabolic process
swa YARS 1p35.1 0.2 0.129 0.661 Apoptosis
his ETFA 15q23-q25 0.2 0.129 0.661 transport;respiratory electron transport
chain
xai FAM205BP 0.2 0.129 0.661
his HMGB3 Xq28 0.2 0.129 0.661 DNA recombination;multicellular organismal
development
xai DAB1 1p32-p31 0.2 0.129 0.661 cell differentiation;multicellular
his ANXA10 4q33 0.2 0.129 0.661
xai NSUN2 5p15.31 0.2 0.129 0.661 tRNA processing;tRNA methylation
his NGDN 14q11.2 0.2 0.129 0.661 regulation of translation
his ELP3 8p21.1 0.2 0.129 0.661 regulation of transcription from RNA
hs4 C17orf102 17q12 0.2 0.129 0.661
hs4 TMEM132E 17q12 0.2 0.129 0.661
his BTBD6 14q32 0.2 0.129 0.661
his BRPF3 6p21 0.2 0.129 0.661 blood coagulation;chromatin modification
his DNAJB4 1p31.1 0.2 0.129 0.661 protein folding;response to
unfolded protein
his FUBP1 1p31.1 0.2 0.129 0.661 Tumor Suppressors
xai NCAPD3 11q25 0.2 0.129 0.661 DNA Damage Response (DDR)
xai PANX3 11q24.2 0.2 0.129 0.661 cell-cell signaling;protein
hexamerization
his TMEM33 4p13 0.2 0.129 0.661
his ERICH1 8p23.3 0.2 0.129 0.661
hs4 MPPE1 18p11.21 0.2 0.129 0.661 GPI anchor biosynthetic process;ER to
xai OR5AW1P Xq26.2 0.2 0.129 0.662
hs4 SNORA9 0.2 0.129 0.662
hs4 SNHG15 7p13 0.2 0.129 0.662
swa LSM4 19p13.11 0.2 0.129 0.662 RNA splicing;gene expression
his NT5C 17q25.1 0.2 0.129 0.662 purine base metabolic process;nucleobase-
xai C21orf59 21q22.1 0.2 0.129 0.662
xai MS4A15 11q12.2 0.2 0.129 0.662
his GPATCH8 17q21.31 0.2 0.129 0.662
his RPS7 2p25 0.2 0.129 0.662 translational initiation;viral infectious cycle
xai TCF12 15q21 0.2 0.129 0.662 regulation of transcription from RNA polymerase
xai FPR2 19q13.3-q13.4 0.2 0.129 0.662 G-protein coupled receptor
his LINC00998 0.2 0.129 0.662
xai POLR1D 13q12.2 0.2 0.129 0.662 transcription elongation from RNA
his COPB1 11p15.2 0.2 0.129 0.662 COPI coating of Golgi
hs4 TMEM132C 12q24.32 0.2 0.129 0.662
dependent"
exp LOC100129775 0.2 0.129 0.662
hs4 PAIP2B 2p13.3 0.2 0.129 0.662 negative regulation of
xai RNU11 1p35 0.2 0.129 0.662
xai LTB4R 14q11.2-q12 0.2 0.129 0.662 cellular component movement;muscle
contraction
exp YME1L1P1 0.2 0.129 0.662
xai CYP2F1 19q13.2 0.2 0.129 0.662 xenobiotic metabolic
his SPEF1 20p13 0.2 0.129 0.662
his CENPB 20p13 0.2 0.129 0.662 regulation of transcription, DNA-dependent"
xai LRRC26 9q34.3 0.2 0.129 0.662 ion transport
exp SLC35E1P1 0.2 0.129 0.662
xai BANP 16q24 0.2 0.129 0.662 multicellular organismal development;chromatin
modification
cop TGFBR1 9q22 0.198 0.129 0.661 Apoptosis
cop DEFB125 20p13 0.198 0.129 0.661
cop DEFB126 20p13 0.198 0.129 0.661 defense response to bacterium
cop DEFB127 20p13 0.198 0.129 0.661 innate immune response;defense response
to bacterium
cop DEFB128 0.198 0.129 0.661 defense response to bacterium
cop DEFB129 0.198 0.129 0.661
cop DEFB132 0.198 0.129 0.661
exp CA4 17q23 0.198 0.129 0.661 one-carbon metabolic process;bicarbonate
transport
xsq RCL1 9p24.1-p23 0.198 0.129 0.661 RNA processing;ribosome biogenesis
xsq CCDC57 17q25.3 0.198 0.129 0.661
met APOL1 22q13.1 0.198 0.129 0.661 lipoprotein metabolic process;transport
cop SOX12 20p13 0.198 0.129 0.661 spinal cord development;cell fate commitment
xsq SSSCA1 11q13.1 0.198 0.129 0.661 cell division;cell cycle
met GTSF1L 20q13.12 0.198 0.129 0.661
met LCE2A 1q21.3 0.198 0.129 0.661 keratinization
xsq SRSF9 12q24.31 0.198 0.129 0.661 termination of RNA polymerase II
met PRAMEF11 1p36.21 0.198 0.129 0.661
cop BCL2 18q21.3 0.198 0.129 0.661 Apoptosis; Protein Kinases
mut NHS Xp22.13 0.198 0.129 0.661 lens development in camera-type eye;cell
differentiation
cop CCDC121 2p23.3 0.198 0.129 0.661
cop GPN1 2p23.3 0.198 0.129 0.661
cop SUPT7L 2p23.3 0.198 0.129 0.661 regulation of transcription, DNA-
cop SLC4A1AP 2p23.3 0.198 0.129 0.661 Solute Carriers
cop MRPL33 2p21 0.198 0.129 0.661 translation
mut ABCD3 1p21.3 0.198 0.129 0.662 ABC Transporters
exp ELL 19p13.1 0.198 0.129 0.662 negative regulation of phosphatase
xsq MRS2P2 12q21.1 0.198 0.129 0.662
dependent"
met PLEKHH1 14q24.1 0.198 0.129 0.662
xsq RANBP3 19p13.3 0.198 0.129 0.662 protein transport;intracellular
transport
exp TELO2 16p13.3 0.198 0.129 0.662 DNA Damage Response (DDR); DDR (FA)
exp PINK1-AS 0.198 0.129 0.662
cop OCIAD2 4p11 0.198 0.129 0.662
mut PTPRA 20p13 0.198 0.129 0.662 protein phosphorylation;axon guidance
xsq KRT82 12q13 0.198 0.129 0.662
xsq YIPF7 4p12 0.198 0.129 0.662
met MTM1 Xq28 0.198 0.129 0.662 protein dephosphorylation;endosome to lysosome
transport
exp CD3EAP 19q13.3 0.198 0.129 0.662 rRNA transcription;transmembrane
xsq USE1 19p13.11 0.198 0.129 0.662 ER to Golgi vesicle-mediated
transport;lysosomal transport
mut TSC2 16p13.3 0.198 0.129 0.662 Apoptosis; Protein Kinases; Tumor
Suppressors
xsq LINC00538 0.198 0.129 0.662
xsq FRMPD2B 0.198 0.129 0.662
exp RPS8 1p34.1-p32 0.198 0.129 0.662 translational elongation;viral
transcription
xsq LIN7A 12q21 0.198 0.129 0.662 protein transport;protein complex assembly
exp MNDA 1q22 0.198 0.129 0.662 negative regulation of B cell
xsq PWP1 12q23.3 0.198 0.129 0.662 transcription, DNA-dependent"
xsq CRY1 12q23-q24.1 0.198 0.129 0.662 DNA Damage Response (DDR)
exp MDH2 7cen-q22 0.198 0.129 0.662 glucose metabolic process;small molecule
metabolic process
exp DNAH1 3p21.1 0.198 0.129 0.662 ciliary or flagellar
mut PAQR9 3q23 0.198 0.129 0.662
exp SNORD1A 17q25.1 0.198 0.129 0.662
xsq TMSB15A Xq21.33-q22.3 0.198 0.129 0.662 actin cytoskeleton
cop GRP 18q21.1-q21.32 0.198 0.129 0.662
pro PRKCA 17q22-q23.2 0.198 0.129 0.662 Apoptosis; Protein Kinases
mut PDCD11 10q24.33 0.198 0.129 0.662 Apoptosis
cop KHDC1L 6q13 0.198 0.129 0.662
cop KHDC1 6q13 0.198 0.129 0.662
cop C6orf147 6q13 0.198 0.129 0.662
cop DPPA5 6q13 0.198 0.129 0.662
cop KHDC3L 6q13 0.198 0.129 0.662
cop OOEP 6q13 0.198 0.129 0.662 establishment or maintenance of apical/basal
cell polarity;cellular protein complex assembly
cop DDX43 6q13 0.198 0.129 0.662
cop MB21D1 6q13 0.198 0.129 0.662 response to virus
met GLRB 4q31.3 0.198 0.129 0.662 startle response;ion transmembrane
transport
xsq C14orf39 14q23.1 0.198 0.129 0.662 regulation of sequence-specific DNA
xsq RPL38 17q25.1 0.198 0.129 0.662 translation;mRNA metabolic process
cop MMP15 16q13 0.198 0.129 0.662 Apoptosis
xsq HIST1H3J 6p22.1 0.198 0.129 0.662
exp PTP4A2 1p35 0.198 0.129 0.662
xsq LINC01006 0.198 0.129 0.662
xsq UCN 2p23-p21 0.198 0.129 0.662 positive regulation of cell
xsq RPL23AP64 11q23.3 0.198 0.129 0.662
xsq PRUNE 1q21 0.198 0.129 0.662
exp C21orf59 21q22.1 0.198 0.129 0.662
mut ASB5 4q34.2 0.198 0.129 0.662 intracellular signal transduction
exp CEBPA-AS1 19q13.11 0.198 0.129 0.662
cop VAT1L 16q23.1 0.198 0.129 0.662
exp COL5A3 19p13.2 -0.198 0.129 0.662 cell adhesion;cell-matrix
adhesion
exp CD9 12p13.3 -0.198 0.129 0.662 response to water
exp TUBA1A 12q13.12 -0.198 0.129 0.662 cellular protein metabolic
process;'de novo' posttranslational protein folding
exp RASD2 22q13.1 -0.198 0.129 0.662 synaptic transmission,
exp UGT2B7 4q13 -0.198 0.129 0.662 metabolic process;cellular
glucuronidation
exp TULP3 12p13.3 -0.198 0.129 0.662 regulation of transcription, DNA-
met NEU3 11q13.5 -0.198 0.129 0.662 carbohydrate metabolic
xsq NBPF13P 1q21.1 -0.198 0.129 0.662
xsq WNT5B 12p13.3 -0.198 0.129 0.662 Oncogenes
exp SERINC1 6q22.31 -0.198 0.129 0.662 lipid metabolic
exp PMP2 8q21.3-q22.1 -0.198 0.129 0.662
exp FKRP 19q13.32 -0.198 0.129 0.662 glycoprotein biosynthetic
process;protein processing
exp ANKRD36BP1 1q24.2 -0.198 0.129 0.662
xsq HOXB-AS3 17q21.32 -0.198 0.129 0.662
exp USP47 11p15.3 -0.198 0.129 0.662 cellular response to
UV;monoubiquitinated protein deubiquitination
xsq GCNT1 9q13 -0.198 0.129 0.662 O-glycan processing;post-translational
xsq BCAS4 20q13.13 -0.198 0.129 0.662
xsq C2 6p21.3 -0.198 0.129 0.662 proteolysis;complement activation
exp RDH5 12q13-q14 -0.198 0.129 0.662 response to stimulus;visual
perception
met GAST 17q21 -0.198 0.129 0.661
exp ZC3H12C 11q22.3 -0.198 0.129 0.661
cop RAB6B 3q22.1 -0.198 0.129 0.661 retrograde vesicle-mediated
transport, Golgi to ER;small GTPase mediated signal transduction
xsq PCDHGA4 -0.198 0.129 0.661 homophilic cell adhesion;cell
adhesion
met IL16 15q26.3 -0.198 0.129 0.661 regulation of transcription, DNA-
exp SYNE2 14q23.2 -0.198 0.129 0.661 positive regulation of cell
migration;nuclear migration along microfilament
cop THSD7A 7p21.3 -0.198 0.129 0.661
his LOC101928273 -0.2 0.129 0.662
swa UFSP2 4q35.1 -0.2 0.129 0.662 proteolysis;metabolic process
his BAG3 10q25.2-q26.2 -0.2 0.129 0.662 Apoptosis
xai SH3D21 1p34.3 -0.2 0.129 0.662
xai PRKAA2 1p31 -0.2 0.129 0.662 Protein Kinases
xai ZNF415 19q13.42 -0.2 0.129 0.662 regulation of transcription, DNA-
dependent"
his SSH1 12q24.11 -0.2 0.129 0.662 protein dephosphorylation;regulation of
his STX3 11q12.1 -0.2 0.129 0.662 cellular membrane fusion;neuron
hs4 PLPP1 -0.2 0.129 0.662 lipid metabolic process;androgen receptor
signaling pathway
hs4 RNF138P1 -0.2 0.129 0.662
xai KRTAP13-3 -0.2 0.129 0.662
xai FBLN5 14q32.1 -0.2 0.129 0.662 regulation of removal of superoxide
hs4 ROBO1 3p12 -0.2 0.129 0.662 multicellular organismal development;cell
differentiation
xai AP2A1 19q13.33 -0.2 0.129 0.662 epidermal growth factor receptor
swa BAG6 6p21.3 -0.2 0.129 0.662 transport;lung development
his FUT2 19q13.3 -0.2 0.129 0.662 carbohydrate metabolic process;protein
glycosylation
xai PLSCR2 3q24 -0.2 0.129 0.662 phospholipid scrambling
his LRRN4CL 11q12.3 -0.2 0.129 0.662
xai STAP2 19p13.3 -0.2 0.129 0.662
his IFFO2 1p36.13 -0.2 0.129 0.662
exp AGPAT5P1 Yp11.2 -0.2 0.129 0.662
xai LRRTM2 5q31.2 -0.2 0.129 0.662
xai AGPAT5P1 Yp11.2 -0.2 0.129 0.662
exp KRTAP13-3 -0.2 0.129 0.662
swa BLVRB 19q13.1-q13.2 -0.2 0.129 0.661 small molecule metabolic
swa PON2 7q21.3 -0.2 0.129 0.661 response to oxidative stress;aromatic
compound catabolic process
xai SLC9A1 1p36.1-p35 -0.2 0.129 0.661 Solute Carriers
xai GFRA1 10q26.11 -0.2 0.129 0.661 glial cell-derived neurotrophic factor
receptor signaling pathway;cell surface receptor signaling pathway
hs4 LMLN 3q29 -0.2 0.129 0.661 cell cycle;mitosis
hs4 PCDHB1 -0.2 0.129 0.661
his PSEN2 1q42.13 -0.2 0.129 0.661 Apoptosis
swa SEC13 3p25-p24 -0.2 0.129 0.661 cellular membrane organization;vesicle-
mediated transport
his P2RY13 3q24 -0.2 0.129 0.661
his MISP3 0.2 0.13 0.662
his MIR1199 0.2 0.13 0.662
hs4 MIR9-3 0.2 0.13 0.662
his DDX17 22q13.1 0.2 0.13 0.662 RNA processing;positive regulation of
intracellular estrogen receptor signaling pathway
hs4 LBHD1 0.2 0.13 0.662
hs4 UQCC3 0.2 0.13 0.662
his SERPINB13 18q21.33 0.2 0.13 0.663 response to UV;negative regulation
of endopeptidase activity
xai LOC100133130 0.2 0.13 0.663
xai SVBP 0.2 0.13 0.663
xai RAE1 20q13.31 0.2 0.13 0.663 mRNA export from nucleus;cellular
his PROK2 3p13 0.2 0.13 0.663 spermatogenesis;activation of MAPK activity
xai CATSPERD 19p13.3 0.2 0.13 0.663
swa PCBP2 12q13.13 0.2 0.13 0.663 mRNA metabolic process;negative
xai MRPL54 19p13.3 0.199 0.13 0.663
xai LOC100129775 0.199 0.13 0.663
exp BMP8A 1p34.3 0.199 0.13 0.663 ossification;multicellular organismal
development
hs4 HORMAD2-AS1 0.199 0.13 0.663
hs4 HORMAD2 22q12.2 0.199 0.13 0.663 meiosis
hs4 RNVU1-17 0.199 0.13 0.663
exp TCL6 14q32.1 0.199 0.13 0.663
his LDHA 11p15.4 0.199 0.13 0.663 pyruvate metabolic process;glycolysis
xai PLA2G7 6p21.2-p12 0.199 0.13 0.663 low-density lipoprotein particle
xai MTMR6 13q12 0.199 0.13 0.663 protein dephosphorylation;peptidyl-tyrosine
dephosphorylation
hs4 PLCD1 3p22-p21.3 0.199 0.13 0.663 phospholipid metabolic process;lipid
catabolic process
his KCNJ6 21q22.1 0.199 0.13 0.663 potassium ion transport;synaptic
transmission
his MEF2C 5q14.3 0.199 0.13 0.663 osteoblast differentiation;regulation of
germinal center formation
his TMEM72-AS1 0.199 0.13 0.663
his RASSF4 10q11.21 0.199 0.13 0.663 cell cycle;signal transduction
exp MFSD2B 2p23.3 0.199 0.13 0.663 transport
exp FRA10AC1 10q23.33 0.199 0.13 0.663
his C11orf24 11q13 0.199 0.13 0.663
xai CHCHD2P8 13q12.2 0.199 0.13 0.663
his ART3 4q21.1 0.199 0.13 0.663 protein ADP-ribosylation
his LINC01931 0.199 0.13 0.663
his EP400NL 12q24.33 0.199 0.13 0.663
exp LOC286083 0.199 0.13 0.663
his MMS19 10q24-q25 0.199 0.13 0.663 DNA Damage Response (DDR)
his UBTD1 10q24.2 0.199 0.13 0.663
his TMED1 19p13.2 0.199 0.13 0.663 signal transduction;cell-cell signaling
his RPIA 2p11.2 0.199 0.13 0.663 carbohydrate metabolic process;pentose-
phosphate shunt
xai ATRAID 2p23.3 0.199 0.13 0.663
his PNRC2 1p36.11 0.199 0.13 0.663 regulation of transcription, DNA-
his NRIP2 12p13.33 0.199 0.13 0.663
his LOC100507424 0.199 0.13 0.663
his GUSBP2 6p21 0.199 0.13 0.663
his LINC00240 6p22.2 0.199 0.13 0.663
hs4 INGX Xq12 0.199 0.13 0.663
his LINC00526 18p11.31 0.199 0.13 0.663
his LINC00667 18p11.31 0.199 0.13 0.663
his RNVU1-14 0.199 0.13 0.663
xai KIAA1143 3p21.31 0.199 0.13 0.663
xai HAUS5 19q13.12 0.199 0.13 0.663 spindle assembly;centrosome organization
xai SEPHS1 10p14 0.199 0.13 0.663 protein modification process
xai VRK3 19q13 0.199 0.13 0.663 positive regulation of phosphoprotein
xai RFC1 4p14-p13 0.199 0.13 0.663 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
his ALG9 11q23 0.199 0.13 0.663 GPI anchor biosynthetic process;protein N-
linked glycosylation via asparagine
his PCDHA4 0.199 0.13 0.663 cell adhesion;homophilic cell adhesion
his P4HA1 10q21.3-q23.1 0.199 0.13 0.663 peptidyl-proline hydroxylation to
4-hydroxy-L-proline;collagen fibril organization
his MIR4750 0.199 0.13 0.663
his POM121C 7q11.2 0.199 0.13 0.663 protein transport;mRNA transport
xai MPC1 6q27 0.199 0.13 0.663
xai GID4 17p11.2 0.199 0.13 0.663
xai DNAAF2 14q21.3 0.199 0.13 0.663 ciliary cell motility;flagellar
cell motility
his IFNGR1 6q23.3 0.199 0.13 0.663 regulation of interferon-gamma-
mediated signaling pathway;signal transduction
hs4 ELP2 18q12.2 0.199 0.13 0.663 regulation of transcription from RNA
his PPM1L 3q26.1 0.199 0.13 0.663 small molecule metabolic process;MAPK
cascade
met GLT8D1 3p21.1 0.198 0.13 0.662
cop MTO1 6q13 0.198 0.13 0.662 tRNA processing;oxidation-reduction process
xsq EIF4EBP2 10q21-q22 0.198 0.13 0.662 negative regulation of
xsq HNRNPA2B1 7p15 0.198 0.13 0.662 RNA transport;nuclear mRNA splicing, via
spliceosome
exp C1orf123 1p32.3 0.198 0.13 0.662
cop C20orf27 20p13 0.198 0.13 0.662
exp PPM1M 3p21.2 0.198 0.13 0.662 protein dephosphorylation
exp HAO2 1p13.3-p13.1 0.198 0.13 0.663 mandelate metabolic process;fatty
acid oxidation
cop DUSP22 6p25.3 0.198 0.13 0.663 Apoptosis
cop ADD2 2p13.3 0.198 0.13 0.663 actin cytoskeleton
organization;hemopoiesis
xsq EHHADH-AS1 0.198 0.13 0.663
cop EEF1A1 6q14.1 0.198 0.13 0.663 translation;translational
elongation
exp HILPDA 7q32.1 0.198 0.13 0.663 positive regulation of cell
xsq PPP6R1 19q13.42 0.198 0.13 0.663 DNA Damage Response (DDR)
xsq SIRT3 11p15.5 0.198 0.13 0.663 protein ADP-ribosylation;protein
deacetylation
xsq THADA 2p21 0.198 0.13 0.663
xsq SUV420H2 19q13.42 0.198 0.13 0.663
xsq CMAHP 6p21.32 0.198 0.13 0.663
xsq HDAC2 6q21 0.198 0.13 0.663 negative regulation of neuron projection
met FAT1 4q35 0.198 0.13 0.663 anatomical structure morphogenesis;cell-cell
adhesion
cop CTRB1 0.198 0.13 0.663
exp ASCC1 10pter-q25.3 0.198 0.13 0.663 regulation of transcription, DNA-
dependent"
met SYBU 8q23.2 0.198 0.13 0.663
cop SNORD111B 0.198 0.13 0.663
cop SNORD111 16q22.1 0.198 0.13 0.663
xsq ARL2 11q13 0.198 0.13 0.663 tubulin complex assembly;centrosome
organization
xsq ARL5A 2q23.3 0.198 0.13 0.663 small GTPase mediated signal transduction
xsq MON1B 16q23.1 0.198 0.13 0.663
met KLHL42 12p11.22 0.198 0.13 0.663
met DCLK2 4q31.3 0.198 0.13 0.663 intracellular signal transduction
mut PNMAL1 19q13.32 0.198 0.13 0.663
exp TOR2A 9q34.11 0.198 0.13 0.663 chaperone mediated protein folding
requiring cofactor
exp RPL31P35 7p11.2 0.198 0.13 0.663
cop PLA2G15 16q22.1 0.198 0.13 0.663 lipid metabolic process;ceramide
metabolic process
cop SLC7A6OS 16q22.1 0.198 0.13 0.663 Solute Carriers
cop PRMT7 16q22.1 0.198 0.13 0.663 spliceosomal snRNP assembly;histone
xsq SMIM12 1p34.3 0.198 0.13 0.663
cop MALT1 18q21 0.198 0.13 0.663 Apoptosis
exp DDX23 12q13.12 0.198 0.13 0.663 RNA splicing, via transesterification
exp RPS11P6 12q14.2 0.198 0.13 0.663
met PBX4 19p12 0.198 0.13 0.663 transcription from RNA polymerase II
cop BCAR1 16q23.1 0.198 0.13 0.663 G-protein coupled receptor signaling
pathway;cellular response to hepatocyte growth factor stimulus
exp LEMD3 12q14 0.198 0.13 0.663 negative regulation of transforming growth
met NOVA1 14q 0.198 0.13 0.663 RNA processing;synaptic transmission
cop ARRB1 11q13 0.198 0.13 0.663 cellular membrane organization;positive
regulation of histone acetylation
exp PLD5 1q43 0.198 0.13 0.663
cop PPM1B 2p21 0.198 0.13 0.663 protein dephosphorylation;cytokine-mediated
signaling pathway
cop PREPL 2p21 0.198 0.13 0.663 proteolysis
cop MIR548AD 0.198 0.13 0.663
xsq LOC100128288 17p13.1 0.198 0.13 0.663
xsq PRR13 0.198 0.13 0.663 regulation of transcription, DNA-dependent"
xsq TAF1L 9p21.1 0.198 0.13 0.663 male meiosis;histone acetylation
exp MCRS1 12q13.12 0.198 0.13 0.663 DNA Damage Response (DDR); DDR
(Chromatin)
dependent"
xsq TRAPPC4 11q23.3 0.198 0.13 0.663 ER to Golgi vesicle-mediated
xsq CEP95 17q23.3 0.198 0.13 0.663
xsq RPS7 2p25 0.197 0.13 0.663 translational initiation;viral infectious cycle
mut KRT1 12q13.13 0.197 0.13 0.663 complement activation, lectin
xsq CACNA2D1 7q21-q22 0.197 0.13 0.663 regulation of calcium ion transport
via voltage-gated calcium channel activity;ion transport
xsq RPSAP58 19p12 0.197 0.13 0.663
exp MUC12 7q22 0.197 0.13 0.663 post-translational protein
xsq PPP1R3E 14q11.2 0.197 0.13 0.663 regulation of glycogen catabolic
exp ETNPPL 4q25 -0.197 0.13 0.663
exp SYNPO 5q33.1 -0.197 0.13 0.663 positive regulation of actin
cop ZFPM2 8q23 -0.197 0.13 0.663 blood coagulation;negative regulation of
cell death
cop CTNNA1 5q31.2 -0.197 0.13 0.663 Apoptosis; Tumor Suppressors
cop ZNF704 8q21.13 -0.198 0.13 0.663
xsq PIP 7q34 -0.198 0.13 0.663
met WNT2B 1p13 -0.198 0.13 0.663 Apoptosis; Oncogenes
xsq LOC100132735 -0.198 0.13 0.663
mut DNAJB4 1p31.1 -0.198 0.13 0.663 protein folding;response to
unfolded protein
exp MCOLN1 19p13.2 -0.198 0.13 0.663 transferrin
exp RHOD 11q14.3 -0.198 0.13 0.663 GTP catabolic process;small GTPase
exp LCE1A 1q21.3 -0.198 0.13 0.663 keratinization
cop NDUFS4 5q11.1 -0.198 0.13 0.663 transport;response to cAMP
exp PSAP 10q21-q22 -0.198 0.13 0.663 glycosphingolipid metabolic
exp OPN1SW 7q32.1 -0.198 0.13 0.663 visual
perception;phototransduction
xsq LARGE 22q12.3 -0.198 0.13 0.663 protein
cop DLG1 3q29 -0.198 0.13 0.663 mitotic cell cycle G1/S transition
cop LOC100129427 -0.198 0.13 0.663
xsq DBNDD1 16q24.3 -0.198 0.13 0.663
exp DUBR -0.198 0.13 0.663
exp CAB39L 13q14.2 -0.198 0.13 0.663 cell cycle arrest;insulin
exp MYADM 19q13.42 -0.198 0.13 0.663
met GNB3 12p13 -0.198 0.13 0.663 small molecule metabolic process;cellular
met ART1 11p15 -0.198 0.13 0.663 protein ADP-ribosylation;innate immune
response
xsq CNR1 6q14-q15 -0.198 0.13 0.663 positive regulation of acute
exp MRPS7P2 12p13.1 -0.198 0.13 0.663
exp VCAN 5q14.3 -0.198 0.13 0.662 axon regeneration;cell adhesion
cop LOC647323 -0.198 0.13 0.662
exp PP14571 2q37.3 -0.198 0.13 0.662
xai INPP4B 4q31.21 -0.199 0.13 0.663 signal
exp MIPEPP1 -0.199 0.13 0.663
xai C8orf49 8p23.1 -0.199 0.13 0.663
exp C8orf49 8p23.1 -0.199 0.13 0.663
his LINC00696 -0.199 0.13 0.663
hs4 DNAL1 14q24.3 -0.199 0.13 0.663
his NUPR1 16p11.2 -0.199 0.13 0.663 induction of apoptosis;cell growth
xai MGAT5B 17q25.2 -0.199 0.13 0.663
xai LOC100506136 -0.199 0.13 0.663
his TACC1 8p11.22 -0.199 0.13 0.663 regulation of microtubule-based
hs4 ALDH1L1 3q21.3 -0.199 0.13 0.663 biosynthetic process;10-
hs4 ALDH1L1-AS2 -0.199 0.13 0.663
exp CUX2 12q24.12 -0.199 0.13 0.663 regulation of transcription, DNA-
hs4 IL20RA 6q23.3 -0.199 0.13 0.663
xai PCDHGC3 -0.199 0.13 0.663 cell adhesion;homophilic cell
adhesion
hs4 NPY5R 4q31-q32 -0.199 0.13 0.663 cardiac left ventricle
morphogenesis;positive regulation of smooth muscle cell proliferation
hs4 IL1RL2 2q12 -0.199 0.13 0.663 cellular defense response;signal
transduction
hs4 C19orf33 19q13.2 -0.199 0.13 0.663
his FBXO10 9p13.2 -0.199 0.13 0.663 protein ubiquitination
exp LRGUK 7q33 -0.199 0.13 0.663
xai LOC100996348 -0.199 0.13 0.663
xai GLIPR2 9p13.3 -0.199 0.13 0.663
xai FZD4 11q14.2 -0.199 0.13 0.663 brain development;substrate
xai IGF2BP2 3q27.2 -0.199 0.13 0.663 anatomical structure
exp LOC100507516 -0.199 0.13 0.663
swa RECQL 12p12 -0.199 0.13 0.663 DNA Damage Response (DDR); DDR (HR)
swa PLD3 19q13.2 -0.199 0.13 0.663 lipid catabolic process
his PELO 5q11.2 -0.199 0.13 0.663 cell cycle;cell proliferation
his ITGA1 5q11.2 -0.199 0.13 0.663 activation of MAPK
hs4 MYO18A 17q11.2 -0.199 0.13 0.663 DNA metabolic process;anti-
apoptosis
his PLAC1 Xq26 -0.199 0.13 0.663 placenta development;multicellular
his STK32A 5q32 -0.199 0.13 0.663
his MT1M 16q13 -0.2 0.13 0.663 negative regulation of growth
his ZDHHC7 16q24.1 -0.2 0.13 0.663
hs4 TMEM51-AS1 1p36.21 -0.2 0.13 0.663
hs4 TMEM51 1p36.21 -0.2 0.13 0.663
hs4 DNAL4 22q13.1 -0.2 0.13 0.662 nerve growth factor receptor signaling
pathway;microtubule-based movement
his TLL2 10q23-q24 -0.2 0.13 0.662 proteolysis;multicellular organismal
development
his GFOD2 16q22.1 0.199 0.131 0.663 extracellular matrix organization
his RPL9 4p13 0.199 0.131 0.663 gene expression;viral reproduction
his LIAS 4p14 0.199 0.131 0.663 lipoate biosynthetic process;response to
lipopolysaccharide
xai DCPS 11q24.2 0.199 0.131 0.663 deadenylation-dependent decapping of
nuclear-transcribed mRNA;gene expression
xai NAPG 18p11.22 0.199 0.131 0.663 protein complex assembly;intracellular
protein transport
exp FAM205BP 0.199 0.131 0.663
his TRMT1 19p13.2 0.199 0.131 0.663 tRNA processing
his NACC1 19p13.2 0.199 0.131 0.663 induction of apoptosis;positive
xai TMEM143 19q13.33 0.199 0.131 0.663
xai GATAD2B 1q21.3 0.199 0.131 0.663
xai LZIC 1p36.22 0.199 0.131 0.663 response to ionizing radiation
his PAQR4 16p13.3 0.199 0.131 0.663
his CYTH1 17q25 0.199 0.131 0.663 vesicle-mediated transport;regulation of cell
adhesion
xai STK4 20q11.2-q13.2 0.199 0.131 0.663 Apoptosis
xai KLHL7-AS1 0.199 0.131 0.663
his PKLR 1q21 0.199 0.131 0.663 response to nutrient;response to ATP
his FDPS 1q22 0.199 0.131 0.663 cholesterol biosynthetic process;isoprenoid
xai ZBTB2 6q25.1 0.199 0.131 0.663 regulation of transcription, DNA-
dependent"
hs4 NFATC1 18q23 0.199 0.131 0.663 transcription from RNA polymerase II
his SMUG1 12q13.13 0.199 0.131 0.663 DNA Damage Response (DDR); DDR (BER)
xai AEN 15q26.1 0.199 0.131 0.663 apoptotic process;response to DNA damage
stimulus
his HNRNPAB 5q35.3 0.199 0.131 0.664 epithelial to mesenchymal
hs4 HMSD 18q22.1 0.199 0.131 0.664
exp KRTAP10-3 0.199 0.131 0.664
hs4 RFX7 15q21.3 0.199 0.131 0.664 regulation of transcription, DNA-
dependent"
exp FGF23 12p13.3 0.199 0.131 0.664 insulin receptor signaling
xai GRK6P1 13q12.11 0.199 0.131 0.664
xai FEM1AP3 6q21 0.199 0.131 0.664
exp HAUS5 19q13.12 0.199 0.131 0.664 spindle assembly;centrosome organization
hs4 TEX22 14q32.33 0.199 0.131 0.664
his STAU2 8q21.11 0.199 0.131 0.664 transport
xai KRTAP10-3 0.199 0.131 0.664
his SNAPC4 9q34.3 0.199 0.131 0.664 regulation of transcription, DNA-
his SEPSECS 4p15.2 0.199 0.131 0.664 selenocysteine
his SEPSECS-AS1 0.199 0.131 0.664
hs4 COG4 16q22.1 0.199 0.131 0.664 Golgi vesicle prefusion complex
hs4 SF3B3 16q22.1 0.199 0.131 0.664 RNA splicing, via transesterification
hs4 SNORD111B 0.199 0.131 0.664
exp RPL5P30 11q23.3 0.199 0.131 0.664
xai EXOG 3p21.3 0.199 0.131 0.664 DNA Damage Response (DDR)
xai TPGS2 18q12.2 0.199 0.131 0.664
his PEX12 17q12 0.199 0.131 0.664 protein import into peroxisome matrix;protein
targeting to peroxisome
exp OR2AG2 11p15.4 0.199 0.131 0.664 response to stimulus
hs4 CCR1 3p21 0.199 0.131 0.664 dendritic cell chemotaxis;cell surface receptor
signaling pathway
xai RAB40C 16p13.3 0.199 0.131 0.664 small GTPase mediated signal
his RNF186 1p36.13 0.199 0.131 0.664
xai GTF3C2-AS1 0.199 0.131 0.664
his SPATA32 17q21.31 0.199 0.131 0.664
xai CD3EAP 19q13.3 0.199 0.131 0.664 rRNA transcription;transmembrane
his SNORA100 0.199 0.131 0.664
his HNRNPU 1q44 0.199 0.131 0.664 RNA processing;RNA splicing
xai PBX2 6p21.3 0.199 0.131 0.664 positive regulation of transcription from
xai NACA3P 4q32.3 0.199 0.131 0.664
xai ICAM4 19p13.2 0.199 0.131 0.664 cell-cell adhesion;regulation of immune
response
his RPL32 3p25-p24 0.199 0.131 0.665 SRP-dependent cotranslational protein
his SNORA7A 3p25 0.199 0.131 0.665
xai CISD3 17q12 0.199 0.131 0.665
hs4 RAD52 12p13-p12.2 0.199 0.131 0.665 DNA Damage Response (DDR); DDR (HR)
exp EEF1A1P42 6p12.3 0.199 0.131 0.665
cop SUSD3 9q22.31 0.197 0.131 0.663
xsq HGF 7q21.1 0.197 0.131 0.663 proteolysis;positive regulation of
xsq KRT32 17q21.2 0.197 0.131 0.663 epidermis development
xsq DUSP6 12q22-q23 0.197 0.131 0.663 MyD88-independent toll-like receptor
cop SEH1L 18p11.21 0.197 0.131 0.663 mitotic prometaphase;protein transport
xsq TFB1M 6q25.1-q25.3 0.197 0.131 0.663 regulation of transcription, DNA-
dependent"
mut SLAMF9 1q23.2 0.197 0.131 0.663
cop CDC25B 20p13 0.197 0.131 0.663 DNA Damage Response (DDR)
cop AP5S1 20p13 0.197 0.131 0.663 double-strand break repair via homologous
recombination;DNA repair
cop PSMG2 18p11.21 0.197 0.131 0.663 mitotic cell cycle spindle assembly
cop CEP76 18p11.21 0.197 0.131 0.663 G2/M transition of mitotic cell
cop PTPN2 18p11.3-p11.2 0.197 0.131 0.663 protein dephosphorylation;insulin
met TSHZ2 20q13.2 0.197 0.131 0.663 multicellular organismal development
xsq DNAJA3 16p13.3 0.197 0.131 0.663 Apoptosis
xsq CPSF2 14q31.1 0.197 0.131 0.663 gene expression;nuclear mRNA splicing,
via spliceosome
exp LINC00926 15q21.3 0.197 0.131 0.663
exp ZDHHC17 12q21.2 0.197 0.131 0.663 signal transduction;magnesium ion
transport
exp MYCBP 1p33-p32.2 0.197 0.131 0.663 spermatogenesis;regulation of
mut BHMT2 5q13 0.197 0.131 0.663 methionine biosynthetic process
exp EXOSC6 16q22.1 0.197 0.131 0.663 DNA deamination;nuclear-transcribed
mRNA catabolic process, deadenylation-dependent decay
cop CEP192 18p11.21 0.197 0.131 0.663 G2/M transition of mitotic cell
exp MTMR6 13q12 0.197 0.131 0.664 protein dephosphorylation;peptidyl-tyrosine
dephosphorylation
xsq PMPCB 7q22.1 0.197 0.131 0.664 proteolysis
xsq COX15 10q24 0.197 0.131 0.664 mitochondrial electron transport, cytochrome c
to oxygen;heme a biosynthetic process
cop NRSN2 20p13 0.197 0.131 0.664
xsq METTL18 1q24.2 0.197 0.131 0.664
exp RPL7AP46 0.197 0.131 0.664
cop GABARAPL2 16q22.1 0.197 0.131 0.664 positive regulation of ATPase
activity;intra-Golgi vesicle-mediated transport
cop ADAT1 16q23.1 0.197 0.131 0.664 RNA processing;tRNA processing
xsq IDH3A 15q25.1-q25.2 0.197 0.131 0.664 carbohydrate metabolic
met LIPG 18q21.1 0.197 0.131 0.664 cell proliferation;regulation of
xsq PRDM10 11q25 0.197 0.131 0.664 regulation of transcription, DNA-
dependent"
cop FIGLA 2p13.3 0.197 0.131 0.664 cell differentiation;oogenesis
cop CLEC4F 2p13.3 0.197 0.131 0.664 endocytosis
cop CD207 2p13 0.197 0.131 0.664 antigen processing and presentation of peptide
antigen via MHC class I;antigen processing and presentation of exogenous peptide
antigen via MHC class I, TAP-dependent
cop VAX2 2p13 0.197 0.131 0.664 multicellular organismal development;ectoderm
development
cop ATP6V1B1 2p13.1 0.197 0.131 0.664 ossification;transferrin transport
cop ANKRD53 2p13.3 0.197 0.131 0.664
cop TEX261 2p13.3 0.197 0.131 0.664 positive regulation of apoptotic
process
cop SEC11C 18q21.32 0.197 0.131 0.664 small molecule metabolic
exp LOC100129478 16p13.3 0.197 0.131 0.664
mut EDEM3 1q25 0.197 0.131 0.664 glycoprotein catabolic process;response to
unfolded protein
xsq SERP1 3q25.1 0.197 0.131 0.664 glucose metabolic process;protein
transport
met EHD2 19q13.3 0.197 0.131 0.664 endocytosis;blood coagulation
exp ODF3B 22q13.33 0.197 0.131 0.664
met MRPS24 7p14 0.197 0.131 0.664 translation
xsq ELANE 19p13.3 0.197 0.131 0.664 cellular calcium ion homeostasis;negative
exp CCDC125 5q13.2 0.197 0.131 0.664
cop MAN2C1 15q24.2 0.197 0.131 0.664 mannose metabolic
exp UQCRFS1P1 22q13.1 0.197 0.131 0.664 response to hormone
mut DLG2 11q14.1 0.197 0.131 0.664 receptor clustering;neuronal ion channel
clustering
xsq UBOX5 20p13 0.197 0.131 0.664 protein polyubiquitination
met THBS3 1q21 0.197 0.131 0.664 cell adhesion;cell-matrix adhesion
mut SPATA13 13q12.12 0.197 0.131 0.664 filopodium assembly;cell migration
xsq NDUFB10 16p13.3 0.197 0.131 0.664 mitochondrial electron transport,
cop BIRC6 2p22.3 0.197 0.131 0.664 Apoptosis
cop PPP1R21 2p16.3 0.197 0.131 0.664
xsq TG 8q24 0.197 0.131 0.664 regulation of myelination;response to
lipopolysaccharide
mut FZR1 19p13.3 0.197 0.131 0.664 DNA repair;cell division
exp DSG3 18q12.1 0.197 0.131 0.664 cellular component disassembly involved
mut CNTRL 9q33.2 0.197 0.131 0.665 G2/M transition of mitotic cell
exp WNT10B 12q13 0.197 0.131 0.665 Apoptosis; Oncogenes
exp USP49 6p21 0.197 0.131 0.665 ubiquitin-dependent protein catabolic
process;proteolysis
mut APPL1 3p21.1-p14.3 0.197 0.131 0.665 signal transduction;cell
proliferation
met COLCA2 0.197 0.131 0.665
exp RPSAP10 10p12.1 0.197 0.131 0.665
exp NKX1-2 10q26.13 -0.197 0.131 0.665 multicellular organismal
development
cop TMEM67 8q22.1 -0.197 0.131 0.665 cilium assembly;branching
met BST1 4p15 -0.197 0.131 0.665 humoral immune response;multicellular
exp BCL9L 11q23.3 -0.197 0.131 0.665 negative regulation of transforming
met CST9 20p11.21 -0.197 0.131 0.664
xsq NCAM1 11q23.1 -0.197 0.131 0.664 interferon-gamma-mediated signaling
exp CXorf23 Xp22.12 -0.197 0.131 0.664
exp C5orf47 5q35.2 -0.197 0.131 0.664
exp C6orf1 6p21.31 -0.197 0.131 0.664
DNA-dependent"
exp LRP12 8q22.2 -0.197 0.131 0.664 EMT (Mesenchymal)
exp RLN2 9p24.1 -0.197 0.131 0.664 female pregnancy
cop RNU6-72P -0.197 0.131 0.664
xsq PLEKHA1 10q26.13 -0.197 0.131 0.664 female gonad
met GCHFR 15q15 -0.197 0.131 0.664 negative regulation of GTP cyclohydrolase
met DNPH1 6p21.1 -0.197 0.131 0.664
xsq VWA2 10q25.3 -0.197 0.131 0.664
exp SEC24A 5q31.1 -0.197 0.131 0.664 ER to Golgi vesicle-mediated
xsq C1QTNF6 22q13.1 -0.197 0.131 0.663
xsq NEAT1 11q13.1 -0.197 0.131 0.663
exp TRPC4 13q13.3 -0.197 0.131 0.663 ion transport;calcium ion transport
exp C3orf52 3q13.2 -0.197 0.131 0.663
exp PELO 5q11.2 -0.197 0.131 0.663 cell cycle;cell proliferation
exp KLF6 10p15 -0.197 0.131 0.663 regulation of transcription, DNA-
dependent;cytokine-mediated signaling pathway
exp ARL2BP 16q13 -0.197 0.131 0.663 maintenance of protein location in
xsq ANXA5 4q27 -0.197 0.131 0.663 Apoptosis
xsq ATP6V0A4 7q34 -0.197 0.131 0.663 ion transport;transferrin transport
mut CHMP2A 19q -0.197 0.131 0.663 protein transport;cellular membrane
organization
hs4 SRC 20q12-q13 -0.199 0.131 0.665 Apoptosis; Oncogenes; Protein
Kinases
xai LZTS1-AS1 -0.199 0.131 0.665
his NRP2 2q33.3 -0.199 0.131 0.665 angiogenesis;positive regulation of
his LOC389273 -0.199 0.131 0.665
his FGF18 5q34 -0.199 0.131 0.665 chondrocyte development;positive
regulation of vascular endothelial growth factor receptor signaling pathway
xai TSPAN15 10q22.1 -0.199 0.131 0.664
hs4 MEDAG 13q12.3 -0.199 0.131 0.664
his IFI44L 1p31.1 -0.199 0.131 0.664 immune response;response to
virus
hs4 PLA2G16 11q12.3 -0.199 0.131 0.664 phospholipid metabolic
his RIN1 11q13.2 -0.199 0.131 0.664 endocytosis;signal transduction
exp FAM183BP -0.199 0.131 0.664
xai CMTM4 16q21-q22.1 -0.199 0.131 0.664 chemotaxis
hs4 KIAA2026 9p24.1 -0.199 0.131 0.664
hs4 MIR4665 -0.199 0.131 0.664
his TMEM100 17q22 -0.199 0.131 0.664
xai CACNA1C-IT3 -0.199 0.131 0.664
xai FAXDC2 5q31-q32 -0.199 0.131 0.664
hs4 TBC1D9B 5q35.3 -0.199 0.131 0.664
xai PKMP2 Xq12 -0.199 0.131 0.664
swa REEP5 5q22-q23 -0.199 0.131 0.664
hs4 C9orf50 9q34.11 -0.199 0.131 0.664
exp MSANTD1 4p16.3 -0.199 0.131 0.664
his MIR4260 -0.199 0.131 0.664
xai ZCCHC24 10q22.3 -0.199 0.131 0.664
swa ADAM9 8p11.22 -0.199 0.131 0.664 membrane protein ectodomain
swa PICALM 11q14 -0.199 0.131 0.664 vesicle-mediated transport;clathrin
coat assembly
swa LAMA5 20q13.2-q13.3 -0.199 0.131 0.663 integrin-mediated signaling
pathway;cell differentiation
his TGM1 14q11.2 -0.199 0.131 0.663 protein modification
process;peptide cross-linking
xai MS4A18 11q12.2 -0.199 0.131 0.663
xai ENTPD4 8p21.3 -0.199 0.131 0.663 UDP catabolic process
his TRIL 7p14.3 -0.199 0.131 0.663 innate immune response;regulation
his MIR589 -0.199 0.131 0.663
hs4 RHOJ 14q23.2 -0.199 0.131 0.663 GTP catabolic process;small GTPase
met ARL4A 7p21.3 0.2 0.132 0.665 brown fat cell differentiation;small
his ADA 20q13.12 0.199 0.132 0.665 in utero embryonic development;negative
regulation of mature B cell apoptosis
his HCK 20q11-q12 0.199 0.132 0.665 exocytosis;cytokine-mediated signaling
pathway
his LOC101927768 0.199 0.132 0.665
his HDAC2 6q21 0.199 0.132 0.665 negative regulation of neuron projection
xai NCOA5 20q12-q13.12 0.199 0.132 0.665 regulation of transcription, DNA-
dependent"
xai FRA10AC1 10q23.33 0.199 0.132 0.665
xai MYH4 17p13.1 0.199 0.132 0.665 muscle contraction;response to activity
his ZNF675 19p12 0.199 0.132 0.665 I-kappaB kinase/NF-kappaB
cascade;negative regulation of interleukin-1-mediated signaling pathway
exp GTF3C2-AS1 0.199 0.132 0.665
xai HIST1H2BH 6p21.3 0.198 0.132 0.665 nucleosome assembly
xai C14orf39 14q23.1 0.198 0.132 0.665 regulation of sequence-specific DNA
his BRD2 6p21.3 0.198 0.132 0.665 spermatogenesis
xai BTF3P10 6q25.1 0.198 0.132 0.665
xai ADAMTS18 16q23 0.198 0.132 0.665 proteolysis
his GABPA 21q21.3 0.198 0.132 0.665 Transcription Factors
his ATP5J 21q21.1 0.198 0.132 0.665 ATP catabolic process;transport
hs4 TGFB1 19q13.1 0.198 0.132 0.665 Apoptosis; DDR (DNA replication); Tumor
Suppressors
xai LOC286083 0.198 0.132 0.665
his SGMS1 10q11.2 0.198 0.132 0.665 cell growth;sphingolipid biosynthetic
process
his SGMS1-AS1 0.198 0.132 0.665
xai TMEM18 2p25.3 0.198 0.132 0.665 transcription, DNA-dependent;cell
migration"
xai RIC8B 12q23.3 0.198 0.132 0.665 regulation of G-protein coupled receptor
xai RPL5P30 11q23.3 0.198 0.132 0.665
xai PANK4 1p36.32 0.198 0.132 0.665 coenzyme A biosynthetic process
xai RPL30P4 3p22.3 0.198 0.132 0.665
xai PCGF1 2p13.1 0.198 0.132 0.665 regulation of transcription, DNA-
xai OSGEP 14q11.2 0.198 0.132 0.665 proteolysis;tRNA processing
his CEACAM4 19q13.2 0.198 0.132 0.665
xai FABP5 8q21.13 0.198 0.132 0.665 lipid metabolic
xai OR2AG2 11p15.4 0.198 0.132 0.665 response to stimulus
hs4 KIAA1324L 7q21.12 0.198 0.132 0.665
exp MUC2 11p15.5 0.198 0.132 0.666 O-glycan processing;post-translational
exp BTF3P10 6q25.1 0.198 0.132 0.666
xai IRG1 13q22.3 0.198 0.132 0.666 propionate catabolic process
his CD3D 11q23 0.198 0.132 0.666 T cell differentiation;T cell costimulation
his CD3G 11q23 0.198 0.132 0.666 protein transport;T cell costimulation
xai ODF3B 22q13.33 0.198 0.132 0.666
xai MAP4K2 11q13 0.198 0.132 0.666 JNK cascade;activation of JUN kinase
activity
swa MVD 16q24.3 0.198 0.132 0.666 response to drug;small molecule metabolic
process
his ARL11 13q14.2 0.198 0.132 0.666 small GTPase mediated signal transduction
his TEPSIN 0.198 0.132 0.666
his NDUFAF8 0.198 0.132 0.666
mut CCT6B 17q12 0.197 0.132 0.665 spermatogenesis;protein transport
met ZBTB7B 1q21.3 0.197 0.132 0.665 multicellular organismal
development;ectoderm development
xsq SYNE3 14q32.13 0.197 0.132 0.665
xsq MRPL46 15q25.3 0.197 0.132 0.665
met ENAH 1q42.12 0.197 0.132 0.665 intracellular transport;T cell receptor
signaling pathway
xsq COMMD3 10p12.2 0.197 0.132 0.665
exp ACIN1 14q11.2 0.197 0.132 0.665 apoptotic chromosome
cop NPFFR1 10q21-q22 0.197 0.132 0.665 G-protein coupled receptor
met ALDH1L2 12q23.3 0.197 0.132 0.665 biosynthetic process;10-
met PXDC1 6p25.2 0.197 0.132 0.665 cell communication
xsq LINC01252 0.197 0.132 0.665
xsq OR6N1 1q23.1 0.197 0.132 0.665
cop VPS4A 16q22.1 0.197 0.132 0.665 cellular membrane organization;vesicle-
mediated transport
cop COG8 16q22.1 0.197 0.132 0.665 protein transport
cop PDF 16q22.1 0.197 0.132 0.665 translation;positive regulation of cell
proliferation
cop NIP7 16q22.1 0.197 0.132 0.665 ribosome assembly
cop TMED6 16q22.1 0.197 0.132 0.665 transport
cop TERF2 16q22.1 0.197 0.132 0.665 DNA Damage Response (DDR); DDR (DNA
replication)
cop CYB5B 16q22.1 0.197 0.132 0.665 transport;electron transport chain
cop OR7E91P 2p13.3 0.197 0.132 0.665
exp MED30 8q24.11 0.197 0.132 0.665 transcription initiation from RNA
xsq PPIL4 6q25.1 0.197 0.132 0.665 protein folding
met SETD4 21q22.13 0.197 0.132 0.665
exp MRPL3 3q21-q23 0.197 0.132 0.665 translation
xsq DNAH3 16p12.3 0.197 0.132 0.665 ciliary or flagellar
met IGF1R 15q26.3 0.197 0.132 0.665 Apoptosis; Protein Kinases
xsq KCNF1 2p25 0.197 0.132 0.665 transmembrane transport;potassium ion
xsq HIST1H3H 6p22.1 0.197 0.132 0.665
cop GNAO1 16q13 0.197 0.132 0.665 GTP catabolic process;response to organic
nitrogen
met PROSER2 10p14 0.197 0.132 0.665
met WTIP 19q13.11 0.197 0.132 0.665 regulation of transcription, DNA-
dependent;cytoskeleton organization
xsq IRAK3 12q14.3 0.197 0.132 0.665 Protein Kinases
xsq LARP4B 10p15.3 0.197 0.132 0.665
met BIN1 2q14 0.197 0.132 0.665 positive regulation of GTPase
cop BRE 2p23.2 0.197 0.132 0.665 Apoptosis; DNA Damage Response (DDR); DDR
(FA)
xsq RPL6 12q24.1 0.197 0.132 0.665 SRP-dependent cotranslational protein
met FAM13C 10q21.1 0.197 0.132 0.665
dependent"
met CCDC70 13q14.3 0.197 0.132 0.665
exp RPL13AP23 12q13.3 0.197 0.132 0.665
xsq PTMA 2q37.1 0.197 0.132 0.665 transcription, DNA-dependent"
xsq KNCN 1p33 0.197 0.132 0.665
xsq LCN15 9q34.3 0.197 0.132 0.665 lipid metabolic process
xsq EP300-AS1 0.197 0.132 0.665
xsq LYRM4 6p25.1 0.197 0.132 0.665
xsq SAMM50 22q13.31 0.197 0.132 0.665 protein import into mitochondrial
outer membrane
mut TFAP2E 1p34.3 0.197 0.132 0.665 positive regulation of
met NUDT16P1 3q22.1 0.197 0.132 0.665
xsq SLMO2 20q13.32 0.197 0.132 0.665
xsq COL6A4P1 3p25.1 0.197 0.132 0.665
exp UBP1 3p22.3 0.197 0.132 0.665 angiogenesis;regulation of transcription
mut PLA2G4A 1q25 0.197 0.132 0.665 metabolic process;platelet activation
exp PFDN4 20q13.2 0.197 0.132 0.665 protein folding;cellular protein
metabolic process
met SDHAP3 5p15.33 0.197 0.132 0.665
exp SRSF8 11q22 0.197 0.132 0.666 mRNA processing;RNA splicing
exp SLX4IP 20p12.2 0.197 0.132 0.666
mut TTC7B 14q32.11 0.197 0.132 0.666
met APC 5q21-q22 0.197 0.132 0.666 Apoptosis; Cell Signaling; DNA Damage
Response (DDR); Tumor Suppressors
exp MAPKAPK3 3p21.3 0.197 0.132 0.666 signal transduction;toll-like
met PLA2G12A 4q25 0.197 0.132 0.666 lipid catabolic process;phospholipid
metabolic process
xsq SNRPD2 19q13.2 0.197 0.132 0.666 spliceosome assembly;spliceosomal
snRNP assembly
exp CASC3 17q21.1 0.197 0.132 0.666 intracellular mRNA localization;RNA
splicing
met CFAP161 0.197 0.132 0.666
exp GART 21q22.11 0.197 0.132 0.666 purine base biosynthetic process;purine
xsq TPM3 1q21.2 0.197 0.132 0.666 cellular component movement;muscle
contraction
exp ALG10 12p11.1 0.197 0.132 0.666 dolichol-linked oligosaccharide
xsq FAM122C Xq26.3 0.197 0.132 0.666
xsq FLJ25758 0.196 0.132 0.666
exp PAXIP1-AS1 0.196 0.132 0.666
exp YAF2 12q12 0.196 0.132 0.666 negative regulation of transcription, DNA-
cop C3orf36 3q22.1 -0.196 0.132 0.666
xsq BICD1 12p11.2-p11.1 -0.196 0.132 0.666 positive regulation of
cop BASP1 5p15.1 -0.197 0.132 0.666 diaphragm development;metanephric
mesenchyme development
cop MIR548F1 -0.197 0.132 0.666
xsq CD44 11p13 -0.197 0.132 0.666 cell-matrix adhesion;negative regulation
exp STXBP6 14q12 -0.197 0.132 0.666 vesicle-mediated transport
mut LTBP3 11q13.1 -0.197 0.132 0.666 transforming growth factor beta
receptor signaling pathway;negative regulation of bone mineralization
exp CLIC5 6p12.3 -0.197 0.132 0.666 ion transport;chloride transport
exp CETN2 Xq28 -0.197 0.132 0.665 DNA Damage Response (DDR); DDR (NER)
exp BVES 6q21 -0.197 0.132 0.665 vesicle-mediated transport;regulation of
Rac GTPase activity
mut GJA10 6q15-q16 -0.197 0.132 0.665
xsq MICALL1 22q13.1 -0.197 0.132 0.665
xsq IGFN1 1q32.1 -0.197 0.132 0.665
exp OSMR 5p13.1 -0.197 0.132 0.665 positive regulation of acute
met NUP214 9q34.1 -0.197 0.132 0.665 mRNA export from
nucleus;viral reproduction
cop CRB1 1q31-q32.1 -0.197 0.132 0.665 establishment or maintenance of
cell polarity;cell-cell signaling
exp TOLLIP 11p15.5 -0.197 0.132 0.665 inflammatory response;signal
transduction
xsq DEGS1 1q42.11 -0.197 0.132 0.665 unsaturated fatty acid biosynthetic
exp SKP1P1 7q11.21 -0.197 0.132 0.665
exp THAP8 19q13.12 -0.197 0.132 0.665
exp LOC732538 -0.197 0.132 0.665
met PTMA 2q37.1 -0.197 0.132 0.665 transcription, DNA-dependent"
cop IVNS1ABP 1q25.1-q31.1 -0.197 0.132 0.665 transcription from RNA
polymerase III promoter;RNA splicing
cop LOC100288079 -0.197 0.132 0.665
xsq OASL 12q24.2 -0.197 0.132 0.665 immune response;cytokine-mediated
signaling pathway
cop DDC 7p12.2 -0.197 0.132 0.665 isoquinoline alkaloid metabolic
exp ZBTB22 6p21.3 -0.197 0.132 0.665 regulation of transcription,
DNA-dependent"
exp PPP1R3G 6p25.1 -0.197 0.132 0.665
exp SEC61A1 3q21.3 -0.197 0.132 0.665 antigen processing and
presentation of peptide antigen via MHC class I;antigen processing and presentation
of exogenous peptide antigen via MHC class I, TAP-dependent
xsq PICALM 11q14 -0.197 0.132 0.665 vesicle-mediated transport;clathrin
coat assembly
hs4 PREX2 8q13.2 -0.198 0.132 0.666 G-protein coupled receptor
xai C3orf52 3q13.2 -0.198 0.132 0.666
hs4 NOV 8q24.1 -0.198 0.132 0.666 regulation of cell growth
exp CEACAMP8 19q13.2 -0.198 0.132 0.666
xai ITGA7 12q13 -0.198 0.132 0.666 regulation of cell shape;cell adhesion
xai PLPPR2 -0.198 0.132 0.665
xai LOC100130547 -0.198 0.132 0.665
hs4 COPRS 17q11.2 -0.198 0.132 0.665
xai CPNE2 16q13 -0.198 0.132 0.665
hs4 HLA-F 6p21.3 -0.198 0.132 0.665 antigen processing and presentation
hs4 SLC35D3 6q23.3 -0.198 0.132 0.665 Solute Carriers
his FAM102A 9q34.11 -0.198 0.132 0.665
his IRF1 5q31.1 -0.198 0.132 0.665 Apoptosis
xai KRT86 12q13 -0.198 0.132 0.665 cytoskeleton organization
hs4 SBNO2 19p13.3 -0.199 0.132 0.665 macrophage activation involved in
swa TMEM43 3p25.1 -0.199 0.132 0.665
hs4 FAM171A1 10p13 -0.199 0.132 0.665
xai TULP3 12p13.3 -0.199 0.132 0.665 regulation of transcription, DNA-
his LOC105376633 -0.199 0.132 0.665
his PACSIN2 22q13.2-q13.33 -0.199 0.132 0.665 negative regulation of
hs4 SULT1C2 2q12.3 -0.199 0.132 0.665 xenobiotic metabolic
swa NPM1 5q35.1 -0.199 0.132 0.665 Apoptosis; DNA Damage Response
(DDR); Tumor Suppressors
his COL18A1 21q22.3 -0.199 0.132 0.665 negative regulation of cell
proliferation;organ morphogenesis
his COL18A1-AS2 -0.199 0.132 0.665
his TMEM216 11q13.1 0.198 0.133 0.666 cell projection organization;cilium
morphogenesis
swa OSBP 11q12-q13 0.198 0.133 0.666 transport;lipid transport
exp RNU11 1p35 0.198 0.133 0.666
xai RPL7P15 3q21.2 0.198 0.133 0.667
exp MPPED1 22q13.31 0.198 0.133 0.667
xai IL9 5q31.1 0.198 0.133 0.667 inflammatory response;immune response
his RNF44 5q35.2 0.198 0.133 0.667
his CDHR2 5q35.2 0.198 0.133 0.667 cell adhesion;homophilic cell adhesion
xai SPATA31E1 9q22.1 0.198 0.133 0.667
xai GRIN2D 19q13.33 0.198 0.133 0.667 signal transduction;synaptic
transmission
his MIR4500HG 0.198 0.133 0.667
his SLITRK5 13q31.2 0.198 0.133 0.667 axonogenesis
his ALOXE3 17p13.1 0.198 0.133 0.667 leukotriene biosynthetic process
his HES7 17p13.1 0.198 0.133 0.667 regulation of transcription, DNA-
exp HNRNPH1P1 0.198 0.133 0.667
xai DPY19L2P4 7q21.13 0.198 0.133 0.667
hs4 FAM231D 0.198 0.133 0.667
his ARMC7 17q25.1 0.198 0.133 0.667
cop RAX 18q21.32 0.198 0.133 0.667 hypothalamus development;camera-type eye
development
xai FAN1 15q13.2-q13.3 0.198 0.133 0.667 DNA Damage Response (DDR); DDR (FA)
hs4 PALD1 10q22.1 0.198 0.133 0.667
his BOD1L1 4p16.1 0.198 0.133 0.667
his MIR5091 0.198 0.133 0.667
exp LOC100652777 0.198 0.133 0.667
xai OSTF1 9q13-q21.2 0.198 0.133 0.667 ossification;signal transduction
xai LOC100652777 0.198 0.133 0.667
xai HIST1H2BPS2 6p22.1 0.198 0.133 0.667
swa RPS6KA3 Xp22.2-p22.1 0.198 0.133 0.667 Protein Kinases
xai HNRNPH1P1 0.198 0.133 0.667
xai EIF4A1P7 13q12.3 0.198 0.133 0.667
hs4 PI4KB 1q21 0.198 0.133 0.667 phosphatidylinositol biosynthetic
exp HIST1H2BPS2 6p22.1 0.198 0.133 0.667
his FICD 12q24.1 0.198 0.133 0.667 protein adenylylation;negative regulation
exp FABP5P14 0.198 0.133 0.667
cop GJD2 0.198 0.133 0.667
xai ECH1 19q13.1 0.198 0.133 0.667 lipid metabolic process;fatty acid
metabolic process
exp RPL12P37 17q25.3 0.198 0.133 0.667
xai GUSBP11 22q11.23 0.198 0.133 0.667
his NBAS 2p24 0.198 0.133 0.667
xai FABP5P14 0.198 0.133 0.667
his XAB2 19p13.2 0.198 0.133 0.667 DNA Damage Response (DDR); DDR (NER)
his PET100 19p13.2 0.198 0.133 0.667
his PCP2 19p13.2 0.198 0.133 0.667 signal transduction;regulation of
catalytic activity
xai MPPED1 22q13.31 0.198 0.133 0.667
xai OR10Q2P 11q12.1 0.198 0.133 0.667
swa PQBP1 Xp11.23 0.198 0.133 0.667 regulation of transcription, DNA-
dependent"
his NCOR1 17p11.2 0.198 0.133 0.667 transcription from RNA polymerase II
promoter;cholesterol homeostasis
his PIGL 17p12-p11.2 0.198 0.133 0.667 C-terminal protein lipidation;GPI anchor
exp C17orf78 17q12 0.198 0.133 0.667
xai KHSRP 19p13.3 0.198 0.133 0.667 RNA splicing;gene expression
his MCM7 7q21.3-q22.1 0.198 0.133 0.667 DDR (DNA replication)
his AP4M1 7q22.1 0.198 0.133 0.667 intracellular protein transport;vesicle-
mediated transport
his SNORD112 14q32.31 0.198 0.133 0.667
mir hsa-miR-301b 0.196 0.133 0.666
exp CRTC2 1q21.3 0.196 0.133 0.666 gluconeogenesis;regulation of
met METTL11B 1q24.2 0.196 0.133 0.666
exp DYNC1LI1 3p22.3 0.196 0.133 0.667 cell cycle;mitosis
exp ZBTB16 11q23.1 0.196 0.133 0.667 mesonephros development;positive
cop ARHGEF33 2p22.1 0.196 0.133 0.667 regulation of Rho protein signal
transduction
xsq HRH4 18q11.2 0.196 0.133 0.667 inflammatory response
xsq FCRL1 1q21-q22 0.196 0.133 0.667
exp CMC1 3p24.1 0.196 0.133 0.667
met MTNR1A 4q35.1 0.196 0.133 0.667 circadian rhythm;G-protein
signaling, coupled to cyclic nucleotide second messenger
xsq VAPA 18p11.22 0.196 0.133 0.667 sphingolipid biosynthetic process;neuron
cop KIFC3 16q13-q21 0.196 0.133 0.667 zonula adherens maintenance;epithelial
cell-cell adhesion
exp DNAAF2 14q21.3 0.196 0.133 0.667 ciliary cell motility;flagellar
cell motility
mir hsa-miR-629 0.196 0.133 0.667
xsq RANBP10 16q22.1 0.196 0.133 0.667 microtubule cytoskeleton
organization;regulation of catalytic activity
mut USP34 2p15 0.196 0.133 0.667 protein K48-linked deubiquitination;positive
regulation of canonical Wnt receptor signaling pathway
xsq CRNDE 16q12.2 0.196 0.133 0.667
mut RAF1 3p25 0.196 0.133 0.667 Apoptosis; Oncogenes; Protein Kinases
xsq STRA13 17q25.3 0.196 0.133 0.667 DNA Damage Response (DDR); DDR (FA)
dependent"
dependent"
cop OACYLP 18q21.32 0.196 0.133 0.667
exp GOPC 6q21 0.196 0.133 0.667 spermatid nucleus differentiation;protein
transport
met TRIP6 7q22 0.196 0.133 0.667 cell adhesion;release of cytoplasmic
sequestered NF-kappaB
exp SIRPD 20p13 0.196 0.133 0.667
xsq DNAJC12 10q22.1 0.196 0.133 0.667 protein folding
xsq CD207 2p13 0.196 0.133 0.667 antigen processing and presentation of peptide
antigen via MHC class I;antigen processing and presentation of exogenous peptide
antigen via MHC class I, TAP-dependent
exp CATSPER3 5q31.1 0.196 0.133 0.667 ion transport;multicellular
cop CNRIP1 2p14 0.196 0.133 0.667
xsq ZMYM3 Xq13.1 0.196 0.133 0.667 multicellular organismal
mut PROP1 5q35.3 0.196 0.133 0.667 dorsal/ventral pattern
formation;somatotropin secreting cell differentiation
xsq CRAMP1L 16p13.3 0.196 0.133 0.667
exp MAP4K2 11q13 0.196 0.133 0.667 JNK cascade;activation of JUN kinase
activity
xsq MBD3L2 0.196 0.133 0.667
exp RPS2P18 0.196 0.133 0.667
exp RAC2 22q13.1 0.196 0.133 0.667 GTP catabolic process;actin cytoskeleton
organization
exp LOC376818 22q11.21 0.196 0.133 0.667
xsq DNAAF5 0.196 0.133 0.667
xsq FARS2 6p25.1 0.196 0.133 0.667 tRNA processing;gene expression
cop CWH43 4p11 0.196 0.133 0.667 GPI anchor biosynthetic process
met C14orf132 14q32.2 0.196 0.133 0.667
exp NPM1P46 2q33.1 0.196 0.133 0.667
cop CPLX4 18q21.32 0.196 0.133 0.667 neurotransmitter transport;exocytosis
xsq GPR152 0.196 0.133 0.667
cop SMPD3 16q22.1 0.196 0.133 0.667 sphingomyelin catabolic
xsq VDAC2 10q22 0.196 0.133 0.667 Apoptosis
xsq PNOC 8p21 0.196 0.133 0.667 signal transduction;neuropeptide signaling
pathway
met NDUFC2 11q14.1 0.196 0.133 0.667 mitochondrial electron transport,
exp LOC283070 10p13 0.196 0.133 0.667
exp LOC100287896 11q13.4 0.196 0.133 0.667
xsq CES1P2 16q12.2 0.196 0.133 0.667
xsq FASTKD2 2q33.3 0.196 0.133 0.667 cellular respiration
mut IFT172 2p23.3 0.196 0.133 0.667 protein processing;cilium assembly
xsq ISCU 12q24.1 0.196 0.133 0.667 nitrogen fixation;iron-sulfur cluster
assembly
xsq KIFC1 6p21.3 0.196 0.133 0.667 microtubule-based movement;cell cycle
xsq TOP1 20q12-q13.1 0.196 0.133 0.667 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
met LARGE 22q12.3 0.196 0.133 0.667 protein glycosylation;glycosphingolipid
mut TTC19 17p12 0.196 0.133 0.667 cytokinesis;cell cycle
dependent"
xsq CHST8 19q13.1 0.196 0.133 0.667 proteoglycan biosynthetic process;hormone
xsq ZSCAN30 18q12.2 0.196 0.133 0.667 viral reproduction
exp RHOT2 16p13.3 0.196 0.133 0.667 Apoptosis
exp PRAM1 19p13.2 0.196 0.133 0.667 integrin-mediated signaling
met SERPINB13 18q21.33 0.196 0.133 0.667 response to UV;negative regulation
cop CFDP1 16q22.2-q22.3 0.196 0.133 0.667 regulation of cell
xsq C4orf46 4q32.1 0.196 0.133 0.667
xsq LINC01479 0.196 0.133 0.667
xsq LOC105373609 0.196 0.133 0.667
exp SCAF4 21q22.1 0.196 0.133 0.667 mRNA processing
exp CSRP3 11p15.1 -0.196 0.133 0.667 skeletal muscle tissue
xsq SHISA2 13q12.13 -0.196 0.133 0.667 multicellular organismal
development
cop NECAB3 20q11.22 -0.196 0.133 0.667 protein secretion;protein
metabolic process
cop C20orf144 20q11.22 -0.196 0.133 0.667
cop ACTL10 20q11.22 -0.196 0.133 0.667
cop E2F1 20q11.2 -0.196 0.133 0.667 Apoptosis; Tumor Suppressors
cop PXMP4 20q11.22 -0.196 0.133 0.667
cop ZNF341 20q11.22 -0.196 0.133 0.667 regulation of transcription,
DNA-dependent"
cop CHMP4B 20q11.22 -0.196 0.133 0.667 protein transport;cellular
exp POU2F3 11q23.3 -0.196 0.133 0.667 epidermis
met SOCS2 12q -0.196 0.133 0.667 Apoptosis
xsq BDKRB2 14q32.1-q32.2 -0.196 0.133 0.667 inflammatory
exp NXPH4 12q13.3 -0.196 0.133 0.667 neuropeptide signaling pathway
exp ACSL3 2q34-q35 -0.196 0.133 0.667 brain development;response to
nutrient
cop UG0898H09 -0.196 0.133 0.667
cop GGH 8q12.3 -0.196 0.133 0.667 response to insulin
cop TTPA 8q12.3 -0.196 0.133 0.667 response to pH;response to toxin
cop RXFP3 5p15.1-p14 -0.196 0.133 0.667 G-protein coupled receptor
signaling pathway;elevation of cytosolic calcium ion concentration involved in G-
protein signaling coupled to IP3 second messenger
cop RTP1 3q27.3 -0.196 0.133 0.667 protein insertion into membrane
xsq FAM110B 8q12.1 -0.196 0.133 0.667
cop LOC285696 5p15.1 -0.196 0.133 0.667
cop LRRC72 -0.196 0.133 0.667
exp CC2D1A 19p13.12 -0.196 0.133 0.667 regulation of transcription,
DNA-dependent;signal transduction
cop FST 5q11.2 -0.196 0.133 0.667 negative regulation of
transcription from RNA polymerase II promoter;hemopoietic progenitor cell
differentiation
met VWCE 11q12.2 -0.196 0.133 0.667
xsq EPG5 18q12.3 -0.196 0.133 0.667 autophagy
xsq MTSS1 8p22 -0.196 0.133 0.667 negative regulation of epithelial cell
exp CASC1 12p12.1 -0.196 0.133 0.667
cop ISPD 7p21.2 -0.196 0.133 0.667 isoprenoid biosynthetic process
xsq ARL8A 1q32.1 -0.196 0.133 0.667 GTP catabolic process;cell cycle
mut NUP155 5p13.1 -0.196 0.133 0.667 nucleocytoplasmic
exp COL1A1 17q21.33 -0.196 0.133 0.667 blood vessel
mut CNTN4 3p26.3 -0.196 0.133 0.667 axon guidance;axonal fasciculation
met FOXL2NB -0.196 0.133 0.667
cop COA1 7p13 -0.196 0.133 0.667
xsq MAMDC2-AS1 -0.196 0.133 0.667
xsq GPC4 Xq26.1 -0.196 0.133 0.667 cell proliferation;anatomical
xsq TTLL7 1p31.1 -0.196 0.133 0.667 multicellular organismal
xsq LRRN1 3p26.2 -0.196 0.133 0.666
cop LOC100506895 -0.196 0.133 0.666
met IL24 1q32 -0.196 0.133 0.666 apoptotic process
hs4 DTX3L 3q21.1 -0.198 0.133 0.667 response to DNA damage
hs4 PARP9 3q21 -0.198 0.133 0.667 cell migration;regulation of response to
interferon-gamma
xai LOC100507464 -0.198 0.133 0.667
his MSANTD3-TMEFF1 -0.198 0.133 0.667
hs4 IQCE 7p22.3 -0.198 0.133 0.667
swa DNAJB11 3q27.3 -0.198 0.133 0.667 protein folding;activation of
his CYLD 16q12.1 -0.198 0.133 0.667 Tumor Suppressors
his MIR3181 -0.198 0.133 0.667
hs4 MOV10 1p13.2 -0.198 0.133 0.667 regulation of transcription, DNA-
his PRKAG3 2q35 -0.198 0.133 0.667 intracellular protein kinase
cascade;insulin receptor signaling pathway
hs4 DENND2C 1p13.2 -0.198 0.133 0.667
hs4 SULT1A2 16p12.1 -0.198 0.133 0.667 small molecule metabolic
process;3'-phosphoadenosine 5'-phosphosulfate metabolic process
exp LOC100507464 -0.198 0.133 0.667
hs4 KDM4C 9p24.1 -0.198 0.133 0.667 chromatin modification;histone H3-
K9 demethylation
hs4 TTC26 7q34 -0.198 0.133 0.667
hs4 DCBLD2 3q12.1 -0.198 0.133 0.667 intracellular receptor
hs4 HELZ2 20q13.33 -0.198 0.133 0.667
hs4 VDR 12q13.11 -0.198 0.133 0.667 negative regulation of
differentiation
his C20orf85 20q13.32 -0.198 0.133 0.667
hs4 KCP 7q32.1 -0.198 0.133 0.667
exp CTBP2P7 19q13.12 -0.198 0.133 0.667
his LOC100289333 19p13.2 -0.198 0.133 0.667
swa SSR3 3q25.31 -0.198 0.133 0.667 SRP-dependent cotranslational
hs4 PGF 14q24.3 -0.198 0.133 0.667 cell differentiation;vascular
hs4 HOST2 -0.198 0.133 0.667
hs4 C10orf99 10q23.1 -0.198 0.133 0.667
his MIR3907 -0.198 0.133 0.667
xai MED8 1p34.2 -0.198 0.133 0.667 regulation of transcription from
xai SULF1 8q13.2 -0.198 0.133 0.667 esophagus smooth muscle
his HFE 6p21.3 -0.198 0.133 0.667 female pregnancy;antigen processing
and presentation of peptide antigen via MHC class I
his LOC108783645 -0.198 0.133 0.667
hs4 LHFP 13q12 -0.198 0.133 0.667
his DNAJC5B 8q13.1 -0.198 0.133 0.667 protein folding
hs4 SPSB1 1p36.22 -0.198 0.133 0.667 intracellular signal transduction
hs4 CXXC5 5q31.2 -0.198 0.133 0.667 signal transduction;positive
his UBE2Z 17q21.32 -0.198 0.133 0.666 apoptotic process
his LOC105371814 -0.198 0.133 0.666
exp RPS2P5 0.198 0.134 0.667
exp LOC730202 14q32.2 0.198 0.134 0.667
his PYY 17q21.1 0.198 0.134 0.667 negative regulation of response to
food;cellular component movement
his NAGS 17q21.31 0.198 0.134 0.667 urea cycle;glutamate metabolic process
xai SPATA3-AS1 0.198 0.134 0.667
his EXOSC4 8q24.3 0.198 0.134 0.667 RNA metabolic process;mRNA
metabolic process
his MIR6847 0.198 0.134 0.667
his GPAA1 8q24.3 0.198 0.134 0.667 C-terminal protein lipidation;protein
retention in ER lumen
exp IRG1 13q22.3 0.198 0.134 0.667 propionate catabolic process
swa PSMB4 1q21 0.198 0.134 0.667 S phase of mitotic cell cycle;apoptotic process
xai SRP14-AS1 0.198 0.134 0.667
his FAM122A 0.198 0.134 0.668
exp SHANK1 19q13.3 0.197 0.134 0.668 neuromuscular process controlling
xai RPS2P5 0.197 0.134 0.668
his RAB3D 19p13.2 0.197 0.134 0.668 GTP catabolic process;small GTPase
hs4 INTS7 1q32.3 0.197 0.134 0.668 snRNA processing;cellular response to
ionizing radiation
hs4 DTL 1q32 0.197 0.134 0.668 DDR (DNA replication)
his POMGNT2 0.197 0.134 0.668
xai TOMM5 9p13.2 0.197 0.134 0.668 protein targeting to mitochondrion
his DCAF8 1q22-q23 0.197 0.134 0.668 protein ubiquitination
exp RNU5D-2P 0.197 0.134 0.668
xai VPS33A 12q24.31 0.197 0.134 0.668 protein transport;vesicle-mediated
transport
xai RNU5D-2P 0.197 0.134 0.668
his PSMD5 9q33.2 0.197 0.134 0.668 protein polyubiquitination;gene
expression
his PSMD5-AS1 9q33.2 0.197 0.134 0.668
his MND1 4q31.3 0.197 0.134 0.668 DNA recombination;meiosis
his CRYBB2P1 22q11.2-q12.1 0.197 0.134 0.668
swa CPNE1 20q11.22 0.197 0.134 0.668 lipid metabolic process;vesicle-mediated
transport
xai TOMM70A 3q12.2 0.197 0.134 0.668 protein targeting to mitochondrion
his POTEF 2q21.1 0.197 0.134 0.668
his MED15P9 0.197 0.134 0.668
xai PPP1R14B 11q13 0.197 0.134 0.668 regulation of phosphorylation
xai SPIB 19q13.3-q13.4 0.197 0.134 0.668 Transcription Factors
his GIN1 5q21.1 0.197 0.134 0.668 DNA integration
his PPIP5K2 5q21.1 0.197 0.134 0.668 inositol metabolic process
his MIR135A1 0.197 0.134 0.668
swa MAP2K2 19p13.3 0.197 0.134 0.668 Protein Kinases
xai DNAH1 3p21.1 0.197 0.134 0.668 ciliary or flagellar
his CENPA 2p23.3 0.197 0.134 0.668 kinetochore assembly;M phase of mitotic
cell cycle
hs4 NOTUM 17q25.3 0.197 0.134 0.668
his HSD17B7 1q23 0.197 0.134 0.668 steroid biosynthetic process;cholesterol
xai PSMB2 1p34.2 0.197 0.134 0.668 antigen processing and presentation of
hs4 PIF1 15q22.31 0.197 0.134 0.668 DNA Damage Response (DDR); DDR (DNA
replication)
xai SIRT4 12q 0.197 0.134 0.668 protein ADP-ribosylation;protein deacetylation
hs4 TRIM59 3q25.33 0.197 0.134 0.668
exp KLK12 19q13.33 0.197 0.134 0.669 proteolysis
hs4 EBP Xp11.23-p11.22 0.197 0.134 0.669 cholesterol metabolic
process;hemopoiesis
xai HVCN1 12q24.11 0.197 0.134 0.669 response to zinc ion;proton transport
cop GOLGA8A 15q11.2 0.196 0.134 0.667
mut SCAF8 6q25.1-q25.3 0.196 0.134 0.667 transcription from RNA polymerase
xsq LOC100507462 0.196 0.134 0.667
exp EIF3J 15q21.1 0.196 0.134 0.667 translation;translational initiation
xsq MRPS30 5q11 0.196 0.134 0.667 Apoptosis
met BGN Xq28 0.196 0.134 0.667 blood vessel remodeling;peptide cross-linking
via chondroitin 4-sulfate glycosaminoglycan
xsq GNB1 1p36.33 0.196 0.134 0.667 activation of phospholipase C activity by
messenger;small molecule metabolic process
xsq SH3BP1 22q13.1 0.196 0.134 0.667 signal transduction
cop WNK2 9q22.3 0.196 0.134 0.667 negative regulation of ERK1 and ERK2
cascade;regulation of ion homeostasis
xsq SARM1 17q11 0.196 0.134 0.667 innate immune response;signal transduction
exp LOC100287221 16q24.2 0.196 0.134 0.667
cop SRSF1 17q22 0.196 0.134 0.667 transcription from RNA polymerase II
cop DYNLL2 17q22 0.196 0.134 0.667 transport;apoptotic process
cop OR4D1 0.196 0.134 0.667
cop MSX2P1 0.196 0.134 0.667
cop OR4D2 17q22 0.196 0.134 0.667 response to stimulus
cop EPX 17q23.1 0.196 0.134 0.667 response to oxidative stress;hydrogen
peroxide catabolic process
cop MKS1 17q22 0.196 0.134 0.667 cilium morphogenesis;cell projection
organization
cop SIX3 2p21 0.196 0.134 0.667 diencephalon development;telencephalon
development
exp CEP72 5p15.33 0.196 0.134 0.668 mitotic cell cycle;spindle organization
xsq C7orf34 7q34 0.196 0.134 0.668
met ADGRE4P 0.196 0.134 0.668
exp XPO4 13q11 0.196 0.134 0.668 protein transport;positive regulation of
cop LMAN1 18q21.3-q22 0.196 0.134 0.668 blood coagulation;cellular protein
metabolic process
exp C14orf39 14q23.1 0.196 0.134 0.668 regulation of sequence-specific DNA
exp FANCD2 3p26 0.196 0.134 0.668 DNA Damage Response (DDR); DDR (FA)
met ARL6IP1 16p12-p11.2 0.196 0.134 0.668 cotranslational protein targeting
to membrane
exp BACH2 6q15 0.196 0.134 0.668
met PPP1R9A 7q21.3 0.196 0.134 0.668 multicellular organismal
exp SYN1 Xp11.23 0.196 0.134 0.668 transport;synaptic transmission
met IRS2 13q34 0.196 0.134 0.668 Apoptosis
met SLCO5A1 8q13.3 0.196 0.134 0.668 Solute Carriers
dependent"
exp DCAF13 8q22.3 0.196 0.134 0.668 rRNA processing;protein
ubiquitination
met ATP5S 14q21.3 0.196 0.134 0.668 ATP biosynthetic process;ion transport
xsq SLC35B1 17q21.33 0.196 0.134 0.668 Solute Carriers
met LYN 8q13 0.196 0.134 0.668 Protein Kinases
cop C16orf78 16q12.1 0.196 0.134 0.668
xsq C18orf21 18q12.2 0.196 0.134 0.668
xsq EIF3CL 0.196 0.134 0.668
mut CCDC38 12q23.1 0.196 0.134 0.668
exp EXOC3L4 14q32.32 0.196 0.134 0.668
cop KCNQ5-AS1 0.196 0.134 0.668
xsq CCDC141 2q31.2 0.196 0.134 0.668
cop PQLC3 2p25.1 0.196 0.134 0.668
exp CD79B 17q23 0.196 0.134 0.668 immune response;signal transduction
xsq RIOK3 18q11.2 0.196 0.134 0.668 protein phosphorylation;chromosome
segregation
cop TMEM170A 16q23.1 0.196 0.134 0.668
xsq ITGA2B 17q21.32 0.196 0.134 0.668 blood coagulation;platelet
activation
xsq FAM96B 16q22.1 0.196 0.134 0.668 chromosome segregation
xsq FPGS 9q34.1 0.196 0.134 0.668 water-soluble vitamin metabolic
xsq FBXO18 10p15.1 0.196 0.134 0.668 DNA Damage Response (DDR)
xsq SLC25A51P1 6q12 0.195 0.134 0.668
xsq LINC00892 0.195 0.134 0.668
met GPR21 9q33 0.195 0.134 0.668 G-protein coupled receptor signaling pathway
exp CLDN14 21q22.3 0.195 0.134 0.669 cell junction assembly;cell-cell
xsq DDX3X Xp11.3-p11.23 0.195 0.134 0.669 interspecies interaction between
organisms
met RABL2A 2q13 0.195 0.134 0.669 GTP catabolic process;small GTPase
exp KHSRP 19p13.3 0.195 0.134 0.669 RNA splicing;gene expression
cop THBS2 6q27 0.195 0.134 0.669 cell adhesion;negative regulation of
angiogenesis
cop WDR27 6q27 0.195 0.134 0.669
met C12orf75 12q23.3 -0.195 0.134 0.669
xsq RNASE1 14q11.2 -0.195 0.134 0.669
xsq PLEKHG3 14q23.3 -0.195 0.134 0.668 regulation of Rho protein
signal transduction
xsq AKT3 1q44 -0.196 0.134 0.668 Protein Kinases
met MRPL28 16p13.3 -0.196 0.134 0.668 translation
exp SP100 2q37.1 -0.196 0.134 0.668 response to type I
factor activity
cop ISL1 5q11.1 -0.196 0.134 0.668 regulation of secondary heart field
cardioblast proliferation;pancreas development
xsq SMIM10 Xq26.3 -0.196 0.134 0.668
met RORC 1q21 -0.196 0.134 0.668 multicellular organismal development;gene
expression
exp VWF 12p13.3 -0.196 0.134 0.668 platelet degranulation;protein
homooligomerization
xsq GPNMB 7p15 -0.196 0.134 0.668 cell adhesion;negative regulation of cell
proliferation
exp FAM174A 5q21.1 -0.196 0.134 0.668
xsq BEND7 10p13 -0.196 0.134 0.668
exp SH3GLB1 1p22 -0.196 0.134 0.668 Apoptosis
xsq BCL2L1 20q11.21 -0.196 0.134 0.668 Apoptosis; Protein Kinases
met CTDSP1 2q35 -0.196 0.134 0.668 negative regulation of neuron
cop CA8 8q12.1 -0.196 0.134 0.668 one-carbon metabolic
process;phosphatidylinositol-mediated signaling
exp NEDD4 15q -0.196 0.134 0.668 nervous system development;neuron
exp ZCCHC14 16q24.2 -0.196 0.134 0.668 cell communication
cop TLR4 9q33.1 -0.196 0.134 0.668 Cell Signaling
xsq ISM1 20p12.1 -0.196 0.134 0.668
xsq TCEAL4 Xq22.2 -0.196 0.134 0.668 regulation of transcription,
DNA-dependent"
exp FAS 10q24.1 -0.196 0.134 0.668 Apoptosis
xsq TMEM45A 3q12.2 -0.196 0.134 0.668
cop LOC100130298 8q12.2 -0.196 0.134 0.668
met DCAF4L2 8q21.3 -0.196 0.134 0.668
xsq XXYLT1-AS2 -0.196 0.134 0.668
xsq FAM25A 10q23.2 -0.196 0.134 0.667
xsq PCDHB13 5q31 -0.196 0.134 0.667 homophilic cell adhesion;synaptic
transmission
xsq MYO5B 18q21 -0.196 0.134 0.667 regulation of protein
exp SFRP2 4q31.3 -0.196 0.134 0.667 chondrocyte development;negative
xsq CTIF 18q21.1 -0.196 0.134 0.667 nuclear-transcribed mRNA catabolic
his CCDC80 3q13.2 -0.197 0.134 0.669 positive regulation of cell-
xai CEACAMP8 19q13.2 -0.197 0.134 0.668
xai LZTS3 20p13 -0.197 0.134 0.668
his MIR4759 -0.197 0.134 0.668
hs4 ZFP37 9q32 -0.197 0.134 0.668 regulation of transcription, DNA-
dependent;cell proliferation
hs4 VCAM1 1p32-p31 -0.197 0.134 0.668 heart development;interspecies
swa DPM1 20q13.13 -0.197 0.134 0.668 protein O-linked
mannosylation;dolichol-linked oligosaccharide biosynthetic process
xai NCSTN 1q22-q23 -0.197 0.134 0.668 protein processing;membrane protein
his TSPAN2 1p13.2 -0.197 0.134 0.668 brain development
xai UST 6q25.1 -0.197 0.134 0.668 protein sulfation
exp CSPG4P11 -0.197 0.134 0.668
his CGB3 -0.197 0.134 0.668
xai AGBL1 15q25.3 -0.197 0.134 0.668 proteolysis;C-terminal protein
deglutamylation
hs4 IRAK2 3p25.3 -0.197 0.134 0.668 Protein Kinases
his NOS1AP 1q23.3 -0.197 0.134 0.668 regulation of apoptotic
xai HSBP1L1 18q23 -0.197 0.134 0.668 viral envelope fusion with host
membrane
hs4 EXD3 9q34.3 -0.197 0.134 0.668 nucleobase-containing compound
metabolic process
hs4 NOXA1 9q34.3 -0.197 0.134 0.668 superoxide metabolic
his TM4SF1-AS1 -0.197 0.134 0.668
his TM4SF1 3q21-q25 -0.197 0.134 0.668
his CREB3 9p13.3 -0.197 0.134 0.668 reactivation of latent
his TLN1 9p13 -0.197 0.134 0.668 muscle contraction;platelet activation
his MIR6853 -0.197 0.134 0.668
hs4 SIX2 2p21 -0.197 0.134 0.668 regulation of transcription, DNA-
xai HMGB1P29 -0.197 0.134 0.668
cop SOSTDC1 7p21.1 -0.197 0.134 0.668 pattern specification
process;Wnt receptor signaling pathway
his SLCO2A1 3q21 -0.197 0.134 0.668 Solute Carriers
his TMEM40 3p25.2 -0.198 0.134 0.668
xai TRPC4 13q13.3 -0.198 0.134 0.668 ion transport;calcium ion transport
exp CACNA1C-IT3 -0.198 0.134 0.668
swa ERLIN1 10q24.31 -0.198 0.134 0.667 ER-associated protein
catabolic process
xai PIK3C2A 11p15.5-p14 -0.198 0.134 0.667 Protein Kinases
xai ABCD3 1p21.3 -0.198 0.134 0.667 ABC Transporters
his MGP 12p12.3 -0.198 0.134 0.667 response to hormone stimulus;cell
differentiation
exp HMGB1P29 -0.198 0.134 0.667
his MIR3202-1 0.197 0.135 0.669
his MIR3202-2 0.197 0.135 0.669
xai SRRT 7q21 0.197 0.135 0.669 gene silencing by RNA;primary miRNA processing
his RGS16 1q25-q31 0.197 0.135 0.669 visual perception;regulation of G-protein
coupled receptor protein signaling pathway
xai KCNT2 1q31.3 0.197 0.135 0.669 potassium ion transport;potassium ion
swa ECE1 1p36.1 0.197 0.135 0.669 heart development;hormone catabolic
process
xai LOC1720 2p12 0.197 0.135 0.669
xai PPM1M 3p21.2 0.197 0.135 0.669 protein dephosphorylation
his MAGEB2 Xp21.3 0.197 0.135 0.669
his STAG3L2 7q11.23 0.197 0.135 0.669
his PMS2P5 7q11.23 0.197 0.135 0.669 DNA Damage Response (DDR)
xai LTA 6p21.3 0.197 0.135 0.669 response to hypoxia;response to nutrient
hs4 LOC100506844 0.197 0.135 0.669
his CACTIN 19p13.3 0.197 0.135 0.669
xai HCG17 0.197 0.135 0.669
xai OR2B8P 6p21.3 0.197 0.135 0.669 response to stimulus
xai IPO11 5q12.1 0.197 0.135 0.669 intracellular protein transport
xai RBM44 2q37.3 0.197 0.135 0.669
xai EIF3J 15q21.1 0.197 0.135 0.669 translation;translational initiation
xai CCDC78 16p13.3 0.197 0.135 0.669
xai HNRNPA1 12q13.1 0.197 0.135 0.669 interspecies interaction between
hs4 GZMA 5q11-q12 0.197 0.135 0.669 cleavage of lamin;immune response
his NEIL1 15q24.2 0.197 0.135 0.669 DNA Damage Response (DDR); DDR (BER)
exp TEX21P 14q23.3 0.197 0.135 0.669
xai RPS7 2p25 0.197 0.135 0.669 translational initiation;viral infectious cycle
his DUSP12 1q21-q22 0.197 0.135 0.67 protein dephosphorylation;JNK
cascade
exp CCL1 17q12 0.197 0.135 0.67 cellular calcium ion homeostasis;chemotaxis
his IPO9 1q32.1 0.197 0.135 0.67 protein import into nucleus;intracellular
protein transport
his IPO9-AS1 0.197 0.135 0.67
his GRPEL2 5q32 0.197 0.135 0.67 protein folding
hs4 CCR10 17q21.1-q21.3 0.197 0.135 0.67 chemotaxis;G-protein coupled
hs4 CNTNAP1 17q21 0.197 0.135 0.67 signal transduction;axon guidance
dependent"
his NLRP12 19q13.42 0.197 0.135 0.67 negative regulation of protein
autophosphorylation;positive regulation of inflammatory response
hs4 MCM10 10p13 0.197 0.135 0.67 DDR (DNA replication)
hs4 NOC2L 1p36.33 0.197 0.135 0.67 negative regulation of apoptotic
hs4 KLHL17 1p36.33 0.197 0.135 0.67 brain development;actin
exp HMGB1P39 0.197 0.135 0.67
his LOC101929698 0.197 0.135 0.67
his TMEM38B 9q31.2 0.197 0.135 0.67 ion transport;potassium ion
transport
xai LOC643387 2q37.3 0.197 0.135 0.67
xai GIMAP1 7q36.1 0.197 0.135 0.67 B cell differentiation;T cell
differentiation
his LOC100128885 7q11.21 0.197 0.135 0.67
hs4 CHCHD10 22q11.23 0.197 0.135 0.67
met DMRTA1 9p21.3 0.197 0.135 0.67 regulation of transcription, DNA-
dependent;sex differentiation
his EVI2B 17q11.2 0.197 0.135 0.67
his EVI2A 17q11.2 0.197 0.135 0.67
his ATP5G2 12q13.13 0.197 0.135 0.67 transport;ion transport
his SECISBP2L 15q21.1 0.197 0.135 0.67
xai ARHGAP25 2p13.3 0.197 0.135 0.67 regulation of small GTPase mediated
his ALG2 9q22.33 0.197 0.135 0.67 protein N-linked glycosylation via
asparagine;protein glycosylation in endoplasmic reticulum
his SEC61B 9q22.32-q31.3 0.197 0.135 0.67 translation;SRP-dependent
met CTNNBL1 20q11.23-q12 0.195 0.135 0.669 Apoptosis
exp CYTH1 17q25 0.195 0.135 0.669 vesicle-mediated transport;regulation of cell
adhesion
exp RNF214 11q23.3 0.195 0.135 0.669
exp ADIPOR2 12p13.31 0.195 0.135 0.669 lipid metabolic process;hormone-
met PFKM 12q13.3 0.195 0.135 0.669 glycolysis;protein homotetramerization
xsq ESRRB 14q24.3 0.195 0.135 0.669 embryonic placenta development;gene
expression
xsq ASIC1 12q12 0.195 0.135 0.669 transport;ion transport
exp HIST1H4G 6p22.1 0.195 0.135 0.669 nucleosome assembly
xsq RNF219 13q31.1 0.195 0.135 0.669
xsq RPL32 3p25-p24 0.195 0.135 0.669 SRP-dependent cotranslational protein
exp CEP83-AS1 0.195 0.135 0.669
cop TRIB3 20p13-p12.2 0.195 0.135 0.669 Apoptosis
cop RBCK1 20p13 0.195 0.135 0.669 T cell receptor signaling pathway;protein
polyubiquitination
cop TBC1D20 20p13 0.195 0.135 0.669 interspecies interaction between
organisms
cop GOLGA6C 15q24.2 0.195 0.135 0.669
cop GOLGA6D 0.195 0.135 0.669
cop COMMD4 15q24.2 0.195 0.135 0.669
cop NEIL1 15q24.2 0.195 0.135 0.669 DNA Damage Response (DDR); DDR (BER)
cop MIR631 0.195 0.135 0.669
met CDK2AP1 12q24.31 0.195 0.135 0.669 S phase of mitotic cell cycle;DNA-
dependent DNA replication
xsq PMF1 1q12 0.195 0.135 0.669 cell division;M phase of mitotic cell cycle
exp SCAF11 12q12 0.195 0.135 0.669 spliceosome assembly;RNA splicing, via
transesterification reactions
met C19orf33 19q13.2 0.195 0.135 0.669
cop GPR56 16q13 0.195 0.135 0.669
exp EEF1E1 6p24.3 0.195 0.135 0.669 Apoptosis
xsq GIT1 17p11.2 0.195 0.135 0.669 regulation of G-protein coupled receptor
met MCF2 Xq27 0.195 0.135 0.669 regulation of small GTPase mediated signal
transduction;apoptotic process
cop VEZF1 17q22 0.195 0.135 0.669 transcription from RNA polymerase II
exp FLJ45248 8q22.3 0.195 0.135 0.669
exp LINC00667 18p11.31 0.195 0.135 0.669
pro EP300_14_26530 0.195 0.135 0.669
mut CSDE1 1p22 0.195 0.135 0.669 regulation of transcription, DNA-dependent;male
gonad development"
mir hsa-miR-602 0.195 0.135 0.67
met FAM20C 7p22.3 0.195 0.135 0.67
met SGCZ 8p22 0.195 0.135 0.67 muscle cell development;cytoskeleton
organization
xsq TNXB 6p21.3 0.195 0.135 0.67 actin cytoskeleton organization;collagen
metabolic process
xsq GCM1 6p12.1 0.195 0.135 0.67 cell differentiation involved in
embryonic placenta development;regulation of transcription, DNA-dependent
exp LINC00317 0.195 0.135 0.67
mut DMGDH 5q14.1 0.195 0.135 0.67 glycine metabolic process;glycine
catabolic process
xsq KLRK1 12p13.2-p12.3 0.195 0.135 0.67
exp NAAA 4q21.1 0.195 0.135 0.67 lipid metabolic process
dependent"
exp EZH1 17q21.1-q21.3 0.195 0.135 0.67 peptidyl-lysine
mut MYOC 1q23-q24 0.195 0.135 0.67 anatomical structure morphogenesis
exp LOC390714 16p11.2 0.195 0.135 0.67
cop UVRAG 11q13.5 0.195 0.135 0.67 DNA Damage Response (DDR)
exp ASB13 10p15.1 0.195 0.135 0.67 intracellular signal transduction
dependent"
xsq PRPF40A 2q23.3 0.195 0.135 0.67 cell cycle;regulation of cell shape
exp DUSP6 12q22-q23 0.195 0.135 0.67 MyD88-independent toll-like receptor
xsq RPS23 5q14.2 0.195 0.135 0.67 nuclear-transcribed mRNA catabolic
xsq USP30-AS1 12q24.11 0.195 0.135 0.67
xsq LINC00886 0.195 0.135 0.67
cop TTC27 2p22.3 0.195 0.135 0.67
met PRSS8 16p11.2 0.195 0.135 0.67 EMT (Epithelial)
xsq ARPC4-TTLL3 0.195 0.135 0.67
exp BORCS5 0.195 0.135 0.67
xsq KCNC4-AS1 0.195 0.135 0.67
mut F5 1q23 0.195 0.135 0.67 platelet degranulation;cell adhesion
cop LRPPRC 2p21 0.195 0.135 0.67 regulation of transcription, DNA-
dependent;transport
mut CAPS2 12q14.1 0.195 0.135 0.67
exp ELF1 13q13 0.195 0.135 0.67 Transcription Factors
DNA-dependent"
exp DMRTC1B -0.195 0.135 0.67 regulation of transcription, DNA-
dependent"
exp EMC3 3p25.3 -0.195 0.135 0.67
xsq FGF18 5q34 -0.195 0.135 0.67 chondrocyte development;positive
met ZFP90 16q22.1 -0.195 0.135 0.67 negative regulation of DNA
xsq C14orf132 14q32.2 -0.195 0.135 0.67
xsq CBR3 21q22.2 -0.195 0.135 0.67 phylloquinone catabolic process
exp C14orf132 14q32.2 -0.195 0.135 0.67
xsq LFNG 7p22.2 -0.195 0.135 0.67 ovarian follicle development;female
meiosis
xsq ATP9A 20q13.2 -0.195 0.135 0.67 cation transport;phospholipid
translocation
exp COL8A2 1p34.2 -0.195 0.135 0.67 angiogenesis;cell-cell
adhesion
exp IGDCC4 15q22.31 -0.195 0.135 0.67
xsq NEU1 6p21.3 -0.195 0.135 0.669 sphingolipid metabolic
exp VPS41 7p14-p13 -0.195 0.135 0.669 intracellular protein
cop OSBPL3 7p15 -0.195 0.135 0.669 transport;lipid transport
xsq USP43 17p13.1 -0.195 0.135 0.669 proteolysis;ubiquitin-dependent
xsq LOC100130705 7q32.1 -0.195 0.135 0.669
exp MKX 10p12.1 -0.195 0.135 0.669 multicellular organismal
xsq PCAT6 -0.195 0.135 0.669
xsq TINAGL1 1p35.2 -0.195 0.135 0.669 proteolysis;immune response
xsq CAMK1 3p25.3 -0.195 0.135 0.669 nervous system development;positive
regulation of synapse structural plasticity
xsq DNAJC6 1p31.3 -0.195 0.135 0.669 post-Golgi vesicle-mediated
xsq LOC441204 7p15.2 -0.195 0.135 0.669
xsq PSG1 19q13.2 -0.195 0.135 0.669 female pregnancy
xsq TAB3 Xp21.2 -0.195 0.135 0.669 MyD88-independent toll-like
xsq SRPX2 Xq21.33-q23 -0.195 0.135 0.669 angiogenesis;cell-cell adhesion
his INHBA-AS1 7p14.1 -0.197 0.135 0.67
his INHBA 7p15-p13 -0.197 0.135 0.67 hair follicle development;nervous
system development
exp DGCR9 22q11.21 -0.197 0.135 0.67
his MLPH 2q37.3 -0.197 0.135 0.67 intracellular protein transport
his MIR6811 -0.197 0.135 0.67
xai SDCBP 8q12 -0.197 0.135 0.67 axon guidance;actin cytoskeleton
organization
xai GADD45A 1p31.2 -0.197 0.135 0.67 Apoptosis; DNA Damage
Response (DDR); DDR (BER)
hs4 MIR30A -0.197 0.135 0.67
hs4 C1R 12p13 -0.197 0.135 0.67 complement activation, classical
his ZNF321P 19q13.41 -0.197 0.135 0.67
his HLA-G 6p21.3 -0.197 0.135 0.67 cytokine-mediated signaling
hs4 LINC00899 22q13.31 -0.197 0.135 0.67
his TDO2 4q31-q32 -0.197 0.135 0.67 tryptophan catabolic
hs4 SULT2B1 19q13.3 -0.197 0.135 0.67 steroid metabolic
hs4 DIRAS2 9q22.2 -0.197 0.135 0.67 signal transduction;small
his IVL 1q21 -0.197 0.135 0.67 keratinocyte
his LINC00293 8q11.1 -0.197 0.135 0.67
his HCG4 6p21.3 -0.197 0.135 0.67
his LOC554223 -0.197 0.135 0.67
exp KRT8P5 18q12.3 -0.197 0.135 0.67
hs4 PLCH1 3q25.31 -0.197 0.135 0.67 intracellular signal
his DNAH5 5p15.2 -0.197 0.135 0.669 ciliary or flagellar
swa SUCLG1 2p11.2 -0.197 0.135 0.669 tricarboxylic acid
hs4 ENC1 5q13 -0.197 0.135 0.669 nervous system development;multicellular
hs4 HEXB 5q13 -0.197 0.135 0.669 carbohydrate metabolic process;sensory
perception of sound
xai NEXN 1p31.1 -0.197 0.135 0.669 regulation of cell
migration;regulation of cytoskeleton organization
his DOCK9 13q32.3 -0.197 0.135 0.669 blood coagulation
his DOCK9-AS2 -0.197 0.135 0.669
xai VMP1 17q23.1 -0.197 0.135 0.669 regulation of autophagy;cell-cell
adhesion
hs4 AQP11 11q14.1 -0.197 0.135 0.669 urea transport;endosomal lumen
acidification
his LOC101928304 -0.197 0.135 0.669
hs4 LMO7DN -0.197 0.135 0.669
his MIR564 -0.197 0.135 0.669
his TMEM42 3p21.31 -0.197 0.135 0.669
xai C4orf19 4p14 -0.197 0.135 0.669
swa NDUFAF3 3p21.31 -0.197 0.135 0.669 mitochondrial respiratory
hs4 SOWAHA 5q31.1 -0.197 0.135 0.669
xai VCAN 5q14.3 -0.197 0.135 0.669 axon regeneration;cell adhesion
hs4 GPX3 5q23 -0.197 0.135 0.669 response to organic cyclic
his TMEM136 11q23.3 -0.197 0.135 0.669
exp FMO10P 1q24.1 -0.197 0.135 0.669
cop CHCHD2 7p11.2 -0.199 0.135 0.669
cop NUPR1L 7p11.2 -0.199 0.135 0.669
his TMEM55A 8q21.3 0.197 0.136 0.67
xai BATF3 1q32.3 0.197 0.136 0.67 regulation of transcription, DNA-
his TMEM141 9q34.3 0.197 0.136 0.67
his CCDC183 0.197 0.136 0.67
xai C12orf42 12q23.2 0.197 0.136 0.67
his EXOSC1 10q24 0.197 0.136 0.67 mRNA metabolic process;exonucleolytic
decay
his ZDHHC16 10q24.1 0.197 0.136 0.67 apoptotic process
hs4 AGAP1-IT1 0.197 0.136 0.67
his THUMPD3 3p25.3 0.197 0.136 0.67
dependent"
dependent"
hs4 LINC01726 0.197 0.136 0.67
hs4 PAX1 20p11.2 0.197 0.136 0.67 positive regulation of transcription from
RNA polymerase II promoter;skeletal system development
hs4 SNAR-F 0.197 0.136 0.67
his NDC1 1p32.3 0.197 0.136 0.67
xai SATB1 3p23 0.197 0.136 0.67 interspecies interaction between
cop MIR4498 0.197 0.136 0.67
exp HIST1H4D 6p22.1 0.196 0.136 0.67
xai OR10AA1P 1q23.1 0.196 0.136 0.67
xai ACAA2 18q21.1 0.196 0.136 0.67 acetyl-CoA metabolic process;lipid
metabolic process
his RBM45 2q31.2 0.196 0.136 0.67 multicellular organismal
xai TACC3 4p16.3 0.196 0.136 0.67 microtubule cytoskeleton
hs4 RPS24 10q22 0.196 0.136 0.67 translation;mRNA metabolic process
his CCPG1 15q21.1 0.196 0.136 0.67 cell cycle
his C15orf65 0.196 0.136 0.67
hs4 PAX5 9p13 0.196 0.136 0.67 Tumor Suppressors
his IL21R-AS1 0.196 0.136 0.67
hs4 NFAM1 22q13.2 0.196 0.136 0.671 regulation of B cell
xai LOC100131432 0.196 0.136 0.671
his NUDT9 4q22.1 0.196 0.136 0.671 ADP catabolic process;IDP catabolic
process
xai PIAS4 19p13.3 0.196 0.136 0.671 DNA Damage Response (DDR)
his ZNF658B 9p12 0.196 0.136 0.671 regulation of transcription, DNA-
dependent"
exp LOC100131432 0.196 0.136 0.671
exp HCG17 0.196 0.136 0.671
his TMEM41B 11p15.4 0.196 0.136 0.671
his AGO1 1p34.3 0.196 0.136 0.671
cop LOC728739 12q23.3 0.196 0.136 0.671
xai ADGRL4 0.196 0.136 0.671 G-protein coupled receptor signaling
exp NCL 2q37.1 0.196 0.136 0.671 angiogenesis
his MAMSTR 19q13.33 0.196 0.136 0.671 regulation of transcription, DNA-
dependent;positive regulation of myotube differentiation
his LOC105373496 0.196 0.136 0.671
his ARID5A 2q11.2 0.196 0.136 0.671 negative regulation of
swa ESD 13q14.1-q14.2 0.196 0.136 0.671 metabolic process
swa MRPS31 13q14.11 0.196 0.136 0.671
xai SI 3q25.2-q26.2 0.196 0.136 0.671 response to vitamin A;response to
starvation
his CABP1 12q24.31 0.196 0.136 0.672 negative regulation of catalytic activity
xsq PTPRN 2q35-q36.1 0.195 0.136 0.67 cytokine-mediated signaling
mir hsa-miR-219-5p 0.195 0.136 0.67
mir hsa-miR-219-5p(3) 0.195 0.136 0.67
mir hsa-miR-219-5p(4) 0.195 0.136 0.67
mir hsa-miR-219-5p(5) 0.195 0.136 0.67
mir hsa-miR-219-5p(6) 0.195 0.136 0.67
mir hsa-miR-219-5p(7) 0.195 0.136 0.67
mir hsa-miR-219-5p(2) 0.195 0.136 0.67
xsq ARHGEF6 Xq26.3 0.195 0.136 0.67 positive regulation of GTPase
xsq MROH8 20q11.22 0.195 0.136 0.67
exp LOC100128297 0.195 0.136 0.67
met FASTKD3 5p15.31 0.195 0.136 0.67 cellular respiration
exp HSPA9 5q31.1 0.195 0.136 0.67 Apoptosis
exp NDUFS5P2 1p21.3 0.195 0.136 0.67
mut PDGFRA 4q12 0.195 0.136 0.67 Cell Signaling; Oncogenes; Protein
Kinases
xsq PTP4A2 1p35 0.195 0.136 0.67
met NHEJ1 2q35 0.195 0.136 0.67 DNA Damage Response (DDR); DDR (NHEJ)
cop CD9 12p13.3 0.195 0.136 0.67 response to water deprivation;platelet
degranulation
exp ZNF217 20q13.2 0.195 0.136 0.67 transcription, DNA-
exp POLR1D 13q12.2 0.195 0.136 0.67 transcription elongation from RNA
exp DHX33 17p13.2 0.195 0.136 0.67 positive regulation of transcription from
RNA polymerase I promoter
dependent"
xsq PRSS3P2 7q34 0.195 0.136 0.67
xsq STAC2 17q12 0.195 0.136 0.67 intracellular signal transduction
cop MAVS 20p13 0.195 0.136 0.67 positive regulation of interferon-alpha
xsq OR9G4 0.195 0.136 0.671
xsq ADPRM 17p13.1 0.195 0.136 0.671
mut ZCCHC12 Xq24 0.195 0.136 0.671 regulation of transcription, DNA-
dependent"
xsq HYDIN2 0.195 0.136 0.671
exp MYH4 17p13.1 0.195 0.136 0.671 muscle contraction;response to activity
met CHGA 14q32 0.195 0.136 0.671 regulation of blood pressure
exp ADAMTS18 16q23 0.195 0.136 0.671 proteolysis
met KIAA1804 1q42 0.195 0.136 0.671
xsq OR10K2 0.195 0.136 0.671
cop BRSK2 11p15.5 0.195 0.136 0.671 protein phosphorylation;nervous system
development
cop DUSP8 11p15.5 0.195 0.136 0.671 inactivation of MAPK activity;protein
dephosphorylation
cop KRTAP5-1 11p15.5 0.195 0.136 0.671
cop KRTAP5-2 0.195 0.136 0.671
cop KRTAP5-3 11p15.5 0.195 0.136 0.671
cop KRTAP5-4 11p15.5 0.195 0.136 0.671
cop KRTAP5-5 0.195 0.136 0.671
cop FAM99A 0.195 0.136 0.671
xsq NTRK3-AS1 0.195 0.136 0.671
met GPRC5A 12p13-p12.3 0.195 0.136 0.671 G-protein coupled receptor
cop LOC283214 0.195 0.136 0.671
xsq C9orf156 9q22.33 0.195 0.136 0.671
xsq LINC01104 0.195 0.136 0.671
met ABO 9q34.2 0.195 0.136 0.671 carbohydrate metabolic process;protein
glycosylation
cop SLC52A3 20p13 0.195 0.136 0.671 transport;sensory perception of sound
exp RPL6P13 4q21.3 0.195 0.136 0.671
xsq HSF2 6q22.31 0.195 0.136 0.671 regulation of transcription, DNA-
cop TRABD2A 2p11.2 0.195 0.136 0.671
xsq APPL1 3p21.1-p14.3 0.195 0.136 0.671 signal transduction;cell
proliferation
xsq ADGRG5 0.195 0.136 0.671 G-protein coupled receptor signaling
xsq FADS2 11q12.2 0.195 0.136 0.671 unsaturated fatty acid biosynthetic
process;transport
exp FBXO22 15q24.2 0.195 0.136 0.671 protein modification
xsq WDR27 6q27 0.195 0.136 0.671
mut ARAP3 5q31.3 0.195 0.136 0.671 regulation of cell shape;vesicle-mediated
transport
met CACNB1 17q21-q22 0.195 0.136 0.671 protein targeting to
membrane;transport
exp ZXDB Xp11.21 0.195 0.136 0.671 regulation of transcription, DNA-
dependent"
xsq FLJ33581 0.194 0.136 0.671
exp COX8A 11q12-q13 0.194 0.136 0.671 generation of precursor metabolites and
exp FAM185A 7q22.1 0.194 0.136 0.671
cop PBOV1 6q23.3 0.194 0.136 0.672
cop PSMD7 16q22.3 0.194 0.136 0.672 protein polyubiquitination;gene
expression
exp UST 6q25.1 -0.194 0.136 0.672 protein sulfation
mut COL22A1 8q24.3 -0.195 0.136 0.671 cell adhesion
xsq ABCC3 17q22 -0.195 0.136 0.671 ABC Transporters
cop TMEM41A 3q27.2 -0.195 0.136 0.671
cop LIPH 3q27 -0.195 0.136 0.671 lipid catabolic process
cop SENP2 3q27.2 -0.195 0.136 0.671 protein transport;protein
desumoylation
cop IGF2BP2 3q27.2 -0.195 0.136 0.671 anatomical structure
cop C3orf65 3q27.2 -0.195 0.136 0.671
exp TNFSF13 17p13.1 -0.195 0.136 0.671 positive regulation of cell
proliferation;gene expression
exp FAM21C 10q11.1 -0.195 0.136 0.671 transport;retrograde
transport, endosome to Golgi"
exp MEX3D 19p13.3 -0.195 0.136 0.671 posttranscriptional regulation of
gene expression by mRNA localization;regulation of anti-apoptosis
cop TRA2B 3q26.2-q27 -0.195 0.136 0.671 response to reactive oxygen
xsq TMEM136 11q23.3 -0.195 0.136 0.67
met SSR4P1 21q22.3 -0.195 0.136 0.67
cop RFWD2 1q25.1-q25.2 -0.195 0.136 0.67 DNA damage response, signal
transduction by p53 class mediator resulting in cell cycle arrest;cell cycle
checkpoint"
cop DMRT2 9p24.3 -0.195 0.136 0.67 regulation of transcription, DNA-
cop ARL15 5p15.2 -0.195 0.136 0.67 small GTPase mediated signal
transduction
cop ABCA13 7p12.3 -0.195 0.136 0.67 ABC Transporters
xsq C10orf55 10q22.2 -0.195 0.136 0.67
hs4 FMO6P 1q24.3 -0.196 0.136 0.672
hs4 PLA2G4C-AS1 -0.196 0.136 0.671
exp MTND1P9 -0.196 0.136 0.671
hs4 RAB2A 8q12.1 -0.196 0.136 0.671 GTP catabolic process;ER to Golgi
xai MTND1P9 -0.196 0.136 0.671
his MYLK 3q21 -0.196 0.136 0.671 positive regulation of cell
xai PP14571 2q37.3 -0.196 0.136 0.671
xai TRAM1 8q13.3 -0.196 0.136 0.671 translation;cotranslational protein
his MIR4634 -0.196 0.136 0.671
his UPK3B 7q11.2 -0.196 0.136 0.671 negative regulation of gene
expression
xai GRHPR 9q12 -0.196 0.136 0.671 excretion;metabolic process
his PKP3 11p15 -0.196 0.136 0.671 cell adhesion
hs4 AHR 7p15 -0.196 0.136 0.671 Apoptosis
xai USP43 17p13.1 -0.196 0.136 0.671 proteolysis;ubiquitin-dependent
his GFPT2 5q34-q35 -0.196 0.136 0.671 dolichol-linked oligosaccharide
biosynthetic process;glutamine metabolic process
xai RGS20 8q11.23 -0.196 0.136 0.671 regulation of G-protein coupled
exp GAPDHP54 -0.196 0.136 0.671
exp COL2A1 12q13.11 -0.196 0.136 0.67 heart morphogenesis;notochord
development
xai CLIP3 19q13.12 -0.196 0.136 0.67 negative regulation of microtubule
xai MIR34A -0.196 0.136 0.67
xai CCDC110 4q35.1 -0.196 0.136 0.67
his NRG1 8p12 -0.196 0.136 0.67 transmembrane receptor protein tyrosine
kinase signaling pathway;positive regulation of cell growth
hs4 LINC00674 -0.196 0.136 0.67
his MIR591 -0.196 0.136 0.67
hs4 SNX19 11q25 -0.196 0.136 0.67 protein transport;cell communication
xai BBOX1 11p14.2 -0.197 0.136 0.67 cellular nitrogen compound
hs4 MIR100HG 11q24.1 -0.197 0.136 0.67
hs4 RHOBTB2 8p21.3 -0.197 0.136 0.67 small GTPase mediated signal
hs4 STC1 8p21-p11.2 -0.197 0.136 0.67 cell-cell signaling;cellular
response to hypoxia
xai SOWAHB 4q21.1 -0.197 0.136 0.67 EMT (Epithelial)
hs4 NAT14 19q13.42 -0.197 0.136 0.67 transcription initiation, DNA-
hs4 SSC5D 19q13.42 -0.197 0.136 0.67
his LINC01501 -0.197 0.136 0.67
exp PTOV1-AS1 -0.197 0.136 0.67
cop FIGNL1 7p12.1 -0.197 0.136 0.67 regulation of cell
cycle;osteoblast differentiation
exp GLRA2 Xp22.2 -0.197 0.136 0.67 ion transport;neuropeptide
signaling pathway
xai DGCR9 22q11.21 -0.197 0.136 0.67
xai DMRTB1 1p32.3 0.196 0.137 0.672 regulation of transcription, DNA-
dependent;sex differentiation"
hs4 HYAL3 3p21.3 0.196 0.137 0.672 response to antibiotic;cartilage
development
hs4 NAT6 3p21.3 0.196 0.137 0.672
exp RPL7P15 3q21.2 0.196 0.137 0.672
his LINC01934 0.196 0.137 0.672
hs4 COL9A1 6q13 0.196 0.137 0.672 cell adhesion;axon guidance
his SPRYD4 12q13.3 0.196 0.137 0.672
xai RRS1 8q13.1 0.196 0.137 0.672 mitotic metaphase plate
his DGKG 3q27.2-q27.3 0.196 0.137 0.672 signal transduction;activation of
his S100A7 1q21 0.196 0.137 0.672
swa AIFM2 10q22.1 0.196 0.137 0.672 apoptotic mitochondrial
his ERGIC2 12p11.22 0.196 0.137 0.672 vesicle-mediated transport
his FBXL22 15q22.31 0.196 0.137 0.672
his USP3-AS1 15q22.31 0.196 0.137 0.672
his GUK1 1q32-q41 0.196 0.137 0.672 small molecule metabolic
his SS18 18q11.2 0.196 0.137 0.672 intracellular protein kinase
xai ECHDC1 6q22.33 0.196 0.137 0.672
his SRP14 15q22 0.196 0.137 0.672 cotranslational protein targeting to
membrane;SRP-dependent cotranslational protein targeting to membrane
his SRP14-AS1 0.196 0.137 0.672
his DDX21 10q21 0.196 0.137 0.672
his HDC 15q21.2 0.196 0.137 0.672 small molecule metabolic
process;histamine metabolic process
swa ARHGDIA 17q25.3 0.196 0.137 0.672 Apoptosis
exp VSIG4 Xq12-q13.3 0.196 0.137 0.672 complement activation, alternative
his RPS21 20q13.3 0.196 0.137 0.672 endonucleolytic cleavage in ITS1 to
dependent"
swa HMGN5 Xq13.3 0.196 0.137 0.672 regulation of transcription, DNA-
xai ATAD1 10q23.31 0.196 0.137 0.672 positive regulation of receptor
xai ZNHIT3 17q12 0.196 0.137 0.672 regulation of transcription, DNA-
dependent"
his BCAS3 17q23 0.196 0.137 0.672
his LOC101929541 0.196 0.137 0.672
his PPP2R5A 1q32.2-q32.3 0.196 0.137 0.672 signal transduction;positive
xai BORCS5 0.196 0.137 0.672
hs4 RAG1 11p13 0.196 0.137 0.672 B cell differentiation;T cell differentiation
in thymus
hs4 CAMKK2 12q24.2 0.196 0.137 0.672 positive regulation of
xai CRY2 11p11.2 0.196 0.137 0.672 DNA Damage Response (DDR)
his REV1 2q11.1-q11.2 0.196 0.137 0.672 DNA Damage Response (DDR); DDR (DNA
xai RPAIN 17p13.2 0.196 0.137 0.672 DNA Damage Response (DDR)
swa PBDC1 Xq13.3 0.196 0.137 0.672
hs4 ENKD1 16q22.1 0.196 0.137 0.672
hs4 C16orf86 16q22.1 0.196 0.137 0.672
his MGAT5 2q21.3 0.196 0.137 0.672 protein N-linked glycosylation;metabolic
process
dependent"
his ARHGAP25 2p13.3 0.196 0.137 0.672 regulation of small GTPase mediated
exp DSCAM-IT1 0.196 0.137 0.672
hs4 FDPS 1q22 0.196 0.137 0.672 cholesterol biosynthetic process;isoprenoid
cop MIR1178 0.196 0.137 0.672
dependent"
exp RPL30P4 3p22.3 0.196 0.137 0.672
his PSMD10 Xq22.3 0.196 0.137 0.672 cell cycle checkpoint;antigen
dependent
his ATG4A Xq22.1-q22.3 0.196 0.137 0.672 proteolysis;autophagy
his RAD54L 1p32 0.196 0.137 0.672 DNA Damage Response (DDR); DDR (HR)
xai HMGA1P4 0.196 0.137 0.672
his ULK4P3 15q13.2 0.196 0.137 0.672
hs4 VAMP1 12p 0.196 0.137 0.672 neurotransmitter secretion;vesicle-mediated
transport
his MS4A14 11q12.2 0.196 0.137 0.672
hs4 H2AFX 11q23.3 0.196 0.137 0.672 DNA Damage Response (DDR); DDR (HR)
xai PARD6A 16q22.1 0.196 0.137 0.672 cell-cell junction maintenance;cell
division
his SEPT7P9 10p11.1 0.196 0.137 0.672
xai SLC35E2B 1p36.33 0.196 0.137 0.672 Solute Carriers
mut SLITRK2 Xq27.3 0.194 0.137 0.672 axonogenesis
mut HOOK3 8p11.21 0.194 0.137 0.672 cytoplasmic microtubule
organization;microtubule anchoring
xsq DPAGT1 11q23.3 0.194 0.137 0.672 dolichol biosynthetic process;post-
exp ATP9B 18q23 0.194 0.137 0.672 cation transport;aminophospholipid transport
xsq LOC100129083 0.194 0.137 0.672
xsq BRINP3 0.194 0.137 0.672 nervous system development;negative
xsq YAF2 12q12 0.194 0.137 0.672 negative regulation of transcription, DNA-
cop APAF1 12q23 0.194 0.137 0.672 Apoptosis
xsq MUC3A 7q22 0.194 0.137 0.672 post-translational protein
exp PROCA1 17q11.2 0.194 0.137 0.672 lipid catabolic process
met KCND1 Xp11.23 0.194 0.137 0.672 synaptic transmission;transmembrane
transport
mut ENPP1 6q22-q23 0.194 0.137 0.672 nucleoside triphosphate catabolic
xsq ATP6V0A2 12q24.31 0.194 0.137 0.672 immune response;insulin receptor
signaling pathway
exp EIF3F 11p15.4 0.194 0.137 0.672 translation;translational initiation
xsq LOC100507391 0.194 0.137 0.672
xsq PRELID1 5q35.3 0.194 0.137 0.672 immune response;multicellular
cop C2orf91 2p21 0.194 0.137 0.672
met CYP1B1 2p22.2 0.194 0.137 0.672 cellular aromatic compound
exp CLEC4A 12p13 0.194 0.137 0.672 cell adhesion;cell surface receptor
signaling pathway
mut UTP20 12q23 0.194 0.137 0.672 rRNA processing;negative regulation of cell
proliferation
cop SRXN1 20p13 0.194 0.137 0.672 response to oxidative stress
cop SCRT2 20p13 0.194 0.137 0.672
exp GUSBP11 22q11.23 0.194 0.137 0.672
xsq ZWINT 10q21-q22 0.194 0.137 0.672 spindle organization;mitotic cell cycle
checkpoint
xsq LARP1B 4q28.2 0.194 0.137 0.672
xsq MRPL42 12q22 0.194 0.137 0.672 translation
xsq TMEM164 Xq22.3 0.194 0.137 0.672
exp CBLL1 7q22.3 0.194 0.137 0.672 negative regulation of cell
xsq LINC01600 0.194 0.137 0.672
met ZBTB47 3p22.1 0.194 0.137 0.672 regulation of transcription, DNA-
dependent"
exp KCNQ1 11p15.5 0.194 0.137 0.672 synaptic transmission;regulation of
xsq SKAP1 17q21.32 0.194 0.137 0.672 positive regulation of transcription,
mda Casp8 0.194 0.137 0.672
cop FAM222A 12q24.11 0.194 0.137 0.672
cop FAM222A-AS1 12q24.11 0.194 0.137 0.672
mut MR1 1q25.3 0.194 0.137 0.672 antigen processing and presentation of
peptide antigen via MHC class I;immune response
exp CDC34 19p13.3 0.194 0.137 0.672 negative regulation of cAMP-mediated
signaling;G1/S transition of mitotic cell cycle
exp GNAT2 1p13.1 0.194 0.137 0.672 elevation of cytosolic calcium ion
concentration;detection of light stimulus involved in visual perception
mut BRD8 5q31 0.194 0.137 0.672 histone H4 acetylation;histone H2A acetylation
xsq SMAD4 18q21.1 0.194 0.137 0.672 Apoptosis; Cell Signaling; Tumor
Suppressors
exp LDHB 12p12.2-p12.1 0.194 0.137 0.672 lactate metabolic process;pyruvate
metabolic process
xsq INSR 19p13.3-p13.2 0.194 0.137 0.672 positive regulation of cell
xsq ZNF3 7q22.1 0.194 0.137 0.672 cell differentiation;leukocyte activation
exp RPS6KA1 1p 0.194 0.137 0.672 Protein Kinases
exp CRIP1 14q32.33 0.194 0.137 0.672 heart development;cell proliferation
met DRD2 11q23 0.194 0.137 0.672 regulation of sodium ion
transport;intracellular protein kinase cascade
met EMCN 4q24 0.194 0.137 0.672
xsq NDUFA5 7q31.33 0.194 0.137 0.672 mitochondrial electron transport,
cop SIN3A 15q24.2 0.194 0.137 0.672 in utero embryonic development;cellular
cop PTPN9 15q24.2 0.194 0.137 0.672 protein dephosphorylation;peptidyl-
cop SNUPN 15q24.2 0.194 0.137 0.672 ncRNA metabolic process;snRNA import into
nucleus
cop IMP3 15q24 0.194 0.137 0.672 rRNA processing
cop SNX33 15q24.2 0.194 0.137 0.672 cell communication
cop CSPG4 15q24.2 0.194 0.137 0.672 neuron fate commitment;tissue remodeling
cop ODF3L1 15q24.2 0.194 0.137 0.672
xsq LINC00934 12q24.23 0.194 0.137 0.672
exp CKS1BP3 0.194 0.137 0.672
met PHLDA1 12q15 0.194 0.137 0.672 Apoptosis
exp GLTSCR1L 6p21.1 0.194 0.137 0.672
met LRRC16B 14q11.2 0.194 0.137 0.672
exp COX6A1 12q24.2 0.194 0.137 0.672 generation of precursor metabolites
xsq SMARCA5 4q31.1-q31.2 0.194 0.137 0.672 DNA Damage Response (DDR);
DDR (Chromatin)
met CENPI Xq22.1 0.194 0.137 0.672 CenH3-containing nucleosome assembly at
centromere;follicle-stimulating hormone signaling pathway
exp LOC642897 11q21 -0.194 0.137 0.672
mir hsa-miR-130a -0.194 0.137 0.672
cop MIR5681A -0.194 0.137 0.672
cop MIR5681B -0.194 0.137 0.672
exp FABP3 1p33-p32 -0.194 0.137 0.672 fatty acid metabolic
cop LOC642366 5q11.1 -0.194 0.137 0.672
xsq AIFM3 22q11.21 -0.194 0.137 0.672 induction of apoptosis;activation
of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome
c
exp RABGAP1 9q34.11 -0.194 0.137 0.672 cell cycle;positive
xsq SORBS1 10q23.33 -0.194 0.137 0.672 cellular response to insulin
xsq ARAP3 5q31.3 -0.194 0.137 0.672 regulation of cell shape;vesicle-
mediated transport
exp PRNP 20p13 -0.194 0.137 0.672 negative regulation of protein
exp MFAP3L 4q32.3 -0.194 0.137 0.672
met DOCK2 5q35.1 -0.194 0.137 0.672 actin cytoskeleton
xsq CTTNBP2 7q31 -0.194 0.137 0.672 brain development
cop PDE1C 7p14.3 -0.194 0.137 0.672 activation of phospholipase C
cop COL6A4P2 3q22.1 -0.194 0.137 0.672
cop FAM154A 9p22.1 -0.194 0.137 0.672
cop RRAGA 9p22.1 -0.194 0.137 0.672 Apoptosis
cop HAUS6 9p22.1 -0.194 0.137 0.672 centrosome organization;cell
division
cop SCARNA8 -0.194 0.137 0.672
cop PLIN2 9p22.1 -0.194 0.137 0.672 lipid storage;response to drug
cop DENND4C 9p22.1 -0.194 0.137 0.672
cop RPS6 9p21 -0.194 0.137 0.672 translational elongation;viral
reproduction
exp MIR10A -0.194 0.137 0.672
met MT1G 16q13 -0.194 0.137 0.672 cellular response to zinc ion;monocyte
differentiation
cop NID1 1q43 -0.194 0.137 0.672 cell adhesion;cell-matrix adhesion
exp SMS Xp22.1 -0.194 0.137 0.672 methionine metabolic
exp POU3F1 1p34.1 -0.194 0.137 0.672 myelination in peripheral
cop GPR137B 1q42-q43 -0.194 0.137 0.672
exp CACNG1 17q24 -0.194 0.137 0.672 transport;ion transport
xsq PRRG1 Xp21.1 -0.194 0.137 0.672
exp POMGNT1 1p34.1 -0.194 0.137 0.672 protein N-linked
glycosylation;protein O-linked glycosylation
xsq LINC00839 10q11.21 -0.194 0.137 0.672
mut GGA1 22q13.31 -0.194 0.137 0.672 intracellular protein
exp PCDH1 5q31.3 -0.194 0.137 0.672 nervous system development;cell
adhesion
cop ANKMY2 7p21 -0.194 0.137 0.672
mut TICAM1 19p13.3 -0.194 0.137 0.672 inflammatory
response;positive regulation of protein binding
exp P2RY6 11q13.5 -0.194 0.137 0.672 activation of phospholipase C
second messenger
cop PRG4 1q25-q31 -0.194 0.137 0.672 immune response;cell proliferation
exp RPS12P17 10q21.1 -0.194 0.137 0.672
xsq DTX2P1-UPK3BP1-PMS2P11 7q11.23 -0.194 0.137 0.672
hs4 GATA6-AS1 18q11.2 -0.196 0.137 0.672
hs4 GATA6 18q11.1-q11.2 -0.196 0.137 0.672 pancreatic A cell
swa GLIPR2 9p13.3 -0.196 0.137 0.672
exp KRT8P47 1p34.1 -0.196 0.137 0.672
xai SLC25A39P1 -0.196 0.137 0.672
xai LACC1 13q14.11 -0.196 0.137 0.672
xai MUC4 3q29 -0.196 0.137 0.672 cell adhesion;cell-matrix adhesion
his HNMT 2q22.1 -0.196 0.137 0.672 brain development;respiratory
gaseous exchange
xai TACR1 2p12 -0.196 0.137 0.672 inflammatory response;response to heat
exp SFTPD 10q22.2-q23.1 -0.196 0.137 0.672 surfactant
his CD82 11p11.2 -0.196 0.137 0.672
hs4 SERPINB9P1 -0.196 0.137 0.672
hs4 GDF15 19p13.11 -0.196 0.137 0.672 signal transduction;transforming
hs4 MIR3189 -0.196 0.137 0.672
xai KDM4B 19p13.3 -0.196 0.137 0.672 regulation of transcription, DNA-
hs4 TGFBR3 1p33-p32 -0.196 0.137 0.672 Apoptosis
xai SMS Xp22.1 -0.196 0.137 0.672 methionine metabolic
hs4 SNX24 5q23.2 -0.196 0.137 0.672 cell communication;protein
transport
his GAS2L3 12q23.1 -0.196 0.137 0.672 cell cycle arrest
xai ATOH8 2p11.2 -0.196 0.137 0.672 regulation of transcription, DNA-
xai KRTAP10-8 -0.196 0.137 0.672
swa PDLIM5 4q22 -0.196 0.137 0.672 regulation of synapse
assembly;regulation of dendritic spine morphogenesis
hs4 ZNRF3 22q12.1 -0.196 0.137 0.672
his IGFBP1 7p12.3 -0.196 0.137 0.672 positive regulation of cell
his ANKRD1 10q23.31 -0.196 0.137 0.672 positive regulation of
his XLOC_008559 -0.196 0.137 0.672
exp KRTAP10-8 -0.196 0.137 0.672
hs4 LINC01535 -0.196 0.137 0.672
xai C10orf111 10p13 -0.196 0.137 0.672
swa SPATA5 4q28.1 -0.196 0.137 0.672 multicellular organismal
his ASB2 14q31-q32 -0.196 0.137 0.672 signal transduction;intracellular
signal transduction
exp KRT8P40 -0.196 0.137 0.672
hs4 AKAP13 15q24-q25 -0.196 0.137 0.672 nerve growth factor receptor
hs4 MIR7706 -0.196 0.137 0.672
xai SNCG 10q23.2-q23.3 -0.196 0.137 0.672 regulation of dopamine
xai SEC61G 7p11.2 -0.196 0.137 0.672 antigen processing and
presentation of exogenous peptide antigen via MHC class I;cellular protein
metabolic process
hs4 HNF4G 8q21.11 -0.196 0.137 0.672 regulation of transcription from
xai LOC388882 22q11.23 -0.196 0.137 0.672
hs4 LY6D 8q24 -0.196 0.137 0.672 cell adhesion;lymphocyte differentiation
his LINC00920 -0.196 0.137 0.672
xai SDHAF4 0.196 0.138 0.672
his TIGD3 11q13.1 0.196 0.138 0.672 regulation of transcription, DNA-
dependent"
xai SWSAP1 19p13.2 0.196 0.138 0.673 DNA repair;DNA recombination
xai TTK 6q14.1 0.196 0.138 0.673 Tumor Suppressors
xai GTF3C6 6q21 0.196 0.138 0.673 transcription, DNA-
his RBM23 14q11.2 0.196 0.138 0.673 mRNA processing
his PRMT5-AS1 0.196 0.138 0.673
his ASGR1 17p13.2 0.196 0.138 0.673 receptor-mediated endocytosis;cellular
response to extracellular stimulus
hs4 IGLL1 22q11.23 0.196 0.138 0.673 immune response
his CWF19L1 10q24.31 0.196 0.138 0.673
exp CBX3P1 11p14.1 0.196 0.138 0.673
his LOC105374693 0.196 0.138 0.673
xai CBX3P1 11p14.1 0.196 0.138 0.673
xai METTL18 1q24.2 0.196 0.138 0.673
hs4 DMXL2 15q21.2 0.195 0.138 0.673
xai HAX1 1q21.3 0.195 0.138 0.673
swa HSP90AA4P 4q35.2 0.195 0.138 0.673 response to stress;protein folding
hs4 RABL6 9q34.3 0.195 0.138 0.673
hs4 CCDC183-AS1 0.195 0.138 0.673
his USF3 0.195 0.138 0.673
xai CCDC125 5q13.2 0.195 0.138 0.673
xai ASB6 9q34.13 0.195 0.138 0.673 intracellular signal transduction
his NUCKS1 1q32.1 0.195 0.138 0.673
xai RPS29P20 0.195 0.138 0.673
his SNRPC 6p21.31 0.195 0.138 0.673 spliceosomal snRNP assembly;nuclear mRNA
splicing, via spliceosome"
hs4 RNF126 19p13.3 0.195 0.138 0.673
exp PRSS41 16p13.3 0.195 0.138 0.673 proteolysis
dependent"
his DESI1 22q13.2 0.195 0.138 0.673
his NRGN 11q24 0.195 0.138 0.673 signal transduction;nervous system development
his RBM8A 1q21.1 0.195 0.138 0.673 RNA splicing;nuclear-transcribed mRNA
his SRSF4 1p35.3 0.195 0.138 0.673 RNA splicing, via transesterification
hs4 MIR124-3 0.195 0.138 0.673
exp RPS29P20 0.195 0.138 0.673
xai ZXDB Xp11.21 0.195 0.138 0.673 regulation of transcription, DNA-
dependent"
his CPEB3 10q23.32 0.195 0.138 0.673
his MARCH5 10q23.32-q23.33 0.195 0.138 0.673 protein
polyubiquitination;protein ubiquitination
swa USP7 16p13.3 0.195 0.138 0.673 protein deubiquitination;regulation of
protein stability
xai LOC283194 0.195 0.138 0.673
hs4 DERL3 22q11.23 0.195 0.138 0.673 ER-associated protein catabolic
his XRN2 20p11.2-p11.1 0.195 0.138 0.673 RNA processing;mRNA processing
swa EIF4E 4q21-q25 0.195 0.138 0.674 translation;cellular protein metabolic
process
xai RNU4-6P 0.195 0.138 0.674
xai ZNF217 20q13.2 0.195 0.138 0.674 transcription, DNA-
xai IL3RA 0.195 0.138 0.674 cellular response to interleukin-3
hs4 SPC25 2q31.1 0.195 0.138 0.674 mitotic cell cycle;mitotic spindle
organization
xai DHX33 17p13.2 0.195 0.138 0.674 positive regulation of transcription from
RNA polymerase I promoter
exp RNU6-82P 0.195 0.138 0.674
xsq MSTO1 1q22 0.194 0.138 0.672 mitochondrion organization;mitochondrion
distribution
exp ETFDH 4q32-q35 0.194 0.138 0.672 transport;response to oxidative stress
xsq DCAF11 14q11.2 0.194 0.138 0.673 protein ubiquitination
met MIR889 0.194 0.138 0.673
mut AGMO 7p21.2 0.194 0.138 0.673 fatty acid biosynthetic process;membrane
xsq CNTNAP4 16q23.1 0.194 0.138 0.673 cell adhesion;signal transduction
xsq POLR1D 13q12.2 0.194 0.138 0.673 transcription elongation from RNA
met SEMA6D 15q21.1 0.194 0.138 0.673 multicellular organismal
exp LINC00337 1p36.31 0.194 0.138 0.673
xsq RAD9B 12q24.11 0.194 0.138 0.673 DNA Damage Response (DDR)
xsq PIEZO1 16q24.3 0.194 0.138 0.673 ion transport;positive regulation
of integrin activation
met HUNK 21q22.1 0.194 0.138 0.673 signal transduction;multicellular
mut OR9K2 0.194 0.138 0.673
cop GRIN2B 12p12 0.194 0.138 0.673 learning or memory;hippocampus
development
dependent"
xsq RFX7 15q21.3 0.194 0.138 0.673 regulation of transcription, DNA-
dependent"
xsq ERAL1 17q11.2 0.194 0.138 0.673 ribosomal small subunit assembly;ribosome
biogenesis
mut ALX3 1p13.3 0.194 0.138 0.673 multicellular organismal development
mut KLHL18 3p21.31 0.194 0.138 0.673
mut ACOX3 4p15.3 0.194 0.138 0.673 fatty acid metabolic process;fatty acid
beta-oxidation using acyl-CoA oxidase
mut HARBI1 11p11.2 0.194 0.138 0.673
mut ORAI3 16p11.2 0.194 0.138 0.673
mut FOXA3 19q13.32 0.194 0.138 0.673 embryo development;regulation of
mut TRMT2A 22q11.21 0.194 0.138 0.673 RNA processing
mut PAPOLG 2p16.1 0.194 0.138 0.673 transcription, DNA-dependent;mRNA
processing
mut OR10Q1 0.194 0.138 0.673
exp E2F5 8q21.2 0.194 0.138 0.673 G1 phase of mitotic cell cycle;mitotic
cell cycle
met PARP14 3q21.1 0.194 0.138 0.673 regulation of transcription, DNA-
dependent"
exp PDCD1 2q37.3 0.194 0.138 0.673 apoptotic process;humoral immune response
mir hsa-miR-212 0.194 0.138 0.673
xsq LRFN5 14q21.1 0.194 0.138 0.673
met MIR382 0.194 0.138 0.673
dependent"
dependent"
xsq LRRC59 17q21.33 0.194 0.138 0.673
pro ISGF3G_26 0.194 0.138 0.673
mut USP49 6p21 0.194 0.138 0.673 ubiquitin-dependent protein catabolic
process;proteolysis
xsq NOL6 9p13.3 0.194 0.138 0.673 rRNA processing
xsq ETNK1 12p12.1 0.194 0.138 0.673 phosphatidylethanolamine biosynthetic
exp PSMB10 16q22.1 0.194 0.138 0.673 mitotic cell cycle;viral
reproduction
exp PGK1P2 19p13.3 0.194 0.138 0.673
xsq CIRBP 19p13.3 0.194 0.138 0.673 response to cold;response to UV
xsq OAZ1 19p13.3 0.194 0.138 0.673 regulation of cellular amino acid
xsq PLAC8L1 5q32 0.194 0.138 0.673
exp TMEM135 11q14.2 0.194 0.138 0.673 peroxisome organization
cop ZFHX3 16q22.3 0.194 0.138 0.673 negative regulation of myoblast
exp CILP2 19p13.11 0.194 0.138 0.673
cop LPIN1 2p25.1 0.194 0.138 0.673 small molecule metabolic
xsq GPBP1L1 1p34.1 0.194 0.138 0.673 regulation of transcription, DNA-
dependent"
cop LOH12CR1 12p12 0.194 0.138 0.673
cop PPP3R1 2p15 0.194 0.138 0.673 induction of apoptosis by intracellular
signals;activation of pro-apoptotic gene products
mut DYX1C1 15q21.3 0.194 0.138 0.674 neuron migration;nervous system
development
met TRPC4 13q13.3 0.194 0.138 0.674 ion transport;calcium ion transport
xsq PARK7 1p36.23 0.194 0.138 0.674 proteolysis;hydrogen peroxide metabolic
process
met MIR19A -0.194 0.138 0.674
cop ZPBP -0.194 0.138 0.674 binding of sperm to zona pellucida
xsq KLK5 19q13.33 -0.194 0.138 0.674 proteolysis;epidermis development
met DKFZp434J0226 19q13.32 -0.194 0.138 0.674
xsq KIAA1549 7q34 -0.194 0.138 0.674
exp SVIL 10p11.2 -0.194 0.138 0.674 cytoskeleton organization;skeletal
xsq SPATA12 3p14.3 -0.194 0.138 0.673
exp TNFRSF11B 8q24 -0.194 0.138 0.673 response to nutrient;extracellular
matrix organization
cop MTR 1q43 -0.194 0.138 0.673 protein methylation;tetrahydrofolate
metabolic process
cop EMB 5q11.1 -0.194 0.138 0.673 cell adhesion
exp C2 6p21.3 -0.194 0.138 0.673 proteolysis;complement activation
cop MAP6D1 3q27.1 -0.194 0.138 0.673 N-terminal peptidyl-L-
cysteine N-palmitoylation;negative regulation of microtubule depolymerization
cop MYO10 5p15.1-p14.3 -0.194 0.138 0.673 axon guidance;regulation of
cell shape
exp CMTM4 16q21-q22.1 -0.194 0.138 0.673 chemotaxis
mut HIC2 22q11.21 -0.194 0.138 0.673 negative regulation of
exp ECHDC3 10p14 -0.194 0.138 0.673
exp BAD 11q13.1 -0.194 0.138 0.673 Apoptosis
exp ADGRA2 -0.194 0.138 0.673 sprouting angiogenesis;G-protein
exp IGKV2D-29 2p12 -0.194 0.138 0.673
exp ORMDL2 12q13.2 -0.194 0.138 0.673 ceramide metabolic process
xsq TTPA 8q12.3 -0.194 0.138 0.673 response to pH;response to toxin
exp TAB3 Xp21.2 -0.194 0.138 0.673 MyD88-independent toll-like
exp NPTXR 22q13.1 -0.194 0.138 0.673 response to hydrogen peroxide
cop ACTN2 1q42-q43 -0.194 0.138 0.673 muscle filament sliding;platelet
activation
met HIST1H2BJ 6p22.1 -0.194 0.138 0.673 nucleosome assembly;defense
exp RUSC1-AS1 1q22 -0.194 0.138 0.673
exp CXCL16 17p13 -0.194 0.138 0.673 response to tumor necrosis
factor;lymphocyte chemotaxis
exp LYRM9 17q11.2 -0.194 0.138 0.673
exp C4orf19 4p14 -0.194 0.138 0.673
xsq MTERF2 -0.194 0.138 0.673 regulation of transcription, DNA-
exp LOC553939 Xq28 -0.194 0.138 0.673
exp C2orf70 2p23.3 -0.194 0.138 0.673
xsq GOLGB1 3q13 -0.194 0.138 0.673 Golgi organization
exp DOPEY2 21q22.2 -0.194 0.138 0.673 Golgi to endosome
met ANXA2R 5p12 -0.194 0.138 0.673
xsq LOC102724323 -0.194 0.138 0.673
cop ERO1LB 1q42.2-q43 -0.194 0.138 0.673
cop EPHB3 3q27.1 -0.194 0.138 0.673 axon guidance;substrate adhesion-
xsq LMOD1 1q32 -0.194 0.138 0.673 muscle contraction
xai ADAM7 8p21.2 -0.195 0.138 0.674 proteolysis
xai TAB2 6q25.1 -0.195 0.138 0.674 Toll signaling pathway;innate
immune response
xai GALNT5 2q24.1 -0.195 0.138 0.673 glycosaminoglycan
xai KRT8P47 1p34.1 -0.195 0.138 0.673
hs4 CLIP3 19q13.12 -0.195 0.138 0.673 negative regulation of microtubule
hs4 COX7B2 4p12 -0.195 0.138 0.673
hs4 LOC101927418 -0.195 0.138 0.673
exp ENO1P3 -0.195 0.138 0.673
his GPR173 Xp11 -0.195 0.138 0.673 signal transduction;G-protein
his ARHGEF3 3p14.3 -0.195 0.138 0.673 regulation of small GTPase
swa CUL4A 13q34 -0.195 0.138 0.673 Apoptosis; DNA Damage Response (DDR); DDR
hs4 PCDHA10 -0.195 0.138 0.673 cell adhesion;homophilic cell
adhesion
his SRGAP3 3p25.3 -0.195 0.138 0.673 signal transduction;small
his LOC100507477 -0.195 0.138 0.673
xai LOC642648 22q13.31 -0.195 0.138 0.673
xai LGR4 11p14-p13 -0.195 0.138 0.673 male genitalia
hs4 ABLIM1 10q25 -0.195 0.138 0.673 axon guidance;visual perception
hs4 LOC101927692 -0.195 0.138 0.673
hs4 C5orf42 5p13.2 -0.195 0.138 0.673
hs4 LOC105374727 -0.195 0.138 0.673
hs4 PTGES 9q34.3 -0.195 0.138 0.673 prostaglandin biosynthetic
swa CDH1 16q22.1 -0.195 0.138 0.673 Cell Signaling; Tumor Suppressors
his TMEM171 5q13.2 -0.195 0.138 0.673
his LINC01446 -0.195 0.138 0.673
DNA-dependent"
hs4 MMP7 11q21-q22 -0.195 0.138 0.673 Apoptosis
his LARP1 5q33.2 -0.196 0.138 0.673
hs4 CTTNBP2NL 1p13.2 -0.196 0.138 0.673
exp OXCT1-AS1 -0.196 0.138 0.673
hs4 KCNS3 2p24 -0.196 0.138 0.673 ion transport;potassium ion transport
xai DACT1 14q23.1 -0.196 0.138 0.673 multicellular organismal
xai OXCT1-AS1 -0.196 0.138 0.673
hs4 STOX2 4q35.1 -0.196 0.138 0.673 maternal placenta
xai AGT 1q42.2 -0.196 0.138 0.673 regulation of cell growth;renin-
hs4 TMEM158 3p21.3 -0.196 0.138 0.673
his PLEKHD1 14q24.1 -0.196 0.138 0.673
xai RHOBTB2 8p21.3 -0.196 0.138 0.672 small GTPase mediated signal
xai HIF1A-AS1 -0.196 0.138 0.672
exp HIF1A-AS1 -0.196 0.138 0.672
his GLIS2-AS1 -0.196 0.138 0.672
exp CHKB-AS1 22q13.33 0.195 0.139 0.674
exp RNU4-6P 0.195 0.139 0.674
xai PSMB3 17q12 0.195 0.139 0.674 protein polyubiquitination;gene expression
his NEU1 6p21.3 0.195 0.139 0.674 sphingolipid metabolic
exp LOC100133130 0.195 0.139 0.674
xai TPTE2P6 13q12.12 0.195 0.139 0.674
his ANKRD17 4q13.3 0.195 0.139 0.674 interspecies interaction between
organisms
xai LOC100419743 0.195 0.139 0.674
swa PRDX1 1p34.1 0.195 0.139 0.674 hydrogen peroxide catabolic
process;skeletal system development
his ENG 9q34.11 0.195 0.139 0.674 heart looping;cell migration
xai RNU6-82P 0.195 0.139 0.674
exp PIAS4 19p13.3 0.195 0.139 0.674 DNA Damage Response (DDR)
xai RPS4XP14 12p13.33 0.195 0.139 0.674
hs4 PRKX Xp22.3 0.195 0.139 0.674 cell adhesion;protein autophosphorylation
his FAM114A2 5q31-q33 0.195 0.139 0.674
his MFAP3 5q32-q33.2 0.195 0.139 0.674
his HNRNPA3 2q31.2 0.195 0.139 0.674 nuclear mRNA splicing, via
his MIR4444-1 0.195 0.139 0.674
exp PAPOLB 0.195 0.139 0.674 DDR (DNA replication)
his RPAP1 15q15.1 0.195 0.139 0.674
exp EFCAB12 3q21.3 0.195 0.139 0.674
xai LINC00317 0.195 0.139 0.674
his NAA25 12q24.13 0.195 0.139 0.674
swa ASS1 9q34.1 0.195 0.139 0.674 liver development;response to zinc ion
his MYO5A 15q21 0.195 0.139 0.674 transport;regulation of inositol 1,4,5-
trisphosphate-sensitive calcium-release channel activity
xai EBAG9 8q23 0.195 0.139 0.674 Apoptosis
his C19orf84 0.195 0.139 0.674
swa HEATR3 16q12.1 0.195 0.139 0.674
exp ANTXRLP1 0.195 0.139 0.674
his KMT5B 0.195 0.139 0.674 regulation of transcription, DNA-
xai TTN 2q31 0.195 0.139 0.674 muscle filament sliding;regulation of catalytic
activity
exp FUS 16p11.2 0.195 0.139 0.674 nuclear mRNA splicing, via
his SNX12 Xq13.1 0.195 0.139 0.674 cell communication;protein transport
hs4 CTSG 14q11.2 0.195 0.139 0.674 positive regulation of immune
xai POTEC 18p11.21 0.195 0.139 0.675
exp CYP2F1 19q13.2 0.195 0.139 0.675 xenobiotic metabolic
xai TMEM135 11q14.2 0.195 0.139 0.675 peroxisome organization
exp HSPA8P14 12q24.12 0.195 0.139 0.675
his DNM2 19p13.2 0.195 0.139 0.675 Apoptosis; Tumor Suppressors
his MIR638 0.195 0.139 0.675
xai ZNF736P7Y 0.195 0.139 0.675
xai E2F5 8q21.2 0.195 0.139 0.675 G1 phase of mitotic cell cycle;mitotic
cell cycle
xai LOC402125 0.195 0.139 0.675
cop SNORD115-31 0.195 0.139 0.675
cop SNORD115-32 0.195 0.139 0.675
cop SNORD115-33 0.195 0.139 0.675
cop SNORD115-34 0.195 0.139 0.675
cop SNORD115-35 0.195 0.139 0.675
cop SNORD115-37 0.195 0.139 0.675
cop SNORD115-38 0.195 0.139 0.675
cop SNORD115-39 0.195 0.139 0.675
cop SNORD115-40 0.195 0.139 0.675
cop SNORD115-41 0.195 0.139 0.675
cop SNORD115-42 0.195 0.139 0.675
cop SNORD115-44 0.195 0.139 0.675
cop SNORD115-45 0.195 0.139 0.675
cop SNORD115-47 0.195 0.139 0.675
cop SNORD115-48 0.195 0.139 0.675
xai LSMEM2 3p21.31 0.195 0.139 0.675
exp GPC3 Xq26.1 0.193 0.139 0.674 anatomical structure
exp RPARP-AS1 0.193 0.139 0.674
cop LOC283856 16q12.2 0.193 0.139 0.674
xsq KIAA1875 8q24.3 0.193 0.139 0.674
exp HIBCH 2q32.2 0.193 0.139 0.674 branched chain family amino acid
xsq CCDC178 18q12.1 0.193 0.139 0.674
cop NTSR2 2p25.1 0.193 0.139 0.674
exp JSRP1 19p13.3 0.193 0.139 0.674
met PLA2G15 16q22.1 0.193 0.139 0.674 lipid metabolic process;ceramide
metabolic process
exp SYCP2L 6p24.2 0.193 0.139 0.674
xsq HS6ST1 2q21 0.193 0.139 0.674 labyrinthine layer blood vessel
development;angiogenesis
cop CHST6 16q22 0.193 0.139 0.674 sulfur compound metabolic process;keratan
sulfate biosynthetic process
cop CHST5 16q22.3 0.193 0.139 0.674 carbohydrate metabolic process;N-
cop TMEM231 16q23.1 0.193 0.139 0.674 smoothened signaling pathway;cell
xsq ABCF2 7q36 0.193 0.139 0.674 ABC Transporters
mut MRPL46 15q25.3 0.193 0.139 0.674
xsq MLYCD 16q24 0.193 0.139 0.674 acetyl-CoA biosynthetic process;fatty acid
mut EPAS1 2p21-p16 0.193 0.139 0.674 response to hypoxia;multicellular
xsq LOC285627 5q33.3 0.193 0.139 0.674
xsq SALL4 20q13.2 0.193 0.139 0.674 DNA Damage Response (DDR)
xsq YTHDF2 1p35 0.193 0.139 0.674 humoral immune response
met DLC1 8p22 0.193 0.139 0.674 induction of apoptosis;actin cytoskeleton
organization
xsq NUDT6 4q26 0.193 0.139 0.674
xsq USP45 6q16.2 0.193 0.139 0.674 proteolysis;ubiquitin-dependent protein
catabolic process
xsq OR4C12 0.193 0.139 0.674 response to stimulus
xsq HYAL3 3p21.3 0.193 0.139 0.674 response to antibiotic;cartilage
development
xsq HSD17B7 1q23 0.193 0.139 0.674 steroid biosynthetic process;cholesterol
exp SNORD18A 15q22 0.193 0.139 0.674
xsq ANO9 11p15.5 0.193 0.139 0.674 ion transport
exp NUDT7 16q23.1 0.193 0.139 0.674 nucleoside diphosphate metabolic process
xsq MTERF4 0.193 0.139 0.674
xsq NDUFS7 19p13.3 0.193 0.139 0.674 transport;respiratory electron
transport chain
exp PWP1 12q23.3 0.193 0.139 0.674 transcription, DNA-dependent"
met POM121 7q11.23 0.193 0.139 0.674 cytokine-mediated signaling
pathway;small molecule metabolic process
xsq FAM228A 2p23.3 0.193 0.139 0.674
dependent"
exp LINC01018 0.193 0.139 0.674
exp RPL7AP39 7q22.1 0.193 0.139 0.674
cop GOLGA8B 15q14 0.193 0.139 0.674
xsq CALCB 0.193 0.139 0.674 vasodilation;cellular calcium ion homeostasis
cop MIR1233-1 0.193 0.139 0.674
cop MIR1233-2 0.193 0.139 0.674
met ASTN2 9q33.1 0.193 0.139 0.674
exp RPAIN 17p13.2 0.193 0.139 0.674 DNA Damage Response (DDR)
mut CER1 0.193 0.139 0.674
met KLK13 19q13.33 0.193 0.139 0.675 protein processing;proteolysis
xsq SUPT3H 6p21.1-p21.3 0.193 0.139 0.675 histone
exp JPH3 16q24.3 0.193 0.139 0.675 memory;exploration behavior
mut SEPT11 4q21.1 0.193 0.139 0.675 cell cycle;protein
exp AGO3 1p34 0.193 0.139 0.675
exp LOC729973 1p36.11 0.193 0.139 0.675
xsq PRPF38B 1p13.3 0.193 0.139 0.675 mRNA processing;RNA splicing
xsq LOC643387 2q37.3 0.193 0.139 0.675
xsq AZU1 19p13.3 0.193 0.139 0.675 microglial cell activation;positive
mut SERPINI2 3q26.1 0.193 0.139 0.675
xsq GCSHP3 0.193 0.139 0.675
xsq PSMB6 17p13 0.193 0.139 0.675 antigen processing and presentation of peptide
antigen via MHC class I;RNA metabolic process
cop CAMKMT 2p21 0.193 0.139 0.675
dependent"
xsq LOC101928443 0.193 0.139 0.675
met LMOD1 1q32 0.193 0.139 0.675 muscle contraction
xsq ABCA12 2q34 -0.193 0.139 0.675 ABC Transporters
exp ACKR1 -0.193 0.139 0.675 G-protein coupled receptor signaling
pathway;defense response
exp PBLD 10q21.3 -0.193 0.139 0.675 biosynthetic process
xsq GPR137B 1q42-q43 -0.193 0.139 0.675
xsq OTOR 20p12.1-p11.23 -0.193 0.139 0.675 cartilage
cop EDARADD 1q42.3 -0.193 0.139 0.675 hair follicle
xsq LGR4 11p14-p13 -0.193 0.139 0.675 male genitalia
met SERPINB7 18q21.33 -0.193 0.139 0.675 negative regulation of
cop MSC 8q21 -0.193 0.139 0.675 regulation of transcription, DNA-
cop LOC100132891 8q13.3 -0.193 0.139 0.675
cop TRPA1 8q13 -0.193 0.139 0.675 detection of mechanical stimulus involved
in sensory perception of pain;ion transport
cop LOC392232 8q13.3 -0.193 0.139 0.675
cop CHRD 3q27 -0.193 0.139 0.675 gastrulation with mouth forming
second;forebrain development
met DAOA 13q33.2 -0.193 0.139 0.675
exp LOC100289351 -0.193 0.139 0.675
cop DPY19L1P1 7p14.3 -0.193 0.139 0.674
cop ZNRF2P1 -0.193 0.139 0.674
cop MIR550A2 -0.193 0.139 0.674
cop MIR550B2 -0.193 0.139 0.674
cop LOC401321 -0.193 0.139 0.674
cop KBTBD2 7p14.3 -0.193 0.139 0.674
cop RP9P 7p14.3 -0.193 0.139 0.674
mda SF8 -0.193 0.139 0.674
exp CDC20B 5q11.2 -0.193 0.139 0.674
exp CRISP3 6p12.3 -0.193 0.139 0.674 innate immune
exp LOC728989 1q21.1 -0.193 0.139 0.674
exp MAP1LC3B 16q24.2 -0.193 0.139 0.674 autophagy
cop LGALS8-AS1 1q43 -0.193 0.139 0.674
met SNORA71B 20q11.23 -0.193 0.139 0.674
met MIR181B1 -0.193 0.139 0.674
cop SLCO5A1 8q13.3 -0.193 0.139 0.674 Solute Carriers
exp TNFRSF19 13q12.11-q12.3 -0.193 0.139 0.674 hair follicle
cop BZW2 7p21.1 -0.193 0.139 0.674 multicellular organismal
DNA-dependent"
met CASC5 15q14 -0.193 0.139 0.674 acrosome assembly;nucleosome assembly
xsq SYDE1 19p13.12 -0.193 0.139 0.674 EMT (Mesenchymal)
xsq SNAI2 8q11 -0.193 0.139 0.674 multicellular organismal
his ABCC6P1 16p12.3 -0.195 0.139 0.675
xai C7orf50 7p22.3 -0.195 0.139 0.675
swa PHIP 6q14 -0.195 0.139 0.675 DDR (DNA replication)
xai KRT19 17q21.2 -0.195 0.139 0.675 cell differentiation involved in
xai TAB3 Xp21.2 -0.195 0.139 0.675 MyD88-independent toll-like
dependent"
hs4 ITGB6 2q24.2 -0.195 0.139 0.675
his LINC01479 -0.195 0.139 0.675
xai BAX 19q13.3-q13.4 -0.195 0.139 0.675 Apoptosis; Protein Kinases
xai C6orf25 6p21.33 -0.195 0.139 0.674
his NEDD4L 18q21.31 -0.195 0.139 0.674 protein ubiquitination;water
homeostasis
xai FAM174A 5q21.1 -0.195 0.139 0.674
hs4 IFFO2 1p36.13 -0.195 0.139 0.674
xai CARMN -0.195 0.139 0.674
xai TNFAIP1 17q22-q23 -0.195 0.139 0.674 protein
hs4 JAG1 20p12.1-p11.23 -0.195 0.139 0.674 cell communication;regulation
of cell migration
his KCNS1 20q12 -0.195 0.139 0.674 potassium ion transport;synaptic
transmission
swa ARPC2 2q36.1 -0.195 0.139 0.674 cellular component
movement;positive regulation of actin filament polymerization
hs4 CACHD1 1p31.3 -0.195 0.139 0.674 ion transport;calcium ion
transport
hs4 PKNOX2 11q24.2 -0.195 0.139 0.674 regulation of transcription
hs4 PKNOX2-AS1 -0.195 0.139 0.674
his CSF2 5q31.1 -0.195 0.139 0.674 positive regulation of tyrosine
his SLC16A12-AS1 -0.195 0.139 0.674
hs4 TP63 3q28 -0.195 0.139 0.674 Apoptosis; Oncogenes
xai TRIM3 11p15.5 -0.195 0.139 0.674 nervous system development;protein
transport
hs4 NACAD 7p13 -0.195 0.139 0.674 protein transport
hs4 GLIPR1L1 12q21.2 -0.195 0.139 0.674
hs4 AGRN 1p36.33 -0.195 0.139 0.674 neuromuscular junction
hs4 LOC101929470 -0.195 0.139 0.674
xai SEC24A 5q31.1 -0.195 0.139 0.674 ER to Golgi vesicle-mediated
his SNORA105C -0.195 0.139 0.674
his RBMS2 12q13.3 -0.195 0.139 0.674 RNA processing
exp C9orf106 9q34.11 -0.195 0.139 0.674
xai TMEM133 11q22.1 -0.195 0.139 0.674
xai UNC13B 9p13.3 -0.195 0.139 0.674 induction of apoptosis;signal
transduction
exp ADAD1 4q27 -0.195 0.139 0.674 spermatogenesis;spermatid development
met ALPP 2q37 0.204 0.14 0.675
his TXNDC11 16p13.13 0.195 0.14 0.675 cell redox homeostasis
xai LOC100506458 0.195 0.14 0.675
dependent"
xai PLD5 1q43 0.195 0.14 0.675
xai PSME4 2p16.2 0.195 0.14 0.675 antigen processing and presentation of
his DPY19L4 8q22.1 0.195 0.14 0.675
exp ZNF736P7Y 0.195 0.14 0.675
his PANK4 1p36.32 0.195 0.14 0.675 coenzyme A biosynthetic process
xai YBX1 1p34 0.195 0.14 0.675 DNA Damage Response (DDR)
hs4 FRAT1 10q24.1 0.195 0.14 0.675 Wnt receptor signaling pathway;embryonic
axis specification
xai HNRNPKP1 5q23.2 0.195 0.14 0.675
swa OXSR1 3p22.2 0.195 0.14 0.675 protein phosphorylation;response to
oxidative stress
his SETD3 14q32.2 0.195 0.14 0.675 positive regulation of transcription,
DNA-dependent;histone H3-K36 methylation
his CCNK 14q32 0.195 0.14 0.675 cell division;regulation of cyclin-dependent
xai RFESD 5q15 0.195 0.14 0.675
hs4 GRPEL1 4p16 0.195 0.14 0.675 protein folding;protein import into
exp THOC3 5q35.2 0.195 0.14 0.675 transport;RNA splicing
his GCLM 1p22.1 0.194 0.14 0.675 cysteine metabolic process;negative
his R3HCC1L 10q24.2 0.194 0.14 0.675
hs4 RNF125 18q12.1 0.194 0.14 0.675 negative regulation of type I
his LUC7L2 7q34 0.194 0.14 0.675
his FMC1 0.194 0.14 0.675
his C7orf55-LUC7L2 0.194 0.14 0.675
xai EPRS 1q41 0.194 0.14 0.675 glutamyl-tRNA aminoacylation;prolyl-tRNA
aminoacylation
hs4 STMN1 1p36.11 0.194 0.14 0.675 response to virus;cell differentiation
hs4 MIR3917 0.194 0.14 0.675
xai PRSS41 16p13.3 0.194 0.14 0.675 proteolysis
his PLA2G2C 1p36.12 0.194 0.14 0.675 phospholipid metabolic
his TMEM52 1p36.33 0.194 0.14 0.675
xai RPS16P8 17q11.1 0.194 0.14 0.675
swa PAK2 3q29 0.194 0.14 0.675 Protein Kinases
his TNIP2 4p16.3 0.194 0.14 0.675 Apoptosis
his LINC01433 0.194 0.14 0.675
hs4 SLC6A3 5p15.3 0.194 0.14 0.675 lactation;response to nicotine
xai KLHDC7B 22q13.33 0.194 0.14 0.675
his CENPI Xq22.1 0.194 0.14 0.675 CenH3-containing nucleosome assembly at
centromere;follicle-stimulating hormone signaling pathway
his MIR4300 0.194 0.14 0.675
xai ETV2 19q13.12 0.194 0.14 0.675 Transcription Factors
xsq LINC00616 0.193 0.14 0.675
xsq OARD1 6p21.1 0.193 0.14 0.675
exp PSMB3 17q12 0.193 0.14 0.675 protein polyubiquitination;gene expression
xsq SMARCC1 3p21.31 0.193 0.14 0.675 DNA Damage Response (DDR); DDR
(Chromatin)
xsq LOC101928961 0.193 0.14 0.675
met U2SURP 3q23 0.193 0.14 0.675 RNA processing
exp POGLUT1 3q13.33 0.193 0.14 0.675
met APOBEC1 12p13.1 0.193 0.14 0.675 cytidine deamination;lipoprotein
mut PPP4R3B 0.193 0.14 0.675 DNA Damage Response (DDR)
xsq SF3B1 2q33.1 0.193 0.14 0.675 Oncogenes
mut GRIK3 1p34.3 0.193 0.14 0.675 regulation of membrane potential;negative
regulation of synaptic transmission, glutamatergic
exp KBTBD3 11q22.3 0.193 0.14 0.675
met CCDC71 3p21.31 0.193 0.14 0.675
mut AIM1L 1p36.11 0.193 0.14 0.675
cop FGD6 12q22 0.193 0.14 0.675 regulation of Rho protein signal
transduction;regulation of Cdc42 GTPase activity
xsq WRN 8p12 0.193 0.14 0.675 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
xsq MCEE 2p13.3 0.193 0.14 0.675 fatty acid beta-oxidation;short-chain
fatty acid catabolic process
exp HAGHL 16p13.3 0.193 0.14 0.675
exp TUBBP6 7p11.2 0.193 0.14 0.675
xsq IKZF2 2q34 0.193 0.14 0.675 regulation of transcription, DNA-
mut COL3A1 2q31 0.193 0.14 0.675 heart development;fibril organization
xsq LOC441454 9q22.33 0.193 0.14 0.675
mut ASB4 7q21-q22 0.193 0.14 0.675 intracellular signal transduction
met ITGB4 17q25 0.193 0.14 0.675 cell-matrix adhesion;integrin-mediated
signaling pathway
xsq RBM4B 11q13 0.193 0.14 0.675 mRNA processing;regulation of translation
xsq LINC01520 0.193 0.14 0.675
xsq INIP 9q32 0.193 0.14 0.675
met CNTN4 3p26.3 0.193 0.14 0.675 axon guidance;axonal fasciculation
mut C14orf37 14q23.1 0.193 0.14 0.675
exp PALD1 10q22.1 0.193 0.14 0.675
exp NUP98 11p15.5 0.193 0.14 0.675 M phase of mitotic cell cycle;regulation
mut GALNT8 12p13.3 0.193 0.14 0.675 cellular protein metabolic
xsq INTS4P2 0.193 0.14 0.675
xsq RAB33B 4q28 0.193 0.14 0.675 small GTPase mediated signal
cop EHBP1 2p15 0.193 0.14 0.675
exp RRS1 8q13.1 0.193 0.14 0.675 mitotic metaphase plate
cop TCF15 20p13 0.193 0.14 0.675 regulation of transcription from RNA polymerase
II promoter;paraxial mesoderm development
exp PSMB6 17p13 0.193 0.14 0.675 antigen processing and presentation of peptide
met ADAMTS15 11q25 0.193 0.14 0.675 proteolysis
xsq DAPP1 4q25-q27 0.193 0.14 0.675 protein dephosphorylation;signal
transduction
xsq GABRB2 5q34 0.193 0.14 0.675 chloride transport;gamma-aminobutyric
xsq EXOC2 6p25.3 0.193 0.14 0.675 exocytosis;protein transport
dependent"
xsq RGPD2 2p11.2 0.193 0.14 0.675
exp DDX39A 19p13.12 0.193 0.14 0.675 nuclear mRNA splicing, via
exp MRPS16 10q22.1 0.193 0.14 0.675 translation
exp PKIB 6q22.31 0.193 0.14 0.675 negative regulation of protein kinase
activity
mut PCYOX1 2p13.3 0.193 0.14 0.675 chloride transport;prenylated
xsq CDNF 10p13 0.193 0.14 0.675
xsq STAU2-AS1 8q21.11 0.193 0.14 0.675
met TBX5 12q24.1 0.193 0.14 0.675 ventricular septum development;lung
development
exp COQ5 12q24.31 0.193 0.14 0.675 ubiquinone biosynthetic process
met LPIN3 20q12 0.193 0.14 0.675 dephosphorylation;lipid metabolic process
xsq DHRS4L2 14q11.2 0.193 0.14 0.675
xsq ARHGAP27 17q21.31 0.193 0.14 0.675 receptor-mediated
endocytosis;signal transduction
exp CHCHD2P10 8q11.23 0.193 0.14 0.675
exp TACC3 4p16.3 0.193 0.14 0.675 microtubule cytoskeleton
xsq NUFIP1 13q14 0.193 0.14 0.675 box C/D snoRNP assembly;RNA processing
xsq SIDT1 3q13.2 0.193 0.14 0.675
mut MYLK3 16q11.2 0.193 0.14 0.675 protein phosphorylation;sarcomere
organization
cop UCN 2p23-p21 0.193 0.14 0.675 positive regulation of cell
cop MPV17 2p23.3 0.193 0.14 0.675 regulation of reactive oxygen species
metabolic process;mitochondrial genome maintenance
cop GTF3C2 2p23.3 0.193 0.14 0.675 transcription, DNA-
cop LOC100505624 0.193 0.14 0.675
cop EIF2B4 2p23.3 0.193 0.14 0.675 gene expression;cellular response
to stimulus
cop SNX17 2p23-p22 0.193 0.14 0.675 receptor-mediated endocytosis;signal
transduction
cop ZNF513 2p23.3 0.193 0.14 0.675 visual perception;response to
stimulus
cop PPM1G 2p23.3 0.193 0.14 0.675 protein dephosphorylation;cell cycle
arrest
cop FTH1P3 2p23.3 0.193 0.14 0.675
cop NRBP1 2p23 0.193 0.14 0.675 ER to Golgi vesicle-mediated transport;gene
expression
cop KRTCAP3 2p23.3 0.193 0.14 0.675
cop IFT172 2p23.3 0.193 0.14 0.675 protein processing;cilium assembly
cop FNDC4 2p23.3 0.193 0.14 0.675
cop GCKR 2p23 0.193 0.14 0.675 carbohydrate metabolic process;small molecule
metabolic process
met C4orf50 4p16.2 0.193 0.14 0.675
xsq NBPF11 0.193 0.14 0.675
xsq ELP3 8p21.1 0.193 0.14 0.675 regulation of transcription from RNA
mir hsa-miR-629* 0.193 0.14 0.675
pro CASP7_6 0.193 0.14 0.675
xsq DOPEY2 21q22.2 -0.193 0.14 0.675 Golgi to endosome
met VILL 3p21.3 -0.193 0.14 0.675 cytoskeleton organization;actin
filament capping
xsq TUSC1 9p21.2 -0.193 0.14 0.675 Tumor Suppressors
met ACE 17q23.3 -0.193 0.14 0.675 proteolysis;regulation of
vasodilation
met CIZ1 9q34.1 -0.193 0.14 0.675 positive regulation of DNA-
dependent DNA replication initiation
cop ABCC5 3q27 -0.193 0.14 0.675 ABC Transporters
cop ABCC5-AS1 -0.193 0.14 0.675
cop LOC100506025 -0.193 0.14 0.675
cop FKBP9 7p11.1 -0.193 0.14 0.675 protein peptidyl-prolyl
exp PRSS8 16p11.2 -0.193 0.14 0.675 EMT (Epithelial)
exp RETSAT 2p11.2 -0.193 0.14 0.675 retinol metabolic
cop ASTN1 1q25.2 -0.193 0.14 0.675 cell adhesion;neuron cell-cell
adhesion
cop FLJ16171 -0.193 0.14 0.675
cop FLJ22447 -0.193 0.14 0.675
met GNGT1 7q21.3 -0.193 0.14 0.675 synaptic
cop LINC00583 -0.193 0.14 0.675
xsq C8orf34 8q13 -0.193 0.14 0.675 signal transduction
xsq TLL2 10q23-q24 -0.193 0.14 0.675 proteolysis;multicellular
exp SEMA5A 5p15.2 -0.193 0.14 0.675 cell
cop PRDM14 8q13.3 -0.193 0.14 0.675 regulation of transcription,
DNA-dependent;germ cell development
cop NCOA2 8q13.3 -0.193 0.14 0.675 regulation of transcription, DNA-
dependent;cerebellum development
cop TRAM1 8q13.3 -0.193 0.14 0.675 translation;cotranslational protein
cop LOC286190 -0.193 0.14 0.675
cop LACTB2 8q13.3 -0.193 0.14 0.675
cop XKR9 8q13.3 -0.193 0.14 0.675
cop LINC00474 9q31.3 -0.193 0.14 0.675
met OSBPL8 12q14 -0.193 0.14 0.675 transport;lipid transport
exp LZTR1 22q11.21 -0.193 0.14 0.675 regulation of transcription, DNA-
mir hsa-miR-196b -0.193 0.14 0.675
xsq DAPK2 15q22.31 -0.193 0.14 0.675 Apoptosis
xsq SLITRK2 Xq27.3 -0.193 0.14 0.675 axonogenesis
mut ARMC5 16p11.2 -0.193 0.14 0.675
xsq SPOCK1 5q31.2 -0.193 0.14 0.675 cell adhesion;signal
transduction
xsq SMPDL3A 6q22.31 -0.193 0.14 0.675 sphingomyelin catabolic
exp GPNMB 7p15 -0.193 0.14 0.675 cell adhesion;negative regulation of cell
proliferation
exp MRGPRF 11q13.3 -0.193 0.14 0.675
met PBX2 6p21.3 -0.193 0.14 0.675 positive regulation of
transcription from RNA polymerase II promoter;proximal/distal pattern formation
xsq RBPMS2 15q22.31 -0.193 0.14 0.675
exp AZIN2 -0.193 0.14 0.675 agmatine biosynthetic process;ornithine
metabolic process
xsq SEMA6A 5q23.1 -0.193 0.14 0.675 cell surface receptor
signaling pathway;multicellular organismal development
cop PARL 3q27.1 -0.193 0.14 0.675 proteolysis
met MB21D1 6q13 -0.193 0.14 0.675 response to virus
cop LOC401177 -0.193 0.14 0.675
xsq ZMIZ1-AS1 10q22.3 -0.193 0.14 0.675
exp HERC6 4q22.1 -0.193 0.14 0.675 protein modification
process
cop FAM134B 5p15.1 -0.193 0.14 0.675 sensory perception of pain
xai BVES 6q21 -0.194 0.14 0.675 vesicle-mediated transport;regulation of
Rac GTPase activity
hs4 FAM210B 20q13.2 -0.194 0.14 0.675
xai ACTR10 14q23.1 -0.194 0.14 0.675 microtubule-based movement
his C10orf142 -0.194 0.14 0.675
his MIR4325 -0.194 0.14 0.675
his SPO11 20q13.31 -0.194 0.14 0.675 DNA Damage Response (DDR); DDR (HR)
xai FANK1 10q26.2 -0.194 0.14 0.675
exp PSORS1C1 6p21.3 -0.194 0.14 0.675
exp RIT2 18q12.3 -0.194 0.14 0.675 GTP catabolic process;signal
transduction
hs4 MPP3 17q21.31 -0.194 0.14 0.675 signal transduction
his ZBTB20-AS5 -0.194 0.14 0.675
swa UFL1 6q16.1 -0.194 0.14 0.675 negative regulation of protein
exp CCDC188 -0.194 0.14 0.675
xai TCTN1 12q24.11 -0.194 0.14 0.675 cilium morphogenesis;multicellular
his RTKN2 10q21.2 -0.194 0.14 0.675 signal transduction;positive
hs4 SUOX 12q13.2 -0.194 0.14 0.675 sulfide oxidation, using
sulfide:quinone oxidoreductase;sulfur amino acid metabolic process
xai TTPAL 20q13.12 -0.194 0.14 0.675
hs4 DNAJB13 11q13.4 -0.194 0.14 0.675 protein folding;apoptotic
process
hs4 FLOT1 6p21.3 -0.194 0.14 0.675
hs4 IER3 6p21.3 -0.194 0.14 0.675 Apoptosis
xai DMBX1 1p33 -0.194 0.14 0.675 negative regulation of transcription,
his TMEM54 1p35-p34 -0.194 0.14 0.675
swa BRD7 16q12 -0.194 0.14 0.675 DNA Damage Response (DDR); DDR
(Chromatin)
hs4 GAS6 13q34 -0.194 0.14 0.675 proteolysis;cellular protein metabolic
process
hs4 GAS6-AS2 -0.194 0.14 0.675
his PDCD1LG2 9p24.2 -0.194 0.14 0.675 immune response;T cell
costimulation
hs4 GRM2 3p21.2 -0.195 0.14 0.675 inhibition of adenylate cyclase
activity by G-protein coupled glutamate receptor signaling pathway;synaptic
transmission
xai FAM90A1 12p13.31 -0.195 0.14 0.675
his MGAT5B 17q25.2 -0.195 0.14 0.675
swa SIPA1 11q13 -0.195 0.14 0.675 Apoptosis
exp OR4F15 15q26.3 -0.195 0.14 0.675 response to stimulus
xai MOCS2 5q11 -0.195 0.14 0.675 vitamin metabolic process;water-soluble
his LOC105370024 -0.195 0.14 0.675
his HSPB8 12q24.23 -0.195 0.14 0.675 response to stress;cell death
hs4 LOC283140 -0.195 0.14 0.675
xai LOC728989 1q21.1 -0.195 0.14 0.675
hs4 DEPDC7 11p13 -0.195 0.14 0.675 small GTPase mediated signal
hs4 UPK1A-AS1 -0.195 0.14 0.675
hs4 PRAF2 Xp11.23 -0.195 0.14 0.675 L-glutamate transport;protein
transport
xai ANKAR 2q32.2 -0.195 0.14 0.675
xai TMTC3 12q21.32 -0.195 0.14 0.675
mda Numerical_heterogeneity -0.205 0.14 0.675
his CCDC174 3p25.1 0.194 0.141 0.675
his ATP5E 20q13.32 0.194 0.141 0.676 ATP catabolic process;ion transport
exp MAP2K7 19p13.3-p13.2 0.194 0.141 0.676 Protein Kinases
xai DDX39A 19p13.12 0.194 0.141 0.676 nuclear mRNA splicing, via
xai BTF3P12 8q13.3 0.194 0.141 0.676
xai IDH3A 15q25.1-q25.2 0.194 0.141 0.676 carbohydrate metabolic
exp DUTP7 0.194 0.141 0.676
his S100A7A 1q21.3 0.194 0.141 0.676
his SAR1A 10q22.1 0.194 0.141 0.676 intracellular protein transport;ER to
his TBCC 6p21.1 0.194 0.141 0.676 GTP catabolic process;protein folding
his GLTSCR1L 6p21.1 0.194 0.141 0.676
his SAMD13 1p31.1 0.194 0.141 0.676
his MKL2 16p13.12 0.194 0.141 0.676 cell differentiation;positive regulation
of striated muscle tissue development
his CPNE7 16q24.3 0.194 0.141 0.676 lipid metabolic process;transport
xai PDE1A 2q32.1 0.194 0.141 0.676 signal transduction;epidermal growth
xai SNX1 15q22.31 0.194 0.141 0.676 cell communication;early endosome to
Golgi transport
his SNORA53 12q23.1 0.194 0.141 0.676
hs4 GPX7 1p32 0.194 0.141 0.676 response to oxidative stress
xai CDK12 17q12 0.194 0.141 0.676 Protein Kinases
xai SOST 17q11.2 0.194 0.141 0.676 response to mechanical stimulus;negative
regulation of ossification
xai ASF1B 19p13.12 0.194 0.141 0.676 DNA Damage Response (DDR); DDR (DNA
replication)
xai DUTP7 0.194 0.141 0.676
his TSPAN16 19p13.2 0.194 0.141 0.676
xai SNRPG 2p13.3 0.194 0.141 0.676 spliceosomal snRNP assembly;RNA metabolic
process
hs4 LDHD 16q23.1 0.194 0.141 0.676
his BRICD5 16p13.3 0.194 0.141 0.676
his PGP 16p13.3 0.194 0.141 0.676 metabolic process;carbohydrate metabolic
process
hs4 NEUROD1 2q32 0.194 0.141 0.676
his PTPN9 15q24.2 0.194 0.141 0.676 protein dephosphorylation;peptidyl-
his LOC100287896 11q13.4 0.194 0.141 0.676
his LIPT2 11q13.4 0.194 0.141 0.676 protein modification process;lipoate
his BTN2A1 6p22.1 0.194 0.141 0.676 lipid metabolic process
his AATK-AS1 17q25.3 0.194 0.141 0.676
his KIAA2022 Xq13.3 0.194 0.141 0.676 S phase of mitotic cell cycle;base-
excision repair, gap-filling
exp LOC100506688 0.194 0.141 0.676
xai ATG2B 14q32.2 0.194 0.141 0.676
xai DUSP22 6p25.3 0.194 0.141 0.676 Apoptosis
hs4 EOMES 3p24.1 0.194 0.141 0.677 mesoderm formation;positive regulation of
hs4 LOC100652758 0.194 0.141 0.677
hs4 G3BP1 5q33.1 0.194 0.141 0.677 transport;Ras protein signal transduction
his GRK6 5q35 0.194 0.141 0.677 signal transduction;regulation of G-protein
swa H1FX 3q21.3 0.194 0.141 0.677 nucleosome assembly
his JAKMIP1 4p16.1 0.194 0.141 0.677 protein transport
his LOC285484 4p16.1 0.194 0.141 0.677
xai RPEP2 3p24.2 0.194 0.141 0.677
xai ACOT13 6p22.3 0.194 0.141 0.677 protein homotetramerization
his GSK3B 3q13.3 0.194 0.141 0.677 Apoptosis; Protein Kinases
xsq KRTAP17-1 17q21.2 0.193 0.141 0.675
exp NCAPD3 11q25 0.193 0.141 0.675 DNA Damage Response (DDR)
exp ZNF8 19q13.43 0.193 0.141 0.676 negative regulation of transcription from
xsq FAM124B 2q36.2 0.193 0.141 0.676
xsq OR6C4 0.193 0.141 0.676
met UNC93B1 11q13 0.193 0.141 0.676 toll-like receptor 7 signaling
met TMC5 16p12.3 0.192 0.141 0.676
exp OSTC 4q25 0.192 0.141 0.676 protein N-linked glycosylation via asparagine
xsq MPPED1 22q13.31 0.192 0.141 0.676
met KCNIP3 2q21.1 0.192 0.141 0.676 behavior;sensory perception of pain
exp CLEC5A 7q33 0.192 0.141 0.676 signal transduction;response to virus
xsq MTX1 1q21 0.192 0.141 0.676 protein targeting to mitochondrion;protein
transport
met ALS2CR11 2q33.1 0.192 0.141 0.676
mut VAMP8 2p12-p11.2 0.192 0.141 0.676 protein complex assembly;post-Golgi
exp XPO6 16p11.2 0.192 0.141 0.676 protein export from nucleus;intracellular
protein transport
exp PIGV 1p36.11 0.192 0.141 0.676 GPI anchor biosynthetic
xsq CCNE2 8q22.1 0.192 0.141 0.676 DDR (DNA replication); Oncogenes
exp TMEM31 Xq22.2 0.192 0.141 0.676
xsq ZC4H2 Xq11.2 0.192 0.141 0.676
xsq ATP5G1 17q21.32 0.192 0.141 0.676 mitochondrial ATP synthesis coupled
proton transport;small molecule metabolic process
met CD83 6p23 0.192 0.141 0.676 humoral immune response;signal transduction
xsq AURKA 20q13 0.192 0.141 0.676 DNA Damage Response (DDR); Protein Kinases
exp CHCHD1 10q22.2 0.192 0.141 0.676
met MIR1258 0.192 0.141 0.676
exp PPP1R10 6p21.3 0.192 0.141 0.676 transcription, DNA-
exp E2F3 6p22 0.192 0.141 0.676 Tumor Suppressors
xsq CASP8AP2 6q15 0.192 0.141 0.676 Apoptosis
cop DKFZP434H168 16q12.2 0.192 0.141 0.676
xsq ZC3HC1 7q32.2 0.192 0.141 0.676 anti-apoptosis;cell cycle
met PCK1 20q13.31 0.192 0.141 0.676 internal protein amino acid
acetylation;lipid metabolic process
xsq UTF1 10q26 0.192 0.141 0.676 regulation of transcription from RNA polymerase
II promoter;male gonad development
xsq EHMT1 9q34.3 0.192 0.141 0.676 DNA methylation;histone H3-K9 methylation
xsq CENPC 4q13.2 0.192 0.141 0.676
exp LOC728524 0.192 0.141 0.676
mut UGGT2 13q32.1 0.192 0.141 0.676 protein folding;protein glycosylation
xsq OR5H6 0.192 0.141 0.676
cop MOB2 11p15.5 0.192 0.141 0.676
xsq RPAP3 12q13.11 0.192 0.141 0.676
xsq CASD1 7q21.3 0.192 0.141 0.677
exp VAMP1 12p 0.192 0.141 0.677 neurotransmitter secretion;vesicle-mediated
transport
exp NSUN2 5p15.31 0.192 0.141 0.677 tRNA processing;tRNA methylation
met IKBKE 1q32.1 0.192 0.141 0.677 Protein Kinases
exp LINS1 0.192 0.141 0.677
xsq OR1K1 0.192 0.141 0.677
cop MIR4262 0.192 0.141 0.677
cop LGALS8 1q43 -0.192 0.141 0.677
exp PTPRF 1p34 -0.192 0.141 0.677 cell adhesion;positive regulation of
neuron apoptosis
mut GIMAP2 7q36.1 -0.192 0.141 0.677
xsq CCDC186 -0.192 0.141 0.677
cop C9orf66 9p24.3 -0.192 0.141 0.677
xsq SEMA5A 5p15.2 -0.192 0.141 0.677 cell
exp FLJ46906 6q24.1 -0.192 0.141 0.677
met S1PR3 9q22.1-q22.2 -0.192 0.141 0.677 cytokine
production;inflammatory response
xsq PCDHB17P -0.192 0.141 0.677 cell adhesion;homophilic cell
adhesion
xsq TNFRSF19 13q12.11-q12.3 -0.192 0.141 0.677 hair follicle
met USP44 12q22 -0.192 0.141 0.676 cell division;anaphase
exp PRKAG1 12q12-q14 -0.192 0.141 0.676 positive regulation of
protein kinase activity;regulation of glycolysis
exp ZFAND3 6p21.2 -0.192 0.141 0.676
xsq STXBP6 14q12 -0.192 0.141 0.676 vesicle-mediated transport
xsq DDX60L 4q32.3 -0.192 0.141 0.676
met TAGAP 6q25.3 -0.192 0.141 0.676 signal transduction;small GTPase
cop ZNF622 5p15.1 -0.192 0.141 0.676 positive regulation of JNK
cascade;induction of apoptosis by oxidative stress
exp COQ10B 2q33.1 -0.192 0.141 0.676
exp CLEC14A 14q21.1 -0.192 0.141 0.676
pro STAT1_20 -0.192 0.141 0.676
exp ELF4 Xq26 -0.192 0.141 0.676 Transcription Factors
exp LOC100287049 1q23.2 -0.192 0.141 0.676
met RFX8 2q11.2 -0.192 0.141 0.676 regulation of transcription, DNA-
dependent"
exp UBXN6 19p13 -0.192 0.141 0.676
xsq ACTG2 2p13.1 -0.192 0.141 0.676 muscle contraction
cop SWT1 1q25 -0.192 0.141 0.676
xsq CRTAP 3p22.3 -0.192 0.141 0.676 spermatogenesis
exp CEACAM19 19q13.31 -0.192 0.141 0.676
exp CTF1 16p11.2 -0.192 0.141 0.676 neuron development;leukemia
cop LGR6 1q32.1 -0.192 0.141 0.676
met TMEM206 1q32.3 -0.192 0.141 0.676
exp PCDHB16 5q31 -0.192 0.141 0.676 synapse assembly;calcium-dependent
cell-cell adhesion
met HIST1H2AG 6p22.1 -0.192 0.141 0.676
mir hsa-miR-10b -0.192 0.141 0.676
cop EYA1 8q13.3 -0.192 0.141 0.676 DNA Damage Response (DDR)
exp IFIT2 10q23.31 -0.192 0.141 0.676 negative regulation of protein
binding;cellular response to interferon-alpha
exp CPNE2 16q13 -0.193 0.141 0.676
xsq EEA1 12q22 -0.193 0.141 0.676 endocytosis;vesicle fusion
exp UNC13B 9p13.3 -0.193 0.141 0.676 induction of apoptosis;signal
transduction
hs4 TSC22D1-AS1 -0.194 0.141 0.677
his KCNJ5 11q24 -0.194 0.141 0.677 Oncogenes
DNA-dependent"
xai KLF12 13q22 -0.194 0.141 0.677 negative regulation of transcription from
promoter
xai HECW1-IT1 -0.194 0.141 0.677
swa VCL 10q22.2 -0.194 0.141 0.677 cellular component
xai SLC51A 3q29 -0.194 0.141 0.676
his PVRL3-AS1 -0.194 0.141 0.676
his NECTIN3 -0.194 0.141 0.676
hs4 FAM110B 8q12.1 -0.194 0.141 0.676
his NPIPA3 -0.194 0.141 0.676
his PROM1 4p15.32 -0.194 0.141 0.676 retina layer
formation;photoreceptor cell maintenance
his CEBPD 8p11.2-p11.1 -0.194 0.141 0.676 transcription from RNA
xai ACVR1 2q23-q24 -0.194 0.141 0.676 G1/S transition of mitotic cell
hs4 ARFGEF1 8q13 -0.194 0.141 0.676 exocytosis;regulation of ARF
hs4 LOC102724708 -0.194 0.141 0.676
his LOC105375014 -0.194 0.141 0.676
xai FDX1L 19p13.2 -0.194 0.141 0.676 transport;electron transport chain
hs4 KCNIP3 2q21.1 -0.194 0.141 0.676 behavior;sensory perception
of pain
swa FAM129B 9q34.13 -0.194 0.141 0.676 negative regulation of
apoptotic process
swa SDC1 2p24.1 -0.194 0.141 0.676 wound healing;response to calcium
ion
his ADAMTS7 15q24.2 -0.194 0.141 0.676 proteolysis
his IGFBP4 17q21.2 -0.194 0.141 0.676 cell proliferation;regulation
of glucose metabolic process
his PRR5-ARHGAP8 22q13 -0.194 0.141 0.676
his PRR5 22q13 -0.194 0.141 0.676 cell cycle
hs4 PHLDA2 11p15.4 -0.194 0.141 0.676 apoptotic process;organ
morphogenesis
xai PMP2 8q21.3-q22.1 -0.194 0.141 0.676
his RPL29P2 -0.194 0.141 0.676
his STRC 15q15.3 -0.194 0.141 0.676 sensory perception of sound
xai CYP2U1 4q25 -0.194 0.141 0.676 xenobiotic metabolic process;small
swa GFM1 3q25 -0.194 0.141 0.676 GTP catabolic process;mitochondrial
translational elongation
swa GOLGB1 3q13 -0.194 0.141 0.676 Golgi organization
exp HECW1-IT1 -0.194 0.141 0.676
xai PSG11 19q13.2 -0.194 0.141 0.676 female pregnancy
his AKR1B1 7q35 -0.194 0.141 0.676 small molecule metabolic
his MIR4652 -0.194 0.141 0.676
exp LOC100506136 -0.194 0.141 0.676
xai CYP4X1 1p33 -0.194 0.141 0.676
hs4 ATP11C Xq27.1 -0.194 0.141 0.676 cation transport;ion
xai IGHV1-69 0.195 0.142 0.677
hs4 RPS3 11q13.3-q13.5 0.194 0.142 0.677 translational termination;mRNA
metabolic process
hs4 SNORD15A 0.194 0.142 0.677
hs4 SNORD15B 11q13.4 0.194 0.142 0.677
xai EIF3F 11p15.4 0.194 0.142 0.677 translation;translational initiation
exp OLIG3 6q23.3 0.194 0.142 0.677 regulation of transcription, DNA-
dependent"
xai FANCF 11p15 0.194 0.142 0.677 DNA Damage Response (DDR); DDR (FA)
xai TRMU 22q13 0.194 0.142 0.677 tRNA metabolic process;tRNA processing
his INO80D 2q33.3 0.194 0.142 0.677 DNA Damage Response (DDR); DDR
(Chromatin)
xai DHPS 19p13.2 0.194 0.142 0.677 protein homotetramerization;translation
xai GATAD2A 19p13.11 0.194 0.142 0.677 anterior neuropore closure;negative
exp LINC01625 0.194 0.142 0.677
hs4 PACS2 14q32.33 0.194 0.142 0.677 apoptotic process;interspecies
hs4 BRF1 14q 0.194 0.142 0.677 positive regulation of transcription, DNA-
xai LARP4B 10p15.3 0.194 0.142 0.677
xai LINC00939 0.194 0.142 0.677
his LOC101927905 0.194 0.142 0.677
his FAM86FP 12p13.31 0.194 0.142 0.677
xai GAPDHP66 18p11.31 0.194 0.142 0.677
his SNX29P2 16p11.2 0.194 0.142 0.677
hs4 UQCRC1 3p21.3 0.194 0.142 0.677 oxidative phosphorylation;small
xai RNF219 13q31.1 0.194 0.142 0.677
xai PSMD4 1q21.3 0.194 0.142 0.677 S phase of mitotic cell cycle;DNA damage
exp LOC100132874 0.194 0.142 0.677
xai UNC93B1 11q13 0.194 0.142 0.677 toll-like receptor 7 signaling
his CXCR6 3p21 0.194 0.142 0.677 G-protein coupled receptor signaling
pathway;viral genome replication
his EIF3D 22q13.1 0.194 0.142 0.677 cellular protein metabolic
his TRIM69 15q21.1 0.194 0.142 0.677 apoptotic process
exp HIST1H2BM 6p22.1 0.194 0.142 0.677 nucleosome assembly
xai EFCAB12 3q21.3 0.194 0.142 0.677
xai HIST1H2BM 6p22.1 0.193 0.142 0.677 nucleosome assembly
his PANK1 10q23.31 0.193 0.142 0.677 small molecule metabolic process;vitamin
metabolic process
xai CLYBL 13q32 0.193 0.142 0.677 cellular aromatic compound metabolic process
his CPXCR1 Xq21.3 0.193 0.142 0.677
his ZNF219 14q11 0.193 0.142 0.677 transcription, DNA-dependent;regulation
his TMEM253 14q11.2 0.193 0.142 0.677
his NCBP1 9q34.1 0.193 0.142 0.677 termination of RNA polymerase II
his TSTD2 9q22.33 0.193 0.142 0.677
exp RPEP2 3p24.2 0.193 0.142 0.677
xai OLIG3 6q23.3 0.193 0.142 0.677 regulation of transcription, DNA-
dependent"
his ERMAP 1p34.2 0.193 0.142 0.677
his SVBP 0.193 0.142 0.677
his DPEP1 16q24.3 0.193 0.142 0.677 cellular response to drug;negative
xai PCMTD2 20q13.33 0.193 0.142 0.677 protein modification process
exp LOC402125 0.193 0.142 0.677
xai MANEAL 1p34.3 0.193 0.142 0.677
his LCT 2q21 0.193 0.142 0.677 carbohydrate metabolic process;response to
estrogen stimulus
his CNBP 3q21 0.193 0.142 0.677 regulation of transcription, DNA-
xai TRAJ46 0.193 0.142 0.677
hs4 GOT2 16q21 0.193 0.142 0.677 2-oxoglutarate metabolic process;biosynthetic
process
xai EDRF1 0.193 0.142 0.678 regulation of transcription, DNA-dependent"
his TIAL1 10q 0.193 0.142 0.678 Apoptosis
exp IPO11 5q12.1 0.193 0.142 0.678 intracellular protein transport
xai C19orf44 19p13.11 0.193 0.142 0.678
hs4 TFDP1 13q34 0.193 0.142 0.678 Apoptosis
exp TRAJ46 0.193 0.142 0.678
xai PTP4A2 1p35 0.193 0.142 0.678
his TRO Xp11.22-p11.21 0.193 0.142 0.678 cell adhesion;homophilic cell
adhesion
exp CDH22 20q13.1 0.193 0.142 0.678 homophilic cell adhesion;cell adhesion
exp SMARCD2 17q23.3 0.192 0.142 0.677 nucleosome disassembly;chromatin
remodeling
mut AOC1 7q36.1 0.192 0.142 0.677
met ELF3 1q32.2 0.192 0.142 0.677 Transcription Factors
exp ENTHD2 17q25.3 0.192 0.142 0.677
xsq SPCS2 11q13.4 0.192 0.142 0.677 signal peptide processing;proteolysis
xsq TMEM26 10q21.2 0.192 0.142 0.677
met CILP2 19p13.11 0.192 0.142 0.677
exp ATP5G2P1 1q32.2 0.192 0.142 0.677
cop CSK 15q24.1 0.192 0.142 0.677 Apoptosis
cop MIR4513 0.192 0.142 0.677
cop LMAN1L 15q24.1 0.192 0.142 0.677
cop CPLX3 15q24.1 0.192 0.142 0.677
cop ULK3 15q24.1 0.192 0.142 0.677 autophagy;negative regulation of
cop SCAMP2 15q23-q25 0.192 0.142 0.677 post-Golgi vesicle-mediated
cop MPI 15q24.1 0.192 0.142 0.677 carbohydrate metabolic process;dolichol-
cop FAM219B 15q24.1 0.192 0.142 0.677
cop COX5A 15q24.1 0.192 0.142 0.677 small molecule metabolic
cop RPP25 15q24.2 0.192 0.142 0.677 tRNA processing
cop SCAMP5 15q24.2 0.192 0.142 0.677 exocytosis;protein transport
cop PPCDC 15q24.2 0.192 0.142 0.677 coenzyme A biosynthetic
cop C15orf39 15q24.2 0.192 0.142 0.677
exp ZNF330 4q31.21 0.192 0.142 0.677
exp SUGT1P3 13q14.11 0.192 0.142 0.677
xsq POGLUT1 3q13.33 0.192 0.142 0.677
met WDR60 7q36.3 0.192 0.142 0.677
xsq CELF2 10p13 0.192 0.142 0.677 RNA processing;mRNA processing
exp TSTD2 9q22.33 0.192 0.142 0.677
cop LOC100505716 0.192 0.142 0.677
met LOC401127 4p14 0.192 0.142 0.677
met ADAM5 8p11.22 0.192 0.142 0.677
exp TSPEAR-AS2 0.192 0.142 0.677
xsq PGA4 0.192 0.142 0.677
xsq CETP 16q21 0.192 0.142 0.677 cholesterol metabolic process;lipoprotein
metabolic process
xsq ZGLP1 19p13.2 0.192 0.142 0.677 oocyte development;positive regulation of
ERK1 and ERK2 cascade
exp POU4F2 4q31.2 0.192 0.142 0.677 MAPK cascade;positive regulation of
mut HOXD4 2q31.1 0.192 0.142 0.677 stem cell differentiation;regulation of
mut PDK3 Xp22.11 0.192 0.142 0.677 regulation of acetyl-CoA biosynthetic
process from pyruvate;peptidyl-histidine phosphorylation
exp RAB35 12q24.31 0.192 0.142 0.677 endosome transport;cytokinesis
xsq TAT-AS1 0.192 0.142 0.677
met CACNA1A 19p13 0.192 0.142 0.677 synaptic transmission;regulation of
calcium ion-dependent exocytosis
xsq TNFRSF10A 8p21 0.192 0.142 0.677 Apoptosis
cop PLEKHH2 2p21 0.192 0.142 0.677
cop LOC728819 2p21 0.192 0.142 0.677
cop DYNC2LI1 2p25.1-p24.1 0.192 0.142 0.677 multicellular organismal
development;determination of left/right symmetry
cop ABCG5 2p21 0.192 0.142 0.677 ABC Transporters
cop ABCG8 2p21 0.192 0.142 0.677 ABC Transporters
xsq KLHL25 15q25.3 0.192 0.142 0.677
exp SIAH2 3q25 0.192 0.142 0.677 Apoptosis
exp PIGY 4q22.1 0.192 0.142 0.677 GPI anchor biosynthetic process;positive
regulation of metabolic process
cop PRKAB1 12q24.1-q24.3 0.192 0.142 0.677 Protein Kinases
met SEMA3C 7q21-q31 0.192 0.142 0.677 blood vessel remodeling;neural tube
development
exp CENPBD1 16q24.3 0.192 0.142 0.677 regulation of transcription, DNA-
dependent"
xsq TMEM174 5q13.2 0.192 0.142 0.677
xsq CLDN6 16p13.3 0.192 0.142 0.677 calcium-independent cell-cell adhesion
xsq AGAP5 10q22.2 0.192 0.142 0.677 regulation of ARF GTPase activity
xsq LINC01473 0.192 0.142 0.677
met AKR7L 1p36.13 0.192 0.142 0.677
mut AGT 1q42.2 0.192 0.142 0.677 regulation of cell growth;renin-
xsq ZFP90 16q22.1 0.192 0.142 0.677 negative regulation of DNA
mut COPB2 3q23 0.192 0.142 0.677 COPI coating of Golgi vesicle;intracellular
protein transport
xsq ISX 22q12.3 0.192 0.142 0.678
met EBI3 19p13.3 0.192 0.142 0.678 positive regulation of alpha-beta T cell
proliferation;humoral immune response
met PRKCA 17q22-q23.2 0.192 0.142 0.678 Apoptosis; Protein Kinases
exp GIMAP1 7q36.1 0.192 0.142 0.678 B cell differentiation;T cell
differentiation
exp ROPN1L 5p15.2 0.192 0.142 0.678 ciliary or flagellar
met GIMAP4 7q36.1 0.192 0.142 0.678
exp MYSM1 1p32.1 0.192 0.142 0.678 proteolysis;chromatin modification
xsq IFNAR2 21q22.11 0.192 0.142 0.678 cell surface receptor signaling
pathway;JAK-STAT cascade
exp FNTB 14q23.3 -0.192 0.142 0.678 protein farnesylation;response to
cytokine stimulus
cop COL6A6 3q22.1 -0.192 0.142 0.678 cell adhesion
exp PYGO1 15q21.3 -0.192 0.142 0.678 kidney development;post-embryonic
development
mut ITGA4 2q31.3 -0.192 0.142 0.678 B cell differentiation;blood vessel
remodeling
xsq PPP1R1A 12q13.2 -0.192 0.142 0.678 carbohydrate metabolic
met USP19 3p21.31 -0.192 0.142 0.678 negative regulation of skeletal
cop SMAD5 5q31 -0.192 0.142 0.678 transforming growth factor beta receptor
signaling pathway;embryonic pattern specification
cop TPR 1q25 -0.192 0.142 0.678 protein transport;glucose transport
met TBR1 2q24 -0.192 0.142 0.677 regulation of transcription, DNA-
exp SHARPIN 8q24.3 -0.192 0.142 0.677 mitochondrion
organization;protein homooligomerization
exp TTC30A 2q31.2 -0.192 0.142 0.677 cell projection organization
xsq DCLK2 4q31.3 -0.192 0.142 0.677 intracellular signal transduction
met NDUFA4L2 12q13.3 -0.192 0.142 0.677
xsq PLSCR3 17p13.1 -0.192 0.142 0.677 phospholipid scrambling
met LIF 22q12.2 -0.192 0.142 0.677 multicellular organismal
xsq ABCB9 12q24 -0.192 0.142 0.677 ABC Transporters
cop YEATS2 3q27.1 -0.192 0.142 0.677 negative regulation of
transcription from RNA polymerase II promoter;histone H3 acetylation
met MTO1 6q13 -0.192 0.142 0.677 tRNA processing;oxidation-reduction
process
exp LAMA1 18p11.3 -0.192 0.142 0.677 establishment of epithelial cell
apical/basal polarity;morphogenesis of an epithelial sheet
exp LAMA4 6q21 -0.192 0.142 0.677 regulation of embryonic development;brown
xai SFTPD 10q22.2-q23.1 -0.193 0.142 0.678 surfactant
his STEAP3-AS1 -0.193 0.142 0.678
DNA-dependent"
swa CD44 11p13 -0.193 0.142 0.678 cell-matrix adhesion;negative regulation
his DIRAS2 9q22.2 -0.193 0.142 0.678 signal transduction;small
hs4 RARRES1 3q25.32 -0.193 0.142 0.677 negative regulation of cell
proliferation
xai PRKAG1 12q12-q14 -0.193 0.142 0.677 positive regulation of
protein kinase activity;regulation of glycolysis
exp C14orf144 -0.193 0.142 0.677
cop APOD 3q29 -0.193 0.142 0.677 lipid transport;negative regulation of
swa ENAH 1q42.12 -0.193 0.142 0.677 intracellular transport;T cell
xai ACSL3 2q34-q35 -0.193 0.142 0.677 brain development;response to
nutrient
hs4 PPP1R42 8q13.1 -0.193 0.142 0.677
hs4 CYP1B1 2p22.2 -0.193 0.142 0.677 cellular aromatic compound
his WFDC2 20q13.12 -0.193 0.142 0.677 negative regulation of
endopeptidase activity;proteolysis
hs4 LOC101928335 -0.193 0.142 0.677
his RGAG1 Xq23 -0.194 0.142 0.677
xai KLF17 1p34.1 -0.194 0.142 0.677 regulation of transcription from
hs4 LINC00028 -0.194 0.142 0.677
xai CEP70 3q22.3 -0.194 0.142 0.677 mitotic cell cycle;G2/M transition
xai PLIN3 19p13.3 -0.194 0.142 0.677 vesicle-mediated transport
hs4 C1QTNF2 5q33.3 -0.194 0.142 0.677 positive regulation of
xai RDH5 12q13-q14 -0.194 0.142 0.677 response to stimulus;visual
perception
his ZFHX4 8q21.11 -0.194 0.142 0.677
his ZFHX4-AS1 8q21.11 -0.194 0.142 0.677
xai IGDCC4 15q22.31 -0.194 0.142 0.677
hs4 RGMA 15q26.1 -0.194 0.142 0.677 axon guidance
xai C19orf33 19q13.2 -0.194 0.142 0.677
his IQSEC2 Xp11.22 -0.194 0.142 0.677 regulation of ARF protein
signal transduction
his HOXB-AS1 -0.194 0.142 0.677
his HOXB2 17q21.32 -0.194 0.142 0.677 anterior/posterior pattern
his HOXB3 17q21.3 -0.194 0.142 0.677 multicellular organismal
his HOXB4 -0.194 0.142 0.677 morphogenesis of an epithelial
sheet;embryonic skeletal system morphogenesis
his MIR10A -0.194 0.142 0.677
his HOXB-AS3 17q21.32 -0.194 0.142 0.677
development;anatomical structure morphogenesis
development;anterior/posterior axis specification, embryo
his HOXB7 17q21.3 -0.194 0.142 0.677 myeloid cell
differentiation;embryonic skeletal system morphogenesis
his HOXB8 17q21.3 -0.194 0.142 0.677 sensory perception of pain;dorsal
spinal cord development
his HOXB9 17q21.3 -0.194 0.142 0.677 embryonic skeletal system
development;canonical Wnt receptor signaling pathway
his MIR196A1 -0.194 0.142 0.677
hs4 COPZ2 17q21.32 -0.194 0.142 0.677 intracellular protein
hs4 MIR152 -0.194 0.142 0.677
his TGFB2-OT1 -0.194 0.142 0.677
hs4 CDK18 1q31-q32 -0.194 0.142 0.677 Protein Kinases
his C2orf78 2p13.1 -0.194 0.142 0.677
hs4 FRMPD4 Xp22.2 -0.194 0.142 0.677 positive regulation of
synapse structural plasticity
xai CRISP3 6p12.3 -0.194 0.142 0.677 innate immune
xai RYKP1 17p13.2 -0.194 0.142 0.677
xai ZMIZ1-AS1 10q22.3 -0.194 0.142 0.677
xai SYNE2 14q23.2 -0.194 0.142 0.677 positive regulation of cell
xai PIP 7q34 -0.194 0.142 0.677
his ADRM1 20q13.33 0.193 0.143 0.678 transcription elongation from RNA
exp SALL4P6 3p22.1 0.193 0.143 0.678
his ALG1 16p13.3 0.193 0.143 0.678 protein N-linked glycosylation via
his GTPBP8 3q13.2 0.193 0.143 0.678 barrier septum assembly
his KIF27 9q21.32 0.193 0.143 0.678 cilium assembly;microtubule-based
movement
hs4 MIR4488 0.193 0.143 0.678
hs4 LRRC10B 11q12.2 0.193 0.143 0.678
hs4 MIR3675 0.193 0.143 0.678
exp HNRNPKP1 5q23.2 0.193 0.143 0.678
exp IGHV1-69 0.193 0.143 0.678
hs4 ZFP36L2 2p22.3-p21 0.193 0.143 0.678 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;regulation of transcription, DNA-dependent
hs4 LINC01126 0.193 0.143 0.678
xai SRP9 1q42.12 0.193 0.143 0.678 translation;SRP-dependent cotranslational
hs4 RPL36A-HNRNPH2 0.193 0.143 0.678
hs4 BTK Xq21.33-q22 0.193 0.143 0.678 regulation of transcription, DNA-
hs4 RPL36A Xq22.1 0.193 0.143 0.678 translational initiation;viral
infectious cycle
xai ZNF121 19p 0.193 0.143 0.678 regulation of transcription, DNA-
dependent"
his TLE3 15q22 0.193 0.143 0.678 regulation of transcription, DNA-
swa DNTTIP2 1p22.1 0.193 0.143 0.678 DNA Damage Response (DDR); DDR (DNA
replication)
his MAP1S 19p13.11 0.193 0.143 0.678 microtubule bundle formation;apoptotic
process
xai MAP2K7 19p13.3-p13.2 0.193 0.143 0.678 Protein Kinases
his NIPA1 15q11.2 0.193 0.143 0.678 ion transport;cell death
xai AGO3 1p34 0.193 0.143 0.678
xai HS2ST1 1p22.3 0.193 0.143 0.678 heparin metabolic process;ureteric
bud formation
exp ETV2 19q13.12 0.193 0.143 0.678 Transcription Factors
his GK Xp21.3 0.193 0.143 0.678 glycerol metabolic process;triglyceride
metabolic process
hs4 ZNF280D 15q21.3 0.193 0.143 0.678
xai TDP1 14q32.11 0.193 0.143 0.678 DNA Damage Response (DDR); DDR (BER)
his PCBP2 12q13.13 0.193 0.143 0.678 mRNA metabolic process;negative
xai ZBTB25 14q23-q24 0.193 0.143 0.678 regulation of transcription, DNA-
his GEMIN6 2p22.1 0.193 0.143 0.678 RNA splicing;gene expression
xai HEATR6 17q23.1 0.193 0.143 0.678
exp OR52I2 11p15.4 0.193 0.143 0.678 response to stimulus
xai OR52I2 11p15.4 0.193 0.143 0.678 response to stimulus
his PDF 16q22.1 0.193 0.143 0.678 translation;positive regulation of cell
proliferation
hs4 KRT27 17q21.2 0.193 0.143 0.679 hair follicle morphogenesis
hs4 KCNH2 7q36.1 0.193 0.143 0.679 synaptic transmission;blood circulation
hs4 SMARCA4 19p13.2 0.193 0.143 0.679 DNA Damage Response (DDR); DDR
his ZFYVE27 10q24.2 0.193 0.143 0.679 neuron projection development;nerve
his MYL6B 12q13.13 0.193 0.143 0.679 muscle filament sliding;muscle
contraction
his MYL6 12q13.2 0.193 0.143 0.679 muscle contraction;axon guidance
xai BZW2 7p21.1 0.193 0.143 0.679 multicellular organismal
xai GPR183 13q32.3 0.193 0.143 0.679 immune response;humoral immune
response
his CPNE4 3q22.1 0.193 0.143 0.679
his MAP4K1 19q13.1-q13.4 0.193 0.143 0.679 response to
his EIF3K 19q13.2 0.193 0.143 0.679 translation;translational initiation
his ATP8B2 1q21.3 0.193 0.143 0.679 cation transport;phospholipid
transport
dependent"
hs4 PKMYT1 16p13.3 0.193 0.143 0.679 regulation of mitosis;negative
regulation of phosphatase activity
xai KRT72 12q13.13 0.193 0.143 0.679
xai TECRP2 4q28.1 0.193 0.143 0.679
xai HSPA9P1 2q36.3 0.193 0.143 0.679
his EOMES 3p24.1 0.193 0.143 0.679 mesoderm formation;positive regulation of
exp KDM4A-AS1 0.193 0.143 0.679
his CXCR2 2q35 0.193 0.143 0.679 dendritic cell chemotaxis;neutrophil chemotaxis
his RABIF 1q32.1 0.193 0.143 0.679 cellular membrane fusion;small GTPase
exp BTBD2 19p13.3 0.192 0.143 0.678
mut ERCC8 5q12.1 0.192 0.143 0.678 DNA Damage Response (DDR); DDR (NER)
met ZFHX3 16q22.3 0.192 0.143 0.678 negative regulation of myoblast
dependent"
cop APCDD1 18p11.22 0.192 0.143 0.678 hair follicle development;negative
regulation of Wnt receptor signaling pathway
cop NAPG 18p11.22 0.192 0.143 0.678 protein complex assembly;intracellular
protein transport
met C11orf92 0.192 0.143 0.678
exp HMGB3P22 5q35.3 0.192 0.143 0.678
exp CCDC168 13q33.1 0.192 0.143 0.678
met RANBP17 5q34 0.192 0.143 0.678 protein import into nucleus;intracellular
protein transport
xsq E2F5 8q21.2 0.192 0.143 0.678 G1 phase of mitotic cell cycle;mitotic
cell cycle
exp MATK 19p13.3 0.191 0.143 0.678 mesoderm development;cell proliferation
cop MIR326 0.191 0.143 0.678
xsq RPL35 9q34.1 0.191 0.143 0.678 viral reproduction;nuclear-transcribed
exp PPP1R15B 1q32.1 0.191 0.143 0.678 dephosphorylation;response to
hydrogen peroxide
met APP 21q21.3 0.191 0.143 0.678 Apoptosis
exp FUT4 11q21 0.191 0.143 0.678 carbohydrate metabolic process;protein
glycosylation
xsq CHORDC1 11q14.3 0.191 0.143 0.678 regulation of centrosome
exp LOC100288798 12q13.11 0.191 0.143 0.678
exp CISD3 17q12 0.191 0.143 0.678
xsq LINC00161 21q21.3 0.191 0.143 0.678
met RAB5C 17q21.2 0.191 0.143 0.678 regulation of endocytosis;GTP catabolic
process
mut DMRTA1 9p21.3 0.191 0.143 0.678 regulation of transcription, DNA-
exp HIC2 22q11.21 0.191 0.143 0.678 negative regulation of transcription,
DNA-dependent"
cop RPS6KA2-IT1 0.191 0.143 0.678
cop MIR1913 0.191 0.143 0.678
xsq LRR1 14q21.3 0.191 0.143 0.678
met C1orf185 1p32.3 0.191 0.143 0.678
cop SIX2 2p21 0.191 0.143 0.678 regulation of transcription, DNA-
cop LINC01121 0.191 0.143 0.678
met BDNF 11p13 0.191 0.143 0.678 feeding behavior;fear response
xsq LOC101928794 0.191 0.143 0.678
exp CHEK2 22q12.1 0.191 0.143 0.678 DNA Damage Response (DDR); Protein
Kinases
xsq PAPOLA 14q32.31 0.191 0.143 0.678 RNA splicing;gene expression
met ADORA1 1q32.1 0.191 0.143 0.678 Apoptosis
met MIR1827 0.191 0.143 0.678
mut CYR61 1p22.3 0.191 0.143 0.678 positive regulation of protein
met ZIC2 13q32 0.191 0.143 0.678 retinal ganglion cell axon guidance;negative
cop SKINTL 1p33 0.191 0.143 0.678
xsq PANK4 1p36.32 0.191 0.143 0.678 coenzyme A biosynthetic process
xsq FIP1L1 4q12 0.191 0.143 0.678 mRNA processing
met ADAM21 14q24.1 0.191 0.143 0.679 single fertilization;proteolysis
exp VIPR2 7q36.3 0.191 0.143 0.679 G-protein coupled receptor signaling
mut BEND6 6p12.1 0.191 0.143 0.679
met MAOA Xp11.3 0.191 0.143 0.679 neurotransmitter secretion;behavior
cop SRBD1 2p21 0.191 0.143 0.679 nucleobase-containing compound metabolic
process
xsq TM4SF20 2q36.3 0.191 0.143 0.679
xsq CCDC168 13q33.1 0.191 0.143 0.679
met MIR1249 0.191 0.143 0.679
mut ANKRD50 4q28.1 0.191 0.143 0.679
met AMOTL2 3q21-q22 0.191 0.143 0.679
met C1orf186 1q32.1 0.191 0.143 0.679
xsq NYAP1 7q22.1 0.191 0.143 0.679
xsq LOC105377348 0.191 0.143 0.679
xsq ZBTB26 9q33.2 0.191 0.143 0.679 regulation of transcription, DNA-
dependent"
xsq OTC Xp21.1 0.191 0.143 0.679 response to zinc ion;protein
homotrimerization
xsq TAF11 6p21.31 0.191 0.143 0.679 regulation of transcription, DNA-
exp PARS2 1p32.2 0.191 0.143 0.679 tRNA aminoacylation for protein
xsq CRNN 1q21 0.191 0.143 0.679
cop CSNK2A1 20p13 0.191 0.143 0.679 Protein Kinases
xsq OTUD6B 8q21.3 0.191 0.143 0.679
xsq C9orf9 9q34 0.191 0.143 0.679
xsq CCER2 0.191 0.143 0.679
mir hsa-miR-15a* 0.191 0.143 0.679
xsq KGFLP1 0.191 0.143 0.679
cop ALDH1A2 15q21.3 0.191 0.143 0.679 heart morphogenesis;positive
met HNRNPCL1 1p36.21 0.191 0.143 0.679
xsq DNAJB4 1p31.1 -0.191 0.143 0.679 protein folding;response to
unfolded protein
met HMSD 18q22.1 -0.191 0.143 0.679
met MRGPRX2 11p15.1 -0.191 0.143 0.679
exp EPB41L1 20q11.2-q12 -0.191 0.143 0.679 synaptic
exp UAP1L1 9q34.3 -0.191 0.143 0.679 metabolic process
xsq DCDC2 6p22.1 -0.191 0.143 0.679 cellular defense response;nervous
system development
exp TMEM136 11q23.3 -0.191 0.143 0.679
DNA-dependent"
mut USP20 9q34.11 -0.191 0.143 0.679 protein K48-linked
exp EYA4 6q23 -0.191 0.143 0.678 DNA repair;regulation of transcription,
DNA-dependent
exp LOC100288233 -0.191 0.143 0.678
xsq FBXO17 19q13.2 -0.191 0.143 0.678 protein catabolic process
xsq PLA2R1 2q23-q24 -0.191 0.143 0.678 positive regulation of
xsq ME3 11cen-q22.3 -0.191 0.143 0.678 oxidation-reduction process;oxygen
metabolic process
xsq PCDHB2 5q31 -0.191 0.143 0.678 synaptic transmission;nervous
system development
xsq TRIP10 19p13.3 -0.191 0.143 0.678 cell communication;signal
transduction
xsq PCDHB11 5q31 -0.191 0.143 0.678 homophilic cell adhesion;synaptic
transmission
cop COBL 7p12.1 -0.191 0.143 0.678 neural tube closure
met FAM43A 3q29 -0.192 0.143 0.678
cop COL6A5 3q22.1 -0.192 0.143 0.678 cell adhesion
xsq ST6GALNAC2 17q25.1 -0.192 0.143 0.678 protein glycosylation;O-
glycan processing
exp ACVR2A 2q22.3 -0.192 0.143 0.678 Cell Signaling; Tumor
Suppressors
xsq SYNPO 5q33.1 -0.192 0.143 0.678 positive regulation of actin
xai SERINC1 6q22.31 -0.193 0.143 0.679 lipid metabolic
his CYP27A1 2q35 -0.193 0.143 0.679 bile acid metabolic process;small
hs4 ROPN1L-AS1 -0.193 0.143 0.679
hs4 ROPN1L 5p15.2 -0.193 0.143 0.679 ciliary or flagellar
exp EVPLL 17p11.2 -0.193 0.143 0.679
his NCALD 8q22.2 -0.193 0.143 0.679 synaptic transmission;vesicle-
mediated transport
his LOC102724958 -0.193 0.143 0.679
his MX1 21q22.3 -0.193 0.143 0.679 Apoptosis
xai HSPB2 11q22-q23 -0.193 0.143 0.679 Apoptosis
hs4 CEP70 3q22.3 -0.193 0.143 0.679 mitotic cell cycle;G2/M transition
swa KPNA4 3q25.33 -0.193 0.143 0.678 NLS-bearing substrate import into
nucleus;cytokine-mediated signaling pathway
his LINC01608 -0.193 0.143 0.678
his TTLL3 3p25.3 -0.193 0.143 0.678 protein polyglycylation;axoneme
assembly
DNA-dependent;stem cell maintenance
hs4 PSG9 19q13.2 -0.193 0.143 0.678 defense response;female pregnancy
exp CEACAMP7 -0.193 0.143 0.678
his BTG4 11q23 -0.193 0.143 0.678 cell cycle arrest;negative regulation of
cell proliferation
his MIR34B -0.193 0.143 0.678
his MIR34C -0.193 0.143 0.678
his C11orf88 11q23.1 -0.193 0.143 0.678
xai TOLLIP 11p15.5 -0.193 0.143 0.678 inflammatory response;signal
transduction
xai DPY19L4 8q22.1 -0.193 0.143 0.678
hs4 OR4F6 -0.193 0.143 0.678
hs4 PTGIS 20q13.13 -0.193 0.143 0.678 prostaglandin biosynthetic
hs4 MMP19 12q14 -0.193 0.143 0.678 Apoptosis
xai TERF1 8q21.11 -0.193 0.143 0.678 DNA Damage Response (DDR)
hs4 SEC24A 5q31.1 -0.193 0.143 0.678 ER to Golgi vesicle-mediated
his WARS2-IT1 -0.193 0.143 0.678
hs4 PLEKHH2 2p21 -0.193 0.143 0.678
cop PSG1 19q13.2 -0.193 0.143 0.678 female pregnancy
his MIR6868 -0.193 0.143 0.678
his WWC2-AS1 -0.193 0.143 0.678
his SCP2 1p32 0.193 0.144 0.679 lipid transport;peroxisome organization
his MIR1273F 0.193 0.144 0.679
hs4 UQCR11 19p13.3 0.193 0.144 0.679 generation of precursor metabolites
and energy;transport
swa IMP3 15q24 0.193 0.144 0.679 rRNA processing
his COQ9 16q21 0.193 0.144 0.679 ubiquinone biosynthetic process
his CIAPIN1 16q21 0.193 0.144 0.679 apoptotic process;anti-apoptosis
xai LOC100506634 0.193 0.144 0.679
hs4 OLIG2 21q22.11 0.193 0.144 0.679 myelination;negative regulation of neuron
differentiation
xai ESM1 5q11.2 0.193 0.144 0.679 angiogenesis;regulation of cell growth
his ESF1 20p12.1 0.193 0.144 0.679 regulation of transcription, DNA-
dependent"
his NDUFAF5 20p12.1 0.193 0.144 0.679
xai FUS 16p11.2 0.193 0.144 0.679 nuclear mRNA splicing, via
xai PGAP2 11p15.5 0.193 0.144 0.679 GPI anchor biosynthetic process;anti-
apoptosis
his DNAH8 6p21.2 0.193 0.144 0.679 ciliary or flagellar
xai SSBP2 5q14.1 0.193 0.144 0.679 regulation of transcription, DNA-
dependent"
xai FGF23 12p13.3 0.193 0.144 0.679 insulin receptor signaling
xai C17orf78 17q12 0.193 0.144 0.679
his SMYD5 2p13.2 0.193 0.144 0.679
his ARMC5 16p11.2 0.193 0.144 0.679
xai EDEM3 1q25 0.193 0.144 0.679 glycoprotein catabolic process;response to
unfolded protein
hs4 FAM135A 6q13 0.193 0.144 0.679
xai H2AFZ 4q24 0.193 0.144 0.679 DNA Damage Response (DDR)
his NAGK 2p13.3 0.193 0.144 0.679 N-acetylglucosamine metabolic process;N-
xai MIR181A1 0.193 0.144 0.679
exp MIR181A1 0.193 0.144 0.679
his CASC11 0.193 0.144 0.679
his MYC 8q24.21 0.193 0.144 0.679 Apoptosis; Oncogenes; Protein Kinases
xai HSPE1 2q33.1 0.193 0.144 0.679 Apoptosis
hs4 RPARP-AS1 0.193 0.144 0.679
hs4 C10orf95 10q24.32 0.193 0.144 0.679
his RALGAPA1 14q13.2 0.192 0.144 0.679 positive regulation of GTPase
xai THADA 2p21 0.192 0.144 0.679
exp SDHAF4 0.192 0.144 0.68
hs4 LRRC9 14q23.1 0.192 0.144 0.68
his C17orf107 17p13.2 0.192 0.144 0.68
his CHRNE 17p13.2 0.192 0.144 0.68 transport;cation transport
his NECTIN1 0.192 0.144 0.68
his LOC102724301 0.192 0.144 0.68
xai RFWD2P1 18p11.23 0.192 0.144 0.68
his PPM1G 2p23.3 0.192 0.144 0.68 protein dephosphorylation;cell cycle
arrest
swa PTPRC 1q31-q32 0.192 0.144 0.68 protein dephosphorylation;peptidyl-
his U2AF2 19q13.42 0.192 0.144 0.68 mRNA export from nucleus;RNA splicing
his TUBB4B 9q34 0.192 0.144 0.68 Apoptosis
his MIR3128 0.192 0.144 0.68
his NFE2L2 2q31 0.192 0.144 0.68 positive regulation of transcription from
RNA polymerase II promoter;regulation of embryonic development
xai ALG5 13q13.3 0.192 0.144 0.68 cellular protein metabolic
his PLAC8 4q21.22 0.192 0.144 0.68
exp SPANXN4 Xq27.3 0.192 0.144 0.68
xai KDM4A-AS1 0.192 0.144 0.68
xsq ATP6V1G2-DDX39B 0.191 0.144 0.679
xsq CCNL1 3q25.31 0.191 0.144 0.679 regulation of cyclin-dependent protein
kinase activity;regulation of transcription, DNA-dependent
xsq HMGN4 6p21.3 0.191 0.144 0.679
xsq FLVCR1 1q32.3 0.191 0.144 0.679 heme transport;head morphogenesis
met GJB3 1p34 0.191 0.144 0.679 cell communication;sensory perception of sound
dependent"
xsq MCHR1 22q13.2 0.191 0.144 0.679
exp LOC100288102 0.191 0.144 0.679
xsq LINC01020 0.191 0.144 0.679
xsq CPSF1 8q24.23 0.191 0.144 0.679 nuclear mRNA splicing, via
cop AQP9 15q 0.191 0.144 0.679 immune response;amine transport
xsq LINC00954 0.191 0.144 0.679
met SLC22A10 11q12.3 0.191 0.144 0.679
mir hsa-miR-505* 0.191 0.144 0.679
exp LOC401777 14q22.3 0.191 0.144 0.679
xsq RRS1 8q13.1 0.191 0.144 0.679 mitotic metaphase plate
xsq DSCAM-IT1 0.191 0.144 0.679
mut GPSM2 1p13.3 0.191 0.144 0.679 G-protein coupled receptor signaling
pathway;regulation of G-protein coupled receptor protein signaling pathway
mut MOV10 1p13.2 0.191 0.144 0.679 regulation of transcription, DNA-
mut OR13G1 0.191 0.144 0.679
mut KCNIP3 2q21.1 0.191 0.144 0.679 behavior;sensory perception of pain
mut PKP4 2q24.1 0.191 0.144 0.679 cell adhesion;positive regulation of Rho
GTPase activity
mut ARHGEF3 3p14.3 0.191 0.144 0.679 regulation of small GTPase mediated
signal transduction;apoptotic process
mut ACOX2 3p14.3 0.191 0.144 0.679 fatty acid beta-oxidation using acyl-CoA
oxidase;cellular lipid metabolic process
mut STC2 5q35.1 0.191 0.144 0.679 cell surface receptor signaling
mut ABRACL 6q24.1 0.191 0.144 0.679
mut DEFA4 8p23 0.191 0.144 0.679 killing of cells of other organism;defense
mut TRIB1 8q24.13 0.191 0.144 0.679 response to lipopolysaccharide;regulation
of MAP kinase activity
mut FBXW2 9q34 0.191 0.144 0.679 proteolysis;protein ubiquitination
mut PWWP2B 10q26.3 0.191 0.144 0.679
mut EIF3M 11p13 0.191 0.144 0.679 translational initiation
mut LLPH 12q14.3 0.191 0.144 0.679
mut KCTD10 12q24.11 0.191 0.144 0.679 potassium ion transport;protein
ubiquitination
mut TCTN1 12q24.11 0.191 0.144 0.679 cilium morphogenesis;multicellular
mut RCVRN 0.191 0.144 0.679
mut P3H4 0.191 0.144 0.679 synaptonemal complex assembly
mut ARHGAP28 18p11.31 0.191 0.144 0.679 signal transduction;small GTPase
dependent"
mut BCAS4 20q13.13 0.191 0.144 0.679
mut WDR4 21q22.3 0.191 0.144 0.679 tRNA modification
mut LSS 21q22.3 0.191 0.144 0.679 steroid biosynthetic process;cholesterol
mut C22orf42 0.191 0.144 0.679
mut POF1B Xq21.2 0.191 0.144 0.679
mut FATE1 Xq28 0.191 0.144 0.679
mut CD1E 1q23.1 0.191 0.144 0.679 immune response;antigen processing and
presentation
mut VAX2 2p13 0.191 0.144 0.679 multicellular organismal development;ectoderm
development
mut HHATL 3p22.1 0.191 0.144 0.679 negative regulation of N-terminal protein
palmitoylation
mut EMCN 4q24 0.191 0.144 0.679
mut MYOZ3 5q33.1 0.191 0.144 0.679
mut PEX2 8q21.1 0.191 0.144 0.679 cholesterol homeostasis;regulation of
cholesterol biosynthetic process
mut GRHPR 9q12 0.191 0.144 0.679 excretion;metabolic process
mut CACUL1 10q26.11 0.191 0.144 0.679
mut SERPING1 11q12.1 0.191 0.144 0.679 blood circulation;negative
mut GLRX5 14q32.13 0.191 0.144 0.679 hemopoiesis;cell redox homeostasis
mut CES5A 16q12.2 0.191 0.144 0.679
mut LMAN1 18q21.3-q22 0.191 0.144 0.679 blood coagulation;cellular protein
metabolic process
cop LOC100506274 0.191 0.144 0.679
cop MORN2 2p22.1 0.191 0.144 0.679
xsq SGOL1 3p24.3 0.191 0.144 0.679 centriole-centriole cohesion;meiotic
chromosome segregation
cop SNTB2 16q22.1 0.191 0.144 0.679
xsq CROCC 1p36.13 0.191 0.144 0.679 centrosome organization;cell cycle
dependent"
xsq KRTAP10-1 0.191 0.144 0.679
exp SIKE1 1p13.2 0.191 0.144 0.679 innate immune response
exp TPGS2 18q12.2 0.191 0.144 0.679
xsq LINC01363 0.191 0.144 0.679
xsq CPSF4 7q22.1 0.191 0.144 0.679 virus-host interaction;modulation by
virus of host cellular process
cop TEPP 16q21 0.191 0.144 0.679
dependent"
mut KIDINS220 2p24 0.191 0.144 0.679 activation of MAPKK activity;nerve growth
xsq ARHGDIG 16p13.3 0.191 0.144 0.679 regulation of small GTPase mediated
signal transduction;negative regulation of cell adhesion
exp TBRG4 7p13 0.191 0.144 0.679 Apoptosis
xsq PRAMEF4 0.191 0.144 0.679
xsq RCAN3AS 0.191 0.144 0.68
mut PLEKHH3 17q21.2 0.191 0.144 0.68 signal transduction
met BTNL2 6p21.3 0.191 0.144 0.68
xsq INO80B-WBP1 0.191 0.144 0.68
xsq LRFN4 11q13.2 0.191 0.144 0.68
cop RNF24 20p13 0.191 0.144 0.68
xsq SPSB2 12p13.31 0.191 0.144 0.68 intracellular signal transduction
xsq KRT71 12q13.13 0.191 0.144 0.68 hair follicle morphogenesis
xsq TNNI3 19q13.4 0.191 0.144 0.68 regulation of smooth muscle
xsq WDR48 3p21.33 0.191 0.144 0.68 DNA Damage Response (DDR); DDR (FA)
xsq GOLGA6A 0.191 0.144 0.68
xsq MAPK12 22q13.33 0.191 0.144 0.68 Protein Kinases
met CCDC169 13q13.3 0.191 0.144 0.68
xsq PPID 4q31.3 0.191 0.144 0.68 protein folding
xsq NR5A2 1q32.1 0.191 0.144 0.68 gene expression;intracellular receptor
met CERS3 15q26.3 0.191 0.144 0.68 sphingolipid metabolic process;lipid
cop TRIM54 2p23.3 0.191 0.144 0.68 negative regulation of microtubule
depolymerization;signal transduction
met FAM160A1 4q31.3 0.191 0.144 0.68
xsq KIFC3 16q13-q21 -0.191 0.144 0.68 zonula adherens
met HIST1H3J 6p22.1 -0.191 0.144 0.68
mut GUCY2C 12p12 -0.191 0.144 0.68 regulation of cell
proliferation;cGMP biosynthetic process
xsq MTUS1 8p22 -0.191 0.144 0.68
exp S100A11P2 7p14.2 -0.191 0.144 0.68
exp AHCYL1 1p13.2 -0.191 0.144 0.68 mRNA polyadenylation;protein
export from nucleus
exp ARSD Xp22.3 -0.191 0.144 0.68
cop KLHL24 3q27.1 -0.191 0.144 0.679
exp EMP1 12p12.3 -0.191 0.144 0.679 multicellular organismal
exp MUC4 3q29 -0.191 0.144 0.679 cell adhesion;cell-matrix adhesion
xsq COL27A1 9q32 -0.191 0.144 0.679 cell adhesion
xsq SLCO3A1 15q26 -0.191 0.144 0.679 Solute Carriers
xsq LINC01508 -0.191 0.144 0.679
mut MCCC1 3q27 -0.191 0.144 0.679 cellular nitrogen compound metabolic
cop KLHL6 3q27.3 -0.191 0.144 0.679 germinal center formation;B cell
mut LRRC32 11q13.5-q14 -0.191 0.144 0.679
met KRT38 17q21.2 -0.191 0.144 0.679
exp KRT8P23 15q24.3 -0.191 0.144 0.679
exp TRBV5-1 7q34 -0.191 0.144 0.679
xsq PARP14 3q21.1 -0.191 0.144 0.679 regulation of transcription,
DNA-dependent"
xsq TSKU 11q13.5 -0.191 0.144 0.679
exp LOC100287485 11q12.1 -0.191 0.144 0.679
xsq C9orf131 9p13.3 -0.191 0.144 0.679
met DMC1 22q13.1 -0.191 0.144 0.679 DNA Damage Response (DDR); DDR (DNA
replication)
his FUT5 19p13.3 -0.192 0.144 0.68
his MRPS24 7p14 -0.192 0.144 0.68 translation
his DIP2C 10p15.3 -0.192 0.144 0.68
his SNAR-G2 -0.192 0.144 0.68
his CGB2 19q13.32 -0.192 0.144 0.68
xai KIAA2026 9p24.1 -0.192 0.144 0.68
hs4 GAL3ST1 22q12.2 -0.192 0.144 0.68 spermatogenesis;biosynthetic
process
xai SGIP1 1p31.3 -0.192 0.144 0.68 response to dietary excess;positive
regulation of receptor-mediated endocytosis
xai TNFRSF19 13q12.11-q12.3 -0.192 0.144 0.68 hair follicle
his GEM 8q13-q21 -0.192 0.144 0.68 GTP catabolic process;immune
response
xai LAMA1 18p11.3 -0.192 0.144 0.679 establishment of epithelial cell
his GDNF 5p13.1-p12 -0.193 0.144 0.679 Apoptosis
his GDNF-AS1 -0.193 0.144 0.679
his RPS6KA2 6q27 -0.193 0.144 0.679 Protein Kinases
his NFIB 9p24.1 -0.193 0.144 0.679 negative regulation of cell
hs4 GPR152 -0.193 0.144 0.679
hs4 CABP4 11q13.2 -0.193 0.144 0.679 photoreceptor cell
xai ZNF319 16q21 -0.193 0.144 0.679 regulation of transcription, DNA-
dependent"
hs4 ZMYND10 3p21.3 -0.193 0.144 0.679
exp LOC642648 22q13.31 -0.193 0.144 0.679
hs4 ARMCX3 Xq22.1 -0.193 0.144 0.679
xai EHHADH 3q26.3-q28 -0.193 0.144 0.679 fatty acid beta-
exp AMDHD2 16p13.3 -0.193 0.144 0.679 carbohydrate metabolic
process;N-acetylglucosamine metabolic process
xai KRT8P19 12q14.1 -0.193 0.144 0.679
swa PODXL 7q32-q33 -0.193 0.144 0.679 cell migration;negative regulation
of cell-cell adhesion
swa POR 7q11.2 -0.193 0.144 0.679 fatty acid oxidation;positive
his MIR4261 -0.193 0.144 0.679
xai HRAS 11p15.5 -0.193 0.144 0.679 Apoptosis; Oncogenes; Protein
Kinases
his RHOD 11q14.3 -0.193 0.144 0.679 GTP catabolic process;small GTPase
hs4 LINP1 -0.193 0.144 0.679
his MSTO2P 1q22 0.192 0.145 0.68
xai RAB35 12q24.31 0.192 0.145 0.68 endosome transport;cytokinesis
swa RNASEH2A 19p13.2 0.192 0.145 0.68 DNA Damage Response (DDR); DDR (DNA
replication)
his ZMAT1 Xq21 0.192 0.145 0.68
hs4 SMOC1 14q24.2 0.192 0.145 0.68 eye development;signal transduction
xai PDCD1 2q37.3 0.192 0.145 0.68 apoptotic process;humoral immune response
xai STRA13 17q25.3 0.192 0.145 0.68 DNA Damage Response (DDR); DDR (FA)
his FAAH2 Xp11.21 0.192 0.145 0.68
hs4 CD8A 2p12 0.192 0.145 0.68 regulation of immune response;T cell mediated
immunity
his C11orf21 11p15.5 0.192 0.145 0.68
his TSPAN32 11p15.5 0.192 0.145 0.68 cell-cell signaling
his SMIM7 19p13.11 0.192 0.145 0.68
his TMEM38A 19p13.11 0.192 0.145 0.68 potassium ion transport;potassium
ion transmembrane transport
xai ADIPOR2 12p13.31 0.192 0.145 0.681 lipid metabolic process;hormone-
hs4 PITPNC1 17q24.2 0.192 0.145 0.681 transport;lipid transport
xai SIRT6 19p13.3 0.192 0.145 0.681 protein deacetylation;protein ADP-
ribosylation
hs4 CD1E 1q23.1 0.192 0.145 0.681 immune response;antigen processing and
presentation
swa RPL29 3p21.3-p21.2 0.192 0.145 0.681 nuclear-transcribed mRNA catabolic
dependent"
xai SNAP47 1q42.13 0.192 0.145 0.681
hs4 TMEM241 18q11.2 0.192 0.145 0.681
xai THOC3 5q35.2 0.192 0.145 0.681 transport;RNA splicing
his ITK 5q31-q32 0.192 0.145 0.681 activation of phospholipase C
his HIST2H2BF 1q21.2 0.192 0.145 0.681 nucleosome assembly
his HIST2H3D 0.192 0.145 0.681 blood coagulation;negative regulation of
his ADH4 4q22 0.192 0.145 0.681
hs4 MYL12A 18p11.31 0.192 0.145 0.681
exp RPL21P129 0.192 0.145 0.681
his ADAL 15q15.3 0.192 0.145 0.681 adenosine catabolic process;nucleotide
metabolic process
his LCMT2 15q15.3 0.192 0.145 0.681 tRNA processing
exp HMGN1P28 0.192 0.145 0.681
hs4 NADK 1p36.33 0.192 0.145 0.681 vitamin metabolic process;water-soluble
hs4 MTIF2 2p16.1 0.192 0.145 0.681 translation;regulation of translational
initiation
his SGF29 0.192 0.145 0.681 establishment of protein localization to
his BLMH 17q11.2 0.192 0.145 0.681 protein polyubiquitination;antigen
xai GRWD1 19q13.33 0.192 0.145 0.681
xai HIST1H4D 6p22.1 0.192 0.145 0.681
xai RPL21P129 0.192 0.145 0.681
xai DCAF13 8q22.3 0.192 0.145 0.681 rRNA processing;protein
ubiquitination
exp LOC100287166 20p11.23 0.192 0.145 0.681
exp SRP9 1q42.12 0.192 0.145 0.682 translation;SRP-dependent cotranslational
exp KARSP2 0.192 0.145 0.682
swa CPSF1 8q24.23 0.192 0.145 0.682 nuclear mRNA splicing, via
his SRSF10 1p36.11 0.192 0.145 0.682 nuclear mRNA splicing, via
xai SCARNA22 4p16.3 0.192 0.145 0.682
his SUN2 22q13.1 0.192 0.145 0.682 mitotic spindle organization;nuclear
migration
xai TMCO5B 0.192 0.145 0.682
exp AMN 14q32.3 0.191 0.145 0.68 multicellular organismal
xsq PCMTD2 20q13.33 0.191 0.145 0.68 protein modification process
met TDRD9 14q32.33 0.191 0.145 0.68 fertilization;cell differentiation
met FAM120B 6q27 0.191 0.145 0.68 regulation of transcription, DNA-
mut HSP90AB1 6p12 0.191 0.145 0.68 Apoptosis
cop CNGB1 16q13 0.191 0.145 0.68 photoreceptor cell maintenance;response to
stimulus
xsq BLOC1S5-TXNDC5 0.191 0.145 0.68
xsq CECR5 0.191 0.145 0.68 metabolic process
met SUCLG2 3p14.1 0.191 0.145 0.68 succinyl-CoA metabolic
xsq UCKL1 20q13.33 0.191 0.145 0.68 interspecies interaction between
xsq LINC00547 0.191 0.145 0.68
cop SMOX 20p13 0.191 0.145 0.68 cellular nitrogen compound metabolic
cop LOC728228 0.191 0.145 0.68
met HDAC11 3p25.1 0.191 0.145 0.68 regulation of transcription, DNA-
dependent;oligodendrocyte development
xsq TARDBP 1p36.22 0.191 0.145 0.68 3'-UTR-mediated mRNA
stabilization;regulation of transcription, DNA-dependent
xsq HTR1E 6q14-q15 0.191 0.145 0.68 G-protein coupled receptor signaling
met AJUBA 14q11.2 0.19 0.145 0.681 Cell Signaling
xsq MRAP 21q22.1 0.19 0.145 0.681 positive regulation of cAMP biosynthetic
process;protein localization at cell surface
xsq RBM45 2q31.2 0.19 0.145 0.681 multicellular organismal
exp FIGNL1 7p12.1 0.19 0.145 0.681 regulation of cell cycle;osteoblast
differentiation
cop USB1 16q21 0.19 0.145 0.681
mut GAS2L3 12q23.1 0.19 0.145 0.681 cell cycle arrest
xsq THEM6 8q24.3 0.19 0.145 0.681
cop PCBP1-AS1 0.19 0.145 0.681
xsq LYRM1 16p11.2 0.19 0.145 0.681
xsq CYP2W1 7p22.3 0.19 0.145 0.681 small molecule metabolic
exp CCL3 17q12 0.19 0.145 0.681 MAPK cascade;chemotaxis
exp SNHG20 0.19 0.145 0.681
met PF4 4q12-q21 0.19 0.145 0.681 leukocyte chemotaxis;chemotaxis
mut AKAP9 7q21-q22 0.19 0.145 0.681 mitotic cell cycle;transport
met HAVCR1 5q33.2 0.19 0.145 0.681 interspecies interaction between
organisms
xsq CASP1P2 11q22.3 0.19 0.145 0.681
met MAPK1 22q11.21 0.19 0.145 0.681 Apoptosis; Protein Kinases
exp ASPRV1 2p13.3 0.19 0.145 0.681 proteolysis;protein processing
exp AK2 1p34 0.19 0.145 0.681 nucleobase-containing small molecule
exp KRT37 17q21.2 0.19 0.145 0.681
xsq C19orf60 19p13.11 0.19 0.145 0.681
xsq C9orf40 9q21.13 0.19 0.145 0.681
exp YPEL1 22q11.2 0.19 0.145 0.681
xsq SAMD1 19p13.12 0.19 0.145 0.681
exp PRUNE 1q21 0.19 0.145 0.681
xsq THEG 19p13.3 0.19 0.145 0.681 multicellular organismal
met AOX1 2q33 0.19 0.145 0.682 inflammatory response;reactive oxygen species
metabolic process
xsq LINC00574 6q27 0.19 0.145 0.682
cop MATN3 2p24-p23 0.19 0.145 0.682 skeletal system development
cop LAPTM4A 2p24.1 0.19 0.145 0.682 transport
met TNNC1 3p21.1 0.19 0.145 0.682 regulation of muscle contraction;muscle
filament sliding
exp LOC402229 5q23.3 0.19 0.145 0.682
met UBE2C 20q13.12 0.19 0.145 0.682 mitosis;phosphatidylinositol-mediated
signaling
xsq OR10W1 11q12.1 0.19 0.145 0.682 response to stimulus
exp CAPN15 16p13.3 0.19 0.145 0.682
exp SEC61B 9q22.32-q31.3 0.19 0.145 0.682 translation;SRP-dependent
xsq C15orf65 0.19 0.145 0.682
xsq LOC100506497 -0.19 0.145 0.682
met C20orf197 20q13.33 -0.19 0.145 0.682
cop C7orf72 7p12.2 -0.19 0.145 0.682
xsq LENG8 19q13.42 -0.19 0.145 0.682
xsq SFRP2 4q31.3 -0.19 0.145 0.681 chondrocyte development;negative
exp NCAM1 11q23.1 -0.19 0.145 0.681 interferon-gamma-mediated signaling
exp FGF18 5q34 -0.19 0.145 0.681 chondrocyte development;positive regulation of
vascular endothelial growth factor receptor signaling pathway
met MIR18A -0.19 0.145 0.681
xsq DHRS12 13q14.3 -0.19 0.145 0.681
xsq HEXB 5q13 -0.19 0.145 0.681 carbohydrate metabolic process;sensory
perception of sound
exp MLIP 6p12.1 -0.19 0.145 0.681
exp C5orf58 5q35.1 -0.19 0.145 0.681
met NPY 7p15.1 -0.19 0.145 0.681 G-protein signaling, coupled to cyclic
nucleotide second messenger;adult feeding behavior
exp DCLK2 4q31.3 -0.19 0.145 0.681 intracellular signal transduction
exp ZCCHC24 10q22.3 -0.19 0.145 0.681
xsq LOC100128398 19q13.43 -0.19 0.145 0.681
xsq SERTAD1 19q13.1-q13.2 -0.19 0.145 0.681 regulation of cyclin-
exp ZNF717 3p12.3 -0.19 0.145 0.681 regulation of transcription, DNA-
dependent"
met DCPS 11q24.2 -0.19 0.145 0.681 deadenylation-dependent decapping of
met CPA1 7q32 -0.19 0.145 0.681 proteolysis
xsq LOC100506476 -0.191 0.145 0.681
cop PIK3R4 3q22.1 -0.191 0.145 0.681 protein
phosphorylation;insulin receptor signaling pathway
xsq CYP4X1 1p33 -0.191 0.145 0.681
exp CNN1 19p13.2-p13.1 -0.191 0.145 0.68 regulation of smooth muscle
contraction;actomyosin structure organization
xsq TTC9 14q24.2 -0.191 0.145 0.68
xsq PPAP2B 1p32.2 -0.191 0.145 0.68
xsq LOC149684 -0.191 0.145 0.68
cop NMNAT3 3q23 -0.191 0.145 0.68 small molecule metabolic
exp PKM 15q22 -0.191 0.145 0.68
exp MAMLD1 Xq28 -0.191 0.145 0.68 regulation of transcription, DNA-
his OCIAD2 4p11 -0.192 0.145 0.682
xai TBC1D19 4p15.2 -0.192 0.145 0.682
xai RAC1 7p22 -0.192 0.145 0.682 axon guidance;lamellipodium assembly
exp LINC01020 -0.192 0.145 0.681
xai BDNF 11p13 -0.192 0.145 0.681 feeding behavior;fear response
xai CEACAMP7 -0.192 0.145 0.681
his TBCEL 11q23.3 -0.192 0.145 0.681
hs4 NTF4 19q13.3 -0.192 0.145 0.681 ganglion mother cell fate
determination;long-term memory
hs4 TOM1L1 17q23.2 -0.192 0.145 0.681 intracellular protein
transport;positive regulation of catalytic activity
hs4 DLG1 3q29 -0.192 0.145 0.681 mitotic cell cycle G1/S transition
hs4 MIR4797 -0.192 0.145 0.681
hs4 DLG1-AS1 -0.192 0.145 0.681
xai SEMA5A 5p15.2 -0.192 0.145 0.681 cell
his SORBS3 8p21.3 -0.192 0.145 0.681 cell adhesion;cell-substrate
adhesion
xai PDPN 1p36.21 -0.192 0.145 0.681 lymphangiogenesis;cell
proliferation
his MIR583 -0.192 0.145 0.681
hs4 LOC100131496 20q13.12 -0.192 0.145 0.681
his PRSS22 16p13.3 -0.192 0.145 0.681 proteolysis
xai ADIRF-AS1 -0.192 0.145 0.681
xai SAA2 11p15.1-p14 -0.192 0.145 0.681
his PECR 2q35 -0.192 0.145 0.68 regulation of apoptotic
his TMEM169 2q35 -0.192 0.145 0.68
xai C2orf70 2p23.3 -0.192 0.145 0.68
hs4 CCDC185 -0.192 0.145 0.68
swa PARVA 11p15.3 -0.192 0.145 0.68 cell projection organization;actin
xai EVPLL 17p11.2 -0.192 0.145 0.68
DNA-dependent"
hs4 LIX1 5q15 -0.192 0.145 0.68
hs4 INPP5J 22q12.2 -0.192 0.145 0.68 phosphatidylinositol
phosphorylation
his RAPGEF3 12q13.1 -0.192 0.145 0.68 small molecule metabolic
swa MYOF 10q24 -0.192 0.145 0.68 plasma membrane repair;muscle contraction
exp C10orf111 10p13 -0.192 0.145 0.68
his GABRR2 6q15 -0.192 0.145 0.68 gamma-aminobutyric acid signaling
xai CMYA5 5q14.1 -0.192 0.145 0.68
his LOC101928661 0.192 0.146 0.682
his ADGB 6q24.3 0.192 0.146 0.682 proteolysis;oxygen transport
xai NIPBL-AS1 0.192 0.146 0.682
his SLC22A31 16q24.3 0.192 0.146 0.682 ion transport
hs4 SYNGR3 16p13 0.192 0.146 0.682 positive regulation of transporter
activity
his SIK1 21q22.3 0.192 0.146 0.682 multicellular organismal
development;cardiac muscle cell differentiation
exp FCRL1 1q21-q22 0.192 0.146 0.682
exp SCARNA22 4p16.3 0.192 0.146 0.682
his C6orf203 6q21 0.192 0.146 0.682
xai ATP2B1 12q21.3 0.192 0.146 0.682 ATP biosynthetic process;transport
his FAM135B 8q24.23 0.192 0.146 0.682
xai UBE2N 12q22 0.192 0.146 0.682 DNA Damage Response (DDR); DDR (TLS)
his NELL2 12q12 0.192 0.146 0.682 cell adhesion;regulation of growth
hs4 DISP2 15q15.1 0.192 0.146 0.682 smoothened signaling pathway
hs4 NPW 16p13.3 0.192 0.146 0.682 G-protein coupled receptor signaling
exp TRDJ4 0.192 0.146 0.682
xai SEPHS2 16p11.2 0.192 0.146 0.682 selenocysteine biosynthetic process
xai TRDJ4 0.192 0.146 0.682
his CACNG8 19q13.4 0.192 0.146 0.682 synaptic transmission;regulation of
calcium ion transport via voltage-gated calcium channel activity
his CHMP7 8p21.3 0.192 0.146 0.682 protein transport;cellular membrane
organization
his IDH3B 20p13 0.192 0.146 0.682 tricarboxylic acid cycle;isocitrate metabolic
process
exp POTEC 18p11.21 0.191 0.146 0.683
xai FAM222A-AS1 12q24.11 0.191 0.146 0.683
his DTX2P1-UPK3BP1-PMS2P11 7q11.23 0.191 0.146 0.683
his LOC644919 0.191 0.146 0.683
xai AASDH 4q12 0.191 0.146 0.683 lipid metabolic process;fatty acid metabolic
process
xai RPP38 10p13 0.191 0.146 0.683 tRNA processing
his PIH1D1 19q13.33 0.191 0.146 0.683 box C/D snoRNP assembly
his ALDH16A1 19q13.33 0.191 0.146 0.683
hs4 UBALD1 16p13.3 0.191 0.146 0.683
his LOC105377623 0.191 0.146 0.683
his USP38 0.191 0.146 0.683 proteolysis;ubiquitin-dependent protein
catabolic process
xai FAM131B 7q34 0.191 0.146 0.683
hs4 EEF2K 16p12.2 0.191 0.146 0.683 insulin receptor signaling
xsq DARS 2q21.3 0.19 0.146 0.682 translation;tRNA aminoacylation for
protein translation
xsq NR4A2 2q22-q23 0.19 0.146 0.682 post-embryonic development;intracellular
xsq OR11H2 0.19 0.146 0.682 response to stimulus
exp LZIC 1p36.22 0.19 0.146 0.682 response to ionizing radiation
met PRICKLE1 12q12 0.19 0.146 0.682 negative regulation of transcription,
met DLG2 11q14.1 0.19 0.146 0.682 receptor clustering;neuronal ion channel
clustering
xsq AKR1E2 10p15.1 0.19 0.146 0.682
exp TNFRSF6B 20q13.3 0.19 0.146 0.682 Apoptosis
xsq ADORA3 1p13.2 0.19 0.146 0.682 inflammatory response;signal
transduction
mir hsa-miR-545 0.19 0.146 0.682
met TMEM231 16q23.1 0.19 0.146 0.682 smoothened signaling pathway;cell
dependent"
exp TMEM150C 4q21.22 0.19 0.146 0.682
met CDC20B 5q11.2 0.19 0.146 0.682
met POU2F3 11q23.3 0.19 0.146 0.682 epidermis development;keratinocyte
differentiation
xsq NACA2 17q23.2 0.19 0.146 0.682 protein transport
mut SNX25 4q35.1 0.19 0.146 0.682 cell communication;protein transport
exp VPS13C 15q22.2 0.19 0.146 0.682 protein localization
exp RPL26P4 14q32.31 0.19 0.146 0.682
exp NFAM1 22q13.2 0.19 0.146 0.682 regulation of B cell
met WDFY3-AS2 4q21.3 0.19 0.146 0.682
xsq GNA15 19p13.3 0.19 0.146 0.682 blood coagulation;GTP catabolic process
exp CD1A 1q23.1 0.19 0.146 0.682 immune response;antigen processing and
presentation
xsq TBC1D32 6q22.31 0.19 0.146 0.682
exp CRADD 12q21.33-q23.1 0.19 0.146 0.682 Apoptosis
exp NPM1P7 0.19 0.146 0.682
xsq ACADM 1p31 0.19 0.146 0.682 carnitine metabolic process, CoA-linked;fatty
acid beta-oxidation using acyl-CoA dehydrogenase
met NXF5 Xq22 0.19 0.146 0.682 transport;multicellular organismal development
xsq PPM1B 2p21 0.19 0.146 0.682 protein dephosphorylation;cytokine-mediated
signaling pathway
xsq C3orf30 3q13.32 0.19 0.146 0.682
mut TBX2 17q23.2 0.19 0.146 0.682 heart morphogenesis;developmental growth
involved in morphogenesis
cop MPC1 6q27 0.19 0.146 0.682
xsq KDM3B 5q31 0.19 0.146 0.682 regulation of transcription, DNA-
exp CCNF 16p13.3 0.19 0.146 0.682 placenta development;cell cycle
cop SLC35F6 2p23.3 0.19 0.146 0.682
cop CENPA 2p23.3 0.19 0.146 0.682 kinetochore assembly;M phase of mitotic
cell cycle
cop DPYSL5 2p23.3 0.19 0.146 0.682 nervous system development;axon
guidance
cop MAPRE3 2p23.3-p23.1 0.19 0.146 0.682 cell division;cell cycle
cop TMEM214 2p23.3 0.19 0.146 0.682
cop AGBL5 2p23.3 0.19 0.146 0.682 proteolysis;protein deglutamylation
cop OST4 2p23.3 0.19 0.146 0.682
cop EMILIN1 2p23.3-p23.2 0.19 0.146 0.682 cell adhesion;positive
cop KHK 2p23.3 0.19 0.146 0.682 response to sucrose stimulus;response to
glucose stimulus
cop CGREF1 2p23.3 0.19 0.146 0.682 response to stress;cell cycle
cop ABHD1 2p23.3 0.19 0.146 0.682
cop PREB 2p23.3 0.19 0.146 0.682 cellular membrane organization;vesicle-
mediated transport
cop PRR30 0.19 0.146 0.682
cop TCF23 2p23.3 0.19 0.146 0.682 multicellular organismal
cop ATRAID 2p23.3 0.19 0.146 0.682
cop CAD 2p22-p21 0.19 0.146 0.682 Apoptosis
xsq ZNF24 18q12 0.19 0.146 0.682 viral reproduction;myelination
exp CRY2 11p11.2 0.19 0.146 0.682 DNA Damage Response (DDR)
cop FAM95A 0.19 0.146 0.682
xsq ANKRD39 2q11.2 0.19 0.146 0.682
xsq PSME3 17q21 0.19 0.146 0.682 M/G1 transition of mitotic cell cycle;positive
exp ATG2B 14q32.2 0.19 0.146 0.682
xsq MEF2BNB-MEF2B 19p13.11 0.19 0.146 0.682
xsq SPATC1 8q24.3 0.19 0.146 0.683
xsq PGLYRP4 1q21 0.19 0.146 0.683 innate immune response;defense response
to Gram-positive bacterium
met FBXO42 1p36.23-p36.11 0.19 0.146 0.683
exp SEPHS2 16p11.2 0.19 0.146 0.683 selenocysteine biosynthetic process
met RAB20 13q34 0.19 0.146 0.683 small GTPase mediated signal
cop KIAA1244 6q23.3 0.19 0.146 0.683
cop SNX22 15q22.31 0.19 0.146 0.683 cell communication;protein transport
cop PPIB 15q21-q22 0.19 0.146 0.683 protein peptidyl-prolyl
met ROR1 1p32-p31 0.19 0.146 0.683 transmembrane receptor protein tyrosine
kinase signaling pathway
xsq TEX264 3p21.31 0.19 0.146 0.683
mut ELF1 13q13 0.19 0.146 0.683 Transcription Factors
xsq PIGZ 3q29 -0.19 0.146 0.683 GPI anchor biosynthetic process
xsq CELSR1 22q13.3 -0.19 0.146 0.683 locomotory behavior;orthogonal
xsq PROS1 3q11.2 -0.19 0.146 0.683 cellular protein metabolic
process;platelet degranulation
xsq STBD1 4q21.1 -0.19 0.146 0.683 muscle contraction
exp PRLR 5p13.2 -0.19 0.146 0.683 embryo implantation;prostate gland growth
met FABP6 5q33.3-q34 -0.19 0.146 0.683 small molecule metabolic process;lipid
metabolic process
xsq ZC2HC1A 8q21.12 -0.19 0.146 0.683
cop PRPS1L1 7p21.1 -0.19 0.146 0.683 nucleoside metabolic
process;ribonucleoside monophosphate biosynthetic process
exp ZDHHC19 3q29 -0.19 0.146 0.682
xsq JAZF1 7p15.2-p15.1 -0.19 0.146 0.682 negative regulation of
dependent"
met GOLPH3L 1q21.3 -0.19 0.146 0.682
exp ABCD3 1p21.3 -0.19 0.146 0.682 ABC Transporters
met S1PR5 19p13.2 -0.19 0.146 0.682
cop HES1 3q28-q29 -0.19 0.146 0.682 DNA Damage Response (DDR); DDR (FA)
cop CPN2 3q29 -0.19 0.146 0.682 regulation of catalytic activity;protein
stabilization
cop LRRC15 3q29 -0.19 0.146 0.682
cop GP5 3q29 -0.19 0.146 0.682 cell adhesion;cell-matrix adhesion
cop ATP13A3 3q29 -0.19 0.146 0.682 cation transport
cop HEATR1 1q43 -0.19 0.146 0.682 rRNA processing
xsq GDF15 19p13.11 -0.19 0.146 0.682 signal transduction;transforming growth
xsq IGFBP3 7p12.3 -0.19 0.146 0.682 Apoptosis
xsq EGLN3 14q13.1 -0.19 0.146 0.682 Apoptosis
xsq TRIM8 10q24.3 -0.19 0.146 0.682
met KCNC4 1p21 -0.19 0.146 0.682 ion transport;potassium ion transport
met NR2C1 12q22 -0.19 0.146 0.682 positive regulation of retinoic acid receptor
promoter
met LTB4R 14q11.2-q12 -0.19 0.146 0.682 cellular component movement;muscle
contraction
xsq OGFRL1 6q13 -0.19 0.146 0.682
dependent"
cop SNX13 7p21.1 -0.19 0.146 0.682 intracellular protein transport;cell
communication
met KAZALD1 10q24.31 -0.19 0.146 0.682 ossification;regulation of cell
growth
exp LRRN4CL 11q12.3 -0.19 0.146 0.682
exp SCML4 6q21 -0.19 0.146 0.682 regulation of transcription, DNA-dependent"
met SRGN 10q22.1 -0.19 0.146 0.682 mast cell secretory granule
exp BBS1 11q13 -0.19 0.146 0.682 retina homeostasis;nonmotile primary cilium
assembly
exp ATP6AP2 Xp11.4 -0.19 0.146 0.682 regulation of MAPK
cascade;angiotensin maturation
cop KCNU1 8p11.23 -0.19 0.146 0.682 transmembrane transport;potassium ion
met LOC284798 20p11.21 -0.19 0.146 0.682
xsq KRT19 17q21.2 -0.19 0.146 0.682 cell differentiation involved in
his FAM149A 4q35.1 -0.191 0.146 0.683
xai PAK3 Xq23 -0.191 0.146 0.683 Protein Kinases
xai WDR13 Xp11.23 -0.191 0.146 0.683
his MGLL 3q21.3 -0.191 0.146 0.683 regulation of signal
hs4 NFIX 19p13.3 -0.192 0.146 0.682 negative regulation of
his DCN 12q21.33 -0.192 0.146 0.682 peptide cross-linking via
his CNTF 11q12.2 -0.192 0.146 0.682
his LOC101928858 -0.192 0.146 0.682
his ATP6V1B1 2p13.1 -0.192 0.146 0.682 ossification;transferrin
transport
xai SYT16 14q23.2 -0.192 0.146 0.682
hs4 FAM218A 4q32.3 -0.192 0.146 0.682
hs4 PAMR1 11p13 -0.192 0.146 0.682
xai POLH 6p21.1 -0.192 0.146 0.682 DNA Damage Response (DDR); DDR
xai DOPEY2 21q22.2 -0.192 0.146 0.682 Golgi to endosome
xai CSPG4P5 15q25.2 -0.192 0.146 0.682
his EFTUD1P1 15q25.2 -0.192 0.146 0.682
xai TTC23L 5p13.2 -0.192 0.146 0.682
xai MAMLD1 Xq28 -0.192 0.146 0.682 regulation of transcription, DNA-
exp SAA2 11p15.1-p14 -0.192 0.146 0.682
met FGD3 0.222 0.147 0.684 regulation of Cdc42 GTPase activity;apoptotic
process
his SLC25A5-AS1 0.191 0.147 0.683
his SLC25A5 Xq24 0.191 0.147 0.683 Solute Carriers
xai REG1A 2p12 0.191 0.147 0.684 positive regulation of cell proliferation
hs4 LSM2 6p21.3 0.191 0.147 0.684 nuclear mRNA splicing, via
his RFWD2 1q25.1-q25.2 0.191 0.147 0.684 DNA damage response, signal
transduction by p53 class mediator resulting in cell cycle arrest;cell cycle
checkpoint"
xai CLEC1A 12p13.2 0.191 0.147 0.684 defense response;cell surface
his LOC729652 16p13.3 0.191 0.147 0.684
exp MRPS16P2 20q13.32 0.191 0.147 0.684
his LNP1 3q12.2 0.191 0.147 0.684
his TOMM70 0.191 0.147 0.684
his ZNF670-ZNF695 0.191 0.147 0.684
dependent"
hs4 EIF5 14q32.32 0.191 0.147 0.684 translational initiation;regulation of
hs4 SNORA28 0.191 0.147 0.684
exp LOC401220 0.191 0.147 0.684
xai TXNL1 18q21.31 0.191 0.147 0.684 Apoptosis
xai TRNE 0.191 0.147 0.684
exp RPL23AP53 8p23.3 0.191 0.147 0.684
his KPNA6 1p35.1 0.191 0.147 0.684 NLS-bearing substrate import into nucleus
his PRPF3 1q21.1 0.191 0.147 0.684 RNA splicing, via transesterification
xai SNORA49 0.191 0.147 0.684
xai FABP5P6 5q23.1 0.191 0.147 0.684
his PYM1 0.191 0.147 0.684 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;positive regulation of translation"
his DGKA 12q13.3 0.191 0.147 0.684 activation of protein kinase C activity
xai RPS7P14 0.191 0.147 0.684
xai TSR1 17p13.3 0.191 0.147 0.684 ribosome assembly
exp SNORA49 0.191 0.147 0.684
exp FABP5P6 5q23.1 0.191 0.147 0.684
xai HNRNPFP1 1p34.2 0.191 0.147 0.684
his CWC22 2q31.3 0.191 0.147 0.684 nuclear mRNA splicing, via
xai LINC01018 0.191 0.147 0.684
xai CHCHD3P3 1p36.11 0.191 0.147 0.684
exp UNC79 14q32.12 0.191 0.147 0.684
swa CARM1 19p13.2 0.191 0.147 0.684 chromatin modification;peptidyl-arginine
N-methylation
his RNF180 5q12.3 0.191 0.147 0.684 positive regulation of proteasomal
xai LOC730202 14q32.2 0.191 0.147 0.684
his FAM168B 2q21.1 0.191 0.147 0.684
xai LOC100129461 6p25.1 0.191 0.147 0.684
xai TEX21P 14q23.3 0.191 0.147 0.684
his IWS1 2q14.3 0.191 0.147 0.684 transcription, DNA-dependent"
xai VPS13C 15q22.2 0.191 0.147 0.684 protein localization
exp RPS7P14 0.191 0.147 0.684
exp SNRPG 2p13.3 0.191 0.147 0.684 spliceosomal snRNP assembly;RNA metabolic
process
hs4 ADAMTS13 9q34 0.191 0.147 0.684 cell-matrix adhesion;response to chemical
stimulus
hs4 REXO4 9q34.2 0.191 0.147 0.684 regulation of transcription, DNA-
dependent"
hs4 NKX2-5 5q34 0.191 0.147 0.684 outflow tract septum
his TBL2 7q11.23 0.191 0.147 0.684
hs4 CCDC86 11q12.2 0.191 0.147 0.684 interspecies interaction between
organisms
exp CEACAM18 19q13.41 0.191 0.147 0.684
xsq KRT85 12q13 0.19 0.147 0.683 epidermis development
exp NR0B2 1p36.1 0.19 0.147 0.683 positive regulation of insulin
secretion;negative regulation of sequence-specific DNA binding transcription factor
activity
met PRAP1 10q26.3 0.19 0.147 0.683
met RIF1 2q23.3 0.19 0.147 0.683 DNA Damage Response (DDR)
xsq EXOSC3 9p11 0.19 0.147 0.683 exonucleolytic nuclear-transcribed mRNA
catabolic process involved in deadenylation-dependent decay;DNA deamination
met VSIG1 Xq22.3 0.19 0.147 0.683
xsq TRIM43 0.19 0.147 0.683
xsq GP9 0.19 0.147 0.683
xsq CDCA3 12p13 0.19 0.147 0.683 cell cycle;mitosis
xsq DUSP22 6p25.3 0.19 0.147 0.683 Apoptosis
cop LDHAL6B 15q22.2 0.19 0.147 0.683
exp RPL22 1p36.31 0.19 0.147 0.684 translational elongation;viral
transcription
xsq CMPK1 1p32 0.19 0.147 0.684 small molecule metabolic process;nucleobase-
exp ZNF121 19p 0.19 0.147 0.684 regulation of transcription, DNA-
dependent"
xsq PRADC1 2p13.2 0.19 0.147 0.684
met MSX1 4p16.2 0.19 0.147 0.684 multicellular organismal
exp TDP1 14q32.11 0.19 0.147 0.684 DNA Damage Response (DDR); DDR (BER)
exp CDK12 17q12 0.19 0.147 0.684 Protein Kinases
dependent"
met EPC2 2q23.1 0.19 0.147 0.684 chromatin modification;DNA repair
xsq PFN1 17p13.3 0.19 0.147 0.684 neural tube closure;positive regulation
of DNA metabolic process
mut HEXIM2 17q21.31 0.19 0.147 0.684 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of cyclin-
mut GOLGA5 14q32.12 0.19 0.147 0.684 retrograde transport, vesicle
recycling within Golgi;Golgi organization
exp TMEM147-AS1 0.19 0.147 0.684
met CTBP1-AS2 4p16.3 0.19 0.147 0.684
exp TMEM164 Xq22.3 0.19 0.147 0.684
xsq SUV39H2 10p13 0.19 0.147 0.684 chromatin assembly or
xsq TNR 1q24 0.19 0.147 0.684 negative regulation of neuron projection
xsq KCNJ6 21q22.1 0.19 0.147 0.684 potassium ion transport;synaptic
transmission
xsq FAM222A-AS1 12q24.11 0.19 0.147 0.684
xsq RPA3 7p22 0.189 0.147 0.684 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
mut ADCY1 7p13-p12 0.189 0.147 0.684 inhibition of adenylate cyclase activity
by G-protein signaling pathway;activation of protein kinase A activity
exp KCNK15 20q13.12 0.189 0.147 0.684 potassium ion transport;ion
transport
xsq RBFADN 0.189 0.147 0.684
xsq LOC101927683 0.189 0.147 0.684
met ST8SIA3 18q21.31 0.189 0.147 0.684 oligosaccharide metabolic
xsq FAM73B 9q34.11 0.189 0.147 0.684
met THSD1P1 13q14.3 0.189 0.147 0.684
met CHRNA7 15q14 0.189 0.147 0.684 signal transduction;cognition
xsq UFSP2 4q35.1 0.189 0.147 0.684 proteolysis;metabolic process
xsq C17orf89 17q25.3 0.189 0.147 0.684
met GRPR Xp22.2 0.189 0.147 0.684 G-protein coupled receptor signaling
pathway;learning or memory
met CCHCR1 6p21.3 0.189 0.147 0.684 multicellular organismal
met NOS1 12q24.22 0.189 0.147 0.684 nitric oxide biosynthetic
process;positive regulation of histone acetylation
xsq TRAF2 9q34 0.189 0.147 0.684 Apoptosis
xsq OR5C1 9q33.2 0.189 0.147 0.684 response to stimulus
mut OR2AE1 0.189 0.147 0.684
exp IGF2BP1 17q21.32 0.189 0.147 0.684 RNA localization;regulation of mRNA
stability involved in response to stress
xsq LOC101929631 0.189 0.147 0.684
cop SFT2D1 6q27 0.189 0.147 0.684 protein transport;vesicle-mediated
transport
cop LOC100289495 0.189 0.147 0.684
met TVP23C 17p12 0.189 0.147 0.684
xsq TUBGCP6 22q13.31-q13.33 0.189 0.147 0.684 mitotic cell
exp LCK 1p34.3 0.189 0.147 0.684 Protein Kinases
exp TTN 2q31 0.189 0.147 0.685 muscle filament sliding;regulation of catalytic
activity
xsq OR4K15 14q11.2 0.189 0.147 0.685
mut EPHA10 1p34.3 -0.189 0.147 0.684
xsq OR4F17 -0.189 0.147 0.684
exp MEIS1 2p14 -0.189 0.147 0.684 multicellular organismal development
exp VPS9D1 16q24 -0.189 0.147 0.684
DNA-dependent"
cop GLUL 1q31 -0.189 0.147 0.684 cellular nitrogen compound metabolic
process;neurotransmitter uptake
cop TEDDM1 1q25.3 -0.189 0.147 0.684
mut KCNH1 1q32.2 -0.189 0.147 0.684 ion transport;potassium ion
transport
cop RPL39L 3q27 -0.189 0.147 0.684 translation;spermatogenesis
xsq ID4 6p22.3 -0.189 0.147 0.684 negative regulation of
met PRM2 16p13.2 -0.189 0.147 0.684
exp SLC2A4RG 20q13.33 -0.189 0.147 0.684 Solute Carriers
xsq ANXA3 4q21.21 -0.19 0.147 0.684 positive regulation of
xsq RAB19 7q34 -0.19 0.147 0.684 protein transport;small GTPase mediated signal
transduction
exp TSPAN15 10q22.1 -0.19 0.147 0.684
xsq BCAR4 16p13.13 -0.19 0.147 0.684
exp NEXN 1p31.1 -0.19 0.147 0.684 regulation of cell migration;regulation
of cytoskeleton organization
exp HIPK4 19q13.2 -0.19 0.147 0.684
mir hsa-miR-24-1* -0.19 0.147 0.684
exp WDR13 Xp11.23 -0.19 0.147 0.684
met ARAP1 11q13.4 -0.19 0.147 0.684 actin filament reorganization involved in
xsq C1orf195 -0.19 0.147 0.684
xsq ZNF454 5q35.3 -0.19 0.147 0.684 regulation of transcription, DNA-
dependent"
exp LHPP 10q26.13 -0.19 0.147 0.684 protein dephosphorylation;phosphate-
met C16orf91 16p13.3 -0.19 0.147 0.683
exp TBC1D19 4p15.2 -0.19 0.147 0.683
exp RGS20 8q11.23 -0.19 0.147 0.683 regulation of G-protein coupled receptor
protein signaling pathway;negative regulation of signal transduction
exp STRN4 19q13.2 -0.19 0.147 0.683
exp ADAMTS1 21q21.2 -0.19 0.147 0.683 integrin-mediated signaling
pathway;negative regulation of cell proliferation
hs4 MAFB 20q11.2-q13.1 -0.191 0.147 0.685 negative regulation of
swa EIF3C -0.191 0.147 0.684 translation;translational initiation
xai EML1 14q32 -0.191 0.147 0.684
his TBC1D26 17p11.2 -0.191 0.147 0.684
his KRTAP4-6 -0.191 0.147 0.684
hs4 SGK3 8q12 -0.191 0.147 0.684
xai MMP2 16q13-q21 -0.191 0.147 0.684 Apoptosis
hs4 CLIC3 9q34.3 -0.191 0.147 0.684 ion transport;chloride transport
xai ETNPPL 4q25 -0.191 0.147 0.684
exp FOLR3 11q13 -0.191 0.147 0.684 folic acid transport
xai DAPK2 15q22.31 -0.191 0.147 0.684 Apoptosis
xai PELO 5q11.2 -0.191 0.147 0.684 cell cycle;cell proliferation
his DDX58 9p12 -0.191 0.147 0.684 innate immune response;positive
xai TMEM136 11q23.3 -0.191 0.147 0.684
his MFSD13B -0.191 0.147 0.684
his LOC102724804 -0.191 0.147 0.684
xai BBS1 11q13 -0.191 0.147 0.684 retina homeostasis;nonmotile primary
cilium assembly
his TFEB 6p21 -0.191 0.147 0.684 positive regulation of transcription from
xai ZBTB22 6p21.3 -0.191 0.147 0.684 regulation of transcription,
DNA-dependent"
his ZNF32-AS2 -0.191 0.147 0.684
his ZNF32 10q22-q25 -0.191 0.147 0.684 regulation of transcription, DNA-
dependent"
his UTRN 6q24 -0.191 0.147 0.684 positive regulation of cell-matrix
hs4 OR7E91P 2p13.3 -0.191 0.147 0.684
hs4 CA5B Xp21.1 -0.191 0.147 0.683 one-carbon metabolic
hs4 CYP7B1 8q21.3 -0.191 0.147 0.683 memory;positive regulation of
xai RAB23 6p11 -0.191 0.147 0.683 protein transport;spinal cord
dorsal/ventral patterning
hs4 ZC3H12C 11q22.3 -0.191 0.147 0.683
hs4 RBBP8NL 20q13.33 -0.191 0.147 0.683
xai LOC401220 0.191 0.148 0.685
xai SYCP2L 6p24.2 0.191 0.148 0.685
xai MIR519A2 0.191 0.148 0.685
xai LINC01625 0.191 0.148 0.685
xai TMEM147-AS1 0.191 0.148 0.685
his RAD52 12p13-p12.2 0.191 0.148 0.685 DNA Damage Response (DDR); DDR (HR)
his ERC1 12p13.3 0.191 0.148 0.685 positive regulation of anti-
hs4 MIR4734 0.191 0.148 0.685
hs4 MLLT6 17q21 0.191 0.148 0.685 regulation of transcription, DNA-dependent"
swa RBM14 11q13.2 0.191 0.148 0.685 glucocorticoid receptor signaling
his PAN3 13q12.2 0.191 0.148 0.685 gene expression;RNA metabolic process
his PAN3-AS1 13q12.2 0.191 0.148 0.685
hs4 FABP5 8q21.13 0.191 0.148 0.685 lipid metabolic
his MIR759 0.191 0.148 0.685
exp MIR519A2 0.191 0.148 0.685
his KLHL11 17q21.2 0.191 0.148 0.685
xai LOC100506688 0.191 0.148 0.685
hs4 NDUFS7 19p13.3 0.191 0.148 0.685 transport;respiratory electron
transport chain
his KMT2E-AS1 0.191 0.148 0.685
his KMT2E 7q22.1 0.191 0.148 0.685
hs4 LINC00317 0.191 0.148 0.685
exp TECRP2 4q28.1 0.191 0.148 0.685
xai CLINT1 5q33.3 0.191 0.148 0.685 post-Golgi vesicle-mediated
his ARL2 11q13 0.191 0.148 0.685 tubulin complex assembly;centrosome
organization
his ARL2-SNX15 0.191 0.148 0.685
xai TMEM216 11q13.1 0.191 0.148 0.685 cell projection organization;cilium
morphogenesis
his RPUSD4 11q24.2 0.191 0.148 0.685 pseudouridine synthesis
his FAM118B 11q24.2 0.191 0.148 0.685
his TCERG1 5q31 0.191 0.148 0.685 negative regulation of transcription from
hs4 RNF103-CHMP3 0.191 0.148 0.685
hs4 RMND5A 2p11.2 0.191 0.148 0.685
xai DEPDC1B 5q12.1 0.191 0.148 0.685 small GTPase mediated signal
exp PSMC1P2 7p15.2 0.191 0.148 0.685
swa CAPN11 6p12 0.191 0.148 0.685 proteolysis
his ZDHHC24 11q13.2 0.191 0.148 0.685
his ACTN3 11q13.1 0.191 0.148 0.685 muscle filament sliding;regulation of
apoptotic process
his WDR53 3q29 0.191 0.148 0.685
his FBXO45 3q29 0.191 0.148 0.685 nervous system development;protein
ubiquitination
his LOC101927666 0.191 0.148 0.685
his DYNLL2 17q22 0.191 0.148 0.685 transport;apoptotic process
xai TMEM31 Xq22.2 0.191 0.148 0.685
exp PGA3 0.191 0.148 0.685
xai CEP95 17q23.3 0.191 0.148 0.685
hs4 TCIRG1 11q13.2 0.191 0.148 0.685 proton transport;transferrin
transport
hs4 CCNE1 19q12 0.191 0.148 0.685 DNA Damage Response (DDR); Oncogenes
his SDR9C7 12q13.3 0.191 0.148 0.685
his LINC01381 0.191 0.148 0.685
xai UBXN1 11q12.3 0.191 0.148 0.685 negative regulation of protein
catabolic process
hs4 MIR548D2 0.191 0.148 0.685
hs4 MIR548AA2 0.191 0.148 0.685
xai CASD1 7q21.3 0.191 0.148 0.685
exp LOC100419743 0.191 0.148 0.685
his ZNF780B 19q13.2 0.191 0.148 0.685 regulation of transcription, DNA-
dependent"
xai CWC27 5q12.3 0.191 0.148 0.685 nuclear mRNA splicing, via
his ITGA4 2q31.3 0.191 0.148 0.685 B cell differentiation;blood vessel
remodeling
xai LOC100132874 0.191 0.148 0.685
his CHMP2A 19q 0.191 0.148 0.685 protein transport;cellular membrane
organization
his UBE2M 19q13.43 0.191 0.148 0.685 protein modification process;protein
ubiquitination
his MZF1-AS1 0.191 0.148 0.685
xai OR8A1 11q24.2 0.191 0.148 0.685 response to stimulus
his H3F3B 17q25.1 0.191 0.148 0.685 nucleosome assembly;blood coagulation
his MIR4738 0.191 0.148 0.685
his UNK 17q25.1 0.191 0.148 0.685
hs4 RGS16 1q25-q31 0.191 0.148 0.685 visual perception;regulation of G-protein
his FLJ36777 0.191 0.148 0.685
xai ABHD14A 3p21.1 0.191 0.148 0.685
xai LOC100506100 0.191 0.148 0.685
xai ATP9B 18q23 0.19 0.148 0.685 cation transport;aminophospholipid transport
his CADM2 3p12.1 0.19 0.148 0.685 cell junction assembly;adherens junction
organization
dependent"
xai RFFL 17q12 0.19 0.148 0.686 intracellular protein transport;apoptotic
process
met ABCC13 21q11.2 0.19 0.148 0.686 ABC Transporters
hs4 TMPO-AS1 12q23.1 0.19 0.148 0.686
hs4 TMPO 12q22 0.19 0.148 0.686 regulation of transcription, DNA-dependent"
xsq ZNF804A 2q32.1 0.189 0.148 0.685
exp SAMD13 1p31.1 0.189 0.148 0.685
xsq OR2T4 0.189 0.148 0.685
xsq TMEM246-AS1 0.189 0.148 0.685
xsq DIS3 13q22.1 0.189 0.148 0.685 gene expression;RNA metabolic process
xsq MIR4697HG 11q25 0.189 0.148 0.685
xsq UTP20 12q23 0.189 0.148 0.685 rRNA processing;negative regulation of cell
proliferation
xsq KRTAP9-4 17q21.2 0.189 0.148 0.685
mir hsa-miR-191* 0.189 0.148 0.685
mut COL9A1 6q13 0.189 0.148 0.685 cell adhesion;axon guidance
xsq GLT6D1 9q34.3 0.189 0.148 0.685
xsq AP4E1 15q21.2 0.189 0.148 0.685 intracellular protein transport;vesicle-
mediated transport
exp RFFL 17q12 0.189 0.148 0.685 intracellular protein transport;apoptotic
process
xsq INPP5B 1p34 0.189 0.148 0.685 signal transduction;small GTPase mediated
signal transduction
mut C16orf71 16p13.3 0.189 0.148 0.685
exp PDIK1L 1p36.11 0.189 0.148 0.685
cop HSF5 17q22 0.189 0.148 0.685
cop MTMR4 17q22-q23 0.189 0.148 0.685 protein dephosphorylation;peptidyl-
cop SEPT4 17q22 0.189 0.148 0.685 brain development;sperm mitochondrion
organization
cop C17orf47 17q22 0.189 0.148 0.685
exp RNF5 6p21.3 0.189 0.148 0.685 ER-associated misfolded protein catabolic
process;cellular protein catabolic process
xsq TAB1 22q13.1 0.189 0.148 0.685 toll-like receptor signaling pathway;lung
development
exp HEPACAM 11q24.2 0.189 0.148 0.685 cell cycle;cell cycle arrest
met SNAPC4 9q34.3 0.189 0.148 0.685 regulation of transcription, DNA-
cop LOC654342 2p11.1 0.189 0.148 0.685
cop GGT8P 2p11.1 0.189 0.148 0.685
cop ACTR3BP2 2p11.1 0.189 0.148 0.685
xsq PRAMEF6 0.189 0.148 0.685
xsq PACS2 14q32.33 0.189 0.148 0.685 apoptotic process;interspecies
exp OLIG2 21q22.11 0.189 0.148 0.685 myelination;negative regulation of neuron
differentiation
xsq LOC101928150 0.189 0.148 0.685
xsq LOC283194 0.189 0.148 0.685
exp DCPS 11q24.2 0.189 0.148 0.685 deadenylation-dependent decapping of
xsq LINC01560 0.189 0.148 0.685
met FBXL17 5q21.3 0.189 0.148 0.685
met CA10 17q21.33 0.189 0.148 0.685 brain development
xsq FAM49B 8q24.21 0.189 0.148 0.685
xsq HS3ST6 16p13.3 0.189 0.148 0.685
cop SPIRE1 18p11.21 0.189 0.148 0.685 transport
cop C1D 2p13-p12 0.189 0.148 0.685 negative regulation of transcription,
DNA-dependent;maturation of 5.8S rRNA
cop WDR92 2p14 0.189 0.148 0.685 apoptotic process;histone lysine methylation
cop PNO1 2p14 0.189 0.148 0.685
exp PAX9 14q13.3 0.189 0.148 0.685 face morphogenesis;cellular response to
growth factor stimulus
xsq GBAS 7p12 0.189 0.148 0.685
mut BPIFA3 20q11.21 0.189 0.148 0.685
xsq NLRC4 2p22-p21 0.189 0.148 0.685 Apoptosis
xsq MTHFD1 14q24 0.189 0.148 0.685 water-soluble vitamin metabolic
xsq LOC100288637 15q13.2 0.189 0.148 0.685
xsq ORC3 6q14.3-q16.1 0.189 0.148 0.685 DDR (DNA replication)
xsq SPANXN4 Xq27.3 0.189 0.148 0.685
xsq LINC00577 0.189 0.148 0.685
cop TMEM233 12q24.23 0.189 0.148 0.685 response to biotic stimulus
xsq ADORA2A 22q11.23 0.189 0.148 0.685 G-protein signaling, coupled to
cAMP nucleotide second messenger;activation of adenylate cyclase activity
xsq C16orf86 16q22.1 0.189 0.148 0.686
exp KRT8P11 9q22.33 -0.189 0.148 0.685
exp SGIP1 1p31.3 -0.189 0.148 0.685 response to dietary excess;positive
xsq TEKT4P2 21p11.2 -0.189 0.148 0.685
cop SIL1 5q31 -0.189 0.148 0.685 protein folding;intracellular protein
transport
exp TRIB2 2p24.3 -0.189 0.148 0.685 negative regulation of protein
kinase activity;positive regulation of proteasomal ubiquitin-dependent protein
catabolic process
DNA-dependent"
xsq ARRDC4 15q26.3 -0.189 0.148 0.685 signal transduction
met LINC00593 15q23 -0.189 0.148 0.685
exp ZMYND10 3p21.3 -0.189 0.148 0.685
exp EPHB2 1p36.1-p35 -0.189 0.148 0.685 Protein Kinases
exp TBCEL 11q23.3 -0.189 0.148 0.685
cop DOCK8 9p24.3 -0.189 0.148 0.685 blood coagulation
exp TYRO3 15q15 -0.189 0.148 0.685 signal transduction by
phosphorylation;negative regulation of neuron apoptosis
met BNC1 15q25.2 -0.189 0.148 0.685 regulation of transcription, DNA-
xsq GSAP 7q11.23 -0.189 0.148 0.685
exp ARHGEF4 2q22 -0.189 0.148 0.685 nerve growth factor receptor
xsq SDSL 12q24.13 -0.189 0.148 0.685 cellular amino acid metabolic
process
exp HR 8p21.2 -0.189 0.148 0.685 regulation of transcription, DNA-
activity
xsq RNF128 Xq22.3 -0.189 0.148 0.685 negative regulation of
cytokine biosynthetic process
met APOBEC3H 22q13.1 -0.189 0.148 0.685 cytidine deamination;negative
regulation of transposition
met MIR634 -0.189 0.148 0.685
mut ADCY2 5p15.3 -0.189 0.148 0.685 cAMP biosynthetic process;synaptic
transmission
xsq POU6F1 -0.189 0.148 0.685 muscle organ development;regulation
cop RGS5 1q23.1 -0.189 0.148 0.685 signal transduction;regulation of
cop AVL9 7p14.3 -0.189 0.148 0.685
his TSPAN9 12p13.33-p13.32 -0.19 0.148 0.686
his GABRE Xq28 -0.19 0.148 0.686 transport;ion transport
xai MIR218-2 -0.19 0.148 0.686
his CRTAM 11q24.1 -0.19 0.148 0.686 positive regulation of natural killer
cell mediated cytotoxicity directed against tumor cell target;cell recognition
swa ITGB4 17q25 -0.19 0.148 0.686 cell-matrix adhesion;integrin-mediated
signaling pathway
his RMDN2-AS1 -0.191 0.148 0.685
xai ARL2BP 16q13 -0.191 0.148 0.685 maintenance of protein location in
xai LRP12 8q22.2 -0.191 0.148 0.685 EMT (Mesenchymal)
his DUSP14 17q12 -0.191 0.148 0.685 peptidyl-tyrosine dephosphorylation
hs4 GALNT5 2q24.1 -0.191 0.148 0.685 glycosaminoglycan
his LINC01740 -0.191 0.148 0.685
his SUSD4 1q41 -0.191 0.148 0.685
his PEA15 1q21.1 -0.191 0.148 0.685 transport;anti-apoptosis
his LOC729867 -0.191 0.148 0.685
xai PLD2 17p13.1 -0.191 0.148 0.685 cell communication;response to
hydrogen peroxide
his FAM131A 3q27.1 -0.191 0.148 0.685
cop MIR875 -0.191 0.148 0.685
his PSD2-AS1 -0.191 0.148 0.685
xai ABCC11 16q12.1 -0.191 0.148 0.685 ABC Transporters
xai FTLP14 -0.191 0.148 0.685
his FMOD 1q32 -0.191 0.148 0.685 wound healing;odontogenesis
hs4 CLDN4 7q11.23 -0.191 0.148 0.685 EMT (Epithelial)
exp FTLP14 -0.191 0.148 0.685
xai CYGB 17q25 -0.191 0.148 0.685 transport;response to oxidative stress
xai ACVR2A 2q22.3 -0.191 0.148 0.685 Cell Signaling; Tumor
Suppressors
hs4 LYN 8q13 -0.191 0.148 0.685 Protein Kinases
hs4 SNAI2 8q11 -0.191 0.148 0.685 multicellular organismal
hs4 HEG1 3q21.2 -0.191 0.148 0.685 endothelial cell
his OSTN-AS1 -0.191 0.148 0.685
xai KLF6 10p15 -0.191 0.148 0.685 regulation of transcription, DNA-
xai LOC100287896 11q13.4 0.19 0.149 0.686
his AMPD3 11p15 0.19 0.149 0.686 purine base metabolic process;IMP biosynthetic
process
exp OR8A1 11q24.2 0.19 0.149 0.686 response to stimulus
xai NEUROG2 4q25 0.19 0.149 0.686 cell fate commitment;neuron migration
his DECR1 8q21.3 0.19 0.149 0.686 fatty acid beta-oxidation;cellular lipid
metabolic process
hs4 MYOM1 18p11.31 0.19 0.149 0.686 muscle contraction
his SSFA2 2q31.3 0.19 0.149 0.686
swa PSMD9 12q24.31-q24.32 0.19 0.149 0.686 M/G1 transition of mitotic cell
cop DNM1P35 15q24.2 0.19 0.149 0.686
xai CCL3 17q12 0.19 0.149 0.686 MAPK cascade;chemotaxis
his STRBP 9q33.3 0.19 0.149 0.686 cellular component movement;multicellular
xai MIS18BP1 14q21.2 0.19 0.149 0.686 mitosis;CenH3-containing nucleosome
assembly at centromere
his SMN2 0.19 0.149 0.686
his SMYD4 17p13.3 0.19 0.149 0.686
his RPA1 17p13.3 0.19 0.149 0.686 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
his AMD1 6q21 0.19 0.149 0.686 small molecule metabolic process;polyamine
metabolic process
his TMEM164 Xq22.3 0.19 0.149 0.686
xai SS18 18q11.2 0.19 0.149 0.686 intracellular protein kinase
his TNNT1 19q13.4 0.19 0.149 0.686 muscle filament sliding;slow-twitch
skeletal muscle fiber contraction
xai TRMT112 11q13.1 0.19 0.149 0.686 peptidyl-glutamine methylation
his GIMAP7 7q36.1 0.19 0.149 0.687
xai GAN 16q24.1 0.19 0.149 0.687 cell death
his NMBR 6q24.1 0.19 0.149 0.687 G-protein coupled receptor signaling
pathway;activation of phospholipase C activity by G-protein coupled receptor
protein signaling pathway coupled to IP3 second messenger
his VTA1 6q24.1 0.19 0.149 0.687 endosome transport;protein transport
his NR2C1 12q22 0.19 0.149 0.687 positive regulation of retinoic acid receptor
promoter
swa ZC3H4 19q13.32 0.19 0.149 0.687
exp DUXAP10 0.19 0.149 0.687
his TAF5L 1q42.13 0.19 0.149 0.687 regulation of transcription, DNA-
his URB2 1q42.13 0.19 0.149 0.687
xai SALL4P6 3p22.1 0.19 0.149 0.687
xai MCPH1 8p23.1 0.19 0.149 0.687 DNA Damage Response (DDR)
exp SLC25A5P2 2p22.3 0.19 0.149 0.687
xai SPATA31E2P 15q11.2 0.19 0.149 0.687
xai HMBOX1 8p21.1 0.19 0.149 0.687 negative regulation of
transcription, DNA-dependent;positive regulation of transcription, DNA-dependent"
hs4 LYPLAL1-AS1 0.19 0.149 0.687
hs4 LYPLAL1 1q41 0.19 0.149 0.687
his TRA2B 3q26.2-q27 0.19 0.149 0.687 response to reactive oxygen species;RNA
splicing, via transesterification reactions
his MIR7849 0.19 0.149 0.687
dependent"
his BRCA1 17q21 0.19 0.149 0.687 Apoptosis; DNA Damage Response (DDR); DDR (FA);
DDR (DNA replication); Tumor Suppressors
his NBR2 17q21 0.19 0.149 0.687
xai MLLT10 10p12 0.19 0.149 0.687 regulation of transcription, DNA-
exp POTEA 8p11.1 0.19 0.149 0.687
exp ALG1L9P 11q13.4 0.19 0.149 0.687
his RILPL2 12q24.31 0.19 0.149 0.687
his CUX1 7q22.1 0.19 0.149 0.687 lung development;auditory receptor cell
differentiation
exp SEPHS1 10p14 0.189 0.149 0.686 protein modification process
exp HIPK1 1p13.2 0.189 0.149 0.686 eye development;regulation of
exp GOLGA6L10 0.189 0.149 0.686
xsq EML3 11q12.3 0.189 0.149 0.686
exp KLB 4p14 0.189 0.149 0.686 insulin receptor signaling pathway;fibroblast
xsq HDGFRP2 19p13.3 0.189 0.149 0.686
xsq VRK3 19q13 0.189 0.149 0.686 positive regulation of phosphoprotein
exp UBE2V1P6 2q31.1 0.189 0.149 0.686
xsq FSCN3 7q31.3 0.189 0.149 0.686
exp PCIF1 20q13.12 0.189 0.149 0.686 negative regulation of phosphatase
activity
met PLG 6q26 0.189 0.149 0.686 fibrinolysis;platelet degranulation
exp XK Xp21.1 0.189 0.149 0.686 transport;amino acid transport
xsq STAMBPL1 10q23.31 0.189 0.149 0.686 proteolysis
xsq GDF3 0.189 0.149 0.686
xsq MRPL54 19p13.3 0.189 0.149 0.686
met SHTN1 0.189 0.149 0.686 multicellular organismal development;axon
guidance
xsq ZNF182 Xp11.23 0.189 0.149 0.686 regulation of transcription, DNA-
dependent"
xsq ZNF663P 0.189 0.149 0.686 regulation of transcription, DNA-
dependent"
met ALOX12 17p13.1 0.189 0.149 0.686 leukotriene biosynthetic
process;positive regulation of endothelial cell differentiation
xsq UMPS 3q13 0.189 0.149 0.686 'de novo' UMP biosynthetic process;small
met POTEA 8p11.1 0.189 0.149 0.686
xsq LINC00908 18q23 0.189 0.149 0.686
met AHNAK 11q12.2 0.189 0.149 0.686 nervous system development
xsq ADAMTS18 16q23 0.189 0.149 0.686 proteolysis
xsq PAX4 7q32 0.189 0.149 0.686 organ morphogenesis;cell differentiation
exp UQCR11 19p13.3 0.189 0.149 0.687 generation of precursor metabolites
met GCNT2 6p24.2 0.189 0.149 0.687 glycosaminoglycan biosynthetic
met F3 1p22-p21 0.189 0.149 0.687 anti-apoptosis;positive regulation of
platelet-derived growth factor receptor signaling pathway
mut DEPTOR 8q24.12 0.189 0.149 0.687 negative regulation of TOR
signaling cascade;intracellular signal transduction
xsq CAT 11p13 0.188 0.149 0.687 response to hypoxia;positive regulation of
phosphatidylinositol 3-kinase cascade
xsq TMEM151B 6p21.1 0.188 0.149 0.687
met NOM1 7q36.3 0.188 0.149 0.687 RNA metabolic process
xsq ARIH2 3p21 0.188 0.149 0.687 protein polyubiquitination;multicellular
exp LOC728996 0.188 0.149 0.687
xsq LOC340074 5q31.1 0.188 0.149 0.687
xsq USP19 3p21.31 0.188 0.149 0.687 negative regulation of skeletal muscle
exp NDUFS6 5p15.33 0.188 0.149 0.687 transport;respiratory electron
transport chain
cop MOGAT2 11q13.5 0.188 0.149 0.687 glycerol metabolic
process;diacylglycerol biosynthetic process
cop RPS6KA2 6q27 0.188 0.149 0.687 Protein Kinases
xsq ZNF587B 0.188 0.149 0.687
cop CCBE1 18q21.32 0.188 0.149 0.687 multicellular organismal
xsq CCDC63 12q24.11 0.188 0.149 0.687
cop LINC00534 -0.188 0.149 0.687
DNA-dependent"
xsq B9D1 17p11.2 -0.188 0.149 0.687 smoothened signaling pathway;cell
exp SPATA6L 9p24.2 -0.188 0.149 0.687
exp LEMD1 1q32.1 -0.188 0.149 0.687
exp SERINC3 20q13.12 -0.188 0.149 0.687 induction of apoptosis
xsq ATP2B4 1q32.1 -0.188 0.149 0.687 ion transmembrane
xsq HAGLR -0.188 0.149 0.687
exp LINC00950 9p13.3 -0.188 0.149 0.687
exp KRT16P1 -0.188 0.149 0.687
cop RAPGEF5 7p15.3 -0.188 0.149 0.687 nervous system
development;regulation of small GTPase mediated signal transduction
cop AARD 8q24.11 -0.189 0.149 0.687 lung development
cop HTR3C 3q27.1 -0.189 0.149 0.687 ion transmembrane
cop HTR3E 3q27.1 -0.189 0.149 0.687 ion transmembrane
cop EIF2B5 3q27.1 -0.189 0.149 0.687 response to glucose
xsq ZNF365 10q21.2 -0.189 0.149 0.687
exp IFT20 17q11.2 -0.189 0.149 0.687 cell projection organization
cop TMEM64 8q21.3 -0.189 0.149 0.686
xsq SEMA3C 7q21-q31 -0.189 0.149 0.686 blood vessel
met PSG9 19q13.2 -0.189 0.149 0.686 defense response;female pregnancy
xsq PTPRU 1p35.3 -0.189 0.149 0.686 homotypic cell-cell
met TMEM201 1p36.22 -0.189 0.149 0.686
met IPCEF1 6q25.2 -0.189 0.149 0.686 response to oxidative
stress;oxygen transport
exp SP140L 2q37.1 -0.189 0.149 0.686
exp CYP2A13 19q13.2 -0.189 0.149 0.686 xenobiotic metabolic
exp TPRA1 3q21.2 -0.189 0.149 0.686 lipid metabolic process;G-protein
exp KRT8P45 1q23.1 -0.189 0.149 0.686
xsq OSBPL3 7p15 -0.189 0.149 0.686 transport;lipid transport
exp RAB23 6p11 -0.189 0.149 0.686 protein transport;spinal cord
dorsal/ventral patterning
xsq ACKR2 3p21.3 -0.189 0.149 0.686
cop NUF2 1q23.3 -0.189 0.149 0.686 M phase of mitotic cell
exp RAB1A 2p14 -0.189 0.149 0.686 protein transport;vesicle-mediated
transport
xsq KAZN 1p36.21 -0.189 0.149 0.686 keratinization
xsq MEGF6 1p36.3 -0.189 0.149 0.686
cop SDHAP2 -0.189 0.149 0.686
cop MIR570 -0.189 0.149 0.686
cop MUC20 3q29 -0.189 0.149 0.686 hepatocyte growth factor receptor
signaling pathway;protein homooligomerization
exp ZNF488 10q11.22 -0.189 0.149 0.686 oligodendrocyte
development;negative regulation of transcription, DNA-dependent
hs4 SLC9C2 1q25.1 -0.19 0.149 0.687 cation transport;sodium ion
transport
his BCAM 19q13.2 -0.19 0.149 0.687 cell-matrix adhesion;signal transduction
xai PPARD 6p21.2 -0.19 0.149 0.687 generation of precursor metabolites and
energy;cell proliferation
hs4 DTX3 12q13.3 -0.19 0.149 0.687 Notch signaling pathway
swa PDIA6 2p25.1 -0.19 0.149 0.687 protein folding;glycerol ether metabolic
process
xai DNM1P41 -0.19 0.149 0.687
xai COQ10B 2q33.1 -0.19 0.149 0.687
xai TNFSF13 17p13.1 -0.19 0.149 0.687 positive regulation of cell
xai ADAMTS1 21q21.2 -0.19 0.149 0.686 integrin-mediated signaling
his MALSU1 7p15.3 -0.19 0.149 0.686 ribosomal large subunit biogenesis
exp MIR218-2 -0.19 0.149 0.686
his ZNF83 19q13.3 -0.19 0.149 0.686 regulation of transcription, DNA-
dependent"
xai MIR301A -0.19 0.149 0.686
hs4 WBP2NL 22q13.2 -0.19 0.149 0.686 meiosis;egg activation
exp MIR301A -0.19 0.149 0.686
xai CSTB 21q22.3 -0.19 0.149 0.686 adult locomotory behavior;negative
regulation of peptidase activity
xai MAP3K9 14q24.2 -0.19 0.149 0.686 Protein Kinases
hs4 HEY1 8q21 -0.19 0.149 0.686 negative regulation of Notch signaling
pathway;negative regulation of transcription, DNA-dependent
hs4 LINC01607 -0.19 0.149 0.686
xai EYA4 6q23 -0.19 0.149 0.686 DNA repair;regulation of transcription, DNA-
dependent
xai RRAGC 1p34 -0.19 0.149 0.686 Apoptosis
his FAM13C 10q21.1 -0.19 0.149 0.686
xai AZIN2 -0.19 0.149 0.686 agmatine biosynthetic process;ornithine
metabolic process
hs4 DAAM2 6p21.2 -0.19 0.149 0.686 actin cytoskeleton organization;cellular
component organization
his ZBTB38 3q23 -0.19 0.149 0.686 positive regulation of transcription from
his CTSO 4q32.1 -0.19 0.149 0.686 proteolysis
xai OR51E2 11p15 0.191 0.15 0.688 detection of chemical stimulus involved
in sensory perception of smell;sensory perception of smell
his LINC00602 6q27 0.19 0.15 0.687
his LINC00473 6q27 0.19 0.15 0.687
his SYNCRIP 6q14-q15 0.19 0.15 0.687 RNA splicing;interspecies
exp MS4A4E 11q12.2 0.19 0.15 0.687
hs4 TCF3 19p13.3 0.19 0.15 0.687 transcription, DNA-dependent;response to
drug
his PEX1 7q21.2 0.19 0.15 0.687 microtubule-based peroxisome
localization;protein targeting to peroxisome
his RBM48 7q21.2 0.19 0.15 0.687
exp TRNE 0.19 0.15 0.687
xai PGK1P2 19p13.3 0.19 0.15 0.687
hs4 PCNA 20pter-p12 0.19 0.15 0.687 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
hs4 PCNA-AS1 0.19 0.15 0.687 DDR (DNA replication)
hs4 LINC00922 16q21 0.19 0.15 0.688
exp MYH1 17p13.1 0.19 0.15 0.688
exp C11orf39 0.19 0.15 0.688
his SUGP2 19p12 0.19 0.15 0.688 mRNA processing;RNA splicing
his ARMC6 19p13.11 0.19 0.15 0.688
his DPP9-AS1 0.19 0.15 0.688
hs4 SCRT2 20p13 0.19 0.15 0.688
his MED7 5q33.3 0.19 0.15 0.688 regulation of transcription from RNA
polymerase II promoter;transcription initiation from RNA polymerase II promoter
hs4 LINC01397 0.19 0.15 0.688
xai LOC645513 4q26 0.19 0.15 0.688
xai TMEM150C 4q21.22 0.19 0.15 0.688
xai FAM86HP 3q22.1 0.19 0.15 0.688
his LIN7C 11p14 0.19 0.15 0.688 exocytosis;neurotransmitter secretion
his BDNF-AS 11p14.1 0.19 0.15 0.688
his BCAP29 7q22.3 0.19 0.15 0.688 Apoptosis
his CALCRL 2q32.1 0.19 0.15 0.688 calcium ion transport;positive
regulation of smooth muscle cell proliferation
his TMEM167A 5q14.2 0.19 0.15 0.688
his PNLDC1 6q25.3 0.19 0.15 0.688
his MIR632 0.19 0.15 0.688
dependent"
xai LPCAT4 15q14 0.19 0.15 0.688 metabolic process;phospholipid
cop RPS3 11q13.3-q13.5 0.19 0.15 0.688 translational termination;mRNA
metabolic process
cop SNORD15A 0.19 0.15 0.688
cop SNORD15B 11q13.4 0.19 0.15 0.688
cop KLHL35 11q13.4 0.19 0.15 0.688
hs4 ZADH2 18q22.3 0.19 0.15 0.688
hs4 TSHZ1 18q22.3 0.19 0.15 0.688 multicellular organismal
his COL24A1 1p22.3 0.19 0.15 0.688 cell adhesion
hs4 MESDC2 15q13 0.19 0.15 0.688 protein folding;mesoderm development
exp DIO1 1p33-p32 0.19 0.15 0.688 hormone biosynthetic process;small
his LINC00471 2q37.1 0.19 0.15 0.688
his TRAPPC6B 14q21.1 0.19 0.15 0.688 vesicle-mediated transport
his PNN 14q21.1 0.19 0.15 0.688 nuclear mRNA splicing, via
hs4 ATP8B3 19p13.3 0.19 0.15 0.688 ATP catabolic process;cation
transport
xai LOC400464 15q26.3 0.19 0.15 0.688
hs4 GALM 2p22.1 0.19 0.15 0.688 carbohydrate metabolic process;hexose
metabolic process
exp SOS1-IT1 0.19 0.15 0.688
hs4 CPXCR1 Xq21.3 0.19 0.15 0.688
hs4 C19orf84 0.19 0.15 0.688
his C12orf77 12p12.1 0.19 0.15 0.688
his LOC645177 12p12.1 0.19 0.15 0.688
his MIR5186 0.19 0.15 0.688
xai SOS1-IT1 0.19 0.15 0.688
his MCPH1-AS1 0.19 0.15 0.688
his AGPAT5 8p23.1 0.19 0.15 0.688 metabolic process;phospholipid
his GOLGA8N 0.19 0.15 0.688
his ADAMTS17 15q24 0.19 0.15 0.688 proteolysis
hs4 EP400NL 12q24.33 0.19 0.15 0.688
exp MIR181A1HG 1q32.1 0.19 0.15 0.688
xai RRP8 11p15.4 0.19 0.15 0.688 chromatin silencing at rDNA;regulation of
his RPE 2q32-q33.3 0.19 0.15 0.688 small molecule metabolic
xai PRDX5 11q13 0.19 0.15 0.688 response to oxidative stress;cellular response
to reactive oxygen species
xai HSPA9 5q31.1 0.19 0.15 0.688 Apoptosis
his TMEM150C 4q21.22 0.19 0.15 0.688
xai PDE3A 12p12 0.19 0.15 0.688 cGMP-mediated signaling;cellular response to
cGMP
hs4 BIRC5 17q25 0.19 0.15 0.688 Apoptosis
xai NBEAL2 3p21.31 0.19 0.15 0.688 platelet formation
exp LOC401433 0.19 0.15 0.688
hs4 SCARB1 12q24.31 0.19 0.15 0.688 Apoptosis
his ZDHHC4 7p22.1 0.19 0.15 0.688
met PDZK1IP1 1p33 0.188 0.15 0.687
met TUBB4B 9q34 0.188 0.15 0.687 Apoptosis
exp GTPBP1 22q13.1 0.188 0.15 0.687 GTP catabolic process;immune
response
mut SSFA2 2q31.3 0.188 0.15 0.687
exp ECH1 19q13.1 0.188 0.15 0.687 lipid metabolic process;fatty acid
metabolic process
met PICK1 22q13.1 0.188 0.15 0.687 protein phosphorylation;receptor
clustering
exp ASF1B 19p13.12 0.188 0.15 0.687 DNA Damage Response (DDR); DDR (DNA
replication)
met CTTNBP2NL 1p13.2 0.188 0.15 0.687
cop MCFD2 2p21 0.188 0.15 0.687 protein transport;vesicle-mediated transport
xsq LINC01522 0.188 0.15 0.687
exp UPF1 19p13.2-p13.11 0.188 0.15 0.688 DNA Damage Response (DDR)
xsq TCEANC Xp22.2 0.188 0.15 0.688 transcription, DNA-
xsq ZCCHC10 5q31.1 0.188 0.15 0.688
exp MBD2 18q21 0.188 0.15 0.688 maternal behavior;cellular protein complex
assembly
met PAGE4 Xp11.23 0.188 0.15 0.688
xsq IDH1-AS1 0.188 0.15 0.688
met HTR1F 3p12 0.188 0.15 0.688 serotonin receptor signaling pathway;synaptic
transmission
mut FSTL5 4q32.3 0.188 0.15 0.688
xsq LOC100505921 0.188 0.15 0.688
exp NFATC2 20q13.2 0.188 0.15 0.688 response to drug;positive
met JRKL 11q21 0.188 0.15 0.688 regulation of transcription, DNA-
dependent;central nervous system development"
cop MIR558 0.188 0.15 0.688
xsq TFCP2 12q13 0.188 0.15 0.688 regulation of transcription from RNA polymerase
II promoter
cop MIR2116 0.188 0.15 0.688
cop LOC388942 0.188 0.15 0.688
exp PCDH11X Xq21.3 0.188 0.15 0.688 cell adhesion;homophilic cell
adhesion
met FUCA2 6q24 0.188 0.15 0.688 fucose metabolic process;carbohydrate metabolic
process
exp RNF220 1p34.1 0.188 0.15 0.688 protein ubiquitination;protein
autoubiquitination
exp CBLN1 16q12.1 0.188 0.15 0.688 synaptic transmission;nervous system
development
exp AASDH 4q12 0.188 0.15 0.688 lipid metabolic process;fatty acid metabolic
process
xsq NCOA7 6q22.32 0.188 0.15 0.688 cell wall macromolecule catabolic
exp SNORD93 7p15.3 0.188 0.15 0.688
exp LYRM4 6p25.1 0.188 0.15 0.688
exp AUNIP 1p36.11 0.188 0.15 0.688
mut SOWAHC 2q13 0.188 0.15 0.688
xsq C6orf222 6p21.31 0.188 0.15 0.688
xsq SDF2L1 22q11.21 0.188 0.15 0.688
met PRR5L 11p13-p12 0.188 0.15 0.688
cop FLJ10038 15q21.2 0.188 0.15 0.688
cop GABPB1-AS1 15q21.2 0.188 0.15 0.688
exp PIGP 21q22.2 0.188 0.15 0.688 preassembly of GPI anchor in ER
met FBXO25 8p23.3 0.188 0.15 0.688 protein ubiquitination
met GPX3 5q23 0.188 0.15 0.688 response to organic cyclic compound;response to
drug
xsq HRASLS5 11q13.2 0.188 0.15 0.688
xsq GHRL 3p26-p25 0.188 0.15 0.688 negative regulation of endothelial cell
xsq HNRNPCL4 0.188 0.15 0.688
exp COX7A1 19q13.1 -0.188 0.15 0.688 generation of precursor
mut MST1R 3p21.3 -0.188 0.15 0.688 Apoptosis
met SSBP4 19p13.1 -0.188 0.15 0.688
xsq CLIP2 7q11.23 -0.188 0.15 0.688
xsq PCP4L1 1q23.3 -0.188 0.15 0.688
met VWDE 7p21.3 -0.188 0.15 0.688
cop MARCH11 5p15.1 -0.188 0.15 0.688
xsq BCL2L13 22q11.1 -0.188 0.15 0.688 Apoptosis
exp DCAF5 14q23-q24.1 -0.188 0.15 0.688 protein ubiquitination
xsq PROL1 4q13.3 -0.188 0.15 0.688 negative regulation of peptidase
activity;negative regulation of endopeptidase activity
xsq HLA-B 6p21.3 -0.188 0.15 0.688 antigen processing and presentation
exp TMEM132A 11q12.2 -0.188 0.15 0.688
cop C1orf27 1q25 -0.188 0.15 0.688
cop OCLM 1q25 -0.188 0.15 0.688 visual perception
cop PDC 1q25.2 -0.188 0.15 0.688
mut UBASH3B 11q24.1 -0.188 0.15 0.688
DNA-dependent"
exp ERBB3 12q13 -0.188 0.15 0.688 signal transduction;Schwann cell
differentiation
DNA-dependent"
cop TRPC7 5q31.1 -0.188 0.15 0.688 ion transport;manganese ion
transport
cop LOC730102 -0.188 0.15 0.688
exp KRT18P12 1q41 -0.188 0.15 0.687
mut CCR5 3p21.31 -0.188 0.15 0.687 calcium ion transport;cell-cell
signaling
xsq ELMSAN1 14q24.3 -0.188 0.15 0.687
cop HTR3D 3q27.1 -0.188 0.15 0.687 ion transmembrane
xai EPB41L5 2q14.2 -0.19 0.15 0.688
swa NDUFA6 22q13.2 -0.19 0.15 0.688 response to oxidative
hs4 FZD4 11q14.2 -0.19 0.15 0.688 brain development;substrate adhesion-
hs4 LOC100506368 -0.19 0.15 0.688
his PSG6 -0.19 0.15 0.688 female pregnancy
hs4 MIR3973 -0.19 0.15 0.688
hs4 MTNR1B 11q21-q22 -0.19 0.15 0.688 G-protein signaling, coupled to
cyclic nucleotide second messenger;synaptic transmission
xai NHLRC1 6p22.3 -0.19 0.15 0.688 protein polyubiquitination;positive
regulation of protein ubiquitination
swa POFUT1 20q11 -0.19 0.15 0.688 somitogenesis;embryo development
swa CCDC6 10q21 -0.19 0.15 0.688
xai TRIM44 11p13 -0.19 0.15 0.688
xai OS9 12q13 -0.19 0.15 0.688 protein retention in ER lumen;protein
ubiquitination
xai OSMR 5p13.1 -0.19 0.15 0.688 positive regulation of acute inflammatory
response;cell surface receptor signaling pathway
hs4 RRS1-AS1 -0.19 0.15 0.688
hs4 RRS1 8q13.1 -0.19 0.15 0.688 mitotic metaphase plate
hs4 ADHFE1 8q13.1 -0.19 0.15 0.688 2-oxoglutarate metabolic
his SEMA3F 3p21.3 -0.19 0.15 0.688 neural crest cell
his MIR566 -0.19 0.15 0.688
hs4 GPR180 13q32.1 -0.19 0.15 0.688
hs4 KIRREL3 11q24 -0.19 0.15 0.688 hemopoiesis
hs4 KIRREL3-AS3 11q24.2 -0.19 0.15 0.688
his ACTG1P17 -0.19 0.15 0.688
xai PROSER3 -0.19 0.15 0.688
hs4 ARID3C 9p13.3 -0.19 0.15 0.688 regulation of transcription, DNA-
dependent"
hs4 MAGI1-IT1 -0.19 0.15 0.688
swa GGH 8q12.3 -0.19 0.15 0.688 response to insulin stimulus;response to
drug
xai PSG9 19q13.2 -0.19 0.15 0.688 defense response;female pregnancy
his FAM150B 2p25.3 -0.19 0.15 0.688
xai CDC20B 5q11.2 -0.19 0.15 0.687
hs4 SUSD5 3p22.3 -0.19 0.15 0.687 cell adhesion
his LRRN1 3p26.2 -0.19 0.15 0.687
hs4 RPRM 2q23.3 -0.19 0.15 0.687 cell cycle arrest;regulation of mitotic
cell cycle
his RAB38 11q14 -0.19 0.15 0.687 GTP catabolic process;small GTPase mediated
signal transduction
his MIR3166 -0.19 0.15 0.687
his LRRC37A5P 9q31.3 -0.19 0.15 0.687
his DCLRE1A 10q25.1 0.19 0.151 0.689 DNA Damage Response (DDR)
his NHLRC2 10q25.3 0.19 0.151 0.689
xai GMDS 6p25 0.189 0.151 0.689 'de novo' GDP-L-fucose biosynthetic
his POLR3E 16p12.2 0.189 0.151 0.689 transcription from RNA polymerase
exp TPTE2 13q12.11 0.189 0.151 0.689 transmembrane transport;ion transport
his BRCAT54 0.189 0.151 0.689
his MRPS30 5q11 0.189 0.151 0.689 Apoptosis
hs4 FAM89A 1q42.2 0.189 0.151 0.689
his CYP4F22 19p13.12 0.189 0.151 0.689
his NAB1 2q32.3-q33 0.189 0.151 0.689 Schwann cell differentiation;myelination
his MBNL3 Xq26.2 0.189 0.151 0.689 mRNA processing;multicellular organismal
development
hs4 SIN3A 15q24.2 0.189 0.151 0.689 in utero embryonic development;cellular
xai CEP72 5p15.33 0.189 0.151 0.689 mitotic cell cycle;spindle organization
swa PLK1 16p12.2 0.189 0.151 0.689 DDR (DNA replication); Protein Kinases
xai TRAPPC5 19p13.2 0.189 0.151 0.689 vesicle-mediated transport
his CSNK1D 17q25 0.189 0.151 0.689 DNA Damage Response (DDR); Protein
Kinases
his LINC01970 0.189 0.151 0.689
his LOC102725022 0.189 0.151 0.689
xai PRKAB1 12q24.1-q24.3 0.189 0.151 0.689 Protein Kinases
xai LOC401433 0.189 0.151 0.689
xai ISCA1P2 1q42.13 0.189 0.151 0.689
hs4 C2orf68 2p11.2 0.189 0.151 0.689
exp PPIG 2q31.1 0.189 0.151 0.689 protein folding;RNA splicing
xai CEACAM18 19q13.41 0.189 0.151 0.689
swa CCT4 2p15 0.189 0.151 0.689 protein folding;cellular protein metabolic
process
hs4 AMDHD1 12q23.1 0.189 0.151 0.689 histidine catabolic
hs4 CCDC38 12q23.1 0.189 0.151 0.689
xai ZNF330 4q31.21 0.189 0.151 0.689
dependent"
xai FBXL6 8q24.3 0.189 0.151 0.689 proteolysis;protein ubiquitination
xai AK2 1p34 0.189 0.151 0.689 nucleobase-containing small molecule
hs4 COX5A 15q24.1 0.189 0.151 0.689 small molecule metabolic
exp NEUROG2 4q25 0.189 0.151 0.689 cell fate commitment;neuron migration
xai ADAT1 16q23.1 0.189 0.151 0.689 RNA processing;tRNA processing
xai NUDT2 9p13 0.189 0.151 0.689 Apoptosis
his GTF3C6 6q21 0.189 0.151 0.689 transcription, DNA-
xai LINC00667 18p11.31 0.189 0.151 0.689
swa UBE3D 6q14.1 0.189 0.151 0.69
dependent"
exp OR5AW1P Xq26.2 0.189 0.151 0.69
his CDAN1 15q15.2 0.189 0.151 0.69
his NICN1 3p21.31 0.189 0.151 0.69
xai TSTD2 9q22.33 0.189 0.151 0.69
his CR2 1q32 0.189 0.151 0.69 complement receptor mediated signaling
his SAP30L-AS1 0.189 0.151 0.69
his SAP30L 5q33.2 0.189 0.151 0.69 regulation of transcription, DNA-
dependent"
exp QRICH1 3p21.31 0.188 0.151 0.688
mut CXorf57 Xq22.3 0.188 0.151 0.689
exp CHD5 1p36.31 0.188 0.151 0.689 regulation of transcription, DNA-
exp CRIP1P4 22q11.2 0.188 0.151 0.689
xsq FSD2 15q25.2 0.188 0.151 0.689
cop CCNB2 15q22.2 0.188 0.151 0.689 DNA Damage Response (DDR)
met SLC46A2 9q32 0.188 0.151 0.689 transport;transmembrane transport
xsq TIMELESS 12q13.3 0.188 0.151 0.689 DNA Damage Response (DDR)
cop WNT11 11q13.5 0.188 0.151 0.689 Apoptosis; Oncogenes
cop RNF43 17q22 0.188 0.151 0.689
met C9orf69 9q34.3 0.188 0.151 0.689
exp RPL13AP16 7q22.3 0.188 0.151 0.689
exp LRRC47 1p36.32 0.188 0.151 0.689
exp GPBP1L1 1p34.1 0.188 0.151 0.689 regulation of transcription, DNA-
dependent"
xsq MSGN1 2p24.2 0.188 0.151 0.689
cop KRTAP5-6 11p15.5 0.188 0.151 0.689
cop IFITM10 0.188 0.151 0.689 response to biotic stimulus
cop CTSD 11p15.5 0.188 0.151 0.689 cell death;proteolysis
cop SYT8 11p15.5 0.188 0.151 0.689
cop TNNI2 11p15.5 0.188 0.151 0.689 skeletal muscle contraction;muscle
filament sliding
cop LSP1 11p15.5 0.188 0.151 0.689 chemotaxis;cellular defense response
cop MIR4298 0.188 0.151 0.689
cop TNNT3 11p15.5 0.188 0.151 0.689 skeletal muscle contraction;regulation of
striated muscle contraction
cop MRPL23 11p15.5 0.188 0.151 0.689 translation
cop MRPL23-AS1 11p15.5 0.188 0.151 0.689
cop H19 11p15.5 0.188 0.151 0.689
cop MIR675 0.188 0.151 0.689
cop INS-IGF2 0.188 0.151 0.689
cop IGF2 11p15.5 0.188 0.151 0.689 Apoptosis
cop MIR483 0.188 0.151 0.689
cop IGF2-AS 11p15.5 0.188 0.151 0.689
cop INS 0.188 0.151 0.689 carbohydrate metabolic process;positive
cop TH 11p15.5 0.188 0.151 0.689 dopamine biosynthetic process from
tyrosine;mating behavior
cop MIR4686 0.188 0.151 0.689
exp GNRHR2P1 14q23.1 0.188 0.151 0.689
xsq HSPA9 5q31.1 0.188 0.151 0.689 Apoptosis
xsq CPSF3L 1p36.33 0.188 0.151 0.689
xsq LINC01524 0.188 0.151 0.689
xsq HNF1A 12q24.2 0.188 0.151 0.689 Tumor Suppressors
met CAMLG 5q23 0.188 0.151 0.689 epidermal growth factor receptor signaling
pathway;receptor recycling
xsq MRPL23-AS1 11p15.5 0.188 0.151 0.689
met C14orf178 14q24.3 0.188 0.151 0.689
exp MRPL45 17q21.2 0.188 0.151 0.689 translation;intracellular protein
transport
mut HECW2 2q32.3 0.188 0.151 0.689 protein modification process;protein
xsq DCXR 17q25.3 0.188 0.151 0.689 glucose metabolic process;NADP metabolic
process
xsq PET117 0.188 0.151 0.689
xsq IFNG-AS1 0.188 0.151 0.689
xsq UBA5 3q22.1 0.188 0.151 0.689 oxidation-reduction process;protein
ufmylation
exp EEF1DP3 13q13.1 0.188 0.151 0.689
xsq FCN1 9q34 0.188 0.151 0.689 opsonization;signal transduction
exp RHNO1 12p13.33 0.188 0.151 0.689
pro ATX2 0.188 0.151 0.689
exp METTL25 12q21.31 0.188 0.151 0.689
exp TRMT112 11q13.1 0.188 0.151 0.689 peptidyl-glutamine methylation
met MTHFD1L 6q25.1 0.188 0.151 0.689 one-carbon metabolic process;folic
exp MYO5BP1 9p11.2 0.188 0.151 0.69
xsq SHPK 17p13 0.188 0.151 0.69 carbohydrate metabolic process
met PI3 20q13.12 0.188 0.151 0.69 copulation;negative regulation of
xsq OTOS 2q37.3 0.188 0.151 0.69 sensory perception of sound
xsq EEF2K 16p12.2 0.188 0.151 0.69 insulin receptor signaling
exp COX4I1 16q24.1 0.187 0.151 0.69 generation of precursor metabolites
and energy;response to nutrient
xsq SRGN 10q22.1 0.187 0.151 0.69 mast cell secretory granule
cop FGF3 11q13 0.187 0.151 0.69 multicellular organismal development;thymus
development
exp LINC00999 0.187 0.151 0.69
exp ZNF425 7q36.1 -0.187 0.151 0.69 negative regulation of
exp FAM110B 8q12.1 -0.187 0.151 0.69
xsq RLN2 9p24.1 -0.187 0.151 0.69 female pregnancy
cop RPL23P8 7p21.1 -0.188 0.151 0.69
exp CEP70 3q22.3 -0.188 0.151 0.69 mitotic cell cycle;G2/M transition
xsq SAA1 11p15.1 -0.188 0.151 0.69 acute-phase response;regulation of
protein secretion
met NFYC 1p32 -0.188 0.151 0.69 regulation of transcription from RNA
exp LOC100128673 12q21.1 -0.188 0.151 0.69
xsq PPAP2A 5q11 -0.188 0.151 0.689
exp SYT16 14q23.2 -0.188 0.151 0.689
xsq POT1-AS1 -0.188 0.151 0.689
met ALMS1P 2p13.1 -0.188 0.151 0.689
mut OR7G1 -0.188 0.151 0.689
xsq FXYD1 19q13.1 -0.188 0.151 0.689 ion transport;chloride transport
xsq IRX1 5p15.3 -0.188 0.151 0.689
exp IRX1 5p15.3 -0.188 0.151 0.689
exp KLF12 13q22 -0.188 0.151 0.689 negative regulation of transcription from
promoter
exp DLSTP1 1p31 -0.188 0.151 0.689
exp CBR3 21q22.2 -0.188 0.151 0.689 phylloquinone catabolic process
exp CALCOCO1 12q13.13 -0.188 0.151 0.689 signal transduction;Wnt
exp ALDH3A2 17p11.2 -0.188 0.151 0.689 cellular aldehyde metabolic
xsq ZFYVE26 14q24.1 -0.188 0.151 0.689 double-strand break repair
via homologous recombination;cytokinesis
cop RAD21 8q24 -0.188 0.151 0.689 Apoptosis; DNA Damage Response (DDR)
exp FANK1 10q26.2 -0.188 0.151 0.689
met STAR 8p11.2 -0.188 0.151 0.688 lipid transport;steroid metabolic
process
xsq LOC101927780 -0.188 0.151 0.688
swa AARS 16q22 -0.189 0.151 0.69 hair follicle development;endoplasmic
his EXT1 8q24.11 -0.189 0.151 0.69 axon guidance;brain development
xai PTPRF 1p34 -0.189 0.151 0.69 cell adhesion;positive regulation of
neuron apoptosis
his OSTCP1 6q25.3 -0.189 0.151 0.69
DNA-dependent"
hs4 LOC101927437 -0.189 0.151 0.689
his TMPRSS3 21q22.3 -0.189 0.151 0.689 sensory perception of
sound;proteolysis
DNA-dependent"
hs4 TMEM2 9q21.13 -0.189 0.151 0.689 multicellular organismal
development
his MIR6888 -0.189 0.151 0.689
xai TMSB10 2p11.2 -0.189 0.151 0.689 actin cytoskeleton
exp QRICH2 17q25.1 -0.189 0.151 0.689
his CTSZ 20q13.32 -0.189 0.151 0.689 proteolysis;epithelial tube
swa RAB7A 3q21.3 -0.189 0.151 0.689 endosome to lysosome
xai FNDC5 1p35.1 -0.189 0.151 0.689
his HOST2 -0.189 0.151 0.689
his C10orf99 10q23.1 -0.189 0.151 0.689
exp PROSER3 -0.189 0.151 0.689
DNA-dependent"
DNA-dependent"
hs4 ELF5 11p13-p12 -0.189 0.151 0.689 Transcription Factors
xai LIF 22q12.2 -0.189 0.151 0.689 multicellular organismal
xai FLJ46906 6q24.1 -0.189 0.151 0.689
xai NCAM1 11q23.1 -0.189 0.151 0.689 interferon-gamma-mediated signaling
exp LOC388882 22q11.23 -0.189 0.151 0.689
exp MS4A18 11q12.2 -0.189 0.151 0.689
his IGF2BP2-AS1 -0.189 0.151 0.689
exp EPB41L5 2q14.2 -0.189 0.151 0.689
xai RABGAP1 9q34.11 -0.19 0.151 0.688 cell cycle;positive regulation of
GTPase activity
his LOC100507557 0.189 0.152 0.69
his EPM2A 6q24 0.189 0.152 0.69 carbohydrate metabolic process;glycogen
metabolic process
xai NDUFS6 5p15.33 0.189 0.152 0.69 transport;respiratory electron
transport chain
his DPF2 11q13 0.189 0.152 0.69 Apoptosis
swa NCBP1 9q34.1 0.189 0.152 0.691 termination of RNA polymerase II
hs4 SLC8A3 14q24.1 0.189 0.152 0.691 telencephalon
development;transmembrane transport
hs4 LOC646548 14q24.2 0.189 0.152 0.691
xai FCGR2C 0.189 0.152 0.691 immune response
cop MIR4712 0.189 0.152 0.691
his ADD2 2p13.3 0.189 0.152 0.691 actin cytoskeleton
xai PPIG 2q31.1 0.189 0.152 0.691 protein folding;RNA splicing
hs4 VRK2 2p16.1 0.189 0.152 0.691 protein phosphorylation;response to
oxidative stress
exp RFPL3S 22q12.3 0.189 0.152 0.691
xai USE1 19p13.11 0.189 0.152 0.691 ER to Golgi vesicle-mediated
exp FAM222A-AS1 12q24.11 0.189 0.152 0.691
his UBAP2L 1q21.3 0.189 0.152 0.691 binding of sperm to zona pellucida
his C1orf43 1q21.2 0.189 0.152 0.691
dependent"
his MIR6850 0.189 0.152 0.691
his RPL8 8q24.3 0.189 0.152 0.691 translational elongation;viral
transcription
exp LOC100128993 8p21.3 0.189 0.152 0.691
xai MTHFD1 14q24 0.189 0.152 0.691 water-soluble vitamin metabolic
xai PARS2 1p32.2 0.189 0.152 0.691 tRNA aminoacylation for protein
swa C12orf10 12q13 0.189 0.152 0.691 pigmentation
hs4 TTF1 9q34.13 0.189 0.152 0.691 regulation of transcription, DNA-
swa COX6B1 19q13.1 0.189 0.152 0.691 small molecule metabolic
his IRX4 5p15.3 0.189 0.152 0.691 heart development;establishment of organ
orientation
xai PRAC1 0.189 0.152 0.692
his LOC729218 4q26 0.189 0.152 0.692
xai MED4 13q14.2 0.189 0.152 0.692 transcription initiation from RNA
xai RINL 19q13.2 0.189 0.152 0.692
swa PPIL1 6p21.1 0.189 0.152 0.692 nuclear mRNA splicing, via
his DEDD2 19q13.2 0.189 0.152 0.692 regulation of apoptotic process;RNA
processing
dependent"
xai TAF6L 11q12.3 0.189 0.152 0.692 chromatin remodeling;transcription
swa RBM8A 1q21.1 0.189 0.152 0.692 RNA splicing;nuclear-transcribed mRNA
xai DLD 7q31-q32 0.189 0.152 0.692 pyruvate metabolic process;branched chain
his TRIM16 17p11.2 0.189 0.152 0.692 positive regulation of keratinocyte
differentiation;positive regulation of transcription, DNA-dependent
met HNRNPH1 5q35.3 0.187 0.152 0.69 gene expression;regulation of RNA
splicing
exp NDUFB9 8q13.3 0.187 0.152 0.69 mitochondrial electron transport,
mut ZNF148 3q21 0.187 0.152 0.69 negative regulation of transcription,
cop CUEDC1 17q23.2 0.187 0.152 0.69
cop GREB1 2p25.1 0.187 0.152 0.69
cop MIR4429 0.187 0.152 0.69
xsq LINC00367 0.187 0.152 0.69
met CHST13 3q21.3 0.187 0.152 0.69 carbohydrate biosynthetic
xsq GPRASP1 Xq22.1 0.187 0.152 0.69
xsq LOC101928751 0.187 0.152 0.69
met ZNF43 19p13.1-p12 0.187 0.152 0.69 regulation of transcription, DNA-
dependent"
xsq LOC646762 7p14.3 0.187 0.152 0.69
exp ZNF296 19q13.32 0.187 0.152 0.691 spermatogenesis;regulation of
met SLC2A2 3q26.1-q26.2 0.187 0.152 0.691 Solute Carriers
xsq SGSM1 22q11.23 0.187 0.152 0.691
exp BRD9 5p15.33 0.187 0.152 0.691
dependent"
cop NUDT13 10q22.1 0.187 0.152 0.691
cop ECD 10q22.3 0.187 0.152 0.691 regulation of transcription, DNA-
xsq TRPM6 9q21.13 0.187 0.152 0.691 ion transport;response to toxin
met IGSF3 1p13 0.187 0.152 0.691
met NXN 17p13.3 0.187 0.152 0.691 cell differentiation;multicellular
xsq SCAF8 6q25.1-q25.3 0.187 0.152 0.691 transcription from RNA polymerase
xsq QTRT1 19p13.3 0.187 0.152 0.691 tRNA modification;queuosine biosynthetic
process
xsq ZPR1 0.187 0.152 0.691 signal transduction;cell proliferation
xsq PIGR 1q31-q41 0.187 0.152 0.691
exp DIS3L2 2q37.1 0.187 0.152 0.691
met MIR448 0.187 0.152 0.691
xsq POLR2E 19p13.3 0.187 0.152 0.691 DNA Damage Response (DDR); DDR
(NER)
exp SEPHS1P1 7q11.21 0.187 0.152 0.691
cop ZNF423 16q12 0.187 0.152 0.691 cell differentiation;positive regulation
of BMP signaling pathway
xsq CWC22 2q31.3 0.187 0.152 0.691 nuclear mRNA splicing, via
mut AR Xq12 0.187 0.152 0.691 transcription, DNA-dependent;positive
exp RRP12 10q24.1 0.187 0.152 0.691
met MAP3K5 6q22.33 0.187 0.152 0.692 Apoptosis; Protein Kinases
dependent"
xsq TCFL5 20q13.33 0.187 0.152 0.692 regulation of cell
proliferation;regulation of cell differentiation
exp MANEAL 1p34.3 0.187 0.152 0.692
xsq MZT2B 2q21.1 0.187 0.152 0.692
exp GID4 17p11.2 0.187 0.152 0.692
met TMPRSS13 11q23 0.187 0.152 0.692 proteolysis
mut JMY 5q14.1 0.187 0.152 0.692 DNA repair;actin polymerization-dependent
cell motility
met SDCBP 8q12 0.187 0.152 0.692 axon guidance;actin cytoskeleton organization
exp RSL24D1P11 18q21.31 0.187 0.152 0.692
xsq PRMT9 0.187 0.152 0.692
exp GAPDHP35 16p11.2 0.187 0.152 0.692
xsq SKIDA1 10p12.31 0.187 0.152 0.692
xsq CNN1 19p13.2-p13.1 -0.187 0.152 0.692 regulation of smooth muscle
exp KRT8P19 12q14.1 -0.187 0.152 0.692
xsq EPS8L1 19q13.42 -0.187 0.152 0.692
exp LOC138159 9q34.3 -0.187 0.152 0.692
exp C19orf12 19q12 -0.187 0.152 0.691 cell death
cop BRINP2 -0.187 0.152 0.691 nervous system development;negative
exp BHLHE41 12p12.1 -0.187 0.152 0.691 cell differentiation;negative
xsq PLXNA1 3q21.3 -0.187 0.152 0.691 signal
mut INSRR 1q21-q23 -0.187 0.152 0.691 protein
autophosphorylation;cellular response to alkalinity
xsq HERPUD2 7p14.2 -0.187 0.152 0.691 response to unfolded
exp NPIPB15 16q23.1 -0.187 0.152 0.691
mut EXOC3L1 16q22.1 -0.187 0.152 0.691 exocytosis;peptide hormone
secretion
cop PER4 -0.187 0.152 0.691
cop MIR378D2 -0.187 0.152 0.691
cop PDP1 8q22.1 -0.187 0.152 0.691 pyruvate metabolic
exp PSKH2 8q21.3 -0.187 0.152 0.691
met BPI 20q11.23 -0.187 0.152 0.691
cop MIR488 -0.187 0.152 0.691
exp LFNG 7p22.2 -0.187 0.152 0.69 ovarian follicle development;female
meiosis
exp GLIPR2 9p13.3 -0.187 0.152 0.69
mut SAFB 19p13.3-p13.2 -0.187 0.152 0.69 regulation of transcription,
xsq ALPK1 4q25 -0.187 0.152 0.69 protein phosphorylation
exp C7orf50 7p22.3 -0.187 0.152 0.69
swa LCK 1p34.3 -0.189 0.152 0.692 Protein Kinases
hs4 TCF7L2 10q25.3 -0.189 0.152 0.692 regulation of transcription
from RNA polymerase II promoter;neurogenesis
hs4 MB21D2 3q29 -0.189 0.152 0.692
hs4 KDM7A -0.189 0.152 0.692 chromatin modification;midbrain
development
hs4 JHDM1D-AS1 -0.189 0.152 0.692
his LOXL2 8p21.3 -0.189 0.152 0.692 protein modification process;cell
adhesion
DNA-dependent"
xai INSIG2 2q14.2 -0.189 0.152 0.691 response to insulin
stimulus;inner ear morphogenesis
xai CYP4V2 4q35.2 -0.189 0.152 0.691 fatty acid omega-
hs4 AIM1L 1p36.11 -0.189 0.152 0.691
xai PEX11A 15q26.1 -0.189 0.152 0.691 peroxisome
swa UQCRC2 16p12 -0.189 0.152 0.691 oxidative
xai AMDHD2 16p13.3 -0.189 0.152 0.691 carbohydrate metabolic
his SYNE1-AS1 -0.189 0.152 0.691
his OR13C2 9q31.1 -0.189 0.152 0.691 response to stimulus
hs4 GRM4 6p21.3 -0.189 0.152 0.691 activation of MAPK activity;G-
xai AFF3 2q11.2-q12 -0.189 0.152 0.691 embryonic hindlimb
swa MCAM 11q23.3 -0.189 0.152 0.691 vascular wound healing;glomerular
filtration
xai ABCB9 12q24 -0.189 0.152 0.691 ABC Transporters
his PPP1R9A 7q21.3 -0.189 0.152 0.691 multicellular organismal
his PDE7B 6q23-q24 -0.189 0.152 0.69 signal transduction;synaptic
transmission
xai COL22A1 8q24.3 -0.189 0.152 0.69 cell adhesion
his LINC00525 -0.189 0.152 0.69
his MGAT4EP -0.189 0.152 0.69
his LINC01127 -0.189 0.152 0.69
his IL1R2 2q12 -0.189 0.152 0.69 immune response
hs4 CPA4 7q32 -0.189 0.152 0.69 proteolysis;histone acetylation
his ZNF697 1p12 -0.189 0.152 0.69 regulation of transcription, DNA-
dependent"
hs4 MLKL 16q23.1 0.189 0.153 0.692
his CHCHD2 7p11.2 0.189 0.153 0.692
his NUPR2 0.189 0.153 0.692
dependent"
exp SCAF8 6q25.1-q25.3 0.189 0.153 0.692 transcription from RNA polymerase
xai ZFP90 16q22.1 0.189 0.153 0.692 negative regulation of DNA
his DDHD1 14q21 0.189 0.153 0.692 lipid catabolic process
his LOC101927620 0.189 0.153 0.692
swa SMC2 9q31.1 0.189 0.153 0.692 DNA Damage Response (DDR); DDR (DNA
replication)
his GMEB2 20q13.33 0.189 0.153 0.692 regulation of transcription, DNA-
his LOC100505771 0.189 0.153 0.692
his PDIA5 3q21.1 0.189 0.153 0.692
xai FAM90A27P 19q13.42 0.189 0.153 0.692
his MIR4317 0.189 0.153 0.692
hs4 LINC01572 0.188 0.153 0.692
his CXCL9 4q21 0.188 0.153 0.692 immune response;cellular defense response
xai DIS3L2 2q37.1 0.188 0.153 0.692
xai BAZ1B 7q11.23 0.188 0.153 0.692 DNA Damage Response (DDR)
his C2CD5 12p12.1 0.188 0.153 0.692
his THRA1/BTR 0.188 0.153 0.692
exp C17orf50 17q12 0.188 0.153 0.692
exp FAM90A27P 19q13.42 0.188 0.153 0.692
his FUT9 6q16 0.188 0.153 0.692 fucosylation;L-fucose catabolic process
xai TATDN1P1 10q21.3 0.188 0.153 0.692
hs4 LINC00690 0.188 0.153 0.692
hs4 SS18 18q11.2 0.188 0.153 0.693 intracellular protein kinase
exp DAOA 13q33.2 0.188 0.153 0.693
cop HSP90AB4P 0.188 0.153 0.693 response to stress;protein folding
xai RAC2 22q13.1 0.188 0.153 0.693 GTP catabolic process;actin cytoskeleton
organization
his RWDD1 6q13-q22.33 0.188 0.153 0.693
his QDPR 4p15.31 0.188 0.153 0.693 response to lead ion;response to glucagon
stimulus
his CLRN2 4p15.32 0.188 0.153 0.693
xai EEF1A1P32 1q31.3 0.188 0.153 0.693
hs4 UBALD2 17q25.1 0.188 0.153 0.693
his CALM2 2p21 0.188 0.153 0.693
exp IL3RA 0.188 0.153 0.693 cellular response to interleukin-3
his C20orf96 20p13 0.188 0.153 0.693
his VTRNA1-3 5q31.3 0.188 0.153 0.693
hs4 DAPP1 4q25-q27 0.188 0.153 0.693 protein dephosphorylation;signal
transduction
hs4 KREMEN2 16p13.3 0.188 0.153 0.693 Wnt receptor signaling pathway
hs4 GUCY2C 12p12 0.188 0.153 0.693 regulation of cell proliferation;cGMP
his MIR548AA2 0.188 0.153 0.693
his MIR548D2 0.188 0.153 0.693
xai COQ5 12q24.31 0.188 0.153 0.693 ubiquinone biosynthetic process
xai SPCS2 11q13.4 0.188 0.153 0.693 signal peptide processing;proteolysis
his FFAR3 0.188 0.153 0.693
xai LILRB4 19q13.4 0.188 0.153 0.693 signal transduction;negative
exp SUMO2P1 6p22.1 0.187 0.153 0.692
xsq CIB1 15q25.3-q26 0.187 0.153 0.692 Apoptosis; DNA Damage Response (DDR)
met FEZF1 7q31.32 0.187 0.153 0.692 olfactory bulb development;negative
xsq LOC101927310 0.187 0.153 0.692
cop ADRA1D 20p13 0.187 0.153 0.692 multicellular organismal development;cell
proliferation
cop P4HA1 10q21.3-q23.1 0.187 0.153 0.692 peptidyl-proline hydroxylation to
exp KIAA0895L 16q22.1 0.187 0.153 0.692
exp TMEM18 2p25.3 0.187 0.153 0.692 transcription, DNA-dependent;cell
migration"
xsq EXOSC1 10q24 0.187 0.153 0.692 mRNA metabolic process;exonucleolytic
decay
exp RAE1 20q13.31 0.187 0.153 0.692 mRNA export from nucleus;cellular
exp C3orf38 3p11.1 0.187 0.153 0.692 apoptotic process
xsq IQCH-AS1 0.187 0.153 0.692
met GXYLT1 12q12 0.187 0.153 0.692 O-glycan processing
exp B3GNTL1 17q25.3 0.187 0.153 0.692
exp MTFR2 6q23.3 0.187 0.153 0.692
exp MAN1A1 6q22 0.187 0.153 0.692 post-translational protein
met KLHL2 4q21.2 0.187 0.153 0.692 intracellular protein transport
exp KRAS 12p12.1 0.187 0.153 0.692 Cell Signaling; Oncogenes; Protein
Kinases
xsq HMG20A 15q24 0.187 0.153 0.692 chromatin organization;regulation of
xsq DIEXF 1q32.2 0.187 0.153 0.692 multicellular organismal development
xsq EXOG 3p21.3 0.187 0.153 0.692 DNA Damage Response (DDR)
xsq PADI6 1p36.13 0.187 0.153 0.692 peptidyl-citrulline biosynthetic process
from peptidyl-arginine;protein modification process
xsq GAS6-AS1 0.187 0.153 0.692
xsq SMU1 9p12 0.187 0.153 0.692
met DMAP1 1p34 0.187 0.153 0.692 negative regulation of transcription from RNA
polymerase II promoter;DNA methylation
cop LINC00658 0.187 0.153 0.692
xsq NCAPG2 7q36.3 0.187 0.153 0.693 DNA Damage Response (DDR)
met PLCD4 2q35 0.187 0.153 0.693 acrosome reaction;lipid catabolic process
cop MIR3935 0.187 0.153 0.693
xsq ZSWIM8-AS1 0.187 0.153 0.693
cop MAPRE2 18q12.1 0.187 0.153 0.693 cell cycle;mitosis
xsq KIAA1958 9q32 0.187 0.153 0.693
exp ZNF473 19q13.33 0.187 0.153 0.693 mRNA processing;histone mRNA 3'-end
processing
cop UBXN2A 2p23.3 0.187 0.153 0.693 regulation of protein
ubiquitination;regulation of protein catabolic process
cop MFSD2B 2p23.3 0.187 0.153 0.693 transport
cop C2orf44 2p23.3 0.187 0.153 0.693
cop FKBP1B 2p23.3 0.187 0.153 0.693 regulation of cardiac muscle
refolding
cop SF3B14 0.187 0.153 0.693
cop FAM228B 2p23.3 0.187 0.153 0.693
cop TP53I3 2p23.3 0.187 0.153 0.693 induction of apoptosis by oxidative
stress;NADP metabolic process
cop PFN4 2p23.3 0.187 0.153 0.693 actin cytoskeleton organization
cop FAM228A 2p23.3 0.187 0.153 0.693
xsq ZNF346 5q35.2 0.187 0.153 0.693 apoptotic process
met DSCR4 21q22.2 0.187 0.153 0.693
exp CCDC184 0.187 0.153 0.693
met CTSO 4q32.1 0.187 0.153 0.693 proteolysis
met SMAP1 6q13 0.187 0.153 0.693 regulation of ARF GTPase activity;positive
regulation of erythrocyte differentiation
cop LINC00654 20p12.3 0.187 0.153 0.693
xsq ETFDH 4q32-q35 0.187 0.153 0.693 transport;response to oxidative stress
met IMPG2 3q12.2-q12.3 0.187 0.153 0.693 visual perception
xsq SLC22A8 11q11 0.187 0.153 0.693 response to toxin;organic anion transport
xsq TNFRSF1B 1p36.22 0.187 0.153 0.693 Apoptosis
met NONO Xq13.1 0.187 0.153 0.693 DNA repair;DNA recombination
exp SUCLG1 2p11.2 0.187 0.153 0.693 tricarboxylic acid cycle;succinyl-
xsq FCN3 1p36.11 0.187 0.153 0.693 complement activation, lectin
pathway;signal transduction"
xsq LAMTOR4 7q22.1 0.187 0.153 0.693
cop PALD1 10q22.1 0.187 0.153 0.693
cop PRF1 10q22 0.187 0.153 0.693 defense response to tumor cell;defense response
to virus
xsq CENPQ 6p12.3 0.187 0.153 0.693 M phase of mitotic cell cycle;mitotic
prometaphase
exp THADA 2p21 0.187 0.153 0.693
xsq TPX2 20q11.2 0.187 0.153 0.693 regulation of mitotic spindle
met RNASE11 14q11.2 0.187 0.153 0.693
dependent"
dependent"
xsq SSU72 1p36.33 0.187 0.153 0.693 mRNA processing
cop ADAD2 16q24.1 0.187 0.153 0.693 RNA processing
cop KCNG4 16q24.1 0.187 0.153 0.693 potassium ion transport;synaptic
transmission
met CCNF 16p13.3 -0.187 0.153 0.693 placenta development;cell cycle
met MIR628 -0.187 0.153 0.693
exp FAM212B 1p13.2 -0.187 0.153 0.693
met CLDND2 19q13.41 -0.187 0.153 0.693
exp LOC100507261 -0.187 0.153 0.693
exp TFG 3q12.2 -0.187 0.153 0.693 signal transduction;positive
xsq ELFN2 22q13.1 -0.187 0.153 0.693 negative regulation of phosphatase
activity
exp MMP2 16q13-q21 -0.187 0.153 0.693 Apoptosis
cop IKZF1 7p12.2 -0.187 0.153 0.693 mesoderm development;positive
exp CYB561 17q23.3 -0.187 0.153 0.693 generation of precursor
cop RP9 7p14.3 -0.187 0.153 0.693 RNA splicing
xsq CTNNB1 3p21 -0.187 0.153 0.693 Apoptosis; Cell Signaling;
Oncogenes
exp RRAGC 1p34 -0.187 0.153 0.693 Apoptosis
mut PPP4R1 18p11.22 -0.187 0.153 0.693 DNA Damage Response (DDR);
DDR (HR)
exp TMED2 12q24.31 -0.187 0.153 0.693 embryonic placenta
exp INSIG2 2q14.2 -0.187 0.153 0.693 response to insulin
stimulus;inner ear morphogenesis
met CCDC94 19p13.3 -0.187 0.153 0.693
met OGFR 20q13.3 -0.187 0.153 0.693 opioid receptor signaling
pathway;regulation of cell growth
exp RRAD 16q22 -0.187 0.153 0.692 GTP catabolic process;signal transduction
exp KRT23 17q21.2 -0.187 0.153 0.692
xsq ANKRD9 14q32.31 -0.187 0.153 0.692
cop PTGS2 1q25.2-q25.3 -0.187 0.153 0.692 prostaglandin metabolic
xsq PACSIN3 11p12-p11.12 -0.187 0.153 0.692 negative regulation of
cop UTP23 8q24.11 -0.187 0.153 0.692 rRNA processing
xsq BLACAT1 -0.187 0.153 0.692
cop NT5C3A 7p14.3 -0.187 0.153 0.692
cop ASTN2 9q33.1 -0.187 0.153 0.692
xsq ZCCHC24 10q22.3 -0.187 0.153 0.692
cop BLVRA 7p13 -0.187 0.153 0.692 porphyrin-containing compound metabolic
exp FAM19A3 1p13.2 -0.187 0.153 0.692
cop PPP2R3A 3q22.1 -0.187 0.153 0.692 protein dephosphorylation
exp MRPS24 7p14 -0.187 0.153 0.692 translation
cop MRPS22 3q23 -0.187 0.153 0.692
cop COPB2 3q23 -0.187 0.153 0.692 COPI coating of Golgi
cop RBP2 3q23 -0.187 0.153 0.692 retinoid metabolic process;vitamin A
metabolic process
cop RBP1 3q23 -0.187 0.153 0.692 response to vitamin A;retinol metabolic
process
exp ZNF319 16q21 -0.187 0.153 0.692 regulation of transcription, DNA-
dependent"
exp PDXK 21q22.3 -0.187 0.153 0.692 small molecule metabolic
cop RAD21-AS1 -0.187 0.153 0.692
his LITAF 16p13.13 -0.188 0.153 0.693 Apoptosis
hs4 NHSL1 6q23.3 -0.188 0.153 0.693
hs4 PLEKHF2 8q22.1 -0.188 0.153 0.693
xai CTSV 9q22.2 -0.188 0.153 0.693
his HTR3D 3q27.1 -0.188 0.153 0.693 ion transmembrane
xai LZTR1 22q11.21 -0.188 0.153 0.693 regulation of transcription, DNA-
xai TMEM132A 11q12.2 -0.188 0.153 0.693
swa BID 22q11.1 -0.188 0.153 0.693 Apoptosis
exp PCDHGC3 -0.188 0.153 0.693 cell adhesion;homophilic cell
adhesion
xai VPS9D1 16q24 -0.188 0.153 0.693
xai RPS7P3 1q42.2 -0.188 0.153 0.692
his NOV 8q24.1 -0.188 0.153 0.692 regulation of cell growth
his ZNF488 10q11.22 -0.188 0.153 0.692 oligodendrocyte
his NCEH1 3q26.31 -0.188 0.153 0.692 lipid catabolic process;metabolic
process
hs4 SSH3 11q13.2 -0.188 0.153 0.692 protein
hs4 FBXO2 1p36.22 -0.188 0.153 0.692 glycoprotein catabolic
hs4 FBXO44 1p36.22 -0.188 0.153 0.692 protein catabolic process
exp RPS7P3 1q42.2 -0.188 0.153 0.692
his LINC01563 -0.189 0.153 0.692
hs4 SIRPG-AS1 -0.189 0.153 0.692
his NLRP10 11p15.4 -0.189 0.153 0.692
his EIF3F 11p15.4 -0.189 0.153 0.692 translation;translational
initiation
hs4 CCNYL2 10q11.21 -0.189 0.153 0.692 regulation of cyclin-
hs4 LINC00839 10q11.21 -0.189 0.153 0.692
xai P2RY6 11q13.5 -0.189 0.153 0.692 activation of phospholipase C
second messenger
xai PGA3 0.188 0.154 0.693
exp OR2B8P 6p21.3 0.188 0.154 0.693 response to stimulus
xai MTCP1 Xq28 0.188 0.154 0.693 cell proliferation
xai IKBKAP 9q31 0.188 0.154 0.693 protein complex assembly;protein
phosphorylation
swa EIF2AK2 2p22-p21 0.188 0.154 0.693 Apoptosis
his PQLC1 18q23 0.188 0.154 0.693
hs4 HAR1A 20q13.33 0.188 0.154 0.693
hs4 HAR1B 20q13.33 0.188 0.154 0.693
his CSDE1 1p22 0.188 0.154 0.693 regulation of transcription, DNA-dependent;male
gonad development"
his GDE1 16p12-p11.2 0.188 0.154 0.693 glycerol metabolic process;lipid
metabolic process
his CCP110 16p12.3 0.188 0.154 0.693 G2/M transition of mitotic cell
hs4 PCSK4 19p13.3 0.188 0.154 0.693 fertilization;sperm capacitation
hs4 REEP6 19p13.3 0.188 0.154 0.693
his KIAA1551 12p11.21 0.188 0.154 0.693
his DBH-AS1 0.188 0.154 0.693
hs4 DHRS13 17q11.2 0.188 0.154 0.693
xai HMGN2P17 1p36.23 0.188 0.154 0.693
his CREBL2 12p13 0.188 0.154 0.693 positive regulation of transcription,
xai SMAD1 4q31 0.188 0.154 0.693 ureteric bud development;transforming growth
xai TCL6 14q32.1 0.188 0.154 0.693
xai PPIL1 6p21.1 0.188 0.154 0.693 nuclear mRNA splicing, via
his LINC00399 0.188 0.154 0.693
his RNF126P1 17q22 0.188 0.154 0.693
hs4 SLCO4C1 5q21.2 0.188 0.154 0.693 Solute Carriers
his CHRM3-AS2 0.188 0.154 0.693
his IL5RA 3p26-p24 0.188 0.154 0.693 signal transduction;cell proliferation
his ARPC4 3p25.3 0.188 0.154 0.693 actin filament polymerization;actin
nucleation
his ARPC4-TTLL3 0.188 0.154 0.693
his TADA3 3p25.3 0.188 0.154 0.693 DNA Damage Response (DDR)
xai EIF4A1P8 10q23.32 0.188 0.154 0.693
hs4 ITGA4 2q31.3 0.188 0.154 0.693 B cell differentiation;blood vessel
remodeling
hs4 RPUSD1 16p13.3 0.188 0.154 0.693 pseudouridine synthesis
hs4 CHTF18 16p13.3 0.188 0.154 0.693 DDR (DNA replication)
his C9orf139 9q34.3 0.188 0.154 0.693
his ABCA2 9q34 0.188 0.154 0.693 ABC Transporters
his FUT7 9q34.3 0.188 0.154 0.693 leukocyte migration involved in immune
response;protein glycosylation
hs4 YY1 14q 0.188 0.154 0.693 DNA recombination;cellular response to UV
exp NFYC-AS1 0.188 0.154 0.693
his CHID1 11p15.5 0.188 0.154 0.693 innate immune response;carbohydrate
metabolic process
xai ZNF725P 19p12 0.188 0.154 0.693 regulation of transcription, DNA-
dependent"
his MAN2C1 15q24.2 0.188 0.154 0.693 mannose metabolic
his CNNM1 10q24.2 0.188 0.154 0.693 ion transport
exp ISCA1P2 1q42.13 0.188 0.154 0.693
exp SNAP47 1q42.13 0.188 0.154 0.693
his RAB11A 15q22.31 0.188 0.154 0.694 neuron projection
development;plasma membrane to endosome transport
hs4 HIST1H2BL 6p22.1 0.188 0.154 0.694 nucleosome assembly
hs4 HIST1H2AI 6p22.1 0.188 0.154 0.694
hs4 HIST1H3H 6p22.1 0.188 0.154 0.694
hs4 HIST1H2AJ 6p22.1 0.188 0.154 0.694
hs4 HIST1H2BM 6p22.1 0.188 0.154 0.694 nucleosome assembly
xai LOC100130156 20q13.31 0.188 0.154 0.694
exp MRPS33P3 0.188 0.154 0.694
exp LOC100130156 20q13.31 0.188 0.154 0.694
hs4 PFN1 17p13.3 0.188 0.154 0.694 neural tube closure;positive regulation
hs4 ENO3 17p13.2 0.188 0.154 0.694 response to drug;skeletal muscle tissue
regeneration
his FAM222A 12q24.11 0.188 0.154 0.694
exp VN1R110P 0.188 0.154 0.694
xai VN1R110P 0.188 0.154 0.694
his CHST11 12q 0.188 0.154 0.694 chondroitin sulfate biosynthetic
process;embryonic viscerocranium morphogenesis
exp UBA52P6 0.188 0.154 0.694
his NT5DC2 3p21.1 0.188 0.154 0.694
his SMIM4 3p21.1 0.188 0.154 0.694
xai KARSP2 0.188 0.154 0.694
xai FANCC 9q22.3 0.188 0.154 0.694 DNA Damage Response (DDR); DDR (FA)
his ANO8 19p13.11 0.188 0.154 0.694 ion transport
his GTPBP3 19p13.11 0.188 0.154 0.694 tRNA modification
his PRPF8 17p13.3 0.188 0.154 0.694 mRNA processing;RNA splicing
his CRNKL1 20p11.2 0.188 0.154 0.694 RNA splicing;spliceosome assembly
his CFAP61 0.188 0.154 0.694
xai UBQLN4 1q21 0.188 0.154 0.694 regulation of proteasomal ubiquitin-
xai JADE3 0.188 0.154 0.694 histone H3 acetylation;histone H4-K5
acetylation
his PKMYT1 16p13.3 0.188 0.154 0.694 regulation of mitosis;negative
xai MRPS33P3 0.188 0.154 0.694
his NEIL3 4q34.3 0.188 0.154 0.694 DNA Damage Response (DDR); DDR (BER)
his EEF1G 11q12.3 0.188 0.154 0.694 translation;translational elongation
xsq OR52L1 11p15.4 0.187 0.154 0.693 response to stimulus
exp UHRF1BP1L 12q23.1 0.187 0.154 0.693
cop FLJ44313 18q23 0.187 0.154 0.693
xsq TMEM247 2p21 0.187 0.154 0.693
cop GABPB1 15q21.2 0.187 0.154 0.693 positive regulation of
exp ZBTB25 14q23-q24 0.187 0.154 0.693 regulation of transcription, DNA-
exp TMEM61 1p32.3 0.187 0.154 0.693
xsq SERPINA7 Xq22.2 0.187 0.154 0.693 response to drug;aging
xsq LINC01018 0.187 0.154 0.693
xsq MPPE1 18p11.21 0.187 0.154 0.693 GPI anchor biosynthetic process;ER to
met PMP2 8q21.3-q22.1 0.187 0.154 0.693
exp KNOP1 16p12.3 0.187 0.154 0.693
xsq SMC3 10q25 0.186 0.154 0.693 DNA Damage Response (DDR); DDR (DNA
replication)
exp HIST1H3D 6p22.1 0.186 0.154 0.693
exp INTS9 8p21.1 0.186 0.154 0.693 snRNA processing
exp BCO2 11q23.1 0.186 0.154 0.693 carotene metabolic process;retinoic acid
metabolic process
xsq TMED6 16q22.1 0.186 0.154 0.693 transport
met C5orf22 5p13.3 0.186 0.154 0.693
xsq CKS2 9q22 0.186 0.154 0.693 cell division;regulation of cyclin-dependent
xsq LECT2 5q31.1 0.186 0.154 0.693 skeletal system development;chemotaxis
met PKHD1 6p12.2 0.186 0.154 0.693 cilium assembly;homeostatic process
xsq SRRT 7q21 0.186 0.154 0.693 gene silencing by RNA;primary miRNA processing
exp GHRL 3p26-p25 0.186 0.154 0.693 negative regulation of endothelial cell
xsq CATSPER3 5q31.1 0.186 0.154 0.693 ion transport;multicellular
xsq MOXD2P 7q34 0.186 0.154 0.693 catecholamine metabolic process
mut SON 21q22.11 0.186 0.154 0.693 Apoptosis
xsq NEUROD2 17q12 0.186 0.154 0.693 protein ubiquitination;cellular response
to electrical stimulus
exp PIK3R6 17p13.1 0.186 0.154 0.693 blood coagulation;platelet
activation
exp APOOL Xq21.1 0.186 0.154 0.693
xsq HSPBP1 19q13.42 0.186 0.154 0.693 protein folding;positive regulation
of protein ubiquitination
met MAPK7 17p11.2 0.186 0.154 0.693 Protein Kinases
met C3orf20 3p25.1 0.186 0.154 0.693
met MSRB2 10p12 0.186 0.154 0.693 regulation of transcription, DNA-
dependent;protein repair"
exp PPIAP1 21q21.1 0.186 0.154 0.693
xsq PPP4C 16p11.2 0.186 0.154 0.693 DNA Damage Response (DDR); DDR (HR)
exp SNX1 15q22.31 0.186 0.154 0.693 cell communication;early endosome to
Golgi transport
cop PCBD1 10q22 0.186 0.154 0.693 tetrahydrobiopterin biosynthetic
mut DEPDC7 11p13 0.186 0.154 0.693 small GTPase mediated signal
met HFE 6p21.3 0.186 0.154 0.693 female pregnancy;antigen processing and
xsq LOC100507506 0.186 0.154 0.693
exp LOC646938 15q25.1 0.186 0.154 0.693
cop MRPS23 17q22-q23 0.186 0.154 0.693 translation
dependent"
xsq SFT2D1 6q27 0.186 0.154 0.694 protein transport;vesicle-mediated
transport
cop HEATR3 16q12.1 0.186 0.154 0.694
mir hsa-miR-33b* 0.186 0.154 0.694
xsq DDX46 5q31.1 0.186 0.154 0.694 RNA splicing;mRNA processing
met PPIP5K1 15q15.3 0.186 0.154 0.694 inositol metabolic process
xsq C17orf102 17q12 0.186 0.154 0.694
exp DENND6A 3p14.3 0.186 0.154 0.694
xsq HK3 5q35.2 0.186 0.154 0.694 small molecule metabolic
xsq RHNO1 12p13.33 0.186 0.154 0.694
cop UST 6q25.1 0.186 0.154 0.694 protein sulfation
cop RNF111 15q21 0.186 0.154 0.694 multicellular organismal
met TMEM196 7p21.1 0.186 0.154 0.694
xsq PGS1 17q25.3 0.186 0.154 0.694 phosphatidylglycerol biosynthetic
met TRIM50 7q11.23 0.186 0.154 0.694
xsq TOMM40 19q13 0.186 0.154 0.694 protein targeting to
exp GLDC 9p22 -0.186 0.154 0.694 cellular amino acid metabolic
exp LOC401320 -0.186 0.154 0.694
exp BGN Xq28 -0.186 0.154 0.694 blood vessel remodeling;peptide cross-
xsq ZBTB7C 18q21.1 -0.186 0.154 0.694
exp SMIM10L2B -0.186 0.154 0.694
exp SYCP2 20q13.33 -0.186 0.154 0.694 cell cycle;meiosis
exp MMP24-AS1 -0.186 0.154 0.694
exp FAM3C2 Xp22.11 -0.186 0.154 0.694
exp TMEM169 2q35 -0.186 0.154 0.694
xsq HIP1 7q11.23 -0.186 0.154 0.693 Apoptosis
exp NHSL1 6q23.3 -0.186 0.154 0.693
exp CAP1P1 3p12.3 -0.186 0.154 0.693
met CRYBB3 22q11.23 -0.186 0.154 0.693 visual perception
xsq S100A11 1q21 -0.186 0.154 0.693 signal transduction;negative
met CD3G 11q23 -0.186 0.154 0.693 protein transport;T cell costimulation
met C2orf57 2q37.1 -0.186 0.154 0.693
mut FZD1 7q21 -0.186 0.154 0.693 Oncogenes
exp RPS24P3 14q31.1 -0.186 0.154 0.693
xsq PHLDA2 11p15.4 -0.186 0.154 0.693 apoptotic process;organ
morphogenesis
cop PDZD2 5p13.3 -0.186 0.154 0.693 cell adhesion
mut SETBP1 18q21.1 -0.186 0.154 0.693
xsq SYT15 10q11.1 -0.186 0.154 0.693
xsq CMTM5 14q11.2 -0.186 0.154 0.693 chemotaxis
met MYOZ1 10q22.1 -0.186 0.154 0.693 myofibril assembly
met SLC22A14 3p21.3 -0.186 0.154 0.693 organic cation transport
xai SRPX Xp21.1 -0.188 0.154 0.694 cell adhesion
hs4 GLDC 9p22 -0.188 0.154 0.694 cellular amino acid metabolic
hs4 KLF9 9q13 -0.188 0.154 0.694 regulation of transcription from RNA
xai LINC01105 -0.188 0.154 0.694
hs4 PKP3 11p15 -0.188 0.154 0.694 cell adhesion
xai SVIL 10p11.2 -0.188 0.154 0.694 cytoskeleton organization;skeletal
hs4 KIF3B 20q11.21 -0.188 0.154 0.694 microtubule-based movement;mitotic
xai PAQR5 15q23 -0.188 0.154 0.694 multicellular organismal development;cell
differentiation
hs4 CAPG 2p11.2 -0.188 0.154 0.694 protein complex assembly;cell
projection assembly
his MIR2117 -0.188 0.154 0.694
xai C19orf12 19q12 -0.188 0.154 0.693 cell death
hs4 FAM221A 7p15.3 -0.188 0.154 0.693
xai VLDLR-AS1 -0.188 0.154 0.693
swa MPZ 1q23.3 -0.188 0.154 0.693 synaptic transmission
his BGLAP 1q22 -0.188 0.154 0.693 cell aging;response to nutrient levels
xai IFT20 17q11.2 -0.188 0.154 0.693 cell projection organization
hs4 GREM2 1q43 -0.188 0.154 0.693 BMP signaling pathway
xai WFDC8 20q13.12 -0.188 0.154 0.693
xai FMO10P 1q24.1 -0.188 0.154 0.693
hs4 SERINC2 1p35.1 -0.188 0.154 0.693
hs4 GNAI1 7q21 -0.188 0.154 0.693 inhibition of adenylate cyclase activity
by G-protein signaling pathway;synaptic transmission
xai LOC100129846 -0.188 0.154 0.693
xai ASCC2 22q12.1 -0.188 0.154 0.693 regulation of transcription, DNA-
dependent"
hs4 ITGA10 1q21 -0.188 0.154 0.693 cell adhesion;cell-matrix adhesion
exp LOC100129846 -0.188 0.154 0.693
hs4 PARK2 6q25.2-q27 -0.188 0.154 0.693 mitochondrion degradation;adult
locomotory behavior
hs4 PACRG 6q26 -0.188 0.154 0.693
his LOC101929259 -0.188 0.154 0.693
his PREX2 8q13.2 -0.188 0.154 0.693 G-protein coupled receptor
xai DCAF5 14q23-q24.1 -0.188 0.154 0.693 protein ubiquitination
hs4 LEKR1 3q25.31 -0.188 0.154 0.693
xai SRRM3 7q11.23 -0.188 0.154 0.693
his MPI 15q24.1 0.188 0.155 0.694 carbohydrate metabolic process;dolichol-
xai ENTHD2 17q25.3 0.188 0.155 0.694
exp LOC100506634 0.188 0.155 0.694
hs4 POU4F1 13q31.1 0.188 0.155 0.694 synapse assembly;positive
dependent"
hs4 PAPOLA 14q32.31 0.188 0.155 0.694 RNA splicing;gene expression
hs4 LOC730202 14q32.2 0.188 0.155 0.694
xai CR2 1q32 0.188 0.155 0.695 complement receptor mediated signaling
xai RPL37P15 6q12-q13 0.188 0.155 0.695
his DRG1 22q12.2 0.188 0.155 0.695 transcription, DNA-
hs4 RPL34-AS1 4q25 0.188 0.155 0.695
hs4 RPL34 4q25 0.188 0.155 0.695 nuclear-transcribed mRNA catabolic process,
xai TNNT3 11p15.5 0.188 0.155 0.695 skeletal muscle contraction;regulation of
xai ELL 19p13.1 0.188 0.155 0.695 negative regulation of phosphatase
his ZNF423 16q12 0.188 0.155 0.695 cell differentiation;positive regulation
hs4 MPO 17q23.1 0.188 0.155 0.695 defense response;hydrogen peroxide
catabolic process
xai C17orf50 17q12 0.188 0.155 0.695
xai SUV39H1 Xp11.23 0.188 0.155 0.695 peptidyl-lysine
xai HP1BP3 1p36.12 0.188 0.155 0.695 nucleosome assembly
his LOC644794 7q11.21 0.188 0.155 0.695
his PHKA2 Xp22.2-p22.1 0.188 0.155 0.695 generation of precursor metabolites
hs4 OLIG1 21q22.11 0.188 0.155 0.695 multicellular organismal
xai UBA52P6 0.188 0.155 0.695
hs4 SH2B2 7q22 0.188 0.155 0.695 signal transduction;blood coagulation
his KLRK1 12p13.2-p12.3 0.188 0.155 0.695
swa RHOG 11p15.5-p15.4 0.188 0.155 0.695 small GTPase mediated signal
exp RPL37P15 6q12-q13 0.188 0.155 0.695
swa AP3S1 5q22 0.187 0.155 0.695 transport;intracellular protein transport
hs4 DICER1 14q32.13 0.187 0.155 0.695 Oncogenes
hs4 DICER1-AS1 14q32.13 0.187 0.155 0.695
his MIR3621 0.187 0.155 0.695
his LRRC26 9q34.3 0.187 0.155 0.695 ion transport
his TMEM210 0.187 0.155 0.695
xai DDX41 5q35.3 0.187 0.155 0.695 Apoptosis
xai GID8 20q13.33 0.187 0.155 0.695
his HLTF-AS1 0.187 0.155 0.695
his HLTF 3q25.1-q26.1 0.187 0.155 0.695 DNA Damage Response (DDR); DDR
(TLS)
his SYNJ1 21q22.2 0.187 0.155 0.695 synaptic vesicle uncoating;response to
retinoic acid
his PAXBP1-AS1 0.187 0.155 0.695
xai CHCHD1 10q22.2 0.187 0.155 0.695
hs4 DNAJC9 10q22.2 0.187 0.155 0.695 protein folding;social behavior
his BBS10 12q21.2 0.187 0.155 0.695 retina homeostasis;nonmotile primary
cilium assembly
xai LOC100287221 16q24.2 0.187 0.155 0.695
hs4 BTBD2 19p13.3 0.187 0.155 0.695
swa EMG1 12p13.3 0.187 0.155 0.696 rRNA processing;ribosomal small subunit
biogenesis
xsq HDAC3 5q31 0.186 0.155 0.694 Apoptosis
met FAM71B 5q33.3 0.186 0.155 0.694
xsq PRPSAP1 17q24-q25 0.186 0.155 0.694 nucleobase-containing compound
metabolic process;nucleotide biosynthetic process
xsq HDHD1 Xp22.32 0.186 0.155 0.694
xsq ARGLU1 13q33.3 0.186 0.155 0.694 regulation of transcription, DNA-
dependent"
cop LPO 17q23.1 0.186 0.155 0.694 hydrogen peroxide catabolic
met ARID5A 2q11.2 0.186 0.155 0.694 negative regulation of
xsq GHET1 0.186 0.155 0.694
dependent"
xsq IREB2 15q25.1 0.186 0.155 0.695 protoporphyrinogen IX biosynthetic
process;intestinal absorption
met ST18 8q11.23 0.186 0.155 0.695 negative regulation of transcription from
cop KDSR 18q21.3 0.186 0.155 0.695 sphingolipid metabolic process;3-keto-
sphinganine metabolic process
met HSD17B1 17q11-q21 0.186 0.155 0.695 small molecule metabolic
xsq SNHG4 0.186 0.155 0.695
xsq BARX1 9q12 0.186 0.155 0.695 anterior/posterior pattern
xsq KIZ-AS1 0.186 0.155 0.695
xsq OR5L2 11q11 0.186 0.155 0.695 response to stimulus
exp FADS1 11q12.2-q13.1 0.186 0.155 0.695 transport;response to organic
cyclic compound
exp CREBZF 11q14 0.186 0.155 0.695 transcription, DNA-dependent;response to
virus
xsq SPPL2B 19p13.3 0.186 0.155 0.695 proteolysis
xsq IL23R 1p31.3 0.186 0.155 0.695 positive regulation of defense response
to virus by host;positive regulation of interleukin-12 production
exp RSRP1 0.186 0.155 0.695
exp MUM1 19p13.3 0.186 0.155 0.695 DNA repair;chromatin organization
xsq DRD3 3q13.3 0.186 0.155 0.695 regulation of blood volume by renin-
angiotensin;learning
met LYG1 2q11.2 0.186 0.155 0.695 cell wall macromolecule catabolic
xsq KNSTRN 15q15.1 0.186 0.155 0.695
cop SOS1 2p21 0.186 0.155 0.695 Ras protein signal transduction;regulation of
met SYCP2 20q13.33 0.186 0.155 0.695 cell cycle;meiosis
xsq THAP4 2q37.3 0.186 0.155 0.695
xsq PRDM15 21q22.3 0.186 0.155 0.695 regulation of transcription, DNA-
dependent"
cop MTA3 2p21 0.186 0.155 0.695
xsq CCDC27 1p36.32 0.186 0.155 0.695
cop HS1BP3 2p24.1 0.186 0.155 0.695 cell communication
met EPS8L2 11p15.5 0.186 0.155 0.695
exp FANCC 9q22.3 0.186 0.155 0.695 DNA Damage Response (DDR); DDR (FA)
xsq NCK1-AS1 0.186 0.155 0.695
mut REG4 1p13.1-p12 0.186 0.155 0.695
xsq LOC102724659 0.186 0.155 0.695
xsq APIP 11p13 0.186 0.155 0.695 methionine biosynthetic process;L-methionine
salvage from methylthioadenosine
exp LOC729930 1p22.2 0.186 0.155 0.695
exp FOXN4 12q24.11 0.186 0.155 0.695 neuron fate commitment;axon extension
cop TNFRSF11A 18q22.1 0.186 0.155 0.695 cell-cell signaling;positive
cop ZCCHC2 18q21.33 0.186 0.155 0.695 cell communication
xsq ZNF330 4q31.21 0.186 0.155 0.695
xsq TNFAIP8L2-SCNM1 0.186 0.155 0.695
met DAPK3 19p13.3 0.186 0.155 0.695 Apoptosis
xsq ZXDB Xp11.21 0.186 0.155 0.695 regulation of transcription, DNA-
dependent"
cop VAC14 16q22.1 0.186 0.155 0.695 signal transduction;interspecies
exp FAN1 15q13.2-q13.3 0.186 0.155 0.695 DNA Damage Response (DDR); DDR (FA)
exp GK3P 4q32.1 0.186 0.155 0.695
xsq LOC101927365 0.186 0.155 0.696
met CST9L 20p11.21 0.186 0.155 0.696
xsq RRAD 16q22 -0.186 0.155 0.696 GTP catabolic process;signal transduction
cop ZNF716 7p11.2 -0.186 0.155 0.696 regulation of transcription,
DNA-dependent"
mut MEOX2 7p22.1-p21.3 -0.186 0.155 0.695 multicellular organismal
met KLRG2 7q34 -0.186 0.155 0.695
exp MAPK8IP1 11p11.2 -0.186 0.155 0.695 Cell Signaling
xsq LOC100130298 8q12.2 -0.186 0.155 0.695
met KBTBD8 3p14 -0.186 0.155 0.695
exp C1orf194 1p13.3 -0.186 0.155 0.695
xsq LOC101927056 -0.186 0.155 0.695
exp GLIPR1 12q21.2 -0.186 0.155 0.695 cellular lipid metabolic
xsq WFDC2 20q13.12 -0.186 0.155 0.695 negative regulation of
exp GRN 17q21.32 -0.186 0.155 0.695 signal transduction;embryo
implantation
met ASGR2 17p -0.186 0.155 0.695 glycoprotein metabolic process;bone
mineralization
xsq PODXL 7q32-q33 -0.186 0.155 0.695 cell migration;negative regulation
exp AFF3 2q11.2-q12 -0.186 0.155 0.695 embryonic hindlimb
cop RIPK2 8q21 -0.186 0.155 0.695 Apoptosis
xsq LOC149950 20q11.21 -0.186 0.155 0.695
cop MSL2 3q22.3 -0.186 0.155 0.695 histone H4-K16 acetylation
exp CCDC110 4q35.1 -0.186 0.155 0.695
xsq KIAA1324 1p13.3 -0.186 0.155 0.695 positive regulation of
vacuole organization;positive regulation of autophagic vacuole assembly
cop CLSTN2 3q23 -0.186 0.155 0.695 cell adhesion;homophilic cell
adhesion
xsq FABP7 6q22-q23 -0.186 0.155 0.694 nervous system development;negative
swa SORT1 1p13.3 -0.187 0.155 0.696 transport;regulation of gene
expression
xai MGLL 3q21.3 -0.187 0.155 0.696 regulation of signal
xai GJB2 13q11-q12 -0.187 0.155 0.695 transport;cell-cell signaling
xai SFRP2 4q31.3 -0.187 0.155 0.695 chondrocyte development;negative
xai ATP10A 15q11.2 -0.187 0.155 0.695 cation transport;regulation
of cell shape
hs4 WWC1 5q34 -0.187 0.155 0.695 regulation of transcription, DNA-
xai CD68 17p13 -0.187 0.155 0.695
xai SOWAHC 2q13 -0.187 0.155 0.695
exp LHFPL3-AS2 -0.187 0.155 0.695
exp C7orf71 7p15.2 -0.187 0.155 0.695
xai SNORD96B -0.187 0.155 0.695
xai LINC00900 11q23.3 -0.187 0.155 0.695
xai HOXB4 -0.187 0.155 0.695 morphogenesis of an epithelial
xai FOXF2 6p25.3 -0.187 0.155 0.695 Apoptosis
exp SNORD96B -0.187 0.155 0.695
hs4 LOC105370333 -0.188 0.155 0.695
hs4 PCCA 13q32 -0.188 0.155 0.695 small molecule metabolic process;fatty
acid beta-oxidation
hs4 FSTL5 4q32.3 -0.188 0.155 0.695
hs4 LOC102724804 -0.188 0.155 0.695
hs4 RHOBTB1 10q21.2 -0.188 0.155 0.695 small GTPase mediated signal
his LOC101928093 -0.188 0.155 0.695
his PLEKHA4 19q13.33 -0.188 0.155 0.695
his PPP1R15A 19q13.2 -0.188 0.155 0.695 Apoptosis
xai EBF3 10q26.3 -0.188 0.155 0.695 regulation of transcription, DNA-
his SPATA12 3p14.3 -0.188 0.155 0.695
xai CTTNBP2 7q31 -0.188 0.155 0.695 brain development
his LOC729870 4q31.3 -0.188 0.155 0.695
xai COL5A3 19p13.2 -0.188 0.155 0.694 cell adhesion;cell-matrix
adhesion
his GLIS3-AS1 9p24.2 -0.188 0.155 0.694
his C4orf51 4q31.21 -0.188 0.155 0.694
exp PCDHB19P 5q31 -0.188 0.155 0.694
xai POMGNT1 1p34.1 -0.188 0.155 0.694 protein N-linked
xai ZNF425 7q36.1 -0.188 0.155 0.694 negative regulation of
xai LOC727808 15q13.1 -0.188 0.155 0.694
his CTSF 11q13 -0.188 0.155 0.694 proteolysis
swa SNX5 20p11 0.187 0.156 0.696 pinocytosis;cell communication
xai CHKB 0.187 0.156 0.696 phosphatidylethanolamine biosynthetic
process;CDP-choline pathway
his FTCD 21q22.3 0.187 0.156 0.696 histidine catabolic process;folic acid-
his PEF1 1p34 0.187 0.156 0.696 response to calcium ion
xai DAPP1 4q25-q27 0.187 0.156 0.696 protein dephosphorylation;signal
transduction
xai RANBP10 16q22.1 0.187 0.156 0.696 microtubule cytoskeleton
his MIR6877 0.187 0.156 0.696
his CEL 9q34.3 0.187 0.156 0.696 fatty acid catabolic process;ceramide
catabolic process
his GTSCR1 0.187 0.156 0.696
his TMOD2 15q21.2 0.187 0.156 0.696 learning or memory;positive regulation of
his TMEM221 19p13.11 0.187 0.156 0.696
his ZNF19 16q22 0.187 0.156 0.696 regulation of transcription, DNA-dependent"
xai ING3 7q31 0.187 0.156 0.696 regulation of transcription, DNA-
hs4 ELANE 19p13.3 0.187 0.156 0.696 cellular calcium ion homeostasis;negative
hs4 TNFRSF1A 12p13.2 0.187 0.156 0.696 Apoptosis
his PURG 8p11 0.187 0.156 0.696
his WRN 8p12 0.187 0.156 0.696 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
hs4 TEX14 17q22 0.187 0.156 0.696
hs4 RAD51C 17q22 0.187 0.156 0.696 DNA Damage Response (DDR); DDR (FA)
his LOC100129697 16q24.3 0.187 0.156 0.696
his CBFA2T3 16q24 0.187 0.156 0.696 cell differentiation;granulocyte
differentiation
his C19orf81 19q13.33 0.187 0.156 0.696
his DHX37 12q24.31 0.187 0.156 0.696
his CALML3 10p15.1 0.187 0.156 0.696
his CALML3-AS1 10p15.1 0.187 0.156 0.696
hs4 EXOSC2 9q34 0.187 0.156 0.696 positive regulation of cell
his DNM1 9q34 0.187 0.156 0.696 endosome organization;GTP catabolic process
his TSC22D4 7p21-p15 0.187 0.156 0.696 regulation of transcription, DNA-
dependent;response to osmotic stress
his OCEL1 19p13.11 0.187 0.156 0.696
his UFC1 1q23.3 0.187 0.156 0.696 protein ufmylation
swa ATP5A1 18q21 0.187 0.156 0.696 lipid metabolic process;small molecule
metabolic process
exp CCR3 3p21.3 0.187 0.156 0.696 cellular defense response;cell adhesion
his LINC01012 0.187 0.156 0.696
his LYPLA1 8q11.23 0.187 0.156 0.696 lipid metabolic process;fatty acid
metabolic process
exp ADGRE4P 0.187 0.156 0.696
xai SPANXN4 Xq27.3 0.187 0.156 0.696
xai VWA8 13q14.11 0.187 0.156 0.696
his DLGAP5 14q22.3 0.187 0.156 0.696 DNA Damage Response (DDR)
swa HMGN1 21q22.2 0.187 0.156 0.696 positive regulation of transcription
elongation, DNA-dependent"
hs4 RAB14 9q32-q34.11 0.187 0.156 0.697 neurotransmitter secretion;intracellular
transport
hs4 TM4SF20 2q36.3 0.187 0.156 0.697
xai ZNF473 19q13.33 0.187 0.156 0.697 mRNA processing;histone mRNA 3'-end
processing
swa LARP7 4q25 0.187 0.156 0.697 RNA processing
xai UBAC2-AS1 13q32.3 0.187 0.156 0.697
his CCDC87 11q13.2 0.187 0.156 0.697
his CCS 11q13 0.187 0.156 0.697 oxidation-reduction process;superoxide
metabolic process
xai CERKL 2q31.3 0.187 0.156 0.697 anti-apoptosis;activation of protein
kinase C activity by G-protein coupled receptor protein signaling pathway
his PSMD1 2q37.1 0.187 0.156 0.697 S phase of mitotic cell cycle;DNA damage
hs4 SHISA6 17p12 0.187 0.156 0.697
xsq DIABLO 12q24.31 0.186 0.156 0.696 Apoptosis
cop FOXB1 15q22.2 0.186 0.156 0.696 urogenital system development;tissue
development
xsq NOX3 6q25.3 0.186 0.156 0.696 temperature homeostasis;detection of
gravity
exp IRAK3 12q14.3 0.186 0.156 0.696 Protein Kinases
exp FBXL21 5q31 0.186 0.156 0.696 protein ubiquitination;rhythmic process
met SMAD3 15q22.33 0.186 0.156 0.696 Apoptosis
xsq NDUFB11 Xp11.23 0.186 0.156 0.696 transport;respiratory electron
transport chain
xsq EBF2 8p21.2 0.186 0.156 0.696 regulation of transcription, DNA-
xsq IER2 19p13.2 0.186 0.156 0.696
exp ETV6 12p13 0.186 0.156 0.696 Transcription Factors
xsq LOC400736 0.186 0.156 0.696
met FARP1 13q32.2 0.186 0.156 0.696 negative regulation of phosphatase
activity;regulation of Rho protein signal transduction
cop ELK3 12q23 0.186 0.156 0.696 Transcription Factors
xsq TRMT61B 2p23.2 0.186 0.156 0.696 tRNA methylation;tRNA processing
met NAV1 1q32.3 0.186 0.156 0.696 microtubule bundle formation;neuron
migration
xsq TREML4 6p21.1 0.186 0.156 0.696
exp OSTF1 9q13-q21.2 0.186 0.156 0.696 ossification;signal transduction
mut MSH3 5q11-q12 0.186 0.156 0.696 DNA Damage Response (DDR); DDR (MMR)
exp ZC4H2 Xq11.2 0.186 0.156 0.696
cop STON1 2p16.3 0.186 0.156 0.696 intracellular protein
xsq OR5T3 11q12.1 0.185 0.156 0.696 response to stimulus
cop ADGB 6q24.3 0.185 0.156 0.696 proteolysis;oxygen transport
cop LOC729176 0.185 0.156 0.696
xsq POLR2G 11q13.1 0.185 0.156 0.696 DNA Damage Response (DDR); DDR
(NER)
cop NUDT7 16q23.1 0.185 0.156 0.696 nucleoside diphosphate metabolic process
mir hsa-miR-361-5p 0.185 0.156 0.696
xsq TAPT1 4p15.32 0.185 0.156 0.696 in utero embryonic development;post-
xsq KRTAP10-2 0.185 0.156 0.696
exp CENPE 4q24-q25 0.185 0.156 0.696 mitotic chromosome movement towards
exp BTF3P12 8q13.3 0.185 0.156 0.696
xsq TCOF1 5q32 0.185 0.156 0.696 transport;skeletal system development
xsq RSRP1 0.185 0.156 0.696
cop CD109 6q13 0.185 0.156 0.696
cop RNASET2 6q27 0.185 0.156 0.696 RNA catabolic process
met ZNF252P-AS1 8q24.3 0.185 0.156 0.696
met LRP1B 2q21.2 0.185 0.156 0.696 receptor-mediated endocytosis;protein
transport
cop KLF11 2p25 0.185 0.156 0.696 negative regulation of cell
cop CYS1 2p25.1 0.185 0.156 0.696
cop RRM2 2p25-p24 0.185 0.156 0.696 DNA Damage Response (DDR)
xsq CHRM4 11p12-p11.2 0.185 0.156 0.696 signal transduction;cell surface receptor
signaling pathway
mut FAM175B 10q26.13 0.185 0.156 0.696 DNA Damage Response (DDR)
met SRP9 1q42.12 0.185 0.156 0.696 translation;SRP-dependent cotranslational
cop ADAMTS14 10q21 0.185 0.156 0.697 proteolysis;collagen catabolic process
cop TBATA 10q22.1 0.185 0.156 0.697
xsq LOC100128993 8p21.3 0.185 0.156 0.697
dependent"
xsq EIF3IP1 0.185 0.156 0.697
mut KAT6B 10q22.2 0.185 0.156 0.697 positive regulation of transcription,
DNA-dependent;nucleosome assembly
xsq NSMCE1 16p12.1 0.185 0.156 0.697 DNA Damage Response (DDR); DDR (HR)
met GPR139 16p12.3 0.185 0.156 0.697
met C21orf15 0.185 0.156 0.697
xsq LOC100132078 0.185 0.156 0.697
met AP1M2 19p13.2 0.185 0.156 0.697 protein targeting;post-Golgi vesicle-
mediated transport
xsq C3orf84 3p21.31 0.185 0.156 0.697
exp GAN 16q24.1 0.185 0.156 0.697 cell death
met DOK5 20q13.2 0.185 0.156 0.697 MAPK cascade;transmembrane receptor
exp PPP1CB 2p23 -0.185 0.156 0.697 cell cycle;triglyceride catabolic
process
exp DRC3 -0.185 0.156 0.697
xsq LOC105447648 -0.185 0.156 0.697
mut PHF24 -0.185 0.156 0.697
xsq LINC01588 -0.185 0.156 0.697
xsq TCTEX1D1 1p31.3 -0.185 0.156 0.696
xsq CAPN13 2p22-p21 -0.185 0.156 0.696 proteolysis
exp SGPL1 10q21 -0.185 0.156 0.696 Apoptosis
exp C2orf54 2q37.3 -0.185 0.156 0.696
met LTA4H 12q22 -0.185 0.156 0.696 prostanoid metabolic process;inflammatory
response
exp SBDS 7q11.21 -0.185 0.156 0.696 leukocyte chemotaxis;mature
ribosome assembly
exp FZD6 8q22.3-q23.1 -0.186 0.156 0.696 gonad development;cell
xsq PDZK1 1q21 -0.186 0.156 0.696 transport;cell proliferation
exp IER3 6p21.3 -0.186 0.156 0.696 Apoptosis
cop C3orf58 3q24 -0.186 0.156 0.696
cop NPR3 5p13.3 -0.186 0.156 0.696 inhibition of adenylate cyclase
messenger
exp RPL39P21 5q13.3 -0.186 0.156 0.696
exp RHOBTB1 10q21.2 -0.186 0.156 0.696 small GTPase mediated signal
mut DAB2 5p13.1 -0.186 0.156 0.696 negative regulation of cell
exp LMAN2L 2q11.2 -0.186 0.156 0.696 protein folding;ER to Golgi
xsq PGF 14q24.3 -0.186 0.156 0.696 cell differentiation;vascular
xai TCTA 3p21 -0.187 0.156 0.697
swa GSTK1 7q34 -0.187 0.156 0.697
his C6orf223 6p21.1 -0.187 0.156 0.697
exp H2AFZP6 -0.187 0.156 0.697
his ANXA2 15q22.2 -0.187 0.156 0.697 positive regulation of vesicle
fusion;fibrinolysis
exp IPO9-AS1 -0.187 0.156 0.696
hs4 SYPL2 1p13.3 -0.187 0.156 0.696 cellular calcium ion homeostasis
his CELSR1 22q13.3 -0.187 0.156 0.696 locomotory
xai MLIP 6p12.1 -0.187 0.156 0.696
hs4 LRRC24 8q24.3 -0.187 0.156 0.696
hs4 C8orf82 8q24 -0.187 0.156 0.696
xai PYGO1 15q21.3 -0.187 0.156 0.696 kidney development;post-embryonic
development
hs4 ASPA 17p13.3 -0.187 0.156 0.696 aspartate catabolic
xai TTC21A 3p22.2 -0.187 0.156 0.696
xai EFNB2 13q33 -0.187 0.156 0.696 angiogenesis;anatomical structure
morphogenesis
xai LOC100130285 16p13.3 -0.187 0.156 0.696
his HN1L 16p13.3 -0.187 0.156 0.696
his CDC42P3 8q24.3 -0.187 0.156 0.696
his LINC01629 -0.187 0.156 0.696
hs4 SNTB1 8q23-q24 -0.187 0.156 0.696 muscle contraction
hs4 OR51Q1 -0.187 0.156 0.696
his CYB5R2 11p15.4 -0.187 0.156 0.696 sterol biosynthetic
hs4 MIR3132 -0.187 0.156 0.696
hs4 PRKG1 10q11.2 -0.187 0.156 0.696 signal transduction;blood
coagulation
xai BTD 3p25 -0.187 0.156 0.696 epidermis development;nitrogen compound
metabolic process
hs4 ATP1B1 1q24 -0.187 0.156 0.696 ATP biosynthetic process;transport
hs4 LOC101928596 -0.187 0.156 0.696
his MIR6870 -0.187 0.156 0.696
his JAG1 20p12.1-p11.23 -0.187 0.156 0.696 cell communication;regulation
of cell migration
cop LINC00272 1q25.3 -0.187 0.156 0.696
hs4 ZMAT3 3q26.32 -0.187 0.156 0.696 response to DNA damage
stimulus;protein transport
his OR4Q3 -0.187 0.156 0.696 response to stimulus
his ABCC11 16q12.1 -0.187 0.156 0.696 ABC Transporters
his LONP2 16q12.1 -0.187 0.156 0.696 protein targeting to
peroxisome;peroxisome organization
cop MIR2052 -0.189 0.156 0.696
met SNORD113-9 14q32.31 0.192 0.157 0.697
exp SNORA38B 0.187 0.157 0.697
xai RPS3AP3 0.187 0.157 0.697
xai CARD18 11q22.3 0.187 0.157 0.697 inflammatory response;regulation of
apoptotic process
hs4 DARS2 1q25.1 0.187 0.157 0.697 tRNA aminoacylation for protein
hs4 CENPL 1q25.1 0.187 0.157 0.697 M phase of mitotic cell cycle;mitotic
prometaphase
xai NBPF3 1p36.12 0.187 0.157 0.697
xai ALG1L9P 11q13.4 0.187 0.157 0.697
his MADD 11p11.2 0.187 0.157 0.697 activation of MAPK activity;positive
his LOC101928943 0.187 0.157 0.697
exp ERVV-1 0.187 0.157 0.697
exp RPS3AP3 0.187 0.157 0.697
xai LRFN5 14q21.1 0.187 0.157 0.697
xai SMU1 9p12 0.187 0.157 0.697
xai SNORA38B 0.187 0.157 0.697
hs4 PEX10 1p36.32 0.187 0.157 0.697 peroxisome organization;protein import
hs4 SKA1 18q21.1 0.187 0.157 0.697 mitosis;regulation of microtubule
swa NARS 18q21.31 0.187 0.157 0.697 tRNA aminoacylation for protein
his NKTR 3p22.1 0.187 0.157 0.697 protein folding
his MTHFSD 16q24.1 0.187 0.157 0.697 folic acid-containing compound
his FLJ30679 0.187 0.157 0.697
xai ERVV-1 0.187 0.157 0.697
swa IKBIP 12q23.1 0.187 0.157 0.697 EMT (Mesenchymal)
xai CCDC184 0.187 0.157 0.697
his TRNT1 3p25.1 0.187 0.157 0.697 RNA processing;protein targeting to
mitochondrion
xai UQCRHP1 0.187 0.157 0.698
xai POTEE 0.187 0.157 0.698
hs4 PTMA 2q37.1 0.187 0.157 0.698 transcription, DNA-dependent"
hs4 MIR1244-1 0.187 0.157 0.698
his RPL11 1p36.1-p35 0.187 0.157 0.698 translational elongation;viral infectious
cycle
exp UQCRHP1 0.187 0.157 0.698
his TSPYL2 Xp11.2 0.187 0.157 0.698 negative regulation of cell
exp KRTAP10-1 0.187 0.157 0.698
dependent"
his TXLNA 1p35.1 0.187 0.157 0.698 exocytosis;cell proliferation
his CDC42SE2 5q31.1 0.187 0.157 0.698 phagocytosis;regulation of cell
shape
swa TAF5 10q24-q25.2 0.187 0.157 0.698 viral reproduction;chromatin modification
xai GBGT1 0.187 0.157 0.698 metabolic process;glycolipid biosynthetic
process
his CASD1 7q21.3 0.187 0.157 0.698
his HAT1 2q31.2-q33.1 0.187 0.157 0.698 response to nutrient;chromatin
modification
hs4 HEYL 1p34.3 0.186 0.157 0.698 multicellular organismal
his NODAL 10q22.1 0.186 0.157 0.698 heart looping;polarity specification of
proximal/distal axis
xai SUCLG1 2p11.2 0.186 0.157 0.698 tricarboxylic acid cycle;succinyl-
his C1orf123 1p32.3 0.186 0.157 0.698
his RNASEH1 2p25 0.186 0.157 0.698 DDR (DNA replication)
his RNASEH1-AS1 0.186 0.157 0.698
his BTBD11 12q23.3 0.186 0.157 0.698
his FAM187B 19q13.12 0.186 0.157 0.698
xai BRINP2 0.186 0.157 0.698 nervous system development;negative
his RBM22 5q33.1 0.186 0.157 0.698 protein import into nucleus,
translocation;nuclear mRNA splicing, via spliceosome
swa GOT2 16q21 0.186 0.157 0.698 2-oxoglutarate metabolic process;biosynthetic
process
mut POP1 8q22.1 0.185 0.157 0.697 tRNA 5'-leader removal;RNA processing
xsq DGUOK 2p13 0.185 0.157 0.697 nucleotide biosynthetic process;negative
xsq ACTL6B 7q22 0.185 0.157 0.697 chromatin organization;chromatin
remodeling
exp CCDC78 16p13.3 0.185 0.157 0.697
exp CDX1 5q32 0.185 0.157 0.697 anterior/posterior pattern
mut IFI44L 1p31.1 0.185 0.157 0.697 immune response;response to virus
xsq LMBR1 7q36 0.185 0.157 0.697 embryonic digit morphogenesis
met MIR223 0.185 0.157 0.697
cop TTC7A 2p21 0.185 0.157 0.697 cellular iron ion homeostasis;hemopoiesis
cop DNAJC5G 2p23.3 0.185 0.157 0.697 protein folding
met RSPO1 1p34.3 0.185 0.157 0.697 regulation of receptor
internalization;response to stimulus
cop ANGPT4 20p13 0.185 0.157 0.697 positive regulation of endothelial cell
migration;cellular response to hypoxia
exp PSMD5-AS1 9q33.2 0.185 0.157 0.697
xsq LOC283214 0.185 0.157 0.697
exp PLEKHA8 7p21-p11.2 0.185 0.157 0.697 protein transport
xsq ADAL 15q15.3 0.185 0.157 0.697 adenosine catabolic process;nucleotide
metabolic process
met S100A10 1q21 0.185 0.157 0.698 signal transduction;positive regulation
of binding
dependent"
xsq CCDC150 2q33.1 0.185 0.157 0.698
xsq TRIAP1 12q24.31 0.185 0.157 0.698 anti-apoptosis;DNA damage response,
signal transduction by p53 class mediator resulting in cell cycle arrest
met MAGI1 3p14.1 0.185 0.157 0.698 protein complex assembly;cell adhesion
exp MRRF 9q33.2 0.185 0.157 0.698 translation;ribosome disassembly
cop HEBP2 6q24 0.185 0.157 0.698
cop NHSL1 6q23.3 0.185 0.157 0.698
cop MIR3145 0.185 0.157 0.698
cop FLJ46906 6q24.1 0.185 0.157 0.698
exp UNKL 16p13.3 0.185 0.157 0.698
xsq SNRNP70 19q13.3 0.185 0.157 0.698 mRNA processing;RNA splicing
xsq CPT1B 0.185 0.157 0.698
xsq RFC1 4p14-p13 0.185 0.157 0.698 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
cop HDC 15q21.2 0.185 0.157 0.698 small molecule metabolic
xsq CETN3 5q14.3 0.185 0.157 0.698 centrosome cycle;cell division
met MYO5B 18q21 0.185 0.157 0.698 regulation of protein localization;protein
transport
xsq RRP15 1q41 0.185 0.157 0.698
xsq DDX1 2p24 0.185 0.157 0.698 regulation of translational
cop LOC100131655 0.185 0.157 0.698
exp PPIL1 6p21.1 0.185 0.157 0.698 nuclear mRNA splicing, via
cop NAMA 0.185 0.157 0.698
xsq KLHDC3 6p21.1 0.185 0.157 0.698 activation of signaling protein
xsq GNPAT 1q42 0.185 0.157 0.698 phospholipid biosynthetic process;small
met KRT8 12q13 0.185 0.157 0.698 cytoskeleton organization;interspecies
xsq IQCF3 3p21.2 0.185 0.157 0.698
xsq CCNH 5q13.3-q14 0.185 0.157 0.698 DNA Damage Response (DDR)
met OR8A1 11q24.2 0.185 0.157 0.698 response to stimulus
xsq SYNDIG1 20p11.21 0.185 0.157 0.698 intracellular protein
xsq OR2Z1 19p13.2 0.185 0.157 0.698
met SPRR1A 1q21-q22 0.185 0.157 0.698 epidermis development;peptide
cross-linking
xsq PKIB 6q22.31 0.185 0.157 0.698 negative regulation of protein kinase
activity
exp ATP2B1 12q21.3 0.185 0.157 0.698 ATP biosynthetic process;transport
met ITM2C 2q37 0.185 0.157 0.698 negative regulation of neuron projection
mut CD96 3q13.13-q13.2 0.185 0.157 0.698 cell adhesion;regulation of immune
response
xsq ZNHIT3 17q12 0.185 0.157 0.698 regulation of transcription, DNA-
dependent"
mut C6orf58 6q22.33 0.185 0.157 0.698
xsq ALDH5A1 6p22 0.185 0.157 0.698 succinate metabolic process;central
nervous system development
cop PSMD2 3q27.1 -0.185 0.157 0.698 S phase of mitotic cell cycle;DNA
arrest
cop EIF4G1 3q27.1 -0.185 0.157 0.698 insulin receptor signaling
pathway;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
cop SNORD66 -0.185 0.157 0.698
cop FAM131A 3q27.1 -0.185 0.157 0.698
cop CLCN2 3q27.1 -0.185 0.157 0.698 transport;ion transport
cop POLR2H 3q28 -0.185 0.157 0.698 DNA Damage Response (DDR); DDR
(NER)
cop THPO 3q27 -0.185 0.157 0.698 multicellular organismal
met LRSAM1 9q33.3 -0.185 0.157 0.698 ubiquitin-dependent
endocytosis;protein polyubiquitination
cop ECE2 3q27.1 -0.185 0.157 0.698 peptide hormone
exp RPS26P21 3q13.33 -0.185 0.157 0.698
cop VWA5B2 3q27.1 -0.185 0.157 0.698
cop MIR1224 -0.185 0.157 0.698
cop ALG3 3q27.1 -0.185 0.157 0.698 protein N-linked glycosylation via
cop CAMK2N2 3q27.1 -0.185 0.157 0.698
met SNORD1C 17q25.1 -0.185 0.157 0.698
exp DAPK3 19p13.3 -0.185 0.157 0.698 Apoptosis
met HERPUD1 16q13 -0.185 0.157 0.698 cellular calcium ion
homeostasis;response to stress
exp MBTPS2 Xp22.12-p22.11 -0.185 0.157 0.698 endoplasmic reticulum
unfolded protein response;proteolysis
cop AP2M1 3q28 -0.185 0.157 0.698 vesicle-mediated transport;transport
met C7orf65 7p12.3 -0.185 0.157 0.698
cop STEAP1B 7p15.3 -0.185 0.157 0.698
met APBB1IP 10p12.1 -0.185 0.157 0.698 signal transduction;blood
coagulation
xsq ST8SIA1 12p12.1-p11.2 -0.185 0.157 0.698 sphingolipid metabolic
met PRCC 1q21.1 -0.185 0.157 0.698 cell cycle;mitotic cell cycle
checkpoint
met CD226 18q22.3 -0.185 0.157 0.698 signal transduction;cell
recognition
exp CTSH 15q25.1 -0.185 0.157 0.698 positive regulation of cell
cop SEC16B 1q25.2 -0.185 0.157 0.698 protein transport;vesicle-
mediated transport
mut GHRHR 7p14 -0.185 0.157 0.698 determination of adult lifespan;positive
mut DAO 12q24 -0.185 0.157 0.697 proline catabolic process;cellular
cop NDUFA4 7p21.3 -0.185 0.157 0.697 respiratory electron
cop PHF14 7p21.3 -0.185 0.157 0.697
exp LOC642852 21q22.3 -0.185 0.157 0.697
exp ATP6V1C1 8q22.3 -0.185 0.157 0.697 transport;cellular iron ion
homeostasis
met SPEG 2q35 -0.185 0.157 0.697 muscle organ development;negative
exp WNT4 1p36.23-p35.1 -0.185 0.157 0.697 Oncogenes
xsq LOC100286922 2q37.1 -0.185 0.157 0.697
exp PPARD 6p21.2 -0.185 0.157 0.697 generation of precursor metabolites
and energy;cell proliferation
cop TRMT1L 1q25.2 -0.185 0.157 0.697 behavior;tRNA processing
exp CDCP1 3p21.31 -0.185 0.157 0.697
exp HOXA5 7p15.2 -0.185 0.157 0.697 thyroid gland development;embryonic
xsq ST7-OT3 -0.185 0.157 0.697
xai ZNF860 3p23 -0.186 0.157 0.698 regulation of transcription, DNA-
dependent"
xai MMP26 11p15 -0.186 0.157 0.698 collagen catabolic process;proteolysis
xai PDZRN3 3p13 -0.186 0.157 0.698 neuromuscular junction
xai CEBPD 8p11.2-p11.1 -0.186 0.157 0.698 transcription from RNA
swa ARPC1A 7q22.1 -0.186 0.157 0.698 actin cytoskeleton
organization;regulation of actin filament polymerization
xai FGD1 Xp11.21 -0.186 0.157 0.698 organ morphogenesis;apoptotic
process
xai C5orf58 5q35.1 -0.186 0.157 0.698
xai MEIS1 2p14 -0.186 0.157 0.698 multicellular organismal development
hs4 ZNF32 10q22-q25 -0.187 0.157 0.698 regulation of transcription, DNA-
dependent"
hs4 ZNF32-AS2 -0.187 0.157 0.698
xai BARHL1 9q34 -0.187 0.157 0.698 neuron migration;sensory perception
of sound
xai PHLDB1 11q23.3 -0.187 0.157 0.698
xai PTAFR 1p35-p34.3 -0.187 0.157 0.698 pattern recognition receptor
signaling pathway;phosphatidylinositol-mediated signaling
exp LOC100288846 14q21.1 -0.187 0.157 0.698
hs4 MST1R 3p21.3 -0.187 0.157 0.698 Apoptosis
xai TUBA1A 12q13.12 -0.187 0.157 0.698 cellular protein metabolic
process;'de novo' posttranslational protein folding
xai HERC6 4q22.1 -0.187 0.157 0.697 protein modification
process
hs4 NR1D1 17q11.2 -0.187 0.157 0.697 negative regulation of toll-like
receptor 4 signaling pathway;steroid hormone mediated signaling pathway
xai FAM225B 9q32 -0.187 0.157 0.697
xai BHLHE41 12p12.1 -0.187 0.157 0.697 cell differentiation;negative
xai CCDC188 -0.187 0.157 0.697
hs4 PDZK1IP1 1p33 -0.187 0.157 0.697
xai FAS 10q24.1 -0.187 0.157 0.697 Apoptosis
xai DRC3 -0.187 0.157 0.697
xai H2AFZP6 -0.187 0.157 0.697
xai PRNP 20p13 -0.187 0.157 0.697 negative regulation of protein
his RNF148 7q31.33 -0.187 0.157 0.697
exp SERF1AP1 4q28.3 0.186 0.158 0.698
xai HSP90AA5P 3q27.1 0.186 0.158 0.698 protein folding;response to stress
xai TMEM97 17q11.2 0.186 0.158 0.698 regulation of cell
his CEP350 1q25.2 0.186 0.158 0.698
his HIKESHI 0.186 0.158 0.698
hs4 PNP 14q13.1 0.186 0.158 0.698 nicotinamide riboside catabolic
xai RHEBL1 12q13.12 0.186 0.158 0.698 TOR signaling cascade;positive
xai SERF1AP1 4q28.3 0.186 0.158 0.698
hs4 NYX Xp11.4 0.186 0.158 0.698 visual perception;response to stimulus
cop LOC643406 20p12.3 0.186 0.158 0.698
his PGAP2 11p15.5 0.186 0.158 0.698 GPI anchor biosynthetic process;anti-
apoptosis
his NUP98 11p15.5 0.186 0.158 0.698 M phase of mitotic cell cycle;regulation
his PLTP 20q13.12 0.186 0.158 0.698 vitamin E biosynthetic process;sperm
motility
his LOC90784 2p11.2 0.186 0.158 0.698
xai CFD 19p13.3 0.186 0.158 0.698 innate immune response;platelet
degranulation
hs4 LPCAT3 12p13 0.186 0.158 0.698 phospholipid biosynthetic process
exp HNRNPA3P13 4q21.22 0.186 0.158 0.698
xai EIF2S2 20q11.2 0.186 0.158 0.698 male gonad development;gene
expression
his AARS 16q22 0.186 0.158 0.698 hair follicle development;endoplasmic reticulum
his LXN 3q25.32 0.186 0.158 0.698 negative regulation of endopeptidase
activity;detection of temperature stimulus involved in sensory perception of pain
exp IGHV3-42 0.186 0.158 0.698
his VAPB 20q13.33 0.186 0.158 0.698 endoplasmic reticulum unfolded protein
response;small molecule metabolic process
his MEF2C-AS1 0.186 0.158 0.698
his GLIDR 0.186 0.158 0.698
swa AP3B1 5q14.1 0.186 0.158 0.698 protein targeting to
hs4 PLCXD1 Xp22.33 0.186 0.158 0.698 lipid metabolic
xai XRCC5 2q35 0.186 0.158 0.698 DNA Damage Response (DDR); DDR (NHEJ)
his EVL 14q32.2 0.186 0.158 0.699 nervous system development;axon guidance
xai ZSCAN5A 19q13.43 0.186 0.158 0.699 viral reproduction
his TMEM260 14q22.3 0.186 0.158 0.699
his SRSF7 2p22.1 0.186 0.158 0.699 mRNA export from nucleus;RNA splicing
xai AGER 6p21.3 0.186 0.158 0.699 inflammatory response;positive regulation
xai IL5 5q31.1 0.186 0.158 0.699 inflammatory response;positive regulation
of peptidyl-tyrosine phosphorylation
xai GSE1 16q24.1 0.186 0.158 0.699
his EXOC4 7q31 0.186 0.158 0.699 positive regulation of calcium-mediated
xai PSMC1P2 7p15.2 0.186 0.158 0.699
xai ARGLU1 13q33.3 0.186 0.158 0.699 regulation of transcription, DNA-
dependent"
xai ATXN7L3 17q21.31 0.186 0.158 0.699 chromatin modification;histone
deubiquitination
his GPKOW Xp11.23 0.186 0.158 0.699
xai DDX49 19p12 0.186 0.158 0.699
exp SPATA31E2P 15q11.2 0.186 0.158 0.699
hs4 TMCO6 5q31.3 0.186 0.158 0.699 protein import into nucleus
met CADM4 19q13.31 0.186 0.158 0.699 cell adhesion
hs4 VHL 3p25.3 0.186 0.158 0.699 Protein Kinases; Tumor Suppressors
his ZNF217 20q13.2 0.186 0.158 0.699 transcription, DNA-
his LOC105372672 0.186 0.158 0.699
swa AKAP2 9q31.3 0.186 0.158 0.699
his FECH 18q21.3 0.186 0.158 0.699 generation of precursor metabolites and
xai SUPT20H 13q13.3 0.186 0.158 0.699
xai HMGN1P28 0.186 0.158 0.699
his MIR7114 0.186 0.158 0.699
hs4 TRPV2 17p11.2 0.186 0.158 0.699 response to heat;ion transmembrane
transport
xai ESPL1 12q 0.186 0.158 0.699 Apoptosis
xai PPP1R35 7q22.1 0.186 0.158 0.699 negative regulation of phosphatase
activity
xai IGF2BP1 17q21.32 0.186 0.158 0.699 RNA localization;regulation of mRNA
hs4 LINC00350 0.186 0.158 0.699
xai KRTAP10-1 0.186 0.158 0.699
his BMP2K 4q21.21 0.186 0.158 0.699 regulation of catalytic
activity;regulation of bone mineralization
exp HSPD1P8 13q31.1 0.186 0.158 0.699
xai ITGA4 2q31.3 0.186 0.158 0.699 B cell differentiation;blood vessel
remodeling
xsq CCL4 17q12 0.185 0.158 0.698
xsq TMEM116 12q24.13 0.185 0.158 0.698
cop RLBP1 15q26 0.185 0.158 0.698 vitamin A metabolic process;visual perception
cop FANCI 15q26.1 0.185 0.158 0.698 DNA Damage Response (DDR); DDR (FA)
met SHISA5 3p21.31 0.185 0.158 0.698 apoptotic process;induction of
apoptosis
met GGTA1P 9q33.2 0.185 0.158 0.698 carbohydrate metabolic
dependent"
xsq LOC100287072 17p11.2 0.185 0.158 0.698
exp ZFP36L2 2p22.3-p21 0.185 0.158 0.698 nuclear-transcribed mRNA catabolic
met C3orf79 3q25.2 0.185 0.158 0.698
xsq ISYNA1 19p13.11 0.185 0.158 0.698 phospholipid biosynthetic
process;inositol biosynthetic process
exp PSMD4 1q21.3 0.185 0.158 0.698 S phase of mitotic cell cycle;DNA damage
dependent"
cop UTP4 0.185 0.158 0.698
xsq RPS25 11q23.3 0.185 0.158 0.698 translation;mRNA metabolic process
mut SI 3q25.2-q26.2 0.185 0.158 0.698 response to vitamin A;response to
starvation
cop CHTF8 16q22.1 0.185 0.158 0.698 DDR (DNA replication)
xsq DGKD 2q37.1 0.185 0.158 0.698 endocytosis;cell growth
met PIP4K2A 10p12.2 0.185 0.158 0.698 phosphorylation
cop HAS3 16q22.1 0.185 0.158 0.698 positive regulation of transcription,
DNA-dependent;carbohydrate metabolic process
xsq C1orf50 1p34.2 0.185 0.158 0.698
exp LINC00524 0.185 0.158 0.698
exp PSME3 17q21 0.185 0.158 0.698 M/G1 transition of mitotic cell cycle;positive
xsq HIST1H2BL 6p22.1 0.185 0.158 0.698 nucleosome assembly
exp ATP5O 21q22.11 0.185 0.158 0.698 respiratory electron transport
xsq FAM185A 7q22.1 0.185 0.158 0.698
cop NCOR2 12q24 0.185 0.158 0.698 negative regulation of transcription from RNA
xsq RPS18 6p21.3 0.185 0.158 0.698 nuclear-transcribed mRNA catabolic
xsq LOC102724699 0.185 0.158 0.699
exp EPC2 2q23.1 0.185 0.158 0.699 chromatin modification;DNA repair
xsq CA11 19q13.3 0.185 0.158 0.699
xsq MED30 8q24.11 0.185 0.158 0.699 transcription initiation from RNA
xsq KLHL11 17q21.2 0.185 0.158 0.699
xsq CDC34 19p13.3 0.185 0.158 0.699 negative regulation of cAMP-mediated
xsq ABCC10 6p21.1 0.185 0.158 0.699 ABC Transporters
met MS4A6A 11q12.1 0.185 0.158 0.699
xsq INSC 11p15.2 0.185 0.158 0.699 multicellular organismal
met LILRA4 19q13.4 0.184 0.158 0.699
xsq LOC103344931 0.184 0.158 0.699
xsq ATAD3B 1p36.33 0.184 0.158 0.699
xsq RPL39 Xq24 0.184 0.158 0.699 translational termination;cellular protein
metabolic process
met DGCR2 22q11.21 0.184 0.158 0.699 cell adhesion;organ morphogenesis
mut COLGALT2 1q25 0.184 0.158 0.699
mir hsa-miR-130b* 0.184 0.158 0.699
xsq TRIM59 3q25.33 0.184 0.158 0.699
cop TRPM5 11p15.5 0.184 0.158 0.699 ion transport
xsq RASSF2 20p13 0.184 0.158 0.699 cell cycle;signal transduction
met VWA3A 16p12.2 0.184 0.158 0.699
exp GPR183 13q32.3 0.184 0.158 0.699 immune response;humoral immune
response
mir hsa-miR-432 0.184 0.158 0.699
xsq PCDHGB5 -0.184 0.158 0.699 cell adhesion;homophilic cell
adhesion
xsq MGAT5B 17q25.2 -0.184 0.158 0.699
exp LLGL1 17p11.2 -0.184 0.158 0.699 protein complex assembly;exocytosis
met SNORD65 17p11.2 -0.184 0.158 0.699
xsq RUNX1T1 8q22 -0.184 0.158 0.699 generation of precursor metabolites
and energy;regulation of transcription, DNA-dependent
cop MUC4 3q29 -0.184 0.158 0.699 cell adhesion;cell-matrix adhesion
met TUBB6 18p11.21 -0.184 0.158 0.699 microtubule-based movement;cellular
met LIPC 15q21-q23 -0.184 0.158 0.699 cholesterol metabolic
process;phosphatidylcholine catabolic process
exp EML1 14q32 -0.184 0.158 0.699
exp COL4A3BP 5q13.3 -0.185 0.158 0.699 cell morphogenesis;muscle
contraction
exp SERPINA6 14q32.1 -0.185 0.158 0.699 regulation of
exp KRT5 12q13.13 -0.185 0.158 0.699 epidermis development;hemidesmosome
assembly
met ITGA4 2q31.3 -0.185 0.158 0.699 B cell differentiation;blood vessel
remodeling
cop TOMM7 7p15.3 -0.185 0.158 0.699 protein targeting to
xsq SLC51A 3q29 -0.185 0.158 0.699
exp TICAM2 5q23.1 -0.185 0.158 0.699 inflammatory response;innate
immune response
cop ATP2C1 3q22.1 -0.185 0.158 0.699 manganese ion transport;Golgi
calcium ion transport
mut SMPDL3A 6q22.31 -0.185 0.158 0.699 sphingomyelin catabolic
exp CAPN13 2p22-p21 -0.185 0.158 0.699 proteolysis
exp ANKRD29 18q11.2 -0.185 0.158 0.698
met UBASH3A 21q22.3 -0.185 0.158 0.698 regulation of cytokine
xsq CXCL16 17p13 -0.185 0.158 0.698 response to tumor necrosis
mut ARNTL2 12p12.2-p11.2 -0.185 0.158 0.698 entrainment of circadian
clock;positive regulation of transcription from RNA polymerase II promoter
mut M1AP 2p13.1 -0.185 0.158 0.698
cop LOC100130673 7p14.3 -0.185 0.158 0.698
cop LSM5 7p14.3 -0.185 0.158 0.698 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;mRNA processing
xsq CLIC5 6p12.3 -0.185 0.158 0.698 ion transport;chloride transport
mut PER2 2q37.3 -0.185 0.158 0.698 DNA Damage Response (DDR)
cop PAPPA 9q33.2 -0.185 0.158 0.698 proteolysis;female pregnancy
xsq DMBX1 1p33 -0.185 0.158 0.698 negative regulation of transcription,
xsq PCDH1 5q31.3 -0.185 0.158 0.698 nervous system development;cell
adhesion
xai LOC100288846 14q21.1 -0.186 0.158 0.699
swa HMOX2 16p13.3 -0.186 0.158 0.699 small molecule metabolic
xai ATP1B1P1 4p13 -0.186 0.158 0.699
xai MFI2 3q28-q29 -0.186 0.158 0.699 ion transport;iron ion transport
xai KRT8P34 -0.186 0.158 0.699
exp LOC727808 15q13.1 -0.186 0.158 0.699
xai ARSD Xp22.3 -0.186 0.158 0.699
exp C14orf28 14q21.2 -0.186 0.158 0.699
xai LOC541472 7p21 -0.186 0.158 0.699
xai TBCEL 11q23.3 -0.186 0.158 0.699
xai PPP1CB 2p23 -0.186 0.158 0.699 cell cycle;triglyceride catabolic
process
xai ERBB3 12q13 -0.186 0.158 0.699 signal transduction;Schwann cell
differentiation
xai HEBP1 12p13.1 -0.186 0.158 0.699 circadian rhythm
hs4 PECR 2q35 -0.186 0.158 0.699 regulation of apoptotic
hs4 TMEM169 2q35 -0.186 0.158 0.699
hs4 CD9 12p13.3 -0.186 0.158 0.699 response to water
xai SLC9A3R2 16p13.3 -0.186 0.158 0.699 Solute Carriers
exp WFDC8 20q13.12 -0.186 0.158 0.699
hs4 TNKS1BP1 11q12.1 -0.186 0.158 0.699 nuclear-transcribed mRNA
xai NUDCD3 7p13-p12 -0.186 0.158 0.699
his OR4F6 -0.186 0.158 0.698
his OR4F15 15q26.3 -0.186 0.158 0.698 response to stimulus
xai CXCL16 17p13 -0.186 0.158 0.698 response to tumor necrosis
hs4 LINC00601 -0.186 0.158 0.698
xai HCP5 6p21.3 -0.186 0.158 0.698 defense response
swa HPCAL1 2p25.1 -0.186 0.158 0.698
his RUSC2 9p13.3 -0.186 0.158 0.698
hs4 ARMC9 2q37.1 -0.186 0.158 0.698
DNA-dependent"
xai PDLIM1P -0.186 0.158 0.698
hs4 FEZ1 11q24.2 -0.186 0.158 0.698 transport;cell adhesion
hs4 LOC403312 -0.186 0.158 0.698
his CKM 19q13.32 -0.186 0.158 0.698
hs4 TTPA 8q12.3 -0.186 0.158 0.698 response to pH;response to toxin
xai SBDS 7q11.21 -0.186 0.158 0.698 leukocyte chemotaxis;mature
ribosome assembly
his LMO7-AS1 -0.186 0.158 0.698
his LIMS2 2q14.3 -0.186 0.158 0.698 cell junction assembly
hs4 MXRA7 17q25.1 -0.186 0.158 0.698
xai ETV6 12p13 0.186 0.159 0.699 Transcription Factors
xai VIP 6q25 0.186 0.159 0.699 G-protein coupled receptor signaling
his BEGAIN 14q32.2 0.186 0.159 0.699
his SNORD88B 0.186 0.159 0.699
his SNORD88A 0.186 0.159 0.699
his SNORD88C 19q13.33 0.186 0.159 0.699
his C19orf48 19q13.33 0.186 0.159 0.699
hs4 RNF208 9q34.3 0.186 0.159 0.699
hs4 CYSRT1 0.186 0.159 0.699
xai CPSF7 11q12.2 0.186 0.159 0.699 protein tetramerization;nuclear mRNA
his BPNT1 1q41 0.186 0.159 0.699 nucleobase-containing compound metabolic
his OR2A5 0.186 0.159 0.699
xai ADSS 1q44 0.186 0.159 0.699 purine nucleotide biosynthetic process;AMP
hs4 CD72 9p13.3 0.186 0.159 0.699 cell adhesion;axon guidance
hs4 LRRFIP1 2q37.3 0.186 0.159 0.699 regulation of transcription from
RNA polymerase II promoter;negative regulation of transcription, DNA-dependent"
his AKAP9 7q21-q22 0.186 0.159 0.699 mitotic cell cycle;transport
xai CLEC5A 7q33 0.186 0.159 0.699 signal transduction;response to virus
his PTPRA 20p13 0.186 0.159 0.699 protein phosphorylation;axon guidance
his NAGA 22q11 0.186 0.159 0.7 carbohydrate catabolic process;glycoside
catabolic process
his FAM109B 22q13.2 0.186 0.159 0.7 endosome organization;retrograde
hs4 BMP8A 1p34.3 0.186 0.159 0.7 ossification;multicellular organismal
development
his NSUN5P1 0.186 0.159 0.7
xai TMEM97P2 8p21.3 0.186 0.159 0.7
xai LOC100287166 20p11.23 0.186 0.159 0.7
his HDAC3 5q31 0.186 0.159 0.7 Apoptosis
his RELL2 5q31.3 0.186 0.159 0.7 positive regulation of cell-substrate
adhesion
xai IGHG3 0.186 0.159 0.7 immune response;complement activation
xai SH3BP1 22q13.1 0.186 0.159 0.7 signal transduction
xai BAHD1 15q15.1 0.186 0.159 0.7 chromatin modification;heterochromatin
assembly
xai LPXN 11q12.1 0.186 0.159 0.7 negative regulation of B cell receptor
hs4 MPI 15q24.1 0.186 0.159 0.7 carbohydrate metabolic process;dolichol-
xai DUXAP10 0.186 0.159 0.7
his ZNF8 19q13.43 0.186 0.159 0.7 negative regulation of transcription from
his ZNF8-ERVK3-1 0.186 0.159 0.7
hs4 ARC 8q24.3 0.186 0.159 0.701 regulation of cell
his LRFN4 11q13.2 0.186 0.159 0.701
hs4 KARS 16q23.1 0.186 0.159 0.701 tRNA aminoacylation for protein
hs4 TERF2IP 16q23.1 0.186 0.159 0.701 DNA Damage Response (DDR)
xai FAM135B 8q24.23 0.186 0.159 0.701
his RPL21 13q12.2 0.186 0.159 0.701 nuclear-transcribed mRNA catabolic
his SNORD102 0.186 0.159 0.701
his SNORA27 0.186 0.159 0.701
hs4 MST1 3p21 0.186 0.159 0.701
hs4 RNF123 3p24.3 0.186 0.159 0.701
met PATE1 11q24.2 0.184 0.159 0.699
xsq LIPT1 0.184 0.159 0.699 protein modification process;lipid metabolic
process
exp RFC1 4p14-p13 0.184 0.159 0.699 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
met POU6F2 7p14.1 0.184 0.159 0.699 regulation of transcription, DNA-
xsq PI4K2B 4p15.2 0.184 0.159 0.699
xsq AP5M1 14q22.3 0.184 0.159 0.699 intracellular protein transport;vesicle-
mediated transport
met MEX3D 19p13.3 0.184 0.159 0.699 posttranscriptional regulation of gene
expression by mRNA localization;regulation of anti-apoptosis
exp LIN7A 12q21 0.184 0.159 0.699 protein transport;protein complex assembly
exp STAG2 Xq25 0.184 0.159 0.699 DNA Damage Response (DDR); Tumor Suppressors
xsq VPS33B 15q26.1 0.184 0.159 0.699 protein transport;vesicle-mediated
transport
xsq RPL10A 6p21.31 0.184 0.159 0.699 translational termination;viral
transcription
met AGBL4 1p33 0.184 0.159 0.699 C-terminal protein deglutamylation;protein side
chain deglutamylation
exp TARBP2P 0.184 0.159 0.699
xsq HDHD2 18q21.1 0.184 0.159 0.699 metabolic process
xsq SEC61B 9q22.32-q31.3 0.184 0.159 0.699 translation;SRP-dependent
met CCDC64 12q24.23 0.184 0.159 0.699 transport;nervous system
development
xsq LOC101928936 0.184 0.159 0.699
met OR2G3 1q44 0.184 0.159 0.699 response to stimulus
met AK4 1p31.3 0.184 0.159 0.699
cop CDK17 12q23.1 0.184 0.159 0.699 Protein Kinases
xsq C9orf24 9p13.3 0.184 0.159 0.699 cellular protein complex assembly
xsq EBP Xp11.23-p11.22 0.184 0.159 0.699 cholesterol metabolic
process;hemopoiesis
exp UTS2B 3q28 0.184 0.159 0.699
exp EXOG 3p21.3 0.184 0.159 0.699 DNA Damage Response (DDR)
exp MLLT10 10p12 0.184 0.159 0.699 regulation of transcription, DNA-
exp EDRF1 0.184 0.159 0.699 regulation of transcription, DNA-dependent"
exp IL23R 1p31.3 0.184 0.159 0.699 positive regulation of defense response
exp ADSS 1q44 0.184 0.159 0.7 purine nucleotide biosynthetic process;AMP
exp CHEK2P1 0.184 0.159 0.7
met CBR3 21q22.2 0.184 0.159 0.7 phylloquinone catabolic process
met PPP1R26 9q34.3 0.184 0.159 0.7 negative regulation of phosphatase
activity
cop STXBP5-AS1 0.184 0.159 0.7
xsq ZCCHC13 Xq13.2 0.184 0.159 0.7
xsq DTYMK 2q37.3 0.184 0.159 0.7 cell cycle;cell proliferation
xsq TALDO1 11p15.5-p15.4 0.184 0.159 0.7 fructose 6-phosphate
exp ARGLU1 13q33.3 0.184 0.159 0.7 regulation of transcription, DNA-
dependent"
exp NUCB2 11p15.1 0.184 0.159 0.7
xsq NT5C1A 1p34.3-p33 0.184 0.159 0.7
xsq SLC35G1 10q23.33 0.184 0.159 0.7
met ZDHHC18 1p36.11 0.184 0.159 0.7 metabolic process;cellular protein
localization
exp EHMT1 9q34.3 0.184 0.159 0.7 DNA methylation;histone H3-K9 methylation
exp PRMT6 1p13.3 0.184 0.159 0.7 DNA Damage Response (DDR)
exp ZNF252P-AS1 8q24.3 0.184 0.159 0.7
xsq TRIM28 19q13.4 0.184 0.159 0.7 DNA Damage Response (DDR)
xsq TLR7 Xp22.3 0.184 0.159 0.7 microglial cell activation involved in
immune response;positive regulation of NF-kappaB import into nucleus
mut ADAP2 17q11.2 0.184 0.159 0.7 heart development;regulation of ARF
GTPase activity
met GP2 16p12 0.184 0.159 0.7
exp SMARCD1 12q13-q14 0.184 0.159 0.7 DNA Damage Response (DDR); DDR
(Chromatin)
cop THADA 2p21 0.184 0.159 0.7
exp PTPRN2 7q36 0.184 0.159 0.7 protein dephosphorylation;negative
xsq SAMD7 3q26.2 0.184 0.159 0.7
exp RFESD 5q15 0.184 0.159 0.7
xsq SF3A1 22q12.2 0.184 0.159 0.7 gene expression;nuclear mRNA 3'-splice
site recognition
xsq STRA6 15q24.1 0.184 0.159 0.7 ventricular septum development;vocal
learning
mut GPR156 3q13.33 0.184 0.159 0.7
cop ASCL2 11p15.5 0.184 0.159 0.7 in utero embryonic development;cell
differentiation
cop C11orf21 11p15.5 0.184 0.159 0.7
cop TSPAN32 11p15.5 0.184 0.159 0.7 cell-cell signaling
cop CD81 11p15.5 0.184 0.159 0.7 phosphatidylinositol biosynthetic
process;phosphatidylinositol metabolic process
cop TSSC4 11p15.5 0.184 0.159 0.7
met CCDC160 Xq26.2 0.184 0.159 0.7
exp FKBP3 14q21.2 0.184 0.159 0.7 protein folding;peptidyl-proline
modification
met CAMK1 3p25.3 0.184 0.159 0.701 nervous system development;positive
cop DYSF 2p13.3 0.184 0.159 0.701
xsq DHX16 6p21.3 0.184 0.159 0.701 mRNA processing;RNA splicing
cop MCEE 2p13.3 0.184 0.159 0.701 fatty acid beta-oxidation;short-chain
cop MPHOSPH10 2p13.3 0.184 0.159 0.701 RNA processing;RNA splicing
cop PAIP2B 2p13.3 0.184 0.159 0.701 negative regulation of
dependent;RNA splicing"
xsq UBA2 19q12 0.184 0.159 0.701 DNA Damage Response (DDR)
xsq MBP 18q23 -0.184 0.159 0.7 immune response;synaptic transmission
exp MFI2 3q28-q29 -0.184 0.159 0.7 ion transport;iron ion transport
met LINC00312 3p25.3 -0.184 0.159 0.7
cop IL6 7p21 -0.184 0.159 0.7 Apoptosis
exp PLIN3 19p13.3 -0.184 0.159 0.7 vesicle-mediated transport
met MKNK2 19p13.3 -0.184 0.159 0.7 Protein Kinases
met RFC4 3q27 -0.184 0.159 0.699 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
exp APOA1 -0.184 0.159 0.699 cholesterol biosynthetic process;lipid
storage
cop ACAP2 3q29 -0.184 0.159 0.699 regulation of ARF GTPase activity
exp CLDN9 16p13.3 -0.184 0.159 0.699 calcium-independent cell-cell
mut LMBR1L 12q13.12 -0.184 0.159 0.699 endocytosis
xsq COL7A1 3p21.1 -0.184 0.159 0.699 cell adhesion;epidermis
development
xsq AXL 19q13.1 -0.184 0.159 0.699 Protein Kinases
xsq HLA-DRB1 6p21.3 -0.184 0.159 0.699 T cell costimulation;T cell
xsq NOL3 16q22.1 -0.184 0.159 0.699 Apoptosis
cop LOC650226 7p11.2 -0.184 0.159 0.699
cop DKFZp434L192 7p11.2 -0.184 0.159 0.699
xsq TANC2 17q23.3 -0.184 0.159 0.699
met TIFAB 5q31.1 -0.184 0.159 0.699
xsq TFEB 6p21 -0.184 0.159 0.699 positive regulation of transcription from
his LINC00691 3p24.2 -0.186 0.159 0.701
hs4 SPATA20 17q21.33 -0.186 0.159 0.701 mannose metabolic
xai ECM1 1q21 -0.186 0.159 0.701 positive regulation of endothelial cell
dependent"
his CCDC169-SOHLH2 -0.186 0.159 0.7
his CCDC169 13q13.3 -0.186 0.159 0.7
exp LINC01446 -0.186 0.159 0.7
xai C1orf226 1q23.3 -0.186 0.159 0.7
hs4 FRMD4A 10p13 -0.186 0.159 0.7
hs4 LOC100233156 -0.186 0.159 0.7
xai LHFPL3-AS2 -0.186 0.159 0.7
xai PHLDA2 11p15.4 -0.186 0.159 0.7 apoptotic process;organ
morphogenesis
xai SERPINE1 7q22.1 -0.186 0.159 0.7 response to reactive oxygen
species;negative regulation of smooth muscle cell migration
xai ELF4 Xq26 -0.186 0.159 0.7 Transcription Factors
hs4 HRH1 3p25 -0.186 0.159 0.7 synaptic transmission;response to gravity
xai PDZK1IP1 1p33 -0.186 0.159 0.7
his C9orf170 9q21.33 -0.186 0.159 0.7
hs4 HOGA1 10q24.2 -0.186 0.159 0.7 glyoxylate catabolic process
his UPP1 7p12.3 -0.186 0.159 0.7 nucleotide catabolic
his BOD1 5q35.2 -0.186 0.159 0.7 cell cycle;mitosis
hs4 GABRA4 4p12 -0.186 0.159 0.7 ion transmembrane
his RUNX2 6p21 -0.186 0.159 0.7 negative regulation of transcription,
DNA-dependent;positive regulation of transcription, DNA-dependent
xai CXorf23 Xp22.12 -0.186 0.159 0.699
hs4 AXL 19q13.1 -0.186 0.159 0.699 Protein Kinases
xai ALS2CR11 2q33.1 -0.186 0.159 0.699
xai LOC440934 2q36.1 -0.186 0.159 0.699
xai KIF26B 1q44 -0.186 0.159 0.699 microtubule-based
xai CLIC5 6p12.3 -0.186 0.159 0.699 ion transport;chloride transport
his TGM2 20q12 -0.186 0.159 0.699 metabolic process;protein
homooligomerization
xai POU6F1 -0.186 0.159 0.699 muscle organ development;regulation
his ITGB2 21q22.3 -0.186 0.159 0.699 Apoptosis
his LOC101928596 -0.186 0.159 0.699
his ATP1B1 1q24 -0.186 0.159 0.699 ATP biosynthetic process;transport
dependent"
exp POU6F1 -0.186 0.159 0.699 muscle organ development;regulation
his C9orf69 9q34.3 0.186 0.16 0.701
his KPNA2 17q24.2 0.185 0.16 0.701 regulation of DNA recombination;M phase
specific microtubule process
xai DPP3 11q12-q13.1 0.185 0.16 0.701 proteolysis
xai ORC5 7q22.1 0.185 0.16 0.701 DDR (DNA replication)
xai KIAA0907 1q22 0.185 0.16 0.701
exp RINL 19q13.2 0.185 0.16 0.701
his EIF3CL 0.185 0.16 0.701
xai CILP2 19p13.11 0.185 0.16 0.701
xai IL23R 1p31.3 0.185 0.16 0.701 positive regulation of defense response
xai PRPF4B 6p25.2 0.185 0.16 0.701 nuclear mRNA splicing, via
xai FLJ45825 0.185 0.16 0.701
his DHTKD1 10p14 0.185 0.16 0.701 glycolysis;tricarboxylic acid cycle
xai SETD2 3p21.31 0.185 0.16 0.701 Tumor Suppressors
his F13A1 6p25.3-p24.3 0.185 0.16 0.701 peptide cross-linking;platelet
activation
xai LOC100129215 0.185 0.16 0.701
exp FTLP4 9p21.1 0.185 0.16 0.701
xai RBM22 5q33.1 0.185 0.16 0.701 protein import into nucleus,
xai PDE4D 5q12 0.185 0.16 0.701 establishment of endothelial barrier;cAMP
catabolic process
xai TRIM60P14 4q32.3 0.185 0.16 0.701
his LINC01578 0.185 0.16 0.701
his CHD2 15q26 0.185 0.16 0.701 regulation of transcription from RNA polymerase
II promoter
his MIR3175 0.185 0.16 0.701
his POTED 21q11.2 0.185 0.16 0.701
his ATXN7L2 1p13.3 0.185 0.16 0.701
his BBX 3q13.1 0.185 0.16 0.701 regulation of transcription, DNA-
dependent"
xai CCDC12 3p21.31 0.185 0.16 0.701
his PPP1R14B 11q13 0.185 0.16 0.701 regulation of phosphorylation
his PLCB3 11q13 0.185 0.16 0.701 lipid catabolic process;intracellular signal
transduction
exp TRIM60P14 4q32.3 0.185 0.16 0.701
swa BUB3 10q26 0.185 0.16 0.701 attachment of spindle microtubules to
his SELL 1q23-q25 0.185 0.16 0.701 cell adhesion;blood coagulation
xai RFPL3S 22q12.3 0.185 0.16 0.701
xai CCDC117 22q12.1 0.185 0.16 0.701
swa USP14 18p11.32 0.185 0.16 0.701 proteolysis;ubiquitin-dependent protein
catabolic process
his NRL 14q11.1-q11.2 0.185 0.16 0.701 transcription from RNA polymerase
his CCDC97 19q13.2 0.185 0.16 0.701
xai UHRF1BP1L 12q23.1 0.185 0.16 0.701
his PHF2 9q22.31 0.185 0.16 0.701 protein demethylation;chromatin
modification
his VPS51 11q13 0.185 0.16 0.701
xai TFR2 7q22 0.185 0.16 0.701 proteolysis;iron ion transport
his LOC105372179 0.185 0.16 0.701
his NAAA 4q21.1 0.185 0.16 0.701 lipid metabolic process
exp LTA 6p21.3 0.185 0.16 0.701 response to hypoxia;response to nutrient
xai FTLP4 9p21.1 0.185 0.16 0.701
hs4 CDHR2 5q35.2 0.185 0.16 0.701 cell adhesion;homophilic cell adhesion
his PTGER2 14q22 0.185 0.16 0.701 G-protein coupled receptor signaling
pathway;regulation of cell proliferation
hs4 TMEM97 17q11.2 0.185 0.16 0.701 regulation of cell
exp SMG1P7 0.185 0.16 0.701
his CACNB1 17q21-q22 0.185 0.16 0.701 protein targeting to
membrane;transport
his RPL19 17q12 0.185 0.16 0.701 SRP-dependent cotranslational protein targeting
to membrane;gene expression
xai SMG1P7 0.185 0.16 0.701
his ANKRD44-IT1 0.185 0.16 0.701
his ANKRD44 2q33.1 0.185 0.16 0.701 DNA Damage Response (DDR)
exp RPSAP29 3q13.13 0.184 0.16 0.701
exp GOLGA8Q 15q13.2 0.184 0.16 0.701
met LOC339788 0.184 0.16 0.701
exp EIF3D 22q13.1 0.184 0.16 0.701 cellular protein metabolic
cop UBE3A 15q11.2 0.184 0.16 0.701 positive regulation of
cop ATP10A 15q11.2 0.184 0.16 0.701 cation transport;regulation of cell
shape
cop MIR4715 0.184 0.16 0.701
met KCNQ1 11p15.5 0.184 0.16 0.701 synaptic transmission;regulation of
exp RANBP2 2q12.3 0.184 0.16 0.701 protein import into nucleus;small
met GAS2L1 22q12.2 0.184 0.16 0.701 regulation of cell
xsq OR1L4 0.184 0.16 0.701
exp TMEM216 11q13.1 0.184 0.16 0.701 cell projection organization;cilium
morphogenesis
exp PLPPR5 0.184 0.16 0.701
xsq REPS1 6q24.1 0.184 0.16 0.701
dependent"
met KANK4 1p31.3 0.184 0.16 0.701
xsq CD1B 1q23.1 0.184 0.16 0.701 immune response;antigen processing and
presentation
xsq PTER 10p12 0.184 0.16 0.701 catabolic process
exp C12orf56 12q14.2 0.184 0.16 0.701
exp TET1 10q21 0.184 0.16 0.701 stem cell maintenance;DNA demethylation
mut AKAP3 12p13.3 0.184 0.16 0.701 cellular component movement;transmembrane
receptor protein serine/threonine kinase signaling pathway
met TTC23 15q26.3 0.184 0.16 0.701
met CCL8 17q11.2 0.184 0.16 0.701 calcium ion transport;response to virus
met TCEAL8 Xq22.1 0.184 0.16 0.701 regulation of transcription, DNA-
dependent"
met MIR1253 0.184 0.16 0.701
exp LOC728417 1q41 0.184 0.16 0.701
xsq ERCC8 5q12.1 0.184 0.16 0.701 DNA Damage Response (DDR); DDR (NER)
xsq CMC2 16q23.2 0.184 0.16 0.701
xsq TFIP11 22q12.1 0.184 0.16 0.701 nuclear mRNA splicing, via
mut CCDC70 13q14.3 0.184 0.16 0.701
xsq NKAPP1 Xq24 0.184 0.16 0.701
xsq TBCD 17q25.3 0.184 0.16 0.701 negative regulation of cell-substrate
adhesion;negative regulation of microtubule polymerization
mut ADGRG5 0.184 0.16 0.701 G-protein coupled receptor signaling
cop ABHD2 15q26.1 0.184 0.16 0.701 response to wounding;negative regulation
of cell migration
xsq MRPS34 16p13.3 0.184 0.16 0.701
mut OR10X1 1q23.1 0.184 0.16 0.701
xsq DDC-AS1 0.184 0.16 0.701
cop GTF2H3 12q24.31 0.184 0.16 0.701 DNA Damage Response (DDR); DDR
(NER)
cop TCTN2 12q24.31 0.184 0.16 0.701 cell projection organization;cilium
assembly
cop ATP6V0A2 12q24.31 0.184 0.16 0.701 immune response;insulin receptor
signaling pathway
xsq EML2 19q13.32 0.184 0.16 0.701 visual perception;sensory perception of
sound
mut AGFG1 2q36.3 0.184 0.16 0.701 multicellular organismal
cop LOC100507462 0.184 0.16 0.701
exp BTF3P11 13q22 0.184 0.16 0.701
exp VDAC2P2 12p13.31 0.184 0.16 0.701
exp RPS28 19p13.2 0.184 0.16 0.701 nuclear-transcribed mRNA catabolic
xsq ARHGDIB 12p12.3 0.184 0.16 0.701 multicellular organismal
xsq FAM182B 20p11.1 0.184 0.16 0.701
met WNK3 Xp11.22 0.184 0.16 0.701 positive regulation of sodium ion
transport;regulation of ion homeostasis
xsq C10orf111 10p13 0.184 0.16 0.701
xsq TMPRSS15 21q21.1 0.184 0.16 0.701 proteolysis
xsq PEX5L 3q26.33 0.184 0.16 0.701 protein import into peroxisome
met FOXK1 7p22.1 0.183 0.16 0.701 negative regulation of transcription,
dependent"
cop TRIM42 3q23 -0.183 0.16 0.701
mut PHLDB2 3q13.2 -0.183 0.16 0.701
exp CCDC65 12q13.12 -0.184 0.16 0.701
xsq ABCC11 16q12.1 -0.184 0.16 0.701 ABC Transporters
DNA-dependent"
exp TRABD2B 1p33 -0.184 0.16 0.701
exp MGAT4EP -0.184 0.16 0.701
met B3GNT7 2q37.1 -0.184 0.16 0.701 protein glycosylation;O-
glycan processing
exp MGLL 3q21.3 -0.184 0.16 0.701 regulation of signal
exp KRT8P26 11q13.1 -0.184 0.16 0.701
exp PRKAA2 1p31 -0.184 0.16 0.701 Protein Kinases
exp LGR4 11p14-p13 -0.184 0.16 0.701 male genitalia
cop MRPS17 7p11 -0.184 0.16 0.701 translation
cop GBAS 7p12 -0.184 0.16 0.701
xsq AKT1S1 19q13.33 -0.184 0.16 0.701 nerve growth factor receptor
signaling pathway;negative regulation of protein kinase activity
xsq NUDT16P1 3q22.1 -0.184 0.16 0.701
exp CTRB2 16q23.1 -0.184 0.16 0.701 proteolysis;digestion
cop SEC61A1 3q21.3 -0.184 0.16 0.701 antigen processing and
cop RUVBL1 3q21 -0.184 0.16 0.701 Apoptosis; DNA Damage Response
cop EEFSEC 3q21.3 -0.184 0.16 0.701 selenocysteine
incorporation;GTP catabolic process
cop DNAJB8 3q21.3 -0.184 0.16 0.701
cop DNAJB8-AS1 -0.184 0.16 0.701
cop GATA2 3q21.3 -0.184 0.16 0.701 Oncogenes
cop LOC90246 3q21.3 -0.184 0.16 0.701
cop C3orf27 3q21 -0.184 0.16 0.701
cop RPN1 3q21.3 -0.184 0.16 0.701 translation;protein modification
process
cop RAB7A 3q21.3 -0.184 0.16 0.701 endosome to lysosome
cop LOC653712 3q21.3 -0.184 0.16 0.701
met FAM96A 15q22.31 -0.184 0.16 0.701 chromosome segregation
cop MRPS24 7p14 -0.184 0.16 0.701 translation
xsq LOC729609 Xp22.12 -0.184 0.16 0.701
xsq ARHGAP1 11p11.2 -0.184 0.16 0.701 positive regulation of Rho
GTPase activity;regulation of GTPase activity
exp PRX 19q13.2 -0.184 0.16 0.701 axon ensheathment;nerve development
xsq RHOBTB2 8p21.3 -0.184 0.16 0.701 small GTPase mediated signal
exp UBTD2 5q35.1 -0.184 0.16 0.701
mut BSN 3p21.31 -0.184 0.16 0.701 synaptic transmission
met KEAP1 19p13.2 -0.184 0.16 0.701 in utero embryonic
xsq PRSS8 16p11.2 -0.184 0.16 0.701 EMT (Epithelial)
exp TSPAN10 17q25.3 -0.184 0.16 0.701
xsq RAPGEF3 12q13.1 -0.184 0.16 0.701 small molecule metabolic
mut ERP27 12p12.3 -0.184 0.16 0.701
exp CRB3 19p13.3 -0.184 0.16 0.701 cell junction assembly;cell-cell
mut BANK1 4q24 -0.184 0.16 0.701 B cell activation
xsq LINC01511 -0.184 0.16 0.701
xsq RRAGA 9p22.1 -0.184 0.16 0.701 Apoptosis
xsq CLDN24 4q35.1 -0.184 0.16 0.701
met MGC16275 17q25.1 -0.184 0.16 0.701
his RPE65 1p31 -0.185 0.16 0.701 vitamin A metabolic process;visual
perception
xai SEC61A1 3q21.3 -0.185 0.16 0.701 antigen processing and
xai XCL2 -0.185 0.16 0.701 chemotaxis;immune response
exp RPLP2P1 6p22.1 -0.185 0.16 0.701
exp SNTG1 8q11-q12 -0.185 0.16 0.701 cell communication
xai RPLP2P1 6p22.1 -0.185 0.16 0.701
xai PSEN2 1q42.13 -0.185 0.16 0.701 Apoptosis
DNA-dependent"
hs4 ZNF667-AS1 19q13.43 -0.185 0.16 0.701
xai SAR1B 5q31.1 -0.185 0.16 0.701 cellular membrane
xai TMEM40 3p25.2 -0.185 0.16 0.701
his F3 1p22-p21 -0.185 0.16 0.701 anti-apoptosis;positive regulation
hs4 TMEM62 15q15.2 -0.185 0.16 0.701
his LINC01405 -0.185 0.16 0.701
his FAM83B 6p12.1 -0.185 0.16 0.701
his UNC5D 8p12 -0.185 0.16 0.701 apoptotic process;signal transduction
his DTX2 7q11.23 -0.185 0.16 0.701 Notch signaling pathway
cop B3GNT5 3q28 -0.185 0.16 0.701 protein glycosylation;multicellular
xai SPATA20 17q21.33 -0.185 0.16 0.701 mannose metabolic
xai KRT8P5 18q12.3 -0.185 0.16 0.701
xai KRT8P26 11q13.1 -0.185 0.16 0.701
hs4 FZD7 2q33 -0.185 0.16 0.701 G-protein signaling, coupled to cGMP
nucleotide second messenger;stem cell maintenance
xai CTAGE11P 13q22.2 -0.185 0.16 0.701
his PLEKHA1 10q26.13 -0.185 0.16 0.701 female gonad
hs4 EPHB4 7q22 -0.185 0.16 0.701 protein autophosphorylation;ephrin
exp PCDHB18P -0.185 0.16 0.701 cell adhesion;homophilic cell
adhesion
his HDAC11-AS1 -0.185 0.16 0.701
his HDAC11 3p25.1 -0.185 0.16 0.701 regulation of transcription,
DNA-dependent;oligodendrocyte development
hs4 SULT1E1 4q13.1 -0.185 0.16 0.701 xenobiotic metabolic
process;female pregnancy
xai RNH1 11p15.5 -0.185 0.16 0.701 mRNA catabolic process;regulation
of angiogenesis
xai GOLGA3 12q24.33 -0.185 0.16 0.701 intra-Golgi vesicle-mediated
transport
xai LNX1 4q12 -0.185 0.16 0.701 protein ubiquitination involved in
xai LOC401052 3p25.3 -0.185 0.16 0.701
hs4 TNS1 2q35-q36 -0.185 0.16 0.701 cell-substrate junction
xai IFITM9P 11q13.3 -0.185 0.16 0.701
exp AMTN 4q13.3 -0.185 0.16 0.701 cell adhesion;biomineral tissue
development
hs4 LOC100505984 -0.185 0.16 0.701
xai FRMD7 Xq26.2 -0.185 0.16 0.701 nervous system
swa TIMM50 19q13.2 -0.186 0.16 0.701 mitochondrial membrane
his NPFF 12q13.13 -0.186 0.16 0.701 neuropeptide signaling
cop MIR4313 0.187 0.161 0.702
exp VSTM5 11q21 0.185 0.161 0.701
hs4 SSBP3 1p32.3 0.185 0.161 0.701 prechordal plate formation;midbrain-
hindbrain boundary initiation
exp LOC100129215 0.185 0.161 0.701
his SNORA75 0.185 0.161 0.702
swa SH3BGRL3 1p36.11 0.185 0.161 0.702 cell redox homeostasis
his HNRNPH1 5q35.3 0.185 0.161 0.702 gene expression;regulation of RNA
splicing
hs4 DSG1-AS1 0.185 0.161 0.702
his SMN1 0.185 0.161 0.702
xai TRIM35 8p21.2 0.185 0.161 0.702 positive regulation of apoptotic
process;negative regulation of mitotic cell cycle
swa HDAC2 6q21 0.185 0.161 0.702 negative regulation of neuron projection
exp FAM9B Xp22.32 0.185 0.161 0.702
swa CHTOP 1q21.3 0.185 0.161 0.702 regulation of transcription, DNA-
dependent"
xai PAX9 14q13.3 0.185 0.161 0.702 face morphogenesis;cellular response to
his WRAP53 17p13.1 0.185 0.161 0.702 DNA Damage Response (DDR)
his TP53 17p13.1 0.185 0.161 0.702 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication); Tumor Suppressors
xai CEACAM6 19q13.2 0.185 0.161 0.702 signal transduction;cell-cell
signaling
hs4 USP44 12q22 0.185 0.161 0.702 cell division;anaphase
swa C9orf114 9q34.11 0.185 0.161 0.702
xai KDM3A 2p11.2 0.185 0.161 0.702 histone H3-K9 demethylation;positive
cop BAHD1 15q15.1 0.185 0.161 0.702 chromatin modification;heterochromatin
assembly
cop CHST14 15q15.1 0.185 0.161 0.702 carbohydrate biosynthetic
process;dermatan sulfate proteoglycan metabolic process
xai GIMAP8 7q36.1 0.185 0.161 0.702
his TBC1D5 3p24.3 0.185 0.161 0.702
his LOC105376975 0.185 0.161 0.702
dependent"
his PCCA-AS1 0.185 0.161 0.702
xai IDE 10q23-q25 0.185 0.161 0.702 proteolysis;protein homotetramerization
hs4 CD320 19p13.3-p13.2 0.185 0.161 0.702 regulation of cell growth
exp KIAA0907 1q22 0.185 0.161 0.702
his CKS2 9q22 0.185 0.161 0.702 cell division;regulation of cyclin-dependent
his MIR3153 0.185 0.161 0.702
his SECISBP2 9q22.2 0.185 0.161 0.702 translation
xai BAATP1 9q31.1 0.185 0.161 0.702
xai CD96 3q13.13-q13.2 0.185 0.161 0.702 cell adhesion;regulation of immune
response
hs4 LOC105369632 0.185 0.161 0.702
his SETD7 4q28 0.185 0.161 0.702 chromatin modification;peptidyl-lysine
monomethylation
xai TPTE2P5 0.185 0.161 0.702
xsq KHDC1L 6q13 0.183 0.161 0.701
cop SAMD3 6q23.1 0.183 0.161 0.701
mut CD101 1p13 0.183 0.161 0.701 cell surface receptor signaling pathway
exp POM121L7 22q11.21 0.183 0.161 0.701
met FBXO44 1p36.22 0.183 0.161 0.701 protein catabolic process
xsq CALML6 1p36.33 0.183 0.161 0.701
cop TAF1C 16q24 0.183 0.161 0.702 regulation of transcription, DNA-
xsq STRN 2p22.2 0.183 0.161 0.702 locomotory behavior;negative regulation
exp HMBOX1 8p21.1 0.183 0.161 0.702 negative regulation of
transcription, DNA-dependent;positive regulation of transcription, DNA-dependent"
xsq CD2BP2 16p11.2 0.183 0.161 0.702 nuclear mRNA splicing, via
exp SIRT5 6p23 0.183 0.161 0.702 chromatin silencing;protein ADP-ribosylation
xsq ASGR2 17p 0.183 0.161 0.702 glycoprotein metabolic process;bone
mineralization
exp KIZ 0.183 0.161 0.702 spindle organization
exp SPC25 2q31.1 0.183 0.161 0.702 mitotic cell cycle;mitotic spindle
organization
xsq M6PR 12p13 0.183 0.161 0.702 transport;receptor-mediated endocytosis
exp C17orf75 17q11.2 0.183 0.161 0.702 spermatogenesis
cop LOC100506172 0.183 0.161 0.702
xsq PPTC7 12q24.11 0.183 0.161 0.702
mut CALCR 7q21.3 0.183 0.161 0.702 positive regulation of adenylate cyclase
activity;activation of adenylate cyclase activity by G-protein signaling pathway
exp TATDN1 8q24.13 0.183 0.161 0.702
xsq ORM1 9q32 0.183 0.161 0.702 regulation of immune system process;transport
xsq OR4K14 0.183 0.161 0.702
dependent;induction of apoptosis
cop VAPA 18p11.22 0.183 0.161 0.702 sphingolipid biosynthetic process;neuron
xsq LOC102606465 0.183 0.161 0.702
met TRRAP 7q21.2-q22.1 0.183 0.161 0.702 Apoptosis; Oncogenes
met CALB1 8q21.3 0.183 0.161 0.702 metanephric distal convoluted tubule
development;learning or memory
met ULBP2 6q25 0.183 0.161 0.702 antigen processing and presentation;natural
xsq PIGL 17p12-p11.2 0.183 0.161 0.702 C-terminal protein lipidation;GPI anchor
xsq VWA3A 16p12.2 0.183 0.161 0.702
exp GRIN2D 19q13.33 0.183 0.161 0.702 signal transduction;synaptic
transmission
cop MOAP1 14q32 0.183 0.161 0.702 Apoptosis
exp IDH3A 15q25.1-q25.2 0.183 0.161 0.702 carbohydrate metabolic
exp BSND 1p32.1 0.183 0.161 0.702 chloride transport
exp TXNDC17 17p13.1 0.183 0.161 0.702 tumor necrosis factor-mediated
signaling pathway
cop POLG 15q25 0.183 0.161 0.702 DNA Damage Response (DDR)
met AVPI1 10q24.2 0.183 0.161 0.702 cell cycle;activation of MAPK activity
met SESN3 11q21 0.183 0.161 0.702 cell cycle arrest
xsq GALNT4 12q21.33 0.183 0.161 0.702
dependent"
xsq PNPLA1 6p21.31 0.183 0.161 0.702 metabolic process;lipid catabolic
process
xsq LOC285696 5p15.1 0.183 0.161 0.702
xsq NECAB1 8q21.3 0.183 0.161 0.702
exp LIN54 4q21.22 0.183 0.161 0.702 regulation of transcription, DNA-
mut CCDC102B 18q22.1 0.183 0.161 0.702
met PABPC1L2A Xq13.2 0.183 0.161 0.702
exp VWA8 13q14.11 0.183 0.161 0.702
cop MYEOV 11q13 0.183 0.161 0.702
xsq THG1L 5q33.3 0.183 0.161 0.702 tRNA modification;tRNA processing
mut SLC25A2 5q31 0.183 0.161 0.702 transport;cellular nitrogen compound
metabolic process
mut CALN1 7q11 0.183 0.161 0.702
xsq FAM186B 12q13.12 0.183 0.161 0.702
xsq LINC00184 0.183 0.161 0.702
xsq LOC148413 1p36.33 0.183 0.161 0.702
xsq PMS2P5 7q11.23 0.183 0.161 0.702 DNA Damage Response (DDR)
xsq LOC100133077 0.183 0.161 0.702
xsq TBC1D17 19q13.33 -0.183 0.161 0.702
mut PCDH9 13q21.32 -0.183 0.161 0.702 cell adhesion;homophilic cell
adhesion
exp KIAA1715 2q31 -0.183 0.161 0.702 limb development;multicellular
mut RCAN3 1p35.3-p33 -0.183 0.161 0.702 anatomical structure
morphogenesis;calcium-mediated signaling
mut TNNT2 1q32 -0.183 0.161 0.702 response to calcium ion;ventricular
mut FAM53A 4p16.3 -0.183 0.161 0.702
mut SLC31A1 9q32 -0.183 0.161 0.702 Solute Carriers
mut ST6GALNAC6 9q34.11 -0.183 0.161 0.702 glycosylceramide metabolic
mut CAMK1D 10p13 -0.183 0.161 0.702 regulation of apoptotic
process;positive regulation of phagocytosis
mut COX15 10q24 -0.183 0.161 0.702 mitochondrial electron transport,
mut OR4C11 11q11 -0.183 0.161 0.702 response to stimulus
mut OR4S2 -0.183 0.161 0.702
mut GPRC5A 12p13-p12.3 -0.183 0.161 0.702 G-protein coupled receptor
mut ARHGDIB 12p12.3 -0.183 0.161 0.702 multicellular organismal
mut PCK2 14q11.2 -0.183 0.161 0.702 glucose metabolic
mut EIF2B2 14q24.3 -0.183 0.161 0.702 central nervous system
development;cellular protein metabolic process
mut ECI1 -0.183 0.161 0.702 fatty acid metabolic process;fatty acid
beta-oxidation
mut ARHGEF15 17p13.1 -0.183 0.161 0.702 regulation of Rho protein
signal transduction;regulation of catalytic activity
mut CARD14 17q25 -0.183 0.161 0.702 positive regulation of protein
phosphorylation;activation of NF-kappaB-inducing kinase activity
mut ADNP2 18q23 -0.183 0.161 0.702 neuron differentiation;positive
mut NFKBID 19q13.12 -0.183 0.161 0.702 positive regulation of
thymocyte apoptosis;inflammatory response
mut PTGIR 19q13.3 -0.183 0.161 0.702 G-protein signaling, coupled to
cyclic nucleotide second messenger;cell-cell signaling
mut DEFB115 20q11.1 -0.183 0.161 0.702
mut MAGEB1 Xp21.3 -0.183 0.161 0.702
mut RCOR1 14q32.31 -0.183 0.161 0.702 interspecies interaction between
mut SERPINF1 17p13.3 -0.183 0.161 0.702 negative regulation of
angiogenesis;regulation of proteolysis
mut CHGA 14q32 -0.183 0.161 0.702 regulation of blood pressure
exp RAC1 7p22 -0.183 0.161 0.702 axon guidance;lamellipodium assembly
exp CYP21A2 -0.183 0.161 0.702 progesterone metabolic
exp ZNF148 3q21 -0.183 0.161 0.702 negative regulation of
exp LOC100270746 6p22.2 -0.183 0.161 0.702
exp LOC100126784 11p15.1 -0.183 0.161 0.702
exp APCDD1L-AS1 -0.183 0.161 0.702
exp CYP2U1 4q25 -0.183 0.161 0.702 xenobiotic metabolic process;small
exp LOC100127947 -0.183 0.161 0.702
exp ST6GALNAC5 1p31.1 -0.183 0.161 0.702 protein
mut PDK1 2q31.1 -0.183 0.161 0.702 cell surface receptor signaling
pathway;small GTPase mediated signal transduction
exp HPCAL1 2p25.1 -0.183 0.161 0.702
met HOXA11 7p15.2 -0.183 0.161 0.702 metanephros
cop LOC100506178 -0.183 0.161 0.702
xsq TTBK2 15q15.2 -0.183 0.161 0.702 cell death;peptidyl-serine
phosphorylation
cop DVL3 3q27 -0.183 0.161 0.702 Wnt receptor signaling pathway;Wnt
xsq CSRP1 1q32 -0.183 0.161 0.701
cop FKBP9P1 -0.183 0.161 0.701
cop SEPT14 7p11.2 -0.183 0.161 0.701 cell cycle;cell division
exp BBOX1 11p14.2 -0.183 0.161 0.701 cellular nitrogen compound
exp EVI5L 19p13.2 -0.183 0.161 0.701
mut OR8D2 -0.183 0.161 0.701
his DEC1 9q32 -0.185 0.161 0.702 negative regulation of cell proliferation
his EHD2 19q13.3 -0.185 0.161 0.702 endocytosis;blood coagulation
his ADAMTS9-AS2 -0.185 0.161 0.702
his ADAMTS9 3p14.1 -0.185 0.161 0.702 proteolysis;glycoprotein
catabolic process
his LOC340581 -0.185 0.161 0.702
his SNX8 7p22.3 -0.185 0.161 0.702
xai GLIPR1 12q21.2 -0.185 0.161 0.702 cellular lipid metabolic
hs4 ZSCAN12 6p21 -0.185 0.161 0.702 viral reproduction
hs4 RP9 7p14.3 -0.185 0.161 0.702 RNA splicing
swa TACSTD2 1p32 -0.185 0.161 0.702 response to stimulus;negative
xai MIR210HG -0.185 0.161 0.702
xai GPX5 6p22.1 -0.185 0.161 0.702 lipid metabolic process;response to
oxidative stress
swa RASA1 5q13.3 -0.185 0.161 0.702 Apoptosis
xai RAC1P8 -0.185 0.161 0.702
xai GRM1 6q24 -0.185 0.161 0.702 locomotory behavior;calcium-mediated
signaling
xai CCDC40 17q25.3 -0.185 0.161 0.702 axonemal dynein complex
hs4 POU6F1 -0.185 0.161 0.702 muscle organ development;regulation
xai FAM110B 8q12.1 -0.185 0.161 0.702
xai TGOLN2 2p11.2 -0.185 0.161 0.702
hs4 CNKSR3 6q25.2 -0.185 0.161 0.702 negative regulation of
swa CALR 19p13.3-p13.2 -0.185 0.161 0.702 Apoptosis
DNA-dependent"
hs4 ZNF793-AS1 -0.185 0.161 0.702
hs4 MUC20 3q29 -0.185 0.161 0.702 hepatocyte growth factor receptor
xai LINC00961 9p13.3 -0.185 0.161 0.702
xai MIR205HG 1q32.2 -0.185 0.161 0.701
xai IFITM4P 6p22.1 -0.185 0.161 0.701
hs4 FAM225B 9q32 -0.185 0.161 0.701
hs4 FAM225A 9q32 -0.185 0.161 0.701
exp RAC1P8 -0.185 0.161 0.701
exp XCL2 -0.185 0.161 0.701 chemotaxis;immune response
xai PGM1 1p31 -0.185 0.161 0.701 glycogen biosynthetic process;glycogen
catabolic process
exp CMYA5 5q14.1 -0.185 0.161 0.701
his PER3 1p36.23 -0.185 0.161 0.701 DNA Damage Response (DDR)
his NOL9 1p36.31 0.185 0.162 0.702 maturation of 5.8S rRNA
his TAS1R1 1p36.23 0.185 0.162 0.702 response to stimulus;detection of
his CDPF1 22q13.31 0.185 0.162 0.702
xai ARPP19 15q21.2 0.185 0.162 0.703 G2/M transition of mitotic cell
cycle;cell cycle
his YES1 18p11.31-p11.21 0.185 0.162 0.703 Apoptosis
hs4 FAM173A 16p13.3 0.185 0.162 0.703
his C1QL4 12q13.12 0.185 0.162 0.703
his ASPM 1q31 0.185 0.162 0.703 cell cycle;mitosis
xai T1560 0.185 0.162 0.703
exp RPS7 2p25 0.185 0.162 0.703 translational initiation;viral infectious cycle
his DERL2 17p13.2 0.185 0.162 0.703 ER-associated protein catabolic
his MIS12 17p13.2 0.185 0.162 0.703 kinetochore assembly;M phase of mitotic
cell cycle
hs4 PARP1 1q41-q42 0.185 0.162 0.703 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
his CCHCR1 6p21.3 0.185 0.162 0.703 multicellular organismal
his TCF19 6p21.3 0.185 0.162 0.703 regulation of transcription from RNA
polymerase II promoter;cell proliferation
his ATP13A2 1p36 0.184 0.162 0.703 cation transport
xai ATP6AP1L 5q14.2 0.184 0.162 0.703 ATP hydrolysis coupled proton
transport
xai PCBD2 5q31.1 0.184 0.162 0.703 protein heterooligomerization;oxidation-
reduction process
hs4 C9orf69 9q34.3 0.184 0.162 0.703
hs4 LINC01635 0.184 0.162 0.703
hs4 LINC00339 1p36.12 0.184 0.162 0.703
xai FNBP1 9q34 0.184 0.162 0.703 endocytosis;nervous system development
xai NT5CP2 0.184 0.162 0.703
xai LOC100506860 0.184 0.162 0.703
xai METTL4 18p11.32 0.184 0.162 0.703 nucleobase-containing compound
metabolic process
exp NT5CP2 0.184 0.162 0.703
his ADCY7 16q12.1 0.184 0.162 0.703 GTP catabolic process;fibroblast growth
his DCTN4 5q31-q32 0.184 0.162 0.703
hs4 AUH 9q22.31 0.184 0.162 0.703 mRNA catabolic process;branched chain
his TSN 2q21.1 0.184 0.162 0.704 DNA recombination
his PTCD1 7q22.1 0.184 0.162 0.704
his CPSF4 7q22.1 0.184 0.162 0.704 virus-host interaction;modulation by
virus of host cellular process
his DNAH17-AS1 0.184 0.162 0.704
his KATNB1 16q21 0.184 0.162 0.704 microtubule severing;protein targeting
his LIG1 19q13.2-q13.3 0.184 0.162 0.704 DNA Damage Response (DDR); DDR
his C19orf68 19q13.33 0.184 0.162 0.704
xai EIF2D 1q32.1 0.184 0.162 0.704 translational initiation;intracellular
protein transport
xai DHFRL1 3q11.1 0.184 0.162 0.704 nucleotide biosynthetic
his ABHD17A 19p13.3 0.184 0.162 0.704
exp OR51E2 11p15 0.183 0.162 0.702 detection of chemical stimulus involved
met DCLK1 13q13 0.183 0.162 0.702 response to virus;endosome transport
exp USP21 1q22 0.183 0.162 0.702 protein modification process;proteolysis
xsq PPP4R3B 0.183 0.162 0.702 DNA Damage Response (DDR)
xsq CENPN 16q23.2 0.183 0.162 0.702 M phase of mitotic cell cycle;mitotic
prometaphase
met AP3S2 15q26.1 0.183 0.162 0.702 intracellular protein transport;vesicle-
mediated transport
xsq CPA1 7q32 0.183 0.162 0.702 proteolysis
met NAGK 2p13.3 0.183 0.162 0.702 N-acetylglucosamine metabolic process;N-
met ZAR1 4p11 0.183 0.162 0.702 sodium ion transport;multicellular organismal
development
xsq RTCB 22q12 0.183 0.162 0.702
dependent"
met SP6 17q21.32 0.183 0.162 0.702 regulation of transcription, DNA-
xsq LINC00243 0.183 0.162 0.702
xsq GSG1 12p13.1 0.183 0.162 0.703
met DEFB115 20q11.1 0.183 0.162 0.703
cop ABCB9 12q24 0.183 0.162 0.703 ABC Transporters
met TCEAL3 Xq22.2 0.183 0.162 0.703 regulation of transcription, DNA-
dependent"
met C1orf53 1q31.3 0.183 0.162 0.703
xsq MKRN2 3p25 0.183 0.162 0.703
xsq LAMP5 20p12 0.183 0.162 0.703
xsq TNFSF11 13q14 0.183 0.162 0.703 Apoptosis
xsq C21orf62-AS1 0.183 0.162 0.703
xsq SMYD4 17p13.3 0.183 0.162 0.703
mut FAM65A 16q22.1 0.183 0.162 0.703
exp LARP4B 10p15.3 0.183 0.162 0.703
xsq IMPA1 8q21.13-q21.3 0.183 0.162 0.703 phosphatidylinositol biosynthetic
process;phosphate-containing compound metabolic process
met ZXDA Xp11.1 0.183 0.162 0.703 positive regulation of transcription,
DNA-dependent"
xsq CTBP1 4p16 0.183 0.162 0.703 protein phosphorylation;negative regulation of
dependent"
exp RNF219 13q31.1 0.183 0.162 0.703
cop TMEM244 6q22.33 0.183 0.162 0.703
met KCNIP4 4p15.32 0.183 0.162 0.703 ion transport;potassium ion
transport
xsq RPS14P3 0.183 0.162 0.703
cop L3MBTL3 6q23 0.183 0.162 0.703 regulation of transcription, DNA-
met MEIS3P1 17p12 0.183 0.162 0.703
cop SLTM 15q22.1 0.183 0.162 0.703 regulation of transcription, DNA-
xsq COX7A2 6q12 0.183 0.162 0.703
cop ASXL2 2p24.1 0.183 0.162 0.703 regulation of transcription, DNA-
dependent"
met ACOT1 14q24.3 0.183 0.162 0.703 lipid metabolic process;acyl-CoA
metabolic process
met PROKR2 20p12.3 0.183 0.162 0.703
xsq CLDND2 19q13.41 0.183 0.162 0.703
xsq MID1IP1 Xp11.4 0.183 0.162 0.703 negative regulation of microtubule
depolymerization;positive regulation of fatty acid biosynthetic process
exp OSTCP1 6q25.3 0.183 0.162 0.703
met DHRS7 14q23.1 0.183 0.162 0.703
xsq BMP15 Xp11.2 0.183 0.162 0.703 ovarian follicle development;female
gamete generation
met SNTG1 8q11-q12 0.183 0.162 0.703 cell communication
cop KSR2 12q24.22-q24.23 0.183 0.162 0.703 intracellular signal transduction
met LTBP3 11q13.1 0.183 0.162 0.703 transforming growth factor beta receptor
signaling pathway;negative regulation of bone mineralization
xsq DOT1L 19p13.3 0.183 0.162 0.704 DDR (DNA replication)
exp SPOP 17q21.33 0.183 0.162 0.704 mRNA processing
met ACBD7 10p13 0.183 0.162 0.704
exp POM121 7q11.23 0.183 0.162 0.704 cytokine-mediated signaling
xsq TSPYL2 Xp11.2 0.183 0.162 0.704 negative regulation of cell
xsq IFT88 13q12.1 0.183 0.162 0.704 in utero embryonic development;protein
processing
exp FITM2 20q13.12 -0.183 0.162 0.704 positive regulation of sequestering
of triglyceride;regulation of cell morphogenesis
cop CALB1 8q21.3 -0.183 0.162 0.704 metanephric distal convoluted
tubule development;learning or memory
exp KRT8P41 11p15.4 -0.183 0.162 0.704
xsq FBXL5 4p15.32 -0.183 0.162 0.703 protein ubiquitination;SCF-
exp STT3A 11q23.3 -0.183 0.162 0.703 post-translational protein
exp SHISA2 13q12.13 -0.183 0.162 0.703 multicellular organismal
development
xsq RYK 3q22 -0.183 0.162 0.703 Wnt receptor signaling
xsq OTOGL 12q21.31 -0.183 0.162 0.703
exp APCDD1 18p11.22 -0.183 0.162 0.703 hair follicle
exp RGPD8 2q13 -0.183 0.162 0.703 protein targeting to Golgi;intracellular
transport
cop MIR1537 -0.183 0.162 0.703
met PLIN4 19p13.3 -0.183 0.162 0.703
met PMS2P5 7q11.23 -0.183 0.162 0.703 DNA Damage Response (DDR)
exp GADD45A 1p31.2 -0.183 0.162 0.703 Apoptosis; DNA Damage
exp DSTYK 1q32.1 -0.183 0.162 0.703
met GBP5 1p22.2 -0.183 0.162 0.703 cellular response to interferon-
gamma
xsq EFNB3 17p13.1 -0.183 0.162 0.703 nervous system development;adult
walking behavior
xsq GSN-AS1 9q33.2 -0.183 0.162 0.703
xsq SYCE1 10q26.3 -0.183 0.162 0.703 cell cycle;meiosis
exp SAR1B 5q31.1 -0.183 0.162 0.702 cellular membrane
exp RPL37AP9 12p13.1 -0.183 0.162 0.702
exp LOC100133286 21q22.12 -0.183 0.162 0.702
xai LOC100128198 -0.184 0.162 0.704
hs4 FNDC5 1p35.1 -0.184 0.162 0.704
his LOC283140 -0.184 0.162 0.704
DNA-dependent"
xai C7orf25 7p14.1 -0.184 0.162 0.704
hs4 KAAG1 6p22.1 -0.184 0.162 0.704 immune response
hs4 CCDC73 11p13 -0.184 0.162 0.704
his SAXO1 -0.184 0.162 0.703
his RRAGA 9p22.1 -0.184 0.162 0.703 Apoptosis
xai SMC5-AS1 -0.184 0.162 0.703
hs4 TFEB 6p21 -0.184 0.162 0.703 positive regulation of transcription from
his KNDC1 10q26.3 -0.184 0.162 0.703 regulation of dendrite
xai STXBP6 14q12 -0.184 0.162 0.703 vesicle-mediated transport
his MIR3164 -0.184 0.162 0.703
exp MIR4422 -0.184 0.162 0.703
xai AMTN 4q13.3 -0.184 0.162 0.703 cell adhesion;biomineral tissue
development
xai KRTAP4-6 -0.184 0.162 0.703
hs4 KLHDC9 1q23.3 -0.184 0.162 0.703
hs4 LINC01444 -0.184 0.162 0.703
xai LOC145474 14q24.2 -0.184 0.162 0.703
swa G3BP1 5q33.1 -0.184 0.162 0.703 transport;Ras protein signal
transduction
exp RYKP1 17p13.2 -0.184 0.162 0.703
xai MCOLN1 19p13.2 -0.185 0.162 0.703 transferrin
xai HS6ST3 13q32.1 -0.185 0.162 0.703
hs4 MECOM 3q26.2 -0.185 0.162 0.703 response to external
swa APIP 11p13 -0.185 0.162 0.703 methionine biosynthetic process;L-
methionine salvage from methylthioadenosine
hs4 OXR1 8q23 -0.185 0.162 0.703 response to oxidative stress;cell wall
cop RNU6-16P -0.185 0.162 0.703
exp KRTAP4-6 -0.185 0.162 0.703
xai LRRC75A -0.185 0.162 0.703
xai SHISA2 13q12.13 -0.185 0.162 0.703 multicellular organismal
development
hs4 FOXS1 20q11.21 -0.185 0.162 0.703 lymphangiogenesis;collagen fibril
organization
hs4 ZSCAN31 6p21.31 -0.185 0.162 0.703
xai DSEL 18q22.1 -0.185 0.162 0.703
xai CHMP5 9p13.3 -0.185 0.162 0.703 lysosome organization;endosome to
lysosome transport
his MYO1B 2q12-q34 -0.185 0.162 0.702 actin filament-based movement;actin
xai LOC100129089 -0.185 0.162 0.702
xai PMF1 1q12 0.186 0.163 0.705 cell division;M phase of mitotic cell cycle
xai KRTAP4-8 17q21.2 0.185 0.163 0.705
his HPD 12q24.31 0.184 0.163 0.704 L-phenylalanine catabolic
his PSMD9 12q24.31-q24.32 0.184 0.163 0.704 M/G1 transition of mitotic cell
his KCND2 7q31 0.184 0.163 0.704 regulation of action potential;ion transport
hs4 F8A3 0.184 0.163 0.704
hs4 MIR1184-3 0.184 0.163 0.704
hs4 H2AFB3 Xq28 0.184 0.163 0.704
his MIR346 0.184 0.163 0.704
xai NR6A1 9q33.3 0.184 0.163 0.704 negative regulation of transcription from
swa PCMT1 6q24-q25 0.184 0.163 0.704 protein repair;S-adenosylhomocysteine
metabolic process
xai IGBP1P3 3p22.3 0.184 0.163 0.704
xai PKMYT1 16p13.3 0.184 0.163 0.704 regulation of mitosis;negative
hs4 DAB1 1p32-p31 0.184 0.163 0.704 cell differentiation;multicellular
xai DOLPP1 9q34.1 0.184 0.163 0.704 protein N-linked glycosylation via
his PCF11 11q13 0.184 0.163 0.705 RNA splicing;gene expression
his ARNT 1q21 0.184 0.163 0.705 cell differentiation;positive regulation of
his SYNE3 14q32.13 0.184 0.163 0.705
xai RAD17 5q13 0.184 0.163 0.705 DNA Damage Response (DDR)
his NPW 16p13.3 0.184 0.163 0.705 G-protein coupled receptor signaling
xai IMP4 2q21.1 0.184 0.163 0.705 rRNA processing
his TDRKH 1q21 0.184 0.163 0.705
xai VPS4A 16q22.1 0.184 0.163 0.705 cellular membrane organization;vesicle-
mediated transport
swa TPT1 13q14 0.184 0.163 0.705 Apoptosis
exp WDR64 1q43 0.184 0.163 0.705
xai GOLGA8M 15q13.1 0.184 0.163 0.705
exp PARGP1 0.184 0.163 0.705
xai BZW1P1 3q26.31 0.184 0.163 0.705
his ELF1 13q13 0.184 0.163 0.705 Transcription Factors
his PSMD12 17q24.2 0.184 0.163 0.705 antigen processing and presentation
of peptide antigen via MHC class I;mRNA metabolic process
xai SCAF8 6q25.1-q25.3 0.184 0.163 0.705 transcription from RNA polymerase
xai MARCH7 2q24.2 0.184 0.163 0.705
hs4 LINC01046 0.184 0.163 0.705
xai PARGP1 0.184 0.163 0.705
exp LOC643387 2q37.3 0.184 0.163 0.705
xai KCNK15 20q13.12 0.184 0.163 0.705 potassium ion transport;ion
transport
his DDX59 1q32.1 0.184 0.163 0.705
his LOC101929224 0.184 0.163 0.705
swa DNAJC19 3q26.33 0.184 0.163 0.705 protein folding;protein targeting
to mitochondrion
xai LAMTOR4 7q22.1 0.184 0.163 0.706
his EIF3E 8q22-q23 0.184 0.163 0.706 negative regulation of translational
initiation;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
xai POM121 7q11.23 0.184 0.163 0.706 cytokine-mediated signaling
xai PRM1 16p13.2 0.184 0.163 0.706 chromosome condensation;DNA packaging
his NORAD 0.184 0.163 0.706
exp GAPDHP14 0.184 0.163 0.706
his ATP6V1E2 2p21 0.184 0.163 0.706 cellular iron ion homeostasis;insulin
his RHOQ 2p21 0.184 0.163 0.706 insulin receptor signaling pathway;positive
regulation of filopodium assembly
hs4 RPL13 16q24.3 0.184 0.163 0.706 gene expression;viral reproduction
hs4 SNORD68 0.184 0.163 0.706
xai MEFV 16p13.3 0.184 0.163 0.706 inflammatory response;nucleotide-binding
domain, leucine rich repeat containing receptor signaling pathway
his MIR181C 0.184 0.163 0.706
his MIR181D 0.184 0.163 0.706
xsq SCN10A 3p22.2 0.183 0.163 0.704 transmembrane transport;ion
transport
mut CCER1 12q21.33 0.183 0.163 0.704
xsq NR0B2 1p36.1 0.183 0.163 0.704 positive regulation of insulin
activity
xsq LINC01070 0.183 0.163 0.704
exp RPL6P17 6p23 0.183 0.163 0.704
xsq ABI3 17q21.3 0.183 0.163 0.704 cellular component movement;peptidyl-
tyrosine phosphorylation
exp LTA4H 12q22 0.183 0.163 0.704 prostanoid metabolic process;inflammatory
response
exp LRIF1 1p13.3 0.183 0.163 0.704 regulation of transcription, DNA-
dependent"
xsq ENTHD2 17q25.3 0.183 0.163 0.704
xsq IPO5P1 0.183 0.163 0.704
xsq LOC441242 7q11.21 0.182 0.163 0.704
xsq ARHGEF39 9p13.3 0.182 0.163 0.705
xsq TMEM81 1q32.1 0.182 0.163 0.705
xsq ORAOV1 11q13.3 0.182 0.163 0.705
cop EPCAM 2p21 0.182 0.163 0.705 positive regulation of cell
proliferation;ureteric bud development
cop MIR559 0.182 0.163 0.705
xsq LOC102723376 0.182 0.163 0.705
xsq LOC100272217 0.182 0.163 0.705
xsq BLOC1S4 4p16.1 0.182 0.163 0.705
xsq FOPNL 16p13.11 0.182 0.163 0.705 cilium assembly;cell projection
organization
xsq CD177 19q13.2 0.182 0.163 0.705 blood coagulation;leukocyte migration
cop RSPO4 20p13 0.182 0.163 0.705 Wnt receptor signaling pathway;response to
stimulus
met ACSM3 16p13.11 0.182 0.163 0.705 lipid metabolic process;fatty acid
met MIR503 0.182 0.163 0.705
exp KDM3A 2p11.2 0.182 0.163 0.705 histone H3-K9 demethylation;positive
met ARHGEF7 13q34 0.182 0.163 0.705 apoptotic process;positive regulation of
apoptotic process
cop IKBIP 12q23.1 0.182 0.163 0.706 EMT (Mesenchymal)
xsq LOC101928682 0.182 0.163 0.706
exp FGFBP3 10q23.32 0.182 0.163 0.706 positive regulation of fibroblast
growth factor receptor signaling pathway;positive regulation of vascular
permeability
xsq GUCY2C 12p12 0.182 0.163 0.706 regulation of cell proliferation;cGMP
xsq RGCC 13q14.11 0.182 0.163 0.706 regulation of cyclin-dependent protein
kinase activity;cell cycle
met SERPINB6 6p25 0.182 0.163 0.706 negative regulation of endopeptidase
activity;regulation of proteolysis
xsq C6orf136 6p21.33 0.182 0.163 0.706
mut GUCY1A2 11q21-q22 -0.182 0.163 0.706 intracellular signal
transduction;cGMP biosynthetic process
cop TOX 8q12.1 -0.182 0.163 0.706
cop HCN1 5p12 -0.182 0.163 0.705 potassium ion transport;synaptic
transmission
exp EGLN3 14q13.1 -0.182 0.163 0.705 Apoptosis
cop MFI2 3q28-q29 -0.182 0.163 0.705 ion transport;iron ion transport
mut CDAN1 15q15.2 -0.182 0.163 0.705
xsq C1QTNF9B-AS1 13q12 -0.182 0.163 0.705
xsq C8orf58 8p21 -0.182 0.163 0.705
exp MRPS33P4 20q13.13 -0.182 0.163 0.705
cop SNORD93 7p15.3 -0.182 0.163 0.705
cop FAM126A 7p15.3 -0.182 0.163 0.705 EMT (Mesenchymal)
met KRT39 17q21.2 -0.182 0.163 0.705
exp GFRA1 10q26.11 -0.182 0.163 0.704 glial cell-derived neurotrophic
xsq KLF8 Xp11.21 -0.183 0.163 0.704 regulation of transcription, DNA-
dependent"
exp TMSB10 2p11.2 -0.183 0.163 0.704 actin cytoskeleton
exp MRPS6 21q22.11 -0.183 0.163 0.704 translation
exp EHHADH 3q26.3-q28 -0.183 0.163 0.704 fatty acid beta-
met EVI2A 17q11.2 -0.183 0.163 0.704
exp RFNG 17q25 -0.183 0.163 0.704 pattern specification process;nervous
system development
met ING4 12p13.31 -0.183 0.163 0.704 Tumor Suppressors
xsq COL18A1-AS1 -0.183 0.163 0.704
exp EFNB2 13q33 -0.183 0.163 0.704 angiogenesis;anatomical structure
morphogenesis
xsq TNFRSF11B 8q24 -0.183 0.163 0.704 response to nutrient;extracellular
matrix organization
xai RHOD 11q14.3 -0.184 0.163 0.706 GTP catabolic process;small GTPase
xai CSRP3 11p15.1 -0.184 0.163 0.706 skeletal muscle tissue
hs4 KRT19 17q21.2 -0.184 0.163 0.705 cell differentiation involved in
xai OAZ2 15q22.31 -0.184 0.163 0.705 cellular nitrogen compound
xai SP140L 2q37.1 -0.184 0.163 0.705
swa LRP10 14q11.2 -0.184 0.163 0.705 lipid metabolic process;lipid
transport
exp AKR1B1P6 18p11.22 -0.184 0.163 0.705
xai SOX9 17q24.3 -0.184 0.163 0.705 epithelial to mesenchymal
his MIR4478 -0.184 0.163 0.705
his VCAN-AS1 -0.184 0.163 0.705
xai MSX1 4p16.2 -0.184 0.163 0.705 multicellular organismal
his ARHGAP23 17q12 -0.184 0.163 0.705 signal transduction
his MID1 Xp22 -0.184 0.163 0.705 microtubule cytoskeleton
exp IL1RAPL2 Xq22 -0.184 0.163 0.705 signal transduction;central nervous
system development
his SYT12 11q13.2 -0.184 0.163 0.705
his HES2 1p36.31 -0.184 0.163 0.704 negative regulation of
his ESPN 1p36.31 -0.184 0.163 0.704 locomotory behavior;parallel actin
exp SLC25A39P1 -0.184 0.163 0.704
xai HOXA-AS3 7p15.2 -0.184 0.163 0.704
his MIR649 -0.184 0.163 0.704
his P2RX6P 22q11.21 -0.184 0.163 0.704
his LRRC74B -0.184 0.163 0.704
xai CNN1 19p13.2-p13.1 -0.184 0.163 0.704 regulation of smooth muscle
his SERPINB9 6p25 -0.184 0.163 0.704 Apoptosis
xai MIR4422 -0.184 0.163 0.704
xai ABCC3 17q22 -0.184 0.163 0.704 ABC Transporters
xai KRT8P11 9q22.33 -0.184 0.163 0.704
his FSBP -0.184 0.163 0.704
xai LOC723805 19q13.2 -0.184 0.163 0.704
his LINC01591 -0.184 0.163 0.704
hs4 LOC102723769 -0.184 0.163 0.704
exp LOC723805 19q13.2 -0.184 0.163 0.704
his RNF152 18q21.33 -0.184 0.163 0.704 apoptotic process;protein
swa GRSF1 4q13 -0.184 0.163 0.704 morphogenesis of embryonic
epithelium;mRNA polyadenylation
hs4 TMEM171 5q13.2 -0.184 0.163 0.704
met WDR49 3q26.1 0.185 0.164 0.706
xai GPR132 14q32.3 0.184 0.164 0.706 G1/S transition of mitotic cell
cycle;response to stress
his KIAA1191 5q35.2 0.184 0.164 0.706
swa TNFAIP8 5q23.1 0.184 0.164 0.706 Apoptosis
xai WDR82 3p21.2 0.184 0.164 0.706 histone H3-K4 methylation
swa NME2 0.184 0.164 0.706
his NRBP1 2p23 0.184 0.164 0.706 ER to Golgi vesicle-mediated transport;gene
expression
xai RPL23AP32 0.184 0.164 0.706
his TSSC4 11p15.5 0.184 0.164 0.706
exp PRM1 16p13.2 0.184 0.164 0.706 chromosome condensation;DNA packaging
his RBM41 Xq22.3 0.184 0.164 0.706
exp FLJ42220 0.184 0.164 0.706
xai KIAA0895L 16q22.1 0.184 0.164 0.706
swa POLR2B 4q12 0.184 0.164 0.706 DNA Damage Response (DDR); DDR (NER)
xai C18orf8 18q11.2 0.184 0.164 0.706
his BZW1 2q33 0.184 0.164 0.706 regulation of transcription, DNA-dependent;RNA
metabolic process"
his LOC101927795 0.184 0.164 0.706
hs4 FOCAD 9p21 0.184 0.164 0.706
xai NDUFAF5 20p12.1 0.184 0.164 0.706
hs4 MSMO1 4q32-q34 0.183 0.164 0.706 fatty acid metabolic process;fatty acid
his NSD1 5q35 0.183 0.164 0.706 negative regulation of transcription from RNA
hs4 FAM72B 0.183 0.164 0.706
xai KIAA0391 14q13.2 0.183 0.164 0.707 tRNA processing
his LOC101927657 0.183 0.164 0.707
his PM20D2 6q15 0.183 0.164 0.707 metabolic process
his NTNG2 9q34 0.183 0.164 0.707 multicellular organismal development;nervous
system development
xai DAOA 13q33.2 0.183 0.164 0.707
xai NCAPH2 22q13.33 0.183 0.164 0.707 DNA Damage Response (DDR)
his POLR3C 1q21.1 0.183 0.164 0.707 positive regulation of innate
his RNF115 1q21.1 0.183 0.164 0.707 protein autoubiquitination
his SHANK2-AS1 0.183 0.164 0.707
met GNG7 19p13.3 0.182 0.164 0.706 energy reserve metabolic process;receptor
exp XRCC5 2q35 0.182 0.164 0.706 DNA Damage Response (DDR); DDR (NHEJ)
mut DHX15 4p15.3 0.182 0.164 0.706 mRNA processing;RNA splicing
xsq LINC01270 0.182 0.164 0.706
xsq TMEM135 11q14.2 0.182 0.164 0.706 peroxisome organization
xsq C19orf68 19q13.33 0.182 0.164 0.706
xsq LOC440896 9q21.11 0.182 0.164 0.706
xsq SPOP 17q21.33 0.182 0.164 0.706 mRNA processing
exp CCKAR 4p15.2 0.182 0.164 0.706 activation of phospholipase C activity by
messenger;insulin secretion
xsq ASXL3 18q11 0.182 0.164 0.706 regulation of transcription, DNA-dependent"
cop CCDC28A 6q23.1-q24.1 0.182 0.164 0.706
xsq AFG3L1P 16q24.3 0.182 0.164 0.706
xsq HMGN2 1p36.1 0.182 0.164 0.706 chromatin organization;regulation of
xsq C1orf43 1q21.2 0.182 0.164 0.706
mir hsa-miR-519e* 0.182 0.164 0.706
xsq LMNB2 19p13.3 0.182 0.164 0.706
met TMEM51-AS1 1p36.21 0.182 0.164 0.706
xsq DCAF13 8q22.3 0.182 0.164 0.706 rRNA processing;protein
ubiquitination
met HIC2 22q11.21 0.182 0.164 0.706 negative regulation of transcription,
DNA-dependent"
xsq GHRHR 7p14 0.182 0.164 0.706 determination of adult lifespan;positive
cop FBXW8 12q24.22 0.182 0.164 0.706 spongiotrophoblast layer
development;labyrinthine layer blood vessel development
cop TESC 12q24.22 0.182 0.164 0.706 positive regulation of gene
cop FBXO21 12q24.22 0.182 0.164 0.706 ubiquitin-dependent protein
met PWRN1 15q11.2 0.182 0.164 0.706
met TRO Xp11.22-p11.21 0.182 0.164 0.706 cell adhesion;homophilic cell
adhesion
xsq POLR2J3 7q22.1 0.182 0.164 0.706
xsq TTC32 2p24.1 0.182 0.164 0.706
xsq TSR1 17p13.3 0.182 0.164 0.706 ribosome assembly
xsq KLHL28 14q21.2 0.182 0.164 0.706
xsq C12orf77 12p12.1 0.182 0.164 0.706
cop GDPD3 0.182 0.164 0.706 glycerol metabolic process;lipid metabolic
process
met NR2F1 5q14 0.182 0.164 0.706 neuron migration;regulation of transcription,
DNA-dependent
cop TMEM200A 6q23.1 0.182 0.164 0.706
mut KCNK10 14q31.3 0.182 0.164 0.706 transport;ion transport
cop PLXNC1 12q23.3 0.182 0.164 0.706 axon guidance;cell adhesion
cop SASH1 6q24.3 0.182 0.164 0.706
exp ARHGAP25 2p13.3 0.182 0.164 0.706 regulation of small GTPase mediated
exp RPL31P4 14q23.1 0.182 0.164 0.706
cop MSH6 2p16 0.182 0.164 0.706 DNA Damage Response (DDR); DDR (MMR); Tumor
Suppressors
met SLC36A2 5q33.1 0.182 0.164 0.706 ion transport;amino acid transport
cop GNRH2 20p13 0.182 0.164 0.706 multicellular organismal development;signal
transduction
cop MRPS26 20p13 0.182 0.164 0.706 DNA damage response, detection of DNA
damage;peptide biosynthetic process"
cop OXT 20p13 0.182 0.164 0.706 maternal aggressive behavior;response to
sucrose stimulus
cop AVP 0.182 0.164 0.706
cop UBOX5-AS1 0.182 0.164 0.706
cop UBOX5 20p13 0.182 0.164 0.706 protein polyubiquitination
cop FASTKD5 0.182 0.164 0.706 cellular respiration
cop LZTS3 20p13 0.182 0.164 0.706
cop DDRGK1 20p13 0.182 0.164 0.706
cop ITPA 20p 0.182 0.164 0.706 metabolic process;nucleotide metabolic process
xsq FBF1 17q25.1 0.182 0.164 0.706 apical junction assembly;establishment of
epithelial cell polarity
met CRIP2 14q32.3 0.182 0.164 0.706 positive regulation of cell
xsq NFE2 12q13 0.182 0.164 0.706 multicellular organismal development;blood
coagulation
exp FAM162B 6q22.1 0.182 0.164 0.706
met MOGAT1 2q36.1 0.182 0.164 0.706 glycerol metabolic
xsq LOC642361 10q22.3 0.182 0.164 0.706
xsq MID1IP1-AS1 0.182 0.164 0.706
dependent"
xsq DENND4B 1q21 0.182 0.164 0.707
xsq B3GNT8 19q13.2 0.182 0.164 0.707 O-glycan processing;poly-N-
acetyllactosamine biosynthetic process
met SOX4 6p22.3 0.182 0.164 0.707 cardiac right ventricle
morphogenesis;glial cell proliferation
cop FBXO11 2p16.3 0.182 0.164 0.707 protein ubiquitination;peptidyl-
arginine N-methylation
cop FAM63B 15q21.3 0.182 0.164 0.707
cop AGR2 7p21.3 -0.182 0.164 0.707 mucus secretion
cop AGR3 7p21.1 -0.182 0.164 0.707
exp GPSM2 1p13.3 -0.182 0.164 0.707 G-protein coupled receptor
signaling pathway;regulation of G-protein coupled receptor protein signaling
pathway
met RFPL2 22q12.3 -0.182 0.164 0.707
cop NCBP2 3q29 -0.182 0.164 0.707 nuclear mRNA splicing, via
spliceosome;regulation of translational initiation
cop PIGZ 3q29 -0.182 0.164 0.707 GPI anchor biosynthetic process
cop MFI2-AS1 -0.182 0.164 0.707
xsq OR52N5 11p15.4 -0.182 0.164 0.707 response to stimulus
exp PGM1 1p31 -0.182 0.164 0.707 glycogen biosynthetic process;glycogen
catabolic process
exp EPHB1 3q21-q23 -0.182 0.164 0.706 optic nerve morphogenesis;ephrin
met RAC3 17q25.3 -0.182 0.164 0.706 actin cytoskeleton
cop KLHL7-AS1 -0.182 0.164 0.706
cop KLHL7 7p15.3 -0.182 0.164 0.706
cop NUPL2 7p15 -0.182 0.164 0.706 protein export from nucleus;mRNA
transport
cop GPNMB 7p15 -0.182 0.164 0.706 cell adhesion;negative regulation of cell
proliferation
met DDX43 6q13 -0.182 0.164 0.706
cop LOC100128505 -0.182 0.164 0.706
cop MIR3147 -0.182 0.164 0.706
exp CCBE1 18q21.32 -0.182 0.164 0.706 multicellular organismal
exp PRKAB2 1q21.1 -0.182 0.164 0.706 cellular lipid metabolic
exp ACVR1 2q23-q24 -0.182 0.164 0.706 G1/S transition of mitotic cell
xsq BST2 19p13.1 -0.182 0.164 0.706 positive regulation of I-kappaB
cop NKAIN3 8q12.3 -0.182 0.164 0.706
exp ANKAR 2q32.2 -0.182 0.164 0.706
xsq CYP21A1P -0.182 0.164 0.706
met HMX3 10q26.13 -0.182 0.164 0.706 brain development;embryo
implantation
xsq KLF6 10p15 -0.182 0.164 0.706 regulation of transcription, DNA-
xsq TTC28 22q12.1 -0.182 0.164 0.706
his SH3GL2 9p22 -0.183 0.164 0.707 axon guidance;central nervous
system development
exp GALP 19q13.43 -0.183 0.164 0.707 neuropeptide signaling
pathway;response to hormone stimulus
his DUSP10 1q41 -0.183 0.164 0.707 JNK cascade;response to organic
substance
his PLEKHA2 8p11.22 -0.183 0.164 0.707 positive regulation of cell-
matrix adhesion
xai GPM6A 4q34 -0.183 0.164 0.707
DNA-dependent"
DNA-dependent"
hs4 CTTN 11q13 -0.183 0.164 0.707
his LRP1B 2q21.2 -0.183 0.164 0.707 receptor-mediated
his C5orf67 -0.183 0.164 0.706
his RIPK4 21q22.3 -0.183 0.164 0.706
xai IRX1 5p15.3 -0.183 0.164 0.706
hs4 LOC100128531 -0.183 0.164 0.706
his SLIT2 4p15.2 -0.183 0.164 0.706 cell migration involved in
hs4 DAG1 3p21 -0.184 0.164 0.706 interspecies interaction between
his MIR521-1 -0.184 0.164 0.706
hs4 NDRG3 20q11.21-q11.23 -0.184 0.164 0.706 spermatogenesis;cell
differentiation
xai MYL6P3 10q21.3 -0.184 0.164 0.706
DNA-dependent"
his MURC 9q31.1 -0.184 0.164 0.706 positive regulation of
dependent
hs4 LOC101928820 -0.184 0.164 0.706
hs4 LINC01204 -0.184 0.164 0.706
xai CAP1 1p34.2 -0.184 0.164 0.706 signal transduction;activation of
adenylate cyclase activity
xai LY6E 8q24.3 -0.184 0.164 0.706 cell surface receptor signaling
pathway;adrenal gland development
exp IFNE 9p21.3 -0.184 0.164 0.706 defense response;response to virus
his ACP7 -0.184 0.164 0.706
his NEK10 3p24.1 -0.184 0.164 0.706
hs4 SCCPDH 1q44 -0.184 0.164 0.706
xai APCDD1 18p11.22 -0.184 0.164 0.706 hair follicle
DNA-dependent"
his LOC284581 -0.184 0.164 0.706
hs4 GLRA2 Xp22.2 -0.184 0.164 0.706 ion transport;neuropeptide
signaling pathway
xai TMED4 7p13 -0.184 0.164 0.706 positive regulation of I-kappaB
kinase/NF-kappaB cascade;signal transduction
xai PDXK 21q22.3 -0.184 0.164 0.706 small molecule metabolic
his KRTAP2-2 17q21.2 -0.184 0.164 0.706
his KRTAP2-3 -0.184 0.164 0.706
his KRTAP2-4 -0.184 0.164 0.706
cop MAGEF1 3q13 -0.184 0.164 0.706
his METRNL 17q25.3 -0.184 0.164 0.706
xai NHSL1 6q23.3 -0.184 0.164 0.706
xai OR4F14P 15q26.3 -0.184 0.164 0.706
xai NXPH4 12q13.3 -0.184 0.164 0.706 neuropeptide signaling pathway
his KCNE2 21q22.12 -0.184 0.164 0.706 muscle contraction;blood
circulation
xai PRELID1 5q35.3 0.183 0.165 0.707 immune response;multicellular
xai UBE2J1 6q15 0.183 0.165 0.707
xai RPL7P58 Xp21.3 0.183 0.165 0.707
xai KBTBD3 11q22.3 0.183 0.165 0.707
exp HMGN2P32 0.183 0.165 0.707
xai CENPW 6q22.32 0.183 0.165 0.707 chromosome segregation;centromeric core
chromatin assembly
xai PYGO2 1q21.3 0.183 0.165 0.707 developmental growth;palate development
his FHL3 1p34 0.183 0.165 0.707 muscle organ development;actin cytoskeleton
organization
his UTP11 0.183 0.165 0.707
swa CLUH 17p13.3 0.183 0.165 0.707
xai POTEA 8p11.1 0.183 0.165 0.707
exp PRSS3P1 0.183 0.165 0.707
dependent"
hs4 LOC401127 4p14 0.183 0.165 0.707
xai PHACTR3 20q13.32-q13.33 0.183 0.165 0.707
his GTF3C4 9q34.13 0.183 0.165 0.707 positive regulation of catalytic
activity;transcription, DNA-dependent
his DDX31 9q34.13 0.183 0.165 0.707
his NEFH 22q12.2 0.183 0.165 0.707 microtubule cytoskeleton
organization;nervous system development
xai RPL7AP4 14q22.3 0.183 0.165 0.707
his RBM28 7q32.1 0.183 0.165 0.707 mRNA processing;RNA splicing
his PCDHGB2 0.183 0.165 0.707 homophilic cell adhesion;cell adhesion
his BLOC1S5-TXNDC5 0.183 0.165 0.707
his BLOC1S5 6p25.1-p24.3 0.183 0.165 0.707
his ADAR 1q21.3 0.183 0.165 0.707 adenosine to inosine editing;type I
his SHANK3 22q13.3 0.183 0.165 0.707 positive regulation of synaptic
transmission, glutamatergic;striatal medium spiny neuron differentiation
xai MTHFD1P1 0.183 0.165 0.707
dependent"
xai USF1 1q22-q23 0.183 0.165 0.707 response to hypoxia;positive regulation
his PLEKHB2 2q21.1 0.183 0.165 0.707
his NAF1 4q32.2 0.183 0.165 0.707 rRNA processing;snRNA pseudouridine
synthesis
exp ACTG1P17 0.183 0.165 0.707
his STX2 12q24.33 0.183 0.165 0.707 cytokinetic cell separation;epithelial
his CXCR4 2q21 0.183 0.165 0.707 activation of MAPK activity;viral reproduction
his DDX39A 19p13.12 0.183 0.165 0.707 nuclear mRNA splicing, via
hs4 SREBF2 22q13 0.183 0.165 0.707 response to hormone stimulus;cellular
response to laminar fluid shear stress
xai FLJ42220 0.183 0.165 0.707
xai HSP90AA4P 4q35.2 0.183 0.165 0.707 response to stress;protein folding
his RSF1 11q14.1 0.183 0.165 0.707 nucleosome positioning;CenH3-containing
his AAMDC 11q14.1 0.183 0.165 0.707
his C4B 6p21.3 0.183 0.165 0.707
swa DYNC1LI1 3p22.3 0.183 0.165 0.707 cell cycle;mitosis
his AP1B1 22q12.2 0.183 0.165 0.707 intracellular protein transport;post-
his AHCYL2 7q32.1 0.183 0.165 0.707 one-carbon metabolic process
xai GPALPP1 0.183 0.165 0.707
exp TMEM97P2 8p21.3 0.183 0.165 0.707
xai CLEC11A 19q13.3 0.183 0.165 0.707 positive regulation of cell
proliferation
exp RPL39P 20q13.2 0.183 0.165 0.707
hs4 SAMSN1-AS1 0.183 0.165 0.707
hs4 C19orf35 0.183 0.165 0.707
exp SNORA31 13q14.13 0.183 0.165 0.707
his RSRP1 0.183 0.165 0.707
hs4 CXorf65 Xq13.1 0.183 0.165 0.707
his GM2A 5q33.1 0.183 0.165 0.707 glycolipid catabolic process;lipid
storage
xai SNORA31 13q14.13 0.183 0.165 0.707
xai HSPA8P14 12q24.12 0.183 0.165 0.707
xai RPL39P 20q13.2 0.183 0.165 0.707
hs4 DGKG 3q27.2-q27.3 0.183 0.165 0.707 signal transduction;activation of
xsq KCNMB4 12q 0.182 0.165 0.707 detection of calcium ion;potassium ion
mut SEPSECS 4p15.2 0.182 0.165 0.707 selenocysteine
cop OIT3 10q22.1 0.182 0.165 0.707
cop PLA2G12B 10q22.1 0.182 0.165 0.707
met MIR301B 0.182 0.165 0.707
cop SEC61B 9q22.32-q31.3 0.182 0.165 0.707 translation;SRP-dependent
xsq SMARCB1 22q11.23 0.182 0.165 0.707 DNA Damage Response (DDR); DDR
cop LINC00486 2p22.3 0.182 0.165 0.707
cop TAF1B 2p25 0.182 0.165 0.707 transcription, DNA-dependent;regulation of
cop GRHL1 2p25.1 0.182 0.165 0.707 small molecule metabolic
dependent"
cop C2orf61 2p21 0.182 0.165 0.707
cop CALM2 2p21 0.182 0.165 0.707
xsq ORM2 9q32 0.182 0.165 0.707
xsq KIF4A Xq13.1 0.182 0.165 0.707 organelle organization;microtubule-based
movement
xsq NQO2 6p25.2 0.182 0.165 0.707
xsq TTC13 1q42.2 0.182 0.165 0.707
cop HCCAT5 16q22.3 0.182 0.165 0.707
xsq KCNK5 6p21 0.182 0.165 0.707 ion transport;potassium ion transport
xsq CYB561A3 11q12.2 0.182 0.165 0.707
xsq PRSS3 9p11.2 0.182 0.165 0.707 digestion;zymogen activation
exp E4F1 16p13.3 0.182 0.165 0.707 negative regulation of transcription from
RNA polymerase II promoter;regulation of cell cycle process
met SIPA1L1 14q24.2 0.182 0.165 0.707 actin cytoskeleton
reorganization;regulation of Rap GTPase activity
exp CECR6 0.182 0.165 0.707
exp PCMTD2 20q13.33 0.182 0.165 0.707 protein modification process
exp CENPV 17p11.2 0.182 0.165 0.707 cell cycle;mitosis
cop ALG2 9q22.33 0.182 0.165 0.707 protein N-linked glycosylation via
exp BAZ1B 7q11.23 0.182 0.165 0.707 DNA Damage Response (DDR)
cop MIR9-3 0.182 0.165 0.707
cop RHCG 15q25 0.182 0.165 0.707 transmembrane transport;transepithelial
ammonium transport
cop TICRR 15q26.1 0.182 0.165 0.707 DDR (DNA replication)
cop KIF7 15q26.1 0.182 0.165 0.707 microtubule-based movement;negative
cop PLIN1 15q26 0.182 0.165 0.707 small molecule metabolic process;lipid
metabolic process
cop PEX11A 15q26.1 0.182 0.165 0.707 peroxisome organization;signal
transduction
xsq RTP2 3q27.3 0.182 0.165 0.707
met PATL1 11q12.1 0.182 0.165 0.707 deadenylation-dependent decapping of
nuclear-transcribed mRNA;cytoplasmic mRNA processing body assembly
xsq TMCC1-AS1 0.182 0.165 0.707
xsq PRKACB 1p31.1 0.182 0.165 0.707 Protein Kinases
xsq DEAF1 11p15.5 0.182 0.165 0.707 multicellular organismal development;germ
cell development
xsq LOC642943 0.181 0.165 0.707
exp ESM1 5q11.2 0.181 0.165 0.707 angiogenesis;regulation of cell growth
xsq TACR3 4q25 0.181 0.165 0.707 response to morphine;tachykinin receptor
signaling pathway
xsq LOC100507437 0.181 0.165 0.707
exp PROP1 5q35.3 0.181 0.165 0.707 dorsal/ventral pattern
formation;somatotropin secreting cell differentiation
cop MIR3939 0.181 0.165 0.707
cop FGFR1OP 6q27 0.181 0.165 0.707 positive regulation of cell
cop CCR6 6q27 0.181 0.165 0.707 signal transduction;elevation of cytosolic
calcium ion concentration
cop GPR31 6q27 0.181 0.165 0.707
cop TCP10L2 6q27 0.181 0.165 0.707
cop UNC93A 6q27 0.181 0.165 0.707
cop TTLL2 6q27 0.181 0.165 0.707 protein modification process
cop NOS1 12q24.22 0.181 0.165 0.707 nitric oxide biosynthetic
process;positive regulation of histone acetylation
exp LPXN 11q12.1 0.181 0.165 0.707 negative regulation of B cell receptor
met ANP32D 12q13.11 0.181 0.165 0.707
met TNFRSF9 1p36 0.181 0.165 0.707 Apoptosis
cop RAB32 6q24.3 0.181 0.165 0.707 small GTPase mediated signal
cop GPCPD1 20p12.3 0.181 0.165 0.707 glycerol metabolic process;lipid
metabolic process
cop PTPRA 20p13 0.181 0.165 0.707 protein phosphorylation;axon guidance
xsq CPSF6 12q15 0.181 0.165 0.707 mRNA polyadenylation;mRNA processing
exp HEPACAM2 7q21.3 0.181 0.165 0.707
mut HAVCR1 5q33.2 0.181 0.165 0.707 interspecies interaction between
organisms
xsq PNLIPRP1 10q25.3 0.181 0.165 0.707 response to glucocorticoid
stimulus;lipid metabolic process
cop CNEP1R1 16q12.1 0.181 0.165 0.707 lipid metabolic process;positive
regulation of triglyceride biosynthetic process
mut KCNAB1 3q26.1 0.181 0.165 0.707 ion transport;potassium ion
transport
xsq SPATA31E1 9q22.1 0.181 0.165 0.707
xsq IFRD1 7q31.1 0.181 0.165 0.707 multicellular organismal
development;myoblast cell fate determination
xsq TSL -0.181 0.165 0.707
xsq BMP4 14q22-q23 -0.181 0.165 0.707 activation of MAPKK
activity;endochondral ossification
xsq SEC16B 1q25.2 -0.181 0.165 0.707 protein transport;vesicle-
mediated transport
cop LINC00536 -0.181 0.165 0.707
mut CCKBR 11p15.4 -0.181 0.165 0.707 behavioral defense response;cell
proliferation
xsq POFUT2 21q22.3 -0.181 0.165 0.707 carbohydrate metabolic
xsq FGF2 4q26 -0.181 0.165 0.707 branching involved in ureteric bud
met MTOR 1p36.2 -0.181 0.165 0.707 Apoptosis; Cell Signaling; DNA
Damage Response (DDR); Protein Kinases
xsq OTUD1 10p12.2 -0.181 0.165 0.707
xsq GLIPR1 12q21.2 -0.181 0.165 0.707 cellular lipid metabolic
xsq ARSD Xp22.3 -0.181 0.165 0.707
xsq PSG4 19q13.2 -0.182 0.165 0.707 defense response;female pregnancy
cop FAM20B 1q25 -0.182 0.165 0.707
exp PDLIM5 4q22 -0.182 0.165 0.707 regulation of synapse
cop LOC729987 -0.182 0.165 0.707
exp LOC100506476 -0.182 0.165 0.707
exp TMED4 7p13 -0.182 0.165 0.707 positive regulation of I-kappaB
met MIR122 -0.182 0.165 0.707
exp SDCBP 8q12 -0.182 0.165 0.707 axon guidance;actin cytoskeleton
organization
cop GADD45A 1p31.2 -0.182 0.165 0.707 Apoptosis; DNA Damage
exp PDZK1IP1 1p33 -0.182 0.165 0.707
xsq MTCL1 -0.182 0.165 0.707
cop MED30 8q24.11 -0.182 0.165 0.707 transcription initiation from RNA
exp MAGI3 1p12-p11.2 -0.182 0.165 0.707 intracellular signal
transduction;interspecies interaction between organisms
exp PPP1R3D 20q13.3 -0.182 0.165 0.707 regulation of glycogen
exp CNR1 6q14-q15 -0.182 0.165 0.707 positive regulation of acute
exp BDNF 11p13 -0.182 0.165 0.707 feeding behavior;fear response
cop EXT1 8q24.11 -0.182 0.165 0.707 axon guidance;brain development
exp SLCO3A1 15q26 -0.182 0.165 0.707 Solute Carriers
xsq FHOD3 18q12 -0.182 0.165 0.707 cellular component organization;actin
exp GBA 1q21 -0.182 0.165 0.707 termination of signal
met MT1L 16q13 -0.182 0.165 0.707
xsq ODF4 17p13.1 -0.182 0.165 0.707 cell differentiation;multicellular
exp TRIM8 10q24.3 -0.182 0.165 0.707
xsq SEPT5-GP1BB -0.182 0.165 0.707
exp CCDC89 11q14.1 -0.182 0.165 0.707
met FOXI1 5q34 -0.182 0.165 0.707 Apoptosis
hs4 MIR3139 -0.183 0.165 0.707
hs4 FGF18 5q34 -0.183 0.165 0.707 chondrocyte development;positive
his NAALADL2 3q26.31 -0.183 0.165 0.707 proteolysis
swa FKBP7 2q31.2 -0.183 0.165 0.707 protein peptidyl-prolyl
his LOC643542 -0.183 0.165 0.707
his DSEL 18q22.1 -0.183 0.165 0.707
xai LAMA4 6q21 -0.183 0.165 0.707 regulation of embryonic development;brown
hs4 IL17B 5q33.1 -0.183 0.165 0.707 inflammatory response;immune
response
hs4 CARMN -0.183 0.165 0.707
xai TPM3P6 19q13.42 -0.183 0.165 0.707
his LOC101928371 -0.183 0.165 0.707
xai GLI3 7p13 -0.183 0.165 0.707 axon guidance;pallium development
xai LMO7 13q22.2 -0.183 0.165 0.707 protein ubiquitination
hs4 PLXNC1 12q23.3 -0.183 0.165 0.707 axon guidance;cell adhesion
hs4 DAPK2 15q22.31 -0.183 0.165 0.707 Apoptosis
his PSMG3 7p22.3 -0.183 0.165 0.707
his PSMG3-AS1 7p22.3 -0.183 0.165 0.707
xai FABP3 1p33-p32 -0.183 0.165 0.707 fatty acid metabolic
exp MIRLET7I -0.183 0.165 0.707
his LINC01555 -0.183 0.165 0.707
xai COL7A1 3p21.1 -0.183 0.165 0.707 cell adhesion;epidermis
development
his LINC02080 -0.183 0.165 0.707
xai LRRC29 16q22.1 -0.183 0.165 0.707
xai MIRLET7I -0.183 0.165 0.707
hs4 LINC01194 -0.183 0.165 0.707
hs4 LINC00887 3q29 -0.183 0.165 0.707
xai ENG 9q34.11 -0.183 0.165 0.707 heart looping;cell migration
xai KRT8P45 1q23.1 -0.183 0.165 0.707
xai AMZ1 7p22.3 -0.183 0.165 0.707 proteolysis
exp PZP 12p13-p12.2 -0.183 0.165 0.707 female pregnancy;negative
xai ORMDL2 12q13.2 -0.183 0.165 0.707 ceramide metabolic process
hs4 SMURF2 17q22-q23 -0.183 0.165 0.707 protein
pathway
xai LOC100127947 -0.183 0.165 0.707
DNA-dependent"
exp LOC100129089 -0.183 0.165 0.707
hs4 ALPK1 4q25 -0.183 0.165 0.707 protein phosphorylation
hs4 LOC101927865 -0.183 0.165 0.707
his LINC01050 -0.183 0.165 0.707
xai APOA2 1q23.3 -0.183 0.165 0.707 cholesterol metabolic
his TMEM44 3q29 -0.183 0.165 0.707
xai CTSH 15q25.1 -0.183 0.165 0.707 positive regulation of cell
met HLA-DQA1 6p21.3 0.223 0.166 0.709
xai EEF1DP1 19p13.12 0.183 0.166 0.708
hs4 FCGR1A 1q21.2-q21.3 0.183 0.166 0.708 innate immune
xai XRCC6 22q13.2 0.183 0.166 0.708 DNA Damage Response (DDR); DDR (NHEJ)
xai CHD8 14q11.2 0.183 0.166 0.708 DNA duplex unwinding;ATP-dependent
chromatin remodeling
hs4 NPTX1 17q25.3 0.183 0.166 0.708 axonogenesis involved in
hs4 NEU3 11q13.5 0.183 0.166 0.708 carbohydrate metabolic
xai DCAF8 1q22-q23 0.183 0.166 0.708 protein ubiquitination
xai MUM1 19p13.3 0.183 0.166 0.708 DNA repair;chromatin organization
exp FLJ45825 0.183 0.166 0.708
hs4 PANO1 0.183 0.166 0.708
his PPP4R2 3p13 0.183 0.166 0.708 DNA Damage Response (DDR); DDR (HR)
swa POLD1 19q13.3 0.183 0.166 0.708 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
swa EEF1G 11q12.3 0.183 0.166 0.708 translation;translational elongation
his POLR3GL 1q21.1 0.183 0.166 0.708 transcription from RNA polymerase
his ANKRD34A 1q21.1 0.183 0.166 0.708
his LIX1L 1q21.1 0.183 0.166 0.708 EMT (Mesenchymal)
exp TMCO5B 0.183 0.166 0.708
xai C3orf38 3p11.1 0.183 0.166 0.708 apoptotic process
xai SNRPD2 19q13.2 0.183 0.166 0.708 spliceosome assembly;spliceosomal
snRNP assembly
his NEU4 2q37.3 0.183 0.166 0.708 sphingolipid metabolic
xai DENND6A 3p14.3 0.183 0.166 0.708
xai BCL2L12 19q13.3 0.183 0.166 0.708 apoptotic process
xai RUFY4 2q35 0.183 0.166 0.708
xai USP3 15q22.3 0.183 0.166 0.708 proteolysis;ubiquitin-dependent protein
catabolic process
hs4 FOXD4L6 0.183 0.166 0.708
hs4 ACTL6B 7q22 0.183 0.166 0.708 chromatin organization;chromatin
remodeling
hs4 LOC105375429 0.183 0.166 0.708
xai CHCHD2P5 0.183 0.166 0.708
xai COX6A1 12q24.2 0.183 0.166 0.708 generation of precursor metabolites
dependent"
xai BMP8A 1p34.3 0.183 0.166 0.708 ossification;multicellular organismal
development
xai FAM117A 17q21.33 0.183 0.166 0.708
exp MEFV 16p13.3 0.183 0.166 0.708 inflammatory response;nucleotide-binding
his ENSA 1q21.3 0.183 0.166 0.709 response to nutrient;cell division
his ATAD3B 1p36.33 0.183 0.166 0.709
hs4 FCGR1CP 0.183 0.166 0.709
dependent"
exp CHCHD2P5 0.183 0.166 0.709
his TARSL2 15q26.3 0.183 0.166 0.709 threonyl-tRNA aminoacylation
his ADNP2 18q23 0.183 0.166 0.709 neuron differentiation;positive regulation of
cell growth
his LOC102725191 0.183 0.166 0.709
hs4 TMEM259 19p13.3 0.183 0.166 0.709
hs4 RNU6-2 19p13.3 0.183 0.166 0.709
hs4 LOC100507616 0.183 0.166 0.709
xai TCHP 12q24.11 0.183 0.166 0.709 apoptotic process;negative regulation of
cell growth
swa PARP1 1q41-q42 0.183 0.166 0.709 Apoptosis; DNA Damage Response (DDR); DDR
(BER)
xai KCNV2 9p24.2 0.183 0.166 0.709 transmembrane transport;ion transport
mut TMEM266 0.181 0.166 0.708
xsq NAA20 20p11.23 0.181 0.166 0.708
cop GRM1 6q24 0.181 0.166 0.708 locomotory behavior;calcium-mediated signaling
exp CEP68 2p14 0.181 0.166 0.708 centrosome organization
met COX16 14q24.2 0.181 0.166 0.708
met YJEFN3 19p13.11 0.181 0.166 0.708
exp ZPR1 0.181 0.166 0.708 signal transduction;cell proliferation
exp PAPD4 5q14.1 0.181 0.166 0.708 RNA polyadenylation;histone mRNA
catabolic process
exp HNRNPA1 12q13.1 0.181 0.166 0.708 interspecies interaction between
xsq LOC101243545 0.181 0.166 0.708
exp ANKHD1-EIF4EBP3 5q31.3 0.181 0.166 0.708
xsq LOC100506985 0.181 0.166 0.708
exp MIR4697HG 11q25 0.181 0.166 0.708
exp BCL2L10 15q21 0.181 0.166 0.708 Apoptosis
exp NLRP2P Xp11.21 0.181 0.166 0.708
xsq ATP1A4 1q23.2 0.181 0.166 0.708 potassium ion transport;sodium ion
transport
xsq H2AFY 5q31.1 0.181 0.166 0.708 dosage compensation;chromatin
modification
met DGCR5 22q11 0.181 0.166 0.708
mut USP2 11q23.3 0.181 0.166 0.708 protein deubiquitination;positive
regulation of mitotic cell cycle
cop C15orf57 15q15.1 0.181 0.166 0.708
cop MRPL42P5 15q13.3 0.181 0.166 0.708
cop RPUSD2 15q13.3 0.181 0.166 0.708 pseudouridine synthesis
cop CASC5 15q14 0.181 0.166 0.708 acrosome assembly;nucleosome assembly
cop RAD51 15q15.1 0.181 0.166 0.708 DNA Damage Response (DDR); DDR (FA)
cop RMDN3 15q15.1 0.181 0.166 0.708
cop GCHFR 15q15 0.181 0.166 0.708 negative regulation of GTP cyclohydrolase I
cop C15orf62 15q15.1 0.181 0.166 0.708
exp OSM 22q12.2 0.181 0.166 0.708 multicellular organismal
xsq VARS 6p21.3 0.181 0.166 0.708 gene expression;translational elongation
xsq MDC1 6p21.3 0.181 0.166 0.708 DNA Damage Response (DDR); DDR (NHEJ)
exp NKAIN2 6q21 0.181 0.166 0.708
exp CHD8 14q11.2 0.181 0.166 0.708 DNA duplex unwinding;ATP-dependent
mir hsa-miR-199b-5p 0.181 0.166 0.708
dependent"
met ZNF436-AS1 0.181 0.166 0.708
met TCHH 1q21.3 0.181 0.166 0.708 keratinization
exp HNRNPAB 5q35.3 0.181 0.166 0.708 epithelial to mesenchymal
xsq RPL34 4q25 0.181 0.166 0.708 nuclear-transcribed mRNA catabolic process,
xsq LOC100128593 0.181 0.166 0.708
exp MTHFD1 14q24 0.181 0.166 0.708 water-soluble vitamin metabolic
cop TCP10 6q27 0.181 0.166 0.708
xsq RPS15A 16p 0.181 0.166 0.708 nuclear-transcribed mRNA catabolic
exp NACA2 17q23.2 0.181 0.166 0.708 protein transport
xsq GEMIN2 14q13 0.181 0.166 0.709 RNA metabolic process;ncRNA metabolic
process
cop ARHGAP18 6q22.33 0.181 0.166 0.709 signal transduction;small GTPase
xsq TSNAXIP1 16q22.1 0.181 0.166 0.709 multicellular organismal
met SNTG2 2p25.3 0.181 0.166 0.709 central nervous system development
xsq PILRA 7q22.1 0.181 0.166 0.709 signal transduction;interspecies
xsq ATP5EP2 13q12 0.181 0.166 0.709 proton transport;ion transport
met SPTBN1 2p21 0.181 0.166 0.709 axon guidance;actin filament capping
mut KRT73 12q13.3 0.181 0.166 0.709
met BCL11B 14q32.2 -0.181 0.166 0.709 regulation of lipid metabolic
xsq GSTA1 6p12.1 -0.181 0.166 0.709 glutathione metabolic
exp PAK3 Xq23 -0.181 0.166 0.709 Protein Kinases
xsq PTGER3 1p31.2 -0.181 0.166 0.709 intracellular receptor
mediated signaling pathway;positive regulation of fever generation
xsq LINC00152 2p11.2 -0.181 0.166 0.709
cop SENP5 3q29 -0.181 0.166 0.709 proteolysis;cell cycle
exp ZBTB43 9q33.3 -0.181 0.166 0.708 regulation of transcription,
DNA-dependent"
met CARD19 -0.181 0.166 0.708 negative regulation of I-kappaB
kinase/NF-kappaB cascade
exp PPP2R1A 19q13.41 -0.181 0.166 0.708 Apoptosis; Oncogenes
xsq B4GALT4 3q13.3 -0.181 0.166 0.708 post-translational protein
exp PDE5A 4q27 -0.181 0.166 0.708 response to hypoxia;positive regulation
of cardiac muscle hypertrophy
exp GFOD1 6pter-p22.1 -0.181 0.166 0.708
mut SMC1B 22q13.31 -0.181 0.166 0.708 DNA Damage Response (DDR); DDR (DNA
replication)
exp NAT14 19q13.42 -0.181 0.166 0.708 transcription initiation, DNA-
cop UNC5D 8p12 -0.181 0.166 0.708 apoptotic process;signal transduction
cop TSPAN13 7p21.1 -0.181 0.166 0.708
exp MPZL2 11q24 -0.181 0.166 0.708 T cell differentiation in
thymus;homophilic cell adhesion
exp LOC388242 -0.181 0.166 0.708
cop RGS21 1q31.2 -0.181 0.166 0.708
cop KCNB2 8q13.2 -0.181 0.166 0.708 synaptic transmission;transmembrane
transport
xsq SAA2 11p15.1-p14 -0.181 0.166 0.708
hs4 COX7A1 19q13.1 -0.183 0.166 0.709 generation of precursor
exp MYL6P3 10q21.3 -0.183 0.166 0.709
his SPG20-AS1 -0.183 0.166 0.709
his SPG20 13q13.3 -0.183 0.166 0.709 EMT (Mesenchymal)
his APOL6 22q12.3 -0.183 0.166 0.709 lipoprotein metabolic
process;transport
hs4 CDK14 7q21-q22 -0.183 0.166 0.709 Protein Kinases
xai EFR3A 8q24.22 -0.183 0.166 0.709
his MIR4660 -0.183 0.166 0.709
his C1orf127 1p36.22 -0.183 0.166 0.709
exp HS6ST2-AS1 -0.183 0.166 0.709
xai PRLR 5p13.2 -0.183 0.166 0.709 embryo implantation;prostate gland
growth
hs4 HESX1 3p14.3 -0.183 0.166 0.708 brain development;otic vesicle
formation
xai WNT5B 12p13.3 -0.183 0.166 0.708 Oncogenes
xai HS6ST2-AS1 -0.183 0.166 0.708
xai CAPN13 2p22-p21 -0.183 0.166 0.708 proteolysis
xai IFNE 9p21.3 -0.183 0.166 0.708 defense response;response to virus
hs4 C2orf78 2p13.1 -0.183 0.166 0.708
xai NPTXR 22q13.1 -0.183 0.166 0.708 response to hydrogen peroxide
DNA-dependent"
his RPL23AP32 -0.183 0.166 0.708
his VWA2 10q25.3 -0.183 0.166 0.708
his LINC01615 -0.183 0.166 0.708
xai ZNF148 3q21 -0.183 0.166 0.708 negative regulation of
xai SPIN3 Xp11.21 -0.183 0.166 0.708 gamete generation
hs4 SPATA6L 9p24.2 -0.183 0.166 0.708
hs4 PLPP6 -0.183 0.166 0.708
his ATP1B4 Xq24 -0.183 0.166 0.708 transport;potassium ion transport
xai AHR 7p15 -0.183 0.166 0.708 Apoptosis
his MT2A 16q13 -0.183 0.166 0.708 cellular response to interleukin-
his MT1L 16q13 -0.183 0.166 0.708
his ACOT4 14q24.3 -0.183 0.166 0.708 unsaturated monocarboxylic acid
xai EBPL 13q12-q13 0.183 0.167 0.709 sterol metabolic process
his DLST 14q24.3 0.182 0.167 0.709 small molecule metabolic
xai EIF3D 22q13.1 0.182 0.167 0.709 cellular protein metabolic
his LINC01925 0.182 0.167 0.709
xai CDC5L 6p21 0.182 0.167 0.709 DNA Damage Response (DDR)
his VGF 7q22.1 0.182 0.167 0.709 generation of precursor metabolites and
energy;response to cAMP
swa SCYL1 11q13 0.182 0.167 0.709 regulation of transcription, DNA-
swa RPL24 3q12 0.182 0.167 0.709 SRP-dependent cotranslational protein targeting
to membrane;optic nerve development
his EML5 14q31.3 0.182 0.167 0.709
his SCGB1B2P 0.182 0.167 0.709
dependent"
dependent"
exp STARD4-AS1 0.182 0.167 0.709
hs4 MON1A 3p21.31 0.182 0.167 0.709
swa HARS 5q31.3 0.182 0.167 0.709
exp ATRIP 0.182 0.167 0.709 DNA Damage Response (DDR); DDR (G1-S
exp LOC401098 3q25.33 0.182 0.167 0.71
xai PLPPR3 0.182 0.167 0.71
hs4 DNTT 10q23-q24 0.182 0.167 0.71 DNA Damage Response (DDR); DDR (NHEJ);
his GOLGA8O 0.182 0.167 0.71
xai C12orf56 12q14.2 0.182 0.167 0.71
exp LHX3 9q34.3 0.182 0.167 0.71 positive regulation of transcription,
DNA-dependent;inner ear development
his HIGD2A 5q35.2 0.182 0.167 0.71
his NOP16 5q35.2 0.182 0.167 0.71
his VPREB1 0.182 0.167 0.71 immune response
xai CWF19L2 11q22.3 0.182 0.167 0.71
his SCN9A 2q24 0.182 0.167 0.71 ion transport;sodium ion transport
xai HUS1B 6p25.3 0.182 0.167 0.71 DNA Damage Response (DDR)
exp T1560 0.182 0.167 0.71
his CCNT2-AS1 0.182 0.167 0.71
his CCNT2 2q21.3 0.182 0.167 0.71 regulation of cyclin-dependent protein
kinase activity;cell division
his HJURP 2q37.1 0.182 0.167 0.71 nucleosome assembly;cell cycle
xai SCARNA1 1p35.3 0.182 0.167 0.71
hs4 PYCARD 16p11.2 0.182 0.167 0.71 nucleotide-binding domain, leucine
hs4 PYCARD-AS1 0.182 0.167 0.71
his USP24 1p32.3 0.182 0.167 0.71 proteolysis;ubiquitin-dependent protein
catabolic process
his LOC100507634 0.182 0.167 0.71
his AKIRIN1 1p34.3 0.182 0.167 0.71
cop LRRN4CL 11q12.3 0.182 0.167 0.71
exp SCARNA1 1p35.3 0.182 0.167 0.71
hs4 MIR5093 0.182 0.167 0.71
his LACE1 6q22.1 0.182 0.167 0.71
his SH3YL1 2p25.3 0.182 0.167 0.71
his ACP1 2p25 0.182 0.167 0.71
exp CCDC63 12q24.11 0.182 0.167 0.71
xai HSPD1P8 13q31.1 0.182 0.167 0.71
his KAT2A 17q21 0.182 0.167 0.71 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
his HSPB9 17q21.2 0.182 0.167 0.71 response to stress
his LOC440117 0.182 0.167 0.71
hs4 SNUPN 15q24.2 0.182 0.167 0.71 ncRNA metabolic process;snRNA import into
nucleus
hs4 RARG 12q13 0.182 0.167 0.71 negative regulation of transcription from RNA
promoter
hs4 LINC01783 0.182 0.167 0.71
xai LIN54 4q21.22 0.182 0.167 0.71 regulation of transcription, DNA-
swa PGAM5 12q24.33 0.182 0.167 0.71
exp CR2 1q32 0.181 0.167 0.709 complement receptor mediated signaling
exp FABP5P10 2q23.3 0.181 0.167 0.709
exp LOC645513 4q26 0.181 0.167 0.709
met ODF1 8q22.3 0.181 0.167 0.709
xsq MAN1A1 6q22 0.181 0.167 0.709 post-translational protein
exp PRORSD1P 2p16.1 0.181 0.167 0.709
xsq ROCK1 18q11.1 0.181 0.167 0.709 Apoptosis; Protein Kinases
met PLIN5 19p13.3 0.181 0.167 0.709
xsq CTDSPL2 15q15.3-q21.1 0.181 0.167 0.709
cop VPS16 20p13 0.181 0.167 0.709 intracellular protein transport
met RACGAP1P 12q12 0.181 0.167 0.709
xsq GPC3 Xq26.1 0.181 0.167 0.709 anatomical structure
mut CLDN1 3q28-q29 0.181 0.167 0.709 cell adhesion;calcium-independent cell-
cell adhesion
cop KCNK3 2p23 0.181 0.167 0.709 brain development;response to drug
xsq TIAL1 10q 0.181 0.167 0.709 Apoptosis
xsq EGR4 2p13 0.181 0.167 0.709 regulation of transcription, DNA-
mut SLC5A7 2q12 0.181 0.167 0.709 ion transport;transmembrane transport
cop EML4 2p21 0.181 0.167 0.709 microtubule-based process;mitosis
xsq TMEM27 Xp22 0.181 0.167 0.709 proteolysis
exp MRPL53 2p13.1 0.181 0.167 0.709
xsq PSMB1 6q27 0.181 0.167 0.709 antigen processing and presentation of
met DGCR14 22q11.21 0.181 0.167 0.71
xsq DDX43 6q13 0.181 0.167 0.71
met KREMEN1 22q12.1 0.181 0.167 0.71 cell communication;Wnt receptor
signaling pathway
cop GPR113 2p23.3 0.181 0.167 0.71
exp DDX41 5q35.3 0.181 0.167 0.71 Apoptosis
xsq OR5M3 11q12.1 0.181 0.167 0.71 response to stimulus
met CCNJ 10q23.33 0.181 0.167 0.71
exp BATF3 1q32.3 0.181 0.167 0.71 regulation of transcription, DNA-
met RNF6 13q12.2 0.181 0.167 0.71 protein K48-linked
ubiquitination;regulation of transcription, DNA-dependent
cop PDCD11 10q24.33 0.181 0.167 0.71 Apoptosis
mut EVL 14q32.2 0.181 0.167 0.71 nervous system development;axon guidance
mut IRF1 5q31.1 0.181 0.167 0.71 Apoptosis
xsq ANKRD33 12q13.13 0.181 0.167 0.71
xsq NUP155 5p13.1 0.181 0.167 0.71 nucleocytoplasmic transport;mRNA
transport
met GLTSCR1L 6p21.1 0.181 0.167 0.71
xsq ACSM2A 0.181 0.167 0.71
exp PDE4D 5q12 0.181 0.167 0.71 establishment of endothelial barrier;cAMP
catabolic process
xsq SFT2D3 2q14.3 0.181 0.167 0.71 protein transport;vesicle-mediated
transport
exp SLC39A8 4q22-q24 0.181 0.167 0.71 Solute Carriers
cop ANKRD26P1 16q11.2 0.181 0.167 0.71
exp METTL4 18p11.32 0.181 0.167 0.71 nucleobase-containing compound
metabolic process
met OSBPL2 20q13.3 0.181 0.167 0.71 transport;lipid transport
cop WDR93 15q26.1 0.181 0.167 0.71 electron transport chain
exp RASSF4 10q11.21 0.181 0.167 0.71 cell cycle;signal transduction
xsq RTN4RL2 11q12.1 0.181 0.167 0.71 axon regeneration
cop SNRPB 20p13 0.181 0.167 0.71 RNA splicing;gene expression
cop SNORD119 0.181 0.167 0.71
xsq RRH 4q25 0.181 0.167 0.71 G-protein coupled receptor signaling
pathway;visual perception
cop FGF4 11q13.3 0.181 0.167 0.71
xsq LAMC3 9q31-q34 0.181 0.167 0.71 cell adhesion;visual perception
exp PSME4 2p16.2 0.181 0.167 0.71 antigen processing and presentation of
exp DPY19L2P4 7q21.13 0.181 0.167 0.71
xsq CEP104 1p36.32 0.181 0.167 0.71
exp DHFRP1 18q11.2 0.181 0.167 0.71 one-carbon metabolic process;folic
xsq PLA2G5 1p36-p34 0.181 0.167 0.71 response to cAMP;phospholipid
metabolic process
xsq CDRT15 0.181 0.167 0.71
xsq NADK2 5p13.2 0.181 0.167 0.71
xsq RAP1GAP2 17p13.3 0.181 0.167 0.71 regulation of small GTPase mediated
signal transduction
exp DNASE1L1 Xq28 -0.181 0.167 0.71 DNA metabolic process;DNA catabolic
process
cop TOR3A 1q25.2 -0.181 0.167 0.71 chaperone mediated protein folding
requiring cofactor
exp FAM20B 1q25 -0.181 0.167 0.71
xsq SNX21 20q13.12 -0.181 0.167 0.71 cell communication;protein
transport
met ZNF654 3p11.1 -0.181 0.167 0.71 regulation of transcription,
DNA-dependent"
exp CAMK2B 7p14.3-p14.1 -0.181 0.167 0.71 synaptic
transmission;induction of apoptosis in response to chemical stimulus
xsq FOXS1 20q11.21 -0.181 0.167 0.71 lymphangiogenesis;collagen fibril
organization
met CPA2 7q32 -0.181 0.167 0.71 proteolysis;vacuolar protein catabolic
process
exp GPR176 15q14-q15.1 -0.181 0.167 0.71 G-protein coupled receptor
exp CCDC186 -0.181 0.167 0.71
met TMEM31 Xq22.2 -0.181 0.167 0.71
xsq TSPAN6 Xq22 -0.181 0.167 0.71 signal transduction;positive
xsq FAM110C 2p25.3 -0.181 0.167 0.71
mut PNCK Xq28 -0.181 0.167 0.71
exp LOC100129852 6q16.3 -0.181 0.167 0.71
xsq NHSL1 6q23.3 -0.181 0.167 0.71
xsq C20orf194 20p13 -0.181 0.167 0.71
xsq MYO1B 2q12-q34 -0.181 0.167 0.71 actin filament-based movement;actin
met ATP5G3 2q31.1 -0.181 0.167 0.71 aging;ATP synthesis coupled
proton transport
exp AK3 9p24.1 -0.181 0.167 0.709 nucleobase-containing compound
metabolic process;AMP phosphorylation
met CCL5 17q12 -0.181 0.167 0.709 cellular calcium ion homeostasis;response
to virus
met TES 7q31.2 -0.181 0.167 0.709 negative regulation of cell
proliferation
exp RNF112 17p11.2 -0.181 0.167 0.709
xsq ARMCX1 Xq21.33-q22.2 -0.181 0.167 0.709
met MIR365B -0.181 0.167 0.709
exp TMEM133 11q22.1 -0.181 0.167 0.709
met C1orf162 1p13.2 -0.181 0.167 0.709
cop NLGN1 3q26.31 -0.181 0.167 0.709 positive regulation of
intracellular protein kinase cascade;protein heterotetramerization
xai PDLIM3 4q35 -0.182 0.167 0.71 actin filament organization;heart
development
his KRT42P 17q21.2 -0.182 0.167 0.71
xai LOC100506119 -0.182 0.167 0.71
DNA-dependent"
his PCGF5 10q23.32 -0.182 0.167 0.71 regulation of transcription, DNA-
dependent"
hs4 APOE 19q13.2 -0.182 0.167 0.71 response to reactive oxygen
species;anti-apoptosis
exp DNM1P41 -0.182 0.167 0.71
hs4 SMS Xp22.1 -0.182 0.167 0.71 methionine metabolic
xai PHACTR2 6q24.2 -0.182 0.167 0.71
xai CBR3 21q22.2 -0.182 0.167 0.71 phylloquinone catabolic process
his HRAT17 -0.182 0.167 0.71
his HABP2 10q25.3 -0.182 0.167 0.71 cell adhesion;proteolysis
his KCCAT333 -0.182 0.167 0.71
xai CNR1 6q14-q15 -0.182 0.167 0.71 positive regulation of acute
exp LINC01553 -0.182 0.167 0.709
hs4 DBNDD1 16q24.3 -0.182 0.167 0.709
hs4 GAS8 16q24.3 -0.182 0.167 0.709 negative regulation of cell
xai TRIB2 2p24.3 -0.182 0.167 0.709 negative regulation of protein
catabolic process
xai EPB41L1 20q11.2-q12 -0.182 0.167 0.709 synaptic
xai C7orf71 7p15.2 -0.182 0.167 0.709
hs4 ZNF833P 19p13.2 -0.182 0.167 0.709
his SPACA6 -0.182 0.167 0.709
his MIR99B -0.182 0.167 0.709
his MIRLET7E -0.182 0.167 0.709
his MIR125A -0.182 0.167 0.709
his SPACA6P-AS -0.182 0.167 0.709
hs4 LOC643441 -0.182 0.167 0.709
his LCMT1-AS2 -0.183 0.167 0.709
exp RPL5P5 1q25.3 0.182 0.168 0.71
exp TNNT3 11p15.5 0.182 0.168 0.71 skeletal muscle contraction;regulation of
his HIST1H1A 6p21.3 0.182 0.168 0.71 nucleosome assembly;spermatogenesis
his HIST1H3A 6p22.1 0.182 0.168 0.71
his HIST1H4A 6p22.1 0.182 0.168 0.71
his HIST1H4B 6p22.1 0.182 0.168 0.71
his HIST1H3B 6p22.1 0.182 0.168 0.71
his HIST1H2AB 6p22.1 0.182 0.168 0.71 nucleosome assembly
xai TOPBP1 3q22.1 0.182 0.168 0.71 DNA Damage Response (DDR); DDR (DNA
replication); DDR (G2-M checkpoint)
xai PCSK4 19p13.3 0.182 0.168 0.71 fertilization;sperm capacitation
xai AP4E1 15q21.2 0.182 0.168 0.71 intracellular protein transport;vesicle-
mediated transport
hs4 DCAF7 17q23.3 0.182 0.168 0.71 multicellular organismal
exp MMP20 11q22.3 0.182 0.168 0.71 Apoptosis
his ARGLU1 13q33.3 0.182 0.168 0.71 regulation of transcription, DNA-
dependent"
xai GTF2H2B 5q13.2 0.182 0.168 0.71
xai PDDC1 11p15.5 0.182 0.168 0.711
his P3H1 0.182 0.168 0.711 negative regulation of cell proliferation;cell
growth
his C1orf50 1p34.2 0.182 0.168 0.711
his NUDT11 Xp11.22 0.182 0.168 0.711
xai COPS2 15q21.2 0.182 0.168 0.711 DNA Damage Response (DDR)
exp FAM209B 20q13.31 0.182 0.168 0.711
his NUDCD2 5q34 0.182 0.168 0.711
his HMMR 5q34 0.182 0.168 0.711
xai ADGRG5 0.182 0.168 0.711 G-protein coupled receptor signaling
his KRT16P2 17p11.2 0.182 0.168 0.711
xai SMIM19 8p11.21 0.182 0.168 0.711
xai WDR27 6q27 0.182 0.168 0.711
exp RPL24P2 20p11.23 0.182 0.168 0.711
his ALG3 3q27.1 0.182 0.168 0.711 protein N-linked glycosylation via
his ECE2 3q27.1 0.182 0.168 0.711 peptide hormone processing;proteolysis
his ACD 16q22.1 0.182 0.168 0.711 DNA Damage Response (DDR)
his PARD6A 16q22.1 0.182 0.168 0.711 cell-cell junction maintenance;cell
division
xai MON1A 3p21.31 0.182 0.168 0.711
his POC1A 3p21.2 0.182 0.168 0.711
his EPC1 10p11 0.182 0.168 0.711 histone H2A acetylation;negative regulation of
his LOC102031319 0.182 0.168 0.711
his BTN3A2 6p22.1 0.182 0.168 0.712
xai LOC100288842 9q33.2 0.182 0.168 0.712
xsq OR2T34 0.181 0.168 0.71
xsq DHX9 1q25 0.181 0.168 0.71 nuclear mRNA splicing, via spliceosome;RNA
splicing
met IGBP1P1 14q13.2 0.18 0.168 0.71
xsq HIST1H2BJ 6p22.1 0.18 0.168 0.71 nucleosome assembly;defense
exp CHCHD3P3 1p36.11 0.18 0.168 0.71
met CAPN2 1q41-q42 0.18 0.168 0.711 response to hypoxia;blastocyst
development
xsq PRSS1 0.18 0.168 0.711 digestion;proteolysis
met LYRM9 17q11.2 0.18 0.168 0.711
mut TCF7L2 10q25.3 0.18 0.168 0.711 regulation of transcription from
RNA polymerase II promoter;neurogenesis
xsq RPL21P28 1q32.3 0.18 0.168 0.711
met SLC35D3 6q23.3 0.18 0.168 0.711 Solute Carriers
met RLBP1 15q26 0.18 0.168 0.711 vitamin A metabolic process;visual perception
exp DUSP22 6p25.3 0.18 0.168 0.711 Apoptosis
xsq ELP6 3p21.31 0.18 0.168 0.711
exp VHL 3p25.3 0.18 0.168 0.711 Protein Kinases; Tumor Suppressors
xsq SUMO1P1 20q13.2 0.18 0.168 0.711
exp DDX19B 16q22.1 0.18 0.168 0.711 mRNA export from nucleus;protein
transport
xsq SPATA21 1p36.13 0.18 0.168 0.711
exp PRMT9 0.18 0.168 0.711
xsq VHL 3p25.3 0.18 0.168 0.711 Protein Kinases; Tumor Suppressors
exp PLCG2 16q24.1 0.18 0.168 0.711 blood coagulation;response to magnesium
ion
exp BZW1 2q33 0.18 0.168 0.711 regulation of transcription, DNA-dependent;RNA
metabolic process"
met OR51S1 11p15.4 0.18 0.168 0.711
xsq RPL27 17q21 0.18 0.168 0.711 translational termination;cellular protein
metabolic process
xsq PLCXD3 5p13.1 0.18 0.168 0.711 lipid catabolic
cop PSMF1 20p13 0.18 0.168 0.711 S phase of mitotic cell cycle;apoptotic process
cop TMEM74B 20p13 0.18 0.168 0.711
cop C20orf202 20p13 0.18 0.168 0.711
xsq GLOD4 17p13.3 0.18 0.168 0.711
exp GDI2P1 7p12.3 0.18 0.168 0.711
exp CNNM3 2p12-p11.2 0.18 0.168 0.711 ion transport
exp ZNF41 Xp11.23 0.18 0.168 0.711 regulation of transcription, DNA-
dependent"
met G0S2 1q32.2 0.18 0.168 0.711 cell cycle;cellular lipid metabolic
process
cop LOC388948 0.18 0.168 0.711
cop LOC100134259 0.18 0.168 0.711
cop LAMA2 6q22-q23 0.18 0.168 0.711 muscle organ development;regulation of
cell adhesion
xsq RGS22 8q22.2 0.18 0.168 0.711 negative regulation of signal
transduction;termination of G-protein coupled receptor signaling pathway
xsq SLAMF1 1q23.3 0.18 0.168 0.711 positive regulation of cell
proliferation;interspecies interaction between organisms
met C1QTNF4 11q11 0.18 0.168 0.711
met RPL23AP7 2q14 0.18 0.168 0.711
xsq LOC101928766 0.18 0.168 0.711
exp SMIM19 8p11.21 0.18 0.168 0.711
cop GOLGA6L6 0.18 0.168 0.711
cop GOLGA8CP 15q11.2 0.18 0.168 0.711
cop NBEAP1 15q11.2 0.18 0.168 0.711
cop POTEB 0.18 0.168 0.711
cop NF1P2 0.18 0.168 0.711
cop LINC01193 0.18 0.168 0.711
cop LOC646214 0.18 0.168 0.711
cop CXADRP2 0.18 0.168 0.711
cop LOC727924 15q11.2 0.18 0.168 0.711
cop OR4M2 0.18 0.168 0.711
cop OR4N4 15q11.2 0.18 0.168 0.711 response to stimulus
cop OR4N3P 15q11.2 0.18 0.168 0.711
xsq NPHS1 19q13.1 0.18 0.168 0.712 MAPK cascade;glomerular basement membrane
development
exp LINC00961 9p13.3 -0.18 0.168 0.712
exp ZNF655 7q22.1 -0.18 0.168 0.712 G1 phase;regulation of
exp EDA2R Xq12 -0.18 0.168 0.711 positive regulation of JNK cascade;positive
cop NRROS 3q29 -0.18 0.168 0.711
xsq A2M 12p13.31 -0.18 0.168 0.711 negative regulation of complement
exp OSBPL6 2q32.1 -0.18 0.168 0.711 transport;lipid transport
exp LINC00900 11q23.3 -0.18 0.168 0.711
cop CEP19 3q29 -0.18 0.168 0.711
cop PIGX 3q29 -0.18 0.168 0.711 C-terminal protein lipidation;preassembly of
cop PAK2 3q29 -0.18 0.168 0.711 Protein Kinases
xsq TAS2R8 12p13 -0.18 0.168 0.711 response to stimulus;detection of
mut ZBTB40 1p36 -0.18 0.168 0.711 bone mineralization;regulation of
exp SNTB1 8q23-q24 -0.18 0.168 0.711 muscle contraction
xsq TCEAL6 -0.18 0.168 0.711
mut HNRNPDL 4q21.22 -0.18 0.168 0.711
xsq ZBED2 3q13.2 -0.18 0.168 0.711
cop DECR1 8q21.3 -0.18 0.168 0.711 fatty acid beta-oxidation;cellular lipid
metabolic process
xsq RAMP1 2q36-q37.1 -0.18 0.168 0.711 angiogenesis;protein localization in
plasma membrane
exp SRPX Xp21.1 -0.18 0.168 0.711 cell adhesion
cop SAMD7 3q26.2 -0.18 0.168 0.71
cop LOC100128164 3q26.2 -0.18 0.168 0.71
exp ADAM8 10q26.3 -0.18 0.168 0.71 leukocyte migration involved in
inflammatory response;positive regulation of cell migration
cop MAP1LC3A 20q11.22 -0.181 0.168 0.71 autophagic vacuole
assembly;autophagy
cop PIGU 20q11.22 -0.181 0.168 0.71 attachment of GPI anchor to
protein;post-translational protein modification
xsq GJB2 13q11-q12 -0.181 0.168 0.71 transport;cell-cell signaling
hs4 LIPH 3q27 -0.182 0.168 0.712 lipid catabolic process
his MIR3156-1 -0.182 0.168 0.712
his COL12A1 6q12-q13 -0.182 0.168 0.712 skeletal system
his LCN2 9q34 -0.182 0.168 0.711 siderophore transport;regulation of
apoptotic process
his CAPN13 2p22-p21 -0.182 0.168 0.711 proteolysis
xai MICE -0.182 0.168 0.711
his MIR98 -0.182 0.168 0.711
his MIRLET7F2 -0.182 0.168 0.711
xai LOC100505504 -0.182 0.168 0.711
his CST5 -0.182 0.168 0.711
hs4 ZNF83 19q13.3 -0.182 0.168 0.711 regulation of transcription, DNA-
dependent"
xai LIN7B 19q13.3 -0.182 0.168 0.711 exocytosis;neurotransmitter
secretion
exp SLC51A 3q29 -0.182 0.168 0.711
exp SMC5-AS1 -0.182 0.168 0.711
xai IRAK2 3p25.3 -0.182 0.168 0.711 Protein Kinases
his TNNC2 20q12-q13.11 -0.182 0.168 0.711 regulation of muscle
xai ANKDD1B 5q13.3 -0.182 0.168 0.711 signal transduction
hs4 MAMDC2 9q21.12 -0.182 0.168 0.711
xai TMEM67 8q22.1 -0.182 0.168 0.711 cilium assembly;branching
his HIPK2 7q32-q34 -0.182 0.168 0.711 Apoptosis
his TBXAS1 7q34-q35 -0.182 0.168 0.711 fatty acid biosynthetic
process;icosanoid metabolic process
cop MIR3610 -0.182 0.168 0.711
hs4 PMEPA1 20q13.31-q13.33 -0.182 0.168 0.711 androgen receptor
signaling pathway
hs4 NKILA -0.182 0.168 0.711
xai TRIOBP 22q13.1 -0.182 0.168 0.711 actin modification;barbed-end
actin filament capping
xai LINC01553 -0.182 0.168 0.711
his PSG10P 19q13.2 -0.182 0.168 0.71
xai ALPK3 15q25.2 -0.182 0.168 0.71 protein
xai FZD6 8q22.3-q23.1 -0.182 0.168 0.71 gonad development;cell
xai C6orf106 6p21.31 -0.182 0.168 0.71
hs4 TUBB2A 6p25 -0.182 0.168 0.71 protein polymerization;protein
folding
xai VHL 3p25.3 0.182 0.169 0.712 Protein Kinases; Tumor Suppressors
his GRSF1 4q13 0.182 0.169 0.712 morphogenesis of embryonic epithelium;mRNA
polyadenylation
his NKD2 5p15.3 0.182 0.169 0.712 transport;exocytosis
his CNOT4 7q33 0.182 0.169 0.712 nuclear-transcribed mRNA catabolic process,
deadenylation-dependent decay;nuclear-transcribed mRNA poly(A) tail shortening
hs4 CD34 1q32 0.182 0.169 0.712 tissue homeostasis;cell proliferation
xai PSMB6 17p13 0.182 0.169 0.712 antigen processing and presentation of peptide
hs4 M6PR 12p13 0.182 0.169 0.712 transport;receptor-mediated endocytosis
hs4 KLRG1 12p13.31 0.182 0.169 0.712 inflammatory response;cellular defense
response
xai RPS18 6p21.3 0.182 0.169 0.712 nuclear-transcribed mRNA catabolic
xai ATAD3B 1p36.33 0.182 0.169 0.712
his R3HDM2 12q13.3 0.182 0.169 0.712
his INHBC 12q13.1 0.182 0.169 0.712 growth
xai TET2 4q24 0.182 0.169 0.712 Tumor Suppressors
xai CENPV 17p11.2 0.181 0.169 0.712 cell cycle;mitosis
xai AHCY 20q11.22 0.181 0.169 0.712 sulfur amino acid metabolic process;one-
hs4 OIP5 15q15.1 0.181 0.169 0.712 cell communication;CenH3-containing
hs4 NUSAP1 15q15.1 0.181 0.169 0.712 positive regulation of mitosis;cell
division
xai CMC2 16q23.2 0.181 0.169 0.712
his EBF2 8p21.2 0.181 0.169 0.712 regulation of transcription, DNA-
xai GUCY2C 12p12 0.181 0.169 0.712 regulation of cell proliferation;cGMP
xai UCN 2p23-p21 0.181 0.169 0.712 positive regulation of cell
xai MTFMT 15q22.31 0.181 0.169 0.712 biosynthetic process
his MIR6849 0.181 0.169 0.712
hs4 INPP4A 2q11.2 0.181 0.169 0.712 signal transduction
xai LOC100132071 0.181 0.169 0.712
hs4 RBM38 20q13.31 0.181 0.169 0.712 DNA damage response, signal transduction
by p53 class mediator resulting in transcription of p21 class mediator;cell cycle
xai GJC2 1q42.13 0.181 0.169 0.712 transmembrane transport;cell-cell
signaling
his LINC00092 9q22.32 0.181 0.169 0.712
xai CELF2-AS1 0.181 0.169 0.712
xai HIST1H1D 6p21.3 0.181 0.169 0.712 nucleosome assembly;nucleosome
positioning
xai IRAK3 12q14.3 0.181 0.169 0.712 Protein Kinases
hs4 MAP1LC3B2 12q24.22 0.181 0.169 0.712 autophagy
his ABCC5 3q27 0.181 0.169 0.712 ABC Transporters
xai TSSC4 11p15.5 0.181 0.169 0.712
xai YTHDF2 1p35 0.181 0.169 0.712 humoral immune response
hs4 TFEC 7q31.2 0.181 0.169 0.712 regulation of transcription, DNA-
his PTBP1 19p13.3 0.181 0.169 0.712 negative regulation of RNA
his MIR4745 0.181 0.169 0.712
hs4 MIR887 0.181 0.169 0.712
exp HIST1H4J 6p22.1 0.18 0.169 0.712
exp AHCY 20q11.22 0.18 0.169 0.712 sulfur amino acid metabolic process;one-
cop RAD21L1 20p13 0.18 0.169 0.712 chromosome segregation;meiosis
cop SNPH 20p13 0.18 0.169 0.712 neurotransmitter secretion;synaptic vesicle
xsq CCDC125 5q13.2 0.18 0.169 0.712
xsq ACAT2 6q25.3 0.18 0.169 0.712 lipid metabolic process
exp CD96 3q13.13-q13.2 0.18 0.169 0.712 cell adhesion;regulation of immune
response
exp PRPF4B 6p25.2 0.18 0.169 0.712 nuclear mRNA splicing, via
exp ZNHIT3 17q12 0.18 0.169 0.712 regulation of transcription, DNA-
dependent"
xsq KCNK15 20q13.12 0.18 0.169 0.712 potassium ion transport;ion
transport
xsq LOC101927697 0.18 0.169 0.712
xsq LOC648987 5p12 0.18 0.169 0.712
exp CRNKL1 20p11.2 0.18 0.169 0.712 RNA splicing;spliceosome assembly
exp RYR3 15q14-q15 0.18 0.169 0.712 cellular response to calcium ion;ion
transport
cop SHPRH 6q24.3 0.18 0.169 0.712 DNA Damage Response (DDR); DDR (TLS)
met MRAP2 6q14.2 0.18 0.169 0.712 positive regulation of cAMP biosynthetic
process;protein localization at cell surface
xsq RREB1 6p25 0.18 0.169 0.712 regulation of transcription, DNA-
cop SUPT4H1 17q22 0.18 0.169 0.712 viral reproduction;negative regulation of
met GPR158 10p12.1 0.18 0.169 0.712
met ATP13A3 3q29 0.18 0.169 0.712 cation transport
exp MCPH1 8p23.1 0.18 0.169 0.712 DNA Damage Response (DDR)
xsq TMX4 20p12 0.18 0.169 0.712 electron transport chain;cell redox homeostasis
met GTF2IRD2 7q11.23 0.18 0.169 0.712 regulation of transcription, DNA-
dependent"
mut MBOAT7 19q13.4 0.18 0.169 0.712 phospholipid biosynthetic process
xsq IQCF6 0.18 0.169 0.712
cop FKBP1A-SDCBP2 0.18 0.169 0.712
cop SDCBP2 20p13 0.18 0.169 0.712 nervous system development;intracellular
signal transduction
xsq DKFZP434A062 9q34.3 0.18 0.169 0.712
exp SMU1 9p12 0.18 0.169 0.712
xsq STOX1 10q22.1 0.18 0.169 0.712
xsq ABCD2 12q12 0.18 0.169 0.712 ABC Transporters
exp CCDC34 11p14.1 0.18 0.169 0.712
mut IPO5 13q32.2 0.18 0.169 0.712 intracellular protein
xsq PAPOLB 0.18 0.169 0.712 DDR (DNA replication)
exp PAPOLA 14q32.31 0.18 0.169 0.712 RNA splicing;gene expression
xsq DTNB 2p24 0.18 0.169 0.712
xsq UBAC2-AS1 13q32.3 0.18 0.169 0.712
xsq OSTC 4q25 0.18 0.169 0.712 protein N-linked glycosylation via asparagine
exp KHDC1L 6q13 0.18 0.169 0.712
cop EMSY 0.18 0.169 0.712 DNA repair;regulation of transcription, DNA-
dependent
xsq LOC100133315 11q13.4 0.18 0.169 0.712
xsq LINC00317 0.18 0.169 0.712
xsq FZD8 10p11.21 0.18 0.169 0.712 positive regulation of protein
phosphorylation;positive regulation of transcription from RNA polymerase II
promoter
xsq GEMIN8P4 1p22 0.18 0.169 0.712
cop MRPL19 2p11.1-q11.2 0.18 0.169 0.712 translation
dependent"
exp AGER 6p21.3 0.18 0.169 0.712 inflammatory response;positive regulation
xsq UQCC2 0.18 0.169 0.712
xsq SLC25A14 Xq24 0.18 0.169 0.712 Solute Carriers
xsq NDUFAF5 20p12.1 0.18 0.169 0.712
met COL4A5 Xq22 0.18 0.169 0.712 axon guidance
mut C15orf59 15q24.1 0.18 0.169 0.712
met CABLES1 18q11.2 0.18 0.169 0.712 regulation of cell cycle;nervous
system development
exp SH3BP1 22q13.1 0.18 0.169 0.712 signal transduction
cop MSH2 2p21 0.18 0.169 0.712 DNA Damage Response (DDR); DDR (MMR); Tumor
Suppressors
xsq ABCA9-AS1 0.18 0.169 0.712
cop MESP1 15q26.1 0.18 0.169 0.712 heart looping;multicellular organismal
development
cop MESP2 15q26.1 0.18 0.169 0.712 mesodermal cell migration;signal
cop ANPEP 15q25-q26 0.18 0.169 0.712 cell differentiation;negative regulation
of renal sodium excretion
cop C15orf38-AP3S2 0.18 0.169 0.712
cop AP3S2 15q26.1 0.18 0.169 0.712 intracellular protein transport;vesicle-
mediated transport
cop MIR5094 0.18 0.169 0.712
cop C15orf38 0.18 0.169 0.712
exp MAGEF1 3q13 -0.18 0.169 0.712
exp TCAF1 -0.18 0.169 0.712
xsq HLA-DMA 6p21.3 -0.18 0.169 0.712 antigen processing and presentation
of exogenous peptide antigen via MHC class II;T cell costimulation
xsq MITF 3p14.2-p14.1 -0.18 0.169 0.712 multicellular organismal
cop SEC62 3q26.2 -0.18 0.169 0.712 cotranslational protein targeting to
membrane
met NOC2L 1p36.33 -0.18 0.169 0.712 negative regulation of apoptotic
xsq IFI6 1p35 -0.18 0.169 0.712 negative regulation of mitochondrial
depolarization;type I interferon-mediated signaling pathway
xsq FBXO44 1p36.22 -0.18 0.169 0.712 protein catabolic process
cop ABL2 1q25.2 -0.18 0.169 0.712 signal transduction;cellular response to
retinoic acid
exp KIAA1841 2q14 -0.18 0.169 0.712
exp PLAUR 19q13 -0.18 0.169 0.712 cellular component movement;fibrinolysis
met UBALD1 16p13.3 -0.18 0.169 0.712
cop GNG12 1p31.3 -0.18 0.169 0.712 signal transduction;G-protein coupled
mut ZBTB43 9q33.3 -0.18 0.169 0.712 regulation of transcription, DNA-
dependent"
exp ATN1 12p13.31 -0.18 0.169 0.712 negative regulation of transcription from
RNA polymerase II promoter;neuron apoptosis
exp ALPK1 4q25 -0.18 0.169 0.712 protein phosphorylation
cop NEK7 1q31.3 -0.18 0.169 0.712 cytokinesis;protein phosphorylation
exp SPRR3 1q21-q22 -0.18 0.169 0.712 keratinization;wound healing
exp C1orf64 1p36.13 -0.18 0.169 0.712
met PLCB4 20p12 -0.18 0.169 0.712 lipid metabolic process;lipid catabolic process
exp C1orf226 1q23.3 -0.18 0.169 0.712
exp VWA2 10q25.3 -0.18 0.169 0.712
xsq ARMCX3 Xq22.1 -0.18 0.169 0.712
cop BRINP1 -0.18 0.169 0.712 cell cycle arrest;cell death
exp KRT14 17q21.2 -0.18 0.169 0.712 intermediate filament bundle
assembly;epidermis development
exp ME3 11cen-q22.3 -0.18 0.169 0.712 oxidation-reduction process;oxygen
metabolic process
exp TBC1D23 3q12.2 -0.18 0.169 0.712
met MYCBPAP 17q21.33 -0.18 0.169 0.712 synaptic transmission;multicellular
xsq WSB2 12q24.23 -0.18 0.169 0.712 intracellular signal transduction
xsq RAB27B 18q21.2 -0.18 0.169 0.712 small GTPase mediated signal
met APOL4 22q11.2-q13.2 -0.18 0.169 0.712 lipoprotein metabolic process;lipid
metabolic process
xsq ARMC9 2q37.1 -0.18 0.169 0.712
exp LOC391349 2p25.2 -0.18 0.169 0.712
xsq MPP3 17q21.31 -0.18 0.169 0.712 signal transduction
cop UBXN7 3q29 -0.18 0.169 0.712
cop RNF168 3q29 -0.18 0.169 0.712 DNA Damage Response (DDR); DDR (NHEJ)
cop SMCO1 -0.18 0.169 0.712
cop WDR53 3q29 -0.18 0.169 0.712
cop FBXO45 3q29 -0.18 0.169 0.712 nervous system development;protein
ubiquitination
xai ADH7 4q23-q24 -0.181 0.169 0.712 ethanol oxidation;xenobiotic
metabolic process
hs4 OSER1 20q13.11 -0.181 0.169 0.712
hs4 OSER1-AS1 -0.181 0.169 0.712
his LINC01948 -0.181 0.169 0.712
his PLCB4 20p12 -0.181 0.169 0.712 lipid metabolic process;lipid catabolic
process
xai ATP6V1B1 2p13.1 -0.181 0.169 0.712 ossification;transferrin
transport
xai CLTA 9p13 -0.181 0.169 0.712 post-Golgi vesicle-mediated
xai TFAP2A 6p24 -0.181 0.169 0.712 optic vesicle
xai RHOBTB1 10q21.2 -0.181 0.169 0.712 small GTPase mediated signal
his SHMT2 12q12-q14 -0.181 0.169 0.712 glycine biosynthetic process from
serine;protein homotetramerization
exp HSPA8P17 -0.181 0.169 0.712
xai RRAD 16q22 -0.181 0.169 0.712 GTP catabolic process;signal transduction
swa FES 15q26.1 -0.181 0.169 0.712 regulation of cell shape;positive
xai HSPA8P17 -0.181 0.169 0.712
his BMP1 8p21.3 -0.181 0.169 0.712 cartilage condensation;positive
regulation of cartilage development
exp LRRC29 16q22.1 -0.181 0.169 0.712
xai UBE2U 1p31.3 -0.181 0.169 0.712
his CCNO 5q11.2 -0.181 0.169 0.712 DNA Damage Response (DDR)
swa ARSA 22q13.33 -0.181 0.169 0.712 sphingolipid metabolic
exp LOC100507156 -0.181 0.169 0.712
hs4 LIFR 5p13-p12 -0.181 0.169 0.712 response to cytokine
stimulus;response to chemical stimulus
hs4 LIFR-AS1 -0.181 0.169 0.712
hs4 MIR3650 -0.181 0.169 0.712
hs4 GPR75-ASB3 -0.181 0.169 0.712
hs4 GPR75 2p16 -0.181 0.169 0.712 G-protein coupled receptor signaling
pathway
xai ATP6V1C1 8q22.3 -0.181 0.169 0.712 transport;cellular iron ion
homeostasis
xai EMC3 3p25.3 -0.181 0.169 0.712
hs4 TMEM44 3q29 -0.182 0.169 0.712
hs4 ALS2CR12 2q33.1 -0.182 0.169 0.712 regulation of GTPase activity
xai KIF23 15q23 -0.182 0.169 0.712 M phase of mitotic cell cycle;positive
hs4 TTC23 15q26.3 -0.182 0.169 0.712
hs4 LRRC28 15q26.3 -0.182 0.169 0.712
his MIR193BHG -0.182 0.169 0.712
his MIR193B -0.182 0.169 0.712
his MIR365A -0.182 0.169 0.712
hs4 CTSD 11p15.5 -0.182 0.169 0.712 cell death;proteolysis
his LOC102724933 -0.182 0.169 0.712
hs4 KCNK3 2p23 -0.182 0.169 0.712 brain development;response to drug
his MIR1273A -0.182 0.169 0.712
his TMEM75 -0.182 0.169 0.712
hs4 LOC389705 9p22.3 -0.182 0.169 0.712
his PDE6G 17q25 -0.182 0.169 0.712 activation of MAPK activity;blood
coagulation
his NBPF10 1q21.1 0.181 0.17 0.712
swa CASP6 4q25 0.181 0.17 0.712 Apoptosis
hs4 BCR 22q11.23 0.181 0.17 0.712 actin cytoskeleton organization;positive
exp RPL7AP4 14q22.3 0.181 0.17 0.712
xai TBX5-AS1 0.181 0.17 0.712
xai DTNB 2p24 0.181 0.17 0.712
hs4 PHF10 6q27 0.181 0.17 0.712 regulation of transcription, DNA-
dependent"
xai TBC1D14 4p16.1 0.181 0.17 0.713
his MTHFD2 2p13.1 0.181 0.17 0.713 one-carbon metabolic process;folic
acid-containing compound biosynthetic process
xai CENPE 4q24-q25 0.181 0.17 0.713 mitotic chromosome movement towards
hs4 RAN 12q24.3 0.181 0.17 0.713 nucleocytoplasmic transport;androgen
his HMSD 18q22.1 0.181 0.17 0.713
xai BEX5 Xq22.1 0.181 0.17 0.713
xai CEP78 9q21.2 0.181 0.17 0.713 G2/M transition of mitotic cell
his GLCCI1 7p21.3 0.181 0.17 0.713
his LOC100505921 0.181 0.17 0.713
hs4 ZBTB42 14q32.33 0.181 0.17 0.713 regulation of transcription, DNA-
dependent"
xai CDH22 20q13.1 0.181 0.17 0.713 homophilic cell adhesion;cell adhesion
xai LRRC47 1p36.32 0.181 0.17 0.713
his MIR3909 0.181 0.17 0.713
his MIR6069 0.181 0.17 0.713
xai ZCCHC4 4p15.2 0.181 0.17 0.713
swa TPP2 13q32-q33 0.181 0.17 0.713 antigen processing and presentation of
xai IGHV3-42 0.181 0.17 0.713
exp WDR27 6q27 0.181 0.17 0.713
xai TSPEAR-AS2 0.181 0.17 0.713
xai RSF1 11q14.1 0.181 0.17 0.713 nucleosome positioning;CenH3-containing
xai CENPBD1 16q24.3 0.181 0.17 0.713 regulation of transcription, DNA-
dependent"
exp LOC100288842 9q33.2 0.181 0.17 0.713
xai ZNF593 1p36.11 0.181 0.17 0.713 negative regulation of
dependent"
his RBBP7 Xp22.2 0.181 0.17 0.713 nucleosome assembly;regulation of
his HCG27 6p21.33 0.181 0.17 0.713
hs4 MIR4494 0.181 0.17 0.713
his PYCRL 8q24.3 0.181 0.17 0.713 proline biosynthetic process;cellular
amino acid biosynthetic process
his MEIOC 0.181 0.17 0.713
hs4 GPC2 7q22.1 0.181 0.17 0.713 neuron differentiation
hs4 STAG3 7q22.1 0.181 0.17 0.713 cell cycle;chromosome segregation
xai ING2 4q35.1 0.181 0.17 0.714 positive regulation of transforming
dependent
hs4 VWDE 7p21.3 0.181 0.17 0.714
his TSR1 17p13.3 0.181 0.17 0.714 ribosome assembly
his SGSM2 17p13.3 0.181 0.17 0.714
cop SDCBP2-AS1 0.18 0.17 0.712
cop FKBP1A 20p13 0.18 0.17 0.712 'de novo' protein folding;regulation of
activin receptor signaling pathway
mut FAM111B 11q12.1 0.18 0.17 0.712
cop CDC42EP3 2p21 0.18 0.17 0.712 signal transduction;regulation of cell
shape
cop FAM174B 15q26.1 0.18 0.17 0.712
cop ASB9P1 15q26.1 0.18 0.17 0.712
cop LOC100507217 0.18 0.17 0.712
cop CHD2 15q26 0.18 0.17 0.712 regulation of transcription from RNA polymerase
II promoter
cop MIR3175 0.18 0.17 0.712
xsq ZCCHC11 1p32.3 0.18 0.17 0.712 cytokine production;negative
met H2BFWT Xq22.2 0.18 0.17 0.712
cop LDLRAD4 18p11.21 0.18 0.17 0.712
xsq KAT6B 10q22.2 0.18 0.17 0.712 positive regulation of transcription,
DNA-dependent;nucleosome assembly
exp ZFP90 16q22.1 0.18 0.17 0.712 negative regulation of DNA
xsq GOLGA8DP 15q11.2 0.18 0.17 0.712
exp TMEM97 17q11.2 0.18 0.17 0.712 regulation of cell
xsq HIST3H2A 1q42.13 0.18 0.17 0.712 nucleosome assembly
cop HRK 12q24.22 0.18 0.17 0.712 positive regulation of neuron
apoptosis;cellular response to potassium ion starvation
exp PNISR 6q16.3 0.18 0.17 0.712
cop EPB41L2 6q23 0.18 0.17 0.713 cortical actin cytoskeleton organization
exp ATXN7L3 17q21.31 0.18 0.17 0.713 chromatin modification;histone
deubiquitination
cop CEP83 0.18 0.17 0.713
cop MIR5700 0.18 0.17 0.713
cop TMCC3 12q22 0.18 0.17 0.713
cop MIR492 0.18 0.17 0.713
cop KRT19P2 12q22 0.18 0.17 0.713
xsq TPI1 12p13 0.18 0.17 0.713 carbohydrate metabolic process;glucose
metabolic process
met TBCA 5q14.1 0.18 0.17 0.713 'de novo' posttranslational protein
met ABCB4 7q21.1 0.18 0.17 0.713 ABC Transporters
exp SLC25A25-AS1 0.18 0.17 0.713
cop RMDN2 2p22.2 0.18 0.17 0.713
cop CYP1B1 2p22.2 0.18 0.17 0.713 cellular aromatic compound
cop RGMA 15q26.1 0.18 0.17 0.713 axon guidance
met FAM110B 8q12.1 0.18 0.17 0.713
cop DTWD1 15q21.2 0.18 0.17 0.713
mut LIMCH1 4p13 0.179 0.17 0.713 actomyosin structure organization
xsq ACTR3B 7q36.1 0.179 0.17 0.713 regulation of actin filament
polymerization
exp DEAF1 11p15.5 0.179 0.17 0.713 multicellular organismal development;germ
cell development
dependent"
cop ROCK2 2p24 0.179 0.17 0.713 Protein Kinases
met DGAT2 11q13.5 0.179 0.17 0.713 triglyceride biosynthetic
xsq KRTAP10-9 0.179 0.17 0.713
cop LOC100271832 0.179 0.17 0.713
xsq SIRPG 20p13 0.179 0.17 0.713 positive regulation of cell
proliferation;negative regulation of cell proliferation
met REEP1 2p11.2 0.179 0.17 0.713 cell death;protein insertion into
membrane
cop PCED1A 20p13 0.179 0.17 0.713
cop TGM6 20p13 0.179 0.17 0.713 peptide cross-linking;cell death
xsq SLIT1-AS1 0.179 0.17 0.713
exp PANK4 1p36.32 0.179 0.17 0.713 coenzyme A biosynthetic process
cop ADCY3 2p23.3 0.179 0.17 0.713 energy reserve metabolic
cop STXBP5 6q24.3 0.179 0.17 0.713 protein transport;positive
met ATF7IP2 16p13.13 0.179 0.17 0.713 regulation of transcription, DNA-
dependent"
cop HAPLN3 15q26.1 0.179 0.17 0.713 cell adhesion
xsq LOC101927285 0.179 0.17 0.713
met HTR7P1 12p13.1 0.179 0.17 0.713
xsq JADE1 0.179 0.17 0.713 histone H4-K5 acetylation;histone H4-K8
acetylation
mut WDR7 18q21.31 0.179 0.17 0.713
xsq MEGF11 15q22.31 0.179 0.17 0.713
cop NDUFA12 12q22 0.179 0.17 0.713 transport;response to oxidative stress
dependent"
cop BZRAP1-AS1 0.179 0.17 0.714
xsq HCP5 6p21.3 -0.179 0.17 0.714 defense response
xsq FAM219A 9p13.3 -0.179 0.17 0.713
cop PPP1R12B 1q32.1 -0.179 0.17 0.713 signal transduction;positive
exp UNC5B 10q22.1 -0.179 0.17 0.713 Apoptosis
xsq HOXD-AS2 -0.179 0.17 0.713
xsq PSAPL1 4p16.1 -0.179 0.17 0.713 lipid metabolic
xsq ZNF503-AS2 10q22.2 -0.179 0.17 0.713
cop NUDCD3 7p13-p12 -0.179 0.17 0.713
cop NPC1L1 7p13 -0.179 0.17 0.713 small molecule metabolic
cop MIR4279 -0.179 0.17 0.713
met PSG4 19q13.2 -0.179 0.17 0.713 defense response;female pregnancy
cop TERC -0.179 0.17 0.713
cop ACTRT3 3q26.2 -0.179 0.17 0.713
cop MYNN 3q26.2 -0.179 0.17 0.713 transcription, DNA-
cop LRRC34 3q26.2 -0.179 0.17 0.713
cop LRRIQ4 3q26.2 -0.179 0.17 0.713
cop LRRC31 3q26.2 -0.179 0.17 0.713
met RNF183 9q32 -0.179 0.17 0.713
cop ZFR 5p13.3 -0.179 0.17 0.713 multicellular organismal
development
exp RBPMS2 15q22.31 -0.18 0.17 0.713
met C1QTNF7 4p15.3 -0.18 0.17 0.713
mut VSIG4 Xq12-q13.3 -0.18 0.17 0.713 complement activation, alternative
cop GNG12-AS1 1p31.3 -0.18 0.17 0.713
exp PAQR5 15q23 -0.18 0.17 0.713 multicellular organismal development;cell
differentiation
xsq TMEM178B -0.18 0.17 0.713
exp GPM6A 4q34 -0.18 0.17 0.713
exp HOXB-AS3 17q21.32 -0.18 0.17 0.713
met TPRKB 2p24.3-p24.1 -0.18 0.17 0.713 protein catabolic process
met SNORD34 19q13.3 -0.18 0.17 0.713
met SNORD35A 19q13.3 -0.18 0.17 0.713
mut SLC6A18 5p15.33 -0.18 0.17 0.713 ion transport;neurotransmitter
transport
mut MEIS2 15q14 -0.18 0.17 0.712 negative regulation of transcription from RNA
met PP14571 2q37.3 -0.18 0.17 0.712
exp DBX2 12q12 -0.18 0.17 0.712
xsq DDR1 6p21.3 -0.18 0.17 0.712 embryo implantation;skin development
cop DBNL 7p13 -0.18 0.17 0.712 endocytosis;apoptotic process
cop PGAM2 7p13-p12 -0.18 0.17 0.712 response to inorganic substance;small
cop POLM 7p13 -0.18 0.17 0.712 DNA Damage Response (DDR); DDR (NHEJ); DDR (DNA
replication)
cop AEBP1 7p13 -0.18 0.17 0.712 cell adhesion;muscle organ development
cop MIR4649 -0.18 0.17 0.712
cop POLD2 7p13 -0.18 0.17 0.712 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
cop MYL7 7p21-p11.2 -0.18 0.17 0.712 smooth muscle contraction;actin filament-
based movement
cop GCK 7p15.3-p15.1 -0.18 0.17 0.712
cop YKT6 7p15.1 -0.18 0.17 0.712 protein transport;retrograde transport,
endosome to Golgi
cop CAMK2B 7p14.3-p14.1 -0.18 0.17 0.712 synaptic
xai ALDH3A2 17p11.2 -0.181 0.17 0.714 cellular aldehyde metabolic
hs4 FGF1 5q31 -0.181 0.17 0.714 positive regulation of protein
phosphorylation;positive regulation of intracellular protein kinase cascade
his MIR4495 -0.181 0.17 0.713
xai RPS15AP3 14q21.3 -0.181 0.17 0.713
his KCNIP3 2q21.1 -0.181 0.17 0.713 behavior;sensory perception
of pain
his CYP4X1 1p33 -0.181 0.17 0.713
xai KRT8P29 1q32.1 -0.181 0.17 0.713
his LOC105370757 -0.181 0.17 0.713
exp C6orf25 6p21.33 -0.181 0.17 0.713
hs4 PNMA1 14q24.3 -0.181 0.17 0.713 inflammatory response to antigenic
hs4 DOK7 4p16.3 -0.181 0.17 0.713 positive regulation of protein
tyrosine kinase activity
exp UBE2U 1p31.3 -0.181 0.17 0.713
his ENTPD3 3p21.3 -0.181 0.17 0.713 nucleoside diphosphate
his DPYSL3 5q32 -0.181 0.17 0.713 axon guidance;actin crosslink
formation
xai MAEL 1q24.1 -0.181 0.17 0.713 synapsis;piRNA metabolic process
his MAL2 8q23 -0.181 0.17 0.713
exp LOC100128198 -0.181 0.17 0.713
hs4 VTRNA2-1 -0.181 0.17 0.713
xai PCDHB19P 5q31 -0.181 0.17 0.713
xai MAGI1-IT1 -0.181 0.17 0.713
swa CASP14 19p13.1 -0.181 0.17 0.713 apoptotic process;induction
of apoptosis
xai CLPTM1 19q13.3 -0.181 0.17 0.713 multicellular organismal
hs4 TVP23C-CDRT4 -0.181 0.17 0.712
hs4 TVP23C 17p12 -0.181 0.17 0.712
his ACVR1 2q23-q24 -0.181 0.17 0.712 G1/S transition of mitotic cell
xai KRT5 12q13.13 -0.181 0.17 0.712 epidermis development;hemidesmosome
assembly
xai SYCP2 20q13.33 -0.181 0.17 0.712 cell cycle;meiosis
exp TACR1 2p12 -0.181 0.17 0.712 inflammatory response;response to heat
hs4 CGB7 -0.181 0.17 0.712
hs4 PER3 1p36.23 -0.181 0.17 0.712 DNA Damage Response (DDR)
his C8orf46 8q13.1 -0.181 0.17 0.712
xai FER 5q21 -0.181 0.17 0.712 cell adhesion;regulation of epidermal
his CD5 11q13 0.181 0.171 0.714 induction of apoptosis by extracellular
xai RYR3 15q14-q15 0.181 0.171 0.714 cellular response to calcium ion;ion
transport
cop C12orf36 12p13.1 0.181 0.171 0.714
his FTL 19q13.33 0.181 0.171 0.714 transmembrane transport;iron ion
transport
xai KCNJ3 2q24.1 0.181 0.171 0.714 response to electrical stimulus;ion
transport
exp SERPINE3 13q14.3 0.181 0.171 0.714 negative regulation of
exp TRNY 0.181 0.171 0.714
his HSD11B2 16q22 0.181 0.171 0.714 response to insulin stimulus;response to
drug
exp SKCG-1 0.181 0.171 0.714
xai SKCG-1 0.181 0.171 0.714
dependent"
xai UMODL1-AS1 0.181 0.171 0.714
his MIR618 0.181 0.171 0.714
his LIN7A 12q21 0.181 0.171 0.714 protein transport;protein complex assembly
his ZBED5 11p15.3 0.181 0.171 0.714
his ZBED5-AS1 0.181 0.171 0.714
his SOCS2 12q 0.181 0.171 0.714 Apoptosis
his SOCS2-AS1 0.181 0.171 0.714
his CLEC3B 3p22-p21.3 0.181 0.171 0.714 skeletal system
development;ossification
dependent"
xai PSMB1 6q27 0.181 0.171 0.714 antigen processing and presentation of
his ADAMTSL2 9q34.2 0.181 0.171 0.714 negative regulation of transforming
dependent"
his CCNF 16p13.3 0.181 0.171 0.714 placenta development;cell cycle
hs4 HCN2 19p13.3 0.181 0.171 0.714 brain development;aging
xai CRNKL1 20p11.2 0.181 0.171 0.714 RNA splicing;spliceosome assembly
xai CDKN1B 12p13.1-p12 0.181 0.171 0.714 DDR (DNA replication)
his MTOR 1p36.2 0.181 0.171 0.714 Apoptosis; Cell Signaling; DNA Damage
Response (DDR); Protein Kinases
his UBXN1 11q12.3 0.181 0.171 0.714 negative regulation of protein
catabolic process
his RNF14 5q23.3-q31.1 0.181 0.171 0.714 signal transduction;protein
ubiquitination
swa OSBPL11 3q21 0.181 0.171 0.714 transport;lipid transport
his NLRC3 16p13.3 0.181 0.171 0.714 I-kappaB kinase/NF-kappaB
his THAP11 16q22.1 0.181 0.171 0.714 regulation of transcription, DNA-
dependent"
his NUTF2 16q22.1 0.181 0.171 0.714 protein import into nucleus;protein
export from nucleus
his CENPT 16q22.1 0.181 0.171 0.714 M phase of mitotic cell cycle;mitotic
prometaphase
xai TET1 10q21 0.181 0.171 0.714 stem cell maintenance;DNA demethylation
hs4 DKC1 Xq28 0.18 0.171 0.714 DNA Damage Response (DDR)
his FBXO3 11p13 0.18 0.171 0.714 proteolysis;protein ubiquitination
his FBXO3-AS1 0.18 0.171 0.714
his GTF2IP12 0.18 0.171 0.714
his LOC645513 4q26 0.18 0.171 0.714
his CLYBL 13q32 0.18 0.171 0.714 cellular aromatic compound metabolic process
his CASC19 0.18 0.171 0.714
hs4 CLUH 17p13.3 0.18 0.171 0.715
hs4 LOC105371592 0.18 0.171 0.715
exp NOS2P1 17q11.2 0.18 0.171 0.715
his OR52A1 11p15.5 0.18 0.171 0.715 signal transduction;sensory
perception of smell
cop HSPA12B 20p13 0.179 0.171 0.714 response to stress
xsq ARFIP2 11p15 0.179 0.171 0.714 cellular component movement;small GTPase
xsq OR1E1 0.179 0.171 0.714
met NKAPP1 Xq24 0.179 0.171 0.714
exp CASD1 7q21.3 0.179 0.171 0.714
exp LOC100288365 11p15.3 0.179 0.171 0.714
exp ATAD3B 1p36.33 0.179 0.171 0.714
cop BOD1L2 18q21.31 0.179 0.171 0.714
xsq RPS24 10q22 0.179 0.171 0.714 translation;mRNA metabolic process
mut CFAP44 0.179 0.171 0.714
cop C15orf32 15q26.1 0.179 0.171 0.714
xsq LONRF2 2q11.2 0.179 0.171 0.714 proteolysis
xsq LINC01413 0.179 0.171 0.714
exp POM121B 7q11.23 0.179 0.171 0.714 mRNA transport;protein transport
exp AHCYP3 2q12.1 0.179 0.171 0.714
exp HMGN3 6q14.1 0.179 0.171 0.714 regulation of insulin secretion involved
in cellular response to glucose stimulus;chromatin modification
exp IGHV3-74 14q32.33 0.179 0.171 0.714
xsq ZNF839 14q32.31 0.179 0.171 0.714
met CXorf23 Xp22.12 0.179 0.171 0.714
mut KCNK13 14q32.11 0.179 0.171 0.714 potassium ion transmembrane
dependent"
exp TRMU 22q13 0.179 0.171 0.714 tRNA metabolic process;tRNA processing
xsq C10orf53 10q11.23 0.179 0.171 0.714
met EFHD1 2q37.1 0.179 0.171 0.714 neuron projection development
met ADCY6 12q12-q13 0.179 0.171 0.714 water transport;activation of protein
kinase A activity
exp PCGF6 10q24.33 0.179 0.171 0.714 negative regulation of transcription,
DNA-dependent"
exp CENPW 6q22.32 0.179 0.171 0.714 chromosome segregation;centromeric core
chromatin assembly
met TPH1 11p15.3-p14 0.179 0.171 0.714 response to stress;aromatic amino acid
family metabolic process
xsq KIF9 3p21.31 0.179 0.171 0.714 microtubule-based movement;blood
coagulation
exp BMS1P4 10q22.2 0.179 0.171 0.714
exp PRELID1P4 15q14 0.179 0.171 0.714
cop ECT2L 6q24.1 0.179 0.171 0.714 regulation of Rho protein signal
transduction
met NTF3 12p13 0.179 0.171 0.714 neuromuscular synaptic
cop KCNK12 2p16.3 0.179 0.171 0.714 ion transport;potassium ion
transport
xsq ADGRE4P 0.179 0.171 0.714
exp CWC27 5q12.3 0.179 0.171 0.714 nuclear mRNA splicing, via
met RNF114 20q13.13 0.179 0.171 0.714 spermatogenesis;cell
differentiation
xsq APOOP5 16q21 0.179 0.171 0.714
exp CSTF2T 10q11 0.179 0.171 0.714 mRNA processing
xsq RPS11 19q13.3 0.179 0.171 0.714
met MAG 19q13.1 0.179 0.171 0.714 nerve growth factor receptor signaling
xsq CNDP2 18q22.3 0.179 0.171 0.715 glutathione biosynthetic
xsq LOC101927870 0.179 0.171 0.715
met PAPD7 5p15 0.179 0.171 0.715 DNA Damage Response (DDR)
exp KDELC2 11q22.3 -0.179 0.171 0.715
xsq LINC01446 -0.179 0.171 0.715
exp FGFBP2 4p16 -0.179 0.171 0.715
exp MITF 3p14.2-p14.1 -0.179 0.171 0.714 multicellular organismal
xsq GSTT2 -0.179 0.171 0.714
exp CORO1C 12q24.1 -0.179 0.171 0.714 phagocytosis;signal
transduction
xsq OR52N4 -0.179 0.171 0.714
xsq LINC01489 -0.179 0.171 0.714
xsq BEAN1 16q21 -0.179 0.171 0.714 cell death
exp FGD1 Xp11.21 -0.179 0.171 0.714 organ morphogenesis;apoptotic
process
xsq MGST1 12p12.3-p12.1 -0.179 0.171 0.714 response to organic
nitrogen;response to lipopolysaccharide
exp NHS Xp22.13 -0.179 0.171 0.714 lens development in camera-type
eye;cell differentiation
mut GDPD4 11q13.5 -0.179 0.171 0.714 glycerol metabolic process;lipid
metabolic process
mut GDF10 10q11.22 -0.179 0.171 0.714 skeletal system
xsq KIAA1755 20q11.23 -0.179 0.171 0.714
exp HCAR1 12q24.31 -0.179 0.171 0.714 response to estradiol stimulus
exp CTTNBP2 7q31 -0.179 0.171 0.714 brain development
met ATP11B 3q27 -0.179 0.171 0.714 transmembrane transport;ion
transport
exp EIF2AK4 15q15.1 -0.179 0.171 0.714 cellular response to
starvation;negative regulation of translation
xsq PDZRN3 3p13 -0.179 0.171 0.714 neuromuscular junction
cop TNK2 3q29 -0.179 0.171 0.714 positive regulation of peptidyl-tyrosine
phosphorylation;regulation of clathrin-mediated endocytosis
exp LY6E 8q24.3 -0.179 0.171 0.714 cell surface receptor signaling
xsq LOC284454 -0.179 0.171 0.714
exp GOLGA3 12q24.33 -0.179 0.171 0.714 intra-Golgi vesicle-mediated
transport
xsq THOC7-AS1 -0.179 0.171 0.714
exp SEMA6A 5q23.1 -0.179 0.171 0.714 cell surface receptor
xsq ERVV-2 -0.179 0.171 0.714
cop URGCP-MRPS24 -0.179 0.171 0.714
xsq LINC01085 -0.179 0.171 0.714
cop EIF3H 8q24.11 -0.179 0.171 0.714 translation;translational
initiation
exp AP1M2 19p13.2 -0.179 0.171 0.714 protein targeting;post-Golgi
exp TMEM67 8q22.1 -0.179 0.171 0.714 cilium assembly;branching
exp SHISA9 16p13.12 -0.179 0.171 0.714 regulation of short-term
mut ACER1 19p13.3 -0.179 0.171 0.714 sphingolipid metabolic
hs4 ARHGEF19 1p36.13 -0.18 0.171 0.715 positive regulation of Rho GTPase
activity;regulation of actin cytoskeleton organization
his SRGAP1 12q14.2 -0.18 0.171 0.715 signal transduction;small GTPase
xai TBC1D23 3q12.2 -0.18 0.171 0.715
xai RACGAP1 12q13.12 -0.18 0.171 0.714 cytokinesis, actomyosin contractile
ring assembly;blood coagulation
hs4 IRS2 13q34 -0.18 0.171 0.714 Apoptosis
his CNKSR3 6q25.2 -0.18 0.171 0.714 negative regulation of peptidyl-
serine phosphorylation;negative regulation of ERK1 and ERK2 cascade
xai RNU1-19P -0.181 0.171 0.714
xai RETSAT 2p11.2 -0.181 0.171 0.714 retinol metabolic
hs4 MKRN2OS -0.181 0.171 0.714
swa MYEF2 15q21.1 -0.181 0.171 0.714 neuron
differentiation;transcription, DNA-dependent
his LOC105370792 -0.181 0.171 0.714
his SPTBN5 15q21 -0.181 0.171 0.714 axon guidance;actin cytoskeleton
organization
hs4 LOC90768 -0.181 0.171 0.714
xai LINC01020 -0.181 0.171 0.714
his MIR1178 -0.181 0.171 0.714
his MIR450B -0.181 0.171 0.714
his MIR450A1 -0.181 0.171 0.714
his MIR450A2 -0.181 0.171 0.714
xai GBA 1q21 -0.181 0.171 0.714 termination of signal
xai CLTC-IT1 -0.181 0.171 0.714
hs4 TRPC4 13q13.3 -0.181 0.171 0.714 ion transport;calcium ion transport
hs4 NECTIN3 -0.181 0.171 0.714
hs4 PVRL3-AS1 -0.181 0.171 0.714
xai CDRT15P1 -0.181 0.171 0.714
exp RNU1-19P -0.181 0.171 0.714
xai GRN 17q21.32 -0.181 0.171 0.714 signal transduction;embryo
implantation
xai ZDHHC19 3q29 -0.181 0.171 0.714
xai UBA52P9 18q11.2-q12.1 -0.181 0.171 0.714
his PTK2 8q24.3 -0.181 0.171 0.714 Apoptosis
cop FPR3 19q13.3-q13.4 -0.181 0.171 0.714
xai CATSPER1 11q12.1 -0.181 0.171 0.714 spermatogenesis;fusion of
xai PLAUR 19q13 -0.181 0.171 0.714 cellular component movement;fibrinolysis
xai LRRC31 3q26.2 -0.181 0.171 0.714
xai PTOV1-AS1 -0.181 0.171 0.714
exp UBA52P9 18q11.2-q12.1 -0.181 0.171 0.714
swa KTN1 14q22.1 -0.181 0.171 0.714 microtubule-based movement
hs4 TOM1 22q13.1 -0.181 0.171 0.714 intracellular protein
hs4 CLMN 14q32.13 -0.181 0.171 0.714
hs4 SRRM4 12q24.23 0.18 0.172 0.715 mRNA processing;nervous system
development
xai FSD1 19p13.3 0.18 0.172 0.715 cell division;cell cycle
exp PWWP2AP1 13q31.1 0.18 0.172 0.715
exp LOC101059935 0.18 0.172 0.715
xai COX8A 11q12-q13 0.18 0.172 0.715 generation of precursor metabolites and
xai LHX3 9q34.3 0.18 0.172 0.715 positive regulation of transcription,
DNA-dependent;inner ear development
xai HIBCH 2q32.2 0.18 0.172 0.715 branched chain family amino acid
xai XYLB 3p22-p21.3 0.18 0.172 0.715 generation of precursor metabolites and
energy;D-xylose metabolic process
exp VIP 6q25 0.18 0.172 0.715 G-protein coupled receptor signaling
cop CDHR5 11p15.5 0.18 0.172 0.715 cell adhesion;homophilic cell adhesion
cop SCT 11p15.5 0.18 0.172 0.715
cop DRD4 11p15.5 0.18 0.172 0.715 dopamine receptor signaling
pathway;social behavior
his LRP2 2q31.1 0.18 0.172 0.715 forebrain development;protein
glycosylation
hs4 SCARA5 8p21.1 0.18 0.172 0.715 cellular response to heat;iron ion
his ABL1 9q34.1 0.18 0.172 0.715 Apoptosis; DNA Damage Response (DDR); DDR
(G2-M checkpoint); Oncogenes; Protein Kinases
xai EHMT1 9q34.3 0.18 0.172 0.715 DNA methylation;histone H3-K9 methylation
xai LOC101059935 0.18 0.172 0.715
his MTF1 1p33 0.18 0.172 0.715 regulation of transcription from RNA polymerase
II promoter;response to oxidative stress
swa SLC12A2 5q23.3 0.18 0.172 0.715 Solute Carriers
his COPS2 15q21.2 0.18 0.172 0.715 DNA Damage Response (DDR)
his NDUFAF4P1 0.18 0.172 0.715
his NUDT10 Xp11.23 0.18 0.172 0.715
his PLEK 2p13.3 0.18 0.172 0.715 integrin-mediated signaling
his MGAT1 5q35 0.18 0.172 0.715 cellular protein metabolic process;carbohydrate
metabolic process
hs4 ZNF839 14q32.31 0.18 0.172 0.715
his PRKAR1A 17q24.2 0.18 0.172 0.715 water transport;small molecule
metabolic process
his PPM1E 17q22 0.18 0.172 0.715 negative regulation of protein kinase
his BCRP3 22q11.23 0.18 0.172 0.715
his SCAF4 21q22.1 0.18 0.172 0.715 mRNA processing
his PSD 10q24 0.18 0.172 0.715 regulation of ARF protein signal
his FBXL15 10q24.32 0.18 0.172 0.715 protein ubiquitination;bone
mineralization
his PPM1B 2p21 0.18 0.172 0.715 protein dephosphorylation;cytokine-mediated
signaling pathway
xai MIF4GD 17q25.1 0.18 0.172 0.715 RNA metabolic process;regulation of
translation
his LOC101927415 0.18 0.172 0.715
his TMED2 12q24.31 0.18 0.172 0.715 embryonic placenta development;negative
xai KHDC1L 6q13 0.18 0.172 0.715
hs4 HIST1H4K 6p22.1 0.18 0.172 0.715
his ERF 19q13 0.18 0.172 0.715 Transcription Factors
hs4 SRSF9 12q24.31 0.18 0.172 0.715 termination of RNA polymerase II
his THUMPD1 16p12.3 0.18 0.172 0.715
xai KRT33B 17q21.2 0.18 0.172 0.715
xai C11orf39 0.18 0.172 0.715
swa EPB41 1p33-p32 0.18 0.172 0.715 blood circulation;actin cytoskeleton
organization
his GIPC3 19p13.3 0.18 0.172 0.715
xai LOC100288318 8q24.3 0.18 0.172 0.715
hs4 FLJ36777 0.18 0.172 0.715
xai STXBP4 17q22 0.18 0.172 0.715 protein targeting;insulin receptor
signaling pathway
swa ECHDC1 6q22.33 0.18 0.172 0.715
met GLT1D1 12q24.33 0.179 0.172 0.715 biosynthetic process
cop SERPINB10 18q21.3 0.179 0.172 0.715 negative regulation of
xsq TCF7 5q31.1 0.179 0.172 0.715 brain development;Wnt receptor signaling
pathway
cop ACP1 2p25 0.179 0.172 0.715
cop FAM150B 2p25.3 0.179 0.172 0.715
met DIRAS2 9q22.2 0.179 0.172 0.715 signal transduction;small GTPase
met GLI4 8q24.3 0.179 0.172 0.715
met ATP2C1 3q22.1 0.179 0.172 0.715 manganese ion transport;Golgi
mut LRPPRC 2p21 0.179 0.172 0.715 regulation of transcription, DNA-
dependent;transport
exp STXBP4 17q22 0.179 0.172 0.715 protein targeting;insulin receptor
signaling pathway
exp NME4 16p13.3 0.179 0.172 0.715 CTP biosynthetic process;nucleoside
metabolic process
xsq UNC45B 17q12 0.179 0.172 0.715 multicellular organismal
mut HSF5 17q22 0.179 0.172 0.715
met SIX6 14q23.1 0.179 0.172 0.715 multicellular organismal
development;visual perception
cop ADIPOR2 12p13.31 0.179 0.172 0.715 lipid metabolic process;hormone-
xsq LOC101927987 0.179 0.172 0.715
xsq CRHR1-IT1 17q21.31 0.179 0.172 0.715
exp DTNB 2p24 0.179 0.172 0.715
xsq SCLY 2q37.3 0.179 0.172 0.715 cellular amino acid metabolic process
exp ACTL6A 3q26.33 0.179 0.172 0.715 DNA Damage Response (DDR); DDR
(Chromatin)
xsq FAM181A-AS1 14q32.12 0.179 0.172 0.715
cop FBXO30 6q24 0.179 0.172 0.715
xsq EIF2D 1q32.1 0.179 0.172 0.715 translational initiation;intracellular
protein transport
exp ZNF593 1p36.11 0.179 0.172 0.715 negative regulation of
dependent"
exp C19orf24 19p13.3 0.179 0.172 0.715
mut GRIA4 11q22 0.179 0.172 0.715 transport;ion transport
met CYB561 17q23.3 0.179 0.172 0.715 generation of precursor metabolites
xsq LOC101928580 0.179 0.172 0.715
xsq EIF3F 11p15.4 0.179 0.172 0.715 translation;translational initiation
met AP2M1 3q28 0.179 0.172 0.715 vesicle-mediated transport;transport
xsq CHEK2P2 15q11.1 0.179 0.172 0.715
xsq FKBP4 12p13.33 0.179 0.172 0.715 peptidyl-proline modification;androgen
exp MAGEE1 Xq13.3 0.179 0.172 0.715
met ANKRD30BP3 0.179 0.172 0.715
met C2orf47 2q33.1 0.179 0.172 0.715
xsq IQCF1 3p21.2 0.179 0.172 0.715
exp APOBEC3A 22q13.1-q13.2 0.179 0.172 0.715 cytidine deamination;DNA
demethylation
exp PRDM1 6q21 0.179 0.172 0.715 Tumor Suppressors
exp EBPL 13q12-q13 0.179 0.172 0.715 sterol metabolic process
mut CREB3L3 19p13.3 0.179 0.172 0.715 response to unfolded protein
cop RNF138 18q12.1 0.179 0.172 0.715 Wnt receptor signaling pathway
met TTC7A 2p21 0.179 0.172 0.715 cellular iron ion homeostasis;hemopoiesis
xsq VPS4B 18q21.33 0.179 0.172 0.715 protein transport;cellular membrane
organization
mut FBXO38 5q32 0.179 0.172 0.715
xsq EFCAB10 7q22.3 0.179 0.172 0.715 signal transduction
met DSCR10 21q22.13 0.179 0.172 0.715
cop MPO 17q23.1 0.179 0.172 0.715 defense response;hydrogen peroxide
catabolic process
cop BZRAP1 17q22-q23 0.179 0.172 0.715
cop MIR142 0.179 0.172 0.715
cop MIR4736 0.179 0.172 0.715
xsq CRIP3 6p21.1 0.179 0.172 0.715
xsq SNHG8 4q26 0.179 0.172 0.715
met L3MBTL1 20q13.12 0.179 0.172 0.715 regulation of mitosis;chromatin
modification
cop ATAD2B 2p24.1-p23.3 0.179 0.172 0.715
xsq SNX17 2p23-p22 0.179 0.172 0.715 receptor-mediated endocytosis;signal
transduction
cop TUBB6 18p11.21 0.179 0.172 0.715 microtubule-based movement;cellular
cop AFG3L2 18p11 0.179 0.172 0.715 myelination;proteolysis
cop PRELID3A 0.179 0.172 0.715
xsq LINC01271 0.179 0.172 0.715
xsq MCM9 6q22.31 0.179 0.172 0.715 DNA replication
exp VRK3 19q13 0.179 0.172 0.715 positive regulation of phosphoprotein
met MIR152 0.179 0.172 0.715
xsq TRPC5OS 0.179 0.172 0.715
xsq RPS13 11p15 0.179 0.172 0.715 nuclear-transcribed mRNA catabolic process,
exp ATG9B 7q36.1 0.179 0.172 0.715 autophagic vacuole assembly;autophagy
met CTDSPL 3p21.3 0.179 0.172 0.715
met PTPRU 1p35.3 0.179 0.172 0.715 homotypic cell-cell adhesion;protein
dephosphorylation
xsq LINC00869 0.178 0.172 0.715
cop SMLR1 0.178 0.172 0.715
xsq HINFP 11q23.3 0.178 0.172 0.715 DNA Damage Response (DDR)
xsq LINC01361 0.178 0.172 0.715
exp GATAD2A 19p13.11 0.178 0.172 0.715 anterior neuropore closure;negative
xsq FLJ36000 17p11.2 0.178 0.172 0.715
cop CSNK1G1 15q22.1-q22.31 0.178 0.172 0.715 Protein Kinases
mut C10orf2 10q24 -0.178 0.172 0.715 DNA replication;mitochondrial DNA
replication
exp SYTL5 Xp21.1 -0.179 0.172 0.715 intracellular protein transport
xsq ZNF626 19p12 -0.179 0.172 0.715 regulation of transcription, DNA-
dependent"
exp ACSF2 17q21.33 -0.179 0.172 0.715 lipid metabolic process;fatty acid
metabolic process
xsq HOXB7 17q21.3 -0.179 0.172 0.715 myeloid cell
xsq FAM46B 1p36.11 -0.179 0.172 0.715
met MIR1246 -0.179 0.172 0.715
xsq LINC01563 -0.179 0.172 0.715
xsq CERS1 19p12 -0.179 0.172 0.715 small molecule metabolic process;ceramide
exp TNNC1 3p21.1 -0.179 0.172 0.715 regulation of muscle
exp GRIK3 1p34.3 -0.179 0.172 0.715 regulation of membrane
potential;negative regulation of synaptic transmission, glutamatergic
xsq SULT1C2 2q12.3 -0.179 0.172 0.715 xenobiotic metabolic
xsq FAM63A 1q21.3 -0.179 0.172 0.715
mut SLC35F5 2q14.1 -0.179 0.172 0.715 Solute Carriers
exp SYT11 1q21.2 -0.179 0.172 0.715
mut MEFV 16p13.3 -0.179 0.172 0.715 inflammatory response;nucleotide-
binding domain, leucine rich repeat containing receptor signaling pathway
exp C11orf44 11q24.3 -0.179 0.172 0.715
cop NFIB 9p24.1 -0.179 0.172 0.715 negative regulation of cell
met TIAM2 6q25.2 -0.179 0.172 0.715 regulation of Rho protein signal
cop MTMR12 5p13.3 -0.179 0.172 0.715
met TLE3 15q22 -0.179 0.172 0.715 regulation of transcription, DNA-
exp ABCC3 17q22 -0.179 0.172 0.715 ABC Transporters
exp ALPK3 15q25.2 -0.179 0.172 0.715 protein
exp ADH7 4q23-q24 -0.179 0.172 0.715 ethanol oxidation;xenobiotic
metabolic process
exp FAM124A 13q14.3 -0.179 0.172 0.715
xsq MAP2 2q34-q35 -0.179 0.172 0.715 microtubule bundle
exp NUDT16P1 3q22.1 -0.179 0.172 0.715
his NTN1 17p13-p12 -0.18 0.172 0.715 mammary gland development;neuron
migration
hs4 NFIA-AS1 -0.18 0.172 0.715
xai TM9SF2 13q32.3 -0.18 0.172 0.715 transport
xai TNNC1 3p21.1 -0.18 0.172 0.715 regulation of muscle contraction;muscle
filament sliding
exp POU5F1P5 -0.18 0.172 0.715
xai ZBTB8A 1p35.1 -0.18 0.172 0.715 regulation of transcription, DNA-
dependent"
xai PCDHB16 5q31 -0.18 0.172 0.715 synapse assembly;calcium-dependent cell-
cell adhesion
his DTNA 18q12 -0.18 0.172 0.715 striated muscle contraction;signal transduction
his UACA 15q22-q24 -0.18 0.172 0.715
xai DUBR -0.18 0.172 0.715
hs4 ANK2 4q25-q27 -0.18 0.172 0.715 axon guidance;signal transduction
hs4 RHOBTB3 5q15 -0.18 0.172 0.715 ATP catabolic process;transport
xai IGFBP4 17q21.2 -0.18 0.172 0.715 cell proliferation;regulation of
glucose metabolic process
xai CDCP1 3p21.31 -0.18 0.172 0.715
hs4 LSP1 11p15.5 -0.18 0.172 0.715 chemotaxis;cellular defense response
swa ARRB1 11q13 -0.18 0.172 0.715 cellular membrane organization;positive
hs4 NECAB1 8q21.3 -0.18 0.172 0.715
xai PDE5A 4q27 -0.18 0.172 0.715 response to hypoxia;positive regulation of
cardiac muscle hypertrophy
swa PRPF38B 1p13.3 -0.18 0.172 0.715 mRNA processing;RNA splicing
xai PZP 12p13-p12.2 -0.18 0.172 0.715 female pregnancy;negative regulation of
his WDFY1 2q36.1 -0.18 0.172 0.715
his CES4A 16q22.1 -0.18 0.172 0.715
xai POU5F1P5 -0.18 0.172 0.715
xai EPHB1 3q21-q23 -0.18 0.172 0.715 optic nerve morphogenesis;ephrin receptor
signaling pathway
his LINC02085 -0.18 0.172 0.715
hs4 SIX5 19q13.32 -0.18 0.172 0.715 multicellular organismal
exp KRT8P29 1q32.1 -0.18 0.172 0.715
hs4 MASP1 3q27-q28 -0.18 0.172 0.715 negative regulation of complement
activation;complement activation, lectin pathway
hs4 LOC101929130 -0.18 0.172 0.715
xai TSPAN2 1p13.2 -0.18 0.172 0.715 brain development
hs4 ANKRD30BP2 21q11.2 -0.18 0.172 0.715
xai DCUN1D3 16p12.3 -0.18 0.172 0.715 positive regulation of apoptotic
process;negative regulation of S phase of mitotic cell cycle
hs4 MAL2 8q23 -0.18 0.172 0.715
swa TOR1AIP1 1q24.2 -0.18 0.172 0.715
his ARTN 1p33-p32 -0.18 0.172 0.715 signal transduction;neuroblast
proliferation
xai MTSS1L 16q22.1 -0.18 0.172 0.715 filopodium assembly;signal
transduction
hs4 GJB6 13q12 -0.18 0.172 0.715 cell communication;sensory perception of sound
met MS4A6E 11q12.2 0.182 0.173 0.715
xai STARD7-AS1 0.18 0.173 0.715
xai NFE2 12q13 0.18 0.173 0.715 multicellular organismal development;blood
coagulation
xai PRELID3B 0.18 0.173 0.715
hs4 GRAMD4 22q13.31 0.18 0.173 0.715 apoptotic process
xai OLIG2 21q22.11 0.18 0.173 0.715 myelination;negative regulation of neuron
differentiation
xai RBM23 14q11.2 0.18 0.173 0.715 mRNA processing
xai NCLN 19p13.3 0.18 0.173 0.715 regulation of signal
his IFNAR2 21q22.11 0.18 0.173 0.715 cell surface receptor signaling
pathway;JAK-STAT cascade
hs4 GRK3 0.18 0.173 0.715
his DNAJC11 1p36.31 0.18 0.173 0.715 protein folding
his CYP17A1 10q24.3 0.18 0.173 0.715 response to herbicide;phthalate
metabolic process
xai BRD9 5p15.33 0.18 0.173 0.716
his MRPS22 3q23 0.18 0.173 0.716
xai RPUSD3 3p25.3 0.18 0.173 0.716 pseudouridine synthesis
his RAP1B 12q14 0.18 0.173 0.716 blood coagulation;cell proliferation
hs4 TXNL4A 18q23 0.18 0.173 0.716 nuclear mRNA splicing, via
his CTPS2 Xp22 0.18 0.173 0.716 nucleobase-containing small molecule
his ARAF Xp11.4-p11.2 0.18 0.173 0.716 Apoptosis; Protein Kinases
exp CDHR4 3p21.31 0.18 0.173 0.716 cell adhesion;homophilic cell adhesion
his BICD2 9q22.31 0.18 0.173 0.716 EMT (Mesenchymal)
exp LOC100288318 8q24.3 0.18 0.173 0.716
swa PGAM1 10q25.3 0.18 0.173 0.716 small molecule metabolic
process;respiratory burst
hs4 CPLX2 5q35.2 0.18 0.173 0.716 neurotransmitter transport;vesicle
his SFSWAP 12q24.33 0.18 0.173 0.716 RNA splicing;negative regulation of
nuclear mRNA splicing, via spliceosome
hs4 C9orf142 9q34.3 0.18 0.173 0.716 DNA Damage Response (DDR)
his MIR1238 0.18 0.173 0.716
swa GAPDH 12p13 0.18 0.173 0.716 glucose metabolic process;gluconeogenesis
exp HNRNPH1 5q35.3 0.18 0.173 0.716 gene expression;regulation of RNA
splicing
his SMARCD2 17q23.3 0.18 0.173 0.716 nucleosome disassembly;chromatin
remodeling
his RNF138 18q12.1 0.18 0.173 0.716 Wnt receptor signaling pathway
xai ADGRE4P 0.18 0.173 0.716
his TRIB1 8q24.13 0.18 0.173 0.716 response to lipopolysaccharide;regulation
his LOC105370802 0.18 0.173 0.716
his P2RY11 19p13.2 0.18 0.173 0.716
xai PWWP2AP1 13q31.1 0.18 0.173 0.716
his WBP11 12p12.3 0.18 0.173 0.716 rRNA processing;mRNA processing
his C12orf60 12p12.3 0.18 0.173 0.716
exp AHCTF1P1 2q24.2 0.18 0.173 0.716
exp TBX5-AS1 0.18 0.173 0.716
hs4 MIR2052HG 0.18 0.173 0.716
swa AKAP1 17q22 0.18 0.173 0.716 Apoptosis
his RAG1 11p13 0.18 0.173 0.716 B cell differentiation;T cell differentiation
in thymus
swa MIF 22q11.23 0.18 0.173 0.716 Apoptosis
met LIPH 3q27 0.178 0.173 0.715 lipid catabolic process
dependent"
cop ACAN 15q26.1 0.178 0.173 0.715 skeletal system development;proteolysis
xsq PCBP2 12q13.13 0.178 0.173 0.715 mRNA metabolic process;negative
cop KIF3C 2p23 0.178 0.173 0.715 microtubule-based movement;blood coagulation
cop RAB10 2p23.3 0.178 0.173 0.715 small GTPase mediated signal
cop GAREML 2p23.3 0.178 0.173 0.715
cop HADHA 2p23 0.178 0.173 0.715 cellular lipid metabolic process;small molecule
metabolic process
cop HADHB 2p23 0.178 0.173 0.715 fatty acid metabolic process;fatty acid beta-
oxidation
met MIR188 0.178 0.173 0.715
xsq METAP1D 2q31.1 0.178 0.173 0.715 proteolysis;cellular process
exp TRMT5 14q23.1 0.178 0.173 0.716 tRNA processing
xsq TTLL12 22q13.31 0.178 0.173 0.716 protein modification process
met CHST3 10q22.1 0.178 0.173 0.716 T cell homeostasis;positive regulation of
cellular component movement
xsq HBA1 16p13.3 0.178 0.173 0.716
xsq CCDC124 19p13.11 0.178 0.173 0.716
met MTHFSD 16q24.1 0.178 0.173 0.716 folic acid-containing compound
exp RIMS3 1p34.2 0.178 0.173 0.716 neurotransmitter transport;calcium ion-
dependent exocytosis
met MIR411 0.178 0.173 0.716
xsq GSTTP2 22q11.23 0.178 0.173 0.716
exp SS18 18q11.2 0.178 0.173 0.716 intracellular protein kinase
cop TGM3 20q11.2 0.178 0.173 0.716 hair follicle
morphogenesis;keratinization
exp LOC100128326 0.178 0.173 0.716
xsq MRPL38 17q25.3 0.178 0.173 0.716
xsq TMEM212 3q26.31 0.178 0.173 0.716
xsq LINC01281 0.178 0.173 0.716
cop CPXM1 20p13 0.178 0.173 0.716 proteolysis;cell adhesion
cop C20orf141 0.178 0.173 0.716
cop TMEM239 20p13 0.178 0.173 0.716
cop LINC00226 0.178 0.173 0.716
cop LINC00221 0.178 0.173 0.716
met TTLL11 9q33.2 0.178 0.173 0.716 protein modification process
mut LIAS 4p14 0.178 0.173 0.716 lipoate biosynthetic process;response to
lipopolysaccharide
exp REG1A 2p12 0.178 0.173 0.716 positive regulation of cell proliferation
cop PMAIP1 18q21.32 0.178 0.173 0.716 Apoptosis
dependent"
exp CEP95 17q23.3 0.178 0.173 0.716
cop ITSN2 2p23.3 0.178 0.173 0.716 endocytosis;regulation of Rho protein
signal transduction
cop TMED2 12q24.31 0.178 0.173 0.716 embryonic placenta development;negative
xsq LINC01012 0.178 0.173 0.716
met KCNA10 1p13.1 0.178 0.173 0.716
xsq PATL2 15q21.1 0.178 0.173 0.716 negative regulation of translation
xsq GOLGA6L6 0.178 0.173 0.716
xsq CYLC2 9q31.1 0.178 0.173 0.716
exp PLPPR3 0.178 0.173 0.716
exp PLAC8 4q21.22 0.178 0.173 0.716
met GSDMC 8q24.21 0.178 0.173 0.716
cop TRPV4 12q24.1 0.178 0.173 0.716 ion transport;cell death
xsq CPNE1 20q11.22 0.178 0.173 0.716 lipid metabolic process;vesicle-mediated
transport
met KIAA1841 2q14 0.178 0.173 0.716
exp HMGN2 1p36.1 0.178 0.173 0.716 chromatin organization;regulation of
met USP25 21q11.2 0.178 0.173 0.716 ubiquitin-dependent protein catabolic
process;protein K63-linked deubiquitination
exp NBEAL2 3p21.31 0.178 0.173 0.716 platelet formation
met TPST2 22q12.1 0.178 0.173 0.716 peptidyl-tyrosine sulfation
cop PDP2 16q22.1 0.178 0.173 0.716 pyruvate metabolic process;protein
dephosphorylation
xsq CDC20 1p34.1 0.178 0.173 0.716 cell cycle checkpoint;cell
differentiation
xsq OR51E1 11p15.4 0.178 0.173 0.716 response to stimulus
met NCAN 19p12 0.178 0.173 0.716 cell adhesion;axon guidance
xsq ADGRG2 0.178 0.173 0.716 G-protein coupled receptor signaling
xsq ZNF702P 19q13.41 -0.178 0.173 0.716 regulation of transcription,
DNA-dependent"
cop KBTBD12 3q21.3 -0.178 0.173 0.716
xsq KIAA1456 8p22 -0.178 0.173 0.716 metabolic process
mut CLMP 11q24.1 -0.178 0.173 0.716
mut RPGRIP1L 16q12.2 -0.178 0.173 0.716 liver development;olfactory
bulb development
exp LAMC2 1q25-q31 -0.178 0.173 0.716 cell adhesion;epidermis development
xsq LINC01158 -0.178 0.173 0.716
exp HYPM -0.178 0.173 0.716
xsq LIPG 18q21.1 -0.178 0.173 0.716 cell proliferation;regulation of
exp ACTR10 14q23.1 -0.178 0.173 0.716 microtubule-based movement
mut ADAL 15q15.3 -0.178 0.173 0.716 adenosine catabolic
met NKX2-5 5q34 -0.178 0.173 0.716 outflow tract septum
cop SUB1 5p13.3 -0.178 0.173 0.716 regulation of transcription from
xsq ECHDC3 10p14 -0.178 0.173 0.716
met C17orf47 17q22 -0.178 0.173 0.716
mut GTF2H3 12q24.31 -0.178 0.173 0.716 DNA Damage Response (DDR);
DDR (NER)
cop MIR5692C1 -0.178 0.173 0.716
cop PPP1R2 3q29 -0.178 0.173 0.716 carbohydrate metabolic
xsq LCN2 9q34 -0.178 0.173 0.716 siderophore transport;regulation of
apoptotic process
cop CPA6 8q13.2 -0.178 0.173 0.716 proteolysis
exp CAP1 1p34.2 -0.178 0.173 0.716 signal transduction;activation of
adenylate cyclase activity
met SUDS3 12q24.23 -0.178 0.173 0.716 chromatin modification;negative
xsq HR 8p21.2 -0.178 0.173 0.716 regulation of transcription, DNA-
activity
exp SLC35E3 12q15 -0.178 0.173 0.716 Solute Carriers
met ICAM5 19p13.2 -0.178 0.173 0.715 cell-cell adhesion
mut GABRP 5q35.1 -0.178 0.173 0.715 ion transport
mut MTUS2 13q12.3 -0.178 0.173 0.715
exp PDZRN3 3p13 -0.178 0.173 0.715 neuromuscular junction
his LRRC75A -0.18 0.173 0.716
xai GNG5P5 13q14.2 -0.18 0.173 0.716
exp PLCZ1 12p12.3 -0.18 0.173 0.716 metabolic process;lipid catabolic process
xai ENOX1 13q14.11 -0.18 0.173 0.716 transport;electron transport chain
hs4 CUTA 6p21.32 -0.18 0.173 0.716 protein localization;response to metal
ion
hs4 SYNGAP1 6p21.3 -0.18 0.173 0.716 dendrite development;negative
regulation of axonogenesis
xai PDGFB 22q13.1 -0.18 0.173 0.716 Apoptosis; Oncogenes
his MIR30A -0.18 0.173 0.716
his LINC00472 6q13 -0.18 0.173 0.716
his LINC01626 -0.18 0.173 0.716
xai OSBPL6 2q32.1 -0.18 0.173 0.716 transport;lipid transport
xai RIBC1 Xp11.22 -0.18 0.173 0.716
his LOC101927523 -0.18 0.173 0.716
his SIM1 6q16.3 -0.18 0.173 0.716 cell differentiation;ureteric bud
development
exp SLC25A34 1p36.21 -0.18 0.173 0.716 transport
xai HPCAL1 2p25.1 -0.18 0.173 0.716
exp SPTLC1P5 -0.18 0.173 0.716
his DYSF 2p13.3 -0.18 0.173 0.716
xai SPTLC1P5 -0.18 0.173 0.716
xai SNTB1 8q23-q24 -0.18 0.173 0.716 muscle contraction
his CGB8 -0.18 0.173 0.716
cop FGF20 8p22 -0.18 0.173 0.716 signal transduction;positive regulation of ERK1
and ERK2 cascade
his S100A16 1q21 -0.18 0.173 0.716 response to calcium ion
his S100A14 1q21.3 -0.18 0.173 0.716 EMT (Epithelial)
his LRP2BP 4q35.1 -0.18 0.173 0.716
hs4 ATP6V1C1 8q22.3 -0.18 0.173 0.716 transport;cellular iron ion
homeostasis
xai SHARPIN 8q24.3 -0.18 0.173 0.716 mitochondrion organization;protein
homooligomerization
xai CAMK2B 7p14.3-p14.1 -0.18 0.173 0.716 synaptic
swa PRAF2 Xp11.23 -0.18 0.173 0.716 L-glutamate transport;protein transport
hs4 DIO2-AS1 -0.18 0.173 0.716
hs4 DIO2 14q24.2-q24.3 -0.18 0.173 0.716 selenocysteine
incorporation;thyroid hormone generation
his BCRP2 -0.18 0.173 0.716
xai CORO1C 12q24.1 -0.18 0.173 0.715 phagocytosis;signal transduction
his USP2 11q23.3 -0.18 0.173 0.715 protein deubiquitination;positive
his USP2-AS1 -0.18 0.173 0.715
hs4 LGR6 1q32.1 -0.18 0.173 0.715
xai MARCH2 19p13.2 -0.18 0.173 0.715 endocytosis;protein ubiquitination
xai MFSD5 12q13.13 -0.18 0.173 0.715 transport
swa RAB21 12q21.1 -0.18 0.173 0.715 GTP catabolic process;small GTPase
his DTD1 20p11.23 -0.18 0.173 0.715 DDR (DNA replication)
hs4 MAP6D1 3q27.1 -0.18 0.173 0.715 N-terminal peptidyl-L-cysteine N-
palmitoylation;negative regulation of microtubule depolymerization
xai LFNG 7p22.2 -0.18 0.173 0.715 ovarian follicle development;female
meiosis
his ANTXRLP1 0.18 0.174 0.717
xai UNC79 14q32.12 0.18 0.174 0.717
his CLPTM1 19q13.3 0.18 0.174 0.717 multicellular organismal
xai DSCAM-IT1 0.179 0.174 0.717
his TMEM39A 3q13.33 0.179 0.174 0.717
his YDJC 22q11.21 0.179 0.174 0.717 carbohydrate metabolic process
his CCDC116 22q11.21 0.179 0.174 0.717
his CDC34 19p13.3 0.179 0.174 0.717 negative regulation of cAMP-mediated
his LOC101929099 0.179 0.174 0.717
his TTF2 1p22 0.179 0.174 0.717 mRNA processing;RNA splicing
his GOLGA8R 0.179 0.174 0.717
xai MBD2 18q21 0.179 0.174 0.717 maternal behavior;cellular protein complex
assembly
hs4 SMARCD2 17q23.3 0.179 0.174 0.717 nucleosome disassembly;chromatin
remodeling
exp TSSK4 14q12 0.179 0.174 0.717 spermatogenesis;cell differentiation
his VILL 3p21.3 0.179 0.174 0.717 cytoskeleton organization;actin filament
capping
xai TCFL5 20q13.33 0.179 0.174 0.717 regulation of cell
xai ZBTB33 Xq23 0.179 0.174 0.718 regulation of transcription, DNA-
dependent;Wnt receptor signaling pathway
xai LOC100129112 0.179 0.174 0.718
hs4 EGFEM1P 3q26.2 0.179 0.174 0.718
his WDR27 6q27 0.179 0.174 0.718
his C6orf120 6q27 0.179 0.174 0.718
hs4 CLEC4GP1 19p13.2 0.179 0.174 0.718
xai JADE1 0.179 0.174 0.718 histone H4-K5 acetylation;histone H4-K8
acetylation
xai OGFRP1 0.179 0.174 0.718
his LINC01224 0.179 0.174 0.718
hs4 SLC30A2 1p35.3 0.179 0.174 0.718 zinc ion transport;transmembrane
transport
hs4 BAP1 3p21.31-p21.2 0.179 0.174 0.718 DNA Damage Response (DDR); Tumor
Suppressors
hs4 PHF7 3p21.1 0.179 0.174 0.718
his MGC70870 0.179 0.174 0.718
exp TOPBP1 3q22.1 0.178 0.174 0.716 DNA Damage Response (DDR); DDR (DNA
exp UGT3A2 5p13.2 0.178 0.174 0.716 metabolic process
mut SIGLEC9 19q13.41 0.178 0.174 0.717 cell adhesion;cell surface receptor
signaling pathway
xsq RPL23P8 7p21.1 0.178 0.174 0.717
met ANGPTL7 1p36 0.178 0.174 0.717 response to oxidative stress;signal
transduction
met ELFN1 7p22.3 0.178 0.174 0.717 negative regulation of phosphatase
activity
met PACRGL 4p15.31 0.178 0.174 0.717
cop MFGE8 15q25 0.178 0.174 0.717 phagocytosis, recognition;phagocytosis,
engulfment
exp SMG1P5 0.178 0.174 0.717
cop KCNQ5 6q14 0.178 0.174 0.717 protein complex assembly;ion transport
xsq LOC101928203 0.178 0.174 0.717
xsq HSPA8 11q24.1 0.178 0.174 0.717 Apoptosis
xsq OR1L6 0.178 0.174 0.717
met CXCL10 4q21 0.178 0.174 0.717 chemotaxis;positive regulation of cell
proliferation
mut CUBN 10p12.31 0.178 0.174 0.717 cholesterol metabolic process;cobalamin
transport
xsq MUC2 11p15.5 0.178 0.174 0.717 O-glycan processing;post-translational
exp TMEM38B 9q31.2 0.178 0.174 0.717 ion transport;potassium ion
transport
xsq RAC2 22q13.1 0.178 0.174 0.717 GTP catabolic process;actin cytoskeleton
organization
met L2HGDH 14q21.3 0.178 0.174 0.717 cellular protein metabolic
dependent"
exp POLR3E 16p12.2 0.178 0.174 0.717 transcription from RNA polymerase
mut PICALM 11q14 0.178 0.174 0.717 vesicle-mediated transport;clathrin coat
assembly
met ZFR2 19p13.3 0.178 0.174 0.717
xsq LOC101929116 0.178 0.174 0.717
met UBE2DNL Xq21.1 0.178 0.174 0.717
mut PUM2 2p22-p21 0.178 0.174 0.717 regulation of translation
exp ARMC12 6p21.31 0.178 0.174 0.718
cop SERPINB2 18q21.3 0.178 0.174 0.718 fibrinolysis;anti-apoptosis
xsq COA5 2q11.2 0.178 0.174 0.718
xsq FAM76B 11q21 0.178 0.174 0.718
xsq AP4M1 7q22.1 0.178 0.174 0.718 intracellular protein transport;vesicle-
mediated transport
met FGFR2 10q26 0.178 0.174 0.718 Cell Signaling; Oncogenes; Protein Kinases
xsq LOC100130476 0.178 0.174 0.718
mut ASNSD1 2p24.3-q21.3 0.178 0.174 0.718 asparagine biosynthetic
exp IMP4 2q21.1 0.178 0.174 0.718 rRNA processing
exp CARD18 11q22.3 0.178 0.174 0.718 inflammatory response;regulation of
apoptotic process
met EIF2B2 14q24.3 0.178 0.174 0.718 central nervous system
xsq FAM227A 22q13.1 0.178 0.174 0.718
xsq TMIGD3 0.178 0.174 0.718
exp RBM22 5q33.1 0.178 0.174 0.718 protein import into nucleus,
exp TXN2 22q13.1 0.178 0.174 0.718 response to nutrient;response to axon
injury
exp GPR132 14q32.3 0.178 0.174 0.718 G1/S transition of mitotic cell
exp SMAD1 4q31 0.178 0.174 0.718 ureteric bud development;transforming growth
exp POP5 12q24.31 0.178 0.174 0.718 tRNA processing;RNA metabolic process
met C9orf50 9q34.11 0.178 0.174 0.718
met FAM92A1 8q22.1 0.178 0.174 0.718
xsq AP3S2 15q26.1 0.178 0.174 0.718 intracellular protein transport;vesicle-
mediated transport
exp TAF1C 16q24 0.178 0.174 0.718 regulation of transcription, DNA-
xsq S100A7A 1q21.3 0.178 0.174 0.718
exp XYLB 3p22-p21.3 0.178 0.174 0.718 generation of precursor metabolites and
energy;D-xylose metabolic process
exp NUP50 22q13.31 0.178 0.174 0.718 protein transport;glucose transport
exp SERPINE1 7q22.1 -0.178 0.174 0.718 response to reactive oxygen
met ISL2 15q23 -0.178 0.174 0.718 multicellular organismal
cop AMACR 5p13 -0.178 0.174 0.718 bile acid biosynthetic process;bile acid
metabolic process
mut SGK494 17q11.2 -0.178 0.174 0.718
exp HEBP1 12p13.1 -0.178 0.174 0.718 circadian rhythm
cop AKT3 1q44 -0.178 0.174 0.718 Protein Kinases
cop GOLPH3 5p13.3 -0.178 0.174 0.718 regulation of mitochondrion
exp ANKRD50 4q28.1 -0.178 0.174 0.718
mut KCTD8 4p13 -0.178 0.174 0.718 potassium ion transport
cop CDC73 1q25 -0.178 0.174 0.718 Tumor Suppressors
mut HOXB7 17q21.3 -0.178 0.174 0.717 myeloid cell
exp HLA-A -0.178 0.174 0.717 cytokine-mediated signaling
pathway;antigen processing and presentation
exp NANOS1 10q26.11 -0.178 0.174 0.717 epithelial cell
met TRANK1 3p22.2 -0.178 0.174 0.717
met ARPC1B 7q22.1 -0.178 0.174 0.717 regulation of actin filament
polymerization;cellular component movement
xsq CMTM4 16q21-q22.1 -0.178 0.174 0.717 chemotaxis
exp DMBT1 10q26.13 -0.178 0.174 0.717 blastocyst development;epithelial
met ZBTB43 9q33.3 -0.178 0.174 0.717 regulation of transcription,
DNA-dependent"
xsq PPFIA4 1q32.1 -0.178 0.174 0.717 cell communication
exp GATAD1 7q21-q22 -0.178 0.174 0.717
mut FMO5 1q21.1 -0.178 0.174 0.717 oxidation-reduction process
cop OSGIN2 8q21 -0.178 0.174 0.717 meiosis;germ cell development
cop NBN 8q21 -0.178 0.174 0.717 DNA Damage Response (DDR); DDR (HR)
cop SOAT1 1q25 -0.178 0.174 0.717 EMT (Mesenchymal)
mut C5AR2 19q13.33 -0.178 0.174 0.717
mut IL22 12q15 -0.178 0.174 0.717 acute-phase response;inflammatory
response
mut IL12RB2 1p31.3-p31.2 -0.178 0.174 0.717 response to cytokine
stimulus;cell surface receptor signaling pathway
mir hsa-miR-125b -0.178 0.174 0.717
mir hsa-miR-125b(2) -0.178 0.174 0.717
met ERAP2 5q15 -0.178 0.174 0.717 antigen processing and presentation of
endogenous peptide antigen via MHC class I;antigen processing and presentation of
hs4 TFAP2E 1p34.3 -0.179 0.174 0.718 positive regulation of
xai DYNLT3P1 -0.179 0.174 0.718
his LOC101927780 -0.179 0.174 0.718
his FLJ22447 -0.179 0.174 0.718
xai SYTL5 Xp21.1 -0.179 0.174 0.718 intracellular protein transport
xai KLHDC8A 1q32.1 -0.179 0.174 0.718
his MIR5680 -0.179 0.174 0.718
xai SULF2 20q12-q13.2 -0.179 0.174 0.718 glomerular basement membrane
hs4 PDLIM4 5q31.1 -0.179 0.174 0.718
his ASIC2 17q12 -0.179 0.174 0.718 monovalent inorganic cation transport;ion
transport
his LOC105373156 -0.179 0.174 0.718
his NLGN4X Xp22.33 -0.179 0.174 0.718 social behavior;cell-cell
hs4 AR Xq12 -0.179 0.174 0.718 transcription, DNA-dependent;positive
xai LOC100129675 -0.179 0.174 0.717
xai UBTD2 5q35.1 -0.179 0.174 0.717
xai THBD 20p11.2 -0.179 0.174 0.717 response to
swa PMEL 12q13-q14 -0.179 0.174 0.717 melanosome organization;melanin
xai NUMBL 19q13.13-q13.2 -0.179 0.174 0.717 multicellular organismal
xai RPS6KA2-IT1 -0.179 0.174 0.717
his ARNTL 11p15 -0.179 0.174 0.717 circadian rhythm;positive regulation of
exp LOC100505504 -0.179 0.174 0.717
xai HEATR4 14q24.3 -0.179 0.174 0.717
hs4 YKT6 7p15.1 -0.179 0.174 0.717 protein transport;retrograde
cop MIR4755 -0.179 0.174 0.717
hs4 TSPEAR 21q22.3 -0.18 0.174 0.717 cell adhesion
exp GNG5P5 13q14.2 -0.18 0.174 0.717
xai USP47 11p15.3 -0.18 0.174 0.717 cellular response to UV;monoubiquitinated
protein deubiquitination
hs4 CXCL14 5q31 -0.18 0.174 0.717 chemotaxis;immune response
xai FAM124A 13q14.3 -0.18 0.174 0.717
xai SCML4 6q21 -0.18 0.174 0.717 regulation of transcription, DNA-dependent"
his KLC3 19q13 -0.18 0.174 0.717 metabolic process
xai NME5 5q31 -0.18 0.174 0.717 GTP biosynthetic process;UTP biosynthetic
process
xai VPS41 7p14-p13 -0.18 0.174 0.717 intracellular protein transport;vesicle-
mediated transport
hs4 HCP5 6p21.3 -0.18 0.174 0.717 defense response
xai PSORS1C1 6p21.3 -0.18 0.174 0.717
cop GDF7 2p24.1 0.186 0.175 0.718 neural tube development;positive
xai SELO 22q13.33 0.179 0.175 0.718
his KIAA1328 18q12.2 0.179 0.175 0.718
his TPGS2 18q12.2 0.179 0.175 0.718
his CCT6P3 7q11.21 0.179 0.175 0.718
his MON1B 16q23.1 0.179 0.175 0.718
his DIABLO 12q24.31 0.179 0.175 0.718 Apoptosis
his LOC101593348 0.179 0.175 0.718
hs4 ADRA2B 2q11.1 0.179 0.175 0.718 cell-cell signaling;positive
xai STX2 12q24.33 0.179 0.175 0.718 cytokinetic cell separation;epithelial
his NASP 1p34.1 0.179 0.175 0.718 cell proliferation;protein transport
xai STAMBPL1 10q23.31 0.179 0.175 0.718 proteolysis
exp MIR573 0.179 0.175 0.718
xai PKIB 6q22.31 0.179 0.175 0.718 negative regulation of protein kinase
activity
hs4 STXBP5L 3q13.33 0.179 0.175 0.718 exocytosis;protein transport
xai MIR573 0.179 0.175 0.718
xai FAM9B Xp22.32 0.179 0.175 0.718
xai LOC90784 2p11.2 0.179 0.175 0.718
xai C15orf39 15q24.2 0.179 0.175 0.718
hs4 LRFN4 11q13.2 0.179 0.175 0.718
hs4 NTMT1 9q34.11 0.179 0.175 0.718
xai CSTF2T 10q11 0.179 0.175 0.718 mRNA processing
exp GLOD5 Xp11.23 0.179 0.175 0.718
xai HELZ 17q24.2 0.179 0.175 0.718
hs4 TUBD1 17q23.1 0.179 0.175 0.718 protein polymerization;microtubule-based
movement
hs4 RPS6KB1 17q23.1 0.179 0.175 0.718 Apoptosis; Protein Kinases
his MIR331 0.179 0.175 0.718
his NEK1 4q33 0.179 0.175 0.718 cell division;protein phosphorylation
his CLCN3 4q33 0.179 0.175 0.718 transport;ion transport
hs4 WNT3 17q21 0.179 0.175 0.718 Oncogenes
xai NAA20 20p11.23 0.179 0.175 0.718
hs4 TARP 7p15-p14 0.179 0.175 0.718
xai KCNAB2 1p36.3 0.179 0.175 0.718 potassium ion transport;synaptic
transmission
exp RPL7 8q21.11 0.179 0.175 0.718 nuclear-transcribed mRNA catabolic
exp USF1 1q22-q23 0.179 0.175 0.718 response to hypoxia;positive regulation
xai DNAJC4 11q13 0.179 0.175 0.718 protein folding;response to unfolded
protein
xai HEATR1 1q43 0.179 0.175 0.718 rRNA processing
his RPS27 1q21 0.179 0.175 0.718 translational elongation;viral infectious cycle
his RNASE3 14q11.2 0.179 0.175 0.718 RNA catabolic process;defense
hs4 ANXA13 8q24.13 0.179 0.175 0.718 cell differentiation
xai HSPA8P6 2q34 0.179 0.175 0.719
hs4 DISC1FP1 0.179 0.175 0.719
hs4 SPTBN1 2p21 0.179 0.175 0.719 axon guidance;actin filament capping
xai FBXL21 5q31 0.179 0.175 0.719 protein ubiquitination;rhythmic process
xai MSL3P1 2q37.1 0.179 0.175 0.719 regulation of transcription, DNA-
his BRPF1 3p26-p25 0.179 0.175 0.719 chromatin modification;histone H3
acetylation
his AURKAIP1 1p36.33 0.179 0.175 0.719 negative regulation of
mitosis;positive regulation of proteolysis
xai PNISR 6q16.3 0.179 0.175 0.719
xsq COX7B Xq21.1 0.178 0.175 0.718 respiratory electron transport
met MFGE8 15q25 0.178 0.175 0.718 phagocytosis, recognition;phagocytosis,
engulfment
mut DRP2 Xq22 0.178 0.175 0.718 central nervous system development
xsq KRT83 12q13 0.178 0.175 0.718 epidermis development
xsq TMEM18 2p25.3 0.178 0.175 0.718 transcription, DNA-dependent;cell
migration"
xsq EVI2A 17q11.2 0.178 0.175 0.718
xsq CACNA2D2 3p21.3 0.178 0.175 0.718 small molecule metabolic
xsq LOC101929572 0.178 0.175 0.718
xsq FAM151A 0.178 0.175 0.718
exp ING2 4q35.1 0.178 0.175 0.718 positive regulation of transforming
dependent
xsq OTX2-AS1 0.178 0.175 0.718
met MAP3K9 14q24.2 0.178 0.175 0.718 Protein Kinases
xsq TMEM183B 3q25.1 0.178 0.175 0.718
exp PHACTR3 20q13.32-q13.33 0.178 0.175 0.718
xsq C7orf26 7p22.1 0.178 0.175 0.718
exp TPT1 13q14 0.178 0.175 0.718 Apoptosis
cop SDC1 2p24.1 0.178 0.175 0.718 wound healing;response to calcium ion
xsq RNF2 1q25.3 0.178 0.175 0.718 negative regulation of transcription from
RNA polymerase II promoter;mitotic cell cycle
cop ST8SIA2 15q26 0.178 0.175 0.718 ganglioside biosynthetic process;protein
N-linked glycosylation via asparagine
dependent"
exp VPS33A 12q24.31 0.178 0.175 0.718 protein transport;vesicle-mediated
transport
xsq NDUFA13 19p13.2 0.178 0.175 0.718 apoptotic nuclear change;protein
import into nucleus
xsq DHRS4L1 14q11.2 0.178 0.175 0.718
mir hsa-miR-107 0.178 0.175 0.718
xsq CLEC1A 12p13.2 0.178 0.175 0.718 defense response;cell surface
exp C15orf65 0.178 0.175 0.718
exp FAM131B 7q34 0.178 0.175 0.718
exp PPIAP7 1p21.2 0.178 0.175 0.718
met STBD1 4q21.1 0.178 0.175 0.718 muscle contraction
met ENTPD1 10q24 0.178 0.175 0.718 ATP catabolic process;cell adhesion
cop AFAP1-AS1 4p16.1 0.178 0.175 0.718
xsq CEACAM4 19q13.2 0.177 0.175 0.718
xsq FAM205A 9p12 0.177 0.175 0.718
xsq TTC39C 18q11.2 0.177 0.175 0.718
met HTT 4p16.3 0.177 0.175 0.718 regulation of protein phosphatase type 2A
activity;vesicle transport along microtubule
exp IKBKAP 9q31 0.177 0.175 0.718 protein complex assembly;protein
phosphorylation
cop LOC100289473 20p13 0.177 0.175 0.718
cop SIRPA 20p13 0.177 0.175 0.718 cell adhesion;blood coagulation
cop PDYN 20p13 0.177 0.175 0.718 neuropeptide signaling pathway;synaptic
transmission
cop STK35 20p13 0.177 0.175 0.718
xsq SPRR2G 1q21-q22 0.177 0.175 0.718
cop CALHM2 10q24.33 0.177 0.175 0.718
exp NADK2 5p13.2 0.177 0.175 0.718
xsq SLC22A12 11q13.1 0.177 0.175 0.718
exp HP1BP3 1p36.12 0.177 0.175 0.718 nucleosome assembly
pro EP300_8_8884 0.177 0.175 0.718
xsq PRAMEF15 0.177 0.175 0.718
met LGSN 6pter-q22.33 0.177 0.175 0.718 glutamine biosynthetic
exp METTL2A 17q23.2 0.177 0.175 0.718
met HMGB4 1p35.1 0.177 0.175 0.718
xsq IGF2BP1 17q21.32 0.177 0.175 0.718 RNA localization;regulation of mRNA
xsq UNC13A 19p13.11 0.177 0.175 0.718 exocytosis;intracellular signal
transduction
exp LOC100630923 0.177 0.175 0.718
xsq TGS1 8q11 0.177 0.175 0.718 regulation of transcription, DNA-
mut PDE11A 2q31.2 0.177 0.175 0.718 cAMP catabolic process;signal
transduction
cop CITED2 6q23.3 0.177 0.175 0.719 vasculogenesis;lens morphogenesis
in camera-type eye
cop LOC645434 0.177 0.175 0.719
xsq OR10G8 0.177 0.175 0.719
xsq MAZ 16p11.2 0.177 0.175 0.719 regulation of transcription, DNA-
met STAT3 17q21.31 0.177 0.175 0.719 Apoptosis
xsq EHMT2 6p21.31 0.177 0.175 0.719 negative regulation of transcription from
RNA polymerase II promoter;organ growth
xsq EXOC3L2 19q13.32 0.177 0.175 0.719
met TMEM232 5q22.1 0.177 0.175 0.719
xsq MUC17 7q22.1 0.177 0.175 0.719 O-glycan processing;cellular homeostasis
xsq FANCG 9p13 0.177 0.175 0.719 DNA Damage Response (DDR); DDR (FA)
mut OR1J2 9q34.11 0.177 0.175 0.719 response to stimulus
exp TOMM5 9p13.2 0.177 0.175 0.719 protein targeting to mitochondrion
xsq CBX8 17q25.3 0.177 0.175 0.719 negative regulation of transcription from
met POM121C 7q11.2 0.177 0.175 0.719 protein transport;mRNA transport
mut KLB 4p14 0.177 0.175 0.719 insulin receptor signaling pathway;fibroblast
xsq FAM214B 9p13.3 -0.177 0.175 0.719
xsq TTC12 11q23.2 -0.177 0.175 0.719
xsq MAPK8IP1 11p11.2 -0.177 0.175 0.719 Cell Signaling
pro CDH3 16q22.1 -0.177 0.175 0.719 response to stimulus;cell adhesion
met JAM3 11q25 -0.177 0.175 0.718 angiogenesis;cell adhesion
met TP53INP2 20q11.22 -0.177 0.175 0.718
exp CHL1-AS2 3p26.3 -0.177 0.175 0.718
xsq CDH19 18q22.1 -0.177 0.175 0.718 cell-cell adhesion;cell adhesion
exp PIAS3 1q21 -0.177 0.175 0.718 DNA Damage Response (DDR)
met SIRT4 12q -0.177 0.175 0.718 protein ADP-ribosylation;protein
deacetylation
mut ATP6V0D1 16q22.1 -0.177 0.175 0.718 activation of signaling
exp SYS1 20q13.12 -0.177 0.175 0.718 protein transport
exp MPZ 1q23.3 -0.177 0.175 0.718 synaptic transmission
exp FAM65A 16q22.1 -0.177 0.175 0.718
cop LYST 1q42.1-q42.2 -0.177 0.175 0.718 natural killer cell mediated
exp MICALL2 7p22.3 -0.177 0.175 0.718 endocytosis
mut PDPN 1p36.21 -0.178 0.175 0.718 lymphangiogenesis;cell
proliferation
mut CPO 2q33.3 -0.178 0.175 0.718 proteolysis
mut OR51A7 11p15.4 -0.178 0.175 0.718 response to stimulus
mut OR5T3 11q12.1 -0.178 0.175 0.718 response to stimulus
mut PLVAP 19p13.2 -0.178 0.175 0.718
exp PHACTR2 6q24.2 -0.178 0.175 0.718
xsq LPPR2 19p13.2 -0.178 0.175 0.718
exp NR1H2 19q13.3 -0.178 0.175 0.718 positive regulation of lipid
storage;positive regulation of fatty acid biosynthetic process
cop UBE2T 1q32.1 -0.178 0.175 0.718 DNA Damage Response (DDR); DDR (FA)
xsq HOXA4 7p15.2 -0.178 0.175 0.718 anatomical structure
mut FAM217B 20q13.33 -0.178 0.175 0.718
xsq CACNG4 17q24 -0.178 0.175 0.718 transport;ion transport
exp ESRP2 16q22.1 -0.178 0.175 0.718 EMT (Epithelial)
cop NPHS2 1q25.2 -0.178 0.175 0.718 excretion;actin cytoskeleton
reorganization
exp FRMD7 Xq26.2 -0.178 0.175 0.718 nervous system
xsq CREB3 9p13.3 -0.178 0.175 0.718 reactivation of latent
xai PCDHB18P -0.179 0.175 0.719 cell adhesion;homophilic cell
adhesion
hs4 MTSS1L 16q22.1 -0.179 0.175 0.719 filopodium assembly;signal
transduction
exp AGBL1 15q25.3 -0.179 0.175 0.719 proteolysis;C-terminal protein
deglutamylation
his FOXO6 1p34.2 -0.179 0.175 0.719 response to DNA damage
stimulus;organ development
xai ANKRD29 18q11.2 -0.179 0.175 0.719
hs4 ADAMTS7 15q24.2 -0.179 0.175 0.719 proteolysis
his LINC01973 -0.179 0.175 0.719
his ZBTB7C 18q21.1 -0.179 0.175 0.719
xai CYSTM1 5q31.3 -0.179 0.175 0.718
hs4 FOXCUT -0.179 0.175 0.718
hs4 FOXC1 6p25 -0.179 0.175 0.718 Apoptosis
his MIR548Q -0.179 0.175 0.718
exp ADIRF-AS1 -0.179 0.175 0.718
xai PDLIM5 4q22 -0.179 0.175 0.718 regulation of synapse
hs4 C8orf31 8q24.3 -0.179 0.175 0.718
his GHR 5p13-p12 -0.179 0.175 0.718 succinate metabolic
hs4 TNK1 17p13.1 -0.179 0.175 0.718 protein autophosphorylation;protein
phosphorylation
xai CST6 11q13 -0.179 0.175 0.718 epidermis development;anatomical
DNA-dependent"
hs4 ZNF529-AS1 -0.179 0.175 0.718
swa VDAC2 10q22 -0.179 0.175 0.718 Apoptosis
his LOC145474 14q24.2 -0.179 0.175 0.718
exp PLSCR2 3q24 -0.179 0.175 0.718 phospholipid scrambling
hs4 SIM1 6q16.3 -0.179 0.175 0.718 cell differentiation;ureteric bud
development
his CREB3L2 7q34 -0.179 0.175 0.718 chondrocyte differentiation;ER to
exp DYNLT3P1 -0.179 0.175 0.718
exp FSCN3 7q31.3 -0.179 0.175 0.718
hs4 LIN28B-AS1 -0.179 0.175 0.718
his WFDC21P -0.179 0.175 0.718
xai TMLHE Xq28 -0.179 0.175 0.718 cellular nitrogen compound metabolic
swa NDUFAF2 5q12.1 -0.179 0.175 0.718
xai CNGA1 4p12 -0.181 0.175 0.718 transport;ion transport
hs4 BOLA2-SMG1P6 0.179 0.176 0.719
hs4 BOLA2 16p11.2 0.179 0.176 0.719
hs4 SLX1B 0.179 0.176 0.719 DNA Damage Response (DDR)
hs4 SLX1B-SULT1A4 0.179 0.176 0.719
swa PHF6 Xq26.3 0.179 0.176 0.719 regulation of transcription, DNA-
dependent"
his GNB5 15q21.2 0.179 0.176 0.719 GTP catabolic process;signal transduction
his CERNA1 0.179 0.176 0.719
swa GLO1 6p21.3-p21.1 0.179 0.176 0.719 Apoptosis
xai AGMAT 1p36.21 0.179 0.176 0.719 polyamine metabolic process;spermidine
hs4 DENND4A 15q22.31 0.179 0.176 0.719 regulation of transcription, DNA-
dependent"
xai MRPS16P2 20q13.32 0.179 0.176 0.719
exp PFKFB1 Xp11.21 0.179 0.176 0.719 Apoptosis
his RICTOR 5p13.1 0.179 0.176 0.719 epidermal growth factor receptor
signaling pathway;regulation of actin cytoskeleton organization
exp CDC20P1 9q21.33 0.179 0.176 0.719
his MIR3186 0.179 0.176 0.72
his IDE 10q23-q25 0.179 0.176 0.72 proteolysis;protein homotetramerization
his DIS3L2 2q37.1 0.179 0.176 0.72
xai MAP1S 19p13.11 0.179 0.176 0.72 microtubule bundle formation;apoptotic
process
hs4 SCG3 15q21 0.179 0.176 0.72 platelet degranulation;blood coagulation
hs4 FARSA 19p13.2 0.179 0.176 0.72 tRNA aminoacylation for protein
hs4 PPAT 4q12 0.179 0.176 0.72 lactation;nucleobase-containing small molecule
metabolic process
hs4 PAICS 4q12 0.179 0.176 0.72 purine base metabolic process;purine nucleotide
his XIRP2 2q24.3 0.179 0.176 0.72 actin cytoskeleton organization
swa TNPO1 5q13.2 0.179 0.176 0.72 protein import into nucleus,
translocation;gene expression
exp MTHFD1P1 0.179 0.176 0.72
xai CDR1 Xq27.1 0.178 0.176 0.72
dependent"
cop HAVCR1P1 19p 0.178 0.176 0.72
xai ZNF324B 19q13.43 0.178 0.176 0.72 regulation of transcription, DNA-
dependent"
exp TMEM201 1p36.22 0.178 0.176 0.72
his TAF10 11p15.3 0.178 0.176 0.72 transcription from RNA polymerase II
promoter;transcription initiation from RNA polymerase II promoter
swa CSTF2 Xq22.1 0.178 0.176 0.72 gene expression;nuclear mRNA splicing,
via spliceosome
his SHARPIN 8q24.3 0.178 0.176 0.72 mitochondrion organization;protein
homooligomerization
his MAF1 8q24.3 0.178 0.176 0.72 regulation of transcription, DNA-
dependent;negative regulation of transcription from RNA polymerase III promoter"
his WDR97 0.178 0.176 0.72
his JADE2 0.178 0.176 0.72 histone H3 acetylation;histone H4-K5
acetylation
hs4 KBTBD8 3p14 0.178 0.176 0.72
his KANK3 19p13.2 0.178 0.176 0.72
his TNNC1 3p21.1 0.178 0.176 0.72 regulation of muscle contraction;muscle
filament sliding
his NISCH 3p21.1 0.178 0.176 0.72 regulation of blood pressure;Rac protein
signal transduction
xsq LPO 17q23.1 0.177 0.176 0.719 hydrogen peroxide catabolic
met PER2 2q37.3 0.177 0.176 0.719 DNA Damage Response (DDR)
met BMP2 20p12 0.177 0.176 0.719 positive regulation of protein
phosphorylation;cell-cell signaling
xsq SNORA62 3p22.1 0.177 0.176 0.719
mut OTUD6A Xq13.1 0.177 0.176 0.719
xsq TRMT10C 3q12.3 0.177 0.176 0.719
xsq SLC8A2 19q13.3 0.177 0.176 0.719 transmembrane transport;ion
transport
met SEMA4B 15q25 0.177 0.176 0.719 multicellular organismal
xsq CDRT15L2 0.177 0.176 0.719
met SHROOM4 Xp11.22 0.177 0.176 0.719 actin filament
cop MLLT4 6q27 0.177 0.176 0.719 cell junction assembly;adherens junction
organization
xsq DLD 7q31-q32 0.177 0.176 0.719 pyruvate metabolic process;branched chain
mut MAGEA11 Xq28 0.177 0.176 0.719
xsq NUP205 7q33 0.177 0.176 0.719 protein transport;glucose transport
xsq PTGES3L 0.177 0.176 0.719
xsq PRAMEF20 1p36.21 0.177 0.176 0.719
xsq MED18 1p35.3 0.177 0.176 0.719 regulation of transcription from RNA
xsq KRTAP4-8 17q21.2 0.177 0.176 0.719
xsq ABHD14A 3p21.1 0.177 0.176 0.719
xsq POU4F2 4q31.2 0.177 0.176 0.719 MAPK cascade;positive regulation of
exp DCAF8 1q22-q23 0.177 0.176 0.719 protein ubiquitination
exp SETD2 3p21.31 0.177 0.176 0.719 Tumor Suppressors
met PAX8 2q13 0.177 0.176 0.719 mesenchymal to epithelial transition involved
in metanephros morphogenesis;pronephric field specification
cop LINC00570 0.177 0.176 0.719
cop E2F6 2p25.1 0.177 0.176 0.719 regulation of transcription involved in
xsq AWAT1 Xq13.1 0.177 0.176 0.719 lipid biosynthetic process
mut ROR2 9q22 0.177 0.176 0.719 skeletal system development;negative regulation
xsq SKOR1 15q23 0.177 0.176 0.719 negative regulation of transcription from RNA
cop NR2C1 12q22 0.177 0.176 0.72 positive regulation of retinoic acid receptor
promoter
xsq FAM35A 10q23.2 0.177 0.176 0.72
xsq ZPBP2 17q12 0.177 0.176 0.72 binding of sperm to zona pellucida
xsq CCDC121 2p23.3 0.177 0.176 0.72
met GCNT1 9q13 0.177 0.176 0.72 O-glycan processing;post-translational protein
modification
exp LRFN5 14q21.1 0.177 0.176 0.72
cop TXLNB 6q24.1 0.177 0.176 0.72
xsq MACROD1 11q11 0.177 0.176 0.72 purine nucleoside metabolic process
dependent"
xsq SPEN 1p36 0.177 0.176 0.72 negative regulation of transcription from RNA
polymerase II promoter;Notch signaling pathway
exp MIS18BP1 14q21.2 0.177 0.176 0.72 mitosis;CenH3-containing nucleosome
xsq FLJ27354 0.177 0.176 0.72
cop MDH1 2p13.3 0.177 0.176 0.72 carbohydrate metabolic process;glucose
metabolic process
xsq DNAH17-AS1 0.177 0.176 0.72
met HSPB3 5q11.2 0.177 0.176 0.72 Apoptosis
met DPYSL3 5q32 0.177 0.176 0.72 axon guidance;actin crosslink formation
cop PRKRIR 11q13.5 0.177 0.176 0.72 response to stress;signal
transduction
xsq LOC283731 15q24.1 0.177 0.176 0.72
met PPP1R15B 1q32.1 0.177 0.176 0.72 dephosphorylation;response to
hydrogen peroxide
xsq BAALC-AS1 0.177 0.176 0.72
met ANO8 19p13.11 0.177 0.176 0.72 ion transport
xsq LRRC14B 0.177 0.176 0.72
mir hsa-miR-887 0.177 0.176 0.72
met SDHA 5p15 0.177 0.176 0.72 small molecule metabolic process;oxidation-
reduction process
xsq CDX1 5q32 0.177 0.176 0.72 anterior/posterior pattern
exp EIF3M 11p13 0.177 0.176 0.72 translational initiation
xsq CDKN1B 12p13.1-p12 0.177 0.176 0.72 DDR (DNA replication)
xsq CYTL1 4p16-p15 -0.177 0.176 0.72 positive regulation of
xsq SNX24 5q23.2 -0.177 0.176 0.72 cell communication;protein
transport
cop ASTE1 3q22.1 -0.177 0.176 0.72 DNA repair
exp LOC442446 Xp11.4 -0.177 0.176 0.72
met PBXIP1 1q21.3 -0.177 0.176 0.72 negative regulation of
met KRT32 17q21.2 -0.177 0.176 0.72 epidermis development
exp LOC729296 20q13.33 -0.177 0.176 0.72
exp LINC00113 21q21.3 -0.177 0.176 0.72
exp SOWAHB 4q21.1 -0.177 0.176 0.72 EMT (Epithelial)
xsq CMBL 5p15.2 -0.177 0.176 0.72
met ATP9B 18q23 -0.177 0.176 0.72 cation transport;aminophospholipid
transport
cop SFXN1 5q35.3 -0.177 0.176 0.72 transmembrane transport;iron ion
transport
cop FGF10 5p13-p12 -0.177 0.176 0.72
xsq PIK3CB 3q22.3 -0.177 0.176 0.719 Oncogenes; Protein Kinases
xsq AHNAK 11q12.2 -0.177 0.176 0.719 nervous system development
xsq ZNF32-AS1 -0.177 0.176 0.719
exp NAV3 12q14.3 -0.177 0.176 0.719
met SMARCAD1 4q22-q23 -0.177 0.176 0.719 DNA Damage Response (DDR)
xsq MOK 14q32 -0.177 0.176 0.719 protein phosphorylation;signal
transduction
exp APLP2 11q24 -0.177 0.176 0.719 regulation of epidermal growth factor-
activated receptor activity;neuromuscular process controlling balance
cop DDX56 7p13 -0.177 0.176 0.719 rRNA processing
xsq FOXF2 6p25.3 -0.177 0.176 0.719 Apoptosis
xsq ST7-OT4 -0.177 0.176 0.719
xsq PCDH18 4q31 -0.177 0.176 0.719 homophilic cell adhesion;brain
development
exp PARP14 3q21.1 -0.177 0.176 0.719 regulation of transcription,
DNA-dependent"
exp FTHL17 Xp21 -0.177 0.176 0.719 iron ion transport;cellular iron
ion homeostasis
mut C7orf34 7q34 -0.177 0.176 0.719
xai IQUB 7q31.32 -0.178 0.176 0.72
xai STRN4 19q13.2 -0.178 0.176 0.72
hs4 KIF25 6q27 -0.178 0.176 0.72 mitotic sister chromatid
segregation;organelle organization
xai KRT8P2 14q21.2 -0.178 0.176 0.72
DNA-dependent"
his LOC400706 19q13.32 -0.178 0.176 0.72
hs4 CNR1 6q14-q15 -0.178 0.176 0.72 positive regulation of acute
xai LLGL1 17p11.2 -0.179 0.176 0.72 protein complex assembly;exocytosis
xai TPCN1 12q24.13 -0.179 0.176 0.72 ion transport;transmembrane
transport
his DTX3 12q13.3 -0.179 0.176 0.72 Notch signaling pathway
xai ME3 11cen-q22.3 -0.179 0.176 0.72 oxidation-reduction process;oxygen
metabolic process
hs4 NMT2 10p13 -0.179 0.176 0.72 N-terminal protein myristoylation;protein
lipoylation
his C11orf45 11q24.3 -0.179 0.176 0.72
xai INHBB 2cen-q13 -0.179 0.176 0.72 cell differentiation;positive
regulation of follicle-stimulating hormone secretion
hs4 GHR 5p13-p12 -0.179 0.176 0.72 succinate metabolic
swa RMDN3 15q15.1 -0.179 0.176 0.72
swa ZFPL1 11q13 -0.179 0.176 0.72 regulation of transcription, DNA-
xai MAD1L1 7p22 -0.179 0.176 0.72 mitotic anaphase;mitotic telophase
xai LOC100130744 -0.179 0.176 0.72
swa TST 22q13.1 -0.179 0.176 0.72 small molecule metabolic
process;rRNA transport
hs4 LONP2 16q12.1 -0.179 0.176 0.72 protein targeting to
xai POU5F1 6p21.31 -0.179 0.176 0.72 blastocyst
development;regulation of asymmetric cell division
hs4 COLEC12 18p11.32 -0.179 0.176 0.719 innate immune
response;protein homooligomerization
xai WDR91 7q33 -0.179 0.176 0.719
his MIR924HG -0.179 0.176 0.719
his TJP1 15q13 -0.179 0.176 0.719 blastocyst formation;apoptotic process
xai DNAJB4 1p31.1 -0.179 0.176 0.719 protein folding;response to
unfolded protein
xai VWA2 10q25.3 -0.179 0.176 0.719
xai HCAR1 12q24.31 -0.179 0.176 0.719 response to estradiol stimulus
xai MYADM 19q13.42 -0.179 0.176 0.719
swa NAE1 16q22 -0.179 0.176 0.719 Apoptosis
xai KIAA1715 2q31 -0.179 0.176 0.719 limb development;multicellular
DNA-dependent"
his TAF9B Xq13.1-q21.1 0.178 0.177 0.72 negative regulation of apoptotic
hs4 PGPEP1L 15q26.3 0.178 0.177 0.72 proteolysis
met MGST1 12p12.3-p12.1 0.178 0.177 0.72 response to organic
xai LOC401098 3q25.33 0.178 0.177 0.72
his DSG3 18q12.1 0.178 0.177 0.72 cellular component disassembly involved
xai CHI3L2 1p13.3 0.178 0.177 0.721 carbohydrate metabolic
xai CHKB-AS1 22q13.33 0.178 0.177 0.721
hs4 UBTF 17q21.31 0.178 0.177 0.721 chromatin silencing at rDNA;regulation of
hs4 COQ2 4q21.23 0.178 0.177 0.721 glycerol metabolic process;ubiquinone
xai NUCB2 11p15.1 0.178 0.177 0.721
xai IP6K2 3p21.31 0.178 0.177 0.721 Apoptosis
xai ING1 13q34 0.178 0.177 0.721 positive regulation of transcription, DNA-
dependent;protein import into nucleus
his HS6ST1 2q21 0.178 0.177 0.721 labyrinthine layer blood vessel
exp INCENP 11q12.3 0.178 0.177 0.721 M phase of mitotic cell
his TCTE3 6q27 0.178 0.177 0.721 transport
his ERMARD 0.178 0.177 0.721
his PRMT6 1p13.3 0.178 0.177 0.721 DNA Damage Response (DDR)
his AURKB 17p13.1 0.178 0.177 0.721 Protein Kinases
xai FBXO42 1p36.23-p36.11 0.178 0.177 0.721
hs4 RPLP2 11p15.5 0.178 0.177 0.721 translation;mRNA metabolic process
hs4 SNORA52 0.178 0.177 0.721
xai NADK2 5p13.2 0.178 0.177 0.721
xai CHCHD10 22q11.23 0.178 0.177 0.721
his FAM76B 11q21 0.178 0.177 0.721
his CEP57 11q21 0.178 0.177 0.721 protein import into nucleus, translocation;G2/M
his LINC00863 0.178 0.177 0.721
his NUTM2A-AS1 10q23.2 0.178 0.177 0.721
his GALT 9p13 0.178 0.177 0.721 small molecule metabolic process;carbohydrate
metabolic process
hs4 RPA2 1p35 0.178 0.177 0.721 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
his ACRBP 12p13.31 0.178 0.177 0.721
his PDE8A 15q25.3 0.178 0.177 0.721 regulation of transcription, DNA-
dependent;cyclic nucleotide metabolic process"
his LINC00221 0.178 0.177 0.722
hs4 TNFRSF8 1p36 0.178 0.177 0.722 Apoptosis
xai CEBPA 19q13.1 0.178 0.177 0.722 Tumor Suppressors
xai OBFC1 10q24.33 0.178 0.177 0.722 DNA Damage Response (DDR)
his SLC16A1-AS1 0.178 0.177 0.722
xsq CLDN15 7q11.22 0.177 0.177 0.72 calcium-independent cell-cell
xsq TXN2 22q13.1 0.177 0.177 0.72 response to nutrient;response to axon
injury
xsq LOC100240735 12q13.13 0.177 0.177 0.72
met LIN7B 19q13.3 0.177 0.177 0.72 exocytosis;neurotransmitter secretion
met TTLL3 3p25.3 0.177 0.177 0.72 protein polyglycylation;axoneme assembly
xsq TSSC4 11p15.5 0.177 0.177 0.72
xsq SAMD10 20q13.33 0.177 0.177 0.72
xsq NDUFA6 22q13.2 0.177 0.177 0.72 response to oxidative
exp MAT2B 5q34-q35 0.177 0.177 0.72 cellular nitrogen compound metabolic
met PREX2 8q13.2 0.177 0.177 0.72 G-protein coupled receptor signaling
pathway;positive regulation of Rac GTPase activity
xsq GLTSCR1L 6p21.1 0.177 0.177 0.72
dependent"
met LOC440040 11p11.12 0.177 0.177 0.72
exp VPS33B 15q26.1 0.177 0.177 0.72 protein transport;vesicle-mediated
transport
xsq ISY1 3q21.3 0.177 0.177 0.72 nuclear mRNA splicing, via
met C8orf22 8q11 0.177 0.177 0.721
cop HMSD 18q22.1 0.177 0.177 0.721
cop VPS26A 10q21.1 0.177 0.177 0.721 retrograde transport, endosome to
Golgi;vacuolar transport
met GBP1 1p22.2 0.177 0.177 0.721 interferon-gamma-mediated signaling
pathway;cytokine-mediated signaling pathway
exp EIF2D 1q32.1 0.177 0.177 0.721 translational initiation;intracellular
protein transport
exp LOC390806 17q23.3 0.177 0.177 0.721
met TAOK3 12q 0.177 0.177 0.721 Protein Kinases
met C1orf21 1q25 0.177 0.177 0.721
met FAM222B 17q11.2 0.177 0.177 0.721
cop AACS 12q24.31 0.177 0.177 0.721 liver development;response to drug
dependent"
xsq COG3 13q14.13 0.177 0.177 0.721 protein localization to organelle;protein
stabilization
cop VWF 12p13.3 0.177 0.177 0.721 platelet degranulation;protein
homooligomerization
cop HECA 6q23-q24 0.177 0.177 0.721 multicellular organismal
development;respiratory tube development
exp IL23A 12q13.3 0.177 0.177 0.721 positive regulation of activation of JAK2
kinase activity;positive regulation of natural killer cell activation
exp GIMAP5 7q36.1 0.177 0.177 0.721 positive regulation of humoral
immune response mediated by circulating immunoglobulin;negative regulation of
nitric oxide biosynthetic process
xsq EBLN2 3p13 0.177 0.177 0.721
cop LOC100128176 0.177 0.177 0.721
exp EDEM3 1q25 0.177 0.177 0.721 glycoprotein catabolic process;response to
unfolded protein
met SOX1 13q34 0.177 0.177 0.721 chromatin organization;regulation of
exp MGC12916 17p12 0.177 0.177 0.721
dependent"
met FRMPD4 Xp22.2 0.176 0.177 0.722 positive regulation of synapse
structural plasticity
met LOXL2 8p21.3 0.176 0.177 0.722 protein modification process;cell
adhesion
xsq MANEA 6q16.1 0.176 0.177 0.722 protein N-linked glycosylation via
xsq PRSS54 16q21 0.176 0.177 0.722
met ANKRD30BP2 21q11.2 0.176 0.177 0.722
xsq LINC01336 -0.176 0.177 0.722
met MAPK6 15q21 -0.176 0.177 0.722 Protein Kinases
met PFN4 2p23.3 -0.176 0.177 0.722 actin cytoskeleton organization
xsq SLIT3 5q35 -0.176 0.177 0.722 multicellular organismal development;axon
exp DSEL 18q22.1 -0.176 0.177 0.722
exp ECM1 1q21 -0.176 0.177 0.722 positive regulation of endothelial cell
mut CCDC130 19p13.2 -0.176 0.177 0.722 response to virus
xsq LOC644285 -0.176 0.177 0.722
cop TRPS1 8q24.12 -0.177 0.177 0.721 skeletal system
exp BAX 19q13.3-q13.4 -0.177 0.177 0.721 Apoptosis; Protein Kinases
exp ZNF436 1p36 -0.177 0.177 0.721 regulation of transcription, DNA-
dependent"
exp MEIS3 19q13.32 -0.177 0.177 0.721
cop MIR599 -0.177 0.177 0.721
xsq VCAM1 1p32-p31 -0.177 0.177 0.721 heart development;interspecies
xsq RBM11 21q11 -0.177 0.177 0.721
xsq SMURF1 7q22.1 -0.177 0.177 0.721 protein
exp SPIN1 9q22.1 -0.177 0.177 0.721 cell cycle;multicellular organismal
development
exp SPIDR 8q11.21 -0.177 0.177 0.72
exp CYP4V2 4q35.2 -0.177 0.177 0.72 fatty acid omega-
mut LIM2 19q13.4 -0.177 0.177 0.72 lens development in camera-type
eye;cell-cell junction assembly
met BLID 11q24.1 -0.177 0.177 0.72 apoptotic process
exp FER 5q21 -0.177 0.177 0.72 cell adhesion;regulation of epidermal
met FOXL2 3q23 -0.177 0.177 0.72 Oncogenes
exp BNIPL 1q21.3 -0.177 0.177 0.72 apoptotic process;induction of
apoptosis
met PSG1 19q13.2 -0.177 0.177 0.72 female pregnancy
mut CNTROB 17p13.1 -0.177 0.177 0.72 centrosome
separation;cytokinesis
cop AXDND1 1q25.2 -0.177 0.177 0.72
xai LOC390203 -0.178 0.177 0.722
hs4 TDRP 8p23.3 -0.178 0.177 0.722
xai NAT14 19q13.42 -0.178 0.177 0.722 transcription initiation, DNA-
xai TYRO3 15q15 -0.178 0.177 0.722 signal transduction by
xai LOC100129175 -0.178 0.177 0.722
his TGFA-IT1 -0.178 0.177 0.722
xai LINC00968 -0.178 0.177 0.722
hs4 C7orf77 -0.178 0.177 0.721
exp MAGI1-IT1 -0.178 0.177 0.721
xai C14orf28 14q21.2 -0.178 0.177 0.721
swa S100B 21q22.3 -0.178 0.177 0.721 learning or memory;memory
xai ANO2 12p13.3 -0.178 0.177 0.721 ion transport;chloride transport
his RAPH1 2q33 -0.178 0.177 0.721 cell-matrix adhesion;signal transduction
his KCNK3 2p23 -0.178 0.177 0.721 brain development;response to drug
xai WTAPP1 11q22.2 -0.178 0.177 0.721
xai IPO9 1q32.1 -0.178 0.177 0.721 protein import into
swa MGLL 3q21.3 -0.178 0.177 0.721 regulation of signal
his MIR6780B -0.178 0.177 0.721
hs4 YWHAEP7 -0.178 0.177 0.721
xai SPIDR 8q11.21 -0.178 0.177 0.721
hs4 CAST 5q15 -0.178 0.177 0.721 negative regulation of endopeptidase
activity
xai ENO1P3 -0.178 0.177 0.721
his CACNA1C-IT3 -0.178 0.177 0.721
xai TFG 3q12.2 -0.178 0.177 0.721 signal transduction;positive
his LOC105371795 -0.178 0.177 0.721
swa KRT19 17q21.2 -0.178 0.177 0.721 cell differentiation involved in
exp LOC100506119 -0.178 0.177 0.721
his MOXD1 6q23.2 -0.178 0.177 0.72 catecholamine metabolic process
his IGDCC4 15q22.31 -0.178 0.177 0.72
hs4 APOD 3q29 -0.178 0.177 0.72 lipid transport;negative regulation of
xai PLA2G4C 19q13.3 -0.178 0.177 0.72 metabolic process;lipid
catabolic process
xai APLP2 11q24 -0.178 0.177 0.72 regulation of epidermal growth factor-
xai APCDD1L-AS1 -0.178 0.177 0.72
hs4 NEXN 1p31.1 -0.178 0.177 0.72 regulation of cell
hs4 NEXN-AS1 1p31.1 -0.178 0.177 0.72
his LTB4R2 14q12 0.178 0.178 0.722 chemotaxis;signal transduction
his CIDEB 14q12 0.178 0.178 0.722 apoptotic process;induction of apoptosis
his LTB4R 14q11.2-q12 0.178 0.178 0.722 cellular component movement;muscle
contraction
dependent"
his OGG1 3p26.2 0.178 0.178 0.722 DNA Damage Response (DDR); DDR (BER)
hs4 RNF126P1 17q22 0.178 0.178 0.722
xai TEX264 3p21.31 0.178 0.178 0.722
his GABRB3 15q12 0.178 0.178 0.722 synaptic transmission;sensory perception
of sound
xai PRSS3P1 0.178 0.178 0.722
xai RPL12P37 17q25.3 0.178 0.178 0.722
swa CDIPT 16p11.2 0.178 0.178 0.722 phosphatidylinositol biosynthetic
exp OR8C1P 11q24.2 0.178 0.178 0.722
his ALDH4A1 1p36 0.178 0.178 0.722 proline metabolic process;proline
his COA1 7p13 0.178 0.178 0.722
swa GLRX 5q14 0.178 0.178 0.722 transport;nucleobase-containing small molecule
interconversion
his RAB39B Xq28 0.178 0.178 0.722 synapse organization;small GTPase
hs4 NOP56 20p13 0.178 0.178 0.722 rRNA processing;cell death
hs4 MIR1292 0.178 0.178 0.722
hs4 SNORD110 0.178 0.178 0.722
hs4 SNORA51 0.178 0.178 0.722
hs4 SNORD86 0.178 0.178 0.722
hs4 SNORD56 0.178 0.178 0.722
hs4 SNORD57 0.178 0.178 0.722
hs4 MIR5787 0.178 0.178 0.722
xai GOLPH3L 1q21.3 0.178 0.178 0.722
xai AFG3L1P 16q24.3 0.178 0.178 0.722
hs4 CDS2 20p13 0.178 0.178 0.722 phospholipid biosynthetic process
his RWDD4 4q35.1 0.178 0.178 0.722
his TRAPPC11 4q35.1 0.178 0.178 0.722 vesicle-mediated transport
his RNF111 15q21 0.178 0.178 0.722 multicellular organismal
hs4 CSF3 17q11.2-q12 0.178 0.178 0.722 granulocyte differentiation;immune
response
exp NCOR1P3 0.178 0.178 0.723
xai TRNY 0.178 0.178 0.723
his MIR5194 0.178 0.178 0.723
xai NCOR1P3 0.178 0.178 0.723
his LTBP4 19q13.1-q13.2 0.178 0.178 0.723 protein folding;multicellular
exp RPL18P11 15q25.1 0.178 0.178 0.723
his TFAM 10q21 0.178 0.178 0.723 regulation of transcription from RNA polymerase
I promoter;transcription from mitochondrial promoter
hs4 CHCHD4 3p25.1 0.178 0.178 0.723 protein transport
hs4 TMEM43 3p25.1 0.178 0.178 0.723
exp EIF5AP2 0.178 0.178 0.723
hs4 FAM198A 3p22.1 0.178 0.178 0.723
his TMEM106C 12q13.1 0.178 0.178 0.723
xai RPL18P11 15q25.1 0.178 0.178 0.723
his XXYLT1 3q29 0.178 0.178 0.723
his SCAI 9q33.3 0.178 0.178 0.723 regulation of transcription, DNA-
his NBPF12 0.178 0.178 0.723
exp HRH3 20q13.33 0.178 0.178 0.723 G-protein signaling, coupled to cyclic
nucleotide second messenger;neurotransmitter secretion"
xai VSTM5 11q21 0.178 0.178 0.723
cop PRNP 20p13 0.176 0.178 0.722 negative regulation of protein
cop PRND 20p13 0.176 0.178 0.722 cellular copper ion homeostasis;protein
homooligomerization
cop PRNT 20p13 0.176 0.178 0.722
mut CASR 3q13 0.176 0.178 0.722 detection of calcium ion;cellular calcium ion
homeostasis
xsq LPPR5 1p21.3 0.176 0.178 0.722
cop TEX14 17q22 0.176 0.178 0.722
exp SPERT 13q14.13 0.176 0.178 0.722
xsq UMODL1-AS1 0.176 0.178 0.722
xsq DGUOK-AS1 0.176 0.178 0.722
exp LRRC8B 1p22.2 0.176 0.178 0.722
xsq TBX6 16p11.2 0.176 0.178 0.722 mesoderm development;anatomical structure
morphogenesis
cop C6orf123 6q27 0.176 0.178 0.722
cop MLLT4-AS1 6q27 0.176 0.178 0.722
exp ARL14EP 11p14.1 0.176 0.178 0.722
met CPT2 1p32 0.176 0.178 0.722 fatty acid beta-oxidation;transport
exp PRDX5 11q13 0.176 0.178 0.722 response to oxidative stress;cellular response
exp GOLPH3L 1q21.3 0.176 0.178 0.722
xsq HORMAD2 22q12.2 0.176 0.178 0.722 meiosis
pro CASP7_16 0.176 0.178 0.722
cop BRAP 12q24 0.176 0.178 0.722 MAPK cascade;Ras protein signal transduction
met SAMD5 6q24.3 0.176 0.178 0.722
cop GPT2 16q12.1 0.176 0.178 0.722 small molecule metabolic process;2-
cop DNAJA2 16q12.1 0.176 0.178 0.722 protein folding;positive regulation
cop C20orf196 20p12.3 0.176 0.178 0.722
met FAXDC2 5q31-q32 0.176 0.178 0.722
met CHMP2A 19q 0.176 0.178 0.722 protein transport;cellular membrane
organization
exp SYT3 19q13.33 0.176 0.178 0.722
cop MYLK3 16q11.2 0.176 0.178 0.722 protein phosphorylation;sarcomere
organization
mut CDH2 18q11.2 0.176 0.178 0.722 homophilic cell adhesion;adherens
exp VPS4A 16q22.1 0.176 0.178 0.723 cellular membrane organization;vesicle-
mediated transport
exp THAP2 12q21.1 0.176 0.178 0.723
exp CHCHD10 22q11.23 0.176 0.178 0.723
xsq CEP68 2p14 0.176 0.178 0.723 centrosome organization
exp PDCL3P4 3q12.3 0.176 0.178 0.723
xsq MTRF1L 6q25-q26 0.176 0.178 0.723 translational termination
xsq TMEM80 11p15.5 0.176 0.178 0.723
cop LOC100132215 2p15 0.176 0.178 0.723
cop OTX1 2p13 0.176 0.178 0.723 multicellular organismal
cop DBIL5P2 0.176 0.178 0.723
cop WDPCP 2p15 0.176 0.178 0.723 regulation of embryonic cell shape;cell
met SCIN 7p21.3 0.176 0.178 0.723 regulation of chondrocyte
xsq CUEDC2 10q24.32 0.176 0.178 0.723
cop CCND1 11q13 0.176 0.178 0.723 DNA Damage Response (DDR); DDR (G1-S
cop ORAOV1 11q13.3 0.176 0.178 0.723
dependent"
xsq TRY2P 0.176 0.178 0.723
xsq HRC 19q13.3 0.176 0.178 0.723 muscle contraction
cop C18orf61 0.176 0.178 0.723
cop CIDEA 18p11.21 0.176 0.178 0.723 lipid metabolic process;negative
xsq LINC00314 21q21.3 0.176 0.178 0.723
cop IRX3 16q12.2 0.176 0.178 0.723 multicellular organismal development
met OTOP3 17q25.1 0.176 0.178 0.723
xsq LOC439994 0.176 0.178 0.723
exp TRIOBP 22q13.1 -0.176 0.178 0.723 actin modification;barbed-end
actin filament capping
exp AK4P3 12p11.21 -0.176 0.178 0.723
xsq SLC35F6 2p23.3 -0.176 0.178 0.723
xsq NLGN1-AS1 -0.176 0.178 0.723
exp PBX1 1q23 -0.176 0.178 0.723 organ morphogenesis;negative regulation
xsq PITPNM3 -0.176 0.178 0.723
mut RELT 11q13.4 -0.176 0.178 0.723
exp CHMP5 9p13.3 -0.176 0.178 0.723 lysosome organization;endosome to
lysosome transport
xsq ADAMTS7 15q24.2 -0.176 0.178 0.723 proteolysis
xsq COL1A1 17q21.33 -0.176 0.178 0.723 blood vessel
cop LAMC1 1q31 -0.176 0.178 0.723 axon guidance;endoderm development
exp WDR45P 4q31.3 -0.176 0.178 0.723
cop RNF2 1q25.3 -0.176 0.178 0.722 negative regulation of
transcription from RNA polymerase II promoter;mitotic cell cycle
met CSRP2 12q21.1 -0.176 0.178 0.722 multicellular organismal
exp TERF1 8q21.11 -0.176 0.178 0.722 DNA Damage Response (DDR)
xsq PADI1 1p36.13 -0.176 0.178 0.722 protein modification
xsq ANKRD30B 18p11.21 -0.176 0.178 0.722
cop NECAB1 8q21.3 -0.176 0.178 0.722
met KXD1 19p13.11 -0.176 0.178 0.722
xsq KIAA0513 16q24.1 -0.176 0.178 0.722
exp MACROD2 20p12.1 -0.176 0.178 0.722 purine nucleoside metabolic
process
mut CLIP2 7q11.23 -0.176 0.178 0.722
exp TMLHE Xq28 -0.176 0.178 0.722 cellular nitrogen compound metabolic
xsq RNF39 6p21.3 -0.176 0.178 0.722
cop GLIS3-AS1 9p24.2 -0.176 0.178 0.722
xsq LRP1B 2q21.2 -0.176 0.178 0.722 receptor-mediated
exp SEPT7P7 9q22.33 -0.176 0.178 0.722
his DMPK 19q13.3 -0.178 0.178 0.723 regulation of excitatory
his SLC35E4 22q12.2 -0.178 0.178 0.723 Solute Carriers
xai ECHDC3 10p14 -0.178 0.178 0.723
xai FOSL1 11q13 -0.178 0.178 0.723 Apoptosis
his AMT 3p21.2-p21.1 -0.178 0.178 0.723 glycine catabolic process
xai HR 8p21.2 -0.178 0.178 0.723 regulation of transcription, DNA-
activity
hs4 RIN2 20p11.22 -0.178 0.178 0.723 endocytosis;signal transduction
xai PSG4 19q13.2 -0.178 0.178 0.723 defense response;female pregnancy
xai FSCN3 7q31.3 -0.178 0.178 0.723
xai DYNLT3 Xp21 -0.178 0.178 0.723 transport;cell cycle
xai MYO15A 17p11.2 -0.178 0.178 0.722 sensory perception of
sound;locomotory behavior
his TRERNA1 -0.178 0.178 0.722
swa NIPSNAP1 22q12.2 -0.178 0.178 0.722
his KDM4B 19p13.3 -0.178 0.178 0.722 regulation of transcription, DNA-
hs4 ARMCX4 Xq22.1 -0.178 0.178 0.722
his FAM129A 1q25 -0.178 0.178 0.722 positive regulation of protein
hs4 ZC2HC1A 8q21.12 -0.178 0.178 0.722
hs4 MAATS1 3q12-q13.3 -0.178 0.178 0.722
hs4 IFITM1 11p15.5 -0.178 0.178 0.722 response to virus;cytokine-
hs4 IFITM3 11p15.5 -0.178 0.178 0.722 innate immune response;type I
hs4 TTC12 11q23.2 -0.178 0.178 0.722
hs4 NRP1 10p12 -0.178 0.178 0.722 cell adhesion;response to wounding
exp LOC100129175 -0.178 0.178 0.722
hs4 CABYR 18q11.2 -0.178 0.178 0.722 signal transduction;sperm
capacitation
hs4 DDX60 4q32.3 -0.178 0.178 0.722 response to virus
swa DHRS7 14q23.1 -0.178 0.178 0.722
xai LOC100130419 -0.178 0.178 0.722
xai DIRAS2 9q22.2 -0.178 0.178 0.722 signal transduction;small
xai COL8A2 1p34.2 -0.179 0.178 0.722 angiogenesis;cell-cell
adhesion
exp LY6G6F 0.178 0.179 0.723
his TMEM61 1p32.3 0.178 0.179 0.723
xai COX10 17p12 0.178 0.179 0.723 heme a biosynthetic process;respiratory chain
complex IV assembly
his SIRPG 20p13 0.178 0.179 0.723 positive regulation of cell
his LOC101927592 0.178 0.179 0.723
xai TLR1 4p14 0.178 0.179 0.723 signal transduction;pathogen-associated
molecular pattern dependent induction by symbiont of host innate immune response
xai TPTE2 13q12.11 0.178 0.179 0.723 transmembrane transport;ion transport
his RHOA 3p21.3 0.177 0.179 0.723 cell cycle;actin cytoskeleton
organization
his TCTA 3p21 0.177 0.179 0.723
cop C2CD4B 15q22.2 0.177 0.179 0.723
exp KIAA0391 14q13.2 0.177 0.179 0.723 tRNA processing
his LMBR1 7q36 0.177 0.179 0.723 embryonic digit morphogenesis
his H2AFY2 10q22.1 0.177 0.179 0.723 nucleosome assembly;dosage
compensation
hs4 WDR72 15q21.3 0.177 0.179 0.723
xai LY6G6F 0.177 0.179 0.723
xai HMGN3 6q14.1 0.177 0.179 0.723 regulation of insulin secretion involved
xai RHBDD3 22q12.2 0.177 0.179 0.723
his CCDC73 11p13 0.177 0.179 0.723
xai ZNF41 Xp11.23 0.177 0.179 0.723 regulation of transcription, DNA-
dependent"
his CLEC4GP1 19p13.2 0.177 0.179 0.723
his MTFR1L 1p36.11 0.177 0.179 0.723
his LOC646471 1p36.11 0.177 0.179 0.723
his ZNF202 11q24 0.177 0.179 0.723 transcription from RNA polymerase II
promoter;lipid metabolic process
his MANSC1 12p13.2 0.177 0.179 0.723
his LOH12CR2 12p13.2 0.177 0.179 0.723
his BORCS5 0.177 0.179 0.723
his LOC646214 0.177 0.179 0.723
hs4 DRAXIN 1p36.22 0.177 0.179 0.723
his ZXDB Xp11.21 0.177 0.179 0.723 regulation of transcription, DNA-
dependent"
xai NDUFAF1 15q11.2-q21.3 0.177 0.179 0.724 mitochondrial electron
xai KBTBD13 15q22.31 0.177 0.179 0.724
xai HNRNPA3P13 4q21.22 0.177 0.179 0.724
his OARD1 6p21.1 0.177 0.179 0.724
his NFYA 6p21.3 0.177 0.179 0.724 regulation of transcription, DNA-
xai KCNN4 19q13.2 0.177 0.179 0.724 phospholipid translocation;ion transport
his LINC00299 0.177 0.179 0.724
hs4 TRAF1 9q33-q34 0.177 0.179 0.724 Apoptosis
hs4 LOC100287042 17q25.1 0.177 0.179 0.724
hs4 MIF4GD 17q25.1 0.177 0.179 0.724 RNA metabolic process;regulation of
translation
xai C15orf53 15q14 0.177 0.179 0.724
xai UBE2DNL Xq21.1 0.177 0.179 0.724
xai ZMYND12 1p34.2 0.177 0.179 0.724
exp ZNF324B 19q13.43 0.177 0.179 0.724 regulation of transcription, DNA-
dependent"
xai MNX1 7q36 0.177 0.179 0.724 regulation of transcription from RNA polymerase
II promoter;central nervous system neuron differentiation
swa ERGIC2 12p11.22 0.177 0.179 0.724 vesicle-mediated transport
hs4 COL6A5 3q22.1 0.177 0.179 0.724 cell adhesion
his LIG4 13q33-q34 0.177 0.179 0.724 DNA Damage Response (DDR); DDR (NHEJ)
his ABHD13 13q33.3 0.177 0.179 0.724
xai CCDC70 13q14.3 0.177 0.179 0.724
xai BRCC3 Xq28 0.177 0.179 0.724 DNA Damage Response (DDR)
exp CCDC70 13q14.3 0.177 0.179 0.724
his PLCB2 15q15 0.177 0.179 0.724 phospholipid metabolic process;activation of
xai GSPT2 Xp11.22 0.177 0.179 0.724 translational termination;cell cycle
his GNPDA1 5q21 0.177 0.179 0.724 carbohydrate metabolic
process;glucosamine catabolic process
exp POTEG 0.177 0.179 0.724
xai MARCH9 12q14.1 0.177 0.179 0.724
hs4 CYP4F22 19p13.12 0.177 0.179 0.724
hs4 LOC101927267 0.177 0.179 0.724
hs4 TROAP 12q13.12 0.177 0.179 0.724 cell adhesion
his ENGASE 17q25.3 0.177 0.179 0.724 metabolic process
xai PRDM1 6q21 0.177 0.179 0.724 Tumor Suppressors
his SSSCA1-AS1 0.177 0.179 0.724
his SSSCA1 11q13.1 0.177 0.179 0.724 cell division;cell cycle
his FAM89B 11q13 0.177 0.179 0.724
his EHBP1L1 11q13.1 0.177 0.179 0.724
his XRCC5 2q35 0.177 0.179 0.724 DNA Damage Response (DDR); DDR (NHEJ)
met WNT9B 17q21 0.176 0.179 0.723 endoderm development;regulation of tube size
cop PXDN 2p25 0.176 0.179 0.723 hydrogen peroxide catabolic process;oxidation-
reduction process
met TRIQK 8q22.1 0.176 0.179 0.723
mut SCAI 9q33.3 0.176 0.179 0.723 regulation of transcription, DNA-
exp LOC440514 19p13.11 0.176 0.179 0.723
cop MIR5190 0.176 0.179 0.723
exp CHCHD2 7p11.2 0.176 0.179 0.723
exp FASTKD5 0.176 0.179 0.723 cellular respiration
xsq ACP1 2p25 0.176 0.179 0.723
mir hsa-miR-93* 0.176 0.179 0.723
xsq CSNK2A3 11p15.3 0.176 0.179 0.723 Protein Kinases
cop MIR187 0.176 0.179 0.723
cop C18orf21 18q12.2 0.176 0.179 0.723
xsq ELFN1 7p22.3 0.176 0.179 0.723 negative regulation of phosphatase
activity
xsq CSTL1 20p11.21 0.176 0.179 0.723
xsq GDAP1L1 20q12 0.176 0.179 0.723
cop SMAD6 15q22.31 0.176 0.179 0.723 negative regulation of SMAD protein
xsq SCN3A 2q24 0.176 0.179 0.723 ion transport;sodium ion transport
xsq RFC2 7q11.23 0.176 0.179 0.723 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xsq COLEC11 2p25.3 0.176 0.179 0.723 multicellular organismal
development;developmental process
met MIR1185-1 0.176 0.179 0.723
met OLFM3 1p22 0.176 0.179 0.724
met PHF1 6p21.3 0.176 0.179 0.724 regulation of transcription, DNA-
xsq ALG5 13q13.3 0.176 0.179 0.724 cellular protein metabolic
met CTAGE5 14q13.3 0.176 0.179 0.724 positive regulation of catalytic
activity
xsq BRICD5 16p13.3 0.176 0.179 0.724
xsq ACPP 3q22.1 0.176 0.179 0.724
met DUOX2 15q15.3 0.176 0.179 0.724 cytokine-mediated signaling pathway;inner
ear development
exp TAC1 7q21-q22 0.176 0.179 0.724 insemination;sensory perception of pain
xsq MDH1 2p13.3 0.176 0.179 0.724 carbohydrate metabolic process;glucose
metabolic process
exp COX5B 2q11.2 0.176 0.179 0.724 respiratory gaseous exchange;respiratory
met LOXL1 15q22 0.176 0.179 0.724 protein deamination;oxidation-reduction process
exp FNBP1 9q34 0.176 0.179 0.724 endocytosis;nervous system development
met EDN3 20q13.2-q13.3 0.176 0.179 0.724 multicellular organismal
development;neuron differentiation
xsq GPR171 3q25.1 0.176 0.179 0.724 G-protein coupled receptor
signaling pathway
exp GRWD1 19q13.33 0.176 0.179 0.724
exp LAMTOR4 7q22.1 0.176 0.179 0.724
exp LOC100128775 1p31.1 0.176 0.179 0.724
xsq CYP4A11 1p33 0.176 0.179 0.724
cop DHCR7 11q13.4 0.176 0.179 0.724 cholesterol biosynthetic process;post-
xsq STAT5A 17q11.2 0.176 0.179 0.724 Apoptosis
dependent"
exp STX2 12q24.33 0.176 0.179 0.724 cytokinetic cell separation;epithelial
met MAL2 8q23 0.176 0.179 0.724
cop FAM101A 12q24.31 0.176 0.179 0.724
cop LINC-ROR 0.176 0.179 0.724
met ECHS1 10q26.2-q26.3 0.176 0.179 0.724 fatty acid metabolic process;fatty
acid beta-oxidation
xsq ZCWPW1 7q22.1 0.176 0.179 0.724
met FGD5 3p25.1 0.176 0.179 0.724 actin cytoskeleton
cop FLJ26245 0.176 0.179 0.724
cop RNA5SP411 0.176 0.179 0.724
xsq DESI2 1q44 0.176 0.179 0.724
xsq WDR33 2q14.3 0.176 0.179 0.724 postreplication repair;mRNA processing
exp POM121C 7q11.2 0.176 0.179 0.724 protein transport;mRNA transport
met RARRES2 7q36.1 0.176 0.179 0.724 retinoid metabolic process;in utero
xsq NLRP9 19q13.42 0.176 0.179 0.724
exp RPP38 10p13 0.176 0.179 0.724 tRNA processing
xsq IPPK 9q22.31 0.176 0.179 0.724 inositol phosphorylation
xsq RWDD2B 21q22.11 0.176 0.179 0.724
xsq CDRT15P1 0.176 0.179 0.724
met CHRD 3q27 0.176 0.179 0.724 gastrulation with mouth forming
second;forebrain development
xsq ACSL1 4q35.1 -0.176 0.179 0.724 fatty acid metabolic
exp TTC28 22q12.1 -0.176 0.179 0.724
xsq KLF3 4p14 -0.176 0.179 0.724 regulation of transcription, DNA-
xsq TSHZ2 20q13.2 -0.176 0.179 0.724 multicellular organismal
development
exp NTN4 12q22 -0.176 0.179 0.724 axon guidance;neuron remodeling
cop TM4SF19-TCTEX1D2 -0.176 0.179 0.724
cop TM4SF19 3q29 -0.176 0.179 0.724
exp LOC100288911 2p22.3 -0.176 0.179 0.724
xsq TRPV4 12q24.1 -0.176 0.179 0.724 ion transport;cell death
exp APOE 19q13.2 -0.176 0.179 0.724 response to reactive oxygen
met ANP32A-IT1 15q23 -0.176 0.179 0.724
xsq CLPSL2 6p21.31 -0.176 0.179 0.724 digestion;lipid catabolic
process
exp C4orf26 4q21.1 -0.176 0.179 0.724
cop LAMC2 1q25-q31 -0.176 0.179 0.724 cell adhesion;epidermis development
exp CIDECP 3p25.3 -0.176 0.179 0.723
xsq SNORA31 13q14.13 -0.176 0.179 0.723
exp SMPDL3A 6q22.31 -0.176 0.179 0.723 sphingomyelin catabolic
exp PTAFR 1p35-p34.3 -0.176 0.179 0.723 pattern recognition receptor
mut NOD1 7p15-p14 -0.176 0.179 0.723 apoptotic process;detection of
biotic stimulus
exp BEND7 10p13 -0.176 0.179 0.723
exp SORBS1 10q23.33 -0.176 0.179 0.723 cellular response to insulin
exp SNED1 2q37.3 -0.176 0.179 0.723 cell-matrix adhesion
met LOC285548 -0.176 0.179 0.723
cop LOC100130301 8q21.11 -0.176 0.179 0.723
exp HOGA1 10q24.2 -0.176 0.179 0.723 glyoxylate catabolic process
xai EGLN3 14q13.1 -0.177 0.179 0.724 Apoptosis
xai ROS1 6q22 -0.177 0.179 0.724 spermatogenesis;cell proliferation
hs4 FAM66E 8p23.1 -0.177 0.179 0.724
his PRKCG 19q13.4 -0.177 0.179 0.724 DNA Damage Response (DDR)
hs4 DUSP10 1q41 -0.177 0.179 0.724 JNK cascade;response to organic
substance
hs4 CEP126 -0.177 0.179 0.724
hs4 ANGPTL5 11q22.1 -0.177 0.179 0.724 signal transduction
his MIR125B1 -0.177 0.179 0.724
his TBC1D16 17q25.3 -0.177 0.179 0.724
his CCDC40 17q25.3 -0.177 0.179 0.724 axonemal dynein complex
xai NCLP1 -0.177 0.179 0.724
dependent"
his GLIS2 16p13.3 -0.177 0.179 0.724 positive regulation of
his LYPD6 2q23.2 -0.177 0.179 0.724
his IGFL2 19q13.32 -0.177 0.179 0.724
exp APBA1 9q13-q21.1 -0.177 0.179 0.724 intracellular protein
transport;gamma-aminobutyric acid secretion
his RPL23AP87 -0.177 0.179 0.724
xai HEXIM1 17q21.31 -0.177 0.179 0.724 negative regulation of
xai PCDHA1 -0.177 0.179 0.724 cell adhesion;homophilic cell
adhesion
swa SEC23A 14q21.1 -0.177 0.179 0.724 protein N-linked
hs4 SGK1 6q23 -0.177 0.179 0.724 Apoptosis
swa ARPC1B 7q22.1 -0.177 0.179 0.724 regulation of actin filament
polymerization;cellular component movement
exp OR4F14P 15q26.3 -0.177 0.179 0.723
his NCKAP5 2q21.2 -0.177 0.179 0.723
his MIR548AP -0.177 0.179 0.723
his MITF 3p14.2-p14.1 -0.177 0.179 0.723 multicellular organismal
xai PDZK1 1q21 -0.177 0.179 0.723 transport;cell proliferation
xai KCNIP4 4p15.32 -0.177 0.179 0.723 ion transport;potassium ion
transport
exp DLL1 6q27 -0.177 0.179 0.723 compartment pattern
hs4 LOC105371907 -0.177 0.179 0.723
xai PPP1R1A 12q13.2 -0.177 0.179 0.723 carbohydrate metabolic
xai PPP1R3D 20q13.3 -0.177 0.179 0.723 regulation of glycogen
DNA-dependent"
his SH3RF1 4q32.3 -0.177 0.179 0.723 induction of
his LOC729609 Xp22.12 -0.177 0.179 0.723
hs4 PAK4 19q13.2 -0.178 0.179 0.723 Protein Kinases
xai PRPF40B 12q13.12 -0.178 0.179 0.723 mRNA processing;RNA splicing
xai POPDC3 6q21 -0.178 0.179 0.723
xai DMBT1 10q26.13 -0.178 0.179 0.723 blastocyst development;epithelial
hs4 IL22RA1 1p36.11 -0.178 0.179 0.723
xai LOC100287015 8p23.1 0.177 0.18 0.724
his MAGED4B Xp11 0.177 0.18 0.724
xai TRRAP 7q21.2-q22.1 0.177 0.18 0.724 Apoptosis; Oncogenes
xai IGHVII-65-1 0.177 0.18 0.724
his RNF26 11q23 0.177 0.18 0.724
xai ANTXR2 4q21.21 0.177 0.18 0.724
hs4 USP8 15q21.2 0.177 0.18 0.724 protein K63-linked
his ZDBF2 2q33.3 0.177 0.18 0.724
exp IGHVII-65-1 0.177 0.18 0.724
xai LRRC8B 1p22.2 0.177 0.18 0.724
hs4 SLC7A6OS 16q22.1 0.177 0.18 0.724 Solute Carriers
hs4 PRMT7 16q22.1 0.177 0.18 0.724 spliceosomal snRNP assembly;histone
hs4 U2AF1 21q22.3 0.177 0.18 0.724 Oncogenes
his PPIF 10q22-q23 0.177 0.18 0.724 protein folding;apoptotic mitochondrial
changes
his RPL37A 2q35 0.177 0.18 0.724 gene expression;viral reproduction
xai IREB2 15q25.1 0.177 0.18 0.724 protoporphyrinogen IX biosynthetic
xai LRRC3 21q22.3 0.177 0.18 0.724
his EPN1 19q13.42 0.177 0.18 0.724 endocytosis;epidermal growth factor
his ZBTB33 Xq23 0.177 0.18 0.724 regulation of transcription, DNA-
his ANXA2R 5p12 0.177 0.18 0.724
his LOC153684 5p12 0.177 0.18 0.724
his PMCHL1 5p14.3 0.177 0.18 0.724
hs4 SNHG3 0.177 0.18 0.724
hs4 RCC1 1p36.1 0.177 0.18 0.724 cell cycle;mitotic spindle organization
hs4 SNORA73A 0.177 0.18 0.724
hs4 SNORA73B 0.177 0.18 0.724
his PPP1R10 6p21.3 0.177 0.18 0.724 transcription, DNA-
his MRPS18B 6p21.3 0.177 0.18 0.724 translation
swa LSM2 6p21.3 0.177 0.18 0.724 nuclear mRNA splicing, via
hs4 PIK3AP1 10q24.1 0.177 0.18 0.725
his MIRLET7G 0.177 0.18 0.725
his WDR82 3p21.2 0.177 0.18 0.725 histone H3-K4 methylation
his GLYCTK 3p21.1 0.177 0.18 0.725 protein phosphorylation
his GLYCTK-AS1 0.177 0.18 0.725
xai GEMIN7 19q13.32 0.177 0.18 0.725 RNA splicing;gene expression
his LOC644656 0.177 0.18 0.725
his ZNF143 11p15.4 0.177 0.18 0.725 gene expression;regulation of
swa RPL19 17q12 0.177 0.18 0.725 SRP-dependent cotranslational protein targeting
to membrane;gene expression
xai CCDC137 17q25.3 0.177 0.18 0.725
xai BSND 1p32.1 0.177 0.18 0.725 chloride transport
hs4 ESCO1 18q11.2 0.177 0.18 0.725 regulation of DNA replication;cell cycle
exp MARCH7 2q24.2 0.177 0.18 0.725
exp LOXHD1 18q21.1 0.177 0.18 0.725 sensory perception of sound
hs4 MBD3 19p13.3 0.177 0.18 0.725 negative regulation of transcription from
xai ZRANB2-AS1 1p31.1 0.177 0.18 0.725
his NDUFA4 7p21.3 0.177 0.18 0.725 respiratory electron transport
xsq PRAMEF11 1p36.21 0.176 0.18 0.724
xsq C2CD4B 15q22.2 0.176 0.18 0.724
cop EBF4 20p13 0.176 0.18 0.724 regulation of transcription, DNA-
met ITGB6 2q24.2 0.176 0.18 0.724
mut DNAH5 5p15.2 0.176 0.18 0.724 ciliary or flagellar
xsq ACSS1 20p11.23-p11.21 0.176 0.18 0.724 xenobiotic metabolic
process;acetate biosynthetic process
met BAG2 6p12.1-p11.2 0.176 0.18 0.724 Apoptosis
xsq BOLA3 2p13.1 0.176 0.18 0.724
xsq TCF15 20p13 0.176 0.18 0.724 regulation of transcription from RNA polymerase
cop COX7A2L 2p21 0.175 0.18 0.724 respiratory electron transport
met RIT1 1q22 0.175 0.18 0.724 nerve growth factor receptor signaling
xsq EIF1 17q21.2 0.175 0.18 0.724 translation;translational initiation
xsq NDUFC1 4q31.1 0.175 0.18 0.724 mitochondrial electron transport,
exp LINC00623 1q21.1 0.175 0.18 0.724
xsq B3GALT6 1p36.33 0.175 0.18 0.724 protein
xsq BCR 22q11.23 0.175 0.18 0.724 actin cytoskeleton organization;positive
cop REPS1 6q24.1 0.175 0.18 0.724
cop ABRACL 6q24.1 0.175 0.18 0.724
xsq NET1 10p15 0.175 0.18 0.724 small GTPase mediated signal
transduction;cellular response to ionizing radiation
exp AP4E1 15q21.2 0.175 0.18 0.724 intracellular protein transport;vesicle-
mediated transport
xsq CBLN1 16q12.1 0.175 0.18 0.724 synaptic transmission;nervous system
development
cop METAP2 12q22 0.175 0.18 0.724 proteolysis;cellular process
exp FBXO46 19q13.3 0.175 0.18 0.724
xsq CCDC59 12q21.31 0.175 0.18 0.724 regulation of transcription, DNA-
dependent"
exp CCDC90B 11q14.1 0.175 0.18 0.724
exp YTHDF2 1p35 0.175 0.18 0.724 humoral immune response
xsq HIST2H2BC 1q21.2 0.175 0.18 0.724
dependent"
exp CD226 18q22.3 0.175 0.18 0.725 signal transduction;cell recognition
met NRSN2 20p13 0.175 0.18 0.725
xsq LINC00566 0.175 0.18 0.725
exp ZBTB2 6q25.1 0.175 0.18 0.725 regulation of transcription, DNA-
dependent"
exp BTBD1 15q24 0.175 0.18 0.725 regulation of protein binding
met BMPR2 2q33-q34 0.175 0.18 0.725 transmembrane receptor protein
serine/threonine kinase signaling pathway;negative regulation of cell growth
xsq LOC101928708 0.175 0.18 0.725
xsq ELK2AP 0.175 0.18 0.725
cop FBXL14 12p13.33 0.175 0.18 0.725 protein ubiquitination involved in
cop WNT5B 12p13.3 0.175 0.18 0.725 Oncogenes
cop MIR3649 0.175 0.18 0.725
met LRRC8D 1p22.2 0.175 0.18 0.725
xsq NBAS 2p24 0.175 0.18 0.725
exp HEATR6 17q23.1 0.175 0.18 0.725
xsq TEX13A Xq22.3 0.175 0.18 0.725
exp TARS2 1q21.3 0.175 0.18 0.725 threonyl-tRNA aminoacylation;gene
expression
exp SLC35A2 Xp11.23-p11.22 -0.175 0.18 0.725 Solute Carriers
met LOC442293 7p14.2 -0.175 0.18 0.725
exp DNMT3AP1 2p14 -0.175 0.18 0.725
exp TFAP2A 6p24 -0.175 0.18 0.725 optic vesicle
cop RCL1 9p24.1-p23 -0.175 0.18 0.725 RNA processing;ribosome biogenesis
xsq PSD3 8p21.3 -0.175 0.18 0.725 regulation of ARF protein signal
transduction
exp MAEL 1q24.1 -0.175 0.18 0.724 synapsis;piRNA metabolic process
DNA-dependent"
exp FOSL1 11q13 -0.175 0.18 0.724 Apoptosis
xsq LOC101927018 -0.175 0.18 0.724
mut CCIN 9p13.3 -0.175 0.18 0.724 multicellular organismal
exp CDS1 4q21.23 -0.175 0.18 0.724 CDP-choline
pathway;phosphatidylinositol biosynthetic process
xsq LOC101929234 -0.175 0.18 0.724
exp GSAP 7q11.23 -0.175 0.18 0.724
xsq CCDC183-AS1 -0.175 0.18 0.724
mut IL1RL1 2q12 -0.175 0.18 0.724 immune response;positive regulation
of inflammatory response
xsq IFI44 1p31.1 -0.175 0.18 0.724 response to virus
mut NR4A2 2q22-q23 -0.175 0.18 0.724 post-embryonic
development;intracellular receptor mediated signaling pathway
exp SDK1 7p22.2 -0.175 0.18 0.724 cell adhesion
met NLRP10 11p15.4 -0.175 0.18 0.724
exp ENG 9q34.11 -0.175 0.18 0.724 heart looping;cell migration
exp DIRC2 3q21.1 -0.175 0.18 0.724 transport
xsq TMCC3 12q22 -0.176 0.18 0.724
exp TMF1 3p21-p12 -0.176 0.18 0.724 regulation of transcription, DNA-
cop C1orf110 1q23.3 -0.176 0.18 0.724
exp HOXB4 -0.176 0.18 0.724 morphogenesis of an epithelial
exp SAR1AP3 4q27 -0.176 0.18 0.724
exp POPDC3 6q21 -0.176 0.18 0.724
met RPL39L 3q27 -0.176 0.18 0.724 translation;spermatogenesis
xsq CPNE5 6p21.1 -0.176 0.18 0.724
xai MAP1LC3B 16q24.2 -0.177 0.18 0.725 autophagy
hs4 PTH1R 3p22-p21.1 -0.177 0.18 0.725 activation of adenylate cyclase
activity by G-protein signaling pathway;cell maturation
hs4 BICC1 10q21.1 -0.177 0.18 0.725 multicellular organismal
swa CAV1 7q31.1 -0.177 0.18 0.725 vasculogenesis;skeletal muscle
tissue development
hs4 HDAC9 7p21.1 -0.177 0.18 0.725 inflammatory response;negative
xai PPP2R1A 19q13.41 -0.177 0.18 0.725 Apoptosis; Oncogenes
exp ANKDD1B 5q13.3 -0.177 0.18 0.725 signal transduction
xai POU2F3 11q23.3 -0.177 0.18 0.724 epidermis
his ATP1A1 1p21 -0.177 0.18 0.724 ATP biosynthetic process;positive
regulation of heart contraction
hs4 TRIM17 1q42 -0.177 0.18 0.724 protein autoubiquitination
xai KDELC2 11q22.3 -0.177 0.18 0.724
exp OR7E22P 3p13 -0.177 0.18 0.724
xai TPRA1 3q21.2 -0.177 0.18 0.724 lipid metabolic process;G-protein
hs4 TP53TG1 7q21.1 -0.177 0.18 0.724 response to stress;response
to DNA damage stimulus
hs4 CROT 7q21.1 -0.177 0.18 0.724 fatty acid metabolic process;fatty
acid beta-oxidation
hs4 PCSK1 5q15-q21 -0.177 0.18 0.724 energy reserve metabolic
process;peptide hormone processing
his BAIAP2L2 22q13.1 -0.177 0.18 0.724 signal transduction;cellular
his TMEM56 1p21.3 -0.177 0.18 0.724
xai ADAM32 8p11.22 -0.177 0.18 0.724 proteolysis
his ISPD 7p21.2 -0.177 0.18 0.724 isoprenoid biosynthetic process
xai CAB39L 13q14.2 -0.177 0.18 0.724 cell cycle arrest;insulin
his LOC102467655 -0.177 0.18 0.724
exp CDRT15P1 -0.177 0.18 0.724
hs4 SMARCA2 9p22.3 -0.177 0.18 0.724 DNA Damage Response (DDR);
DDR (Chromatin)
exp CLTC-IT1 -0.177 0.18 0.724
swa SYNM 15q26.3 -0.177 0.18 0.724 intermediate filament cytoskeleton
organization
hs4 FKBP9P1 -0.177 0.18 0.724
xai OR7E22P 3p13 -0.177 0.18 0.724
xai GRIK3 1p34.3 -0.177 0.18 0.724 regulation of membrane
potential;negative regulation of synaptic transmission, glutamatergic
his SLC2A2 3q26.1-q26.2 -0.177 0.18 0.724 Solute Carriers
his TAF1B 2p25 0.177 0.181 0.725 transcription, DNA-dependent;regulation of
xai HNRNPA1P53 11p15.4 0.177 0.181 0.725
his APBA2 15q11-q12 0.177 0.181 0.725 nervous system development;protein
transport
xai AS3MT 10q24.32 0.177 0.181 0.725 toxin metabolic process;arsonoacetate
metabolic process
hs4 HSPC324 0.177 0.181 0.725
hs4 EGFL7 9q34.3 0.177 0.181 0.725 angiogenesis;blood vessel development
hs4 MIR153-1 0.177 0.181 0.725
his C20orf24 20q11.23 0.177 0.181 0.725
xai ATE1 10q26.13 0.177 0.181 0.725 protein arginylation
his LOC101928227 0.177 0.181 0.725
hs4 DUOXA1 15q21.1 0.177 0.181 0.725 protein transport
hs4 DUOX1 15q15.3 0.177 0.181 0.725 response to oxidative stress;oxidation-
reduction process
exp OR51A7 11p15.4 0.177 0.181 0.725 response to stimulus
his RPL36AL 14q21 0.177 0.181 0.725 translation
his MGAT2 14q21 0.177 0.181 0.725 protein N-linked glycosylation;oligosaccharide
metabolic process
his MIR2052HG 0.177 0.181 0.726
xai NXF4 Xq22 0.177 0.181 0.726
xai MS4A14 11q12.2 0.177 0.181 0.726
his FBF1 17q25.1 0.177 0.181 0.726 apical junction assembly;establishment of
his FAM234B 0.177 0.181 0.726
his C10orf55 10q22.2 0.177 0.181 0.726
exp LINC00616 0.177 0.181 0.726
hs4 RORA-AS1 0.177 0.181 0.726
hs4 ICE2 0.177 0.181 0.726
xai RNPC3 1p21 0.177 0.181 0.726 mRNA processing;RNA splicing
xai NPM1P46 2q33.1 0.176 0.181 0.726
xai RRM2P3 Xp11.4 0.176 0.181 0.726
xai RPL15 3p24.2 0.176 0.181 0.726 translation;mRNA metabolic process
hs4 ZNF280B 22q11.22 0.176 0.181 0.726 regulation of transcription, DNA-
dependent"
hs4 CTBP1 4p16 0.176 0.181 0.726 protein phosphorylation;negative regulation of
hs4 CTBP1-AS2 4p16.3 0.176 0.181 0.726
his TTC38 22q13 0.176 0.181 0.726
xai LRP8 1p34 0.176 0.181 0.726 cytokine-mediated signaling pathway;hippocampus
development
his MIR4716 0.176 0.181 0.726
his GALK2 15q21.1-q21.2 0.176 0.181 0.726 carbohydrate metabolic
his CRTC2 1q21.3 0.176 0.181 0.726 gluconeogenesis;regulation of
his PET117 0.176 0.181 0.726
his KAT14 0.176 0.181 0.726
xai LINC00238 14q23.3 0.176 0.181 0.726
his CLTC 17q23.1 0.176 0.181 0.726 vesicle-mediated transport;intracellular
protein transport
dependent;negative regulation of transcription from RNA polymerase II promoter"
exp OR1R1P 17p13.3 0.176 0.181 0.726
hs4 SFN 1p36.11 0.176 0.181 0.726 Apoptosis
xai CLCA3P 1p31-p22 0.176 0.181 0.726 transport;ion transport
xai ATP2A1-AS1 0.176 0.181 0.726
xsq PAPSS1 4q24 0.175 0.181 0.725 3'-phosphoadenosine 5'-phosphosulfate
metabolic process;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process
xsq FBXL6 8q24.3 0.175 0.181 0.725 proteolysis;protein ubiquitination
exp CPSF7 11q12.2 0.175 0.181 0.725 protein tetramerization;nuclear mRNA
xsq MCRS1 12q13.12 0.175 0.181 0.725 DNA Damage Response (DDR); DDR
(Chromatin)
xsq LINC01584 0.175 0.181 0.725
mir hsa-miR-484 0.175 0.181 0.725
met SFXN1 5q35.3 0.175 0.181 0.725 transmembrane transport;iron ion
transport
met LRBA 4q31.3 0.175 0.181 0.725
xsq RAP2C Xq25 0.175 0.181 0.725 signal transduction;small GTPase mediated
signal transduction
mut KIAA1919 6q22 0.175 0.181 0.725 transmembrane transport;ion transport
met SHH 7q36 0.175 0.181 0.725 response to hypoxia;lymphoid progenitor cell
differentiation
mut OSBPL3 7p15 0.175 0.181 0.725 transport;lipid transport
mut ZFP2 5q35.3 0.175 0.181 0.725 regulation of transcription, DNA-
dependent"
xsq HCK 20q11-q12 0.175 0.181 0.725 exocytosis;cytokine-mediated signaling
pathway
exp LOC728611 0.175 0.181 0.725
cop LRTM2 12p13.33 0.175 0.181 0.725
xsq COQ4 9q34.11 0.175 0.181 0.726 ubiquinone biosynthetic process
xsq CEACAM6 19q13.2 0.175 0.181 0.726 signal transduction;cell-cell
signaling
mut GDPD3 0.175 0.181 0.726 glycerol metabolic process;lipid metabolic
process
xsq WBP11 12p12.3 0.175 0.181 0.726 rRNA processing;mRNA processing
xsq TMPRSS6 22q12.3 0.175 0.181 0.726 angiogenesis;proteolysis
xsq DMRTC1 0.175 0.181 0.726
xsq TNFSF13B 13q32-q34 0.175 0.181 0.726 positive regulation of cell
proliferation;positive regulation of B cell proliferation
exp RBM23 14q11.2 0.175 0.181 0.726 mRNA processing
met PPP6R2 22q13.33 0.175 0.181 0.726 DNA Damage Response (DDR)
xsq ZKSCAN5 7q22 0.175 0.181 0.726 regulation of transcription, DNA-
xsq PCBP3 21q22.3 0.175 0.181 0.726 mRNA metabolic process
met PCDH7 4p15 0.175 0.181 0.726 cell adhesion;homophilic cell adhesion
xsq PNMAL2 19q13.32 0.175 0.181 0.726
cop MGC15885 15q22.2 0.175 0.181 0.726
cop LOC150622 0.175 0.181 0.726
cop LOC400940 2p25.2 0.175 0.181 0.726
xsq CKMT2-AS1 0.175 0.181 0.726
cop ANKRD19P 9q22.31 0.175 0.181 0.726
dependent"
cop FGD3 0.175 0.181 0.726 regulation of Cdc42 GTPase activity;apoptotic
process
xsq TGFB1 19q13.1 0.175 0.181 0.726 Apoptosis; DDR (DNA replication); Tumor
Suppressors
met AGBL1 15q25.3 0.175 0.181 0.726 proteolysis;C-terminal protein
deglutamylation
met OR3A4P 17p13.3 0.175 0.181 0.726
exp ESD 13q14.1-q14.2 0.175 0.181 0.726 metabolic process
xsq LOC101928989 0.175 0.181 0.726
xsq SENP7 3q12 0.175 0.181 0.726 proteolysis
xsq RBBP6 16p12.2 0.175 0.181 0.726 protein ubiquitination involved in
exp OBFC1 10q24.33 0.175 0.181 0.726 DNA Damage Response (DDR)
pro MGMT_2 0.175 0.181 0.726
dependent"
met ZNF365 10q21.2 0.175 0.181 0.726
cop MEP1B 18q12.2-q12.3 0.175 0.181 0.726 digestion;proteolysis
met SLCO2A1 3q21 0.175 0.181 0.726 Solute Carriers
xsq JTB 1q21 0.175 0.181 0.726 regulation of cell proliferation;negative
cop ANTXR1 2p13.1 0.175 0.181 0.726 actin cytoskeleton
reorganization;substrate adhesion-dependent cell spreading
xsq LINC00634 0.175 0.181 0.726
met KPRP 1q21.3 0.175 0.181 0.726
xsq EPRS 1q41 0.175 0.181 0.726 glutamyl-tRNA aminoacylation;prolyl-tRNA
aminoacylation
met VTI1B 14q24.1 0.175 0.181 0.726 intracellular protein transport;vesicle
cop C1QTNF3 5p13 -0.175 0.181 0.726 negative regulation of
gluconeogenesis
exp TPCN1 12q24.13 -0.175 0.181 0.726 ion transport;transmembrane
transport
exp CCL28 5p12 -0.175 0.181 0.726 chemotaxis;immune response
exp SNAI2 8q11 -0.175 0.181 0.726 multicellular organismal
exp C1orf168 1p32.2 -0.175 0.181 0.726
met NAP1L5 4q22.1 -0.175 0.181 0.726 nucleosome assembly
xsq LOC102723968 -0.175 0.181 0.726
xsq FRS2 12q15 -0.175 0.181 0.726 activation of phospholipase C
xsq PTHLH 12p12.1-p11.2 -0.175 0.181 0.726 cell-cell signaling;positive
regulation of cAMP biosynthetic process
cop TMED4 7p13 -0.175 0.181 0.726 positive regulation of I-kappaB
cop OGDH 7p14-p13 -0.175 0.181 0.726 oxidation-reduction
cop ZMIZ2 7p13 -0.175 0.181 0.726 regulation of transcription, DNA-
cop PPIA 7p13 -0.175 0.181 0.726 provirus integration;initiation of viral
infection
cop H2AFV 7p13 -0.175 0.181 0.726 nucleosome assembly
cop PURB 7p13 -0.175 0.181 0.726 regulation of myeloid cell
cop MIR4657 -0.175 0.181 0.726
cop MYO1G 7p13-p11.2 -0.175 0.181 0.726
cop SNHG15 7p13 -0.175 0.181 0.726
cop SNORA9 -0.175 0.181 0.726
exp HOXD10 2q31.1 -0.175 0.181 0.726 spinal cord motor neuron cell
exp KIF3C 2p23 -0.175 0.181 0.726 microtubule-based movement;blood
coagulation
xsq FBLIM1 1p36.21 -0.175 0.181 0.726 cell adhesion;regulation of
cell shape
xsq LEMD1 1q32.1 -0.175 0.181 0.726
cop DAP 5p15.2 -0.175 0.181 0.726 Apoptosis
cop CCM2 7p13 -0.175 0.181 0.726 multicellular organismal
development;stress-activated MAPK cascade
cop JAK2 9p24 -0.175 0.181 0.726 Oncogenes; Protein Kinases
exp PLA2G4C 19q13.3 -0.175 0.181 0.726 metabolic process;lipid
catabolic process
exp TECTA 11q22-q24 -0.175 0.181 0.726 cell-matrix adhesion;sensory
perception of sound
xsq MOCOS 18q12 -0.175 0.181 0.726 molybdopterin cofactor metabolic
exp POU5F1 6p21.31 -0.175 0.181 0.725 blastocyst
mut PDHA2 4q22-q23 -0.175 0.181 0.725
exp PLD2 17p13.1 -0.175 0.181 0.725 cell communication;response to
hydrogen peroxide
cop NACAD 7p13 -0.175 0.181 0.725 protein transport
cop TBRG4 7p13 -0.175 0.181 0.725 Apoptosis
cop SNORA5A -0.175 0.181 0.725
cop SNORA5C -0.175 0.181 0.725
cop SNORA5B 7p13 -0.175 0.181 0.725
exp RASEF 9q21.32 -0.175 0.181 0.725 small GTPase mediated signal
mut SLC12A5 20q13.12 -0.175 0.181 0.725 ammonium
xsq PLEKHS1 10q25.3 -0.175 0.181 0.725
met GHRH 20q11.2 -0.175 0.181 0.725
cop LAPTM4B 8q22.1 -0.175 0.181 0.725 transport
met MAPKAP1 9q33.3 -0.175 0.181 0.725 response to stress;epidermal
xsq ETNPPL 4q25 -0.175 0.181 0.725
xsq USP53 4q26 -0.175 0.181 0.725 ubiquitin-dependent protein catabolic
process
xsq CTC-436P18.1 -0.175 0.181 0.725
his MIR570 -0.176 0.181 0.726
xai DLL1 6q27 -0.176 0.181 0.726 compartment pattern
xai KRT7 12q13.13 -0.176 0.181 0.726 regulation of
translation;cytoskeleton organization
exp TUBB2BP1 6p25.2 -0.176 0.181 0.726
his SYBU 8q23.2 -0.176 0.181 0.726
his LOC100132813 8q23.2 -0.176 0.181 0.726
his CACNA1C 12p13.3 -0.176 0.181 0.726 transmembrane
xai RACGAP1P 12q12 -0.176 0.181 0.726
hs4 NIPAL2 8q22.2 -0.176 0.181 0.726
his MIR1276 -0.176 0.181 0.726
xai LOC441086 5q13.3 -0.176 0.181 0.726
xai CALCOCO1 12q13.13 -0.176 0.181 0.726 signal transduction;Wnt
hs4 LINC01301 -0.177 0.181 0.726
exp ADAM32 8p11.22 -0.177 0.181 0.726 proteolysis
DNA-dependent"
hs4 MAP9 4q32.1 -0.177 0.181 0.726 cell division;cell cycle
his SLC9A3R2 16p13.3 -0.177 0.181 0.726 Solute Carriers
his MAMDC2 9q21.12 -0.177 0.181 0.726
hs4 SRPX2 Xq21.33-q23 -0.177 0.181 0.726 angiogenesis;cell-cell adhesion
his NXNL2 9q22.1 -0.177 0.181 0.726
exp LOC441086 5q13.3 -0.177 0.181 0.726
exp MYO15A 17p11.2 -0.177 0.181 0.726 sensory perception of
sound;locomotory behavior
hs4 KRT23 17q21.2 -0.177 0.181 0.726
his CETP 16q21 -0.177 0.181 0.726 cholesterol metabolic process;lipoprotein
metabolic process
his TTC12 11q23.2 -0.177 0.181 0.725
hs4 HSPB3 5q11.2 -0.177 0.181 0.725 Apoptosis
xai NAV3 12q14.3 -0.177 0.181 0.725
his TRIO 5p15.2 -0.177 0.181 0.725 transmembrane receptor protein
exp CLNK 4p16.1 -0.177 0.181 0.725 immune response;transmembrane
hs4 CD302 2q24.2 -0.177 0.181 0.725
swa HKDC1 10q22.1 -0.177 0.181 0.725 carbohydrate metabolic
process;glycolysis
exp CAP1P2 10q11.21 -0.177 0.181 0.725
xai SMPDL3A 6q22.31 -0.177 0.181 0.725 sphingomyelin catabolic
xai PLAC9 10q22.3 -0.178 0.181 0.726
xai HMGN2P32 0.176 0.182 0.726
xai C6orf120 6q27 0.176 0.182 0.726
xai EDC3 15q24.1 0.176 0.182 0.726 RNA metabolic process;mRNA metabolic
process
hs4 ATP1A3 19q13.31 0.176 0.182 0.726
xai RBBP4P5 14q11.2 0.176 0.182 0.726
dependent"
xai PTBP1P 14q23.3 0.176 0.182 0.726
hs4 DUT 15q21.1 0.176 0.182 0.726 DNA Damage Response (DDR)
his IL17RC 3p25.3 0.176 0.182 0.726
exp RHEBL1 12q13.12 0.176 0.182 0.726 TOR signaling cascade;positive
exp EIF4E2P1 20p11.23 0.176 0.182 0.726
xai DUX4L9 4q35.2 0.176 0.182 0.726 cell proliferation;regulation of
gene expression
exp OR5BQ1P 0.176 0.182 0.726
his OCRL Xq25 0.176 0.182 0.726 regulation of small GTPase mediated signal
transduction;lipid metabolic process
exp BEND3P3 10q22.3 0.176 0.182 0.726
xai POLDIP3 22q13.2 0.176 0.182 0.726 positive regulation of translation
xai OR5BQ1P 0.176 0.182 0.726
his DLG2 11q14.1 0.176 0.182 0.726 receptor clustering;neuronal ion channel
clustering
his TMEM126B 11q14.1 0.176 0.182 0.726
his NSUN4 1p34 0.176 0.182 0.726
xai ALG1 16p13.3 0.176 0.182 0.726 protein N-linked glycosylation via
his RNVU1-7 0.176 0.182 0.726
his USP51 Xp11.21 0.176 0.182 0.726 proteolysis;ubiquitin-dependent protein
catabolic process
swa EIF2B3 1p34.1 0.176 0.182 0.726 negative regulation of
hs4 HIST2H2BF 1q21.2 0.176 0.182 0.726 nucleosome assembly
hs4 HIST2H3D 0.176 0.182 0.726 blood coagulation;negative regulation of
his C3orf80 3q25.33 0.176 0.182 0.726
xai LOC643870 0.176 0.182 0.726
xai ELAVL3 19p13.2 0.176 0.182 0.726 multicellular organismal
exp TPTE2P5 0.176 0.182 0.726
his ST13 22q13.2 0.176 0.182 0.726 chaperone cofactor-dependent protein
refolding;protein folding
his XPNPEP3 22q13.2 0.176 0.182 0.726 proteolysis;cellular process
hs4 TXLNB 6q24.1 0.176 0.182 0.726
his MT3 16q13 0.176 0.182 0.726 energy reserve metabolic process;positive
regulation of necrotic cell death
hs4 DIO3 14q32 0.176 0.182 0.726 thyroid hormone generation;cellular nitrogen
xai BTBD1 15q24 0.176 0.182 0.726 regulation of protein binding
hs4 RHPN1-AS1 8q24 0.176 0.182 0.726
hs4 RHPN1 8q24.3 0.176 0.182 0.726 signal transduction
his LOC100129917 4p16.3 0.176 0.182 0.726
his TFB1M 6q25.1-q25.3 0.176 0.182 0.726 regulation of transcription, DNA-
dependent"
xai LPAR3 1p22.3 0.176 0.182 0.726 synaptic transmission;bleb assembly
xai RAB3A 19p13.2 0.176 0.182 0.726 neuromuscular synaptic transmission;lung
development
exp PPP3CB 10q22.2 0.175 0.182 0.726 negative regulation of T cell
mediated cytotoxicity;regulation of gene expression
met FAM86DP 3p12.3 0.175 0.182 0.726
xsq GOT1 10q24.1-q25.1 0.175 0.182 0.726 carbohydrate metabolic
exp ATP5G3 2q31.1 0.175 0.182 0.726 aging;ATP synthesis coupled proton
transport
met TAS1R1 1p36.23 0.175 0.182 0.726 response to stimulus;detection of
xsq TRAPPC2L 16q24.3 0.175 0.182 0.726 ER to Golgi vesicle-mediated
xsq NDUFA1 Xq24 0.175 0.182 0.726 mitochondrial electron transport, NADH to
ubiquinone;transport
pro STAT3_20 0.175 0.182 0.726
xsq KLF1 19p13.2 0.175 0.182 0.726 regulation of transcription, DNA-
xsq OR2L13 1q44 0.175 0.182 0.726 response to stimulus
xsq TOP3B 22q11.22 0.175 0.182 0.726 DNA Damage Response (DDR); DDR (FA); DDR
(DNA replication)
cop ANKRD62 18p11.21 0.175 0.182 0.726
mir hsa-miR-769-3p 0.175 0.182 0.726
xsq FBXL15 10q24.32 0.175 0.182 0.726 protein ubiquitination;bone
mineralization
met KIAA2013 1p36.22 0.175 0.182 0.726
xsq ABCA10 17q24 0.175 0.182 0.726 ABC Transporters
xsq HBA2 16p13.3 0.175 0.182 0.726 transport;positive regulation of cell
death
exp LOC100287757 Xq27.3 0.175 0.182 0.726
cop SOX11 2p25 0.175 0.182 0.726 outflow tract morphogenesis;negative regulation
of gene expression
met MIR210 0.175 0.182 0.726
met CDIP1 16p13.3 0.175 0.182 0.726
met HTN1 4q13 0.175 0.182 0.726 defense response to bacterium;defense response
to fungus
mut PRSS53 16p11.2 0.175 0.182 0.726 proteolysis
xsq GTPBP8 3q13.2 0.175 0.182 0.726 barrier septum assembly
xsq ITGAD 16p11.2 0.175 0.182 0.726 integrin-mediated signaling pathway;cell-
cell adhesion
xsq NAPSA 19q13.33 0.175 0.182 0.726 proteolysis;membrane protein proteolysis
mut TOP3A 17p12-p11.2 0.175 0.182 0.726 DNA Damage Response (DDR); DDR (FA)
exp STAR 8p11.2 0.175 0.182 0.726 lipid transport;steroid metabolic process
met JAKMIP1 4p16.1 0.175 0.182 0.726 protein transport
xsq TEC 4p12 0.175 0.182 0.726 protein phosphorylation;integrin-mediated
signaling pathway
cop SGPL1 10q21 0.175 0.182 0.726 Apoptosis
xsq LHFPL1 Xq23 0.175 0.182 0.726
met GALNT8 12p13.3 0.175 0.182 0.726 cellular protein metabolic
cop FCHSD2 11q13.4 0.175 0.182 0.726
cop ADAMTS18 16q23 0.175 0.182 0.726 proteolysis
xsq PRTN3 19p13.3 0.175 0.182 0.726 proteolysis;positive regulation of cell
proliferation
exp HMGN2P41 16p11.1 0.175 0.182 0.726
cop DNAAF1 16q24.1 0.175 0.182 0.726 cilium morphogenesis;axonemal
dynein complex assembly
cop HGC6.3 6q27 0.175 0.182 0.726
xsq SETDB2 13q14 0.175 0.182 0.726 heart looping;histone H3-K9 methylation
xsq FABP2 4q28-q31 0.175 0.182 0.726 intestinal absorption;fatty acid
metabolic process
met CLEC2L 7q34 0.175 0.182 0.726
exp TSR1 17p13.3 0.175 0.182 0.726 ribosome assembly
met CCDC178 18q12.1 0.175 0.182 0.726
cop LOC145783 15q21.3 0.175 0.182 0.726
xsq ATRAID 2p23.3 0.175 0.182 0.726
xsq NUP153 6p22.3 0.175 0.182 0.726 carbohydrate metabolic
exp FCAR 19q13.42 0.175 0.182 0.726 immune response
exp TCF7 5q31.1 0.175 0.182 0.726 brain development;Wnt receptor signaling
pathway
met MEIOB 16p13.3 0.175 0.182 0.726
xsq CCDC137 17q25.3 0.175 0.182 0.726
xsq GCN1 0.175 0.182 0.726 translation;regulation of translation
exp CDC5L 6p21 0.175 0.182 0.726 DNA Damage Response (DDR)
met DYRK4 12p13.32 0.175 0.182 0.726 protein phosphorylation
met FBXO31 16q24.2 0.175 0.182 0.726 response to DNA damage
stimulus;cell cycle
exp PCSK4 19p13.3 0.175 0.182 0.726 fertilization;sperm capacitation
xsq RGAG4 Xq13.1 0.175 0.182 0.726
xsq WDR34 9q34.11 0.175 0.182 0.726
xsq TRMT5 14q23.1 0.174 0.182 0.726 tRNA processing
xsq TBC1D5 3p24.3 0.174 0.182 0.726
xsq CHERP 19p13.1 0.174 0.182 0.726 nervous system development;negative
cop ORC6 16q12 0.174 0.182 0.726 DDR (DNA replication)
mut TRIP11 14q31-q32 0.174 0.182 0.726 protein targeting to
Golgi;transcription from RNA polymerase II promoter
exp HCCAT4 0.174 0.182 0.726
xsq CENPW 6q22.32 0.174 0.182 0.726 chromosome segregation;centromeric core
chromatin assembly
exp PGM2 4p14 0.174 0.182 0.726 glycogen catabolic process;glucose metabolic
process
xsq PAX5 9p13 0.174 0.182 0.726 Tumor Suppressors
mut FYTTD1 3q29 0.174 0.182 0.726 mRNA export from nucleus;transport
met KCNJ5 11q24 0.174 0.182 0.726 Oncogenes
xsq LOC101927691 0.174 0.182 0.726
exp LOC100049716 12p13.33 0.174 0.182 0.726
cop SDHAP1 3q29 -0.174 0.182 0.726
cop TFRC 3q29 -0.174 0.182 0.726 response to hypoxia;response to inorganic
substance
cop ZDHHC19 3q29 -0.174 0.182 0.726
cop SLC51A 3q29 -0.174 0.182 0.726
cop PCYT1A 3q29 -0.174 0.182 0.726 CDP-choline pathway;phospholipid
cop TCTEX1D2 3q29 -0.174 0.182 0.726
met MIR935 -0.174 0.182 0.726
exp CLSTN2 3q23 -0.174 0.182 0.726 cell adhesion;homophilic cell
adhesion
exp NFE2L2 2q31 -0.174 0.182 0.726 positive regulation of
transcription from RNA polymerase II promoter;regulation of embryonic development
cop RPL7 8q21.11 -0.174 0.182 0.726 nuclear-transcribed mRNA catabolic
cop RDH10 8q21.11 -0.174 0.182 0.726 neural crest cell
development;primary lung bud formation
cop STAU2-AS1 8q21.11 -0.174 0.182 0.726
met C1orf123 1p32.3 -0.174 0.182 0.726
exp KIF12 9q32 -0.174 0.182 0.726 microtubule-based movement
cop C1QTNF3-AMACR -0.175 0.182 0.726
exp NCOA2 8q13.3 -0.175 0.182 0.726 regulation of transcription, DNA-
met DDX3X Xp11.3-p11.23 -0.175 0.182 0.726 interspecies interaction
between organisms
xsq SEMA3E 7q21.11 -0.175 0.182 0.726 multicellular organismal
cop LOC100507391 -0.175 0.182 0.726
met VHL 3p25.3 -0.175 0.182 0.726 Protein Kinases; Tumor Suppressors
exp RRM2B 8q23.1 -0.175 0.182 0.726 DNA Damage Response (DDR)
xsq SLC2A1-AS1 -0.175 0.182 0.726
exp YIPF6 Xq12 -0.175 0.182 0.726
xsq MTRNR2L9 -0.175 0.182 0.726
exp ABCA1 9q31.1 -0.175 0.182 0.726 ABC Transporters
xsq LOC101927811 -0.175 0.182 0.726
xsq STMND1 6p22.3 -0.175 0.182 0.726
met TCF7 5q31.1 -0.175 0.182 0.726 brain development;Wnt receptor
signaling pathway
cop SPDYE1 7p13 -0.175 0.182 0.726
cop RASA4CP -0.175 0.182 0.726
cop SPSB4 3q23 -0.175 0.182 0.726 intracellular signal transduction
exp TMEM117 12q12 -0.175 0.182 0.726
exp KIAA0355 19q13.11 -0.175 0.182 0.726
exp PACSIN3 11p12-p11.12 -0.175 0.182 0.726 negative regulation of
exp UGT2B28 4q13.2 -0.175 0.182 0.726 xenobiotic metabolic
exp VTI1BP2 4q35.1 -0.175 0.182 0.726
met EIF4E3 3p14 -0.175 0.182 0.726 regulation of translation;cytokine-
exp CATSPER1 11q12.1 -0.175 0.182 0.726 spermatogenesis;fusion of
exp TMEM30A 6q14.1 -0.175 0.182 0.726 protein localization to
cop FLJ31662 -0.175 0.182 0.726
xsq CTSH 15q25.1 -0.175 0.182 0.726 positive regulation of cell
mir hsa-miR-100 -0.175 0.182 0.726
met NLRP12 19q13.42 -0.175 0.182 0.726 negative regulation of
protein autophosphorylation;positive regulation of inflammatory response
met SOX2 3q26.3-q27 -0.175 0.182 0.726 eye development;glial cell fate
commitment
exp SPAG17 1p12 -0.175 0.182 0.726
exp LOC441768 16q11.2 -0.175 0.182 0.726
cop URGCP 7p13 -0.175 0.182 0.726 cell cycle
met S100Z 5q13.3 -0.175 0.182 0.726
his CXXC5 5q31.2 -0.176 0.182 0.726 signal transduction;positive
xai RLN2 9p24.1 -0.176 0.182 0.726 female pregnancy
his PRICKLE1 12q12 -0.176 0.182 0.726 negative regulation of
signaling pathway
his DIAPH2-AS1 -0.176 0.182 0.726
hs4 SELENBP1 1q21.3 -0.176 0.182 0.726 protein transport
swa CYR61 1p22.3 -0.176 0.182 0.726 positive regulation of protein
his BAIAP2L1 7q22.1 -0.176 0.182 0.726 response to
swa ASPH 8q12.1 -0.176 0.182 0.726 peptidyl-amino acid
DNA-dependent"
hs4 LOC101928323 -0.176 0.182 0.726
hs4 ZBTB47 3p22.1 -0.176 0.182 0.726 regulation of transcription,
DNA-dependent"
hs4 C2orf54 2q37.3 -0.176 0.182 0.726
xai KIF12 9q32 -0.176 0.182 0.726 microtubule-based movement
xai AVIL 12q14.1 -0.176 0.182 0.726 nervous system development;positive
exp RNU5F-1 1p34.1 -0.176 0.182 0.726
xai SEMA6A 5q23.1 -0.176 0.182 0.726 cell surface receptor
xai LOC284344 -0.176 0.182 0.726
exp SH2D7 15q25.1 -0.176 0.182 0.726
his LSMEM1 7q31.1 -0.176 0.182 0.726
his GSTTP1 -0.176 0.182 0.726
his MPP2 17q12-q21 -0.176 0.182 0.726 signal transduction
xai PRSS8 16p11.2 -0.176 0.182 0.726 EMT (Epithelial)
his MIR4789 -0.176 0.182 0.726
his EMP2 16p13.2 -0.176 0.182 0.726 cell proliferation
his JAKMIP2-AS1 -0.176 0.182 0.726
xai SCGB1D2 11q13 -0.176 0.182 0.726
his MIR6742 -0.176 0.182 0.726
hs4 LINC01285 -0.176 0.182 0.726
hs4 PTPRK 6q22.2-q22.3 -0.176 0.182 0.726 cell migration;focal adhesion
assembly
xai CCDC186 -0.176 0.182 0.726
xai CMBL 5p15.2 -0.176 0.182 0.726
xai AKR1B1P6 18p11.22 -0.176 0.182 0.726
hs4 LINC01179 -0.176 0.182 0.726
hs4 PRSS35 6q14.2 -0.176 0.182 0.726
xai C16orf96 16p13.3 -0.176 0.182 0.726
his CSH2 17q24.2 -0.176 0.182 0.726
his ETS1 11q23.3 -0.176 0.182 0.726 EMT (Mesenchymal); Transcription
Factors
his MIR6090 -0.176 0.182 0.726
his LOC101929517 -0.176 0.182 0.726
his ELFN2 22q13.1 -0.176 0.182 0.726 negative regulation of phosphatase
activity
his TMEM114 16p13.2 -0.176 0.182 0.726
swa AHSA1 14q24 0.176 0.183 0.726 positive regulation of ATPase activity;protein
folding
hs4 LOC100240735 12q13.13 0.176 0.183 0.726
his MIR548T 0.176 0.183 0.726
his GP2 16p12 0.176 0.183 0.726
xai SMAD2 18q21.1 0.176 0.183 0.727 Apoptosis; Cell Signaling
xai TBX6 16p11.2 0.176 0.183 0.727 mesoderm development;anatomical structure
morphogenesis
his MFSD13A 0.176 0.183 0.727
hs4 IZUMO4 19p13.3 0.176 0.183 0.727
hs4 MOB3A 19p13.3 0.176 0.183 0.727
xai LOC285423 4q31.23 0.176 0.183 0.727
xai PLCG2 16q24.1 0.176 0.183 0.727 blood coagulation;response to magnesium
ion
hs4 LOC101928491 0.176 0.183 0.727
swa HNRNPD 4q21 0.176 0.183 0.727 RNA processing;RNA catabolic process
his WASF3 13q12 0.176 0.183 0.727 protein complex assembly;cytoskeleton
organization
exp GNG5P2 Xq23 0.176 0.183 0.727
xai C11orf73 11q14.2 0.176 0.183 0.727 Golgi organization;multicellular
hs4 RNU1-1 1p36.1 0.176 0.183 0.727
hs4 PVRIG 7q22.1 0.176 0.183 0.727
dependent"
xai SEC23B 20p11.23 0.176 0.183 0.727 intracellular protein transport;ER
his LAMC3 9q31-q34 0.176 0.183 0.727 cell adhesion;visual perception
xai GNG5P2 Xq23 0.176 0.183 0.727
xai PLAC8 4q21.22 0.176 0.183 0.727
his WASIR1 0.176 0.183 0.727
xai TMEM201 1p36.22 0.176 0.183 0.728
hs4 PHYKPL 5q35.3 0.176 0.183 0.728
exp RRM2P3 Xp11.4 0.176 0.183 0.728
his SNRK-AS1 0.176 0.183 0.728
his DEPDC4 12q23.1 0.176 0.183 0.728 intracellular signal transduction
his SCYL2 12q23.1 0.176 0.183 0.728 endosome to lysosome transport;negative
exp DUX4L9 4q35.2 0.176 0.183 0.728 cell proliferation;regulation of
gene expression
hs4 IL3RA 0.176 0.183 0.728 cellular response to interleukin-3
xai METTL2A 17q23.2 0.176 0.183 0.728
cop CCDC60 12q24.23 0.174 0.183 0.726
exp RPS2P9 1q32.1 0.174 0.183 0.726
xsq RNF220 1p34.1 0.174 0.183 0.726 protein ubiquitination;protein
autoubiquitination
xsq ST8SIA3 18q21.31 0.174 0.183 0.726 oligosaccharide metabolic
exp NDUFAF1 15q11.2-q21.3 0.174 0.183 0.726 mitochondrial electron
xsq AMER1 Xq11.2 0.174 0.183 0.726
exp WHSC1 4p16.3 0.174 0.183 0.726 regulation of transcription, DNA-
xsq RPTN 1q21.3 0.174 0.183 0.726
xsq SHCBP1 16q11.2 0.174 0.183 0.727
xsq ACSBG2 19p13.3 0.174 0.183 0.727 cell differentiation;lipid
metabolic process
cop IMPA2 18p11.2 0.174 0.183 0.727 signal transduction;phosphatidylinositol
phosphorylation
cop KCNG3 2p21 0.174 0.183 0.727 transmembrane transport;ion transport
xsq SFTPB 2p12-p11.2 0.174 0.183 0.727 lipid metabolic process;response to
exp CCDC117 22q12.1 0.174 0.183 0.727
met LSM14B 20q13.33 0.174 0.183 0.727 multicellular organismal
development;regulation of translation
exp PGDP1 18q12.1 0.174 0.183 0.727
xsq VSTM2A-OT1 0.174 0.183 0.727
met PCDHA5 5q31 0.174 0.183 0.727 cell adhesion;homophilic cell adhesion
xsq ITLN2 1q22-q23 0.174 0.183 0.727 signal transduction
met IL18 11q22.2-q22.3 0.174 0.183 0.727 osteoblast
differentiation;regulation of cell adhesion
exp HNRNPLL 2p22.1 0.174 0.183 0.727
xsq HIST1H2AJ 6p22.1 0.174 0.183 0.727
xsq FAM92A1P2 4q35.1 0.174 0.183 0.727
cop UGP2 2p14-p13 0.174 0.183 0.727 phosphorylation;glucose 1-phosphate
metabolic process
cop VPS54 2p13-p14 0.174 0.183 0.727 homeostasis of number of cells within a
tissue;musculoskeletal movement
xsq NAPRT 0.174 0.183 0.727 nicotinamide metabolic process;response to
oxidative stress
exp SOX12 20p13 0.174 0.183 0.727 spinal cord development;cell fate commitment
xsq KLHDC2 14q21.3 0.174 0.183 0.727
exp CEL 9q34.3 0.174 0.183 0.727 fatty acid catabolic process;ceramide
catabolic process
exp C11orf21 11p15.5 0.174 0.183 0.727
exp SRRM2 16p13.3 0.174 0.183 0.727 nuclear mRNA splicing, via
xsq HPCAL4 1p34.2 0.174 0.183 0.727 central nervous system development
exp GPR116P2 0.174 0.183 0.727
met PGD 1p36.22 0.174 0.183 0.728 pentose biosynthetic process;small
exp DKKL1P1 0.174 0.183 0.728
cop NSFL1C 20p13 0.174 0.183 0.728
xsq ING1 13q34 0.174 0.183 0.728 positive regulation of transcription, DNA-
xsq LINC00412 0.174 0.183 0.728
xsq ZBTB16 11q23.1 0.174 0.183 0.728 mesonephros development;positive
cop TMEM18 2p25.3 0.174 0.183 0.728 transcription, DNA-dependent;cell
migration"
xsq ATP13A1 19p13.11 0.174 0.183 0.728 cation transport
xsq SIX6 14q23.1 0.174 0.183 0.728 multicellular organismal
exp GTPBP8 3q13.2 0.174 0.183 0.728 barrier septum assembly
xsq RASA2 3q22-q23 0.174 0.183 0.728 positive regulation of Ras GTPase
xsq RAP1GDS1 4q23-q25 0.174 0.183 0.728 positive regulation of GTPase
activity
mut ADAMTS16 5p15 0.174 0.183 0.728 proteolysis
cop SH2B3 12q24 0.174 0.183 0.728 cell differentiation;embryonic hemopoiesis
mut OR2T11 1q44 -0.174 0.183 0.728 response to stimulus
met LINC00339 1p36.12 -0.174 0.183 0.728
xsq C20orf141 -0.174 0.183 0.728
xsq NALCN-AS1 -0.174 0.183 0.728
xsq ZFHX4 8q21.11 -0.174 0.183 0.728
xsq RSAD2 2p25.2 -0.174 0.183 0.728 regulation of ossification;defense
response to virus
cop TRIM32 9q33.1 -0.174 0.183 0.728 response to tumor necrosis
cop GHSR 3q26.31 -0.174 0.183 0.728
exp CTSV 9q22.2 -0.174 0.183 0.728
mut CASC5 15q14 -0.174 0.183 0.728 acrosome assembly;nucleosome assembly
cop UBE2D4 7p13 -0.174 0.183 0.728 protein K29-linked
DNA-dependent"
xsq LOXL3 2p13 -0.174 0.183 0.727 oxidation-reduction process
xsq EPHA2 1p36 -0.174 0.183 0.727 Protein Kinases
exp DNAH5 5p15.2 -0.174 0.183 0.727 ciliary or flagellar
met KRT40 17q21.2 -0.174 0.183 0.727
exp AKT3 1q44 -0.174 0.183 0.727 Protein Kinases
mut MKL2 16p13.12 -0.174 0.183 0.727 cell differentiation;positive
regulation of striated muscle tissue development
xsq PLEKHA2 8p11.22 -0.174 0.183 0.727 positive regulation of cell-
matrix adhesion
exp YAE1D1 7p14.1 -0.174 0.183 0.727
exp LOC649873 17p12 -0.174 0.183 0.727
xsq QPCT 2p22.2 -0.174 0.183 0.727 protein modification
process;proteolysis
cop POLR2J4 7p13 -0.174 0.183 0.727
xsq BOK 2q37.3 -0.174 0.183 0.726 male gonad
exp KRT8P37 10p14 -0.174 0.183 0.726
DNA-dependent"
his MIR3605 -0.176 0.183 0.728
his PHC2 1p34.3 -0.176 0.183 0.728 multicellular organismal
his LOC101929464 -0.176 0.183 0.728
DNA-dependent"
his LINC01094 -0.176 0.183 0.728
hs4 FMO4 1q24.3 -0.176 0.183 0.728 xenobiotic metabolic process
his RNF39 6p21.3 -0.176 0.183 0.728
exp LOC100130419 -0.176 0.183 0.728
xai ARHGAP42 11q22.1 -0.176 0.183 0.727 signal
transduction;filopodium assembly
hs4 MAP7 6q23.3 -0.176 0.183 0.727 microtubule cytoskeleton
xai FLJ44124 -0.176 0.183 0.727
his HRH1 3p25 -0.176 0.183 0.727 synaptic transmission;response to gravity
his CLSTN2 3q23 -0.176 0.183 0.727 cell adhesion;homophilic cell
adhesion
xai SDK1 7p22.2 -0.176 0.183 0.727 cell adhesion
exp FLJ44124 -0.176 0.183 0.727
xai FGFRL1 4p16 -0.176 0.183 0.727 negative regulation of cell
xai OR10S1 11q24.1 -0.176 0.183 0.727 response to stimulus
his DAB2 5p13.1 -0.176 0.183 0.727 negative regulation of cell
hs4 PCDHGA4 -0.176 0.183 0.727 homophilic cell adhesion;cell
adhesion
hs4 C7orf25 7p14.1 -0.176 0.183 0.727
his LINC01101 -0.176 0.183 0.727
xai BVES-AS1 -0.176 0.183 0.727
his CPAMD8 19p13.11 -0.176 0.183 0.727
swa TGFBI 5q31 -0.176 0.183 0.727 visual perception;cell proliferation
hs4 ZNF703 8p11.23 -0.176 0.183 0.727 positive regulation of cell
migration;positive regulation of mammary gland epithelial cell proliferation
his LOC100133669 8q24.3 -0.176 0.183 0.727
his LY6E 8q24.3 -0.176 0.183 0.727 cell surface receptor signaling
his PLAT 8p12 -0.176 0.183 0.727 protein modification process;proteolysis
his TAB3 Xp21.2 -0.176 0.183 0.726 MyD88-independent toll-like
DNA-dependent"
hs4 ZNF649-AS1 -0.176 0.183 0.726
swa CCNK 14q32 -0.176 0.183 0.726 cell division;regulation of cyclin-
hs4 PERP 6q24 -0.176 0.183 0.726 Apoptosis
his UGT1A9 -0.176 0.183 0.726 metabolic process;flavonoid
glucuronidation
exp RACGAP1P 12q12 -0.176 0.183 0.726
xai DIRC2 3q21.1 -0.176 0.183 0.726 transport
xai RNU5F-1 1p34.1 -0.176 0.183 0.726
hs4 GPT2 16q12.1 -0.176 0.183 0.726 small molecule metabolic process;2-
xai LOC729887 16q23.3 0.177 0.184 0.729
xai PTPRA 20p13 0.176 0.184 0.728 protein phosphorylation;axon guidance
hs4 SET 9q34 0.176 0.184 0.728 nucleosome disassembly;nucleocytoplasmic
transport
his RAB27A 15q15-q21.1 0.176 0.184 0.728 melanosome localization;GTP
catabolic process
his LOC105372480 0.176 0.184 0.728
his ANKDD1A 15q22.31 0.176 0.184 0.728 signal transduction
his LARS 5q32 0.176 0.184 0.728 gene expression;tRNA aminoacylation for protein
translation
xai CYCSP10 0.176 0.184 0.728
xai S100A12 1q21 0.175 0.184 0.728 killing of cells of other
his LRRC14B 0.175 0.184 0.728
exp CERKL 2q31.3 0.175 0.184 0.728 anti-apoptosis;activation of protein
his FCGBP 19q13.1 0.175 0.184 0.728
exp LOC100996266 0.175 0.184 0.728
exp BZW1P1 3q26.31 0.175 0.184 0.728
cop FGF19 11q13.1 0.175 0.184 0.728 positive regulation of glucose
import;positive regulation of JNK cascade
xai MEF2D 1q12-q23 0.175 0.184 0.728 multicellular organismal
his OR51E2 11p15 0.175 0.184 0.728 detection of chemical stimulus involved
xai CHTF18 16p13.3 0.175 0.184 0.728 DDR (DNA replication)
xai NFYC-AS1 0.175 0.184 0.728
xai NDUFB9 8q13.3 0.175 0.184 0.728 mitochondrial electron transport,
xai PAPOLA 14q32.31 0.175 0.184 0.728 RNA splicing;gene expression
xai CD226 18q22.3 0.175 0.184 0.728 signal transduction;cell recognition
xai C8orf33 8q24.3 0.175 0.184 0.728
his LOC100652758 0.175 0.184 0.728
his G3BP1 5q33.1 0.175 0.184 0.728 transport;Ras protein signal transduction
hs4 TMEM101 17q21.31 0.175 0.184 0.728 signal transduction;positive
xai ACTL6A 3q26.33 0.175 0.184 0.728 DNA Damage Response (DDR); DDR
(Chromatin)
xai LOC728392 0.175 0.184 0.728
his C5orf30 5q21.1 0.175 0.184 0.728 protein transport;cell projection
organization
xai USP36 17q25.3 0.175 0.184 0.728 proteolysis;ubiquitin-dependent protein
catabolic process
xai PHYKPL 5q35.3 0.175 0.184 0.728
swa ATXN10 22q13.31 0.175 0.184 0.728 nervous system development;cell
death
his COL10A1 6q21-q22 0.175 0.184 0.728 skeletal system development
hs4 ODC1 2p25 0.175 0.184 0.728 small molecule metabolic process;kidney
development
hs4 SNORA80B 0.175 0.184 0.728
hs4 LOC101929715 0.175 0.184 0.728
dependent"
his LOC100130987 11q13.2 0.175 0.184 0.729
his CFAP20 0.175 0.184 0.729 multicellular organismal development
his UNC13A 19p13.11 0.175 0.184 0.729 exocytosis;intracellular signal
transduction
xai RPL7P23 5q13.3 0.175 0.184 0.729
exp PTBP1P 14q23.3 0.175 0.184 0.729
hs4 TMOD2 15q21.2 0.175 0.184 0.729 learning or memory;positive regulation of
xai FCRL1 1q21-q22 0.175 0.184 0.729
xsq AURKC 19q13.43 0.174 0.184 0.728 Protein Kinases
xsq RPS19 19q13.2 0.174 0.184 0.728 translation;viral reproduction
met DNAH1 3p21.1 0.174 0.184 0.728 ciliary or flagellar
xsq CACNG3 16p12.1 0.174 0.184 0.728
mut APOB 2p24-p23 0.174 0.184 0.728 lipid metabolic process;cholesterol
metabolic process
cop SOCS5 2p21 0.174 0.184 0.728 cytokine-mediated signaling pathway;positive
regulation of proteasomal ubiquitin-dependent protein catabolic process
exp AFG3L1P 16q24.3 0.174 0.184 0.728
met SLC18B1 6q22.3-q23.3 0.174 0.184 0.728 transmembrane transport
cop KIF25 6q27 0.174 0.184 0.728 mitotic sister chromatid segregation;organelle
organization
mut GATA3 10p15 0.174 0.184 0.728 Tumor Suppressors
xsq LOC100128317 7q21.11 0.174 0.184 0.728
xsq CDH10 5p14.2 0.174 0.184 0.728 adherens junction organization;cell-cell
cop CRADD 12q21.33-q23.1 0.174 0.184 0.728 Apoptosis
exp ANKRD16 10p15.1 0.174 0.184 0.728
xsq GIN1 5q21.1 0.174 0.184 0.728 DNA integration
exp ANTXR2 4q21.21 0.174 0.184 0.728
exp GINS1 20p11.21 0.174 0.184 0.728 DDR (DNA replication)
met VPS53 17p13.3 0.174 0.184 0.728 protein transport
mut TAAR1 0.174 0.184 0.728
met GPR137 11cen-q22.3 0.174 0.184 0.728
xsq APOC4-APOC2 0.174 0.184 0.728
cop PDE2A 11q13.4 0.174 0.184 0.728 metabolic process;negative regulation of
vascular permeability
cop MIR139 0.174 0.184 0.728
cop ARAP1 11q13.4 0.174 0.184 0.728 actin filament reorganization involved in
met PABPC3 13q12-q13 0.174 0.184 0.728 mRNA metabolic process
xsq GCLC 6p12 0.174 0.184 0.728 response to heat;small molecule metabolic
process
cop AKAP7 6q23 0.174 0.184 0.728 ion transport;protein localization
xsq IQCH 15q23 0.174 0.184 0.728
mut SEC24C 10q22.2 0.174 0.184 0.728 post-translational protein
xsq NDUFS5 1p34.2-p33 0.174 0.184 0.728 mitochondrial electron transport,
xsq SYNRG 17q12 0.174 0.184 0.728 intracellular protein transport;endocytosis
mda MutSig11_Alkylating_agent 0.174 0.184 0.728
exp NAA20 20p11.23 0.174 0.184 0.728
exp ORC5 7q22.1 0.174 0.184 0.728 DDR (DNA replication)
xsq PLEKHJ1 19p13.3 0.174 0.184 0.728
exp CCDC12 3p21.31 0.174 0.184 0.728
met FAM124A 13q14.3 0.174 0.184 0.729
cop PELI1 2p13.3 0.174 0.184 0.729 MyD88-dependent toll-like receptor
cop PIGN 18q21.33 0.174 0.184 0.729 C-terminal protein lipidation;preassembly
xsq EIF3K 19q13.2 0.174 0.184 0.729 translation;translational initiation
cop SFTPB 2p12-p11.2 0.174 0.184 0.729 lipid metabolic process;response to
cop GNLY 2p11.2 0.174 0.184 0.729 cellular defense response;killing of
cells of other organism
cop ATOH8 2p11.2 0.174 0.184 0.729 regulation of transcription, DNA-
met CYP11B2 8q21-q22 0.174 0.184 0.729 xenobiotic metabolic process;sodium
ion homeostasis
xsq CRYGS 3q27.3 0.174 0.184 0.729 morphogenesis of an epithelium;lens
met PNKP 19q13.3-q13.4 0.174 0.184 0.729 DNA Damage Response (DDR); DDR
(BER)
xsq MAFG-AS1 17q25.3 0.174 0.184 0.729
met ZMAT4 8p11.21 0.174 0.184 0.729
cop CES4A 16q22.1 0.174 0.184 0.729
xsq CHD1 5q15-q21 0.174 0.184 0.729 chromatin remodeling;regulation of
exp RNU6ATAC2P 5q11.2 -0.174 0.184 0.729
xsq NAALADL1 11q12 -0.174 0.184 0.729 proteolysis
met OPN5 6p12.3 -0.174 0.184 0.729 protein-chromophore
exp TM9SF2 13q32.3 -0.174 0.184 0.729 transport
exp ANO2 12p13.3 -0.174 0.184 0.729 ion transport;chloride transport
met EPB42 15q15-q21 -0.174 0.184 0.729 regulation of cell shape;peptide
cross-linking
cop TMEM261 -0.174 0.184 0.728
exp SMUG1 12q13.13 -0.174 0.184 0.728 DNA Damage Response (DDR); DDR
(BER)
exp WNT5B 12p13.3 -0.174 0.184 0.728 Oncogenes
xsq PEAK1 15q24.3 -0.174 0.184 0.728
exp GJB2 13q11-q12 -0.174 0.184 0.728 transport;cell-cell signaling
xsq LDOC1L 22q13.31 -0.174 0.184 0.728
mut GNPAT 1q42 -0.174 0.184 0.728 phospholipid biosynthetic process;small
xsq UTY Yq11 -0.174 0.184 0.728 chromatin modification
exp AGXT2 5p13 -0.174 0.184 0.728 glyoxylate metabolic process;nucleobase-
mut NCOA5 20q12-q13.12 -0.174 0.184 0.728 regulation of transcription,
DNA-dependent"
exp CCDC190 -0.174 0.184 0.728
xsq CCDC148-AS1 -0.174 0.184 0.728
xsq ATP6V1B1 2p13.1 -0.174 0.184 0.728 ossification;transferrin
transport
cop LHX9 1q31.1 -0.174 0.184 0.728 male gonad development;female gonad
development
met GBP2 1p22.2 -0.174 0.184 0.728 immune response;cytokine-mediated
signaling pathway
xsq PLXNB1 3p21.31 -0.174 0.184 0.728 negative regulation of
met FAM110D 1p36.11 -0.174 0.184 0.728
cop MTDH 8q22.1 -0.174 0.184 0.728 lipopolysaccharide-mediated
signaling pathway;negative regulation of apoptotic process
exp UPP1 7p12.3 -0.174 0.184 0.728 nucleotide catabolic
exp RPS6KC1 1q41 -0.174 0.184 0.728 Protein Kinases
cop TNFSF10 3q26 -0.174 0.184 0.728 Apoptosis
his LINC02139 -0.175 0.184 0.729
dependent"
hs4 APOBEC3F 22q13.1 -0.175 0.184 0.729 negative regulation of
host
his DDO 6q21 -0.175 0.184 0.729 grooming behavior;hormone metabolic
process
his CDHR4 3p21.31 -0.175 0.184 0.729 cell adhesion;homophilic cell
adhesion
swa UBR4 1p36.13 -0.175 0.184 0.729 Tumor Suppressors
xai EPHB2 1p36.1-p35 -0.175 0.184 0.729 Protein Kinases
his LINC01270 -0.175 0.184 0.729
xai C1S 12p13 -0.175 0.184 0.729 proteolysis;complement activation
hs4 CEBPB-AS1 -0.175 0.184 0.729
hs4 CEBPB 20q13.1 -0.175 0.184 0.729 embryonic placenta
his SPOCK1 5q31.2 -0.175 0.184 0.729 cell adhesion;signal
transduction
xai ZNF655 7q22.1 -0.175 0.184 0.728 G1 phase;regulation of
xai C2orf54 2q37.3 -0.175 0.184 0.728
xai PLCZ1 12p12.3 -0.175 0.184 0.728 metabolic process;lipid catabolic
process
xai PARP14 3q21.1 -0.175 0.184 0.728 regulation of transcription,
DNA-dependent"
exp MMP26 11p15 -0.175 0.184 0.728 collagen catabolic process;proteolysis
xai ANKRD34B 5q14.1 -0.175 0.184 0.728
hs4 LINC00517 -0.175 0.184 0.728
xai DSTYK 1q32.1 -0.175 0.184 0.728
hs4 MIR4634 -0.175 0.184 0.728
hs4 ZNF287 17p11.2 -0.175 0.184 0.728 positive regulation of
xai PPARGC1A 4p15.1 -0.175 0.184 0.728 mRNA processing;respiratory
hs4 MAGI3 1p12-p11.2 -0.175 0.184 0.728 intracellular signal
exp NME5 5q31 -0.175 0.184 0.728 GTP biosynthetic process;UTP biosynthetic
process
xai MAPK7 17p11.2 -0.175 0.184 0.728 Protein Kinases
xai OR5M3 11q12.1 -0.175 0.184 0.728 response to stimulus
hs4 SEMA6A 5q23.1 -0.175 0.184 0.728 cell surface receptor
his SOX6 11p15.3 -0.175 0.184 0.728 oligodendrocyte cell fate
specification;erythrocyte development
exp OR5M3 11q12.1 -0.175 0.184 0.728 response to stimulus
his PTPRG 3p21-p14 -0.176 0.184 0.728 transmembrane receptor protein
tyrosine kinase signaling pathway;peptidyl-tyrosine dephosphorylation
swa TMED9 5q35.3 -0.176 0.184 0.728 Golgi organization;positive
xai GALP 19q13.43 -0.176 0.184 0.728 neuropeptide signaling
pathway;response to hormone stimulus
hs4 CDC42EP5 19q13.42 -0.176 0.184 0.728 positive regulation of actin
filament polymerization;positive regulation of pseudopodium assembly
xai B4GALNT3 12p13.33 -0.176 0.184 0.728
hs4 PTAFR 1p35-p34.3 -0.176 0.184 0.728 pattern recognition receptor
xai ANXA4 2p13 -0.176 0.184 0.728 Apoptosis
hs4 PTPN20 -0.176 0.184 0.728
his FABP6 5q33.3-q34 -0.176 0.184 0.728 small molecule metabolic
his FANCB Xp22.2 0.175 0.185 0.729 DNA Damage Response (DDR); DDR (FA)
his MOSPD2 Xp22.2 0.175 0.185 0.729
hs4 BOLA2B 0.175 0.185 0.729
hs4 SLX1A 0.175 0.185 0.729 DNA Damage Response (DDR); DDR (HR)
hs4 SLX1A-SULT1A3 0.175 0.185 0.729
his TMEM55B 14q11.2 0.175 0.185 0.729
xai PEBP1 12q24.23 0.175 0.185 0.729 regulation of neurotransmitter
xai SPINT3 0.175 0.185 0.729
his GMCL1 2p13.3 0.175 0.185 0.729 regulation of transcription, DNA-
xai MMP20 11q22.3 0.175 0.185 0.729 Apoptosis
xai ZMYM4 1p32-p34 0.175 0.185 0.729 cytoskeleton organization;multicellular
exp SIGLEC22P 19q13.41 0.175 0.185 0.729
xai PTGS2 1q25.2-q25.3 0.175 0.185 0.729 prostaglandin metabolic
his PCP4 21q22.2 0.175 0.185 0.729 central nervous system development
hs4 CHD4 12p13 0.175 0.185 0.729 DNA Damage Response (DDR)
hs4 MIR3939 0.175 0.185 0.729
hs4 FGFR1OP 6q27 0.175 0.185 0.729 positive regulation of cell
hs4 NFE2 12q13 0.175 0.185 0.729 multicellular organismal development;blood
coagulation
xai BCO2 11q23.1 0.175 0.185 0.729 carotene metabolic process;retinoic acid
metabolic process
his CCDC58 3q21.1 0.175 0.185 0.729
his FAM162A 3q21.1 0.175 0.185 0.729
his NR4A1 12q13 0.175 0.185 0.729 gene expression;intracellular receptor mediated
signaling pathway
xai CD79B 17q23 0.175 0.185 0.729 immune response;signal transduction
xai BIK 22q13.31 0.175 0.185 0.729 Apoptosis
hs4 CAMK2G 10q22 0.175 0.185 0.729 cytokine-mediated signaling
hs4 AUNIP 1p36.11 0.175 0.185 0.729
xai LOC100288869 20q11.23 0.175 0.185 0.729
hs4 SUZ12P1 17q11.2 0.175 0.185 0.729
exp LOC100288869 20q11.23 0.175 0.185 0.729
his SMCO1 0.175 0.185 0.729
dependent"
xai CD1B 1q23.1 0.175 0.185 0.729 immune response;antigen processing and
presentation
xai SFI1 22q12.2 0.175 0.185 0.729 G2/M transition of mitotic cell
exp RPS2P1 20q11.2 0.175 0.185 0.729
xai PQBP1 Xp11.23 0.175 0.185 0.729 regulation of transcription, DNA-
dependent"
hs4 SAMD1 19p13.12 0.175 0.185 0.729
his DET1 15q25.3 0.175 0.185 0.73
xai MRPS15 1p34.3 0.175 0.185 0.73 translation
hs4 POC1A 3p21.2 0.175 0.185 0.73
his PRR14L 22q12.2 0.175 0.185 0.73
his DEPDC5 22q12.3 0.175 0.185 0.73 intracellular signal transduction
exp MRPS31P5 0.175 0.185 0.73
met MAT1A 10q22 0.175 0.185 0.73 xenobiotic metabolic process;methylation
his MFSD14A 0.175 0.185 0.73 transmembrane transport
hs4 DHODH 16q22 0.175 0.185 0.73 nucleobase-containing small molecule metabolic
process;pyrimidine base metabolic process
his CHD5 1p36.31 0.175 0.185 0.73 regulation of transcription, DNA-
xsq C1QTNF3 5p13 0.174 0.185 0.729 negative regulation of gluconeogenesis
met FDCSP 4q13 0.174 0.185 0.729
xsq PPA1 10q11.1-q24 0.174 0.185 0.729 tRNA aminoacylation for protein
mut STIM1 11p15.5 0.174 0.185 0.729 detection of calcium ion;cation transport
met KIRREL3 11q24 0.174 0.185 0.729 hemopoiesis
xsq FBXO22 15q24.2 0.174 0.185 0.729 protein modification
xsq NEFH 22q12.2 0.174 0.185 0.729 microtubule cytoskeleton
xsq NELFB 9q34 0.174 0.185 0.729
exp FSD1 19p13.3 0.174 0.185 0.729 cell division;cell cycle
met ADNP 20q13.13 0.174 0.185 0.729 response to inorganic substance;nitric
oxide homeostasis
exp TRNAE39P 0.174 0.185 0.729
exp GPR68 14q31 0.174 0.185 0.729 inflammatory response;G-protein coupled
xsq PRR29-AS1 0.174 0.185 0.729
met INPP5J 22q12.2 0.174 0.185 0.729 phosphatidylinositol
phosphorylation
met PMPCA 9q34.3 0.174 0.185 0.729 proteolysis
exp CCDC189 0.174 0.185 0.729
exp DHPS 19p13.2 0.174 0.185 0.729 protein homotetramerization;translation
dependent"
cop MPPE1 18p11.21 0.173 0.185 0.729 GPI anchor biosynthetic process;ER to
xsq MEX3C 18q21.2 0.173 0.185 0.729
cop LOC339822 0.173 0.185 0.729
xsq MSL1 17q21.1 0.173 0.185 0.729 chromatin modification;histone H4-K16
acetylation
xsq CCDC88A 2p16.1 0.173 0.185 0.729 EMT (Mesenchymal)
xsq OR5B2 0.173 0.185 0.729
cop N4BP1 16q12.1 0.173 0.185 0.729 negative regulation of protein
catabolic process
exp UXT Xp11.23-p11.22 0.173 0.185 0.729 protein folding;mitochondrion
transport along microtubule
xsq C4orf32 4q25 0.173 0.185 0.729
exp ELAVL1 19p13.2 0.173 0.185 0.729 mRNA stabilization;3'-UTR-mediated
mRNA stabilization
exp RPL13AP11 0.173 0.185 0.729
exp SDHD 0.173 0.185 0.729 respiratory electron transport chain;small
met NUAK1 12q23.3 0.173 0.185 0.729 regulation of myosin-light-chain-
phosphatase activity;regulation of cell proliferation
cop MYO1E 15q21-q22 0.173 0.185 0.729 glomerular filtration;nitrogen compound
metabolic process
xsq SLC35G6 17p13.1 0.173 0.185 0.729
xsq ERP29 12q24.13 0.173 0.185 0.729 protein folding;intracellular protein
transport
met MIR762 0.173 0.185 0.729
xsq NRARP 9q34.3 0.173 0.185 0.729 regulation of cell-cell adhesion;negative
regulation of T cell differentiation
xsq PAX9 14q13.3 0.173 0.185 0.729 face morphogenesis;cellular response to
met LOC550643 0.173 0.185 0.729
mut HIVEP2 6q23-q24 0.173 0.185 0.729 regulation of transcription, DNA-
dependent"
mut ADAMTS5 21q21.3 0.173 0.185 0.729 proteolysis
xsq SRR 17p13 0.173 0.185 0.73 L-serine metabolic process;response to morphine
met DND1 5q31.3 0.173 0.185 0.73 multicellular organismal development;germ
cell development
xsq LOC285819 0.173 0.185 0.73
met KCNC1 11p15 0.173 0.185 0.73 potassium ion transport;synaptic transmission
xsq LINC00606 3p25.3 0.173 0.185 0.73
mut PLXDC2 10p12.31 0.173 0.185 0.73
xsq LOC285847 6p21.31 0.173 0.185 0.73
cop MRPL42 12q22 0.173 0.185 0.73 translation
cop SOCS2-AS1 0.173 0.185 0.73
cop SOCS2 12q 0.173 0.185 0.73 Apoptosis
cop SNTG2 2p25.3 0.173 0.185 0.73 central nervous system development
met GOLM1 9q21.33 0.173 0.185 0.73
met VPS54 2p13-p14 0.173 0.185 0.73 homeostasis of number of cells within a
met ADAM12 10q26 0.173 0.185 0.73 myoblast fusion;proteolysis
exp PRH1 0.173 0.185 0.73
exp IREB2 15q25.1 0.173 0.185 0.73 protoporphyrinogen IX biosynthetic
exp CDH12P4 0.173 0.185 0.73
xsq IL16 15q26.3 0.173 0.185 0.73 regulation of transcription, DNA-
exp PHKA1 Xq12-q13 0.173 0.185 0.73 glucose metabolic process;generation of
xsq FLAD1 1q21.3 0.173 0.185 0.73 small molecule metabolic process;FAD
xsq ATF4 22q13.1 0.173 0.185 0.73 activation of signaling protein activity
response
xsq GPR158 10p12.1 -0.173 0.185 0.73
exp CSTB 21q22.3 -0.173 0.185 0.73 adult locomotory behavior;negative
regulation of peptidase activity
xsq CTSZ 20q13.32 -0.173 0.185 0.73 proteolysis;epithelial tube
exp SOX9 17q24.3 -0.173 0.185 0.73 epithelial to mesenchymal
xsq GRIK1-AS2 -0.173 0.185 0.73
xsq NFATC4 14q11.2 -0.173 0.185 0.73 transcription from RNA
polymerase II promoter;inflammatory response
exp ROBO2 3p12.3 -0.173 0.185 0.729 metanephros development;olfactory
xsq HIST1H3C 6p22.1 -0.173 0.185 0.729
xsq EBF1 5q34 -0.173 0.185 0.729 multicellular organismal
development;positive regulation of transcription, DNA-dependent"
xsq SNED1 2q37.3 -0.173 0.185 0.729 cell-matrix adhesion
xsq LINC00639 14q21.1 -0.173 0.185 0.729
xsq ZFY Yp11.3 -0.173 0.185 0.729 regulation of transcription, DNA-
dependent"
met ZNF333 19p13 -0.173 0.185 0.729 regulation of transcription, DNA-
dependent"
xsq SERPINB4 18q21.3 -0.173 0.185 0.729 regulation of
proteolysis;immune response
xsq PKNOX2 11q24.2 -0.173 0.185 0.729 regulation of transcription
met POU5F1B 8q24.21 -0.173 0.185 0.729 regulation of transcription,
DNA-dependent"
exp DCUN1D3 16p12.3 -0.173 0.185 0.729 positive regulation of
apoptotic process;negative regulation of S phase of mitotic cell cycle
exp IPO9 1q32.1 -0.173 0.185 0.729 protein import into
exp PFKFB4 3p22-p21 -0.173 0.185 0.729 Apoptosis
exp CCIN 9p13.3 -0.174 0.185 0.729 multicellular organismal
cop MLF1 3q25.1 -0.174 0.185 0.729 cell cycle arrest;multicellular
cop GFM1 3q25 -0.174 0.185 0.729 GTP catabolic process;mitochondrial
cop LXN 3q25.32 -0.174 0.185 0.729 negative regulation of
endopeptidase activity;detection of temperature stimulus involved in sensory
perception of pain
cop RARRES1 3q25.32 -0.174 0.185 0.729 negative regulation of cell
proliferation
cop MFSD1 3q25.32 -0.174 0.185 0.729 transmembrane transport
mut PLXNB2 22q13.33 -0.174 0.185 0.729 brain development;regulation
of cell shape
exp RACGAP1 12q13.12 -0.174 0.185 0.729 cytokinesis, actomyosin
contractile ring assembly;blood coagulation
met HNF4G 8q21.11 -0.174 0.185 0.729 regulation of transcription from
met C6orf223 6p21.1 -0.174 0.185 0.729
exp IFT22 -0.174 0.185 0.729 small GTPase mediated signal transduction
met TAF15 17q11.1-q11.2 -0.174 0.185 0.729 positive regulation of
exp TRAK1 3p22.1 -0.174 0.185 0.729 protein targeting;endosome to
lysosome transport
xsq HECW1 7p13 -0.174 0.185 0.729 protein modification process;protein
met TMEM204 16p13.3 -0.174 0.185 0.729 lymph vessel
cop DYNLRB1 20q11.21 -0.174 0.185 0.729 transport;microtubule-based
movement
met LDHAL6B 15q22.2 -0.174 0.185 0.729
mut ZSWIM3 20q13.12 -0.174 0.185 0.729
mut SLC35F3 1q42.2 -0.174 0.185 0.729 Solute Carriers
hs4 THBS4 5q13 -0.175 0.185 0.73 neuron projection morphogenesis;positive
regulation of peptidyl-tyrosine phosphorylation
hs4 MTX3 5q14.1 -0.175 0.185 0.73 protein targeting to
xai MIR10A -0.175 0.185 0.73
his LOC102467080 -0.175 0.185 0.729
xai SNED1 2q37.3 -0.175 0.185 0.729 cell-matrix adhesion
exp APOA2 1q23.3 -0.175 0.185 0.729 cholesterol metabolic
xai LOC100506797 -0.175 0.185 0.729
hs4 LOC102723895 -0.175 0.185 0.729
exp LOC284412 -0.175 0.185 0.729
his UBL3 13q12-q13 -0.175 0.185 0.729
his GLI3 7p13 -0.175 0.185 0.729 axon guidance;pallium development
hs4 HOXA4 7p15.2 -0.175 0.185 0.729 anatomical structure
his OLFML3 1p13.2 -0.175 0.185 0.729 multicellular organismal
development
xai C9orf106 9q34.11 -0.175 0.185 0.729
hs4 BHLHE40-AS1 -0.175 0.185 0.729
hs4 BHLHE40 3p26 -0.175 0.185 0.729 circadian regulation of gene
xai LOC100129233 -0.175 0.185 0.729
hs4 AMDHD2 16p13.3 -0.175 0.185 0.729 carbohydrate metabolic
hs4 LOC101929234 -0.175 0.185 0.729
xai NUDT16P1 3q22.1 -0.175 0.185 0.729
xai FLJ45513 17q21.33 -0.175 0.185 0.729
exp TRAJ1 -0.175 0.185 0.729
his C3orf52 3q13.2 -0.175 0.185 0.729
swa ACOX1 17q25.1 -0.175 0.185 0.729 very long-chain fatty acid
exp LOC100129233 -0.175 0.185 0.729
his GCSAM 3q13.2 -0.175 0.185 0.729
exp SCAF1 19q13.3-q13.4 -0.175 0.185 0.729 transcription from RNA
xai LOC151484 -0.175 0.185 0.729
his WFIKKN1 -0.175 0.185 0.729
hs4 ARHGAP6 Xp22.3 -0.175 0.185 0.729 positive regulation of
phospholipase activity;actin filament polymerization
his STRA6 15q24.1 -0.175 0.185 0.729 ventricular septum
development;vocal learning
exp LOC151484 -0.175 0.185 0.729
xai EVI5L 19p13.2 -0.175 0.185 0.729
xai TRAJ1 -0.175 0.185 0.729
xai EDA2R Xq12 -0.175 0.185 0.729 positive regulation of JNK
hs4 SCHIP1 3q25.32-q25.33 -0.175 0.185 0.729
xai SFTA1P 10p14 -0.175 0.185 0.729
hs4 ARHGAP31 3q13.33 -0.175 0.185 0.729 regulation of small GTPase
xai ACTG1P17 0.175 0.186 0.73
xai RPL24P2 20p11.23 0.175 0.186 0.73
xai CYB561A3 11q12.2 0.175 0.186 0.73
hs4 LOC388692 1q21.2 0.175 0.186 0.73
xai GMFBP1 0.175 0.186 0.73
xai AADAC 3q25.1 0.175 0.186 0.73 metabolic process;positive regulation of
triglyceride catabolic process
xai OR12D3 6p22.1 0.175 0.186 0.73 response to stimulus
hs4 NTRK3 15q25 0.175 0.186 0.73 cell differentiation;response to corticosterone
stimulus
hs4 NTRK3-AS1 0.175 0.186 0.73
xai RPL5P5 1q25.3 0.175 0.186 0.73
xai PTER 10p12 0.175 0.186 0.73 catabolic process
his NSUN5P2 7q11.23 0.175 0.186 0.73
exp RNPC3 1p21 0.175 0.186 0.73 mRNA processing;RNA splicing
hs4 CHI3L1 1q32.1 0.175 0.186 0.73 response to tumor necrosis
factor;cellular response to tumor necrosis factor
hs4 KEAP1 19p13.2 0.175 0.186 0.73 in utero embryonic development;regulation
xai MRPS31P5 0.175 0.186 0.73
swa SH2D1A Xq25 0.175 0.186 0.73 humoral immune response;cellular defense
response
xai LOC339862 0.175 0.186 0.73
his LOC100288069 0.175 0.186 0.73
xai RPL7P10 1p31.1 0.175 0.186 0.73
exp GMFBP1 0.175 0.186 0.73
hs4 PCBP1-AS1 0.175 0.186 0.73
hs4 PCBP1 2p13-p12 0.175 0.186 0.73 nuclear mRNA splicing, via
xai CCR3 3p21.3 0.175 0.186 0.73 cellular defense response;cell adhesion
his RAP1GDS1 4q23-q25 0.175 0.186 0.73 positive regulation of GTPase
activity
his FSIP2-AS1 0.175 0.186 0.73
xai EIF4A1P10 0.175 0.186 0.73
exp FLJ43879 2q37.3 0.175 0.186 0.73
hs4 SLC6A8 Xq28 0.175 0.186 0.73 Solute Carriers
dependent"
his LRRN2 1q32.1 0.175 0.186 0.73 signal transduction;cell adhesion
exp TNFSF8 9q33 0.175 0.186 0.73 cell-cell signaling;cell proliferation
his B3GALT4 6p21.3 0.175 0.186 0.73 protein glycosylation
his BSN-AS2 3p21.31 0.175 0.186 0.73
his BSN 3p21.31 0.175 0.186 0.73 synaptic transmission
cop HIST2H2BE 1q21.2 0.175 0.186 0.73 nucleosome assembly;defense
cop HIST2H2AC 1q21.2 0.175 0.186 0.73 nucleosome assembly
cop HIST2H2AB 0.175 0.186 0.73 nucleosome assembly
xai OR51N1P 11p15.4 0.174 0.186 0.73
his FAM234A 0.174 0.186 0.73
xai LOXHD1 18q21.1 0.174 0.186 0.73 sensory perception of sound
xai TCF7 5q31.1 0.174 0.186 0.73 brain development;Wnt receptor signaling
pathway
his LOC730183 0.174 0.186 0.73
his SRCAP 16p11.2 0.174 0.186 0.73 regulation of transcription from RNA
polymerase II promoter;chromatin modification
swa MAGEA10 Xq28 0.174 0.186 0.73
his CFP Xp11.4 0.174 0.186 0.73 complement activation;complement
xai CCDC152 5p12 0.174 0.186 0.73
xai FCAR 19q13.42 0.174 0.186 0.73 immune response
xai HERC2P10 15q13.2 0.174 0.186 0.73
xai PFKFB1 Xp11.21 0.174 0.186 0.73 Apoptosis
xsq PSME4 2p16.2 0.173 0.186 0.73 antigen processing and presentation of
exp BAHD1 15q15.1 0.173 0.186 0.73 chromatin modification;heterochromatin
assembly
xsq SPATA33 16q24.3 0.173 0.186 0.73
xsq AHSA2 2p15 0.173 0.186 0.73 response to stress
dependent"
mut LRP5 11q13.4 0.173 0.186 0.73 positive regulation of cell
met RSPH4A 6q22.1 0.173 0.186 0.73 cilium axoneme assembly;cilium
movement
cop USMG5 10q24.33 0.173 0.186 0.73
exp RPL23AP29 2q23.3 0.173 0.186 0.73
xsq PRH1 0.173 0.186 0.73
cop SERPINB4 18q21.3 0.173 0.186 0.73 regulation of proteolysis;immune
response
mut IREB2 15q25.1 0.173 0.186 0.73 protoporphyrinogen IX biosynthetic
cop CACNA2D4 12p13.33 0.173 0.186 0.73 ion transport
cop PLA2G4F 15q15.1 0.173 0.186 0.73 fatty acid transport;lipid
catabolic process
cop TANC2 17q23.3 0.173 0.186 0.73
exp KCNN4 19q13.2 0.173 0.186 0.73 phospholipid translocation;ion transport
dependent"
exp POGK 1q24.1 0.173 0.186 0.73 regulation of transcription, DNA-
cop C16orf87 16q11.2 0.173 0.186 0.73
xsq RPS27 1q21 0.173 0.186 0.73 translational elongation;viral infectious cycle
xsq VENTX 10q26.3 0.173 0.186 0.73
dependent"
xsq PHF8 Xp11.22 0.173 0.186 0.73 G1/S transition of mitotic cell
xsq METTL9 16p12.2 0.173 0.186 0.73
cop TRMT61B 2p23.2 0.173 0.186 0.73 tRNA methylation;tRNA processing
cop WDR43 2p23.2 0.173 0.186 0.73
cop SNORD92 2p23.2 0.173 0.186 0.73
cop SNORD53 2p23.2 0.173 0.186 0.73
exp LOC100132161 0.173 0.186 0.73
xsq CLINT1 5q33.3 0.173 0.186 0.73 post-Golgi vesicle-mediated
xsq MMD 17q 0.173 0.186 0.73 cytolysis
met MAGEA2 Xq28 0.173 0.186 0.73
exp RPL31P46 11q13.4 0.173 0.186 0.73
cop CCDC96 4p16.1 0.173 0.186 0.73
cop TADA2B 4p16.1 0.173 0.186 0.73 regulation of transcription, DNA-
dependent"
cop GRPEL1 4p16 0.173 0.186 0.73 protein folding;protein import into
cop FLJ36777 0.173 0.186 0.73
exp SPIB 19q13.3-q13.4 0.173 0.186 0.73 Transcription Factors
met C1orf106 1q32.1 0.173 0.186 0.73
xsq NME6 3p21 0.173 0.186 0.73 Apoptosis
exp SNORD72 5p13 0.173 0.186 0.73
exp RRP7A 22q13.2 0.173 0.186 0.73
mut MYBPC1 12q23.2 0.173 0.186 0.73 muscle filament sliding;cell
adhesion
xsq SSTR3 22q13.1 0.173 0.186 0.73 cell-cell signaling;cellular response to
estradiol stimulus
xsq OR2L3 0.173 0.186 0.73 response to stimulus
dependent"
xsq CLUH 17p13.3 0.173 0.186 0.73
xsq FAM156A Xp11.22 0.173 0.186 0.73
met LOC650226 7p11.2 0.173 0.186 0.73
xsq HEMGN 9q22.33 0.173 0.186 0.73 multicellular organismal development;cell
differentiation
met FAM81A 15q22.2 0.173 0.186 0.73
exp STAMBPL1 10q23.31 0.173 0.186 0.73 proteolysis
xsq SNW1 14q24.3 0.173 0.186 0.73 positive regulation of transcription from
RNA polymerase II promoter;retinoic acid receptor signaling pathway
exp MLST8 16p13.3 0.173 0.186 0.73 fibroblast growth factor receptor
cop CUX2 12q24.12 0.173 0.186 0.73 regulation of transcription, DNA-
cop FAM109A 12q24.12 0.173 0.186 0.73 receptor recycling;endosome
organization
met PLOD1 1p36.22 0.173 0.186 0.73 response to hypoxia;protein modification
process
xsq MPC1 6q27 0.173 0.186 0.73
cop TMC2 20p13 0.173 0.186 0.73
cop NOP56 20p13 0.173 0.186 0.73 rRNA processing;cell death
cop MIR1292 0.173 0.186 0.73
cop SNORD110 0.173 0.186 0.73
cop SNORA51 0.173 0.186 0.73
cop SNORD86 0.173 0.186 0.73
cop SNORD56 0.173 0.186 0.73
cop SNORD57 0.173 0.186 0.73
cop IDH3B 20p13 0.173 0.186 0.73 tricarboxylic acid cycle;isocitrate metabolic
process
exp YIPF2 19p13.2 -0.173 0.186 0.73
exp ATP6V1B1 2p13.1 -0.173 0.186 0.73 ossification;transferrin
transport
pro TP53_1_5429 -0.173 0.186 0.73
xsq FNTB 14q23.3 -0.173 0.186 0.73 protein farnesylation;response to
cytokine stimulus
xsq PAPSS2 10q24 -0.173 0.186 0.73 xenobiotic metabolic process;small
cop PI4KA 22q11.21 -0.173 0.186 0.73 phosphatidylinositol-mediated
signaling;phosphatidylinositol biosynthetic process
xsq COL4A2-AS1 -0.173 0.186 0.73
xsq UPP1 7p12.3 -0.173 0.186 0.73 nucleotide catabolic
met LINC00521 14q32.12 -0.173 0.186 0.73
exp RALGAPB 20q11.23 -0.173 0.186 0.73 activation of Ral GTPase
exp MAP6D1 3q27.1 -0.173 0.186 0.73 N-terminal peptidyl-L-
xsq LOC103611081 -0.173 0.186 0.73
exp WBP1L 10q24.32 -0.173 0.186 0.73
xsq HEXIM1 17q21.31 -0.173 0.186 0.73 negative regulation of
xsq MAGED1 Xp11.23 -0.173 0.186 0.73 regulation of transcription,
met CERKL 2q31.3 -0.173 0.186 0.73 anti-apoptosis;activation of
xsq HCAR1 12q24.31 -0.173 0.186 0.73 response to estradiol stimulus
exp EFNA1 1q21-q22 -0.173 0.186 0.73 endocardial cushion to mesenchymal
cell migration
exp CYSTM1 5q31.3 -0.173 0.186 0.73
exp USP18 22q11.21 -0.173 0.186 0.73 proteolysis;ubiquitin-dependent
cop C8orf46 8q13.1 -0.173 0.186 0.73
exp ULBP3 6q25 -0.173 0.186 0.73 antigen processing and
met RNF10 12q24.31 -0.173 0.186 0.73 negative regulation of Schwann cell
exp LOC100288803 5q35.3 -0.173 0.186 0.73
xsq SHISA9 16p13.12 -0.173 0.186 0.73 regulation of short-term
xsq MT1M 16q13 -0.173 0.186 0.73 negative regulation of growth
exp KIAA1644 -0.173 0.186 0.73
cop DEC1 9q32 -0.173 0.186 0.73 negative regulation of cell proliferation
cop TMEM191A 22q11.21 -0.173 0.186 0.73
cop SERPIND1 22q11.21 -0.173 0.186 0.73 regulation of
proteolysis;chemotaxis
xsq GBA 1q21 -0.173 0.186 0.73 termination of signal
exp CNIH4 1q42.11 -0.173 0.186 0.73 intracellular signal transduction
exp RPS2P49 17q21 -0.173 0.186 0.73
his KIF23 15q23 -0.174 0.186 0.73 M phase of mitotic cell cycle;positive
his LOC145694 -0.174 0.186 0.73
xai SNTA1 20q11.2 -0.174 0.186 0.73 muscle contraction;neuromuscular
junction development
xai B3GALNT1 3q25 -0.174 0.186 0.73 protein
glycosylation;oligosaccharide biosynthetic process
xai C10orf55 10q22.2 -0.174 0.186 0.73
hs4 ARFGEF3 -0.174 0.186 0.73 negative regulation of phosphatase
activity;regulation of ARF protein signal transduction
hs4 FGF20 8p22 -0.174 0.186 0.73 signal transduction;positive regulation
of ERK1 and ERK2 cascade
xai SLCO3A1 15q26 -0.174 0.186 0.73 Solute Carriers
xai KRT23 17q21.2 -0.174 0.186 0.73
hs4 ZNF382 19q13.12 -0.174 0.186 0.73 negative regulation of
swa CCDC47 17q23.3 -0.174 0.186 0.73 ER overload response;embryo
development
his CAPS 19p13.3 -0.174 0.186 0.73 intracellular signal transduction
exp GAPDHP20 -0.174 0.186 0.73
xai TMEM132C 12q24.32 -0.175 0.186 0.73
xai LINC00113 21q21.3 -0.175 0.186 0.73
xai SPDYA 2p23.2 -0.175 0.186 0.73 positive regulation of cell
proliferation;positive regulation of cyclin-dependent protein kinase activity
xai ABCA1 9q31.1 -0.175 0.186 0.73 ABC Transporters
his SLIT2-IT1 -0.175 0.186 0.73
hs4 DIAPH2-AS1 -0.175 0.186 0.73
xai PIGZ 3q29 -0.175 0.186 0.73 GPI anchor biosynthetic process
xai GAPDHP20 -0.175 0.186 0.73
hs4 LINC01160 -0.175 0.186 0.73
exp PCDHA1 -0.175 0.186 0.73 cell adhesion;homophilic cell
adhesion
hs4 LOC440982 -0.175 0.186 0.73
hs4 C10orf35 10q22.1 -0.175 0.186 0.73
his FER1L6-AS1 -0.175 0.186 0.73
hs4 CAV2 7q31.1 -0.175 0.186 0.73 mitochondrion organization;protein
oligomerization
xai PACSIN3 11p12-p11.12 -0.175 0.186 0.73 negative regulation of
hs4 RPS4X Xq13.1 0.174 0.187 0.731 translational elongation;mRNA metabolic
process
exp RPS15AP12 1q41 0.174 0.187 0.731
exp BAATP1 9q31.1 0.174 0.187 0.731
xai ENKD1 16q22.1 0.174 0.187 0.731
exp OR51N1P 11p15.4 0.174 0.187 0.731
exp TRBV25-1 0.174 0.187 0.731
xai STAG2 Xq25 0.174 0.187 0.731 DNA Damage Response (DDR); Tumor Suppressors
xai UXT Xp11.23-p11.22 0.174 0.187 0.731 protein folding;mitochondrion
xai RPS15AP12 1q41 0.174 0.187 0.731
his MIR636 0.174 0.187 0.731
his MFSD11 17q25 0.174 0.187 0.731
his SRSF2 17q25.1 0.174 0.187 0.731 Oncogenes
his LOC100288798 12q13.11 0.174 0.187 0.731
hs4 PPM1D 17q23.2 0.174 0.187 0.731 DNA Damage Response (DDR)
xai TRBV25-1 0.174 0.187 0.731
xai RNU5B-4P 0.174 0.187 0.731
xai INCENP 11q12.3 0.174 0.187 0.731 M phase of mitotic cell
xai CCDC63 12q24.11 0.174 0.187 0.731
exp EIF4A1P10 0.174 0.187 0.731
exp RNU5B-4P 0.174 0.187 0.731
hs4 LOC285074 2p11.2 0.174 0.187 0.731
exp IGBP1P3 3p22.3 0.174 0.187 0.731
cop MIR4310 0.174 0.187 0.731
his TOPBP1 3q22.1 0.174 0.187 0.731 DNA Damage Response (DDR); DDR (DNA
his LOC101927919 0.174 0.187 0.731
his NUS1 6q22.1 0.174 0.187 0.731 cell differentiation;angiogenesis
xai C1orf123 1p32.3 0.174 0.187 0.731
his TNRC6B 22q13.1 0.174 0.187 0.731 regulation of translation;gene
silencing by RNA
his MIR4520-2 0.174 0.187 0.731
his MIR4520-1 0.174 0.187 0.731
his ALOX15P1 0.174 0.187 0.731
hs4 SPSB2 12p13.31 0.174 0.187 0.731 intracellular signal transduction
his NFIC 19p13.3 0.174 0.187 0.731 negative regulation of transcription from
RNA polymerase II promoter;DNA replication
xai PFDN4 20q13.2 0.174 0.187 0.731 protein folding;cellular protein
metabolic process
hs4 GAPT 5q11.2 0.174 0.187 0.731 B cell activation
his FASTKD3 5p15.31 0.174 0.187 0.731 cellular respiration
his MTRR 5p15.31 0.174 0.187 0.731 methionine metabolic process;cellular
xai CACNA1C-AS1 0.174 0.187 0.731
his SYNRG 17q12 0.174 0.187 0.731 intracellular protein transport;endocytosis
his PSMB2 1p34.2 0.174 0.187 0.731 antigen processing and presentation of
xai DEPDC5 22q12.3 0.174 0.187 0.731 intracellular signal transduction
xai TATDN1 8q24.13 0.174 0.187 0.731
his PRMT1 19q13.3 0.174 0.187 0.732 histone methylation;peptidyl-arginine
methylation
his MIR5088 0.174 0.187 0.732
his ZAR1L 13q13.1 0.174 0.187 0.732
his BRCA2 13q12.3 0.174 0.187 0.732 Apoptosis; DNA Damage Response (DDR); DDR
met CYP27B1 12q14.1 0.173 0.187 0.731 negative regulation of calcidiol 1-
monooxygenase activity;response to tumor necrosis factor
met MORF4L1 15q24 0.173 0.187 0.731 histone H2A acetylation;DNA repair
dependent"
xsq CHRNB2 1q21.3 0.173 0.187 0.731 calcium ion transport;memory
exp HNRNPA3P6 3p12.3 0.173 0.187 0.731
xsq NMRK1 9q21.13 0.173 0.187 0.731 pyridine nucleotide biosynthetic process
xsq CNBP 3q21 0.173 0.187 0.731 regulation of transcription, DNA-
xsq MRPS12 19q13.1-q13.2 0.173 0.187 0.731 translation
met NSA2 5q13.3 0.173 0.187 0.731 rRNA processing
cop CCDC63 12q24.11 0.173 0.187 0.731
cop MYL2 12q24.11 0.173 0.187 0.731 cardiac myofibril assembly;ventricular
cop LOC100131138 0.173 0.187 0.731
xsq SUGP1 19p13.11 0.173 0.187 0.731 RNA splicing;gene expression
cop LOC100129931 0.173 0.187 0.731
exp GEMIN7 19q13.32 0.173 0.187 0.731 RNA splicing;gene expression
xsq PIGA Xp22.1 0.173 0.187 0.731 cellular protein metabolic process;C-
xsq ACAD8 11q25 0.173 0.187 0.731 regulation of transcription, DNA-
xsq LINC00907 0.173 0.187 0.731
xsq NAT9 17q25.1 0.173 0.187 0.731
dependent"
xsq ACTL9 19p13.2 0.173 0.187 0.731
xsq CD300LG 17q21.31 0.173 0.187 0.731
xsq TRIM39-RPP21 0.173 0.187 0.731
xsq H3F3C 12p11.21 0.173 0.187 0.731 nucleosome assembly
xsq ADI1 2p25.3 0.173 0.187 0.731 cellular nitrogen compound metabolic
exp PDE1A 2q32.1 0.173 0.187 0.731 signal transduction;epidermal growth
xsq RPL9 4p13 0.173 0.187 0.731 gene expression;viral reproduction
xsq TUBA3D 0.173 0.187 0.731
mut GCFC2 2p12 0.173 0.187 0.731 regulation of transcription, DNA-
met LRRC36 16q22.1 0.173 0.187 0.731
cop TPO 2p25 0.173 0.187 0.731 thyroid hormone generation;response to
oxidative stress
exp SUPT20H 13q13.3 0.173 0.187 0.731
cop FLJ42102 0.173 0.187 0.731
xsq OR7E14P 11p15.1 0.173 0.187 0.732
xsq PIM3 22q13 0.173 0.187 0.732 cell cycle;regulation of mitotic cell cycle
cop KIAA0101 15q22.31 0.173 0.187 0.732
mut CCKAR 4p15.2 0.173 0.187 0.732 activation of phospholipase C activity by
xsq RNASE10 14q11.2 0.173 0.187 0.732
xsq DMRTC1B 0.173 0.187 0.732 regulation of transcription, DNA-
dependent"
exp SIGLEC15 18q12.3 0.173 0.187 0.732
exp ESPL1 12q 0.173 0.187 0.732 Apoptosis
exp ATP5J 21q21.1 0.173 0.187 0.732 ATP catabolic process;transport
xsq UBE2Q1 1q21.3 0.173 0.187 0.732
cop TBC1D14 4p16.1 0.173 0.187 0.732
xsq CTBP1-AS2 4p16.3 0.173 0.187 0.732
exp FRMD3 9q21.32 0.173 0.187 0.732
xsq WDR62 19q13.12 0.173 0.187 0.732 neurogenesis;cerebral cortex development
xsq HSD17B7P2 10p11.1 0.173 0.187 0.732
exp NUMBL 19q13.13-q13.2 -0.173 0.187 0.732 multicellular organismal
met MAP3K11 11q13.1-q13.3 -0.173 0.187 0.732 Apoptosis; Protein
Kinases
cop TERF1 8q21.11 -0.173 0.187 0.732 DNA Damage Response (DDR)
cop SBSPON 8q21.11 -0.173 0.187 0.732
xsq GPR176 15q14-q15.1 -0.173 0.187 0.732 G-protein coupled receptor
xsq PFKFB4 3p22-p21 -0.173 0.187 0.731 Apoptosis
xsq ST7-AS1 7q31.2 -0.173 0.187 0.731
exp TRIM61 4q32.3 -0.173 0.187 0.731
cop SNAP29 22q11.21 -0.173 0.187 0.731 exocytosis;vesicle targeting
xsq NIPAL2 8q22.2 -0.173 0.187 0.731
mut FOXQ1 6p25 -0.173 0.187 0.731 hair follicle morphogenesis;positive
xsq C22orf23 22q13.1 -0.173 0.187 0.731
exp MAP4 3p21 -0.173 0.187 0.731 negative regulation of microtubule
depolymerization
cop CRH 8q13 -0.173 0.187 0.731 parturition;locomotory exploration
behavior
exp GDNF 5p13.1-p12 -0.173 0.187 0.731 Apoptosis
met SPRED2 2p14 -0.173 0.187 0.731 multicellular organismal
exp RNF128 Xq22.3 -0.173 0.187 0.731 negative regulation of
xsq LRCOL1 -0.173 0.187 0.731
xsq KRT6A 12q13.13 -0.173 0.187 0.731 ectoderm development;positive
hs4 LOXL2 8p21.3 -0.174 0.187 0.732 protein modification process;cell
adhesion
swa ATP6V0A1 17q21 -0.174 0.187 0.732 transferrin transport;transmembrane
transport
xai ZEB2P1 -0.174 0.187 0.732
hs4 FLJ31356 -0.174 0.187 0.732
hs4 FOSL2 2p23.3 -0.174 0.187 0.732 regulation of transcription from
RNA polymerase II promoter;cell death
exp ROS1 6q22 -0.174 0.187 0.732 spermatogenesis;cell proliferation
hs4 PAPSS2 10q24 -0.174 0.187 0.732 xenobiotic metabolic process;small
swa COMT 22q11.21 -0.174 0.187 0.731 methylation;response to pain
his LOC100131626 -0.174 0.187 0.731
his DHX58 17q21.2 -0.174 0.187 0.731 innate immune response
xai SPACA4 -0.174 0.187 0.731 cell adhesion
his UBE2L6 11q12 -0.174 0.187 0.731 protein modification
exp SPACA4 -0.174 0.187 0.731 cell adhesion
hs4 GPD1L 3p22.3 -0.174 0.187 0.731 carbohydrate metabolic
process;glycerol-3-phosphate catabolic process
xai LOC100996590 -0.174 0.187 0.731
xai SPAG17 1p12 -0.174 0.187 0.731
xai LOC100126784 11p15.1 -0.174 0.187 0.731
hs4 UPK3A 22q13.31 -0.174 0.187 0.731 urinary bladder development;cell
morphogenesis
xai SGPL1 10q21 -0.174 0.187 0.731 Apoptosis
xai TRIM8 10q24.3 -0.174 0.187 0.731
xai PBX1 1q23 -0.174 0.187 0.731 organ morphogenesis;negative regulation
swa SRXN1 20p13 -0.174 0.187 0.731 response to oxidative stress
xai RRM2B 8q23.1 -0.174 0.187 0.731 DNA Damage Response (DDR)
swa PLOD1 1p36.22 -0.174 0.187 0.731 response to hypoxia;protein
hs4 LOC613266 -0.174 0.187 0.731
exp PCDHGA7 -0.174 0.187 0.731 cell adhesion;homophilic cell
adhesion
his BAALC-AS1 -0.174 0.187 0.731
his BCAS4 20q13.13 -0.174 0.187 0.731
his LOC105377143 -0.174 0.187 0.731
his FAM227B 15q21.2 0.174 0.188 0.732
his DTWD1 15q21.2 0.174 0.188 0.732
xai ATP5G2 12q13.13 0.174 0.188 0.732 transport;ion transport
his LOC101929124 0.174 0.188 0.732
his LINC01233 0.174 0.188 0.732
xai LOC100288798 12q13.11 0.174 0.188 0.732
swa DRG2 17p11.2 0.174 0.188 0.732 signal transduction
his MTR 1q43 0.174 0.188 0.732 protein methylation;tetrahydrofolate metabolic
process
xai PRMT6 1p13.3 0.174 0.188 0.732 DNA Damage Response (DDR)
hs4 LOC101928042 0.174 0.188 0.732
hs4 ARHGAP11A 15q13.2 0.174 0.188 0.732 signal transduction;small GTPase
swa HBG2 11p15.5 0.174 0.188 0.732 transport;blood coagulation
hs4 PRC1 15q26.1 0.174 0.188 0.732 cell cycle;mitotic spindle elongation
xai OR9R1P 12q13.2 0.174 0.188 0.732
dependent"
exp SNORD11 2q33.1 0.174 0.188 0.732
hs4 CYP46A1 14q32.1 0.174 0.188 0.732 bile acid biosynthetic
hs4 AS-PTPRE 0.174 0.188 0.732
his HIST1H4G 6p22.1 0.174 0.188 0.732 nucleosome assembly
his HIST1H3F 6p22.2 0.174 0.188 0.732 nucleosome assembly;blood
coagulation
his HIST1H2BH 6p21.3 0.174 0.188 0.732 nucleosome assembly
his DHX29 5q11.2 0.174 0.188 0.732
his SKIV2L2 5q11.2 0.174 0.188 0.732 nuclear mRNA splicing, via
spliceosome;maturation of 5.8S rRNA
hs4 PTPN2 18p11.3-p11.2 0.174 0.188 0.732 protein dephosphorylation;insulin
his MIR675 0.174 0.188 0.732
his H19 11p15.5 0.174 0.188 0.732
xai TRAPPC9 8q24.3 0.174 0.188 0.732 cell differentiation
his TEX40 11q13.1 0.174 0.188 0.732
xai UGT3A2 5p13.2 0.174 0.188 0.732 metabolic process
xai SNORD11 2q33.1 0.174 0.188 0.732
his SCARNA26B 0.174 0.188 0.732
xai RPL22L1 3q26.2 0.174 0.188 0.732 translation
xai LRIF1 1p13.3 0.174 0.188 0.732 regulation of transcription, DNA-
dependent"
xai FAM104B Xp11.21 0.174 0.188 0.733
hs4 SUN2 22q13.1 0.174 0.188 0.733 mitotic spindle organization;nuclear
migration
xai SHISA3 4p13 0.174 0.188 0.733 multicellular organismal development
xai MTM1 Xq28 0.174 0.188 0.733 protein dephosphorylation;endosome to lysosome
transport
his L2HGDH 14q21.3 0.174 0.188 0.733 cellular protein metabolic
his ATP5S 14q21.3 0.174 0.188 0.733 ATP biosynthetic process;ion transport
his SH3BP1 22q13.1 0.174 0.188 0.733 signal transduction
his OR8G2 11q24.2 0.174 0.188 0.733 sensory perception of smell;response to
stimulus
his PMCHL2 0.174 0.188 0.733
his DNAJC28 21q22.11 0.174 0.188 0.733
his TEKT3 17p12 0.174 0.188 0.733 microtubule cytoskeleton organization
hs4 EPOP 0.174 0.188 0.733
cop RILPL1 12q24.31 0.174 0.188 0.733 neuroprotection
cop MIR3908 0.174 0.188 0.733
xai ZKSCAN8 6p21.3 0.174 0.188 0.733
met GP1BA 17p13.2 0.172 0.188 0.732 blood coagulation, intrinsic
pathway;platelet activation
met ALDH16A1 19q13.33 0.172 0.188 0.732
xsq FAM86FP 12p13.31 0.172 0.188 0.732
cop DNAH6 2p11.2 0.172 0.188 0.732 microtubule-based movement
xsq BTBD1 15q24 0.172 0.188 0.732 regulation of protein binding
cop TRIP4 15q22.31 0.172 0.188 0.732 transcription from RNA polymerase II
xsq ARMC7 17q25.1 0.172 0.188 0.732
cop ST3GAL5 2p11.2 0.172 0.188 0.732 carbohydrate metabolic
xsq ELOVL5 6p21.1-p12.1 0.172 0.188 0.732 EMT (Mesenchymal)
met PRAME 22q11.22 0.172 0.188 0.732 negative regulation of cell
differentiation;negative regulation of transcription, DNA-dependent
xsq PTX4 16p13.3 0.172 0.188 0.732
xsq RBM4 11q13 0.172 0.188 0.732 cell differentiation;regulation of
xsq NAP1L1 12q21.2 0.172 0.188 0.732 DNA replication;nucleosome assembly
xsq SEMA4A 1q22 0.172 0.188 0.732 multicellular organismal
exp LMAN1 18q21.3-q22 0.172 0.188 0.732 blood coagulation;cellular protein
metabolic process
met DNHD1 11p15.4 0.172 0.188 0.732 microtubule-based movement
cop CHGB 20p12.3 0.172 0.188 0.732
cop TRMT6 20p12.3 0.172 0.188 0.732 regulation of translational
xsq ENTPD1 10q24 0.172 0.188 0.732 ATP catabolic process;cell adhesion
xsq ACY3 11q13.2 0.172 0.188 0.732 metabolic process;interspecies
xsq PSMG3 7p22.3 0.172 0.188 0.732
cop LOC728323 2q37.3 0.172 0.188 0.732
xsq PLA2G4A 1q25 0.172 0.188 0.732 metabolic process;platelet activation
xsq SCLT1 4q28.2 0.172 0.188 0.732
exp AP5B1 11q13.1 0.172 0.188 0.732 protein transport
xsq JMJD4 1q42.13 0.172 0.188 0.732
met POMGNT2 0.172 0.188 0.732
xsq CCND3 6p21 0.172 0.188 0.732 DNA Damage Response (DDR); DDR (G1-S
met OMG 17q11.2 0.172 0.188 0.732 regulation of collateral sprouting of
intact axon in response to injury;regulation of axonogenesis
cop LOC606724 0.172 0.188 0.732
cop BOLA2 16p11.2 0.172 0.188 0.732
cop BOLA2B 0.172 0.188 0.732
cop SLX1B 0.172 0.188 0.732 DNA Damage Response (DDR)
cop SLX1A 0.172 0.188 0.732 DNA Damage Response (DDR); DDR (HR)
cop SLX1B-SULT1A4 0.172 0.188 0.732
cop SLX1A-SULT1A3 0.172 0.188 0.732
cop SULT1A4 16p11.2 0.172 0.188 0.732 catecholamine metabolic
process;sulfation
cop SULT1A3 16p11.2 0.172 0.188 0.732
cop LOC388242 0.172 0.188 0.732
cop LOC613038 0.172 0.188 0.732
cop LOC440354 0.172 0.188 0.732
met PDE1C 7p14.3 0.172 0.188 0.732 activation of phospholipase C
met WBP5 Xq22.2 0.172 0.188 0.732
xsq SORCS3-AS1 0.172 0.188 0.732
met SVOP 12q24.11 0.172 0.188 0.732
cop SERPINB5 18q21.33 0.172 0.188 0.732 cellular component
movement;negative regulation of endopeptidase activity
xsq COX6B1 19q13.1 0.172 0.188 0.732 small molecule metabolic
met TMEM14EP 0.172 0.188 0.732
met PCDHGA3 5q31 0.172 0.188 0.733 cell adhesion;homophilic cell adhesion
exp HMGN1P37 Xq28 0.172 0.188 0.733
xsq USP21 1q22 0.172 0.188 0.733 protein modification process;proteolysis
xsq PRAMEF14 0.172 0.188 0.733
exp PCGF1 2p13.1 0.172 0.188 0.733 regulation of transcription, DNA-
xsq ADIPOR2 12p13.31 0.172 0.188 0.733 lipid metabolic process;hormone-
exp GUCY2C 12p12 0.172 0.188 0.733 regulation of cell proliferation;cGMP
xsq BCKDHB 6q14.1 0.172 0.188 0.733 response to nutrient;branched chain
xsq PDZD9 16p12.2 0.172 0.188 0.733
xsq LOC145783 15q21.3 0.172 0.188 0.733
cop VPS4B 18q21.33 0.172 0.188 0.733 protein transport;cellular membrane
organization
xsq CLPTM1L 5p15.33 0.172 0.188 0.733 apoptotic process
exp BPY2C 0.172 0.188 0.733 spermatogenesis;single fertilization
cop GIT2 12q24.1 0.172 0.188 0.733 regulation of G-protein coupled receptor
mut PDZRN3 3p13 -0.172 0.188 0.733 neuromuscular junction
met C2orf42 2p13.3 -0.172 0.188 0.733
exp FAM134B 5p15.1 -0.172 0.188 0.733 sensory perception of pain
exp KIF23 15q23 -0.172 0.188 0.733 M phase of mitotic cell cycle;positive
exp TSPAN2 1p13.2 -0.172 0.188 0.733 brain development
mut PKD1L2 16q23.2 -0.172 0.188 0.733 ion transport;neuropeptide
signaling pathway
xsq ZNF667-AS1 19q13.43 -0.172 0.188 0.733
cop DRD1 5q35.1 -0.172 0.188 0.733 response to amphetamine;activation
of adenylate cyclase activity by dopamine receptor signaling pathway
xsq IRF9 14q11.2 -0.172 0.188 0.733 type I interferon-mediated
xsq TAF13 1p13.3 -0.172 0.188 0.733 regulation of transcription, DNA-
xsq TSC22D2 3q25.1 -0.172 0.188 0.733 response to osmotic stress
exp THBD 20p11.2 -0.172 0.188 0.733 response to
xsq UBD 6p21.3 -0.172 0.188 0.733 DNA Damage Response (DDR)
cop SNX7 1p21.3 -0.172 0.188 0.732 cell communication;protein
transport
mut NFE2 12q13 -0.172 0.188 0.732 multicellular organismal
cop NEK11 3q22.1 -0.172 0.188 0.732 DNA Damage Response (DDR)
cop ADCY1 7p13-p12 -0.172 0.188 0.732 inhibition of adenylate cyclase
activity by G-protein signaling pathway;activation of protein kinase A activity
exp CREBRF 5q35.1 -0.172 0.188 0.732
exp CP 3q23-q25 -0.172 0.188 0.732 cellular iron ion
exp S100A7P2 1q21.3 -0.172 0.188 0.732
exp LOC90246 3q21.3 -0.172 0.188 0.732
xsq HLA-C 6p21.3 -0.172 0.188 0.732 antigen processing and presentation
of peptide antigen via MHC class I;regulation of immune response
exp SPATA20 17q21.33 -0.172 0.188 0.732 mannose metabolic
xsq CLN5 13q21.1-q32 -0.172 0.188 0.732 cell death;neurogenesis
met MIR216A -0.172 0.188 0.732
xsq PCDHGB6 -0.172 0.188 0.732 cell adhesion;homophilic cell
adhesion
met PBOV1 6q23.3 -0.172 0.188 0.732
mut ABCC1 16p13.1 -0.172 0.188 0.732 ABC Transporters
exp POU3F3 2q12.1 -0.172 0.188 0.732 cerebral cortex radially
oriented cell migration;metanephric thick ascending limb development
mut GML 8q24.3 -0.172 0.188 0.732
xsq NEXN 1p31.1 -0.172 0.188 0.732 regulation of cell
exp FGFRL1 4p16 -0.172 0.188 0.732 negative regulation of cell
exp PURB 7p13 -0.172 0.188 0.732 regulation of myeloid cell
his LOC441204 7p15.2 -0.174 0.188 0.733
hs4 MIR6887 -0.174 0.188 0.733
his LOC646730 3q23 -0.174 0.188 0.733
xai FITM2 20q13.12 -0.174 0.188 0.733 positive regulation of sequestering
swa PSMB7 9q34.11-q34.12 -0.174 0.188 0.732 M/G1 transition of mitotic
cell cycle;viral reproduction
his RAET1E 6q25.1 -0.174 0.188 0.732 immune response;antigen
his APOL3 22q13.1 -0.174 0.188 0.732 transport;lipid transport
his MAP6D1 3q27.1 -0.174 0.188 0.732 N-terminal peptidyl-L-
xai LINC00691 3p24.2 -0.174 0.188 0.732
exp CPZ 4p16.1 -0.174 0.188 0.732 proteolysis;Wnt receptor signaling
pathway
swa RAPH1 2q33 -0.174 0.188 0.732 cell-matrix adhesion;signal transduction
swa TPP1 11p15 -0.174 0.188 0.732 endoplasmic reticulum unfolded protein
response;proteolysis
hs4 IP6K3 6p21.31 -0.174 0.188 0.732 DNA Damage Response (DDR)
xai CCBE1 18q21.32 -0.174 0.188 0.732 multicellular organismal
hs4 VPS37D 7q11.23 -0.174 0.188 0.732 protein transport;viral
reproduction
xai TMEM117 12q12 -0.174 0.188 0.732
xai PICK1 22q13.1 -0.174 0.188 0.732 protein phosphorylation;receptor
clustering
his CA6 1p36.2 -0.174 0.188 0.732 one-carbon metabolic process
xai STMND1 6p22.3 -0.174 0.188 0.732
his GLUD1P7 -0.174 0.188 0.732
his BMS1P5 -0.174 0.188 0.732
exp RPS15AP3 14q21.3 -0.174 0.188 0.732
hs4 LINC00958 -0.174 0.188 0.732
xai SCAF1 19q13.3-q13.4 -0.174 0.188 0.732 transcription from RNA
his LOC338694 -0.174 0.188 0.732
exp LOC100129112 0.174 0.189 0.733
exp MLNR 13q14-q21 0.174 0.189 0.733 G-protein coupled receptor signaling
pathway;digestion
his SLCO1B3 12p12 0.174 0.189 0.733 Solute Carriers
xai KRT75 12q13 0.174 0.189 0.733
his ATP6V1G1 9q32 0.173 0.189 0.734 proton transport;transferrin transport
his MIR5692B 0.173 0.189 0.734
xai PTBP3 9q32 0.173 0.189 0.734 mRNA processing;anatomical structure
morphogenesis
xai RNF123 3p24.3 0.173 0.189 0.734
xai RIMKLA 1p34.2 0.173 0.189 0.734 protein modification process
his TMEM14B 6p25.1-p23 0.173 0.189 0.734
xai UBL4A Xq28 0.173 0.189 0.734 protein modification process;transport
cop MIR3682 0.173 0.189 0.734
his MIR1908 0.173 0.189 0.734
his FADS2 11q12.2 0.173 0.189 0.734 unsaturated fatty acid biosynthetic
process;transport
his FADS1 11q12.2-q13.1 0.173 0.189 0.734 transport;response to organic
cyclic compound
xai DDC 7p12.2 0.173 0.189 0.734 isoquinoline alkaloid metabolic
swa RPL32 3p25-p24 0.173 0.189 0.734 SRP-dependent cotranslational protein
hs4 INTS11 0.173 0.189 0.734
hs4 CPTP 0.173 0.189 0.734
his CTSC 11q14.2 0.173 0.189 0.734 proteolysis;immune response
his GIGYF2 2q37.1 0.173 0.189 0.734 cell death
hs4 PTPRA 20p13 0.173 0.189 0.734 protein phosphorylation;axon guidance
hs4 MST1P2 1p36.2 0.173 0.189 0.734
met FAM26E 6q22.1 0.173 0.189 0.734
xai EIF5AP2 0.173 0.189 0.734
xsq FBXW12 3p21.31 0.172 0.189 0.733
exp DHFRL1 3q11.1 0.172 0.189 0.733 nucleotide biosynthetic
xsq LTB4R 14q11.2-q12 0.172 0.189 0.733 cellular component movement;muscle
contraction
met EYS 6q12 0.172 0.189 0.733 visual perception;response to stimulus
cop SERPINB11 18q21.33 0.172 0.189 0.733 regulation of proteolysis;negative
xsq CCT5 5p15.2 0.172 0.189 0.733 response to virus;cellular protein
metabolic process
exp CHPT1 12q 0.172 0.189 0.733 regulation of cell growth;lipid metabolic
process
met RBMXL2 11p15 0.172 0.189 0.733
met S100A2 1q21 0.172 0.189 0.733 endothelial cell migration
xsq XRCC6P5 Xq22.1 0.172 0.189 0.733
met BAD 11q13.1 0.172 0.189 0.733 Apoptosis
exp GSE1 16q24.1 0.172 0.189 0.733
xsq CDC25B 20p13 0.172 0.189 0.733 DNA Damage Response (DDR)
exp GID8 20q13.33 0.172 0.189 0.733
xsq CNPPD1 2q35 0.172 0.189 0.734 regulation of cyclin-dependent protein
kinase activity
xsq NINL 20p11.22-p11.1 0.172 0.189 0.734 G2/M transition of mitotic cell
xsq SLC35G4 0.172 0.189 0.734
exp FAAP100 0.172 0.189 0.734 DNA Damage Response (DDR); DDR (FA)
xsq CEP97 3q12.3 0.172 0.189 0.734
mut BEND5 1p33 0.172 0.189 0.734
xsq MYBPC1 12q23.2 0.172 0.189 0.734 muscle filament sliding;cell
adhesion
met PVRL3 3q13 0.172 0.189 0.734 adherens junction organization;cell-cell
cop MEGF11 15q22.31 0.172 0.189 0.734
met CD44 11p13 0.172 0.189 0.734 cell-matrix adhesion;negative regulation of DNA
damage response, signal transduction by p53 class mediator
exp DNAJA1 9p13.3 0.172 0.189 0.734 protein folding;response to
unfolded protein
xsq INO80C 18q12.2 0.172 0.189 0.734 DNA Damage Response (DDR); DDR
(Chromatin)
mir hsa-miR-342-3p 0.172 0.189 0.734
xsq CEP120 5q23.2 0.172 0.189 0.734 microtubule cytoskeleton
dependent"
met EFR3A 8q24.22 0.172 0.189 0.734
exp NTMT1 9q34.11 0.172 0.189 0.734
xsq IL17A 6p12 0.172 0.189 0.734
xsq NLGN3 Xq13.1 0.172 0.189 0.734 social behavior;axon extension
xsq HHLA1 8q24 0.172 0.189 0.734
xsq GALK1 17q24 0.172 0.189 0.734 small molecule metabolic process;carbohydrate
phosphorylation
cop SAMD5 6q24.3 0.172 0.189 0.734
xsq TCAIM 3p21.31 0.172 0.189 0.734
met TMEM252 9q21.11 0.172 0.189 0.734
cop NUDT4P1 1q21.1 0.172 0.189 0.734
cop NUDT4 12q21 0.172 0.189 0.734 intracellular signal transduction;regulation of
RNA export from nucleus
cop UBE2N 12q22 0.172 0.189 0.734 DNA Damage Response (DDR); DDR (TLS)
cop MIR4311 0.172 0.189 0.734
cop DIS3L 15q22.31 0.172 0.189 0.734 rRNA catabolic process
cop TIPIN 15q22.31 0.172 0.189 0.734 DNA Damage Response (DDR)
cop SCARNA14 15q22.31 0.172 0.189 0.734
cop MAP2K1 15q22.1-q22.33 0.172 0.189 0.734 Oncogenes; Protein Kinases
cop SNAPC5 15q22.31 0.172 0.189 0.734 regulation of transcription, DNA-
cop RPL4 15q22 0.172 0.189 0.734 translational initiation;viral infectious cycle
cop SNORD18C 0.172 0.189 0.734
cop SNORD18B 0.172 0.189 0.734
cop SNORD16 0.172 0.189 0.734
cop SNORD18A 15q22 0.172 0.189 0.734
cop ZWILCH 15q22.31 0.172 0.189 0.734 DNA Damage Response (DDR)
cop LCTL 15q22.31 0.172 0.189 0.734 carbohydrate metabolic process
exp S100A12 1q21 0.172 0.189 0.734 killing of cells of other
xsq OR6K2 1q23.1 0.172 0.189 0.734
met EFCAB11 14q32.11 0.172 0.189 0.734
xsq AGO4 1p34 0.172 0.189 0.734
met ABCA8 17q24 0.172 0.189 0.734 ABC Transporters
xsq SEPSECS-AS1 0.172 0.189 0.734
exp LINC00654 20p12.3 0.172 0.189 0.734
exp LOC90784 2p11.2 0.172 0.189 0.734
exp C6orf48 6p21.3 0.172 0.189 0.734
met MMP19 12q14 0.172 0.189 0.734 Apoptosis
met ALS2CR12 2q33.1 0.172 0.189 0.734 regulation of GTPase activity
met RHOV 15q13.3 0.172 0.189 0.734 signal transduction;small GTPase mediated
signal transduction
exp NET1 10p15 0.172 0.189 0.734 small GTPase mediated signal
exp RPUSD3 3p25.3 0.172 0.189 0.734 pseudouridine synthesis
exp LOC100289034 0.172 0.189 0.734
met MIR299 0.172 0.189 0.734
exp ARNT 1q21 0.172 0.189 0.734 cell differentiation;positive regulation of
cop PLA2G4D 15q15.1 0.172 0.189 0.734 metabolic process;phospholipid
catabolic process
xsq IL18RAP 2q12 0.172 0.189 0.734 inflammatory response;immune response
xsq SPATA9 5q15 0.172 0.189 0.734 multicellular organismal
exp ZBTB33 Xq23 0.172 0.189 0.734 regulation of transcription, DNA-
xsq LOC728673 0.172 0.189 0.734
met F11 4q35 0.172 0.189 0.734 positive regulation of fibrinolysis;proteolysis
xsq NEURL1-AS1 0.172 0.189 0.734
met IL1RAPL1 Xp22.1-p21.3 0.172 0.189 0.734 negative regulation of
calcium ion transport via voltage-gated calcium channel activity;signal
transduction
mut SLCO1A2 12p12 -0.172 0.189 0.734 Solute Carriers
cop GNG4 1q42.3 -0.172 0.189 0.734 energy reserve metabolic
xsq IL15 4q31 -0.172 0.189 0.734 immune response;positive regulation of
xsq LOC101927318 -0.172 0.189 0.734
exp TMEM8A 16p13.3 -0.172 0.189 0.734 cell adhesion
xsq GRM7-AS3 -0.172 0.189 0.734
exp FAM210B 20q13.2 -0.172 0.189 0.734
xsq EHHADH 3q26.3-q28 -0.172 0.189 0.734 fatty acid beta-
exp HS6ST3 13q32.1 -0.172 0.189 0.734
cop MALSU1 7p15.3 -0.172 0.189 0.734 ribosomal large subunit
biogenesis
exp MN1 22q12.1 -0.172 0.189 0.734 intramembranous ossification
exp KCTD10 12q24.11 -0.172 0.189 0.734 potassium ion
transport;protein ubiquitination
exp KIF26B 1q44 -0.172 0.189 0.734 microtubule-based
exp LARGE 22q12.3 -0.172 0.189 0.734 protein
xsq TMEM158 3p21.3 -0.172 0.189 0.734
xsq UCN2 3p21.3 -0.172 0.189 0.734 cAMP biosynthetic process;response
to stress
xsq PCGF5 10q23.32 -0.172 0.189 0.734 regulation of transcription, DNA-
dependent"
exp SEMA3E 7q21.11 -0.172 0.189 0.734 multicellular organismal
met MIR549A -0.172 0.189 0.734
exp PCGF2 17q12 -0.172 0.189 0.734 negative regulation of transcription from
cop LPPR5 1p21.3 -0.172 0.189 0.734
cop LOC100129620 -0.172 0.189 0.734
xsq LOC284344 -0.172 0.189 0.734
met PRSS36 16p11.2 -0.172 0.189 0.734 proteolysis
DNA-dependent"
exp CD68 17p13 -0.172 0.189 0.734
xsq KIF1B 1p36.2 -0.172 0.189 0.733 microtubule-based movement;neuron-
exp B3GALNT1 3q25 -0.172 0.189 0.733 protein
met KLHL17 1p36.33 -0.172 0.189 0.733 brain development;actin
exp KIAA1755 20q11.23 -0.172 0.189 0.733
exp DDAH2 6p21.3 -0.172 0.189 0.733 Apoptosis
exp HES2 1p36.31 -0.172 0.189 0.733 negative regulation of
exp DNAJB4 1p31.1 -0.172 0.189 0.733 protein folding;response to
unfolded protein
his PITPNM3 -0.173 0.189 0.734
swa MTX2 2q31.1 -0.173 0.189 0.734 protein targeting to
mitochondrion;mitochondrial transport
xai SAXO2 -0.173 0.189 0.734
exp HEATR4 14q24.3 -0.173 0.189 0.734
exp ADAM7 8p21.2 -0.173 0.189 0.734 proteolysis
xai ACSF2 17q21.33 -0.173 0.189 0.734 lipid metabolic process;fatty acid
metabolic process
hs4 LOC729867 -0.173 0.189 0.734
hs4 PEA15 1q21.1 -0.173 0.189 0.734 transport;anti-apoptosis
his CAV1 7q31.1 -0.173 0.189 0.734 vasculogenesis;skeletal muscle
tissue development
xai RASEF 9q21.32 -0.173 0.189 0.734 small GTPase mediated signal
xai MYADML 2p22.3 -0.173 0.189 0.734
cop MIR1262 -0.173 0.189 0.734
hs4 SPG20-AS1 -0.173 0.189 0.734
hs4 SPG20 13q13.3 -0.173 0.189 0.734 EMT (Mesenchymal)
his NOX4 11q14.2-q21 -0.173 0.189 0.734 superoxide anion
xai ALPK1 4q25 -0.173 0.189 0.734 protein phosphorylation
hs4 FOXP1 3p14.1 -0.173 0.189 0.734 positive regulation of
immunoglobulin production;immunoglobulin V(D)J recombination
hs4 ESRRG 1q41 -0.173 0.189 0.734 gene expression;positive regulation of
his DNAH7 2q32.3 -0.173 0.189 0.734 ciliary or flagellar
xai AP1M2 19p13.2 -0.173 0.189 0.734 protein targeting;post-Golgi
xai HMGB3P9 -0.173 0.189 0.734
xai YIPF6 Xq12 -0.173 0.189 0.734
his ECHDC3 10p14 -0.173 0.189 0.734
hs4 AAED1 9q22.32 -0.174 0.189 0.734
hs4 GEM 8q13-q21 -0.174 0.189 0.733 GTP catabolic process;immune
response
hs4 ALDH1L1-AS1 -0.174 0.189 0.733
exp GPX5 6p22.1 -0.174 0.189 0.733 lipid metabolic process;response to
oxidative stress
xai FOLR3 11q13 -0.174 0.189 0.733 folic acid transport
his LOC284898 -0.174 0.189 0.733
his LINC01392 -0.174 0.189 0.733
his LOC643441 -0.174 0.189 0.733
hs4 RFPL3 22q12.3 -0.174 0.189 0.733
his AP2A2 11p15.5 0.173 0.19 0.734 endocytosis;epidermal growth factor
cop PSMB10 16q22.1 0.173 0.19 0.734 mitotic cell cycle;viral
reproduction
his SPECC1L 22q11.23 0.173 0.19 0.734 cell cycle;cell division
his SPECC1L-ADORA2A 0.173 0.19 0.734
dependent"
his CAMKK2 12q24.2 0.173 0.19 0.734 positive regulation of
hs4 EEF2 19p13.3 0.173 0.19 0.734 gene expression;cellular protein
metabolic process
hs4 SNORD37 19p13.3 0.173 0.19 0.734
his TRAF3 14q32.32 0.173 0.19 0.734 Apoptosis
swa GOLGA7 8p11.21 0.173 0.19 0.734
hs4 MRPL20 1p36.3-p36.2 0.173 0.19 0.734 translation
xai LOC200772 0.173 0.19 0.734
exp CELF2-AS1 0.173 0.19 0.734
xai TACO1 17q23.3 0.173 0.19 0.734 regulation of translation
hs4 TACR3 4q25 0.173 0.19 0.734 response to morphine;tachykinin receptor
signaling pathway
hs4 CD226 18q22.3 0.173 0.19 0.734 signal transduction;cell recognition
his MIR3913-2 0.173 0.19 0.734
his MIR3913-1 0.173 0.19 0.734
his CCT2 12q15 0.173 0.19 0.734 protein folding;cellular protein metabolic
process
xai AHCYP3 2q12.1 0.173 0.19 0.734
hs4 MXD1 2p13-p12 0.173 0.19 0.734 Apoptosis
his ERC2-IT1 0.173 0.19 0.734
his WBSCR22 7q11.23 0.173 0.19 0.734 metabolic process;methylation
swa NUP214 9q34.1 0.173 0.19 0.734 mRNA export from nucleus;viral
reproduction
his ALKBH3 11p11.2 0.173 0.19 0.734 DNA Damage Response (DDR); DDR
(Direct Repair)
xai TNFSF8 9q33 0.173 0.19 0.734 cell-cell signaling;cell proliferation
exp MS4A14 11q12.2 0.173 0.19 0.734
xai ANAPC7 12q24.11 0.173 0.19 0.735 anaphase-promoting complex-
his VPS29 12q24 0.173 0.19 0.735 protein transport
his RAD9B 12q24.11 0.173 0.19 0.735 DNA Damage Response (DDR)
xai DCAF16 4p15.31 0.173 0.19 0.735 protein ubiquitination
swa UCHL3 13q22.2 0.173 0.19 0.735 proteolysis;ubiquitin-dependent protein
catabolic process
his COX20 1q44 0.173 0.19 0.735
hs4 DPP6 7q36.2 0.173 0.19 0.735 proteolysis;cell death
xai KIR2DS4 19q13.4 0.173 0.19 0.735
his NIPSNAP3A 9q31.1 0.173 0.19 0.735
xai NOD1 7p15-p14 0.173 0.19 0.735 apoptotic process;detection of biotic
stimulus
hs4 LINC01864 0.173 0.19 0.735
his GINM1 6q25.1 0.173 0.19 0.735
his GPR141 7p14.1 0.173 0.19 0.735 G-protein coupled receptor
signaling pathway
swa TALDO1 11p15.5-p15.4 0.173 0.19 0.735 fructose 6-phosphate
his LOC105369921 0.173 0.19 0.735
his SNRPF 12q23.1 0.173 0.19 0.735 termination of RNA polymerase II
his ANKRD18DP 3q29 0.173 0.19 0.735
his FAM72D 0.173 0.19 0.735
exp CEACAM6 19q13.2 0.172 0.19 0.734 signal transduction;cell-cell
signaling
xsq INTS12 4q24 0.172 0.19 0.734 snRNA processing
xsq LOC101927641 0.172 0.19 0.734
xsq CRIPAK 4p16.3 0.172 0.19 0.734 negative regulation of protein
kinase activity;negative regulation of intracellular estrogen receptor signaling
pathway
met ADRA2A 10q25.2 0.172 0.19 0.734 signal transduction;actin
xsq BRD8 5q31 0.172 0.19 0.734 histone H4 acetylation;histone H2A acetylation
cop PAPD5 16q12.1 0.172 0.19 0.734 DNA replication;cell cycle
exp TET2 4q24 0.172 0.19 0.734 Tumor Suppressors
met GLCE 15q23 0.172 0.19 0.734 heparan sulfate proteoglycan biosynthetic
process;heparin biosynthetic process
xsq CDH9 5p14 0.172 0.19 0.734 homophilic cell adhesion;cell-cell adhesion
met ECHDC3 10p14 0.172 0.19 0.734
exp PARD6A 16q22.1 0.172 0.19 0.734 cell-cell junction maintenance;cell
division
met RBPJ 4p15.2 0.172 0.19 0.734 DNA recombination;regulation of
mut ZNF106 15q15.1 0.172 0.19 0.734
met GLTSCR2 19q13.3 0.172 0.19 0.734
cop MIR4282 0.172 0.19 0.734
xsq TBRG4 7p13 0.172 0.19 0.734 Apoptosis
xsq CLEC19A 16p12.3 0.172 0.19 0.734
cop SLCO3A1 15q26 0.172 0.19 0.734 Solute Carriers
cop CHPT1 12q 0.172 0.19 0.734 regulation of cell growth;lipid metabolic
process
xsq VMO1 17p13.2 0.172 0.19 0.734 vitelline membrane formation
cop KCNQ1 11p15.5 0.172 0.19 0.734 synaptic transmission;regulation of
met METAP1D 2q31.1 0.172 0.19 0.734 proteolysis;cellular process
exp TCFL5 20q13.33 0.172 0.19 0.734 regulation of cell
xsq AIMP2 7p22 0.172 0.19 0.734 gene expression;cell differentiation
xsq EGFL7 9q34.3 0.172 0.19 0.734 angiogenesis;blood vessel development
xsq ATP8B2 1q21.3 0.172 0.19 0.734 cation transport;phospholipid
transport
met MIR2278 0.172 0.19 0.734
exp PTGES3 12q13.3 0.172 0.19 0.734 glycogen biosynthetic process;lung
saccule development
xsq CCSAP 1q42.13 0.172 0.19 0.734
xsq FOXA3 19q13.32 0.172 0.19 0.734 embryo development;regulation of
cop RFC5 12q24.23 0.172 0.19 0.734 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
met LSR 19q13.12 0.172 0.19 0.734 liver development;embryo development
cop SPG21 15q21-q22 0.172 0.19 0.734 cell death;antigen receptor-mediated
signaling pathway
cop MTFMT 15q22.31 0.172 0.19 0.734 biosynthetic process
xsq SNORA12 0.172 0.19 0.734
xsq POMT1 9q34.1 0.172 0.19 0.735 extracellular matrix
organization;carbohydrate metabolic process
met LCA5L 21q22.2 0.172 0.19 0.735
exp FAM96B 16q22.1 0.171 0.19 0.735 chromosome segregation
xsq SOX7 8p23.1 0.171 0.19 0.735 positive regulation of cysteine-type
endopeptidase activity involved in apoptotic process;negative regulation of
xsq RLIM Xq13-q21 0.171 0.19 0.735 negative regulation of transcription,
DNA-dependent;random inactivation of X chromosome
cop KIAA1468 18q21.33 0.171 0.19 0.735
xsq DDX53 Xp22.11 0.171 0.19 0.735
exp TRA2B 3q26.2-q27 0.171 0.19 0.735 response to reactive oxygen species;RNA
xsq UFC1 1q23.3 0.171 0.19 0.735 protein ufmylation
exp CCDC152 5p12 0.171 0.19 0.735
met ATP1A1-AS1 0.171 0.19 0.735
exp UBXN1 11q12.3 0.171 0.19 0.735 negative regulation of protein
catabolic process
met PHLDA3 1q31 0.171 0.19 0.735 negative regulation of protein kinase B
signaling cascade;apoptotic process
exp FUZ 19q13.33 0.171 0.19 0.735 cell projection
organization;establishment of planar polarity
xsq PKMYT1 16p13.3 0.171 0.19 0.735 regulation of mitosis;negative
cop WDR72 15q21.3 0.171 0.19 0.735
exp STMN1 1p36.11 0.171 0.19 0.735 response to virus;cell differentiation
xsq RRP12 10q24.1 0.171 0.19 0.735
met ATP6V0A1 17q21 0.171 0.19 0.735 transferrin transport;transmembrane
transport
met CLDN18 3q22.3 -0.171 0.19 0.735
xsq CSRP3 11p15.1 -0.171 0.19 0.735 skeletal muscle tissue
met ELOVL5 6p21.1-p12.1 -0.171 0.19 0.735 EMT (Mesenchymal)
exp PLEKHA5 12p12 -0.171 0.19 0.735
mut TRPV6 7q34 -0.171 0.19 0.735 transmembrane transport;calcium ion
mut TBC1D2 9q22.33 -0.171 0.19 0.735 positive regulation of Rab
GTPase activity
cop FAM129A 1q25 -0.171 0.19 0.735 positive regulation of protein
xsq MUC20 3q29 -0.171 0.19 0.735 hepatocyte growth factor receptor
xsq ALK 2p23 -0.171 0.19 0.735 Oncogenes
xsq UNC5B 10q22.1 -0.171 0.19 0.735 Apoptosis
cop MIR383 -0.171 0.19 0.735
met DOK1 2p13 -0.172 0.19 0.734 intracellular protein kinase cascade;Ras
cop TUSC3 8p22 -0.172 0.19 0.734 Tumor Suppressors
xsq DOCK7 1p31.3 -0.172 0.19 0.734 axonogenesis;cell differentiation
xsq FBLN7 2q13 -0.172 0.19 0.734 cell adhesion
exp FAM161B 14q24.3 -0.172 0.19 0.734
mut RAB11FIP5 2p13 -0.172 0.19 0.734 protein transport
exp TRIM23 5q12.3 -0.172 0.19 0.734 positive regulation of
catalytic activity;interspecies interaction between organisms
exp LOC100130497 -0.172 0.19 0.734
exp HDAC7 12q13.1 -0.172 0.19 0.734 vasculogenesis;cell-cell junction
assembly
exp PCTP 17q21-q24 -0.172 0.19 0.734 lipid transport;cholesterol
metabolic process
met HBP1 7q22-q31 -0.172 0.19 0.734 regulation of transcription, DNA-
xsq OSBPL6 2q32.1 -0.172 0.19 0.734 transport;lipid transport
exp KRT7 12q13.13 -0.172 0.19 0.734 regulation of
mut TBC1D14 4p16.1 -0.172 0.19 0.734
xai UAP1L1 9q34.3 -0.173 0.19 0.735 metabolic process
hs4 PLEKHA2 8p11.22 -0.173 0.19 0.735 positive regulation of cell-
matrix adhesion
his C7orf61 7q22.1 -0.173 0.19 0.735
xai TMEM30A 6q14.1 -0.173 0.19 0.735 protein localization to
xai KIAA1841 2q14 -0.173 0.19 0.735
his STMND1 6p22.3 -0.173 0.19 0.735
hs4 GLIS3 9p24.2 -0.173 0.19 0.735 negative regulation of
promoter
hs4 LOC108783645 -0.173 0.19 0.735
hs4 HFE 6p21.3 -0.173 0.19 0.735 female pregnancy;antigen processing
and presentation of peptide antigen via MHC class I
xai ZBTB43 9q33.3 -0.173 0.19 0.735 regulation of transcription,
DNA-dependent"
swa GLUD1 10q23.3 -0.173 0.19 0.735 cellular amino acid biosynthetic
process;positive regulation of insulin secretion
exp RPS27P1 10q23.32 -0.173 0.19 0.734
his TMEM140 7q33 -0.173 0.19 0.734
hs4 ZSCAN16 6p22.1 -0.173 0.19 0.734 viral reproduction
his CTTNBP2 7q31 -0.173 0.19 0.734 brain development
swa SARS2 19q13.2 -0.173 0.19 0.734 tRNA aminoacylation for protein
hs4 NMRAL2P -0.173 0.19 0.734
xai CMTM5 14q11.2 -0.173 0.19 0.734 chemotaxis
hs4 RAB29 -0.173 0.19 0.734 GTP catabolic process;small GTPase
swa ILVBL 19p13.1 -0.173 0.19 0.734
hs4 LINC00355 -0.173 0.19 0.734
xai C2 6p21.3 -0.173 0.19 0.734 proteolysis;complement activation
his RGS4 1q23.3 -0.173 0.19 0.734 regulation of G-protein coupled
his KIF3A 5q31 -0.173 0.19 0.734 plus-end-directed vesicle transport along
microtubule;organelle organization
exp FLJ45513 17q21.33 -0.173 0.19 0.734
hs4 TBC1D19 4p15.2 -0.173 0.19 0.734
xai RPS27P1 10q23.32 -0.173 0.19 0.734
hs4 HOXA-AS3 7p15.2 -0.173 0.19 0.734
hs4 HOXA6 7p15.2 -0.173 0.19 0.734 multicellular organismal
hs4 CP 3q23-q25 -0.173 0.19 0.734 cellular iron ion
xai SEPT7 7p14.2 -0.173 0.19 0.734 cytokinesis;cell cycle
xai SYT11 1q21.2 -0.173 0.19 0.734
exp LINC01239 -0.173 0.19 0.734
exp LOC284344 -0.173 0.19 0.734
xai FAM189A2 9q21.11 -0.173 0.19 0.734
hs4 AHDC1 1p36.13 -0.173 0.19 0.734
xai TNR 1q24 -0.173 0.19 0.734 negative regulation of neuron projection
xai MORN5 9q33.2 -0.175 0.19 0.735
his LOC100505817 0.173 0.191 0.735
swa HECTD3 1p34.1 0.173 0.191 0.735 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;proteasomal ubiquitin-dependent
his NME3 16q13.3 0.173 0.191 0.735 Apoptosis
his MRPS34 16p13.3 0.173 0.191 0.735
his EME2 16p13.3 0.173 0.191 0.735 DNA Damage Response (DDR); DDR (HR)
hs4 HMGN1 21q22.2 0.173 0.191 0.735 positive regulation of transcription
his PRKRA 2q31.2 0.173 0.191 0.735 immune response;skeletal system
morphogenesis
his DFNB59 2q31.2 0.173 0.191 0.735 sensory perception of sound
his PPP3CA 4q24 0.173 0.191 0.735 protein dephosphorylation;negative
his FLJ20021 4q24 0.173 0.191 0.735
hs4 FCAR 19q13.42 0.173 0.191 0.735 immune response
hs4 RAPGEF4 2q31-q32 0.173 0.191 0.735 blood coagulation;regulation of
catalytic activity
hs4 RAPGEF4-AS1 2q31.1 0.173 0.191 0.735
hs4 GPR12 13q12 0.173 0.191 0.735 cellular calcium ion homeostasis;G-protein
swa EHMT1 9q34.3 0.173 0.191 0.735 DNA methylation;histone H3-K9 methylation
his LINC00635 3q13.12 0.173 0.191 0.735
his GPN2 1p36.11 0.173 0.191 0.735
his PPIE 1p32 0.173 0.191 0.735 nuclear mRNA splicing, via spliceosome;protein
peptidyl-prolyl isomerization
xai GNPDA2 4p12 0.173 0.191 0.735 carbohydrate metabolic process;N-
xai SMG1P5 0.173 0.191 0.735
his G3BP2 4q21.1 0.173 0.191 0.735 small GTPase mediated signal
transduction;Ras protein signal transduction
xai TFF1 21q22.3 0.173 0.191 0.735 carbohydrate metabolic process;response
to stress
his DCUN1D1 3q26.3 0.173 0.191 0.735
met MIR520D 0.173 0.191 0.735
his MAGIX Xp11.23 0.173 0.191 0.735
his PLP2 Xp11.23 0.173 0.191 0.735 ion transport;chemotaxis
swa SCARB1 12q24.31 0.173 0.191 0.735 Apoptosis
xai GAFA3 4p14 0.173 0.191 0.735
exp GFY 0.173 0.191 0.735
hs4 TBC1D5 3p24.3 0.173 0.191 0.735
hs4 LOC105376975 0.173 0.191 0.735
hs4 LINC01089 0.173 0.191 0.735
hs4 SETD1B 12q24.31 0.173 0.191 0.735 regulation of transcription, DNA-
his FABP2 4q28-q31 0.173 0.191 0.735 intestinal absorption;fatty acid
metabolic process
xai OR51A7 11p15.4 0.173 0.191 0.735 response to stimulus
xai CNST 1q44 0.173 0.191 0.735 negative regulation of phosphatase
activity;positive regulation of Golgi to plasma membrane protein transport
xai STARD4-AS1 0.173 0.191 0.735
swa NIT1 1q21-q22 0.173 0.191 0.735 nitrogen compound metabolic process
xai TUSC2 3p21.3 0.173 0.191 0.735 cell cycle;cell-cell signaling
hs4 NLE1 17q12 0.173 0.191 0.735 inner cell mass cell differentiation;Notch
signaling pathway
hs4 PTP4A2 1p35 0.173 0.191 0.735
hs4 HNRNPD 4q21 0.173 0.191 0.735 RNA processing;RNA catabolic process
his ATP6V0A2 12q24.31 0.173 0.191 0.735 immune response;insulin receptor
signaling pathway
hs4 SGO1 0.173 0.191 0.735
hs4 GALK1 17q24 0.173 0.191 0.735 small molecule metabolic process;carbohydrate
phosphorylation
xai BARX1 9q12 0.173 0.191 0.735 anterior/posterior pattern
xai HRH3 20q13.33 0.173 0.191 0.735 G-protein signaling, coupled to cyclic
nucleotide second messenger;neurotransmitter secretion"
his PFKL 21q22.3 0.173 0.191 0.735 small molecule metabolic process;negative
exp LOC100129033 6p25.1 0.173 0.191 0.735
his ERICH6-AS1 0.173 0.191 0.735
his ERICH6 0.173 0.191 0.735
his MIR3649 0.173 0.191 0.735
xai ANKRD39 2q11.2 0.173 0.191 0.735
exp UBE2DNL Xq21.1 0.173 0.191 0.735
hs4 BEGAIN 14q32.2 0.173 0.191 0.735
his UPF2 10p14-p13 0.173 0.191 0.735 mRNA export from nucleus;gene expression
his LBP 20q11.23 0.173 0.191 0.735 lipid transport;response to
lipopolysaccharide
exp ZRANB2-AS1 1p31.1 0.173 0.191 0.735
hs4 SNORD131 0.173 0.191 0.735
hs4 SPOUT1 0.173 0.191 0.735
his PDP2 16q22.1 0.172 0.191 0.735 pyruvate metabolic process;protein
dephosphorylation
his DPAGT1 11q23.3 0.172 0.191 0.735 dolichol biosynthetic process;post-
xai MAN1A1 6q22 0.172 0.191 0.735 post-translational protein
exp MEP1B 18q12.2-q12.3 0.172 0.191 0.735 digestion;proteolysis
hs4 DDX43 6q13 0.172 0.191 0.735
his CCDC114 19q13.33 0.172 0.191 0.735
his EMP3 19q13.3 0.172 0.191 0.735 EMT (Mesenchymal)
polymerase III promoter
met GOLT1A 1q32.1 0.171 0.191 0.735 protein transport;vesicle-mediated
transport
xsq C19orf25 19p13.3 0.171 0.191 0.735
xsq NUDT2 9p13 0.171 0.191 0.735 Apoptosis
exp DIABLO 12q24.31 0.171 0.191 0.735 Apoptosis
xsq LINC00163 0.171 0.191 0.735
cop ARL1 12q23.2 0.171 0.191 0.735 Golgi organization;small GTPase mediated
signal transduction
cop SPIC 12q23.2 0.171 0.191 0.735 Transcription Factors
met GPHB5 14q23.2 0.171 0.191 0.735
exp RNF180 5q12.3 0.171 0.191 0.735 positive regulation of proteasomal
xsq DISP2 15q15.1 0.171 0.191 0.735 smoothened signaling pathway
exp LILRB4 19q13.4 0.171 0.191 0.735 signal transduction;negative
xsq MROH7 1p32.3 0.171 0.191 0.735
xsq GUCY2D 17p13.1 0.171 0.191 0.735 cGMP biosynthetic process;receptor
xsq LILRP2 19q13.4 0.171 0.191 0.735
xsq WDR76 15q15.3 0.171 0.191 0.735
xsq IL17C 0.171 0.191 0.735
xsq BCYRN1 2p21 0.171 0.191 0.735
exp PPID 4q31.3 0.171 0.191 0.735 protein folding
exp PTPRA 20p13 0.171 0.191 0.735 protein phosphorylation;axon guidance
exp CLYBL 13q32 0.171 0.191 0.735 cellular aromatic compound metabolic process
xsq C14orf177 14q32.2 0.171 0.191 0.735
exp RIC8B 12q23.3 0.171 0.191 0.735 regulation of G-protein coupled receptor
exp SMAD2 18q21.1 0.171 0.191 0.735 Apoptosis; Cell Signaling
xsq HMGN1 21q22.2 0.171 0.191 0.735 positive regulation of transcription
met FOXQ1 6p25 0.171 0.191 0.735 hair follicle morphogenesis;positive regulation
of cysteine-type endopeptidase activity involved in apoptotic process
exp EPRS 1q41 0.171 0.191 0.735 glutamyl-tRNA aminoacylation;prolyl-tRNA
aminoacylation
cop SMAD3 15q22.33 0.171 0.191 0.735 Apoptosis
xsq LOC401557 0.171 0.191 0.735
dependent"
cop C9orf129 9q22.31 0.171 0.191 0.735
cop FAM120AOS 9q22.31 0.171 0.191 0.735
cop FAM120A 9q22.31 0.171 0.191 0.735
cop PHF2 9q22.31 0.171 0.191 0.735 protein demethylation;chromatin
modification
xsq RRP7A 22q13.2 0.171 0.191 0.735
xsq NDUFS3 11p11.11 0.171 0.191 0.735 small molecule metabolic
process;reactive oxygen species metabolic process
exp GIMAP7 7q36.1 0.171 0.191 0.735
exp MTM1 Xq28 0.171 0.191 0.735 protein dephosphorylation;endosome to lysosome
transport
met DDAH2 6p21.3 0.171 0.191 0.735 Apoptosis
exp UPF3AP1 17p11.2 0.171 0.191 0.735
exp RHOXF2B Xq24 0.171 0.191 0.735
met SCG5 15q13-q14 0.171 0.191 0.735 peptide hormone processing;negative
xsq ADAMTS17 15q24 0.171 0.191 0.735 proteolysis
met NLRP6 11p15 0.171 0.191 0.735 regulation of inflammatory response
xsq NCAPH2 22q13.33 0.171 0.191 0.735 DNA Damage Response (DDR)
met SLC25A51P1 6q12 0.171 0.191 0.735
exp KCNJ3 2q24.1 0.171 0.191 0.735 response to electrical stimulus;ion
transport
cop WSB2 12q24.23 0.171 0.191 0.735 intracellular signal transduction
mut GPLD1 6p22.1 0.171 0.191 0.735 insulin receptor signaling
pathway;cellular response to insulin stimulus
xsq CLDN14 21q22.3 0.171 0.191 0.735 cell junction assembly;cell-cell
cop CHD9 16q12.2 0.171 0.191 0.735 regulation of transcription, DNA-
cop LOC643802 16q12.2 0.171 0.191 0.735
cop RBL2 16q12.2 0.171 0.191 0.735 G1 phase of mitotic cell cycle;mitotic
cell cycle
cop AKTIP 16q12.2 0.171 0.191 0.735 positive regulation of protein
binding;early endosome to late endosome transport
met CEACAM1 19q13.2 0.171 0.191 0.735 homophilic cell adhesion;integrin-
mut SOX5 12p12.1 -0.171 0.191 0.735 transcription from RNA polymerase
II promoter;positive regulation of chondrocyte differentiation
met CD300A 17q25.1 -0.171 0.191 0.735 cell adhesion
exp LOC643058 12q13.11 -0.171 0.191 0.735
exp SFRP1 8p11.21 -0.171 0.191 0.735 ureteric bud development;negative
mut NUDCD2 5q34 -0.171 0.191 0.735
mut ZBTB25 14q23-q24 -0.171 0.191 0.735 regulation of transcription,
DNA-dependent;gene expression"
cop PTEN 10q23.3 -0.171 0.191 0.735 Apoptosis; Cell Signaling; DNA
Damage Response (DDR); DDR (DNA replication); Protein Kinases; Tumor Suppressors
met CELA2A 1p36.21 -0.171 0.191 0.735 proteolysis
xsq ERBB2IP 5q12.3 -0.171 0.191 0.735 signal transduction;epidermal
mut TMEFF2 2q32.3 -0.171 0.191 0.735
exp PTPRZ1 7q31.3 -0.171 0.191 0.735 protein
xsq BCAS1 20q13.2 -0.171 0.191 0.735
cop MSR1 8p22 -0.171 0.191 0.735 response to chemical stimulus;lipoprotein
transport
mut TGM6 20p13 -0.171 0.191 0.735 peptide cross-linking;cell death
mir hsa-miR-34c-5p -0.171 0.191 0.735
mut AAR2 20pter-q12 -0.171 0.191 0.735
met DLG4 17p13.1 -0.171 0.191 0.735 synaptic transmission;receptor
localization to synapse
cop SDCCAG8 1q43 -0.171 0.191 0.735 mitotic cell cycle;establishment of
cell polarity
cop MYBL1 8q13.1 -0.171 0.191 0.735 regulation of transcription, DNA-
cop ALG10B 12q12 -0.171 0.191 0.735 dolichol-linked oligosaccharide
exp B4GALT2 1p34-p33 -0.171 0.191 0.735 post-translational protein
xsq CPA6 8q13.2 -0.171 0.191 0.735 proteolysis
mut RUNX3 1p36 -0.171 0.191 0.735 Apoptosis
cop PSPH 7p11.2 -0.171 0.191 0.735 L-serine biosynthetic
cop CCT6A 7p11.2 -0.171 0.191 0.735 protein folding;cellular protein
metabolic process
cop SNORA15 -0.171 0.191 0.735
cop SUMF2 7q11.1 -0.171 0.191 0.735
cop PHKG1 7p11.2 -0.171 0.191 0.735 carbohydrate metabolic
xsq IFNGR2 21q22.11 -0.171 0.191 0.735 cell surface receptor
mut CLIC3 9q34.3 -0.171 0.191 0.735 ion transport;chloride transport
met MYBL2 20q13.1 -0.171 0.191 0.735 Apoptosis
met GPR27 3p21-p14 -0.171 0.191 0.735 signal transduction;G-protein
mut ETFB 19q13.3 -0.171 0.191 0.735 transport;respiratory electron
transport chain
exp NID1 1q43 -0.171 0.191 0.735 cell adhesion;cell-matrix adhesion
exp PRPF40B 12q13.12 -0.171 0.191 0.735 mRNA processing;RNA splicing
his MIR7112 -0.172 0.191 0.735
his SCX -0.172 0.191 0.735
hs4 SULF1 8q13.2 -0.172 0.191 0.735 esophagus smooth muscle
hs4 GPR1-AS -0.173 0.191 0.735
exp LINC00691 3p24.2 -0.173 0.191 0.735
his HDAC7 12q13.1 -0.173 0.191 0.735 vasculogenesis;cell-cell junction
assembly
xai HMCN1 1q25.3-q31.1 -0.173 0.191 0.735 visual perception;response to
stimulus
exp GPR173 Xp11 -0.173 0.191 0.735 signal transduction;G-protein
his LINC00882 -0.173 0.191 0.735
his DUBR -0.173 0.191 0.735
xai LOC440300 -0.173 0.191 0.735
xai SBF2 11p15.4 -0.173 0.191 0.735 regulation of catalytic
activity;protein tetramerization
hs4 DOCK7 1p31.3 -0.173 0.191 0.735 axonogenesis;cell differentiation
xai KIAA1644 -0.173 0.191 0.735
hs4 CLDN8 21q22.11 -0.173 0.191 0.735 calcium-independent cell-cell
adhesion
hs4 MAGEF1 3q13 -0.173 0.191 0.735
xai LINC00310 21q22.11 -0.173 0.191 0.735
xai BNIPL 1q21.3 -0.173 0.191 0.735 apoptotic process;induction of
apoptosis
his TNK1 17p13.1 -0.173 0.191 0.735 protein autophosphorylation;protein
phosphorylation
his MIR107 -0.173 0.191 0.735
swa LIMA1 12q13 -0.173 0.191 0.735 negative regulation of actin filament
depolymerization;ruffle organization
xai LOC100507156 -0.173 0.191 0.735
hs4 PI4KA 22q11.21 -0.173 0.191 0.735 phosphatidylinositol-mediated
hs4 SNAP29 22q11.21 -0.173 0.191 0.735 exocytosis;vesicle targeting
xai CTNNAL1 9q31.2 -0.173 0.191 0.735 Apoptosis
hs4 LOC553103 -0.173 0.191 0.735
xai TMEM178B -0.173 0.191 0.735
exp HOXA-AS3 7p15.2 -0.173 0.191 0.735
exp FMO4 1q24.3 -0.173 0.191 0.735 xenobiotic metabolic process
xai EPHB4 7q22 -0.173 0.191 0.735 protein autophosphorylation;ephrin
his GSTA7P 6p12.2 -0.173 0.191 0.735
hs4 MGLL 3q21.3 -0.173 0.191 0.735 regulation of signal
hs4 FLCN 17p11.2 -0.173 0.191 0.735 regulation of protein
phosphorylation
exp OR10S1 11q24.1 -0.173 0.191 0.735 response to stimulus
his PBX4 19p12 -0.173 0.191 0.735 transcription from RNA polymerase II
xai EIF2AK4 15q15.1 -0.173 0.191 0.735 cellular response to
starvation;negative regulation of translation
hs4 ADAMTS16 5p15 -0.173 0.191 0.735 proteolysis
hs4 CTD-2297D10.2 -0.173 0.191 0.735
xai FAM19A3 1p13.2 -0.173 0.191 0.735
his LINC01203 -0.173 0.191 0.735
hs4 JAK2 9p24 -0.173 0.191 0.735 Oncogenes; Protein Kinases
his ZFPM2-AS1 -0.173 0.191 0.735
hs4 LINC00909 18q22.3 0.172 0.192 0.735
hs4 C15orf39 15q24.2 0.172 0.192 0.736
his LOC100996385 0.172 0.192 0.736
his FAM153B 5q35.2 0.172 0.192 0.736
hs4 KCNK9 8q24.3 0.172 0.192 0.736 synaptic transmission;potassium ion
xai HOXB13 17q21.2 0.172 0.192 0.736 regulation of growth;prostate
epithelial cord arborization involved in prostate glandular acinus morphogenesis
xai CACNA2D4 12p13.33 0.172 0.192 0.736 ion transport
xai THEMIS2 1p35.3 0.172 0.192 0.736
xai STRN 2p22.2 0.172 0.192 0.736 locomotory behavior;negative regulation
xai ANAPC15 11q13.4 0.172 0.192 0.736
his POGZ 1q21.3 0.172 0.192 0.736 regulation of transcription, DNA-
his UMAD1 0.172 0.192 0.736
his C1orf145 0.172 0.192 0.736
hs4 ROCK1 18q11.1 0.172 0.192 0.736 Apoptosis; Protein Kinases
swa HBS1L 6q23.3 0.172 0.192 0.736 signal transduction;translation
exp TRBV4-1 0.172 0.192 0.736
hs4 NAA20 20p11.23 0.172 0.192 0.736
his TRADD 16q22 0.172 0.192 0.736 Apoptosis
his FBXL8 16q22.1 0.172 0.192 0.736
his HSF4 16q21 0.172 0.192 0.736 positive regulation of cell
proliferation;histone H3-K9 demethylation
hs4 SH3BP1 22q13.1 0.172 0.192 0.736 signal transduction
xai COX10-AS1 0.172 0.192 0.736
his ZSCAN31 6p21.31 0.172 0.192 0.736
xai FUZ 19q13.33 0.172 0.192 0.736 cell projection
exp NDUFA3P3 1q42.12 0.172 0.192 0.736
xai TRBV4-1 0.172 0.192 0.736
exp ZC3H10 12q13.2 0.172 0.192 0.736
xai GIMAP7 7q36.1 0.172 0.192 0.736
xai AP1G1 16q23 0.172 0.192 0.736 post-Golgi vesicle-mediated
xai ARNT 1q21 0.172 0.192 0.736 cell differentiation;positive regulation of
his PRR25 16p13.3 0.172 0.192 0.736
xai ACIN1 14q11.2 0.172 0.192 0.736 apoptotic chromosome
his NAA40 11q13.1 0.172 0.192 0.736
xai RPS28 19p13.2 0.172 0.192 0.736 nuclear-transcribed mRNA catabolic
his LSM10 1p34.3 0.172 0.192 0.736 mRNA processing;histone mRNA metabolic
process
his PCSK4 19p13.3 0.172 0.192 0.736 fertilization;sperm capacitation
his REEP6 19p13.3 0.172 0.192 0.736
his PIEZO2 18p11.22 0.172 0.192 0.736 ion transport
xai KRAS 12p12.1 0.172 0.192 0.736 Cell Signaling; Oncogenes; Protein
Kinases
xai FAM206BP 13q14.13 0.172 0.192 0.736
swa UBE2C 20q13.12 0.172 0.192 0.736 mitosis;phosphatidylinositol-mediated
signaling
xai NEFH 22q12.2 0.172 0.192 0.736 microtubule cytoskeleton
xai MRPS18B 6p21.3 0.172 0.192 0.736 translation
xai EBP Xp11.23-p11.22 0.172 0.192 0.736 cholesterol metabolic
process;hemopoiesis
his SFXN1 5q35.3 0.172 0.192 0.736 transmembrane transport;iron ion
transport
his IL21R 16p11 0.172 0.192 0.736 natural killer cell activation
xai ZNF496 1q44 0.172 0.192 0.736 negative regulation of transcription from
RNA polymerase II promoter;viral reproduction
his MIR4465 0.172 0.192 0.736
exp STRN 2p22.2 0.172 0.192 0.736 locomotory behavior;negative regulation
xai BZW1 2q33 0.172 0.192 0.736 regulation of transcription, DNA-dependent;RNA
metabolic process"
xai ZDHHC12 9q34.11 0.172 0.192 0.736
exp ECEL1P3 2q37.1 0.172 0.192 0.736
hs4 NDUFS8 11q13 0.172 0.192 0.736 small molecule metabolic
hs4 MIR7113 0.172 0.192 0.736
hs4 MIR4691 0.172 0.192 0.736
xai IL6R 1q21 0.172 0.192 0.736 positive regulation of cell
xai CDC34 19p13.3 0.172 0.192 0.736 negative regulation of cAMP-mediated
his SLC18B1 6q22.3-q23.3 0.172 0.192 0.736 transmembrane transport
his NOSTRIN 2q31.1 0.172 0.192 0.736 endocytosis;small molecule
metabolic process
his LOC339862 0.172 0.192 0.736
xsq EGFLAM-AS4 0.171 0.192 0.735
exp CCND3 6p21 0.171 0.192 0.736 DNA Damage Response (DDR); DDR (G1-S
exp BEX5 Xq22.1 0.171 0.192 0.736
xsq NUTM2B-AS1 0.171 0.192 0.736
met PSMC3 11p11.2 0.171 0.192 0.736 antigen processing and presentation of
peptide antigen via MHC class I;mRNA metabolic process
exp PDCL3 2q11.2 0.171 0.192 0.736 Apoptosis
met STX3 11q12.1 0.171 0.192 0.736 cellular membrane fusion;neuron
xsq SCFD2 4q12 0.171 0.192 0.736 vesicle docking involved in exocytosis;protein
transport
cop UTP20 12q23 0.171 0.192 0.736 rRNA processing;negative regulation of cell
proliferation
xsq TBC1D15 12q21.1 0.171 0.192 0.736 regulation of Rab GTPase
activity;positive regulation of Rab GTPase activity
met CHCHD6 3q21.3 0.171 0.192 0.736
cop ACAD10 12q24.12 0.171 0.192 0.736
cop AQR 15q14 0.171 0.192 0.736 nuclear mRNA splicing, via spliceosome;RNA
splicing"
dependent"
xsq LEMD3 12q14 0.171 0.192 0.736 negative regulation of transforming growth
xsq NPIPB4 16p12.2 0.171 0.192 0.736
xsq AGPAT2 9q34.3 0.171 0.192 0.736 positive regulation of cytokine
met RSPH10B2 7p22.1 0.171 0.192 0.736
exp SARNP 12q13.2 0.171 0.192 0.736 regulation of transcription, DNA-
xsq TATDN1 8q24.13 0.171 0.192 0.736
xsq HCN4 15q24.1 0.171 0.192 0.736 in utero embryonic development;cation
transport
cop FRMD1 6q27 0.171 0.192 0.736
exp TBPL1 6q22.1-q22.3 0.171 0.192 0.736 transcription initiation from RNA
met XKR3 22q11.1 0.171 0.192 0.736
xsq ZCCHC4 4p15.2 0.171 0.192 0.736
met PLA2G5 1p36-p34 0.171 0.192 0.736 response to cAMP;phospholipid
metabolic process
exp TBC1D14 4p16.1 0.171 0.192 0.736
xsq TBX5-AS1 0.171 0.192 0.736
xsq TMEM213 7q34 0.171 0.192 0.736
xsq LOC100128568 0.171 0.192 0.736
exp IMPA1 8q21.13-q21.3 0.171 0.192 0.736 phosphatidylinositol biosynthetic
xsq PHF14 7p21.3 0.171 0.192 0.736
met PXDN 2p25 0.171 0.192 0.736 hydrogen peroxide catabolic process;oxidation-
reduction process
cop CDH16 16q22.1 0.171 0.192 0.736 cell adhesion;homophilic cell adhesion
cop RRAD 16q22 0.171 0.192 0.736 GTP catabolic process;signal transduction
cop FAM96B 16q22.1 0.171 0.192 0.736 chromosome segregation
cop CES2 16q22.1 0.171 0.192 0.736 catabolic process
cop CES3 16q22.1 0.171 0.192 0.736
met CNGA2 Xq27 0.171 0.192 0.736 ion transmembrane transport;response to
stimulus
exp RPL7P56 Xq26.3 0.171 0.192 0.736
met WDFY3 4q21.23 0.171 0.192 0.736 metabolic process
exp FLVCR1-AS1 1q32.3 0.171 0.192 0.736
exp AADAC 3q25.1 0.171 0.192 0.736 metabolic process;positive regulation of
triglyceride catabolic process
xsq ZRANB2 1p31 0.171 0.192 0.736 regulation of transcription, DNA-
met SLC9A3R2 16p13.3 0.171 0.192 0.736 Solute Carriers
exp C8orf33 8q24.3 0.171 0.192 0.736
exp ING3 7q31 0.171 0.192 0.736 regulation of transcription, DNA-
xsq DHX34 19q13.3 0.171 0.192 0.736
exp NDUFAF5 20p12.1 0.171 0.192 0.736
exp TMPRSS15 21q21.1 0.171 0.192 0.736 proteolysis
exp SEC16B 1q25.2 -0.171 0.192 0.736 protein transport;vesicle-
mediated transport
exp SYAP1 Xp22.2 -0.171 0.192 0.736
xsq PDZK1IP1 1p33 -0.171 0.192 0.736
mut ARCN1 11q23.3 -0.171 0.192 0.736 retrograde vesicle-mediated
transport, Golgi to ER;cellular membrane organization
met DFNB59 2q31.2 -0.171 0.192 0.736 sensory perception of sound
met HAAO 2p21 -0.171 0.192 0.736 small molecule metabolic process;response
to cadmium ion
xsq APOBEC3F 22q13.1 -0.171 0.192 0.736 negative regulation of
host
exp GLI3 7p13 -0.171 0.192 0.736 axon guidance;pallium development
exp PTCHD4 6p12.3 -0.171 0.192 0.736
cop VCPIP1 8q13 -0.171 0.192 0.736 endoplasmic reticulum membrane
fusion;protein ubiquitination
cop C8orf44 8q13.1 -0.171 0.192 0.736
cop PTTG3P 8q13.1 -0.171 0.192 0.736 DNA metabolic
process;chromosome organization
exp COL7A1 3p21.1 -0.171 0.192 0.736 cell adhesion;epidermis
development
exp IRAK2 3p25.3 -0.171 0.192 0.736 Protein Kinases
xsq SERPINA6 14q32.1 -0.171 0.192 0.736 regulation of
met E2F8 11p15.1 -0.171 0.192 0.736 cell cycle
xsq LINC01151 -0.171 0.192 0.736
exp LOC401770 14q21.2 -0.171 0.192 0.736
exp AMZ1 7p22.3 -0.171 0.192 0.736 proteolysis
met TAC4 17q21.33 -0.171 0.192 0.736
met TMEM82 1p36.21 -0.171 0.192 0.736
dependent"
exp LMO7 13q22.2 -0.171 0.192 0.736 protein ubiquitination
exp EFR3A 8q24.22 -0.171 0.192 0.736
xsq TAX1BP3 17p13 -0.171 0.192 0.736 negative regulation of cell
exp SFTA1P 10p14 -0.171 0.192 0.736
met ABHD14B 3p21.2 -0.171 0.192 0.736
met MIR137 -0.171 0.192 0.736
xsq CDCP1 3p21.31 -0.171 0.192 0.736
cop GLIS3 9p24.2 -0.171 0.192 0.736 negative regulation of
promoter
xsq RNASE7 14q11.2 -0.171 0.192 0.735 response to bacterium;defense
xai DKFZp434J0226 19q13.32 -0.172 0.192 0.736
xai MITF 3p14.2-p14.1 -0.172 0.192 0.736 multicellular organismal
DNA-dependent"
xai MT1F 16q13 -0.172 0.192 0.736 negative regulation of growth;cellular
his FAM155A-IT1 -0.172 0.192 0.736
xai CFI 4q25 -0.172 0.192 0.736 complement activation, classical
hs4 SYT13 11p12-p11 -0.172 0.192 0.736 vesicle-mediated transport
xai SLC25A34 1p36.21 -0.172 0.192 0.736 transport
exp LOC100507006 -0.172 0.192 0.736
hs4 MAF 16q22-q23 -0.172 0.192 0.736 transcription from RNA polymerase
II promoter
his LOC101927640 -0.172 0.192 0.736
his LOC105376365 -0.172 0.192 0.736
hs4 PICK1 22q13.1 -0.172 0.192 0.736 protein phosphorylation;receptor
clustering
his LINC01119 -0.172 0.192 0.736
his IFIT1 10q23.31 -0.172 0.192 0.736 negative regulation of viral genome
hs4 ALS2CR11 2q33.1 -0.172 0.192 0.736
xai ANKRD35 1q21.1 -0.172 0.192 0.736
his LOC613266 -0.172 0.192 0.736
his SLC35D2 9q22.32 -0.172 0.192 0.736 Solute Carriers
his MIR4694 -0.172 0.192 0.736
hs4 TRIM61 4q32.3 -0.172 0.192 0.736
xai TBC1D3P5 17q11.1 -0.172 0.192 0.736
his WWC1 5q34 -0.172 0.192 0.736 regulation of transcription, DNA-
his CAV2 7q31.1 -0.172 0.192 0.736 mitochondrion organization;protein
oligomerization
his GPR39 2q21-q22 -0.172 0.192 0.735 G-protein coupled receptor
signaling pathway
xai LINC00115 0.174 0.193 0.737
xai KAT2A 17q21 0.172 0.193 0.736 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
xai ZC3H10 12q13.2 0.172 0.193 0.736
xai ATG9B 7q36.1 0.172 0.193 0.737 autophagic vacuole assembly;autophagy
xai POP5 12q24.31 0.172 0.193 0.737 tRNA processing;RNA metabolic process
his GPR68 14q31 0.172 0.193 0.737 inflammatory response;G-protein coupled
his CH17-340M24.3 0.172 0.193 0.737
his ATP6AP1 Xq28 0.172 0.193 0.737 ion transport;aging
his GGA2 16p12 0.172 0.193 0.737 vesicle-mediated transport;intracellular
protein transport
exp MTND5P8 0.172 0.193 0.737
hs4 SMARCC1 3p21.31 0.172 0.193 0.737 DNA Damage Response (DDR); DDR
(Chromatin)
his AP4E1 15q21.2 0.172 0.193 0.737 intracellular protein transport;vesicle-
mediated transport
his SMU1 9p12 0.172 0.193 0.737
his MTMR6 13q12 0.172 0.193 0.737 protein dephosphorylation;peptidyl-tyrosine
dephosphorylation
xai ULK3 15q24.1 0.172 0.193 0.737 autophagy;negative regulation of
hs4 KHK 2p23.3 0.172 0.193 0.737 response to sucrose stimulus;response to
glucose stimulus
xai GAPDHP14 0.172 0.193 0.737
hs4 IRAK3 12q14.3 0.172 0.193 0.737 Protein Kinases
exp OR5H14 0.172 0.193 0.737 response to stimulus
his TDG 12q24.1 0.172 0.193 0.737 DNA Damage Response (DDR); DDR (BER)
xai OR5H14 0.172 0.193 0.737 response to stimulus
exp CYCSP10 0.172 0.193 0.737
exp CACNA1C-AS1 0.172 0.193 0.737
xai LMF1 16p13.3 0.172 0.193 0.737 protein glycosylation in
Golgi;chylomicron remnant clearance
hs4 ANKRD36C 2q11.1 0.172 0.193 0.737
xai MTND5P8 0.172 0.193 0.737
hs4 DCTPP1 16p11.2 0.172 0.193 0.737 nucleoside triphosphate catabolic
process;protein homotetramerization
hs4 MFSD13A 0.172 0.193 0.737
his OR2T10 1q44 0.172 0.193 0.737 response to stimulus
his CCDC78 16p13.3 0.172 0.193 0.737
his HAGHL 16p13.3 0.172 0.193 0.737
exp TSEN15P1 0.172 0.193 0.737
xai KCNJ6 21q22.1 0.172 0.193 0.737 potassium ion transport;synaptic
transmission
swa USP10 16q24.1 0.172 0.193 0.737 protein deubiquitination;DNA damage
hs4 HNRNPK 9q21.32-q21.33 0.172 0.193 0.737 nuclear mRNA splicing, via
spliceosome;positive regulation of transcription from RNA polymerase II promoter
hs4 RMI1 9q21.32 0.172 0.193 0.737 DNA Damage Response (DDR)
hs4 PGP 16p13.3 0.172 0.193 0.737 metabolic process;carbohydrate metabolic
process
his NUDT16L1 16p13.3 0.172 0.193 0.737
his RND1 12q12 0.172 0.193 0.737 actin filament organization;negative regulation
of cell adhesion
his RAVER1 19p13.2 0.172 0.193 0.737
xai TSEN15P1 0.172 0.193 0.737
his TNPO3 7q32.1 0.172 0.193 0.737 protein transport;splicing factor protein
import into nucleus
his TPI1P2 7q32.1 0.172 0.193 0.737
xai MESDC2 15q13 0.172 0.193 0.737 protein folding;mesoderm development
hs4 PIGS 17p13.2 0.172 0.193 0.737 C-terminal protein lipidation;attachment
of GPI anchor to protein
his HOMEZ 14q11.2 0.172 0.193 0.737
swa CORO7 16p13.3 0.172 0.193 0.737 actin cytoskeleton organization
hs4 F8 Xq28 0.172 0.193 0.737 blood coagulation;blood coagulation, intrinsic
pathway
hs4 H2AFB1 0.172 0.193 0.737
hs4 F8A1 0.172 0.193 0.737
hs4 MIR1184-1 0.172 0.193 0.737
xai GAK 4p16 0.172 0.193 0.737 cell cycle
hs4 TRPM7 15q21 0.172 0.193 0.737 transmembrane transport;ion transport
hs4 BLK 8p23-p22 0.172 0.193 0.737 Apoptosis
his MCUR1 6p23 0.172 0.193 0.737
xai SOCS2 12q 0.172 0.193 0.737 Apoptosis
swa NSUN2 5p15.31 0.172 0.193 0.737 tRNA processing;tRNA methylation
hs4 INSIG1 7q36 0.172 0.193 0.737 ER-nuclear sterol response
pathway;triglyceride metabolic process
exp ZEB1 10p11.2 0.171 0.193 0.737 central nervous system
cop CBLN1 16q12.1 0.171 0.193 0.737 synaptic transmission;nervous system
development
xsq OR10Z1 1q23.1 0.171 0.193 0.737 response to stimulus
xsq P2RY13 3q24 0.171 0.193 0.737
cop VPS39 15q15.1 0.171 0.193 0.737 protein transport
xsq ZNF674-AS1 Xp11.23 0.171 0.193 0.737
cop VSIG10 12q24.23 0.171 0.193 0.737
dependent"
xsq IP6K2 3p21.31 0.171 0.193 0.737 Apoptosis
met CMTM4 16q21-q22.1 0.171 0.193 0.737 chemotaxis
xsq FAAP24 0.17 0.193 0.737 DNA Damage Response (DDR); DDR (FA)
exp GMDS 6p25 0.17 0.193 0.737 'de novo' GDP-L-fucose biosynthetic
met SMG8 17q22 0.17 0.193 0.737 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;gene expression
xsq RNF122 8p12 0.17 0.193 0.737
xsq RIPK3 14q11.2 0.17 0.193 0.737 induction of apoptosis by extracellular
signals;protein modification process
met BLNK 10q23.2-q23.33 0.17 0.193 0.737 inflammatory response;humoral
immune response
exp NSUN5P1 0.17 0.193 0.737
xsq HNRNPA1P33 10q11.22 0.17 0.193 0.737
met SNORA37 18q21.2 0.17 0.193 0.737
xsq MRPS16 10q22.1 0.17 0.193 0.737 translation
exp RIMKLA 1p34.2 0.17 0.193 0.737 protein modification process
mut ALDH1A1 9q21.13 0.17 0.193 0.737 cellular aldehyde metabolic
cop ZNF19 16q22 0.17 0.193 0.737 regulation of transcription, DNA-dependent"
cop NARG2 0.17 0.193 0.737
met FAAH 1p35-p34 0.17 0.193 0.737 fatty acid catabolic process
xsq NME2 0.17 0.193 0.737
mut IMPG1 6q14.2-q15 0.17 0.193 0.737
cop DCUN1D4 4q12 0.17 0.193 0.737
mut TGFBR3 1p33-p32 0.17 0.193 0.737 Apoptosis
xsq LINC01341 0.17 0.193 0.737
cop LOC153910 6q24.2 0.17 0.193 0.737
cop HIVEP2 6q23-q24 0.17 0.193 0.737 regulation of transcription, DNA-
dependent"
cop LOC100507489 0.17 0.193 0.737
cop AIG1 6q24.2 0.17 0.193 0.737
xsq HNF4A-AS1 0.17 0.193 0.737
exp RPS6KA6 Xq21 0.17 0.193 0.737 Protein Kinases
met PDILT 16p12.3 0.17 0.193 0.737
met LOC643406 20p12.3 0.17 0.193 0.737
cop GNAL 18p11.22-p11.21 0.17 0.193 0.737 signal transduction;G-protein
exp MAMSTR 19q13.33 0.17 0.193 0.737 regulation of transcription, DNA-
cop MIR548W 0.17 0.193 0.737
xsq PGD 1p36.22 0.17 0.193 0.737 pentose biosynthetic process;small
xsq RPL37 5p13 0.17 0.193 0.737 translational elongation;viral transcription
cop B3GNT9 16q22.1 0.17 0.193 0.737 protein glycosylation
cop TRADD 16q22 0.17 0.193 0.737 Apoptosis
cop FBXL8 16q22.1 0.17 0.193 0.737
cop HSF4 16q21 0.17 0.193 0.737 positive regulation of cell
cop NOL3 16q22.1 0.17 0.193 0.737 Apoptosis
cop KIAA0895L 16q22.1 0.17 0.193 0.737
cop EXOC3L1 16q22.1 0.17 0.193 0.737 exocytosis;peptide hormone
secretion
cop E2F4 16q22.1 0.17 0.193 0.737 mitotic cell cycle;cilium assembly
cop ELMO3 16q22.1 0.17 0.193 0.737 EMT (Epithelial)
cop MIR328 0.17 0.193 0.737
cop LRRC29 16q22.1 0.17 0.193 0.737
cop TMEM208 16q22.1 0.17 0.193 0.737
cop FHOD1 16q22 0.17 0.193 0.737 positive regulation of transcription from RNA
polymerase II promoter;positive regulation of stress fiber assembly
cop PLEKHG4 16q22.1 0.17 0.193 0.737 regulation of Rho protein signal
transduction
cop KCTD19 16q22.1 0.17 0.193 0.737 potassium ion transport
cop LRRC36 16q22.1 0.17 0.193 0.737
cop TPPP3 16q22.1 0.17 0.193 0.737 microtubule bundle formation
cop ZDHHC1 16q22.1 0.17 0.193 0.737 protein palmitoylation
cop HSD11B2 16q22 0.17 0.193 0.737 response to insulin stimulus;response to
drug
cop ATP6V0D1 16q22.1 0.17 0.193 0.737 activation of signaling protein
activity involved in unfolded protein response;transmembrane transport
cop AGRP 16q22 0.17 0.193 0.737
cop FAM65A 16q22.1 0.17 0.193 0.737
xsq NDUFS6 5p15.33 0.17 0.193 0.737 transport;respiratory electron
transport chain
met COX7A1 19q13.1 0.17 0.193 0.737 generation of precursor metabolites
and energy
met SRSF6 20q12-q13.1 0.17 0.193 0.737 RNA splicing;gene expression
dependent"
dependent"
xsq RFFL 17q12 0.17 0.193 0.737 intracellular protein transport;apoptotic
process
exp TMEM115 3p21.3 -0.17 0.193 0.737 replicative cell aging;negative
exp MSI1 12q24 -0.17 0.193 0.737 nervous system development;response to hormone
stimulus
xsq MARCH3 5q23.2 -0.17 0.193 0.737 endocytosis
xsq PLEKHH2 2p21 -0.17 0.193 0.737
xsq RORA 15q22.2 -0.17 0.193 0.737 positive regulation of transcription from
RNA polymerase II promoter;cGMP metabolic process
met GSE1 16q24.1 -0.17 0.193 0.737
cop FNDC3B 3q26.31 -0.17 0.193 0.737
exp KNDC1 10q26.3 -0.17 0.193 0.737 regulation of dendrite
xsq GFRA1 10q26.11 -0.17 0.193 0.737 glial cell-derived neurotrophic factor
receptor signaling pathway;cell surface receptor signaling pathway
met TFB1M 6q25.1-q25.3 -0.17 0.193 0.737 regulation of transcription, DNA-
dependent"
xsq SIRPA 20p13 -0.17 0.193 0.737 cell adhesion;blood coagulation
exp PICK1 22q13.1 -0.17 0.193 0.737 protein phosphorylation;receptor
clustering
xsq LOC101927087 -0.17 0.193 0.737
exp DYNLT3 Xp21 -0.17 0.193 0.737 transport;cell cycle
exp ATP6V0A1 17q21 -0.17 0.193 0.737 transferrin transport;transmembrane
transport
xsq LOC101928535 -0.17 0.193 0.737
met TPK1 7q34-q35 -0.17 0.193 0.737 small molecule metabolic process;vitamin
metabolic process
xsq CSRP2 12q21.1 -0.17 0.193 0.737 multicellular organismal development;cell
differentiation
xsq TMTC3 12q21.32 -0.17 0.193 0.737
met CDCA7 2q31 -0.17 0.193 0.737 regulation of transcription, DNA-
xsq CTB-113P19.1 -0.17 0.193 0.737
xsq NRCAM 7q31 -0.17 0.193 0.737 axonal fasciculation;synapse assembly
xsq TSPAN17 5q35.3 -0.17 0.193 0.737 protein ubiquitination
xsq OR6T1 -0.17 0.193 0.737
met SLC10A4 4p11 -0.17 0.193 0.737 Solute Carriers
xsq APCDD1L-AS1 -0.171 0.193 0.737
xsq LINC00592 -0.171 0.193 0.737
xsq NCALD 8q22.2 -0.171 0.193 0.737 synaptic transmission;vesicle-
mediated transport
xsq ENO4 10q25.3 -0.171 0.193 0.737 glycolysis
mut BAHD1 15q15.1 -0.171 0.193 0.737 chromatin
modification;heterochromatin assembly
mut OR2A5 -0.171 0.193 0.737
xsq SC5D 11q23.3 -0.171 0.193 0.737
met TMEM141 9q34.3 -0.171 0.193 0.737
exp AKIP1 11p15.3 -0.171 0.193 0.737 substrate adhesion-dependent cell
spreading
xai SH2D7 15q25.1 -0.172 0.193 0.737
his LOC101928335 -0.172 0.193 0.737
his EIF2B2 14q24.3 -0.172 0.193 0.737 central nervous system
hs4 FAM229A -0.172 0.193 0.737
hs4 TSSK3 1p35-p34 -0.172 0.193 0.737 protein
his NID2 14q22.1 -0.172 0.193 0.737 cell adhesion;cell-matrix adhesion
his LYST 1q42.1-q42.2 -0.172 0.193 0.737 natural killer cell mediated
xai RAB19 7q34 -0.172 0.193 0.737 protein transport;small GTPase mediated
signal transduction
his BLID 11q24.1 -0.172 0.193 0.737 apoptotic process
xai SEPT7P7 9q22.33 -0.172 0.193 0.737
xai MAGI3 1p12-p11.2 -0.172 0.193 0.737 intracellular signal
xai FMO4 1q24.3 -0.172 0.193 0.737 xenobiotic metabolic process
xai PQLC2 1p36.13 -0.172 0.193 0.737
hs4 PCDHB17P -0.172 0.193 0.737 cell adhesion;homophilic cell
adhesion
exp ST7-OT4 -0.172 0.193 0.737
DNA-dependent"
xai GSAP 7q11.23 -0.172 0.193 0.737
exp SELV 19q13.2 -0.172 0.193 0.737
xai FTH1P20 2q31.3 -0.172 0.193 0.737
hs4 LGI2 4p15.2 -0.172 0.193 0.737
xai SERINC3 20q13.12 -0.172 0.193 0.737 induction of apoptosis
xai MSC-AS1 -0.172 0.193 0.737
hs4 BNIPL 1q21.3 -0.172 0.193 0.737 apoptotic process;induction of
apoptosis
hs4 LINC01220 -0.172 0.193 0.737
xai PTPRZ1 7q31.3 -0.172 0.193 0.737 protein
hs4 TMC7 16p12.3 -0.172 0.193 0.737
hs4 SPOCK1 5q31.2 -0.172 0.193 0.737 cell adhesion;signal
transduction
hs4 BDKRB1 14q32.1-q32.2 -0.172 0.193 0.737 activation of protein
kinase C activity by G-protein coupled receptor protein signaling pathway;cell
migration
his LINC01102 -0.172 0.193 0.737
exp SAXO2 -0.172 0.193 0.737
xai LINC01260 0.172 0.194 0.737
exp RTP5 0.172 0.194 0.737
his THOC7-AS1 0.172 0.194 0.737
his THOC7 3p14.1 0.172 0.194 0.737 mRNA export from nucleus;transport
his ATXN7 3p21.1-p12 0.172 0.194 0.737 histone deubiquitination;negative
regulation of phosphorylation
his CASP10 2q33-q34 0.172 0.194 0.737 Apoptosis
exp FAM206BP 13q14.13 0.172 0.194 0.737
mda Ratio_gX_TotX 0.172 0.194 0.737
swa HNRNPF 10q11.21 0.172 0.194 0.737 nuclear mRNA splicing, via
his MPC2 1q24 0.172 0.194 0.737
his DCAF6 1q24.2 0.172 0.194 0.737 protein ubiquitination;positive
xai UPRT Xq13.3 0.172 0.194 0.737
dependent"
dependent"
xai C12orf60 12p12.3 0.172 0.194 0.737
exp CHRNB4 15q24 0.172 0.194 0.737 synaptic transmission;synaptic
his APOC4 19q13.2 0.172 0.194 0.737
his APOC4-APOC2 0.172 0.194 0.737
his APOC2 19q13.2 0.172 0.194 0.737 positive regulation of phospholipase
activity;triglyceride-rich lipoprotein particle remodeling
his DROSHA 5p13.3 0.172 0.194 0.738 gene silencing by RNA;ribosome
biogenesis
his C5orf22 5p13.3 0.172 0.194 0.738
xai PTDSS1 8q22 0.172 0.194 0.738 phosphatidylserine biosynthetic
swa CNDP2 18q22.3 0.171 0.194 0.738 glutathione biosynthetic
exp LOC100132071 0.171 0.194 0.738
his PDIK1L 1p36.11 0.171 0.194 0.738
his SCYL3 1q24.2 0.171 0.194 0.738 cell migration
his GNL3L Xp11.22 0.171 0.194 0.738 ribosome biogenesis
xai ZNF839 14q32.31 0.171 0.194 0.738
his HBB 11p15.5 0.171 0.194 0.738 transport;positive regulation of nitric
oxide biosynthetic process
his MED13 17q22-q23 0.171 0.194 0.738 intracellular steroid hormone receptor
signaling pathway;androgen receptor signaling pathway
exp ZNF496 1q44 0.171 0.194 0.738 negative regulation of transcription from
RNA polymerase II promoter;viral reproduction
hs4 BST1 4p15 0.171 0.194 0.738 humoral immune response;multicellular
hs4 GATAD2A 19p13.11 0.171 0.194 0.738 anterior neuropore closure;negative
his NCK2 2q12 0.171 0.194 0.738 signal transduction;positive regulation of
actin filament polymerization
his SLC35A2 Xp11.23-p11.22 0.171 0.194 0.738 Solute Carriers
his PIM2 Xp11.23 0.171 0.194 0.738 anti-apoptosis;positive regulation of I-
kappaB kinase/NF-kappaB cascade
hs4 RBBP8 18q11.2 0.171 0.194 0.738 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
hs4 MIR4741 0.171 0.194 0.738
xai ATL2 2p22.3 0.171 0.194 0.738 GTP catabolic process;ER to Golgi
his TTC39C 18q11.2 0.171 0.194 0.738
his TTC39C-AS1 0.171 0.194 0.738
xai BOLA1 1q21 0.171 0.194 0.738
swa OGFOD1 16q12.2 0.171 0.194 0.738
xsq UBE2DNL Xq21.1 0.17 0.194 0.737
exp PLCXD3 5p13.1 0.17 0.194 0.737 lipid catabolic
xsq CASC15 0.17 0.194 0.737
cop ATP8B4 15q21.2 0.17 0.194 0.737 phospholipid transport;cation
transport
cop DCP1B 12p13.33 0.17 0.194 0.737 gene expression;RNA metabolic process
cop TCF12 15q21 0.17 0.194 0.737 regulation of transcription from RNA polymerase
xsq PWARSN 0.17 0.194 0.737
xsq SYT3 19q13.33 0.17 0.194 0.737
met CSMD3 8q23.3 0.17 0.194 0.737
cop FAM227B 15q21.2 0.17 0.194 0.737
xsq KRT36 0.17 0.194 0.737
exp FBXL6 8q24.3 0.17 0.194 0.737 proteolysis;protein ubiquitination
mir hsa-miR-9* 0.17 0.194 0.737
mir hsa-miR-9*(2) 0.17 0.194 0.737
mir hsa-miR-9*(3) 0.17 0.194 0.737
exp CWF19L2 11q22.3 0.17 0.194 0.737
met LRRC17 7q22.1 0.17 0.194 0.737 osteoblast
met ZSCAN9 6p21.3 0.17 0.194 0.738
xsq ZNF280D 15q21.3 0.17 0.194 0.738
mut NRAS 1p13.2 0.17 0.194 0.738 Cell Signaling; Oncogenes; Protein
Kinases
xsq THAP5 7q31.1 0.17 0.194 0.738 negative regulation of cell cycle
xsq LOC101927849 0.17 0.194 0.738
mut FAM208A 3p14.3 0.17 0.194 0.738
cop CALB2 16q22.2 0.17 0.194 0.738
dependent"
cop RAB11A 15q22.31 0.17 0.194 0.738 neuron projection
development;plasma membrane to endosome transport
xsq LINC00471 2q37.1 0.17 0.194 0.738
xsq WEE2 7q32 0.17 0.194 0.738 Protein Kinases
cop FGF7 15q21.2 0.17 0.194 0.738 insulin receptor signaling pathway;hair
follicle morphogenesis
met PPARA 22q13.31 0.17 0.194 0.738 regulation of transcription, DNA-
dependent;negative regulation of cholesterol storage
met PUS3 11q24.2 0.17 0.194 0.738 tRNA processing;tRNA pseudouridine
synthesis
met SRRM4 12q24.23 0.17 0.194 0.738 mRNA processing;nervous system
development
xsq FAM195A 16p13.3 0.17 0.194 0.738
xsq PARN 16p13 0.17 0.194 0.738 RNA modification;gene expression
exp TTTY21B 0.17 0.194 0.738
met ANKRD13D 11q13.2 0.17 0.194 0.738
cop ATXN2 12q24.1 0.17 0.194 0.738 neuron projection
morphogenesis;regulation of translation
met MRO 18q21 0.17 0.194 0.738
xsq HID1-AS1 0.17 0.194 0.738
exp RNF123 3p24.3 0.17 0.194 0.738
met SPATA19 11q25 0.17 0.194 0.738 multicellular organismal
exp PEG3-AS1 19q13.43 0.17 0.194 0.738
xsq LCE1A 1q21.3 0.17 0.194 0.738 keratinization
met FAT4 4q28.1 0.17 0.194 0.738 cell adhesion;homophilic cell adhesion
mut WDR63 1p22.3 0.17 0.194 0.738
exp CUL3 2q36.2 0.17 0.194 0.738 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
met LINC01105 0.17 0.194 0.738
mir hsa-miR-361-3p 0.17 0.194 0.738
met RAB22A 20q13.32 0.17 0.194 0.738 GTP catabolic process;endocytosis
cop SNN 16p13 0.17 0.194 0.738 response to stress;response to abiotic stimulus
met ARHGEF11 1q21 0.17 0.194 0.738 Rho protein signal transduction;nerve
xsq DPYSL3 5q32 -0.17 0.194 0.738 axon guidance;actin crosslink formation
met OPN1SW 7q32.1 -0.17 0.194 0.738 visual perception;phototransduction
exp KCNE1 21q22.12 -0.17 0.194 0.738 sensory perception of sound;blood
circulation
cop TRIM55 8q13.1 -0.17 0.194 0.738 signal transduction
exp TMEM130 7q22.1 -0.17 0.194 0.738
cop SLC1A1 9p24 -0.17 0.194 0.738 Solute Carriers
cop SPATA6L 9p24.2 -0.17 0.194 0.738
xsq DCN 12q21.33 -0.17 0.194 0.738 peptide cross-linking via chondroitin 4-
sulfate glycosaminoglycan;response to lipopolysaccharide
exp NFE2L3 7p15.2 -0.17 0.194 0.738 regulation of transcription, DNA-
xsq LOC389831 -0.17 0.194 0.738
cop CLVS1 8q12.3 -0.17 0.194 0.738 lysosome organization
exp TP53AIP1 11q24 -0.17 0.194 0.738 apoptotic process
exp TSC22D3 Xq22.3 -0.17 0.194 0.738 regulation of transcription, DNA-
dependent;body fluid secretion"
exp LOC100130856 19p13.3 -0.17 0.194 0.738
met RHO 3q21-q24 -0.17 0.194 0.738
cop GUSBP10 7p11.2 -0.17 0.194 0.737
xsq MED14OS -0.17 0.194 0.737
exp AKAP6 14q12 -0.17 0.194 0.737 protein targeting;regulation of protein kinase
A signaling cascade
xsq FOXD3-AS1 -0.17 0.194 0.737
xsq TMEM256-PLSCR3 -0.17 0.194 0.737
met IGFLR1 19q13.12 -0.17 0.194 0.737
met CAMKV 3p21.31 -0.17 0.194 0.737
exp PLEKHG1 6q25.1 -0.17 0.194 0.737 regulation of Rho protein signal
transduction
exp HRAS 11p15.5 -0.17 0.194 0.737 Apoptosis; Oncogenes; Protein Kinases
exp EMX2OS 10q26.1 -0.17 0.194 0.737
exp LINC00968 -0.17 0.194 0.737
exp INHBB 2cen-q13 -0.17 0.194 0.737 cell differentiation;positive regulation
of follicle-stimulating hormone secretion
xsq KRT23 17q21.2 -0.17 0.194 0.737
exp MYL10 7q22.1 -0.17 0.194 0.737
exp LOC400446 15q26.1 -0.17 0.194 0.737
hs4 CD74 5q32 -0.171 0.194 0.738 positive regulation of dendritic cell
antigen processing and presentation;signal transduction
swa S100P 4p16 -0.171 0.194 0.738 response to organic substance;endothelial
cell migration
swa HSDL2 9q32 -0.171 0.194 0.738
xai SELV 19q13.2 -0.171 0.194 0.738
his TMEM5-AS1 -0.171 0.194 0.738
his FAM83F 22q13.1 -0.171 0.194 0.738
hs4 DCAF12L1 Xq25 -0.171 0.194 0.738
his MIR4256 -0.171 0.194 0.738
his WNT2B 1p13 -0.171 0.194 0.738 Apoptosis; Oncogenes
hs4 CTSH 15q25.1 -0.171 0.194 0.738 positive regulation of cell
xai IFT22 -0.171 0.194 0.738 small GTPase mediated signal transduction
his NUAK1 12q23.3 -0.171 0.194 0.738 regulation of myosin-light-chain-
phosphatase activity;regulation of cell proliferation
exp LOC100996590 -0.171 0.194 0.738
hs4 TGM2 20q12 -0.171 0.194 0.738 metabolic process;protein
homooligomerization
his BEND7 10p13 -0.171 0.194 0.738
his LIPG 18q21.1 -0.171 0.194 0.738 cell proliferation;regulation of
his MTSS1L 16q22.1 -0.171 0.194 0.738 filopodium assembly;signal
transduction
xai BDNF-AS 11p14.1 -0.171 0.194 0.738
xai CLNK 4p16.1 -0.171 0.194 0.738 immune response;transmembrane
hs4 DSTN 20p12.1 -0.172 0.194 0.738 cellular component movement;actin
hs4 BFSP1 20p12.1 -0.172 0.194 0.738 cell maturation;lens fiber cell
development
xai MSANTD3 9q31.1 -0.172 0.194 0.738
his MIR6165 -0.172 0.194 0.738
xai MTERF2 -0.172 0.194 0.738 regulation of transcription, DNA-
xai MARCKS 6q22.2 -0.172 0.194 0.738 energy reserve metabolic
his LIF 22q12.2 -0.172 0.194 0.737 multicellular organismal
his OSM 22q12.2 -0.172 0.194 0.737 multicellular organismal
his RPS10P7 1q32.1 -0.172 0.194 0.737
xai TRIM61 4q32.3 -0.172 0.194 0.737
exp FTH1P20 2q31.3 -0.172 0.194 0.737
xai REP15 12p11.22 -0.172 0.194 0.737
exp RBBP8NL 20q13.33 -0.172 0.194 0.737
xai RNASE1 14q11.2 -0.172 0.194 0.737
xai PCDHGA7 -0.172 0.194 0.737 cell adhesion;homophilic cell
adhesion
his BDKRB1 14q32.1-q32.2 -0.172 0.194 0.737 activation of protein
migration
xai LINC00943 -0.172 0.194 0.737
xai INSM1 20p11.2 -0.173 0.194 0.737 endocrine pancreas
cop LINC00662 19q11 0.173 0.195 0.738
xai AKR1E2 10p15.1 0.171 0.195 0.738
his INPP5E 9q34.3 0.171 0.195 0.738
dephosphorylation;phosphatidylinositol phosphorylation
his G2E3 14q12 0.171 0.195 0.738 protein modification process;multicellular
hs4 HVCN1 12q24.11 0.171 0.195 0.738 response to zinc ion;proton transport
xai FBXO40 3q13.33 0.171 0.195 0.738 muscle cell differentiation
his DSCC1 8q24.12 0.171 0.195 0.738 cell cycle;maintenance of mitotic sister
chromatid cohesion
his DEPTOR 8q24.12 0.171 0.195 0.738 negative regulation of TOR
hs4 FGFBP3 10q23.32 0.171 0.195 0.738 positive regulation of fibroblast
growth factor receptor signaling pathway;positive regulation of vascular
permeability
xai MYCBP 1p33-p32.2 0.171 0.195 0.738 spermatogenesis;regulation of
xai GPR152 0.171 0.195 0.738
hs4 SOCS2-AS1 0.171 0.195 0.738
hs4 SOCS2 12q 0.171 0.195 0.738 Apoptosis
exp RPL7P23 5q13.3 0.171 0.195 0.738
his MTMR9 8p23-p22 0.171 0.195 0.738
hs4 CSF1R 5q32 0.171 0.195 0.738 Oncogenes
exp FAM90A20P 8p23.1 0.171 0.195 0.738
xai C16orf87 16q11.2 0.171 0.195 0.738
xai MEP1B 18q12.2-q12.3 0.171 0.195 0.738 digestion;proteolysis
his ALDH6A1 14q24.3 0.171 0.195 0.738 thymine metabolic process;cellular
his LIN52 14q24.3 0.171 0.195 0.738 mitotic cell cycle
hs4 IFRD2 3p21.3 0.171 0.195 0.738
hs4 SEMA6C 1q21.2 0.171 0.195 0.738 cell differentiation;multicellular
exp GPR152 0.171 0.195 0.738
his MIR301A 0.171 0.195 0.738
his SKA2 17q22 0.171 0.195 0.738 mitotic prometaphase;mitotic cell cycle
his PRR11 17q22 0.171 0.195 0.738
his RASA4B 0.171 0.195 0.738
his LOC101927420 0.171 0.195 0.738
his DMTF1 7q21 0.171 0.195 0.738 regulation of transcription, DNA-dependent;cell
cycle"
his VASP 19q13.32 0.171 0.195 0.738 neural tube closure;axon guidance
xai ERICH6 0.171 0.195 0.739
exp VN2R3P 9p13.1 0.171 0.195 0.739
his FRZB 2q32.1 0.171 0.195 0.739 gonad development;convergent extension
involved in organogenesis
his BTBD2 19p13.3 0.171 0.195 0.739
his DDRGK1 20p13 0.171 0.195 0.739
xai FAM90A20P 8p23.1 0.171 0.195 0.739
xai ST6GALNAC4 9q34 0.171 0.195 0.739 glycolipid metabolic process;O-glycan
processing
xai NLGN3 Xq13.1 0.171 0.195 0.739 social behavior;axon extension
swa PCCB 3q21-q22 0.171 0.195 0.739 fatty acid beta-oxidation;short-chain
met UPF3B Xq25-q26 0.17 0.195 0.738 transport;nucleocytoplasmic transport
xsq EDA Xq12-q13.1 0.17 0.195 0.738 signal transduction;pigmentation
xsq CCDC112 5q22.3 0.17 0.195 0.738
xsq PCF11 11q13 0.17 0.195 0.738 RNA splicing;gene expression
cop MRC2 17q23.2 0.17 0.195 0.738 endocytosis
cop MARCH10 17q23.2 0.17 0.195 0.738
mut PTPRR 12q15 0.17 0.195 0.738 neuron differentiation;peptidyl-tyrosine
dephosphorylation
met SLCO1B3 12p12 0.17 0.195 0.738 Solute Carriers
mut BACE1 11q23.2-q23.3 0.17 0.195 0.738 proteolysis;membrane protein
cop SYK 9q22 0.17 0.195 0.738 adaptive immune response;integrin-mediated
signaling pathway
xsq EPHA1-AS1 0.17 0.195 0.738
xsq SMKR1 7q32.1 0.17 0.195 0.738
xsq RNF32 7q36 0.17 0.195 0.738
xsq ETV6 12p13 0.17 0.195 0.738 Transcription Factors
cop MBTPS1 16q24 0.17 0.195 0.738 regulation of transcription factor import
into nucleus;proteolysis
exp BARX1 9q12 0.17 0.195 0.738 anterior/posterior pattern
exp TRIM35 8p21.2 0.17 0.195 0.738 positive regulation of apoptotic
xsq EVL 14q32.2 0.17 0.195 0.738 nervous system development;axon guidance
xsq OR10T2 0.17 0.195 0.738
xsq ETAA1 2p14 0.17 0.195 0.738
cop ANKDD1A 15q22.31 0.17 0.195 0.738 signal transduction
cop SORCS2 4p16.1 0.17 0.195 0.738 neuropeptide signaling pathway
cop ASPRV1 2p13.3 0.17 0.195 0.738 proteolysis;protein processing
xsq ACTRT1 0.17 0.195 0.738
cop ADAM6 0.17 0.195 0.738
xsq BMS1P20 0.17 0.195 0.738
met MYL9 20q11.23 0.17 0.195 0.738 axon guidance;muscle contraction
xsq LOC100129027 21q22.3 0.17 0.195 0.738
exp NFYA 6p21.3 0.17 0.195 0.738 regulation of transcription, DNA-
exp TLK2 17q23 0.17 0.195 0.738 DDR (DNA replication)
xsq TELO2 16p13.3 0.17 0.195 0.739 DNA Damage Response (DDR); DDR (FA)
cop ADAM10 15q22 0.17 0.195 0.739 proteolysis;positive regulation of cell
proliferation
exp RPL22L1 3q26.2 0.17 0.195 0.739 translation
xsq COQ9 16q21 0.17 0.195 0.739 ubiquinone biosynthetic process
cop DNAJC17 15q15.1 0.17 0.195 0.739 protein folding
met DCTN4 5q31-q32 0.17 0.195 0.739
cop SIRPG 20p13 0.17 0.195 0.739 positive regulation of cell
exp LOC100128373 14q32.31 0.17 0.195 0.739
xsq CDK5R2 2q35 0.169 0.195 0.739 regulation of cyclin-dependent protein
kinase activity
dependent"
xsq LDB2 4p16 -0.169 0.195 0.739 positive regulation of cellular component
mut LRRFIP2 3p22.2 -0.169 0.195 0.739 Wnt receptor signaling
pathway
exp MOK 14q32 -0.17 0.195 0.739 protein phosphorylation;signal transduction
exp CYP1A1 15q24.1 -0.17 0.195 0.739 amine metabolic process;response to
iron(III) ion
xsq DYX1C1 15q21.3 -0.17 0.195 0.739 neuron migration;nervous system
development
xsq NLGN4X Xp22.33 -0.17 0.195 0.739 social behavior;cell-cell junction
organization
exp PRSS22 16p13.3 -0.17 0.195 0.739 proteolysis
exp NAGLU 17q21 -0.17 0.195 0.739 middle ear morphogenesis;locomotor rhythm
cop ADHFE1 8q13.1 -0.17 0.195 0.739 2-oxoglutarate metabolic
cop ITCH 20q11.22 -0.17 0.195 0.739 protein ubiquitination;innate immune
response
met HMHA1 19p13.3 -0.17 0.195 0.739 small GTPase mediated signal
exp CACNG4 17q24 -0.17 0.195 0.739 transport;ion transport
exp AIM1L 1p36.11 -0.17 0.195 0.739
exp ZBTB8A 1p35.1 -0.17 0.195 0.739 regulation of transcription, DNA-
dependent"
cop RPS10P7 1q32.1 -0.17 0.195 0.738
cop MIR5191 -0.17 0.195 0.738
mut SGCB 4q12 -0.17 0.195 0.738 cytoskeleton organization;muscle organ
development
xsq PKD1L1 7p12.3 -0.17 0.195 0.738 detection of nodal flow;cell-cell
adhesion
xsq DISP1 1q41 -0.17 0.195 0.738 diaphragm development;smoothened signaling
pathway
xsq PVRL3 3q13 -0.17 0.195 0.738 adherens junction organization;cell-cell
xsq OR2L5 -0.17 0.195 0.738 response to stimulus
exp EDN2 1p34 -0.17 0.195 0.738 prostaglandin biosynthetic process;activation
of protein kinase C activity by G-protein coupled receptor protein signaling
pathway
xsq SIM1 6q16.3 -0.17 0.195 0.738 cell differentiation;ureteric bud
development
xsq BTBD9 6p21 -0.17 0.195 0.738 cell adhesion
met MGA 15q14 -0.17 0.195 0.738 Apoptosis
cop LOC286186 -0.17 0.195 0.738
cop MCF2L2 3q27.1 -0.17 0.195 0.738 regulation of Rho protein signal
transduction
exp RECK 9p13.3 -0.17 0.195 0.738 EMT (Mesenchymal)
his TMEM189-UBE2V1 20q13.2 -0.171 0.195 0.739
his TMEM189 20q13.2 -0.171 0.195 0.739
xai AKT3 1q44 -0.171 0.195 0.739 Protein Kinases
hs4 THEM4 1q21 -0.171 0.195 0.739 Apoptosis
hs4 LOC100505874 -0.171 0.195 0.739
his PTCHD4 6p12.3 -0.171 0.195 0.739
xai USP32P3 17p11.1 -0.171 0.195 0.739
xai SHISA9 16p13.12 -0.171 0.195 0.739 regulation of short-term
xai LOC100507261 -0.171 0.195 0.739
hs4 SYDE2 1p22.3 -0.171 0.195 0.739 activation of Rho GTPase
xai ADAMTS2 5qter -0.171 0.195 0.739 protein processing;collagen fibril
organization
hs4 MN1 22q12.1 -0.171 0.195 0.739 intramembranous ossification
xai FGF18 5q34 -0.171 0.195 0.739 chondrocyte development;positive
hs4 LINC00880 -0.171 0.195 0.739
xai PRSS22 16p13.3 -0.171 0.195 0.739 proteolysis
hs4 LOC101929709 -0.171 0.195 0.739
hs4 RIPK2 8q21 -0.171 0.195 0.739 Apoptosis
exp TMEM132C 12q24.32 -0.171 0.195 0.739
his WFS1 4p16.1 -0.171 0.195 0.738 sensory perception of
sound;regulation of apoptotic process
his NXN 17p13.3 -0.171 0.195 0.738 cell differentiation;multicellular
his PTCHD1-AS -0.171 0.195 0.738
xai KRT8P41 11p15.4 -0.171 0.195 0.738
xai KRT8P23 15q24.3 -0.171 0.195 0.738
hs4 ANXA2 15q22.2 -0.171 0.195 0.738 positive regulation of vesicle
fusion;fibrinolysis
his RAB27B 18q21.2 -0.171 0.195 0.738 small GTPase mediated signal
xai CRB3 19p13.3 -0.171 0.195 0.738 cell junction assembly;cell-cell
xai CC2D1A 19p13.12 -0.171 0.195 0.738 regulation of transcription,
DNA-dependent;signal transduction
swa MPDU1 17p13.1-p12 -0.171 0.195 0.738 dolichol-linked oligosaccharide
biosynthetic process;transport
xai MIR873 -0.171 0.195 0.738
xai LOC100131232 -0.171 0.195 0.738
exp MIR873 -0.171 0.195 0.738
his FHOD3 18q12 -0.171 0.195 0.738 cellular component organization;actin
hs4 LINC01948 -0.171 0.195 0.738
xai ESR2 14q23.2 -0.171 0.195 0.738 neuron migration;intracellular
exp LOC390203 -0.171 0.195 0.738
DNA-dependent"
DNA-dependent;negative regulation of transcription, DNA-dependent"
DNA-dependent"
DNA-dependent"
exp LOC100131232 -0.171 0.195 0.738
hs4 SLC2A4RG 20q13.33 -0.171 0.195 0.738 Solute Carriers
xai FAM160A2 11p15.4 0.171 0.196 0.739 endosome organization;lysosome
organization
swa SYNE1 6q25 0.171 0.196 0.739 nucleus organization;Golgi organization
his FKBP7 2q31.2 0.171 0.196 0.739 protein peptidyl-prolyl
his PLEKHA3 2q31.2 0.171 0.196 0.739
hs4 STPG3-AS1 0.171 0.196 0.739
hs4 STPG3 0.171 0.196 0.739
hs4 NELFB 9q34 0.171 0.196 0.739
his KLHL12 1q32.1 0.171 0.196 0.739 Wnt receptor signaling pathway
hs4 FAM124B 2q36.2 0.171 0.196 0.739
hs4 MAN1B1 9q34 0.171 0.196 0.739 cellular protein metabolic
process;protein folding
hs4 MAN1B1-AS1 9q34.3 0.171 0.196 0.739
xai CCDC28B 1p36.11-p34.2 0.171 0.196 0.739
dependent"
hs4 FANCA 16q24.3 0.171 0.196 0.739 DNA Damage Response (DDR); DDR (FA)
swa AKR1B10 7q33 0.171 0.196 0.739 cellular aldehyde metabolic
process;digestion
his AOC3 17q21 0.171 0.196 0.739 inflammatory response;cell adhesion
hs4 AFF2 Xq28 0.171 0.196 0.74 learning or memory;regulation of RNA splicing
xai FAM96AP2 1q42.13 0.171 0.196 0.74
exp FAM96AP2 1q42.13 0.171 0.196 0.74
dependent"
his NAA35 9q21.33 0.171 0.196 0.74 smooth muscle cell proliferation
his CNR2 1p36.11 0.171 0.196 0.74 negative regulation of mast cell
xai ABI1 10p11.2 0.171 0.196 0.74 peptidyl-tyrosine
xai RPL7P56 Xq26.3 0.171 0.196 0.74
xai LOC100190986 0.171 0.196 0.74
xai CEL 9q34.3 0.171 0.196 0.74 fatty acid catabolic process;ceramide
catabolic process
his NRSN2-AS1 0.171 0.196 0.74
his SOX12 20p13 0.171 0.196 0.74 spinal cord development;cell fate commitment
exp SI 3q25.2-q26.2 0.171 0.196 0.74 response to vitamin A;response to
starvation
hs4 AJAP1 1p36.32 0.171 0.196 0.74 cell adhesion
xai OARD1 6p21.1 0.171 0.196 0.74
xai NUDT16L1 16p13.3 0.171 0.196 0.74
xai LOC100272217 0.171 0.196 0.74
xai GLIDR 0.171 0.196 0.74
xai IDH3G Xq28 0.171 0.196 0.74 2-oxoglutarate metabolic process;NADH metabolic
process
xai STMN1 1p36.11 0.171 0.196 0.74 response to virus;cell differentiation
his PROX2 14q24.3 0.171 0.196 0.74 regulation of transcription, DNA-
dependent"
xai FSTL4 5q31.1 0.171 0.196 0.74
his ISY1-RAB43 0.171 0.196 0.74
his ISY1 3q21.3 0.171 0.196 0.74 nuclear mRNA splicing, via
exp MLIP-IT1 0.171 0.196 0.74
exp PIGPP3 0.171 0.196 0.74
xai PIGPP3 0.171 0.196 0.74
his TREML2 6p21.1 0.171 0.196 0.74 T cell activation
hs4 RPS13 11p15 0.171 0.196 0.74 nuclear-transcribed mRNA catabolic process,
hs4 SNORD14A 0.171 0.196 0.74
hs4 SNORD14B 11p15 0.171 0.196 0.74
xai GGTLC1 20p11.1 0.171 0.196 0.74 glutathione metabolic
hs4 GBA 1q21 0.171 0.196 0.74 termination of signal transduction;cellular
response to tumor necrosis factor
his CERKL 2q31.3 0.171 0.196 0.74 anti-apoptosis;activation of protein
met SAMD4A 14q22.2 0.169 0.196 0.739 negative regulation of
met LOC649395 0.169 0.196 0.739
met LIFR 5p13-p12 0.169 0.196 0.739 response to cytokine stimulus;response to
chemical stimulus
met EDA Xq12-q13.1 0.169 0.196 0.739 signal transduction;pigmentation
cop GCFC2 2p12 0.169 0.196 0.739 regulation of transcription, DNA-
met SLC6A18 5p15.33 0.169 0.196 0.739 ion transport;neurotransmitter
transport
xsq PLAC8 4q21.22 0.169 0.196 0.739
cop ANXA2 15q22.2 0.169 0.196 0.739 positive regulation of vesicle
fusion;fibrinolysis
met CAMK2B 7p14.3-p14.1 0.169 0.196 0.739 synaptic
met MFAP5 12p13.1-p12.3 0.169 0.196 0.739
exp HEATR1 1q43 0.169 0.196 0.739 rRNA processing
cop IGHMBP2 11q13.3 0.169 0.196 0.739 DNA Damage Response (DDR)
exp MFI2-AS1 0.169 0.196 0.739
met NEDD9 6p25-p24 0.169 0.196 0.739 regulation of growth;actin filament
bundle assembly
exp TRRAP 7q21.2-q22.1 0.169 0.196 0.739 Apoptosis; Oncogenes
mut PTPN21 14q31.3 0.169 0.196 0.739 protein dephosphorylation;peptidyl-
mut CSPP1 8q13.2 0.169 0.196 0.739 positive regulation of cell
division;positive regulation of cell cycle cytokinesis
met HOOK1 1p32.1 0.169 0.196 0.739 protein transport;microtubule
met ZNF474 5q23.2 0.169 0.196 0.739
xsq STIM2 4p15.2 0.169 0.196 0.739 negative regulation of calcium ion
xsq KCNJ3 2q24.1 0.169 0.196 0.739 response to electrical stimulus;ion
transport
xsq EBPL 13q12-q13 0.169 0.196 0.739 sterol metabolic process
met INPP5F 10q26.11 0.169 0.196 0.74
exp HSP90AA4P 4q35.2 0.169 0.196 0.74 response to stress;protein folding
cop ZFP36L2 2p22.3-p21 0.169 0.196 0.74 nuclear-transcribed mRNA catabolic
cop LOC100129726 0.169 0.196 0.74
xsq GHITM 10q23.1 0.169 0.196 0.74 apoptotic process
met GPR37 7q31 0.169 0.196 0.74 G-protein coupled receptor signaling pathway
mut DZIP3 3q13.13 0.169 0.196 0.74 protein polyubiquitination
met HS6ST3 13q32.1 0.169 0.196 0.74
cop SIRPB1 20p13 0.169 0.196 0.74 signal transduction;cell surface receptor
signaling pathway
exp C16orf87 16q11.2 0.169 0.196 0.74
met SIMC1 5q35.2 0.169 0.196 0.74
xsq AOC3 17q21 0.169 0.196 0.74 inflammatory response;cell adhesion
xsq PHF10 6q27 0.169 0.196 0.74 regulation of transcription, DNA-
met ZER1 9q34.11 0.169 0.196 0.74 ATP hydrolysis coupled proton
met GRM1 6q24 0.169 0.196 0.74 locomotory behavior;calcium-mediated signaling
met LHX5 12q24 0.169 0.196 0.74 hippocampus development;cell proliferation in
forebrain
xsq RWDD4 4q35.1 0.169 0.196 0.74
met ZNF287 17p11.2 0.169 0.196 0.74 positive regulation of
xsq ABHD13 13q33.3 0.169 0.196 0.74
xsq ATP2B1 12q21.3 0.169 0.196 0.74 ATP biosynthetic process;transport
exp DCDC1 11p13 0.169 0.196 0.74 intracellular signal transduction
xsq PDRG1 20q11.21 0.169 0.196 0.74 protein folding
xsq DNAJC27 2p23.3 0.169 0.196 0.74 small GTPase mediated signal
xsq LOC101928402 0.169 0.196 0.74
mut CFAP69 0.169 0.196 0.74
met NPNT 4q24 0.169 0.196 0.74 cell adhesion;multicellular organismal
development
exp PKHD1 6p12.2 0.169 0.196 0.74 cilium assembly;homeostatic process
cop C20orf194 20p13 0.169 0.196 0.74
exp ENKD1 16q22.1 0.169 0.196 0.74
cop UBAP1L 15q22.31 0.169 0.196 0.74
xsq TOP3A 17p12-p11.2 0.169 0.196 0.74 DNA Damage Response (DDR); DDR (FA)
xsq MAPK11 22q13.33 0.169 0.196 0.74 Protein Kinases
met CTH 1p31.1 0.169 0.196 0.74 cellular amino acid biosynthetic
xsq PRAMEF1 0.169 0.196 0.74
xsq TNXA 0.169 0.196 0.74
xsq POLDIP2 17q11.2 0.169 0.196 0.74 DDR (DNA replication)
xsq SDHD 0.169 0.196 0.74 respiratory electron transport chain;small
exp ACOXL 2q13 0.169 0.196 0.74 fatty acid beta-oxidation
exp PTDSS1 8q22 0.169 0.196 0.74 phosphatidylserine biosynthetic
met MRPS6 21q22.11 0.169 0.196 0.74 translation
met IL31RA 5q11.2 0.169 0.196 0.74 anti-apoptosis;positive regulation
of tyrosine phosphorylation of Stat3 protein
xsq NLGN2 17p13.1 -0.169 0.196 0.74 locomotory exploration
xsq PCDHB10 5q31 -0.169 0.196 0.74 synapse assembly;calcium-dependent
cell-cell adhesion
met C19orf24 19p13.3 -0.169 0.196 0.74
xsq DCAF5 14q23-q24.1 -0.169 0.196 0.74 protein ubiquitination
xsq AP1M2 19p13.2 -0.169 0.196 0.74 protein targeting;post-Golgi
mut GDF5 20q11.2 -0.169 0.196 0.74 cell-cell signaling;cartilage
development
exp KRT8P20 7p14.1 -0.169 0.196 0.74
xsq SPRED3 19q13 -0.169 0.196 0.74 multicellular organismal
cop SYT2 1q32.1 -0.169 0.196 0.74 synaptic
met NT5C 17q25.1 -0.169 0.196 0.74 purine base metabolic
exp CCDC85C 14q32.31 -0.169 0.196 0.74 cerebral cortex development
mut CSF3R 1p35-p34.3 -0.169 0.196 0.74 defense response;cell adhesion
xsq FOLH1 11p11.2 -0.169 0.196 0.74 proteolysis;folic acid-containing
xsq STK3 8q22.2 -0.169 0.196 0.74 Apoptosis
mut MSI2 17q22 -0.169 0.196 0.74 stem cell development
met CD160 1q21.1 -0.169 0.196 0.74 cell surface receptor signaling
pathway;cell proliferation
met PPP1R16B 20q11.23 -0.169 0.196 0.74 signal
exp CTNNAL1 9q31.2 -0.169 0.196 0.74 Apoptosis
mut HIST1H1C 6p21.3 -0.169 0.196 0.739 nucleosome
cop LRP12 8q22.2 -0.169 0.196 0.739 EMT (Mesenchymal)
exp SOWAHC 2q13 -0.169 0.196 0.739
xsq HRH1 3p25 -0.169 0.196 0.739 synaptic transmission;response to gravity
xsq GDNF 5p13.1-p12 -0.169 0.196 0.739 Apoptosis
cop COA6 1q42.2 -0.169 0.196 0.739
cop TARBP1 1q42.3 -0.169 0.196 0.739 regulation of transcription
from RNA polymerase II promoter;RNA processing
cop LOC100506795 -0.169 0.196 0.739
cop IRF2BP2 1q42.3 -0.169 0.196 0.739 regulation of transcription,
DNA-dependent"
cop LINC00184 -0.169 0.196 0.739
cop LOC100506810 -0.169 0.196 0.739
mut SIGLEC8 19q13.33-q13.41 -0.169 0.196 0.739 cell adhesion;signal
transduction
xsq ENOX1 13q14.11 -0.169 0.196 0.739 transport;electron transport chain
xsq S100A6 1q21 -0.169 0.196 0.739 positive regulation of fibroblast
met FLJ44635 Xq13.1 -0.169 0.196 0.739
mut FBXO32 8q24.13 -0.169 0.196 0.739 muscle atrophy
met PHC1 12p13 -0.169 0.196 0.739 multicellular organismal development
xai MICALL2 7p22.3 -0.171 0.196 0.74 endocytosis
hs4 CRISPLD2 16q24.1 -0.171 0.196 0.74
hs4 THBS2 6q27 -0.171 0.196 0.74 cell adhesion;negative regulation of
angiogenesis
xai CCL28 5p12 -0.171 0.196 0.74 chemotaxis;immune response
his TLR5 1q41-q42 -0.171 0.196 0.74 cellular response to mechanical
stimulus;MyD88-dependent toll-like receptor signaling pathway
xai LOC100131132 10q22.3 -0.171 0.196 0.74
hs4 SFT2D2 1q24.2 -0.171 0.196 0.74 protein transport;vesicle-
mediated transport
xai NOS2P3 -0.171 0.196 0.74
his CAP2 6p22.3 -0.171 0.196 0.74 activation of adenylate cyclase
exp LOC100131132 10q22.3 -0.171 0.196 0.74
xai KRT18P5 22q11.21 -0.171 0.196 0.74
his C1orf158 1p36.21 -0.171 0.196 0.74
hs4 LAMC2 1q25-q31 -0.171 0.196 0.74 cell adhesion;epidermis development
hs4 ENG 9q34.11 -0.171 0.196 0.74 heart looping;cell migration
hs4 RBPMS2 15q22.31 -0.171 0.196 0.74
his MIR6076 -0.171 0.196 0.74
xai BGN Xq28 -0.171 0.196 0.74 blood vessel remodeling;peptide cross-
his ERBB3 12q13 -0.171 0.196 0.74 signal transduction;Schwann cell
differentiation
his SCN2B 11q23 -0.171 0.196 0.74 positive regulation of sodium ion
transport via voltage-gated sodium channel activity;ion transport
hs4 RGAG1 Xq23 -0.171 0.196 0.74
hs4 PDLIM5 4q22 -0.171 0.196 0.74 regulation of synapse
swa WDR26 1q42.13 -0.171 0.196 0.739
xai LOC284379 19q13.42 -0.171 0.196 0.739
xai YAE1D1 7p14.1 -0.171 0.196 0.739
exp LINC00310 21q22.11 -0.171 0.196 0.739
xai SEMA3E 7q21.11 -0.171 0.196 0.739 multicellular organismal
xai PIWIL2 8p21.3 -0.171 0.196 0.739 multicellular organismal
xai NFE2L3 7p15.2 -0.171 0.196 0.739 regulation of transcription,
xai RPS6KC1 1q41 -0.171 0.196 0.739 Protein Kinases
his MIR4761 -0.171 0.196 0.739
xai GSTM2 1p13.3 -0.171 0.196 0.739 glutathione metabolic
xai ADAM8 10q26.3 -0.171 0.196 0.739 leukocyte migration involved in
his UHRF1BP1L 12q23.1 0.171 0.197 0.74
hs4 TMEM52 1p36.33 0.171 0.197 0.74
xai FOXJ3 1p34.2 0.171 0.197 0.74 regulation of sequence-specific DNA
xai MLIP-IT1 0.171 0.197 0.74
xai DPY19L2P2 7q22.1 0.171 0.197 0.74
xai MS4A4E 11q12.2 0.171 0.197 0.74
xai STAR 8p11.2 0.17 0.197 0.74 lipid transport;steroid metabolic process
hs4 ANKRD39 2q11.2 0.17 0.197 0.74
hs4 MARK3 14q32.32 0.17 0.197 0.74
hs4 FLT1 13q12 0.17 0.197 0.74 Protein Kinases
his FIZ1 19q13.42 0.17 0.197 0.74 regulation of transcription, DNA-
dependent"
dependent"
xai CRY1 12q23-q24.1 0.17 0.197 0.741 DNA Damage Response (DDR)
his RBM6 3p21.3 0.17 0.197 0.741 RNA processing
hs4 C20orf96 20p13 0.17 0.197 0.741
xai ARIH2 3p21 0.17 0.197 0.741 protein polyubiquitination;multicellular
his GLI2 2q14 0.17 0.197 0.741 osteoblast development;hindgut morphogenesis
xai HIST1H3D 6p22.1 0.17 0.197 0.741
swa DOCK7 1p31.3 0.17 0.197 0.741 axonogenesis;cell differentiation
xai HNRNPLL 2p22.1 0.17 0.197 0.741
xai POT1 7q31.33 0.17 0.197 0.741 DNA Damage Response (DDR)
xai COX7A2L 2p21 0.17 0.197 0.741 respiratory electron transport
xai NEMP1 0.17 0.197 0.741
xai FAM234B 0.17 0.197 0.741
exp AWAT2 Xq13.1 0.17 0.197 0.741 lipid biosynthetic process;wax
swa PAFAH1B2 11q23 0.17 0.197 0.741 lipid metabolic process;lipid catabolic
process
his DSCAS 0.17 0.197 0.741
his DSC2 18q12.1 0.17 0.197 0.741 cell adhesion;homophilic cell adhesion
exp LARP1BP1 4q13.1 0.17 0.197 0.741
his TRIM23 5q12.3 0.17 0.197 0.741 positive regulation of catalytic
his TRAPPC13 5q12.3 0.17 0.197 0.741
hs4 ERVH48-1 0.17 0.197 0.741
hs4 LINC01970 0.17 0.197 0.741
xai TUBG1P 7p13 0.17 0.197 0.741
hs4 HTR6 1p36-p35 0.17 0.197 0.741 synaptic transmission;G-protein
his B3GNT8 19q13.2 0.17 0.197 0.741 O-glycan processing;poly-N-
xai NAA50 3q13.2 0.17 0.197 0.741 N-terminal protein amino acid acetylation
his KCTD15 19q13.11 0.17 0.197 0.741 potassium ion transport
his MRPS31P5 0.17 0.197 0.741
hs4 TMEM143 19q13.33 0.17 0.197 0.741
hs4 SYNGR4 19q13.3 0.17 0.197 0.741
his TUSC2 3p21.3 0.17 0.197 0.741 cell cycle;cell-cell signaling
his OAZ2 15q22.31 0.17 0.197 0.741 cellular nitrogen compound metabolic
hs4 PYY 17q21.1 0.17 0.197 0.741 negative regulation of response to
hs4 NAGS 17q21.31 0.17 0.197 0.741 urea cycle;glutamate metabolic process
xai JAML 0.17 0.197 0.741 cell adhesion;heterophilic cell-cell adhesion
hs4 DCDC5 11p14.1 0.17 0.197 0.741 intracellular signal transduction
xai RPS18P12 17p12 0.17 0.197 0.741
xsq FAM161A 2p15 0.169 0.197 0.74 response to stimulus;visual perception
met SMC6 2p24.2 0.169 0.197 0.74 DNA Damage Response (DDR); DDR (HR); DDR
(DNA replication)
xsq LINC01053 0.169 0.197 0.74
met CST2 20p11.21 0.169 0.197 0.74
met ATP6V0E2 7q36.1 0.169 0.197 0.74 vacuolar acidification;insulin
met ARMC3 10p12.31 0.169 0.197 0.74
xsq KANSL1 17q21.31 0.169 0.197 0.74 histone H4-K5 acetylation;histone
H4-K8 acetylation
xsq NEMP1 0.169 0.197 0.74
xsq PRR35 0.169 0.197 0.74
met SLC35G6 17p13.1 0.169 0.197 0.74
met ADGRG2 0.169 0.197 0.74 G-protein coupled receptor signaling
exp CHI3L2 1p13.3 0.169 0.197 0.74 carbohydrate metabolic
xsq TPRX1 19q13.33 0.169 0.197 0.74
exp FANCL 2p16.1 0.169 0.197 0.741 DNA Damage Response (DDR); DDR (FA)
mut DMXL1 5q22 0.169 0.197 0.741
xsq OR10G7 0.169 0.197 0.741
cop PEBP1 12q24.23 0.169 0.197 0.741 regulation of neurotransmitter
xsq SDCBP2 20p13 0.169 0.197 0.741 nervous system development;intracellular
signal transduction
cop FTO 16q12.2 0.169 0.197 0.741 DNA Damage Response (DDR)
mut CDC42BPA 1q42.11 0.169 0.197 0.741 Protein Kinases
xsq DNAJA1 9p13.3 0.169 0.197 0.741 protein folding;response to
unfolded protein
xsq LOC389602 7q36.3 0.169 0.197 0.741
cop TNP2 16p13.13 0.169 0.197 0.741 penetration of zona pellucida;cell
differentiation
cop PRM3 16p13.3 0.169 0.197 0.741 multicellular organismal
cop PRM2 16p13.2 0.169 0.197 0.741
cop PRM1 16p13.2 0.169 0.197 0.741 chromosome condensation;DNA packaging
cop RMI2 16p13.13 0.169 0.197 0.741 DNA Damage Response (DDR); DDR (FA)
exp ADAT1 16q23.1 0.169 0.197 0.741 RNA processing;tRNA processing
xsq CLEC7A 12p13.2 0.169 0.197 0.741 phagocytosis, recognition;defense
response to protozoan
cop C16orf70 16q22.1 0.169 0.197 0.741 Golgi to plasma membrane protein
transport
xsq C14orf169 14q24.3 0.169 0.197 0.741 chromatin modification;histone H3-
K4 demethylation
met CDADC1 13q14.2 0.169 0.197 0.741
cop MYBPC1 12q23.2 0.169 0.197 0.741 muscle filament sliding;cell
adhesion
exp CRY1 12q23-q24.1 0.169 0.197 0.741 DNA Damage Response (DDR)
cop RASSF2 20p13 0.169 0.197 0.741 cell cycle;signal transduction
xsq ZNF385D-AS1 0.169 0.197 0.741
exp NBPF3 1p36.12 0.169 0.197 0.741
met VSNL1 2p24.3 0.169 0.197 0.741
met PCLO 7q11.23-q21.3 0.169 0.197 0.741 cytoskeleton organization;synaptic
vesicle exocytosis
xsq ACVRL1 12q13.13 0.169 0.197 0.741 regulation of endothelial cell
proliferation;negative regulation of cell adhesion
exp HMGN2P17 1p36.23 0.169 0.197 0.741
met PURB 7p13 0.169 0.197 0.741 regulation of myeloid cell
pro CASP7_26 0.169 0.197 0.741
exp ATP6AP1L 5q14.2 0.169 0.197 0.741 ATP hydrolysis coupled proton
transport
cop LOC100507557 0.169 0.197 0.741
met ACTA1 1q42.13 0.169 0.197 0.741 response to mechanical stimulus;skeletal
muscle fiber development
exp FLJ39632 0.169 0.197 0.741
xsq FLJ45079 17q25.3 0.169 0.197 0.741
xsq NARFL 16p13.3 0.169 0.197 0.741 oxygen homeostasis;response to hypoxia
xsq HRSP12 8q22 0.169 0.197 0.741 regulation of translational termination
exp HIRA 22q11.21 0.169 0.197 0.741 anatomical structure
met PPL 16p13.3 0.169 0.197 0.741 keratinization
met THRSP 11q14.1 0.169 0.197 0.741 regulation of transcription, DNA-
cop GDAP1 8q21.11 -0.169 0.197 0.741 response to retinoic acid
exp LOC727930 5q11.2 -0.169 0.197 0.741
exp ASPN 9q22 -0.169 0.197 0.741 bone mineralization;negative regulation
of transforming growth factor beta receptor signaling pathway
exp ODF3L1 15q24.2 -0.169 0.197 0.741
xsq GPSM1 9q34.3 -0.169 0.197 0.741 signal transduction;multicellular
xsq YPEL5 2p23.1 -0.169 0.197 0.741 oxidation-reduction process
xsq DMWD 19q13.3 -0.169 0.197 0.741 meiosis
xsq CFHR1 1q32 -0.169 0.197 0.741 complement activation
cop MIR4637 -0.169 0.197 0.741
xsq CLSTN2 3q23 -0.169 0.197 0.741 cell adhesion;homophilic cell
adhesion
exp PLAC9 10q22.3 -0.169 0.197 0.741
met ZNF516 18q23 -0.169 0.197 0.741 regulation of transcription, DNA-
dependent"
exp PKN2 1p22.2 -0.169 0.197 0.741 Apoptosis
exp LOC100130582 12p13.31 -0.169 0.197 0.741
cop ASIC5 4q32.1 -0.169 0.197 0.74 ion transport
cop TDO2 4q31-q32 -0.169 0.197 0.74 tryptophan catabolic
cop CTSO 4q32.1 -0.169 0.197 0.74 proteolysis
cop ABCB5 7p21.1 -0.169 0.197 0.74 ABC Transporters
mut KIF15 3p21.31 -0.169 0.197 0.74 microtubule-based movement;mitosis
xsq LOC100506990 -0.169 0.197 0.74
xsq CACNA1C 12p13.3 -0.169 0.197 0.74 transmembrane
exp MFSD5 12q13.13 -0.169 0.197 0.74 transport
mut MTCL1 -0.169 0.197 0.74
mut RAB11FIP2 10q26.11 -0.169 0.197 0.74 protein
transport;establishment of cell polarity
his C1orf87 1p32.1 -0.17 0.197 0.741
xai ANKRD26P1 16q11.2 -0.17 0.197 0.741
hs4 PSG4 19q13.2 -0.17 0.197 0.741 defense response;female pregnancy
his LOC101927188 -0.17 0.197 0.741
exp HDAC11-AS1 -0.17 0.197 0.741
hs4 DAB2 5p13.1 -0.17 0.197 0.741 negative regulation of cell growth;cell
morphogenesis involved in differentiation
xai RBBP8NL 20q13.33 -0.17 0.197 0.741
xai MEX3D 19p13.3 -0.17 0.197 0.741 posttranscriptional regulation of gene
xai GPR173 Xp11 -0.17 0.197 0.741 signal transduction;G-protein coupled
hs4 ITGAX 16p11.2 -0.17 0.197 0.741 leukocyte migration;defense response to
virus
hs4 RAB13 1q21.2 -0.17 0.197 0.741 vesicle-mediated transport;GTP catabolic
process
xai NAT8B 2p13.1 -0.17 0.197 0.741 gastrulation with mouth forming
xai GFOD1 6pter-p22.1 -0.17 0.197 0.741
hs4 WFDC2 20q13.12 -0.17 0.197 0.741 negative regulation of endopeptidase
activity;proteolysis
hs4 TEF 22q13.2 -0.17 0.197 0.741 regulation of transcription from RNA
promoter
his PAPLN 14q24.2 -0.17 0.197 0.741
his ZNF365 10q21.2 -0.17 0.197 0.741
his LOC283045 -0.17 0.197 0.741
xai PPP1R12C 19q13.42 -0.17 0.197 0.741
xai ZFAND3 6p21.2 -0.17 0.197 0.741
his SPATA46 -0.17 0.197 0.741
exp LOC284379 19q13.42 -0.17 0.197 0.741
his LOC730338 -0.17 0.197 0.74
xai PBLD 10q21.3 -0.17 0.197 0.74 biosynthetic process
hs4 DUSP5 10q25 -0.17 0.197 0.74 endoderm formation;protein dephosphorylation
xai SYAP1 Xp22.2 -0.17 0.197 0.74
exp RAB19 7q34 -0.17 0.197 0.74 protein transport;small GTPase mediated signal
transduction
exp BDNF-AS 11p14.1 -0.171 0.197 0.74
hs4 ANKRD6 6q14.2-q16.1 -0.171 0.197 0.74
hs4 SDS 12q24.13 -0.171 0.197 0.74 cellular amino acid metabolic
process;L-serine catabolic process
exp LOC100129675 -0.171 0.197 0.74
xai PLEKHM1 17q21.31 -0.171 0.197 0.74 intracellular signal
transduction
his GDF15 19p13.11 -0.171 0.197 0.74 signal transduction;transforming
his MIR3189 -0.171 0.197 0.74
his PIGO 9p13.3 0.17 0.198 0.741 post-translational protein
xai FAM105A 5p15.2 0.17 0.198 0.741
exp RPS18P12 17p12 0.17 0.198 0.741
xai RCE1 11q13 0.17 0.198 0.741 proteolysis
hs4 HIST1H3B 6p22.1 0.17 0.198 0.741
hs4 HIST1H2AB 6p22.1 0.17 0.198 0.741 nucleosome assembly
xai LINC00301 11q12.2 0.17 0.198 0.741
xai SPC25 2q31.1 0.17 0.198 0.741 mitotic cell cycle;mitotic spindle
organization
his KTN1-AS1 14q22.3 0.17 0.198 0.741
his KTN1 14q22.1 0.17 0.198 0.741 microtubule-based movement
hs4 PIKFYVE 2q34 0.17 0.198 0.741 protein localization to
his RPL10 Xq28 0.17 0.198 0.741 translation;mRNA metabolic process
his SNORA70 0.17 0.198 0.741
xai PPP3CB 10q22.2 0.17 0.198 0.741 negative regulation of T cell
swa PRPF4 9q31-q33 0.17 0.198 0.741 nuclear mRNA splicing, via
his CXorf36 Xp11.3 0.17 0.198 0.741
his MAN2B2 4p16.1 0.17 0.198 0.741 carbohydrate metabolic
xai RPL7 8q21.11 0.17 0.198 0.741 nuclear-transcribed mRNA catabolic
xai PHKA1 Xq12-q13 0.17 0.198 0.741 glucose metabolic process;generation of
his PAFAH1B2 11q23 0.17 0.198 0.741 lipid metabolic process;lipid catabolic
process
hs4 WDR5 9q34 0.17 0.198 0.741 regulation of transcription, DNA-
his MCF2L2 3q27.1 0.17 0.198 0.741 regulation of Rho protein signal
transduction
xai LRRC37A4P 17q21.31 0.17 0.198 0.741
xai GINS1 20p11.21 0.17 0.198 0.741 DDR (DNA replication)
hs4 LINC01526 0.17 0.198 0.742
xai TRIM41 5q35.3 0.17 0.198 0.742
xai MRPL39 21q21.3 0.17 0.198 0.742
his USH1G 0.17 0.198 0.742
his OTOP2 17q25.1 0.17 0.198 0.742
his MIR4743 0.17 0.198 0.742
his C18orf32 18q21.1 0.17 0.198 0.742 signal transduction;positive
his MIR1539 0.17 0.198 0.742
his SNORD58C 0.17 0.198 0.742
his SNORD58A 0.17 0.198 0.742
his RPL17-C18orf32 0.17 0.198 0.742
his SNORD58B 18q21 0.17 0.198 0.742
his RPL17 18q21 0.17 0.198 0.742 translational termination;cellular protein
metabolic process
hs4 ZWINT 10q21-q22 0.17 0.198 0.742 spindle organization;mitotic cell cycle
checkpoint
hs4 TRPC2 11p15.4 0.17 0.198 0.742
his PEBP1 12q24.23 0.17 0.198 0.742 regulation of neurotransmitter
his FILIP1 6q14.1 0.17 0.198 0.742
his EIF4B 12q13.13 0.17 0.198 0.742 gene expression;RNA metabolic process
his LOC101929210 0.17 0.198 0.742
his SMARCAD1 4q22-q23 0.17 0.198 0.742 DNA Damage Response (DDR)
exp LOC100505727 0.17 0.198 0.742
exp RTEL1P1 0.17 0.198 0.742
xai DUSP28 2q37.3 0.17 0.198 0.742 peptidyl-tyrosine dephosphorylation
his COL23A1 5q35.3 0.17 0.198 0.742 protein homotrimerization
xai OR7E154P 0.17 0.198 0.742
exp KGFLP1 0.169 0.198 0.741
mut ADAMTS10 19p13.2 0.169 0.198 0.741 proteolysis;integrin-mediated
signaling pathway
xsq ZNF8 19q13.43 0.169 0.198 0.741 negative regulation of transcription from
exp IP6K2 3p21.31 0.169 0.198 0.741 Apoptosis
xsq TSPEAR-AS2 0.169 0.198 0.741
met C9orf116 9q34.3 0.169 0.198 0.741
met PGM5 9q13 0.169 0.198 0.741 carbohydrate metabolic process;glycogen
met EDN2 1p34 0.169 0.198 0.741 prostaglandin biosynthetic process;activation
pathway
xsq REPIN1 7q36.1 0.169 0.198 0.741 DNA replication
xsq LOC101927876 0.169 0.198 0.741
xsq CCNK 14q32 0.169 0.198 0.741 cell division;regulation of cyclin-dependent
xsq FAM156B Xp11.22 0.169 0.198 0.741
met VCAM1 1p32-p31 0.169 0.198 0.741 heart development;interspecies
xsq MESDC1 15q13 0.169 0.198 0.741
xsq LGALS17A 19q13.2 0.169 0.198 0.741
exp COPS2 15q21.2 0.169 0.198 0.741 DNA Damage Response (DDR)
met FOXC1 6p25 0.169 0.198 0.741 Apoptosis
cop UGGT1 2q14.3 0.169 0.198 0.741 protein folding;protein glycosylation
xsq FLJ37035 0.169 0.198 0.741
xsq HTR4 5q31-q33 0.169 0.198 0.741 G-protein coupled receptor signaling
xsq DICER1 14q32.13 0.169 0.198 0.741 Oncogenes
cop SNORA70D 0.169 0.198 0.741
cop AP1G1 16q23 0.169 0.198 0.741 post-Golgi vesicle-mediated
cop SNORD71 16q22.2 0.169 0.198 0.741
cop ATXN1L 16q22.2 0.169 0.198 0.741 regulation of transcription, DNA-
dependent"
dependent"
cop IST1 16q22.2 0.169 0.198 0.741 cell division;cell cycle
cop PKD1L3 16q22.2 0.169 0.198 0.741 detection of chemical stimulus
involved in sensory perception of sour taste;cation transport
cop DHODH 16q22 0.169 0.198 0.741 nucleobase-containing small molecule metabolic
process;pyrimidine base metabolic process
cop HP 16q22.2 0.169 0.198 0.741 negative regulation of hydrogen peroxide
catabolic process;cellular iron ion homeostasis
exp TFR2 7q22 0.169 0.198 0.741 proteolysis;iron ion transport
xsq HEIH 0.169 0.198 0.741
cop HSDL1 16q23.3 0.169 0.198 0.741
exp NUDT2 9p13 0.169 0.198 0.741 Apoptosis
exp GPATCH11 2p22.2 0.169 0.198 0.741
exp PAIP2 5q31.2 0.169 0.198 0.741 regulation of translation;negative
regulation of translational initiation
exp HVCN1 12q24.11 0.169 0.198 0.741 response to zinc ion;proton transport
exp PSMA5 1p13 0.169 0.198 0.741 mitotic cell cycle;viral reproduction
xsq NFYA 6p21.3 0.169 0.198 0.741 regulation of transcription, DNA-
mut MCM5 22q13.1 0.169 0.198 0.742 DDR (DNA replication)
mut EBF1 5q34 0.169 0.198 0.742 multicellular organismal development;positive
exp OSGEP 14q11.2 0.169 0.198 0.742 proteolysis;tRNA processing
exp GTF2I 7q11.23 0.169 0.198 0.742 transcription from RNA polymerase II
met MAP6D1 3q27.1 0.168 0.198 0.742 N-terminal peptidyl-L-cysteine N-
palmitoylation;negative regulation of microtubule depolymerization
mut ZNF142 2q35 0.168 0.198 0.742 regulation of transcription, DNA-
dependent"
xsq PIH1D1 19q13.33 0.168 0.198 0.742 box C/D snoRNP assembly
met RPRM 2q23.3 0.168 0.198 0.742 cell cycle arrest;regulation of mitotic
cell cycle
met TRMT5 14q23.1 0.168 0.198 0.742 tRNA processing
met OR1J4 9q34.11 0.168 0.198 0.742
exp RPL26P11 1q25.1 0.168 0.198 0.742
xsq IL12A-AS1 0.168 0.198 0.742
cop VWA9 15q22.31 0.168 0.198 0.742
cop DENND4A 15q22.31 0.168 0.198 0.742 regulation of transcription, DNA-
dependent"
cop MIR4511 0.168 0.198 0.742
dependent"
xsq VWA5B1 1p36.12 0.168 0.198 0.742
cop AFAP1 4p16 0.168 0.198 0.742
xsq COPS4 4q21.22 0.168 0.198 0.742 DNA Damage Response (DDR)
exp ITSN1 21q22.1-q22.2 -0.168 0.198 0.742 small GTPase mediated signal
transduction;positive regulation of protein kinase B signaling cascade
xsq NPAS1 19q13.2-q13.3 -0.168 0.198 0.742 negative regulation of
dependent
exp AHR 7p15 -0.168 0.198 0.742 Apoptosis
exp ARHGEF5 7q35 -0.168 0.198 0.742 regulation of Rho protein signal
met FOXB1 15q22.2 -0.168 0.198 0.742 urogenital system
xsq CIART -0.168 0.198 0.742
xsq SP100 2q37.1 -0.168 0.198 0.742 response to type I
factor activity
mut ZAR1 4p11 -0.168 0.198 0.742 sodium ion transport;multicellular
met FKBP7 2q31.2 -0.169 0.198 0.742 protein peptidyl-prolyl
exp LOC728061 -0.169 0.198 0.741
exp FTH1P4 3q21.3 -0.169 0.198 0.741
exp ROGDI 16p13.3 -0.169 0.198 0.741 positive regulation of cell
met KLHL38 8q24.13 -0.169 0.198 0.741
exp LTBP3 11q13.1 -0.169 0.198 0.741 transforming growth factor beta
xsq PCDHGA9 -0.169 0.198 0.741 homophilic cell adhesion;cell
adhesion
mut MTM1 Xq28 -0.169 0.198 0.741 protein dephosphorylation;endosome to
lysosome transport
xsq EFNB2 13q33 -0.169 0.198 0.741 angiogenesis;anatomical structure
morphogenesis
exp RNH1 11p15.5 -0.169 0.198 0.741 mRNA catabolic process;regulation
of angiogenesis
exp AZIN1 8q22.3 -0.169 0.198 0.741 positive regulation of catalytic
activity;negative regulation of catalytic activity
cop PHC3 3q26.2 -0.169 0.198 0.741 multicellular organismal
development
xsq VANGL2 1q22-q23 -0.169 0.198 0.741 heart looping;regulation of
actin cytoskeleton organization
xai PTCHD4 6p12.3 -0.17 0.198 0.742
xai MOK 14q32 -0.17 0.198 0.742 protein phosphorylation;signal transduction
his ZNF750 17q25.3 -0.17 0.198 0.742
hs4 TIAM2 6q25.2 -0.17 0.198 0.742 regulation of Rho protein signal
xai SORBS1 10q23.33 -0.17 0.198 0.742 cellular response to insulin
his ANKRD10 13q34 -0.17 0.198 0.742
xai CLRN1 3q25 -0.17 0.198 0.742 sensory perception of sound;photoreceptor cell
maintenance
hs4 OSR1 2p24.1 -0.17 0.198 0.742 ureteric bud development;positive
regulation of bone mineralization
hs4 ZNF816-ZNF321P -0.17 0.198 0.742
hs4 ZNF816 19q13.41 -0.17 0.198 0.742
his ANK3 10q21 -0.17 0.198 0.742 signal transduction;establishment of protein
localization
xai LOC100288911 2p22.3 -0.17 0.198 0.742
exp KRT18P5 22q11.21 -0.17 0.198 0.742
xai HTR1A 5q11.2-q13 -0.17 0.198 0.742 serotonin receptor signaling
pathway;behavior
his ZNF462 9q31.2 -0.17 0.198 0.742 positive regulation of
dependent
swa MRPS18B 6p21.3 -0.17 0.198 0.742 translation
exp MYADML 2p22.3 -0.17 0.198 0.741
xai ZFHX4 8q21.11 -0.17 0.198 0.741
xai TRIM22 11p15 -0.17 0.198 0.741 immune response;response to virus
xai MTND5P3 -0.17 0.198 0.741
swa SEC31A 4q21.22 -0.17 0.198 0.741 activation of signaling protein
his TSPAN18 11p11.2 -0.17 0.198 0.741
swa HIBADH 7p15.2 -0.17 0.198 0.741 valine metabolic process;branched
xai SERPINA6 14q32.1 -0.17 0.198 0.741 regulation of proteolysis;transport
his DHX32 10q26.2 -0.17 0.198 0.741
xai HDAC11-AS1 -0.17 0.198 0.741
his OAS2 12q24.2 -0.17 0.198 0.741 purine nucleotide biosynthetic
xai SAV1 14q13-q23 -0.17 0.198 0.741 negative regulation of epithelial cell
proliferation;negative regulation of cardiac muscle cell proliferation
xai AKAP6 14q12 -0.17 0.198 0.741 protein targeting;regulation of protein kinase
A signaling cascade
xai TAF15 17q11.1-q11.2 0.17 0.199 0.742 positive regulation of
exp CCDC79 16q22.1 0.17 0.199 0.742 regulation of transcription, DNA-
dependent"
xai TRND 0.17 0.199 0.742
his COX10 17p12 0.17 0.199 0.742 heme a biosynthetic process;respiratory chain
complex IV assembly
his COX10-AS1 0.17 0.199 0.742
his POMP 13q12.3 0.17 0.199 0.742 proteasome assembly
his LOC375196 0.17 0.199 0.742
his TUBB4A 19p13.3 0.17 0.199 0.742 protein folding;microtubule-based
movement
exp CRYGFP 2q34 0.17 0.199 0.742
xai MAGEE1 Xq13.3 0.17 0.199 0.742
xai SLC13A2 17p13.2 0.17 0.199 0.742 transport;ion transport
hs4 CALR 19p13.3-p13.2 0.17 0.199 0.742 Apoptosis
hs4 MIR6515 0.17 0.199 0.742
hs4 RAD23A 19p13.2 0.17 0.199 0.742 DNA Damage Response (DDR); DDR
(NER)
his MIR6831 0.17 0.199 0.742
his APBB3 5q31 0.17 0.199 0.742
exp TRND 0.17 0.199 0.742
xai RPL7P52 22q13.1 0.17 0.199 0.742
exp UGT2B15 0.17 0.199 0.742 xenobiotic metabolic process;metabolic
process
hs4 ANXA2R 5p12 0.17 0.199 0.742
hs4 LOC153684 5p12 0.17 0.199 0.742
hs4 CLNS1A 11q13.5-q14 0.17 0.199 0.742 blood circulation;gene expression
xai CRYGFP 2q34 0.17 0.199 0.742
his PEX19 1q23.2 0.17 0.199 0.742 protein targeting to
exp OR7E154P 0.17 0.199 0.742
xai SUPT3H 6p21.1-p21.3 0.17 0.199 0.742 histone
xai LARP1BP1 4q13.1 0.17 0.199 0.742
xai FBXO43 8q22.2 0.17 0.199 0.742 meiosis
his BCL2 18q21.3 0.17 0.199 0.742 Apoptosis; Protein Kinases
his RYR1 19q13.1 0.17 0.199 0.743 response to caffeine;calcium ion
his HDAC6 Xp11.23 0.17 0.199 0.743 response to toxin;chromatin modification
his ATG4D 19p13.2 0.17 0.199 0.743 proteolysis;autophagy
xai TBC1D5 3p24.3 0.17 0.199 0.743
xai FLJ39632 0.17 0.199 0.743
exp KBTBD13 15q22.31 0.17 0.199 0.743
swa RSL1D1 16p13.13 0.17 0.199 0.743 translation;regulation of protein
localization
xai PPIAP29 6p22.3 0.17 0.199 0.743
his MIR4710 0.17 0.199 0.743
swa LMNB1 5q23.2 0.17 0.199 0.743 apoptotic process;cellular component
his LOC401261 0.17 0.199 0.743
his TRIM59 3q25.33 0.17 0.199 0.743
his GPS2 17p13 0.17 0.199 0.743 negative regulation of transcription from RNA
polymerase II promoter;inactivation of MAPK activity
his UBA6 4q13.2 0.17 0.199 0.743 protein modification process;ubiquitin-
his UBA6-AS1 0.17 0.199 0.743
swa EIF2S2 20q11.2 0.17 0.199 0.743 male gonad development;gene
expression
hs4 SYTL1 1p36.11 0.17 0.199 0.743 intracellular protein
hs4 KTI12 1p32.3 0.169 0.199 0.743
xai LOC100506272 0.169 0.199 0.743
swa TXLNA 1p35.1 0.169 0.199 0.743 exocytosis;cell proliferation
his PRRT1 6p21.32 0.169 0.199 0.743 response to biotic stimulus
his LOC100507547 0.169 0.199 0.743
his PPT2 6p21.3 0.169 0.199 0.743 protein modification process
his PPT2-EGFL8 0.169 0.199 0.743
his FBXW7 4q31.3 0.169 0.199 0.743 DNA Damage Response (DDR); Tumor
Suppressors
his DKFZP434I0714 4q31.23 0.169 0.199 0.743
his MIR4453 0.169 0.199 0.743
exp CACNG8 19q13.4 0.168 0.199 0.742 synaptic transmission;regulation of
xsq PIGW 17q12 0.168 0.199 0.742 C-terminal protein lipidation;preassembly of
mut ECD 10q22.3 0.168 0.199 0.742 regulation of transcription, DNA-
xsq PCCB 3q21-q22 0.168 0.199 0.742 fatty acid beta-oxidation;short-chain
xsq SIGLEC9 19q13.41 0.168 0.199 0.742 cell adhesion;cell surface receptor
signaling pathway
met C8orf33 8q24.3 0.168 0.199 0.742
exp TAF15 17q11.1-q11.2 0.168 0.199 0.742 positive regulation of
xsq LPAR3 1p22.3 0.168 0.199 0.742 synaptic transmission;bleb assembly
xsq SLIT2-IT1 0.168 0.199 0.742
xsq MYBBP1A 17p13.3 0.168 0.199 0.742 DNA Damage Response (DDR)
xsq GOLGA6L1 0.168 0.199 0.742
exp BRD7P2 3q25.33 0.168 0.199 0.742
cop PSAPL1 4p16.1 0.168 0.199 0.742 lipid metabolic
cop MIR4274 0.168 0.199 0.742
xsq ZFAND1 8q21.13 0.168 0.199 0.742
met UMPS 3q13 0.168 0.199 0.742 'de novo' UMP biosynthetic process;small
met SLC5A3 21q22.12 0.168 0.199 0.742 transport;ion transport
met FNIP2 4q32.1 0.168 0.199 0.742 regulation of protein
phosphorylation;protein phosphorylation
xsq IDH2 15q26.1 0.168 0.199 0.742 Oncogenes
mut PPP1R13B 14q32.33 0.168 0.199 0.742 apoptotic process;induction of
apoptosis
exp SETMAR 3p26.1 0.168 0.199 0.742 DNA Damage Response (DDR)
xsq SELO 22q13.33 0.168 0.199 0.742
exp MED4 13q14.2 0.168 0.199 0.742 transcription initiation from RNA
met TFAP2A 6p24 0.168 0.199 0.742 optic vesicle morphogenesis;trigeminal
nerve development
exp CDR1 Xq27.1 0.168 0.199 0.742
cop TWSG1 18p11.3 0.168 0.199 0.742 mesoderm formation;forebrain development
cop RALBP1 18p11.3 0.168 0.199 0.742 transport;regulation of small
cop PPP4R1 18p11.22 0.168 0.199 0.742 DNA Damage Response (DDR); DDR (HR)
cop PDCD7 15q22.31 0.168 0.199 0.742 induction of apoptosis;RNA splicing
cop CLPX 15q22.31 0.168 0.199 0.742 ATP catabolic process;protein folding
cop CILP 15q22 0.168 0.199 0.742 negative regulation of insulin-like growth
cop PARP16 15q22.31 0.168 0.199 0.742
cop IGDCC3 15q22.3-q23 0.168 0.199 0.742 neuromuscular process controlling
balance
cop IGDCC4 15q22.31 0.168 0.199 0.742
xsq KRTAP10-4 0.168 0.199 0.743
xsq LOC100129617 0.168 0.199 0.743
exp SNW1 14q24.3 0.168 0.199 0.743 positive regulation of transcription from
mut PLCH1 3q25.31 0.168 0.199 0.743 intracellular signal
exp COX7A2L 2p21 0.168 0.199 0.743 respiratory electron transport
xsq PSMC5 17q23.3 0.168 0.199 0.743 S phase of mitotic cell cycle;regulation
cop MRGPRD 11q13.3 0.168 0.199 0.743
cop MRGPRF 11q13.3 0.168 0.199 0.743
cop LOC100505964 0.168 0.199 0.743
met KRT19 17q21.2 0.168 0.199 0.743 cell differentiation involved in
exp MRPL39 21q21.3 0.168 0.199 0.743
xsq PROSER1 13q13.3 0.168 0.199 0.743
cop SERPINB12 18q21.33 0.168 0.199 0.743
cop SERPINB13 18q21.33 0.168 0.199 0.743 response to UV;negative regulation
xsq ZBTB24 6q21 0.168 0.199 0.743 regulation of transcription, DNA-
dependent"
exp RPL7L1 6p21.1 0.168 0.199 0.743 translation
met ZNF252P 8q24.3 0.168 0.199 0.743
exp ATP2B2 3p25.3 -0.168 0.199 0.743 cell morphogenesis;brain
development
cop DFNA5 7p15 -0.168 0.199 0.743 sensory perception of sound;inner ear
xsq PCDHB7 5q31 -0.168 0.199 0.743 cell adhesion;homophilic cell
adhesion
cop FAM83B 6p12.1 -0.168 0.199 0.743
mut CREBRF 5q35.1 -0.168 0.199 0.743
xsq C8G 9q34.3 -0.168 0.199 0.743 cytolysis;innate immune response
exp SLCO2B1 11q13 -0.168 0.199 0.743 Solute Carriers
cop LPPR4 1p21.2 -0.168 0.199 0.743
exp TMEM178B -0.168 0.199 0.743
xsq OLFML3 1p13.2 -0.168 0.199 0.743 multicellular organismal
development
xsq FLRT2 14q24-q32 -0.168 0.199 0.743 cell adhesion
met UTS2 1p36 -0.168 0.199 0.743 muscle contraction;synaptic transmission
met INHBA 7p15-p13 -0.168 0.199 0.743 hair follicle development;nervous
system development
met CTRB2 16q23.1 -0.168 0.199 0.742 proteolysis;digestion
met SLC9A4 2q12.1 -0.168 0.199 0.742 ion transport;cation
transport
exp MTSS1L 16q22.1 -0.168 0.199 0.742 filopodium assembly;signal
transduction
xsq HCG4 6p21.3 -0.168 0.199 0.742
exp TSPAN31 12q13.3 -0.168 0.199 0.742 positive regulation of cell
proliferation
xsq STK32A 5q32 -0.168 0.199 0.742
xsq LBH 2p23.1 -0.168 0.199 0.742 multicellular organismal
exp ALDH3B2 11q13 -0.168 0.199 0.742 alcohol metabolic process;cellular
hs4 PABPC3 13q12-q13 -0.169 0.199 0.743 mRNA metabolic process
xai C14orf144 -0.169 0.199 0.743
hs4 PRSS12 4q28.1 -0.169 0.199 0.743 proteolysis;zymogen
activation
exp KRT16P4 -0.169 0.199 0.743
xai KRT16P4 -0.169 0.199 0.743
xai KIF7 15q26.1 -0.17 0.199 0.743 microtubule-based movement;negative
hs4 COL21A1 6p12.3-p11.2 -0.17 0.199 0.743 cell adhesion
xai HECW1 7p13 -0.17 0.199 0.743 protein modification process;protein
hs4 DANT2 -0.17 0.199 0.743
his STC1 8p21-p11.2 -0.17 0.199 0.743 cell-cell signaling;cellular response to
hypoxia
xai MYH11 16p13.11 -0.17 0.199 0.743 muscle contraction;smooth muscle
contraction
xai ST7-OT4 -0.17 0.199 0.743
xai NFE2L2 2q31 -0.17 0.199 0.743 positive regulation of transcription from
RNA polymerase II promoter;regulation of embryonic development
hs4 LOC100287846 8q11.21 -0.17 0.199 0.743
his DBNDD1 16q24.3 -0.17 0.199 0.743
his GAS8 16q24.3 -0.17 0.199 0.743 negative regulation of cell
hs4 FLJ33534 -0.17 0.199 0.743
hs4 C2orf50 2p25.1 -0.17 0.199 0.743
xai LAMC2 1q25-q31 -0.17 0.199 0.743 cell adhesion;epidermis development
exp NOS2P3 -0.17 0.199 0.742
his CCIN 9p13.3 -0.17 0.199 0.742 multicellular organismal
hs4 SCUBE2 11p15.3 -0.17 0.199 0.742
hs4 MIR5691 -0.17 0.199 0.742
hs4 KRT8P41 11p15.4 -0.17 0.199 0.742
xai C1orf168 1p32.2 -0.17 0.199 0.742
exp DKFZp434L192 7p11.2 -0.17 0.199 0.742
exp OR4A13P 11q11 -0.17 0.199 0.742
xai PLEKHA5 12p12 -0.17 0.199 0.742
xai STARD6 18q21.2 -0.17 0.199 0.742 transport;lipid transport
exp LOC100130744 -0.17 0.199 0.742
xai AIM1L 1p36.11 -0.17 0.199 0.742
xai GLDC 9p22 -0.17 0.199 0.742 cellular amino acid metabolic process;glycine
catabolic process
xai AGXT2 5p13 -0.17 0.199 0.742 glyoxylate metabolic process;nucleobase-
his GADD45A 1p31.2 -0.17 0.199 0.742 Apoptosis; DNA Damage Response
(DDR); DDR (BER)
his C5orf66 -0.17 0.199 0.742
his PITX1 5q31.1 -0.17 0.199 0.742 anatomical structure
his MIR6715A -0.17 0.199 0.742
his MIR6715B -0.17 0.199 0.742
exp MTND5P3 -0.17 0.199 0.742
xai S100A2 1q21 -0.17 0.199 0.742 endothelial cell migration
xai UGT2B15 0.171 0.2 0.744 xenobiotic metabolic process;metabolic
process
his MGA 15q14 0.169 0.2 0.743 Apoptosis
hs4 NUP37 12q23.2 0.169 0.2 0.743 mitotic cell cycle;cytokine-mediated
signaling pathway
hs4 PARPBP 12q23.2 0.169 0.2 0.743 DNA Damage Response (DDR)
hs4 TMEM31 Xq22.2 0.169 0.2 0.743
his HEPH Xq11-q12 0.169 0.2 0.743 cellular iron ion homeostasis;erythrocyte
differentiation
his PPRC1 10q24.32 0.169 0.2 0.743 regulation of transcription, DNA-
dependent"
xai RWDD4 4q35.1 0.169 0.2 0.743
cop MIR3614 0.169 0.2 0.743
his SMG9 19q13.31 0.169 0.2 0.743 nuclear-transcribed mRNA catabolic
exp DCC 18q21.3 0.169 0.2 0.743 Tumor Suppressors
his PIM1 6p21.2 0.169 0.2 0.743 Apoptosis; Oncogenes
xai BCAS3 17q23 0.169 0.2 0.743
his ELAVL3 19p13.2 0.169 0.2 0.743 multicellular organismal
his DHRS4L2 14q11.2 0.169 0.2 0.743
hs4 OXLD1 17q25.3 0.169 0.2 0.743
hs4 CCDC137 17q25.3 0.169 0.2 0.743
xai NECAP1 12p13.31 0.169 0.2 0.744 endocytosis;protein transport
xai SERGEF 11p14.3 0.169 0.2 0.744 signal transduction;negative
regulation of protein secretion
xai SPPL2B 19p13.3 0.169 0.2 0.744 proteolysis
xai POGK 1q24.1 0.169 0.2 0.744 regulation of transcription, DNA-
hs4 CR2 1q32 0.169 0.2 0.744 complement receptor mediated signaling
dependent"
exp LOC101060040 0.169 0.2 0.744
xai LOC645177 12p12.1 0.169 0.2 0.744
xai PDHA1 Xp22.1 0.169 0.2 0.744 pyruvate metabolic process;glycolysis
xai FAM207A 21q22.3 0.169 0.2 0.744
his CEBPA 19q13.1 0.169 0.2 0.744 Tumor Suppressors
his CEBPA-AS1 19q13.11 0.169 0.2 0.744
xai LOC100128517 0.169 0.2 0.744
exp LOC100128517 0.169 0.2 0.744
xai LINC01146 0.169 0.2 0.744
hs4 SNAR-A3 0.169 0.2 0.744
met KLK6 19q13.3 0.169 0.2 0.744 central nervous system
development;regulation of cell differentiation
xai CCDC34 11p14.1 0.169 0.2 0.744
his ZBTB17 1p36.13 0.169 0.2 0.744 negative regulation of cell
cycle;positive regulation of transcription, DNA-dependent
xai THOC6 16p13.3 0.169 0.2 0.744 mRNA processing;mRNA export from nucleus
his MIR548AV 0.169 0.2 0.744
his POLR1E 9p13.2 0.169 0.2 0.744 rRNA transcription
exp CCP110 16p12.3 0.168 0.2 0.743 G2/M transition of mitotic cell
exp MAFG-AS1 17q25.3 0.168 0.2 0.743
cop LOC284950 0.168 0.2 0.743
xsq POU4F1 13q31.1 0.168 0.2 0.743 synapse assembly;positive
mut TCP11 6p21.31 0.168 0.2 0.743 multicellular organismal
xsq LOC101927746 0.168 0.2 0.743
exp TGDS 13q32.1 0.168 0.2 0.743 nucleotide-sugar metabolic
exp KRT75 12q13 0.168 0.2 0.743
met DDX47 12p13.1 0.168 0.2 0.743 mRNA processing;apoptotic process
met TXNRD2 22q11.21 0.168 0.2 0.743 response to selenium
ion;hemopoiesis
cop UTP18 17q21.33 0.168 0.2 0.743 rRNA processing
mut OSBPL11 3q21 0.168 0.2 0.743 transport;lipid transport
mut DGKH 13q14.11 0.168 0.2 0.743 activation of protein kinase C activity
exp DUSP28 2q37.3 0.168 0.2 0.743 peptidyl-tyrosine dephosphorylation
met FCRL3 1q21-q22 0.168 0.2 0.743
met ABCA5 17q24.3 0.168 0.2 0.743 ABC Transporters
xsq MBD3L5 0.168 0.2 0.743
cop OAZ2 15q22.31 0.168 0.2 0.743 cellular nitrogen compound metabolic
cop RBPMS2 15q22.31 0.168 0.2 0.743
cop MIR1272 0.168 0.2 0.743
cop PIF1 15q22.31 0.168 0.2 0.743 DNA Damage Response (DDR); DDR (DNA
replication)
cop PLEKHO2 15q22.1 0.168 0.2 0.743
exp SHISA3 4p13 0.168 0.2 0.743 multicellular organismal development
cop DNAH10 12q24.31 0.168 0.2 0.743 microtubule-based movement
xsq LOC113230 19p13.12 0.168 0.2 0.743
cop MIR4798 0.168 0.2 0.743
exp MSL1 17q21.1 0.168 0.2 0.743 chromatin modification;histone H4-K16
acetylation
xsq HIBCH 2q32.2 0.168 0.2 0.744 branched chain family amino acid
xsq SNRPG 2p13.3 0.168 0.2 0.744 spliceosomal snRNP assembly;RNA metabolic
process
exp LPAR3 1p22.3 0.168 0.2 0.744 synaptic transmission;bleb assembly
xsq HAGHL 16p13.3 0.168 0.2 0.744
met OXT 20p13 0.168 0.2 0.744 maternal aggressive behavior;response to
sucrose stimulus
cop MBD2 18q21 0.168 0.2 0.744 maternal behavior;cellular protein complex
assembly
exp TSIX Xq13.2 0.168 0.2 0.744
exp FOXJ3 1p34.2 0.168 0.2 0.744 regulation of sequence-specific DNA
xsq TRMT13 1p21.2 0.168 0.2 0.744
met IRF9 14q11.2 0.168 0.2 0.744 type I interferon-mediated signaling
pathway;regulation of transcription, DNA-dependent
cop LRRC32 11q13.5-q14 0.168 0.2 0.744
mut NAGPA 16p13.3 0.168 0.2 0.744 carbohydrate metabolic process;protein
xsq NAB1 2q32.3-q33 0.168 0.2 0.744 Schwann cell differentiation;myelination
xsq ETFA 15q23-q25 0.168 0.2 0.744 transport;respiratory electron transport
chain
cop C2CD4A 15q22.2 0.168 0.2 0.744
cop CDKL4 2p22.1 0.168 0.2 0.744
xsq COG7 16p12.2 0.168 0.2 0.744 protein localization to organelle;protein
localization in Golgi apparatus
met CRYBA2 2q35 0.168 0.2 0.744
xsq MT1G 16q13 0.168 0.2 0.744 cellular response to zinc ion;monocyte
differentiation
xsq KRTAP4-1 17q21.2 0.168 0.2 0.744
mut NRAP 10q24-q26 0.168 0.2 0.744
xsq ANKRD18DP 3q29 0.168 0.2 0.744
xsq CREM 10p11.21 0.168 0.2 0.744 cell differentiation;regulation of
met GCM2 6p23 0.168 0.2 0.744 cellular calcium ion homeostasis;multicellular
met VSTM2A 7p11.2 0.168 0.2 0.744
met RERG 12p12.3 0.168 0.2 0.744 GTP catabolic process;signal transduction
xsq ANP32A-IT1 15q23 0.168 0.2 0.744
met TAS1R3 1p36.33 0.168 0.2 0.744 sensory perception of umami
taste;detection of chemical stimulus involved in sensory perception of sweet taste
xsq PKIA-AS1 0.168 0.2 0.744
met BORA 13q22.1 0.168 0.2 0.744 cell cycle;regulation of mitosis
exp WHAMMP1 15q13.3 0.168 0.2 0.744
xsq ZDHHC23 3q13.31 0.168 0.2 0.744
exp IVL 1q21 -0.168 0.2 0.744 keratinocyte
exp DCN 12q21.33 -0.168 0.2 0.744 peptide cross-linking via
exp HRH1 3p25 -0.168 0.2 0.744 synaptic transmission;response to gravity
cop IGF2BP3 7p11 -0.168 0.2 0.744 regulation of cytokine biosynthetic
process;translation
xsq HOXD4 2q31.1 -0.168 0.2 0.744 stem cell
exp RGL2 6p21.3 -0.168 0.2 0.744 Ras protein signal
exp BCAN 1q31 -0.168 0.2 0.744 cell adhesion;hippocampus development
exp LOC642969 12q22 -0.168 0.2 0.744
met SREBF1 17p11.2 -0.168 0.2 0.744 cellular response to
starvation;positive regulation of triglyceride biosynthetic process
xsq MIR143HG 5q32 -0.168 0.2 0.744
exp POU6F2 7p14.1 -0.168 0.2 0.744 regulation of transcription,
mut PRR11 17q22 -0.168 0.2 0.744
met FAM71F2 7q32.1 -0.168 0.2 0.744
xsq GSTT1 22q11.23 -0.168 0.2 0.744 glutathione metabolic process
xsq HCG22 6p21.33 -0.168 0.2 0.744
cop CDH17 8q22.1 -0.168 0.2 0.744 transport;cell adhesion
met TSC1 9q34 -0.168 0.2 0.744 Apoptosis; Protein Kinases; Tumor
Suppressors
exp SEC23A 14q21.1 -0.168 0.2 0.744 protein N-linked
xsq CLIC6 21q22.12 -0.168 0.2 0.744 ion transport
exp CARMN -0.168 0.2 0.744
exp MSC 8q21 -0.168 0.2 0.743 regulation of transcription, DNA-
cop TAF2 8q24.12 -0.168 0.2 0.743 G2/M transition of mitotic cell
cycle;regulation of transcription, DNA-dependent
xsq OR4F15 15q26.3 -0.168 0.2 0.743 response to stimulus
exp IGF2R 6q26 -0.168 0.2 0.743 receptor-mediated endocytosis;signal
transduction
xsq GADD45A 1p31.2 -0.168 0.2 0.743 Apoptosis; DNA Damage
cop C8orf44-SGK3 -0.168 0.2 0.743
cop SGK3 8q12 -0.168 0.2 0.743
exp DNAJC18 5q31.2 -0.168 0.2 0.743 protein folding
DNA-dependent"
cop ITGB8 7p21.1 -0.168 0.2 0.743 multicellular organismal
xai PCGF2 17q12 -0.169 0.2 0.744 negative regulation of transcription from
his IL1R1 2q12 -0.169 0.2 0.744 ovulation;innate immune response
hs4 HRASLS 3q29 -0.169 0.2 0.744
hs4 MGC2889 3q29 -0.169 0.2 0.744
swa GDF15 19p13.11 -0.169 0.2 0.744 signal transduction;transforming
his MIR3972 -0.169 0.2 0.744
his AGXT2 5p13 -0.169 0.2 0.744 glyoxylate metabolic process;nucleobase-
his MMP14 14q11.2 -0.169 0.2 0.744 Apoptosis
xai DNALI1 1p35.1 -0.169 0.2 0.744 cellular component
hs4 FOXQ1 6p25 -0.169 0.2 0.744 hair follicle morphogenesis;positive
exp HAO2-IT1 -0.169 0.2 0.744
his BFSP2-AS1 -0.169 0.2 0.744
xai APBA1 9q13-q21.1 -0.169 0.2 0.744 intracellular protein
exp ANKRD26P1 16q11.2 -0.169 0.2 0.743
hs4 KIFAP3 1q24.2 -0.169 0.2 0.743 negative regulation of cell
hs4 MYOM3 1p36.11 -0.169 0.2 0.743
swa LRPAP1 4p16.3 -0.169 0.2 0.743 protein folding;negative
regulation of signal transduction
hs4 SERPING1 11q12.1 -0.169 0.2 0.743 blood circulation;negative
his LINC00705 10p15.1 -0.169 0.2 0.743
exp LOC646014 -0.169 0.2 0.743
exp LINC00943 -0.169 0.2 0.743
swa COPE 19p13.11 -0.169 0.2 0.743 cellular membrane
his TEF 22q13.2 -0.169 0.2 0.743 regulation of transcription from
RNA polymerase II promoter;positive regulation of transcription from RNA polymerase
II promoter
hs4 SLC2A1-AS1 -0.169 0.2 0.743
cop C1orf53 1q31.3 -0.169 0.2 0.743
swa ACTL6A 3q26.33 0.169 0.201 0.744 DNA Damage Response (DDR); DDR
(Chromatin)
xai LOC101060040 0.169 0.201 0.744
his GTF2H2 0.169 0.201 0.744 DNA Damage Response (DDR); DDR (NER)
hs4 NPDC1 9q34.3 0.169 0.201 0.744
his KIAA0895L 16q22.1 0.169 0.201 0.744
xai TYK2 19p13.2 0.169 0.201 0.744 intracellular protein kinase
hs4 ZBTB4 17p13.1 0.169 0.201 0.744 regulation of transcription, DNA-
dependent"
hs4 SLC35G6 17p13.1 0.169 0.201 0.744
hs4 POLR2A 17p13.1 0.169 0.201 0.744 DNA Damage Response (DDR); DDR
(NER)
exp LARP7 4q25 0.169 0.201 0.744 RNA processing
his ANKMY1 2q37.3 0.169 0.201 0.744
his DUSP28 2q37.3 0.169 0.201 0.744 peptidyl-tyrosine dephosphorylation
his RNPEPL1 2q37.3 0.169 0.201 0.744 proteolysis;leukotriene
xai CASP2 7q34-q35 0.169 0.201 0.744 Apoptosis
exp FAM9C Xp22.2 0.169 0.201 0.744
exp IGHG3 0.169 0.201 0.744 immune response;complement activation
xai GHRL 3p26-p25 0.169 0.201 0.744 negative regulation of endothelial cell
xai TBCK 4q24 0.169 0.201 0.744 protein phosphorylation
xai ZSCAN12 6p21 0.169 0.201 0.744 viral reproduction
his MIR4683 0.169 0.201 0.744
his FZD8 10p11.21 0.169 0.201 0.744 positive regulation of protein
promoter
xai C4orf50 4p16.2 0.169 0.201 0.744
hs4 KLHL8 4q22.1 0.169 0.201 0.744
his CALCOCO2 17q21.32 0.169 0.201 0.744 viral reproduction;response to
interferon-gamma
his C14orf39 14q23.1 0.169 0.201 0.744 regulation of sequence-specific DNA
xai MARCH11 5p15.1 0.169 0.201 0.744
xai DTD2 0.169 0.201 0.744
his GLA Xq22 0.169 0.201 0.744 glycosphingolipid catabolic
his HNRNPH2 Xq22 0.169 0.201 0.744
cop ARRDC5 19p13.3 0.169 0.201 0.744 signal transduction
hs4 GTSE1-AS1 22q13.31 0.169 0.201 0.744
hs4 GTSE1 22q13.2-q13.3 0.169 0.201 0.744 G2 phase of mitotic cell cycle;DNA
arrest
hs4 ABHD2 15q26.1 0.169 0.201 0.744 response to wounding;negative regulation
of cell migration
hs4 MND1 4q31.3 0.169 0.201 0.744 DNA recombination;meiosis
xai EEF1DP3 13q13.1 0.169 0.201 0.744
xai TDRD12 19q13.11 0.169 0.201 0.744
his LRP3 19q13.11 0.169 0.201 0.744 receptor-mediated endocytosis
xai RMND1 6q25.1 0.169 0.201 0.744
his IL17RE 3p25.3 0.169 0.201 0.744
his FRAT2 10q24.1 0.169 0.201 0.744 Apoptosis
dependent"
his UPF3A 13q34 0.169 0.201 0.744 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;transport
his PPP2R5E 14q23.1 0.169 0.201 0.744 signal transduction
xai HMGN2P16 9p22.3 0.169 0.201 0.744
swa TMSB4X Xq21.3-q22 0.169 0.201 0.744 blood coagulation;actin
swa TRIM28 19q13.4 0.169 0.201 0.744 DNA Damage Response (DDR)
his SMC1A Xp11.22-p11.21 0.169 0.201 0.744 DNA Damage Response (DDR); DDR (DNA
replication)
his RIBC1 Xp11.22 0.169 0.201 0.744
his L3MBTL2 22q13.31-q13.33 0.169 0.201 0.744 regulation of transcription,
DNA-dependent;chromatin modification"
exp HMGN2P16 9p22.3 0.169 0.201 0.744
his ATG2B 14q32.2 0.169 0.201 0.744
his GSKIP 14q32.2 0.169 0.201 0.744
hs4 SHISA8 22q13.2 0.169 0.201 0.744
hs4 MRM1 17q12 0.169 0.201 0.744 RNA processing
xai VN1R46P 8p11.21 0.169 0.201 0.744
his NRON 0.169 0.201 0.744
his POLR3H 22q13.2 0.169 0.201 0.744 termination of RNA polymerase III
transcription;response to virus
xai ARL14EP 11p14.1 0.169 0.201 0.744
met HPCAL1 2p25.1 0.168 0.201 0.744
cop TMEM87A 15q15.1 0.168 0.201 0.744
cop GANC 15q15.2 0.168 0.201 0.744 carbohydrate metabolic process
xsq LALBA 12q13 0.168 0.201 0.744 cell-cell signaling;defense response to
bacterium
met PTGFR 1p31.1 0.168 0.201 0.744 G-protein coupled receptor signaling
pathway;parturition
met SPOP 17q21.33 0.168 0.201 0.744 mRNA processing
met ATP9A 20q13.2 0.168 0.201 0.744 cation transport;phospholipid
translocation
xsq ERICH6-AS1 0.168 0.201 0.744
exp BIK 22q13.31 0.168 0.201 0.744 Apoptosis
xsq TMEM55A 8q21.3 0.168 0.201 0.744
cop LITAF 16p13.13 0.168 0.201 0.744 Apoptosis
xsq NLRP4 19q13.43 0.168 0.201 0.744
met CHCHD5 2q13 0.168 0.201 0.744
cop SIRPB2 20p13 0.168 0.201 0.744
cop SIRPD 20p13 0.168 0.201 0.744
xsq C1orf87 1p32.1 0.168 0.201 0.744
xsq RPUSD3 3p25.3 0.168 0.201 0.744 pseudouridine synthesis
mut TAF4 20q13.33 0.168 0.201 0.744 ovarian follicle development;interspecies
mut KIAA1755 20q11.23 0.168 0.201 0.744
xsq PHRF1 11p15.5 0.168 0.201 0.744 transcription from RNA polymerase II
xsq THYN1 11q25 0.168 0.201 0.744
xsq AP1M1 19p13.12 0.168 0.201 0.744 EMT (Mesenchymal)
exp HDGF 1q23.1 0.168 0.201 0.744 regulation of transcription, DNA-
response
exp UNC93B1 11q13 0.168 0.201 0.744 toll-like receptor 7 signaling
xsq DPP3 11q12-q13.1 0.167 0.201 0.744 proteolysis
xsq NT5DC2 3p21.1 0.167 0.201 0.744
xsq HIST1H2AI 6p22.1 0.167 0.201 0.744
met CLDN20 6q25 0.167 0.201 0.744 tight junction assembly;calcium-
met AMY2B 1p21 0.167 0.201 0.744
xsq MRPL51 12p13.3-p13.1 0.167 0.201 0.744 translation
xsq RPS3A 4q31.2-q31.3 0.167 0.201 0.744 Apoptosis
exp PYGO2 1q21.3 0.167 0.201 0.744 developmental growth;palate development
mut CCR2 3p21.31 0.167 0.201 0.744 cellular calcium ion homeostasis;response
to wounding
exp ATP5G2 12q13.13 0.167 0.201 0.744 transport;ion transport
exp EML2-AS1 0.167 0.201 0.744
xsq FLJ34503 6q21 0.167 0.201 0.744
cop WFDC1 16q24.3 0.167 0.201 0.744 negative regulation of cell
growth;response to estradiol stimulus
xsq LPCAT3 12p13 0.167 0.201 0.744 phospholipid biosynthetic process
met ZNF354A 5q35.3 0.167 0.201 0.744 regulation of transcription from
RNA polymerase II promoter;sensory perception of sound
xsq PNN 14q21.1 0.167 0.201 0.744 nuclear mRNA splicing, via
cop BIN1 2q14 0.167 0.201 0.744 positive regulation of GTPase
cop CYP27C1 2q14.3 0.167 0.201 0.744
cop ERCC3 2q21 0.167 0.201 0.744 Apoptosis; DNA Damage Response (DDR); DDR (NER)
cop MAP3K2 2q14.3 0.167 0.201 0.744 Protein Kinases
cop PROC 2q13-q14 0.167 0.201 0.744 peptidyl-glutamic acid
carboxylation;negative regulation of blood coagulation
cop MIR4783 0.167 0.201 0.744
cop IWS1 2q14.3 0.167 0.201 0.744 transcription, DNA-dependent"
cop MYO7B 2q21.1 0.167 0.201 0.744
cop LIMS2 2q14.3 0.167 0.201 0.744 cell junction assembly
cop GPR17 2q21 0.167 0.201 0.744 G-protein coupled receptor signaling pathway
cop SFT2D3 2q14.3 0.167 0.201 0.744 protein transport;vesicle-mediated
transport
cop WDR33 2q14.3 0.167 0.201 0.744 postreplication repair;mRNA processing
cop POLR2D 2q21 0.167 0.201 0.744 DNA Damage Response (DDR); DDR (NER)
cop AMMECR1L 2q21 0.167 0.201 0.744
cop SAP130 2q14.3 0.167 0.201 0.744 regulation of transcription, DNA-
xsq PPIL1 6p21.1 0.167 0.201 0.744 nuclear mRNA splicing, via
exp LOC100289656 0.167 0.201 0.744
xsq RPS9 19q13.4 0.167 0.201 0.744 SRP-dependent cotranslational protein
xsq RHO 3q21-q24 0.167 0.201 0.744
cop POU5F1B 8q24.21 0.167 0.201 0.744 regulation of transcription, DNA-
dependent"
cop RAB31 18p11.3 0.167 0.201 0.744 GTP catabolic process;small GTPase
xsq DCHS2 4q31.3 0.167 0.201 0.744 cell adhesion;homophilic cell adhesion
dependent"
xsq CASP10 2q33-q34 0.167 0.201 0.744 Apoptosis
xsq RPS7P5 1q43 0.167 0.201 0.744
exp RAD17 5q13 0.167 0.201 0.744 DNA Damage Response (DDR)
met TMEM158 3p21.3 0.167 0.201 0.744
exp RHOXF2 Xq24 0.167 0.201 0.744
met ATAD3B 1p36.33 0.167 0.201 0.744
xsq SS18 18q11.2 0.167 0.201 0.744 intracellular protein kinase
xsq KCNMB3 3q26.3-q27 0.167 0.201 0.744 ion transport;potassium ion
transport
met RXFP3 5p15.1-p14 0.167 0.201 0.744 G-protein coupled receptor signaling
pathway;elevation of cytosolic calcium ion concentration involved in G-protein
signaling coupled to IP3 second messenger
cop PTPLAD1 15q22.2 0.167 0.201 0.744
xsq SENP6 6q13-q14.3 0.167 0.201 0.744 protein modification by small protein
exp CLDN8 21q22.11 -0.167 0.201 0.744 calcium-independent cell-cell
adhesion
mut THBS3 1q21 -0.167 0.201 0.744 cell adhesion;cell-matrix adhesion
xsq AMOTL1 11q14.3 -0.167 0.201 0.744
exp DAP 5p15.2 -0.167 0.201 0.744 Apoptosis
met C12orf57 12p13.31 -0.167 0.201 0.744
xsq CEP295NL -0.167 0.201 0.744
cop DNAJC5B 8q13.1 -0.167 0.201 0.744 protein folding
xsq PC 11q13.4-q13.5 -0.167 0.201 0.744 carbohydrate metabolic
met CTSE 1q31 -0.167 0.201 0.744 proteolysis;digestion
xsq COBLL1 2q24.3 -0.167 0.201 0.744
xsq APOBEC3H 22q13.1 -0.167 0.201 0.744 cytidine deamination;negative
exp RPL10P10 6p12.1 -0.167 0.201 0.744
xsq LOC102724719 -0.167 0.201 0.744
xsq FGD1 Xp11.21 -0.167 0.201 0.744 organ morphogenesis;apoptotic
process
cop ABCD3 1p21.3 -0.167 0.201 0.744 ABC Transporters
cop F3 1p22-p21 -0.167 0.201 0.744 anti-apoptosis;positive regulation
cop PLD1 3q26 -0.167 0.201 0.744 phospholipid catabolic process;lipid
catabolic process
cop TMEM212 3q26.31 -0.167 0.201 0.744
exp ATP6V0D2 -0.167 0.201 0.744 transmembrane transport;ion
transport
cop PRLR 5p13.2 -0.167 0.201 0.744 embryo implantation;prostate gland
growth
exp SPSB1 1p36.22 -0.167 0.201 0.744 intracellular signal transduction
met SPEM1 17p13.1 -0.167 0.201 0.744 multicellular organismal
mir hsa-miR-517c -0.168 0.201 0.744
cop RGSL1 1q25 -0.168 0.201 0.744 termination of G-protein coupled receptor
signaling pathway
xsq CLLU1OS 12q22 -0.168 0.201 0.744
cop LOC100130849 7p11.2 -0.168 0.201 0.744
cop ZNF479 7p11.2 -0.168 0.201 0.744
exp TFPT 19q13 -0.168 0.201 0.744 DNA Damage Response (DDR); DDR
(Chromatin)
exp ZNF667-AS1 19q13.43 -0.168 0.201 0.744
xsq CTAGE4 -0.168 0.201 0.744
xsq RNF152 18q21.33 -0.168 0.201 0.744 apoptotic process;protein
met TTC29 4q31.22 -0.168 0.201 0.744
xsq FNDC5 1p35.1 -0.168 0.201 0.744
exp PPARGC1A 4p15.1 -0.168 0.201 0.744 mRNA processing;respiratory
exp NUDT9P1 10q23.32 -0.168 0.201 0.744
xai TRBV6-8 -0.169 0.201 0.744
hs4 C11orf84 11q13.1 -0.169 0.201 0.744
hs4 SERPINH1 11q13.5 -0.169 0.201 0.744 response to stress;response
to unfolded protein
swa GLS 2q32-q34 -0.169 0.201 0.744 glutamine catabolic
xai KRT14 17q21.2 -0.169 0.201 0.744 intermediate filament bundle
his TTPAL 20q13.12 -0.169 0.201 0.744
his LOC100505795 -0.169 0.201 0.744
xai FREM2 13q13.3 -0.169 0.201 0.744 homophilic cell
his LOC105376671 -0.169 0.201 0.744
his LGR4 11p14-p13 -0.169 0.201 0.744 male genitalia
hs4 TEKT4P2 21p11.2 -0.169 0.201 0.744
xai RBPMS2 15q22.31 -0.169 0.201 0.744
his HK1 10q22 -0.169 0.201 0.744 transmembrane transport;carbohydrate
metabolic process
hs4 KDM5B 1q32.1 -0.169 0.201 0.744 histone H3-K4 demethylation,
hs4 PCAT6 -0.169 0.201 0.744
cop MIR644A -0.169 0.201 0.744
xai NDEL1 17p13.1 -0.169 0.201 0.744 M phase of mitotic cell
cycle;multicellular organismal development
his CRYGD -0.169 0.201 0.744
xai LOC100507006 -0.169 0.201 0.744
hs4 FLNB 3p14.3 -0.169 0.201 0.744 multicellular organismal
hs4 TPM3P9 19q13.42 -0.169 0.201 0.744
DNA-dependent"
swa MX1 21q22.3 -0.169 0.201 0.744 Apoptosis
hs4 ARL8A 1q32.1 -0.169 0.201 0.744 GTP catabolic process;cell cycle
his STOX2 4q35.1 -0.169 0.201 0.744 maternal placenta
xai LOC646014 -0.169 0.201 0.744
xai RAB9B Xq22.1-q22.3 -0.169 0.201 0.744 small GTPase mediated signal
xai KIAA0355 19q13.11 -0.169 0.201 0.744
his SEC24A 5q31.1 -0.169 0.201 0.744 ER to Golgi vesicle-mediated
swa BCAT1 12p12.1 -0.169 0.201 0.744 small molecule metabolic
process;G1/S transition of mitotic cell cycle
hs4 LOC101928977 -0.169 0.201 0.744
his RAB17 2q37.3 -0.169 0.201 0.744 protein transport;small GTPase
his ANXA3 4q21.21 -0.169 0.201 0.744 positive regulation of
xai COL4A3BP 5q13.3 -0.169 0.201 0.744 cell morphogenesis;muscle
contraction
xai SPIN1 9q22.1 -0.169 0.201 0.744 cell cycle;multicellular organismal
development
hs4 CCDC3 10p13 -0.169 0.201 0.744
hs4 OPTN 10p13 -0.169 0.201 0.744 protein targeting to Golgi;Golgi
organization
his ADGRA2 -0.169 0.201 0.744 sprouting angiogenesis;G-protein
his LINC01214 -0.169 0.201 0.744
his CYP7B1 8q21.3 -0.169 0.201 0.744 memory;positive regulation of
xai AMER3 2q21.1 -0.169 0.201 0.744
xai NCOA2 8q13.3 -0.169 0.201 0.744 regulation of transcription, DNA-
xai HAO2-IT1 -0.169 0.201 0.744
his ERICH1-AS1 -0.169 0.201 0.744
his DLGAP2 8p23 -0.169 0.201 0.744
his LOC401442 8p23.3 -0.169 0.201 0.744
his LOC105369438 -0.169 0.201 0.744
his BDH2 4q24 0.169 0.202 0.744 siderophore biosynthetic process;heme metabolic
process
his DCAF11 14q11.2 0.169 0.202 0.744 protein ubiquitination
hs4 RNVU1-18 0.169 0.202 0.744
his LINC00898 0.169 0.202 0.744
his LOC284930 0.169 0.202 0.744
his LRRC70 5q12.1 0.169 0.202 0.744
his IPO11-LRRC70 0.169 0.202 0.744
xai VN2R3P 9p13.1 0.169 0.202 0.744
xai GLOD5 Xp11.23 0.169 0.202 0.744
his FAM199X Xq22.2 0.169 0.202 0.744
his KMO 1q42-q44 0.169 0.202 0.744 tryptophan catabolic process to
kynurenine;NAD metabolic process
his MAP10 1q42.2 0.169 0.202 0.744
xai CDKN2B-AS1 9p21.3 0.169 0.202 0.744
his MIR4655 0.169 0.202 0.744
his SCFD1 14q12 0.169 0.202 0.745 response to hypoxia;retrograde vesicle-mediated
transport, Golgi to ER
xai DPY30 2p22.3 0.169 0.202 0.745 histone H3-K4 methylation;regulation of
his CKMT2-AS1 0.169 0.202 0.745
his ZCCHC9 5q14.1 0.169 0.202 0.745 negative regulation of phosphatase
activity
xai LINC00654 20p12.3 0.169 0.202 0.745
exp OR9R1P 12q13.2 0.169 0.202 0.745
dependent"
his EDEM3 1q25 0.169 0.202 0.745 glycoprotein catabolic process;response to
unfolded protein
his INAFM2 0.169 0.202 0.745
his DACH1 13q22 0.169 0.202 0.745 regulation of transcription, DNA-
hs4 ANP32B 9q22.32 0.169 0.202 0.745
xai ICE1 0.169 0.202 0.745
his RNASEH2C 11q13.1 0.169 0.202 0.745 DNA Damage Response (DDR); DDR (DNA
replication)
xai MYT1 20q13.33 0.169 0.202 0.745 Protein Kinases
xai PDE8B 5q13.3 0.169 0.202 0.745 regulation of transcription, DNA-
dependent;cyclic nucleotide metabolic process
his KIAA0408 0.169 0.202 0.745
xai NCAPG 4p15.33 0.168 0.202 0.745 DNA Damage Response (DDR)
his NOS3 7q36 0.168 0.202 0.745 regulation of sodium ion transport;blood
coagulation
his GLE1 9q34.11 0.168 0.202 0.745 protein transport;poly(A)+ mRNA export
from nucleus
hs4 TCF24 8q13.1 0.168 0.202 0.745 regulation of transcription, DNA-
dependent"
his RANBP10 16q22.1 0.168 0.202 0.745 microtubule cytoskeleton
his TSNAXIP1 16q22.1 0.168 0.202 0.745 multicellular organismal
exp LINC00301 11q12.2 0.168 0.202 0.745
xai OR8C1P 11q24.2 0.168 0.202 0.745
hs4 CDHR4 3p21.31 0.168 0.202 0.745 cell adhesion;homophilic cell adhesion
hs4 FAM212A 3p21.31 0.168 0.202 0.745
hs4 MIR5193 0.168 0.202 0.745
xai LOC100505727 0.168 0.202 0.745
xai SYMPK 19q13.3 0.168 0.202 0.745 mRNA processing;cell adhesion
hs4 KCNK12 2p16.3 0.168 0.202 0.745 ion transport;potassium ion
transport
hs4 CMTM3 16q21 0.168 0.202 0.745 EMT (Mesenchymal)
his LIG3 17q11.2-q12 0.168 0.202 0.745 DNA Damage Response (DDR); DDR (BER)
his RS1 Xp22.13 0.168 0.202 0.745 cell adhesion;multicellular organismal
development
his ACTR2 2p14 0.168 0.202 0.745 cellular component movement
his DPP9 19p13.3 0.168 0.202 0.745 proteolysis
his SERGEF 11p14.3 0.168 0.202 0.745 signal transduction;negative
his DUSP16 12p13 0.168 0.202 0.745 protein
dephosphorylation;dephosphorylation
xai PLCXD3 5p13.1 0.168 0.202 0.745 lipid catabolic
mut FER1L6 8q24.1 0.167 0.202 0.744
xsq SNORD22 0.167 0.202 0.744
exp RPS20P23 8q22.3 0.167 0.202 0.744
met LHFPL2 5q14.1 0.167 0.202 0.744
xsq PELI2 14q21 0.167 0.202 0.744 toll-like receptor 1 signaling pathway;toll-
like receptor 2 signaling pathway
cop TLK2 17q23 0.167 0.202 0.744 DDR (DNA replication)
met STKLD1 0.167 0.202 0.744
exp NCOA5 20q12-q13.12 0.167 0.202 0.744 regulation of transcription, DNA-
dependent"
met NTSR2 2p25.1 0.167 0.202 0.744
xsq COMTD1 10q22.2 0.167 0.202 0.744
cop MLYCD 16q24 0.167 0.202 0.744 acetyl-CoA biosynthetic process;fatty acid
cop NADSYN1 11q13.4 0.167 0.202 0.744 vitamin metabolic process;water-
cop ARG1 6q23 0.167 0.202 0.744 response to zinc ion;response to drug
cop MED23 6q22.33-q24.1 0.167 0.202 0.744 regulation of transcription from
exp XIAP Xq25 0.167 0.202 0.744 Apoptosis
exp LRRC34 3q26.2 0.167 0.202 0.744
cop ADAT2 6q24.2 0.167 0.202 0.744 tRNA processing
cop PEX3 6q24.2 0.167 0.202 0.744 peroxisome organization;peroxisome
membrane biogenesis
cop FUCA2 6q24 0.167 0.202 0.744 fucose metabolic process;carbohydrate metabolic
process
cop LOC285740 6q24.2 0.167 0.202 0.744
cop PHACTR2 6q24.2 0.167 0.202 0.744
cop LTV1 6q24.2 0.167 0.202 0.744
cop ZC2HC1B 6q24.2 0.167 0.202 0.744
cop PLAGL1 6q24-q25 0.167 0.202 0.744 Apoptosis
cop HYMAI 0.167 0.202 0.744
cop SF3B5 6q24.2 0.167 0.202 0.744 nuclear mRNA splicing, via
cop STX11 6q24.2 0.167 0.202 0.744 intracellular protein transport;cellular
membrane fusion
xsq RPL27A 11p15 0.167 0.202 0.744 translational initiation;viral infectious
cycle
dependent"
mut PCDHB1 0.167 0.202 0.744
met TRDN 6q22.31 0.167 0.202 0.745 muscle contraction
pro EP300_8_8881 0.167 0.202 0.745
met COL6A5 3q22.1 0.167 0.202 0.745 cell adhesion
xsq C2orf91 2p21 0.167 0.202 0.745
xsq PAGE1 Xp11.23 0.167 0.202 0.745 cellular defense response
cop ZNF236 18q22-q23 0.167 0.202 0.745 regulation of transcription, DNA-
xsq AADACP1 0.167 0.202 0.745
xsq SNRNP200 2q11.2 0.167 0.202 0.745 RNA splicing;gene expression
exp ZMYM4 1p32-p34 0.167 0.202 0.745 cytoskeleton organization;multicellular
met MARVELD3 16q22.2 0.167 0.202 0.745 EMT (Epithelial)
xsq LOC101929517 0.167 0.202 0.745
cop MON1B 16q23.1 0.167 0.202 0.745
met MIRLET7B 0.167 0.202 0.745
met TAF8 6p21.1 0.167 0.202 0.745 inner cell mass cell
proliferation;multicellular organismal development
exp C11orf73 11q14.2 0.167 0.202 0.745 Golgi organization;multicellular
xsq KIAA0895L 16q22.1 0.167 0.202 0.745
xsq C6orf120 6q27 0.167 0.202 0.745
xsq OR2F1 7q35 0.167 0.202 0.745 signal transduction;response to stimulus
xsq MTFMT 15q22.31 0.167 0.202 0.745 biosynthetic process
xsq CCT6P1 7q11.21 0.167 0.202 0.745
xsq LOC100130950 0.167 0.202 0.745
cop GPR75 2p16 0.167 0.202 0.745 G-protein coupled receptor signaling pathway
exp CNST 1q44 0.167 0.202 0.745 negative regulation of phosphatase
cop MIR1827 0.167 0.202 0.745
exp GM2A 5q33.1 0.167 0.202 0.745 glycolipid catabolic process;lipid
storage
xsq WDR90 16p13.3 0.167 0.202 0.745
dependent"
xsq TM2D3 15q26.3 0.167 0.202 0.745
exp FAM189A2 9q21.11 -0.167 0.202 0.745
met TRIML2 4q35.2 -0.167 0.202 0.745
exp CGRRF1 14q22.2 -0.167 0.202 0.745 response to stress;cell cycle
cop SEPT7P2 7p12.3 -0.167 0.202 0.745
exp ENOX1 13q14.11 -0.167 0.202 0.745 transport;electron transport chain
xsq KRT5 12q13.13 -0.167 0.202 0.745 epidermis development;hemidesmosome
assembly
cop MPP6 7p15 -0.167 0.202 0.745 protein complex assembly
exp UBAP1 9p13.3 -0.167 0.202 0.745
exp C1S 12p13 -0.167 0.202 0.745 proteolysis;complement activation
xsq HOGA1 10q24.2 -0.167 0.202 0.745 glyoxylate catabolic process
mut ARVCF 22q11.21 -0.167 0.202 0.745 cell adhesion;multicellular
exp SBF2 11p15.4 -0.167 0.202 0.745 regulation of catalytic
activity;protein tetramerization
xsq OR52E8 11p15.4 -0.167 0.202 0.745 response to stimulus
xsq ACVR1 2q23-q24 -0.167 0.202 0.745 G1/S transition of mitotic cell
cop STAU2 8q21.11 -0.167 0.202 0.745 transport
exp DPYSL3 5q32 -0.167 0.202 0.745 axon guidance;actin crosslink
formation
cop MATN2 8q22 -0.167 0.202 0.745
cop RPL30 8q22 -0.167 0.202 0.745 viral reproduction;nuclear-transcribed
cop SNORA72 8q22 -0.167 0.202 0.745
cop ERICH5 -0.167 0.202 0.745
cop HRSP12 8q22 -0.167 0.202 0.745 regulation of translational
termination
met MIR92B -0.167 0.202 0.745
exp GFPT2 5q34-q35 -0.167 0.202 0.745 dolichol-linked oligosaccharide
xsq ADAMTS16 5p15 -0.167 0.202 0.745 proteolysis
exp HAGLR -0.167 0.202 0.745
exp CCDC40 17q25.3 -0.167 0.202 0.745 axonemal dynein complex
xsq P3H4 -0.167 0.202 0.745 synaptonemal complex assembly
mut TCFL5 20q13.33 -0.167 0.202 0.744 regulation of cell
exp HIGD1AP1 12q13.13 -0.167 0.202 0.744
xsq CTAGE9 6q23.2 -0.167 0.202 0.744
cop MAL2 8q23 -0.167 0.202 0.744
xsq ZNF704 8q21.13 -0.167 0.202 0.744
xsq CST2 20p11.21 -0.167 0.202 0.744
met ATP2B2 3p25.3 -0.167 0.202 0.744 cell morphogenesis;brain
development
xsq CTSA 20q13.1 -0.167 0.202 0.744 positive regulation of catalytic
exp FJX1 11p13 -0.167 0.202 0.744
exp HECW1 7p13 -0.167 0.202 0.744 protein modification process;protein
hs4 MCMDC2 8q13.1 -0.168 0.202 0.745 DNA replication
swa APOBEC3C 22q13.1 -0.168 0.202 0.745 response to virus;negative
xai IFT172 2p23.3 -0.168 0.202 0.745 protein processing;cilium
assembly
xai GGT2 -0.168 0.202 0.745 glutathione metabolic process;glutathione
swa BLM 15q26.1 -0.168 0.202 0.745 DNA Damage Response (DDR); DDR (FA)
his LINC01490 -0.168 0.202 0.745
his CPN2 3q29 -0.168 0.202 0.745 regulation of catalytic activity;protein
stabilization
swa GNPDA2 4p12 -0.168 0.202 0.745 carbohydrate metabolic process;N-
xai LRRC4C 11p12 -0.168 0.202 0.745 regulation of axonogenesis
his TMEM67 8q22.1 -0.168 0.202 0.745 cilium assembly;branching
hs4 MIR130A -0.168 0.202 0.745
hs4 FBXO27 19q13.2 -0.168 0.202 0.745 protein catabolic process
hs4 ZNF257 19q13 -0.169 0.202 0.745 regulation of transcription, DNA-
dependent"
hs4 LINC01605 -0.169 0.202 0.745
xai AZIN1 8q22.3 -0.169 0.202 0.745 positive regulation of catalytic
xai RECK 9p13.3 -0.169 0.202 0.745 EMT (Mesenchymal)
hs4 HKDC1 10q22.1 -0.169 0.202 0.745 carbohydrate metabolic
process;glycolysis
hs4 APBA1 9q13-q21.1 -0.169 0.202 0.745 intracellular protein
his LMNA 1q22 -0.169 0.202 0.745 establishment or maintenance of
his CALU 7q32.1 -0.169 0.202 0.745 platelet activation;platelet
degranulation
hs4 ZNF528-AS1 -0.169 0.202 0.744
dependent"
exp GGT2 -0.169 0.202 0.744 glutathione metabolic process;glutathione
hs4 GPRC5A 12p13-p12.3 -0.169 0.202 0.744 G-protein coupled receptor
his PTPN13 4q21.3 -0.169 0.202 0.744 protein
his WDR61 15q25.1 -0.169 0.202 0.744
exp TRBV6-8 -0.169 0.202 0.744
his LOC105371083 0.168 0.203 0.745
his RMI2 16p13.13 0.168 0.203 0.745 DNA Damage Response (DDR); DDR (FA)
exp ATP5LP2 0.168 0.203 0.745
hs4 NKX6-2 10q26 0.168 0.203 0.745 regulation of transcription, DNA-
dependent;endocrine pancreas development
xai CDK5 7q36 0.168 0.203 0.745 Apoptosis; Protein Kinases
hs4 TPM3 1q21.2 0.168 0.203 0.745 cellular component movement;muscle
contraction
xai TXNDC17 17p13.1 0.168 0.203 0.745 tumor necrosis factor-mediated
signaling pathway
his HPS6 10q24.32 0.168 0.203 0.745 organelle organization;blood coagulation
his NCR2 6p21.1 0.168 0.203 0.745 cellular defense response;signal
transduction
his NUP93 16q13 0.168 0.203 0.745 regulation of glucose transport;protein
transport
xai MTHFD2L 4q13.3 0.168 0.203 0.745 methionine biosynthetic
his P3H3 0.168 0.203 0.745 negative regulation of cell proliferation
xai SIGLEC15 18q12.3 0.168 0.203 0.745
xai HMGN2P41 16p11.1 0.168 0.203 0.745
exp NPBWR2 20q13.3 0.168 0.203 0.745 opioid receptor signaling
his TRIM4 7q22-q31.1 0.168 0.203 0.745 protein trimerization
hs4 TRPM2-AS 0.168 0.203 0.745
hs4 TRPM2 21q22.3 0.168 0.203 0.745 ion transport;calcium ion transport
xai ATP5LP2 0.168 0.203 0.745
swa CRABP2 1q21.3 0.168 0.203 0.746 regulation of transcription, DNA-
xai RALGAPA2 20p11.22 0.168 0.203 0.746 activation of Ral GTPase
xai C17orf89 17q25.3 0.168 0.203 0.746
xai POLDIP2 17q11.2 0.168 0.203 0.746 DDR (DNA replication)
xai BANK1 4q24 0.168 0.203 0.746 B cell activation
his LRP8 1p34 0.168 0.203 0.746 cytokine-mediated signaling pathway;hippocampus
development
his LINC01771 0.168 0.203 0.746
his NTSR1 20q13 0.168 0.203 0.746 G-protein coupled receptor signaling
xai GPR12 13q12 0.168 0.203 0.746 cellular calcium ion homeostasis;G-protein
xai C6orf203 6q21 0.168 0.203 0.746
xai WHSC1 4p16.3 0.168 0.203 0.746 regulation of transcription, DNA-
hs4 FGF14 13q34 0.168 0.203 0.746 cell death;fibroblast growth factor receptor
signaling pathway
his LINC01262 0.168 0.203 0.746
exp RPL7P52 22q13.1 0.168 0.203 0.746
hs4 NOP14 4p16.3 0.168 0.203 0.746 endonucleolytic cleavage to generate
hs4 GRK4 4p16.3 0.168 0.203 0.746 regulation of G-protein coupled receptor
protein signaling pathway;receptor internalization
hs4 NLRP12 19q13.42 0.168 0.203 0.746 negative regulation of protein
autophosphorylation;positive regulation of inflammatory response
xai PCBP3 21q22.3 0.168 0.203 0.746 mRNA metabolic process
his CCDC124 19p13.11 0.168 0.203 0.746
hs4 BRIP1 17q22.2 0.168 0.203 0.746 DNA Damage Response (DDR); DDR (FA)
his LRRC63 13q14.13 0.168 0.203 0.746
his ZNF280D 15q21.3 0.168 0.203 0.746
xai EIF3M 11p13 0.168 0.203 0.746 translational initiation
hs4 NCAPH 2q11.2 0.168 0.203 0.746 DNA Damage Response (DDR)
his WNT10A 2q35 0.168 0.203 0.746 Oncogenes
exp LINC01146 0.168 0.203 0.746
exp LINC00421 13q12.11 0.168 0.203 0.746
xai LINC00421 13q12.11 0.168 0.203 0.746
hs4 EML6 2p16.1 0.168 0.203 0.746
his CYP2R1 11p15.2 0.168 0.203 0.746 vitamin metabolic
his LINC01744 0.168 0.203 0.746
swa ACAA2 18q21.1 0.168 0.203 0.746 acetyl-CoA metabolic process;lipid
metabolic process
xai TATDN2P3 0.168 0.203 0.746
xai AKAP8L 19p13.12 0.168 0.203 0.746
swa MACF1 1p32-p31 0.168 0.203 0.746 establishment or maintenance of cell
polarity;regulation of epithelial cell migration
xai FAM96B 16q22.1 0.168 0.203 0.746 chromosome segregation
xsq PLA2G7 6p21.2-p12 0.167 0.203 0.745 low-density lipoprotein particle
cop PPM1D 17q23.2 0.167 0.203 0.745 DNA Damage Response (DDR)
xsq PRPSAP2 17p11.2-p12 0.167 0.203 0.745 nucleobase-containing compound
met FAM201A 9p13.1 0.167 0.203 0.745
xsq EDEM1 3p26.1 0.167 0.203 0.745 protein N-linked glycosylation via
exp HMGN2P7 3p25.1 0.167 0.203 0.745
met RND3 2q23.3 0.167 0.203 0.745 GTP catabolic process;cell adhesion
mut TDO2 4q31-q32 0.167 0.203 0.745 tryptophan catabolic process;tryptophan
catabolic process to kynurenine
xsq TTC5 14q11.2 0.167 0.203 0.745 DNA repair
exp NEMP1 0.167 0.203 0.745
exp PDDC1 11p15.5 0.167 0.203 0.745
exp EEF1A1P15 Xq21.33 0.167 0.203 0.745
xsq LOC101927914 0.167 0.203 0.745
xsq GAPDH 12p13 0.167 0.203 0.745 glucose metabolic process;gluconeogenesis
xsq SLCO4C1 5q21.2 0.167 0.203 0.745 Solute Carriers
exp CEP78 9q21.2 0.167 0.203 0.746 G2/M transition of mitotic cell
xsq FLJ31662 0.167 0.203 0.746
met JOSD1 22q13.1 0.167 0.203 0.746 proteolysis
xsq NFS1 20q11.22 0.167 0.203 0.746 vitamin metabolic process;water-soluble
exp ATL2 2p22.3 0.167 0.203 0.746 GTP catabolic process;ER to Golgi
met RHOBTB1 10q21.2 0.167 0.203 0.746 small GTPase mediated signal
xsq LINC01304 0.167 0.203 0.746
exp TBCK 4q24 0.167 0.203 0.746 protein phosphorylation
mut TXLNG Xp22.2 0.167 0.203 0.746 regulation of transcription, DNA-
xsq SETMAR 3p26.1 0.167 0.203 0.746 DNA Damage Response (DDR)
mut SNAP25 20p12-p11.2 0.167 0.203 0.746 synaptic vesicle docking involved
in exocytosis;regulation of insulin secretion
met BMP2K 4q21.21 0.167 0.203 0.746 regulation of catalytic
exp NPY 7p15.1 0.167 0.203 0.746 G-protein signaling, coupled to cyclic
cop ERP44 9q31.1 0.167 0.203 0.746 glycoprotein metabolic process;cell redox
homeostasis
xsq LINC01189 0.167 0.203 0.746
cop LOC728730 2p22.1 0.167 0.203 0.746
xsq ANKRD20A4 0.167 0.203 0.746
exp VDAC2 10q22 0.167 0.203 0.746 Apoptosis
exp C18orf8 18q11.2 0.167 0.203 0.746
met DTNA 18q12 0.167 0.203 0.746 striated muscle contraction;signal transduction
xsq AKIRIN1 1p34.3 0.167 0.203 0.746
cop NXNL2 9q22.1 0.167 0.203 0.746
dependent"
xsq YY1P2 2q22.1 0.167 0.203 0.746
mut NAPA 19q13.33 0.167 0.203 0.746 post-Golgi vesicle-mediated
met PKD1L3 16q22.2 0.167 0.203 0.746 detection of chemical stimulus
mut EIF2AK3 2p12 0.167 0.203 0.746 skeletal system development;response to
unfolded protein
exp CACNA2D4 12p13.33 0.167 0.203 0.746 ion transport
cop NRP1 10p12 0.167 0.203 0.746 cell adhesion;response to wounding
mut ELF3 1q32.2 -0.167 0.203 0.746 Transcription Factors
exp MEGF8 19q12 -0.167 0.203 0.746
xsq C3orf52 3q13.2 -0.167 0.203 0.746
cop AGXT2 5p13 -0.167 0.203 0.746 glyoxylate metabolic process;nucleobase-
exp SNX30 9q32 -0.167 0.203 0.746 cell communication;protein transport
cop SLIT2-IT1 -0.167 0.203 0.746
xsq NYAP2 2q36.3 -0.167 0.203 0.746
cop GEM 8q13-q21 -0.167 0.203 0.746 GTP catabolic process;immune
response
xsq NATD1 -0.167 0.203 0.746
exp LRRC10B 11q12.2 -0.167 0.203 0.746
xsq RNF19A 8q22 -0.167 0.203 0.746 microtubule cytoskeleton
xsq PPARGC1A 4p15.1 -0.167 0.203 0.746 mRNA processing;respiratory
xsq PTX3 3q25 -0.167 0.203 0.746 response to yeast;inflammatory response
mut PTPN14 1q32.2 -0.167 0.203 0.746 lymphangiogenesis;protein
dephosphorylation
xsq TJP2 9q13-q21 -0.167 0.203 0.746 apoptotic process;cellular
cop ARFGEF1 8q13 -0.167 0.203 0.746 exocytosis;regulation of ARF
exp HOXD11 2q31.1 -0.167 0.203 0.746 skeletal system
exp OAZ2 15q22.31 -0.167 0.203 0.746 cellular nitrogen compound
exp DUSP8 11p15.5 -0.167 0.203 0.746 inactivation of MAPK
activity;protein dephosphorylation
cop TMEM56 1p21.3 -0.167 0.203 0.746
exp C1orf115 1q41 -0.167 0.203 0.746
met HIST1H2BI 6p22.1 -0.167 0.203 0.746
cop ENPP2 8q24.1 -0.167 0.203 0.745 phosphatidylcholine catabolic
exp KIF7 15q26.1 -0.167 0.203 0.745 microtubule-based movement;negative
cop RALY 20q11.21-q11.23 -0.167 0.203 0.745 nuclear mRNA splicing, via
xsq ATP6V0E1 5q35.1 -0.167 0.203 0.745 ATP hydrolysis coupled proton
transport;proton transport
exp C18orf12 18q21.1 -0.167 0.203 0.745
cop DSCC1 8q24.12 -0.167 0.203 0.745 cell cycle;maintenance of mitotic
mut PRKD3 2p21 -0.167 0.203 0.745 protein phosphorylation;activation of
xsq SNORD15A -0.167 0.203 0.745
exp KLHDC8A 1q32.1 -0.167 0.203 0.745
exp LOC100132824 15q14 -0.167 0.203 0.745
hs4 EPB41L4A 5q21.3 -0.168 0.203 0.746
hs4 EPB41L4A-AS2 -0.168 0.203 0.746
xai FXYD7 19q13.12 -0.168 0.203 0.746 regulation of ion transport
xai LYRM9 17q11.2 -0.168 0.203 0.746
xai TTC28 22q12.1 -0.168 0.203 0.746
hs4 CCDC169-SOHLH2 -0.168 0.203 0.746
hs4 CCDC169 13q13.3 -0.168 0.203 0.746
hs4 LINC00870 -0.168 0.203 0.746
his RASGRF1 15q24.2 -0.168 0.203 0.746 regulation of Ras protein
signal transduction;long-term memory
hs4 ITGA9 3p21.3 -0.168 0.203 0.746 cell adhesion;integrin-mediated
signaling pathway
his B3GALNT1 3q25 -0.168 0.203 0.746 protein
exp LOC440300 -0.168 0.203 0.746
his LINC01487 -0.168 0.203 0.746
exp NEU4 2q37.3 -0.168 0.203 0.746 sphingolipid metabolic
xai QRICH2 17q25.1 -0.168 0.203 0.746
xai LEMD2 6p21.31 -0.168 0.203 0.746 skeletal muscle cell
differentiation
his PRELID2 5q32 -0.168 0.203 0.746
hs4 ISM1 20p12.1 -0.168 0.203 0.746
exp MICE -0.168 0.203 0.746
xai FAM210B 20q13.2 -0.168 0.203 0.746
hs4 CRYBA2 2q35 -0.168 0.203 0.745
his LOC101929579 -0.168 0.203 0.745
xai ZBTB20-AS1 -0.168 0.203 0.745
exp TNR 1q24 -0.168 0.203 0.745 negative regulation of neuron projection
xai HOXB-AS3 17q21.32 -0.168 0.203 0.745
xai TMF1 3p21-p12 -0.168 0.203 0.745 regulation of transcription, DNA-
hs4 ABCB9 12q24 -0.168 0.203 0.745 ABC Transporters
xai IGF2R 6q26 -0.168 0.203 0.745 receptor-mediated endocytosis;signal
transduction
his TRIM34 -0.168 0.203 0.745 protein trimerization
xai MAGEF1 3q13 -0.168 0.203 0.745
xai DKFZp434L192 7p11.2 -0.168 0.203 0.745
xai OR7E62P 2p13.3 -0.168 0.203 0.745
hs4 NHLRC1 6p22.3 -0.168 0.203 0.745 protein
polyubiquitination;positive regulation of protein ubiquitination
xai LEMD1 1q32.1 -0.168 0.203 0.745
swa MTPN 0.168 0.204 0.746 cerebellar granule cell differentiation;neuron
differentiation
hs4 VWCE 11q12.2 0.168 0.204 0.746
his LOC101927539 0.168 0.204 0.746
xai HNRNPH1 5q35.3 0.168 0.204 0.746 gene expression;regulation of RNA
splicing
his CCAR1 10q21.3 0.168 0.204 0.746 Apoptosis
xai SNRPC 6p21.31 0.168 0.204 0.746 spliceosomal snRNP assembly;nuclear mRNA
dependent"
xai ATP11C Xq27.1 0.168 0.204 0.746 cation transport;ion transmembrane
transport
hs4 NMB 15q22-qter 0.168 0.204 0.746 neuropeptide signaling pathway;cell-cell
signaling
xai PKHD1 6p12.2 0.168 0.204 0.746 cilium assembly;homeostatic process
hs4 ARMC7 17q25.1 0.168 0.204 0.747
his EDARADD 1q42.3 0.168 0.204 0.747 hair follicle development;signal
transduction
xai ZNF367 9q22 0.168 0.204 0.747 regulation of transcription from RNA
hs4 CKB 14q32 0.168 0.204 0.747 creatine metabolic process;brain development
his GUSB 7q21.11 0.168 0.204 0.747 carbohydrate metabolic
process;glycosaminoglycan catabolic process
xai GCSAM 3q13.2 0.168 0.204 0.747
his CCNB1 5q12 0.168 0.204 0.747 DNA Damage Response (DDR)
his CD47 3q13.1-q13.2 0.168 0.204 0.747 blood coagulation;positive
dependent"
his ARHGAP19-SLIT1 0.168 0.204 0.747
his ARHGAP19 10q24.1 0.168 0.204 0.747 signal transduction;small GTPase
xai NOTCH1 9q34.3 0.168 0.204 0.747 Tumor Suppressors
his GSE1 16q24.1 0.168 0.204 0.747
swa YWHAH 22q12.3 0.168 0.204 0.747 Apoptosis
his NUFIP2 17q11.2 0.168 0.204 0.747
hs4 NUP214 9q34.1 0.168 0.204 0.747 mRNA export from nucleus;viral
reproduction
his OSBPL8 12q14 0.168 0.204 0.747 transport;lipid transport
hs4 BEX5 Xq22.1 0.168 0.204 0.747
exp BCAS3 17q23 0.168 0.204 0.747
his CBR4 4q32.3 0.168 0.204 0.747 fatty acid biosynthetic
process;antibiotic metabolic process
his EIF5A 17p13-p12 0.168 0.204 0.747 protein export from nucleus;positive
regulation of translational elongation
xai LDHB 12p12.2-p12.1 0.168 0.204 0.747 lactate metabolic process;pyruvate
metabolic process
his ISX 22q12.3 0.168 0.204 0.747
his RAB30 11q12-q14 0.168 0.204 0.747 small GTPase mediated signal
his RAB30-AS1 0.168 0.204 0.747
his STARD3 17q11-q12 0.168 0.204 0.747 lipid transport;steroid metabolic
process
xai CCP110 16p12.3 0.168 0.204 0.747 G2/M transition of mitotic cell
met ABI2 2q33 0.167 0.204 0.746 actin polymerization or depolymerization;cell
migration
cop CIB4 2p23.3 0.167 0.204 0.746
exp CCNL1 3q25.31 0.167 0.204 0.746 regulation of cyclin-dependent protein
exp ATP5I 4p16.3 0.167 0.204 0.746 small molecule metabolic process;ATP
catabolic process
mut INO80 15q15.1 0.166 0.204 0.746 DNA Damage Response (DDR); DDR
(Chromatin)
met STX19 3q11 0.166 0.204 0.746 intracellular protein transport;vesicle-
mediated transport
cop OCIAD1 4p11 0.166 0.204 0.746
mut DNAH9 17p12 0.166 0.204 0.746 cellular component movement;microtubule-based
movement
exp CD300C 17q25.1 0.166 0.204 0.746 cellular defense response
xsq MAGEE2 Xq13.3 0.166 0.204 0.746
cop SYCE1L 16q23.1 0.166 0.204 0.746 meiosis
met GPR22 7q22-q31.1 0.166 0.204 0.746 G-protein coupled receptor signaling
pathway
mut SOS1 2p21 0.166 0.204 0.746 Ras protein signal transduction;regulation of
xsq HCFC1 Xq28 0.166 0.204 0.746 histone H4-K8 acetylation;negative regulation
mut CHSY3 5q23.3 0.166 0.204 0.746
cop MAPKAPK5-AS1 12q24.12 0.166 0.204 0.746
cop PLA2G4E 15q15.1 0.166 0.204 0.747 phospholipid catabolic
met COQ6 14q24.3 0.166 0.204 0.747 ubiquinone biosynthetic process
xsq SCARNA13 14q32.12 0.166 0.204 0.747
met GDAP1L1 20q12 0.166 0.204 0.747
cop MFSD10 4p16.3 0.166 0.204 0.747 transport;apoptotic process
cop NOP14-AS1 4p16.3 0.166 0.204 0.747
cop NOP14 4p16.3 0.166 0.204 0.747 endonucleolytic cleavage to generate
xsq AATK-AS1 17q25.3 0.166 0.204 0.747
mut SMC2 9q31.1 0.166 0.204 0.747 DNA Damage Response (DDR); DDR (DNA
replication)
cop TXNDC2 0.166 0.204 0.747 cell redox homeostasis;protein thiol-
disulfide exchange
exp DLD 7q31-q32 0.166 0.204 0.747 pyruvate metabolic process;branched chain
xsq TMEM177 2q14.2 0.166 0.204 0.747
xsq LINC00661 19p13.12 0.166 0.204 0.747
met PHLPP1 18q21.33 0.166 0.204 0.747 Apoptosis
xsq MZT1 13q22.1 0.166 0.204 0.747 gamma-tubulin complex localization
xsq IRF3 19q13.3-q13.4 0.166 0.204 0.747 Apoptosis
mut KTN1 14q22.1 0.166 0.204 0.747 microtubule-based movement
met LRRC18 10q11.23 0.166 0.204 0.747
xsq LRIT1 10q23 0.166 0.204 0.747
xsq CXorf40A Xq28 0.166 0.204 0.747
cop MAP4K3 2p22.1 0.166 0.204 0.747 response to stress;intracellular
xsq BHLHA15 7q21.3 0.166 0.204 0.747 Golgi organization;G-protein
met ATXN7 3p21.1-p12 0.166 0.204 0.747 histone deubiquitination;negative
mut GPR107 9q34.11 0.166 0.204 0.747
xsq GINS4 8p11.21 0.166 0.204 0.747 DDR (DNA replication)
exp RALGAPA2 20p11.22 0.166 0.204 0.747 activation of Ral GTPase
cop GRK4 4p16.3 0.166 0.204 0.747 regulation of G-protein coupled receptor
protein signaling pathway;receptor internalization
xsq PSD2 5q31.2 0.166 0.204 0.747 regulation of ARF protein signal
transduction
xsq HS2ST1 1p22.3 0.166 0.204 0.747 heparin metabolic process;ureteric
bud formation
mut OR5F1 0.166 0.204 0.747
xsq GRM5-AS1 0.166 0.204 0.747
met NEIL1 15q24.2 0.166 0.204 0.747 DNA Damage Response (DDR); DDR (BER)
xsq SMIM21 18q23 0.166 0.204 0.747
xsq LSM6 4q31.22 0.166 0.204 0.747 mRNA processing;tRNA processing
mut RBM17 10p15.1 0.166 0.204 0.747 mRNA processing;RNA splicing
xsq MTMR14 3p26 0.166 0.204 0.747
exp GTF2H2B 5q13.2 0.166 0.204 0.747
xsq KCTD18 2q33.1 0.166 0.204 0.747 potassium ion transport
exp MARCH9 12q14.1 0.166 0.204 0.747
mut ADGRB2 0.166 0.204 0.747 G-protein coupled receptor signaling
mut ALS2CL 3p21.31 0.166 0.204 0.747 endosome organization;regulation of
met DACT1 14q23.1 0.166 0.204 0.747 multicellular organismal development;Wnt
exp KCNJ6 21q22.1 0.166 0.204 0.747 potassium ion transport;synaptic
transmission
pro ANXA1 9q21.13 0.166 0.204 0.747 Apoptosis
exp SNRPC 6p21.31 0.166 0.204 0.747 spliceosomal snRNP assembly;nuclear mRNA
xsq LINC01101 0.166 0.204 0.747
exp JADE1 0.166 0.204 0.747 histone H4-K5 acetylation;histone H4-K8
acetylation
xsq BRD1 22q13.33 0.166 0.204 0.747 chromatin modification;histone H3
acetylation
exp SRP72P2 6q25.3 0.166 0.204 0.747
exp TOM1L1 17q23.2 -0.166 0.204 0.747 intracellular protein
exp PITRM1 10p15.2 -0.166 0.204 0.747 proteolysis;positive
cop CDC37L1 9p24.1 -0.166 0.204 0.747
cop AK3 9p24.1 -0.166 0.204 0.747 nucleobase-containing compound
cop ANKH 5p15.1 -0.166 0.204 0.747 locomotory behavior;regulation of
bone mineralization
cop RGS1 1q31 -0.166 0.204 0.747 inhibition of adenylate cyclase activity
by G-protein signaling pathway;negative regulation of signal transduction
cop RGS13 1q31.2 -0.166 0.204 0.747 termination of G-protein coupled
receptor signaling pathway;positive regulation of GTPase activity
cop RGS2 1q31 -0.166 0.204 0.747 negative regulation of phospholipase
cop RWDD3 1p21.3 -0.166 0.204 0.747
xsq IFIT1B -0.166 0.204 0.747
xsq DNAJC22 12q13.12 -0.166 0.204 0.747 protein folding
xsq MBOAT7 19q13.4 -0.166 0.204 0.747 phospholipid biosynthetic
process
xsq CRYBA1 17q11.2 -0.166 0.204 0.747
mut SRPK2 7q22-q31.1 -0.166 0.204 0.747 intracellular protein kinase
cop PLSCR5 3q24 -0.166 0.204 0.747
xsq GTF2A1L 2p16.3 -0.166 0.204 0.747
exp LOC643219 2q11.1 -0.166 0.204 0.747
met PRKRA 2q31.2 -0.166 0.204 0.747 immune response;skeletal system
morphogenesis
met TYRP1 9p23 -0.166 0.204 0.747 acetoacetic acid metabolic
exp ADCY2 5p15.3 -0.166 0.204 0.747 cAMP biosynthetic process;synaptic
transmission
met EVX1 7p15.2 -0.166 0.204 0.747 regulation of transcription from
RNA polymerase II promoter involved in ventral spinal cord interneuron
exp PKNOX2 11q24.2 -0.166 0.204 0.747 regulation of transcription
exp KRT8P17 Xp11.21 -0.166 0.204 0.747
xsq LOC101927204 -0.166 0.204 0.747
xsq IDS Xq28 -0.166 0.204 0.747
exp FAM133A Xq21.32 -0.166 0.204 0.747
exp DCTN2 12q13.3 -0.166 0.204 0.747 cell proliferation;G2/M transition
exp GPRC5A 12p13-p12.3 -0.166 0.204 0.747 G-protein coupled receptor
xsq PCDHGB8P -0.166 0.204 0.747
xsq SEPT5 22q11.21 -0.166 0.204 0.747 GTP catabolic process;cell cycle
xsq CPD 17q11.2 -0.166 0.204 0.746 proteolysis;cellular response to
interleukin-2
mut C9orf131 9p13.3 -0.166 0.204 0.746
met ACTG1 17q25 -0.166 0.204 0.746 cell junction assembly;adherens junction
organization
exp HKDC1 10q22.1 -0.166 0.204 0.746 carbohydrate metabolic
process;glycolysis
xsq KRT27 17q21.2 -0.166 0.204 0.746 hair follicle morphogenesis
exp KCNJ10 1q23.2 -0.166 0.204 0.746 response to blue
light;regulation of sensory perception of pain
met IRGM 5q33.1 -0.167 0.204 0.746 autophagy;inflammatory response
hs4 DENND4C 9p22.1 -0.168 0.204 0.747
hs4 SH2D4A 8p21.2 -0.168 0.204 0.747 negative regulation of
xai FZD1 7q21 -0.168 0.204 0.747 Oncogenes
swa NDUFA9 12p13.3 -0.168 0.204 0.747 mitochondrial electron
DNA-dependent"
xai LOC100132605 5p15.33 -0.168 0.204 0.747
hs4 LOC730102 -0.168 0.204 0.747
xai MSC 8q21 -0.168 0.204 0.747 regulation of transcription, DNA-
hs4 DIAPH2 Xq21.33 -0.168 0.204 0.747 actin cytoskeleton
his RNASE8 -0.168 0.204 0.747
hs4 GCNT2 6p24.2 -0.168 0.204 0.747 glycosaminoglycan biosynthetic
his LINC01812 -0.168 0.204 0.747
his MIR4709 -0.168 0.204 0.747
xai EPN3 17q21.33 -0.168 0.204 0.746
his CHRDL1 Xq23 -0.168 0.204 0.746 nervous system development;cell
differentiation
hs4 TMEM240 1p36.33 -0.168 0.204 0.746
xai MAPK8IP3 16p13.3 -0.168 0.204 0.746 respiratory gaseous
exchange;lung morphogenesis
hs4 KIF3A 5q31 -0.168 0.204 0.746 plus-end-directed vesicle transport along
xai GPSM2 1p13.3 -0.168 0.204 0.746 G-protein coupled receptor
pathway
xai PCDHGB6 -0.168 0.204 0.746 cell adhesion;homophilic cell
adhesion
xai SIN3B 19p13.11 -0.168 0.204 0.746 skeletal muscle tissue
hs4 LAMA5-AS1 -0.168 0.204 0.746
hs4 MICALCL 11p15.3 -0.168 0.204 0.746 multicellular organismal
swa DNAJC17 15q15.1 0.168 0.205 0.747 protein folding
his COMTD1 10q22.2 0.168 0.205 0.747
exp RPS18 6p21.3 0.168 0.205 0.747 nuclear-transcribed mRNA catabolic
xai TULP2 19q13.1 0.168 0.205 0.747 visual perception
exp KRTAP5-4 11p15.5 0.168 0.205 0.747
his LOC100505736 0.168 0.205 0.747
xai PGPEP1 19p13.11 0.168 0.205 0.747 proteolysis
his LOC155060 7q36.1 0.168 0.205 0.747
hs4 NECAP1 12p13.31 0.167 0.205 0.747 endocytosis;protein transport
swa CHD4 12p13 0.167 0.205 0.748 DNA Damage Response (DDR)
his TTC17 11p11.2 0.167 0.205 0.748
dependent"
exp YBX1P5 0.167 0.205 0.748
exp GPR12 13q12 0.167 0.205 0.748 cellular calcium ion homeostasis;G-protein
xai LOC400927 22q13.1 0.167 0.205 0.748
exp FDPSP5 Xp11.3 0.167 0.205 0.748
hs4 UBE2E1 3p24.2 0.167 0.205 0.748 mitotic cell cycle spindle assembly
checkpoint;positive regulation of ubiquitin-protein ligase activity involved in
mitotic cell cycle
hs4 UBE2E1-AS1 0.167 0.205 0.748
xai NDUFA3P3 1q42.12 0.167 0.205 0.748
hs4 MIAT 22q12.1 0.167 0.205 0.748
swa PHB 17q21 0.167 0.205 0.748 Apoptosis
swa EEF1B2 2q33.3 0.167 0.205 0.748 translational elongation;gene
expression
his SUMF1 3p26.1 0.167 0.205 0.748
xai ATP5F1P6 6q24.1 0.167 0.205 0.748
exp C15orf53 15q14 0.167 0.205 0.748
swa GALM 2p22.1 0.167 0.205 0.748 carbohydrate metabolic process;hexose
metabolic process
his TMEM233 12q24.23 0.167 0.205 0.748 response to biotic stimulus
xai KRTAP5-4 11p15.5 0.167 0.205 0.748
xai YBX1P5 0.167 0.205 0.748
xai SEC24B 4q25 0.167 0.205 0.748 protein N-linked glycosylation via
his ACAT2 6q25.3 0.167 0.205 0.748 lipid metabolic process
his LOC100129518 0.167 0.205 0.748
his SOD2 6q25.3 0.167 0.205 0.748 liver development;heart development
xai PLG 6q26 0.167 0.205 0.748 fibrinolysis;platelet degranulation
his LOC100132078 0.167 0.205 0.748
xai CTGLF12P 10q11.22 0.167 0.205 0.748
hs4 MMP9 20q11.2-q13.1 0.167 0.205 0.748 Apoptosis
his NAGPA-AS1 0.167 0.205 0.748
his NAGPA 16p13.3 0.167 0.205 0.748 carbohydrate metabolic process;protein
exp EIF4A1P3 0.167 0.205 0.748
his PAPD4 5q14.1 0.167 0.205 0.748 RNA polyadenylation;histone mRNA
catabolic process
his FASN 17q25 0.167 0.205 0.748 energy reserve metabolic process;long-chain
fatty-acyl-CoA biosynthetic process
his TRIM28 19q13.4 0.167 0.205 0.748 DNA Damage Response (DDR)
exp HSP90AA5P 3q27.1 0.167 0.205 0.748 protein folding;response to stress
xai DNTT 10q23-q24 0.167 0.205 0.748 DNA Damage Response (DDR); DDR (NHEJ);
exp LINC01270 0.166 0.205 0.747
mut NTM 11q25 0.166 0.205 0.747 cell adhesion;neuron recognition
cop RNFT2 12q24.22 0.166 0.205 0.747
cop DPP8 15q22 0.166 0.205 0.747 proteolysis;immune response
met SERTM1 13q13.3 0.166 0.205 0.747
xsq PAIP2 5q31.2 0.166 0.205 0.747 regulation of translation;negative
xsq NAP1L3 Xq21.3-q22 0.166 0.205 0.747 nucleosome assembly
xsq SPIN4 Xq11.1 0.166 0.205 0.747 gamete generation
met TTC28 22q12.1 0.166 0.205 0.747
met VPS4B 18q21.33 0.166 0.205 0.747 protein transport;cellular membrane
organization
met ZMYND10 3p21.3 0.166 0.205 0.747
xsq RAB35 12q24.31 0.166 0.205 0.747 endosome transport;cytokinesis
xsq PABPC1L2B-AS1 0.166 0.205 0.747
mut CCPG1 15q21.1 0.166 0.205 0.747 cell cycle
met SSX6 Xp11.2 0.166 0.205 0.747 regulation of transcription, DNA-
dependent"
met AFF4 5q31 0.166 0.205 0.747 spermatid development;regulation of
exp PFDN5 12q12 0.166 0.205 0.747 protein folding;cellular protein metabolic
process
xsq LINC01276 0.166 0.205 0.748
met HSPB2 11q22-q23 0.166 0.205 0.748 Apoptosis
xsq ERMARD 0.166 0.205 0.748
cop PTPN11 12q24 0.166 0.205 0.748 Oncogenes
xsq FADS1 11q12.2-q13.1 0.166 0.205 0.748 transport;response to organic
cyclic compound
xsq LINC00269 0.166 0.205 0.748
exp TBCD 17q25.3 0.166 0.205 0.748 negative regulation of cell-substrate
exp PTER 10p12 0.166 0.205 0.748 catabolic process
xsq CILP2 19p13.11 0.166 0.205 0.748
xsq BAHD1 15q15.1 0.166 0.205 0.748 chromatin modification;heterochromatin
assembly
mut FBN2 5q23-q31 0.166 0.205 0.748 embryonic limb morphogenesis;positive
cop PHLPP2 16q22.2 0.166 0.205 0.748
xsq C22orf31 22q12.1 0.166 0.205 0.748
met PXMP4 20q11.22 0.166 0.205 0.748
met EHF 11p12 0.166 0.205 0.748 Transcription Factors
xsq IWS1 2q14.3 0.166 0.205 0.748 transcription, DNA-dependent"
xsq ALMS1 2p13 0.166 0.205 0.748 sensory perception of sound;epithelial cell
proliferation
exp TCHP 12q24.11 0.166 0.205 0.748 apoptotic process;negative regulation of
cell growth
met GSS 20q11.2 0.166 0.205 0.748 xenobiotic metabolic process;small
met MICAL2 11p15.3 0.166 0.205 0.748
exp DAP3 1q22 0.166 0.205 0.748 Apoptosis
xsq CXorf36 Xp11.3 0.166 0.205 0.748
xsq GPANK1 6p21.3 0.166 0.205 0.748
xsq LOC101929181 0.166 0.205 0.748
cop CCDC85A 2p16.1 0.166 0.205 0.748
cop MIR627 0.166 0.205 0.748
mut ROBO4 11q24.2 0.166 0.205 0.748 angiogenesis;multicellular organismal
development
pro EP300_2_8423 0.166 0.205 0.748
met CCNDBP1 15q14-q15 -0.166 0.205 0.748 cell cycle
met CELA2B 1p36.21 -0.166 0.205 0.748
xsq UBL3 13q12-q13 -0.166 0.205 0.748
exp SMO 7q32.3 -0.166 0.205 0.748 Oncogenes
mut CCDC117 22q12.1 -0.166 0.205 0.748
mut DZIP1L 3q22.3 -0.166 0.205 0.748
exp BTG1P1 12p13.31 -0.166 0.205 0.748
xsq CASQ2 1p13.1 -0.166 0.205 0.748 striated muscle contraction;heart
development
cop COL14A1 8q23 -0.166 0.205 0.748 cell-cell adhesion;extracellular
matrix organization
cop PBX1 1q23 -0.166 0.205 0.748 organ morphogenesis;negative regulation
exp AR Xq12 -0.166 0.205 0.748 transcription, DNA-dependent;positive
xsq GULP1 2q32.3-q33 -0.166 0.205 0.748 Apoptosis
xsq PMS2P9 -0.166 0.205 0.748
cop MARCH6 5p15.2 -0.166 0.205 0.748 protein K48-linked
ubiquitination;protein ubiquitination
xsq ZDHHC21 9p22.3 -0.166 0.205 0.748 small molecule metabolic
exp WDFY1 2q36.1 -0.166 0.205 0.748
xsq ASL 7q11.21 -0.166 0.205 0.748 argininosuccinate metabolic
exp NF2 22q12.2 -0.166 0.205 0.748 Tumor Suppressors
cop NPY 7p15.1 -0.166 0.205 0.747 G-protein signaling, coupled to
xsq IFFO2 1p36.13 -0.166 0.205 0.747
exp ATP10A 15q11.2 -0.166 0.205 0.747 cation transport;regulation
of cell shape
xsq HOTAIRM1 -0.166 0.205 0.747
xsq CD68 17p13 -0.166 0.205 0.747
swa PGM3 6q14.1-q15 -0.167 0.205 0.748 glucosamine metabolic
his LOC101927023 -0.167 0.205 0.748
xai RGL2 6p21.3 -0.167 0.205 0.748 Ras protein signal
his LINC01843 -0.167 0.205 0.748
xai FAM134B 5p15.1 -0.167 0.205 0.748 sensory perception of pain
xai PCTP 17q21-q24 -0.167 0.205 0.748 lipid transport;cholesterol
metabolic process
hs4 SH3PXD2A 10q24.33 -0.167 0.205 0.748 superoxide metabolic
swa ZC3H7B 22q13.2 -0.167 0.205 0.748 interspecies interaction
between organisms
xai HDAC7 12q13.1 -0.167 0.205 0.748 vasculogenesis;cell-cell junction
assembly
exp DKFZp434J0226 19q13.32 -0.167 0.205 0.748
xai LOC100128398 19q13.43 -0.167 0.205 0.748
hs4 RGPD3 2q13 -0.167 0.205 0.748
xai ANKRD1 10q23.31 -0.167 0.205 0.748 positive regulation of
xai CLCN4 Xp22.3 -0.167 0.205 0.748 chloride transport;transmembrane
transport
his SERPINA5 14q32.1 -0.167 0.205 0.748 spermatogenesis;fusion of
xai PCDH1 5q31.3 -0.167 0.205 0.748 nervous system development;cell
adhesion
hs4 ZFHX4 8q21.11 -0.167 0.205 0.748
hs4 ZFHX4-AS1 8q21.11 -0.167 0.205 0.748
his EHF 11p12 -0.167 0.205 0.748 Transcription Factors
exp GAS1RR -0.167 0.205 0.748
hs4 SPIRE1 18p11.21 -0.167 0.205 0.748 transport
xai SPRY3 -0.167 0.205 0.748 multicellular organismal
DNA-dependent"
his GPR45 2q11.1-q12 -0.168 0.205 0.747
xai MTND5P14 -0.168 0.205 0.747
xai TCF23 2p23.3 -0.168 0.205 0.747 multicellular organismal
his LOC101928590 -0.168 0.205 0.747
adhesion
his GNA14-AS1 -0.168 0.205 0.747
hs4 LINC00642 -0.168 0.205 0.747
hs4 KIF7 15q26.1 -0.168 0.205 0.747 microtubule-based movement;negative
hs4 C8orf46 8q13.1 -0.168 0.205 0.747
xai LOC100506497 -0.168 0.205 0.747
his RFPL1S 22q12 -0.168 0.205 0.747
xai MEGF8 19q12 -0.168 0.205 0.747
xai OR2H2 6p21.3 0.168 0.206 0.749 detection of chemical stimulus involved
in sensory perception of smell;defense response
xai EIF4A1P3 0.167 0.206 0.748
his KRTAP20-1 21q22.1 0.167 0.206 0.748
his KRTAP20-4 0.167 0.206 0.748
xai DCC 18q21.3 0.167 0.206 0.748 Tumor Suppressors
hs4 SDHAF4 0.167 0.206 0.748
hs4 OIP5-AS1 15q15.1 0.167 0.206 0.748
xai CACNG8 19q13.4 0.167 0.206 0.748 synaptic transmission;regulation of
cop MIR7-2 0.167 0.206 0.748
cop MIR3529 0.167 0.206 0.748
xai RASSF2 20p13 0.167 0.206 0.748 cell cycle;signal transduction
xai ADGRG2 0.167 0.206 0.748 G-protein coupled receptor signaling
hs4 ANKRD13D 11q13.2 0.167 0.206 0.748
xai AWAT2 Xq13.1 0.167 0.206 0.749 lipid biosynthetic process;wax
hs4 SH2D4B 10q23.1 0.167 0.206 0.749
hs4 LOC101929574 0.167 0.206 0.749
xai TBPL1 6q22.1-q22.3 0.167 0.206 0.749 transcription initiation from RNA
hs4 RPS15 19p13.3 0.167 0.206 0.749 ribosomal small subunit export from
hs4 ZNF397 18q12.2 0.167 0.206 0.749 viral reproduction
hs4 ITPRIPL1 2q11.2 0.167 0.206 0.749
swa BOP1 8q24.3 0.167 0.206 0.749
his ATXN7L3 17q21.31 0.167 0.206 0.749 chromatin modification;histone
deubiquitination
exp GLUD1P4 18q21.32 0.167 0.206 0.749
his ULK4P2 0.167 0.206 0.749
xai RPL7P54 Xq21.1 0.167 0.206 0.749
hs4 KIF26A 14q32.33 0.167 0.206 0.749 regulation of cell growth by
his KLHL6 3q27.3 0.167 0.206 0.749 germinal center formation;B cell receptor
signaling pathway
his ARID1B 6q25.1 0.167 0.206 0.749 DNA Damage Response (DDR); DDR
(Chromatin)
his MIR4466 0.167 0.206 0.749
dependent"
xai SMAD4 18q21.1 0.167 0.206 0.749 Apoptosis; Cell Signaling; Tumor
Suppressors
xai TSPYL5 8q22.1 0.167 0.206 0.749 nucleosome assembly;positive
his COX17 3q13.33 0.167 0.206 0.749 brain development;heart development
xai ANKRD23 2q11.2 0.167 0.206 0.749 fatty acid metabolic process
dependent"
mut SHROOM2 Xp22.3 0.166 0.206 0.748 eye pigment granule
xsq LINC00559 0.166 0.206 0.748
xsq CHRNA10 11p15.5 0.166 0.206 0.748 cation transport;elevation of
xsq FAM212A 3p21.31 0.166 0.206 0.748
xsq ZNF767P 0.166 0.206 0.748
xsq LOC102724084 0.166 0.206 0.748
mut HPSE2 10q23-q24 0.166 0.206 0.748 carbohydrate metabolic process
met NAPEPLD 7q22.1 0.166 0.206 0.748 lipid metabolic
xsq EED 11q14.2-q22.3 0.166 0.206 0.748 regulation of gene expression by
genetic imprinting;chromatin modification
met KRT80 12q13.13 0.166 0.206 0.748
exp HOXB13 17q21.2 0.166 0.206 0.748 regulation of growth;prostate
xsq FAM76A 1p35.3 0.166 0.206 0.748
exp LOC729915 5p13.2 0.166 0.206 0.748
cop LOC286238 9q22.1 0.166 0.206 0.748
xsq SOCS2 12q 0.166 0.206 0.748 Apoptosis
exp PCBD2 5q31.1 0.166 0.206 0.748 protein heterooligomerization;oxidation-
reduction process
met FBXO30 6q24 0.166 0.206 0.748
exp GLRA3 4q34.1 0.166 0.206 0.748 synaptic transmission;ion transmembrane
transport
xsq PRNCR1 0.166 0.206 0.748
cop ALDH2 12q24.2 0.166 0.206 0.748 synaptic transmission;neurotransmitter
met TWSG1 18p11.3 0.166 0.206 0.749 mesoderm formation;forebrain development
xsq EIF5B 2q11.2 0.166 0.206 0.749 translation;translational initiation
met UGT8 4q26 0.166 0.206 0.749 paranodal junction assembly;neuron projection
morphogenesis
cop SPDYA 2p23.2 0.166 0.206 0.749 positive regulation of cell
exp FOXL1 16q24 0.166 0.206 0.749 regulation of transcription, DNA-
dependent;regulation of Wnt receptor signaling pathway
xsq IRAK1 Xq28 0.166 0.206 0.749 Apoptosis; Protein Kinases
xsq LRRC72 0.166 0.206 0.749
xsq HADHB 2p23 0.166 0.206 0.749 fatty acid metabolic process;fatty acid beta-
oxidation
exp DPY30 2p22.3 0.166 0.206 0.749 histone H3-K4 methylation;regulation of
xsq HYDIN 16q22.2 0.166 0.206 0.749
exp PKIA 8q21.12 0.166 0.206 0.749 negative regulation of transcription from
xsq ATXN2L 0.166 0.206 0.749
xsq ULK3 15q24.1 0.166 0.206 0.749 autophagy;negative regulation of
xsq LIN54 4q21.22 0.166 0.206 0.749 regulation of transcription, DNA-
met IFIH1 2q24 0.166 0.206 0.749 positive regulation of interferon-alpha
production;positive regulation of interferon-beta production
xsq FAM47C Xp21.1 0.166 0.206 0.749
xsq MRPL39 21q21.3 0.166 0.206 0.749
cop RHOB 2p24 0.165 0.206 0.749 Apoptosis
cop TBC1D3P2 0.165 0.206 0.749
xsq ANKRD19P 9q22.31 0.165 0.206 0.749
exp LRRC3 21q22.3 0.165 0.206 0.749
xsq HIST1H4L 6p22.1 0.165 0.206 0.749
exp SSBP1 7q34 0.165 0.206 0.749 positive regulation of helicase
activity;mitochondrion morphogenesis
met TSPAN13 7p21.1 0.165 0.206 0.749
xsq NPBWR2 20q13.3 0.165 0.206 0.749 opioid receptor signaling
met GRM6 5q35 0.165 0.206 0.749 retina development in camera-type eye;G-protein
cop ACTR6 12q23.1 0.165 0.206 0.749
xsq LINC01355 0.165 0.206 0.749
exp CMBL 5p15.2 -0.165 0.206 0.749
xsq CTAGE8 -0.165 0.206 0.749
exp IFT57 3q13.13 -0.165 0.206 0.749 activation of cysteine-type
process
cop RSRC1 3q25.32 -0.165 0.206 0.749 nucleocytoplasmic transport;RNA
splicing
exp CLIC6 21q22.12 -0.166 0.206 0.749 ion transport
exp MORN2 2p22.1 -0.166 0.206 0.749
cop RAD1 5p13.2 -0.166 0.206 0.749 DNA Damage Response (DDR)
cop BRIX1 5p13.2 -0.166 0.206 0.749 ribosome biogenesis
cop DNAJC21 5p13.2 -0.166 0.206 0.749 protein folding
exp TGM2 20q12 -0.166 0.206 0.749 metabolic process;protein
homooligomerization
mut MYH11 16p13.11 -0.166 0.206 0.749 muscle contraction;smooth muscle
contraction
exp ELFN2 22q13.1 -0.166 0.206 0.749 negative regulation of phosphatase
activity
cop NOV 8q24.1 -0.166 0.206 0.749 regulation of cell growth
exp KIAA0930 22q13.31 -0.166 0.206 0.749
met CRB1 1q31-q32.1 -0.166 0.206 0.749 establishment or maintenance of
cell polarity;cell-cell signaling
exp DMGDH 5q14.1 -0.166 0.206 0.749 glycine metabolic process;glycine
catabolic process
mut MYO1E 15q21-q22 -0.166 0.206 0.748 glomerular filtration;nitrogen
cop INSL6 -0.166 0.206 0.748
cop INSL4 9p24 -0.166 0.206 0.748 signal transduction;cell-cell signaling
cop RLN2 9p24.1 -0.166 0.206 0.748 female pregnancy
cop RLN1 9p24.1 -0.166 0.206 0.748 signal transduction;female
pregnancy
exp SPDYA 2p23.2 -0.166 0.206 0.748 positive regulation of cell
xsq PIK3C2G 12p12 -0.166 0.206 0.748 chemotaxis;cell communication
xsq USP9Y Yq11.2 -0.166 0.206 0.748 ubiquitin-dependent protein
catabolic process;transforming growth factor beta receptor signaling pathway
mut SFTPB 2p12-p11.2 -0.166 0.206 0.748 lipid metabolic process;response to
exp KRT8P21 1p31.1 -0.166 0.206 0.748
cop RNASEL 1q25 -0.166 0.206 0.748 mRNA processing;protein
phosphorylation
cop RGS16 1q25-q31 -0.166 0.206 0.748 visual perception;regulation of G-
cop LOC284648 1q25.3 -0.166 0.206 0.748
cop RGS8 1q25 -0.166 0.206 0.748 negative regulation of signal
cop GPR160 3q26.2-q27 -0.166 0.206 0.748
xsq MFI2 3q28-q29 -0.166 0.206 0.748 ion transport;iron ion transport
exp GRIK2 6q16.3 -0.166 0.206 0.748 intracellular protein
cop ATP6V1G3 1q31.3 -0.166 0.206 0.748 transmembrane transport;ATP
catabolic process
cop PTPRC 1q31-q32 -0.166 0.206 0.748 protein dephosphorylation;peptidyl-
cop MIR181B1 -0.166 0.206 0.748
cop MIR181A1 -0.166 0.206 0.748
xsq TBC1D16 17q25.3 -0.166 0.206 0.748
met MSS51 10q22.2 -0.166 0.206 0.748 social behavior
xsq PRELP 1q32 -0.166 0.206 0.748 skeletal system development;cell aging
exp CRK 17p13.3 -0.166 0.206 0.748 regulation of actin cytoskeleton
organization;regulation of Rac protein signal transduction
met TSR1 17p13.3 -0.166 0.206 0.748 ribosome assembly
xsq RIPK2 8q21 -0.166 0.206 0.748 Apoptosis
exp HIVEP1 6p24-p22.3 -0.166 0.206 0.748 negative regulation of
hs4 BCL2L2 14q11.2-q12 -0.167 0.206 0.749 Apoptosis
hs4 BCL2L2-PABPN1 -0.167 0.206 0.749
his CEP170B 14q32.33 -0.167 0.206 0.749
his RNF112 17p11.2 -0.167 0.206 0.749
xai COX7A1 19q13.1 -0.167 0.206 0.749 generation of precursor
swa AK1 9q34.1 -0.167 0.206 0.749 ATP metabolic process;nucleobase-
his SFTPD 10q22.2-q23.1 -0.167 0.206 0.749 surfactant
exp CPO 2q33.3 -0.167 0.206 0.749 proteolysis
hs4 PMP2 8q21.3-q22.1 -0.167 0.206 0.749
hs4 HOXA5 7p15.2 -0.167 0.206 0.749 thyroid gland development;embryonic
hs4 ADAMTS14 10q21 -0.167 0.206 0.749 proteolysis;collagen catabolic
process
xai RPS3P2 -0.167 0.206 0.749
xai GJA1P1 5q21.3 -0.167 0.206 0.749
xai C6orf15 6p21.3 -0.167 0.206 0.749 extracellular matrix
organization
his BLZF1 1q24 -0.167 0.206 0.749 vesicle-mediated transport;Golgi to
his NME7 1q24 -0.167 0.206 0.749 GTP biosynthetic process;UTP biosynthetic
process
xai SYDE2 1p22.3 -0.167 0.206 0.749 activation of Rho GTPase
hs4 LOC105369423 -0.167 0.206 0.749
xai LOC642852 21q22.3 -0.167 0.206 0.749
his ZNF385D 3p24.3 -0.167 0.206 0.749
hs4 GFRA2 8p21.3 -0.167 0.206 0.749 transmembrane receptor protein
tyrosine kinase signaling pathway;glial cell-derived neurotrophic factor receptor
signaling pathway
his CBX7 22q13.1 -0.167 0.206 0.748 negative regulation of
dependent
exp LOC100418770 -0.167 0.206 0.748
xai OR4A13P 11q11 -0.167 0.206 0.748
hs4 HSPG2 1p36.1-p34 -0.167 0.206 0.748 chondrocyte differentiation;cardiac
xai NEU4 2q37.3 -0.167 0.206 0.748 sphingolipid metabolic
his PLPP2 -0.167 0.206 0.748 sphingolipid metabolic
exp HTR1A 5q11.2-q13 -0.167 0.206 0.748 serotonin receptor signaling
pathway;behavior
his GPRC5B 16p12 -0.167 0.206 0.748
his LOC105372833 -0.167 0.206 0.748
cop LOC100134317 -0.169 0.206 0.749
cop LINC00665 -0.169 0.206 0.749
hs4 CNNM3 2p12-p11.2 0.167 0.207 0.749 ion transport
hs4 FAM86C2P 11q13.2 0.167 0.207 0.749
exp OR11H4 14q11.2 0.167 0.207 0.749 response to stimulus
his CENPV 17p11.2 0.167 0.207 0.749 cell cycle;mitosis
his VAMP7 0.167 0.207 0.749 post-Golgi vesicle-mediated
transport;eosinophil degranulation
his HDAC4 2q37.3 0.167 0.207 0.749 skeletal system development;regulation of
cardiac muscle contraction by calcium ion signaling
his LOC101928111 0.167 0.207 0.749
his COQ10B 2q33.1 0.167 0.207 0.749
hs4 FASTKD1 2q31 0.167 0.207 0.749 cellular respiration
his PIP4K2A 10p12.2 0.167 0.207 0.749 phosphorylation
his KIF1A 2q37.3 0.167 0.207 0.749 microtubule-based movement;anterograde
axon cargo transport
his KLC4 6p21.1 0.167 0.207 0.749
his MATR3 5q31.2 0.167 0.207 0.749
his OR2L3 0.167 0.207 0.749 response to stimulus
xai CCDC189 0.167 0.207 0.75
hs4 DGUOK-AS1 0.167 0.207 0.75
hs4 TET3 2p13.1 0.167 0.207 0.75
hs4 EVADR 0.167 0.207 0.75
xai MSL1 17q21.1 0.167 0.207 0.75 chromatin modification;histone H4-K16
acetylation
xai LDB1 10q24-q25 0.167 0.207 0.75 gastrulation with mouth forming
second;cerebellum development
xai NPM1P37 0.167 0.207 0.75
xai FASTKD2 2q33.3 0.167 0.207 0.75 cellular respiration
swa CSDE1 1p22 0.167 0.207 0.75 regulation of transcription, DNA-dependent;male
gonad development"
xai LINC00632 Xq27.1 0.167 0.207 0.75
exp SLC13A2 17p13.2 0.167 0.207 0.75 transport;ion transport
xai CMAS 12p12.1 0.167 0.207 0.75 lipopolysaccharide biosynthetic process
his RBP4 10q23.33 0.167 0.207 0.75 male gonad development;retinol metabolic
process
his PUM1 1p35.2 0.167 0.207 0.75 regulation of translation;post-Golgi
hs4 TREM2 6p21.1 0.167 0.207 0.75 humoral immune response;axon guidance
xai EIF3IP1 0.167 0.207 0.75
his MIR6737 0.167 0.207 0.75
his CREB3L4 1q21.3 0.167 0.207 0.75 response to unfolded
exp LINC00426 13q12.3 0.167 0.207 0.75
his LOC105374546 0.167 0.207 0.75
his STIM2 4p15.2 0.167 0.207 0.75 negative regulation of calcium ion
his RNY5 0.167 0.207 0.75
exp C20orf187 0.167 0.207 0.75
xai GPR141 7p14.1 0.167 0.207 0.75 G-protein coupled receptor
signaling pathway
xai APPL1 3p21.1-p14.3 0.167 0.207 0.75 signal transduction;cell
proliferation
xai OTOL1 3q26.1 0.167 0.207 0.75
his VMO1 17p13.2 0.167 0.207 0.75 vitelline membrane formation
his GLTPD2 17p13.2 0.167 0.207 0.75
xai SDHD 0.167 0.207 0.75 respiratory electron transport chain;small
his NSMCE4A 10q26.13 0.167 0.207 0.75 DNA Damage Response (DDR); DDR (HR)
xai CCAR2 0.167 0.207 0.75 positive regulation of apoptotic
met MRGPRX3 11p15.1 0.165 0.207 0.749
xsq NRD1 1p32.2-p32.1 0.165 0.207 0.749
cop MPHOSPH9 12q24.31 0.165 0.207 0.749 M phase of mitotic cell cycle
cop C12orf65 12q24.31 0.165 0.207 0.749 translational termination
cop CDK2AP1 12q24.31 0.165 0.207 0.749 S phase of mitotic cell cycle;DNA-
dependent DNA replication
cop SBNO1 12q24.31 0.165 0.207 0.749
xsq TBC1D2B 15q24.3-q25.1 0.165 0.207 0.749
cop SNORA37 18q21.2 0.165 0.207 0.749
xsq SOSTDC1 7p21.1 0.165 0.207 0.749 pattern specification process;Wnt
xsq FKBPL 6p21.3 0.165 0.207 0.749 response to radiation;peptidyl-proline
modification
xsq LINC00994 0.165 0.207 0.749
exp YARS2 12p11.21 0.165 0.207 0.749 mitochondrial tyrosyl-tRNA
aminoacylation;translation
mut RALA 7p15-p13 0.165 0.207 0.749 interspecies interaction between
organisms;cytokinesis
xsq FAM96A 15q22.31 0.165 0.207 0.75 chromosome segregation
xsq BIVM-ERCC5 0.165 0.207 0.75
exp DNAAF5 0.165 0.207 0.75
met EPN3 17q21.33 0.165 0.207 0.75
dependent"
met LRRC4C 11p12 0.165 0.207 0.75 regulation of axonogenesis
xsq DHX57 2p22.1 0.165 0.207 0.75
cop NUBP1 16p13.13 0.165 0.207 0.75 cell growth;iron-sulfur cluster assembly
xsq HARBI1 11p11.2 0.165 0.207 0.75
met CAST 5q15 0.165 0.207 0.75 negative regulation of endopeptidase activity
met KCTD1 18q11.2 0.165 0.207 0.75 potassium ion transport;negative
met LOC100134368 16p13.3 0.165 0.207 0.75
xsq APOL5 22q12.3 0.165 0.207 0.75 lipid metabolic process;transport
met SAA2 11p15.1-p14 0.165 0.207 0.75
mut PGAM2 7p13-p12 0.165 0.207 0.75 response to inorganic substance;small
xsq CCDC58 3q21.1 0.165 0.207 0.75
exp RPSAP46 7q22.1 0.165 0.207 0.75
cop MYZAP 0.165 0.207 0.75
cop GCOM1 15q21.3 0.165 0.207 0.75
cop POLR2M 15q21.3 0.165 0.207 0.75 maintenance of ER location
xsq IHH 2q33-q35 0.165 0.207 0.75 morphogenesis of a branching
structure;embryonic pattern specification
cop ENPP3 6q22 0.165 0.207 0.75 phosphate-containing compound metabolic
process;immune response
dependent"
exp ICE1 0.165 0.207 0.75
exp RASSF2 20p13 0.165 0.207 0.75 cell cycle;signal transduction
met SEMA6A 5q23.1 0.165 0.207 0.75 cell surface receptor signaling
pathway;multicellular organismal development
xsq UQCR11 19p13.3 0.165 0.207 0.75 generation of precursor metabolites
xsq POLR2M 15q21.3 0.165 0.207 0.75 maintenance of ER location
met RXRG 1q22-q23 0.165 0.207 0.75 neuron differentiation;response to
retinoic acid
met PDZD8 10q26.12 0.165 0.207 0.75 regulation of cell
morphogenesis;intracellular signal transduction
exp ZWINT 10q21-q22 0.165 0.207 0.75 spindle organization;mitotic cell cycle
checkpoint
xsq CTD-2151A2.1 0.165 0.207 0.75
exp IL4 5q31.1 0.165 0.207 0.75 negative regulation of chronic
xsq NUP98 11p15.5 0.165 0.207 0.75 M phase of mitotic cell cycle;regulation
xsq LRRC52 1q24.1 0.165 0.207 0.75
mir hsa-miR-512-3p 0.165 0.207 0.75
mir hsa-miR-512-3p(2) 0.165 0.207 0.75
exp ATP11C Xq27.1 0.165 0.207 0.75 cation transport;ion transmembrane
transport
xsq LOC349160 0.165 0.207 0.75
xsq SLC38A2 12q 0.165 0.207 0.75 Solute Carriers
met LMNTD1 0.165 0.207 0.75 cell proliferation
exp FES 15q26.1 0.165 0.207 0.75 regulation of cell shape;positive
exp GAPDHP30 8q22.1 0.165 0.207 0.75
xsq SNX5 20p11 0.165 0.207 0.75 pinocytosis;cell communication
exp AKR1B1P5 14q23.1 -0.165 0.207 0.75
exp ANXA4 2p13 -0.165 0.207 0.75 Apoptosis
cop ARMC1 8q13.1 -0.165 0.207 0.75 metal ion transport
met CDSN 6p21.3 -0.165 0.207 0.75 epidermis development;cell-cell
adhesion
met COA7 -0.165 0.207 0.75
met KIAA1671 22q11.23 -0.165 0.207 0.75
met TOMM40L 1q23.3 -0.165 0.207 0.75 protein
cop TSPYL5 8q22.1 -0.165 0.207 0.75 nucleosome assembly;positive
xsq SPATA20 17q21.33 -0.165 0.207 0.75 mannose metabolic
xsq TSC22D3 Xq22.3 -0.165 0.207 0.75 regulation of transcription,
DNA-dependent;body fluid secretion"
exp SIN3B 19p13.11 -0.165 0.207 0.75 skeletal muscle tissue
xsq IER3 6p21.3 -0.165 0.207 0.75 Apoptosis
xsq HPD 12q24.31 -0.165 0.207 0.75 L-phenylalanine catabolic
mut TMEM8B 9p13.3 -0.165 0.207 0.75 cell adhesion;cell-matrix
adhesion
xsq SPINK5 5q32 -0.165 0.207 0.75 anagen;regulation of T cell
differentiation
cop DPYS 8q22 -0.165 0.207 0.75 uracil catabolic process;beta-alanine
metabolic process
exp CTAG1A Xq28 -0.165 0.207 0.75
xsq INHBA 7p15-p13 -0.165 0.207 0.75 hair follicle development;nervous
system development
met RPS6KA3 Xp22.2-p22.1 -0.165 0.207 0.75 Protein Kinases
xsq LOC101928738 -0.165 0.207 0.749
cop DEPTOR 8q24.12 -0.165 0.207 0.749 negative regulation of TOR
met TBX21 17q21.32 -0.165 0.207 0.749 positive regulation of
transcription, DNA-dependent;positive regulation of isotype switching to IgG
isotypes
exp CCDC24 1p34.1 -0.165 0.207 0.749
met AMHR2 12q13 -0.165 0.207 0.749 Mullerian duct regression;signal
transduction
met PDIA3 15q15 -0.165 0.207 0.749 protein retention in ER lumen;cell redox
homeostasis
met SIPA1 11q13 -0.165 0.207 0.749 Apoptosis
cop RIMS2 8q22.3 -0.165 0.207 0.749 intracellular protein transport
hs4 SRXN1 20p13 -0.167 0.207 0.75 response to oxidative stress
xai C1orf210 1p34.2 -0.167 0.207 0.75 EMT (Epithelial)
his TNS3 7p12.3 -0.167 0.207 0.75 positive regulation of cell
xai VPS37C 11q12.2 -0.167 0.207 0.75 protein transport;viral
reproduction
his MUC15 11p14.3 -0.167 0.207 0.75 post-translational protein
hs4 KCNMA1 10q22.3 -0.167 0.207 0.75 ion transport;positive
his MIR4776-1 -0.167 0.207 0.75
his MIR4776-2 -0.167 0.207 0.75
his SMIM10 Xq26.3 -0.167 0.207 0.75
xai CAP1P2 10q11.21 -0.167 0.207 0.75
hs4 DGCR2 22q11.21 -0.167 0.207 0.75 cell adhesion;organ morphogenesis
xai SNTG1 8q11-q12 -0.167 0.207 0.75 cell communication
his VEZF1 17q22 -0.167 0.207 0.749 transcription from RNA polymerase II
hs4 TSKU 11q13.5 -0.167 0.207 0.749
hs4 LOC101928837 -0.167 0.207 0.749
exp GJA1P1 5q21.3 -0.167 0.207 0.749
xai GRIK2 6q16.3 -0.167 0.207 0.749 intracellular protein
hs4 ASB11 Xp22.31 -0.167 0.207 0.749 intracellular signal transduction
mda Fraction_normal_chromosomes_with_numerical_heterogeneity -0.174
0.207 0.75
xai GLUD1P4 18q21.32 0.167 0.208 0.75
xai SAPCD2 9q34.3 0.166 0.208 0.75
hs4 TCFL5 20q13.33 0.166 0.208 0.75 regulation of cell
his MYSM1 1p32.1 0.166 0.208 0.75 proteolysis;chromatin modification
xai C20orf187 0.166 0.208 0.75
xai GDPGP1 15q26.1 0.166 0.208 0.75
xai GTF2B 1p22-p21 0.166 0.208 0.75 viral reproduction;interspecies
his PALD1 10q22.1 0.166 0.208 0.75
xai MGC39584 0.166 0.208 0.75
exp MARCH11 5p15.1 0.166 0.208 0.751
xai ATP5O 21q22.11 0.166 0.208 0.751 respiratory electron transport
his VPS35 16q12 0.166 0.208 0.751 cell death;protein transport
his ORC6 16q12 0.166 0.208 0.751 DDR (DNA replication)
his ZNRF1 16q23.1 0.166 0.208 0.751 proteasomal ubiquitin-dependent protein
xai ISY1 3q21.3 0.166 0.208 0.751 nuclear mRNA splicing, via
his CCNT1 12q13.11 0.166 0.208 0.751 transcription elongation from RNA
xai RASSF4 10q11.21 0.166 0.208 0.751 cell cycle;signal transduction
his ATP8B3 19p13.3 0.166 0.208 0.751 ATP catabolic process;cation
transport
his MIR1909 0.166 0.208 0.751
hs4 WT1 11p13 0.166 0.208 0.751 Apoptosis; Tumor Suppressors
hs4 WT1-AS 11p13 0.166 0.208 0.751
his MTMR14 3p26 0.166 0.208 0.751
hs4 MIR124-2HG 0.166 0.208 0.751
hs4 MIR124-2 0.166 0.208 0.751
his RTP5 0.166 0.208 0.751
his CNTNAP3P2 0.166 0.208 0.751
his GABRR1 6q15 0.166 0.208 0.751 chloride transport;gamma-aminobutyric
his TSPEAR-AS2 0.166 0.208 0.751
swa OSTC 4q25 0.166 0.208 0.751 protein N-linked glycosylation via asparagine
exp LOC100506458 0.166 0.208 0.751
xai SLC25A25-AS1 0.166 0.208 0.751
xai TCF4 18q21.1 0.166 0.208 0.751 positive regulation of transcription,
hs4 POLR1E 9p13.2 0.166 0.208 0.751 rRNA transcription
his C19orf43 19p13.2 0.166 0.208 0.751
his ASNA1 19q13.3 0.166 0.208 0.751 transport;arsenite transport
his TLX2 2p13.1 0.166 0.208 0.751
swa CTPS1 1p34.1 0.166 0.208 0.751 nucleobase-containing small molecule
interconversion;response to drug
his MAGEA1 Xq28 0.166 0.208 0.751 negative regulation of transcription from
RNA polymerase II promoter;negative regulation of Notch signaling pathway
his ANO9 11p15.5 0.166 0.208 0.751 ion transport
his PTDSS2 11p15.5 0.166 0.208 0.751 phosphatidylserine biosynthetic
xai MRPL3 3q21-q23 0.166 0.208 0.751 translation
his GUCA1B 6p21.1 0.166 0.208 0.751 phototransduction;regulation of
guanylate cyclase activity
his SUV39H1 Xp11.23 0.166 0.208 0.751 peptidyl-lysine
dependent"
exp LOC400464 15q26.3 0.166 0.208 0.751
xai HARBI1 11p11.2 0.166 0.208 0.751
exp OR6C69P 12q13.2 0.166 0.208 0.751
xai CA4 17q23 0.166 0.208 0.751 one-carbon metabolic process;bicarbonate
transport
swa DHFR 5q11.2-q13.2 0.166 0.208 0.751
xai TTC13 1q42.2 0.166 0.208 0.751
his STYXL1 7q11.23 0.166 0.208 0.751 protein
his MDH2 7cen-q22 0.166 0.208 0.751 glucose metabolic process;small molecule
metabolic process
cop EFCAB3 17q23.2 0.165 0.208 0.75
exp RPL3P7 6q21 0.165 0.208 0.75
exp BRD7 16q12 0.165 0.208 0.75 DNA Damage Response (DDR); DDR (Chromatin)
exp CALR3 19p13.11 0.165 0.208 0.75 spermatogenesis;cell differentiation
xsq TRPV5 7q35 0.165 0.208 0.75 ion transport;calcium ion transport
xsq ANKRD35 1q21.1 0.165 0.208 0.75
met SSBP2 5q14.1 0.165 0.208 0.75 regulation of transcription, DNA-
dependent"
xsq SEL1L2 20p12.1 0.165 0.208 0.75
met SERTAD1 19q13.1-q13.2 0.165 0.208 0.75 regulation of cyclin-
exp SEC24B 4q25 0.165 0.208 0.75 protein N-linked glycosylation via
met RASSF4 10q11.21 0.165 0.208 0.75 cell cycle;signal transduction
xsq FAM19A4 3p14.1 0.165 0.208 0.75
exp PRAC1 0.165 0.208 0.751
met LEKR1 3q25.31 0.165 0.208 0.751
cop ZNF664-FAM101A 0.165 0.208 0.751
xsq LOC101927159 0.165 0.208 0.751
xsq C20orf173 20q11.22 0.165 0.208 0.751
exp MTHFD2L 4q13.3 0.165 0.208 0.751 methionine biosynthetic
xsq NR2C2AP 19p13.11 0.165 0.208 0.751 cell adhesion;gene expression
exp UPRT Xq13.3 0.165 0.208 0.751
xsq METTL11B 1q24.2 0.165 0.208 0.751
xsq PPIA 7p13 0.165 0.208 0.751 provirus integration;initiation of viral
infection
xsq HP1BP3 1p36.12 0.165 0.208 0.751 nucleosome assembly
exp HDAC8 Xq13 0.165 0.208 0.751 negative regulation of transcription from RNA
polymerase II promoter;chromatin assembly or disassembly
met RAX 18q21.32 0.165 0.208 0.751 hypothalamus development;camera-type eye
development
mut FAM161A 2p15 0.165 0.208 0.751 response to stimulus;visual perception
exp SHPK 17p13 0.165 0.208 0.751 carbohydrate metabolic process
exp BOLA1 1q21 0.165 0.208 0.751
exp SMARCE1 17q21.2 0.165 0.208 0.751 DNA Damage Response (DDR); DDR
(Chromatin)
xsq MRPL12 17q25 0.165 0.208 0.751 transcription from mitochondrial
mir hsa-miR-424* 0.165 0.208 0.751
xsq HIST1H2BG 6p21.3 0.165 0.208 0.751
mut ROCK1 18q11.1 0.165 0.208 0.751 Apoptosis; Protein Kinases
met VGLL2 6q22.1 0.165 0.208 0.751 regulation of transcription, DNA-
mut ABHD14A 3p21.1 0.165 0.208 0.751
cop FAM179A 2p23.2 0.165 0.208 0.751
xsq EIF1B 3p22.1 0.165 0.208 0.751 regulation of translational initiation
xsq XPO6 16p11.2 0.165 0.208 0.751 protein export from nucleus;intracellular
protein transport
xsq FAM105A 5p15.2 0.165 0.208 0.751
exp TLR1 4p14 0.165 0.208 0.751 signal transduction;pathogen-associated
molecular pattern dependent induction by symbiont of host innate immune response
xsq STAB1 3p21.1 0.165 0.208 0.751 inflammatory response;cell adhesion
mut KITLG 12q22 0.165 0.208 0.751 ovarian follicle development;hemopoiesis
exp SUPT3H 6p21.1-p21.3 0.165 0.208 0.751 histone
met USP31 16p12.2 0.165 0.208 0.751 proteolysis;ubiquitin-dependent protein
catabolic process
exp SERGEF 11p14.3 0.165 0.208 0.751 signal transduction;negative
cop POP1 8q22.1 -0.165 0.208 0.751 tRNA 5'-leader removal;RNA
processing
exp SEC31A 4q21.22 -0.165 0.208 0.751 activation of signaling
protein activity involved in unfolded protein response;COPII vesicle coating
xsq MYADM 19q13.42 -0.165 0.208 0.751
xsq DOCK9 13q32.3 -0.165 0.208 0.751 blood coagulation
exp SPOCD1 1p35.2 -0.165 0.208 0.751 transcription, DNA-
dependent;negative regulation of phosphatase activity"
cop MIR4275 -0.165 0.208 0.751
xsq C8orf48 8p22 -0.165 0.208 0.751
exp SAV1 14q13-q23 -0.165 0.208 0.751 negative regulation of epithelial
cell proliferation;negative regulation of cardiac muscle cell proliferation
xsq ARHGEF11 1q21 -0.165 0.208 0.751 Rho protein signal
exp NAT8 2p13.2 -0.165 0.208 0.751 gastrulation with mouth forming
xsq KCNE4 2q36.1 -0.165 0.208 0.751 ion transport;potassium ion
transport
xsq OCM2 7q21.2 -0.165 0.208 0.751
met POLB 8p11.2 -0.165 0.208 0.751 DNA Damage Response (DDR); DDR
met AVPR2 Xq28 -0.165 0.208 0.751 G-protein signaling, coupled to cAMP
nucleotide second messenger;interferon-gamma production
xsq CITED4 1p34.2 -0.165 0.208 0.751 response to estrogen
stimulus;positive regulation of transcription, DNA-dependent"
exp SOX17 8q11.23 -0.165 0.208 0.751 Cell Signaling
met LOC644936 5q14.1 -0.165 0.208 0.751
exp IGFBP4 17q21.2 -0.165 0.208 0.751 cell proliferation;regulation
mut TAS2R3 7q31.3-q32 -0.165 0.208 0.751 signal transduction;response
to stimulus
exp HOXC9 12q13.3 -0.165 0.208 0.751 multicellular organismal
development
cop TTC23L 5p13.2 -0.165 0.208 0.751
exp LRRC31 3q26.2 -0.165 0.208 0.751
xsq TPT1-AS1 13q14.13 -0.165 0.208 0.751
exp SULF2 20q12-q13.2 -0.165 0.208 0.75 glomerular basement membrane
cop MCMDC2 8q13.1 -0.165 0.208 0.75 DNA replication
cop SNHG6 8q13 -0.165 0.208 0.75
cop SNORD87 8q13.1 -0.165 0.208 0.75
cop TCF24 8q13.1 -0.165 0.208 0.75 regulation of transcription, DNA-
dependent"
met MTHFD2 2p13.1 -0.165 0.208 0.75 one-carbon metabolic
exp CACUL1 10q26.11 -0.165 0.208 0.75
xsq KIAA0355 19q13.11 -0.165 0.208 0.75
met MAP10 1q42.2 -0.165 0.208 0.75
xsq PPM1J 1p13.2 -0.165 0.208 0.75 protein dephosphorylation
his ZFYVE1 14q24.2 -0.166 0.208 0.751 negative regulation of
hs4 GNAZ 22q11.22 -0.166 0.208 0.751 GTP catabolic process;G-protein
hs4 SLIT3 5q35 -0.166 0.208 0.751 multicellular organismal development;axon
xai BEND7 10p13 -0.166 0.208 0.751
xai ROBO2 3p12.3 -0.166 0.208 0.751 metanephros development;olfactory
xai CACUL1 10q26.11 -0.166 0.208 0.751
hs4 PDE9A 21q22.3 -0.166 0.208 0.751 signal transduction;blood
coagulation
his IDO1 8p12-p11 -0.166 0.208 0.751 female pregnancy;cellular nitrogen
xai PIAS3 1q21 -0.166 0.208 0.751 DNA Damage Response (DDR)
xai IFT57 3q13.13 -0.166 0.208 0.751 activation of cysteine-type
process
his DKFZP586I1420 7p14.3 -0.166 0.208 0.751
hs4 EPB41L1 20q11.2-q12 -0.166 0.208 0.751 synaptic
hs4 ACKR2 3p21.3 -0.166 0.208 0.751
his PARP10 8q24.3 -0.166 0.208 0.751 regulation of chromatin
assembly;negative regulation of fibroblast proliferation
his GRINA 8q24.3 -0.166 0.208 0.751
hs4 PRPF40B 12q13.12 -0.166 0.208 0.751 mRNA processing;RNA splicing
swa C2orf47 2q33.1 -0.166 0.208 0.751
hs4 PALM 19p13.3 -0.166 0.208 0.751 negative regulation of adenylate
cyclase activity;protein targeting to plasma membrane
his EPG5 18q12.3 -0.166 0.208 0.751 autophagy
his ZHX1-C8orf76 -0.166 0.208 0.751
his ZHX1 8q24.13 -0.166 0.208 0.751 negative regulation of
DNA-dependent"
swa TSR1 17p13.3 -0.166 0.208 0.751 ribosome assembly
xai LOC401320 -0.166 0.208 0.751
xai SEC16B 1q25.2 -0.166 0.208 0.751 protein transport;vesicle-
mediated transport
his CD274 9p24 -0.166 0.208 0.751 immune response;signal transduction
xai POLR2K 8q22.2 -0.166 0.208 0.751 DNA Damage Response (DDR);
DDR (NER)
hs4 MRPS24 7p14 -0.166 0.208 0.751 translation
his FAM47E-STBD1 -0.166 0.208 0.751
his TFAP2C 20q13.2 -0.166 0.208 0.751 trophectodermal cell
xai MKRN1 7q34 -0.166 0.208 0.75
xai ZNF33AP1 10p11 -0.166 0.208 0.75
hs4 KCNQ4 1p34 -0.166 0.208 0.75 synaptic transmission;sensory perception
of sound
his EVI5 1p22.1 -0.166 0.208 0.75 cell cycle;multicellular organismal
development
his SCARF2 22q11.21 -0.166 0.208 0.75 cell adhesion
hs4 P2RY6 11q13.5 -0.166 0.208 0.75 activation of phospholipase C
second messenger
hs4 TRIM31-AS1 -0.166 0.208 0.75
xai FN1 2q34 -0.167 0.208 0.75 response to wounding;cell migration
his MPPE1 18p11.21 0.166 0.209 0.751 GPI anchor biosynthetic process;ER to
his NAIF1 9q34.11 0.166 0.209 0.751 apoptotic process;induction of apoptosis
xai IARS 9q21 0.166 0.209 0.751 gene expression;tRNA aminoacylation for protein
translation
swa DRAP1 11q13.3 0.166 0.209 0.751 negative regulation of transcription from
hs4 CEP68 2p14 0.166 0.209 0.751 centrosome organization
hs4 H2AFB2 0.166 0.209 0.751
hs4 F8A2 0.166 0.209 0.751
hs4 MIR1184-2 0.166 0.209 0.751
hs4 SRSF7 2p22.1 0.166 0.209 0.751 mRNA export from nucleus;RNA splicing
xai PITPNM1 11q13 0.166 0.209 0.751 protein transport;lipid metabolic process
xai PES1P2 9p23 0.166 0.209 0.751
his SIL1 5q31 0.166 0.209 0.751 protein folding;intracellular protein transport
his INGX Xq12 0.166 0.209 0.751
xai FDPSP5 Xp11.3 0.166 0.209 0.751
hs4 COX8A 11q12-q13 0.166 0.209 0.751 generation of precursor metabolites and
xai SMARCC2 12q13.2 0.166 0.209 0.751 DNA Damage Response (DDR); DDR
(Chromatin)
his RABEP2 16p11.2 0.166 0.209 0.751 endocytosis;protein transport
dependent"
xai NPIPB11 16p11.2 0.166 0.209 0.751
swa FBL 19q13.1 0.166 0.209 0.751 snoRNA metabolic process;rRNA processing
exp MRPL50P4 0.166 0.209 0.752
his C19orf54 19q13.2 0.166 0.209 0.752
his SNRPA 19q13.1 0.166 0.209 0.752 nuclear mRNA splicing, via
his TMEM19 12q21.1 0.166 0.209 0.752
exp ATP5F1P6 6q24.1 0.166 0.209 0.752
his UBE2A Xq24 0.166 0.209 0.752 DNA Damage Response (DDR); DDR (TLS)
his IFT140 16p13.3 0.166 0.209 0.752
his CRAMP1 0.166 0.209 0.752
xai FAM136BP 6p25.2 0.166 0.209 0.752
his LOC729603 0.166 0.209 0.752
dependent"
hs4 ISX 22q12.3 0.166 0.209 0.752
his LINC00229 0.166 0.209 0.752
hs4 PAGR1 16p11.2 0.166 0.209 0.752
hs4 MVP 16p11.2 0.166 0.209 0.752 DNA Damage Response (DDR)
xai DHX8 17q21.31 0.166 0.209 0.752 RNA splicing;nuclear mRNA splicing, via
spliceosome
exp CCDC155 19q13.33 0.166 0.209 0.752 protein dephosphorylation
xai C6orf48 6p21.3 0.166 0.209 0.752
xai UBE2E4P Xp22.2 0.166 0.209 0.752
his GLRA3 4q34.1 0.166 0.209 0.752 synaptic transmission;ion transmembrane
transport
his LOC101928551 0.166 0.209 0.752
exp NPIPB11 16p11.2 0.166 0.209 0.752
xai MRPL50P4 0.166 0.209 0.752
his PNPLA8 7q31 0.166 0.209 0.752 lipid catabolic process;fatty acid
metabolic process
xai PHRF1 11p15.5 0.166 0.209 0.752 transcription from RNA polymerase II
xsq PGA5 11q13 0.165 0.209 0.751
xsq PABPC1L2B Xq13.2 0.165 0.209 0.751
exp DDX49 19p12 0.165 0.209 0.751
met GPD2 2q24.1 0.165 0.209 0.751 cellular lipid metabolic process;small
met PLD2 17p13.1 0.165 0.209 0.751 cell communication;response to hydrogen
peroxide
xsq APOOL Xq21.1 0.165 0.209 0.751
mut PLPPR4 0.165 0.209 0.751
cop RILPL2 12q24.31 0.165 0.209 0.751
cop SNRNP35 12q24.31 0.165 0.209 0.751 mRNA processing;RNA splicing
xsq PPP6C 9q33.3 0.165 0.209 0.751 DNA Damage Response (DDR)
met ACOT4 14q24.3 0.165 0.209 0.751 unsaturated monocarboxylic acid metabolic
process;very long-chain fatty acid metabolic process
xsq STRADA 17q23.3 0.165 0.209 0.751 positive regulation of protein
phosphorylation;protein heterooligomerization
met RPS6KA4 11q11-q13 0.165 0.209 0.751 Protein Kinases
cop METTL2A 17q23.2 0.165 0.209 0.751
dependent"
met ARHGEF9 Xq11.1 0.165 0.209 0.751 apoptotic process;transmembrane
transport
cop HTT-AS 0.165 0.209 0.751
xsq BTRC 10q24.32 0.165 0.209 0.751 protein ubiquitination;interspecies
exp KREMEN2 16p13.3 0.165 0.209 0.751 Wnt receptor signaling pathway
cop KIAA0125 14q32.33 0.165 0.209 0.751
cop ZNF609 15q22.31 0.165 0.209 0.752
met SCAMP3 1q21 0.165 0.209 0.752 response to chemical stimulus;post-Golgi
cop CES1 16q22.2 0.165 0.209 0.752 metabolic process;response to toxin
cop CES5A 16q12.2 0.165 0.209 0.752
xsq GIF 11q13 0.165 0.209 0.752 cobalt ion transport;cobalamin metabolic
process
exp UBQLN4 1q21 0.165 0.209 0.752 regulation of proteasomal ubiquitin-
xsq RBM26 13q31.1 0.165 0.209 0.752 mRNA processing;negative regulation of
cop CIITA 16p13 0.165 0.209 0.752 positive regulation of MHC class I biosynthetic
process;positive regulation of MHC class II biosynthetic process
exp GPALPP1 0.165 0.209 0.752
exp MTFMT 15q22.31 0.164 0.209 0.752 biosynthetic process
mut PLCB1 20p12 0.164 0.209 0.752 signal transduction;lipid catabolic process
met ACAD9 3q21.3 0.164 0.209 0.752
xsq RGS16 1q25-q31 0.164 0.209 0.752 visual perception;regulation of G-protein
xsq LINC00885 3q29 0.164 0.209 0.752
exp AKR1E2 10p15.1 0.164 0.209 0.752
xsq P2RY14 3q24-q25.1 0.164 0.209 0.752
xsq CWF19L1 10q24.31 0.164 0.209 0.752
met NDUFS4 5q11.1 0.164 0.209 0.752 transport;response to cAMP
xsq GDAP1 8q21.11 0.164 0.209 0.752 response to retinoic acid
cop ASCL4 12q23.3 0.164 0.209 0.752
xsq WDR37 10p15.3 0.164 0.209 0.752
xsq NBEAP1 15q11.2 0.164 0.209 0.752
cop DACT2 6q27 0.164 0.209 0.752
cop SMOC2 6q27 0.164 0.209 0.752 signal transduction
exp PDE3A 12p12 0.164 0.209 0.752 cGMP-mediated signaling;cellular response to
cGMP
exp POT1 7q31.33 0.164 0.209 0.752 DNA Damage Response (DDR)
xsq CCL28 5p12 -0.164 0.209 0.752 chemotaxis;immune response
met CEBPE 14q11.2 -0.164 0.209 0.752 cellular response to
cop PDE7A 8q13 -0.164 0.209 0.752 signal transduction;cAMP-mediated
signaling
xsq ITGA11 15q23 -0.164 0.209 0.752 integrin-mediated signaling
pathway;muscle organ development
met SLC25A3P1 1p32.3 -0.164 0.209 0.752
xsq LINC01117 -0.164 0.209 0.752
exp IQUB 7q31.32 -0.164 0.209 0.752
exp SMTN 22q12.2 -0.164 0.209 0.752 smooth muscle contraction;muscle
organ development
exp LIX1 5q15 -0.164 0.209 0.752
cop CSPP1 8q13.2 -0.164 0.209 0.752 positive regulation of cell
xsq LGALS1 22q13.1 -0.164 0.209 0.752 Apoptosis
xsq RAET1G 6q24.1-q25.1 -0.164 0.209 0.752 immune response;antigen
exp RIBC1 Xp11.22 -0.165 0.209 0.752
xsq EHD4-AS1 -0.165 0.209 0.751
cop ROPN1L 5p15.2 -0.165 0.209 0.751 ciliary or flagellar
exp ATP2C1 3q22.1 -0.165 0.209 0.751 manganese ion transport;Golgi
xsq DENND2A 7q34 -0.165 0.209 0.751
cop PISRT1 3q23 -0.165 0.209 0.751
cop LOC100505676 -0.165 0.209 0.751
cop RRS1 8q13.1 -0.165 0.209 0.751 mitotic metaphase plate
cop MTFR1 8q13.1 -0.165 0.209 0.751
met KRT83 12q13 -0.165 0.209 0.751 epidermis development
met CRIP1 14q32.33 -0.165 0.209 0.751 heart development;cell
proliferation
mut TTC7A 2p21 -0.165 0.209 0.751 cellular iron ion homeostasis;hemopoiesis
pro KRT18 12q13 -0.165 0.209 0.751 anatomical structure morphogenesis;tumor
cop PPP1R42 8q13.1 -0.165 0.209 0.751
cop COPS5 8q13.1 -0.165 0.209 0.751 DNA Damage Response (DDR)
xsq SYDE2 1p22.3 -0.165 0.209 0.751 activation of Rho GTPase
xsq TNS2 -0.165 0.209 0.751 negative regulation of cell
mut GPC1 2q35-q37 -0.165 0.209 0.751 axon guidance
xsq TRIM29 11q23.3 -0.165 0.209 0.751 regulation of transcription,
cop HUS1 7p13-p12 -0.165 0.209 0.751 DNA Damage Response (DDR); DDR
(BER)
xsq MEIS3 19q13.32 -0.165 0.209 0.751
exp SNTA1 20q11.2 -0.165 0.209 0.751 muscle contraction;neuromuscular
swa POMP 13q12.3 -0.166 0.209 0.752 proteasome assembly
exp LOC554223 -0.166 0.209 0.752
xai MAP4 3p21 -0.166 0.209 0.752 negative regulation of microtubule
depolymerization
hs4 EDA2R Xq12 -0.166 0.209 0.752 positive regulation of JNK
hs4 LINC00702 -0.166 0.209 0.752
his CTSL 9q21.33 -0.166 0.209 0.752
exp TCF23 2p23.3 -0.166 0.209 0.752 multicellular organismal
hs4 PDCD1LG2 9p24.2 -0.166 0.209 0.752 immune response;T cell
costimulation
xai PLXND1 3q22.1 -0.166 0.209 0.752 multicellular organismal
hs4 P2RY12 3q24-q25 -0.166 0.209 0.752 blood coagulation;hemostasis
his CLDN6 16p13.3 -0.166 0.209 0.752 calcium-independent cell-cell
adhesion
his TNFRSF12A 16p13.3 -0.166 0.209 0.752 Apoptosis
his THOC6 16p13.3 -0.166 0.209 0.752 mRNA processing;mRNA export from
nucleus
his HCFC1R1 16p13.3 -0.166 0.209 0.752
his IL18 11q22.2-q22.3 -0.166 0.209 0.752 osteoblast
his TEX12 11q22 -0.166 0.209 0.752
his SH2D4A 8p21.2 -0.166 0.209 0.752 negative regulation of
DNA-dependent"
hs4 GRAMD1C 3q13.31 -0.166 0.209 0.752
his AGT 1q42.2 -0.166 0.209 0.752 regulation of cell growth;renin-
his CTSD 11p15.5 -0.166 0.209 0.751 cell death;proteolysis
his ALDH1L1-AS2 -0.166 0.209 0.751
his ALDH1L1 3q21.3 -0.166 0.209 0.751 biosynthetic process;10-
xai NDUFA9P1 22q12.3 -0.166 0.209 0.751
xai CCDC89 11q14.1 -0.166 0.209 0.751
xai KCTD7 -0.166 0.209 0.751 potassium ion transport
xai FAM65A 16q22.1 -0.166 0.209 0.751
exp NHLRC1 6p22.3 -0.166 0.209 0.751 protein
his SNAI2 8q11 -0.166 0.209 0.751 multicellular organismal
his ARPC3 12q24.11 0.166 0.21 0.752 cellular component movement;regulation of
his WDR19 4p14 0.166 0.21 0.752 cell projection organization
exp LDB1 10q24-q25 0.166 0.21 0.752 gastrulation with mouth forming
xai CUL3 2q36.2 0.166 0.21 0.752 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
his LRCH1 13q14.11 0.166 0.21 0.752
his SIRT5 6p23 0.166 0.21 0.752 chromatin silencing;protein ADP-ribosylation
exp UBE2E4P Xp22.2 0.166 0.21 0.752
swa SMS Xp22.1 0.166 0.21 0.752 methionine metabolic process;polyamine
metabolic process
his WT1 11p13 0.166 0.21 0.752 Apoptosis; Tumor Suppressors
his WT1-AS 11p13 0.166 0.21 0.752
hs4 NTNG2 9q34 0.166 0.21 0.752 multicellular organismal development;nervous
system development
xai NLN 5q12.3 0.166 0.21 0.752 proteolysis
xai IMPA1 8q21.13-q21.3 0.166 0.21 0.752 phosphatidylinositol biosynthetic
hs4 GNRH2 20p13 0.166 0.21 0.752 multicellular organismal development;signal
transduction
hs4 MRPS26 20p13 0.166 0.21 0.752 DNA damage response, detection of DNA
xai LCLAT1 2p23.1 0.166 0.21 0.752 multicellular organismal
development;metabolic process
swa GATAD2A 19p13.11 0.166 0.21 0.752 anterior neuropore closure;negative
his FBP1 9q22.3 0.166 0.21 0.752 dephosphorylation;cellular response to
magnesium ion
his LOC100506688 0.166 0.21 0.752
xai TRIM21 11p15.5 0.166 0.21 0.752 protein autoubiquitination;protein
trimerization
hs4 RHOF 12q24.31 0.166 0.21 0.752 GTP catabolic process;actin filament
organization
his DPH3 3p25.1 0.166 0.21 0.752 peptidyl-diphthamide biosynthetic process
from peptidyl-histidine;negative regulation of protein secretion
his OXNAD1 3p25-p24 0.166 0.21 0.752
his ADARB2 10p15.3 0.166 0.21 0.752 mRNA processing;RNA processing
xai PAIP2 5q31.2 0.166 0.21 0.752 regulation of translation;negative
his METTL9 16p12.2 0.166 0.21 0.752
his LOC101927814 0.166 0.21 0.752
his MON1A 3p21.31 0.166 0.21 0.752
his MTIF3 13q12.2 0.166 0.21 0.752 translation;regulation of translational
initiation
his DPY19L2P2 7q22.1 0.166 0.21 0.752
xai C1orf233 1p36.33 0.166 0.21 0.752
xai RTL1 14q32.2 0.166 0.21 0.752 multicellular organismal development
xai DIS3 13q22.1 0.166 0.21 0.752 gene expression;RNA metabolic process
xai RTEL1P1 0.166 0.21 0.752
xai DDX19B 16q22.1 0.166 0.21 0.752 mRNA export from nucleus;protein
transport
hs4 AARSD1 17q21.31 0.166 0.21 0.752 translation;alanyl-tRNA
aminoacylation
his SLC6A19 5p15.33 0.166 0.21 0.752 amino acid transmembrane
swa EEF1E1 6p24.3 0.165 0.21 0.753 Apoptosis
xai CDC20P1 9q21.33 0.165 0.21 0.753
xai BTF3P7 6p25.1 0.165 0.21 0.753
xai XIAP Xq25 0.165 0.21 0.753 Apoptosis
cop INTS2 17q23.2 0.164 0.21 0.752 snRNA processing
xsq GPR179 17q21.1 0.164 0.21 0.752
xsq ALAS1 3p21.1 0.164 0.21 0.752 tetrapyrrole biosynthetic
xsq LOC100132146 3p21.31 0.164 0.21 0.752
xsq SPECC1L-ADORA2A 0.164 0.21 0.752
xsq LINC01093 0.164 0.21 0.752
met SNORA74B 5q35.1 0.164 0.21 0.752
exp JADE3 0.164 0.21 0.752 histone H3 acetylation;histone H4-K5
acetylation
met PRODH 22q11.21 0.164 0.21 0.752 proline catabolic process;induction of
apoptosis by oxidative stress
cop KMT5A 0.164 0.21 0.752 negative regulation of transcription, DNA-
dependent;negative regulation of transcription from RNA polymerase II promoter
exp FANCF 11p15 0.164 0.21 0.752 DNA Damage Response (DDR); DDR (FA)
xsq MSTN 2q32.2 0.164 0.21 0.752 ovulation cycle process;response to
xsq MBD2 18q21 0.164 0.21 0.752 maternal behavior;cellular protein complex
assembly
met PPP1R2P9 Xp11.3 0.164 0.21 0.752
xsq MGC34796 1p32 0.164 0.21 0.752
met ATP13A4 3q29 0.164 0.21 0.752 cation transport;ATP biosynthetic process
xsq TMEM150C 4q21.22 0.164 0.21 0.752
xsq LRRC75A-AS1 0.164 0.21 0.752
met SERINC2 1p35.1 0.164 0.21 0.752
xsq EXOC3 5p15.33 0.164 0.21 0.752 exocytosis;protein transport
met FAM8A1 6p23 0.164 0.21 0.752
cop CLLU1 12q22 0.164 0.21 0.752
mda MutSig13_APOBEC 0.164 0.21 0.752
mut C8orf33 8q24.3 0.164 0.21 0.752
cop CACNA1C 12p13.3 0.164 0.21 0.752 transmembrane transport;energy
exp OLA1P1 22q13.2 0.164 0.21 0.752
xsq LOC153684 5p12 0.164 0.21 0.752
met SS18 18q11.2 0.164 0.21 0.752 intracellular protein kinase
cop NME2 0.164 0.21 0.752
cop UHRF1BP1L 12q23.1 0.164 0.21 0.752
exp C4orf32 4q25 0.164 0.21 0.752
xsq GPATCH3 1p35.3-p35.1 0.164 0.21 0.752
exp C6orf203 6q21 0.164 0.21 0.752
exp THEMIS2 1p35.3 0.164 0.21 0.752
cop LCAT 16q22.1 0.164 0.21 0.752 cholesterol metabolic process;reverse
cholesterol transport
mut EOMES 3p24.1 0.164 0.21 0.752 mesoderm formation;positive regulation of
exp BRINP2 0.164 0.21 0.752 nervous system development;negative
xsq C17orf51 17p11.2 0.164 0.21 0.752
cop METTL6 3p25.1 0.164 0.21 0.752
xsq NEK4 3p21.1 0.164 0.21 0.752 cell division;protein phosphorylation
xsq ANKRD49 11q21 0.164 0.21 0.752 positive regulation of transcription,
DNA-dependent"
mut PRKG1 10q11.2 0.164 0.21 0.752 signal transduction;blood coagulation
exp OARD1 6p21.1 0.164 0.21 0.752
xsq RPL23 17q 0.164 0.21 0.752 nuclear-transcribed mRNA catabolic process,
cop CGNL1 15q21.3 0.164 0.21 0.752
xsq LINC01126 0.164 0.21 0.752
dependent
xsq MAP2K3 17q11.2 0.164 0.21 0.752 Protein Kinases
cop IFT81 12q24.13 0.164 0.21 0.752 multicellular organismal
xsq TUSC2 3p21.3 0.164 0.21 0.752 cell cycle;cell-cell signaling
xsq KIZ 0.164 0.21 0.752 spindle organization
xsq LTF 3p21.31 0.164 0.21 0.752 proteolysis;ion transport
met RNH1 11p15.5 0.164 0.21 0.752 mRNA catabolic process;regulation of
angiogenesis
cop CLLU1OS 12q22 0.164 0.21 0.752
xsq OR6Y1 0.164 0.21 0.752
met TCL6 14q32.1 0.164 0.21 0.752
cop LOC283440 12p13.33 0.164 0.21 0.752
cop FKBP4 12p13.33 0.164 0.21 0.752 peptidyl-proline modification;androgen
cop ITFG2 12p13.33 0.164 0.21 0.752
cop NRIP2 12p13.33 0.164 0.21 0.752
cop LOC100507424 0.164 0.21 0.752
cop FOXM1 12p13 0.164 0.21 0.752 Apoptosis
cop RHNO1 12p13.33 0.164 0.21 0.752
cop TULP3 12p13.3 0.164 0.21 0.752 regulation of transcription, DNA-
cop TEAD4 12p13.3-p13.2 0.164 0.21 0.752 regulation of transcription, DNA-
cop TSPAN9 12p13.33-p13.32 0.164 0.21 0.752
xsq HINT2 9p13.3 0.164 0.21 0.752 steroid biosynthetic process;apoptotic
process
xsq HIST2H3C 0.164 0.21 0.752
exp PSMD10 Xq22.3 0.164 0.21 0.752 cell cycle checkpoint;antigen
dependent
xsq RAPSN 11p11.2 0.164 0.21 0.752 synaptic transmission;synaptic
mut ABCG4 11q23.3 0.164 0.21 0.752 ABC Transporters
xsq C9orf117 9q34.11 0.164 0.21 0.752
exp NAPG 18p11.22 0.164 0.21 0.753 protein complex assembly;intracellular
protein transport
met GNRHR2 1q12 0.164 0.21 0.753
met CLDN1 3q28-q29 0.164 0.21 0.753 cell adhesion;calcium-independent cell-
cell adhesion
met MROH6 8q24.3 0.164 0.21 0.753
xsq CPS1-IT1 2q34 0.164 0.21 0.753
met SPAG6 10p12.2 -0.164 0.21 0.753 spermatid development;cell
exp TSKU 11q13.5 -0.164 0.21 0.753
xsq POU5F1 6p21.31 -0.164 0.21 0.753 blastocyst
cop GUCY1B3 4q31.3-q33 -0.164 0.21 0.753 nitric oxide mediated signal
xsq EDNRB 13q22 -0.164 0.21 0.752 peripheral nervous system
development;vasoconstriction
exp LOC158948 Xq22.1 -0.164 0.21 0.752
mut GOLGB1 3q13 -0.164 0.21 0.752 Golgi organization
met ARHGDIB 12p12.3 -0.164 0.21 0.752 multicellular organismal
cop MRPL13 8q22.1-q22.3 -0.164 0.21 0.752 translation
met MT1E 16q13 -0.164 0.21 0.752 negative regulation of growth;cellular
met STARD6 18q21.2 -0.164 0.21 0.752 transport;lipid transport
xsq ZEB2 2q22.3 -0.164 0.21 0.752 cell proliferation in
forebrain;positive regulation of Wnt receptor signaling pathway
met NOB1 16q22.3 -0.164 0.21 0.752
DNA-dependent"
mut ABCC10 6p21.1 -0.164 0.21 0.752 ABC Transporters
exp TK2 16q22-q23.1 -0.164 0.21 0.752 DNA replication;pyrimidine
nucleoside salvage
DNA-dependent"
met ATP1A4 1q23.2 -0.164 0.21 0.752 potassium ion
met ARHGAP4 Xq28 -0.164 0.21 0.752 induction of apoptosis by
cop NCEH1 3q26.31 -0.164 0.21 0.752 lipid catabolic process;metabolic
process
xsq COL10A1 6q21-q22 -0.164 0.21 0.752 skeletal system development
exp DNASE2B 1p22.3 -0.164 0.21 0.752 DNA metabolic
exp HMCN1 1q25.3-q31.1 -0.164 0.21 0.752 visual perception;response to
stimulus
xsq LOC101927142 -0.164 0.21 0.752
exp ZBTB7C 18q21.1 -0.164 0.21 0.752
exp E2F7 12q21.2 -0.164 0.21 0.752 cell cycle;negative regulation of
cell proliferation
exp WFDC2 20q13.12 -0.164 0.21 0.752 negative regulation of
exp HS1BP3 2p24.1 -0.164 0.21 0.752 cell communication
exp AMER3 2q21.1 -0.165 0.21 0.753
hs4 TFAP2B 6p12 -0.165 0.21 0.753 nervous system development;hindlimb
morphogenesis
his WLS 1p31.3 -0.165 0.21 0.753 Wnt receptor signaling
hs4 AGPAT4 6q26 -0.165 0.21 0.753 metabolic process;phospholipid
hs4 VEGFB 11q13 -0.165 0.21 0.753 positive regulation of vascular
division
xai VCAM1 1p32-p31 -0.165 0.21 0.753 heart development;interspecies
xai CCIN 9p13.3 -0.165 0.21 0.752 multicellular organismal
xai HIVEP1 6p24-p22.3 -0.165 0.21 0.752 negative regulation of
xai AR Xq12 -0.165 0.21 0.752 transcription, DNA-dependent;positive
xai CEACAM19 19q13.31 -0.165 0.21 0.752
his CLIP1 12q24.3 -0.166 0.21 0.752 transport;mitosis
swa MRPL49 11q13 -0.166 0.21 0.752 translation
hs4 ELOVL2 6p24.2 -0.166 0.21 0.752 triglyceride biosynthetic
process;fatty acid elongation, polyunsaturated fatty acid
hs4 ELOVL2-AS1 -0.166 0.21 0.752
his FAM71F1 7q32.1 -0.166 0.21 0.752
xai TTC30A 2q31.2 -0.166 0.21 0.752 cell projection organization
hs4 ABCB6 2q36 -0.166 0.21 0.752 ABC Transporters
xai FAM161B 14q24.3 -0.166 0.21 0.752
exp DGCR6L 22q11.21 -0.166 0.21 0.752
xai POU6F2 7p14.1 -0.166 0.21 0.752 regulation of transcription,
xai CARS2 13q34 -0.166 0.21 0.752 gene expression;tRNA aminoacylation for
protein translation
hs4 LINC01777 -0.166 0.21 0.752
hs4 PKHD1 6p12.2 -0.166 0.21 0.752 cilium assembly;homeostatic process
exp IFT172 2p23.3 -0.166 0.21 0.752 protein processing;cilium
assembly
his CRYGC -0.166 0.21 0.752
hs4 ZNF655 7q22.1 -0.166 0.21 0.752 G1 phase;regulation of
his CES3 16q22.1 -0.166 0.21 0.752
xai DGCR6L 22q11.21 -0.166 0.21 0.752
hs4 ZNF204P 6p21.3 -0.166 0.21 0.752
exp MIR15B -0.166 0.21 0.752
xai EFNA1 1q21-q22 -0.166 0.21 0.752 endocardial cushion to mesenchymal
cell migration
xai DMGDH 5q14.1 -0.166 0.21 0.752 glycine metabolic process;glycine
catabolic process
xai HKDC1 10q22.1 -0.166 0.21 0.752 carbohydrate metabolic
process;glycolysis
hs4 PAEP 9q34 -0.166 0.21 0.752 transport;multicellular organismal
development
swa RBM3 Xp11.2 -0.166 0.21 0.752 response to cold;production of
miRNAs involved in gene silencing by miRNA
hs4 RYK 3q22 -0.166 0.21 0.752 Wnt receptor signaling
his ZNF35 3p21.32 -0.166 0.21 0.752 regulation of transcription, DNA-
hs4 COL5A1 9q34.2-q34.3 -0.166 0.21 0.752 wound healing, spreading
of epidermal cells;blood vessel development
xai P4HB 17q25 -0.166 0.21 0.752 small molecule metabolic process;cell
redox homeostasis
his LOC102723481 -0.166 0.21 0.752
hs4 CLTCL1 22q11.21 -0.166 0.21 0.752 vesicle-mediated
xai MIR15B -0.166 0.21 0.752
exp KRT8P1 14q21.1 -0.166 0.21 0.752
xai ZNF561-AS1 -0.166 0.21 0.752
cop MIR4677 -0.167 0.21 0.752
xai RPLP2 11p15.5 0.167 0.211 0.753 translation;mRNA metabolic process
hs4 TGFBRAP1 2q12.1 0.165 0.211 0.753 regulation of transcription, DNA-
his SCN8A 12q13 0.165 0.211 0.753 sodium ion transport;myelination
his RFX1 19p13.1 0.165 0.211 0.753 regulation of transcription, DNA-
his DHRS11 17q12 0.165 0.211 0.753
his MRM1 17q12 0.165 0.211 0.753 RNA processing
cop FAM99B 0.165 0.211 0.753
xai UGT3A1 5p13.2 0.165 0.211 0.753 metabolic process
xai THG1L 5q33.3 0.165 0.211 0.753 tRNA modification;tRNA processing
hs4 CTCF 16q21-q22.3 0.165 0.211 0.753 chromosome segregation;regulation of
molecular function, epigenetic
hs4 C9orf24 9p13.3 0.165 0.211 0.753 cellular protein complex assembly
hs4 ULK3 15q24.1 0.165 0.211 0.753 autophagy;negative regulation of
hs4 MIR6882 0.165 0.211 0.753
his CPE 4q32.3 0.165 0.211 0.753 protein modification process;proteolysis
his MIR578 0.165 0.211 0.753
his PAPSS1 4q24 0.165 0.211 0.753 3'-phosphoadenosine 5'-phosphosulfate
hs4 POLG2 17q 0.165 0.211 0.753 DNA Damage Response (DDR)
xai PSMA5 1p13 0.165 0.211 0.753 mitotic cell cycle;viral reproduction
xai LINC00426 13q12.3 0.165 0.211 0.753
his OR3A2 17p13.3 0.165 0.211 0.753
xai FGG 4q28 0.165 0.211 0.753 platelet degranulation;signal transduction
hs4 POF1B Xq21.2 0.165 0.211 0.753
his PMS2P3 7q11.23 0.165 0.211 0.753 DNA Damage Response (DDR)
his AWAT2 Xq13.1 0.165 0.211 0.753 lipid biosynthetic process;wax
xai ATP1B2 17p13.1 0.165 0.211 0.753 transport;potassium ion transport
his EARS2 16p12.2 0.165 0.211 0.753 glutamyl-tRNA aminoacylation;gene
expression
his UBFD1 16p12 0.165 0.211 0.753 DNA Damage Response (DDR)
xai SNW1 14q24.3 0.165 0.211 0.753 positive regulation of transcription from
his NUP62CL Xq22.3 0.165 0.211 0.753 protein transport
his PIH1D3 Xq22.3 0.165 0.211 0.753
dependent"
exp OGFRP1 0.165 0.211 0.753
hs4 TRAF2 9q34 0.165 0.211 0.753 Apoptosis
hs4 MIR4479 0.165 0.211 0.753
his PLRG1 4q31.2-q32.1 0.165 0.211 0.753 DNA Damage Response (DDR)
dependent"
met SUGT1P3 13q14.11 0.164 0.211 0.753
dependent"
exp C11orf71 11q23.2 0.164 0.211 0.753
xsq MGC12916 17p12 0.164 0.211 0.753
xsq RGS2 1q31 0.164 0.211 0.753 negative regulation of phospholipase
met PLXNB3 Xq28 0.164 0.211 0.753 signal transduction;multicellular
exp TMEM182 2q12.1 0.164 0.211 0.753
exp TRIM41 5q35.3 0.164 0.211 0.753
xsq FCRL5 1q21 0.164 0.211 0.753
xsq R3HCC1L 10q24.2 0.164 0.211 0.753
exp NCLN 19p13.3 0.164 0.211 0.753 regulation of signal
mut TRIM24 7q32-q34 0.164 0.211 0.753 negative regulation of cell
proliferation;calcium ion homeostasis
mut EIF5B 2q11.2 0.164 0.211 0.753 translation;translational initiation
met TACC1 8p11.22 0.164 0.211 0.753 regulation of microtubule-based
met MIR1-1 0.164 0.211 0.753
xsq NUP54 4q21.1 0.164 0.211 0.753 viral reproduction;cytokine-mediated
signaling pathway
cop CACNA1C-AS4 0.164 0.211 0.753
cop CACNA1C-IT3 0.164 0.211 0.753
mir hsa-miR-339-3p 0.164 0.211 0.753
met VIPR1 3p22 0.164 0.211 0.753 muscle contraction;immune response
xsq MAT2A 2p11.2 0.164 0.211 0.753 response to light stimulus;response to
hormone stimulus
met SEPT9 17q25 0.164 0.211 0.753 GTP catabolic process;cell cycle
met SOWAHA 5q31.1 0.164 0.211 0.753
exp DPY19L2P2 7q22.1 0.164 0.211 0.753
xsq LOC286370 0.164 0.211 0.753
xsq MRFAP1L1 4p16.1 0.164 0.211 0.753
mut FPR1 19q13.4 0.164 0.211 0.753 signal transduction;G-protein coupled
cop PRDM4 12q23-q24.1 0.164 0.211 0.753 signal transduction;cell proliferation
met KLHL29 2p24.1 0.164 0.211 0.753
xsq GDPD4 11q13.5 0.164 0.211 0.753 glycerol metabolic process;lipid
metabolic process
xsq LINC01425 0.164 0.211 0.753
met NOL4L 0.164 0.211 0.753
xsq CEP63 3q22.2 0.164 0.211 0.753 mitosis;signal transduction in response
to DNA damage
met ATP5E 20q13.32 0.164 0.211 0.753 ATP catabolic process;ion transport
exp CCDC88A 2p16.1 0.164 0.211 0.753 EMT (Mesenchymal)
exp PKMYT1 16p13.3 0.164 0.211 0.753 regulation of mitosis;negative
xsq CA7 16q22.1 0.164 0.211 0.753 one-carbon metabolic process
exp FAM114A2 5q31-q33 0.164 0.211 0.753
mut CDK12 17q12 0.164 0.211 0.753 Protein Kinases
xsq ALPPL2 0.164 0.211 0.753
exp CNTNAP4 16q23.1 0.164 0.211 0.753 cell adhesion;signal transduction
exp TRNAE31P 0.164 0.211 0.753
met SCARNA22 4p16.3 0.164 0.211 0.753
cop EHD4 15q11.1 0.164 0.211 0.753 regulation of endocytosis;endocytic
recycling
xsq NCAPG 4p15.33 0.164 0.211 0.753 DNA Damage Response (DDR)
cop TXNDC11 16p13.13 0.164 0.211 0.753 cell redox homeostasis
exp CDK5 7q36 0.164 0.211 0.753 Apoptosis; Protein Kinases
exp UBALD1 16p13.3 0.164 0.211 0.753
xsq YY1AP1 1q22 0.164 0.211 0.753 regulation of transcription, DNA-
cop NFATC3 16q22.2 0.164 0.211 0.753 regulation of transcription from
RNA polymerase II promoter;cellular response to lithium ion
cop CHST4 16q22.2 0.164 0.211 0.753 sulfur compound metabolic
process;cellular component movement
exp USP3 15q22.3 0.164 0.211 0.753 proteolysis;ubiquitin-dependent protein
catabolic process
xsq VMA21 Xq28 0.164 0.211 0.753 vacuolar proton-transporting V-type ATPase
complex assembly
exp KCNAB2 1p36.3 0.164 0.211 0.753 potassium ion transport;synaptic
transmission
mut TBX18 6q14-q15 0.164 0.211 0.753 negative regulation of transcription from
RNA polymerase II promoter;negative regulation of canonical Wnt receptor signaling
pathway involved in neural plate anterior/posterior pattern formation
exp CCDC28B 1p36.11-p34.2 0.164 0.211 0.753
xsq CHCHD2 7p11.2 0.164 0.211 0.753
mut MAGEC1 Xq26 0.164 0.211 0.753
met FRMD4B 3p14.1 0.164 0.211 0.753
met RFX5 1q21 -0.164 0.211 0.753 negative regulation of transcription from
cop LOC100506050 -0.164 0.211 0.753
cop ZNF727 -0.164 0.211 0.753 regulation of transcription, DNA-
dependent"
xsq OR52N2 -0.164 0.211 0.753
DNA-dependent"
exp MKRN1 7q34 -0.164 0.211 0.753
exp ZFYVE16 5q14 -0.164 0.211 0.753 protein targeting to
lysosome;signal transduction
exp C1orf210 1p34.2 -0.164 0.211 0.753 EMT (Epithelial)
cop GGPS1 1q43 -0.164 0.211 0.753 small molecule metabolic
cop TBCE 1q42.3 -0.164 0.211 0.753 protein folding;'de novo'
posttranslational protein folding
pro PGR 11q22-q23 -0.164 0.211 0.753 epithelial cell
xsq DGCR6 22q11.21 -0.164 0.211 0.753 organ morphogenesis;cell adhesion
exp LOC124865 17q21.33 -0.164 0.211 0.753
exp MUC16 19p13.2 -0.164 0.211 0.753 O-glycan processing;post-
xsq NCEH1 3q26.31 -0.164 0.211 0.753 lipid catabolic process;metabolic
process
met MRPL11 11q13.3 -0.164 0.211 0.753 translation
cop B3GALNT2 1q42.3 -0.164 0.211 0.753 protein glycosylation
mut MZF1 19q13.4 -0.164 0.211 0.753 regulation of transcription, DNA-
exp CALCP 11p15.1 -0.164 0.211 0.753
exp GPSM1 9q34.3 -0.164 0.211 0.753 signal transduction;multicellular
xsq NCKAP5L 12q13.12 -0.164 0.211 0.753
xsq HOXD11 2q31.1 -0.164 0.211 0.753 skeletal system
cop CMBL 5p15.2 -0.164 0.211 0.753
cop SPEF2 5p13.2 -0.164 0.211 0.753 nucleobase-containing compound
metabolic process
met TBPL2 14q22.3 -0.164 0.211 0.753 transcription initiation from RNA
exp P4HB 17q25 -0.164 0.211 0.753 small molecule metabolic process;cell
redox homeostasis
DNA-dependent"
xsq PLEKHG5 1p36.31 -0.164 0.211 0.753 small GTPase mediated signal
met NDC80 18p11.32 -0.164 0.211 0.753 attachment of spindle microtubules
xsq TNFSF9 19p13.3 -0.164 0.211 0.753 Apoptosis
exp PPP1R12C 19q13.42 -0.164 0.211 0.753
exp TREM2 6p21.1 -0.164 0.211 0.753 humoral immune response;axon
guidance
exp PKD2 4q22.1 -0.164 0.211 0.753 embryonic placenta
cop CNN3 1p22-p21 -0.164 0.211 0.753 negative regulation of ATPase
exp GS1-259H13.2 -0.164 0.211 0.753
mut PXK 3p14.3 -0.164 0.211 0.753 cell communication;negative
regulation of ATPase activity
xsq LOC643733 11q22.3 -0.164 0.211 0.753
exp PCDHA7 -0.164 0.211 0.753 homophilic cell adhesion;nervous
system development
mut CRTC3 15q26.1 -0.164 0.211 0.753 positive regulation of CREB
xsq SVIL 10p11.2 -0.164 0.211 0.753 cytoskeleton organization;skeletal
exp PSMD2 3q27.1 -0.164 0.211 0.753 S phase of mitotic cell cycle;DNA
arrest
xsq CD81-AS1 -0.164 0.211 0.753
xsq LOC729987 -0.164 0.211 0.753
dependent"
cop SAMD12 8q24.12 -0.164 0.211 0.753
mut ARHGEF7 13q34 -0.164 0.211 0.753 apoptotic process;positive
xai PFKFB4 3p22-p21 -0.165 0.211 0.753 Apoptosis
xai KIAA1755 20q11.23 -0.165 0.211 0.753
exp SPRY3 -0.165 0.211 0.753 multicellular organismal
his TBX15 1p11.1 -0.165 0.211 0.753 embryonic cranial skeleton
morphogenesis
xai SNX30 9q32 -0.165 0.211 0.753 cell communication;protein transport
xai PLEKHG1 6q25.1 -0.165 0.211 0.753 regulation of Rho protein
signal transduction
xai AK3 9p24.1 -0.165 0.211 0.753 nucleobase-containing compound
xai LOC100233156 -0.165 0.211 0.753
xai NUAK2 1q32.1 -0.165 0.211 0.753 Apoptosis
his TRIM17 1q42 -0.165 0.211 0.753 protein autoubiquitination
his LOC101929268 -0.165 0.211 0.753
hs4 IKBKE 1q32.1 -0.165 0.211 0.753 Protein Kinases
hs4 MIR6769B -0.165 0.211 0.753
his KIR2DL1 -0.165 0.211 0.753 natural killer cell inhibitory
signaling pathway;immune response
his LOC101928804 -0.165 0.211 0.753
his MIR744 -0.165 0.211 0.753
xai TNFAIP2 14q32 -0.165 0.211 0.753 angiogenesis;multicellular
xai LINC00461 5q14.3 -0.165 0.211 0.753
exp ALG1L6P 3p12.3 -0.165 0.211 0.753
hs4 PCDHB10 5q31 -0.165 0.211 0.753 synapse assembly;calcium-dependent
cell-cell adhesion
hs4 PDZK1 1q21 -0.165 0.211 0.753 transport;cell proliferation
hs4 HACD1 -0.165 0.211 0.753 fatty acid biosynthetic process;signal
transduction
xai ALG1L6P 3p12.3 -0.165 0.211 0.753
hs4 CYTOR -0.165 0.211 0.753
his EEA1 12q22 -0.165 0.211 0.753 endocytosis;vesicle fusion
his EFNA5 5q21 -0.165 0.211 0.753 apoptotic process;regulation of Rho
GTPase activity
his RPEL1 -0.165 0.211 0.753
exp REP15 12p11.22 -0.165 0.211 0.753
his MYOC 1q23-q24 -0.165 0.211 0.753 anatomical structure morphogenesis
hs4 LINC00941 12p11.21 -0.165 0.211 0.753
his NHP2 5q35.3 0.165 0.212 0.753 DNA Damage Response (DDR)
hs4 TDRD12 19q13.11 0.165 0.212 0.754
xai HMGB3P22 5q35.3 0.165 0.212 0.754
his TBL1X Xp22.3 0.165 0.212 0.754 cellular lipid metabolic process;small
hs4 NUDT7 16q23.1 0.165 0.212 0.754 nucleoside diphosphate metabolic process
xai CGGBP1 3p12-p11.1 0.165 0.212 0.754 regulation of transcription, DNA-
dependent"
his INO80 15q15.1 0.165 0.212 0.754 DNA Damage Response (DDR); DDR
(Chromatin)
swa PEF1 1p34 0.165 0.212 0.754 response to calcium ion
exp ERMN 2q24.1 0.165 0.212 0.754 morphogenesis of a branching
xai UBOX5-AS1 0.165 0.212 0.754
swa IKBKAP 9q31 0.165 0.212 0.754 protein complex assembly;protein
phosphorylation
his BMP3 4q21 0.165 0.212 0.754 ossification;cell-cell signaling
exp NPM1P21 8q12.1 0.165 0.212 0.754
xai LMAN1 18q21.3-q22 0.165 0.212 0.754 blood coagulation;cellular protein
metabolic process
his LOC102724467 0.165 0.212 0.754
hs4 TESMIN 0.165 0.212 0.754
xai MAFG-AS1 17q25.3 0.165 0.212 0.754
swa FUBP1 1p31.1 0.165 0.212 0.754 Tumor Suppressors
hs4 MIR4519 0.165 0.212 0.754
hs4 MIR762HG 0.165 0.212 0.754
xai PES1P1 4q28.3 0.165 0.212 0.754
swa CSNK2A1 20p13 0.165 0.212 0.754 Protein Kinases
xai NPM1P21 8q12.1 0.165 0.212 0.754
his KLHDC4 16q24 0.165 0.212 0.754
xai AP5B1 11q13.1 0.165 0.212 0.754 protein transport
xai AGO1 1p34.3 0.165 0.212 0.754
xai SMYD4 17p13.3 0.165 0.212 0.754
hs4 GPR141 7p14.1 0.165 0.212 0.754 G-protein coupled receptor
signaling pathway
his ANO6 12q12 0.165 0.212 0.754 activation of blood coagulation via clotting
cascade;ion transport
his PLEKHA8P1 12q 0.165 0.212 0.754
his CDKN3 14q22 0.165 0.212 0.754 regulation of cyclin-dependent protein kinase
activity;G1/S transition of mitotic cell cycle
his PNPLA6 19p13.2 0.165 0.212 0.754 lipid catabolic
process;phosphatidylcholine metabolic process
xai TRIM52 5q35.3 0.165 0.212 0.754
xai OR2T10 1q44 0.165 0.212 0.754 response to stimulus
his FAM27C 0.165 0.212 0.754
xai NPBWR2 20q13.3 0.165 0.212 0.754 opioid receptor signaling
xai PIGP 21q22.2 0.165 0.212 0.754 preassembly of GPI anchor in ER
hs4 NFATC3 16q22.2 0.165 0.212 0.754 regulation of transcription from
RNA polymerase II promoter;cellular response to lithium ion
hs4 NARF 17q25.3 0.165 0.212 0.754
xai MUC5AC 11p15.5 0.165 0.212 0.754 digestion;O-glycan processing
his CEACAM3 19q13.2 0.165 0.212 0.754
hs4 LINC01201 0.165 0.212 0.754
hs4 ARHGAP36 Xq26.1 0.165 0.212 0.754 small GTPase mediated signal
met SERPINA13P 14q32.13 0.164 0.212 0.753
exp SLC8A2 19q13.3 0.164 0.212 0.753 transmembrane transport;ion
transport
exp FAM35DP 0.164 0.212 0.754
cop MIR4289 0.164 0.212 0.754
cop C9orf47 9q22.1 0.164 0.212 0.754
cop S1PR3 9q22.1-q22.2 0.164 0.212 0.754 cytokine production;inflammatory
response
xsq DDHD2 8p11.23 0.164 0.212 0.754 lipid catabolic process
cop ABCC12 16q12.1 0.164 0.212 0.754 ABC Transporters
xsq BCDIN3D-AS1 0.164 0.212 0.754
xsq ANKRD36BP2 2p11.2 0.164 0.212 0.754
mut TRAPPC10 21q22.3 0.164 0.212 0.754 sodium ion export;sodium ion
transport
exp HIST1H2BN 6p22.1 0.164 0.212 0.754 nucleosome assembly
xsq RFPL3 22q12.3 0.164 0.212 0.754
xsq CD300E 17q25.1 0.164 0.212 0.754
cop FAM110A 20p13 0.164 0.212 0.754
exp DPP3 11q12-q13.1 0.164 0.212 0.754 proteolysis
xsq CCDC87 11q13.2 0.164 0.212 0.754
cop DPEP3 16q22.1 0.164 0.212 0.754 proteolysis;meiosis
cop MC2R 18p11.2 0.163 0.212 0.754
xsq WASH1 0.163 0.212 0.754 transport;endosome transport
exp DHX16 6p21.3 0.163 0.212 0.754 mRNA processing;RNA splicing
xsq ATG9B 7q36.1 0.163 0.212 0.754 autophagic vacuole assembly;autophagy
met HEATR4 14q24.3 0.163 0.212 0.754
met SCRT1 8q24.3 0.163 0.212 0.754 regulation of transcription, DNA-
dependent"
xsq NPIPB11 16p11.2 0.163 0.212 0.754
xsq MYCNUT 0.163 0.212 0.754
mut ZWILCH 15q22.31 0.163 0.212 0.754 DNA Damage Response (DDR)
met NAT14 19q13.42 0.163 0.212 0.754 transcription initiation, DNA-
xsq ASAH2 10q11.21 0.163 0.212 0.754 small molecule metabolic process;lipid
metabolic process
xsq LOC100129307 13q22.3 0.163 0.212 0.754
xsq KIAA0101 15q22.31 0.163 0.212 0.754
met GAS8 16q24.3 0.163 0.212 0.754 negative regulation of cell
exp RHBDD3 22q12.2 0.163 0.212 0.754
met ALAS1 3p21.1 0.163 0.212 0.754 tetrapyrrole biosynthetic
cop CLEC16A 16p13.13 0.163 0.212 0.754
xsq SELP 1q22-q25 0.163 0.212 0.754 inflammatory response;response to
lipopolysaccharide
met CDH6 5p13.3 0.163 0.212 0.754 cell adhesion;homophilic cell adhesion
met TOLLIP 11p15.5 0.163 0.212 0.754 inflammatory response;signal
transduction
mut SLC17A6 11p14.3 0.163 0.212 0.754 ion transport;sodium ion transport
cop OR2A4 0.163 0.212 0.754 response to stimulus
cop CTAGE9 6q23.2 0.163 0.212 0.754
cop ENPP1 6q22-q23 0.163 0.212 0.754 nucleoside triphosphate catabolic
cop CTGF 6q23.1 0.163 0.212 0.754 response to wounding;positive regulation
of collagen biosynthetic process
exp NDUFS5 1p34.2-p33 0.163 0.212 0.754 mitochondrial electron transport,
met MRGPRE 11p15.4 0.163 0.212 0.754
mut PPOX 1q22 0.163 0.212 0.754 porphyrin-containing compound biosynthetic
xsq LINC00847 5q35.3 0.163 0.212 0.754
cop PXMP2 12q24.33 0.163 0.212 0.754
cop PGAM5 12q24.33 0.163 0.212 0.754
cop ANKLE2 12q24.33 0.163 0.212 0.754
xsq EPOR 19p13.3-p13.2 0.163 0.212 0.754 signal transduction;elevation of
cop C2orf70 2p23.3 0.163 0.212 0.754
cop FAM149B1 10q22.2 0.163 0.212 0.754
exp PPP1R35 7q22.1 0.163 0.212 0.754 negative regulation of phosphatase
activity
mut NPY2R 4q31 0.163 0.212 0.754
exp C15orf39 15q24.2 0.163 0.212 0.754
exp MEF2D 1q12-q23 0.163 0.212 0.754 multicellular organismal
mut ATIC 2q35 0.163 0.212 0.754 purine ribonucleoside monophosphate
xsq NAPB 20p12.3-p11.21 0.163 0.212 0.754 SNARE complex
disassembly;intracellular protein transport
met LMO1 11p15 0.163 0.212 0.754 negative regulation of transcription from RNA
promoter
xsq SSBP1 7q34 0.163 0.212 0.754 positive regulation of helicase
xsq LGALS9C 0.163 0.212 0.754
xsq ATP6AP1L 5q14.2 0.163 0.212 0.754 ATP hydrolysis coupled proton
transport
mut DCC 18q21.3 0.163 0.212 0.754 Tumor Suppressors
met CTNNA2 2p12-p11.1 0.163 0.212 0.754 radial glia guided migration of
Purkinje cell;muscle cell differentiation
cop SATB1 3p23 0.163 0.212 0.754 interspecies interaction between
met CSPP1 8q13.2 0.163 0.212 0.754 positive regulation of cell
exp IGHE 14q32.33 -0.163 0.212 0.754 immune response
exp EBF1 5q34 -0.163 0.212 0.754 multicellular organismal
xsq C19orf71 19p13.3 -0.163 0.212 0.754
xsq CYB5R3 22q13.2 -0.163 0.212 0.754 cholesterol biosynthetic
DNA-dependent"
met CHRNA6 8p11.21 -0.163 0.212 0.754 cation transport;signal
transduction
exp VN1R6P -0.163 0.212 0.754
xsq SETBP1 18q21.1 -0.163 0.212 0.754
mut NLRP9 19q13.42 -0.163 0.212 0.754
cop CACNA1E 1q25.3 -0.163 0.212 0.754 locomotory behavior;membrane
depolarization
exp CA9 9p13.3 -0.163 0.212 0.754 secretion;morphogenesis of an
epithelium
exp GUCY1A2 11q21-q22 -0.163 0.212 0.754 intracellular signal
xsq FILIP1L 3q12.1 -0.163 0.212 0.754
xsq LINC01095 -0.163 0.212 0.754
mut TCF25 16q24.3 -0.163 0.212 0.754 negative regulation of
transcription from RNA polymerase II promoter;heart development
xsq ABCA1 9q31.1 -0.163 0.212 0.754 ABC Transporters
cop RAI14 5p13.3-p13.2 -0.163 0.212 0.754
xsq GPR157 1p36.23 -0.163 0.212 0.754
cop SUN3 7p12.3 -0.163 0.212 0.754
exp NOXA1 9q34.3 -0.163 0.212 0.754 superoxide metabolic
xsq PDLIM7 5q35.3 -0.164 0.212 0.754 positive regulation of
cop LOC729970 1p21.3 -0.164 0.212 0.754
exp EXD2 14q24.1 -0.164 0.212 0.754 nucleobase-containing compound
metabolic process
met UCP2 11q13 -0.164 0.212 0.754 transport;small molecule metabolic
process
xsq LINGO2 9p21.2 -0.164 0.212 0.754
xsq CLDN9 16p13.3 -0.164 0.212 0.754 calcium-independent cell-cell
xsq MAP1LC3A 20q11.22 -0.164 0.212 0.754 autophagic vacuole
assembly;autophagy
xsq EDN2 1p34 -0.164 0.212 0.754 prostaglandin biosynthetic
xsq LINC00702 -0.164 0.212 0.754
exp SPRR1B 1q21-q22 -0.164 0.212 0.754 peptide cross-
linking;keratinocyte differentiation
xsq SFRP1 8p11.21 -0.164 0.212 0.754 ureteric bud development;negative
cop JPH1 8q21 -0.164 0.212 0.754 muscle organ development;regulation of
ryanodine-sensitive calcium-release channel activity
cop ALG14 1p21.3 -0.164 0.212 0.754 post-translational protein
met BHLHB9 Xq23 -0.164 0.212 0.754
xai SEC23A 14q21.1 -0.165 0.212 0.754 protein N-linked
xai LOC100129520 Xq25 -0.165 0.212 0.754
hs4 MC5R 18p11.2 -0.165 0.212 0.754
xai SMUG1 12q13.13 -0.165 0.212 0.754 DNA Damage Response (DDR); DDR
(BER)
hs4 SVILP1 10p11.23 -0.165 0.212 0.754
his MIR6784 -0.165 0.212 0.754
xai PKD2 4q22.1 -0.165 0.212 0.754 embryonic placenta
xai NHS Xp22.13 -0.165 0.212 0.754 lens development in camera-type
xai ATP6V0D2 -0.165 0.212 0.754 transmembrane transport;ion
transport
exp NCLP1 -0.165 0.212 0.754
hs4 LCN2 9q34 -0.165 0.212 0.754 siderophore transport;regulation of
apoptotic process
swa PRNP 20p13 -0.165 0.212 0.754 negative regulation of protein
xai KRTAP1-4 17q21.2 -0.165 0.212 0.754
his LOC101927296 -0.165 0.212 0.754
xai MSI1 12q24 -0.165 0.212 0.754 nervous system development;response to
hormone stimulus
hs4 APCDD1L-AS1 -0.165 0.212 0.754
hs4 APCDD1L 20q13.32 -0.165 0.212 0.754
xai EMX2 10q26.1 -0.165 0.212 0.754 multicellular organismal
development
hs4 KCTD1 18q11.2 -0.165 0.212 0.754 potassium ion transport;negative
hs4 HOXC12 12q13.13 -0.165 0.212 0.754 multicellular organismal
development
hs4 TMEM5-AS1 -0.165 0.212 0.754
xai MRGPRF 11q13.3 -0.165 0.212 0.754
hs4 CDV3 3q22.1 -0.165 0.212 0.754 cell proliferation
his LINC00398 -0.165 0.212 0.754
xai PKN2 1p22.2 -0.165 0.212 0.754 Apoptosis
xai B3GAT1 11q25 -0.165 0.212 0.754 carbohydrate metabolic
his LINC00316 -0.165 0.212 0.754
xai PRELP 1q32 -0.165 0.212 0.754 skeletal system development;cell aging
xai HRH1 3p25 -0.165 0.212 0.754 synaptic transmission;response to gravity
xai CLSTN2 3q23 -0.165 0.212 0.754 cell adhesion;homophilic cell
adhesion
hs4 LACTB2 8q13.3 -0.165 0.212 0.754
hs4 XKR9 8q13.3 -0.165 0.212 0.754
his LINC02056 -0.165 0.212 0.754
his ZCCHC11 1p32.3 0.165 0.213 0.754 cytokine production;negative
hs4 ALOX15 17p13.3 0.165 0.213 0.754 inflammatory response;leukotriene
his TAOK3 12q 0.165 0.213 0.754 Protein Kinases
his SUDS3 12q24.23 0.165 0.213 0.754 chromatin modification;negative
his SLK 10q24.33 0.165 0.213 0.754 Apoptosis
his HBA1 16p13.3 0.165 0.213 0.754
his YTHDF2 1p35 0.165 0.213 0.754 humoral immune response
exp OTOL1 3q26.1 0.165 0.213 0.754
his SOX11 2p25 0.165 0.213 0.754 outflow tract morphogenesis;negative regulation
of gene expression
his LOC81691 16p12.3 0.165 0.213 0.754
his ERI2 16p12.3 0.165 0.213 0.754
swa MYO1G 7p13-p11.2 0.165 0.213 0.754
his ZNF385D-AS1 0.165 0.213 0.754
xai TGDS 13q32.1 0.165 0.213 0.755 nucleotide-sugar metabolic
hs4 MED12 Xq13 0.165 0.213 0.755 Oncogenes
xai MAGEB18 Xp21.3 0.165 0.213 0.755
exp CEACAM7 19q13.2 0.165 0.213 0.755
xai B4GALT3 1q21-q23 0.165 0.213 0.755 carbohydrate metabolic
xai RBL1 20q11.2 0.165 0.213 0.755 G1 phase of mitotic cell cycle;negative
xai JMJD4 1q42.13 0.165 0.213 0.755
xai TLK1 2q31.1 0.165 0.213 0.755 DDR (DNA replication)
his SCLY 2q37.3 0.165 0.213 0.755 cellular amino acid metabolic process
exp LOC643870 0.165 0.213 0.755
swa ECH1 19q13.1 0.164 0.213 0.755 lipid metabolic process;fatty acid
metabolic process
swa HBA1 16p13.3 0.164 0.213 0.755
exp FBXO40 3q13.33 0.164 0.213 0.755 muscle cell differentiation
xai NLK 17q11.2 0.164 0.213 0.755 negative regulation of Wnt receptor
his IRAK3 12q14.3 0.164 0.213 0.755 Protein Kinases
xai RHOT1 17q11.2 0.164 0.213 0.755 Apoptosis
exp CDKN2B-AS1 9p21.3 0.164 0.213 0.755
xai RRP7A 22q13.2 0.164 0.213 0.755
his C1GALT1C1 Xq24 0.164 0.213 0.755 post-translational protein
hs4 SOCS1 16p13.13 0.164 0.213 0.755 Tumor Suppressors
dependent"
hs4 ARHGAP25 2p13.3 0.164 0.213 0.755 regulation of small GTPase mediated
xai MFI2-AS1 0.164 0.213 0.755
his NXF1 11q12-q13 0.164 0.213 0.755 mRNA export from nucleus;transport
xsq NEBL-AS1 10p12.31 0.163 0.213 0.754
met STPG2 4q22.3-q23 0.163 0.213 0.754
met TPST1 7q11.21 0.163 0.213 0.754 peptidyl-tyrosine sulfation;inflammatory
response
xsq CCDC166 8q24.3 0.163 0.213 0.754
met COL14A1 8q23 0.163 0.213 0.754 cell-cell adhesion;extracellular matrix
organization
exp HS2ST1 1p22.3 0.163 0.213 0.754 heparin metabolic process;ureteric
bud formation
exp ANAPC7 12q24.11 0.163 0.213 0.754 anaphase-promoting complex-
xsq C1orf68 1q21.3 0.163 0.213 0.754 epidermis development
mut KIAA1958 9q32 0.163 0.213 0.754
exp PDE8B 5q13.3 0.163 0.213 0.754 regulation of transcription, DNA-
dependent;cyclic nucleotide metabolic process
xsq ATG2B 14q32.2 0.163 0.213 0.754
xsq GPRIN3 4q22.1 0.163 0.213 0.754
dependent"
cop ERP29 12q24.13 0.163 0.213 0.754 protein folding;intracellular protein
transport
xsq RPL14 3p22-p21.2 0.163 0.213 0.754 SRP-dependent cotranslational protein
xsq TARSL2 15q26.3 0.163 0.213 0.754 threonyl-tRNA aminoacylation
xsq LRRC37A11P 17q12 0.163 0.213 0.754
exp HAND2 4q33 0.163 0.213 0.754 regulation of secondary heart field cardioblast
proliferation;negative regulation of cardiac muscle cell apoptosis
exp PRELID1 5q35.3 0.163 0.213 0.754 immune response;multicellular
xsq CNOT11 2q11.2 0.163 0.213 0.754
met FBLN5 14q32.1 0.163 0.213 0.754 regulation of removal of superoxide
xsq MYT1L-AS1 0.163 0.213 0.754
dependent"
cop MAPKAPK5 12q24.13 0.163 0.213 0.754 Ras protein signal
cop ATP2C2 16q24.1 0.163 0.213 0.754 EMT (Epithelial)
xsq DET1 15q25.3 0.163 0.213 0.754
cop BCAS3 17q23 0.163 0.213 0.754
xsq CENPL 1q25.1 0.163 0.213 0.754 M phase of mitotic cell cycle;mitotic
prometaphase
xsq KCNAB2 1p36.3 0.163 0.213 0.754 potassium ion transport;synaptic
transmission
mut C3orf70 3q27.2 0.163 0.213 0.754
mut KIF5B 10p11.22 0.163 0.213 0.754 stress granule disassembly;vesicle
xsq CAND1 12q14 0.163 0.213 0.754 regulation of transcription, DNA-
exp SUMO4 6q25 0.163 0.213 0.754 DNA Damage Response (DDR)
xsq HNRNPDL 4q21.22 0.163 0.213 0.755
met PDCD5 19q13.11 0.163 0.213 0.755 Apoptosis
mir hsa-miR-328 0.163 0.213 0.755
cop SOCS1 16p13.13 0.163 0.213 0.755 Tumor Suppressors
met SKP2 5p13 0.163 0.213 0.755 G1/S transition of mitotic cell cycle;anaphase-
promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic
process
xsq LOC100131107 1q21.3 0.163 0.213 0.755
met TEAD4 12p13.3-p13.2 0.163 0.213 0.755 regulation of transcription, DNA-
xsq BGLAP 1q22 0.163 0.213 0.755 cell aging;response to nutrient levels
met SDC2 8q22-q23 0.163 0.213 0.755 response to hypoxia;response to caffeine
mut IDE 10q23-q25 0.163 0.213 0.755 proteolysis;protein homotetramerization
met TDP1 14q32.11 0.163 0.213 0.755 DNA Damage Response (DDR); DDR (BER)
xsq FAM35DP 0.163 0.213 0.755
met NME8 7p14.1 0.163 0.213 0.755
met ATP5J 21q21.1 0.163 0.213 0.755 ATP catabolic process;transport
xsq LRRC37A6P 10p12.1 0.163 0.213 0.755
cop PWP1 12q23.3 0.163 0.213 0.755 transcription, DNA-dependent"
xsq TFB2M 1q44 0.163 0.213 0.755 transcription from mitochondrial
exp MGME1 20p11.23 0.163 0.213 0.755
mut ATR 3q23 0.163 0.213 0.755 DNA Damage Response (DDR); DDR (G1-S
checkpoint); DDR (DNA replication); Protein Kinases
exp MEX3B 15q25.2 0.163 0.213 0.755 protein phosphorylation;protein
autophosphorylation
met DNAJC18 5q31.2 0.163 0.213 0.755 protein folding
met ANXA5 4q27 0.163 0.213 0.755 Apoptosis
cop SLIT2 4p15.2 -0.163 0.213 0.755 cell migration involved in
cop STK31 7p15.3 -0.163 0.213 0.755
cop TDRD5 1q25.2 -0.163 0.213 0.755 spermatid development;cell
differentiation
met C10orf25 10q11.21 -0.163 0.213 0.755
exp KIAA1033 12q24.11 -0.163 0.213 0.755 endosome transport
xsq HOXD10 2q31.1 -0.163 0.213 0.755 spinal cord motor neuron cell
exp SPAG16 2q34 -0.163 0.213 0.755 cell projection organization;cilium
assembly
xsq LOC101929524 -0.163 0.213 0.755
xsq MYBPH 1q32.1 -0.163 0.213 0.755 regulation of striated muscle
exp KRT8P2 14q21.2 -0.163 0.213 0.755
cop ZDHHC21 9p22.3 -0.163 0.213 0.755 small molecule metabolic
exp SYTL4 Xq21.33 -0.163 0.213 0.755 positive regulation of
mut EMILIN1 2p23.3-p23.2 -0.163 0.213 0.754 cell adhesion;positive
exp CALHM3 10q24.33 -0.163 0.213 0.754
exp LOC646548 14q24.2 -0.163 0.213 0.754
exp LOC145474 14q24.2 -0.163 0.213 0.754
cop MAP9 4q32.1 -0.163 0.213 0.754 cell division;cell cycle
cop RPS2P32 7p15.3 -0.163 0.213 0.754
cop TRA2A 7p15.3 -0.163 0.213 0.754 nuclear mRNA splicing, via
xsq KRT14 17q21.2 -0.163 0.213 0.754 intermediate filament bundle
cop PLGRKT 9p24.1 -0.163 0.213 0.754 positive regulation of
xsq PROX2 14q24.3 -0.163 0.213 0.754 regulation of transcription, DNA-
cop RAD54B 8q22.1 -0.163 0.213 0.754 DNA Damage Response (DDR);
DDR (HR)
cop FSBP -0.163 0.213 0.754
cop ARID4B 1q42.1-q43 -0.163 0.213 0.754 regulation of transcription,
DNA-dependent"
cop TMEM56-RWDD3 -0.163 0.213 0.754
pro HSPD1 2q33.1 -0.163 0.213 0.754 Apoptosis
DNA-dependent"
xsq GATA6 18q11.1-q11.2 -0.163 0.213 0.754 pancreatic A cell
his GLRA4 Xq22.2 -0.164 0.213 0.755 ion transport
xai TMED2 12q24.31 -0.164 0.213 0.755 embryonic placenta
xai GNA12 7p22.2 -0.164 0.213 0.755 G-protein signaling, coupled to
exp MAPK8IP3 16p13.3 -0.164 0.213 0.755 respiratory gaseous
DNA-dependent"
hs4 HBEGF 5q23 -0.164 0.213 0.755 positive regulation of cell
growth;positive regulation of cell migration
exp NUTM1 15q14 -0.164 0.213 0.755
cop CA11 19q13.3 -0.164 0.213 0.755
his EFNB2 13q33 -0.164 0.213 0.755 angiogenesis;anatomical structure
morphogenesis
xai GDNF 5p13.1-p12 -0.164 0.213 0.755 Apoptosis
hs4 TMEM37 2q14.2 -0.164 0.213 0.755 ion transport
xai HOGA1 10q24.2 -0.164 0.213 0.755 glyoxylate catabolic process
xai MAP2 2q34-q35 -0.164 0.213 0.755 microtubule bundle
xai UGT2B28 4q13.2 -0.165 0.213 0.755 xenobiotic metabolic
his SH3PXD2A 10q24.33 -0.165 0.213 0.755 superoxide metabolic
his LOC387810 -0.165 0.213 0.755
his SAMD9 7q21.2 -0.165 0.213 0.755
DNA-dependent"
xai MYH14 19q13.33 -0.165 0.213 0.754 ATP catabolic process;axon guidance
xai LARGE 22q12.3 -0.165 0.213 0.754 protein
his RPS6KA2-IT1 -0.165 0.213 0.754
xai LCTL 15q22.31 -0.165 0.213 0.754 carbohydrate metabolic process
hs4 CFAP54 -0.165 0.213 0.754
xai SFRP1 8p11.21 -0.165 0.213 0.754 ureteric bud development;negative
hs4 HIF1A-AS1 -0.165 0.213 0.754
hs4 HIF1A 14q23.2 -0.165 0.213 0.754 Protein Kinases
xai DNAH5 5p15.2 -0.165 0.213 0.754 ciliary or flagellar
hs4 PTCHD1-AS -0.165 0.213 0.754
his PROSER2-AS1 -0.165 0.213 0.754
xai ASPN 9q22 -0.165 0.213 0.754 bone mineralization;negative regulation
swa TYMS 18p11.32 0.164 0.214 0.755 DNA Damage Response (DDR)
xai SRRM2 16p13.3 0.164 0.214 0.755 nuclear mRNA splicing, via
hs4 LOC100507250 0.164 0.214 0.756
hs4 NUP107 12q15 0.164 0.214 0.756 mitotic cell cycle;viral reproduction
swa RPS23 5q14.2 0.164 0.214 0.756 nuclear-transcribed mRNA catabolic
his ASF1A 6q22.31 0.164 0.214 0.756 DNA Damage Response (DDR); DDR (DNA
replication)
his EBAG9 8q23 0.164 0.214 0.756 Apoptosis
his IFT122 3q21 0.164 0.214 0.756
his MBD4 3q21.3 0.164 0.214 0.756 DNA Damage Response (DDR); DDR (BER)
xai CCND3 6p21 0.164 0.214 0.756 DNA Damage Response (DDR); DDR (G1-S
his CGREF1 2p23.3 0.164 0.214 0.756 response to stress;cell cycle
exp GCSAM 3q13.2 0.164 0.214 0.756
his KCNQ3 8q24 0.164 0.214 0.756 ion transport;potassium ion transport
xai STAG3L3 0.164 0.214 0.756
his DHDDS 1p36.11 0.164 0.214 0.756
his RINL 19q13.2 0.164 0.214 0.756
hs4 SACM1L 3p21.3 0.164 0.214 0.756
hs4 LIMD1-AS1 0.164 0.214 0.756
his LUC7L 16p13.3 0.164 0.214 0.756 negative regulation of striated muscle
tissue development
xai LIMD1 3p21.3 0.164 0.214 0.756 cell migration;cytoplasmic mRNA
hs4 GGT6 17p13.2 0.164 0.214 0.756 glutathione metabolic process;glutathione
hs4 DAZAP1 19p13.3 0.164 0.214 0.756 multicellular organismal
xai THRA 17q11.2 0.164 0.214 0.756 regulation of transcription from RNA
polymerase II promoter;transcription from RNA polymerase II promoter
xai LOC155060 7q36.1 0.164 0.214 0.756
xai FKBP3 14q21.2 0.164 0.214 0.756 protein folding;peptidyl-proline
modification
his NDUFV3 21q22.3 0.164 0.214 0.756 transport;respiratory electron
transport chain
xai HNRNPABP1 0.164 0.214 0.756
xai SCO1 17p13.1 0.164 0.214 0.756 generation of precursor metabolites and
energy;copper ion transport
xsq MAN1B1-AS1 9q34.3 0.163 0.214 0.755
met LRRN1 3p26.2 0.163 0.214 0.755
met KLF11 2p25 0.163 0.214 0.755 negative regulation of cell
mut DCLRE1A 10q25.1 0.163 0.214 0.755 DNA Damage Response (DDR)
met HMGCLL1 6p12.1 0.163 0.214 0.755
xsq KRT84 12q13 0.163 0.214 0.756 regulation of keratinocyte differentiation;hair
xsq SDR39U1 14q12 0.163 0.214 0.756
mut SMAP2 1p35.3-p34.1 0.163 0.214 0.756 regulation of ARF GTPase activity
cop MSI2 17q22 0.163 0.214 0.756 stem cell development
xsq ERH 14q24.1 0.163 0.214 0.756 nucleobase-containing compound metabolic
process;pyrimidine nucleoside metabolic process
xsq RPL26 17p13 0.163 0.214 0.756 translational initiation;viral infectious cycle
met VDR 12q13.11 0.163 0.214 0.756 negative regulation of transcription from
RNA polymerase II promoter;positive regulation of keratinocyte differentiation
exp RWDD1 6q13-q22.33 0.163 0.214 0.756
cop LINC01122 0.163 0.214 0.756
met C15orf59 15q24.1 0.163 0.214 0.756
met ALG6 1p31.3 0.163 0.214 0.756 protein N-linked glycosylation;dolichol-
mut ARHGEF18 19p13.3 0.163 0.214 0.756 regulation of cell shape;induction
cop MARVELD3 16q22.2 0.163 0.214 0.756 EMT (Epithelial)
cop GOLGA3 12q24.33 0.163 0.214 0.756 intra-Golgi vesicle-mediated
transport
met CHIC1 Xq13.2 0.163 0.214 0.756
mut KRT32 17q21.2 0.163 0.214 0.756 epidermis development
cop GOLGA2P5 12q23.1 0.163 0.214 0.756
xsq TMEM123 11q22.1 0.163 0.214 0.756 oncosis
xsq SUDS3 12q24.23 0.163 0.214 0.756 chromatin modification;negative
exp LOC100289564 0.163 0.214 0.756
exp LOC729887 16q23.3 0.163 0.214 0.756
met CLSTN1 1p36.22 0.163 0.214 0.756 cell adhesion;homophilic cell
adhesion
exp IGHG4 14q32.33 0.163 0.214 0.756 complement activation, classical
xsq ART4 12p13-p12 0.163 0.214 0.756 protein ADP-ribosylation;arginine
metabolic process
xsq UGT2A2 4q13.3 0.163 0.214 0.756
exp JAKMIP1 4p16.1 0.163 0.214 0.756 protein transport
xsq NPHP4 1p36 0.163 0.214 0.756 signal transduction;visual behavior
xsq ARHGEF33 2p22.1 0.163 0.214 0.756 regulation of Rho protein signal
transduction
met DBNDD2 20q13.12 0.163 0.214 0.756 negative regulation of protein
kinase activity
cop DPEP2 16q22.1 0.163 0.214 0.756 leukotriene biosynthetic process;small
cop DDX28 16q22.1 0.163 0.214 0.756
cop DUS2 0.163 0.214 0.756 tRNA processing
mut SECISBP2 9q22.2 0.163 0.214 0.756 translation
met SULT4A1 22q13.2 0.163 0.214 0.756 xenobiotic metabolic
process;steroid metabolic process
exp LOC643043 Xp11.4 0.163 0.214 0.756
exp FKBP1C 6q12 0.163 0.214 0.756 protein folding
exp MIB2 1p36.33 0.163 0.214 0.756 signal transduction;Notch signaling
pathway
xsq VDAC3 8p11.2 0.163 0.214 0.756 Apoptosis
xsq P2RY11 19p13.2 0.163 0.214 0.756
met LRPAP1 4p16.3 0.163 0.214 0.756 protein folding;negative regulation
exp TPGS1 19p13.3 0.163 0.214 0.756 adult behavior;multicellular organismal
development
met CCNYL1 2q33.3 0.163 0.214 0.756 regulation of cyclin-dependent
xsq AUH 9q22.31 0.163 0.214 0.756 mRNA catabolic process;branched chain
xsq SNORA76A 0.163 0.214 0.756
xsq STAR 8p11.2 0.163 0.214 0.756 lipid transport;steroid metabolic process
met CFAP126 0.163 0.214 0.756
met GYS2 12p12.2 0.163 0.214 0.756 carbohydrate metabolic process;glycogen
cop ESRP2 16q22.1 0.163 0.214 0.756 EMT (Epithelial)
xsq GLA Xq22 0.163 0.214 0.756 glycosphingolipid catabolic
dependent"
xsq SDHAP3 5p15.33 0.163 0.214 0.756
cop LRRC66 4q12 0.163 0.214 0.756
exp PGPEP1 19p13.11 0.163 0.214 0.756 proteolysis
cop LOC100505795 -0.163 0.214 0.756
exp RGAG1 Xq23 -0.163 0.214 0.756
xsq TRAK2 2q33 -0.163 0.214 0.756 regulation of transcription from RNA
cop KIAA1429 8q22.1 -0.163 0.214 0.756 RNA splicing;mRNA processing
cop PLSCR1 3q23 -0.163 0.214 0.756 apoptotic process;positive
met TRIM7 5q35.3 -0.163 0.214 0.756
exp B4GALNT3 12p13.33 -0.163 0.214 0.756
xsq LOC101054525 -0.163 0.214 0.756
exp HCG22 6p21.33 -0.163 0.214 0.756
cop CLK2P 7p15.3 -0.163 0.214 0.756
xsq HPX 11p15.5-p15.4 -0.163 0.214 0.756 heme metabolic
process;positive regulation of tyrosine phosphorylation of Stat1 protein
met GOLGA8B 15q14 -0.163 0.214 0.756
mut MAATS1 3q12-q13.3 -0.163 0.214 0.756
cop SNORA14B -0.163 0.214 0.756
cop RBM34 1q42.3 -0.163 0.214 0.756
cop MIR4753 -0.163 0.214 0.756
xsq KIAA0895 7p14.2 -0.163 0.214 0.756
cop RNF19A 8q22 -0.163 0.214 0.756 microtubule cytoskeleton
met GCM1 6p12.1 -0.163 0.214 0.756 cell differentiation involved in
embryonic placenta development;regulation of transcription, DNA-dependent
xsq CPAMD8 19p13.11 -0.163 0.214 0.756
cop LINC00251 -0.163 0.214 0.756
xsq ABI3BP 3q12 -0.163 0.214 0.756 positive regulation of cell-
exp PCDHB7 5q31 -0.163 0.214 0.756 cell adhesion;homophilic cell
adhesion
exp SAMD4B 19q13.2 -0.163 0.214 0.756
xsq EPN3 17q21.33 -0.163 0.214 0.755
xsq TSPAN10 17q25.3 -0.163 0.214 0.755
met C5orf64 5q12.1 -0.163 0.214 0.755
met PTX4 16p13.3 -0.163 0.214 0.755
exp C16orf96 16p13.3 -0.164 0.214 0.756
his MYO1E 15q21-q22 -0.164 0.214 0.756 glomerular filtration;nitrogen
cop MIR218-1 -0.164 0.214 0.756
his HIF3A 19q13.32 -0.164 0.214 0.756 response to hypoxia;positive
xai ZBBX 3q26.1 -0.164 0.214 0.756
DNA-dependent"
hs4 RANBP6 9p24.1 -0.164 0.214 0.756 protein transport
xai GAS1RR -0.164 0.214 0.756
xai KRT8P49 11p15.4 -0.164 0.214 0.756
xai HOXA4 7p15.2 -0.164 0.214 0.756 anatomical structure
xai SNHG18 -0.164 0.214 0.756
xai ST6GALNAC5 1p31.1 -0.164 0.214 0.756 protein
swa CHMP6 17q25.3 -0.164 0.214 0.756 protein transport;cellular membrane
organization
xai TRAK1 3p22.1 -0.164 0.214 0.756 protein targeting;endosome to
lysosome transport
xai ECHS1 10q26.2-q26.3 -0.164 0.214 0.756 fatty acid metabolic
hs4 RGMB 5q15 -0.164 0.214 0.756 cell adhesion;signal transduction
hs4 RGMB-AS1 -0.164 0.214 0.756
xai TRIM23 5q12.3 -0.164 0.214 0.756 positive regulation of
catalytic activity;interspecies interaction between organisms
xai TMEM59 1p32.3 -0.164 0.214 0.756
xai TOM1L1 17q23.2 -0.164 0.214 0.756 intracellular protein
hs4 IFI6 1p35 -0.164 0.214 0.755 negative regulation of mitochondrial
depolarization;type I interferon-mediated signaling pathway
his PBX1 1q23 -0.164 0.214 0.755 organ morphogenesis;negative regulation
his CYP4B1 1p33 -0.164 0.214 0.755 small molecule metabolic
hs4 PAK1 11q13-q14 -0.164 0.214 0.755 Apoptosis; Protein Kinases
swa RPL37A 2q35 0.164 0.215 0.757 gene expression;viral reproduction
xai RPL7AP2 14q21.1 0.164 0.215 0.757
dependent"
xai ERCC8 5q12.1 0.164 0.215 0.757 DNA Damage Response (DDR); DDR (NER)
swa KRT15 17q21.2 0.164 0.215 0.757 epidermis development
hs4 CDPF1 22q13.31 0.164 0.215 0.757
his LOC645166 0.164 0.215 0.757
xai PSMA6 14q13 0.164 0.215 0.757 M/G1 transition of mitotic cell cycle;gene
expression
his RPL14 3p22-p21.2 0.164 0.215 0.757 SRP-dependent cotranslational protein
his ACOT7 1p36 0.164 0.215 0.757 lipid metabolic process
his SNORA79 0.164 0.215 0.757
xai OGG1 3p26.2 0.164 0.215 0.757 DNA Damage Response (DDR); DDR (BER)
hs4 GSC2 22q11.21 0.164 0.215 0.757
xai C10orf107 10q21.2 0.164 0.215 0.757
his SMDT1 22q13.2 0.164 0.215 0.757
xai TBX5 12q24.1 0.164 0.215 0.757 ventricular septum development;lung
development
exp RPL29P22 0.164 0.215 0.757
xai SNORA70B 0.164 0.215 0.757
his NAT1 8p22 0.164 0.215 0.757 xenobiotic metabolic process;small molecule
metabolic process
xai TBRG4 7p13 0.164 0.215 0.757 Apoptosis
xai FDPS 1q22 0.164 0.215 0.757 cholesterol biosynthetic process;isoprenoid
hs4 SNAR-B2 0.164 0.215 0.757
hs4 SNAR-D 0.164 0.215 0.757
hs4 PLEKHJ1 19p13.3 0.164 0.215 0.757
hs4 MIR1227 0.164 0.215 0.757
hs4 MIR6789 0.164 0.215 0.757
hs4 SF3A2 19p13.3 0.164 0.215 0.757 mRNA processing;RNA splicing
hs4 TMEM201 1p36.22 0.164 0.215 0.757
exp LOC100128792 0.164 0.215 0.757
exp ZSCAN12 6p21 0.164 0.215 0.757 viral reproduction
xai TIMM9 14q21 0.164 0.215 0.757 sensory perception of sound;protein import into
exp CT62 15q23 0.164 0.215 0.757
hs4 MRI1 19p13.2 0.164 0.215 0.757 L-methionine salvage from
xai EXOSC6 16q22.1 0.164 0.215 0.757 DNA deamination;nuclear-transcribed
mRNA catabolic process, deadenylation-dependent decay
his DOCK10 2q36.2 0.164 0.215 0.757 regulation of catalytic activity
his DNAAF2 14q21.3 0.164 0.215 0.757 ciliary cell motility;flagellar
cell motility
xai MIR181A1HG 1q32.1 0.164 0.215 0.757
his OLIG1 21q22.11 0.164 0.215 0.757 multicellular organismal
his LMF1 16p13.3 0.164 0.215 0.757 protein glycosylation in
exp SNORA70B 0.164 0.215 0.757
hs4 MRPS25 3p25 0.164 0.215 0.757 translation
exp RPL7P8 0.164 0.215 0.757
his WDR6 3p21.31 0.164 0.215 0.757 negative regulation of cell
proliferation;cell cycle
xai FANCL 2p16.1 0.164 0.215 0.757 DNA Damage Response (DDR); DDR (FA)
his CHMP6 17q25.3 0.164 0.215 0.757 protein transport;cellular membrane
organization
xai MIR4523 0.164 0.215 0.757
xai RPL29P22 0.164 0.215 0.757
exp MIR4523 0.164 0.215 0.757
swa IARS 9q21 0.164 0.215 0.757 gene expression;tRNA aminoacylation for protein
translation
xai MORN3 12q24.31 0.164 0.215 0.757
xai SLC25A14 Xq24 0.164 0.215 0.757 Solute Carriers
xai NDUFA2 5q31.2 0.164 0.215 0.757 respiratory electron transport
his VPS11 11q23 0.164 0.215 0.757 intracellular protein transport;vesicle-
mediated transport
met MOXD2P 7q34 0.163 0.215 0.757 catecholamine metabolic process
mut SRGAP3 3p25.3 0.163 0.215 0.757 signal transduction;small GTPase
met SLC22A9 11q13.1 0.163 0.215 0.757 transmembrane transport
xsq OR6F1 0.163 0.215 0.757 response to stimulus
cop DEXI 16p13.13 0.163 0.215 0.757
cop ADD1 4p16.3 0.163 0.215 0.757 cellular component disassembly involved
in apoptosis;activation of signaling protein activity involved in unfolded protein
response
xsq EML2-AS1 0.163 0.215 0.757
xsq LINC01206 0.163 0.215 0.757
xsq WSPAR 0.163 0.215 0.757
exp SLFN11 17q12 0.163 0.215 0.757 DNA Damage Response (DDR)
mda SLFN11_transcript_expression 0.163 0.215 0.757
xsq MCF2 Xq27 0.163 0.215 0.757 regulation of small GTPase mediated signal
transduction;apoptotic process
met GABRA1 5q34 0.163 0.215 0.757 transport;chloride transport
mut MYO9A 15q22-q23 0.163 0.215 0.757 small GTPase mediated signal
transduction;visual perception
dependent"
xsq ZNF37A 10p11.2 0.163 0.215 0.757 regulation of transcription, DNA-
dependent"
exp NLN 5q12.3 0.163 0.215 0.757 proteolysis
exp DDC 7p12.2 0.162 0.215 0.757 isoquinoline alkaloid metabolic
met IER5 1q25.3 0.162 0.215 0.757
exp LOC728392 0.162 0.215 0.757
xsq ACAP3 0.162 0.215 0.757 filopodium assembly;signal transduction
mut ROCK2 2p24 0.162 0.215 0.757 Protein Kinases
xsq OSBP2 22q12.2 0.162 0.215 0.757 transport;lipid transport
mut ACO1 9p21.1 0.162 0.215 0.757 response to iron(II) ion;regulation of
gene expression
xsq C9orf142 9q34.3 0.162 0.215 0.757 DNA Damage Response (DDR)
xsq GAPVD1 9q33.3 0.162 0.215 0.757 endocytosis;signal transduction
xsq CDS2 20p13 0.162 0.215 0.757 phospholipid biosynthetic process
xsq LOC101927844 0.162 0.215 0.757
exp KCNQ5 6q14 0.162 0.215 0.757 protein complex assembly;ion transport
cop LOC100128361 9q22.31 0.162 0.215 0.757
mir hsa-miR-146b-5p 0.162 0.215 0.757
cop WDR7 18q21.31 0.162 0.215 0.757
exp EIF2B5 3q27.1 0.162 0.215 0.757 response to glucose
xsq MAU2 19p13.11 0.162 0.215 0.757 cell cycle;chromosome segregation
xsq PRIM2 6p12-p11.1 0.162 0.215 0.757 DNA replication;DNA replication,
synthesis of RNA primer
met TBXA2R 19p13.3 0.162 0.215 0.757 G-protein coupled receptor
signaling pathway;blood coagulation
xsq CCHCR1 6p21.3 0.162 0.215 0.757 multicellular organismal
xsq ELF1 13q13 0.162 0.215 0.757 Transcription Factors
mut CLCN3 4q33 0.162 0.215 0.757 transport;ion transport
cop LOC440243 0.162 0.215 0.757
cop HERC2P7 15q11.2 0.162 0.215 0.757
cop GOLGA8EP 0.162 0.215 0.757
cop GOLGA8S 0.162 0.215 0.757
cop LOC644669 18p11.21 0.162 0.215 0.757
cop MEIS1 2p14 0.162 0.215 0.757 multicellular organismal development
xsq VRK2 2p16.1 0.162 0.215 0.757 protein phosphorylation;response to
oxidative stress
xsq PRDX5 11q13 0.162 0.215 0.757 response to oxidative stress;cellular response
cop TAT 16q22.1 0.162 0.215 0.757 tyrosine catabolic process;response to
oxidative stress
cop PROKR2 20p12.3 0.162 0.215 0.757
xsq DNMT3L 21q22.3 0.162 0.215 0.757 spermatogenesis;positive regulation
of catalytic activity
pro TUBB 6p21.33 0.162 0.215 0.757 Apoptosis
exp HAUS8 19p13.11 0.162 0.215 0.757 cell cycle;mitosis
xsq ANKHD1 0.162 0.215 0.757
mut DSEL 18q22.1 0.162 0.215 0.757
met DKFZp434L192 7p11.2 0.162 0.215 0.757
met EPHA4 2q36.1 0.162 0.215 0.757 adult walking behavior;negative
regulation of axon regeneration
xsq GCH1 14q22.1-q22.2 0.162 0.215 0.757 induction of apoptosis;pteridine-
containing compound biosynthetic process
xsq GATAD2A 19p13.11 0.162 0.215 0.757 anterior neuropore closure;negative
exp ARIH2 3p21 0.162 0.215 0.757 protein polyubiquitination;multicellular
cop MEIS1-AS3 2p14 0.162 0.215 0.757
met CCNB3 Xp11 0.162 0.215 0.757 DNA Damage Response (DDR)
xsq NECAP1 12p13.31 0.162 0.215 0.757 endocytosis;protein transport
cop LINC00311 16q24.1 0.162 0.215 0.757
cop MIR5093 0.162 0.215 0.757
exp TTC39A 1p32.3 -0.162 0.215 0.757
exp LOC100128398 19q13.43 -0.162 0.215 0.757
cop TOMM20 1q42 -0.162 0.215 0.757 protein targeting to mitochondrion
exp GALNT5 2q24.1 -0.162 0.215 0.757 glycosaminoglycan
cop PLXND1 3q22.1 -0.162 0.215 0.757 multicellular organismal
xsq TCF7L2 10q25.3 -0.162 0.215 0.757 regulation of transcription
cop ZNF462 9q31.2 -0.162 0.215 0.757 positive regulation of
dependent
exp RGMB 5q15 -0.162 0.215 0.757 cell adhesion;signal transduction
xsq FLNB 3p14.3 -0.162 0.215 0.757 multicellular organismal
met ST6GAL1 3q27-q28 -0.162 0.215 0.757 protein modification
exp LRP10 14q11.2 -0.162 0.215 0.757 lipid metabolic process;lipid
transport
exp ZBBX 3q26.1 -0.162 0.215 0.757
exp LINC00162 21q22.3 -0.162 0.215 0.757
xsq ATP6V0D2 -0.162 0.215 0.757 transmembrane transport;ion
transport
mut TLDC1 16q24.1 -0.162 0.215 0.757
met TMEM107 17p13.1 -0.162 0.215 0.757
xsq ANK2 4q25-q27 -0.162 0.215 0.757 axon guidance;signal transduction
exp PLEKHA6 1q32.1 -0.162 0.215 0.757
met LPIN1 2p25.1 -0.163 0.215 0.757 small molecule metabolic
exp RAB9B Xq22.1-q22.3 -0.163 0.215 0.757 small GTPase mediated signal
mut ZMIZ1 10q22.3 -0.163 0.215 0.757 in utero embryonic
development;artery morphogenesis
exp ARPC1A 7q22.1 -0.163 0.215 0.757 actin cytoskeleton
cop MIR548AJ2 -0.163 0.215 0.757
exp TMEM43 3p25.1 -0.163 0.215 0.757
exp MSC-AS1 -0.163 0.215 0.757
mut LTA4H 12q22 -0.163 0.215 0.757 prostanoid metabolic process;inflammatory
response
met FAM71F1 7q32.1 -0.163 0.215 0.757
met MPP2 17q12-q21 -0.163 0.215 0.757 signal transduction
exp WBP2 17q25 -0.163 0.215 0.757
met OPTC 1q32.1 -0.163 0.215 0.757
hs4 STAT3 17q21.31 -0.164 0.215 0.757 Apoptosis
xai MIR3189 -0.164 0.215 0.757
his SH3RF3 2q13 -0.164 0.215 0.757
his SH3RF3-AS1 2q12.3 -0.164 0.215 0.757
swa PRKDC 8q11 -0.164 0.215 0.757 Apoptosis; DNA Damage Response (DDR); DDR
(NHEJ); Protein Kinases
hs4 ARHGAP21 10p12.1 -0.164 0.215 0.757 signal transduction
his KIAA1217 10p12.31 -0.164 0.215 0.757 multicellular organismal
his KCNE1 21q22.12 -0.164 0.215 0.757 sensory perception of sound;blood
circulation
his LINC01444 -0.164 0.215 0.757
DNA-dependent"
exp GCNT6 6p24.2 -0.164 0.215 0.757
xai CYFIP1 15q11 -0.164 0.215 0.757 regulation of cell
hs4 CLMP 11q24.1 -0.164 0.215 0.757
his FLJ26245 -0.164 0.215 0.757
exp PCDHGB6 -0.164 0.215 0.757 cell adhesion;homophilic cell
adhesion
hs4 NFKBIZ 3p12-q12 -0.164 0.215 0.757 regulation of transcription,
xai LMAN2L 2q11.2 -0.164 0.215 0.757 protein folding;ER to Golgi
xai CCDC190 -0.164 0.215 0.757
xai OTOP1 -0.164 0.215 0.757 biomineral tissue development
cop MIR1286 -0.164 0.215 0.757
his LPAR4 Xq21.1 -0.164 0.215 0.757 G-protein coupled receptor
signaling pathway
hs4 PHGDH 1p12 -0.164 0.215 0.757 L-serine biosynthetic process;brain
development
cop MIR2682 -0.164 0.215 0.757
cop MIR137 -0.164 0.215 0.757
xai GMFB 14q22.2 -0.164 0.215 0.757 protein phosphorylation;signal
transduction
his CCDC144B 17p11.2 -0.164 0.215 0.757
xai IPO9-AS1 -0.164 0.215 0.757
his STC2 5q35.1 -0.164 0.215 0.757 cell surface receptor signaling
hs4 MIR5580 -0.164 0.215 0.757
hs4 BMP4 14q22-q23 -0.164 0.215 0.757 activation of MAPKK
hs4 LRFN3 19q13.12 -0.164 0.215 0.757 cell adhesion
hs4 ATXN1 6p23 -0.164 0.215 0.757 cell death;regulation of excitatory
hs4 LOC101928433 -0.164 0.215 0.757
swa NUCKS1 1q32.1 -0.164 0.215 0.757
his FBLN7 2q13 -0.164 0.215 0.757 cell adhesion
his ADM2 22q13.33 -0.164 0.215 0.757 activation of adenylate cyclase
activity by G-protein signaling pathway;digestion
his MIOX 22q13.3 -0.164 0.215 0.757 inositol catabolic process
hs4 KLF7 2q32 -0.164 0.215 0.757 regulation of transcription from RNA
hs4 MIR7845 -0.164 0.215 0.757
hs4 ZNF704 8q21.13 -0.164 0.215 0.757
hs4 TMEM14A 6p12.2 -0.164 0.215 0.757
his TENM2 5q34 -0.164 0.215 0.757
xai MYL10 7q22.1 -0.164 0.215 0.757
xai MPZ 1q23.3 -0.164 0.215 0.757 synaptic transmission
hs4 PYGL 14q21-q22 -0.164 0.215 0.757 glycogen metabolic process;glycogen
catabolic process
cop PRSS8 16p11.2 0.164 0.216 0.757 EMT (Epithelial)
exp RPL31P11 1q23.3 0.164 0.216 0.757
xai EIF4E2P1 20p11.23 0.164 0.216 0.757
xai GMPS 3q24 0.164 0.216 0.757 purine base metabolic process;purine nucleotide
his CD164 6q21 0.164 0.216 0.757 muscle organ development;negative regulation of
cell proliferation
hs4 PPA2 4q25 0.164 0.216 0.757 tRNA aminoacylation for protein
hs4 FBXO15 18q22.3 0.164 0.216 0.757
hs4 TIMM21 18q22.3 0.164 0.216 0.757 protein transport
hs4 NDNF 4q27 0.164 0.216 0.757 cell growth;peptide cross-linking via
his SMIM11A 0.164 0.216 0.757
hs4 LINC01162 0.164 0.216 0.757
his MYBPC2 19q13.33 0.164 0.216 0.757 cell adhesion;muscle filament
sliding
his C10orf105 0.164 0.216 0.757
exp KIR2DL2 0.164 0.216 0.757 regulation of immune response
xai CCNL1 3q25.31 0.164 0.216 0.757 regulation of cyclin-dependent protein
his GABRA1 5q34 0.164 0.216 0.757 transport;chloride transport
xai GAPDH 12p13 0.164 0.216 0.757 glucose metabolic process;gluconeogenesis
hs4 TTC31 2p13.1 0.164 0.216 0.757
hs4 CCDC142 2p13.1 0.164 0.216 0.757
hs4 CATIP-AS1 0.164 0.216 0.757
exp PES1P2 9p23 0.163 0.216 0.757
his STAT5A 17q11.2 0.163 0.216 0.757 Apoptosis
his CLDN10 13q31-q34 0.163 0.216 0.757 cell adhesion;calcium-independent
cell-cell adhesion
hs4 CD248 11q13 0.163 0.216 0.757
exp HMX3 10q26.13 0.163 0.216 0.757 brain development;embryo implantation
xai ATP5I 4p16.3 0.163 0.216 0.758 small molecule metabolic process;ATP
catabolic process
hs4 PLIN2 9p22.1 0.163 0.216 0.758 lipid storage;response to drug
his MEFV 16p13.3 0.163 0.216 0.758 inflammatory response;nucleotide-binding
his ACOT11 1p32.3 0.163 0.216 0.758 fatty acid metabolic
process;response to temperature stimulus
his SH3BP5L 1q44 0.163 0.216 0.758
his MIR3124 0.163 0.216 0.758
exp FLJ32154 0.163 0.216 0.758
xai PCSK6 15q26.3 0.163 0.216 0.758 regulation of BMP signaling pathway;nerve
growth factor processing
xai ZNF33A 10p11.2 0.163 0.216 0.758 regulation of transcription, DNA-
dependent"
exp RPS10P31 22q13.31 0.162 0.216 0.757
exp CRNDE 16q12.2 0.162 0.216 0.757
met ZRANB1 10q26.13 0.162 0.216 0.757 protein K63-linked
deubiquitination;protein deubiquitination involved in ubiquitin-dependent protein
catabolic process
met PRKAR2A 3p21.3-p21.2 0.162 0.216 0.757 signal
transduction;regulation of protein kinase activity
xsq FOXL1 16q24 0.162 0.216 0.757 regulation of transcription, DNA-
xsq KRT28 17q21.2 0.162 0.216 0.757
xsq CFD 19p13.3 0.162 0.216 0.757 innate immune response;platelet
degranulation
cop HERC2P2 15q11.2 0.162 0.216 0.757
xsq LINC01163 0.162 0.216 0.757
exp TLK1 2q31.1 0.162 0.216 0.757 DDR (DNA replication)
xsq RNF5P1 8p11.22 0.162 0.216 0.757
exp LOC375196 0.162 0.216 0.757
exp LOC100287361 2p14 0.162 0.216 0.757
exp CYP2F1P 0.162 0.216 0.757
exp AAGAB 15q22.33-q23 0.162 0.216 0.757 protein transport
xsq ERI1 8p23.1 0.162 0.216 0.757 gene silencing by RNA;rRNA 3'-end
processing
cop TVP23A 16p13.13 0.162 0.216 0.757
xsq OR1C1 0.162 0.216 0.757
mut CHPF 2q35 0.162 0.216 0.757
xsq CLK1 2q33 0.162 0.216 0.757 cell proliferation;peptidyl-serine
phosphorylation
exp NECAP1 12p13.31 0.162 0.216 0.757 endocytosis;protein transport
xsq WNT1 12q13 0.162 0.216 0.757 Apoptosis; Oncogenes
xsq PPA2 4q25 0.162 0.216 0.757 tRNA aminoacylation for protein
xsq NPHP3-AS1 3q22.1 0.162 0.216 0.757
cop POLI 18q21.1 0.162 0.216 0.757 DNA Damage Response (DDR); DDR (DNA
exp POTEI 2q21.1 0.162 0.216 0.757
mut OR10AG1 0.162 0.216 0.757
exp ACYP2 2p16.2 0.162 0.216 0.757 phosphate-containing compound metabolic
process
met FAM84A 2p24.3 0.162 0.216 0.757
cop IPPK 9q22.31 0.162 0.216 0.757 inositol phosphorylation
met LPA 6q26 0.162 0.216 0.757 transport;lipid transport
xsq NPM1 5q35.1 0.162 0.216 0.757 Apoptosis; DNA Damage Response (DDR);
Tumor Suppressors
xsq OR5M9 0.162 0.216 0.757
mir hsa-miR-370 0.162 0.216 0.757
xsq MIPEPP3 13q12.11 0.162 0.216 0.757
exp NR6A1 9q33.3 0.162 0.216 0.757 negative regulation of transcription from
met MTERF4 0.162 0.216 0.757
cop WHAMMP3 15q11.2 0.162 0.216 0.757
cop GOLGA8I 0.162 0.216 0.757
cop PCNA 20pter-p12 0.162 0.216 0.757 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq DLEU1-AS1 0.162 0.216 0.757
exp DNAJC4 11q13 0.162 0.216 0.757 protein folding;response to unfolded
protein
exp TSPYL5 8q22.1 0.162 0.216 0.757 nucleosome assembly;positive
cop TMEM230 20p13 0.162 0.216 0.758
dependent"
xsq COX10-AS1 0.162 0.216 0.758
cop LOC90784 2p11.2 0.162 0.216 0.758
exp TEX38 1p33 0.162 0.216 0.758
xsq PIK3AP1 10q24.1 0.162 0.216 0.758
xsq CMSS1 3q12.1 0.162 0.216 0.758
exp ATP5L 11q23.3 0.162 0.216 0.758 ATP catabolic process;ion transport
xsq LOC101929767 0.162 0.216 0.758
met DCSTAMP 8q23 0.162 0.216 0.758 osteoclast differentiation
exp HSPD1P9 13q13.3 0.162 0.216 0.758
xsq NOL9 1p36.31 0.162 0.216 0.758 maturation of 5.8S rRNA
exp ABI1 10p11.2 0.162 0.216 0.758 peptidyl-tyrosine
cop SGCB 4q12 0.162 0.216 0.758 cytoskeleton organization;muscle organ
development
xsq CERS6 2q24.3 0.162 0.216 0.758 sphingolipid metabolic process;lipid
xsq CTRB2 16q23.1 0.162 0.216 0.758 proteolysis;digestion
xsq GUSBP2 6p21 0.162 0.216 0.758
xsq PCDHGB7 -0.162 0.216 0.758 homophilic cell adhesion;cell
adhesion
xsq MAP3K1 5q11.2 -0.162 0.216 0.758 Apoptosis; Cell Signaling;
Protein Kinases
met CXCL6 4q13.3 -0.162 0.216 0.758 chemotaxis;inflammatory response
met ACSS2 20q11.22 -0.162 0.216 0.758 ethanol oxidation;acetyl-CoA
exp TNFAIP2 14q32 -0.162 0.216 0.758 angiogenesis;multicellular
met COPS6 7q22.1 -0.162 0.216 0.758 DNA Damage Response (DDR)
xsq LOC101927884 -0.162 0.216 0.758
exp CERS1 19p12 -0.162 0.216 0.758 small molecule metabolic process;ceramide
xsq CDC42BPB 14q32.3 -0.162 0.216 0.758 Protein Kinases
xsq RBMS3-AS3 -0.162 0.216 0.757
xsq LOC100130744 -0.162 0.216 0.757
mut BCL7A 12q24.13 -0.162 0.216 0.757 negative regulation of
exp CYP1B1 2p22.2 -0.162 0.216 0.757 cellular aromatic compound
xsq KRBOX1 -0.162 0.216 0.757 regulation of transcription, DNA-
dependent"
cop LOC100288748 8q22.1 -0.162 0.216 0.757 EMT (Epithelial)
cop ESRP1 8q22.1 -0.162 0.216 0.757 EMT (Epithelial)
exp CARS2 13q34 -0.162 0.216 0.757 gene expression;tRNA aminoacylation for
protein translation
cop CER1 -0.162 0.216 0.757
cop FREM1 9p22.3 -0.162 0.216 0.757 multicellular organismal
development;cell communication
cop LOC389705 9p22.3 -0.162 0.216 0.757
met ECHDC1 6q22.33 -0.162 0.216 0.757
met C8orf34 8q13 -0.162 0.216 0.757 signal transduction
met TM2D1 1p31.3 -0.162 0.216 0.757 apoptotic process;induction of
exp CFI 4q25 -0.162 0.216 0.757 complement activation, classical
xsq LINC00601 -0.162 0.216 0.757
exp ZNF322P1 -0.162 0.216 0.757
cop CCDC126 7p15.3 -0.162 0.216 0.757
xsq DMRTA1 9p21.3 -0.162 0.216 0.757 regulation of transcription,
DNA-dependent;sex differentiation
cop CSRP1 1q32 -0.162 0.216 0.757
exp LNX1 4q12 -0.162 0.216 0.757 protein ubiquitination involved in
exp LOC100131943 -0.162 0.216 0.757
cop C7orf57 7p12.3 -0.162 0.216 0.757
xsq APCDD1 18p11.22 -0.162 0.216 0.757 hair follicle
his PFN2 3q25.1 -0.163 0.216 0.758 regulation of actin polymerization
or depolymerization;actin cytoskeleton organization
his LOC646903 -0.163 0.216 0.758
xai RUSC1-AS1 1q22 -0.163 0.216 0.758
his PPFIA4 1q32.1 -0.163 0.216 0.758 cell communication
his LOC101927087 -0.163 0.216 0.758
hs4 LOC101927043 -0.163 0.216 0.758
xai ENDOU 12q13.1 -0.163 0.216 0.758 female pregnancy;proteolysis
his MIR548U -0.163 0.216 0.758
hs4 SAMD5 6q24.3 -0.163 0.216 0.758
exp LCTL 15q22.31 -0.163 0.216 0.758 carbohydrate metabolic process
xai SERINC2 1p35.1 -0.163 0.216 0.758
hs4 THSD4-AS2 -0.163 0.216 0.758
hs4 RNY4 7q36 -0.163 0.216 0.757
xai MACROD2 20p12.1 -0.163 0.216 0.757 purine nucleoside metabolic
process
hs4 RBM46 4q32.1 -0.163 0.216 0.757
hs4 SLC6A14 Xq23 -0.163 0.216 0.757 Solute Carriers
his CA9 9p13.3 -0.163 0.216 0.757 secretion;morphogenesis of an
epithelium
xai PSMD2 3q27.1 -0.163 0.216 0.757 S phase of mitotic cell cycle;DNA
arrest
xai FAM133A Xq21.32 -0.163 0.216 0.757
xai TSC22D3 Xq22.3 -0.163 0.216 0.757 regulation of transcription,
DNA-dependent;body fluid secretion"
swa ERGIC1 5q35.1 -0.163 0.216 0.757 ER to Golgi vesicle-mediated
his MIR3116-1 -0.163 0.216 0.757
his MIR3116-2 -0.163 0.216 0.757
hs4 PNPLA4 Xp22.3 -0.164 0.216 0.757 metabolic process;lipid
catabolic process
hs4 SEMA6D 15q21.1 -0.164 0.216 0.757 multicellular organismal
exp BAALC-AS1 -0.164 0.216 0.757
xai C7orf57 7p12.3 -0.164 0.216 0.757
xai IL1RAPL2 Xq22 -0.164 0.216 0.757 signal transduction;central nervous
system development
his LGALS12 11q13 -0.164 0.216 0.757 induction of apoptosis by
DNA-dependent"
xai CHMP2A 19q -0.164 0.216 0.757 protein transport;cellular membrane
organization
his EPHX4 1p22.1 -0.164 0.216 0.757
xai UBQLNL 11p15.4 -0.164 0.216 0.757
exp MIR3189 -0.164 0.216 0.757
hs4 POP7 7q22 0.163 0.217 0.758 tRNA processing
xai FLJ32154 0.163 0.217 0.758
exp TRHR 8q23 0.163 0.217 0.758 G-protein coupled receptor signaling pathway
his CDCA7L 7p15.3 0.163 0.217 0.758 regulation of transcription, DNA-
xai RBM8A 1q21.1 0.163 0.217 0.758 RNA splicing;nuclear-transcribed mRNA
his KIAA1257 3q21.3 0.163 0.217 0.758
xai CHRNB4 15q24 0.163 0.217 0.758 synaptic transmission;synaptic
xai WRN 8p12 0.163 0.217 0.758 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
his BAK1 6p21.3 0.163 0.217 0.758 Apoptosis
his GGNBP1 6p21 0.163 0.217 0.758 mitochondrial fission;multicellular
his AP1G1 16q23 0.163 0.217 0.758 post-Golgi vesicle-mediated
xai CCDC73 11p13 0.163 0.217 0.758
his CTDNEP1 17p13 0.163 0.217 0.758 protein dephosphorylation;nuclear
his ELP5 17p13.1 0.163 0.217 0.758
his LOC100130992 10p12.31 0.163 0.217 0.758
xai OR4A50P 11q11 0.163 0.217 0.758
swa RTCA 1p21.2 0.163 0.217 0.758 RNA processing
his TGIF2LX 0.163 0.217 0.758
xai ZNF143 11p15.4 0.163 0.217 0.758 gene expression;regulation of
dependent"
exp EQTN 9p21 0.163 0.217 0.758
his SH3BGRL Xq13.3 0.163 0.217 0.758
his HMGN5 Xq13.3 0.163 0.217 0.758 regulation of transcription, DNA-
hs4 KCNIP2 10q24 0.163 0.217 0.758 signal transduction;synaptic transmission
cop SEMA6B 19p13.3 0.163 0.217 0.758 multicellular organismal
his AQP3 9p13 0.163 0.217 0.758 urea transport;response to retinoic acid
his TRIM24 7q32-q34 0.163 0.217 0.759 negative regulation of cell
exp LOC285423 4q31.23 0.163 0.217 0.759
xai CNOT2 12q15 0.163 0.217 0.759 RNA metabolic process;mRNA metabolic process
his LOC338797 12q24.33 0.163 0.217 0.759
his ATP5I 4p16.3 0.163 0.217 0.759 small molecule metabolic process;ATP
catabolic process
his MYL5 4p16.3 0.163 0.217 0.759 regulation of muscle contraction
xai LOC442075 0.163 0.217 0.759
his FAM27B 9q13 0.163 0.217 0.759
xai TYMP 22q13.33 0.163 0.217 0.759 pyrimidine nucleotide metabolic
hs4 TPI1 12p13 0.163 0.217 0.759 carbohydrate metabolic process;glucose
metabolic process
hs4 CCHCR1 6p21.3 0.163 0.217 0.759 multicellular organismal
xai FAM114A2 5q31-q33 0.163 0.217 0.759
his CFDP1 16q22.2-q22.3 0.163 0.217 0.759 regulation of cell
exp OR4A50P 11q11 0.163 0.217 0.759
hs4 BMP6 6p24-p23 0.163 0.217 0.759 immune response;positive regulation of
xai YARS2 12p11.21 0.163 0.217 0.759 mitochondrial tyrosyl-tRNA
xai CCDC155 19q13.33 0.163 0.217 0.759 protein dephosphorylation
xai SEL1L2 20p12.1 0.163 0.217 0.759
xai COL23A1 5q35.3 0.163 0.217 0.759 protein homotrimerization
his LOC105371925 0.163 0.217 0.759
exp RPL7AP2 14q21.1 0.163 0.217 0.759
xai LGALS17A 19q13.2 0.163 0.217 0.759
xai PRPF8 17p13.3 0.163 0.217 0.759 mRNA processing;RNA splicing
his FAM72A 1q32.1 0.163 0.217 0.759
exp TMEM81 1q32.1 0.163 0.217 0.759
exp FBXO43 8q22.2 0.163 0.217 0.759 meiosis
xai HIRA 22q11.21 0.163 0.217 0.759 anatomical structure
xsq HSPE1 2q33.1 0.162 0.217 0.758 Apoptosis
xsq TINCR 19p13.3 0.162 0.217 0.758
xsq RGPD3 2q13 0.162 0.217 0.758
cop NDUFAF1 15q11.2-q21.3 0.162 0.217 0.758 mitochondrial electron
cop RTF1 15q15.1 0.162 0.217 0.758 transcription initiation, DNA-
cop ITPKA 15q15.1 0.162 0.217 0.758 inositol metabolic process;signal
transduction
cop LTK 15q15.1-q21.1 0.162 0.217 0.758 apoptotic process;signal
transduction
cop RPAP1 15q15.1 0.162 0.217 0.758
xsq LRRC8B 1p22.2 0.162 0.217 0.758
xsq LINC01017 0.162 0.217 0.758
xsq TTF2 1p22 0.162 0.217 0.758 mRNA processing;RNA splicing
exp FAM234B 0.162 0.217 0.758
xsq HP 16q22.2 0.162 0.217 0.758 negative regulation of hydrogen peroxide
catabolic process;cellular iron ion homeostasis
xsq TOMM5 9p13.2 0.162 0.217 0.758 protein targeting to mitochondrion
mut CERS6 2q24.3 0.162 0.217 0.758 sphingolipid metabolic process;lipid
exp FASTKD2 2q33.3 0.162 0.217 0.758 cellular respiration
mut PLD2 17p13.1 0.162 0.217 0.758 cell communication;response to hydrogen
peroxide
xsq JARID2 6p24-p23 0.162 0.217 0.758 multicellular organismal
exp GUSBP4 6p11.2 0.162 0.217 0.758
xsq TRMU 22q13 0.162 0.217 0.758 tRNA metabolic process;tRNA processing
cop RPL6 12q24.1 0.162 0.217 0.758 SRP-dependent cotranslational protein
cop LOC339862 0.162 0.217 0.758
xsq FDPS 1q22 0.162 0.217 0.758 cholesterol biosynthetic process;isoprenoid
cop BICD2 9q22.31 0.162 0.217 0.758 EMT (Mesenchymal)
met CMKLR1 12q24.1 0.162 0.217 0.758 negative regulation of interleukin-
12 production;regulation of calcium-mediated signaling
met CHST9 18q11.2 0.162 0.217 0.758 proteoglycan biosynthetic
met SCARNA17 18q21.1 0.162 0.217 0.758
exp ATE1 10q26.13 0.162 0.217 0.759 protein arginylation
xsq NCOA5 20q12-q13.12 0.162 0.217 0.759 regulation of transcription, DNA-
dependent"
xsq SHISA3 4p13 0.162 0.217 0.759 multicellular organismal development
xsq CENPVP2 Xp11.22 0.162 0.217 0.759
xsq GPR89B 1q21.1 0.162 0.217 0.759
xsq TBL3 16p13.3 0.162 0.217 0.759 G-protein signaling, coupled to cGMP
nucleotide second messenger;rRNA processing"
exp C9orf40 9q21.13 0.162 0.217 0.759
met C19orf47 19q13.2 0.162 0.217 0.759
cop LOC643339 12q22 0.162 0.217 0.759
met SYNGR3 16p13 0.162 0.217 0.759 positive regulation of transporter
activity
xsq INTS9 8p21.1 0.162 0.217 0.759 snRNA processing
xsq ATP4B 13q34 0.162 0.217 0.759 proton transport;response to lipopolysaccharide
xsq ATAD1 10q23.31 0.162 0.217 0.759 positive regulation of receptor
xsq S100A8 1q21 0.162 0.217 0.759 inflammatory response;response to zinc
ion
met LRRC75A 0.162 0.217 0.759
xsq LOC101928775 0.162 0.217 0.759
mut ANKH 5p15.1 0.162 0.217 0.759 locomotory behavior;regulation of bone
mineralization
cop SERPINH1 11q13.5 0.162 0.217 0.759 response to stress;response to
unfolded protein
cop MAP6 11q13.5 0.162 0.217 0.759
met CYP2E1 10q26.3 0.162 0.217 0.759 heterocycle metabolic
cop MIR1307 0.162 0.217 0.759
xsq ZNF675 19p12 0.162 0.217 0.759 I-kappaB kinase/NF-kappaB
cop TMEM116 12q24.13 0.162 0.217 0.759
xsq NID1 1q43 -0.162 0.217 0.759 cell adhesion;cell-matrix adhesion
exp UPK3B 7q11.2 -0.162 0.217 0.759 negative regulation of gene
expression
xsq MPZL2 11q24 -0.162 0.217 0.759 T cell differentiation in
cop MIR137HG 1p21.3 -0.162 0.217 0.759
exp PLEKHH2 2p21 -0.162 0.217 0.759
exp MRPL48P1 6p24.3 -0.162 0.217 0.759
xsq FAM212B 1p13.2 -0.162 0.217 0.759
met ST13 22q13.2 -0.162 0.217 0.759 chaperone cofactor-dependent
protein refolding;protein folding
cop FAM221A 7p15.3 -0.162 0.217 0.759
exp CYFIP1 15q11 -0.162 0.217 0.759 regulation of cell
xsq MAGED2 Xp11.2 -0.162 0.217 0.759
exp PQLC2 1p36.13 -0.162 0.217 0.759
xsq FUCA1 1p34 -0.162 0.217 0.759 carbohydrate metabolic process;fucose
metabolic process
xsq RNF113B 13q32.2 -0.162 0.217 0.759
cop NPL 1q25 -0.162 0.217 0.759 carbohydrate metabolic process
xsq HPS3 3q24 -0.162 0.217 0.759 organelle organization;pigmentation
exp GOLGA4 3p22-p21.3 -0.162 0.217 0.758 protein targeting to
Golgi;vesicle-mediated transport
exp VCAM1 1p32-p31 -0.162 0.217 0.758 heart development;interspecies
exp NCKAP5L 12q13.12 -0.162 0.217 0.758
xsq PLAC9 10q22.3 -0.162 0.217 0.758
xsq HEPHL1 11q21 -0.162 0.217 0.758 ion transport;copper ion transport
xsq TMEM217 6p21.2 -0.162 0.217 0.758
xsq MEOX2 7p22.1-p21.3 -0.162 0.217 0.758 multicellular organismal
exp VPS37D 7q11.23 -0.162 0.217 0.758 protein transport;viral
reproduction
his BCO2 11q23.1 -0.163 0.217 0.759 carotene metabolic process;retinoic
xai MINOS1P1 -0.163 0.217 0.759
his LINC00622 -0.163 0.217 0.759
xai EGR3 8p23-p21 -0.163 0.217 0.759 positive regulation of endothelial
cell proliferation;cellular response to vascular endothelial growth factor stimulus
his ATP5L2 22q13.2 -0.163 0.217 0.759 ion transport;ATP synthesis
hs4 CTNNB1 3p21 -0.163 0.217 0.759 Apoptosis; Cell Signaling;
Oncogenes
hs4 GPC4 Xq26.1 -0.163 0.217 0.759 cell proliferation;anatomical
hs4 PPP5D1 -0.163 0.217 0.759
hs4 CALM3 19q13.2-q13.3 -0.163 0.217 0.759 carbohydrate metabolic
dependent"
exp LOC100506797 -0.163 0.217 0.759
his KCNIP4 4p15.32 -0.163 0.217 0.759 ion transport;potassium ion
transport
xai PCDHGA2 5q31 -0.163 0.217 0.759 cell adhesion;homophilic cell
adhesion
xai MN1 22q12.1 -0.163 0.217 0.759 intramembranous ossification
xai HS1BP3 2p24.1 -0.163 0.217 0.759 cell communication
exp KRTAP1-4 17q21.2 -0.163 0.217 0.758
his CACNG4 17q24 -0.163 0.217 0.758 transport;ion transport
his COL5A1 9q34.2-q34.3 -0.163 0.217 0.758 wound healing, spreading
his COL5A1-AS1 -0.163 0.217 0.758
hs4 UNC5B-AS1 -0.163 0.217 0.758
hs4 TENM2 5q34 -0.163 0.217 0.758
xai SPOCD1 1p35.2 -0.163 0.217 0.758 transcription, DNA-
exp MTND5P14 -0.163 0.217 0.758
his FAM49A 2p24.2 -0.163 0.217 0.758
xai LINC00893 Xq28 -0.163 0.217 0.758
hs4 STEAP2-AS1 -0.163 0.217 0.758
hs4 STEAP2 7q21.13 -0.163 0.217 0.758 regulated secretory
hs4 LOC101927243 -0.163 0.217 0.758
hs4 GSAP 7q11.23 -0.163 0.217 0.758
xai FLJ38717 6p21.1 0.164 0.218 0.759
his ZNRD1ASP 0.163 0.218 0.759
his ZNRD1 6p21.3 0.163 0.218 0.759 nucleobase-containing compound metabolic
process
hs4 RPUSD3 3p25.3 0.163 0.218 0.759 pseudouridine synthesis
xai RPL7P8 0.163 0.218 0.759
hs4 FAM214A 15q21.2-q21.3 0.163 0.218 0.759
dependent"
his HARS2 5q31.3 0.163 0.218 0.759 translation;tRNA aminoacylation for
protein translation
his HARS 5q31.3 0.163 0.218 0.759
his TMEM156 4p14 0.163 0.218 0.759
his KLHL5 4p14 0.163 0.218 0.759
xai RAP1GAP2 17p13.3 0.163 0.218 0.759 regulation of small GTPase mediated
signal transduction
xai DDX3YP1 Xq13.2 0.163 0.218 0.759
swa FASN 17q25 0.163 0.218 0.759 energy reserve metabolic process;long-chain
fatty-acyl-CoA biosynthetic process
xai TRHR 8q23 0.163 0.218 0.759 G-protein coupled receptor signaling pathway
xai ASH2L 8p11.2 0.163 0.218 0.759 transcription from RNA polymerase II
hs4 GABRA1 5q34 0.163 0.218 0.759 transport;chloride transport
his PHKG2 16p11.2 0.163 0.218 0.759 glycogen metabolic process;glycogen
xai LOC100630923 0.163 0.218 0.759
xai PROCA1 17q11.2 0.163 0.218 0.759 lipid catabolic process
swa PSMD5 9q33.2 0.163 0.218 0.759 protein polyubiquitination;gene
expression
his POLE4 2p12 0.163 0.218 0.759 DNA Damage Response (DDR); DDR (NER); DDR (DNA
replication)
his CHMP3 2p11.2 0.163 0.218 0.759 cellular membrane organization;endosome
transport
hs4 MIR1182 0.163 0.218 0.759
hs4 SUMO1P1 20q13.2 0.163 0.218 0.759
his NREP 5q22.1 0.163 0.218 0.759 regulation of neuron
pathway
hs4 ACSF3 16q24.3 0.163 0.218 0.759 lipid metabolic process;fatty acid
metabolic process
his LRRC75A-AS1 0.163 0.218 0.759
his SNORD49B 0.163 0.218 0.759
his SNORD49A 0.163 0.218 0.759
his SNORD65 17p11.2 0.163 0.218 0.759
xai TBCD 17q25.3 0.163 0.218 0.759 negative regulation of cell-substrate
xai COA1 7p13 0.163 0.218 0.759
xai PIBF1 13q22.1 0.163 0.218 0.759
cop ELOVL3 10q24.32 0.163 0.218 0.759 fatty acid elongation,
monounsaturated fatty acid;fatty acid elongation, polyunsaturated fatty acid
xai DTYMK 2q37.3 0.163 0.218 0.759 cell cycle;cell proliferation
hs4 LINC01588 0.163 0.218 0.759
hs4 FADS2 11q12.2 0.163 0.218 0.759 unsaturated fatty acid biosynthetic
process;transport
hs4 FADS1 11q12.2-q13.1 0.163 0.218 0.759 transport;response to organic
cyclic compound
hs4 MIR1908 0.163 0.218 0.759
his HMCN2 9q34.11 0.163 0.218 0.76 response to stimulus
cop SRRM4 12q24.23 0.162 0.218 0.759 mRNA processing;nervous system
development
cop HSPB8 12q24.23 0.162 0.218 0.759 response to stress;cell death
met LOC148709 1q32.1 0.162 0.218 0.759
dependent"
met INSR 19p13.3-p13.2 0.162 0.218 0.759 positive regulation of cell
xsq KCMF1 2p11.2 0.162 0.218 0.759
exp DOLPP1 9q34.1 0.161 0.218 0.759 protein N-linked glycosylation via
cop CES1P2 16q12.2 0.161 0.218 0.759
xsq WEE2-AS1 7q34 0.161 0.218 0.759
met RBM41 Xq22.3 0.161 0.218 0.759
exp TM2D3 15q26.3 0.161 0.218 0.759
xsq SON 21q22.11 0.161 0.218 0.759 Apoptosis
xsq CCDC159 19p13.2 0.161 0.218 0.759
exp RPL18P3 5q23.1 0.161 0.218 0.759
xsq FAM149B1 10q22.2 0.161 0.218 0.759
dependent"
xsq KRTAP26-1 0.161 0.218 0.759
exp PCSK1N Xp11.23 0.161 0.218 0.759 response to dietary
excess;neuropeptide signaling pathway
exp ANKRD39 2q11.2 0.161 0.218 0.759
exp BANK1 4q24 0.161 0.218 0.759 B cell activation
met MIR595 0.161 0.218 0.759
cop NME1-NME2 0.161 0.218 0.759 CTP biosynthetic process;GTP biosynthetic
process
xsq LOC339059 0.161 0.218 0.759
xsq LOC100507351 0.161 0.218 0.759
xsq LINC00476 9q22.32 0.161 0.218 0.759
met CYP2B7P 0.161 0.218 0.759 oxidation-reduction process
cop NECAB2 16q23.3 0.161 0.218 0.759
xsq MANEAL 1p34.3 0.161 0.218 0.759
xsq LOC440311 15q26.2 0.161 0.218 0.759
cop HTT 4p16.3 0.161 0.218 0.759 regulation of protein phosphatase type 2A
activity;vesicle transport along microtubule
xsq LILRA5 19q13.4 0.161 0.218 0.759 innate immune response
xsq PRC1 15q26.1 0.161 0.218 0.759 cell cycle;mitotic spindle elongation
xsq ING3 7q31 0.161 0.218 0.759 regulation of transcription, DNA-
exp THRA 17q11.2 0.161 0.218 0.759 regulation of transcription from RNA
met GLRA2 Xp22.2 0.161 0.218 0.759 ion transport;neuropeptide signaling
pathway
xsq SOCS4 14q22.1 0.161 0.218 0.759 negative regulation of epidermal growth
factor-activated receptor activity;negative regulation of signal transduction
cop KCNQ1OT1 11p15 0.161 0.218 0.759
met LCE2D 1q21.3 0.161 0.218 0.759
xsq SYCE3 22q13.33 0.161 0.218 0.759
cop MBTD1 17q21.33 0.161 0.218 0.759 regulation of transcription, DNA-
xsq PSPC1 13q12.11 0.161 0.218 0.759 regulation of transcription, DNA-
dependent"
cop ATP2A2 12q24.11 0.161 0.218 0.759 transmembrane transport;ATP
cop ANAPC7 12q24.11 0.161 0.218 0.759 anaphase-promoting complex-
cop ARPC3 12q24.11 0.161 0.218 0.759 cellular component movement;regulation of
cop GPN3 12q24.11 0.161 0.218 0.759
cop FAM216A 12q24.11 0.161 0.218 0.759
cop VPS29 12q24 0.161 0.218 0.759 protein transport
cop RAD9B 12q24.11 0.161 0.218 0.759 DNA Damage Response (DDR)
xsq NDUFA8 9q33.2 0.161 0.218 0.759 mitochondrial electron transport,
met TTC31 2p13.1 0.161 0.218 0.759
xsq PGBD2 1q44 0.161 0.218 0.759
exp DEPDC5 22q12.3 0.161 0.218 0.759 intracellular signal transduction
mut CNTN3 3p12.3 0.161 0.218 0.759 cell adhesion;nervous system development
xsq ACIN1 14q11.2 0.161 0.218 0.759 apoptotic chromosome
exp GTF2B 1p22-p21 0.161 0.218 0.759 viral reproduction;interspecies
cop FMO5 1q21.1 0.161 0.218 0.759 oxidation-reduction process
met DAAM1 14q23.1 0.161 0.218 0.759 cellular component organization;actin
xsq EIF4H 7q11.23 0.161 0.218 0.759 translation;translational initiation
xsq CCDC116 22q11.21 0.161 0.218 0.759
met RPS20 8q12 0.161 0.218 0.759 gene expression;viral reproduction
xsq PRF1 10q22 0.161 0.218 0.759 defense response to tumor cell;defense response
to virus
xsq AP3B1 5q14.1 0.161 0.218 0.759 protein targeting to
cop SHCBP1 16q11.2 0.161 0.218 0.759
cop MPP7 10p12.1 0.161 0.218 0.759 protein localization to adherens
junction;positive regulation of signal transduction
exp KAT2A 17q21 0.161 0.218 0.759 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
met HCN3 1q22 0.161 0.218 0.759 ion transport;potassium ion transport
xsq LYSMD1 1q21.3 0.161 0.218 0.76 cell wall macromolecule catabolic
process
exp ZBED8 -0.161 0.218 0.76
cop HCRTR2 6p12 -0.161 0.218 0.759 neuropeptide signaling
met LRFN4 11q13.2 -0.161 0.218 0.759
met PAX3 2q35 -0.161 0.218 0.759 apoptotic process;spinal cord association
exp UBE3B 12q24.11 -0.161 0.218 0.759 protein modification
process
cop LRAT 4q32.1 -0.161 0.218 0.759 visual perception;steroid metabolic
process
cop DPY19L4 8q22.1 -0.161 0.218 0.759
cop UPP1 7p12.3 -0.161 0.218 0.759 nucleotide catabolic
met F9 Xq27.1-q27.2 -0.161 0.218 0.759
cop OPRK1 8q11.2 -0.161 0.218 0.759 inhibition of adenylate cyclase
messenger
exp HEATR5A 14q12 -0.161 0.218 0.759
met SNORD36C 9q34 -0.161 0.218 0.759
met GPR45 2q11.1-q12 -0.161 0.218 0.759
mut LRRC41 1p34.1 -0.161 0.218 0.759
exp PSG4 19q13.2 -0.161 0.218 0.759 defense response;female pregnancy
xsq IL17RD 3p14.3 -0.161 0.218 0.759
cop MRPS30 5q11 -0.161 0.218 0.759 Apoptosis
met ZKSCAN8 6p21.3 -0.161 0.218 0.759
cop TNFRSF11B 8q24 -0.161 0.218 0.759 response to nutrient;extracellular
matrix organization
cop FBXO43 8q22.2 -0.161 0.218 0.759 meiosis
met TNFSF14 19p13.3 -0.161 0.218 0.759 T cell proliferation;T cell
activation
exp LRRC37BP1 17q11.2 -0.161 0.218 0.759
met NREP 5q22.1 -0.161 0.218 0.759 regulation of neuron
pathway
xsq STMN2 8q21.13 -0.161 0.218 0.759 positive regulation of microtubule
xsq TMEM117 12q12 -0.161 0.218 0.759
exp ABCB1 7q21.12 -0.161 0.218 0.759 ABC Transporters
exp LOC100288778 12p13.33 -0.162 0.218 0.759
met NME4 16p13.3 -0.162 0.218 0.759 CTP biosynthetic process;nucleoside
metabolic process
cop C7orf69 7p12.3 -0.162 0.218 0.759
xsq RCAN2 6p12.3 -0.162 0.218 0.759 calcium-mediated signaling;central
met CCDC184 -0.162 0.218 0.759
xai HOXA5 7p15.2 -0.163 0.218 0.759 thyroid gland development;embryonic
hs4 BCAS1 20q13.2 -0.163 0.218 0.759
hs4 MIR4756 -0.163 0.218 0.759
exp KRT121P -0.163 0.218 0.759
his LRRN4 20p12.3 -0.163 0.218 0.759
met MIR548Q -0.163 0.218 0.759
xai ARPC1A 7q22.1 -0.163 0.218 0.759 actin cytoskeleton
his CLMN 14q32.13 -0.163 0.218 0.759
hs4 SETBP1 18q21.1 -0.163 0.218 0.759
xai TBC1D8B Xq22.3 -0.163 0.218 0.759
xai JKAMP 14q23.1 -0.163 0.218 0.759 response to unfolded protein;ER-
xai MEIS3 19q13.32 -0.163 0.218 0.759
hs4 ARHGAP42 11q22.1 -0.163 0.218 0.759 signal
hs4 LOC100128386 11q22.1 -0.163 0.218 0.759
his CAST 5q15 -0.163 0.218 0.759 negative regulation of endopeptidase
activity
hs4 CALCR 7q21.3 -0.163 0.218 0.759 positive regulation of adenylate
cyclase activity;activation of adenylate cyclase activity by G-protein signaling
pathway
his AJUBA 14q11.2 -0.163 0.218 0.759 Cell Signaling
his DRC1 2p23.3 -0.163 0.218 0.759
hs4 C1orf210 1p34.2 -0.163 0.218 0.759 EMT (Epithelial)
hs4 ANKRD50 4q28.1 -0.163 0.218 0.759
hs4 LOC727751 -0.163 0.218 0.759
exp LINC00893 Xq28 -0.163 0.218 0.759
his LAMA5-AS1 -0.163 0.218 0.759
his LAMA5 20q13.2-q13.3 -0.163 0.218 0.759 integrin-mediated signaling
xai LINC00313 21q22.3 -0.163 0.218 0.759
his PLSCR1 3q23 -0.163 0.218 0.759 apoptotic process;positive
xai DCTN2 12q13.3 -0.163 0.218 0.759 cell proliferation;G2/M transition
swa PPP6R3 11q13 -0.163 0.218 0.759 DNA Damage Response (DDR)
his DCAF12L1 Xq25 -0.163 0.218 0.759
xai SEC31A 4q21.22 -0.163 0.218 0.759 activation of signaling
protein activity involved in unfolded protein response;COPII vesicle coating
xai CYB561 17q23.3 -0.163 0.218 0.759 generation of precursor
his ESYT2 7q36.3 -0.163 0.218 0.759
xai CDS1 4q21.23 -0.163 0.218 0.759 CDP-choline
hs4 UBE2H 7q32 -0.163 0.218 0.759 protein K11-linked
xai ZFYVE16 5q14 -0.163 0.218 0.759 protein targeting to
lysosome;signal transduction
xai GRIN3A 9q31.1 -0.163 0.218 0.759 ion transport;calcium ion
transport
hs4 SPON2 -0.163 0.218 0.759 cell adhesion;axon guidance
hs4 PCDHAC2 -0.163 0.218 0.759 cell adhesion;homophilic cell
adhesion
xai KIR2DL2 0.164 0.219 0.76 regulation of immune response
his OR1D5 0.163 0.219 0.76 G-protein coupled receptor signaling
pathway;sensory perception of smell
his PAIP2 5q31.2 0.163 0.219 0.76 regulation of translation;negative
swa SSRP1 11q12 0.163 0.219 0.76 DNA replication;DNA repair
his CLIC2 Xq28 0.163 0.219 0.76 chloride transport;signal transduction
xai HMGB1P9 2q35 0.163 0.219 0.76
exp WNT9B 17q21 0.163 0.219 0.76 endoderm development;regulation of tube size
his SLC35E2 0.163 0.219 0.76
dependent"
cop PLIN4 19p13.3 0.163 0.219 0.76
cop PLIN5 19p13.3 0.163 0.219 0.76
cop LRG1 19p13.3 0.163 0.219 0.76 brown fat cell differentiation
cop TYRO3P 15q24.2 0.163 0.219 0.76
his C1orf74 1q32.2 0.163 0.219 0.76
cop OSGIN1 16q23.3 0.163 0.219 0.76 multicellular organismal
dependent"
exp RPLP2 11p15.5 0.162 0.219 0.76 translation;mRNA metabolic process
swa EFTUD2 17q21.31 0.162 0.219 0.76 RNA splicing;gene expression
his TAOK2 16p11.2 0.162 0.219 0.76 Protein Kinases
his H2AFB1 0.162 0.219 0.76
his F8A1 0.162 0.219 0.76
his MIR1184-1 0.162 0.219 0.76
xai WDR64 1q43 0.162 0.219 0.76
his TMEM168 7q31.32 0.162 0.219 0.76
hs4 CABP1 12q24.31 0.162 0.219 0.76 negative regulation of catalytic activity
his NFIA 1p31.3-p31.2 0.162 0.219 0.76 DNA replication;regulation of
xai TAS2R46 0.162 0.219 0.76 response to stimulus;sensory perception
of taste
xai WNT9B 17q21 0.162 0.219 0.76 endoderm development;regulation of tube size
his CAPN10-AS1 0.162 0.219 0.76
his CAPN10 2q37.3 0.162 0.219 0.76 positive regulation of insulin
secretion;positive regulation of intracellular transport
xai EARS2 16p12.2 0.162 0.219 0.76 glutamyl-tRNA aminoacylation;gene
expression
xai OR6M2P 0.162 0.219 0.76
his DCLRE1C 10p13 0.162 0.219 0.76 DNA Damage Response (DDR); DDR (NHEJ)
xai DHX16 6p21.3 0.162 0.219 0.76 mRNA processing;RNA splicing
his ANKRD28 3p25.1 0.162 0.219 0.76 DNA Damage Response (DDR)
hs4 FLJ32255 5p12 0.162 0.219 0.76
his PCDH9 13q21.32 0.162 0.219 0.76 cell adhesion;homophilic cell adhesion
exp OR6M2P 0.162 0.219 0.76
xai KLK12 19q13.33 0.162 0.219 0.76 proteolysis
exp TAS2R46 0.162 0.219 0.76 response to stimulus;sensory perception
of taste
xai AOX2P 2q33.1 0.162 0.219 0.76
hs4 C9orf129 9q22.31 0.162 0.219 0.76
his MIR4457 0.162 0.219 0.76
his LGALS2 22q13.1 0.162 0.219 0.76
xai ARIH2P1 18q12.1 0.162 0.219 0.76
xai NDUFA6-AS1 22q13.2 0.162 0.219 0.76
his ELMO2 20q13 0.162 0.219 0.76 Apoptosis
xai LOC100506603 0.162 0.219 0.76
xai LINC00689 7q36.3 0.162 0.219 0.76
exp UBOX5-AS1 0.162 0.219 0.76
xai PPID 4q31.3 0.162 0.219 0.76 protein folding
hs4 NDST2 10q22 0.162 0.219 0.76 cellular process;heparan sulfate proteoglycan
cop UTRN 6q24 0.161 0.219 0.76 positive regulation of cell-matrix
cop CDS2 20p13 0.161 0.219 0.76 phospholipid biosynthetic process
mut INPP4B 4q31.21 0.161 0.219 0.76 signal
exp HELZ 17q24.2 0.161 0.219 0.76
xsq LINC00337 1p36.31 0.161 0.219 0.76
met SPIN1 9q22.1 0.161 0.219 0.76 cell cycle;multicellular organismal
development
cop TRIB2 2p24.3 0.161 0.219 0.76 negative regulation of protein kinase
activity;positive regulation of proteasomal ubiquitin-dependent protein catabolic
process
cop MIR3125 0.161 0.219 0.76
mut LAMA3 18q11.2 0.161 0.219 0.76 regulation of cell adhesion;regulation of
cell migration
met PNPLA1 6p21.31 0.161 0.219 0.76 metabolic process;lipid catabolic
process
xsq C15orf27 15q24.2 0.161 0.219 0.76
cop IRX6 16q12.2 0.161 0.219 0.76
xsq ROPN1L 5p15.2 0.161 0.219 0.76 ciliary or flagellar
exp TBC1D5 3p24.3 0.161 0.219 0.76
cop STON1-GTF2A1L 2p16.3 0.161 0.219 0.76 transcription initiation from
RNA polymerase II promoter;intracellular protein transport
cop CLIP4 2p23.2 0.161 0.219 0.76
exp LOC730974 5p12 0.161 0.219 0.76
xsq PIK3CA 3q26.3 0.161 0.219 0.76 Cell Signaling; Oncogenes; Protein
Kinases
xsq IARS 9q21 0.161 0.219 0.76 gene expression;tRNA aminoacylation for protein
translation
cop EVA1A 2p12 0.161 0.219 0.76
cop MIR548AE2 0.161 0.219 0.76
cop SIAH1 16q12.1 0.161 0.219 0.76 Apoptosis
cop ABCC11 16q12.1 0.161 0.219 0.76 ABC Transporters
cop LONP2 16q12.1 0.161 0.219 0.76 protein targeting to
cop LOC100507577 0.161 0.219 0.76
mut ACTN2 1q42-q43 0.161 0.219 0.76 muscle filament sliding;platelet
activation
dependent"
met CDC14C 7p12.3 0.161 0.219 0.76
cop SKA1 18q21.1 0.161 0.219 0.76 mitosis;regulation of microtubule
xsq MTMR4 17q22-q23 0.161 0.219 0.76 protein dephosphorylation;peptidyl-
cop ERLEC1 2p16.2 0.161 0.219 0.76 ER-associated protein catabolic
process
met KLK10 19q13 0.161 0.219 0.76 proteolysis;cell cycle
mut MYO1D 17q11-q12 0.161 0.219 0.76 negative regulation of phosphatase
activity
met C14orf28 14q21.2 0.161 0.219 0.76
xsq ZCCHC9 5q14.1 0.161 0.219 0.76 negative regulation of phosphatase
activity
mut FANCM 14q21.2 0.161 0.219 0.76 DNA Damage Response (DDR); DDR (FA)
met PPP1R14C 6q24.3-q25.3 0.161 0.219 0.76 regulation of phosphorylation
exp UBE2J1 6q15 0.161 0.219 0.76
xsq RPL13AP3 14q22.3 0.161 0.219 0.76 translation
cop HVCN1 12q24.11 0.161 0.219 0.76 response to zinc ion;proton transport
met FAM47A Xp21.1 0.161 0.219 0.76
xsq C1orf123 1p32.3 0.161 0.219 0.76
exp DTX1 12q24.13 0.161 0.219 0.76 transcription, DNA-
mut C6orf118 6q27 0.161 0.219 0.76
xsq EFCAB6-AS1 0.161 0.219 0.76
exp SMAD4 18q21.1 0.161 0.219 0.76 Apoptosis; Cell Signaling; Tumor
Suppressors
mda SMAD4_transcript_expression 0.161 0.219 0.76
mut NPS 10q26.2 0.161 0.219 0.76
xsq SCAMP5 15q24.2 0.161 0.219 0.76 exocytosis;protein transport
dependent"
met FKBP6 7q11.23 0.161 0.219 0.76 pachytene;protein peptidyl-prolyl
isomerization
mut TIMD4 5q33.3 0.161 0.219 0.76
xsq GNB1L 22q11.2 0.161 0.219 0.76 G-protein coupled receptor signaling
xsq LINC00208 0.161 0.219 0.76
cop HERC2 15q13 0.161 0.219 0.76 protein ubiquitination involved in ubiquitin-
cop C12orf76 12q24.11 0.161 0.219 0.76
exp LOC100506497 -0.161 0.219 0.76
mut PIK3CA 3q26.3 -0.161 0.219 0.76 Cell Signaling; Oncogenes;
Protein Kinases
mut DSPP 4q21.3 -0.161 0.219 0.76 ossification;multicellular
cop CEP350 1q25.2 -0.161 0.219 0.76
met IKZF1 7p12.2 -0.161 0.219 0.76 mesoderm development;positive
exp ANKRD34B 5q14.1 -0.161 0.219 0.76
cop DCAF13 8q22.3 -0.161 0.219 0.76 rRNA processing;protein
ubiquitination
exp CLDN16 3q28 -0.161 0.219 0.76 cellular metal ion
exp LOC100506498 -0.161 0.219 0.76
cop MTBP 8q24.12 -0.161 0.219 0.76 DDR (DNA replication)
met KRTAP5-11 11q13.4 -0.161 0.219 0.76
mut GAB1 4q31.21 -0.161 0.219 0.76 epidermal growth factor receptor
xsq CASZ1 1p36.22 -0.161 0.219 0.76 regulation of transcription, DNA-
dependent"
cop PACRGL 4p15.31 -0.161 0.219 0.76
exp DYNLL1 12q24.23 -0.161 0.219 0.76 Apoptosis
exp TNNI2 11p15.5 -0.161 0.219 0.76 skeletal muscle contraction;muscle
filament sliding
met OXCT2 1p34 -0.161 0.219 0.76 ketone body catabolic process;metabolic
process
met ICOS 2q33 -0.161 0.219 0.76 immune response;T cell costimulation
xsq REEP5 5q22-q23 -0.161 0.219 0.76
xsq ALPL 1p36.12 -0.161 0.219 0.76 biomineral tissue
xsq TSPAN31 12q13.3 -0.161 0.219 0.76 positive regulation of cell
proliferation
xsq SGIP1 1p31.3 -0.161 0.219 0.76 response to dietary excess;positive
xsq ABCC12 16q12.1 -0.161 0.219 0.76 ABC Transporters
cop C8orf69 -0.161 0.219 0.76
met PLCB3 11q13 -0.161 0.219 0.76 lipid catabolic process;intracellular
signal transduction
xsq BBC3 19q13.3-q13.4 -0.161 0.219 0.76 Apoptosis
xsq CYP1A1 15q24.1 -0.161 0.219 0.76 amine metabolic
process;response to iron(III) ion
hs4 PRELP 1q32 -0.162 0.219 0.76 skeletal system development;cell aging
xai KRT8P1 14q21.1 -0.162 0.219 0.76
swa THOP1 19p13.3 -0.162 0.219 0.76 proteolysis
xai ANGPT2 8p23.1 -0.162 0.219 0.76 multicellular organismal
development;response to activity
his SYDE1 19p13.12 -0.162 0.219 0.76 EMT (Mesenchymal)
hs4 ANKUB1 3q25.1 -0.162 0.219 0.76
xai CREBRF 5q35.1 -0.162 0.219 0.76
his LOC101928132 -0.162 0.219 0.76
exp STX19 3q11 -0.162 0.219 0.76 intracellular protein transport;vesicle-
mediated transport
xai PIH1D2 11q23.1 -0.162 0.219 0.76
hs4 ANOS1 -0.162 0.219 0.76 cell adhesion;axon guidance
xai DDAH2 6p21.3 -0.162 0.219 0.76 Apoptosis
xai TNNI2 11p15.5 -0.162 0.219 0.76 skeletal muscle contraction;muscle
filament sliding
swa ACAA1 3p22.2 -0.162 0.219 0.76 small molecule metabolic
process;fatty acid metabolic process
xai PYGL 14q21-q22 -0.162 0.219 0.76 glycogen metabolic process;glycogen
catabolic process
xai LYST 1q42.1-q42.2 -0.162 0.219 0.76 natural killer cell mediated
xai KCNJ10 1q23.2 -0.162 0.219 0.76 response to blue
xai NUTM1 15q14 -0.162 0.219 0.76
swa RPL23 17q -0.162 0.219 0.76 nuclear-transcribed mRNA catabolic
xai EMC10 19q13.33 -0.162 0.219 0.76
swa SLC25A1 22q11.21 -0.162 0.219 0.76 Solute Carriers
xai GATAD1 7q21-q22 -0.162 0.219 0.76
xai EBF1 5q34 -0.162 0.219 0.76 multicellular organismal
xai CRK 17p13.3 -0.162 0.219 0.76 regulation of actin cytoskeleton
xai SAMD4B 19q13.2 -0.162 0.219 0.76
hs4 PTPN1 20q13.1-q13.2 -0.162 0.219 0.76 regulation of
exp PIWIL2 8p21.3 -0.162 0.219 0.76 multicellular organismal
xai NID1 1q43 -0.162 0.219 0.76 cell adhesion;cell-matrix adhesion
exp ZNF561-AS1 -0.163 0.219 0.76
hs4 MIR4648 -0.163 0.219 0.76
xai NR1H2 19q13.3 -0.163 0.219 0.76 positive regulation of lipid
storage;positive regulation of fatty acid biosynthetic process
cop MIR101-2 -0.163 0.219 0.76
hs4 IFIH1 2q24 -0.163 0.219 0.76 positive regulation of interferon-alpha
swa NOL9 1p36.31 0.162 0.22 0.76 maturation of 5.8S rRNA
his COL6A4P1 3p25.1 0.162 0.22 0.76
his CAPN7 3p24 0.162 0.22 0.76 proteolysis
hs4 TMEM247 2p21 0.162 0.22 0.76
his MIR6882 0.162 0.22 0.76
his ULK3 15q24.1 0.162 0.22 0.76 autophagy;negative regulation of
dependent"
his SNX22 15q22.31 0.162 0.22 0.76 cell communication;protein transport
hs4 IRX4 5p15.3 0.162 0.22 0.76 heart development;establishment of organ
orientation
hs4 AGPAT2 9q34.3 0.162 0.22 0.76 positive regulation of cytokine
cop KBTBD13 15q22.31 0.162 0.22 0.76
xai NPTX1 17q25.3 0.162 0.22 0.76 axonogenesis involved in
exp KRTAP19-8 0.162 0.22 0.76
xai FRAT2 10q24.1 0.162 0.22 0.76 Apoptosis
xai PCID2 13q34 0.162 0.22 0.761 positive regulation of mitotic cell cycle
activity
exp TMEM202 15q24.1 0.162 0.22 0.761
xai C1orf112 1q24.2 0.162 0.22 0.761
his RAB39A 11q22.3 0.162 0.22 0.761 small GTPase mediated signal
his SAP30 4q34.1 0.162 0.22 0.761 negative regulation of transcription from
xai RPL18 19q13 0.162 0.22 0.761 viral reproduction;nuclear-transcribed mRNA
hs4 CIT 12q24 0.162 0.22 0.761
xai EIF2B5 3q27.1 0.162 0.22 0.761 response to glucose
swa SRSF11 1p31 0.162 0.22 0.761 RNA splicing;gene expression
xai ECEL1P3 2q37.1 0.162 0.22 0.761
xai PRPF38AP1 10p14 0.162 0.22 0.761
his SUMO1P1 20q13.2 0.162 0.22 0.761
his GATAD2A 19p13.11 0.162 0.22 0.761 anterior neuropore closure;negative
hs4 SDCCAG3 9q34.3 0.162 0.22 0.761
hs4 PMPCA 9q34.3 0.162 0.22 0.761 proteolysis
hs4 HDGFRP2 19p13.3 0.162 0.22 0.761
hs4 ISG20L2 1q23.1 0.162 0.22 0.761 ribosome biogenesis
hs4 RRNAD1 1q23.1 0.162 0.22 0.761
met EEF1A1P9 4q24 0.162 0.22 0.761
cop HDGFRP2 19p13.3 0.162 0.22 0.761
dependent"
his RPL23AP53 8p23.3 0.162 0.22 0.761
exp LOC574538 0.162 0.22 0.761
his RIDA 0.162 0.22 0.761
his POP1 8q22.1 0.162 0.22 0.761 tRNA 5'-leader removal;RNA processing
his NDUFA2 5q31.2 0.162 0.22 0.761 respiratory electron transport
his IK 5q31.3 0.162 0.22 0.761 immune response;cell-cell signaling
his MIR3655 0.162 0.22 0.761
swa RAB5A 3p24-p22 0.162 0.22 0.761 nervous system development;blood
coagulation
xai SLC22A20 11q13.1 0.162 0.22 0.761 ion transport
his PSME3 17q21 0.162 0.22 0.761 M/G1 transition of mitotic cell cycle;positive
his LINC00544 0.162 0.22 0.761
met CHTOP 1q21.3 0.161 0.22 0.76 regulation of transcription, DNA-
dependent"
xsq RCHY1 4q21.1 0.161 0.22 0.76 protein autoubiquitination;protein
ubiquitination
xsq C1QB 1p36.12 0.161 0.22 0.76 complement activation;complement
activation, classical pathway
met UPP2 2q24.1 0.161 0.22 0.76
xsq TPRKB 2p24.3-p24.1 0.161 0.22 0.76 protein catabolic process
xsq DDX20 1p21.1-p13.2 0.161 0.22 0.76 negative regulation of
exp CYP2D6 22q13.1 0.161 0.22 0.76 alkaloid catabolic
xsq BZW1 2q33 0.161 0.22 0.76 regulation of transcription, DNA-dependent;RNA
metabolic process"
xsq MSS51 10q22.2 0.161 0.22 0.76 social behavior
mut GPRC6A 6q22.1 0.161 0.22 0.76
xsq BTBD11 12q23.3 0.161 0.22 0.76
met ARMCX2 Xq21.33-q22.2 0.161 0.22 0.76
xsq BRIP1 17q22.2 0.161 0.22 0.76 DNA Damage Response (DDR); DDR (FA)
met CDH8 16q22.1 0.161 0.22 0.76 cell adhesion;homophilic cell adhesion
xsq DIP2A 21q22.3 0.161 0.22 0.761 multicellular organismal development
dependent"
exp MSL3P1 2q37.1 0.161 0.22 0.761 regulation of transcription, DNA-
xsq RPRD1B 20q11.21-q12 0.161 0.22 0.761 dephosphorylation of RNA
exp LOC400099 13q12.11 0.161 0.22 0.761
exp PPIAP29 6p22.3 0.161 0.22 0.761
cop PHKB 16q12-q13 0.161 0.22 0.761 generation of precursor metabolites and
energy;small molecule metabolic process
met PNMA2 8p21.2 0.161 0.22 0.761 apoptotic process
cop PITPNM2 12q24.31 0.161 0.22 0.761 transport;metabolic process
exp FAM72A 1q32.1 0.161 0.22 0.761
xsq LACE1 6q22.1 0.161 0.22 0.761
cop MAPK4 18q21.1 0.161 0.22 0.761 Protein Kinases
xsq OR10A7 0.161 0.22 0.761
xsq NLRP2 19q13.42 0.161 0.22 0.761 positive regulation of cysteine-type
interleukin-1 beta secretion
met RGS22 8q22.2 0.161 0.22 0.761 negative regulation of signal
met LDOC1 Xq27 0.161 0.22 0.761 negative regulation of cell proliferation
cop ANKRD28 3p25.1 0.161 0.22 0.761 DNA Damage Response (DDR)
cop PANK2 20p13 0.161 0.22 0.761 coenzyme A biosynthetic process;pantothenate
metabolic process
cop MIR103A2 0.161 0.22 0.761
cop MIR103B2 0.161 0.22 0.761
cop TNFRSF17 16p13.1 0.161 0.22 0.761 multicellular organismal
xsq AKAP3 12p13.3 0.161 0.22 0.761 cellular component movement;transmembrane
exp ATP5H 17q25 0.161 0.22 0.761 ATP catabolic process;ion transport
exp EARS2 16p12.2 0.161 0.22 0.761 glutamyl-tRNA aminoacylation;gene
expression
xsq BRIX1 5p13.2 0.161 0.22 0.761 ribosome biogenesis
exp CERS6 2q24.3 0.161 0.22 0.761 sphingolipid metabolic process;lipid
exp PA2G4P5 6q21 0.161 0.22 0.761
xsq GADD45GIP1 19p13.2 0.161 0.22 0.761 cell cycle;interspecies interaction
between organisms
xsq KRT75 12q13 0.161 0.22 0.761
exp TMEM86B 19q13.42 0.161 0.22 0.761 ether lipid metabolic process
xsq CLEC12B 0.161 0.22 0.761
exp RPS6P13 9q21.33 0.161 0.22 0.761
mut DZIP1 13q32.1 0.161 0.22 0.761 multicellular organismal development;germ
cell development
xsq CCDC117 22q12.1 0.161 0.22 0.761
xsq RALGAPA2 20p11.22 0.161 0.22 0.761 activation of Ral GTPase
xsq TWISTNB 7p21.1 0.161 0.22 0.761
xsq NDUFAF1 15q11.2-q21.3 0.161 0.22 0.761 mitochondrial electron
met C4orf22 4q21.21 0.161 0.22 0.761
dependent"
mut SLK 10q24.33 0.161 0.22 0.761 Apoptosis
xsq SIGIRR 11p15.5 0.161 0.22 0.761 innate immune response;negative
regulation of cytokine-mediated signaling pathway
xsq ARMC2-AS1 -0.161 0.22 0.761
exp CSNK1A1 5q32 -0.161 0.22 0.761 cell division;protein
phosphorylation
cop INTS8 8q22.1 -0.161 0.22 0.761 snRNA processing
cop CCNE2 8q22.1 -0.161 0.22 0.761 DDR (DNA replication); Oncogenes
met PSMB7 9q34.11-q34.12 -0.161 0.22 0.761 M/G1 transition of mitotic
cell cycle;viral reproduction
met SAXO2 -0.161 0.22 0.761
met PKD1L2 16q23.2 -0.161 0.22 0.761 ion transport;neuropeptide
signaling pathway
met GMCL1 2p13.3 -0.161 0.22 0.761 regulation of transcription, DNA-
exp S100A2 1q21 -0.161 0.22 0.761 endothelial cell migration
xsq THCAT158 -0.161 0.22 0.761
exp BTBD10 11p15.2 -0.161 0.22 0.761
xsq ARHGEF5 7q35 -0.161 0.22 0.761 regulation of Rho protein signal
exp NCKAP5 2q21.2 -0.161 0.22 0.761
met NFATC1 18q23 -0.161 0.22 0.761 transcription from RNA polymerase
met RGPD2 2p11.2 -0.161 0.22 0.761
met ZNF581 19q13.42 -0.161 0.22 0.761 regulation of transcription,
DNA-dependent"
exp FAM131A 3q27.1 -0.161 0.22 0.76
cop ADAM32 8p11.22 -0.161 0.22 0.76 proteolysis
exp HUS1 7p13-p12 -0.161 0.22 0.76 DNA Damage Response (DDR); DDR
(BER)
xsq LOC101928371 -0.161 0.22 0.76
xsq HKDC1 10q22.1 -0.161 0.22 0.76 carbohydrate metabolic
process;glycolysis
DNA-dependent"
xsq CCDC153 11q23.3 -0.161 0.22 0.76
cop DHX9 1q25 -0.161 0.22 0.76 nuclear mRNA splicing, via
cop SHCBP1L 1q25.3 -0.161 0.22 0.76
xsq B3GLCT -0.161 0.22 0.76 carbohydrate metabolic
exp TRIM22 11p15 -0.161 0.22 0.76 immune response;response to virus
mut ASPM 1q31 -0.161 0.22 0.76 cell cycle;mitosis
exp SYDE2 1p22.3 -0.161 0.22 0.76 activation of Rho GTPase
xsq EFCAB14 1p33 -0.161 0.22 0.76
xsq SCML4 6q21 -0.161 0.22 0.76 regulation of transcription, DNA-
dependent"
xsq MAFIP -0.161 0.22 0.76 microtubule cytoskeleton
met CCDC53 12q23.2 -0.161 0.22 0.76
xai PLEKHA6 1q32.1 -0.162 0.22 0.761
his RAB32 6q24.3 -0.162 0.22 0.761 small GTPase mediated signal
xai PEG10 7q21 -0.162 0.22 0.761 apoptotic process;cell differentiation
xai GULP1 2q32.3-q33 -0.162 0.22 0.761 Apoptosis
hs4 SCNN1A 12p13 -0.162 0.22 0.761 ion transport;sodium ion transport
xai SYTL4 Xq21.33 -0.162 0.22 0.761 positive regulation of
xai NKX1-2 10q26.13 -0.162 0.22 0.761 multicellular organismal
development
his MIR4497 -0.162 0.22 0.761
his TRPV4 12q24.1 -0.162 0.22 0.761 ion transport;cell death
xai LOC100996345 -0.162 0.22 0.761
xai HNF1B 17q12 -0.162 0.22 0.761 regulation of Wnt receptor signaling
xai LTBP3 11q13.1 -0.162 0.22 0.761 transforming growth factor beta
xai DAP 5p15.2 -0.162 0.22 0.761 Apoptosis
his ROS1 6q22 -0.162 0.22 0.761 spermatogenesis;cell proliferation
his PRR32 -0.162 0.22 0.761
his PRTG 15q21.3 -0.162 0.22 0.761 multicellular organismal
development
hs4 PRTG 15q21.3 -0.162 0.22 0.761 multicellular organismal
development
his MIR3197 -0.162 0.22 0.761
his BACE2 21q22.3 -0.162 0.22 0.761 proteolysis;membrane protein
hs4 FBLL1 5q34 -0.162 0.22 0.761 rRNA processing;tRNA processing
xai CYP51A1 7q21.2 -0.162 0.22 0.761 cholesterol biosynthetic
xai GUCY1A2 11q21-q22 -0.162 0.22 0.761 intracellular signal
hs4 C1orf21 1q25 -0.162 0.22 0.761
xai GCNT6 6p24.2 -0.162 0.22 0.761
xai WBP2 17q25 -0.162 0.22 0.761
his TTC9B 19q13.2 -0.162 0.22 0.761
exp MIR210HG -0.162 0.22 0.761
exp RPL7L1P12 -0.162 0.22 0.76
his MIR584 -0.162 0.22 0.76
his SH3TC2 5q32 -0.162 0.22 0.76
his LOC255187 -0.162 0.22 0.76
cop C14orf142 14q32.12 0.162 0.221 0.761
exp NPM1P37 0.162 0.221 0.761
swa ATP5B 12q13.13 0.162 0.221 0.761 ADP biosynthetic process;ATP hydrolysis
xai KRTAP19-8 0.162 0.221 0.761
exp LOC100272217 0.162 0.221 0.761
xai LINC00623 1q21.1 0.162 0.221 0.761
xai MESP2 15q26.1 0.162 0.221 0.761 mesodermal cell migration;signal
swa ISCU 12q24.1 0.162 0.221 0.761 nitrogen fixation;iron-sulfur cluster
assembly
exp EIF3IP1 0.162 0.221 0.761
his SERF1B 5q13.2 0.162 0.221 0.761 nervous system development
xai HERC2 15q13 0.162 0.221 0.761 protein ubiquitination involved in ubiquitin-
his LOC101927746 0.162 0.221 0.761
xai TMEM81 1q32.1 0.162 0.221 0.761
exp FSTL4 5q31.1 0.162 0.221 0.761
hs4 PPCDC 15q24.2 0.162 0.221 0.762 coenzyme A biosynthetic
his CHTOP 1q21.3 0.162 0.221 0.762 regulation of transcription, DNA-
dependent"
his S100A13 1q21 0.162 0.221 0.762 positive regulation of I-kappaB
kinase/NF-kappaB cascade;mast cell degranulation
xai METTL14 4q26 0.162 0.221 0.762 RNA methylation;nucleobase-containing
exp HMGN2P11 0.162 0.221 0.762
hs4 MANEAL 1p34.3 0.162 0.221 0.762
cop MIR4526 0.162 0.221 0.762
xai NOL6 9p13.3 0.162 0.221 0.762 rRNA processing
his SGTB 5q12.3 0.162 0.221 0.762
his NLN 5q12.3 0.162 0.221 0.762 proteolysis
xai TIMM10B 11p15.4 0.162 0.221 0.762
dependent"
exp BTF3P7 6p25.1 0.162 0.221 0.762
xai HMGN2P11 0.162 0.221 0.762
his NSRP1 17q11.2 0.162 0.221 0.762 regulation of alternative nuclear mRNA
his MIR423 0.162 0.221 0.762
his MIR3184 0.162 0.221 0.762
his SNRNP70 19q13.3 0.162 0.221 0.762 mRNA processing;RNA splicing
his MIR6855 0.162 0.221 0.762
his LOC100379224 0.162 0.221 0.762
dependent"
his GRID2 4q22 0.162 0.221 0.762 transport;ion transport
xai SRP68 17q25.1 0.162 0.221 0.762 gene expression;response to drug
xai PUS3 11q24.2 0.162 0.221 0.762 tRNA processing;tRNA pseudouridine
synthesis
his IMPA2 18p11.2 0.162 0.221 0.762 signal transduction;phosphatidylinositol
phosphorylation
his CCNE1 19q12 0.162 0.221 0.762 DNA Damage Response (DDR); Oncogenes
xai FAM104A 17q25.1 0.162 0.221 0.762
hs4 FAM222A-AS1 12q24.11 0.162 0.221 0.762
xai DAP3 1q22 0.162 0.221 0.762 Apoptosis
his STYK1 12p13.2 0.162 0.221 0.762
his XPO7 8p21 0.162 0.221 0.762 intracellular protein transport;mRNA transport
xai OR6C69P 12q13.2 0.162 0.221 0.762
xai SEC63 6q21 0.162 0.221 0.762 protein folding;protein targeting to membrane
exp FAM207A 21q22.3 0.162 0.221 0.762
his ZNF37A 10p11.2 0.162 0.221 0.762 regulation of transcription, DNA-
dependent"
his LOC101928283 0.162 0.221 0.762
met HAR1A 20q13.33 0.161 0.221 0.761
mut KDM4A 1p34.1 0.161 0.221 0.761 chromatin modification;histone
demethylation
xsq HYPK 15q15.3 0.161 0.221 0.761
xsq MCM3AP 21q22.3 0.161 0.221 0.761 DNA replication;protein import into
nucleus
xsq PCBP2-OT1 0.161 0.221 0.761
met ETNK2 1q32.1 0.16 0.221 0.761 phosphatidylethanolamine biosynthetic
xsq SF3B6 0.16 0.221 0.761
met TP73 1p36.3 0.16 0.221 0.761 Apoptosis; DNA Damage Response (DDR); DDR
(G2-M checkpoint)
xsq RPL22 1p36.31 0.16 0.221 0.761 translational elongation;viral
transcription
xsq GOLGA8T 0.16 0.221 0.761
met FRAS1 4q21.21 0.16 0.221 0.761 cell communication
cop PPP1CC 12q24.1-q24.2 0.16 0.221 0.761 carbohydrate metabolic
xsq MAGEA5 Xq28 0.16 0.221 0.761
cop TLDC1 16q24.1 0.16 0.221 0.761
exp RPSAP45 6q21 0.16 0.221 0.761
dependent"
exp NUDT16L1 16p13.3 0.16 0.221 0.762
xsq SPG21 15q21-q22 0.16 0.221 0.762 cell death;antigen receptor-mediated
signaling pathway
xsq LINC01061 0.16 0.221 0.762
met LINC00264 10p12.1 0.16 0.221 0.762
xsq LMBR1L 12q13.12 0.16 0.221 0.762 endocytosis
mut DMKN 19q13.12 0.16 0.221 0.762
exp AGMAT 1p36.21 0.16 0.221 0.762 polyamine metabolic process;spermidine
xsq TXNL1 18q21.31 0.16 0.221 0.762 Apoptosis
exp LOC100128909 0.16 0.221 0.762
exp TACO1 17q23.3 0.16 0.221 0.762 regulation of translation
exp GOLGA8S 0.16 0.221 0.762
cop VPS35 16q12 0.16 0.221 0.762 cell death;protein transport
xsq HNRNPA1P10 19p13.2 0.16 0.221 0.762
xsq DGAT1 8q24.3 0.16 0.221 0.762 triglyceride metabolic
xsq SMG6 17p13.3 0.16 0.221 0.762 DNA Damage Response (DDR)
xsq KIF26A 14q32.33 0.16 0.221 0.762 regulation of cell growth by
dependent"
met ACOX3 4p15.3 0.16 0.221 0.762 fatty acid metabolic process;fatty acid
met LINC00238 14q23.3 0.16 0.221 0.762
xsq RHOT2 16p13.3 0.16 0.221 0.762 Apoptosis
mut LBR 1q42.1 0.16 0.221 0.762 cholesterol biosynthetic process;small
xsq PDS5B 13q12.3 0.16 0.221 0.762 DNA Damage Response (DDR)
xsq DHX15 4p15.3 0.16 0.221 0.762 mRNA processing;RNA splicing
met COX8C 14q32.12 0.16 0.221 0.762
exp MRPS18B 6p21.3 0.16 0.221 0.762 translation
mut YTHDC2 5q22.2 0.16 0.221 0.762
xsq RPS6KA2-IT1 0.16 0.221 0.762
cop RPGRIP1L 16q12.2 0.16 0.221 0.762 liver development;olfactory bulb
development
met DHFRL1 3q11.1 0.16 0.221 0.762 nucleotide biosynthetic
xsq NAIP 0.16 0.221 0.762 Apoptosis
xsq CHEK1 11q24.2 0.16 0.221 0.762 DNA Damage Response (DDR); Protein
Kinases
met VSIG4 Xq12-q13.3 0.16 0.221 0.762 complement activation, alternative
xsq GPR119 Xq26.1 0.16 0.221 0.762 insulin secretion
xsq HORMAD2-AS1 0.16 0.221 0.762
cop MIR4317 0.16 0.221 0.762
xsq LRRC26 9q34.3 0.16 0.221 0.762 ion transport
mut SENP8 15q23 -0.16 0.221 0.762 proteolysis
exp GPR158 10p12.1 -0.16 0.221 0.762
xsq CST1 20p11.21 -0.16 0.221 0.762
met HS3ST3B1 17p12 -0.16 0.221 0.762 heparan sulfate proteoglycan biosynthetic
process;heparan sulfate proteoglycan biosynthetic process, enzymatic modification"
dependent"
cop ASPH 8q12.1 -0.16 0.221 0.762 peptidyl-amino acid modification;limb
morphogenesis
exp MARCH2 19p13.2 -0.16 0.221 0.762 endocytosis;protein ubiquitination
exp PTGER3 1p31.2 -0.16 0.221 0.762 intracellular receptor mediated
signaling pathway;positive regulation of fever generation
exp WHAMM 15q25.2 -0.16 0.221 0.762
cop PPARGC1A 4p15.1 -0.16 0.221 0.762 mRNA processing;respiratory
met PROKR1 2p13.1 -0.16 0.221 0.762 anti-apoptosis
exp LINC00313 21q22.3 -0.16 0.221 0.762
xsq ERMP1 9p24 -0.16 0.221 0.762 ovarian follicle development;proteolysis
met LCP2 5q35.1 -0.16 0.221 0.762 immune response;transmembrane receptor
met KRT79 12q13.13 -0.16 0.221 0.762
xsq CTB-7E3.1 -0.16 0.221 0.762
exp HNF1B 17q12 -0.16 0.221 0.761 regulation of Wnt receptor signaling
pro CDKN2A 9p21 -0.16 0.221 0.761 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication); Protein Kinases; Tumor Suppressors
exp ETV7 6p21 -0.16 0.221 0.761 Transcription Factors
exp PYGL 14q21-q22 -0.16 0.221 0.761 glycogen metabolic process;glycogen
catabolic process
xsq LOC400043 12q13.13 -0.16 0.221 0.761
cop LOC100128885 7q11.21 -0.16 0.221 0.761
xsq SNORA70G -0.161 0.221 0.761
cop CD274 9p24 -0.161 0.221 0.761 immune response;signal transduction
cop PDCD1LG2 9p24.2 -0.161 0.221 0.761 immune response;T cell
costimulation
cop KIAA1432 -0.161 0.221 0.761
cop ERMP1 9p24 -0.161 0.221 0.761 ovarian follicle development;proteolysis
met ELANE 19p13.3 -0.161 0.221 0.761 cellular calcium ion
his TXNRD3 -0.162 0.221 0.762
DNA-dependent"
his SNORD103A -0.162 0.221 0.762
his KCP 7q32.1 -0.162 0.221 0.762
hs4 C10orf142 -0.162 0.221 0.762
hs4 MAGI2-AS3 -0.162 0.221 0.762
hs4 MAGI2 7q21 -0.162 0.221 0.762 protein heterooligomerization;positive
regulation of receptor internalization
his POU6F2-AS1 -0.162 0.221 0.762
xai GPRC5A 12p13-p12.3 -0.162 0.221 0.762 G-protein coupled receptor
xai DPYSL3 5q32 -0.162 0.221 0.762 axon guidance;actin crosslink
formation
his PELI1 2p13.3 -0.162 0.221 0.762 MyD88-dependent toll-like receptor
xai ATP6V0A1 17q21 -0.162 0.221 0.762 transferrin transport;transmembrane
transport
xai NKIRAS1 3p24.2 -0.162 0.221 0.762 GTP catabolic process;signal
transduction
DNA-dependent"
swa SUMF2 7q11.1 -0.162 0.221 0.762
his FHAD1 1p36.21 -0.162 0.221 0.762
hs4 KIF12 9q32 -0.162 0.221 0.762 microtubule-based movement
hs4 C4orf22 4q21.21 -0.162 0.221 0.762
xai LRP10 14q11.2 -0.162 0.221 0.762 lipid metabolic process;lipid
transport
his LOC100132146 3p21.31 -0.162 0.221 0.762
swa TSPAN13 7p21.1 -0.162 0.221 0.761
swa LNPEP 5q15 -0.162 0.221 0.761 antigen processing and presentation of
exp LOC100996345 -0.162 0.221 0.761
xai COL11A1 1p21 -0.162 0.221 0.761 ossification;collagen fibril
organization
xai CD81 11p15.5 -0.162 0.221 0.761 phosphatidylinositol biosynthetic
xai RPL7L1P12 -0.162 0.221 0.761
hs4 ATXN7L1 7q22.3 -0.162 0.221 0.761
hs4 PCDHB6 5q31 -0.162 0.221 0.761 synapse assembly;calcium-dependent
cell-cell adhesion
his LPIN3 20q12 -0.162 0.221 0.761 dephosphorylation;lipid metabolic process
hs4 ILF2 1q21.3 0.162 0.222 0.762 positive regulation of transcription,
xai VDAC2 10q22 0.162 0.222 0.762 Apoptosis
hs4 ICAM2 17q23.3 0.162 0.222 0.762 cell-cell adhesion;regulation of immune
response
his BHLHA15 7q21.3 0.162 0.222 0.762 Golgi organization;G-protein
xai RPL7P29 6q14.3 0.162 0.222 0.762
hs4 CNDP2 18q22.3 0.162 0.222 0.762 glutathione biosynthetic
his SIRT3 11p15.5 0.162 0.222 0.762 protein ADP-ribosylation;protein
deacetylation
his PSMD13 11p15.5 0.162 0.222 0.762 antigen processing and presentation
his SDC1 2p24.1 0.162 0.222 0.762 wound healing;response to calcium ion
xai PPP1R11P2 Xp11.21 0.162 0.222 0.762
his GLYR1 16p13.3 0.162 0.222 0.762 pentose-phosphate shunt
his UBN1 16p13.3 0.162 0.222 0.762 negative regulation of phosphatase
dependent"
xai CHPT1 12q 0.162 0.222 0.762 regulation of cell growth;lipid metabolic
process
xai HMGN2 1p36.1 0.161 0.222 0.762 chromatin organization;regulation of
his EPHA1-AS1 0.161 0.222 0.762
his EPHA1 7q34 0.161 0.222 0.762 EMT (Epithelial)
his MIR3671 0.161 0.222 0.762
his MIR101-1 0.161 0.222 0.762
dependent"
xai ABRACL 6q24.1 0.161 0.222 0.762
his POLL 10q23 0.161 0.222 0.762 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
his DPCD 10q24.32 0.161 0.222 0.762
hs4 HN1 17q25.1 0.161 0.222 0.762
swa HPDL 1p34.1 0.161 0.222 0.762 aromatic amino acid family metabolic
process
xai LAT2 7q11.23 0.161 0.222 0.762 intracellular signal transduction;B cell
activation
his HSD17B7P2 10p11.1 0.161 0.222 0.762
his FYCO1 3p21.31 0.161 0.222 0.762 transport;plus-end-directed vesicle
cop TNFAIP8L1 19p13.3 0.161 0.222 0.762
hs4 DNMT1 19p13.2 0.161 0.222 0.762 DNA Damage Response (DDR)
xai SNRPGP14 0.161 0.222 0.762
his ANKRD11 16q24.3 0.161 0.222 0.762 in utero embryonic
xai ANAPC16 10q22.1 0.161 0.222 0.762 cell cycle;mitosis
his LOC102546294 0.161 0.222 0.762
his FBXO38 5q32 0.161 0.222 0.762
his LPL 8p22 0.161 0.222 0.762 fatty acid biosynthetic process;triglyceride
catabolic process
hs4 HMGA1 6p21 0.161 0.222 0.762 protein complex assembly;interspecies
hs4 MIR6835 0.161 0.222 0.762
xai MGME1 20p11.23 0.161 0.222 0.762
swa RPS19 19q13.2 0.161 0.222 0.762 translation;viral reproduction
xai LINC00843 0.161 0.222 0.762
his ITSN2 2p23.3 0.161 0.222 0.762 endocytosis;regulation of Rho protein
signal transduction
exp SNRPGP14 0.161 0.222 0.762
his SNORD126 14q11.2 0.161 0.222 0.762
hs4 DDX28 16q22.1 0.161 0.222 0.762
hs4 DUS2 0.161 0.222 0.762 tRNA processing
his RPL5 1p22.1 0.161 0.222 0.762 translational termination;ribosomal large
subunit biogenesis
his SNORD21 1p22.1 0.161 0.222 0.762
exp PPP1R11P2 Xp11.21 0.161 0.222 0.763
his CEP83 0.161 0.222 0.763
his CEP83-AS1 0.161 0.222 0.763
exp PKD1L3 16q22.2 0.161 0.222 0.763 detection of chemical stimulus
hs4 STX10 19p13.2 0.161 0.222 0.763 intracellular protein
hs4 IER2 19p13.2 0.161 0.222 0.763
exp OR9H1P 1q44 0.161 0.222 0.763
his RAB1B 11q12 0.161 0.222 0.763 small GTPase mediated signal
his NPAS1 19q13.2-q13.3 0.161 0.222 0.763 negative regulation of
dependent
xai RXFP2 13q13.1 0.161 0.222 0.763 inhibition of adenylate cyclase activity
by G-protein signaling pathway;negative regulation of cell proliferation
his LOC100132249 9q13 0.161 0.222 0.763
his PTGER4P2-CDK2AP2P2 0.161 0.222 0.763
his LOC101928725 0.161 0.222 0.763
his FAM63B 15q21.3 0.161 0.222 0.763
xai AKIRIN1 1p34.3 0.161 0.222 0.763
exp HEIH 0.16 0.222 0.762
dependent"
cop MIR4497 0.16 0.222 0.762
exp PTGS2 1q25.2-q25.3 0.16 0.222 0.762 prostaglandin metabolic
exp ATAD1 10q23.31 0.16 0.222 0.762 positive regulation of receptor
exp NCAPH2 22q13.33 0.16 0.222 0.762 DNA Damage Response (DDR)
xsq OR10J3 1q23.2 0.16 0.222 0.762 response to stimulus
xsq NUBP2 16p13.3 0.16 0.222 0.762
xsq C15orf32 15q26.1 0.16 0.222 0.762
cop KARS 16q23.1 0.16 0.222 0.762 tRNA aminoacylation for protein
xsq SLC22A25 11q12.3 0.16 0.222 0.762 transmembrane transport
xsq C3orf17 3q13.2 0.16 0.222 0.762
met PRDM2 1p36.21 0.16 0.222 0.762 regulation of transcription, DNA-
dependent;response to estradiol stimulus"
xsq PTTG2 4p12 0.16 0.222 0.762
met VEGFB 11q13 0.16 0.222 0.762 positive regulation of vascular endothelial
growth factor receptor signaling pathway;positive regulation of cell division
mut SUOX 12q13.2 0.16 0.222 0.762 sulfide oxidation, using sulfide:quinone
oxidoreductase;sulfur amino acid metabolic process
met GIMAP7 7q36.1 0.16 0.222 0.762
exp IARS 9q21 0.16 0.222 0.762 gene expression;tRNA aminoacylation for protein
translation
met OXGR1 13q32.1 0.16 0.222 0.762 G-protein coupled receptor signaling
pathway
exp ANKRD20A1 0.16 0.222 0.762
xsq SF3A2 19p13.3 0.16 0.222 0.762 mRNA processing;RNA splicing
xsq RPL37A 2q35 0.16 0.222 0.762 gene expression;viral reproduction
exp PMPCB 7q22.1 0.16 0.222 0.762 proteolysis
met DENND2C 1p13.2 0.16 0.222 0.762
cop STARD6 18q21.2 0.16 0.222 0.762 transport;lipid transport
cop C18orf54 18q21.2 0.16 0.222 0.762
mut SEZ6L 22q12.1 0.16 0.222 0.762
met FAM47C Xp21.1 0.16 0.222 0.762
xsq SKIV2L2 5q11.2 0.16 0.222 0.762 nuclear mRNA splicing, via
xsq PCDH11Y Yp11.2 0.16 0.222 0.762 cell adhesion;homophilic cell
adhesion
exp ATP5SL 19q13.2 0.16 0.222 0.762
exp YTHDF2P1 14q21.1 0.16 0.222 0.762
dependent"
xsq POLG 15q25 0.16 0.222 0.762 DNA Damage Response (DDR)
xsq FER1L6-AS1 0.16 0.222 0.762
exp TBX5 12q24.1 0.16 0.222 0.763 ventricular septum development;lung
development
met NRIP2 12p13.33 0.16 0.222 0.763
exp CFD 19p13.3 0.16 0.222 0.763 innate immune response;platelet
degranulation
exp LOC155060 7q36.1 0.16 0.222 0.763
met SFXN5 2p13 0.16 0.222 0.763 iron ion homeostasis;transmembrane transport
cop ANKRD13A 12q24.11 0.16 0.222 0.763
exp IDE 10q23-q25 0.16 0.222 0.763 proteolysis;protein homotetramerization
xsq IDH3G Xq28 0.16 0.222 0.763 2-oxoglutarate metabolic process;NADH metabolic
process
xsq PLCG1-AS1 0.16 0.222 0.763
met PPP2R5B 11q12 0.16 0.222 0.763 activation of signaling protein activity
involved in unfolded protein response;positive regulation of sequence-specific DNA
binding transcription factor activity
xsq LOC101928597 0.16 0.222 0.763
mut SECISBP2L 15q21.1 0.16 0.222 0.763
mir hsa-miR-139-3p 0.16 0.222 0.763
met LINC01011 0.16 0.222 0.763
exp ZKSCAN8 6p21.3 0.16 0.222 0.763
met MIR1185-2 0.16 0.222 0.763
exp LPCAT4 15q14 0.16 0.222 0.763 metabolic process;phospholipid
xsq TUBGCP4 15q15 0.16 0.222 0.763 G2/M transition of mitotic cell
cop SLC6A2 16q12.2 0.16 0.222 0.763 synaptic transmission;monoamine
transport
xsq AGTR2 Xq22-q23 0.16 0.222 0.763 brain renin-angiotensin system;behavior
xsq LOC285740 6q24.2 0.16 0.222 0.763
xsq KCTD19 16q22.1 0.16 0.222 0.763 potassium ion transport
xsq MT1H -0.16 0.222 0.763 cellular zinc ion homeostasis;nitric oxide
met IL13 5q31 -0.16 0.222 0.763
xsq KCTD4 13q14.12 -0.16 0.222 0.763 potassium ion transport
xsq PVRL3-AS1 -0.16 0.222 0.763
xsq SPDYE5 7q11.23 -0.16 0.222 0.763
xsq JAK1 1p32.3-p31.3 -0.16 0.222 0.763 Oncogenes
cop IL7R 5p13 -0.16 0.222 0.763 Oncogenes
cop CAPSL 5p13.2 -0.16 0.222 0.763
cop UGT3A1 5p13.2 -0.16 0.222 0.763 metabolic process
cop UGT3A2 5p13.2 -0.16 0.222 0.763 metabolic process
exp TMEM173 5q31.2 -0.16 0.222 0.763 apoptotic process;cellular response
to exogenous dsRNA
mda TMEM173_transcript_expression -0.16 0.222 0.763
xsq HOXA2 7p15.2 -0.16 0.222 0.763 anterior/posterior pattern
exp ZNF542P -0.16 0.222 0.763 regulation of transcription, DNA-
dependent"
xsq AAK1 2p14 -0.16 0.222 0.763 regulation of clathrin-mediated
xsq HMCN1 1q25.3-q31.1 -0.16 0.222 0.763 visual perception;response to
stimulus
mut MCM3AP 21q22.3 -0.16 0.222 0.762 DNA replication;protein import into
nucleus
xsq MYADML2 17q25.3 -0.16 0.222 0.762
xsq SULT1C3 2q12.3 -0.16 0.222 0.762
exp LOC100507311 -0.16 0.222 0.762
cop MLANA 9p24.1 -0.16 0.222 0.762
cop KIAA2026 9p24.1 -0.16 0.222 0.762
cop MIR4665 -0.16 0.222 0.762
cop RANBP6 9p24.1 -0.16 0.222 0.762 protein transport
cop IL33 9p24.1 -0.16 0.222 0.762 negative regulation of T-helper 1 type
immune response;positive regulation of macrophage activation
xsq MAPK10 4q22.1-q23 -0.16 0.222 0.762 Protein Kinases
mut FAM208B 10p15.1 -0.16 0.222 0.762
mut LRRC16B 14q11.2 -0.16 0.222 0.762
xsq GABRP 5q35.1 -0.16 0.222 0.762 ion transport
exp RPL22P2 14q24.3 -0.16 0.222 0.762
xsq FNBP1L 1p22.1 -0.16 0.222 0.762 endocytosis
cop C8orf37 8q22.1 -0.16 0.222 0.762
dependent"
xsq BHLHE41 12p12.1 -0.16 0.222 0.762 cell differentiation;negative
his FGF1 5q31 -0.161 0.222 0.763 positive regulation of protein
his MIR3194 -0.161 0.222 0.763
hs4 ACSM3 16p13.11 -0.161 0.222 0.763 lipid metabolic process;fatty acid
xai ATP2B2 3p25.3 -0.161 0.222 0.763 cell morphogenesis;brain
development
exp NWD2 -0.161 0.222 0.763
his LOC554206 16p12.1 -0.161 0.222 0.763
his CLMP 11q24.1 -0.161 0.222 0.763
his XDH 2p23.1 -0.161 0.222 0.762 small molecule metabolic
xai TGM2 20q12 -0.161 0.222 0.762 metabolic process;protein
homooligomerization
hs4 COL16A1 1p35-p34 -0.161 0.222 0.762 cell adhesion;integrin-
his FOXK1 7p22.1 -0.161 0.222 0.762 negative regulation of
promoter
xai ANKRD50 4q28.1 -0.161 0.222 0.762
hs4 THRB 3p24.2 -0.161 0.222 0.762 regulation of transcription, DNA-
hs4 THRB-AS1 3p24.2 -0.161 0.222 0.762
hs4 PDE4DIP 1q12 -0.161 0.222 0.762 cellular protein complex assembly
xai ZSCAN31 6p21.31 -0.161 0.222 0.762
xai NUDT9P1 10q23.32 -0.161 0.222 0.762
xai PODXL 7q32-q33 -0.161 0.222 0.762 cell migration;negative regulation
xai DCN 12q21.33 -0.161 0.222 0.762 peptide cross-linking via
his FAM3D-AS1 -0.161 0.222 0.762
hs4 LOC101929464 -0.161 0.222 0.762
hs4 PHC2 1p34.3 -0.161 0.222 0.762 multicellular organismal
hs4 SLC34A3 -0.162 0.222 0.762 sodium ion transport;phosphate ion
transport
exp BARHL1 9q34 -0.162 0.222 0.762 neuron migration;sensory perception
of sound
exp C1orf195 -0.162 0.222 0.762
his COTL1 16q24.1 -0.162 0.222 0.762 defense response to fungus
his CARHSP1 16p13.2 0.161 0.223 0.763 regulation of transcription, DNA-
his TET1 10q21 0.161 0.223 0.763 stem cell maintenance;DNA demethylation
his WDR43 2p23.2 0.161 0.223 0.763
his CALML4 15q23 0.161 0.223 0.763
xai SLITRK1 13q31.1 0.161 0.223 0.763 axonogenesis
exp BRK1P2 0.161 0.223 0.763
exp TBX6 16p11.2 0.161 0.223 0.763 mesoderm development;anatomical structure
morphogenesis
his PDCD10 3q26.1 0.161 0.223 0.763 Apoptosis
his SERPINI1 3q26.1 0.161 0.223 0.763 peripheral nervous system
xai KIF18B 17q21.31 0.161 0.223 0.763 mitotic cell cycle;microtubule-
based movement
exp ANGPT4 20p13 0.161 0.223 0.763 positive regulation of endothelial cell
xai DPPA5P2 0.161 0.223 0.763
his SNAPIN 1q21.3 0.161 0.223 0.763 synaptic vesicle
exocytosis;synaptic vesicle maturation
his ADGRE5 0.161 0.223 0.763 cell adhesion;cell surface receptor
signaling pathway
hs4 ENGASE 17q25.3 0.161 0.223 0.763 metabolic process
hs4 RSAD1 17q21.33 0.161 0.223 0.763 porphyrin-containing compound
his AQP7 9p13 0.161 0.223 0.763 glycerol transport;urea transport
xai VRK2 2p16.1 0.161 0.223 0.763 protein phosphorylation;response to
oxidative stress
hs4 CHAC2 2p16 0.161 0.223 0.763
his MIRLET7D 0.161 0.223 0.763
his ACADM 1p31 0.161 0.223 0.763 carnitine metabolic process, CoA-linked;fatty
xai SARNP 12q13.2 0.161 0.223 0.763 regulation of transcription, DNA-
xai OR5M4P 11q12.1 0.161 0.223 0.763
xai BRK1P2 0.161 0.223 0.763
his FADD 11q13.3 0.161 0.223 0.763 Apoptosis
xai CT62 15q23 0.161 0.223 0.763
his NPRL3 16p13.3 0.161 0.223 0.763
hs4 UBE2G2 21q22.3 0.161 0.223 0.763 ubiquitin-dependent protein
hs4 LINC01424 0.161 0.223 0.763
his MIR770 0.161 0.223 0.763
exp DPPA5P2 0.161 0.223 0.763
xai LOC100049716 12p13.33 0.161 0.223 0.763
xai NET1 10p15 0.161 0.223 0.763 small GTPase mediated signal
exp OR5M4P 11q12.1 0.161 0.223 0.763
his PTGDR 14q22.1 0.161 0.223 0.763 G-protein coupled receptor signaling
pathway;male sex determination
hs4 CCNF 16p13.3 0.161 0.223 0.763 placenta development;cell cycle
exp HNRNPABP1 0.161 0.223 0.763
xai FEM1B 15q22 0.161 0.223 0.763 Apoptosis
his SAP130 2q14.3 0.161 0.223 0.763 regulation of transcription, DNA-
his FGF9 13q11-q12 0.161 0.223 0.763 positive regulation of mesenchymal cell
proliferation;male gonad development
exp AOX2P 2q33.1 0.161 0.223 0.763
hs4 FGF9 13q11-q12 0.161 0.223 0.763 positive regulation of mesenchymal cell
proliferation;male gonad development
hs4 RNF44 5q35.2 0.161 0.223 0.763
hs4 NUP93 16q13 0.161 0.223 0.763 regulation of glucose transport;protein
transport
exp TATDN2P3 0.161 0.223 0.763
hs4 HMX3 10q26.13 0.161 0.223 0.763 brain development;embryo implantation
his TMEM167B 1p13.3 0.161 0.223 0.763
his PRDX2 19p13.2 0.161 0.223 0.763 Apoptosis
xai MEMO1 0.161 0.223 0.763 regulation of microtubule-based process
hs4 INPP5B 1p34 0.161 0.223 0.763 signal transduction;small GTPase mediated
signal transduction
xai UQCR11 19p13.3 0.161 0.223 0.763 generation of precursor metabolites
hs4 PARVB 22q13.2-q13.33 0.161 0.223 0.763 cell adhesion;cell junction
assembly
his KCNJ3 2q24.1 0.161 0.223 0.763 response to electrical stimulus;ion
transport
cop SPTBN5 15q21 0.16 0.223 0.763 axon guidance;actin cytoskeleton
organization
exp POLR2J 7q22.1 0.16 0.223 0.763 DNA Damage Response (DDR); DDR
(NER)
xsq RSG1 1p36.13 0.16 0.223 0.763 small GTPase mediated signal
exp LRP8 1p34 0.16 0.223 0.763 cytokine-mediated signaling pathway;hippocampus
development
xsq MAPK14 6p21.3-p21.2 0.16 0.223 0.763 Protein Kinases
exp METTL14 4q26 0.16 0.223 0.763 RNA methylation;nucleobase-containing
xsq OR10J5 0.16 0.223 0.763
xsq GMNN 6p22.3 0.16 0.223 0.763 DDR (DNA replication)
xsq TFRC 3q29 0.16 0.223 0.763 response to hypoxia;response to inorganic
substance
exp KRT38 17q21.2 0.16 0.223 0.763
mut LCK 1p34.3 0.16 0.223 0.763 Protein Kinases
xsq GRIPAP1 Xp11.23 0.16 0.223 0.763
xsq LINC01136 0.16 0.223 0.763
cop ADAM1A 12q24.13 0.16 0.223 0.763
mut SMOX 20p13 0.16 0.223 0.763 cellular nitrogen compound metabolic
xsq CD40LG Xq26 0.16 0.223 0.763 inflammatory response;positive regulation
of interleukin-12 production
cop CCDC42B 12q24.13 0.16 0.223 0.763
cop DDX54 12q24.13 0.16 0.223 0.763 regulation of transcription, DNA-
cop RITA1 0.16 0.223 0.763 nuclear export;negative regulation of
cop IQCD 12q24.13 0.16 0.223 0.763
cop TPCN1 12q24.13 0.16 0.223 0.763 ion transport;transmembrane transport
cop SLC8B1 0.16 0.223 0.763 sodium ion transport;calcium ion
transport
cop PLBD2 12q24.13 0.16 0.223 0.763 lipid catabolic process
cop SDS 12q24.13 0.16 0.223 0.763 cellular amino acid metabolic process;L-
serine catabolic process
cop CAPNS2 0.16 0.223 0.763
exp PGAP2 11p15.5 0.16 0.223 0.763 GPI anchor biosynthetic process;anti-
apoptosis
cop NUSAP1 15q15.1 0.16 0.223 0.763 positive regulation of mitosis;cell
division
mut LAMC1 1q31 0.16 0.223 0.763 axon guidance;endoderm development
xsq MSI2 17q22 0.16 0.223 0.763 stem cell development
met LATS2 13q11-q12 0.16 0.223 0.763 protein phosphorylation;negative
xsq NRSN2-AS1 0.16 0.223 0.763
xsq PLRG1 4q31.2-q32.1 0.16 0.223 0.763 DNA Damage Response (DDR)
xsq TMEM233 12q24.23 0.16 0.223 0.763 response to biotic stimulus
xsq THCAT155 0.16 0.223 0.763
xsq LOC646029 0.16 0.223 0.763
xsq GTPBP10 7q21.13 0.16 0.223 0.763
met SMPD3 16q22.1 0.16 0.223 0.763 sphingomyelin catabolic
xsq GIT2 12q24.1 0.16 0.223 0.763 regulation of G-protein coupled receptor
xsq MAFK 7p22.3 0.16 0.223 0.763 regulation of transcription, DNA-
dependent;blood coagulation"
exp GRM7 3p26.1-p25.1 0.16 0.223 0.763 negative regulation of glutamate
secretion;conditioned taste aversion
xsq FUK 16q22.1 0.16 0.223 0.763 metabolic process
met SYNJ1 21q22.2 0.16 0.223 0.763 synaptic vesicle uncoating;response to
retinoic acid
mut LRRK2 12q12 0.16 0.223 0.763 negative regulation of neuroblast
proliferation;tangential migration from the subventricular zone to the olfactory
bulb
xsq PTGER4P2-CDK2AP2P2 0.16 0.223 0.763
xsq UBLCP1 5q33.3 0.16 0.223 0.763
exp LIMD1 3p21.3 0.16 0.223 0.763 cell migration;cytoplasmic mRNA
xsq AGO3 1p34 0.16 0.223 0.763
exp RSF1 11q14.1 0.16 0.223 0.763 nucleosome positioning;CenH3-containing
exp NOTCH1 9q34.3 0.16 0.223 0.763 Tumor Suppressors
xsq ZNF733P 0.16 0.223 0.763
xsq NBPF1 1p36.13 0.16 0.223 0.763
met CORO2B 15q23 0.16 0.223 0.763 actin cytoskeleton organization
xsq KLHL23 2q31.1 0.16 0.223 0.763
xsq OR52M1 0.16 0.223 0.763 response to stimulus
cop MIR563 0.16 0.223 0.763
xsq LINC01424 0.16 0.223 0.763
mut PKN2 1p22.2 0.16 0.223 0.763 Apoptosis
xsq POLDIP3 22q13.2 0.16 0.223 0.763 positive regulation of translation
cop C2orf71 2p23.2 0.16 0.223 0.763 response to stimulus;visual
perception
exp RANBP1 22q11.21 0.16 0.223 0.763 viral reproduction;positive
regulation of mitotic centrosome separation
cop MSANTD1 4p16.3 0.16 0.223 0.763
exp GLIDR 0.16 0.223 0.763
cop CRISPLD2 16q24.1 0.16 0.223 0.763
xsq LOC100996351 0.159 0.223 0.763
met CNPY3 6p21.1 -0.16 0.223 0.763 innate immune response
xsq C6orf7 -0.16 0.223 0.763
xsq EBF3 10q26.3 -0.16 0.223 0.763 regulation of transcription, DNA-
xsq LOC100507468 -0.16 0.223 0.763
cop MED15 22q11.2 -0.16 0.223 0.763 regulation of transcription from RNA
exp FREM2 13q13.3 -0.16 0.223 0.763 homophilic cell adhesion;multicellular
cop TNS3 7p12.3 -0.16 0.223 0.763 positive regulation of cell
cop C7orf65 7p12.3 -0.16 0.223 0.763
cop LINC00525 -0.16 0.223 0.763
xsq TAS2R30 -0.16 0.223 0.763 sensory perception of taste;response to
stimulus
met IRF7 11p15.5 -0.16 0.223 0.763 Apoptosis
met DNAJB1 19p13.2 -0.16 0.223 0.763 response to stress;response to
unfolded protein
xsq ARRDC3 5q14.3 -0.16 0.223 0.763 signal transduction
exp C7orf57 7p12.3 -0.16 0.223 0.763
xsq ITGA9-AS1 -0.16 0.223 0.763
xsq ERCC6-PGBD3 -0.16 0.223 0.763
met FGR 1p36.2-p36.1 -0.16 0.223 0.763 immune response-regulating cell
xsq LOC101927418 -0.16 0.223 0.763
xsq LOC100133669 8q24.3 -0.16 0.223 0.763
exp RIC1 -0.16 0.223 0.763
mut CLCN1 7q35 -0.16 0.223 0.763 transmembrane transport;transport
cop GBA3 4p15.2 -0.16 0.223 0.763 small molecule metabolic
process;glycosylceramide catabolic process
dependent"
met MRPL48 11q13.4 -0.16 0.223 0.763 translation
xai DSCAML1 11q23 -0.161 0.223 0.763 homophilic cell adhesion;negative
regulation of cell adhesion
xai GUSBP10 7p11.2 -0.161 0.223 0.763
hs4 BAALC 8q22.3 -0.161 0.223 0.763
hs4 BAALC-AS2 -0.161 0.223 0.763
exp TBC1D3P5 17q11.1 -0.161 0.223 0.763
xai NLGN2 17p13.1 -0.161 0.223 0.763 locomotory exploration
hs4 SOX4 6p22.3 -0.161 0.223 0.763 cardiac right ventricle
morphogenesis;glial cell proliferation
his PGS1 17q25.3 -0.161 0.223 0.763 phosphatidylglycerol biosynthetic
swa GPR143 Xp22.3 -0.161 0.223 0.763 melanosome
transport;melanosome organization
hs4 LIF 22q12.2 -0.161 0.223 0.763 multicellular organismal
his LINC01510 -0.161 0.223 0.763
hs4 CACNA2D3 3p21.1 -0.161 0.223 0.763 ion transport
exp MIR99A -0.161 0.223 0.763
xai TXNIP 1q21.1 -0.161 0.223 0.763 protein import into
nucleus;nucleotide-binding domain, leucine rich repeat containing receptor
signaling pathway
his RNF157-AS1 -0.161 0.223 0.763
his FOXJ1 17q25.1 -0.161 0.223 0.763 Apoptosis
swa ITGA3 17q21.33 -0.161 0.223 0.763 leukocyte migration;neuron
migration
xai GCOM2 4q12 -0.161 0.223 0.763 maintenance of ER location
xai LRRC37BP1 17q11.2 -0.161 0.223 0.763
xai SLC35A2 Xp11.23-p11.22 -0.161 0.223 0.763 Solute Carriers
his PDZK1 1q21 -0.161 0.223 0.763 transport;cell proliferation
xai FJX1 11p13 -0.161 0.223 0.763
xai CTAGE12P 9p21.2 -0.161 0.223 0.763
xai NOTCH4 6p21.3 -0.161 0.223 0.763 cell fate
determination;hemopoiesis
his ITGB6 2q24.2 -0.161 0.223 0.763
xai HOXD10 2q31.1 -0.161 0.223 0.763 spinal cord motor neuron cell
hs4 CSRNP2 12q13.11-q13.12 -0.161 0.223 0.763 positive regulation of
transcription from RNA polymerase II promoter;apoptotic process
exp GCOM2 4q12 -0.161 0.223 0.763 maintenance of ER location
xai PLGLB2 0.162 0.224 0.764
xai ZMYM6 1p34.2 0.161 0.224 0.763 cytoskeleton organization;multicellular
hs4 OSBPL5 11p15.4 0.161 0.224 0.763 transport;lipid transport
xai TARSL2 15q26.3 0.161 0.224 0.763 threonyl-tRNA aminoacylation
xai MKI67IPP6 0.161 0.224 0.763
his BAG6 6p21.3 0.161 0.224 0.763 transport;lung development
his APOM 6p21.33 0.161 0.224 0.763 transport;cholesterol homeostasis
xai JAKMIP1 4p16.1 0.161 0.224 0.763 protein transport
his CNTNAP3 9p13.1 0.161 0.224 0.764 cell adhesion;signal transduction
xai BCKDHA 19q13.1-q13.2 0.161 0.224 0.764 branched chain family amino
acid catabolic process;cellular nitrogen compound metabolic process
hs4 MICB 6p21.3 0.161 0.224 0.764 immune response-activating cell surface
receptor signaling pathway;gamma-delta T cell activation
xai ART4 12p13-p12 0.161 0.224 0.764 protein ADP-ribosylation;arginine
metabolic process
his BUB1 2q14 0.161 0.224 0.764 DNA Damage Response (DDR); Protein Kinases
xai BRWD3 Xq21.1 0.161 0.224 0.764 cytoskeleton organization;regulation of
cell shape
xai CDK17 12q23.1 0.161 0.224 0.764 Protein Kinases
swa NUBP2 16p13.3 0.161 0.224 0.764
exp ZNF143 11p15.4 0.161 0.224 0.764 gene expression;regulation of
xai LOC150051 21q22.11 0.161 0.224 0.764
swa GCLM 1p22.1 0.161 0.224 0.764 cysteine metabolic process;negative
his PEAK1 15q24.3 0.161 0.224 0.764
his HMG20A 15q24 0.161 0.224 0.764 chromatin organization;regulation of
hs4 BCL6B 17p13.1 0.161 0.224 0.764 negative regulation of transcription from
his LPCAT1 5p15.33 0.161 0.224 0.764 phospholipid biosynthetic
process;retina development in camera-type eye
his SPDYA 2p23.2 0.161 0.224 0.764 positive regulation of cell
his RPS14 5q31-q33 0.161 0.224 0.764 nuclear-transcribed mRNA catabolic
xai RASA2 3q22-q23 0.161 0.224 0.764 positive regulation of Ras GTPase
xai LRRC34 3q26.2 0.161 0.224 0.764
hs4 RPP25L 9p13.3 0.161 0.224 0.764
exp ZNF317P1 8q22.1 0.161 0.224 0.764
xai CPNE7 16q24.3 0.161 0.224 0.764 lipid metabolic process;transport
xai NLRP2 19q13.42 0.161 0.224 0.764 positive regulation of cysteine-type
his PRORSD1P 2p16.1 0.161 0.224 0.764
hs4 NHLH1 0.161 0.224 0.764
his MORF4L1 15q24 0.161 0.224 0.764 histone H2A acetylation;DNA repair
exp LINC01538 0.161 0.224 0.764
his HBP1 7q22-q31 0.161 0.224 0.764 regulation of transcription, DNA-
xai CADM2 3p12.1 0.161 0.224 0.764 cell junction assembly;adherens junction
organization
cop COMTD1 10q22.2 0.161 0.224 0.764
his TWF1 12q12 0.161 0.224 0.764 negative regulation of actin filament
polymerization;sequestering of actin monomers
his CDR2 16p12.3 0.161 0.224 0.764
hs4 MC1R 16q24.3 0.161 0.224 0.764 intracellular protein kinase
cascade;positive regulation of protein kinase B signaling cascade
hs4 TUBB3 16q24.3 0.161 0.224 0.764 protein folding;microtubule-based
movement
xai OR1N2 9q33.2 0.161 0.224 0.764 response to stimulus
xai LOC100128175 0.161 0.224 0.764
xai DIABLO 12q24.31 0.161 0.224 0.764 Apoptosis
xai GDAP1 8q21.11 0.161 0.224 0.764 response to retinoic acid
his RNU6-7 0.161 0.224 0.764
his RNU6-8 0.161 0.224 0.764
xai FAM72A 1q32.1 0.161 0.224 0.764
xai MSTO1 1q22 0.161 0.224 0.764 mitochondrion organization;mitochondrion
distribution
his TMEM64 8q21.3 0.161 0.224 0.764
his AOAH 7p14-p12 0.161 0.224 0.764 lipopolysaccharide metabolic
his MTMR8 Xq11.2 0.161 0.224 0.764
xai HEIH 0.161 0.224 0.764
his RIF1 2q23.3 0.161 0.224 0.764 DNA Damage Response (DDR)
hs4 TEX264 3p21.31 0.161 0.224 0.764
cop MIR3714 0.159 0.224 0.763
met DDX26B Xq26.3 0.159 0.224 0.763
xsq GBGT1 0.159 0.224 0.763 metabolic process;glycolipid biosynthetic
process
xsq DUSP11 2p13.1 0.159 0.224 0.763 RNA processing;peptidyl-tyrosine
dephosphorylation
cop CHFR 12q24.33 0.159 0.224 0.763 mitotic cell cycle
checkpoint;modification-dependent protein catabolic process
xsq CUL2 10p11.21 0.159 0.224 0.763 Apoptosis
xsq LOC100129461 6p25.1 0.159 0.224 0.763
cop HTRA3 4p16.1 0.159 0.224 0.763 regulation of cell growth;proteolysis
cop LOC100132735 0.159 0.224 0.764
xsq VPS13A 9q21 0.159 0.224 0.764 Golgi to endosome transport;nervous
system development
xsq SNHG21 0.159 0.224 0.764
met OR5B21 11q12.1 0.159 0.224 0.764 response to stimulus
exp SMG1P3 0.159 0.224 0.764
met SDR42E1 16q23.3 0.159 0.224 0.764 steroid biosynthetic process
xsq RNF168 3q29 0.159 0.224 0.764 DNA Damage Response (DDR); DDR (NHEJ)
exp NDUFA2 5q31.2 0.159 0.224 0.764 respiratory electron transport
xsq STK38L 12p11.23 0.159 0.224 0.764 protein
phosphorylation;intracellular protein kinase cascade
met CSF2 5q31.1 0.159 0.224 0.764 positive regulation of tyrosine
xsq OR10G4 11q24.1 0.159 0.224 0.764 response to stimulus
exp IMPDH1P8 3p25.1 0.159 0.224 0.764
mut WRAP53 17p13.1 0.159 0.224 0.764 DNA Damage Response (DDR)
exp KIAA0586 14q23.1 0.159 0.224 0.764
xsq AES 19p13.3 0.159 0.224 0.764 cellular response to extracellular
xsq PIN4 Xq13 0.159 0.224 0.764 rRNA processing;protein folding
mut TLR6 4p14 0.159 0.224 0.764 signal transduction;defense response to
bacterium
xsq TAF6L 11q12.3 0.159 0.224 0.764 chromatin remodeling;transcription
met MTMR9 8p23-p22 0.159 0.224 0.764
xsq MTERF3 0.159 0.224 0.764 negative regulation of transcription,
DNA-dependent"
exp LOC646639 5p13.3 0.159 0.224 0.764
met ST7-AS1 7q31.2 0.159 0.224 0.764
dependent;negative regulation of transcription from RNA polymerase II promoter"
met EIF2S1 14q23.3 0.159 0.224 0.764 activation of signaling protein
activity involved in unfolded protein response;gene expression
met VWA3B 2q11.2 0.159 0.224 0.764
mir hsa-miR-340* 0.159 0.224 0.764
xsq PSMD13 11p15.5 0.159 0.224 0.764 antigen processing and presentation
cop PPP1CB 2p23 0.159 0.224 0.764 cell cycle;triglyceride catabolic process
cop LOC400548 0.159 0.224 0.764
cop ZC3H7A 16p13-p12 0.159 0.224 0.764
cop BCAR4 16p13.13 0.159 0.224 0.764
cop RSL1D1 16p13.13 0.159 0.224 0.764 translation;regulation of protein
localization
cop KCNQ1DN 11p15.4 0.159 0.224 0.764
cop CDKN1C 11p15.5 0.159 0.224 0.764 positive regulation of transforming
growth factor beta receptor signaling pathway;negative regulation of kinase
activity
met MIR367 0.159 0.224 0.764
exp PBX2P1 3q24 0.159 0.224 0.764
met TUBB2A 6p25 0.159 0.224 0.764 protein polymerization;protein folding
exp NAA50 3q13.2 0.159 0.224 0.764 N-terminal protein amino acid acetylation
met PEX11B 1q21.1 0.159 0.224 0.764 peroxisome organization;signal
transduction
xsq LOC101928381 0.159 0.224 0.764
xsq PEF1 1p34 0.159 0.224 0.764 response to calcium ion
cop BTBD11 12q23.3 0.159 0.224 0.764
mut SGK223 8p23.1 0.159 0.224 0.764
xsq MRPS11 15q25 0.159 0.224 0.764 translation;DNA damage response,
xsq AARS 16q22 0.159 0.224 0.764 hair follicle development;endoplasmic reticulum
cop RBM46 4q32.1 -0.159 0.224 0.764
cop NPY2R 4q31 -0.159 0.224 0.764
met DUSP12 1q21-q22 -0.159 0.224 0.764 protein dephosphorylation;JNK
cascade
exp C7orf65 7p12.3 -0.159 0.224 0.764
cop SGCZ 8p22 -0.159 0.224 0.764 muscle cell development;cytoskeleton
organization
met F2R 5q13 -0.159 0.224 0.764 Apoptosis
met PRORSD1P 2p16.1 -0.159 0.224 0.764
exp SNPH 20p13 -0.159 0.224 0.764 neurotransmitter secretion;synaptic
vesicle docking involved in exocytosis
cop PKD1L1 7p12.3 -0.159 0.224 0.764 detection of nodal flow;cell-
cell adhesion
xsq CEACAM20 19q13.31 -0.159 0.224 0.764
cop LOC100130744 -0.159 0.224 0.764
xsq EYA2 20q13.1 -0.159 0.224 0.764 histone dephosphorylation;DNA
repair
xsq RRBP1 20p12 -0.159 0.224 0.764 protein transport;translation
xsq HHAT 1q32 -0.159 0.224 0.764 multicellular organismal development
exp RALA 7p15-p13 -0.159 0.224 0.764 interspecies interaction between
mut ST5 11p15 -0.159 0.224 0.764 positive regulation of ERK1 and ERK2
cascade
met FTH1 11q13 -0.159 0.224 0.764 iron ion transport;transmembrane
transport
cop UBE2W 8q21.11 -0.159 0.224 0.764 protein monoubiquitination;protein
cop TCEB1 8q21.11 -0.159 0.224 0.764 DNA Damage Response (DDR); DDR
(NER)
cop TMEM70 8q21.11 -0.159 0.224 0.764 mitochondrial proton-
transporting ATP synthase complex assembly
cop LY96 8q21.11 -0.159 0.224 0.764 MyD88-independent toll-like
receptor signaling pathway;detection of lipopolysaccharide
cop CCT5 5p15.2 -0.159 0.224 0.764 response to virus;cellular protein
metabolic process
xsq TBC1D22A-AS1 -0.159 0.224 0.764
exp VPS53 17p13.3 -0.159 0.224 0.764 protein transport
exp ZSWIM8 10q22.2 -0.159 0.224 0.764
xsq IGFBP4 17q21.2 -0.159 0.224 0.764 cell proliferation;regulation
exp SIRPA 20p13 -0.159 0.224 0.764 cell adhesion;blood coagulation
cop IL23R 1p31.3 -0.159 0.224 0.764 positive regulation of defense
response to virus by host;positive regulation of interleukin-12 production
exp HOXA4 7p15.2 -0.159 0.224 0.764 anatomical structure
xsq TPMT 6p22.3 -0.159 0.224 0.764 nucleobase-containing compound
metabolic process;xenobiotic metabolic process
mut SYNPO2 4q26 -0.159 0.224 0.764
exp VPS18 15q14-q15 -0.159 0.224 0.764 intracellular protein
transport;endosome organization
exp IGFL1 19q13.32 -0.159 0.224 0.763
xsq PPP1R37 19q13.32 -0.159 0.224 0.763 negative regulation of
cop MIR4470 -0.159 0.224 0.763
his PCDHB16 5q31 -0.161 0.224 0.764 synapse assembly;calcium-dependent
cell-cell adhesion
his PSG2 19q13.1-q13.2 -0.161 0.224 0.764 cell migration;female
pregnancy
hs4 LRRC1 6p12.1 -0.161 0.224 0.764
his TUBA3FP 22q11.21 -0.161 0.224 0.764
his P2RX6 22q11.21 -0.161 0.224 0.764 ion transport;cation transport
cop SEC1P 19q13.33 -0.161 0.224 0.764
xai MSRB2 10p12 -0.161 0.224 0.764 regulation of transcription, DNA-
xai CACNG4 17q24 -0.161 0.224 0.764 transport;ion transport
his TPST1 7q11.21 -0.161 0.224 0.764 peptidyl-tyrosine
his ANKRD2 10q23 -0.161 0.224 0.764 muscle contraction;muscle organ
development
his HP09053 -0.161 0.224 0.764
DNA-dependent"
hs4 SLCO3A1 15q26 -0.161 0.224 0.764 Solute Carriers
hs4 LINC01198 -0.161 0.224 0.764
hs4 ACOT2 -0.161 0.224 0.764 very long-chain fatty acid metabolic
hs4 BACE1 11q23.2-q23.3 -0.161 0.224 0.764 proteolysis;membrane protein
exp SERPINA11 14q32.13 -0.161 0.224 0.764 negative regulation of
xai CTF1 16p11.2 -0.161 0.224 0.764 neuron development;leukemia
his MIR3914-2 -0.161 0.224 0.764
his MIR3914-1 -0.161 0.224 0.764
xai SMTN 22q12.2 -0.161 0.224 0.764 smooth muscle contraction;muscle
organ development
his C14orf132 14q32.2 -0.161 0.224 0.764
his KLF4 9q31 -0.161 0.224 0.764 mesodermal cell fate
swa TNC 9q33 -0.161 0.224 0.764 positive regulation of gene
hs4 FAM151B 5q14.1 -0.161 0.224 0.764
his LOC401286 6q27 -0.161 0.224 0.764
his LOC441178 6q27 -0.161 0.224 0.764
hs4 GPR158 10p12.1 -0.161 0.224 0.764
hs4 GPR158-AS1 10p12.1 -0.161 0.224 0.764
xai CLCA2 1p22.3 -0.161 0.224 0.764 transport;chloride transport
hs4 MAB21L3 1p13.1 -0.161 0.224 0.764
xai GPR158 10p12.1 -0.161 0.224 0.764
xai RALA 7p15-p13 -0.161 0.224 0.764 interspecies interaction between
xai C4orf26 4q21.1 -0.161 0.224 0.764
xai MIR99A -0.161 0.224 0.764
xai HEXA-AS1 15q23 -0.161 0.224 0.764
hs4 GOLGA6D -0.161 0.224 0.763
his LOC101927727 -0.161 0.224 0.763
his BOC 3q13.2 -0.161 0.224 0.763 muscle cell
his ZFP2 5q35.3 -0.161 0.224 0.763 regulation of transcription, DNA-
dependent"
his RAB11FIP4 17q11.2 -0.161 0.224 0.763 cytokinesis;transport
hs4 HSPA4L 4q28 -0.161 0.224 0.763 response to unfolded
protein;protein folding
xai ECM2 9q22.3 -0.161 0.224 0.763 positive regulation of cell-
xai EBF4 20p13 -0.161 0.224 0.763 regulation of transcription, DNA-
xai RNF182 6p23 -0.161 0.224 0.763 protein ubiquitination
xai STX19 3q11 -0.162 0.224 0.764 intracellular protein transport;vesicle-
mediated transport
xai HSPA6 1q23 0.162 0.225 0.764 Apoptosis
xai B3GNT2 2p15 0.161 0.225 0.764 post-translational protein
exp TULP2 19q13.1 0.161 0.225 0.764 visual perception
his LINC02106 0.161 0.225 0.764
xai CDHR4 3p21.31 0.161 0.225 0.764 cell adhesion;homophilic cell adhesion
xai PKD1L3 16q22.2 0.161 0.225 0.764 detection of chemical stimulus
xai ZNF449 Xq26.3 0.161 0.225 0.764 viral reproduction
exp CTGLF12P 10q11.22 0.161 0.225 0.764
hs4 TMEM150C 4q21.22 0.161 0.225 0.764
his PUS7L 12q12 0.16 0.225 0.764 pseudouridine synthesis;tRNA processing
his IRAK4 12q12 0.16 0.225 0.764 Protein Kinases
his EPRS 1q41 0.16 0.225 0.764 glutamyl-tRNA aminoacylation;prolyl-tRNA
aminoacylation
his PIAS2 18q21.1 0.16 0.225 0.764 DNA Damage Response (DDR)
xai PACS2 14q32.33 0.16 0.225 0.764 apoptotic process;interspecies
xai TNFRSF8 1p36 0.16 0.225 0.764 Apoptosis
exp LOC100128175 0.16 0.225 0.764
his MIR1184-3 0.16 0.225 0.764
his F8A3 0.16 0.225 0.764
his H2AFB3 Xq28 0.16 0.225 0.764
swa PDCD6IP 3p22.3 0.16 0.225 0.764 Apoptosis
his MRPS18A 6p21.3 0.16 0.225 0.764 translation
cop TERF2IP 16q23.1 0.16 0.225 0.764 DNA Damage Response (DDR)
hs4 DEAF1 11p15.5 0.16 0.225 0.764 multicellular organismal development;germ
cell development
hs4 TMEM80 11p15.5 0.16 0.225 0.764
swa DAZAP1 19p13.3 0.16 0.225 0.764 multicellular organismal
xai ITIH4 3p21.1 0.16 0.225 0.764 acute-phase response;negative regulation
exp VN1R46P 8p11.21 0.16 0.225 0.764
his ERCC5 13q33 0.16 0.225 0.764 DNA Damage Response (DDR); DDR (NER)
xai PCSK1N Xp11.23 0.16 0.225 0.764 response to dietary
excess;neuropeptide signaling pathway
his NSUN5 7q11.23 0.16 0.225 0.764
exp OR52W1 11p15.4 0.16 0.225 0.764 response to stimulus
hs4 GIPC3 19p13.3 0.16 0.225 0.764
his TLK2 17q23 0.16 0.225 0.764 DDR (DNA replication)
xai LIPT1 0.16 0.225 0.764 protein modification process;lipid metabolic
process
xai RPS16P5 6p12.1 0.16 0.225 0.764
xai OR52W1 11p15.4 0.16 0.225 0.764 response to stimulus
exp RBMXL2 11p15 0.16 0.225 0.764
xai POC1A 3p21.2 0.16 0.225 0.764
exp LAG3 12p13.32 0.16 0.225 0.764 cell surface receptor signaling
hs4 PARTICL 0.16 0.225 0.764
hs4 MAT2A 2p11.2 0.16 0.225 0.764 response to light stimulus;response to
hormone stimulus
hs4 OLMALINC 0.16 0.225 0.764
his VAMP3 1p36.23 0.16 0.225 0.764 protein complex assembly;retrograde
his CUL4B Xq23 0.16 0.225 0.764 DNA repair;ubiquitin-dependent protein
catabolic process
his CPLX2 5q35.2 0.16 0.225 0.764 neurotransmitter transport;vesicle
hs4 KHDRBS2 6q11.1 0.16 0.225 0.765 regulation of transcription, DNA-
dependent"
swa CCT7 2p13.2 0.16 0.225 0.765 protein folding;cellular protein
metabolic process
xsq PFKFB1 Xp11.21 0.159 0.225 0.764 Apoptosis
xsq GRWD1 19q13.33 0.159 0.225 0.764
exp C17orf89 17q25.3 0.159 0.225 0.764
met CASP14 19p13.1 0.159 0.225 0.764 apoptotic process;induction of
apoptosis
mut EXOC4 7q31 0.159 0.225 0.764 positive regulation of calcium-mediated
xsq GRHL3 1p36.11 0.159 0.225 0.764 epidermis development;positive regulation
exp CCDC137 17q25.3 0.159 0.225 0.764
xsq ATP1B4 Xq24 0.159 0.225 0.764 transport;potassium ion transport
exp BTF3P5 2p16.1 0.159 0.225 0.764
mut COL12A1 6q12-q13 0.159 0.225 0.764 skeletal system development;cell
adhesion
met METTL7A 12q13.12 0.159 0.225 0.764 metabolic process
cop APPL2 12q24.1 0.159 0.225 0.764 cell cycle;signal transduction
xsq SNRPC 6p21.31 0.159 0.225 0.764 spliceosomal snRNP assembly;nuclear mRNA
xsq ATP6V0B 1p32.3 0.159 0.225 0.764 cellular iron ion
xsq SPATA22 17p13.3 0.159 0.225 0.764
cop UBE2Q2 15q24.2 0.159 0.225 0.764 protein K48-linked ubiquitination
xsq OOEP 6q13 0.159 0.225 0.764 establishment or maintenance of apical/basal
cell polarity;cellular protein complex assembly
met GRP 18q21.1-q21.32 0.159 0.225 0.764
met BRINP1 0.159 0.225 0.764 cell cycle arrest;cell death
met NRSN1 6p22.3 0.159 0.225 0.764 nervous system development
exp LOC100996579 0.159 0.225 0.764
exp TDRD12 19q13.11 0.159 0.225 0.764
cop FAM210A 18p11.21 0.159 0.225 0.764
cop RNMT 18p11.21 0.159 0.225 0.764 viral reproduction;transcription from RNA
met TRPC4AP 20q11.22 0.159 0.225 0.764 ubiquitin-dependent protein
xsq KCNK16 6p21.2-p21.1 0.159 0.225 0.764 ion transport;potassium ion
transport
met TENM4 11q14.1 0.159 0.225 0.764
xsq UBL4A Xq28 0.159 0.225 0.764 protein modification process;transport
met ZBTB41 1q31.3 0.159 0.225 0.764 regulation of transcription, DNA-
dependent"
xsq FBXO36 2q36.3 0.159 0.225 0.764
met SF1 11q13 0.159 0.225 0.764 nuclear mRNA 3'-splice site recognition;nuclear
xsq CAMSAP1 9q34.3 0.159 0.225 0.764 cytoskeleton
xsq FAM199X Xq22.2 0.159 0.225 0.764
met MIR539 0.159 0.225 0.764
met MRPS18A 6p21.3 0.159 0.225 0.764 translation
exp NLRP2 19q13.42 0.159 0.225 0.764 positive regulation of cysteine-type
exp RHOT1 17q11.2 0.159 0.225 0.764 Apoptosis
met ZC3H7A 16p13-p12 0.159 0.225 0.764
cop TBX2 17q23.2 0.159 0.225 0.764 heart morphogenesis;developmental growth
cop C17orf82 17q23.2 0.159 0.225 0.764
cop TBX4 17q21-q22 0.159 0.225 0.764 skeletal system
morphogenesis;angiogenesis
cop NACA2 17q23.2 0.159 0.225 0.764 protein transport
xsq TMEM230 20p13 0.159 0.225 0.764
met PCDH11X Xq21.3 0.159 0.225 0.764 cell adhesion;homophilic cell
adhesion
xsq PPIG 2q31.1 0.159 0.225 0.764 protein folding;RNA splicing
met ANOS1 0.159 0.225 0.764 cell adhesion;axon guidance
exp RAB6A 11q13.3 0.159 0.225 0.764 peptidyl-cysteine methylation;protein
localization in Golgi apparatus
exp FAM117A 17q21.33 0.159 0.225 0.764
met TSC22D1 13q14 0.159 0.225 0.764 negative regulation of apoptotic
cop C2orf43 2p24.1 0.159 0.225 0.765
cop ABLIM2 4p16.1 0.159 0.225 0.765 cytoskeleton organization;axon
guidance
cop BTD 3p25 0.159 0.225 0.765 epidermis development;nitrogen compound
metabolic process
exp IFT80 3q25.33 -0.159 0.225 0.765
xsq NFE2L3 7p15.2 -0.159 0.225 0.765 regulation of transcription,
xsq SLURP1 8q24.3 -0.159 0.225 0.764 cell activation;cell adhesion
cop SPAG1 8q22.2 -0.159 0.225 0.764 single fertilization
exp SMCR5 -0.159 0.225 0.764
cop NPHP3 3q22.1 -0.159 0.225 0.764 photoreceptor cell
maintenance;maintenance of organ identity
xsq VCX2 Xp22.32 -0.159 0.225 0.764
met FBLN2 3p25.1 -0.159 0.225 0.764
cop C22orf29 22q11.21 -0.159 0.225 0.764
exp KCNMA1 10q22.3 -0.159 0.225 0.764 ion transport;positive
cop PLSCR4 3q24 -0.159 0.225 0.764 phospholipid scrambling;cellular
response to lipopolysaccharide
cop PLSCR2 3q24 -0.159 0.225 0.764 phospholipid scrambling
exp SCNN1A 12p13 -0.159 0.225 0.764 ion transport;sodium ion transport
cop TOR1AIP2 1q25.2 -0.159 0.225 0.764
cop TOR1AIP1 1q24.2 -0.159 0.225 0.764
exp ANGPTL8 -0.159 0.225 0.764
xsq PSG6 -0.159 0.225 0.764 female pregnancy
xsq FOXC1 6p25 -0.159 0.225 0.764 Apoptosis
exp DBNDD1 16q24.3 -0.159 0.225 0.764
xsq PYROXD2 10q24.2 -0.159 0.225 0.764
cop SNX4 3q21.2 -0.159 0.225 0.764 endocytosis;cell communication
cop TTTY12 Yp11.2 -0.159 0.225 0.764
exp GNA12 7p22.2 -0.159 0.225 0.764 G-protein signaling, coupled to
mut IRS2 13q34 -0.159 0.225 0.764 Apoptosis
xsq MEGF8 19q12 -0.159 0.225 0.764
cop RGS22 8q22.2 -0.159 0.225 0.764 negative regulation of signal
exp MAATS1 3q12-q13.3 -0.159 0.225 0.764
exp LINC-PINT -0.159 0.225 0.764
met C17orf75 17q11.2 -0.159 0.225 0.764 spermatogenesis
exp SEPN1 1p36.13 -0.159 0.225 0.764
DNA-dependent"
xsq MUC4 3q29 -0.159 0.225 0.764 cell adhesion;cell-matrix adhesion
exp AATK 17q25.3 -0.159 0.225 0.764 apoptotic process;protein
autophosphorylation
cop IL12RB2 1p31.3-p31.2 -0.159 0.225 0.764 response to cytokine
stimulus;cell surface receptor signaling pathway
xsq NGF 1p13.1 -0.159 0.225 0.764 transmembrane receptor protein
tyrosine kinase signaling pathway;induction of apoptosis by extracellular signals
xsq PTCHD4 6p12.3 -0.159 0.225 0.764
exp NKIRAS1 3p24.2 -0.159 0.225 0.764 GTP catabolic process;signal
transduction
cop MAT1A 10q22 -0.159 0.225 0.764 xenobiotic metabolic process;methylation
cop DYDC1 10q23.1 -0.159 0.225 0.764
cop TMEM44-AS1 -0.159 0.225 0.764
cop TMEM44 3q29 -0.159 0.225 0.764
cop LSG1 3q29 -0.159 0.225 0.764 nuclear export;protein transport
cop FAM43A 3q29 -0.159 0.225 0.764
hs4 ANKRD60 20q13.32 -0.16 0.225 0.765
exp PLAC4 21q22.2 -0.16 0.225 0.765
xai NIPAL2 8q22.2 -0.16 0.225 0.765
exp ACSM1 16p12.3 -0.16 0.225 0.765 xenobiotic metabolic process;energy
xai RIPK2 8q21 -0.16 0.225 0.764 Apoptosis
xai ITSN1 21q22.1-q22.2 -0.16 0.225 0.764 small GTPase mediated signal
transduction;positive regulation of protein kinase B signaling cascade
xai PIFO 1p13.2 -0.16 0.225 0.764
hs4 TBX2-AS1 -0.16 0.225 0.764
hs4 TBX2 17q23.2 -0.16 0.225 0.764 heart morphogenesis;developmental growth
hs4 CDCP1 3p21.31 -0.16 0.225 0.764
xai TMEM8A 16p13.3 -0.16 0.225 0.764 cell adhesion
his IFI44 1p31.1 -0.16 0.225 0.764 response to virus
his EPHX3 19p13.12 -0.16 0.225 0.764
xai TMEM173 5q31.2 -0.16 0.225 0.764 apoptotic process;cellular response
to exogenous dsRNA
xai LRRN4 20p12.3 -0.16 0.225 0.764
his MSX1 4p16.2 -0.16 0.225 0.764 multicellular organismal
hs4 LINC00113 21q21.3 -0.16 0.225 0.764
hs4 KIFC3 16q13-q21 -0.16 0.225 0.764 zonula adherens maintenance;epithelial
cell-cell adhesion
hs4 CD274 9p24 -0.16 0.225 0.764 immune response;signal transduction
xai KCNMA1 10q22.3 -0.16 0.225 0.764 ion transport;positive regulation
hs4 LOC100507477 -0.16 0.225 0.764
xai CYP4Z1 1p33 -0.16 0.225 0.764
his LINC01085 -0.16 0.225 0.764
hs4 MSC-AS1 -0.16 0.225 0.764
hs4 MSC 8q21 -0.16 0.225 0.764 regulation of transcription, DNA-
hs4 DRC1 2p23.3 -0.16 0.225 0.764
his FCRLA 1q23.3 -0.16 0.225 0.764 cell differentiation
his LINC01182 -0.16 0.225 0.764
xai ATP11A 13q34 -0.161 0.225 0.764 cation transport;phospholipid
translocation
xai CAMTA1 1p36.31-p36.23 -0.161 0.225 0.764 regulation of
xai CEACAM7 19q13.2 0.161 0.226 0.765
exp C4orf50 4p16.2 0.16 0.226 0.765
xai RPL31P11 1q23.3 0.16 0.226 0.765
xai LARP7 4q25 0.16 0.226 0.765 RNA processing
hs4 DRP2 Xq22 0.16 0.226 0.765 central nervous system development
his USP48 1p36.12 0.16 0.226 0.765 proteolysis;ubiquitin-dependent protein
catabolic process
his SMARCE1 17q21.2 0.16 0.226 0.765 DNA Damage Response (DDR); DDR
(Chromatin)
his FAM156A Xp11.22 0.16 0.226 0.765
his TMEM175 4p16.3 0.16 0.226 0.765
his GAK 4p16 0.16 0.226 0.765 cell cycle
exp OR2T10 1q44 0.16 0.226 0.765 response to stimulus
hs4 KCNQ5 6q14 0.16 0.226 0.765 protein complex assembly;ion transport
xai FOXA3 19q13.32 0.16 0.226 0.765 embryo development;regulation of
his MIR7160 0.16 0.226 0.765
xai LIPT1P1 13q33.1 0.16 0.226 0.765
his PPP3CB-AS1 0.16 0.226 0.765
his PPP3CB 10q22.2 0.16 0.226 0.765 negative regulation of T cell
xai KIAA0141 5q31.3 0.16 0.226 0.765 apoptotic process;regulation of
cysteine-type endopeptidase activity involved in apoptotic process
his METTL17 14q11.2 0.16 0.226 0.765 translation
his TMEM30A 6q14.1 0.16 0.226 0.765 protein localization to
his LOC100506804 0.16 0.226 0.765
xai GHRLOS 3p25.3 0.16 0.226 0.765
exp RPL7L1P4 5q23.1 0.16 0.226 0.765
his TET2 4q24 0.16 0.226 0.765 Tumor Suppressors
his UBE2S 19q13.43 0.16 0.226 0.765 protein modification process;activation
of anaphase-promoting complex activity
xai TNFRSF1B 1p36.22 0.16 0.226 0.765 Apoptosis
hs4 NSFP1 17q21.31 0.16 0.226 0.765
swa C1QBP 17p13.3 0.16 0.226 0.765 blood coagulation;blood coagulation,
intrinsic pathway
his TRIM11 1q42.13 0.16 0.226 0.765 response to virus
his SECTM1 17q25 0.16 0.226 0.765 immune response;signal transduction
hs4 DOLPP1 9q34.1 0.16 0.226 0.765 protein N-linked glycosylation via
swa RELA 11q13 0.16 0.226 0.765 Apoptosis
his STRN 2p22.2 0.16 0.226 0.765 locomotory behavior;negative regulation
exp ERCC8 5q12.1 0.16 0.226 0.765 DNA Damage Response (DDR); DDR (NER)
exp LOC100128233 0.16 0.226 0.765
hs4 TEX261 2p13.3 0.16 0.226 0.765 positive regulation of apoptotic
process
his ZNF346 5q35.2 0.16 0.226 0.765 apoptotic process
xai FOXL1 16q24 0.16 0.226 0.765 regulation of transcription, DNA-
his LMBR1L 12q13.12 0.16 0.226 0.765 endocytosis
his NPPA-AS1 0.16 0.226 0.765
his LOC100130698 10q23.1 0.16 0.226 0.765
swa VWA9 15q22.31 0.16 0.226 0.765
dependent"
xai PPCDC 15q24.2 0.16 0.226 0.765 coenzyme A biosynthetic
xai GSDMB 17q12 0.16 0.226 0.765
his LOC100286922 2q37.1 0.16 0.226 0.765
his UGT1A1 2q37 0.16 0.226 0.765
xai GPR150 5q15 0.16 0.226 0.765
met GPATCH1 19q13.11 0.159 0.226 0.765 nuclear mRNA splicing, via
spliceosome"
xsq SMDT1 22q13.2 0.159 0.226 0.765
exp ISCA1 9q21.33 0.159 0.226 0.765 iron-sulfur cluster assembly
met WWC1 5q34 0.159 0.226 0.765 regulation of transcription, DNA-dependent;cell
migration
mir hsa-miR-182* 0.159 0.226 0.765
mut LY86 6p25.1 0.159 0.226 0.765 apoptotic process;inflammatory response
exp SNRPD3 22q11.23 0.159 0.226 0.765 spliceosomal snRNP assembly;RNA
metabolic process
xsq ZNF890P 7p22.1 0.159 0.226 0.765
met TRAK2 2q33 0.159 0.226 0.765 regulation of transcription from RNA polymerase
II promoter;protein O-linked glycosylation
mut RLF 1p32 0.159 0.226 0.765 positive regulation of transcription from RNA
polymerase II promoter;chromosome organization
xsq FAM110A 20p13 0.159 0.226 0.765
met S100A6 1q21 0.159 0.226 0.765 positive regulation of fibroblast
xsq SMC2 9q31.1 0.159 0.226 0.765 DNA Damage Response (DDR); DDR (DNA
replication)
exp HSPBP1 19q13.42 0.159 0.226 0.765 protein folding;positive regulation
met GPR15 3q11.2-q13.1 0.159 0.226 0.765 G-protein coupled receptor
signaling pathway
met CFAP45 0.159 0.226 0.765
met MIR1-2 0.159 0.226 0.765
xsq CACNA1A 19p13 0.159 0.226 0.765 synaptic transmission;regulation of
met ASPH 8q12.1 0.159 0.226 0.765 peptidyl-amino acid modification;limb
morphogenesis
mut BTN3A1 6p22.1 0.159 0.226 0.765 lipid metabolic process
xsq ACSBG1 15q23-q24 0.159 0.226 0.765 response to glucocorticoid
stimulus;very long-chain fatty acid metabolic process
xsq GTSF1L 20q13.12 0.159 0.226 0.765
xsq FAM122B Xq26.3 0.159 0.226 0.765
cop MIR4320 0.159 0.226 0.765
exp TCF4 18q21.1 0.159 0.226 0.765 positive regulation of transcription,
exp RAB3A 19p13.2 0.159 0.226 0.765 neuromuscular synaptic transmission;lung
development
met C3orf14 3p14.2 0.159 0.226 0.765
xsq TOLLIP-AS1 11p15.5 0.159 0.226 0.765
mut PRIMA1 14q32.12 0.159 0.226 0.765 neurotransmitter catabolic
process;establishment of localization in cell
xsq SNX1 15q22.31 0.159 0.226 0.765 cell communication;early endosome to
Golgi transport
xsq AKR7A2 1p36.13 0.159 0.226 0.765 carbohydrate metabolic
process;cellular aldehyde metabolic process
dependent"
cop OCA2 15q 0.159 0.226 0.765 melanin biosynthetic process;developmental
pigmentation
cop MIR3922 0.159 0.226 0.765
met DOK6 18q22.2 0.159 0.226 0.765
cop CCDC11 0.159 0.226 0.765
cop MBD1 18q21 0.159 0.226 0.765 regulation of transcription, DNA-
cop CXXC1 18q12 0.159 0.226 0.765 regulation of transcription, DNA-
response
dependent"
met RAB15 14q23.3 0.159 0.226 0.765 small GTPase mediated signal
exp CBX8 17q25.3 0.159 0.226 0.765 negative regulation of transcription from
cop C12orf74 0.159 0.226 0.765
cop PLEKHG7 12q22 0.159 0.226 0.765 regulation of Rho protein signal
transduction
xsq ANKRD23 2q11.2 0.159 0.226 0.765 fatty acid metabolic process
xsq SNORA44 0.159 0.226 0.765
exp SVBP 0.159 0.226 0.765
xsq ATE1 10q26.13 0.159 0.226 0.765 protein arginylation
cop TCTN1 12q24.11 0.159 0.226 0.765 cilium morphogenesis;multicellular
xsq TRIM11 1q42.13 0.159 0.226 0.765 response to virus
met FAM183A 1p34.2 0.159 0.226 0.765
cop FBXO22 15q24.2 0.159 0.226 0.765 protein modification
cop FBXO22-AS1 0.159 0.226 0.765
cop NRG4 15q24.2 0.159 0.226 0.765
cop C15orf27 15q24.2 0.159 0.226 0.765
xsq USP5 12p13 0.159 0.226 0.765 positive regulation of proteasomal ubiquitin-
dependent protein catabolic process;protein K48-linked deubiquitination
exp CYP2W1 7p22.3 0.159 0.226 0.765 small molecule metabolic
xsq TMEM181 6q25.3 0.159 0.226 0.765 pathogenesis
xsq NDN 15q11.2-q12 0.158 0.226 0.765 central nervous system development;axon
extension involved in development
xsq UCKL1-AS1 20q13.33 -0.158 0.226 0.765
exp EYA2 20q13.1 -0.158 0.226 0.765 histone dephosphorylation;DNA
repair
xsq C1GALT1C1L -0.159 0.226 0.765
mut DLK1 14q32 -0.159 0.226 0.765 multicellular organismal
mut DDX28 16q22.1 -0.159 0.226 0.765
exp EMC10 19q13.33 -0.159 0.226 0.765
xsq NEURL3 2q11.2 -0.159 0.226 0.765
xsq LDLRAD3 11p13 -0.159 0.226 0.765
cop TRIO 5p15.2 -0.159 0.226 0.765 transmembrane receptor protein
met TLX1 10q24 -0.159 0.226 0.765 cell fate commitment;positive regulation
exp FAM3D 3p14.2 -0.159 0.226 0.765 negative regulation of insulin
secretion
exp NIPAL2 8q22.2 -0.159 0.226 0.765
exp WNT3 17q21 -0.159 0.226 0.765 Oncogenes
met ADAD2 16q24.1 -0.159 0.226 0.765 RNA processing
exp MARCKS 6q22.2 -0.159 0.226 0.765 energy reserve metabolic
exp ITCH 20q11.22 -0.159 0.226 0.765 protein ubiquitination;innate
immune response
exp RPL7AP36 6p24.3 -0.159 0.226 0.765
xsq EMC10 19q13.33 -0.159 0.226 0.765
xsq CRTAC1 10q22 -0.159 0.226 0.765
exp SYNE1 6q25 -0.159 0.226 0.765 nucleus organization;Golgi organization
met F2RL3 19p12 -0.159 0.226 0.765 thrombin receptor signaling
cop MIR548Q -0.159 0.226 0.765
exp SPDL1 5q35.1 -0.159 0.226 0.765
exp SPATA6 1p33 -0.159 0.226 0.765 multicellular organismal
exp YPEL4 11q12.1 -0.159 0.226 0.765
cop GUCY1A3 4q31.1-q31.2 -0.159 0.226 0.765 cGMP biosynthetic
process;nitric oxide mediated signal transduction
exp KIF18A 11p14.1 -0.159 0.226 0.765 protein transport;M phase of
mitotic cell cycle
exp NUAK2 1q32.1 -0.159 0.226 0.765 Apoptosis
cop FAM163A 1q25.2 -0.159 0.226 0.765
xsq MLIP 6p12.1 -0.159 0.226 0.765
xsq BTD 3p25 -0.159 0.226 0.765 epidermis development;nitrogen compound
metabolic process
xsq NXPH2 2q22.1 -0.159 0.226 0.765 neuropeptide signaling pathway
xai STT3A 11q23.3 -0.16 0.226 0.765 post-translational protein
his LINC01152 -0.16 0.226 0.765
xai BTBD10 11p15.2 -0.16 0.226 0.765
his NUB1 7q36 -0.16 0.226 0.765 response to interferon-gamma;response to tumor
necrosis factor
cop MIR4469 -0.16 0.226 0.765
exp PIH1D2 11q23.1 -0.16 0.226 0.765
cop SNORA70C 9q33.1 -0.16 0.226 0.765
his PINK1 1p36 -0.16 0.226 0.765 positive regulation of synaptic transmission,
dopaminergic;mitochondrion degradation
his MIR6084 -0.16 0.226 0.765
exp GRIN3A 9q31.1 -0.16 0.226 0.765 ion transport;calcium ion transport
his ZNF542P -0.16 0.226 0.765 regulation of transcription, DNA-
dependent"
his NHSL1 6q23.3 -0.16 0.226 0.765
xai SPATA6 1p33 -0.16 0.226 0.765 multicellular organismal
hs4 KCNQ1DN 11p15.4 -0.16 0.226 0.765
exp PRRT3 3p25.3 -0.16 0.226 0.765
his NCKAP5L 12q13.12 -0.16 0.226 0.765
his BCDIN3D-AS1 -0.16 0.226 0.765
hs4 CSRNP3 2q24.3 -0.16 0.226 0.765 negative regulation of phosphatase
activity;positive regulation of apoptotic process
xai CYP1B1 2p22.2 -0.16 0.226 0.765 cellular aromatic compound
xai E2F7 12q21.2 -0.16 0.226 0.765 cell cycle;negative regulation of cell
proliferation
his NEURL1 -0.16 0.226 0.765 sperm motility;sperm axoneme assembly
hs4 FOXF2 6p25.3 -0.16 0.226 0.765 Apoptosis
hs4 MIR6720 -0.16 0.226 0.765
exp AHCYP2 9q33.2 -0.16 0.226 0.765
xai EGFL6 Xp22 -0.16 0.226 0.765 cell cycle;cell adhesion
hs4 PARP10 8q24.3 -0.16 0.226 0.765 regulation of chromatin
xai SEC11A 15q25.3 -0.16 0.226 0.765 energy reserve metabolic
his KIAA0754 -0.16 0.226 0.765
hs4 SMAD3 15q22.33 -0.16 0.226 0.765 Apoptosis
hs4 LOC102723493 -0.16 0.226 0.765
hs4 NR5A2 1q32.1 -0.16 0.226 0.765 gene expression;intracellular receptor
hs4 LRRC6 8q24.22 -0.16 0.226 0.765 male gonad development;pachytene
exp BVES-AS1 -0.16 0.226 0.765
xai CA9 9p13.3 -0.16 0.226 0.765 secretion;morphogenesis of an epithelium
hs4 HSBP1L1 18q23 -0.16 0.226 0.765 viral envelope fusion with host membrane
his BACH1-IT2 -0.16 0.226 0.765
xai LIX1 5q15 -0.16 0.226 0.765
xai ELFN2 22q13.1 -0.16 0.226 0.765 negative regulation of phosphatase
activity
xai BAG5 14q32.33 0.16 0.227 0.765 Apoptosis
hs4 RAD51L3-RFFL 0.16 0.227 0.765
hs4 RAD51D 17q11 0.16 0.227 0.765 DNA Damage Response (DDR); DDR (HR)
hs4 FNDC8 17q12 0.16 0.227 0.765
xai VILL 3p21.3 0.16 0.227 0.765 cytoskeleton organization;actin filament
capping
xai CRNDE 16q12.2 0.16 0.227 0.765
his CIC 19q13.2 0.16 0.227 0.765 Tumor Suppressors
xai KREMEN2 16p13.3 0.16 0.227 0.765 Wnt receptor signaling pathway
hs4 MCM3 6p12 0.16 0.227 0.765 DDR (DNA replication)
xai HIGD1AP4 0.16 0.227 0.765
his SDR39U1 14q12 0.16 0.227 0.765
his LOC101927045 0.16 0.227 0.765
exp MEMO1 0.16 0.227 0.765 regulation of microtubule-based process
hs4 ALKBH3-AS1 0.16 0.227 0.765
exp HIGD1AP4 0.16 0.227 0.765
xai RNF125 18q12.1 0.16 0.227 0.765 negative regulation of type I
cop OR7E12P 11p15 0.16 0.227 0.765
exp GRAMD4P2 0.16 0.227 0.765
hs4 DUS1L 17q25.3 0.16 0.227 0.765 tRNA processing
exp OVOS 12p13 0.16 0.227 0.765
xai DGAT1 8q24.3 0.16 0.227 0.765 triglyceride metabolic
hs4 MAP10 1q42.2 0.16 0.227 0.765
xai TMEM69 1p34.1 0.16 0.227 0.765
exp RPL3P2 6p21.3 0.16 0.227 0.765
xai CCT6P3 7q11.21 0.16 0.227 0.766
xai SYP Xp11.23-p11.22 0.16 0.227 0.766 endocytosis;synaptic vesicle
maturation
his LOC440173 0.16 0.227 0.766
xai HCRT 17q21 0.16 0.227 0.766 elevation of cytosolic calcium ion
xai RPL7L1 6p21.1 0.16 0.227 0.766 translation
xai CCDC79 16q22.1 0.16 0.227 0.766 regulation of transcription, DNA-
dependent"
hs4 TMEM176B 7q36.1 0.16 0.227 0.766 organ morphogenesis;cell
differentiation
hs4 TMEM176A 7q36.1 0.16 0.227 0.766
xai RPL3P2 6p21.3 0.16 0.227 0.766
xai LOC100128242 11q24.1 0.16 0.227 0.766
his XIAP Xq25 0.16 0.227 0.766 Apoptosis
xai GNA15 19p13.3 0.16 0.227 0.766 blood coagulation;GTP catabolic process
exp RNU5E-9P 0.16 0.227 0.766
xai BTRC 10q24.32 0.16 0.227 0.766 protein ubiquitination;interspecies
xai CEBPA-AS1 19q13.11 0.16 0.227 0.766
xai RNU5E-9P 0.16 0.227 0.766
his HIST4H4 12p12.3 0.16 0.227 0.766
his H2AFJ 12p12.3 0.16 0.227 0.766 nucleosome assembly
his MSH6 2p16 0.16 0.227 0.766 DNA Damage Response (DDR); DDR (MMR); Tumor
Suppressors
xai FES 15q26.1 0.16 0.227 0.766 regulation of cell shape;positive
xai IBTK 6q14.1 0.16 0.227 0.766 negative regulation of protein
phosphorylation;release of sequestered calcium ion into cytosol
cop YWHAQ 2p25.1 0.158 0.227 0.765 protein targeting;small GTPase mediated
signal transduction
exp RMND1 6q25.1 0.158 0.227 0.765
cop USP10 16q24.1 0.158 0.227 0.765 protein deubiquitination;DNA damage
met PAQR5 15q23 0.158 0.227 0.765 multicellular organismal development;cell
differentiation
xsq C21orf2 21q22.3 0.158 0.227 0.765 cytoskeleton
mut ORMDL2 12q13.2 0.158 0.227 0.765 ceramide metabolic process
exp SNHG15 7p13 0.158 0.227 0.765
exp MIR924HG 0.158 0.227 0.765
cop RNF152 18q21.33 0.158 0.227 0.765 apoptotic process;protein K48-
linked ubiquitination
dependent"
met SH3YL1 2p25.3 0.158 0.227 0.765
met CYP17A1 10q24.3 0.158 0.227 0.765 response to herbicide;phthalate
metabolic process
cop GSPT1 16p13.1 0.158 0.227 0.765 G1/S transition of mitotic cell
xsq WNT8B 10q24 0.158 0.227 0.765 Apoptosis; Oncogenes
xsq LINC01011 0.158 0.227 0.765
met PRRG1 Xp21.1 0.158 0.227 0.765
xsq CES1P1 16q12.2 0.158 0.227 0.765
xsq CCDC94 19p13.3 0.158 0.227 0.765
met NFU1 2p15-p13 0.158 0.227 0.765 iron-sulfur cluster assembly
xsq GPALPP1 0.158 0.227 0.765
exp DCAF16 4p15.31 0.158 0.227 0.765 protein ubiquitination
cop COTL1 16q24.1 0.158 0.227 0.765 defense response to fungus
cop KLHL36 16q24.1 0.158 0.227 0.765
cop DTNA 18q12 0.158 0.227 0.765 striated muscle contraction;signal transduction
xsq OR14A16 1q44 0.158 0.227 0.765 response to stimulus
met NPB 17q25.3 0.158 0.227 0.765 G-protein coupled receptor signaling
cop WHSC1 4p16.3 0.158 0.227 0.765 regulation of transcription, DNA-
cop SCARNA22 4p16.3 0.158 0.227 0.765
cop NELFA 4p16.3 0.158 0.227 0.765
cop MIR943 0.158 0.227 0.765
cop C4orf48 4p16.3 0.158 0.227 0.765
cop NAT8L 4p16.3 0.158 0.227 0.765
cop POLN 4p16.3 0.158 0.227 0.765 DNA Damage Response (DDR); DDR (DNA
cop HAUS3 0.158 0.227 0.765 centrosome organization;cell division
cop MXD4 4p16.3 0.158 0.227 0.765 negative regulation of transcription from
RNA polymerase II promoter;negative regulation of cell proliferation
cop MIR4800 0.158 0.227 0.765
cop ZFYVE28 4p16.3 0.158 0.227 0.765 negative regulation of epidermal
growth factor-activated receptor activity;negative regulation of epidermal growth
cop LOC402160 0.158 0.227 0.765
cop RNF4 4p16.3 0.158 0.227 0.765 DNA Damage Response (DDR)
cop FAM193A 4p16.3 0.158 0.227 0.765
cop TNIP2 4p16.3 0.158 0.227 0.765 Apoptosis
cop SH3BP2 4p16.3 0.158 0.227 0.765 signal transduction
exp AP1G1 16q23 0.158 0.227 0.765 post-Golgi vesicle-mediated
exp DTD2 0.158 0.227 0.765
xsq TXNDC11 16p13.13 0.158 0.227 0.765 cell redox homeostasis
cop NME1 0.158 0.227 0.765 Apoptosis
mut CASP2 7q34-q35 0.158 0.227 0.765 Apoptosis
exp ADGRG2 0.158 0.227 0.765 G-protein coupled receptor signaling
xsq MBD4 3q21.3 0.158 0.227 0.765 DNA Damage Response (DDR); DDR (BER)
xsq PRR23A 0.158 0.227 0.765
cop SPATA18 4q12 0.158 0.227 0.765 response to DNA damage stimulus;cellular
response to stress
cop NR4A3 9q22 0.158 0.227 0.765 mesoderm formation;response to peptide hormone
stimulus
cop LOC441461 0.158 0.227 0.765
exp LOC442058 2q31.1 0.158 0.227 0.766
met LMO3 12p12.3 0.158 0.227 0.766 regulation of transcription, DNA-
dependent"
xsq NT5C 17q25.1 0.158 0.227 0.766 purine base metabolic process;nucleobase-
cop PPTC7 12q24.11 0.158 0.227 0.766
met WHAMM 15q25.2 0.158 0.227 0.766
dependent"
met PDZRN4 12q12 0.158 0.227 0.766
cop UBR7 14q32.12 0.158 0.227 0.766
cop MC5R 18p11.2 0.158 0.227 0.766
met CCNL1 3q25.31 0.158 0.227 0.766 regulation of cyclin-dependent protein
met DNAH9 17p12 0.158 0.227 0.766 cellular component movement;microtubule-based
movement
xsq USP26 Xq26.2 0.158 0.227 0.766
dependent"
met DLGAP5 14q22.3 0.158 0.227 0.766 DNA Damage Response (DDR)
mir hsa-miR-454 0.158 0.227 0.766
xsq POTEA 8p11.1 0.158 0.227 0.766
cop LOC650368 0.158 0.227 0.766
xsq NMB 15q22-qter 0.158 0.227 0.766 neuropeptide signaling pathway;cell-cell
signaling
xsq OR52K2 0.158 0.227 0.766
cop EPT1 2p23.3 0.158 0.227 0.766 phospholipid biosynthetic process
exp PODXL 7q32-q33 -0.158 0.227 0.766 cell migration;negative regulation
xsq MSX1 4p16.2 -0.158 0.227 0.766 multicellular organismal
exp VPS37C 11q12.2 -0.158 0.227 0.766 protein transport;viral
reproduction
exp AQP7P2 -0.158 0.227 0.766
cop UBA5 3q22.1 -0.158 0.227 0.766 oxidation-reduction process;protein
ufmylation
xsq TTC23 15q26.3 -0.158 0.227 0.766
xsq EPHB2 1p36.1-p35 -0.158 0.227 0.766 Protein Kinases
xsq PCDHGA1 5q31 -0.158 0.227 0.766 cell adhesion;homophilic cell
adhesion
xsq CCL11 17q12 -0.158 0.227 0.766 immune response;positive regulation of
cell migration
met TUBGCP5 15q11.2 -0.158 0.227 0.766 mitotic cell
exp XYLT2 17q21.33 -0.158 0.227 0.766 glycosaminoglycan biosynthetic
process
exp GOLGA5 14q32.12 -0.158 0.227 0.766 retrograde transport, vesicle
xsq FAM133A Xq21.32 -0.158 0.227 0.766
exp CLEC18B 16q22.3 -0.158 0.227 0.766
xsq PIP4K2C 12q13.3 -0.158 0.227 0.766
met GLB1L3 11q25 -0.158 0.227 0.766 carbohydrate metabolic process
met CTSW 11q13.1 -0.158 0.227 0.766 proteolysis;immune response
exp CSPG4P2Y -0.158 0.227 0.766
exp TFEB 6p21 -0.158 0.227 0.766 positive regulation of transcription from
cop RP1 8q12.1 -0.158 0.227 0.766 photoreceptor cell
maintenance;visual perception
cop NPHP3-AS1 3q22.1 -0.158 0.227 0.766
xsq KIF12 9q32 -0.158 0.227 0.766 microtubule-based movement
exp CLCA2 1p22.3 -0.158 0.227 0.766 transport;chloride transport
DNA-dependent"
met METTL4 18p11.32 -0.158 0.227 0.765 nucleobase-containing
xsq RBPMS-AS1 8p12 -0.158 0.227 0.765
met HIST1H4F 6p22.1 -0.158 0.227 0.765
met F7 13q34 -0.158 0.227 0.765 positive regulation of leukocyte
chemotaxis;response to organic cyclic compound
cop XKR4 8q12.1 -0.158 0.227 0.765
xsq LOC102724552 -0.158 0.227 0.765
mut RNF113A Xq24 -0.158 0.227 0.765
exp PEG10 7q21 -0.158 0.227 0.765 apoptotic process;cell differentiation
cop COL21A1 6p12.3-p11.2 -0.158 0.227 0.765 cell adhesion
cop KCNIP4-IT1 4p15.2 -0.158 0.227 0.765
exp MT1F 16q13 -0.158 0.227 0.765 negative regulation of growth;cellular
xsq HOXA3 7p15.2 -0.158 0.227 0.765 glossopharyngeal nerve
exp MKRN4P Xp21.1 -0.158 0.227 0.765
cop ZBTB18 1q44 -0.158 0.227 0.765
xsq SRXN1 20p13 -0.158 0.227 0.765 response to oxidative stress
his LINC00396 -0.16 0.227 0.766
hs4 TSC22D1 13q14 -0.16 0.227 0.766 negative regulation of apoptotic
his AR Xq12 -0.16 0.227 0.766 transcription, DNA-dependent;positive
hs4 CDKN1C 11p15.5 -0.16 0.227 0.766 positive regulation of transforming
activity
hs4 AMPH 7p14-p13 -0.16 0.227 0.766 synaptic transmission;learning
xai UOX 1p22 -0.16 0.227 0.766
swa KPNB1 17q21.32 -0.16 0.227 0.766 NLS-bearing substrate import into
his ITGB5 3q21.2 -0.16 0.227 0.766 antigen processing and presentation of
exogenous peptide antigen via MHC class I;antigen processing and presentation of
xai TFPT 19q13 -0.16 0.227 0.766 DNA Damage Response (DDR); DDR (Chromatin)
swa CHP1 15q13.3 -0.16 0.227 0.766
hs4 LINC00202-2 10p12.1 -0.16 0.227 0.765
hs4 RNF128 Xq22.3 -0.16 0.227 0.765 negative regulation of cytokine
swa KIAA0196 8q24.13 -0.16 0.227 0.765 cell death
swa IMMT 2p11.2 -0.16 0.227 0.765
xai RNF128 Xq22.3 -0.16 0.227 0.765 negative regulation of cytokine
his DLC1 8p22 -0.16 0.227 0.765 induction of apoptosis;actin cytoskeleton
organization
his MYEOV 11q13 -0.16 0.227 0.765
xai LINC-PINT -0.16 0.227 0.765
hs4 LRRC75A -0.16 0.227 0.765
hs4 TAGLN3 3q13.2 -0.16 0.227 0.765 central nervous system
xai GFPT2 5q34-q35 -0.16 0.227 0.765 dolichol-linked oligosaccharide
his BIN3-IT1 -0.16 0.227 0.765
hs4 FGF7 15q21.2 -0.16 0.227 0.765 insulin receptor signaling pathway;hair
hs4 COL5A3 19p13.2 -0.16 0.227 0.765 cell adhesion;cell-matrix adhesion
hs4 RDH8 19p13.2 -0.16 0.227 0.765 response to stimulus;steroid biosynthetic
process
exp ZNF859P -0.16 0.227 0.765
his ZFHX3 16q22.3 -0.16 0.227 0.765 negative regulation of myoblast
hs4 GRIN3B 19p13.3 0.16 0.228 0.766
exp PON1 7q21.3 0.159 0.228 0.766 positive regulation of transporter
hs4 POLE 12q24.3 0.159 0.228 0.766 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
hs4 PXMP2 12q24.33 0.159 0.228 0.766
xai NT5C 17q25.1 0.159 0.228 0.766 purine base metabolic process;nucleobase-
xai CCNB1IP1P2 0.159 0.228 0.766
exp UGT3A1 5p13.2 0.159 0.228 0.766 metabolic process
his RPL38 17q25.1 0.159 0.228 0.766 translation;mRNA metabolic process
his MGC16275 17q25.1 0.159 0.228 0.766
his TTYH2 17q25.1 0.159 0.228 0.766 ion transport
exp ABLIM2 4p16.1 0.159 0.228 0.766 cytoskeleton organization;axon
guidance
hs4 ULK1 12q24.3 0.159 0.228 0.766 neuron projection regeneration;neuron
his UBE2QL1 5p15.31 0.159 0.228 0.766
his ENTPD1-AS1 10q24.1 0.159 0.228 0.766
exp PSMC1P3 7q33 0.159 0.228 0.766
his USP32 17q23.3 0.159 0.228 0.766 proteolysis;ubiquitin-dependent protein
catabolic process
xai LONP1 19p13.2 0.159 0.228 0.766 cellular response to oxidative
his LOC100507600 0.159 0.228 0.766
xai LINC01538 0.159 0.228 0.766
dependent"
xai HDAC8 Xq13 0.159 0.228 0.766 negative regulation of transcription from RNA
polymerase II promoter;chromatin assembly or disassembly
his PSME4 2p16.2 0.159 0.228 0.766 antigen processing and presentation of
his KCNE3 11q13.4 0.159 0.228 0.766 ion transport;regulation of potassium ion
transport
hs4 DPAGT1 11q23.3 0.159 0.228 0.766 dolichol biosynthetic process;post-
exp NXF4 Xq22 0.159 0.228 0.766
his LOC643201 5q35.2 0.159 0.228 0.766
xai LINC01220 0.159 0.228 0.766
xai HINT2 9p13.3 0.159 0.228 0.766 steroid biosynthetic process;apoptotic
process
hs4 RPL35 9q34.1 0.159 0.228 0.766 viral reproduction;nuclear-transcribed
hs4 ARPC5L 9q33.3 0.159 0.228 0.766 regulation of actin filament
polymerization
xai CRIP1P4 22q11.2 0.159 0.228 0.766
exp CCNB1IP1P2 0.159 0.228 0.766
dependent"
xai NBR2 17q21 0.159 0.228 0.767
xai SSPO 7q36.1 0.159 0.228 0.767 cell adhesion
xai MYOD1 11p15.4 0.159 0.228 0.767 regulation of transcription from RNA
polymerase II promoter;skeletal muscle cell differentiation
xai CREB3L3 19p13.3 0.159 0.228 0.767 response to unfolded protein
hs4 WDR7 18q21.31 0.159 0.228 0.767
xai REV1 2q11.1-q11.2 0.159 0.228 0.767 DNA Damage Response (DDR); DDR (DNA
hs4 MED22 9q34.2 0.159 0.228 0.767 regulation of transcription from RNA
hs4 RPL7A 9q34 0.159 0.228 0.767 translation;mRNA metabolic process
hs4 SNORD24 0.159 0.228 0.767
hs4 SNORD36B 0.159 0.228 0.767
hs4 SNORD36A 0.159 0.228 0.767
hs4 SNORD36C 9q34 0.159 0.228 0.767
hs4 FOXO4 Xq13.1 0.159 0.228 0.767 Apoptosis
his PCGF2 17q12 0.159 0.228 0.767 negative regulation of transcription from RNA
polymerase II promoter;in utero embryonic development
his PSMB3 17q12 0.159 0.228 0.767 protein polyubiquitination;gene expression
hs4 METTL26 0.159 0.228 0.767
his BCR 22q11.23 0.159 0.228 0.767 actin cytoskeleton organization;positive
xsq DDX50 10q22.1 0.158 0.228 0.766
xsq ARMCX5 Xq22.1-q22.3 0.158 0.228 0.766
exp OGG1 3p26.2 0.158 0.228 0.766 DNA Damage Response (DDR); DDR (BER)
xsq LOC221122 11p11.2 0.158 0.228 0.766
mut TAF12 1p35.3 0.158 0.228 0.766 transcription from RNA polymerase II
xsq TMEM258 11q12.2 0.158 0.228 0.766
exp KHDC1 6q13 0.158 0.228 0.766
cop VPS13C 15q22.2 0.158 0.228 0.766 protein localization
cop ZNF385C 17q21.2 0.158 0.228 0.766
cop CDKN2B 9p21 0.158 0.228 0.766 Apoptosis
met DKK3 11p15.2 0.158 0.228 0.766 negative regulation of canonical Wnt
receptor signaling pathway;negative regulation of cortisol biosynthetic process
cop COLQ 3p25 0.158 0.228 0.766 acetylcholine catabolic process in synaptic
cleft;asymmetric protein localization
cop MIR4270 0.158 0.228 0.766
met OTX2 14q22.3 0.158 0.228 0.766 axon guidance;primitive streak formation
exp TMA7 3p21.31 0.158 0.228 0.766
xsq DGKZ 11p11.2 0.158 0.228 0.766 negative regulation of mitotic cell
xsq NUP62 0.158 0.228 0.766 Apoptosis
mir hsa-miR-181c* 0.158 0.228 0.766
xsq POLR2F 22q13.1 0.158 0.228 0.766 DNA Damage Response (DDR); DDR
(NER)
cop LPCAT2 16q12.2 0.158 0.228 0.766 metabolic process;phospholipid
exp CLCA3P 1p31-p22 0.158 0.228 0.766 transport;ion transport
met MIR431 0.158 0.228 0.766
exp ASB6 9q34.13 0.158 0.228 0.766 intracellular signal transduction
cop NETO1 18q22.2 0.158 0.228 0.766 visual learning;regulation of long-term
mut SP100 2q37.1 0.158 0.228 0.766 response to type I interferon;positive
xsq PGM2 4p14 0.158 0.228 0.766 glycogen catabolic process;glucose metabolic
process
exp SMG7 1q25 0.158 0.228 0.766 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;mRNA export from nucleus
xsq TRPT1 11q13.1 0.158 0.228 0.766 tRNA splicing, via endonucleolytic
cleavage and ligation"
xsq OSTF1 9q13-q21.2 0.158 0.228 0.766 ossification;signal transduction
mut FAM65C 20q13.13 0.158 0.228 0.766
exp ANAPC15 11q13.4 0.158 0.228 0.767
met TACSTD2 1p32 0.158 0.228 0.767 response to stimulus;negative regulation
of stress fiber assembly
exp GAK 4p16 0.158 0.228 0.767 cell cycle
cop CDH20 18q21.33 0.158 0.228 0.767 homophilic cell adhesion;cell-cell
adhesion
cop ZNF106 15q15.1 0.158 0.228 0.767
xsq CLRN1 3q25 0.158 0.228 0.767 sensory perception of sound;photoreceptor cell
maintenance
xsq CCDC184 0.158 0.228 0.767
xsq RAD18 3p25-p24 0.158 0.228 0.767 DNA Damage Response (DDR); DDR (TLS)
xsq NRN1L 16q22.1 0.158 0.228 0.767
cop BRIP1 17q22.2 0.158 0.228 0.767 DNA Damage Response (DDR); DDR (FA)
met HERC4 10q21.3 0.158 0.228 0.767 protein modification
met PPP1R18 6p21.3 -0.158 0.228 0.767
xsq LINC01111 -0.158 0.228 0.767
met TGIF2 20q11.23 -0.158 0.228 0.767 regulation of transcription, DNA-
exp OTOR 20p12.1-p11.23 -0.158 0.228 0.767 cartilage
cop COX6C 8q22.2 -0.158 0.228 0.767 generation of precursor metabolites
xsq BBOX1-AS1 -0.158 0.228 0.767
exp LINC00856 10q22.3 -0.158 0.228 0.767
met MPG 16p13.3 -0.158 0.228 0.766 DNA Damage Response (DDR); DDR
(BER)
exp LOC729960 11p11.12 -0.158 0.228 0.766
met CCL23 17q12 -0.158 0.228 0.766 immune response;signal transduction
exp HTR5BP 2q14.1 -0.158 0.228 0.766
exp ANKRD13C 1p32.3-p31.3 -0.158 0.228 0.766 protein retention in ER
lumen;regulation of receptor biosynthetic process
xsq CLIP1 12q24.3 -0.158 0.228 0.766 transport;mitosis
mut GTF3C1 16p12 -0.158 0.228 0.766 transcription, DNA-
met BIN3 8p21.3 -0.158 0.228 0.766 unidimensional cell
growth;cytokinesis
xsq ATN1 12p13.31 -0.158 0.228 0.766 negative regulation of
xsq LYST 1q42.1-q42.2 -0.158 0.228 0.766 natural killer cell mediated
cop RNPC3 1p21 -0.158 0.228 0.766 mRNA processing;RNA splicing
exp COPB1 11p15.2 -0.158 0.228 0.766 COPI coating of Golgi
cop LINC00558 -0.158 0.228 0.766
exp GGT6 17p13.2 -0.158 0.228 0.766 glutathione metabolic
xsq CASK Xp11.4 -0.158 0.228 0.766 negative regulation of wound
cop TXNRD2 22q11.21 -0.158 0.228 0.766 response to selenium
ion;hemopoiesis
met RGS1 1q31 -0.158 0.228 0.766 inhibition of adenylate cyclase activity
by G-protein signaling pathway;negative regulation of signal transduction
exp RASSF10 11p15.2 -0.158 0.228 0.766 signal transduction
xsq IQGAP1 15q26.1 -0.158 0.228 0.766 energy reserve metabolic
xai FGFBP2 4p16 -0.159 0.228 0.767
swa PPP1CC 12q24.1-q24.2 -0.159 0.228 0.767 carbohydrate metabolic
xai C14orf132 14q32.2 -0.159 0.228 0.767
his KIAA1211L 2q11.2 -0.159 0.228 0.767
hs4 DENND6B 22q13.33 -0.159 0.228 0.767
hs4 FITM2 20q13.12 -0.159 0.228 0.767 positive regulation of sequestering
hs4 PPARGC1A 4p15.1 -0.159 0.228 0.767 mRNA processing;respiratory
xai RNF217-AS1 -0.159 0.228 0.767
his SLIT3 5q35 -0.159 0.228 0.767 multicellular organismal development;axon
swa ABHD11 7q11.23 -0.159 0.228 0.767
hs4 CLIC4 1p36.11 -0.159 0.228 0.766 ion transport;chloride transport
hs4 TBX15 1p11.1 -0.159 0.228 0.766 embryonic cranial skeleton
morphogenesis
hs4 FAM83B 6p12.1 -0.159 0.228 0.766
hs4 BATF2 11q13.1 -0.159 0.228 0.766
his MIR6746 -0.159 0.228 0.766
DNA-dependent"
hs4 UBXN6 19p13 -0.159 0.228 0.766
his RHOJ 14q23.2 -0.159 0.228 0.766 GTP catabolic process;small GTPase
xai POU3F1 1p34.1 -0.159 0.228 0.766 myelination in peripheral
xai ZSCAN5C 19q13.43 -0.159 0.228 0.766 viral reproduction
exp KRT8P8 Xq28 -0.159 0.228 0.766
swa HINT2 9p13.3 -0.159 0.228 0.766 steroid biosynthetic
process;apoptotic process
his TOM1 22q13.1 -0.159 0.228 0.766 intracellular protein
his SCCPDH 1q44 -0.16 0.228 0.766
xai SYNE1 6q25 -0.16 0.228 0.766 nucleus organization;Golgi organization
xai HEATR5A 14q12 -0.16 0.228 0.766
his CSN3 4q21.1 0.159 0.229 0.767 lactation
exp SEL1L2 20p12.1 0.159 0.229 0.767
xai CHP2 16p12.2 0.159 0.229 0.767
exp GPR141 7p14.1 0.159 0.229 0.767 G-protein coupled receptor
signaling pathway
his PAN2 12q13.2 0.159 0.229 0.767 nuclear-transcribed mRNA catabolic
his IL23A 12q13.3 0.159 0.229 0.767 positive regulation of activation of JAK2
kinase activity;positive regulation of natural killer cell activation
his LOC100507507 0.159 0.229 0.767
his ZYX 7q32 0.159 0.229 0.767 signal transduction;cell-cell signaling
his MIR6892 0.159 0.229 0.767
his ANXA6 5q33.1 0.159 0.229 0.767 regulation of muscle contraction;calcium
ion transport
his WNT2 7q31.2 0.159 0.229 0.767 Apoptosis; Oncogenes
xai NUDT11 Xp11.22 0.159 0.229 0.767
xai ATM 11q22-q23 0.159 0.229 0.767 Apoptosis; DNA Damage Response (DDR); DDR
xai SNRPE 1q32 0.159 0.229 0.767 histone mRNA metabolic process;RNA splicing
his METTL1 12q13 0.159 0.229 0.767 tRNA modification
his METTL21B 12q14.1 0.159 0.229 0.767
exp PTENP1 9p21 0.159 0.229 0.767
xai KLHDC3 6p21.1 0.159 0.229 0.767 activation of signaling protein
xai LINC00616 0.159 0.229 0.767
hs4 GRB2 17q24-q25 0.159 0.229 0.767 cell-cell signaling;T cell costimulation
hs4 MIR3678 0.159 0.229 0.767
swa PPM1F 22q11.22 0.159 0.229 0.767 Apoptosis
xai NPY 7p15.1 0.159 0.229 0.767 G-protein signaling, coupled to cyclic
exp TIMM9 14q21 0.159 0.229 0.767 sensory perception of sound;protein import into
his CNPPD1 2q35 0.159 0.229 0.767 regulation of cyclin-dependent protein
kinase activity
his FAM134A 2q35 0.159 0.229 0.767
xai RPL18P10 0.159 0.229 0.767
his FBXO48 2p13.3 0.159 0.229 0.767
his APLF 2p13.3 0.159 0.229 0.767 DNA Damage Response (DDR); DDR (BER)
xai LOC100996412 0.159 0.229 0.767
his TMEM87B 2q13 0.159 0.229 0.767
xai KLHL40 3p22.1 0.159 0.229 0.767
xai KCNQ5 6q14 0.159 0.229 0.767 protein complex assembly;ion transport
exp RPL7P29 6q14.3 0.159 0.229 0.767
xai PPP6C 9q33.3 0.159 0.229 0.767 DNA Damage Response (DDR)
his LRRC23 12p13 0.159 0.229 0.767
exp B4GALT3 1q21-q23 0.158 0.229 0.767 carbohydrate metabolic
mut NT5C1A 1p34.3-p33 0.158 0.229 0.767
met DMRT2 9p24.3 0.158 0.229 0.767 regulation of transcription, DNA-
xsq HIST1H3B 6p22.1 0.158 0.229 0.767
xsq CDC42 1p36.1 0.158 0.229 0.767 small GTPase mediated signal
cop LOC340515 0.158 0.229 0.767
xsq C9orf171 9q34.13 0.158 0.229 0.767
exp LOC644456 2p16.1 0.158 0.229 0.767
exp TTC13 1q42.2 0.158 0.229 0.767
met OR7A5 19p13.1 0.158 0.229 0.767 sensory perception of smell;response to
stimulus
xsq SMCR2 0.158 0.229 0.767
xsq MYH8 17p13.1 0.158 0.229 0.767 muscle filament sliding;muscle
contraction
exp TYK2 19p13.2 0.158 0.229 0.767 intracellular protein kinase
xsq LINC00632 Xq27.1 0.158 0.229 0.767
xsq KRT78 12q13.13 0.158 0.229 0.767
xsq ICE1 0.158 0.229 0.767
met PDCD1LG2 9p24.2 0.158 0.229 0.767 immune response;T cell
costimulation
xsq AGL 1p21 0.158 0.229 0.767 carbohydrate metabolic process;glycogen
met CDC42EP1 22q13.1 0.158 0.229 0.767 regulation of cell shape;positive
regulation of pseudopodium assembly
xsq PDZD3 11q23.3 0.158 0.229 0.767 ion transport;water transport
exp SPDYE5 7q11.23 0.158 0.229 0.767
xsq UBE2J2 1p36.33 0.158 0.229 0.767 response to unfolded protein
mut LYPLA1 8q11.23 0.158 0.229 0.767 lipid metabolic process;fatty acid
metabolic process
met TBX20 7p14.3 0.158 0.229 0.767 endoderm formation;cardiac right
ventricle morphogenesis
cop PLCL2 3p24.3 0.158 0.229 0.767 lipid metabolic process;intracellular
signal transduction
met PCDH11Y Yp11.2 0.158 0.229 0.767 cell adhesion;homophilic cell
adhesion
mut KCNQ2 20q13.3 0.158 0.229 0.767 potassium ion transmembrane transport;ion
transport
exp CPLX2 5q35.2 0.158 0.229 0.767 neurotransmitter transport;vesicle
xsq SRP9 1q42.12 0.158 0.229 0.767 translation;SRP-dependent cotranslational
met ACSS3 12q21.31 0.158 0.229 0.767
met DSCR8 21q22.2 0.158 0.229 0.767
xsq ETF1 5q31.1 0.158 0.229 0.767 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;cellular protein metabolic process
xsq SARS2 19q13.2 0.158 0.229 0.767 tRNA aminoacylation for protein
xsq NEUROD6 7p14.3 0.158 0.229 0.767
cop OIP5 15q15.1 0.158 0.229 0.767 cell communication;CenH3-containing
xsq ABCC5 3q27 0.158 0.229 0.767 ABC Transporters
exp FAM162A 3q21.1 0.158 0.229 0.767
exp JTB 1q21 0.158 0.229 0.767 regulation of cell proliferation;negative
met MAATS1 3q12-q13.3 0.158 0.229 0.767
exp CCDC109B 4q25 0.158 0.229 0.767
met WISP2 20q13.12 0.158 0.229 0.767 Oncogenes
exp RPS26P54 18q21.32 0.158 0.229 0.767
met ZNF239 10q11.22-q11.23 0.158 0.229 0.767 regulation of transcription,
DNA-dependent"
exp SRP68 17q25.1 0.158 0.229 0.767 gene expression;response to drug
xsq DBIL5P 17p13.3 0.158 0.229 0.767
xsq RANBP1 22q11.21 0.158 0.229 0.767 viral reproduction;positive
xsq LOC101928303 0.158 0.229 0.767
xsq SCN4A 17q23.3 0.158 0.229 0.767 ion transport;sodium ion transport
cop DIRAS2 9q22.2 0.158 0.229 0.767 signal transduction;small GTPase
cop EXD1 15q15.1 0.158 0.229 0.767 nucleobase-containing compound metabolic
process
cop CHP1 15q13.3 0.158 0.229 0.767
cop OIP5-AS1 15q15.1 0.158 0.229 0.767
xsq ZC3H10 12q13.2 0.158 0.229 0.767
cop ZDHHC7 16q24.1 0.157 0.229 0.767
met CLVS1 8q12.3 0.157 0.229 0.767 lysosome organization
xsq KCND2 7q31 0.157 0.229 0.767 regulation of action potential;ion transport
met GK2 4q13 0.157 0.229 0.767
xsq OR8B12 0.157 0.229 0.767 response to stimulus
cop LOC284294 0.157 0.229 0.767
mut MAP1B 5q13 0.157 0.229 0.767 central nervous system development;response to
insecticide
xsq QARS 3p21.31 0.157 0.229 0.767 tRNA aminoacylation for protein
xsq HIVEP1 6p24-p22.3 -0.157 0.229 0.767 negative regulation of
exp SLC16A2 Xq13.2 -0.158 0.229 0.767 Solute Carriers
cop GPR125 4p15.2 -0.158 0.229 0.767
met TBCB 19q13.11-q13.12 -0.158 0.229 0.767 multicellular organismal
xsq CCDC148 2q24.1 -0.158 0.229 0.767
cop POLR2K 8q22.2 -0.158 0.229 0.767 DNA Damage Response (DDR);
DDR (NER)
xsq SPTBN5 15q21 -0.158 0.229 0.767 axon guidance;actin cytoskeleton
organization
xsq LOC101927911 -0.158 0.229 0.767
exp CLTA 9p13 -0.158 0.229 0.767 post-Golgi vesicle-mediated
cop LOC641746 7q11.21 -0.158 0.229 0.767
DNA-dependent"
cop LOC649395 -0.158 0.229 0.767
DNA-dependent"
exp SERINC2 1p35.1 -0.158 0.229 0.767
xsq SMARCD3 7q35-q36 -0.158 0.229 0.767 secondary heart field
specification;muscle cell differentiation
cop OTULIN -0.158 0.229 0.767
cop PLEKHF2 8q22.1 -0.158 0.229 0.767
exp CCR10 17q21.1-q21.3 -0.158 0.229 0.767 chemotaxis;G-protein coupled
exp RIPK2 8q21 -0.158 0.229 0.767 Apoptosis
met ABCF3 3q27.1 -0.158 0.229 0.767
exp ARHGEF16 1p36.3 -0.158 0.229 0.767 apoptotic process;cell
chemotaxis
cop DPYD 1p22 -0.158 0.229 0.767 thymidine catabolic process;UMP
cop ANKRD33B 5p15.2 -0.158 0.229 0.767
cop C1orf21 1q25 -0.158 0.229 0.767
met ABCA12 2q34 -0.158 0.229 0.767 ABC Transporters
exp DSCAML1 11q23 -0.158 0.229 0.767 homophilic cell adhesion;negative
regulation of cell adhesion
cop MIR185 -0.158 0.229 0.767
cop QSOX1 1q24 -0.158 0.229 0.767 protein thiol-disulfide exchange;cell
redox homeostasis
cop FLJ23867 1q25.2 -0.158 0.229 0.767
cop LHX4 1q25.2 -0.158 0.229 0.767 anti-apoptosis;motor axon guidance
cop LOC100527964 -0.158 0.229 0.767
cop ACBD6 1q25.1 -0.158 0.229 0.767
cop MIR3121 -0.158 0.229 0.767
exp ZFHX4 8q21.11 -0.158 0.229 0.767
xsq ELK3 12q23 -0.158 0.229 0.767 Transcription Factors
xsq TCTN1 12q24.11 -0.158 0.229 0.767 cilium morphogenesis;multicellular
his BASP1P1 13q12.12 -0.159 0.229 0.767
exp TNPO1P1 -0.159 0.229 0.767
his SNORA50A -0.159 0.229 0.767
his ARMC3 10p12.31 -0.159 0.229 0.767
his FNIP2 4q32.1 -0.159 0.229 0.767 regulation of protein
hs4 ECHDC2 1p32.3 -0.159 0.229 0.767 fatty acid metabolic
hs4 LYST 1q42.1-q42.2 -0.159 0.229 0.767 natural killer cell mediated
xai CGRRF1 14q22.2 -0.159 0.229 0.767 response to stress;cell cycle
xai TNC 9q33 -0.159 0.229 0.767 positive regulation of gene
exp TCEAL4P1 -0.159 0.229 0.767
hs4 KRBA2 17p13.1 -0.159 0.229 0.767 DNA integration;regulation of
his MIR6513 -0.159 0.229 0.767
his TMBIM1 2q35 -0.159 0.229 0.767
xai TCEAL4P1 -0.159 0.229 0.767
xai NFE2L3P1 18q21.32 -0.159 0.229 0.767
hs4 DDIT3 12q13.1-q13.2 -0.159 0.229 0.767 Apoptosis
hs4 MIR616 -0.159 0.229 0.767
hs4 MBD6 -0.159 0.229 0.767
cop PPP5D1 -0.159 0.229 0.767
cop CALM3 19q13.2-q13.3 -0.159 0.229 0.767 carbohydrate metabolic
cop PTGIR 19q13.3 -0.159 0.229 0.767 G-protein signaling, coupled to
cyclic nucleotide second messenger;cell-cell signaling
cop GNG8 19q13.32 -0.159 0.229 0.767
exp CYP4Z1 1p33 -0.159 0.229 0.767
xai KRT8P8 Xq28 -0.159 0.229 0.767
xai SOX17 8q11.23 -0.159 0.229 0.767 Cell Signaling
xai LOC100418770 -0.159 0.229 0.767
xai LOC151760 3q13.13 -0.159 0.229 0.767
his KRTAP2-1 17q21.2 -0.159 0.229 0.767
his GIP 17q21.3-q22 -0.159 0.229 0.767 response to selenium ion;positive
xai ADAM20 14q24.1 -0.159 0.229 0.767 proteolysis;single
fertilization
xai ZNF859P -0.159 0.229 0.767
xai SPDL1 5q35.1 -0.159 0.229 0.767
hs4 LOC102724156 -0.159 0.229 0.767
his LMLN 3q29 -0.159 0.229 0.767 cell cycle;mitosis
exp LOC645967 6q25.1 -0.159 0.229 0.767
exp FSIP1 15q14 -0.159 0.229 0.767
hs4 IL20RB 3q22.3 -0.159 0.229 0.767 positive regulation of
hs4 PPP1R3B 8p23.1 -0.159 0.229 0.767 carbohydrate metabolic
xai SPAG16 2q34 -0.159 0.229 0.767 cell projection organization;cilium
assembly
xai POU3F3 2q12.1 -0.159 0.229 0.767 cerebral cortex radially
oriented cell migration;metanephric thick ascending limb development
hs4 PRDM8 4q21 0.159 0.23 0.767 regulation of transcription, DNA-dependent"
xai CERS6 2q24.3 0.159 0.23 0.767 sphingolipid metabolic process;lipid
hs4 DLGAP4-AS1 0.159 0.23 0.767
hs4 TGIF2 20q11.23 0.159 0.23 0.767 regulation of transcription, DNA-
hs4 TGIF2-C20orf24 0.159 0.23 0.767
his DIS3L 15q22.31 0.159 0.23 0.768 rRNA catabolic process
xai CECR6 0.159 0.23 0.768
xai TMEM202 15q24.1 0.159 0.23 0.768
exp HSPA6 1q23 0.159 0.23 0.768 Apoptosis
exp RPL6P7 3q25.31 0.159 0.23 0.768
xai RPS3AP9 1q31.1 0.159 0.23 0.768
his RBM27 5q32 0.159 0.23 0.768 mRNA processing
his SMARCB1 22q11.23 0.159 0.23 0.768 DNA Damage Response (DDR); DDR
exp KLHL40 3p22.1 0.159 0.23 0.768
hs4 RPLP1 15q22 0.159 0.23 0.768 gene expression;viral reproduction
his C22orf23 22q13.1 0.159 0.23 0.768
his POLR2F 22q13.1 0.159 0.23 0.768 DNA Damage Response (DDR); DDR
(NER)
hs4 FGR 1p36.2-p36.1 0.159 0.23 0.768 immune response-regulating cell
xai NAP1L4 11p15.5 0.159 0.23 0.768 nucleosome assembly
swa CSTA 3q21 0.159 0.23 0.768 cell-cell adhesion;peptide cross-linking
his RAD1 5p13.2 0.159 0.23 0.768 DNA Damage Response (DDR)
his BRIX1 5p13.2 0.159 0.23 0.768 ribosome biogenesis
hs4 MTHFD2 2p13.1 0.159 0.23 0.768 one-carbon metabolic process;folic
acid-containing compound biosynthetic process
cop LOC100131094 0.159 0.23 0.768
xai SNX17 2p23-p22 0.159 0.23 0.769 receptor-mediated endocytosis;signal
transduction
his ACTR10 14q23.1 0.159 0.23 0.769 microtubule-based movement
xai PRDM12 9q33-q34 0.159 0.23 0.769 regulation of transcription, DNA-
dependent;neurogenesis"
xai CUL2 10p11.21 0.159 0.23 0.769 Apoptosis
xai WHAMMP1 15q13.3 0.159 0.23 0.769
exp GDPGP1 15q26.1 0.159 0.23 0.769
his MIR4287 0.159 0.23 0.769
xai EIF1AD 11q13.1 0.159 0.23 0.769
his H1FX-AS1 3q21.3 0.159 0.23 0.769
his H1FX 3q21.3 0.159 0.23 0.769 nucleosome assembly
exp ZMYM6 1p34.2 0.159 0.23 0.769 cytoskeleton organization;multicellular
swa STX5 11q12.3 0.159 0.23 0.769 retrograde transport, endosome to
Golgi;vesicle fusion with Golgi apparatus
hs4 TCAP 17q12 0.159 0.23 0.769 adult heart development;detection of mechanical
stimulus
hs4 PNMT 17q 0.159 0.23 0.769 cellular nitrogen compound metabolic
process;catecholamine biosynthetic process
xai PIGN 18q21.33 0.159 0.23 0.769 C-terminal protein lipidation;preassembly
met UBE2D4 7p13 0.157 0.23 0.767 protein K29-linked ubiquitination;protein
xsq CAPN15 16p13.3 0.157 0.23 0.767
exp ARMC10P1 3q11.2 0.157 0.23 0.767
cop TMEM178A 2p22.1 0.157 0.23 0.767
cop ZAR1 4p11 0.157 0.23 0.767 sodium ion transport;multicellular organismal
development
mut OR6N1 1q23.1 0.157 0.23 0.768
exp FRAT2 10q24.1 0.157 0.23 0.768 Apoptosis
xsq SPAM1 7q31.3 0.157 0.23 0.768 carbohydrate metabolic process;cell
adhesion
xsq TMEM187 Xq28 0.157 0.23 0.768
xsq PPIF 10q22-q23 0.157 0.23 0.768 protein folding;apoptotic mitochondrial
changes
exp PIGN 18q21.33 0.157 0.23 0.768 C-terminal protein lipidation;preassembly
cop HACL1 3p25.1 0.157 0.23 0.768 small molecule metabolic process;protein
oligomerization
xsq IL17RA 22q11.1 0.157 0.23 0.768 cell surface receptor signaling
exp C6orf120 6q27 0.157 0.23 0.768
xsq ATMIN 16q23.2 0.157 0.23 0.768 response to DNA damage stimulus
met VCPIP1 8q13 0.157 0.23 0.768 endoplasmic reticulum membrane
fusion;protein ubiquitination
met ANO1 11q13.3 0.157 0.23 0.768 chloride transport;multicellular
xsq HNRNPCL2 0.157 0.23 0.768
xsq SMARCD1 12q13-q14 0.157 0.23 0.768 DNA Damage Response (DDR); DDR
(Chromatin)
met HNRNPA1L2 13q14.3 0.157 0.23 0.768 RNA splicing;mRNA transport
met KIF7 15q26.1 0.157 0.23 0.768 microtubule-based movement;negative
dependent"
xsq LOC100128233 0.157 0.23 0.768
exp BTRC 10q24.32 0.157 0.23 0.768 protein ubiquitination;interspecies
cop MYO7A 11q13.5 0.157 0.23 0.768 inner ear morphogenesis;phagolysosome
assembly
xsq MIR646HG 0.157 0.23 0.768
xsq BRINP2 0.157 0.23 0.768 nervous system development;negative
xsq LOC100131257 7p22.1 0.157 0.23 0.768
xsq MYH2 17p13.1 0.157 0.23 0.768 muscle contraction;muscle filament
sliding
exp COX10 17p12 0.157 0.23 0.769 heme a biosynthetic process;respiratory chain
complex IV assembly
exp RELN 7q22 0.157 0.23 0.769 brain development;reelin-mediated signaling
pathway
xsq SIGLEC15 18q12.3 0.157 0.23 0.769
exp USP36 17q25.3 0.157 0.23 0.769 proteolysis;ubiquitin-dependent protein
catabolic process
xsq TACO1 17q23.3 0.157 0.23 0.769 regulation of translation
xsq PES1 22q12.1 0.157 0.23 0.769 cell proliferation;ribosomal large
subunit biogenesis
mut GRM3 7q21.1-q21.2 0.157 0.23 0.769
xsq LINC00987 0.157 0.23 0.769
met SGSM3 22q13.1-q13.2 0.157 0.23 0.769 cell cycle arrest;regulation of Rab
xsq RAD23A 19p13.2 0.157 0.23 0.769 DNA Damage Response (DDR); DDR
(NER)
xsq TPO 2p25 0.157 0.23 0.769 thyroid hormone generation;response to
oxidative stress
exp ARG1 6q23 0.157 0.23 0.769 response to zinc ion;response to drug
met MIR519E 0.157 0.23 0.769
exp UBE2T 1q32.1 0.157 0.23 0.769 DNA Damage Response (DDR); DDR (FA)
xsq WNT7B 22q13 -0.157 0.23 0.769 Oncogenes
cop CCDC171 9p22.3 -0.157 0.23 0.769
xsq GPM6B Xp22.2 -0.157 0.23 0.769 multicellular organismal
met MTPAP 10p11.23 -0.157 0.23 0.769 cell death;histone mRNA catabolic
process
cop AMY2B 1p21 -0.157 0.23 0.769
cop DIRAS3 1p31 -0.157 0.23 0.769 regulation of cyclin-dependent
protein kinase activity;GTP catabolic process
exp SLC5A3 21q22.12 -0.157 0.23 0.769 transport;ion transport
exp LINC00479 21q22.3 -0.157 0.23 0.769
exp TCEA1P1 9q22.33 -0.157 0.23 0.769
met CLNS1A 11q13.5-q14 -0.157 0.23 0.769 blood circulation;gene
expression
exp TRAF4 17q11-q12 -0.157 0.23 0.768 Apoptosis
exp LYST 1q42.1-q42.2 -0.157 0.23 0.768 natural killer cell mediated
exp LOC100289650 19q13.2 -0.157 0.23 0.768
exp AMOTL1 11q14.3 -0.157 0.23 0.768
xsq OR7E91P 2p13.3 -0.157 0.23 0.768
xsq KIAA1644 -0.157 0.23 0.768
cop CRKL 22q11.21 -0.157 0.23 0.768 heart development;organ
morphogenesis
cop LOC100616530 -0.157 0.23 0.768
mut RUSC1 1q21-q22 -0.157 0.23 0.768
exp CMTM5 14q11.2 -0.157 0.23 0.768 chemotaxis
cop DPYD-AS1 -0.157 0.23 0.768
xsq CIC 19q13.2 -0.157 0.23 0.768 Tumor Suppressors
exp ESRP1 8q22.1 -0.157 0.23 0.768 EMT (Epithelial)
exp SIM1 6q16.3 -0.157 0.23 0.768 cell differentiation;ureteric bud
development
exp SHANK2 11q13.2 -0.157 0.23 0.768 intracellular signal
transduction
xsq HS6ST3 13q32.1 -0.157 0.23 0.768
mut LZTR1 22q11.21 -0.157 0.23 0.768 regulation of transcription, DNA-
met BCR 22q11.23 -0.157 0.23 0.767 actin cytoskeleton
organization;positive regulation of phagocytosis
xsq LOC100130451 -0.157 0.23 0.767
xai KRT9 17q21.2 -0.159 0.23 0.769 skin development;intermediate
his CALD1 7q33 -0.159 0.23 0.769 cellular component movement;muscle
contraction
DNA-dependent"
exp NOTCH4 6p21.3 -0.159 0.23 0.769 cell fate
determination;hemopoiesis
his NKX3-1 8p21.2 -0.159 0.23 0.769 DNA Damage Response (DDR)
his SLC19A3 2q37 -0.159 0.23 0.769 Solute Carriers
hs4 DIP2B 12q13.12 -0.159 0.23 0.769
exp CPSF4L 17q25.1 -0.159 0.23 0.769
his PRR34-AS1 -0.159 0.23 0.769
his PRR34 -0.159 0.23 0.769
his MIRLET7BHG 22q13.31 -0.159 0.23 0.769
his MIR3619 -0.159 0.23 0.769
his SCARA3 8p21 -0.159 0.23 0.769 response to oxidative stress;UV
protection
exp FGF20 8p22 -0.159 0.23 0.769 signal transduction;positive regulation
xai C1orf195 -0.159 0.23 0.769
his CPA3 3q24 -0.159 0.23 0.769 proteolysis
hs4 AKR7L 1p36.13 -0.159 0.23 0.769
xai DNAJC18 5q31.2 -0.159 0.23 0.768 protein folding
hs4 STAT2 12q13.3 -0.159 0.23 0.768 Apoptosis
hs4 APOF -0.159 0.23 0.768
hs4 GJA1 6q22.31 -0.159 0.23 0.768 signal transduction;gap junction
assembly
his LOC100506188 -0.159 0.23 0.768
cop HAS1 19q13.4 -0.159 0.23 0.768 glycosaminoglycan biosynthetic
his MSC-AS1 -0.159 0.23 0.768
his MSC 8q21 -0.159 0.23 0.768 regulation of transcription, DNA-
swa ARFGEF2 20q13.13 -0.159 0.23 0.768 exocytosis;vesicle-mediated
transport
xai ZNF488 10q11.22 -0.159 0.23 0.768 oligodendrocyte
his LINC01879 -0.159 0.23 0.768
his RPLP0P2 11cen-q12 -0.159 0.23 0.768
swa SEC63 6q21 -0.159 0.23 0.768 protein folding;protein targeting to
membrane
exp C10orf55 10q22.2 -0.159 0.23 0.768
xai BAALC-AS1 -0.159 0.23 0.768
his AHR 7p15 -0.159 0.23 0.768 Apoptosis
his MMP19 12q14 -0.159 0.23 0.767 Apoptosis
cop PNMAL2 19q13.32 -0.16 0.23 0.768
exp LGALS17A 19q13.2 0.158 0.231 0.769
his RNF8 6p21.3 0.158 0.231 0.769 DNA Damage Response (DDR); DDR (NHEJ)
his CXCL6 4q13.3 0.158 0.231 0.769 chemotaxis;inflammatory response
swa RANBP3 19p13.3 0.158 0.231 0.769 protein transport;intracellular
transport
his CWC15 11q21 0.158 0.231 0.769 nuclear mRNA splicing, via spliceosome;RNA
splicing"
his KDM4D 11q21 0.158 0.231 0.769 regulation of transcription, DNA-
hs4 HNRNPA1P10 19p13.2 0.158 0.231 0.769
hs4 PPP2R5C 14q32.31 0.158 0.231 0.769 protein processing;DNA damage
apoptosis
hs4 KIFC1 6p21.3 0.158 0.231 0.769 microtubule-based movement;cell cycle
his TAF1 Xq13.1 0.158 0.231 0.769 regulation of transcription involved in
his GPRIN1 5q35.2 0.158 0.231 0.769 neuron projection development
xai KIAA0586 14q23.1 0.158 0.231 0.769
swa RSF1 11q14.1 0.158 0.231 0.769 nucleosome positioning;CenH3-containing
his AOX3P-AOX2P 0.158 0.231 0.769
hs4 ORC1 1p32 0.158 0.231 0.769 DDR (DNA replication)
hs4 PRPF38A 1p32.3 0.158 0.231 0.769 mRNA processing;RNA splicing
his MIR548X2 0.158 0.231 0.769
his FAM86JP 3q21.2 0.158 0.231 0.769
xai KIF26A 14q32.33 0.158 0.231 0.769 regulation of cell growth by
exp SSPO 7q36.1 0.158 0.231 0.769 cell adhesion
exp RPL18 19q13 0.158 0.231 0.769 viral reproduction;nuclear-transcribed mRNA
xai BRIP1 17q22.2 0.158 0.231 0.769 DNA Damage Response (DDR); DDR (FA)
hs4 LMTK3 19q13.33 0.158 0.231 0.769 negative regulation of phosphatase
activity
exp IGLV2-28 0.158 0.231 0.769
swa RNF213 17q25.3 0.158 0.231 0.769 protein ubiquitination;protein
autoubiquitination
exp ERICH6 0.158 0.231 0.769
hs4 PROSER2-AS1 0.158 0.231 0.769
hs4 CAD 2p22-p21 0.158 0.231 0.769 Apoptosis
exp RTL1 14q32.2 0.158 0.231 0.769 multicellular organismal development
his BLOC1S6 15q21.1 0.158 0.231 0.769
hs4 RFWD3 16q23.1 0.158 0.231 0.769 DNA repair;response to ionizing radiation
his ECHDC1 6q22.33 0.158 0.231 0.769
xai IGLV2-28 0.158 0.231 0.769
xai HMGN1P20 0.158 0.231 0.769
swa DCAF7 17q23.3 0.158 0.231 0.769 multicellular organismal
exp LINC01592 0.158 0.231 0.769
hs4 IRF8 16q24.1 0.158 0.231 0.769 immune response;positive regulation of
xai LINC01592 0.158 0.231 0.769
exp HMGN1P20 0.158 0.231 0.769
xai INSL4 9p24 0.158 0.231 0.769 signal transduction;cell-cell signaling
his ATP2C1 3q22.1 0.158 0.231 0.769 manganese ion transport;Golgi
xai CRIPAK 4p16.3 0.158 0.231 0.769 negative regulation of protein
pathway
xai SPATA22 17p13.3 0.158 0.231 0.769
exp SEC63 6q21 0.157 0.231 0.769 protein folding;protein targeting to membrane
xsq CXorf57 Xq22.3 0.157 0.231 0.769
exp SEZ6L 22q12.1 0.157 0.231 0.769
mut LRP2 2q31.1 0.157 0.231 0.769 forebrain development;protein
glycosylation
xsq KEAP1 19p13.2 0.157 0.231 0.769 in utero embryonic development;regulation
xsq LINC00936 12q21.33 0.157 0.231 0.769
cop RPRD1A 18q12.2 0.157 0.231 0.769 dephosphorylation of RNA polymerase
II C-terminal domain
mut DSCAM 21q22.2 0.157 0.231 0.769 cell adhesion;dendrite self-avoidance
xsq C1orf233 1p36.33 0.157 0.231 0.769
exp FOSB 19q13.32 0.157 0.231 0.769 behavior;cellular response to calcium ion
xsq BDH2 4q24 0.157 0.231 0.769 siderophore biosynthetic process;heme metabolic
process
met FSTL5 4q32.3 0.157 0.231 0.769
exp CASP2 7q34-q35 0.157 0.231 0.769 Apoptosis
exp SCO1 17p13.1 0.157 0.231 0.769 generation of precursor metabolites and
met NMS 2q11.2 0.157 0.231 0.769 regulation of smooth muscle
met BACE1 11q23.2-q23.3 0.157 0.231 0.769 proteolysis;membrane protein
met PRKAG2 7q36.1 0.157 0.231 0.769 negative regulation of protein
kinase activity;regulation of fatty acid metabolic process
xsq RHOT1 17q11.2 0.157 0.231 0.769 Apoptosis
xsq NDUFS1 2q33-q34 0.157 0.231 0.769 ATP synthesis coupled electron
transport;small molecule metabolic process
met LMX1A 1q24.1 0.157 0.231 0.769 negative regulation of neuron
differentiation;regulation of cell growth
met DCAF12L2 Xq25 0.157 0.231 0.769
xsq GCAT 22q13.1 0.157 0.231 0.769 biosynthetic process;cellular amino acid
metabolic process
cop LINC00305 18q22.1 0.157 0.231 0.769
xsq PTCHD1 Xp22.11 0.157 0.231 0.769 smoothened signaling
pathway;cognition
met MIR449C 0.157 0.231 0.769
cop ZFYVE19 15q15.1 0.157 0.231 0.769
xsq NXPE1 11q23.2 0.157 0.231 0.769
met SMARCAL1 2q35 0.157 0.231 0.769 DNA Damage Response (DDR)
xsq FLOT2 17q11-q12 0.157 0.231 0.769 epidermis development;cell adhesion
exp CSNK2B 6p21.3 0.157 0.231 0.769 Protein Kinases
xsq CD80 3q13.3-q21 0.157 0.231 0.769 interspecies interaction between
organisms;positive regulation of interleukin-2 biosynthetic process
met SNAP25 20p12-p11.2 0.157 0.231 0.769 synaptic vesicle docking involved
in exocytosis;regulation of insulin secretion
cop SCGB1A1 11q12.3 0.157 0.231 0.769 negative regulation of interleukin-
4 production;negative regulation of interleukin-5 production
cop PKD1L2 16q23.2 0.157 0.231 0.769 ion transport;neuropeptide
signaling pathway
xsq SERGEF 11p14.3 0.157 0.231 0.769 signal transduction;negative
xsq ADO 10q21.3 0.157 0.231 0.769
mut ZBTB26 9q33.2 0.157 0.231 0.769 regulation of transcription, DNA-
dependent"
met B4GALNT3 12p13.33 0.157 0.231 0.769
met VSTM5 11q21 0.157 0.231 0.769
xsq ZNF705D 0.157 0.231 0.769
exp BAG5 14q32.33 0.157 0.231 0.769 Apoptosis
xsq COL2A1 12q13.11 -0.157 0.231 0.769 heart morphogenesis;notochord
development
cop OSBPL11 3q21 -0.157 0.231 0.769 transport;lipid transport
exp CAMK1 3p25.3 -0.157 0.231 0.769 nervous system development;positive
cop TTC39B 9p22.3 -0.157 0.231 0.769
cop SNAPC3 9p22.3 -0.157 0.231 0.769 regulation of transcription,
cop PSIP1 9p22.3 -0.157 0.231 0.769 provirus integration;initiation of
viral infection
exp CHMP2A 19q -0.157 0.231 0.769 protein transport;cellular membrane
organization
exp FLRT2 14q24-q32 -0.157 0.231 0.769 cell adhesion
cop TBL1Y Yp11.2 -0.157 0.231 0.769 proteasomal ubiquitin-dependent
protein catabolic process;response to estrogen stimulus
exp SVILP1 10p11.23 -0.157 0.231 0.769
met FNDC1 6q25 -0.157 0.231 0.769 cellular response to hypoxia;positive
exp IGSF8 1q23.1 -0.157 0.231 0.769 cell proliferation;cellular
component movement
mut TTLL9 20q11.21 -0.157 0.231 0.769 protein modification process
exp TMTC1 12p11.22 -0.157 0.231 0.769
cop LOC100505912 -0.157 0.231 0.769
xsq EPHB1 3q21-q23 -0.157 0.231 0.769 optic nerve morphogenesis;ephrin
mut OR52W1 11p15.4 -0.157 0.231 0.769 response to stimulus
pro NCAM1 11q23.1 -0.157 0.231 0.769 interferon-gamma-mediated signaling
exp TMC4 19q13.42 -0.157 0.231 0.769 EMT (Epithelial)
cop LOC285577 -0.157 0.231 0.769
exp ECHS1 10q26.2-q26.3 -0.157 0.231 0.769 fatty acid metabolic
exp IGFL2 19q13.32 -0.157 0.231 0.769
cop NCALD 8q22.2 -0.157 0.231 0.769 synaptic transmission;vesicle-
mediated transport
cop CPQ 8q22.2 -0.157 0.231 0.769 proteolysis;peptide metabolic
process
exp PKD1 16p13.3 -0.157 0.231 0.769 cartilage condensation;homophilic
cell adhesion
xsq RHOJ 14q23.2 -0.157 0.231 0.769 GTP catabolic process;small GTPase
xsq USP2 11q23.3 -0.157 0.231 0.769 protein deubiquitination;positive
cop TMEM108 3q21 -0.157 0.231 0.769
xsq DGCR2 22q11.21 -0.157 0.231 0.769 cell adhesion;organ morphogenesis
mut MAPK7 17p11.2 -0.157 0.231 0.769 Protein Kinases
cop CDV3 3q22.1 -0.157 0.231 0.769 cell proliferation
cop TOPBP1 3q22.1 -0.157 0.231 0.769 DNA Damage Response (DDR);
DDR (DNA replication); DDR (G2-M checkpoint)
xsq LOC101928404 -0.157 0.231 0.769
xsq SCRG1 4q34.1 -0.157 0.231 0.769 nervous system development
xsq TDO2 4q31-q32 -0.157 0.231 0.769 tryptophan catabolic
xsq IQCD 12q24.13 -0.157 0.231 0.769
dependent"
met SLAIN1 13q22.3 -0.157 0.231 0.769
swa C8orf82 8q24 -0.158 0.231 0.769
his CTNNAL1 9q31.2 -0.158 0.231 0.769 Apoptosis
swa RMDN1 8q21.3 -0.158 0.231 0.769
hs4 CLDN22 4q35.1 -0.158 0.231 0.769 calcium-independent cell-cell
hs4 CLDN24 4q35.1 -0.158 0.231 0.769
swa SRC 20q12-q13 -0.158 0.231 0.769 Apoptosis; Oncogenes; Protein
Kinases
hs4 ACHE 7q22 -0.158 0.231 0.769 regulation of receptor recycling;synapse
assembly
xai KAAG1 6p22.1 -0.158 0.231 0.769 immune response
cop FPR1 19q13.4 -0.158 0.231 0.769 signal transduction;G-protein
exp BOLL 2q33 -0.158 0.231 0.769 meiosis;multicellular organismal
development
xai PARP9 3q21 -0.158 0.231 0.769 cell migration;regulation of response to
interferon-gamma
exp MROH2A 2q37.1 -0.158 0.231 0.769
xai FZD5 2q33.3 -0.158 0.231 0.769 Oncogenes
xai LOC645967 6q25.1 -0.158 0.231 0.769
xai LINC00336 6p21.31 -0.158 0.231 0.769
hs4 AMY1C -0.158 0.231 0.769
xai WIF1 12q14.3 -0.158 0.231 0.769 signal transduction;multicellular
his OR2A42 -0.158 0.231 0.769
swa FHL2 2q12.2 -0.158 0.231 0.769 negative regulation of
development
his LOC730668 22q13.31 -0.158 0.231 0.769
his LINC01137 -0.158 0.231 0.769
his ZC3H12A 1p34.3 -0.158 0.231 0.769 cell
differentiation;angiogenesis
his MIR6732 -0.158 0.231 0.769
hs4 LOC101928279 -0.158 0.231 0.769
his LOC101928433 -0.158 0.231 0.769
his ATXN1 6p23 -0.158 0.231 0.769 cell death;regulation of excitatory
his SPON2 -0.158 0.231 0.769 cell adhesion;axon guidance
exp ZNF33AP1 10p11 -0.158 0.231 0.769
xai LOC100996521 -0.158 0.231 0.769
exp LOC100996521 -0.158 0.231 0.769
hs4 NDFIP2 13q31.1 -0.158 0.231 0.769 signal transduction;negative
hs4 NDFIP2-AS1 -0.158 0.231 0.769
xai GBP5 1p22.2 -0.158 0.231 0.769 cellular response to interferon-
gamma
xai SPRR3 1q21-q22 -0.158 0.231 0.769 keratinization;wound healing
xai PBX3 9q33.3 -0.158 0.231 0.769 regulation of respiratory gaseous
exchange by neurological system process;anterior compartment pattern formation
xai TSPAN10 17q25.3 -0.158 0.231 0.769
cop ZFP14 19q13.12 -0.158 0.231 0.769 regulation of transcription, DNA-
dependent"
hs4 RBM47 4p14 -0.158 0.231 0.769
swa ADAM10 15q22 -0.158 0.231 0.769 proteolysis;positive regulation of
cell proliferation
hs4 TCEAL8 Xq22.1 -0.158 0.231 0.769 regulation of transcription,
DNA-dependent"
exp LOC643770 0.158 0.232 0.77
xai LRIT1 10q23 0.158 0.232 0.77
his PRPF39 14q21.2 0.158 0.232 0.77 mRNA processing;RNA splicing
hs4 CRLF3 17q11.2 0.158 0.232 0.77 negative regulation of cell
his CNTNAP3B 0.158 0.232 0.77
exp LRIT1 10q23 0.158 0.232 0.77
exp IGHV3-43 0.158 0.232 0.77
swa LRPPRC 2p21 0.158 0.232 0.77 regulation of transcription, DNA-
dependent;transport
xai ROBO4 11q24.2 0.158 0.232 0.77 angiogenesis;multicellular organismal
development
hs4 SAMD11 1p36.33 0.158 0.232 0.77
xai IGHV3-43 0.158 0.232 0.77
hs4 MIF-AS1 0.158 0.232 0.77
hs4 MIF 22q11.23 0.158 0.232 0.77 Apoptosis
exp C9orf24 9p13.3 0.158 0.232 0.77 cellular protein complex assembly
his COASY 17q12-q21 0.158 0.232 0.77 pantothenate metabolic process;small
his MLX 17q21.1 0.158 0.232 0.77 energy reserve metabolic
exp LOC100506859 0.158 0.232 0.77
his CYC1 8q24.3 0.158 0.232 0.77 transport;respiratory electron transport
chain
hs4 FAM227B 15q21.2 0.158 0.232 0.77
hs4 DTWD1 15q21.2 0.158 0.232 0.77
xai CLEC4D 12p13.31 0.158 0.232 0.77 innate immune response
exp HERC2P10 15q13.2 0.158 0.232 0.77
xai TRUB2 9q34.11 0.158 0.232 0.77 RNA processing;tRNA processing
xai LINC01088 0.158 0.232 0.77
xai TMEM187 Xq28 0.158 0.232 0.77
xai LACRT 12q13 0.158 0.232 0.77 positive regulation of cell
proliferation;positive regulation of NFAT protein import into nucleus
hs4 NTS 12q21 0.158 0.232 0.77 signal transduction;regulation of blood vessel
size
his ELOF1 19p13.2 0.158 0.232 0.77 regulation of transcription, DNA-
dependent"
xai MEX3B 15q25.2 0.158 0.232 0.77 protein phosphorylation;protein
autophosphorylation
his TLE2 19p13.3 0.158 0.232 0.77 negative regulation of canonical Wnt
receptor signaling pathway;signal transduction
his LIPF 10q23.31 0.158 0.232 0.77
exp ALG3P1 5p15.32 0.158 0.232 0.77
xai FAM9C Xp22.2 0.158 0.232 0.77
hs4 WDR74 11q12.3 0.158 0.232 0.77
hs4 SMC3 10q25 0.158 0.232 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
his PIP5K1C 19p13.3 0.158 0.232 0.77 neutrophil chemotaxis;adherens
junction assembly
xai LOC100506859 0.158 0.232 0.77
mut ERMAP 1p34.2 0.157 0.232 0.769
exp ALDH5A1 6p22 0.157 0.232 0.77 succinate metabolic process;central
met FKRP 19q13.32 0.157 0.232 0.77 glycoprotein biosynthetic process;protein
processing
mut NPTX1 17q25.3 0.157 0.232 0.77 axonogenesis involved in
cop CENPO 2p23.3 0.157 0.232 0.77 nucleosome assembly;chromosome
segregation
xsq NTN5 19q13.33 0.157 0.232 0.77
exp EIF1AD 11q13.1 0.157 0.232 0.77
xsq LOC100507387 0.157 0.232 0.77
xsq GOLGA6L7P 15q13.1 0.157 0.232 0.77
mut USP9X Xp11.4 0.157 0.232 0.77 mitosis;transforming growth factor beta
cop INO80 15q15.1 0.157 0.232 0.77 DNA Damage Response (DDR); DDR
(Chromatin)
xsq FLJ40288 0.157 0.232 0.77
mut ATP8B4 15q21.2 0.157 0.232 0.77 phospholipid transport;cation
transport
cop TBC1D5 3p24.3 0.157 0.232 0.77
cop ETFA 15q23-q25 0.157 0.232 0.77 transport;respiratory electron transport
chain
met PARP6 15q23 0.157 0.232 0.77
cop OTOF 2p23.1 0.157 0.232 0.77 cellular membrane fusion;sensory
perception of sound
xsq NBPF20 0.157 0.232 0.77
met PPP2R2C 4p16.1 0.157 0.232 0.77 signal transduction
cop POLE 12q24.3 0.157 0.232 0.77 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
xsq ATG4B 2q37.3 0.157 0.232 0.77 protein transport;autophagic vacuole
assembly
xsq ADAM1A 12q24.13 0.157 0.232 0.77
met PRR25 16p13.3 0.157 0.232 0.77
mut ADAD1 4q27 0.157 0.232 0.77 spermatogenesis;spermatid development
met ANKRD27 19q13.11 0.157 0.232 0.77 early endosome to late endosome
transport
met AACSP1 5q35.3 0.157 0.232 0.77
xsq TDP2 6p22.3-p22.1 0.157 0.232 0.77 DNA Damage Response (DDR)
xsq NKAPL 0.157 0.232 0.77
met ERN2 16p12.2 0.157 0.232 0.77 cell cycle arrest;rRNA catabolic process
met GNG11 7q21 0.157 0.232 0.77 GTP catabolic process;signal transduction
met CHODL 21q11.2 0.157 0.232 0.77 muscle organ development
exp ATP2A1-AS1 0.157 0.232 0.77
cop MIR3654 0.157 0.232 0.77
cop AHNAK 11q12.2 0.157 0.232 0.77 nervous system development
cop EEF1G 11q12.3 0.157 0.232 0.77 translation;translational elongation
xsq LOC100289361 3q23 0.157 0.232 0.77
xsq PSMD10 Xq22.3 0.157 0.232 0.77 cell cycle checkpoint;antigen
dependent
cop TUT1 11q12.2 0.157 0.232 0.77 mRNA polyadenylation;mRNA cleavage
exp RNASEH2A 19p13.2 0.157 0.232 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
met BTNL8 5q35.3 0.156 0.232 0.77
cop MTA2 11q12-q13.1 0.156 0.232 0.77 negative regulation of transcription from
cop EML3 11q12.3 0.156 0.232 0.77
cop ROM1 11q13 0.156 0.232 0.77 cell adhesion;visual perception
cop B3GAT3 11q12.3 0.156 0.232 0.77 glycosaminoglycan biosynthetic
process
cop GANAB 11q12.3 0.156 0.232 0.77 carbohydrate metabolic process;protein
folding
cop C11orf48 11q12.3 0.156 0.232 0.77
cop METTL12 11q12.3 0.156 0.232 0.77
cop SNORA57 11q12.2 0.156 0.232 0.77
cop C11orf83 0.156 0.232 0.77
cop UBXN1 11q12.3 0.156 0.232 0.77 negative regulation of protein
catabolic process
exp WRB 21q22.3 0.156 0.232 0.77
xsq PWWP2B 10q26.3 -0.156 0.232 0.77
xsq NUAK2 1q32.1 -0.157 0.232 0.77 Apoptosis
xsq TMPRSS11E 4q13.2 -0.157 0.232 0.77 proteolysis
exp LOC100129942 15q26.1 -0.157 0.232 0.77
exp PBX3 9q33.3 -0.157 0.232 0.77 regulation of respiratory gaseous
exchange by neurological system process;anterior compartment pattern formation
met GSN 9q33 -0.157 0.232 0.77 cell projection organization;response to
folic acid
cop LYN 8q13 -0.157 0.232 0.77 Protein Kinases
exp STK32A 5q32 -0.157 0.232 0.77
cop DYDC2 10q23.1 -0.157 0.232 0.77
xsq IFITM4P 6p22.1 -0.157 0.232 0.77
xsq LOC440895 -0.157 0.232 0.77
met DDX6 11q23.3 -0.157 0.232 0.77 nuclear-transcribed mRNA catabolic
exp PLXND1 3q22.1 -0.157 0.232 0.77 multicellular organismal
met CYP4A11 1p33 -0.157 0.232 0.77
met RBM4 11q13 -0.157 0.232 0.77 cell differentiation;regulation of
cop LOC401497 -0.157 0.232 0.77
xsq LINC01545 -0.157 0.232 0.77
xsq LOC283140 -0.157 0.232 0.77
xsq SNAPC1 14q22 -0.157 0.232 0.77 regulation of transcription, DNA-
xsq BIN1 2q14 -0.157 0.232 0.77 positive regulation of GTPase
cop EDEM3 1q25 -0.157 0.232 0.77 glycoprotein catabolic process;response
to unfolded protein
mut NAV1 1q32.3 -0.157 0.232 0.77 microtubule bundle formation;neuron
migration
cop COMT 22q11.21 -0.157 0.232 0.77 methylation;response to pain
cop MIR4761 -0.157 0.232 0.77
cop ARVCF 22q11.21 -0.157 0.232 0.77 cell adhesion;multicellular
xsq ADM 11p15.4 -0.157 0.232 0.77 progesterone biosynthetic
xsq CRB3 19p13.3 -0.157 0.232 0.77 cell junction assembly;cell-cell
xai PLEKHH2 2p21 -0.158 0.232 0.77
his LINP1 -0.158 0.232 0.77
xai PRADC1P1 3p22.2 -0.158 0.232 0.77
exp ZBTB20-AS1 -0.158 0.232 0.77
exp PRADC1P1 3p22.2 -0.158 0.232 0.77
his DNM3 1q24.3 -0.158 0.232 0.77 GTP catabolic process;endocytosis
his CREB5 7p15.1 -0.158 0.232 0.77 transcription from RNA polymerase
xai HCG22 6p21.33 -0.158 0.232 0.77
his PRKAB2 1q21.1 -0.158 0.232 0.77 cellular lipid metabolic
his SERPINA1 14q32.1 -0.158 0.232 0.77 response to lead ion;response
to triglyceride
hs4 SNAPC1 14q22 -0.158 0.232 0.77 regulation of transcription, DNA-
his DDC-AS1 -0.158 0.232 0.77
xai IGFL3 19q13.32 -0.158 0.232 0.77
swa RAB10 2p23.3 -0.158 0.232 0.77 small GTPase mediated signal
swa SPTAN1 9q34.11 -0.158 0.232 0.77 apoptotic process;cellular
exp PROKR1 2p13.1 -0.158 0.232 0.77 anti-apoptosis
his LOC641367 19p12 -0.158 0.232 0.77
xai LOC554223 -0.158 0.232 0.77
xai EPHA3 3p11.2 -0.158 0.232 0.77 Cell Signaling
xai SMO 7q32.3 -0.158 0.232 0.77 Oncogenes
xai MPZL2 11q24 -0.158 0.232 0.77 T cell differentiation in
hs4 CSPG4 15q24.2 -0.158 0.232 0.77 neuron fate commitment;tissue
remodeling
xai PP13439 -0.158 0.232 0.769
his MIR3156-2 -0.158 0.232 0.769
cop MIR1323 -0.161 0.232 0.77
cop MIR498 -0.161 0.232 0.77
cop MIR520E -0.161 0.232 0.77
hs4 MTFP1 22q 0.158 0.233 0.77 mitochondrial fission;apoptotic process
his FTHL17 Xp21 0.158 0.233 0.77 iron ion transport;cellular iron ion
homeostasis
his CD300LB 17q25.1 0.158 0.233 0.77
hs4 FEM1A 19p13.3 0.158 0.233 0.77 regulation of ubiquitin-protein ligase
hs4 CDC34 19p13.3 0.158 0.233 0.77 negative regulation of cAMP-mediated
his POLDIP3 22q13.2 0.158 0.233 0.77 positive regulation of translation
his RNU12 22q13.2 0.158 0.233 0.77
xai CDS2 20p13 0.158 0.233 0.77 phospholipid biosynthetic process
exp LOC100131047 0.158 0.233 0.77
his VWA8 13q14.11 0.158 0.233 0.77
his VWA8-AS1 0.158 0.233 0.77
his LINC01736 0.158 0.233 0.77
his YTHDF1 20q13.33 0.158 0.233 0.77
his TPX2 20q11.2 0.158 0.233 0.77 regulation of mitotic spindle
hs4 ELOVL5 6p21.1-p12.1 0.158 0.233 0.77 EMT (Mesenchymal)
xai C4orf32 4q25 0.158 0.233 0.77
xai KIAA0100 17q11.2 0.158 0.233 0.77
his HNRNPLL 2p22.1 0.158 0.233 0.77
xai OR9H1P 1q44 0.158 0.233 0.77
xai CPLX4 18q21.32 0.158 0.233 0.77 neurotransmitter transport;exocytosis
xai GYPE 4q31.1 0.158 0.233 0.77
xai SKIV2L2 5q11.2 0.158 0.233 0.77 nuclear mRNA splicing, via
hs4 ACD 16q22.1 0.158 0.233 0.77 DNA Damage Response (DDR)
hs4 PARD6A 16q22.1 0.158 0.233 0.77 cell-cell junction maintenance;cell
division
his SSNA1 9q34.3 0.158 0.233 0.77 G2/M transition of mitotic cell
his ANAPC2 9q34.3 0.158 0.233 0.77 cyclin catabolic process;negative
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle
xai EIF2S2P5 1p13.1 0.158 0.233 0.77
hs4 DOK3 5q35.3 0.158 0.233 0.77 Ras protein signal transduction
hs4 SUV39H1 Xp11.23 0.158 0.233 0.77 peptidyl-lysine
his ZRANB2 1p31 0.158 0.233 0.77 regulation of transcription, DNA-
his ZRANB2-AS2 0.158 0.233 0.77
xai USP8 15q21.2 0.158 0.233 0.77 protein K63-linked
xai LOC100128792 0.158 0.233 0.77
xai SARS2 19q13.2 0.158 0.233 0.77 tRNA aminoacylation for protein
his RAP2C Xq25 0.158 0.233 0.77 signal transduction;small GTPase mediated
signal transduction
his RAP2C-AS1 0.158 0.233 0.77
hs4 SRRT 7q21 0.158 0.233 0.77 gene silencing by RNA;primary miRNA processing
his MFSD14B 0.158 0.233 0.77 transmembrane transport
exp REV1 2q11.1-q11.2 0.158 0.233 0.77 DNA Damage Response (DDR); DDR (DNA
his YARS2 12p11.21 0.158 0.233 0.77 mitochondrial tyrosyl-tRNA
exp CREB3L3 19p13.3 0.158 0.233 0.77 response to unfolded protein
hs4 TMEM244 6q22.33 0.158 0.233 0.77
met C7orf34 7q34 0.156 0.233 0.77
met PFN3 5q35.3 0.156 0.233 0.77 actin cytoskeleton organization
xsq FAM32A 19pter-p13.3 0.156 0.233 0.77
exp CD1B 1q23.1 0.156 0.233 0.77 immune response;antigen processing and
presentation
mut DISP1 1q41 0.156 0.233 0.77 diaphragm development;smoothened signaling
pathway
xsq CDC14C 7p12.3 0.156 0.233 0.77
xsq NKAP Xq24 0.156 0.233 0.77 Notch signaling pathway;negative regulation of
xsq METTL14 4q26 0.156 0.233 0.77 RNA methylation;nucleobase-containing
exp C1orf50 1p34.2 0.156 0.233 0.77
met KLF8 Xp11.21 0.156 0.233 0.77 regulation of transcription, DNA-
dependent"
cop HIST2H4A 0.156 0.233 0.77
cop HIST2H4B 0.156 0.233 0.77 nucleosome assembly;CenH3-containing
cop HIST2H3C 0.156 0.233 0.77
cop HIST2H3A 1q21.2 0.156 0.233 0.77
cop HIST2H2AA3 0.156 0.233 0.77
cop HIST2H2AA4 1q21.2 0.156 0.233 0.77 nucleosome assembly
cop HIST2H2BC 1q21.2 0.156 0.233 0.77
cop KLHL29 2p24.1 0.156 0.233 0.77
xsq LRRC25 0.156 0.233 0.77
xsq ZDHHC12 9q34.11 0.156 0.233 0.77
xsq TBC1D4 13q22.2 0.156 0.233 0.77
cop RNU6-76P 0.156 0.233 0.77
exp RYR1 19q13.1 0.156 0.233 0.77 response to caffeine;calcium ion
cop EPM2A 6q24 0.156 0.233 0.77 carbohydrate metabolic process;glycogen
metabolic process
xsq LINC01366 0.156 0.233 0.77
xsq LOC399886 0.156 0.233 0.77
exp GJC2 1q42.13 0.156 0.233 0.77 transmembrane transport;cell-cell
signaling
mir hsa-miR-770-5p 0.156 0.233 0.77
exp IBTK 6q14.1 0.156 0.233 0.77 negative regulation of protein
phosphorylation;release of sequestered calcium ion into cytosol
xsq C12orf29 12q21.32 0.156 0.233 0.77
xsq LOC100129973 0.156 0.233 0.77
met ANKRD34C 15q25.1 0.156 0.233 0.77
xsq LOC343052 1q21.3 0.156 0.233 0.77
exp LOC100129831 19p13.3 0.156 0.233 0.77
xsq DZANK1 20p11.23 0.156 0.233 0.77
mut ALOXE3 17p13.1 0.156 0.233 0.77 leukotriene biosynthetic process
xsq ZCCHC16 Xq23 0.156 0.233 0.77
xsq MLST8 16p13.3 0.156 0.233 0.77 fibroblast growth factor receptor
met PPP1R13L 19q13.32 0.156 0.233 0.77 apoptotic process;post-embryonic
development
xsq DENND2D 1p13.3 0.156 0.233 0.77
exp RPSAP18 1q23.2 0.156 0.233 0.77
xsq HIST1H2BD 6p21.3 0.156 0.233 0.77 nucleosome assembly
xsq AATF 17q12 0.156 0.233 0.77 embryonic cleavage;apoptotic process
met NEK5 13q14.3 0.156 0.233 0.77
dependent"
dependent"
met TIMD4 5q33.3 0.156 0.233 0.77
met NBPF15 1q21.2 0.156 0.233 0.77
xsq UBAC2 13q32.3 0.156 0.233 0.77
cop NDUFC2-KCTD14 0.156 0.233 0.77
cop THRSP 11q14.1 0.156 0.233 0.77 regulation of transcription, DNA-
cop NDUFC2 11q14.1 0.156 0.233 0.77 mitochondrial electron transport,
xsq PARL 3q27.1 0.156 0.233 0.77 proteolysis
exp NCAPG 4p15.33 0.156 0.233 0.77 DNA Damage Response (DDR)
xsq STX2 12q24.33 0.156 0.233 0.77 cytokinetic cell separation;epithelial
xsq HIST2H3A 1q21.2 0.156 0.233 0.77
xsq GOLGA8B 15q14 0.156 0.233 0.77
met DCAF13 8q22.3 0.156 0.233 0.77 rRNA processing;protein
ubiquitination
exp TLE1 9q21.32 -0.156 0.233 0.77 organ morphogenesis;negative
regulation of Wnt receptor signaling pathway
xsq CAPN12 19q13.2 -0.156 0.233 0.77 proteolysis
exp B3GNT4 12q24 -0.156 0.233 0.77 post-translational protein
xsq CDKN1A 6p21.2 -0.156 0.233 0.77 Apoptosis; DNA Damage
Response (DDR); DDR (DNA replication)
xsq COL11A1 1p21 -0.156 0.233 0.77 ossification;collagen fibril
organization
cop SBF1P1 -0.156 0.233 0.77
cop TMEM68 8q12.1 -0.156 0.233 0.77 metabolic process
cop TGS1 8q11 -0.156 0.233 0.77 regulation of transcription, DNA-
exp TEKT5 16p13.13 -0.156 0.233 0.77 microtubule cytoskeleton
organization
xsq SSH1 12q24.11 -0.156 0.233 0.77 protein
exp C14orf79 14q32.33 -0.156 0.233 0.77
exp DENND2C 1p13.2 -0.156 0.233 0.77
cop SERBP1 1p31 -0.156 0.233 0.77 regulation of anti-
xsq ANKRD29 18q11.2 -0.156 0.233 0.77
DNA-dependent"
cop MIR5680 -0.156 0.233 0.77
cop RRM2B 8q23.1 -0.156 0.233 0.77 DNA Damage Response (DDR)
exp COL11A1 1p21 -0.156 0.233 0.77 ossification;collagen fibril
organization
exp ATP11A 13q34 -0.156 0.233 0.77 cation transport;phospholipid
translocation
xsq TAS2R46 -0.156 0.233 0.77 response to stimulus;sensory
perception of taste
met VPS13A 9q21 -0.156 0.233 0.77 Golgi to endosome transport;nervous
system development
exp NDUFB8P3 11p13 -0.156 0.233 0.77
met AOX2P 2q33.1 -0.156 0.233 0.77
met PHLPP2 16q22.2 -0.156 0.233 0.77
exp MMP24 20q11.2 -0.156 0.233 0.77 Apoptosis
xsq LOC101927969 -0.156 0.233 0.77
exp ACSBG1 15q23-q24 -0.156 0.233 0.77 response to glucocorticoid
xsq PRRG4 11p13 -0.156 0.233 0.77
exp RAB38 11q14 -0.156 0.233 0.77 GTP catabolic process;small GTPase
exp FAM126A 7p15.3 -0.156 0.233 0.77 EMT (Mesenchymal)
cop BFSP2 3q22.1 -0.156 0.233 0.77 intermediate filament cytoskeleton
organization;cell maturation
xai ELK3 12q23 -0.158 0.233 0.77 Transcription Factors
hs4 PLEKHD1 14q24.1 -0.158 0.233 0.77
xai SLC4A9 5q31 -0.158 0.233 0.77 bicarbonate transport;transmembrane
transport
xai AIF1L 9q34.13-q34.3 -0.158 0.233 0.77
hs4 LOC102723672 -0.158 0.233 0.77
hs4 LOC100507642 -0.158 0.233 0.77
exp CGB7 -0.158 0.233 0.77
xai CLDN16 3q28 -0.158 0.233 0.77 cellular metal ion
hs4 DNAH1 3p21.1 -0.158 0.233 0.77 ciliary or flagellar
his MS4A2 11q12-q13 -0.158 0.233 0.77 activation of protein kinase C
activity by G-protein coupled receptor protein signaling pathway;cell proliferation
exp LOC100132215 2p15 -0.158 0.233 0.77
xai MUC16 19p13.2 -0.158 0.233 0.77 O-glycan processing;post-
his CFAP69 -0.158 0.233 0.77
exp C4orf47 4q35.1 -0.158 0.233 0.77
DNA-dependent"
his HLA-DOB 6p21.3 -0.158 0.233 0.77 T cell costimulation;T cell
xai PLAC4 21q22.2 -0.158 0.233 0.77
xai PSPH 7p11.2 -0.158 0.233 0.77 L-serine biosynthetic
xai GOLGA5 14q32.12 -0.158 0.233 0.77 retrograde transport, vesicle
xai ZBTB7C 18q21.1 -0.158 0.233 0.77
cop HSFY1P1 -0.158 0.233 0.77
hs4 MYBL1 8q13.1 -0.158 0.233 0.77 regulation of transcription, DNA-
cop FPR2 19q13.3-q13.4 -0.158 0.233 0.77 G-protein coupled receptor
his SLAIN2 4p11 -0.158 0.233 0.77 microtubule nucleation;positive
regulation of microtubule polymerization
hs4 ZSCAN1 19q13.43 -0.158 0.233 0.77 viral reproduction
his DNAH12 3p14.3 -0.158 0.233 0.77 microtubule-based movement
xai PSG7 -0.158 0.233 0.77 female pregnancy
his CBX5 12q13.13 -0.158 0.233 0.77 blood coagulation;interspecies
cop MIR512-2 -0.16 0.233 0.77
cop MIR512-1 -0.16 0.233 0.77
hs4 PAQR4 16p13.3 0.158 0.234 0.77
hs4 INTS13 0.157 0.234 0.77
hs4 FGFR1OP2 12p11.23 0.157 0.234 0.77 response to wounding
hs4 CBX2 17q25.3 0.157 0.234 0.77 development of primary sexual
his MEAF6 1p35.3-p33 0.157 0.234 0.77 regulation of transcription, DNA-
xai MAT2B 5q34-q35 0.157 0.234 0.77 cellular nitrogen compound metabolic
xai PTENP1 9p21 0.157 0.234 0.77
exp OR7E8P 8p23.1 0.157 0.234 0.77
xai HIST1H2BN 6p22.1 0.157 0.234 0.77 nucleosome assembly
his MIR4641 0.157 0.234 0.77
hs4 NLRP2 19q13.42 0.157 0.234 0.77 positive regulation of cysteine-type
hs4 MRPS21 1q21 0.157 0.234 0.77 translation
his MYLPF 16p11.2 0.157 0.234 0.77 immune response;skeletal muscle tissue
development
dependent"
his C16orf72 16p13.2 0.157 0.234 0.77
his DNAJC8 1p35.3 0.157 0.234 0.77 nuclear mRNA splicing, via
his ATPIF1 1p35.3 0.157 0.234 0.77 angiogenesis;negative regulation of
hydrolase activity
exp CLEC4D 12p13.31 0.157 0.234 0.77 innate immune response
hs4 AMIGO3 3p21 0.157 0.234 0.77 cell adhesion;heterophilic cell-cell
adhesion
xai NME4 16p13.3 0.157 0.234 0.77 CTP biosynthetic process;nucleoside
metabolic process
his SEPHS1 10p14 0.157 0.234 0.77 protein modification process
xai ALDH5A1 6p22 0.157 0.234 0.77 succinate metabolic process;central
xai HS6ST1 2q21 0.157 0.234 0.77 labyrinthine layer blood vessel
his ITPKB-IT1 0.157 0.234 0.77
xai RPS2P1 20q11.2 0.157 0.234 0.77
xai TOP3A 17p12-p11.2 0.157 0.234 0.77 DNA Damage Response (DDR); DDR (FA)
hs4 LINC00632 Xq27.1 0.157 0.234 0.77
xai OR7E8P 8p23.1 0.157 0.234 0.77
xai SUGT1 13q14.3 0.157 0.234 0.77 mitosis;nucleotide-binding domain,
xai FAM53B 10q26.13 0.157 0.234 0.77
xai HNRNPAB 5q35.3 0.157 0.234 0.77 epithelial to mesenchymal
exp JAML 0.157 0.234 0.77 cell adhesion;heterophilic cell-cell adhesion
his CHRNA3 15q24 0.157 0.234 0.77 cation transport;locomotory behavior
xai FRMD3 9q21.32 0.157 0.234 0.77
xai LINC00658 0.157 0.234 0.77
hs4 LSM7 19p13.3 0.157 0.234 0.77 nuclear mRNA splicing, via
hs4 SPPL2B 19p13.3 0.157 0.234 0.77 proteolysis
exp EIF5B 2q11.2 0.157 0.234 0.77 translation;translational initiation
exp ARIH2P1 18q12.1 0.157 0.234 0.77
xai DNAAF5 0.157 0.234 0.77
hs4 MSH3 5q11-q12 0.157 0.234 0.77 DNA Damage Response (DDR); DDR (MMR)
hs4 DHFR 5q11.2-q13.2 0.157 0.234 0.77
hs4 MTRNR2L2 0.157 0.234 0.77
exp TSKS 19q13.3 0.157 0.234 0.77 negative regulation of phosphatase
activity
xai RPL22 1p36.31 0.157 0.234 0.77 translational elongation;viral
transcription
xai LOC643201 5q35.2 0.157 0.234 0.77
exp EXOC5P1 4q13.1 0.157 0.234 0.77
xai PEX14 1p36.22 0.157 0.234 0.77 peroxisome organization;protein transport
his TCF15 20p13 0.157 0.234 0.77 regulation of transcription from RNA polymerase
his NET1 10p15 0.157 0.234 0.77 small GTPase mediated signal
xai CCDC88A 2p16.1 0.157 0.234 0.77 EMT (Mesenchymal)
xai IL33 9p24.1 0.157 0.234 0.77 negative regulation of T-helper 1 type
his C21orf91-OT1 0.157 0.234 0.77
hs4 CHST8 19q13.1 0.157 0.234 0.77 proteoglycan biosynthetic process;hormone
cop CACNA1C-AS1 0.157 0.234 0.77
exp OR11J5P 0.157 0.234 0.77
hs4 AKAP3 12p13.3 0.157 0.234 0.77 cellular component movement;transmembrane
hs4 NDUFA9 12p13.3 0.157 0.234 0.77 mitochondrial electron transport,
his ALDH1A1 9q21.13 0.157 0.234 0.77 cellular aldehyde metabolic
his TRMU 22q13 0.157 0.234 0.77 tRNA metabolic process;tRNA processing
xai EIF2A 3q25.1 0.157 0.234 0.77 translational initiation;regulation of
translation
xsq FCRL6 1q23.2 0.156 0.234 0.77
xsq CCND2-AS1 0.156 0.234 0.77
met ACTBL2 5q11.2 0.156 0.234 0.77
xsq TLR8-AS1 0.156 0.234 0.77
exp FOCAD 9p21 0.156 0.234 0.77
cop GOLGA8DP 15q11.2 0.156 0.234 0.77
cop GOLGA6L1 0.156 0.234 0.77
met IGDCC3 15q22.3-q23 0.156 0.234 0.77 neuromuscular process controlling
balance
met ASPHD1 16p11.2 0.156 0.234 0.77 peptidyl-amino acid modification
xsq LOC81691 16p12.3 0.156 0.234 0.77
exp CNOT2 12q15 0.156 0.234 0.77 RNA metabolic process;mRNA metabolic process
xsq RHOXF2 Xq24 0.156 0.234 0.77
xsq MDM4 1q32 0.156 0.234 0.77 Apoptosis; DNA Damage Response (DDR)
xsq CLYBL 13q32 0.156 0.234 0.77 cellular aromatic compound metabolic process
met SPG20 13q13.3 0.156 0.234 0.77 EMT (Mesenchymal)
xsq FLJ41278 0.156 0.234 0.77
cop TMEM92 17q21.33 0.156 0.234 0.77
cop LETM1 4p16.3 0.156 0.234 0.77 cristae formation
met PPHLN1 12q12 0.156 0.234 0.77 keratinization
xsq SLC14A2 18q12.1-q21.1 0.156 0.234 0.77
xsq PTCD1 7q22.1 0.156 0.234 0.77
cop IRX5 16q12.2 0.156 0.234 0.77 retinal bipolar neuron
xsq TROAP 12q13.12 0.156 0.234 0.77 cell adhesion
exp ZCCHC4 4p15.2 0.156 0.234 0.77
cop MANSC1 12p13.2 0.156 0.234 0.77
exp CYB561A3 11q12.2 0.156 0.234 0.77
xsq CBWD5 9q21.11 0.156 0.234 0.77
met BBOF1 0.156 0.234 0.77
exp NEFH 22q12.2 0.156 0.234 0.77 microtubule cytoskeleton
xsq OTULIN 0.156 0.234 0.77
met ULK2 17p11.2 0.156 0.234 0.77 signal transduction;nervous system
development
met C8orf48 8p22 0.156 0.234 0.77
mut QRICH2 17q25.1 0.156 0.234 0.77
mut ING1 13q34 0.156 0.234 0.77 positive regulation of transcription, DNA-
xsq TBX5 12q24.1 0.156 0.234 0.77 ventricular septum development;lung
development
cop DLGAP1-AS5 18p11.31 0.156 0.234 0.77
xsq AXIN1 16p13.3 0.156 0.234 0.77 Apoptosis
xsq LINC01399 0.156 0.234 0.77
xsq NDUFS2 1q23 0.156 0.234 0.77 response to oxidative stress;respiratory
met SPRYD3 12q13.13 0.156 0.234 0.77
mir hsa-miR-191 0.156 0.234 0.77
cop MC4R 18q22 0.156 0.234 0.77 positive regulation of cAMP biosynthetic
cop MCM8 20p12.3 0.156 0.234 0.77 S phase of mitotic cell cycle;M/G1
xsq SLC35G3 17q12 0.156 0.234 0.77
exp RPL31 2q11.2 0.156 0.234 0.77 translational initiation;viral infectious
cycle
xsq TMEM210 0.156 0.234 0.77
xsq FAM24B 0.156 0.234 0.77
xsq LOC100506725 0.156 0.234 0.77
exp HMGB3 Xq28 0.156 0.234 0.77 DNA recombination;multicellular organismal
development
exp NDRG2 14q11.2 -0.156 0.234 0.77 Wnt receptor signaling pathway;cell
differentiation
met NEK10 3p24.1 -0.156 0.234 0.77
exp SMAD3 15q22.33 -0.156 0.234 0.77 Apoptosis
exp C2orf72 2q37.1 -0.156 0.234 0.77
xsq LOC101929719 -0.156 0.234 0.77
xsq MYO3B 2q31.1-q31.2 -0.156 0.234 0.77 visual perception;response to
stimulus
xsq LOC100268168 5q35.1 -0.156 0.234 0.77
exp EBF4 20p13 -0.156 0.234 0.77 regulation of transcription, DNA-
exp PTPN20 -0.156 0.234 0.77
xsq APLP2 11q24 -0.156 0.234 0.77 regulation of epidermal growth factor-
DNA-dependent"
exp GRHL1 2p25.1 -0.156 0.234 0.77 small molecule metabolic
exp GP1BB -0.156 0.234 0.77 blood coagulation, intrinsic
exp PLXDC1 17q21.1 -0.156 0.234 0.77 angiogenesis;spinal cord
development
cop MIR876 -0.156 0.234 0.77
cop MIR873 -0.156 0.234 0.77
exp RIPK1 6p25.2 -0.156 0.234 0.77 Apoptosis
exp MGC4294 -0.156 0.234 0.77
exp TTC23L 5p13.2 -0.156 0.234 0.77
xsq DZIP1 13q32.1 -0.156 0.234 0.77 multicellular organismal
cop ZNF74 22q11.21 -0.156 0.234 0.77 regulation of transcription, DNA-
cop SCARF2 22q11.21 -0.156 0.234 0.77 cell adhesion
cop KLHL22 22q11.21 -0.156 0.234 0.77 cell division
cop XXYLT1 3q29 -0.156 0.234 0.77
exp CROT 7q21.1 -0.156 0.234 0.77 fatty acid metabolic process;fatty
acid beta-oxidation
exp EGR3 8p23-p21 -0.156 0.234 0.77 positive regulation of endothelial
exp LEMD2 6p21.31 -0.156 0.234 0.77 skeletal muscle cell
differentiation
cop NDUFAF6 8q22.1 -0.156 0.234 0.77
cop MIR3150B -0.156 0.234 0.77
cop MIR3150A -0.156 0.234 0.77
swa ECI2 6p24.3 -0.157 0.234 0.77 fatty acid catabolic process
hs4 RBMS1 2q24.2 -0.157 0.234 0.77 DNA replication;RNA processing
xai TSPY23P -0.157 0.234 0.77
xai NAGLU 17q21 -0.157 0.234 0.77 middle ear morphogenesis;locomotor rhythm
exp IGFL3 19q13.32 -0.157 0.234 0.77
exp TSPY23P -0.157 0.234 0.77
hs4 ENPEP 4q25 -0.157 0.234 0.77 metabolic process;cell proliferation
his TRPM3 9q21.12 -0.157 0.234 0.77 cation transport;transmembrane
transport
exp COX6B1P2 -0.157 0.234 0.77
hs4 GLIPR1 12q21.2 -0.157 0.234 0.77 cellular lipid metabolic
xai PXDN 2p25 -0.157 0.234 0.77 hydrogen peroxide catabolic
xai ARHGEF5 7q35 -0.157 0.234 0.77 regulation of Rho protein signal
xai LOC149351 -0.157 0.234 0.77
his ASAP2 2p25 -0.157 0.234 0.77 regulation of ARF GTPase
xai COL25A1 4q25 -0.157 0.234 0.77
xai PNMAL1 19q13.32 -0.157 0.234 0.77
DNA-dependent"
hs4 CNN1 19p13.2-p13.1 -0.157 0.234 0.77 regulation of smooth muscle
xai COX6B1P2 -0.157 0.234 0.77
xai ITCH 20q11.22 -0.157 0.234 0.77 protein ubiquitination;innate
immune response
xai CROT 7q21.1 -0.157 0.234 0.77 fatty acid metabolic process;fatty
acid beta-oxidation
hs4 FAM49A 2p24.2 -0.157 0.234 0.77
swa DBN1 5q35.3 -0.157 0.234 0.77 actin filament
his CEP112 17q24.1 -0.157 0.234 0.77
hs4 ALDH3B1 11q13 -0.157 0.234 0.77 alcohol metabolic process;lipid
metabolic process
xai PPIAP21 20q12 0.157 0.235 0.77
xai NKIRAS2 17q21.2 0.157 0.235 0.77 I-kappaB kinase/NF-kappaB
cascade;small GTPase mediated signal transduction
xai USP3-AS1 15q22.31 0.157 0.235 0.77
hs4 VMP1 17q23.1 0.157 0.235 0.77 regulation of autophagy;cell-cell
adhesion
hs4 PTRH2 17q23.1 0.157 0.235 0.77 apoptotic process
his NR4A2 2q22-q23 0.157 0.235 0.77 post-embryonic development;intracellular
hs4 HCG27 6p21.33 0.157 0.235 0.77
his HBD 11p15.5 0.157 0.235 0.77 transport;blood coagulation
his MAP3K3 17q23.3 0.157 0.235 0.77 Protein Kinases
swa PSME2 14q11.2 0.157 0.235 0.77 cell cycle checkpoint;regulation of
xai PYROXD1 12p12.1 0.157 0.235 0.77
hs4 THOC1 18p11.32 0.157 0.235 0.77 apoptotic process;signal transduction
hs4 TRIM37 17q23.2 0.157 0.235 0.77
his GABBR1 6p21.31 0.157 0.235 0.77 negative regulation of cell
proliferation;negative regulation of synaptic transmission
xai LINC01270 0.157 0.235 0.77
exp HCRT 17q21 0.157 0.235 0.77 elevation of cytosolic calcium ion
his KRTAP10-6 0.157 0.235 0.77
hs4 MEF2D 1q12-q23 0.157 0.235 0.77 multicellular organismal
hs4 PMPCB 7q22.1 0.157 0.235 0.77 proteolysis
exp PRSS44 0.157 0.235 0.77 proteolysis
his RLIM Xq13-q21 0.157 0.235 0.77 negative regulation of transcription,
DNA-dependent;random inactivation of X chromosome
swa UBQLN4 1q21 0.157 0.235 0.77 regulation of proteasomal ubiquitin-
exp TMPPE 0.157 0.235 0.77
exp OR4C13 0.157 0.235 0.77 response to stimulus
xai RWDD1 6q13-q22.33 0.157 0.235 0.77
his DLK2 6p21.1 0.157 0.235 0.77 regulation of fat cell differentiation
xai EXOC5P1 4q13.1 0.157 0.235 0.77
dependent"
exp MRPS21P6 10q26 0.157 0.235 0.77
his GTF2H4 6p21.3 0.157 0.235 0.77 DNA Damage Response (DDR); DDR
(NER)
xai OR4C13 0.157 0.235 0.77 response to stimulus
exp MKI67IPP6 0.157 0.235 0.77
his EPB41 1p33-p32 0.157 0.235 0.77 blood circulation;actin cytoskeleton
organization
cop S100A10 1q21 0.156 0.235 0.77 signal transduction;positive regulation
of binding
cop S100A11 1q21 0.156 0.235 0.77 signal transduction;negative regulation
of DNA replication
cop SH3YL1 2p25.3 0.156 0.235 0.77
mut MMEL1 1p36 0.156 0.235 0.77 proteolysis
exp NPTX1 17q25.3 0.156 0.235 0.77 axonogenesis involved in
exp HEYL 1p34.3 0.156 0.235 0.77 multicellular organismal
cop DDX55 12q24.31 0.156 0.235 0.77
exp DDX46 5q31.1 0.156 0.235 0.77 RNA splicing;mRNA processing
cop ITPK1-AS1 14q32.12 0.156 0.235 0.77
xsq SH3TC1 4p16.1 0.156 0.235 0.77
xsq CDC26 9q32 0.156 0.235 0.77 cell division;negative regulation of ubiquitin-
protein ligase activity involved in mitotic cell cycle
exp SLITRK1 13q31.1 0.156 0.235 0.77 axonogenesis
cop OGFOD2 12q24.31 0.156 0.235 0.77
cop ARL6IP4 12q24.31 0.156 0.235 0.77 RNA splicing
cop MIR4304 0.156 0.235 0.77
cop LOC100507091 0.156 0.235 0.77
met MAP1LC3A 20q11.22 0.156 0.235 0.77 autophagic vacuole
assembly;autophagy
met BTN3A2 6p22.1 0.156 0.235 0.77
exp DDX50 10q22.1 0.156 0.235 0.77
dependent;viral reproduction
exp DEPDC1B 5q12.1 0.156 0.235 0.77 small GTPase mediated signal
met ADD3 10q25.2 0.156 0.235 0.77 response to drug
xsq FAM35BP 10q11.22 0.156 0.235 0.77
met RPE 2q32-q33.3 0.156 0.235 0.77 small molecule metabolic
xsq AVPR1B 0.156 0.235 0.77
exp CLEC16A 16p13.13 0.156 0.235 0.77
met SELP 1q22-q25 0.156 0.235 0.77 inflammatory response;response to
lipopolysaccharide
mut B4GALNT3 12p13.33 0.156 0.235 0.77
mut STXBP4 17q22 0.156 0.235 0.77 protein targeting;insulin receptor
signaling pathway
cop IFT140 16p13.3 0.156 0.235 0.77
cop TMEM204 16p13.3 0.156 0.235 0.77 lymph vessel development;response
to stress
cop CRAMP1L 16p13.3 0.156 0.235 0.77
xsq STXBP5 6q24.3 0.156 0.235 0.77 protein transport;positive
cop NKIRAS2 17q21.2 0.156 0.235 0.77 I-kappaB kinase/NF-kappaB
xsq HPYR1 8q24.22 0.156 0.235 0.77
cop LOC400654 0.156 0.235 0.77
mut AVPR1A 12q14-q15 0.156 0.235 0.77 response to stress;response to
organic substance
xsq RAP1B 12q14 0.156 0.235 0.77 blood coagulation;cell proliferation
mut DENND6A 3p14.3 0.156 0.235 0.77
exp ABRACL 6q24.1 0.156 0.235 0.77
xsq OR4S2 0.156 0.235 0.77
met VPS37D 7q11.23 0.156 0.235 0.77 protein transport;viral
reproduction
exp KLK5 19q13.33 -0.156 0.235 0.77 proteolysis;epidermis development
xsq SOGA1 20q11.23 -0.156 0.235 0.77
xsq GATA4 8p23.1-p22 -0.156 0.235 0.77 gastrulation with mouth forming
second;ventricular cardiac muscle tissue development
cop ATP6V1H 8q11.2 -0.156 0.235 0.77 ion transport;transferrin
transport
xsq GSTM2 1p13.3 -0.156 0.235 0.77 glutathione metabolic
cop DCSTAMP 8q23 -0.156 0.235 0.77 osteoclast differentiation
cop PCDH7 4p15 -0.156 0.235 0.77 cell adhesion;homophilic cell adhesion
xsq LRRC32 11q13.5-q14 -0.156 0.235 0.77
exp PSPH 7p11.2 -0.156 0.235 0.77 L-serine biosynthetic
cop GRHL2 8q22.3 -0.156 0.235 0.77 EMT (Epithelial)
cop TROVE2 1q31 -0.156 0.235 0.77 transcription from RNA polymerase
III promoter
cop GLRX2 1q31.2 -0.156 0.235 0.77 Apoptosis
cop MIR1278 -0.156 0.235 0.77
cop B3GALT2 1q31 -0.156 0.235 0.77 protein
met CD22 19q13.1 -0.156 0.235 0.77 cell adhesion
mut RTF1 15q15.1 -0.156 0.235 0.77 transcription initiation, DNA-
xsq CACNA1C-AS4 -0.156 0.235 0.77
cop ZNF703 8p11.23 -0.156 0.235 0.77 positive regulation of cell
cop ERLIN2 8p11.2 -0.156 0.235 0.77 ER-associated protein
catabolic process
cop LOC728024 8p11.23 -0.156 0.235 0.77
DNA-dependent"
xsq THY1 11q23.3 -0.156 0.235 0.77 cytoskeleton organization;T cell
cop LOC339529 -0.156 0.235 0.77
met MARCKSL1 1p35.1 -0.156 0.235 0.77 positive regulation of cell
proliferation;vesicle-mediated transport
exp NLGN2 17p13.1 -0.156 0.235 0.77 locomotory exploration
exp FAM171A1 10p13 -0.156 0.235 0.77
xsq CLSTN1 1p36.22 -0.156 0.235 0.77 cell adhesion;homophilic cell
adhesion
xai CP 3q23-q25 -0.157 0.235 0.77 cellular iron ion
his MXRA7 17q25.1 -0.157 0.235 0.77
hs4 MAJIN -0.157 0.235 0.77
xai LOC285556 4q23 -0.157 0.235 0.77
his MIR4288 -0.157 0.235 0.77
hs4 TCEAL1 Xq22.1 -0.157 0.235 0.77 negative regulation of
dependent"
his RNF215 22q12.2 -0.157 0.235 0.77
his CLDN23 8p23.1 -0.157 0.235 0.77 tight junction
his HCAR1 12q24.31 -0.157 0.235 0.77 response to estradiol stimulus
hs4 HES1 3q28-q29 -0.157 0.235 0.77 DNA Damage Response (DDR); DDR (FA)
xai LOC100132593 -0.157 0.235 0.77
xai IFT80 3q25.33 -0.157 0.235 0.77
his LOC403312 -0.157 0.235 0.77
his FEZ1 11q24.2 -0.157 0.235 0.77 transport;cell adhesion
hs4 MIR6881 -0.157 0.235 0.77
xai CPSF4L 17q25.1 -0.157 0.235 0.77
xai PROKR1 2p13.1 -0.157 0.235 0.77 anti-apoptosis
xai NCKAP5 2q21.2 -0.157 0.235 0.77
swa SCFD1 14q12 -0.157 0.235 0.77 response to hypoxia;retrograde vesicle-
mediated transport, Golgi to ER
xai LOC100132495 -0.157 0.235 0.77
dependent"
xai KRT8P17 Xp11.21 -0.157 0.235 0.77
hs4 LAMA1 18p11.3 -0.157 0.235 0.77 establishment of epithelial cell
hs4 VWA5A 11q24.1 -0.157 0.235 0.77
his SEPT10 2q13 -0.157 0.235 0.77 cell cycle;cell division
his SOWAHC 2q13 -0.157 0.235 0.77
exp LOC100132593 -0.157 0.235 0.77
hs4 CAMK2D 4q26 -0.157 0.235 0.77 calcium ion transport;regulation of
xai CYP1A2 15q24.1 -0.157 0.235 0.77 steroid catabolic
process;monoterpenoid metabolic process
exp LOC100132495 -0.157 0.235 0.77
hs4 PPM1H 12q14.1 -0.157 0.235 0.77
his COX7B2 4p12 -0.157 0.235 0.77
swa SCRN1 7p14.3-p14.1 -0.157 0.235 0.77 proteolysis;exocytosis
xai ZNF542P -0.157 0.235 0.77 regulation of transcription, DNA-
dependent"
hs4 RAB5C 17q21.2 -0.157 0.235 0.77 regulation of endocytosis;GTP
catabolic process
his PMS2 7p22.2 -0.157 0.235 0.77 DNA Damage Response (DDR); DDR
(MMR)
his AIMP2 7p22 -0.157 0.235 0.77 gene expression;cell differentiation
swa EIF1AX Xp22.12 -0.157 0.235 0.77 translation;translational
initiation
hs4 LOC101929882 -0.157 0.235 0.77
hs4 KLF11 2p25 -0.157 0.235 0.77 negative regulation of cell
xai LOC100128276 12q24.33 0.157 0.236 0.77
xai MRE11A 11q21 0.157 0.236 0.77 DNA Damage Response (DDR); DDR (HR)
xai NELL2 12q12 0.157 0.236 0.77 cell adhesion;regulation of growth
xai SMTNL2 17p13.2 0.157 0.236 0.77
xai MRPS21P6 10q26 0.157 0.236 0.77
xai MAPK14 6p21.3-p21.2 0.157 0.236 0.77 Protein Kinases
hs4 BUB3 10q26 0.157 0.236 0.77 attachment of spindle microtubules to
hs4 ARID3B 15q24 0.157 0.236 0.77 regulation of transcription, DNA-
dependent"
exp RPS3AP9 1q31.1 0.157 0.236 0.77
exp LOC728868 0.157 0.236 0.77
xai LOC100131047 0.157 0.236 0.77
swa PDAP1 7q22.1 0.157 0.236 0.77 signal transduction;cell proliferation
hs4 CCDC84 11q23.3 0.157 0.236 0.77
his ELOB 0.157 0.236 0.77
his RHOF 12q24.31 0.157 0.236 0.77 GTP catabolic process;actin filament
organization
his LINC01089 0.157 0.236 0.77
his SETD1B 12q24.31 0.157 0.236 0.77 regulation of transcription, DNA-
xai U2SURP 3q23 0.157 0.236 0.77 RNA processing
swa SARS 1p13.3 0.157 0.236 0.77 tRNA aminoacylation for protein
xai BRD7 16q12 0.157 0.236 0.77 DNA Damage Response (DDR); DDR (Chromatin)
hs4 FCHSD2 11q13.4 0.157 0.236 0.77
exp PLG 6q26 0.157 0.236 0.77 fibrinolysis;platelet degranulation
xai MKNK2 19p13.3 0.157 0.236 0.77 Protein Kinases
his LCORL 4p15.31 0.157 0.236 0.77 regulation of transcription from RNA
his HINT1 5q31.2 0.157 0.236 0.77 signal transduction
dependent"
xai LOC100292290 0.157 0.236 0.77
exp LOC100292290 0.157 0.236 0.77
xai LOC728868 0.157 0.236 0.77
dependent"
xai HMGB3 Xq28 0.157 0.236 0.77 DNA recombination;multicellular organismal
development
his TCF20 22q13.3 0.157 0.236 0.77 regulation of transcription, DNA-
dependent"
his NARF 17q25.3 0.157 0.236 0.77
his TSPAN3 15q24.3 0.157 0.236 0.77
his HERC4 10q21.3 0.157 0.236 0.77 protein modification
his AKNAD1 1p13.3 0.157 0.236 0.77
his SPATA42 0.157 0.236 0.77
xai AAGAB 15q22.33-q23 0.157 0.236 0.77 protein transport
his WASF2 1p36.11 0.157 0.236 0.77 G-protein signaling, coupled to cAMP
nucleotide second messenger;Rac protein signal transduction
xai WDR6 3p21.31 0.157 0.236 0.77 negative regulation of cell
xai TMPRSS15 21q21.1 0.157 0.236 0.77 proteolysis
his CNOT8 5q31-q33 0.157 0.236 0.77 gene expression;RNA metabolic process
dependent"
his ZNF436-AS1 0.157 0.236 0.77
xai GC 4q12-q13 0.157 0.236 0.77 steroid metabolic process;vitamin D
metabolic process
exp ACOX3 4p15.3 0.155 0.236 0.77 fatty acid metabolic process;fatty acid
met C5orf49 5p15.31 0.155 0.236 0.77
cop TMPO 12q22 0.155 0.236 0.77 regulation of transcription, DNA-dependent"
xsq CES5A 16q12.2 0.155 0.236 0.77
dependent"
xsq FOXRED1 11q24.2 0.155 0.236 0.77
exp KLRF1 12p13.31 0.155 0.236 0.77 cell surface receptor signaling pathway
xsq DAB1 1p32-p31 0.155 0.236 0.77 cell differentiation;multicellular
met NRG1 8p12 0.155 0.236 0.77 transmembrane receptor protein tyrosine kinase
signaling pathway;positive regulation of cell growth
cop PLAC9 10q22.3 0.155 0.236 0.77
cop ANXA11 10q23 0.155 0.236 0.77 phagocytosis;cell cycle
xsq GTF2B 1p22-p21 0.155 0.236 0.77 viral reproduction;interspecies
mut GPR45 2q11.1-q12 0.155 0.236 0.77
xsq LOC642426 0.155 0.236 0.77
mut ZSCAN32 16p13.3 0.155 0.236 0.77
xsq LOC387810 0.155 0.236 0.77
cop POLR1A 2p11.2 0.155 0.236 0.77 transcription initiation from RNA
polymerase I promoter;transcription elongation from RNA polymerase I promoter
exp PAK1IP1 6p24.2 0.155 0.236 0.77 negative regulation of signal
transduction
cop TRMT44 4p16.1 0.155 0.236 0.77
cop EAF1 3p25.1 0.155 0.236 0.77 regulation of transcription, DNA-
dependent"
exp WRN 8p12 0.155 0.236 0.77 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
exp TOP3A 17p12-p11.2 0.155 0.236 0.77 DNA Damage Response (DDR); DDR (FA)
xsq FAM215A 0.155 0.236 0.77
met MS4A3 11q12.1 0.155 0.236 0.77
cop CTCF 16q21-q22.3 0.155 0.236 0.77 chromosome segregation;regulation of
xsq PTP4A1 6q12 0.155 0.236 0.77 multicellular organismal
cop KIAA0513 16q24.1 0.155 0.236 0.77
xsq CBL 11q23.3 0.155 0.236 0.77 Oncogenes
cop ATRN 20p13 0.155 0.236 0.77 regulation of multicellular organism
growth;pigmentation
cop GFRA4 20p13-p12 0.155 0.236 0.77
cop ADAM33 20p13 0.155 0.236 0.77 proteolysis;integrin-mediated signaling
pathway
cop SIGLEC1 20p13 0.155 0.236 0.77 endocytosis;inflammatory response
xsq LOC401357 0.155 0.236 0.77
xsq GNL1 6p21.3 0.155 0.236 0.77 T cell mediated immunity;response to DNA
damage stimulus
exp LOC100287966 22q11.22 0.155 0.236 0.77
met PABPC1L2B Xq13.2 0.155 0.236 0.77
xsq MON1A 3p21.31 0.155 0.236 0.77
mut OR4C16 11q11 0.155 0.236 0.77
xsq POLR2H 3q28 0.155 0.236 0.77 DNA Damage Response (DDR); DDR (NER)
mir hsa-miR-129-3p 0.155 0.236 0.77
met SEPT5 22q11.21 0.155 0.236 0.77 GTP catabolic process;cell cycle
exp ZHX1-C8orf76 0.155 0.236 0.77
exp CARF 2q33.2 0.155 0.236 0.77
xsq DRC1 2p23.3 0.155 0.236 0.77
dependent"
xsq KIAA1143 3p21.31 0.155 0.236 0.77
exp C1orf112 1q24.2 0.155 0.236 0.77
xsq SAPCD1-AS1 0.155 0.236 0.77
xsq IL1R2 2q12 -0.155 0.236 0.77 immune response
exp MT1X 16q13 -0.155 0.236 0.77 response to metal ion;cellular response
to erythropoietin
cop SOX14 3q22-q23 -0.155 0.236 0.77 negative regulation of
transcription from RNA polymerase II promoter;nervous system development
met TMEM52 1p36.33 -0.155 0.236 0.77
exp RAB3B 1p32-p31 -0.155 0.236 0.77 regulation of exocytosis;peptidyl-
cysteine methylation
mut POT1 7q31.33 -0.155 0.236 0.77 DNA Damage Response (DDR)
exp WIPF2 17q21.2 -0.155 0.236 0.77
cop IRX1 5p15.3 -0.155 0.236 0.77
exp RPS27AP14 9p24.3 -0.155 0.236 0.77
cop NPHP3-ACAD11 -0.155 0.236 0.77
xsq LOXL2 8p21.3 -0.155 0.236 0.77 protein modification process;cell
adhesion
pro CRK 17p13.3 -0.155 0.236 0.77 regulation of actin cytoskeleton
xsq GDNF-AS1 -0.155 0.236 0.77
met RAD51AP1 12p13.2-p13.1 -0.155 0.236 0.77 DNA Damage Response
(DDR)
exp ENTPD7 -0.155 0.236 0.77
xsq ASPA 17p13.3 -0.155 0.236 0.77 aspartate catabolic
xsq FABP3 1p33-p32 -0.155 0.236 0.77 fatty acid metabolic
xsq KRTAP2-1 17q21.2 -0.155 0.236 0.77
cop GLDC 9p22 -0.155 0.236 0.77 cellular amino acid metabolic
xsq PDGFA 7p22 -0.155 0.236 0.77 Apoptosis
xsq LIX1 5q15 -0.155 0.236 0.77
cop NMNAT2 1q25 -0.155 0.236 0.77 vitamin metabolic process;water-
met GHRL 3p26-p25 -0.155 0.236 0.77 negative regulation of endothelial
cell proliferation;hormone-mediated signaling pathway
xsq SH3PXD2B 5q35.1 -0.155 0.236 0.77 extracellular matrix
exp CDYL 6p25.1 -0.155 0.236 0.77 spermatogenesis;regulation of
mut MYNN 3q26.2 -0.155 0.236 0.77 transcription, DNA-
mut ZC3H7B 22q13.2 -0.155 0.236 0.77 interspecies interaction
between organisms
exp UBE2W 8q21.11 -0.155 0.236 0.77 protein monoubiquitination;protein
exp FAM180B 11p11.2 -0.155 0.236 0.77
met KDM2B 12q24.31 -0.155 0.236 0.77 negative regulation of
exp PRKCSH 19p13.2 -0.155 0.236 0.77 protein folding;intracellular
mut GLCE 15q23 -0.155 0.236 0.77 heparan sulfate proteoglycan biosynthetic
exp CHPF 2q35 -0.155 0.236 0.77
cop GFRAL 6p12.1 -0.155 0.236 0.77 anti-apoptosis;stress-activated
protein kinase signaling cascade
cop HMGCLL1 6p12.1 -0.155 0.236 0.77
xai LDB2 4p16 -0.157 0.236 0.77 positive regulation of cellular component
his H1FNT 12q13.11 -0.157 0.236 0.77
hs4 MIR4632 -0.157 0.236 0.77
xai LINC00628 1q32.1 -0.157 0.236 0.77
hs4 RNF185 22q12.2 -0.157 0.236 0.77 autophagy
hs4 MIR3928 -0.157 0.236 0.77
his HIF1A 14q23.2 -0.157 0.236 0.77 Protein Kinases
his HIF1A-AS1 -0.157 0.236 0.77
swa NUP62 -0.157 0.236 0.77 Apoptosis
his ESR1 6q25.1 -0.157 0.236 0.77 androgen metabolic process;negative
hs4 HS6ST3 13q32.1 -0.157 0.236 0.77
xai EYA2 20q13.1 -0.157 0.236 0.77 histone dephosphorylation;DNA
repair
xai C1orf122 1p34.3 -0.157 0.236 0.77
xai SLCO2B1 11q13 -0.157 0.236 0.77 Solute Carriers
exp LINC00628 1q32.1 -0.157 0.236 0.77
xai ACBD3 1q42.12 -0.157 0.236 0.77 steroid biosynthetic
process;transport
xai FAM171A1 10p13 -0.157 0.236 0.77
his LAMA4 6q21 -0.157 0.236 0.77 regulation of embryonic development;brown
hs4 TMEM154 4q31.3 -0.157 0.236 0.77
his MIR8067 -0.157 0.236 0.77
his MIR320C1 -0.157 0.236 0.77
hs4 LINC01465 -0.157 0.236 0.77
hs4 MIRLET7I -0.157 0.236 0.77
xai FSIP1 15q14 -0.157 0.236 0.77
his SEPT9 17q25 -0.157 0.236 0.77 GTP catabolic process;cell cycle
his LOC644762 -0.157 0.236 0.77
his PDE6A 5q31.2-q34 -0.157 0.236 0.77 signal transduction;blood
coagulation
hs4 RORA 15q22.2 -0.157 0.236 0.77 positive regulation of
transcription from RNA polymerase II promoter;cGMP metabolic process
xai HOXC-AS2 -0.157 0.236 0.77
hs4 LINC02026 -0.157 0.236 0.77
xai CPO 2q33.3 -0.157 0.236 0.77 proteolysis
hs4 PHF1 6p21.3 -0.157 0.236 0.77 regulation of transcription, DNA-
hs4 LOC101928605 -0.157 0.236 0.77
hs4 ARHGEF35 7q35 -0.157 0.236 0.77
his TRIM45 1p13.1 -0.157 0.236 0.77
xai ACSBG1 15q23-q24 -0.157 0.236 0.77 response to glucocorticoid
his LOC400043 12q13.13 -0.157 0.236 0.77
his LINC01759 -0.157 0.236 0.77
his MIR34AHG -0.157 0.236 0.77
his RASSF10 11p15.2 -0.157 0.236 0.77 signal transduction
DNA-dependent"
his PRAF2 Xp11.23 -0.157 0.236 0.77 L-glutamate transport;protein
transport
cop CALHM1 10q24.33 0.158 0.237 0.77 ion transport
xai DNAJC19 3q26.33 0.157 0.237 0.77 protein folding;protein targeting
to mitochondrion
xai RPL14 3p22-p21.2 0.157 0.237 0.77 SRP-dependent cotranslational protein
hs4 PDP2 16q22.1 0.156 0.237 0.77 pyruvate metabolic process;protein
dephosphorylation
swa RPL5 1p22.1 0.156 0.237 0.77 translational termination;ribosomal large
subunit biogenesis
swa DNAJB4 1p31.1 0.156 0.237 0.77 protein folding;response to
unfolded protein
xai FOCAD 9p21 0.156 0.237 0.77
hs4 FBLN2 3p25.1 0.156 0.237 0.77
hs4 CTNNBIP1 1p36.22 0.156 0.237 0.77 anterior/posterior pattern
specification;negative regulation of smooth muscle cell proliferation
xai RAP1GDS1 4q23-q25 0.156 0.237 0.77 positive regulation of GTPase
activity
his TOR4A 9q34.3 0.156 0.237 0.77 chaperone mediated protein folding
requiring cofactor
his CDK5R1 17q11.2 0.156 0.237 0.77 Apoptosis
hs4 DDA1 19p13.11 0.156 0.237 0.77
hs4 ABHD8 19p13.11 0.156 0.237 0.77
xai PRELID1P4 15q14 0.156 0.237 0.77
hs4 MSH5 6p21.3 0.156 0.237 0.77 DNA Damage Response (DDR); DDR (MMR)
hs4 MSH5-SAPCD1 0.156 0.237 0.77
hs4 TLE3 15q22 0.156 0.237 0.77 regulation of transcription, DNA-
his LOC285095 2q37.3 0.156 0.237 0.77
exp FER1L6 8q24.1 0.156 0.237 0.77
his CBL 11q23.3 0.156 0.237 0.77 Oncogenes
xai DCUN1D5 11q22.3 0.156 0.237 0.77
xai RNF180 5q12.3 0.156 0.237 0.77 positive regulation of proteasomal
his C2CD2L 11q23.3 0.156 0.237 0.77
xai C9orf142 9q34.3 0.156 0.237 0.77 DNA Damage Response (DDR)
xai EIF5B 2q11.2 0.156 0.237 0.77 translation;translational initiation
his DBNL 7p13 0.156 0.237 0.77 endocytosis;apoptotic process
exp SOAT2 12q13.13 0.156 0.237 0.77 steroid metabolic process;cholesterol
metabolic process
exp TCF21 6q23.2 0.156 0.237 0.77 sex determination;embryonic digestive
tract morphogenesis
hs4 LINC00939 0.156 0.237 0.77
hs4 C19orf25 19p13.3 0.156 0.237 0.77
hs4 YBX1 1p34 0.156 0.237 0.77 DNA Damage Response (DDR)
hs4 RPS7 2p25 0.156 0.237 0.77 translational initiation;viral infectious cycle
xai BTF3P11 13q22 0.156 0.237 0.77
hs4 LINC01816 0.156 0.237 0.77
xai LOC100996266 0.156 0.237 0.77
swa CPD 17q11.2 0.156 0.237 0.77 proteolysis;cellular response to
interleukin-2
his NBPF3 1p36.12 0.156 0.237 0.77
xai CLEC16A 16p13.13 0.156 0.237 0.77
hs4 PRR12 19q13.33 0.156 0.237 0.77
his IER3IP1 18q12 0.156 0.237 0.77 regulation of apoptotic process
his NCOA7 6q22.32 0.156 0.237 0.77 cell wall macromolecule catabolic
xsq BEST3 12q14.2-q15 0.155 0.237 0.77 ion transmembrane transport;negative
regulation of ion transport
xsq CORO6 17q11.2 0.155 0.237 0.77 actin cytoskeleton organization
exp TARSL2 15q26.3 0.155 0.237 0.77 threonyl-tRNA aminoacylation
exp F10 13q34 0.155 0.237 0.77 post-translational protein
met ZDHHC14 6q25.3 0.155 0.237 0.77
mut CFAP58 0.155 0.237 0.77
exp ARIH1 15q24 0.155 0.237 0.77 cytokine-mediated signaling pathway;ubiquitin-
cop ISL2 15q23 0.155 0.237 0.77 multicellular organismal development;neuron
development
xsq SLFN14 17q12 0.155 0.237 0.77
xsq C2orf83 2q36.3 0.155 0.237 0.77
xsq OR1N1 9q33.2 0.155 0.237 0.77 response to stimulus
exp ICAM4 19p13.2 0.155 0.237 0.77 cell-cell adhesion;regulation of immune
response
xsq EIF2B5 3q27.1 0.155 0.237 0.77 response to glucose
exp CTSC 11q14.2 0.155 0.237 0.77 proteolysis;immune response
exp KLHDC3 6p21.1 0.155 0.237 0.77 activation of signaling protein
exp FDPS 1q22 0.155 0.237 0.77 cholesterol biosynthetic process;isoprenoid
exp CEP104 1p36.32 0.155 0.237 0.77
exp RAP1GDS1 4q23-q25 0.155 0.237 0.77 positive regulation of GTPase
activity
cop NETO2 16q11 0.155 0.237 0.77
cop SLC9A7P1 12q23.1 0.155 0.237 0.77
cop LOC643770 0.155 0.237 0.77
cop TMPO-AS1 12q23.1 0.155 0.237 0.77
met STIM2 4p15.2 0.155 0.237 0.77 negative regulation of calcium ion
exp CDCA3 12p13 0.155 0.237 0.77 cell cycle;mitosis
met MIR141 0.155 0.237 0.77
cop STX2 12q24.33 0.155 0.237 0.77 cytokinetic cell separation;epithelial
cop RAN 12q24.3 0.155 0.237 0.77 nucleocytoplasmic transport;androgen
met RAB40AL Xq22.2 0.155 0.237 0.77
met CPNE2 16q13 0.155 0.237 0.77
exp LOC100289290 0.155 0.237 0.77
exp CLEC11A 19q13.3 0.155 0.237 0.77 positive regulation of cell
proliferation
mut FEM1B 15q22 0.155 0.237 0.77 Apoptosis
cop MED13 17q22-q23 0.155 0.237 0.77 intracellular steroid hormone receptor
xsq LOC101927694 0.155 0.237 0.77
xsq PTBP3 9q32 0.155 0.237 0.77 mRNA processing;anatomical structure
morphogenesis
xsq FAM209A 20q13.31 0.155 0.237 0.77
cop SCAPER 15q24 0.155 0.237 0.77
xsq LRRC55 11q12.1 0.155 0.237 0.77
xsq OR10K1 0.155 0.237 0.77
exp METTL18 1q24.2 0.155 0.237 0.77
met GCOM1 15q21.3 0.155 0.237 0.77
xsq CTH 1p31.1 0.155 0.237 0.77 cellular amino acid biosynthetic
xsq COX7A1 19q13.1 -0.155 0.237 0.77 generation of precursor
met HHIPL2 1q41 -0.155 0.237 0.77 carbohydrate metabolic process
exp EGR2 10q21.1 -0.155 0.237 0.77 learning or memory;regulation of
ossification
exp NCALD 8q22.2 -0.155 0.237 0.77 synaptic transmission;vesicle-
mediated transport
xsq DMGDH 5q14.1 -0.155 0.237 0.77 glycine metabolic process;glycine
catabolic process
xsq C4orf26 4q21.1 -0.155 0.237 0.77
exp FOXO1 13q14.1 -0.155 0.237 0.77 Apoptosis
met LOXL3 2p13 -0.155 0.237 0.77 oxidation-reduction process
exp LOC643014 4q13.3 -0.155 0.237 0.77
xsq FAM210B 20q13.2 -0.155 0.237 0.77
met PTMS 12p13 -0.155 0.237 0.77 DNA replication
xsq CEP112 17q24.1 -0.155 0.237 0.77
DNA-dependent;hemopoiesis"
xsq CYGB 17q25 -0.155 0.237 0.77 transport;response to oxidative stress
met CPA5 7q32 -0.155 0.237 0.77 proteolysis;metabolic process
xsq GPR155 2q31.1 -0.155 0.237 0.77 intracellular signal
transduction;transmembrane transport
xsq LBX2-AS1 2p13.1 -0.155 0.237 0.77
exp FAM101A 12q24.31 -0.155 0.237 0.77
exp GMFB 14q22.2 -0.155 0.237 0.77 protein phosphorylation;signal
transduction
cop EFCAB2 1q44 -0.155 0.237 0.77
exp TP53TG1 7q21.1 -0.155 0.237 0.77 response to stress;response
xsq B4GALT4-AS1 -0.155 0.237 0.77
exp CD81 11p15.5 -0.155 0.237 0.77 phosphatidylinositol biosynthetic
cop ACAD9 3q21.3 -0.155 0.237 0.77
xsq ACCS 11p11 -0.155 0.237 0.77 biosynthetic process
mut TRPM4 19q13.33 -0.155 0.237 0.77 dendritic cell
exp S100A1 1q21 -0.155 0.237 0.77 negative regulation of
xsq LYN 8q13 -0.155 0.237 0.77 Protein Kinases
xai MIER2 19p13.3 -0.156 0.237 0.77 regulation of transcription, DNA-
dependent"
hs4 MIR6717 -0.156 0.237 0.77
his LOC105371267 -0.156 0.237 0.77
his CHD9 16q12.2 -0.156 0.237 0.77 regulation of transcription, DNA-
his PTTG1IP 21q22.3 -0.156 0.237 0.77 protein import into nucleus
his LINC01118 -0.156 0.237 0.77
his KDELR2 7p22.1 -0.156 0.237 0.77 vesicle-mediated
his DOK5 20q13.2 -0.156 0.237 0.77 MAPK cascade;transmembrane receptor
xai ATRNL1 10q26 -0.156 0.237 0.77 G-protein coupled receptor
signaling pathway
hs4 BCO1 -0.156 0.237 0.77 retinoid metabolic process;steroid
metabolic process
hs4 COL7A1 3p21.1 -0.156 0.237 0.77 cell adhesion;epidermis
development
hs4 SORBS1 10q23.33 -0.156 0.237 0.77 cellular response to insulin
xai GOLGA4 3p22-p21.3 -0.156 0.237 0.77 protein targeting to
Golgi;vesicle-mediated transport
cop NTN5 19q13.33 -0.156 0.237 0.77
cop FUT2 19q13.3 -0.156 0.237 0.77 carbohydrate metabolic
cop MAMSTR 19q13.33 -0.156 0.237 0.77 regulation of transcription,
DNA-dependent;positive regulation of myotube differentiation
cop RASIP1 19q13.33 -0.156 0.237 0.77 regulation of Rho GTPase
activity;branching morphogenesis of a tube
cop IZUMO1 19q13.33 -0.156 0.237 0.77 fusion of sperm to egg plasma
membrane;cell adhesion
cop FUT1 19q13.3 -0.156 0.237 0.77 protein glycosylation;fucosylation
cop FGF21 19q13.33 -0.156 0.237 0.77 signal transduction;cell-cell
signaling
cop BCAT2 19q13 -0.156 0.237 0.77 cellular nitrogen compound metabolic
process;isoleucine catabolic process
cop HSD17B14 19q13.33 -0.156 0.237 0.77 steroid catabolic process
cop PLEKHA4 19q13.33 -0.156 0.237 0.77
cop PPP1R15A 19q13.2 -0.156 0.237 0.77 Apoptosis
cop TULP2 19q13.1 -0.156 0.237 0.77 visual perception
cop NUCB1 19q13.33 -0.156 0.237 0.77
cop DHDH 19q13.3 -0.156 0.237 0.77 D-xylose catabolic
cop BAX 19q13.3-q13.4 -0.156 0.237 0.77 Apoptosis; Protein Kinases
cop FTL 19q13.33 -0.156 0.237 0.77 transmembrane transport;iron ion
transport
cop GYS1 19q13.3 -0.156 0.237 0.77 small molecule metabolic
cop RUVBL2 19q13.3 -0.156 0.237 0.77 Apoptosis; DNA Damage
Response (DDR); DDR (Chromatin)
his SNORA14A -0.156 0.237 0.77
his ZNF382 19q13.12 -0.156 0.237 0.77 negative regulation of
xai KRT8P9 15q23 -0.156 0.237 0.77
his NMRAL2P -0.156 0.237 0.77
hs4 VN1R4 19q13.42 -0.156 0.237 0.77
xai MAPKAPK2 1q32 -0.156 0.237 0.77 response to stress;peptidyl-serine
phosphorylation
xai CNTN6 3p26-p25 -0.156 0.237 0.77 cell adhesion;Notch signaling
pathway
swa DLG1 3q29 -0.156 0.237 0.77 mitotic cell cycle G1/S transition
xai TECTA 11q22-q24 -0.156 0.237 0.77 cell-matrix adhesion;sensory
perception of sound
xai RALGAPB 20q11.23 -0.156 0.237 0.77 activation of Ral GTPase
xai C4orf47 4q35.1 -0.156 0.237 0.77
xai TMEM108 3q21 -0.156 0.237 0.77
hs4 PDE2A 11q13.4 -0.156 0.237 0.77 metabolic process;negative
xai ATN1 12p13.31 -0.157 0.237 0.77 negative regulation of
hs4 EPAS1 2p21-p16 -0.157 0.237 0.77 response to hypoxia;multicellular
xai THY1 11q23.3 -0.157 0.237 0.77 cytoskeleton organization;T cell
cop PLIN3 19p13.3 0.156 0.238 0.77 vesicle-mediated transport
his SF1 11q13 0.156 0.238 0.77 nuclear mRNA 3'-splice site recognition;nuclear
his HADH 4q22-q26 0.156 0.238 0.77 fatty acid beta-oxidation;response to
hormone stimulus
his MIR3662 0.156 0.238 0.77
xai ANKRD34A 1q21.1 0.156 0.238 0.77
his GATB 0.156 0.238 0.77 translation;mitochondrial translation
xai CALR3 19p13.11 0.156 0.238 0.77 spermatogenesis;cell differentiation
hs4 HJURP 2q37.1 0.156 0.238 0.77 nucleosome assembly;cell cycle
his STRAP 12p12.3 0.156 0.238 0.77 negative regulation of transforming
growth factor beta receptor signaling pathway;negative regulation of transcription
hs4 CXCL6 4q13.3 0.156 0.238 0.77 chemotaxis;inflammatory response
xai EEF1E1 6p24.3 0.156 0.238 0.77 Apoptosis
his PHACTR1 6p24.1 0.156 0.238 0.77
xai C14orf169 14q24.3 0.156 0.238 0.77 chromatin modification;histone H3-
K4 demethylation
xai PRSS44 0.156 0.238 0.77 proteolysis
his EIF4G2 11p15 0.156 0.238 0.77 translational initiation;regulation of
his LOC101928053 0.156 0.238 0.77
hs4 METTL24 6q21 0.156 0.238 0.77
his DCAF12 9p13.3 0.156 0.238 0.77 protein ubiquitination
his LINC01307 0.156 0.238 0.77
exp SIGLEC8 19q13.33-q13.41 0.156 0.238 0.77 cell adhesion;signal
transduction
his HEATR1 1q43 0.156 0.238 0.77 rRNA processing
his POLE 12q24.3 0.156 0.238 0.77 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
his PXMP2 12q24.33 0.156 0.238 0.77
his SERF1A 5q13 0.156 0.238 0.77
xai CSNK2B 6p21.3 0.156 0.238 0.77 Protein Kinases
xai FOXR1 11q23.3 0.156 0.238 0.77 pattern specification process;embryo
development
his HINFP 11q23.3 0.156 0.238 0.77 DNA Damage Response (DDR)
cop PCNA-AS1 0.156 0.238 0.77 DDR (DNA replication)
exp LOC100128242 11q24.1 0.156 0.238 0.77
his CEBPE 14q11.2 0.156 0.238 0.77 cellular response to
his IRAK1 Xq28 0.156 0.238 0.77 Apoptosis; Protein Kinases
his MIR718 0.156 0.238 0.77
his PTP4A2 1p35 0.156 0.238 0.77
his CANT1 17q25.3 0.156 0.238 0.77 signal transduction;positive regulation
xai C20orf203 20q11.21 0.156 0.238 0.77
xai MTND5P9 0.156 0.238 0.77
cop ATG16L2 11q13.4 0.155 0.238 0.77 autophagy;protein transport
met RGS21 1q31.2 0.155 0.238 0.77
exp LIPT1 0.155 0.238 0.77 protein modification process;lipid metabolic
process
exp PRPF8 17p13.3 0.155 0.238 0.77 mRNA processing;RNA splicing
xsq LOC101928254 0.155 0.238 0.77
xsq ARSF Xp22.3 0.155 0.238 0.77
met DHX40 17q23.1 0.155 0.238 0.77
exp LINC01260 0.155 0.238 0.77
xsq RAD51AP2 2p24.2 0.155 0.238 0.77
xsq VIT 2p22.2 0.155 0.238 0.77
met KIR2DS4 19q13.4 0.155 0.238 0.77
xsq FAM114A2 5q31-q33 0.155 0.238 0.77
cop LOH12CR2 12p13.2 0.155 0.238 0.77
xsq LRRC3-AS1 0.155 0.238 0.77
xsq ANAPC15 11q13.4 0.155 0.238 0.77
xsq REG3A 2p12 0.155 0.238 0.77
met SUPT20H 13q13.3 0.155 0.238 0.77
cop SNX29 16p13.13-p13.12 0.155 0.238 0.77 cell communication
met SYT13 11p12-p11 0.155 0.238 0.77 vesicle-mediated transport
exp EDC3 15q24.1 0.155 0.238 0.77 RNA metabolic process;mRNA metabolic
process
mut HMGCS2 1p13-p12 0.155 0.238 0.77 response to temperature
stimulus;response to glucagon stimulus
mut PIK3R4 3q22.1 0.155 0.238 0.77 protein phosphorylation;insulin
xsq WDR73 15q25.2 0.155 0.238 0.77
xsq NR2C2 3p25 0.155 0.238 0.77 regulation of transcription, DNA-
exp SPPL2B 19p13.3 0.155 0.238 0.77 proteolysis
exp LOC100506125 0.155 0.238 0.77
met SCGB2A1 11q13 0.155 0.238 0.77
xsq CACNG8 19q13.4 0.155 0.238 0.77 synaptic transmission;regulation of
cop FAM92B 16q24.1 0.155 0.238 0.77
exp BRWD3 Xq21.1 0.155 0.238 0.77 cytoskeleton organization;regulation of
cell shape
xsq PARP11 12p13.3 0.155 0.238 0.77
xsq OXCT2 1p34 0.155 0.238 0.77 ketone body catabolic process;metabolic process
xsq PITPNM1 11q13 0.155 0.238 0.77 protein transport;lipid metabolic process
exp SEC23B 20p11.23 0.155 0.238 0.77 intracellular protein transport;ER
met LRIG1 3p14 0.155 0.238 0.77
xsq KIAA1551 12p11.21 0.155 0.238 0.77
cop ACER3 11q13.5 0.155 0.238 0.77 positive regulation of cell
proliferation;sphingolipid biosynthetic process
cop B3GNT6 11q13.4 0.155 0.238 0.77 post-translational protein
cop CAPN5 11q14 0.155 0.238 0.77 granulosa cell differentiation;ovarian follicle
development
cop OMP 0.155 0.238 0.77 signal transduction;synaptic transmission
met SNORD114-31 14q32 0.155 0.238 0.77
met MZT1 13q22.1 0.155 0.238 0.77 gamma-tubulin complex localization
dependent"
met SEPT7P2 7p12.3 0.155 0.238 0.77
mut ABCB1 7q21.12 0.155 0.238 0.77 ABC Transporters
cop LIPC 15q21-q23 0.155 0.238 0.77 cholesterol metabolic
process;phosphatidylcholine catabolic process
xsq RBMXL3 Xq23 0.155 0.238 0.77
xsq FAR2P1 0.155 0.238 0.77
xsq RPAIN 17p13.2 0.155 0.238 0.77 DNA Damage Response (DDR)
exp NUBP2 16p13.3 0.155 0.238 0.77
exp PDE4B 1p31 0.155 0.238 0.77 cAMP catabolic process;signal transduction
met LRP12 8q22.2 0.155 0.238 0.77 EMT (Mesenchymal)
exp THAP5 7q31.1 0.155 0.238 0.77 negative regulation of cell cycle
met LRRIQ1 12q21.31 0.155 0.238 0.77
met FNDC3B 3q26.31 0.155 0.238 0.77
exp TAS2R1 5p15 0.155 0.238 0.77 response to stimulus;detection of
cop KAT8 16p11.2 0.155 0.238 0.77 histone H4-K16 acetylation;negative
xsq LINC00884 3q29 0.155 0.238 0.77
mut MTSS1L 16q22.1 0.155 0.238 0.77 filopodium assembly;signal
transduction
xsq SPATA31D5P 9q21.32 0.155 0.238 0.77
xsq GGCT 7p15-p14 0.155 0.238 0.77 glutathione biosynthetic
xsq PCNT 21q22.3 0.155 0.238 0.77 in utero embryonic development;cilium
assembly
dependent"
exp UBE2B 5q31.1 -0.155 0.238 0.77 DNA Damage Response (DDR); DDR
(TLS)
exp MAPKAPK2 1q32 -0.155 0.238 0.77 response to stress;peptidyl-serine
phosphorylation
exp FTH1P2 1q42.13 -0.155 0.238 0.77
mut CDK20 9q22.1 -0.155 0.238 0.77 Protein Kinases
met ERC1 12p13.3 -0.155 0.238 0.77 positive regulation of anti-
xsq TRIM60 -0.155 0.238 0.77
mut MSRA 8p23.1 -0.155 0.238 0.77 protein modification
process;methionine metabolic process
xsq ARHGEF34P 7q35 -0.155 0.238 0.77
cop ACAD11 3q22.1 -0.155 0.238 0.77 fatty acid beta-oxidation
using acyl-CoA dehydrogenase
cop DGCR6L 22q11.21 -0.155 0.238 0.77
xsq TCEAL1 Xq22.1 -0.155 0.238 0.77 negative regulation of
dependent"
xsq TEX38 1p33 -0.155 0.238 0.77
cop PROSC 8p11.2 -0.155 0.238 0.77
xsq TMTC1 12p11.22 -0.155 0.238 0.77
xsq ANO2 12p13.3 -0.155 0.238 0.77 ion transport;chloride transport
exp GAL3ST1 22q12.2 -0.155 0.238 0.77 spermatogenesis;biosynthetic
process
cop UHRF2 9p24.1 -0.155 0.238 0.77 positive regulation of cell cycle
arrest;ubiquitin-dependent protein catabolic process
exp LOC90768 -0.155 0.238 0.77
xsq LINC00961 9p13.3 -0.155 0.238 0.77
xsq PROSER3 -0.155 0.238 0.77
exp TMEM86A 11p15.1 -0.155 0.238 0.77
xsq FAM24B-CUZD1 -0.155 0.238 0.77
exp GAPDHS 19q13.12 -0.155 0.238 0.77 small molecule metabolic
process;positive regulation of glycolysis
cop KANK1 9p24.3 -0.155 0.238 0.77 negative regulation of actin
xsq ALPK3 15q25.2 -0.155 0.238 0.77 protein
exp HDAC9 7p21.1 -0.155 0.238 0.77 inflammatory response;negative
mut EXO1 1q42-q43 -0.155 0.238 0.77 DNA Damage Response (DDR); DDR
(MMR)
exp ADAMTS8 11q25 -0.155 0.238 0.77 proteolysis;negative regulation of
cell proliferation
DNA-dependent"
exp GFRA2 8p21.3 -0.155 0.238 0.77 transmembrane receptor protein
signaling pathway
exp RPL21P48 4q23 -0.155 0.238 0.77
xsq KLF3-AS1 -0.155 0.238 0.77
xai CYB5R2 11p15.4 -0.156 0.238 0.77 sterol biosynthetic
swa IL18 11q22.2-q22.3 -0.156 0.238 0.77 osteoblast
xai FGF20 8p22 -0.156 0.238 0.77 signal transduction;positive regulation
hs4 PLEKHH1 14q24.1 -0.156 0.238 0.77
his DCLK2 4q31.3 -0.156 0.238 0.77 intracellular signal transduction
xai SPINK5 5q32 -0.156 0.238 0.77 anagen;regulation of T cell
differentiation
exp CLEC4M 19p13 -0.156 0.238 0.77 endocytosis;interspecies
xai SMIM14 4p14 -0.156 0.238 0.77
xai KIF18A 11p14.1 -0.156 0.238 0.77 protein transport;M phase of
mitotic cell cycle
xai TGFBR2 3p22 -0.156 0.238 0.77 Apoptosis; Cell Signaling; Tumor
Suppressors
xai GPR137B 1q42-q43 -0.156 0.238 0.77
xai MICAL2 11p15.3 -0.156 0.238 0.77
his LOC400940 2p25.2 -0.156 0.238 0.77
his MOK 14q32 -0.156 0.238 0.77 protein phosphorylation;signal
transduction
xai ARHGEF10 8p23 -0.156 0.238 0.77 myelination in peripheral nervous
swa LIN7C 11p14 -0.156 0.238 0.77 exocytosis;neurotransmitter secretion
hs4 LOC401554 -0.156 0.238 0.77
hs4 RUBCN -0.156 0.238 0.77 negative regulation of
endocytosis;negative regulation of autophagy
hs4 FYTTD1 3q29 -0.156 0.238 0.77 mRNA export from nucleus;transport
xai FBXO39 17p13.1 -0.156 0.238 0.77
his SIX2 2p21 -0.156 0.238 0.77 regulation of transcription, DNA-
hs4 LOC105375483 -0.156 0.238 0.77
xai PLEKHS1 10q25.3 -0.156 0.238 0.77
swa EMD Xq28 -0.156 0.238 0.77 negative regulation of catenin import
into nucleus;positive regulation of protein export from nucleus
xai MFSD4 1q32.1 -0.156 0.238 0.77 transmembrane transport
exp LOC100996517 -0.156 0.238 0.77
hs4 LINC01530 -0.156 0.238 0.77
xai LOC100996517 -0.156 0.238 0.77
xai C2orf72 2q37.1 -0.156 0.238 0.77
xai KRT8P36 -0.156 0.238 0.77
his STK31 7p15.3 -0.156 0.238 0.77
his C5orf66-AS2 -0.156 0.238 0.77
xai ZWINT 10q21-q22 0.156 0.239 0.77 spindle organization;mitotic cell cycle
checkpoint
xai RBMXL2 11p15 0.156 0.239 0.77
cop OR10G2 0.156 0.239 0.77
his LOC100288570 2q13 0.156 0.239 0.77
xai LDHBP1 13q34 0.156 0.239 0.77
his FOXRED2 22q12.3 0.156 0.239 0.77 ER-associated protein catabolic
process
his C14orf79 14q32.33 0.156 0.239 0.77
exp LDHBP1 13q34 0.156 0.239 0.77
xai CNTNAP4 16q23.1 0.156 0.239 0.77 cell adhesion;signal transduction
swa DCTN2 12q13.3 0.156 0.239 0.77 cell proliferation;G2/M transition of
mitotic cell cycle
his RPN2 20q12-q13.1 0.156 0.239 0.77 translation;protein modification process
his MROH8 20q11.22 0.156 0.239 0.77
his REXO1 19p13.3 0.156 0.239 0.77
xai LOC100506036 0.156 0.239 0.77
exp CCT6P3 7q11.21 0.156 0.239 0.77
exp EIF2S2P5 1p13.1 0.156 0.239 0.77
his FBXW5 9q34.3 0.156 0.239 0.77 centrosome duplication;protein
ubiquitination
his C8G 9q34.3 0.156 0.239 0.77 cytolysis;innate immune response
his LCN12 9q34.3 0.156 0.239 0.77 lipid metabolic process
hs4 GPR89B 1q21.1 0.156 0.239 0.77
his CMSS1 3q12.1 0.156 0.239 0.77
xai ACLY 17q21.2 0.156 0.239 0.77 energy reserve metabolic process;cellular
xai HTR3A 11q23.1 0.156 0.239 0.77 ion transmembrane transport;transmembrane
transport
exp MTND5P9 0.156 0.239 0.77
his SAP30BP 17q25.1 0.156 0.239 0.77 Apoptosis
his RECQL5 17q25 0.156 0.239 0.77 DNA Damage Response (DDR); DDR (HR)
exp C10orf107 10q21.2 0.156 0.239 0.77
hs4 C6orf48 6p21.3 0.156 0.239 0.77
hs4 SNORD48 0.156 0.239 0.77
hs4 SNORD52 6p21.33 0.156 0.239 0.77
hs4 ALKBH2 12q24.11 0.156 0.239 0.77 DNA Damage Response (DDR); DDR
(Direct Repair)
exp LOC100506325 0.156 0.239 0.77
his EZH1 17q21.1-q21.3 0.156 0.239 0.77 peptidyl-lysine
exp SLC22A20 11q13.1 0.156 0.239 0.77 ion transport
xai LRRC69 8q21.3 0.156 0.239 0.77
xai PGGT1B 5q22.3 0.156 0.239 0.77 positive regulation of cell
swa METAP2 12q22 0.156 0.239 0.77 proteolysis;cellular process
exp LOC100506036 0.156 0.239 0.77
his PITPNM2 12q24.31 0.156 0.239 0.77 transport;metabolic process
his MLXIP 12q24.31 0.156 0.239 0.77 regulation of transcription, DNA-
dependent"
xai MITD1 2q11.2 0.156 0.239 0.77 protein transport
exp MRS2P2 12q21.1 0.156 0.239 0.77
xai RPL39L 3q27 0.156 0.239 0.77 translation;spermatogenesis
hs4 MRPL12 17q25 0.156 0.239 0.77 transcription from mitochondrial
hs4 IMPA2 18p11.2 0.156 0.239 0.77 signal transduction;phosphatidylinositol
phosphorylation
his CERS2 1q21.3 0.156 0.239 0.77 small molecule metabolic process;ceramide
his ANXA9 1q21 0.156 0.239 0.77 cell-cell adhesion
exp MIR106B 0.156 0.239 0.77
exp MYOD1 11p15.4 0.156 0.239 0.77 regulation of transcription from RNA
polymerase II promoter;skeletal muscle cell differentiation
dependent"
his NUCB2 11p15.1 0.156 0.239 0.77
xai KIAA0125 14q32.33 0.156 0.239 0.77
hs4 CXXC1 18q12 0.156 0.239 0.77 regulation of transcription, DNA-
response
xai RNASEH2A 19p13.2 0.156 0.239 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
xai REPIN1 7q36.1 0.156 0.239 0.77 DNA replication
xai TECR 19p13.12 0.156 0.239 0.77 long-chain fatty-acyl-CoA biosynthetic
process;very long-chain fatty acid biosynthetic process
hs4 C2orf82 2q37.1 0.156 0.239 0.77
his CHUK 10q24-q25 0.156 0.239 0.77 Apoptosis; Protein Kinases
swa ACP1 2p25 0.156 0.239 0.77
xsq LOC101928461 0.155 0.239 0.77
met PDCD2L 19q13.11 0.154 0.239 0.77 cell cycle
exp FAM193B 5q35.3 0.154 0.239 0.77
xsq R3HDM1 2q21.3 0.154 0.239 0.77
exp NPM1P33 2q33.2 0.154 0.239 0.77
xsq CTSS 1q21 0.154 0.239 0.77 antigen processing and presentation of
xsq ALG2 9q22.33 0.154 0.239 0.77 protein N-linked glycosylation via
xsq LOC101929431 0.154 0.239 0.77
met CYC1 8q24.3 0.154 0.239 0.77 transport;respiratory electron transport
chain
mut COG2 1q42.2 0.154 0.239 0.77 protein glycosylation;intracellular
protein transport
exp POTEB 0.154 0.239 0.77
met HEATR5A 14q12 0.154 0.239 0.77
exp RASA2 3q22-q23 0.154 0.239 0.77 positive regulation of Ras GTPase
cop NUPR1 16p11.2 0.154 0.239 0.77 induction of apoptosis;cell growth
dependent"
mut AKT3 1q44 0.154 0.239 0.77 Protein Kinases
cop ELK2AP 0.154 0.239 0.77
xsq YARS2 12p11.21 0.154 0.239 0.77 mitochondrial tyrosyl-tRNA
mut OR52N2 0.154 0.239 0.77
cop TSKU 11q13.5 0.154 0.239 0.77
xsq EIF2A 3q25.1 0.154 0.239 0.77 translational initiation;regulation of
translation
met ST6GALNAC5 1p31.1 0.154 0.239 0.77 protein
exp RSG1 1p36.13 0.154 0.239 0.77 small GTPase mediated signal
xsq CAPN10-AS1 0.154 0.239 0.77
met UBE2F 2q37.3 0.154 0.239 0.77 protein neddylation
xsq SETSIP 0.154 0.239 0.77
xsq LINC01122 0.154 0.239 0.77
exp NAP1L1 12q21.2 0.154 0.239 0.77 DNA replication;nucleosome assembly
xsq TRAPPC12 2p25.3 0.154 0.239 0.77 vesicle-mediated transport
met MAMDC2 9q21.12 0.154 0.239 0.77
mut PDE4DIP 1q12 0.154 0.239 0.77 cellular protein complex assembly
cop WAC-AS1 0.154 0.239 0.77
cop MIR5586 0.154 0.239 0.77
cop GUCY2EP 11q13.5 0.154 0.239 0.77
cop GDPD4 11q13.5 0.154 0.239 0.77 glycerol metabolic process;lipid
metabolic process
cop RSF1 11q14.1 0.154 0.239 0.77 nucleosome positioning;CenH3-containing
mut MYH1 17p13.1 0.154 0.239 0.77
met BEX1 Xq22.1 0.154 0.239 0.77 nervous system development;cell
differentiation
cop UCHL5 1q32 -0.154 0.239 0.77 DNA repair;midbrain development
met FCGR2A 1q23 -0.154 0.239 0.77
exp PHLDA2 11p15.4 -0.154 0.239 0.77 apoptotic process;organ
morphogenesis
exp GPR137B 1q42-q43 -0.154 0.239 0.77
exp PIGQ 16p13.3 -0.154 0.239 0.77 cellular protein metabolic
exp SEMA4C 2q11.2 -0.154 0.239 0.77 neural tube
exp TXNIP 1q21.1 -0.154 0.239 0.77 protein import into
signaling pathway
mut ERCC2 19q13.3 -0.154 0.239 0.77 DNA Damage Response (DDR); DDR
(NER)
cop BPESC1 -0.154 0.239 0.77
xsq RAB18 10p12.1 -0.154 0.239 0.77 protein transport;eye development
xsq PLGRKT 9p24.1 -0.154 0.239 0.77 positive regulation of
met FAM192A 16q13 -0.154 0.239 0.77
exp KRT8P3 8q12.3 -0.154 0.239 0.77
xsq ALS2 2q33.1 -0.154 0.239 0.77 regulation of Rho protein signal
transduction;positive regulation of protein kinase activity
cop LOC100500773 -0.154 0.239 0.77
exp CYP4B1 1p33 -0.154 0.239 0.77 small molecule metabolic
exp LOC100132736 6q15 -0.154 0.239 0.77
met HBBP1 11p15.5 -0.154 0.239 0.77
xsq SIL1 5q31 -0.154 0.239 0.77 protein folding;intracellular protein
transport
exp FZD5 2q33.3 -0.154 0.239 0.77 Oncogenes
exp RNU7-64P -0.154 0.239 0.77
exp LINC00839 10q11.21 -0.154 0.239 0.77
xsq MTMR11 1q12-q21 -0.154 0.239 0.77
exp PAX5 9p13 -0.154 0.239 0.77 Tumor Suppressors
met RSAD1 17q21.33 -0.154 0.239 0.77 porphyrin-containing compound
met MAP1S 19p13.11 -0.155 0.239 0.77 microtubule bundle
formation;apoptotic process
exp KRT8P32 5q15 -0.155 0.239 0.77
his MIR942 -0.156 0.239 0.77
hs4 GPM6A 4q34 -0.156 0.239 0.77
hs4 BCL2L1 20q11.21 -0.156 0.239 0.77 Apoptosis; Protein Kinases
hs4 ABALON -0.156 0.239 0.77
his CACNA2D3-AS1 -0.156 0.239 0.77
xai MMP24-AS1 -0.156 0.239 0.77
his IL15 4q31 -0.156 0.239 0.77 immune response;positive regulation of
his TOM1L2 17p11.2 -0.156 0.239 0.77 intracellular protein
transport
his DRC3 -0.156 0.239 0.77
swa UGDH 4p15.1 -0.156 0.239 0.77 xenobiotic metabolic process;small
hs4 LINC02103 -0.156 0.239 0.77
exp ZSCAN5C 19q13.43 -0.156 0.239 0.77 viral reproduction
hs4 ANGPTL1 1q25.2 -0.156 0.239 0.77 signal
hs4 MIR200B -0.156 0.239 0.77
hs4 MIR200A -0.156 0.239 0.77
hs4 MIR429 -0.156 0.239 0.77
swa RNH1 11p15.5 -0.156 0.239 0.77 mRNA catabolic process;regulation
of angiogenesis
his NPIPB8 -0.156 0.239 0.77
xai MT1X 16q13 -0.156 0.239 0.77 response to metal ion;cellular response
to erythropoietin
exp HMGB3P9 -0.156 0.239 0.77
xai NRG1 8p12 -0.156 0.239 0.77 transmembrane receptor protein tyrosine
his HSD17B3 9q22 -0.156 0.239 0.77 insecticide metabolic
process;response to L-ascorbic acid
xai CIDECP 3p25.3 -0.156 0.239 0.77
hs4 SLC25A48 5q31.1 -0.156 0.239 0.77 transmembrane transport
xai TMTC1 12p11.22 -0.156 0.239 0.77
his CCDC8 19q13.32 -0.156 0.239 0.77 negative regulation of phosphatase
activity
xai KRT8P38 -0.156 0.239 0.77
hs4 PIGR 1q31-q41 -0.156 0.239 0.77
xai MIR106B 0.156 0.24 0.77
swa DCPS 11q24.2 0.156 0.24 0.77 deadenylation-dependent decapping of
swa RARS 5q35.1 0.156 0.24 0.77 tRNA aminoacylation for protein
his MYOM1 18p11.31 0.156 0.24 0.77 muscle contraction
his CTSS 1q21 0.156 0.24 0.77 antigen processing and presentation of
his JOSD1 22q13.1 0.156 0.24 0.77 proteolysis
his GTPBP1 22q13.1 0.156 0.24 0.77 GTP catabolic process;immune
response
xai TCEANC Xp22.2 0.155 0.24 0.77 transcription, DNA-
xai SETP14 3q25.31 0.155 0.24 0.77
his TDP2 6p22.3-p22.1 0.155 0.24 0.77 DNA Damage Response (DDR)
his ACOT13 6p22.3 0.155 0.24 0.77 protein homotetramerization
dependent"
his ATF6B 6p21.3 0.155 0.24 0.77 signal transduction;transcription, DNA-
dependent
his FKBPL 6p21.3 0.155 0.24 0.77 response to radiation;peptidyl-proline
modification
his TSPYL1 6q22.1 0.155 0.24 0.77 nucleosome assembly
hs4 MIR3945HG 0.155 0.24 0.77
his TNFRSF13B 17p11.2 0.155 0.24 0.77 B cell homeostasis;cell surface
dependent"
his SCAF8 6q25.1-q25.3 0.155 0.24 0.77 transcription from RNA polymerase
exp ARHGAP42P4 14q11.2 0.155 0.24 0.77
his UBQLN2 Xp11.21 0.155 0.24 0.77 cell death
hs4 SSBP2 5q14.1 0.155 0.24 0.77 regulation of transcription, DNA-
dependent"
exp SETP14 3q25.31 0.155 0.24 0.77
his SCN2A 2q24.3 0.155 0.24 0.77 nervous system development;myelination
his STX18 4p16.3-p16.2 0.155 0.24 0.77 ER to Golgi vesicle-mediated
his STX18-AS1 0.155 0.24 0.77
his LOC100507195 0.155 0.24 0.77
cop DPP9 19p13.3 0.155 0.24 0.77 proteolysis
xai OR1F1 16p13.3 0.155 0.24 0.77 signal transduction;response to stimulus
exp CACNG7 19q13.4 0.155 0.24 0.77 ion transport;calcium ion transport
xai ARHGAP42P4 14q11.2 0.155 0.24 0.77
exp SUDS3P1 5q35.3 0.155 0.24 0.77
xai PAK1IP1 6p24.2 0.155 0.24 0.77 negative regulation of signal
transduction
xai PNRC1 6q15 0.155 0.24 0.77 regulation of transcription, DNA-dependent"
his LTV1 6q24.2 0.155 0.24 0.77
hs4 SH3BGRL3 1p36.11 0.155 0.24 0.77 cell redox homeostasis
xai CXorf56 Xq23 0.155 0.24 0.77
hs4 BSG 19p13.3 0.155 0.24 0.77 lactate transmembrane
his MIR6848 0.155 0.24 0.77
hs4 LOC150776 2q21.1 0.155 0.24 0.77
hs4 MZT2A 2q21.1 0.155 0.24 0.77
hs4 MIR4784 0.155 0.24 0.77
his IL19 1q32.2 0.155 0.24 0.77 induction of apoptosis;immune response
met RAB38 11q14 0.154 0.24 0.77 GTP catabolic process;small GTPase mediated
signal transduction
xsq LINC00304 16q24.3 0.154 0.24 0.77
exp NLGN3 Xq13.1 0.154 0.24 0.77 social behavior;axon extension
met CDCP1 3p21.31 0.154 0.24 0.77
met KLK1 19q13.3 0.154 0.24 0.77 proteolysis
cop ANO4 12q23.1 0.154 0.24 0.77 ion transport
cop WAC 10p12.1 0.154 0.24 0.77 positive regulation of transcription,
DNA-dependent;histone H2B conserved C-terminal lysine ubiquitination
cop RAB12 18p11.22 0.154 0.24 0.77 small GTPase mediated signal
cop C17orf67 17q22 0.154 0.24 0.77
cop DGKE 17q22 0.154 0.24 0.77 activation of protein kinase C activity by G-
protein coupled receptor protein signaling pathway;blood coagulation
cop MTVR2 17q23 0.154 0.24 0.77
exp OTUD4 4q31.21 0.154 0.24 0.77
xsq C6orf58 6q22.33 0.154 0.24 0.77
xsq WIBG 12q13.2 0.154 0.24 0.77
cop AAMDC 11q14.1 0.154 0.24 0.77
xsq GSG1L2 0.154 0.24 0.77
mut MSRB3 12q14.3 0.154 0.24 0.77 protein repair
met DEFB119 20q11.21 0.154 0.24 0.77 defense response to bacterium
xsq UTP11L 1p34.3 0.154 0.24 0.77 rRNA processing;induction of
apoptosis
xsq LOC101927027 0.154 0.24 0.77
xsq MEX3B 15q25.2 0.154 0.24 0.77 protein phosphorylation;protein
autophosphorylation
mir hsa-miR-30b* 0.154 0.24 0.77
exp CXorf40B Xq28 0.154 0.24 0.77
cop SLC22A18AS 11p15.5 0.154 0.24 0.77 Solute Carriers
mir hsa-miR-539 0.154 0.24 0.77
xsq LOXHD1 18q21.1 0.154 0.24 0.77 sensory perception of sound
xsq RPL28 19q13.4 0.154 0.24 0.77
xsq CCDC43 17q21.31 0.154 0.24 0.77
dependent"
met LILRP2 19q13.4 0.154 0.24 0.77
exp RPS2P36 10q24.1 0.154 0.24 0.77
xsq SV2C 5q13.3 0.154 0.24 0.77 neurotransmitter transport
xsq DESI1 22q13.2 0.154 0.24 0.77
dependent"
xsq TRIM41 5q35.3 0.154 0.24 0.77
cop CYP26B1 2p13.2 0.154 0.24 0.77 male meiosis;negative regulation of
retinoic acid receptor signaling pathway
met TRAPPC6A 19q13.32 0.154 0.24 0.77 vesicle-mediated transport
exp SYP Xp11.23-p11.22 0.154 0.24 0.77 endocytosis;synaptic vesicle
maturation
exp MEGF9 9q32-q33.3 -0.154 0.24 0.77
cop CLDN18 3q22.3 -0.154 0.24 0.77
cop DZIP1L 3q22.3 -0.154 0.24 0.77
cop A4GNT 3p14.3 -0.154 0.24 0.77 carbohydrate metabolic
process;protein O-linked glycosylation
cop DBR1 3q22.3 -0.154 0.24 0.77 nuclear mRNA splicing, via
spliceosome;RNA splicing, via transesterification reactions"
met PREB 2p23.3 -0.154 0.24 0.77 cellular membrane
exp LAD1 1q25.1-q32.3 -0.154 0.24 0.77
cop ASAP1-IT1 8q24.21 -0.154 0.24 0.77
xsq CREB5 7p15.1 -0.154 0.24 0.77 transcription from RNA polymerase
exp GABRP 5q35.1 -0.154 0.24 0.77 ion transport
xsq LINC00896 22q11.21 -0.154 0.24 0.77
mut BCL2L1 20q11.21 -0.154 0.24 0.77 Apoptosis; Protein Kinases
xsq GPM6A 4q34 -0.154 0.24 0.77
met TLDC1 16q24.1 -0.154 0.24 0.77
xsq HACD2 -0.154 0.24 0.77 fatty acid biosynthetic process
exp MIER2 19p13.3 -0.154 0.24 0.77 regulation of transcription, DNA-
dependent"
xsq ANTXR1 2p13.1 -0.154 0.24 0.77 actin cytoskeleton
reorganization;substrate adhesion-dependent cell spreading
xsq ATP6V1D 14q23-q24.2 -0.154 0.24 0.77 proton transport;transferrin
transport
exp MT1G 16q13 -0.154 0.24 0.77 cellular response to zinc ion;monocyte
differentiation
xsq XAF1 17p13.1 -0.154 0.24 0.77 apoptotic process;cytokine-mediated
signaling pathway
cop TPD52L3 9p24.1 -0.154 0.24 0.77
exp TMEM59 1p32.3 -0.154 0.24 0.77
DNA-dependent"
cop ZNF679 7q11.21 -0.154 0.24 0.77
met PLAGL1 6q24-q25 -0.154 0.24 0.77 Apoptosis
exp PARP9 3q21 -0.154 0.24 0.77 cell migration;regulation of response to
interferon-gamma
xsq MIR622 -0.154 0.24 0.77
xsq PLXND1 3q22.1 -0.154 0.24 0.77 multicellular organismal
xsq CPNE2 16q13 -0.154 0.24 0.77
exp NPAS1 19q13.2-q13.3 -0.154 0.24 0.77 negative regulation of
dependent
xai PIGQ 16p13.3 -0.155 0.24 0.77 cellular protein metabolic
exp DEFA8P 8p23.1 -0.155 0.24 0.77
his ZNF655 7q22.1 -0.155 0.24 0.77 G1 phase;regulation of
swa BCAT2 19q13 -0.155 0.24 0.77 cellular nitrogen compound metabolic
process;isoleucine catabolic process
hs4 NBL1 1p36.13 -0.155 0.24 0.77 positive regulation of neuron
swa S100A6 1q21 -0.155 0.24 0.77 positive regulation of fibroblast
exp FTH1P12 9p22.3 -0.155 0.24 0.77
xai DAD1 14q11.2 -0.155 0.24 0.77 Apoptosis
hs4 PLCD4 2q35 -0.155 0.24 0.77 acrosome reaction;lipid catabolic process
swa TUBB2A 6p25 -0.155 0.24 0.77 protein polymerization;protein
folding
his HTRA1 10q26.3 -0.155 0.24 0.77 regulation of cell
growth;proteolysis
exp LOC100652871 -0.155 0.24 0.77
his TLR3 4q35 -0.155 0.24 0.77 activation of NF-kappaB-inducing kinase
xai CLEC4M 19p13 -0.155 0.24 0.77 endocytosis;interspecies
his RASL12 15q11.2-q22.33 -0.155 0.24 0.77 signal
swa DARS2 1q25.1 -0.155 0.24 0.77 tRNA aminoacylation for protein
xai TNK1 17p13.1 -0.155 0.24 0.77 protein autophosphorylation;protein
phosphorylation
xai SEPN1 1p36.13 -0.155 0.24 0.77
exp OTOP1 -0.155 0.24 0.77 biomineral tissue development
his SLITRK2 Xq27.3 -0.155 0.24 0.77 axonogenesis
his HEATR4 14q24.3 -0.155 0.24 0.77
xai ARMCX6 Xq21.33-q22.3 -0.155 0.24 0.77
xai BRK1 3p25.3 -0.155 0.24 0.77
xai YWHAZP2 2q14.3 -0.155 0.24 0.77
his ZFYVE28 4p16.3 0.155 0.241 0.77 negative regulation of epidermal
growth factor-activated receptor activity;negative regulation of epidermal growth
his CFAP99 0.155 0.241 0.77
xai RUNX1-IT1 21q22.12 0.155 0.241 0.77
hs4 HCFC1 Xq28 0.155 0.241 0.77 histone H4-K8 acetylation;negative regulation
hs4 HCFC1-AS1 0.155 0.241 0.77
hs4 TMEM187 Xq28 0.155 0.241 0.77
swa ATAD3A 1p36.33 0.155 0.241 0.77 cell growth;negative regulation of
apoptotic process
his LOC102723828 0.155 0.241 0.77
swa RPL10 Xq28 0.155 0.241 0.77 translation;mRNA metabolic process
hs4 RIPK3 14q11.2 0.155 0.241 0.77 induction of apoptosis by extracellular
signals;protein modification process
his DYRK1A 21q22.13 0.155 0.241 0.77 mitotic cell cycle;protein
phosphorylation
swa PFN1 17p13.3 0.155 0.241 0.77 neural tube closure;positive regulation
hs4 IL10RA 11q23 0.155 0.241 0.77 signal transduction
xai SUDS3P1 5q35.3 0.155 0.241 0.77
exp LOC150051 21q22.11 0.155 0.241 0.77
xai CARF 2q33.2 0.155 0.241 0.77
his ZNF75D Xq26.3 0.155 0.241 0.77 regulation of transcription, DNA-
his ZNF449 Xq26.3 0.155 0.241 0.77 viral reproduction
xai SRSF2 17q25.1 0.155 0.241 0.77 Oncogenes
swa FTO 16q12.2 0.155 0.241 0.77 DNA Damage Response (DDR)
his CBARP 0.155 0.241 0.77
his ATP5D 19p13.3 0.155 0.241 0.77 ATP catabolic process;ATP biosynthetic
process
his MIDN 19p13.3 0.155 0.241 0.77
his CIRBP 19p13.3 0.155 0.241 0.77 response to cold;response to UV
his CIRBP-AS1 19p13.3 0.155 0.241 0.77
his C19orf24 19p13.3 0.155 0.241 0.77
hs4 TCF12 15q21 0.155 0.241 0.77 regulation of transcription from RNA polymerase
hs4 LOC145783 15q21.3 0.155 0.241 0.77
xai ATRIP 0.155 0.241 0.77 DNA Damage Response (DDR); DDR (G1-S
his C5orf24 5q31.1 0.155 0.241 0.77
his RGCC 13q14.11 0.155 0.241 0.77 regulation of cyclin-dependent protein
kinase activity;cell cycle
his WASHC3 0.155 0.241 0.77
his CCNC 6q21 0.155 0.241 0.77 DNA Damage Response (DDR)
hs4 TRIM36 5q22.3 0.155 0.241 0.77 acrosome reaction
hs4 ARHGAP19-SLIT1 0.155 0.241 0.77
hs4 ARHGAP19 10q24.1 0.155 0.241 0.77 signal transduction;small GTPase
hs4 PDSS1 10p12.1 0.155 0.241 0.77 protein heterotetramerization;ubiquinone
xai DDX50 10q22.1 0.155 0.241 0.77
exp KLF16 19p13.3 0.155 0.241 0.77 regulation of transcription from RNA
hs4 GALNTL6 4q34.1 0.155 0.241 0.77
hs4 LOC441052 4q34.1 0.155 0.241 0.77
swa COL14A1 8q23 0.155 0.241 0.77 cell-cell adhesion;extracellular matrix
organization
his GPD1 12q13.12 0.155 0.241 0.77 triglyceride biosynthetic
his SRP54 14q13.2 0.155 0.241 0.77 SRP-dependent cotranslational protein
targeting to membrane, translocation;SRP-dependent cotranslational protein
xai GPA33 1q24.1 0.155 0.241 0.77
his DNAJC19 3q26.33 0.155 0.241 0.77 protein folding;protein targeting
to mitochondrion
xai SIGIRR 11p15.5 0.155 0.241 0.77 innate immune response;negative
xai KLF16 19p13.3 0.155 0.241 0.77 regulation of transcription from RNA
his DHCR7 11q13.4 0.155 0.241 0.77 cholesterol biosynthetic process;post-
cop MIR7-3HG 19p13.3 0.155 0.241 0.77
cop MIR7-3 0.155 0.241 0.77
cop FEM1A 19p13.3 0.155 0.241 0.77 regulation of ubiquitin-protein ligase
cop TICAM1 19p13.3 0.155 0.241 0.77 inflammatory response;positive
his MBNL1 3q25 0.155 0.241 0.77 embryonic limb morphogenesis;regulation of
his MBNL1-AS1 3q25.1 0.155 0.241 0.77
xai CHEK1 11q24.2 0.155 0.241 0.77 DNA Damage Response (DDR); Protein
Kinases
xai NLRP8 19q13.43 0.155 0.241 0.77
hs4 FGF8 10q24 0.155 0.241 0.77 outflow tract septum
hs4 NPM3 10q24.31 0.155 0.241 0.77 rRNA transcription;rRNA processing
his LRRC40 1p31.1 0.155 0.241 0.77
his SRSF11 1p31 0.155 0.241 0.77 RNA splicing;gene expression
met SCARA3 8p21 0.154 0.241 0.77 response to oxidative stress;UV
protection
xsq CLDN25 0.154 0.241 0.77
met LPAR2 19p12 0.154 0.241 0.77 activation of MAPK activity;G-protein coupled
met HTR1E 6q14-q15 0.154 0.241 0.77 G-protein coupled receptor signaling
met KCTD3 1q41 0.154 0.241 0.77 potassium ion transport
mut SNTG1 8q11-q12 0.154 0.241 0.77 cell communication
met C6orf1 6p21.31 0.154 0.241 0.77
exp LOC100287723 0.154 0.241 0.77
cop ALG8 11q14.1 0.154 0.241 0.77 dolichol-linked oligosaccharide
xsq OR4M2 0.154 0.241 0.77
exp LONP1 19p13.2 0.154 0.241 0.77 cellular response to oxidative
xsq BCLAF1 6q22-q23 0.154 0.241 0.77 Apoptosis
exp SMYD4 17p13.3 0.154 0.241 0.77
exp GNA15 19p13.3 0.154 0.241 0.77 blood coagulation;GTP catabolic process
xsq USP34 2p15 0.154 0.241 0.77 protein K48-linked deubiquitination;positive
exp HERC5 4q22.1 0.154 0.241 0.77 cytokine-mediated signaling
pathway;ISG15-protein conjugation
cop SNORA53 12q23.1 0.154 0.241 0.77
cop LOC100996455 0.154 0.241 0.77
cop SLC22A11 11q13.1 0.154 0.241 0.77 urate metabolic
cop SLC22A12 11q13.1 0.154 0.241 0.77
xsq MPHOSPH9 12q24.31 0.154 0.241 0.77 M phase of mitotic cell cycle
exp SNX17 2p23-p22 0.154 0.241 0.77 receptor-mediated endocytosis;signal
transduction
xsq C1QL4 12q13.12 0.154 0.241 0.77
met ANO3 11p14.2 0.154 0.241 0.77 ion transport
xsq KDSR 18q21.3 0.154 0.241 0.77 sphingolipid metabolic process;3-keto-
exp PPP4R2 3p13 0.154 0.241 0.77 DNA Damage Response (DDR); DDR (HR)
xsq OR14I1 1q44 0.154 0.241 0.77 response to stimulus
cop KDM3A 2p11.2 0.154 0.241 0.77 histone H3-K9 demethylation;positive
exp MAP1S 19p13.11 0.154 0.241 0.77 microtubule bundle formation;apoptotic
process
mut DCX Xq22.3-q23 0.154 0.241 0.77 neuron migration;intracellular signal
transduction
met TARM1 19q13.42 0.154 0.241 0.77
mut SBF2 11p15.4 0.154 0.241 0.77 regulation of catalytic activity;protein
tetramerization
exp PHYKPL 5q35.3 0.154 0.241 0.77
mut NEU4 2q37.3 0.154 0.241 0.77 sphingolipid metabolic
xsq HIST1H4B 6p22.1 0.154 0.241 0.77
exp ASH2L 8p11.2 0.154 0.241 0.77 transcription from RNA polymerase II
exp CCAR2 0.154 0.241 0.77 positive regulation of apoptotic
met DUSP22 6p25.3 0.154 0.241 0.77 Apoptosis
met GRINA 8q24.3 0.154 0.241 0.77
xsq SRD5A1P1 0.154 0.241 0.77
cop METRNL 17q25.3 0.154 0.241 0.77
cop FLJ43681 0.154 0.241 0.77
cop CHRM1 11q13 0.154 0.241 0.77 signal transduction;positive regulation of cell
proliferation
xsq SAP25 0.154 0.241 0.77 regulation of transcription, DNA-dependent"
cop PRIMA1 14q32.12 0.154 0.241 0.77 neurotransmitter catabolic
exp IL6R 1q21 0.154 0.241 0.77 positive regulation of cell
xsq RPLP0P2 11cen-q12 0.154 0.241 0.77
exp KLHL14 18q12.1 -0.154 0.241 0.77
xsq TPCN1 12q24.13 -0.154 0.241 0.77 ion transport;transmembrane
transport
xsq LOC101927560 -0.154 0.241 0.77
xsq PDLIM2 8p21.3 -0.154 0.241 0.77
met PJA1 Xq13.1 -0.154 0.241 0.77 protein catabolic process
met TNFRSF13B 17p11.2 -0.154 0.241 0.77 B cell homeostasis;cell
xsq GPR52 -0.154 0.241 0.77 G-protein coupled receptor signaling
pathway
exp PCAT6 -0.154 0.241 0.77
xsq GCNT4 5q12 -0.154 0.241 0.77 inter-male aggressive
behavior;homeostasis of number of cells
cop ACTG1P4 1p21.1 -0.154 0.241 0.77
cop AMY2A -0.154 0.241 0.77 carbohydrate catabolic
cop AMY1A -0.154 0.241 0.77
cop AMY1C -0.154 0.241 0.77
cop AMY1B 1p21 -0.154 0.241 0.77 carbohydrate metabolic process
mut PTPRF 1p34 -0.154 0.241 0.77 cell adhesion;positive regulation of
neuron apoptosis
met ST3GAL2 16q22.1 -0.154 0.241 0.77 protein glycosylation;O-
glycan processing
exp CHST15 10q26 -0.154 0.241 0.77 hexose biosynthetic process
cop LOC729444 -0.154 0.241 0.77
cop TMEM191B -0.154 0.241 0.77
cop PI4KAP1 -0.154 0.241 0.77 phosphatidylinositol
phosphorylation;phosphatidylinositol-mediated signaling
cop RIMBP3 -0.154 0.241 0.77
xsq LOC102724596 -0.154 0.241 0.77
cop PTDSS1 8q22 -0.154 0.241 0.77 phosphatidylserine biosynthetic
exp HCFC1R1 16p13.3 -0.154 0.241 0.77
met SNORD72 5p13 -0.154 0.241 0.77
exp GRPR Xp22.2 -0.154 0.241 0.77 G-protein coupled receptor
signaling pathway;learning or memory
cop PTBP2 1p21.3 -0.154 0.241 0.77 mRNA splice site selection;mRNA
processing
exp GADD45G 9q22.1-q22.2 -0.154 0.241 0.77 DNA Damage Response
(DDR); DDR (BER)
xsq IGF2BP2-AS1 -0.154 0.241 0.77
exp ARFIP1 4q31.3 -0.154 0.241 0.77 intracellular protein
transport;regulation of protein secretion
exp FBXO39 17p13.1 -0.155 0.241 0.77
xai PTPN20 -0.155 0.241 0.77
hs4 BAG3 10q25.2-q26.2 -0.155 0.241 0.77 Apoptosis
his GIPC1 19p13.1 -0.155 0.241 0.77 protein targeting;regulation of
synaptic plasticity
his IGSF3 1p13 -0.155 0.241 0.77
hs4 SLC26A1 4p16.3 -0.155 0.241 0.77 ion transport;sulfate
transport
xai NF2 22q12.2 -0.155 0.241 0.77 Tumor Suppressors
xai LOC100506328 -0.155 0.241 0.77
his MIR6881 -0.155 0.241 0.77
his NIPAL4 5q33.3 -0.155 0.241 0.77 ion transport;magnesium ion
transport
his LOC102724404 -0.155 0.241 0.77
hs4 RAB11FIP5 2p13 -0.155 0.241 0.77 protein transport
his KLF12 13q22 -0.155 0.241 0.77 negative regulation of transcription from
promoter
xai DEFA8P 8p23.1 -0.155 0.241 0.77
his SLC25A48 5q31.1 -0.155 0.241 0.77 transmembrane transport
hs4 KCNIP1 5q35.1 -0.155 0.241 0.77 synaptic
xai LOC100131831 19p13.13 -0.155 0.241 0.77
xai NDRG2 14q11.2 -0.155 0.241 0.77 Wnt receptor signaling pathway;cell
differentiation
his LOC101927437 -0.155 0.241 0.77
exp LOC100129115 -0.155 0.241 0.77
xai HDAC9 7p21.1 -0.155 0.241 0.77 inflammatory response;negative
xai TSGA10IP 11q13.1 -0.155 0.241 0.77
his PPFIBP1 12p12.1 -0.155 0.241 0.77 cell adhesion
his LIMS3 -0.155 0.241 0.77
his LIMS3-LOC440895 2q13 -0.155 0.241 0.77
his LOC101929384 -0.155 0.241 0.77
hs4 LOC644554 19q13.13 -0.155 0.241 0.77
hs4 TRIM6-TRIM34 -0.155 0.241 0.77
hs4 TRIM6 11p15.4 -0.155 0.241 0.77 protein trimerization
xai LOC100129115 -0.155 0.241 0.77
hs4 CELSR2 1p21 -0.155 0.241 0.77 G-protein coupled receptor
cop CGB -0.155 0.241 0.77
cop SNAR-G2 -0.155 0.241 0.77
cop CGB2 19q13.32 -0.155 0.241 0.77
cop CGB1 -0.155 0.241 0.77
cop SNAR-G1 19q13.33 -0.155 0.241 0.77
cop CGB5 19q13.32 -0.155 0.241 0.77
cop CGB8 -0.155 0.241 0.77
cop CGB7 -0.155 0.241 0.77
cop NTF4 19q13.3 -0.155 0.241 0.77 ganglion mother cell fate
cop KCNA7 19q13.3 -0.155 0.241 0.77 ion transport;potassium ion
transport
cop SNRNP70 19q13.3 -0.155 0.241 0.77 mRNA processing;RNA splicing
cop LIN7B 19q13.3 -0.155 0.241 0.77 exocytosis;neurotransmitter
secretion
hs4 CPE 4q32.3 -0.155 0.241 0.77 protein modification
process;proteolysis
his PTPN20 -0.155 0.241 0.77
hs4 IDNK 9q21.32 0.155 0.242 0.77 carbohydrate metabolic process
his BCAS2 1p13.2 0.155 0.242 0.77 DNA Damage Response (DDR)
his PWWP2A 5q33.3 0.155 0.242 0.77
xai SAMD3 6q23.1 0.155 0.242 0.77
xai CPLX2 5q35.2 0.155 0.242 0.77 neurotransmitter transport;vesicle
his PTEN 10q23.3 0.155 0.242 0.77 Apoptosis; Cell Signaling; DNA Damage
Response (DDR); DDR (DNA replication); Protein Kinases; Tumor Suppressors
his KLLN 10q23 0.155 0.242 0.77 cell cycle;apoptotic process
hs4 MRGBP 20q13.33 0.155 0.242 0.77
hs4 LOC400927-CSNK1E 0.155 0.242 0.77
hs4 LOC400927 22q13.1 0.155 0.242 0.77
xai UBALD1 16p13.3 0.155 0.242 0.77
his CBX8 17q25.3 0.155 0.242 0.77 negative regulation of transcription from
exp ARPC3P5 6p22.3 0.155 0.242 0.77
xai PCDHAC1 0.155 0.242 0.77 homophilic cell adhesion;nervous system
development
exp ART4 12p13-p12 0.155 0.242 0.77 protein ADP-ribosylation;arginine
metabolic process
exp TUBB8P4 12p11.1 0.155 0.242 0.77
xai SMC2 9q31.1 0.155 0.242 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
exp OR1F1 16p13.3 0.155 0.242 0.77 signal transduction;response to stimulus
his DCDC5 11p14.1 0.155 0.242 0.77 intracellular signal transduction
his HNRNPUL1 19q13.2 0.155 0.242 0.77 RNA splicing;response to virus
exp LOC100996291 0.155 0.242 0.77
his ETFB 19q13.3 0.155 0.242 0.77 transport;respiratory electron transport
chain
his CLDND2 19q13.41 0.155 0.242 0.77
xai SH2B2 7q22 0.155 0.242 0.77 signal transduction;blood coagulation
his MIR611 0.155 0.242 0.77
his TMEM258 11q12.2 0.155 0.242 0.77
his FEN1 11q12 0.155 0.242 0.77 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
xai AP3B2 15q 0.155 0.242 0.77 post-Golgi vesicle-mediated
xai SCARA5 8p21.1 0.155 0.242 0.77 cellular response to heat;iron ion
xai F10 13q34 0.155 0.242 0.77 post-translational protein
xai GTF2I 7q11.23 0.155 0.242 0.77 transcription from RNA polymerase II
his DPH2 1p34 0.155 0.242 0.77 peptidyl-diphthamide biosynthetic process from
peptidyl-histidine
his KIF24 9p13.3 0.155 0.242 0.77 microtubule-based movement
his NUDT2 9p13 0.155 0.242 0.77 Apoptosis
xai PSMC1P3 7q33 0.155 0.242 0.77
his MIR4508 0.155 0.242 0.77
his MKRN3 15q11-q13 0.155 0.242 0.77
his SCO1 17p13.1 0.155 0.242 0.77 generation of precursor metabolites and
his ADPRM 17p13.1 0.155 0.242 0.77
hs4 UBE2Q2 15q24.2 0.155 0.242 0.77 protein K48-linked ubiquitination
xsq ADPGK-AS1 15q24.1 0.154 0.242 0.77
mut SCN3B 11q23.3 0.154 0.242 0.77 sodium ion transport;nervous system
development
xsq KBTBD13 15q22.31 0.154 0.242 0.77
cop CLNS1A 11q13.5-q14 0.154 0.242 0.77 blood circulation;gene expression
cop GOLGA8F 0.154 0.242 0.77
cop GOLGA8G 0.154 0.242 0.77
cop HERC2P9 15q13.1 0.154 0.242 0.77
cop WHAMMP2 15q13.1 0.154 0.242 0.77
cop LOC100289656 0.154 0.242 0.77
cop TYRO3 15q15 0.154 0.242 0.77 signal transduction by phosphorylation;negative
cop MGA 15q14 0.154 0.242 0.77 Apoptosis
cop MIR626 0.154 0.242 0.77
cop MAPKBP1 15q15.1 0.154 0.242 0.77
cop JMJD7-PLA2G4B 15q11.2-q21.3 0.154 0.242 0.77
cop JMJD7 0.154 0.242 0.77
cop PLA2G4B 0.154 0.242 0.77 parturition;metabolic process
xsq MTBP 8q24.12 0.154 0.242 0.77 DDR (DNA replication)
xsq FOXD4L4 0.153 0.242 0.77
xsq CCL3 17q12 0.153 0.242 0.77 MAPK cascade;chemotaxis
cop NPTN 15q22 0.153 0.242 0.77 elevation of cytosolic calcium ion
xsq BPI 20q11.23 0.153 0.242 0.77
exp NAP1L4 11p15.5 0.153 0.242 0.77 nucleosome assembly
xsq PPP1R15B 1q32.1 0.153 0.242 0.77 dephosphorylation;response to
hydrogen peroxide
met NDP Xp11.4 0.153 0.242 0.77 visual perception;canonical Wnt receptor
signaling pathway
cop RPGRIP1 14q11 0.153 0.242 0.77 eye photoreceptor cell
cop SUPT16H 14q11.2 0.153 0.242 0.77 transcription from RNA polymerase
II promoter;transcription elongation from RNA polymerase II promoter
cop CHD8 14q11.2 0.153 0.242 0.77 DNA duplex unwinding;ATP-dependent
cop SNORD9 0.153 0.242 0.77
cop SNORD8 0.153 0.242 0.77
cop RAB2B 14q11.2 0.153 0.242 0.77 small GTPase mediated signal
cop TOX4 14q11.2 0.153 0.242 0.77
cop METTL3 14q11.1 0.153 0.242 0.77 gene expression;RNA methylation
cop SALL2 14q11.1-q12 0.153 0.242 0.77 neural tube development;negative
cop OR10G3 0.153 0.242 0.77
cop DANCR 4q12 0.153 0.242 0.77
cop MIR4449 0.153 0.242 0.77
cop SNORA26 4q12 0.153 0.242 0.77
cop ERVMER34-1 4q12 0.153 0.242 0.77
cop LOC152578 0.153 0.242 0.77
xsq ZNF37BP 10q11.21 0.153 0.242 0.77
exp NELL2 12q12 0.153 0.242 0.77 cell adhesion;regulation of growth
exp CXorf56 Xq23 0.153 0.242 0.77
cop EIF3CL 0.153 0.242 0.77
cop EIF3C 0.153 0.242 0.77 translation;translational initiation
cop MIR4719 0.153 0.242 0.77
xsq CYBA 16q24 0.153 0.242 0.77 transport;response to drug
cop CRNDE 16q12.2 0.153 0.242 0.77
met BOD1 5q35.2 0.153 0.242 0.77 cell cycle;mitosis
cop MYO5B 18q21 0.153 0.242 0.77 regulation of protein localization;protein
transport
exp NOP10 15q14-q15 0.153 0.242 0.77 DNA Damage Response (DDR)
xsq CREBZF 11q14 0.153 0.242 0.77 transcription, DNA-dependent;response to
virus
exp ATM 11q22-q23 0.153 0.242 0.77 Apoptosis; DNA Damage Response (DDR); DDR
xsq ANKZF1 2q35 0.153 0.242 0.77
exp GMPS 3q24 0.153 0.242 0.77 purine base metabolic process;purine nucleotide
xsq C1orf167 1p36.22 0.153 0.242 0.77
xsq GPATCH1 19q13.11 0.153 0.242 0.77 nuclear mRNA splicing, via
spliceosome"
xsq ACOT13 6p22.3 0.153 0.242 0.77 protein homotetramerization
cop XYLT2 17q21.33 0.153 0.242 0.77 glycosaminoglycan biosynthetic process
exp LYPLA2P1 6p21.32 0.153 0.242 0.77
met LRRC3B 3p24 0.153 0.242 0.77
xsq MAGEC3 Xq27.2 0.153 0.242 0.77
xsq BPESC1 0.153 0.242 0.77
xsq UXT Xp11.23-p11.22 0.153 0.242 0.77 protein folding;mitochondrion
exp RPL28P1 3q26.2 0.153 0.242 0.77
cop TOB1 17q21 0.153 0.242 0.77 negative regulation of cell proliferation
cop TOB1-AS1 0.153 0.242 0.77
exp PHRF1 11p15.5 0.153 0.242 0.77 transcription from RNA polymerase II
xsq PLA2G12A 4q25 0.153 0.242 0.77 lipid catabolic process;phospholipid
metabolic process
xsq TOMM34 0.153 0.242 0.77 protein targeting to mitochondrion
xsq SOD1 21q22.11 0.153 0.242 0.77 DNA Damage Response (DDR)
exp MORF4L1P1 1q41 0.153 0.242 0.77
cop DRC1 2p23.3 0.153 0.242 0.77
xsq LHFPL3-AS2 0.153 0.242 0.77
xsq KMT2E-AS1 0.153 0.242 0.77
met SPNS3 17p13.2 -0.153 0.242 0.77 lipid transport;transmembrane
transport
exp CLCN4 Xp22.3 -0.153 0.242 0.77 chloride transport;transmembrane
transport
xsq MKX 10p12.1 -0.153 0.242 0.77 multicellular organismal
xsq LINC01444 -0.153 0.242 0.77
exp LOC653354 -0.153 0.242 0.77
exp MAP3K1 5q11.2 -0.153 0.242 0.77 Apoptosis; Cell Signaling;
Protein Kinases
xsq ACOT9 Xp22.11 -0.153 0.242 0.77 acyl-CoA metabolic process
xsq GPR143 Xp22.3 -0.153 0.242 0.77 melanosome
exp FN1 2q34 -0.153 0.242 0.77 response to wounding;cell migration
mda FN1_transcript_expression -0.153 0.242 0.77
exp KCNJ13 2q37 -0.153 0.242 0.77 ion transport;potassium ion
transport
xsq STARD6 18q21.2 -0.153 0.242 0.77 transport;lipid transport
exp ZNRF3 22q12.1 -0.153 0.242 0.77
cop RAB9BP1 5q21.2 -0.153 0.242 0.77
met ENKUR 10p12.1 -0.153 0.242 0.77
xsq GPER1 -0.153 0.242 0.77 intracellular steroid hormone receptor
pathway
met ZNF22 10q11 -0.153 0.242 0.77 odontogenesis;regulation of
DNA-dependent"
met TRIM72 16p11.2 -0.153 0.242 0.77 protein
mut IDUA 4p16.3 -0.153 0.242 0.77 cell morphogenesis;carbohydrate
metabolic process
cop TP53INP1 8q22 -0.153 0.242 0.77 apoptotic process;induction of
apoptosis
xsq RASEF 9q21.32 -0.153 0.242 0.77 small GTPase mediated signal
cop PRR23C -0.153 0.242 0.77
exp CLDN4 7q11.23 -0.153 0.242 0.77 EMT (Epithelial)
mda CLDN4_transcript_expression -0.153 0.242 0.77
xsq NMNAT2 1q25 -0.153 0.242 0.77 vitamin metabolic process;water-
exp SNHG18 -0.153 0.242 0.77
xsq GFOD1 6pter-p22.1 -0.153 0.242 0.77
mut OGDH 7p14-p13 -0.153 0.242 0.77 oxidation-reduction
exp INPPL1 11q13 -0.153 0.242 0.77 actin filament
organization;negative regulation of neuron projection development
exp NAPA 19q13.33 -0.153 0.242 0.77 post-Golgi vesicle-mediated
xsq CDH16 16q22.1 -0.154 0.242 0.77 cell adhesion;homophilic cell
adhesion
xsq DNM1P35 15q24.2 -0.154 0.242 0.77
exp PSG7 -0.154 0.242 0.77 female pregnancy
xai DENND2C 1p13.2 -0.155 0.242 0.77
xai LCN2 9q34 -0.155 0.242 0.77 siderophore transport;regulation of
apoptotic process
exp RBMY2KP Yp11.2 -0.155 0.242 0.77
his LOC101928105 -0.155 0.242 0.77
exp RPS3P2 -0.155 0.242 0.77
xai RBM11 21q11 -0.155 0.242 0.77
hs4 LINC00265 7p14.1 -0.155 0.242 0.77
hs4 ZNF321P 19q13.41 -0.155 0.242 0.77
xai WDFY1 2q36.1 -0.155 0.242 0.77
his PHF24 -0.155 0.242 0.77
xai PAMR1 11p13 -0.155 0.242 0.77
his IL4R 16p12.1-p11.2 -0.155 0.242 0.77 ovulation;interleukin-4-
xai PRDX3P3 13q13.3 -0.155 0.242 0.77
exp ND4 -0.155 0.242 0.77
xai NPAS1 19q13.2-q13.3 -0.155 0.242 0.77 negative regulation of
dependent
hs4 ADAMTS5 21q21.3 -0.155 0.242 0.77 proteolysis
hs4 PCDHA7 -0.155 0.242 0.77 homophilic cell adhesion;nervous
system development
exp LOC644285 -0.155 0.242 0.77
hs4 LRRIQ1 12q21.31 -0.155 0.242 0.77
hs4 TSPAN19 12q21.31 -0.155 0.242 0.77
hs4 GRHL2 8q22.3 -0.155 0.242 0.77 EMT (Epithelial)
xai CGB7 -0.155 0.242 0.77
his PRLR 5p13.2 -0.155 0.242 0.77 embryo implantation;prostate gland
growth
swa PRSS21 16p13.3 -0.155 0.242 0.77 proteolysis
hs4 C9orf170 9q21.33 -0.155 0.242 0.77
xai FAM127C Xq26.3 -0.155 0.242 0.77
his NIPAL3 1p36.12-p35.1 -0.155 0.242 0.77
his STPG1 1p36.11 -0.155 0.242 0.77
cop FAM173B 5p15.2 -0.155 0.242 0.77
exp LINC00336 6p21.31 -0.155 0.242 0.77
his BST2 19p13.1 -0.155 0.242 0.77 positive regulation of I-kappaB
his BISPR -0.155 0.242 0.77
hs4 MEIS3 19q13.32 -0.155 0.242 0.77
hs4 FNDC3B 3q26.31 -0.155 0.242 0.77
xai LOC644285 -0.155 0.242 0.77
xai COPB1 11p15.2 -0.155 0.242 0.77 COPI coating of Golgi
his DMRTA1 9p21.3 -0.155 0.242 0.77 regulation of transcription,
DNA-dependent;sex differentiation
hs4 FERMT2 14q22.1 -0.155 0.242 0.77 cell adhesion;regulation of
cell shape
exp FAM180A 7q33 -0.155 0.242 0.77
his MIR296 -0.155 0.242 0.77
his MIR298 -0.155 0.242 0.77
xai TMEM14C 6p24.2 -0.155 0.242 0.77 heme biosynthetic process
his NOL7 6p23 0.155 0.243 0.77
hs4 GRIN2C 17q25.1 0.155 0.243 0.77 transport;directional locomotion
his PDZD9 16p12.2 0.155 0.243 0.77
his PRKG2 4q13.1-q21.1 0.155 0.243 0.77 small molecule metabolic
xai OR6J1 14q11.2 0.155 0.243 0.77 response to stimulus
xai TSKS 19q13.3 0.155 0.243 0.77 negative regulation of phosphatase
activity
swa CHCHD4 3p25.1 0.154 0.243 0.77 protein transport
xai LOC100506125 0.154 0.243 0.77
exp KLRD1 12p13 0.154 0.243 0.77 cell surface receptor signaling
his STXBP3 1p13.3 0.154 0.243 0.77 blood coagulation;protein transport
xai PRKAR1B 7p22 0.154 0.243 0.77 protein phosphorylation;small molecule
metabolic process
xai PIP5KL1 9q34.11 0.154 0.243 0.77
xai CYP2W1 7p22.3 0.154 0.243 0.77 small molecule metabolic
xai SLC8A1-AS1 0.154 0.243 0.77
xai LOC339529 0.154 0.243 0.77
hs4 DPY30 2p22.3 0.154 0.243 0.77 histone H3-K4 methylation;regulation of
xai HAUS8 19p13.11 0.154 0.243 0.77 cell cycle;mitosis
hs4 CISH 3p21.3 0.154 0.243 0.77 intracellular signal transduction;JAK-
STAT cascade involved in growth hormone signaling pathway
his SLC25A47 14q32.2 0.154 0.243 0.77
his VARS 6p21.3 0.154 0.243 0.77 gene expression;translational elongation
cop ZNF503-AS1 0.154 0.243 0.77
his TMEM60 7q11.23 0.154 0.243 0.77
his PHTF2 7q11.23-q21 0.154 0.243 0.77 regulation of transcription, DNA-
dependent"
his SSU72 1p36.33 0.154 0.243 0.77 mRNA processing
xai DDX59 1q32.1 0.154 0.243 0.77
his POF1B Xq21.2 0.154 0.243 0.77
hs4 MIR4783 0.154 0.243 0.77
xai RIOK3 18q11.2 0.154 0.243 0.77 protein phosphorylation;chromosome
segregation
his LOC102723727 0.154 0.243 0.77
his LPGAT1 1q32 0.154 0.243 0.77 metabolic process;phospholipid
swa RPS26 12q13 0.154 0.243 0.77 translational termination;negative regulation
of RNA splicing
hs4 CLN6 15q23 0.154 0.243 0.77 protein catabolic process;glycosaminoglycan
metabolic process
his TMEM244 6q22.33 0.154 0.243 0.77
his FITM2 20q13.12 0.154 0.243 0.77 positive regulation of sequestering of
triglyceride;regulation of cell morphogenesis
his KHDC1L 6q13 0.154 0.243 0.77
xai OTUD4 4q31.21 0.154 0.243 0.77
exp SYN3 22q12.3 0.154 0.243 0.77 neurotransmitter secretion
his USO1 4q21.1 0.154 0.243 0.77 intracellular protein transport;vesicle
fusion with Golgi apparatus
his SET 9q34 0.154 0.243 0.77 nucleosome disassembly;nucleocytoplasmic
transport
xai ZDHHC11B 5p15.33 0.154 0.243 0.77
his GDPD3 0.154 0.243 0.77 glycerol metabolic process;lipid metabolic
process
xsq INO80 15q15.1 0.153 0.243 0.77 DNA Damage Response (DDR); DDR
(Chromatin)
dependent"
met C1orf210 1p34.2 0.153 0.243 0.77 EMT (Epithelial)
cop ACOX3 4p15.3 0.153 0.243 0.77 fatty acid metabolic process;fatty acid
xsq PURG 8p11 0.153 0.243 0.77
xsq TSIX Xq13.2 0.153 0.243 0.77
met CADM3 1q21.2-q22 0.153 0.243 0.77 heterophilic cell-cell adhesion;cell
junction assembly
mut DHRS3 1p36.1 0.153 0.243 0.77 visual perception;retinol metabolic
process
mut ETV5 3q28 0.153 0.243 0.77 Transcription Factors
xsq OR6V1 7q34 0.153 0.243 0.77
xsq WDR61 15q25.1 0.153 0.243 0.77
xsq CFHR5 1q31.3 0.153 0.243 0.77 complement activation, alternative
pathway"
cop GCSH 16q23.2 0.153 0.243 0.77 glycine catabolic process;glycine
met EEPD1 7p14.2 0.153 0.243 0.77 DNA repair
xsq FAM46A 6q14 0.153 0.243 0.77
exp SOCS2 12q 0.153 0.243 0.77 Apoptosis
exp ABHD17AP4 0.153 0.243 0.77
xsq PPP2R5D 6p21.1 0.153 0.243 0.77 signal transduction;nervous system
development
exp HARBI1 11p11.2 0.153 0.243 0.77
met HSPB1 7q11.23 0.153 0.243 0.77 Apoptosis
cop FLRT1 11q13.1 0.153 0.243 0.77 cell adhesion
cop USP46 4q12 0.153 0.243 0.77 regulation of synaptic transmission,
GABAergic;proteolysis
mut PPP1CC 12q24.1-q24.2 0.153 0.243 0.77 carbohydrate metabolic
xsq GIGYF1 7q22 0.153 0.243 0.77 insulin-like growth factor receptor
signaling pathway
xsq GRM3 7q21.1-q21.2 0.153 0.243 0.77
cop CRIPAK 4p16.3 0.153 0.243 0.77 negative regulation of protein
pathway
cop FAM53A 4p16.3 0.153 0.243 0.77
cop SLBP 4p16.3 0.153 0.243 0.77 transcription from RNA polymerase II
promoter;regulation of S phase
cop TMEM129 4p16.3 0.153 0.243 0.77
cop TACC3 4p16.3 0.153 0.243 0.77 microtubule cytoskeleton
exp ARL11 13q14.2 0.153 0.243 0.77 small GTPase mediated signal transduction
cop RASAL1 12q23-q24 0.153 0.243 0.77 signal transduction;positive
met TMEM45B 11q24.3 0.153 0.243 0.77
cop SH2B1 0.153 0.243 0.77 blood coagulation;intracellular signal
transduction
cop ATP2A1 0.153 0.243 0.77 cation transport;ion transmembrane
transport
cop LOC100289092 16p11.2 0.153 0.243 0.77
cop RABEP2 16p11.2 0.153 0.243 0.77 endocytosis;protein transport
cop CD19 0.153 0.243 0.77 cell surface receptor signaling
cop NFATC2IP 0.153 0.243 0.77 DNA Damage Response (DDR); DDR (HR)
cop MIR4517 0.153 0.243 0.77
cop SPNS1 0.153 0.243 0.77 lipid transport;transmembrane transport
cop LAT 16p11.2 0.153 0.243 0.77 T cell activation;immune response
xsq LOC389906 Xp22.33 0.153 0.243 0.77
cop ULK1 12q24.3 0.153 0.243 0.77 neuron projection regeneration;neuron
cop PUS1 12q24.33 0.153 0.243 0.77 tRNA processing;metabolic process
cop EP400 12q24.33 0.153 0.243 0.77 regulation of transcription, DNA-
cop SNORA49 0.153 0.243 0.77
cop STARD10 11q13 0.153 0.243 0.77
xsq OSGEP 14q11.2 0.153 0.243 0.77 proteolysis;tRNA processing
xsq LINC01214 0.153 0.243 0.77
cop SGF29 0.153 0.243 0.77 establishment of protein localization to
exp U2SURP 3q23 0.153 0.243 0.77 RNA processing
cop UNC79 14q32.12 0.153 0.243 0.77
cop GLTP 12q24.11 0.153 0.243 0.77 transport;glycolipid transport
xsq TGFBRAP1 2q12.1 0.153 0.243 0.77 regulation of transcription, DNA-
exp PIBF1 13q22.1 0.153 0.243 0.77
met MIR200C 0.153 0.243 0.77
cop CNP 17q21 0.153 0.243 0.77 microtubule cytoskeleton organization;synaptic
transmission
cop DNAJC7 17q11.2 0.153 0.243 0.77 protein folding;chaperone cofactor-
xsq GPX6 6p22.1 0.153 0.243 0.77 response to oxidative stress
xsq FGD5-AS1 0.153 0.243 0.77
cop FAM181A-AS1 14q32.12 0.153 0.243 0.77
cop FAM181A 14q32.12 0.153 0.243 0.77
cop ASB2 14q31-q32 0.153 0.243 0.77 signal transduction;intracellular signal
transduction
cop LINC00521 14q32.12 0.153 0.243 0.77
cop OTUB2 14q32.12 0.153 0.243 0.77 proteolysis;cellular amino acid metabolic
process
cop DDX24 14q32 0.153 0.243 0.77 RNA metabolic process
cop IFI27L1 14q32.12 0.153 0.243 0.77
cop IFI27 14q32 0.153 0.243 0.77 activation of cysteine-type endopeptidase
signals
cop IFI27L2 14q32.12 0.153 0.243 0.77
cop PPP4R4 14q32.2 0.153 0.243 0.77 DNA Damage Response (DDR); DDR (HR)
cop SERPINA10 14q32.13 0.153 0.243 0.77 regulation of proteolysis;tissue
regeneration
cop SERPINA6 14q32.1 0.153 0.243 0.77 regulation of proteolysis;transport
met P4HA2 5q31 0.153 0.243 0.77 peptidyl-proline hydroxylation to 4-hydroxy-L-
proline
xsq VAMP4 1q24-q25 0.153 0.243 0.77 vesicle-mediated transport
met LRRC8E 19p13.2 0.153 0.243 0.77
met LYRM4 6p25.1 0.153 0.243 0.77
exp TRAPPC5 19p13.2 0.153 0.243 0.77 vesicle-mediated transport
cop PAK1 11q13-q14 0.153 0.243 0.77 Apoptosis; Protein Kinases
xsq WDR83OS 19p13.2 0.153 0.243 0.77
exp COL23A1 5q35.3 0.153 0.243 0.77 protein homotrimerization
xsq LY6E 8q24.3 -0.153 0.243 0.77 cell surface receptor signaling
exp BFAR 16p13.12 -0.153 0.243 0.77 Apoptosis
xsq TLN2 15q15-q21 -0.153 0.243 0.77 cell-cell junction assembly;cell
adhesion
DNA-dependent"
cop FSTL5 4q32.3 -0.153 0.243 0.77
xsq BMF 15q14 -0.153 0.243 0.77 Apoptosis
xsq KLF4 9q31 -0.153 0.243 0.77 mesodermal cell fate
xsq PPP1R36 14q23.3 -0.153 0.243 0.77 negative regulation of
exp UBE2CP4 15q13.3 -0.153 0.243 0.77
xsq LOC100505984 -0.153 0.243 0.77
xsq SEMA4F 2p13.1 -0.153 0.243 0.77 cell differentiation;negative
xsq PRICKLE2-AS2 -0.153 0.243 0.77
exp SCN4B 11q23.3 -0.153 0.243 0.77 ion transport;sodium ion transport
xsq SCNN1A 12p13 -0.153 0.243 0.77 ion transport;sodium ion transport
exp KAAG1 6p22.1 -0.153 0.243 0.77 immune response
xsq SIRT2 19q13 -0.153 0.243 0.77 regulation of exit from mitosis;response
to redox state
met SECISBP2L 15q21.1 -0.153 0.243 0.77
xsq TMC4 19q13.42 -0.153 0.243 0.77 EMT (Epithelial)
xsq TNFAIP8L3 15q21.2 -0.153 0.243 0.77
exp PXDN 2p25 -0.153 0.243 0.77 hydrogen peroxide catabolic
xsq ARHGEF25 12q13.3 -0.153 0.243 0.77 regulation of Rho protein
signal transduction
his ZNF703 8p11.23 -0.154 0.243 0.77 positive regulation of cell
his LOC100129046 1p22.1 -0.154 0.243 0.77
xai SMAD3 15q22.33 -0.154 0.243 0.77 Apoptosis
exp GAPDHP15 -0.154 0.243 0.77
hs4 DNAH6 2p11.2 -0.154 0.243 0.77 microtubule-based movement
dependent"
his FAM181A-AS1 14q32.12 -0.154 0.243 0.77
his FAM181A 14q32.12 -0.154 0.243 0.77
his LIMS4 -0.154 0.243 0.77
hs4 ADAM28 8p21.2 -0.154 0.243 0.77 proteolysis;spermatogenesis
xai DNM1P34 15q24.2 -0.154 0.243 0.77
xai ZMYND10 3p21.3 -0.154 0.243 0.77
his FHL1 Xq26 -0.154 0.243 0.77 multicellular organismal
swa NVL 1q41-q42.2 -0.154 0.243 0.77
his KRT14 17q21.2 -0.154 0.243 0.77 intermediate filament bundle
hs4 SNAR-E -0.154 0.243 0.77
exp LOC149351 -0.154 0.243 0.77
xai C10orf10 10q11.21 -0.154 0.243 0.77
exp GUSBP10 7p11.2 -0.154 0.243 0.77
xai KRTAP4-3 17q21.2 -0.154 0.243 0.77
his TENM3 4q35.1 -0.154 0.243 0.77
hs4 PCDH8 13q21.1 -0.154 0.243 0.77 homophilic cell adhesion;cell-cell
signaling
xai CSNK1A1 5q32 -0.154 0.243 0.77 cell division;protein
phosphorylation
xai VWA5B1 1p36.12 -0.154 0.243 0.77
exp KRTAP4-3 17q21.2 -0.154 0.243 0.77
exp PRDX3P3 13q13.3 -0.155 0.243 0.77
hs4 LINC00862 -0.155 0.243 0.77
hs4 OGFRL1 6q13 -0.155 0.243 0.77
xai PITRM1 10p15.2 -0.155 0.243 0.77 proteolysis;positive
met TTTY13 Yq11.223 -0.281 0.243 0.77
xai PNOC 8p21 0.154 0.244 0.77 signal transduction;neuropeptide signaling
pathway
dependent"
hs4 CD300C 17q25.1 0.154 0.244 0.77 cellular defense response
his SLC35B4 7q33 0.154 0.244 0.77 EMT (Mesenchymal); Solute Carriers
hs4 ZDBF2 2q33.3 0.154 0.244 0.77
xai PPP4R2 3p13 0.154 0.244 0.77 DNA Damage Response (DDR); DDR (HR)
hs4 KIF15 3p21.31 0.154 0.244 0.77 microtubule-based movement;mitosis
hs4 KIAA1143 3p21.31 0.154 0.244 0.77
hs4 MED18 1p35.3 0.154 0.244 0.77 regulation of transcription from RNA
xai NUP62CL Xq22.3 0.154 0.244 0.77 protein transport
xai HSP90AA6P 4q33 0.154 0.244 0.77
xai FER1L6 8q24.1 0.154 0.244 0.77
swa SRP9 1q42.12 0.154 0.244 0.77 translation;SRP-dependent cotranslational
hs4 EXOC7 17q25.1 0.154 0.244 0.77 exocytosis;protein transport
exp MAGEB18 Xp21.3 0.154 0.244 0.77
his MIS18BP1 14q21.2 0.154 0.244 0.77 mitosis;CenH3-containing nucleosome
xai SMG1P1 0.154 0.244 0.77
hs4 RPS8 1p34.1-p32 0.154 0.244 0.77 translational elongation;viral
transcription
hs4 SNORD55 0.154 0.244 0.77
hs4 SNORD46 0.154 0.244 0.77
hs4 SNORD38A 0.154 0.244 0.77
hs4 SNORD38B 1p34.1 0.154 0.244 0.77
hs4 PEX5 12p13.31 0.154 0.244 0.77 protein targeting to peroxisome;protein
transport
xai LCMT1 16p12.1 0.154 0.244 0.77 C-terminal protein methylation;protein
exp SMG1P1 0.154 0.244 0.77
swa DDT 22q11.23 0.154 0.244 0.77 melanin biosynthetic process
his THUMPD3-AS1 0.154 0.244 0.77
his SETD5 3p25.3 0.154 0.244 0.77
xai CCDC90B 11q14.1 0.154 0.244 0.77
his SPRED2 2p14 0.154 0.244 0.77 multicellular organismal
xai CLASRP 19q13.3 0.154 0.244 0.77 mRNA processing;RNA splicing
his FBL 19q13.1 0.154 0.244 0.77 snoRNA metabolic process;rRNA processing
his JPH3 16q24.3 0.154 0.244 0.77 memory;exploration behavior
hs4 CMTR2 0.154 0.244 0.77
xai CTAGE1 18p11.2 0.154 0.244 0.77
xai THAP5 7q31.1 0.154 0.244 0.77 negative regulation of cell cycle
hs4 CTPS1 1p34.1 0.154 0.244 0.77 nucleobase-containing small molecule
interconversion;response to drug
his METTL26 0.154 0.244 0.77
exp MSMP 9p13.3 0.154 0.244 0.77
his WNT3 17q21 0.154 0.244 0.77 Oncogenes
exp LOC389765 9q21.33 0.154 0.244 0.77
exp C20orf203 20q11.21 0.154 0.244 0.77
xai PDE4B 1p31 0.154 0.244 0.77 cAMP catabolic process;signal transduction
xai LOC100506504 0.154 0.244 0.77
met CCDC186 0.153 0.244 0.77
cop FLG 1q21.3 0.153 0.244 0.77 multicellular organismal
cop FLG2 1q21.3 0.153 0.244 0.77
cop CRNN 1q21 0.153 0.244 0.77
mut SPECC1L 22q11.23 0.153 0.244 0.77 cell cycle;cell division
dependent"
met TMEM163 2q21.3 0.153 0.244 0.77
xsq HIST2H3D 0.153 0.244 0.77 blood coagulation;negative regulation of
met NME5 5q31 0.153 0.244 0.77 GTP biosynthetic process;UTP biosynthetic
process
xsq GEN1 2p24.2 0.153 0.244 0.77 DNA Damage Response (DDR); DDR (HR)
pro MAP2K2_3 0.153 0.244 0.77
xsq BBS10 12q21.2 0.153 0.244 0.77 retina homeostasis;nonmotile primary
cilium assembly
xsq C12orf76 12q24.11 0.153 0.244 0.77
exp ANKRD20A7P 0.153 0.244 0.77
met CPSF1 8q24.23 0.153 0.244 0.77 nuclear mRNA splicing, via
xsq LOC729296 20q13.33 0.153 0.244 0.77
exp EIF3I 1p34.1 0.153 0.244 0.77 gene expression;cellular protein
metabolic process
xsq PTPRT 20q12-q13 0.153 0.244 0.77 protein dephosphorylation;cell adhesion
exp LOC100128441 8p12 0.153 0.244 0.77
xsq RHBDD3 22q12.2 0.153 0.244 0.77
cop TUFM 16p11.2 0.153 0.244 0.77 translational elongation
xsq MAMSTR 19q13.33 0.153 0.244 0.77 regulation of transcription, DNA-
cop UBN1 16p13.3 0.153 0.244 0.77 negative regulation of phosphatase
cop PPL 16p13.3 0.153 0.244 0.77 keratinization
exp LOC643862 7q11.23 0.153 0.244 0.77
xsq PYROXD1 12p12.1 0.153 0.244 0.77
exp LOC100996583 0.153 0.244 0.77
met MIR487A 0.153 0.244 0.77
dependent"
xsq EIF3A 10q26 0.153 0.244 0.77 translational initiation;gene expression
met SEC13 3p25-p24 0.153 0.244 0.77 cellular membrane organization;vesicle-
mediated transport
exp RPL7P10 1p31.1 0.153 0.244 0.77
xsq OSBPL5 11p15.4 0.153 0.244 0.77 transport;lipid transport
xsq PMVK 1q22 0.153 0.244 0.77 response to cholesterol;cholesterol
exp ANAPC16 10q22.1 0.153 0.244 0.77 cell cycle;mitosis
cop AUH 9q22.31 0.153 0.244 0.77 mRNA catabolic process;branched chain
met IDH2 15q26.1 0.153 0.244 0.77 Oncogenes
xsq CDC25C 5q31 0.153 0.244 0.77 DDR (DNA replication)
xsq C5orf66 0.153 0.244 0.77
met VCX3A Xp22 0.153 0.244 0.77 brain development
met EIF2B5 3q27.1 0.153 0.244 0.77 response to glucose
met TPRA1 3q21.2 0.153 0.244 0.77 lipid metabolic process;G-protein coupled
exp POLDIP3 22q13.2 0.153 0.244 0.77 positive regulation of translation
met ABCA6 17q24.3 0.153 0.244 0.77 ABC Transporters
met ZIM3 0.153 0.244 0.77 regulation of transcription, DNA-dependent"
dependent"
exp CLASRP 19q13.3 0.153 0.244 0.77 mRNA processing;RNA splicing
xsq POM121L10P 22q11.23 0.153 0.244 0.77
xsq PAK1IP1 6p24.2 0.153 0.244 0.77 negative regulation of signal
transduction
exp RANBP10 16q22.1 0.153 0.244 0.77 microtubule cytoskeleton
xsq MMGT1 Xq26.3 0.153 0.244 0.77 transport;magnesium ion transport
xsq BMS1 10q11.21 0.153 0.244 0.77 ribosome assembly
dependent"
met PALM2 9q31.3 0.153 0.244 0.77 regulation of cell shape
xsq ASB9P1 15q26.1 0.153 0.244 0.77
xsq C6orf52 6p24.1 0.153 0.244 0.77
xsq MXI1 10q24-q25 0.153 0.244 0.77 Apoptosis
xsq CWC25 17q12 0.153 0.244 0.77
xsq SPIB 19q13.3-q13.4 0.153 0.244 0.77 Transcription Factors
exp OSBPL2 20q13.3 -0.153 0.244 0.77 transport;lipid transport
xsq CYB561 17q23.3 -0.153 0.244 0.77 generation of precursor
cop FAM105A 5p15.2 -0.153 0.244 0.77
xsq XDH 2p23.1 -0.153 0.244 0.77 small molecule metabolic
met DCTPP1 16p11.2 -0.153 0.244 0.77 nucleoside triphosphate
exp SEPT7 7p14.2 -0.153 0.244 0.77 cytokinesis;cell cycle
xsq RGPD8 2q13 -0.153 0.244 0.77 protein targeting to Golgi;intracellular
transport
xsq ITPKC 19q13.1 -0.153 0.244 0.77
xsq CREB3L1 11p11.2 -0.153 0.244 0.77 response to unfolded protein
xsq TMCO3 13q34 -0.153 0.244 0.77 cation transport;transmembrane transport
exp MSX1 4p16.2 -0.153 0.244 0.77 multicellular organismal
exp PNMAL1 19q13.32 -0.153 0.244 0.77
met FGFR1OP2 12p11.23 -0.153 0.244 0.77 response to wounding
xsq TRIM6 11p15.4 -0.153 0.244 0.77 protein trimerization
xsq SYBU 8q23.2 -0.153 0.244 0.77
exp ERCC2 19q13.3 -0.153 0.244 0.77 DNA Damage Response (DDR); DDR
(NER)
cop GDF6 8q22.1 -0.153 0.244 0.77 growth;positive regulation of
cop UQCRB 8q22 -0.153 0.244 0.77 oxidative phosphorylation;mitochondrial
electron transport, ubiquinol to cytochrome c
cop MTERFD1 -0.153 0.244 0.77
cop LOC284865 -0.153 0.244 0.77
exp LOC644051 6p24.3 -0.153 0.244 0.77
met HTRA3 4p16.1 -0.153 0.244 0.77 regulation of cell
growth;proteolysis
xsq TNFSF13 17p13.1 -0.153 0.244 0.77 positive regulation of cell
cop KCNIP4 4p15.32 -0.153 0.244 0.77 ion transport;potassium ion
transport
cop KDM4C 9p24.1 -0.153 0.244 0.77 chromatin modification;histone H3-
K9 demethylation
exp SEPP1 5q31 -0.153 0.244 0.77 response to oxidative stress
xsq DCLK1 13q13 -0.153 0.244 0.77 response to virus;endosome transport
met HSH2D 19p13.12 -0.153 0.244 0.77 T cell activation
met RPS5 19q13.4 -0.153 0.244 0.77 regulation of translational
exp A2M 12p13.31 -0.153 0.244 0.77 negative regulation of complement
exp WNT2B 1p13 -0.153 0.244 0.77 Apoptosis; Oncogenes
hs4 ALG10B 12q12 -0.154 0.244 0.77 dolichol-linked oligosaccharide
xai RIC1 -0.154 0.244 0.77
xai ZMYND15 17p13.2 -0.154 0.244 0.77 spermatogenesis;cell
differentiation
xai FHOD3 18q12 -0.154 0.244 0.77 cellular component organization;actin
his HLA-DQA1 6p21.3 -0.154 0.244 0.77
hs4 PIP4K2C 12q13.3 -0.154 0.244 0.77
xai SEMA4C 2q11.2 -0.154 0.244 0.77 neural tube
hs4 TTC7B 14q32.11 -0.154 0.244 0.77
DNA-dependent"
xai SIM1 6q16.3 -0.154 0.244 0.77 cell differentiation;ureteric bud
development
exp VN2R1P 3q25.31 -0.154 0.244 0.77
his TRPS1 8q24.12 -0.154 0.244 0.77 skeletal system
exp LOC100652768 -0.154 0.244 0.77
hs4 SMAD7 18q21.1 -0.154 0.244 0.77 Apoptosis
hs4 STBD1 4q21.1 -0.154 0.244 0.77 muscle contraction
xai ADCY2 5p15.3 -0.154 0.244 0.77 cAMP biosynthetic process;synaptic
transmission
swa ABHD10 3q13.2 -0.154 0.244 0.77 proteolysis
xai IL36RN 2q14 -0.154 0.244 0.77 negative regulation of cytokine-
xai LRRC16A 6p22.2 -0.154 0.244 0.77 lamellipodium assembly;ruffle
organization
xai ABCB1 7q21.12 -0.154 0.244 0.77 ABC Transporters
his SCARNA27 6p24.3 -0.154 0.244 0.77
his FAM171A1 10p13 -0.154 0.244 0.77
his LYSMD1 1q21.3 0.154 0.245 0.77 cell wall macromolecule catabolic
process
his SCNM1 1q21.3 0.154 0.245 0.77 mRNA processing;RNA splicing
xai RPS10 6p21.31 0.154 0.245 0.77 viral reproduction;nuclear-transcribed
his EZH2 7q35-q36 0.154 0.245 0.77 Oncogenes; Tumor Suppressors
his DSG1-AS1 0.154 0.245 0.77
his ZNF12 7p22.1 0.154 0.245 0.77 negative regulation of transcription,
DNA-dependent"
his CPS1-IT1 2q34 0.154 0.245 0.77
his PPP2R1B 11q23.2 0.154 0.245 0.77 Apoptosis
exp LOC645177 12p12.1 0.154 0.245 0.77
hs4 DIP2A 21q22.3 0.154 0.245 0.77 multicellular organismal development
hs4 DIP2A-IT1 0.154 0.245 0.77
xai OVOS 12p13 0.154 0.245 0.77
his GZMA 5q11-q12 0.154 0.245 0.77 cleavage of lamin;immune response
xai ABLIM2 4p16.1 0.154 0.245 0.77 cytoskeleton organization;axon
guidance
his CEP63 3q22.2 0.154 0.245 0.77 mitosis;signal transduction in response
to DNA damage
his ANAPC13 3q22.2 0.154 0.245 0.77 cell cycle;mitosis
xai PET100 19p13.2 0.154 0.245 0.77
xai FKBPL 6p21.3 0.154 0.245 0.77 response to radiation;peptidyl-proline
modification
his TMED8 14q24.3 0.154 0.245 0.77 transport
his SAMD15 14q24.3 0.154 0.245 0.77
xai DPF2 11q13 0.154 0.245 0.77 Apoptosis
xai TXLNB 6q24.1 0.154 0.245 0.77
hs4 ECHDC1 6q22.33 0.154 0.245 0.77
exp RPS2P44 16q12.1 0.154 0.245 0.77
hs4 TBC1D2B 15q24.3-q25.1 0.154 0.245 0.77
hs4 RPL39 Xq24 0.154 0.245 0.77 translational termination;cellular protein
metabolic process
hs4 SNORA69 0.154 0.245 0.77
hs4 TRMT2B Xq22.1 0.154 0.245 0.77 tRNA processing
xai SYT3 19q13.33 0.154 0.245 0.77
his SPATA41 15q26.3 0.154 0.245 0.77
xai ATP5L 11q23.3 0.154 0.245 0.77 ATP catabolic process;ion transport
his FGL2 7q11.23 0.154 0.245 0.77 signal transduction
swa HMGCS1 5p14-p13 0.154 0.245 0.77 cholesterol biosynthetic
process;response to gonadotropin stimulus
his SPANXA2-OT1 0.154 0.245 0.77
hs4 RNF4 4p16.3 0.154 0.245 0.77 DNA Damage Response (DDR)
exp OR2V1 0.154 0.245 0.77 response to stimulus
his PLBD2 12q24.13 0.154 0.245 0.77 lipid catabolic process
xai SMG7 1q25 0.154 0.245 0.77 nuclear-transcribed mRNA catabolic process,
his DEPDC1B 5q12.1 0.154 0.245 0.77 small GTPase mediated signal
met DAW1 2q36.3 0.153 0.245 0.77
mut SUPT6H 17q11.2 0.153 0.245 0.77 regulation of transcription from
RNA polymerase II promoter;regulation of transcription elongation, DNA-dependent
xsq IPO9-AS1 0.153 0.245 0.77
exp UQCRFS1 19q12 0.153 0.245 0.77 transport;response to hormone stimulus
exp ABHD17B 9q21.13 0.153 0.245 0.77
exp SERPINA9 14q32.13 0.153 0.245 0.77 negative regulation of
exp SUGT1 13q14.3 0.153 0.245 0.77 mitosis;nucleotide-binding domain,
dependent"
met EPHA8 1p36.12 0.153 0.245 0.77 substrate-dependent cell
xsq OR2W5 1q44 0.153 0.245 0.77 response to stimulus
xsq LOC728613 5p15.33 0.153 0.245 0.77
exp VGLL2 6q22.1 0.153 0.245 0.77 regulation of transcription, DNA-
met RORA 15q22.2 0.153 0.245 0.77 positive regulation of transcription from
xsq BIRC5 17q25 0.152 0.245 0.77 Apoptosis
xsq LRP2 2q31.1 0.152 0.245 0.77 forebrain development;protein
glycosylation
met PELI1 2p13.3 0.152 0.245 0.77 MyD88-dependent toll-like receptor
xsq SPPL2C 17q21.31 0.152 0.245 0.77
cop SPRR2A 0.152 0.245 0.77
cop SPRR2B 1q21-q22 0.152 0.245 0.77 keratinization;epidermis
development
cop SPRR2E 0.152 0.245 0.77
cop SPRR2F 1q21-q22 0.152 0.245 0.77 keratinocyte
cop SPRR2C 0.152 0.245 0.77
cop SPRR2G 1q21-q22 0.152 0.245 0.77
cop LELP1 1q21.3 0.152 0.245 0.77
cop PRR9 0.152 0.245 0.77
xsq TMEM205 19p13.2 0.152 0.245 0.77
cop LINC00869 0.152 0.245 0.77
cop LOC388692 1q21.2 0.152 0.245 0.77
cop FCGR1C 0.152 0.245 0.77
xsq LRRC58 3q13.33 0.152 0.245 0.77
exp PMS2P3 7q11.23 0.152 0.245 0.77 DNA Damage Response (DDR)
xsq LMOD2 7q31.32 0.152 0.245 0.77
met HTR3A 11q23.1 0.152 0.245 0.77 ion transmembrane transport;transmembrane
transport
exp DIS3 13q22.1 0.152 0.245 0.77 gene expression;RNA metabolic process
exp HMGN4 6p21.3 0.152 0.245 0.77
cop RAD51C 17q22 0.152 0.245 0.77 DNA Damage Response (DDR); DDR (FA)
met CNTN1 12q11-q12 0.152 0.245 0.77 cell adhesion;Notch signaling pathway
exp KIF18B 17q21.31 0.152 0.245 0.77 mitotic cell cycle;microtubule-
based movement
met RNASE10 14q11.2 0.152 0.245 0.77
xsq ARRDC5 19p13.3 0.152 0.245 0.77 signal transduction
xsq CEP57 11q21 0.152 0.245 0.77 protein import into nucleus, translocation;G2/M
cop NDUFV2 18p11.22 0.152 0.245 0.77 mitochondrial electron transport,
cop ANKRD12 18p11.22 0.152 0.245 0.77
xsq TRIM71 3p22.3 0.152 0.245 0.77 multicellular organismal
cop SULT1A2 16p12.1 0.152 0.245 0.77 small molecule metabolic
process;3'-phosphoadenosine 5'-phosphosulfate metabolic process
cop SULT1A1 16p12.1 0.152 0.245 0.77 sulfation;catecholamine metabolic
process
cop ATXN2L 0.152 0.245 0.77
cop MIR4721 0.152 0.245 0.77
met SERTAD3 19q13.2 0.152 0.245 0.77 negative regulation of cell
mir hsa-miR-92a-1* 0.152 0.245 0.77
xsq NUTF2 16q22.1 0.152 0.245 0.77 protein import into nucleus;protein
export from nucleus
xsq C14orf142 14q32.12 0.152 0.245 0.77
met PRKCDBP 11p15.4 0.152 0.245 0.77
xsq PCBD2 5q31.1 0.152 0.245 0.77 protein heterooligomerization;oxidation-
reduction process
met TSPAN19 12q21.31 0.152 0.245 0.77
xsq UTS2 1p36 0.152 0.245 0.77 muscle contraction;synaptic transmission
xsq TSHR 14q31 0.152 0.245 0.77 Oncogenes
exp SWSAP1 19p13.2 0.152 0.245 0.77 DNA repair;DNA recombination
cop LOC100288974 0.152 0.245 0.77
cop SFTPD 10q22.2-q23.1 0.152 0.245 0.77 surfactant homeostasis;negative
cop TMEM254-AS1 0.152 0.245 0.77
cop TMEM254 10q22.3 0.152 0.245 0.77
met XKR9 8q13.3 0.152 0.245 0.77
mut SRPX Xp21.1 0.152 0.245 0.77 cell adhesion
exp GBAS 7p12 0.152 0.245 0.77
met PPP3R2 9q31.1 0.152 0.245 0.77
met STAG3 7q22.1 0.152 0.245 0.77 cell cycle;chromosome segregation
xsq CGGBP1 3p12-p11.1 0.152 0.245 0.77 regulation of transcription, DNA-
dependent"
met SFT2D2 1q24.2 0.152 0.245 0.77 protein transport;vesicle-mediated
transport
exp ADAMTSL3 15q25.2 -0.152 0.245 0.77
exp NRG1 8p12 -0.152 0.245 0.77 transmembrane receptor protein tyrosine
xsq C1QTNF5 -0.152 0.245 0.77
cop LYPLA1 8q11.23 -0.152 0.245 0.77 lipid metabolic process;fatty
cop SLC9A9-AS1 -0.152 0.245 0.77
xsq PGAP3 17q12 -0.152 0.245 0.77 GPI anchor metabolic process;GPI anchor
exp LOC392352 -0.152 0.245 0.77
met MIR30C2 -0.152 0.245 0.77
xsq STAP2 19p13.3 -0.152 0.245 0.77
met GPR171 3q25.1 -0.152 0.245 0.77 G-protein coupled receptor
signaling pathway
met SEL1L3 4p15.2 -0.152 0.245 0.77
exp HCFC2 12q23.3 -0.152 0.245 0.77 negative regulation of
exp ACBD3 1q42.12 -0.152 0.245 0.77 steroid biosynthetic
process;transport
exp ARHGEF34P 7q35 -0.152 0.245 0.77
DNA-dependent"
met CPSF4L 17q25.1 -0.152 0.245 0.77
exp GBP5 1p22.2 -0.152 0.245 0.77 cellular response to interferon-
gamma
xsq LOC101927587 -0.153 0.245 0.77
cop SDC2 8q22-q23 -0.153 0.245 0.77 response to hypoxia;response to
caffeine
exp USP2 11q23.3 -0.153 0.245 0.77 protein deubiquitination;positive
exp H3F3AP1 15q15.1 -0.153 0.245 0.77
met E2F6 2p25.1 -0.153 0.245 0.77 regulation of transcription
involved in G1/S phase of mitotic cell cycle;negative regulation of transcription
mut TIMELESS 12q13.3 -0.153 0.245 0.77 DNA Damage Response (DDR)
met MYBPHL 1p13.3 -0.153 0.245 0.77
xsq TOB1 17q21 -0.153 0.245 0.77 negative regulation of cell proliferation
exp ANKRD33B 5p15.2 -0.153 0.245 0.77
hs4 FOS 14q24.3 -0.154 0.245 0.77 Apoptosis; Oncogenes
exp DCSTAMP 8q23 -0.154 0.245 0.77 osteoclast differentiation
his PTGES 9q34.3 -0.154 0.245 0.77 prostaglandin biosynthetic
hs4 TNFAIP6 2q23.3 -0.154 0.245 0.77 inflammatory response;cell
adhesion
hs4 PTCH2 1p34.1 -0.154 0.245 0.77 hair cycle;skin development
xai RNF150 4q31.21 -0.154 0.245 0.77
hs4 FLRT2 14q24-q32 -0.154 0.245 0.77 cell adhesion
xai KRT121P -0.154 0.245 0.77
hs4 LINC00552 13q34 -0.154 0.245 0.77
exp SHCBP1L 1q25.3 -0.154 0.245 0.77
xai MAP3K1 5q11.2 -0.154 0.245 0.77 Apoptosis; Cell Signaling;
Protein Kinases
hs4 PDGFRB 5q33.1 -0.154 0.245 0.77 Protein Kinases
hs4 AGMO 7p21.2 -0.154 0.245 0.77 fatty acid biosynthetic
process;membrane lipid metabolic process
hs4 ARHGEF5 7q35 -0.154 0.245 0.77 regulation of Rho protein signal
hs4 OR2A1-AS1 -0.154 0.245 0.77
xai LOC441178 6q27 -0.154 0.245 0.77
xai LOC100130627 -0.154 0.245 0.77
hs4 MRO 18q21 -0.154 0.245 0.77
xai GDF15 19p13.11 -0.154 0.245 0.77 signal transduction;transforming
xai SHCBP1L 1q25.3 -0.154 0.245 0.77
xai ZNF667-AS1 19q13.43 -0.154 0.245 0.77
his SVOPL 7q34 -0.154 0.245 0.77
his GPC6-AS2 -0.154 0.245 0.77
swa HYOU1 11q23.1-q23.3 -0.154 0.245 0.77 response to stress;activation
his SNORA71B 20q11.23 -0.154 0.245 0.77
his SNORA71A -0.154 0.245 0.77
swa L1CAM Xq28 -0.154 0.245 0.77 leukocyte cell-cell adhesion;cell
differentiation
xai RAC1P7 -0.154 0.245 0.77
exp MACROD2-AS1 -0.154 0.245 0.77
his GPR1 2q33.3 -0.154 0.245 0.77 G-protein coupled receptor
signaling pathway
xai LINC00973 -0.154 0.245 0.77
xai PCYT1B Xp22.11 -0.154 0.245 0.77 CDP-choline
exp RAC1P7 -0.154 0.245 0.77
his DST 6p12.1 -0.154 0.245 0.77 axonogenesis;intracellular
transport
his LOC101930010 -0.154 0.245 0.77
xai GPSM1 9q34.3 -0.154 0.245 0.77 signal transduction;multicellular
xai FTH1P12 9p22.3 -0.154 0.245 0.77
cop DACT3 19q13.32 -0.154 0.245 0.77
hs4 BCL9L 11q23.3 -0.154 0.245 0.77 negative regulation of transforming
hs4 MIR4492 -0.154 0.245 0.77
xai LOC100131510 2p23.3 0.155 0.246 0.77
exp PFN1P7 0.154 0.246 0.77
xai OR2V1 0.154 0.246 0.77 response to stimulus
his LOC100507412 0.154 0.246 0.77
xai LOC283070 10p13 0.154 0.246 0.77
his TMEM89 3p21.31 0.154 0.246 0.77
xai CNOT11 2q11.2 0.154 0.246 0.77
hs4 LOC284241 0.154 0.246 0.77
hs4 CTDP1 18q23 0.154 0.246 0.77 viral reproduction;positive regulation of viral
transcription
his DNAAF5 0.154 0.246 0.77
his PRKAR1B 7p22 0.154 0.246 0.77 protein phosphorylation;small molecule
metabolic process
swa HN1L 16p13.3 0.154 0.246 0.77
hs4 RPL36 19p13.3 0.154 0.246 0.77 translational termination;cellular
his RPL13A 19q13.3 0.154 0.246 0.77
his SNORD32A 0.154 0.246 0.77
his SNORD33 0.154 0.246 0.77
his SNORD34 19q13.3 0.154 0.246 0.77
his SNORD35A 19q13.3 0.154 0.246 0.77
dependent"
his FBXO18 10p15.1 0.153 0.246 0.77 DNA Damage Response (DDR)
his ANKRD16 10p15.1 0.153 0.246 0.77
exp MESP2 15q26.1 0.153 0.246 0.77 mesodermal cell migration;signal
hs4 LINC01049 0.153 0.246 0.77
hs4 SNAR-A12 0.153 0.246 0.77
exp LINC00163 0.153 0.246 0.77
xai TNNI1 1q31.3 0.153 0.246 0.77 muscle filament sliding;ventricular
his THSD7A 7p21.3 0.153 0.246 0.77
xai LINC00163 0.153 0.246 0.77
xai AAR2 20pter-q12 0.153 0.246 0.77
xai SYN3 22q12.3 0.153 0.246 0.77 neurotransmitter secretion
his WNT11 11q13.5 0.153 0.246 0.77 Apoptosis; Oncogenes
his RPTOR 17q25.3 0.153 0.246 0.77 cell growth;cellular response to nutrient
levels
his ATP6V1G2-DDX39B 0.153 0.246 0.77
his ATP6V1G2 6p21.3 0.153 0.246 0.77 insulin receptor signaling
his NFKBIL1 6p21.3 0.153 0.246 0.77 cytoplasmic sequestering of
transcription factor
his LMBRD1 6q13 0.153 0.246 0.77 transport;interspecies interaction
between organisms
xai LOC100288181 8q24.3 0.153 0.246 0.77
his UBOX5-AS1 0.153 0.246 0.77
exp COL6A4P1 3p25.1 0.153 0.246 0.77
exp CACNA1G-AS1 0.153 0.246 0.77
his FBXO46 19q13.3 0.153 0.246 0.77
his POGK 1q24.1 0.153 0.246 0.77 regulation of transcription, DNA-
dependent"
xai GIPR 19q13.3 0.153 0.246 0.77 desensitization of G-protein coupled
receptor protein signaling pathway;positive regulation of cAMP biosynthetic process
xai TMEM35 Xq22.1 0.153 0.246 0.77
hs4 DBF4 7q21.3 0.153 0.246 0.77 DDR (DNA replication)
his CUL1 7q36.1 0.153 0.246 0.77 Apoptosis
xai PMS2CL 7p22.1 0.153 0.246 0.77 mismatch repair;somatic
hypermutation of immunoglobulin genes
hs4 CDH22 20q13.1 0.153 0.246 0.77 homophilic cell adhesion;cell adhesion
hs4 RNASEH2B 13q14.3 0.153 0.246 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
hs4 RNASEH2B-AS1 0.153 0.246 0.77
xai EHBP1L1 11q13.1 0.153 0.246 0.77
his RCOR2 11q13.1 0.153 0.246 0.77 negative regulation of transcription,
DNA-dependent"
his HAND2-AS1 4q34.1 0.153 0.246 0.77
his HAND2 4q33 0.153 0.246 0.77 regulation of secondary heart field cardioblast
his MFSD14C 0.153 0.246 0.77 transmembrane transport
mut RAPGEF6 5q31.1 0.152 0.246 0.77 signal transduction;Ras protein
signal transduction
xsq MED6 14q24.2 0.152 0.246 0.77 gene expression;positive regulation of
met TMEM98 17q11.2 0.152 0.246 0.77
exp PCID2 13q34 0.152 0.246 0.77 positive regulation of mitotic cell cycle
activity
cop NIPA1 15q11.2 0.152 0.246 0.77 ion transport;cell death
cop LOC283683 0.152 0.246 0.77
exp PHF3 6q12 0.152 0.246 0.77 transcription, DNA-dependent;multicellular
organismal development"
dependent"
xsq MBD3 19p13.3 0.152 0.246 0.77 negative regulation of transcription from
dependent"
xsq SCO1 17p13.1 0.152 0.246 0.77 generation of precursor metabolites and
xsq LOC100144595 0.152 0.246 0.77
xsq DUSP12 1q21-q22 0.152 0.246 0.77 protein dephosphorylation;JNK
cascade
xsq FPR3 19q13.3-q13.4 0.152 0.246 0.77
cop SBK1 16p11.2 0.152 0.246 0.77 peptidyl-serine phosphorylation;peptidyl-
threonine phosphorylation
cop HIST2H2BF 1q21.2 0.152 0.246 0.77 nucleosome assembly
cop HIST2H3D 0.152 0.246 0.77 blood coagulation;negative regulation of
met ASIC2 17q12 0.152 0.246 0.77 monovalent inorganic cation transport;ion
transport
xsq NHLH1 0.152 0.246 0.77
xsq LINC01277 0.152 0.246 0.77
exp GDAP1 8q21.11 0.152 0.246 0.77 response to retinoic acid
xsq FOXJ1 17q25.1 0.152 0.246 0.77 Apoptosis
exp TNFRSF1A 12p13.2 0.152 0.246 0.77 Apoptosis
cop SDSL 12q24.13 0.152 0.246 0.77 cellular amino acid metabolic process
xsq WEE1 11p15.4 0.152 0.246 0.77 DNA Damage Response (DDR); Protein
Kinases
xsq TCF23 2p23.3 0.152 0.246 0.77 multicellular organismal
xsq CLN6 15q23 0.152 0.246 0.77 protein catabolic process;glycosaminoglycan
metabolic process
cop JUP 17q21 0.152 0.246 0.77 desmosome assembly;morphogenesis of embryonic
epithelium
cop LEPREL4 17q21.2 0.152 0.246 0.77
cop FKBP10 17q21.2 0.152 0.246 0.77 peptidyl-proline
cop NT5C3B 17q21.2 0.152 0.246 0.77
cop KLHL10 17q21.2 0.152 0.246 0.77
cop KLHL11 17q21.2 0.152 0.246 0.77
cop ACLY 17q21.2 0.152 0.246 0.77 energy reserve metabolic process;cellular
cop TTC25 17q21.2 0.152 0.246 0.77
xsq CNKSR2 Xp22.12 0.152 0.246 0.77 regulation of signal transduction
xsq PCSK4 19p13.3 0.152 0.246 0.77 fertilization;sperm capacitation
cop CASKIN2 17q25.1 0.152 0.246 0.77
cop TSEN54 17q25.1 0.152 0.246 0.77 mRNA processing;tRNA splicing, via
endonucleolytic cleavage and ligation"
cop LLGL2 17q25.1 0.152 0.246 0.77 exocytosis;cell cycle
cop MYO15B 17q25.1 0.152 0.246 0.77
cop RECQL5 17q25 0.152 0.246 0.77 DNA Damage Response (DDR); DDR (HR)
cop SMIM5 17q25.1 0.152 0.246 0.77
cop SMIM6 0.152 0.246 0.77
cop SAP30BP 17q25.1 0.152 0.246 0.77 Apoptosis
cop ITGB4 17q25 0.152 0.246 0.77 cell-matrix adhesion;integrin-mediated
signaling pathway
cop GALK1 17q24 0.152 0.246 0.77 small molecule metabolic process;carbohydrate
phosphorylation
cop H3F3B 17q25.1 0.152 0.246 0.77 nucleosome assembly;blood coagulation
cop MIR4738 0.152 0.246 0.77
exp ASAH2B 10q11.23 0.152 0.246 0.77
exp ADGRG5 0.152 0.246 0.77 G-protein coupled receptor signaling
xsq VTA1 6q24.1 0.152 0.246 0.77 endosome transport;protein transport
xsq PPOX 1q22 0.152 0.246 0.77 porphyrin-containing compound biosynthetic
exp UBL4A Xq28 0.152 0.246 0.77 protein modification process;transport
xsq RFX4 12q24 0.152 0.246 0.77 regulation of transcription, DNA-dependent"
met SEPHS1 10p14 0.152 0.246 0.77 protein modification process
met PDPN 1p36.21 0.152 0.246 0.77 lymphangiogenesis;cell proliferation
xsq OR2AG2 11p15.4 0.152 0.246 0.77 response to stimulus
dependent"
cop EEA1 12q22 0.152 0.246 0.77 endocytosis;vesicle fusion
exp RFPL1S 22q12 0.152 0.246 0.77
xsq YME1L1 10p14 0.152 0.246 0.77 proteolysis;protein catabolic process
met PDXK 21q22.3 0.152 0.246 0.77 small molecule metabolic process;vitamin
metabolic process
xsq GTF3C6 6q21 0.152 0.246 0.77 transcription, DNA-
met GPR149 3q25.2 0.152 0.246 0.77
cop TAOK3 12q 0.152 0.246 0.77 Protein Kinases
mut ITGA9 3p21.3 0.152 0.246 0.77 cell adhesion;integrin-mediated signaling
pathway
cop HGFAC 4p16 0.152 0.246 0.77 proteolysis
met SPACA1 6q15 0.152 0.246 0.77
met ANKEF1 20p12.2 0.152 0.246 0.77
met KCNQ1DN 11p15.4 0.152 0.246 0.77
xsq DUOXA1 15q21.1 0.152 0.246 0.77 protein transport
xsq LARS2-AS1 0.152 0.246 0.77
exp MRPS15 1p34.3 0.152 0.246 0.77 translation
exp CDK17 12q23.1 0.152 0.246 0.77 Protein Kinases
met SCAMP5 15q24.2 0.152 0.246 0.77 exocytosis;protein transport
cop TCHHL1 1q21.3 0.152 0.246 0.77
cop TCHH 1q21.3 0.152 0.246 0.77 keratinization
cop RPTN 1q21.3 0.152 0.246 0.77
cop HRNR 1q21.3 0.152 0.246 0.77 tryptophan metabolic
exp GSTM2 1p13.3 -0.152 0.246 0.77 glutathione metabolic
met CCNT2 2q21.3 -0.152 0.246 0.77 regulation of cyclin-dependent
protein kinase activity;cell division
cop GPR124 8p11.23 -0.152 0.246 0.77
xsq LOC646903 -0.152 0.246 0.77
exp PLEKHA7 11p15.1 -0.152 0.246 0.77 zonula adherens
exp HACD2 -0.152 0.246 0.77 fatty acid biosynthetic process
xsq GABBR1 6p21.31 -0.152 0.246 0.77 negative regulation of cell
exp RAB27B 18q21.2 -0.152 0.246 0.77 small GTPase mediated signal
met HIST1H3H 6p22.1 -0.152 0.246 0.77
exp EXPH5 11q22.3 -0.152 0.246 0.77 intracellular protein
transport;positive regulation of exocytosis
exp EEF1G 11q12.3 -0.152 0.246 0.77 translation;translational
elongation
met ABHD14A 3p21.1 -0.152 0.246 0.77
met SLFN5 17q12 -0.152 0.246 0.77 cell differentiation
mir hsa-miR-429 -0.152 0.246 0.77
exp TMEM100 17q22 -0.152 0.246 0.77
met RIMS2 8q22.3 -0.152 0.246 0.77 intracellular protein transport
mut ABCA7 19p13.3 -0.152 0.246 0.77 ABC Transporters
xsq NHS-AS1 -0.152 0.246 0.77
met RAN 12q24.3 -0.152 0.246 0.77 nucleocytoplasmic
cop COL11A1 1p21 -0.152 0.246 0.77 ossification;collagen fibril
organization
exp MUC20 3q29 -0.152 0.246 0.77 hepatocyte growth factor receptor
exp GMPR 6p23 -0.152 0.246 0.77 purine base metabolic process;nucleotide
metabolic process
xsq OR4F5 -0.152 0.246 0.77
cop COX20 1q44 -0.152 0.246 0.77
cop HNRNPU-AS1 1q44 -0.152 0.246 0.77
cop HNRNPU 1q44 -0.152 0.246 0.77 RNA processing;RNA splicing
xsq PDE4DIP 1q12 -0.152 0.246 0.77 cellular protein complex assembly
xsq CHST15 10q26 -0.152 0.246 0.77 hexose biosynthetic process
exp CCL11 17q12 -0.152 0.246 0.77 immune response;positive regulation of
cell migration
exp RNF19B 1p35.1 -0.152 0.246 0.77
hs4 SGSM1 22q11.23 -0.153 0.246 0.77
hs4 ADRA2A 10q25.2 -0.153 0.246 0.77 signal transduction;actin
xai CTNNA2 2p12-p11.1 -0.153 0.246 0.77 radial glia guided migration
of Purkinje cell;muscle cell differentiation
his RAET1E-AS1 -0.153 0.246 0.77
his LRP11 6q25.1 -0.153 0.246 0.77
exp ZMYND15 17p13.2 -0.153 0.246 0.77 spermatogenesis;cell
differentiation
hs4 MIR4792 -0.153 0.246 0.77
his PTGIS 20q13.13 -0.153 0.246 0.77 prostaglandin biosynthetic
swa SPINT2 19q13.1 -0.153 0.246 0.77 cellular component
hs4 TLN1 9p13 -0.153 0.246 0.77 muscle contraction;platelet activation
hs4 CREB3 9p13.3 -0.153 0.246 0.77 reactivation of latent
hs4 MIR6853 -0.153 0.246 0.77
his FLII 17p11.2 -0.153 0.246 0.77 regulation of transcription, DNA-
dependent;muscle contraction
his MIEF2 -0.153 0.246 0.77 mitochondrion organization
his LOC101928008 -0.153 0.246 0.77
hs4 DGCR6L 22q11.21 -0.153 0.246 0.77
his SYT13 11p12-p11 -0.153 0.246 0.77 vesicle-mediated transport
exp VN1R68P 16p11.2 -0.153 0.246 0.77
exp LOC400706 19q13.32 -0.153 0.246 0.77
his FPR1 19q13.4 -0.154 0.246 0.77 signal transduction;G-protein
xai KLHL14 18q12.1 -0.154 0.246 0.77
his LOC100288911 2p22.3 -0.154 0.246 0.77
his CRIM1 2p21 -0.154 0.246 0.77 regulation of cell growth;nervous system
development
his MAT1A 10q22 -0.154 0.246 0.77 xenobiotic metabolic process;methylation
xai DNASE1L1 Xq28 -0.154 0.246 0.77 DNA metabolic process;DNA catabolic
process
his PMEPA1 20q13.31-q13.33 -0.154 0.246 0.77 androgen receptor
signaling pathway
his NKILA -0.154 0.246 0.77
xai LOC400706 19q13.32 -0.154 0.246 0.77
hs4 PPP1R13L 19q13.32 -0.154 0.246 0.77 apoptotic process;post-
hs4 CD3EAP 19q13.3 -0.154 0.246 0.77 rRNA
hs4 MOGAT1 2q36.1 -0.154 0.246 0.77 glycerol metabolic
swa DNAJC3 13q32.1 -0.154 0.246 0.77 response to virus;endoplasmic
his BTAF1 10q22-q23 0.153 0.247 0.77 negative regulation of transcription,
DNA-dependent"
hs4 FICD 12q24.1 0.153 0.247 0.77 protein adenylylation;negative regulation
swa PRRC2C 1q23.3 0.153 0.247 0.77
xai CACNA1G-AS1 0.153 0.247 0.77
xai PGAM1P6 0.153 0.247 0.77
xai DCXR 17q25.3 0.153 0.247 0.77 glucose metabolic process;NADP metabolic
process
his KRIT1 7q21.2 0.153 0.247 0.77 negative regulation of endothelial cell
apoptosis;negative regulation of endothelial cell proliferation
his ANKIB1 7q21.2 0.153 0.247 0.77
xai AHCTF1P1 2q24.2 0.153 0.247 0.77
his TBXA2R 19p13.3 0.153 0.247 0.77 G-protein coupled receptor
signaling pathway;blood coagulation
his CACTIN-AS1 19p13.3 0.153 0.247 0.77
hs4 RIMKLA 1p34.2 0.153 0.247 0.77 protein modification process
his CHST12 7p22 0.153 0.247 0.77 carbohydrate biosynthetic
his TMEM88 17p13.1 0.153 0.247 0.77
his CYB5D1 17p13.1 0.153 0.247 0.77
his NAA38 17p13.1 0.153 0.247 0.77
hs4 NPC1 18q11.2 0.153 0.247 0.77 autophagy;lysosomal transport
his MIF 22q11.23 0.153 0.247 0.77 Apoptosis
his MIF-AS1 0.153 0.247 0.77
his BORA 13q22.1 0.153 0.247 0.77 cell cycle;regulation of mitosis
his MZT1 13q22.1 0.153 0.247 0.77 gamma-tubulin complex localization
hs4 PRKRA 2q31.2 0.153 0.247 0.77 immune response;skeletal system
morphogenesis
hs4 DFNB59 2q31.2 0.153 0.247 0.77 sensory perception of sound
hs4 ING4 12p13.31 0.153 0.247 0.77 Tumor Suppressors
his ZER1 9q34.11 0.153 0.247 0.77 ATP hydrolysis coupled proton
his SMARCC2 12q13.2 0.153 0.247 0.77 DNA Damage Response (DDR); DDR
(Chromatin)
his GTF3A 13q12.3-q13.1 0.153 0.247 0.77 gene expression;regulation of
his PIK3R2 19q13.2-q13.4 0.153 0.247 0.77 Apoptosis
xai AIMP1P1 0.153 0.247 0.77
exp RPL7P58 Xp21.3 0.152 0.247 0.77
exp RPS19 19q13.2 0.152 0.247 0.77 translation;viral reproduction
exp DNTT 10q23-q24 0.152 0.247 0.77 DNA Damage Response (DDR); DDR (NHEJ);
xsq FHIT 3p14.2 0.152 0.247 0.77 diadenosine triphosphate catabolic
process;DNA replication
exp FGG 4q28 0.152 0.247 0.77 platelet degranulation;signal transduction
met ADAMTS14 10q21 0.152 0.247 0.77 proteolysis;collagen catabolic process
met HOMER1 5q14.2 0.152 0.247 0.77 regulation of store-operated
xsq COASY 17q12-q21 0.152 0.247 0.77 pantothenate metabolic process;small
cop GMCL1 2p13.3 0.152 0.247 0.77 regulation of transcription, DNA-
cop SNRNP27 2p13.3 0.152 0.247 0.77 mRNA processing;RNA splicing
cop MXD1 2p13-p12 0.152 0.247 0.77 Apoptosis
met SLC7A10 19q13.1 0.152 0.247 0.77 amino acid transport;blood
coagulation
xsq FAM104A 17q25.1 0.152 0.247 0.77
met MICB 6p21.3 0.152 0.247 0.77 immune response-activating cell surface
mut MADD 11p11.2 0.152 0.247 0.77 activation of MAPK activity;positive
xsq MYH1 17p13.1 0.152 0.247 0.77
cop GJA8 1q21.1 0.152 0.247 0.77 visual perception;lens development in
camera-type eye
cop GPR89B 1q21.1 0.152 0.247 0.77
cop MIR5087 0.152 0.247 0.77
met NEB 2q22 0.152 0.247 0.77 muscle organ development;somatic muscle
development
xsq CABLES2 20q13.33 0.152 0.247 0.77 regulation of cell
division;regulation of cell cycle
xsq NSUN3 3q11.1 0.152 0.247 0.77
met CROCCP2 1p36.13 0.152 0.247 0.77
exp HMGN1 21q22.2 0.152 0.247 0.77 positive regulation of transcription
xsq CPLX4 18q21.32 0.152 0.247 0.77 neurotransmitter transport;exocytosis
xsq GPRC5D 12p13.3 0.152 0.247 0.77
exp NUDT11 Xp11.22 0.152 0.247 0.77
cop LOC100505474 0.152 0.247 0.77
xsq PRPS1L1 7p21.1 0.152 0.247 0.77 nucleoside metabolic
process;ribonucleoside monophosphate biosynthetic process
cop RORA 15q22.2 0.152 0.247 0.77 positive regulation of transcription from
exp PDCD4 10q24 0.152 0.247 0.77 Apoptosis
xsq ZFR 5p13.3 0.152 0.247 0.77 multicellular organismal development
xsq DHX40 17q23.1 0.152 0.247 0.77
met NWD2 0.152 0.247 0.77
cop MMP2 16q13-q21 0.152 0.247 0.77 Apoptosis
exp TMEM266 0.152 0.247 0.77
xsq SLC5A7 2q12 0.152 0.247 0.77 ion transport;transmembrane transport
xsq ID3 1p36.13-p36.12 0.152 0.247 0.77 metanephros development;notochord
development
exp CDK9 9q34.1 0.152 0.247 0.77 Protein Kinases
cop CCDC92 12q24.31 0.152 0.247 0.77
dependent"
met TINCR 19p13.3 0.152 0.247 0.77
cop MIR4509-2 0.152 0.247 0.77
cop MIR4509-1 0.152 0.247 0.77
cop MIR4509-3 0.152 0.247 0.77
dependent"
exp SUV39H1 Xp11.23 0.152 0.247 0.77 peptidyl-lysine
met ITSN2 2p23.3 0.152 0.247 0.77 endocytosis;regulation of Rho protein
signal transduction
exp AMPD3 11p15 0.152 0.247 0.77 purine base metabolic process;IMP biosynthetic
process
xsq MRGPRF 11q13.3 -0.152 0.247 0.77
exp SPTLC2 14q24.3 -0.152 0.247 0.77 sphingosine biosynthetic
xsq USP18 22q11.21 -0.152 0.247 0.77 proteolysis;ubiquitin-dependent
xsq IL7 8q12-q13 -0.152 0.247 0.77 positive regulation of cell
met MIF 22q11.23 -0.152 0.247 0.77 Apoptosis
exp ZSCAN26 6p21.31 -0.152 0.247 0.77
xsq FLRT3 20p11 -0.152 0.247 0.77 cell adhesion
exp OPN1MW -0.152 0.247 0.77
exp LSMEM1 7q31.1 -0.152 0.247 0.77
exp SARS 1p13.3 -0.152 0.247 0.77 tRNA aminoacylation for protein
exp LAMP2 Xq24 -0.152 0.247 0.77 platelet activation;platelet
degranulation
xsq TTC39A 1p32.3 -0.152 0.247 0.77
xsq PDLIM3 4q35 -0.152 0.247 0.77 actin filament organization;heart
development
met ATRAID 2p23.3 -0.152 0.247 0.77
xsq SPATA1 1p22.3 -0.152 0.247 0.77
exp LOC100128772 3p25.1 -0.152 0.247 0.77
met TUBA1B 12q13.12 -0.152 0.247 0.77 microtubule cytoskeleton
met C10orf82 10q25.3 -0.152 0.247 0.77
cop BAALC 8q22.3 -0.152 0.247 0.77
met GPR179 17q21.1 -0.152 0.247 0.77
exp DNAH9 17p12 -0.152 0.247 0.77 cellular component movement;microtubule-
based movement
met LOC100130331 1q43 -0.152 0.247 0.77
xsq SMURF2 17q22-q23 -0.152 0.247 0.77 protein
pathway
exp IFNA10 -0.152 0.247 0.77 blood coagulation;response to virus
exp VSX1 20p11.21 -0.153 0.247 0.77 neuron maturation;response to
stimulus
his PRSS8 16p11.2 -0.153 0.247 0.77 EMT (Epithelial)
xai HCFC2 12q23.3 -0.153 0.247 0.77 negative regulation of
xai KALP Yq11 -0.153 0.247 0.77
his SLC6A14 Xq23 -0.153 0.247 0.77 Solute Carriers
his EPHA2 1p36 -0.153 0.247 0.77 Protein Kinases
xai LOC100132188 -0.153 0.247 0.77
xai RAB27B 18q21.2 -0.153 0.247 0.77 small GTPase mediated signal
hs4 MTA3 2p21 -0.153 0.247 0.77
DNA-dependent"
xai MOSPD1 Xq26.3 -0.153 0.247 0.77 negative regulation of
transcription from RNA polymerase II promoter;positive regulation of transcription
swa ERMP1 9p24 -0.153 0.247 0.77 ovarian follicle development;proteolysis
xai TMEM100 17q22 -0.153 0.247 0.77
his LPP-AS1 -0.153 0.247 0.77
swa AP3D1 19p13.3 -0.153 0.247 0.77 eye pigment biosynthetic
process;regulation of sequestering of zinc ion
hs4 GGTA1P 9q33.2 -0.153 0.247 0.77 carbohydrate metabolic
exp SPINK5 5q32 -0.153 0.247 0.77 anagen;regulation of T cell
differentiation
his DAB2IP 9q33.1-q33.3 -0.153 0.247 0.77 negative regulation of
epithelial cell migration;negative regulation of I-kappaB kinase/NF-kappaB cascade
swa MED24 17q21.1 -0.153 0.247 0.77 protein
hs4 LOC101926905 -0.153 0.247 0.77
cop OR4X2 11p11.2 -0.16 0.247 0.77 response to stimulus
hs4 CEP76 18p11.21 0.153 0.248 0.77 G2/M transition of mitotic cell
hs4 PSMG2 18p11.21 0.153 0.248 0.77 mitotic cell cycle spindle assembly
his SP1 12q13.1 0.153 0.248 0.77 megakaryocyte differentiation;embryonic
skeletal system development
swa URM1 9q34.11 0.153 0.248 0.77 tRNA wobble uridine modification;tRNA
processing
xai MARCKSL1P2 0.153 0.248 0.77
his NARFL 16p13.3 0.153 0.248 0.77 oxygen homeostasis;response to hypoxia
his CUL5 11q22.3 0.153 0.248 0.77 Apoptosis; DNA Damage Response (DDR); DDR
(NER)
xai TMEM80 11p15.5 0.153 0.248 0.77
his DENND2D 1p13.3 0.153 0.248 0.77
dependent"
xai AGO2 8q24 0.153 0.248 0.77
exp MIR105-1 0.153 0.248 0.77
his LOC101929445 0.153 0.248 0.77
xai HDAC3 5q31 0.153 0.248 0.77 Apoptosis
his NRAV 0.153 0.248 0.77
his DYNLL1 12q24.23 0.153 0.248 0.77 Apoptosis
xai ACOX3 4p15.3 0.153 0.248 0.77 fatty acid metabolic process;fatty acid
exp LOC100130673 7p14.3 0.153 0.248 0.77
xai MIR105-1 0.153 0.248 0.77
xai CEP104 1p36.32 0.153 0.248 0.77
hs4 BORCS5 0.153 0.248 0.77
hs4 LOH12CR2 12p13.2 0.153 0.248 0.77
hs4 TDRKH 1q21 0.153 0.248 0.77
his UIMC1 5q35.2 0.153 0.248 0.77 DNA Damage Response (DDR); DDR (HR)
his RBM39 20q11.22 0.153 0.248 0.77 regulation of transcription, DNA-
exp TSPY1 0.153 0.248 0.77 nucleosome assembly;multicellular organismal
development
xai C19orf43 19p13.2 0.153 0.248 0.77
xai KDM5C Xp11.22-p11.21 0.153 0.248 0.77 Tumor Suppressors
exp MARCKSL1P2 0.153 0.248 0.77
xai TMPPE 0.153 0.248 0.77
exp TTC32 2p24.1 0.153 0.248 0.77
his MMAB 12q24 0.153 0.248 0.77 cobalamin biosynthetic process
his MVK 12q24 0.153 0.248 0.77 cholesterol biosynthetic process;isoprenoid
his VARS2 6p21.33 0.153 0.248 0.77 tRNA aminoacylation for protein
xai PHF3 6q12 0.153 0.248 0.77 transcription, DNA-dependent;multicellular
organismal development"
his TAF1A-AS1 0.153 0.248 0.77
his TAF1A 1q42 0.153 0.248 0.77 transcription from RNA polymerase I
hs4 PRRT4 7q32.1 0.153 0.248 0.77
his HRAS 11p15.5 0.153 0.248 0.77 Apoptosis; Oncogenes; Protein Kinases
his LRRC56 11p15.5 0.153 0.248 0.77
xai NKAIN2 6q21 0.153 0.248 0.77
xai TRA2B 3q26.2-q27 0.153 0.248 0.77 response to reactive oxygen species;RNA
his NFU1 2p15-p13 0.153 0.248 0.77 iron-sulfur cluster assembly
xai AP5S1 20p13 0.153 0.248 0.77 double-strand break repair via homologous
xai BPIFB3 20q11.21 0.153 0.248 0.77 innate immune response
hs4 SAA2-SAA4 0.153 0.248 0.77
hs4 SAA2 11p15.1-p14 0.153 0.248 0.77
xai HEYL 1p34.3 0.153 0.248 0.77 multicellular organismal
xai TUBGCP3 13q34 0.153 0.248 0.77 mitotic cell cycle;microtubule nucleation
xai HERC5 4q22.1 0.153 0.248 0.77 cytokine-mediated signaling
swa SRRM2 16p13.3 0.153 0.248 0.77 nuclear mRNA splicing, via
dependent"
exp EVI2A 17q11.2 0.152 0.248 0.77
cop AQP11 11q14.1 0.152 0.248 0.77 urea transport;endosomal lumen
acidification
met REG1B 2p12 0.152 0.248 0.77 cell proliferation
cop APPBP2 17q23.2 0.152 0.248 0.77 intracellular protein
xsq PTPN3 9q31 0.152 0.248 0.77 protein dephosphorylation;peptidyl-tyrosine
dephosphorylation
xsq HOXB13 17q21.2 0.152 0.248 0.77 regulation of growth;prostate
xsq TPTEP1 22q11.1 0.152 0.248 0.77
cop SHC3 9q22.1 0.152 0.248 0.77 intracellular signal
exp PLCH2 1p36.32 0.152 0.248 0.77 lipid catabolic process;intracellular
signal transduction
xsq PPM1K 4q22.1 0.152 0.248 0.77 protein dephosphorylation
exp EXOC2 6p25.3 0.152 0.248 0.77 exocytosis;protein transport
xsq MTHFS 15q25.1 0.152 0.248 0.77 folic acid-containing compound
biosynthetic process;formate metabolic process
xsq MMD2 7p22.1 0.152 0.248 0.77
xsq OR5AR1 11q12.1 0.152 0.248 0.77
xsq PMCHL2 0.152 0.248 0.77
cop TUFT1 1q21 0.152 0.248 0.77 odontogenesis;bone mineralization
dependent"
xsq SNRPD3 22q11.23 0.152 0.248 0.77 spliceosomal snRNP assembly;RNA
metabolic process
mut ITGA8 10p13 0.152 0.248 0.77 integrin-mediated signaling pathway;positive
xsq FBXL4 6q16.1-q16.3 0.152 0.248 0.77 ubiquitin-dependent protein
catabolic process
met SCOC 4q31.1 0.152 0.248 0.77
xsq MBD3L3 19p13.2 0.152 0.248 0.77
met B4GALT7 5q35.2-q35.3 0.152 0.248 0.77 glycosaminoglycan
biosynthetic process;proteoglycan metabolic process
mut PAX4 7q32 0.152 0.248 0.77 organ morphogenesis;cell differentiation
met TFAP2E 1p34.3 0.151 0.248 0.77 positive regulation of
xsq SNORA14A 0.151 0.248 0.77
xsq LINC00993 0.151 0.248 0.77
mut TAF13 1p13.3 0.151 0.248 0.77 regulation of transcription, DNA-
mut FAM63A 1q21.3 0.151 0.248 0.77
mut FBXO48 2p13.3 0.151 0.248 0.77
mut C2orf15 0.151 0.248 0.77
mut NIFK 0.151 0.248 0.77 rRNA transcription;negative regulation of
mut HCLS1 3q13 0.151 0.248 0.77 regulation of transcription, DNA-
mut MBLAC1 7q22.1 0.151 0.248 0.77
mut RNF133 0.151 0.248 0.77
mut TRPV5 7q35 0.151 0.248 0.77 ion transport;calcium ion transport
mut FGL1 8p22 0.151 0.248 0.77 signal transduction
mut PYCRL 8q24.3 0.151 0.248 0.77 proline biosynthetic process;cellular
mut OR52H1 0.151 0.248 0.77
mut UQCC3 0.151 0.248 0.77
mut NDC80 18p11.32 0.151 0.248 0.77 attachment of spindle microtubules to
kinetochore;establishment of mitotic spindle orientation
mut ARID3A 19p13.3 0.151 0.248 0.77 regulation of transcription, DNA-
dependent"
mut GDF15 19p13.11 0.151 0.248 0.77 signal transduction;transforming growth
mut PAF1 19q13.1 0.151 0.248 0.77 regulation of transcription, DNA-
mut PCBP3 21q22.3 0.151 0.248 0.77 mRNA metabolic process
mut FH 1q42.1 0.151 0.248 0.77 tricarboxylic acid cycle;fumarate
metabolic process
mut DCLK3 3p22.2 0.151 0.248 0.77
mut AMT 3p21.2-p21.1 0.151 0.248 0.77 glycine catabolic process
mut F12 5q35.3 0.151 0.248 0.77 protein autoprocessing;plasma kallikrein-
kinin cascade
mut FUCA2 6q24 0.151 0.248 0.77 fucose metabolic process;carbohydrate metabolic
process
mut GIMAP1 7q36.1 0.151 0.248 0.77 B cell differentiation;T cell
differentiation
mut CUL2 10p11.21 0.151 0.248 0.77 Apoptosis
mut NDE1 16p13.11 0.151 0.248 0.77 multicellular organismal
mut TCEA2 20q13.33 0.151 0.248 0.77 transcription, DNA-
dependent;transcription elongation, DNA-dependent
xsq FRMD1 6q27 0.151 0.248 0.77
xsq C3orf38 3p11.1 0.151 0.248 0.77 apoptotic process
exp ZNF33A 10p11.2 0.151 0.248 0.77 regulation of transcription, DNA-
dependent"
xsq PLEKHA8 7p21-p11.2 0.151 0.248 0.77 protein transport
cop POLR3GL 1q21.1 0.151 0.248 0.77 transcription from RNA polymerase
exp FAM105A 5p15.2 0.151 0.248 0.77
exp PITPNM1 11q13 0.151 0.248 0.77 protein transport;lipid metabolic process
xsq SAP18 13q12.11 0.151 0.248 0.77 regulation of transcription from RNA
cop BTBD7 14q32.12 0.151 0.248 0.77
xsq LINC00501 0.151 0.248 0.77
xsq FAN1 15q13.2-q13.3 0.151 0.248 0.77 DNA Damage Response (DDR); DDR (FA)
xsq SMIM19 8p11.21 0.151 0.248 0.77
mut MERTK 2q14.1 0.151 0.248 0.77 spermatogenesis;negative regulation of
lymphocyte activation
mut TCAIM 3p21.31 0.151 0.248 0.77
cop ATP2B1 12q21.3 0.151 0.248 0.77 ATP biosynthetic process;transport
cop RPH3A 12q24.13 0.151 0.248 0.77 intracellular protein transport
met NALCN 13q32.3 0.151 0.248 0.77 ion transport;transmembrane transport
exp PI3 20q13.12 0.151 0.248 0.77 copulation;negative regulation of
met ABCA17P 16p13.3 0.151 0.248 0.77
met TIFA 4q25 0.151 0.248 0.77 I-kappaB kinase/NF-kappaB cascade
exp DCUN1D5 11q22.3 0.151 0.248 0.77
exp ARRDC1-AS1 0.151 0.248 0.77
cop SKA2 17q22 0.151 0.248 0.77 mitotic prometaphase;mitotic cell cycle
xsq FAM153C 0.151 0.248 0.77
met IREB2 15q25.1 0.151 0.248 0.77 protoporphyrinogen IX biosynthetic
xsq ETFB 19q13.3 0.151 0.248 0.77 transport;respiratory electron transport
chain
mut BAIAP3 16p13.3 0.151 0.248 0.77 G-protein coupled receptor
signaling pathway;neurotransmitter secretion
cop CLPB 11q13.4 0.151 0.248 0.77 cellular response to heat
mda MutSig10_polymerase_epsilon 0.151 0.248 0.77
exp ACTR3P2 Xq13.1 -0.151 0.248 0.77
mut CHST15 10q26 -0.151 0.248 0.77 hexose biosynthetic process
xsq GOLGA2 9q34.11 -0.151 0.248 0.77 positive regulation of
met BTN2A2 6p22.1 -0.151 0.248 0.77 negative regulation of
cytokine secretion;negative regulation of cellular metabolic process
met OR1I1 19p13.12 -0.151 0.248 0.77 response to stimulus
cop HINT1 5q31.2 -0.151 0.248 0.77 signal transduction
cop LYRM7 5q23.3 -0.151 0.248 0.77
xsq BMS1P5 -0.151 0.248 0.77
xsq ZNRF3 22q12.1 -0.151 0.248 0.77
xsq FIBIN 11p14.2 -0.151 0.248 0.77
met TCN1 11q11-q12 -0.151 0.248 0.77 cobalt ion transport;cobalamin
metabolic process
mut ATP9B 18q23 -0.151 0.248 0.77 cation transport;aminophospholipid
transport
xsq AFF3 2q11.2-q12 -0.151 0.248 0.77 embryonic hindlimb
exp ESR2 14q23.2 -0.151 0.248 0.77 neuron migration;intracellular
met NFAM1 22q13.2 -0.151 0.248 0.77 regulation of B cell
met EEF1E1 6p24.3 -0.151 0.248 0.77 Apoptosis
xsq EPHA3 3p11.2 -0.151 0.248 0.77 Cell Signaling
xsq LINC01050 -0.151 0.248 0.77
met UBA3 3p14.1 -0.151 0.248 0.77 negative regulation of
transcription, DNA-dependent;regulation of cell cycle
exp PINK1 1p36 -0.152 0.248 0.77 positive regulation of synaptic
transmission, dopaminergic;mitochondrion degradation
xsq AZIN2 -0.152 0.248 0.77 agmatine biosynthetic process;ornithine
metabolic process
met TGM7 15q15.2 -0.152 0.248 0.77 peptide cross-linking
xsq SUN1 7p22.3 -0.152 0.248 0.77 cytoskeletal anchoring at nuclear
met TNK2 3q29 -0.152 0.248 0.77 positive regulation of peptidyl-tyrosine
phosphorylation;regulation of clathrin-mediated endocytosis
met PTGER3 1p31.2 -0.152 0.248 0.77 intracellular receptor
xsq KRTAP3-1 17q21.2 -0.152 0.248 0.77
xsq AHR 7p15 -0.152 0.248 0.77 Apoptosis
xsq SYNE1 6q25 -0.152 0.248 0.77 nucleus organization;Golgi organization
cop CEP170 1q44 -0.152 0.248 0.77
exp AIF1L 9q34.13-q34.3 -0.152 0.248 0.77
exp CETN4P 4q27 -0.152 0.248 0.77
exp CYP51A1 7q21.2 -0.152 0.248 0.77 cholesterol biosynthetic
exp AKAP13 15q24-q25 -0.152 0.248 0.77 nerve growth factor receptor
xsq HSD3BP4 1p13.1 -0.152 0.248 0.77
mut CLASRP 19q13.3 -0.152 0.248 0.77 mRNA processing;RNA splicing
exp MIR28 -0.153 0.248 0.77
xai REXO2 11q23.2 -0.153 0.248 0.77 nucleobase-containing compound
metabolic process;nucleotide metabolic process
his SPTLC2 14q24.3 -0.153 0.248 0.77 sphingosine biosynthetic
his APCDD1L 20q13.32 -0.153 0.248 0.77
his APCDD1L-AS1 -0.153 0.248 0.77
xai C1orf64 1p36.13 -0.153 0.248 0.77
hs4 ETV7 6p21 -0.153 0.248 0.77 Transcription Factors
xai MIR28 -0.153 0.248 0.77
xai NCKAP5L 12q13.12 -0.153 0.248 0.77
xai PLOD3 7q22 -0.153 0.248 0.77 cellular response to hormone
xai EXPH5 11q22.3 -0.153 0.248 0.77 intracellular protein
hs4 AGR3 7p21.1 -0.153 0.248 0.77
hs4 DMWD 19q13.3 -0.153 0.248 0.77 meiosis
exp PP13439 -0.153 0.248 0.77
hs4 C6orf141 6p12.3 -0.153 0.248 0.77
xai LOC100132215 2p15 -0.153 0.248 0.77
hs4 MEGF10 5q33 -0.153 0.248 0.77 cell adhesion;phagocytosis
exp KRT8P38 -0.153 0.248 0.77
xai TOMM7 7p15.3 -0.153 0.248 0.77 protein targeting to
xai WFDC2 20q13.12 -0.153 0.248 0.77 negative regulation of
his MOB2 11p15.5 -0.153 0.248 0.77
xai DCSTAMP 8q23 -0.153 0.248 0.77 osteoclast differentiation
xai NPAS2 2q11.2 -0.153 0.248 0.77 regulation of transcription, DNA-
swa TCP1 6q25.3-q26 -0.153 0.248 0.77 protein folding;tubulin complex
assembly
his NIM1K -0.153 0.248 0.77
xai SLC35E3 12q15 -0.153 0.248 0.77 Solute Carriers
xai KIF3C 2p23 -0.153 0.248 0.77 microtubule-based movement;blood
coagulation
hs4 RNASE1 14q11.2 -0.153 0.248 0.77
xai TTC39A 1p32.3 -0.153 0.248 0.77
xai LOC730102 -0.153 0.248 0.77
exp PSMD10P3 0.153 0.249 0.77
xai SLC25A51 9p13.3-p12 0.153 0.249 0.77 transport
his MIR1538 0.153 0.249 0.77
his NFAT5 16q22.1 0.153 0.249 0.77 regulation of transcription, DNA-
exp RPL7P17 4q21.1 0.153 0.249 0.77
xai FAM193B 5q35.3 0.153 0.249 0.77
his FAN1 15q13.2-q13.3 0.153 0.249 0.77 DNA Damage Response (DDR); DDR (FA)
hs4 LTB 6p21.3 0.153 0.249 0.77 immune response;signal transduction
his EIF4EBP2 10q21-q22 0.153 0.249 0.77 negative regulation of
exp NUP210P1 3q21.3 0.153 0.249 0.77
his RAE1 20q13.31 0.153 0.249 0.77 mRNA export from nucleus;cellular
his HN1 17q25.1 0.153 0.249 0.77
xai PSMD10P3 0.153 0.249 0.77
xai LINC01558 0.153 0.249 0.77
his SEC23B 20p11.23 0.153 0.249 0.77 intracellular protein transport;ER
his KDM3A 2p11.2 0.153 0.249 0.77 histone H3-K9 demethylation;positive
exp AIMP1P1 0.153 0.249 0.77
xai ARPC5L 9q33.3 0.153 0.249 0.77 regulation of actin filament
polymerization
his AGMAT 1p36.21 0.152 0.249 0.77 polyamine metabolic process;spermidine
hs4 MT1DP 16q13 0.152 0.249 0.77
xai HSPBP1 19q13.42 0.152 0.249 0.77 protein folding;positive regulation
swa AP1M1 19p13.12 0.152 0.249 0.77 EMT (Mesenchymal)
exp NBR2 17q21 0.152 0.249 0.77
his PTGES3L-AARSD1 0.152 0.249 0.77
his PTGES3L 0.152 0.249 0.77
his RUNDC1 17q21.31 0.152 0.249 0.77
dependent"
xai PIK3CA 3q26.3 0.152 0.249 0.77 Cell Signaling; Oncogenes; Protein
Kinases
exp RPL23P11 10p11.22 0.152 0.249 0.77
hs4 SPSB4 3q23 0.152 0.249 0.77 intracellular signal transduction
hs4 MLST8 16p13.3 0.152 0.249 0.77 fibroblast growth factor receptor
hs4 PGGHG 0.152 0.249 0.77
hs4 ADCY3 2p23.3 0.152 0.249 0.77 energy reserve metabolic
hs4 ASCL4 12q23.3 0.152 0.249 0.77
his PEMT 17p11.2 0.152 0.249 0.77 phosphatidylcholine biosynthetic
process;S-adenosylhomocysteine metabolic process
his TRUB1 10q25.3 0.152 0.249 0.77 pseudouridine synthesis;RNA processing
exp PGAM1P6 0.152 0.249 0.77
his AGO3 1p34 0.152 0.249 0.77
his C20orf203 20q11.21 0.152 0.249 0.77
his ACSM4 12p13.31 0.152 0.249 0.77
hs4 FNBP1 9q34 0.152 0.249 0.77 endocytosis;nervous system development
hs4 SNRPB 20p13 0.152 0.249 0.77 RNA splicing;gene expression
xai SYNRG 17q12 0.152 0.249 0.77 intracellular protein transport;endocytosis
xai LOC100130673 7p14.3 0.152 0.249 0.77
xai RPL23P11 10p11.22 0.152 0.249 0.77
xai TSPYL4 6q22.1 0.152 0.249 0.77 nucleosome assembly
xai MMS19 10q24-q25 0.152 0.249 0.77 DNA Damage Response (DDR)
xai LINC00847 5q35.3 0.152 0.249 0.77
exp RXFP2 13q13.1 0.152 0.249 0.77 inhibition of adenylate cyclase activity
by G-protein signaling pathway;negative regulation of cell proliferation
his ZNF767P 0.152 0.249 0.77
hs4 RFT1 3p21.1 0.152 0.249 0.77 cellular protein metabolic
his FAM156B Xp11.22 0.152 0.249 0.77
exp OR2H2 6p21.3 0.152 0.249 0.77 detection of chemical stimulus involved
in sensory perception of smell;defense response
xai KRT26 17q21.2 0.152 0.249 0.77
cop MIR4472-2 0.151 0.249 0.77
cop LINC00173 12q24.22 0.151 0.249 0.77
cop MAP1LC3B2 12q24.22 0.151 0.249 0.77 autophagy
cop C12orf49 12q24.22 0.151 0.249 0.77
exp C3orf62 3p21.31 0.151 0.249 0.77
xsq DBR1 3q22.3 0.151 0.249 0.77 nuclear mRNA splicing, via
xsq CST9 20p11.21 0.151 0.249 0.77
met MIR1911 0.151 0.249 0.77
met AKR7A3 1p36.13 0.151 0.249 0.77 cellular aldehyde metabolic process
met UCN2 3p21.3 0.151 0.249 0.77 cAMP biosynthetic process;response to
stress
exp RPL7AP45 9p11.2 0.151 0.249 0.77
met ETFA 15q23-q25 0.151 0.249 0.77 transport;respiratory electron transport
chain
cop ANP32E 1q21.2 0.151 0.249 0.77 DNA Damage Response (DDR)
cop CA14 1q21 0.151 0.249 0.77
cop APH1A 1p36.13-q31.3 0.151 0.249 0.77 protein processing;metanephros
development
cop C1orf54 1q21.2 0.151 0.249 0.77
cop CIART 0.151 0.249 0.77
cop MRPS21 1q21 0.151 0.249 0.77 translation
cop PRPF3 1q21.1 0.151 0.249 0.77 RNA splicing, via transesterification
cop RPRD2 1q21.3 0.151 0.249 0.77
met CCK 3p22.1 0.151 0.249 0.77 activation of cysteine-type endopeptidase
activity involved in apoptotic process;positive regulation of apoptotic process
cop GPR75-ASB3 0.151 0.249 0.77
xsq BAZ1B 7q11.23 0.151 0.249 0.77 DNA Damage Response (DDR)
cop CD6 11q13 0.151 0.249 0.77 cell adhesion
xsq PRKAR1B 7p22 0.151 0.249 0.77 protein phosphorylation;small molecule
metabolic process
exp LOC389473 7p15.3 0.151 0.249 0.77
cop SEC14L5 16p13.3 0.151 0.249 0.77
xsq RTCA-AS1 0.151 0.249 0.77
met NRP2 2q33.3 0.151 0.249 0.77 angiogenesis;positive regulation of
cop AK7 14q32.2 0.151 0.249 0.77 nucleobase-containing compound metabolic
process;cell projection organization
exp PQBP1 Xp11.23 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
xsq REG1A 2p12 0.151 0.249 0.77 positive regulation of cell proliferation
xsq NDUFAF3 3p21.31 0.151 0.249 0.77 mitochondrial respiratory chain
complex I assembly
xsq FGL1 8p22 0.151 0.249 0.77 signal transduction
xsq DAO 12q24 0.151 0.249 0.77 proline catabolic process;cellular nitrogen
xsq LINC00924 15q26.2 0.151 0.249 0.77
xsq GM2A 5q33.1 0.151 0.249 0.77 glycolipid catabolic process;lipid
storage
met ZFAND1 8q21.13 0.151 0.249 0.77
exp GHRLOS 3p25.3 0.151 0.249 0.77
xsq ZDHHC6 10q25.2 0.151 0.249 0.77
mut COL5A2 2q14-q32 0.151 0.249 0.77 collagen fibril organization;skin
development
mut CD58 1p13 0.151 0.249 0.77 Tumor Suppressors
mut KCNN3 1q21.3 0.151 0.249 0.77 potassium ion transmembrane transport;ion
transport
mut SERTAD4 1q32.1-q41 0.151 0.249 0.77
mut GPR137B 1q42-q43 0.151 0.249 0.77
mut SDCCAG8 1q43 0.151 0.249 0.77 mitotic cell cycle;establishment of cell
polarity
mut AHCTF1 1q44 0.151 0.249 0.77 cytokinesis;protein transport
mut CPSF3 2p25.1 0.151 0.249 0.77 nuclear mRNA splicing, via
mut GFPT1 2p13 0.151 0.249 0.77 carbohydrate biosynthetic process;fructose 6-
phosphate metabolic process
mut ST3GAL5 2p11.2 0.151 0.249 0.77 carbohydrate metabolic
mut TRNT1 3p25.1 0.151 0.249 0.77 RNA processing;protein targeting to
mitochondrion
mut OXSR1 3p22.2 0.151 0.249 0.77 protein phosphorylation;response to
oxidative stress
mut NPRL2 3p21.3 0.151 0.249 0.77 protein phosphorylation;negative
mut UBA3 3p14.1 0.151 0.249 0.77 negative regulation of transcription,
DNA-dependent;regulation of cell cycle
mut MRAS 3q22.3 0.151 0.249 0.77 GTP catabolic process;signal transduction
mut WDR49 3q26.1 0.151 0.249 0.77
mut ZNF518B 4p16.1 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut G3BP2 4q21.1 0.151 0.249 0.77 small GTPase mediated signal
mut NDNF 4q27 0.151 0.249 0.77 cell growth;peptide cross-linking via
mut SH3D19 4q31.3 0.151 0.249 0.77 post-Golgi vesicle-mediated
mut HAND1 5q33 0.151 0.249 0.77
mut FAXDC2 5q31-q32 0.151 0.249 0.77
mut UIMC1 5q35.2 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (HR)
dependent"
mut RHOBTB2 8p21.3 0.151 0.249 0.77 small GTPase mediated signal
mut AP3M2 8p11.2 0.151 0.249 0.77 intracellular protein transport;vesicle-
mediated transport
mut MCMDC2 8q13.1 0.151 0.249 0.77 DNA replication
mut CPA6 8q13.2 0.151 0.249 0.77 proteolysis
mut XKR9 8q13.3 0.151 0.249 0.77
mut GARNL3 9q33.3 0.151 0.249 0.77 regulation of small GTPase mediated
signal transduction
mut CERCAM 9q34.11 0.151 0.249 0.77 cellular component movement;cell
adhesion
mut PHYHD1 9q34.11 0.151 0.249 0.77
mut MSRB2 10p12 0.151 0.249 0.77 regulation of transcription, DNA-
mut SYCE1 10q26.3 0.151 0.249 0.77 cell cycle;meiosis
mut OR10A3 11p15.4 0.151 0.249 0.77 detection of chemical stimulus
involved in sensory perception of smell;sensory perception of smell
mut LUZP2 11p14.3 0.151 0.249 0.77
mut KCNA4 11p14 0.151 0.249 0.77 synaptic transmission;transmembrane transport
mut OR4X1 11p11.2 0.151 0.249 0.77 response to stimulus
mut TMX2 11cen-q22.3 0.151 0.249 0.77 cell redox homeostasis
mut SPDYC 11q13.1 0.151 0.249 0.77 cell cycle
mut MMP27 11q24 0.151 0.249 0.77 proteolysis;metabolic process
mut KDELC2 11q22.3 0.151 0.249 0.77
mut TAS2R9 12p13 0.151 0.249 0.77 response to stimulus;detection of
mut KLHL42 12p11.22 0.151 0.249 0.77
mut PFKM 12q13.3 0.151 0.249 0.77 glycolysis;protein homotetramerization
mut TPH2 12q21.1 0.151 0.249 0.77 response to nutrient levels;cellular
response to lithium ion
mut RPH3A 12q24.13 0.151 0.249 0.77 intracellular protein transport
mut SPERT 13q14.13 0.151 0.249 0.77
mut RNASEH2B 13q14.3 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
mut MYO16 13q33.3 0.151 0.249 0.77 cerebellum development;negative
regulation of S phase of mitotic cell cycle
mut ADAM10 15q22 0.151 0.249 0.77 proteolysis;positive regulation of cell
proliferation
mut OMG 17q11.2 0.151 0.249 0.77 regulation of collateral sprouting of
intact axon in response to injury;regulation of axonogenesis
mut L3MBTL4 18p11.31 0.151 0.249 0.77 chromatin modification
mut CCDC68 18q21 0.151 0.249 0.77
mut CEACAM7 19q13.2 0.151 0.249 0.77
mut SIRPA 20p13 0.151 0.249 0.77 cell adhesion;blood coagulation
mut BPIFB2 20q11.21 0.151 0.249 0.77
mut WFDC10A 20q13.12 0.151 0.249 0.77
mut TMEM50B 21q22.11 0.151 0.249 0.77
mut GNL3L Xp11.22 0.151 0.249 0.77 ribosome biogenesis
mut CXorf65 Xq13.1 0.151 0.249 0.77
mut DACH2 Xq21.3 0.151 0.249 0.77 regulation of transcription, DNA-
mut DIAPH2 Xq21.33 0.151 0.249 0.77 actin cytoskeleton
mut MBNL3 Xq26.2 0.151 0.249 0.77 mRNA processing;multicellular organismal
development
mut NOL9 1p36.31 0.151 0.249 0.77 maturation of 5.8S rRNA
mut CASP9 1p36.21 0.151 0.249 0.77 Apoptosis
mut LDLRAD2 1p36.12 0.151 0.249 0.77
mut HNRNPR 1p36.12 0.151 0.249 0.77 nuclear mRNA splicing, via
mut SRRM1 1p36.11 0.151 0.249 0.77 transcription from RNA polymerase II
mut CLIC4 1p36.11 0.151 0.249 0.77 ion transport;chloride transport
mut SYF2 1p36.11 0.151 0.249 0.77 nuclear mRNA splicing, via
mut CEP85 1p36.11 0.151 0.249 0.77
mut WASF2 1p36.11 0.151 0.249 0.77 G-protein signaling, coupled to cAMP
nucleotide second messenger;Rac protein signal transduction
mut KHDRBS1 1p32 0.151 0.249 0.77 negative regulation of transcription,
DNA-dependent;G2/M transition of mitotic cell cycle
mut SFPQ 1p34.3 0.151 0.249 0.77 alternative nuclear mRNA splicing, via
spliceosome;DNA repair
mut MEAF6 1p35.3-p33 0.151 0.249 0.77 regulation of transcription, DNA-
mut YRDC 1p34.3 0.151 0.249 0.77 negative regulation of transport
mut PABPC4 1p34.2 0.151 0.249 0.77
mut HEYL 1p34.3 0.151 0.249 0.77 multicellular organismal
mut PPT1 1p32 0.151 0.249 0.77 receptor-mediated endocytosis;grooming behavior
mut ZMPSTE24 1p34 0.151 0.249 0.77 proteolysis;nuclear envelope organization
dependent"
mut FOXJ3 1p34.2 0.151 0.249 0.77 regulation of sequence-specific DNA
mut ATP6V0B 1p32.3 0.151 0.249 0.77 cellular iron ion
mut NASP 1p34.1 0.151 0.249 0.77 cell proliferation;protein transport
mut IPP 1p34-p32 0.151 0.249 0.77
mut ZYG11B 1p32.3 0.151 0.249 0.77
mut MRPL37 1p32.1 0.151 0.249 0.77 translation
mut CYP2J2 1p31.3-p31.2 0.151 0.249 0.77 xenobiotic metabolic
mut ANGPTL3 1p31.3 0.151 0.249 0.77 cell-matrix adhesion;positive
mut JAK1 1p32.3-p31.3 0.151 0.249 0.77 Oncogenes
mut DNAJC6 1p31.3 0.151 0.249 0.77 post-Golgi vesicle-mediated
mut NEGR1 1p31.1 0.151 0.249 0.77 cell adhesion
mut CRYZ 1p31.1 0.151 0.249 0.77 xenobiotic catabolic process;protein
homotetramerization
mut ACADM 1p31 0.151 0.249 0.77 carnitine metabolic process, CoA-linked;fatty
mut IFI44 1p31.1 0.151 0.249 0.77 response to virus
mut TTLL7 1p31.1 0.151 0.249 0.77 multicellular organismal
mut COL24A1 1p22.3 0.151 0.249 0.77 cell adhesion
mut CLCA2 1p22.3 0.151 0.249 0.77 transport;chloride transport
mut CDC7 1p22 0.151 0.249 0.77 DDR (DNA replication)
mut EPHX4 1p22.1 0.151 0.249 0.77
mut BTBD8 1p22.1 0.151 0.249 0.77
mut EVI5 1p22.1 0.151 0.249 0.77 cell cycle;multicellular organismal
development
mut SASS6 1p21.2 0.151 0.249 0.77 cell cycle;centriole replication
mut FAM102B 1p13.3 0.151 0.249 0.77
mut KCNA2 1p13 0.151 0.249 0.77 potassium ion transmembrane transport;ion
transport
mut LRIF1 1p13.3 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut PTPN22 1p13.2 0.151 0.249 0.77 regulation of B cell receptor
mut SYCP1 1p13-p12 0.151 0.249 0.77 synaptonemal complex assembly;reciprocal
meiotic recombination
mut MAN1A2 1p13 0.151 0.249 0.77 protein N-linked glycosylation via
mut GJA8 1q21.1 0.151 0.249 0.77 visual perception;lens development in
camera-type eye
mut ANP32E 1q21.2 0.151 0.249 0.77 DNA Damage Response (DDR)
mut LINGO4 1q21.3 0.151 0.249 0.77
mut THEM5 1q21.3 0.151 0.249 0.77
mut TCHHL1 1q21.3 0.151 0.249 0.77
mut S100A9 1q21 0.151 0.249 0.77 signal transduction;cell-cell signaling
mut S100A12 1q21 0.151 0.249 0.77 killing of cells of other
mut SHE 1q21.3 0.151 0.249 0.77
mut SLAMF7 1q23.1-q24.1 0.151 0.249 0.77 natural killer cell
activation;natural killer cell mediated cytotoxicity
mut CD244 1q23.3 0.151 0.249 0.77 leukocyte migration;signal transduction
mut DEDD 1q23.3 0.151 0.249 0.77 Apoptosis
mut FCGR2A 1q23 0.151 0.249 0.77
mut UCK2 1q23 0.151 0.249 0.77 response to axon injury;nucleobase-containing
small molecule metabolic process
mut MAEL 1q24.1 0.151 0.249 0.77 synapsis;piRNA metabolic process
mut SFT2D2 1q24.2 0.151 0.249 0.77 protein transport;vesicle-mediated
transport
mut ANGPTL1 1q25.2 0.151 0.249 0.77 signal transduction;transmembrane
mut ACBD6 1q25.1 0.151 0.249 0.77
mut SHCBP1L 1q25.3 0.151 0.249 0.77
mut NMNAT2 1q25 0.151 0.249 0.77 vitamin metabolic process;water-soluble
mut RGS21 1q31.2 0.151 0.249 0.77
mut UCHL5 1q32 0.151 0.249 0.77 DNA repair;midbrain development
mut TROVE2 1q31 0.151 0.249 0.77 transcription from RNA polymerase III
promoter
mut CDC73 1q25 0.151 0.249 0.77 Tumor Suppressors
mut F13B 1q31-q32.1 0.151 0.249 0.77 blood coagulation
mut IL24 1q32 0.151 0.249 0.77 apoptotic process
mut NENF 1q32.3 0.151 0.249 0.77 positive regulation of MAPK cascade
mut TATDN3 1q32.3 0.151 0.249 0.77
mut RAB3GAP2 1q41 0.151 0.249 0.77 positive regulation of GTPase
activity;intracellular protein transport
mut SUSD4 1q41 0.151 0.249 0.77
mut WDR26 1q42.13 0.151 0.249 0.77
mut RAB4A 1q42-q43 0.151 0.249 0.77
mut ACTA1 1q42.13 0.151 0.249 0.77 response to mechanical stimulus;skeletal
muscle fiber development
mut OPN3 1q43 0.151 0.249 0.77 response to stimulus;G-protein coupled receptor
signaling pathway
mut C1orf101 1q44 0.151 0.249 0.77
mut DESI2 1q44 0.151 0.249 0.77
mut TFB2M 1q44 0.151 0.249 0.77 transcription from mitochondrial
mut OR1C1 0.151 0.249 0.77
mut TRIM58 1q44 0.151 0.249 0.77
dependent"
mut PREB 2p23.3 0.151 0.249 0.77 cellular membrane organization;vesicle-
mediated transport
mut SPDYA 2p23.2 0.151 0.249 0.77 positive regulation of cell
mut ATL2 2p22.3 0.151 0.249 0.77 GTP catabolic process;ER to Golgi
mut HAAO 2p21 0.151 0.249 0.77 small molecule metabolic process;response to
cadmium ion
mut FBXO11 2p16.3 0.151 0.249 0.77 protein ubiquitination;peptidyl-
arginine N-methylation
mut RTN4 2p16.3 0.151 0.249 0.77 Apoptosis
mut EFEMP1 2p16 0.151 0.249 0.77 peptidyl-tyrosine
mut TMEM17 2p15 0.151 0.249 0.77 smoothened signaling pathway;cell
mut VPS54 2p13-p14 0.151 0.249 0.77 homeostasis of number of cells within a
mut C1D 2p13-p12 0.151 0.249 0.77 negative regulation of transcription,
DNA-dependent;maturation of 5.8S rRNA
mut MXD1 2p13-p12 0.151 0.249 0.77 Apoptosis
mut TEX261 2p13.3 0.151 0.249 0.77 positive regulation of apoptotic
process
mut WDR54 2p13.1 0.151 0.249 0.77
mut KDM3A 2p11.2 0.151 0.249 0.77 histone H3-K9 demethylation;positive
mut RMND5A 2p11.2 0.151 0.249 0.77
dependent"
mut TSGA10 2q11.2 0.151 0.249 0.77 spermatogenesis;cell projection
assembly
mut IL18RAP 2q12 0.151 0.249 0.77 inflammatory response;immune response
mut NCK2 2q12 0.151 0.249 0.77 signal transduction;positive regulation of
mut C2orf40 2q12.2 0.151 0.249 0.77 G1 to G0 transition;cellular
senescence
mut ORC4 2q22-q23 0.151 0.249 0.77 DDR (DNA replication)
mut STAM2 2q23.3 0.151 0.249 0.77 cellular membrane organization;endosome
transport
mut PPIG 2q31.1 0.151 0.249 0.77 protein folding;RNA splicing
mut CIR1 2q31.1 0.151 0.249 0.77 regulation of transcription, DNA-
mut ATP5G3 2q31.1 0.151 0.249 0.77 aging;ATP synthesis coupled proton
transport
mut KIAA1715 2q31 0.151 0.249 0.77 limb development;multicellular organismal
development
mut OSBPL6 2q32.1 0.151 0.249 0.77 transport;lipid transport
mut DFNB59 2q31.2 0.151 0.249 0.77 sensory perception of sound
mut NEUROD1 2q32 0.151 0.249 0.77
mut PPIL3 2q33.1 0.151 0.249 0.77 protein folding;RNA splicing
mut WDR12 2q33.2 0.151 0.249 0.77 maturation of LSU-rRNA from tricistronic
rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from
tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
mut ABI2 2q33 0.151 0.249 0.77 actin polymerization or depolymerization;cell
migration
mut RPE 2q32-q33.3 0.151 0.249 0.77 small molecule metabolic
mut RNF25 2q35 0.151 0.249 0.77 protein ubiquitination;positive regulation of
NF-kappaB transcription factor activity
mut CRYBA2 2q35 0.151 0.249 0.77
mut GMPPA 2q35 0.151 0.249 0.77 post-translational protein
mut INHA 2q35 0.151 0.249 0.77 Apoptosis
mut SCG2 2q35-q36 0.151 0.249 0.77 inflammatory response;protein secretion
mut GPR55 2q37 0.151 0.249 0.77 G-protein coupled receptor signaling
mut LRRFIP1 2q37.3 0.151 0.249 0.77 regulation of transcription from
mut MYEOV2 2q37.3 0.151 0.249 0.77
mut MTERF4 0.151 0.249 0.77
mut CAV3 3p25 0.151 0.249 0.77 regulation of heart contraction;T-tubule
organization
mut RAD18 3p25-p24 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (TLS)
mut TAMM41 3p25.2 0.151 0.249 0.77 protein transport;protein import
into mitochondrial matrix
mut MKRN2 3p25 0.151 0.249 0.77
mut COLQ 3p25 0.151 0.249 0.77 acetylcholine catabolic process in synaptic
cleft;asymmetric protein localization
mut TBC1D5 3p24.3 0.151 0.249 0.77
mut SGOL1 3p24.3 0.151 0.249 0.77 centriole-centriole cohesion;meiotic
mut TRIM71 3p22.3 0.151 0.249 0.77 multicellular organismal
mut WDR48 3p21.33 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (FA)
mut CCDC13 3p22.1 0.151 0.249 0.77
dependent"
mut SACM1L 3p21.3 0.151 0.249 0.77
mut FBXW12 3p21.31 0.151 0.249 0.77
mut C3orf62 3p21.31 0.151 0.249 0.77
mut RBM5 3p21.3 0.151 0.249 0.77 RNA splicing;gene expression
mut RASSF1 3p21.3 0.151 0.249 0.77 positive regulation of protein
ubiquitination;intracellular signal transduction
mut CYB561D2 3p21.3 0.151 0.249 0.77 transport;electron transport chain
mut ASB14 3p21.1 0.151 0.249 0.77 intracellular signal transduction
mut PSMD6 3p14.1 0.151 0.249 0.77 antigen processing and presentation of
exogenous peptide antigen via MHC class I, TAP-dependent;RNA metabolic process
mut OR5K2 0.151 0.249 0.77
mut ST3GAL6 3q12.1 0.151 0.249 0.77 protein modification
mut TMEM45A 3q12.2 0.151 0.249 0.77
mut TRAT1 3q13 0.151 0.249 0.77 positive regulation of T cell receptor
mut PARP9 3q21 0.151 0.249 0.77 cell migration;regulation of response to
interferon-gamma
mut DTX3L 3q21.1 0.151 0.249 0.77 response to DNA damage stimulus;histone
monoubiquitination
mut DNAJB8 3q21.3 0.151 0.249 0.77
mut CNBP 3q21 0.151 0.249 0.77 regulation of transcription, DNA-
mut COPG1 3q21.3 0.151 0.249 0.77 intracellular protein
mut TF 3q22.1 0.151 0.249 0.77 ion transport;iron ion transport
mut PCCB 3q21-q22 0.151 0.249 0.77 fatty acid beta-oxidation;short-chain
mut A4GNT 3p14.3 0.151 0.249 0.77 carbohydrate metabolic process;protein O-
mut NME9 3q22.3 0.151 0.249 0.77 GTP biosynthetic process;UTP biosynthetic
process
mut PLOD2 3q24 0.151 0.249 0.77 response to hypoxia;protein modification
process
mut P2RY1 3q25.2 0.151 0.249 0.77 response to mechanical stimulus;positive
regulation of ion transport
mut LRRC34 3q26.2 0.151 0.249 0.77
mut GNB4 3q26.33 0.151 0.249 0.77 EMT (Mesenchymal)
mut ATP11B 3q27 0.151 0.249 0.77 transmembrane transport;ion transport
mut KLHL24 3q27.1 0.151 0.249 0.77
mut PARL 3q27.1 0.151 0.249 0.77 proteolysis
mut LSG1 3q29 0.151 0.249 0.77 nuclear export;protein transport
mut FAM43A 3q29 0.151 0.249 0.77
mut TM4SF19 3q29 0.151 0.249 0.77
mut ADD1 4p16.3 0.151 0.249 0.77 cellular component disassembly involved
in apoptosis;activation of signaling protein activity involved in unfolded protein
response
mut STIM2 4p15.2 0.151 0.249 0.77 negative regulation of calcium ion
mut PGM2 4p14 0.151 0.249 0.77 glycogen catabolic process;glucose metabolic
process
mut TMEM156 4p14 0.151 0.249 0.77
mut NSUN7 4p14 0.151 0.249 0.77
mut UCHL1 4p14 0.151 0.249 0.77 proteolysis;protein deubiquitination
mut GSX2 4q12 0.151 0.249 0.77 multicellular organismal development
mut REST 4q12 0.151 0.249 0.77 positive regulation of apoptotic
mut RUFY3 4q13.3 0.151 0.249 0.77 cell differentiation;negative regulation
of axonogenesis
mut BMP2K 4q21.21 0.151 0.249 0.77 regulation of catalytic
mut GK2 4q13 0.151 0.249 0.77
mut HNRNPD 4q21 0.151 0.249 0.77 RNA processing;RNA catabolic process
mut SNCA 4q21 0.151 0.249 0.77 Apoptosis
mut HPGDS 4q22.3 0.151 0.249 0.77 prostaglandin biosynthetic process;fatty
mut TRMT10A 4q23 0.151 0.249 0.77
mut AP1AR 4q25 0.151 0.249 0.77 protein transport
mut IL21 4q26-q27 0.151 0.249 0.77 positive regulation of interleukin-17
production;positive regulation of natural killer cell differentiation
mut SCOC 4q31.1 0.151 0.249 0.77
mut SMARCA5 4q31.1-q31.2 0.151 0.249 0.77 DNA Damage Response (DDR);
DDR (Chromatin)
mut KIAA0922 4q31.3 0.151 0.249 0.77
mut FGG 4q28 0.151 0.249 0.77 platelet degranulation;signal transduction
mut RBM46 4q32.1 0.151 0.249 0.77
mut MAP9 4q32.1 0.151 0.249 0.77 cell division;cell cycle
mut PPID 4q31.3 0.151 0.249 0.77 protein folding
mut AADAT 4q33 0.151 0.249 0.77 small molecule metabolic process;2-oxoglutarate
metabolic process
mut TRAPPC11 4q35.1 0.151 0.249 0.77 vesicle-mediated transport
mut ACSL1 4q35.1 0.151 0.249 0.77 fatty acid metabolic process;triglyceride
mut HELT 4q35.1 0.151 0.249 0.77
mut CCDC110 4q35.1 0.151 0.249 0.77
mut AHRR 5p15.3 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut LPCAT1 5p15.33 0.151 0.249 0.77 phospholipid biosynthetic
process;retina development in camera-type eye
mut FAM134B 5p15.1 0.151 0.249 0.77 sensory perception of pain
mut MTMR12 5p13.3 0.151 0.249 0.77
mut DNAJC21 5p13.2 0.151 0.249 0.77 protein folding
mut C5orf51 5p13.1 0.151 0.249 0.77
mut ANKRD55 5q11.2 0.151 0.249 0.77
mut RAB3C 5q13 0.151 0.249 0.77 small GTPase mediated signal
mut ELOVL7 5q12.1 0.151 0.249 0.77 small molecule metabolic
mut IPO11 5q12.1 0.151 0.249 0.77 intracellular protein transport
mut HTR1A 5q11.2-q13 0.151 0.249 0.77 serotonin receptor signaling
pathway;behavior
mut ERBB2IP 5q12.3 0.151 0.249 0.77 signal transduction;epidermal
mut CD180 5q12 0.151 0.249 0.77 inflammatory response;innate immune response
mut TAF9 5q13.2 0.151 0.249 0.77 regulation of transcription, DNA-
process
mut FAM172A 5q15 0.151 0.249 0.77
mut SNX2 5q23 0.151 0.249 0.77 intracellular protein transport;endocytosis
mut MYOT 5q31 0.151 0.249 0.77 muscle contraction
mut FAM13B 5q31 0.151 0.249 0.77 signal transduction;small GTPase mediated
signal transduction
mut KIF20A 5q31 0.151 0.249 0.77 microtubule bundle formation;microtubule-
based movement
mut PCDHB3 5q31 0.151 0.249 0.77 cell adhesion;homophilic cell adhesion
mut PCDHB16 5q31 0.151 0.249 0.77 synapse assembly;calcium-dependent cell-
cell adhesion
mut PCDHB15 5q31 0.151 0.249 0.77 homophilic cell adhesion;nervous system
development
mut PDGFRB 5q33.1 0.151 0.249 0.77 Protein Kinases
dependent"
mut FABP6 5q33.3-q34 0.151 0.249 0.77 small molecule metabolic process;lipid
metabolic process
mut GABRA1 5q34 0.151 0.249 0.77 transport;chloride transport
mut FAF2 5q35.2 0.151 0.249 0.77 response to unfolded protein
mut LMAN2 5q35.3 0.151 0.249 0.77 protein transport
mut RNF130 5q35.3 0.151 0.249 0.77 Apoptosis
mut DUSP22 6p25.3 0.151 0.249 0.77 Apoptosis
mut BPHL 6p25 0.151 0.249 0.77 cellular amino acid metabolic process;response
to toxin
mut TUBB2B 6p25 0.151 0.249 0.77 protein folding;microtubule-based
movement
mut RIOK1 6p24.3 0.151 0.249 0.77
mut SLC35B3 6p24.3 0.151 0.249 0.77 Solute Carriers
mut DCDC2 6p22.1 0.151 0.249 0.77 cellular defense response;nervous system
development
mut PRSS16 6p21 0.151 0.249 0.77 proteolysis;protein catabolic process
mut OR2B6 6p21.3 0.151 0.249 0.77 response to stimulus
mut NKAPL 0.151 0.249 0.77
mut APOBEC2 6p21 0.151 0.249 0.77 mRNA processing;cytidine deamination
mut GTPBP2 6p21 0.151 0.249 0.77
mut RSPH9 6p21.1 0.151 0.249 0.77 cilium movement;cilium axoneme assembly
mut SPATS1 6p21.1 0.151 0.249 0.77
mut PLA2G7 6p21.2-p12 0.151 0.249 0.77 low-density lipoprotein particle
mut TFAP2B 6p12 0.151 0.249 0.77 nervous system development;hindlimb
morphogenesis
mut DPPA5 6q13 0.151 0.249 0.77
mut DDX43 6q13 0.151 0.249 0.77
mut ELOVL4 6q14 0.151 0.249 0.77 fatty acid biosynthetic process;detection
of visible light
mut FAM46A 6q14 0.151 0.249 0.77
mut HTR1E 6q14-q15 0.151 0.249 0.77 G-protein coupled receptor signaling
mut CFAP206 0.151 0.249 0.77
mut MANEA 6q16.1 0.151 0.249 0.77 protein N-linked glycosylation via
mut PDSS2 6q21 0.151 0.249 0.77 isoprenoid biosynthetic process;regulation of
body fluid levels
mut LACE1 6q22.1 0.151 0.249 0.77
mut SESN1 6q21 0.151 0.249 0.77 negative regulation of cell
proliferation;response to DNA damage stimulus
mut PPIL6 6q21 0.151 0.249 0.77 protein folding
mut WISP3 6q21 0.151 0.249 0.77 Oncogenes
mut FAM229B 6q21 0.151 0.249 0.77
mut RFPL4B 6q21 0.151 0.249 0.77
mut RWDD1 6q13-q22.33 0.151 0.249 0.77
mut CEP85L 6q22 0.151 0.249 0.77
mut HSF2 6q22.31 0.151 0.249 0.77 regulation of transcription, DNA-
mut RSPO3 6q22.33 0.151 0.249 0.77 response to stimulus;canonical Wnt
mut ECHDC1 6q22.33 0.151 0.249 0.77
mut BCLAF1 6q22-q23 0.151 0.249 0.77 Apoptosis
mut MAP7 6q23.3 0.151 0.249 0.77 microtubule cytoskeleton
mut NMBR 6q24.1 0.151 0.249 0.77 G-protein coupled receptor signaling
pathway;activation of phospholipase C activity by G-protein coupled receptor
mut SASH1 6q24.3 0.151 0.249 0.77
mut CCDC170 6q25.1 0.151 0.249 0.77
mut FBXO5 6q25.2 0.151 0.249 0.77 G1/S transition of mitotic cell
mut SERAC1 6q25.3 0.151 0.249 0.77 GPI anchor metabolic
mut MAS1 6q25.3-q26 0.151 0.249 0.77 cell proliferation;positive regulation of
DNA replication
mut TCTE3 6q27 0.151 0.249 0.77 transport
mut RBAK 7p22.1 0.151 0.249 0.77 regulation of transcription, DNA-
mut DAGLB 7p22.1 0.151 0.249 0.77 blood coagulation;lipid catabolic process
mut TWISTNB 7p21.1 0.151 0.249 0.77
mut CDCA7L 7p15.3 0.151 0.249 0.77 regulation of transcription, DNA-
mut HOXA11 7p15.2 0.151 0.249 0.77 metanephros
mut CHN2 7p15.3 0.151 0.249 0.77 acrosome assembly;small GTPase mediated
signal transduction
mut SCRN1 7p14.3-p14.1 0.151 0.249 0.77 proteolysis;exocytosis
mut AQP1 7p14 0.151 0.249 0.77 cell volume homeostasis;establishment or
mut NT5C3A 7p14.3 0.151 0.249 0.77
mut HERPUD2 7p14.2 0.151 0.249 0.77 response to unfolded
mut ANLN 7p15-p14 0.151 0.249 0.77 cytokinesis;septin ring assembly
mut STARD3NL 7p14-p13 0.151 0.249 0.77
dependent"
mut CCL24 7q11.23 0.151 0.249 0.77 inflammatory response;positive regulation
of Rac GTPase activity
mut C7orf62 7q21.13 0.151 0.249 0.77
mut PDK4 7q21.3 0.151 0.249 0.77 peptidyl-histidine phosphorylation;small
mut BAIAP2L1 7q22.1 0.151 0.249 0.77 response to bacterium;positive
mut TAF6 7q22.1 0.151 0.249 0.77 transcription elongation from RNA
mut CNPY4 7q22.1 0.151 0.249 0.77
mut LRCH4 7q22 0.151 0.249 0.77 nervous system development;negative regulation
mut SERPINE1 7q22.1 0.151 0.249 0.77 response to reactive oxygen
mut PIK3CG 7q22.3 0.151 0.249 0.77 Apoptosis; Cell Signaling;
mut PRKAR2B 7q22 0.151 0.249 0.77 energy reserve metabolic
process;fibroblast growth factor receptor signaling pathway
mut TFEC 7q31.2 0.151 0.249 0.77 regulation of transcription, DNA-
mut CAV2 7q31.1 0.151 0.249 0.77 mitochondrion organization;protein
oligomerization
mut CPED1 7q31.31 0.151 0.249 0.77
mut FEZF1 7q31.32 0.151 0.249 0.77 olfactory bulb development;negative
mut MKLN1 7q32 0.151 0.249 0.77 signal transduction
mut STRA8 7q33 0.151 0.249 0.77 fertilization;ovarian follicle development
mut ATP6V0A4 7q34 0.151 0.249 0.77 ion transport;transferrin transport
mut OR2A25 7q35 0.151 0.249 0.77 response to stimulus
mut LMBR1 7q36 0.151 0.249 0.77 embryonic digit morphogenesis
mut MNX1 7q36 0.151 0.249 0.77 regulation of transcription from RNA polymerase
mut PPP1R3B 8p23.1 0.151 0.249 0.77 carbohydrate metabolic
mut LONRF1 8p23.1 0.151 0.249 0.77 proteolysis
mut MICU3 8p22 0.151 0.249 0.77
mut SFTPC 8p21 0.151 0.249 0.77 response to hormone stimulus;response to
interleukin-6
mut PHYHIP 8p21.3 0.151 0.249 0.77
mut FBXO16 8p21.1 0.151 0.249 0.77
mut GTF2E2 8p12 0.151 0.249 0.77 regulation of transcription, DNA-
mut ADRB3 8p12 0.151 0.249 0.77
mut DDHD2 8p11.23 0.151 0.249 0.77 lipid catabolic process
mut CHRNA6 8p11.21 0.151 0.249 0.77 cation transport;signal
transduction
mut FNTA 8p11 0.151 0.249 0.77 transforming growth factor beta receptor
mut EFCAB1 8q11.21 0.151 0.249 0.77
mut LYN 8q13 0.151 0.249 0.77 Protein Kinases
mut CYP7B1 8q21.3 0.151 0.249 0.77 memory;positive regulation of
mut PPP1R42 8q13.1 0.151 0.249 0.77
mut COPS5 8q13.1 0.151 0.249 0.77 DNA Damage Response (DDR)
mut DECR1 8q21.3 0.151 0.249 0.77 fatty acid beta-oxidation;cellular lipid
metabolic process
mut GEM 8q13-q21 0.151 0.249 0.77 GTP catabolic process;immune response
mut CCNE2 8q22.1 0.151 0.249 0.77 DDR (DNA replication); Oncogenes
mut GDF6 8q22.1 0.151 0.249 0.77 growth;positive regulation of neuron
differentiation
mut NCALD 8q22.2 0.151 0.249 0.77 synaptic transmission;vesicle-mediated
transport
mut FZD6 8q22.3-q23.1 0.151 0.249 0.77 gonad development;cell
mut DPYS 8q22 0.151 0.249 0.77 uracil catabolic process;beta-alanine metabolic
process
mut NUDCD1 8q23 0.151 0.249 0.77
mut UTP23 8q24.11 0.151 0.249 0.77 rRNA processing
mut ZHX1 8q24.13 0.151 0.249 0.77 negative regulation of transcription from
dependent"
mut NSMCE2 8q24.13 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (HR)
mut TMEM71 8q24.22 0.151 0.249 0.77
mut ARC 8q24.3 0.151 0.249 0.77 regulation of cell
mut RFX3 9p24.2 0.151 0.249 0.77 cell differentiation;ciliary cell
motility
mut SPATA6L 9p24.2 0.151 0.249 0.77
mut PSIP1 9p22.3 0.151 0.249 0.77 provirus integration;initiation of viral
infection
mut CCDC171 9p22.3 0.151 0.249 0.77
mut SAXO1 0.151 0.249 0.77
mut MLLT3 9p22 0.151 0.249 0.77 regulation of transcription, DNA-
dependent;segment specification
mut IFNE 9p21.3 0.151 0.249 0.77 defense response;response to virus
mut LRRC19 9p21.2 0.151 0.249 0.77
mut ARID3C 9p13.3 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut HINT2 9p13.3 0.151 0.249 0.77 steroid biosynthetic process;apoptotic
process
mut VPS13A 9q21 0.151 0.249 0.77 Golgi to endosome transport;nervous
system development
mut TLE4 9q21.31 0.151 0.249 0.77 negative regulation of transcription from
RNA polymerase II promoter;Wnt receptor signaling pathway
mut C9orf64 9q21.32 0.151 0.249 0.77
mut ZNF367 9q22 0.151 0.249 0.77 regulation of transcription from RNA
mut HEMGN 9q22.33 0.151 0.249 0.77 multicellular organismal development;cell
differentiation
mut TGFBR1 9q22 0.151 0.249 0.77 Apoptosis
mut STX17 9q31.1 0.151 0.249 0.77 intracellular protein transport;vesicle-
mediated transport
mut MRPL50 9q31.1 0.151 0.249 0.77
mut CYLC2 9q31.1 0.151 0.249 0.77
mut FRRS1L 9q31 0.151 0.249 0.77
mut TXNDC8 0.151 0.249 0.77
mut DNAJC25 9q31.3 0.151 0.249 0.77 protein folding
mut ZFP37 9q32 0.151 0.249 0.77 regulation of transcription, DNA-dependent;cell
proliferation
mut CDC26 9q32 0.151 0.249 0.77 cell division;negative regulation of ubiquitin-
protein ligase activity involved in mitotic cell cycle
mut C9orf43 9q32 0.151 0.249 0.77
mut STOM 9q34.1 0.151 0.249 0.77 protein homooligomerization
mut MED22 9q34.2 0.151 0.249 0.77 regulation of transcription from RNA
mut C9orf116 9q34.3 0.151 0.249 0.77
mut ATP5C1 10p15.1 0.151 0.249 0.77 ATP biosynthetic process;ion
transport
mut ST8SIA6 10p12.33 0.151 0.249 0.77 glycoprotein metabolic
process;glycolipid biosynthetic process
mut ARMC3 10p12.31 0.151 0.249 0.77
mut ENKUR 10p12.1 0.151 0.249 0.77
mut THNSL1 10p12.1 0.151 0.249 0.77 threonine biosynthetic process
mut MASTL 10p12.1 0.151 0.249 0.77 regulation of cell cycle;G2/M transition
mut ACBD5 10p12.1 0.151 0.249 0.77 transport
mut MTPAP 10p11.23 0.151 0.249 0.77 cell death;histone mRNA catabolic process
mut EPC1 10p11 0.151 0.249 0.77 histone H2A acetylation;negative regulation of
mut LRRC18 10q11.23 0.151 0.249 0.77
mut MSMB 10q11.2 0.151 0.249 0.77
mut RTKN2 10q21.2 0.151 0.249 0.77 signal transduction;positive regulation
mut DNAJC12 10q22.1 0.151 0.249 0.77 protein folding
mut AIFM2 10q22.1 0.151 0.249 0.77 apoptotic mitochondrial
mut TBATA 10q22.1 0.151 0.249 0.77
mut P4HA1 10q21.3-q23.1 0.151 0.249 0.77 peptidyl-proline hydroxylation to
mut FAM213A 10q23.1 0.151 0.249 0.77 regulation of osteoclast
mut ANKRD22 10q23.31 0.151 0.249 0.77
mut IFIT1B 0.151 0.249 0.77
mut KIF20B 10q23.31 0.151 0.249 0.77 cell cycle arrest;regulation of
mitosis
mut FRA10AC1 10q23.33 0.151 0.249 0.77
mut PLCE1 10q23 0.151 0.249 0.77 diacylglycerol biosynthetic process;heart
development
mut NOC3L 10q23.33 0.151 0.249 0.77 fat cell differentiation
mut CYP2C18 10q24 0.151 0.249 0.77 xenobiotic metabolic process;small
mut SORBS1 10q23.33 0.151 0.249 0.77 cellular response to insulin
mut CC2D2B 10q24.1 0.151 0.249 0.77
mut PYROXD2 10q24.2 0.151 0.249 0.77
mut HIF1AN 10q24 0.151 0.249 0.77 oxidation-reduction process;regulation of
mut PDCD4 10q24 0.151 0.249 0.77 Apoptosis
mut CCDC186 0.151 0.249 0.77
mut ABLIM1 10q25 0.151 0.249 0.77 axon guidance;visual perception
mut VAX1 10q26.1 0.151 0.249 0.77 camera-type eye development;negative
mut SEC23IP 10q25-q26 0.151 0.249 0.77 intracellular protein
mut WDR11 10q26 0.151 0.249 0.77
mut ATE1 10q26.13 0.151 0.249 0.77 protein arginylation
mut NSMCE4A 10q26.13 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (HR)
mut C10orf120 10q26.13 0.151 0.249 0.77
mut ACADSB 10q26.13 0.151 0.249 0.77 lipid metabolic process;fatty acid
metabolic process
mut ECHS1 10q26.2-q26.3 0.151 0.249 0.77 fatty acid metabolic process;fatty
acid beta-oxidation
mut KCNQ1 11p15.5 0.151 0.249 0.77 synaptic transmission;regulation of
mut RHOG 11p15.5-p15.4 0.151 0.249 0.77 small GTPase mediated signal
mut NLRP14 11p15.4 0.151 0.249 0.77 cell differentiation;multicellular
mut OR5P2 11p15.4 0.151 0.249 0.77 response to stimulus
mut ARNTL 11p15 0.151 0.249 0.77 circadian rhythm;positive regulation of
mut COPB1 11p15.2 0.151 0.249 0.77 COPI coating of Golgi
mut PDE3B 11p15.1 0.151 0.249 0.77 cellular response to insulin
mut NUCB2 11p15.1 0.151 0.249 0.77
mut HPS5 11p14 0.151 0.249 0.77 organelle organization;blood coagulation
mut IGSF22 11p15.1 0.151 0.249 0.77
mut E2F8 11p15.1 0.151 0.249 0.77 cell cycle
mut GAS2 11p14.3 0.151 0.249 0.77 apoptotic process;cellular component
mut FIBIN 11p14.2 0.151 0.249 0.77
mut CAPRIN1 11p13 0.151 0.249 0.77 negative regulation of translation;cell
differentiation
mut API5 11p11.2 0.151 0.249 0.77 Apoptosis
mut TSPAN18 11p11.2 0.151 0.249 0.77
mut CRY2 11p11.2 0.151 0.249 0.77 DNA Damage Response (DDR)
mut ARFGAP2 11p11.2-p11.12 0.151 0.249 0.77 protein transport;vesicle-
mediated transport
mut MTCH2 11p11.2 0.151 0.249 0.77 transport
mut OR4A16 11q11 0.151 0.249 0.77 response to stimulus
mut OR5AK2 11q12.1 0.151 0.249 0.77
mut OR6Q1 0.151 0.249 0.77
mut OR9Q2 0.151 0.249 0.77
mut GLYATL1 11q12.1 0.151 0.249 0.77
mut OR4D11 0.151 0.249 0.77
mut MS4A5 11q12 0.151 0.249 0.77
mut MS4A1 11q12 0.151 0.249 0.77 immune response;B cell activation
mut VWCE 11q12.2 0.151 0.249 0.77
mut TUT1 11q12.2 0.151 0.249 0.77 mRNA polyadenylation;mRNA cleavage
mut GPR137 11cen-q22.3 0.151 0.249 0.77
mut PPP2R5B 11q12 0.151 0.249 0.77 activation of signaling protein activity
mut SF3B2 11q13.1 0.151 0.249 0.77 nuclear mRNA splicing, via
mut SYT12 11q13.2 0.151 0.249 0.77
mut MYEOV 11q13 0.151 0.249 0.77
mut POLD3 11q14 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
mut DGAT2 11q13.5 0.151 0.249 0.77 triglyceride biosynthetic
mut PRKRIR 11q13.5 0.151 0.249 0.77 response to stress;signal
transduction
mut PAK1 11q13-q14 0.151 0.249 0.77 Apoptosis; Protein Kinases
mut MED17 11q14 0.151 0.249 0.77 positive regulation of transcription, DNA-
mut SESN3 11q21 0.151 0.249 0.77 cell cycle arrest
mut MTMR2 11q22 0.151 0.249 0.77 negative regulation of receptor catabolic
process;negative regulation of receptor internalization
mut CEP126 0.151 0.249 0.77
mut MMP20 11q22.3 0.151 0.249 0.77 Apoptosis
mut MMP3 11q22.3 0.151 0.249 0.77 Apoptosis
mut DDI1 11q22.3 0.151 0.249 0.77
mut C11orf65 11q22.3 0.151 0.249 0.77
mut LAYN 11q23.1 0.151 0.249 0.77
mut CRYAB 11q22.3-q23.1 0.151 0.249 0.77 protein folding;anti-apoptosis
mut DRD2 11q23 0.151 0.249 0.77 regulation of sodium ion
transport;intracellular protein kinase cascade
mut CADM1 11q23.2 0.151 0.249 0.77 homophilic cell adhesion;susceptibility
to natural killer cell mediated cytotoxicity
mut SCN4B 11q23.3 0.151 0.249 0.77 ion transport;sodium ion transport
mut OAF 11q23.3 0.151 0.249 0.77
mut CRTAM 11q24.1 0.151 0.249 0.77 positive regulation of natural killer
cell mediated cytotoxicity directed against tumor cell target;cell recognition
mut ETS1 11q23.3 0.151 0.249 0.77 EMT (Mesenchymal); Transcription Factors
mut KCNJ5 11q24 0.151 0.249 0.77 Oncogenes
mut SPATA19 11q25 0.151 0.249 0.77 multicellular organismal
mut DPPA3 0.151 0.249 0.77
mut CLEC4A 12p13 0.151 0.249 0.77 cell adhesion;cell surface receptor
signaling pathway
mut RIMKLB 12p13.31 0.151 0.249 0.77 protein modification process
mut PHC1 12p13 0.151 0.249 0.77 multicellular organismal development
mut CLEC12A 12p13.2 0.151 0.249 0.77
mut CLEC12B 0.151 0.249 0.77
mut CLEC1A 12p13.2 0.151 0.249 0.77 defense response;cell surface
mut OLR1 12p13.2-p12.3 0.151 0.249 0.77 blood circulation;cell death
mut TAS2R10 12p13 0.151 0.249 0.77 response to stimulus;detection of
mut RECQL 12p12 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (HR)
mut CMAS 12p12.1 0.151 0.249 0.77 lipopolysaccharide biosynthetic process
mut LMNTD1 0.151 0.249 0.77 cell proliferation
mut TM7SF3 12q11-q12 0.151 0.249 0.77
mut CCDC91 12p11.22 0.151 0.249 0.77 protein transport
mut TMTC1 12p11.22 0.151 0.249 0.77
mut IPO8 12p11.21 0.151 0.249 0.77 intracellular protein transport;signal
transduction
mut C12orf40 12q12 0.151 0.249 0.77
mut CCNT1 12q13.11 0.151 0.249 0.77 transcription elongation from RNA
mut BCDIN3D 12q13.12 0.151 0.249 0.77
mut GALNT6 12q13 0.151 0.249 0.77 post-translational protein
mut KRT83 12q13 0.151 0.249 0.77 epidermis development
mut C12orf10 12q13 0.151 0.249 0.77 pigmentation
mut PCBP2 12q13.13 0.151 0.249 0.77 mRNA metabolic process;negative
mut CALCOCO1 12q13.13 0.151 0.249 0.77 signal transduction;Wnt receptor
signaling pathway
mut HOXC11 12q13.3 0.151 0.249 0.77 endoderm development;multicellular
mut HOXC9 12q13.3 0.151 0.249 0.77 multicellular organismal development
mut SMUG1 12q13.13 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (BER)
mut OR6C68 0.151 0.249 0.77
mut KIF5A 12q13.13 0.151 0.249 0.77 microtubule-based movement;synaptic
transmission
mut XPOT 12q14.2 0.151 0.249 0.77 tRNA export from nucleus;transport
mut IRAK3 12q14.3 0.151 0.249 0.77 Protein Kinases
mut MDM1 12q15 0.151 0.249 0.77 retina development in camera-type eye
mut PAWR 12q21 0.151 0.249 0.77 Apoptosis
mut NTS 12q21 0.151 0.249 0.77 signal transduction;regulation of blood vessel
size
mut MGAT4C 12q21 0.151 0.249 0.77 cellular protein metabolic
mut C12orf50 12q21.32 0.151 0.249 0.77
mut DCN 12q21.33 0.151 0.249 0.77 peptide cross-linking via chondroitin 4-
sulfate glycosaminoglycan;response to lipopolysaccharide
mut CEP83 0.151 0.249 0.77
mut NR2C1 12q22 0.151 0.249 0.77 positive regulation of retinoic acid receptor
promoter
mut SYCP3 12q 0.151 0.249 0.77 cell division;cell cycle
mut DRAM1 12q23.2 0.151 0.249 0.77 autophagy;apoptotic process
mut PMCH 12q23.2 0.151 0.249 0.77 lactation;negative regulation of blood
pressure
mut HSP90B1 12q24.2-q24.3 0.151 0.249 0.77 protein folding;regulation of
phosphoprotein phosphatase activity
mut KIAA1033 12q24.11 0.151 0.249 0.77 endosome transport
mut RIC8B 12q23.3 0.151 0.249 0.77 regulation of G-protein coupled receptor
mut ALKBH2 12q24.11 0.151 0.249 0.77 DNA Damage Response (DDR); DDR
(Direct Repair)
mut CABP1 12q24.31 0.151 0.249 0.77 negative regulation of catalytic activity
mut UNC119B 12q24.31 0.151 0.249 0.77 cell projection
organization;lipoprotein transport
mut DDX55 12q24.31 0.151 0.249 0.77
mut GLT1D1 12q24.33 0.151 0.249 0.77 biosynthetic process
mut PIWIL1 12q24.33 0.151 0.249 0.77 gene silencing by RNA;piRNA
metabolic process
mut ZMYM5 13q12 0.151 0.249 0.77
mut MICU2 13q12.11 0.151 0.249 0.77
mut PARP4 13q11 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (BER)
mut RNF17 13q12.12 0.151 0.249 0.77 multicellular organismal
mut RASL11A 13q12.2 0.151 0.249 0.77 regulation of transcription, DNA-
mut MTIF3 13q12.2 0.151 0.249 0.77 translation;regulation of translational
initiation
mut LNX2 13q12.2 0.151 0.249 0.77 protein homooligomerization
mut AKAP11 13q14.11 0.151 0.249 0.77 intracellular protein kinase
cascade;regulation of protein kinase A signaling cascade
mut SUCLA2 13q12.2-q13.3 0.151 0.249 0.77 succinate metabolic
process;succinyl-CoA pathway
mut CKAP2 13q14 0.151 0.249 0.77 Apoptosis
mut PCCA 13q32 0.151 0.249 0.77 small molecule metabolic process;fatty acid
beta-oxidation
mut TFDP1 13q34 0.151 0.249 0.77 Apoptosis
mut OR11H4 14q11.2 0.151 0.249 0.77 response to stimulus
mut RNASE13 14q11.1 0.151 0.249 0.77
mut C14orf93 14q11.2 0.151 0.249 0.77
mut LTB4R 14q11.2-q12 0.151 0.249 0.77 cellular component movement;muscle
contraction
mut MIPOL1 14q13.3 0.151 0.249 0.77
mut C14orf28 14q21.2 0.151 0.249 0.77
mut MDGA2 14q21.3 0.151 0.249 0.77 spinal cord motor neuron differentiation
mut PTGDR 14q22.1 0.151 0.249 0.77 G-protein coupled receptor signaling
pathway;male sex determination
mut PTGER2 14q22 0.151 0.249 0.77 G-protein coupled receptor signaling
pathway;regulation of cell proliferation
mut OTX2 14q22.3 0.151 0.249 0.77 axon guidance;primitive streak formation
mut NAA30 14q22.3 0.151 0.249 0.77
mut C14orf105 14q22.3 0.151 0.249 0.77
mut ACTR10 14q23.1 0.151 0.249 0.77 microtubule-based movement
mut PPM1A 14q23.1 0.151 0.249 0.77 insulin receptor signaling
pathway;positive regulation of transcription, DNA-dependent
mut SIX1 14q23.1 0.151 0.249 0.77 regulation of transcription, DNA-
dependent;negative regulation of neuron apoptosis
mut HIF1A 14q23.2 0.151 0.249 0.77 Protein Kinases
mut MAX 14q23 0.151 0.249 0.77 Apoptosis
mut DLST 14q24.3 0.151 0.249 0.77 small molecule metabolic
mut GSTZ1 14q24.3 0.151 0.249 0.77 glutathione metabolic process;aromatic
amino acid family metabolic process
mut ADCK1 14q24.3 0.151 0.249 0.77
mut RPS6KA5 14q31-q32.1 0.151 0.249 0.77 Protein Kinases
mut C14orf159 14q32.11 0.151 0.249 0.77
mut ASB2 14q31-q32 0.151 0.249 0.77 signal transduction;intracellular signal
transduction
mut PPP4R4 14q32.2 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (HR)
mut SERPINA10 14q32.13 0.151 0.249 0.77 regulation of proteolysis;tissue
regeneration
mut SETD3 14q32.2 0.151 0.249 0.77 positive regulation of transcription,
DNA-dependent;histone H3-K36 methylation
mut C14orf2 14q32.33 0.151 0.249 0.77
mut ARHGAP11A 15q13.2 0.151 0.249 0.77 signal transduction;small GTPase
mut PGBD4 15q14 0.151 0.249 0.77
mut FSIP1 15q14 0.151 0.249 0.77
mut PAK6 15q14 0.151 0.249 0.77 Protein Kinases
mut OIP5 15q15.1 0.151 0.249 0.77 cell communication;CenH3-containing
mut VPS39 15q15.1 0.151 0.249 0.77 protein transport
mut TUBGCP4 15q15 0.151 0.249 0.77 G2/M transition of mitotic cell
mut DUOX2 15q15.3 0.151 0.249 0.77 cytokine-mediated signaling pathway;inner
ear development
mut DUOXA2 15q15.1 0.151 0.249 0.77 protein transport
mut DUOX1 15q15.3 0.151 0.249 0.77 response to oxidative stress;oxidation-
reduction process
mut FGF7 15q21.2 0.151 0.249 0.77 insulin receptor signaling pathway;hair
mut LYSMD2 15q21.2 0.151 0.249 0.77 cell wall macromolecule catabolic
process
mut TMOD2 15q21.2 0.151 0.249 0.77 learning or memory;positive regulation of
mut PYGO1 15q21.3 0.151 0.249 0.77 kidney development;post-embryonic
development
mut ZNF280D 15q21.3 0.151 0.249 0.77
mut SLTM 15q22.1 0.151 0.249 0.77 regulation of transcription, DNA-
mut CCNB2 15q22.2 0.151 0.249 0.77 DNA Damage Response (DDR)
mut SMAD3 15q22.33 0.151 0.249 0.77 Apoptosis
mut GRAMD2 15q23 0.151 0.249 0.77
mut BBS4 15q22.3-q23 0.151 0.249 0.77 microtubule cytoskeleton
organization;striatum development
mut ADPGK 15q24.1 0.151 0.249 0.77 glycolysis;carbohydrate metabolic process
mut TBC1D21 15q24.1 0.151 0.249 0.77
mut FBXO22 15q24.2 0.151 0.249 0.77 protein modification
mut TSPAN3 15q24.3 0.151 0.249 0.77
mut HMG20A 15q24 0.151 0.249 0.77 chromatin organization;regulation of
mut DNAJA4 15q25.1 0.151 0.249 0.77 protein folding;response to heat
mut CPEB1 15q25.2 0.151 0.249 0.77 mRNA processing;regulation of translation
mut ANPEP 15q25-q26 0.151 0.249 0.77 cell differentiation;negative regulation
of renal sodium excretion
mut LINS1 0.151 0.249 0.77
mut MEIOB 16p13.3 0.151 0.249 0.77
mut TIGD7 16p13.3 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut SRL 16p13.3 0.151 0.249 0.77
mut TNFRSF17 16p13.1 0.151 0.249 0.77 multicellular organismal
mut CCP110 16p12.3 0.151 0.249 0.77 G2/M transition of mitotic cell
mut ERI2 16p12.3 0.151 0.249 0.77
mut LOC81691 16p12.3 0.151 0.249 0.77
mut SGF29 0.151 0.249 0.77 establishment of protein localization to
mut FAM57B 16p11.2 0.151 0.249 0.77
dependent"
mut BRD7 16q12 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (Chromatin)
mut RBL2 16q12.2 0.151 0.249 0.77 G1 phase of mitotic cell cycle;mitotic
cell cycle
mut AKTIP 16q12.2 0.151 0.249 0.77 positive regulation of protein
binding;early endosome to late endosome transport
mut NUP93 16q13 0.151 0.249 0.77 regulation of glucose transport;protein
transport
mut CSNK2A2 16q21 0.151 0.249 0.77 Protein Kinases
mut CHST4 16q22.2 0.151 0.249 0.77 sulfur compound metabolic
process;cellular component movement
mut RFWD3 16q23.1 0.151 0.249 0.77 DNA repair;response to ionizing radiation
mut DYNLRB2 16q23.3 0.151 0.249 0.77 transport;microtubule-based
movement
mut CENPN 16q23.2 0.151 0.249 0.77 M phase of mitotic cell cycle;mitotic
prometaphase
mut C16orf46 16q23.2 0.151 0.249 0.77
mut WFDC1 16q24.3 0.151 0.249 0.77 negative regulation of cell
growth;response to estradiol stimulus
mut VPS9D1 16q24 0.151 0.249 0.77
mut TSR1 17p13.3 0.151 0.249 0.77 ribosome assembly
mut ASGR2 17p 0.151 0.249 0.77 glycoprotein metabolic process;bone
mineralization
mut TMEM95 17p13.1 0.151 0.249 0.77
mut CHRNB1 17p13.1 0.151 0.249 0.77 behavioral response to
nicotine;postsynaptic membrane organization
mut CYB5D1 17p13.1 0.151 0.249 0.77
mut ADPRM 17p13.1 0.151 0.249 0.77
mut MAP2K4 17p12 0.151 0.249 0.77 Cell Signaling; Protein Kinases; Tumor
Suppressors
mut MYOCD 17p11.2 0.151 0.249 0.77 vasculogenesis;negative regulation of
myotube differentiation
mut SHMT1 17p11.2 0.151 0.249 0.77 one-carbon metabolic process;folic acid
metabolic process
mut RAB34 17q11.2 0.151 0.249 0.77 protein transport;endocytosis
mut CORO6 17q11.2 0.151 0.249 0.77 actin cytoskeleton organization
mut TMEM132E 17q12 0.151 0.249 0.77
mut LIG3 17q11.2-q12 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (BER)
mut KRT26 17q21.2 0.151 0.249 0.77
mut KRT9 17q21.2 0.151 0.249 0.77 skin development;intermediate filament
organization
mut ACLY 17q21.2 0.151 0.249 0.77 energy reserve metabolic process;cellular
mut BECN1 17q21 0.151 0.249 0.77 Apoptosis
mut ETV4 17q21 0.151 0.249 0.77 Transcription Factors
mut DCAKD 17q21.31 0.151 0.249 0.77 coenzyme A biosynthetic process
mut SCPEP1 17q22 0.151 0.249 0.77 proteolysis;retinoic acid metabolic
process
mut TRIM37 17q23.2 0.151 0.249 0.77
mut MED13 17q22-q23 0.151 0.249 0.77 intracellular steroid hormone receptor
mut RGS9 17q24 0.151 0.249 0.77 dopamine receptor signaling pathway;response to
estrogen stimulus
mut CACNG5 17q24 0.151 0.249 0.77 transport;ion transmembrane transport
mut FAM20A 17q24.2 0.151 0.249 0.77
mut ABCA9 17q24.2 0.151 0.249 0.77 ABC Transporters
mut NARF 17q25.3 0.151 0.249 0.77
mut TYMS 18p11.32 0.151 0.249 0.77 DNA Damage Response (DDR)
mut ADCYAP1 18p11 0.151 0.249 0.77 cell-cell signaling;female pregnancy
mut RALBP1 18p11.3 0.151 0.249 0.77 transport;regulation of small
mut GNAL 18p11.22-p11.21 0.151 0.249 0.77 signal transduction;G-protein
mut DSC1 18q12.1 0.151 0.249 0.77 cell adhesion;homophilic cell adhesion
mut DSG3 18q12.1 0.151 0.249 0.77 cellular component disassembly involved
mut CCDC178 18q12.1 0.151 0.249 0.77
mut MOCOS 18q12 0.151 0.249 0.77 molybdopterin cofactor metabolic process;small
mut KATNAL2 18q21.1 0.151 0.249 0.77
mut SMAD2 18q21.1 0.151 0.249 0.77 Apoptosis; Cell Signaling
mut FECH 18q21.3 0.151 0.249 0.77 generation of precursor metabolites and
mut THEG 19p13.3 0.151 0.249 0.77 multicellular organismal
mut RANBP3 19p13.3 0.151 0.249 0.77 protein transport;intracellular
transport
dependent"
dependent"
mut ICAM5 19p13.2 0.151 0.249 0.77 cell-cell adhesion
dependent"
dependent"
dependent"
mut RAD23A 19p13.2 0.151 0.249 0.77 DNA Damage Response (DDR); DDR
(NER)
mut SMIM7 19p13.11 0.151 0.249 0.77
mut ABHD8 19p13.11 0.151 0.249 0.77
mut LRRC25 0.151 0.249 0.77
mut ZNF85 19p12 0.151 0.249 0.77 regulation of transcription, DNA-dependent"
mut ZNF43 19p13.1-p12 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut HAMP 19q13.1 0.151 0.249 0.77
dependent"
dependent"
mut ZNF585A 19q13.12 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut DLL3 19q13 0.151 0.249 0.77 tissue development;cell differentiation
mut ZNF155 19q13.2-q13.32 0.151 0.249 0.77 regulation of transcription,
DNA-dependent"
mut ZNF224 19q13.2 0.151 0.249 0.77 negative regulation of
mut MAMSTR 19q13.33 0.151 0.249 0.77 regulation of transcription, DNA-
mut KLK12 19q13.33 0.151 0.249 0.77 proteolysis
dependent"
dependent"
mut VN1R1 19q13.4 0.151 0.249 0.77 response to pheromone
mut ZSCAN18 19q13.43 0.151 0.249 0.77 viral reproduction
mut STK35 20p13 0.151 0.249 0.77
mut ZNF343 20p13 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut BMP2 20p12 0.151 0.249 0.77 positive regulation of protein
phosphorylation;cell-cell signaling
mut SUN5 20q11.21 0.151 0.249 0.77 spermatogenesis
mut UQCC1 0.151 0.249 0.77
mut GHRH 20q11.2 0.151 0.249 0.77
mut SEMG2 20q12-q13.1 0.151 0.249 0.77
dependent"
mut OSBPL2 20q13.3 0.151 0.249 0.77 transport;lipid transport
mut PCMTD2 20q13.33 0.151 0.249 0.77 protein modification process
mut CLDN8 21q22.11 0.151 0.249 0.77 calcium-independent cell-cell adhesion
mut KRTAP24-1 0.151 0.249 0.77
mut KRTAP13-3 0.151 0.249 0.77
mut TCP10L 21q22.11 0.151 0.249 0.77
mut DNAJC28 21q22.11 0.151 0.249 0.77
mut CBR3 21q22.2 0.151 0.249 0.77 phylloquinone catabolic process
mut B3GALT5 21q22.3 0.151 0.249 0.77 protein glycosylation
mut MX2 21q22.3 0.151 0.249 0.77 GTP catabolic process;defense response
mut AGPAT3 21q22.3 0.151 0.249 0.77 metabolic process;phospholipid
mut DGCR8 22q11.2 0.151 0.249 0.77 primary miRNA processing
mut SUSD2 22q11-q12 0.151 0.249 0.77 immune response
mut ADRBK2 22q12.1 0.151 0.249 0.77 protein phosphorylation;signal
transduction
mut CABP7 22q12.2 0.151 0.249 0.77
mut ASCC2 22q12.1 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut YWHAH 22q12.3 0.151 0.249 0.77 Apoptosis
mut FBXO7 22q12.3 0.151 0.249 0.77 protein ubiquitination;regulation of
protein stability
mut EIF3L 22q 0.151 0.249 0.77 translational initiation
mut PICK1 22q13.1 0.151 0.249 0.77 protein phosphorylation;receptor
clustering
mut NDUFA6 22q13.2 0.151 0.249 0.77 response to oxidative
mut TLR7 Xp22.3 0.151 0.249 0.77 microglial cell activation involved in
immune response;positive regulation of NF-kappaB import into nucleus
mut ASB9 Xp22.2 0.151 0.249 0.77 protein ubiquitination;intracellular
signal transduction
mut ASB11 Xp22.31 0.151 0.249 0.77 intracellular signal transduction
mut PIGA Xp22.1 0.151 0.249 0.77 cellular protein metabolic process;C-
mut MAP3K15 Xp22.12 0.151 0.249 0.77 Protein Kinases
mut SH3KBP1 Xp22.1-p21.3 0.151 0.249 0.77 cell-cell
signaling;regulation of cell shape
mut SMS Xp22.1 0.151 0.249 0.77 methionine metabolic process;polyamine
metabolic process
mut ACOT9 Xp22.11 0.151 0.249 0.77 acyl-CoA metabolic process
mut PCYT1B Xp22.11 0.151 0.249 0.77 CDP-choline pathway;spermatogenesis
mut ARX Xp21.3 0.151 0.249 0.77 axon guidance;regulation of cell
proliferation
mut MAGEB2 Xp21.3 0.151 0.249 0.77
mut MAGEB4 0.151 0.249 0.77
mut GK Xp21.3 0.151 0.249 0.77 glycerol metabolic process;triglyceride
metabolic process
mut MAGEB16 0.151 0.249 0.77
mut CASK Xp11.4 0.151 0.249 0.77 negative regulation of wound
mut MAOA Xp11.3 0.151 0.249 0.77 neurotransmitter secretion;behavior
mut DUSP21 Xp11.4-p11.23 0.151 0.249 0.77 peptidyl-tyrosine
dephosphorylation
mut KDM6A Xp11.2 0.151 0.249 0.77 Tumor Suppressors
mut SLC9A7 Xp11.3 0.151 0.249 0.77 Solute Carriers
mut ZNF81 Xp11.23 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut HDAC6 Xp11.23 0.151 0.249 0.77 response to toxin;chromatin modification
mut PQBP1 Xp11.23 0.151 0.249 0.77 regulation of transcription, DNA-
dependent"
mut CLCN5 Xp11.23-p11.22 0.151 0.249 0.77 transport;ion transport
mut BMP15 Xp11.2 0.151 0.249 0.77 ovarian follicle development;female
gamete generation
mut SMC1A Xp11.22-p11.21 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (DNA
replication)
mut FAM120C Xp11.22 0.151 0.249 0.77
mut PFKFB1 Xp11.21 0.151 0.249 0.77 Apoptosis
mut RRAGB Xp11.21 0.151 0.249 0.77 signal transduction;positive regulation
of TOR signaling cascade
mut P2RY4 0.151 0.249 0.77
mut SNX12 Xq13.1 0.151 0.249 0.77 cell communication;protein transport
mut NONO Xq13.1 0.151 0.249 0.77 DNA repair;DNA recombination
mut ACRC Xq13.1 0.151 0.249 0.77
mut ERCC6L Xq13.1 0.151 0.249 0.77 mitotic prometaphase;mitotic cell
cycle
mut UPRT Xq13.3 0.151 0.249 0.77
mut MAGT1 Xq21.1 0.151 0.249 0.77 protein N-linked glycosylation;transport
mut SH3BGRL Xq13.3 0.151 0.249 0.77
mut RPS6KA6 Xq21 0.151 0.249 0.77 Protein Kinases
mut CHM Xq21.2 0.151 0.249 0.77 protein geranylgeranylation;response to
stimulus
mut NAP1L3 Xq21.3-q22 0.151 0.249 0.77 nucleosome assembly
mut TNMD Xq21.33-q23 0.151 0.249 0.77 endothelial cell morphogenesis;negative
regulation of endothelial cell proliferation
mut ARMCX5 Xq22.1-q22.3 0.151 0.249 0.77
mut GLRA4 Xq22.2 0.151 0.249 0.77 ion transport
mut RAB9B Xq22.1-q22.3 0.151 0.249 0.77 small GTPase mediated signal
mut TBC1D8B Xq22.3 0.151 0.249 0.77
mut CAPN6 Xq23 0.151 0.249 0.77 microtubule bundle formation;proteolysis
mut IL13RA1 Xq24 0.151 0.249 0.77 cell surface receptor signaling pathway
mut UPF3B Xq25-q26 0.151 0.249 0.77 transport;nucleocytoplasmic transport
mut NKAP Xq24 0.151 0.249 0.77 Notch signaling pathway;negative regulation of
mut ATP1B4 Xq24 0.151 0.249 0.77 transport;potassium ion transport
mut LAMP2 Xq24 0.151 0.249 0.77 platelet activation;platelet degranulation
mut C1GALT1C1 Xq24 0.151 0.249 0.77 post-translational protein
mut DCAF12L2 Xq25 0.151 0.249 0.77
mut AIFM1 Xq26.1 0.151 0.249 0.77 Apoptosis
mut USP26 Xq26.2 0.151 0.249 0.77
mut FAM122B Xq26.3 0.151 0.249 0.77
mut DDX26B Xq26.3 0.151 0.249 0.77
mut SAGE1 Xq26 0.151 0.249 0.77
mut BRS3 0.151 0.249 0.77 glucose metabolic process;regulation of blood
pressure
mut FGF13 Xq26.3 0.151 0.249 0.77 positive regulation of protein
mut F9 Xq27.1-q27.2 0.151 0.249 0.77
mut ATP11C Xq27.1 0.151 0.249 0.77 cation transport;ion transmembrane
transport
mut FMR1 Xq27.3 0.151 0.249 0.77 transport;central nervous system
development
mut FMR1NB Xq28 0.151 0.249 0.77
mut MAMLD1 Xq28 0.151 0.249 0.77 regulation of transcription, DNA-
mut MTMR1 Xq28 0.151 0.249 0.77
mut CETN2 Xq28 0.151 0.249 0.77 DNA Damage Response (DDR); DDR (NER)
mut HAUS7 Xq28 0.151 0.249 0.77 mitosis;spindle assembly
mut FAM50A Xq28 0.151 0.249 0.77 spermatogenesis
mut CLIC2 Xq28 0.151 0.249 0.77 chloride transport;signal transduction
mut RPF1 1p22.3 0.151 0.249 0.77 rRNA processing
mut LRRC8D 1p22.2 0.151 0.249 0.77
mut PIGM 1q23.2 0.151 0.249 0.77 C-terminal protein lipidation;preassembly
mut TAF1A 1q42 0.151 0.249 0.77 transcription from RNA polymerase I
mut C2orf49 2q12.1 0.151 0.249 0.77 embryonic morphogenesis
mut WDSUB1 2q24.2 0.151 0.249 0.77
mut SPAG16 2q34 0.151 0.249 0.77 cell projection organization;cilium
assembly
mut MITF 3p14.2-p14.1 0.151 0.249 0.77 multicellular organismal
mut RAB7A 3q21.3 0.151 0.249 0.77 endosome to lysosome transport;protein
transport
mut KCNMB2 3q26.32 0.151 0.249 0.77 regulation of action potential in
neuron;regulation of vasoconstriction
mut KIT 4q12 0.151 0.249 0.77 Cell Signaling; Oncogenes; Protein Kinases
mut ETFDH 4q32-q35 0.151 0.249 0.77 transport;response to oxidative stress
mut NDUFAF2 5q12.1 0.151 0.249 0.77
mut NUP43 6q25.1 0.151 0.249 0.77 mitotic cell cycle;cytokine-mediated
signaling pathway
mut SYT9 11p15.4 0.151 0.249 0.77 regulation of calcium ion-dependent
mut TMEM136 11q23.3 0.151 0.249 0.77
mut CLEC4E 12p13.31 0.151 0.249 0.77 immune response;positive regulation
of cytokine secretion
mut PRKAG1 12q12-q14 0.151 0.249 0.77 positive regulation of protein
kinase activity;regulation of glycolysis
mut CBX5 12q13.13 0.151 0.249 0.77 blood coagulation;interspecies
mut GNS 12q14 0.151 0.249 0.77 glycosaminoglycan catabolic process;keratan
sulfate catabolic process
mut COCH 14q11.2-q13 0.151 0.249 0.77 sensory perception of sound
mut APOPT1 14q32.33 0.151 0.249 0.77 positive regulation of release of
cytochrome c from mitochondria;induction of apoptosis by intracellular signals
mut PPM1D 17q23.2 0.151 0.249 0.77 DNA Damage Response (DDR)
mut BIRC5 17q25 0.151 0.249 0.77 Apoptosis
mut TIMP2 17q25 0.151 0.249 0.77 negative regulation of cell
mut HRH4 18q11.2 0.151 0.249 0.77 inflammatory response
dependent"
mut SPEF1 20p13 0.151 0.249 0.77
mut PANK2 20p13 0.151 0.249 0.77 coenzyme A biosynthetic process;pantothenate
metabolic process
exp KIAA0100 17q11.2 0.151 0.249 0.77
xsq TSPYL5 8q22.1 0.151 0.249 0.77 nucleosome assembly;positive
xsq LOC100507472 0.151 0.249 0.77
xsq MPEG1 11q12.1 0.151 0.249 0.77
met HPSE2 10q23-q24 0.151 0.249 0.77 carbohydrate metabolic process
xsq SNORA37 18q21.2 0.151 0.249 0.77
xsq EIF3M 11p13 0.151 0.249 0.77 translational initiation
xsq CYB5R2 11p15.4 -0.151 0.249 0.77 sterol biosynthetic
met UNC45A 15q26.1 -0.151 0.249 0.77 cell
exp LRRN4 20p12.3 -0.151 0.249 0.77
xsq ADIG 20q11.23 -0.151 0.249 0.77 positive regulation of fat cell
differentiation;white fat cell differentiation
xsq LOC100507144 -0.151 0.249 0.77
xsq LINC00900 11q23.3 -0.151 0.249 0.77
cop FAM9B Xp22.32 -0.151 0.249 0.77
xsq IGFBP1 7p12.3 -0.151 0.249 0.77 positive regulation of cell
met PPM1N 19q13.32 -0.151 0.249 0.77
xsq ADGRL3 -0.151 0.249 0.77 G-protein coupled receptor
met CNN2 19p13.3 -0.151 0.249 0.77 actomyosin structure
organization;regulation of actin filament-based process
xsq TRIM45 1p13.1 -0.151 0.249 0.77
exp NMNAT2 1q25 -0.151 0.249 0.77 vitamin metabolic process;water-
cop GNB1L 22q11.2 -0.151 0.249 0.77 G-protein coupled receptor
exp LINC00969 -0.151 0.249 0.77
exp CGN 1q21 -0.151 0.249 0.77
exp MSRB2 10p12 -0.151 0.249 0.77 regulation of transcription, DNA-
cop LOC646719 5p13.2 -0.151 0.249 0.77
met CCDC74A 2q21.1 -0.151 0.249 0.77
xsq PAMR1 11p13 -0.151 0.249 0.77
exp EPHA3 3p11.2 -0.151 0.249 0.77 Cell Signaling
exp SMIM14 4p14 -0.151 0.249 0.77
met DOCK3 3p21.2 -0.151 0.249 0.77
exp GOLGA6L16P -0.151 0.249 0.77
xsq UGT2B11 4q13.2 -0.151 0.249 0.77
xsq PLN 6q22.1 -0.151 0.249 0.77 regulation of the force of heart
contraction;cellular calcium ion homeostasis
xsq ARSE Xp22.3 -0.151 0.249 0.77 skeletal system development
exp CCNA1 13q12.3-q13 -0.151 0.249 0.77 DNA Damage Response (DDR)
xsq NPR1 1q21-q22 -0.151 0.249 0.77 body fluid secretion;regulation of
vasodilation
xsq PI4K2A 10q24 -0.151 0.249 0.77 phosphatidylinositol biosynthetic
process
exp SOWAHA 5q31.1 -0.151 0.249 0.77
xsq LOC101929473 -0.151 0.249 0.77
exp CYB5R2 11p15.4 -0.151 0.249 0.77 sterol biosynthetic
exp PI4KA 22q11.21 -0.151 0.249 0.77 phosphatidylinositol-mediated
exp LOC285556 4q23 -0.151 0.249 0.77
his LINC00309 -0.152 0.249 0.77
his HNF1B 17q12 -0.152 0.249 0.77 regulation of Wnt receptor signaling
his ACMSD 2q21.3 -0.152 0.249 0.77 quinolinate metabolic
exp TSGA10IP 11q13.1 -0.152 0.249 0.77
his ZBTB18 1q44 -0.152 0.249 0.77
xai ANKRD20A12P -0.152 0.249 0.77
his TNFRSF10C 8p22-p21 -0.152 0.249 0.77 Apoptosis
his LOC101929095 -0.152 0.249 0.77
swa TMOD3 15q21.1-q21.2 -0.152 0.249 0.77
his LAPTM4B 8q22.1 -0.152 0.249 0.77 transport
xai PLAT 8p12 -0.152 0.249 0.77 protein modification process;proteolysis
xai EMX2OS 10q26.1 -0.152 0.249 0.77
xai PGAP3 17q12 -0.152 0.249 0.77 GPI anchor metabolic process;GPI anchor
exp KRT8P22 16q23.1 -0.152 0.249 0.77
xai SSMEM1 7q32.2 -0.152 0.249 0.77
xai DGCR5 22q11 -0.152 0.249 0.77
swa ALYREF 17q25.3 -0.152 0.249 0.77 gene expression;mRNA 3'-end
processing
hs4 SFTA3 14q13.3 -0.152 0.249 0.77
hs4 NKX2-1 14q13 -0.152 0.249 0.77 endoderm development;hippocampus
development
hs4 NKX2-1-AS1 -0.152 0.249 0.77
xai RABAC1 19q13.2 -0.153 0.249 0.77
hs4 PTCHD4 6p12.3 -0.153 0.249 0.77
xai TUBB 6p21.33 -0.153 0.249 0.77 Apoptosis
xai VPS53 17p13.3 -0.153 0.249 0.77 protein transport
xai LOC642633 -0.153 0.249 0.77
hs4 CLCN5 Xp11.23-p11.22 -0.153 0.249 0.77 transport;ion transport
hs4 PRRX1 1q24 -0.153 0.249 0.77 multicellular organismal development
xai LINC00601 -0.153 0.249 0.77
hs4 MT1M 16q13 -0.153 0.249 0.77 negative regulation of growth
hs4 ZSCAN20 1p34.3 -0.153 0.249 0.77 viral reproduction
xai CHPF 2q35 -0.153 0.249 0.77
hs4 LINC01320 -0.153 0.249 0.77
his ADAMTS5 21q21.3 -0.153 0.249 0.77 proteolysis
xai AP4S1 14q12 0.152 0.25 0.77 transport
his SLTM 15q22.1 0.152 0.25 0.77 regulation of transcription, DNA-
exp RPS16P5 6p12.1 0.152 0.25 0.77
exp OR2L8 0.152 0.25 0.77 response to stimulus
swa C15orf48 15q21.1 0.152 0.25 0.77
xai LOC100128233 0.152 0.25 0.77
his MTHFD2P1 3q11.2 0.152 0.25 0.77
his TMEM165 4q12 0.152 0.25 0.77
dependent"
xai GRAMD4P2 0.152 0.25 0.771
xai PRKACB 1p31.1 0.152 0.25 0.771 Protein Kinases
xai HTR6 1p36-p35 0.152 0.25 0.771 synaptic transmission;G-protein
dependent"
his LINC02049 0.152 0.25 0.771
xai LOC100506325 0.152 0.25 0.771
his CLCN1 7q35 0.152 0.25 0.771 transmembrane transport;transport
xai OR2L8 0.152 0.25 0.771 response to stimulus
hs4 IQCB1 3q13.33 0.152 0.25 0.771 cilium assembly;photoreceptor cell
maintenance
hs4 EAF2 3q13.33 0.152 0.25 0.771 induction of apoptosis;negative
xai CACNG7 19q13.4 0.152 0.25 0.771 ion transport;calcium ion transport
hs4 PLEK 2p13.3 0.152 0.25 0.771 integrin-mediated signaling
hs4 KIAA2013 1p36.22 0.152 0.25 0.771
xai NOS2P1 17q11.2 0.152 0.25 0.771
his VHL 3p25.3 0.152 0.25 0.771 Protein Kinases; Tumor Suppressors
xai GCLC 6p12 0.152 0.25 0.771 response to heat;small molecule metabolic
process
xai OR5G3 11q12.1 0.152 0.25 0.771
mut CCDC73 11p13 0.151 0.25 0.77
exp PTP4A1 6q12 0.151 0.25 0.77 multicellular organismal
cop FAM81A 15q22.2 0.151 0.25 0.77
xsq OR2A5 0.151 0.25 0.77
xsq SKA1 18q21.1 0.151 0.25 0.77 mitosis;regulation of microtubule
met CC2D1A 19p13.12 0.151 0.25 0.77 regulation of transcription, DNA-
mut TNRC6A 16p11.2 0.151 0.25 0.77 gene silencing by RNA;negative
regulation of translation involved in gene silencing by miRNA
exp LOC727941 0.151 0.25 0.77
exp WIPF1 2q31.1 0.151 0.25 0.77 positive regulation of protein export
from nucleus;protein complex assembly
xsq FOXO3B 17p11.2 0.151 0.25 0.77
xsq LRRC3C 0.151 0.25 0.77
cop STX17 9q31.1 0.151 0.25 0.77 intracellular protein transport;vesicle-
mediated transport
cop PSTPIP1 15q24.3 0.151 0.25 0.77 cell adhesion;signal transduction
cop TSPAN3 15q24.3 0.151 0.25 0.77
xsq TIFA 4q25 0.151 0.25 0.77 I-kappaB kinase/NF-kappaB cascade
exp FAM135B 8q24.23 0.151 0.25 0.77
xsq RPL32P3 3q21.3 0.151 0.25 0.77
xsq PPIL3 2q33.1 0.151 0.25 0.77 protein folding;RNA splicing
met KLHDC7A 1p36.13 0.151 0.25 0.77
xsq LRRC37B 0.151 0.25 0.77
xsq GRSF1 4q13 0.151 0.25 0.771 morphogenesis of embryonic epithelium;mRNA
polyadenylation
xsq NOC3L 10q23.33 0.151 0.25 0.771 fat cell differentiation
xsq C1orf159 1p36.33 0.151 0.25 0.771
exp RBL1 20q11.2 0.151 0.25 0.771 G1 phase of mitotic cell cycle;negative
mut ITGA1 5q11.2 0.151 0.25 0.771 activation of MAPK activity;positive
cop RCN2 15q23 0.151 0.25 0.771
cop SRD5A2 2p23 0.151 0.25 0.771 androgen biosynthetic process;cell-cell
signaling
exp MTHFD1L 6q25.1 0.151 0.25 0.771 one-carbon metabolic process;folic
mut BPTF 17q24.3 0.151 0.25 0.771 chromatin remodeling;transcription, DNA-
dependent
met ACTN1 14q24 0.151 0.25 0.771 Apoptosis
xsq ANXA11 10q23 0.151 0.25 0.771 phagocytosis;cell cycle
met SPINK2 4q12 0.151 0.25 0.771 negative regulation of endopeptidase
activity
cop FGD5 3p25.1 0.151 0.25 0.771 actin cytoskeleton
xsq MARCKSL1 1p35.1 0.151 0.25 0.771 positive regulation of cell
xsq LINC00922 16q21 0.151 0.25 0.771
met LAYN 11q23.1 0.151 0.25 0.771
xsq C11orf53 11q23.1 0.151 0.25 0.771
exp NR5A2 1q32.1 0.151 0.25 0.771 gene expression;intracellular receptor
xsq LOC400794 1q23.3-q24.1 0.151 0.25 0.771
exp ZCCHC11 1p32.3 0.151 0.25 0.771 cytokine production;negative
exp TBCA 5q14.1 0.151 0.25 0.771 'de novo' posttranslational protein
cop PPM1E 17q22 0.151 0.25 0.771 negative regulation of protein kinase
cop TRIM37 17q23.2 0.151 0.25 0.771
xsq GJC3 7q22.1 0.151 0.25 0.771 myelination;cell communication
met DPF3 14q24.2 0.151 0.25 0.771 regulation of transcription, DNA-
dependent;nervous system development
met SNAI3 16q24.3 0.151 0.25 0.771
met TMEM63B 6p21.1 0.151 0.25 0.771
xsq TMEM257 Xq27.3 -0.151 0.25 0.771
exp NMRK2 19p13.3 -0.151 0.25 0.771
mut DIS3L2 2q37.1 -0.151 0.25 0.771
DNA-dependent"
xsq NUCB1 19q13.33 -0.151 0.25 0.771
xsq FGF1 5q31 -0.151 0.25 0.771 positive regulation of protein
xsq MMP24 20q11.2 -0.151 0.25 0.771 Apoptosis
xsq MOCS1 6p21.3 -0.151 0.25 0.771 vitamin metabolic process;water-
met CCL24 7q11.23 -0.151 0.25 0.771 inflammatory response;positive
regulation of Rac GTPase activity
DNA-dependent"
met LYPLAL1 1q41 -0.151 0.25 0.771
xsq C9orf173 -0.151 0.25 0.771
met LINC00523 14q32.2 -0.151 0.25 0.771
exp TBC1D8B Xq22.3 -0.151 0.25 0.771
cop RAD23B 9q31.2 -0.151 0.25 0.771 DNA Damage Response (DDR);
DDR (NER)
met SNRNP35 12q24.31 -0.151 0.25 0.77 mRNA processing;RNA splicing
mut TMPRSS4 11q23.3 -0.151 0.25 0.77 proteolysis
xsq CAPN6 Xq23 -0.151 0.25 0.77 microtubule bundle formation;proteolysis
cop TANGO2 22q11.21 -0.151 0.25 0.77
met SCGB1A1 11q12.3 -0.151 0.25 0.77 negative regulation of
interleukin-4 production;negative regulation of interleukin-5 production
exp KRT18P43 -0.151 0.25 0.77
mut FASTK 7q35 -0.151 0.25 0.77 apoptotic process;induction of apoptosis
xsq ACO1 9p21.1 -0.151 0.25 0.77 response to iron(II) ion;regulation
of gene expression
met C16orf92 16p11.2 -0.151 0.25 0.77
xsq LOC101928495 -0.151 0.25 0.77
exp FAM92A1P2 4q35.1 -0.151 0.25 0.77
exp OXR1 8q23 -0.151 0.25 0.77 response to oxidative stress;cell wall
hs4 PLBD2 12q24.13 -0.152 0.25 0.771 lipid catabolic process
his LINC01033 -0.152 0.25 0.771
hs4 FJX1 11p13 -0.152 0.25 0.771
xai PHOX2B 4p12 -0.152 0.25 0.771 Tumor Suppressors
hs4 MCOLN3 1p22.3 -0.152 0.25 0.771 ion transport;sensory
perception of sound
xai LOC100128697 -0.152 0.25 0.771
hs4 LINC02079 -0.152 0.25 0.771
hs4 LRRC37A11P 17q12 -0.152 0.25 0.771
xai PSG10P 19q13.2 -0.152 0.25 0.771
xai HOXC9 12q13.3 -0.152 0.25 0.771 multicellular organismal
development
hs4 AFF4 5q31 -0.152 0.25 0.771 spermatid development;regulation of
hs4 FAM220A 7p22.1 -0.152 0.25 0.771
hs4 LOC105369739 -0.152 0.25 0.771
hs4 ITGBL1 13q33 -0.152 0.25 0.771 integrin-mediated signaling
hs4 C16orf62 16p12.3 -0.152 0.25 0.771
xai ZYX 7q32 -0.152 0.25 0.77 signal transduction;cell-cell signaling
xai CLEC10A 17p13.1 -0.152 0.25 0.77 endocytosis;innate immune
response
xai TEKT5 16p13.13 -0.152 0.25 0.77 microtubule cytoskeleton
organization
cop LOC339568 20q12 -0.152 0.25 0.77
his HEPACAM 11q24.2 -0.152 0.25 0.77 cell cycle;cell cycle arrest
xai SLC16A2 Xq13.2 -0.152 0.25 0.77 Solute Carriers
exp LOC100128697 -0.152 0.25 0.77
xai PRSS27 16p13.3 -0.152 0.25 0.77 proteolysis
hs4 PRCD 17q25.1 -0.152 0.25 0.77 visual perception;response to
stimulus
mda Microsatellite_instability 0.153 0.251 0.772
cop MIR1203 0.153 0.251 0.772
xai OR11J5P 0.152 0.251 0.772
xai FAM120AOS 9q22.31 0.152 0.251 0.772
his MRPS21 1q21 0.152 0.251 0.772 translation
exp LOC100506217 0.152 0.251 0.772
hs4 PPP1R35 7q22.1 0.152 0.251 0.772 negative regulation of phosphatase
activity
xai CDK9 9q34.1 0.152 0.251 0.772 Protein Kinases
hs4 LOC105274304 0.152 0.251 0.772
xai NOP10 15q14-q15 0.152 0.251 0.772 DNA Damage Response (DDR)
his PIGR 1q31-q41 0.152 0.251 0.772
his DNM1P35 15q24.2 0.152 0.251 0.772
his SKIDA1 10p12.31 0.152 0.251 0.772
his MLLT10 10p12 0.152 0.251 0.772 regulation of transcription, DNA-
his GUSBP11 22q11.23 0.152 0.251 0.772
xai MED13 17q22-q23 0.152 0.251 0.772 intracellular steroid hormone receptor
exp CENPIP1 0.152 0.251 0.772
his INTS11 0.152 0.251 0.772
his CPTP 0.152 0.251 0.772
xai LOC100506217 0.152 0.251 0.772
his PRPF18 10p13 0.152 0.251 0.772 mRNA processing;RNA splicing
hs4 TEC 4p12 0.152 0.251 0.772 protein phosphorylation;integrin-mediated
signaling pathway
xai LOC100507560 0.152 0.251 0.772
xai UFL1 6q16.1 0.152 0.251 0.772 negative regulation of protein
xai PBX2P1 3q24 0.152 0.251 0.772
met TADA2B 4p16.1 0.151 0.251 0.771 regulation of transcription, DNA-
dependent"
xsq LINC00238 14q23.3 0.151 0.251 0.771
mut MARVELD2 5q13.2 0.151 0.251 0.771 sensory perception of sound
exp SULT1A1 16p12.1 0.151 0.251 0.771 sulfation;catecholamine metabolic
process
cop MIR548H4 0.151 0.251 0.771
xsq GGTLC1 20p11.1 0.151 0.251 0.771 glutathione metabolic
cop LOC645166 0.151 0.251 0.771
exp RAB40C 16p13.3 0.151 0.251 0.772 small GTPase mediated signal
xsq BTBD6 14q32 0.151 0.251 0.772
xsq BPIFB3 20q11.21 0.151 0.251 0.772 innate immune response
exp DGAT1 8q24.3 0.151 0.251 0.772 triglyceride metabolic
met IGSF5 21q22.2 0.151 0.251 0.772
xsq ING4 12p13.31 0.151 0.251 0.772 Tumor Suppressors
cop MIR4312 0.151 0.251 0.772
cop ANP32A-IT1 15q23 0.151 0.251 0.772
cop SPESP1 15q23 0.151 0.251 0.772 multicellular organismal development
xsq C16orf87 16q11.2 0.151 0.251 0.772
xsq MNX1 7q36 0.151 0.251 0.772 regulation of transcription from RNA polymerase
exp NOL6 9p13.3 0.151 0.251 0.772 rRNA processing
mut ANGPTL5 11q22.1 0.151 0.251 0.772 signal transduction
xsq SATB2-AS1 0.151 0.251 0.772
xsq SDHA 5p15 0.151 0.251 0.772 small molecule metabolic process;oxidation-
reduction process
xsq MRPL53 2p13.1 0.151 0.251 0.772
exp ZDHHC11B 5p15.33 0.151 0.251 0.772
exp PPIAP21 20q12 0.151 0.251 0.772
xsq CXorf49B 0.151 0.251 0.772
xsq GH2 0.151 0.251 0.772
xsq LOC101927972 0.151 0.251 0.772
met STK24 13q31.2-q32.3 0.151 0.251 0.772 protein autophosphorylation;protein
phosphorylation
xsq DPY19L1P1 7p14.3 0.151 0.251 0.772
dependent"
exp EIF2A 3q25.1 0.15 0.251 0.772 translational initiation;regulation of
translation
met CCDC142 2p13.1 0.15 0.251 0.772
xsq PRAMEF12 1p36.21 0.15 0.251 0.772
xsq HBS1L 6q23.3 0.15 0.251 0.772 signal transduction;translation
cop ANKRD36BP2 2p11.2 0.15 0.251 0.772
cop MIR4436A 0.15 0.251 0.772
mut CS 12q13.2 0.15 0.251 0.772 small molecule metabolic
dependent"
cop LOC400655 0.15 0.251 0.772
cop HAAO 2p21 0.15 0.251 0.772 small molecule metabolic process;response to
cadmium ion
met TTC9 14q24.2 0.15 0.251 0.772
xsq NSUN5P1 0.15 0.251 0.772
met C1orf115 1q41 0.15 0.251 0.772
xsq PPIAL4A 0.15 0.251 0.772
cop C10orf55 10q22.2 0.15 0.251 0.772
cop PLAU 10q22.2 0.15 0.251 0.772 response to hypoxia;regulation of cell
adhesion mediated by integrin
met ZNF354B 5q35.3 0.15 0.251 0.772 regulation of transcription, DNA-
dependent"
mir hsa-miR-501-5p 0.15 0.251 0.772
met KLF5 13q22.1 0.15 0.251 0.772 microvillus assembly;positive regulation
xsq LOC101927189 0.15 0.251 0.772
cop MRPL27 17q21.3-q22 0.15 0.251 0.772 translation
cop EME1 17q21.33 0.15 0.251 0.772 DNA Damage Response (DDR); DDR (HR); DDR
(DNA replication)
cop LRRC59 17q21.33 0.15 0.251 0.772
cop ACSF2 17q21.33 0.15 0.251 0.772 lipid metabolic process;fatty acid
metabolic process
cop CHAD 17q21.33 0.15 0.251 0.772 regulation of cell growth
cop RSAD1 17q21.33 0.15 0.251 0.772 porphyrin-containing compound
met TOPAZ1 3p21.31 0.15 0.251 0.772
xsq CNOT2 12q15 0.15 0.251 0.772 RNA metabolic process;mRNA metabolic process
cop PLB1 2p23.2 0.15 0.251 0.772 retinoid metabolic process;steroid
metabolic process
xsq LOC101927079 0.15 0.251 0.772
xsq OR4D11 0.15 0.251 0.772
xsq SMARCE1 17q21.2 0.15 0.251 0.772 DNA Damage Response (DDR); DDR
(Chromatin)
xsq SIKE1 1p13.2 0.15 0.251 0.772 innate immune response
xsq BTF3 5q13.2 0.15 0.251 0.772 in utero embryonic development;regulation
exp AGO2 8q24 0.15 0.251 0.772
met WDR64 1q43 0.15 0.251 0.772
xsq TRAPPC5 19p13.2 0.15 0.251 0.772 vesicle-mediated transport
xsq LOC100506207 -0.15 0.251 0.772
exp IFIT1 10q23.31 -0.15 0.251 0.772 negative regulation of viral genome
met RPP25 15q24.2 -0.15 0.251 0.772 tRNA processing
xsq DNASE2 19p13.2 -0.15 0.251 0.772 Apoptosis
met RHOH 4p13 -0.15 0.251 0.772 regulation of transcription, DNA-
xsq LOC100505622 -0.15 0.251 0.772
cop RYK 3q22 -0.15 0.251 0.772 Wnt receptor signaling pathway;commissural
neuron axon guidance
exp HOXA-AS2 7p15.2 -0.15 0.251 0.772
met NSD1 5q35 -0.15 0.251 0.772 negative regulation of transcription from RNA
exp KRT18P46 2q24.2 -0.15 0.251 0.772
exp LOC728825 Xq23 -0.15 0.251 0.772
exp SDF2 17q11.2 -0.15 0.251 0.772 protein glycosylation
exp RNF216 7p22.1 -0.15 0.251 0.772 interspecies interaction between
organisms;regulation of defense response to virus by host
met CSDC2 22q13.2 -0.15 0.251 0.772 regulation of transcription, DNA-
met TNIP2 4p16.3 -0.15 0.251 0.772 Apoptosis
exp KCNIP4 4p15.32 -0.15 0.251 0.772 ion transport;potassium ion
transport
met KLF13 15q12 -0.15 0.251 0.772 negative regulation of cell
cop LMBRD2 5p13.2 -0.15 0.251 0.772
cop MIR580 -0.15 0.251 0.772
cop SKP2 5p13 -0.15 0.251 0.772 G1/S transition of mitotic cell cycle;anaphase-
promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic
process
cop NADK2 5p13.2 -0.15 0.251 0.772
cop RANBP3L 5p13.2 -0.15 0.251 0.772 intracellular transport
met BNIP2 15q22.2 -0.15 0.251 0.772 Apoptosis
mut PLP1 Xq22 -0.15 0.251 0.772 synaptic transmission;cell death
exp KRT8 12q13 -0.151 0.251 0.772 cytoskeleton organization;interspecies
xsq ANKRD30BP3 -0.151 0.251 0.772
exp ATP13A3 3q29 -0.151 0.251 0.772 cation transport
exp BBX 3q13.1 -0.151 0.251 0.772 regulation of transcription, DNA-
dependent"
exp HOXB7 17q21.3 -0.151 0.251 0.772 myeloid cell
exp LOC390614 -0.151 0.251 0.772
xsq GLI3 7p13 -0.151 0.251 0.772 axon guidance;pallium development
mut OR10K1 -0.151 0.251 0.772
mut MFSD14A -0.151 0.251 0.772 transmembrane transport
exp ITGB4 17q25 -0.151 0.251 0.771 cell-matrix adhesion;integrin-mediated
signaling pathway
exp HUNK 21q22.1 -0.151 0.251 0.771 signal transduction;multicellular
xai MIRLET7BHG 22q13.31 -0.152 0.251 0.772
xai ALDH3B1 11q13 -0.152 0.251 0.772 alcohol metabolic process;lipid
metabolic process
his YOD1 1q32.2 -0.152 0.251 0.772 response to unfolded protein;ER-
his PFKFB2 1q31 -0.152 0.251 0.772 Apoptosis
xai CLIC6 21q22.12 -0.152 0.251 0.772 ion transport
xai TMEM130 7q22.1 -0.152 0.251 0.772
his SMIM19 8p11.21 -0.152 0.251 0.772
swa OCIAD1 4p11 -0.152 0.251 0.772
xai PRRT3 3p25.3 -0.152 0.251 0.772
hs4 TMEM202 15q24.1 -0.152 0.251 0.772
dependent"
cop LOC644189 19q13.12 -0.152 0.251 0.772
xai ALDH3B2 11q13 -0.152 0.251 0.772 alcohol metabolic process;cellular
hs4 CACNB4 2q22-q23 -0.152 0.251 0.772 synaptic transmission;axon
guidance
his LOC101927460 -0.152 0.251 0.772
his LINC01995 -0.152 0.251 0.772
hs4 CCDC89 11q14.1 -0.152 0.251 0.772
exp KRT9 17q21.2 -0.152 0.251 0.772 skin development;intermediate
xai SCTR 2q14.1 -0.152 0.251 0.772 digestion;excretion
hs4 STAP2 19p13.3 -0.152 0.251 0.772
xai FAM180A 7q33 -0.152 0.251 0.772
xai VN2R17P -0.152 0.251 0.772
his PDGFB 22q13.1 -0.152 0.251 0.772 Apoptosis; Oncogenes
his MIR4252 -0.152 0.251 0.772
hs4 IGFBP5 2q35 -0.152 0.251 0.771 negative regulation of smooth
his PNMAL1 19q13.32 -0.152 0.251 0.771
swa NUP85 17q25.1 -0.152 0.251 0.771 protein transport;transmembrane
transport
hs4 RAET1E-AS1 -0.152 0.251 0.771
hs4 LRP11 6q25.1 -0.152 0.251 0.771
his MCOLN1 19p13.2 0.152 0.252 0.772 transferrin transport;transmembrane
transport
his PDE4C 19p13.11 0.152 0.252 0.772 cAMP catabolic process;signal
transduction
hs4 SNHG7 9q34.3 0.152 0.252 0.772
hs4 SNORA17B 0.152 0.252 0.772
hs4 SNORA17A 0.152 0.252 0.772
his NEK2 1q32.3 0.152 0.252 0.772 DNA Damage Response (DDR)
hs4 HCG11 6p22.2 0.152 0.252 0.772
exp LOC100507560 0.152 0.252 0.772
his LINC01579 0.152 0.252 0.772
his LINC01580 0.152 0.252 0.772
his CALM1 14q32.11 0.152 0.252 0.772
xai SLFN11 17q12 0.152 0.252 0.772 DNA Damage Response (DDR)
hs4 SCGB3A1 5q35.3 0.152 0.252 0.772
his ERLIN2 8p11.2 0.152 0.252 0.772 ER-associated protein catabolic
process
his LOC102723701 0.152 0.252 0.772
hs4 GCN1 0.152 0.252 0.772 translation;regulation of translation
hs4 RPLP0 12q24.2 0.152 0.252 0.772 SRP-dependent cotranslational protein
hs4 PXN-AS1 0.152 0.252 0.772
swa PIN4 Xq13 0.152 0.252 0.772 rRNA processing;protein folding
hs4 MIR4658 0.152 0.252 0.772
hs4 C7orf43 7q22.1 0.152 0.252 0.772
xai COX4I1 16q24.1 0.152 0.252 0.772 generation of precursor metabolites
hs4 ZCCHC6 9q21 0.152 0.252 0.772 RNA 3'-end processing;histone mRNA
catabolic process
dependent"
hs4 TANGO6 16q22.1 0.152 0.252 0.772
xai FLJ46284 0.152 0.252 0.772
his RNU5D-1 1p34.1 0.152 0.252 0.772
his SLU7 5q33.3 0.152 0.252 0.772 cellular response to stress;RNA splicing,
his PTTG1 5q35.1 0.152 0.252 0.772 mitotic cell cycle;chromosome
organization
his RAPGEF4 2q31-q32 0.152 0.252 0.772 blood coagulation;regulation of
catalytic activity
exp CCDC33 15q24.1 0.152 0.252 0.772
his AIDA 1q41 0.152 0.252 0.772 dorsal/ventral pattern formation;regulation of
protein homodimerization activity
his BROX 1q41 0.152 0.252 0.772
his YPEL1 22q11.2 0.151 0.252 0.772
hs4 ZNF367 9q22 0.151 0.252 0.772 regulation of transcription from RNA
his MIR3183 0.151 0.252 0.772
his CASP7 10q25 0.151 0.252 0.772 Apoptosis
his MIR6785 0.151 0.252 0.772
his IL17RA 22q11.1 0.151 0.252 0.772 cell surface receptor signaling
exp MIR138-2 0.151 0.252 0.772
his F2RL3 19p12 0.151 0.252 0.772 thrombin receptor signaling pathway;signal
transduction
xai SMPD5 8q24.3 0.151 0.252 0.772
his TMEM74B 20p13 0.151 0.252 0.772
xai PSMD10 Xq22.3 0.151 0.252 0.772 cell cycle checkpoint;antigen
dependent
exp RAD21L1 20p13 0.151 0.252 0.772 chromosome segregation;meiosis
hs4 PRDM15 21q22.3 0.151 0.252 0.772 regulation of transcription, DNA-
dependent"
his PDK1 2q31.1 0.151 0.252 0.772 cell surface receptor signaling
pathway;small GTPase mediated signal transduction
xai ETV5 3q28 0.151 0.252 0.772 Transcription Factors
his TIMM10 11q12.1-q12.3 0.151 0.252 0.772 protein targeting to
hs4 ACE 17q23.3 0.151 0.252 0.772 proteolysis;regulation of vasodilation
his PRSS3 9p11.2 0.151 0.252 0.772 digestion;zymogen activation
his RPL21P28 1q32.3 0.151 0.252 0.772
xai IGHVII-60-1 0.151 0.252 0.772
xai ATP5J 21q21.1 0.151 0.252 0.772 ATP catabolic process;transport
xai EPC1 10p11 0.151 0.252 0.772 histone H2A acetylation;negative regulation of
hs4 USP19 3p21.31 0.151 0.252 0.772 negative regulation of skeletal muscle
exp KIAA0125 14q32.33 0.151 0.252 0.772
xai MIR138-2 0.151 0.252 0.772
his ARPC1A 7q22.1 0.151 0.252 0.772 actin cytoskeleton
his FLJ27354 0.151 0.252 0.772
his LRRC8C 1p22.2 0.151 0.252 0.772
his TMEM186 16p13.2 0.151 0.252 0.772
his PMM2 16p13 0.151 0.252 0.772 protein glycosylation;dolichol-linked
oligosaccharide biosynthetic process
xai NMRAL1 16p13.3 0.151 0.252 0.772
xai PHKA1P1 1p22.2 0.151 0.252 0.772
his LSM6 4q31.22 0.151 0.252 0.772 mRNA processing;tRNA processing
his MEPCE 7q22.1 0.151 0.252 0.772
his ZCWPW1 7q22.1 0.151 0.252 0.772
his PPP1R35 7q22.1 0.151 0.252 0.772 negative regulation of phosphatase
activity
met FLG 1q21.3 0.15 0.252 0.772 multicellular organismal
xsq FAM135B 8q24.23 0.15 0.252 0.772
met ATP7B 13q14.3 0.15 0.252 0.772 cellular zinc ion
met MIR522 0.15 0.252 0.772
xsq NLRP3 1q44 0.15 0.252 0.772 defense response;positive regulation of
mut ZNF711 Xq21.1 0.15 0.252 0.772 positive regulation of
exp NDUFB2-AS1 7q34 0.15 0.252 0.772
xsq CPSF7 11q12.2 0.15 0.252 0.772 protein tetramerization;nuclear mRNA
mut SMOC2 6q27 0.15 0.252 0.772 signal transduction
xsq LOC100128164 3q26.2 0.15 0.252 0.772
xsq SNX15 11q12 0.15 0.252 0.772 cell communication;intracellular protein
transport
met ZNF780A 19q13.2 0.15 0.252 0.772 regulation of transcription, DNA-
dependent"
exp USP30-AS1 12q24.11 0.15 0.252 0.772
mut IQUB 7q31.32 0.15 0.252 0.772
mut MORC1 3q13 0.15 0.252 0.772 multicellular organismal
xsq RAVER1 19p13.2 0.15 0.252 0.772
met LYZL4 3p22.1 0.15 0.252 0.772 cell wall macromolecule catabolic process
met ZNF479 7p11.2 0.15 0.252 0.772
met PISD 22q12.2 0.15 0.252 0.772 phospholipid biosynthetic process
cop MCU 10q22.1 0.15 0.252 0.772 ion transport;mitochondrial calcium ion
transport
exp MRFAP1L1 4p16.1 0.15 0.252 0.772
xsq RHOXF1P1 0.15 0.252 0.772
xsq TCP10 6q27 0.15 0.252 0.772
cop TMEM94 0.15 0.252 0.772
exp CENPA 2p23.3 0.15 0.252 0.772 kinetochore assembly;M phase of mitotic
cell cycle
cop CRIP2 14q32.3 0.15 0.252 0.772 positive regulation of cell
cop CRIP1 14q32.33 0.15 0.252 0.772 heart development;cell proliferation
cop C14orf80 14q32.33 0.15 0.252 0.772
cop TMEM121 14q32.33 0.15 0.252 0.772
met MAGEC1 Xq26 0.15 0.252 0.772
cop MIR4779 0.15 0.252 0.772
cop MRPL35 2p11.2 0.15 0.252 0.772 translation
mut ZFP69B 1p34.2 0.15 0.252 0.772
met TRIM32 9q33.1 0.15 0.252 0.772 response to tumor necrosis
mut SLCO6A1 5q21.1 0.15 0.252 0.772 Solute Carriers
dependent"
exp TRAPPC9 8q24.3 0.15 0.252 0.772 cell differentiation
met CBLN2 18q22.3 0.15 0.252 0.772
exp API5P1 Xq24 0.15 0.252 0.772
cop TEX22 14q32.33 0.15 0.252 0.772
cop MTA1 14q32.3 0.15 0.252 0.772 signal transduction
exp PPIAP11 5q14.1 0.15 0.252 0.772
exp PACS2 14q32.33 0.15 0.252 0.772 apoptotic process;interspecies
cop NCOA1 2p23 0.15 0.252 0.772 response to retinoic acid;response to
progesterone stimulus
xsq LRFN2 6p21.2-p21.1 0.15 0.252 0.772
xsq ASB9 Xp22.2 0.15 0.252 0.772 protein ubiquitination;intracellular
signal transduction
cop INVS 9q31 0.15 0.252 0.772 pancreas development;embryonic heart tube
left/right pattern formation
cop AAGAB 15q22.33-q23 0.15 0.252 0.772 protein transport
cop CENPP 9q22.31 0.15 0.252 0.772 M phase of mitotic cell cycle;mitotic
prometaphase
xsq FAM110D 1p36.11 0.15 0.252 0.772
met SNHG20 0.15 0.252 0.772
xsq AGMAT 1p36.21 0.15 0.252 0.772 polyamine metabolic process;spermidine
xsq PPIAL4G 0.15 0.252 0.772 protein folding
mut FAM184A 6q22.31 0.15 0.252 0.772
exp FAM209A 20q13.31 0.15 0.252 0.772
xsq RP1L1 8p23.1 0.15 0.252 0.772 cell projection
cop SCARNA20 0.15 0.252 0.772
exp ZNF582-AS1 -0.15 0.252 0.772
exp EMX2 10q26.1 -0.15 0.252 0.772 multicellular organismal development
exp GREB1 2p25.1 -0.15 0.252 0.772
xsq SOX17 8q11.23 -0.15 0.252 0.772 Cell Signaling
exp PTP4A1P6 11q14.2 -0.15 0.252 0.772
cop PRR23A -0.15 0.252 0.772
cop PRR23B -0.15 0.252 0.772
exp MTMR2 11q22 -0.15 0.252 0.772 negative regulation of receptor catabolic
process;negative regulation of receptor internalization
mut CREB3 9p13.3 -0.15 0.252 0.772 reactivation of latent virus;positive
xsq INHBB 2cen-q13 -0.15 0.252 0.772 cell differentiation;positive regulation
of follicle-stimulating hormone secretion
xsq B3GALNT1 3q25 -0.15 0.252 0.772 protein glycosylation;oligosaccharide
dependent"
exp MAD1L1 7p22 -0.15 0.252 0.772 mitotic anaphase;mitotic telophase
met C9orf172 9q34.3 -0.15 0.252 0.772
xsq CCSER2 10q23.1 -0.15 0.252 0.772
met EHBP1L1 11q13.1 -0.15 0.252 0.772
exp NUDT4P1 1q21.1 -0.15 0.252 0.772
mut ZNF365 10q21.2 -0.15 0.252 0.772
mut DNM2 19p13.2 -0.15 0.252 0.772 Apoptosis; Tumor Suppressors
exp PABPC1L2B Xq13.2 -0.15 0.252 0.772
xsq MTRNR2L5 -0.15 0.252 0.772
met AQP3 9p13 -0.15 0.252 0.772 urea transport;response to retinoic acid
exp CAMTA1 1p36.31-p36.23 -0.15 0.252 0.772 regulation of transcription,
DNA-dependent"
met IDUA 4p16.3 -0.15 0.252 0.772 cell morphogenesis;carbohydrate metabolic
process
mut AAMP 2q35 -0.15 0.252 0.772 cell differentiation;angiogenesis
exp PIFO 1p13.2 -0.15 0.252 0.772
exp LOC100506328 -0.15 0.252 0.772
cop AMOTL2 3q21-q22 -0.15 0.252 0.772
mut AOAH 7p14-p12 -0.15 0.252 0.772 lipopolysaccharide metabolic
cop SPOCK1 5q31.2 -0.15 0.252 0.772 cell adhesion;signal transduction
exp RPL21P115 15q22 -0.15 0.252 0.772
cop BRF2 8p11.23 -0.15 0.252 0.772 transcription from RNA polymerase III
promoter;gene expression
cop RAB11FIP1 8p11.22 -0.15 0.252 0.772 protein transport
cop GOT1L1 8p11.23 -0.15 0.252 0.772 cellular amino acid metabolic
cop ADRB3 8p12 -0.15 0.252 0.772
cop EIF4EBP1 8p12 -0.15 0.252 0.772 negative regulation of protein complex
assembly;TOR signaling cascade
exp DGCR5 22q11 -0.15 0.252 0.772
exp OR7E62P 2p13.3 -0.15 0.252 0.772
xsq TMEM40 3p25.2 -0.15 0.252 0.772
xsq C1orf210 1p34.2 -0.15 0.252 0.772 EMT (Epithelial)
hs4 NLGN1 3q26.31 -0.151 0.252 0.772 positive regulation of
intracellular protein kinase cascade;protein heterotetramerization
his MN1 22q12.1 -0.151 0.252 0.772 intramembranous ossification
xai CD274 9p24 -0.151 0.252 0.772 immune response;signal transduction
xai TEF 22q13.2 -0.151 0.252 0.772 regulation of transcription from
II promoter
swa IST1 16q22.2 -0.151 0.252 0.772 cell division;cell cycle
hs4 DACT3 19q13.32 -0.151 0.252 0.772
hs4 DACT3-AS1 -0.151 0.252 0.772
xai FAM229B 6q21 -0.151 0.252 0.772
DNA-dependent"
swa XRCC6 22q13.2 -0.151 0.252 0.772 DNA Damage Response (DDR); DDR
(NHEJ)
xai TP53TG1 7q21.1 -0.151 0.252 0.772 response to stress;response
xai IFIT1 10q23.31 -0.151 0.252 0.772 negative regulation of viral genome
hs4 NMNAT2 1q25 -0.151 0.252 0.772 vitamin metabolic process;water-
xai UBE3B 12q24.11 -0.151 0.252 0.772 protein modification
process
hs4 HDAC11-AS1 -0.151 0.252 0.772
hs4 HDAC11 3p25.1 -0.151 0.252 0.772 regulation of transcription,
DNA-dependent;oligodendrocyte development
his ATP8B1 18q21.31 -0.151 0.252 0.772 bile acid and bile salt
his BAIAP2-AS1 17q25.3 -0.152 0.252 0.772
his BAIAP2 17q25 -0.152 0.252 0.772 insulin receptor signaling
hs4 RNF114 20q13.13 -0.152 0.252 0.772 spermatogenesis;cell
differentiation
hs4 JAKMIP3 10q26.3 -0.152 0.252 0.772
his BCO1 -0.152 0.252 0.772 retinoid metabolic process;steroid
metabolic process
his TNFSF15 9q32 -0.152 0.252 0.772 cytokine metabolic process;positive
DNA-dependent"
his HYI 1p34.2 -0.152 0.252 0.772
swa VDAC3 8p11.2 -0.152 0.252 0.772 Apoptosis
his LINC01592 -0.152 0.252 0.772
DNA-dependent"
swa NDUFS4 5q11.1 -0.152 0.252 0.772 transport;response to cAMP
xai SERPINA11 14q32.13 -0.152 0.252 0.772 negative regulation of
exp IDSP1 Xq27.3-q28 -0.152 0.252 0.772
hs4 GAS2 11p14.3 -0.152 0.252 0.772 apoptotic process;cellular
xai LOC100652871 -0.152 0.252 0.772
hs4 MEI4 -0.152 0.252 0.772
his TRAF4 17q11-q12 -0.152 0.252 0.772 Apoptosis
xai IDSP1 Xq27.3-q28 -0.152 0.252 0.772
his PCMTD2 20q13.33 0.151 0.253 0.772 protein modification process
swa FKBP5 6p21.31 0.151 0.253 0.772 peptidyl-proline modification;protein
exp PCDHAC1 0.151 0.253 0.772 homophilic cell adhesion;nervous system
development
his SNORA77 1q32.1 0.151 0.253 0.772
swa CAT 11p13 0.151 0.253 0.772 response to hypoxia;positive regulation of
phosphatidylinositol 3-kinase cascade
swa MTHFD1 14q24 0.151 0.253 0.772 water-soluble vitamin metabolic
swa HMCES 0.151 0.253 0.772
exp BPIFB3 20q11.21 0.151 0.253 0.772 innate immune response
xai NKTR 3p22.1 0.151 0.253 0.772 protein folding
swa NUP93 16q13 0.151 0.253 0.773 regulation of glucose transport;protein
transport
exp IGHVII-60-1 0.151 0.253 0.773
xai JMJD1C 10q21.3 0.151 0.253 0.773 regulation of transcription, DNA-
xai SFR1 10q25.1 0.151 0.253 0.773 DNA Damage Response (DDR)
xai NUDCD1 8q23 0.151 0.253 0.773
his LOC101928495 0.151 0.253 0.773
hs4 NME4 16p13.3 0.151 0.253 0.773 CTP biosynthetic process;nucleoside
metabolic process
hs4 DECR2 16p13.3 0.151 0.253 0.773 unsaturated fatty acid biosynthetic
process
hs4 GAL 11q13.3 0.151 0.253 0.773 inflammatory response;response to insulin
stimulus
his LAMTOR5-AS1 0.151 0.253 0.773
his LAMTOR5 1p13.3 0.151 0.253 0.773
his ZNF281 1q32.1 0.151 0.253 0.773 negative regulation of gene
expression;negative regulation of transcription, DNA-dependent
his COL4A4 2q35-q37 0.151 0.253 0.773 axon guidance;glomerular basement
membrane development
his COL4A3 2q36-q37 0.151 0.253 0.773 Apoptosis
xai RPL7P4 6p21.33 0.151 0.253 0.773
xai TSPY1 0.151 0.253 0.773 nucleosome assembly;multicellular organismal
development
xai CENPT 16q22.1 0.151 0.253 0.773 M phase of mitotic cell cycle;mitotic
prometaphase
his PREPL 2p21 0.151 0.253 0.773 proteolysis
his CAMKMT 2p21 0.151 0.253 0.773
xai FAM209B 20q13.31 0.151 0.253 0.773
xai CCDC91 12p11.22 0.151 0.253 0.773 protein transport
his OTUD3 1p36.13 0.151 0.253 0.773
xai LDHAP3 2p21 0.151 0.253 0.773
exp TUBB3P1 6q15 0.151 0.253 0.773
xai GNG13 16p13.3 0.151 0.253 0.773 energy reserve metabolic
process;activation of phospholipase C activity by G-protein coupled receptor
his TINCR 19p13.3 0.151 0.253 0.773
his CYMP 1p13.3 0.151 0.253 0.773
his VMA21 Xq28 0.151 0.253 0.773 vacuolar proton-transporting V-type ATPase
complex assembly
hs4 WDR4 21q22.3 0.151 0.253 0.773 tRNA modification
exp MTBP 8q24.12 0.151 0.253 0.773 DDR (DNA replication)
his FGG 4q28 0.151 0.253 0.773 platelet degranulation;signal transduction
his LAX1 1q32.1 0.151 0.253 0.773 negative regulation of T cell
hs4 GPX4 19p13.3 0.151 0.253 0.773 response to oxidative
stress;multicellular organismal development
dependent"
xsq HACL1 3p25.1 0.15 0.253 0.772 small molecule metabolic process;protein
oligomerization
xsq LOC100508046 0.15 0.253 0.772
met TPM1 15q22.1 0.15 0.253 0.772 positive regulation of heart rate by
epinephrine;ruffle organization
xsq CMTM3 16q21 0.15 0.253 0.772 EMT (Mesenchymal)
cop GLCE 15q23 0.15 0.253 0.772 heparan sulfate proteoglycan biosynthetic
cop PAQR5 15q23 0.15 0.253 0.772 multicellular organismal development;cell
differentiation
cop KIF23 15q23 0.15 0.253 0.772 M phase of mitotic cell cycle;positive
cop RPLP1 15q22 0.15 0.253 0.772 gene expression;viral reproduction
met VLDLR 9p24 0.15 0.253 0.772 nervous system development;cerebral cortex
development
cop TXNL1 18q21.31 0.15 0.253 0.772 Apoptosis
met SUSD5 3p22.3 0.15 0.253 0.772 cell adhesion
xsq NUP50 22q13.31 0.15 0.253 0.772 protein transport;glucose transport
dependent"
met ARSD Xp22.3 0.15 0.253 0.772
xsq BACE1-AS 0.15 0.253 0.772
met TLR4 9q33.1 0.15 0.253 0.772 Cell Signaling
mut AMER3 2q21.1 0.15 0.253 0.773
met B9D1 17p11.2 0.15 0.253 0.773 smoothened signaling pathway;cell
exp FAM156B Xp11.22 0.15 0.253 0.773
xsq ADORA2A-AS1 0.15 0.253 0.773
xsq KCNK18 10q25.3 0.15 0.253 0.773 ion transport;potassium ion
transport
cop TMEM132A 11q12.2 0.15 0.253 0.773
cop ANXA4 2p13 0.15 0.253 0.773 Apoptosis
mut UBE2F 2q37.3 0.15 0.253 0.773 protein neddylation
cop LRCOL1 0.15 0.253 0.773
cop P2RX2 12q24.33 0.15 0.253 0.773 purinergic nucleotide receptor signaling
pathway;positive regulation of calcium-mediated signaling
xsq LOC100132831 Xp11.4 0.15 0.253 0.773
met MIR17 0.15 0.253 0.773
xsq HAP1 17q21.2-q21.3 0.15 0.253 0.773 protein localization;synaptic
transmission
xsq DPPA4 3q13.13 0.15 0.253 0.773 multicellular organismal development
met ADGRE3 0.15 0.253 0.773 G-protein coupled receptor signaling
cop LOC146880 17q24 0.15 0.253 0.773
xsq GUCA1B 6p21.1 0.15 0.253 0.773 phototransduction;regulation of
guanylate cyclase activity
dependent"
met RPL30 8q22 0.15 0.253 0.773 viral reproduction;nuclear-transcribed mRNA
xsq DKKL1 19q13.33 0.15 0.253 0.773 positive regulation of fat cell
differentiation;signal transduction
cop THUMPD2 2p22.1 0.15 0.253 0.773
xsq UBTFL1 0.15 0.253 0.773
xsq ESF1 20p12.1 0.15 0.253 0.773 regulation of transcription, DNA-
dependent"
exp SPRY1 4q28.1 0.15 0.253 0.773 metanephros development;negative
regulation of fibroblast growth factor receptor signaling pathway
exp SSSCA1 11q13.1 0.15 0.253 0.773 cell division;cell cycle
xsq KIAA2012 0.15 0.253 0.773
xsq PHOX2A 11q13.2 0.15 0.253 0.773 regulation of transcription, DNA-
dependent;somatic motor neuron differentiation
met SLC30A2 1p35.3 -0.15 0.253 0.773 zinc ion transport;transmembrane
transport
xsq ODF3L1 15q24.2 -0.15 0.253 0.773
exp LOC730102 -0.15 0.253 0.773
xsq ACTBL2 5q11.2 -0.15 0.253 0.773
exp GATA4 8p23.1-p22 -0.15 0.253 0.773 gastrulation with mouth forming
exp ANKRD20A12P -0.15 0.253 0.773
xsq TMEM9 -0.15 0.253 0.773 transport
xsq DLG5 10q23 -0.15 0.253 0.773 signal transduction;negative regulation of cell
proliferation
mut OXA1L 14q11.2 -0.15 0.253 0.773 mitochondrial proton-transporting ATP
mut CAPN15 16p13.3 -0.15 0.253 0.773
exp ADAMTS2 5qter -0.15 0.253 0.773 protein processing;collagen fibril
organization
xsq RPL13AP5 10q24.1 -0.15 0.253 0.773
met RMI2 16p13.13 -0.15 0.253 0.773 DNA Damage Response (DDR); DDR (FA)
xsq IGF2R 6q26 -0.15 0.253 0.773 receptor-mediated endocytosis;signal
transduction
exp RAB7A 3q21.3 -0.15 0.253 0.773 endosome to lysosome transport;protein
transport
exp EPHB4 7q22 -0.15 0.253 0.773 protein autophosphorylation;ephrin receptor
signaling pathway
met NMUR1 2q37.1 -0.15 0.253 0.773 calcium-mediated signaling;calcium ion
transport
mut DAB1 1p32-p31 -0.15 0.253 0.773 cell differentiation;multicellular
xsq FTH1 11q13 -0.15 0.253 0.773 iron ion transport;transmembrane transport
met STAT5A 17q11.2 -0.15 0.253 0.773 Apoptosis
xsq KRT4 12q13.13 -0.15 0.253 0.773 cytoskeleton organization;epithelial cell
differentiation
cop ROPN1B 3q21.2 -0.15 0.253 0.773 cytokinesis;signal transduction
xsq SPTAN1 9q34.11 -0.15 0.253 0.773 apoptotic process;cellular
exp HMGA2 12q15 -0.15 0.253 0.772 mesodermal-endodermal cell
xsq SPACA3 17q11.2 -0.15 0.253 0.772 defense response to Gram-positive
bacterium;peptidoglycan catabolic process
mut XAF1 17p13.1 -0.15 0.253 0.772 apoptotic process;cytokine-mediated
signaling pathway
exp LRAT 4q32.1 -0.15 0.253 0.772 visual perception;steroid metabolic
process
met CPXM1 20p13 -0.15 0.253 0.772 proteolysis;cell adhesion
met LMAN1L 15q24.1 -0.15 0.253 0.772
his LMOD3 3p14.1 -0.151 0.253 0.773
xai ITGB4 17q25 -0.151 0.253 0.773 cell-matrix adhesion;integrin-mediated
signaling pathway
his TMEM200B 1p35 -0.151 0.253 0.773
xai BOLL 2q33 -0.151 0.253 0.773 meiosis;multicellular organismal
development
dependent"
cop RNU6-66P -0.151 0.253 0.773
cop DKFZp434J0226 19q13.32 -0.151 0.253 0.773
cop IGFL1 19q13.32 -0.151 0.253 0.773
cop HIF3A 19q13.32 -0.151 0.253 0.773 response to hypoxia;positive
cop PPP5C 19q13.3 -0.151 0.253 0.773 signal transduction;positive
cop CCDC8 19q13.32 -0.151 0.253 0.773 negative regulation of phosphatase
activity
cop PNMAL1 19q13.32 -0.151 0.253 0.773
his NAMA -0.151 0.253 0.773
swa AKAP8 19p13.1 -0.151 0.253 0.773 signal transduction;mitosis
his MKRN9P 12q21.32 -0.151 0.253 0.773
xai RAB3B 1p32-p31 -0.151 0.253 0.773 regulation of exocytosis;peptidyl-
cysteine methylation
xai RIPK1 6p25.2 -0.151 0.253 0.773 Apoptosis
cop ZC3H4 19q13.32 -0.151 0.253 0.773
xai SFTPC 8p21 -0.151 0.253 0.773 response to hormone stimulus;response to
interleukin-6
swa POLR2M 15q21.3 -0.151 0.253 0.773 maintenance of ER location
xai SV2C 5q13.3 -0.151 0.253 0.773 neurotransmitter transport
his KDELR3 22q13.1 -0.151 0.253 0.773 protein retention in ER
response
hs4 SDSL 12q24.13 -0.151 0.253 0.773 cellular amino acid metabolic
process
xai SLC5A3 21q22.12 -0.151 0.253 0.773 transport;ion transport
xai ENPP7P8 -0.151 0.253 0.773
xai HAGLR -0.151 0.253 0.773
exp NWD1 19p13.11 -0.151 0.253 0.773
exp ENPP7P8 -0.151 0.253 0.773
hs4 PNPLA7 9q34.3 -0.151 0.253 0.773 lipid metabolic
hs4 MRPL41 9q34.3 -0.151 0.253 0.773 translation;apoptotic process
xai MORN2 2p22.1 -0.151 0.253 0.772
swa DSG2 18q12.1 -0.151 0.253 0.772 apoptotic process;cellular
xai PARP10 8q24.3 -0.151 0.253 0.772 regulation of chromatin
xai MUC20 3q29 -0.151 0.253 0.772 hepatocyte growth factor receptor
cop CCDC61 19q13.32 -0.151 0.253 0.772
cop MIR769 -0.151 0.253 0.772
cop PGLYRP1 19q13.2-q13.3 -0.151 0.253 0.772
cop IGFL4 19q13.32 -0.151 0.253 0.772
cop IGFL3 19q13.32 -0.151 0.253 0.772
cop IGFL2 19q13.32 -0.151 0.253 0.772
hs4 LATS2 13q11-q12 -0.151 0.253 0.772 protein phosphorylation;negative
cop PRR19 19q13.2 -0.151 0.253 0.772
cop TMEM145 19q13.2 -0.151 0.253 0.772
xai CCDC134 22q13.2 0.151 0.254 0.773
xai PTDSS2 11p15.5 0.151 0.254 0.773 phosphatidylserine biosynthetic
his SNURF 0.151 0.254 0.773
his SNRPN 15q11.2 0.151 0.254 0.773 RNA splicing
hs4 RSG1 1p36.13 0.151 0.254 0.773 small GTPase mediated signal
his SP3 2q31 0.151 0.254 0.773 liver development;granulocyte differentiation
exp ZP4 1q43 0.151 0.254 0.773 positive regulation of protein kinase
activity;acrosomal vesicle exocytosis
dependent"
exp GMNC 3q28 0.151 0.254 0.773 cell cycle;cell proliferation
xai CTSS 1q21 0.151 0.254 0.773 antigen processing and presentation of
xai IGBP1P4 4q21.22 0.151 0.254 0.773
hs4 PFKL 21q22.3 0.151 0.254 0.773 small molecule metabolic process;negative
his LINC01625 0.151 0.254 0.773
his TNFRSF4 1p36 0.151 0.254 0.773 Apoptosis
xai SEZ6L 22q12.1 0.151 0.254 0.773
hs4 KCTD15 19q13.11 0.151 0.254 0.773 potassium ion transport
his DLEU2 13q14.3 0.151 0.254 0.773
xai ISCA1 9q21.33 0.151 0.254 0.773 iron-sulfur cluster assembly
his MYL12A 18p11.31 0.151 0.254 0.773
his LOC104968399 0.151 0.254 0.773
his MYL12B 18p11.31 0.151 0.254 0.773 muscle contraction;axon guidance
swa AARSD1 17q21.31 0.151 0.254 0.773 translation;alanyl-tRNA
aminoacylation
xai NUBP2 16p13.3 0.151 0.254 0.773
xai TBC1D24 16p13.3 0.151 0.254 0.773 neuron projection development
xai ZDHHC6 10q25.2 0.151 0.254 0.773
his ANG 14q11.1-q11.2 0.151 0.254 0.773 response to hypoxia;cell death
his RNASE4 14q11 0.151 0.254 0.773 mRNA cleavage
hs4 PIWIL1 12q24.33 0.151 0.254 0.773 gene silencing by RNA;piRNA
metabolic process
his LOC105375800 0.151 0.254 0.773
xai RPL6P7 3q25.31 0.151 0.254 0.773
his KPNA3 13q14.3 0.151 0.254 0.774 protein complex assembly;NLS-bearing
his WDR37 10p15.3 0.151 0.254 0.774
xai PTCH1 9q22.3 0.151 0.254 0.774 Tumor Suppressors
his FAHD2B 2q11.2 0.151 0.254 0.774
hs4 ARHGAP11B 15q13.2 0.151 0.254 0.774
xai PRADC1 2p13.2 0.151 0.254 0.774
xai SRPK3 Xq28 0.151 0.254 0.774 protein phosphorylation;multicellular
his BHLHA9 0.151 0.254 0.774 regulation of transcription, DNA-
dependent"
swa HSD17B11 4q22.1 0.151 0.254 0.774 steroid biosynthetic
xai LOC375196 0.151 0.254 0.774
exp USP3-AS1 15q22.31 0.151 0.254 0.774
his A2ML1 12p13.31 0.151 0.254 0.774 negative regulation of peptidase
activity;regulation of endopeptidase activity
xai KIAA1524 3q13.13 0.151 0.254 0.774
xai PMPCB 7q22.1 0.151 0.254 0.774 proteolysis
his AGPAT1 6p21.3 0.151 0.254 0.774 phospholipid metabolic
process;phosphatidic acid biosynthetic process
his RNF5 6p21.3 0.151 0.254 0.774 ER-associated misfolded protein catabolic
process;cellular protein catabolic process
his MIR6833 0.151 0.254 0.774
exp LACRT 12q13 0.151 0.254 0.774 positive regulation of cell
hs4 LINC00235 16p13.3 0.151 0.254 0.774
hs4 CAPN15 16p13.3 0.151 0.254 0.774
exp LOC100506504 0.151 0.254 0.774
exp COL18A1-AS1 0.151 0.254 0.774
hs4 E2F1 20q11.2 0.151 0.254 0.774 Apoptosis; Tumor Suppressors
met GSC2 22q11.21 0.15 0.254 0.773
xsq MFSD9 2q12.1 0.15 0.254 0.773 transmembrane transport
exp CLEC7A 12p13.2 0.15 0.254 0.773 phagocytosis, recognition;defense
xsq HIST1H2BK 6p21.33 0.15 0.254 0.773 nucleosome assembly;defense
xsq GZF1 20p11.21 0.15 0.254 0.773 negative regulation of transcription from
RNA polymerase II promoter;branching involved in ureteric bud morphogenesis
cop GPR89C 0.15 0.254 0.773
cop NBPF24 0.15 0.254 0.773
cop NBPF11 0.15 0.254 0.773
cop PDZK1P1 0.15 0.254 0.773
met TNFAIP6 2q23.3 0.15 0.254 0.773 inflammatory response;cell adhesion
met ACO1 9p21.1 0.15 0.254 0.773 response to iron(II) ion;regulation of
gene expression
cop FGD5-AS1 0.15 0.254 0.773
exp MAST3 19p13.11 0.15 0.254 0.773
met FMR1 Xq27.3 0.15 0.254 0.773 transport;central nervous system
development
xsq PTRH2 17q23.1 0.15 0.254 0.773 apoptotic process
xsq LINC01100 0.15 0.254 0.773
xsq C9orf16 9q34.1 0.15 0.254 0.773
mut TPR 1q25 0.15 0.254 0.773 protein transport;glucose transport
xsq H3F3B 17q25.1 0.15 0.254 0.773 nucleosome assembly;blood coagulation
xsq PSMA4 15q25.1 0.15 0.254 0.773 antigen processing and presentation of
exogenous peptide antigen via MHC class I, TAP-dependent;mRNA metabolic process
met SPRY4 5q31.3 0.15 0.254 0.774 regulation of signal
transduction;negative regulation of MAP kinase activity
xsq NREP 5q22.1 0.15 0.254 0.774 regulation of neuron
pathway
xsq ILKAP 2q37.3 0.15 0.254 0.774 protein dephosphorylation;regulation of S
phase of mitotic cell cycle
exp ATP1B2 17p13.1 0.15 0.254 0.774 transport;potassium ion transport
exp KATNBL1 15q14 0.15 0.254 0.774
xsq KATNBL1P6 0.15 0.254 0.774
cop C3orf20 3p25.1 0.15 0.254 0.774
xsq FBXL12 19p13.2 0.15 0.254 0.774 ubiquitin-dependent protein
catabolic process
exp METTL9 16p12.2 0.15 0.254 0.774
xsq LOC101927571 0.15 0.254 0.774
met SERP2 13q14.11 0.15 0.254 0.774 protein transport
xsq RXFP4 0.15 0.254 0.774
xsq MYO15B 17q25.1 0.149 0.254 0.774
xsq TMEM209 7q32.2 0.149 0.254 0.774
cop ASRGL1 11q12.3 0.149 0.254 0.774 asparagine catabolic process via L-
met HHLA1 8q24 0.149 0.254 0.774
mut ATG2B 14q32.2 0.149 0.254 0.774
xsq BARD1 2q34-q35 0.149 0.254 0.774 Apoptosis; DNA Damage Response (DDR); DDR
(FA)
cop C14orf177 14q32.2 0.149 0.254 0.774
xsq LINC00629 0.149 0.254 0.774
mut SWT1 1q25 0.149 0.254 0.774
xsq CERS3 15q26.3 0.149 0.254 0.774 sphingolipid metabolic process;lipid
met WIPI2 7p22.1 0.149 0.254 0.774 autophagic vacuole fusion;autophagy
mut PDE10A 6q26 0.149 0.254 0.774 signal transduction;blood coagulation
cop PHLDA2 11p15.4 0.149 0.254 0.774 apoptotic process;organ
morphogenesis
cop NAP1L4 11p15.5 0.149 0.254 0.774 nucleosome assembly
cop SNORA54 0.149 0.254 0.774
cop CARS 11p15.5 0.149 0.254 0.774 tRNA aminoacylation for protein
mut PCDH10 4q28.3 0.149 0.254 0.774 cell adhesion;homophilic cell
adhesion
exp ANKRD20A2 0.149 0.254 0.774
exp LCLAT1 2p23.1 0.149 0.254 0.774 multicellular organismal
xsq WDR25 14q32.2 0.149 0.254 0.774
exp GINM1 6q25.1 -0.149 0.254 0.774
met IL37 2q12-q14.1 -0.149 0.254 0.774 immune response
exp MPP3 17q21.31 -0.149 0.254 0.774 signal transduction
cop TENM2 5q34 -0.149 0.254 0.774
cop ANGPT1 8q23.1 -0.149 0.254 0.774 anti-apoptosis;cell
differentiation
exp FAM229B 6q21 -0.149 0.254 0.774
xsq C3orf14 3p14.2 -0.149 0.254 0.774
met OR1F2P 16p13.3 -0.149 0.254 0.774 response to stimulus
exp WI2-2373I1.2 -0.149 0.254 0.774
xsq SACS-AS1 -0.149 0.254 0.774
xsq NCOA2 8q13.3 -0.149 0.254 0.774 regulation of transcription, DNA-
exp NRAV -0.149 0.254 0.774
xsq PCDHGA3 5q31 -0.149 0.254 0.774 cell adhesion;homophilic cell
adhesion
cop PCMTD1 8q11.23 -0.15 0.254 0.774 protein modification process
xsq ZNF528-AS1 -0.15 0.254 0.774
met B3GALT6 1p36.33 -0.15 0.254 0.774 protein
met GDI2 10p15 -0.15 0.254 0.774 signal transduction;small GTPase mediated
signal transduction
xsq TRIM44 11p13 -0.15 0.254 0.774
exp SEC61G 7p11.2 -0.15 0.254 0.774 antigen processing and presentation
of exogenous peptide antigen via MHC class I;cellular protein metabolic process
exp CD274 9p24 -0.15 0.254 0.774 immune response;signal transduction
met ATG7 3p25.3 -0.15 0.254 0.774 protein modification process;protein
transport
xsq PTPRM 18p11.2 -0.15 0.254 0.773 negative regulation of
angiogenesis;negative regulation of endothelial cell proliferation
mut MYH9 22q13.1 -0.15 0.254 0.773 membrane protein ectodomain
exp C5orf24 5q31.1 -0.15 0.254 0.773
exp PTGES 9q34.3 -0.15 0.254 0.773 prostaglandin biosynthetic process;fatty
exp LRRC8A 9q34.11 -0.15 0.254 0.773 pre-B cell differentiation;cell
differentiation
exp CRYL1 13q12.11 -0.15 0.254 0.773 fatty acid metabolic process
xsq LINC01594 -0.15 0.254 0.773
xsq ENPP2 8q24.1 -0.15 0.254 0.773 phosphatidylcholine catabolic
xsq GATA2-AS1 -0.15 0.254 0.773
mut GRASP 12q13.13 -0.15 0.254 0.773 signal transduction;protein localization
hs4 PPFIA2 12q21.31 -0.151 0.254 0.774 cell-matrix adhesion
xai LHPP 10q26.13 -0.151 0.254 0.774 protein
hs4 ITGB3 17q21.32 -0.151 0.254 0.774 integrin-mediated signaling
signaling pathway
hs4 FGF12 3q28 -0.151 0.254 0.774 signal transduction;JNK cascade
hs4 LOC100506474 -0.151 0.254 0.774
exp KRT8P9 15q23 -0.151 0.254 0.774
xai CHL1-AS2 3p26.3 -0.151 0.254 0.774
xai KRT18P19 2q32.2 -0.151 0.254 0.774
his MIR6506 -0.151 0.254 0.774
dependent"
hs4 PMP22 17p12 -0.151 0.254 0.774 peripheral nervous system
development;negative regulation of cell proliferation
his LOC101927476 -0.151 0.254 0.774
hs4 CARD6 5p13.1 -0.151 0.254 0.773 regulation of apoptotic process
hs4 KPNA4 3q25.33 -0.151 0.254 0.773 NLS-bearing substrate import into
his LOC102723886 -0.151 0.254 0.773
xai STK32A 5q32 -0.151 0.254 0.773
hs4 LIMA1 12q13 -0.151 0.254 0.773 negative regulation of actin filament
depolymerization;ruffle organization
xai YWHAB 20q13.1 -0.151 0.254 0.773 small GTPase mediated signal
xai CHST15 10q26 -0.151 0.254 0.773 hexose biosynthetic process
his AVPR2 Xq28 -0.151 0.254 0.773 G-protein signaling, coupled to cAMP
nucleotide second messenger;interferon-gamma production
swa ZMYM3 Xq13.1 -0.151 0.254 0.773 multicellular organismal
his CCDC3 10p13 -0.151 0.254 0.773
his OPTN 10p13 -0.151 0.254 0.773 protein targeting to Golgi;Golgi
organization
hs4 LOC100506207 -0.151 0.254 0.773
hs4 SLC35B3 6p24.3 -0.151 0.254 0.773 Solute Carriers
his KLHL30 2q37.3 -0.151 0.254 0.773
hs4 LAMP1 13q34 -0.151 0.254 0.773 autophagy;autophagic cell death
his CH25H 10q23 -0.151 0.254 0.773 bile acid metabolic process;sterol
his NCKAP1 2q32 -0.151 0.254 0.773 Apoptosis
hs4 CCDC114 19q13.33 0.151 0.255 0.774
hs4 EMP3 19q13.3 0.151 0.255 0.774 EMT (Mesenchymal)
hs4 UTP3 4q13.3 0.151 0.255 0.774 chromatin modification;multicellular
swa EPRS 1q41 0.151 0.255 0.774 glutamyl-tRNA aminoacylation;prolyl-tRNA
aminoacylation
exp LOC400927 22q13.1 0.151 0.255 0.774
his AGBL3 7q33 0.151 0.255 0.774 proteolysis
xai CLDN15 7q11.22 0.151 0.255 0.774 calcium-independent cell-cell
hs4 RRM1 11p15.5 0.151 0.255 0.774 DNA Damage Response (DDR)
hs4 KIRREL2 19q13.12 0.151 0.255 0.774 cell adhesion
his CAND1 12q14 0.151 0.255 0.774 regulation of transcription, DNA-
hs4 MAML3 4q28 0.151 0.255 0.774 positive regulation of transcription from RNA
his KTI12 1p32.3 0.151 0.255 0.774
his SART1 11q13.1 0.151 0.255 0.774 Apoptosis
his GSPT2 Xp11.22 0.151 0.255 0.774 translational termination;cell cycle
xai ZNF299P 21q21.1 0.151 0.255 0.774
xai JARID2 6p24-p23 0.151 0.255 0.774 multicellular organismal
hs4 ZMYND19 9q34.3 0.151 0.255 0.774
his ILKAP 2q37.3 0.151 0.255 0.774 protein dephosphorylation;regulation of S
phase of mitotic cell cycle
his CHRNA6 8p11.21 0.151 0.255 0.774 cation transport;signal
transduction
his TRRAP 7q21.2-q22.1 0.151 0.255 0.774 Apoptosis; Oncogenes
his MIR3609 0.151 0.255 0.774
his SCARNA28 0.151 0.255 0.774
xai BDH2P1 6q16.2 0.151 0.255 0.774
swa MSI2 17q22 0.151 0.255 0.774 stem cell development
his TBL1XR1 3q26.32 0.151 0.255 0.774 Cell Signaling
xai FLJ27354 0.151 0.255 0.774
xai MAST1 19p13.2 0.151 0.255 0.774 cytoskeleton organization;intracellular
xai TBX20 7p14.3 0.151 0.255 0.774 endoderm formation;cardiac right
his CDK17 12q23.1 0.15 0.255 0.775 Protein Kinases
his TMEM238 19q13.42 0.15 0.255 0.775
his RPL28 19q13.4 0.15 0.255 0.775
his MIR6805 0.15 0.255 0.775
xai PARVB 22q13.2-q13.33 0.15 0.255 0.775 cell adhesion;cell junction
assembly
exp ZNF299P 21q21.1 0.15 0.255 0.775
xai UBE2T 1q32.1 0.15 0.255 0.775 DNA Damage Response (DDR); DDR (FA)
his GAS5-AS1 0.15 0.255 0.775
his SNORD81 0.15 0.255 0.775
his SNORD47 0.15 0.255 0.775
his SNORD80 0.15 0.255 0.775
his SNORD79 0.15 0.255 0.775
his SNORD78 0.15 0.255 0.775
his SNORD44 0.15 0.255 0.775
his SNORA103 0.15 0.255 0.775
his SNORD77 0.15 0.255 0.775
his SNORD76 0.15 0.255 0.775
his SNORD75 0.15 0.255 0.775
his SNORD74 1q25.1 0.15 0.255 0.775
his GAS5 1q25.1 0.15 0.255 0.775
dependent"
exp TCEANC Xp22.2 0.149 0.255 0.774 transcription, DNA-
xsq PCGF6 10q24.33 0.149 0.255 0.774 negative regulation of transcription,
DNA-dependent"
met CDK2 12q13 0.149 0.255 0.774 DNA Damage Response (DDR); DDR (DNA
replication); Protein Kinases
exp PTCH1 9q22.3 0.149 0.255 0.774 Tumor Suppressors
xsq SNORA63 0.149 0.255 0.774
exp WDR25 14q32.2 0.149 0.255 0.774
mut IGSF10 3q25.1 0.149 0.255 0.774 multicellular organismal
mut HOXD11 2q31.1 0.149 0.255 0.774 skeletal system
mut TMEM63A 1q42.12 0.149 0.255 0.774
xsq CASC20 0.149 0.255 0.774
exp MIF4GD 17q25.1 0.149 0.255 0.774 RNA metabolic process;regulation of
translation
cop OTUD7B 1q21.2 0.149 0.255 0.774 proteolysis;protein
deubiquitination
met GFM2 5q13 0.149 0.255 0.774 mitochondrial translational elongation;GTP
catabolic process
exp MKI67IPP1 0.149 0.255 0.774
mut C4orf26 4q21.1 0.149 0.255 0.774
xsq DRP2 Xq22 0.149 0.255 0.774 central nervous system development
met ERC2 3p14.3 0.149 0.255 0.774
met GLB1L 2q35 0.149 0.255 0.774 carbohydrate metabolic process
met ROMO1 20q11.22 0.149 0.255 0.774 defense response to bacterium;positive
regulation of reactive oxygen species metabolic process
exp PMS2CL 7p22.1 0.149 0.255 0.774 mismatch repair;somatic
hypermutation of immunoglobulin genes
xsq OR13F1 9q31.1 0.149 0.255 0.774
exp SLC25A14 Xq24 0.149 0.255 0.774 Solute Carriers
xsq OR7E5P 0.149 0.255 0.774
xsq GTSE1 22q13.2-q13.3 0.149 0.255 0.774 G2 phase of mitotic cell cycle;DNA
arrest
xsq DMXL2 15q21.2 0.149 0.255 0.774
met MYLIP 6p23-p22.3 0.149 0.255 0.774 protein ubiquitination;protein
destabilization
dependent"
cop WNT8B 10q24 0.149 0.255 0.774 Apoptosis; Oncogenes
mut PDE1A 2q32.1 0.149 0.255 0.774 signal transduction;epidermal growth
xsq SS18L2 3p21 0.149 0.255 0.774
mut AGXT2 5p13 0.149 0.255 0.774 glyoxylate metabolic process;nucleobase-
exp RPS17P6 1q24.1 0.149 0.255 0.774
xsq CYCS 7p15.3 0.149 0.255 0.774 Apoptosis
xsq FAM184B 4p16 0.149 0.255 0.774
exp APPL1 3p21.1-p14.3 0.149 0.255 0.774 signal transduction;cell
proliferation
exp R3HDM4 19p13.3 0.149 0.255 0.774
cop ANP32A 15q23 0.149 0.255 0.774 regulation of transcription, DNA-
cop PIEZO2 18p11.22 0.149 0.255 0.774 ion transport
mut DRD1 5q35.1 0.149 0.255 0.774 response to amphetamine;activation of
adenylate cyclase activity by dopamine receptor signaling pathway
mut OR1N2 9q33.2 0.149 0.255 0.774 response to stimulus
cop PACS2 14q32.33 0.149 0.255 0.774 apoptotic process;interspecies
xsq SREK1IP1 5q12.3 0.149 0.255 0.774 mRNA processing;RNA splicing
mut MTUS1 8p22 0.149 0.255 0.775
met DSCC1 8q24.12 0.149 0.255 0.775 cell cycle;maintenance of mitotic sister
chromatid cohesion
xsq LOC200772 0.149 0.255 0.775
exp LAT2 7q11.23 0.149 0.255 0.775 intracellular signal transduction;B cell
activation
xsq PABPC1L2A Xq13.2 0.149 0.255 0.775
exp LINC00973 -0.149 0.255 0.775
cop ARMC8 3q22.3 -0.149 0.255 0.775
cop NME9 3q22.3 -0.149 0.255 0.775 GTP biosynthetic process;UTP
xsq CRYBB3 22q11.23 -0.149 0.255 0.775 visual perception
exp COL10A1 6q21-q22 -0.149 0.255 0.775 skeletal system development
mut SRSF5 14q24 -0.149 0.255 0.775 RNA splicing;gene expression
xsq AFP 4q13.3 -0.149 0.255 0.775 progesterone metabolic
process;ovulation from ovarian follicle
cop FAM9A Xp22.32 -0.149 0.255 0.775
cop CHSY3 5q23.3 -0.149 0.255 0.775
cop SCAND1 20q11.1-q11.23 -0.149 0.255 0.774 regulation of
transcription, DNA-dependent;viral reproduction"
cop PRODH 22q11.21 -0.149 0.255 0.774 proline catabolic process;induction
of apoptosis by oxidative stress
xsq ECSCR 5q31.2 -0.149 0.255 0.774 angiogenesis;chemotaxis
mut WFIKKN2 17q21.33 -0.149 0.255 0.774 transforming growth factor
exp DUSP5 10q25 -0.149 0.255 0.774 endoderm formation;protein
dephosphorylation
exp TMEM108 3q21 -0.149 0.255 0.774
exp TUBA1C 12q13.12 -0.149 0.255 0.774 microtubule-based
process;microtubule-based movement
met CDKN2B-AS1 9p21.3 -0.149 0.255 0.774
xsq LINC01186 -0.149 0.255 0.774
exp LINC00643 14q23.2 -0.149 0.255 0.774
exp RTKN 2p13.1 -0.149 0.255 0.774 Apoptosis
met LINC00160 21q22.12 -0.149 0.255 0.774
met PYY2 17q11 -0.149 0.255 0.774
met MB 22q13.1 -0.149 0.255 0.774 response to hydrogen
peroxide;enucleate erythrocyte differentiation
exp IL1RL2 2q12 -0.149 0.255 0.774 cellular defense response;signal
transduction
exp LRRC16A 6p22.2 -0.149 0.255 0.774 lamellipodium assembly;ruffle
organization
met MSTO2P 1q22 -0.149 0.255 0.774
met C7 5p13 -0.149 0.255 0.774 cytolysis;innate immune response
his MIR6510 -0.15 0.255 0.775
his KRT19 17q21.2 -0.15 0.255 0.775 cell differentiation involved in
his LINC00974 -0.15 0.255 0.775
xai EPB41L4A-AS2 -0.15 0.255 0.775
hs4 ELF3 1q32.2 -0.151 0.255 0.774 Transcription Factors
his BVES 6q21 -0.151 0.255 0.774 vesicle-mediated transport;regulation of
Rac GTPase activity
his BVES-AS1 -0.151 0.255 0.774
hs4 NUCB1 19q13.33 -0.151 0.255 0.774
hs4 TULP2 19q13.1 -0.151 0.255 0.774 visual perception
swa SNX6 14q13.1 -0.151 0.255 0.774 negative regulation of transforming
growth factor beta receptor signaling pathway;retrograde transport, endosome to
Golgi
his C4orf26 4q21.1 -0.151 0.255 0.774
xai HCFC1R1 16p13.3 -0.151 0.255 0.774
xai MT1G 16q13 -0.151 0.255 0.774 cellular response to zinc ion;monocyte
differentiation
xai CCDC120 Xp11.23 -0.151 0.255 0.774
his FREM1 9p22.3 -0.151 0.255 0.774 multicellular organismal
hs4 LOC101927023 -0.151 0.255 0.774
xai AMOTL1 11q14.3 -0.151 0.255 0.774
his C19orf33 19q13.2 -0.151 0.255 0.774
hs4 HOXC6 12q13.3 -0.151 0.255 0.774 regulation of transcription from
hs4 HOXC5 -0.151 0.255 0.774 regulation of transcription from RNA
hs4 HOXC4 12q13.3 -0.151 0.255 0.774 regulation of transcription, DNA-
his CCDC129 7p14.3 -0.151 0.255 0.774
DNA-dependent"
xai AKIP1 11p15.3 -0.151 0.255 0.774 substrate adhesion-dependent cell
spreading
his GABARAPL3 15q26.1 -0.151 0.255 0.774
DNA-dependent"
xai KRT8P24 15q21.1 -0.151 0.255 0.774
his LOC101928226 -0.151 0.255 0.774
his ABCB4 7q21.1 -0.151 0.255 0.774 ABC Transporters
hs4 JDP2 14q24.3 -0.151 0.255 0.774 negative regulation of
his HGD 3q13.33 -0.151 0.255 0.774 tyrosine catabolic process;cellular
adhesion
xai AKAP13 15q24-q25 -0.151 0.255 0.774 nerve growth factor receptor
xai C9orf57 9q21.13 0.151 0.256 0.775
hs4 TMEM33 4p13 0.15 0.256 0.775
his ADAM10 15q22 0.15 0.256 0.775 proteolysis;positive regulation of cell
proliferation
xai SMOC1 14q24.2 0.15 0.256 0.775 eye development;signal transduction
xai GDPD1 17q22 0.15 0.256 0.775 lipid metabolic process;glycerol metabolic
process
xai LCE4A 1q21.3 0.15 0.256 0.775 keratinization
his FAF2 5q35.2 0.15 0.256 0.775 response to unfolded protein
exp SLC5A5 19p13.11 0.15 0.256 0.775 cellular nitrogen compound
xai SULT1A1 16p12.1 0.15 0.256 0.775 sulfation;catecholamine metabolic
process
xai MUC17 7q22.1 0.15 0.256 0.775 O-glycan processing;cellular homeostasis
his UBE2N 12q22 0.15 0.256 0.775 DNA Damage Response (DDR); DDR (TLS)
hs4 LOC101928295 0.15 0.256 0.775
hs4 CCDC155 19q13.33 0.15 0.256 0.775 protein dephosphorylation
hs4 COMTD1 10q22.2 0.15 0.256 0.775
his TMEM102 17p13.1 0.15 0.256 0.775 signal transduction;response to
cytokine stimulus
his FGF11 17p13.1 0.15 0.256 0.775 nervous system development;signal
transduction
swa PRKRA 2q31.2 0.15 0.256 0.775 immune response;skeletal system
morphogenesis
hs4 MLF2 12p13 0.15 0.256 0.775 defense response
hs4 TBC1D10B 16p11.2 0.15 0.256 0.775 positive regulation of Rab GTPase
activity;regulation of Rab GTPase activity
exp RPL21P32 2q32.1 0.15 0.256 0.775
hs4 DYDC1 10q23.1 0.15 0.256 0.775
hs4 DYDC2 10q23.1 0.15 0.256 0.775
xai RITA1 0.15 0.256 0.775 nuclear export;negative regulation of
his SNORA16B 0.15 0.256 0.775
xai MAMSTR 19q13.33 0.15 0.256 0.775 regulation of transcription, DNA-
exp RNU4-2 0.15 0.256 0.775
swa MERTK 2q14.1 0.15 0.256 0.775 spermatogenesis;negative regulation of
xai ORAI2 7q22.1 0.15 0.256 0.775
his SPATA25 20q13.12 0.15 0.256 0.775 spermatogenesis;cell
differentiation
his CTSA 20q13.1 0.15 0.256 0.775 positive regulation of catalytic
his NEURL2 20q13.12 0.15 0.256 0.775 intracellular signal
transduction;sarcomere organization
his RNF10 12q24.31 0.15 0.256 0.775 negative regulation of Schwann cell
hs4 LOC400464 15q26.3 0.15 0.256 0.775
hs4 DNM1P46 0.15 0.256 0.775
his PAXIP1-AS2 0.15 0.256 0.775
hs4 RPL10 Xq28 0.15 0.256 0.775 translation;mRNA metabolic process
hs4 SNORA70 0.15 0.256 0.775
xai MTBP 8q24.12 0.15 0.256 0.775 DDR (DNA replication)
his RNU4ATAC 2q14.2 0.15 0.256 0.775
hs4 DIAPH1 5q31 0.15 0.256 0.775 regulation of microtubule-based
his GDF11 12q13.2 0.15 0.256 0.775 nervous system development;cell
maturation
his TMEM134 11q13.2 0.15 0.256 0.775
his DCTN6 8p12-p11 0.15 0.256 0.775
xai COL18A1-AS1 0.15 0.256 0.775
his RPS4X Xq13.1 0.15 0.256 0.775 translational elongation;mRNA metabolic
process
hs4 SENP6 6q13-q14.3 0.15 0.256 0.775 protein modification by small protein
his ZAK 2q24.2 0.15 0.256 0.775
xai VWDE 7p21.3 0.15 0.256 0.775
xai LIMD1-AS1 0.15 0.256 0.775
xai C6orf136 6p21.33 0.15 0.256 0.775
met TFAP2C 20q13.2 0.149 0.256 0.775 trophectodermal cell
exp DEFA1 8p23.1 0.149 0.256 0.775
exp PRKACB 1p31.1 0.149 0.256 0.775 Protein Kinases
exp SPRED2 2p14 0.149 0.256 0.775 multicellular organismal
xsq TMEM203 9q34.3 0.149 0.256 0.775
cop CACNA1G 17q22 0.149 0.256 0.775 transport;ion transport
mut FGD1 Xp11.21 0.149 0.256 0.775 organ morphogenesis;apoptotic process
met HDAC7 12q13.1 0.149 0.256 0.775 vasculogenesis;cell-cell junction
assembly
met TNFAIP3 6q23 0.149 0.256 0.775 Apoptosis; Tumor Suppressors
cop PAPOLA 14q32.31 0.149 0.256 0.775 RNA splicing;gene expression
cop EIF2AK3 2p12 0.149 0.256 0.775 skeletal system development;response to
unfolded protein
met LDHC 11p15.1 0.149 0.256 0.775 glycolysis;cellular carbohydrate
metabolic process
xsq TMEM249 8q24.3 0.149 0.256 0.775
mut GZF1 20p11.21 0.149 0.256 0.775 negative regulation of transcription from
RNA polymerase II promoter;branching involved in ureteric bud morphogenesis
xsq SMPD2 6q21 0.149 0.256 0.775 ceramide biosynthetic process;sphingolipid
metabolic process
mut HUWE1 Xp11.22 0.149 0.256 0.775 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;protein polyubiquitination
xsq LDHA 11p15.4 0.149 0.256 0.775 pyruvate metabolic process;glycolysis
xsq BSND 1p32.1 0.149 0.256 0.775 chloride transport
cop MYT1L 2p25.3 0.149 0.256 0.775 multicellular organismal
xsq OR5AS1 11q12.1 0.149 0.256 0.775
cop FEM1B 15q22 0.149 0.256 0.775 Apoptosis
xsq FOXD4L6 0.149 0.256 0.775
cop IMMT 2p11.2 0.149 0.256 0.775
cop NRXN2 11q13 0.149 0.256 0.775 neuroligin clustering;postsynaptic density
xsq GATB 0.149 0.256 0.775 translation;mitochondrial translation
cop PTRHD1 2p23.3 0.149 0.256 0.775
cop FRYL 4p11 0.149 0.256 0.775 regulation of transcription, DNA-dependent"
exp CMAS 12p12.1 0.149 0.256 0.775 lipopolysaccharide biosynthetic process
met CNST 1q44 0.149 0.256 0.775 negative regulation of phosphatase
exp CUL2 10p11.21 0.149 0.256 0.775 Apoptosis
cop PCAT1 0.149 0.256 0.775
met SRRM5 19q13.31 0.149 0.256 0.775
xsq TMTC4 13q32.3 0.149 0.256 0.775
xsq SLX1A-SULT1A3 0.149 0.256 0.775
xsq OR56A1 11p15.4 0.149 0.256 0.775 response to stimulus
xsq EDC3 15q24.1 0.149 0.256 0.775 RNA metabolic process;mRNA metabolic
process
exp SAMD3 6q23.1 0.149 0.256 0.775
exp NUDCD1 8q23 0.149 0.256 0.775
xsq CEBPA-AS1 19q13.11 0.149 0.256 0.775
xsq NLRP13 19q13.43 0.149 0.256 0.775
xsq MYOT 5q31 0.149 0.256 0.775 muscle contraction
mut DHX38 16q22 0.149 0.256 0.775 RNA splicing;gene expression
xsq MED12 Xq13 0.149 0.256 0.775 Oncogenes
xsq ATP5C1 10p15.1 0.149 0.256 0.775 ATP biosynthetic process;ion
transport
xsq AQP2 12q12-q13 0.149 0.256 0.775 hyperosmotic response;actin filament
depolymerization
cop LINGO1 15q24.3 0.149 0.256 0.775 negative regulation of
oligodendrocyte differentiation;regulation of axonogenesis
cop LOC253044 0.149 0.256 0.775
xsq CCNT2 2q21.3 0.149 0.256 0.775 regulation of cyclin-dependent protein
exp FLJ13224 12p11.21 0.149 0.256 0.775
exp FAM53B 10q26.13 0.149 0.256 0.775
met CCDC173 2q31.1 0.149 0.256 0.775
met PRDM14 8q13.3 0.149 0.256 0.775 regulation of transcription, DNA-
dependent;germ cell development
cop CHAC1 15q15.1 0.149 0.256 0.775 response to unfolded protein;apoptosis in
response to endoplasmic reticulum stress
exp CYBA 16q24 0.149 0.256 0.775 transport;response to drug
cop PPIAL4F 0.149 0.256 0.775
cop PPIAL4D 0.149 0.256 0.775
cop PPIAL4E 0.149 0.256 0.775
cop NBPF14 0.149 0.256 0.775
cop NBPF15 1q21.2 0.149 0.256 0.775
cop NBPF16 0.149 0.256 0.775
xsq RNF186 1p36.13 0.149 0.256 0.775
cop LOC100133461 0.149 0.256 0.775
met TAS2R60 7q35 0.149 0.256 0.775 response to stimulus;sensory perception
of bitter taste
cop SNAP23 15q14 0.149 0.256 0.775 exocytosis;post-Golgi vesicle-mediated
transport
exp REPIN1 7q36.1 0.149 0.256 0.775 DNA replication
cop ST18 8q11.23 -0.149 0.256 0.775 negative regulation of
cop SMAD5-AS1 -0.149 0.256 0.775
xsq HS1BP3-IT1 -0.149 0.256 0.775
met AQP1 7p14 -0.149 0.256 0.775 cell volume homeostasis;establishment or
met TAF6L 11q12.3 -0.149 0.256 0.775 chromatin remodeling;transcription
mut TBX3 12q24.21 -0.149 0.256 0.775 atrioventricular bundle cell
differentiation;specification of organ position
xsq ZFYVE9 1p32.3 -0.149 0.256 0.775 endocytosis;transforming
xsq TMEM133 11q22.1 -0.149 0.256 0.775
exp RIN3 14q32.12 -0.149 0.256 0.775 endocytosis;signal transduction
exp TCF7L2 10q25.3 -0.149 0.256 0.775 regulation of transcription
exp ZNF750 17q25.3 -0.149 0.256 0.775
exp C1QTNF5 -0.149 0.256 0.775
exp LOC100288568 -0.149 0.256 0.775
mut NBAS 2p24 -0.149 0.256 0.775
xsq DYNLRB2 16q23.3 -0.149 0.256 0.775 transport;microtubule-based
movement
exp KRT8P24 15q21.1 -0.149 0.256 0.775
xsq TMEM98 17q11.2 -0.149 0.256 0.775
cop RB1CC1 8q11 -0.149 0.256 0.775 regulation of autophagy;autophagic
vacuole assembly
cop NPBWR1 8p22-q21.13 -0.149 0.256 0.775
exp PCDHB13 5q31 -0.149 0.256 0.775 homophilic cell adhesion;synaptic
transmission
exp IER5L 9q34.11 -0.149 0.256 0.775
exp NDEL1 17p13.1 -0.149 0.256 0.775 M phase of mitotic cell
cycle;multicellular organismal development
exp WNT7A 3p25 -0.149 0.256 0.775 Apoptosis; Oncogenes
exp AP5Z1 7p22.2 -0.149 0.256 0.775 double-strand break repair via
homologous recombination;DNA repair
mut HCFC1 Xq28 -0.149 0.256 0.775 histone H4-K8 acetylation;negative
xsq ARHGEF35 7q35 -0.149 0.256 0.775
xsq SSX9 Xp11.23 -0.149 0.256 0.775
cop FAM150A 8q11.23 -0.149 0.256 0.775
xsq CD82 11p11.2 -0.149 0.256 0.775
exp TRAM1L1 4q26 -0.149 0.256 0.775 protein transport
exp HPN 19q13.12 -0.149 0.256 0.775 negative regulation of apoptotic
process;positive regulation of hepatocyte proliferation
exp SEL1L 14q31 -0.149 0.256 0.775 Notch signaling pathway
xai MMP24 20q11.2 -0.15 0.256 0.775 Apoptosis
his GRIK3 1p34.3 -0.15 0.256 0.775 regulation of membrane potential;negative
regulation of synaptic transmission, glutamatergic
his MIR4724 -0.15 0.256 0.775
his LINC01797 -0.15 0.256 0.775
xai C1orf115 1q41 -0.15 0.256 0.775
xai DNAH9 17p12 -0.15 0.256 0.775 cellular component movement;microtubule-based
movement
xai MEGF9 9q32-q33.3 -0.15 0.256 0.775
hs4 TRIM34 -0.15 0.256 0.775 protein trimerization
xai WNT2B 1p13 -0.15 0.256 0.775 Apoptosis; Oncogenes
hs4 LINC00467 1q32.3 -0.15 0.256 0.775
his LOC149684 -0.15 0.256 0.775
his KIAA1755 20q11.23 -0.15 0.256 0.775
swa SNTB2 16q22.1 -0.15 0.256 0.775
xai PHAX 5q23.2 -0.15 0.256 0.775 gene expression;protein transport
xai ARHGAP31 3q13.33 -0.15 0.256 0.775 regulation of small GTPase mediated
hs4 TRIM29 11q23.3 -0.15 0.256 0.775 regulation of transcription, DNA-
xai MACROD2-AS1 -0.15 0.256 0.775
his LOC105374960 -0.15 0.256 0.775
his MIR4792 -0.15 0.256 0.775
his MIR371A -0.15 0.256 0.775
his MIR371B -0.15 0.256 0.775
his MIR372 -0.15 0.256 0.775
his MIR373 -0.15 0.256 0.775
hs4 ZNF28 19q13.41 -0.15 0.256 0.775 regulation of transcription, DNA-
dependent"
his SEC14L2 22q12.2 -0.15 0.256 0.775 regulation of cholesterol
biosynthetic process;positive regulation of transcription, DNA-dependent"
his GNGT1 7q21.3 -0.15 0.256 0.775 synaptic transmission;phototransduction
his GNG11 7q21 -0.15 0.256 0.775 GTP catabolic process;signal transduction
swa BCKDK 16p11.2 -0.15 0.256 0.775 branched chain family amino acid
his C9orf106 9q34.11 -0.15 0.256 0.775
his TP53TG1 7q21.1 -0.15 0.256 0.775 response to stress;response to DNA
damage stimulus
his CROT 7q21.1 -0.15 0.256 0.775 fatty acid metabolic process;fatty acid
beta-oxidation
his LOC105371414 -0.15 0.256 0.775
hs4 NEIL1 15q24.2 -0.15 0.256 0.775 DNA Damage Response (DDR); DDR (BER)
cop MIR206 -0.152 0.256 0.775
xai ITPR1-AS1 0.15 0.257 0.775
his PPP2R5B 11q12 0.15 0.257 0.775 activation of signaling protein activity
hs4 PUM2 2p22-p21 0.15 0.257 0.775 regulation of translation
his THAP1 8p11.21 0.15 0.257 0.775 transcription, DNA-dependent;regulation
hs4 RNASEH2A 19p13.2 0.15 0.257 0.775 DNA Damage Response (DDR); DDR (DNA
replication)
his SNORA15 0.15 0.257 0.775
his SUMF2 7q11.1 0.15 0.257 0.775
hs4 FAM110A 20p13 0.15 0.257 0.775
xai RNU4-2 0.15 0.257 0.775
hs4 GAS2L2 17q12 0.15 0.257 0.775 negative regulation of microtubule
depolymerization;cell cycle arrest
hs4 C9orf16 9q34.1 0.15 0.257 0.775
exp LOC100507346 0.15 0.257 0.775
xai GCH1 14q22.1-q22.2 0.15 0.257 0.775 induction of apoptosis;pteridine-
xai ZNRD1-AS1 6p22.1 0.15 0.257 0.775
xai ARIH1 15q24 0.15 0.257 0.775 cytokine-mediated signaling pathway;ubiquitin-
his MYH7 14q12 0.15 0.257 0.775 response to reactive oxygen species;regulation
of heart rate
hs4 FYCO1 3p21.31 0.15 0.257 0.775 transport;plus-end-directed vesicle
exp LOC339529 0.15 0.257 0.775
his HIGD2B 0.15 0.257 0.775
his BBS4 15q22.3-q23 0.15 0.257 0.775 microtubule cytoskeleton
organization;striatum development
xai IL17RA 22q11.1 0.15 0.257 0.775 cell surface receptor signaling
his HDAC10 22q13.31 0.15 0.257 0.775 negative regulation of
dependent
hs4 CYTH1 17q25 0.15 0.257 0.775 vesicle-mediated transport;regulation of cell
adhesion
xai WIPF1 2q31.1 0.15 0.257 0.775 positive regulation of protein export
xai CMAHP 6p21.32 0.15 0.257 0.775
hs4 LIMD1 3p21.3 0.15 0.257 0.775 cell migration;cytoplasmic mRNA
his HTRA3 4p16.1 0.15 0.257 0.775 regulation of cell growth;proteolysis
his FAM89A 1q42.2 0.15 0.257 0.775
xai DDX46 5q31.1 0.15 0.257 0.775 RNA splicing;mRNA processing
his LOC101927139 0.15 0.257 0.775
hs4 TMEM238 19q13.42 0.15 0.257 0.775
hs4 RPL28 19q13.4 0.15 0.257 0.775
hs4 MIR6805 0.15 0.257 0.775
cop CIRBP-AS1 19p13.3 0.15 0.257 0.775
cop CIRBP 19p13.3 0.15 0.257 0.775 response to cold;response to UV
cop C19orf24 19p13.3 0.15 0.257 0.775
cop EFNA2 19p13.3 0.15 0.257 0.775 axon guidance;olfactory bulb development
cop MUM1 19p13.3 0.15 0.257 0.775 DNA repair;chromatin organization
cop NDUFS7 19p13.3 0.15 0.257 0.775 transport;respiratory electron
transport chain
cop GAMT 19p13.3 0.15 0.257 0.775 creatine metabolic process;creatine
cop DAZAP1 19p13.3 0.15 0.257 0.775 multicellular organismal
cop RPS15 19p13.3 0.15 0.257 0.775 ribosomal small subunit export from
cop APC2 19p13.3 0.15 0.257 0.775 Wnt receptor signaling pathway;negative
regulation of catenin import into nucleus
cop C19orf25 19p13.3 0.15 0.257 0.775
cop PCSK4 19p13.3 0.15 0.257 0.775 fertilization;sperm capacitation
cop REEP6 19p13.3 0.15 0.257 0.775
cop ADAMTSL5 19p13.3 0.15 0.257 0.775
cop PLK5 19p13.3 0.15 0.257 0.775 transformed cell apoptosis;regulation of
G1/S transition of mitotic cell cycle
cop MEX3D 19p13.3 0.15 0.257 0.775 posttranscriptional regulation of gene
cop MBD3 19p13.3 0.15 0.257 0.775 negative regulation of transcription from
cop UQCR11 19p13.3 0.15 0.257 0.775 generation of precursor metabolites
cop TCF3 19p13.3 0.15 0.257 0.775 transcription, DNA-dependent;response to
drug
his SLCO4A1 20q13.33 0.15 0.257 0.775 Solute Carriers
swa RBM39 20q11.22 0.15 0.257 0.775 regulation of transcription, DNA-
hs4 ARHGDIA 17q25.3 0.15 0.257 0.775 Apoptosis
xai NDN 15q11.2-q12 0.15 0.257 0.775 central nervous system development;axon
hs4 AGMAT 1p36.21 0.15 0.257 0.775 polyamine metabolic process;spermidine
xai EXOC2 6p25.3 0.15 0.257 0.775 exocytosis;protein transport
his DBR1 3q22.3 0.15 0.257 0.775 nuclear mRNA splicing, via
xai TAF11 6p21.31 0.15 0.257 0.775 regulation of transcription, DNA-
his DNTT 10q23-q24 0.15 0.257 0.775 DNA Damage Response (DDR); DDR (NHEJ);
his LINC01483 0.15 0.257 0.775
hs4 KLRC2 0.15 0.257 0.775 cellular defense response;signal transduction
his PPIL4 6q25.1 0.15 0.257 0.775 protein folding
dependent"
mut HEATR1 1q43 0.149 0.257 0.775 rRNA processing
met SIM1 6q16.3 0.149 0.257 0.775 cell differentiation;ureteric bud
development
xsq RUFY3 4q13.3 0.149 0.257 0.775 cell differentiation;negative regulation
of axonogenesis
xsq CYP4A22 1p33 0.149 0.257 0.775
cop ABCC3 17q22 0.149 0.257 0.775 ABC Transporters
cop MYCBPAP 17q21.33 0.149 0.257 0.775 synaptic transmission;multicellular
cop EPN3 17q21.33 0.149 0.257 0.775
cop SPATA20 17q21.33 0.149 0.257 0.775 mannose metabolic
cop CACNA1G-AS1 0.149 0.257 0.775
xsq KDM4D 11q21 0.149 0.257 0.775 regulation of transcription, DNA-
xsq TRPM5 11p15.5 0.149 0.257 0.775 ion transport
met C20orf24 20q11.23 0.149 0.257 0.775
met IFIT5 10q23.31 0.149 0.257 0.775
cop SH3TC1 4p16.1 0.149 0.257 0.775
met XRCC3 14q32.3 0.149 0.257 0.775 DNA Damage Response (DDR); DDR (NHEJ)
dependent"
xsq FAAP100 0.149 0.257 0.775 DNA Damage Response (DDR); DDR (FA)
cop HCN4 15q24.1 0.149 0.257 0.775 in utero embryonic development;cation
transport
cop C15orf60 0.149 0.257 0.775
met MIR665 0.149 0.257 0.775
met BCL7C 16p11 0.149 0.257 0.775 Apoptosis
exp ING1 13q34 0.149 0.257 0.775 positive regulation of transcription, DNA-
xsq MRPS18A 6p21.3 0.149 0.257 0.775 translation
exp LINC00847 5q35.3 0.149 0.257 0.775
xsq GCM2 6p23 0.149 0.257 0.775 cellular calcium ion homeostasis;multicellular
met MGAM 7q34 0.149 0.257 0.775 carbohydrate metabolic process;starch catabolic
process
met MROH8 20q11.22 0.149 0.257 0.775
cop SLC8A1-AS1 0.149 0.257 0.775
mut PKDREJ 22q13.31 0.149 0.257 0.775 ion transport;neuropeptide
signaling pathway
cop CD276 15q23-q24 0.149 0.257 0.775 cell proliferation;positive regulation of
osteoblast differentiation
xsq PSMB5 14q11.2 0.149 0.257 0.775 cell cycle checkpoint;regulation of
met SPIN4 Xq11.1 0.149 0.257 0.775 gamete generation
cop SCGB2A2 11q13 0.149 0.257 0.775
cop SCGB1D4 0.149 0.257 0.775
xsq BECN2 0.149 0.257 0.775
cop BTG1 12q22 0.149 0.257 0.775 Apoptosis
xsq LTA4H 12q22 0.149 0.257 0.775 prostanoid metabolic process;inflammatory
response
xsq ONECUT3 19p13.3 0.149 0.257 0.775 endocrine pancreas
xsq SLCO1C1 12p12.2 0.149 0.257 0.775 Solute Carriers
xsq IPW 15q11.2 0.149 0.257 0.775
exp SPATA22 17p13.3 0.149 0.257 0.775
met C11orf24 11q13 0.149 0.257 0.775
cop VPS45 1q21.2 0.149 0.257 0.775 intracellular protein transport;vesicle
cop NOX5 15q23 0.149 0.257 0.775 induction of apoptosis;oxidation-reduction
process
exp RWDD4 4q35.1 0.149 0.257 0.775
exp HRASLS5 11q13.2 0.149 0.257 0.775
met SCNN1G 16p12 0.149 0.257 0.775 response to stimulus;sensory perception
of taste
met FAM89B 11q13 0.149 0.257 0.775
xsq SNHG19 0.149 0.257 0.775
met ACVR1C 2q24.1 0.149 0.257 0.775 response to glucose stimulus;lipid
storage
mut KLHL12 1q32.1 0.149 0.257 0.775 Wnt receptor signaling pathway
exp CMTM3 16q21 0.149 0.257 0.775 EMT (Mesenchymal)
mut GAMT 19p13.3 0.149 0.257 0.775 creatine metabolic process;creatine
met PARD3B 2q33.3 0.149 0.257 0.775 cell division;cell cycle
cop REEP1 2p11.2 0.149 0.257 0.775 cell death;protein insertion into
membrane
exp IQCH 15q23 0.149 0.257 0.775
met MMP7 11q21-q22 0.149 0.257 0.775 Apoptosis
xsq GABARAPL2 16q22.1 0.149 0.257 0.775 positive regulation of ATPase
pro G22P1 0.149 0.257 0.775
xsq GDPGP1 15q26.1 0.149 0.257 0.775
xsq TBC1D3P1-DHX40P1 17q23 0.149 0.257 0.775
mut MYLK 3q21 0.148 0.257 0.775 positive regulation of cell migration;bleb
assembly
xsq DIRAS2 9q22.2 -0.149 0.257 0.775 signal transduction;small
cop ALG1L 3q21.2 -0.149 0.257 0.775
exp KCNIP4-IT1 4p15.2 -0.149 0.257 0.775
cop SMG7-AS1 -0.149 0.257 0.775
cop SMG7 1q25 -0.149 0.257 0.775 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;mRNA export from nucleus
cop NCF2 1q25 -0.149 0.257 0.775 response to lipopolysaccharide;innate
immune response
cop ARPC5 1q25.3 -0.149 0.257 0.775 cellular component movement;actin
cop APOBEC4 1q25.3 -0.149 0.257 0.775 mRNA processing
cop CDC42SE2 5q31.1 -0.149 0.257 0.775 phagocytosis;regulation of
cell shape
xsq LOC101929282 -0.149 0.257 0.775
xsq RANBP3L 5p13.2 -0.149 0.257 0.775 intracellular transport
xsq LOC102606466 -0.149 0.257 0.775
met CAPN11 6p12 -0.149 0.257 0.775 proteolysis
exp C20orf194 20p13 -0.149 0.257 0.775
xsq FAM92A1 8q22.1 -0.149 0.257 0.775
exp SCGB1D2 11q13 -0.149 0.257 0.775
cop ARHGAP40 20q11.23 -0.149 0.257 0.775 signal transduction;small
xsq KDELR1 19q13.3 -0.149 0.257 0.775 protein retention in ER
cop FZD6 8q22.3-q23.1 -0.149 0.257 0.775 gonad development;cell
mut TNFAIP8L3 15q21.2 -0.149 0.257 0.775
exp FHOD3 18q12 -0.149 0.257 0.775 cellular component organization;actin
mut TMEM187 Xq28 -0.149 0.257 0.775
xsq MTRNR2L2 -0.149 0.257 0.775
met ZFP36L2 2p22.3-p21 -0.149 0.257 0.775 nuclear-transcribed mRNA
dependent
exp B3GAT1 11q25 -0.149 0.257 0.775 carbohydrate metabolic
met ACTL7B 9q31 -0.149 0.257 0.775
xsq LINC00687 20p12.2 -0.149 0.257 0.775
exp CYLD 16q12.1 -0.149 0.257 0.775 Tumor Suppressors
xsq STARD10 11q13 -0.149 0.257 0.775
cop AMELY Yp11.2 -0.149 0.257 0.775
xsq KLHL14 18q12.1 -0.149 0.257 0.775
xsq FBXO3-AS1 -0.149 0.257 0.775
xsq LOC100233156 -0.149 0.257 0.775
hs4 LOC400710 -0.15 0.257 0.775
xai CPZ 4p16.1 -0.15 0.257 0.775 proteolysis;Wnt receptor signaling
pathway
xai MROH2A 2q37.1 -0.15 0.257 0.775
xai CYP1A1 15q24.1 -0.15 0.257 0.775 amine metabolic process;response to
iron(III) ion
exp PSG10P 19q13.2 -0.15 0.257 0.775
his LIMCH1 4p13 -0.15 0.257 0.775 actomyosin structure organization
his MIR4756 -0.15 0.257 0.775
his BCAS1 20q13.2 -0.15 0.257 0.775
xai EXD2 14q24.1 -0.15 0.257 0.775 nucleobase-containing compound metabolic
process
xai RGMB 5q15 -0.15 0.257 0.775 cell adhesion;signal transduction
hs4 HOXC9 12q13.3 -0.15 0.257 0.775 multicellular organismal development
hs4 HOXC-AS2 -0.15 0.257 0.775
hs4 HOXC-AS1 -0.15 0.257 0.775
his NGF 1p13.1 -0.15 0.257 0.775 transmembrane receptor protein tyrosine
kinase signaling pathway;induction of apoptosis by extracellular signals
his CXCL2 4q21 -0.15 0.257 0.775 response to molecule of bacterial
origin;chemotaxis
exp CYP1A2 15q24.1 -0.15 0.257 0.775 steroid catabolic
his MIR4685 -0.15 0.257 0.775
his FAM134B 5p15.1 -0.15 0.257 0.775 sensory perception of pain
hs4 ARL15 5p15.2 -0.15 0.257 0.775 small GTPase mediated signal transduction
exp IL17REL 22q13.33 -0.15 0.257 0.775
xai VN1R68P 16p11.2 -0.15 0.257 0.775
xai MAATS1 3q12-q13.3 -0.15 0.257 0.775
cop CLDN11 3q26.2-q26.3 -0.15 0.257 0.775 cell adhesion;spermatogenesis
his ME3 11cen-q22.3 -0.15 0.257 0.775 oxidation-reduction process;oxygen
metabolic process
xai IL1RL2 2q12 -0.15 0.257 0.775 cellular defense response;signal
transduction
hs4 MARC2 1q41 -0.15 0.257 0.775 nitrate metabolic process;detoxification of
nitrogen compound
hs4 ITM2B 13q14.3 -0.15 0.257 0.775 nervous system development;apoptotic
process
xai SNRPD3 22q11.23 0.15 0.258 0.775 spliceosomal snRNP assembly;RNA
metabolic process
xai ALDH18A1 10q24.3 0.15 0.258 0.775 small molecule metabolic
process;proline biosynthetic process
cop CLN3 16p12.1 0.15 0.258 0.775 cellular amino acid metabolic
process;lysosome organization
cop APOBR 16p11 0.15 0.258 0.775 triglyceride metabolic process;transport
cop IL27 16p11 0.15 0.258 0.775 inflammatory response;response to bacterium
his ATPAF1 1p33-p32.3 0.15 0.258 0.775 protein complex assembly
his TEX38 1p33 0.15 0.258 0.775
his NDUFB10 16p13.3 0.15 0.258 0.775 mitochondrial electron transport,
his SNORA10 0.15 0.258 0.775
his SNORA64 0.15 0.258 0.775
his RPS2 16p13.3 0.15 0.258 0.775 translation;mRNA metabolic process
his SNHG9 0.15 0.258 0.775
his SNORA78 0.15 0.258 0.775
his RNF151 0.15 0.258 0.775
swa DHX38 16q22 0.15 0.258 0.776 RNA splicing;gene expression
xai USP24 1p32.3 0.15 0.258 0.776 proteolysis;ubiquitin-dependent protein
catabolic process
hs4 LINC00920 0.15 0.258 0.776
hs4 CD1A 1q23.1 0.15 0.258 0.776 immune response;antigen processing and
presentation
his ZNF780A 19q13.2 0.15 0.258 0.776 regulation of transcription, DNA-
dependent"
his LOC101928370 0.15 0.258 0.776
his S1PR1 1p21 0.15 0.258 0.776 cell adhesion;positive regulation of Ras GTPase
activity
xai ASNSD1 2p24.3-q21.3 0.15 0.258 0.776 asparagine biosynthetic
his PINX1 8p23 0.15 0.258 0.776 DNA Damage Response (DDR)
his LOC101929229 0.15 0.258 0.776
his DYNC1LI1 3p22.3 0.15 0.258 0.776 cell cycle;mitosis
his RNASE6 14q11.2 0.15 0.258 0.776 RNA catabolic process;defense
response
hs4 SRSF1 17q22 0.15 0.258 0.776 transcription from RNA polymerase II
exp SUGT1P2 0.15 0.258 0.776
xai HDGF 1q23.1 0.15 0.258 0.776 regulation of transcription, DNA-
response
hs4 CARNMT1 0.15 0.258 0.776
his ARHGEF1 19q13.13 0.15 0.258 0.776 regulation of axonogenesis;negative
regulation of axonogenesis
his INTS3 1q21.3 0.15 0.258 0.776 DNA repair;response to DNA damage
stimulus
xai CENPM 22q13.2 0.15 0.258 0.776 M phase of mitotic cell cycle;mitotic
prometaphase
swa LUC7L3 17q21.33 0.15 0.258 0.776 mRNA processing;apoptotic process
xai PIGR 1q31-q41 0.15 0.258 0.776
his RD3L 0.15 0.258 0.776
hs4 OAZ1 19p13.3 0.15 0.258 0.776 regulation of cellular amino acid
xai RABGGTA 14q11.2 0.15 0.258 0.776 protein modification process;visual
perception
hs4 MRPS23 17q22-q23 0.15 0.258 0.776 translation
hs4 ANKRD36B 2q11.2 0.15 0.258 0.776
xai LOC100505616 0.15 0.258 0.776
xai SLC35B4 7q33 0.15 0.258 0.776 EMT (Mesenchymal); Solute Carriers
swa RNPS1 16p13.3 0.15 0.258 0.776 termination of RNA polymerase II
exp CYCSP1 14q24.3 0.15 0.258 0.776
his FAM173B 5p15.2 0.15 0.258 0.776
his CCT5 5p15.2 0.15 0.258 0.776 response to virus;cellular protein
metabolic process
exp CHP2 16p12.2 0.15 0.258 0.776
hs4 CD46 1q32 0.15 0.258 0.776 complement activation, classical pathway;single
fertilization
xai PPP1R9B 17q21.33 0.15 0.258 0.776 RNA splicing;cell migration
hs4 FAM228B 2p23.3 0.15 0.258 0.776
hs4 SF3B6 0.15 0.258 0.776
dependent"
his COQ10A 12q13.3 0.15 0.258 0.776
xai PUM1 1p35.2 0.15 0.258 0.776 regulation of translation;post-Golgi
exp LINC00658 0.15 0.258 0.776
xai SH2D4B 10q23.1 0.149 0.258 0.776
his TARP 7p15-p14 0.149 0.258 0.776
xai FARS2 6p25.1 0.149 0.258 0.776 tRNA processing;gene expression
cop NEO1 15q22.3-q23 0.148 0.258 0.775 muscle cell differentiation;positive
regulation of muscle cell differentiation
met GGCT 7p15-p14 0.148 0.258 0.775 glutathione biosynthetic
exp HRSP12 8q22 0.148 0.258 0.775 regulation of translational termination
met KRTAP12-1 21q22.3 0.148 0.258 0.776
xsq LOC389765 9q21.33 0.148 0.258 0.776
exp MRE11A 11q21 0.148 0.258 0.776 DNA Damage Response (DDR); DDR (HR)
met LRP3 19q13.11 0.148 0.258 0.776 receptor-mediated endocytosis
met TCL1A 14q32.1 0.148 0.258 0.776 multicellular organismal development
xsq ACTRT2 1p36.32 0.148 0.258 0.776
cop GRB2 17q24-q25 0.148 0.258 0.776 cell-cell signaling;T cell costimulation
cop MIR3678 0.148 0.258 0.776
xsq INSL4 9p24 0.148 0.258 0.776 signal transduction;cell-cell signaling
met C19orf57 19p13.12 0.148 0.258 0.776 multicellular organismal
development
met GPIHBP1 8q24.3 0.148 0.258 0.776 positive regulation of lipoprotein
lipase activity;lipid transport
xsq LOC101928865 0.148 0.258 0.776
cop B3GNTL1 17q25.3 0.148 0.258 0.776
xsq C1orf105 1q24.3 0.148 0.258 0.776
cop HS6ST1 2q21 0.148 0.258 0.776 labyrinthine layer blood vessel
xsq RNF103-CHMP3 0.148 0.258 0.776
exp PSMA6 14q13 0.148 0.258 0.776 M/G1 transition of mitotic cell cycle;gene
expression
exp MESDC2 15q13 0.148 0.258 0.776 protein folding;mesoderm development
met C22orf46 22q13.2 0.148 0.258 0.776
mir hsa-miR-15b* 0.148 0.258 0.776
xsq AGGF1 5q13.3 0.148 0.258 0.776 vasculogenesis;positive regulation of
endothelial cell proliferation
exp HSP90AA6P 4q33 0.148 0.258 0.776
met TTC3 21q22.2 0.148 0.258 0.776 ubiquitin-dependent protein catabolic
process;negative regulation of cell morphogenesis involved in differentiation
xsq LILRB1 19q13.4 0.148 0.258 0.776 negative regulation of T cell
mediated cytotoxicity;positive regulation of gene expression
exp LOC100190986 0.148 0.258 0.776
met MIR33B 0.148 0.258 0.776
met ZNF136 19p13.2 0.148 0.258 0.776 negative regulation of
dependent
xsq ADRM1 20q13.33 0.148 0.258 0.776 transcription elongation from RNA
xsq KRT26 17q21.2 0.148 0.258 0.776
xsq MMAA 4q31.21 0.148 0.258 0.776
met TCEA1 8q11.2 0.148 0.258 0.776 DNA Damage Response (DDR)
exp CDR2 16p12.3 0.148 0.258 0.776
met HTR4 5q31-q33 0.148 0.258 0.776 G-protein coupled receptor signaling
met AP1G1 16q23 0.148 0.258 0.776 post-Golgi vesicle-mediated
xsq FAM168B 2q21.1 0.148 0.258 0.776
met PDE1B 12q13 0.148 0.258 0.776 signal transduction;cellular response to
xsq HCRTR1 1p33 0.148 0.258 0.776 neuropeptide signaling pathway;synaptic
transmission
cop LOC100505817 0.148 0.258 0.776
xsq POT1 7q31.33 0.148 0.258 0.776 DNA Damage Response (DDR)
xsq EMCN 4q24 0.148 0.258 0.776
exp SACS 13q12 0.148 0.258 0.776 EMT (Mesenchymal)
cop BAMBI 10p12.3-p11.2 0.148 0.258 0.776 cell migration;negative regulation
exp RPL39L 3q27 0.148 0.258 0.776 translation;spermatogenesis
xsq LOC100288778 12p13.33 0.148 0.258 0.776
cop NUDT14 14q32.33 0.148 0.258 0.776
cop BRF1 14q 0.148 0.258 0.776 positive regulation of transcription, DNA-
cop BTBD6 14q32 0.148 0.258 0.776
met SNORA80A 0.148 0.258 0.776
xsq CCAR1 10q21.3 0.148 0.258 0.776 Apoptosis
xsq PNKD 2q35 0.148 0.258 0.776
xsq ATP1B3 3q23 0.148 0.258 0.776 transport;potassium ion transport
met NXT2 Xq23 0.148 0.258 0.776 protein transport;mRNA transport
exp MED13 17q22-q23 0.148 0.258 0.776 intracellular steroid hormone receptor
cop PRKAB2 1q21.1 0.148 0.258 0.776 cellular lipid metabolic
xsq HIST2H2AA4 1q21.2 0.148 0.258 0.776 nucleosome assembly
exp ETAA1 2p14 0.148 0.258 0.776
exp CLDN10 13q31-q34 0.148 0.258 0.776 cell adhesion;calcium-independent
cell-cell adhesion
exp ARPC5L 9q33.3 0.148 0.258 0.776 regulation of actin filament
polymerization
met MRPL52 14q11.2 0.148 0.258 0.776 translation
exp ANKRD1 10q23.31 -0.148 0.258 0.776 positive regulation of
exp OVOL2 20p11.23 -0.148 0.258 0.776 dorsal/ventral pattern
formation;regulation of cell cycle
mut PKP3 11p15 -0.148 0.258 0.776 cell adhesion
exp APOL6 22q12.3 -0.148 0.258 0.776 lipoprotein metabolic
process;transport
xsq TAS2R43 -0.148 0.258 0.776 sensory perception of
taste;detection of chemical stimulus involved in sensory perception of bitter taste
exp ARHGAP31 3q13.33 -0.148 0.258 0.776 regulation of small GTPase
mut BCAS3 17q23 -0.148 0.258 0.776
exp ATP6AP1 Xq28 -0.148 0.258 0.776 ion transport;aging
met AQP7 9p13 -0.148 0.258 0.776 glycerol transport;urea transport
exp MICAL2 11p15.3 -0.148 0.258 0.776
exp RASGRP3 2p25.1-p24.1 -0.148 0.258 0.776 small GTPase mediated
xsq SPAG11A 8p23.1 -0.148 0.258 0.776
met PYCARD 16p11.2 -0.148 0.258 0.776 nucleotide-binding domain,
leucine rich repeat containing receptor signaling pathway;regulation of apoptotic
process
xsq CXorf66 Xq27.1 -0.148 0.258 0.776
dependent"
cop DHX35 20q11.22-q12 -0.148 0.258 0.776 nuclear mRNA splicing, via
exp THY1 11q23.3 -0.148 0.258 0.776 cytoskeleton organization;T cell
cop SPATA16 3q26.31 -0.148 0.258 0.776 cell
exp ANXA8L1 10q11.22 -0.148 0.258 0.776
xsq TLDC1 16q24.1 -0.148 0.258 0.776
met ASUN 12p11.23 -0.148 0.258 0.776 cell cycle;mitosis
met GSTM5 1p13.3 -0.148 0.258 0.776 metabolic process;small molecule
metabolic process
xsq LOC101929297 -0.148 0.258 0.775
exp PRKACA 19p13.1 -0.148 0.258 0.775 Protein Kinases
met ZDBF2 2q33.3 -0.148 0.258 0.775
his XGY2 -0.149 0.258 0.776
xai ANKRD30BP2 21q11.2 -0.149 0.258 0.776
his LOC100506895 -0.149 0.258 0.776
xai CAMK1 3p25.3 -0.15 0.258 0.776 nervous system development;positive
exp SNORD114-6 14q32 -0.15 0.258 0.776
exp LOC401134 -0.15 0.258 0.776
xai TMPRSS5 11q -0.15 0.258 0.776 proteolysis
xai ZNF417 19q13.43 -0.15 0.258 0.776 regulation of transcription, DNA-
dependent"
swa TAX1BP3 17p13 -0.15 0.258 0.776 negative regulation of cell
his SCN4A 17q23.3 -0.15 0.258 0.776 ion transport;sodium ion transport
xai OSBPL2 20q13.3 -0.15 0.258 0.776 transport;lipid transport
hs4 GLYATL2 11q12.1 -0.15 0.258 0.776
his TMC3 15q25.1 -0.15 0.258 0.776
xai TLE1 9q21.32 -0.15 0.258 0.776 organ morphogenesis;negative regulation
of Wnt receptor signaling pathway
hs4 ASPH 8q12.1 -0.15 0.258 0.776 peptidyl-amino acid modification;limb
morphogenesis
hs4 MIR4470 -0.15 0.258 0.776
his RECK 9p13.3 -0.15 0.258 0.776 EMT (Mesenchymal)
his TREX1 3p21.31 -0.15 0.258 0.776 DNA Damage Response (DDR)
his TNFAIP6 2q23.3 -0.15 0.258 0.776 inflammatory response;cell adhesion
his LOC101929128 -0.15 0.258 0.775
xai LRRC6 8q24.22 0.149 0.259 0.776 male gonad development;pachytene
swa TCOF1 5q32 0.149 0.259 0.776 transport;skeletal system development
his HBZ 16p13.3 0.149 0.259 0.776 transport;oxygen transport
his ATF4 22q13.1 0.149 0.259 0.776 activation of signaling protein activity
response
hs4 TSEN2 3p25.2 0.149 0.259 0.776 tRNA splicing, via endonucleolytic
swa CD55 1q32 0.149 0.259 0.776 respiratory burst;complement activation,
classical pathway
his GPR160 3q26.2-q27 0.149 0.259 0.776
his HIST1H2BC 6p22.1 0.149 0.259 0.776 nucleosome assembly;defense
his HIST1H2AC 6p22.1 0.149 0.259 0.776 nucleosome assembly
his LINC01258 0.149 0.259 0.776
hs4 FIBP 11q13.1 0.149 0.259 0.776 fibroblast growth factor receptor
signaling pathway
hs4 CCDC85B 11q12.1 0.149 0.259 0.776 negative regulation of fat cell
hs4 ANP32E 1q21.2 0.149 0.259 0.776 DNA Damage Response (DDR)
exp ZPBP2 17q12 0.149 0.259 0.776 binding of sperm to zona pellucida
xai TRAJ30 0.149 0.259 0.776
xai TMEM181 6q25.3 0.149 0.259 0.776 pathogenesis
hs4 PAX7 1p36.13 0.149 0.259 0.776 spinal cord association neuron
differentiation;dorsal/ventral neural tube patterning
xai CYCSP1 14q24.3 0.149 0.259 0.776
exp HMGB1P9 2q35 0.149 0.259 0.776
his ZNF728 19p12 0.149 0.259 0.776
exp TRAJ30 0.149 0.259 0.776
exp SLC8A1-AS1 0.149 0.259 0.776
his LINC01387 0.149 0.259 0.776
his MTHFD2L 4q13.3 0.149 0.259 0.776 methionine biosynthetic
xai HCK 20q11-q12 0.149 0.259 0.776 exocytosis;cytokine-mediated signaling
pathway
hs4 MPND 19p13.3 0.149 0.259 0.777 proteolysis
xai HAND2 4q33 0.149 0.259 0.777 regulation of secondary heart field cardioblast
his RAET1K 6q25.1 0.149 0.259 0.777
xai RELN 7q22 0.149 0.259 0.777 brain development;reelin-mediated signaling
pathway
exp VWC2L 2q34-q35 0.149 0.259 0.777
xai FKBP1A-SDCBP2 0.149 0.259 0.777
xai MPPE1 18p11.21 0.149 0.259 0.777 GPI anchor biosynthetic process;ER to
xai SEMA4D 9q22.2 0.149 0.259 0.777 multicellular organismal
xai MIR924HG 0.149 0.259 0.777
his NAB2 12q13.3 0.149 0.259 0.777 negative regulation of transcription from
RNA polymerase III promoter;myelination
swa NME1 0.149 0.259 0.777 Apoptosis
xai RNF10 12q24.31 0.149 0.259 0.777 negative regulation of Schwann cell
xai CPNE1 20q11.22 0.149 0.259 0.777 lipid metabolic process;vesicle-mediated
transport
exp ASAH2 10q11.21 0.149 0.259 0.777 small molecule metabolic process;lipid
metabolic process
xai DGAT2 11q13.5 0.149 0.259 0.777 triglyceride biosynthetic
his NPDC1 9q34.3 0.149 0.259 0.777
hs4 TOP2B 3p24 0.149 0.259 0.777 Apoptosis; DNA Damage Response (DDR); DDR (DNA
replication)
hs4 MIR4442 0.149 0.259 0.777
his TBC1D22A 22q13.3 0.149 0.259 0.777
met GPR143 Xp22.3 0.148 0.259 0.776 melanosome transport;melanosome
organization
xsq LOC101929741 0.148 0.259 0.776
mut KLK9 19q13.41 0.148 0.259 0.776 proteolysis
cop RPIA 2p11.2 0.148 0.259 0.776 carbohydrate metabolic process;pentose-
phosphate shunt
met ZNF232 17p13.2 0.148 0.259 0.776 viral reproduction
xsq WDR20 14q32.31 0.148 0.259 0.776
xsq ADAT1 16q23.1 0.148 0.259 0.776 RNA processing;tRNA processing
xsq OR10H1 19p13.1 0.148 0.259 0.776
xsq NFKB1 4q24 0.148 0.259 0.776 Apoptosis
cop ACAA2 18q21.1 0.148 0.259 0.776 acetyl-CoA metabolic process;lipid
metabolic process
cop SCARNA17 18q21.1 0.148 0.259 0.776
xsq OR2T27 1q44 0.148 0.259 0.776 response to stimulus
met LECT1 13q14.3 0.148 0.259 0.776 negative regulation of vascular
met IL22RA1 1p36.11 0.148 0.259 0.776
xsq CD2 1p13.1 0.148 0.259 0.776 blood coagulation;cell-cell adhesion
exp SELO 22q13.33 0.148 0.259 0.776
mut COL1A1 17q21.33 0.148 0.259 0.776 blood vessel development;sensory
perception of sound
xsq CHST11 12q 0.148 0.259 0.776 chondroitin sulfate biosynthetic
xsq LINC01485 0.148 0.259 0.776
met HES1 3q28-q29 0.148 0.259 0.776 DNA Damage Response (DDR); DDR (FA)
cop BOLA1 1q21 0.148 0.259 0.776
cop SV2A 1q21.2 0.148 0.259 0.776 neurotransmitter transport;cellular
exp TUBGCP3 13q34 0.148 0.259 0.776 mitotic cell cycle;microtubule nucleation
cop MMP17 12q24.3 0.148 0.259 0.776 Apoptosis
met TBX2 17q23.2 0.148 0.259 0.776 heart morphogenesis;developmental growth
cop STARD9 15q15.2 0.148 0.259 0.776 EMT (Mesenchymal)
xsq PLA2G6 22q13.1 0.148 0.259 0.776 metabolic process;cell death
xsq WDR38 9q33.3 0.148 0.259 0.776
xsq TRMT112 11q13.1 0.148 0.259 0.776 peptidyl-glutamine methylation
exp SPICE1 3q13.2 0.148 0.259 0.776 cell cycle;regulation of centriole
replication
mut MTOR 1p36.2 0.148 0.259 0.776 Apoptosis; Cell Signaling; DNA Damage
Response (DDR); Protein Kinases
mut PYHIN1 1q23.1 0.148 0.259 0.776 cell cycle
xsq ANAPC2 9q34.3 0.148 0.259 0.776 cyclin catabolic process;negative
cop TUBD1 17q23.1 0.148 0.259 0.776 protein polymerization;microtubule-based
movement
cop RPS6KB1 17q23.1 0.148 0.259 0.776 Apoptosis; Protein Kinases
cop RNFT1 17q23.1 0.148 0.259 0.776
cop TBC1D3P1-DHX40P1 17q23 0.148 0.259 0.776
cop MIR4737 0.148 0.259 0.776
cop HEATR6 17q23.1 0.148 0.259 0.776
cop LOC645638 0.148 0.259 0.776
cop LOC653653 17q23.1 0.148 0.259 0.776
cop CA4 17q23 0.148 0.259 0.776 one-carbon metabolic process;bicarbonate
transport
exp USE1 19p13.11 0.148 0.259 0.776 ER to Golgi vesicle-mediated
exp LOC339862 0.148 0.259 0.776
xsq SWT1 1q25 0.148 0.259 0.776
exp ULK3 15q24.1 0.148 0.259 0.776 autophagy;negative regulation of
xsq NUCB2 11p15.1 0.148 0.259 0.776
cop GALNT9 12q24.33 0.148 0.259 0.776 O-glycan processing;post-
cop LOC100130238 12q24.33 0.148 0.259 0.776
cop FBRSL1 12q24.33 0.148 0.259 0.776
met CCDC82 11q21 0.148 0.259 0.777
mir hsa-miR-590-5p 0.148 0.259 0.777
xsq KRTAP24-1 0.148 0.259 0.777
cop OSBPL5 11p15.4 0.148 0.259 0.777 transport;lipid transport
xsq OR2L8 0.148 0.259 0.777 response to stimulus
cop DHX40 17q23.1 0.148 0.259 0.777
xsq PCDHAC2 0.148 0.259 0.777 cell adhesion;homophilic cell adhesion
met NAT1 8p22 -0.148 0.259 0.777 xenobiotic metabolic process;small
met MACROD1 11q11 -0.148 0.259 0.777 purine nucleoside metabolic process
met SOD3 4p15.2 -0.148 0.259 0.777 removal of superoxide
exp KCTD1 18q11.2 -0.148 0.259 0.777 potassium ion transport;negative
exp LDB2 4p16 -0.148 0.259 0.777 positive regulation of cellular component
cop LOC100129138 1p21.1 -0.148 0.259 0.777
xsq LINC00894 -0.148 0.259 0.777
exp SAMD9 7q21.2 -0.148 0.259 0.776
xsq TCAF1 -0.148 0.259 0.776
exp TNFSF15 9q32 -0.148 0.259 0.776 cytokine metabolic process;positive
exp EVPL 17q25 -0.148 0.259 0.776 epidermis development;peptide cross-
linking
met MAPK12 22q13.33 -0.148 0.259 0.776 Protein Kinases
xsq CDH24 14q11.2 -0.148 0.259 0.776 homophilic cell adhesion;cell-cell
adhesion
xsq PHYH 10p13 -0.148 0.259 0.776 fatty acid alpha-oxidation;cellular lipid
metabolic process
cop PPAPDC1B 8p11.23 -0.148 0.259 0.776
cop WHSC1L1 8p11.2 -0.148 0.259 0.776 regulation of transcription,
DNA-dependent;cell growth
exp ZSCAN31 6p21.31 -0.148 0.259 0.776
xsq VMAC 19p13.3 -0.148 0.259 0.776
met CPNE7 16q24.3 -0.148 0.259 0.776 lipid metabolic process;transport
cop SDCBP 8q12 -0.148 0.259 0.776 axon guidance;actin cytoskeleton
organization
cop NSMAF 8q12-q13 -0.148 0.259 0.776 Apoptosis
cop LINC01194 -0.148 0.259 0.776
mut ZBTB11 3q12.3 -0.148 0.259 0.776 regulation of transcription,
DNA-dependent"
xsq AGXT2 5p13 -0.148 0.259 0.776 glyoxylate metabolic process;nucleobase-
exp CNTN6 3p26-p25 -0.148 0.259 0.776 cell adhesion;Notch signaling
pathway
met RAE1 20q13.31 -0.148 0.259 0.776 mRNA export from nucleus;cellular
swa STX12 1p35.3 -0.149 0.259 0.777 vesicle-mediated
transport;cholesterol efflux
xai ZSWIM8 10q22.2 -0.149 0.259 0.777
hs4 ARMC3 10p12.31 -0.149 0.259 0.777
hs4 FOXO1 13q14.1 -0.149 0.259 0.777 Apoptosis
xai ULBP3 6q25 -0.149 0.259 0.777 antigen processing and
his PDZRN3-AS1 -0.149 0.259 0.777
his PDZRN3 3p13 -0.149 0.259 0.777 neuromuscular junction
his DGAT2L6 Xq13.1 -0.149 0.259 0.777 lipid biosynthetic process
his LINC00605 -0.149 0.259 0.777
xai RGAG1 Xq23 -0.149 0.259 0.777
his SGIP1 1p31.3 -0.149 0.259 0.777 response to dietary excess;positive
hs4 PARP6 15q23 -0.149 0.259 0.776
hs4 AFAP1L1 5q32 -0.149 0.259 0.776
hs4 GPR146 7p22.3 -0.149 0.259 0.776
xai FOXO1 13q14.1 -0.149 0.259 0.776 Apoptosis
cop NOVA2 19q13.3 -0.149 0.259 0.776
xai HLA-P 6p21.2 -0.149 0.259 0.776
hs4 CALD1 7q33 -0.149 0.259 0.776 cellular component movement;muscle
contraction
xai FAM126A 7p15.3 -0.149 0.259 0.776 EMT (Mesenchymal)
xai SPSB1 1p36.22 -0.149 0.259 0.776 intracellular signal transduction
his OR2A1 -0.149 0.259 0.776
his KL 13q12 -0.149 0.259 0.776 aging;insulin receptor signaling pathway
his METRN 16p13.3 -0.149 0.259 0.776 multicellular organismal
hs4 PARP14 3q21.1 -0.149 0.259 0.776 regulation of transcription,
DNA-dependent"
exp LOC100131170 -0.149 0.259 0.776
xai GRHL1 2p25.1 -0.149 0.259 0.776 small molecule metabolic
his THRB-AS1 3p24.2 -0.149 0.259 0.776
his THRB 3p24.2 -0.149 0.259 0.776 regulation of transcription, DNA-
his HSPB1 7q11.23 -0.149 0.259 0.776 Apoptosis
his PHEX-AS1 -0.149 0.259 0.776
hs4 KLK6 19q13.3 -0.149 0.259 0.776 central nervous system
development;regulation of cell differentiation
xai SNORD114-6 14q32 -0.149 0.259 0.776
his GNPTAB 12q23.2 0.149 0.26 0.777 protein secretion;cell
differentiation
his GADD45B 19p13.3 0.149 0.26 0.777 Apoptosis
hs4 LOC104968399 0.149 0.26 0.777
hs4 MYL12B 18p11.31 0.149 0.26 0.777 muscle contraction;axon guidance
dependent"
his RPL23AP7 2q14 0.149 0.26 0.777
his RABL2A 2q13 0.149 0.26 0.777 GTP catabolic process;small GTPase
hs4 GNB5 15q21.2 0.149 0.26 0.777 GTP catabolic process;signal transduction
hs4 CERNA1 0.149 0.26 0.777
exp FKBP1A-SDCBP2 0.149 0.26 0.777
his ACAA2 18q21.1 0.149 0.26 0.777 acetyl-CoA metabolic process;lipid
metabolic process
his SCARNA17 18q21.1 0.149 0.26 0.777
his SNHG22 0.149 0.26 0.777
xai TFIP11 22q12.1 0.149 0.26 0.777 nuclear mRNA splicing, via
his C14orf178 14q24.3 0.149 0.26 0.777
his SNW1 14q24.3 0.149 0.26 0.777 positive regulation of transcription from
xai THAP1 8p11.21 0.149 0.26 0.777 transcription, DNA-dependent;regulation
his ADPRHL1 13q34 0.149 0.26 0.777 protein de-ADP-ribosylation
his KCTD8 4p13 0.149 0.26 0.777 potassium ion transport
xai CTSC 11q14.2 0.149 0.26 0.777 proteolysis;immune response
swa TCERG1 5q31 0.149 0.26 0.777 negative regulation of transcription from
cop LSM7 19p13.3 0.149 0.26 0.777 nuclear mRNA splicing, via
his MAN2A2 15q26.1 0.149 0.26 0.777 carbohydrate metabolic
his HLF 17q22 0.149 0.26 0.777 transcription from RNA polymerase II
promoter;multicellular organismal development
hs4 SLURP1 8q24.3 0.149 0.26 0.777 cell activation;cell adhesion
xai SYTL1 1p36.11 0.149 0.26 0.777 intracellular protein
xai FLJ43879 2q37.3 0.149 0.26 0.777
his LOC730101 6p12.2 0.149 0.26 0.777
xai SNORA16B 0.149 0.26 0.777
xai PMS2P3 7q11.23 0.149 0.26 0.777 DNA Damage Response (DDR)
xai HIST1H3F 6p22.2 0.149 0.26 0.777 nucleosome assembly;blood
coagulation
hs4 C9orf78 9q34.11 0.149 0.26 0.777
hs4 USP20 9q34.11 0.149 0.26 0.777 protein K48-linked
hs4 CLDN10 13q31-q34 0.149 0.26 0.777 cell adhesion;calcium-independent
cell-cell adhesion
his DPF1 19q13.2 0.149 0.26 0.777 DDR (DNA replication)
xai CLEC7A 12p13.2 0.149 0.26 0.777 phagocytosis, recognition;defense
xai LOC100507346 0.149 0.26 0.777
xai ZCCHC11 1p32.3 0.149 0.26 0.777 cytokine production;negative
xai C9orf24 9p13.3 0.149 0.26 0.777 cellular protein complex assembly
xai LRRIQ3 1p31.1 0.149 0.26 0.777
his FPGS 9q34.1 0.149 0.26 0.777 water-soluble vitamin metabolic
his LINC01679 0.149 0.26 0.777
hs4 EHMT1 9q34.3 0.149 0.26 0.777 DNA methylation;histone H3-K9 methylation
hs4 ARRDC1-AS1 0.149 0.26 0.777
his DPY19L2P4 7q21.13 0.149 0.26 0.777
hs4 KDM4A-AS1 0.149 0.26 0.777
hs4 ST3GAL3 1p34.1 0.149 0.26 0.777 EMT (Mesenchymal)
exp HIST1H3F 6p22.2 0.149 0.26 0.777 nucleosome assembly;blood
coagulation
exp OR52B6 11p15.4 0.149 0.26 0.777 response to stimulus
exp LOC643802 16q12.2 0.149 0.26 0.777
exp SNORA16B 0.149 0.26 0.777
his SLF2 0.149 0.26 0.777
his SNORA7B 3q21.3 0.149 0.26 0.777
his RPL32P3 3q21.3 0.149 0.26 0.777
xai TMEM198B 12q13.2 0.149 0.26 0.777
his MYH4 17p13.1 0.149 0.26 0.777 muscle contraction;response to activity
his COX7A2 6q12 0.149 0.26 0.777
xsq TMX1 14q22.1 0.148 0.26 0.777 transport;cell redox homeostasis
cop FOXI3 2p11.2 0.148 0.26 0.777 epidermal cell fate specification;otic
placode formation
cop TEX37 2p11.2 0.148 0.26 0.777
xsq SNHG25 0.148 0.26 0.777
exp PTGES3P3 4q33 0.148 0.26 0.777
met ACACA 17q21 0.148 0.26 0.777 long-chain fatty-acyl-CoA biosynthetic
process;tissue homeostasis
xsq ATP5J2 0.148 0.26 0.777 respiratory electron transport
met ZDHHC21 9p22.3 0.148 0.26 0.777 small molecule metabolic
cop ITFG1 16q12.1 0.148 0.26 0.777
xsq CFDP1 16q22.2-q22.3 0.148 0.26 0.777 regulation of cell
exp ZNF367 9q22 0.148 0.26 0.777 regulation of transcription from RNA
xsq RABGGTA 14q11.2 0.148 0.26 0.777 protein modification process;visual
perception
xsq LOC100130673 7p14.3 0.148 0.26 0.777
cop C11orf85 11q13.1 0.148 0.26 0.777
cop BATF2 11q13.1 0.148 0.26 0.777
cop TRIM25 17q23.2 0.148 0.26 0.777 interspecies interaction between
organisms;innate immune response
cop COIL 17q22 0.148 0.26 0.777 oxidation-reduction process
cop SCPEP1 17q22 0.148 0.26 0.777 proteolysis;retinoic acid metabolic
process
cop RNF126P1 17q22 0.148 0.26 0.777
cop AKAP1 17q22 0.148 0.26 0.777 Apoptosis
met SNORD94 2p11.2 0.148 0.26 0.777
met HERC2P2 15q11.2 0.148 0.26 0.777
exp GBGT1 0.148 0.26 0.777 metabolic process;glycolipid biosynthetic
process
met REG1CP 0.148 0.26 0.777
exp PYM1 0.148 0.26 0.777 nuclear-transcribed mRNA catabolic process,
xsq ERCC6L2 9q22.32 0.148 0.26 0.777 DNA repair
met MIR154 0.148 0.26 0.777
cop THNSL2 2p11.2 0.148 0.26 0.777 serine family amino acid catabolic
process;threonine biosynthetic process
xsq ARHGEF7-AS1 0.148 0.26 0.777
met FGF1 5q31 0.148 0.26 0.777 positive regulation of protein
cop SF3B4 1q21.2 0.148 0.26 0.777 mRNA processing;RNA splicing
cop MTMR11 1q12-q21 0.148 0.26 0.777
cop OR4P4 0.148 0.26 0.777
cop OR4S2 0.148 0.26 0.777
cop PEAK1 15q24.3 0.148 0.26 0.777
exp SEMA4D 9q22.2 0.148 0.26 0.777 multicellular organismal
exp GSDMB 17q12 0.148 0.26 0.777
mut CHRNB4 15q24 0.148 0.26 0.777 synaptic transmission;synaptic
cop CORO2B 15q23 0.148 0.26 0.777 actin cytoskeleton organization
met KIF3C 2p23 0.148 0.26 0.777 microtubule-based movement;blood coagulation
exp BCL2L12 19q13.3 0.148 0.26 0.777 apoptotic process
exp BCDIN3D 12q13.12 0.148 0.26 0.777
met ADAMTS5 21q21.3 0.148 0.26 0.777 proteolysis
exp LOC728254 5q22.3 0.148 0.26 0.777
xsq TAS2R38 0.148 0.26 0.777
cop SPAG9 17q21.33 0.148 0.26 0.777 positive regulation of cell
migration;negative regulation of protein homodimerization activity
xsq RFK 9q21.13 0.148 0.26 0.777 riboflavin biosynthetic process;small
xsq FAM172A 5q15 0.148 0.26 0.777
xsq PPP1R14B 11q13 0.148 0.26 0.777 regulation of phosphorylation
xsq CKLF 16q21 0.148 0.26 0.777 neutrophil chemotaxis;secretion by cell
mut FAP 2q23 0.148 0.26 0.777 endothelial cell migration;regulation of
fibrinolysis
exp TNFRSF8 1p36 0.148 0.26 0.777 Apoptosis
xsq TBPL1 6q22.1-q22.3 0.148 0.26 0.777 transcription initiation from RNA
met CD1E 1q23.1 0.148 0.26 0.777 immune response;antigen processing and
presentation
exp MEOX2 7p22.1-p21.3 -0.148 0.26 0.777 multicellular organismal
xsq ATP6V1H 8q11.2 -0.148 0.26 0.777 ion transport;transferrin
transport
exp LOC151760 3q13.13 -0.148 0.26 0.777
mut GPC2 7q22.1 -0.148 0.26 0.777 neuron differentiation
exp NPAS2 2q11.2 -0.148 0.26 0.777 regulation of transcription, DNA-
mut KLC4 6p21.1 -0.148 0.26 0.777
mir hsa-miR-22* -0.148 0.26 0.777
exp MSANTD3 9q31.1 -0.148 0.26 0.777
xsq NPAS3 14q13.1 -0.148 0.26 0.777 maternal behavior;positive
mut BAP1 3p21.31-p21.2 -0.148 0.26 0.777 DNA Damage Response (DDR);
Tumor Suppressors
xsq FBN1 15q21.1 -0.148 0.26 0.777 skeletal system development;heart
development
xsq SUGCT -0.148 0.26 0.777
xsq GJA1 6q22.31 -0.148 0.26 0.777 signal transduction;gap junction
assembly
cop MCCC1 3q27 -0.148 0.26 0.777 cellular nitrogen compound metabolic
met LPAR5 12p13.31 -0.148 0.26 0.777
xsq EXPH5 11q22.3 -0.148 0.26 0.777 intracellular protein
exp TMEM245 9q31 -0.148 0.26 0.777
cop RTN4R 22q11.21 -0.148 0.26 0.777 axonogenesis;nerve growth factor
mut GTF2F1 19p13.3 -0.148 0.26 0.777 transcription from RNA
promoter
xsq NLGN4Y Yq11.221 -0.148 0.26 0.777 cell adhesion;synapse
assembly
cop SMC2 9q31.1 -0.148 0.26 0.777 DNA Damage Response (DDR); DDR (DNA
replication)
xsq PARD6G 18q23 -0.148 0.26 0.777 cell junction assembly;cell-cell
xsq ANKAR 2q32.2 -0.148 0.26 0.777
mut RMDN3 15q15.1 -0.148 0.26 0.777
exp SELENBP1 1q21.3 -0.148 0.26 0.777 protein transport
xsq FAM107A 3p21.1 -0.148 0.26 0.777 regulation of cell growth
mut RAI14 5p13.3-p13.2 -0.148 0.26 0.777
mut BACH1 21q22.11 -0.148 0.26 0.777 regulation of transcription
involved in G1/S phase of mitotic cell cycle;regulation of transcription involved
in G2/M-phase of mitotic cell cycle
mut ITIH4 3p21.1 -0.148 0.26 0.777 acute-phase response;negative
mut TNFSF11 13q14 -0.148 0.26 0.777 Apoptosis
cop CCDC39 3q26.33 -0.148 0.26 0.777 axonemal dynein complex
met SPEF2 5p13.2 -0.148 0.26 0.777 nucleobase-containing compound
metabolic process
cop NACAP1 8q22.3 -0.148 0.26 0.777
swa OSBPL8 12q14 -0.149 0.26 0.777 transport;lipid transport
his NTRK3 15q25 -0.149 0.26 0.777 cell differentiation;response to
corticosterone stimulus
xai ATOX1 5q32 -0.149 0.26 0.777 ion transport;copper ion transport
swa CLINT1 5q33.3 -0.149 0.26 0.777 post-Golgi vesicle-mediated
DNA-dependent"
his LINC01186 -0.149 0.26 0.777
his AP2S1 19q13.2-q13.3 -0.149 0.26 0.777 protein transport;viral
reproduction
his CDC42EP1 22q13.1 -0.149 0.26 0.777 regulation of cell
xai AFM 4q13.3 -0.149 0.26 0.777 vitamin transport
xai UBE2C 20q13.12 -0.149 0.26 0.777 mitosis;phosphatidylinositol-
mediated signaling
his CPQ 8q22.2 -0.149 0.26 0.777 proteolysis;peptide metabolic
process
hs4 LOC100507291 -0.149 0.26 0.777
hs4 COPB2 3q23 -0.149 0.26 0.777 COPI coating of Golgi
hs4 VEGFC 4q34.3 -0.149 0.26 0.777 platelet degranulation;cell
differentiation
his LINC00307 -0.149 0.26 0.777
xai ANKRD33B 5p15.2 -0.149 0.26 0.777
hs4 KIF16B 20p11.23 -0.149 0.26 0.777 transport;early endosome to
late endosome transport
xai CHST5 16q22.3 -0.149 0.26 0.777 carbohydrate metabolic process;N-
hs4 MIR181A2HG -0.149 0.26 0.777
xai NWD2 -0.149 0.26 0.777
his C1orf100 1q44 -0.149 0.26 0.777
xai TRAM1L1 4q26 -0.149 0.26 0.777 protein transport
xai TSKU 11q13.5 -0.149 0.26 0.777
his FAM110B 8q12.1 -0.149 0.26 0.777
hs4 TBC1D10A 22q12.2 -0.149 0.26 0.777
xai B4GALT2 1p34-p33 -0.149 0.26 0.777 post-translational protein
hs4 IGDCC4 15q22.31 -0.149 0.26 0.777
exp ANKRD30BP2 21q11.2 -0.149 0.26 0.777
xai CYP8B1 3p22.1 -0.149 0.26 0.777 bile acid biosynthetic
exp HBG2 11p15.5 0.149 0.261 0.777 transport;blood coagulation
his SND1 7q31.3 0.149 0.261 0.777 interspecies interaction between
organisms;regulation of transcription, DNA-dependent
hs4 KDM8 16p12.1 0.149 0.261 0.777 G2/M transition of mitotic cell
cycle;cell cycle
xai TRPC5OS 0.149 0.261 0.777
his ZMYM5 13q12 0.149 0.261 0.777
his SP7 12q13.13 0.149 0.261 0.777
xai KLRD1 12p13 0.149 0.261 0.777 cell surface receptor signaling
xai C9orf43 9q32 0.149 0.261 0.777
his CCDC162P 6q21 0.149 0.261 0.777
xai EXD1 15q15.1 0.149 0.261 0.777 nucleobase-containing compound metabolic
process
his SUPV3L1 10q22.1 0.149 0.261 0.777 positive regulation of cell
his NDUFAF4 6q16.1 0.149 0.261 0.777 mitochondrial respiratory chain
complex I assembly
his KLHL32 6q16.1 0.149 0.261 0.777
hs4 EDARADD 1q42.3 0.149 0.261 0.777 hair follicle development;signal
transduction
exp MSTO1 1q22 0.149 0.261 0.777 mitochondrion organization;mitochondrion
distribution
hs4 ALKBH8 11q22.3 0.149 0.261 0.777 DNA Damage Response (DDR)
his GTF2A2 15q22.2 0.149 0.261 0.777 positive regulation of
dependent
xai DPP8 15q22 0.149 0.261 0.777 proteolysis;immune response
xai TSACC 1q22 0.149 0.261 0.777
xai MRS2P2 12q21.1 0.149 0.261 0.777
xai BLK 8p23-p22 0.149 0.261 0.777 Apoptosis
hs4 LINC00957 7p13 0.149 0.261 0.777
hs4 RASA4CP 0.149 0.261 0.777
hs4 METTL17 14q11.2 0.149 0.261 0.777 translation
his ELAC2 17p11.2 0.149 0.261 0.777 tRNA processing
hs4 MALRD1 0.149 0.261 0.777
exp LOC93463 2q37.3 0.149 0.261 0.777
exp IGANRP 0.149 0.261 0.777
his VCPKMT 0.149 0.261 0.777
exp ZNF849P 19p12 0.149 0.261 0.777
hs4 MMD 17q 0.149 0.261 0.777 cytolysis
his RIMS3 1p34.2 0.149 0.261 0.777 neurotransmitter transport;calcium ion-
hs4 CHD3 17p13.1 0.149 0.261 0.777 regulation of transcription, DNA-
xsq PMM2 16p13 0.148 0.261 0.777 protein glycosylation;dolichol-linked
oligosaccharide biosynthetic process
exp ZNF449 Xq26.3 0.148 0.261 0.777 viral reproduction
cop ITGA11 15q23 0.148 0.261 0.777 integrin-mediated signaling
dependent"
met PEX6 6p21.1 0.148 0.261 0.777 ATP catabolic process;protein targeting
to peroxisome
xsq FLJ31104 0.148 0.261 0.777
mut OR1A2 0.148 0.261 0.777
met PTPN13 4q21.3 0.148 0.261 0.777 protein dephosphorylation;peptidyl-
exp RAP1GAP2 17p13.3 0.148 0.261 0.777 regulation of small GTPase mediated
signal transduction
exp ZDHHC6 10q25.2 0.148 0.261 0.777
mut ATP12A 13q12.12 0.148 0.261 0.777 ATP biosynthetic process;potassium
ion transport
exp ASRGL1 11q12.3 0.148 0.261 0.777 asparagine catabolic process via L-
xsq GPN1 2p23.3 0.147 0.261 0.777
met LACRT 12q13 0.147 0.261 0.777 positive regulation of cell
met VCX3B Xp22.31 0.147 0.261 0.777
dependent"
xsq APBB1IP 10p12.1 0.147 0.261 0.777 signal transduction;blood
coagulation
exp ZCCHC9 5q14.1 0.147 0.261 0.777 negative regulation of phosphatase
activity
xsq DPYSL5 2p23.3 0.147 0.261 0.777 nervous system development;axon
guidance
xsq TECPR1 7q21.3 0.147 0.261 0.777
exp CNBP 3q21 0.147 0.261 0.777 regulation of transcription, DNA-
met RPL37 5p13 0.147 0.261 0.777 translational elongation;viral transcription
met RGS5 1q23.1 0.147 0.261 0.777 signal transduction;regulation of G-
cop EP400NL 12q24.33 0.147 0.261 0.777
exp SMC2 9q31.1 0.147 0.261 0.777 DNA Damage Response (DDR); DDR (DNA
replication)
exp DRP2 Xq22 0.147 0.261 0.777 central nervous system development
cop TCHP 12q24.11 0.147 0.261 0.777 apoptotic process;negative regulation of
cell growth
met NAA11 4q21.21 0.147 0.261 0.777
exp WASF1 6q21 0.147 0.261 0.777 protein complex assembly;cellular component
movement
met SRCIN1 17q12 0.147 0.261 0.777 positive regulation of protein tyrosine
kinase activity;negative regulation of protein tyrosine kinase activity
cop RNASE3 14q11.2 0.147 0.261 0.777 RNA catabolic process;defense
cop ECRP 14q11.2 0.147 0.261 0.777
met FKBPL 6p21.3 0.147 0.261 0.777 response to radiation;peptidyl-proline
modification
exp ZNF98 19p12 0.147 0.261 0.777 regulation of transcription, DNA-dependent"
dependent"
cop ME2 18q21 0.147 0.261 0.777 malate metabolic process
cop ELAC1 18q21 0.147 0.261 0.777 tRNA processing;tRNA 3'-trailer cleavage
exp SGTA 19p13 0.147 0.261 0.777 interspecies interaction between organisms
xsq LINC01209 0.147 0.261 0.777
exp C14orf169 14q24.3 0.147 0.261 0.777 chromatin modification;histone H3-
K4 demethylation
exp CCDC91 12p11.22 0.147 0.261 0.777 protein transport
xsq MANF 3p21.1 0.147 0.261 0.777 response to unfolded protein
exp PRPF39 14q21.2 0.147 0.261 0.777 mRNA processing;RNA splicing
exp D2HGDH 2q37.3 0.147 0.261 0.777 response to manganese ion;response
to zinc ion
met HPS3 3q24 0.147 0.261 0.777 organelle organization;pigmentation
cop LOC646278 0.147 0.261 0.777
xsq CRACR2A 0.147 0.261 0.777 activation of store-operated calcium
cop PLEKHO1 1q21.2 0.147 0.261 0.777
met CENPF 1q41 0.147 0.261 0.777 mitotic cell cycle;protein transport
xsq KIAA0391 14q13.2 0.147 0.261 0.777 tRNA processing
xsq LSM12 17q21.31 0.147 0.261 0.777
met ASXL1 20q11 0.147 0.261 0.777 Tumor Suppressors
xsq CXorf58 Xp22.11 0.147 0.261 0.777
xsq MBL1P 0.147 0.261 0.777
xsq CSF2 5q31.1 -0.147 0.261 0.777 positive regulation of tyrosine
cop ANKRD46 8q22.2 -0.147 0.261 0.777
cop AKAP10 17p11.1 -0.147 0.261 0.777 signal transduction;blood
coagulation
exp DNAJC22 12q13.12 -0.147 0.261 0.777 protein folding
met APOBEC3D 22q13.1 -0.147 0.261 0.777 negative regulation of
transposition
exp IL17B 5q33.1 -0.147 0.261 0.777 inflammatory response;immune
response
xsq ZBTB41 1q31.3 -0.147 0.261 0.777 regulation of transcription,
DNA-dependent"
met TMUB1 7q36.1 -0.147 0.261 0.777
cop LAMP3 3q26.3-q27 -0.147 0.261 0.777 cell proliferation
cop ZNF148 3q21 -0.147 0.261 0.777 negative regulation of
xsq LOC101927058 -0.147 0.261 0.777
exp HEY2 6q21 -0.147 0.261 0.777 negative regulation of transcription from
RNA polymerase II promoter;pattern specification process
exp TLN2 15q15-q21 -0.147 0.261 0.777 cell-cell junction assembly;cell
adhesion
mut AMHR2 12q13 -0.147 0.261 0.777 Mullerian duct regression;signal
transduction
xsq CASP4 11q22.2-q22.3 -0.147 0.261 0.777 Apoptosis
met NFATC4 14q11.2 -0.147 0.261 0.777 transcription from RNA
polymerase II promoter;inflammatory response
xsq APOL6 22q12.3 -0.147 0.261 0.777 lipoprotein metabolic
process;transport
exp VMAC 19p13.3 -0.147 0.261 0.777
exp TNIK 3q26.31 -0.147 0.261 0.777 protein phosphorylation;protein
autophosphorylation
exp PKP3 11p15 -0.147 0.261 0.777 cell adhesion
exp FAM225A 9q32 -0.147 0.261 0.777
exp LINC00624 1q21.1 -0.147 0.261 0.777
xsq CACNA1C-IT3 -0.147 0.261 0.777
xsq AADACL2-AS1 -0.147 0.261 0.777
xsq EMX2OS 10q26.1 -0.148 0.261 0.777
xsq FAM174A 5q21.1 -0.148 0.261 0.777
xsq AIFM2 10q22.1 -0.148 0.261 0.777 apoptotic mitochondrial
mut ZNF256 19q13.43 -0.148 0.261 0.777 regulation of transcription,
mut ACVR1B 12q13 -0.148 0.261 0.777 Cell Signaling
mut AARS 16q22 -0.148 0.261 0.777 hair follicle development;endoplasmic
exp LOC645773 4q28.1 -0.148 0.261 0.777
xsq AR Xq12 -0.148 0.261 0.777 transcription, DNA-dependent;positive
met ABCA4 1p22 -0.148 0.261 0.777 ABC Transporters
mut ARHGEF12 11q23.3 -0.148 0.261 0.777 nerve growth factor receptor
met CCDC63 12q24.11 -0.148 0.261 0.777
xsq ANKRD52 12q13.3 -0.148 0.261 0.777 DNA Damage Response (DDR)
xai STARD10 11q13 -0.149 0.261 0.777
xai RAB5CP1 -0.149 0.261 0.777
xai PRKAB2 1q21.1 -0.149 0.261 0.777 cellular lipid metabolic
hs4 PVR 19q13.2 -0.149 0.261 0.777 cell junction assembly;adherens
his MIR449A -0.149 0.261 0.777
his MIR449B -0.149 0.261 0.777
his MIR449C -0.149 0.261 0.777
his CDC20B 5q11.2 -0.149 0.261 0.777
xai KRT8 12q13 -0.149 0.261 0.777 cytoskeleton organization;interspecies
his GSTT1 22q11.23 -0.149 0.261 0.777 glutathione metabolic process
hs4 PTGS1 9q32-q33.3 -0.149 0.261 0.777 xenobiotic metabolic
his TGFB3 14q24 -0.149 0.261 0.777 Apoptosis
his IFT43 14q24.3 -0.149 0.261 0.777 cell projection
his LOC105369486 -0.149 0.261 0.777
his MIR6852 -0.149 0.261 0.777
xai HOXB7 17q21.3 -0.149 0.261 0.777 myeloid cell
xai LOC284412 -0.149 0.261 0.777
hs4 SEMA3F 3p21.3 -0.149 0.261 0.777 neural crest cell
hs4 SEMA3F-AS1 -0.149 0.261 0.777
his TRPC2 11p15.4 -0.149 0.261 0.777
swa TCP11L2 12q23.3 -0.149 0.261 0.777
hs4 SPAG17 1p12 -0.149 0.261 0.777
his LINC01010 -0.149 0.261 0.777
exp FLJ27354 0.149 0.262 0.777
his ACYP2 2p16.2 0.149 0.262 0.777 phosphate-containing compound metabolic
process
dependent"
his LINC00242 6q27 0.149 0.262 0.777
exp CCDC7 10p11.22 0.149 0.262 0.777
exp NPM1P9 Xp22.2 0.149 0.262 0.777
xai ARL11 13q14.2 0.149 0.262 0.777 small GTPase mediated signal transduction
hs4 MAP1S 19p13.11 0.148 0.262 0.777 microtubule bundle formation;apoptotic
process
dependent"
xai LINC00662 19q11 0.148 0.262 0.777
xai NPM1P9 Xp22.2 0.148 0.262 0.777
hs4 SFXN4 10q26.11 0.148 0.262 0.777 iron ion homeostasis;transmembrane
transport
xai PHLPP1 18q21.33 0.148 0.262 0.777 Apoptosis
hs4 HFE2 1q21.1 0.148 0.262 0.777 axon guidance
xai SERPINA9 14q32.13 0.148 0.262 0.777 negative regulation of
cop PDIA3P1 0.148 0.262 0.777
exp UBDP1 6p22.1 0.148 0.262 0.777
xai MIR30C1 0.148 0.262 0.777
xai LOC643770 0.148 0.262 0.777
his ESM1 5q11.2 0.148 0.262 0.777 angiogenesis;regulation of cell growth
xai HCG8 0.148 0.262 0.777
xai MADD 11p11.2 0.148 0.262 0.777 activation of MAPK activity;positive
xai MSMP 9p13.3 0.148 0.262 0.777
his ATXN7L3B 12q21 0.148 0.262 0.777
his FMO5 1q21.1 0.148 0.262 0.777 oxidation-reduction process
exp SRPK3 Xq28 0.148 0.262 0.777 protein phosphorylation;multicellular
his CFL1 11q13 0.148 0.262 0.777 Apoptosis
his MUS81 11q13 0.148 0.262 0.777 DNA Damage Response (DDR); DDR (HR); DDR (DNA
replication)
xai RPL7P17 4q21.1 0.148 0.262 0.777
xai SSBP1 7q34 0.148 0.262 0.777 positive regulation of helicase
hs4 RORB 9q22 0.148 0.262 0.777 positive regulation of transcription, DNA-
dependent;response to stimulus
hs4 RORB-AS1 0.148 0.262 0.777
his CAMTA2 17p13.2 0.148 0.262 0.777 regulation of transcription from
RNA polymerase II promoter;cardiac muscle hypertrophy in response to stress
his DCST1-AS1 0.148 0.262 0.777
his ADAM15 1q21.3 0.148 0.262 0.777 proteolysis;cell adhesion
xai RPS6KA6 Xq21 0.148 0.262 0.777 Protein Kinases
exp MITD1 2q11.2 0.148 0.262 0.777 protein transport
his FOXD2-AS1 1p33 0.148 0.262 0.777
his FOXD2 1p34-p32 0.148 0.262 0.777 Apoptosis
his LINC01389 0.148 0.262 0.777
xai PKIA 8q21.12 0.148 0.262 0.777 negative regulation of transcription from
exp FOXR1 11q23.3 0.148 0.262 0.777 pattern specification process;embryo
development
xai ZNF849P 19p12 0.148 0.262 0.777
xai UBDP1 6p22.1 0.148 0.262 0.777
exp MIR30C1 0.148 0.262 0.777
xai HIST1H4E 6p22.1 0.148 0.262 0.777
cop LRRC57 15q15.2 0.147 0.262 0.777
cop HAUS2 15q15.2 0.147 0.262 0.777 cell division;G2/M transition of mitotic
cell cycle
met CRKL 22q11.21 0.147 0.262 0.777 heart development;organ morphogenesis
mut ITGA2 5q11.2 0.147 0.262 0.777 blood coagulation;organ morphogenesis
xsq LOC253573 0.147 0.262 0.777
xsq LOC101929144 0.147 0.262 0.777
exp HDAC3 5q31 0.147 0.262 0.777 Apoptosis
exp FAM133DP 2q24.1 0.147 0.262 0.777
xsq SH2B1 0.147 0.262 0.777 blood coagulation;intracellular signal
transduction
xsq WDR6 3p21.31 0.147 0.262 0.777 negative regulation of cell
xsq LOC101929441 0.147 0.262 0.777
xsq CAPN11 6p12 0.147 0.262 0.777 proteolysis
exp PUS3 11q24.2 0.147 0.262 0.777 tRNA processing;tRNA pseudouridine
synthesis
xsq CDC23 5q31 0.147 0.262 0.777 mitotic metaphase plate congression;negative
exp PRADC1 2p13.2 0.147 0.262 0.777
xsq NIPA2 15q11.2 0.147 0.262 0.777 ion transport;magnesium ion transport
xsq CCDC74A 2q21.1 0.147 0.262 0.777
cop LOC145837 15q23 0.147 0.262 0.777
xsq SNORA84 0.147 0.262 0.777
xsq TMEM9B-AS1 0.147 0.262 0.777
xsq TAF15 17q11.1-q11.2 0.147 0.262 0.777 positive regulation of
cop TARS2 1q21.3 0.147 0.262 0.777 threonyl-tRNA aminoacylation;gene
expression
mut LRRC66 4q12 0.147 0.262 0.777
exp KRT33A 17q21.2 0.147 0.262 0.777
xsq GUSBP9 0.147 0.262 0.777
xsq GFM1 3q25 0.147 0.262 0.777 GTP catabolic process;mitochondrial
cop RTTN 18q22.2 0.147 0.262 0.777 determination of left/right
cop SOCS6 18q22.2 0.147 0.262 0.777 defense response;JAK-STAT cascade
xsq OSGIN2 8q21 0.147 0.262 0.777 meiosis;germ cell development
cop SMAD4 18q21.1 0.147 0.262 0.777 Apoptosis; Cell Signaling; Tumor
Suppressors
xsq KRTAP5-7 0.147 0.262 0.777
xsq PABPN1 14q11.2 0.147 0.262 0.777 muscle contraction;modification by
virus of host mRNA processing
met TBC1D13 9q34.11 0.147 0.262 0.777
xsq CBR4 4q32.3 0.147 0.262 0.777 fatty acid biosynthetic
process;antibiotic metabolic process
dependent"
xsq DNAJC27-AS1 0.147 0.262 0.777
exp MUC5AC 11p15.5 0.147 0.262 0.777 digestion;O-glycan processing
cop ALK 2p23 0.147 0.262 0.777 Oncogenes
cop SFSWAP 12q24.33 0.147 0.262 0.777 RNA splicing;negative regulation of
nuclear mRNA splicing, via spliceosome
met SLC6A19 5p15.33 0.147 0.262 0.777 amino acid transmembrane
met GOT1L1 8p11.23 0.147 0.262 0.777 cellular amino acid metabolic
exp C16orf74 16q24.1 -0.147 0.262 0.777
met PKMYT1 16p13.3 -0.147 0.262 0.777 regulation of
mitosis;negative regulation of phosphatase activity
exp PELI1 2p13.3 -0.147 0.262 0.777 MyD88-dependent toll-like receptor
exp STK32C 10q26.3 -0.147 0.262 0.777
xsq HOTAIR 12q13.13 -0.147 0.262 0.777
mut ACSF2 17q21.33 -0.147 0.262 0.777 lipid metabolic process;fatty acid
metabolic process
exp HECTD3 1p34.1 -0.147 0.262 0.777 protein ubiquitination
involved in ubiquitin-dependent protein catabolic process;proteasomal ubiquitin-
xsq FLNA Xq28 -0.147 0.262 0.777 actin cytoskeleton reorganization;early
endosome to late endosome transport
mut SP1 12q13.1 -0.147 0.262 0.777 megakaryocyte
differentiation;embryonic skeletal system development
xsq VEGFC 4q34.3 -0.147 0.262 0.777 platelet degranulation;cell
differentiation
exp YPEL3 16p11.2 -0.147 0.262 0.777
exp TTTY2B -0.147 0.262 0.777
exp EGFL6 Xp22 -0.147 0.262 0.777 cell cycle;cell adhesion
mut SZT2 1p34.2 -0.147 0.262 0.777 central nervous system
development;post-embryonic development
xsq ANKRD20A12P -0.147 0.262 0.777
mut P2RY2 11q13.5-q14.1 -0.147 0.262 0.777 aging;wound healing
cop HRH2 5q35.2 -0.147 0.262 0.777 G-protein signaling, coupled to
exp MOSPD1 Xq26.3 -0.147 0.262 0.777 negative regulation of
transcription from RNA polymerase II promoter;positive regulation of transcription
exp SVOPL 7q34 -0.147 0.262 0.777
exp KLF3 4p14 -0.147 0.262 0.777 regulation of transcription, DNA-
exp LOC100132498 2p11.2 -0.147 0.262 0.777
met ARHGAP9 12q13.3 -0.147 0.262 0.777 positive regulation of GTPase
xsq ACSL3 2q34-q35 -0.147 0.262 0.777 brain development;response to
nutrient
xsq WNT5A 3p21-p14 -0.147 0.262 0.777 Apoptosis; Oncogenes
cop UBR5 8q22 -0.147 0.262 0.777 DNA Damage Response (DDR)
exp AMFR 16q21 -0.147 0.262 0.777 ER-associated protein catabolic
process;protein polyubiquitination
xsq LINC01127 -0.147 0.262 0.777
cop FAM83D 20q11.23 -0.147 0.262 0.777 cell division;cell cycle
mut ARHGEF10 8p23 -0.147 0.262 0.777 myelination in peripheral nervous
xsq IGFL2 19q13.32 -0.147 0.262 0.777
hs4 COQ8B -0.148 0.262 0.777
hs4 ITPKC 19q13.1 -0.148 0.262 0.777
exp IFITM9P 11q13.3 -0.148 0.262 0.777
hs4 ANKRD9 14q32.31 -0.148 0.262 0.777
DNA-dependent"
DNA-dependent"
xai PTTG1 5q35.1 -0.148 0.262 0.777 mitotic cell cycle;chromosome
organization
hs4 SYBU 8q23.2 -0.148 0.262 0.777
hs4 LOC100132813 8q23.2 -0.148 0.262 0.777
his ASTN2-AS1 -0.148 0.262 0.777
xai VPS18 15q14-q15 -0.148 0.262 0.777 intracellular protein
his LRRC2 3p21.31 -0.148 0.262 0.777
swa GM2A 5q33.1 -0.148 0.262 0.777 glycolipid catabolic process;lipid
storage
xai GINM1 6q25.1 -0.148 0.262 0.777
xai B3GNT4 12q24 -0.148 0.262 0.777 post-translational protein
his MIR587 -0.148 0.262 0.777
his LOC100422737 -0.148 0.262 0.777
hs4 CYGB 17q25 -0.148 0.262 0.777 transport;response to oxidative stress
hs4 LOC730159 1q25.1 -0.148 0.262 0.777
exp ZEB2P1 -0.148 0.262 0.777
hs4 GDNF 5p13.1-p12 -0.148 0.262 0.777 Apoptosis
hs4 GDNF-AS1 -0.148 0.262 0.777
xai SAMD9 7q21.2 -0.148 0.262 0.777
DNA-dependent"
hs4 NXPH4 12q13.3 -0.148 0.262 0.777 neuropeptide signaling pathway
xai CCDC85C 14q32.31 -0.148 0.262 0.777 cerebral cortex development
swa RPLP0 12q24.2 -0.149 0.262 0.777 SRP-dependent cotranslational
xai PSG6 -0.149 0.262 0.777 female pregnancy
hs4 KCNE4 2q36.1 -0.149 0.262 0.777 ion transport;potassium ion
transport
hs4 SLC5A3 21q22.12 -0.149 0.262 0.777 transport;ion transport
hs4 MRPS6 21q22.11 -0.149 0.262 0.777 translation
cop DACT3-AS1 -0.149 0.262 0.777
cop PRKD2 19q13.3 -0.149 0.262 0.777 positive regulation of interleukin-
2 production;positive regulation of angiogenesis
cop MIR320E -0.149 0.262 0.777
cop STRN4 19q13.2 -0.149 0.262 0.777
cop FKRP 19q13.32 -0.149 0.262 0.777 glycoprotein biosynthetic
process;protein processing
cop CHMP1B 18p11.21 0.149 0.263 0.777 cell division;cell cycle
his SRD5A3 4q12 0.148 0.263 0.777 dolichol-linked oligosaccharide
xai TONSL 8q24.3 0.148 0.263 0.777 DNA Damage Response (DDR)
his NT5C2 10q24.32 0.148 0.263 0.777 nucleotide metabolic process;small
hs4 EXO1 1q42-q43 0.148 0.263 0.777 DNA Damage Response (DDR); DDR (MMR)
his EPB41L4A-AS1 5q22.2 0.148 0.263 0.777
his SNORA13 5q22.2 0.148 0.263 0.777
hs4 RRP1B 21q22.3 0.148 0.263 0.777 rRNA processing;negative regulation of
hs4 HSF2BP 21q22.3 0.148 0.263 0.777 transcription from RNA polymerase
II promoter;spermatogenesis
his DCAF15 19p13.12 0.148 0.263 0.777
his PODNL1 19p13.12 0.148 0.263 0.777
xai LRRC70 5q12.1 0.148 0.263 0.777
xai NXPH1 7p22 0.148 0.263 0.777
xai WRB 21q22.3 0.148 0.263 0.777
exp IGBP1P4 4q21.22 0.148 0.263 0.777
xai C7orf43 7q22.1 0.148 0.263 0.777
hs4 ATP2A2 12q24.11 0.148 0.263 0.777 transmembrane transport;ATP
hs4 TXNL4B 16q22.2 0.148 0.263 0.777 mRNA processing;cell cycle
hs4 DHX38 16q22 0.148 0.263 0.777 RNA splicing;gene expression
xai HSD11B1 1q32-q41 0.148 0.263 0.777 steroid metabolic process;lung
development
exp LOC166994 0.148 0.263 0.777
his TRIM8 10q24.3 0.148 0.263 0.777
his ITPK1 14q31 0.148 0.263 0.777 signal transduction;blood coagulation
swa NUTF2 16q22.1 0.148 0.263 0.777 protein import into nucleus;protein
export from nucleus
xai TUBB3P1 6q15 0.148 0.263 0.777
hs4 PSMB10 16q22.1 0.148 0.263 0.777 mitotic cell cycle;viral
reproduction
his ZC3H3 8q24.3 0.148 0.263 0.777 mRNA polyadenylation;regulation of mRNA
export from nucleus
exp TYW1B 7q11.23 0.148 0.263 0.777 tRNA processing
xai MAST3 19p13.11 0.148 0.263 0.777
hs4 LOC400553 16q24.2 0.148 0.263 0.777
hs4 CERKL 2q31.3 0.148 0.263 0.777 anti-apoptosis;activation of protein
swa SRRM1 1p36.11 0.148 0.263 0.777 transcription from RNA polymerase II
met MIR376A1 0.148 0.263 0.777
xai DENND2D 1p13.3 0.148 0.263 0.777
xai PEF1 1p34 0.148 0.263 0.777 response to calcium ion
his ZNF76 6p21.31 0.148 0.263 0.777 regulation of transcription from RNA
polymerase III promoter;regulation of transcription from RNA polymerase II promoter
cop TMEM251 14q32.12 0.148 0.263 0.777
hs4 MAL 2q11.1 0.148 0.263 0.777 membrane raft polarization;induction of
apoptosis
xai TNFRSF1A 12p13.2 0.148 0.263 0.777 Apoptosis
xai SLC7A10 19q13.1 0.148 0.263 0.777 amino acid transport;blood
coagulation
his MIR4309 0.148 0.263 0.777
his GPBAR1 2q35 0.148 0.263 0.777
hs4 PALM3 19p13.12 0.148 0.263 0.777 negative regulation of cytokine-mediated
signaling pathway;Toll signaling pathway
his CCR1 3p21 0.148 0.263 0.777 dendritic cell chemotaxis;cell surface receptor
signaling pathway
dependent"
his TIGD7 16p13.3 0.148 0.263 0.777 regulation of transcription, DNA-
dependent"
swa C16orf62 16p12.3 0.148 0.263 0.777
exp VILL 3p21.3 0.147 0.263 0.777 cytoskeleton organization;actin filament
capping
pro EP300_26_GBL00052 0.147 0.263 0.777
cop DOK6 18q22.2 0.147 0.263 0.777
exp TFF1 21q22.3 0.147 0.263 0.777 carbohydrate metabolic process;response
to stress
cop CMTM2 0.147 0.263 0.777
met ACTR1B 2q11.1-q11.2 0.147 0.263 0.777
met PNMAL1 19q13.32 0.147 0.263 0.777
exp PARVB 22q13.2-q13.33 0.147 0.263 0.777 cell adhesion;cell junction
assembly
cop PIAS2 18q21.1 0.147 0.263 0.777 DNA Damage Response (DDR)
xsq XRCC5 2q35 0.147 0.263 0.777 DNA Damage Response (DDR); DDR (NHEJ)
xsq RASGRF2 5q13 0.147 0.263 0.777 synaptic transmission;induction of
exp KLHDC2 14q21.3 0.147 0.263 0.777
xsq SLFNL1 1p34.2 0.147 0.263 0.777
exp LRRC37A4P 17q21.31 0.147 0.263 0.777
xsq KCNC1 11p15 0.147 0.263 0.777 potassium ion transport;synaptic transmission
cop MEX3C 18q21.2 0.147 0.263 0.777
xsq CASC23 0.147 0.263 0.777
cop SPRR4 1q21.3 0.147 0.263 0.777
cop SPRR1A 1q21-q22 0.147 0.263 0.777 epidermis development;peptide
cross-linking
cop SPRR3 1q21-q22 0.147 0.263 0.777 keratinization;wound healing
cop SPRR1B 1q21-q22 0.147 0.263 0.777 peptide cross-linking;keratinocyte
differentiation
cop SPRR2D 1q21-q22 0.147 0.263 0.777 epidermis development;keratinocyte
differentiation
mut TDRD5 1q25.2 0.147 0.263 0.777 spermatid development;cell
differentiation
exp LOC100130100 2q13 0.147 0.263 0.777
exp JAKMIP2 5q32 0.147 0.263 0.777
exp UBA2 19q12 0.147 0.263 0.777 DNA Damage Response (DDR)
xsq LINC00330 0.147 0.263 0.777
xsq LINC01128 0.147 0.263 0.777
exp FBXO42 1p36.23-p36.11 0.147 0.263 0.777
met RANBP3 19p13.3 0.147 0.263 0.777 protein transport;intracellular
transport
xsq NVL 1q41-q42.2 0.147 0.263 0.777
met UNG 12q23-q24.1 0.147 0.263 0.777 DNA Damage Response (DDR); DDR (BER)
cop GSKIP 14q32.2 0.147 0.263 0.777
mut CCDC81 11q14.2 0.147 0.263 0.777
xsq TRIM4 7q22-q31.1 0.147 0.263 0.777 protein trimerization
exp HS6ST1P1 1p36.12 0.147 0.263 0.777
xsq CHRNG 2q37.1 0.147 0.263 0.777
met PPARGC1B 5q32 0.147 0.263 0.777 positive regulation of transcription from
RNA polymerase II promoter;response to glucocorticoid stimulus
met FZD9 7q11.23 0.147 0.263 0.777 embryo development;B cell differentiation
met ABCA3 16p13.3 0.147 0.263 0.777 ABC Transporters
exp CDH1 16q22.1 -0.147 0.263 0.777 Cell Signaling; Tumor Suppressors
mda CDH1_transcript_expression -0.147 0.263 0.777
exp ARHGAP16P 14q21.2 -0.147 0.263 0.777
mut GRIN3B 19p13.3 -0.147 0.263 0.777
exp CCNYL2 10q11.21 -0.147 0.263 0.777 regulation of cyclin-
xsq BMPR1A 10q22.3 -0.147 0.263 0.777 Apoptosis
xsq SP140L 2q37.1 -0.147 0.263 0.777
xsq B4GALT5 20q13.1-q13.2 -0.147 0.263 0.777 O-glycan
DNA-dependent"
cop ATP11B 3q27 -0.147 0.263 0.777 transmembrane transport;ion
transport
exp PHC3 3q26.2 -0.147 0.263 0.777 multicellular organismal
development
exp PLEKHH1 14q24.1 -0.147 0.263 0.777
cop DCUN1D1 3q26.3 -0.147 0.263 0.777
mut ORAI1 12q24.31 -0.147 0.263 0.777 ion transport;blood coagulation
cop YIPF7 4p12 -0.147 0.263 0.777
cop GUF1 4p12 -0.147 0.263 0.777 translation
cop GNPDA2 4p12 -0.147 0.263 0.777 carbohydrate metabolic process;N-
mut PTPDC1 9q22.32 -0.147 0.263 0.777
met GBP7 1p22.2 -0.147 0.263 0.777
exp HOOK3 8p11.21 -0.147 0.263 0.777 cytoplasmic microtubule
exp THSD1 13q14.3 -0.147 0.263 0.777
cop ECT2 3q26.1-q26.2 -0.147 0.263 0.777 positive regulation of Cdc42
GTPase activity;regulation of attachment of spindle microtubules to kinetochore
mut LRRC46 17q21.32 -0.147 0.263 0.777
met WBP1L 10q24.32 -0.147 0.263 0.777
pro CDH2_1 -0.147 0.263 0.777
mut MFSD5 12q13.13 -0.147 0.263 0.777 transport
xsq IL1RL2 2q12 -0.147 0.263 0.777 cellular defense response;signal
transduction
mut CARS 11p15.5 -0.147 0.263 0.777 tRNA aminoacylation for protein
mut BAZ1A 14q13.2 -0.147 0.263 0.777 DNA Damage Response (DDR); DDR
(Chromatin)
exp TMPRSS5 11q -0.147 0.263 0.777 proteolysis
xsq TDRD7 9q22.33 -0.147 0.263 0.777 lens morphogenesis in camera-type
mut NUP85 17q25.1 -0.147 0.263 0.777 protein transport;transmembrane
transport
met GAREM2 -0.147 0.263 0.777
xsq SGK3 8q12 -0.147 0.263 0.777
DNA-dependent"
cop RAPGEF6 5q31.1 -0.147 0.263 0.777 signal transduction;Ras
mut FARS2 6p25.1 -0.147 0.263 0.777 tRNA processing;gene expression
cop SNTB1 8q23-q24 -0.147 0.263 0.777 muscle contraction
cop SLC1A3 5p13 -0.147 0.263 0.777 Solute Carriers
xsq LINC01116 -0.147 0.263 0.777
met MIR451A -0.147 0.263 0.777
mut HKR1 19q13.12 -0.147 0.263 0.777 regulation of transcription, DNA-
his SPATA31E1 9q22.1 -0.148 0.263 0.777
xai YES1 18p11.31-p11.21 -0.148 0.263 0.777 Apoptosis
his TMC4 19q13.42 -0.148 0.263 0.777 EMT (Epithelial)
xai HUNK 21q22.1 -0.148 0.263 0.777 signal transduction;multicellular
hs4 CYP4X1 1p33 -0.148 0.263 0.777
xai VN2R1P 3q25.31 -0.148 0.263 0.777
hs4 MPP7 10p12.1 -0.148 0.263 0.777 protein localization to adherens
junction;positive regulation of signal transduction
xai HCRTR2 6p12 -0.148 0.263 0.777 neuropeptide signaling
xai RAB38 11q14 -0.148 0.263 0.777 GTP catabolic process;small GTPase
hs4 MEOX2 7p22.1-p21.3 -0.148 0.263 0.777 multicellular organismal
hs4 MEOX2-AS1 -0.148 0.263 0.777
exp LOC100233156 -0.148 0.263 0.777
xai KIAA1614 1q25.3 -0.148 0.263 0.777
his PTGR2 14q24.3 -0.148 0.263 0.777 prostaglandin metabolic process
xai LINC00624 1q21.1 -0.148 0.263 0.777
exp CHST5 16q22.3 -0.148 0.263 0.777 carbohydrate metabolic process;N-
exp CYP8B1 3p22.1 -0.148 0.263 0.777 bile acid biosynthetic
xai FAM20A 17q24.2 -0.148 0.263 0.777
his KRTAP7-1 21q22.1 -0.148 0.263 0.777
hs4 OXGR1 13q32.1 -0.148 0.263 0.777 G-protein coupled receptor
signaling pathway
his KIZ-AS1 -0.148 0.263 0.777
exp KRT8P42 -0.148 0.263 0.777
xai ND4 -0.149 0.263 0.777
cop LOC643923 11q22.3 0.148 0.264 0.777
hs4 RPL29 3p21.3-p21.2 0.148 0.264 0.777 nuclear-transcribed mRNA catabolic
exp ZNRD1-AS1 6p22.1 0.148 0.264 0.777
xai ASAH2B 10q11.23 0.148 0.264 0.777
xai CCDC18 1p22.1 0.148 0.264 0.777
hs4 SIGLEC15 18q12.3 0.148 0.264 0.777
exp POLR3KP1 13q21.2 0.148 0.264 0.777
xai LRRC9 14q23.1 0.148 0.264 0.777
his LINC00454 0.148 0.264 0.777
his KCNK13 14q32.11 0.148 0.264 0.777 potassium ion transmembrane
his GAPT 5q11.2 0.148 0.264 0.777 B cell activation
swa TBL3 16p13.3 0.148 0.264 0.777 G-protein signaling, coupled to cGMP
exp MAST1 19p13.2 0.148 0.264 0.777 cytoskeleton organization;intracellular
xai C1orf74 1q32.2 0.148 0.264 0.777
swa ALDH3A1 17p11.2 0.148 0.264 0.777 response to organic cyclic
hs4 HDAC1 1p34 0.148 0.264 0.777 Apoptosis
swa NT5DC1 6q22.1 0.148 0.264 0.777
hs4 PRTN3 19p13.3 0.148 0.264 0.777 proteolysis;positive regulation of cell
proliferation
xai WDR25 14q32.2 0.148 0.264 0.777
his MAEA 4p16.3 0.148 0.264 0.777 erythrocyte maturation;enucleate
erythrocyte development
his ATP7B 13q14.3 0.148 0.264 0.777 cellular zinc ion
his ALG11 13q14.2 0.148 0.264 0.777 dolichol-linked oligosaccharide
biosynthetic process;biosynthetic process
dependent"
swa PCNA 20pter-p12 0.148 0.264 0.777 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
hs4 LINC00461 5q14.3 0.148 0.264 0.777
hs4 MIR9-2 0.148 0.264 0.777
his TBCB 19q13.11-q13.12 0.148 0.264 0.777 multicellular organismal
his POLR2I 19q12 0.148 0.264 0.777 DNA Damage Response (DDR); DDR (NER)
his GART 21q22.11 0.148 0.264 0.777 purine base biosynthetic process;purine
his SON 21q22.11 0.148 0.264 0.777 Apoptosis
hs4 LOC102724265 0.148 0.264 0.777
his CDC5L 6p21 0.148 0.264 0.777 DNA Damage Response (DDR)
his LOC101928516 0.148 0.264 0.777
xai UBN2 7q34 0.148 0.264 0.777
xai ZP4 1q43 0.148 0.264 0.777 positive regulation of protein kinase
exp RPL21P109 13q22 0.148 0.264 0.777
his BECN1 17q21 0.148 0.264 0.777 Apoptosis
his MIR6781 0.148 0.264 0.777
his OR4F16 0.148 0.264 0.777
his NKAP Xq24 0.148 0.264 0.777 Notch signaling pathway;negative regulation of
hs4 MEPCE 7q22.1 0.148 0.264 0.777
hs4 ZCWPW1 7q22.1 0.148 0.264 0.777
his GNB2 7q22 0.148 0.264 0.777 synaptic transmission;small molecule metabolic
process
xai NSUN5 7q11.23 0.148 0.264 0.777
his ABCF1 6p21.33 0.148 0.264 0.777 ABC Transporters
met AKAP4 Xp11.2 0.147 0.264 0.777 cell projection organization;sperm
motility
xsq C11orf57 11q23.1 0.147 0.264 0.777
met MTG1 10q26.3 0.147 0.264 0.777
xsq DRC7 0.147 0.264 0.777 ciliary or flagellar motility;spermatogenesis
xsq LOC105447645 0.147 0.264 0.777
met PRR22 19p13.3 0.147 0.264 0.777
cop GPR78 0.147 0.264 0.777
xsq POGZ 1q21.3 0.147 0.264 0.777 regulation of transcription, DNA-
xsq LRRC46 17q21.32 0.147 0.264 0.777
xsq CHRND 2q37.1 0.147 0.264 0.777 muscle contraction;signal transduction
xsq PPRC1 10q24.32 0.147 0.264 0.777 regulation of transcription, DNA-
dependent"
exp SKIV2L2 5q11.2 0.147 0.264 0.777 nuclear mRNA splicing, via
exp PPCDC 15q24.2 0.147 0.264 0.777 coenzyme A biosynthetic
exp ASNSD1 2p24.3-q21.3 0.147 0.264 0.777 asparagine biosynthetic
xsq KLHL26 19p13.11 0.147 0.264 0.777
xsq RINT1 7q22.3 0.147 0.264 0.777 cell cycle;protein transport
met ZSCAN5A 19q13.43 0.147 0.264 0.777 viral reproduction
cop SUDS3 12q24.23 0.147 0.264 0.777 chromatin modification;negative
xsq USMG5 10q24.33 0.146 0.264 0.777
xsq TPSAB1 0.146 0.264 0.777 defense response;proteolysis
exp FAM19A2 12q14.1 0.146 0.264 0.777
mut IMP4 2q21.1 0.146 0.264 0.777 rRNA processing
exp ANKRD34A 1q21.1 0.146 0.264 0.777
met ESRP2 16q22.1 0.146 0.264 0.777 EMT (Epithelial)
xsq SYCN 0.146 0.264 0.777
exp RPS2P3 14q32.2 0.146 0.264 0.777
mut ARHGAP9 12q13.3 0.146 0.264 0.777 positive regulation of GTPase
exp EMID1 22q12.2 0.146 0.264 0.777
cop MEN1 11q13 0.146 0.264 0.777 DNA Damage Response (DDR); Tumor Suppressors
cop CDC42BPG 11q13.1 0.146 0.264 0.777 EMT (Epithelial); Protein Kinases
cop EHD1 11q13 0.146 0.264 0.777 protein homooligomerization;intracellular
protein transport
cop MIR192 0.146 0.264 0.777
cop MIR194-2 0.146 0.264 0.777
cop ATG2A 11q13.1 0.146 0.264 0.777
cop PPP2R5B 11q12 0.146 0.264 0.777 activation of signaling protein activity
cop GPHA2 11q13.1 0.146 0.264 0.777
cop TTC24 1q23.1 0.146 0.264 0.777
cop APOA1BP 1q21 0.146 0.264 0.777
cop GPATCH4 1q22 0.146 0.264 0.777
xsq FCRL3 1q21-q22 0.146 0.264 0.777
met HERC6 4q22.1 0.146 0.264 0.777 protein modification process;protein
xsq CRX 19q13.3 0.146 0.264 0.777 positive regulation of transcription from
RNA polymerase II promoter;response to stimulus
exp MAPK14 6p21.3-p21.2 0.146 0.264 0.777 Protein Kinases
dependent"
met SENP5 3q29 0.146 0.264 0.777 proteolysis;cell cycle
exp BDH2P1 6q16.2 0.146 0.264 0.777
xsq OPRM1 6q24-q25 0.146 0.264 0.777 sensory perception;negative regulation of
nitric oxide biosynthetic process
xsq DKFZp451B082 0.146 0.264 0.777
xsq MTL5 11q13.2-q13.3 0.146 0.264 0.777 cellular metal ion
homeostasis;multicellular organismal development
exp RPL21P90 10q23.33 0.146 0.264 0.777
met MIR1323 0.146 0.264 0.777
exp GYPE 4q31.1 0.146 0.264 0.777
exp GABBR1 6p21.31 -0.146 0.264 0.777 negative regulation of cell
met RRN3 16p12 -0.146 0.264 0.777 regulation of transcription, DNA-
xsq MAP3K9 14q24.2 -0.146 0.264 0.777 Protein Kinases
cop TCEA1 8q11.2 -0.146 0.264 0.777 DNA Damage Response (DDR)
cop SMIM15 5q12.1 -0.146 0.264 0.777
met GRAMD4 22q13.31 -0.146 0.264 0.777 apoptotic process
exp ATRNL1 10q26 -0.146 0.264 0.777 G-protein coupled receptor
signaling pathway
xsq TSEN34 19q13.4 -0.146 0.264 0.777 tRNA-type intron splice site
xsq LOC441666 10q11.21 -0.146 0.264 0.777
xsq LOC101928418 -0.146 0.264 0.777
met PWWP2B 10q26.3 -0.146 0.264 0.777
mut OR13D1 -0.146 0.264 0.777
cop ALDH1L1-AS1 -0.147 0.264 0.777
xsq PRR36 -0.147 0.264 0.777
met ERO1B -0.147 0.264 0.777 oxidation-reduction process;protein
folding
met ARL4C 2q37.1 -0.147 0.264 0.777 GTP catabolic process;transport
exp PLEKHS1 10q25.3 -0.147 0.264 0.777
exp SERAC1 6q25.3 -0.147 0.264 0.777 GPI anchor metabolic
exp CILP 15q22 -0.147 0.264 0.777 negative regulation of insulin-like
exp SH3BP5L 1q44 -0.147 0.264 0.777
exp MAGI1 3p14.1 -0.147 0.264 0.777 protein complex assembly;cell
adhesion
exp PCYT1B Xp22.11 -0.147 0.264 0.777 CDP-choline
pro RIPK1 6p25.2 -0.147 0.264 0.777 Apoptosis
xsq RERG 12p12.3 -0.147 0.264 0.777 GTP catabolic process;signal
transduction
cop ZNF706 8q22.3 -0.147 0.264 0.777
met HNRNPF 10q11.21 -0.147 0.264 0.777 nuclear mRNA splicing, via
xai PI4KA 22q11.21 -0.148 0.264 0.777 phosphatidylinositol-mediated
xai IRF9 14q11.2 -0.148 0.264 0.777 type I interferon-mediated
xai GAPDHS 19q13.12 -0.148 0.264 0.777 small molecule metabolic
hs4 PDGFRL 8p22-p21.3 -0.148 0.264 0.777 platelet-derived growth
factor receptor-beta signaling pathway
swa MRPL53 2p13.1 -0.148 0.264 0.777
hs4 ABCD3 1p21.3 -0.148 0.264 0.777 ABC Transporters
his PYGB 20p11.21 -0.148 0.264 0.777 carbohydrate metabolic
his EDN1 6p24.1 -0.148 0.264 0.777 negative regulation of
pathway
his CRYGB -0.148 0.264 0.777
his EPN3 17q21.33 -0.148 0.264 0.777
his LUM 12q21.33 -0.148 0.264 0.777 visual perception;response to
DNA-dependent"
xai LOC100131170 -0.148 0.264 0.777
xai TMEM144 4q32.1 -0.148 0.264 0.777
xai FIBIN 11p14.2 -0.148 0.264 0.777
his RHOBTB3 5q15 -0.148 0.264 0.777 ATP catabolic process;transport
xai CLDN4 7q11.23 -0.148 0.264 0.777 EMT (Epithelial)
exp HCRTR2 6p12 -0.148 0.264 0.777 neuropeptide signaling
xai NRBP1 2p23 -0.148 0.264 0.777 ER to Golgi vesicle-mediated
transport;gene expression
xai TMEM43 3p25.1 -0.148 0.264 0.777
his LOC90768 -0.148 0.264 0.777
xai GS1-279B7.1 -0.148 0.264 0.777
hs4 CD36 7q11.2 -0.148 0.264 0.777 pattern recognition receptor
his PNCK Xq28 -0.148 0.264 0.777
met HACD4 0.15 0.265 0.777 fatty acid biosynthetic process
xai ZPBP2 17q12 0.148 0.265 0.777 binding of sperm to zona pellucida
xai COX5B 2q11.2 0.148 0.265 0.777 respiratory gaseous exchange;respiratory
his TMEM121 14q32.33 0.148 0.265 0.777
his LOC105370697 0.148 0.265 0.777
his ZUFSP 6q22.1 0.148 0.265 0.777
his MAP3K14-AS1 17q21.31 0.148 0.265 0.777
hs4 PLAC8 4q21.22 0.148 0.265 0.777
xai RPL21P109 13q22 0.148 0.265 0.777
hs4 GNA15 19p13.3 0.148 0.265 0.777 blood coagulation;GTP catabolic process
swa ZNF784 19q13.42 0.148 0.265 0.777 regulation of transcription, DNA-
dependent"
hs4 C1orf61 1q22 0.148 0.265 0.777
hs4 MIR9-1 0.148 0.265 0.777
xai BMI1 10p11.23 0.148 0.265 0.777 segment specification;positive regulation
exp TONSL 8q24.3 0.148 0.265 0.777 DNA Damage Response (DDR)
his FAM204A 10q26.11 0.148 0.265 0.777
exp LOC100128276 12q24.33 0.148 0.265 0.777
xai IGANRP 0.148 0.265 0.777
exp LOC730100 2p16.3 0.148 0.265 0.777
xai KRT33A 17q21.2 0.148 0.265 0.777
his RSRC1 3q25.32 0.148 0.265 0.777 nucleocytoplasmic transport;RNA splicing
xai GMNC 3q28 0.147 0.265 0.777 cell cycle;cell proliferation
dependent"
xai MEX3C 18q21.2 0.147 0.265 0.777
his DHX36 3q25.2 0.147 0.265 0.777
his RAB44 0.147 0.265 0.777 small GTPase mediated signal
his NFX1 9p13.3 0.147 0.265 0.777 interspecies interaction between
organisms;negative regulation of MHC class II biosynthetic process
xai CISD1 10q21.1 0.147 0.265 0.777 regulation of cellular respiration
his PIGP 21q22.2 0.147 0.265 0.777 preassembly of GPI anchor in ER
his TTC3 21q22.2 0.147 0.265 0.777 ubiquitin-dependent protein catabolic
process;negative regulation of cell morphogenesis involved in differentiation
hs4 EGR3 8p23-p21 0.147 0.265 0.777 positive regulation of endothelial cell
proliferation;cellular response to vascular endothelial growth factor stimulus
xai ICT1 17q25.1 0.147 0.265 0.777 mitochondrial translational termination
xai LOC389765 9q21.33 0.147 0.265 0.777
xai LOC574538 0.147 0.265 0.777
xai CCDC109B 4q25 0.147 0.265 0.777
xai SVIP 11p14.2 0.147 0.265 0.777
xai HMGN2P7 3p25.1 0.147 0.265 0.777
hs4 GABPB2 1q21.3 0.147 0.265 0.777 regulation of transcription, DNA-
swa RICTOR 5p13.1 0.147 0.265 0.777 epidermal growth factor receptor
signaling pathway;regulation of actin cytoskeleton organization
his LOC541473 0.147 0.265 0.777
his TRIM73 7q11.23 0.147 0.265 0.777
swa GMPPB 3p21.31 0.147 0.265 0.777 GDP-mannose biosynthetic process;protein
N-linked glycosylation via asparagine
xsq SLC51B 15q22.31 0.146 0.265 0.777
exp PPFIA3 19q13.33 0.146 0.265 0.777 regulation of short-term neuronal
exp PIK3CA 3q26.3 0.146 0.265 0.777 Cell Signaling; Oncogenes; Protein
Kinases
exp NFE2 12q13 0.146 0.265 0.777 multicellular organismal development;blood
coagulation
cop TPPP2 14q11.2 0.146 0.265 0.777
cop RNASE13 14q11.1 0.146 0.265 0.777
cop RNASE7 14q11.2 0.146 0.265 0.777 response to bacterium;defense
cop RNASE8 0.146 0.265 0.777
xsq LINC01585 0.146 0.265 0.777
exp MPV17L 16p13.11 0.146 0.265 0.777
xsq ZFAND2B 2q35 0.146 0.265 0.777
xsq REEP4 8p21.3 0.146 0.265 0.777
xsq IMMP1L 11p13 0.146 0.265 0.777 proteolysis
xsq ACLY 17q21.2 0.146 0.265 0.777 energy reserve metabolic process;cellular
xsq LINC01258 0.146 0.265 0.777
met HEG1 3q21.2 0.146 0.265 0.777 endothelial cell morphogenesis;cell-cell
dependent"
mut BRWD1 21q22.2 0.146 0.265 0.777 regulation of transcription from RNA
polymerase II promoter;cytoskeleton organization
met FAM114A2 5q31-q33 0.146 0.265 0.777
xsq IPO11 5q12.1 0.146 0.265 0.777 intracellular protein transport
exp TNFRSF1B 1p36.22 0.146 0.265 0.777 Apoptosis
xsq FAM170A 5q23.1 0.146 0.265 0.777
met SATL1 Xq21.1 0.146 0.265 0.777
met SNORD54 8q12 0.146 0.265 0.777
xsq KIF27 9q21.32 0.146 0.265 0.777 cilium assembly;microtubule-based
movement
met METTL13 1q24-q25.3 0.146 0.265 0.777 metabolic process
xsq PP7080 5p15.33 0.146 0.265 0.777
met RTN4R 22q11.21 0.146 0.265 0.777 axonogenesis;nerve growth factor receptor
signaling pathway
mut GRIA1 5q31.1 0.146 0.265 0.777 ion transport;signal transduction
exp NICN1 3p21.31 0.146 0.265 0.777
cop IRF4 6p25-p23 0.146 0.265 0.777 Apoptosis
met CCDC66 3p14.3 0.146 0.265 0.777
met MAN2C1 15q24.2 0.146 0.265 0.777 mannose metabolic
cop LOC100129345 0.146 0.265 0.777
xsq PITPNA-AS1 0.146 0.265 0.777
mut HCN1 5p12 0.146 0.265 0.777 potassium ion transport;synaptic transmission
exp USP24 1p32.3 0.146 0.265 0.777 proteolysis;ubiquitin-dependent protein
catabolic process
exp ATP5C1 10p15.1 0.146 0.265 0.777 ATP biosynthetic process;ion
transport
exp LIG4 13q33-q34 0.146 0.265 0.777 DNA Damage Response (DDR); DDR (NHEJ)
xsq KCNJ11 11p15.1 0.146 0.265 0.777 potassium ion transport;negative
cop LOXHD1 18q21.1 0.146 0.265 0.777 sensory perception of sound
met ARG2 14q24.1 0.146 0.265 0.777 urea cycle;response to herbicide
cop LINC00277 15q23 0.146 0.265 0.777
xsq CSNK2B 6p21.3 0.146 0.265 0.777 Protein Kinases
cop SNX27 1q21.3 0.146 0.265 0.777 signal transduction;protein transport
cop CELF3 1q21 0.146 0.265 0.777 spermatogenesis;RNA splicing
cop LHX5 12q24 0.146 0.265 0.777 hippocampus development;cell proliferation in
forebrain
mut BRICD5 16p13.3 -0.146 0.265 0.777
xsq S100A3 1q21 -0.146 0.265 0.777
exp SAR1AP2 10q26.2 -0.146 0.265 0.777
mut AIP 11q13.3 -0.146 0.265 0.777 regulation of protein kinase A
xsq LOC102723766 -0.146 0.265 0.777
cop KIAA0947 -0.146 0.265 0.777
met FOLR3 11q13 -0.146 0.265 0.777 folic acid transport
cop ASAP1 8q24.1-q24.2 -0.146 0.265 0.777 signal transduction;cell
xsq TWIST2 2q37.3 -0.146 0.265 0.777 negative regulation of
molecular function;negative regulation of transcription from RNA polymerase II
promoter
cop TTTY11 Yp11.2 -0.146 0.265 0.777
xsq LINC00883 3q13.12 -0.146 0.265 0.777
exp LDLRAP1 1p36-p35 -0.146 0.265 0.777 steroid metabolic
process;regulation of establishment of protein localization in plasma membrane
exp MYBPH 1q32.1 -0.146 0.265 0.777 regulation of striated muscle
mut FARSA 19p13.2 -0.146 0.265 0.777 tRNA aminoacylation for protein
exp TUG1 22q12.2 -0.146 0.265 0.777
cop LPHN3 4q13.1 -0.146 0.265 0.777
met EGFEM1P 3q26.2 -0.146 0.265 0.777
met MIR1208 -0.146 0.265 0.777
exp MALT1 18q21 -0.146 0.265 0.777 Apoptosis
exp PPP1R2P5 2q12.3 -0.146 0.265 0.777
cop ACTR5 20q11.23 -0.146 0.265 0.777 DNA Damage Response (DDR); DDR
(Chromatin)
xsq SECISBP2L 15q21.1 -0.146 0.265 0.777
exp PAF1 19q13.1 -0.146 0.265 0.777 regulation of transcription, DNA-
met CAMK1D 10p13 -0.146 0.265 0.777 regulation of apoptotic
process;positive regulation of phagocytosis
met WAS Xp11.4-p11.21 -0.146 0.265 0.777 defense response;T cell
activation
exp CTIF 18q21.1 -0.146 0.265 0.777 nuclear-transcribed mRNA catabolic
mut LETM1 4p16.3 -0.146 0.265 0.777 cristae formation
exp REXO2 11q23.2 -0.146 0.265 0.777 nucleobase-containing compound
metabolic process;nucleotide metabolic process
xsq AFAP1L1 5q32 -0.146 0.265 0.777
xsq CLPSL1 6p21.31 -0.146 0.265 0.777 digestion;lipid catabolic
process
xai C14orf79 14q32.33 -0.147 0.265 0.777
xai BMPER 7p14.3 -0.147 0.265 0.777 ureteric bud development;blood
hs4 ROPN1B 3q21.2 -0.147 0.265 0.777 cytokinesis;signal
transduction
hs4 LOC101929413 -0.147 0.265 0.777
DNA-dependent"
hs4 DCAF12L2 Xq25 -0.147 0.265 0.777
his MAB21L3 1p13.1 -0.147 0.265 0.777
swa FAHD1 16p13.3 -0.147 0.265 0.777
his TYRP1 9p23 -0.147 0.265 0.777 acetoacetic acid metabolic
hs4 SLC9C1 3q13.2 -0.147 0.265 0.777 sperm motility;transmembrane
transport
xai RIN3 14q32.12 -0.147 0.265 0.777 endocytosis;signal transduction
xai SUPT5H 19q13 -0.147 0.265 0.777 transcription from RNA polymerase
II promoter;positive regulation of transcription elongation, DNA-dependent
xai CCNYL2 10q11.21 -0.147 0.265 0.777 regulation of cyclin-
xai APOE 19q13.2 -0.147 0.265 0.777 response to reactive oxygen
his ELF4 Xq26 -0.147 0.265 0.777 Transcription Factors
hs4 PAK3 Xq23 -0.147 0.265 0.777 Protein Kinases
his ALPP 2q37 -0.147 0.265 0.777
xai FOXP1-IT1 -0.147 0.265 0.777
his XG Xp22.33 -0.147 0.265 0.777
hs4 MICAL2 11p15.3 -0.148 0.265 0.777
hs4 LOC102467080 -0.148 0.265 0.777
hs4 LOC643542 -0.148 0.265 0.777
hs4 DSEL 18q22.1 -0.148 0.265 0.777
xai ZFHX4-AS1 8q21.11 -0.148 0.265 0.777
xai IL17REL 22q13.33 -0.148 0.265 0.777
hs4 RAD21L1 20p13 -0.148 0.265 0.777 chromosome segregation;meiosis
his PDPN 1p36.21 -0.148 0.265 0.777 lymphangiogenesis;cell
proliferation
his LGALS8 1q43 -0.148 0.265 0.777
his LGALS8-AS1 1q43 -0.148 0.265 0.777
xai ADAMTSL3 15q25.2 -0.148 0.265 0.777
hs4 UBXN10-AS1 -0.148 0.265 0.777
hs4 UBXN10 1p36.12 -0.148 0.265 0.777
his LOC101927854 -0.148 0.265 0.777
exp LOC100129520 Xq25 -0.148 0.265 0.777
cop LHB -0.149 0.265 0.777 cell-cell signaling;male gonad
development
cop LOC101059948 -0.149 0.265 0.777
xai OR51C4P 11p15.4 0.147 0.266 0.777
his OTUD4 4q31.21 0.147 0.266 0.777
hs4 SLAIN1 13q22.3 0.147 0.266 0.777
hs4 MIR3665 0.147 0.266 0.777
his GTF2H2B 5q13.2 0.147 0.266 0.777
his TGDS 13q32.1 0.147 0.266 0.777 nucleotide-sugar metabolic
swa WDR36 5q22.1 0.147 0.266 0.777 response to stimulus;rRNA processing
exp FGF21 19q13.33 0.147 0.266 0.777 signal transduction;cell-cell signaling
hs4 PPP3R1 2p15 0.147 0.266 0.777 induction of apoptosis by intracellular
signals;activation of pro-apoptotic gene products
hs4 ST3GAL2 16q22.1 0.147 0.266 0.777 protein glycosylation;O-glycan
processing
xai NSMCE3 0.147 0.266 0.777 regulation of transcription, DNA-
exp MORN3 12q24.31 0.147 0.266 0.777
hs4 MCM7 7q21.3-q22.1 0.147 0.266 0.777 DDR (DNA replication)
hs4 AP4M1 7q22.1 0.147 0.266 0.777 intracellular protein transport;vesicle-
mediated transport
hs4 CRTC1 19p13.11 0.147 0.266 0.777 regulation of transcription, DNA-
dependent;positive regulation of CREB transcription factor activity
hs4 LOC100192426 18p11.23 0.147 0.266 0.777
his LINC01047 0.147 0.266 0.777
xai HMGN2P20 2p23.3 0.147 0.266 0.777
his STIM1 11p15.5 0.147 0.266 0.777 detection of calcium ion;cation transport
his MIR4687 0.147 0.266 0.777
swa FAM193A 4p16.3 0.147 0.266 0.777
xai MRPS31P2 13q12.11 0.147 0.266 0.777
exp HMGN2P20 2p23.3 0.147 0.266 0.777
hs4 RFX5 1q21 0.147 0.266 0.777 negative regulation of transcription from RNA
polymerase II promoter;regulation of transcription, DNA-dependent"
hs4 GBAT2 0.147 0.266 0.777
his TMEM8C 9q34.2 0.147 0.266 0.777
xsq RTP5 0.146 0.266 0.777
xsq DRD5P2 1q21.1 0.146 0.266 0.777
xsq HES5 1p36.32 0.146 0.266 0.777 cell adhesion;glial cell fate commitment
xsq GBX1 7q36.1 0.146 0.266 0.777
met MGAT2 14q21 0.146 0.266 0.777 protein N-linked glycosylation;oligosaccharide
metabolic process
xsq NUDT16L1 16p13.3 0.146 0.266 0.777
xsq RNF212B 0.146 0.266 0.777
exp AP4S1 14q12 0.146 0.266 0.777 transport
exp RANGRF 17p13.1 0.146 0.266 0.777 protein transport
exp DPP8 15q22 0.146 0.266 0.777 proteolysis;immune response
exp CGGBP1 3p12-p11.1 0.146 0.266 0.777 regulation of transcription, DNA-
dependent"
xsq C17orf74 17p13.1 0.146 0.266 0.777
mut ABCG5 2p21 0.146 0.266 0.777 ABC Transporters
xsq APOF 0.146 0.266 0.777
cop NAGPA 16p13.3 0.146 0.266 0.777 carbohydrate metabolic process;protein
cop NAGPA-AS1 0.146 0.266 0.777
mut C2orf42 2p13.3 0.146 0.266 0.777
xsq GNA14 9q21 0.146 0.266 0.777 protein ADP-ribosylation;signal transduction
xsq MIF 22q11.23 0.146 0.266 0.777 Apoptosis
xsq OR2T29 0.146 0.266 0.777 response to stimulus
cop PTHLH 12p12.1-p11.2 0.146 0.266 0.777 cell-cell signaling;positive
exp CLIC2 Xq28 0.146 0.266 0.777 chloride transport;signal transduction
xsq EPHX2 8p21 0.146 0.266 0.777 inflammatory response;regulation of blood
pressure
exp PYROXD1 12p12.1 0.146 0.266 0.777
met TMEM132C 12q24.32 0.146 0.266 0.777
exp LDHAP3 2p21 0.146 0.266 0.777
met AGER 6p21.3 0.146 0.266 0.777 inflammatory response;positive regulation
xsq FAM95B1 0.146 0.266 0.777
met NRN1L 16q22.1 0.146 0.266 0.777
xsq ARMC10 7q22.1 0.146 0.266 0.777 regulation of growth
xsq COL6A4P2 3q22.1 0.146 0.266 0.777
xsq COL23A1 5q35.3 0.146 0.266 0.777 protein homotrimerization
met PLEKHG6 12p13.31 0.146 0.266 0.777 regulation of Rho protein signal
transduction
xsq ARL16 17q25.3 0.146 0.266 0.777 small GTPase mediated signal transduction
exp CADM2 3p12.1 0.146 0.266 0.777 cell junction assembly;adherens junction
organization
xsq EREG 4q13.3 0.146 0.266 0.777 female meiosis;organ morphogenesis
met IPO9 1q32.1 0.146 0.266 0.777 protein import into nucleus;intracellular
protein transport
xsq NUPL2 7p15 0.146 0.266 0.777 protein export from nucleus;mRNA transport
xsq RPS6 9p21 0.146 0.266 0.777 translational elongation;viral reproduction
cop SCG5 15q13-q14 0.146 0.266 0.777 peptide hormone processing;negative
cop GREM1 15q13.3 0.146 0.266 0.777 cell-cell signaling;negative regulation
xsq PTRHD1 2p23.3 0.146 0.266 0.777
exp LOC100130987 11q13.2 0.146 0.266 0.777
xsq CASC21 0.146 0.266 0.777
met SCRT2 20p13 0.146 0.266 0.777
cop FAM110C 2p25.3 0.146 0.266 0.777
exp COX10-AS1 0.146 0.266 0.777
cop ST8SIA5 18q21.1 0.146 0.266 0.777 carbohydrate metabolic
exp CCDC18 1p22.1 0.146 0.266 0.777
xsq TCF4 18q21.1 0.146 0.266 0.777 positive regulation of transcription,
exp RPL27AP6 6q25.2 0.146 0.266 0.777
xsq ARMC8 3q22.3 0.146 0.266 0.777
xsq LINC00656 20p11.21 0.146 0.266 0.777
met SAA1 11p15.1 0.146 0.266 0.777 acute-phase response;regulation of
protein secretion
mir hsa-miR-30d* 0.146 0.266 0.777
xsq PRMT5-AS1 0.146 0.266 0.777
cop DDX51 12q24.33 0.146 0.266 0.777 rRNA processing
cop NOC4L 12q24.33 0.146 0.266 0.777 rRNA processing
met TRMT10B 9p13.2 0.146 0.266 0.777
cop CBFB 16q22.1 0.146 0.266 0.777 regulation of transcription, DNA-
cop LOC729020 0.146 0.266 0.777
cop INA 10q24.33 0.146 0.266 0.777 multicellular organismal
cop PCGF6 10q24.33 0.146 0.266 0.777 negative regulation of transcription,
DNA-dependent"
cop TAF5 10q24-q25.2 0.146 0.266 0.777 viral reproduction;chromatin modification
cop RBM5-AS1 0.146 0.266 0.777
met EYA4 6q23 0.146 0.266 0.777 DNA repair;regulation of transcription, DNA-
dependent
xsq OR4C46 11p11.12 0.146 0.266 0.777 response to stimulus
xsq LOC100129924 1p34.2 0.146 0.266 0.777
dependent"
cop LOC645949 0.146 0.266 0.777
exp LRRIQ3 1p31.1 0.146 0.266 0.777
xsq GSTM5 1p13.3 -0.146 0.266 0.777 metabolic process;small molecule
metabolic process
met NCF2 1q25 -0.146 0.266 0.777 response to lipopolysaccharide;innate
immune response
exp PDE11A 2q31.2 -0.146 0.266 0.777 cAMP catabolic process;signal
transduction
exp PLOD3 7q22 -0.146 0.266 0.777 cellular response to hormone
xsq TMEM125 1p34.2 -0.146 0.266 0.777 EMT (Epithelial)
exp SUPT5H 19q13 -0.146 0.266 0.777 transcription from RNA polymerase
met CCDC87 11q13.2 -0.146 0.266 0.777
exp HMOX1 22q13.1 -0.146 0.266 0.777 negative regulation of leukocyte
cop LOC340094 -0.146 0.266 0.777
mut SLC38A5 Xp11.23 -0.146 0.266 0.777 Solute Carriers
xsq LOC652276 16p13.3 -0.146 0.266 0.777
xsq CHPF 2q35 -0.146 0.266 0.777
exp SNORD3C 17p11.2 -0.146 0.266 0.777
cop ADAMTS16 5p15 -0.146 0.266 0.777 proteolysis
xsq CXCL14 5q31 -0.146 0.266 0.777 chemotaxis;immune response
cop PXYLP1 -0.146 0.266 0.777
xsq GAS8 16q24.3 -0.146 0.266 0.777 negative regulation of cell
cop PRKY Yp11.2 -0.146 0.266 0.777 protein phosphorylation
mut ALDOA 16p11.2 -0.146 0.266 0.777 striated muscle contraction;protein
homotetramerization
mut MITD1 2q11.2 -0.146 0.266 0.777 protein transport
mut MYO1B 2q12-q34 -0.146 0.266 0.777 actin filament-based movement;actin
mut SYCP2L 6p24.2 -0.146 0.266 0.777
mut CORO1B 11q13.2 -0.146 0.266 0.777 actin cytoskeleton
organization
mut SPIRE1 18p11.21 -0.146 0.266 0.777 transport
mut WDR75 2q32.2 -0.146 0.266 0.777
mut FBXL17 5q21.3 -0.146 0.266 0.777
mut SNX14 6q14.3 -0.146 0.266 0.777 cell communication;protein
transport
mut KIF25 6q27 -0.146 0.266 0.777 mitotic sister chromatid
segregation;organelle organization
mut DPP7 9q34.3 -0.146 0.266 0.777 proteolysis
mut ITIH2 10p15 -0.146 0.266 0.777 negative regulation of endopeptidase
activity;hyaluronan metabolic process
mut NPFF 12q13.13 -0.146 0.266 0.777 neuropeptide signaling
mut COG8 16q22.1 -0.146 0.266 0.777 protein transport
mut KISS1R 19p13.3 -0.146 0.266 0.777 neuropeptide signaling
mut ZNRF3 22q12.1 -0.146 0.266 0.777
mut KLF8 Xp11.21 -0.146 0.266 0.777 regulation of transcription, DNA-
dependent"
xsq RBBP8NL 20q13.33 -0.146 0.266 0.777
exp STARD10 11q13 -0.146 0.266 0.777
cop MIR548I1 -0.146 0.266 0.777
cop FAM86JP 3q21.2 -0.146 0.266 0.777
mut HSPA9 5q31.1 -0.146 0.266 0.777 Apoptosis
exp CCM2L 20q11.2 -0.146 0.266 0.777
cop RANBP1 22q11.21 -0.146 0.266 0.777 viral reproduction;positive
exp DKK2 4q25 -0.146 0.266 0.777 multicellular organismal
met SH2B2 7q22 -0.146 0.266 0.777 signal transduction;blood coagulation
cop TTTY18 Yp11.2 -0.146 0.266 0.777
cop TTTY19 Yp11.2 -0.146 0.266 0.777
met ZCCHC17 1p35.2 -0.146 0.266 0.777
hs4 PSEN1 14q24.3 -0.147 0.266 0.777 Apoptosis
xai PLEKHA7 11p15.1 -0.147 0.266 0.777 zonula adherens
exp IGSF23 19q13.31 -0.147 0.266 0.777
xai KITLG 12q22 -0.147 0.266 0.777 ovarian follicle development;hemopoiesis
xai THSD1 13q14.3 -0.147 0.266 0.777
xai HUS1 7p13-p12 -0.147 0.266 0.777 DNA Damage Response (DDR); DDR
(BER)
his RAB20 13q34 -0.147 0.266 0.777 small GTPase mediated signal
hs4 CCND1 11q13 -0.147 0.266 0.777 DNA Damage Response (DDR); DDR (G1-S
his HECTD2-AS1 -0.147 0.266 0.777
xai NCALD 8q22.2 -0.147 0.266 0.777 synaptic transmission;vesicle-
mediated transport
xai LOC441052 4q34.1 -0.147 0.266 0.777
swa KRT7 12q13.13 -0.147 0.266 0.777 regulation of
exp PCDHGA2 5q31 -0.147 0.266 0.777 cell adhesion;homophilic cell
adhesion
his AHNAK2 14q32.33 -0.147 0.266 0.777
xai CLDN23 8p23.1 -0.147 0.266 0.777 tight junction
xai ATP6AP1 Xq28 -0.147 0.266 0.777 ion transport;aging
xai C17orf64 17q23.2 -0.147 0.266 0.777
xai INPPL1 11q13 -0.147 0.266 0.777 actin filament
organization;negative regulation of neuron projection development
xai IFI44 1p31.1 -0.147 0.266 0.777 response to virus
xai RNF216 7p22.1 -0.147 0.266 0.777 interspecies interaction
between organisms;regulation of defense response to virus by host
swa RAB12 18p11.22 -0.147 0.266 0.777 small GTPase mediated signal
his ANKRD34B 5q14.1 -0.147 0.266 0.777
his THAP3 1p36.31 -0.147 0.266 0.777
cop MYPOP 19q13.32 -0.147 0.266 0.777 negative regulation of
cop NANOS2 19q13.32 -0.147 0.266 0.777 spermatogenesis;cell
differentiation
xai SCGB2A1 11q13 -0.147 0.266 0.777
hs4 SERTAD1 19q13.1-q13.2 -0.147 0.266 0.777 regulation of cyclin-
exp MINOS1P1 -0.147 0.266 0.777
cop ERV3-1 7q11.2 -0.147 0.266 0.777
his IER5 1q25.3 -0.147 0.266 0.777
xai EDIL3 5q14 -0.147 0.266 0.777 cell adhesion;multicellular organismal
development
his TSKU 11q13.5 -0.147 0.266 0.777
his LOC101928837 -0.147 0.266 0.777
xai LETMD1 12q13.12 0.147 0.267 0.777
his ZNF213-AS1 0.147 0.267 0.777
xai GRIPAP1 Xp11.23 0.147 0.267 0.777
his LINC00491 0.147 0.267 0.777
xai ERG 21q22.3 0.147 0.267 0.777 Transcription Factors
his RCAN3 1p35.3-p33 0.147 0.267 0.777 anatomical structure
morphogenesis;calcium-mediated signaling
his RCAN3AS 0.147 0.267 0.777
his GUCD1 22q11.2 0.147 0.267 0.777
his SNRPD3 22q11.23 0.147 0.267 0.777 spliceosomal snRNP assembly;RNA
metabolic process
hs4 MIS18A 21q22.11 0.147 0.267 0.777 nucleosome assembly;cell cycle
hs4 MADD 11p11.2 0.147 0.267 0.777 activation of MAPK activity;positive
hs4 LOC101928943 0.147 0.267 0.777
swa PADI1 1p36.13 0.147 0.267 0.777 protein modification process;peptidyl-
citrulline biosynthetic process from peptidyl-arginine
hs4 MAD2L1 4q27 0.147 0.267 0.777 DNA Damage Response (DDR)
xai RPL7L1P4 5q23.1 0.147 0.267 0.777
xai HSD11B2 16q22 0.147 0.267 0.777 response to insulin stimulus;response to
drug
xai ARMC10 7q22.1 0.147 0.267 0.777 regulation of growth
xai HBG2 11p15.5 0.147 0.267 0.777 transport;blood coagulation
exp UBN2 7q34 0.147 0.267 0.777
xai RANGRF 17p13.1 0.147 0.267 0.777 protein transport
his KATNAL1 13q12.3 0.147 0.267 0.777
cop TXNIP 1q21.1 0.147 0.267 0.777 protein import into nucleus;nucleotide-
binding domain, leucine rich repeat containing receptor signaling pathway
his KBTBD8 3p14 0.147 0.267 0.777
xai TM2D3 15q26.3 0.147 0.267 0.777
xai FOPNL 16p13.11 0.147 0.267 0.777 cilium assembly;cell projection
organization
xai CLPTM1L 5p15.33 0.147 0.267 0.777 apoptotic process
his IRX2 5p15.33 0.147 0.267 0.777 metanephros development;specification of
loop of Henle identity
his C5orf38 5p15.33 0.147 0.267 0.777
hs4 IST1 16q22.2 0.147 0.267 0.777 cell division;cell cycle
his CCDC61 19q13.32 0.147 0.267 0.777
xai SACS 13q12 0.147 0.267 0.777 EMT (Mesenchymal)
hs4 ENPP7P13 0.147 0.267 0.777
xai SMKR1 7q32.1 0.147 0.267 0.777
xai MAU2 19p13.11 0.147 0.267 0.777 cell cycle;chromosome segregation
xai PES1 22q12.1 0.147 0.267 0.777 cell proliferation;ribosomal large
subunit biogenesis
hs4 MAST1 19p13.2 0.147 0.267 0.777 cytoskeleton organization;intracellular
xai CCNT2 2q21.3 0.147 0.267 0.777 regulation of cyclin-dependent protein
xai N6AMT2 13q12.11 0.147 0.267 0.777
hs4 ZFP1 16q23.1 0.147 0.267 0.777 regulation of transcription, DNA-
dependent"
hs4 IL10 1q31-q32 0.147 0.267 0.777 Apoptosis
swa PPP1R7 2q37.3 0.147 0.267 0.777 regulation of catalytic activity
swa PCBD1 10q22 0.147 0.267 0.777 tetrahydrobiopterin biosynthetic
his MIR6089 0.147 0.267 0.777
his CD99P1 0.147 0.267 0.777
xai TRAV6 0.147 0.267 0.777
his CD3E 11q23 0.147 0.267 0.777 cell surface receptor signaling
xsq MAPKAPK3 3p21.3 0.146 0.267 0.777 signal transduction;toll-like
exp DENND2D 1p13.3 0.146 0.267 0.777
xsq MIR3180-5 0.146 0.267 0.777
cop NDRG2 14q11.2 0.146 0.267 0.777 Wnt receptor signaling pathway;cell
differentiation
xsq CFAP46 0.146 0.267 0.777
xsq MAB21L1 13q13 0.146 0.267 0.777
exp IL5 5q31.1 0.146 0.267 0.777 inflammatory response;positive regulation
of peptidyl-tyrosine phosphorylation
exp CKS1BP6 Xp21.2 0.146 0.267 0.777
xsq LOC100506603 0.146 0.267 0.777
exp VMA21 Xq28 0.146 0.267 0.777 vacuolar proton-transporting V-type ATPase
complex assembly
met LOC100127888 0.146 0.267 0.777
xsq PDE12 3p14.3 0.146 0.267 0.777
exp PHLPP1 18q21.33 0.146 0.267 0.777 Apoptosis
xsq POM121L1P 22q11.22 0.146 0.267 0.777
xsq ALKBH7 19p13.3 0.146 0.267 0.777 DNA Damage Response (DDR)
cop PUM2 2p22-p21 0.146 0.267 0.777 regulation of translation
xsq LOC101929378 0.146 0.267 0.777
exp WDR6 3p21.31 0.146 0.267 0.777 negative regulation of cell
xsq BEND5 1p33 0.146 0.267 0.777
xsq SMG9 19q13.31 0.146 0.267 0.777 nuclear-transcribed mRNA catabolic
met OR6B1 7q35 0.146 0.267 0.777
xsq LOC101929592 0.146 0.267 0.777
met PPP1R3C 10q23-q24 0.146 0.267 0.777 carbohydrate metabolic
xsq TIMM10B 11p15.4 0.146 0.267 0.777
xsq TMX3 18q22 0.146 0.267 0.777 glycerol ether metabolic process;cell redox
homeostasis
xsq TAF1C 16q24 0.146 0.267 0.777 regulation of transcription, DNA-
met RAB29 0.146 0.267 0.777 GTP catabolic process;small GTPase mediated
signal transduction
cop TCF4 18q21.1 0.146 0.267 0.777 positive regulation of transcription,
xsq NLRP8 19q13.43 0.146 0.267 0.777
met NRIP1 21q11.2 0.146 0.267 0.777 negative regulation of transcription from
RNA polymerase II promoter;ovarian follicle rupture
xsq CDK4 12q14 0.146 0.267 0.777 DNA Damage Response (DDR); Protein Kinases
dependent"
met MIR376A2 0.146 0.267 0.777
cop UNK 17q25.1 0.146 0.267 0.777
exp TRIM52 5q35.3 0.146 0.267 0.777
xsq RAB40C 16p13.3 0.146 0.267 0.777 small GTPase mediated signal
xsq IK 5q31.3 0.146 0.267 0.777 immune response;cell-cell signaling
mut OSTN 3q28 0.145 0.267 0.777 ossification;multicellular organismal
development
exp ARMC7 17q25.1 0.145 0.267 0.777
xsq SLC22A11 11q13.1 0.145 0.267 0.777 urate metabolic
xsq TCF20 22q13.3 0.145 0.267 0.777 regulation of transcription, DNA-
dependent"
mut F11 4q35 0.145 0.267 0.777 positive regulation of fibrinolysis;proteolysis
xsq ALKBH3 11p11.2 0.145 0.267 0.777 DNA Damage Response (DDR); DDR
(Direct Repair)
cop CD226 18q22.3 0.145 0.267 0.777 signal transduction;cell recognition
cop CHMP3 2p11.2 0.145 0.267 0.777 cellular membrane organization;endosome
transport
cop LINC00593 15q23 0.145 0.267 0.777
cop TLE3 15q22 0.145 0.267 0.777 regulation of transcription, DNA-
cop MIR629 0.145 0.267 0.777
cop CKLF 16q21 0.145 0.267 0.777 neutrophil chemotaxis;secretion by cell
cop CKLF-CMTM1 0.145 0.267 0.777
cop CMTM1 16q21 0.145 0.267 0.777 chemotaxis
xsq FAM189A2 9q21.11 -0.145 0.267 0.777
xsq GRB14 2q22-q24 -0.145 0.267 0.777 blood coagulation;intracellular
signal transduction
xsq ZNF750 17q25.3 -0.145 0.267 0.777
cop FRG1 4q35 -0.145 0.267 0.777
exp ZYX 7q32 -0.145 0.267 0.777 signal transduction;cell-cell signaling
exp PARP10 8q24.3 -0.146 0.267 0.777 regulation of chromatin
cop C8orf48 8p22 -0.146 0.267 0.777
exp LRP6 12p13.2 -0.146 0.267 0.777 pericardium morphogenesis;neural
exp CTBP2P4 5q15 -0.146 0.267 0.777
xsq SELENBP1 1q21.3 -0.146 0.267 0.777 protein transport
DNA-dependent"
exp EXOC6B 2p13.2 -0.146 0.267 0.777 protein transport;vesicle
pro MAPK1 22q11.21 -0.146 0.267 0.777 Apoptosis; Protein Kinases
cop PPP1R16B 20q11.23 -0.146 0.267 0.777 signal
xsq ZCCHC14 16q24.2 -0.146 0.267 0.777 cell communication
xsq PDE7B 6q23-q24 -0.146 0.267 0.777 signal transduction;synaptic
transmission
xsq ATP10A 15q11.2 -0.146 0.267 0.777 cation transport;regulation
of cell shape
xsq ATOH8 2p11.2 -0.146 0.267 0.777 regulation of transcription, DNA-
xsq LOC100303749 -0.146 0.267 0.777
xsq EML1 14q32 -0.146 0.267 0.777
exp ERCC6 10q11.23 -0.146 0.267 0.777 DNA Damage Response (DDR); DDR
(NER)
xsq ERV3-1 7q11.2 -0.146 0.267 0.777
xsq KRTAP29-1 -0.146 0.267 0.777
xsq SUCLG2-AS1 -0.146 0.267 0.777
cop JADE2 -0.146 0.267 0.777 histone H3 acetylation;histone H4-K5
acetylation
cop SAR1B 5q31.1 -0.146 0.267 0.777 cellular membrane
xsq IGDCC4 15q22.31 -0.146 0.267 0.777
hs4 CHRDL2 11q14 -0.147 0.267 0.777 ossification;multicellular
his EHD1 11q13 -0.147 0.267 0.777 protein homooligomerization;intracellular
protein transport
swa DNASE2 19p13.2 -0.147 0.267 0.777 Apoptosis
xai PPP6R2P1 -0.147 0.267 0.777
adhesion
hs4 NPHP3-ACAD11 -0.147 0.267 0.777
hs4 NPHP3-AS1 3q22.1 -0.147 0.267 0.777
hs4 NPHP3 3q22.1 -0.147 0.267 0.777 photoreceptor cell
maintenance;maintenance of organ identity
his TAS2R14 -0.147 0.267 0.777 detection of chemical stimulus
involved in sensory perception of bitter taste;G-protein coupled receptor signaling
pathway
xai ZPBP -0.147 0.267 0.777 binding of sperm to zona pellucida
xai PKNOX2 11q24.2 -0.147 0.267 0.777 regulation of transcription
hs4 PDGFA 7p22 -0.147 0.267 0.777 Apoptosis
hs4 HRAT92 -0.147 0.267 0.777
xai SERPINE2 2q36.1 -0.147 0.267 0.777 multicellular organismal
development;negative regulation of proteolysis
xai GAPDHP15 -0.147 0.267 0.777
hs4 FGD4 12p11.21 -0.147 0.267 0.777 lamellipodium assembly;microspike
assembly
his DDX60 4q32.3 -0.147 0.267 0.777 response to virus
exp LOC642633 -0.147 0.267 0.777
xai APOL6 22q12.3 -0.147 0.267 0.777 lipoprotein metabolic
process;transport
hs4 LRRC75B -0.147 0.267 0.777
his SLC6A8 Xq28 -0.147 0.267 0.777 Solute Carriers
his LINC01320 -0.147 0.267 0.777
hs4 KCNG3 2p21 -0.147 0.267 0.777 transmembrane transport;ion transport
hs4 EHD3 2p21 -0.147 0.267 0.777 blood coagulation;endocytic recycling
hs4 CAPN14 2p23.1-p21 -0.147 0.267 0.777 proteolysis
xai LINC00260 -0.147 0.267 0.777
hs4 ARL4C 2q37.1 -0.147 0.267 0.777 GTP catabolic process;transport
xai PCDHB7 5q31 -0.147 0.267 0.777 cell adhesion;homophilic cell
adhesion
exp HTR6 1p36-p35 0.147 0.268 0.777 synaptic transmission;G-protein
exp AP3B2 15q 0.147 0.268 0.777 post-Golgi vesicle-mediated
exp PRDX2P1 13p12 0.147 0.268 0.777
hs4 HMGB2 4q31 0.147 0.268 0.777 DNA Damage Response (DDR); DDR (BER)
hs4 SF3B4 1q21.2 0.147 0.268 0.777 mRNA processing;RNA splicing
his SNORA49 0.147 0.268 0.777
his SFXN4 10q26.11 0.147 0.268 0.777 iron ion homeostasis;transmembrane
transport
his MLXIPL 7q11.23 0.147 0.268 0.777 regulation of transcription, DNA-
dependent;glucose homeostasis
swa PHF14 7p21.3 0.147 0.268 0.777
exp OR51F3P 11p15.4 0.147 0.268 0.777
hs4 POLR3K 16p13.3 0.147 0.268 0.777 transcription from RNA polymerase
hs4 SNRNP25 16p13.3 0.147 0.268 0.777 mRNA processing;RNA splicing
xai COL6A4P1 3p25.1 0.147 0.268 0.777
xai ITGA2B 17q21.32 0.147 0.268 0.777 blood coagulation;platelet
activation
xai CDCA3 12p13 0.147 0.268 0.777 cell cycle;mitosis
his ACVR1B 12q13 0.147 0.268 0.777 Cell Signaling
xai AK7 14q32.2 0.147 0.268 0.777 nucleobase-containing compound metabolic
his RPP21 6p22.1 0.147 0.268 0.777 tRNA processing;response to drug
hs4 PLCL1 2q33 0.147 0.268 0.777 lipid metabolic process;behavior
xai AHSP 16p11.2 0.147 0.268 0.777 protein folding;hemoglobin metabolic
process
xai ALG3P1 5p15.32 0.147 0.268 0.777
hs4 HDAC5 17q21 0.147 0.268 0.777 chromatin remodeling;cellular response to
insulin stimulus
his FAM86B3P 8p23.1 0.147 0.268 0.777
his HNRNPA2B1 7p15 0.147 0.268 0.777 RNA transport;nuclear mRNA splicing, via
spliceosome
his CBX3 7p15.2 0.147 0.268 0.777 chromatin remodeling;negative regulation
his PPBPP2 4q13.3 0.147 0.268 0.777
xai HSPBAP1 3q21.1 0.146 0.268 0.777 DDR (DNA replication)
his SLAIN1 13q22.3 0.146 0.268 0.777
his MIR3665 0.146 0.268 0.777
his GTSE1-AS1 22q13.31 0.146 0.268 0.777
his GTSE1 22q13.2-q13.3 0.146 0.268 0.777 G2 phase of mitotic cell cycle;DNA
arrest
xai UBAC2 13q32.3 0.146 0.268 0.777
xai ESD 13q14.1-q14.2 0.146 0.268 0.777 metabolic process
his GCLC 6p12 0.146 0.268 0.777 response to heat;small molecule metabolic
process
hs4 ALAS1 3p21.1 0.146 0.268 0.777 tetrapyrrole biosynthetic
hs4 CACNA1A 19p13 0.146 0.268 0.777 synaptic transmission;regulation of
his PRDM5 4q25-q26 0.146 0.268 0.777 mitotic cell cycle;chromatin modification
his KCNMB2 3q26.32 0.146 0.268 0.777 regulation of action potential in
neuron;regulation of vasoconstriction
cop CPZ 4p16.1 0.145 0.268 0.777 proteolysis;Wnt receptor signaling
pathway
xsq LINC00469 17q25.1 0.145 0.268 0.777
xsq NCLN 19p13.3 0.145 0.268 0.777 regulation of signal
xsq TET1 10q21 0.145 0.268 0.777 stem cell maintenance;DNA demethylation
xsq LINC00658 0.145 0.268 0.777
xsq LOC646938 15q25.1 0.145 0.268 0.777
xsq OR1M1 19p13.2 0.145 0.268 0.777 response to stimulus
xsq C19orf44 19p13.11 0.145 0.268 0.777
exp RPL31P29 6q25.2 0.145 0.268 0.777
dependent"
xsq TLK1 2q31.1 0.145 0.268 0.777 DDR (DNA replication)
cop NANP 20p11.1 0.145 0.268 0.777 carbohydrate metabolic process;metabolic
process
cop GABRG3 15q12 0.145 0.268 0.777 chloride transport;gamma-aminobutyric
cop XIAP Xq25 0.145 0.268 0.777 Apoptosis
met HS3ST1 4p16 0.145 0.268 0.777
xsq DDX4 5p15.2-p13.1 0.145 0.268 0.777 sperm motility;multicellular
met USP43 17p13.1 0.145 0.268 0.777 proteolysis;ubiquitin-dependent protein
catabolic process
exp PRKAB1 12q24.1-q24.3 0.145 0.268 0.777 Protein Kinases
exp IDH3G Xq28 0.145 0.268 0.777 2-oxoglutarate metabolic process;NADH metabolic
process
xsq MRPS15 1p34.3 0.145 0.268 0.777 translation
xsq LOC101929124 0.145 0.268 0.777
exp VWDE 7p21.3 0.145 0.268 0.777
xsq EAF1 3p25.1 0.145 0.268 0.777 regulation of transcription, DNA-
dependent"
xsq OR4K1 0.145 0.268 0.777
cop DRD5 4p16.1 0.145 0.268 0.777
met SPINK1 5q32 0.145 0.268 0.777 negative regulation of endopeptidase
activity
met MYRF 11q12-q13.1 0.145 0.268 0.777
exp TXLNB 6q24.1 0.145 0.268 0.777
xsq C15orf59 15q24.1 0.145 0.268 0.777
xsq FRA10AC1 10q23.33 0.145 0.268 0.777
xsq RNASEH2C 11q13.1 0.145 0.268 0.777 DNA Damage Response (DDR); DDR (DNA
replication)
met NIPAL2 8q22.2 0.145 0.268 0.777
exp HIST1H4E 6p22.1 0.145 0.268 0.777
xsq OXT 20p13 0.145 0.268 0.777 maternal aggressive behavior;response to
sucrose stimulus
xsq STARD5 15q26 0.145 0.268 0.777 C21-steroid hormone biosynthetic
process;transport
met FAM167A 8p23-p22 0.145 0.268 0.777
met SLC10A1 14q24.1 0.145 0.268 0.777 small molecule metabolic
process;transport
xsq LOC100147773 0.145 0.268 0.777
xsq TNFAIP8L1 19p13.3 0.145 0.268 0.777
exp C1orf233 1p36.33 0.145 0.268 0.777
exp UMAD1 0.145 0.268 0.777
cop MMP14 14q11.2 0.145 0.268 0.777 Apoptosis
cop RNASE2 14q11.2 0.145 0.268 0.777 RNA catabolic process;chemotaxis
cop METTL17 14q11.2 0.145 0.268 0.777 translation
xsq NPAP1 15q11-q13 0.145 0.268 0.777
met LCOR 10q24 0.145 0.268 0.777 negative regulation of transcription from RNA
xsq LOC101928191 0.145 0.268 0.777
cop AVEN 15q13.1 0.145 0.268 0.777 Apoptosis
xsq LOC101929718 0.145 0.268 0.777
xsq RPL7 8q21.11 0.145 0.268 0.777 nuclear-transcribed mRNA catabolic
cop TRMT2A 22q11.21 -0.145 0.268 0.777 RNA processing
xsq LAMC2 1q25-q31 -0.145 0.268 0.777 cell adhesion;epidermis development
cop RGL1 1q25.3 -0.145 0.268 0.777 signal transduction;small GTPase
met RTN4RL1 17p13.3 -0.145 0.268 0.777 axon regeneration
exp LOC100132735 -0.145 0.268 0.777
mut SLC22A1 6q25.3 -0.145 0.268 0.777 epinephrine
DNA-dependent"
DNA-dependent"
xsq CLDN16 3q28 -0.145 0.268 0.777 cellular metal ion
exp KRT8P49 11p15.4 -0.145 0.268 0.777
exp IL20RB 3q22.3 -0.145 0.268 0.777 positive regulation of
exp LOC642590 6q13 -0.145 0.268 0.777
cop XG Xp22.33 -0.145 0.268 0.777
cop MRAS 3q22.3 -0.145 0.268 0.777 GTP catabolic process;signal
transduction
mut KLHL20 1q25.1 -0.145 0.268 0.777 cytoskeleton
organization;protein ubiquitination
mut TM9SF1 14q11.2 -0.145 0.268 0.777 autophagy
cop LETM2 8p11.23 -0.145 0.268 0.777
exp SRPX2 Xq21.33-q23 -0.145 0.268 0.777 angiogenesis;cell-cell adhesion
exp LCE1F -0.145 0.268 0.777 keratinization
cop ZSWIM6 5q12.1 -0.145 0.268 0.777
met TNFSF8 9q33 -0.145 0.268 0.777 cell-cell signaling;cell
proliferation
mut GFRA1 10q26.11 -0.145 0.268 0.777 glial cell-derived neurotrophic
mut C2orf76 2q14.2 -0.145 0.268 0.777
cop GSDMC 8q24.21 -0.145 0.268 0.777
xsq TMEM9B 11p15.3 -0.145 0.268 0.777 signal transduction;positive
met LOC728743 7q36.1 -0.145 0.268 0.777
mut MAN2B1 19p13.2 -0.145 0.268 0.777 protein
hs4 THSD1 13q14.3 -0.146 0.268 0.777
his CTIF 18q21.1 -0.146 0.268 0.777 nuclear-transcribed mRNA catabolic
his HMGA1P7 -0.146 0.268 0.777
hs4 RGPD6 -0.146 0.268 0.777
his SPTBN2 11q13 -0.146 0.268 0.777 axon guidance;cell death
hs4 ROPN1 3q21.1 -0.146 0.268 0.777 signal transduction
hs4 EIF5A2 3q26.2 -0.146 0.268 0.777 peptidyl-lysine modification
to hypusine;polyamine homeostasis
swa GFRA1 10q26.11 -0.147 0.268 0.777 glial cell-derived neurotrophic
hs4 LOC100128076 9q22.31 -0.147 0.268 0.777
xai A2M 12p13.31 -0.147 0.268 0.777 negative regulation of complement
xai ETV7 6p21 -0.147 0.268 0.777 Transcription Factors
xai SNPH 20p13 -0.147 0.268 0.777 neurotransmitter secretion;synaptic
vesicle docking involved in exocytosis
exp KRT18P19 2q32.2 -0.147 0.268 0.777
exp LOC441178 6q27 -0.147 0.268 0.777
swa H3F3A 1q42.12 -0.147 0.268 0.777
xai HYI 1p34.2 -0.147 0.268 0.777
hs4 SYT14 1q32.2 -0.147 0.268 0.777 cell death
his APLP2 11q24 -0.147 0.268 0.777 regulation of epidermal growth factor-
his LINC00552 13q34 -0.147 0.268 0.777
his MEPE 4q21.1 -0.147 0.268 0.777 skeletal system development
xai IL15 4q31 -0.147 0.268 0.777 immune response;positive regulation of
hs4 PPM1J 1p13.2 -0.147 0.268 0.777 protein dephosphorylation
his LOC101927131 -0.147 0.268 0.777
exp CLEC10A 17p13.1 -0.147 0.268 0.777 endocytosis;innate immune
response
xai CCNA1 13q12.3-q13 -0.147 0.268 0.777 DNA Damage Response (DDR)
his LINC01170 -0.147 0.268 0.777
his MECOM 3q26.2 -0.147 0.268 0.777 response to external
xai MUC15 11p14.3 -0.147 0.268 0.777 post-translational protein
his LINC01143 0.146 0.269 0.777
his EIF1B 3p22.1 0.146 0.269 0.777 regulation of translational initiation
his EIF1B-AS1 0.146 0.269 0.777
xai CCDC47 17q23.3 0.146 0.269 0.777 ER overload response;embryo
development
xai GM2A 5q33.1 0.146 0.269 0.777 glycolipid catabolic process;lipid
storage
his COX6C 8q22.2 0.146 0.269 0.777 generation of precursor metabolites and
xai ETAA1 2p14 0.146 0.269 0.777
swa EVPL 17q25 0.146 0.269 0.777 epidermis development;peptide cross-linking
exp TNNI1 1q31.3 0.146 0.269 0.777 muscle filament sliding;ventricular
his CHRNB4 15q24 0.146 0.269 0.777 synaptic transmission;synaptic
hs4 FUT6 19p13.3 0.146 0.269 0.777 protein glycosylation;fucosylation
hs4 EML2 19q13.32 0.146 0.269 0.777 visual perception;sensory perception of
sound
hs4 MIR330 0.146 0.269 0.777
hs4 EML2-AS1 0.146 0.269 0.777
hs4 ZNF804B 7q21.13 0.146 0.269 0.777
cop UHRF1 19p13.3 0.146 0.269 0.777 positive regulation of DNA topoisomerase
(ATP-hydrolyzing) activity;DNA repair
his TFR2 7q22 0.146 0.269 0.777 proteolysis;iron ion transport
his HIST3H2A 1q42.13 0.146 0.269 0.777 nucleosome assembly
his HIST3H2BB 1q42.13 0.146 0.269 0.777 nucleosome assembly
his MIR4666A 0.146 0.269 0.777
xai OST4 2p23.3 0.146 0.269 0.777
swa PSMD13 11p15.5 0.146 0.269 0.777 antigen processing and presentation
his MFN1 3q26.33 0.146 0.269 0.777 GTP catabolic process;mitochondrial
fusion
swa GTF2F1 19p13.3 0.146 0.269 0.777 transcription from RNA polymerase
II promoter;positive regulation of transcription from RNA polymerase II promoter
his SPIN2A Xp11.1 0.146 0.269 0.777 cell cycle;gamete generation
hs4 NOLC1 10q24.32 0.146 0.269 0.777 positive regulation of cell
his PSMC1 14q32.11 0.146 0.269 0.777 protein polyubiquitination;DNA damage
his LINC00094 9q34 0.146 0.269 0.777
his WAC-AS1 0.146 0.269 0.777
his WAC 10p12.1 0.146 0.269 0.777 positive regulation of transcription,
his KIR3DX1 19q13.42 0.146 0.269 0.777
xai POU4F1 13q31.1 0.146 0.269 0.777 synapse assembly;positive
hs4 MIR4254 0.146 0.269 0.777
xai EQTN 9p21 0.146 0.269 0.777
his ZNRF2P1 0.146 0.269 0.777
his MIR550A2 0.146 0.269 0.777
his MIR550B2 0.146 0.269 0.777
hs4 EIF3C 0.146 0.269 0.777 translation;translational initiation
xai CCR1 3p21 0.146 0.269 0.777 dendritic cell chemotaxis;cell surface receptor
signaling pathway
hs4 LOC101929099 0.146 0.269 0.777
hs4 TTF2 1p22 0.146 0.269 0.777 mRNA processing;RNA splicing
xai OR51F3P 11p15.4 0.146 0.269 0.777
exp FAM181A-AS1 14q32.12 0.146 0.269 0.777
cop AAK1 2p14 0.145 0.269 0.777 regulation of clathrin-mediated
exp RFC4 3q27 0.145 0.269 0.777 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
cop LCE3A 1q21.3 0.145 0.269 0.777 keratinization
cop LCE2D 1q21.3 0.145 0.269 0.777
cop LCE2C 1q21.3 0.145 0.269 0.777 keratinization
cop LCE2B 1q21 0.145 0.269 0.777
cop C1orf68 1q21.3 0.145 0.269 0.777 epidermis development
cop KPRP 1q21.3 0.145 0.269 0.777
cop LCE1F 0.145 0.269 0.777 keratinization
cop LCE1E 1q21.3 0.145 0.269 0.777 keratinization
cop LCE1D 0.145 0.269 0.777
cop LCE1C 1q21.3 0.145 0.269 0.777
cop LCE1B 0.145 0.269 0.777 keratinization
cop LCE6A 0.145 0.269 0.777
cop SMCP 1q21.3 0.145 0.269 0.777
cop IVL 1q21 0.145 0.269 0.777 keratinocyte differentiation;keratinization
met KRBOX4 Xp11.3 0.145 0.269 0.777
mut OR6C74 0.145 0.269 0.777
cop CISH 3p21.3 0.145 0.269 0.777 intracellular signal transduction;JAK-
xsq ATP5L 11q23.3 0.145 0.269 0.777 ATP catabolic process;ion transport
met CCDC96 4p16.1 0.145 0.269 0.777
exp RPL32P36 Xp11.4 0.145 0.269 0.777
xsq MEF2C 5q14.3 0.145 0.269 0.777 osteoblast differentiation;regulation of
xsq RBM18 9q33.2 0.145 0.269 0.777
mut MRS2 6p22.3-p22.1 0.145 0.269 0.777 ion transport
xsq WIPI2 7p22.1 0.145 0.269 0.777 autophagic vacuole fusion;autophagy
xsq PSMB7 9q34.11-q34.12 0.145 0.269 0.777 M/G1 transition of mitotic cell
cycle;viral reproduction
xsq TNPO2 19p13.2 0.145 0.269 0.777 intracellular protein transport
cop SNORD94 2p11.2 0.145 0.269 0.777
exp PRSS30P 16p13.3 0.145 0.269 0.777
xsq UGT1A1 2q37 0.145 0.269 0.777
xsq RTFDC1 20q13.31 0.145 0.269 0.777
xsq TAF10 11p15.3 0.145 0.269 0.777 transcription from RNA polymerase II
met MCTS1 Xq24 0.145 0.269 0.777 positive regulation of cell
proliferation;regulation of growth
met GPC2 7q22.1 0.145 0.269 0.777 neuron differentiation
met HOXC6 12q13.3 0.145 0.269 0.777 regulation of transcription from RNA
exp IGLV1-47 0.145 0.269 0.777
exp COA1 7p13 0.145 0.269 0.777
met TUSC1 9p21.2 0.145 0.269 0.777 Tumor Suppressors
cop C14orf180 14q32.33 0.145 0.269 0.777
cop TMEM179 14q32.33 0.145 0.269 0.777
cop MIR4710 0.145 0.269 0.777
cop INF2 14q32.33 0.145 0.269 0.777 cellular component organization;actin
met GEMIN8 Xp22.2 0.145 0.269 0.777 RNA splicing;spliceosomal snRNP
assembly
met FADS6 17q25.1 0.145 0.269 0.777 fatty acid biosynthetic process
met MIR937 0.145 0.269 0.777
mut NDST4 4q26 0.145 0.269 0.777
met PLN 6q22.1 0.145 0.269 0.777 regulation of the force of heart
cop C16orf89 16p13.3 0.145 0.269 0.777
xsq ZP2 16p12 0.145 0.269 0.777 manganese ion transport;intracellular protein
transport
met FBXO33 14q21.1 0.145 0.269 0.777
xsq AK7 14q32.2 0.145 0.269 0.777 nucleobase-containing compound metabolic
exp LOC100131510 2p23.3 0.145 0.269 0.777
mut TRIM42 3q23 0.145 0.269 0.777
xsq TMEM19 12q21.1 0.145 0.269 0.777
exp POLR2E 19p13.3 0.145 0.269 0.777 DNA Damage Response (DDR); DDR
(NER)
met NUP54 4q21.1 0.145 0.269 0.777 viral reproduction;cytokine-mediated
signaling pathway
cop MIR3668 0.145 0.269 0.777
exp NMRAL1 16p13.3 0.145 0.269 0.777
exp LRRC8C 1p22.2 0.145 0.269 0.777
xsq RAB14 9q32-q34.11 0.145 0.269 0.777 neurotransmitter secretion;intracellular
transport
xsq SLC9A3R2 16p13.3 -0.145 0.269 0.777 Solute Carriers
cop OR13F1 9q31.1 -0.145 0.269 0.777
cop OR13C4 9q31.1 -0.145 0.269 0.777 response to stimulus
cop OR13C3 -0.145 0.269 0.777
xsq ATRNL1 10q26 -0.145 0.269 0.777 G-protein coupled receptor
signaling pathway
exp PTHLH 12p12.1-p11.2 -0.145 0.269 0.777 cell-cell signaling;positive
xsq PDXK 21q22.3 -0.145 0.269 0.777 small molecule metabolic
met XYLB 3p22-p21.3 -0.145 0.269 0.777 generation of precursor metabolites
cop LOC339975 -0.145 0.269 0.777
xsq ALDH3B2 11q13 -0.145 0.269 0.777 alcohol metabolic process;cellular
exp B3GALT5 21q22.3 -0.145 0.269 0.777 protein glycosylation
xsq KIAA0319L 1p34.2 -0.145 0.269 0.777
mut UBE2J1 6q15 -0.145 0.269 0.777
mut SUSD1 9q31.3-q33.1 -0.145 0.269 0.777
met CFAP58 -0.145 0.269 0.777
mut MIS18BP1 14q21.2 -0.145 0.269 0.777 mitosis;CenH3-containing
exp CLDN11 3q26.2-q26.3 -0.145 0.269 0.777 cell
adhesion;spermatogenesis
cop CNOT6 5q35.3 -0.145 0.269 0.777 nuclear-transcribed mRNA poly(A)
tail shortening;regulation of transcription, DNA-dependent
cop SCGB3A1 5q35.3 -0.145 0.269 0.777
mut GCC1 7q32.1 -0.145 0.269 0.777 protein targeting to Golgi
exp MAN2B1 19p13.2 -0.145 0.269 0.777 protein
exp ELK3 12q23 -0.145 0.269 0.777 Transcription Factors
xsq SHC4 15q21.1-q21.2 -0.145 0.269 0.777 intracellular signal
transduction
exp GPR143 Xp22.3 -0.145 0.269 0.777 melanosome
exp FAM127B Xq26.3 -0.145 0.269 0.777
xsq ZDHHC19 3q29 -0.145 0.269 0.777
xsq LAMA1 18p11.3 -0.145 0.269 0.777 establishment of epithelial cell
xsq GGT6 17p13.2 -0.145 0.269 0.777 glutathione metabolic
exp FAM127C Xq26.3 -0.145 0.269 0.777
exp GJB1 Xq13.1 -0.145 0.269 0.777 transport;cell-cell signaling
exp CERS5 12q13.12 -0.145 0.269 0.777 sphingolipid metabolic
cop ZBTB38 3q23 -0.145 0.269 0.777 positive regulation of
xsq PCAT4 4q21.1 -0.145 0.269 0.777
met LTB4R2 14q12 -0.145 0.269 0.777 chemotaxis;signal transduction
mut PRKCD 3p21.31 -0.145 0.269 0.777 Protein Kinases
met STK31 7p15.3 -0.145 0.269 0.777
exp TSC2 16p13.3 -0.145 0.269 0.777 Apoptosis; Protein Kinases; Tumor
Suppressors
his LOC101929470 -0.146 0.269 0.777
xai KALRN 3q21.2 -0.146 0.269 0.777 protein
phosphorylation;intracellular signal transduction
dependent"
xai ITFG1 16q12.1 -0.146 0.269 0.777
exp FLJ16779 20q13.33 -0.146 0.269 0.777
hs4 LINC00348 -0.146 0.269 0.777
xai PCDHB11 5q31 -0.146 0.269 0.777 homophilic cell adhesion;synaptic
transmission
his HSPG2 1p36.1-p34 -0.146 0.269 0.777 chondrocyte differentiation;cardiac
his CAPN9 1q42.11-q42.3 -0.146 0.269 0.777 proteolysis;digestion
hs4 PRSS22 16p13.3 -0.146 0.269 0.777 proteolysis
xai BLACAT1 -0.146 0.269 0.777
mda MDR -0.146 0.269 0.777
his FLJ46284 -0.146 0.269 0.777
xai IGSF23 19q13.31 -0.146 0.269 0.777
xai SRPX2 Xq21.33-q23 -0.146 0.269 0.777 angiogenesis;cell-cell adhesion
hs4 PDLIM1 10q23.1 -0.146 0.269 0.777 response to oxidative
exp KRTAP19-2 21q22.1 -0.146 0.269 0.777
his ANKRD53 2p13.3 -0.146 0.269 0.777
hs4 NHS Xp22.13 -0.146 0.269 0.777 lens development in camera-type
xai KIAA0930 22q13.31 -0.146 0.269 0.777
his ECT2L 6q24.1 -0.146 0.269 0.777 regulation of Rho protein signal
transduction
xai ATP2C1 3q22.1 -0.146 0.269 0.777 manganese ion transport;Golgi
xai KRTAP19-2 21q22.1 -0.146 0.269 0.777
hs4 CCL2 17q11.2-q12 -0.146 0.269 0.777 angiogenesis;inflammatory response
xai LOC100131180 9p21.1 -0.146 0.269 0.777
xai LOC100507311 -0.146 0.269 0.777
his MIR4762 -0.146 0.269 0.777
xai C10orf67 10p12.2 -0.146 0.269 0.777
his LOC100129148 7q34 -0.146 0.269 0.777
hs4 C5orf46 5q32 -0.146 0.269 0.777
xai C1orf167 1p36.22 -0.146 0.269 0.777
xai LINC00592 -0.146 0.269 0.777
hs4 ENTPD5 14q24 -0.146 0.269 0.777 metabolic process;cell
proliferation
hs4 BBOF1 -0.146 0.269 0.777
cop MIR99B -0.148 0.269 0.777
cop MIRLET7E -0.148 0.269 0.777
cop MIR125A -0.148 0.269 0.777
his TMEM26-AS1 0.146 0.27 0.777
his LINC01526 0.146 0.27 0.777
xai TNFRSF13C 22q13.1-q13.31 0.146 0.27 0.777 regulation of immune
response;B cell homeostasis
xai MRPL20P1 0.146 0.27 0.777
his PRR3 6p21.33 0.146 0.27 0.777
his GNL1 6p21.3 0.146 0.27 0.777 T cell mediated immunity;response to DNA
damage stimulus
hs4 DNAJC12 10q22.1 0.146 0.27 0.777 protein folding
cop ONECUT3 19p13.3 0.146 0.27 0.777 endocrine pancreas
exp MRPL20P1 0.146 0.27 0.777
exp HLFP1 0.146 0.27 0.777
hs4 ATP6V0CP3 6p21.1 0.146 0.27 0.777
his SALRNA3 0.146 0.27 0.777
his TEX30 13q33.1 0.146 0.27 0.777
his CTNNBL1 20q11.23-q12 0.146 0.27 0.777 Apoptosis
xai LAG3 12p13.32 0.146 0.27 0.777 cell surface receptor signaling
xai NDUFA6 22q13.2 0.146 0.27 0.777 response to oxidative
xai SMARCE1P1 0.146 0.27 0.777
his SNORD99 0.146 0.27 0.777
his SNORA61 0.146 0.27 0.777
his SNORA44 0.146 0.27 0.777
his SNORA16A 0.146 0.27 0.777
his SNHG12 1p35.3 0.146 0.27 0.777
exp LINC00200 10p15.3 0.146 0.27 0.777
swa TES 7q31.2 0.146 0.27 0.777 negative regulation of cell proliferation
his RASA4 7q22 0.146 0.27 0.777 regulation of small GTPase mediated signal
xai SPATA31D3 9q21.32 0.146 0.27 0.777
cop COX8C 14q32.12 0.146 0.27 0.777
his PGPEP1 19p13.11 0.146 0.27 0.777 proteolysis
hs4 STIP1 11q13 0.146 0.27 0.777 response to stress;axon guidance
xai TMA7 3p21.31 0.146 0.27 0.777
exp SPATA31D3 9q21.32 0.146 0.27 0.777
exp OR6J1 14q11.2 0.146 0.27 0.777 response to stimulus
hs4 SMIM1 1p36.32 0.146 0.27 0.777
xai OR5M8 11q12.1 0.146 0.27 0.777 response to stimulus
xai KRT17P5 0.146 0.27 0.777
xai MKRN2 3p25 0.146 0.27 0.777
his DHX8 17q21.31 0.146 0.27 0.777 RNA splicing;nuclear mRNA splicing, via
spliceosome
hs4 DDX6 11q23.3 0.146 0.27 0.777 nuclear-transcribed mRNA catabolic
his NLRP2 19q13.42 0.146 0.27 0.777 positive regulation of cysteine-type
xai RBMX Xq26.3 0.146 0.27 0.777 transcription from RNA polymerase II
hs4 EMBP1 1p11.2 0.146 0.27 0.777
exp LCE4A 1q21.3 0.146 0.27 0.777 keratinization
exp OR5M8 11q12.1 0.146 0.27 0.777 response to stimulus
hs4 PTPRT 20q12-q13 0.146 0.27 0.777 protein dephosphorylation;cell adhesion
xai HLFP1 0.146 0.27 0.777
exp OFD1P3Y Yp11.2 0.146 0.27 0.777
exp SRSF2 17q25.1 0.146 0.27 0.777 Oncogenes
met PRKACG 9q13 0.145 0.27 0.777 Protein Kinases
mut DDX58 9p12 0.145 0.27 0.777 innate immune response;positive regulation of
cop PTCD3 2p11.2 0.145 0.27 0.777
exp PES1 22q12.1 0.145 0.27 0.777 cell proliferation;ribosomal large
subunit biogenesis
cop ARHGEF40 14q11.2 0.145 0.27 0.777 regulation of Rho protein signal
transduction
cop ZNF219 14q11 0.145 0.27 0.777 transcription, DNA-dependent;regulation
cop TMEM253 14q11.2 0.145 0.27 0.777
cop OR5AU1 0.145 0.27 0.777
xsq PSKH2 8q21.3 0.145 0.27 0.777
met CAPN13 2p22-p21 0.145 0.27 0.777 proteolysis
xsq S1PR5 19p13.2 0.145 0.27 0.777
exp PDHA1 Xp22.1 0.145 0.27 0.777 pyruvate metabolic process;glycolysis
met GABRA6 5q34 0.145 0.27 0.777 transmembrane transport;transport
xsq LOC101929413 0.145 0.27 0.777
xsq ARL17A 17q21.31 0.145 0.27 0.777
xsq LINC01570 0.145 0.27 0.777
met MAP4K5 14q11.2-q21 0.145 0.27 0.777 protein phosphorylation;response to
stress
xsq FBXO42 1p36.23-p36.11 0.145 0.27 0.777
cop HIF1AN 10q24 0.145 0.27 0.777 oxidation-reduction process;regulation of
xsq NUP210 3p25.1 0.145 0.27 0.777 glucose transport;viral
reproduction
exp USP8 15q21.2 0.145 0.27 0.777 protein K63-linked
dependent"
met FOLR1 11q13.3-q14.1 0.145 0.27 0.777 cell death;folic acid transport
cop C3orf18 3p21.3 0.145 0.27 0.777
cop HEMK1 3p21.3 0.145 0.27 0.777 DNA methylation
xsq ADAM29 0.145 0.27 0.777
xsq SNORA2A 0.145 0.27 0.777
xsq CLRN1-AS1 3q25.1 0.145 0.27 0.777
mut OPA1 3q29 0.145 0.27 0.777 Apoptosis
cop CMTM3 16q21 0.145 0.27 0.777 EMT (Mesenchymal)
cop SEC24B-AS1 0.145 0.27 0.777
xsq NUP62CL Xq22.3 0.145 0.27 0.777 protein transport
met MIR543 0.145 0.27 0.777
met LILRB4 19q13.4 0.145 0.27 0.777 signal transduction;negative
met OMD 9q22.31 0.145 0.27 0.777 cell adhesion
cop ALLC 2q35 0.145 0.27 0.777
met DIRAS3 1p31 0.145 0.27 0.777 regulation of cyclin-dependent protein
kinase activity;GTP catabolic process
cop LRP10 14q11.2 0.145 0.27 0.777 lipid metabolic process;lipid transport
cop REM2 14q11.2 0.145 0.27 0.777 regulation of transcription, DNA-
cop RBM23 14q11.2 0.145 0.27 0.777 mRNA processing
cop PRMT5 14q11.2 0.145 0.27 0.777 regulation of transcription, DNA-
cop HAUS4 14q11.2 0.145 0.27 0.777 cell cycle;mitosis
cop MIR4707 0.145 0.27 0.777
cop AJUBA 14q11.2 0.145 0.27 0.777 Cell Signaling
cop C14orf93 14q11.2 0.145 0.27 0.777
cop PSMB5 14q11.2 0.145 0.27 0.777 cell cycle checkpoint;regulation of
cop PSMB11 14q11.2 0.145 0.27 0.777
cop CDH24 14q11.2 0.145 0.27 0.777 homophilic cell adhesion;cell-cell
adhesion
met SNORA77 1q32.1 0.145 0.27 0.777
met MIR432 0.145 0.27 0.777
met RBBP5 1q32 0.145 0.27 0.777 regulation of transcription, DNA-
mut MYH7B 20q11.22 0.145 0.27 0.777
xsq SGMS1-AS1 0.145 0.27 0.777
xsq LSM10 1p34.3 0.145 0.27 0.777 mRNA processing;histone mRNA metabolic
process
met MAN1A1 6q22 0.145 0.27 0.777 post-translational protein
xsq ALG9 11q23 0.145 0.27 0.777 GPI anchor biosynthetic process;protein N-
xsq PHYKPL 5q35.3 0.145 0.27 0.777
xsq LOC440390 0.145 0.27 0.777
exp RBMX Xq26.3 0.145 0.27 0.777 transcription from RNA polymerase II
met GATA1 Xp11.23 0.145 0.27 0.777 Tumor Suppressors
cop CCDC12 3p21.31 0.145 0.27 0.777
met ENTPD5 14q24 0.145 0.27 0.777 metabolic process;cell proliferation
exp DNMBP 10q24.2 -0.145 0.27 0.777 regulation of Rho protein signal
exp LOC100129027 21q22.3 -0.145 0.27 0.777
exp ARHGEF10 8p23 -0.145 0.27 0.777 myelination in peripheral nervous
xsq AIF1L 9q34.13-q34.3 -0.145 0.27 0.777
exp APOBEC3B 22q13.1-q13.2 -0.145 0.27 0.777 negative regulation of
transposition
met FKBP1B 2p23.3 -0.145 0.27 0.777 regulation of cardiac muscle
refolding
cop ADIG 20q11.23 -0.145 0.27 0.777 positive regulation of fat cell
met TBXAS1 7q34-q35 -0.145 0.27 0.777 fatty acid biosynthetic
exp TGFBR3 1p33-p32 -0.145 0.27 0.777 Apoptosis
met FAM161A 2p15 -0.145 0.27 0.777 response to stimulus;visual
perception
exp UHMK1 1q23.3 -0.145 0.27 0.777 cell cycle arrest;peptidyl-serine
phosphorylation
exp L3MBTL4 18p11.31 -0.145 0.27 0.777 chromatin modification
mut RNF44 5q35.2 -0.145 0.27 0.777
mut PATZ1 22q12.2 -0.145 0.27 0.777 regulation of transcription, DNA-
xsq ALDH3B1 11q13 -0.145 0.27 0.777 alcohol metabolic process;lipid
metabolic process
exp TNNT2 1q32 -0.145 0.27 0.777 response to calcium ion;ventricular
cop GFPT2 5q34-q35 -0.145 0.27 0.777 dolichol-linked oligosaccharide
xsq GALNT5 2q24.1 -0.145 0.27 0.777 glycosaminoglycan
xsq ZMYND15 17p13.2 -0.145 0.27 0.777 spermatogenesis;cell
differentiation
xsq ELF3 1q32.2 -0.145 0.27 0.777 Transcription Factors
xsq PPP5D1 -0.145 0.27 0.777
exp HYI 1p34.2 -0.145 0.27 0.777
exp DNAJC3 13q32.1 -0.145 0.27 0.777 response to virus;endoplasmic
xai PTGER3 1p31.2 -0.146 0.27 0.777 intracellular receptor
his RERG 12p12.3 -0.146 0.27 0.777 GTP catabolic process;signal
transduction
swa CASP12 11q22.3 -0.146 0.27 0.777 proteolysis;regulation of
apoptotic process
cop CIC 19q13.2 -0.146 0.27 0.777 Tumor Suppressors
hs4 PASD1 Xq28 -0.146 0.27 0.777
DNA-dependent"
cop PAFAH1B3 19q13.1 -0.146 0.27 0.777 lipid metabolic
process;nervous system development
xai LOC100506253 -0.146 0.27 0.777
hs4 EYA4 6q23 -0.146 0.27 0.777 DNA repair;regulation of transcription,
DNA-dependent
exp HCAR2 12q24.31 -0.146 0.27 0.777 neutrophil apoptosis;apoptotic
process
xai KRT8P32 5q15 -0.146 0.27 0.777
exp LOC100506253 -0.146 0.27 0.777
hs4 BBOX1-AS1 -0.146 0.27 0.777
xai TMEM115 3p21.3 -0.146 0.27 0.777 replicative cell
aging;negative regulation of cell proliferation
his DMWD 19q13.3 -0.146 0.27 0.777 meiosis
hs4 TCTN2 12q24.31 -0.146 0.27 0.777 cell projection organization;cilium
assembly
xai OXR1 8q23 -0.146 0.27 0.777 response to oxidative stress;cell wall
exp DCDC2C 2p25.3 -0.146 0.27 0.777 intracellular signal
transduction
his LOC339166 -0.146 0.27 0.777
xai PHF2P1 13q11 -0.146 0.27 0.777
hs4 EFNB3 17p13.1 -0.146 0.27 0.777 nervous system development;adult
walking behavior
xai YPEL4 11q12.1 -0.146 0.27 0.777
his CLTCL1 22q11.21 -0.146 0.27 0.777 vesicle-mediated
met MIR518C 0.183 0.271 0.777
xai OFD1P3Y Yp11.2 0.146 0.271 0.777
his KDM4A 1p34.1 0.146 0.271 0.777 chromatin modification;histone
demethylation
hs4 HP1BP3 1p36.12 0.146 0.271 0.777 nucleosome assembly
his LINC00317 0.146 0.271 0.777
his UBE2D3 4q24 0.146 0.271 0.777 protein modification process;proteasomal
his LOC105377348 0.146 0.271 0.777
his MYCNUT 0.146 0.271 0.777
his ITFG1 16q12.1 0.146 0.271 0.777
his PHKB 16q12-q13 0.146 0.271 0.777 generation of precursor metabolites and
hs4 FAM53B 10q26.13 0.146 0.271 0.777
swa NUP133 1q42.13 0.146 0.271 0.777 carbohydrate metabolic
hs4 CCDC78 16p13.3 0.146 0.271 0.777
hs4 HAGHL 16p13.3 0.146 0.271 0.777
hs4 FAM96A 15q22.31 0.146 0.271 0.777 chromosome segregation
hs4 SNX1 15q22.31 0.146 0.271 0.777 cell communication;early endosome to
Golgi transport
hs4 DDX51 12q24.33 0.146 0.271 0.777 rRNA processing
hs4 NOC4L 12q24.33 0.146 0.271 0.777 rRNA processing
exp OR1N2 9q33.2 0.146 0.271 0.777 response to stimulus
his ME1 6q12 0.146 0.271 0.777 malate metabolic process;NADP biosynthetic
process
his LOC101927765 0.146 0.271 0.777
his COA6 1q42.2 0.146 0.271 0.777
his SPATC1L 21q22.3 0.146 0.271 0.777
xai APBB1IP 10p12.1 0.146 0.271 0.777 signal transduction;blood
coagulation
his DDX46 5q31.1 0.146 0.271 0.777 RNA splicing;mRNA processing
his CCDC74B 2q21.1 0.146 0.271 0.777
xai FAM208B 10p15.1 0.146 0.271 0.777
exp SMARCE1P1 0.146 0.271 0.777
xai NICN1 3p21.31 0.146 0.271 0.777
xai MLNR 13q14-q21 0.146 0.271 0.777 G-protein coupled receptor signaling
pathway;digestion
his KCNMB3 3q26.3-q27 0.146 0.271 0.777 ion transport;potassium ion
transport
his ATP5F1 1p13.2 0.146 0.271 0.777 ATP synthesis coupled proton
transport;respiratory electron transport chain
his WDR77 1p13.2 0.146 0.271 0.777 regulation of transcription from RNA
polymerase II promoter;positive regulation of cell proliferation
xai ATP1A1-AS1 0.146 0.271 0.777
xai RPL21 13q12.2 0.146 0.271 0.777 nuclear-transcribed mRNA catabolic
xai NUP210 3p25.1 0.146 0.271 0.777 glucose transport;viral
reproduction
swa RPL13 16q24.3 0.146 0.271 0.777 gene expression;viral reproduction
exp CICP3 1p36.33 0.146 0.271 0.777
exp RPL21 13q12.2 0.146 0.271 0.777 nuclear-transcribed mRNA catabolic
hs4 NHLRC4 16p13.3 0.146 0.271 0.777
hs4 PIGQ 16p13.3 0.146 0.271 0.777 cellular protein metabolic
his UBALD1 16p13.3 0.146 0.271 0.777
xai OR52B6 11p15.4 0.146 0.271 0.777 response to stimulus
his DOCK4 7q31.1 0.146 0.271 0.777 positive regulation of Rac GTPase
activity;cell chemotaxis
dependent"
xai ATRX Xq21.1 0.146 0.271 0.777 DNA Damage Response (DDR); Tumor
Suppressors
xai CICP3 1p36.33 0.146 0.271 0.777
xai PCCB 3q21-q22 0.146 0.271 0.777 fatty acid beta-oxidation;short-chain
met FEM1C 5q22 0.145 0.271 0.777
met ZNF354C 5q35 0.145 0.271 0.777 regulation of transcription, DNA-
dependent"
xsq IL19 1q32.2 0.145 0.271 0.777 induction of apoptosis;immune response
exp LOC391247 20q11.23 0.145 0.271 0.777
xsq SNORA45A 0.145 0.271 0.777
xsq ARF1 1q42 0.145 0.271 0.777 viral reproduction;cellular membrane
organization
met PGAM5 12q24.33 0.145 0.271 0.777
exp TRIM21 11p15.5 0.145 0.271 0.777 protein autoubiquitination;protein
trimerization
xsq WDR82 3p21.2 0.145 0.271 0.777 histone H3-K4 methylation
xsq CST13P 20p11.21 0.145 0.271 0.777
cop ATG2B 14q32.2 0.144 0.271 0.777
met MOB1B 4q13.3 0.144 0.271 0.777 hippo signaling cascade;positive
cop SPIN1 9q22.1 0.144 0.271 0.777 cell cycle;multicellular organismal
development
cop SEC31B 10q24.31 0.144 0.271 0.777 protein transport;vesicle-mediated
transport
cop NDUFB8 10q24.31 0.144 0.271 0.777 transport;respiratory electron
transport chain
cop IQCH 15q23 0.144 0.271 0.777
xsq LOC101928205 0.144 0.271 0.777
met KCNK10 14q31.3 0.144 0.271 0.777 transport;ion transport
cop FMN1 15q13.3 0.144 0.271 0.777 cellular component organization;actin
cop LINC00597 15q23-q24 0.144 0.271 0.777
cop SNORA36C 0.144 0.271 0.777
xsq ARGFX 0.144 0.271 0.777
met SYDE1 19p13.12 0.144 0.271 0.777 EMT (Mesenchymal)
met ARHGEF28 5q13.2 0.144 0.271 0.777
xsq GNAS 20q13.3 0.144 0.271 0.777 Oncogenes
cop MRO 18q21 0.144 0.271 0.777
exp RUNX1-IT1 21q22.12 0.144 0.271 0.777
xsq TRMT10B 9p13.2 0.144 0.271 0.777
exp TMEM69 1p34.1 0.144 0.271 0.777
exp CEBPA 19q13.1 0.144 0.271 0.777 Tumor Suppressors
xsq ALDH18A1 10q24.3 0.144 0.271 0.777 small molecule metabolic
cop NOG 17q22 0.144 0.271 0.777 osteoblast differentiation;neural tube closure
xsq CRCT1 1q21 0.144 0.271 0.777
xsq KCNQ5 6q14 0.144 0.271 0.777 protein complex assembly;ion transport
met ZNF738 19p12 0.144 0.271 0.777 protein polyubiquitination;regulation of
met NR4A2 2q22-q23 0.144 0.271 0.777 post-embryonic development;intracellular
met GFRA2 8p21.3 0.144 0.271 0.777 transmembrane receptor protein tyrosine
kinase signaling pathway;glial cell-derived neurotrophic factor receptor signaling
pathway
xsq PCDHA11 0.144 0.271 0.777 nervous system development;cell adhesion
met WDR72 15q21.3 0.144 0.271 0.777
exp LCMT1 16p12.1 0.144 0.271 0.777 C-terminal protein methylation;protein
xsq CXCR5 11q23.3 0.144 0.271 0.777 B cell activation;lymph node development
xsq LINC00974 0.144 0.271 0.777
xsq LINC00570 0.144 0.271 0.777
exp KDM5C Xp11.22-p11.21 0.144 0.271 0.777 Tumor Suppressors
xsq ADAT3 0.144 0.271 0.777 tRNA processing
met ADRBK2 22q12.1 0.144 0.271 0.777 protein phosphorylation;signal
transduction
xsq TAF1B 2p25 0.144 0.271 0.777 transcription, DNA-dependent;regulation of
exp CPNE1 20q11.22 0.144 0.271 0.777 lipid metabolic process;vesicle-mediated
transport
xsq KRTAP10-11 0.144 0.271 0.777
exp ZBED9 0.144 0.271 0.777 DNA integration;viral reproduction
cop CCDC79 16q22.1 0.144 0.271 0.777 regulation of transcription, DNA-
dependent"
cop HMG20A 15q24 0.144 0.271 0.777 chromatin organization;regulation of
xsq SIRT7 17q25 0.144 0.271 0.777 protein deacetylation;positive regulation of
transcription on exit from mitosis
exp CHTF18 16p13.3 0.144 0.271 0.777 DDR (DNA replication)
cop JAG2 14q32 0.144 0.271 0.777 Notch receptor processing;regulation of cell
migration
cop LOC401134 -0.144 0.271 0.777
xsq DTX2 7q11.23 -0.144 0.271 0.777 Notch signaling pathway
met ZSCAN12 6p21 -0.144 0.271 0.777 viral reproduction
mut RETNLB 3q13.1 -0.144 0.271 0.777
exp ICK 6p12.1 -0.144 0.271 0.777 multicellular organismal
xsq COX7B2 4p12 -0.144 0.271 0.777
xsq MIA 19q13.2 -0.144 0.271 0.777 cell proliferation
cop TNIK 3q26.31 -0.144 0.271 0.777 protein phosphorylation;protein
autophosphorylation
met ZDHHC8 22q11.21 -0.144 0.271 0.777
xsq DNAJC18 5q31.2 -0.144 0.271 0.777 protein folding
DNA-dependent"
cop LINC00032 9p21 -0.144 0.271 0.777
met MLST8 16p13.3 -0.144 0.271 0.777 fibroblast growth factor receptor
mut EPHB6 7q33-q35 -0.144 0.271 0.777 Cell Signaling
mut CES4A 16q22.1 -0.144 0.271 0.777
mut CREBZF 11q14 -0.144 0.271 0.777 transcription, DNA-
dependent;response to virus
exp PQLC1P2 4q21.22 -0.144 0.271 0.777
exp IGSF5 21q22.2 -0.144 0.271 0.777
xsq TMEM59L 19p12 -0.144 0.271 0.777
met CCDC140 2q36.1 -0.144 0.271 0.777
met SYT5 19q13.42 -0.144 0.271 0.777 energy reserve metabolic
cop RNF130 5q35.3 -0.144 0.271 0.777 Apoptosis
cop MIR340 -0.144 0.271 0.777
cop RASGEF1C 5q35.3 -0.144 0.271 0.777 regulation of small GTPase
cop MAPK9 5q35 -0.144 0.271 0.777 Protein Kinases
met MIR486-1 -0.144 0.271 0.777
xsq UNC13B 9p13.3 -0.144 0.271 0.777 induction of apoptosis;signal
transduction
mut GPC6 13q32 -0.144 0.271 0.777
xsq PTK7 6p21.1-p12.2 -0.144 0.271 0.777 establishment of planar
exp GDF15 19p13.11 -0.144 0.271 0.777 signal transduction;transforming
xsq CT45A1 -0.144 0.271 0.777
xsq ELF4 Xq26 -0.144 0.271 0.777 Transcription Factors
xsq RPS6KC1 1q41 -0.145 0.271 0.777 Protein Kinases
mut L1CAM Xq28 -0.145 0.271 0.777 leukocyte cell-cell adhesion;cell
differentiation
exp NBR1 17q21.31 -0.145 0.271 0.777 macroautophagy;regulation of bone
mineralization
xai CYB5AP5 14q12 -0.146 0.271 0.777
hs4 FER1L4 20q11.22 -0.146 0.271 0.777
hs4 C15orf59 15q24.1 -0.146 0.271 0.777
his PIWIL3 22q11.23 -0.146 0.271 0.777 regulation of
translation;meiosis
xai IGHV3-76 14q32.33 -0.146 0.271 0.777
hs4 MEIOB 16p13.3 -0.146 0.271 0.777
xai KRT8P22 16q23.1 -0.146 0.271 0.777
his MTSS1 8p22 -0.146 0.271 0.777 negative regulation of epithelial cell
swa RBM47 4p14 -0.146 0.271 0.777
xai RDH14 2p24.2 -0.146 0.271 0.777
xai MEOX2 7p22.1-p21.3 -0.146 0.271 0.777 multicellular organismal
xai PCAT1 -0.146 0.271 0.777
xai LAMP2 Xq24 -0.146 0.271 0.777 platelet activation;platelet
degranulation
swa PKP3 11p15 -0.146 0.271 0.777 cell adhesion
hs4 SEPT3 22q13.2 -0.146 0.271 0.777 cell cycle;cytokinesis
hs4 RASEF 9q21.32 -0.146 0.271 0.777 small GTPase mediated signal
hs4 SCRN1 7p14.3-p14.1 -0.146 0.271 0.777 proteolysis;exocytosis
xai PBX4 19p12 -0.146 0.271 0.777 transcription from RNA polymerase II
hs4 WNT16 7q31 -0.146 0.271 0.777 Oncogenes
hs4 ARHGEF17 11q13.4 -0.146 0.271 0.777 regulation of small GTPase
xai ENTPD7 -0.146 0.271 0.777
exp IGHV3-76 14q32.33 -0.146 0.271 0.777
xai RYBP 3p13 -0.146 0.271 0.777 Apoptosis
exp CYB5AP5 14q12 -0.146 0.271 0.777
his PDGFC 4q32 -0.146 0.271 0.777 positive regulation of DNA
cop SPACA6 -0.147 0.271 0.777
xai ASRGL1 11q12.3 0.145 0.272 0.777 asparagine catabolic process via L-
hs4 KATNB1 16q21 0.145 0.272 0.777 microtubule severing;protein targeting
xai LOC100506014 0.145 0.272 0.777
xai PGD 1p36.22 0.145 0.272 0.777 pentose biosynthetic process;small
hs4 NTN3 16p13.3 0.145 0.272 0.777 axon guidance;muscle cell differentiation
hs4 TBC1D24 16p13.3 0.145 0.272 0.777 neuron projection development
hs4 LAMTOR4 7q22.1 0.145 0.272 0.777
his RPS8 1p34.1-p32 0.145 0.272 0.777 translational elongation;viral
transcription
his SNORD55 0.145 0.272 0.777
his SNORD46 0.145 0.272 0.777
his SNORD38A 0.145 0.272 0.777
his SNORD38B 1p34.1 0.145 0.272 0.777
xai POLR2E 19p13.3 0.145 0.272 0.777 DNA Damage Response (DDR); DDR
(NER)
xai PDCL 9q12-q13 0.145 0.272 0.777 visual perception;response to stimulus
his TTC41P 0.145 0.272 0.777
his HSP90B1 12q24.2-q24.3 0.145 0.272 0.777 protein folding;regulation of
phosphoprotein phosphatase activity
his MIR3652 0.145 0.272 0.777
exp MIR216A 0.145 0.272 0.777
xai NPRL3 16p13.3 0.145 0.272 0.777
his SREBF2 22q13 0.145 0.272 0.777 response to hormone stimulus;cellular
response to laminar fluid shear stress
his ARHGDIG 16p13.3 0.145 0.272 0.777 regulation of small GTPase mediated
signal transduction;negative regulation of cell adhesion
his PDIA2 16p13.3 0.145 0.272 0.777 response to hypoxia;protein folding
hs4 FAM162B 6q22.1 0.145 0.272 0.777
his CYP2S1 19q13.1 0.145 0.272 0.777 xenobiotic metabolic process;small
xai HEPACAM2 7q21.3 0.145 0.272 0.777
xai LOC100506965 0.145 0.272 0.777
dependent"
his MYOZ1 10q22.1 0.145 0.272 0.777 myofibril assembly
exp FLJ46284 0.145 0.272 0.777
hs4 TPGS1 19p13.3 0.145 0.272 0.777 adult behavior;multicellular organismal
development
his NUDT17 1q21.1 0.145 0.272 0.777
his PPP2R2A 8p21.2 0.145 0.272 0.777 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;protein dephosphorylation
his SNORD83B 0.145 0.272 0.777
his SNORD83A 0.145 0.272 0.777
his SNORD139 0.145 0.272 0.777
his SNORD43 22q13 0.145 0.272 0.777
his RPL3 22q13 0.145 0.272 0.777 translational termination;cellular protein
metabolic process
hs4 FNDC10 0.145 0.272 0.777
swa HGS 17q25 0.145 0.272 0.777 negative regulation of epidermal growth factor
receptor signaling pathway;intracellular protein transport
xai MIR216A 0.145 0.272 0.777
his INPPL1 11q13 0.145 0.272 0.777 actin filament organization;negative
his LDB1 10q24-q25 0.145 0.272 0.777 gastrulation with mouth forming
his TGFBR2 3p22 0.145 0.272 0.777 Apoptosis; Cell Signaling; Tumor
Suppressors
his FLJ13224 12p11.21 0.145 0.272 0.777
his FAM60A 12p11 0.145 0.272 0.777
process;proteolysis
xsq PFDN5 12q12 0.144 0.272 0.777 protein folding;cellular protein metabolic
process
exp LOC100132790 0.144 0.272 0.777
met POLM 7p13 0.144 0.272 0.777 DNA Damage Response (DDR); DDR (NHEJ); DDR (DNA
replication)
exp ZBED5 11p15.3 0.144 0.272 0.777
xsq GMPS 3q24 0.144 0.272 0.777 purine base metabolic process;purine nucleotide
xsq H1FNT 12q13.11 0.144 0.272 0.777
cop FOXK2 17q25 0.144 0.272 0.777 regulation of transcription, DNA-
cop SKOR1 15q23 0.144 0.272 0.777 negative regulation of transcription from RNA
exp HCK 20q11-q12 0.144 0.272 0.777 exocytosis;cytokine-mediated signaling
pathway
exp HMGN2P4 5q13.3 0.144 0.272 0.777
met IL17A 6p12 0.144 0.272 0.777
xsq TMEM208 16q22.1 0.144 0.272 0.777
xsq DHX36 3q25.2 0.144 0.272 0.777
met CASP4 11q22.2-q22.3 0.144 0.272 0.777 Apoptosis
xsq ZBTB40 1p36 0.144 0.272 0.777 bone mineralization;regulation of
xsq FLJ43879 2q37.3 0.144 0.272 0.777
met GABRG3 15q12 0.144 0.272 0.777 chloride transport;gamma-aminobutyric
met SRPRB 3q22.1 0.144 0.272 0.777 cellular protein metabolic
process;translation
exp ZDHHC14 6q25.3 0.144 0.272 0.777
met MOGAT3 7q22.1 0.144 0.272 0.777 lipid biosynthetic process;glycerol
metabolic process
met DYNC2H1 11q21-q22.1 0.144 0.272 0.777 microtubule-based movement;Golgi
organization
xsq MCMDC2 8q13.1 0.144 0.272 0.777 DNA replication
xsq MAST3 19p13.11 0.144 0.272 0.777
cop PDK2 17q21.33 0.144 0.272 0.777 protein phosphorylation;regulation of
acetyl-CoA biosynthetic process from pyruvate
cop SAMD14 17q21.33 0.144 0.272 0.777
cop PPP1R9B 17q21.33 0.144 0.272 0.777 RNA splicing;cell migration
cop SGCA 17q21 0.144 0.272 0.777 muscle organ development;muscle contraction
cop HILS1 17q21.33 0.144 0.272 0.777 germ cell development;spermatogenesis
cop COL1A1 17q21.33 0.144 0.272 0.777 blood vessel development;sensory
perception of sound
met MITF 3p14.2-p14.1 0.144 0.272 0.777 multicellular organismal
cop GNGT2 17q21 0.144 0.272 0.777 synaptic transmission;phototransduction
cop ABI3 17q21.3 0.144 0.272 0.777 cellular component movement;peptidyl-
cop PHOSPHO1 17q21.32 0.144 0.272 0.777 metabolic process;regulation of
bone mineralization
cop FLJ40194 17q21.32 0.144 0.272 0.777
met RNF32 7q36 0.144 0.272 0.777
xsq EVADR 0.144 0.272 0.777
met TOB1 17q21 0.144 0.272 0.777 negative regulation of cell proliferation
met NATD1 0.144 0.272 0.777
cop ITGA3 17q21.33 0.144 0.272 0.777 leukocyte migration;neuron migration
exp TUBB1 20q13.32 0.144 0.272 0.777 protein folding;microtubule-based
movement
met OR52B4 11p15.4 0.144 0.272 0.777 response to stimulus
cop UBE2MP1 16p11.2 0.144 0.272 0.777
met PTRF 17q21.2 0.144 0.272 0.777 transcription initiation from RNA
cop RNF103-CHMP3 0.144 0.272 0.777
xsq ANAPC10 4q31 0.144 0.272 0.777 G2/M transition of mitotic cell
catabolic process
xsq PRM3 16p13.3 0.144 0.272 0.777 multicellular organismal
met BCL9 1q21 0.144 0.272 0.777 Wnt receptor signaling pathway;regulation of
xsq ANO7 2q37.3 0.144 0.272 0.777 ion transport
cop YIPF4 2p22.3 0.144 0.272 0.777
met PODNL1 19p13.12 0.144 0.272 0.777
met SCUBE1 22q13 0.144 0.272 0.777 blood coagulation;post-embryonic
development
xsq C3orf56 3q21.3 0.144 0.272 0.777
met IRX2 5p15.33 0.144 0.272 0.777 metanephros development;specification of
loop of Henle identity
cop CNTNAP4 16q23.1 0.144 0.272 0.777 cell adhesion;signal transduction
xsq ADGRE1 0.144 0.272 0.777 cell adhesion;G-protein coupled receptor
signaling pathway
xsq RAD1 5p13.2 0.144 0.272 0.777 DNA Damage Response (DDR)
cop DLX4 17q21.33 0.144 0.272 0.777 regulation of transcription, DNA-
cop DLX3 17q21 0.144 0.272 0.777 placenta development;regulation of
cop LOC284080 0.144 0.272 0.777
exp DLG4 17p13.1 0.144 0.272 0.777 synaptic transmission;receptor
met RAI2 Xp22 0.144 0.272 0.777 embryo development
cop LINC00273 16p11.2 0.144 0.272 0.777
dependent"
xsq SNORA41 2q33 0.144 0.272 0.777
xsq MTVR2 17q23 0.144 0.272 0.777
xsq CLEC11A 19q13.3 0.144 0.272 0.777 positive regulation of cell
proliferation
exp CTSLP7 0.144 0.272 0.777
mut PAXBP1 21q21.3 0.144 0.272 0.777
cop EXOC2 6p25.3 0.144 0.272 0.777 exocytosis;protein transport
cop HUS1B 6p25.3 0.144 0.272 0.777 DNA Damage Response (DDR)
exp SEC11A 15q25.3 -0.144 0.272 0.777 energy reserve metabolic
xsq LINC00310 21q22.11 -0.144 0.272 0.777
met FKBP1A 20p13 -0.144 0.272 0.777 'de novo' protein
folding;regulation of activin receptor signaling pathway
exp INHBA 7p15-p13 -0.144 0.272 0.777 hair follicle development;nervous
system development
exp PRRG4 11p13 -0.144 0.272 0.777
cop EQTN 9p21 -0.144 0.272 0.777
mut IL27RA 19p13.11 -0.144 0.272 0.777 cell surface receptor
xsq GLT8D2 12q -0.144 0.272 0.777
mut AIRE 21q22.3 -0.144 0.272 0.777 positive regulation of
mut SSBP3 1p32.3 -0.144 0.272 0.777 prechordal plate
mut DNMT1 19p13.2 -0.144 0.272 0.777 DNA Damage Response (DDR)
xsq PINK1 1p36 -0.144 0.272 0.777 positive regulation of synaptic
xsq TICAM1 19p13.3 -0.144 0.272 0.777 inflammatory
response;positive regulation of protein binding
mut PFKL 21q22.3 -0.144 0.272 0.777 small molecule metabolic
process;negative regulation of insulin secretion
cop NDUFAF2 5q12.1 -0.144 0.272 0.777
xsq COL6A1 21q22.3 -0.144 0.272 0.777 cell adhesion;axon guidance
xsq MINOS1-NBL1 -0.144 0.272 0.777
exp TMUB2 17q21.31 -0.144 0.272 0.777
xsq ELF5 11p13-p12 -0.144 0.272 0.777 Transcription Factors
exp FBXW11 5q35.1 -0.144 0.272 0.777 protein
destabilization;negative regulation of NF-kappaB import into nucleus
exp IFI44 1p31.1 -0.144 0.272 0.777 response to virus
xsq LIMK1 7q11.23 -0.144 0.272 0.777 Protein Kinases
exp PCDHB11 5q31 -0.144 0.272 0.777 homophilic cell adhesion;synaptic
transmission
xsq ARMCX2 Xq21.33-q22.2 -0.144 0.272 0.777
cop MICU3 8p22 -0.144 0.272 0.777
cop LOC644554 19q13.13 -0.145 0.272 0.777
hs4 EFNB2 13q33 -0.145 0.272 0.777 angiogenesis;anatomical structure
morphogenesis
his FLJ37201 10q23.31 -0.145 0.272 0.777
xai BFAR 16p13.12 -0.145 0.272 0.777 Apoptosis
xai TAAR6 6q23.2 -0.145 0.272 0.777 G-protein coupled receptor
signaling pathway
his INSC 11p15.2 -0.145 0.272 0.777 multicellular organismal
DNA-dependent"
xai KRT8P44 6q26 -0.145 0.272 0.777
exp LINC00202-1 10p12.1 -0.145 0.272 0.777
xai ASB18 2q37.2 -0.145 0.272 0.777 intracellular signal transduction
xai HMGA2 12q15 -0.145 0.272 0.777 mesodermal-endodermal cell
hs4 SEMA3E 7q21.11 -0.145 0.272 0.777 multicellular organismal
xai TMC4 19q13.42 -0.145 0.272 0.777 EMT (Epithelial)
xai EDN2 1p34 -0.145 0.272 0.777 prostaglandin biosynthetic
hs4 EFCC1 3q21.3 -0.145 0.272 0.777
his C8orf74 8p23.1 -0.145 0.272 0.777
xai DCBLD1 6q22.1 -0.145 0.272 0.777 cell adhesion
his EGFL6 Xp22 -0.145 0.272 0.777 cell cycle;cell adhesion
DNA-dependent"
xai MIR105-2 -0.145 0.272 0.777
xai TLN2 15q15-q21 -0.145 0.272 0.777 cell-cell junction assembly;cell
adhesion
hs4 LOC148709 1q32.1 -0.145 0.272 0.777
xai OSER1-AS1 -0.145 0.272 0.777
xai NBR1 17q21.31 -0.145 0.272 0.777 macroautophagy;regulation of bone
mineralization
his TRAM2 6p21.1-p12 -0.145 0.272 0.777 protein transport;collagen
his TRAM2-AS1 -0.145 0.272 0.777
swa PDCL 9q12-q13 -0.145 0.272 0.777 visual perception;response to
stimulus
hs4 CERS4 19p13.2 -0.145 0.272 0.777 ceramide biosynthetic
exp LINC01015 -0.145 0.272 0.777
xai UBE2W 8q21.11 -0.145 0.272 0.777 protein monoubiquitination;protein
xai RBMY2KP Yp11.2 -0.145 0.272 0.777
hs4 SLC1A2 11p13-p12 -0.145 0.272 0.777 Solute Carriers
exp MIR105-2 -0.146 0.272 0.777
xai HNRNPDLP2 0.145 0.273 0.777
his PMF1 1q12 0.145 0.273 0.777 cell division;M phase of mitotic cell cycle
his PMF1-BGLAP 0.145 0.273 0.777
xai DRP2 Xq22 0.145 0.273 0.777 central nervous system development
swa RAN 12q24.3 0.145 0.273 0.777 nucleocytoplasmic transport;androgen
his SP9 2q31.1 0.145 0.273 0.777 regulation of transcription, DNA-
dependent;embryonic limb morphogenesis"
xai JTB 1q21 0.145 0.273 0.777 regulation of cell proliferation;negative
hs4 KCNQ3 8q24 0.145 0.273 0.777 ion transport;potassium ion transport
hs4 LTK 15q15.1-q21.1 0.145 0.273 0.777 apoptotic process;signal
transduction
xai FLJ26850 19q13.33 0.145 0.273 0.777
his CREBZF 11q14 0.145 0.273 0.777 transcription, DNA-dependent;response to
virus
xai BLOC1S4 4p16.1 0.145 0.273 0.777
hs4 PIAS4 19p13.3 0.145 0.273 0.777 DNA Damage Response (DDR)
xai NUP62 0.145 0.273 0.777 Apoptosis
xai SYNPR 3p14.2 0.145 0.273 0.777
his WIPF3 7p14.3 0.145 0.273 0.777 multicellular organismal
hs4 ESRRA 11q13 0.145 0.273 0.777 positive regulation of transcription from RNA
polymerase II promoter;cartilage development
hs4 ZBTB14 18p11.31 0.145 0.273 0.777
hs4 CISD2 4q24 0.145 0.273 0.777 mitochondrion degradation;multicellular
organismal aging
exp HNRNPDLP2 0.145 0.273 0.777
swa RPA2 1p35 0.145 0.273 0.777 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
xai BCL2L11 2q13 0.145 0.273 0.777 Apoptosis
hs4 FAM153A 5q35.3 0.145 0.273 0.777
his MRPL10 17q21.32 0.145 0.273 0.777 translation;ribosome biogenesis
his LRRC46 17q21.32 0.145 0.273 0.777
xai CDC23 5q31 0.145 0.273 0.777 mitotic metaphase plate congression;negative
his COMMD10 5q23.1 0.145 0.273 0.777
hs4 PCGF6 10q24.33 0.145 0.273 0.777 negative regulation of transcription,
DNA-dependent"
xai TSIX Xq13.2 0.145 0.273 0.777
xai LOC100506869 0.145 0.273 0.777
exp TRAV6 0.145 0.273 0.777
hs4 CHPT1 12q 0.145 0.273 0.777 regulation of cell growth;lipid metabolic
process
xai LOC100129033 6p25.1 0.145 0.273 0.777
swa PGM2 4p14 0.145 0.273 0.777 glycogen catabolic process;glucose metabolic
process
exp KIR2DS5 0.144 0.273 0.777 immune response
exp FAAP20 0.144 0.273 0.777 DNA Damage Response (DDR)
xsq PGPEP1 19p13.11 0.144 0.273 0.777 proteolysis
exp STAT5A 17q11.2 0.144 0.273 0.777 Apoptosis
exp MAU2 19p13.11 0.144 0.273 0.777 cell cycle;chromosome segregation
xsq KCNN4 19q13.2 0.144 0.273 0.777 phospholipid translocation;ion transport
xsq ARFGAP2 11p11.2-p11.12 0.144 0.273 0.777 protein transport;vesicle-
mediated transport
cop PTH1R 3p22-p21.1 0.144 0.273 0.777 activation of adenylate cyclase activity
by G-protein signaling pathway;cell maturation
xsq DXO 0.144 0.273 0.777
xsq URB1 21q22.11 0.144 0.273 0.777
mut STK25 2q37.3 0.144 0.273 0.777 Golgi localization;protein
phosphorylation
exp CHKB 0.144 0.273 0.777 phosphatidylethanolamine biosynthetic
process;CDP-choline pathway
xsq NXF4 Xq22 0.144 0.273 0.777
cop L3MBTL4 18p11.31 0.144 0.273 0.777 chromatin modification
exp BLK 8p23-p22 0.144 0.273 0.777 Apoptosis
xsq RPL31 2q11.2 0.144 0.273 0.777 translational initiation;viral infectious
cycle
xsq ERCC3 2q21 0.144 0.273 0.777 Apoptosis; DNA Damage Response (DDR); DDR (NER)
cop RASGRP2 11q13 0.144 0.273 0.777 Ras protein signal transduction;blood
coagulation
cop PYGM 11q12-q13.2 0.144 0.273 0.777 glycogen metabolic process;glycogen
catabolic process
cop SF1 11q13 0.144 0.273 0.777 nuclear mRNA 3'-splice site recognition;nuclear
met BCO2 11q23.1 0.144 0.273 0.777 carotene metabolic process;retinoic acid
metabolic process
cop COLEC11 2p25.3 0.144 0.273 0.777 multicellular organismal
xsq TMEM191C 22q11.21 0.144 0.273 0.777
xsq HIC1 17p13.3 0.144 0.273 0.777 negative regulation of transcription from
xsq FCF1 14q24.3 0.144 0.273 0.777 rRNA processing
cop RIIAD1 1q21.3 0.144 0.273 0.777 signal transduction
cop MRPL9 1q21 0.144 0.273 0.777 translation
cop OAZ3 1q21.3 0.144 0.273 0.777 regulation of cellular amino acid
metabolic process;spermatogenesis
cop TDRKH 1q21 0.144 0.273 0.777
cop LINGO4 1q21.3 0.144 0.273 0.777
cop RORC 1q21 0.144 0.273 0.777 multicellular organismal development;gene
expression
cop C2CD4D 1q21.3 0.144 0.273 0.777
cop LOC100132111 1q21.3 0.144 0.273 0.777
cop THEM5 1q21.3 0.144 0.273 0.777
cop BUD13 11q23.3 0.144 0.273 0.777 nuclear mRNA splicing, via
exp EEF2K 16p12.2 0.144 0.273 0.777 insulin receptor signaling
xsq LOC101928882 0.144 0.273 0.777
xsq PABPC3 13q12-q13 0.144 0.273 0.777 mRNA metabolic process
cop OAS1 12q24.2 0.144 0.273 0.777 cellular response to interferon-
alpha;negative regulation of viral genome replication
cop OAS3 12q24.2 0.144 0.273 0.777 cytokine-mediated signaling
pathway;negative regulation of viral genome replication
met KIZ 0.144 0.273 0.777 spindle organization
met TMEM243 7q21.12 0.144 0.273 0.777
exp PAPSS1 4q24 0.144 0.273 0.777 3'-phosphoadenosine 5'-phosphosulfate
xsq TMEM235 17q25.3 0.144 0.273 0.777
xsq MST1L 1p36.13 0.144 0.273 0.777
exp FAM160A2 11p15.4 0.144 0.273 0.777 endosome organization;lysosome
organization
exp PPIAL4G 0.144 0.273 0.777 protein folding
exp C1orf74 1q32.2 0.144 0.273 0.777
dependent"
cop CMTM4 16q21-q22.1 0.144 0.273 0.777 chemotaxis
xsq UFSP1 7q22.1 0.144 0.273 0.777 metabolic process
met NACA2 17q23.2 0.144 0.273 0.777 protein transport
cop MAP2K5 15q23 0.144 0.273 0.777 Protein Kinases
cop WDR45B 17q25.3 0.144 0.273 0.777
cop LIX1L 1q21.1 0.144 0.273 0.777 EMT (Mesenchymal)
exp CNTFR 9p13 0.144 0.273 0.777 positive regulation of cell
mut MBTPS1 16q24 0.144 0.273 0.777 regulation of transcription factor import
into nucleus;proteolysis
exp CTSS 1q21 0.144 0.273 0.777 antigen processing and presentation of
cop FOXA2 20p11 0.144 0.273 0.777 endoderm development;regulation of blood
coagulation
cop TP53TG3B 16p11.2 0.144 0.273 0.777
cop TP53TG3 16p13 0.144 0.273 0.777
cop TP53TG3C 0.144 0.273 0.777
cop SLC6A10P 16p11.2 0.144 0.273 0.777 Solute Carriers
exp IL9 5q31.1 0.144 0.273 0.777 inflammatory response;immune response
xsq ZSCAN21 7q22.1 0.144 0.273 0.777 regulation of transcription, DNA-
dependent;viral reproduction
xsq DPF2 11q13 0.144 0.273 0.777 Apoptosis
xsq DKFZP434I0714 4q31.23 0.144 0.273 0.777
xsq OR10H2 0.144 0.273 0.777
xsq LINC00487 2p25.2 0.144 0.273 0.777
exp LINC00238 14q23.3 0.144 0.273 0.777
xsq TRPM7 15q21 0.144 0.273 0.777 transmembrane transport;ion transport
exp TECR 19p13.12 0.144 0.273 0.777 long-chain fatty-acyl-CoA biosynthetic
met TTC26 7q34 0.144 0.273 0.777
mut NFATC1 18q23 0.144 0.273 0.777 transcription from RNA polymerase II
xsq FAM182A 20p11.1 0.144 0.273 0.777
xsq ADAMTS9 3p14.1 -0.144 0.273 0.777 proteolysis;glycoprotein
catabolic process
xsq LPIN3 20q12 -0.144 0.273 0.777 dephosphorylation;lipid metabolic process
cop TCEANC Xp22.2 -0.144 0.273 0.777 transcription, DNA-
cop RAB9A Xp22.2 -0.144 0.273 0.777 positive regulation of
cop TRAPPC2 Xp22 -0.144 0.273 0.777 skeletal system
cop OFD1 Xp22 -0.144 0.273 0.777 epithelial cilium movement involved in
determination of left/right asymmetry;G2/M transition of mitotic cell cycle
exp DCBLD1 6q22.1 -0.144 0.273 0.777 cell adhesion
cop SKIL 3q26 -0.144 0.273 0.777 protein heterotrimerization;cell cycle
arrest
met FLI1 11q24.1-q24.3 -0.144 0.273 0.777 Transcription Factors
exp FAM109A 12q24.12 -0.144 0.273 0.777 receptor recycling;endosome
organization
met PRRT1 6p21.32 -0.144 0.273 0.777 response to biotic stimulus
mut TINF2 14q12 -0.144 0.273 0.777 DNA Damage Response (DDR)
xsq SPSB1 1p36.22 -0.144 0.273 0.777 intracellular signal transduction
xsq LOC101929128 -0.144 0.273 0.777
met XPNPEP1 10q25.3 -0.144 0.273 0.777 proteolysis;cellular process
dependent"
cop BCL2L13 22q11.1 -0.144 0.273 0.777 Apoptosis
exp RNF182 6p23 -0.144 0.273 0.777 protein ubiquitination
exp OSTM1 6q21 -0.144 0.273 0.777 osteoclast differentiation
mir hsa-miR-145 -0.144 0.273 0.777
xsq LOC100133286 21q22.12 -0.144 0.273 0.777
xai PHTF1 1p13 -0.145 0.273 0.777 regulation of transcription, DNA-
dependent"
hs4 VWA3B 2q11.2 -0.145 0.273 0.777
exp LOC101060146 -0.145 0.273 0.777
xai FAM20B 1q25 -0.145 0.273 0.777
exp NATD1 -0.145 0.273 0.777
hs4 BTBD3 20p12.2 -0.145 0.273 0.777
hs4 ZBBX 3q26.1 -0.145 0.273 0.777
his CADM4 19q13.31 -0.145 0.273 0.777 cell adhesion
exp SLC8A3 14q24.1 -0.145 0.273 0.777 telencephalon
hs4 MIR4435-2HG -0.145 0.273 0.777
xai CASP4 11q22.2-q22.3 -0.145 0.273 0.777 Apoptosis
xai MAMDC2-AS1 -0.145 0.273 0.777
DNA-dependent"
exp FOSL1P1 -0.145 0.273 0.777
hs4 CNGA1 4p12 -0.145 0.273 0.777 transport;ion transport
hs4 NIPAL1 4p12 -0.145 0.273 0.777
his PHGDH 1p12 -0.145 0.273 0.777 L-serine biosynthetic process;brain
development
his LOC101927697 -0.145 0.273 0.777
xai WHAMM 15q25.2 -0.145 0.273 0.777
exp TAAR6 6q23.2 -0.145 0.273 0.777 G-protein coupled receptor
signaling pathway
his UPP2 2q24.1 -0.145 0.273 0.777
his COL5A3 19p13.2 -0.145 0.273 0.777 cell adhesion;cell-matrix
adhesion
xai SCNN1A 12p13 -0.145 0.273 0.777 ion transport;sodium ion transport
xai KL 13q12 -0.145 0.273 0.777 aging;insulin receptor signaling pathway
his PPY 17q21 -0.145 0.273 0.777
xai ZNRF3 22q12.1 -0.145 0.273 0.777
hs4 LRRC4 7q31.3 -0.145 0.273 0.777
his OLFML1 11p15.4 -0.145 0.273 0.777
xai PLN 6q22.1 -0.146 0.273 0.777 regulation of the force of heart
xai SBF1P1 0.145 0.274 0.777
his RCE1 11q13 0.145 0.274 0.777 proteolysis
his PREP 6q22 0.145 0.274 0.777 proteolysis
hs4 SOX18 20q13.33 0.145 0.274 0.777 angiogenesis;outflow tract morphogenesis
his RPF2 6q21 0.145 0.274 0.777
swa PRIM1 12q13 0.145 0.274 0.777 DDR (DNA replication)
his MCUB 0.145 0.274 0.777
xai ISG20 15q26 0.145 0.274 0.777 type I interferon-mediated signaling
pathway;DNA catabolic process, exonucleolytic
xai LPAR5 12p13.31 0.145 0.274 0.777
his TATDN1 8q24.13 0.145 0.274 0.777
his NDUFB9 8q13.3 0.145 0.274 0.777 mitochondrial electron transport,
hs4 CEP85 1p36.11 0.145 0.274 0.777
hs4 NOB1 16q22.3 0.145 0.274 0.777
xai KLHDC2 14q21.3 0.145 0.274 0.777
hs4 MT1X 16q13 0.145 0.274 0.777 response to metal ion;cellular response to
erythropoietin
his PIN1 19p13 0.145 0.274 0.777 protein folding;regulation of cell
proliferation
hs4 ANKRD36 2q11.2 0.145 0.274 0.777
his LOC101928438 0.145 0.274 0.777
his NR4A3 9q22 0.145 0.274 0.777 mesoderm formation;response to peptide hormone
stimulus
hs4 ME2 18q21 0.145 0.274 0.777 malate metabolic process
hs4 POLN 4p16.3 0.145 0.274 0.777 DNA Damage Response (DDR); DDR (DNA
hs4 HAUS3 0.145 0.274 0.777 centrosome organization;cell division
xai TMTC4 13q32.3 0.145 0.274 0.777
exp HCG8 0.145 0.274 0.777
his SHPK 17p13 0.145 0.274 0.777 carbohydrate metabolic process
his CTNS 17p13 0.145 0.274 0.777 glutathione metabolic process;transport
hs4 IRF7 11p15.5 0.145 0.274 0.777 Apoptosis
xai MIR1251 0.145 0.274 0.777
xai OTUD3 1p36.13 0.145 0.274 0.777
his MICU2 13q12.11 0.145 0.274 0.777
xai ACOXL 2q13 0.145 0.274 0.777 fatty acid beta-oxidation
swa DUSP3 17q21 0.145 0.274 0.777 toll-like receptor 2 signaling pathway;negative
regulation of JNK cascade
cop SPPL2B 19p13.3 0.145 0.274 0.777 proteolysis
hs4 ZSCAN30 18q12.2 0.145 0.274 0.777 viral reproduction
hs4 ZNF271P 0.145 0.274 0.777
xsq LOC101927575 0.144 0.274 0.777
cop HPS6 10q24.32 0.144 0.274 0.777 organelle organization;blood coagulation
cop LDB1 10q24-q25 0.144 0.274 0.777 gastrulation with mouth forming
cop PPRC1 10q24.32 0.144 0.274 0.777 regulation of transcription, DNA-
dependent"
cop NOLC1 10q24.32 0.144 0.274 0.777 positive regulation of cell
exp ATP2A2 12q24.11 0.144 0.274 0.777 transmembrane transport;ATP
exp CDO1 5q23.2 0.144 0.274 0.777 sulfur amino acid metabolic
cop DYNC1LI2 16q22.1 0.144 0.274 0.777 transport
exp LPAR5 12p13.31 0.144 0.274 0.777
cop SCGB1D2 11q13 0.144 0.274 0.777
xsq TECR 19p13.12 0.144 0.274 0.777 long-chain fatty-acyl-CoA biosynthetic
exp LOC645984 0.144 0.274 0.777
met TRPC5 Xq23 0.144 0.274 0.777 axon guidance;transmembrane transport
exp RPS6P26 Xq13.2 0.144 0.274 0.777
cop CRY1 12q23-q24.1 0.144 0.274 0.777 DNA Damage Response (DDR)
xsq MAP2K7 19p13.3-p13.2 0.144 0.274 0.777 Protein Kinases
xsq TYK2 19p13.2 0.144 0.274 0.777 intracellular protein kinase
dependent;cytoskeleton organization
cop TMEM263 0.144 0.274 0.777
cop MTERFD3 0.144 0.274 0.777
exp OR51E1 11p15.4 0.144 0.274 0.777 response to stimulus
met DIO3 14q32 0.144 0.274 0.777 thyroid hormone generation;cellular nitrogen
xsq LOC101927964 0.144 0.274 0.777
cop MRGPRE 11p15.4 0.144 0.274 0.777
met PPP1R1C 2q31.3 0.144 0.274 0.777 signal transduction
cop OR4F21 0.144 0.274 0.777
xsq SIAH1 16q12.1 0.144 0.274 0.777 Apoptosis
xsq TFR2 7q22 0.144 0.274 0.777 proteolysis;iron ion transport
xsq LCE5A 1q21.3 0.144 0.274 0.777
xsq MDP1 14q12 0.144 0.274 0.777
exp NUP62CL Xq22.3 0.144 0.274 0.777 protein transport
met TCTN2 12q24.31 0.144 0.274 0.777 cell projection organization;cilium
assembly
xsq TMX2 11cen-q22.3 0.144 0.274 0.777 cell redox homeostasis
exp RAN 12q24.3 0.144 0.274 0.777 nucleocytoplasmic transport;androgen
exp POF1B Xq21.2 0.144 0.274 0.777
xsq FOXE3 0.144 0.274 0.777
xsq SNF8 17q21.32 0.143 0.274 0.777 regulation of transcription from RNA
polymerase II promoter;protein transport
met NTRK1 1q21-q22 0.143 0.274 0.777 activation of adenylate cyclase
xsq CS 12q13.2 0.143 0.274 0.777 small molecule metabolic
exp GRIPAP1 Xp11.23 0.143 0.274 0.777
exp MEX3C 18q21.2 0.143 0.274 0.777
exp AGO1 1p34.3 0.143 0.274 0.777
met NDUFB4 3q13.33 0.143 0.274 0.777 response to oxidative
met SRPK3 Xq28 0.143 0.274 0.777 protein phosphorylation;multicellular
xsq CECR2 22q11.2 0.143 0.274 0.777 chromatin modification;cytokinesis
cop LOC100134868 20p11.1 0.143 0.274 0.777
cop FAM182A 20p11.1 0.143 0.274 0.777
cop APOB 2p24-p23 0.143 0.274 0.777 lipid metabolic process;cholesterol
metabolic process
cop EXOC6B 2p13.2 0.143 0.274 0.777 protein transport;vesicle docking
xsq ADH1C 4q23 0.143 0.274 0.777 ethanol oxidation;xenobiotic metabolic process
exp EIF1B 3p22.1 0.143 0.274 0.777 regulation of translational initiation
mut AEBP1 7p13 0.143 0.274 0.777 cell adhesion;muscle organ development
xsq LINC01441 0.143 0.274 0.777
xsq PAFAH2 1p36 0.143 0.274 0.777 lipid metabolic process;anti-apoptosis
exp HNRNPH3 10q22 0.143 0.274 0.777 nuclear mRNA splicing, via
xsq HNRNPL 19q13.2 0.143 0.274 0.777 nuclear mRNA splicing, via
exp CLPTM1L 5p15.33 0.143 0.274 0.777 apoptotic process
met SPG21 15q21-q22 0.143 0.274 0.777 cell death;antigen receptor-mediated
signaling pathway
xsq SMIM10L2A 0.143 0.274 0.777
xsq C17orf99 17q25.3 0.143 0.274 0.777
xsq GAPDHS 19q13.12 -0.143 0.274 0.777 small molecule metabolic
cop XPR1 1q25.1 -0.143 0.274 0.777 G-protein coupled receptor
cop ESYT3 3q22.3 -0.143 0.274 0.777
met PLA2G6 22q13.1 -0.143 0.274 0.777 metabolic process;cell death
met SPC25 2q31.1 -0.143 0.274 0.777 mitotic cell cycle;mitotic spindle
organization
xsq CDSN 6p21.3 -0.143 0.274 0.777 epidermis development;cell-cell
adhesion
xsq MOB3C 1p33 -0.143 0.274 0.777
DNA-dependent"
exp TMEM14C 6p24.2 -0.143 0.274 0.777 heme biosynthetic process
exp RNF150 4q31.21 -0.143 0.274 0.777
cop ATP6V1E1 22q11.1 -0.143 0.274 0.777 ion transport;cellular iron
ion homeostasis
exp LMCD1-AS1 3p26.1 -0.143 0.274 0.777
met ITPK1 14q31 -0.143 0.274 0.777 signal transduction;blood coagulation
exp PHTF1 1p13 -0.143 0.274 0.777 regulation of transcription, DNA-
dependent"
cop MRPL15 8q11.2-q13 -0.143 0.274 0.777 translation
cop SOX17 8q11.23 -0.143 0.274 0.777 Cell Signaling
met TMEM102 17p13.1 -0.144 0.274 0.777 signal transduction;response
to cytokine stimulus
cop KCNV1 8q23.2 -0.144 0.274 0.777 ion transport;potassium ion
transport
met KRT25 17q21.2 -0.144 0.274 0.777 hair follicle
morphogenesis;intermediate filament organization
xsq CYP2J2 1p31.3-p31.2 -0.144 0.274 0.777 xenobiotic metabolic
xsq RIN1 11q13.2 -0.144 0.274 0.777 endocytosis;signal transduction
xsq CDS1 4q21.23 -0.144 0.274 0.777 CDP-choline
cop MSGN1 2p24.2 -0.144 0.274 0.777
xsq YPEL4 11q12.1 -0.144 0.274 0.777
xsq RIC1 -0.144 0.274 0.777
xsq PRICKLE2-AS1 -0.144 0.274 0.777
exp KLRG2 7q34 -0.144 0.274 0.777
cop C8orf86 8p11.22 -0.144 0.274 0.777
xsq ZFHX4-AS1 8q21.11 -0.144 0.274 0.777
exp PBX4 19p12 -0.144 0.274 0.777 transcription from RNA polymerase II
cop RAD51AP2 2p24.2 -0.144 0.274 0.777
mir hsa-miR-29a -0.144 0.274 0.777
cop OR13C9 -0.144 0.274 0.777
cop PHF20 20q11.22-q11.23 -0.144 0.274 0.777 histone H4-K16
acetylation;regulation of transcription, DNA-dependent
met SCIMP 17p13.2 -0.144 0.274 0.777 positive regulation of ERK1 and
ERK2 cascade
cop C8orf56 -0.144 0.274 0.777
his JPH1 8q21 -0.145 0.274 0.777 muscle organ development;regulation of
hs4 ABCB4 7q21.1 -0.145 0.274 0.777 ABC Transporters
hs4 OTULIN -0.145 0.274 0.777
xai BMP15 Xp11.2 -0.145 0.274 0.777 ovarian follicle development;female
gamete generation
xai NOTCH2NL 1q21.2 -0.145 0.274 0.777 Notch signaling
hs4 KIAA0355 19q13.11 -0.145 0.274 0.777
hs4 LOC105369438 -0.145 0.274 0.777
xai TM9SF1 14q11.2 -0.145 0.274 0.777 autophagy
his AXL 19q13.1 -0.145 0.274 0.777 Protein Kinases
hs4 CCDC171 9p22.3 -0.145 0.274 0.777
his LOC101929586 -0.145 0.274 0.777
his DACT3-AS1 -0.145 0.274 0.777
his DACT3 19q13.32 -0.145 0.274 0.777
swa MRPS36 5q13.2 -0.145 0.274 0.777 translation
his LINC01093 -0.145 0.274 0.777
DNA-dependent"
xai ZFAND5 9q13-q21 -0.145 0.274 0.777 smooth muscle tissue
development;face development
his LMAN1L 15q24.1 -0.145 0.274 0.777
hs4 PPP2CB 8p12 -0.145 0.274 0.777 regulation of gene
xai KRT8P30 2q35 -0.145 0.274 0.777
exp C2CD4D 1q21.3 -0.145 0.274 0.777
exp PLN 6q22.1 -0.145 0.274 0.777 regulation of the force of heart
exp C16orf89 16p13.3 -0.145 0.274 0.777
exp ASB18 2q37.2 -0.145 0.274 0.777 intracellular signal transduction
hs4 WNT6 2q35 -0.145 0.274 0.777 axis specification;epithelial-mesenchymal
cell signaling
xai C16orf97 16q12.1 -0.145 0.274 0.777
xai WNT4 1p36.23-p35.1 -0.145 0.274 0.777 Oncogenes
xai KRT8P31 5q12.1 -0.145 0.274 0.777
xai KLF3 4p14 -0.145 0.274 0.777 regulation of transcription, DNA-
his CLDN22 4q35.1 -0.145 0.274 0.777 calcium-independent cell-cell
his CLDN24 4q35.1 -0.145 0.274 0.777
his IFT20 17q11.2 -0.145 0.274 0.777 cell projection organization
his TNFAIP1 17q22-q23 -0.145 0.274 0.777 protein
xai FBXW11 5q35.1 -0.145 0.274 0.777 protein
destabilization;negative regulation of NF-kappaB import into nucleus
hs4 ADGB 6q24.3 -0.145 0.274 0.777 proteolysis;oxygen transport
hs4 LOC101928661 -0.145 0.274 0.777
his RAB11FIP3 16p13.3 -0.145 0.274 0.777 cell cycle;vesicle-mediated
transport
xai ERRFI1 1p36 -0.145 0.274 0.777 response to stress;lung vasculature
development
hs4 DGCR8 22q11.2 -0.145 0.274 0.777 primary miRNA processing
DNA-dependent"
xai JAKMIP2 5q32 0.145 0.275 0.777
his NMRK1 9q21.13 0.145 0.275 0.777 pyridine nucleotide biosynthetic process
his OSTF1 9q13-q21.2 0.145 0.275 0.777 ossification;signal transduction
his MYOM2 8p23.3 0.145 0.275 0.777 muscle contraction
hs4 CCDC25 8p21.1 0.145 0.275 0.777
hs4 ESCO2 8p21.1 0.145 0.275 0.777 regulation of DNA replication;cell cycle
xai SOX1 13q34 0.145 0.275 0.777 chromatin organization;regulation of
his TRIM72 16p11.2 0.145 0.275 0.777 protein homooligomerization;plasma
membrane repair
his PYDC1 16p11.2 0.145 0.275 0.777 positive regulation of interleukin-1 beta
secretion;negative regulation of protein kinase activity
his SRSF3 6p21 0.145 0.275 0.777 nuclear mRNA splicing, via
exp SNORD13 8p12 0.145 0.275 0.777
xai CTRC 1p36.21 0.145 0.275 0.777 proteolysis
hs4 PRIM1 12q13 0.145 0.275 0.777 DDR (DNA replication)
hs4 UBL4A Xq28 0.145 0.275 0.777 protein modification process;transport
his WDR72 15q21.3 0.145 0.275 0.777
xai CSNK1G1 15q22.1-q22.31 0.145 0.275 0.777 Protein Kinases
hs4 HBQ1 16p13.3 0.145 0.275 0.777 transport;oxygen transport
xai ARRDC1-AS1 0.145 0.275 0.777
xai ZNF37BP 10q11.21 0.144 0.275 0.777
his PRPSAP2 17p11.2-p12 0.144 0.275 0.777 nucleobase-containing compound
xai SNORD13 8p12 0.144 0.275 0.777
his SVEP1 9q32 0.144 0.275 0.777 cell adhesion
hs4 LINC00689 7q36.3 0.144 0.275 0.777
his NUGGC 8p21.1 0.144 0.275 0.777
swa SRRT 7q21 0.144 0.275 0.777 gene silencing by RNA;primary miRNA processing
his MRRF 9q33.2 0.144 0.275 0.777 translation;ribosome disassembly
his RBM18 9q33.2 0.144 0.275 0.777
xai ZNF317P1 8q22.1 0.144 0.275 0.777
xai LOC101060026 0.144 0.275 0.777
xai SUPT7L 2p23.3 0.144 0.275 0.777 regulation of transcription, DNA-
exp HSFY1P1 0.144 0.275 0.777
exp LOC101060026 0.144 0.275 0.777
hs4 SWSAP1 19p13.2 0.144 0.275 0.777 DNA repair;DNA recombination
exp IGHV1OR15-3 0.144 0.275 0.777
xai FAM110D 1p36.11 0.144 0.275 0.777
xai HSFY1P1 0.144 0.275 0.777
his RNPS1 16p13.3 0.144 0.275 0.777 termination of RNA polymerase II
his LOC106660606 0.144 0.275 0.777
his MIR3677 0.144 0.275 0.777
his MIR940 0.144 0.275 0.777
his STARD4-AS1 0.144 0.275 0.777
his STARD4 5q22.1 0.144 0.275 0.777 transport;lipid transport
his DRAXIN 1p36.22 0.144 0.275 0.777
hs4 MGME1 20p11.23 0.144 0.275 0.777
hs4 SNX5 20p11 0.144 0.275 0.777 pinocytosis;cell communication
hs4 SNORD17 20p11.23 0.144 0.275 0.777
his PCMTD1 8q11.23 0.144 0.275 0.777 protein modification process
exp MIR1251 0.144 0.275 0.777
his ANKRD18A 9p13.1 0.144 0.275 0.777
his FAM201A 9p13.1 0.144 0.275 0.777
his DCUN1D5 11q22.3 0.144 0.275 0.777
xai LINC00200 10p15.3 0.144 0.275 0.777
xai LOC100505824 0.144 0.275 0.777
hs4 UBE2J1 6q15 0.144 0.275 0.777
hs4 NME6 3p21 0.144 0.275 0.777 Apoptosis
his PPP1R12A 12q15-q21 0.144 0.275 0.777 protein dephosphorylation;mitosis
his TMEM209 7q32.2 0.144 0.275 0.777
his SSMEM1 7q32.2 0.144 0.275 0.777
exp SERF2 15q15.3 0.143 0.275 0.777
met MTSS1L 16q22.1 0.143 0.275 0.777 filopodium assembly;signal
transduction
met CERS4 19p13.2 0.143 0.275 0.777 ceramide biosynthetic
xsq BRAT1 7p22.3 0.143 0.275 0.777 response to ionizing radiation
mut LATS1 6q25.1 0.143 0.275 0.777 G2/M transition of mitotic cell
cop KATNAL2 18q21.1 0.143 0.275 0.777
mut ZKSCAN4 6p21 0.143 0.275 0.777 viral reproduction
exp EBP Xp11.23-p11.22 0.143 0.275 0.777 cholesterol metabolic
process;hemopoiesis
dependent"
xsq NMNAT3 3q23 0.143 0.275 0.777 small molecule metabolic process;vitamin
metabolic process
mut CCNA1 13q12.3-q13 0.143 0.275 0.777 DNA Damage Response (DDR)
cop FGFR3 4p16.3 0.143 0.275 0.777 Cell Signaling; Oncogenes
xsq CA5A 16q24.3 0.143 0.275 0.777
mut MFSD6 2q32.2 0.143 0.275 0.777 transmembrane transport
xsq LARP1 5q33.2 0.143 0.275 0.777
exp GIPR 19q13.3 0.143 0.275 0.777 desensitization of G-protein coupled
receptor protein signaling pathway;positive regulation of cAMP biosynthetic process
cop FN3KRP 17q25.3 0.143 0.275 0.777
xsq CENPU 0.143 0.275 0.777 mitotic prometaphase;mitotic cell cycle
exp LOC100506299 0.143 0.275 0.777
cop MIR4529 0.143 0.275 0.777
cop IQCH-AS1 0.143 0.275 0.777
cop C15orf61 15q23 0.143 0.275 0.777
cop LRPAP1 4p16.3 0.143 0.275 0.777 protein folding;negative regulation
xsq CAMK2G 10q22 0.143 0.275 0.777 cytokine-mediated signaling
mut EPHA8 1p36.12 0.143 0.275 0.777 substrate-dependent cell
xsq FOXP3 Xp11.23 0.143 0.275 0.777 T cell mediated immunity;regulation of
cop EMC7 15q14 0.143 0.275 0.777
cop PGBD4 15q14 0.143 0.275 0.777
cop KATNBL1 15q14 0.143 0.275 0.777
cop EMC4 15q14 0.143 0.275 0.777
cop NOP10 15q14-q15 0.143 0.275 0.777 DNA Damage Response (DDR)
exp NUP210 3p25.1 0.143 0.275 0.777 glucose transport;viral
reproduction
cop NUTM1 15q14 0.143 0.275 0.777
xsq MFAP4 17p11.2 0.143 0.275 0.777 cell adhesion;signal transduction
met CAPN5 11q14 0.143 0.275 0.777 granulosa cell differentiation;ovarian follicle
development
cop LPCAT4 15q14 0.143 0.275 0.777 metabolic process;phospholipid
mut NCOR1 17p11.2 0.143 0.275 0.777 transcription from RNA polymerase II
promoter;cholesterol homeostasis
mut COL28A1 7p21.3 0.143 0.275 0.777 cell adhesion
cop MAPKAPK3 3p21.3 0.143 0.275 0.777 signal transduction;toll-like
xsq ZDHHC4 7p22.1 0.143 0.275 0.777
cop CHRM5 15q26 0.143 0.275 0.777 inhibition of adenylate cyclase activity by G-
protein coupled acetylcholine receptor signaling pathway;G-protein coupled
acetylcholine receptor signaling pathway
met LUC7L 16p13.3 0.143 0.275 0.777 negative regulation of striated muscle
tissue development
xsq KRT17P5 0.143 0.275 0.777
xsq RAD51B 14q23-q24.2 0.143 0.275 0.777 DNA Damage Response (DDR); DDR (HR)
cop POLL 10q23 0.143 0.275 0.777 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
exp FAM208B 10p15.1 0.143 0.275 0.777
cop NAE1 16q22 0.143 0.275 0.777 Apoptosis
met CYP46A1 14q32.1 0.143 0.275 0.777 bile acid biosynthetic
met BRI3 7q21.3 0.143 0.275 0.777
mut WDR59 16q23.1 0.143 0.275 0.777
cop FAM182B 20p11.1 0.143 0.275 0.777
xsq C5 9q33-q34 0.143 0.275 0.777 inflammatory response;negative regulation
of macrophage chemotaxis
xsq ZC3H12D 6q25.1 0.143 0.275 0.777 negative regulation of cell
exp LOC100506272 0.143 0.275 0.777
exp HBQ1 16p13.3 0.143 0.275 0.777 transport;oxygen transport
xsq OXSR1 3p22.2 0.143 0.275 0.777 protein phosphorylation;response to
oxidative stress
xsq LUCAT1 0.143 0.275 0.777
xsq DCAF16 4p15.31 0.143 0.275 0.777 protein ubiquitination
xsq TMED7 5q22.3 -0.143 0.275 0.777 protein transport
cop LINC00635 3q13.12 -0.143 0.275 0.777
cop LINC00636 3q13.12 -0.143 0.275 0.777
xsq DCAF6 1q24.2 -0.143 0.275 0.777 protein ubiquitination;positive
xsq ATP1A1 1p21 -0.143 0.275 0.777 ATP biosynthetic process;positive
cop FGFR1 8p11.23-p11.22 -0.143 0.275 0.777 positive regulation of cell
proliferation;chordate embryonic development
exp ARRDC3 5q14.3 -0.143 0.275 0.777 signal transduction
exp LRRC42 1p33-p32.1 -0.143 0.275 0.777
exp LOC642441 1q21.2 -0.143 0.275 0.777
xsq TMEM127 2q11.2 -0.143 0.275 0.777 negative regulation of TOR
signaling cascade;negative regulation of cell proliferation
met MATN1 1p35 -0.143 0.275 0.777 protein complex assembly
exp VCY1B Yq11.21 -0.143 0.275 0.777
exp DGCR8 22q11.2 -0.143 0.275 0.777 primary miRNA processing
exp PRICKLE4 6p21.31 -0.143 0.275 0.777
xsq HOPX 4q12 -0.143 0.275 0.777 negative regulation of cell
differentiation;trophectodermal cell differentiation
met LTB 6p21.3 -0.143 0.275 0.777 immune response;signal transduction
exp NRBP1 2p23 -0.143 0.275 0.777 ER to Golgi vesicle-mediated
transport;gene expression
mut RPS6KA4 11q11-q13 -0.143 0.275 0.777 Protein Kinases
mut RFX1 19p13.1 -0.143 0.275 0.777 regulation of transcription, DNA-
xsq C1orf194 1p13.3 -0.143 0.275 0.777
cop TBL1XR1 3q26.32 -0.143 0.275 0.777 Cell Signaling
met STAMBP 2p13.1 -0.143 0.275 0.777 proteolysis;anti-apoptosis
mut TTC26 7q34 -0.143 0.275 0.777
exp GALR1 18q23 -0.143 0.275 0.777 neuropeptide signaling pathway;digestion
xsq GFPT2 5q34-q35 -0.143 0.275 0.777 dolichol-linked oligosaccharide
exp MBP 18q23 -0.143 0.275 0.777 immune response;synaptic transmission
mut LRRC4C 11p12 -0.143 0.275 0.777 regulation of axonogenesis
exp MUC15 11p14.3 -0.143 0.275 0.777 post-translational protein
exp BAMBI 10p12.3-p11.2 -0.143 0.275 0.777 cell migration;negative
exp TMEM192 4q32.3 -0.143 0.275 0.777
swa TINAGL1 1p35.2 -0.144 0.275 0.777 proteolysis;immune response
exp MYCLP2 -0.144 0.275 0.777
exp SPATA1 1p22.3 -0.144 0.275 0.777
exp APOBEC2 6p21 -0.144 0.275 0.777 mRNA processing;cytidine
deamination
hs4 USP27X-AS1 Xp11.23 -0.144 0.275 0.777
hs4 USP27X Xp11.23 -0.144 0.275 0.777 proteolysis;ubiquitin-
hs4 RBAKDN 7p22.1 -0.144 0.275 0.777
hs4 HOXD11 2q31.1 -0.144 0.275 0.777 skeletal system
DNA-dependent"
xai MYCLP2 -0.144 0.275 0.777
hs4 BST2 19p13.1 -0.144 0.275 0.777 positive regulation of I-kappaB
hs4 BISPR -0.144 0.275 0.777
xai LINC01102 -0.144 0.275 0.777
exp C10orf67 10p12.2 -0.144 0.275 0.777
xai FGF2 4q26 -0.144 0.275 0.777 branching involved in ureteric bud
hs4 LINC00437 -0.144 0.275 0.777
hs4 FREM2 13q13.3 -0.144 0.275 0.777 homophilic cell
xai ARHGAP39 8q24.3 -0.144 0.275 0.777 signal transduction;small
xai HOXD11 2q31.1 -0.144 0.275 0.777 skeletal system
xai LINC00839 10q11.21 -0.144 0.275 0.777
hs4 GREB1 2p25.1 -0.145 0.275 0.777
hs4 MIR4429 -0.145 0.275 0.777
swa PYCR1 17q25.3 -0.145 0.275 0.777 response to stress;cellular amino
his UBTD2 5q35.1 -0.145 0.275 0.777
his LOC100288254 -0.145 0.275 0.777
his HLA-DRA 6p21.3 -0.145 0.275 0.777 immune response;cytokine-
DNA-dependent"
xai HIGD1A 3p22.1 -0.145 0.275 0.777 response to stress
his EPHA3 3p11.2 -0.145 0.275 0.777 Cell Signaling
his SNORA108 -0.145 0.275 0.777
exp LOC57399 -0.145 0.275 0.777
xai HOXA-AS2 7p15.2 -0.145 0.275 0.777
xai GREB1 2p25.1 -0.145 0.275 0.777
his SOX17 8q11.23 -0.145 0.275 0.777 Cell Signaling
xai PDE11A 2q31.2 -0.145 0.275 0.777 cAMP catabolic process;signal
transduction
xai IGSF8 1q23.1 -0.145 0.275 0.777 cell proliferation;cellular
component movement
his IL7R 5p13 -0.145 0.275 0.777 Oncogenes
swa UTP14A Xq26.1 0.144 0.276 0.777 rRNA processing
swa RPL15 3p24.2 0.144 0.276 0.777 translation;mRNA metabolic process
xai DPP10-AS1 0.144 0.276 0.777
hs4 VPREB1 0.144 0.276 0.777 immune response
xai ZNF965P 13q11 0.144 0.276 0.777
xai MRPS36 5q13.2 0.144 0.276 0.777 translation
xai ZCCHC9 5q14.1 0.144 0.276 0.777 negative regulation of phosphatase
activity
xai KLC1 14q32.3 0.144 0.276 0.777 microtubule-based movement;blood
coagulation
exp HCP5B 0.144 0.276 0.777
hs4 EIF3CL 0.144 0.276 0.777
hs4 ATRAID 2p23.3 0.144 0.276 0.777
his GPATCH2L 14q24.3 0.144 0.276 0.777
xai IGHV1OR15-3 0.144 0.276 0.777
his FCER1A 0.144 0.276 0.777
xai CHST11 12q 0.144 0.276 0.777 chondroitin sulfate biosynthetic
exp ZNF965P 13q11 0.144 0.276 0.777
xai DLG4 17p13.1 0.144 0.276 0.777 synaptic transmission;receptor
xai HAPLN1 5q14.3 0.144 0.276 0.777 cell adhesion
his APOOL Xq21.1 0.144 0.276 0.777
his AMBRA1 11p11.2 0.144 0.276 0.777 autophagy;multicellular organismal
development
xai RPS20 8q12 0.144 0.276 0.777 gene expression;viral reproduction
his CCR9 3p21.3 0.144 0.276 0.777 immune response;cellular defense response
hs4 C14orf2 14q32.33 0.144 0.276 0.777
xai SPCS3 4q34.2 0.144 0.276 0.777 small molecule metabolic process;energy
xai AKR1C8P 0.144 0.276 0.777
xai MAFK 7p22.3 0.144 0.276 0.777 regulation of transcription, DNA-
dependent;blood coagulation"
xai HCP5B 0.144 0.276 0.777
swa ABRACL 6q24.1 0.144 0.276 0.777
swa SERPINB5 18q21.33 0.144 0.276 0.777 cellular component
xai C15orf65 0.144 0.276 0.777
his GOLGA6L3 15q25.3 0.144 0.276 0.777
xai LOC100996291 0.144 0.276 0.777
exp INSL5 1p31.3 0.144 0.276 0.777
hs4 PLD5 1q43 0.144 0.276 0.777
hs4 WDR27 6q27 0.144 0.276 0.777
hs4 C6orf120 6q27 0.144 0.276 0.777
hs4 RPRD2 1q21.3 0.144 0.276 0.777
his HOMER1 5q14.2 0.144 0.276 0.777 regulation of store-operated
his DNASE1 16p13.3 0.144 0.276 0.777 apoptotic process;DNA catabolic
process
xai PRDM2 1p36.21 0.144 0.276 0.777 regulation of transcription, DNA-
dependent;response to estradiol stimulus"
his EIF2D 1q32.1 0.144 0.276 0.777 translational initiation;intracellular
protein transport
xai ZBED5 11p15.3 0.144 0.276 0.777
swa PSCA 8q24.2 0.144 0.276 0.777
his MFSD2B 2p23.3 0.144 0.276 0.777 transport
his OCSTAMP 20q13.12 0.144 0.276 0.777
met MALL 2q13 0.143 0.276 0.777 cholesterol homeostasis
xsq RPS10P7 1q32.1 0.143 0.276 0.777
met DHCR7 11q13.4 0.143 0.276 0.777 cholesterol biosynthetic process;post-
xsq ZBTB8B 1p35.1 0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
xsq HIST1H2BO 6p22.1 0.143 0.276 0.777 nucleosome assembly
xsq CXCR3 Xq13 0.143 0.276 0.777 cellular component movement;chemotaxis
met LRRC6 8q24.22 0.143 0.276 0.777 male gonad development;pachytene
cop TCL1A 14q32.1 0.143 0.276 0.777 multicellular organismal development
cop TUNAR 0.143 0.276 0.777
cop C14orf132 14q32.2 0.143 0.276 0.777
cop BDKRB2 14q32.1-q32.2 0.143 0.276 0.777 inflammatory
cop BDKRB1 14q32.1-q32.2 0.143 0.276 0.777 activation of protein kinase
C activity by G-protein coupled receptor protein signaling pathway;cell migration
met WNT1 12q13 0.143 0.276 0.777 Apoptosis; Oncogenes
xsq LOC150935 0.143 0.276 0.777
mut BCKDK 16p11.2 0.143 0.276 0.777 branched chain family amino acid
exp TMEM198B 12q13.2 0.143 0.276 0.777
met CRYM 16p12.2 0.143 0.276 0.777 negative regulation of transcription from
RNA polymerase II promoter;sensory perception of sound
xsq C11orf98 0.143 0.276 0.777
xsq ACY1 3p21.1 0.143 0.276 0.777 proteolysis;cellular amino acid metabolic
process
xsq TBCK 4q24 0.143 0.276 0.777 protein phosphorylation
mut QSER1 11p13 0.143 0.276 0.777
xsq LY75 2q24 0.143 0.276 0.777 endocytosis;inflammatory response
xsq GPR78 0.143 0.276 0.777
mut PDZD2 5p13.3 0.143 0.276 0.777 cell adhesion
xsq C17orf104 17q21.31 0.143 0.276 0.777
cop TMCO5B 0.143 0.276 0.777
xsq TIMM22 17p13 0.143 0.276 0.777 protein transport;protein import into
xsq UBXN1 11q12.3 0.143 0.276 0.777 negative regulation of protein
catabolic process
met SLC35F5 2q14.1 0.143 0.276 0.777 Solute Carriers
xsq LINC01530 0.143 0.276 0.777
met CLEC5A 7q33 0.143 0.276 0.777 signal transduction;response to virus
cop RYR3 15q14-q15 0.143 0.276 0.777 cellular response to calcium ion;ion
transport
exp NPIPB3 16p12.2 0.143 0.276 0.777
met EXPH5 11q22.3 0.143 0.276 0.777 intracellular protein transport;positive
xsq MRGPRE 11p15.4 0.143 0.276 0.777
exp MAF 16q22-q23 0.143 0.276 0.777 transcription from RNA polymerase II
promoter
xsq FUNDC2 Xq28 0.143 0.276 0.777
exp NT5C 17q25.1 0.143 0.276 0.777 purine base metabolic process;nucleobase-
exp SSNA1 9q34.3 0.143 0.276 0.777 G2/M transition of mitotic cell
met BPIFA1 20q11.2 0.143 0.276 0.777 innate immune response
xsq RPL22L1 3q26.2 0.143 0.276 0.777 translation
met LOC100134229 0.143 0.276 0.777
exp LYPLAL1 1q41 0.143 0.276 0.777
xsq FAM99A 0.143 0.276 0.777
met KLHL14 18q12.1 0.143 0.276 0.777
met ACSM1 16p12.3 -0.143 0.276 0.777 xenobiotic metabolic process;energy
met MEI1 22q13.2 -0.143 0.276 0.777 meiosis;male meiosis I
cop TECRL 4q13.1 -0.143 0.276 0.777
xsq LOC100506178 -0.143 0.276 0.777
mut EPS15 1p32 -0.143 0.276 0.777 cell proliferation;protein transport
mut IGSF3 1p13 -0.143 0.276 0.777
mut SUCO 1q24 -0.143 0.276 0.777
mut ALS2CR11 2q33.1 -0.143 0.276 0.777
mut PHF7 3p21.1 -0.143 0.276 0.777
mut GAP43 3q13.31 -0.143 0.276 0.777 activation of protein kinase C
mut SLC51A 3q29 -0.143 0.276 0.777
mut MSANTD1 4p16.3 -0.143 0.276 0.777
mut ODAM 4q13.3 -0.143 0.276 0.777 biomineral tissue
development;odontogenesis of dentin-containing tooth
mut PAPD4 5q14.1 -0.143 0.276 0.777 RNA polyadenylation;histone mRNA
catabolic process
mut TFB1M 6q25.1-q25.3 -0.143 0.276 0.777 regulation of transcription,
DNA-dependent"
mut CPA2 7q32 -0.143 0.276 0.777 proteolysis;vacuolar protein catabolic
process
mut HTR5A 7q36.1 -0.143 0.276 0.777 G-protein coupled receptor
messenger
mut LYPD2 8q24.3 -0.143 0.276 0.777
mut FAR1 11p15.2 -0.143 0.276 0.777 small molecule metabolic
mut PROZ 13q34 -0.143 0.276 0.777 proteolysis;blood coagulation
mut CYFIP1 15q11 -0.143 0.276 0.777 regulation of cell
mut OTUD7A 15q13.3 -0.143 0.276 0.777 proteolysis
mut TMEM199 17q11.2 -0.143 0.276 0.777
mut KRT40 17q21.2 -0.143 0.276 0.777
mut C17orf47 17q22 -0.143 0.276 0.777
mut RINL 19q13.2 -0.143 0.276 0.777
mut HSD17B14 19q13.33 -0.143 0.276 0.777 steroid catabolic process
mut APOBEC3G 22q13.1-q13.2 -0.143 0.276 0.777 negative regulation of
viral genome replication;positive regulation of defense response to virus by host
mut MAPK11 22q13.33 -0.143 0.276 0.777 Protein Kinases
mut TTLL10 1p36.33 -0.143 0.276 0.777 protein polyglycylation
mut MIB2 1p36.33 -0.143 0.276 0.777 signal transduction;Notch signaling
pathway
mut CALML6 1p36.33 -0.143 0.276 0.777
mut CEP104 1p36.32 -0.143 0.276 0.777
mut UTS2 1p36 -0.143 0.276 0.777 muscle contraction;synaptic transmission
mut SLC25A33 1p36.22 -0.143 0.276 0.777 Solute Carriers
mut MAD2L2 1p36 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR (DNA
mut FBXO42 1p36.23-p36.11 -0.143 0.276 0.777
mut CAPZB 1p36.1 -0.143 0.276 0.777 cell projection
organization;lamellipodium assembly
mut EXTL1 1p36.1 -0.143 0.276 0.777 skeletal system development
mut TRIM63 1p34-p33 -0.143 0.276 0.777 signal
transduction;proteasomal ubiquitin-dependent protein catabolic process
mut PTAFR 1p35-p34.3 -0.143 0.276 0.777 pattern recognition receptor
mut MED18 1p35.3 -0.143 0.276 0.777 regulation of transcription from
mut IQCC 1p36.11-p34.2 -0.143 0.276 0.777
mut STK40 1p34.3 -0.143 0.276 0.777
mut OSCP1 1p34.3 -0.143 0.276 0.777 transport
mut DNALI1 1p35.1 -0.143 0.276 0.777 cellular component
mut SCMH1 1p34 -0.143 0.276 0.777 gene silencing;negative regulation of
mut C1orf50 1p34.2 -0.143 0.276 0.777
mut GPBP1L1 1p34.1 -0.143 0.276 0.777 regulation of transcription,
DNA-dependent"
mut BTF3L4 1p32.3 -0.143 0.276 0.777
mut COA7 -0.143 0.276 0.777
mut MYSM1 1p32.1 -0.143 0.276 0.777 proteolysis;chromatin modification
mut MIER1 1p31.3 -0.143 0.276 0.777 regulation of transcription, DNA-
mut PIGK 1p31.1 -0.143 0.276 0.777 protein thiol-disulfide exchange;C-
mut HS2ST1 1p22.3 -0.143 0.276 0.777 heparin metabolic
process;ureteric bud formation
mut GBP7 1p22.2 -0.143 0.276 0.777
mut RPAP2 1p22.1 -0.143 0.276 0.777 snRNA
transcription;dephosphorylation of RNA polymerase II C-terminal domain
mut PTBP2 1p21.3 -0.143 0.276 0.777 mRNA splice site selection;mRNA
processing
mut OLFM3 1p22 -0.143 0.276 0.777
mut MYBPHL 1p13.3 -0.143 0.276 0.777
mut KCNA3 1p13.3 -0.143 0.276 0.777 ion transport;potassium ion
transport
mut DDX20 1p21.1-p13.2 -0.143 0.276 0.777 negative regulation of
mut DCLRE1B 1p13.2 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut SYT6 1p13.2 -0.143 0.276 0.777 acrosomal vesicle exocytosis
mut TSPAN2 1p13.2 -0.143 0.276 0.777 brain development
mut TBX15 1p11.1 -0.143 0.276 0.777 embryonic cranial skeleton
morphogenesis
mut TXNIP 1q21.1 -0.143 0.276 0.777 protein import into
signaling pathway
mut ITGA10 1q21 -0.143 0.276 0.777 cell adhesion;cell-matrix adhesion
mut HIST2H2AB -0.143 0.276 0.777 nucleosome assembly
mut SV2A 1q21.2 -0.143 0.276 0.777 neurotransmitter transport;cellular
mut LYSMD1 1q21.3 -0.143 0.276 0.777 cell wall macromolecule
catabolic process
mut PSMD4 1q21.3 -0.143 0.276 0.777 S phase of mitotic cell cycle;DNA
arrest
mut RFX5 1q21 -0.143 0.276 0.777 negative regulation of transcription from
mut MRPL9 1q21 -0.143 0.276 0.777 translation
mut GATAD2B 1q21.3 -0.143 0.276 0.777
mut JTB 1q21 -0.143 0.276 0.777 regulation of cell proliferation;negative
mut TDRD10 1q21.3 -0.143 0.276 0.777
mut LMNA 1q22 -0.143 0.276 0.777 establishment or maintenance of
mut SEMA4A 1q22 -0.143 0.276 0.777 multicellular organismal
mut GLMP -0.143 0.276 0.777 intracellular receptor mediated signaling
mut ARHGEF11 1q21 -0.143 0.276 0.777 Rho protein signal
mut KCNJ10 1q23.2 -0.143 0.276 0.777 response to blue
mut SLAMF1 1q23.3 -0.143 0.276 0.777 positive regulation of cell
proliferation;interspecies interaction between organisms
mut ARHGAP30 1q23.3 -0.143 0.276 0.777 signal transduction;small
mut CFAP126 -0.143 0.276 0.777
mut FCGR2B 1q23 -0.143 0.276 0.777 immune response;signal transduction
mut MPZL1 1q24.2 -0.143 0.276 0.777 transmembrane receptor protein
mut TBX19 1q24.2 -0.143 0.276 0.777 regulation of transcription from
RNA polymerase II promoter;anatomical structure morphogenesis
mut ABL2 1q25.2 -0.143 0.276 0.777 signal transduction;cellular
DNA-dependent"
mut DHX9 1q25 -0.143 0.276 0.777 nuclear mRNA splicing, via
mut RGL1 1q25.3 -0.143 0.276 0.777 signal transduction;small GTPase
mut FAM129A 1q25 -0.143 0.276 0.777 positive regulation of protein
mut KIF14 1q32.1 -0.143 0.276 0.777 microtubule-based movement
mut IKBKE 1q32.1 -0.143 0.276 0.777 Protein Kinases
mut IRF6 1q32.3-q41 -0.143 0.276 0.777 EMT (Epithelial); Tumor Suppressors
mut SDE2 1q42.12 -0.143 0.276 0.777
mut SNAP47 1q42.13 -0.143 0.276 0.777
mut ARV1 1q42.2 -0.143 0.276 0.777 lipid metabolic
mut KIAA1804 1q42 -0.143 0.276 0.777
mut CNST 1q44 -0.143 0.276 0.777 negative regulation of phosphatase
mut ASAP2 2p25 -0.143 0.276 0.777 regulation of ARF GTPase
mut MYCN 2p24.3 -0.143 0.276 0.777 Protein Kinases
mut HADHA 2p23 -0.143 0.276 0.777 cellular lipid metabolic process;small
mut SLC35F6 2p23.3 -0.143 0.276 0.777
mut ZNF513 2p23.3 -0.143 0.276 0.777 visual perception;response to
stimulus
mut SLC4A1AP 2p23.3 -0.143 0.276 0.777 Solute Carriers
mut YPEL5 2p23.1 -0.143 0.276 0.777 oxidation-reduction process
mut LCLAT1 2p23.1 -0.143 0.276 0.777 multicellular organismal
mut CEBPZ 2p22.2 -0.143 0.276 0.777 regulation of transcription, DNA-
mut EML4 2p21 -0.143 0.276 0.777 microtubule-based process;mitosis
mut CCT4 2p15 -0.143 0.276 0.777 protein folding;cellular protein
metabolic process
mut ANXA4 2p13 -0.143 0.276 0.777 Apoptosis
mut ANKRD53 2p13.3 -0.143 0.276 0.777
mut MPHOSPH10 2p13.3 -0.143 0.276 0.777 RNA processing;RNA splicing
mut STAMBP 2p13.1 -0.143 0.276 0.777 proteolysis;anti-apoptosis
mut PCGF1 2p13.1 -0.143 0.276 0.777 regulation of transcription, DNA-
mut HK2 2p13 -0.143 0.276 0.777 Apoptosis
mut TACR1 2p12 -0.143 0.276 0.777 inflammatory response;response to heat
mut DNAH6 2p11.2 -0.143 0.276 0.777 microtubule-based movement
mut PTCD3 2p11.2 -0.143 0.276 0.777
mut LYG1 2q11.2 -0.143 0.276 0.777 cell wall macromolecule catabolic
mut GCC2 2q12.3 -0.143 0.276 0.777 protein transport;recycling
endosome to Golgi transport
mut RANBP2 2q12.3 -0.143 0.276 0.777 protein import into
mut GPR148 -0.143 0.276 0.777
mut ARHGEF4 2q22 -0.143 0.276 0.777 nerve growth factor receptor
mut MGAT5 2q21.3 -0.143 0.276 0.777 protein N-linked
glycosylation;metabolic process
mut RND3 2q23.3 -0.143 0.276 0.777 GTP catabolic process;cell adhesion
mut ARL5A 2q23.3 -0.143 0.276 0.777 small GTPase mediated signal
transduction
mut STK39 2q24.3 -0.143 0.276 0.777 protein phosphorylation;response to
stress
mut KLHL41 2q31.1 -0.143 0.276 0.777
mut CHRNA1 2q31.1 -0.143 0.276 0.777 ion transport;skeletal muscle
tissue growth
mut HOXD13 2q31.1 -0.143 0.276 0.777 anterior/posterior pattern
specification;morphogenesis of an epithelial fold
mut NUP35 2q32.1 -0.143 0.276 0.777 regulation of glucose
mut FAM171B 2q32.1 -0.143 0.276 0.777
mut ANKAR 2q32.2 -0.143 0.276 0.777
mut MSTN 2q32.2 -0.143 0.276 0.777 ovulation cycle process;response to
mut BMPR2 2q33-q34 -0.143 0.276 0.777 transmembrane receptor protein
serine/threonine kinase signaling pathway;negative regulation of cell growth
mut CD28 2q33 -0.143 0.276 0.777 humoral immune response;negative thymic T
cell selection
mut CRYGD -0.143 0.276 0.777
mut ANKZF1 2q35 -0.143 0.276 0.777
mut KCNE4 2q36.1 -0.143 0.276 0.777 ion transport;potassium ion
transport
mut RHBDD1 2q36.3 -0.143 0.276 0.777 proteolysis
mut COPS7B 2q37.1 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut COPS8 2q37.3 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut ING5 2q37.3 -0.143 0.276 0.777 histone H3 acetylation;positive
mut GAL3ST2 2q37.3 -0.143 0.276 0.777 biosynthetic process
mut IL5RA 3p26-p24 -0.143 0.276 0.777 signal transduction;cell
proliferation
mut SETMAR 3p26.1 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut OXTR 3p25 -0.143 0.276 0.777 cell surface receptor signaling
pathway;telencephalon development
mut PRRT3 3p25.3 -0.143 0.276 0.777
mut FANCD2 3p26 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR (FA)
mut TATDN2 3p25.3 -0.143 0.276 0.777 activation of signaling
mut HRH1 3p25 -0.143 0.276 0.777 synaptic transmission;response to gravity
mut CAND2 3p25.2 -0.143 0.276 0.777 positive regulation of
mut MRPS25 3p25 -0.143 0.276 0.777 translation
mut SH3BP5 3p24.3 -0.143 0.276 0.777 signal
mut SATB1 3p23 -0.143 0.276 0.777 interspecies interaction between
mut OXSM 3p24.2 -0.143 0.276 0.777 acyl-CoA metabolic process;short-
mut LRRC3B 3p24 -0.143 0.276 0.777
mut SLC4A7 3p22 -0.143 0.276 0.777 Solute Carriers
mut CCR4 3p24 -0.143 0.276 0.777 neuron migration;tolerance induction
mut UBP1 3p22.3 -0.143 0.276 0.777 angiogenesis;regulation of
mut MYD88 3p22 -0.143 0.276 0.777 Apoptosis; Oncogenes
mut MYRIP 3p22.1 -0.143 0.276 0.777 intracellular protein transport
mut ULK4 3p22.1 -0.143 0.276 0.777
mut ZNF445 3p21.32 -0.143 0.276 0.777 viral reproduction
DNA-dependent"
mut TMIE 3p21 -0.143 0.276 0.777 sensory perception of sound;inner ear
morphogenesis
mut QARS 3p21.31 -0.143 0.276 0.777 tRNA aminoacylation for protein
mut UBA7 3p21 -0.143 0.276 0.777
mut CACNA2D2 3p21.3 -0.143 0.276 0.777 small molecule metabolic
mut RBM15B 3p21.2 -0.143 0.276 0.777 mRNA
processing;nucleocytoplasmic transport
mut GPR62 3p21.1 -0.143 0.276 0.777
mut PDHB 3p21.1-p14.2 -0.143 0.276 0.777 glycolysis;tricarboxylic acid
cycle
mut VGLL3 3p12.1 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ALCAM 3q13.1 -0.143 0.276 0.777 cell adhesion;signal transduction
mut PLCXD2 3q13.2 -0.143 0.276 0.777 lipid catabolic
mut TAGLN3 3q13.2 -0.143 0.276 0.777 central nervous system
mut C3orf17 3q13.2 -0.143 0.276 0.777
mut SIDT1 3q13.2 -0.143 0.276 0.777
mut PLA1A 3q13.13-q13.2 -0.143 0.276 0.777 lipid metabolic
mut PDIA5 3q21.1 -0.143 0.276 0.777
mut C3orf22 3q21.3 -0.143 0.276 0.777
mut RPN1 3q21.3 -0.143 0.276 0.777 translation;protein modification
process
mut PLS1 3q23 -0.143 0.276 0.777
mut P2RY12 3q24-q25 -0.143 0.276 0.777 blood coagulation;hemostasis
mut CCNL1 3q25.31 -0.143 0.276 0.777 regulation of cyclin-dependent
protein kinase activity;regulation of transcription, DNA-dependent
mut NDUFB5 3q26.33 -0.143 0.276 0.777 mitochondrial electron
mut FXR1 3q28 -0.143 0.276 0.777 Apoptosis
mut LIPH 3q27 -0.143 0.276 0.777 lipid catabolic process
mut TRA2B 3q26.2-q27 -0.143 0.276 0.777 response to reactive oxygen
mut SST -0.143 0.276 0.777
mut HRASLS 3q29 -0.143 0.276 0.777
mut IQCG 3q29 -0.143 0.276 0.777
mut DGKQ 4p16.3 -0.143 0.276 0.777 G-protein coupled receptor
signaling pathway;protein kinase C signaling cascade
mut UGDH 4p15.1 -0.143 0.276 0.777 xenobiotic metabolic process;small
mut GRXCR1 4p13 -0.143 0.276 0.777
mut OCIAD2 4p11 -0.143 0.276 0.777
mut PPAT 4q12 -0.143 0.276 0.777 lactation;nucleobase-containing small
mut AMBN 4q21 -0.143 0.276 0.777 cell adhesion;cell proliferation
mut JCHAIN -0.143 0.276 0.777 immune response
mut RASGEF1B 4q21.21 -0.143 0.276 0.777 regulation of small GTPase
mut SCD5 4q21.22 -0.143 0.276 0.777 fatty acid biosynthetic
mut THAP9 4q21.22 -0.143 0.276 0.777
mut HSD17B11 4q22.1 -0.143 0.276 0.777 steroid biosynthetic
mut HERC5 4q22.1 -0.143 0.276 0.777 cytokine-mediated signaling
mut PDLIM5 4q22 -0.143 0.276 0.777 regulation of synapse
mut TBCK 4q24 -0.143 0.276 0.777 protein phosphorylation
mut LRIT3 4q25 -0.143 0.276 0.777
mut TNIP3 4q27 -0.143 0.276 0.777
mut JADE1 -0.143 0.276 0.777 histone H4-K5 acetylation;histone H4-K8
acetylation
mut NAA15 4q31.1 -0.143 0.276 0.777 angiogenesis;N-terminal protein
mut MMAA 4q31.21 -0.143 0.276 0.777
mut ARHGAP10 4q31.23 -0.143 0.276 0.777 regulation of small GTPase
mut MAB21L2 4q31 -0.143 0.276 0.777 multicellular organismal
mut PDGFC 4q32 -0.143 0.276 0.777 positive regulation of DNA
mut CEP72 5p15.33 -0.143 0.276 0.777 mitotic cell cycle;spindle
organization
mut CLPTM1L 5p15.33 -0.143 0.276 0.777 apoptotic process
mut CDH9 5p14 -0.143 0.276 0.777 homophilic cell adhesion;cell-cell
adhesion
mut TARS 5p13.2 -0.143 0.276 0.777 translation;tRNA aminoacylation for
protein translation
mut NADK2 5p13.2 -0.143 0.276 0.777
mut RPL37 5p13 -0.143 0.276 0.777 translational elongation;viral
transcription
mut CDC20B 5q11.2 -0.143 0.276 0.777
mut MIER3 5q11.2 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut HMGCR 5q13.3-q14 -0.143 0.276 0.777 germ cell migration;gonad
development
mut F2RL2 5q13 -0.143 0.276 0.777 blood coagulation;response to wounding
mut ACOT12 5q14.1 -0.143 0.276 0.777 acetyl-CoA metabolic
mut NR2F1 5q14 -0.143 0.276 0.777 neuron migration;regulation of
mut RHOBTB3 5q15 -0.143 0.276 0.777 ATP catabolic process;transport
mut FAM174A 5q21.1 -0.143 0.276 0.777
mut FER 5q21 -0.143 0.276 0.777 cell adhesion;regulation of epidermal
mut CAMK4 5q21.3 -0.143 0.276 0.777 long-term memory;myeloid dendritic
cell cytokine production
mut AP3S1 5q22 -0.143 0.276 0.777 transport;intracellular protein transport
mut FAM170A 5q23.1 -0.143 0.276 0.777
mut LEAP2 5q31.1 -0.143 0.276 0.777 defense response to bacterium
mut GFRA3 5q31.1-q31.3 -0.143 0.276 0.777 neuron development;neuron
migration
mut PAIP2 5q31.2 -0.143 0.276 0.777 regulation of translation;negative
mut TMEM173 5q31.2 -0.143 0.276 0.777 apoptotic process;cellular
response to exogenous dsRNA
mut NRG2 5q23-q33 -0.143 0.276 0.777 signal transduction;embryo
development
mut PURA 5q31 -0.143 0.276 0.777 Apoptosis
mut PCDHB2 5q31 -0.143 0.276 0.777 synaptic transmission;nervous
system development
mut PCDHGA2 5q31 -0.143 0.276 0.777 cell adhesion;homophilic cell
adhesion
mut DIAPH1 5q31 -0.143 0.276 0.777 regulation of microtubule-based
mut RELL2 5q31.3 -0.143 0.276 0.777 positive regulation of cell-
substrate adhesion
mut RBM27 5q32 -0.143 0.276 0.777 mRNA processing
mut AFAP1L1 5q32 -0.143 0.276 0.777
mut DCTN4 5q31-q32 -0.143 0.276 0.777
mut GLRA1 5q32 -0.143 0.276 0.777 startle response;adult walking behavior
mut LARP1 5q33.2 -0.143 0.276 0.777
mut FNDC9 5q33.3 -0.143 0.276 0.777
mut ERGIC1 5q35.1 -0.143 0.276 0.777 ER to Golgi vesicle-mediated
mut SNCB 5q35 -0.143 0.276 0.777 negative regulation of neuron
apoptosis;dopamine metabolic process
mut DDX41 5q35.3 -0.143 0.276 0.777 Apoptosis
mut N4BP3 5q35.3 -0.143 0.276 0.777
mut MYLK4 6p25.2 -0.143 0.276 0.777
mut DSP 6p24 -0.143 0.276 0.777 cell-cell adhesion;peptide cross-linking
mut GCNT2 6p24.2 -0.143 0.276 0.777 glycosaminoglycan biosynthetic
mut NOL7 6p23 -0.143 0.276 0.777
mut RNF182 6p23 -0.143 0.276 0.777 protein ubiquitination
mut JARID2 6p24-p23 -0.143 0.276 0.777 multicellular organismal
mut TPMT 6p22.3 -0.143 0.276 0.777 nucleobase-containing compound
metabolic process;xenobiotic metabolic process
mut DEK 6p22.3 -0.143 0.276 0.777 regulation of transcription from
mut CDKAL1 6p22.3 -0.143 0.276 0.777 RNA modification
mut ACOT13 6p22.3 -0.143 0.276 0.777 protein homotetramerization
mut HIST1H1T 6p21.3 -0.143 0.276 0.777 spermatogenesis;binding of
sperm to zona pellucida
mut HIST1H4F 6p22.1 -0.143 0.276 0.777
mut HIST1H2BI 6p22.1 -0.143 0.276 0.777
mut HIST1H3I 6p22.1 -0.143 0.276 0.777
mut ZSCAN9 6p21.3 -0.143 0.276 0.777
mut IP6K3 6p21.31 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut DEF6 6p21.33-p21.1 -0.143 0.276 0.777
mut BRPF3 6p21 -0.143 0.276 0.777 blood coagulation;chromatin modification
mut CMTR1 -0.143 0.276 0.777 mRNA capping;mRNA methylation
mut NFYA 6p21.3 -0.143 0.276 0.777 regulation of transcription, DNA-
mut BYSL 6p21.1 -0.143 0.276 0.777 cell adhesion;female pregnancy
mut DLK2 6p21.1 -0.143 0.276 0.777 regulation of fat cell
differentiation
mut LRRC73 6p21.1 -0.143 0.276 0.777
mut POLR1C 6p21.1 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut ENPP5 6p21.1-p11.2 -0.143 0.276 0.777 cell communication
mut OPN5 6p12.3 -0.143 0.276 0.777 protein-chromophore
mut B3GAT2 6q13 -0.143 0.276 0.777
mut OGFRL1 6q13 -0.143 0.276 0.777
mut RRAGD 6q15-q16 -0.143 0.276 0.777 positive regulation of TOR
signaling cascade;cellular protein localization
mut UFL1 6q16.1 -0.143 0.276 0.777 negative regulation of protein
mut POU3F2 6q16 -0.143 0.276 0.777 cerebral cortex radially oriented
cell migration;regulation of axonogenesis
mut HACE1 6q16.3 -0.143 0.276 0.777 protein ubiquitination;Rac protein
signal transduction
mut SOBP 6q21 -0.143 0.276 0.777 sensory perception of sound;locomotory
behavior
mut OSTM1 6q21 -0.143 0.276 0.777 osteoclast differentiation
mut SLC16A10 6q21-q22 -0.143 0.276 0.777 Solute Carriers
mut FAM162B 6q22.1 -0.143 0.276 0.777
mut CLVS2 6q22.31 -0.143 0.276 0.777
mut TAAR8 -0.143 0.276 0.777
mut VTA1 6q24.1 -0.143 0.276 0.777 endosome transport;protein
transport
mut STX11 6q24.2 -0.143 0.276 0.777 intracellular protein
mut KATNA1 6q25.1 -0.143 0.276 0.777 mitosis;protein localization
mut RAET1E 6q25.1 -0.143 0.276 0.777 immune response;antigen
mut PLEKHG1 6q25.1 -0.143 0.276 0.777 regulation of Rho protein
signal transduction
mut ARID1B 6q25.1 -0.143 0.276 0.777 DNA Damage Response (DDR);
DDR (Chromatin)
mut TMEM242 6q25.3 -0.143 0.276 0.777
mut FRMD1 6q27 -0.143 0.276 0.777
mut GPR146 7p22.3 -0.143 0.276 0.777
mut EIF3B 7p22.3 -0.143 0.276 0.777 translation;translational
initiation
mut WIPI2 7p22.1 -0.143 0.276 0.777 autophagic vacuole fusion;autophagy
mut ZDHHC4 7p22.1 -0.143 0.276 0.777
mut SOSTDC1 7p21.1 -0.143 0.276 0.777 pattern specification
process;Wnt receptor signaling pathway
mut AHR 7p15 -0.143 0.276 0.777 Apoptosis
mut NPY 7p15.1 -0.143 0.276 0.777 G-protein signaling, coupled to
mut HNRNPA2B1 7p15 -0.143 0.276 0.777 RNA transport;nuclear mRNA
mut HOXA3 7p15.2 -0.143 0.276 0.777 glossopharyngeal nerve
mut POLD2 7p13 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR (BER); DDR
(DNA replication)
mut TNS3 7p12.3 -0.143 0.276 0.777 positive regulation of cell
DNA-dependent"
mut ASL 7q11.21 -0.143 0.276 0.777 argininosuccinate metabolic
mut GNAI1 7q21 -0.143 0.276 0.777 inhibition of adenylate cyclase activity
mut KIAA1324L 7q21.12 -0.143 0.276 0.777
mut GNGT1 7q21.3 -0.143 0.276 0.777 synaptic
mut DLX5 7q22 -0.143 0.276 0.777 multicellular organismal development;ear
development
mut TMEM130 7q22.1 -0.143 0.276 0.777
mut ARPC1A 7q22.1 -0.143 0.276 0.777 actin cytoskeleton
mut ZNF394 7q22.1 -0.143 0.276 0.777 viral reproduction
mut TRIM56 7q22.1 -0.143 0.276 0.777 interferon-beta
production;response to type I interferon
mut KMT2E 7q22.1 -0.143 0.276 0.777
mut DNAJB9 7q31 -0.143 0.276 0.777 protein folding;activation of
mut CAPZA2 7q31.2-q31.3 -0.143 0.276 0.777 actin cytoskeleton
organization;innate immune response
mut FAM71F1 7q32.1 -0.143 0.276 0.777
mut CEP41 7q32 -0.143 0.276 0.777 G2/M transition of mitotic cell
mut TBXAS1 7q34-q35 -0.143 0.276 0.777 fatty acid biosynthetic
mut OR9A2 7q34 -0.143 0.276 0.777 response to stimulus
mut OR6B1 7q35 -0.143 0.276 0.777
mut ZNF746 7q36.1 -0.143 0.276 0.777 regulation of cell
death;negative regulation of transcription, DNA-dependent
mut LRRC61 7q31-q35 -0.143 0.276 0.777
mut RARRES2 7q36.1 -0.143 0.276 0.777 retinoid metabolic process;in
utero embryonic development
DNA-dependent"
mut PRKAG2 7q36.1 -0.143 0.276 0.777 negative regulation of
mut LZTS1 8p22 -0.143 0.276 0.777 transcription elongation from RNA
polymerase III promoter;termination of RNA polymerase III transcription
mut FGF17 8p21 -0.143 0.276 0.777 cell-cell signaling;multicellular
mut PEBP4 8p21.3 -0.143 0.276 0.777
mut NEFM 8p21 -0.143 0.276 0.777
mut EBF2 8p21.2 -0.143 0.276 0.777 regulation of transcription, DNA-
mut DPYSL2 8p22-p21 -0.143 0.276 0.777 pyrimidine base catabolic
process;spinal cord development
mut TRIM35 8p21.2 -0.143 0.276 0.777 positive regulation of
apoptotic process;negative regulation of mitotic cell cycle
mut SCARA3 8p21 -0.143 0.276 0.777 response to oxidative stress;UV
protection
mut SCARA5 8p21.1 -0.143 0.276 0.777 cellular response to
heat;iron ion transmembrane transport
mut PROSC 8p11.2 -0.143 0.276 0.777
mut FGFR1 8p11.23-p11.22 -0.143 0.276 0.777 positive regulation of cell
proliferation;chordate embryonic development
mut HTRA4 8p11.22 -0.143 0.276 0.777 regulation of cell
growth;proteolysis
mut ADAM2 8p11.2 -0.143 0.276 0.777 proteolysis;cell adhesion
mut UBE2V2 8q11.21 -0.143 0.276 0.777 DNA Damage Response (DDR);
DDR (TLS)
mut SOX17 8q11.23 -0.143 0.276 0.777 Cell Signaling
mut PENK 8q23-q24 -0.143 0.276 0.777 behavioral fear response;signal
transduction
mut GGH 8q12.3 -0.143 0.276 0.777 response to insulin
mut EYA1 8q13.3 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut TMEM70 8q21.11 -0.143 0.276 0.777 mitochondrial proton-
transporting ATP synthase complex assembly
mut PI15 8q21.11 -0.143 0.276 0.777
mut ZNF704 8q21.13 -0.143 0.276 0.777
mut RMDN1 8q21.3 -0.143 0.276 0.777
mut CNGB3 8q21.3 -0.143 0.276 0.777 cation transport;signal
transduction
mut OSGIN2 8q21 -0.143 0.276 0.777 meiosis;germ cell development
mut KIAA1429 8q22.1 -0.143 0.276 0.777 RNA splicing;mRNA processing
mut PLEKHF2 8q22.1 -0.143 0.276 0.777
mut NIPAL2 8q22.2 -0.143 0.276 0.777
mut ATP6V1C1 8q22.3 -0.143 0.276 0.777 transport;cellular iron ion
homeostasis
mut ENPP2 8q24.1 -0.143 0.276 0.777 phosphatidylcholine catabolic
mut ATAD2 8q24.13 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut FAM49B 8q24.21 -0.143 0.276 0.777
mut PTP4A3 8q24.3 -0.143 0.276 0.777
mut GPAA1 8q24.3 -0.143 0.276 0.777 C-terminal protein
lipidation;protein retention in ER lumen
mut SCRT1 8q24.3 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ZNF16 8q24 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut PLGRKT 9p24.1 -0.143 0.276 0.777 positive regulation of
mut ERMP1 9p24 -0.143 0.276 0.777 ovarian follicle development;proteolysis
mut RANBP6 9p24.1 -0.143 0.276 0.777 protein transport
mut TYRP1 9p23 -0.143 0.276 0.777 acetoacetic acid metabolic
mut ZDHHC21 9p22.3 -0.143 0.276 0.777 small molecule metabolic
mut SNAPC3 9p22.3 -0.143 0.276 0.777 regulation of transcription,
mut HACD4 -0.143 0.276 0.777 fatty acid biosynthetic process
mut BAG1 9p12 -0.143 0.276 0.777 Apoptosis
mut UBAP1 9p13.3 -0.143 0.276 0.777
mut MSMP 9p13.3 -0.143 0.276 0.777
mut MELK 9p13.2 -0.143 0.276 0.777 hemopoiesis;positive regulation of
apoptotic process
mut IGFBPL1 9p13.1 -0.143 0.276 0.777 regulation of cell growth
mut KLF9 9q13 -0.143 0.276 0.777 regulation of transcription from RNA
mut RFK 9q21.13 -0.143 0.276 0.777 riboflavin biosynthetic
mut RASEF 9q21.32 -0.143 0.276 0.777 small GTPase mediated signal
mut IARS 9q21 -0.143 0.276 0.777 gene expression;tRNA aminoacylation for
protein translation
mut CORO2A 9q22.3 -0.143 0.276 0.777 actin cytoskeleton
mut INVS 9q31 -0.143 0.276 0.777 pancreas development;embryonic heart tube
left/right pattern formation
mut MURC 9q31.1 -0.143 0.276 0.777 positive regulation of
dependent
mut TAL2 9q32 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent;behavior
mut TMEM245 9q31 -0.143 0.276 0.777
mut PTBP3 9q32 -0.143 0.276 0.777 mRNA processing;anatomical structure
morphogenesis
mut BSPRY 9q32 -0.143 0.276 0.777 EMT (Epithelial)
mut OLFML2A 9q33.3 -0.143 0.276 0.777 extracellular matrix
organization
mut WDR38 9q33.3 -0.143 0.276 0.777
mut ANGPTL2 9q34 -0.143 0.276 0.777 signal transduction;multicellular
mut TBC1D13 9q34.11 -0.143 0.276 0.777
mut PRRX2 9q34.1 -0.143 0.276 0.777 embryonic limb morphogenesis;inner
ear morphogenesis
mut C9orf78 9q34.11 -0.143 0.276 0.777
mut NCS1 9q34 -0.143 0.276 0.777 positive regulation of
mut RALGDS 9q34.3 -0.143 0.276 0.777 Ras protein signal
mut SLC2A6 9q34 -0.143 0.276 0.777 Solute Carriers
mut TRAF2 9q34 -0.143 0.276 0.777 Apoptosis
mut ENTPD2 9q34 -0.143 0.276 0.777 purine ribonucleoside diphosphate
catabolic process;platelet activation
mut SAPCD2 9q34.3 -0.143 0.276 0.777
mut TPRN 9q34.3 -0.143 0.276 0.777 sensory perception of sound
mut CALML3 10p15.1 -0.143 0.276 0.777
mut ANKRD16 10p15.1 -0.143 0.276 0.777
mut SEPHS1 10p14 -0.143 0.276 0.777 protein modification process
mut NMT2 10p13 -0.143 0.276 0.777 N-terminal protein myristoylation;protein
lipoylation
mut CSGALNACT2 10q11.21 -0.143 0.276 0.777 proteoglycan biosynthetic
process;chondroitin sulfate proteoglycan biosynthetic process
mut C10orf10 10q11.21 -0.143 0.276 0.777
mut HNRNPH3 10q22 -0.143 0.276 0.777 nuclear mRNA splicing, via
mut STOX1 10q22.1 -0.143 0.276 0.777
mut NODAL 10q22.1 -0.143 0.276 0.777 heart looping;polarity
specification of proximal/distal axis
mut SGPL1 10q21 -0.143 0.276 0.777 Apoptosis
mut PPP3CB 10q22.2 -0.143 0.276 0.777 negative regulation of T cell
mut AP3M1 10q22.2 -0.143 0.276 0.777 protein targeting to
mut DUPD1 10q22.2 -0.143 0.276 0.777 protein dephosphorylation
mut SAMD8 10q22.2 -0.143 0.276 0.777 lipid metabolic
mut TSPAN14 10q23.1 -0.143 0.276 0.777
mut GHITM 10q23.1 -0.143 0.276 0.777 apoptotic process
mut LIPJ 10q23.31 -0.143 0.276 0.777 lipid catabolic process
mut IFIT5 10q23.31 -0.143 0.276 0.777
mut PANK1 10q23.31 -0.143 0.276 0.777 small molecule metabolic
mut CPEB3 10q23.32 -0.143 0.276 0.777
mut CYP2C9 10q24 -0.143 0.276 0.777 monoterpenoid metabolic
mut ALDH18A1 10q24.3 -0.143 0.276 0.777 small molecule metabolic
mut PI4K2A 10q24 -0.143 0.276 0.777 phosphatidylinositol biosynthetic
process
mut AVPI1 10q24.2 -0.143 0.276 0.777 cell cycle;activation of MAPK
activity
mut CPN1 10q24.2 -0.143 0.276 0.777 response to glucocorticoid
stimulus;proteolysis
mut MGEA5 10q24.1-q24.3 -0.143 0.276 0.777 N-acetylglucosamine metabolic
mut C10orf76 10q24.32 -0.143 0.276 0.777
mut SFXN2 10q24.32 -0.143 0.276 0.777 iron ion homeostasis;transmembrane
transport
mut PCGF6 10q24.33 -0.143 0.276 0.777 negative regulation of
mut ADRA2A 10q25.2 -0.143 0.276 0.777 signal transduction;actin
mut ADRB1 10q25.3 -0.143 0.276 0.777 positive regulation of heart rate
by epinephrine-norepinephrine;activation of adenylate cyclase activity
mut HTRA1 10q26.3 -0.143 0.276 0.777 regulation of cell
growth;proteolysis
mut ZRANB1 10q26.13 -0.143 0.276 0.777 protein K63-linked
deubiquitination;protein deubiquitination involved in ubiquitin-dependent protein
catabolic process
mut STK32C 10q26.3 -0.143 0.276 0.777
mut INPP5A 10q26.3 -0.143 0.276 0.777 cell
communication;phosphatidylinositol phosphorylation
mut ANO9 11p15.5 -0.143 0.276 0.777 ion transport
mut NUP98 11p15.5 -0.143 0.276 0.777 M phase of mitotic cell
cycle;regulation of glucose transport
mut OR51E1 11p15.4 -0.143 0.276 0.777 response to stimulus
mut TAF10 11p15.3 -0.143 0.276 0.777 transcription from RNA polymerase
mut TMEM41B 11p15.4 -0.143 0.276 0.777
mut CTR9 11p15.3 -0.143 0.276 0.777 histone monoubiquitination;histone
H2B ubiquitination
mut MYOD1 11p15.4 -0.143 0.276 0.777 regulation of transcription from
RNA polymerase II promoter;skeletal muscle cell differentiation
mut TMEM86A 11p15.1 -0.143 0.276 0.777
mut PRMT3 11p15.1 -0.143 0.276 0.777 peptidyl-arginine N-methylation
mut LGR4 11p14-p13 -0.143 0.276 0.777 male genitalia
mut DCDC1 11p13 -0.143 0.276 0.777 intracellular signal transduction
mut COMMD9 11p13 -0.143 0.276 0.777
mut ACCS 11p11 -0.143 0.276 0.777 biosynthetic process
mut ACP2 11p11.2 -0.143 0.276 0.777 skeletal system
development;lysosome organization
mut CELF1 11p11 -0.143 0.276 0.777 mRNA splice site selection;mRNA
processing
mut OR5D13 -0.143 0.276 0.777
mut OR5T2 -0.143 0.276 0.777 response to stimulus
mut RTN4RL2 11q12.1 -0.143 0.276 0.777 axon regeneration
mut FAM111A 11q12.1 -0.143 0.276 0.777
mut CCDC86 11q12.2 -0.143 0.276 0.777 interspecies interaction
between organisms
mut SCGB1D1 -0.143 0.276 0.777
mut EML3 11q12.3 -0.143 0.276 0.777
mut GANAB 11q12.3 -0.143 0.276 0.777 carbohydrate metabolic
mut LBHD1 -0.143 0.276 0.777
mut FLRT1 11q13.1 -0.143 0.276 0.777 cell adhesion
mut TRPT1 11q13.1 -0.143 0.276 0.777 tRNA splicing, via endonucleolytic
cleavage and ligation"
mut CCDC88B 11q12.3 -0.143 0.276 0.777 microtubule cytoskeleton
organization
mut EHD1 11q13 -0.143 0.276 0.777 protein homooligomerization;intracellular
protein transport
mut FRMD8 11q13 -0.143 0.276 0.777
mut TMEM151A 11q13.2 -0.143 0.276 0.777
mut RBM14 11q13.2 -0.143 0.276 0.777 glucocorticoid receptor signaling
mut PC 11q13.4-q13.5 -0.143 0.276 0.777 carbohydrate metabolic
mut PTPRCAP 11q13.3 -0.143 0.276 0.777 defense response
mut CABP4 11q13.2 -0.143 0.276 0.777 photoreceptor cell
mut CPT1A 11q13.2 -0.143 0.276 0.777 positive regulation of fatty acid
mut OR2AT4 11q13.4 -0.143 0.276 0.777
mut SERPINH1 11q13.5 -0.143 0.276 0.777 response to stress;response
to unfolded protein
mut TSKU 11q13.5 -0.143 0.276 0.777
mut RSF1 11q14.1 -0.143 0.276 0.777 nucleosome positioning;CenH3-
mut ME3 11cen-q22.3 -0.143 0.276 0.777 oxidation-reduction process;oxygen
metabolic process
mut CHORDC1 11q14.3 -0.143 0.276 0.777 regulation of centrosome
mut PANX1 11q21 -0.143 0.276 0.777 calcium ion transport;positive regulation
of interleukin-1 beta secretion
mut BIRC3 11q22 -0.143 0.276 0.777 Apoptosis
mut MSANTD4 11q22 -0.143 0.276 0.777
mut C11orf87 11q22.3 -0.143 0.276 0.777
mut PPP2R1B 11q23.2 -0.143 0.276 0.777 Apoptosis
mut PIH1D2 11q23.1 -0.143 0.276 0.777
mut ZPR1 -0.143 0.276 0.777 signal transduction;cell proliferation
mut CEP164 11q23.3 -0.143 0.276 0.777 mitotic cell cycle;DNA repair
mut TMEM25 11q23.3 -0.143 0.276 0.777
mut HYOU1 11q23.1-q23.3 -0.143 0.276 0.777 response to stress;activation
mut C2CD2L 11q23.3 -0.143 0.276 0.777
mut HEPACAM 11q24.2 -0.143 0.276 0.777 cell cycle;cell cycle arrest
mut PUS3 11q24.2 -0.143 0.276 0.777 tRNA processing;tRNA pseudouridine
synthesis
mut RPUSD4 11q24.2 -0.143 0.276 0.777 pseudouridine synthesis
mut ST3GAL4 11q24.2 -0.143 0.276 0.777 cellular protein metabolic
mut ST14 11q24-q25 -0.143 0.276 0.777 EMT (Epithelial)
mut SNX19 11q25 -0.143 0.276 0.777 protein transport;cell communication
mut ACAD8 11q25 -0.143 0.276 0.777 regulation of transcription, DNA-
mut SLC6A12 12p13 -0.143 0.276 0.777 Solute Carriers
mut ADIPOR2 12p13.31 -0.143 0.276 0.777 lipid metabolic
mut ING4 12p13.31 -0.143 0.276 0.777 Tumor Suppressors
mut CLEC6A -0.143 0.276 0.777
mut GABARAPL1 12p13.2 -0.143 0.276 0.777
mut SPX -0.143 0.276 0.777
mut PCED1B 12q13.11 -0.143 0.276 0.777
mut H1FNT 12q13.11 -0.143 0.276 0.777
mut FMNL3 12q13.12 -0.143 0.276 0.777 cell migration;actin cytoskeleton
organization
mut ASIC1 12q12 -0.143 0.276 0.777 transport;ion transport
mut NR4A1 12q13 -0.143 0.276 0.777 gene expression;intracellular receptor
mut KRT80 12q13.13 -0.143 0.276 0.777
mut TARBP2 12q13.13 -0.143 0.276 0.777 negative regulation of
mut OR6C6 -0.143 0.276 0.777 response to stimulus
mut MMP19 12q14 -0.143 0.276 0.777 Apoptosis
mut ZC3H10 12q13.2 -0.143 0.276 0.777
mut NABP2 12q13.3 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut ATP5B 12q13.13 -0.143 0.276 0.777 ADP biosynthetic process;ATP
mut AGAP2 12q14.1 -0.143 0.276 0.777 axon guidance;protein transport
mut SRGAP1 12q14.2 -0.143 0.276 0.777 signal transduction;small
mut TBK1 12q14.1 -0.143 0.276 0.777 response to virus;TRIF-dependent
toll-like receptor signaling pathway
mut LGR5 12q22-q23 -0.143 0.276 0.777 G-protein coupled receptor
signaling pathway
mut MYF6 12q21 -0.143 0.276 0.777 regulation of transcription from RNA
promoter
mut PRDM4 12q23-q24.1 -0.143 0.276 0.777 signal transduction;cell
proliferation
mut TRAFD1 12q -0.143 0.276 0.777 response to cytokine
stimulus;negative regulation of innate immune response
mut TCTN2 12q24.31 -0.143 0.276 0.777 cell projection organization;cilium
assembly
mut DDX51 12q24.33 -0.143 0.276 0.777 rRNA processing
mut GALNT9 12q24.33 -0.143 0.276 0.777 O-glycan processing;post-
mut PSPC1 13q12.11 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut IL17D 13q11 -0.143 0.276 0.777 inflammatory response
mut LATS2 13q11-q12 -0.143 0.276 0.777 protein phosphorylation;negative
mut SHISA2 13q12.13 -0.143 0.276 0.777 multicellular organismal
development
mut HSPH1 13q12.3 -0.143 0.276 0.777 response to stress;response to
unfolded protein
mut WBP4 13q14.11 -0.143 0.276 0.777 mRNA processing;RNA splicing
mut MTRF1 13q14.1-q14.3 -0.143 0.276 0.777 regulation of translational
termination
mut RGCC 13q14.11 -0.143 0.276 0.777 regulation of cyclin-dependent
protein kinase activity;cell cycle
mut ENOX1 13q14.11 -0.143 0.276 0.777 transport;electron transport chain
mut ESD 13q14.1-q14.2 -0.143 0.276 0.777 metabolic process
mut ARL11 13q14.2 -0.143 0.276 0.777 small GTPase mediated signal
transduction
mut NEK5 13q14.3 -0.143 0.276 0.777
mut LMO7 13q22.2 -0.143 0.276 0.777 protein ubiquitination
mut POU4F1 13q31.1 -0.143 0.276 0.777 synapse assembly;positive
mut GPC5 13q32 -0.143 0.276 0.777
mut ZIC2 13q32 -0.143 0.276 0.777 retinal ganglion cell axon
guidance;negative regulation of transcription, DNA-dependent
mut DCUN1D2 13q34 -0.143 0.276 0.777
mut NGDN 14q11.2 -0.143 0.276 0.777 regulation of translation
mut IRF9 14q11.2 -0.143 0.276 0.777 type I interferon-mediated
mut LTB4R2 14q12 -0.143 0.276 0.777 chemotaxis;signal transduction
mut KHNYN 14q12 -0.143 0.276 0.777
mut FOXG1 14q13 -0.143 0.276 0.777 Apoptosis
mut SCFD1 14q12 -0.143 0.276 0.777 response to hypoxia;retrograde vesicle-
mediated transport, Golgi to ER
mut PAX9 14q13.3 -0.143 0.276 0.777 face morphogenesis;cellular
response to growth factor stimulus
mut SEC23A 14q21.1 -0.143 0.276 0.777 protein N-linked
mut SAMD4A 14q22.2 -0.143 0.276 0.777 negative regulation of
mut PELI2 14q21 -0.143 0.276 0.777 toll-like receptor 1 signaling
mut GPR135 14q23.1 -0.143 0.276 0.777
mut DHRS7 14q23.1 -0.143 0.276 0.777
mut COQ6 14q24.3 -0.143 0.276 0.777 ubiquinone biosynthetic process
mut BATF 14q24.3 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut SEL1L 14q31 -0.143 0.276 0.777 Notch signaling pathway
mut RIN3 14q32.12 -0.143 0.276 0.777 endocytosis;signal transduction
mut SERPINA6 14q32.1 -0.143 0.276 0.777 regulation of
mut AK7 14q32.2 -0.143 0.276 0.777 nucleobase-containing compound
metabolic process;cell projection organization
mut C14orf79 14q32.33 -0.143 0.276 0.777
mut ATP10A 15q11.2 -0.143 0.276 0.777 cation transport;regulation
of cell shape
mut LPCAT4 15q14 -0.143 0.276 0.777 metabolic process;phospholipid
mut EXD1 15q15.1 -0.143 0.276 0.777 nucleobase-containing compound
metabolic process
mut NDUFAF1 15q11.2-q21.3 -0.143 0.276 0.777 mitochondrial electron
mut BLOC1S6 15q21.1 -0.143 0.276 0.777
mut SQRDL 15q15 -0.143 0.276 0.777 sulfur amino acid metabolic
mut COPS2 15q21.2 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut CGNL1 15q21.3 -0.143 0.276 0.777
mut USP3 15q22.3 -0.143 0.276 0.777 proteolysis;ubiquitin-dependent
mut PLEKHO2 15q22.1 -0.143 0.276 0.777
mut THSD4 15q23 -0.143 0.276 0.777 elastic fiber assembly
mut CYP1A2 15q24.1 -0.143 0.276 0.777 steroid catabolic
mut CSK 15q24.1 -0.143 0.276 0.777 Apoptosis
mut ISL2 15q23 -0.143 0.276 0.777 multicellular organismal
mut ARNT2 15q24 -0.143 0.276 0.777 positive regulation of transcription,
mut MESDC2 15q13 -0.143 0.276 0.777 protein folding;mesoderm
development
mut MESDC1 15q13 -0.143 0.276 0.777
mut STARD5 15q26 -0.143 0.276 0.777 C21-steroid hormone biosynthetic
process;transport
mut C15orf40 15q25.2 -0.143 0.276 0.777
mut HDGFRP3 15q25.2 -0.143 0.276 0.777
mut MRPS11 15q25 -0.143 0.276 0.777 translation;DNA damage response,
mut LRRC28 15q26.3 -0.143 0.276 0.777
mut LRRK1 15q26.3 -0.143 0.276 0.777 small GTPase mediated signal
transduction
mut FAM234A -0.143 0.276 0.777
mut ARHGDIG 16p13.3 -0.143 0.276 0.777 regulation of small GTPase
mut MAPK8IP3 16p13.3 -0.143 0.276 0.777 respiratory gaseous
mut TRAF7 16p13.3 -0.143 0.276 0.777 protein ubiquitination;regulation
mut CASKIN1 16p13.3 -0.143 0.276 0.777 signal transduction
mut TCEB2 16p12.3 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR
(NER)
mut PRSS22 16p13.3 -0.143 0.276 0.777 proteolysis
mut ERCC4 16p13.12 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR
(NER)
mut SYT17 16p12.3 -0.143 0.276 0.777
mut SCNN1B 16p12.2-p12.1 -0.143 0.276 0.777 ion transport;sodium ion
transport
mut ARHGAP17 16p12.1 -0.143 0.276 0.777 actin filament
mut NSMCE1 16p12.1 -0.143 0.276 0.777 DNA Damage Response (DDR);
DDR (HR)
mut ATXN2L -0.143 0.276 0.777
mut MAZ 16p11.2 -0.143 0.276 0.777 regulation of transcription, DNA-
mut TBX6 16p11.2 -0.143 0.276 0.777 mesoderm development;anatomical
mut CCDC189 -0.143 0.276 0.777
mut MT1H -0.143 0.276 0.777 cellular zinc ion homeostasis;nitric
mut LRRC36 16q22.1 -0.143 0.276 0.777
mut NRN1L 16q22.1 -0.143 0.276 0.777
mut COG4 16q22.1 -0.143 0.276 0.777 Golgi vesicle prefusion complex
mut IL34 16q22.1 -0.143 0.276 0.777 positive regulation of protein
phosphorylation;inflammatory response
mut VAC14 16q22.1 -0.143 0.276 0.777 signal transduction;interspecies
mut DHODH 16q22 -0.143 0.276 0.777 nucleobase-containing small molecule
mut CRISPLD2 16q24.1 -0.143 0.276 0.777
mut KIAA0513 16q24.1 -0.143 0.276 0.777
mut WDR81 17p13.3 -0.143 0.276 0.777 negative regulation of phosphatase
activity
mut TRPV3 17p13.2 -0.143 0.276 0.777 cation transport;response to
temperature stimulus
mut MYBBP1A 17p13.3 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut ZMYND15 17p13.2 -0.143 0.276 0.777 spermatogenesis;cell
differentiation
mut RABEP1 17p13.2 -0.143 0.276 0.777 Apoptosis
mut AIPL1 17p13.1 -0.143 0.276 0.777 phototransduction, visible
light;protein farnesylation
mut ZBTB4 17p13.1 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ALOX12B 17p13.1 -0.143 0.276 0.777 lipid metabolic
mut PER1 17p13.1 -0.143 0.276 0.777 DNA Damage Response (DDR)
mut TRPV2 17p11.2 -0.143 0.276 0.777 response to heat;ion transmembrane
transport
mut FAM83G 17p11.2 -0.143 0.276 0.777
mut FOXN1 17q11-q12 -0.143 0.276 0.777 organ morphogenesis;keratinocyte
differentiation
mut PIGS 17p13.2 -0.143 0.276 0.777 C-terminal protein
lipidation;attachment of GPI anchor to protein
mut ABHD15 17q11.2 -0.143 0.276 0.777
mut GIT1 17p11.2 -0.143 0.276 0.777 regulation of G-protein coupled
mut RFFL 17q12 -0.143 0.276 0.777 intracellular protein transport;apoptotic
process
mut RASL10B 17q12 -0.143 0.276 0.777 signal transduction;small GTPase
mut AATF 17q12 -0.143 0.276 0.777 embryonic cleavage;apoptotic process
mut PLXDC1 17q21.1 -0.143 0.276 0.777 angiogenesis;spinal cord
development
mut STAC2 17q12 -0.143 0.276 0.777 intracellular signal transduction
mut ORMDL3 17q12 -0.143 0.276 0.777 ceramide metabolic process
mut KRTAP4-3 17q21.2 -0.143 0.276 0.777
mut KRT13 17q21.2 -0.143 0.276 0.777 tongue morphogenesis;cellular
mut GHDC 17q21.2 -0.143 0.276 0.777
mut AOC2 17q21 -0.143 0.276 0.777 catecholamine metabolic process;visual
perception
mut SOST 17q11.2 -0.143 0.276 0.777 response to mechanical
stimulus;negative regulation of ossification
mut G6PC3 17q21.31 -0.143 0.276 0.777 carbohydrate metabolic
mut HDAC5 17q21 -0.143 0.276 0.777 chromatin remodeling;cellular response to
insulin stimulus
mut CDK5RAP3 17q21.32 -0.143 0.276 0.777 regulation of cyclin-
mut NFE2L1 17q21.3 -0.143 0.276 0.777 heme biosynthetic
mut GIP 17q21.3-q22 -0.143 0.276 0.777 response to selenium ion;positive
mut MKS1 17q22 -0.143 0.276 0.777 cilium morphogenesis;cell projection
organization
mut PPM1E 17q22 -0.143 0.276 0.777 negative regulation of protein kinase
mut ARSG 17q24.2 -0.143 0.276 0.777 sulfur compound metabolic process
mut SLC39A11 17q24.3-q25.1 -0.143 0.276 0.777 Solute Carriers
mut DNAI2 17q25 -0.143 0.276 0.777 cell projection organization;cilium
assembly
mut SAP30BP 17q25.1 -0.143 0.276 0.777 Apoptosis
mut SPHK1 17q25.2 -0.143 0.276 0.777 calcium-mediated signaling;cellular
mut SEC14L1 17q25.2 -0.143 0.276 0.777 transport
mut SGSH 17q25.3 -0.143 0.276 0.777 proteoglycan metabolic process
mut ANAPC11 17q25.3 -0.143 0.276 0.777 mitosis;protein K11-linked
ubiquitination
mut PYCR1 17q25.3 -0.143 0.276 0.777 response to stress;cellular amino
mut CD7 17q25.2-q25.3 -0.143 0.276 0.777 homeostasis of number of
mut HEXDC 17q25.3 -0.143 0.276 0.777 carbohydrate metabolic process
mut ZBTB14 18p11.31 -0.143 0.276 0.777
mut LRRC30 18p11.23 -0.143 0.276 0.777
mut TUBB6 18p11.21 -0.143 0.276 0.777 microtubule-based movement;cellular
mut FAM210A 18p11.21 -0.143 0.276 0.777
mut GATA6 18q11.1-q11.2 -0.143 0.276 0.777 pancreatic A cell
mut NPC1 18q11.2 -0.143 0.276 0.777 autophagy;lysosomal transport
mut ACAA2 18q21.1 -0.143 0.276 0.777 acetyl-CoA metabolic process;lipid
metabolic process
mut CFAP53 -0.143 0.276 0.777
mut MBD1 18q21 -0.143 0.276 0.777 regulation of transcription, DNA-
mut CXXC1 18q12 -0.143 0.276 0.777 regulation of transcription, DNA-
response
mut ZADH2 18q22.3 -0.143 0.276 0.777
mut MIER2 19p13.3 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut TPGS1 19p13.3 -0.143 0.276 0.777 adult behavior;multicellular
mut BSG 19p13.3 -0.143 0.276 0.777 lactate transmembrane
mut MED16 19p13.3 -0.143 0.276 0.777 positive regulation of
promoter
mut MUM1 19p13.3 -0.143 0.276 0.777 DNA repair;chromatin organization
mut AMH 19p13.3 -0.143 0.276 0.777 sex determination;sex
differentiation
DNA-dependent"
mut NCLN 19p13.3 -0.143 0.276 0.777 regulation of signal
mut GIPC3 19p13.3 -0.143 0.276 0.777
mut C19orf70 19p13.3 -0.143 0.276 0.777
mut MLLT1 19p13.3 -0.143 0.276 0.777 negative regulation of protein
mut C19orf45 19p13.2 -0.143 0.276 0.777
DNA-dependent"
mut KANK2 19p13.2 -0.143 0.276 0.777
mut TSPAN16 19p13.2 -0.143 0.276 0.777
mut ELAVL3 19p13.2 -0.143 0.276 0.777 multicellular organismal
DNA-dependent"
mut GADD45GIP1 19p13.2 -0.143 0.276 0.777 cell cycle;interspecies
mut C19orf53 19p13.2 -0.143 0.276 0.777
mut ADGRL1 -0.143 0.276 0.777 G-protein coupled receptor
mut TECR 19p13.12 -0.143 0.276 0.777 long-chain fatty-acyl-CoA
biosynthetic process;very long-chain fatty acid biosynthetic process
mut AP1M1 19p13.12 -0.143 0.276 0.777 EMT (Mesenchymal)
mut C19orf44 19p13.11 -0.143 0.276 0.777
mut CHERP 19p13.1 -0.143 0.276 0.777 nervous system development;negative
mut MRPL34 19p13.1 -0.143 0.276 0.777 translation
mut COMP 19p13.1 -0.143 0.276 0.777 organ morphogenesis;limb
development
mut LPAR2 19p12 -0.143 0.276 0.777 activation of MAPK activity;G-protein
mut ZNF682 19p12 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ZNF675 19p12 -0.143 0.276 0.777 I-kappaB kinase/NF-kappaB
mut FXYD5 19q13.12 -0.143 0.276 0.777 negative regulation of calcium-
dependent cell-cell adhesion;ion transport
mut FFAR2 19q13.1 -0.143 0.276 0.777
mut ZFP82 19q13.12 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ZNF585B 19q13.12 -0.143 0.276 0.777 regulation of transcription,
DNA-dependent"
DNA-dependent"
mut KCNK6 19q13.1 -0.143 0.276 0.777 ion transport;potassium ion
transport
mut SARS2 19q13.2 -0.143 0.276 0.777 tRNA aminoacylation for protein
mut MRPS12 19q13.1-q13.2 -0.143 0.276 0.777 translation
mut PAK4 19q13.2 -0.143 0.276 0.777 Protein Kinases
mut EID2B 19q13.2 -0.143 0.276 0.777 regulation of transcription, DNA-
mut NUMBL 19q13.13-q13.2 -0.143 0.276 0.777 multicellular organismal
mut SNRPA 19q13.1 -0.143 0.276 0.777 nuclear mRNA splicing, via
mut B9D2 19q13.2 -0.143 0.276 0.777 mitotic cell cycle;cell projection
organization
mut TMEM91 19q13.2 -0.143 0.276 0.777 response to biotic stimulus
mut CIC 19q13.2 -0.143 0.276 0.777 Tumor Suppressors
mut PLAUR 19q13 -0.143 0.276 0.777 cellular component movement;fibrinolysis
mut ZNF112 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut NKPD1 19q13.32 -0.143 0.276 0.777
mut CD3EAP 19q13.3 -0.143 0.276 0.777 rRNA
mut ERCC1 19q13.32 -0.143 0.276 0.777 DNA Damage Response (DDR); DDR
(NER)
mut EML2 19q13.32 -0.143 0.276 0.777 visual perception;sensory
perception of sound
mut MYPOP 19q13.32 -0.143 0.276 0.777 negative regulation of
mut PPP5C 19q13.3 -0.143 0.276 0.777 signal transduction;positive
mut AP2S1 19q13.2-q13.3 -0.143 0.276 0.777 protein transport;viral
reproduction
mut MEIS3 19q13.32 -0.143 0.276 0.777
mut CYTH2 19q13.33 -0.143 0.276 0.777 endocytosis;actin cytoskeleton
organization
mut SPHK2 19q13.2 -0.143 0.276 0.777 sphingolipid metabolic
mut FUT1 19q13.3 -0.143 0.276 0.777 protein glycosylation;fucosylation
mut NUCB1 19q13.33 -0.143 0.276 0.777
mut NOSIP 19q13.33 -0.143 0.276 0.777 negative regulation of catalytic
mut PRMT1 19q13.3 -0.143 0.276 0.777 histone methylation;peptidyl-
mut VRK3 19q13 -0.143 0.276 0.777 positive regulation of phosphoprotein
mut JOSD2 19q13.33 -0.143 0.276 0.777 proteolysis;protein
deubiquitination
mut KLK7 19q13.41 -0.143 0.276 0.777 proteolysis;epidermis development
mut KLK14 -0.143 0.276 0.777
mut FPR3 19q13.3-q13.4 -0.143 0.276 0.777
mut VSTM1 19q13.42 -0.143 0.276 0.777
mut EPS8L1 19q13.42 -0.143 0.276 0.777
mut FIZ1 19q13.42 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
mut ZFP28 -0.143 0.276 0.777 regulation of transcription, DNA-
dependent"
DNA-dependent"
DNA-dependent"
DNA-dependent"
mut UBE2M 19q13.43 -0.143 0.276 0.777 protein modification
mut SDCBP2 20p13 -0.143 0.276 0.777 nervous system
development;intracellular signal transduction
mut SLX4IP 20p12.2 -0.143 0.276 0.777
mut PCSK2 20p11.2 -0.143 0.276 0.777 nervous system development;protein
autoprocessing
mut NAA20 20p11.23 -0.143 0.276 0.777
mut MAPRE1 20q11.1-q11.23 -0.143 0.276 0.777 protein localization to
mut AHCY 20q11.22 -0.143 0.276 0.777 sulfur amino acid metabolic
process;one-carbon metabolic process
mut NDRG3 20q11.21-q11.23 -0.143 0.276 0.777 spermatogenesis;cell
differentiation
mut TLDC2 20q11.23 -0.143 0.276 0.777
mut PPP1R16B 20q11.23 -0.143 0.276 0.777 signal
mut WISP2 20q13.12 -0.143 0.276 0.777 Oncogenes
mut TOMM34 -0.143 0.276 0.777 protein targeting to mitochondrion
mut STK4 20q11.2-q13.2 -0.143 0.276 0.777 Apoptosis
mut TP53TG5 20q13.12 -0.143 0.276 0.777
mut EYA2 20q13.1 -0.143 0.276 0.777 histone dephosphorylation;DNA
repair
mut PTPN1 20q13.1-q13.2 -0.143 0.276 0.777 regulation of
mut DPM1 20q13.13 -0.143 0.276 0.777 protein O-linked
mannosylation;dolichol-linked oligosaccharide biosynthetic process
mut YTHDF1 20q13.33 -0.143 0.276 0.777
mut LKAAEAR1 -0.143 0.276 0.777
mut APP 21q21.3 -0.143 0.276 0.777 Apoptosis
mut KRTAP27-1 -0.143 0.276 0.777
mut OLIG2 21q22.11 -0.143 0.276 0.777 myelination;negative regulation of
mut KCNE1 21q22.12 -0.143 0.276 0.777 sensory perception of sound;blood
circulation
mut RCAN1 21q22.12 -0.143 0.276 0.777 regulation of phosphoprotein
mut PDE9A 21q22.3 -0.143 0.276 0.777 signal transduction;blood
coagulation
mut C21orf33 21q22.3 -0.143 0.276 0.777
mut COL6A1 21q22.3 -0.143 0.276 0.777 cell adhesion;axon guidance
mut PRMT2 21q22.3 -0.143 0.276 0.777 negative regulation of
mut CECR1 22q11.2 -0.143 0.276 0.777 adenosine catabolic
mut TSSK2 22q11.21 -0.143 0.276 0.777
mut SEPT5 22q11.21 -0.143 0.276 0.777 GTP catabolic process;cell cycle
mut TANGO2 22q11.21 -0.143 0.276 0.777
mut MN1 22q12.1 -0.143 0.276 0.777 intramembranous ossification
mut C22orf31 22q12.1 -0.143 0.276 0.777
mut OSM 22q12.2 -0.143 0.276 0.777 multicellular organismal
mut MTFP1 22q -0.143 0.276 0.777 mitochondrial fission;apoptotic process
mut SEC14L4 22q12.2 -0.143 0.276 0.777
mut BPIFC 22q12.3 -0.143 0.276 0.777
mut MPST 22q13.1 -0.143 0.276 0.777 cyanate catabolic process;response
to toxin
mut SOX10 22q13.1 -0.143 0.276 0.777 positive regulation of
gliogenesis;oligodendrocyte differentiation
mut CSNK1E 22q13.1 -0.143 0.276 0.777 DNA Damage Response (DDR);
Protein Kinases
mut TBC1D22A 22q13.3 -0.143 0.276 0.777
mut PANX2 22q13.33 -0.143 0.276 0.777 ion transport;synaptic transmission
mut LMF2 22q13.33 -0.143 0.276 0.777
mut TYMP 22q13.33 -0.143 0.276 0.777 pyrimidine nucleotide metabolic
mut BMX Xp22.2 -0.143 0.276 0.777 mesoderm development;intracellular
signal transduction
mut CA5B Xp21.1 -0.143 0.276 0.777 one-carbon metabolic
mut DDX53 Xp22.11 -0.143 0.276 0.777
mut LANCL3 Xp21.1 -0.143 0.276 0.777
mut JADE3 -0.143 0.276 0.777 histone H3 acetylation;histone H4-K5
acetylation
mut ITIH6 Xp11.22-p11.21 -0.143 0.276 0.777 hyaluronan metabolic process
mut ZMYM3 Xq13.1 -0.143 0.276 0.777 multicellular organismal
mut NAP1L2 Xq13 -0.143 0.276 0.777 nucleosome assembly
mut BEX5 Xq22.1 -0.143 0.276 0.777
mut MID2 Xq22.3 -0.143 0.276 0.777
mut ACSL4 Xq22.3-q23 -0.143 0.276 0.777 fatty acid metabolic
process;dendritic spine development
mut ZBTB33 Xq23 -0.143 0.276 0.777 regulation of transcription, DNA-
mut DDX3Y Yq11 -0.143 0.276 0.777
mda TMEM173_mutation -0.143 0.276 0.777
mut ACOT7 1p36 -0.143 0.276 0.777 lipid metabolic process
mut ZNF691 1p34.2 -0.143 0.276 0.777
mut USP33 1p31.1 -0.143 0.276 0.777 endocytosis;axon guidance
mut CCBL2 -0.143 0.276 0.777 cellular amino acid metabolic
mut FAM19A3 1p13.2 -0.143 0.276 0.777
mut DCST2 1q22 -0.143 0.276 0.777
mut CD1C 1q23.1 -0.143 0.276 0.777 T cell activation involved in
mut PIK3C2B 1q32 -0.143 0.276 0.777 Protein Kinases
mut C1orf95 1q42.12 -0.143 0.276 0.777
mut HIST3H3 1q42 -0.143 0.276 0.777 telomere maintenance;nucleosome
assembly
mut GCKR 2p23 -0.143 0.276 0.777 carbohydrate metabolic process;small
mut EGR4 2p13 -0.143 0.276 0.777 regulation of transcription, DNA-
mut MDH1B 2q33.3 -0.143 0.276 0.777 carbohydrate metabolic
mut CTDSP1 2q35 -0.143 0.276 0.777 negative regulation of neuron
mut AP2M1 3q28 -0.143 0.276 0.777 vesicle-mediated transport;transport
mut LRCH3 3q29 -0.143 0.276 0.777
mut NELFA 4p16.3 -0.143 0.276 0.777
mut CPEB2 4p15.33 -0.143 0.276 0.777 regulation of translation
mut ADH7 4q23-q24 -0.143 0.276 0.777 ethanol oxidation;xenobiotic
metabolic process
mut PARP8 5q11.1 -0.143 0.276 0.777
mut FGF18 5q34 -0.143 0.276 0.777 chondrocyte development;positive
mut SERPINB6 6p25 -0.143 0.276 0.777 negative regulation of
mut RNF146 6q22.1-q22.33 -0.143 0.276 0.777 Wnt receptor signaling
pathway;protein ubiquitination involved in ubiquitin-dependent protein catabolic
process
mut MTURN -0.143 0.276 0.777
mut DLD 7q31-q32 -0.143 0.276 0.777 pyruvate metabolic process;branched
mut TSPAN33 7q32.1 -0.143 0.276 0.777
mut WEE2 7q32 -0.143 0.276 0.777 Protein Kinases
mut IFNW1 9p22 -0.143 0.276 0.777
mut FAM171A1 10p13 -0.143 0.276 0.777
mut MYPN 10q21.3 -0.143 0.276 0.777 sarcomere organization
mut CH25H 10q23 -0.143 0.276 0.777 bile acid metabolic process;sterol
DNA-dependent"
mut KCNJ11 11p15.1 -0.143 0.276 0.777 potassium ion
transport;negative regulation of insulin secretion
mut CATSPER1 11q12.1 -0.143 0.276 0.777 spermatogenesis;fusion of
mut CDK8 13q12 -0.143 0.276 0.777 Protein Kinases
mut SPTLC2 14q24.3 -0.143 0.276 0.777 sphingosine biosynthetic
mut KCTD13 -0.143 0.276 0.777 proteasomal ubiquitin-dependent
protein catabolic process;DNA replication
mut KDM6B 17p13.1 -0.143 0.276 0.777 negative regulation of
mut KRT34 17q21.2 -0.143 0.276 0.777 epidermis development
mut GALR1 18q23 -0.143 0.276 0.777 neuropeptide signaling pathway;digestion
mut PARD6G 18q23 -0.143 0.276 0.777 cell junction assembly;cell-cell
mut TRIP10 19p13.3 -0.143 0.276 0.777 cell communication;signal
transduction
mut NFKBIB 19q13.1 -0.143 0.276 0.777 Apoptosis
mut CCDC97 19q13.2 -0.143 0.276 0.777
mut IRF2BP1 19q13.32 -0.143 0.276 0.777 regulation of transcription,
DNA-dependent"
mut KMT5C -0.143 0.276 0.777 regulation of transcription, DNA-
DNA-dependent"
mut SGK2 20q13.2 -0.143 0.276 0.777 regulation of cell growth;protein
phosphorylation
mut PCIF1 20q13.12 -0.143 0.276 0.777 negative regulation of phosphatase
activity
mut TTC3 21q22.2 -0.143 0.276 0.777 ubiquitin-dependent protein
catabolic process;negative regulation of cell morphogenesis involved in
differentiation
cop MOB3B 9p21.2 -0.143 0.276 0.777
met KRT24 17q21.2 -0.143 0.276 0.777
met CCNI2 5q31.1 -0.143 0.276 0.777 regulation of cyclin-dependent
cop KCTD8 4p13 -0.143 0.276 0.777 potassium ion transport
met INTS4 11q14.1 -0.143 0.276 0.777 snRNA processing
mut BCL9 1q21 -0.143 0.276 0.777 Wnt receptor signaling pathway;regulation
xsq PNMA1 14q24.3 -0.143 0.276 0.777 inflammatory response to antigenic
xsq BCL9L 11q23.3 -0.143 0.276 0.777 negative regulation of transforming
mut TULP2 19q13.1 -0.143 0.276 0.777 visual perception
xsq BNIP3L 8p21 -0.143 0.276 0.777 Apoptosis
exp HMGCL 1p36.1-p35 -0.143 0.276 0.777 response to starvation;cellular
exp IRF9 14q11.2 -0.143 0.276 0.777 type I interferon-mediated
xsq CYSTM1 5q31.3 -0.143 0.276 0.777
exp SNAP29 22q11.21 -0.143 0.276 0.777 exocytosis;vesicle targeting
met WDR37 10p15.3 -0.143 0.276 0.777
exp PIK3R1 5q13.1 -0.143 0.276 0.777 Apoptosis; Cell Signaling;
Tumor Suppressors
exp DCAF10 9p13.2 -0.143 0.276 0.777 protein ubiquitination
exp KL 13q12 -0.143 0.276 0.777 aging;insulin receptor signaling pathway
mut POMGNT1 1p34.1 -0.143 0.276 0.777 protein N-linked
met TMEM30A 6q14.1 -0.143 0.276 0.777 protein localization to
mut ZSWIM1 20q13.12 -0.143 0.276 0.777
xsq TOM1L1 17q23.2 -0.143 0.276 0.777 intracellular protein
xsq CERS4 19p13.2 -0.143 0.276 0.777 ceramide biosynthetic
hs4 CDK2 12q13 -0.144 0.276 0.777 DNA Damage Response (DDR); DDR (DNA
hs4 PMEL 12q13-q14 -0.144 0.276 0.777 melanosome organization;melanin
exp UNGP3 14q31.1 -0.144 0.276 0.777
DNA-dependent"
DNA-dependent"
DNA-dependent"
dependent"
xai DCDC2C 2p25.3 -0.144 0.276 0.777 intracellular signal
transduction
xai PHC3 3q26.2 -0.144 0.276 0.777 multicellular organismal
development
xai GPR83 11q21 -0.144 0.276 0.777 G-protein coupled receptor signaling
pathway;response to glucocorticoid stimulus
his TGFBI 5q31 -0.144 0.276 0.777 visual perception;cell proliferation
xai GABRP 5q35.1 -0.144 0.276 0.777 ion transport
his SFTA1P 10p14 -0.144 0.276 0.777
his CELF2 10p13 -0.144 0.276 0.777 RNA processing;mRNA processing
DNA-dependent"
cop LOC389332 5q31.1 -0.144 0.276 0.777
xai SHANK2 11q13.2 -0.144 0.276 0.777 intracellular signal
transduction
xai CCDC122 13q14.11 -0.144 0.276 0.777
hs4 MIR6843 -0.144 0.276 0.777
hs4 CLU 8p21-p12 -0.144 0.276 0.777 Apoptosis
his MPP4 2q33.2 -0.144 0.276 0.777
xai GPR137C 14q22.1 -0.144 0.276 0.777
his MIR6874 -0.144 0.276 0.777
cop LOC100631378 -0.144 0.276 0.777
xai FTH1P3 2p23.3 -0.144 0.276 0.777
xai ZBED8 -0.144 0.276 0.777
xai ZNF883 9q32 -0.144 0.276 0.777 regulation of transcription, DNA-
dependent"
xai CDKN3 14q22 -0.144 0.276 0.777 regulation of cyclin-dependent protein
kinase activity;G1/S transition of mitotic cell cycle
his SYT14 1q32.2 -0.144 0.276 0.777 cell death
DNA-dependent"
swa RPL8 8q24.3 -0.144 0.276 0.777 translational elongation;viral
transcription
xai NAPA 19q13.33 -0.144 0.276 0.777 post-Golgi vesicle-mediated
hs4 GON7 0.144 0.277 0.777
hs4 UBR7 14q32.12 0.144 0.277 0.777
xai ABHD17B 9q21.13 0.144 0.277 0.777
his PNPLA1 6p21.31 0.144 0.277 0.777 metabolic process;lipid catabolic
process
his ARHGDIB 12p12.3 0.144 0.277 0.777 multicellular organismal
hs4 CCDC69 5q33.1 0.144 0.277 0.777
his PHF21B 22q13.31 0.144 0.277 0.777
cop ANKRD34A 1q21.1 0.144 0.277 0.777
xai FGF21 19q13.33 0.144 0.277 0.777 signal transduction;cell-cell signaling
xai TBC1D2B 15q24.3-q25.1 0.144 0.277 0.777
hs4 OCEL1 19p13.11 0.144 0.277 0.778
cop AP3D1 19p13.3 0.144 0.277 0.778 eye pigment biosynthetic
process;regulation of sequestering of zinc ion
cop DOT1L 19p13.3 0.144 0.277 0.778 DDR (DNA replication)
cop PLEKHJ1 19p13.3 0.144 0.277 0.778
cop MIR1227 0.144 0.277 0.778
cop SF3A2 19p13.3 0.144 0.277 0.778 mRNA processing;RNA splicing
cop AMH 19p13.3 0.144 0.277 0.778 sex determination;sex differentiation
cop MIR4321 0.144 0.277 0.778
cop JSRP1 19p13.3 0.144 0.277 0.778
cop OAZ1 19p13.3 0.144 0.277 0.778 regulation of cellular amino acid
cop C19orf35 0.144 0.277 0.778
cop LINGO3 19p13.3 0.144 0.277 0.778
xai B3GNT8 19q13.2 0.144 0.277 0.778 O-glycan processing;poly-N-
xai POF1B Xq21.2 0.144 0.277 0.778
hs4 NONO Xq13.1 0.144 0.277 0.778 DNA repair;DNA recombination
xai FEN1P1 1p22.2 0.144 0.277 0.778
xai LPA 6q26 0.144 0.277 0.778 transport;lipid transport
his ACVR1C 2q24.1 0.144 0.277 0.778 response to glucose stimulus;lipid
storage
exp ALDOAP2 0.144 0.277 0.778
hs4 NEFH 22q12.2 0.144 0.277 0.778 microtubule cytoskeleton
xai CMTM3 16q21 0.144 0.277 0.778 EMT (Mesenchymal)
his TAS2R40 7q34 0.144 0.277 0.778
exp LOC100505616 0.144 0.277 0.778
xai MTR 1q43 0.144 0.277 0.778 protein methylation;tetrahydrofolate metabolic
process
xsq GTF3C2-AS1 0.143 0.277 0.777
met FRG1BP 0.143 0.277 0.777
xsq TBC1D3P5 17q11.1 0.143 0.277 0.777
xsq POLR2A 17p13.1 0.143 0.277 0.777 DNA Damage Response (DDR); DDR
(NER)
cop DCC 18q21.3 0.143 0.277 0.777 Tumor Suppressors
xsq POLR3D 8q21 0.143 0.277 0.777 positive regulation of interferon-beta
production;positive regulation of innate immune response
exp C16orf52 16p12.2 0.143 0.277 0.777
exp SCARA5 8p21.1 0.143 0.277 0.777 cellular response to heat;iron ion
xsq CHIT1 1q32.1 0.143 0.277 0.777 response to bacterium;polysaccharide
catabolic process
exp FCGR2C 0.143 0.277 0.777 immune response
cop THOC2 Xq25-q26.3 0.143 0.277 0.777 mRNA export from nucleus;transport
mut TMPO 12q22 0.143 0.277 0.777 regulation of transcription, DNA-dependent"
met PPT2 6p21.3 0.143 0.277 0.777 protein modification process
cop ANKRD40 17q21.33 0.143 0.277 0.777
met RIPK4 21q22.3 0.143 0.277 0.777
xsq ERICH1 8p23.3 0.143 0.277 0.777
mut POLR2A 17p13.1 0.143 0.277 0.777 DNA Damage Response (DDR); DDR
(NER)
exp MAP2K6 17q24.3 0.143 0.277 0.777 Protein Kinases
cop LINC00641 0.143 0.277 0.777
met LOC284441 19p12 0.143 0.277 0.777
xsq LOC100132174 17q25.3 0.143 0.277 0.777
cop RIC8B 12q23.3 0.143 0.277 0.777 regulation of G-protein coupled receptor
met PCBD1 10q22 0.143 0.277 0.777 tetrahydrobiopterin biosynthetic
met FGD1 Xp11.21 0.143 0.277 0.777 organ morphogenesis;apoptotic process
exp AKIRIN1 1p34.3 0.143 0.277 0.777
xsq SPERT 13q14.13 0.143 0.277 0.777
mut PPM1F 22q11.22 0.143 0.277 0.777 Apoptosis
mut MEGF6 1p36.3 0.143 0.277 0.777
xsq ARFRP1 20q13.3 0.143 0.277 0.777 small GTPase mediated signal
transduction;gastrulation
mut FSCN3 7q31.3 0.143 0.277 0.778
exp CENPM 22q13.2 0.143 0.277 0.778 M phase of mitotic cell cycle;mitotic
prometaphase
cop CHCHD1 10q22.2 0.143 0.277 0.778
mut ACACB 12q24.11 0.143 0.277 0.778 energy reserve metabolic process;fatty
met NNMT 11q23.1 0.143 0.277 0.778 small molecule metabolic
met ABCD4 14q24.3 0.143 0.277 0.778 ABC Transporters
xsq LOC100128239 11q25 0.143 0.277 0.778
xsq SPATA3 2q37.1 0.143 0.277 0.778 apoptotic process;spermatogenesis
met SNCAIP 5q23.2 0.143 0.277 0.778 cell death;dopamine metabolic
process
cop ADSSL1 14q32.33 0.143 0.277 0.778 immune system process;purine base
metabolic process
xsq IFI27L1 14q32.12 0.143 0.277 0.778
exp ITPR1-AS1 0.143 0.277 0.778
met FZD8 10p11.21 0.143 0.277 0.778 positive regulation of protein
promoter
xsq CREB3L4 1q21.3 0.143 0.277 0.778 response to unfolded
xsq RGPD4-AS1 0.143 0.277 0.778
xsq IKBKB 8p11.2 0.143 0.277 0.778 Apoptosis; Protein Kinases
exp VRK2 2p16.1 0.143 0.277 0.778 protein phosphorylation;response to
oxidative stress
cop CDYL2 16q23.2 0.143 0.277 0.778
cop DPY30 2p22.3 0.143 0.277 0.778 histone H3-K4 methylation;regulation of
cop SPAST 2p24-p21 0.143 0.277 0.778 cytokinesis, completion of
cop NLRC4 2p22-p21 0.143 0.277 0.778 Apoptosis
exp ANXA10 4q33 0.143 0.277 0.778
cop KRT15 17q21.2 0.142 0.277 0.778 epidermis development
cop KRT19 17q21.2 0.142 0.277 0.778 cell differentiation involved in
xsq CCDC114 19q13.33 0.142 0.277 0.778
xsq GPR26 10q26.13 0.142 0.277 0.778 activation of adenylate cyclase activity
by G-protein signaling pathway
xsq KRTAP1-1 17q12 0.142 0.277 0.778
mut SARDH 9q33-q34 0.142 0.277 0.778 glycine catabolic process
cop FAM49B 8q24.21 -0.142 0.277 0.778
mut COL8A2 1p34.2 -0.142 0.277 0.778 angiogenesis;cell-cell
adhesion
met FABP5P3 7q36.1 -0.142 0.277 0.778 glucose metabolic
mut CHIA 1p13.2 -0.142 0.277 0.778 production of molecular mediator
involved in inflammatory response;response to fungus
met CALML4 15q23 -0.143 0.277 0.778
exp GGT3P -0.143 0.277 0.778 glutathione metabolic process;glutathione
xsq SYT14 1q32.2 -0.143 0.277 0.778 cell death
cop KLF10 8q22.2 -0.143 0.277 0.778 cell-cell signaling;cell
proliferation
cop AZIN1 8q22.3 -0.143 0.277 0.778 positive regulation of catalytic
cop ATP6V1C1 8q22.3 -0.143 0.277 0.778 transport;cellular iron ion
homeostasis
met SGSM2 17p13.3 -0.143 0.277 0.778
exp MMP15 16q13 -0.143 0.277 0.778 Apoptosis
exp LENG8 19q13.42 -0.143 0.277 0.778
exp IL36RN 2q14 -0.143 0.277 0.778 negative regulation of cytokine-
met TBC1D29 17q11.2 -0.143 0.277 0.778
met TMEM145 19q13.2 -0.143 0.277 0.778
exp TM9SF3 10q24.1 -0.143 0.277 0.778
met PLCZ1 12p12.3 -0.143 0.277 0.778 metabolic process;lipid catabolic
process
cop RARS 5q35.1 -0.143 0.277 0.777 tRNA aminoacylation for protein
cop FBLL1 5q34 -0.143 0.277 0.777 rRNA processing;tRNA processing
cop PANK3 5q34 -0.143 0.277 0.777 coenzyme A biosynthetic process
cop MIR103A1 -0.143 0.277 0.777
cop MIR103B1 -0.143 0.277 0.777
xsq LRRN3 7q31.1 -0.143 0.277 0.777 positive regulation of protein
phosphorylation
exp AP1S2 Xp22.2 -0.143 0.277 0.777 post-Golgi vesicle-mediated
mda APM -0.143 0.277 0.777
exp MIR31HG 9p21.3 -0.143 0.277 0.777
exp STOX2 4q35.1 -0.143 0.277 0.777 maternal placenta
exp C1orf122 1p34.3 -0.143 0.277 0.777
exp ITFG1 16q12.1 -0.143 0.277 0.777
cop SEPT5 22q11.21 -0.143 0.277 0.777 GTP catabolic process;cell cycle
cop SEPT5-GP1BB -0.143 0.277 0.777
cop GP1BB -0.143 0.277 0.777 blood coagulation, intrinsic
cop TBX1 22q11.21 -0.143 0.277 0.777 angiogenesis;outflow tract septum
morphogenesis
exp ENPP2 8q24.1 -0.143 0.277 0.777 phosphatidylcholine catabolic
xsq HOXC-AS1 -0.143 0.277 0.777
xsq IGSF23 19q13.31 -0.143 0.277 0.777
xsq PCA3 -0.143 0.277 0.777
met PKN1 19p13.12 -0.143 0.277 0.777 activation of JUN kinase
activity;epithelial cell migration
xai HOMER2 15q24.3 -0.144 0.277 0.778 G-protein coupled glutamate
hs4 ARID5B 10q21.2 -0.144 0.277 0.778 fibroblast migration;skeletal
xai LCAT 16q22.1 -0.144 0.277 0.778 cholesterol metabolic
process;reverse cholesterol transport
his SERPINB6 6p25 -0.144 0.277 0.778 negative regulation of
DNA-dependent"
his WSB2 12q24.23 -0.144 0.277 0.778 intracellular signal transduction
xai CADM1 11q23.2 -0.144 0.277 0.778 homophilic cell
hs4 PICSAR -0.144 0.277 0.778
his TRH 3q13.3-q21 -0.144 0.277 0.778
cop LOC728752 19q13.12 -0.144 0.277 0.778
xai NXPH2 2q22.1 -0.144 0.277 0.778 neuropeptide signaling pathway
cop ZNF585A 19q13.12 -0.144 0.277 0.777 regulation of transcription,
DNA-dependent"
cop ZNF585B 19q13.12 -0.144 0.277 0.777 regulation of transcription,
DNA-dependent"
exp AFM 4q13.3 -0.144 0.277 0.777 vitamin transport
swa MCCC2 5q12-q13 -0.144 0.277 0.777 small molecule metabolic
process;leucine catabolic process
hs4 XXYLT1 3q29 -0.144 0.277 0.777
xai CDKN1A 6p21.2 -0.144 0.277 0.777 Apoptosis; DNA Damage
hs4 RAB38 11q14 -0.144 0.277 0.777 GTP catabolic process;small GTPase
hs4 MIR3166 -0.144 0.277 0.777
xai FBXL7 5p15.1 -0.144 0.277 0.777 ubiquitin-dependent protein
DNA-dependent"
his CPEB2-AS1 -0.144 0.277 0.777
his CPEB2 4p15.33 -0.144 0.277 0.777 regulation of translation
his PRDM6 5q23.2 -0.144 0.277 0.777 chromatin modification;neurogenesis
his RAB40C 16p13.3 0.144 0.278 0.778 small GTPase mediated signal
his TBL3 16p13.3 0.144 0.278 0.778 G-protein signaling, coupled to cGMP
xai HNRNPU-AS1 1q44 0.144 0.278 0.778
xai MSS51 10q22.2 0.144 0.278 0.778 social behavior
his MIR1273C 0.144 0.278 0.778
xai NDUFB3 2q31.3 0.144 0.278 0.778 mitochondrial electron transport,
xai RPP21 6p22.1 0.144 0.278 0.778 tRNA processing;response to drug
exp CLUL1 18p11.32 0.144 0.278 0.778 cell death
swa RAD23B 9q31.2 0.144 0.278 0.778 DNA Damage Response (DDR); DDR
(NER)
xai BAG6 6p21.3 0.144 0.278 0.778 transport;lung development
hs4 LINC00963 0.144 0.278 0.778
his GTF2B 1p22-p21 0.144 0.278 0.778 viral reproduction;interspecies
xai MAP2K6 17q24.3 0.144 0.278 0.778 Protein Kinases
dependent"
exp LINC00562 0.144 0.278 0.778
xai UBAP2L 1q21.3 0.144 0.278 0.778 binding of sperm to zona pellucida
xai CYP4F24P 19p13.12 0.144 0.278 0.778
hs4 NUP155 5p13.1 0.144 0.278 0.778 nucleocytoplasmic transport;mRNA
transport
his TNFRSF10A 8p21 0.144 0.278 0.778 Apoptosis
his LOC389641 0.144 0.278 0.778
his SRSF8 11q22 0.144 0.278 0.778 mRNA processing;RNA splicing
xai GATB 0.144 0.278 0.778 translation;mitochondrial translation
hs4 LRCH4 7q22 0.144 0.278 0.778 nervous system development;negative regulation
hs4 FBXO24 7q22 0.144 0.278 0.778 protein ubiquitination
xai LINC00562 0.144 0.278 0.778
exp TUBBP2 13q14.11 0.144 0.278 0.778
exp LOC100505824 0.144 0.278 0.778
his TMEM214 2p23.3 0.144 0.278 0.778
hs4 PHKG2 16p11.2 0.144 0.278 0.778 glycogen metabolic process;glycogen
xai PYCARD 16p11.2 0.144 0.278 0.778 nucleotide-binding domain, leucine
xai DDIT4L 4q24 0.143 0.278 0.778 negative regulation of signal
transduction
hs4 MKI67 10q26.2 0.143 0.278 0.778 meiosis;cell proliferation
hs4 GRIN2D 19q13.33 0.143 0.278 0.778 signal transduction;synaptic
transmission
xai EMID1 22q12.2 0.143 0.278 0.778
his TMIGD3 0.143 0.278 0.778
his ADORA3 1p13.2 0.143 0.278 0.778 inflammatory response;signal
transduction
his ELL3 15q15.3 0.143 0.278 0.778 positive regulation of transcription from
RNA polymerase II promoter;transcription elongation, DNA-dependent
hs4 SCO2 22q13.33 0.143 0.278 0.778 respiratory chain complex IV
assembly;response to activity
his TXNDC2 0.143 0.278 0.778 cell redox homeostasis;protein thiol-
disulfide exchange
xsq ADCK5 8q24.3 0.142 0.278 0.778
exp TBC1D27 17p11.2 0.142 0.278 0.778
xsq RPP25 15q24.2 0.142 0.278 0.778 tRNA processing
cop ITPK1 14q31 0.142 0.278 0.778 signal transduction;blood coagulation
xsq FAM78B 1q24.1 0.142 0.278 0.778
xsq CCDC130 19p13.2 0.142 0.278 0.778 response to virus
dependent"
cop LINC00341 14q32.13 0.142 0.278 0.778
cop SYNE3 14q32.13 0.142 0.278 0.778
cop SNHG10 14q32.13 0.142 0.278 0.778
cop SCARNA13 14q32.12 0.142 0.278 0.778
cop GLRX5 14q32.13 0.142 0.278 0.778 hemopoiesis;cell redox homeostasis
cop TCL6 14q32.1 0.142 0.278 0.778
cop TCL1B 14q32.1 0.142 0.278 0.778
xsq PSMC1 14q32.11 0.142 0.278 0.778 protein polyubiquitination;DNA damage
mut MON2 12q14.1 0.142 0.278 0.778 Golgi to endosome transport;protein
transport
met FANCE 6p22-p21 0.142 0.278 0.778 DNA Damage Response (DDR); DDR (FA)
xsq FAM69B 9q34.3 0.142 0.278 0.778
cop ASTL 2q11.1 0.142 0.278 0.778 proteolysis
cop DUSP2 2q11 0.142 0.278 0.778 regulation of apoptotic process;inactivation of
MAPK activity
cop STARD7 2q11.2 0.142 0.278 0.778
cop LOC285033 0.142 0.278 0.778
cop TMEM127 2q11.2 0.142 0.278 0.778 negative regulation of TOR
signaling cascade;negative regulation of cell proliferation
cop CIAO1 2q11.2 0.142 0.278 0.778 regulation of transcription from RNA
polymerase II promoter;chromosome segregation
cop SNRNP200 2q11.2 0.142 0.278 0.778 RNA splicing;gene expression
cop ITPRIPL1 2q11.2 0.142 0.278 0.778
cop NCAPH 2q11.2 0.142 0.278 0.778 DNA Damage Response (DDR)
cop NEURL3 2q11.2 0.142 0.278 0.778
cop ARID5A 2q11.2 0.142 0.278 0.778 negative regulation of
met CAMK2N2 3q27.1 0.142 0.278 0.778
exp LTB4R 14q11.2-q12 0.142 0.278 0.778 cellular component movement;muscle
contraction
xsq SARNP 12q13.2 0.142 0.278 0.778 regulation of transcription, DNA-
dependent"
xsq RFC4 3q27 0.142 0.278 0.778 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
met DCAF8L1 Xp21.3 0.142 0.278 0.778
met DFNA5 7p15 0.142 0.278 0.778 sensory perception of sound;inner ear receptor
xsq HEATR3 16q12.1 0.142 0.278 0.778
cop CLMN 14q32.13 0.142 0.278 0.778
xsq CDH20 18q21.33 0.142 0.278 0.778 homophilic cell adhesion;cell-cell
adhesion
xsq CRBN 3p26.2 0.142 0.278 0.778 negative regulation of protein
xsq HAUS3 0.142 0.278 0.778 centrosome organization;cell division
mut NUMA1 11q13 0.142 0.278 0.778 mitotic anaphase;establishment of mitotic
spindle orientation
exp METTL12 11q12.3 0.142 0.278 0.778
cop RBM5 3p21.3 0.142 0.278 0.778 RNA splicing;gene expression
xsq NUDT18 8p21.3 0.142 0.278 0.778
xsq TLX3 5q35.1 0.142 0.278 0.778 respiratory gaseous exchange;negative
met SAGE1 Xq26 0.142 0.278 0.778
cop DOK7 4p16.3 0.142 0.278 0.778 positive regulation of protein tyrosine
kinase activity
exp HINT2 9p13.3 0.142 0.278 0.778 steroid biosynthetic process;apoptotic
process
cop USP32 17q23.3 0.142 0.278 0.778 proteolysis;ubiquitin-dependent protein
catabolic process
exp IGKV3-15 0.142 0.278 0.778
xsq UBN1 16p13.3 0.142 0.278 0.778 negative regulation of phosphatase
cop MTCL1 0.142 0.278 0.778
xsq GOLGA8A 15q11.2 0.142 0.278 0.778
exp NRN1L 16q22.1 0.142 0.278 0.778
cop DICER1 14q32.13 0.142 0.278 0.778 Oncogenes
cop MIR3173 0.142 0.278 0.778
cop DICER1-AS1 14q32.13 0.142 0.278 0.778
cop ANXA9 1q21 0.142 0.278 0.778 cell-cell adhesion
xsq BLOC1S6 15q21.1 0.142 0.278 0.778
exp TMEM26 10q21.2 0.142 0.278 0.778
exp NKIRAS2 17q21.2 0.142 0.278 0.778 I-kappaB kinase/NF-kappaB
mut OR6Y1 -0.142 0.278 0.778
met IL23R 1p31.3 -0.142 0.278 0.778 positive regulation of defense
response to virus by host;positive regulation of interleukin-12 production
xsq LOC101928272 -0.142 0.278 0.778
met ARL13A Xq22.1 -0.142 0.278 0.778 small GTPase mediated signal
transduction
xsq SULF2 20q12-q13.2 -0.142 0.278 0.778 glomerular basement membrane
exp FAM149A 4q35.1 -0.142 0.278 0.778
xsq PKP3 11p15 -0.142 0.278 0.778 cell adhesion
exp DAZAP2 12q12 -0.142 0.278 0.778
exp TM9SF1 14q11.2 -0.142 0.278 0.778 autophagy
exp RPS27P21 12q12 -0.142 0.278 0.778
cop MANBAL 20q11.23 -0.142 0.278 0.778
xsq KIF26B 1q44 -0.142 0.278 0.778 microtubule-based
exp PLD3 19q13.2 -0.142 0.278 0.778 lipid catabolic process
mut PLA2G3 -0.142 0.278 0.778 cell projection organization;cilium
morphogenesis
xsq EVI5 1p22.1 -0.142 0.278 0.778 cell cycle;multicellular organismal
development
xsq PAPPA-AS1 9q33.2 -0.142 0.278 0.778
mut ELMO3 16q22.1 -0.142 0.278 0.778 EMT (Epithelial)
exp PQLC3 2p25.1 -0.142 0.278 0.778
met PADI1 1p36.13 -0.142 0.278 0.778 protein modification
xsq USP9X Xp11.4 -0.142 0.278 0.778 mitosis;transforming growth factor
met CCS 11q13 -0.142 0.278 0.778 oxidation-reduction process;superoxide
metabolic process
mut NADK 1p36.33 -0.142 0.278 0.778 vitamin metabolic process;water-
xsq PRKCG 19q13.4 -0.142 0.278 0.778 DNA Damage Response (DDR)
exp FURIN 15q26.1 -0.142 0.278 0.778 peptide hormone processing;negative
hs4 TRAM1 8q13.3 -0.143 0.278 0.778 translation;cotranslational protein
hs4 LACTB2-AS1 -0.143 0.278 0.778
xai HPN 19q13.12 -0.143 0.278 0.778 negative regulation of apoptotic
hs4 KCNH7 2q24.2 -0.143 0.278 0.778 circadian rhythm;protein
xai TRABD2B 1p33 -0.144 0.278 0.778
DNA-dependent"
his TBC1D12 10q23.33 -0.144 0.278 0.778
xai STOX2 4q35.1 -0.144 0.278 0.778 maternal placenta
xai LOC648570 -0.144 0.278 0.778
xai AMFR 16q21 -0.144 0.278 0.778 ER-associated protein catabolic
process;protein polyubiquitination
xai LINC01015 -0.144 0.278 0.778
exp LOC648570 -0.144 0.278 0.778
xai LRRC32 11q13.5-q14 -0.144 0.278 0.778
his HIPSTR -0.144 0.278 0.778
his TFAP2A-AS1 -0.144 0.278 0.778
his TFAP2A 6p24 -0.144 0.278 0.778 optic vesicle
exp LOC100134868 20p11.1 -0.144 0.278 0.778
swa PSIP1 9p22.3 -0.144 0.278 0.778 provirus integration;initiation of
viral infection
hs4 PADI1 1p36.13 -0.144 0.278 0.778 protein modification
xai C1RL 12p13.31 -0.144 0.278 0.778 proteolysis;complement activation,
classical pathway
xai QPCT 2p22.2 -0.144 0.278 0.778 protein modification
process;proteolysis
hs4 DLX5 7q22 -0.144 0.278 0.778 multicellular organismal development;ear
development
xai FBN3 19p13 -0.144 0.278 0.778
his TPM1 15q22.1 -0.144 0.278 0.778 positive regulation of heart rate
his DOK6 18q22.2 -0.144 0.278 0.778
hs4 HOXC-AS3 -0.144 0.278 0.778
hs4 HOXC10 12q13.3 -0.144 0.278 0.778 multicellular organismal
development;positive regulation of cell proliferation
hs4 KLHL22 22q11.21 -0.144 0.278 0.778 cell division
hs4 DZIP1 13q32.1 -0.144 0.278 0.778 multicellular organismal
xai LOC100134868 20p11.1 -0.144 0.278 0.778
his RNF19B 1p35.1 -0.144 0.278 0.778
hs4 LINC00709 -0.144 0.278 0.778
xai PCDHB13 5q31 -0.144 0.278 0.778 homophilic cell adhesion;synaptic
transmission
hs4 LAMA2 6q22-q23 -0.144 0.278 0.778 muscle organ development;regulation
of cell adhesion
his ARHGEF5 7q35 -0.144 0.278 0.778 regulation of Rho protein signal
his OR2A1-AS1 -0.144 0.278 0.778
DNA-dependent"
exp NFE2L3P1 18q21.32 -0.144 0.278 0.778
hs4 PADI3 1p36.13 -0.144 0.278 0.778 protein modification
xai CNIH4 1q42.11 -0.144 0.278 0.778 intracellular signal transduction
xai MYO19 17q12 0.143 0.279 0.779
xai PRORSD1P 2p16.1 0.143 0.279 0.779
xai DHX35 20q11.22-q12 0.143 0.279 0.779 nuclear mRNA splicing, via
his LINC00382 0.143 0.279 0.779
hs4 CFD 19p13.3 0.143 0.279 0.779 innate immune response;platelet
degranulation
his TMEM184C 4q31.23 0.143 0.279 0.779
his TMEM41A 3q27.2 0.143 0.279 0.779
his HNRNPA1L2 13q14.3 0.143 0.279 0.779 RNA splicing;mRNA transport
his DUSP6 12q22-q23 0.143 0.279 0.779 MyD88-independent toll-like receptor
xai PON1 7q21.3 0.143 0.279 0.779 positive regulation of transporter
dependent"
xai ABCC10 6p21.1 0.143 0.279 0.779 ABC Transporters
hs4 PCP4 21q22.2 0.143 0.279 0.779 central nervous system development
his ACTR8 0.143 0.279 0.779 DNA Damage Response (DDR); DDR (Chromatin)
xai NDUFS3 11p11.11 0.143 0.279 0.779 small molecule metabolic
exp HMGA1P6 13q12.12 0.143 0.279 0.779
his CELA3B 0.143 0.279 0.779
xai IGHVIII-67-3 0.143 0.279 0.779
xai GPAM 10q25.2 0.143 0.279 0.779 response to glucose stimulus;positive
regulation of activated T cell proliferation
exp PES1P1 4q28.3 0.143 0.279 0.779
exp LOC100506869 0.143 0.279 0.779
his PSMD4 1q21.3 0.143 0.279 0.779 S phase of mitotic cell cycle;DNA damage
exp IGHVIII-67-3 0.143 0.279 0.779
cop MKNK2 19p13.3 0.143 0.279 0.779 Protein Kinases
cop MOB3A 19p13.3 0.143 0.279 0.779
cop IZUMO4 19p13.3 0.143 0.279 0.779
his LOC729966 0.143 0.279 0.779
xai HMGA1P6 13q12.12 0.143 0.279 0.779
xai CCDC7 10p11.22 0.143 0.279 0.779
xai METTL9 16p12.2 0.143 0.279 0.779
swa SEC16A 9q34.3 0.143 0.279 0.779 COPII vesicle coating;protein
transport
hs4 LOC100131655 0.143 0.279 0.779
hs4 ZNF236 18q22-q23 0.143 0.279 0.779 regulation of transcription, DNA-
hs4 SELPLG 12q24 0.143 0.279 0.779 leukocyte migration;leukocyte tethering
or rolling
xai DUSP7 3p21 0.143 0.279 0.779 MyD88-dependent toll-like receptor signaling
pathway;TRIF-dependent toll-like receptor signaling pathway
xai STAT5A 17q11.2 0.143 0.279 0.779 Apoptosis
exp RABGGTA 14q11.2 0.142 0.279 0.779 protein modification process;visual
perception
met GMNN 6p22.3 0.142 0.279 0.779 DDR (DNA replication)
cop NARF 17q25.3 0.142 0.279 0.779
xsq C8orf33 8q24.3 0.142 0.279 0.779
met SUCLA2 13q12.2-q13.3 0.142 0.279 0.779 succinate metabolic
exp TAF11 6p21.31 0.142 0.279 0.779 regulation of transcription, DNA-
met SMARCA1 Xq25 0.142 0.279 0.779 transcription, DNA-dependent;brain
development
mut FAM166A 9q34.3 0.142 0.279 0.779
xsq HEATR6 17q23.1 0.142 0.279 0.779
cop TBCD 17q25.3 0.142 0.279 0.779 negative regulation of cell-substrate
exp HSD11B2 16q22 0.142 0.279 0.779 response to insulin stimulus;response to
drug
met MKI67 10q26.2 0.142 0.279 0.779 meiosis;cell proliferation
met LYPLA1 8q11.23 0.142 0.279 0.779 lipid metabolic process;fatty acid
metabolic process
dependent"
xsq RELL2 5q31.3 0.142 0.279 0.779 positive regulation of cell-substrate
adhesion
exp ACLY 17q21.2 0.142 0.279 0.779 energy reserve metabolic process;cellular
exp ZBTB34 9q33.3 0.142 0.279 0.779 regulation of transcription, DNA-
dependent"
cop C2orf15 0.142 0.279 0.779
cop LIPT1 0.142 0.279 0.779 protein modification process;lipid metabolic
process
cop MITD1 2q11.2 0.142 0.279 0.779 protein transport
cop LYG2 2q11.2 0.142 0.279 0.779 metabolic process;peptidoglycan catabolic
process
exp LOC100506014 0.142 0.279 0.779
xsq GPR150 5q15 0.142 0.279 0.779
xsq LYPD4 19q13.2 0.142 0.279 0.779
met PIWIL3 22q11.23 0.142 0.279 0.779 regulation of translation;meiosis
xsq OR10P1 12q13.2 0.142 0.279 0.779
met LMO2 11p13 0.142 0.279 0.779 cellular response to thyroid hormone
xsq LINC00242 6q27 0.142 0.279 0.779
cop CLTC 17q23.1 0.142 0.279 0.779 vesicle-mediated transport;intracellular
protein transport
exp MKNK2 19p13.3 0.142 0.279 0.779 Protein Kinases
met ZNF75D Xq26.3 0.142 0.279 0.779 regulation of transcription, DNA-
cop ZSWIM8 10q22.2 0.142 0.279 0.779
met MXRA7 17q25.1 0.142 0.279 0.779
cop MIR454 0.142 0.279 0.779
cop MIR301A 0.142 0.279 0.779
cop PRR11 17q22 0.142 0.279 0.779
cop SMG8 17q22 0.142 0.279 0.779 nuclear-transcribed mRNA catabolic process,
nonsense-mediated decay;gene expression
cop GDPD1 17q22 0.142 0.279 0.779 lipid metabolic process;glycerol metabolic
process
cop YPEL2 17q22 0.142 0.279 0.779
cop MIR4729 0.142 0.279 0.779
cop PIAS1 15q 0.142 0.279 0.779 DNA Damage Response (DDR)
xsq MARCH9 12q14.1 0.142 0.279 0.779
met RGN Xp11.3 0.142 0.279 0.779
exp CPNE7 16q24.3 0.142 0.279 0.779 lipid metabolic process;transport
mut TFE3 Xp11.22 0.142 0.279 0.779 regulation of transcription, DNA-
dependent;humoral immune response
xsq C3orf22 3q21.3 0.142 0.279 0.779
met NASP 1p34.1 -0.142 0.279 0.779 cell proliferation;protein
transport
exp RBM11 21q11 -0.142 0.279 0.779
exp LINGO2 9p21.2 -0.142 0.279 0.779
xsq TRIM34 -0.142 0.279 0.779 protein trimerization
cop UQCC1 -0.142 0.279 0.779
exp STEAP2 7q21.13 -0.142 0.279 0.779 regulated secretory
met NAAA 4q21.1 -0.142 0.279 0.779 lipid metabolic process
xsq RNF157 17q25.1 -0.142 0.279 0.779
xsq LILRB2 19q13.4 -0.142 0.279 0.779 immune response-inhibiting
cell surface receptor signaling pathway;heterotypic cell-cell adhesion
met MX2 21q22.3 -0.142 0.279 0.779 GTP catabolic process;defense
response
cop ULK2 17p11.2 -0.142 0.279 0.779 signal transduction;nervous system
development
xsq CDH1 16q22.1 -0.142 0.279 0.779 Cell Signaling; Tumor Suppressors
exp SLC25A43 Xq24 -0.142 0.279 0.779 Solute Carriers
mut ARSD Xp22.3 -0.142 0.279 0.779
exp TP53 17p13.1 -0.142 0.279 0.779 Apoptosis; DNA Damage Response
(DDR); DDR (DNA replication); Tumor Suppressors
met PARP15 3q21.1 -0.142 0.279 0.779 regulation of transcription,
DNA-dependent"
exp PPP2R4 9q34 -0.142 0.279 0.779 Apoptosis
exp NFIL3 9q22 -0.142 0.279 0.779 immune response;circadian rhythm
exp GRM1 6q24 -0.142 0.279 0.779 locomotory behavior;calcium-mediated
signaling
hs4 SKIL 3q26 -0.143 0.279 0.779 protein heterotrimerization;cell cycle
arrest
his LOC100506700 -0.143 0.279 0.779
his VDR 12q13.11 -0.143 0.279 0.779 negative regulation of
differentiation
hs4 TNIK 3q26.31 -0.143 0.279 0.779 protein phosphorylation;protein
autophosphorylation
hs4 NOL4L -0.143 0.279 0.779
hs4 FADS3 11q12-q13.1 -0.143 0.279 0.779 electron transport
xai KRT18P43 -0.143 0.279 0.779
hs4 LMO1 11p15 -0.143 0.279 0.779 negative regulation of transcription from
II promoter
exp PHF2P1 13q11 -0.143 0.279 0.779
swa UAP1L1 9q34.3 -0.143 0.279 0.779 metabolic process
hs4 ZBED2 3q13.2 -0.143 0.279 0.779
xai ZNF503-AS2 10q22.2 -0.143 0.279 0.779
xai AP1S2 Xp22.2 -0.143 0.279 0.779 post-Golgi vesicle-mediated
his FAM183CP 8p12 -0.143 0.279 0.779
his MIR4469 -0.143 0.279 0.779
his RNF170 8p11.21 -0.143 0.279 0.779
his HOOK3 8p11.21 -0.143 0.279 0.779 cytoplasmic microtubule
exp MAMDC2-AS1 -0.143 0.279 0.779
his ALPK3 15q25.2 -0.143 0.279 0.779 protein
hs4 ALDH3B2 11q13 -0.143 0.279 0.779 alcohol metabolic process;cellular
hs4 TRIM62 1p35.1 -0.143 0.279 0.779
xai USP18 22q11.21 -0.143 0.279 0.779 proteolysis;ubiquitin-dependent
hs4 TIMP4 3p25 -0.143 0.279 0.779 response to peptide hormone
stimulus;central nervous system development
hs4 PGM1 1p31 -0.143 0.279 0.779 glycogen biosynthetic process;glycogen
catabolic process
hs4 MPPED2 11p13 -0.143 0.279 0.779 nervous system development
hs4 WNT7B 22q13 -0.143 0.279 0.779 Oncogenes
hs4 CELSR3 3p21.31 -0.143 0.279 0.779 G-protein coupled receptor
hs4 CELSR3-AS1 -0.143 0.279 0.779
hs4 CFAP53 -0.143 0.279 0.779
his MEIS1-AS3 2p14 -0.143 0.279 0.779
his MEIS1 2p14 -0.143 0.279 0.779 multicellular organismal development
his MEIS1-AS2 -0.143 0.279 0.779
hs4 B3GALT5 21q22.3 -0.143 0.279 0.779 protein glycosylation
hs4 B3GALT5-AS1 -0.143 0.279 0.779
his CDK18 1q31-q32 -0.143 0.279 0.779 Protein Kinases
hs4 C14orf105 14q22.3 -0.143 0.279 0.779
xai TFEB 6p21 -0.143 0.279 0.779 positive regulation of transcription from
hs4 MPP6 7p15 -0.143 0.279 0.779 protein complex assembly
DNA-dependent"
xai COL27A1 9q32 -0.143 0.279 0.779 cell adhesion
swa HNRNPA3 2q31.2 -0.143 0.279 0.779 nuclear mRNA splicing, via
xai DNMBP 10q24.2 -0.143 0.279 0.779 regulation of Rho protein signal
his ME2 18q21 0.143 0.28 0.779 malate metabolic process
xai MID1IP1 Xp11.4 0.143 0.28 0.779 negative regulation of microtubule
depolymerization;positive regulation of fatty acid biosynthetic process
xai SNRPFP3 0.143 0.28 0.779
his JAKMIP2 5q32 0.143 0.28 0.779
xai POTEG 0.143 0.28 0.779
xai ASAH2 10q11.21 0.143 0.28 0.779 small molecule metabolic process;lipid
metabolic process
xai ANKHD1 0.143 0.28 0.779
hs4 FAM180B 11p11.2 0.143 0.28 0.779
dependent"
his UBXN4 2q21.3 0.143 0.28 0.779 response to unfolded protein
xai BANF1P3 0.143 0.28 0.779
his IRF7 11p15.5 0.143 0.28 0.779 Apoptosis
his PDDC1 11p15.5 0.143 0.28 0.779
his LOC171391 0.143 0.28 0.779
exp LOC100996643 0.143 0.28 0.779
his MRNIP 0.143 0.28 0.779
his LOC100996419 0.143 0.28 0.779
his LOC343052 1q21.3 0.143 0.28 0.779
hs4 LRPPRC 2p21 0.143 0.28 0.779 regulation of transcription, DNA-
dependent;transport
swa RB1 13q14.2 0.143 0.28 0.779 Apoptosis; DDR (DNA replication); Tumor
Suppressors
his FAM133B 7q21.2 0.143 0.28 0.779
exp SRP72P1 0.143 0.28 0.779
hs4 LINC00514 0.143 0.28 0.779
xai ELAVL4 1p34 0.143 0.28 0.779 RNA processing;mRNA processing
hs4 RRP7BP 0.143 0.28 0.779
his TREM2 6p21.1 0.143 0.28 0.779 humoral immune response;axon guidance
xai CHRNA5 15q24 0.143 0.28 0.779 signal transduction;synaptic transmission
his MIR3198-1 0.143 0.28 0.779
xai RANBP1 22q11.21 0.143 0.28 0.779 viral reproduction;positive
xai PGAM1P4 3p25.3 0.143 0.28 0.779
hs4 AP1G2 14q11.2 0.143 0.28 0.779 intracellular protein transport;vesicle-
mediated transport
his IFITM5 0.143 0.28 0.779
his EIF3A 10q26 0.143 0.28 0.779 translational initiation;gene expression
exp OR7A1P 19p13.12 0.143 0.28 0.78
his C19orf67 19p13.12 0.143 0.28 0.78
dependent"
swa GTF3C2 2p23.3 0.143 0.28 0.78 transcription, DNA-
xai HRSP12 8q22 0.143 0.28 0.78 regulation of translational termination
exp RPL9P5 14q23.1 0.143 0.28 0.78
xai TYW1 7q11.21 0.143 0.28 0.78 tRNA processing
his CD248 11q13 0.143 0.28 0.78
his MOB1B 4q13.3 0.143 0.28 0.78 hippo signaling cascade;positive
hs4 ULBP1 6q25 0.143 0.28 0.78 antigen processing and presentation;natural
exp BANF1P3 0.143 0.28 0.78
his ANKRD18B 9p13.3 0.143 0.28 0.78
hs4 NSUN6 10p12.31 0.143 0.28 0.78
exp SH2D4B 10q23.1 0.143 0.28 0.78
hs4 MTA2 11q12-q13.1 0.143 0.28 0.78 negative regulation of transcription from
xsq TBC1D14 4p16.1 0.142 0.28 0.779
xsq LOC102546226 0.142 0.28 0.779
met ISCA2 14q24.3 0.142 0.28 0.779 iron-sulfur cluster assembly
cop GDPD5 11q13.4-q13.5 0.142 0.28 0.779 glycerol metabolic process;lipid
metabolic process
xsq METTL23 17q25.1 0.142 0.28 0.779
exp SLC38A2 12q 0.142 0.28 0.779 Solute Carriers
xsq TIAF1 17q11.2 0.142 0.28 0.779 Apoptosis
exp TRPM6 9q21.13 0.142 0.28 0.779 ion transport;response to toxin
exp GCLC 6p12 0.142 0.28 0.779 response to heat;small molecule metabolic
process
met TRIM3 11p15.5 0.142 0.28 0.779 nervous system development;protein
transport
met ATP6V1E1 22q11.1 0.142 0.28 0.779 ion transport;cellular iron ion
homeostasis
met ANXA1 9q21.13 0.142 0.28 0.779 Apoptosis
cop KRT9 17q21.2 0.142 0.28 0.779 skin development;intermediate filament
organization
cop KRT14 17q21.2 0.142 0.28 0.779 intermediate filament bundle
cop KRT16 17q21.2 0.142 0.28 0.779 cytoskeleton organization;cell
proliferation
cop KRT17 17q21.2 0.142 0.28 0.779
cop KRT42P 17q21.2 0.142 0.28 0.779
cop EIF1 17q21.2 0.142 0.28 0.779 translation;translational initiation
cop GAST 17q21 0.142 0.28 0.779
cop HAP1 17q21.2-q21.3 0.142 0.28 0.779 protein localization;synaptic
transmission
xsq OR51D1 11p15.4 0.142 0.28 0.779 response to stimulus
cop LCE5A 1q21.3 0.142 0.28 0.779
cop CRCT1 1q21 0.142 0.28 0.779
cop LCE3E 0.142 0.28 0.779 keratinization
cop LCE3D 0.142 0.28 0.779
mut CDH26 20q13.33 0.142 0.28 0.779 cell adhesion;homophilic cell adhesion
exp MUC17 7q22.1 0.142 0.28 0.779 O-glycan processing;cellular homeostasis
xsq FAM138B 0.142 0.28 0.779
exp HPR 16q22.1 0.142 0.28 0.779
xsq LOC155060 7q36.1 0.142 0.28 0.779
xsq LINC01105 0.142 0.28 0.779
met IRX1 5p15.3 0.142 0.28 0.779
cop DPCD 10q24.32 0.142 0.28 0.779
xsq ADSS 1q44 0.142 0.28 0.779 purine nucleotide biosynthetic process;AMP
cop CCDC68 18q21 0.142 0.28 0.779
xsq LEFTY2 1q42.1 0.142 0.28 0.779 transforming growth factor beta
receptor signaling pathway;multicellular organismal development
xsq TRUB1 10q25.3 0.142 0.28 0.779 pseudouridine synthesis;RNA processing
met PCDH20 13q21 0.142 0.28 0.779 cell adhesion;homophilic cell adhesion
met ADAMTSL3 15q25.2 0.142 0.28 0.779
exp PCSK6 15q26.3 0.142 0.28 0.779 regulation of BMP signaling pathway;nerve
growth factor processing
xsq LOC100506730 0.142 0.28 0.779
xsq GMCL1P1 5q35.3 0.142 0.28 0.78
met LRRC27 10q26.3 0.142 0.28 0.78
xsq TLK2 17q23 0.142 0.28 0.78 DDR (DNA replication)
met CHD6 20q12 0.142 0.28 0.78 chromatin remodeling;regulation of
xsq CCDC157 22q12.2 0.142 0.28 0.78
cop CALML4 15q23 0.142 0.28 0.78
cop CLN6 15q23 0.142 0.28 0.78 protein catabolic process;glycosaminoglycan
metabolic process
dependent"
met ASPM 1q31 0.142 0.28 0.78 cell cycle;mitosis
xsq ST6GAL1 3q27-q28 0.142 0.28 0.78 protein modification
met CHIA 1p13.2 0.142 0.28 0.78 production of molecular mediator involved
in inflammatory response;response to fungus
cop UNC13D 17q25.1 0.142 0.28 0.78 phagocytosis;regulation of mast
cell degranulation
cop WBP2 17q25 0.142 0.28 0.78
cop TRIM47 17q25 0.142 0.28 0.78
cop TRIM65 17q25.1 0.142 0.28 0.78
xsq UTS2B 3q28 0.142 0.28 0.78
xsq ZNF189 9q22-q31 0.142 0.28 0.78 negative regulation of
xsq IMP4 2q21.1 0.142 0.28 0.78 rRNA processing
xsq NEK2 1q32.3 0.142 0.28 0.78 DNA Damage Response (DDR)
cop KIAA1033 12q24.11 0.142 0.28 0.78 endosome transport
met DNASE1L1 Xq28 0.142 0.28 0.78 DNA metabolic process;DNA catabolic
process
xsq FUNDC2P2 2p11.2 0.142 0.28 0.78
met HS3ST2 16p12 0.142 0.28 0.78 circadian rhythm
exp AK7 14q32.2 0.142 0.28 0.78 nucleobase-containing compound metabolic
met VAX2 2p13 0.142 0.28 0.78 multicellular organismal development;ectoderm
development
cop H2AFJ 12p12.3 0.142 0.28 0.78 nucleosome assembly
xsq FAM50A Xq28 -0.142 0.28 0.78 spermatogenesis
xsq BIRC7 20q13.3 -0.142 0.28 0.78 Apoptosis
mut ZIK1 19q13.43 -0.142 0.28 0.78 regulation of transcription, DNA-
dependent"
mut TBX10 11q13.2 -0.142 0.28 0.78 anatomical structure
exp LOC100131216 3q26.32 -0.142 0.28 0.78
cop RBMY3AP -0.142 0.28 0.78
exp CCDC120 Xp11.23 -0.142 0.28 0.78
xsq PHC3 3q26.2 -0.142 0.28 0.779 multicellular organismal
development
cop COLGALT2 1q25 -0.142 0.28 0.779
cop TSEN15 1q25 -0.142 0.28 0.779 mRNA processing;tRNA processing
exp ENTPD6 20p11.21 -0.142 0.28 0.779 response to magnesium
ion;response to calcium ion
mut FTSJ3 17q23.3 -0.142 0.28 0.779 RNA methylation;rRNA processing
xsq PCGF2 17q12 -0.142 0.28 0.779 negative regulation of transcription from
exp PLEKHF2 8q22.1 -0.142 0.28 0.779
xsq EDIL3 5q14 -0.142 0.28 0.779 cell adhesion;multicellular organismal
development
exp LDLRAD3 11p13 -0.142 0.28 0.779
xsq GEM 8q13-q21 -0.142 0.28 0.779 GTP catabolic process;immune
response
xsq RTN4R 22q11.21 -0.142 0.28 0.779 axonogenesis;nerve growth factor
met HERC5 4q22.1 -0.142 0.28 0.779 cytokine-mediated signaling
cop RASA2 3q22-q23 -0.142 0.28 0.779 positive regulation of Ras GTPase
met TMEM55A 8q21.3 -0.142 0.28 0.779
exp LOC727721 1p36.22 -0.142 0.28 0.779
cop KLF4 9q31 -0.142 0.28 0.779 mesodermal cell fate
exp BMPER 7p14.3 -0.142 0.28 0.779 ureteric bud development;blood
his COL6A3 2q37 -0.143 0.28 0.78 response to glucose stimulus;cell
adhesion
xai SYCE1 10q26.3 -0.143 0.28 0.78 cell cycle;meiosis
xai RGR 10q23 -0.143 0.28 0.78 G-protein coupled receptor signaling
xai HEY2 6q21 -0.143 0.28 0.78 negative regulation of transcription from
RNA polymerase II promoter;pattern specification process
xai RAB7A 3q21.3 -0.143 0.28 0.78 endosome to lysosome
swa NDUFB10 16p13.3 -0.143 0.28 0.78 mitochondrial electron
his MIR7706 -0.143 0.28 0.78
his AKAP13 15q24-q25 -0.143 0.28 0.78 nerve growth factor receptor
xai KRT18P46 2q24.2 -0.143 0.28 0.78
his C2orf73 2p16.2 -0.143 0.28 0.78
exp LOC100130761 -0.143 0.28 0.78
his LINC00504 -0.143 0.28 0.78
hs4 FUCA1 1p34 -0.143 0.28 0.78 carbohydrate metabolic process;fucose
metabolic process
xai SDHC 1q23.3 -0.143 0.28 0.78 tricarboxylic acid cycle;transport
his LOC100134868 20p11.1 -0.143 0.28 0.78
swa CTSZ 20q13.32 -0.143 0.28 0.78 proteolysis;epithelial tube
hs4 SIPA1L1 14q24.2 -0.143 0.28 0.78 actin cytoskeleton
reorganization;regulation of Rap GTPase activity
xai PPP4R1L 20q13.32 -0.143 0.28 0.779
xai MFGE8 15q25 -0.143 0.28 0.779 phagocytosis, recognition;phagocytosis,
engulfment
hs4 FAM50A Xq28 -0.143 0.28 0.779 spermatogenesis
xai LOC100130761 -0.143 0.28 0.779
xai KCTD10 12q24.11 -0.143 0.28 0.779 potassium ion
hs4 LINC00683 -0.143 0.28 0.779
his CAMSAP2 1q32.1 -0.143 0.28 0.779
his LOC101927243 -0.143 0.28 0.779
his GSAP 7q11.23 -0.143 0.28 0.779
his LOC101929592 -0.143 0.28 0.779
his ZXDC 3q21.3 -0.143 0.28 0.779 positive regulation of
his LINC02101 -0.143 0.28 0.779
hs4 DLG5 10q23 -0.143 0.28 0.779 signal transduction;negative regulation
hs4 DLG5-AS1 10q22.3 -0.143 0.28 0.779
DNA-dependent"
cop LOC284412 -0.143 0.28 0.779
cop HKR1 19q13.12 -0.143 0.28 0.779 regulation of transcription, DNA-
DNA-dependent"
xai SERAC1 6q25.3 -0.143 0.28 0.779 GPI anchor metabolic
hs4 ATP10D 4p12 -0.143 0.28 0.779 cation transport;ion transmembrane
transport
xai DYTN 2q33.3 -0.143 0.28 0.779
xai ITGA11 15q23 -0.143 0.28 0.779 integrin-mediated signaling
hs4 BLVRA 7p13 -0.143 0.28 0.779 porphyrin-containing compound metabolic
xai FLJ16779 20q13.33 -0.143 0.28 0.779
hs4 RNF39 6p21.3 -0.143 0.28 0.779
xai KIAA1033 12q24.11 -0.143 0.28 0.779 endosome transport
exp MYO5BP3 -0.143 0.28 0.779
hs4 S100B 21q22.3 -0.143 0.28 0.779 learning or memory;memory
xai TUSC3 8p22 -0.143 0.28 0.779 Tumor Suppressors
exp AKR1B1P4 13q14.13 -0.143 0.28 0.779
exp LOC101448202 0.143 0.281 0.78
xai ASTL 2q11.1 0.143 0.281 0.78 proteolysis
xai ARPC3P5 6p22.3 0.143 0.281 0.78
hs4 DEF6 6p21.33-p21.1 0.143 0.281 0.78
xai DHX36 3q25.2 0.143 0.281 0.78
his ADH5 4q23 0.143 0.281 0.78 retinoid metabolic process;formaldehyde
catabolic process
his LOC100507053 0.143 0.281 0.78
exp SNRPFP3 0.143 0.281 0.78
his STMN3 20q13.3 0.143 0.281 0.78 nervous system development;cytoplasmic
exp OR5G3 11q12.1 0.143 0.281 0.78
xai FAM161A 2p15 0.143 0.281 0.78 response to stimulus;visual perception
his EXD1 15q15.1 0.143 0.281 0.78 nucleobase-containing compound metabolic
process
his CHP1 15q13.3 0.143 0.281 0.78
swa G3BP2 4q21.1 0.143 0.281 0.78 small GTPase mediated signal
his BTN3A3 6p21.3 0.143 0.281 0.78
his RPS3A 4q31.2-q31.3 0.143 0.281 0.78 Apoptosis
his SNORD73A 4q31.3 0.143 0.281 0.78
xai RPL9P5 14q23.1 0.143 0.281 0.78
his STAR 8p11.2 0.143 0.281 0.78 lipid transport;steroid metabolic process
his CREG1 1q24 0.143 0.281 0.78 regulation of transcription from RNA polymerase
xai ACE3P 0.143 0.281 0.78
exp RPL31P58 0.143 0.281 0.78
his LINC00845 0.143 0.281 0.78
exp SMPD4P2 13q12.11 0.143 0.281 0.78
xai ZHX1-C8orf76 0.143 0.281 0.78
his ATG7 3p25.3 0.143 0.281 0.78 protein modification process;protein
transport
his BTBD7 14q32.12 0.143 0.281 0.78
his UNC79 14q32.12 0.143 0.281 0.78
hs4 ETV6 12p13 0.143 0.281 0.78 Transcription Factors
cop SLC7A5P2 0.143 0.281 0.78
hs4 MSN Xq11.1 0.143 0.281 0.78 EMT (Mesenchymal)
his DHX40 17q23.1 0.143 0.281 0.78
xai ITGAM 16p11.2 0.143 0.281 0.78 cell adhesion;integrin-mediated signaling
pathway
his NDUFA7 19p13.2 0.143 0.281 0.78 mitochondrial electron transport,
his RPS28 19p13.2 0.143 0.281 0.78 nuclear-transcribed mRNA catabolic
xai RPL31P58 0.143 0.281 0.78
swa PTK7 6p21.1-p12.2 0.143 0.281 0.78 establishment of planar
xai HRASLS5 11q13.2 0.143 0.281 0.78
exp LOC284930 0.143 0.281 0.78
his GAREM1 0.143 0.281 0.78
his ARPP21 3p22.3 0.143 0.281 0.78 cellular response to heat
xai CYCSP8 2q21.1 0.143 0.281 0.78
xai SRP72P1 0.143 0.281 0.78
cop RHBDL1 16p13.3 0.142 0.281 0.78 proteolysis;signal transduction
cop STUB1 16p13.3 0.142 0.281 0.78 protein polyubiquitination;positive
cop JMJD8 16p13.3 0.142 0.281 0.78
cop WDR24 16p13.3 0.142 0.281 0.78
cop ATF7IP 12p13.1 0.142 0.281 0.78 negative regulation of
transcription from RNA polymerase II promoter;DNA methylation
met SGCD 5q33-q34 0.142 0.281 0.78 cytoskeleton organization;muscle organ
development
cop FN3K 17q25.3 0.142 0.281 0.78 fructoselysine metabolic process
cop ZNF750 17q25.3 0.142 0.281 0.78
xsq ACTR3BP2 2p11.1 0.142 0.281 0.78
exp PCBP3 21q22.3 0.142 0.281 0.78 mRNA metabolic process
xsq NPTX2 7q21.3-q22.1 0.142 0.281 0.78 synaptic transmission
cop GOLPH3L 1q21.3 0.142 0.281 0.78
cop HORMAD1 1q21.3 0.142 0.281 0.78 meiosis;regulation of homologous
cop CTSS 1q21 0.142 0.281 0.78 antigen processing and presentation of
cop CTSK 1q21 0.142 0.281 0.78 intramembranous ossification;proteolysis
met PYDC1 16p11.2 0.142 0.281 0.78 positive regulation of interleukin-1 beta
xsq CHMP4A 14q12 0.142 0.281 0.78 endosome transport;protein transport
mut WHSC1 4p16.3 0.142 0.281 0.78 regulation of transcription, DNA-
xsq ANKRD11 16q24.3 0.142 0.281 0.78 in utero embryonic
xsq VN1R2 19q13.42 0.142 0.281 0.78 response to pheromone
cop RGS12 4p16.3 0.142 0.281 0.78 positive regulation of GTPase
activity;signal transduction
exp RNF10 12q24.31 0.141 0.281 0.78 negative regulation of Schwann cell
cop B4GALNT2 17q21.32 0.141 0.281 0.78 negative regulation of cell-cell
adhesion;lipid glycosylation
mut SGTA 19p13 0.141 0.281 0.78 interspecies interaction between organisms
met PPP1R2P3 5q33.3 0.141 0.281 0.78 glycogen metabolic
process;regulation of signal transduction
xsq APCS 0.141 0.281 0.78
met DCD 12q13.1 0.141 0.281 0.78
cop MAP4K2 11q13 0.141 0.281 0.78 JNK cascade;activation of JUN kinase
activity
dependent"
xsq OR10H5 0.141 0.281 0.78
met FAM160B2 8p21.3 0.141 0.281 0.78
xsq DNAI2 17q25 0.141 0.281 0.78 cell projection organization;cilium assembly
xsq COA1 7p13 0.141 0.281 0.78
dependent"
met TYW5 2q33.1 0.141 0.281 0.78 tRNA processing;wybutosine biosynthetic
process
cop GABRA5 15q12 0.141 0.281 0.78 brain development;cochlea development
xsq F12 5q35.3 0.141 0.281 0.78 protein autoprocessing;plasma kallikrein-
kinin cascade
xsq RAP1GAP 1p36.1-p35 0.141 0.281 0.78 regulation of Ras GTPase
activity;positive regulation of GTPase activity
exp CSNK1G1 15q22.1-q22.31 0.141 0.281 0.78 Protein Kinases
xsq RUVBL2 19q13.3 0.141 0.281 0.78 Apoptosis; DNA Damage Response
xsq SHMT2 12q12-q14 0.141 0.281 0.78 glycine biosynthetic process from
serine;protein homotetramerization
met RBM45 2q31.2 0.141 0.281 0.78 multicellular organismal
xsq MAP1S 19p13.11 0.141 0.281 0.78 microtubule bundle formation;apoptotic
process
xsq MKNK1 1p33 0.141 0.281 0.78 Protein Kinases
cop HIST4H4 12p12.3 0.141 0.281 0.78
cop ZSWIM8-AS1 0.141 0.281 0.78
cop NDST2 10q22 0.141 0.281 0.78 cellular process;heparan sulfate proteoglycan
cop CAMK2G 10q22 0.141 0.281 0.78 cytokine-mediated signaling
mut CD48 1q21.3-q22 0.141 0.281 0.78 T cell activation;mast cell activation
met CCDC113 16q21 0.141 0.281 0.78
met WBSCR27 7q11.23 0.141 0.281 0.78
xsq RECQL5 17q25 0.141 0.281 0.78 DNA Damage Response (DDR); DDR (HR)
dependent"
cop HNRNPC 14q11.2 0.141 0.281 0.78 nuclear mRNA splicing, via
mut TPPP2 14q11.2 -0.141 0.281 0.78
xsq TSPAN4 11p15.5 -0.141 0.281 0.78 protein complex assembly
exp LINC00540 -0.141 0.281 0.78
xsq HLA-DRB5 6p21.3 -0.141 0.281 0.78 T cell receptor signaling
pathway;interferon-gamma-mediated signaling pathway
exp DLX3 17q21 -0.141 0.281 0.78 placenta development;regulation of
xsq ADCY2 5p15.3 -0.141 0.281 0.78 cAMP biosynthetic process;synaptic
transmission
xsq ATP11A 13q34 -0.141 0.281 0.78 cation transport;phospholipid
translocation
cop FLJ42969 -0.141 0.281 0.78
xsq DLG2 11q14.1 -0.141 0.281 0.78 receptor clustering;neuronal ion
channel clustering
mut KIRREL 1q21-q25 -0.141 0.281 0.78 excretion
exp ABHD5 3p21 -0.141 0.281 0.78 negative regulation of sequestering of
exp FAM205A 9p12 -0.141 0.281 0.78
met CALML3 10p15.1 -0.141 0.281 0.78
xsq PPAN-P2RY11 19p13 -0.141 0.281 0.78
xsq SMCO2 12p11.23 -0.141 0.281 0.78
xsq IFIH1 2q24 -0.141 0.281 0.78 positive regulation of interferon-alpha
met SMYD1 2p11.2 -0.141 0.281 0.78 chromatin remodeling;heart
development
xsq S1PR2 19p13.2 -0.141 0.281 0.78 G-protein coupled receptor
signaling pathway;behavior
mut ACE 17q23.3 -0.141 0.281 0.78 proteolysis;regulation of
vasodilation
DNA-dependent"
exp AKT2 19q13.1-q13.2 -0.141 0.281 0.78 Protein Kinases
exp GJB6 13q12 -0.141 0.281 0.78 cell communication;sensory perception of
sound
xsq CT45A3 Xq26.3 -0.142 0.281 0.78
xsq GALNT3 2q24-q31 -0.142 0.281 0.78 protein O-linked
glycosylation via serine;protein O-linked glycosylation via threonine
cop IFNK -0.142 0.281 0.78
cop C9orf72 9p21.2 -0.142 0.281 0.78 cell death
xsq FBLN5 14q32.1 -0.142 0.281 0.78 regulation of removal of superoxide
xsq ERCC6 10q11.23 -0.142 0.281 0.78 DNA Damage Response (DDR); DDR
(NER)
xsq SMO 7q32.3 -0.142 0.281 0.78 Oncogenes
xsq LOC101927481 -0.142 0.281 0.78
xsq C5orf15 5q31.1 -0.142 0.281 0.78
exp FRMPD3-AS1 -0.143 0.281 0.78
xai IER5 1q25.3 -0.143 0.281 0.78
xai NMNAT2 1q25 -0.143 0.281 0.78 vitamin metabolic process;water-
xai MIA 19q13.2 -0.143 0.281 0.78 cell proliferation
hs4 AK5 1p31 -0.143 0.281 0.78 nucleotide biosynthetic
process;pyrimidine ribonucleotide biosynthetic process
his FRMD6-AS2 -0.143 0.281 0.78
xai WBP1L 10q24.32 -0.143 0.281 0.78
xai DNASE2B 1p22.3 -0.143 0.281 0.78 DNA metabolic
exp C17orf64 17q23.2 -0.143 0.281 0.78
xai FRMPD3-AS1 -0.143 0.281 0.78
hs4 LARGE1 -0.143 0.281 0.78
his SEPT4 17q22 -0.143 0.281 0.78 brain development;sperm mitochondrion
organization
hs4 FNBP1L 1p22.1 -0.143 0.281 0.78 endocytosis
hs4 GJB3 1p34 -0.143 0.281 0.78 cell communication;sensory perception of
sound
exp SS18L2P1 10p11.21 -0.143 0.281 0.78
xai NRAV -0.143 0.281 0.78
his SNORA80A -0.143 0.281 0.78
exp KALP Yq11 -0.143 0.281 0.78
his C10orf67 10p12.2 -0.143 0.281 0.78
xai BAMBI 10p12.3-p11.2 -0.143 0.281 0.78 cell migration;negative
hs4 KDELR2 7p22.1 -0.143 0.281 0.78 vesicle-mediated
his EPSTI1 13q13.3 -0.143 0.281 0.78
hs4 HOXB3 17q21.3 -0.143 0.281 0.78 multicellular organismal
hs4 HOXB4 -0.143 0.281 0.78 morphogenesis of an epithelial
hs4 MIR10A -0.143 0.281 0.78
hs4 HOXB-AS3 17q21.32 -0.143 0.281 0.78
hs4 HOXB7 17q21.3 -0.143 0.281 0.78 myeloid cell
hs4 HOXB8 17q21.3 -0.143 0.281 0.78 sensory perception of pain;dorsal
spinal cord development
xai SS18L2P1 10p11.21 -0.143 0.281 0.78
xai C2CD4D 1q21.3 -0.143 0.281 0.78
hs4 ATP1A1 1p21 -0.143 0.281 0.78 ATP biosynthetic process;positive
cop ALG1 16p13.3 0.144 0.282 0.781 protein N-linked glycosylation via
his SNORD131 0.143 0.282 0.78
hs4 DGAT1 8q24.3 0.143 0.282 0.78 triglyceride metabolic
cop FAM86A 16p13.3 0.143 0.282 0.78
xai GFY 0.143 0.282 0.78
xai PAPSS1 4q24 0.143 0.282 0.78 3'-phosphoadenosine 5'-phosphosulfate
xai ATP2A2 12q24.11 0.143 0.282 0.78 transmembrane transport;ATP
hs4 PARM1 4q13.3-q21.3 0.143 0.282 0.78 positive regulation of telomerase
activity
his RAD17 5q13 0.143 0.282 0.78 DNA Damage Response (DDR)
his AK6 0.143 0.282 0.78
his TAF9 5q13.2 0.143 0.282 0.78 regulation of transcription, DNA-
process
xai OR7A1P 19p13.12 0.142 0.282 0.781
hs4 AKAP1 17q22 0.142 0.282 0.781 Apoptosis
his IRF8 16q24.1 0.142 0.282 0.781 immune response;positive regulation of
cop MIR4465 0.142 0.282 0.781
his RPL13AP5 10q24.1 0.142 0.282 0.781
his CENPU 0.142 0.282 0.781 mitotic prometaphase;mitotic cell cycle
dependent"
exp CYCSP8 2q21.1 0.142 0.282 0.781
hs4 NFKBID 19q13.12 0.142 0.282 0.781 positive regulation of thymocyte
apoptosis;inflammatory response
hs4 HCST 19q13.1 0.142 0.282 0.781 regulation of immune response
exp RPL7P4 6p21.33 0.142 0.282 0.781
his SFPQ 1p34.3 0.142 0.282 0.781 alternative nuclear mRNA splicing, via
spliceosome;DNA repair
xai IGHV3-6 0.142 0.282 0.781
xai ZNF75A 16p13.3 0.142 0.282 0.781 regulation of transcription, DNA-
dependent"
hs4 P2RX5-TAX1BP3 0.142 0.282 0.781
hs4 P2RX5 17p13.3 0.142 0.282 0.781 signal transduction;nervous system
development
hs4 RIMBP3 0.142 0.282 0.781
hs4 VPS4B 18q21.33 0.142 0.282 0.781 protein transport;cellular membrane
organization
exp LOC283922 16q23.1 0.142 0.282 0.781
hs4 GATAD2B 1q21.3 0.142 0.282 0.781
his GATAD1 7q21-q22 0.142 0.282 0.781
exp NPM1P51 6p21.1 0.142 0.282 0.781
dependent"
xai SSXP4 Xp11.2 0.142 0.282 0.781
xai ATXN1L 16q22.2 0.142 0.282 0.781 regulation of transcription, DNA-
dependent"
xai IZUMO2 19q13.33 0.142 0.282 0.781
his OTUD5 Xp11.23 0.142 0.282 0.781 protein K48-linked
xai NPM1P51 6p21.1 0.142 0.282 0.781
his BAZ1A 14q13.2 0.142 0.282 0.781 DNA Damage Response (DDR); DDR
(Chromatin)
his NUBPL 14q12 0.142 0.282 0.781 mitochondrial respiratory chain complex I
assembly;mitochondrion morphogenesis
xai LOC100287210 7q36.2 0.142 0.282 0.781
met CNTN6 3p26-p25 0.141 0.282 0.78 cell adhesion;Notch signaling pathway
met MARC2 1q41 0.141 0.282 0.78 nitrate metabolic process;detoxification of
nitrogen compound
exp KHDRBS2 6q11.1 0.141 0.282 0.78 regulation of transcription, DNA-
dependent"
xsq HNF1A-AS1 12q24.31 0.141 0.282 0.781
met ZNF816 19q13.41 0.141 0.282 0.781
exp MADD 11p11.2 0.141 0.282 0.781 activation of MAPK activity;positive
exp UFL1 6q16.1 0.141 0.282 0.781 negative regulation of protein
exp ATRX Xq21.1 0.141 0.282 0.781 DNA Damage Response (DDR); Tumor
Suppressors
mut MTHFD1 14q24 0.141 0.282 0.781 water-soluble vitamin metabolic
xsq MAP3K15 Xp22.12 0.141 0.282 0.781 Protein Kinases
cop GUCY2C 12p12 0.141 0.282 0.781 regulation of cell proliferation;cGMP
cop NEDD1 12q23.1 0.141 0.282 0.781 G2/M transition of mitotic cell
mut SULT1E1 4q13.1 0.141 0.282 0.781 xenobiotic metabolic process;female
pregnancy
met CD151 11p15.5 0.141 0.282 0.781 cell adhesion;hemidesmosome assembly
mut ZFAT 8q24.22 0.141 0.282 0.781 regulation of transcription, DNA-
dependent"
met SELK 3p21.31 0.141 0.282 0.781
xsq CST7 20p11.21 0.141 0.282 0.781 immune response;negative regulation of
met MIR323A 0.141 0.282 0.781
met SNAR-H 2p12 0.141 0.282 0.781
exp DUSP7 3p21 0.141 0.282 0.781 MyD88-dependent toll-like receptor signaling
pathway;TRIF-dependent toll-like receptor signaling pathway
cop PLBD1 12p13.1 0.141 0.282 0.781 lipid catabolic process
exp HS6ST1 2q21 0.141 0.282 0.781 labyrinthine layer blood vessel
xsq MRPL19 2p11.1-q11.2 0.141 0.282 0.781 translation
xsq MESDC2 15q13 0.141 0.282 0.781 protein folding;mesoderm development
xsq TAS1R3 1p36.33 0.141 0.282 0.781 sensory perception of umami
taste;detection of chemical stimulus involved in sensory perception of sweet taste
met MIR30B 0.141 0.282 0.781
mut CRYGS 3q27.3 0.141 0.282 0.781 morphogenesis of an epithelium;lens
exp RPS27P22 12p12.1 0.141 0.282 0.781
xsq RYR1 19q13.1 0.141 0.282 0.781 response to caffeine;calcium ion
dependent"
cop GLUD1P3 10q22.2 0.141 0.282 0.781
cop SEC24C 10q22.2 0.141 0.282 0.781 post-translational protein
cop FUT11 10q22.2 0.141 0.282 0.781 protein glycosylation
xsq CLECL1 0.141 0.282 0.781
mut PDE6A 5q31.2-q34 -0.141 0.282 0.781 signal transduction;blood
coagulation
xsq PDZK1P1 -0.141 0.282 0.781
xsq DUSP5 10q25 -0.141 0.282 0.781 endoderm formation;protein
dephosphorylation
cop SDK1 7p22.2 -0.141 0.282 0.781 cell adhesion
met SPPL3 12q24.31 -0.141 0.282 0.781 proteolysis
cop SAMD12-AS1 -0.141 0.282 0.781
xsq GUCY1A3 4q31.1-q31.2 -0.141 0.282 0.781 cGMP biosynthetic
process;nitric oxide mediated signal transduction
met TMOD3 15q21.1-q21.2 -0.141 0.282 0.781
exp TMEM144 4q32.1 -0.141 0.282 0.781
xsq NMT2 10p13 -0.141 0.282 0.781 N-terminal protein myristoylation;protein
lipoylation
xsq SKI 1p36.33 -0.141 0.282 0.781 negative regulation of
transcription from RNA polymerase II promoter;negative regulation of Schwann cell
proliferation
cop EIF2S2 20q11.2 -0.141 0.282 0.781 male gonad development;gene
expression
cop ASIP 20q11.2-q12 -0.141 0.282 0.781 hormone-mediated signaling
cop AHCY 20q11.22 -0.141 0.282 0.781 sulfur amino acid metabolic
process;one-carbon metabolic process
xsq PHACTR2 6q24.2 -0.141 0.282 0.781
exp BCL3 19q13.1-q13.2 -0.141 0.282 0.781 marginal zone B cell
differentiation;antimicrobial humoral response
exp DTX3 12q13.3 -0.141 0.282 0.781 Notch signaling pathway
met GET4 7p22.3 -0.141 0.282 0.781 transport;tail-anchored membrane
protein insertion into ER membrane
cop TRIML1 4q35.2 -0.141 0.282 0.781
xsq CAPN5 11q14 -0.141 0.282 0.781 granulosa cell differentiation;ovarian
cop PXDNL 8q11.22-q11.23 -0.141 0.282 0.781 response to oxidative
exp LMOD1 1q32 -0.141 0.282 0.781 muscle contraction
mut NLRP1 17p13.2 -0.141 0.282 0.781 defense response to
bacterium;regulation of apoptotic process
xsq TACR1 2p12 -0.141 0.282 0.781 inflammatory response;response to heat
xsq OCLM 1q25 -0.141 0.282 0.781 visual perception
exp IRF6 1q32.3-q41 -0.141 0.282 0.781 EMT (Epithelial); Tumor Suppressors
met PHLDB1 11q23.3 -0.141 0.282 0.781
mut GMNN 6p22.3 -0.141 0.282 0.781 DDR (DNA replication)
met CCDC155 19q13.33 -0.141 0.282 0.781 protein dephosphorylation
exp RPS6KA4 11q11-q13 -0.141 0.282 0.781 Protein Kinases
met SPP1 4q22.1 -0.141 0.282 0.781 ossification;response to vitamin D
exp LINC00268-2P Yq11.1 -0.141 0.282 0.781
xsq LAMA5-AS1 -0.141 0.282 0.781
met A4GNT 3p14.3 -0.141 0.282 0.781 carbohydrate metabolic
process;protein O-linked glycosylation
xsq SERPINA5 14q32.1 -0.141 0.282 0.781 spermatogenesis;fusion of
xsq LINC00968 -0.141 0.282 0.781
exp SLC7A14 3q26.2 -0.141 0.282 0.78 transport;negative regulation
mut MUT 6p12.3 -0.141 0.282 0.78 fatty acid beta-oxidation;post-
met SHCBP1L 1q25.3 -0.141 0.282 0.78
mut NPY4R 10q11.2 -0.141 0.282 0.78
met MYL12A 18p11.31 -0.141 0.282 0.78
exp GOLGA7B 10q24.2 -0.141 0.282 0.78
xai OR7E90P 2q24.1 -0.142 0.282 0.781
hs4 FAAH 1p35-p34 -0.142 0.282 0.781 fatty acid catabolic process
swa ACTBL2 5q11.2 -0.142 0.282 0.781
his MIR1202 -0.142 0.282 0.781
exp PPP6R2P1 -0.142 0.282 0.781
exp OR7E90P 2q24.1 -0.142 0.282 0.781
xai SLC8A3 14q24.1 -0.142 0.282 0.781 telencephalon
exp VWA5B1 1p36.12 -0.142 0.282 0.781
his KLKP1 -0.142 0.282 0.781
his LAMB1 7q22 -0.142 0.282 0.781 embryo implantation;positive regulation
of cell migration
his FAM157B -0.142 0.282 0.781
hs4 SPATC1L 21q22.3 -0.142 0.282 0.781
DNA-dependent"
hs4 HLA-DMA 6p21.3 -0.142 0.282 0.781 antigen processing and
presentation of exogenous peptide antigen via MHC class II;T cell costimulation
hs4 GGN 19q13.2 -0.142 0.282 0.781 cell differentiation;multicellular
hs4 SPRED3 19q13 -0.142 0.282 0.781 multicellular organismal
swa USP9X Xp11.4 -0.142 0.282 0.781 mitosis;transforming growth factor
xai LOC100507420 -0.142 0.282 0.781
hs4 ATP6V1E1 22q11.1 -0.142 0.282 0.781 ion transport;cellular iron
ion homeostasis
his ACKR2 3p21.3 -0.142 0.282 0.781
his LINC01204 -0.142 0.282 0.78
exp ECT2L 6q24.1 -0.143 0.282 0.78 regulation of Rho protein signal
transduction
xai CSRP2 12q21.1 -0.143 0.282 0.78 multicellular organismal
hs4 FBLIM1 1p36.21 -0.143 0.282 0.78 cell adhesion;regulation of
cell shape
xai ADD3-AS1 0.142 0.283 0.781
xai FAM181A-AS1 14q32.12 0.142 0.283 0.781
xai SMCO4 11q21 0.142 0.283 0.781
exp KRT17P5 0.142 0.283 0.781
xai VPS35 16q12 0.142 0.283 0.781 cell death;protein transport
his ZBTB24 6q21 0.142 0.283 0.781 regulation of transcription, DNA-
dependent"
swa STMN1 1p36.11 0.142 0.283 0.781 response to virus;cell differentiation
xai CLDN10 13q31-q34 0.142 0.283 0.781 cell adhesion;calcium-independent
cell-cell adhesion
exp BPIFA4P 20q11.21 0.142 0.283 0.781
his LGALS7 0.142 0.283 0.781
xai PRKD2 19q13.3 0.142 0.283 0.781 positive regulation of interleukin-2
production;positive regulation of angiogenesis
exp SSXP4 Xp11.2 0.142 0.283 0.781
xai CASP3 4q34 0.142 0.283 0.781 Apoptosis
hs4 RNU1-4 1p36.1 0.142 0.283 0.781
xai LOC730100 2p16.3 0.142 0.283 0.781
hs4 LRRC23 12p13 0.142 0.283 0.781
his HMGA1 6p21 0.142 0.283 0.781 protein complex assembly;interspecies
his MIR6835 0.142 0.283 0.781
his C6orf1 6p21.31 0.142 0.283 0.781
xai SPICE1 3q13.2 0.142 0.283 0.781 cell cycle;regulation of centriole
replication
his KANK1 9p24.3 0.142 0.283 0.781 negative regulation of actin filament
polymerization
dependent"
xai CLUL1 18p11.32 0.142 0.283 0.781 cell death
his CEP170 1q44 0.142 0.283 0.781
his SDCCAG8 1q43 0.142 0.283 0.781 mitotic cell cycle;establishment of cell
polarity
his MIR4269 0.142 0.283 0.781
hs4 CBX5 12q13.13 0.142 0.283 0.781 blood coagulation;interspecies
hs4 HNRNPA1 12q13.1 0.142 0.283 0.781 interspecies interaction between
exp ADD3-AS1 0.142 0.283 0.781
exp RPP21 6p22.1 0.142 0.283 0.781 tRNA processing;response to drug
xai ANXA10 4q33 0.142 0.283 0.782
cop UNC5B-AS1 0.142 0.283 0.782
xai LOC100996643 0.142 0.283 0.782
his POM121 7q11.23 0.142 0.283 0.782 cytokine-mediated signaling
his BMS1 10q11.21 0.142 0.283 0.782 ribosome assembly
his TMEM80 11p15.5 0.142 0.283 0.782
his DEAF1 11p15.5 0.142 0.283 0.782 multicellular organismal development;germ
cell development
xai FIRRE 0.142 0.283 0.782
swa PAFAH1B1 17p13.3 0.142 0.283 0.782 M phase of mitotic cell
cycle;microtubule-based process
his RELN 7q22 0.142 0.283 0.782 brain development;reelin-mediated signaling
pathway
exp OR51C4P 11p15.4 0.142 0.283 0.782
his DNAJC27 2p23.3 0.142 0.283 0.782 small GTPase mediated signal
his DNAJC27-AS1 0.142 0.283 0.782
his CCND3 6p21 0.142 0.283 0.782 DNA Damage Response (DDR); DDR (G1-S
his TAF8 6p21.1 0.142 0.283 0.782 inner cell mass cell
exp FNDC3CP 0.142 0.283 0.782
his MNS1 15q21.3 0.142 0.283 0.782 meiosis
exp HRH4 18q11.2 0.142 0.283 0.782 inflammatory response
xai GTF2H4 6p21.3 0.142 0.283 0.782 DNA Damage Response (DDR); DDR
(NER)
exp RBM15B 3p21.2 0.141 0.283 0.781 mRNA processing;nucleocytoplasmic
transport
exp ITGA2B 17q21.32 0.141 0.283 0.781 blood coagulation;platelet
activation
met UFD1L 22q11.21 0.141 0.283 0.781 skeletal system development;ubiquitin-
mut TRMT1L 1q25.2 0.141 0.283 0.781 behavior;tRNA processing
exp NIPBL 5p13.2 0.141 0.283 0.781 brain development;positive regulation of
multicellular organism growth
mut AP5M1 14q22.3 0.141 0.283 0.781 intracellular protein transport;vesicle-
mediated transport
cop CA7 16q22.1 0.141 0.283 0.781 one-carbon metabolic process
xsq FLJ38122 0.141 0.283 0.781
mut PTPRK 6q22.2-q22.3 0.141 0.283 0.781 cell migration;focal adhesion
assembly
exp BCL2L11 2q13 0.141 0.283 0.781 Apoptosis
xsq SFTPA1 10q22.3 0.141 0.283 0.781
exp SIGIRR 11p15.5 0.141 0.283 0.781 innate immune response;negative
met ITGA5 12q11-q13 0.141 0.283 0.781 heterophilic cell-cell adhesion;wound
healing, spreading of epidermal cells
xsq IER3IP1 18q12 0.141 0.283 0.781 regulation of apoptotic process
xsq GP2 16p12 0.141 0.283 0.781
met VTCN1 1p13.1 0.141 0.283 0.781 negative regulation of T cell activation
met IL6 7p21 0.141 0.283 0.781 Apoptosis
xsq NPIPA3 0.141 0.283 0.781
xsq UTAT33 0.141 0.283 0.781
xsq SGK494 17q11.2 0.141 0.283 0.781
exp ZNF609 15q22.31 0.141 0.283 0.781
met ARHGAP33 19q13.12 0.141 0.283 0.781 signal transduction;protein
transport
met CCNG2 4q21.1 0.141 0.283 0.781 cell cycle checkpoint;mitosis
xsq KIAA1586 6p12.1 0.141 0.283 0.781
xsq PTPRA 20p13 0.141 0.283 0.781 protein phosphorylation;axon guidance
exp NKTR 3p22.1 0.141 0.283 0.781 protein folding
cop KLHL14 18q12.1 0.141 0.283 0.782
exp SUCLA2 13q12.2-q13.3 0.141 0.283 0.782 succinate metabolic
met PLEKHF1 19q12 0.141 0.283 0.782 apoptotic process
xsq CAB39 2q37.1 0.141 0.283 0.782 protein heterooligomerization;positive
xsq GSS 20q11.2 0.141 0.283 0.782 xenobiotic metabolic process;small
met REC114 0.141 0.283 0.782 DNA recombination;meiosis
met ADAM8 10q26.3 0.141 0.283 0.782 leukocyte migration involved in
met PAK7 20p12 0.141 0.283 0.782 Protein Kinases
met SPHKAP 2q36 0.141 0.283 0.782
met FILIP1L 3q12.1 0.141 0.283 0.782
cop SLC5A7 2q12 0.141 0.283 0.782 ion transport;transmembrane transport
met REG3A 2p12 0.141 0.283 0.782
xsq FNBP4 11p11.2 0.141 0.283 0.782
met NHLRC1 6p22.3 0.141 0.283 0.782 protein polyubiquitination;positive
regulation of protein ubiquitination
xsq NLK 17q11.2 0.141 0.283 0.782 negative regulation of Wnt receptor
met CRYAB 11q22.3-q23.1 0.141 0.283 0.782 protein folding;anti-apoptosis
met KIF2A 5q12-q13 0.141 0.283 0.782 mitotic cell cycle;microtubule-based
movement
exp CREM 10p11.21 0.141 0.283 0.782 cell differentiation;regulation of
exp CCDC94 19p13.3 0.141 0.283 0.782
met TMEM11 17p11.2 0.141 0.283 0.782 mitochondrion organization
exp COL25A1 4q25 -0.141 0.283 0.782
mut ITGA5 12q11-q13 -0.141 0.283 0.782 heterophilic cell-cell
adhesion;wound healing, spreading of epidermal cells
exp SERPINE2 2q36.1 -0.141 0.283 0.782 multicellular organismal
xsq KALRN 3q21.2 -0.141 0.283 0.782 protein
phosphorylation;intracellular signal transduction
cop CSMD3 8q23.3 -0.141 0.283 0.782
exp SLC34A3 -0.141 0.283 0.782 sodium ion transport;phosphate ion
transport
xsq PSORS1C3 6p21.33 -0.141 0.283 0.782
cop TTTY22 -0.141 0.283 0.782
exp ACSL4 Xq22.3-q23 -0.141 0.283 0.782 fatty acid metabolic
xsq NAV3 12q14.3 -0.141 0.283 0.781
xsq APOE 19q13.2 -0.141 0.283 0.781 response to reactive oxygen
exp ID4 6p22.3 -0.141 0.283 0.781 negative regulation of
exp POLK 5q13 -0.141 0.283 0.781 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
cop MGAT4B 5q35 -0.141 0.283 0.781 protein N-linked glycosylation via
cop SQSTM1 5q35 -0.141 0.283 0.781 Apoptosis
cop C5orf45 5q35.3 -0.141 0.283 0.781
cop TBC1D9B 5q35.3 -0.141 0.283 0.781
exp DAD1 14q11.2 -0.141 0.283 0.781 Apoptosis
cop PKP2 12p11 -0.141 0.283 0.781 heart development;cell-cell adhesion
cop GEN1 2p24.2 -0.141 0.283 0.781 DNA Damage Response (DDR); DDR (HR)
exp LDB3 10q22.3-q23.2 -0.141 0.283 0.781
xsq ASH1L 1q22 -0.141 0.283 0.781 regulation of transcription, DNA-
exp SEPT5 22q11.21 -0.141 0.283 0.781 GTP catabolic process;cell cycle
xsq LRGUK 7q33 -0.141 0.283 0.781
exp UPK2 11q23 -0.141 0.283 0.781 epithelial cell
exp STAM 10p14-p13 -0.141 0.283 0.781 intracellular protein
transport;signal transduction
DNA-dependent"
met GIPC3 19p13.3 -0.141 0.283 0.781
dependent;meiosis
met WDR59 16q23.1 -0.141 0.283 0.781
DNA-dependent"
xai NECAB2 16q23.3 -0.142 0.283 0.782
his KRTAP9-7 -0.142 0.283 0.782
hs4 RGN Xp11.3 -0.142 0.283 0.782
hs4 LOC100506801 -0.142 0.283 0.782
hs4 SHC4 15q21.1-q21.2 -0.142 0.283 0.782 intracellular signal
transduction
his NUAK2 1q32.1 -0.142 0.283 0.782 Apoptosis
his TTLL4 2p24.3-p24.1 -0.142 0.283 0.782 protein modification
process;protein polyglutamylation
his KIAA1683 19p13.1 -0.142 0.283 0.782
exp TRGV11 -0.142 0.283 0.782
xai POLK 5q13 -0.142 0.283 0.782 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
DNA-dependent"
hs4 LOC286059 -0.142 0.283 0.782
hs4 TNFRSF10B 8p22-p21 -0.142 0.283 0.782 Apoptosis
xai TP53RK 20q13.2 -0.142 0.283 0.782 protein
phosphorylation;lipopolysaccharide biosynthetic process
his RBFOX2 22q13.1 -0.142 0.283 0.781 RNA splicing;regulation of
definitive erythrocyte differentiation
exp C16orf97 16q12.1 -0.142 0.283 0.781
xai TRGV11 -0.142 0.283 0.781
xai LRRC42 1p33-p32.1 -0.142 0.283 0.781
his RHOB 2p24 -0.142 0.283 0.781 Apoptosis
xai GPR143 Xp22.3 -0.142 0.283 0.781 melanosome
his ZNF528-AS1 -0.142 0.283 0.781
his ZNF528 19q13 -0.142 0.283 0.781 regulation of transcription, DNA-
dependent"
his LOC105378146 -0.142 0.283 0.781
xai ECT2L 6q24.1 -0.142 0.283 0.781 regulation of Rho protein signal
transduction
exp SYCE1 10q26.3 -0.142 0.283 0.781 cell cycle;meiosis
xai PDGFRB 5q33.1 -0.142 0.283 0.781 Protein Kinases
hs4 COL13A1 10q22 -0.142 0.283 0.781 morphogenesis of a branching
structure;endochondral ossification
his PACRG-AS3 -0.142 0.283 0.781
hs4 CDYL 6p25.1 -0.142 0.283 0.781 spermatogenesis;regulation of
hs4 SMARCD3 7q35-q36 -0.142 0.283 0.781 secondary heart field
specification;muscle cell differentiation
his RDH12 14q24.1 -0.142 0.283 0.781 visual perception;retinol metabolic
process
swa CRTAP 3p22.3 -0.142 0.283 0.781 spermatogenesis
his GPR135 14q23.1 -0.142 0.283 0.781
his MYL2 12q24.11 -0.142 0.283 0.781 cardiac myofibril
assembly;ventricular cardiac muscle tissue morphogenesis
his MIR4306 -0.142 0.283 0.781
his UNC93B1 11q13 -0.142 0.283 0.781 toll-like receptor 7 signaling
his ALDH3B1 11q13 -0.142 0.283 0.781 alcohol metabolic process;lipid
metabolic process
hs4 TUB 11p15.5 -0.142 0.283 0.781 positive regulation of
phagocytosis;response to stimulus
swa SORD 15q15.3 0.142 0.284 0.782 glucose metabolic process;sorbitol
catabolic process
his SERTAD2 2p14 0.142 0.284 0.782 negative regulation of cell
his IGFBPL1 9p13.1 0.142 0.284 0.782 regulation of cell growth
xai FAM162A 3q21.1 0.142 0.284 0.782
his RCOR3 1q32.2 0.142 0.284 0.782 regulation of transcription, DNA-
dependent"
exp LINGO3 19p13.3 0.142 0.284 0.782
hs4 MYL6B 12q13.13 0.142 0.284 0.782 muscle filament sliding;muscle
contraction
xai ATF7 12q13 0.142 0.284 0.782 regulation of transcription, DNA-
dependent;interspecies interaction between organisms"
xai LOC100505817 0.142 0.284 0.782
xai ADAL 15q15.3 0.142 0.284 0.782 adenosine catabolic process;nucleotide
metabolic process
xai LOC100131347 17q12 0.142 0.284 0.782
hs4 C17orf75 17q11.2 0.142 0.284 0.782 spermatogenesis
xai SETMAR 3p26.1 0.142 0.284 0.782 DNA Damage Response (DDR)
xai GBAS 7p12 0.142 0.284 0.782
hs4 ZFPM1 16q24.2 0.142 0.284 0.782 negative regulation of transcription from
RNA polymerase II promoter;blood coagulation
xai LOC100506302 0.142 0.284 0.782
xai PARN 16p13 0.142 0.284 0.782 RNA modification;gene expression
hs4 ABCC8 11p15.1 0.142 0.284 0.782 ABC Transporters
hs4 GNB1 1p36.33 0.142 0.284 0.782 activation of phospholipase C activity by
messenger;small molecule metabolic process
his LOC100507091 0.142 0.284 0.782
hs4 CLPX 15q22.31 0.142 0.284 0.782 ATP catabolic process;protein folding
his XPO6 16p11.2 0.142 0.284 0.782 protein export from nucleus;intracellular
protein transport
xai SMPD4P2 13q12.11 0.142 0.284 0.782
xai LRRC25 0.142 0.284 0.782
met KAT2A 17q21 0.142 0.284 0.782 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
met FBLN7 2q13 0.142 0.284 0.782 cell adhesion
his HFE2 1q21.1 0.142 0.284 0.782 axon guidance
xai CSF3R 1p35-p34.3 0.142 0.284 0.782 defense response;cell adhesion
his GRHPR 9q12 0.142 0.284 0.782 excretion;metabolic process
exp LINC00649 0.142 0.284 0.782
swa MPP1 Xq28 0.142 0.284 0.783 signal transduction;regulation of neutrophil
chemotaxis
hs4 CHST2 3q24 0.142 0.284 0.783 metabolic process;carbohydrate metabolic
process
hs4 FGB 4q28 0.142 0.284 0.783 response to calcium ion;platelet degranulation
hs4 RIMBP3C 0.142 0.284 0.783
exp EPC1 10p11 0.141 0.284 0.782 histone H2A acetylation;negative regulation of
dependent"
mir hsa-miR-129* 0.141 0.284 0.782
met MSX2 5q35.2 0.141 0.284 0.782 negative regulation of transcription from
xsq SUB1 5p13.3 0.141 0.284 0.782 regulation of transcription from RNA
xsq SNORA8 0.141 0.284 0.782
met NPHS2 1q25.2 0.141 0.284 0.782 excretion;actin cytoskeleton
reorganization
xsq CLIC2 Xq28 0.141 0.284 0.782 chloride transport;signal transduction
met MIR127 0.141 0.284 0.782
xsq DHRS7B 17p12 0.141 0.284 0.782
xsq KCNT1 9q34.3 0.141 0.284 0.782 potassium ion transmembrane transport;ion
transport
xsq FAM71A 1q32.3 0.141 0.284 0.782
xsq UBE2K 4p14 0.141 0.284 0.782 ubiquitin-dependent protein catabolic
xsq LANCL1-AS1 0.141 0.284 0.782
xsq ZBTB33 Xq23 0.141 0.284 0.782 regulation of transcription, DNA-
xsq PLEKHO1 1q21.2 0.141 0.284 0.782
met CMTM1 16q21 0.141 0.284 0.782 chemotaxis
cop MSLN 16p13.3 0.141 0.284 0.782 cell adhesion
cop MIR662 0.141 0.284 0.782
cop RPUSD1 16p13.3 0.141 0.284 0.782 pseudouridine synthesis
cop CHTF18 16p13.3 0.141 0.284 0.782 DDR (DNA replication)
cop GNG13 16p13.3 0.141 0.284 0.782 energy reserve metabolic
process;activation of phospholipase C activity by G-protein coupled receptor
cop PRR25 16p13.3 0.141 0.284 0.782
cop LMF1 16p13.3 0.141 0.284 0.782 protein glycosylation in
cop SOX8 16p13.3 0.141 0.284 0.782 signal transduction;cell fate commitment
cop SSTR5-AS1 16p13.3 0.141 0.284 0.782
cop SSTR5 16p13.3 0.141 0.284 0.782 glucose homeostasis;regulation of insulin
secretion
cop C1QTNF8 16p13.3 0.141 0.284 0.782
cop CACNA1H 16p13.3 0.141 0.284 0.782 regulation of heart
contraction;aldosterone biosynthetic process
cop TPSG1 16p13.3 0.141 0.284 0.782
cop TPSB2 16p13.3 0.141 0.284 0.782 proteolysis
cop TPSAB1 0.141 0.284 0.782 defense response;proteolysis
cop TPSD1 16p13.3 0.141 0.284 0.782
cop UBE2I 16p13.3 0.141 0.284 0.782 DNA Damage Response (DDR)
cop BAIAP3 16p13.3 0.141 0.284 0.782 G-protein coupled receptor
signaling pathway;neurotransmitter secretion
cop TSR3 16p13.3 0.141 0.284 0.782
cop GNPTG 16p13.3 0.141 0.284 0.782
cop UNKL 16p13.3 0.141 0.284 0.782
cop C16orf91 16p13.3 0.141 0.284 0.782
cop CCDC154 16p13.3 0.141 0.284 0.782
xsq MLH3 14q24.3 0.141 0.284 0.782 DNA Damage Response (DDR); DDR (MMR)
cop VCL 10q22.2 0.141 0.284 0.782 cellular component movement;negative
mut DACT1 14q23.1 0.141 0.284 0.782 multicellular organismal development;Wnt
met FLJ13224 12p11.21 0.141 0.284 0.782
exp KIAA1524 3q13.13 0.141 0.284 0.782
mut SPAG6 10p12.2 0.141 0.284 0.782 spermatid development;cell projection
organization
xsq H2AFX 11q23.3 0.141 0.284 0.782 DNA Damage Response (DDR); DDR (HR)
met CD74 5q32 0.141 0.284 0.782 positive regulation of dendritic cell antigen
processing and presentation;signal transduction
xsq CIDEA 18p11.21 0.141 0.284 0.782 lipid metabolic process;negative
xsq ZBED9 0.141 0.284 0.782 DNA integration;viral reproduction
met ARHGAP23 17q12 0.141 0.284 0.782 signal transduction
cop MIR548I2 0.141 0.284 0.782
xsq HTR2C Xq24 0.141 0.284 0.782 response to drug;release of sequestered calcium
ion into cytosol
xsq ACBD7 10p13 0.141 0.284 0.782
xsq COPE 19p13.11 0.141 0.284 0.782 cellular membrane organization;vesicle-
mediated transport
met RUBCN 0.141 0.284 0.782 negative regulation of endocytosis;negative
regulation of autophagy
cop ETAA1 2p14 0.141 0.284 0.782
xsq TRIM77 11q14.3 0.141 0.284 0.782
exp DHX36 3q25.2 0.14 0.284 0.782
xsq DCUN1D4 4q12 0.14 0.284 0.782
xsq PKHD1 6p12.2 0.14 0.284 0.782 cilium assembly;homeostatic process
met CAPN10 2q37.3 0.14 0.284 0.782 positive regulation of insulin
secretion;positive regulation of intracellular transport
xsq NUGGC 8p21.1 0.14 0.284 0.782
met PHF24 0.14 0.284 0.783
mut AKAP7 6q23 0.14 0.284 0.783 ion transport;protein localization
met ZNHIT2 11q13 0.14 0.284 0.783
xsq ATP5F1 1p13.2 0.14 0.284 0.783 ATP synthesis coupled proton
transport;respiratory electron transport chain
exp C3orf70 3q27.2 -0.14 0.284 0.783
met C11orf71 11q23.2 -0.14 0.284 0.783
exp KALRN 3q21.2 -0.14 0.284 0.782 protein phosphorylation;intracellular
signal transduction
exp KRBOX4 Xp11.3 -0.14 0.284 0.782
exp LOC728056 -0.14 0.284 0.782
exp YWHAB 20q13.1 -0.141 0.284 0.782 small GTPase mediated signal
xsq ZNF239 10q11.22-q11.23 -0.141 0.284 0.782 regulation of
met SEPHS2 16p11.2 -0.141 0.284 0.782 selenocysteine biosynthetic
process
xsq TAS2R3 7q31.3-q32 -0.141 0.284 0.782 signal transduction;response
to stimulus
exp ATF6B 6p21.3 -0.141 0.284 0.782 signal transduction;transcription,
DNA-dependent
cop PRKCI 3q26.3 -0.141 0.284 0.782 Protein Kinases
cop TRIML2 4q35.2 -0.141 0.284 0.782
met BANK1 4q24 -0.141 0.284 0.782 B cell activation
mut GALNT13 2q24.1 -0.141 0.284 0.782 O-glycan processing;post-
cop SNX31 8q22.3 -0.141 0.284 0.782 cell communication;protein
transport
cop PABPC1 8q22.2-q23 -0.141 0.284 0.782 nuclear-transcribed mRNA
catabolic process, deadenylation-dependent decay;RNA metabolic process
cop YWHAZ 8q23.1 -0.141 0.284 0.782 Apoptosis
exp NKAIN4 20q13.33 -0.141 0.284 0.782
xsq PEG10 7q21 -0.141 0.284 0.782 apoptotic process;cell differentiation
exp STAM2 2q23.3 -0.141 0.284 0.782 cellular membrane
organization;endosome transport
xsq NXNL2 9q22.1 -0.141 0.284 0.782
xsq TMEM14A 6p12.2 -0.141 0.284 0.782
xsq LOC102723703 -0.141 0.284 0.782
exp SGPP1 14q23.2 -0.141 0.284 0.782 sphingolipid metabolic
process;sphinganine-1-phosphate metabolic process
exp FMO2 1q24.3 -0.141 0.284 0.782 NADPH oxidation;oxygen metabolic
process
cop ZDHHC2 8p22 -0.141 0.284 0.782 protein palmitoylation
his C14orf159 14q32.11 -0.142 0.284 0.783
hs4 OSBPL11 3q21 -0.142 0.284 0.783 transport;lipid transport
xai LOC401134 -0.142 0.284 0.783
hs4 KCTD16 5q31.3 -0.142 0.284 0.783 potassium ion transport
hs4 YIPF5 5q31.3 -0.142 0.284 0.783 protein transport;vesicle-mediated
transport
xai NOX1 Xq22 -0.142 0.284 0.782 angiogenesis;regulation of blood pressure
his RAI1 17p11.2 -0.142 0.284 0.782 skeletal system
his SNORD93 7p15.3 -0.142 0.284 0.782
xai ESRRG 1q41 -0.142 0.284 0.782 gene expression;positive regulation of
xai NFIL3 9q22 -0.142 0.284 0.782 immune response;circadian rhythm
his LINC00548 -0.142 0.284 0.782
his GPX3 5q23 -0.142 0.284 0.782 response to organic cyclic
xai LOC100652768 -0.142 0.284 0.782
xai TNFSF15 9q32 -0.142 0.284 0.782 cytokine metabolic process;positive
hs4 DENND5B 12p11.21 -0.142 0.284 0.782
hs4 DENND5B-AS1 -0.142 0.284 0.782
his KCTD6 3p14.3 -0.142 0.284 0.782 potassium ion transport
xai NPIPB15 16q23.1 -0.142 0.284 0.782
exp SPATA31B1 -0.142 0.284 0.782
hs4 MIR4516 -0.142 0.284 0.782
xai ROGDI 16p13.3 -0.142 0.284 0.782 positive regulation of cell
his DENND5A 11p15.4 -0.142 0.284 0.782
xai KRT8P42 -0.142 0.284 0.782
xai TSPAN31 12q13.3 -0.142 0.284 0.782 positive regulation of cell
proliferation
his HOXD8 2q31.1 -0.142 0.284 0.782 negative regulation of
dependent
his HOXD-AS2 -0.142 0.284 0.782
his TBC1D10A 22q12.2 -0.142 0.284 0.782
hs4 PF4 4q12-q21 -0.142 0.284 0.782 leukocyte chemotaxis;chemotaxis
hs4 LOC105369486 -0.142 0.284 0.782
his LINC01534 0.142 0.285 0.783
dependent"
his NUP210L 1q21.3 0.142 0.285 0.783
his SEC24B 4q25 0.142 0.285 0.783 protein N-linked glycosylation via
his SEC24B-AS1 0.142 0.285 0.783
xai DLG5-AS1 10q22.3 0.142 0.285 0.783
xai ELFN1 7p22.3 0.142 0.285 0.783 negative regulation of phosphatase
activity
exp KRT26 17q21.2 0.142 0.285 0.783
his FAM30C 0.142 0.285 0.783
his ARAP1 11q13.4 0.142 0.285 0.783 actin filament reorganization involved in
exp ERICH6B 0.142 0.285 0.783
xai SGTA 19p13 0.142 0.285 0.783 interspecies interaction between organisms
his LOC339803 2p15 0.142 0.285 0.783
his C2orf74 2p15 0.142 0.285 0.783
his SNORD56B 14q24.2 0.142 0.285 0.783
his TMEM27 Xp22 0.142 0.285 0.783 proteolysis
his CA5BP1 Xp22.2 0.142 0.285 0.783
xai CLIC2 Xq28 0.142 0.285 0.783 chloride transport;signal transduction
his FAM84A 2p24.3 0.142 0.285 0.783
xai EVI2A 17q11.2 0.142 0.285 0.783
hs4 SCAI 9q33.3 0.142 0.285 0.783 regulation of transcription, DNA-
his ADRA2C 4p16 0.142 0.285 0.783 platelet activation;activation of protein
kinase B activity
xai LOC646214 0.142 0.285 0.783
xai MYL3 3p21.3-p21.2 0.142 0.285 0.783 ventricular cardiac muscle tissue
morphogenesis;cardiac muscle contraction
xai KRTAP3-3 17q21.2 0.141 0.285 0.783
his LGR5 12q22-q23 0.141 0.285 0.783 G-protein coupled receptor signaling
pathway
xai CYYR1 21q21.2 0.141 0.285 0.783
xai USP51 Xp11.21 0.141 0.285 0.783 proteolysis;ubiquitin-dependent protein
catabolic process
his CEBPZOS 0.141 0.285 0.783
his PRPSAP1 17q24-q25 0.141 0.285 0.783 nucleobase-containing compound
xai FAM24B 0.141 0.285 0.783
his PITX3 10q24.32 0.141 0.285 0.783 multicellular organismal
development;locomotory behavior
his GBF1 10q24 0.141 0.285 0.783 retrograde vesicle-mediated transport, Golgi to
ER;post-Golgi vesicle-mediated transport
his CACYBP 1q24-q25 0.141 0.285 0.783 response to growth hormone
his LINC00115 0.141 0.285 0.783
his LINC01128 0.141 0.285 0.783
hs4 DLEC1 3p21.3 0.141 0.285 0.783 negative regulation of cell proliferation
cop LYG1 2q11.2 0.14 0.285 0.783 cell wall macromolecule catabolic
cop TXNDC9 2q11.2 0.14 0.285 0.783 cell redox homeostasis
cop EIF5B 2q11.2 0.14 0.285 0.783 translation;translational initiation
cop REV1 2q11.1-q11.2 0.14 0.285 0.783 DNA Damage Response (DDR); DDR (DNA
cop MIR3158-2 0.14 0.285 0.783
cop MIR3158-1 0.14 0.285 0.783
cop FBXW4 10q24 0.14 0.285 0.783 embryonic digit morphogenesis;cartilage
development
met TSC22D3 Xq22.3 0.14 0.285 0.783 regulation of transcription, DNA-
dependent;body fluid secretion"
mut USF3 0.14 0.285 0.783
met SEPT7 7p14.2 0.14 0.285 0.783 cytokinesis;cell cycle
xsq SUPT4H1 17q22 0.14 0.285 0.783 viral reproduction;negative regulation of
met MEFV 16p13.3 0.14 0.285 0.783 inflammatory response;nucleotide-binding
met LRP1 12q13.3 0.14 0.285 0.783 multicellular organismal
xsq NFKBIB 19q13.1 0.14 0.285 0.783 Apoptosis
xsq RBM5 3p21.3 0.14 0.285 0.783 RNA splicing;gene expression
met AGT 1q42.2 0.14 0.285 0.783 regulation of cell growth;renin-
mut ZSCAN10 16p13.3 0.14 0.285 0.783 viral reproduction;negative
cop NR2C2 3p25 0.14 0.285 0.783 regulation of transcription, DNA-
met KCNH7 2q24.2 0.14 0.285 0.783 circadian rhythm;protein
exp LDHAP5 10q26.11 0.14 0.285 0.783
xsq AOC2 17q21 0.14 0.285 0.783 catecholamine metabolic process;visual
perception
exp FARS2 6p25.1 0.14 0.285 0.783 tRNA processing;gene expression
dependent"
met C5orf45 5q35.3 0.14 0.285 0.783
cop WBP11 12p12.3 0.14 0.285 0.783 rRNA processing;mRNA processing
exp FKBP1A 20p13 0.14 0.285 0.783 'de novo' protein folding;regulation of
xsq LOC101928020 0.14 0.285 0.783
met NARF 17q25.3 0.14 0.285 0.783
met EFHC1 6p12.3 0.14 0.285 0.783
mut ENAM 4q13.3 0.14 0.285 0.783 bone mineralization;odontogenesis
met KLKB1 4q35 0.14 0.285 0.783 inflammatory response;blood coagulation
xsq PRR11 17q22 0.14 0.285 0.783
xsq OR6K6 1q23.1 0.14 0.285 0.783 response to stimulus
met PPFIA1 11q13.3 0.14 0.285 0.783 cell-matrix adhesion;signal
transduction
xsq PCDHA9 0.14 0.285 0.783 homophilic cell adhesion;cell adhesion
xsq TRNAU1AP 1p35.3 0.14 0.285 0.783 selenocysteine
met SPRR4 1q21.3 0.14 0.285 0.783
met ZNF75A 16p13.3 0.14 0.285 0.783 regulation of transcription, DNA-
dependent"
exp GNPDA2 4p12 0.14 0.285 0.783 carbohydrate metabolic process;N-
xsq VENTXP1 Xp21.3 0.14 0.285 0.783
met CHST6 16q22 0.14 0.285 0.783 sulfur compound metabolic process;keratan
met RSPH3 6q25.3 0.14 0.285 0.783
cop THEM4 1q21 0.14 0.285 0.783 Apoptosis
cop GFPT1 2p13 0.14 0.285 0.783 carbohydrate biosynthetic process;fructose 6-
phosphate metabolic process
cop NFU1 2p15-p13 0.14 0.285 0.783 iron-sulfur cluster assembly
exp NDUFA6 22q13.2 0.14 0.285 0.783 response to oxidative
xsq DCDC5 11p14.1 0.14 0.285 0.783 intracellular signal transduction
cop SIVA1 14q32.33 0.14 0.285 0.783 Apoptosis
cop AKT1 14q32.32 0.14 0.285 0.783 Apoptosis; Cell Signaling; Oncogenes;
Protein Kinases
cop ZBTB42 14q32.33 0.14 0.285 0.783 regulation of transcription, DNA-
dependent"
cop LINC00638 14q32.33 0.14 0.285 0.783
cop CEP170B 14q32.33 0.14 0.285 0.783
cop PLD4 14q32.33 0.14 0.285 0.783 lipid catabolic process
cop AHNAK2 14q32.33 0.14 0.285 0.783
cop C14orf79 14q32.33 0.14 0.285 0.783
cop CDCA4 14q32.33 0.14 0.285 0.783
cop GPR132 14q32.3 0.14 0.285 0.783 G1/S transition of mitotic cell
xsq ZDBF2 2q33.3 0.14 0.285 0.783
cop LRRC2-AS1 3p21.3 0.14 0.285 0.783
xsq LOC101928855 0.14 0.285 0.783
met ST6GALNAC2 17q25.1 0.14 0.285 0.783 protein glycosylation;O-glycan
processing
met FAM227B 15q21.2 -0.14 0.285 0.783
met PAX6 11p13 -0.14 0.285 0.783 regulation of transcription, DNA-
dependent;positive regulation of gene expression
xsq SLCO2B1 11q13 -0.14 0.285 0.783 Solute Carriers
cop CNBD2 20q11.23 -0.14 0.285 0.783
cop DKK4 8p11.2-p11.1 -0.14 0.285 0.783 multicellular organismal
cop VDAC3 8p11.2 -0.14 0.285 0.783 Apoptosis
xsq NCAM1-AS1 11q23.2 -0.14 0.285 0.783
xsq LAD1 1q25.1-q32.3 -0.14 0.285 0.783
exp C10orf10 10q11.21 -0.14 0.285 0.783
mut ZNF441 19p13.2 -0.14 0.285 0.783 regulation of transcription, DNA-
dependent"
exp ARSI 5q32 -0.14 0.285 0.783
xsq MAL2 8q23 -0.14 0.285 0.783
xsq CCNYL2 10q11.21 -0.14 0.285 0.783 regulation of cyclin-dependent
xsq SYNJ2BP 14q24.2 -0.14 0.285 0.783 intracellular distribution of
mitochondria
exp ATP5F1P7 16q23.1 -0.14 0.285 0.783
xsq C9orf172 9q34.3 -0.14 0.285 0.783
cop HAS2 8q24.12 -0.14 0.285 0.783 hyaluronan biosynthetic process;positive
regulation of urine volume
cop HAS2-AS1 8q24.13 -0.14 0.285 0.783
cop ODF1 8q22.3 -0.14 0.285 0.783
exp CD46 1q32 -0.14 0.285 0.783 complement activation, classical pathway;single
fertilization
xsq SERPINE1 7q22.1 -0.14 0.285 0.783 response to reactive oxygen
xsq LOC101928994 -0.14 0.285 0.783
his TEKT2 1p34.3 -0.141 0.285 0.783 sperm motility;microtubule
his C1orf21 1q25 -0.141 0.285 0.783
xai FAM149A 4q35.1 -0.141 0.285 0.783
his COQ8B -0.141 0.285 0.783
his ITPKC 19q13.1 -0.141 0.285 0.783
hs4 TSC22D2 3q25.1 -0.141 0.285 0.783 response to osmotic stress
his LINC01395 -0.141 0.285 0.783
hs4 EVA1C 21q22.11 -0.141 0.285 0.783
xai FLJ26245 -0.141 0.285 0.783
dependent"
xai LAD1 1q25.1-q32.3 -0.141 0.285 0.783
hs4 FNDC4 2p23.3 -0.141 0.285 0.783
hs4 GCKR 2p23 -0.141 0.285 0.783 carbohydrate metabolic process;small
his C11orf70 11q22.1 -0.141 0.285 0.783
his TMEM56-RWDD3 -0.141 0.285 0.783
cop PEG3 19q13.4 -0.141 0.285 0.783 viral reproduction;apoptotic
process
cop PEG3-AS1 19q13.43 -0.141 0.285 0.783
cop MIMT1 19q13.43 -0.141 0.285 0.783
hs4 LOC730668 22q13.31 -0.142 0.285 0.783
xai RRAGB Xp11.21 -0.142 0.285 0.783 signal transduction;positive
xai HECTD3 1p34.1 -0.142 0.285 0.783 protein ubiquitination
involved in ubiquitin-dependent protein catabolic process;proteasomal ubiquitin-
xai SH3BP5L 1q44 -0.142 0.285 0.783
his ABCC5-AS1 -0.142 0.285 0.783
hs4 CGN 1q21 -0.142 0.285 0.783
xai SVILP1 10p11.23 -0.142 0.285 0.783
xai LINC00540 -0.142 0.285 0.783
xai SH3TC2 5q32 -0.142 0.285 0.783
hs4 ACTC1 15q14 -0.142 0.285 0.783 ATP catabolic process;response to ethanol
xai PELI1 2p13.3 -0.142 0.285 0.783 MyD88-dependent toll-like receptor
xai CPT2 1p32 0.141 0.286 0.783 fatty acid beta-oxidation;transport
hs4 PSMC3IP 17q21.2 0.141 0.286 0.784 DNA recombination;meiosis
xai UMAD1 0.141 0.286 0.784
his PRR13 0.141 0.286 0.784 regulation of transcription, DNA-dependent"
hs4 NAP1L4 11p15.5 0.141 0.286 0.784 nucleosome assembly
his MIR1915 0.141 0.286 0.784
his CASC10 0.141 0.286 0.784
exp LIMD1-AS1 0.141 0.286 0.784
his CUTC 10q24.2 0.141 0.286 0.784 copper ion transport;protein
tetramerization
his COX15 10q24 0.141 0.286 0.784 mitochondrial electron transport, cytochrome c
to oxygen;heme a biosynthetic process
xai SDHAF2 11q12.2 0.141 0.286 0.784 mitochondrial electron transport,
his CHEK2 22q12.1 0.141 0.286 0.784 DNA Damage Response (DDR); Protein
Kinases
his HSCB 22q12.1 0.141 0.286 0.784 protein folding;iron-sulfur cluster
assembly
exp TBL1YP1 Yq11.223 0.141 0.286 0.784
hs4 MAD2L2 1p36 0.141 0.286 0.784 DNA Damage Response (DDR); DDR (DNA
his TRIM52 5q35.3 0.141 0.286 0.784
his TRIM52-AS1 0.141 0.286 0.784
hs4 PABPC4L 4q28.3 0.141 0.286 0.784
his IGF1 12q23.2 0.141 0.286 0.784 Apoptosis
xai EXOC3L4 14q32.32 0.141 0.286 0.784
hs4 TCP1 6q25.3-q26 0.141 0.286 0.784 protein folding;tubulin complex assembly
hs4 SNORA29 6q25.3 0.141 0.286 0.784
hs4 MRPL18 6q25.3 0.141 0.286 0.784 translation;transport
hs4 CENPO 2p23.3 0.141 0.286 0.784 nucleosome assembly;chromosome
segregation
hs4 PTRHD1 2p23.3 0.141 0.286 0.784
hs4 ELF1 13q13 0.141 0.286 0.784 Transcription Factors
cop FCGR1A 1q21.2-q21.3 0.141 0.286 0.784 innate immune
xai URB1 21q22.11 0.141 0.286 0.784
xai OR9I2P 0.141 0.286 0.784
xai UBA2 19q12 0.141 0.286 0.784 DNA Damage Response (DDR)
his LINC01882 0.141 0.286 0.784
hs4 HDAC10 22q13.31 0.141 0.286 0.784 negative regulation of
dependent
xai ATG4B 2q37.3 0.141 0.286 0.784 protein transport;autophagic vacuole
assembly
xai DNAH10 12q24.31 0.141 0.286 0.784 microtubule-based movement
his TDRG1 6p21.2 0.141 0.286 0.784
his TMEM35B 0.141 0.286 0.784
dependent"
hs4 LOC101927755 0.141 0.286 0.784
hs4 RNFT1 17q23.1 0.141 0.286 0.784
exp NLRP8 19q13.43 0.141 0.286 0.784
exp LOC100287210 7q36.2 0.141 0.286 0.784
hs4 LOC375196 0.141 0.286 0.784
hs4 TRMT6 20p12.3 0.141 0.286 0.784 regulation of translational
hs4 MCM8 20p12.3 0.141 0.286 0.784 S phase of mitotic cell cycle;M/G1
xai ARHGAP36 Xq26.1 0.141 0.286 0.784 small GTPase mediated signal
his WEE2-AS1 7q34 0.141 0.286 0.784
his SSBP1 7q34 0.141 0.286 0.784 positive regulation of helicase
hs4 RAB40C 16p13.3 0.141 0.286 0.784 small GTPase mediated signal
xai SLC38A2 12q 0.141 0.286 0.784 Solute Carriers
his TPP1 11p15 0.141 0.286 0.784 endoplasmic reticulum unfolded protein
response;proteolysis
his PTPRN 2q35-q36.1 0.141 0.286 0.784 cytokine-mediated signaling
hs4 LINC00668 0.141 0.286 0.784
hs4 TNFAIP8L1 19p13.3 0.141 0.286 0.784
his TNFSF14 19p13.3 0.141 0.286 0.784 T cell proliferation;T cell
activation
his LOC102723703 0.141 0.286 0.784
his LOC101929574 0.141 0.286 0.784
his SH2D4B 10q23.1 0.141 0.286 0.784
met ZNF679 7q11.21 0.14 0.286 0.783
cop C17orf62 17q25.3 0.14 0.286 0.784
exp RPL23AP63 11p11.2 0.14 0.286 0.784
cop ARHGAP11A 15q13.2 0.14 0.286 0.784 signal transduction;small GTPase
xsq TIMMDC1 3q13.33 0.14 0.286 0.784
cop HEXDC 17q25.3 0.14 0.286 0.784 carbohydrate metabolic process
xsq NAAA 4q21.1 0.14 0.286 0.784 lipid metabolic process
met SSX7 Xp11.23 0.14 0.286 0.784 regulation of transcription, DNA-
dependent"
cop BMS1P4 10q22.2 0.14 0.286 0.784
cop IFT46 11q23.3 0.14 0.286 0.784 flagellum assembly;intraflagellar
transport
mir hsa-miR-103 0.14 0.286 0.784
mir hsa-miR-103(2) 0.14 0.286 0.784
met LGALS3 14q22.3 0.14 0.286 0.784 skeletal system development;mRNA
processing
xsq ASB10 7q36.1 0.14 0.286 0.784 intracellular signal transduction
xsq C3P1 19p13.2 0.14 0.286 0.784
exp RRP8 11p15.4 0.14 0.286 0.784 chromatin silencing at rDNA;regulation of
cop BCMO1 0.14 0.286 0.784
xsq ZFP92 Xq28 0.14 0.286 0.784 regulation of transcription, DNA-dependent"
met LINC00482 17q25.3 0.14 0.286 0.784
exp C16orf86 16q22.1 0.14 0.286 0.784
cop KMT2A 11q23 0.14 0.286 0.784
xsq OR51E2 11p15 0.14 0.286 0.784 detection of chemical stimulus involved
exp TMTC4 13q32.3 0.14 0.286 0.784
xsq KAT2A 17q21 0.14 0.286 0.784 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
exp SMARCC2 12q13.2 0.14 0.286 0.784 DNA Damage Response (DDR); DDR
(Chromatin)
xsq GPR149 3q25.2 0.14 0.286 0.784
exp PRR22 19p13.3 0.14 0.286 0.784
xsq LINC01435 0.14 0.286 0.784
mut CACHD1 1p31.3 0.14 0.286 0.784 ion transport;calcium ion transport
xsq NFKBID 19q13.12 0.14 0.286 0.784 positive regulation of thymocyte
apoptosis;inflammatory response
xsq KCNJ1 11q24 0.14 0.286 0.784 synaptic transmission;excretion
met HNRNPUL1 19q13.2 0.14 0.286 0.784 RNA splicing;response to virus
met PTPRT 20q12-q13 0.14 0.286 0.784 protein dephosphorylation;cell adhesion
exp TYMP 22q13.33 0.14 0.286 0.784 pyrimidine nucleotide metabolic
exp DCXR 17q25.3 0.14 0.286 0.784 glucose metabolic process;NADP metabolic
process
cop NBEAL2 3p21.31 0.14 0.286 0.784 platelet formation
met ENPEP 4q25 0.14 0.286 0.784 metabolic process;cell proliferation
exp SMNP 9p21.3 0.14 0.286 0.784
cop LOC645355 0.14 0.286 0.784
xsq VPS13C 15q22.2 0.14 0.286 0.784 protein localization
met ABHD8 19p13.11 0.14 0.286 0.784
exp ICT1 17q25.1 0.14 0.286 0.784 mitochondrial translational termination
met DNAJC5 20q13.33 0.14 0.286 0.784 protein folding;synaptic
transmission
cop TTC36 11q23.3 0.14 0.286 0.784
cop TMEM25 11q23.3 0.14 0.286 0.784
exp LOC393078 7q36.3 -0.14 0.286 0.784
cop ARL14 3q25.33 -0.14 0.286 0.784 small GTPase mediated signal transduction
met MT1X 16q13 -0.14 0.286 0.784 response to metal ion;cellular response to
erythropoietin
met POLR2G 11q13.1 -0.14 0.286 0.784 DNA Damage Response (DDR); DDR
(NER)
exp PLAT 8p12 -0.14 0.286 0.784 protein modification process;proteolysis
xsq SMAD3 15q22.33 -0.14 0.286 0.784 Apoptosis
xsq GSDMC 8q24.21 -0.14 0.286 0.784
met ANO6 12q12 -0.14 0.286 0.784 activation of blood coagulation via clotting
mut KRT25 17q21.2 -0.14 0.286 0.784 hair follicle morphogenesis;intermediate
xsq PACS1 11q13.1-q13.2 -0.14 0.286 0.784 positive regulation of protein
binding;cellular protein localization
xsq NTF3 12p13 -0.14 0.286 0.784 neuromuscular synaptic
exp LOC100287598 -0.14 0.286 0.784
xsq TP63 3q28 -0.14 0.286 0.784 Apoptosis; Oncogenes
cop ADAM5 8p11.22 -0.14 0.286 0.784
xsq SWAP70 11p15 -0.14 0.286 0.784 somatic cell DNA recombination;isotype
switching
exp PHAX 5q23.2 -0.14 0.286 0.784 gene expression;protein transport
xsq PAX8-AS1 -0.14 0.286 0.784
met POU4F1 13q31.1 -0.14 0.286 0.784 synapse assembly;positive
exp CTHRC1 8q22.3 -0.14 0.286 0.784 cell migration;positive regulation
of protein binding
pro BCAR1 16q23.1 -0.14 0.286 0.784 G-protein coupled receptor signaling
pathway;cellular response to hepatocyte growth factor stimulus
xsq ANKRD1 10q23.31 -0.14 0.286 0.784 positive regulation of protein
secretion;response to muscle stretch
exp RHOJ 14q23.2 -0.14 0.286 0.784 GTP catabolic process;small GTPase
cop MMP24 20q11.2 -0.14 0.286 0.784 Apoptosis
cop EIF6 20q12 -0.14 0.286 0.784 mature ribosome assembly;ribosome biogenesis
cop FAM83C 20q11.22 -0.14 0.286 0.784
xsq DANT2 -0.14 0.286 0.784
exp ARHGAP39 8q24.3 -0.14 0.286 0.784 signal transduction;small GTPase
xsq CYP1B1-AS1 2p22.2 -0.14 0.286 0.784
met EML1 14q32 -0.14 0.286 0.784
mut PTCHD1 Xp22.11 -0.14 0.286 0.784 smoothened signaling
pathway;cognition
cop PRKCH 14q23.1 -0.14 0.286 0.784 Protein Kinases
xsq TULP3 12p13.3 -0.14 0.286 0.783 regulation of transcription, DNA-
hs4 TRPC1 3q23 -0.141 0.286 0.784 ion transport;calcium ion transport
hs4 AMOTL1 11q14.3 -0.141 0.286 0.784
xai PEAK1 15q24.3 -0.141 0.286 0.784
his LOC101927418 -0.141 0.286 0.784
exp PCAT1 -0.141 0.286 0.784
cop ERVV-1 -0.141 0.286 0.784
cop ERVV-2 -0.141 0.286 0.784
xai SPON2 -0.141 0.286 0.784 cell adhesion;axon guidance
xai ENPP2 8q24.1 -0.141 0.286 0.784 phosphatidylcholine catabolic
his CBFA2T2 20q11 -0.141 0.286 0.784 positive regulation of neuron
projection development;negative regulation of neuron projection development
hs4 ACTG2 2p13.1 -0.141 0.286 0.784 muscle contraction
swa CAPS 19p13.3 -0.141 0.286 0.784 intracellular signal transduction
his PLEKHH2 2p21 -0.141 0.286 0.784
xai AATK 17q25.3 -0.141 0.286 0.784 apoptotic process;protein
autophosphorylation
xai MAN2B1 19p13.2 -0.141 0.286 0.784 protein
xai PRKCSH 19p13.2 -0.141 0.286 0.784 protein folding;intracellular
his KPRP 1q21.3 -0.141 0.286 0.784
exp TPM3P6 19q13.42 -0.141 0.286 0.784
his LURAP1 1p34 -0.141 0.286 0.784 positive regulation of cytokine
production;positive regulation of I-kappaB kinase/NF-kappaB cascade
exp KRT8P43 6p22.3 -0.141 0.286 0.784
his LOC101927142 -0.141 0.286 0.784
his MAP1B 5q13 -0.141 0.286 0.784 central nervous system
hs4 LINC01968 -0.141 0.286 0.784
his ZNF625-ZNF20 -0.141 0.286 0.784
DNA-dependent"
xai ERCC2 19q13.3 -0.141 0.286 0.784 DNA Damage Response (DDR); DDR
(NER)
swa RDX 11q23 -0.141 0.286 0.783 microvillus assembly;apical protein
localization
hs4 LINC00567 13q34 -0.141 0.286 0.783
his ZNF385D-AS2 -0.141 0.286 0.783
his PLD6 17p11.2 0.141 0.287 0.784 piRNA metabolic process;meiosis
his HORMAD1 1q21.3 0.141 0.287 0.784 meiosis;regulation of homologous
his RPL22L1 3q26.2 0.141 0.287 0.784 translation
exp LINC01220 0.141 0.287 0.784
exp RPL29P2 0.141 0.287 0.784
hs4 UVRAG 11q13.5 0.141 0.287 0.784 DNA Damage Response (DDR)
hs4 LOC100506113 0.141 0.287 0.784
xai MPV17L 16p13.11 0.141 0.287 0.784
hs4 C5 9q33-q34 0.141 0.287 0.784 inflammatory response;negative regulation
of macrophage chemotaxis
exp FLJ36848 2p15 0.141 0.287 0.784
his STYX 0.141 0.287 0.784 spermatogenesis;protein dephosphorylation
xai FOXP3 Xp11.23 0.141 0.287 0.784 T cell mediated immunity;regulation of
hs4 LOC100420587 0.141 0.287 0.784
xai ZDHHC20P4 13q21.33 0.141 0.287 0.784
hs4 XPA 9q22.3 0.141 0.287 0.784 DNA Damage Response (DDR); DDR (NER)
xai TMEM86B 19q13.42 0.141 0.287 0.784 ether lipid metabolic process
his TECPR1 7q21.3 0.141 0.287 0.784
xai SUGT1P2 0.141 0.287 0.784
swa TRAP1 16p13.3 0.141 0.287 0.784 Apoptosis
xai SPRED2 2p14 0.141 0.287 0.784 multicellular organismal
his MVB12A 19p13.11 0.141 0.287 0.784
exp VIM-AS1 0.141 0.287 0.784
his MIR663B 0.141 0.287 0.784
his ANKRD30BL 2q21.2 0.141 0.287 0.784
xai METTL22 16p13.2 0.141 0.287 0.784
xai OLFM2 19p13.2 0.141 0.287 0.784
his ELAVL1 19p13.2 0.141 0.287 0.784 mRNA stabilization;3'-UTR-mediated
mRNA stabilization
exp FLJ26850 19q13.33 0.141 0.287 0.784
his VPS26A 10q21.1 0.141 0.287 0.784 retrograde transport, endosome to
Golgi;vacuolar transport
his TXNDC17 17p13.1 0.141 0.287 0.785 tumor necrosis factor-mediated
signaling pathway
his KIAA0753 17p13.1 0.141 0.287 0.785
exp GAPDHP67 Xq26.3 0.141 0.287 0.785
swa POLR1C 6p21.1 0.141 0.287 0.785 DNA Damage Response (DDR)
exp ST8SIA3 18q21.31 0.141 0.287 0.785 oligosaccharide metabolic
xai LOC643802 16q12.2 0.141 0.287 0.785
xai RFC4 3q27 0.141 0.287 0.785 DNA Damage Response (DDR); DDR (MMR); DDR (DNA
replication)
xai CDO1 5q23.2 0.141 0.287 0.785 sulfur amino acid metabolic
xai TTLL4 2p24.3-p24.1 0.141 0.287 0.785 protein modification
xai PRL 6p22.3 0.141 0.287 0.785 cell proliferation;regulation of
his SYT9 11p15.4 0.141 0.287 0.785 regulation of calcium ion-dependent
his DCAKD 17q21.31 0.141 0.287 0.785 coenzyme A biosynthetic process
his NMT1 17q21.31 0.141 0.287 0.785 N-terminal protein
hs4 DDX23 12q13.12 0.141 0.287 0.785 RNA splicing, via transesterification
xai BBS2 16q21 0.141 0.287 0.785 striatum development;negative regulation of
his ERGIC1 5q35.1 0.141 0.287 0.785 ER to Golgi vesicle-mediated
dependent"
xsq UBALD2 17q25.1 0.14 0.287 0.784
met FARP2 2q37.3 0.14 0.287 0.784 axon guidance;neuron remodeling
met ZNF106 15q15.1 0.14 0.287 0.784
xsq DNAH8 6p21.2 0.14 0.287 0.784 ciliary or flagellar
exp TSACC 1q22 0.14 0.287 0.784
cop GSG1L 16p12.1 0.14 0.287 0.784
exp BMI1 10p11.23 0.14 0.287 0.784 segment specification;positive regulation
mut GPR176 15q14-q15.1 0.14 0.287 0.784 G-protein coupled receptor
met GCC2 2q12.3 0.14 0.287 0.784 protein transport;recycling endosome to
Golgi transport
met LPGAT1 1q32 0.14 0.287 0.784 metabolic process;phospholipid
met LAMA5 20q13.2-q13.3 0.14 0.287 0.784 integrin-mediated signaling
met IDI2-AS1 10p15.3 0.14 0.287 0.784
xsq LOC101060091 0.14 0.287 0.784
exp N6AMT2 13q12.11 0.14 0.287 0.784
exp GDPD1 17q22 0.14 0.287 0.784 lipid metabolic process;glycerol metabolic
process
exp TBC1D2B 15q24.3-q25.1 0.14 0.287 0.784
exp IL33 9p24.1 0.14 0.287 0.784 negative regulation of T-helper 1 type
met CYR61 1p22.3 0.14 0.287 0.784 positive regulation of protein
exp C2orf42 2p13.3 0.14 0.287 0.784
exp RPL23AP60 0.14 0.287 0.784
xsq MC5R 18p11.2 0.14 0.287 0.784
cop UFM1 13q13.3 0.14 0.287 0.784 protein ufmylation
xsq RPAP2 1p22.1 0.14 0.287 0.784 snRNA transcription;dephosphorylation of
RNA polymerase II C-terminal domain
cop C18orf42 18p11.31 0.14 0.287 0.784
met CALB2 16q22.2 0.14 0.287 0.784
cop SUFU 10q24.32 0.14 0.287 0.784 negative regulation of transcription from
RNA polymerase II promoter;determination of left/right symmetry
cop TRIM8 10q24.3 0.14 0.287 0.784
cop ARL3 10q23.3 0.14 0.287 0.784 photoreceptor cell development;cilium
morphogenesis
cop SFXN2 10q24.32 0.14 0.287 0.784 iron ion homeostasis;transmembrane
transport
mut LRRC49 15q23 0.14 0.287 0.784
xsq CCDC17 1p34.1 0.14 0.287 0.784
xsq LOC285804 0.14 0.287 0.784
cop KIAA0556 16p12.1 0.14 0.287 0.784
exp MRPS36 5q13.2 0.14 0.287 0.784 translation
xsq SMC2-AS1 0.14 0.287 0.784
xsq CBLL1 7q22.3 0.14 0.287 0.784 negative regulation of cell
xsq RPL13AP6 10q25.2 0.14 0.287 0.784
mut ASCL3 0.14 0.287 0.784
met MIR101-1 0.14 0.287 0.784
exp THOC6 16p13.3 0.14 0.287 0.784 mRNA processing;mRNA export from nucleus
met TIGD3 11q13.1 0.14 0.287 0.784 regulation of transcription, DNA-
dependent"
xsq NDUFV3 21q22.3 0.14 0.287 0.785 transport;respiratory electron
transport chain
xsq LINC01539 0.14 0.287 0.785
met ALKBH3 11p11.2 0.14 0.287 0.785 DNA Damage Response (DDR); DDR
(Direct Repair)
mut OR4K13 14q11.2 0.14 0.287 0.785
met ZFAND6 15q25.1 0.14 0.287 0.785 signal transduction
xsq FBXO22-AS1 0.14 0.287 0.785
exp LMF1 16p13.3 0.14 0.287 0.785 protein glycosylation in
met RAC1 7p22 0.14 0.287 0.785 axon guidance;lamellipodium assembly
xsq CCDC22 Xp11.23 0.14 0.287 0.785
xsq VNN3 6q23.2 0.14 0.287 0.785 nitrogen compound metabolic process
xsq LOC392196 0.14 0.287 0.785
xsq TNPO3 7q32.1 0.14 0.287 0.785 protein transport;splicing factor protein
import into nucleus
mut PNPLA7 9q34.3 0.14 0.287 0.785 lipid metabolic process;metabolic
process
met HELZ 17q24.2 0.14 0.287 0.785
exp LRRC32 11q13.5-q14 -0.14 0.287 0.785
exp TNK1 17p13.1 -0.14 0.287 0.785 protein autophosphorylation;protein
phosphorylation
xsq ANKRD33B 5p15.2 -0.14 0.287 0.785
exp NOL3 16q22.1 -0.14 0.287 0.785 Apoptosis
met FER1L5 2q11.2 -0.14 0.287 0.785
met PARP11 12p13.3 -0.14 0.287 0.785
xsq OR6C6 -0.14 0.287 0.785 response to stimulus
xsq ZBTB18 1q44 -0.14 0.287 0.785
met RHOF 12q24.31 -0.14 0.287 0.785 GTP catabolic process;actin filament
organization
xsq KCNS3 2p24 -0.14 0.287 0.785 ion transport;potassium ion transport
met APC2 19p13.3 -0.14 0.287 0.784 Wnt receptor signaling pathway;negative
regulation of catenin import into nucleus
xsq SRRM3 7q11.23 -0.14 0.287 0.784
exp SPTBN1 2p21 -0.14 0.287 0.784 axon guidance;actin filament capping
exp SH3TC2 5q32 -0.14 0.287 0.784
exp FAM196A 10q26.2 -0.14 0.287 0.784
exp NFATC4 14q11.2 -0.14 0.287 0.784 transcription from RNA polymerase
II promoter;inflammatory response
cop VSNL1 2p24.3 -0.14 0.287 0.784
exp ELF5 11p13-p12 -0.14 0.287 0.784 Transcription Factors
exp DGCR6 22q11.21 -0.14 0.287 0.784 organ morphogenesis;cell adhesion
exp TUBA3GP 22q11.21 -0.141 0.287 0.785
xai SEPP1 5q31 -0.141 0.287 0.785 response to oxidative stress
his MIR3141 -0.141 0.287 0.785
his RNF128 Xq22.3 -0.141 0.287 0.785 negative regulation of
xai PLXDC1 17q21.1 -0.141 0.287 0.785 angiogenesis;spinal cord
development
DNA-dependent"
xai PRCP 11q14 -0.141 0.287 0.785 proteolysis;blood coagulation
hs4 NACC2 9q34.3 -0.141 0.287 0.785 positive regulation of cell
his LINC01023 -0.141 0.287 0.785
his PRDM11 11p11 -0.141 0.287 0.785
cop NT5C1B-RDH14 -0.141 0.287 0.784
cop RDH14 2p24.2 -0.141 0.287 0.784
cop NT5C1B 2p24.2 -0.141 0.287 0.784
his ACTC1 15q14 -0.141 0.287 0.784 ATP catabolic process;response to ethanol
xai TLN1 9p13 -0.141 0.287 0.784 muscle contraction;platelet activation
xai SUN3 7p12.3 -0.141 0.287 0.784
hs4 TRIM38 6p21.3 -0.141 0.287 0.784 signal transduction;positive
his SLFN5 17q12 -0.141 0.287 0.784 cell differentiation
xai CTIF 18q21.1 -0.141 0.287 0.784 nuclear-transcribed mRNA catabolic
exp SCTR 2q14.1 -0.141 0.287 0.784 digestion;excretion
exp RNF217-AS1 -0.141 0.287 0.784
hs4 HUNK 21q22.1 -0.141 0.287 0.784 signal transduction;multicellular
his PLA2G4B -0.141 0.287 0.784 parturition;metabolic process
hs4 PICALM 11q14 -0.141 0.287 0.784 vesicle-mediated transport;clathrin
coat assembly
his C7orf65 7p12.3 -0.141 0.287 0.784
xai CD46P1 1q32 -0.141 0.287 0.784
hs4 PCDH17 13q21.1 -0.141 0.287 0.784 cell adhesion;homophilic cell
adhesion
his NOTCH3 19p13.2-p13.1 -0.141 0.287 0.784 Tumor Suppressors
xai ATP13A3 3q29 -0.141 0.287 0.784 cation transport
xai UNGP3 14q31.1 -0.141 0.287 0.784
his ST6GALNAC4 9q34 0.141 0.288 0.785 glycolipid metabolic process;O-glycan
processing
his SRSF6 20q12-q13.1 0.141 0.288 0.785 RNA splicing;gene expression
exp SNORA60 20q11.23 0.141 0.288 0.785
his EFR3B 2p23.3 0.141 0.288 0.785
his MRC2 17q23.2 0.141 0.288 0.785 endocytosis
his KRTAP23-1 0.141 0.288 0.785
hs4 PHF12 17q11.2 0.141 0.288 0.785 negative regulation of transcription,
DNA-dependent"
xai EFNA3 1q21-q22 0.141 0.288 0.785 cell-cell signaling;ephrin receptor
signaling pathway
hs4 MTHFD2L 4q13.3 0.141 0.288 0.785 methionine biosynthetic
his CTDSP2 12q14.1 0.141 0.288 0.785 protein
dephosphorylation;activation of signaling protein activity involved in unfolded
protein response
his CTNNA3 10q22.2 0.141 0.288 0.785 cell-cell adhesion
his TMEM198B 12q13.2 0.141 0.288 0.785
his DNAJC14 12q13.2 0.141 0.288 0.785 protein folding;protein transport
hs4 LINC01012 0.141 0.288 0.785
exp ASTE1 3q22.1 0.141 0.288 0.785 DNA repair
hs4 KIF1A 2q37.3 0.141 0.288 0.785 microtubule-based movement;anterograde
axon cargo transport
his HIPK1-AS1 0.141 0.288 0.785
his HIPK1 1p13.2 0.141 0.288 0.785 eye development;regulation of
his NBPF22P 5q14.3 0.141 0.288 0.785
exp IFNA7 0.141 0.288 0.785 innate immune response;type I interferon-
his ARL1 12q23.2 0.141 0.288 0.785 Golgi organization;small GTPase mediated
signal transduction
xai SEC24B-AS1 0.141 0.288 0.785
xai IFNA7 0.141 0.288 0.785 innate immune response;type I interferon-
hs4 NOTO 0.141 0.288 0.785
xai PRSS3 9p11.2 0.141 0.288 0.785 digestion;zymogen activation
hs4 KEL 7q33 0.141 0.288 0.785 proteolysis;vasoconstriction
xai LINC01252 0.141 0.288 0.785
hs4 RBMX Xq26.3 0.141 0.288 0.785 transcription from RNA polymerase II
hs4 SNORD61 Xq26.3 0.141 0.288 0.785
his IREB2 15q25.1 0.141 0.288 0.785 protoporphyrinogen IX biosynthetic
exp EML5 14q31.3 0.141 0.288 0.785
his CMC4 0.141 0.288 0.785
his MTCP1 Xq28 0.141 0.288 0.785 cell proliferation
his BRCC3 Xq28 0.141 0.288 0.785 DNA Damage Response (DDR)
hs4 D2HGDH 2q37.3 0.141 0.288 0.785 response to manganese ion;response
to zinc ion
hs4 GFRA3 5q31.1-q31.3 0.141 0.288 0.785 neuron development;neuron migration
his PFDN4 20q13.2 0.141 0.288 0.785 protein folding;cellular protein
metabolic process
swa HSPA4 5q31.1 0.141 0.288 0.785 Apoptosis
hs4 LOC105371038 0.141 0.288 0.785
hs4 WDR90 16p13.3 0.141 0.288 0.785
xsq PPP2R3C 14q13.2 0.14 0.288 0.785
xsq YTHDC1 4q13.2 0.14 0.288 0.785 nuclear mRNA splicing, via
xsq LINC01523 0.14 0.288 0.785
xsq ORMDL1 2q32 0.14 0.288 0.785 ceramide metabolic process
mut TRAPPC8 18q12.1 0.14 0.288 0.785 vesicle-mediated transport;ER to
cop TEX19 17q25.3 0.14 0.288 0.785
met RAB4B 19q13.2 0.14 0.288 0.785 GTP catabolic process;small GTPase
cop LOC644838 0.14 0.288 0.785
xsq MXD1 2p13-p12 0.14 0.288 0.785 Apoptosis
mut RITA1 0.14 0.288 0.785 nuclear export;negative regulation of
xsq TK1 17q23.2-q25.3 0.14 0.288 0.785 DNA replication;nucleotide
cop AFF3 2q11.2-q12 0.14 0.288 0.785 embryonic hindlimb
exp LOC100132167 0.14 0.288 0.785
exp MIRLET7D 0.139 0.288 0.785
cop TELO2 16p13.3 0.139 0.288 0.785 DNA Damage Response (DDR); DDR (FA)
met AMBN 4q21 0.139 0.288 0.785 cell adhesion;cell proliferation
exp LOC643201 5q35.2 0.139 0.288 0.785
cop KANSL3 2q11.2 0.139 0.288 0.785 histone H4-K5 acetylation;histone
H4-K8 acetylation
cop FER1L5 2q11.2 0.139 0.288 0.785
cop LMAN2L 2q11.2 0.139 0.288 0.785 protein folding;ER to Golgi
mut LPAR6 13q14 0.139 0.288 0.785 G-protein coupled receptor signaling pathway
xsq LOC101928569 0.139 0.288 0.785
met RYR3 15q14-q15 0.139 0.288 0.785 cellular response to calcium ion;ion
transport
dependent"
met FBXL19 16p11.2 0.139 0.288 0.785
xsq CMTR1 0.139 0.288 0.785 mRNA capping;mRNA methylation
exp CEACAM5 19q13.1-q13.2 0.139 0.288 0.785
met OTUD6A Xq13.1 0.139 0.288 0.785
cop MIR4687 0.139 0.288 0.785
xsq C11orf73 11q14.2 0.139 0.288 0.785 Golgi organization;multicellular
mut TMEM176A 7q36.1 0.139 0.288 0.785
met ATP2B4 1q32.1 0.139 0.288 0.785 ion transmembrane
exp RPL26L1 5q35.1 0.139 0.288 0.785 translational elongation;viral
transcription
dependent;negative regulation of neuron differentiation
cop SCD 10q24.31 0.139 0.288 0.785 fatty acid biosynthetic process
cop LINC00263 10q24.31 0.139 0.288 0.785
xsq NUDCD1 8q23 0.139 0.288 0.785
xsq IGFBPL1 9p13.1 0.139 0.288 0.785 regulation of cell growth
xsq RFPL2 22q12.3 0.139 0.288 0.785
cop CLCN7 16p13 0.139 0.288 0.785 response to pH;transmembrane transport
xsq IL10RB-AS1 21q22.11 0.139 0.288 0.785
dependent"
cop SLC28A1 15q25.3 0.139 0.288 0.785 nucleobase-containing compound
metabolic process;nucleoside transport
cop RLTPR 16q22.1 0.139 0.288 0.785
cop ACD 16q22.1 0.139 0.288 0.785 DNA Damage Response (DDR)
cop PARD6A 16q22.1 0.139 0.288 0.785 cell-cell junction maintenance;cell
division
cop ENKD1 16q22.1 0.139 0.288 0.785
cop C16orf86 16q22.1 0.139 0.288 0.785
cop GFOD2 16q22.1 0.139 0.288 0.785 extracellular matrix organization
cop RANBP10 16q22.1 0.139 0.288 0.785 microtubule cytoskeleton
cop TSNAXIP1 16q22.1 0.139 0.288 0.785 multicellular organismal
cop CENPT 16q22.1 0.139 0.288 0.785 M phase of mitotic cell cycle;mitotic
prometaphase
mut KCNMA1 10q22.3 0.139 0.288 0.785 ion transport;positive regulation
mut PJA1 Xq13.1 0.139 0.288 0.785 protein catabolic process
xsq RPP30 10q23.31 0.139 0.288 0.785 tRNA processing
exp SH3PXD2B 5q35.1 -0.139 0.288 0.785 extracellular matrix
met GPR68 14q31 -0.139 0.288 0.785 inflammatory response;G-protein coupled
cop DDR2 1q23.3 -0.139 0.288 0.785 peptidyl-tyrosine
factor activity
cop HSD17B7 1q23 -0.139 0.288 0.785 steroid biosynthetic
cop NUDCD1 8q23 -0.139 0.288 0.785
exp ARMCX6 Xq21.33-q22.3 -0.139 0.288 0.785
cop FNIP1 5q23.3 -0.139 0.288 0.785 regulation of protein
phosphorylation
cop LTC4S 5q35 -0.139 0.288 0.785 prostanoid metabolic process;response to
inorganic substance
xsq FGFBP2 4p16 -0.139 0.288 0.785
exp TBC1D10A 22q12.2 -0.139 0.288 0.785
xsq B3GAT1 11q25 -0.139 0.288 0.785 carbohydrate metabolic
met DIRC3 2q35 -0.139 0.288 0.785
exp TDRD7 9q22.33 -0.139 0.288 0.785 lens morphogenesis in camera-type
exp CPA2 7q32 -0.139 0.288 0.785 proteolysis;vacuolar protein catabolic
process
exp OGDH 7p14-p13 -0.139 0.288 0.785 oxidation-reduction
met DNAI2 17q25 -0.139 0.288 0.785 cell projection organization;cilium
assembly
xsq PDZD7 10q24.31 -0.139 0.288 0.785
xsq RAB5C 17q21.2 -0.139 0.288 0.785 regulation of endocytosis;GTP
catabolic process
met OR10A3 11p15.4 -0.139 0.288 0.785 detection of chemical
stimulus involved in sensory perception of smell;sensory perception of smell
cop C5orf64 5q12.1 -0.139 0.288 0.785
xsq ZFYVE1 14q24.2 -0.139 0.288 0.785 negative regulation of
exp LOC100506563 -0.139 0.288 0.785
exp FAM174B 15q26.1 -0.139 0.288 0.785
exp XKR4 8q12.1 -0.139 0.288 0.785
cop SPECC1 17p11.2 -0.14 0.288 0.785
exp CDKN3 14q22 -0.14 0.288 0.785 regulation of cyclin-dependent protein kinase
activity;G1/S transition of mitotic cell cycle
exp IGKV4-1 2p12 -0.14 0.288 0.785 immune response;complement activation
xsq PRAF2 Xp11.23 -0.14 0.288 0.785 L-glutamate transport;protein transport
xsq C1orf64 1p36.13 -0.14 0.288 0.785
xsq MAPK7 17p11.2 -0.14 0.288 0.785 Protein Kinases
exp GLTP 12q24.11 -0.14 0.288 0.785 transport;glycolipid transport
exp MIOX 22q13.3 -0.14 0.288 0.785 inositol catabolic process
mut DPH1 17p13.3 -0.14 0.288 0.785 cell proliferation;peptidyl-diphthamide
biosynthetic process from peptidyl-histidine
met PAGR1 16p11.2 -0.14 0.288 0.785
met CLSTN2 3q23 -0.14 0.288 0.785 cell adhesion;homophilic cell adhesion
exp HOXA2 7p15.2 -0.14 0.288 0.785 anterior/posterior pattern
exp VTI1B 14q24.1 -0.14 0.288 0.785 intracellular protein transport;vesicle
cop EPHA5 4q13.1 -0.14 0.288 0.785 axon guidance;dendritic spine
morphogenesis
xsq ADAMTS1 21q21.2 -0.14 0.288 0.785 integrin-mediated signaling
xai COMMD6 13q22 -0.141 0.288 0.785
xai LINC00958 -0.141 0.288 0.785
his GGT8P 2p11.1 -0.141 0.288 0.785
his SCML1 Xp22 -0.141 0.288 0.785 regulation of transcription, DNA-
xai PPP1R3G 6p25.1 -0.141 0.288 0.785
exp LOC653581 -0.141 0.288 0.785
his MIR6088 -0.141 0.288 0.785
xai SVOPL 7q34 -0.141 0.288 0.785
xai SORBS3 8p21.3 -0.141 0.288 0.785 cell adhesion;cell-substrate
adhesion
hs4 RCN3 19q13.33 -0.141 0.288 0.785
hs4 ACOT4 14q24.3 -0.141 0.288 0.785 unsaturated monocarboxylic acid
exp PRSS51 8p23.1 -0.141 0.288 0.785
dependent"
his SCUBE3 6p21.3 -0.141 0.288 0.785 protein
his FAS 10q24.1 -0.141 0.288 0.785 Apoptosis
his ACTA2 10q23.3 -0.141 0.288 0.785 muscle contraction;regulation of
blood pressure
his FAS-AS1 -0.141 0.288 0.785
his CCBE1 18q21.32 -0.141 0.288 0.785 multicellular organismal
his RP1L1 8p23.1 -0.141 0.288 0.785 cell projection
swa RALY 20q11.21-q11.23 -0.141 0.288 0.785 nuclear mRNA splicing, via
xai LOC100506725 -0.141 0.288 0.785
hs4 SGPP2 2q36.1 -0.141 0.288 0.785 sphingolipid metabolic
process;sphingosine metabolic process
DNA-dependent"
cop ZNF790-AS1 -0.141 0.288 0.785
DNA-dependent"
cop ZNF345 19q13.12 -0.141 0.288 0.785 negative regulation of
polymerase III promoter
DNA-dependent"
hs4 MIR937 -0.141 0.288 0.785
hs4 SCRIB 8q24.3 -0.141 0.288 0.785 multicellular organismal
swa NOP2 12p13 -0.141 0.288 0.785 rRNA processing;positive regulation of
cell proliferation
xai PGAM1P11 -0.141 0.288 0.785
his SPATS2L 2q33.1 -0.141 0.288 0.785
exp PGAM1P11 -0.141 0.288 0.785
his MAPRE3 2p23.3-p23.1 -0.141 0.288 0.785 cell division;cell cycle
swa KIF2A 5q12-q13 -0.141 0.288 0.785 mitotic cell cycle;microtubule-
based movement
his HOXA1 7p15.3 -0.141 0.288 0.785 multicellular organismal
his HOTAIRM1 -0.141 0.288 0.785
his HOXA2 7p15.2 -0.141 0.288 0.785 anterior/posterior pattern
his HOXA3 7p15.2 -0.141 0.288 0.785 glossopharyngeal nerve
his HOXA-AS2 7p15.2 -0.141 0.288 0.785
his HOXA4 7p15.2 -0.141 0.288 0.785 anatomical structure
his HOXA-AS3 7p15.2 -0.141 0.288 0.785
his HOXA5 7p15.2 -0.141 0.288 0.785 thyroid gland development;embryonic
his HOXA6 7p15.2 -0.141 0.288 0.785 multicellular organismal
his HOXA7 7p15.2 -0.141 0.288 0.785 negative regulation of cell-matrix
adhesion;embryonic skeletal system morphogenesis
his HOXA9 7p15.2 -0.141 0.288 0.785 definitive
hemopoiesis;multicellular organismal development
his HOXA10-AS -0.141 0.288 0.785
his MIR196B -0.141 0.288 0.785
his HOXA10 7p15.2 -0.141 0.288 0.785 skeletal system
his HOXA10-HOXA9 -0.141 0.288 0.785
his HOXA11 7p15.2 -0.141 0.288 0.785 metanephros
his HOXA11-AS 7p15.2 -0.141 0.288 0.785
his HOXA13 7p15.2 -0.141 0.288 0.785 skeletal system
development;male genitalia development
his HOTTIP -0.141 0.288 0.785
hs4 B9D1 17p11.2 -0.141 0.288 0.785 smoothened signaling pathway;cell
hs4 MAPK7 17p11.2 -0.141 0.288 0.785 Protein Kinases
cop RRN3P1 0.142 0.289 0.785
xai PIN1P1 1p31 0.141 0.289 0.785
swa PDLIM2 8p21.3 0.141 0.289 0.785
xai CEACAM5 19q13.1-q13.2 0.14 0.289 0.785
xai SMPD4P1 22q11.21 0.14 0.289 0.785
hs4 C2CD4A 15q22.2 0.14 0.289 0.785
xai ASTE1 3q22.1 0.14 0.289 0.785 DNA repair
xai D2HGDH 2q37.3 0.14 0.289 0.785 response to manganese ion;response
to zinc ion
his MEX3A 1q22 0.14 0.289 0.785
hs4 DMRTA2 1p32.3 0.14 0.289 0.785 sex differentiation;regulation of
swa YWHAG 7q11.23 0.14 0.289 0.785 regulation of neuron
differentiation;regulation of synaptic plasticity
xai ERCC3 2q21 0.14 0.289 0.785 Apoptosis; DNA Damage Response (DDR); DDR (NER)
xai OGFOD3 17q25.3 0.14 0.289 0.785
hs4 LETM1 4p16.3 0.14 0.289 0.785 cristae formation
his ZFAND3 6p21.2 0.14 0.289 0.785
his SULT1C3 2q12.3 0.14 0.289 0.785
hs4 MUM1 19p13.3 0.14 0.289 0.785 DNA repair;chromatin organization
his GRID1 10q22 0.14 0.289 0.785 ion transport
xai TYSND1 10q22.1 0.14 0.289 0.785 proteolysis;protein processing
hs4 GABRQ Xq28 0.14 0.289 0.785 signal transduction;ion transport
his TM7SF3 12q11-q12 0.14 0.289 0.785
his LINC01169 0.14 0.289 0.785
hs4 PGS1 17q25.3 0.14 0.289 0.785 phosphatidylglycerol biosynthetic
his RAB24 5q35.3 0.14 0.289 0.785 autophagy;small GTPase mediated signal
transduction
his PRELID1 5q35.3 0.14 0.289 0.785 immune response;multicellular
his MXD3 5q35.3 0.14 0.289 0.785 negative regulation of transcription,
DNA-dependent"
his AMN1 12p11.21 0.14 0.289 0.785 DNA Damage Response (DDR)
hs4 SIGLEC6 19q13.3 0.14 0.289 0.785 cell adhesion;cell-cell signaling
xai EML5 14q31.3 0.14 0.289 0.785
xai TAS2R30 0.14 0.289 0.785 sensory perception of taste;response to
stimulus
xai ADPRM 17p13.1 0.14 0.289 0.785
hs4 FKBP8 19p12 0.14 0.289 0.785 interspecies interaction between
organisms;protein peptidyl-prolyl isomerization
his PROSER1 13q13.3 0.14 0.289 0.785
his NHLRC3 13q13.3 0.14 0.289 0.785
swa IPO4 14q12 0.14 0.289 0.785 intracellular protein transport;protein
transport
hs4 CRHR1 17q12-q22 0.14 0.289 0.785 immune response;female pregnancy
his DNAJC7 17q11.2 0.14 0.289 0.785 protein folding;chaperone cofactor-
his NKIRAS2 17q21.2 0.14 0.289 0.785 I-kappaB kinase/NF-kappaB
exp TBX20 7p14.3 0.14 0.289 0.785 endoderm formation;cardiac right
xai CCNY 10p11.21 0.14 0.289 0.785 cell cycle;Wnt receptor signaling pathway
xai LOC284930 0.14 0.289 0.785
xai HLA-DRB6 0.14 0.289 0.785
his ZBED8 0.14 0.289 0.786
xsq HIST1H2BN 6p22.1 0.139 0.289 0.785 nucleosome assembly
cop ALPK3 15q25.2 0.139 0.289 0.785 protein phosphorylation;multicellular
cop KRT35 17q21.2 0.139 0.289 0.785 anatomical structure morphogenesis
xsq NADSYN1 11q13.4 0.139 0.289 0.785 vitamin metabolic process;water-
xsq RBM22 5q33.1 0.139 0.289 0.785 protein import into nucleus,
cop TK2 16q22-q23.1 0.139 0.289 0.785 DNA replication;pyrimidine nucleoside
salvage
xsq ADCY4 14q12 0.139 0.289 0.785 energy reserve metabolic process;inhibition of
xsq IFNA21 9p22 0.139 0.289 0.785 response to virus;cytokine-mediated
signaling pathway
xsq OPN3 1q43 0.139 0.289 0.785 response to stimulus;G-protein coupled receptor
signaling pathway
met LOC729609 Xp22.12 0.139 0.289 0.785
xsq CAPZA1 1p13.2 0.139 0.289 0.785 cellular component movement;blood
coagulation
exp NDN 15q11.2-q12 0.139 0.289 0.785 central nervous system development;axon
met MCCC1 3q27 0.139 0.289 0.785 cellular nitrogen compound metabolic
met GIT1 17p11.2 0.139 0.289 0.785 regulation of G-protein coupled receptor
met FHL5 6q16.1-q16.3 0.139 0.289 0.785
xsq TRAF3 14q32.32 0.139 0.289 0.785 Apoptosis
cop OGFOD3 17q25.3 0.139 0.289 0.785
cop MEMO1 0.139 0.289 0.785 regulation of microtubule-based process
exp SFI1 22q12.2 0.139 0.289 0.785 G2/M transition of mitotic cell
met FKBP1AP1 19q13.43 0.139 0.289 0.785
xsq HIST1H2AH 6p21.33 0.139 0.289 0.785 nucleosome assembly
cop GOLGA6L7P 15q13.1 0.139 0.289 0.785
cop FOSL2 2p23.3 0.139 0.289 0.785 regulation of transcription from RNA
polymerase II promoter;cell death
cop MIR4303 0.139 0.289 0.785
cop CCDC178 18q12.1 0.139 0.289 0.785
exp SMCO4 11q21 0.139 0.289 0.785
cop ARCN1 11q23.3 0.139 0.289 0.785 retrograde vesicle-mediated transport,
Golgi to ER;cellular membrane organization
cop DDX6 11q23.3 0.139 0.289 0.785 nuclear-transcribed mRNA catabolic
cop CXCR5 11q23.3 0.139 0.289 0.785 B cell activation;lymph node development
cop BCL9L 11q23.3 0.139 0.289 0.785 negative regulation of transforming
cop MIR4492 0.139 0.289 0.785
cop UPK2 11q23 0.139 0.289 0.785 epithelial cell differentiation;multicellular
cop FOXR1 11q23.3 0.139 0.289 0.785 pattern specification process;embryo
development
cop CCDC84 11q23.3 0.139 0.289 0.785
cop RPL23AP64 11q23.3 0.139 0.289 0.785
cop RPS25 11q23.3 0.139 0.289 0.785 translation;mRNA metabolic process
cop TRAPPC4 11q23.3 0.139 0.289 0.785 ER to Golgi vesicle-mediated
cop MIR3656 0.139 0.289 0.785
cop HYOU1 11q23.1-q23.3 0.139 0.289 0.785 response to stress;activation of
xsq LINC00523 14q32.2 0.139 0.289 0.785
exp RPL18AP8 3q11.2 0.139 0.289 0.785
xsq PRR23B 0.139 0.289 0.785
xsq RNFT2 12q24.22 0.139 0.289 0.785
exp C1orf43 1q21.2 0.139 0.289 0.785
exp JARID2 6p24-p23 0.139 0.289 0.785 multicellular organismal
cop DEFB131 4p16.1 0.139 0.289 0.785
xsq LOC101929237 0.139 0.289 0.785
xsq LCMT2 15q15.3 0.139 0.289 0.785 tRNA processing
met ADAM32 8p11.22 0.139 0.289 0.785 proteolysis
xsq TAF8 6p21.1 0.139 0.289 0.785 inner cell mass cell
mut PROC 2q13-q14 0.139 0.289 0.785 peptidyl-glutamic acid
cop SMC6 2p24.2 -0.139 0.289 0.785 DNA Damage Response (DDR); DDR
met CCDC175 14q23.1 -0.139 0.289 0.785
xsq OAS3 12q24.2 -0.139 0.289 0.785 cytokine-mediated signaling
pathway;negative regulation of viral genome replication
exp ANKRD53 2p13.3 -0.139 0.289 0.785
xsq FN1 2q34 -0.139 0.289 0.785 response to wounding;cell migration
xsq LOC105375734 -0.139 0.289 0.785
xsq EGR3 8p23-p21 -0.139 0.289 0.785 positive regulation of endothelial
exp SORBS3 8p21.3 -0.139 0.289 0.785 cell adhesion;cell-substrate
adhesion
cop ZIC4 3q24 -0.139 0.289 0.785
cop ZIC1 3q24 -0.139 0.289 0.785 positive regulation of protein import
into nucleus;regulation of transcription, DNA-dependent
met STARD4 5q22.1 -0.139 0.289 0.785 transport;lipid transport
cop IQCJ-SCHIP1 -0.139 0.289 0.785
cop IQCJ 3q25.32 -0.139 0.289 0.785
cop SCHIP1 3q25.32-q25.33 -0.139 0.289 0.785
cop MIR3919 -0.139 0.289 0.785
cop IL12A 3q25.33 -0.139 0.289 0.785 cell cycle arrest;positive
cop LOC339874 -0.139 0.289 0.785
cop NUDT16P1 3q22.1 -0.139 0.289 0.785
cop NUDT16 3q22.1 -0.139 0.289 0.785
cop MRPL3 3q21-q23 -0.139 0.289 0.785 translation
cop SNORA58 3q21.2 -0.139 0.289 0.785
cop CPNE4 3q22.1 -0.139 0.289 0.785
cop MIR5704 -0.139 0.289 0.785
cop ACPP 3q22.1 -0.139 0.289 0.785
xsq PERP 6q24 -0.139 0.289 0.785 Apoptosis
xsq CNTN6 3p26-p25 -0.139 0.289 0.785 cell adhesion;Notch signaling
pathway
xsq MORN4 10q24.2 -0.139 0.289 0.785
xsq YPEL3 16p11.2 -0.139 0.289 0.785
cop TINAG 6p12.1 -0.139 0.289 0.785 proteolysis;immune response
exp RABAC1 19q13.2 -0.139 0.289 0.785
cop KIAA1024L 5q23.3 -0.139 0.289 0.785
xsq SPIDR 8q11.21 -0.139 0.289 0.785
exp LOC100128843 -0.139 0.289 0.785
exp KRT19P3 4q25 -0.139 0.289 0.785
met BTF3P11 13q22 -0.139 0.289 0.785
cop MGC32805 -0.139 0.289 0.785
xsq MIA-RAB4B -0.139 0.289 0.785
exp TLN1 9p13 -0.139 0.289 0.785 muscle contraction;platelet activation
exp EDIL3 5q14 -0.139 0.289 0.785 cell adhesion;multicellular organismal
development
cop C4orf45 4q32.1 -0.139 0.289 0.785
cop MIR3688-1 -0.139 0.289 0.785
cop MIR3688-2 -0.139 0.289 0.785
cop RAPGEF2 4q32.1 -0.139 0.289 0.785 cAMP-mediated
signaling;positive regulation of Rap GTPase activity
met HIST1H4K 6p22.1 -0.139 0.289 0.785
cop SRC 20q12-q13 -0.139 0.289 0.785 Apoptosis; Oncogenes; Protein
Kinases
xsq MDGA2 14q21.3 -0.139 0.289 0.785 spinal cord motor neuron
differentiation
cop TEK 9p21 -0.139 0.289 0.785 endothelial cell proliferation;blood
coagulation
xai ZFX Xp21.3 -0.14 0.289 0.785 regulation of transcription, DNA-
dependent"
hs4 FAXDC2 5q31-q32 -0.14 0.289 0.785
his LOC101927143 -0.14 0.289 0.785
exp LOC100505923 -0.14 0.289 0.785
his LIMS1 2q12.3 -0.14 0.289 0.785 cell aging;cell junction assembly
swa SMTN 22q12.2 -0.14 0.289 0.785 smooth muscle contraction;muscle organ
development
xai KCTD1 18q11.2 -0.14 0.289 0.785 potassium ion transport;negative
his ZG16 16p11.2 -0.14 0.289 0.785 protein transport
cop CAPN12 19q13.2 -0.14 0.289 0.785 proteolysis
cop LGALS7 -0.14 0.289 0.785
cop LGALS7B 19q13.2 -0.14 0.289 0.785 apoptotic process;heterophilic
cell-cell adhesion
cop LGALS4 19q13.2 -0.14 0.289 0.785 cell adhesion
cop ECH1 19q13.1 -0.14 0.289 0.785 lipid metabolic process;fatty acid
metabolic process
cop HNRNPL 19q13.2 -0.14 0.289 0.785 nuclear mRNA splicing, via
cop RINL 19q13.2 -0.14 0.289 0.785
cop SIRT2 19q13 -0.14 0.289 0.785 regulation of exit from mitosis;response to
redox state
cop NFKBIB 19q13.1 -0.14 0.289 0.785 Apoptosis
cop LOC643669 -0.14 0.289 0.785
cop SARS2 19q13.2 -0.14 0.289 0.785 tRNA aminoacylation for protein
cop MRPS12 19q13.1-q13.2 -0.14 0.289 0.785 translation
hs4 LRRTM3 10q21.3 -0.14 0.289 0.785
xai LOC100505923 -0.14 0.289 0.785
exp LRRIQ1 12q21.31 -0.14 0.289 0.785
cop TTC14 3q26.33 -0.14 0.289 0.785
hs4 IL7 8q12-q13 -0.14 0.289 0.785 positive regulation of cell
xai APOBEC2 6p21 -0.14 0.289 0.785 mRNA processing;cytidine deamination
hs4 LOC100505658 -0.14 0.289 0.785
hs4 RNF216 7p22.1 -0.14 0.289 0.785 interspecies interaction between
organisms;regulation of defense response to virus by host
dependent;hemopoiesis"
dependent"
dependent"
his CARS2 13q34 -0.14 0.289 0.785 gene expression;tRNA aminoacylation for protein
translation
his LOC100499484 0.14 0.29 0.786
his LOC100499484-C9ORF174 0.14 0.29 0.786
his ANKRD18CP 9q22.33 0.14 0.29 0.786
xai OR2AF1P 0.14 0.29 0.786
xai NIPBL 5p13.2 0.14 0.29 0.786 brain development;positive regulation of
xai SOAT2 12q13.13 0.14 0.29 0.786 steroid metabolic process;cholesterol
metabolic process
xai PYM1 0.14 0.29 0.786 nuclear-transcribed mRNA catabolic process,
his HERPUD1 16q13 0.14 0.29 0.786 cellular calcium ion homeostasis;response
to stress
xai ZNF609 15q22.31 0.14 0.29 0.786
xai TBL1YP1 Yq11.223 0.14 0.29 0.786
xai ATP5G3 2q31.1 0.14 0.29 0.786 aging;ATP synthesis coupled proton
transport
exp OR2AF1P 0.14 0.29 0.786
hs4 ARMC4P1 0.14 0.29 0.786
his MAP2K4P1 0.14 0.29 0.786
his CHIC1 Xq13.2 0.14 0.29 0.786
swa VRK1 14q32 0.14 0.29 0.786 Golgi disassembly;protein phosphorylation
xai DNAJA1 9p13.3 0.14 0.29 0.786 protein folding;response to
unfolded protein
exp NAALADL1 11q12 0.14 0.29 0.786 proteolysis
hs4 DQX1 2p13.1 0.14 0.29 0.786
hs4 AUP1 2p13 0.14 0.29 0.786
hs4 HTRA2 2p12 0.14 0.29 0.786 Apoptosis
xai POLR2J 7q22.1 0.14 0.29 0.786 DNA Damage Response (DDR); DDR
(NER)
his GXYLT1P3 0.14 0.29 0.786
his MIR6816 0.14 0.29 0.786
his RANBP1 22q11.21 0.14 0.29 0.786 viral reproduction;positive
his TRMT2A 22q11.21 0.14 0.29 0.786 RNA processing
his APOBEC3A 22q13.1-q13.2 0.14 0.29 0.786 cytidine deamination;DNA
demethylation
xai GNPATP 16q21 0.14 0.29 0.786
his NUBP1 16p13.13 0.14 0.29 0.786 cell growth;iron-sulfur cluster assembly
his LOC101929549 0.14 0.29 0.786
his GALNT8 12p13.3 0.14 0.29 0.786 cellular protein metabolic
exp IGSF21 1p36.13 0.14 0.29 0.786
his ZFAND6 15q25.1 0.14 0.29 0.786 signal transduction
his LOC102723753 0.14 0.29 0.786
his HERC2P4 0.14 0.29 0.786
xai NUP210P1 3q21.3 0.14 0.29 0.786
xai GAPDHP67 Xq26.3 0.14 0.29 0.786
swa SNRNP200 2q11.2 0.14 0.29 0.786 RNA splicing;gene expression
exp LOC100506302 0.14 0.29 0.786
xai THAP2 12q21.1 0.14 0.29 0.786
his PTP4A1 6q12 0.14 0.29 0.786 multicellular organismal
his LINC02043 0.14 0.29 0.786
exp RGS17P1 0.14 0.29 0.786
his CRYBB1 22q12.1 0.14 0.29 0.786 visual perception
his CRYBA4 22q12.1 0.14 0.29 0.786 camera-type eye development;visual
perception
hs4 SNORD143 0.14 0.29 0.786
hs4 SNORD144 0.14 0.29 0.786
hs4 SEC31A 4q21.22 0.14 0.29 0.786 activation of signaling protein
hs4 THAP9 4q21.22 0.14 0.29 0.786
hs4 THAP9-AS1 0.14 0.29 0.786
xai RGS17P1 0.14 0.29 0.786
his LAMTOR1 11q13.4 0.14 0.29 0.786 lysosome localization;regulation of
receptor recycling
xai FAM90A25P 8p23.1 0.14 0.29 0.786
his MAPRE1 20q11.1-q11.23 0.14 0.29 0.786 protein localization to
his GPX5 6p22.1 0.14 0.29 0.786 lipid metabolic process;response to
oxidative stress
hs4 LINC01287 0.14 0.29 0.786
xai NAALADL1 11q12 0.14 0.29 0.786 proteolysis
swa KRT9 17q21.2 0.14 0.29 0.786 skin development;intermediate filament
organization
swa ENSA 1q21.3 0.14 0.29 0.786 response to nutrient;cell division
his CCDC191 0.14 0.29 0.786
his QTRT2 0.14 0.29 0.786
his RASD1 17p11.2 0.14 0.29 0.786 GTP catabolic process;signal transduction
exp FAM90A25P 8p23.1 0.14 0.29 0.786
his CD2 1p13.1 0.14 0.29 0.786 blood coagulation;cell-cell adhesion
xai PFN1P7 0.14 0.29 0.786
his R3HCC1 8p21.3 0.14 0.29 0.786
met EFNA5 5q21 0.139 0.29 0.786 apoptotic process;regulation of Rho GTPase
activity
xsq USP24 1p32.3 0.139 0.29 0.786 proteolysis;ubiquitin-dependent protein
catabolic process
exp CISD1 10q21.1 0.139 0.29 0.786 regulation of cellular respiration
cop FAM63A 1q21.3 0.139 0.29 0.786
xsq LOC101926966 0.139 0.29 0.786
met VAV2 9q34.1 0.139 0.29 0.786 angiogenesis;lamellipodium assembly
mir hsa-miR-487b 0.139 0.29 0.786
cop MBP 18q23 0.139 0.29 0.786 immune response;synaptic transmission
xsq TSACC 1q22 0.139 0.29 0.786
xsq SMCO4 11q21 0.139 0.29 0.786
met NCS1 9q34 0.139 0.29 0.786 positive regulation of
xsq TRIM31-AS1 0.139 0.29 0.786
met CCDC126 7p15.3 0.139 0.29 0.786
mut TMEM202 15q24.1 0.139 0.29 0.786
exp RCHY1 4q21.1 0.139 0.29 0.786 protein autoubiquitination;protein
ubiquitination
cop C12orf60 12p12.3 0.139 0.29 0.786
cop SMCO3 12p12.3 0.139 0.29 0.786
cop ART4 12p13-p12 0.139 0.29 0.786 protein ADP-ribosylation;arginine
metabolic process
cop MGP 12p12.3 0.139 0.29 0.786 response to hormone stimulus;cell
differentiation
cop ERP27 12p12.3 0.139 0.29 0.786
cop ARHGDIB 12p12.3 0.139 0.29 0.786 multicellular organismal
cop PDE6H 12p13 0.139 0.29 0.786
xsq SASS6 1p21.2 0.139 0.29 0.786 cell cycle;centriole replication
dependent"
met VIP 6q25 0.139 0.29 0.786 G-protein coupled receptor signaling
met NLRX1 11q23.3 0.139 0.29 0.786 negative regulation of type I interferon
exp PPT1 1p32 0.139 0.29 0.786 receptor-mediated endocytosis;grooming behavior
met PEX26 22q11.21 0.139 0.29 0.786 protein transport;protein import into
peroxisome matrix
xsq PIGP 21q22.2 0.139 0.29 0.786 preassembly of GPI anchor in ER
xsq CLEC17A 19p13.12 0.139 0.29 0.786
xsq LOC401324 0.139 0.29 0.786
met RAPGEFL1 17q21.1 0.139 0.29 0.786 G-protein coupled receptor
cop AGAP5 10q22.2 0.139 0.29 0.786 regulation of ARF GTPase activity
met XBP1 22q12.1 0.139 0.29 0.786 regulation of transcription, DNA-
dependent;serotonin secretion, neurotransmission
exp KANSL3 2q11.2 0.139 0.29 0.786 histone H4-K5 acetylation;histone
H4-K8 acetylation
cop GCNT3 15q21.3 0.139 0.29 0.786 carbohydrate metabolic process;protein O-
xsq FAM175A 4q21.23 0.139 0.29 0.786 DNA Damage Response (DDR)
xsq VPS72 1q21 0.139 0.29 0.786 somatic stem cell maintenance;negative
xsq OR51G1 0.139 0.29 0.786
mut CFH 1q32 0.139 0.29 0.786 complement activation, alternative
mut SCG3 15q21 0.139 0.29 0.786 platelet degranulation;blood coagulation
exp NDUFB3 2q31.3 0.139 0.29 0.786 mitochondrial electron transport,
cop PKD2L1 10q24 0.139 0.29 0.786 potassium ion transmembrane
taste
exp JMJD1C 10q21.3 0.139 0.29 0.786 regulation of transcription, DNA-
xsq SPON2 -0.139 0.29 0.786 cell adhesion;axon guidance
met NID2 14q22.1 -0.139 0.29 0.786 cell adhesion;cell-matrix adhesion
exp PRCP 11q14 -0.139 0.29 0.786 proteolysis;blood coagulation
xsq FKBP10 17q21.2 -0.139 0.29 0.786 peptidyl-proline
xsq B3GALT5 21q22.3 -0.139 0.29 0.786 protein glycosylation
cop PROCR 20q11.2 -0.139 0.29 0.786 immune response;blood coagulation
cop BPI 20q11.23 -0.139 0.29 0.786
xsq ARMC3 10p12.31 -0.139 0.29 0.786
exp STAG3L4 7p11.2-q11.2 -0.139 0.29 0.786
xsq SNORA55 1p34.3 -0.139 0.29 0.786
xsq C2orf72 2q37.1 -0.139 0.29 0.786
xsq PSG7 -0.139 0.29 0.786 female pregnancy
xsq DGCR11 22q11.21 -0.139 0.29 0.786
mut TUBGCP6 22q13.31-q13.33 -0.139 0.29 0.786 mitotic cell
DNA-dependent"
exp LCAT 16q22.1 -0.139 0.29 0.786 cholesterol metabolic
process;reverse cholesterol transport
met KTI12 1p32.3 -0.139 0.29 0.786
exp RAP2A 13q34 -0.139 0.29 0.786 actin cytoskeleton
exp TPSB2 16p13.3 -0.139 0.29 0.786 proteolysis
xsq SLIT2 4p15.2 -0.139 0.29 0.786 cell migration involved in
cop UAP1 1q23.3 -0.139 0.29 0.786 protein N-linked glycosylation via
xsq ERICH2 2q31.1 -0.139 0.29 0.786
xsq HNF1B 17q12 -0.139 0.29 0.786 regulation of Wnt receptor signaling
cop MLIP 6p12.1 -0.139 0.29 0.786
hs4 RAD54L2 3p21.2 -0.14 0.29 0.786
his SERINC2 1p35.1 -0.14 0.29 0.786
cop ZNF382 19q13.12 -0.14 0.29 0.786 negative regulation of
dependent"
dependent"
his LINC01594 -0.14 0.29 0.786
hs4 LINC00513 -0.14 0.29 0.786
his LINC01349 -0.14 0.29 0.786
his LOC100506679 -0.14 0.29 0.786
exp SPON2 -0.14 0.29 0.786 cell adhesion;axon guidance
xai FAM196B 5q35.1 -0.14 0.29 0.786
swa PRDX3 10q25-q26 -0.14 0.29 0.786 cellular response to reactive oxygen
species;maternal placenta development
xai PNPLA4 Xp22.3 -0.14 0.29 0.786 metabolic process;lipid catabolic
process
his ARNT2 15q24 -0.14 0.29 0.786 positive regulation of transcription, DNA-
his CELF6 15q24 -0.14 0.29 0.786 regulation of alternative nuclear mRNA
splicing, via spliceosome;mRNA processing"
xai PDE9A 21q22.3 -0.14 0.29 0.786 signal transduction;blood coagulation
his LYNX1 8q24.3 -0.14 0.29 0.786
his COL27A1 9q32 -0.14 0.29 0.786 cell adhesion
xai RDH12 14q24.1 -0.14 0.29 0.786 visual perception;retinol metabolic
process
xai SELENBP1 1q21.3 -0.14 0.29 0.786 protein transport
swa NDUFA4 7p21.3 -0.14 0.29 0.786 respiratory electron transport
xai CFAP45 -0.14 0.29 0.786
xai ARHGEF25 12q13.3 -0.14 0.29 0.786 regulation of Rho protein signal
transduction
hs4 SDK1 7p22.2 -0.14 0.29 0.786 cell adhesion
exp FLJ26245 -0.14 0.29 0.786
hs4 PCDH18 4q31 -0.14 0.29 0.786 homophilic cell adhesion;brain
development
xai ANKRD13C 1p32.3-p31.3 -0.14 0.29 0.786 protein retention in ER
lumen;regulation of receptor biosynthetic process
hs4 LVCAT5 -0.14 0.29 0.786
hs4 LINC01075 -0.14 0.29 0.786
xai IER5L 9q34.11 -0.14 0.29 0.786
his LOC100129034 -0.14 0.29 0.786
his GPC3 Xq26.1 0.14 0.291 0.786 anatomical structure
xai NRBF2P3 1p13.3 0.14 0.291 0.786
exp RPL21P132 0.14 0.291 0.786
xai RPL21P132 0.14 0.291 0.786
hs4 DPP7 9q34.3 0.14 0.291 0.786 proteolysis
hs4 PLD6 17p11.2 0.14 0.291 0.786 piRNA metabolic process;meiosis
his ALDH1A2 15q21.3 0.14 0.291 0.786 heart morphogenesis;positive
xai TYW1B 7q11.23 0.14 0.291 0.786 tRNA processing
hs4 WDR34 9q34.11 0.14 0.291 0.786
xai C3orf80 3q25.33 0.14 0.291 0.786
xai ZDHHC14 6q25.3 0.14 0.291 0.786
hs4 LOC105376271 0.14 0.291 0.786
hs4 RABEPK 9q33.3 0.14 0.291 0.786 receptor-mediated
his KCNA7 19q13.3 0.14 0.291 0.786 ion transport;potassium ion transport
dependent"
his LOC100507670 0.14 0.291 0.786
hs4 MRPL57 0.14 0.291 0.786 translation
hs4 SKA3 13q12.11 0.14 0.291 0.786 chromosome segregation;mitosis
his POLR3B 12q23.3 0.14 0.291 0.786 transcription elongation from RNA
polymerase III promoter;termination of RNA polymerase III transcription
xai TMEM203 9q34.3 0.14 0.291 0.786
xai YWHAQP8 Xq22.1 0.14 0.291 0.786
xai TNFSF13B 13q32-q34 0.14 0.291 0.786 positive regulation of cell
hs4 ADIPOR2 12p13.31 0.14 0.291 0.786 lipid metabolic process;hormone-
xai LIG4 13q33-q34 0.14 0.291 0.786 DNA Damage Response (DDR); DDR (NHEJ)
swa NIP7 16q22.1 0.14 0.291 0.786 ribosome assembly
his MIR4484 0.14 0.291 0.786
xai GLB1L2 11q25 0.14 0.291 0.786 carbohydrate metabolic process
exp YWHAQP8 Xq22.1 0.14 0.291 0.786
xai NINJ2 12p13 0.14 0.291 0.786 cell adhesion;neuron cell-cell adhesion
his ZNF185 Xq28 0.14 0.291 0.786
xai LOC100505915 0.14 0.291 0.786
his USHBP1 19p13 0.14 0.291 0.786
his BABAM1 19p13.11 0.14 0.291 0.786 DNA Damage Response (DDR)
xai SCFD2 4q12 0.14 0.291 0.786 vesicle docking involved in exocytosis;protein
transport
hs4 STXBP4 17q22 0.14 0.291 0.786 protein targeting;insulin receptor
signaling pathway
hs4 COX11 17q22 0.14 0.291 0.786 respiratory gaseous exchange;respiratory chain
complex IV assembly
hs4 POGLUT1 3q13.33 0.14 0.291 0.786
his KIAA0922 4q31.3 0.14 0.291 0.786
xai RPS6P20 12q24.33 0.14 0.291 0.786
exp SDCBP2-AS1 0.14 0.291 0.786
hs4 CALM1 14q32.11 0.14 0.291 0.786
hs4 COPS6 7q22.1 0.14 0.291 0.786 DNA Damage Response (DDR)
xai TUBBP2 13q14.11 0.14 0.291 0.786
his KCTD3 1q41 0.14 0.291 0.786 potassium ion transport
met WNT7B 22q13 0.139 0.291 0.786 Oncogenes
met CDC45 22q11.21 0.139 0.291 0.786 DDR (DNA replication)
xsq LCE1E 1q21.3 0.139 0.291 0.786 keratinization
xsq DAXX 6p21.3 0.139 0.291 0.786 Apoptosis; DNA Damage Response (DDR);
Tumor Suppressors
xsq CADM2 3p12.1 0.139 0.291 0.786 cell junction assembly;adherens junction
organization
exp C19orf43 19p13.2 0.139 0.291 0.786
cop RIMS1 6q12-q13 0.139 0.291 0.786 protein complex assembly;calcium ion-
mut PNISR 6q16.3 0.139 0.291 0.786
cop TTLL6 17q21.32 0.139 0.291 0.786 protein modification process;protein
polyglutamylation
cop CALCOCO2 17q21.32 0.139 0.291 0.786 viral reproduction;response to
interferon-gamma
cop ATP5G1 17q21.32 0.139 0.291 0.786 mitochondrial ATP synthesis coupled
proton transport;small molecule metabolic process
cop UBE2Z 17q21.32 0.139 0.291 0.786 apoptotic process
cop SNF8 17q21.32 0.139 0.291 0.786 regulation of transcription from RNA
polymerase II promoter;protein transport
cop GIP 17q21.3-q22 0.139 0.291 0.786 response to selenium ion;positive
cop IGF2BP1 17q21.32 0.139 0.291 0.786 RNA localization;regulation of mRNA
xsq IL27 16p11 0.139 0.291 0.786 inflammatory response;response to bacterium
xsq CRYZ 1p31.1 0.139 0.291 0.786 xenobiotic catabolic process;protein
homotetramerization
met ATP6V1C1 8q22.3 0.139 0.291 0.786 transport;cellular iron ion
homeostasis
xsq ZNF33A 10p11.2 0.139 0.291 0.786 regulation of transcription, DNA-
dependent"
xsq ANTXR2 4q21.21 0.139 0.291 0.786
met MIR940 0.139 0.291 0.786
met FAM83B 6p12.1 0.139 0.291 0.786
xsq SAG 2q37.1 0.139 0.291 0.786 rhodopsin mediated
phototransduction;rhodopsin mediated signaling pathway
cop SDC3 1p35.2 0.139 0.291 0.786 cell adhesion
cop PUM1 1p35.2 0.139 0.291 0.786 regulation of translation;post-Golgi
cop SNORD103A 0.139 0.291 0.786
cop SNORD103B 0.139 0.291 0.786
cop SNORD85 0.139 0.291 0.786
cop NKAIN1 1p35.2 0.139 0.291 0.786
cop SNRNP40 1p35.2 0.139 0.291 0.786 RNA splicing;gene expression
cop ZCCHC17 1p35.2 0.139 0.291 0.786
cop FABP3 1p33-p32 0.139 0.291 0.786 fatty acid metabolic
cop SERINC2 1p35.1 0.139 0.291 0.786
cop LOC149086 0.139 0.291 0.786
cop LOC284551 0.139 0.291 0.786
dependent"
cop FERMT1 20p12.3 0.139 0.291 0.786 cell adhesion;keratinocyte
proliferation
mut DOCK11 Xq24 0.139 0.291 0.786 blood coagulation;regulation of catalytic
activity
met SHC4 15q21.1-q21.2 0.139 0.291 0.786 intracellular signal transduction
exp CLDN6 16p13.3 0.139 0.291 0.786 calcium-independent cell-cell adhesion
met MSH3 5q11-q12 0.139 0.291 0.786 DNA Damage Response (DDR); DDR (MMR)
exp PLGLB2 0.139 0.291 0.786
met TMEM255A Xq24 0.139 0.291 0.786
exp FBXL20 17q12 0.139 0.291 0.786
met AKR1C2 10p15-p14 0.139 0.291 0.786 progesterone metabolic
process;prostaglandin metabolic process
exp LOC246784 1q21.3 0.139 0.291 0.786
cop TDGF1 3p21.31 0.139 0.291 0.786 positive regulation of cell-matrix
adhesion;regulation of signal transduction
mut PCDHA3 0.139 0.291 0.786 cell adhesion;homophilic cell adhesion
cop PHLDB1 11q23.3 0.139 0.291 0.786
mut GPN3 12q24.11 0.139 0.291 0.786
met GRHL2 8q22.3 0.139 0.291 0.786 EMT (Epithelial)
met NEK7 1q31.3 0.139 0.291 0.786 cytokinesis;protein phosphorylation
exp POU4F1 13q31.1 0.139 0.291 0.786 synapse assembly;positive
mut GPR87 3q24 0.139 0.291 0.786
exp LINC00662 19q11 0.139 0.291 0.786
exp AKAP8L 19p13.12 0.139 0.291 0.786
met PMEPA1 20q13.31-q13.33 0.139 0.291 0.786 androgen receptor signaling
pathway
exp PCCB 3q21-q22 0.139 0.291 0.786 fatty acid beta-oxidation;short-chain
cop INCENP 11q12.3 0.138 0.291 0.786 M phase of mitotic cell
cop SCGB1D1 0.138 0.291 0.786
cop SCGB2A1 11q13 0.138 0.291 0.786
cop CD7 17q25.2-q25.3 0.138 0.291 0.786 homeostasis of number of cells
within a tissue;immune response
cop SECTM1 17q25 0.138 0.291 0.786 immune response;signal transduction
exp RNF5P1 8p11.22 0.138 0.291 0.786
met NDUFA3 19q13.42 0.138 0.291 0.786 mitochondrial electron transport,
xsq NUDT3 6p21.2 0.138 0.291 0.786 diadenosine polyphosphate catabolic
exp ARMC10 7q22.1 0.138 0.291 0.786 regulation of growth
cop CRLS1 20p13-p12.3 0.138 0.291 0.786 phospholipid biosynthetic process
cop LRRN4 20p12.3 0.138 0.291 0.786
met MIR647 0.138 0.291 0.786
cop MYOZ1 10q22.1 0.138 0.291 0.786 myofibril assembly
cop SYNPO2L 10q22.2 0.138 0.291 0.786
cop LONRF2 2q11.2 0.138 0.291 0.786 proteolysis
xsq CARHSP1 16p13.2 0.138 0.291 0.786 regulation of transcription, DNA-
exp TFAP2E 1p34.3 0.138 0.291 0.786 positive regulation of
mut TIAM1 21q22.11 0.138 0.291 0.786 small GTPase mediated signal
transduction;induction of apoptosis by extracellular signals
cop BLOC1S2 10q24.31 0.138 0.291 0.786 regulation of apoptotic
process;positive regulation of transcription, DNA-dependent
xsq OR2C1 16p13.3 0.138 0.291 0.786
met PABPC1P2 2q22.3 -0.138 0.291 0.786
met GCG 2q36-q37 -0.138 0.291 0.786 G-protein coupled receptor
signaling pathway;negative regulation of appetite
mut TBC1D16 17q25.3 -0.138 0.291 0.786
xsq LINC01411 -0.138 0.291 0.786
exp MIA 19q13.2 -0.138 0.291 0.786 cell proliferation
xsq NUMBL 19q13.13-q13.2 -0.138 0.291 0.786 multicellular organismal
xsq TMEM100 17q22 -0.138 0.291 0.786
xsq FURIN 15q26.1 -0.138 0.291 0.786 peptide hormone processing;negative
met CD36 7q11.2 -0.138 0.291 0.786 pattern recognition receptor
cop UHMK1 1q23.3 -0.139 0.291 0.786 cell cycle arrest;peptidyl-serine
phosphorylation
met CD3E 11q23 -0.139 0.291 0.786 cell surface receptor signaling
exp ALPL 1p36.12 -0.139 0.291 0.786 biomineral tissue
exp TTTY6B -0.139 0.291 0.786
cop ZDHHC8 22q11.21 -0.139 0.291 0.786
xsq SPARCL1 4q22.1 -0.139 0.291 0.786 signal transduction
mir hsa-miR-21* -0.139 0.291 0.786
exp LYN 8q13 -0.139 0.291 0.786 Protein Kinases
xsq MX1 21q22.3 -0.139 0.291 0.786 Apoptosis
exp SRGAP3-AS3 3p25.3 -0.139 0.291 0.786
exp HMGN2P46 15q21.1 -0.139 0.291 0.786
met TRAF1 9q33-q34 -0.139 0.291 0.786 Apoptosis
xsq LOC101927543 -0.139 0.291 0.786
xsq C10orf90 10q26.2 -0.139 0.291 0.786 negative regulation of cell
growth;protein stabilization
xsq DCAF12L1 Xq25 -0.139 0.291 0.786
exp P3H4 -0.139 0.291 0.786 synaptonemal complex assembly
mut CRISP2 6p12.3 -0.139 0.291 0.786
cop TCERG1L 10q26.3 -0.139 0.291 0.786
xsq KIAA1279 10q22.1 -0.139 0.291 0.786 cell
cop RPN2 20q12-q13.1 -0.139 0.291 0.786 translation;protein modification
process
xai KIAA1211L 2q11.2 -0.14 0.291 0.786
xai PLD3 19q13.2 -0.14 0.291 0.786 lipid catabolic process
hs4 SH3GL2 9p22 -0.14 0.291 0.786 axon guidance;central nervous system
development
hs4 MIR6809 -0.14 0.291 0.786
xai TMEM236 10p12.33 -0.14 0.291 0.786
hs4 PHF24 -0.14 0.291 0.786
his SCGB3A1 5q35.3 -0.14 0.291 0.786
hs4 LOC100288866 17q21.33 -0.14 0.291 0.786
xai PPIAP30 -0.14 0.291 0.786
his TAC3 12q13-q21 -0.14 0.291 0.786 response to morphine;positive regulation
of blood pressure
hs4 RAB7A 3q21.3 -0.14 0.291 0.786 endosome to lysosome transport;protein
transport
xai ESRP1 8q22.1 -0.14 0.291 0.786 EMT (Epithelial)
swa HEXB 5q13 -0.14 0.291 0.786 carbohydrate metabolic process;sensory
perception of sound
xai FAM131A 3q27.1 -0.14 0.291 0.786
his FAM83D 20q11.23 -0.14 0.291 0.786 cell division;cell cycle
exp PPIAP30 -0.14 0.291 0.786
xai ERCC6 10q11.23 -0.14 0.291 0.786 DNA Damage Response (DDR); DDR (NER)
hs4 NME9 3q22.3 -0.14 0.291 0.786 GTP biosynthetic process;UTP biosynthetic
process
exp MIR378D2 -0.14 0.291 0.786
xai FLJ37786 1q21 -0.14 0.291 0.786
his EMX2 10q26.1 -0.14 0.291 0.786 multicellular organismal development
his EMX2OS 10q26.1 -0.14 0.291 0.786
xai LOC642934 10q23.1 -0.14 0.291 0.786
xai MIR378D2 -0.14 0.291 0.786
hs4 PKP4 2q24.1 -0.14 0.291 0.786 cell adhesion;positive regulation of Rho
GTPase activity
hs4 CCDC148 2q24.1 -0.14 0.291 0.786
dependent"
his SEMA6A-AS1 -0.14 0.291 0.786
xai TRBV5-2 7q34 -0.14 0.291 0.786
xai MPP3 17q21.31 -0.14 0.291 0.786 signal transduction
xai SCN4B 11q23.3 -0.14 0.291 0.786 ion transport;sodium ion transport
xai PSENEN 19q13.12 -0.14 0.291 0.786 membrane protein ectodomain
proteolysis;positive regulation of catalytic activity
his LINC01637 -0.14 0.291 0.786
exp TRBV5-2 7q34 -0.14 0.291 0.786
hs4 LOC100133669 8q24.3 -0.14 0.291 0.786
hs4 LY6E 8q24.3 -0.14 0.291 0.786 cell surface receptor signaling
his ALK 2p23 -0.14 0.291 0.786 Oncogenes
his EDN2 1p34 -0.14 0.291 0.786 prostaglandin biosynthetic process;activation
pathway
hs4 APBB1 11p15 -0.14 0.291 0.786 axonogenesis;chromatin modification
xai NACA2 17q23.2 0.141 0.292 0.787 protein transport
exp PKD2L2 5q31 0.14 0.292 0.786 ion transport
xai TRPM6 9q21.13 0.14 0.292 0.786 ion transport;response to toxin
xai GLTPD2 17p13.2 0.14 0.292 0.787
his TTC13 1q42.2 0.14 0.292 0.787
his ARV1 1q42.2 0.14 0.292 0.787 lipid metabolic process;sphingolipid
metabolic process
xai SSNA1 9q34.3 0.14 0.292 0.787 G2/M transition of mitotic cell
his MC4R 18q22 0.14 0.292 0.787 positive regulation of cAMP biosynthetic
swa FAM136A 2p13.3 0.14 0.292 0.787
hs4 ZMYM3 Xq13.1 0.14 0.292 0.787 multicellular organismal
his MIR4536-2 0.14 0.292 0.787
his MIR4536-1 0.14 0.292 0.787
his MAGEH1 Xp11.21 0.14 0.292 0.787 Apoptosis
his KCTD2 17q25.1 0.14 0.292 0.787 potassium ion transport
hs4 HADH 4q22-q26 0.14 0.292 0.787 fatty acid beta-oxidation;response to
hormone stimulus
dependent"
hs4 NDC1 1p32.3 0.139 0.292 0.787
xai MESTP4 3p24.1 0.139 0.292 0.787
hs4 CREG1 1q24 0.139 0.292 0.787 regulation of transcription from RNA polymerase
his TRIM35 8p21.2 0.139 0.292 0.787 positive regulation of apoptotic
his PTK2B 8p21.1 0.139 0.292 0.787 MAPK cascade;apoptotic process
hs4 HOOK2 19p13.2 0.139 0.292 0.787 early endosome to late endosome
transport;microtubule cytoskeleton organization
exp CCNT2 2q21.3 0.139 0.292 0.787 regulation of cyclin-dependent protein
his LINC00403 0.139 0.292 0.787
xai ERMN 2q24.1 0.139 0.292 0.787 morphogenesis of a branching
hs4 EPS8L1 19q13.42 0.139 0.292 0.787
hs4 MEX3B 15q25.2 0.139 0.292 0.787 protein phosphorylation;protein
autophosphorylation
exp LOC100505915 0.139 0.292 0.787
dependent"
his VPS9D1 16q24 0.139 0.292 0.787
his TSC1 9q34 0.139 0.292 0.787 Apoptosis; Protein Kinases; Tumor Suppressors
his GFI1B 9q34.13 0.139 0.292 0.787 cell proliferation;chromatin modification
his MIR548AW 0.139 0.292 0.787
hs4 GMCL1 2p13.3 0.139 0.292 0.787 regulation of transcription, DNA-
hs4 SPANXN1 Xq27 0.139 0.292 0.787
xai HIST3H2A 1q42.13 0.139 0.292 0.787 nucleosome assembly
xsq ESM1 5q11.2 0.138 0.292 0.786 angiogenesis;regulation of cell growth
exp SCFD1 14q12 0.138 0.292 0.786 response to hypoxia;retrograde vesicle-mediated
met TMEM240 1p36.33 0.138 0.292 0.787
xsq DPH3P1 20q13.33 0.138 0.292 0.787
xsq HMX3 10q26.13 0.138 0.292 0.787 brain development;embryo implantation
exp MESDC1 15q13 0.138 0.292 0.787
xsq OR7G3 19p13.2 0.138 0.292 0.787
xsq FGF10-AS1 0.138 0.292 0.787
cop LINC00526 18p11.31 0.138 0.292 0.787
cop LINC00667 18p11.31 0.138 0.292 0.787
cop ZBTB14 18p11.31 0.138 0.292 0.787
xsq ZC3H3 8q24.3 0.138 0.292 0.787 mRNA polyadenylation;regulation of mRNA
export from nucleus
xsq POLR3H 22q13.2 0.138 0.292 0.787 termination of RNA polymerase III
transcription;response to virus
mut COL4A4 2q35-q37 0.138 0.292 0.787 axon guidance;glomerular basement
membrane development
exp THG1L 5q33.3 0.138 0.292 0.787 tRNA modification;tRNA processing
xsq MINA 3q11.2 0.138 0.292 0.787 ribosome biogenesis
xsq CLSTN2-AS1 0.138 0.292 0.787
mut GSTP1 11q13 0.138 0.292 0.787 Apoptosis
cop MRPL38 17q25.3 0.138 0.292 0.787
met PAFAH1B1 17p13.3 0.138 0.292 0.787 M phase of mitotic cell
cycle;microtubule-based process
exp TRIB1 8q24.13 0.138 0.292 0.787 response to lipopolysaccharide;regulation
xsq KANK3 19p13.2 0.138 0.292 0.787
exp TRPC5OS 0.138 0.292 0.787
cop XPO6 16p11.2 0.138 0.292 0.787 protein export from nucleus;intracellular
protein transport
met GCNT3 15q21.3 0.138 0.292 0.787 carbohydrate metabolic process;protein O-
cop UTS2R 17q25.3 0.138 0.292 0.787 blood circulation;positive regulation of
blood pressure
xsq BSN-AS2 3p21.31 0.138 0.292 0.787
xsq UBE2M 19q13.43 0.138 0.292 0.787 protein modification process;protein
ubiquitination
exp ZNF839 14q32.31 0.138 0.292 0.787
xsq XPOT 12q14.2 0.138 0.292 0.787 tRNA export from nucleus;transport
dependent"
cop CHST10 2q11.2 0.138 0.292 0.787 EMT (Mesenchymal)
cop NMS 2q11.2 0.138 0.292 0.787 regulation of smooth muscle
cop PDCL3 2q11.2 0.138 0.292 0.787 Apoptosis
cop TAC4 17q21.33 0.138 0.292 0.787
xsq TRIM64C 0.138 0.292 0.787
met C8orf74 8p23.1 0.138 0.292 0.787
xsq LINC01449 0.138 0.292 0.787
cop LINC00483 17q21.33 0.138 0.292 0.787
mir hsa-miR-486-3p 0.138 0.292 0.787
xsq NDUFA12 12q22 0.138 0.292 0.787 transport;response to oxidative stress
xsq POLR3C 1q21.1 0.138 0.292 0.787 positive regulation of innate
cop ACIN1 14q11.2 0.138 0.292 0.787 apoptotic chromosome
exp HAGH 16p13.3 -0.138 0.292 0.787 carbohydrate metabolic
xsq REEP3 10q21.3 -0.138 0.292 0.787
exp MFGE8 15q25 -0.138 0.292 0.787 phagocytosis, recognition;phagocytosis,
engulfment
exp CCDC122 13q14.11 -0.138 0.292 0.787
met CIDEB 14q12 -0.138 0.292 0.787 apoptotic process;induction of apoptosis
cop ABCA4 1p22 -0.138 0.292 0.787 ABC Transporters
mut CARKD 13q34 -0.138 0.292 0.787
met TUBA4B 2q35 -0.138 0.292 0.787 microtubule-based movement;protein
polymerization
cop PDZRN4 12q12 -0.138 0.292 0.787
xsq FAM155A 13q33.3 -0.138 0.292 0.787
xsq IFT43 14q24.3 -0.138 0.292 0.787 cell projection
xsq SERPINE2 2q36.1 -0.138 0.292 0.787 multicellular organismal
xsq LOC100631378 -0.138 0.292 0.787
xsq SNORA5A -0.138 0.292 0.787
exp DPYS 8q22 -0.138 0.292 0.787 uracil catabolic process;beta-alanine
metabolic process
exp TSPAN18 11p11.2 -0.138 0.292 0.787
cop CEP70 3q22.3 -0.138 0.292 0.787 mitotic cell cycle;G2/M transition
cop SMIM19 8p11.21 -0.138 0.292 0.787
exp GULP1 2q32.3-q33 -0.138 0.292 0.787 Apoptosis
exp PERM1 -0.138 0.292 0.787
exp PNPLA4 Xp22.3 -0.138 0.292 0.787 metabolic process;lipid
catabolic process
xsq LOC100294362 -0.138 0.292 0.787
xsq TMEM56-RWDD3 -0.138 0.292 0.786
exp BLACAT1 -0.138 0.292 0.786
exp TP63 3q28 -0.138 0.292 0.786 Apoptosis; Oncogenes
hs4 MIR657 -0.139 0.292 0.787
hs4 MIR3065 -0.139 0.292 0.787
hs4 MIR338 -0.139 0.292 0.787
exp SLC4A9 5q31 -0.139 0.292 0.787 bicarbonate transport;transmembrane
transport
his CCL28 5p12 -0.139 0.292 0.787 chemotaxis;immune response
his TRPV6 7q34 -0.139 0.292 0.787 transmembrane transport;calcium ion
xai ICK 6p12.1 -0.139 0.292 0.787 multicellular organismal
hs4 LRRN1 3p26.2 -0.139 0.292 0.787
xai ENPP5 6p21.1-p11.2 -0.139 0.292 0.787 cell communication
xai RAP2A 13q34 -0.139 0.292 0.787 actin cytoskeleton
xai TCF7L2 10q25.3 -0.139 0.292 0.787 regulation of transcription
swa SPTBN1 2p21 -0.139 0.292 0.787 axon guidance;actin filament
capping
xai DDO 6q21 -0.139 0.292 0.787 grooming behavior;hormone metabolic
process
swa SPTLC2 14q24.3 -0.139 0.292 0.787 sphingosine biosynthetic
xai MT1M 16q13 -0.139 0.292 0.787 negative regulation of growth
xai SEC13 3p25-p24 -0.139 0.292 0.787 cellular membrane
hs4 WDFY3 4q21.23 -0.139 0.292 0.787 metabolic process
hs4 WDFY3-AS2 4q21.3 -0.139 0.292 0.787
xai MYBPH 1q32.1 -0.139 0.292 0.787 regulation of striated muscle
exp TMEM236 10p12.33 -0.139 0.292 0.787
exp CPN2 3q29 -0.139 0.292 0.787 regulation of catalytic activity;protein
stabilization
dependent"
his ZNF667-AS1 19q13.43 -0.14 0.292 0.787
xai TBR1 2q24 -0.14 0.292 0.787 regulation of transcription, DNA-dependent;axon
guidance
xai KRT8P20 7p14.1 -0.14 0.292 0.787
xai KNDC1 10q26.3 -0.14 0.292 0.787 regulation of dendrite
dependent"
xai FREM1 9p22.3 -0.14 0.292 0.786 multicellular organismal development;cell
communication
hs4 INSRR 1q21-q23 0.139 0.293 0.787 protein autophosphorylation;cellular
response to alkalinity
hs4 NTRK1 1q21-q22 0.139 0.293 0.787 activation of adenylate cyclase
xai UCP3 11q13.4 0.139 0.293 0.787 response to nutrient;small molecule
metabolic process
his SLC35C2 20q13.12 0.139 0.293 0.787 Solute Carriers
xai CDAN1 15q15.2 0.139 0.293 0.787
swa GIGYF2 2q37.1 0.139 0.293 0.787 cell death
hs4 PRR11 17q22 0.139 0.293 0.787
hs4 SKA2 17q22 0.139 0.293 0.787 mitotic prometaphase;mitotic cell cycle
hs4 MIR301A 0.139 0.293 0.787
hs4 NDN 15q11.2-q12 0.139 0.293 0.787 central nervous system development;axon
his TMEM145 19q13.2 0.139 0.293 0.787
xai ZBED9 0.139 0.293 0.787 DNA integration;viral reproduction
his PAX5 9p13 0.139 0.293 0.787 Tumor Suppressors
his PHF8 Xp11.22 0.139 0.293 0.787 G1/S transition of mitotic cell
hs4 LAS1L Xq12 0.139 0.293 0.787 rRNA processing
swa PRPF8 17p13.3 0.139 0.293 0.788 mRNA processing;RNA splicing
xai CCDC94 19p13.3 0.139 0.293 0.788
hs4 SLC35E2B 1p36.33 0.139 0.293 0.788 Solute Carriers
his USE1 19p13.11 0.139 0.293 0.788 ER to Golgi vesicle-mediated
hs4 TOP2A 17q21-q22 0.139 0.293 0.788 Apoptosis; DNA Damage Response (DDR); DDR
(DNA replication)
his LOC101928464 0.139 0.293 0.788
hs4 STARD6 18q21.2 0.139 0.293 0.788 transport;lipid transport
hs4 C18orf54 18q21.2 0.139 0.293 0.788
xai MTCYBP4 0.139 0.293 0.788
xai LINC00305 18q22.1 0.139 0.293 0.788
xai IGLV3-32 0.139 0.293 0.788
xai RPL5P21 0.139 0.293 0.788
exp FLJ45508 0.139 0.293 0.788
exp RPS20P4 0.139 0.293 0.788
xai LINGO3 19p13.3 0.139 0.293 0.788
exp RPL5P21 0.139 0.293 0.788
dependent"
exp MTCYBP4 0.139 0.293 0.788
xai RPS20P4 0.139 0.293 0.788
exp IGLV3-32 0.139 0.293 0.788
dependent"
cop TREH 11q23.3 0.138 0.293 0.787 carbohydrate metabolic process;trehalose
metabolic process
xsq LRRC10 12q15 0.138 0.293 0.787
xsq TRIM54 2p23.3 0.138 0.293 0.787 negative regulation of microtubule
depolymerization;signal transduction
xsq LOC101927954 0.138 0.293 0.787
xsq RRP8 11p15.4 0.138 0.293 0.787 chromatin silencing at rDNA;regulation of
met CDC34 19p13.3 0.138 0.293 0.787 negative regulation of cAMP-mediated
met HCRTR2 6p12 0.138 0.293 0.787 neuropeptide signaling pathway;synaptic
transmission
met CBFA2T3 16q24 0.138 0.293 0.787 cell differentiation;granulocyte
differentiation
xsq EMC9 14q11.2 0.138 0.293 0.787
met FAM151B 5q14.1 0.138 0.293 0.787
xsq GFRA3 5q31.1-q31.3 0.138 0.293 0.787 neuron development;neuron migration
met FAM184B 4p16 0.138 0.293 0.787
met RAB18 10p12.1 0.138 0.293 0.787 protein transport;eye development
xsq LRP8 1p34 0.138 0.293 0.787 cytokine-mediated signaling pathway;hippocampus
development
xsq TYW1 7q11.21 0.138 0.293 0.787 tRNA processing
exp ERG 21q22.3 0.138 0.293 0.787 Transcription Factors
cop PTX4 16p13.3 0.138 0.293 0.787
xsq SUMO2 17q25.1 0.138 0.293 0.787 DNA Damage Response (DDR)
xsq BIRC3 11q22 0.138 0.293 0.787 Apoptosis
exp LOC100996412 0.138 0.293 0.787
met SPRY1 4q28.1 0.138 0.293 0.787 metanephros development;negative
cop CALML3 10p15.1 0.138 0.293 0.787
met VPS13B 8q22.2 0.138 0.293 0.787 protein localization;protein
transport
xsq SGTA 19p13 0.138 0.293 0.788 interspecies interaction between organisms
xsq COPS3 17p11.2 0.138 0.293 0.788 DNA Damage Response (DDR)
cop C12orf75 12q23.3 0.138 0.293 0.788
cop TCEB3CL 0.138 0.293 0.788
cop TCEB3C 0.138 0.293 0.788
cop TCEB3B 18q21.1 0.138 0.293 0.788 transcription from RNA polymerase
II promoter;regulation of transcription elongation, DNA-dependent"
cop HDHD2 18q21.1 0.138 0.293 0.788 metabolic process
cop IER3IP1 18q12 0.138 0.293 0.788 regulation of apoptotic process
cop FGF8 10q24 0.138 0.293 0.788 outflow tract septum
xsq LINC01185 0.138 0.293 0.788
xsq SNORA71A 0.138 0.293 0.788
exp DNAJC24 11p13 0.138 0.293 0.788 protein folding
xsq CACNG2 22q13.1 0.138 0.293 0.788 synaptic transmission;neuromuscular
mut NXPE4 11q23.2 0.138 0.293 0.788
exp F8 Xq28 0.138 0.293 0.788 blood coagulation;blood coagulation, intrinsic
pathway
xsq IMPDH1 7q31.3-q32 0.138 0.293 0.788 lymphocyte
proliferation;nucleobase-containing small molecule metabolic process
met SLC35F6 2p23.3 0.138 0.293 0.788
exp USP51 Xp11.21 0.138 0.293 0.788 proteolysis;ubiquitin-dependent protein
catabolic process
exp DTYMK 2q37.3 0.138 0.293 0.788 cell cycle;cell proliferation
cop MIR3976 0.138 0.293 0.788
xsq EPB41L4A-AS1 5q22.2 0.138 0.293 0.788
pro ADPRT_6 0.138 0.293 0.788
met CCDC85A 2p16.1 0.138 0.293 0.788
xsq CASP16P 0.138 0.293 0.788
cop ZBTB7C 18q21.1 0.138 0.293 0.788
mut NOL6 9p13.3 -0.138 0.293 0.788 rRNA processing
exp COL27A1 9q32 -0.138 0.293 0.788 cell adhesion
exp FAM20A 17q24.2 -0.138 0.293 0.788
xsq WNT2B 1p13 -0.138 0.293 0.788 Apoptosis; Oncogenes
xsq MMP15 16q13 -0.138 0.293 0.788 Apoptosis
xsq SYT13 11p12-p11 -0.138 0.293 0.788 vesicle-mediated transport
cop RGS7 1q43 -0.138 0.293 0.788 termination of G-protein coupled receptor
signaling pathway;positive regulation of GTPase activity
met PLEKHA8P1 12q -0.138 0.293 0.788
exp PWWP2B 10q26.3 -0.138 0.293 0.788
mut UQCRC1 3p21.3 -0.138 0.293 0.788 oxidative
exp LOC100128334 7q22.1 -0.138 0.293 0.788
cop POTEA 8p11.1 -0.138 0.293 0.787
met MR1 1q25.3 -0.138 0.293 0.787 antigen processing and presentation
of peptide antigen via MHC class I;immune response
met ACOT12 5q14.1 -0.138 0.293 0.787 acetyl-CoA metabolic
xsq DPH6-AS1 -0.138 0.293 0.787
exp TESK1 9p13 -0.138 0.293 0.787 spermatogenesis;cell junction assembly
mut CLDN7 17p13.1 -0.138 0.293 0.787 EMT (Epithelial)
xsq FMO4 1q24.3 -0.138 0.293 0.787 xenobiotic metabolic process
exp LOC100128077 9q34.11 -0.138 0.293 0.787
cop ACSS2 20q11.22 -0.138 0.293 0.787 ethanol oxidation;acetyl-CoA
cop GSS 20q11.2 -0.138 0.293 0.787 xenobiotic metabolic process;small
cop MYH7B 20q11.22 -0.138 0.293 0.787
cop MIR499A -0.138 0.293 0.787
cop MIR499B -0.138 0.293 0.787
cop TRPC4AP 20q11.22 -0.138 0.293 0.787 ubiquitin-dependent protein
cop EDEM2 20q11.22 -0.138 0.293 0.787 protein folding;response to
unfolded protein
met RNF165 18q21.1 -0.138 0.293 0.787
xsq OXTR 3p25 -0.138 0.293 0.787 cell surface receptor signaling
exp RDH8 19p13.2 -0.138 0.293 0.787 response to stimulus;steroid
exp GS1-279B7.1 -0.139 0.293 0.788
his AADACL2-AS1 -0.139 0.293 0.788
his SEPT11 4q21.1 -0.139 0.293 0.788 cell cycle;protein
xai DLX3 17q21 -0.139 0.293 0.788 placenta development;regulation of
xai SH3PXD2B 5q35.1 -0.139 0.293 0.788 extracellular matrix
his ARHGAP31-AS1 -0.139 0.293 0.788
xai EPN2 17p11.2 -0.139 0.293 0.788 regulation of endocytosis
xai SRC 20q12-q13 -0.139 0.293 0.788 Apoptosis; Oncogenes; Protein
Kinases
hs4 PRKAR2A 3p21.3-p21.2 -0.139 0.293 0.788 signal
transduction;regulation of protein kinase activity
hs4 PRKAR2A-AS1 -0.139 0.293 0.788
xai DEFB136 8p23.1 -0.139 0.293 0.788 defense response to bacterium
xai SNORD123 5p15.2 -0.139 0.293 0.788
hs4 ENTPD1 10q24 -0.139 0.293 0.788 ATP catabolic process;cell adhesion
hs4 SP4 7p15.3 -0.139 0.293 0.788 regulation of transcription from
his DMD Xp21.2 -0.139 0.293 0.788 muscle organ development;skeletal
xai GATA4 8p23.1-p22 -0.139 0.293 0.788 gastrulation with mouth forming
xai SPTLC1P1 -0.139 0.293 0.787
hs4 DNAJC5 20q13.33 -0.139 0.293 0.787 protein folding;synaptic
transmission
his NPSR1-AS1 7p14.3 -0.139 0.293 0.787
xai WISP1 8q24.22 -0.139 0.293 0.787 Oncogenes
xai LINC00566 -0.139 0.293 0.787
exp LINC00566 -0.139 0.293 0.787
exp LOC100506725 -0.139 0.293 0.787
exp LOC100631252 -0.139 0.293 0.787
xai TMEM44 3q29 -0.139 0.293 0.787
xai LOC100631252 -0.139 0.293 0.787
xai LOC100506885 -0.139 0.293 0.787
xai INHBA 7p15-p13 -0.139 0.293 0.787 hair follicle development;nervous
system development
hs4 SYT17 16p12.3 -0.139 0.293 0.787
his LINC00926 15q21.3 0.139 0.294 0.788
his MIR5195 0.139 0.294 0.788
xai KCTD13 0.139 0.294 0.788 proteasomal ubiquitin-dependent protein
catabolic process;DNA replication
xai RNF111 15q21 0.139 0.294 0.788 multicellular organismal
swa MEPCE 7q22.1 0.139 0.294 0.788
hs4 GLB1L2 11q25 0.139 0.294 0.788 carbohydrate metabolic process
xai OR2G3 1q44 0.139 0.294 0.788 response to stimulus
his KLHL23 2q31.1 0.139 0.294 0.788
cop MIR4718 0.139 0.294 0.788
his FBXO30 6q24 0.139 0.294 0.788
his GALNT13 2q24.1 0.139 0.294 0.788 O-glycan processing;post-
hs4 SNAR-A10 0.139 0.294 0.788
xai FBXL20 17q12 0.139 0.294 0.788
cop ADAT3 0.139 0.294 0.788 tRNA processing
cop SCAMP4 19p13.3 0.139 0.294 0.788 protein transport
cop CSNK1G2 19p13.3 0.139 0.294 0.788 Protein Kinases
cop CSNK1G2-AS1 0.139 0.294 0.788
cop BTBD2 19p13.3 0.139 0.294 0.788
exp OR2G3 1q44 0.139 0.294 0.788 response to stimulus
his HUWE1 Xp11.22 0.139 0.294 0.788 protein ubiquitination involved in
ubiquitin-dependent protein catabolic process;protein polyubiquitination
xai CCT5P2 13q31.1 0.139 0.294 0.788
xai OTOA 16p12.2 0.139 0.294 0.788 sensory perception of sound
xai TAF1B 2p25 0.139 0.294 0.788 transcription, DNA-dependent;regulation of
xai RBM15B 3p21.2 0.139 0.294 0.788 mRNA processing;nucleocytoplasmic
transport
xai WAC 10p12.1 0.139 0.294 0.788 positive regulation of transcription,
his SFTPA1 10q22.3 0.139 0.294 0.788
exp RUFY4 2q35 0.139 0.294 0.788
hs4 RPRD1A 18q12.2 0.139 0.294 0.788 dephosphorylation of RNA polymerase
II C-terminal domain
xai TSSK5P1 0.139 0.294 0.788
xai RYR1 19q13.1 0.139 0.294 0.788 response to caffeine;calcium ion
hs4 PKD1 16p13.3 0.139 0.294 0.788 cartilage condensation;homophilic cell
adhesion
hs4 MIR3180-5 0.139 0.294 0.788
exp TAS2R30 0.139 0.294 0.789 sensory perception of taste;response to
stimulus
xai KLRAP1 12p13.2 0.139 0.294 0.789
hs4 HEMGN 9q22.33 0.139 0.294 0.789 multicellular organismal development;cell
differentiation
xai PRKXP1 15q26.3 0.139 0.294 0.789
his C16orf87 16q11.2 0.139 0.294 0.789
his LOC101929165 0.139 0.294 0.789
hs4 MAPK12 22q13.33 0.139 0.294 0.789 Protein Kinases
exp MIR18B 0.139 0.294 0.789
xai KATNBL1 15q14 0.139 0.294 0.789
his NCSTN 1q22-q23 0.139 0.294 0.789 protein processing;membrane protein
his COPA 1q23.2 0.139 0.294 0.789 pancreatic juice secretion;COPI coating
of Golgi vesicle
his STXBP1 9q34.1 0.139 0.294 0.789 regulation of synaptic vesicle
priming;platelet aggregation
hs4 TRAPPC10 21q22.3 0.139 0.294 0.789 sodium ion export;sodium ion
transport
exp MSS51 10q22.2 0.139 0.294 0.789 social behavior
xai LYPLAL1 1q41 0.139 0.294 0.789
dependent"
xsq GSTT1-AS1 0.138 0.294 0.788
xsq USP4 3p21.3 0.138 0.294 0.788 negative regulation of protein
xsq C10orf88 10q26.13 0.138 0.294 0.788
met HPCAL4 1p34.2 0.138 0.294 0.788 central nervous system development
exp LINC01088 0.138 0.294 0.788
xsq NUDT10 Xp11.23 0.138 0.294 0.788
xsq ZEB1 10p11.2 0.138 0.294 0.788 central nervous system
xsq CIPC 0.138 0.294 0.788
cop PDZK1 1q21 0.138 0.294 0.788 transport;cell proliferation
cop GPR89A 1q21.1 0.138 0.294 0.788 signal transduction;protein
transport
cop MANSC4 12p11.22 0.138 0.294 0.788
cop KLHL42 12p11.22 0.138 0.294 0.788
xsq SEC63 6q21 0.138 0.294 0.788 protein folding;protein targeting to membrane
xsq G6PC2 2q24.3 0.138 0.294 0.788 gluconeogenesis;hexose transport
met GOLGA2 9q34.11 0.138 0.294 0.788 positive regulation of
xsq ICT1 17q25.1 0.138 0.294 0.788 mitochondrial translational termination
xsq PIGC 1q23-q25 0.138 0.294 0.788 C-terminal protein lipidation;GPI anchor
xsq PRPF8 17p13.3 0.138 0.294 0.788 mRNA processing;RNA splicing
xsq AP4B1-AS1 0.138 0.294 0.788
xsq RPL24 3q12 0.138 0.294 0.788 SRP-dependent cotranslational protein targeting
xsq NEK3 13q14.13 0.138 0.294 0.788 protein phosphorylation;cell cycle
xsq OR51B5 0.138 0.294 0.788 sensory perception of smell;response to
stimulus
met BNIP1 5q33-q34 0.138 0.294 0.788 Apoptosis
xsq KRTAP10-12 21q22.3 0.138 0.294 0.788
cop ARMC4 10p12.1-p11.23 0.138 0.294 0.788
xsq G6PC 17q21 0.138 0.294 0.788
xsq FRY 13q13.1 0.138 0.294 0.788 regulation of transcription, DNA-
dependent"
xsq MIB2 1p36.33 0.138 0.294 0.788 signal transduction;Notch signaling
pathway
xsq RPS15AP10 0.138 0.294 0.788
xsq LPPR3 19p13.3 0.138 0.294 0.788
met KLHL5 4p14 0.138 0.294 0.788
dependent"
xsq LOC339807 0.138 0.294 0.789
pro RELA_6 0.138 0.294 0.789
xsq NOL7 6p23 0.138 0.294 0.789
xsq KHSRP 19p13.3 0.138 0.294 0.789 RNA splicing;gene expression
xsq PMCH 12q23.2 0.138 0.294 0.789 lactation;negative regulation of blood
pressure
exp ABI3 17q21.3 0.138 0.294 0.789 cellular component movement;peptidyl-
exp PRG4 1q25-q31 0.138 0.294 0.789 immune response;cell proliferation
met DRD5 4p16.1 0.138 0.294 0.789
met LRRTM1 2p12 0.138 0.294 0.789
met C5orf15 5q31.1 0.138 0.294 0.789
xsq LOC643542 0.138 0.294 0.789
xsq MIR658 -0.138 0.294 0.789
exp FTH1P11 8q21.13 -0.138 0.294 0.789
cop FNIP2 4q32.1 -0.138 0.294 0.789 regulation of protein
cop MIR5194 -0.138 0.294 0.789
met C11orf95 11q13 -0.138 0.294 0.789
xsq TACC2 10q26 -0.138 0.294 0.788 interkinetic nuclear migration;astral
exp FREM1 9p22.3 -0.138 0.294 0.788 multicellular organismal
cop OR13D1 -0.138 0.294 0.788
exp PDE9A 21q22.3 -0.138 0.294 0.788 signal transduction;blood
coagulation
xsq RTKN2 10q21.2 -0.138 0.294 0.788 signal transduction;positive
met STAT6 12q13 -0.138 0.294 0.788 Apoptosis
met IGF1 12q23.2 -0.138 0.294 0.788 Apoptosis
cop CECR1 22q11.2 -0.138 0.294 0.788 adenosine catabolic
met TTLL12 22q13.31 -0.138 0.294 0.788 protein modification process
cop GDF5 20q11.2 -0.138 0.294 0.788 cell-cell signaling;cartilage
development
cop CEP250 20q11.22 -0.138 0.294 0.788 regulation of centriole-
centriole cohesion;G2/M transition of mitotic cell cycle
cop C20orf173 20q11.22 -0.138 0.294 0.788
cop ERGIC3 20pter-q12 -0.138 0.294 0.788 vesicle-mediated transport
cop SPAG4 20q11.21 -0.138 0.294 0.788 spermatogenesis
cop CPNE1 20q11.22 -0.138 0.294 0.788 lipid metabolic process;vesicle-
mediated transport
cop RBM12 20q11.21 -0.138 0.294 0.788
cop NFS1 20q11.22 -0.138 0.294 0.788 vitamin metabolic process;water-
cop ROMO1 20q11.22 -0.138 0.294 0.788 defense response to
bacterium;positive regulation of reactive oxygen species metabolic process
cop RBM39 20q11.22 -0.138 0.294 0.788 regulation of transcription, DNA-
met NXF3 Xq22 -0.138 0.294 0.788 mRNA export from nucleus;transport
cop GK5 3q23 -0.138 0.294 0.788 glycerol metabolic process;carbohydrate
metabolic process
mut STAB1 3p21.1 -0.138 0.294 0.788 inflammatory response;cell adhesion
mut GUCA1A 6p21.1 -0.138 0.294 0.788 signal transduction;visual
perception
xsq STEAP2 7q21.13 -0.138 0.294 0.788 regulated secretory
xsq LRRC75A -0.138 0.294 0.788
his SPRR3 1q21-q22 -0.139 0.294 0.789 keratinization;wound healing
swa TRIP12 2q36.3 -0.139 0.294 0.789 protein modification
exp SEC14L5 16p13.3 -0.139 0.294 0.789
xai SGK1 6q23 -0.139 0.294 0.789 Apoptosis
DNA-dependent"
DNA-dependent"
dependent"
DNA-dependent"
exp SERINC4 15q15.3 -0.139 0.294 0.789 lipid metabolic
xai HOOK3 8p11.21 -0.139 0.294 0.789 cytoplasmic microtubule
xai ENO1 1p36.2 -0.139 0.294 0.789 gluconeogenesis;glycolysis
exp KRT8P31 5q12.1 -0.139 0.294 0.789
his LINC00842 -0.139 0.294 0.788
hs4 SLC16A2 Xq13.2 -0.139 0.294 0.788 Solute Carriers
hs4 RAP2A 13q34 -0.139 0.294 0.788 actin cytoskeleton
xai CCDC14 3q21.1 -0.139 0.294 0.788
xai CYP4B1 1p33 -0.139 0.294 0.788 small molecule metabolic
hs4 GET4 7p22.3 -0.139 0.294 0.788 transport;tail-anchored membrane
protein insertion into ER membrane
his SFRP1 8p11.21 -0.139 0.294 0.788 ureteric bud development;negative
xai EIF4G1 3q27.1 -0.139 0.294 0.788 insulin receptor signaling
hs4 LRRC73 6p21.1 -0.139 0.294 0.788
xai UBE2CP4 15q13.3 -0.139 0.294 0.788
cop THEG5 -0.139 0.294 0.788
exp OPN5 6p12.3 -0.139 0.294 0.788 protein-chromophore
xai RASGRP3 2p25.1-p24.1 -0.139 0.294 0.788 small GTPase mediated
exp TBR1 2q24 -0.139 0.294 0.788 regulation of transcription, DNA-
DNA-dependent"
DNA-dependent"
cop VN1R2 19q13.42 -0.139 0.294 0.788 response to pheromone
cop VN1R4 19q13.42 -0.139 0.294 0.788
cop FAM90A27P 19q13.42 -0.139 0.294 0.788
cop BIRC8 -0.139 0.294 0.788
xai ATF6B 6p21.3 -0.139 0.294 0.788 signal transduction;transcription,
DNA-dependent
hs4 TGFA 2p13 -0.139 0.294 0.788 anti-apoptosis;positive regulation of
mitosis
xai STAM 10p14-p13 -0.139 0.294 0.788 intracellular protein
transport;signal transduction
cop EID2B 19q13.2 -0.14 0.294 0.789 regulation of transcription, DNA-
xai CDSN 6p21.3 0.139 0.295 0.789 epidermis development;cell-cell adhesion
xai VIM-AS1 0.139 0.295 0.789
xai MIR18B 0.139 0.295 0.789
his FAM177A1 14q13.2 0.139 0.295 0.789
xai WASF1 6q21 0.139 0.295 0.789 protein complex assembly;cellular component
movement
xai AXIN1 16p13.3 0.139 0.295 0.789 Apoptosis
his GJA8 1q21.1 0.139 0.295 0.789 visual perception;lens development in
camera-type eye
xai HRH4 18q11.2 0.139 0.295 0.789 inflammatory response
his CDC23 5q31 0.139 0.295 0.789 mitotic metaphase plate congression;negative
xai SDCBP2-AS1 0.139 0.295 0.789
dependent"
his FXYD4 10q11.21 0.139 0.295 0.789 ion transport
exp LOC100507530 0.139 0.295 0.789
exp PABPC1P1 4p14 0.139 0.295 0.789
hs4 C4orf32 4q25 0.139 0.295 0.789
swa LDHA 11p15.4 0.139 0.295 0.789 pyruvate metabolic process;glycolysis
hs4 NKRF Xq24 0.139 0.295 0.789 negative regulation of transcription, DNA-
dependent"
his NEDD1 12q23.1 0.139 0.295 0.789 G2/M transition of mitotic cell
hs4 ZNF445 3p21.32 0.139 0.295 0.789 viral reproduction
exp CDC42P6 0.139 0.295 0.789
exp GDPD4 11q13.5 0.139 0.295 0.789 glycerol metabolic process;lipid
metabolic process
his MAP3K7 6q15 0.139 0.295 0.789 Protein Kinases
his RHBDD3 22q12.2 0.139 0.295 0.789
his EWSR1 22q12.2 0.139 0.295 0.789 regulation of transcription, DNA-
dependent"
xai CFAP52 0.139 0.295 0.789
hs4 PIDD1 0.139 0.295 0.789 response to DNA damage stimulus;DNA damage
hs4 C18orf25 18q21.1 0.139 0.295 0.789
xai SUDS3 12q24.23 0.139 0.295 0.789 chromatin modification;negative
xai PFDN5 12q12 0.139 0.295 0.789 protein folding;cellular protein metabolic
process
exp RPS20 8q12 0.139 0.295 0.789 gene expression;viral reproduction
xai TRBV30 7q34 0.139 0.295 0.789
his IMMP1L 11p13 0.139 0.295 0.789 proteolysis
his ELP4 11p13 0.139 0.295 0.789 transcription elongation from RNA polymerase II
promoter;histone acetylation
xai LEXM 0.139 0.295 0.789
xai LOC100507530 0.139 0.295 0.789
hs4 MAPK10 4q22.1-q23 0.139 0.295 0.789 Protein Kinases
his ALKBH7 19p13.3 0.139 0.295 0.789 DNA Damage Response (DDR)
his PSPN 19p13.3 0.139 0.295 0.789 branching involved in ureteric bud
morphogenesis;nervous system development
xsq AASDH 4q12 0.138 0.295 0.789 lipid metabolic process;fatty acid metabolic
process
met FAM47B Xp21.1 0.138 0.295 0.789
xsq GRM7-AS1 0.138 0.295 0.789
met CMTM5 14q11.2 0.138 0.295 0.789 chemotaxis
exp TSPYL4 6q22.1 0.138 0.295 0.789 nucleosome assembly
cop IARS 9q21 0.138 0.295 0.789 gene expression;tRNA aminoacylation for protein
translation
cop MIR3651 0.138 0.295 0.789
cop SNORA84 0.138 0.295 0.789
cop NOL8 9q22.31 0.138 0.295 0.789 DNA replication;rRNA processing
cop OGN 9q22 0.138 0.295 0.789 negative regulation of smooth muscle cell
proliferation
cop OMD 9q22.31 0.138 0.295 0.789 cell adhesion
cop ASPN 9q22 0.138 0.295 0.789 bone mineralization;negative regulation of
exp HSPBAP1 3q21.1 0.138 0.295 0.789 DDR (DNA replication)
xsq KANSL3 2q11.2 0.138 0.295 0.789 histone H4-K5 acetylation;histone
H4-K8 acetylation
met SMIM19 8p11.21 0.138 0.295 0.789
met ARHGAP36 Xq26.1 0.138 0.295 0.789 small GTPase mediated signal
xsq ISL1 5q11.1 0.138 0.295 0.789 regulation of secondary heart field
cardioblast proliferation;pancreas development
xsq ENPP7P13 0.138 0.295 0.789
cop C15orf56 15q15.1 0.137 0.295 0.789
cop ANKRD63 0.137 0.295 0.789
cop PLCB2 15q15 0.137 0.295 0.789 phospholipid metabolic process;activation of
cop C15orf52 15q15.1 0.137 0.295 0.789
cop PHGR1 15q15.1 0.137 0.295 0.789
cop DISP2 15q15.1 0.137 0.295 0.789 smoothened signaling pathway
cop KNSTRN 15q15.1 0.137 0.295 0.789
cop IVD 15q14-q15 0.137 0.295 0.789 leucine catabolic process;branched chain
dependent"
xsq LRRC6 8q24.22 0.137 0.295 0.789 male gonad development;pachytene
exp TRUB2 9q34.11 0.137 0.295 0.789 RNA processing;tRNA processing
met AOC2 17q21 0.137 0.295 0.789 catecholamine metabolic process;visual
perception
xsq ZSCAN25 7q22.1 0.137 0.295 0.789
met TTC21A 3p22.2 0.137 0.295 0.789
exp PCP4 21q22.2 0.137 0.295 0.789 central nervous system development
xsq INSM2 14q13.2 0.137 0.295 0.789 regulation of transcription, DNA-
dependent"
xsq MICB 6p21.3 0.137 0.295 0.789 immune response-activating cell surface
met DHFR 5q11.2-q13.2 0.137 0.295 0.789
cop PRSS46 3p21.31 0.137 0.295 0.789
cop PRSS45 3p21.31 0.137 0.295 0.789
cop MYL3 3p21.3-p21.2 0.137 0.295 0.789 ventricular cardiac muscle tissue
morphogenesis;cardiac muscle contraction
cop SPTLC1 9q22.2 0.137 0.295 0.789 sphinganine biosynthetic
cop LOC100128076 9q22.31 0.137 0.295 0.789
cop LINC00475 0.137 0.295 0.789
xsq CKMT1A 15q15 0.137 0.295 0.789 creatine metabolic process;cellular
xsq PQLC1 18q23 0.137 0.295 0.789
met SPRY2 13q31.1 0.137 0.295 0.789 sensory perception of sound;negative
regulation of epidermal growth factor receptor signaling pathway
xsq PSMA6 14q13 0.137 0.295 0.789 M/G1 transition of mitotic cell cycle;gene
expression
cop FLJ45513 17q21.33 0.137 0.295 0.789
met C17orf100 17p13.1 0.137 0.295 0.789
xsq PSMB4 1q21 0.137 0.295 0.789 S phase of mitotic cell cycle;apoptotic process
met PLXDC2 10p12.31 0.137 0.295 0.789
xsq FUT6 19p13.3 0.137 0.295 0.789 protein glycosylation;fucosylation
xsq HIGD2A 5q35.2 0.137 0.295 0.789
exp RGMA 15q26.1 0.137 0.295 0.789 axon guidance
xsq PRAMEF7 0.137 0.295 0.789
cop DNAJC9 10q22.2 0.137 0.295 0.789 protein folding;social behavior
cop DNAJC9-AS1 0.137 0.295 0.789
cop MRPS16 10q22.1 0.137 0.295 0.789 translation
cop TTC18 0.137 0.295 0.789
cop ANXA7 10q22.2 0.137 0.295 0.789 cellular calcium ion
cop MSS51 10q22.2 0.137 0.295 0.789 social behavior
exp GRHL3 1p36.11 0.137 0.295 0.789 epidermis development;positive regulation
exp MYO19 17q12 0.137 0.295 0.789
exp PGD 1p36.22 0.137 0.295 0.789 pentose biosynthetic process;small
xsq LOC101927709 0.137 0.295 0.789
met ENSA 1q21.3 0.137 0.295 0.789 response to nutrient;cell division
xsq CACNA2D3 3p21.1 -0.137 0.295 0.789 ion transport
exp ANGPT2 8p23.1 -0.137 0.295 0.789 multicellular organismal
development;response to activity
met DERL3 22q11.23 -0.137 0.295 0.789 ER-associated protein catabolic
cop KAL1 Xp22.32 -0.137 0.295 0.789
mut MAP2K7 19p13.3-p13.2 -0.137 0.295 0.789 Protein Kinases
xsq LOC102467224 -0.137 0.295 0.789
cop GGT7 20q11.22 -0.137 0.295 0.789 glutathione metabolic
cop MIR4788 -0.137 0.295 0.789
xsq FOXC2-AS1 -0.137 0.295 0.789
xsq RUFY2 10q21.3 -0.137 0.295 0.789
met RBM7 11q23.1-q23.2 -0.137 0.295 0.789 meiosis
exp SDHC 1q23.3 -0.137 0.295 0.789 tricarboxylic acid cycle;transport
xsq SOX6 11p15.3 -0.137 0.295 0.789 oligodendrocyte cell fate
specification;erythrocyte development
xsq CTSF 11q13 -0.137 0.295 0.789 proteolysis
xsq AGAP2-AS1 12q14.1 -0.137 0.295 0.789
xsq CSN2 4q21.1 -0.137 0.295 0.789
xsq KCCAT198 -0.137 0.295 0.789
exp HCG4P4 6p21.3 -0.137 0.295 0.789
cop GPM6B Xp22.2 -0.137 0.295 0.789 multicellular organismal
cop TTI1 20q11.23 -0.137 0.295 0.789 DNA Damage Response (DDR)
cop RPRD1B 20q11.21-q12 -0.137 0.295 0.789 dephosphorylation of RNA
cop TGM2 20q12 -0.137 0.295 0.789 metabolic process;protein
homooligomerization
cop KIAA1755 20q11.23 -0.137 0.295 0.789
exp TWIST2 2q37.3 -0.137 0.295 0.789 negative regulation of
molecular function;negative regulation of transcription from RNA polymerase II
promoter
xsq FAM43A 3q29 -0.137 0.295 0.789
mut DYRK4 12p13.32 -0.138 0.295 0.789 protein phosphorylation
exp THSD4 15q23 -0.138 0.295 0.789 elastic fiber assembly
mut KLHDC7A 1p36.13 -0.138 0.295 0.789
xsq RCN3 19q13.33 -0.138 0.295 0.789
xsq APLP1 19q13.1 -0.138 0.295 0.789 cell death;mRNA polyadenylation
mut EOGT 3p14.1 -0.138 0.295 0.789
cop GYG2 Xp22.3 -0.138 0.295 0.789 carbohydrate metabolic
cop RALGAPB 20q11.23 -0.138 0.295 0.789 activation of Ral GTPase
xsq ZBBX 3q26.1 -0.138 0.295 0.789
xsq GSTM1 1p13.3 -0.138 0.295 0.789 xenobiotic metabolic process;small
exp HOMER2 15q24.3 -0.138 0.295 0.789 G-protein coupled glutamate
xai ORAI3 16p11.2 -0.139 0.295 0.789
his MIR3944 -0.139 0.295 0.789
his ECHS1 10q26.2-q26.3 -0.139 0.295 0.789 fatty acid metabolic
xai RGS11 16p13.3 -0.139 0.295 0.789 G-protein coupled receptor
pathway
xai TPH2 12q21.1 -0.139 0.295 0.789 response to nutrient
levels;cellular response to lithium ion
hs4 EDAR 2q13 -0.139 0.295 0.789 odontogenesis of dentin-containing
tooth;hair follicle development
hs4 MIR6891 -0.139 0.295 0.789
dependent"
xai PAF1 19q13.1 -0.139 0.295 0.789 regulation of transcription, DNA-
exp SDHAP1 3q29 -0.139 0.295 0.789
DNA-dependent"
his WNK3 Xp11.22 -0.139 0.295 0.789 positive regulation of sodium ion
hs4 FILIP1L 3q12.1 -0.139 0.295 0.789
xai STAG3L4 7p11.2-q11.2 -0.139 0.295 0.789
hs4 TCEA1 8q11.2 -0.139 0.295 0.789 DNA Damage Response (DDR)
xai C5orf24 5q31.1 -0.139 0.295 0.789
xai FIGLA 2p13.3 -0.139 0.295 0.789 cell differentiation;oogenesis
swa CBR1 21q22.13 -0.139 0.295 0.789 oxidation-reduction process;drug
metabolic process
hs4 MIR1287 -0.139 0.295 0.789
xai NMRK2 19p13.3 -0.139 0.295 0.789
swa ACTR3 2q14.1 -0.139 0.295 0.789 response to antibiotic;cellular
component movement
xai USP2 11q23.3 -0.139 0.295 0.789 protein deubiquitination;positive
swa PHGDH 1p12 -0.139 0.295 0.789 L-serine biosynthetic process;brain
development
swa GNL1 6p21.3 -0.139 0.295 0.789 T cell mediated immunity;response
his NPY 7p15.1 0.138 0.296 0.789 G-protein signaling, coupled to cyclic
xai ALG3 3q27.1 0.138 0.296 0.79 protein N-linked glycosylation via
hs4 RAB39B Xq28 0.138 0.296 0.79 synapse organization;small GTPase
xai CDC42P6 0.138 0.296 0.79
hs4 GCDH 19p13.2 0.138 0.296 0.79 lysine catabolic process;acyl-CoA
metabolic process
xai C3orf20 3p25.1 0.138 0.296 0.79
hs4 POLI 18q21.1 0.138 0.296 0.79 DNA Damage Response (DDR); DDR (DNA
hs4 KCNMB2-AS1 0.138 0.296 0.79
exp TRBV30 7q34 0.138 0.296 0.79
his LINC01556 0.138 0.296 0.79
his HBM 0.138 0.296 0.79
xai FLJ36848 2p15 0.138 0.296 0.79
xai UGT2A2 4q13.3 0.138 0.296 0.79
hs4 ZNRF1 16q23.1 0.138 0.296 0.79 proteasomal ubiquitin-dependent protein
xai KNOP1P4 0.138 0.296 0.79
exp DLG5-AS1 10q22.3 0.138 0.296 0.79
swa PFAS 17p13.1 0.138 0.296 0.79 purine base metabolic process;purine
his CLEC4E 12p13.31 0.138 0.296 0.79 immune response;positive regulation
of cytokine secretion
xai DTX1 12q24.13 0.138 0.296 0.79 transcription, DNA-
hs4 RNVU1-1 0.138 0.296 0.79
swa LIG3 17q11.2-q12 0.138 0.296 0.79 DNA Damage Response (DDR); DDR (BER)
his LOC100133091 7q11.23 0.138 0.296 0.79
his DZIP3 3q13.13 0.138 0.296 0.79 protein polyubiquitination
his KIAA1524 3q13.13 0.138 0.296 0.79
exp IGHV3-36 0.138 0.296 0.79
xai NFKBIB 19q13.1 0.138 0.296 0.79 Apoptosis
his RFESD 5q15 0.138 0.296 0.79
xai CXorf58 Xp22.11 0.138 0.296 0.79
xai FAM122B Xq26.3 0.138 0.296 0.79
exp TUBAP 21q21.1 0.138 0.296 0.79
hs4 PIGBOS1 0.138 0.296 0.79
hs4 PIGB 15q21.3 0.138 0.296 0.79 post-translational protein
met MLPH 2q37.3 0.137 0.296 0.789 intracellular protein transport
exp SAC3D1 11q13.1 0.137 0.296 0.789 cell cycle;mitosis
mut CNTLN 9p22.2 0.137 0.296 0.79
cop GTF2A2 15q22.2 0.137 0.296 0.79 positive regulation of
dependent
exp LOC343508 1q42.3 0.137 0.296 0.79
xsq LOC101928336 0.137 0.296 0.79
exp GPAM 10q25.2 0.137 0.296 0.79 response to glucose stimulus;positive
regulation of activated T cell proliferation
met DROSHA 5p13.3 0.137 0.296 0.79 gene silencing by RNA;ribosome
biogenesis
exp GPR3 1p36.1-p35 0.137 0.296 0.79 regulation of meiosis;activation of
met CLDN7 17p13.1 0.137 0.296 0.79 EMT (Epithelial)
cop CCDC88C 14q32.11 0.137 0.296 0.79 microtubule cytoskeleton
mut ANO5 11p14.3 0.137 0.296 0.79 ion transport
xsq STXBP2 19p13.3-p13.2 0.137 0.296 0.79 leukocyte mediated
cytotoxicity;vesicle docking involved in exocytosis
exp PPP1R9B 17q21.33 0.137 0.296 0.79 RNA splicing;cell migration
met YIPF2 19p13.2 0.137 0.296 0.79
mut IGFL3 19q13.32 0.137 0.296 0.79
dependent"
mut MMS22L 6q16.1 0.137 0.296 0.79 DNA Damage Response (DDR)
xsq LOC101928273 0.137 0.296 0.79
exp CDC23 5q31 0.137 0.296 0.79 mitotic metaphase plate congression;negative
xsq LINC00222 0.137 0.296 0.79
xsq KCNQ1-AS1 0.137 0.296 0.79
xsq NPIPB8 0.137 0.296 0.79
xsq LINC01039 0.137 0.296 0.79
exp LRRC6 8q24.22 0.137 0.296 0.79 male gonad development;pachytene
cop OR4E2 0.137 0.296 0.79 response to stimulus
dependent"
exp PRR29 0.137 0.296 0.79
cop EPB41L3 18p11.32 0.137 0.296 0.79 cortical actin cytoskeleton
organization
xsq TGIF2-C20orf24 0.137 0.296 0.79
xsq STAT5B 17q11.2 0.137 0.296 0.79 Apoptosis
met YDJC 22q11.21 0.137 0.296 0.79 carbohydrate metabolic process
cop PRKCQ 10p15 0.137 0.296 0.79 Protein Kinases
cop SLC51B 15q22.31 0.137 0.296 0.79
cop RASL12 15q11.2-q22.33 0.137 0.296 0.79 signal transduction;small
cop LOC643711 12q23.1 0.137 0.296 0.79
met RP9 7p14.3 0.137 0.296 0.79 RNA splicing
met FAM167A-AS1 0.137 0.296 0.79
met CRISP1 6p21.3 0.137 0.296 0.79 fusion of sperm to egg plasma
membrane
met KIF27 9q21.32 0.137 0.296 0.79 cilium assembly;microtubule-based
movement
dependent"
xsq CISD3 17q12 0.137 0.296 0.79
met LOC285074 2p11.2 0.137 0.296 0.79
met MIR668 0.137 0.296 0.79
xsq BDKRB1 14q32.1-q32.2 -0.137 0.296 0.79 activation of protein
migration
xsq AGBL5-AS1 -0.137 0.296 0.79
met ORC3 6q14.3-q16.1 -0.137 0.296 0.79 DDR (DNA replication)
mut UPB1 22q11.2 -0.137 0.296 0.79 nucleobase-containing small
exp PPP4R1L 20q13.32 -0.137 0.296 0.79
DNA-dependent"
xsq GRHL2 8q22.3 -0.137 0.296 0.79 EMT (Epithelial)
exp ZFAND5 9q13-q21 -0.137 0.296 0.79 smooth muscle tissue
development;face development
xsq LINC01030 -0.137 0.296 0.79
cop WLS 1p31.3 -0.137 0.296 0.79 Wnt receptor signaling
exp KRT8P14 Xp11.3 -0.137 0.296 0.79
exp TNC 9q33 -0.137 0.296 0.79 positive regulation of gene
met CCND2 12p13 -0.137 0.296 0.79 DNA Damage Response (DDR); DDR (G1-S
checkpoint)
cop CTNNBL1 20q11.23-q12 -0.137 0.296 0.79 Apoptosis
met CH25H 10q23 -0.137 0.296 0.79 bile acid metabolic process;sterol
xsq MMP24-AS1 -0.137 0.296 0.79
exp BDKRB1 14q32.1-q32.2 -0.137 0.296 0.79 activation of protein
migration
xsq CCDC169 13q13.3 -0.137 0.296 0.789
xai XYLT2 17q21.33 -0.138 0.296 0.79 glycosaminoglycan biosynthetic
process
hs4 GMFB 14q22.2 -0.138 0.296 0.79 protein phosphorylation;signal
transduction
xai LOC100132735 -0.138 0.296 0.79
his PHACTR2 6q24.2 -0.138 0.296 0.79
exp DOCK9-AS1 -0.138 0.296 0.79
hs4 PDLIM7 5q35.3 -0.138 0.296 0.79 positive regulation of
xai C20orf194 20p13 -0.138 0.296 0.79
xai WDFY3-AS2 4q21.3 -0.138 0.296 0.79
xai VENTXP2 13q31.1 -0.138 0.296 0.79
his NHLRC1 6p22.3 -0.138 0.296 0.79 protein
hs4 GFPT2 5q34-q35 -0.138 0.296 0.79 dolichol-linked oligosaccharide
DNA-dependent"
his LEMD1-AS1 -0.138 0.296 0.79
his LRRC15 3q29 -0.138 0.296 0.79
hs4 TMEM253 14q11.2 -0.138 0.296 0.79
his HECW1 7p13 -0.138 0.296 0.79 protein modification process;protein
his PLXND1 3q22.1 -0.138 0.296 0.79 multicellular organismal
hs4 LIN28A 1p36.11 -0.138 0.296 0.79 positive regulation of neuron
hs4 CD37 19q13.3 -0.138 0.296 0.79 positive regulation of
hs4 PACS1 11q13.1-q13.2 -0.138 0.296 0.79 positive regulation of
his CA12 15q22 -0.138 0.296 0.79 one-carbon metabolic process
DNA-dependent"
hs4 LOC101928118 -0.138 0.296 0.79
hs4 RWDD3 1p21.3 -0.138 0.296 0.79
his PKNOX2-AS1 -0.138 0.296 0.79
his PKNOX2 11q24.2 -0.138 0.296 0.79 regulation of transcription
xai NTNG1 1p13.3 -0.138 0.296 0.79 axonogenesis;cell differentiation
hs4 ERICH3 -0.138 0.296 0.79
exp VN2R17P -0.138 0.296 0.79
xai S100A1 1q21 -0.138 0.296 0.79 negative regulation of
swa PAWR 12q21 -0.138 0.296 0.79 Apoptosis
xai ARSE Xp22.3 -0.138 0.296 0.79 skeletal system development
his MIR4263 -0.138 0.296 0.79
xai BBS12 4q27 -0.138 0.296 0.79 cellular protein metabolic
process;chaperone-mediated protein complex assembly
xai TP53 17p13.1 -0.138 0.296 0.79 Apoptosis; DNA Damage Response
(DDR); DDR (DNA replication); Tumor Suppressors
his CAMK1 3p25.3 -0.138 0.296 0.79 nervous system development;positive
xai METTL20 12p11.21 -0.138 0.296 0.79
xai FAM109A 12q24.12 -0.138 0.296 0.79 receptor recycling;endosome
organization
xai TUBB4B 9q34 -0.138 0.296 0.79 Apoptosis
xai PRRG4 11p13 -0.138 0.296 0.79
xai SLC25A43 Xq24 -0.138 0.296 0.79 Solute Carriers
xai IDO2 8p11.21 -0.138 0.296 0.79 tryptophan catabolic
xai DOCK9-AS1 -0.138 0.296 0.79
xai ACSL4 Xq22.3-q23 -0.138 0.296 0.789 fatty acid metabolic
xai C3orf70 3q27.2 -0.138 0.296 0.789
his MIR3151 -0.138 0.296 0.789
his CLDN15 7q11.22 0.138 0.297 0.79 calcium-independent cell-cell
his FIS1 7q22.1 0.138 0.297 0.79 Apoptosis
his KLHDC2 14q21.3 0.138 0.297 0.79
hs4 RNU1-3 0.138 0.297 0.79
xai IGSF21 1p36.13 0.138 0.297 0.79
hs4 MIR129-2 0.138 0.297 0.79
hs4 ANKRD20A3 9p12 0.138 0.297 0.791
his DAZAP1 19p13.3 0.138 0.297 0.791 multicellular organismal
xai IGHV3-36 0.138 0.297 0.791
his SNORA65 9q34 0.138 0.297 0.791
his RPL12 9q34 0.138 0.297 0.791 translational elongation;viral transcription
his LRSAM1 9q33.3 0.138 0.297 0.791 ubiquitin-dependent
endocytosis;protein polyubiquitination
xai ZSCAN29 15q15.3 0.138 0.297 0.791 viral reproduction
hs4 SPANXN3 0.138 0.297 0.791
xai SEC63P1 0.138 0.297 0.791
his CAPRIN1 11p13 0.138 0.297 0.791 negative regulation of translation;cell
differentiation
exp UGT2A2 4q13.3 0.138 0.297 0.791
xai IGHVIII-51-1 0.138 0.297 0.791
hs4 PIP5K1B 9q13 0.138 0.297 0.791 phosphorylation
hs4 HMX2 10q26.13 0.138 0.297 0.791 multicellular organismal
his C1QTNF3 5p13 0.138 0.297 0.791 negative regulation of gluconeogenesis
his FPR2 19q13.3-q13.4 0.138 0.297 0.791 G-protein coupled receptor
exp IGHVIII-51-1 0.138 0.297 0.791
his ASXL2 2p24.1 0.138 0.297 0.791 regulation of transcription, DNA-
dependent"
xai FNDC3CP 0.138 0.297 0.791
his SEC23A 14q21.1 0.138 0.297 0.791 protein N-linked glycosylation via
exp CTRC 1p36.21 0.138 0.297 0.791 proteolysis
his PGM2L1 11q13.4 0.138 0.297 0.791 carbohydrate metabolic
his MIR548AL 0.138 0.297 0.791
his PARP16 15q22.31 0.138 0.297 0.791
hs4 GPR3 1p36.1-p35 0.138 0.297 0.791 regulation of meiosis;activation of
xai UBR4 1p36.13 0.138 0.297 0.791 Tumor Suppressors
xai ZFAS1 20q13.13 0.138 0.297 0.791
xai PPFIA3 19q13.33 0.138 0.297 0.791 regulation of short-term neuronal
his NENF 1q32.3 0.138 0.297 0.791 positive regulation of MAPK cascade
xai RHBDD1 2q36.3 0.138 0.297 0.791 proteolysis
xai LDHAP5 10q26.11 0.138 0.297 0.791
hs4 CGGBP1 3p12-p11.1 0.138 0.297 0.791 regulation of transcription, DNA-
dependent"
hs4 C3orf38 3p11.1 0.138 0.297 0.791 apoptotic process
his RAB31 18p11.3 0.138 0.297 0.791 GTP catabolic process;small GTPase
hs4 ITM2C 2q37 0.138 0.297 0.791 negative regulation of neuron projection
mut GPRASP1 Xq22.1 0.137 0.297 0.79
exp BRIP1 17q22.2 0.137 0.297 0.79 DNA Damage Response (DDR); DDR (FA)
xsq SYF2 1p36.11 0.137 0.297 0.79 nuclear mRNA splicing, via
xsq FGD5P1 3p25.1 0.137 0.297 0.79
xsq CBARP 0.137 0.297 0.79
xsq MED4 13q14.2 0.137 0.297 0.791 transcription initiation from RNA
exp ISG20 15q26 0.137 0.297 0.791 type I interferon-mediated signaling
xsq DUXA 19q13.43 0.137 0.297 0.791
xsq LOC100652768 0.137 0.297 0.791
xsq SNHG11 20q11.23 0.137 0.297 0.791
xsq C8B 1p32.2 0.137 0.297 0.791 immune response;complement activation
cop PPP3CB 10q22.2 0.137 0.297 0.791 negative regulation of T cell
met TMEM5 12q14.2 0.137 0.297 0.791
xsq FAR1 11p15.2 0.137 0.297 0.791 small molecule metabolic process;lipid
xsq PSMD14 2q24.2 0.137 0.297 0.791 G1/S transition of mitotic cell
xsq PPP2R5E 14q23.1 0.137 0.297 0.791 signal transduction
exp ALG3 3q27.1 0.137 0.297 0.791 protein N-linked glycosylation via
mir hsa-miR-513b 0.137 0.297 0.791
xsq KNOP1 16p12.3 0.137 0.297 0.791
exp RNF111 15q21 0.137 0.297 0.791 multicellular organismal
xsq LOC645752 15q24.3 0.137 0.297 0.791
mut PAN3 13q12.2 0.137 0.297 0.791 gene expression;RNA metabolic process
mut CTBP2 10q26.13 0.137 0.297 0.791 negative regulation of transcription,
DNA-dependent;white fat cell differentiation
xsq LINC01221 0.137 0.297 0.791
exp IGKV3D-7 2p12 0.137 0.297 0.791
dependent"
met FAM19A5 22q13.32 0.137 0.297 0.791
xsq C22orf39 22q11.21 0.137 0.297 0.791
exp PHKA1P1 1p22.2 0.137 0.297 0.791
cop ECM2 9q22.3 0.137 0.297 0.791 positive regulation of cell-substrate
adhesion;extracellular matrix organization
mut DHCR7 11q13.4 0.137 0.297 0.791 cholesterol biosynthetic process;post-
xsq NDUFAF4P1 0.137 0.297 0.791
met CCDC150 2q33.1 0.137 0.297 0.791
xsq VSX2 14q24.3 0.137 0.297 0.791 multicellular organismal
cop ANAPC1 2q12.1 0.137 0.297 0.791 mitotic cell cycle;protein K11-
linked ubiquitination
cop DHX30 3p21.31 0.137 0.297 0.791
cop MIR1226 0.137 0.297 0.791
cop MAP4 3p21 0.137 0.297 0.791 negative regulation of microtubule
depolymerization
mut FRMPD2 10q11.22 0.137 0.297 0.791
xsq PGR 11q22-q23 -0.137 0.297 0.791 epithelial cell
cop POMK -0.137 0.297 0.791
exp PAEP 9q34 -0.137 0.297 0.791 transport;multicellular organismal
development
xsq OR6C3 -0.137 0.297 0.791
cop CNOT7 8p22-p21.3 -0.137 0.297 0.791 DNA Damage Response (DDR)
cop MIR648 -0.137 0.297 0.791
mut APPBP2 17q23.2 -0.137 0.297 0.791 intracellular protein
cop ARSD Xp22.3 -0.137 0.297 0.791
cop ARSE Xp22.3 -0.137 0.297 0.791 skeletal system development
cop ARSH Xp22.33 -0.137 0.297 0.791
cop DGCR8 22q11.2 -0.137 0.297 0.791 primary miRNA processing
cop MIR3618 -0.137 0.297 0.791
cop MIR1306 -0.137 0.297 0.791
xsq LOC101927378 -0.137 0.297 0.791
cop XRN1 3q23 -0.137 0.297 0.791 rRNA catabolic process;exonucleolytic
decay
xsq GBP4 1p22.2 -0.137 0.297 0.791
exp FAM71C 12q23.1 -0.137 0.297 0.791
xsq TRIM61 4q32.3 -0.137 0.297 0.791
xsq ANO4 12q23.1 -0.137 0.297 0.791 ion transport
met GNB4 3q26.33 -0.137 0.297 0.791 EMT (Mesenchymal)
cop KDM5B 1q32.1 -0.137 0.297 0.791 histone H3-K4 demethylation,
exp BRK1 3p25.3 -0.137 0.297 0.791
exp RBM43 2q23.3 -0.137 0.297 0.791
exp MORC4 Xq22.3 -0.137 0.297 0.791
exp LOC643579 -0.137 0.297 0.791
exp NRSN2 20p13 -0.137 0.297 0.791
xsq C16orf74 16q24.1 -0.137 0.297 0.791
exp PLA2G4F 15q15.1 -0.137 0.297 0.791 fatty acid transport;lipid
catabolic process
cop APC 5q21-q22 -0.137 0.297 0.791 Apoptosis; Cell Signaling; DNA
Damage Response (DDR); Tumor Suppressors
exp SEL1L3 4p15.2 -0.137 0.297 0.791
cop GRK7 3q24 -0.137 0.297 0.79
met EIF1AD 11q13.1 -0.137 0.297 0.79
exp SIX2 2p21 -0.137 0.297 0.79 regulation of transcription, DNA-
cop MIR378C -0.137 0.297 0.79
xai CDYL 6p25.1 -0.138 0.297 0.791 spermatogenesis;regulation of
xai LOC286177 8q12.1 -0.138 0.297 0.791
hs4 HGSNAT 8p11.1 -0.138 0.297 0.791 protein
his GSX2 4q12 -0.138 0.297 0.791 multicellular organismal development
his WFDC3 20q13.12 -0.138 0.297 0.791
his DNTTIP1 20q13.12 -0.138 0.297 0.791 DNA Damage Response (DDR);
xai ITGBL1 13q33 -0.138 0.297 0.791 integrin-mediated signaling
xai LOC100270746 6p22.2 -0.138 0.297 0.791
xai TANGO2 22q11.21 -0.138 0.297 0.791
his LOC101926892 -0.138 0.297 0.791
xai SHMT1P1 1p34 -0.138 0.297 0.791
xai COL3A1 2q31 -0.138 0.297 0.791 heart development;fibril
organization
xai FOXD2 1p34-p32 -0.138 0.297 0.791 Apoptosis
xai GAS1 9q21.3-q22 -0.138 0.297 0.791 cell cycle;cellular response to
vascular endothelial growth factor stimulus
his GBP3 1p22.2 -0.138 0.297 0.791
hs4 AIF1L 9q34.13-q34.3 -0.138 0.297 0.791
his PLA2G4C 19q13.3 -0.138 0.297 0.791 metabolic process;lipid
catabolic process
hs4 EBF3 10q26.3 -0.138 0.297 0.791 regulation of transcription, DNA-
exp SPTLC1P1 -0.138 0.297 0.791
his LINC00853 -0.138 0.297 0.79
his PDZK1IP1 1p33 -0.138 0.297 0.79
cop LILRB2 19q13.4 -0.138 0.297 0.79 immune response-inhibiting
cell surface receptor signaling pathway;heterotypic cell-cell adhesion
cop MIR4752 -0.138 0.297 0.79
exp KRT8P30 2q35 -0.138 0.297 0.79
exp VENTXP2 13q31.1 -0.138 0.297 0.79
his PLAC4 21q22.2 -0.138 0.297 0.79
met BTNL3 5q35.3 0.144 0.298 0.792 lipid metabolic process
his MIEF1 0.138 0.298 0.791 mitochondrial fusion
xai ANGPT4 20p13 0.138 0.298 0.791 positive regulation of endothelial cell
xai ANKZF1 2q35 0.138 0.298 0.791
his WBP1L 10q24.32 0.138 0.298 0.791
his EMC9 14q11.2 0.138 0.298 0.792
xai BTF3P4 9q21.13 0.138 0.298 0.792
hs4 VPS13A 9q21 0.138 0.298 0.792 Golgi to endosome transport;nervous
system development
hs4 VPS13A-AS1 9q21.2 0.138 0.298 0.792
hs4 QTRT1 19p13.3 0.138 0.298 0.792 tRNA modification;queuosine biosynthetic
process
xai SERPINC1 1q25.1 0.138 0.298 0.792 blood coagulation;negative
his RGS2 1q31 0.138 0.298 0.792 negative regulation of phospholipase
exp VN2R10P 16q23.1 0.138 0.298 0.792
his LOC100506022 0.138 0.298 0.792
his SRPK2 7q22-q31.1 0.138 0.298 0.792 intracellular protein kinase
xai SLC5A5 19p13.11 0.138 0.298 0.792 cellular nitrogen compound
his LOC100996583 0.138 0.298 0.792
xai NR5A2 1q32.1 0.138 0.298 0.792 gene expression;intracellular receptor
his FUT6 19p13.3 0.138 0.298 0.792 protein glycosylation;fucosylation
hs4 RIMBP3B 22q11.21 0.138 0.298 0.792
dependent"
hs4 HIST2H2BE 1q21.2 0.138 0.298 0.792 nucleosome assembly;defense
hs4 HIST2H2AC 1q21.2 0.138 0.298 0.792 nucleosome assembly
hs4 HIST2H2AB 0.138 0.298 0.792 nucleosome assembly
hs4 LOC102724691 0.138 0.298 0.792
hs4 MRPS9 2q12.1 0.138 0.298 0.792 DNA damage response, detection of DNA
damage;peptide biosynthetic process
xai FAM19A2 12q14.1 0.138 0.298 0.792
xai OR2L3 0.138 0.298 0.792 response to stimulus
his FGD6 12q22 0.138 0.298 0.792 regulation of Rho protein signal
transduction;regulation of Cdc42 GTPase activity
his VEZT 12q22 0.138 0.298 0.792 cell-cell adhesion;chordate embryonic
development
exp CCDC71 3p21.31 0.138 0.298 0.792
xai SMARCE1 17q21.2 0.138 0.298 0.792 DNA Damage Response (DDR); DDR
(Chromatin)
his SNX15 11q12 0.138 0.298 0.792 cell communication;intracellular protein
transport
hs4 NCLN 19p13.3 0.138 0.298 0.792 regulation of signal
cop KCNIP2 10q24 0.137 0.298 0.791 signal transduction;synaptic transmission
met CWC15 11q21 0.137 0.298 0.791 nuclear mRNA splicing, via spliceosome;RNA
splicing"
exp LOC151457 2p24.1 0.137 0.298 0.791
xsq CNGB3 8q21.3 0.137 0.298 0.792 cation transport;signal transduction
xsq SNORA40 0.137 0.298 0.792
met SYT8 11p15.5 0.137 0.298 0.792
met AFAP1L2 10q25.3 0.137 0.298 0.792 regulation of mitotic cell
mut IFNLR1 1p36.11 0.137 0.298 0.792
xsq MED22 9q34.2 0.137 0.298 0.792 regulation of transcription from RNA
met PCDH8 13q21.1 0.137 0.298 0.792 homophilic cell adhesion;cell-cell
signaling
xsq OR4D2 17q22 0.137 0.298 0.792 response to stimulus
cop CHAC2 2p16 0.137 0.298 0.792
xsq FKBP6 7q11.23 0.137 0.298 0.792 pachytene;protein peptidyl-prolyl
isomerization
xsq C15orf40 15q25.2 0.137 0.298 0.792
dependent"
met RGL3 19p13.2 0.137 0.298 0.792 signal transduction;regulation of small
xsq LINC00229 0.137 0.298 0.792
dependent"
xsq OR7G1 0.137 0.298 0.792
exp ZDHHC12 9q34.11 0.137 0.298 0.792
exp LOC729317 0.137 0.298 0.792
exp CCR1 3p21 0.137 0.298 0.792 dendritic cell chemotaxis;cell surface receptor
signaling pathway
met NRXN1 2p16.3 0.137 0.298 0.792 calcium-dependent cell-cell
adhesion;prepulse inhibition
exp HTR1F 3p12 0.137 0.298 0.792 serotonin receptor signaling pathway;synaptic
transmission
cop CHD1L 1q12 0.137 0.298 0.792 ATP catabolic process;DNA repair
cop LINC00624 1q21.1 0.137 0.298 0.792
cop BCL9 1q21 0.137 0.298 0.792 Wnt receptor signaling pathway;regulation of
cop ACP6 1q21 0.137 0.298 0.792 lipid metabolic process
cop GJA5 1q21.1 0.137 0.298 0.792 muscle contraction;cell-cell junction
assembly
cop LHCGR 2p21 0.137 0.298 0.792 G-protein signaling, coupled to cyclic
nucleotide second messenger;male genitalia development
met NT5DC1 6q22.1 0.137 0.298 0.792
mut SIX3 2p21 0.137 0.298 0.792 diencephalon development;telencephalon
development
exp MMS19 10q24-q25 0.137 0.298 0.792 DNA Damage Response (DDR)
xsq TMEM201 1p36.22 0.137 0.298 0.792
xsq MITD1 2q11.2 0.137 0.298 0.792 protein transport
met HAND2 4q33 0.137 0.298 0.792 regulation of secondary heart field cardioblast
xsq CTRB1 0.137 0.298 0.792
xsq DKFZp434L192 7p11.2 0.136 0.298 0.792
xsq LPP-AS1 0.136 0.298 0.792
xsq IDE 10q23-q25 0.136 0.298 0.792 proteolysis;protein homotetramerization
process
exp SMOC1 14q24.2 0.136 0.298 0.792 eye development;signal transduction
met TMEM211 22q11.23 0.136 0.298 0.792
xsq STMN4 8p21.2 0.136 0.298 0.792 intracellular signal transduction
cop ASB3 2p16.2 0.136 0.298 0.792 intracellular signal transduction
xsq C19orf52 19p13.2 0.136 0.298 0.792
mut RNF169 11q13.4 0.136 0.298 0.792
exp COL15A1 9q21-q22 -0.136 0.298 0.792 signal
met EXOC7 17q25.1 -0.136 0.298 0.792 exocytosis;protein transport
mut KEL 7q33 -0.136 0.298 0.792 proteolysis;vasoconstriction
xsq ZNF20 19p13.2 -0.136 0.298 0.792
cop BLCAP 20q11.23 -0.137 0.298 0.792 apoptotic process;cell cycle
cop NNAT -0.137 0.298 0.792
cop LINC00489 -0.137 0.298 0.792
cop LOC100287792 20q11.23 -0.137 0.298 0.792
mut TRIP12 2q36.3 -0.137 0.298 0.792 protein modification
xsq KIF3C 2p23 -0.137 0.298 0.792 microtubule-based movement;blood
coagulation
xsq CCDC107 9p13.3 -0.137 0.298 0.792
exp MOB4 2q33.1 -0.137 0.298 0.792 transport
met CD96 3q13.13-q13.2 -0.137 0.298 0.792 cell adhesion;regulation of
immune response
exp DENND5B 12p11.21 -0.137 0.298 0.792
exp ASIC2 17q12 -0.137 0.298 0.792 monovalent inorganic cation transport;ion
transport
exp CBLC 19q13.2 -0.137 0.298 0.792 DNA Damage Response (DDR); EMT
(Epithelial)
exp ICMT 1p36.21 -0.137 0.298 0.792 protein targeting to
membrane;protein localization
met UAP1L1 9q34.3 -0.137 0.298 0.792 metabolic process
met HEPACAM2 7q21.3 -0.137 0.298 0.792
exp GRHL2 8q22.3 -0.137 0.298 0.792 EMT (Epithelial)
met C18orf56 -0.137 0.298 0.792
exp PRSS54 16q21 -0.137 0.298 0.792
cop EGFL6 Xp22 -0.137 0.298 0.792 cell cycle;cell adhesion
xsq KL 13q12 -0.137 0.298 0.792 aging;insulin receptor signaling pathway
exp LOC100132658 Xq22.1 -0.137 0.298 0.792
exp ECT2 3q26.1-q26.2 -0.137 0.298 0.792 positive regulation of Cdc42
cop HMGB3P1 20q11.22 -0.137 0.298 0.792
exp F2RL2 5q13 -0.137 0.298 0.792 blood coagulation;response to wounding
exp MROH1 8q24.3 -0.137 0.298 0.792
met SIRPG 20p13 -0.137 0.298 0.792 positive regulation of cell
xsq ADAMTSL3 15q25.2 -0.137 0.298 0.792
exp NOTCH2NL 1q21.2 -0.137 0.298 0.792 Notch signaling
exp QPCT 2p22.2 -0.137 0.298 0.792 protein modification
process;proteolysis
exp TMEM106A 17q21.31 -0.137 0.298 0.791
xsq TMEFF2 2q32.3 -0.137 0.298 0.791
hs4 GACAT2 -0.138 0.298 0.792
his LOC100506801 -0.138 0.298 0.792
hs4 MEF2B -0.138 0.298 0.792 Oncogenes
hs4 CREB3L1 11p11.2 -0.138 0.298 0.792 response to unfolded protein
hs4 RAB25 1q22 -0.138 0.298 0.792 EMT (Epithelial)
his INTU 4q28.1 -0.138 0.298 0.792 nervous system
development;regulation of smoothened signaling pathway
xai RNF157-AS1 -0.138 0.298 0.792
xai MORC4 Xq22.3 -0.138 0.298 0.792
xai ENTPD6 20p11.21 -0.138 0.298 0.792 response to magnesium
ion;response to calcium ion
hs4 CPQ 8q22.2 -0.138 0.298 0.792 proteolysis;peptide metabolic
process
xai TMEM86A 11p15.1 -0.138 0.298 0.792
xai GDI1 Xq28 -0.138 0.298 0.792 signal transduction;small GTPase mediated
signal transduction
xai DYNLRB2 16q23.3 -0.138 0.298 0.792 transport;microtubule-based
movement
xai CGN 1q21 -0.138 0.298 0.792
swa COL4A1 13q34 -0.138 0.298 0.791 epithelial cell
his SETBP1 18q21.1 -0.138 0.298 0.791
hs4 MSL3P1 2q37.1 0.138 0.299 0.792 regulation of transcription, DNA-
swa POLDIP3 22q13.2 0.138 0.299 0.792 positive regulation of translation
his COG6 13q14.11 0.138 0.299 0.792 intra-Golgi vesicle-mediated
exp IZUMO2 19q13.33 0.138 0.299 0.792
exp OR2L3 0.138 0.299 0.792 response to stimulus
hs4 ST8SIA5 18q21.1 0.138 0.299 0.792 carbohydrate metabolic
hs4 NT5C2 10q24.32 0.138 0.299 0.792 nucleotide metabolic process;small
his NAPB 20p12.3-p11.21 0.138 0.299 0.792 SNARE complex
disassembly;intracellular protein transport
hs4 PMF1 1q12 0.138 0.299 0.793 cell division;M phase of mitotic cell cycle
hs4 PMF1-BGLAP 0.138 0.299 0.793
xai FLJ45508 0.138 0.299 0.793
hs4 LOC108783654 0.138 0.299 0.793
hs4 HSD17B1 17q11-q21 0.138 0.299 0.793 small molecule metabolic
xai TNRC6B 22q13.1 0.138 0.299 0.793 regulation of translation;gene
silencing by RNA
xai RAD18 3p25-p24 0.138 0.299 0.793 DNA Damage Response (DDR); DDR (TLS)
his UBXN8 8p12-p11.2 0.137 0.299 0.793 single fertilization
exp NRBF2P3 1p13.3 0.137 0.299 0.793
xai PDE6G 17q25 0.137 0.299 0.793 activation of MAPK activity;blood coagulation
swa NONO Xq13.1 0.137 0.299 0.793 DNA repair;DNA recombination
his MIR4748 0.137 0.299 0.793
exp KCNAB3 17p13.1 0.137 0.299 0.793 potassium ion transport;synaptic
transmission
dependent"
hs4 LOC100505817 0.137 0.299 0.793
xai KIR2DL4 0.137 0.299 0.793 cellular defense response;signal
transduction
xai GBX2 2q37.2 0.137 0.299 0.793 regulation of transcription, DNA-
dependent;hindbrain development
exp SEC24B-AS1 0.137 0.299 0.793
cop GOLGA8O 0.136 0.299 0.792
cop WHAMMP1 15q13.3 0.136 0.299 0.792
mut ANO3 11p14.2 0.136 0.299 0.792 ion transport
cop LRRC2 3p21.31 0.136 0.299 0.792
met KIF20B 10q23.31 0.136 0.299 0.792 cell cycle arrest;regulation of
mitosis
xsq KIAA0907 1q22 0.136 0.299 0.792
cop MERTK 2q14.1 0.136 0.299 0.792 spermatogenesis;negative regulation of
cop SEMA3F 3p21.3 0.136 0.299 0.792 neural crest cell
cop GNAT1 3p21 0.136 0.299 0.792 cell proliferation;positive regulation of
cyclic-nucleotide phosphodiesterase activity
dependent"
xsq FAM162A 3q21.1 0.136 0.299 0.792
xsq NPY2R 4q31 0.136 0.299 0.792
exp RPS16P1 1p36.21 0.136 0.299 0.792
exp OLFM2 19p13.2 0.136 0.299 0.792
mut AKAP8 19p13.1 0.136 0.299 0.792 signal transduction;mitosis
dependent"
exp FAM120AOS 9q22.31 0.136 0.299 0.793
met TAF5L 1q42.13 0.136 0.299 0.793 regulation of transcription, DNA-
exp ACAT1 11q22.3 0.136 0.299 0.793 response to organic cyclic
compound;protein homooligomerization
dependent"
cop LOC728989 1q21.1 0.136 0.299 0.793
xsq ATXN7L3 17q21.31 0.136 0.299 0.793 chromatin modification;histone
deubiquitination
exp HYAL3 3p21.3 0.136 0.299 0.793 response to antibiotic;cartilage
development
xsq DHRS1 14q12 0.136 0.299 0.793
xsq CPT2 1p32 0.136 0.299 0.793 fatty acid beta-oxidation;transport
met RPIA 2p11.2 0.136 0.299 0.793 carbohydrate metabolic process;pentose-
phosphate shunt
xsq EIF4E2 2q37.1 0.136 0.299 0.793 translation;regulation of
translation
xsq TMEM168 7q31.32 0.136 0.299 0.793
xsq JAKMIP1 4p16.1 0.136 0.299 0.793 protein transport
exp AHSP 16p11.2 0.136 0.299 0.793 protein folding;hemoglobin metabolic
process
dependent"
cop C14orf159 14q32.11 0.136 0.299 0.793
cop SNORA11B 14q32.12 0.136 0.299 0.793
cop GPR68 14q31 0.136 0.299 0.793 inflammatory response;G-protein coupled
exp NDUFS3 11p11.11 0.136 0.299 0.793 small molecule metabolic
exp LOC646870 1q25.1 0.136 0.299 0.793
exp METTL23 17q25.1 0.136 0.299 0.793
exp INSL4 9p24 0.136 0.299 0.793 signal transduction;cell-cell signaling
exp DDIT4L 4q24 0.136 0.299 0.793 negative regulation of signal
transduction
cop LOC100506474 0.136 0.299 0.793
cop TMEM200C 18p11.31 0.136 0.299 0.793
xsq LINC01222 0.136 0.299 0.793
mut IFNB1 0.136 0.299 0.793
met PLK1 16p12.2 0.136 0.299 0.793 DDR (DNA replication); Protein Kinases
cop CYB561A3 11q12.2 0.136 0.299 0.793
exp NIPA2 15q11.2 0.136 0.299 0.793 ion transport;magnesium ion transport
exp JMJD4 1q42.13 0.136 0.299 0.793
xsq LINC00887 3q29 0.136 0.299 0.793
exp PPIEL 1p34.3 0.136 0.299 0.793
xsq LOC102723344 0.136 0.299 0.793
mut EXPH5 11q22.3 -0.136 0.299 0.793 intracellular protein
xsq CDRT1 17p12 -0.136 0.299 0.793
mut CD200R1 3q13.2 -0.136 0.299 0.793 interspecies interaction
between organisms;regulation of immune response
xsq DNM3-IT1 -0.136 0.299 0.793
cop XKR3 22q11.1 -0.136 0.299 0.793
exp YES1 18p11.31-p11.21 -0.136 0.299 0.793 Apoptosis
xsq WFDC10A 20q13.12 -0.136 0.299 0.793
cop SRY Yp11.3 -0.136 0.299 0.793 positive regulation of
transcription, DNA-dependent;positive regulation of male gonad development
cop RPS4Y1 Yp11.3 -0.136 0.299 0.793 translational
elongation;viral infectious cycle
exp SUN3 7p12.3 -0.136 0.299 0.793
mir hsa-miR-200b -0.136 0.299 0.793
xsq LOC100129520 Xq25 -0.136 0.299 0.793
mut CMTR2 -0.136 0.299 0.793
cop ARHGAP29 1p22.1 -0.136 0.299 0.793 small GTPase mediated signal
transduction;Rho protein signal transduction
xsq HPSE 4q21.3 -0.136 0.299 0.793 positive regulation vascular
endothelial growth factor production;positive regulation of blood coagulation
xsq PTPN1 20q13.1-q13.2 -0.136 0.299 0.793 regulation of
exp CST1 20p11.21 -0.136 0.299 0.793
mut FOXRED2 22q12.3 -0.136 0.299 0.793 ER-associated protein
catabolic process
xsq ADAMTS9-AS2 -0.136 0.299 0.793
xsq AMBP 9q32-q33 -0.136 0.299 0.793 heme catabolic process;interspecies
exp MPZL3 11q23.3 -0.136 0.299 0.793 cell adhesion
exp NDFIP2 13q31.1 -0.136 0.299 0.792 signal transduction;negative
xsq DNAJC9-AS1 -0.136 0.299 0.792
exp SPRYD7 13q14 -0.136 0.299 0.792
xsq SLC16A2 Xq13.2 -0.136 0.299 0.792 Solute Carriers
exp GTPBP2 6p21 -0.136 0.299 0.792
xsq GPRC5A 12p13-p12.3 -0.136 0.299 0.792 G-protein coupled receptor
cop HOOK3 8p11.21 -0.136 0.299 0.792 cytoplasmic microtubule
xsq TRIM73 7q11.23 -0.136 0.299 0.792
xsq GSTA2 6p12.1 -0.136 0.299 0.792 small molecule metabolic
exp RAI2 Xp22 -0.136 0.299 0.792 embryo development
hs4 TMEM40 3p25.2 -0.137 0.299 0.793
xai CABP7 22q12.2 -0.137 0.299 0.793
xai SHC1 1q21 -0.137 0.299 0.793 response to toxin;response to insulin
stimulus
xai TK2 16q22-q23.1 -0.137 0.299 0.793 DNA replication;pyrimidine
nucleoside salvage
xai KCNK16 6p21.2-p21.1 -0.137 0.299 0.793 ion transport;potassium
ion transport
his KIF12 9q32 -0.137 0.299 0.793 microtubule-based movement
his PICSAR -0.137 0.299 0.793
his LINC00284 13q14.11 -0.137 0.299 0.793
xai APOBEC3B 22q13.1-q13.2 -0.137 0.299 0.793 negative regulation of
transposition
hs4 BCAS4 20q13.13 -0.137 0.299 0.793
xai DKK2 4q25 -0.137 0.299 0.793 multicellular organismal
his MIRLET7A3 -0.137 0.299 0.793
his MIR4763 -0.137 0.299 0.793
his MIRLET7B -0.137 0.299 0.793
xai LDLRAD3 11p13 -0.137 0.299 0.793
hs4 SAA1 11p15.1 -0.137 0.299 0.793 acute-phase response;regulation of
protein secretion
xai PRKRIP1 7q22.1 -0.137 0.299 0.793 negative regulation of
phosphorylation;negative regulation of protein kinase activity
xai C16orf89 16p13.3 -0.137 0.299 0.793
hs4 COL6A1 21q22.3 -0.137 0.299 0.793 cell adhesion;axon guidance
his SEC14L1P1 11p11.2 -0.137 0.299 0.793
xai PHGDH 1p12 -0.137 0.299 0.793 L-serine biosynthetic process;brain
development
hs4 AP2S1 19q13.2-q13.3 -0.138 0.299 0.793 protein transport;viral
reproduction
exp LOC642980 -0.138 0.299 0.793
xai PRSS54 16q21 -0.138 0.299 0.793
xai INAFM1 -0.138 0.299 0.793
hs4 KLHDC8B 3p21.31 -0.138 0.299 0.792
hs4 WDR66 12q24.31 -0.138 0.299 0.792
swa TIMM9 14q21 -0.138 0.299 0.792 sensory perception of sound;protein
import into mitochondrial inner membrane
hs4 LMO4 1p22.3 -0.138 0.299 0.792 spinal cord association neuron
differentiation;negative regulation of protein complex assembly
xai CSF2RA Xp22.32 -0.138 0.299 0.792
cop OR11H1 22q11.2 -0.14 0.299 0.792
swa FADD 11q13.3 0.137 0.3 0.793 Apoptosis
his LOC101929073 0.137 0.3 0.793
his MYO3A 10p11.1 0.137 0.3 0.793 visual perception;sensory perception of
sound
xai LINC00649 0.137 0.3 0.793
xai CARM1 19p13.2 0.137 0.3 0.793 chromatin modification;peptidyl-arginine
N-methylation
xai CXorf40B Xq28 0.137 0.3 0.794
cop PTPRS 19p13.3 0.137 0.3 0.794 cell adhesion;spinal cord development
his ELK1 Xp11.2 0.137 0.3 0.794 Transcription Factors
his TRIT1 1p34.2 0.137 0.3 0.794 tRNA processing
dependent"
cop KDM4B 19p13.3 0.137 0.3 0.794 regulation of transcription, DNA-
exp OTOS 2q37.3 0.137 0.3 0.794 sensory perception of sound
his PTMS 12p13 0.137 0.3 0.794 DNA replication
his LAG3 12p13.32 0.137 0.3 0.794 cell surface receptor signaling
exp TSSK5P1 0.137 0.3 0.794
xai LAMC3 9q31-q34 0.137 0.3 0.794 cell adhesion;visual perception
his MFSD1 3q25.32 0.137 0.3 0.794 transmembrane transport
xai DESI1 22q13.2 0.137 0.3 0.794
xai RPA1 17p13.3 0.137 0.3 0.794 DNA Damage Response (DDR); DDR (MMR); DDR
(DNA replication)
xai DUSP19 2q32.1 0.137 0.3 0.794 JNK cascade;positive regulation of
MAPK cascade
hs4 CCDC74B 2q21.1 0.137 0.3 0.794
hs4 DGKK Xp11.22 0.137 0.3 0.794 platelet activation;intracellular signal
transduction
hs4 CDKL4 2p22.1 0.137 0.3 0.794
hs4 CTD-2194D22.4 0.137 0.3 0.794
hs4 GINS4 8p11.21 0.137 0.3 0.794 DDR (DNA replication)
xai SLC13A4 7q33 0.137 0.3 0.794 ion transport;sodium ion transport
cop MIR5010 0.137 0.3 0.794
hs4 SMYD5 2p13.2 0.137 0.3 0.794
hs4 CSTF2 Xq22.1 0.137 0.3 0.794 gene expression;nuclear mRNA splicing,
via spliceosome
his LINC00371 13q14.3 0.137 0.3 0.794
his SSR1 6p24.3 0.137 0.3 0.794 endoplasmic reticulum unfolded protein
response;cellular protein metabolic process
swa TMEM263 0.137 0.3 0.794
xai ABI3 17q21.3 0.137 0.3 0.794 cellular component movement;peptidyl-
hs4 BCAP31 Xq28 0.137 0.3 0.794 Apoptosis
hs4 ABCD1 Xq28 0.137 0.3 0.794 ABC Transporters
xai ADAMTS17 15q24 0.137 0.3 0.794 proteolysis
his PCDHB3 5q31 0.137 0.3 0.794 cell adhesion;homophilic cell adhesion
hs4 GFOD2 16q22.1 0.137 0.3 0.794 extracellular matrix organization
his MIR1302-5 0.137 0.3 0.794
swa CWC27 5q12.3 0.137 0.3 0.794 nuclear mRNA splicing, via
cop MIR5699 0.136 0.3 0.793
cop PRR26 10p15.3 0.136 0.3 0.793
met C5orf38 5p15.33 0.136 0.3 0.793
met DEFA1 8p23.1 0.136 0.3 0.793
met DEFA3 8p23.1 0.136 0.3 0.793 killing of cells of other
met EDRF1 0.136 0.3 0.793 regulation of transcription, DNA-dependent"
xsq CISH 3p21.3 0.136 0.3 0.793 intracellular signal transduction;JAK-
met AGPAT3 21q22.3 0.136 0.3 0.793 metabolic process;phospholipid
xsq MGMT 10q26 0.136 0.3 0.793 DNA Damage Response (DDR); DDR (Direct Repair)
met WWC2 4q35.1 0.136 0.3 0.793
mut MYCL 1p34.2 0.136 0.3 0.793
met RMND5A 2p11.2 0.136 0.3 0.794
met TMEM33 4p13 0.136 0.3 0.794
cop NR1H4 12q23.1 0.136 0.3 0.794 intracellular receptor mediated signaling
pathway;regulation of urea metabolic process
exp PGM5P1 0.136 0.3 0.794
xsq LINC01544 0.136 0.3 0.794
xsq LOC103908605 0.136 0.3 0.794
cop ERCC6L Xq13.1 0.136 0.3 0.794 mitotic prometaphase;mitotic cell
cycle
cop RPS4X Xq13.1 0.136 0.3 0.794 translational elongation;mRNA metabolic
process
cop CITED1 Xq13.1 0.136 0.3 0.794 branching involved in ureteric bud
morphogenesis;cell proliferation
cop NAA25 12q24.13 0.136 0.3 0.794
met MAGEA1 Xq28 0.136 0.3 0.794 negative regulation of transcription from
RNA polymerase II promoter;negative regulation of Notch signaling pathway
exp RPS20P7 1p31.1 0.136 0.3 0.794
met VWA5B2 3q27.1 0.136 0.3 0.794
cop PRKCQ-AS1 10p14 0.136 0.3 0.794
xsq STMN3 20q13.3 0.136 0.3 0.794 nervous system development;cytoplasmic
xsq PHC1 12p13 0.136 0.3 0.794 multicellular organismal development
cop MIR4670 0.136 0.3 0.794
cop DYNLRB2 16q23.3 0.136 0.3 0.794 transport;microtubule-based
movement
xsq BRCAT54 0.136 0.3 0.794
cop TMEM87B 2q13 0.136 0.3 0.794
xsq LINC00970 0.136 0.3 0.794
met PAPPA2 1q23-q25 0.136 0.3 0.794 regulation of cell
growth;proteolysis
cop LOC390705 16p11.2 0.136 0.3 0.794
cop LOC100192426 18p11.23 0.136 0.3 0.794
mut CCDC47 17q23.3 0.136 0.3 0.794 ER overload response;embryo
development
mut PTH2R 2q33 0.136 0.3 0.794 G-protein coupled receptor signaling pathway
exp WAC 10p12.1 0.136 0.3 0.794 positive regulation of transcription,
exp BAG6 6p21.3 0.136 0.3 0.794 transport;lung development
xsq ASIP 20q11.2-q12 0.136 0.3 0.794 hormone-mediated signaling
exp CMAHP 6p21.32 0.136 0.3 0.794
exp SCFD2 4q12 0.136 0.3 0.794 vesicle docking involved in exocytosis;protein
transport
xsq RABL6 9q34.3 0.136 0.3 0.794
exp BRCC3 Xq28 0.136 0.3 0.794 DNA Damage Response (DDR)
xsq SPATA41 15q26.3 0.136 0.3 0.794
xsq C16orf89 16p13.3 0.136 0.3 0.794
met C4orf48 4p16.3 0.136 0.3 0.794
met ANGPTL6 19p13.2 0.136 0.3 0.794 angiogenesis;signal transduction
xsq EVA1B 1p34.3 -0.136 0.3 0.794
xsq PLAUR 19q13 -0.136 0.3 0.794 cellular component movement;fibrinolysis
xsq SH3GL2 9p22 -0.136 0.3 0.794 axon guidance;central nervous
system development
xsq MIEF2 -0.136 0.3 0.794 mitochondrion organization
met KRTAP4-3 17q21.2 -0.136 0.3 0.794
exp RPN1 3q21.3 -0.136 0.3 0.794 translation;protein modification
process
exp GOLPH3 5p13.3 -0.136 0.3 0.794 regulation of mitochondrion
met LRRC34 3q26.2 -0.136 0.3 0.794
cop EBAG9 8q23 -0.136 0.3 0.794 Apoptosis
cop SYBU 8q23.2 -0.136 0.3 0.794
exp FGF2 4q26 -0.136 0.3 0.794 branching involved in ureteric bud
exp DNAJC5 20q13.33 -0.136 0.3 0.794 protein folding;synaptic
transmission
exp MT1M 16q13 -0.136 0.3 0.794 negative regulation of growth
xsq RBM43 2q23.3 -0.136 0.3 0.794
xsq DPYD-AS2 -0.136 0.3 0.794
exp RDH11 14q24.1 -0.136 0.3 0.794 small molecule metabolic
process;retinoid metabolic process
exp CCDC14 3q21.1 -0.136 0.3 0.794
xsq ACVR2A 2q22.3 -0.136 0.3 0.794 Cell Signaling; Tumor
Suppressors
cop YARS2 12p11.21 -0.136 0.3 0.794 mitochondrial tyrosyl-tRNA
cop LIPJ 10q23.31 -0.136 0.3 0.794 lipid catabolic process
cop LIPF 10q23.31 -0.136 0.3 0.794
cop LIPK 10q23.31 -0.136 0.3 0.794 lipid catabolic process
exp EIF4G1 3q27.1 -0.136 0.3 0.794 insulin receptor signaling
exp BIRC7 20q13.3 -0.136 0.3 0.794 Apoptosis
exp MID2 Xq22.3 -0.136 0.3 0.794
exp AQP12B -0.136 0.3 0.794
exp WDFY3-AS2 4q21.3 -0.136 0.3 0.794
cop PKHD1L1 8q23 -0.136 0.3 0.794 immune response
mut SYNJ2 6q25.3 -0.136 0.3 0.794 phosphatidylinositol
exp FAM21D -0.136 0.3 0.793 retrograde transport, endosome to
Golgi"
xsq DIAPH3 13q21.2 -0.136 0.3 0.793 cellular component
cop ARSF Xp22.3 -0.136 0.3 0.793
mut EPHA2 1p36 -0.136 0.3 0.793 Protein Kinases
xsq ENDOU 12q13.1 -0.136 0.3 0.793 female pregnancy;proteolysis
met SMPD4 2q21.1 -0.136 0.3 0.793 sphingomyelin catabolic
met GPRIN2 10q11.22 -0.136 0.3 0.793
xai TMEM245 9q31 -0.137 0.3 0.794
xai MID2 Xq22.3 -0.137 0.3 0.794
hs4 ARMCX6 Xq21.33-q22.3 -0.137 0.3 0.794
xai MYH10 17p13 -0.137 0.3 0.794 axon guidance;cerebellar Purkinje cell
layer development
hs4 PCYT1A 3q29 -0.137 0.3 0.794 CDP-choline pathway;phospholipid
xai ID4 6p22.3 -0.137 0.3 0.794 negative regulation of
hs4 TRIM55 8q13.1 -0.137 0.3 0.794 signal transduction
hs4 DFNA5 7p15 -0.137 0.3 0.794 sensory perception of sound;inner ear
xai KRT19P4 10q21.3 -0.137 0.3 0.794
xai KRT8P7 11q23.3 -0.137 0.3 0.794
exp METTL20 12p11.21 -0.137 0.3 0.794
hs4 RASGRP1 15q14 -0.137 0.3 0.794 signal transduction;Ras protein
signal transduction
hs4 GOLT1A 1q32.1 -0.137 0.3 0.794 protein transport;vesicle-
mediated transport
his FAM200B 4p15.32 -0.137 0.3 0.794
swa STXBP3 1p13.3 -0.137 0.3 0.794 blood coagulation;protein
transport
swa NDUFA2 5q31.2 -0.137 0.3 0.794 respiratory electron
hs4 LINC02010 -0.137 0.3 0.794
hs4 LINC01085 -0.137 0.3 0.794
xai WNT7A 3p25 -0.137 0.3 0.794 Apoptosis; Oncogenes
hs4 CPSF4L 17q25.1 -0.137 0.3 0.793
his BCAR4 16p13.13 -0.137 0.3 0.793
hs4 SLITRK2 Xq27.3 -0.137 0.3 0.793 axonogenesis
his SAMMSON -0.137 0.3 0.793
hs4 LINC01152 -0.137 0.3 0.793
his PHF10 6q27 0.137 0.301 0.794 regulation of transcription, DNA-
hs4 SAMD15 14q24.3 0.137 0.301 0.794
hs4 TMED8 14q24.3 0.137 0.301 0.794 transport
xai LRBA 4q31.3 0.137 0.301 0.794
exp ADGB 6q24.3 0.137 0.301 0.794 proteolysis;oxygen transport
hs4 CCR9 3p21.3 0.137 0.301 0.794 immune response;cellular defense response
xai CREM 10p11.21 0.137 0.301 0.794 cell differentiation;regulation of
his F5 1q23 0.137 0.301 0.794 platelet degranulation;cell adhesion
hs4 NBPF3 1p36.12 0.137 0.301 0.794
his STAG3L3 0.137 0.301 0.794
his PMS2P7 0.137 0.301 0.794
xai KCNAB3 17p13.1 0.137 0.301 0.794 potassium ion transport;synaptic
transmission
his DNAJA3 16p13.3 0.137 0.301 0.794 Apoptosis
exp IGHV3-6 0.137 0.301 0.794
xai RPS27P14 5q13.2 0.137 0.301 0.794
xai KRASP1 6p12.1 0.137 0.301 0.794
cop MIR554 0.137 0.301 0.794
exp SMPD4P1 22q11.21 0.137 0.301 0.794
exp LOC100506667 0.137 0.301 0.794
hs4 DDX1 2p24 0.137 0.301 0.794 regulation of translational
his TSPAN12 7q31.31 0.137 0.301 0.794 regulation of angiogenesis;cell
xai TPCN2 11q13.3 0.137 0.301 0.794 ion transport;cellular calcium ion
homeostasis
exp RPS27P14 5q13.2 0.137 0.301 0.794
hs4 DUS4L 7q22-q31 0.137 0.301 0.794 tRNA processing
hs4 COG5 7q31 0.137 0.301 0.794 intra-Golgi vesicle-mediated transport;protein
transport
his ZNF518A 10q24.1 0.137 0.301 0.794 regulation of transcription, DNA-
dependent"
swa PSMD3 17q21.1 0.137 0.301 0.794 S phase of mitotic cell cycle;DNA damage
exp GC 4q12-q13 0.137 0.301 0.794 steroid metabolic process;vitamin D
metabolic process
xai SMG9 19q13.31 0.137 0.301 0.794 nuclear-transcribed mRNA catabolic
his RHCG 15q25 0.137 0.301 0.794 transmembrane transport;transepithelial
ammonium transport
exp RPS3AP26 0.137 0.301 0.794
his ANXA7 10q22.2 0.137 0.301 0.794 cellular calcium ion
swa ZFYVE16 5q14 0.137 0.301 0.794 protein targeting to lysosome;signal
transduction
his MMP1 11q22.3 0.137 0.301 0.794 Apoptosis
xai TRIM24 7q32-q34 0.137 0.301 0.794 negative regulation of cell
hs4 CLIC1 6p21.3 0.137 0.301 0.794 transport;ion transport
hs4 CUL2 10p11.21 0.137 0.301 0.794 Apoptosis
his WHAMMP1 15q13.3 0.137 0.301 0.794
his LOC100996255 0.137 0.301 0.794
xai CMIP 16q23 0.137 0.301 0.794
exp SETP7 0.137 0.301 0.794
his RSPO4 20p13 0.137 0.301 0.794 Wnt receptor signaling pathway;response to
stimulus
hs4 ERP29 12q24.13 0.137 0.301 0.794 protein folding;intracellular protein
transport
hs4 TMEM116 12q24.13 0.137 0.301 0.794
exp UBR4 1p36.13 0.137 0.301 0.794 Tumor Suppressors
xai FHIT 3p14.2 0.137 0.301 0.794 diadenosine triphosphate catabolic
his WDR89 14q23.2 0.137 0.301 0.794
xai RPS3AP26 0.137 0.301 0.794
mut IQGAP2 5q13.3 0.136 0.301 0.794 signal transduction;regulation of
met ARSB 5q14.1 0.136 0.301 0.794 central nervous system
development;response to nutrient
xsq CMAS 12p12.1 0.136 0.301 0.794 lipopolysaccharide biosynthetic process
cop CGN 1q21 0.136 0.301 0.794
xsq LOC101927272 0.136 0.301 0.794
cop GTF2A1L 2p16.3 0.136 0.301 0.794
xsq WASH2P 0.136 0.301 0.794
xsq CCDC115 2q21.1 0.136 0.301 0.794
met RHOJ 14q23.2 0.136 0.301 0.794 GTP catabolic process;small GTPase
cop COPS2 15q21.2 0.136 0.301 0.794 DNA Damage Response (DDR)
met MFAP3 5q32-q33.2 0.136 0.301 0.794
exp XKRY2 0.136 0.301 0.794
cop PIN4 Xq13 0.136 0.301 0.794 rRNA processing;protein folding
xsq C6orf118 6q27 0.136 0.301 0.794
xsq PROC 2q13-q14 0.136 0.301 0.794 peptidyl-glutamic acid
mut KIF23 15q23 0.136 0.301 0.794 M phase of mitotic cell cycle;positive
xsq F8A1 0.136 0.301 0.794
met SIRPA 20p13 0.136 0.301 0.794 cell adhesion;blood coagulation
exp BEND5 1p33 0.136 0.301 0.794
mut PPP2R4 9q34 0.136 0.301 0.794 Apoptosis
xsq LYPLA1 8q11.23 0.136 0.301 0.794 lipid metabolic process;fatty acid
metabolic process
cop PAK6 15q14 0.136 0.301 0.794 Protein Kinases
exp CD8BP 2q12.1 0.136 0.301 0.794
exp POTEM 0.136 0.301 0.794
mut LRFN3 19q13.12 0.136 0.301 0.794 cell adhesion
cop GRIA3 Xq25 0.136 0.301 0.794 regulation of receptor recycling;transport
xsq RTBDN 19p12 0.136 0.301 0.794
cop APBA2 15q11-q12 0.136 0.301 0.794 nervous system development;protein
transport
xsq NEBL 10p12 0.136 0.301 0.794 cardiac muscle thin filament assembly
cop SPR 2p14-p12 0.136 0.301 0.794 nitric oxide metabolic process;regulation
of nitric-oxide synthase activity
met ICK 6p12.1 0.136 0.301 0.794 multicellular organismal
xsq CCDC74B 2q21.1 0.136 0.301 0.794
xsq UNC79 14q32.12 0.136 0.301 0.794
cop LUC7L3 17q21.33 0.136 0.301 0.794 mRNA processing;apoptotic process
met TEX261 2p13.3 0.136 0.301 0.794 positive regulation of apoptotic
process
xsq OR51G2 0.136 0.301 0.794
exp EOMES 3p24.1 0.136 0.301 0.794 mesoderm formation;positive regulation of
mut SPG11 15q14 0.136 0.301 0.794 cell death
cop GAB2 11q14.1 0.136 0.301 0.794 transmembrane receptor protein tyrosine
kinase signaling pathway;positive regulation of cell proliferation
xsq UBQLN4 1q21 0.136 0.301 0.794 regulation of proteasomal ubiquitin-
xsq LINC01003 0.136 0.301 0.794
met MYDGF 0.136 0.301 0.794
cop KIF9-AS1 0.136 0.301 0.794
cop VRK1 14q32 0.136 0.301 0.794 Golgi disassembly;protein phosphorylation
xsq FAM166B 9p13.3 0.136 0.301 0.794
cop RGAG4 Xq13.1 0.136 0.301 0.794
cop FLJ44635 Xq13.1 0.136 0.301 0.794
xsq KIR3DX1 19q13.42 0.136 0.301 0.794
xsq DDX41 5q35.3 0.136 0.301 0.794 Apoptosis
exp NSUN5 7q11.23 0.136 0.301 0.794
met LONRF3 Xq24 0.136 0.301 0.794 proteolysis
cop NHSL2 Xq13.1 0.136 0.301 0.794
cop BNIP2 15q22.2 0.136 0.301 0.794 Apoptosis
mut SERPINA3 14q32.1 0.136 0.301 0.794 regulation of
met TGFB1I1 16p11.2 0.136 0.301 0.794 cell adhesion;ubiquitin-dependent
SMAD protein catabolic process
xsq PSMA5 1p13 0.136 0.301 0.794 mitotic cell cycle;viral reproduction
met EPHB4 7q22 0.136 0.301 0.794 protein autophosphorylation;ephrin receptor
signaling pathway
met SCML1 Xp22 0.136 0.301 0.794 regulation of transcription, DNA-
cop GPR133 12q24.33 0.136 0.301 0.794
xsq TYRO3 15q15 -0.136 0.301 0.794 signal transduction by
xsq LHPP 10q26.13 -0.136 0.301 0.794 protein
cop ENY2 8q23.1 -0.136 0.301 0.794 transport;chromatin modification
xsq PAEP 9q34 -0.136 0.301 0.794 transport;multicellular organismal
development
xsq DYRK1B 19q13.2 -0.136 0.301 0.794 protein
phosphorylation;myoblast fusion
exp ARHGAP5 14q12 -0.136 0.301 0.794 Rho protein signal
transduction;positive regulation of Rho GTPase activity
met MIR135B -0.136 0.301 0.794
exp ZFX Xp21.3 -0.136 0.301 0.794 regulation of transcription, DNA-
dependent"
met RIPK3 14q11.2 -0.136 0.301 0.794 induction of apoptosis by
extracellular signals;protein modification process
xsq BASP1P1 13q12.12 -0.136 0.301 0.794
mut CBARP -0.136 0.301 0.794
xsq FMO5 1q21.1 -0.136 0.301 0.794 oxidation-reduction process
met ARRDC2 19p13.11 -0.136 0.301 0.794
exp UBE2C 20q13.12 -0.136 0.301 0.794 mitosis;phosphatidylinositol-
mediated signaling
xsq CFH 1q32 -0.136 0.301 0.794 complement activation, alternative
met GANAB 11q12.3 -0.136 0.301 0.794 carbohydrate metabolic
met DTWD1 15q21.2 -0.136 0.301 0.794
exp PTGR2 14q24.3 -0.136 0.301 0.794 prostaglandin metabolic process
exp TANGO2 22q11.21 -0.136 0.301 0.794
cop HGSNAT 8p11.1 -0.136 0.301 0.794 protein
exp GALNT3 2q24-q31 -0.136 0.301 0.794 protein O-linked
mut PLEKHN1 1p36.33 -0.136 0.301 0.794
met FSCB 14q21.2 -0.136 0.301 0.794 peptidyl-serine phosphorylation
exp GORASP1 3p22-p21.33 -0.136 0.301 0.794 M phase of mitotic cell
cycle;mitotic prophase
mut RPS6KA3 Xp22.2-p22.1 -0.136 0.301 0.794 Protein Kinases
xsq STEAP3 2q14.2 -0.136 0.301 0.794 ion transport;cellular iron
ion homeostasis
mut LDHC 11p15.1 -0.136 0.301 0.794 glycolysis;cellular carbohydrate
metabolic process
xsq LINC00545 -0.136 0.301 0.794
exp ZNF883 9q32 -0.136 0.301 0.794 regulation of transcription, DNA-
dependent"
exp TIRAP 11q24.2 -0.136 0.301 0.794 MyD88-dependent toll-like receptor
signaling pathway;positive regulation of interleukin-12 production
xsq USP40 2q37.1 -0.136 0.301 0.794 proteolysis;ubiquitin-dependent
xsq CDKL5 Xp22 -0.136 0.301 0.794 protein autophosphorylation;regulation of
dendrite development
xsq LETM2 8p11.23 -0.136 0.301 0.794
exp FXYD1 19q13.1 -0.136 0.301 0.794 ion transport;chloride transport
cop TNC 9q33 -0.136 0.301 0.794 positive regulation of gene
mut ALPK2 18q21.31 -0.136 0.301 0.794 protein phosphorylation
cop PCDH20 13q21 -0.136 0.301 0.794 cell adhesion;homophilic cell
adhesion
mut VPS18 15q14-q15 -0.136 0.301 0.794 intracellular protein
xsq TRAM1 8q13.3 -0.136 0.301 0.794 translation;cotranslational protein
xai CILP 15q22 -0.137 0.301 0.794 negative regulation of insulin-like
his AFF4 5q31 -0.137 0.301 0.794 spermatid development;regulation of
his ELOVL3 10q24.32 -0.137 0.301 0.794 fatty acid elongation,
monounsaturated fatty acid;fatty acid elongation, polyunsaturated fatty acid
hs4 MPZL2 11q24 -0.137 0.301 0.794 T cell differentiation in
cop ZNF818P 19q13.42 -0.137 0.301 0.794 regulation of transcription,
DNA-dependent"
xai EXOC6B 2p13.2 -0.137 0.301 0.794 protein transport;vesicle
his MIR1208 -0.137 0.301 0.794
hs4 ACKR4 3q22 -0.137 0.301 0.794
hs4 WSB2 12q24.23 -0.137 0.301 0.794 intracellular signal transduction
his LINC02026 -0.137 0.301 0.794
hs4 CCDC170 6q25.1 -0.137 0.301 0.794
his PTAFR 1p35-p34.3 -0.137 0.301 0.794 pattern recognition receptor
his TCN1 11q11-q12 -0.137 0.301 0.794 cobalt ion transport;cobalamin
metabolic process
hs4 DKFZP434A062 9q34.3 -0.137 0.301 0.794
hs4 GPSM1 9q34.3 -0.137 0.301 0.794 signal transduction;multicellular
his MIR4682 -0.137 0.301 0.794
his CCDC63 12q24.11 -0.137 0.301 0.794
swa AGR2 7p21.3 -0.137 0.301 0.794 mucus secretion
xai TDRD7 9q22.33 -0.137 0.301 0.794 lens morphogenesis in camera-type
xai LINGO2 9p21.2 -0.137 0.301 0.794
hs4 A2M 12p13.31 -0.137 0.301 0.794 negative regulation of complement
xai LRP6 12p13.2 -0.137 0.301 0.794 pericardium morphogenesis;neural
his LOC100506085 -0.137 0.301 0.794
hs4 CACNA1S 1q32 -0.137 0.301 0.794 extraocular skeletal muscle
development;neuromuscular junction development
hs4 ASCL5 -0.137 0.301 0.794
exp GCGR 17q25 -0.137 0.301 0.794 regulation of blood pressure;hormone-
exp FLJ37786 1q21 -0.137 0.301 0.794
hs4 PCDHA9 -0.137 0.301 0.794 homophilic cell adhesion;cell
adhesion
his ERFE -0.137 0.301 0.794
his MIR3149 -0.137 0.301 0.794
xai ECT2 3q26.1-q26.2 -0.137 0.301 0.794 positive regulation of Cdc42
hs4 LOC101928509 -0.137 0.301 0.794
exp XIRP2-AS1 -0.137 0.301 0.794
xai PRRG2 19q13.33 -0.137 0.301 0.794 EMT (Epithelial)
xai ARRDC3 5q14.3 -0.137 0.301 0.794 signal transduction
xai PKMP1 1p13.2 -0.137 0.301 0.794
his BANCR -0.137 0.301 0.794
xai XIRP2-AS1 -0.137 0.301 0.794
hs4 C2CD4C 19p13.3 0.137 0.302 0.794
his ALOX12 17p13.1 0.137 0.302 0.794 leukotriene biosynthetic
process;positive regulation of endothelial cell differentiation
xai TMEM26 10q21.2 0.137 0.302 0.794
exp SLC38A11 2q24.3 0.137 0.302 0.794 ion transport;sodium ion transport
xai LOC100132167 0.137 0.302 0.794
hs4 RPL4 15q22 0.137 0.302 0.794 translational initiation;viral infectious cycle
hs4 SNORD18C 0.137 0.302 0.794
hs4 SNORD18B 0.137 0.302 0.794
hs4 SNORD16 0.137 0.302 0.794
hs4 SNORD18A 15q22 0.137 0.302 0.794
hs4 ZWILCH 15q22.31 0.137 0.302 0.794 DNA Damage Response (DDR)
exp PDE6G 17q25 0.137 0.302 0.794 activation of MAPK activity;blood coagulation
his MIR182 0.137 0.302 0.794
cop RUNDC3A 17q21.31 0.137 0.302 0.794 small GTPase mediated signal
transduction
cop STK11 19p13.3 0.137 0.302 0.794 Cell Signaling; Oncogenes; Protein
Kinases; Tumor Suppressors
cop C19orf26 19p13.3 0.137 0.302 0.794
cop ATP5D 19p13.3 0.137 0.302 0.794 ATP catabolic process;ATP biosynthetic
process
cop MIDN 19p13.3 0.137 0.302 0.794
xai LOC100506667 0.137 0.302 0.794
xai CDH9 5p14 0.137 0.302 0.794 homophilic cell adhesion;cell-cell adhesion
his SYVN1 11q13 0.137 0.302 0.794 ER-associated protein catabolic
xai CLDN19 1p34.2 0.137 0.302 0.794 neuronal action potential
his RRP7A 22q13.2 0.137 0.302 0.794
exp LINC00305 18q22.1 0.137 0.302 0.794
xai RPS24 10q22 0.137 0.302 0.794 translation;mRNA metabolic process
hs4 CHTF8 16q22.1 0.137 0.302 0.794 DDR (DNA replication)
hs4 UTP4 0.137 0.302 0.794
xai DEFB116 20q11.21 0.137 0.302 0.794 defense response to bacterium
dependent"
xai MIR601 0.137 0.302 0.794
exp MIR601 0.137 0.302 0.794
hs4 CTNNA3 10q22.2 0.137 0.302 0.794 cell-cell adhesion
xai SLN 11q22.3 0.137 0.302 0.794 calcium ion transport;regulation of
xai GKN1 2p13.3 0.137 0.302 0.794 digestion;positive regulation of cell
proliferation
his PRF1 10q22 0.137 0.302 0.794 defense response to tumor cell;defense response
to virus
his GPR182 12q13.3 0.137 0.302 0.794 response to hypoxia;cell surface
his RANBP9 6p23 0.137 0.302 0.794 protein complex assembly;microtubule
nucleation
his GNRH2 20p13 0.137 0.302 0.794 multicellular organismal development;signal
transduction
his MRPS26 20p13 0.137 0.302 0.794 DNA damage response, detection of DNA
hs4 C11orf72 0.137 0.302 0.794
hs4 NDUFV1 11q13 0.137 0.302 0.794 mitochondrial electron transport, NADH to
ubiquinone;transport
xai IRX4 5p15.3 0.137 0.302 0.794 heart development;establishment of organ
orientation
xsq PLAGL2 20q11.21 0.136 0.302 0.794 positive regulation of
dependent
cop ZMYM3 Xq13.1 0.136 0.302 0.794 multicellular organismal
cop NONO Xq13.1 0.136 0.302 0.794 DNA repair;DNA recombination
cop ITGB1BP2 Xq12-q13.1 0.136 0.302 0.794 muscle organ development;signal
transduction
cop TAF1 Xq13.1 0.136 0.302 0.794 regulation of transcription involved in
cop INGX Xq12 0.136 0.302 0.794
cop OGT Xq13 0.136 0.302 0.794 induction of apoptosis;histone H4-K8
acetylation
cop ACRC Xq13.1 0.136 0.302 0.794
cop CXCR3 Xq13 0.136 0.302 0.794 cellular component movement;chemotaxis
cop LINC00891 0.136 0.302 0.794
cop LOC100132741 0.136 0.302 0.794
cop CXorf49 0.136 0.302 0.794
cop CXorf49B 0.136 0.302 0.794
xsq ZRSR2 Xp22.1 0.136 0.302 0.794 RNA splicing;spliceosome assembly
exp GPA33 1q24.1 0.136 0.302 0.794
cop ZC3H8 2q13 0.136 0.302 0.794 apoptotic process;negative regulation of T cell
xsq FBXW9 19p13.2 0.136 0.302 0.794
exp MTR 1q43 0.136 0.302 0.794 protein methylation;tetrahydrofolate metabolic
process
cop FBF1 17q25.1 0.136 0.302 0.794 apical junction assembly;establishment of
met PABPC1 8q22.2-q23 0.136 0.302 0.794 nuclear-transcribed mRNA catabolic
process, deadenylation-dependent decay;RNA metabolic process
met SH2D4A 8p21.2 0.136 0.302 0.794 negative regulation of phosphatase
activity
cop NPM3 10q24.31 0.136 0.302 0.794 rRNA transcription;rRNA processing
cop MGEA5 10q24.1-q24.3 0.136 0.302 0.794 N-acetylglucosamine metabolic
xsq SELE 1q22-q25 0.136 0.302 0.794 activation of phospholipase C
activity;positive regulation of receptor internalization
xsq CTRC 1p36.21 0.136 0.302 0.794 proteolysis
xsq ABHD10 3q13.2 0.136 0.302 0.794 proteolysis
xsq GAK 4p16 0.135 0.302 0.794 cell cycle
cop SERPINA1 14q32.1 0.135 0.302 0.794 response to lead ion;response to
triglyceride
cop SERPINA11 14q32.13 0.135 0.302 0.794 negative regulation of
exp PSMD14 2q24.2 0.135 0.302 0.794 G1/S transition of mitotic cell
met SDCCAG3 9q34.3 0.135 0.302 0.794
xsq CKMT1B 15q15 0.135 0.302 0.794
cop TINAGL1 1p35.2 0.135 0.302 0.794 proteolysis;immune response
cop HCRTR1 1p33 0.135 0.302 0.794 neuropeptide signaling pathway;synaptic
transmission
cop PEF1 1p34 0.135 0.302 0.794 response to calcium ion
cop COL16A1 1p35-p34 0.135 0.302 0.794 cell adhesion;integrin-mediated
signaling pathway
cop BAI2 1p35 0.135 0.302 0.794
cop MIR4254 0.135 0.302 0.794
cop SPOCD1 1p35.2 0.135 0.302 0.794 transcription, DNA-
xsq TONSL 8q24.3 0.135 0.302 0.794 DNA Damage Response (DDR)
met PLEKHG1 6q25.1 0.135 0.302 0.794 regulation of Rho protein signal
transduction
xsq LOC101927305 0.135 0.302 0.794
exp FAF2P1 10q23.32 0.135 0.302 0.794
cop HMX1 4p16.1 0.135 0.302 0.794 multicellular organismal
cop LOC650293 0.135 0.302 0.794
cop USP17L10 0.135 0.302 0.794
cop USP17L11 0.135 0.302 0.794
cop USP17L20 0.135 0.302 0.794
cop USP17L18 0.135 0.302 0.794
cop USP17L12 0.135 0.302 0.794
cop USP17L21 0.135 0.302 0.794
cop USP17L13 0.135 0.302 0.794
cop USP17L15 0.135 0.302 0.794
cop USP17L17 0.135 0.302 0.794
cop USP17L19 0.135 0.302 0.794
cop USP17L22 0.135 0.302 0.794
cop USP17L24 0.135 0.302 0.794
cop USP17L26 0.135 0.302 0.794
cop USP17L29 0.135 0.302 0.794
cop USP17L28 0.135 0.302 0.794
cop USP17L27 0.135 0.302 0.794
cop USP17L30 0.135 0.302 0.794
cop USP17L5 0.135 0.302 0.794
cop USP17L25 0.135 0.302 0.794
cop USP17L9P 0.135 0.302 0.794
cop USP17L6P 0.135 0.302 0.794
xsq CNST 1q44 0.135 0.302 0.794 negative regulation of phosphatase
exp ADAL 15q15.3 0.135 0.302 0.794 adenosine catabolic process;nucleotide
metabolic process
met RDH13 19q13.42 0.135 0.302 0.794
xsq STK35 20p13 0.135 0.302 0.794
met PAK1 11q13-q14 0.135 0.302 0.794 Apoptosis; Protein Kinases
met SLC6A2 16q12.2 0.135 0.302 0.794 synaptic transmission;monoamine
transport
exp KLRAP1 12p13.2 0.135 0.302 0.794
cop GAS2L3 12q23.1 0.135 0.302 0.794 cell cycle arrest
xsq OR7D4 0.135 0.302 0.794
xsq C19orf43 19p13.2 0.135 0.302 0.794
met MIR329-1 0.135 0.302 0.794
met CCDC153 11q23.3 0.135 0.302 0.794
met TVP23B 17p11.2 0.135 0.302 0.794
xsq BCRP3 22q11.23 0.135 0.302 0.794
cop CEMIP 0.135 0.302 0.794
met LYPD3 19q13.31 0.135 0.302 0.794
met NECAP2 1p36.13 0.135 0.302 0.794 endocytosis;protein transport
xsq TMF1 3p21-p12 -0.135 0.302 0.794 regulation of transcription, DNA-
xsq LPAL2 6q26-q27 -0.135 0.302 0.794
exp SSH1 12q24.11 -0.135 0.302 0.794 protein
exp ZFHX4-AS1 8q21.11 -0.135 0.302 0.794
mir hsa-miR-30c-2* -0.135 0.302 0.794
xsq MSI1 12q24 -0.135 0.302 0.794 nervous system development;response to
hormone stimulus
exp TP53I11 11p11.2 -0.135 0.302 0.794 response to stress;negative
xsq HDLBP 2q37.3 -0.135 0.302 0.794 lipid transport;steroid metabolic
process
DNA-dependent"
xsq LRP12 8q22.2 -0.135 0.302 0.794 EMT (Mesenchymal)
exp KRT18P2 21q21.1 -0.135 0.302 0.794
met TTC4 1p32.3 -0.135 0.302 0.794
exp CTNNA2 2p12-p11.1 -0.135 0.302 0.794 radial glia guided migration
of Purkinje cell;muscle cell differentiation
cop PRKX Xp22.3 -0.135 0.302 0.794 cell adhesion;protein
autophosphorylation
xsq NKAIN4 20q13.33 -0.135 0.302 0.794
cop MICAL3 22q11.21 -0.135 0.302 0.794
cop FAF1 1p33 -0.135 0.302 0.794 Apoptosis
met GNAT2 1p13.1 -0.135 0.302 0.794 elevation of cytosolic calcium ion
xsq SEL1L3 4p15.2 -0.135 0.302 0.794
cop MXRA5 Xp22.33 -0.136 0.302 0.794
met XPNPEP3 22q13.2 -0.136 0.302 0.794 proteolysis;cellular process
met MIR604 -0.136 0.302 0.794
xsq ADH7 4q23-q24 -0.136 0.302 0.794 ethanol oxidation;xenobiotic
metabolic process
cop TP53INP2 20q11.22 -0.136 0.302 0.794
cop NCOA6 20q11 -0.136 0.302 0.794 DNA replication;myeloid cell
differentiation
exp MORN5 9q33.2 -0.136 0.302 0.794
mir hsa-miR-222 -0.136 0.302 0.794
exp BIN3-IT1 -0.136 0.302 0.794
exp LOC644387 7q11.21 -0.136 0.302 0.794
cop RNLS 10q23.31 -0.136 0.302 0.794
his NRG1-IT1 -0.137 0.302 0.794
xai KRBOX4 Xp11.3 -0.137 0.302 0.794
his TRPM1 15q13.3 -0.137 0.302 0.794 visual perception;response to
stimulus
hs4 VPS37C 11q12.2 -0.137 0.302 0.794 protein transport;viral
reproduction
his ZNF626 19p12 -0.137 0.302 0.794 regulation of transcription, DNA-
dependent"
hs4 GPAT3 -0.137 0.302 0.794 phospholipid biosynthetic
DNA-dependent"
exp RNF157-AS1 -0.137 0.302 0.794
xai HSD3B1 1p13.1 -0.137 0.302 0.794 steroid biosynthetic
his SBSPON 8q21.11 -0.137 0.302 0.794
his LOC105376480 -0.137 0.302 0.794
hs4 LINC01629 -0.137 0.302 0.794
swa GLG1 16q22.3 -0.137 0.302 0.794 negative regulation of protein
signaling pathway
hs4 LRAT 4q32.1 -0.137 0.302 0.794 visual perception;steroid metabolic
process
his SVIL 10p11.2 -0.137 0.302 0.794 cytoskeleton organization;skeletal
hs4 FEM1C 5q22 -0.137 0.302 0.794
xai KRT18P34 3q25.31 -0.137 0.302 0.794
exp FBN3 19p13 -0.137 0.302 0.794
xai CCDC24 1p34.1 -0.137 0.302 0.794
exp ZPBP -0.137 0.302 0.794 binding of sperm to zona pellucida
xai GOLGA7B 10q24.2 -0.137 0.302 0.794
hs4 PDE4A 19p13.2 -0.137 0.302 0.794 response to drug;cAMP catabolic
process
his PRM3 16p13.3 -0.137 0.302 0.794 multicellular organismal
his PRM2 16p13.2 -0.137 0.302 0.794
hs4 ATP6V1B1 2p13.1 -0.137 0.302 0.794 ossification;transferrin
transport
xai FKBP14 7p14.3 -0.137 0.302 0.794 protein folding;activation of
DNA-dependent"
his MAP2K4 17p12 -0.137 0.302 0.794 Cell Signaling; Protein Kinases;
Tumor Suppressors
cop DPRX 19q13.42 -0.138 0.302 0.794
cop RBMY1A3P -0.165 0.302 0.794
hs4 TMX3 18q22 0.137 0.303 0.795 glycerol ether metabolic process;cell redox
homeostasis
hs4 CCDC102B 18q22.1 0.137 0.303 0.795
xai CLN6 15q23 0.137 0.303 0.795 protein catabolic process;glycosaminoglycan
metabolic process
xai CNTFR 9p13 0.137 0.303 0.795 positive regulation of cell
xai ALDOAP2 0.136 0.303 0.795
his LOC105374952 0.136 0.303 0.795
his NUP153 6p22.3 0.136 0.303 0.795 carbohydrate metabolic
hs4 PRMT8 12p13.3 0.136 0.303 0.795 histone methylation;peptidyl-arginine
methylation
hs4 THCAT155 0.136 0.303 0.795
xai OR11H4 14q11.2 0.136 0.303 0.795 response to stimulus
exp LINC01252 0.136 0.303 0.795
xai ZBTB21 21q22.3 0.136 0.303 0.795
his RNF7 3q22-q24 0.136 0.303 0.795 Apoptosis
his AMZ2 17q24.2 0.136 0.303 0.795 proteolysis
exp LRRC25 0.136 0.303 0.795
his TFB2M 1q44 0.136 0.303 0.795 transcription from mitochondrial
his CNST 1q44 0.136 0.303 0.795 negative regulation of phosphatase
hs4 NAAA 4q21.1 0.136 0.303 0.795 lipid metabolic process
his MIR1976 0.136 0.303 0.795
his METTL16 17p13.3 0.136 0.303 0.795
xai LOC101448202 0.136 0.303 0.795
his ZNHIT2 11q13 0.136 0.303 0.795
his FAU 11q13 0.136 0.303 0.795 translational initiation;viral infectious cycle
hs4 KHNYN 14q12 0.136 0.303 0.795
hs4 CBLN3 14q12 0.136 0.303 0.795
xai LOC400968 0.136 0.303 0.795
xai LRRC20 10q22.1 0.136 0.303 0.795
his RPL31 2q11.2 0.136 0.303 0.795 translational initiation;viral infectious
cycle
swa TMPO_P42167 0.136 0.303 0.795
his P2RX4 12q24.32 0.136 0.303 0.795 response to stress;response to ATP
exp LOC392364 9q22.1 0.136 0.303 0.795
xai ASB7 15q26.3 0.136 0.303 0.795 intracellular signal transduction
his SIRT1 10q21.3 0.136 0.303 0.795 Apoptosis; DNA Damage Response (DDR)
swa SMARCC2 12q13.2 0.136 0.303 0.795 DNA Damage Response (DDR); DDR
(Chromatin)
xsq HIST1H2AM 6p22.1 0.135 0.303 0.795
met OR5M1 11q12.1 0.135 0.303 0.795
cop LCLAT1 2p23.1 0.135 0.303 0.795 multicellular organismal
cop ARNT 1q21 0.135 0.303 0.795 cell differentiation;positive regulation of
exp SARS2 19q13.2 0.135 0.303 0.795 tRNA aminoacylation for protein
exp C7orf43 7q22.1 0.135 0.303 0.795
met DPYD 1p22 0.135 0.303 0.795 thymidine catabolic process;UMP biosynthetic
process
met FREM2 13q13.3 0.135 0.303 0.795 homophilic cell adhesion;multicellular
met DNAJC3 13q32.1 0.135 0.303 0.795 response to virus;endoplasmic
exp ARX Xp21.3 0.135 0.303 0.795 axon guidance;regulation of cell
proliferation
mut MAP2 2q34-q35 0.135 0.303 0.795 microtubule bundle formation;negative
regulation of microtubule depolymerization
xsq KIAA1211 4q12 0.135 0.303 0.795
exp TMEM181 6q25.3 0.135 0.303 0.795 pathogenesis
xsq SOX12 20p13 0.135 0.303 0.795 spinal cord development;cell fate commitment
exp DECR2 16p13.3 0.135 0.303 0.795 unsaturated fatty acid biosynthetic
process
met CA5B Xp21.1 0.135 0.303 0.795 one-carbon metabolic process;metabolic
process
cop DAK 11q12.2 0.135 0.303 0.795
exp PNN 14q21.1 0.135 0.303 0.795 nuclear mRNA splicing, via
xsq FAM172BP 3q12.3 0.135 0.303 0.795
xsq SF3B2 11q13.1 0.135 0.303 0.795 nuclear mRNA splicing, via
xsq BRWD1 21q22.2 0.135 0.303 0.795 regulation of transcription from RNA
polymerase II promoter;cytoskeleton organization
cop GALK2 15q21.1-q21.2 0.135 0.303 0.795 carbohydrate metabolic
exp PIM3 22q13 0.135 0.303 0.795 cell cycle;regulation of mitotic cell cycle
exp PARN 16p13 0.135 0.303 0.795 RNA modification;gene expression
exp LINC01558 0.135 0.303 0.795
xsq WASH3P 15q26.3 0.135 0.303 0.795 transport;endosome transport
xsq RAB28 4p15.33 0.135 0.303 0.795 GTP catabolic process;small GTPase
cop SMEK1 14q32.12 0.135 0.303 0.795
cop CATSPERB 14q32.12 0.135 0.303 0.795 multicellular organismal
cop C16orf46 16q23.2 0.135 0.303 0.795
cop GAS1 9q21.3-q22 0.135 0.303 0.795 cell cycle;cellular response to vascular
endothelial growth factor stimulus
met ADH1C 4q23 0.135 0.303 0.795 ethanol oxidation;xenobiotic metabolic process
cop HECTD4 12q24.13 0.135 0.303 0.795
met DNMBP 10q24.2 0.135 0.303 0.795 regulation of Rho protein signal
cop SCNN1G 16p12 0.135 0.303 0.795 response to stimulus;sensory perception
of taste
met METRNL 17q25.3 0.135 0.303 0.795
exp DISP2 15q15.1 0.135 0.303 0.795 smoothened signaling pathway
exp TTC4P1 7p13 0.135 0.303 0.795
xsq PSMG4 6p25.2 0.135 0.303 0.795
met GHR 5p13-p12 0.135 0.303 0.795 succinate metabolic process;hormone-
met SMOC1 14q24.2 -0.135 0.303 0.795 eye development;signal transduction
met RHD 1p36.11 -0.135 0.303 0.795
xsq NPFFR2 4q21 -0.135 0.303 0.795 G-protein coupled receptor
signaling pathway;detection of abiotic stimulus
xsq PCDHGB2 -0.135 0.303 0.795 homophilic cell adhesion;cell
adhesion
exp LOC100128035 3q13.2 -0.135 0.303 0.795
exp BBS12 4q27 -0.135 0.303 0.795 cellular protein metabolic
process;chaperone-mediated protein complex assembly
xsq BLOC1S1-RDH5 -0.135 0.303 0.795
DNA-dependent"
xsq HOOK3 8p11.21 -0.135 0.303 0.795 cytoplasmic microtubule
exp HOOK2 19p13.2 -0.135 0.303 0.795 early endosome to late endosome
xsq FLOT1 6p21.3 -0.135 0.303 0.795
cop RBL1 20q11.2 -0.135 0.303 0.795 G1 phase of mitotic cell
xsq C6orf15 6p21.3 -0.135 0.303 0.795 extracellular matrix
organization
exp FAM218A 4q32.3 -0.135 0.303 0.795
exp P2RX6P 22q11.21 -0.135 0.303 0.795
met CXorf38 Xp11.4 -0.135 0.303 0.795
cop ATR 3q23 -0.135 0.303 0.795 DNA Damage Response (DDR); DDR (G1-S
checkpoint); DDR (DNA replication); Protein Kinases
cop ANAPC13 3q22.2 -0.135 0.303 0.795 cell cycle;mitosis
cop CEP63 3q22.2 -0.135 0.303 0.795 mitosis;signal transduction in
response to DNA damage
cop KY 3q22.2 -0.135 0.303 0.795 proteolysis
mut AGRP 16q22 -0.135 0.303 0.795
exp ARF6 14q21.3 -0.135 0.303 0.795 GTP catabolic process;cell
differentiation
cop CXorf28 -0.135 0.303 0.795
xsq OCA2 15q -0.135 0.303 0.795 melanin biosynthetic
process;developmental pigmentation
xsq STC1 8p21-p11.2 -0.135 0.303 0.795 cell-cell signaling;cellular
response to hypoxia
exp CASP4 11q22.2-q22.3 -0.135 0.303 0.795 Apoptosis
xsq PTGFR 1p31.1 -0.135 0.303 0.795 G-protein coupled receptor
signaling pathway;parturition
exp KLF11 2p25 -0.135 0.303 0.795 negative regulation of cell
exp NXPH2 2q22.1 -0.135 0.303 0.795 neuropeptide signaling pathway
met ADORA2A 22q11.23 -0.135 0.303 0.795 G-protein signaling, coupled
to cAMP nucleotide second messenger;activation of adenylate cyclase activity
exp CEBPD 8p11.2-p11.1 -0.135 0.303 0.795 transcription from RNA
met ANKRD55 5q11.2 -0.135 0.303 0.795
xsq BTBD19 1p34.1 -0.135 0.303 0.795
xsq NPAS2 2q11.2 -0.135 0.303 0.795 regulation of transcription, DNA-
met POU2F2 19q13.2 -0.135 0.303 0.795 regulation of transcription,
exp HOXB6 17q21.3 -0.135 0.303 0.795 multicellular organismal
exp C16orf92 16p11.2 -0.135 0.303 0.794
xai TUBA3GP 22q11.21 -0.136 0.303 0.795
xai HMGCL 1p36.1-p35 -0.136 0.303 0.795 response to starvation;cellular
his LRRC73 6p21.1 -0.136 0.303 0.795
his GJC1 17q21.31 -0.136 0.303 0.795 muscle contraction;cell-cell
junction assembly
xai GADD45G 9q22.1-q22.2 -0.136 0.303 0.795 DNA Damage Response
(DDR); DDR (BER)
DNA-dependent"
his LINC01231 -0.136 0.303 0.795
xai METRN 16p13.3 -0.136 0.303 0.795 multicellular organismal
hs4 IL11 19q13.3-q13.4 -0.136 0.303 0.795 positive regulation of cell
proliferation;negative regulation of hormone secretion
exp LOC100302666 -0.136 0.303 0.795
xai SOWAHA 5q31.1 -0.136 0.303 0.795
hs4 OBSL1 2q35 -0.136 0.303 0.795 cardiac myofibril assembly;cytoskeleton
organization
hs4 INHA 2q35 -0.136 0.303 0.795 Apoptosis
xai LOC441204 7p15.2 -0.136 0.303 0.795
xai OVOL2 20p11.23 -0.136 0.303 0.795 dorsal/ventral pattern
formation;regulation of cell cycle
hs4 KCNJ10 1q23.2 -0.136 0.303 0.795 response to blue
swa IFI35 17q21 -0.136 0.303 0.795 response to virus;cytokine-mediated
signaling pathway
his LOC102723833 -0.136 0.303 0.795
xai NATD1 -0.136 0.303 0.795
his NCAM1 11q23.1 -0.136 0.303 0.795 interferon-gamma-mediated signaling
his LOC101928847 -0.136 0.303 0.795
his CRYAA 21q22.3 -0.136 0.303 0.795
xai PJA1 Xq13.1 -0.136 0.303 0.795 protein catabolic process
his NRG1-IT3 -0.136 0.303 0.795
hs4 GOLGA2P10 -0.136 0.303 0.795
xai PINK1 1p36 -0.137 0.303 0.795 positive regulation of synaptic
swa FAM129A 1q25 -0.137 0.303 0.795 positive regulation of protein
xai FAM218A 4q32.3 -0.137 0.303 0.795
his SPAG6 10p12.2 0.136 0.304 0.795 spermatid development;cell projection
organization
swa MRPL21 11q13.3 0.136 0.304 0.796 translation
his EIF1AX-AS1 0.136 0.304 0.796
his EIF1AX Xp22.12 0.136 0.304 0.796 translation;translational
initiation
xai TTC32 2p24.1 0.136 0.304 0.796
his LINC00290 0.136 0.304 0.796
xai OTOS 2q37.3 0.136 0.304 0.796 sensory perception of sound
his PATL2 15q21.1 0.136 0.304 0.796 negative regulation of translation
hs4 ZNF770 15q14 0.136 0.304 0.796 regulation of transcription, DNA-
dependent"
swa SNX17 2p23-p22 0.136 0.304 0.796 receptor-mediated endocytosis;signal
transduction
xai PTP4A1 6q12 0.136 0.304 0.796 multicellular organismal
xai TUBB8P4 12p11.1 0.136 0.304 0.796
his RAB2B 14q11.2 0.136 0.304 0.796 small GTPase mediated signal
his TOX4 14q11.2 0.136 0.304 0.796
exp ZNF37BP 10q11.21 0.136 0.304 0.796
hs4 P2RX4 12q24.32 0.136 0.304 0.796 response to stress;response to ATP
exp COX6CP1 16p12 0.136 0.304 0.796
hs4 FAM120AOS 9q22.31 0.136 0.304 0.796
hs4 FAM120A 9q22.31 0.136 0.304 0.796
exp DKFZP779L1853 12q13.11 0.136 0.304 0.796
cop ATP8B3 19p13.3 0.136 0.304 0.796 ATP catabolic process;cation
transport
his TSPAN7 Xp11.4 0.136 0.304 0.796 interspecies interaction between
organisms
hs4 FAR2P2 0.136 0.304 0.796
xai FAAP20 0.136 0.304 0.796 DNA Damage Response (DDR)
swa SNCA 4q21 0.136 0.304 0.796 Apoptosis
xai CSTA 3q21 0.136 0.304 0.796 cell-cell adhesion;peptide cross-linking
xai PHF21A 11p11.2 0.136 0.304 0.796 suckling behavior;regulation of
xai EXTL2 1p21 0.136 0.304 0.796 N-acetylglucosamine metabolic process;UDP-N-
acetylgalactosamine metabolic process
xai DRG1 22q12.2 0.136 0.304 0.796 transcription, DNA-
xai PHF10 6q27 0.136 0.304 0.796 regulation of transcription, DNA-
xai EIF4G3 1p36.12 0.136 0.304 0.796 translation;regulation of
xai CXCL10 4q21 0.136 0.304 0.796 chemotaxis;positive regulation of cell
proliferation
exp CCDC58P1 18p11.22 0.136 0.304 0.796
his SMARCA1 Xq25 0.136 0.304 0.796 transcription, DNA-dependent;brain
development
xai RUNDC1 17q21.31 0.136 0.304 0.796
exp GLUD1P7 0.136 0.304 0.796
exp DDX59 1q32.1 0.135 0.304 0.795
exp LECT1 13q14.3 0.135 0.304 0.795 negative regulation of vascular
met CSRNP2 12q13.11-q13.12 0.135 0.304 0.796 positive regulation of
transcription from RNA polymerase II promoter;apoptotic process
xsq FOXJ3 1p34.2 0.135 0.304 0.796 regulation of sequence-specific DNA
xsq USF1 1q22-q23 0.135 0.304 0.796 response to hypoxia;positive regulation
met COL4A6 Xq22 0.135 0.304 0.796 cellular response to amino acid
stimulus;cell adhesion
exp FASTKD3 5p15.31 0.135 0.304 0.796 cellular respiration
exp FAM104A 17q25.1 0.135 0.304 0.796
met MRPS28 8q21.1-q21.2 0.135 0.304 0.796
met GABPA 21q21.3 0.135 0.304 0.796 Transcription Factors
cop NDUFAF4P1 0.135 0.304 0.796
cop MIR4716 0.135 0.304 0.796
xsq TESC-AS1 0.135 0.304 0.796
xsq RBM15B 3p21.2 0.135 0.304 0.796 mRNA processing;nucleocytoplasmic
transport
met DCTN1 2p13 0.135 0.304 0.796 G2/M transition of mitotic cell cycle;mitotic
cell cycle
exp MAP3K15 Xp22.12 0.135 0.304 0.796 Protein Kinases
cop TMIE 3p21 0.135 0.304 0.796 sensory perception of sound;inner ear
morphogenesis
xsq CATSPER4 1p35.3 0.135 0.304 0.796
xsq CCAR2 0.135 0.304 0.796 positive regulation of apoptotic
xsq LOC375196 0.135 0.304 0.796
exp POLR3KP2 0.135 0.304 0.796
exp XYLT1 16p12.3 0.135 0.304 0.796 glycosaminoglycan biosynthetic
process;proteoglycan biosynthetic process
met FBF1 17q25.1 0.135 0.304 0.796 apical junction assembly;establishment of
cop LBH 2p23.1 0.135 0.304 0.796 multicellular organismal
cop ACOX1 17q25.1 0.135 0.304 0.796 very long-chain fatty acid metabolic
xsq NEU4 2q37.3 0.135 0.304 0.796 sphingolipid metabolic
met KIR3DX1 19q13.42 0.135 0.304 0.796
xsq HP09025 0.135 0.304 0.796
xsq DIO3OS 14q32.31 0.135 0.304 0.796
cop LINC00642 0.135 0.304 0.796
met TCEAL2 Xq22.1-q22.3 0.135 0.304 0.796 regulation of transcription,
DNA-dependent"
xsq PPT1 1p32 0.135 0.304 0.796 receptor-mediated endocytosis;grooming behavior
exp AS3MT 10q24.32 0.135 0.304 0.796 toxin metabolic process;arsonoacetate
metabolic process
met LINC00341 14q32.13 0.135 0.304 0.796
xsq ZP4 1q43 0.135 0.304 0.796 positive regulation of protein kinase
cop IQGAP3 1q21.3 0.135 0.304 0.796 G1/S transition of mitotic cell
cycle;positive regulation of mammary gland epithelial cell proliferation
xsq SYNPR 3p14.2 0.135 0.304 0.796
mut STKLD1 0.135 0.304 0.796
exp GCH1 14q22.1-q22.2 0.135 0.304 0.796 induction of apoptosis;pteridine-
met NOTCH2NL 1q21.2 0.135 0.304 0.796 Notch signaling
met MIR941-1 0.135 0.304 0.796
met C5orf42 5p13.2 0.135 0.304 0.796
met MAP3K10 19q13.2 0.135 0.304 0.796 Protein Kinases
met LUZP2 11p14.3 0.135 0.304 0.796
cop RMST 12q23.1 0.135 0.304 0.796
cop MIR1251 0.135 0.304 0.796
cop MIR135A2 0.135 0.304 0.796
exp PHF21A 11p11.2 0.135 0.304 0.796 suckling behavior;regulation of
met MIR1973 0.135 0.304 0.796
xsq AGAP1-IT1 -0.135 0.304 0.796
exp GNMT 6p12 -0.135 0.304 0.796 regulation of gluconeogenesis;protein
exp SMIM7 19p13.11 -0.135 0.304 0.796
met ANGPTL4 19p13.3 -0.135 0.304 0.796 Apoptosis
met ZNF839 14q32.31 -0.135 0.304 0.796
xsq RESP18 2q35 -0.135 0.304 0.796
exp PSENEN 19q13.12 -0.135 0.304 0.796 membrane protein ectodomain
proteolysis;positive regulation of catalytic activity
met SNORA30 16p11.2 -0.135 0.304 0.796
cop LOC401164 -0.135 0.304 0.796
cop CTHRC1 8q22.3 -0.135 0.304 0.796 cell migration;positive
xsq TBX19 1q24.2 -0.135 0.304 0.796 regulation of transcription from
RNA polymerase II promoter;anatomical structure morphogenesis
mut GLYCTK 3p21.1 -0.135 0.304 0.796 protein phosphorylation
mut METTL3 14q11.1 -0.135 0.304 0.796 gene expression;RNA
methylation
exp SHC1 1q21 -0.135 0.304 0.796 response to toxin;response to insulin
stimulus
exp ROBO1 3p12 -0.135 0.304 0.796 multicellular organismal development;cell
differentiation
xsq ASB5 4q34.2 -0.135 0.304 0.796 intracellular signal transduction
mut CD248 11q13 -0.135 0.304 0.796
mut PEX5 12p13.31 -0.135 0.304 0.796 protein targeting to
exp DENND2A 7q34 -0.135 0.304 0.796
exp MCOLN2 1p22 -0.135 0.304 0.796 ion transport
cop LOC100144602 -0.135 0.304 0.796
xsq PBLD 10q21.3 -0.135 0.304 0.796 biosynthetic process
xsq NGFR 17q21-q22 -0.135 0.304 0.796 regulation of gene expression;skin
development
exp KRT18P34 3q25.31 -0.135 0.304 0.796
cop SRP19 5q21-q22 -0.135 0.304 0.796 cotranslational protein targeting
to membrane;SRP-dependent cotranslational protein targeting to membrane
met HK1 10q22 -0.135 0.304 0.796 transmembrane transport;carbohydrate
metabolic process
xsq SECTM1 17q25 -0.135 0.304 0.796 immune response;signal transduction
cop FSD1L 9q31 -0.135 0.304 0.796
cop FKTN 9q31-q33 -0.135 0.304 0.796 nervous system development;muscle
organ development
mut SLC22A12 11q13.1 -0.135 0.304 0.796
xsq FOXP1 3p14.1 -0.135 0.304 0.796 positive regulation of
immunoglobulin production;immunoglobulin V(D)J recombination
xsq FUT11 10q22.2 -0.135 0.304 0.795 protein glycosylation
cop NXPH1 7p22 -0.135 0.304 0.795
xsq COL4A4 2q35-q37 -0.135 0.304 0.795 axon guidance;glomerular
basement membrane development
exp IL15RA 10p15.1 -0.135 0.304 0.795 cytokine-mediated signaling
exp VANGL2 1q22-q23 -0.135 0.304 0.795 heart looping;regulation of
actin cytoskeleton organization
hs4 RARB 3p24.2 -0.136 0.304 0.796 signal transduction;gene expression
xai SEC14L5 16p13.3 -0.136 0.304 0.796
his SACS 13q12 -0.136 0.304 0.796 EMT (Mesenchymal)
his ROBO4 11q24.2 -0.136 0.304 0.796 angiogenesis;multicellular
swa CAPG 2p11.2 -0.136 0.304 0.796 protein complex assembly;cell
projection assembly
xai ROBO1 3p12 -0.136 0.304 0.796 multicellular organismal development;cell
differentiation
his NUDT12 5q21.2 -0.136 0.304 0.796 NADP catabolic process;NAD
catabolic process
his TRIM61 4q32.3 -0.136 0.304 0.796
his ZBED2 3q13.2 -0.136 0.304 0.796
hs4 DCAF5 14q23-q24.1 -0.136 0.304 0.796 protein ubiquitination
xai CFLAR-AS1 -0.136 0.304 0.796
exp LOC338667 11q24.2 -0.136 0.304 0.796
xai ATP6V1C2 -0.136 0.304 0.796 transmembrane transport;ATP
catabolic process
his ADGRA3 -0.136 0.304 0.796 G-protein coupled receptor
hs4 LOC101927809 -0.136 0.304 0.796
hs4 MOCOS 18q12 -0.136 0.304 0.796 molybdopterin cofactor metabolic
xai BBOF1 -0.136 0.304 0.796
his RAPGEFL1 17q21.1 -0.136 0.304 0.796 G-protein coupled receptor
his GPR21 9q33 -0.136 0.304 0.796 G-protein coupled receptor signaling
pathway
his MIR4505 -0.136 0.304 0.796
his ELMSAN1 14q24.3 -0.136 0.304 0.796
his LTBR 12p13 -0.136 0.304 0.796 Apoptosis
his LINC00499 -0.136 0.304 0.795
hs4 SERPINE2 2q36.1 -0.136 0.304 0.795 multicellular organismal
hs4 CXorf49B -0.136 0.304 0.795
swa SPP1 4q22.1 -0.136 0.304 0.795 ossification;response to vitamin D
his NTAN1 16p13.11 0.136 0.305 0.796 memory;metabolic process
hs4 UXS1 2q12.2 0.136 0.305 0.796 cellular metabolic process
xai CCDC58P1 18p11.22 0.136 0.305 0.796
exp CLDN19 1p34.2 0.136 0.305 0.796 neuronal action potential
his LOC728084 0.136 0.305 0.796
hs4 APOC2 19q13.2 0.136 0.305 0.796 positive regulation of phospholipase
activity;triglyceride-rich lipoprotein particle remodeling
xai C2orf42 2p13.3 0.136 0.305 0.796
his CCL3L3 0.136 0.305 0.796
hs4 IMPDH1 7q31.3-q32 0.136 0.305 0.796 lymphocyte
hs4 RRN3P3 16p12.2 0.136 0.305 0.796
hs4 SMG1P1 0.136 0.305 0.796
cop MST1 3p21 0.136 0.305 0.796
xai PTPN4 2q14.2 0.136 0.305 0.796 protein dephosphorylation
hs4 DDHD1 14q21 0.136 0.305 0.796 lipid catabolic process
hs4 LOC101927620 0.136 0.305 0.796
exp OR7E15P 0.136 0.305 0.796
hs4 PITPNM1 11q13 0.136 0.305 0.797 protein transport;lipid metabolic process
hs4 CDK2AP2 11q13 0.136 0.305 0.797
swa FANCI 15q26.1 0.136 0.305 0.797 DNA Damage Response (DDR); DDR (FA)
xai IQCH 15q23 0.136 0.305 0.797
his SCD 10q24.31 0.136 0.305 0.797 fatty acid biosynthetic process
xai STAU2 8q21.11 0.136 0.305 0.797 transport
xai SNORA71D 20q11.23 0.136 0.305 0.797
exp SNORA71D 20q11.23 0.136 0.305 0.797
his SAP18 13q12.11 0.136 0.305 0.797 regulation of transcription from RNA
his SALL4 20q13.2 0.136 0.305 0.797 DNA Damage Response (DDR)
hs4 PBK 8p21.2 0.136 0.305 0.797 protein phosphorylation;mitosis
exp NPM1P22 13q21.32 0.136 0.305 0.797
xai ITSN2 2p23.3 0.136 0.305 0.797 endocytosis;regulation of Rho protein
signal transduction
his IFNGR2 21q22.11 0.136 0.305 0.797 cell surface receptor signaling
pathway;response to virus
hs4 QRICH1 3p21.31 0.136 0.305 0.797
swa GAR1 4q25 0.136 0.305 0.797 DNA Damage Response (DDR)
exp ITSN2 2p23.3 0.136 0.305 0.797 endocytosis;regulation of Rho protein
signal transduction
hs4 LINC01425 0.136 0.305 0.797
xsq MAP2K1 15q22.1-q22.33 0.135 0.305 0.796 Oncogenes; Protein Kinases
xsq KAT7 17q21.32 0.135 0.305 0.796 chromatin modification;histone H3
acetylation
xsq NBEAL2 3p21.31 0.135 0.305 0.796 platelet formation
exp CCDC51 3p21.31 0.135 0.305 0.796
met ZRSR2 Xp22.1 0.135 0.305 0.796 RNA splicing;spliceosome assembly
exp EEF1D 8q24.3 0.135 0.305 0.796 cellular protein metabolic
process;translation
met PIAS1 15q 0.135 0.305 0.796 DNA Damage Response (DDR)
xsq SUCLA2 13q12.2-q13.3 0.135 0.305 0.796 succinate metabolic
met ART3 4q21.1 0.135 0.305 0.796 protein ADP-ribosylation
met CDKN1C 11p15.5 0.135 0.305 0.796 positive regulation of transforming
activity
xsq WDPCP 2p15 0.135 0.305 0.796 regulation of embryonic cell shape;cell
xsq CCER1 12q21.33 0.135 0.305 0.796
xsq SLC35E2 0.135 0.305 0.796
mut ERCC3 2q21 0.135 0.305 0.796 Apoptosis; DNA Damage Response (DDR); DDR (NER)
xsq AIRN 0.135 0.305 0.796
cop IL15RA 10p15.1 0.135 0.305 0.796 cytokine-mediated signaling
cop IL2RA 10p15-p14 0.135 0.305 0.796 cell surface receptor signaling
pathway;negative regulation of defense response to virus
cop RBM17 10p15.1 0.135 0.305 0.796 mRNA processing;RNA splicing
cop PFKFB3 10p15.1 0.135 0.305 0.796 Apoptosis
cop MIR3155A 0.135 0.305 0.796
cop MIR3155B 0.135 0.305 0.796
mut DLGAP1 18p11.31 0.135 0.305 0.796 synaptic transmission
xsq LOC101928509 0.135 0.305 0.796
cop NET1 10p15 0.135 0.305 0.796 small GTPase mediated signal
xsq SLC14A2-AS1 0.135 0.305 0.796
met DYSF 2p13.3 0.135 0.305 0.797
mut CLIP4 2p23.2 0.135 0.305 0.797
met SF3B5 6q24.2 0.135 0.305 0.797 nuclear mRNA splicing, via
mut GNA13 17q24.3 0.135 0.305 0.797 cellular component movement;cell
differentiation
dependent"
cop PTP4A2 1p35 0.135 0.305 0.797
cop KHDRBS1 1p32 0.135 0.305 0.797 negative regulation of transcription,
DNA-dependent;G2/M transition of mitotic cell cycle
cop TMEM39B 1p35.1 0.135 0.305 0.797
xsq AMIGO3 3p21 0.135 0.305 0.797 cell adhesion;heterophilic cell-cell
adhesion
exp ATP1A1-AS1 0.135 0.305 0.797
met CCNA2 4q27 0.135 0.305 0.797 DNA Damage Response (DDR); DDR (DNA
replication)
met BLOC1S1 12q13-q14 0.135 0.305 0.797 post-Golgi vesicle-mediated
met IRX6 16q12.2 0.135 0.305 0.797
xsq TCONS_00029157 0.135 0.305 0.797
xsq SLC22A9 11q13.1 0.135 0.305 0.797 transmembrane transport
exp LOC401316 0.135 0.305 0.797
xsq LOC102724301 0.135 0.305 0.797
mut CP 3q23-q25 0.135 0.305 0.797 cellular iron ion
met BEND2 Xp22.13 0.135 0.305 0.797
cop FAH 15q25.1 0.135 0.305 0.797 arginine catabolic process;L-
phenylalanine catabolic process
cop CYB561 17q23.3 0.135 0.305 0.797 generation of precursor metabolites
cop ACE 17q23.3 0.135 0.305 0.797 proteolysis;regulation of vasodilation
dependent"
met FARS2 6p25.1 0.135 0.305 0.797 tRNA processing;gene expression
met KPNA4 3q25.33 0.135 0.305 0.797 NLS-bearing substrate import into
exp MYT1 20q13.33 0.135 0.305 0.797 Protein Kinases
exp CYYR1 21q21.2 0.135 0.305 0.797
xsq HMGN3 6q14.1 0.135 0.305 0.797 regulation of insulin secretion involved
exp SONP1 1q23.1 0.135 0.305 0.797
met MXRA5 Xp22.33 0.135 0.305 0.797
cop ASB13 10p15.1 0.135 0.305 0.797 intracellular signal transduction
xsq SCARNA9L Xp22.12 0.135 0.305 0.797
met NEK11 3q22.1 0.135 0.305 0.797 DNA Damage Response (DDR)
cop LOC100507389 -0.135 0.305 0.797
cop PAQR9 3q23 -0.135 0.305 0.797
cop LOC100289361 3q23 -0.135 0.305 0.797
cop U2SURP 3q23 -0.135 0.305 0.797 RNA processing
exp TMEM44 3q29 -0.135 0.305 0.797
cop FOXK1 7p22.1 -0.135 0.305 0.797 negative regulation of
promoter
exp CBX6 22q13.1 -0.135 0.305 0.797 negative regulation of
dependent
xsq LOC101929427 -0.135 0.305 0.797
met PSMD14 2q24.2 -0.135 0.305 0.797 G1/S transition of mitotic
cell cycle;ubiquitin-dependent protein catabolic process
exp NOV 8q24.1 -0.135 0.305 0.797 regulation of cell growth
cop RNF7 3q22-q24 -0.135 0.305 0.797 Apoptosis
exp PSG6 -0.135 0.305 0.797 female pregnancy
exp FMOD 1q32 -0.135 0.305 0.797 wound healing;odontogenesis
exp FTH1P14 Xp21.1 -0.135 0.305 0.797
xsq PKD2 4q22.1 -0.135 0.305 0.797 embryonic placenta
exp RUNX1T1 8q22 -0.135 0.305 0.797 generation of precursor metabolites
cop TMEM38B 9q31.2 -0.135 0.305 0.797 ion transport;potassium ion
transport
exp PROS1 3q11.2 -0.135 0.305 0.797 cellular protein metabolic
cop DDHD2 8p11.23 -0.135 0.305 0.796 lipid catabolic process
xsq SH3D21 1p34.3 -0.135 0.305 0.796
mut RMND1 6q25.1 -0.135 0.305 0.796
exp ZSCAN4 19q13.43 -0.135 0.305 0.796 telomere maintenance via
telomere lengthening;viral reproduction
exp ENPP5 6p21.1-p11.2 -0.135 0.305 0.796 cell communication
DNA-dependent"
xsq CHMP1B2P -0.135 0.305 0.796
mut ZNF18 17p11.2 -0.135 0.305 0.796 viral reproduction
DNA-dependent"
xai HOXC10 12q13.3 -0.136 0.305 0.797 multicellular organismal
development;positive regulation of cell proliferation
his HDAC9 7p21.1 -0.136 0.305 0.797 inflammatory response;negative
xai NOXA1 9q34.3 -0.136 0.305 0.797 superoxide metabolic
DNA-dependent"
cop MIR4471 -0.136 0.305 0.797
exp DUSP8P4 -0.136 0.305 0.797
hs4 C3orf70 3q27.2 -0.136 0.305 0.797
his PLS3 Xq23 -0.136 0.305 0.797
his PLS3-AS1 -0.136 0.305 0.797
his PPP1R3B 8p23.1 -0.136 0.305 0.797 carbohydrate metabolic
xai PRR34 -0.136 0.305 0.797
xai GAL3ST1 22q12.2 -0.136 0.305 0.797 spermatogenesis;biosynthetic
process
exp DNM1P50 -0.136 0.305 0.797
exp ADIG 20q11.23 -0.136 0.305 0.797 positive regulation of fat cell
his QRFPR 4q27 -0.136 0.305 0.797 G-protein coupled receptor signaling
pathway
dependent"
swa STIM2 4p15.2 -0.136 0.305 0.797 negative regulation of calcium ion
xai PCDHGA6 -0.136 0.305 0.797 cell adhesion;homophilic cell
adhesion
hs4 HTATIP2 11p15.1 -0.136 0.305 0.797 Apoptosis
his ANKRD45 1q25.1 -0.136 0.305 0.797
xai GALNT3 2q24-q31 -0.136 0.305 0.797 protein O-linked
his PARD3B 2q33.3 -0.136 0.305 0.797 cell division;cell cycle
xai YIPF2 19p13.2 -0.136 0.305 0.797
exp PDIA3P1 -0.136 0.305 0.797
hs4 LGALS8 1q43 -0.136 0.305 0.797
hs4 LGALS8-AS1 1q43 -0.136 0.305 0.797
his PARD6B 20q13.13 -0.136 0.305 0.796 axonogenesis;regulation of
cell migration
swa TJP1 15q13 -0.136 0.305 0.796 blastocyst formation;apoptotic process
xai BPIFA3 20q11.21 -0.136 0.305 0.796
exp RGR 10q23 -0.136 0.305 0.796 G-protein coupled receptor signaling
hs4 IFNL3 -0.136 0.305 0.796
hs4 IFNL4 -0.136 0.305 0.796
exp CLRN1 3q25 -0.136 0.305 0.796 sensory perception of sound;photoreceptor
cell maintenance
his MIR7844 -0.136 0.305 0.796
exp MIRLET7A2 -0.136 0.305 0.796
xai LINC00652 -0.136 0.305 0.796
his MIR6072 -0.136 0.305 0.796
his OXTR 3p25 -0.136 0.305 0.796 cell surface receptor signaling
xai MIRLET7A2 -0.136 0.305 0.796
his ATP6V1H 8q11.2 -0.136 0.305 0.796 ion transport;transferrin
transport
his CBS 21q22.3 0.136 0.306 0.797 superoxide metabolic process;cellular
cop RPS26P11 0.136 0.306 0.797
hs4 CCDC26 0.136 0.306 0.797
xai CHCHD2 7p11.2 0.136 0.306 0.797
his FOXP4-AS1 0.136 0.306 0.797
his FOXP4 6p21.1 0.136 0.306 0.797 pattern specification process;heart
development
exp SPATA25 20q13.12 0.136 0.306 0.797 spermatogenesis;cell
differentiation
exp LINC00297 0.136 0.306 0.797
exp DNAH10 12q24.31 0.136 0.306 0.797 microtubule-based movement
his RBM17 10p15.1 0.136 0.306 0.797 mRNA processing;RNA splicing
his OR4F21 0.136 0.306 0.797
xai NAPRT 0.136 0.306 0.797 nicotinamide metabolic process;response to
oxidative stress
xai NUFIP2 17q11.2 0.136 0.306 0.797
his LINC00960 0.136 0.306 0.797
xai FANCB Xp22.2 0.136 0.306 0.797 DNA Damage Response (DDR); DDR (FA)
his TBCCD1 3q27.3 0.136 0.306 0.797 cell morphogenesis;regulation of
cell shape
his DNAJB11 3q27.3 0.136 0.306 0.797 protein folding;activation of
xai LOC392232 8q13.3 0.136 0.306 0.797
xai LOC392364 9q22.1 0.136 0.306 0.797
xai GNAT2 1p13.1 0.136 0.306 0.797 elevation of cytosolic calcium ion
hs4 ELOVL6 4q25 0.136 0.306 0.797 fatty acid elongation, monounsaturated
fatty acid;long-chain fatty-acyl-CoA biosynthetic process
exp CXorf58 Xp22.11 0.136 0.306 0.797
exp DPEP2 16q22.1 0.136 0.306 0.797 leukotriene biosynthetic process;small
his PDS5B 13q12.3 0.136 0.306 0.797 DNA Damage Response (DDR)
his TMEM35A 0.136 0.306 0.797
his CXorf40B Xq28 0.136 0.306 0.797
his LINC00894 0.136 0.306 0.797
hs4 ITPA 20p 0.136 0.306 0.797 metabolic process;nucleotide metabolic process
hs4 CD96 3q13.13-q13.2 0.136 0.306 0.797 cell adhesion;regulation of immune
response
xai PCDHA2 0.136 0.306 0.797 nervous system development;cell adhesion
swa AGK 7q34 0.136 0.306 0.797 activation of protein kinase C activity by G-
protein coupled receptor protein signaling pathway;metabolic process
xai CYP3A43 7q21.1 0.135 0.306 0.797 xenobiotic metabolic process;small
hs4 PFDN4 20q13.2 0.135 0.306 0.797 protein folding;cellular protein
metabolic process
his NAP1L5 4q22.1 0.135 0.306 0.797 nucleosome assembly
exp SBK3 0.135 0.306 0.797
xai RPL21P32 2q32.1 0.135 0.306 0.797
his C11orf96 11p11.2 0.135 0.306 0.797
his MIR6844 0.135 0.306 0.797
cop BCYRN1 2p21 0.135 0.306 0.797
met PLBD1 12p13.1 0.134 0.306 0.797 lipid catabolic process
met LMBRD2 5p13.2 0.134 0.306 0.797
exp LOC442075 0.134 0.306 0.797
xsq ASB6 9q34.13 0.134 0.306 0.797 intracellular signal transduction
cop CES1P1 16q12.2 0.134 0.306 0.797
met REG1A 2p12 0.134 0.306 0.797 positive regulation of cell proliferation
xsq ARHGEF7 13q34 0.134 0.306 0.797 apoptotic process;positive regulation of
apoptotic process
exp GNB1L 22q11.2 0.134 0.306 0.797 G-protein coupled receptor signaling
met SLIT3 5q35 0.134 0.306 0.797 multicellular organismal development;axon
mir hsa-miR-340 0.134 0.306 0.797
dependent"
met SIGIRR 11p15.5 0.134 0.306 0.797 innate immune response;negative
xsq DDB2 11p12-p11 0.134 0.306 0.797 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
met CALCRL 2q32.1 0.134 0.306 0.797 calcium ion transport;positive
cop C17orf64 17q23.2 0.134 0.306 0.797
exp PI4K2B 4p15.2 0.134 0.306 0.797
met CXorf22 Xp21.1 0.134 0.306 0.797
xsq FUZ 19q13.33 0.134 0.306 0.797 cell projection
met GRIA4 11q22 0.134 0.306 0.797 transport;ion transport
cop ZFAND6 15q25.1 0.134 0.306 0.797 signal transduction
mut SEC24B 4q25 0.134 0.306 0.797 protein N-linked glycosylation via
cop WFIKKN2 17q21.33 0.134 0.306 0.797 transforming growth factor beta
mut BCL6B 17p13.1 0.134 0.306 0.797 negative regulation of transcription from
cop ARNT2 15q24 0.134 0.306 0.797 positive regulation of transcription, DNA-
cop ABHD17C 15q25.1 0.134 0.306 0.797
cop MIR549A 0.134 0.306 0.797
exp TFIP11 22q12.1 0.134 0.306 0.797 nuclear mRNA splicing, via
exp PFN1 17p13.3 0.134 0.306 0.797 neural tube closure;positive regulation
met MIR374A 0.134 0.306 0.797
xsq PPP2R2A 8p21.2 0.134 0.306 0.797 nuclear-transcribed mRNA catabolic
process, nonsense-mediated decay;protein dephosphorylation
dependent"
xsq C17orf107 17p13.2 0.134 0.306 0.797
xsq TFAP2B 6p12 0.134 0.306 0.797 nervous system development;hindlimb
morphogenesis
cop STIP1 11q13 0.134 0.306 0.797 response to stress;axon guidance
met MLF2 12p13 0.134 0.306 0.797 defense response
xsq BCL2L14 12p13-p12 0.134 0.306 0.797 apoptotic process;regulation of
apoptotic process
cop ZC3H6 2q13 0.134 0.306 0.797
cop DYNAP 18q21.2 0.134 0.306 0.797
cop ST20-MTHFS 0.134 0.306 0.797
cop MTHFS 15q25.1 0.134 0.306 0.797 folic acid-containing compound
biosynthetic process;formate metabolic process
cop ST20 15q25.1 0.134 0.306 0.797
cop C15orf37 15q25.1 0.134 0.306 0.797
cop BCL2A1 15q24.3 0.134 0.306 0.797 Apoptosis
met POP4 19q12 0.134 0.306 0.797 mRNA cleavage;tRNA processing
cop KCNH6 17q23.3 0.134 0.306 0.797 potassium ion transport;signal
transduction
xsq KRT86 12q13 0.134 0.306 0.797 cytoskeleton organization
exp APBB1IP 10p12.1 0.134 0.306 0.797 signal transduction;blood
coagulation
met B3GALNT1 3q25 0.134 0.306 0.797 protein glycosylation;oligosaccharide
cop BMF 15q14 0.134 0.306 0.797 Apoptosis
xsq CIAO1 2q11.2 0.134 0.306 0.797 regulation of transcription from RNA
polymerase II promoter;chromosome segregation
xsq ADCYAP1 18p11 0.134 0.306 0.797 cell-cell signaling;female pregnancy
xsq LOC101929698 0.134 0.306 0.797
xsq AADAT 4q33 0.134 0.306 0.797 small molecule metabolic process;2-oxoglutarate
metabolic process
xsq FAT1 4q35 -0.134 0.306 0.797 anatomical structure morphogenesis;cell-
cell adhesion
xsq PSAP 10q21-q22 -0.134 0.306 0.797 glycosphingolipid metabolic
exp PLA1A 3q13.13-q13.2 -0.134 0.306 0.797 lipid metabolic
exp MAP2 2q34-q35 -0.134 0.306 0.797 microtubule bundle
xsq LGI3 8p21.3 -0.134 0.306 0.797 regulation of exocytosis
exp ARHGAP32 11q24.3 -0.134 0.306 0.797 signal transduction;small
cop SAMHD1 20pter-q12 -0.134 0.306 0.797 DNA Damage Response (DDR)
xsq LINC00535 -0.134 0.306 0.797
met ARMC7 17q25.1 -0.134 0.306 0.797
xsq ADAMTS2 5qter -0.134 0.306 0.797 protein processing;collagen fibril
organization
xsq MED29 19q13.2 -0.134 0.306 0.797 regulation of transcription, DNA-
dependent"
mut COL5A1 9q34.2-q34.3 -0.134 0.306 0.797 wound healing, spreading
xsq SPRR1B 1q21-q22 -0.134 0.306 0.797 peptide cross-
linking;keratinocyte differentiation
exp TEF 22q13.2 -0.134 0.306 0.797 regulation of transcription from
II promoter
exp LOC100131779 12q24.31 -0.134 0.306 0.797
exp CDH19 18q22.1 -0.134 0.306 0.797 cell-cell adhesion;cell adhesion
mut CPNE7 16q24.3 -0.134 0.306 0.797 lipid metabolic process;transport
exp GBE1 3p12.3 -0.134 0.306 0.797 carbohydrate metabolic
xsq NTF4 19q13.3 -0.134 0.306 0.797 ganglion mother cell fate
met C6orf89 6p21.2 -0.134 0.306 0.797 wound healing;positive
met ABCC6P1 16p12.3 -0.134 0.306 0.797
xsq TPBG 6q14-q15 -0.134 0.306 0.797 cell adhesion
exp DAPK1-IT1 -0.134 0.306 0.797
met TBKBP1 17q21.32 -0.134 0.306 0.797 innate immune response
exp DCAF12L1 Xq25 -0.134 0.306 0.797
cop LOC389906 Xp22.33 -0.135 0.306 0.797
met TRA2B 3q26.2-q27 -0.135 0.306 0.797 response to reactive oxygen
xsq LINC00645 -0.135 0.306 0.797
xsq LINC00893 Xq28 -0.135 0.306 0.797
swa OGDH 7p14-p13 -0.135 0.306 0.797 oxidation-reduction
hs4 PI15 8q21.11 -0.135 0.306 0.797
his LOC100505478 -0.135 0.306 0.797
xai OXTR 3p25 -0.135 0.306 0.797 cell surface receptor signaling
hs4 MFAP3L 4q32.3 -0.135 0.306 0.797
xai NAALADL2 3q26.31 -0.135 0.306 0.797 proteolysis
his PPP1R3C 10q23-q24 -0.135 0.306 0.797 carbohydrate metabolic
xai RTKN 2p13.1 -0.135 0.306 0.797 Apoptosis
swa CUL4B Xq23 -0.135 0.306 0.797 DNA repair;ubiquitin-dependent protein
catabolic process
hs4 NATD1 -0.136 0.306 0.797
hs4 RNPEP 1q32 -0.136 0.306 0.797 retina development in camera-type
eye;proteolysis
his MIR7161 -0.136 0.306 0.797
xai SLC7A9 19q13.1 -0.136 0.306 0.797 blood coagulation;neutral
amino acid transport
his KCNJ16 17q24.3 -0.136 0.306 0.797 ion transport;potassium ion
transport
xai CRYL1 13q12.11 -0.136 0.306 0.797 fatty acid metabolic process
exp CCL19 9p13 -0.136 0.306 0.797 dendritic cell chemotaxis;response to
virus
his C5orf64 5q12.1 -0.136 0.306 0.797
his LOC105371328 -0.136 0.306 0.797
xai IGFL1 19q13.32 -0.136 0.306 0.797
his TREM1 6p21.1 -0.136 0.306 0.797 humoral immune response;blood
coagulation
hs4 RAB11FIP4 17q11.2 -0.136 0.306 0.797 cytokinesis;transport
xai VSX1 20p11.21 -0.136 0.306 0.797 neuron maturation;response to
stimulus
xai CARD16 11q22 -0.136 0.306 0.797 regulation of apoptotic process
his PCDHGC4 -0.136 0.306 0.797 cell adhesion;homophilic cell
adhesion
his PCDHGC5 5q31 -0.136 0.306 0.797
xai PM20D1 1q32.1 -0.136 0.306 0.797 proteolysis;metabolic process
xai SIRPA 20p13 -0.136 0.306 0.797 cell adhesion;blood coagulation
his MSGN1 2p24.2 -0.136 0.306 0.797
xai ZFY-AS1 -0.136 0.306 0.797
xai KCNMB1 5q34 -0.136 0.306 0.797 potassium ion transport;synaptic
transmission
met MIR891B 0.137 0.307 0.797
xai CCKAR 4p15.2 0.137 0.307 0.797 activation of phospholipase C activity by
his PER1 17p13.1 0.135 0.307 0.797 DNA Damage Response (DDR)
hs4 SMAD6 15q22.31 0.135 0.307 0.797 negative regulation of SMAD protein
his H2AFB2 0.135 0.307 0.797
his F8A2 0.135 0.307 0.797
his MIR1184-2 0.135 0.307 0.797
xai GEMIN8 Xp22.2 0.135 0.307 0.797 RNA splicing;spliceosomal snRNP
assembly
hs4 GOLGA8A 15q11.2 0.135 0.307 0.797
his LINC01506 0.135 0.307 0.797
hs4 AP5S1 20p13 0.135 0.307 0.797 double-strand break repair via homologous
his OR4K17 0.135 0.307 0.797
xai FZD8 10p11.21 0.135 0.307 0.797 positive regulation of protein
promoter
exp C4orf17 4q23 0.135 0.307 0.797
his COMMD9 11p13 0.135 0.307 0.797
xai TUBAP 21q21.1 0.135 0.307 0.797
his DOK2 8p21.3 0.135 0.307 0.797 signal transduction;cell surface receptor
signaling pathway
xai CDH8 16q22.1 0.135 0.307 0.797 cell adhesion;homophilic cell adhesion
xai PITPNA-AS1 0.135 0.307 0.797
hs4 GRIN3A 9q31.1 0.135 0.307 0.797 ion transport;calcium ion transport
his LINC00847 5q35.3 0.135 0.307 0.797
his HEIH 0.135 0.307 0.797
hs4 LINC00092 9q22.32 0.135 0.307 0.797
xai CCDC71 3p21.31 0.135 0.307 0.797
hs4 CCT4 2p15 0.135 0.307 0.797 protein folding;cellular protein metabolic
process
xai NAPSA 19q13.33 0.135 0.307 0.798 proteolysis;membrane protein proteolysis
his CELA3A 1p36.12 0.135 0.307 0.798 proteolysis;digestion
xai NAB1 2q32.3-q33 0.135 0.307 0.798 Schwann cell differentiation;myelination
hs4 NEK10 3p24.1 0.135 0.307 0.798
hs4 ATAD3A 1p36.33 0.135 0.307 0.798 cell growth;negative regulation of
apoptotic process
his ATG5 6q21 0.135 0.307 0.798 Apoptosis
xai TMEM102 17p13.1 0.135 0.307 0.798 signal transduction;response to
cytokine stimulus
exp LRRC69 8q21.3 0.135 0.307 0.798
exp LIPT1P1 13q33.1 0.135 0.307 0.798
xai TBX18 6q14-q15 0.135 0.307 0.798 negative regulation of transcription from
RNA polymerase II promoter;negative regulation of canonical Wnt receptor signaling
pathway involved in neural plate anterior/posterior pattern formation
his TFIP11 22q12.1 0.135 0.307 0.798 nuclear mRNA splicing, via
his LOC100507599 0.135 0.307 0.798
xai AUP1 2p13 0.135 0.307 0.798
dependent"
dependent"
his SESN1 6q21 0.135 0.307 0.798 negative regulation of cell
proliferation;response to DNA damage stimulus
his CEP57L1 6q21 0.135 0.307 0.798
xai CALCRL 2q32.1 0.135 0.307 0.798 calcium ion transport;positive
xai METTL2B 7q32.1 0.135 0.307 0.798
xai CSNK1E 22q13.1 0.135 0.307 0.798 DNA Damage Response (DDR); Protein
Kinases
his ZSWIM2 2q32.1 0.135 0.307 0.798 protein
polyubiquitination;regulation of apoptotic process
cop SFMBT2 10p14 0.134 0.307 0.797 regulation of transcription, DNA-
dependent"
xsq RPF1 1p22.3 0.134 0.307 0.797 rRNA processing
exp FOXA3 19q13.32 0.134 0.307 0.797 embryo development;regulation of
xsq NKAIN2 6q21 0.134 0.307 0.797
met ST3GAL5 2p11.2 0.134 0.307 0.797 carbohydrate metabolic
cop MAGEL2 15q11-q12 0.134 0.307 0.797
met LINC00313 21q22.3 0.134 0.307 0.797
xsq ZNF804B 7q21.13 0.134 0.307 0.797
cop TEN1 17q25.1 0.134 0.307 0.797 DNA Damage Response (DDR)
cop TEN1-CDK3 0.134 0.307 0.797
cop CDK3 17q25.1 0.134 0.307 0.797 Protein Kinases
cop EVPL 17q25 0.134 0.307 0.797 epidermis development;peptide cross-linking
cop SRP68 17q25.1 0.134 0.307 0.797 gene expression;response to drug
cop GALR2 17q25.3 0.134 0.307 0.797
cop ZACN 0.134 0.307 0.797
xsq FGFR1OP2 12p11.23 0.134 0.307 0.797 response to wounding
xsq EIF3B 7p22.3 0.134 0.307 0.797 translation;translational initiation
xsq ASAH2B 10q11.23 0.134 0.307 0.797
cop LOC100506834 0.134 0.307 0.797
met CHRDL2 11q14 0.134 0.307 0.797 ossification;multicellular organismal
development
xsq ATPIF1 1p35.3 0.134 0.307 0.797 angiogenesis;negative regulation of
hydrolase activity
xsq PRAMEF2 0.134 0.307 0.797
cop PGA4 0.134 0.307 0.797
cop PGA5 11q13 0.134 0.307 0.797
cop ADI1 2p25.3 0.134 0.307 0.797 cellular nitrogen compound metabolic
cop RNASEH1 2p25 0.134 0.307 0.797 DDR (DNA replication)
cop LOC100506054 0.134 0.307 0.797
xsq ACO2 22q13.2 0.134 0.307 0.797 generation of precursor metabolites and
xsq AAMP 2q35 0.134 0.307 0.797 cell differentiation;angiogenesis
cop IDNK 9q21.32 0.134 0.307 0.797 carbohydrate metabolic process
cop NRADDP 0.134 0.307 0.797
cop SETD2 3p21.31 0.134 0.307 0.797 Tumor Suppressors
mut N4BP2 4p14 0.134 0.307 0.797
cop FBXO18 10p15.1 0.134 0.307 0.797 DNA Damage Response (DDR)
mut GRM7 3p26.1-p25.1 0.134 0.307 0.797 negative regulation of glutamate
secretion;conditioned taste aversion
xsq SLMO2-ATP5E 0.134 0.307 0.797
mut CASP3 4q34 0.134 0.307 0.798 Apoptosis
met EDC4 16q22.1 0.134 0.307 0.798 mRNA metabolic process;exonucleolytic
decay
xsq TNRC6C 17q25.3 0.134 0.307 0.798 regulation of translation;gene
silencing by RNA
met ENOX2 Xq25 0.134 0.307 0.798 transport;ultradian rhythm
exp RPL12P21 5q31 0.134 0.307 0.798
xsq PACRG-AS1 0.134 0.307 0.798
cop LIMD1 3p21.3 0.134 0.307 0.798 cell migration;cytoplasmic mRNA
xsq GLYAT 11q12.1 0.134 0.307 0.798 acyl-CoA metabolic process;xenobiotic
metabolic process
met SOCS6 18q22.2 0.134 0.307 0.798 defense response;JAK-STAT cascade
mut ADAMTSL1 9p21.3 0.134 0.307 0.798
met C16orf89 16p13.3 0.134 0.307 0.798
exp C2orf47 2q33.1 0.134 0.307 0.798
xsq WNT3A 1q42 0.134 0.307 0.798
cop DCAF7 17q23.3 0.134 0.307 0.798 multicellular organismal
cop TACO1 17q23.3 0.134 0.307 0.798 regulation of translation
cop MAP3K3 17q23.3 0.134 0.307 0.798 Protein Kinases
cop LIMD2 17q23.3 0.134 0.307 0.798
cop LOC729683 17q23.3 0.134 0.307 0.798
cop STRADA 17q23.3 0.134 0.307 0.798 positive regulation of protein
cop CCDC47 17q23.3 0.134 0.307 0.798 ER overload response;embryo
development
xsq TMED8 14q24.3 0.134 0.307 0.798 transport
met PPP1R1A 12q13.2 0.134 0.307 0.798 carbohydrate metabolic
xsq NDNL2 15q13.1 0.134 0.307 0.798 DNA Damage Response (DDR); DDR (HR)
mut NARS2 11q14.1 0.134 0.307 0.798 asparaginyl-tRNA aminoacylation;gene
expression
exp OR2A25 7q35 0.134 0.307 0.798 response to stimulus
cop TFDP2 3q23 -0.134 0.307 0.798 Apoptosis
met NR5A1 9q33 -0.134 0.307 0.798 primary sex determination;regulation of
steroid biosynthetic process
cop TRPC1 3q23 -0.134 0.307 0.798 ion transport;calcium ion transport
met TLX2 2p13.1 -0.134 0.307 0.798
cop VSTM2L 20q11.23 -0.134 0.307 0.798
met HAPLN2 1q23.1 -0.134 0.307 0.798
met ERP27 12p12.3 -0.134 0.307 0.798
xsq TMEM211 22q11.23 -0.134 0.307 0.798
cop FLJ41941 22q11.21 -0.134 0.307 0.798
cop PEX26 22q11.21 -0.134 0.307 0.798 protein transport;protein import
cop TUBA8 22q11.1 -0.134 0.307 0.798 microtubule-based movement;protein
polymerization
xsq SPRR3 1q21-q22 -0.134 0.307 0.798 keratinization;wound healing
xsq DSTN 20p12.1 -0.134 0.307 0.798 cellular component movement;actin
cop TLDC2 20q11.23 -0.134 0.307 0.798
cop PCDH17 13q21.1 -0.134 0.307 0.797 cell adhesion;homophilic cell
adhesion
met FOXD4L1 2q13 -0.134 0.307 0.797 positive regulation of BMP
signaling pathway;cartilage development
met POLR1E 9p13.2 -0.134 0.307 0.797 rRNA transcription
xsq MEG8 14q32.31 -0.134 0.307 0.797
exp RRAGB Xp11.21 -0.134 0.307 0.797 signal transduction;positive
met PLTP 20q13.12 -0.134 0.307 0.797 vitamin E biosynthetic
process;sperm motility
exp HRK 12q24.22 -0.134 0.307 0.797 positive regulation of neuron
apoptosis;cellular response to potassium ion starvation
xsq TNNI2 11p15.5 -0.134 0.307 0.797 skeletal muscle contraction;muscle
filament sliding
xsq HOOK2 19p13.2 -0.134 0.307 0.797 early endosome to late endosome
xsq SNORA47 5q13.3 -0.134 0.307 0.797
met MAP2K5 15q23 -0.134 0.307 0.797 Protein Kinases
xsq SEPN1 1p36.13 -0.134 0.307 0.797
exp COQ6 14q24.3 -0.134 0.307 0.797 ubiquinone biosynthetic process
his LOC440982 -0.135 0.307 0.798
hs4 SUN1 7p22.3 -0.135 0.307 0.798 cytoskeletal anchoring at nuclear
hs4 GALR1 18q23 -0.135 0.307 0.798 neuropeptide signaling pathway;digestion
hs4 HCG4 6p21.3 -0.135 0.307 0.798
hs4 LOC554223 -0.135 0.307 0.798
hs4 PANDAR -0.135 0.307 0.798
hs4 CDKN1A 6p21.2 -0.135 0.307 0.798 Apoptosis; DNA Damage
hs4 DINO -0.135 0.307 0.798
exp NANOGP5 9q31 -0.135 0.307 0.798
exp MIR199A1 -0.135 0.307 0.798
his USP43 17p13.1 -0.135 0.307 0.798 proteolysis;ubiquitin-dependent
his AZGP1 7q22.1 -0.135 0.307 0.798 immune response;cell adhesion
xai SLC5A9 1p33 -0.135 0.307 0.798 ion transport;sodium ion transport
hs4 LOC644936 5q14.1 -0.135 0.307 0.798
xai LOC101060146 -0.135 0.307 0.798
his LOC101928605 -0.135 0.307 0.798
his ARHGEF35 7q35 -0.135 0.307 0.798
xai MIR199B -0.135 0.307 0.798
hs4 TLL1 4q32-q33 -0.135 0.307 0.798 proteolysis;multicellular
hs4 OGDH 7p14-p13 -0.135 0.307 0.798 oxidation-reduction
his LINC01844 -0.135 0.307 0.798
swa VAMP7 -0.135 0.307 0.797 post-Golgi vesicle-mediated
transport;eosinophil degranulation
xai ARSI 5q32 -0.135 0.307 0.797
cop LOC100129046 1p22.1 -0.135 0.307 0.797
xai JPH1 8q21 -0.135 0.307 0.797 muscle organ development;regulation of
xai SIRPAP1 -0.135 0.307 0.797
his FOXO1 13q14.1 -0.135 0.307 0.797 Apoptosis
exp TMED7 5q22.3 -0.135 0.307 0.797 protein transport
xai PCDHGB8P -0.135 0.307 0.797
hs4 DNM3OS -0.135 0.307 0.797
hs4 MIR199A2 -0.135 0.307 0.797
hs4 CTIF 18q21.1 -0.135 0.307 0.797 nuclear-transcribed mRNA catabolic
cop TTYH1 19q13.4 -0.135 0.307 0.797 ion transport;iron ion transport
cop LENG8 19q13.42 -0.135 0.307 0.797
cop LENG9 19q13.4 -0.135 0.307 0.797 RNA metabolic process
cop CDC42EP5 19q13.42 -0.135 0.307 0.797 positive regulation of actin
filament polymerization;positive regulation of pseudopodium assembly
his LINC00452 13q34 -0.135 0.307 0.797
xai DUSP8P4 -0.135 0.307 0.797
xai P4HA1 10q21.3-q23.1 -0.135 0.307 0.797 peptidyl-proline
xai TMED7 5q22.3 -0.135 0.307 0.797 protein transport
hs4 PURA 5q31 -0.135 0.307 0.797 Apoptosis
hs4 ATP2C1 3q22.1 -0.135 0.307 0.797 manganese ion transport;Golgi
his TMEM92 17q21.33 -0.135 0.307 0.797
swa NDUFB9 8q13.3 -0.135 0.307 0.797 mitochondrial electron
hs4 KCNS2 8q22 -0.135 0.307 0.797 ion transport;potassium ion transport
his TBC1D2 9q22.33 -0.135 0.307 0.797 positive regulation of Rab
GTPase activity
exp MIR199B -0.135 0.307 0.797
xai PLA1A 3q13.13-q13.2 -0.135 0.307 0.797 lipid metabolic
hs4 TMEM255B 13q34 -0.135 0.307 0.797
xai GNL3 3p21.1 0.136 0.308 0.798 regulation of cell proliferation
xai ZKSCAN4 6p21 0.135 0.308 0.798 viral reproduction
his BRF2 8p11.23 0.135 0.308 0.798 transcription from RNA polymerase III
hs4 DTYMK 2q37.3 0.135 0.308 0.798 cell cycle;cell proliferation
hs4 ING5 2q37.3 0.135 0.308 0.798 histone H3 acetylation;positive
his ITPR1-AS1 0.135 0.308 0.798
his ITPR1 3p26.1 0.135 0.308 0.798 blood coagulation;transmembrane transport
his ANXA1 9q21.13 0.135 0.308 0.798 Apoptosis
hs4 ANKRD36BP2 2p11.2 0.135 0.308 0.798
his IMPDH1 7q31.3-q32 0.135 0.308 0.798 lymphocyte
exp MIR4500HG 0.135 0.308 0.798
exp MIR93 0.135 0.308 0.798
his PTGES2 9q34.11 0.135 0.308 0.798 prostaglandin biosynthetic
his PTGES2-AS1 9q34.11 0.135 0.308 0.798
his ARL6 3q11.2 0.135 0.308 0.798 cilium assembly;protein targeting to
membrane
xai MYBPC2 19q13.33 0.135 0.308 0.798 cell adhesion;muscle filament
sliding
exp DMRTC2 19q13.2 0.135 0.308 0.798 regulation of transcription, DNA-
hs4 LHX5 12q24 0.135 0.308 0.798 hippocampus development;cell proliferation in
forebrain
hs4 LHX5-AS1 0.135 0.308 0.798
xai MIR93 0.135 0.308 0.798
hs4 VPS13C 15q22.2 0.135 0.308 0.798 protein localization
hs4 LOC101928907 0.135 0.308 0.798
his EIF4ENIF1 22q11.2 0.135 0.308 0.798 protein transport
his SFI1 22q12.2 0.135 0.308 0.798 G2/M transition of mitotic cell
hs4 RBM23 14q11.2 0.135 0.308 0.798 mRNA processing
hs4 PRMT5-AS1 0.135 0.308 0.798
his REEP5 5q22-q23 0.135 0.308 0.798
xai NT5DC1 6q22.1 0.135 0.308 0.798
xai PI16 6p21.2 0.135 0.308 0.798
his SNN 16p13 0.135 0.308 0.798 response to stress;response to abiotic stimulus
his EIF4A1 17p13 0.135 0.308 0.798 translational initiation;gene expression
his SNORA48 0.135 0.308 0.798
his SNORD10 0.135 0.308 0.798
his SNORA67 0.135 0.308 0.798
hs4 MIR6737 0.135 0.308 0.798
hs4 CREB3L4 1q21.3 0.135 0.308 0.798 response to unfolded
xai TBC1D15 12q21.1 0.135 0.308 0.798 regulation of Rab GTPase
xai SNHG17 20q11.23 0.135 0.308 0.798
his TRIQK 8q22.1 0.135 0.308 0.798
xai CLLU1OS 12q22 0.135 0.308 0.798
exp OR52E3P 11p15.4 0.135 0.308 0.798
xai GABRB2 5q34 0.135 0.308 0.798 chloride transport;gamma-aminobutyric
hs4 CRBN 3p26.2 0.135 0.308 0.798 negative regulation of protein
xai MKKS 20p12 0.135 0.308 0.798 heart development;melanosome transport
his PEX6 6p21.1 0.135 0.308 0.798 ATP catabolic process;protein targeting
to peroxisome
his ERVK13-1 0.135 0.308 0.798
his KCTD5 16p13.3 0.135 0.308 0.798 potassium ion transport;interspecies
xai PRR22 19p13.3 0.135 0.308 0.798
xai C6orf183 0.135 0.308 0.798
hs4 CCDC151 19p13.2 0.135 0.308 0.798
hs4 PRKCSH 19p13.2 0.135 0.308 0.798 protein folding;intracellular
his MIR3945 0.135 0.308 0.798
hs4 CDO1 5q23.2 0.135 0.308 0.798 sulfur amino acid metabolic
hs4 NR0B2 1p36.1 0.135 0.308 0.798 positive regulation of insulin
activity
hs4 RHOU 1q42.11-q42.3 0.135 0.308 0.798 G1/S transition of mitotic cell
cycle;cytoskeleton organization
hs4 RNA5S1 0.135 0.308 0.798
hs4 RNA5S2 0.135 0.308 0.798
hs4 RNA5S3 0.135 0.308 0.798
hs4 RNA5S4 0.135 0.308 0.798
hs4 RNA5S5 0.135 0.308 0.798
hs4 RNA5S6 0.135 0.308 0.798
hs4 RNA5S7 0.135 0.308 0.798
hs4 RNA5S8 0.135 0.308 0.798
hs4 RNA5S9 0.135 0.308 0.798
hs4 RNA5S10 0.135 0.308 0.798
hs4 RNA5S11 0.135 0.308 0.798
hs4 RNA5S12 0.135 0.308 0.798
hs4 RNA5S13 0.135 0.308 0.798
hs4 RNA5S14 0.135 0.308 0.798
hs4 RNA5S15 0.135 0.308 0.798
hs4 RNA5S16 0.135 0.308 0.798
hs4 DUSP5P1 1q42.13 0.135 0.308 0.798
hs4 RNA5S17 1q42 0.135 0.308 0.798
his SEMA4B 15q25 0.135 0.308 0.798 multicellular organismal
hs4 HLA-A 0.135 0.308 0.798 cytokine-mediated signaling pathway;antigen
his PDHA1 Xp22.1 0.135 0.308 0.798 pyruvate metabolic process;glycolysis
xai GPR88 1p21.3 0.135 0.308 0.798 G-protein coupled receptor signaling
pathway
xai LOC93463 2q37.3 0.135 0.308 0.798
hs4 CHST12 7p22 0.135 0.308 0.798 carbohydrate biosynthetic
hs4 TEPSIN 0.135 0.308 0.798
hs4 NDUFAF8 0.135 0.308 0.798
exp PWAR5 15q11.2 0.134 0.308 0.798
met ZBTB8A 1p35.1 0.134 0.308 0.798 regulation of transcription, DNA-
dependent"
xsq GUSBP3 5q13.2 0.134 0.308 0.798
exp CYCS 7p15.3 0.134 0.308 0.798 Apoptosis
xsq NUBP1 16p13.13 0.134 0.308 0.798 cell growth;iron-sulfur cluster assembly
met UQCRQ 5q31.1 0.134 0.308 0.798 hippocampus development;thalamus
development
xsq LOC101928279 0.134 0.308 0.798
met AQP9 15q 0.134 0.308 0.798 immune response;amine transport
met COBL 7p12.1 0.134 0.308 0.798 neural tube closure
exp ELAVL3 19p13.2 0.134 0.308 0.798 multicellular organismal
exp PRKAR1B 7p22 0.134 0.308 0.798 protein phosphorylation;small molecule
metabolic process
met SDCCAG8 1q43 0.134 0.308 0.798 mitotic cell cycle;establishment of cell
polarity
xsq OR2A2 0.134 0.308 0.798
cop CD300LG 17q21.31 0.134 0.308 0.798
cop MPP2 17q12-q21 0.134 0.308 0.798 signal transduction
cop FAM215A 0.134 0.308 0.798
cop PPY 17q21 0.134 0.308 0.798
cop PYY 17q21.1 0.134 0.308 0.798 negative regulation of response to
cop NAGS 17q21.31 0.134 0.308 0.798 urea cycle;glutamate metabolic process
cop TMEM101 17q21.31 0.134 0.308 0.798 signal transduction;positive
cop LSM12 17q21.31 0.134 0.308 0.798
cop G6PC3 17q21.31 0.134 0.308 0.798 carbohydrate metabolic
cop HDAC5 17q21 0.134 0.308 0.798 chromatin remodeling;cellular response to
insulin stimulus
cop C17orf53 17q21.31 0.134 0.308 0.798
cop ASB16 17q21.31 0.134 0.308 0.798 intracellular signal transduction
cop ASB16-AS1 17q21.31 0.134 0.308 0.798
cop TMUB2 17q21.31 0.134 0.308 0.798
cop ATXN7L3 17q21.31 0.134 0.308 0.798 chromatin modification;histone
deubiquitination
cop UBTF 17q21.31 0.134 0.308 0.798 chromatin silencing at rDNA;regulation of
cop SLC4A1 17q21.31 0.134 0.308 0.798 anion transport;chloride transport
cop CYP1A2 15q24.1 0.134 0.308 0.798 steroid catabolic
exp NLK 17q11.2 0.134 0.308 0.798 negative regulation of Wnt receptor
xsq CDKN2D 19p13 0.134 0.308 0.798 DNA Damage Response (DDR)
xsq WHAMMP1 15q13.3 0.134 0.308 0.798
exp DRG1 22q12.2 0.134 0.308 0.798 transcription, DNA-
mut IPO9 1q32.1 0.134 0.308 0.798 protein import into nucleus;intracellular
protein transport
cop LOC399715 10p15.1 0.134 0.308 0.798
xsq PTGES2-AS1 9q34.11 0.134 0.308 0.798
cop TTC7B 14q32.11 0.134 0.308 0.798
xsq ARL14EP 11p14.1 0.134 0.308 0.798
mut ANKS1A 6p21.31 0.134 0.308 0.798 neuron remodeling;ephrin receptor
signaling pathway
xsq NACA 12q23-q24.1 0.134 0.308 0.798 transcription, DNA-dependent;translation
exp LOC100128355 Xp22.33 0.134 0.308 0.798
xsq FKBP1A 20p13 0.134 0.308 0.798 'de novo' protein folding;regulation of
cop TMEM216 11q13.1 0.134 0.308 0.798 cell projection organization;cilium
morphogenesis
cop CPSF7 11q12.2 0.134 0.308 0.798 protein tetramerization;nuclear mRNA
cop SDHAF2 11q12.2 0.134 0.308 0.798 mitochondrial electron transport,
met DTX3L 3q21.1 0.134 0.308 0.798 response to DNA damage stimulus;histone
monoubiquitination
xsq GRIA4 11q22 0.134 0.308 0.798 transport;ion transport
xsq PRB4 0.134 0.308 0.798
xsq SRSF11 1p31 0.134 0.308 0.798 RNA splicing;gene expression
xsq TCP10L 21q22.11 0.134 0.308 0.798
exp ZNF675 19p12 0.134 0.308 0.798 I-kappaB kinase/NF-kappaB
xsq OGFOD3 17q25.3 0.134 0.308 0.798
exp DPF2 11q13 0.134 0.308 0.798 Apoptosis
met IFT57 3q13.13 0.134 0.308 0.798 activation of cysteine-type endopeptidase
activity involved in apoptotic process;regulation of apoptotic process
xsq MYF6 12q21 0.134 0.308 0.798 regulation of transcription from RNA polymerase
II promoter;positive regulation of transcription from RNA polymerase II promoter
met PTH2 19q13.33 0.134 0.308 0.798 neuropeptide signaling pathway
cop LOC285074 2p11.2 0.134 0.308 0.798
cop LINC00152 2p11.2 0.134 0.308 0.798
xsq ASTE1 3q22.1 0.134 0.308 0.798 DNA repair
mut RALGAPB 20q11.23 0.134 0.308 0.798 activation of Ral GTPase
met EPHA6 3q11.2 0.134 0.308 0.798
cop KIAA1024 15q25.1 0.134 0.308 0.798
exp CSF3R 1p35-p34.3 0.134 0.308 0.798 defense response;cell adhesion
exp EXTL2 1p21 0.134 0.308 0.798 N-acetylglucosamine metabolic process;UDP-N-
acetylgalactosamine metabolic process
xsq POLR1A 2p11.2 0.134 0.308 0.798 transcription initiation from RNA
polymerase I promoter;transcription elongation from RNA polymerase I promoter
cop TMOD4 1q12 0.134 0.308 0.798
cop VPS72 1q21 0.134 0.308 0.798 somatic stem cell maintenance;negative
cop PIP5K1A 1q21.3 0.134 0.308 0.798 phosphorylation;ruffle assembly
cop PSMD4 1q21.3 0.134 0.308 0.798 S phase of mitotic cell cycle;DNA damage
dependent"
cop PI4KB 1q21 0.134 0.308 0.798 phosphatidylinositol biosynthetic
cop RFX5 1q21 0.134 0.308 0.798 negative regulation of transcription from RNA
polymerase II promoter;regulation of transcription, DNA-dependent"
cop SELENBP1 1q21.3 0.134 0.308 0.798 protein transport
cop PSMB4 1q21 0.134 0.308 0.798 S phase of mitotic cell cycle;apoptotic process
cop POGZ 1q21.3 0.134 0.308 0.798 regulation of transcription, DNA-
cop LIMD1-AS1 0.134 0.308 0.798
cop SACM1L 3p21.3 0.134 0.308 0.798
xsq FOXP2 7q31 0.134 0.308 0.798 positive regulation of mesenchymal cell
cop PPIC 5q23.2 -0.134 0.308 0.798 protein folding;signal transduction
cop PRDM6 5q23.2 -0.134 0.308 0.798 chromatin modification;neurogenesis
cop CEP120 5q23.2 -0.134 0.308 0.798 microtubule cytoskeleton
cop CSNK1G3 5q23 -0.134 0.308 0.798 Protein Kinases
exp TMEM184A 7p22.3 -0.134 0.308 0.798
mut KCTD19 16q22.1 -0.134 0.308 0.798 potassium ion transport
cop RNF170 8p11.21 -0.134 0.308 0.798
met TYMS 18p11.32 -0.134 0.308 0.798 DNA Damage Response (DDR)
met LCK 1p34.3 -0.134 0.308 0.798 Protein Kinases
met CD34 1q32 -0.134 0.308 0.798 tissue homeostasis;cell proliferation
met IL21 4q26-q27 -0.134 0.308 0.798 positive regulation of interleukin-
17 production;positive regulation of natural killer cell differentiation
met RNF222 17p13.1 -0.134 0.308 0.798
met ZNF384 12p12 -0.134 0.308 0.798 regulation of transcription, DNA-
met RFPL4B 6q21 -0.134 0.308 0.798
cop SHOX2 3q25.32 -0.134 0.308 0.798 nervous system development;heart
development
cop NIPSNAP3A 9q31.1 -0.134 0.308 0.798
met LOC285768 6p25.3 -0.134 0.308 0.798
cop SEC24A 5q31.1 -0.134 0.308 0.798 ER to Golgi vesicle-mediated
met FAM3D 3p14.2 -0.134 0.308 0.798 negative regulation of insulin
secretion
xsq GOLGA7B 10q24.2 -0.134 0.308 0.798
met NEU1 6p21.3 -0.134 0.308 0.798 sphingolipid metabolic
exp ANKIB1 7q21.2 -0.134 0.308 0.798
met ARRB1 11q13 -0.134 0.308 0.798 cellular membrane organization;positive
xai BBX 3q13.1 -0.135 0.308 0.798 regulation of transcription, DNA-
dependent"
his LYN 8q13 -0.135 0.308 0.798 Protein Kinases
cop PPP2R1A 19q13.41 -0.135 0.308 0.798 Apoptosis; Oncogenes
hs4 TEKT2 1p34.3 -0.135 0.308 0.798 sperm motility;microtubule
his KLHL33 14q11.2 -0.135 0.308 0.798
xai CDH1 16q22.1 -0.135 0.308 0.798 Cell Signaling; Tumor Suppressors
hs4 LARP1 5q33.2 -0.135 0.308 0.798
hs4 KIAA1257 3q21.3 -0.135 0.308 0.798
his FBLN5 14q32.1 -0.135 0.308 0.798 regulation of removal of superoxide
xai F2RL2 5q13 -0.135 0.308 0.798 blood coagulation;response to wounding
hs4 C17orf98 -0.135 0.308 0.798
xai SRI 7q21.1 -0.135 0.308 0.798 regulation of action
potential;regulation of heart contraction
hs4 ENTPD8 9q34.3 -0.135 0.308 0.798 nucleoside monophosphate
swa MCFD2 2p21 -0.135 0.308 0.798 protein transport;vesicle-mediated
transport
exp RPL32P9 3q25.1 -0.135 0.308 0.798
cop LILRA3 -0.135 0.308 0.798
cop LILRA5 19q13.4 -0.135 0.308 0.798 innate immune response
cop LILRA4 19q13.4 -0.135 0.308 0.798
cop LAIR1 19q13.4 -0.135 0.308 0.798
hs4 C16orf45 16p13.11 -0.135 0.308 0.798
hs4 BMP1 8p21.3 -0.135 0.308 0.798 cartilage condensation;positive
regulation of cartilage development
hs4 LOC101927851 -0.135 0.308 0.798
his CDR2L 17q25.1 -0.135 0.308 0.798
hs4 OPCML 11q25 -0.135 0.308 0.798 cell adhesion;neuron recognition
xai ATG101 -0.135 0.308 0.798 autophagic vacuole
assembly;autophagy
his TMEM150B 19q13.42 -0.135 0.308 0.798
hs4 HMGCLL1 6p12.1 -0.135 0.308 0.798
exp FTH1P3 2p23.3 -0.135 0.308 0.798
xai PLEKHH1 14q24.1 -0.135 0.308 0.798
xai RHOJ 14q23.2 -0.135 0.308 0.798 GTP catabolic process;small GTPase
xai DOCK6 19p13.2 -0.135 0.308 0.798 blood coagulation
xai STEAP2 7q21.13 -0.135 0.308 0.798 regulated secretory
hs4 CCIN 9p13.3 -0.135 0.308 0.798 multicellular organismal
hs4 PJA1 Xq13.1 -0.135 0.308 0.798 protein catabolic process
xai FCRL6 1q23.2 -0.135 0.308 0.798
hs4 S1PR2 19p13.2 -0.135 0.308 0.798 G-protein coupled receptor
signaling pathway;behavior
hs4 MIR4322 -0.135 0.308 0.798
xai MIR199A1 -0.135 0.308 0.798
cop THAP11 16q22.1 0.136 0.309 0.798 regulation of transcription, DNA-
dependent"
his LRRCC1 8q21.2 0.135 0.309 0.798 cell cycle;mitosis
his OVCH1-AS1 0.135 0.309 0.798
hs4 ALMS1 2p13 0.135 0.309 0.798 sensory perception of sound;epithelial cell
proliferation
his TBC1D14 4p16.1 0.135 0.309 0.798
his LOC105274304 0.135 0.309 0.798
swa VPS29 12q24 0.135 0.309 0.798 protein transport
his CARM1 19p13.2 0.135 0.309 0.798 chromatin modification;peptidyl-arginine
N-methylation
hs4 HES5 1p36.32 0.135 0.309 0.798 cell adhesion;glial cell fate commitment
swa HSPA14 10p13 0.135 0.309 0.798 'de novo' cotranslational protein folding
his MRPS28 8q21.1-q21.2 0.135 0.309 0.798
xai ABCG1 21q22.3 0.135 0.309 0.798 ABC Transporters
his PFDN5 12q12 0.135 0.309 0.798 protein folding;cellular protein metabolic
process
his C12orf10 12q13 0.135 0.309 0.798 pigmentation
swa RPS15 19p13.3 0.135 0.309 0.798 ribosomal small subunit export from
hs4 CCT3 1q23 0.135 0.309 0.798 protein folding;cellular protein metabolic
process
hs4 TSACC 1q22 0.135 0.309 0.798
xai ATP5C1 10p15.1 0.135 0.309 0.798 ATP biosynthetic process;ion
transport
hs4 ATOH1 4q22 0.135 0.309 0.798 brain development;neuron migration
hs4 LUC7L3 17q21.33 0.135 0.309 0.798 mRNA processing;apoptotic process
his UBA5 3q22.1 0.135 0.309 0.798 oxidation-reduction process;protein
ufmylation
his ACAD11 3q22.1 0.135 0.309 0.798 fatty acid beta-oxidation using
acyl-CoA dehydrogenase
xai USP4 3p21.3 0.135 0.309 0.798 negative regulation of protein
his IKBIP 12q23.1 0.135 0.309 0.798 EMT (Mesenchymal)
his APAF1 12q23 0.135 0.309 0.798 Apoptosis
his ZMPSTE24 1p34 0.135 0.309 0.798 proteolysis;nuclear envelope organization
xai NDUFS5 1p34.2-p33 0.135 0.309 0.798 mitochondrial electron transport,
his RNF2 1q25.3 0.135 0.309 0.798 negative regulation of transcription from
RNA polymerase II promoter;mitotic cell cycle
hs4 ADPRHL1 13q34 0.135 0.309 0.798 protein de-ADP-ribosylation
xai OLA1P1 22q13.2 0.135 0.309 0.798
exp GNL3 3p21.1 0.135 0.309 0.798 regulation of cell proliferation
hs4 C16orf95 0.135 0.309 0.798
hs4 LOC101928659 0.135 0.309 0.798
xai KIAA1211 4q12 0.135 0.309 0.798
exp VN1R108P 0.135 0.309 0.798
dependent"
dependent"
hs4 MRPL38 17q25.3 0.135 0.309 0.798
hs4 CARF 2q33.2 0.135 0.309 0.798
hs4 WDR12 2q33.2 0.135 0.309 0.798 maturation of LSU-rRNA from tricistronic
rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from
tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
met DNTTIP2 1p22.1 0.134 0.309 0.798 DNA Damage Response (DDR); DDR (DNA
replication)
xsq ENO1-AS1 0.134 0.309 0.798
exp URB1 21q22.11 0.134 0.309 0.798
xsq TWF2 3p21.1 0.134 0.309 0.798 sequestering of actin monomers;positive
exp LETMD1 12q13.12 0.134 0.309 0.798
xsq SPATA5 4q28.1 0.134 0.309 0.798 multicellular organismal
cop TMEM138 11q12.2 0.134 0.309 0.798
xsq DNLZ 9q34.3 0.134 0.309 0.798
xsq DIDO1 20q13.33 0.134 0.309 0.798 transcription, DNA-dependent;apoptotic
process"
xsq SDHAF2 11q12.2 0.134 0.309 0.798 mitochondrial electron transport,
xsq G2E3 14q12 0.134 0.309 0.798 protein modification process;multicellular
met MAP3K12 12q13 0.134 0.309 0.798 Protein Kinases
exp FZD8 10p11.21 0.134 0.309 0.798 positive regulation of protein
promoter
xsq LINC00443 0.134 0.309 0.798
met CYP4X1 1p33 0.134 0.309 0.798
xsq ENDOV 17q25.3 0.134 0.309 0.798 DNA repair
cop C11orf84 11q13.1 0.134 0.309 0.798
xsq CPNE6 14q11.2 0.134 0.309 0.798 lipid metabolic process;synaptic
transmission
mut HIPK1 1p13.2 0.134 0.309 0.798 eye development;regulation of
cop TUBAL3 10p15.1 0.134 0.309 0.798 microtubule-based movement;protein
polymerization
met AP5M1 14q22.3 0.134 0.309 0.798 intracellular protein transport;vesicle-
mediated transport
xsq LINC01567 0.134 0.309 0.798
cop DDX42 17q23.3 0.134 0.309 0.798 regulation of anti-apoptosis;protein
localization
xsq CPLX2 5q35.2 0.134 0.309 0.798 neurotransmitter transport;vesicle
xsq H1FOO 3q22.1 0.134 0.309 0.798 nucleosome assembly;meiosis
xsq SNRPE 1q32 0.134 0.309 0.798 histone mRNA metabolic process;RNA splicing
exp C16orf46 16q23.2 0.134 0.309 0.798
xsq SSR4P1 21q22.3 0.134 0.309 0.798
exp MON1A 3p21.31 0.134 0.309 0.798
cop KRT18P55 17q11.2 0.134 0.309 0.798
met GEMIN4 17p13 0.134 0.309 0.798 RNA metabolic process;ncRNA metabolic
process
mut PDGFD 11q22.3 0.134 0.309 0.798 multicellular organismal
xsq OR5B12 0.134 0.309 0.798
xsq DMAP1 1p34 0.134 0.309 0.798 negative regulation of transcription from RNA
polymerase II promoter;DNA methylation
xsq EEF1E1 6p24.3 0.134 0.309 0.798 Apoptosis
xsq PBX2 6p21.3 0.134 0.309 0.798 positive regulation of transcription from
met ENTPD4 8p21.3 0.134 0.309 0.798 UDP catabolic process
xsq RNF10 12q24.31 0.133 0.309 0.798 negative regulation of Schwann cell
xsq OPN5 6p12.3 0.133 0.309 0.798 protein-chromophore linkage;response to
stimulus
cop ANKRD16 10p15.1 0.133 0.309 0.798
met TGFBRAP1 2q12.1 0.133 0.309 0.798 regulation of transcription, DNA-
xsq PCIF1 20q13.12 0.133 0.309 0.798 negative regulation of phosphatase
activity
met CADPS 3p14.2 0.133 0.309 0.798 exocytosis;protein transport
xsq POLR2L 11p15 0.133 0.309 0.798 DNA Damage Response (DDR); DDR (NER)
xsq SCTR 2q14.1 0.133 0.309 0.798 digestion;excretion
mut HIP1R 12q24 0.133 0.309 0.798 receptor-mediated endocytosis
xsq TSSK6 19p13.11 0.133 0.309 0.798 cell differentiation;sperm chromatin
condensation
xsq ZNF843 16p11.2 0.133 0.309 0.798
xsq MSANTD2 11q24.2 0.133 0.309 0.798
met ZDHHC15 Xq13.3 0.133 0.309 0.798 synaptic vesicle maturation;protein
palmitoylation
mut MRPL20 1p36.3-p36.2 0.133 0.309 0.798 translation
exp LOC100506965 0.133 0.309 0.798
exp ATF4 22q13.1 0.133 0.309 0.798 activation of signaling protein activity
response
met PREPL 2p21 0.133 0.309 0.798 proteolysis
xsq JAZF1-AS1 7p15.1 0.133 0.309 0.798
xsq C9orf106 9q34.11 -0.133 0.309 0.798
mut GJB4 1p34.3 -0.133 0.309 0.798 sensory perception of
smell;olfactory behavior
met FAM219A 9p13.3 -0.133 0.309 0.798
cop PLS1 3q23 -0.133 0.309 0.798
cop FLJ33360 5p15.31 -0.134 0.309 0.798
xsq UGT2A1 4q13 -0.134 0.309 0.798
cop ADAM9 8p11.22 -0.134 0.309 0.798 membrane protein ectodomain
cop MROH8 20q11.22 -0.134 0.309 0.798
exp SRC 20q12-q13 -0.134 0.309 0.798 Apoptosis; Oncogenes; Protein
Kinases
cop WWC1 5q34 -0.134 0.309 0.798 regulation of transcription, DNA-
cop PCOLCE2 3q21-q24 -0.134 0.309 0.798 positive regulation of
peptidase activity
met LGALS4 19q13.2 -0.134 0.309 0.798 cell adhesion
xsq HECW2 2q32.3 -0.134 0.309 0.798 protein modification
process
met PAPSS1 4q24 -0.134 0.309 0.798 3'-phosphoadenosine 5'-
phosphosulfate metabolic process;3'-phosphoadenosine 5'-phosphosulfate biosynthetic
process
exp CDH16 16q22.1 -0.134 0.309 0.798 cell adhesion;homophilic cell
adhesion
cop BID 22q11.1 -0.134 0.309 0.798 Apoptosis
met GSTO1 10q25.1 -0.134 0.309 0.798 cellular response to arsenic-
containing substance;xenobiotic metabolic process
xsq GRINA 8q24.3 -0.134 0.309 0.798
xsq CBLB 3q13.11 -0.134 0.309 0.798 response to gravity;response to
hormone stimulus
xsq SPINK1 5q32 -0.134 0.309 0.798 negative regulation of
met SBF1 22q13.33 -0.134 0.309 0.798 protein dephosphorylation
hs4 PLXNB1 3p21.31 -0.135 0.309 0.798 negative regulation of
xai HCG4 6p21.3 -0.135 0.309 0.798
exp FCRL6 1q23.2 -0.135 0.309 0.798
xai GS1-124K5.11 -0.135 0.309 0.798
hs4 FGD3 -0.135 0.309 0.798 regulation of Cdc42 GTPase
xai LRRIQ1 12q21.31 -0.135 0.309 0.798
xai COQ6 14q24.3 -0.135 0.309 0.798 ubiquinone biosynthetic process
xai LOC642533 16q24.3 -0.135 0.309 0.798
hs4 EXOC6B 2p13.2 -0.135 0.309 0.798 protein transport;vesicle
xai PQLC3 2p25.1 -0.135 0.309 0.798
xai LRRC8A 9q34.11 -0.135 0.309 0.798 pre-B cell
differentiation;cell differentiation
xai ARL4C 2q37.1 -0.135 0.309 0.798 GTP catabolic process;transport
hs4 ATP2B4 1q32.1 -0.135 0.309 0.798 ion transmembrane
xai KRT18P57 1p13.2 -0.135 0.309 0.798
hs4 MUM1L1 Xq22.3 -0.135 0.309 0.798
DNA-dependent"
exp WAC-AS1 -0.135 0.309 0.798
xai MFAP5 12p13.1-p12.3 -0.135 0.309 0.798
xai SEL1L3 4p15.2 -0.135 0.309 0.798
xai GBE1 3p12.3 -0.135 0.309 0.798 carbohydrate metabolic
hs4 SYNJ2BP-COX16 -0.135 0.309 0.798
hs4 SYNJ2BP 14q24.2 -0.135 0.309 0.798 intracellular distribution of
mitochondria
xai LOC100505798 -0.135 0.309 0.798
xai ADIG 20q11.23 -0.135 0.309 0.798 positive regulation of fat cell
exp CFAP126 -0.135 0.309 0.798
xai MALT1 18q21 -0.135 0.309 0.798 Apoptosis
xai CCL11 17q12 -0.136 0.309 0.798 immune response;positive regulation of
cell migration
xai BAIAP2-AS1 17q25.3 -0.136 0.309 0.798
hs4 DLD 7q31-q32 0.135 0.31 0.798 pyruvate metabolic process;branched chain
xai SNORA60 20q11.23 0.135 0.31 0.798
exp CYP4F24P 19p13.12 0.135 0.31 0.798
hs4 CIAPIN1 16q21 0.135 0.31 0.798 apoptotic process;anti-apoptosis
hs4 COQ9 16q21 0.135 0.31 0.798 ubiquinone biosynthetic process
his LINC01730 0.135 0.31 0.798
his AP5S1 20p13 0.135 0.31 0.798 double-strand break repair via homologous
xai LOC728485 19q13.12 0.135 0.31 0.798
xai CCDC33 15q24.1 0.134 0.31 0.798
xai IDH2 15q26.1 0.134 0.31 0.798 Oncogenes
hs4 MIR5684 0.134 0.31 0.798
hs4 JUNB 19p13.2 0.134 0.31 0.798 vasculogenesis;response to organic cyclic
compound
his LINC00689 7q36.3 0.134 0.31 0.799
xai CPT1C 19q13.33 0.134 0.31 0.799 lipid metabolic process;fatty acid
metabolic process
his EDA Xq12-q13.1 0.134 0.31 0.799 signal transduction;pigmentation
his LOC100130899 0.134 0.31 0.799
his ITPR2 12p11 0.134 0.31 0.799 activation of phospholipase C
activity;transmembrane transport
xai UBE2MP1 16p11.2 0.134 0.31 0.799
exp LOC441239 7q11.21 0.134 0.31 0.799
his VIPR2 7q36.3 0.134 0.31 0.799 G-protein coupled receptor signaling
hs4 TEX9 15q21.3 0.134 0.31 0.799
his ASRGL1 11q12.3 0.134 0.31 0.799 asparagine catabolic process via L-
xai KPTN 19q13.32 0.134 0.31 0.799 cellular component movement;actin
hs4 TAF6 7q22.1 0.134 0.31 0.799 transcription elongation from RNA
hs4 CNPY4 7q22.1 0.134 0.31 0.799
xai RALGDS 9q34.3 0.134 0.31 0.799 Ras protein signal
his GPR132 14q32.3 0.134 0.31 0.799 G1/S transition of mitotic cell
his GPI 19q13.1 0.134 0.31 0.799 hemostasis;small molecule metabolic
process
exp LOC100131347 17q12 0.134 0.31 0.799
xai CNBP 3q21 0.134 0.31 0.799 regulation of transcription, DNA-
his GTF2H2C 5q13.2 0.134 0.31 0.799
xai LINC00852 3p25.3 0.134 0.31 0.799
his TERF1 8q21.11 0.134 0.31 0.799 DNA Damage Response (DDR)
xai ACO2 22q13.2 0.134 0.31 0.799 generation of precursor metabolites and
xai GRHL3 1p36.11 0.134 0.31 0.799 epidermis development;positive regulation
his NBEAL1 2q33.2 0.134 0.31 0.799
his TXNDC12-AS1 0.134 0.31 0.799
his TXNDC12 1p32.3 0.134 0.31 0.799 cell redox homeostasis
his BTF3L4 1p32.3 0.134 0.31 0.799
hs4 SCD 10q24.31 0.134 0.31 0.799 fatty acid biosynthetic process
swa XRCC1 19q13.2 0.134 0.31 0.799 DNA Damage Response (DDR); DDR (BER)
xsq TMEM39A 3q13.33 0.133 0.31 0.798
xsq ISPD 7p21.2 0.133 0.31 0.798 isoprenoid biosynthetic process
cop GJB1 Xq13.1 0.133 0.31 0.798 transport;cell-cell signaling
met FPR1 19q13.4 0.133 0.31 0.798 signal transduction;G-protein coupled
cop SNX12 Xq13.1 0.133 0.31 0.798 cell communication;protein transport
met LACTB2 8q13.3 0.133 0.31 0.798
cop NLGN3 Xq13.1 0.133 0.31 0.798 social behavior;axon extension
met CLN8 8p23 0.133 0.31 0.798 lysosome organization;somatic motor neuron
differentiation
met EDNRB 13q22 0.133 0.31 0.798 peripheral nervous system
development;vasoconstriction
xsq AMER3 2q21.1 0.133 0.31 0.798
met OR10H1 19p13.1 0.133 0.31 0.798
xsq ARAP1 11q13.4 0.133 0.31 0.798 actin filament reorganization involved in
xsq CYP24A1 20q13 0.133 0.31 0.798 steroid metabolic process;response to
vitamin D
xsq MYO7A 11q13.5 0.133 0.31 0.798 inner ear morphogenesis;phagolysosome
assembly
met PCDH19 Xq22.1 0.133 0.31 0.798 cell adhesion;homophilic cell
adhesion
cop FOXO4 Xq13.1 0.133 0.31 0.798 Apoptosis
cop CXorf65 Xq13.1 0.133 0.31 0.798
cop IL2RG Xq13.1 0.133 0.31 0.798 immune response;signal transduction
cop MED12 Xq13 0.133 0.31 0.798 Oncogenes
xsq FAM53C 5q31 0.133 0.31 0.799
cop ZFYVE20 3p25.1 0.133 0.31 0.799
xsq LOC400620 0.133 0.31 0.799
dependent"
met METTL15 11p14.1 0.133 0.31 0.799
mut TRPM8 2q37.1 0.133 0.31 0.799 thermoception;protein homotetramerization
exp ITGAM 16p11.2 0.133 0.31 0.799 cell adhesion;integrin-mediated signaling
pathway
mut PLEKHG3 14q23.3 0.133 0.31 0.799 regulation of Rho protein signal
transduction
cop PHB 17q21 0.133 0.31 0.799 Apoptosis
cop NGFR 17q21-q22 0.133 0.31 0.799 regulation of gene expression;skin
development
exp OSCAR 19q13.42 0.133 0.31 0.799
mut CPPED1 16p13.12 0.133 0.31 0.799
xsq UQCC1 0.133 0.31 0.799
exp ZFAS1 20q13.13 0.133 0.31 0.799
cop BUB1B 15q15 0.133 0.31 0.799 DNA Damage Response (DDR)
cop KIZ 0.133 0.31 0.799 spindle organization
cop XRN2 20p11.2-p11.1 0.133 0.31 0.799 RNA processing;mRNA processing
cop NKX2-4 20p11.22 0.133 0.31 0.799 multicellular organismal
development
cop NKX2-2 20p11.22 0.133 0.31 0.799 brain development;digestive tract
development
mut TSC1 9q34 0.133 0.31 0.799 Apoptosis; Protein Kinases; Tumor Suppressors
met URB2 1q42.13 0.133 0.31 0.799
cop CHST11 12q 0.133 0.31 0.799 chondroitin sulfate biosynthetic
met OXTR 3p25 0.133 0.31 0.799 cell surface receptor signaling
xsq KPNB1 17q21.32 0.133 0.31 0.799 NLS-bearing substrate import into
xsq NLRP6 11p15 0.133 0.31 0.799 regulation of inflammatory response
cop FAM208B 10p15.1 0.133 0.31 0.799
cop GDI2 10p15 0.133 0.31 0.799 signal transduction;small GTPase mediated
signal transduction
cop LOC284801 0.133 0.31 0.799
cop MIR663A 0.133 0.31 0.799
exp BCKDHA 19q13.1-q13.2 0.133 0.31 0.799 branched chain family amino
met TP53RK 20q13.2 0.133 0.31 0.799 protein
phosphorylation;lipopolysaccharide biosynthetic process
mut OR5K4 0.133 0.31 0.799
xsq C1orf110 1q23.3 -0.133 0.31 0.799
xsq LOC101928731 -0.133 0.31 0.799
xsq LOC90768 -0.133 0.31 0.799
exp NOX1 Xq22 -0.133 0.31 0.799 angiogenesis;regulation of blood pressure
cop LRRC19 9p21.2 -0.133 0.31 0.799
xsq IFNL2 -0.133 0.31 0.799
exp SLC52A3 20p13 -0.133 0.31 0.799 transport;sensory perception of
sound
mut WDR5B 3q21.1 -0.133 0.31 0.799
xsq STON1 2p16.3 -0.133 0.31 0.799 intracellular protein
xsq IQCJ-SCHIP1-AS1 -0.133 0.31 0.799
exp C1RL 12p13.31 -0.133 0.31 0.799 proteolysis;complement activation,
classical pathway
exp BTBD9 6p21 -0.133 0.31 0.799 cell adhesion
mut TRIM3 11p15.5 -0.133 0.31 0.799 nervous system development;protein
transport
xsq TNNC1 3p21.1 -0.133 0.31 0.799 regulation of muscle
cop IFT74 9p21.2 -0.133 0.31 0.799
met ST6GALNAC1 17q25.1 -0.133 0.31 0.799 protein glycosylation
exp IER5 1q25.3 -0.133 0.31 0.798
xsq DEFB125 20p13 -0.133 0.31 0.798
exp GNAQ 9q21 -0.133 0.31 0.798 Oncogenes
met ROR2 9q22 -0.133 0.31 0.798 skeletal system development;negative
met CTHRC1 8q22.3 -0.133 0.31 0.798 cell migration;positive
met UHRF2 9p24.1 -0.133 0.31 0.798 positive regulation of cell cycle
arrest;ubiquitin-dependent protein catabolic process
xai C1GALT1C1 Xq24 -0.134 0.31 0.799 post-translational protein
xai OGDH 7p14-p13 -0.134 0.31 0.799 oxidation-reduction
DNA-dependent"
cop TARM1 19q13.42 -0.134 0.31 0.799
his BARX2 11q25 -0.134 0.31 0.799 negative regulation of transcription from
RNA polymerase II promoter;cartilage condensation
swa GAPDHS 19q13.12 -0.134 0.31 0.799 small molecule metabolic
xai SPTBN1 2p21 -0.134 0.31 0.799 axon guidance;actin filament
capping
xai LOC100134368 16p13.3 -0.134 0.31 0.799
hs4 ANK3 10q21 -0.134 0.31 0.799 signal transduction;establishment of
xai BCAN 1q31 -0.134 0.31 0.799 cell adhesion;hippocampus development
xai DENND5B 12p11.21 -0.134 0.31 0.799
xai PRKACA 19p13.1 -0.134 0.31 0.799 Protein Kinases
hs4 GRAMD1A 19q13.13 -0.134 0.31 0.799
exp LINC00601 -0.134 0.31 0.799
xai SPTSSA 14q13.1 -0.134 0.31 0.799 sphingolipid biosynthetic
process
cop SIGLEC6 19q13.3 -0.134 0.31 0.799 cell adhesion;cell-cell
signaling
hs4 MPLKIP 7p14.1 -0.134 0.31 0.799 DNA Damage Response (DDR)
hs4 SUGCT -0.134 0.31 0.799
exp KRT18P57 1p13.2 -0.134 0.31 0.799
swa ALB 4q13.3 -0.134 0.31 0.799 response to stress;platelet
activation
DNA-dependent"
hs4 VN1R2 19q13.42 -0.134 0.31 0.799 response to pheromone
exp LOC100506885 -0.134 0.31 0.799
his LINC01297 -0.134 0.31 0.799
xai DNM1P50 -0.134 0.31 0.799
his RP9P 7p14.3 -0.134 0.31 0.798
his MIR4430 -0.135 0.31 0.798
xai PLGRKT 9p24.1 -0.135 0.31 0.798 positive regulation of
hs4 OAS2 12q24.2 -0.135 0.31 0.798 purine nucleotide biosynthetic
exp PCDHGB8P -0.135 0.31 0.798
his HLA-F 6p21.3 -0.135 0.31 0.798 antigen processing and presentation
hs4 TRABD2B 1p33 -0.135 0.31 0.798
cop MIR3198-1 -0.135 0.31 0.798
hs4 MAT1A 10q22 -0.135 0.31 0.798 xenobiotic metabolic process;methylation
his L3MBTL1 20q13.12 -0.135 0.31 0.798 regulation of
mitosis;chromatin modification
hs4 IFT172 2p23.3 -0.135 0.31 0.798 protein processing;cilium
assembly
xai IQSEC1 3p25.2 -0.135 0.31 0.798 regulation of ARF protein
signal transduction
dependent"
hs4 TATDN2 3p25.3 0.134 0.311 0.799 activation of signaling protein
activity involved in unfolded protein response;endoplasmic reticulum unfolded
protein response
swa FECH 18q21.3 0.134 0.311 0.799 generation of precursor metabolites and
xai RFX8 2q11.2 0.134 0.311 0.799 regulation of transcription, DNA-
dependent"
hs4 C10orf91 10q26.3 0.134 0.311 0.799
his NDUFA11 19p13.3 0.134 0.311 0.799 transport;respiratory electron
transport chain
his VMAC 19p13.3 0.134 0.311 0.799
hs4 PPAN-P2RY11 19p13 0.134 0.311 0.799
hs4 ANGPTL6 19p13.2 0.134 0.311 0.799 angiogenesis;signal transduction
hs4 PPAN 19p13 0.134 0.311 0.799
hs4 SNORD105 0.134 0.311 0.799
hs4 SNORD105B 0.134 0.311 0.799
xai L3MBTL3 6q23 0.134 0.311 0.799 regulation of transcription, DNA-
hs4 RPL32 3p25-p24 0.134 0.311 0.799 SRP-dependent cotranslational protein
hs4 SNORA7A 3p25 0.134 0.311 0.799
hs4 CYB5B 16q22.1 0.134 0.311 0.799 transport;electron transport chain
hs4 ADA 20q13.12 0.134 0.311 0.799 in utero embryonic development;negative
regulation of mature B cell apoptosis
exp FOXP3 Xp11.23 0.134 0.311 0.799 T cell mediated immunity;regulation of
xai IGFLR1 19q13.12 0.134 0.311 0.799
exp LOC100506699 0.134 0.311 0.799
his BDP1 5q13 0.134 0.311 0.799 regulation of transcription, DNA-
xai EIF2S2P3 10q23.33 0.134 0.311 0.799
hs4 SCT 11p15.5 0.134 0.311 0.799
exp HOXB1 17q21.3 0.134 0.311 0.799 facial nerve structural
hs4 H3F3B 17q25.1 0.134 0.311 0.799 nucleosome assembly;blood coagulation
xai OR51I1 0.134 0.311 0.799 sensory perception of smell;response to
stimulus
exp PROSER2-AS1 0.134 0.311 0.799
hs4 CENPP 9q22.31 0.134 0.311 0.799 M phase of mitotic cell cycle;mitotic
prometaphase
hs4 NOL8 9q22.31 0.134 0.311 0.799 DNA replication;rRNA processing
xai LRRD1 7q21.2 0.134 0.311 0.799 signal transduction
dependent"
dependent"
his NPTXR 22q13.1 0.134 0.311 0.799 response to hydrogen peroxide
cop ADRA2C 4p16 0.134 0.311 0.799 platelet activation;activation of protein
kinase B activity
his VEGFB 11q13 0.134 0.311 0.799 positive regulation of vascular endothelial
growth factor receptor signaling pathway;positive regulation of cell division
his FKBP2 11q13.1-q13.3 0.134 0.311 0.799 protein peptidyl-prolyl
his LOC105369340 0.134 0.311 0.799
exp LPA 6q26 0.134 0.311 0.799 transport;lipid transport
his ALDOA 16p11.2 0.134 0.311 0.799 striated muscle contraction;protein
homotetramerization
his TBC1D1 4p14 0.134 0.311 0.799 regulation of protein localization
xai OR52E3P 11p15.4 0.134 0.311 0.799
his CMIP 16q23 0.134 0.311 0.799
hs4 EIF4E 4q21-q25 0.134 0.311 0.799 translation;cellular protein metabolic
process
his LOC102724532 0.134 0.311 0.799
his SP2 17q21.32 0.134 0.311 0.799 regulation of transcription from RNA
hs4 CCDC183 0.134 0.311 0.799
met PTF1A 10p12.2 0.133 0.311 0.799 exocrine pancreas development;endocrine
pancreas development
met CSGALNACT1 8p21.3 0.133 0.311 0.799 heparan sulfate proteoglycan
biosynthetic process, polysaccharide chain biosynthetic process;dermatan sulfate
cop FTSJ3 17q23.3 0.133 0.311 0.799 RNA methylation;rRNA processing
cop PSMC5 17q23.3 0.133 0.311 0.799 S phase of mitotic cell cycle;regulation
cop SMARCD2 17q23.3 0.133 0.311 0.799 nucleosome disassembly;chromatin
remodeling
cop TCAM1P 17q23.3 0.133 0.311 0.799
cop CSH2 17q24.2 0.133 0.311 0.799
cop GH2 0.133 0.311 0.799
cop CSH1 17q24.2 0.133 0.311 0.799 signal transduction;female pregnancy
mut ZNF91 19p12 0.133 0.311 0.799 regulation of transcription, DNA-dependent"
met NPC2 14q24.3 0.133 0.311 0.799 phospholipid transport;regulation of
isoprenoid metabolic process
xsq SYNPO2L 10q22.2 0.133 0.311 0.799
exp HIC1 17p13.3 0.133 0.311 0.799 negative regulation of transcription from
exp C6orf136 6p21.33 0.133 0.311 0.799
cop ECM1 1q21 0.133 0.311 0.799 positive regulation of endothelial cell
cop LINC00568 0.133 0.311 0.799
cop ADAMTSL4 1q21.3 0.133 0.311 0.799 extracellular matrix
organization;positive regulation of apoptotic process
cop MIR4257 0.133 0.311 0.799
cop MCL1 1q21 0.133 0.311 0.799 Apoptosis
cop ENSA 1q21.3 0.133 0.311 0.799 response to nutrient;cell division
xsq ADARB2 10p15.3 0.133 0.311 0.799 mRNA processing;RNA processing
xsq LOC101929412 0.133 0.311 0.799
exp ETV5 3q28 0.133 0.311 0.799 Transcription Factors
exp ORAI2 7q22.1 0.133 0.311 0.799
xsq MOB1B 4q13.3 0.133 0.311 0.799 hippo signaling cascade;positive
cop TC2N 14q32.12 0.133 0.311 0.799
cop LOC729121 0.133 0.311 0.799
cop RGPD4 0.133 0.311 0.799 protein targeting to Golgi;intracellular
transport
cop UVSSA 4p16.3 0.133 0.311 0.799 DNA Damage Response (DDR); DDR (NER)
met ADRA1D 20p13 0.133 0.311 0.799 multicellular organismal development;cell
proliferation
mut UBE4B 1p36.3 0.133 0.311 0.799 Apoptosis
xsq BMP7-AS1 0.133 0.311 0.799
xsq KCNJ18 0.133 0.311 0.799
cop DTX1 12q24.13 0.133 0.311 0.799 transcription, DNA-
xsq ANKRD26P1 16q11.2 0.133 0.311 0.799
xsq TCEB3 1p36.1 0.133 0.311 0.799 DNA Damage Response (DDR); DDR (NER)
xsq MRPL45P2 0.133 0.311 0.799
xsq DNAJC24 11p13 0.133 0.311 0.799 protein folding
dependent"
xsq FXR1 3q28 0.133 0.311 0.799 Apoptosis
met ALKBH7 19p13.3 0.133 0.311 0.799 DNA Damage Response (DDR)
exp TYW1 7q11.21 0.133 0.311 0.799 tRNA processing
cop MIR708 0.133 0.311 0.799
cop MIR5579 0.133 0.311 0.799
xsq CD160 1q21.1 0.133 0.311 0.799 cell surface receptor signaling
pathway;cell proliferation
xsq ATP5J 21q21.1 0.133 0.311 0.799 ATP catabolic process;transport
met GPC4 Xq26.1 0.133 0.311 0.799 cell proliferation;anatomical structure
morphogenesis
cop LOC727982 0.133 0.311 0.799
exp IGHV3-33 0.133 0.311 0.799
met PCTP 17q21-q24 0.133 0.311 0.799 lipid transport;cholesterol metabolic
process
xsq ABLIM2 4p16.1 0.133 0.311 0.799 cytoskeleton organization;axon
guidance
xsq GUCY2GP 10q25.2 0.133 0.311 0.799
mut TATDN1 8q24.13 0.133 0.311 0.799
xsq ZNF236 18q22-q23 0.133 0.311 0.799 regulation of transcription, DNA-
dependent"
exp ZC3H12B Xq12 0.133 0.311 0.799
dependent"
met REG3G 2p12 0.133 0.311 0.799
cop ATP5H 17q25 0.133 0.311 0.799 ATP catabolic process;ion transport
cop ARMC7 17q25.1 0.133 0.311 0.799
cop NT5C 17q25.1 0.133 0.311 0.799 purine base metabolic process;nucleobase-
cop HN1 17q25.1 0.133 0.311 0.799
cop SUMO2 17q25.1 0.133 0.311 0.799 DNA Damage Response (DDR)
cop NUP85 17q25.1 0.133 0.311 0.799 protein transport;transmembrane transport
cop GGA3 17q25.1 0.133 0.311 0.799 intracellular protein transport;vesicle-
mediated transport
cop MRPS7 17q25 0.133 0.311 0.799 translation
cop MIF4GD 17q25.1 0.133 0.311 0.799 RNA metabolic process;regulation of
translation
cop LOC100287042 17q25.1 0.133 0.311 0.799
dependent"
xsq CDPF1 22q13.31 0.133 0.311 0.799
xsq SMPD4 2q21.1 0.133 0.311 0.799 sphingomyelin catabolic
xsq HIST2H2AA3 0.133 0.311 0.799
exp KITLG 12q22 -0.133 0.311 0.799 ovarian follicle development;hemopoiesis
mut GYS1 19q13.3 -0.133 0.311 0.799 small molecule metabolic
mut ESYT1 12q13.2 -0.133 0.311 0.799
xsq WFDC3 20q13.12 -0.133 0.311 0.799
exp KIF21A 12q12 -0.133 0.311 0.799 microtubule-based movement
xsq TMEM171 5q13.2 -0.133 0.311 0.799
exp FAM32C 10q22.2 -0.133 0.311 0.799
met TRAPPC5 19p13.2 -0.133 0.311 0.799 vesicle-mediated transport
met MTFP1 22q -0.133 0.311 0.799 mitochondrial fission;apoptotic process
exp PSD3 8p21.3 -0.133 0.311 0.799 regulation of ARF protein signal
transduction
exp DGCR11 22q11.21 -0.133 0.311 0.799
met NPPA 1p36.21 -0.133 0.311 0.799 receptor guanylyl cyclase signaling
pathway;regulation of blood pressure
cop FNTA 8p11 -0.133 0.311 0.799 transforming growth factor beta receptor
xsq NRIP3 11p15.3 -0.133 0.311 0.799 proteolysis
cop FAIM 3q22.3 -0.133 0.311 0.799 Apoptosis
cop PIK3CB 3q22.3 -0.133 0.311 0.799 Oncogenes; Protein Kinases
met CCL22 16q13 -0.133 0.311 0.799 immune response;signal transduction
exp PEX11G 19p13.2 -0.133 0.311 0.799
exp MYO9B 19p13.1 -0.133 0.311 0.799 positive regulation of Rho GTPase
xsq C18orf32 18q21.1 -0.133 0.311 0.799 signal transduction;positive
exp PXYLP1 -0.133 0.311 0.799
xsq CRTAM 11q24.1 -0.133 0.311 0.799 positive regulation of natural
killer cell mediated cytotoxicity directed against tumor cell target;cell
recognition
exp GDE1 16p12-p11.2 -0.133 0.311 0.799 glycerol metabolic process;lipid
metabolic process
xsq LOC101929555 -0.133 0.311 0.799
xsq PKP2 12p11 -0.133 0.311 0.799 heart development;cell-cell adhesion
xsq TSNAX-DISC1 -0.133 0.311 0.799
met CAPZA3 12p12.3 -0.133 0.311 0.799
exp ERRFI1 1p36 -0.133 0.311 0.799 response to stress;lung vasculature
development
xai HCAR2 12q24.31 -0.134 0.311 0.799 neutrophil apoptosis;apoptotic
process
met SFTPA1 10q22.3 -0.134 0.311 0.799
his ALKBH3-AS1 -0.134 0.311 0.799
hs4 COL1A1 17q21.33 -0.134 0.311 0.799 blood vessel
xai CYLD 16q12.1 -0.134 0.311 0.799 Tumor Suppressors
his LOC100506474 -0.134 0.311 0.799
exp MMEL1 1p36 -0.134 0.311 0.799 proteolysis
hs4 C6orf118 6q27 -0.134 0.311 0.799
xai OR2A3P 7q35 -0.134 0.311 0.799
hs4 ZNF239 10q11.22-q11.23 -0.134 0.311 0.799 regulation of
hs4 TMEM181 6q25.3 -0.134 0.311 0.799 pathogenesis
xai FURIN 15q26.1 -0.134 0.311 0.799 peptide hormone processing;negative
hs4 MIR4715 -0.134 0.311 0.799
his MAPK8 10q11.22 -0.134 0.311 0.799 Apoptosis; Protein Kinases
hs4 TMEM125 1p34.2 -0.134 0.311 0.799 EMT (Epithelial)
xai LOC57399 -0.134 0.311 0.799
hs4 PI16 6p21.2 -0.134 0.311 0.799
xai GCNT1P2 -0.134 0.311 0.799
hs4 IGDCC3 15q22.3-q23 -0.134 0.311 0.799 neuromuscular process
controlling balance
his LOC100507002 -0.134 0.311 0.799
hs4 CXCL16 17p13 -0.134 0.311 0.799 response to tumor necrosis
hs4 ZMYND15 17p13.2 -0.134 0.311 0.799 spermatogenesis;cell
differentiation
exp LINC00260 -0.134 0.311 0.799
hs4 EML1 14q32 -0.134 0.311 0.799
his SSC4D -0.134 0.311 0.799
his TMEM192 4q32.3 -0.134 0.311 0.799
his AK4 1p31.3 -0.134 0.311 0.799
xai RASD2 22q13.1 -0.134 0.311 0.799 synaptic transmission,
met ABHD12B 14q22.1 -0.134 0.311 0.799
xai OR10J3 1q23.2 -0.134 0.311 0.799 response to stimulus
exp C1orf167 1p36.22 -0.134 0.311 0.799
swa LSG1 3q29 -0.134 0.311 0.799 nuclear export;protein transport
DNA-dependent"
cop MIR643 -0.134 0.311 0.799
hs4 MIER3 5q11.2 -0.134 0.311 0.799 regulation of transcription, DNA-
dependent"
hs4 LOC105371328 -0.134 0.311 0.799
his LOC729737 1p36.33 -0.134 0.311 0.799
hs4 EPB41L5 2q14.2 -0.134 0.311 0.799
met MIR518A2 0.135 0.312 0.799
his KIF2A 5q12-q13 0.134 0.312 0.799 mitotic cell cycle;microtubule-based
movement
swa BLMH 17q11.2 0.134 0.312 0.799 protein polyubiquitination;antigen
his AFG3L2 18p11 0.134 0.312 0.799 myelination;proteolysis
swa HMGB3 Xq28 0.134 0.312 0.799 DNA recombination;multicellular organismal
development
xai VN1R108P 0.134 0.312 0.799
his DDX3X Xp11.3-p11.23 0.134 0.312 0.799 interspecies interaction between
organisms
his CXCL11 4q21.2 0.134 0.312 0.799 inflammatory response;immune
response
xai RAD23A 19p13.2 0.134 0.312 0.799 DNA Damage Response (DDR); DDR
(NER)
his FAM208A 3p14.3 0.134 0.312 0.799
his MPHOSPH8 13q12.11 0.134 0.312 0.799 cell cycle;regulation of DNA
methylation
hs4 KNSTRN 15q15.1 0.134 0.312 0.799
xai NPHP4 1p36 0.134 0.312 0.799 signal transduction;visual behavior
xai SETDB2 13q14 0.134 0.312 0.799 heart looping;histone H3-K9 methylation
hs4 NUP62CL Xq22.3 0.134 0.312 0.799 protein transport
hs4 PIH1D3 Xq22.3 0.134 0.312 0.799
his LOC100132077 0.134 0.312 0.799
hs4 PFN3 5q35.3 0.134 0.312 0.799 actin cytoskeleton organization
exp TNXB 6p21.3 0.134 0.312 0.799 actin cytoskeleton organization;collagen
metabolic process
his LPIN1 2p25.1 0.134 0.312 0.799 small molecule metabolic
his FKBP11 12q13.12 0.134 0.312 0.799 protein peptidyl-prolyl
exp LOC441025 0.134 0.312 0.799
his GABARAPL2 16q22.1 0.134 0.312 0.799 positive regulation of ATPase
his HIRA 22q11.21 0.134 0.312 0.799 anatomical structure
his MRPL40 22q11.2 0.134 0.312 0.799 anatomical structure morphogenesis
his AEBP1 7p13 0.134 0.312 0.799 cell adhesion;muscle organ development
xai DMRTC2 19q13.2 0.134 0.312 0.799 regulation of transcription, DNA-
exp MTND4P6 0.134 0.312 0.799
his SS18L2 3p21 0.134 0.312 0.799
his SEC22C 3p22.1 0.134 0.312 0.799 ER to Golgi vesicle-mediated
his LINC00282 13q14.3 0.134 0.312 0.799
his SCAND1 20q11.1-q11.23 0.134 0.312 0.799 regulation of transcription,
his TMEM256-PLSCR3 0.134 0.312 0.799
his TMEM256 17p13.1 0.134 0.312 0.799
his NLGN2 17p13.1 0.134 0.312 0.799 locomotory exploration
hs4 RPS29 14q 0.134 0.312 0.799 mRNA metabolic process;translation
hs4 RN7SL1 0.134 0.312 0.799
hs4 TMEM55A 8q21.3 0.134 0.312 0.799
exp RUNDC1 17q21.31 0.134 0.312 0.799
xai CD177 19q13.2 0.134 0.312 0.799 blood coagulation;leukocyte migration
his RLN3 19p13.2 0.134 0.312 0.799
xai ACPT 19q13.4 0.134 0.312 0.799
xai MEF2C 5q14.3 0.134 0.312 0.799 osteoblast differentiation;regulation of
his CMAS 12p12.1 0.134 0.312 0.799 lipopolysaccharide biosynthetic process
xai MTND4P6 0.134 0.312 0.799
swa PUS1 12q24.33 0.134 0.312 0.799 tRNA processing;metabolic process
xai PANK1 10q23.31 0.134 0.312 0.799 small molecule metabolic process;vitamin
metabolic process
hs4 BUB1 2q14 0.134 0.312 0.799 DNA Damage Response (DDR); Protein Kinases
xai GP2 16p12 0.134 0.312 0.799
cop SMAD2 18q21.1 0.133 0.312 0.799 Apoptosis; Cell Signaling
xsq ATP8B3 19p13.3 0.133 0.312 0.799 ATP catabolic process;cation
transport
xsq ZMPSTE24 1p34 0.133 0.312 0.799 proteolysis;nuclear envelope organization
met RAX2 19p13.3 0.133 0.312 0.799 visual perception;response to stimulus
exp SPDYE9P 0.133 0.312 0.799
cop CALML5 10p15.1 0.133 0.312 0.799 signal transduction;epidermis
development
cop HFE2 1q21.1 0.133 0.312 0.799 axon guidance
xsq PRSS46 3p21.31 0.133 0.312 0.799
xsq PGBD4 15q14 0.133 0.312 0.799
xsq GHSR 3q26.31 0.133 0.312 0.799
met PDE12 3p14.3 0.133 0.312 0.799
xsq LOC729950 0.133 0.312 0.799
xsq H2AFV 7p13 0.133 0.312 0.799 nucleosome assembly
dependent"
met ANKRD42 11q14.1 0.133 0.312 0.799
xsq ARPC2 2q36.1 0.133 0.312 0.799 cellular component movement;positive
xsq CELF2-AS2 0.133 0.312 0.799
xsq CENPT 16q22.1 0.133 0.312 0.799 M phase of mitotic cell cycle;mitotic
prometaphase
cop RPS6KA5 14q31-q32.1 0.133 0.312 0.799 Protein Kinases
xsq LOC100505915 0.133 0.312 0.799
met KCNAB1 3q26.1 0.133 0.312 0.799 ion transport;potassium ion
transport
xsq USP6 17p13 0.133 0.312 0.799 ubiquitin-dependent protein catabolic
process;protein deubiquitination
met CLEC4GP1 19p13.2 0.133 0.312 0.799
xsq XRCC2 7q36.1 0.133 0.312 0.799 DNA Damage Response (DDR); DDR (NHEJ)
xsq SALRNA3 0.133 0.312 0.799
xsq ZNF177 19p13.2 0.133 0.312 0.799
xsq C15orf26 15q25.1 0.133 0.312 0.799
xsq DEFB118 20q11.21 0.133 0.312 0.799
met CPE 4q32.3 0.133 0.312 0.799 protein modification process;proteolysis
xsq SPTA1 1q21 0.133 0.312 0.799 porphyrin-containing compound biosynthetic
process;actin filament organization
met C14orf79 14q32.33 0.133 0.312 0.799
xsq ARMT1 0.133 0.312 0.799
xsq ANKRD65 1p36.33 0.133 0.312 0.799
xsq ZDHHC20 13q12.11 0.133 0.312 0.799
met LDB2 4p16 0.133 0.312 0.799 positive regulation of cellular component
cop KPNA6 1p35.1 0.133 0.312 0.799 NLS-bearing substrate import into nucleus
mut SUCLG2 3p14.1 0.133 0.312 0.799 succinyl-CoA metabolic
xsq VN1R4 19q13.42 0.133 0.312 0.799
xsq NBAT1 0.133 0.312 0.799
cop LTF 3p21.31 0.133 0.312 0.799 proteolysis;ion transport
cop RTP3 3p21.3 0.133 0.312 0.799 detection of chemical stimulus involved
in sensory perception of bitter taste;protein targeting to membrane
cop FADS3 11q12-q13.1 0.133 0.312 0.799 electron transport chain;unsaturated
fatty acid biosynthetic process
cop RAB3IL1 11q12.2 0.133 0.312 0.799
cop BEST1 11q13 0.133 0.312 0.799 ion transport;chloride transport
cop FTH1 11q13 0.133 0.312 0.799 iron ion transport;transmembrane transport
xsq TNIK 3q26.31 -0.133 0.312 0.799 protein phosphorylation;protein
autophosphorylation
xsq MTSS1L 16q22.1 -0.133 0.312 0.799 filopodium assembly;signal
transduction
xsq LOC101928211 -0.133 0.312 0.799
xsq SIX2 2p21 -0.133 0.312 0.799 regulation of transcription, DNA-
cop C5orf47 5q35.2 -0.133 0.312 0.799
cop HMP19 5q35.2 -0.133 0.312 0.799
exp STX5 11q12.3 -0.133 0.312 0.799 retrograde transport, endosome to
Golgi;vesicle fusion with Golgi apparatus
cop PLAA 9p21 -0.133 0.312 0.799 phospholipid metabolic
exp MARCH3 5q23.2 -0.133 0.312 0.799 endocytosis
met VAX1 10q26.1 -0.133 0.312 0.799 camera-type eye
development;negative regulation of transcription from RNA polymerase II promoter
exp TCEA3 1p36.12 -0.133 0.312 0.799 regulation of transcription from
RNA polymerase II promoter;regulation of transcription elongation, DNA-dependent"
exp LOC646934 15q25.1 -0.133 0.312 0.799
exp CCDC71L 7q22.3 -0.133 0.312 0.799
xsq SCN4B 11q23.3 -0.133 0.312 0.799 ion transport;sodium ion transport
xsq AHRR 5p15.3 -0.133 0.312 0.799 regulation of transcription, DNA-
dependent"
met SLIT1 10q23.3-q24 -0.133 0.312 0.799 nervous system development;retinal
met HPN 19q13.12 -0.133 0.312 0.799 negative regulation of apoptotic
xsq C11orf97 -0.133 0.312 0.799
exp IL15 4q31 -0.133 0.312 0.799 immune response;positive regulation of
met NTSR1 20q13 -0.133 0.312 0.799 G-protein coupled receptor signaling
cop TTTY23 -0.133 0.312 0.799
cop TTTY23B -0.133 0.312 0.799
cop TTTY1B -0.133 0.312 0.799
cop TTTY1 -0.133 0.312 0.799
cop TTTY2B -0.133 0.312 0.799
cop TTTY2 -0.133 0.312 0.799
cop TTTY21 -0.133 0.312 0.799
cop TTTY21B -0.133 0.312 0.799
cop TTTY7 -0.133 0.312 0.799
cop TTTY7B -0.133 0.312 0.799
cop TTTY8B Yp11.2 -0.133 0.312 0.799
cop TTTY8 -0.133 0.312 0.799
exp NGFR 17q21-q22 -0.133 0.312 0.799 regulation of gene expression;skin
development
mut PRKCZ 1p36.33-p36.2 -0.133 0.312 0.799 Protein Kinases
cop LINC00578 -0.133 0.312 0.799
exp LOC341056 -0.133 0.312 0.799
xsq PDIA3P1 -0.133 0.312 0.799
xsq SH3BP5 3p24.3 -0.133 0.312 0.799 signal
exp MAL2 8q23 -0.133 0.312 0.799
met DYNAP 18q21.2 -0.133 0.312 0.799
exp OXTR 3p25 -0.133 0.312 0.799 cell surface receptor signaling
exp GSTT1 22q11.23 -0.133 0.312 0.799 glutathione metabolic process
cop SMC4 3q26.1 -0.133 0.312 0.799 DNA Damage Response (DDR)
cop MIR15B -0.133 0.312 0.799
cop MIR16-2 -0.133 0.312 0.799
cop TRIM59 3q25.33 -0.133 0.312 0.799
met COPS2 15q21.2 -0.133 0.312 0.799 DNA Damage Response (DDR)
mut EMP1 12p12.3 -0.133 0.312 0.799 multicellular organismal
exp RPL9P26 15q11.2-q12 -0.133 0.312 0.799
xsq LINC00622 -0.133 0.312 0.799
cop REEP5 5q22-q23 -0.133 0.312 0.799
hs4 CREBBP 16p13.3 -0.134 0.312 0.799 Tumor Suppressors
exp LOC644727 -0.134 0.312 0.799
hs4 LINC00851 -0.134 0.312 0.799
hs4 GALNT10 5q33.2 -0.134 0.312 0.799 O-glycan processing;post-
xai LOC100129449 -0.134 0.312 0.799
his LOC101927686 -0.134 0.312 0.799
his CCDC148 2q24.1 -0.134 0.312 0.799
his PKP4 2q24.1 -0.134 0.312 0.799 cell adhesion;positive regulation
xai DNAJC19P6 -0.134 0.312 0.799
cop CACNG6 19q13.4 -0.134 0.312 0.799 calcium ion
transport;regulation of calcium ion transport via voltage-gated calcium channel
activity
cop VSTM1 19q13.42 -0.134 0.312 0.799
hs4 MCC 5q21 -0.134 0.312 0.799 signal transduction;negative regulation
his STON1-GTF2A1L 2p16.3 -0.134 0.312 0.799 transcription initiation
from RNA polymerase II promoter;intracellular protein transport
his STON1 2p16.3 -0.134 0.312 0.799 intracellular protein
swa RPS8 1p34.1-p32 -0.134 0.312 0.799 translational elongation;viral
transcription
swa CYC1 8q24.3 -0.134 0.312 0.799 transport;respiratory electron
transport chain
xai KLHL30 2q37.3 -0.134 0.312 0.799
his ASTN2 9q33.1 -0.134 0.312 0.799
his TRIM32 9q33.1 -0.134 0.312 0.799 response to tumor necrosis
cop SUPT5H 19q13 -0.134 0.312 0.799 transcription from RNA polymerase
cop TIMM50 19q13.2 -0.134 0.312 0.799 mitochondrial membrane
swa KIAA1524 3q13.13 -0.134 0.312 0.799
xai DNAJC22 12q13.12 -0.134 0.312 0.799 protein folding
xai LOC644727 -0.134 0.312 0.799
xai MAP6D1 3q27.1 -0.134 0.312 0.799 N-terminal peptidyl-L-
exp LOC100129449 -0.134 0.312 0.799
exp IGKV2-29 -0.134 0.312 0.799
his LEXM -0.134 0.312 0.799
his EPB41L4B 9q31-q32 -0.134 0.312 0.799
his LOC100507156 -0.134 0.312 0.799
hs4 KIF1B 1p36.2 -0.134 0.312 0.799 microtubule-based movement;neuron-
cop DLL3 19q13 -0.134 0.312 0.799 tissue development;cell differentiation
cop SELV 19q13.2 -0.134 0.312 0.799
swa SSR4 Xq28 -0.134 0.312 0.799 translation;SRP-dependent cotranslational
xai CXCL14 5q31 -0.134 0.312 0.799 chemotaxis;immune response
his PAK6 15q14 -0.134 0.312 0.799 Protein Kinases
xai ZSCAN26 6p21.31 -0.134 0.312 0.799
xai HMOX1 22q13.1 -0.134 0.312 0.799 negative regulation of leukocyte
cop NPAS1 19q13.2-q13.3 -0.134 0.312 0.799 negative regulation of
dependent
cop SIGLEC5 19q13.3 -0.134 0.312 0.799 cell adhesion
xai HOOK2 19p13.2 -0.134 0.312 0.799 early endosome to late endosome
hs4 DLGAP1-AS3 -0.134 0.312 0.799
hs4 PDE4B 1p31 0.134 0.313 0.8 cAMP catabolic process;signal transduction
xai C4orf17 4q23 0.134 0.313 0.8
hs4 ATM 11q22-q23 0.134 0.313 0.8 Apoptosis; DNA Damage Response (DDR); DDR
hs4 NPAT 11q22-q23 0.134 0.313 0.8 regulation of gene expression;positive
hs4 CD2BP2 16p11.2 0.134 0.313 0.8 nuclear mRNA splicing, via
his MNX1 7q36 0.134 0.313 0.8 regulation of transcription from RNA polymerase
his MNX1-AS1 0.134 0.313 0.8
hs4 TRNAU1AP 1p35.3 0.134 0.313 0.8 selenocysteine
his AK2 1p34 0.134 0.313 0.8 nucleobase-containing small molecule
xai DOK6 18q22.2 0.134 0.313 0.8
his MIR1243 0.134 0.313 0.8
xai TOB2 22q13.2 0.134 0.313 0.8 female gamete generation;negative
xai MAGI1-AS1 0.134 0.313 0.8
his ECD 10q22.3 0.134 0.313 0.8 regulation of transcription, DNA-
his FAM149B1 10q22.2 0.134 0.313 0.8
his CCDC71 3p21.31 0.134 0.313 0.8
xai CCDC168 13q33.1 0.134 0.313 0.8
xai DNAJC24 11p13 0.134 0.313 0.8 protein folding
exp FRG1HP 0.134 0.313 0.8
his STMN1 1p36.11 0.134 0.313 0.8 response to virus;cell differentiation
his MIR3917 0.134 0.313 0.8
hs4 SPG7 16q24.3 0.134 0.313 0.8 proteolysis;mitochondrion organization
xai KRT6C 12q13.13 0.134 0.313 0.8 cytoskeleton organization
his KBTBD2 7p14.3 0.134 0.313 0.8
hs4 CORO7-PAM16 0.134 0.313 0.8
hs4 CORO7 16p13.3 0.134 0.313 0.8 actin cytoskeleton organization
exp DEFB116 20q11.21 0.134 0.313 0.8 defense response to bacterium
xai TASP1 20p12.1 0.134 0.313 0.8 proteolysis;asparagine catabolic process
via L-aspartate
his FBN2 5q23-q31 0.134 0.313 0.8 embryonic limb morphogenesis;positive
exp CCDC73 11p13 0.134 0.313 0.8
exp CDH8 16q22.1 0.134 0.313 0.8 cell adhesion;homophilic cell adhesion
xai MTHFR 1p36.3 0.134 0.313 0.8 water-soluble vitamin metabolic
process;blood circulation
swa NOL11 17q24.2 0.134 0.313 0.8
xai XYLT1 16p12.3 0.134 0.313 0.8 glycosaminoglycan biosynthetic
process;proteoglycan biosynthetic process
xai ACVRL1 12q13.13 0.134 0.313 0.8 regulation of endothelial cell
proliferation;negative regulation of cell adhesion
his THAP8 19q13.12 0.134 0.313 0.8
his WDR62 19q13.12 0.134 0.313 0.8 neurogenesis;cerebral cortex development
hs4 DPP10 2q14.1 0.134 0.313 0.8 proteolysis
hs4 DPP10-AS1 0.134 0.313 0.8
xai FOS 14q24.3 0.134 0.313 0.8 Apoptosis; Oncogenes
xai BCDIN3D 12q13.12 0.134 0.313 0.8
his PMS2P2 0.134 0.313 0.8 ATP catabolic process;mismatch repair
his STAG3L1 7q11.23 0.134 0.313 0.8
hs4 AMER3 2q21.1 0.134 0.313 0.8
xsq USP48 1p36.12 0.133 0.313 0.8 proteolysis;ubiquitin-dependent protein
catabolic process
cop OXA1L 14q11.2 0.133 0.313 0.8 mitochondrial proton-transporting ATP
met PP2D1 3p24.3 0.133 0.313 0.8
xsq ONECUT1 15q21.3 0.133 0.313 0.8 glucose metabolic process;cilium
assembly
met GLIPR2 9p13.3 0.133 0.313 0.8
exp DHX35 20q11.22-q12 0.133 0.313 0.8 nuclear mRNA splicing, via
mut PRKCB 16p11.2 0.133 0.313 0.8 Protein Kinases
exp CALCRL 2q32.1 0.133 0.313 0.8 calcium ion transport;positive
xsq CCDC71 3p21.31 0.133 0.313 0.8
mut SEC23B 20p11.23 0.133 0.313 0.8 intracellular protein transport;ER
met SLC6A3 5p15.3 0.133 0.313 0.8 lactation;response to nicotine
met COL6A1 21q22.3 0.132 0.313 0.8 cell adhesion;axon guidance
met TARBP1 1q42.3 0.132 0.313 0.8 regulation of transcription from
RNA polymerase II promoter;RNA processing
exp LOC401913 19q13.11 0.132 0.313 0.8
mut NLRP13 19q13.43 0.132 0.313 0.8
cop ELP2 18q12.2 0.132 0.313 0.8 regulation of transcription from RNA
mut PLEK 2p13.3 0.132 0.313 0.8 integrin-mediated signaling
exp TPR 1q25 0.132 0.313 0.8 protein transport;glucose transport
exp NUFIP2 17q11.2 0.132 0.313 0.8
met DNAL4 22q13.1 0.132 0.313 0.8 nerve growth factor receptor signaling
pathway;microtubule-based movement
exp ADAMTS17 15q24 0.132 0.313 0.8 proteolysis
xsq FALEC 0.132 0.313 0.8
met COL12A1 6q12-q13 0.132 0.313 0.8 skeletal system development;cell
adhesion
exp SSXP10 6q22.31 0.132 0.313 0.8
cop ISG20 15q26 0.132 0.313 0.8 type I interferon-mediated signaling
cop CBLN2 18q22.3 0.132 0.313 0.8
met RAI1 17p11.2 0.132 0.313 0.8 skeletal system development;regulation of
mut NTSR1 20q13 0.132 0.313 0.8 G-protein coupled receptor signaling
xsq THSD4 15q23 -0.132 0.313 0.8 elastic fiber assembly
xsq VPS13A-AS1 9q21.2 -0.132 0.313 0.8
exp FAM107A 3p21.1 -0.132 0.313 0.8 regulation of cell growth
exp TAOK1 17q11.2 -0.132 0.313 0.8 Protein Kinases
xsq NFIL3 9q22 -0.132 0.313 0.8 immune response;circadian rhythm
met PANK2 20p13 -0.132 0.313 0.8 coenzyme A biosynthetic
mut TMEM8A 16p13.3 -0.132 0.313 0.8 cell adhesion
xsq PLEKHA7 11p15.1 -0.132 0.313 0.8 zonula adherens
exp GPRC5C 17q25 -0.132 0.313 0.8 G-protein coupled receptor
signaling pathway
exp HEXA-AS1 15q23 -0.132 0.313 0.8
xsq MUC16 19p13.2 -0.132 0.313 0.8 O-glycan processing;post-
cop GNAI1 7q21 -0.132 0.313 0.8 inhibition of adenylate cyclase activity
cop LBP 20q11.23 -0.132 0.313 0.8 lipid transport;response to
lipopolysaccharide
mut IKZF3 17q21 -0.132 0.313 0.8 mesoderm development;regulation of B cell
proliferation
exp FNDC3A 13q14.2 -0.132 0.313 0.8 cell-cell adhesion;Sertoli
cell development
mut STRIP2 7q32.1 -0.132 0.313 0.8
met TFEC 7q31.2 -0.132 0.313 0.8 regulation of transcription, DNA-
cop HAO2 1p13.3-p13.1 -0.132 0.313 0.8 mandelate metabolic
process;fatty acid oxidation
exp EFHC2 Xp11.3 -0.132 0.313 0.8
exp FGF1 5q31 -0.132 0.313 0.8 positive regulation of protein
mut ALX4 11p11.2 -0.132 0.313 0.8 embryonic forelimb
morphogenesis;skeletal system development
cop LMO4 1p22.3 -0.133 0.313 0.8 spinal cord association neuron
differentiation;negative regulation of protein complex assembly
cop LOC100505768 -0.133 0.313 0.8
met TOMM20L 14q23.1 -0.133 0.313 0.8 protein targeting
exp GDI1 Xq28 -0.133 0.313 0.8 signal transduction;small GTPase mediated
signal transduction
met SLC7A11 4q28-q32 -0.133 0.313 0.8 Solute Carriers
xsq S100B 21q22.3 -0.133 0.313 0.8 learning or memory;memory
met SPANXN2 Xq27.3 -0.133 0.313 0.8
mut ATXN1 6p23 -0.133 0.313 0.8 cell death;regulation of excitatory
cop GGT3P -0.133 0.313 0.8 glutathione metabolic process;glutathione
cop DGCR6 22q11.21 -0.133 0.313 0.8 organ morphogenesis;cell adhesion
cop FAM83G 17p11.2 -0.133 0.313 0.8
cop GRAP 17p11.2 -0.133 0.313 0.8 Ras protein signal
cop GRAPL -0.133 0.313 0.8
cop EPN2-IT1 -0.133 0.313 0.8
exp SAMD8 10q22.2 -0.133 0.313 0.8 lipid metabolic
xsq PLEKHA6 1q32.1 -0.133 0.313 0.8
hs4 LTBP3 11q13.1 -0.134 0.313 0.8 transforming growth factor beta
swa RAB1B 11q12 -0.134 0.313 0.8 small GTPase mediated signal
xai CFAP126 -0.134 0.313 0.8
xai ND4L -0.134 0.313 0.8
swa MGEA5 10q24.1-q24.3 -0.134 0.313 0.8 N-acetylglucosamine metabolic
his CYYR1-AS1 -0.134 0.313 0.8
exp ND4L -0.134 0.313 0.8
hs4 KLK5 19q13.33 -0.134 0.313 0.8 proteolysis;epidermis development
hs4 PATL1 11q12.1 -0.134 0.313 0.8 deadenylation-dependent decapping
of nuclear-transcribed mRNA;cytoplasmic mRNA processing body assembly
xai NWD1 19p13.11 -0.134 0.313 0.8
xai TSC2 16p13.3 -0.134 0.313 0.8 Apoptosis; Protein Kinases; Tumor
Suppressors
xai ZNF582-AS1 -0.134 0.313 0.8
xai GRPR Xp22.2 -0.134 0.313 0.8 G-protein coupled receptor
signaling pathway;learning or memory
hs4 ASMT Xp22.3 -0.134 0.313 0.8 cellular nitrogen compound
hs4 AKAP17A Xp22.33 -0.134 0.313 0.8 mRNA processing;signal
transduction
xai SDHAP1 3q29 -0.134 0.313 0.8
hs4 ITGA11 15q23 -0.134 0.313 0.8 integrin-mediated signaling
exp RPSAP64 -0.134 0.313 0.8
his MAPK13 6p21.31 -0.134 0.313 0.8 Protein Kinases
his SMCO3 12p12.3 -0.134 0.313 0.8
DNA-dependent"
his COLCA2 -0.134 0.313 0.8
his COLCA1 -0.134 0.313 0.8
exp RHBDL1 16p13.3 -0.134 0.313 0.8 proteolysis;signal
transduction
xai RPSAP64 -0.134 0.313 0.8
xai RUNX1T1 8q22 -0.134 0.313 0.8 generation of precursor metabolites
exp DNAJC19P6 -0.134 0.313 0.8
xai GSTT1 22q11.23 -0.134 0.313 0.8 glutathione metabolic process
xai MCOLN2 1p22 -0.134 0.313 0.8 ion transport
hs4 PARP12 7q34 -0.134 0.313 0.8
xai RPL32P9 3q25.1 -0.134 0.313 0.8
his PLA2G4F 15q15.1 -0.134 0.313 0.8 fatty acid transport;lipid
catabolic process
his NHEJ1 2q35 0.133 0.314 0.8 DNA Damage Response (DDR); DDR (NHEJ)
his TAF3 10p15.1 0.133 0.314 0.8 negative regulation of transcription from
xai LOC100130111 15q13.1 0.133 0.314 0.8
exp RNU4-4P 0.133 0.314 0.8
hs4 CORIN 4p13-p12 0.133 0.314 0.8 proteolysis;peptide hormone processing
xai G6PC3 17q21.31 0.133 0.314 0.8 carbohydrate metabolic
xai RNU4-4P 0.133 0.314 0.8
xai BEGAIN 14q32.2 0.133 0.314 0.8
hs4 NRSN2-AS1 0.133 0.314 0.8
hs4 SOX12 20p13 0.133 0.314 0.8 spinal cord development;cell fate commitment
xai SLC51B 15q22.31 0.133 0.314 0.8
xai PNN 14q21.1 0.133 0.314 0.8 nuclear mRNA splicing, via
hs4 LINC01136 0.133 0.314 0.8
hs4 BTG2 1q32 0.133 0.314 0.8 DNA Damage Response (DDR)
his HMGB1 13q12 0.133 0.314 0.8 Apoptosis; DNA Damage Response (DDR); DDR (BER)
his USPL1 13q12-q14 0.133 0.314 0.8 ubiquitin-dependent protein catabolic
process
hs4 PRPF6 20q13.33 0.133 0.314 0.8 RNA splicing, via transesterification
hs4 SAMD10 20q13.33 0.133 0.314 0.8
hs4 LINC01260 0.133 0.314 0.8
xai SNHG10 14q32.13 0.133 0.314 0.8
xai RPP25 15q24.2 0.133 0.314 0.8 tRNA processing
his ALOX12-AS1 0.133 0.314 0.8
his RNASEK 17p13.1 0.133 0.314 0.8
his RNASEK-C17orf49 0.133 0.314 0.8
his C17orf49 17p13.1 0.133 0.314 0.8 chromatin modification
his MIR195 0.133 0.314 0.8
his MIR497 0.133 0.314 0.8
his MIR497HG 0.133 0.314 0.8
his BCL6B 17p13.1 0.133 0.314 0.8 negative regulation of transcription from
xai HOXB1 17q21.3 0.133 0.314 0.8 facial nerve structural
hs4 KIAA1328 18q12.2 0.133 0.314 0.8
hs4 TPGS2 18q12.2 0.133 0.314 0.8
hs4 RAB27A 15q15-q21.1 0.133 0.314 0.8 melanosome localization;GTP
catabolic process
hs4 CCNB2 15q22.2 0.133 0.314 0.8 DNA Damage Response (DDR)
xai LOC441025 0.133 0.314 0.8
hs4 LGALS9 17q11.2 0.133 0.314 0.8 signal transduction;positive
xai SIDT1 3q13.2 0.133 0.314 0.8
hs4 MTFR1L 1p36.11 0.133 0.314 0.8
hs4 LOC646471 1p36.11 0.133 0.314 0.8
hs4 TLCD1 17q11.2 0.133 0.314 0.8
hs4 NEK8 17q11.1 0.133 0.314 0.8
his USP10 16q24.1 0.133 0.314 0.8 protein deubiquitination;DNA damage
xai ATG4D 19p13.2 0.133 0.314 0.8 proteolysis;autophagy
his DPY19L2 12q14.2 0.133 0.314 0.8 cell differentiation;multicellular
his DIO3OS 14q32.31 0.133 0.314 0.8
his MIR1247 0.133 0.314 0.8
xai PILRA 7q22.1 0.133 0.314 0.8 signal transduction;interspecies
hs4 GINS3 16q21 0.133 0.314 0.8 DDR (DNA replication)
xsq GAS2L1P2 0.132 0.314 0.8
met CPLX3 15q24.1 0.132 0.314 0.8
cop TRAPPC12 2p25.3 0.132 0.314 0.8 vesicle-mediated transport
cop VWCE 11q12.2 0.132 0.314 0.8
mut KRTAP12-3 0.132 0.314 0.8
met PLEKHA8 7p21-p11.2 0.132 0.314 0.8 protein transport
exp PNRC1 6q15 0.132 0.314 0.8 regulation of transcription, DNA-dependent"
met TRIM66 11p15.4 0.132 0.314 0.8
xsq RMND1 6q25.1 0.132 0.314 0.8
met LRIT2 10q23.1 0.132 0.314 0.8
xsq HIST1H2BM 6p22.1 0.132 0.314 0.8 nucleosome assembly
exp KNOP1P1 12p12.1 0.132 0.314 0.8
xsq EDEM3 1q25 0.132 0.314 0.8 glycoprotein catabolic process;response to
unfolded protein
exp AGL 1p21 0.132 0.314 0.8 carbohydrate metabolic process;glycogen
mut PSAP 10q21-q22 0.132 0.314 0.8 glycosphingolipid metabolic process;lipid
transport
met PGLYRP3 1q21 0.132 0.314 0.8 peptidoglycan catabolic process;detection
of bacterium
met DUOXA2 15q15.1 0.132 0.314 0.8 protein transport
met TREM2 6p21.1 0.132 0.314 0.8 humoral immune response;axon guidance
cop LOC100287225 18q21.2 0.132 0.314 0.8
xsq RABL2B 22q13.33 0.132 0.314 0.8 small GTPase mediated signal
cop LINC00838 0.132 0.314 0.8
exp LOC100505817 0.132 0.314 0.8
xsq APTX 9p13.3 0.132 0.314 0.8 DNA Damage Response (DDR); DDR (BER)
exp TAF1B 2p25 0.132 0.314 0.8 transcription, DNA-dependent;regulation of
exp TMEM80 11p15.5 0.132 0.314 0.8
exp POLDIP2 17q11.2 0.132 0.314 0.8 DDR (DNA replication)
cop ALDOC 17cen-q12 0.132 0.314 0.8 gluconeogenesis;small molecule metabolic
process
cop SPAG5 17q11.2 0.132 0.314 0.8 regulation of attachment of spindle
cop SPAG5-AS1 0.132 0.314 0.8
cop SGK494 17q11.2 0.132 0.314 0.8
cop EIF2B1 12q24.31 0.132 0.314 0.8 regulation of translational
met APOL6 22q12.3 0.132 0.314 0.8 lipoprotein metabolic process;transport
xsq CDKN2AIP 4q35.1 0.132 0.314 0.8 positive regulation of signal
transduction;negative regulation of cell growth
xsq NEK8 17q11.1 0.132 0.314 0.8
cop MRGPRG 0.132 0.314 0.8
cop MRGPRG-AS1 11p15.4 0.132 0.314 0.8
cop LARS2 3p21.3 0.132 0.314 0.8 tRNA aminoacylation for protein
xsq CENPE 4q24-q25 0.132 0.314 0.8 mitotic chromosome movement towards
dependent"
xsq TMEM79 1q22 0.132 0.314 0.8
exp FIRRE 0.132 0.314 0.8
xsq ITSN2 2p23.3 0.132 0.314 0.8 endocytosis;regulation of Rho protein
signal transduction
xsq WDR24 16p13.3 0.132 0.314 0.8
exp ELFN1 7p22.3 0.132 0.314 0.8 negative regulation of phosphatase
activity
xsq CCDC142 2p13.1 0.132 0.314 0.8
cop RFTN1 3p24.3 0.132 0.314 0.8
xsq LOC100131047 0.132 0.314 0.8
xsq UPK3A 22q13.31 0.132 0.314 0.8 urinary bladder development;cell
morphogenesis
met NKAIN4 20q13.33 0.132 0.314 0.8
xsq LOC101929454 0.132 0.314 0.8
xsq IPO7 11p15.4 0.132 0.314 0.8 signal transduction;interspecies
xsq GPR183 13q32.3 0.132 0.314 0.8 immune response;humoral immune
response
xsq COL6A5 3q22.1 0.132 0.314 0.8 cell adhesion
exp DHX8 17q21.31 0.132 0.314 0.8 RNA splicing;nuclear mRNA splicing, via
spliceosome
exp DDX17 22q13.1 0.132 0.314 0.8 RNA processing;positive regulation of
intracellular estrogen receptor signaling pathway
cop AKAP13 15q24-q25 0.132 0.314 0.8 nerve growth factor receptor
cop FADS6 17q25.1 0.132 0.314 0.8 fatty acid biosynthetic process
cop USH1G 0.132 0.314 0.8
cop OTOP2 17q25.1 0.132 0.314 0.8
cop OTOP3 17q25.1 0.132 0.314 0.8
cop HID1 17q25.1 0.132 0.314 0.8
cop CDR2L 17q25.1 0.132 0.314 0.8
cop ICT1 17q25.1 0.132 0.314 0.8 mitochondrial translational termination
cop FAM86EP 4p16.3 0.132 0.314 0.8
exp SYTL1 1p36.11 0.132 0.314 0.8 intracellular protein
met EGLN1 1q42.1 0.132 0.314 0.8 heart trabecula formation;ventricular
septum morphogenesis
xsq LOC101928009 0.132 0.314 0.8
cop EHD3 2p21 0.132 0.314 0.8 blood coagulation;endocytic recycling
cop ZNF608 5q23.2 -0.132 0.314 0.8
mut UGGT1 2q14.3 -0.132 0.314 0.8 protein folding;protein
glycosylation
mut CXorf21 Xp21.2 -0.132 0.314 0.8
met ZFYVE1 14q24.2 -0.132 0.314 0.8 negative regulation of
met TMEM213 7q34 -0.132 0.314 0.8
exp ARL4C 2q37.1 -0.132 0.314 0.8 GTP catabolic process;transport
xsq COL6A2 21q22.3 -0.132 0.314 0.8 axon guidance;response to
glucose stimulus
xsq RSPO2 8q23.1 -0.132 0.314 0.8 lung growth;epithelial tube
met TNS1 2q35-q36 -0.132 0.314 0.8 cell-substrate junction
xsq TRABD2B 1p33 -0.132 0.314 0.8
cop RUFY1 -0.132 0.314 0.8 protein transport;endocytosis
cop HNRNPH1 5q35.3 -0.132 0.314 0.8 gene expression;regulation of
RNA splicing
cop C5orf60 -0.132 0.314 0.8
cop CBY3 5q35.3 -0.132 0.314 0.8
cop CANX 5q35 -0.132 0.314 0.8 protein folding;protein secretion
cop MAML1 5q35 -0.132 0.314 0.8 gene expression;positive regulation of
myotube differentiation
xsq SOWAHB 4q21.1 -0.132 0.314 0.8 EMT (Epithelial)
exp ATOX1 5q32 -0.132 0.314 0.8 ion transport;copper ion transport
exp LOC100506457 -0.132 0.314 0.8
mut JMJD1C 10q21.3 -0.132 0.314 0.8 regulation of transcription,
DNA-dependent;blood coagulation
exp RYBP 3p13 -0.132 0.314 0.8 Apoptosis
xsq MID2 Xq22.3 -0.132 0.314 0.8
exp RPL7AP44 9q31.2 -0.132 0.314 0.8
met MRPL51 12p13.3-p13.1 -0.132 0.314 0.8 translation
xsq LOC646626 1p22.3 -0.132 0.314 0.8
mut NEIL1 15q24.2 -0.132 0.314 0.8 DNA Damage Response (DDR); DDR
(BER)
met SNORD42B 17q11 -0.132 0.314 0.8
met FOXN1 17q11-q12 -0.132 0.314 0.8 organ morphogenesis;keratinocyte
differentiation
cop DLC1 8p22 -0.132 0.314 0.8 induction of apoptosis;actin cytoskeleton
organization
met SERPINC1 1q25.1 -0.132 0.314 0.8 blood coagulation;negative
cop KIAA1614 1q25.3 -0.132 0.314 0.8
cop STX6 1q25.3 -0.132 0.314 0.8 vesicle fusion;endosome
organization
cop MR1 1q25.3 -0.132 0.314 0.8 antigen processing and presentation
of peptide antigen via MHC class I;immune response
cop IER5 1q25.3 -0.132 0.314 0.8
cop GM140 1q25.3 -0.132 0.314 0.8
cop LPHN2 1p31.1 -0.132 0.314 0.8
exp RERG 12p12.3 -0.132 0.314 0.8 GTP catabolic process;signal
transduction
cop IFT80 3q25.33 -0.132 0.314 0.8
cop TAL2 9q32 -0.132 0.314 0.8 regulation of transcription, DNA-
dependent;behavior
exp ATP6V1C2 -0.132 0.314 0.8 transmembrane transport;ATP
catabolic process
exp PRH2 12p13.2 -0.132 0.314 0.8
xsq OR5E1P 11p15.4 -0.132 0.314 0.8
xai SCUBE1 22q13 -0.133 0.314 0.8 blood coagulation;post-embryonic
development
his SLC14A1 18q11-q12 -0.133 0.314 0.8 Solute Carriers
his ANXA8 -0.133 0.314 0.8 blood coagulation
hs4 STX3 11q12.1 -0.133 0.314 0.8 cellular membrane fusion;neuron
hs4 PYGO1 15q21.3 -0.133 0.314 0.8 kidney development;post-embryonic
development
hs4 DGKI 7q32.3-q33 -0.133 0.314 0.8 blood coagulation;platelet
activation
hs4 SP6 17q21.32 -0.133 0.314 0.8 regulation of transcription, DNA-
his MAATS1 3q12-q13.3 -0.133 0.314 0.8
cop ACTN4 19q13 -0.133 0.314 0.8 Apoptosis
xai TGFBR3 1p33-p32 -0.133 0.314 0.8 Apoptosis
xai HOXB6 17q21.3 -0.133 0.314 0.8 multicellular organismal
hs4 SIPA1L3 19q13.13 -0.133 0.314 0.8 regulation of small GTPase
hs4 WDR87 19q13.13 -0.133 0.314 0.8
hs4 MAP1LC3A 20q11.22 -0.133 0.314 0.8 autophagic vacuole
assembly;autophagy
hs4 LOC401286 6q27 -0.133 0.314 0.8
hs4 BTBD9 6p21 -0.133 0.314 0.8 cell adhesion
xai RHBDL1 16p13.3 -0.133 0.314 0.8 proteolysis;signal
transduction
xai RNF19B 1p35.1 -0.133 0.314 0.8
his C2orf71 2p23.2 -0.133 0.314 0.8 response to stimulus;visual
perception
exp LOC100132188 -0.133 0.314 0.8
DNA-dependent"
hs4 CASP8 2q33-q34 -0.133 0.314 0.8 Apoptosis
DNA-dependent"
xai PDGFA 7p22 -0.133 0.314 0.8 Apoptosis
his PTPRJ 11p11.2 -0.133 0.314 0.8 positive regulation of macrophage
chemotaxis;positive regulation of cell adhesion
his DAGLA 11q12.2 -0.133 0.314 0.8 lipid catabolic process;platelet
activation
his S100A12 1q21 -0.133 0.314 0.8 killing of cells of other
his PRKAG2 7q36.1 -0.133 0.314 0.8 negative regulation of
exp OR2A3P 7q35 -0.133 0.314 0.8
hs4 CALB2 16q22.2 -0.133 0.314 0.8
his PCYT1B Xp22.11 -0.133 0.314 0.8 CDP-choline
his PCYT1B-AS1 -0.133 0.314 0.8
xai PRPSAP2 17p11.2-p12 0.133 0.315 0.801 nucleobase-containing compound
his BAZ2A 12q13.3 0.133 0.315 0.801 histone deacetylation;chromatin silencing
at rDNA
his HNRNPM 19p13.2 0.133 0.315 0.801 alternative nuclear mRNA splicing,
via spliceosome;nuclear mRNA splicing, via spliceosome
xai GLULP3 11q24.1 0.133 0.315 0.801
his RIMBP3C 0.133 0.315 0.801
hs4 POLR2D 2q21 0.133 0.315 0.801 DNA Damage Response (DDR); DDR (NER)
xai RPL23P2 21q22.11 0.133 0.315 0.801
his CASP8 2q33-q34 0.133 0.315 0.801 Apoptosis
his EMC8 16q24 0.133 0.315 0.801
his COX4I1 16q24.1 0.133 0.315 0.801 generation of precursor metabolites
exp LRRD1 7q21.2 0.133 0.315 0.801 signal transduction
cop MIR1237 0.133 0.315 0.801
xai PABPC1P1 4p14 0.133 0.315 0.801
xai DISP2 15q15.1 0.133 0.315 0.801 smoothened signaling pathway
his DBP 19q13.3 0.133 0.315 0.801 regulation of cell proliferation;positive
his SEC1P 19q13.33 0.133 0.315 0.801
xai SERPINE3 13q14.3 0.133 0.315 0.801 negative regulation of
hs4 GPR183 13q32.3 0.133 0.315 0.801 immune response;humoral immune
response
xai MOGS 2p13.1 0.133 0.315 0.801 protein folding;protein N-linked
glycosylation
xai TRAJ9 0.133 0.315 0.801
exp RPL7P54 Xq21.1 0.133 0.315 0.801
swa RPLP1 15q22 0.133 0.315 0.801 gene expression;viral reproduction
his MAT2B 5q34-q35 0.133 0.315 0.801 cellular nitrogen compound metabolic
hs4 RBM17 10p15.1 0.133 0.315 0.801 mRNA processing;RNA splicing
swa TK1 17q23.2-q25.3 0.133 0.315 0.801 DNA replication;nucleotide
exp TRAJ9 0.133 0.315 0.801
xai PDZD8 10q26.12 0.133 0.315 0.801 regulation of cell
morphogenesis;intracellular signal transduction
xai ATPAF2 17p11.2 0.133 0.315 0.801 proton-transporting ATP synthase
complex assembly
swa WDR48 3p21.33 0.133 0.315 0.801 DNA Damage Response (DDR); DDR (FA)
dependent"
his PIGG 4p16.3 0.133 0.315 0.801 C-terminal protein lipidation;GPI anchor
hs4 MEST 7q32 0.133 0.315 0.801 mesoderm development;regulation of lipid
storage
hs4 CDC20 1p34.1 0.133 0.315 0.801 cell cycle checkpoint;cell
differentiation
hs4 USP10 16q24.1 0.133 0.315 0.801 protein deubiquitination;DNA damage
his SRM 1p36-p22 0.133 0.315 0.801 cellular nitrogen compound metabolic
xai AKAP3 12p13.3 0.133 0.315 0.801 cellular component movement;transmembrane
xai MRPL50P1 2p22.3 0.133 0.315 0.801
exp MRPL50P1 2p22.3 0.133 0.315 0.801
xai LOC441239 7q11.21 0.133 0.315 0.801
his KIAA0319L 1p34.2 0.133 0.315 0.801
his NCDN 1p34.3 0.133 0.315 0.801 neuron projection development;bone
resorption
xai PRPF39 14q21.2 0.133 0.315 0.801 mRNA processing;RNA splicing
xai CCDC150 2q33.1 0.133 0.315 0.801
his UEVLD 11p15.1 0.133 0.315 0.801 protein modification process;protein
transport
cop LOC100129316 0.132 0.315 0.801
cop BEAN1 16q21 0.132 0.315 0.801 cell death
cop MRPS25 3p25 0.132 0.315 0.801 translation
met EXO1 1q42-q43 0.132 0.315 0.801 DNA Damage Response (DDR); DDR (MMR)
xsq DLG3-AS1 0.132 0.315 0.801
exp UCP3 11q13.4 0.132 0.315 0.801 response to nutrient;small molecule
metabolic process
met RBAK 7p22.1 0.132 0.315 0.801 regulation of transcription, DNA-
exp COX6B1 19q13.1 0.132 0.315 0.801 small molecule metabolic
xsq AS3MT 10q24.32 0.132 0.315 0.801 toxin metabolic process;arsonoacetate
metabolic process
met TRIM47 17q25 0.132 0.315 0.801
cop USP48 1p36.12 0.132 0.315 0.801 proteolysis;ubiquitin-dependent protein
catabolic process
cop LDLRAD2 1p36.12 0.132 0.315 0.801
xsq PRPF6 20q13.33 0.132 0.315 0.801 RNA splicing, via transesterification
exp TNFSF13B 13q32-q34 0.132 0.315 0.801 positive regulation of cell
exp ID2B 3p14.2 0.132 0.315 0.801
met TDRD3 13q21.2 0.132 0.315 0.801 chromatin modification
met B3GALT5-AS1 0.132 0.315 0.801
met SRA1 5q31.3 0.132 0.315 0.801 Apoptosis
exp CDAN1 15q15.2 0.132 0.315 0.801
met LPP 3q28 0.132 0.315 0.801 cell adhesion
met EI24 11q24 0.132 0.315 0.801 Apoptosis
met TRIM67 1q42.2 0.132 0.315 0.801
xsq ZNF217 20q13.2 0.132 0.315 0.801 transcription, DNA-
met NLGN4X Xp22.33 0.132 0.315 0.801 social behavior;cell-cell junction
organization
exp NUP50P3 5p14 0.132 0.315 0.801
met RPSAP52 12q14.3 0.132 0.315 0.801
mut DOK5 20q13.2 0.132 0.315 0.801 MAPK cascade;transmembrane receptor
cop LOC645752 15q24.3 0.132 0.315 0.801
met RPL36AL 14q21 0.132 0.315 0.801 translation
cop NSMCE3 0.132 0.315 0.801 regulation of transcription, DNA-
mut ST7 7q31.2 0.132 0.315 0.801
mut ASTL 2q11.1 0.132 0.315 0.801 proteolysis
xsq LOC729159 16q21 0.132 0.315 0.801
xsq MMS19 10q24-q25 0.132 0.315 0.801 DNA Damage Response (DDR)
xsq FBXO30 6q24 0.132 0.315 0.801
met UBL4A Xq28 0.132 0.315 0.801 protein modification process;transport
xsq TRAFD1 12q 0.132 0.315 0.801 response to cytokine stimulus;negative
exp MARCKSL1 1p35.1 0.132 0.315 0.801 positive regulation of cell
met ADGRE2 0.132 0.315 0.801 G-protein coupled receptor signaling
exp C3orf20 3p25.1 0.132 0.315 0.801
exp C9orf57 9q21.13 0.132 0.315 0.801
xsq MPLKIP 7p14.1 0.132 0.315 0.801 DNA Damage Response (DDR)
met DNAJC5B 8q13.1 0.132 0.315 0.801 protein folding
cop LOC100131626 0.132 0.315 0.801
met ACVR1B 12q13 0.132 0.315 0.801 Cell Signaling
cop PTRH2 17q23.1 0.132 0.315 0.801 apoptotic process
exp EDA Xq12-q13.1 0.132 0.315 0.801 signal transduction;pigmentation
exp LIX1L 1q21.1 0.132 0.315 0.801 EMT (Mesenchymal)
xsq VPS35 16q12 0.132 0.315 0.801 cell death;protein transport
exp CASC15 0.132 0.315 0.801
exp FANCB Xp22.2 0.132 0.315 0.801 DNA Damage Response (DDR); DDR (FA)
exp PGM5-AS1 9q13 0.132 0.315 0.801
cop EXOC7 17q25.1 0.132 0.315 0.801 exocytosis;protein transport
cop C3orf80 3q25.33 -0.132 0.315 0.801
met SPG7 16q24.3 -0.132 0.315 0.801 proteolysis;mitochondrion
organization
xsq PLXDC2 10p12.31 -0.132 0.315 0.801
cop ODF2L 1p22.3 -0.132 0.315 0.801
cop CLCA2 1p22.3 -0.132 0.315 0.801 transport;chloride transport
cop CLCA1 1p22.3 -0.132 0.315 0.801 calcium ion transport;chloride
transport
cop CLCA4 1p31-p22 -0.132 0.315 0.801 transport;chloride transport
cop CLCA3P 1p31-p22 -0.132 0.315 0.801 transport;ion transport
exp IQSEC1 3p25.2 -0.132 0.315 0.801 regulation of ARF protein
signal transduction
exp DHDDS 1p36.11 -0.132 0.315 0.801
xsq SAA4 11p15.1-p14 -0.132 0.315 0.801 acute-phase response
exp KLHL41 2q31.1 -0.132 0.315 0.801
exp GPT2 16q12.1 -0.132 0.315 0.801 small molecule metabolic process;2-
exp RPL13P14 20q13.12 -0.132 0.315 0.801
exp OR1F2P 16p13.3 -0.132 0.315 0.801 response to stimulus
cop IL13 5q31 -0.132 0.315 0.801
cop IL4 5q31.1 -0.132 0.315 0.801 negative regulation of chronic
cop KIF3A 5q31 -0.132 0.315 0.801 plus-end-directed vesicle transport along
cop CCNI2 5q31.1 -0.132 0.315 0.801 regulation of cyclin-dependent
cop SEPT8 5q31 -0.132 0.315 0.801 cell cycle
cop SOWAHA 5q31.1 -0.132 0.315 0.801
cop SHROOM1 5q31.1 -0.132 0.315 0.801 cell morphogenesis;actin
cop GDF9 5q31.1 -0.132 0.315 0.801 oocyte growth;transforming growth
cop UQCRQ 5q31.1 -0.132 0.315 0.801 hippocampus development;thalamus
development
cop LEAP2 5q31.1 -0.132 0.315 0.801 defense response to bacterium
exp GREM1 15q13.3 -0.132 0.315 0.801 cell-cell signaling;negative
xsq KMO 1q42-q44 -0.132 0.315 0.801 tryptophan catabolic process to
kynurenine;NAD metabolic process
cop CAAP1 9p21.2 -0.132 0.315 0.801 apoptotic process
cop TNFSF8 9q33 -0.132 0.315 0.801 cell-cell signaling;cell
proliferation
xsq MIR4435-2HG -0.132 0.315 0.801
xsq CCDC71L 7q22.3 -0.132 0.315 0.801
xsq PROK1 -0.132 0.315 0.801
hs4 LINC00460 13q33.3 -0.133 0.315 0.801
his ZNF20 19p13.2 -0.133 0.315 0.801
hs4 ZNF542P -0.133 0.315 0.801 regulation of transcription, DNA-
dependent"
xai MINK1 17p13.2 -0.133 0.315 0.801 multicellular organismal
development;regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate
his ASB5 4q34.2 -0.133 0.315 0.801 intracellular signal transduction
xai KCNJ13 2q37 -0.133 0.315 0.801 ion transport;potassium ion
transport
hs4 ELFN2 22q13.1 -0.133 0.315 0.801 negative regulation of phosphatase
activity
his FMO6P 1q24.3 -0.133 0.315 0.801
exp LOC441204 7p15.2 -0.133 0.315 0.801
hs4 DAPK3 19p13.3 -0.133 0.315 0.801 Apoptosis
xai TSPAN18 11p11.2 -0.133 0.315 0.801
DNA-dependent"
DNA-dependent"
cop ZNF528 19q13 -0.133 0.315 0.801 regulation of transcription, DNA-
dependent"
DNA-dependent"
DNA-dependent"
DNA-dependent"
DNA-dependent"
cop ZNF137P 19q13.4 -0.133 0.315 0.801
cop FBXO17 19q13.2 -0.133 0.315 0.801 protein catabolic process
exp FOXP1-IT1 -0.133 0.315 0.801
xai KLK5 19q13.33 -0.133 0.315 0.801 proteolysis;epidermis development
swa PYGM 11q12-q13.2 -0.133 0.315 0.801 glycogen metabolic process;glycogen
catabolic process
his MIR569 -0.133 0.315 0.801
cop LOC388849 22q11.21 -0.133 0.315 0.801
his KLHL22 22q11.21 -0.133 0.315 0.801 cell division
hs4 EMX2OS 10q26.1 -0.133 0.315 0.801
hs4 EMX2 10q26.1 -0.133 0.315 0.801 multicellular organismal
development
hs4 GLYATL1 11q12.1 -0.133 0.315 0.801
xai BMP4 14q22-q23 -0.133 0.315 0.801 activation of MAPKK
xai LOC100131943 -0.133 0.315 0.801
xai GABARAPL1 12p13.2 -0.133 0.315 0.801
hs4 FNIP1 5q23.3 -0.133 0.315 0.801 regulation of protein
phosphorylation
his TRIM2 4q31.3 -0.133 0.315 0.801 protein
exp GOLGA6L5P -0.133 0.315 0.801
cop RPS16 19q13.1 -0.133 0.315 0.801 nuclear-transcribed mRNA catabolic
his LOC101927181 -0.133 0.315 0.801
his MIR3941 -0.133 0.315 0.801
exp KRT8P44 6q26 -0.133 0.315 0.801
hs4 MKX-AS1 -0.133 0.315 0.801
hs4 MKX 10p12.1 -0.133 0.315 0.801 multicellular organismal
swa TBC1D4 13q22.2 -0.133 0.315 0.801
hs4 OSBPL2 20q13.3 -0.133 0.315 0.801 transport;lipid transport
exp PHOX2B 4p12 -0.133 0.315 0.801 Tumor Suppressors
cop CACNG8 19q13.4 -0.133 0.315 0.801 synaptic
transmission;regulation of calcium ion transport via voltage-gated calcium channel
activity
xai IGKV2-29 -0.133 0.315 0.801
xai B3GALT5 21q22.3 -0.133 0.315 0.801 protein glycosylation
his MIR3195 0.133 0.316 0.801
his TAF4 20q13.33 0.133 0.316 0.801 ovarian follicle development;interspecies
his PRAME 22q11.22 0.133 0.316 0.801 negative regulation of cell
his LL22NC03-63E9.3 0.133 0.316 0.801
xai ACAD10 12q24.12 0.133 0.316 0.801
hs4 TIPIN 15q22.31 0.133 0.316 0.801 DNA Damage Response (DDR)
xai RAD21L1 20p13 0.133 0.316 0.801 chromosome segregation;meiosis
his KLHL10 17q21.2 0.133 0.316 0.801
his NT5C3B 17q21.2 0.133 0.316 0.801
hs4 SYT9 11p15.4 0.133 0.316 0.801 regulation of calcium ion-dependent
his MIR3916 0.133 0.316 0.801
his SLC4A1 17q21.31 0.133 0.316 0.801 anion transport;chloride transport
his NAA50 3q13.2 0.133 0.316 0.801 N-terminal protein amino acid acetylation
his ATP6V1A 3q13.31 0.133 0.316 0.801 ion transport;cellular iron ion
homeostasis
xai TCF21 6q23.2 0.133 0.316 0.801 sex determination;embryonic digestive
tract morphogenesis
his DNTTIP2 1p22.1 0.133 0.316 0.801 DNA Damage Response (DDR); DDR (DNA
replication)
hs4 IL17REL 22q13.33 0.133 0.316 0.801
his TADA1 1q24.1 0.133 0.316 0.801 regulation of transcription, DNA-
exp ACE3P 0.133 0.316 0.801
hs4 FBXO43 8q22.2 0.133 0.316 0.801 meiosis
his PIGU 20q11.22 0.133 0.316 0.801 attachment of GPI anchor to protein;post-
his KLC2 11q13.2 0.133 0.316 0.801 microtubule-based movement;blood
coagulation
exp RPS20P32 13q12.13 0.133 0.316 0.801
dependent"
exp RPS6P20 12q24.33 0.133 0.316 0.801
hs4 SHANK2 11q13.2 0.133 0.316 0.801 intracellular signal transduction
his KCNK9 8q24.3 0.133 0.316 0.801 synaptic transmission;potassium ion
xai CYBA 16q24 0.133 0.316 0.801 transport;response to drug
xai ISX 22q12.3 0.133 0.316 0.801
xai LOC283922 16q23.1 0.133 0.316 0.801
his LINC01570 0.133 0.316 0.801
hs4 BTBD11 12q23.3 0.133 0.316 0.801
his LRIF1 1p13.3 0.133 0.316 0.802 regulation of transcription, DNA-
dependent"
xai AGL 1p21 0.133 0.316 0.802 carbohydrate metabolic process;glycogen
xai SETP7 0.133 0.316 0.802
xai HNRNPH3 10q22 0.133 0.316 0.802 nuclear mRNA splicing, via
hs4 RPL39L 3q27 0.133 0.316 0.802 translation;spermatogenesis
his MIR4647 0.133 0.316 0.802
his SLC35B2 6p12.1-p11.2 0.133 0.316 0.802 Solute Carriers
hs4 NOP58 2q33.1 0.133 0.316 0.802 rRNA processing;snRNP protein import into
nucleus
his LPCAT2 16q12.2 0.133 0.316 0.802 metabolic process;phospholipid
mut PDPK1 16p13.3 0.132 0.316 0.801 Apoptosis; Protein Kinases
dependent"
met AKR1C1 10p15-p14 0.132 0.316 0.801 antibiotic metabolic
process;cellular response to jasmonic acid stimulus
dependent"
exp TEX264 3p21.31 0.132 0.316 0.801
met BTBD17 17q25.1 0.132 0.316 0.801
xsq BCKDHA 19q13.1-q13.2 0.132 0.316 0.801 branched chain family amino
xsq C1QC 1p36.11 0.132 0.316 0.801 complement activation;complement
activation, classical pathway
exp ZSCAN29 15q15.3 0.132 0.316 0.801 viral reproduction
met SIAH2 3q25 0.132 0.316 0.801 Apoptosis
dependent"
met RPL24 3q12 0.132 0.316 0.801 SRP-dependent cotranslational protein targeting
exp HAPLN1 5q14.3 0.132 0.316 0.801 cell adhesion
mir hsa-miR-331-3p 0.132 0.316 0.801
xsq FOXD4L3 0.132 0.316 0.801 melanocyte differentiation;regulation of
xsq KRTAP5-8 0.132 0.316 0.801
met HERPUD2 7p14.2 0.132 0.316 0.801 response to unfolded
met CHIT1 1q32.1 0.132 0.316 0.801 response to bacterium;polysaccharide
catabolic process
exp CACYBP 1q24-q25 0.132 0.316 0.801 response to growth hormone
xsq DHRS13 17q11.2 0.132 0.316 0.801
mut CNPY2 12q15 0.132 0.316 0.801
cop ANAPC1P1 2p11.2 0.132 0.316 0.801
dependent"
xsq SPATA3-AS1 0.132 0.316 0.801
xsq LEMD1-AS1 0.132 0.316 0.801
exp LOC728485 19q13.12 0.132 0.316 0.801
xsq WNT10B 12q13 0.132 0.316 0.801 Apoptosis; Oncogenes
xsq LOC105274304 0.132 0.316 0.801
xsq SLC25A52 18q12.1 0.132 0.316 0.801
xsq NT5DC1 6q22.1 0.132 0.316 0.801
met PPP4R3CP 0.132 0.316 0.801
xsq DPP10-AS1 0.132 0.316 0.801
exp TMEM203 9q34.3 0.132 0.316 0.801
exp EHBP1L1 11q13.1 0.132 0.316 0.801
cop CYP1A1 15q24.1 0.132 0.316 0.802 amine metabolic process;response to
iron(III) ion
cop C12orf45 12q23.3 0.132 0.316 0.802
xsq DPP6 7q36.2 0.132 0.316 0.802 proteolysis;cell death
xsq RD3 1q32.3 0.132 0.316 0.802
met LSM14A 19q13.11 0.132 0.316 0.802 regulation of
translation;multicellular organismal development
xsq PIAS2 18q21.1 0.132 0.316 0.802 DNA Damage Response (DDR)
met SPATA25 20q13.12 0.132 0.316 0.802 spermatogenesis;cell
differentiation
xsq U2SURP 3q23 0.132 0.316 0.802 RNA processing
met WDR63 1p22.3 0.132 0.316 0.802
xsq C2orf78 2p13.1 0.132 0.316 0.802
xsq CLEC2L 7q34 0.132 0.316 0.802
exp CHEK1 11q24.2 0.132 0.316 0.802 DNA Damage Response (DDR); Protein
Kinases
mut CCDC158 4q21.1 0.132 0.316 0.802
xsq YWHAQ 2p25.1 0.132 0.316 0.802 protein targeting;small GTPase mediated
signal transduction
mut FGFR4 5q35.2 -0.132 0.316 0.802 glucose homeostasis;positive
regulation of DNA biosynthetic process
cop SCCPDH 1q44 -0.132 0.316 0.802
cop LOC149134 -0.132 0.316 0.802
DNA-dependent"
met CD320 19p13.3-p13.2 -0.132 0.316 0.802 regulation of cell growth
xsq DGCR9 22q11.21 -0.132 0.316 0.801
xsq GOLGA6L2 15q11.2 -0.132 0.316 0.801
cop WDR78 1p31.3 -0.132 0.316 0.801
exp M1AP 2p13.1 -0.132 0.316 0.801
met LOC286094 8q24.22 -0.132 0.316 0.801
xsq LOC100507487 -0.132 0.316 0.801
met CRACR2A -0.132 0.316 0.801 activation of store-operated
exp NAALADL2 3q26.31 -0.132 0.316 0.801 proteolysis
exp MTURN -0.132 0.316 0.801
cop SNX24 5q23.2 -0.132 0.316 0.801 cell communication;protein
transport
cop ATP1B3 3q23 -0.132 0.316 0.801 transport;potassium ion transport
met NDUFAF1 15q11.2-q21.3 -0.132 0.316 0.801 mitochondrial electron
xsq DNAJB2 2q32-q34 -0.132 0.316 0.801 response to unfolded
xsq P4HA1 10q21.3-q23.1 -0.132 0.316 0.801 peptidyl-proline
exp C6orf99 6q25.3 -0.132 0.316 0.801
cop DNM1L 12p11.21 -0.132 0.316 0.801 peroxisome fission;mitochondrial
fragmentation involved in apoptosis
xsq ADAMTS12 5q35 -0.132 0.316 0.801 proteolysis
mut HRAS 11p15.5 -0.132 0.316 0.801 Apoptosis; Oncogenes; Protein
Kinases
xsq SGK1 6q23 -0.132 0.316 0.801 Apoptosis
exp ASB4 7q21-q22 -0.132 0.316 0.801 intracellular signal transduction
met TSPYL5 8q22.1 -0.132 0.316 0.801 nucleosome assembly;positive
exp LOC728477 -0.132 0.316 0.801
mut HMGCS1 5p14-p13 -0.132 0.316 0.801 cholesterol biosynthetic
process;response to gonadotropin stimulus
met ALDH9A1 1q23.1 -0.132 0.316 0.801 hormone metabolic
hs4 ITGA2 5q11.2 -0.133 0.316 0.802 blood coagulation;organ
morphogenesis
his EPB41L1 20q11.2-q12 -0.133 0.316 0.802 synaptic
xai HDC 15q21.2 -0.133 0.316 0.802 small molecule metabolic
his KREMEN1 22q12.1 -0.133 0.316 0.802 cell communication;Wnt
xai COL15A1 9q21-q22 -0.133 0.316 0.802 signal
hs4 PPDPF 20q13.33 -0.133 0.316 0.802 multicellular organismal
hs4 LOC101928386 -0.133 0.316 0.802
his MAP9 4q32.1 -0.133 0.316 0.801 cell division;cell cycle
swa SERPINE1 7q22.1 -0.133 0.316 0.801 response to reactive oxygen
his GRAMD1C 3q13.31 -0.133 0.316 0.801
exp SLC5A9 1p33 -0.133 0.316 0.801 ion transport;sodium ion transport
hs4 LINC00521 14q32.12 -0.133 0.316 0.801
swa ROCK2 2p24 -0.133 0.316 0.801 Protein Kinases
his SQSTM1 5q35 -0.133 0.316 0.801 Apoptosis
xai DNAL4 22q13.1 -0.133 0.316 0.801 nerve growth factor receptor
signaling pathway;microtubule-based movement
his MIR4739 -0.133 0.316 0.801
his LINC02078 -0.133 0.316 0.801
swa TRIP10 19p13.3 -0.133 0.316 0.801 cell communication;signal
transduction
hs4 KCND3 1p13.3 -0.133 0.316 0.801 ion transport;potassium ion
transport
hs4 LINC01750 -0.133 0.316 0.801
his IRF6 1q32.3-q41 -0.133 0.316 0.801 EMT (Epithelial); Tumor Suppressors
swa CHM Xq21.2 -0.133 0.316 0.801 protein
geranylgeranylation;response to stimulus
cop LOC284379 19q13.42 -0.135 0.316 0.802
hs4 MAMSTR 19q13.33 0.133 0.317 0.802 regulation of transcription, DNA-
xai ST8SIA3 18q21.31 0.133 0.317 0.802 oligosaccharide metabolic
his CRACR2A 0.133 0.317 0.802 activation of store-operated calcium
hs4 CSNK2A1 20p13 0.133 0.317 0.802 Protein Kinases
his GNAT2 1p13.1 0.133 0.317 0.802 elevation of cytosolic calcium ion
his AMPD2 1p13.3 0.133 0.317 0.802 purine base metabolic process;purine
nucleotide metabolic process
his SSBP2 5q14.1 0.133 0.317 0.802 regulation of transcription, DNA-
dependent"
hs4 MROH6 8q24.3 0.133 0.317 0.802
his RPL13 16q24.3 0.133 0.317 0.802 gene expression;viral reproduction
his SNORD68 0.133 0.317 0.802
xai SLCO4C1 5q21.2 0.133 0.317 0.802 Solute Carriers
his UBE2O 17q25.1 0.133 0.317 0.802
his AANAT 17q25.1 0.133 0.317 0.802 cellular nitrogen compound metabolic
process;circadian rhythm
xai PSMD3 17q21.1 0.133 0.317 0.802 S phase of mitotic cell cycle;DNA damage
hs4 SNAR-C2 0.133 0.317 0.802
his SUV39H2 10p13 0.133 0.317 0.802 chromatin assembly or
his HSD11B1L 19p13.3 0.133 0.317 0.802
his C19orf70 19p13.3 0.133 0.317 0.802
xai PPIAP10 0.133 0.317 0.802
xai EIF3I 1p34.1 0.133 0.317 0.802 gene expression;cellular protein
metabolic process
xai PPP2R5A 1q32.2-q32.3 0.133 0.317 0.802 signal transduction;positive
his USP44 12q22 0.133 0.317 0.802 cell division;anaphase
xai SUFU 10q24.32 0.133 0.317 0.802 negative regulation of transcription from
RNA polymerase II promoter;determination of left/right symmetry
his CAB39 2q37.1 0.133 0.317 0.802 protein heterooligomerization;positive
dependent"
his ATP6V0A1 17q21 0.133 0.317 0.802 transferrin transport;transmembrane
transport
his NFYB 12q22-q23 0.132 0.317 0.802 regulation of transcription, DNA-
hs4 SZRD1 1p36.13 0.132 0.317 0.802
hs4 HBA1 16p13.3 0.132 0.317 0.802
his LOC100506548 0.132 0.317 0.802
his SNORD72 5p13 0.132 0.317 0.802
his RPL37 5p13 0.132 0.317 0.802 translational elongation;viral transcription
xai PSPC1P1 13q12.11 0.132 0.317 0.802
cop NUDT17 1q21.1 0.132 0.317 0.802
his FRMD3 9q21.32 0.132 0.317 0.802
his LOC105369891 0.132 0.317 0.802
exp GPM6BP3 0.132 0.317 0.802
hs4 BCKDK 16p11.2 0.132 0.317 0.802 branched chain family amino acid
xai DNAH17-AS1 0.132 0.317 0.802
his CLOCK 4q12 0.132 0.317 0.802 regulation of transcription from RNA polymerase
II promoter;signal transduction
his SEC11A 15q25.3 0.132 0.317 0.802 energy reserve metabolic
xai GPM6BP3 0.132 0.317 0.802
hs4 RAB12 18p11.22 0.132 0.317 0.802 small GTPase mediated signal
xai ADGB 6q24.3 0.132 0.317 0.802 proteolysis;oxygen transport
xai TMEM183A 1q32.1 0.132 0.317 0.802
xai C16orf46 16q23.2 0.132 0.317 0.802
his IQCK 16p12.3 0.132 0.317 0.802
his KNOP1 16p12.3 0.132 0.317 0.802
xai ALG9 11q23 0.132 0.317 0.802 GPI anchor biosynthetic process;protein N-
exp CABP1 12q24.31 0.132 0.317 0.802 negative regulation of catalytic activity
met TOM1 22q13.1 0.131 0.317 0.802 intracellular protein
met POPDC3 6q21 0.131 0.317 0.802
met LDLRAP1 1p36-p35 0.131 0.317 0.802 steroid metabolic
process;regulation of establishment of protein localization in plasma membrane
exp RBM8A 1q21.1 0.131 0.317 0.802 RNA splicing;nuclear-transcribed mRNA
xsq LINC00861 0.131 0.317 0.802
cop CALM1 14q32.11 0.131 0.317 0.802
cop PPP1R32 11q12.2 0.131 0.317 0.802
cop MIR4488 0.131 0.317 0.802
cop LRRC10B 11q12.2 0.131 0.317 0.802
cop SYT7 11q12-q13.1 0.131 0.317 0.802 plasma membrane repair;regulation of
cop RPLP0P2 11cen-q12 0.131 0.317 0.802
cop DAGLA 11q12.2 0.131 0.317 0.802 lipid catabolic process;platelet
activation
cop MYRF 11q12-q13.1 0.131 0.317 0.802
cop DKFZP434K028 11q12.2 0.131 0.317 0.802
cop TMEM258 11q12.2 0.131 0.317 0.802
cop MIR611 0.131 0.317 0.802
cop FEN1 11q12 0.131 0.317 0.802 DNA Damage Response (DDR); DDR (BER); DDR (DNA
replication)
cop FADS1 11q12.2-q13.1 0.131 0.317 0.802 transport;response to organic
cyclic compound
cop MIR1908 0.131 0.317 0.802
cop FADS2 11q12.2 0.131 0.317 0.802 unsaturated fatty acid biosynthetic
process;transport
cop UACA 15q22-q24 0.131 0.317 0.802
mut KIAA0895 7p14.2 0.131 0.317 0.802
cop LARS2-AS1 0.131 0.317 0.802
mut ZBTB39 12q13.3 0.131 0.317 0.802 regulation of transcription, DNA-
dependent"
xsq KRTAP5-9 11q13.5 0.131 0.317 0.802 epidermis development
exp EEF1DP5 6q22.33 0.131 0.317 0.802
cop TNFAIP8L2 1q21.3 0.131 0.317 0.802 innate immune response
cop TNFAIP8L2-SCNM1 0.131 0.317 0.802
cop LYSMD1 1q21.3 0.131 0.317 0.802 cell wall macromolecule catabolic
process
cop SCNM1 1q21.3 0.131 0.317 0.802 mRNA processing;RNA splicing
exp PDCL 9q12-q13 0.131 0.317 0.802 visual perception;response to stimulus
dependent"
met TPD52L3 9p24.1 0.131 0.317 0.802
xsq IL6R 1q21 0.131 0.317 0.802 positive regulation of cell
cop UCN3 10p15.1 0.131 0.317 0.802
exp WBSCR16 7q11.23 0.131 0.317 0.802
met FANCD2OS 3p25.3 0.131 0.317 0.802
met SMTN 22q12.2 0.131 0.317 0.802 smooth muscle contraction;muscle organ
development
met WNT10B 12q13 0.131 0.317 0.802 Apoptosis; Oncogenes
mut RNASE9 0.131 0.317 0.802
xsq TUBA1B 12q13.12 0.131 0.317 0.802 microtubule cytoskeleton
cop SH3BP5-AS1 0.131 0.317 0.802
cop SH3BP5 3p24.3 0.131 0.317 0.802 signal transduction;intracellular
signal transduction
mut ADCY9 16p13.3 0.131 0.317 0.802 signal transduction;intracellular signal
transduction
xsq TMEM82 1p36.21 0.131 0.317 0.802
xsq OR10J1 1q23.2 0.131 0.317 0.802
met FEZF2 3p14.2 0.131 0.317 0.802 multicellular organismal
development;dentate gyrus development
xsq VGLL2 6q22.1 0.131 0.317 0.802 regulation of transcription, DNA-
exp DPP10-AS1 0.131 0.317 0.802
xsq ATM 11q22-q23 0.131 0.317 0.802 Apoptosis; DNA Damage Response (DDR); DDR
cop BTRC 10q24.32 0.131 0.317 0.802 protein ubiquitination;interspecies
xsq CEBPA 19q13.1 0.131 0.317 0.802 Tumor Suppressors
xsq LOC100133050 5q21.1 0.131 0.317 0.802
xsq OLIG2 21q22.11 0.131 0.317 0.802 myelination;negative regulation of neuron
differentiation
mut BTNL9 5q35.3 0.131 0.317 0.802
exp SETDB2 13q14 0.131 0.317 0.802 heart looping;histone H3-K9 methylation
xsq ATP5O 21q22.11 0.131 0.317 0.802 respiratory electron transport
mut ANO6 12q12 0.131 0.317 0.802 activation of blood coagulation via clotting
xsq SPRN 10q26.3 0.131 0.317 0.802
xsq RDM1 17q11.2 0.131 0.317 0.802 DNA Damage Response (DDR); DDR (HR)
exp KRT6C 12q13.13 0.131 0.317 0.802 cytoskeleton organization
met PTPN12 7q11.23 0.131 0.317 0.802 protein dephosphorylation
xsq MICALL2 7p22.3 -0.131 0.317 0.802 endocytosis
xsq SLFN5 17q12 -0.131 0.317 0.802 cell differentiation
exp SULT1E1 4q13.1 -0.131 0.317 0.802 xenobiotic metabolic
process;female pregnancy
mut NCR1 19q13.42 -0.131 0.317 0.802 cellular defense response;signal
transduction
met OXR1 8q23 -0.131 0.317 0.802 response to oxidative stress;cell wall
exp S100B 21q22.3 -0.131 0.317 0.802 learning or memory;memory
exp MANSC1 12p13.2 -0.131 0.317 0.802
met PSMA6 14q13 -0.131 0.317 0.802 M/G1 transition of mitotic cell
met SNORD87 8q13.1 -0.131 0.317 0.802
xsq LINC01198 -0.131 0.317 0.802
cop C1orf141 1p31.3 -0.131 0.317 0.802
met C2orf61 2p21 -0.131 0.317 0.802
met TMEM241 18q11.2 -0.131 0.317 0.802
exp CBY1 22q12 -0.131 0.317 0.802 protein localization;negative regulation
met ZNF280B 22q11.22 -0.131 0.317 0.802 regulation of transcription,
DNA-dependent"
cop MIR218-2 -0.131 0.317 0.802
xsq FAM25C -0.131 0.317 0.802
cop LINC00951 -0.131 0.317 0.802
cop TDRG1 6p21.2 -0.131 0.317 0.802
xsq FZD6 8q22.3-q23.1 -0.131 0.317 0.802 gonad development;cell
xsq LCTL 15q22.31 -0.131 0.317 0.802 carbohydrate metabolic process
xsq LOC145474 14q24.2 -0.131 0.317 0.802
mut PEG3 19q13.4 -0.131 0.317 0.802 viral reproduction;apoptotic
process
cop EPHB1 3q21-q23 -0.131 0.317 0.802 optic nerve morphogenesis;ephrin
exp GPR137C 14q22.1 -0.131 0.317 0.802
exp CD248 11q13 -0.131 0.317 0.802
xsq FAM150B 2p25.3 -0.132 0.317 0.802
xsq HEATR5A 14q12 -0.132 0.317 0.802
xsq LOC100507477 -0.132 0.317 0.802
xsq ZNF488 10q11.22 -0.132 0.317 0.802 oligodendrocyte
xai CCR10 17q21.1-q21.3 -0.132 0.317 0.802 chemotaxis;G-protein coupled
xai ABHD5 3p21 -0.132 0.317 0.802 negative regulation of sequestering of
xai CEBPB 20q13.1 -0.132 0.317 0.802 embryonic placenta
his ATL3 11q13.1 -0.132 0.317 0.802 GTP catabolic process;ER to Golgi
his FAM46B 1p36.11 -0.132 0.317 0.802
his RAET1L 6q25.1 -0.132 0.317 0.802 immune response;antigen
exp HDC 15q21.2 -0.132 0.317 0.802 small molecule metabolic
his GHRLOS 3p25.3 -0.132 0.317 0.802
his LOC730102 -0.132 0.317 0.802
xai ARHGEF35 7q35 -0.132 0.317 0.802
xai CALHM3 10q24.33 -0.132 0.317 0.802
xai LOC100132481 -0.132 0.317 0.802
his MIR181A2 -0.132 0.317 0.802
his MIR181B2 -0.132 0.317 0.802
hs4 SALL4 20q13.2 -0.132 0.317 0.802 DNA Damage Response (DDR)
his VWA3A 16p12.2 -0.132 0.317 0.802
his RNF223 1p36.33 -0.132 0.317 0.802
his PCBP4 3p21 -0.133 0.317 0.802 DNA damage response, signal transduction
cop MIR1229 -0.133 0.317 0.802
xai LOC100506476 -0.133 0.317 0.802
hs4 DYX1C1-CCPG1 -0.133 0.317 0.802
xai FAM174B 15q26.1 -0.133 0.317 0.802
his PGLS 19p13.2 -0.133 0.317 0.802 pentose-phosphate shunt, oxidative
branch;small molecule metabolic process
xai SPTLC2 14q24.3 -0.133 0.317 0.802 sphingosine biosynthetic
hs4 LOC101928841 -0.133 0.317 0.802
xai TUG1 22q12.2 -0.133 0.317 0.802
xai DTX3 12q13.3 -0.133 0.317 0.802 Notch signaling pathway
hs4 LOC441666 10q11.21 -0.133 0.317 0.802
xai ACOT6 14q24.3 -0.133 0.317 0.802
swa DNAJC13 3q22.1 -0.133 0.317 0.802
xai PCDHGB7 -0.133 0.317 0.802 homophilic cell adhesion;cell
adhesion
hs4 NNAT -0.133 0.317 0.802
swa S100A7 1q21 -0.133 0.317 0.802
swa PPP2R1B 11q23.2 -0.133 0.317 0.802 Apoptosis
xai FGF6 12p13 0.132 0.318 0.802 cartilage condensation;fibroblast growth factor
xai OR51B3P 0.132 0.318 0.802
hs4 PRH1-PRR4 0.132 0.318 0.802
hs4 PRH1 0.132 0.318 0.802
hs4 PRH1-TAS2R14 0.132 0.318 0.802
hs4 SMIM10L1 0.132 0.318 0.802
hs4 CNMD 0.132 0.318 0.802
hs4 SSTR5-AS1 16p13.3 0.132 0.318 0.802
hs4 SSTR5 16p13.3 0.132 0.318 0.802 glucose homeostasis;regulation of insulin
secretion
hs4 KPNB1 17q21.32 0.132 0.318 0.802 NLS-bearing substrate import into
his LINC00989 0.132 0.318 0.802
hs4 AMZ2 17q24.2 0.132 0.318 0.802 proteolysis
his TM6SF1 15q24-q26 0.132 0.318 0.802
his AKAP8 19p13.1 0.132 0.318 0.802 signal transduction;mitosis
exp OR51I1 0.132 0.318 0.802 sensory perception of smell;response to
stimulus
xai RAD1 5p13.2 0.132 0.318 0.802 DNA Damage Response (DDR)
his DLGAP4-AS1 0.132 0.318 0.802
his TGIF2 20q11.23 0.132 0.318 0.802 regulation of transcription, DNA-
his TGIF2-C20orf24 0.132 0.318 0.802
hs4 TRIM28 19q13.4 0.132 0.318 0.803 DNA Damage Response (DDR)
his UBR5 8q22 0.132 0.318 0.803 DNA Damage Response (DDR)
his KCNH8 3p24.3 0.132 0.318 0.803 negative regulation of apoptotic
hs4 ZNF449 Xq26.3 0.132 0.318 0.803 viral reproduction
hs4 ZNF75D Xq26.3 0.132 0.318 0.803 regulation of transcription, DNA-
his ZFP69 1p34.2 0.132 0.318 0.803
his RBP5 12p13.31 0.132 0.318 0.803 transport
his CLSTN3 12p13.31 0.132 0.318 0.803 cell adhesion;homophilic cell
adhesion
xai RPL30 8q22 0.132 0.318 0.803 viral reproduction;nuclear-transcribed mRNA
swa DHX8 17q21.31 0.132 0.318 0.803 RNA splicing;nuclear mRNA splicing, via
spliceosome
xai C15orf57 15q15.1 0.132 0.318 0.803
xai SBK3 0.132 0.318 0.803
hs4 NDUFC2-KCTD14 0.132 0.318 0.803
hs4 NDUFC2 11q14.1 0.132 0.318 0.803 mitochondrial electron transport,
exp NECAB1 8q21.3 0.132 0.318 0.803
hs4 CHMP1B 18p11.21 0.132 0.318 0.803 cell division;cell cycle
hs4 FBXL21 5q31 0.132 0.318 0.803 protein ubiquitination;rhythmic process
his FAM43B 1p36.12 0.132 0.318 0.803
exp CARD17 11q22.3 0.132 0.318 0.803 proteolysis;regulation of apoptotic
process
xai TMC5 16p12.3 0.132 0.318 0.803
his ANXA13 8q24.13 0.132 0.318 0.803 cell differentiation
dependent"
his SMAD4 18q21.1 0.132 0.318 0.803 Apoptosis; Cell Signaling; Tumor
Suppressors
his BTNL10 1q42.13 0.132 0.318 0.803
hs4 ANKRD20A1 0.132 0.318 0.803
hs4 SARDH 9q33-q34 0.132 0.318 0.803 glycine catabolic process
his HSPH1 13q12.3 0.132 0.318 0.803 response to stress;response to unfolded
protein
hs4 JAKMIP1 4p16.1 0.132 0.318 0.803 protein transport
hs4 LOC285484 4p16.1 0.132 0.318 0.803
met CCDC85C 14q32.31 0.131 0.318 0.802 cerebral cortex development
xsq DUSP9 Xq28 0.131 0.318 0.802 inactivation of MAPK activity;protein
dephosphorylation
met BPIFA3 20q11.21 0.131 0.318 0.802
met MYO3B 2q31.1-q31.2 0.131 0.318 0.802 visual perception;response to
stimulus
exp TTLL4 2p24.3-p24.1 0.131 0.318 0.802 protein modification
xsq IL20 1q32 0.131 0.318 0.802 positive regulation of tyrosine phosphorylation
of Stat3 protein;positive regulation of epidermal cell differentiation
cop METTL9 16p12.2 0.131 0.318 0.802
cop IGSF6 0.131 0.318 0.802 immune response;cell surface receptor signaling
pathway
cop OTOA 16p12.2 0.131 0.318 0.802 sensory perception of sound
xsq OR52I1 0.131 0.318 0.802
met IGSF21 1p36.13 0.131 0.318 0.802
xsq TPI1P3 6q22.1 0.131 0.318 0.802
exp AXIN1 16p13.3 0.131 0.318 0.802 Apoptosis
met NIN 14q22.1 0.131 0.318 0.802 microtubule anchoring at
centrosome;centrosome localization
exp METTL2B 7q32.1 0.131 0.318 0.802
met CNOT7 8p22-p21.3 0.131 0.318 0.802 DNA Damage Response (DDR)
xsq URM1 9q34.11 0.131 0.318 0.802 tRNA wobble uridine modification;tRNA
processing
xsq RHBDD1 2q36.3 0.131 0.318 0.802 proteolysis
cop NUTF2 16q22.1 0.131 0.318 0.802 protein import into nucleus;protein
export from nucleus
cop EDC4 16q22.1 0.131 0.318 0.802 mRNA metabolic process;exonucleolytic
decay
cop NRN1L 16q22.1 0.131 0.318 0.802
cop PSKH1 16q22.1 0.131 0.318 0.802 protein phosphorylation
cop CTRL 16q22.1 0.131 0.318 0.802 proteolysis;digestion
met PRR20A 13q21.1 0.131 0.318 0.802
xsq OLFM4 13q14.3 0.131 0.318 0.803 cell adhesion
xsq LOC101927769 0.131 0.318 0.803
cop RPS6KA4 11q11-q13 0.131 0.318 0.803 Protein Kinases
cop MRPS35 12p11 0.131 0.318 0.803 peptide biosynthetic process;DNA damage
response, detection of DNA damage"
xsq KRTAP9-1 0.131 0.318 0.803
xsq FUBP1 1p31.1 0.131 0.318 0.803 Tumor Suppressors
exp DESI1 22q13.2 0.131 0.318 0.803
cop CAPN14 2p23.1-p21 0.131 0.318 0.803 proteolysis
xsq OR1S2 0.131 0.318 0.803
xsq LOC101927948 0.131 0.318 0.803
cop PRUNE 1q21 0.131 0.318 0.803
cop CDH5 16q22.1 0.131 0.318 0.803 regulation of establishment of cell
polarity;blood vessel maturation
cop AMZ2P1 17q24.1 0.131 0.318 0.803
cop GNA13 17q24.3 0.131 0.318 0.803 cellular component movement;cell
differentiation
mir hsa-miR-29c 0.131 0.318 0.803
met MICU3 8p22 0.131 0.318 0.803
xsq SVILP1 10p11.23 0.131 0.318 0.803
exp HIST1H2BG 6p21.3 0.131 0.318 0.803
exp ZDBF2 2q33.3 0.131 0.318 0.803
xsq KRTAP7-1 21q22.1 0.131 0.318 0.803
xsq TRIB2 2p24.3 -0.131 0.318 0.803 negative regulation of protein
catabolic process
xsq BNIPL 1q21.3 -0.131 0.318 0.803 apoptotic process;induction of
apoptosis
xsq VCX3B Xp22.31 -0.131 0.318 0.803
met POSTN 13q13.3 -0.131 0.318 0.803 extracellular matrix
organization;skeletal system development
xsq DMPK 19q13.3 -0.131 0.318 0.803 regulation of excitatory
exp MUM1L1 Xq22.3 -0.131 0.318 0.803
met LBHD1 -0.131 0.318 0.803
mut GGA2 16p12 -0.131 0.318 0.803 vesicle-mediated transport;intracellular
protein transport
exp KTN1 14q22.1 -0.131 0.318 0.803 microtubule-based movement
met FGFBP2 4p16 -0.131 0.318 0.803
cop KPNA4 3q25.33 -0.131 0.318 0.803 NLS-bearing substrate import into
met TYR 11q14.3 -0.131 0.318 0.803 pigmentation;thymus development
xsq CHSY3 5q23.3 -0.131 0.318 0.803
exp UCK1 9q34.13 -0.131 0.318 0.802 pyrimidine base metabolic
exp LINC00441 -0.131 0.318 0.802
xsq SNX16 8q21.13 -0.131 0.318 0.802 protein targeting to lysosome;cell
communication
exp CASP3P1 1p31.1 -0.131 0.318 0.802
exp POLR2K 8q22.2 -0.131 0.318 0.802 DNA Damage Response (DDR);
DDR (NER)
exp LOC400043 12q13.13 -0.131 0.318 0.802
mut MNT 17p13.3 -0.131 0.318 0.802 Apoptosis
xsq LASP1 17q11-q21.3 -0.131 0.318 0.802 ion transport;ion transmembrane
transport
met FMO6P 1q24.3 -0.131 0.318 0.802
exp EZR 6q25.3 -0.131 0.318 0.802 cytoskeletal anchoring at plasma
membrane;leukocyte cell-cell adhesion
xsq MT1IP 16q13 -0.131 0.318 0.802
xsq MAP4 3p21 -0.131 0.318 0.802 negative regulation of microtubule
depolymerization
met HEXIM1 17q21.31 -0.131 0.318 0.802 negative regulation of
met PADI4 1p36.13 -0.131 0.318 0.802 regulation of transcription, DNA-
swa PSMD4 1q21.3 -0.132 0.318 0.803 S phase of mitotic cell cycle;DNA
arrest
xai FAM186B 12q13.12 -0.132 0.318 0.803
hs4 CDR2L 17q25.1 -0.132 0.318 0.803
his BBS5 2q31.1 -0.132 0.318 0.803 visual perception;flagellum
assembly
his CTBP2 10q26.13 -0.132 0.318 0.803 negative regulation of
hs4 IL15 4q31 -0.132 0.318 0.803 immune response;positive regulation of
exp PM20D1 1q32.1 -0.132 0.318 0.803 proteolysis;metabolic process
xai WIPF2 17q21.2 -0.132 0.318 0.803
hs4 LOC100134317 -0.132 0.318 0.803
his CCNYL2 10q11.21 -0.132 0.318 0.802 regulation of cyclin-
his LINC00839 10q11.21 -0.132 0.318 0.802
his OSER1 20q13.11 -0.132 0.318 0.802
his OSER1-AS1 -0.132 0.318 0.802
xai MT1E 16q13 -0.132 0.318 0.802 negative regulation of growth;cellular
cop PLEKHG2 19q13.2 -0.132 0.318 0.802 regulation of small GTPase
xai RCAN1 21q22.12 -0.132 0.318 0.802 regulation of phosphoprotein
his SERPINE1 7q22.1 -0.132 0.318 0.802 response to reactive oxygen
xai CCDC71L 7q22.3 -0.132 0.318 0.802
exp LOC100132481 -0.132 0.318 0.802
his DGKZ 11p11.2 -0.132 0.318 0.802 negative regulation of mitotic cell
xai KTN1 14q22.1 -0.132 0.318 0.802 microtubule-based movement
xai MMP15 16q13 -0.132 0.318 0.802 Apoptosis
xai LOC338667 11q24.2 -0.132 0.318 0.802
xai FAM188B2 3q25.1 -0.132 0.318 0.802
his RBPMS2 15q22.31 -0.132 0.318 0.802
cop MIR935 -0.133 0.318 0.803
hs4 C18orf32 18q21.1 0.132 0.319 0.803 signal transduction;positive
hs4 MIR1539 0.132 0.319 0.803
hs4 SNORD58C 0.132 0.319 0.803
hs4 SNORD58A 0.132 0.319 0.803
hs4 RPL17-C18orf32 0.132 0.319 0.803
hs4 SNORD58B 18q21 0.132 0.319 0.803
hs4 RPL17 18q21 0.132 0.319 0.803 translational termination;cellular protein
metabolic process
exp HDHD1P3 20q11.21 0.132 0.319 0.803
xai KDSR 18q21.3 0.132 0.319 0.803 sphingolipid metabolic process;3-keto-
hs4 SLC9B2 4q24 0.132 0.319 0.803 cation transport;sodium ion transport
his FANCF 11p15 0.132 0.319 0.803 DNA Damage Response (DDR); DDR (FA)
hs4 GTF3A 13q12.3-q13.1 0.132 0.319 0.803 gene expression;regulation of
hs4 FAM155B Xq13.1 0.132 0.319 0.803
xai C10orf12 10q24.1 0.132 0.319 0.803
xai C16orf52 16p12.2 0.132 0.319 0.803
his FAM124B 2q36.2 0.132 0.319 0.803
exp PRIMPOL 0.132 0.319 0.803 DDR (DNA replication)
xai SPATA25 20q13.12 0.132 0.319 0.803 spermatogenesis;cell
differentiation
hs4 C20orf196 20p12.3 0.132 0.319 0.803
xai FLJ41941 22q11.21 0.132 0.319 0.803
hs4 RREB1 6p25 0.132 0.319 0.803 regulation of transcription, DNA-
hs4 SNAR-C1 0.132 0.319 0.803
exp LOC100128317 7q21.11 0.132 0.319 0.803
dependent"
exp PSPC1P1 13q12.11 0.132 0.319 0.803
xai KMT5C 0.132 0.319 0.803 regulation of transcription, DNA-
exp OR14C36 1q44 0.132 0.319 0.803 response to stimulus
his DDX52 17q21.1 0.132 0.319 0.803
hs4 FDFT1 8p23.1-p22 0.132 0.319 0.803 small molecule metabolic process;farnesyl
diphosphate metabolic process
his YWHAQ 2p25.1 0.132 0.319 0.803 protein targeting;small GTPase mediated
signal transduction
xai EXOSC10 1p36.22 0.132 0.319 0.803 CUT catabolic process;nuclear-
exp MROH9 1q24.3 0.132 0.319 0.803
exp PPIAP10 0.132 0.319 0.803
his LOC100506124 0.132 0.319 0.803
his C1orf53 1q31.3 0.132 0.319 0.803
hs4 CDC25B 20p13 0.132 0.319 0.803 DNA Damage Response (DDR)
cop CMA1 14q11.2 0.132 0.319 0.803 proteolysis;interleukin-1 beta
exp CYP2C19 10q24 0.132 0.319 0.803 steroid metabolic process;monoterpenoid
metabolic process
his DTNB 2p24 0.132 0.319 0.803
his ANKRD20A5P 0.132 0.319 0.803
his IFNB1 0.132 0.319 0.803
exp ACPT 19q13.4 0.132 0.319 0.803
exp FLJ41941 22q11.21 0.132 0.319 0.803
swa CAB39 2q37.1 0.132 0.319 0.803 protein heterooligomerization;positive
dependent"
hs4 AES 19p13.3 0.132 0.319 0.803 cellular response to extracellular
his ACBD7-DCLRE1CP1 0.132 0.319 0.803
his ACBD7 10p13 0.132 0.319 0.803
his RPS11 19q13.3 0.132 0.319 0.803
his SNORD35B 0.132 0.319 0.803
his MIR150 0.132 0.319 0.803
met ADNP2 18q23 0.131 0.319 0.803 neuron differentiation;positive regulation of
cell growth
cop CAPN7 3p24 0.131 0.319 0.803 proteolysis
cop LYAR 4p16.3 0.131 0.319 0.803
cop C14orf119 14q11.2 0.131 0.319 0.803
xsq LINC00701 0.131 0.319 0.803
met SDR16C5 8q12.1 0.131 0.319 0.803 retinol metabolic process;retinal
metabolic process
met YAP1 11q13 0.131 0.319 0.803 Apoptosis
exp FAM161A 2p15 0.131 0.319 0.803 response to stimulus;visual perception
mut SERPINI1 3q26.1 0.131 0.319 0.803 peripheral nervous system
met GNAL 18p11.22-p11.21 0.131 0.319 0.803 signal transduction;G-protein
cop DDB1 11q12-q13 0.131 0.319 0.803 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
exp CYCSP3 8p12 0.131 0.319 0.803
met SCN3B 11q23.3 0.131 0.319 0.803 sodium ion transport;nervous system
development
cop TMEM128 4p16.3 0.131 0.319 0.803
xsq WIPF1 2q31.1 0.131 0.319 0.803 positive regulation of protein export
met THRA 17q11.2 0.131 0.319 0.803 regulation of transcription from RNA
met SYT9 11p15.4 0.131 0.319 0.803 regulation of calcium ion-dependent
mut KL 13q12 0.131 0.319 0.803 aging;insulin receptor signaling pathway
xsq LOC101928730 0.131 0.319 0.803
exp MEF2C 5q14.3 0.131 0.319 0.803 osteoblast differentiation;regulation of
cop KLHL25 15q25.3 0.131 0.319 0.803
cop MIR1276 0.131 0.319 0.803
cop RNF103 0.131 0.319 0.803 protein ubiquitination;ER-associated
met AMIGO1 1p13.3 0.131 0.319 0.803 heterophilic cell-cell
met ZNF598 16p13.3 0.131 0.319 0.803
xsq SEPT12 16p13.3 0.131 0.319 0.803 cell cycle;cell division
cop MACROD1 11q11 0.131 0.319 0.803 purine nucleoside metabolic process
cop MARK2 11q13.1 0.131 0.319 0.803 intracellular protein kinase
cascade;regulation of axonogenesis
xsq GABPB2 1q21.3 0.131 0.319 0.803 regulation of transcription, DNA-
exp LAMC3 9q31-q34 0.131 0.319 0.803 cell adhesion;visual perception
exp LOC100129461 6p25.1 0.131 0.319 0.803
xsq RALGDS 9q34.3 0.131 0.319 0.803 Ras protein signal
xsq MCF2L-AS1 13q34 0.131 0.319 0.803
xsq UNC13C 15q21.3 0.131 0.319 0.803 exocytosis;synaptic transmission
mut ADD2 2p13.3 0.131 0.319 0.803 actin cytoskeleton
xsq GLB1L2 11q25 0.131 0.319 0.803 carbohydrate metabolic process
mir hsa-miR-29a* 0.131 0.319 0.803
exp HIST1H1A 6p21.3 -0.131 0.319 0.803 nucleosome
assembly;spermatogenesis
cop KCNS3 2p24 -0.131 0.319 0.803 ion transport;potassium ion transport
cop SNORA71B 20q11.23 -0.131 0.319 0.803
cop SNORA71A -0.131 0.319 0.803
cop SNORA71C 20q11.23 -0.131 0.319 0.803
cop SNORA71D 20q11.23 -0.131 0.319 0.803
cop SNHG11 20q11.23 -0.131 0.319 0.803
cop SNORA39 -0.131 0.319 0.803
cop SNORA60 20q11.23 -0.131 0.319 0.803
xsq DCBLD1 6q22.1 -0.131 0.319 0.803 cell adhesion
xsq TCN2 22q12.2 -0.131 0.319 0.803 ion transport;cobalt ion transport
cop MIR1289-2 -0.131 0.319 0.803
cop TNFSF15 9q32 -0.131 0.319 0.803 cytokine metabolic process;positive
cop FSTL4 5q31.1 -0.131 0.319 0.803
exp SIX4 14q23 -0.131 0.319 0.803 generation of neurons;multicellular
mut ZSCAN4 19q13.43 -0.131 0.319 0.803 telomere maintenance via
telomere lengthening;viral reproduction
cop EPN2 17p11.2 -0.131 0.319 0.803 regulation of endocytosis
xsq OR7E2P 11q14.2 -0.131 0.319 0.803
exp PJA1 Xq13.1 -0.131 0.319 0.803 protein catabolic process
exp LMO1 11p15 -0.131 0.319 0.803 negative regulation of transcription from
II promoter
xsq MYO1D 17q11-q12 -0.131 0.319 0.803 negative regulation of phosphatase
activity
cop HSD3B1 1p13.1 -0.131 0.319 0.803 steroid biosynthetic
xsq LOC101928523 -0.131 0.319 0.803
exp ARSE Xp22.3 -0.131 0.319 0.803 skeletal system development
exp ADAM20 14q24.1 -0.131 0.319 0.803 proteolysis;single
fertilization
exp ITGBL1 13q33 -0.131 0.319 0.803 integrin-mediated signaling
cop MIER1 1p31.3 -0.131 0.319 0.803 regulation of transcription, DNA-
cop SLC35D1 1p32-p31 -0.131 0.319 0.803 Solute Carriers
mut RET 10q11.2 -0.131 0.319 0.803 Oncogenes
exp BMF 15q14 -0.131 0.319 0.803 Apoptosis
xai THSD4 15q23 -0.132 0.319 0.803 elastic fiber assembly
hs4 CHST6 16q22 -0.132 0.319 0.803 sulfur compound metabolic process;keratan
xai PRKACG 9q13 -0.132 0.319 0.803 Protein Kinases
hs4 GMPR 6p23 -0.132 0.319 0.803 purine base metabolic process;nucleotide
metabolic process
his MAST2 1p34.1 -0.132 0.319 0.803 protein phosphorylation;regulation
his TRDMT1 10p15.1 -0.132 0.319 0.803 C-5 methylation of
cytosine;response to amphetamine
exp CAPN9 1q42.11-q42.3 -0.132 0.319 0.803 proteolysis;digestion
hs4 RSPH1 21q22.3 -0.132 0.319 0.803 meiosis
hs4 LOC101930094 -0.132 0.319 0.803
his MUC20 3q29 -0.132 0.319 0.803 hepatocyte growth factor receptor
his RGMA 15q26.1 -0.132 0.319 0.803 axon guidance
xai TMEM159 16p12 -0.132 0.319 0.803
his MIR4645 -0.132 0.319 0.803
his ZNF853 7p22.1 -0.132 0.319 0.803
hs4 BVES 6q21 -0.132 0.319 0.803 vesicle-mediated transport;regulation of
Rac GTPase activity
hs4 BVES-AS1 -0.132 0.319 0.803
his HOXD3 2q31.1 -0.132 0.319 0.803 thyroid gland development;positive
his AHCTF1P1 2q24.2 -0.132 0.319 0.803
his PLEKHF2 8q22.1 -0.132 0.319 0.803
xai GFRA2 8p21.3 -0.132 0.319 0.803 transmembrane receptor protein
signaling pathway
his LINC01959 -0.132 0.319 0.803
hs4 FAM46D Xq21.1 -0.132 0.319 0.803
hs4 CHMP1B2P -0.132 0.319 0.803
DNA-dependent"
his KLHDC8A 1q32.1 -0.132 0.319 0.803
his COL6A2 21q22.3 -0.132 0.319 0.803 axon guidance;response to
glucose stimulus
his MIR6073 -0.132 0.319 0.803
xai AKR1B1P4 13q14.13 -0.132 0.319 0.803
his LINC01082 -0.132 0.319 0.803
xai SERTM1 13q13.3 -0.132 0.319 0.803
xai PCDH18 4q31 -0.132 0.319 0.803 homophilic cell adhesion;brain
development
hs4 LINC-PINT -0.132 0.319 0.803
xai HYAL2 3p21.3 -0.132 0.319 0.803 response to virus;negative
regulation of MAP kinase activity
xai TCEA3 1p36.12 -0.132 0.319 0.803 regulation of transcription from
RNA polymerase II promoter;regulation of transcription elongation, DNA-dependent"
exp LOC400743 1p36.13 -0.132 0.319 0.803
hs4 MIR6132 -0.132 0.319 0.803
his MCC 5q21 -0.132 0.319 0.803 signal transduction;negative regulation
xai PRSS51 8p23.1 -0.132 0.319 0.803
his PCDHAC1 0.132 0.32 0.803 homophilic cell adhesion;nervous system
development
his MIR4795 0.132 0.32 0.803
his CHMP2B 3p11.2 0.132 0.32 0.803 protein transport;cellular membrane
organization
hs4 ZNF217 20q13.2 0.132 0.32 0.803 transcription, DNA-
his RNF145 5q33.3 0.132 0.32 0.803
hs4 GTF3C2 2p23.3 0.132 0.32 0.803 transcription, DNA-
exp LINC00558 0.132 0.32 0.803
his POMZP3 0.132 0.32 0.803
xai NR2C2AP 19p13.11 0.132 0.32 0.803 cell adhesion;gene expression
xai ZSCAN25 7q22.1 0.132 0.32 0.803
xai CNOT7P2 1p13.1 0.132 0.32 0.803
xai SUCLA2 13q12.2-q13.3 0.132 0.32 0.803 succinate metabolic
his CD2BP2 16p11.2 0.132 0.32 0.803 nuclear mRNA splicing, via
xai PGS1 17q25.3 0.132 0.32 0.803 phosphatidylglycerol biosynthetic
his DUSP21 Xp11.4-p11.23 0.132 0.32 0.803 peptidyl-tyrosine
dephosphorylation
exp PCDHA2 0.132 0.32 0.803 nervous system development;cell adhesion
xai ADIRF 10q23.2 0.132 0.32 0.803
his MIR1278 0.132 0.32 0.803
his TMEM50B 21q22.11 0.132 0.32 0.803
his MIR8072 0.132 0.32 0.803
his SBNO1 12q24.31 0.132 0.32 0.803
his OR9Q2 0.132 0.32 0.803
hs4 VAPA 18p11.22 0.132 0.32 0.803 sphingolipid biosynthetic process;neuron
hs4 ICOS 2q33 0.132 0.32 0.803 immune response;T cell costimulation
xai LINC00602 6q27 0.132 0.32 0.803
his LINC00656 20p11.21 0.132 0.32 0.803
exp EGFL8 0.132 0.32 0.803 in utero embryonic development
xai SCFD1 14q12 0.132 0.32 0.803 response to hypoxia;retrograde vesicle-mediated
xai FLOT2 17q11-q12 0.132 0.32 0.803 epidermis development;cell adhesion
his MED19 11q12.1 0.132 0.32 0.803 regulation of transcription from RNA
his TMX2-CTNND1 0.132 0.32 0.803
his TMX2 11cen-q22.3 0.132 0.32 0.803 cell redox homeostasis
his LINC00893 Xq28 0.132 0.32 0.803
his CXorf40A Xq28 0.132 0.32 0.803
his ZDHHC5 11q12.1 0.132 0.32 0.803
exp BTF3P4 9q21.13 0.132 0.32 0.803
his ARL8B 3p26.1 0.132 0.32 0.803 cell cycle;chromosome segregation
xai SNORA66 1p22.1 0.132 0.32 0.803
his ATG16L1 2q37.1 0.132 0.32 0.803 autophagic vacuole
assembly;autophagy
exp CCT5P2 13q31.1 0.132 0.32 0.803
xai CFL1P2 1p32.3 0.132 0.32 0.803
his MIR4794 0.132 0.32 0.803
xai CHGA 14q32 0.132 0.32 0.803 regulation of blood pressure
xai CECR2 22q11.2 0.132 0.32 0.803 chromatin modification;cytokinesis
hs4 GJD2 0.132 0.32 0.803
hs4 LOC101928174 0.132 0.32 0.803
xai ZDBF2 2q33.3 0.132 0.32 0.803
xai SLC11A1 2q35 0.132 0.32 0.803 protein import into nucleus,
exp FKBPL 6p21.3 0.131 0.32 0.803 response to radiation;peptidyl-proline
modification
met COL5A2 2q14-q32 0.131 0.32 0.803 collagen fibril organization;skin
development
met IFT81 12q24.13 0.131 0.32 0.803 multicellular organismal
cop BSN-AS2 3p21.31 0.131 0.32 0.803
xsq MCPH1-AS1 0.131 0.32 0.803
mir hsa-miR-363 0.131 0.32 0.803
cop USP31 16p12.2 0.131 0.32 0.803 proteolysis;ubiquitin-dependent protein
catabolic process
met LOC284688 0.131 0.32 0.803
xsq LINC01310 0.131 0.32 0.803
exp PTDSS2 11p15.5 0.131 0.32 0.803 phosphatidylserine biosynthetic
met KIAA0040 1q24-q25 0.131 0.32 0.803
met DUSP14 17q12 0.131 0.32 0.803 peptidyl-tyrosine dephosphorylation
xsq UNQ6494 9q22.2 0.131 0.32 0.803
xsq CCR9 3p21.3 0.131 0.32 0.803 immune response;cellular defense response
xsq PGK2 0.131 0.32 0.803
mda MutSig2_APOBEC 0.131 0.32 0.803
xsq ATG4D 19p13.2 0.131 0.32 0.803 proteolysis;autophagy
xsq SRRM1 1p36.11 0.131 0.32 0.803 transcription from RNA polymerase II
cop RNF165 18q21.1 0.131 0.32 0.803
cop COL6A4P1 3p25.1 0.131 0.32 0.803
xsq SRSF6 20q12-q13.1 0.131 0.32 0.803 RNA splicing;gene expression
exp TNRC6B 22q13.1 0.131 0.32 0.803 regulation of translation;gene
silencing by RNA
mut TRMT61A 14q32 0.131 0.32 0.803 tRNA processing;tRNA methylation
cop TSSC1 2p25.3 0.131 0.32 0.803
cop HSPG2 1p36.1-p34 0.131 0.32 0.803 chondrocyte differentiation;cardiac
met RNF144B 6p22.3 0.131 0.32 0.803 apoptotic process;protein
met ACOT13 6p22.3 0.131 0.32 0.803 protein homotetramerization
met MSC 8q21 0.131 0.32 0.803 regulation of transcription, DNA-
cop TXLNA 1p35.1 0.131 0.32 0.803 exocytosis;cell proliferation
cop CCDC28B 1p36.11-p34.2 0.131 0.32 0.803
cop IQCC 1p36.11-p34.2 0.131 0.32 0.803
cop DCDC2B 1p35.1 0.131 0.32 0.803 intracellular signal transduction
cop TMEM234 1p36.11-p34.2 0.131 0.32 0.803
cop EIF3I 1p34.1 0.131 0.32 0.803 gene expression;cellular protein
metabolic process
cop MTMR9LP 1p35.1 0.131 0.32 0.803
cop FAM167B 1p35.1 0.131 0.32 0.803
cop LCK 1p34.3 0.131 0.32 0.803 Protein Kinases
mut CELF3 1q21 0.131 0.32 0.803 spermatogenesis;RNA splicing
met PAFAH1B3 19q13.1 0.131 0.32 0.803 lipid metabolic process;nervous
system development
xsq ALG1 16p13.3 0.131 0.32 0.803 protein N-linked glycosylation via
exp PGM5 9q13 0.131 0.32 0.803 carbohydrate metabolic process;glycogen
xsq PPP1R35 7q22.1 0.131 0.32 0.803 negative regulation of phosphatase
activity
xsq ENPP7 17q25.3 0.131 0.32 0.803 negative regulation of cell
proliferation;small molecule metabolic process
xsq ST3GAL5-AS1 0.131 0.32 0.803
dependent"
mut ACAD11 3q22.1 0.13 0.32 0.803 fatty acid beta-oxidation using
acyl-CoA dehydrogenase
met CLVS2 6q22.31 0.13 0.32 0.803
xsq C1orf177 1p32.3 0.13 0.32 0.803
exp LY86-AS1 6p25.1 0.13 0.32 0.803
mut WDFY1 2q36.1 0.13 0.32 0.803
xsq ZNF728 19p12 0.13 0.32 0.803
xsq MFF 2q36.3 0.13 0.32 0.803
exp SPTSSA 14q13.1 -0.13 0.32 0.803 sphingolipid biosynthetic process
xsq SBF2 11p15.4 -0.13 0.32 0.803 regulation of catalytic activity;protein
tetramerization
xsq NEK7 1q31.3 -0.13 0.32 0.803 cytokinesis;protein phosphorylation
xsq ABCA5 17q24.3 -0.131 0.32 0.803 ABC Transporters
met C11orf53 11q23.1 -0.131 0.32 0.803
exp HSD17B3 9q22 -0.131 0.32 0.803 insecticide metabolic
mut PTEN 10q23.3 -0.131 0.32 0.803 Apoptosis; Cell Signaling; DNA
Damage Response (DDR); DDR (DNA replication); Protein Kinases; Tumor Suppressors
exp ZNF446 19q13.43 -0.131 0.32 0.803 viral reproduction
mut TCN2 22q12.2 -0.131 0.32 0.803 ion transport;cobalt ion transport
xsq RBM24 6p22.3 -0.131 0.32 0.803 regulation of mRNA
xsq PLP1 Xq22 -0.131 0.32 0.803 synaptic transmission;cell death
xsq PSORS1C2 6p21.3 -0.131 0.32 0.803
exp WNK3 Xp11.22 -0.131 0.32 0.803 positive regulation of sodium ion
met HILPDA 7q32.1 -0.131 0.32 0.803 positive regulation of cell
xsq VAMP3 1p36.23 -0.131 0.32 0.803 protein complex assembly;retrograde
met PADI3 1p36.13 -0.131 0.32 0.803 protein modification
cop SCARNA7 3q25.22 -0.131 0.32 0.803
exp SYBU 8q23.2 -0.131 0.32 0.803
xsq GPT2 16q12.1 -0.131 0.32 0.803 small molecule metabolic process;2-
mut FTO 16q12.2 -0.131 0.32 0.803 DNA Damage Response (DDR)
exp ZBED2 3q13.2 -0.131 0.32 0.803
his ANK2 4q25-q27 -0.132 0.32 0.803 axon guidance;signal transduction
hs4 SGIP1 1p31.3 -0.132 0.32 0.803 response to dietary excess;positive
xai DCTN3 9p13 -0.132 0.32 0.803 microtubule-based process;mitosis
cop OSCAR 19q13.42 -0.132 0.32 0.803
cop NDUFA3 19q13.42 -0.132 0.32 0.803 mitochondrial electron
cop TFPT 19q13 -0.132 0.32 0.803 DNA Damage Response (DDR); DDR
(Chromatin)
cop PRPF31 19q13.42 -0.132 0.32 0.803 assembly of spliceosomal tri-
snRNP;nuclear mRNA splicing, via spliceosome
cop CNOT3 19q13.4 -0.132 0.32 0.803 nuclear-transcribed mRNA catabolic
shortening
cop LENG1 19q13.4 -0.132 0.32 0.803
cop TMC4 19q13.42 -0.132 0.32 0.803 EMT (Epithelial)
hs4 CAPN5 11q14 -0.132 0.32 0.803 granulosa cell differentiation;ovarian
his FAM179A 2p23.2 -0.132 0.32 0.803
xai BEND6 6p12.1 -0.132 0.32 0.803
xai KRT8P35 -0.132 0.32 0.803
xai LRRC17 7q22.1 -0.132 0.32 0.803 osteoblast
xai EGOT 3p26.1 -0.132 0.32 0.803
hs4 DUSP15 20q11.21 -0.132 0.32 0.803 protein dephosphorylation
hs4 TTLL9 20q11.21 -0.132 0.32 0.803 protein modification process
xai NME7 1q24 -0.132 0.32 0.803 GTP biosynthetic process;UTP biosynthetic
process
hs4 SYNE2 14q23.2 -0.132 0.32 0.803 positive regulation of cell
xai LYN 8q13 -0.132 0.32 0.803 Protein Kinases
exp ERV3-1 7q11.2 -0.132 0.32 0.803
xai ARHGEF16 1p36.3 -0.132 0.32 0.803 apoptotic process;cell
chemotaxis
his MOBP 3p22.1 -0.132 0.32 0.803 nervous system development
xai TNIK 3q26.31 -0.132 0.32 0.803 protein phosphorylation;protein
autophosphorylation
xai ALPL 1p36.12 -0.132 0.32 0.803 biomineral tissue
hs4 EGOT 3p26.1 -0.132 0.32 0.803
swa PDP1 8q22.1 -0.132 0.32 0.803 pyruvate metabolic
his PSG8-AS1 -0.132 0.32 0.803
hs4 FXYD3 19q13.12 -0.132 0.32 0.803 chloride transport;regulation of
catalytic activity
xai ALDH2 12q24.2 -0.132 0.32 0.803 synaptic
hs4 STMN3 20q13.3 0.132 0.321 0.803 nervous system development;cytoplasmic
hs4 PDIK1L 1p36.11 0.132 0.321 0.803
xai CBX8 17q25.3 0.132 0.321 0.803 negative regulation of transcription from
swa WDR43 2p23.2 0.132 0.321 0.803
xai WBSCR16 7q11.23 0.132 0.321 0.803
his TM2D1 1p31.3 0.132 0.321 0.803 apoptotic process;induction of apoptosis
hs4 FANCG 9p13 0.132 0.321 0.803 DNA Damage Response (DDR); DDR (FA)
exp SNORA66 1p22.1 0.132 0.321 0.803
xai LOC100996583 0.132 0.321 0.803
his FBXO4 5p12 0.132 0.321 0.803 positive regulation of protein
ubiquitination;protein polyubiquitination
dependent"
xai RPL7P42 12q15 0.132 0.321 0.803
swa TBC1D15 12q21.1 0.132 0.321 0.803 regulation of Rab GTPase
his LOC100129620 0.132 0.321 0.803
his PLPPR5 0.132 0.321 0.803
exp RPL7P42 12q15 0.132 0.321 0.803
exp CLLU1OS 12q22 0.132 0.321 0.803
exp KRT28 17q21.2 0.132 0.321 0.803
xai ACAD8 11q25 0.132 0.321 0.803 regulation of transcription, DNA-
his TMEM26 10q21.2 0.132 0.321 0.803
his MAK16 8p12 0.132 0.321 0.803 translation
xai TPR 1q25 0.131 0.321 0.803 protein transport;glucose transport
exp TLR12P 1p35.1 0.131 0.321 0.803
his LOC389765 9q21.33 0.131 0.321 0.803
his EXOC1 4q12 0.131 0.321 0.803 exocytosis;protein transport
his ARC 8q24.3 0.131 0.321 0.803 regulation of cell
exp FGF6 12p13 0.131 0.321 0.803 cartilage condensation;fibroblast growth factor
xai JMJD8 16p13.3 0.131 0.321 0.803
xai KCNK10 14q31.3 0.131 0.321 0.803 transport;ion transport
his LOC101928509 0.131 0.321 0.803
his LOC103191607 0.131 0.321 0.803
exp TNFRSF13C 22q13.1-q13.31 0.131 0.321 0.803 regulation of immune
response;B cell homeostasis
his UGP2 2p14-p13 0.131 0.321 0.803 phosphorylation;glucose 1-phosphate
metabolic process
his DUSP13 10q22.2 0.131 0.321 0.803 protein dephosphorylation;meiosis
his SAMD8 10q22.2 0.131 0.321 0.803 lipid metabolic process;sphingolipid
metabolic process
xai NIPA2 15q11.2 0.131 0.321 0.803 ion transport;magnesium ion transport
his LOC105376271 0.131 0.321 0.803
his RABEPK 9q33.3 0.131 0.321 0.803 receptor-mediated
xai LYG2 2q11.2 0.131 0.321 0.803 metabolic process;peptidoglycan catabolic
process
xai VCPKMT 0.131 0.321 0.803
swa DPP3 11q12-q13.1 0.131 0.321 0.803 proteolysis
xai PNPO 17q21.32 0.131 0.321 0.803 vitamin metabolic process;water-soluble
mut TACR3 4q25 0.13 0.321 0.803 response to morphine;tachykinin receptor
signaling pathway
exp PRSS3 9p11.2 0.13 0.321 0.803 digestion;zymogen activation
exp FHIT 3p14.2 0.13 0.321 0.803 diadenosine triphosphate catabolic
cop FUS 16p11.2 0.13 0.321 0.803 nuclear mRNA splicing, via
mut OR10A6 11p15.4 0.13 0.321 0.803 response to stimulus
cop RGPD2 2p11.2 0.13 0.321 0.803
cop RGPD1 0.13 0.321 0.803
cop PLGLB1 0.13 0.321 0.803
cop PLGLB2 0.13 0.321 0.803
xsq FGGY 1p32.1 0.13 0.321 0.803 carbohydrate metabolic process;cell death
cop PPP4C 16p11.2 0.13 0.321 0.803 DNA Damage Response (DDR); DDR (HR)
cop TBX6 16p11.2 0.13 0.321 0.803 mesoderm development;anatomical structure
morphogenesis
cop YPEL3 16p11.2 0.13 0.321 0.803
met FAIM 3q22.3 0.13 0.321 0.803 Apoptosis
met SYNE1 6q25 0.13 0.321 0.803 nucleus organization;Golgi organization
met FUK 16q22.1 0.13 0.321 0.803 metabolic process
xsq NDUFAF6 8q22.1 0.13 0.321 0.803
cop MIR4692 0.13 0.321 0.803
exp PRPSAP2 17p11.2-p12 0.13 0.321 0.803 nucleobase-containing compound
met CAMKK1 17p13.2 0.13 0.321 0.803 synaptic transmission
exp CDS2 20p13 0.13 0.321 0.803 phospholipid biosynthetic process
cop DAG1 3p21 0.13 0.321 0.803 interspecies interaction between
cop LARP4B 10p15.3 0.13 0.321 0.803
xsq UBE2D1 10q21.1 0.13 0.321 0.803 ubiquitin-dependent protein
catabolic process;regulation of ubiquitin-protein ligase activity involved in
mitotic cell cycle
exp DNAJC19 3q26.33 0.13 0.321 0.803 protein folding;protein targeting
to mitochondrion
exp TBC1D15 12q21.1 0.13 0.321 0.803 regulation of Rab GTPase
xsq LOC643201 5q35.2 0.13 0.321 0.803
mut TMCO1 1q22-q25 0.13 0.321 0.803
xsq FBXL21 5q31 0.13 0.321 0.803 protein ubiquitination;rhythmic process
exp H2AFX 11q23.3 0.13 0.321 0.803 DNA Damage Response (DDR); DDR (HR)
cop SCYL2 12q23.1 0.13 0.321 0.803 endosome to lysosome transport;negative
xsq LOC440117 0.13 0.321 0.803
cop CT62 15q23 0.13 0.321 0.803
exp CHST11 12q 0.13 0.321 0.803 chondroitin sulfate biosynthetic
met PPARG 3p25 0.13 0.321 0.803 placenta development;regulation of blood
pressure
xsq HTR3A 11q23.1 0.13 0.321 0.803 ion transmembrane transport;transmembrane
transport
xsq XKR3 22q11.1 0.13 0.321 0.803
cop LOC100132146 3p21.31 0.13 0.321 0.803
xsq LINC01219 0.13 0.321 0.803
cop TCTA 3p21 0.13 0.321 0.803
cop AMT 3p21.2-p21.1 0.13 0.321 0.803 glycine catabolic process
exp EFNA3 1q21-q22 0.13 0.321 0.803 cell-cell signaling;ephrin receptor
signaling pathway
met ENPP1 6q22-q23 0.13 0.321 0.803 nucleoside triphosphate catabolic
met SDF2L1 22q11.21 0.13 0.321 0.803
met SDHC 1q23.3 0.13 0.321 0.803 tricarboxylic acid cycle;transport
exp SLCO4C1 5q21.2 0.13 0.321 0.803 Solute Carriers
exp RPL22P19 12q24.31 0.13 0.321 0.803
cop FOLR1 11q13.3-q14.1 0.13 0.321 0.803 cell death;folic acid transport
cop FOLR2 11q13.3-q13.5 0.13 0.321 0.803 folic acid transport
cop INPPL1 11q13 0.13 0.321 0.803 actin filament organization;negative
cop PHOX2A 11q13.2 0.13 0.321 0.803 regulation of transcription, DNA-
dependent;somatic motor neuron differentiation
met MTERF1 0.13 0.321 0.803 transcription termination, DNA-
mut ANKRD12 18p11.22 0.13 0.321 0.803
xsq CDC20B 5q11.2 -0.13 0.321 0.803
xsq OLFML2B 1q23.3 -0.13 0.321 0.803 extracellular matrix organization
exp TMEM159 16p12 -0.13 0.321 0.803
exp ORAI3 16p11.2 -0.13 0.321 0.803
xsq SERPINA3 14q32.1 -0.13 0.321 0.803 regulation of
exp FBXL7 5p15.1 -0.13 0.321 0.803 ubiquitin-dependent protein catabolic
xsq SNX30 9q32 -0.13 0.321 0.803 cell communication;protein transport
xsq SIX1 14q23.1 -0.13 0.321 0.803 regulation of transcription, DNA-
dependent;negative regulation of neuron apoptosis
exp DACT3 19q13.32 -0.13 0.321 0.803
exp COL6A1 21q22.3 -0.13 0.321 0.803 cell adhesion;axon guidance
xsq SCIN 7p21.3 -0.13 0.321 0.803 regulation of chondrocyte
mir hsa-miR-193a-5p -0.13 0.321 0.803
cop RAD50 5q31 -0.13 0.321 0.803 DNA Damage Response (DDR); DDR (HR)
mut MARCH7 2q24.2 -0.13 0.321 0.803
xsq ZNRF2P1 -0.13 0.321 0.803
xsq MAP4K3 2p22.1 -0.13 0.321 0.803 response to stress;intracellular
cop CPEB4 5q21 -0.13 0.321 0.803
xsq NDRG2 14q11.2 -0.13 0.321 0.803 Wnt receptor signaling pathway;cell
differentiation
met HIST1H4J 6p22.1 -0.13 0.321 0.803
mut CBX2 17q25.3 -0.13 0.321 0.803 development of primary sexual
xsq SH2D6 2p11.2 -0.13 0.321 0.803
exp LOC100286881 -0.13 0.321 0.803
xsq PXMP4 20q11.22 -0.13 0.321 0.803
xsq PRKD1 14q11 -0.13 0.321 0.803 intracellular protein kinase cascade;cell
differentiation
xsq TLDC2 20q11.23 -0.13 0.321 0.803
xsq GLI2 2q14 -0.13 0.321 0.803 osteoblast development;hindgut morphogenesis
cop CHST2 3q24 -0.13 0.321 0.803 metabolic process;carbohydrate metabolic
process
xsq YIF1B 19q13.2 -0.13 0.321 0.803
xsq SNORA45B -0.13 0.321 0.803
xsq KRTAP5-2 -0.13 0.321 0.803
xai LMOD1 1q32 -0.131 0.321 0.803 muscle contraction
hs4 SHISA9 16p13.12 -0.131 0.321 0.803 regulation of short-term
xai IRF6 1q32.3-q41 -0.131 0.321 0.803 EMT (Epithelial); Tumor Suppressors
exp DLEC1 3p21.3 -0.131 0.321 0.803 negative regulation of cell
proliferation
hs4 ESRP2 16q22.1 -0.131 0.321 0.803 EMT (Epithelial)
hs4 MIR6773 -0.131 0.321 0.803
cop EID2 19q13.2 -0.131 0.321 0.803 multicellular organismal
cop LGALS13 19q13.1 -0.131 0.321 0.803 phospholipid metabolic
cop LOC100129935 -0.131 0.321 0.803
cop LGALS16 19q13.2 -0.131 0.321 0.803
cop LGALS17A 19q13.2 -0.131 0.321 0.803
cop LGALS14 19q13.2 -0.131 0.321 0.803
cop CLC 19q13.1 -0.131 0.321 0.803 multicellular organismal
cop LEUTX 19q13.2 -0.131 0.321 0.803
cop DYRK1B 19q13.2 -0.131 0.321 0.803 protein
phosphorylation;myoblast fusion
cop FBL 19q13.1 -0.131 0.321 0.803 snoRNA metabolic process;rRNA
processing
cop FCGBP 19q13.1 -0.131 0.321 0.803
cop PSMC4 19q13.11-q13.13 -0.131 0.321 0.803 mitotic cell cycle;DNA damage
DNA-dependent"
cop ZNF780B 19q13.2 -0.131 0.321 0.803 regulation of transcription,
DNA-dependent"
cop ZNF780A 19q13.2 -0.131 0.321 0.803 regulation of transcription,
DNA-dependent"
exp ADAM20P1 14q24.2 -0.131 0.321 0.803
hs4 ZNF136 19p13.2 -0.131 0.321 0.803 negative regulation of
dependent
xai CIART -0.131 0.321 0.803
xai CCL19 9p13 -0.131 0.321 0.803 dendritic cell chemotaxis;response to
virus
hs4 KIF1BP -0.131 0.321 0.803
cop CACNG7 19q13.4 -0.131 0.321 0.803 ion transport;calcium ion
transport
xai ADAD2 16q24.1 -0.131 0.321 0.803 RNA processing
xai COL6A6 3q22.1 -0.131 0.321 0.803 cell adhesion
xai HACD2 -0.131 0.321 0.803 fatty acid biosynthetic process
xai CDH19 18q22.1 -0.132 0.321 0.803 cell-cell adhesion;cell adhesion
xai PROS1 3q11.2 -0.132 0.321 0.803 cellular protein metabolic
swa ATP6V1E1 22q11.1 -0.132 0.321 0.803 ion transport;cellular iron
ion homeostasis
exp C20orf173 20q11.22 -0.132 0.321 0.803
his PANDAR -0.132 0.321 0.803
his CDKN1A 6p21.2 -0.132 0.321 0.803 Apoptosis; DNA Damage
his DINO -0.132 0.321 0.803
xai MARCH3 5q23.2 -0.132 0.321 0.803 endocytosis
his LINC01832 -0.132 0.321 0.803
his C1S 12p13 -0.132 0.321 0.803 proteolysis;complement activation
exp ADAD2 16q24.1 -0.132 0.321 0.803 RNA processing
xai HIST1H4J 6p22.1 0.132 0.322 0.803
hs4 SURF6 9q34.2 0.131 0.322 0.803 ribosome biogenesis
hs4 WNT5B 12p13.3 0.131 0.322 0.803 Oncogenes
hs4 LINC01018 0.131 0.322 0.803
his MIR4502 0.131 0.322 0.803
xai LOC554207 14q11.2 0.131 0.322 0.803
his SNHG8 4q26 0.131 0.322 0.803
his SNORA24 4q26 0.131 0.322 0.803
hs4 MEN1 11q13 0.131 0.322 0.803 DNA Damage Response (DDR); Tumor Suppressors
his CRIP3 6p21.1 0.131 0.322 0.803
his ELMOD2 4q31.1 0.131 0.322 0.803 phagocytosis;response to virus
swa SEPT1_Q8WYJ6 0.131 0.322 0.803
hs4 RPL38 17q25.1 0.131 0.322 0.803 translation;mRNA metabolic process
cop ABHD17A 19p13.3 0.131 0.322 0.803
hs4 STIM1 11p15.5 0.131 0.322 0.803 detection of calcium ion;cation transport
hs4 MIR4687 0.131 0.322 0.803
exp GABRB2 5q34 0.131 0.322 0.803 chloride transport;gamma-aminobutyric
swa PWP1 12q23.3 0.131 0.322 0.803 transcription, DNA-dependent"
his LOC105370203 0.131 0.322 0.803
his CDADC1 13q14.2 0.131 0.322 0.803
exp LOC400968 0.131 0.322 0.803
his DCHS2 4q31.3 0.131 0.322 0.803 cell adhesion;homophilic cell adhesion
his FAM72B 0.131 0.322 0.803
xai SNRPN 15q11.2 0.131 0.322 0.803 RNA splicing
hs4 RYR2 1q43 0.131 0.322 0.803 multicellular organismal development;cytosolic
hs4 MCM8-AS1 0.131 0.322 0.803
hs4 CRLS1 20p13-p12.3 0.131 0.322 0.803 phospholipid biosynthetic process
his SNTA1 20q11.2 0.131 0.322 0.803 muscle contraction;neuromuscular junction
development
xai THEM6 8q24.3 0.131 0.322 0.803
his TXLNG Xp22.2 0.131 0.322 0.803 regulation of transcription, DNA-
dependent"
his LINC02059 0.131 0.322 0.803
hs4 KBTBD6 13q14.11 0.131 0.322 0.803
hs4 LOC101929140 0.131 0.322 0.803
exp GPR88 1p21.3 0.131 0.322 0.803 G-protein coupled receptor signaling
pathway
his SOCS5 2p21 0.131 0.322 0.803 cytokine-mediated signaling pathway;positive
his TM4SF5 17p13.3 0.131 0.322 0.803
hs4 SLC16A8 0.131 0.322 0.803
his TUBGCP3 13q34 0.131 0.322 0.803 mitotic cell cycle;microtubule nucleation
hs4 ANAPC15 11q13.4 0.131 0.322 0.803
dependent"
xsq BRCC3 Xq28 0.13 0.322 0.803 DNA Damage Response (DDR)
met IL1A 2q14 0.13 0.322 0.803 immune response;response to organic cyclic
compound
cop LOC440173 0.13 0.322 0.803
met CAMSAP2 1q32.1 0.13 0.322 0.803
exp PSMD3 17q21.1 0.13 0.322 0.803 S phase of mitotic cell cycle;DNA damage
exp PTBP3 9q32 0.13 0.322 0.803 mRNA processing;anatomical structure
morphogenesis
met NRTN 19p13.3 0.13 0.322 0.803 MAPK cascade;neural crest cell migration
xsq GTF2H4 6p21.3 0.13 0.322 0.803 DNA Damage Response (DDR); DDR
(NER)
cop VMP1 17q23.1 0.13 0.322 0.803 regulation of autophagy;cell-cell
adhesion
dependent"
cop TEX10 9q31.1 0.13 0.322 0.803
exp GRIP2 3p24-p23 0.13 0.322 0.803 synaptic transmission
dependent"
xsq C6orf48 6p21.3 0.13 0.322 0.803
xsq HIST1H4H 6p22.1 0.13 0.322 0.803
xsq LINC00593 15q23 0.13 0.322 0.803
dependent"
xsq VAMP8 2p12-p11.2 0.13 0.322 0.803 protein complex assembly;post-Golgi
xsq NOG 17q22 0.13 0.322 0.803 osteoblast differentiation;neural tube closure
xsq ERN2 16p12.2 0.13 0.322 0.803 cell cycle arrest;rRNA catabolic process
mir hsa-miR-125b-2* 0.13 0.322 0.803
xsq C19orf53 19p13.2 0.13 0.322 0.803
met SMAD1 4q31 0.13 0.322 0.803 ureteric bud development;transforming growth
xsq TBC1D24 16p13.3 0.13 0.322 0.803 neuron projection development
cop KIAA1328 18q12.2 0.13 0.322 0.803
xsq TRAF3IP2-AS1 6q21 0.13 0.322 0.803
xsq PFDN4 20q13.2 0.13 0.322 0.803 protein folding;cellular protein
metabolic process
exp CXCL10 4q21 0.13 0.322 0.803 chemotaxis;positive regulation of cell
proliferation
cop CSHL1 17q24.2 0.13 0.322 0.803
cop GH1 17q24.2 0.13 0.322 0.803 response to estradiol stimulus;growth
hormone receptor signaling pathway
cop CD79B 17q23 0.13 0.322 0.803 immune response;signal transduction
met MIR1247 0.13 0.322 0.803
cop SLAIN2 4p11 0.13 0.322 0.803 microtubule nucleation;positive
regulation of microtubule polymerization
met FSD1L 9q31 0.13 0.322 0.803
cop BSN 3p21.31 0.13 0.322 0.803 synaptic transmission
met ZFAS1 20q13.13 0.13 0.322 0.803
xsq LINC01375 0.13 0.322 0.803
met SMG7 1q25 0.13 0.322 0.803 nuclear-transcribed mRNA catabolic process,
exp FLOT2 17q11-q12 0.13 0.322 0.803 epidermis development;cell adhesion
xsq LINC00696 0.13 0.322 0.803
exp RPL30 8q22 0.13 0.322 0.803 viral reproduction;nuclear-transcribed mRNA
cop AKR1C4 10p15.1 0.13 0.322 0.803 small molecule metabolic
process;cellular response to jasmonic acid stimulus
met MAD1L1 7p22 0.13 0.322 0.803 mitotic anaphase;mitotic telophase
xsq FAM104B Xp11.21 0.13 0.322 0.803
xsq TMEM108 3q21 -0.13 0.322 0.803
cop SGIP1 1p31.3 -0.13 0.322 0.803 response to dietary excess;positive
cop MIR3117 -0.13 0.322 0.803
cop TCTEX1D1 1p31.3 -0.13 0.322 0.803
cop INSL5 1p31.3 -0.13 0.322 0.803
xsq EMX2 10q26.1 -0.13 0.322 0.803 multicellular organismal development
exp RNF11P2 20p12.1 -0.13 0.322 0.803
xsq EPHA6 3q11.2 -0.13 0.322 0.803
met VARS2 6p21.33 -0.13 0.322 0.803 tRNA aminoacylation for protein
exp ALDH3B1 11q13 -0.13 0.322 0.803 alcohol metabolic process;lipid metabolic
process
met HLA-DOA 6p21.3 -0.13 0.322 0.803 antigen processing and presentation
of exogenous peptide antigen via MHC class II;T cell costimulation
exp MANBA 4q24 -0.13 0.322 0.803 carbohydrate metabolic process;protein
xsq LINC00162 21q22.3 -0.13 0.322 0.803
met COX7A2 6q12 -0.13 0.322 0.803
exp PCDH20 13q21 -0.13 0.322 0.803 cell adhesion;homophilic cell adhesion
cop MIR4757 -0.13 0.322 0.803
cop OSR1 2p24.1 -0.13 0.322 0.803 ureteric bud development;positive
xsq PCDHB9 5q31 -0.13 0.322 0.803 cell adhesion;homophilic cell adhesion
exp NDUFA4L2 12q13.3 -0.13 0.322 0.803
exp BBOF1 -0.13 0.322 0.803
cop GEMIN8 Xp22.2 -0.13 0.322 0.803 RNA splicing;spliceosomal snRNP
assembly
xsq CLN8 8p23 -0.13 0.322 0.803 lysosome organization;somatic motor neuron
differentiation
exp TNFSF9 19p13.3 -0.13 0.322 0.803 Apoptosis
mut SGCZ 8p22 -0.13 0.322 0.803 muscle cell development;cytoskeleton
organization
mut KIF17 1p36.12 -0.13 0.322 0.803 metabolic process;protein transport
mut B4GALT2 1p34-p33 -0.13 0.322 0.803 post-translational protein
mut OR11L1 1q44 -0.13 0.322 0.803
mut CD14 5q31.1 -0.13 0.322 0.803 Apoptosis
mut MYCT1 6q25.2 -0.13 0.322 0.803
mut LPAR1 9q31.3 -0.13 0.322 0.803 G-protein coupled receptor signaling
pathway;myelination
mut INPP5E 9q34.3 -0.13 0.322 0.803
dephosphorylation;phosphatidylinositol phosphorylation
mut YARS2 12p11.21 -0.13 0.322 0.803 mitochondrial tyrosyl-tRNA
mut KRT79 12q13.13 -0.13 0.322 0.803
mut MAP3K12 12q13 -0.13 0.322 0.803 Protein Kinases
mut OR6C1 12q13.2 -0.13 0.322 0.803 response to stimulus
mut DEPDC4 12q23.1 -0.13 0.322 0.803 intracellular signal transduction
mut CFAP52 -0.13 0.322 0.803
mut WSB1 17q11.1 -0.13 0.322 0.803 intracellular signal transduction
mut PTH2 19q13.33 -0.13 0.322 0.803 neuropeptide signaling pathway
mut CPT1C 19q13.33 -0.13 0.322 0.803 lipid metabolic process;fatty acid
metabolic process
mut HM13 20q11.21 -0.13 0.322 0.803 membrane protein proteolysis
mut ITCH 20q11.22 -0.13 0.322 0.803 protein ubiquitination;innate immune
response
exp RDH12 14q24.1 -0.13 0.322 0.803 visual perception;retinol metabolic
process
xsq SPOCD1 1p35.2 -0.13 0.322 0.803 transcription, DNA-
exp NXPE4 11q23.2 -0.13 0.322 0.803
xsq CRISP1 6p21.3 -0.13 0.322 0.803 fusion of sperm to egg plasma
membrane
exp PRSS12 4q28.1 -0.13 0.322 0.803 proteolysis;zymogen activation
mut ERAP2 5q15 -0.13 0.322 0.803 antigen processing and presentation of
endogenous peptide antigen via MHC class I;antigen processing and presentation of
exp C6orf15 6p21.3 -0.13 0.322 0.803 extracellular matrix organization
xai COL6A1 21q22.3 -0.131 0.322 0.803 cell adhesion;axon guidance
xai TMEM56-RWDD3 -0.131 0.322 0.803
exp TMEM56-RWDD3 -0.131 0.322 0.803
swa GOLM1 9q21.33 -0.131 0.322 0.803
hs4 LOC101928162 -0.131 0.322 0.803
xai MOAP1 14q32 -0.131 0.322 0.803 Apoptosis
xai PCDHGA1 5q31 -0.131 0.322 0.803 cell adhesion;homophilic cell
adhesion
DNA-dependent"
xai PNCK Xq28 -0.131 0.322 0.803
his IL36B 2q14 -0.131 0.322 0.803
his CTSL3P 9q21.33 -0.131 0.322 0.803
his LOC101927164 -0.131 0.322 0.803
xai C20orf173 20q11.22 -0.131 0.322 0.803
hs4 SCYL1 11q13 -0.131 0.322 0.803 regulation of transcription, DNA-
hs4 ADAM32 8p11.22 -0.131 0.322 0.803 proteolysis
hs4 RGPD5 -0.131 0.322 0.803
xai IQCF3 3p21.2 -0.131 0.322 0.803
his LINC02126 -0.131 0.322 0.803
his HELZ2 20q13.33 -0.131 0.322 0.803
his LINC00431 -0.131 0.322 0.803
his PXDN 2p25 -0.131 0.322 0.803 hydrogen peroxide catabolic
his PTPRF 1p34 -0.131 0.322 0.803 cell adhesion;positive regulation of
neuron apoptosis
hs4 LCA5 6q14.1 -0.131 0.322 0.803 protein transport
exp LOC100996506 -0.131 0.322 0.803
xai GCGR 17q25 -0.131 0.322 0.803 regulation of blood pressure;hormone-
exp PRKACG 9q13 -0.131 0.322 0.803 Protein Kinases
hs4 CHRDL1 Xq23 -0.131 0.322 0.803 nervous system development;cell
differentiation
his C10orf10 10q11.21 -0.131 0.322 0.803
hs4 PEX11G 19p13.2 -0.131 0.322 0.803
his MIR4640 -0.131 0.322 0.803
exp IQCF3 3p21.2 -0.131 0.322 0.803
hs4 ALCAM 3q13.1 -0.131 0.322 0.803 cell adhesion;signal transduction
exp DYTN 2q33.3 -0.131 0.322 0.803
hs4 HEXA 15q24.1 -0.131 0.322 0.803 glycosphingolipid metabolic
process;sexual reproduction
hs4 HEXA-AS1 15q23 -0.131 0.322 0.803
his ATP10D 4p12 -0.131 0.322 0.803 cation transport;ion transmembrane
transport
xai OR7D2 19p13.2 -0.131 0.322 0.803 regulation of transcription, DNA-
dependent;response to stimulus"
hs4 HHAT 1q32 -0.131 0.322 0.803 multicellular organismal development
hs4 APOL2 22q12 -0.131 0.322 0.803 lipid metabolic process;transport
xai CBL 11q23.3 0.131 0.323 0.803 Oncogenes
hs4 ILF3-AS1 19p13.2 0.131 0.323 0.803
hs4 ILF3 19p13.2 0.131 0.323 0.803 M phase;negative regulation of
his PIGZ 3q29 0.131 0.323 0.803 GPI anchor biosynthetic process
his MIR129-2 0.131 0.323 0.803
xai SNORD116-23 0.131 0.323 0.803
exp LINC00484 0.131 0.323 0.803
xai ATP5H 17q25 0.131 0.323 0.803 ATP catabolic process;ion transport
exp PRKXP1 15q26.3 0.131 0.323 0.803
xai OR14C36 1q44 0.131 0.323 0.803 response to stimulus
exp PYDC1 16p11.2 0.131 0.323 0.803 positive regulation of interleukin-1 beta
exp HMGN2P13 3q25.2 0.131 0.323 0.803
hs4 LOC101448202 0.131 0.323 0.803
hs4 PANK4 1p36.32 0.131 0.323 0.803 coenzyme A biosynthetic process
his MED14OS 0.131 0.323 0.803
his MED14 Xp11.4 0.131 0.323 0.803 positive regulation of transcription from
promoter
exp SNORD116-23 0.131 0.323 0.803
xai CYB5D1 17p13.1 0.131 0.323 0.803
his MBIP 14q13.3 0.131 0.323 0.803 inactivation of MAPK activity involved in
osmosensory signaling pathway;histone H3 acetylation
his COLEC11 2p25.3 0.131 0.323 0.803 multicellular organismal
xai DCAF13P3 0.131 0.323 0.803
xai EOMES 3p24.1 0.131 0.323 0.803 mesoderm formation;positive regulation of
dependent"
xai CHCHD3P1 10p14 0.131 0.323 0.803
his KMT2B 19q13.1 0.131 0.323 0.803
his FAM102B 1p13.3 0.131 0.323 0.803
xai LINC01056 0.131 0.323 0.803
xai HMGN2P13 3q25.2 0.131 0.323 0.803
his FABP5 8q21.13 0.131 0.323 0.803 lipid metabolic
hs4 SDF4 1p36.33 0.131 0.323 0.803 response to ethanol;zymogen granule
exocytosis
hs4 B3GALT6 1p36.33 0.131 0.323 0.803 protein
xai SPRY1 4q28.1 0.131 0.323 0.803 metanephros development;negative
his C9orf24 9p13.3 0.131 0.323 0.803 cellular protein complex assembly
xai MIR4500HG 0.131 0.323 0.803
hs4 SCARF1 17p13.3 0.131 0.323 0.803 neuron remodeling;dendrite
development
hs4 ORC5 7q22.1 0.131 0.323 0.803 DDR (DNA replication)
hs4 OTUD7A 15q13.3 0.131 0.323 0.803 proteolysis
hs4 MAFG 17q25.3 0.131 0.323 0.803 regulation of transcription, DNA-
hs4 MAFG-AS1 17q25.3 0.131 0.323 0.803
cop PLEKHM1P 17q24.1 0.131 0.323 0.803
cop LRRC37A3 17q24.1 0.131 0.323 0.803
hs4 PRUNE1 0.131 0.323 0.803
hs4 FAM63A 1q21.3 0.131 0.323 0.803
his SLFN11 17q12 0.131 0.323 0.803 DNA Damage Response (DDR)
dependent"
his AMH 19p13.3 0.131 0.323 0.803 sex determination;sex differentiation
his MIR4321 0.131 0.323 0.803
hs4 ALDH4A1 1p36 0.131 0.323 0.803 proline metabolic process;proline
his CEP55 10q23.33 0.131 0.323 0.803 cell cycle;mitosis
exp OGFOD3 17q25.3 0.13 0.323 0.803
xsq SOCS2-AS1 0.13 0.323 0.803
exp C19orf81 19q13.33 0.13 0.323 0.803
cop YPEL5 2p23.1 0.13 0.323 0.803 oxidation-reduction process
xsq REV1 2q11.1-q11.2 0.13 0.323 0.803 DNA Damage Response (DDR); DDR (DNA
mut BICC1 10q21.1 0.13 0.323 0.803 multicellular organismal
xsq AKAP8L 19p13.12 0.13 0.323 0.803
xsq CDK5 7q36 0.13 0.323 0.803 Apoptosis; Protein Kinases
met ZFP69B 1p34.2 0.13 0.323 0.803
cop KRT38 17q21.2 0.13 0.323 0.803
exp SOCS2-AS1 0.13 0.323 0.803
met MIR516B1 0.13 0.323 0.803
met ACSF2 17q21.33 0.13 0.323 0.803 lipid metabolic process;fatty acid
metabolic process
exp ADPRM 17p13.1 0.13 0.323 0.803
xsq LOC101559451 0.13 0.323 0.803
met SET 9q34 0.13 0.323 0.803 nucleosome disassembly;nucleocytoplasmic
transport
xsq PIK3IP1 22q12.2 0.13 0.323 0.803 negative regulation of kinase
activity
exp ELOVL5 6p21.1-p12.1 0.13 0.323 0.803 EMT (Mesenchymal)
exp C14orf166 14q22.1 0.13 0.323 0.803 positive regulation of
xsq VRTN 14q24.3 0.13 0.323 0.803 transposition, DNA-mediated"
exp UBAC2 13q32.3 0.13 0.323 0.803
xsq CHP2 16p12.2 0.13 0.323 0.803
cop MPP3 17q21.31 0.13 0.323 0.803 signal transduction
xsq RBBP7 Xp22.2 0.13 0.323 0.803 nucleosome assembly;regulation of
met MXD4 4p16.3 0.13 0.323 0.803 negative regulation of transcription from
xsq NIPSNAP3B 9q31.1 0.13 0.323 0.803
met VBP1 Xq28 0.13 0.323 0.803 cellular protein metabolic process;'de novo'
mut AHNAK 11q12.2 0.13 0.323 0.803 nervous system development
met ARPC2 2q36.1 0.13 0.323 0.803 cellular component movement;positive
mut HERC2 15q13 0.13 0.323 0.803 protein ubiquitination involved in ubiquitin-
mut CTCF 16q21-q22.3 0.13 0.323 0.803 chromosome segregation;regulation of
xsq DNAH12 3p14.3 0.13 0.323 0.803 microtubule-based movement
exp KLC1 14q32.3 0.13 0.323 0.803 microtubule-based movement;blood
coagulation
xsq TAAR5 0.13 0.323 0.803
xsq MUC22 0.13 0.323 0.803
xsq DVL1 1p36 0.13 0.323 0.803 neurotransmitter secretion;positive regulation
xsq PRDX4 Xp22.11 0.13 0.323 0.803 I-kappaB phosphorylation
exp CPT1C 19q13.33 0.13 0.323 0.803 lipid metabolic process;fatty acid
metabolic process
exp LOC126170 0.13 0.323 0.803
cop TBC1D3P5 17q11.1 0.13 0.323 0.803
cop KSR1 17q11.2 0.13 0.323 0.803 protein phosphorylation;Ras protein
signal transduction
cop LGALS9 17q11.2 0.13 0.323 0.803 signal transduction;positive
cop NOS2 17q11.2 0.13 0.323 0.803 nitric oxide biosynthetic process;defense
response to Gram-negative bacterium
cop LYRM9 17q11.2 0.13 0.323 0.803
cop GADL1 3p24.1-p23 0.13 0.323 0.803 carboxylic acid metabolic process
met ELFN2 22q13.1 0.13 0.323 0.803 negative regulation of phosphatase
activity
xsq TBC1D31 8q24.13 0.13 0.323 0.803
xsq RSRC2 12q24.31 0.13 0.323 0.803
cop KIF9 3p21.31 0.13 0.323 0.803 microtubule-based movement;blood
coagulation
xsq LOC389247 0.13 0.323 0.803
met PRSS50 3p21.31 0.13 0.323 0.803 proteolysis
xsq DENND1B 1q31.3 0.13 0.323 0.803
met DNA2 10q21.3-q22.1 0.13 0.323 0.803 DNA Damage Response (DDR); DDR
(FA); DDR (DNA replication)
exp PET100 19p13.2 0.13 0.323 0.803
cop SCN4A 17q23.3 0.13 0.323 0.803 ion transport;sodium ion transport
exp OR13C7P 9p13.3 -0.13 0.323 0.803
cop HP07349 -0.13 0.323 0.803
met IGF2BP3 7p11 -0.13 0.323 0.803 regulation of cytokine biosynthetic
process;translation
exp DLX6-AS1 7q21.3 -0.13 0.323 0.803
cop TRHR 8q23 -0.13 0.323 0.803 G-protein coupled receptor signaling pathway
xsq LOC100506457 -0.13 0.323 0.803
exp PCDH18 4q31 -0.13 0.323 0.803 homophilic cell adhesion;brain
development
exp HSF4 16q21 -0.13 0.323 0.803 positive regulation of cell
xsq LINC00364 -0.13 0.323 0.803
xsq KRTAP13-3 -0.13 0.323 0.803
mut RER1 1p36 -0.13 0.323 0.803 retrograde vesicle-mediated transport, Golgi to
ER"
mut SPATA21 1p36.13 -0.13 0.323 0.803
mut ZKSCAN7 3p21.32 -0.13 0.323 0.803
mut OTUD4 4q31.21 -0.13 0.323 0.803
mut SH3RF1 4q32.3 -0.13 0.323 0.803 induction of apoptosis;negative
mut PRKAA1 5p12 -0.13 0.323 0.803 Apoptosis; Protein Kinases
mut PPP3CC 8p21.3 -0.13 0.323 0.803 Apoptosis
mut MRRF 9q33.2 -0.13 0.323 0.803 translation;ribosome disassembly
mut ARRDC1-AS1 -0.13 0.323 0.803
mut PRLHR -0.13 0.323 0.803
mut KRT72 12q13.13 -0.13 0.323 0.803
mut C12orf29 12q21.32 -0.13 0.323 0.803
mut CENPJ 13q12.12 -0.13 0.323 0.803 G2/M transition of mitotic cell
mut RHCG 15q25 -0.13 0.323 0.803 transmembrane transport;transepithelial
ammonium transport
mut EPG5 18q12.3 -0.13 0.323 0.803 autophagy
mut DCAF15 19p13.12 -0.13 0.323 0.803
mut NOL12 22q13.1 -0.13 0.323 0.803
mut RGAG1 Xq23 -0.13 0.323 0.803
mut DRD4 11p15.5 -0.13 0.323 0.803 dopamine receptor signaling
mut PPP1R3D 20q13.3 -0.13 0.323 0.803 regulation of glycogen catabolic
xsq RECK 9p13.3 -0.13 0.323 0.803 EMT (Mesenchymal)
mut EPS8L2 11p15.5 -0.13 0.323 0.803
cop ALDH1L1 3q21.3 -0.13 0.323 0.803 biosynthetic process;10-
xsq LOC101929095 -0.13 0.323 0.803
mut ZW10 11q23.2 -0.13 0.323 0.803 DNA Damage Response (DDR)
xsq LOC100506700 -0.13 0.323 0.803
dependent"
exp CIART -0.13 0.323 0.803
exp VPS54 2p13-p14 -0.13 0.323 0.803 homeostasis of number of cells within a
exp TMCC3 12q22 -0.13 0.323 0.803
met NCKAP1L 12q13.1 -0.13 0.323 0.803 myeloid cell homeostasis;negative
regulation of interleukin-6 production
cop CAPZA1 1p13.2 -0.13 0.323 0.803 cellular component movement;blood
coagulation
cop MOV10 1p13.2 -0.13 0.323 0.803 regulation of transcription, DNA-
cop RHOC 1p13.1 -0.13 0.323 0.803 regulation of small GTPase mediated
cop PPM1J 1p13.2 -0.13 0.323 0.803 protein dephosphorylation
cop FAM19A3 1p13.2 -0.13 0.323 0.803
xsq SPRY2 13q31.1 -0.13 0.323 0.803 sensory perception of sound;negative
regulation of epidermal growth factor receptor signaling pathway
exp FIBIN 11p14.2 -0.13 0.323 0.803
his MIR3928 -0.131 0.323 0.803
his RNF185 22q12.2 -0.131 0.323 0.803 autophagy
xai ARL3 10q23.3 -0.131 0.323 0.803 photoreceptor cell
development;cilium morphogenesis
exp UBQLNL 11p15.4 -0.131 0.323 0.803
exp IL5RA 3p26-p24 -0.131 0.323 0.803 signal transduction;cell
proliferation
xai KRT8P14 Xp11.3 -0.131 0.323 0.803
hs4 URGCP 7p13 -0.131 0.323 0.803 cell cycle
hs4 UBE2D4 7p13 -0.131 0.323 0.803 protein K29-linked
his MTM1 Xq28 -0.131 0.323 0.803 protein dephosphorylation;endosome to
lysosome transport
cop FLJ30403 -0.131 0.323 0.803
DNA-dependent"
xai ARMCX1 Xq21.33-q22.2 -0.131 0.323 0.803
xai TP63 3q28 -0.131 0.323 0.803 Apoptosis; Oncogenes
his STAT2 12q13.3 -0.131 0.323 0.803 Apoptosis
his APOF -0.131 0.323 0.803
hs4 LINC01205 -0.131 0.323 0.803
hs4 SESN2 1p35.3 -0.131 0.323 0.803 cell cycle arrest
his B3GALT5-AS1 -0.131 0.323 0.803
hs4 ZCCHC24 10q22.3 -0.131 0.323 0.803
xai TPM2 9p13 -0.131 0.323 0.803 muscle contraction;muscle filament
sliding
his EBF3 10q26.3 -0.131 0.323 0.803 regulation of transcription, DNA-
cop GHRH 20q11.2 -0.131 0.323 0.803
his DYNLT1 6q25.2-q25.3 -0.131 0.323 0.803 regulation of Rac GTPase
activity;establishment of mitotic spindle orientation
his SYTL3 6q25.3 -0.131 0.323 0.803 intracellular protein transport
xai SPIRE2 16q24 -0.131 0.323 0.803 transport
swa SSB 2q31.1 -0.131 0.323 0.803 RNA processing;tRNA modification
his ANKRD29 18q11.2 -0.131 0.323 0.803
his C10orf90 10q26.2 -0.131 0.323 0.803 negative regulation of cell
growth;protein stabilization
his NIPAL2 8q22.2 -0.131 0.323 0.803
hs4 VGLL2 6q22.1 -0.131 0.323 0.803 regulation of transcription, DNA-
hs4 SIAE 11q24 -0.131 0.323 0.803
hs4 SPA17 11q24.2 -0.131 0.323 0.803 spermatogenesis;single
fertilization
xai SERINC4 15q15.3 -0.131 0.323 0.803 lipid metabolic
his LINC00508 -0.131 0.323 0.803
DNA-dependent"
his FAAP100 0.131 0.324 0.803 DNA Damage Response (DDR); DDR (FA)
his NUFIP1 13q14 0.131 0.324 0.803 box C/D snoRNP assembly;RNA processing
his GPALPP1 0.131 0.324 0.803
his EPHX2 8p21 0.131 0.324 0.803 inflammatory response;regulation of blood
pressure
his KATNBL1P6 0.131 0.324 0.803
xai HMGB3P4 0.131 0.324 0.803
xai PPT1 1p32 0.131 0.324 0.803 receptor-mediated endocytosis;grooming behavior
swa PRDX4 Xp22.11 0.131 0.324 0.803 I-kappaB phosphorylation
his NOTCH1 9q34.3 0.131 0.324 0.803 Tumor Suppressors
his MIR4674 0.131 0.324 0.803
his NALT1 0.131 0.324 0.803
his LPAR3 1p22.3 0.131 0.324 0.803 synaptic transmission;bleb assembly
exp CFAP52 0.131 0.324 0.803
xai EEF1D 8q24.3 0.131 0.324 0.803 cellular protein metabolic
process;translation
his TMEM147 19q13.1 0.131 0.324 0.803
his TMEM147-AS1 0.131 0.324 0.803
his FOXH1 8q24.3 0.131 0.324 0.803 Apoptosis
his PPP1R16A 8q24.3 0.131 0.324 0.803
exp LOC100132057 0.131 0.324 0.803
hs4 TEX10 9q31.1 0.131 0.324 0.803
xai C11orf84 11q13.1 0.131 0.324 0.803
xai MROH9 1q24.3 0.131 0.324 0.803
xai PLA2G6 22q13.1 0.131 0.324 0.803 metabolic process;cell death
hs4 C1orf35 1q42.13 0.131 0.324 0.803
exp OR51B3P 0.131 0.324 0.803
hs4 C12orf42 12q23.2 0.131 0.324 0.803
hs4 LOC105369945 0.131 0.324 0.803
hs4 HIST1H4D 6p22.1 0.131 0.324 0.803
hs4 POLR2C 16q13-q21 0.131 0.324 0.803 DNA Damage Response (DDR); DDR
(NER)
exp OR5F2P 11q12.1 0.131 0.324 0.803
exp IGHV7-56 0.131 0.324 0.803
his YAF2 12q12 0.131 0.324 0.803 negative regulation of transcription, DNA-
his LSS 21q22.3 0.131 0.324 0.803 steroid biosynthetic process;cholesterol
his MCM3AP-AS1 21q22.3 0.131 0.324 0.803
exp LINC00852 3p25.3 0.131 0.324 0.803
hs4 NPTXR 22q13.1 0.131 0.324 0.803 response to hydrogen peroxide
exp SLC13A4 7q33 0.131 0.324 0.803 ion transport;sodium ion transport
xai PWAR5 15q11.2 0.131 0.324 0.803
exp HMGB3P4 0.131 0.324 0.803
hs4 MRPL50 9q31.1 0.131 0.324 0.803
hs4 ZNF189 9q22-q31 0.131 0.324 0.803 negative regulation of
hs4 GPR89A 1q21.1 0.131 0.324 0.803 signal transduction;protein
transport
cop USPL1 13q12-q14 0.13 0.324 0.803 ubiquitin-dependent protein catabolic
process
cop ALOX5AP 13q12 0.13 0.324 0.803 leukotriene production involved in
cop LINC00398 0.13 0.324 0.803
cop TEX26-AS1 0.13 0.324 0.803
cop MEDAG 13q12.3 0.13 0.324 0.803
xsq BRF2 8p11.23 0.13 0.324 0.803 transcription from RNA polymerase III
met ZFYVE26 14q24.1 0.13 0.324 0.803 double-strand break repair via
homologous recombination;cytokinesis
xsq CCDC18 1p22.1 0.13 0.324 0.803
xsq ERI2 16p12.3 0.13 0.324 0.803
mut SNX7 1p21.3 0.13 0.324 0.803 cell communication;protein transport
met HIGD1A 3p22.1 0.13 0.324 0.803 response to stress
mut BAZ1B 7q11.23 0.13 0.324 0.803 DNA Damage Response (DDR)
exp LOC389906 Xp22.33 0.13 0.324 0.803
met RCD1 0.13 0.324 0.803
xsq SLC9A7P1 12q23.1 0.13 0.324 0.803
met IL12A 3q25.33 0.13 0.324 0.803 cell cycle arrest;positive regulation of
smooth muscle cell apoptosis
xsq SCRT1 8q24.3 0.13 0.324 0.803 regulation of transcription, DNA-
dependent"
exp PYCARD 16p11.2 0.13 0.324 0.803 nucleotide-binding domain, leucine
xsq DGKH 13q14.11 0.13 0.324 0.803 activation of protein kinase C activity
cop EDC3 15q24.1 0.13 0.324 0.803 RNA metabolic process;mRNA metabolic
process
cop RMND5A 2p11.2 0.13 0.324 0.803
cop CD8A 2p12 0.13 0.324 0.803 regulation of immune response;T cell mediated
immunity
cop CD8B 2p12 0.13 0.324 0.803 regulation of immune response;immune response
cop FBLN7 2q13 0.129 0.324 0.803 cell adhesion
xsq MEFV 16p13.3 0.129 0.324 0.803 inflammatory response;nucleotide-binding
met IFNL1 19q13.13 0.129 0.324 0.803
xsq ULK4P2 0.129 0.324 0.803
xsq RP9 7p14.3 0.129 0.324 0.803 RNA splicing
xsq PNPLA7 9q34.3 0.129 0.324 0.803 lipid metabolic process;metabolic
process
met NHS Xp22.13 0.129 0.324 0.803 lens development in camera-type eye;cell
differentiation
mut CCBE1 18q21.32 0.129 0.324 0.803 multicellular organismal
cop LINC00707 0.129 0.324 0.803
xsq RELN 7q22 0.129 0.324 0.803 brain development;reelin-mediated signaling
pathway
cop ETV4 17q21 0.129 0.324 0.803 Transcription Factors
xsq TMEM126A 11q14.1 0.129 0.324 0.803 optic nerve development
xsq PHKB 16q12-q13 0.129 0.324 0.803 generation of precursor metabolites and
cop CEBPE 14q11.2 0.129 0.324 0.803 cellular response to
cop HOMEZ 14q11.2 0.129 0.324 0.803
cop PPP1R3E 14q11.2 0.129 0.324 0.803 regulation of glycogen catabolic
cop BCL2L2 14q11.2-q12 0.129 0.324 0.803 Apoptosis
cop BCL2L2-PABPN1 0.129 0.324 0.803
cop PABPN1 14q11.2 0.129 0.324 0.803 muscle contraction;modification by
virus of host mRNA processing
met MVB12B 9q33.3 0.129 0.324 0.803
exp SLC13A1 7q31.32 0.129 0.324 0.803 ion transmembrane
dependent"
xsq B4GALNT2 17q21.32 0.129 0.324 0.803 negative regulation of cell-cell
adhesion;lipid glycosylation
met AIF1L 9q34.13-q34.3 0.129 0.324 0.803
cop FDXR 17q25.1 0.129 0.324 0.803 generation of precursor metabolites and
energy;steroid biosynthetic process
met PI4KA 22q11.21 0.129 0.324 0.803 phosphatidylinositol-mediated
xsq LYPLAL1 1q41 0.129 0.324 0.803
met OXA1L 14q11.2 -0.129 0.324 0.803 mitochondrial proton-transporting
cop COL24A1 1p22.3 -0.129 0.324 0.803 cell adhesion
met CD7 17q25.2-q25.3 -0.129 0.324 0.803 homeostasis of number of
exp CSF2RA Xp22.32 -0.129 0.324 0.803
xsq MANBAL 20q11.23 -0.129 0.324 0.803
exp LCN2 9q34 -0.129 0.324 0.803 siderophore transport;regulation of
apoptotic process
met ZNF691 1p34.2 -0.129 0.324 0.803
exp SBDSP1 7q11.23 -0.129 0.324 0.803
mut PAX8 2q13 -0.13 0.324 0.803 mesenchymal to epithelial transition involved
in metanephros morphogenesis;pronephric field specification
exp TGFBR2 3p22 -0.13 0.324 0.803 Apoptosis; Cell Signaling; Tumor
Suppressors
exp PIP5K1C 19p13.3 -0.13 0.324 0.803 neutrophil chemotaxis;adherens
junction assembly
met LOXHD1 18q21.1 -0.13 0.324 0.803 sensory perception of sound
met AES 19p13.3 -0.13 0.324 0.803 cellular response to extracellular
met NGRN 15q26.1 -0.13 0.324 0.803 multicellular organismal
exp TUBB4B 9q34 -0.13 0.324 0.803 Apoptosis
xsq CD58 1p13 -0.13 0.324 0.803 Tumor Suppressors
xsq ARFGEF1 8q13 -0.13 0.324 0.803 exocytosis;regulation of ARF protein
signal transduction
exp CHN1 2q31.1 -0.13 0.324 0.803 ephrin receptor signaling
exp MYH10 17p13 -0.13 0.324 0.803 axon guidance;cerebellar Purkinje cell layer
development
met MLLT6 17q21 -0.13 0.324 0.803 regulation of transcription, DNA-dependent"
cop SNX2 5q23 -0.13 0.324 0.803 intracellular protein transport;endocytosis
met CMTM6 3p22.3 -0.13 0.324 0.803 chemotaxis
exp SUN2 22q13.1 -0.13 0.324 0.803 mitotic spindle organization;nuclear
migration
his FGF2 4q26 -0.131 0.324 0.803 branching involved in ureteric bud
hs4 HSD3B7 16p11.2 -0.131 0.324 0.803 bile acid biosynthetic
process;bile acid metabolic process
hs4 LOC101927495 -0.131 0.324 0.803
xai DAPK1-IT1 -0.131 0.324 0.803
xai KRT8P43 6p22.3 -0.131 0.324 0.803
xai MTURN -0.131 0.324 0.803
xai SUN2 22q13.1 -0.131 0.324 0.803 mitotic spindle
organization;nuclear migration
his PHLDA1 12q15 -0.131 0.324 0.803 Apoptosis
xai HSD17B3 9q22 -0.131 0.324 0.803 insecticide metabolic
hs4 OR10V1 11q12.1 -0.131 0.324 0.803
hs4 ERGIC3 20pter-q12 -0.131 0.324 0.803 vesicle-mediated transport
xai ERV3-1 7q11.2 -0.131 0.324 0.803
hs4 C8orf48 8p22 -0.131 0.324 0.803
xai GRHL2 8q22.3 -0.131 0.324 0.803 EMT (Epithelial)
xai IP6K3 6p21.31 -0.131 0.324 0.803 DNA Damage Response (DDR)
xai KCNG3 2p21 -0.131 0.324 0.803 transmembrane transport;ion transport
his SUGT1P1 9p13.3 -0.131 0.324 0.803
xai DAZAP2 12q12 -0.131 0.324 0.803
his ABCA4 1p22 -0.131 0.324 0.803 ABC Transporters
xai MROH1 8q24.3 -0.131 0.324 0.803
hs4 IL26 12q15 -0.131 0.324 0.803 positive regulation of stress-activated
MAPK cascade;positive regulation of transcription from RNA polymerase II promoter
hs4 PSD2 5q31.2 -0.131 0.324 0.803 regulation of ARF protein signal
transduction
xai TCEAL8 Xq22.1 -0.131 0.324 0.803 regulation of transcription,
DNA-dependent"
xai RPN1 3q21.3 -0.131 0.324 0.803 translation;protein modification
process
hs4 SEMA4B 15q25 -0.131 0.324 0.803 multicellular organismal
his LVCAT1 -0.131 0.324 0.803
swa HIST2H2AB 0.131 0.325 0.803 nucleosome assembly
his YWHAG 7q11.23 0.13 0.325 0.803 regulation of neuron
differentiation;regulation of synaptic plasticity
his RNF6 13q12.2 0.13 0.325 0.803 protein K48-linked
ubiquitination;regulation of transcription, DNA-dependent
his IP6K1 3p21.31 0.13 0.325 0.803 phosphatidylinositol phosphorylation
exp RPL41P2 0.13 0.325 0.803
xai LCMT2 15q15.3 0.13 0.325 0.803 tRNA processing
exp MAGI1-AS1 0.13 0.325 0.803
xai CAPN12 19q13.2 0.13 0.325 0.803 proteolysis
his MIR4432HG 0.13 0.325 0.803
hs4 SLC39A8 4q22-q24 0.13 0.325 0.803 Solute Carriers
his UBXN7-AS1 0.13 0.325 0.803
his UBXN7 3q29 0.13 0.325 0.803
xai IGHV7-56 0.13 0.325 0.803
hs4 PRPH 12q12-q13 0.13 0.325 0.803 intermediate filament cytoskeleton
organization
xai LINC01097 0.13 0.325 0.803
xai RPS2P44 16q12.1 0.13 0.325 0.803
xai ATF2 2q32 0.13 0.325 0.803 DNA Damage Response (DDR)
xai RPL41P2 0.13 0.325 0.803
xai INSL5 1p31.3 0.13 0.325 0.803
hs4 PMAIP1 18q21.32 0.13 0.325 0.803 Apoptosis
xai GOT1 10q24.1-q25.1 0.13 0.325 0.803 carbohydrate metabolic
hs4 CBFB 16q22.1 0.13 0.325 0.803 regulation of transcription, DNA-
hs4 SBF2-AS1 11p15.4 0.13 0.325 0.803
hs4 LOC440028 0.13 0.325 0.803
hs4 LPAR3 1p22.3 0.13 0.325 0.803 synaptic transmission;bleb assembly
cop NICN1 3p21.31 0.13 0.325 0.803
xai CABP1 12q24.31 0.13 0.325 0.803 negative regulation of catalytic activity
hs4 COG2 1q42.2 0.13 0.325 0.803 protein glycosylation;intracellular
protein transport
his RNF149 2q11.2 0.13 0.325 0.803
his MIR5696 0.13 0.325 0.803
xai GDPD4 11q13.5 0.13 0.325 0.803 glycerol metabolic process;lipid
metabolic process
his HLA-A 0.13 0.325 0.803 cytokine-mediated signaling pathway;antigen
hs4 RNU4-2 0.13 0.325 0.803
hs4 RNU4-1 12q24.31 0.13 0.325 0.803
xai LOC221946 0.13 0.325 0.803
xai TMX4 20p12 0.13 0.325 0.803 electron transport chain;cell redox homeostasis
swa POLA1 Xp22.1-p21.3 0.13 0.325 0.803 DNA Damage Response (DDR); DDR (DNA
replication)
exp SFTPB 2p12-p11.2 0.13 0.325 0.803 lipid metabolic process;response to
exp BLOC1S4 4p16.1 0.129 0.325 0.803
xsq MIOS 7p21.3 0.129 0.325 0.803
met PRIMA1 14q32.12 0.129 0.325 0.803 neurotransmitter catabolic
xsq ICAM5 19p13.2 0.129 0.325 0.803 cell-cell adhesion
cop GALNT14 2p23.1 0.129 0.325 0.803 carbohydrate metabolic process;O-
glycan processing
met RPAIN 17p13.2 0.129 0.325 0.803 DNA Damage Response (DDR)
xsq CLDN10 13q31-q34 0.129 0.325 0.803 cell adhesion;calcium-independent
cell-cell adhesion
cop NIPA2 15q11.2 0.129 0.325 0.803 ion transport;magnesium ion transport
mut TRPS1 8q24.12 0.129 0.325 0.803 skeletal system development;regulation of
exp PUM1 1p35.2 0.129 0.325 0.803 regulation of translation;post-Golgi
xsq OTOP3 17q25.1 0.129 0.325 0.803
exp DUSP12 1q21-q22 0.129 0.325 0.803 protein dephosphorylation;JNK
cascade
met YIPF5 5q31.3 0.129 0.325 0.803 protein transport;vesicle-mediated
transport
xsq ERI3 1p32 0.129 0.325 0.803
cop PRR29 0.129 0.325 0.803
cop ICAM2 17q23.3 0.129 0.325 0.803 cell-cell adhesion;regulation of immune
response
cop ERN1 17q24.2 0.129 0.325 0.803 response to unfolded protein;activation
cop SNORD104 17q23.3 0.129 0.325 0.803
cop SNORA76 0.129 0.325 0.803
met MAVS 20p13 0.129 0.325 0.803 positive regulation of interferon-alpha
xsq IPO8 12p11.21 0.129 0.325 0.803 intracellular protein transport;signal
transduction
xsq LOC101448202 0.129 0.325 0.803
cop APEH 3p21.31 0.129 0.325 0.803 proteolysis
mut ESCO1 18q11.2 0.129 0.325 0.803 regulation of DNA replication;cell cycle
xsq PANK2 20p13 0.129 0.325 0.803 coenzyme A biosynthetic process;pantothenate
metabolic process
cop CD5 11q13 0.129 0.325 0.803 induction of apoptosis by extracellular
cop VPS37C 11q12.2 0.129 0.325 0.803 protein transport;viral
reproduction
cop PGA3 0.129 0.325 0.803
xsq UNC93B1 11q13 0.129 0.325 0.803 toll-like receptor 7 signaling
dependent"
met LOC645752 15q24.3 0.129 0.325 0.803
mut KLHL17 1p36.33 0.129 0.325 0.803 brain development;actin
mut MORN1 1p36.33-p36.32 0.129 0.325 0.803
mut DNAJC11 1p36.31 0.129 0.325 0.803 protein folding
mut SRM 1p36-p22 0.129 0.325 0.803 cellular nitrogen compound metabolic
mut C1orf64 1p36.13 0.129 0.325 0.803
mut ARHGEF19 1p36.13 0.129 0.325 0.803 positive regulation of Rho GTPase
activity;regulation of actin cytoskeleton organization
mut SH2D5 1p36.12 0.129 0.325 0.803
mut CATSPER4 1p35.3 0.129 0.325 0.803
mut C1orf216 1p34.3 0.129 0.325 0.803
mut SH3D21 1p34.3 0.129 0.325 0.803
mut POU3F1 1p34.1 0.129 0.325 0.803 myelination in peripheral nervous
system;keratinocyte differentiation
mut HOOK1 1p32.1 0.129 0.325 0.803 protein transport;microtubule
mut SH3GLB1 1p22 0.129 0.325 0.803 Apoptosis
mut PALMD 1p22-p21 0.129 0.325 0.803 regulation of cell shape
mut LRRC39 1p21.2 0.129 0.325 0.803
mut PRMT6 1p13.3 0.129 0.325 0.803 DNA Damage Response (DDR)
mut SORT1 1p13.3 0.129 0.325 0.803 transport;regulation of gene expression
mut PHGDH 1p12 0.129 0.325 0.803 L-serine biosynthetic process;brain development
mut FDPS 1q22 0.129 0.325 0.803 cholesterol biosynthetic process;isoprenoid
mut RRNAD1 1q23.1 0.129 0.325 0.803
mut CD5L 1q21-q23 0.129 0.325 0.803 apoptotic process;cellular defense
response
mut OR10Z1 1q23.1 0.129 0.325 0.803 response to stimulus
mut MPZ 1q23.3 0.129 0.325 0.803 synaptic transmission
mut LRRC52 1q24.1 0.129 0.325 0.803
mut CYB5R1 1q32.1 0.129 0.325 0.803 sterol biosynthetic process
mut OPTC 1q32.1 0.129 0.325 0.803
mut INTS7 1q32.3 0.129 0.325 0.803 snRNA processing;cellular response to
ionizing radiation
mut GJC2 1q42.13 0.129 0.325 0.803 transmembrane transport;cell-cell
signaling
mut NTPCR 1q42.2 0.129 0.325 0.803
mut TBCE 1q42.3 0.129 0.325 0.803 protein folding;'de novo'
mut TRAPPC12 2p25.3 0.129 0.325 0.803 vesicle-mediated transport
mut LAPTM4A 2p24.1 0.129 0.325 0.803 transport
mut KCNK3 2p23 0.129 0.325 0.803 brain development;response to drug
mut TTC31 2p13.1 0.129 0.325 0.803
mut ITPRIPL1 2q11.2 0.129 0.325 0.803
mut GPR17 2q21 0.129 0.325 0.803 G-protein coupled receptor signaling pathway
mut STAT4 2q32.2-q32.3 0.129 0.325 0.803 Apoptosis
mut MOB4 2q33.1 0.129 0.325 0.803 transport
mut VIL1 2q35 0.129 0.325 0.803 response to bacterium;negative regulation of
mut UGT1A6 2q37 0.129 0.325 0.803 small molecule metabolic
mut D2HGDH 2q37.3 0.129 0.325 0.803 response to manganese ion;response
to zinc ion
mut TSEN2 3p25.2 0.129 0.325 0.803 tRNA splicing, via endonucleolytic
mut ANO10 3p22.1 0.129 0.325 0.803 ion transport;cell death
mut LRRC2 3p21.31 0.129 0.325 0.803
mut RHOA 3p21.3 0.129 0.325 0.803 cell cycle;actin cytoskeleton
organization
mut GLT8D1 3p21.1 0.129 0.325 0.803
mut TBC1D23 3q12.2 0.129 0.325 0.803
mut NR1I2 3q12-q13.3 0.129 0.325 0.803 signal transduction;drug export
mut ABTB1 3q21 0.129 0.325 0.803
mut CPNE4 3q22.1 0.129 0.325 0.803
mut RAB6B 3q22.1 0.129 0.325 0.803 retrograde vesicle-mediated transport,
Golgi to ER;small GTPase mediated signal transduction
mut RASA2 3q22-q23 0.129 0.325 0.803 positive regulation of Ras GTPase
mut TFDP2 3q23 0.129 0.325 0.803 Apoptosis
mut TMEM41A 3q27.2 0.129 0.325 0.803
mut HES1 3q28-q29 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (FA)
mut KLF3 4p14 0.129 0.325 0.803 regulation of transcription, DNA-
mut STAP1 4q13.2 0.129 0.325 0.803 intracellular protein transport;cellular
membrane fusion
mut C4orf17 4q23 0.129 0.325 0.803
mut HADH 4q22-q26 0.129 0.325 0.803 fatty acid beta-oxidation;response to
hormone stimulus
mut TRIM2 4q31.3 0.129 0.325 0.803 protein ubiquitination;neuroprotection
mut WDR17 4q34 0.129 0.325 0.803
mut TRIM36 5q22.3 0.129 0.325 0.803 acrosome reaction
mut ABLIM3 5q32 0.129 0.325 0.803 cytoskeleton organization;axon guidance
mut ARSI 5q32 0.129 0.325 0.803
mut TLX3 5q35.1 0.129 0.325 0.803 respiratory gaseous exchange;negative
mut HNRNPAB 5q35.3 0.129 0.325 0.803 epithelial to mesenchymal
mut FKBP5 6p21.31 0.129 0.325 0.803 peptidyl-proline modification;protein
mut CDKN1A 6p21.2 0.129 0.325 0.803 Apoptosis; DNA Damage Response
(DDR); DDR (DNA replication)
mut VEGFA 6p12 0.129 0.325 0.803 patterning of blood vessels;positive regulation
of mesenchymal cell proliferation
mut BEND3 6q21 0.129 0.325 0.803
mut VGLL2 6q22.1 0.129 0.325 0.803 regulation of transcription, DNA-
mut SLC35F1 6q22.31 0.129 0.325 0.803 Solute Carriers
mut TXLNB 6q24.1 0.129 0.325 0.803
mut ZDHHC14 6q25.3 0.129 0.325 0.803
mut TSPAN13 7p21.1 0.129 0.325 0.803
mut SP4 7p15.3 0.129 0.325 0.803 regulation of transcription from RNA
polymerase II promoter;regulation of heart contraction
mut HOXA4 7p15.2 0.129 0.325 0.803 anatomical structure
mut ABCB4 7q21.1 0.129 0.325 0.803 ABC Transporters
mut SGCE 7q21.3 0.129 0.325 0.803 cell-matrix adhesion;muscle organ
development
mut ZKSCAN5 7q22 0.129 0.325 0.803 regulation of transcription, DNA-
mut ACTL6B 7q22 0.129 0.325 0.803 chromatin organization;chromatin
remodeling
mut FIS1 7q22.1 0.129 0.325 0.803 Apoptosis
mut DNAJC2 7q22 0.129 0.325 0.803 positive regulation of transcription,
DNA-dependent;'de novo' cotranslational protein folding
mut TNPO3 7q32.1 0.129 0.325 0.803 protein transport;splicing factor protein
import into nucleus
mut CPA1 7q32 0.129 0.325 0.803 proteolysis
mut TMUB1 7q36.1 0.129 0.325 0.803
mut BNIP3L 8p21 0.129 0.325 0.803 Apoptosis
mut STAR 8p11.2 0.129 0.325 0.803 lipid transport;steroid metabolic process
mut TM2D2 8p11.22 0.129 0.325 0.803
mut RPL7 8q21.11 0.129 0.325 0.803 nuclear-transcribed mRNA catabolic
mut CA2 8q22 0.129 0.325 0.803 response to organic substance;secretion
mut ANKRD46 8q22.2 0.129 0.325 0.803
mut DCSTAMP 8q23 0.129 0.325 0.803 osteoclast differentiation
mut SNTB1 8q23-q24 0.129 0.325 0.803 muscle contraction
mut LY6K 8q24.3 0.129 0.325 0.803
mut EEF1D 8q24.3 0.129 0.325 0.803 cellular protein metabolic
process;translation
mut CYHR1 8q24.3 0.129 0.325 0.803
mut DMRT1 9p24.3 0.129 0.325 0.803 regulation of transcription, DNA-
mut KDM4C 9p24.1 0.129 0.325 0.803 chromatin modification;histone H3-K9
demethylation
mut UBAP2 9p13.3 0.129 0.325 0.803
mut SPTLC1 9q22.2 0.129 0.325 0.803 sphinganine biosynthetic
mut IPPK 9q22.31 0.129 0.325 0.803 inositol phosphorylation
mut WDR31 9q32 0.129 0.325 0.803
mut CFAP157 0.129 0.325 0.803
mut TOR2A 9q34.11 0.129 0.325 0.803 chaperone mediated protein folding
requiring cofactor
mut TOR1B 9q34 0.129 0.325 0.803 chaperone mediated protein folding requiring
cofactor;response to unfolded protein
mut TAF5 10q24-q25.2 0.129 0.325 0.803 viral reproduction;chromatin modification
mut AFAP1L2 10q25.3 0.129 0.325 0.803 regulation of mitotic cell
mut SHTN1 0.129 0.325 0.803 multicellular organismal development;axon
guidance
mut CUZD1 10q26.13 0.129 0.325 0.803 hormone-mediated signaling
mut PTPRE 10q26 0.129 0.325 0.803 protein phosphorylation;protein
dephosphorylation
dependent"
mut PHLDA2 11p15.4 0.129 0.325 0.803 apoptotic process;organ
morphogenesis
mut OR51I2 0.129 0.325 0.803
mut OR2AG1 11p15.4 0.129 0.325 0.803 response to stimulus
mut TUB 11p15.5 0.129 0.325 0.803 positive regulation of
phagocytosis;response to stimulus
mut SERGEF 11p14.3 0.129 0.325 0.803 signal transduction;negative
mut SAAL1 11p15.1 0.129 0.325 0.803 acute-phase response
mut PTPN5 11p15.1 0.129 0.325 0.803 peptidyl-tyrosine
mut FBXO3 11p13 0.129 0.325 0.803 proteolysis;protein ubiquitination
mut RAPSN 11p11.2 0.129 0.325 0.803 synaptic transmission;synaptic
mut ZDHHC5 11q12.1 0.129 0.325 0.803
mut CD5 11q13 0.129 0.325 0.803 induction of apoptosis by extracellular
mut KCNK7 11q13 0.129 0.325 0.803 ion transport;potassium ion transport
mut LRFN4 11q13.2 0.129 0.325 0.803
mut FGF3 11q13 0.129 0.325 0.803 multicellular organismal development;thymus
development
mut GDPD5 11q13.4-q13.5 0.129 0.325 0.803 glycerol metabolic process;lipid
metabolic process
mut NOX4 11q14.2-q21 0.129 0.325 0.803 superoxide anion generation;homocysteine
metabolic process
mut CD9 12p13.3 0.129 0.325 0.803 response to water deprivation;platelet
degranulation
mut DDX47 12p13.1 0.129 0.325 0.803 mRNA processing;apoptotic process
mut RERG 12p12.3 0.129 0.325 0.803 GTP catabolic process;signal transduction
mut MGST1 12p12.3-p12.1 0.129 0.325 0.803 response to organic
mut PRICKLE1 12q12 0.129 0.325 0.803 negative regulation of transcription,
mut SMARCD1 12q13-q14 0.129 0.325 0.803 DNA Damage Response (DDR); DDR
(Chromatin)
mut LACRT 12q13 0.129 0.325 0.803 positive regulation of cell
mut CDK2 12q13 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (DNA
mut AVIL 12q14.1 0.129 0.325 0.803 nervous system development;positive
mut THAP2 12q21.1 0.129 0.325 0.803
mut ALDH1L2 12q23.3 0.129 0.325 0.803 biosynthetic process;10-
mut ASCL4 12q23.3 0.129 0.325 0.803
mut SDSL 12q24.13 0.129 0.325 0.803 cellular amino acid metabolic process
mut VWA8 13q14.11 0.129 0.325 0.803
mut DIAPH3 13q21.2 0.129 0.325 0.803 cellular component
mut BORA 13q22.1 0.129 0.325 0.803 cell cycle;regulation of mitosis
mut RAB20 13q34 0.129 0.325 0.803 small GTPase mediated signal
mut CIDEB 14q12 0.129 0.325 0.803 apoptotic process;induction of apoptosis
mut NFATC4 14q11.2 0.129 0.325 0.803 transcription from RNA polymerase
II promoter;inflammatory response
mut FBXO33 14q21.1 0.129 0.325 0.803
mut POLE2 14q21-q22 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (NER); DDR
(DNA replication)
mut VCPKMT 0.129 0.325 0.803
mut GCH1 14q22.1-q22.2 0.129 0.325 0.803 induction of apoptosis;pteridine-
mut SIX6 14q23.1 0.129 0.325 0.803 multicellular organismal
mut VSX2 14q24.3 0.129 0.325 0.803 multicellular organismal
mut ABCD4 14q24.3 0.129 0.325 0.803 ABC Transporters
mut SYNDIG1L 14q24.3 0.129 0.325 0.803 response to biotic stimulus
mut AREL1 14q24.3 0.129 0.325 0.803
mut IFI27 14q32 0.129 0.325 0.803 activation of cysteine-type endopeptidase
signals
mut WDR25 14q32.2 0.129 0.325 0.803
mut WDR20 14q32.31 0.129 0.325 0.803
mut IQCH 15q23 0.129 0.325 0.803
mut PML 15q22 0.129 0.325 0.803 Apoptosis; Oncogenes
mut RLBP1 15q26 0.129 0.325 0.803 vitamin A metabolic process;visual perception
mut KIF7 15q26.1 0.129 0.325 0.803 microtubule-based movement;negative
mut NGRN 15q26.1 0.129 0.325 0.803 multicellular organismal
mut UNKL 16p13.3 0.129 0.325 0.803
mut TELO2 16p13.3 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (FA)
mut AMDHD2 16p13.3 0.129 0.325 0.803 carbohydrate metabolic process;N-
mut DNASE1 16p13.3 0.129 0.325 0.803 apoptotic process;DNA catabolic
process
mut GLYR1 16p13.3 0.129 0.325 0.803 pentose-phosphate shunt
mut USP7 16p13.3 0.129 0.325 0.803 protein deubiquitination;regulation of
protein stability
mut ABCC6 16p13.1 0.129 0.325 0.803 ABC Transporters
mut MYLPF 16p11.2 0.129 0.325 0.803 immune response;skeletal muscle tissue
development
mut VPS35 16q12 0.129 0.325 0.803 cell death;protein transport
mut ZFP90 16q22.1 0.129 0.325 0.803 negative regulation of DNA
mut FBXO31 16q24.2 0.129 0.325 0.803 response to DNA damage
stimulus;cell cycle
mut SNAI3 16q24.3 0.129 0.325 0.803
mut SPATA2L 16q24.3 0.129 0.325 0.803
dependent"
mut SGSM2 17p13.3 0.129 0.325 0.803
mut METTL16 17p13.3 0.129 0.325 0.803
mut RAD51D 17q11 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (HR)
mut PIP4K2B 17q12 0.129 0.325 0.803 cell surface receptor signaling pathway
mut PNMT 17q 0.129 0.325 0.803 cellular nitrogen compound metabolic
process;catecholamine biosynthetic process
mut KRT23 17q21.2 0.129 0.325 0.803
mut MEOX1 17q21 0.129 0.325 0.803 somite specification;multicellular organismal
development
mut SP6 17q21.32 0.129 0.325 0.803 regulation of transcription, DNA-
mut SP2 17q21.32 0.129 0.325 0.803 regulation of transcription from RNA
mut YPEL2 17q22 0.129 0.325 0.803
mut STRADA 17q23.3 0.129 0.325 0.803 positive regulation of protein
mut DDX42 17q23.3 0.129 0.325 0.803 regulation of anti-apoptosis;protein
localization
mut RNF157 17q25.1 0.129 0.325 0.803
mut UBE2O 17q25.1 0.129 0.325 0.803
mut C1QTNF1 17q25.3 0.129 0.325 0.803 protein homooligomerization
mut LDLRAD4 18p11.21 0.129 0.325 0.803
mut MALT1 18q21 0.129 0.325 0.803 Apoptosis
mut SERPINB8 18q22.1 0.129 0.325 0.803 negative regulation of
mut AZU1 19p13.3 0.129 0.325 0.803 microglial cell activation;positive
mut RNASEH2A 19p13.2 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (DNA
replication)
mut SYCE2 19p13.2 0.129 0.325 0.803 cell division;cell cycle
mut LYL1 19p13.2 0.129 0.325 0.803 regulation of transcription, DNA-
mut TPM4 19p13.1 0.129 0.325 0.803 cellular component movement;muscle
contraction
mut ELL 19p13.1 0.129 0.325 0.803 negative regulation of phosphatase
dependent"
mut HPN 19q13.12 0.129 0.325 0.803 negative regulation of apoptotic
mut TRAPPC6A 19q13.32 0.129 0.325 0.803 vesicle-mediated transport
mut KPTN 19q13.32 0.129 0.325 0.803 cellular component movement;actin
mut RUVBL2 19q13.3 0.129 0.325 0.803 Apoptosis; DNA Damage Response
mut C19orf73 19q13.33 0.129 0.325 0.803
mut PRRG2 19q13.33 0.129 0.325 0.803 EMT (Epithelial)
mut KLK5 19q13.33 0.129 0.325 0.803 proteolysis;epidermis development
mut OSCAR 19q13.42 0.129 0.325 0.803
mut TMC4 19q13.42 0.129 0.325 0.803 EMT (Epithelial)
mut LENG9 19q13.4 0.129 0.325 0.803 RNA metabolic process
mut U2AF2 19q13.42 0.129 0.325 0.803 mRNA export from nucleus;RNA splicing
mut PLCB4 20p12 0.129 0.325 0.803 lipid metabolic process;lipid catabolic process
mut CNBD2 20q11.23 0.129 0.325 0.803
mut MAFB 20q11.2-q13.1 0.129 0.325 0.803 negative regulation of erythrocyte
differentiation;segment specification
mut DNTTIP1 20q13.12 0.129 0.325 0.803 DNA Damage Response (DDR); DDR (DNA
replication)
mut CYP24A1 20q13 0.129 0.325 0.803 steroid metabolic process;response to
vitamin D
mut PHACTR3 20q13.32-q13.33 0.129 0.325 0.803
mut ADRM1 20q13.33 0.129 0.325 0.803 transcription elongation from RNA
mut HUNK 21q22.1 0.129 0.325 0.803 signal transduction;multicellular
mut CHAF1B 21q22.13 0.129 0.325 0.803 DDR (DNA replication)
mut CBS 21q22.3 0.129 0.325 0.803 superoxide metabolic process;cellular
mut ITGB2 21q22.3 0.129 0.325 0.803 Apoptosis
mut HPS4 22cen-q12.3 0.129 0.325 0.803 organelle organization;lysosome
organization
mut RHBDD3 22q12.2 0.129 0.325 0.803
mut MTMR3 22q12.2 0.129 0.325 0.803 phosphatidylinositol
mut SMDT1 22q13.2 0.129 0.325 0.803
mut HDAC10 22q13.31 0.129 0.325 0.803 negative regulation of
dependent
mut PRRG1 Xp21.1 0.129 0.325 0.803
mut AWAT1 Xq13.1 0.129 0.325 0.803 lipid biosynthetic process
mut GJB1 Xq13.1 0.129 0.325 0.803 transport;cell-cell signaling
mut TNFRSF25 1p36.2 0.129 0.325 0.803 Apoptosis
mut SPSB1 1p36.22 0.129 0.325 0.803 intracellular signal transduction
mut MTHFR 1p36.3 0.129 0.325 0.803 water-soluble vitamin metabolic
process;blood circulation
mut EMC1 1p36.13 0.129 0.325 0.803
mut PTPRU 1p35.3 0.129 0.325 0.803 homotypic cell-cell adhesion;protein
dephosphorylation
mut TMEM39B 1p35.1 0.129 0.325 0.803
mut COL9A2 1p33-p32 0.129 0.325 0.803 skeletal system development;axon
guidance
mut CEPT1 1p13.3 0.129 0.325 0.803 lipid metabolic process;phospholipid
mut HAX1 1q21.3 0.129 0.325 0.803
mut UAP1 1q23.3 0.129 0.325 0.803 protein N-linked glycosylation via
mut LHX9 1q31.1 0.129 0.325 0.803 male gonad development;female gonad
development
mut RCOR3 1q32.2 0.129 0.325 0.803 regulation of transcription, DNA-
dependent"
mut TP53BP2 1q41 0.129 0.325 0.803 Apoptosis
mut SH3BP5L 1q44 0.129 0.325 0.803
mut TCF23 2p23.3 0.129 0.325 0.803 multicellular organismal
mut FOSL2 2p23.3 0.129 0.325 0.803 regulation of transcription from RNA
polymerase II promoter;cell death
mut PTPN18 2q21.1 0.129 0.325 0.803 protein dephosphorylation
mut SESTD1 2q31.2 0.129 0.325 0.803 regulat

Pattern Comp All CDB Nci60 Exp TERT Moldata

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pattern Comp All CDB Nci60 Exp TERT Moldata

Uploaded by

Copyright:

Available Formats

Data Type ID Location Correlation P-Value FDR Annotation

exp TERT 5p15.33 1 0 0 DNA Damage Response (DDR)

You might also like